id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
130207047|NCT00224406|468718803|FG000|Overall Study|Re-transplant|0|||
130207048|NCT00224406|468718804|FG001|Overall Study|Re-transplant|2|||
130207049|NCT00224406|468718803|FG000|Overall Study|Death|0|||
130207050|NCT00224406|468718804|FG001|Overall Study|Death|1|||
130207051|NCT00224406|468718803|FG000|Overall Study|Transplant cancelled|0|||
130207052|NCT00224406|468718804|FG001|Overall Study|Transplant cancelled|4|||
130207053|NCT00224406|468718803|FG000|Overall Study|Drug not delivered|2|||
130207054|NCT00224406|468718804|FG001|Overall Study|Drug not delivered|0|||
130207055|NCT00224406|468718803|FG000|Overall Study|Other|4|||
130207056|NCT00224406|468718804|FG001|Overall Study|Other|0|||
130207057|NCT00224406|468718803|FG000|Overall Study|Transplant cancelled|3|||
130207058|NCT00224406|468718804|FG001|Overall Study|Transplant cancelled|0|||
130207059|NCT01556997|468718805|FG000|Overall Study|Adverse Event|10|||
130207060|NCT01556997|468718806|FG001|Overall Study|Adverse Event|12|||
130207061|NCT01556997|468718807|FG002|Overall Study|Adverse Event|12|||
130207062|NCT01556997|468718805|FG000|Overall Study|Lost to Follow-up|6|||
130207063|NCT01556997|468718806|FG001|Overall Study|Lost to Follow-up|6|||
130207064|NCT01556997|468718807|FG002|Overall Study|Lost to Follow-up|4|||
130207065|NCT01556997|468718805|FG000|Overall Study|Physician Decision|1|||
130207066|NCT01556997|468718806|FG001|Overall Study|Physician Decision|1|||
130207067|NCT01556997|468718807|FG002|Overall Study|Physician Decision|1|||
130207068|NCT01556997|468718805|FG000|Overall Study|Withdrawal by Subject|7|||
130207069|NCT01556997|468718806|FG001|Overall Study|Withdrawal by Subject|6|||
130207070|NCT01556997|468718807|FG002|Overall Study|Withdrawal by Subject|8|||
130207071|NCT01556997|468718805|FG000|Overall Study|Other|2|||
130207072|NCT01556997|468718806|FG001|Overall Study|Other|3|||
130207073|NCT01556997|468718807|FG002|Overall Study|Other|7|||
130207074|NCT05459558|468718819|FG000|Overall Study|Adverse Event|1|||
130207075|NCT05459558|468718820|FG001|Overall Study|Adverse Event|0|||
130207076|NCT05459558|468718821|FG002|Overall Study|Adverse Event|0|||
130207077|NCT05459558|468718819|FG000|Overall Study|Scheduling issue|0|||
130207078|NCT05459558|468718820|FG001|Overall Study|Scheduling issue|1|||
130207079|NCT05459558|468718821|FG002|Overall Study|Scheduling issue|3|||
130207080|NCT05459558|468718819|FG000|Overall Study|Withdrawal by Subject|0|||
130207081|NCT05459558|468718820|FG001|Overall Study|Withdrawal by Subject|0|||
130207082|NCT05459558|468718821|FG002|Overall Study|Withdrawal by Subject|2|||
130207083|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
130207084|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
130207085|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
130207086|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
130207087|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
130207088|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
130207089|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
130207090|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
130207091|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
130207092|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
130207093|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
130207094|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
130207095|NCT01777139|468718822|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
130207096|NCT01777139|468718823|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
130207097|NCT01777139|468718822|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
130207098|NCT01777139|468718823|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
130207099|NCT05625477|468718824|FG000|Overall Study|Lost to Follow-up|2|||
130207100|NCT05625477|468718825|FG001|Overall Study|Lost to Follow-up|2|||
130207101|NCT05625477|468718826|FG002|Overall Study|Lost to Follow-up|1|||
130207102|NCT05625477|468718827|FG003|Overall Study|Lost to Follow-up|1|||
130207103|NCT05625477|468718828|FG004|Overall Study|Lost to Follow-up|0|||
130207104|NCT05625477|468718824|FG000|Overall Study|Covid quarantine|1|||
130207105|NCT05625477|468718825|FG001|Overall Study|Covid quarantine|0|||
130207106|NCT05625477|468718826|FG002|Overall Study|Covid quarantine|0|||
130207107|NCT05625477|468718827|FG003|Overall Study|Covid quarantine|0|||
130207108|NCT05625477|468718828|FG004|Overall Study|Covid quarantine|0|||
130207109|NCT01092637|468718829|FG000|Overall Study|Death|47|||
130207110|NCT01092637|468718830|FG001|Overall Study|Death|49|||
130207111|NCT03292458|468718831|FG000|Period 1|Adverse Event|2|||
130207112|NCT03292458|468718832|FG001|Period 1|Adverse Event|0|||
130207113|NCT00593606|468718833|FG000|Overall Study|Adverse Event|13|||
130207114|NCT00593606|468718833|FG000|Overall Study|Withdrawal by Subject|1|||
130540646|NCT00978627|469947114|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
130207115|NCT00593606|468718833|FG000|Overall Study|Protocol Violation|3|||
130540647|NCT00978627|469947115|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
130207116|NCT00593606|468718833|FG000|Overall Study|Lost to Follow-up|2|||
130207117|NCT00593606|468718833|FG000|Overall Study|Run-In Failure|5|||
130207118|NCT00593606|468718833|FG000|Overall Study|Screen Failure|3|||
130207119|NCT02278367|468718834|FG000|Overall Study|Physician Decision|5|||
130207120|NCT02278367|468718835|FG001|Overall Study|Physician Decision|0|||
130207121|NCT02278367|468718834|FG000|Overall Study|Withdrawal by Subject|5|||
130207122|NCT02278367|468718835|FG001|Overall Study|Withdrawal by Subject|0|||
130207123|NCT00308750|468718840|FG000|Overall Study|Adverse Event|9|||
130207124|NCT00308750|468718841|FG001|Overall Study|Adverse Event|9|||
130207125|NCT00308750|468718842|FG002|Overall Study|Adverse Event|13|||
130207126|NCT00308750|468718840|FG000|Overall Study|Withdrawal by Subject|6|||
130207127|NCT00308750|468718841|FG001|Overall Study|Withdrawal by Subject|2|||
130207128|NCT00308750|468718842|FG002|Overall Study|Withdrawal by Subject|3|||
130207129|NCT00308750|468718840|FG000|Overall Study|Physician Decision|3|||
130207130|NCT00308750|468718841|FG001|Overall Study|Physician Decision|4|||
130207131|NCT00308750|468718842|FG002|Overall Study|Physician Decision|3|||
130207132|NCT00308750|468718840|FG000|Overall Study|Sponsor Decision|1|||
130540648|NCT00978627|469947114|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
130540649|NCT00978627|469947115|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
130540650|NCT00978627|469947114|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
130540651|NCT00978627|469947115|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
130540652|NCT00978627|469947114|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
130540653|NCT00978627|469947115|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
130540654|NCT00978627|469947114|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
130540655|NCT00978627|469947115|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
130540656|NCT00978627|469947114|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
130540657|NCT00978627|469947115|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
130540658|NCT00978627|469947114|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
130540659|NCT00978627|469947115|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
130540660|NCT00978627|469947114|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
130540661|NCT00978627|469947115|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
130540662|NCT00978627|469947114|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
130540663|NCT00978627|469947115|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
130540664|NCT02516332|469947116|FG000|Overall Study|Withdrawal by Subject|2|||
130540665|NCT02516332|469947117|FG001|Overall Study|Withdrawal by Subject|1|||
130540666|NCT02516332|469947118|FG002|Overall Study|Withdrawal by Subject|2|||
130540667|NCT03037931|469947119|FG000|Overall Study|Death|354|||
130540668|NCT03037931|469947120|FG001|Overall Study|Death|367|||
130540669|NCT03037931|469947119|FG000|Overall Study|Lost to Follow-up|7|||
130540670|NCT03037931|469947120|FG001|Overall Study|Lost to Follow-up|4|||
130540671|NCT03037931|469947119|FG000|Overall Study|Withdrawal by Subject|48|||
130540672|NCT03037931|469947120|FG001|Overall Study|Withdrawal by Subject|41|||
130540673|NCT00605215|469947121|FG000|Overall Study|Death|0|||
130540674|NCT00605215|469947122|FG001|Overall Study|Death|0|||
130540675|NCT00605215|469947123|FG002|Overall Study|Death|1|||
130540676|NCT00605215|469947121|FG000|Overall Study|Adverse Event|19|||
130540677|NCT00605215|469947122|FG001|Overall Study|Adverse Event|21|||
130540678|NCT00605215|469947123|FG002|Overall Study|Adverse Event|26|||
130540679|NCT00605215|469947121|FG000|Overall Study|Refusal to sign the re-consent form|8|||
130540680|NCT00605215|469947122|FG001|Overall Study|Refusal to sign the re-consent form|3|||
130540681|NCT00605215|469947123|FG002|Overall Study|Refusal to sign the re-consent form|3|||
130540682|NCT00605215|469947121|FG000|Overall Study|Withdrawal by Subject|39|||
130540683|NCT00605215|469947122|FG001|Overall Study|Withdrawal by Subject|37|||
130540684|NCT00605215|469947123|FG002|Overall Study|Withdrawal by Subject|27|||
130540685|NCT00605215|469947121|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
130540686|NCT00605215|469947122|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
130540687|NCT00605215|469947123|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
130540688|NCT00605215|469947121|FG000|Overall Study|Protocol Violation|3|||
130540689|NCT00605215|469947122|FG001|Overall Study|Protocol Violation|4|||
130540690|NCT00605215|469947123|FG002|Overall Study|Protocol Violation|1|||
130540691|NCT00605215|469947121|FG000|Overall Study|Pregnancy|8|||
130540692|NCT00605215|469947122|FG001|Overall Study|Pregnancy|5|||
130540693|NCT00605215|469947123|FG002|Overall Study|Pregnancy|4|||
130540694|NCT00605215|469947121|FG000|Overall Study|Lost to Follow-up|8|||
130540695|NCT00605215|469947122|FG001|Overall Study|Lost to Follow-up|5|||
130540696|NCT00605215|469947123|FG002|Overall Study|Lost to Follow-up|2|||
130540697|NCT00605215|469947121|FG000|Overall Study|Other than specified|0|||
130540698|NCT00605215|469947122|FG001|Overall Study|Other than specified|2|||
130540699|NCT00605215|469947123|FG002|Overall Study|Other than specified|1|||
130540700|NCT02704754|469947127|FG000|Overall Study|Lost to Follow-up|1|||
130540701|NCT02704754|469947128|FG001|Overall Study|Lost to Follow-up|1|||
130540702|NCT02704754|469947127|FG000|Overall Study|Lack of Efficacy|1|||
130540703|NCT02704754|469947128|FG001|Overall Study|Lack of Efficacy|0|||
130540704|NCT02704754|469947127|FG000|Overall Study|Withdrawal by Subject|1|||
130652175|NCT02513732|470349347|FG000|Overall Study|Lost to Follow-up|11|||
130207133|NCT00308750|468718841|FG001|Overall Study|Sponsor Decision|0|||
130207134|NCT00308750|468718842|FG002|Overall Study|Sponsor Decision|0|||
130207135|NCT00308750|468718840|FG000|Overall Study|Disease Progression|47|||
130207136|NCT00308750|468718841|FG001|Overall Study|Disease Progression|24|||
130207137|NCT00308750|468718842|FG002|Overall Study|Disease Progression|28|||
130540705|NCT02704754|469947128|FG001|Overall Study|Withdrawal by Subject|0|||
130540706|NCT00657020|469947129|FG000|PERIOD 1|Adverse Event|0|||
130540707|NCT00657020|469947130|FG001|PERIOD 1|Adverse Event|1|||
130540708|NCT00774930|469947134|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
130540709|NCT00774930|469947135|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
130540710|NCT00774930|469947134|FG000|DB Phase|Adverse Event|1|||
130207138|NCT00308750|468718840|FG000|Overall Study|Unrelated Complication|3|||
130207139|NCT00308750|468718841|FG001|Overall Study|Unrelated Complication|0|||
130207140|NCT00308750|468718842|FG002|Overall Study|Unrelated Complication|1|||
130207141|NCT00308750|468718840|FG000|Overall Study|Death|1|||
130207142|NCT00308750|468718841|FG001|Overall Study|Death|0|||
130207143|NCT00308750|468718842|FG002|Overall Study|Death|1|||
130207144|NCT00308750|468718840|FG000|Overall Study|Protocol Violation|1|||
130207145|NCT00308750|468718841|FG001|Overall Study|Protocol Violation|0|||
130207146|NCT00308750|468718842|FG002|Overall Study|Protocol Violation|0|||
130207147|NCT00308750|468718840|FG000|Overall Study|New Primary Disease Identified|1|||
130207148|NCT00308750|468718841|FG001|Overall Study|New Primary Disease Identified|1|||
130207149|NCT00308750|468718842|FG002|Overall Study|New Primary Disease Identified|0|||
130207150|NCT01358578|468718843|FG000|Induction Period|Adverse Event|2|||
130207151|NCT01358578|468718844|FG001|Induction Period|Adverse Event|4|||
130540711|NCT00774930|469947135|FG001|DB Phase|Adverse Event|2|||
130540712|NCT00774930|469947134|FG000|DB Phase|Subject Decision|1|||
130540713|NCT00774930|469947135|FG001|DB Phase|Subject Decision|5|||
130540714|NCT00774930|469947134|FG000|DB Phase|Sponsor Decision|0|||
130318538|NCT00948064|469133700|FG000|Phase I|No treatment received|1|||
130318539|NCT00948064|469133701|FG001|Phase I|No treatment received|0|||
130318540|NCT00948064|469133702|FG002|Phase I|No treatment received|0|||
130318541|NCT00948064|469133700|FG000|Phase II|Physician Decision|0|||
130318542|NCT00948064|469133701|FG001|Phase II|Physician Decision|0|||
130318543|NCT00948064|469133702|FG002|Phase II|Physician Decision|1|||
130318544|NCT00948064|469133700|FG000|Phase II|Withdrawal by Subject|0|||
130318545|NCT00948064|469133701|FG001|Phase II|Withdrawal by Subject|1|||
130318546|NCT00948064|469133702|FG002|Phase II|Withdrawal by Subject|0|||
130318547|NCT02741128|469133713|FG000|Overall Study|Protocol Violation|4|||
130318548|NCT02741128|469133714|FG001|Overall Study|Protocol Violation|1|||
130318549|NCT02741128|469133713|FG000|Overall Study|Withdrawal by Subject|2|||
130318550|NCT02741128|469133714|FG001|Overall Study|Withdrawal by Subject|0|||
130318551|NCT02741128|469133713|FG000|Overall Study|Lost to Follow-up|1|||
130318552|NCT02741128|469133714|FG001|Overall Study|Lost to Follow-up|0|||
130540715|NCT00774930|469947135|FG001|DB Phase|Sponsor Decision|1|||
130540716|NCT00774930|469947134|FG000|DB Phase|Disease Progression|1|||
130540717|NCT00774930|469947135|FG001|DB Phase|Disease Progression|1|||
130540718|NCT00774930|469947134|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
130540719|NCT00774930|469947135|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
130540720|NCT00774930|469947134|FG000|IOL Phase|Adverse Event|1|||
130540721|NCT00774930|469947135|FG001|IOL Phase|Adverse Event|1|||
130540722|NCT00774930|469947134|FG000|IOL Phase|Subject Decision|4|||
130540723|NCT00774930|469947135|FG001|IOL Phase|Subject Decision|3|||
130540724|NCT00774930|469947134|FG000|IOL Phase|Physician Decision|3|||
130540725|NCT00774930|469947135|FG001|IOL Phase|Physician Decision|2|||
130540726|NCT00774930|469947134|FG000|IOL Phase|Sponsor Decision|1|||
130540727|NCT00774930|469947135|FG001|IOL Phase|Sponsor Decision|0|||
130540728|NCT00774930|469947134|FG000|IOL Phase|Disease Progression|2|||
130540729|NCT00774930|469947135|FG001|IOL Phase|Disease Progression|1|||
130540730|NCT00774930|469947134|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
130540731|NCT00774930|469947135|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
130540732|NCT00774930|469947134|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
130540733|NCT00774930|469947135|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
130540734|NCT00774930|469947134|FG000|IOL Phase|Other|1|||
130540735|NCT00774930|469947135|FG001|IOL Phase|Other|0|||
130540736|NCT00774930|469947134|FG000|IOL Phase|Brain radiation|0|||
130540737|NCT00774930|469947135|FG001|IOL Phase|Brain radiation|1|||
130540738|NCT00774930|469947134|FG000|LTOLE Phase|Adverse Event|7|||
130540739|NCT00774930|469947135|FG001|LTOLE Phase|Adverse Event|3|||
130540740|NCT00774930|469947134|FG000|LTOLE Phase|Subject decision|0|||
130540741|NCT00774930|469947135|FG001|LTOLE Phase|Subject decision|5|||
130540742|NCT00774930|469947134|FG000|LTOLE Phase|Physician Decision|4|||
130540743|NCT00774930|469947135|FG001|LTOLE Phase|Physician Decision|1|||
130540744|NCT00774930|469947134|FG000|LTOLE Phase|Sponsor decision|2|||
130207152|NCT01358578|468718845|FG002|Induction Period|Adverse Event|2|||
130318553|NCT02973100|469133715|FG000|Overall Study|Adverse Event|1|||
130540745|NCT00774930|469947135|FG001|LTOLE Phase|Sponsor decision|1|||
130207153|NCT01358578|468718846|FG003|Induction Period|Adverse Event|6|||
130540746|NCT00774930|469947134|FG000|LTOLE Phase|Disease Progression|2|||
130540747|NCT00774930|469947135|FG001|LTOLE Phase|Disease Progression|5|||
130540748|NCT00774930|469947134|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
130540749|NCT00774930|469947135|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
130540750|NCT00774930|469947134|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
130540751|NCT00774930|469947135|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
130540752|NCT00766363|469947140|FG000|Overall Study|Withdrawal by Subject|1|||
130540753|NCT00766363|469947141|FG001|Overall Study|Withdrawal by Subject|0|||
130540754|NCT00766363|469947142|FG002|Overall Study|Withdrawal by Subject|0|||
130540755|NCT00766363|469947143|FG003|Overall Study|Withdrawal by Subject|0|||
130207154|NCT01358578|468718847|FG004|Induction Period|Adverse Event|0|||
130207155|NCT01358578|468718848|FG005|Induction Period|Adverse Event|0|||
130540756|NCT00766363|469947140|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
130207156|NCT01358578|468718843|FG000|Induction Period|Lack of Efficacy|0|||
130207157|NCT01358578|468718844|FG001|Induction Period|Lack of Efficacy|0|||
130207158|NCT01358578|468718845|FG002|Induction Period|Lack of Efficacy|9|||
130540757|NCT00766363|469947141|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
130540758|NCT00766363|469947142|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
130540759|NCT00766363|469947143|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
130540760|NCT03020576|469947144|FG000|Overall Study|Withdrawal by Subject|1|||
130540761|NCT03020576|469947145|FG001|Overall Study|Withdrawal by Subject|2|||
130540762|NCT01153321|469947146|FG000|Overall Study|Development of study withdrawal criteria|0|||
130540763|NCT01153321|469947147|FG001|Overall Study|Development of study withdrawal criteria|1|||
130540764|NCT01153321|469947146|FG000|Overall Study|Withdrawal by Subject|0|||
130540765|NCT01153321|469947147|FG001|Overall Study|Withdrawal by Subject|1|||
130540766|NCT01153321|469947146|FG000|Overall Study|Adverse Event|1|||
130207159|NCT01358578|468718846|FG003|Induction Period|Lack of Efficacy|1|||
130207160|NCT01358578|468718847|FG004|Induction Period|Lack of Efficacy|0|||
130207161|NCT01358578|468718848|FG005|Induction Period|Lack of Efficacy|0|||
130207162|NCT01358578|468718843|FG000|Induction Period|Lost to Follow-up|0|||
130207163|NCT01358578|468718844|FG001|Induction Period|Lost to Follow-up|0|||
130207164|NCT01358578|468718845|FG002|Induction Period|Lost to Follow-up|1|||
130207165|NCT01358578|468718846|FG003|Induction Period|Lost to Follow-up|4|||
130207166|NCT01358578|468718847|FG004|Induction Period|Lost to Follow-up|0|||
130207167|NCT01358578|468718848|FG005|Induction Period|Lost to Follow-up|0|||
130207168|NCT01358578|468718843|FG000|Induction Period|Physician Decision|2|||
130207169|NCT01358578|468718844|FG001|Induction Period|Physician Decision|1|||
130207170|NCT01358578|468718845|FG002|Induction Period|Physician Decision|2|||
130540767|NCT01153321|469947147|FG001|Overall Study|Adverse Event|1|||
130540768|NCT01177800|469947149|FG000|Overall Study|Adverse Event|9|||
130207171|NCT01358578|468718846|FG003|Induction Period|Physician Decision|0|||
130207172|NCT01358578|468718847|FG004|Induction Period|Physician Decision|0|||
130207173|NCT01358578|468718848|FG005|Induction Period|Physician Decision|0|||
130207174|NCT01358578|468718843|FG000|Induction Period|Protocol Deviation|3|||
130207175|NCT01358578|468718844|FG001|Induction Period|Protocol Deviation|5|||
130207176|NCT01358578|468718845|FG002|Induction Period|Protocol Deviation|0|||
130207177|NCT01358578|468718846|FG003|Induction Period|Protocol Deviation|3|||
130207178|NCT01358578|468718847|FG004|Induction Period|Protocol Deviation|0|||
130207179|NCT01358578|468718848|FG005|Induction Period|Protocol Deviation|0|||
130207180|NCT01358578|468718843|FG000|Induction Period|technical problems|0|||
130207181|NCT01358578|468718844|FG001|Induction Period|technical problems|0|||
130207182|NCT01358578|468718845|FG002|Induction Period|technical problems|1|||
130207183|NCT01358578|468718846|FG003|Induction Period|technical problems|1|||
130207184|NCT01358578|468718847|FG004|Induction Period|technical problems|0|||
130207185|NCT01358578|468718848|FG005|Induction Period|technical problems|0|||
130207186|NCT01358578|468718843|FG000|Induction Period|Withdrawal by Subject|5|||
130207187|NCT01358578|468718844|FG001|Induction Period|Withdrawal by Subject|5|||
130207188|NCT01358578|468718845|FG002|Induction Period|Withdrawal by Subject|10|||
130540769|NCT01177800|469947150|FG001|Overall Study|Adverse Event|3|||
130540770|NCT01177800|469947149|FG000|Overall Study|Protocol Violation|0|||
130540771|NCT01177800|469947150|FG001|Overall Study|Protocol Violation|1|||
130207189|NCT01358578|468718846|FG003|Induction Period|Withdrawal by Subject|6|||
130207190|NCT01358578|468718847|FG004|Induction Period|Withdrawal by Subject|0|||
130207191|NCT01358578|468718848|FG005|Induction Period|Withdrawal by Subject|0|||
130207192|NCT01358578|468718843|FG000|Maintenance Period|Adverse Event|2|||
130207193|NCT01358578|468718844|FG001|Maintenance Period|Adverse Event|7|||
130207194|NCT01358578|468718845|FG002|Maintenance Period|Adverse Event|0|||
130207195|NCT01358578|468718846|FG003|Maintenance Period|Adverse Event|6|||
130207196|NCT01358578|468718847|FG004|Maintenance Period|Adverse Event|4|||
130207197|NCT01358578|468718848|FG005|Maintenance Period|Adverse Event|3|||
130207198|NCT01358578|468718843|FG000|Maintenance Period|Lack of Efficacy|10|||
130207199|NCT01358578|468718844|FG001|Maintenance Period|Lack of Efficacy|2|||
130207200|NCT01358578|468718845|FG002|Maintenance Period|Lack of Efficacy|0|||
130540772|NCT01177800|469947149|FG000|Overall Study|Physician Decision|1|||
130540773|NCT01177800|469947150|FG001|Overall Study|Physician Decision|0|||
130207201|NCT01358578|468718846|FG003|Maintenance Period|Lack of Efficacy|11|||
130207202|NCT01358578|468718847|FG004|Maintenance Period|Lack of Efficacy|3|||
130207203|NCT01358578|468718848|FG005|Maintenance Period|Lack of Efficacy|0|||
130207204|NCT01358578|468718843|FG000|Maintenance Period|Lost to Follow-up|4|||
130207205|NCT01358578|468718844|FG001|Maintenance Period|Lost to Follow-up|0|||
130207206|NCT01358578|468718845|FG002|Maintenance Period|Lost to Follow-up|0|||
130318554|NCT02973100|469133716|FG001|Overall Study|Adverse Event|2|||
130540774|NCT01177800|469947149|FG000|Overall Study|Withdrawal of informed consent|0|||
130207207|NCT01358578|468718846|FG003|Maintenance Period|Lost to Follow-up|5|||
130540775|NCT01177800|469947150|FG001|Overall Study|Withdrawal of informed consent|1|||
130207208|NCT01358578|468718847|FG004|Maintenance Period|Lost to Follow-up|1|||
130207209|NCT01358578|468718848|FG005|Maintenance Period|Lost to Follow-up|1|||
130207210|NCT01358578|468718843|FG000|Maintenance Period|Non-compliance with study treatment|3|||
130207211|NCT01358578|468718844|FG001|Maintenance Period|Non-compliance with study treatment|1|||
130207212|NCT01358578|468718845|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130207213|NCT01358578|468718846|FG003|Maintenance Period|Non-compliance with study treatment|2|||
130207214|NCT01358578|468718847|FG004|Maintenance Period|Non-compliance with study treatment|1|||
130207215|NCT01358578|468718848|FG005|Maintenance Period|Non-compliance with study treatment|2|||
130207216|NCT01358578|468718843|FG000|Maintenance Period|Physician Decision|0|||
130207217|NCT01358578|468718844|FG001|Maintenance Period|Physician Decision|1|||
130207218|NCT01358578|468718845|FG002|Maintenance Period|Physician Decision|0|||
130207219|NCT01358578|468718846|FG003|Maintenance Period|Physician Decision|1|||
130207220|NCT01358578|468718847|FG004|Maintenance Period|Physician Decision|0|||
130207221|NCT01358578|468718848|FG005|Maintenance Period|Physician Decision|0|||
130207222|NCT01358578|468718843|FG000|Maintenance Period|Pregnancy|1|||
130207223|NCT01358578|468718844|FG001|Maintenance Period|Pregnancy|0|||
130207224|NCT01358578|468718845|FG002|Maintenance Period|Pregnancy|0|||
130207225|NCT01358578|468718846|FG003|Maintenance Period|Pregnancy|0|||
130207226|NCT01358578|468718847|FG004|Maintenance Period|Pregnancy|0|||
130207227|NCT01358578|468718848|FG005|Maintenance Period|Pregnancy|0|||
130207228|NCT01358578|468718843|FG000|Maintenance Period|Protocol deviation|7|||
130207229|NCT01358578|468718844|FG001|Maintenance Period|Protocol deviation|4|||
130207230|NCT01358578|468718845|FG002|Maintenance Period|Protocol deviation|0|||
130207231|NCT01358578|468718846|FG003|Maintenance Period|Protocol deviation|2|||
130207232|NCT01358578|468718847|FG004|Maintenance Period|Protocol deviation|2|||
130207233|NCT01358578|468718848|FG005|Maintenance Period|Protocol deviation|2|||
130207234|NCT01358578|468718843|FG000|Maintenance Period|Withdrawal by Subject|12|||
130207235|NCT01358578|468718844|FG001|Maintenance Period|Withdrawal by Subject|7|||
130207236|NCT01358578|468718845|FG002|Maintenance Period|Withdrawal by Subject|2|||
130207237|NCT01358578|468718846|FG003|Maintenance Period|Withdrawal by Subject|15|||
130207238|NCT01358578|468718847|FG004|Maintenance Period|Withdrawal by Subject|6|||
130207239|NCT01358578|468718848|FG005|Maintenance Period|Withdrawal by Subject|3|||
130207240|NCT01358578|468718843|FG000|Follow-up Period|Adverse Event|1|||
130207241|NCT01358578|468718844|FG001|Follow-up Period|Adverse Event|1|||
130207242|NCT01358578|468718845|FG002|Follow-up Period|Adverse Event|0|||
130207243|NCT01358578|468718846|FG003|Follow-up Period|Adverse Event|0|||
130207244|NCT01358578|468718847|FG004|Follow-up Period|Adverse Event|0|||
130207245|NCT01358578|468718848|FG005|Follow-up Period|Adverse Event|0|||
130207246|NCT01358578|468718843|FG000|Follow-up Period|Lack of Efficacy|3|||
130207247|NCT01358578|468718844|FG001|Follow-up Period|Lack of Efficacy|0|||
130207248|NCT01358578|468718845|FG002|Follow-up Period|Lack of Efficacy|4|||
130207249|NCT01358578|468718846|FG003|Follow-up Period|Lack of Efficacy|1|||
130207250|NCT01358578|468718847|FG004|Follow-up Period|Lack of Efficacy|0|||
130207251|NCT01358578|468718848|FG005|Follow-up Period|Lack of Efficacy|0|||
130207252|NCT01358578|468718843|FG000|Follow-up Period|Lost to Follow-up|0|||
130207253|NCT01358578|468718844|FG001|Follow-up Period|Lost to Follow-up|1|||
130207254|NCT01358578|468718845|FG002|Follow-up Period|Lost to Follow-up|0|||
130207255|NCT01358578|468718846|FG003|Follow-up Period|Lost to Follow-up|4|||
130207256|NCT01358578|468718847|FG004|Follow-up Period|Lost to Follow-up|0|||
130207257|NCT01358578|468718848|FG005|Follow-up Period|Lost to Follow-up|0|||
130207258|NCT01358578|468718843|FG000|Follow-up Period|non- compliance with study treatment|1|||
130207259|NCT01358578|468718844|FG001|Follow-up Period|non- compliance with study treatment|0|||
130207260|NCT01358578|468718845|FG002|Follow-up Period|non- compliance with study treatment|0|||
130318555|NCT02973100|469133717|FG002|Overall Study|Adverse Event|1|||
130318556|NCT02973100|469133718|FG003|Overall Study|Adverse Event|2|||
130540776|NCT03527550|469947151|FG000|Overall Study|Lost to Follow-up|4|||
130540777|NCT03527550|469947152|FG001|Overall Study|Lost to Follow-up|2|||
130540778|NCT03527550|469947151|FG000|Overall Study|Withdrawal by Subject|4|||
130540779|NCT03527550|469947152|FG001|Overall Study|Withdrawal by Subject|1|||
130540780|NCT03527550|469947151|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
130540781|NCT03527550|469947152|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
130540782|NCT00911937|469947153|FG000|Overall Study|Death|1|||
130540783|NCT00911937|469947154|FG001|Overall Study|Death|0|||
130540784|NCT00911937|469947153|FG000|Overall Study|Lost to Follow-up|8|||
130652176|NCT02513732|470349347|FG000|Overall Study|Death|9|||
130207261|NCT01358578|468718846|FG003|Follow-up Period|non- compliance with study treatment|0|||
130207262|NCT01358578|468718847|FG004|Follow-up Period|non- compliance with study treatment|0|||
130207263|NCT01358578|468718848|FG005|Follow-up Period|non- compliance with study treatment|0|||
130207264|NCT01358578|468718843|FG000|Follow-up Period|Pregnancy|1|||
130207265|NCT01358578|468718844|FG001|Follow-up Period|Pregnancy|0|||
130207266|NCT01358578|468718845|FG002|Follow-up Period|Pregnancy|0|||
130207267|NCT01358578|468718846|FG003|Follow-up Period|Pregnancy|0|||
130540785|NCT00911937|469947154|FG001|Overall Study|Lost to Follow-up|5|||
130207268|NCT01358578|468718847|FG004|Follow-up Period|Pregnancy|0|||
130207269|NCT01358578|468718848|FG005|Follow-up Period|Pregnancy|0|||
130207270|NCT01358578|468718843|FG000|Follow-up Period|Withdrawal by Subject|3|||
130207271|NCT01358578|468718844|FG001|Follow-up Period|Withdrawal by Subject|3|||
130207272|NCT01358578|468718845|FG002|Follow-up Period|Withdrawal by Subject|1|||
130207273|NCT01358578|468718846|FG003|Follow-up Period|Withdrawal by Subject|12|||
130207274|NCT01358578|468718847|FG004|Follow-up Period|Withdrawal by Subject|0|||
130207275|NCT01358578|468718848|FG005|Follow-up Period|Withdrawal by Subject|0|||
130207276|NCT01358578|468718843|FG000|Follow-up Period|Physician Decision|1|||
130207277|NCT01358578|468718844|FG001|Follow-up Period|Physician Decision|1|||
130540786|NCT00911937|469947153|FG000|Overall Study|Withdrawal by Subject|10|||
130540787|NCT00911937|469947154|FG001|Overall Study|Withdrawal by Subject|7|||
130540788|NCT00911937|469947153|FG000|Overall Study|Withdrawn due to pregnancy|1|||
130540789|NCT00911937|469947154|FG001|Overall Study|Withdrawn due to pregnancy|0|||
130540790|NCT00911937|469947153|FG000|Overall Study|Adverse Event|11|||
130540791|NCT00911937|469947154|FG001|Overall Study|Adverse Event|25|||
130540792|NCT00911937|469947153|FG000|Overall Study|Lack of Efficacy|11|||
130540793|NCT00911937|469947154|FG001|Overall Study|Lack of Efficacy|6|||
130207278|NCT01358578|468718845|FG002|Follow-up Period|Physician Decision|0|||
130207279|NCT01358578|468718846|FG003|Follow-up Period|Physician Decision|2|||
130540794|NCT00911937|469947153|FG000|Overall Study|Did not meet inclusion criteria|9|||
130540795|NCT00911937|469947154|FG001|Overall Study|Did not meet inclusion criteria|11|||
130540796|NCT00911937|469947153|FG000|Overall Study|Protocol Violation|14|||
130540797|NCT00911937|469947154|FG001|Overall Study|Protocol Violation|23|||
130540798|NCT00911937|469947153|FG000|Overall Study|Randomized but not treated|13|||
130207280|NCT01358578|468718847|FG004|Follow-up Period|Physician Decision|0|||
130207281|NCT01358578|468718848|FG005|Follow-up Period|Physician Decision|0|||
130207282|NCT02304380|468718849|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207283|NCT02304380|468718850|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207284|NCT02304380|468718851|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207285|NCT02304380|468718852|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
130207286|NCT02304380|468718853|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207287|NCT02304380|468718854|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207288|NCT01125813|468718855|FG000|Overall Study|Death|1|||
130207289|NCT01125813|468718855|FG000|Overall Study|Withdrawal by Subject|1|||
130207290|NCT01125813|468718855|FG000|Overall Study|Screen Failures|4|||
130207291|NCT02327013|468718856|FG000|Overall Study|Adverse Event|4|||
130207292|NCT02327013|468718857|FG001|Overall Study|Adverse Event|4|||
130207293|NCT02327013|468718858|FG002|Overall Study|Adverse Event|3|||
130207294|NCT02327013|468718859|FG003|Overall Study|Adverse Event|0|||
130207295|NCT02327013|468718860|FG004|Overall Study|Adverse Event|1|||
130207296|NCT02327013|468718856|FG000|Overall Study|Lack of Efficacy|2|||
130207297|NCT02327013|468718857|FG001|Overall Study|Lack of Efficacy|0|||
130207298|NCT02327013|468718858|FG002|Overall Study|Lack of Efficacy|5|||
130207299|NCT02327013|468718859|FG003|Overall Study|Lack of Efficacy|0|||
130207300|NCT02327013|468718860|FG004|Overall Study|Lack of Efficacy|1|||
130207301|NCT02327013|468718856|FG000|Overall Study|Non-compliance with IMP|1|||
130207302|NCT02327013|468718857|FG001|Overall Study|Non-compliance with IMP|2|||
130207303|NCT02327013|468718858|FG002|Overall Study|Non-compliance with IMP|7|||
130207304|NCT02327013|468718859|FG003|Overall Study|Non-compliance with IMP|0|||
130207305|NCT02327013|468718860|FG004|Overall Study|Non-compliance with IMP|0|||
130207306|NCT02327013|468718856|FG000|Overall Study|Withdrawal of Consent|1|||
130207307|NCT02327013|468718857|FG001|Overall Study|Withdrawal of Consent|0|||
130207308|NCT02327013|468718858|FG002|Overall Study|Withdrawal of Consent|3|||
130207309|NCT02327013|468718859|FG003|Overall Study|Withdrawal of Consent|0|||
130207310|NCT02327013|468718860|FG004|Overall Study|Withdrawal of Consent|0|||
130207311|NCT02327013|468718856|FG000|Overall Study|Lost to Follow-up|2|||
130207312|NCT02327013|468718857|FG001|Overall Study|Lost to Follow-up|4|||
130540799|NCT00911937|469947154|FG001|Overall Study|Randomized but not treated|13|||
130540800|NCT00911937|469947153|FG000|Overall Study|Other|9|||
130540801|NCT00911937|469947154|FG001|Overall Study|Other|5|||
130540802|NCT01498679|469947155|FG000|Overall Study|Adverse Event|1|||
130540803|NCT01498679|469947156|FG001|Overall Study|Adverse Event|4|||
130207313|NCT02327013|468718858|FG002|Overall Study|Lost to Follow-up|5|||
130207314|NCT02327013|468718859|FG003|Overall Study|Lost to Follow-up|0|||
130207315|NCT02327013|468718860|FG004|Overall Study|Lost to Follow-up|0|||
130207316|NCT02327013|468718856|FG000|Overall Study|Administrative or other reason(s)|1|||
130207317|NCT02327013|468718857|FG001|Overall Study|Administrative or other reason(s)|5|||
130207318|NCT02327013|468718858|FG002|Overall Study|Administrative or other reason(s)|11|||
130207319|NCT02327013|468718859|FG003|Overall Study|Administrative or other reason(s)|1|||
130207320|NCT02327013|468718860|FG004|Overall Study|Administrative or other reason(s)|1|||
130207321|NCT02327013|468718856|FG000|Overall Study|Protocol Violation|0|||
130207322|NCT02327013|468718857|FG001|Overall Study|Protocol Violation|0|||
130540804|NCT01498679|469947155|FG000|Overall Study|Lack of Efficacy|72|||
130540805|NCT01498679|469947156|FG001|Overall Study|Lack of Efficacy|12|||
130540806|NCT01498679|469947155|FG000|Overall Study|Protocol Violation|4|||
130207323|NCT02327013|468718858|FG002|Overall Study|Protocol Violation|3|||
130207324|NCT02327013|468718859|FG003|Overall Study|Protocol Violation|0|||
130207325|NCT02327013|468718860|FG004|Overall Study|Protocol Violation|1|||
130207326|NCT02327013|468718856|FG000|Overall Study|Withdrawal before treatment|2|||
130207327|NCT02327013|468718857|FG001|Overall Study|Withdrawal before treatment|1|||
130207328|NCT02327013|468718858|FG002|Overall Study|Withdrawal before treatment|5|||
130207329|NCT02327013|468718859|FG003|Overall Study|Withdrawal before treatment|0|||
130207330|NCT02327013|468718860|FG004|Overall Study|Withdrawal before treatment|0|||
130207331|NCT04258254|468718861|FG000|Overall Study|Withdrawal by Subject|0|||
130207332|NCT04258254|468718862|FG001|Overall Study|Withdrawal by Subject|1|||
130207333|NCT04258254|468718863|FG002|Overall Study|Withdrawal by Subject|0|||
130207334|NCT04829331|468718864|FG000|Overall Study|Lost to Follow-up|1|||
130207335|NCT04829331|468718865|FG001|Overall Study|Lost to Follow-up|0|||
130207336|NCT00616603|468718867|FG000|Overall Study|Physician Decision|2|||
130207337|NCT00616603|468718868|FG001|Overall Study|Physician Decision|0|||
130207338|NCT00616603|468718869|FG002|Overall Study|Physician Decision|2|||
130207339|NCT02223819|468718883|FG000|Overall Study|Lost to Follow-up|2|||
130207340|NCT02956057|468718884|FG000|Overall Study|Discontinued intervention|14|||
130207341|NCT02956057|468718885|FG001|Overall Study|Discontinued intervention|10|||
130207342|NCT02956057|468718886|FG002|Overall Study|Discontinued intervention|7|||
130207343|NCT02956057|468718887|FG003|Overall Study|Discontinued intervention|14|||
130207344|NCT02956057|468718888|FG004|Overall Study|Discontinued intervention|4|||
130207345|NCT02956057|468718889|FG005|Overall Study|Discontinued intervention|17|||
130207346|NCT02956057|468718884|FG000|Overall Study|Lost to Follow-up|0|||
130207347|NCT02956057|468718885|FG001|Overall Study|Lost to Follow-up|2|||
130207348|NCT02956057|468718886|FG002|Overall Study|Lost to Follow-up|1|||
130207349|NCT02956057|468718887|FG003|Overall Study|Lost to Follow-up|1|||
130207350|NCT02956057|468718888|FG004|Overall Study|Lost to Follow-up|1|||
130207351|NCT02956057|468718889|FG005|Overall Study|Lost to Follow-up|0|||
130207352|NCT00367484|468718896|FG000|Overall Study|Adverse Event|7|||
130207353|NCT00367484|468718896|FG000|Overall Study|Withdrew informed consent|5|||
130207354|NCT00367484|468718896|FG000|Overall Study|Travel to USA|1|||
130207355|NCT00367484|468718896|FG000|Overall Study|Lost to Follow-up|1|||
130207356|NCT00367484|468718896|FG000|Overall Study|Protocol Violation|1|||
130207357|NCT00367484|468718896|FG000|Overall Study|The choice of the patient|1|||
130207358|NCT00367484|468718896|FG000|Overall Study|Lack of Efficacy|1|||
130207359|NCT00908076|468718897|FG000|Overall Study|Lack of Efficacy|1|||
130207360|NCT00908076|468718898|FG001|Overall Study|Lack of Efficacy|1|||
130207361|NCT02382796|468718899|FG000|Overall Study|Global deterioration of health status|1|||
130207362|NCT02382796|468718899|FG000|Overall Study|Objective progression or relapse|3|||
130207363|NCT02382796|468718899|FG000|Overall Study|Commercial dacomitinib became available|3|||
130207364|NCT04007107|468718906|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207365|NCT04007107|468718907|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
130207366|NCT04007107|468718908|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207367|NCT04007107|468718909|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207368|NCT04068688|468718915|FG000|Overall Study|Lost to Follow-up|1|||
130207369|NCT04068688|468718916|FG001|Overall Study|Lost to Follow-up|1|||
130207370|NCT04068688|468718917|FG002|Overall Study|Lost to Follow-up|0|||
130207371|NCT04068688|468718918|FG003|Overall Study|Lost to Follow-up|0|||
130207372|NCT04068688|468718919|FG004|Overall Study|Lost to Follow-up|5|||
130207373|NCT04068688|468718920|FG005|Overall Study|Lost to Follow-up|5|||
130207374|NCT04068688|468718921|FG006|Overall Study|Lost to Follow-up|0|||
130207375|NCT04068688|468718922|FG007|Overall Study|Lost to Follow-up|0|||
130207376|NCT04068688|468718923|FG008|Overall Study|Lost to Follow-up|1|||
130207377|NCT04068688|468718924|FG009|Overall Study|Lost to Follow-up|0|||
130207378|NCT04068688|468718915|FG000|Overall Study|Withdrawal by Subject|1|||
130207379|NCT04068688|468718916|FG001|Overall Study|Withdrawal by Subject|1|||
130207380|NCT04068688|468718917|FG002|Overall Study|Withdrawal by Subject|0|||
130207381|NCT04068688|468718918|FG003|Overall Study|Withdrawal by Subject|0|||
130207382|NCT04068688|468718919|FG004|Overall Study|Withdrawal by Subject|0|||
130207383|NCT04068688|468718920|FG005|Overall Study|Withdrawal by Subject|0|||
130207384|NCT04068688|468718921|FG006|Overall Study|Withdrawal by Subject|0|||
130207385|NCT04068688|468718922|FG007|Overall Study|Withdrawal by Subject|0|||
130207386|NCT04068688|468718923|FG008|Overall Study|Withdrawal by Subject|0|||
130207387|NCT04068688|468718924|FG009|Overall Study|Withdrawal by Subject|0|||
130207388|NCT04068688|468718915|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130207389|NCT04068688|468718916|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130207390|NCT04068688|468718917|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207391|NCT04068688|468718918|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207392|NCT04068688|468718919|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207393|NCT04068688|468718920|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207394|NCT04068688|468718921|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207395|NCT04068688|468718922|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207396|NCT04068688|468718923|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207397|NCT04068688|468718924|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207398|NCT04679051|468718925|FG000|Overall Study|felt tired after restricted time in bed|3|||
130207399|NCT04679051|468718926|FG001|Overall Study|felt tired after restricted time in bed|0|||
130207400|NCT04679051|468718925|FG000|Overall Study|discomfort with blood pressure cuff|2|||
130207401|NCT04679051|468718926|FG001|Overall Study|discomfort with blood pressure cuff|0|||
130207402|NCT04679051|468718925|FG000|Overall Study|scheduling conflict|1|||
130207403|NCT04679051|468718926|FG001|Overall Study|scheduling conflict|1|||
130207404|NCT04679051|468718925|FG000|Overall Study|Protocol Violation|0|||
130207405|NCT04679051|468718926|FG001|Overall Study|Protocol Violation|4|||
130207406|NCT02554318|468718927|FG000|Overall Study|Withdrawal by Subject|10|||
130207407|NCT02554318|468718928|FG001|Overall Study|Withdrawal by Subject|8|||
130207408|NCT01273155|468718933|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
130207409|NCT01273155|468718934|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
130207410|NCT01273155|468718935|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
130207411|NCT01273155|468718936|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
130207412|NCT01273155|468718937|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
130207413|NCT01273155|468718938|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
130207414|NCT01273155|468718939|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
130207415|NCT01273155|468718933|FG000|Overall Study|Change in liver function/no longer eval.|0|||
130207416|NCT01273155|468718934|FG001|Overall Study|Change in liver function/no longer eval.|1|||
130207417|NCT01273155|468718935|FG002|Overall Study|Change in liver function/no longer eval.|0|||
130207418|NCT01273155|468718936|FG003|Overall Study|Change in liver function/no longer eval.|0|||
130207419|NCT01273155|468718937|FG004|Overall Study|Change in liver function/no longer eval.|1|||
130207420|NCT01273155|468718938|FG005|Overall Study|Change in liver function/no longer eval.|0|||
130207421|NCT01273155|468718939|FG006|Overall Study|Change in liver function/no longer eval.|0|||
130207422|NCT01273155|468718933|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
130207423|NCT01273155|468718934|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
130207424|NCT01273155|468718935|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
130207425|NCT01273155|468718936|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
130207426|NCT01273155|468718937|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
130207427|NCT01273155|468718938|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
130207428|NCT01273155|468718939|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
130207429|NCT01273155|468718933|FG000|Overall Study|Died during Cycle 1|0|||
130207430|NCT01273155|468718934|FG001|Overall Study|Died during Cycle 1|0|||
130207431|NCT01273155|468718935|FG002|Overall Study|Died during Cycle 1|1|||
130207432|NCT01273155|468718936|FG003|Overall Study|Died during Cycle 1|1|||
130207433|NCT01273155|468718937|FG004|Overall Study|Died during Cycle 1|0|||
130207434|NCT01273155|468718938|FG005|Overall Study|Died during Cycle 1|2|||
130207435|NCT01273155|468718939|FG006|Overall Study|Died during Cycle 1|2|||
130207436|NCT01273155|468718933|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
130207437|NCT01273155|468718934|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
130207438|NCT01273155|468718935|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
130207439|NCT01273155|468718936|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
130207440|NCT01273155|468718937|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
130207441|NCT01273155|468718938|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
130207442|NCT01273155|468718939|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
130207443|NCT01438814|468718940|FG000|Overall Study|Adverse Event|3|||
130207444|NCT01438814|468718941|FG001|Overall Study|Adverse Event|3|||
130207445|NCT01438814|468718940|FG000|Overall Study|Protocol Violation|1|||
130207446|NCT01438814|468718941|FG001|Overall Study|Protocol Violation|2|||
130207447|NCT01438814|468718940|FG000|Overall Study|Lost to Follow-up|4|||
130207448|NCT01438814|468718941|FG001|Overall Study|Lost to Follow-up|3|||
130207449|NCT01438814|468718940|FG000|Overall Study|Withdrawal by Subject|4|||
130207450|NCT01438814|468718941|FG001|Overall Study|Withdrawal by Subject|2|||
130318557|NCT02973100|469133715|FG000|Overall Study|Lost to Follow-up|3|||
130318558|NCT02973100|469133716|FG001|Overall Study|Lost to Follow-up|1|||
130318559|NCT02973100|469133717|FG002|Overall Study|Lost to Follow-up|1|||
130318560|NCT02973100|469133718|FG003|Overall Study|Lost to Follow-up|0|||
130318561|NCT02973100|469133715|FG000|Overall Study|Withdrawal by Subject|3|||
130318562|NCT02973100|469133716|FG001|Overall Study|Withdrawal by Subject|5|||
130318563|NCT02973100|469133717|FG002|Overall Study|Withdrawal by Subject|1|||
130318564|NCT02973100|469133718|FG003|Overall Study|Withdrawal by Subject|4|||
130318565|NCT02973100|469133715|FG000|Overall Study|Notification of change in address|0|||
130318566|NCT02973100|469133716|FG001|Overall Study|Notification of change in address|0|||
130318567|NCT02973100|469133717|FG002|Overall Study|Notification of change in address|0|||
130318568|NCT02973100|469133718|FG003|Overall Study|Notification of change in address|1|||
130318569|NCT02973100|469133715|FG000|Overall Study|Failed to attend Safety followup period|0|||
130318570|NCT02973100|469133716|FG001|Overall Study|Failed to attend Safety followup period|0|||
130318571|NCT02973100|469133717|FG002|Overall Study|Failed to attend Safety followup period|1|||
130318572|NCT02973100|469133718|FG003|Overall Study|Failed to attend Safety followup period|0|||
130318573|NCT01419769|469133719|FG000|Overall Study|Did not receive the AXIOS stent|3|||
130318574|NCT01419769|469133719|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
130318575|NCT00878501|469133720|FG000|Overall Study|Adverse Event|11|||
130318576|NCT00878501|469133721|FG001|Overall Study|Adverse Event|3|||
130318577|NCT00878501|469133722|FG002|Overall Study|Adverse Event|3|||
130318578|NCT00878501|469133720|FG000|Overall Study|Lack of Efficacy|2|||
130318579|NCT00878501|469133721|FG001|Overall Study|Lack of Efficacy|1|||
130318580|NCT00878501|469133722|FG002|Overall Study|Lack of Efficacy|0|||
130318581|NCT00878501|469133720|FG000|Overall Study|Withdrawal by Subject|2|||
130318582|NCT00878501|469133721|FG001|Overall Study|Withdrawal by Subject|1|||
130318583|NCT00878501|469133722|FG002|Overall Study|Withdrawal by Subject|2|||
130318584|NCT00878501|469133720|FG000|Overall Study|Protocol Violation|0|||
130318585|NCT00878501|469133721|FG001|Overall Study|Protocol Violation|0|||
130318586|NCT00878501|469133722|FG002|Overall Study|Protocol Violation|1|||
130318587|NCT00878501|469133720|FG000|Overall Study|Incorrect enrolment|1|||
130318588|NCT00878501|469133721|FG001|Overall Study|Incorrect enrolment|2|||
130318589|NCT00878501|469133722|FG002|Overall Study|Incorrect enrolment|0|||
130318590|NCT00878501|469133720|FG000|Overall Study|Intake of prohibited concom. medication|0|||
130318591|NCT00878501|469133721|FG001|Overall Study|Intake of prohibited concom. medication|0|||
130318592|NCT00878501|469133722|FG002|Overall Study|Intake of prohibited concom. medication|1|||
130318593|NCT00878501|469133720|FG000|Overall Study|Mis-randomisation of patient|1|||
130318594|NCT00878501|469133721|FG001|Overall Study|Mis-randomisation of patient|0|||
130318595|NCT00878501|469133722|FG002|Overall Study|Mis-randomisation of patient|0|||
130318596|NCT00878501|469133720|FG000|Overall Study|Administrative|0|||
130318597|NCT00878501|469133721|FG001|Overall Study|Administrative|0|||
130318598|NCT00878501|469133722|FG002|Overall Study|Administrative|1|||
130540807|NCT01498679|469947156|FG001|Overall Study|Protocol Violation|0|||
130540808|NCT01498679|469947155|FG000|Overall Study|Physician Decision|0|||
130540809|NCT01498679|469947156|FG001|Overall Study|Physician Decision|2|||
130540810|NCT01498679|469947155|FG000|Overall Study|Withdrawal by Subject|12|||
130540811|NCT01498679|469947156|FG001|Overall Study|Withdrawal by Subject|4|||
130540812|NCT01844687|469947161|FG000|Visit 1|Protocol Violation|3|||
130540813|NCT01844687|469947161|FG000|Visit 1|Lost to Follow-up|5|||
130540814|NCT01844687|469947161|FG000|Visit 2|Withdrawal by Subject|1|||
130540815|NCT01844687|469947161|FG000|Visit 2|Protocol Violation|1|||
130540816|NCT01844687|469947161|FG000|Visit 3|Lost to Follow-up|1|||
130540817|NCT01844687|469947161|FG000|Visit 3|Withdrawal by Subject|3|||
130540818|NCT01844687|469947161|FG000|Visit 3|child care problems|1|||
130540819|NCT01844687|469947161|FG000|Visit 4|Pregnancy|1|||
130540820|NCT01844687|469947161|FG000|Visit 4|Lost to Follow-up|1|||
130540821|NCT01844687|469947161|FG000|Visit 4|Withdrawal by Subject|2|||
130540822|NCT00635427|469947166|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
130540823|NCT00635427|469947167|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
130540824|NCT00635427|469947168|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
130540825|NCT00635427|469947169|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
130540826|NCT00635427|469947170|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
130540827|NCT00635427|469947166|FG000|Overall Study|Death|0|||
130540828|NCT00635427|469947167|FG001|Overall Study|Death|0|||
130540829|NCT00635427|469947168|FG002|Overall Study|Death|0|||
130540830|NCT00635427|469947169|FG003|Overall Study|Death|1|||
130540831|NCT00635427|469947170|FG004|Overall Study|Death|0|||
130540832|NCT00635427|469947166|FG000|Overall Study|Termination Of Study By Sponsor|12|||
130540833|NCT00635427|469947167|FG001|Overall Study|Termination Of Study By Sponsor|6|||
130540834|NCT00635427|469947168|FG002|Overall Study|Termination Of Study By Sponsor|10|||
130540835|NCT00635427|469947169|FG003|Overall Study|Termination Of Study By Sponsor|6|||
130540836|NCT00635427|469947170|FG004|Overall Study|Termination Of Study By Sponsor|6|||
130540837|NCT00635427|469947166|FG000|Overall Study|Withdrawal Of Consent|0|||
130540838|NCT00635427|469947167|FG001|Overall Study|Withdrawal Of Consent|0|||
130540839|NCT00635427|469947168|FG002|Overall Study|Withdrawal Of Consent|0|||
130540840|NCT00635427|469947169|FG003|Overall Study|Withdrawal Of Consent|2|||
130540841|NCT00635427|469947170|FG004|Overall Study|Withdrawal Of Consent|2|||
130540842|NCT02706899|469947178|FG000|Overall Study|Withdrawal by Subject|1|||
130540843|NCT02706899|469947179|FG001|Overall Study|Withdrawal by Subject|0|||
130540844|NCT02706899|469947178|FG000|Overall Study|Death|8|||
130540845|NCT02706899|469947179|FG001|Overall Study|Death|0|||
130540846|NCT02706899|469947178|FG000|Overall Study|Study Termination by Sponsor|4|||
130652177|NCT02513732|470349347|FG000|Overall Study|Changing hospital|2|||
130652178|NCT01740297|470349349|FG000|Overall Study|Withdrawal by Subject|4|||
130318599|NCT00812708|469133725|FG000|Overall Study|Device could not be implanted|2|||
130318600|NCT00812708|469133725|FG000|Overall Study|Lack of medical insurance|1|||
130540847|NCT02706899|469947179|FG001|Overall Study|Study Termination by Sponsor|6|||
130540848|NCT00324675|469947180|FG000|Overall Study|Adverse Event|1|||
130540849|NCT00324675|469947181|FG001|Overall Study|Adverse Event|0|||
130540850|NCT00735475|469947182|FG000|Overall Study|Adverse Event|0|||
130540851|NCT00735475|469947183|FG001|Overall Study|Adverse Event|1|||
130540852|NCT00735475|469947182|FG000|Overall Study|Death|1|||
130540853|NCT00735475|469947183|FG001|Overall Study|Death|1|||
130652179|NCT01740297|470349350|FG001|Overall Study|Withdrawal by Subject|16|||
130318601|NCT00812708|469133725|FG000|Overall Study|Switched to another study|1|||
130318602|NCT00812708|469133725|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
130318603|NCT00812708|469133725|FG000|Overall Study|Signed consent but later withdrew|3|||
130318604|NCT01959503|469133726|FG000|Overall Study|Death|2|||
130318605|NCT01959503|469133727|FG001|Overall Study|Death|1|||
130318606|NCT01959503|469133726|FG000|Overall Study|Randomized but not treated|1|||
130318607|NCT01959503|469133727|FG001|Overall Study|Randomized but not treated|1|||
130318608|NCT01600326|469133728|FG000|Overall Study|Lost to Follow-up|1|||
130318609|NCT01600326|469133729|FG001|Overall Study|Lost to Follow-up|1|||
130540854|NCT00735475|469947182|FG000|Overall Study|Lost to Follow-up|3|||
130540855|NCT00735475|469947183|FG001|Overall Study|Lost to Follow-up|3|||
130540856|NCT00735475|469947182|FG000|Overall Study|Physician Decision|0|||
130540857|NCT00735475|469947183|FG001|Overall Study|Physician Decision|1|||
130318610|NCT03224130|469133730|FG000|Overall Study|consent issue|0|||
130318611|NCT03224130|469133731|FG001|Overall Study|consent issue|1|||
130318612|NCT03287791|469133734|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130318613|NCT03287791|469133735|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130318614|NCT03287791|469133736|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130318615|NCT03287791|469133734|FG000|Overall Study|Adverse Event|0|||
130318616|NCT03287791|469133735|FG001|Overall Study|Adverse Event|4|||
130318617|NCT03287791|469133736|FG002|Overall Study|Adverse Event|3|||
130318618|NCT03287791|469133734|FG000|Overall Study|Withdrawal by Subject|12|||
130318619|NCT03287791|469133735|FG001|Overall Study|Withdrawal by Subject|12|||
130318620|NCT03287791|469133736|FG002|Overall Study|Withdrawal by Subject|17|||
130318621|NCT03287791|469133734|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
130318622|NCT03287791|469133735|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
130318623|NCT03287791|469133736|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
130318624|NCT03287791|469133734|FG000|Overall Study|Lost to Follow-up|8|||
130318625|NCT03287791|469133735|FG001|Overall Study|Lost to Follow-up|14|||
130318626|NCT03287791|469133736|FG002|Overall Study|Lost to Follow-up|11|||
130318627|NCT03287791|469133734|FG000|Overall Study|Protocol Violation|7|||
130540858|NCT00735475|469947182|FG000|Overall Study|Withdrawal by Subject|4|||
130540859|NCT00735475|469947183|FG001|Overall Study|Withdrawal by Subject|5|||
130540860|NCT02442336|469947186|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
130540861|NCT02442336|469947186|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
130540862|NCT02442336|469947186|FG000|Overall Study|Lost to Follow-up|11|||
130540863|NCT00844532|469947190|FG000|Overall Study|Death|16|||
130318628|NCT03287791|469133735|FG001|Overall Study|Protocol Violation|2|||
130318629|NCT03287791|469133736|FG002|Overall Study|Protocol Violation|1|||
130318630|NCT03287791|469133734|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
130318631|NCT03287791|469133735|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
130318632|NCT03287791|469133736|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
130318633|NCT03287791|469133734|FG000|Overall Study|Too much time between 2 visits|0|||
130318634|NCT03287791|469133735|FG001|Overall Study|Too much time between 2 visits|1|||
130318635|NCT03287791|469133736|FG002|Overall Study|Too much time between 2 visits|0|||
130318636|NCT03287791|469133734|FG000|Overall Study|Non-compliance|0|||
130318637|NCT03287791|469133735|FG001|Overall Study|Non-compliance|1|||
130540864|NCT00844532|469947190|FG000|Overall Study|Withdrawal by Subject|16|||
130540865|NCT00844532|469947190|FG000|Overall Study|Lost to Follow-up|7|||
130540866|NCT01080716|469947191|FG000|Part 1|Physician Decision|1|||
130540867|NCT01080716|469947192|FG001|Part 1|Physician Decision|0|||
130540868|NCT01080716|469947193|FG002|Part 1|Physician Decision|0|||
130540869|NCT01080716|469947194|FG003|Part 1|Physician Decision|0|||
130540870|NCT01056718|469947195|FG000|Overall Study|Withdrawal by Subject|2|||
130540871|NCT01056718|469947195|FG000|Overall Study|Ischemia on baseline stress test|1|||
130540872|NCT05086276|469947196|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
130318638|NCT03287791|469133736|FG002|Overall Study|Non-compliance|0|||
130318639|NCT03287791|469133734|FG000|Overall Study|Did not meet inclusion criteria|1|||
130318640|NCT03287791|469133735|FG001|Overall Study|Did not meet inclusion criteria|0|||
130318641|NCT03287791|469133736|FG002|Overall Study|Did not meet inclusion criteria|0|||
130318642|NCT03095651|469133738|FG000|Overall Study|Lost to Follow-up|1|||
130318643|NCT03095651|469133739|FG001|Overall Study|Lost to Follow-up|1|||
130318644|NCT03095651|469133740|FG002|Overall Study|Lost to Follow-up|0|||
130318645|NCT03095651|469133741|FG003|Overall Study|Lost to Follow-up|1|||
130318646|NCT03095651|469133742|FG004|Overall Study|Lost to Follow-up|0|||
130318647|NCT03095651|469133743|FG005|Overall Study|Lost to Follow-up|0|||
130318648|NCT03095651|469133744|FG006|Overall Study|Lost to Follow-up|0|||
130318649|NCT03095651|469133745|FG007|Overall Study|Lost to Follow-up|0|||
130318650|NCT03095651|469133738|FG000|Overall Study|Withdrawal by Subject|0|||
130318651|NCT03095651|469133739|FG001|Overall Study|Withdrawal by Subject|0|||
130318652|NCT03095651|469133740|FG002|Overall Study|Withdrawal by Subject|0|||
130318653|NCT03095651|469133741|FG003|Overall Study|Withdrawal by Subject|0|||
130318654|NCT03095651|469133742|FG004|Overall Study|Withdrawal by Subject|0|||
130540873|NCT05086276|469947197|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
130540874|NCT00287690|469947198|FG000|Overall Study|Protocol Violation|20|||
130540875|NCT00287690|469947199|FG001|Overall Study|Protocol Violation|26|||
130318655|NCT03095651|469133743|FG005|Overall Study|Withdrawal by Subject|1|||
130318656|NCT03095651|469133744|FG006|Overall Study|Withdrawal by Subject|0|||
130318657|NCT03095651|469133745|FG007|Overall Study|Withdrawal by Subject|0|||
130318658|NCT04247347|469133752|FG000|Overall Study|Withdrawal by Subject|2|||
130318659|NCT04247347|469133753|FG001|Overall Study|Withdrawal by Subject|3|||
130318660|NCT04247347|469133754|FG002|Overall Study|Withdrawal by Subject|3|||
130318661|NCT04247347|469133752|FG000|Overall Study|Lost to Follow-up|1|||
130318662|NCT04247347|469133753|FG001|Overall Study|Lost to Follow-up|1|||
130318663|NCT04247347|469133754|FG002|Overall Study|Lost to Follow-up|1|||
130318664|NCT03562195|469133755|FG000|Overall Study|Adverse Event|0|||
130318665|NCT03562195|469133756|FG001|Overall Study|Adverse Event|6|||
130318666|NCT03562195|469133755|FG000|Overall Study|Lack of Efficacy|0|||
130318667|NCT03562195|469133756|FG001|Overall Study|Lack of Efficacy|5|||
130318668|NCT03562195|469133755|FG000|Overall Study|Protocol Violation|0|||
130318669|NCT03562195|469133756|FG001|Overall Study|Protocol Violation|1|||
130318670|NCT03562195|469133755|FG000|Overall Study|Lost to Follow-up|0|||
130318671|NCT03562195|469133756|FG001|Overall Study|Lost to Follow-up|1|||
130318672|NCT03562195|469133755|FG000|Overall Study|Physician Decision|1|||
130318673|NCT03562195|469133756|FG001|Overall Study|Physician Decision|0|||
130318674|NCT03562195|469133755|FG000|Overall Study|Withdrawal by Subject|3|||
130318675|NCT03562195|469133756|FG001|Overall Study|Withdrawal by Subject|0|||
130318676|NCT02529852|469133757|FG000|Overall Study|Withdrawal by Subject|2|||
130318677|NCT04664153|469133758|FG000|Overall Study|Lack of Efficacy|0|||
130207451|NCT01438814|468718940|FG000|Overall Study|Other|2|||
130207452|NCT01438814|468718941|FG001|Overall Study|Other|4|||
130207453|NCT00990665|468718947|FG000|Overall Study|Unsuccessful Implant|8|||
130207454|NCT00990665|468718947|FG000|Overall Study|Death|29|||
130207455|NCT00990665|468718947|FG000|Overall Study|Heart Transplant|1|||
130318678|NCT04664153|469133759|FG001|Overall Study|Lack of Efficacy|0|||
130318679|NCT04664153|469133760|FG002|Overall Study|Lack of Efficacy|1|||
130207456|NCT00990665|468718947|FG000|Overall Study|Withdrawal by Subject|6|||
130207457|NCT00990665|468718947|FG000|Overall Study|Lost to Follow-up|1|||
130207458|NCT00990665|468718947|FG000|Overall Study|System Explant|3|||
130207459|NCT00672841|468718948|FG000|Overall Study|Comfort care|1|||
130207460|NCT00672841|468718949|FG001|Overall Study|Comfort care|4|||
130207461|NCT00672841|468718948|FG000|Overall Study|icteric specimens|0|||
130207462|NCT00672841|468718949|FG001|Overall Study|icteric specimens|3|||
130207463|NCT00672841|468718948|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
130207464|NCT00672841|468718949|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
130207465|NCT00672841|468718948|FG000|Overall Study|Adverse Event|0|||
130207466|NCT00672841|468718949|FG001|Overall Study|Adverse Event|3|||
130207467|NCT00672841|468718948|FG000|Overall Study|Pregnancy|0|||
130207468|NCT00672841|468718949|FG001|Overall Study|Pregnancy|1|||
130207469|NCT03578146|468718950|FG000|Overall Study|Did Not Receive Treatment|1|||
130207470|NCT03578146|468718951|FG001|Overall Study|Did Not Receive Treatment|0|||
130207471|NCT03578146|468718952|FG002|Overall Study|Did Not Receive Treatment|0|||
130207472|NCT03578146|468718953|FG003|Overall Study|Did Not Receive Treatment|0|||
130207473|NCT03578146|468718954|FG004|Overall Study|Did Not Receive Treatment|0|||
130207474|NCT03578146|468718955|FG005|Overall Study|Did Not Receive Treatment|2|||
130207475|NCT03578146|468718950|FG000|Overall Study|Lost to Follow-up|0|||
130207476|NCT03578146|468718951|FG001|Overall Study|Lost to Follow-up|1|||
130207477|NCT03578146|468718952|FG002|Overall Study|Lost to Follow-up|1|||
130207478|NCT03578146|468718953|FG003|Overall Study|Lost to Follow-up|0|||
130207479|NCT03578146|468718954|FG004|Overall Study|Lost to Follow-up|0|||
130207480|NCT03578146|468718955|FG005|Overall Study|Lost to Follow-up|1|||
130207481|NCT01717391|468718956|FG000|Overall Study|Withdrawal by Subject|5|||
130207482|NCT01717391|468718956|FG000|Overall Study|Physician Decision|1|||
130207483|NCT01717391|468718956|FG000|Overall Study|FLT technical failure|3|||
130207484|NCT03677934|468718957|FG000|Overall Study|Adverse Event|1|||
130207485|NCT03677934|468718958|FG001|Overall Study|Adverse Event|1|||
130207486|NCT03677934|468718957|FG000|Overall Study|Death|8|||
130207487|NCT03677934|468718958|FG001|Overall Study|Death|4|||
130207488|NCT03677934|468718957|FG000|Overall Study|Lost to Follow-up|3|||
130207489|NCT03677934|468718958|FG001|Overall Study|Lost to Follow-up|0|||
130207490|NCT03677934|468718957|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130207491|NCT03677934|468718958|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130207492|NCT03677934|468718957|FG000|Overall Study|Physician Decision|0|||
130207493|NCT03677934|468718958|FG001|Overall Study|Physician Decision|1|||
130207494|NCT03677934|468718957|FG000|Overall Study|Withdrawal by Subject|1|||
130207495|NCT03677934|468718958|FG001|Overall Study|Withdrawal by Subject|7|||
130207496|NCT01731470|468718960|FG000|Overall Study|Withdrawal by Subject|1|||
130207497|NCT01731470|468718960|FG000|Overall Study|Did not meet study criteria|1|||
130207498|NCT00335959|468718961|FG000|Overall Study|Adverse Event|2|||
130540876|NCT02270515|469947200|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
130207499|NCT00335959|468718961|FG000|Overall Study|Ineligible|1|||
130207500|NCT02450552|468718964|FG000|Overall Study|Withdrawal by Subject|4|||
130207501|NCT02450552|468718965|FG001|Overall Study|Withdrawal by Subject|0|||
130207502|NCT02450552|468718966|FG002|Overall Study|Withdrawal by Subject|4|||
130207503|NCT02450552|468718964|FG000|Overall Study|Physician Decision|1|||
130207504|NCT02450552|468718965|FG001|Overall Study|Physician Decision|0|||
130207505|NCT02450552|468718966|FG002|Overall Study|Physician Decision|1|||
130207506|NCT01876979|468718973|FG000|Overall Study|Physician Decision|2|||
130207507|NCT01876979|468718974|FG001|Overall Study|Physician Decision|3|||
130207508|NCT00948506|468718975|FG000|Overall Study|Withdrawal by Subject|3|||
130207509|NCT00948506|468718976|FG001|Overall Study|Withdrawal by Subject|1|||
130207510|NCT00824382|468718977|FG000|Overall Study|Adverse Event|4|||
130207511|NCT00824382|468718978|FG001|Overall Study|Adverse Event|1|||
130207512|NCT00824382|468718979|FG002|Overall Study|Adverse Event|1|||
130207513|NCT00824382|468718980|FG003|Overall Study|Adverse Event|4|||
130207514|NCT00824382|468718977|FG000|Overall Study|Protocol Violation|1|||
130207515|NCT00824382|468718978|FG001|Overall Study|Protocol Violation|0|||
130207516|NCT00824382|468718979|FG002|Overall Study|Protocol Violation|0|||
130207517|NCT00824382|468718980|FG003|Overall Study|Protocol Violation|1|||
130207518|NCT00824382|468718977|FG000|Overall Study|Investigator's decision|0|||
130207519|NCT00824382|468718978|FG001|Overall Study|Investigator's decision|1|||
130207520|NCT00824382|468718979|FG002|Overall Study|Investigator's decision|2|||
130207521|NCT00824382|468718980|FG003|Overall Study|Investigator's decision|0|||
130207522|NCT00721279|468718981|FG000|Overall Study|Lack of Efficacy|6|||
130207523|NCT00721279|468718982|FG001|Overall Study|Lack of Efficacy|3|||
130207524|NCT00721279|468718981|FG000|Overall Study|Tolerability insufficient|5|||
130207525|NCT00721279|468718982|FG001|Overall Study|Tolerability insufficient|2|||
130207526|NCT00721279|468718981|FG000|Overall Study|Withdrawal by Subject|13|||
130207527|NCT00721279|468718982|FG001|Overall Study|Withdrawal by Subject|3|||
130207528|NCT00721279|468718981|FG000|Overall Study|Other|12|||
130207529|NCT00721279|468718982|FG001|Overall Study|Other|16|||
130207530|NCT03467763|468718983|FG000|Overall Study|Lost to Follow-up|1|||
130318680|NCT04664153|469133761|FG003|Overall Study|Lack of Efficacy|0|||
130318681|NCT04664153|469133758|FG000|Overall Study|Physician Decision|0|||
130318682|NCT04664153|469133759|FG001|Overall Study|Physician Decision|0|||
130318683|NCT04664153|469133760|FG002|Overall Study|Physician Decision|1|||
130318684|NCT04664153|469133761|FG003|Overall Study|Physician Decision|0|||
130318685|NCT04664153|469133758|FG000|Overall Study|Withdrawal by Subject|3|||
130318686|NCT04664153|469133759|FG001|Overall Study|Withdrawal by Subject|2|||
130318687|NCT04664153|469133760|FG002|Overall Study|Withdrawal by Subject|1|||
130318688|NCT04664153|469133761|FG003|Overall Study|Withdrawal by Subject|2|||
130318689|NCT04664153|469133758|FG000|Overall Study|Other|0|||
130318690|NCT04664153|469133759|FG001|Overall Study|Other|1|||
130318691|NCT04664153|469133760|FG002|Overall Study|Other|0|||
130318692|NCT04664153|469133761|FG003|Overall Study|Other|0|||
130318693|NCT04664153|469133758|FG000|Overall Study|Adverse Event|4|||
130318694|NCT04664153|469133759|FG001|Overall Study|Adverse Event|0|||
130318695|NCT04664153|469133760|FG002|Overall Study|Adverse Event|1|||
130318696|NCT04664153|469133761|FG003|Overall Study|Adverse Event|0|||
130318697|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130318698|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130318699|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
130318700|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
130318701|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
130318702|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
130318703|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130318704|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
130318705|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
130318706|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
130318707|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
130318708|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
130318709|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
130318710|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
130318711|NCT00642356|469133769|FG000|Overall Study|Adverse Event|1|||
130318712|NCT00642356|469133770|FG001|Overall Study|Adverse Event|0|||
130318713|NCT00642356|469133769|FG000|Overall Study|Protocol Violation|0|||
130318714|NCT00642356|469133770|FG001|Overall Study|Protocol Violation|3|||
130318715|NCT00642356|469133769|FG000|Overall Study|Lack of Efficacy|1|||
130318716|NCT00642356|469133770|FG001|Overall Study|Lack of Efficacy|0|||
130318717|NCT01009060|469133771|FG000|Overall Study|Adverse Event|1|||
130318718|NCT01009060|469133772|FG001|Overall Study|Adverse Event|2|||
130318719|NCT01009060|469133771|FG000|Overall Study|Protocol Violation|0|||
130318720|NCT01009060|469133772|FG001|Overall Study|Protocol Violation|1|||
130318721|NCT01009060|469133771|FG000|Overall Study|Lost to Follow-up|1|||
130318722|NCT01009060|469133772|FG001|Overall Study|Lost to Follow-up|0|||
130652180|NCT01740297|470349351|FG002|Overall Study|Withdrawal by Subject|17|||
130318723|NCT01009060|469133771|FG000|Overall Study|Physician Decision|1|||
130318724|NCT01009060|469133772|FG001|Overall Study|Physician Decision|1|||
130207531|NCT03467763|468718983|FG000|Overall Study|Protocol Violation|2|||
130207532|NCT02407054|468718984|FG000|Overall Study|Adverse Event|1|||
130318725|NCT01009060|469133771|FG000|Overall Study|Withdrawal by Subject|1|||
130318726|NCT01009060|469133772|FG001|Overall Study|Withdrawal by Subject|1|||
130318727|NCT00265564|469133773|FG000|Overall Study|Lost to Follow-up|5|||
130318728|NCT00265564|469133774|FG001|Overall Study|Lost to Follow-up|7|||
130318729|NCT00265564|469133773|FG000|Overall Study|met exclusion criteria|5|||
130318730|NCT00265564|469133774|FG001|Overall Study|met exclusion criteria|2|||
130318731|NCT04913610|469133783|FG000|Randomized Participants|Did Not Receive Treatment|0|||
130318732|NCT04913610|469133784|FG001|Randomized Participants|Did Not Receive Treatment|0|||
130318733|NCT04913610|469133785|FG002|Randomized Participants|Did Not Receive Treatment|1|||
130318734|NCT04913610|469133786|FG003|Randomized Participants|Did Not Receive Treatment|1|||
130318735|NCT04913610|469133787|FG004|Randomized Participants|Did Not Receive Treatment|0|||
130318736|NCT04913610|469133783|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130318737|NCT04913610|469133784|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318738|NCT04913610|469133785|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318739|NCT04913610|469133786|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318740|NCT04913610|469133787|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130318741|NCT00659061|469133788|FG000|Overall Study|Migration due to political unrest|21|||
130318742|NCT00659061|469133789|FG001|Overall Study|Migration due to political unrest|15|||
130318743|NCT01277744|469133792|FG000|Overall Study|Physician Decision|2|||
130318744|NCT01650558|469133795|FG000|Overall Study|Migration out of study area|61|||
130318745|NCT01650558|469133796|FG001|Overall Study|Migration out of study area|71|||
130318746|NCT01650558|469133797|FG002|Overall Study|Migration out of study area|56|||
130318747|NCT01650558|469133795|FG000|Overall Study|Lost to Follow-up|10|||
130318748|NCT01650558|469133796|FG001|Overall Study|Lost to Follow-up|13|||
130318749|NCT01650558|469133797|FG002|Overall Study|Lost to Follow-up|6|||
130318750|NCT01650558|469133795|FG000|Overall Study|Death|10|||
130318751|NCT01650558|469133796|FG001|Overall Study|Death|6|||
130318752|NCT01650558|469133797|FG002|Overall Study|Death|8|||
130318753|NCT01650558|469133795|FG000|Overall Study|Withdrawal by Subject|1|||
130318754|NCT01650558|469133796|FG001|Overall Study|Withdrawal by Subject|1|||
130318755|NCT01650558|469133797|FG002|Overall Study|Withdrawal by Subject|3|||
130318756|NCT01650558|469133795|FG000|Overall Study|Non-compliant participant|1|||
130318757|NCT01650558|469133796|FG001|Overall Study|Non-compliant participant|0|||
130318758|NCT01650558|469133797|FG002|Overall Study|Non-compliant participant|2|||
130318759|NCT01650558|469133795|FG000|Overall Study|Physician Decision|0|||
130318760|NCT01650558|469133796|FG001|Overall Study|Physician Decision|1|||
130318761|NCT01650558|469133797|FG002|Overall Study|Physician Decision|0|||
130318762|NCT01069484|469133800|FG000|Overall Study|Death-in-near-family|1|||
130318763|NCT01069484|469133801|FG001|Overall Study|Death-in-near-family|0|||
130318764|NCT01069484|469133800|FG000|Overall Study|No specific reason|8|||
130318765|NCT01069484|469133801|FG001|Overall Study|No specific reason|2|||
130318766|NCT01069484|469133800|FG000|Overall Study|Illness mother or child|3|||
130318767|NCT01069484|469133801|FG001|Overall Study|Illness mother or child|1|||
130318768|NCT00644358|469133803|FG000|Overall Study|Adverse Event|124|||
130318769|NCT00644358|469133803|FG000|Overall Study|Lost to Follow-up|105|||
130318770|NCT00644358|469133803|FG000|Overall Study|Consent Withdrawal|64|||
130318771|NCT00644358|469133803|FG000|Overall Study|Lack of Effectiveness|39|||
130318772|NCT00644358|469133803|FG000|Overall Study|Protocol Violation|5|||
130318773|NCT00644358|469133803|FG000|Overall Study|Noncompliance|14|||
130318774|NCT00644358|469133803|FG000|Overall Study|Other Unspecified|11|||
130318775|NCT00758771|469133810|FG000|Overall Study|Withdrawal by Subject|1|||
130318776|NCT00758771|469133811|FG001|Overall Study|Withdrawal by Subject|1|||
130318777|NCT00758771|469133810|FG000|Overall Study|Did not meet eligibility criteria|2|||
130318778|NCT00758771|469133811|FG001|Overall Study|Did not meet eligibility criteria|4|||
130318779|NCT00528957|469133812|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
130318780|NCT00528957|469133813|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
130318781|NCT00528957|469133812|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
130318782|NCT00528957|469133813|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
130318783|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
130318784|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
130318785|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
130318786|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
130318787|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
130207533|NCT02407054|468718985|FG001|Overall Study|Adverse Event|4|||
130207534|NCT02407054|468718986|FG002|Overall Study|Adverse Event|1|||
130318788|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
130318789|NCT00528957|469133812|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
130318790|NCT00528957|469133813|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
130318791|NCT00528957|469133812|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
130318792|NCT00528957|469133813|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
130318793|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
130318794|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
130318795|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
130318796|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
130318797|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130318798|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130318799|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
130318800|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
130318801|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
130318802|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
130318803|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
130318804|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
130318805|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
130318806|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
130318807|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
130318808|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
130318809|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130318810|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130318811|NCT02051764|469133818|FG000|Overall Study|Study terminated by sponsor|0|||
130318812|NCT02051764|469133819|FG001|Overall Study|Study terminated by sponsor|7|||
130318813|NCT03624881|469133820|FG000|Overall Study|Screen Failure|14|||
130318814|NCT03624881|469133821|FG001|Overall Study|Screen Failure|0|||
130318815|NCT03624881|469133820|FG000|Overall Study|No Catheter Inserted|6|||
130318816|NCT03624881|469133821|FG001|Overall Study|No Catheter Inserted|1|||
130318817|NCT03624881|469133820|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
130318818|NCT03624881|469133821|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
130318819|NCT03624881|469133820|FG000|Overall Study|Death|2|||
130318820|NCT03624881|469133821|FG001|Overall Study|Death|0|||
130318821|NCT03624881|469133820|FG000|Overall Study|Lost to Follow-up|10|||
130318822|NCT03624881|469133821|FG001|Overall Study|Lost to Follow-up|4|||
130318823|NCT03624881|469133820|FG000|Overall Study|Withdrawal by Subject|12|||
130318824|NCT03624881|469133821|FG001|Overall Study|Withdrawal by Subject|1|||
130429421|NCT00766675|469535314|FG000|Overall Study|Adverse Event|16|||
130429422|NCT00766675|469535314|FG000|Overall Study|Lost to Follow-up|2|||
130429423|NCT00766675|469535314|FG000|Overall Study|Withdrawal by Subject|11|||
130429424|NCT00766675|469535314|FG000|Overall Study|Protocol Violation|8|||
130429425|NCT00766675|469535314|FG000|Overall Study|Participant took prohibited medication|1|||
130429426|NCT00766675|469535314|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
130429427|NCT00766675|469535314|FG000|Overall Study|Insufficient therapy|1|||
130429428|NCT01984697|469535315|FG000|Overall Study|Adverse Event|0|||
130540877|NCT02270515|469947200|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
130540878|NCT02270515|469947200|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
130540879|NCT02270515|469947200|FG000|Intervention Period 1: 0-6 Months|Death|7|||
130540880|NCT02270515|469947200|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
130429429|NCT01984697|469535316|FG001|Overall Study|Adverse Event|0|||
130429430|NCT01984697|469535317|FG002|Overall Study|Adverse Event|2|||
130429431|NCT01984697|469535318|FG003|Overall Study|Adverse Event|0|||
130429432|NCT01984697|469535319|FG004|Overall Study|Adverse Event|0|||
130429433|NCT01984697|469535315|FG000|Overall Study|Lost to Follow-up|14|||
130429434|NCT01984697|469535316|FG001|Overall Study|Lost to Follow-up|5|||
130429435|NCT01984697|469535317|FG002|Overall Study|Lost to Follow-up|10|||
130429436|NCT01984697|469535318|FG003|Overall Study|Lost to Follow-up|6|||
130429437|NCT01984697|469535319|FG004|Overall Study|Lost to Follow-up|21|||
130429438|NCT01984697|469535315|FG000|Overall Study|Physician Decision|3|||
130429439|NCT01984697|469535316|FG001|Overall Study|Physician Decision|0|||
130429440|NCT01984697|469535317|FG002|Overall Study|Physician Decision|0|||
130429441|NCT01984697|469535318|FG003|Overall Study|Physician Decision|1|||
130429442|NCT01984697|469535319|FG004|Overall Study|Physician Decision|0|||
130429443|NCT01984697|469535315|FG000|Overall Study|Protocol Violation|8|||
130429444|NCT01984697|469535316|FG001|Overall Study|Protocol Violation|5|||
130429445|NCT01984697|469535317|FG002|Overall Study|Protocol Violation|3|||
130429446|NCT01984697|469535318|FG003|Overall Study|Protocol Violation|2|||
130429447|NCT01984697|469535319|FG004|Overall Study|Protocol Violation|0|||
130429448|NCT01984697|469535315|FG000|Overall Study|Withdrawal by Subject|15|||
130429449|NCT01984697|469535316|FG001|Overall Study|Withdrawal by Subject|21|||
130429450|NCT01984697|469535317|FG002|Overall Study|Withdrawal by Subject|13|||
130429451|NCT01984697|469535318|FG003|Overall Study|Withdrawal by Subject|11|||
130429452|NCT01984697|469535319|FG004|Overall Study|Withdrawal by Subject|13|||
130429453|NCT01984697|469535315|FG000|Overall Study|Missed last follow-up visit|1|||
130429454|NCT01984697|469535316|FG001|Overall Study|Missed last follow-up visit|0|||
130429455|NCT01984697|469535317|FG002|Overall Study|Missed last follow-up visit|0|||
130429456|NCT01984697|469535318|FG003|Overall Study|Missed last follow-up visit|0|||
130429457|NCT01984697|469535319|FG004|Overall Study|Missed last follow-up visit|0|||
130429458|NCT01984697|469535315|FG000|Overall Study|Death|0|||
130429459|NCT01984697|469535316|FG001|Overall Study|Death|0|||
130652181|NCT01740297|470349349|FG000|Overall Study|Death|8|||
130318825|NCT05435339|469133822|FG000|Overall Study|Death|1|||
130318826|NCT05435339|469133823|FG001|Overall Study|Death|0|||
130318827|NCT05435339|469133824|FG002|Overall Study|Death|3|||
130318828|NCT05435339|469133825|FG003|Overall Study|Death|1|||
130318829|NCT05435339|469133826|FG004|Overall Study|Death|3|||
130318830|NCT05435339|469133827|FG005|Overall Study|Death|2|||
130318831|NCT05435339|469133828|FG006|Overall Study|Death|4|||
130318832|NCT05435339|469133829|FG007|Overall Study|Death|6|||
130318833|NCT05435339|469133822|FG000|Overall Study|Sponsor Decision|0|||
130318834|NCT05435339|469133823|FG001|Overall Study|Sponsor Decision|1|||
130318835|NCT05435339|469133824|FG002|Overall Study|Sponsor Decision|0|||
130318836|NCT05435339|469133825|FG003|Overall Study|Sponsor Decision|0|||
130318837|NCT05435339|469133826|FG004|Overall Study|Sponsor Decision|2|||
130318838|NCT05435339|469133827|FG005|Overall Study|Sponsor Decision|1|||
130318839|NCT05435339|469133828|FG006|Overall Study|Sponsor Decision|2|||
130318840|NCT05435339|469133829|FG007|Overall Study|Sponsor Decision|2|||
130318841|NCT05435339|469133822|FG000|Overall Study|Withdrawal by Subject|0|||
130318842|NCT05435339|469133823|FG001|Overall Study|Withdrawal by Subject|0|||
130318843|NCT05435339|469133824|FG002|Overall Study|Withdrawal by Subject|0|||
130318844|NCT05435339|469133825|FG003|Overall Study|Withdrawal by Subject|0|||
130318845|NCT05435339|469133826|FG004|Overall Study|Withdrawal by Subject|1|||
130318846|NCT05435339|469133827|FG005|Overall Study|Withdrawal by Subject|0|||
130318847|NCT05435339|469133828|FG006|Overall Study|Withdrawal by Subject|1|||
130318848|NCT05435339|469133829|FG007|Overall Study|Withdrawal by Subject|1|||
130318849|NCT03473236|469133834|FG000|Overall Study|Withdrawal by Subject|0|||
130318850|NCT03473236|469133835|FG001|Overall Study|Withdrawal by Subject|0|||
130318851|NCT03473236|469133836|FG002|Overall Study|Withdrawal by Subject|0|||
130318852|NCT03473236|469133837|FG003|Overall Study|Withdrawal by Subject|0|||
130318853|NCT03473236|469133838|FG004|Overall Study|Withdrawal by Subject|0|||
130318854|NCT03473236|469133839|FG005|Overall Study|Withdrawal by Subject|1|||
130318855|NCT03473236|469133840|FG006|Overall Study|Withdrawal by Subject|0|||
130318856|NCT03473236|469133841|FG007|Overall Study|Withdrawal by Subject|0|||
130318857|NCT03473236|469133842|FG008|Overall Study|Withdrawal by Subject|1|||
130318858|NCT03473236|469133843|FG009|Overall Study|Withdrawal by Subject|0|||
130318859|NCT03155724|469133844|FG000|Overall Study|Death|3|||
130318860|NCT03155724|469133844|FG000|Overall Study|Physician Decision|1|||
130318861|NCT03155724|469133844|FG000|Overall Study|Study closure|7|||
130318862|NCT00849940|469133845|FG000|Overall Study|Physician Decision|4|||
130318863|NCT01400698|469133847|FG000|Overall Study|Lost to Follow-up|2|||
130318864|NCT01400698|469133848|FG001|Overall Study|Lost to Follow-up|5|||
130318865|NCT01400698|469133849|FG002|Overall Study|Lost to Follow-up|2|||
130318866|NCT01400698|469133850|FG003|Overall Study|Lost to Follow-up|1|||
130318867|NCT01400698|469133851|FG004|Overall Study|Lost to Follow-up|4|||
130318868|NCT01400698|469133852|FG005|Overall Study|Lost to Follow-up|3|||
130318869|NCT01400698|469133847|FG000|Overall Study|Withdrawal by Subject|8|||
130318870|NCT01400698|469133848|FG001|Overall Study|Withdrawal by Subject|2|||
130318871|NCT01400698|469133849|FG002|Overall Study|Withdrawal by Subject|0|||
130318872|NCT01400698|469133850|FG003|Overall Study|Withdrawal by Subject|4|||
130318873|NCT01400698|469133851|FG004|Overall Study|Withdrawal by Subject|1|||
130318874|NCT01400698|469133852|FG005|Overall Study|Withdrawal by Subject|3|||
130318875|NCT01400698|469133847|FG000|Overall Study|Protocol Violation|0|||
130318876|NCT01400698|469133848|FG001|Overall Study|Protocol Violation|1|||
130318877|NCT01400698|469133849|FG002|Overall Study|Protocol Violation|0|||
130318878|NCT01400698|469133850|FG003|Overall Study|Protocol Violation|0|||
130318879|NCT01400698|469133851|FG004|Overall Study|Protocol Violation|1|||
130318880|NCT01400698|469133852|FG005|Overall Study|Protocol Violation|0|||
130318881|NCT01400698|469133847|FG000|Overall Study|Non-compliance|0|||
130318882|NCT01400698|469133848|FG001|Overall Study|Non-compliance|1|||
130318883|NCT01400698|469133849|FG002|Overall Study|Non-compliance|0|||
130318884|NCT01400698|469133850|FG003|Overall Study|Non-compliance|1|||
130318885|NCT01400698|469133851|FG004|Overall Study|Non-compliance|0|||
130318886|NCT01400698|469133852|FG005|Overall Study|Non-compliance|0|||
130318887|NCT01400698|469133847|FG000|Overall Study|Adverse Event|1|||
130318888|NCT01400698|469133848|FG001|Overall Study|Adverse Event|0|||
130318889|NCT01400698|469133849|FG002|Overall Study|Adverse Event|0|||
130318890|NCT01400698|469133850|FG003|Overall Study|Adverse Event|0|||
130318891|NCT01400698|469133851|FG004|Overall Study|Adverse Event|0|||
130318892|NCT01400698|469133852|FG005|Overall Study|Adverse Event|0|||
130318893|NCT01400698|469133847|FG000|Overall Study|Other|4|||
130318894|NCT01400698|469133848|FG001|Overall Study|Other|2|||
130318895|NCT01400698|469133849|FG002|Overall Study|Other|0|||
130318896|NCT01400698|469133850|FG003|Overall Study|Other|2|||
130318897|NCT01400698|469133851|FG004|Overall Study|Other|1|||
130318898|NCT01400698|469133852|FG005|Overall Study|Other|0|||
130318899|NCT02587520|469135329|FG000|Overall Study|Protocol Violation|2|||
130318900|NCT02587520|469135330|FG001|Overall Study|Protocol Violation|0|||
130318901|NCT02587520|469135331|FG002|Overall Study|Protocol Violation|0|||
130318902|NCT02587520|469135332|FG003|Overall Study|Protocol Violation|2|||
130318903|NCT02587520|469135333|FG004|Overall Study|Protocol Violation|0|||
130318904|NCT02587520|469135334|FG005|Overall Study|Protocol Violation|1|||
130207535|NCT02407054|468718984|FG000|Overall Study|Non-compliance with Study|0|||
130318905|NCT02587520|469135335|FG006|Overall Study|Protocol Violation|1|||
130318906|NCT02587520|469135336|FG007|Overall Study|Protocol Violation|1|||
130318907|NCT02587520|469135337|FG008|Overall Study|Protocol Violation|3|||
130318908|NCT02587520|469135338|FG009|Overall Study|Protocol Violation|3|||
130318909|NCT02587520|469135339|FG010|Overall Study|Protocol Violation|1|||
130318910|NCT02587520|469135340|FG011|Overall Study|Protocol Violation|2|||
130318911|NCT02587520|469135341|FG012|Overall Study|Protocol Violation|0|||
130318912|NCT02587520|469135342|FG013|Overall Study|Protocol Violation|0|||
130318913|NCT02587520|469135343|FG014|Overall Study|Protocol Violation|0|||
130318914|NCT02587520|469135344|FG015|Overall Study|Protocol Violation|0|||
130318915|NCT02587520|469135345|FG016|Overall Study|Protocol Violation|0|||
130318916|NCT02587520|469135346|FG017|Overall Study|Protocol Violation|0|||
130318917|NCT02587520|469135329|FG000|Overall Study|Adverse Event|0|||
130318918|NCT02587520|469135330|FG001|Overall Study|Adverse Event|0|||
130318919|NCT02587520|469135331|FG002|Overall Study|Adverse Event|0|||
130318920|NCT02587520|469135332|FG003|Overall Study|Adverse Event|0|||
130318921|NCT02587520|469135333|FG004|Overall Study|Adverse Event|0|||
130318922|NCT02587520|469135334|FG005|Overall Study|Adverse Event|0|||
130318923|NCT02587520|469135335|FG006|Overall Study|Adverse Event|0|||
130207536|NCT02407054|468718985|FG001|Overall Study|Non-compliance with Study|2|||
130207537|NCT02407054|468718986|FG002|Overall Study|Non-compliance with Study|1|||
130207538|NCT02407054|468718984|FG000|Overall Study|Physician Decision|1|||
130207539|NCT02407054|468718985|FG001|Overall Study|Physician Decision|3|||
130207540|NCT02407054|468718986|FG002|Overall Study|Physician Decision|3|||
130207541|NCT02407054|468718984|FG000|Overall Study|Withdrawal by Subject|5|||
130207542|NCT02407054|468718985|FG001|Overall Study|Withdrawal by Subject|9|||
130207543|NCT02407054|468718986|FG002|Overall Study|Withdrawal by Subject|2|||
130207544|NCT00131365|468718987|FG000|Overall Study|Withdrawal by Subject|1|||
130207545|NCT00131365|468718987|FG000|Overall Study|Alternative treatment|3|||
130207546|NCT04608344|468718988|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
130207547|NCT04608344|468718989|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
130207548|NCT04608344|468718988|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
130207549|NCT04608344|468718989|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
130207550|NCT02044874|468718990|FG000|Overall Study|Adverse Event|5|||
130207551|NCT02044874|468718991|FG001|Overall Study|Adverse Event|6|||
130207552|NCT02044874|468718992|FG002|Overall Study|Adverse Event|6|||
130207553|NCT02044874|468718990|FG000|Overall Study|Withdrawal by Subject|8|||
130207554|NCT02044874|468718991|FG001|Overall Study|Withdrawal by Subject|16|||
130207555|NCT02044874|468718992|FG002|Overall Study|Withdrawal by Subject|23|||
130207556|NCT02044874|468718990|FG000|Overall Study|Physician Decision|0|||
130207557|NCT02044874|468718991|FG001|Overall Study|Physician Decision|2|||
130207558|NCT02044874|468718992|FG002|Overall Study|Physician Decision|1|||
130207559|NCT02044874|468718990|FG000|Overall Study|Lost to Follow-up|10|||
130207560|NCT02044874|468718991|FG001|Overall Study|Lost to Follow-up|27|||
130207561|NCT02044874|468718992|FG002|Overall Study|Lost to Follow-up|21|||
130207562|NCT02044874|468718990|FG000|Overall Study|Sponsor Decision|0|||
130207563|NCT02044874|468718991|FG001|Overall Study|Sponsor Decision|1|||
130207564|NCT02044874|468718992|FG002|Overall Study|Sponsor Decision|1|||
130207565|NCT02044874|468718990|FG000|Overall Study|Other|7|||
130207566|NCT02044874|468718991|FG001|Overall Study|Other|3|||
130207567|NCT02044874|468718992|FG002|Overall Study|Other|8|||
130207568|NCT00415597|468718993|FG000|Enrollment|Withdrawal by Subject|1|||
130207569|NCT00415597|468718993|FG000|Enrollment|Protocol Violation|1|||
130207570|NCT00415597|468718993|FG000|Treatment|Adverse Event|110|||
130207571|NCT00415597|468718993|FG000|Treatment|Lack of Efficacy|39|||
130207572|NCT00415597|468718993|FG000|Treatment|Protocol Violation|67|||
130207573|NCT00415597|468718993|FG000|Treatment|Physician Decision|3|||
130207574|NCT00415597|468718993|FG000|Treatment|Withdrawal by Subject|51|||
130207575|NCT00415597|468718993|FG000|Treatment|Lost to Follow-up|28|||
130207576|NCT00415597|468718993|FG000|Treatment|Drug Screen|2|||
130207577|NCT00415597|468718993|FG000|Treatment|Administrative|3|||
130207578|NCT00415597|468718993|FG000|Treatment|Sponsor Decision|1|||
130207579|NCT00415597|468718993|FG000|Treatment|Multiple Reasons|1|||
130207580|NCT01447927|468718994|FG000|Overall Study|Adverse Event|4|||
130207581|NCT01447927|468718995|FG001|Overall Study|Adverse Event|3|||
130207582|NCT01447927|468718994|FG000|Overall Study|Withdrawal by Subject|1|||
130207583|NCT01447927|468718995|FG001|Overall Study|Withdrawal by Subject|0|||
130207584|NCT04102865|468718997|FG000|Overall Study|Adverse Event|4|||
130207585|NCT04102865|468718998|FG001|Overall Study|Adverse Event|0|||
130207586|NCT04102865|468718997|FG000|Overall Study|Lost to Follow-up|1|||
130207587|NCT04102865|468718998|FG001|Overall Study|Lost to Follow-up|0|||
130207588|NCT04102865|468718997|FG000|Overall Study|Withdrawal by Subject|2|||
130207589|NCT04102865|468718998|FG001|Overall Study|Withdrawal by Subject|0|||
130207590|NCT01764997|468718999|FG000|Run-in Period|Adverse Event|15|||
130207591|NCT01764997|468719000|FG001|Run-in Period|Adverse Event|0|||
130207592|NCT01764997|468719001|FG002|Run-in Period|Adverse Event|0|||
130207593|NCT01764997|468719002|FG003|Run-in Period|Adverse Event|0|||
130207594|NCT01764997|468719003|FG004|Run-in Period|Adverse Event|0|||
130318924|NCT02587520|469135336|FG007|Overall Study|Adverse Event|0|||
130429460|NCT01984697|469535317|FG002|Overall Study|Death|0|||
130429461|NCT01984697|469535318|FG003|Overall Study|Death|1|||
130429462|NCT01984697|469535319|FG004|Overall Study|Death|0|||
130429463|NCT01984697|469535315|FG000|Overall Study|Pregnancy|2|||
130429464|NCT01984697|469535316|FG001|Overall Study|Pregnancy|0|||
130429465|NCT01984697|469535317|FG002|Overall Study|Pregnancy|1|||
130429466|NCT01984697|469535318|FG003|Overall Study|Pregnancy|0|||
130429467|NCT01984697|469535319|FG004|Overall Study|Pregnancy|1|||
130429468|NCT00847405|469535320|FG000|First Intervention|Adverse Event|0|||
130429469|NCT00847405|469535321|FG001|First Intervention|Adverse Event|1|||
130429470|NCT00847405|469535320|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130429471|NCT00847405|469535321|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130429472|NCT02710292|469535328|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
130429473|NCT02710292|469535329|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
130429474|NCT02710292|469535328|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
130429475|NCT02710292|469535329|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
130429476|NCT00710606|469535336|FG000|Overall Study|Adverse Event|0|||
130429477|NCT00710606|469535337|FG001|Overall Study|Adverse Event|2|||
130429478|NCT00514683|469535342|FG000|Overall Study|Not treated|2|||
130429479|NCT00514683|469535343|FG001|Overall Study|Not treated|1|||
130429480|NCT00514683|469535344|FG002|Overall Study|Not treated|0|||
130429481|NCT00514683|469535345|FG003|Overall Study|Not treated|0|||
130429482|NCT00514683|469535346|FG004|Overall Study|Not treated|1|||
130429483|NCT00514683|469535342|FG000|Overall Study|Adverse Event|21|||
130429484|NCT00514683|469535343|FG001|Overall Study|Adverse Event|20|||
130429485|NCT00514683|469535344|FG002|Overall Study|Adverse Event|15|||
130429486|NCT00514683|469535345|FG003|Overall Study|Adverse Event|13|||
130429487|NCT00514683|469535346|FG004|Overall Study|Adverse Event|27|||
130429488|NCT00514683|469535342|FG000|Overall Study|Protocol Violation|1|||
130429489|NCT00514683|469535343|FG001|Overall Study|Protocol Violation|1|||
130429490|NCT00514683|469535344|FG002|Overall Study|Protocol Violation|0|||
130429491|NCT00514683|469535345|FG003|Overall Study|Protocol Violation|1|||
130429492|NCT00514683|469535346|FG004|Overall Study|Protocol Violation|0|||
130429493|NCT00514683|469535342|FG000|Overall Study|Withdrawal by Subject|2|||
130429494|NCT00514683|469535343|FG001|Overall Study|Withdrawal by Subject|2|||
130429495|NCT00514683|469535344|FG002|Overall Study|Withdrawal by Subject|1|||
130429496|NCT00514683|469535345|FG003|Overall Study|Withdrawal by Subject|0|||
130429497|NCT00514683|469535346|FG004|Overall Study|Withdrawal by Subject|4|||
130429498|NCT00514683|469535342|FG000|Overall Study|Reason other than listed above|0|||
130429499|NCT00514683|469535343|FG001|Overall Study|Reason other than listed above|1|||
130429500|NCT00514683|469535344|FG002|Overall Study|Reason other than listed above|2|||
130429501|NCT00514683|469535345|FG003|Overall Study|Reason other than listed above|0|||
130429502|NCT00514683|469535346|FG004|Overall Study|Reason other than listed above|1|||
130429503|NCT00335452|469535347|FG000|Overall Study|Death|156|||
130429504|NCT00335452|469535348|FG001|Overall Study|Death|144|||
130429505|NCT00335452|469535349|FG002|Overall Study|Death|158|||
130429506|NCT00335452|469535350|FG003|Overall Study|Death|129|||
130429507|NCT00335452|469535347|FG000|Overall Study|Lost to Follow-up|2|||
130429508|NCT00335452|469535348|FG001|Overall Study|Lost to Follow-up|3|||
130429509|NCT00335452|469535349|FG002|Overall Study|Lost to Follow-up|1|||
130429510|NCT00335452|469535350|FG003|Overall Study|Lost to Follow-up|2|||
130429511|NCT02736825|469535352|FG000|Overall Study|Lost to Follow-up|10|||
130429512|NCT02736825|469535353|FG001|Overall Study|Lost to Follow-up|11|||
130429513|NCT02736825|469535352|FG000|Overall Study|Early Termination|0|||
130429514|NCT02736825|469535353|FG001|Overall Study|Early Termination|1|||
130429515|NCT01564368|469535362|FG000|Overall Study|Ineligible|18|||
130429516|NCT01564368|469535362|FG000|Overall Study|Not Randomized in Parent study|116|||
130429517|NCT01564368|469535362|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
130429518|NCT01564368|469535362|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
130429519|NCT02901626|469535363|FG000|Overall Study|Lost to Follow-up|1|||
130429520|NCT02901626|469535364|FG001|Overall Study|Lost to Follow-up|1|||
130429521|NCT00331344|469535365|FG000|Phase I|Adverse Event|0|||
130429522|NCT00331344|469535366|FG001|Phase I|Adverse Event|0|||
130429523|NCT00331344|469535367|FG002|Phase I|Adverse Event|0|||
130429524|NCT00331344|469535368|FG003|Phase I|Adverse Event|1|||
130540881|NCT02270515|469947200|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
130429525|NCT00331344|469535369|FG004|Phase I|Adverse Event|2|||
130429526|NCT00331344|469535370|FG005|Phase I|Adverse Event|2|||
130429527|NCT00331344|469535371|FG006|Phase I|Adverse Event|0|||
130429528|NCT00331344|469535372|FG007|Phase I|Adverse Event|1|||
130429529|NCT00331344|469535373|FG008|Phase I|Adverse Event|0|||
130429530|NCT00331344|469535365|FG000|Phase II|Death|0|||
130429531|NCT00331344|469535366|FG001|Phase II|Death|0|||
130429532|NCT00331344|469535367|FG002|Phase II|Death|0|||
130429533|NCT00331344|469535368|FG003|Phase II|Death|0|||
130429534|NCT00331344|469535369|FG004|Phase II|Death|0|||
130429535|NCT00331344|469535370|FG005|Phase II|Death|0|||
130429536|NCT00331344|469535371|FG006|Phase II|Death|0|||
130429537|NCT00331344|469535372|FG007|Phase II|Death|0|||
130429538|NCT00331344|469535373|FG008|Phase II|Death|4|||
130652182|NCT01740297|470349350|FG001|Overall Study|Death|46|||
130429539|NCT01373931|469535374|FG000|Lead-in Period|Adverse Event|2|||
130429540|NCT01373931|469535375|FG001|Lead-in Period|Adverse Event|0|||
130429541|NCT01373931|469535374|FG000|Period 1|Adverse Event|2|||
130429542|NCT01373931|469535375|FG001|Period 1|Adverse Event|0|||
130429543|NCT01373931|469535374|FG000|Period 1|Withdrawal by Subject|0|||
130429544|NCT01373931|469535375|FG001|Period 1|Withdrawal by Subject|2|||
130429545|NCT04857034|469535376|FG000|Placebo-Controlled Period|Request to discontinue|2|||
130429546|NCT04857034|469535377|FG001|Placebo-Controlled Period|Request to discontinue|2|||
130429547|NCT04857034|469535378|FG002|Placebo-Controlled Period|Request to discontinue|0|||
130429548|NCT04857034|469535379|FG003|Placebo-Controlled Period|Request to discontinue|0|||
130429549|NCT04857034|469535380|FG004|Placebo-Controlled Period|Request to discontinue|0|||
130429550|NCT04857034|469535376|FG000|Placebo-Controlled Period|withdrew consent|1|||
130429551|NCT04857034|469535377|FG001|Placebo-Controlled Period|withdrew consent|1|||
130429552|NCT04857034|469535378|FG002|Placebo-Controlled Period|withdrew consent|2|||
130429553|NCT04857034|469535379|FG003|Placebo-Controlled Period|withdrew consent|0|||
130429554|NCT04857034|469535380|FG004|Placebo-Controlled Period|withdrew consent|0|||
130429555|NCT04857034|469535376|FG000|Placebo-Controlled Period|Pregnancy|1|||
130429556|NCT04857034|469535377|FG001|Placebo-Controlled Period|Pregnancy|1|||
130429557|NCT04857034|469535378|FG002|Placebo-Controlled Period|Pregnancy|0|||
130429558|NCT04857034|469535379|FG003|Placebo-Controlled Period|Pregnancy|0|||
130429559|NCT04857034|469535380|FG004|Placebo-Controlled Period|Pregnancy|0|||
130429560|NCT04857034|469535376|FG000|Placebo-Controlled Period|Ongoing study period|0|||
130429561|NCT04857034|469535377|FG001|Placebo-Controlled Period|Ongoing study period|1|||
130429562|NCT04857034|469535378|FG002|Placebo-Controlled Period|Ongoing study period|0|||
130429563|NCT04857034|469535379|FG003|Placebo-Controlled Period|Ongoing study period|0|||
130429564|NCT04857034|469535380|FG004|Placebo-Controlled Period|Ongoing study period|0|||
130429565|NCT04857034|469535376|FG000|Active Treatment Period|Lack of Efficacy|1|||
130429566|NCT04857034|469535377|FG001|Active Treatment Period|Lack of Efficacy|0|||
130429567|NCT04857034|469535378|FG002|Active Treatment Period|Lack of Efficacy|0|||
130429568|NCT04857034|469535379|FG003|Active Treatment Period|Lack of Efficacy|0|||
130429569|NCT04857034|469535380|FG004|Active Treatment Period|Lack of Efficacy|0|||
130429570|NCT04857034|469535376|FG000|Active Treatment Period|request to discontinue|0|||
130429571|NCT04857034|469535377|FG001|Active Treatment Period|request to discontinue|1|||
130429572|NCT04857034|469535378|FG002|Active Treatment Period|request to discontinue|0|||
130429573|NCT04857034|469535379|FG003|Active Treatment Period|request to discontinue|1|||
130429574|NCT04857034|469535380|FG004|Active Treatment Period|request to discontinue|0|||
130429575|NCT04857034|469535376|FG000|Active Treatment Period|administrative reason by sponsor|1|||
130429576|NCT04857034|469535377|FG001|Active Treatment Period|administrative reason by sponsor|5|||
130429577|NCT04857034|469535378|FG002|Active Treatment Period|administrative reason by sponsor|0|||
130429578|NCT04857034|469535379|FG003|Active Treatment Period|administrative reason by sponsor|2|||
130429579|NCT04857034|469535380|FG004|Active Treatment Period|administrative reason by sponsor|2|||
130429580|NCT04857034|469535376|FG000|Active Treatment Period|other reasons|1|||
130429581|NCT04857034|469535377|FG001|Active Treatment Period|other reasons|1|||
130429582|NCT04857034|469535378|FG002|Active Treatment Period|other reasons|0|||
130429583|NCT04857034|469535379|FG003|Active Treatment Period|other reasons|0|||
130429584|NCT04857034|469535380|FG004|Active Treatment Period|other reasons|1|||
130429585|NCT04857034|469535376|FG000|Active Treatment Period|Ongoing Study Period|2|||
130429586|NCT04857034|469535377|FG001|Active Treatment Period|Ongoing Study Period|4|||
130429587|NCT04857034|469535378|FG002|Active Treatment Period|Ongoing Study Period|0|||
130429588|NCT04857034|469535379|FG003|Active Treatment Period|Ongoing Study Period|1|||
130429589|NCT04857034|469535380|FG004|Active Treatment Period|Ongoing Study Period|0|||
130429590|NCT00659490|469535381|FG000|Overall Study|Lost to Follow-up|2|||
130429591|NCT00659490|469535382|FG001|Overall Study|Lost to Follow-up|0|||
130429592|NCT00659490|469535383|FG002|Overall Study|Lost to Follow-up|1|||
130429593|NCT05674890|469535388|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
130429594|NCT05674890|469535389|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
130429595|NCT05674890|469535388|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
130429596|NCT05674890|469535389|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
130429597|NCT05674890|469535388|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
130429598|NCT05674890|469535389|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
130429599|NCT00827541|469535390|FG000|Overall Study|Exitus|1|||
130429600|NCT00827541|469535391|FG001|Overall Study|Exitus|8|||
130429601|NCT00827541|469535390|FG000|Overall Study|Other|1|||
130429602|NCT00827541|469535391|FG001|Overall Study|Other|3|||
130429603|NCT00827541|469535390|FG000|Overall Study|Pathogen not susceptible|1|||
130429604|NCT00827541|469535391|FG001|Overall Study|Pathogen not susceptible|0|||
130429605|NCT00827541|469535390|FG000|Overall Study|Lack of effectiveness|1|||
130429606|NCT00827541|469535391|FG001|Overall Study|Lack of effectiveness|0|||
130429607|NCT01649232|469535392|FG000|Overall Study|Physician Decision|2|||
130429608|NCT01649232|469535393|FG001|Overall Study|Physician Decision|0|||
130429609|NCT02228967|469535394|FG000|Overall Study|Lost to Follow-up|146|||
130652183|NCT01740297|470349351|FG002|Overall Study|Death|40|||
130652184|NCT01740297|470349349|FG000|Overall Study|Lost to Follow-up|1|||
130429610|NCT02228967|469535395|FG001|Overall Study|Lost to Follow-up|142|||
130429611|NCT02228967|469535394|FG000|Overall Study|Withdrawal by Subject|13|||
130429612|NCT02228967|469535395|FG001|Overall Study|Withdrawal by Subject|18|||
130429613|NCT00520975|469535396|FG000|Overall Study|Disease progression|31|||
130429614|NCT00520975|469535397|FG001|Overall Study|Disease progression|23|||
130429615|NCT00520975|469535396|FG000|Overall Study|Adverse Event|7|||
130429616|NCT00520975|469535397|FG001|Overall Study|Adverse Event|10|||
130429617|NCT00520975|469535396|FG000|Overall Study|Death|0|||
130429618|NCT00520975|469535397|FG001|Overall Study|Death|2|||
130429619|NCT00520975|469535396|FG000|Overall Study|Withdrawal by Subject|3|||
130429620|NCT00520975|469535397|FG001|Overall Study|Withdrawal by Subject|5|||
130429621|NCT00520975|469535396|FG000|Overall Study|Other therapy|2|||
130429622|NCT00520975|469535397|FG001|Overall Study|Other therapy|4|||
130429623|NCT00520975|469535396|FG000|Overall Study|Other reasons|4|||
130429624|NCT00520975|469535397|FG001|Overall Study|Other reasons|2|||
130429625|NCT00520975|469535396|FG000|Overall Study|Not start protocol therapy|1|||
130429626|NCT00520975|469535397|FG001|Overall Study|Not start protocol therapy|2|||
130429627|NCT04810221|469535398|FG000|Overall Study|Physician Decision|3|||
130429628|NCT03642938|469535399|FG000|Overall Study|Withdrawal by Subject|0|||
130429629|NCT03642938|469535400|FG001|Overall Study|Withdrawal by Subject|0|||
130429630|NCT03642938|469535401|FG002|Overall Study|Withdrawal by Subject|0|||
130429631|NCT03642938|469535402|FG003|Overall Study|Withdrawal by Subject|1|||
130429632|NCT00105235|469535403|FG000|Overall Study|Death|4|||
130429633|NCT00105235|469535403|FG000|Overall Study|Physician Decision|1|||
130429634|NCT00105235|469535403|FG000|Overall Study|Withdrawal by Subject|2|||
130429635|NCT01964326|469535404|FG000|Overall Study|Adverse Event|48|||
130429636|NCT01964326|469535404|FG000|Overall Study|Death|2|||
130207595|NCT01764997|468718999|FG000|Run-in Period|Lack of Efficacy|5|||
130207596|NCT01764997|468719000|FG001|Run-in Period|Lack of Efficacy|0|||
130207597|NCT01764997|468719001|FG002|Run-in Period|Lack of Efficacy|0|||
130207598|NCT01764997|468719002|FG003|Run-in Period|Lack of Efficacy|0|||
130207599|NCT01764997|468719003|FG004|Run-in Period|Lack of Efficacy|0|||
130207600|NCT01764997|468718999|FG000|Run-in Period|Poor compliance to protocol|1|||
130207601|NCT01764997|468719000|FG001|Run-in Period|Poor compliance to protocol|0|||
130207602|NCT01764997|468719001|FG002|Run-in Period|Poor compliance to protocol|0|||
130207603|NCT01764997|468719002|FG003|Run-in Period|Poor compliance to protocol|0|||
130207604|NCT01764997|468719003|FG004|Run-in Period|Poor compliance to protocol|0|||
130207605|NCT01764997|468718999|FG000|Run-in Period|Other than specified above|17|||
130207606|NCT01764997|468719000|FG001|Run-in Period|Other than specified above|0|||
130207607|NCT01764997|468719001|FG002|Run-in Period|Other than specified above|0|||
130207608|NCT01764997|468719002|FG003|Run-in Period|Other than specified above|0|||
130207609|NCT01764997|468719003|FG004|Run-in Period|Other than specified above|0|||
130207610|NCT01764997|468718999|FG000|Study Drug Treatment Period|Adverse Event|0|||
130207611|NCT01764997|468719000|FG001|Study Drug Treatment Period|Adverse Event|1|||
130207612|NCT01764997|468719001|FG002|Study Drug Treatment Period|Adverse Event|0|||
130207613|NCT01764997|468719002|FG003|Study Drug Treatment Period|Adverse Event|0|||
130207614|NCT01764997|468719003|FG004|Study Drug Treatment Period|Adverse Event|24|||
130207615|NCT01764997|468718999|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
130318925|NCT02587520|469135337|FG008|Overall Study|Adverse Event|0|||
130318926|NCT02587520|469135338|FG009|Overall Study|Adverse Event|0|||
130318927|NCT02587520|469135339|FG010|Overall Study|Adverse Event|0|||
130318928|NCT02587520|469135340|FG011|Overall Study|Adverse Event|1|||
130318929|NCT02587520|469135341|FG012|Overall Study|Adverse Event|0|||
130318930|NCT02587520|469135342|FG013|Overall Study|Adverse Event|0|||
130318931|NCT02587520|469135343|FG014|Overall Study|Adverse Event|0|||
130318932|NCT02587520|469135344|FG015|Overall Study|Adverse Event|0|||
130318933|NCT02587520|469135345|FG016|Overall Study|Adverse Event|0|||
130318934|NCT02587520|469135346|FG017|Overall Study|Adverse Event|0|||
130318935|NCT02587520|469135329|FG000|Overall Study|Withdrawal by Subject|0|||
130318936|NCT02587520|469135330|FG001|Overall Study|Withdrawal by Subject|0|||
130318937|NCT02587520|469135331|FG002|Overall Study|Withdrawal by Subject|1|||
130318938|NCT02587520|469135332|FG003|Overall Study|Withdrawal by Subject|1|||
130318939|NCT02587520|469135333|FG004|Overall Study|Withdrawal by Subject|0|||
130318940|NCT02587520|469135334|FG005|Overall Study|Withdrawal by Subject|1|||
130540882|NCT02270515|469947200|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
130540883|NCT02270515|469947200|FG000|Intervention Period 2: 6-12 Months|Death|5|||
130652185|NCT01740297|470349350|FG001|Overall Study|Lost to Follow-up|2|||
130207616|NCT01764997|468719000|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
130207617|NCT01764997|468719001|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
130207618|NCT01764997|468719002|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
130318941|NCT02587520|469135335|FG006|Overall Study|Withdrawal by Subject|1|||
130318942|NCT02587520|469135336|FG007|Overall Study|Withdrawal by Subject|0|||
130318943|NCT02587520|469135337|FG008|Overall Study|Withdrawal by Subject|0|||
130318944|NCT02587520|469135338|FG009|Overall Study|Withdrawal by Subject|0|||
130429637|NCT01964326|469535404|FG000|Overall Study|Protocol Violation|4|||
130429638|NCT01964326|469535404|FG000|Overall Study|Lost to Follow-up|88|||
130429639|NCT01964326|469535404|FG000|Overall Study|Withdrawal by Subject|87|||
130429640|NCT01964326|469535404|FG000|Overall Study|Pregnancy|1|||
130318945|NCT02587520|469135339|FG010|Overall Study|Withdrawal by Subject|0|||
130318946|NCT02587520|469135340|FG011|Overall Study|Withdrawal by Subject|0|||
130318947|NCT02587520|469135341|FG012|Overall Study|Withdrawal by Subject|0|||
130318948|NCT02587520|469135342|FG013|Overall Study|Withdrawal by Subject|1|||
130318949|NCT02587520|469135343|FG014|Overall Study|Withdrawal by Subject|0|||
130318950|NCT02587520|469135344|FG015|Overall Study|Withdrawal by Subject|0|||
130318951|NCT02587520|469135345|FG016|Overall Study|Withdrawal by Subject|0|||
130318952|NCT02587520|469135346|FG017|Overall Study|Withdrawal by Subject|0|||
130318953|NCT02587520|469135329|FG000|Overall Study|Lost to Follow-up|0|||
130429641|NCT01964326|469535404|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
130429642|NCT01964326|469535404|FG000|Overall Study|Physician Decision|55|||
130429643|NCT01964326|469535404|FG000|Overall Study|Investigator Discretion|1|||
130429644|NCT01964326|469535404|FG000|Overall Study|Other|9|||
130429645|NCT01964326|469535404|FG000|Overall Study|Did not meet eligibility criteria|1|||
130429646|NCT02347657|469535405|FG000|Overall Study|Physician Decision|0|||
130540884|NCT02270515|469947200|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
130540885|NCT02270515|469947200|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
130540886|NCT02270515|469947200|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
130540887|NCT02270515|469947200|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
130540888|NCT02270515|469947200|FG000|Intervention Period 3: 12-18 Months|Death|3|||
130540889|NCT02270515|469947200|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
130540890|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
130540891|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
130540892|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
130540893|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
130540894|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
130540895|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
130540896|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
130540897|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
130540898|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
130540899|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
130540900|NCT01237587|469947203|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
130540901|NCT01237587|469947204|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
130540902|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
130540903|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
130540904|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
130540905|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
130540906|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
130540907|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
130540908|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
130540909|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
130540910|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
130540911|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
130540912|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
130540913|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
130540914|NCT01237587|469947203|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
130540915|NCT01237587|469947204|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
130540916|NCT01237587|469947203|FG000|Taper Phase|Adverse Event|0|||
130540917|NCT01237587|469947204|FG001|Taper Phase|Adverse Event|2|||
130540918|NCT01237587|469947203|FG000|Taper Phase|Protocol Violation|2|||
130540919|NCT01237587|469947204|FG001|Taper Phase|Protocol Violation|0|||
130540920|NCT01237587|469947203|FG000|Taper Phase|Lack of Efficacy|2|||
130540921|NCT01237587|469947204|FG001|Taper Phase|Lack of Efficacy|5|||
130540922|NCT01237587|469947203|FG000|Taper Phase|Parent/Guardian Decision|0|||
130540923|NCT01237587|469947204|FG001|Taper Phase|Parent/Guardian Decision|2|||
130540924|NCT01237587|469947203|FG000|Taper Phase|Sponsor Decision|1|||
130540925|NCT01237587|469947204|FG001|Taper Phase|Sponsor Decision|0|||
130540926|NCT01237587|469947203|FG000|Taper Phase|Withdrawal by Subject|0|||
130540927|NCT01237587|469947204|FG001|Taper Phase|Withdrawal by Subject|1|||
130318954|NCT02587520|469135330|FG001|Overall Study|Lost to Follow-up|2|||
130318955|NCT02587520|469135331|FG002|Overall Study|Lost to Follow-up|0|||
130318956|NCT02587520|469135332|FG003|Overall Study|Lost to Follow-up|2|||
130318957|NCT02587520|469135333|FG004|Overall Study|Lost to Follow-up|0|||
130318958|NCT02587520|469135334|FG005|Overall Study|Lost to Follow-up|1|||
130318959|NCT02587520|469135335|FG006|Overall Study|Lost to Follow-up|1|||
130318960|NCT02587520|469135336|FG007|Overall Study|Lost to Follow-up|1|||
130318961|NCT02587520|469135337|FG008|Overall Study|Lost to Follow-up|0|||
130318962|NCT02587520|469135338|FG009|Overall Study|Lost to Follow-up|2|||
130429647|NCT02347657|469535406|FG001|Overall Study|Physician Decision|1|||
130429648|NCT02347657|469535405|FG000|Overall Study|Adverse Event|8|||
130429649|NCT02347657|469535406|FG001|Overall Study|Adverse Event|4|||
130540928|NCT05017103|469947205|FG000|Overall Study|Death|2|||
130540929|NCT01747551|469947210|FG000|Overall Study|Progressive Disease|24|||
130540930|NCT01747551|469947211|FG001|Overall Study|Progressive Disease|17|||
130540931|NCT01747551|469947210|FG000|Overall Study|Death|3|||
130540932|NCT01747551|469947211|FG001|Overall Study|Death|1|||
130540933|NCT01747551|469947210|FG000|Overall Study|Adverse Event|7|||
130540934|NCT01747551|469947211|FG001|Overall Study|Adverse Event|1|||
130318963|NCT02587520|469135339|FG010|Overall Study|Lost to Follow-up|2|||
130318964|NCT02587520|469135340|FG011|Overall Study|Lost to Follow-up|1|||
130318965|NCT02587520|469135341|FG012|Overall Study|Lost to Follow-up|0|||
130318966|NCT02587520|469135342|FG013|Overall Study|Lost to Follow-up|0|||
130318967|NCT02587520|469135343|FG014|Overall Study|Lost to Follow-up|0|||
130318968|NCT02587520|469135344|FG015|Overall Study|Lost to Follow-up|0|||
130318969|NCT02587520|469135345|FG016|Overall Study|Lost to Follow-up|0|||
130429650|NCT02347657|469535405|FG000|Overall Study|Withdrawal by Subject|6|||
130429651|NCT02347657|469535406|FG001|Overall Study|Withdrawal by Subject|7|||
130429652|NCT02347657|469535405|FG000|Overall Study|Randomized but not treated|1|||
130429653|NCT02347657|469535406|FG001|Overall Study|Randomized but not treated|0|||
130429654|NCT02347657|469535405|FG000|Overall Study|Other|3|||
130429655|NCT02347657|469535406|FG001|Overall Study|Other|3|||
130429656|NCT01995539|469535407|FG000|Overall Study|Screening Failure|1|||
130429657|NCT01995539|469535407|FG000|Overall Study|Withdrawal by Investigator|15|||
130429658|NCT01995539|469535407|FG000|Overall Study|Withdrawal by Subject|11|||
130429659|NCT01995539|469535407|FG000|Overall Study|Lost to Follow-up|5|||
130429660|NCT01995539|469535407|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
130429661|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
130429662|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
130429663|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
130429664|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
130429665|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
130429666|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
130429667|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
130429668|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
130429669|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
130429670|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
130429671|NCT00261495|469535408|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
130429672|NCT00261495|469535409|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
130429673|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
130429674|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
130429675|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
130429676|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
130429677|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
130429678|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
130429679|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
130429680|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
130429681|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
130429682|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
130429683|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
130429684|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
130429685|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
130429686|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
130429687|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
130429688|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
130429689|NCT00261495|469535408|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
130429690|NCT00261495|469535409|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
130429691|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
130429692|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
130429693|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
130429694|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130540935|NCT01747551|469947210|FG000|Overall Study|Prolonged Treatment Delay|2|||
130318970|NCT02587520|469135346|FG017|Overall Study|Lost to Follow-up|0|||
130318971|NCT03924622|469135347|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
130318972|NCT03924622|469135348|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318973|NCT03924622|469135349|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318974|NCT03924622|469135350|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
130318975|NCT03924622|469135351|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318976|NCT03924622|469135352|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318977|NCT02412306|469135354|FG000|Overall Study|Lost to Follow-up|0|||
130318978|NCT02412306|469135355|FG001|Overall Study|Lost to Follow-up|1|||
130318979|NCT02412306|469135356|FG002|Overall Study|Lost to Follow-up|0|||
130318980|NCT02412306|469135357|FG003|Overall Study|Lost to Follow-up|0|||
130429695|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130318981|NCT02412306|469135358|FG004|Overall Study|Lost to Follow-up|0|||
130318982|NCT02412306|469135354|FG000|Overall Study|Withdrawal by Subject|0|||
130318983|NCT02412306|469135355|FG001|Overall Study|Withdrawal by Subject|0|||
130318984|NCT02412306|469135356|FG002|Overall Study|Withdrawal by Subject|1|||
130318985|NCT02412306|469135357|FG003|Overall Study|Withdrawal by Subject|0|||
130318986|NCT02412306|469135358|FG004|Overall Study|Withdrawal by Subject|0|||
130318987|NCT02412306|469135354|FG000|Overall Study|Death|5|||
130318988|NCT02412306|469135355|FG001|Overall Study|Death|7|||
130318989|NCT02412306|469135356|FG002|Overall Study|Death|15|||
130540936|NCT01747551|469947211|FG001|Overall Study|Prolonged Treatment Delay|0|||
130540937|NCT01747551|469947210|FG000|Overall Study|Withdrawal by Subject|3|||
130540938|NCT01747551|469947211|FG001|Overall Study|Withdrawal by Subject|1|||
130540939|NCT01747551|469947210|FG000|Overall Study|Physician Decision|2|||
130540940|NCT01747551|469947211|FG001|Overall Study|Physician Decision|1|||
130540941|NCT01747551|469947210|FG000|Overall Study|Other|2|||
130540942|NCT01747551|469947211|FG001|Overall Study|Other|0|||
130540943|NCT01142115|469947212|FG000|First Intervention|Lack of Efficacy|1|||
130540944|NCT01142115|469947213|FG001|First Intervention|Lack of Efficacy|1|||
130540945|NCT01142115|469947212|FG000|First Intervention|Adverse Event|1|||
130540946|NCT01142115|469947213|FG001|First Intervention|Adverse Event|0|||
130540947|NCT00633880|469947214|FG000|Open Label Titration|Lack of Efficacy|1|||
130540948|NCT00633880|469947215|FG001|Open Label Titration|Lack of Efficacy|0|||
130540949|NCT00633880|469947216|FG002|Open Label Titration|Lack of Efficacy|0|||
130540950|NCT00633880|469947214|FG000|Open Label Titration|Adverse Event|13|||
130540951|NCT00633880|469947215|FG001|Open Label Titration|Adverse Event|0|||
130540952|NCT00633880|469947216|FG002|Open Label Titration|Adverse Event|0|||
130540953|NCT00633880|469947214|FG000|Open Label Titration|Treatment Failure|55|||
130540954|NCT00633880|469947215|FG001|Open Label Titration|Treatment Failure|0|||
130540955|NCT00633880|469947216|FG002|Open Label Titration|Treatment Failure|0|||
130540956|NCT00633880|469947214|FG000|Open Label Titration|Protocol Violation|6|||
130540957|NCT00633880|469947215|FG001|Open Label Titration|Protocol Violation|0|||
130540958|NCT00633880|469947216|FG002|Open Label Titration|Protocol Violation|0|||
130540959|NCT00633880|469947214|FG000|Open Label Titration|Physician Decision|1|||
130540960|NCT00633880|469947215|FG001|Open Label Titration|Physician Decision|0|||
130540961|NCT00633880|469947216|FG002|Open Label Titration|Physician Decision|0|||
130540962|NCT00633880|469947214|FG000|Open Label Titration|Withdrawal by Subject|4|||
130540963|NCT00633880|469947215|FG001|Open Label Titration|Withdrawal by Subject|0|||
130540964|NCT00633880|469947216|FG002|Open Label Titration|Withdrawal by Subject|0|||
130540965|NCT03208036|469947217|FG000|Baseline Assessment|Withdrawal by Subject|1|||
130540966|NCT03208036|469947218|FG001|Baseline Assessment|Withdrawal by Subject|1|||
130540967|NCT03208036|469947217|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
130540968|NCT03208036|469947218|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
130540969|NCT03208036|469947217|FG000|Intervention|Withdrawal by Subject|3|||
130540970|NCT03208036|469947218|FG001|Intervention|Withdrawal by Subject|2|||
130540971|NCT03208036|469947217|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
130540972|NCT03208036|469947218|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
130540973|NCT03406078|469947219|FG000|Overall Study|Death|1|||
130540974|NCT03406078|469947220|FG001|Overall Study|Death|0|||
130540975|NCT03406078|469947219|FG000|Overall Study|Lost to Follow-up|0|||
130540976|NCT03406078|469947220|FG001|Overall Study|Lost to Follow-up|1|||
130540977|NCT03406078|469947219|FG000|Overall Study|Withdrawal by Subject|5|||
130540978|NCT03406078|469947220|FG001|Overall Study|Withdrawal by Subject|2|||
130540979|NCT02091206|469947221|FG000|Treatment Period|Adverse Event|0|||
130540980|NCT02091206|469947222|FG001|Treatment Period|Adverse Event|1|||
130540981|NCT02091206|469947223|FG002|Treatment Period|Adverse Event|0|||
130540982|NCT02091206|469947224|FG003|Treatment Period|Adverse Event|0|||
130540983|NCT02091206|469947221|FG000|Treatment Period|Met withdrawal criteria|0|||
130540984|NCT02091206|469947222|FG001|Treatment Period|Met withdrawal criteria|0|||
130540985|NCT02091206|469947223|FG002|Treatment Period|Met withdrawal criteria|1|||
130540986|NCT02091206|469947224|FG003|Treatment Period|Met withdrawal criteria|0|||
130318990|NCT02412306|469135357|FG003|Overall Study|Death|0|||
130540987|NCT02091206|469947221|FG000|Taper Period|Participant refused study drug|1|||
130652186|NCT01740297|470349351|FG002|Overall Study|Lost to Follow-up|4|||
130318991|NCT02412306|469135358|FG004|Overall Study|Death|2|||
130318992|NCT05543265|469135366|FG000|Overall Study|Lost to Follow-up|3|||
130318993|NCT05543265|469135367|FG001|Overall Study|Lost to Follow-up|3|||
130540988|NCT02091206|469947222|FG001|Taper Period|Participant refused study drug|0|||
130540989|NCT02091206|469947223|FG002|Taper Period|Participant refused study drug|0|||
130540990|NCT02091206|469947224|FG003|Taper Period|Participant refused study drug|1|||
130540991|NCT02091206|469947221|FG000|Taper Period|Lost to Follow-up|0|||
130540992|NCT02091206|469947222|FG001|Taper Period|Lost to Follow-up|0|||
130540993|NCT02091206|469947223|FG002|Taper Period|Lost to Follow-up|0|||
130540994|NCT02091206|469947224|FG003|Taper Period|Lost to Follow-up|1|||
130540995|NCT00700778|469947225|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
130540996|NCT00350103|469947229|FG000|Overall Study|Adverse Event|12|||
130318994|NCT05543265|469135366|FG000|Overall Study|Withdrawal by Subject|0|||
130318995|NCT05543265|469135367|FG001|Overall Study|Withdrawal by Subject|1|||
130318996|NCT05316597|469135368|FG000|First Session|Withdrawal by Subject|0|||
130318997|NCT05316597|469135369|FG001|First Session|Withdrawal by Subject|1|||
130318998|NCT05316597|469135368|FG000|Washout Period|Lost to Follow-up|1|||
130318999|NCT05316597|469135369|FG001|Washout Period|Lost to Follow-up|2|||
130319000|NCT05316597|469135368|FG000|Washout Period|Physician Decision|1|||
130319001|NCT05316597|469135369|FG001|Washout Period|Physician Decision|1|||
130319002|NCT05316597|469135368|FG000|Washout Period|Excluded before second session|1|||
130319003|NCT05316597|469135369|FG001|Washout Period|Excluded before second session|1|||
130319004|NCT05316597|469135368|FG000|Washout Period|Withdrawal by Subject|0|||
130319005|NCT05316597|469135369|FG001|Washout Period|Withdrawal by Subject|4|||
130319006|NCT05526716|469135370|FG000|Overall Study|Death|1|||
130429696|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
130429697|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130429698|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130429699|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
130429700|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
130429701|NCT00261495|469535408|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
130429702|NCT00261495|469535409|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130429703|NCT01059630|469535410|FG000|Overall Study|Death|100|||
130429704|NCT01059630|469535411|FG001|Overall Study|Death|84|||
130429705|NCT01059630|469535410|FG000|Overall Study|Lost to Follow-up|4|||
130429706|NCT01059630|469535411|FG001|Overall Study|Lost to Follow-up|1|||
130429707|NCT01059630|469535410|FG000|Overall Study|Physician Decision|2|||
130429708|NCT01059630|469535411|FG001|Overall Study|Physician Decision|4|||
130429709|NCT01059630|469535410|FG000|Overall Study|Withdrawal by Subject|21|||
130429710|NCT01059630|469535411|FG001|Overall Study|Withdrawal by Subject|14|||
130429711|NCT03351738|469535412|FG000|Overall Study|Withdrawal by Subject|0|||
130429712|NCT03351738|469535413|FG001|Overall Study|Withdrawal by Subject|1|||
130429713|NCT03351738|469535414|FG002|Overall Study|Withdrawal by Subject|0|||
130429714|NCT03351738|469535415|FG003|Overall Study|Withdrawal by Subject|1|||
130429715|NCT03351738|469535416|FG004|Overall Study|Withdrawal by Subject|0|||
130429716|NCT03351738|469535417|FG005|Overall Study|Withdrawal by Subject|0|||
130429717|NCT01375205|469535418|FG000|Overall Study|Lost to Follow-up|15|||
130429718|NCT01375205|469535419|FG001|Overall Study|Lost to Follow-up|12|||
130429719|NCT01375205|469535418|FG000|Overall Study|Withdrawal by Subject|6|||
130429720|NCT01375205|469535419|FG001|Overall Study|Withdrawal by Subject|1|||
130429721|NCT05687032|469535420|FG000|Treatment Phase|Adverse Event|13|||
130429722|NCT05687032|469535420|FG000|Treatment Phase|Death|1|||
130429723|NCT05687032|469535420|FG000|Treatment Phase|Physician Decision|3|||
130540997|NCT00350103|469947230|FG001|Overall Study|Adverse Event|29|||
130540998|NCT00350103|469947231|FG002|Overall Study|Adverse Event|17|||
130540999|NCT00350103|469947229|FG000|Overall Study|Lack of Efficacy|5|||
130541000|NCT00350103|469947230|FG001|Overall Study|Lack of Efficacy|1|||
130541001|NCT00350103|469947231|FG002|Overall Study|Lack of Efficacy|3|||
130541002|NCT00350103|469947229|FG000|Overall Study|Withdrawal by Subject|6|||
130541003|NCT00350103|469947230|FG001|Overall Study|Withdrawal by Subject|6|||
130541004|NCT00350103|469947231|FG002|Overall Study|Withdrawal by Subject|8|||
130541005|NCT00350103|469947229|FG000|Overall Study|Protocol Violation|0|||
130541006|NCT00350103|469947230|FG001|Overall Study|Protocol Violation|0|||
130541007|NCT00350103|469947231|FG002|Overall Study|Protocol Violation|1|||
130541008|NCT00350103|469947229|FG000|Overall Study|Unsatisfactory Compliance|2|||
130541009|NCT00350103|469947230|FG001|Overall Study|Unsatisfactory Compliance|2|||
130541010|NCT00350103|469947231|FG002|Overall Study|Unsatisfactory Compliance|1|||
130541011|NCT00350103|469947229|FG000|Overall Study|Investigator´s decision|1|||
130541012|NCT00350103|469947230|FG001|Overall Study|Investigator´s decision|1|||
130541013|NCT00350103|469947231|FG002|Overall Study|Investigator´s decision|0|||
130541014|NCT00350103|469947229|FG000|Overall Study|Exclusion criteria met|0|||
130541015|NCT00350103|469947230|FG001|Overall Study|Exclusion criteria met|0|||
130541016|NCT00350103|469947231|FG002|Overall Study|Exclusion criteria met|1|||
130541017|NCT00350103|469947229|FG000|Overall Study|Patient relocated|0|||
130429724|NCT05687032|469535420|FG000|Treatment Phase|Progressive disease|9|||
130429725|NCT05687032|469535420|FG000|Treatment Phase|Withdrawal by Subject|5|||
130429726|NCT05687032|469535420|FG000|Follow-Up Phase|Death|16|||
130429727|NCT05687032|469535420|FG000|Follow-Up Phase|Ongoing|26|||
130429728|NCT05614089|469535421|FG000|Overall Study|Pregnancy|5|||
130429729|NCT05614089|469535422|FG001|Overall Study|Pregnancy|2|||
130429730|NCT05614089|469535421|FG000|Overall Study|Lost to Follow-up|5|||
130429731|NCT05614089|469535422|FG001|Overall Study|Lost to Follow-up|1|||
130541018|NCT00350103|469947230|FG001|Overall Study|Patient relocated|0|||
130541019|NCT00350103|469947231|FG002|Overall Study|Patient relocated|1|||
130541020|NCT00350103|469947229|FG000|Overall Study|Need for prohibited medication|1|||
130541021|NCT00350103|469947230|FG001|Overall Study|Need for prohibited medication|0|||
130541022|NCT00350103|469947231|FG002|Overall Study|Need for prohibited medication|0|||
130541023|NCT00350103|469947229|FG000|Overall Study|Personal reasons|0|||
130541024|NCT00350103|469947230|FG001|Overall Study|Personal reasons|0|||
130319007|NCT05526716|469135371|FG001|Overall Study|Death|2|||
130541025|NCT00350103|469947231|FG002|Overall Study|Personal reasons|1|||
130541026|NCT00350103|469947229|FG000|Overall Study|Patient stopped feeling pain|1|||
130541027|NCT00350103|469947230|FG001|Overall Study|Patient stopped feeling pain|0|||
130541028|NCT00350103|469947231|FG002|Overall Study|Patient stopped feeling pain|0|||
130541029|NCT00350103|469947229|FG000|Overall Study|PR greater than 250ms|0|||
130541030|NCT00350103|469947230|FG001|Overall Study|PR greater than 250ms|0|||
130541031|NCT00350103|469947231|FG002|Overall Study|PR greater than 250ms|1|||
130541032|NCT00350103|469947229|FG000|Overall Study|Wrong calculation of QT interval|0|||
130541033|NCT00350103|469947230|FG001|Overall Study|Wrong calculation of QT interval|0|||
130541034|NCT00350103|469947231|FG002|Overall Study|Wrong calculation of QT interval|1|||
130541035|NCT00350103|469947229|FG000|Overall Study|Sponsor mistake|1|||
130541036|NCT00350103|469947230|FG001|Overall Study|Sponsor mistake|0|||
130541037|NCT00350103|469947231|FG002|Overall Study|Sponsor mistake|0|||
130541038|NCT00350103|469947229|FG000|Overall Study|Randomization mistake|0|||
130541039|NCT00350103|469947230|FG001|Overall Study|Randomization mistake|1|||
130541040|NCT00350103|469947231|FG002|Overall Study|Randomization mistake|1|||
130541041|NCT00350103|469947229|FG000|Overall Study|Sponsor´s decision|0|||
130541042|NCT00350103|469947230|FG001|Overall Study|Sponsor´s decision|1|||
130652187|NCT04887922|470349358|FG000|1st Randomization|Decided not to have surgery|0|||
130319008|NCT05526716|469135370|FG000|Overall Study|Lost to Follow-up|17|||
130319009|NCT05526716|469135371|FG001|Overall Study|Lost to Follow-up|15|||
130319010|NCT05526716|469135370|FG000|Overall Study|Physician Decision|0|||
130319011|NCT05526716|469135371|FG001|Overall Study|Physician Decision|1|||
130319012|NCT05526716|469135370|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130319013|NCT05526716|469135371|FG001|Overall Study|Randomized by mistake without study treatment|1|||
130319014|NCT05526716|469135370|FG000|Overall Study|Withdrawal by Subject|12|||
130319015|NCT05526716|469135371|FG001|Overall Study|Withdrawal by Subject|12|||
130319016|NCT05526716|469135370|FG000|Overall Study|Not reported|0|||
130319017|NCT05526716|469135371|FG001|Overall Study|Not reported|2|||
130319018|NCT04750824|469135375|FG000|Overall Study|Toxicity/intolerability|3|||
130319019|NCT04750824|469135376|FG001|Overall Study|Toxicity/intolerability|1|||
130319020|NCT04750824|469135375|FG000|Overall Study|Death|1|||
130319021|NCT04750824|469135376|FG001|Overall Study|Death|3|||
130319022|NCT04750824|469135375|FG000|Overall Study|Scheduled duration of therapy complete|1|||
130319023|NCT04750824|469135376|FG001|Overall Study|Scheduled duration of therapy complete|9|||
130429732|NCT05614089|469535421|FG000|Overall Study|Death|0|||
130429733|NCT05614089|469535422|FG001|Overall Study|Death|1|||
130319024|NCT04750824|469135375|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
130319025|NCT04750824|469135376|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
130319026|NCT00807911|469135377|FG000|Overall Study|Withdrawal by Subject|12|||
130429734|NCT05614089|469535421|FG000|Overall Study|Adverse Event|1|||
130429735|NCT05614089|469535422|FG001|Overall Study|Adverse Event|0|||
130429736|NCT00701038|469535431|FG000|Overall Study|study amended pilot group of patients|4|||
130429737|NCT00701038|469535432|FG001|Overall Study|study amended pilot group of patients|4|||
130429738|NCT01064297|469535438|FG000|Overall Study|Lost to Follow-up|791|||
130429739|NCT01064297|469535439|FG001|Overall Study|Lost to Follow-up|48|||
130429740|NCT01064297|469535440|FG002|Overall Study|Lost to Follow-up|133|||
130429741|NCT00717860|469535444|FG000|Overall Study|Clinical adverse experience|5|||
130429742|NCT00717860|469535445|FG001|Overall Study|Clinical adverse experience|9|||
130429743|NCT00717860|469535444|FG000|Overall Study|Laboratory adverse experience|2|||
130429744|NCT00717860|469535445|FG001|Overall Study|Laboratory adverse experience|2|||
130429745|NCT00717860|469535444|FG000|Overall Study|Lack of Efficacy|7|||
130429746|NCT00717860|469535445|FG001|Overall Study|Lack of Efficacy|13|||
130429747|NCT00717860|469535444|FG000|Overall Study|Discontinued for other reason|6|||
130429748|NCT00717860|469535445|FG001|Overall Study|Discontinued for other reason|1|||
130429749|NCT00717860|469535444|FG000|Overall Study|Withdrew consent|7|||
130429750|NCT00717860|469535445|FG001|Overall Study|Withdrew consent|3|||
130429751|NCT04058353|469535449|FG000|Overall Study|Adverse Event|2|||
130429752|NCT04058353|469535450|FG001|Overall Study|Adverse Event|1|||
130429753|NCT04058353|469535449|FG000|Overall Study|Physician Decision|1|||
130429754|NCT04058353|469535450|FG001|Overall Study|Physician Decision|0|||
130429755|NCT04058353|469535449|FG000|Overall Study|Other|1|||
130429756|NCT04058353|469535450|FG001|Overall Study|Other|0|||
130429757|NCT00698646|469535451|FG000|Overall Study|Adverse Event|8|||
130429758|NCT00698646|469535452|FG001|Overall Study|Adverse Event|7|||
130429759|NCT00698646|469535453|FG002|Overall Study|Adverse Event|8|||
130429760|NCT00698646|469535451|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
130429761|NCT00698646|469535452|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
130541043|NCT00350103|469947231|FG002|Overall Study|Sponsor´s decision|0|||
130541044|NCT00350103|469947229|FG000|Overall Study|Lost, Reason unknown|1|||
130541045|NCT00350103|469947230|FG001|Overall Study|Lost, Reason unknown|1|||
130319027|NCT00807911|469135378|FG001|Overall Study|Withdrawal by Subject|10|||
130319028|NCT00807911|469135377|FG000|Overall Study|Ineligible|0|||
130319029|NCT00807911|469135378|FG001|Overall Study|Ineligible|4|||
130429762|NCT00698646|469535453|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
130429763|NCT00698646|469535451|FG000|Overall Study|Protocol Deviation|6|||
130541046|NCT00350103|469947231|FG002|Overall Study|Lost, Reason unknown|0|||
130541047|NCT01879553|469947232|FG000|Overall Study|Withdrawal by Subject|1|||
130541048|NCT01879553|469947233|FG001|Overall Study|Withdrawal by Subject|0|||
130541049|NCT02712905|469947234|FG000|Monotherapy|Death|2|||
130541050|NCT02712905|469947235|FG001|Monotherapy|Death|5|||
130541051|NCT02712905|469947236|FG002|Monotherapy|Death|0|||
130541052|NCT02712905|469947237|FG003|Monotherapy|Death|3|||
130541053|NCT02712905|469947238|FG004|Monotherapy|Death|15|||
130541054|NCT02712905|469947239|FG005|Monotherapy|Death|1|||
130541055|NCT02712905|469947240|FG006|Monotherapy|Death|3|||
130541056|NCT02712905|469947241|FG007|Monotherapy|Death|3|||
130541057|NCT02712905|469947242|FG008|Monotherapy|Death|0|||
130541058|NCT02712905|469947243|FG009|Monotherapy|Death|27|||
130541059|NCT02712905|469947244|FG010|Monotherapy|Death|2|||
130541060|NCT02712905|469947245|FG011|Monotherapy|Death|5|||
130541061|NCT02712905|469947246|FG012|Monotherapy|Death|0|||
130541062|NCT02712905|469947247|FG013|Monotherapy|Death|0|||
130541063|NCT02712905|469947248|FG014|Monotherapy|Death|0|||
130541064|NCT02712905|469947249|FG015|Monotherapy|Death|0|||
130541065|NCT02712905|469947250|FG016|Monotherapy|Death|0|||
130541066|NCT02712905|469947251|FG017|Monotherapy|Death|0|||
130541067|NCT02712905|469947234|FG000|Monotherapy|Lost to Follow-up|0|||
130541068|NCT02712905|469947235|FG001|Monotherapy|Lost to Follow-up|1|||
130541069|NCT02712905|469947236|FG002|Monotherapy|Lost to Follow-up|0|||
130541070|NCT02712905|469947237|FG003|Monotherapy|Lost to Follow-up|1|||
130541071|NCT02712905|469947238|FG004|Monotherapy|Lost to Follow-up|0|||
130541072|NCT02712905|469947239|FG005|Monotherapy|Lost to Follow-up|0|||
130541073|NCT02712905|469947240|FG006|Monotherapy|Lost to Follow-up|0|||
130541074|NCT02712905|469947241|FG007|Monotherapy|Lost to Follow-up|0|||
130541075|NCT02712905|469947242|FG008|Monotherapy|Lost to Follow-up|0|||
130541076|NCT02712905|469947243|FG009|Monotherapy|Lost to Follow-up|2|||
130541077|NCT02712905|469947244|FG010|Monotherapy|Lost to Follow-up|0|||
130541078|NCT02712905|469947245|FG011|Monotherapy|Lost to Follow-up|0|||
130541079|NCT02712905|469947246|FG012|Monotherapy|Lost to Follow-up|0|||
130541080|NCT02712905|469947247|FG013|Monotherapy|Lost to Follow-up|0|||
130541081|NCT02712905|469947248|FG014|Monotherapy|Lost to Follow-up|0|||
130541082|NCT02712905|469947249|FG015|Monotherapy|Lost to Follow-up|0|||
130541083|NCT02712905|469947250|FG016|Monotherapy|Lost to Follow-up|0|||
130541084|NCT02712905|469947251|FG017|Monotherapy|Lost to Follow-up|0|||
130541085|NCT02712905|469947234|FG000|Monotherapy|Physician Decision|1|||
130541086|NCT02712905|469947235|FG001|Monotherapy|Physician Decision|0|||
130541087|NCT02712905|469947236|FG002|Monotherapy|Physician Decision|0|||
130541088|NCT02712905|469947237|FG003|Monotherapy|Physician Decision|1|||
130319030|NCT03547518|469135381|FG000|Overall Study|Lost to Follow-up|2|||
130319031|NCT03547518|469135382|FG001|Overall Study|Lost to Follow-up|0|||
130319032|NCT04349891|469135389|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
130319033|NCT04349891|469135390|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
130319034|NCT04349891|469135389|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
130319035|NCT04349891|469135390|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
130319036|NCT04349891|469135389|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
130319037|NCT04349891|469135390|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
130319038|NCT04349891|469135389|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
130319039|NCT04349891|469135390|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
130319040|NCT02927301|469135393|FG000|Overall Study|Death|39|||
130319041|NCT02927301|469135393|FG000|Overall Study|Lost to Follow-up|8|||
130319042|NCT02927301|469135393|FG000|Overall Study|Physician Decision|2|||
130319043|NCT02927301|469135393|FG000|Overall Study|Withdrawal by Subject|12|||
130319044|NCT02927301|469135393|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
130319045|NCT02201524|469135396|FG000|Overall Study|Adverse Event|0|||
130319046|NCT02201524|469135397|FG001|Overall Study|Adverse Event|2|||
130319047|NCT02201524|469135398|FG002|Overall Study|Adverse Event|1|||
130319048|NCT02201524|469135399|FG003|Overall Study|Adverse Event|0|||
130319049|NCT02201524|469135396|FG000|Overall Study|Insufficient clinical response|1|||
130319050|NCT02201524|469135397|FG001|Overall Study|Insufficient clinical response|0|||
130319051|NCT02201524|469135398|FG002|Overall Study|Insufficient clinical response|0|||
130541089|NCT02712905|469947238|FG004|Monotherapy|Physician Decision|0|||
130541090|NCT02712905|469947239|FG005|Monotherapy|Physician Decision|0|||
130541091|NCT02712905|469947240|FG006|Monotherapy|Physician Decision|0|||
130541092|NCT02712905|469947241|FG007|Monotherapy|Physician Decision|0|||
130541093|NCT02712905|469947242|FG008|Monotherapy|Physician Decision|0|||
130541094|NCT02712905|469947243|FG009|Monotherapy|Physician Decision|1|||
130319052|NCT02201524|469135399|FG003|Overall Study|Insufficient clinical response|0|||
130319053|NCT02201524|469135396|FG000|Overall Study|Lost to Follow-up|0|||
130319054|NCT02201524|469135397|FG001|Overall Study|Lost to Follow-up|0|||
130541095|NCT02712905|469947244|FG010|Monotherapy|Physician Decision|0|||
130319055|NCT02201524|469135398|FG002|Overall Study|Lost to Follow-up|2|||
130541096|NCT02712905|469947245|FG011|Monotherapy|Physician Decision|0|||
130541097|NCT02712905|469947246|FG012|Monotherapy|Physician Decision|0|||
130541098|NCT02712905|469947247|FG013|Monotherapy|Physician Decision|0|||
130541099|NCT02712905|469947248|FG014|Monotherapy|Physician Decision|0|||
130541100|NCT02712905|469947249|FG015|Monotherapy|Physician Decision|0|||
130319056|NCT02201524|469135399|FG003|Overall Study|Lost to Follow-up|0|||
130319057|NCT02201524|469135396|FG000|Overall Study|No longer meets eligibility criteria|0|||
130319058|NCT02201524|469135397|FG001|Overall Study|No longer meets eligibility criteria|0|||
130319059|NCT02201524|469135398|FG002|Overall Study|No longer meets eligibility criteria|0|||
130319060|NCT02201524|469135399|FG003|Overall Study|No longer meets eligibility criteria|2|||
130319061|NCT02201524|469135396|FG000|Overall Study|Protocol Violation|0|||
130319062|NCT02201524|469135397|FG001|Overall Study|Protocol Violation|0|||
130319063|NCT02201524|469135398|FG002|Overall Study|Protocol Violation|0|||
130319064|NCT02201524|469135399|FG003|Overall Study|Protocol Violation|1|||
130319065|NCT02201524|469135396|FG000|Overall Study|Withdrawal by Subject|0|||
130319066|NCT02201524|469135397|FG001|Overall Study|Withdrawal by Subject|0|||
130319067|NCT02201524|469135398|FG002|Overall Study|Withdrawal by Subject|1|||
130429764|NCT00698646|469535452|FG001|Overall Study|Protocol Deviation|2|||
130541101|NCT02712905|469947250|FG016|Monotherapy|Physician Decision|0|||
130541102|NCT02712905|469947251|FG017|Monotherapy|Physician Decision|0|||
130541103|NCT02712905|469947234|FG000|Monotherapy|Study Terminated by Sponsor|0|||
130541104|NCT02712905|469947235|FG001|Monotherapy|Study Terminated by Sponsor|0|||
130541105|NCT02712905|469947236|FG002|Monotherapy|Study Terminated by Sponsor|0|||
130541106|NCT02712905|469947237|FG003|Monotherapy|Study Terminated by Sponsor|0|||
130541107|NCT02712905|469947238|FG004|Monotherapy|Study Terminated by Sponsor|1|||
130541108|NCT02712905|469947239|FG005|Monotherapy|Study Terminated by Sponsor|0|||
130541109|NCT02712905|469947240|FG006|Monotherapy|Study Terminated by Sponsor|0|||
130541110|NCT02712905|469947241|FG007|Monotherapy|Study Terminated by Sponsor|0|||
130541111|NCT02712905|469947242|FG008|Monotherapy|Study Terminated by Sponsor|0|||
130541112|NCT02712905|469947243|FG009|Monotherapy|Study Terminated by Sponsor|2|||
130541113|NCT02712905|469947244|FG010|Monotherapy|Study Terminated by Sponsor|0|||
130541114|NCT02712905|469947245|FG011|Monotherapy|Study Terminated by Sponsor|0|||
130541115|NCT02712905|469947246|FG012|Monotherapy|Study Terminated by Sponsor|0|||
130541116|NCT02712905|469947247|FG013|Monotherapy|Study Terminated by Sponsor|0|||
130541117|NCT02712905|469947248|FG014|Monotherapy|Study Terminated by Sponsor|0|||
130541118|NCT02712905|469947249|FG015|Monotherapy|Study Terminated by Sponsor|0|||
130541119|NCT02712905|469947250|FG016|Monotherapy|Study Terminated by Sponsor|0|||
130541120|NCT02712905|469947251|FG017|Monotherapy|Study Terminated by Sponsor|0|||
130541121|NCT02712905|469947234|FG000|Monotherapy|Withdrawal by Subject|0|||
130319068|NCT02201524|469135399|FG003|Overall Study|Withdrawal by Subject|1|||
130319069|NCT02201524|469135396|FG000|Overall Study|Other|1|||
130319070|NCT02201524|469135397|FG001|Overall Study|Other|1|||
130319071|NCT02201524|469135398|FG002|Overall Study|Other|0|||
130319072|NCT02201524|469135399|FG003|Overall Study|Other|0|||
130319073|NCT02914639|469135401|FG000|Overall Study|Withdrawal by Subject|0|||
130319074|NCT02914639|469135402|FG001|Overall Study|Withdrawal by Subject|2|||
130319075|NCT01018030|469135403|FG000|Overall Study|Adverse Event|10|||
130319076|NCT01018030|469135404|FG001|Overall Study|Adverse Event|5|||
130319077|NCT01018030|469135405|FG002|Overall Study|Adverse Event|5|||
130319078|NCT01018030|469135403|FG000|Overall Study|Withdrawal by Subject|2|||
130319079|NCT01018030|469135404|FG001|Overall Study|Withdrawal by Subject|2|||
130319080|NCT01018030|469135405|FG002|Overall Study|Withdrawal by Subject|4|||
130319081|NCT01018030|469135403|FG000|Overall Study|Lost to Follow-up|2|||
130319082|NCT01018030|469135404|FG001|Overall Study|Lost to Follow-up|0|||
130319083|NCT01018030|469135405|FG002|Overall Study|Lost to Follow-up|3|||
130319084|NCT01018030|469135403|FG000|Overall Study|Protocol Violation|2|||
130319085|NCT01018030|469135404|FG001|Overall Study|Protocol Violation|1|||
130319086|NCT01018030|469135405|FG002|Overall Study|Protocol Violation|0|||
130319087|NCT01018030|469135403|FG000|Overall Study|Physician Decision|1|||
130319088|NCT01018030|469135404|FG001|Overall Study|Physician Decision|0|||
130319089|NCT01018030|469135405|FG002|Overall Study|Physician Decision|1|||
130319090|NCT01018030|469135403|FG000|Overall Study|Lack of Efficacy|1|||
130319091|NCT01018030|469135404|FG001|Overall Study|Lack of Efficacy|0|||
130319092|NCT01018030|469135405|FG002|Overall Study|Lack of Efficacy|0|||
130319093|NCT01018030|469135403|FG000|Overall Study|Did Not Receive Study Drug|1|||
130319094|NCT01018030|469135404|FG001|Overall Study|Did Not Receive Study Drug|3|||
130319095|NCT01018030|469135405|FG002|Overall Study|Did Not Receive Study Drug|0|||
130319096|NCT03617172|469135406|FG000|Overall Study|Lost to Follow-up|1|||
130319097|NCT03617172|469135407|FG001|Overall Study|Lost to Follow-up|0|||
130429765|NCT00698646|469535453|FG002|Overall Study|Protocol Deviation|3|||
130541122|NCT02712905|469947235|FG001|Monotherapy|Withdrawal by Subject|0|||
130541123|NCT02712905|469947236|FG002|Monotherapy|Withdrawal by Subject|1|||
130541124|NCT02712905|469947237|FG003|Monotherapy|Withdrawal by Subject|0|||
130541125|NCT02712905|469947238|FG004|Monotherapy|Withdrawal by Subject|2|||
130541126|NCT02712905|469947239|FG005|Monotherapy|Withdrawal by Subject|0|||
130541127|NCT02712905|469947240|FG006|Monotherapy|Withdrawal by Subject|0|||
130319098|NCT00189540|469135408|FG000|Overall Study|Withdrawal by Subject|3|||
130319099|NCT00189540|469135409|FG001|Overall Study|Withdrawal by Subject|0|||
130319100|NCT00189540|469135408|FG000|Overall Study|Death|4|||
130319101|NCT00189540|469135409|FG001|Overall Study|Death|1|||
130319102|NCT01089504|469135410|FG000|Overall Study|Lost to Follow-up|1|||
130319103|NCT01089504|469135411|FG001|Overall Study|Lost to Follow-up|1|||
130541128|NCT02712905|469947241|FG007|Monotherapy|Withdrawal by Subject|0|||
130541129|NCT02712905|469947242|FG008|Monotherapy|Withdrawal by Subject|0|||
130541130|NCT02712905|469947243|FG009|Monotherapy|Withdrawal by Subject|4|||
130541131|NCT02712905|469947244|FG010|Monotherapy|Withdrawal by Subject|1|||
130541132|NCT02712905|469947245|FG011|Monotherapy|Withdrawal by Subject|2|||
130541133|NCT02712905|469947246|FG012|Monotherapy|Withdrawal by Subject|0|||
130541134|NCT02712905|469947247|FG013|Monotherapy|Withdrawal by Subject|0|||
130541135|NCT02712905|469947248|FG014|Monotherapy|Withdrawal by Subject|0|||
130541136|NCT02712905|469947249|FG015|Monotherapy|Withdrawal by Subject|0|||
130541137|NCT02712905|469947250|FG016|Monotherapy|Withdrawal by Subject|0|||
130541138|NCT02712905|469947251|FG017|Monotherapy|Withdrawal by Subject|0|||
130541139|NCT02712905|469947234|FG000|Monotherapy|Started New Cancer Drug|0|||
130541140|NCT02712905|469947235|FG001|Monotherapy|Started New Cancer Drug|0|||
130541141|NCT02712905|469947236|FG002|Monotherapy|Started New Cancer Drug|0|||
130541142|NCT02712905|469947237|FG003|Monotherapy|Started New Cancer Drug|0|||
130541143|NCT02712905|469947238|FG004|Monotherapy|Started New Cancer Drug|0|||
130541144|NCT02712905|469947239|FG005|Monotherapy|Started New Cancer Drug|1|||
130541145|NCT02712905|469947240|FG006|Monotherapy|Started New Cancer Drug|0|||
130541146|NCT02712905|469947241|FG007|Monotherapy|Started New Cancer Drug|0|||
130541147|NCT02712905|469947242|FG008|Monotherapy|Started New Cancer Drug|0|||
130541148|NCT02712905|469947243|FG009|Monotherapy|Started New Cancer Drug|0|||
130541149|NCT02712905|469947244|FG010|Monotherapy|Started New Cancer Drug|0|||
130541150|NCT02712905|469947245|FG011|Monotherapy|Started New Cancer Drug|0|||
130541151|NCT02712905|469947246|FG012|Monotherapy|Started New Cancer Drug|0|||
130541152|NCT02712905|469947247|FG013|Monotherapy|Started New Cancer Drug|0|||
130541153|NCT02712905|469947248|FG014|Monotherapy|Started New Cancer Drug|0|||
130541154|NCT02712905|469947249|FG015|Monotherapy|Started New Cancer Drug|0|||
130541155|NCT02712905|469947250|FG016|Monotherapy|Started New Cancer Drug|0|||
130541156|NCT02712905|469947251|FG017|Monotherapy|Started New Cancer Drug|0|||
130541157|NCT02712905|469947234|FG000|Monotherapy|Adverse Event|0|||
130541158|NCT02712905|469947235|FG001|Monotherapy|Adverse Event|0|||
130541159|NCT02712905|469947236|FG002|Monotherapy|Adverse Event|0|||
130541160|NCT02712905|469947237|FG003|Monotherapy|Adverse Event|0|||
130541161|NCT02712905|469947238|FG004|Monotherapy|Adverse Event|0|||
130541162|NCT02712905|469947239|FG005|Monotherapy|Adverse Event|0|||
130541163|NCT02712905|469947240|FG006|Monotherapy|Adverse Event|0|||
130541164|NCT02712905|469947241|FG007|Monotherapy|Adverse Event|0|||
130319104|NCT01089504|469135410|FG000|Overall Study|Withdrawal by Subject|2|||
130319105|NCT01089504|469135411|FG001|Overall Study|Withdrawal by Subject|0|||
130429766|NCT00698646|469535451|FG000|Overall Study|Withdrawal by Subject|10|||
130429767|NCT00698646|469535452|FG001|Overall Study|Withdrawal by Subject|11|||
130429768|NCT00698646|469535453|FG002|Overall Study|Withdrawal by Subject|8|||
130429769|NCT00698646|469535451|FG000|Overall Study|Lost to Follow-up|0|||
130429770|NCT00698646|469535452|FG001|Overall Study|Lost to Follow-up|0|||
130429771|NCT00698646|469535453|FG002|Overall Study|Lost to Follow-up|2|||
130429772|NCT00698646|469535451|FG000|Overall Study|Administrative problems|1|||
130429773|NCT00698646|469535452|FG001|Overall Study|Administrative problems|0|||
130429774|NCT00698646|469535453|FG002|Overall Study|Administrative problems|1|||
130429775|NCT00279201|469535454|FG000|Initiation|Death|1|||
130429776|NCT00279201|469535455|FG001|Initiation|Death|5|||
130429777|NCT00279201|469535456|FG002|Initiation|Death|0|||
130429778|NCT00279201|469535457|FG003|Initiation|Death|0|||
130429779|NCT00279201|469535458|FG004|Initiation|Death|0|||
130429780|NCT00279201|469535459|FG005|Initiation|Death|0|||
130429781|NCT00279201|469535454|FG000|Initiation|Adverse Event|6|||
130429782|NCT00279201|469535455|FG001|Initiation|Adverse Event|15|||
130429783|NCT00279201|469535456|FG002|Initiation|Adverse Event|0|||
130429784|NCT00279201|469535457|FG003|Initiation|Adverse Event|0|||
130429785|NCT00279201|469535458|FG004|Initiation|Adverse Event|0|||
130429786|NCT00279201|469535459|FG005|Initiation|Adverse Event|0|||
130429787|NCT00279201|469535454|FG000|Initiation|Lost to Follow-up|42|||
130429788|NCT00279201|469535455|FG001|Initiation|Lost to Follow-up|41|||
130429789|NCT00279201|469535456|FG002|Initiation|Lost to Follow-up|0|||
130429790|NCT00279201|469535457|FG003|Initiation|Lost to Follow-up|0|||
130429791|NCT00279201|469535458|FG004|Initiation|Lost to Follow-up|0|||
130429792|NCT00279201|469535459|FG005|Initiation|Lost to Follow-up|0|||
130429793|NCT00279201|469535454|FG000|Initiation|Entry Criteria Exclusion|7|||
130429794|NCT00279201|469535455|FG001|Initiation|Entry Criteria Exclusion|9|||
130541165|NCT02712905|469947242|FG008|Monotherapy|Adverse Event|1|||
130541166|NCT02712905|469947243|FG009|Monotherapy|Adverse Event|0|||
130541167|NCT02712905|469947244|FG010|Monotherapy|Adverse Event|0|||
130541168|NCT02712905|469947245|FG011|Monotherapy|Adverse Event|0|||
130541169|NCT02712905|469947246|FG012|Monotherapy|Adverse Event|0|||
130429795|NCT00279201|469535456|FG002|Initiation|Entry Criteria Exclusion|0|||
130429796|NCT00279201|469535457|FG003|Initiation|Entry Criteria Exclusion|0|||
130429797|NCT00279201|469535458|FG004|Initiation|Entry Criteria Exclusion|0|||
130429798|NCT00279201|469535459|FG005|Initiation|Entry Criteria Exclusion|0|||
130429799|NCT00279201|469535454|FG000|Initiation|Protocol Violation|9|||
130429800|NCT00279201|469535455|FG001|Initiation|Protocol Violation|10|||
130429801|NCT00279201|469535456|FG002|Initiation|Protocol Violation|0|||
130541170|NCT02712905|469947247|FG013|Monotherapy|Adverse Event|0|||
130429802|NCT00279201|469535457|FG003|Initiation|Protocol Violation|0|||
130429803|NCT00279201|469535458|FG004|Initiation|Protocol Violation|0|||
130429804|NCT00279201|469535459|FG005|Initiation|Protocol Violation|0|||
130429805|NCT00279201|469535454|FG000|Initiation|Withdrawal by Subject|35|||
130429806|NCT00279201|469535455|FG001|Initiation|Withdrawal by Subject|41|||
130429807|NCT00279201|469535456|FG002|Initiation|Withdrawal by Subject|0|||
130429808|NCT00279201|469535457|FG003|Initiation|Withdrawal by Subject|0|||
130429809|NCT00279201|469535458|FG004|Initiation|Withdrawal by Subject|0|||
130429810|NCT00279201|469535459|FG005|Initiation|Withdrawal by Subject|0|||
130429811|NCT00279201|469535454|FG000|Initiation|Physician Decision|15|||
130429812|NCT00279201|469535455|FG001|Initiation|Physician Decision|18|||
130429813|NCT00279201|469535456|FG002|Initiation|Physician Decision|0|||
130429814|NCT00279201|469535457|FG003|Initiation|Physician Decision|0|||
130429815|NCT00279201|469535458|FG004|Initiation|Physician Decision|0|||
130429816|NCT00279201|469535459|FG005|Initiation|Physician Decision|0|||
130429817|NCT00279201|469535454|FG000|Initiation|Sponsor Decision|13|||
130541171|NCT02712905|469947248|FG014|Monotherapy|Adverse Event|0|||
130541172|NCT02712905|469947249|FG015|Monotherapy|Adverse Event|0|||
130541173|NCT02712905|469947250|FG016|Monotherapy|Adverse Event|0|||
130541174|NCT02712905|469947251|FG017|Monotherapy|Adverse Event|0|||
130429818|NCT00279201|469535455|FG001|Initiation|Sponsor Decision|5|||
130429819|NCT00279201|469535456|FG002|Initiation|Sponsor Decision|0|||
130429820|NCT00279201|469535457|FG003|Initiation|Sponsor Decision|0|||
130429821|NCT00279201|469535458|FG004|Initiation|Sponsor Decision|0|||
130429822|NCT00279201|469535459|FG005|Initiation|Sponsor Decision|0|||
130429823|NCT00279201|469535454|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130429824|NCT00279201|469535455|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
130429825|NCT00279201|469535456|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130429826|NCT00279201|469535457|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130429827|NCT00279201|469535458|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130429828|NCT00279201|469535459|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130429829|NCT00279201|469535454|FG000|Maintenance|Lack of Efficacy|32|||
130429830|NCT00279201|469535455|FG001|Maintenance|Lack of Efficacy|30|||
130429831|NCT00279201|469535456|FG002|Maintenance|Lack of Efficacy|0|||
130429832|NCT00279201|469535457|FG003|Maintenance|Lack of Efficacy|0|||
130429833|NCT00279201|469535458|FG004|Maintenance|Lack of Efficacy|0|||
130429834|NCT00279201|469535459|FG005|Maintenance|Lack of Efficacy|0|||
130429835|NCT00279201|469535454|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
130429836|NCT00279201|469535455|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
130429837|NCT00279201|469535456|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130429838|NCT00279201|469535457|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130429839|NCT00279201|469535458|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130429840|NCT00279201|469535459|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130429841|NCT00279201|469535454|FG000|Maintenance|Adverse Event|4|||
130429842|NCT00279201|469535455|FG001|Maintenance|Adverse Event|4|||
130429843|NCT00279201|469535456|FG002|Maintenance|Adverse Event|0|||
130429844|NCT00279201|469535457|FG003|Maintenance|Adverse Event|0|||
130429845|NCT00279201|469535458|FG004|Maintenance|Adverse Event|0|||
130429846|NCT00279201|469535459|FG005|Maintenance|Adverse Event|0|||
130429847|NCT00279201|469535454|FG000|Maintenance|Death|4|||
130429848|NCT00279201|469535455|FG001|Maintenance|Death|4|||
130429849|NCT00279201|469535456|FG002|Maintenance|Death|0|||
130429850|NCT00279201|469535457|FG003|Maintenance|Death|0|||
130429851|NCT00279201|469535458|FG004|Maintenance|Death|0|||
130429852|NCT00279201|469535459|FG005|Maintenance|Death|0|||
130429853|NCT00279201|469535454|FG000|Maintenance|Lost to Follow-up|17|||
130429854|NCT00279201|469535455|FG001|Maintenance|Lost to Follow-up|13|||
130429855|NCT00279201|469535456|FG002|Maintenance|Lost to Follow-up|0|||
130429856|NCT00279201|469535457|FG003|Maintenance|Lost to Follow-up|0|||
130429857|NCT00279201|469535458|FG004|Maintenance|Lost to Follow-up|0|||
130541175|NCT02712905|469947234|FG000|Combination Therapy|Death|0|||
130541176|NCT02712905|469947235|FG001|Combination Therapy|Death|0|||
130541177|NCT02712905|469947236|FG002|Combination Therapy|Death|0|||
130541178|NCT02712905|469947237|FG003|Combination Therapy|Death|0|||
130541179|NCT02712905|469947238|FG004|Combination Therapy|Death|0|||
130541180|NCT02712905|469947239|FG005|Combination Therapy|Death|0|||
130541181|NCT02712905|469947240|FG006|Combination Therapy|Death|0|||
130541182|NCT02712905|469947241|FG007|Combination Therapy|Death|0|||
130541183|NCT02712905|469947242|FG008|Combination Therapy|Death|0|||
130541184|NCT02712905|469947243|FG009|Combination Therapy|Death|0|||
130541185|NCT02712905|469947244|FG010|Combination Therapy|Death|0|||
130541186|NCT02712905|469947245|FG011|Combination Therapy|Death|0|||
130541187|NCT02712905|469947246|FG012|Combination Therapy|Death|5|||
130541188|NCT02712905|469947247|FG013|Combination Therapy|Death|6|||
130541189|NCT02712905|469947248|FG014|Combination Therapy|Death|1|||
130541190|NCT02712905|469947249|FG015|Combination Therapy|Death|3|||
130541191|NCT02712905|469947250|FG016|Combination Therapy|Death|1|||
130541192|NCT02712905|469947251|FG017|Combination Therapy|Death|3|||
130541193|NCT02712905|469947234|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
130541194|NCT02712905|469947235|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
130541195|NCT02712905|469947236|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
130541196|NCT02712905|469947237|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
130541197|NCT02712905|469947238|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
130541198|NCT02712905|469947239|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
130541199|NCT02712905|469947240|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
130541200|NCT02712905|469947241|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
130541201|NCT02712905|469947242|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
130541202|NCT02712905|469947243|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
130541203|NCT02712905|469947244|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
130541204|NCT02712905|469947245|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
130541205|NCT02712905|469947246|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
130541206|NCT02712905|469947247|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
130541207|NCT02712905|469947248|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
130319106|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
130319107|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
130319108|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
130319109|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
130319110|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Death|1|||
130319111|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Disease progression|2|||
130541208|NCT02712905|469947249|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
130541209|NCT02712905|469947250|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
130541210|NCT02712905|469947251|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
130541211|NCT02712905|469947234|FG000|Combination Therapy|Withdrawal by Subject|0|||
130541212|NCT02712905|469947235|FG001|Combination Therapy|Withdrawal by Subject|0|||
130541213|NCT02712905|469947236|FG002|Combination Therapy|Withdrawal by Subject|0|||
130541214|NCT02712905|469947237|FG003|Combination Therapy|Withdrawal by Subject|0|||
130541215|NCT02712905|469947238|FG004|Combination Therapy|Withdrawal by Subject|0|||
130541216|NCT02712905|469947239|FG005|Combination Therapy|Withdrawal by Subject|0|||
130541217|NCT02712905|469947240|FG006|Combination Therapy|Withdrawal by Subject|0|||
130541218|NCT02712905|469947241|FG007|Combination Therapy|Withdrawal by Subject|0|||
130541219|NCT02712905|469947242|FG008|Combination Therapy|Withdrawal by Subject|0|||
130541220|NCT02712905|469947243|FG009|Combination Therapy|Withdrawal by Subject|0|||
130541221|NCT02712905|469947244|FG010|Combination Therapy|Withdrawal by Subject|0|||
130541222|NCT02712905|469947245|FG011|Combination Therapy|Withdrawal by Subject|0|||
130541223|NCT02712905|469947246|FG012|Combination Therapy|Withdrawal by Subject|0|||
130541224|NCT02712905|469947247|FG013|Combination Therapy|Withdrawal by Subject|0|||
130541225|NCT02712905|469947248|FG014|Combination Therapy|Withdrawal by Subject|0|||
130541226|NCT02712905|469947249|FG015|Combination Therapy|Withdrawal by Subject|1|||
130541227|NCT02712905|469947250|FG016|Combination Therapy|Withdrawal by Subject|0|||
130541228|NCT02712905|469947251|FG017|Combination Therapy|Withdrawal by Subject|2|||
130541229|NCT02712905|469947234|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541230|NCT02712905|469947235|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541231|NCT02712905|469947236|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541232|NCT02712905|469947237|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541233|NCT02712905|469947238|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541234|NCT02712905|469947239|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541235|NCT02712905|469947240|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541236|NCT02712905|469947241|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541237|NCT02712905|469947242|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541238|NCT02712905|469947243|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541239|NCT02712905|469947244|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541240|NCT02712905|469947245|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541241|NCT02712905|469947246|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541242|NCT02712905|469947247|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541243|NCT02712905|469947248|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541244|NCT02712905|469947249|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
130541245|NCT02712905|469947250|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541246|NCT02712905|469947251|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
130541247|NCT04664400|469947254|FG000|Overall Study|Withdrawal by Subject|2|||
130541248|NCT01011153|469947255|FG000|Overall Study|Less than 78 cases completed|8|||
130541249|NCT01011153|469947256|FG001|Overall Study|Less than 78 cases completed|11|||
130541250|NCT01011153|469947257|FG002|Overall Study|Less than 78 cases completed|9|||
130541251|NCT03014479|469947258|FG000|Overall Study|Adverse Event|0|||
130541252|NCT03014479|469947259|FG001|Overall Study|Adverse Event|1|||
130541253|NCT03014479|469947258|FG000|Overall Study|Voluntary Withdrawal|0|||
130541254|NCT03014479|469947259|FG001|Overall Study|Voluntary Withdrawal|2|||
130541255|NCT03014479|469947258|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
130541256|NCT03014479|469947259|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
130541257|NCT01394978|469947263|FG000|Overall Study|Withdrawal by Subject|2|||
130541258|NCT01394978|469947264|FG001|Overall Study|Withdrawal by Subject|4|||
130541259|NCT01394978|469947263|FG000|Overall Study|Lost to Follow-up|13|||
130541260|NCT01394978|469947264|FG001|Overall Study|Lost to Follow-up|20|||
130541261|NCT01394978|469947263|FG000|Overall Study|Death|6|||
130541262|NCT01394978|469947264|FG001|Overall Study|Death|7|||
130541263|NCT02019667|469947265|FG000|First Intervention (6 Months)|Adverse Event|0|||
130541264|NCT02019667|469947266|FG001|First Intervention (6 Months)|Adverse Event|1|||
130541265|NCT02019667|469947265|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
130541266|NCT02019667|469947266|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
130541267|NCT02019667|469947265|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
130541268|NCT02019667|469947266|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
130541269|NCT05038163|469947269|FG000|Stage 1|Did not complete survey|374|||
130541270|NCT05038163|469947270|FG001|Stage 1|Did not complete survey|0|||
130541271|NCT05038163|469947271|FG002|Stage 1|Did not complete survey|0|||
130541272|NCT05038163|469947272|FG003|Stage 1|Did not complete survey|0|||
130541273|NCT05038163|469947273|FG004|Stage 1|Did not complete survey|0|||
130541274|NCT05038163|469947274|FG005|Stage 1|Did not complete survey|0|||
130541275|NCT05038163|469947269|FG000|Stage 2|Did not complete Stage 2 survey|0|||
130541276|NCT05038163|469947270|FG001|Stage 2|Did not complete Stage 2 survey|29|||
130541277|NCT05038163|469947271|FG002|Stage 2|Did not complete Stage 2 survey|30|||
130541278|NCT05038163|469947272|FG003|Stage 2|Did not complete Stage 2 survey|24|||
130541279|NCT05038163|469947273|FG004|Stage 2|Did not complete Stage 2 survey|21|||
130541280|NCT05038163|469947274|FG005|Stage 2|Did not complete Stage 2 survey|100|||
130559349|NCT01514136|470016472|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559350|NCT01514136|470016473|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559351|NCT01514136|470016474|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559352|NCT01514136|470016475|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559353|NCT01514136|470016476|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
130559354|NCT01514136|470016477|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559355|NCT01514136|470016470|FG000|Test Period 2; Test C*|holiday|0|||
130559356|NCT01514136|470016471|FG001|Test Period 2; Test C*|holiday|0|||
130559357|NCT01514136|470016472|FG002|Test Period 2; Test C*|holiday|0|||
130559358|NCT01514136|470016473|FG003|Test Period 2; Test C*|holiday|0|||
130559359|NCT01514136|470016474|FG004|Test Period 2; Test C*|holiday|0|||
130559360|NCT01514136|470016475|FG005|Test Period 2; Test C*|holiday|0|||
130559361|NCT01514136|470016476|FG006|Test Period 2; Test C*|holiday|1|||
130559362|NCT01514136|470016477|FG007|Test Period 2; Test C*|holiday|0|||
130559363|NCT01514136|470016470|FG000|Test Period 2; Test C*|Protocol Violation|0|||
130559364|NCT01514136|470016471|FG001|Test Period 2; Test C*|Protocol Violation|0|||
130559365|NCT01514136|470016472|FG002|Test Period 2; Test C*|Protocol Violation|0|||
130559366|NCT01514136|470016473|FG003|Test Period 2; Test C*|Protocol Violation|0|||
130559367|NCT01514136|470016474|FG004|Test Period 2; Test C*|Protocol Violation|0|||
130559368|NCT01514136|470016475|FG005|Test Period 2; Test C*|Protocol Violation|0|||
130559369|NCT01514136|470016476|FG006|Test Period 2; Test C*|Protocol Violation|1|||
130559370|NCT01514136|470016477|FG007|Test Period 2; Test C*|Protocol Violation|0|||
130559371|NCT02729740|470016478|FG000|Overall Study|Early Termination|130|||
130559372|NCT02729740|470016478|FG000|Overall Study|Other|1|||
130559373|NCT00601705|470016482|FG000|Overall Study|Withdrawal by Subject|1|||
130559374|NCT02101021|470016485|FG000|Overall Study|Death|4|||
130559375|NCT02101021|470016486|FG001|Overall Study|Death|3|||
130559376|NCT02101021|470016487|FG002|Overall Study|Death|6|||
130559377|NCT02101021|470016488|FG003|Overall Study|Death|0|||
130559378|NCT02101021|470016489|FG004|Overall Study|Death|3|||
130559379|NCT02101021|470016485|FG000|Overall Study|Withdrew Consent from study|1|||
130559380|NCT02101021|470016486|FG001|Overall Study|Withdrew Consent from study|1|||
130559381|NCT02101021|470016487|FG002|Overall Study|Withdrew Consent from study|0|||
130559382|NCT02101021|470016488|FG003|Overall Study|Withdrew Consent from study|2|||
130559383|NCT02101021|470016489|FG004|Overall Study|Withdrew Consent from study|0|||
130652188|NCT04887922|470349359|FG001|1st Randomization|Decided not to have surgery|1|||
130559384|NCT02101021|470016485|FG000|Overall Study|Lost to Follow-up|1|||
130559385|NCT02101021|470016486|FG001|Overall Study|Lost to Follow-up|0|||
130559386|NCT02101021|470016487|FG002|Overall Study|Lost to Follow-up|0|||
130559387|NCT02101021|470016488|FG003|Overall Study|Lost to Follow-up|0|||
130559388|NCT02101021|470016489|FG004|Overall Study|Lost to Follow-up|0|||
130652189|NCT04887922|470349360|FG002|1st Randomization|Decided not to have surgery|0|||
130207619|NCT01764997|468719003|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
130559389|NCT02101021|470016485|FG000|Overall Study|Study Terminated by Sponsor|1|||
130559390|NCT02101021|470016486|FG001|Overall Study|Study Terminated by Sponsor|0|||
130559391|NCT02101021|470016487|FG002|Overall Study|Study Terminated by Sponsor|1|||
130559392|NCT02101021|470016488|FG003|Overall Study|Study Terminated by Sponsor|1|||
130559393|NCT02101021|470016489|FG004|Overall Study|Study Terminated by Sponsor|1|||
130559394|NCT01621542|470016490|FG000|Overall Study|Adverse Event|0|||
130559395|NCT01621542|470016491|FG001|Overall Study|Adverse Event|0|||
130541281|NCT00432666|469948794|FG000|Main Period|Adverse Event|1|||
130541282|NCT00432666|469948795|FG001|Main Period|Adverse Event|1|||
130541283|NCT00432666|469948794|FG000|Main Period|Consent Withdrawn|1|||
130541284|NCT00432666|469948795|FG001|Main Period|Consent Withdrawn|0|||
130541285|NCT00432666|469948794|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
130541286|NCT00432666|469948795|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
130541287|NCT00432666|469948794|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
130541288|NCT00432666|469948795|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
130541289|NCT00432666|469948794|FG000|Open-Label Extension Period|Adverse Event|5|||
130541290|NCT00432666|469948795|FG001|Open-Label Extension Period|Adverse Event|0|||
130541291|NCT00432666|469948794|FG000|Open-Label Extension Period|Consent withdrawn|10|||
130541292|NCT00432666|469948795|FG001|Open-Label Extension Period|Consent withdrawn|0|||
130541293|NCT00432666|469948794|FG000|Open-Label Extension Period|Physician Decision|3|||
130541294|NCT00432666|469948795|FG001|Open-Label Extension Period|Physician Decision|0|||
130541295|NCT00565851|469948796|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
130541296|NCT00565851|469948797|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
130541297|NCT00565851|469948798|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
130541298|NCT00565851|469948799|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
130541299|NCT00565851|469948800|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
130541300|NCT00565851|469948801|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
130541301|NCT00565851|469948802|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
130541302|NCT00565851|469948803|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
130541303|NCT00565851|469948796|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
130541304|NCT00565851|469948797|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
130541305|NCT00565851|469948798|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
130541306|NCT00565851|469948799|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
130541307|NCT00565851|469948800|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
130541308|NCT00565851|469948801|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
130541309|NCT00565851|469948802|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
130541310|NCT00565851|469948803|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
130541311|NCT00969709|469948808|FG000|Overall Study|Adverse Event|3|||
130652190|NCT04887922|470349361|FG003|1st Randomization|Decided not to have surgery|0|||
130652191|NCT04887922|470349362|FG004|1st Randomization|Decided not to have surgery|0|||
130652192|NCT00953017|470349363|FG000|Overall Study|DId not show up for colonoscopy|4|||
130652193|NCT00953017|470349364|FG001|Overall Study|DId not show up for colonoscopy|4|||
130541312|NCT00969709|469948809|FG001|Overall Study|Adverse Event|13|||
130541313|NCT00969709|469948810|FG002|Overall Study|Adverse Event|26|||
130541314|NCT00969709|469948811|FG003|Overall Study|Adverse Event|12|||
130541315|NCT00969709|469948808|FG000|Overall Study|Lack of Efficacy|7|||
130652194|NCT00953017|470349365|FG002|Overall Study|DId not show up for colonoscopy|5|||
130652195|NCT00953017|470349366|FG003|Overall Study|DId not show up for colonoscopy|4|||
130652196|NCT00953017|470349363|FG000|Overall Study|Incomplete data|1|||
130652197|NCT00953017|470349364|FG001|Overall Study|Incomplete data|1|||
130652198|NCT00953017|470349365|FG002|Overall Study|Incomplete data|0|||
130652199|NCT00953017|470349366|FG003|Overall Study|Incomplete data|0|||
130652200|NCT00953017|470349363|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
130207620|NCT01764997|468718999|FG000|Study Drug Treatment Period|Other than specified above|0|||
130207621|NCT01764997|468719000|FG001|Study Drug Treatment Period|Other than specified above|0|||
130207622|NCT01764997|468719001|FG002|Study Drug Treatment Period|Other than specified above|0|||
130207623|NCT01764997|468719002|FG003|Study Drug Treatment Period|Other than specified above|0|||
130207624|NCT01764997|468719003|FG004|Study Drug Treatment Period|Other than specified above|10|||
130207625|NCT04438499|468719012|FG000|Overall Study|Lack of Efficacy|3|||
130207626|NCT04918355|468719013|FG000|Overall Study|no qualifying health encounter|497|||
130207627|NCT04918355|468719014|FG001|Overall Study|no qualifying health encounter|192|||
130207628|NCT04918355|468719015|FG002|Overall Study|no qualifying health encounter|438|||
130207629|NCT04918355|468719016|FG003|Overall Study|no qualifying health encounter|424|||
130207630|NCT04683939|468719018|FG000|Overall Study|Study termination by the sponsor|0|||
130207631|NCT04683939|468719019|FG001|Overall Study|Study termination by the sponsor|1|||
130207632|NCT04683939|468719020|FG002|Overall Study|Study termination by the sponsor|2|||
130207633|NCT04683939|468719021|FG003|Overall Study|Study termination by the sponsor|2|||
130207634|NCT04683939|468719018|FG000|Overall Study|Death|1|||
130207635|NCT04683939|468719019|FG001|Overall Study|Death|1|||
130207636|NCT04683939|468719020|FG002|Overall Study|Death|2|||
130207637|NCT04683939|468719021|FG003|Overall Study|Death|1|||
130207638|NCT04683939|468719018|FG000|Overall Study|Withdrawal by Subject|1|||
130207639|NCT04683939|468719019|FG001|Overall Study|Withdrawal by Subject|0|||
130207640|NCT04683939|468719020|FG002|Overall Study|Withdrawal by Subject|0|||
130207641|NCT04683939|468719021|FG003|Overall Study|Withdrawal by Subject|0|||
130207642|NCT04683939|468719018|FG000|Overall Study|Physician Decision|1|||
130207643|NCT04683939|468719019|FG001|Overall Study|Physician Decision|0|||
130207644|NCT04683939|468719020|FG002|Overall Study|Physician Decision|0|||
130207645|NCT04683939|468719021|FG003|Overall Study|Physician Decision|0|||
130207646|NCT04683939|468719018|FG000|Overall Study|Lost to Follow-up|0|||
130541316|NCT00969709|469948809|FG001|Overall Study|Lack of Efficacy|4|||
130541317|NCT00969709|469948810|FG002|Overall Study|Lack of Efficacy|1|||
130541318|NCT00969709|469948811|FG003|Overall Study|Lack of Efficacy|3|||
130541319|NCT00969709|469948808|FG000|Overall Study|Protocol Violation|9|||
130541320|NCT00969709|469948809|FG001|Overall Study|Protocol Violation|5|||
130541321|NCT00969709|469948810|FG002|Overall Study|Protocol Violation|9|||
130541322|NCT00969709|469948811|FG003|Overall Study|Protocol Violation|10|||
130541323|NCT00969709|469948808|FG000|Overall Study|Withdrawal by Subject|9|||
130541324|NCT00969709|469948809|FG001|Overall Study|Withdrawal by Subject|12|||
130541325|NCT00969709|469948810|FG002|Overall Study|Withdrawal by Subject|11|||
130541326|NCT00969709|469948811|FG003|Overall Study|Withdrawal by Subject|23|||
130541327|NCT00969709|469948808|FG000|Overall Study|Lost to Follow-up|10|||
130541328|NCT00969709|469948809|FG001|Overall Study|Lost to Follow-up|14|||
130541329|NCT00969709|469948810|FG002|Overall Study|Lost to Follow-up|8|||
130541330|NCT00969709|469948811|FG003|Overall Study|Lost to Follow-up|15|||
130541331|NCT00969709|469948808|FG000|Overall Study|Other reasons|0|||
130541332|NCT00969709|469948809|FG001|Overall Study|Other reasons|0|||
130541333|NCT00969709|469948810|FG002|Overall Study|Other reasons|3|||
130541334|NCT00969709|469948811|FG003|Overall Study|Other reasons|0|||
130541335|NCT03695237|469948812|FG000|Overall Study|Withdrawal by Subject|1|||
130541336|NCT03695237|469948813|FG001|Overall Study|Withdrawal by Subject|3|||
130541337|NCT03695237|469948812|FG000|Overall Study|Lost to Follow-up|1|||
130541338|NCT03695237|469948813|FG001|Overall Study|Lost to Follow-up|2|||
130541339|NCT03695237|469948812|FG000|Overall Study|Other, Not Specified|8|||
130541340|NCT03695237|469948813|FG001|Overall Study|Other, Not Specified|2|||
130541341|NCT01342341|469948816|FG000|Overall Study|Lost to Follow-up|4|||
130541342|NCT01342341|469948817|FG001|Overall Study|Lost to Follow-up|4|||
130541343|NCT01789567|469948818|FG000|Overall Study|Death|6|||
130541344|NCT02914275|469948819|FG000|Overall Study|Lost to Follow-up|84|||
130541345|NCT02914275|469948820|FG001|Overall Study|Lost to Follow-up|29|||
130541346|NCT02914275|469948819|FG000|Overall Study|Withdrawal by Subject|26|||
130541347|NCT02914275|469948820|FG001|Overall Study|Withdrawal by Subject|10|||
130541348|NCT02914275|469948819|FG000|Overall Study|Protocol Violation|1|||
130541349|NCT02914275|469948820|FG001|Overall Study|Protocol Violation|1|||
130541350|NCT02914275|469948819|FG000|Overall Study|Physician Decision|3|||
130541351|NCT02914275|469948820|FG001|Overall Study|Physician Decision|1|||
130541352|NCT02914275|469948819|FG000|Overall Study|Other|4|||
130541353|NCT02914275|469948820|FG001|Overall Study|Other|1|||
130541354|NCT02914275|469948819|FG000|Overall Study|Excluded due to invalid informed consent|3|||
130541355|NCT02914275|469948820|FG001|Overall Study|Excluded due to invalid informed consent|0|||
130541356|NCT00091169|469948821|FG000|Overall Study|Disease progression|3|||
130541357|NCT00091169|469948822|FG001|Overall Study|Disease progression|1|||
130541358|NCT00091169|469948821|FG000|Overall Study|Adverse Event|11|||
130541359|NCT00091169|469948822|FG001|Overall Study|Adverse Event|17|||
130541360|NCT00091169|469948821|FG000|Overall Study|Death|4|||
130541361|NCT00091169|469948822|FG001|Overall Study|Death|1|||
130541362|NCT00091169|469948821|FG000|Overall Study|Withdrawal by Subject|10|||
130541363|NCT00091169|469948822|FG001|Overall Study|Withdrawal by Subject|13|||
130541364|NCT00091169|469948821|FG000|Overall Study|Other|3|||
130541365|NCT00091169|469948822|FG001|Overall Study|Other|4|||
130541366|NCT00091169|469948821|FG000|Overall Study|Not start protocol therapy|26|||
130541367|NCT00091169|469948822|FG001|Overall Study|Not start protocol therapy|17|||
130541368|NCT00872989|469948823|FG000|Overall Study|Adverse Event|7|||
130541369|NCT00872989|469948824|FG001|Overall Study|Adverse Event|15|||
130541370|NCT00872989|469948823|FG000|Overall Study|Withdrawal by Subject|8|||
130541371|NCT00872989|469948824|FG001|Overall Study|Withdrawal by Subject|5|||
130541372|NCT00872989|469948823|FG000|Overall Study|Progression/relapse|47|||
130541373|NCT00872989|469948824|FG001|Overall Study|Progression/relapse|35|||
130541374|NCT00872989|469948823|FG000|Overall Study|Not protocol specified|3|||
130541375|NCT00872989|469948824|FG001|Overall Study|Not protocol specified|8|||
130541376|NCT01302067|469948831|FG000|Overall Study|Death|0|||
130541377|NCT01302067|469948832|FG001|Overall Study|Death|0|||
130541378|NCT01302067|469948833|FG002|Overall Study|Death|1|||
130541379|NCT01302067|469948831|FG000|Overall Study|Physician Decision|9|||
130541380|NCT01302067|469948832|FG001|Overall Study|Physician Decision|5|||
130541381|NCT01302067|469948833|FG002|Overall Study|Physician Decision|14|||
130541382|NCT01302067|469948831|FG000|Overall Study|Lack of Efficacy|8|||
130541383|NCT01302067|469948832|FG001|Overall Study|Lack of Efficacy|4|||
130541384|NCT01302067|469948833|FG002|Overall Study|Lack of Efficacy|2|||
130541385|NCT01302067|469948831|FG000|Overall Study|Lost to Follow-up|9|||
130541386|NCT01302067|469948832|FG001|Overall Study|Lost to Follow-up|4|||
130541387|NCT01302067|469948833|FG002|Overall Study|Lost to Follow-up|15|||
130541388|NCT01302067|469948831|FG000|Overall Study|Withdrawal by Subject|13|||
130541389|NCT01302067|469948832|FG001|Overall Study|Withdrawal by Subject|6|||
130541390|NCT01302067|469948833|FG002|Overall Study|Withdrawal by Subject|10|||
130541391|NCT01302067|469948831|FG000|Overall Study|Other|1|||
130541392|NCT01302067|469948832|FG001|Overall Study|Other|1|||
130541393|NCT01302067|469948833|FG002|Overall Study|Other|3|||
130541394|NCT01302067|469948831|FG000|Overall Study|Protocol Violation|11|||
130541395|NCT01302067|469948832|FG001|Overall Study|Protocol Violation|0|||
130541396|NCT01302067|469948833|FG002|Overall Study|Protocol Violation|8|||
130541397|NCT01302067|469948831|FG000|Overall Study|Adverse Event|27|||
130541398|NCT01302067|469948832|FG001|Overall Study|Adverse Event|14|||
130541399|NCT01302067|469948833|FG002|Overall Study|Adverse Event|45|||
130541400|NCT02738203|469948834|FG000|Overall Study|Failed IUD Insertion|2|||
130541401|NCT02738203|469948835|FG001|Overall Study|Failed IUD Insertion|2|||
130541402|NCT02738203|469948834|FG000|Overall Study|Protocol Violation|0|||
130541403|NCT02738203|469948835|FG001|Overall Study|Protocol Violation|1|||
130541404|NCT00266227|469948836|FG000|Initial Treatment|Adverse Event|0|||
130541405|NCT00266227|469948837|FG001|Initial Treatment|Adverse Event|0|||
130541406|NCT00266227|469948838|FG002|Initial Treatment|Adverse Event|13|||
130541407|NCT00266227|469948836|FG000|Initial Treatment|Lost to Follow-up|0|||
130541408|NCT00266227|469948837|FG001|Initial Treatment|Lost to Follow-up|0|||
130541409|NCT00266227|469948838|FG002|Initial Treatment|Lost to Follow-up|6|||
130541410|NCT00266227|469948836|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
130541411|NCT00266227|469948837|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
130541412|NCT00266227|469948838|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
130541413|NCT00266227|469948836|FG000|Initial Treatment|Physician decision to withdraw|0|||
130541414|NCT00266227|469948837|FG001|Initial Treatment|Physician decision to withdraw|0|||
130541415|NCT00266227|469948838|FG002|Initial Treatment|Physician decision to withdraw|12|||
130541416|NCT00266227|469948836|FG000|Initial Treatment|Pregnancy|0|||
130541417|NCT00266227|469948837|FG001|Initial Treatment|Pregnancy|0|||
130541418|NCT00266227|469948838|FG002|Initial Treatment|Pregnancy|1|||
130541419|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Death|1|||
130541420|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Death|0|||
130541421|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Death|0|||
130541422|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
130541423|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
130541424|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
130541425|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
130541426|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
130541427|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
130541428|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
130541429|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
130541430|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
130541431|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
130541432|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
130541433|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
130541434|NCT00266227|469948836|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
130541435|NCT00266227|469948837|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
130541436|NCT00266227|469948838|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
130541437|NCT00266227|469948836|FG000|Retreatment: Week 48 to Week 72|Death|1|||
130541438|NCT00266227|469948837|FG001|Retreatment: Week 48 to Week 72|Death|1|||
130541439|NCT00266227|469948838|FG002|Retreatment: Week 48 to Week 72|Death|0|||
130541440|NCT00266227|469948836|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
130541441|NCT00266227|469948837|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
130541442|NCT00266227|469948838|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
130541443|NCT00266227|469948836|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
130541444|NCT00266227|469948837|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
130541445|NCT00266227|469948838|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
130541446|NCT00266227|469948836|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
130541447|NCT00266227|469948837|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
130541448|NCT00266227|469948838|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
130541449|NCT00266227|469948836|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
130541450|NCT00266227|469948837|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
130541451|NCT00266227|469948838|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
130541452|NCT03241927|469948839|FG000|Overall Study|study terminated|1|||
130541453|NCT03241927|469948840|FG001|Overall Study|study terminated|0|||
130541454|NCT03725085|469948845|FG000|Overall Study|Lost to Follow-up|2|||
130541455|NCT00423943|469948846|FG000|Overall Study|Withdrawal by Subject|3|||
130541456|NCT00423943|469948847|FG001|Overall Study|Withdrawal by Subject|1|||
130541457|NCT02383056|469948851|FG000|Overall Study|Adverse Event|1|||
130541458|NCT02383056|469948852|FG001|Overall Study|Adverse Event|0|||
130541459|NCT02383056|469948851|FG000|Overall Study|Lost to Follow-up|0|||
130541460|NCT02383056|469948852|FG001|Overall Study|Lost to Follow-up|2|||
130541461|NCT04214600|469948853|FG000|Overall Study|Lost to Follow-up|9|||
130541462|NCT04214600|469948854|FG001|Overall Study|Lost to Follow-up|14|||
130541463|NCT03245151|469948860|FG000|Overall Study|Withdrawal by Subject|2|||
130541464|NCT03245151|469948861|FG001|Overall Study|Withdrawal by Subject|0|||
130541465|NCT03245151|469948862|FG002|Overall Study|Withdrawal by Subject|0|||
130541466|NCT03245151|469948863|FG003|Overall Study|Withdrawal by Subject|2|||
130541467|NCT03245151|469948864|FG004|Overall Study|Withdrawal by Subject|1|||
130541468|NCT03245151|469948860|FG000|Overall Study|Death|3|||
130541469|NCT03245151|469948861|FG001|Overall Study|Death|14|||
130541470|NCT03245151|469948862|FG002|Overall Study|Death|9|||
130541471|NCT03245151|469948863|FG003|Overall Study|Death|16|||
130541472|NCT03245151|469948864|FG004|Overall Study|Death|7|||
130541473|NCT03245151|469948860|FG000|Overall Study|Sponsor's decision|0|||
130541474|NCT03245151|469948861|FG001|Overall Study|Sponsor's decision|1|||
130541475|NCT03245151|469948862|FG002|Overall Study|Sponsor's decision|0|||
130541476|NCT03245151|469948863|FG003|Overall Study|Sponsor's decision|0|||
130541477|NCT03245151|469948864|FG004|Overall Study|Sponsor's decision|0|||
130541478|NCT02245737|469948865|FG000|Overall Study|Adverse Event|23|||
130541479|NCT02245737|469948866|FG001|Overall Study|Adverse Event|26|||
130541480|NCT02245737|469948867|FG002|Overall Study|Adverse Event|33|||
130541481|NCT02245737|469948865|FG000|Overall Study|Condition Worsened|9|||
130541482|NCT02245737|469948866|FG001|Overall Study|Condition Worsened|10|||
130541483|NCT02245737|469948867|FG002|Overall Study|Condition Worsened|9|||
130541484|NCT02245737|469948865|FG000|Overall Study|Death|2|||
130541485|NCT02245737|469948866|FG001|Overall Study|Death|4|||
130541486|NCT02245737|469948867|FG002|Overall Study|Death|4|||
130541487|NCT02245737|469948865|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
130541488|NCT02245737|469948866|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
130541489|NCT02245737|469948867|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
130541490|NCT02245737|469948865|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
130541491|NCT02245737|469948866|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
130541492|NCT02245737|469948867|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
130541493|NCT02245737|469948865|FG000|Overall Study|Lost to Follow-up|2|||
130541494|NCT02245737|469948866|FG001|Overall Study|Lost to Follow-up|5|||
130541495|NCT02245737|469948867|FG002|Overall Study|Lost to Follow-up|4|||
130541496|NCT02245737|469948865|FG000|Overall Study|Other-determined by Investigator|9|||
130541497|NCT02245737|469948866|FG001|Overall Study|Other-determined by Investigator|10|||
130541498|NCT02245737|469948867|FG002|Overall Study|Other-determined by Investigator|10|||
130541499|NCT02245737|469948865|FG000|Overall Study|Physician Decision|6|||
130541500|NCT02245737|469948866|FG001|Overall Study|Physician Decision|3|||
130541501|NCT02245737|469948867|FG002|Overall Study|Physician Decision|6|||
130541502|NCT02245737|469948865|FG000|Overall Study|Protocol Violation|3|||
130541503|NCT02245737|469948866|FG001|Overall Study|Protocol Violation|2|||
130541504|NCT02245737|469948867|FG002|Overall Study|Protocol Violation|3|||
130541505|NCT02245737|469948865|FG000|Overall Study|Withdrawal by Subject|40|||
130541506|NCT02245737|469948866|FG001|Overall Study|Withdrawal by Subject|41|||
130541507|NCT02245737|469948867|FG002|Overall Study|Withdrawal by Subject|44|||
130541508|NCT02245737|469948865|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
130541509|NCT02245737|469948866|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
130541510|NCT02245737|469948867|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
130541511|NCT02245737|469948865|FG000|Overall Study|Sponsor Decision|445|||
130541512|NCT02245737|469948866|FG001|Overall Study|Sponsor Decision|430|||
130541513|NCT02245737|469948867|FG002|Overall Study|Sponsor Decision|432|||
130541514|NCT02366468|469948869|FG000|Overall Study|Adverse Event|2|||
130207647|NCT04683939|468719019|FG001|Overall Study|Lost to Follow-up|1|||
130207648|NCT04683939|468719020|FG002|Overall Study|Lost to Follow-up|0|||
130207649|NCT04683939|468719021|FG003|Overall Study|Lost to Follow-up|0|||
130207650|NCT02000882|468720962|FG000|Overall Study|Adverse Event|3|||
130207651|NCT02000882|468720962|FG000|Overall Study|Physician Decision|2|||
130207652|NCT02000882|468720962|FG000|Overall Study|Withdrawal by Subject|1|||
130207653|NCT00549601|468720963|FG000|Randomized|Protocol Violation|0|||
130207654|NCT00549601|468720964|FG001|Randomized|Protocol Violation|0|||
130541515|NCT02366468|469948870|FG001|Overall Study|Adverse Event|0|||
130541516|NCT02366468|469948869|FG000|Overall Study|Withdrawal by Subject|1|||
130207655|NCT00549601|468720965|FG002|Randomized|Protocol Violation|1|||
130207656|NCT00549601|468720963|FG000|Randomized|Withdrawal by Subject|0|||
130207657|NCT00549601|468720964|FG001|Randomized|Withdrawal by Subject|1|||
130207658|NCT00549601|468720965|FG002|Randomized|Withdrawal by Subject|1|||
130207659|NCT00549601|468720963|FG000|Received Study Drug|Adverse Event|2|||
130207660|NCT00549601|468720964|FG001|Received Study Drug|Adverse Event|5|||
130207661|NCT00549601|468720965|FG002|Received Study Drug|Adverse Event|1|||
130207662|NCT00549601|468720963|FG000|Received Study Drug|Death|0|||
130541517|NCT02366468|469948870|FG001|Overall Study|Withdrawal by Subject|5|||
130541518|NCT02366468|469948869|FG000|Overall Study|Lost to Follow-up|2|||
130541519|NCT02366468|469948870|FG001|Overall Study|Lost to Follow-up|0|||
130541520|NCT02366468|469948869|FG000|Overall Study|Death|1|||
130541521|NCT02366468|469948870|FG001|Overall Study|Death|2|||
130541522|NCT02366468|469948869|FG000|Overall Study|Other|0|||
130541523|NCT02366468|469948870|FG001|Overall Study|Other|2|||
130541524|NCT01552603|469948871|FG000|Overall Study|Physician Decision|1|||
130541525|NCT04797650|469948876|FG000|Overall Study|Reason Not Specified|5|||
130541526|NCT04797650|469948877|FG001|Overall Study|Reason Not Specified|12|||
130541527|NCT04797650|469948878|FG002|Overall Study|Reason Not Specified|5|||
130541528|NCT04797650|469948876|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
130541529|NCT04797650|469948877|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
130541530|NCT04797650|469948878|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
130541531|NCT04797650|469948876|FG000|Overall Study|Lack of Efficacy|1|||
130541532|NCT04797650|469948877|FG001|Overall Study|Lack of Efficacy|0|||
130541533|NCT04797650|469948878|FG002|Overall Study|Lack of Efficacy|1|||
130541534|NCT04797650|469948876|FG000|Overall Study|Non-compliance with Study Drug|0|||
130541535|NCT04797650|469948877|FG001|Overall Study|Non-compliance with Study Drug|0|||
130541536|NCT04797650|469948878|FG002|Overall Study|Non-compliance with Study Drug|2|||
130541537|NCT04797650|469948876|FG000|Overall Study|Lost to Follow-up|4|||
130541538|NCT04797650|469948877|FG001|Overall Study|Lost to Follow-up|6|||
130541539|NCT04797650|469948878|FG002|Overall Study|Lost to Follow-up|1|||
130541540|NCT00446043|469948879|FG000|Overall Study|Adverse Event|9|||
130541541|NCT00446043|469948879|FG000|Overall Study|Withdrawal by Subject|70|||
130541542|NCT00446043|469948879|FG000|Overall Study|Protocol Violation|2|||
130541543|NCT00446043|469948879|FG000|Overall Study|Lost to Follow-up|42|||
130541544|NCT00446043|469948879|FG000|Overall Study|Pregnancy|2|||
130541545|NCT04772898|469948884|FG000|Overall Study|Withdrawal by Subject|0|||
130541546|NCT04772898|469948885|FG001|Overall Study|Withdrawal by Subject|1|||
130541547|NCT02947087|469948887|FG000|Overall Study|Withdrawal by Subject|3|||
130541548|NCT02947087|469948888|FG001|Overall Study|Withdrawal by Subject|2|||
130541549|NCT01983254|469948892|FG000|Overall Study|Death|6|||
130541550|NCT01983254|469948893|FG001|Overall Study|Death|6|||
130541551|NCT01983254|469948892|FG000|Overall Study|Lost to Follow-up|17|||
130541552|NCT01983254|469948893|FG001|Overall Study|Lost to Follow-up|16|||
130541553|NCT01983254|469948892|FG000|Overall Study|too ill|11|||
130541554|NCT01983254|469948893|FG001|Overall Study|too ill|8|||
130541555|NCT00434213|469948896|FG000|Overall Study|Adverse Event|12|||
130541556|NCT00434213|469948896|FG000|Overall Study|Lack of Efficacy|9|||
130541557|NCT00434213|469948896|FG000|Overall Study|Lost to Follow-up|14|||
130541558|NCT00434213|469948896|FG000|Overall Study|Withdrawal by Subject|7|||
130541559|NCT00434213|469948896|FG000|Overall Study|Protocol Violation|3|||
130541560|NCT00434213|469948896|FG000|Overall Study|Unable to comply with study visit window|2|||
130541561|NCT00434213|469948896|FG000|Overall Study|Application site reaction|1|||
130541562|NCT00434213|469948896|FG000|Overall Study|Non-compliant to study schedule|1|||
130207663|NCT00549601|468720964|FG001|Received Study Drug|Death|1|||
130207664|NCT00549601|468720965|FG002|Received Study Drug|Death|0|||
130207665|NCT00549601|468720963|FG000|Received Study Drug|Lost to Follow-up|0|||
130207666|NCT00549601|468720964|FG001|Received Study Drug|Lost to Follow-up|1|||
130207667|NCT00549601|468720965|FG002|Received Study Drug|Lost to Follow-up|1|||
130207668|NCT00549601|468720963|FG000|Received Study Drug|Protocol Violation|3|||
130207669|NCT00549601|468720964|FG001|Received Study Drug|Protocol Violation|4|||
130207670|NCT00549601|468720965|FG002|Received Study Drug|Protocol Violation|1|||
130207671|NCT00549601|468720963|FG000|Received Study Drug|Withdrawal by Subject|2|||
130207672|NCT00549601|468720964|FG001|Received Study Drug|Withdrawal by Subject|0|||
130207673|NCT00549601|468720965|FG002|Received Study Drug|Withdrawal by Subject|1|||
130207674|NCT04643964|468720970|FG000|Overall Study|Lost to Follow-up|55|||
130207675|NCT04643964|468720971|FG001|Overall Study|Lost to Follow-up|59|||
130207676|NCT04643964|468720972|FG002|Overall Study|Lost to Follow-up|54|||
130207677|NCT04643964|468720973|FG003|Overall Study|Lost to Follow-up|129|||
130207678|NCT04643964|468720974|FG004|Overall Study|Lost to Follow-up|48|||
130207679|NCT04643964|468720970|FG000|Overall Study|Failed attention check|1|||
130207680|NCT04643964|468720971|FG001|Overall Study|Failed attention check|8|||
130207681|NCT04643964|468720972|FG002|Overall Study|Failed attention check|2|||
130207682|NCT04643964|468720973|FG003|Overall Study|Failed attention check|14|||
130207683|NCT04643964|468720974|FG004|Overall Study|Failed attention check|11|||
130207684|NCT05932225|468720975|FG000|Overall Study|Lost to Follow-up|0|||
130207685|NCT05932225|468720976|FG001|Overall Study|Lost to Follow-up|1|||
130207686|NCT05932225|468720977|FG002|Overall Study|Lost to Follow-up|0|||
130207687|NCT05932225|468720975|FG000|Overall Study|Withdrawal by Subject|1|||
130207688|NCT05932225|468720976|FG001|Overall Study|Withdrawal by Subject|0|||
130207689|NCT05932225|468720977|FG002|Overall Study|Withdrawal by Subject|0|||
130207690|NCT05932225|468720975|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
130207691|NCT05932225|468720976|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
130207692|NCT05932225|468720977|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
130207693|NCT02638129|468720978|FG000|Overall Study|Study terminated|28|||
130207694|NCT02638129|468720979|FG001|Overall Study|Study terminated|30|||
130207695|NCT02949908|468720980|FG000|Overall Study|Study termination|2|||
130207696|NCT01472939|468720981|FG000|Overall Study|Adverse Event|3|||
130207697|NCT01472939|468720982|FG001|Overall Study|Adverse Event|7|||
130207698|NCT01472939|468720983|FG002|Overall Study|Adverse Event|7|||
130541563|NCT04988867|469948899|FG000|Overall Study|Study terminated by Sponsor|12|||
130541564|NCT04988867|469948899|FG000|Overall Study|Adverse Event|2|||
130541565|NCT04988867|469948899|FG000|Overall Study|Study drug noncompliance|1|||
130541566|NCT01699503|469948902|FG000|Overall Study|Death|31|||
130541567|NCT01699503|469948903|FG001|Overall Study|Death|40|||
130541568|NCT01699503|469948902|FG000|Overall Study|Withdrawal by Subject|65|||
130207699|NCT01472939|468720984|FG003|Overall Study|Adverse Event|14|||
130207700|NCT01472939|468720981|FG000|Overall Study|Lack of Efficacy|1|||
130541569|NCT01699503|469948903|FG001|Overall Study|Withdrawal by Subject|57|||
130541570|NCT01699503|469948902|FG000|Overall Study|Lost to Follow-up|121|||
130541571|NCT01699503|469948903|FG001|Overall Study|Lost to Follow-up|117|||
130541572|NCT01699503|469948902|FG000|Overall Study|Excluded due to quality|783|||
130541573|NCT01699503|469948903|FG001|Overall Study|Excluded due to quality|791|||
130541574|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
130541575|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
130541576|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
130541577|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
130541578|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
130541579|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
130541580|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
130541581|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
130541582|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
130207701|NCT01472939|468720982|FG001|Overall Study|Lack of Efficacy|0|||
130207702|NCT01472939|468720983|FG002|Overall Study|Lack of Efficacy|0|||
130207703|NCT01472939|468720984|FG003|Overall Study|Lack of Efficacy|1|||
130652201|NCT00953017|470349364|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
130652202|NCT00953017|470349365|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
130652203|NCT00953017|470349366|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
130652204|NCT00953017|470349363|FG000|Overall Study|Brown stool prior to procedure|0|||
130652205|NCT00953017|470349364|FG001|Overall Study|Brown stool prior to procedure|0|||
130652206|NCT00953017|470349365|FG002|Overall Study|Brown stool prior to procedure|1|||
130652207|NCT00953017|470349366|FG003|Overall Study|Brown stool prior to procedure|0|||
130652208|NCT00718809|470349369|FG000|Overall Study|Disease progression|9|||
130652209|NCT00718809|470349370|FG001|Overall Study|Disease progression|7|||
130652210|NCT00718809|470349369|FG000|Overall Study|Adverse Event|1|||
130652211|NCT00718809|470349370|FG001|Overall Study|Adverse Event|1|||
130652212|NCT00718809|470349369|FG000|Overall Study|Withdrawal by Subject|0|||
130652213|NCT00718809|470349370|FG001|Overall Study|Withdrawal by Subject|1|||
130652214|NCT00718809|470349369|FG000|Overall Study|Lost to Follow-up|1|||
130541583|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
130541584|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
130541585|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
130541586|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
130541587|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
130541588|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
130652215|NCT00718809|470349370|FG001|Overall Study|Lost to Follow-up|0|||
130652216|NCT00718809|470349369|FG000|Overall Study|Noncompliance|1|||
130652217|NCT00718809|470349370|FG001|Overall Study|Noncompliance|0|||
130652218|NCT00463385|470349371|FG000|Overall Study|Other|4|||
130652219|NCT00463385|470349372|FG001|Overall Study|Other|3|||
130652220|NCT00463385|470349373|FG002|Overall Study|Other|6|||
130652221|NCT00463385|470349374|FG003|Overall Study|Other|4|||
130652222|NCT00463385|470349371|FG000|Overall Study|Adverse Event|5|||
130652223|NCT00463385|470349372|FG001|Overall Study|Adverse Event|8|||
130652224|NCT00463385|470349373|FG002|Overall Study|Adverse Event|4|||
130652225|NCT00463385|470349374|FG003|Overall Study|Adverse Event|2|||
130652226|NCT00463385|470349371|FG000|Overall Study|Lack of Efficacy|6|||
130652227|NCT00463385|470349372|FG001|Overall Study|Lack of Efficacy|6|||
130652228|NCT00463385|470349373|FG002|Overall Study|Lack of Efficacy|7|||
130652229|NCT00463385|470349374|FG003|Overall Study|Lack of Efficacy|9|||
130652230|NCT00463385|470349371|FG000|Overall Study|Withdrawal by Subject|3|||
130652231|NCT00463385|470349372|FG001|Overall Study|Withdrawal by Subject|3|||
130652232|NCT00463385|470349373|FG002|Overall Study|Withdrawal by Subject|3|||
130652233|NCT00463385|470349374|FG003|Overall Study|Withdrawal by Subject|4|||
130652234|NCT00463385|470349371|FG000|Overall Study|Lost to Follow-up|0|||
130652235|NCT00463385|470349372|FG001|Overall Study|Lost to Follow-up|0|||
130652236|NCT00463385|470349373|FG002|Overall Study|Lost to Follow-up|0|||
130652237|NCT00463385|470349374|FG003|Overall Study|Lost to Follow-up|1|||
130652238|NCT00463385|470349371|FG000|Overall Study|Death|2|||
130652239|NCT00463385|470349372|FG001|Overall Study|Death|1|||
130652240|NCT00463385|470349373|FG002|Overall Study|Death|2|||
130652241|NCT00463385|470349374|FG003|Overall Study|Death|0|||
130652242|NCT00463385|470349371|FG000|Overall Study|Missing|2|||
130541589|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
130652243|NCT00463385|470349372|FG001|Overall Study|Missing|0|||
130652244|NCT00463385|470349373|FG002|Overall Study|Missing|0|||
130652245|NCT00463385|470349374|FG003|Overall Study|Missing|2|||
130652246|NCT00463385|470349371|FG000|Overall Study|1 participant received commercial drug|0|||
130652247|NCT00463385|470349372|FG001|Overall Study|1 participant received commercial drug|1|||
130541590|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
130652248|NCT00463385|470349373|FG002|Overall Study|1 participant received commercial drug|0|||
130652249|NCT00463385|470349374|FG003|Overall Study|1 participant received commercial drug|0|||
130652250|NCT00449761|470349375|FG000|Overall Study|Disease progression|12|||
130652251|NCT00449761|470349375|FG000|Overall Study|Death|5|||
130652252|NCT00449761|470349375|FG000|Overall Study|New cancer therapy|1|||
130652253|NCT00344968|470349378|FG000|Overall Study|Adverse Event|5|||
130652254|NCT00344968|470349379|FG001|Overall Study|Adverse Event|4|||
130652255|NCT00344968|470349380|FG002|Overall Study|Adverse Event|15|||
130652256|NCT00344968|470349378|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130652257|NCT00344968|470349379|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130652258|NCT00344968|470349380|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130652259|NCT00344968|470349378|FG000|Overall Study|Protocol Violation|2|||
130652260|NCT00344968|470349379|FG001|Overall Study|Protocol Violation|2|||
130652261|NCT00344968|470349380|FG002|Overall Study|Protocol Violation|5|||
130652262|NCT00344968|470349378|FG000|Overall Study|Withdrawal by Subject|14|||
130652263|NCT00344968|470349379|FG001|Overall Study|Withdrawal by Subject|31|||
130652264|NCT00344968|470349380|FG002|Overall Study|Withdrawal by Subject|27|||
130652265|NCT00344968|470349378|FG000|Overall Study|Lost to Follow-up|24|||
130652266|NCT00344968|470349379|FG001|Overall Study|Lost to Follow-up|37|||
130207704|NCT01472939|468720981|FG000|Overall Study|Lost to Follow-up|3|||
130541591|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
130541592|NCT03412747|469948910|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
130541593|NCT03412747|469948911|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
130541594|NCT03412747|469948912|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
130541595|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
130541596|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
130541597|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
130541598|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
130541599|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
130541600|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
130541601|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
130541602|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
130541603|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
130541604|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
130541605|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
130541606|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
130541607|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
130541608|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
130541609|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
130541610|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
130541611|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
130541612|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
130541613|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
130541614|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
130541615|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
130541616|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
130541617|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
130541618|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
130541619|NCT03412747|469948910|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
130541620|NCT03412747|469948911|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
130541621|NCT03412747|469948912|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
130541622|NCT02081417|469948913|FG000|Overall Study|Lost to Follow-up|26|||
130541623|NCT02081417|469948914|FG001|Overall Study|Lost to Follow-up|23|||
130541624|NCT02081417|469948913|FG000|Overall Study|Moved Away|1|||
130541625|NCT02081417|469948914|FG001|Overall Study|Moved Away|2|||
130541626|NCT02081417|469948913|FG000|Overall Study|Incarcerated|2|||
130541627|NCT02081417|469948914|FG001|Overall Study|Incarcerated|2|||
130541628|NCT02081417|469948913|FG000|Overall Study|Death|4|||
130541629|NCT02081417|469948914|FG001|Overall Study|Death|3|||
130541630|NCT02081417|469948913|FG000|Overall Study|Withdrawal by Subject|4|||
130541631|NCT02081417|469948914|FG001|Overall Study|Withdrawal by Subject|0|||
130541632|NCT02081417|469948913|FG000|Overall Study|Admitted to Residential Treatment|2|||
130541633|NCT02081417|469948914|FG001|Overall Study|Admitted to Residential Treatment|0|||
130541634|NCT02081417|469948913|FG000|Overall Study|Did not start treatment|17|||
130541635|NCT02081417|469948914|FG001|Overall Study|Did not start treatment|21|||
130541636|NCT01263665|469948918|FG000|Overall Study|Withdrew Consent|1|||
130541637|NCT01263665|469948918|FG000|Overall Study|Lost to Follow-up|3|||
130541638|NCT01263665|469948918|FG000|Overall Study|Death|2|||
130541639|NCT01263665|469948918|FG000|Overall Study|Amputation above the ankle|1|||
130541640|NCT01263665|469948918|FG000|Overall Study|Surgical Bypass|2|||
130541641|NCT00381615|469948919|FG000|Overall Study|Withdrawal by Subject|1|||
130541642|NCT00381615|469948920|FG001|Overall Study|Withdrawal by Subject|3|||
130541643|NCT00381615|469948921|FG002|Overall Study|Withdrawal by Subject|0|||
130207705|NCT01472939|468720982|FG001|Overall Study|Lost to Follow-up|0|||
130207706|NCT01472939|468720983|FG002|Overall Study|Lost to Follow-up|2|||
130207707|NCT01472939|468720984|FG003|Overall Study|Lost to Follow-up|0|||
130376451|NCT03655691|469343693|FG002|Overall Study|Protocol Violation|0|||
130541644|NCT00381615|469948922|FG003|Overall Study|Withdrawal by Subject|1|||
130541645|NCT00381615|469948919|FG000|Overall Study|Lost to Follow-up|3|||
130541646|NCT00381615|469948920|FG001|Overall Study|Lost to Follow-up|2|||
130541647|NCT00381615|469948921|FG002|Overall Study|Lost to Follow-up|0|||
130541648|NCT00381615|469948922|FG003|Overall Study|Lost to Follow-up|1|||
130541649|NCT00381615|469948919|FG000|Overall Study|Protocol Violation|0|||
130541650|NCT00381615|469948920|FG001|Overall Study|Protocol Violation|0|||
130541651|NCT00381615|469948921|FG002|Overall Study|Protocol Violation|1|||
130541652|NCT00381615|469948922|FG003|Overall Study|Protocol Violation|0|||
130541653|NCT01801735|469948925|FG000|Overall Study|Adverse Event|79|||
130541654|NCT01801735|469948925|FG000|Overall Study|Lack of Efficacy|28|||
130541655|NCT01801735|469948925|FG000|Overall Study|Withdrawal by Subject|27|||
130541656|NCT01801735|469948925|FG000|Overall Study|Protocol Violation|25|||
130541657|NCT01801735|469948925|FG000|Overall Study|Lost to Follow-up|15|||
130541658|NCT01801735|469948925|FG000|Overall Study|Non-compliance with Trial Drug|13|||
130541659|NCT01801735|469948925|FG000|Overall Study|Physician Decision|3|||
130541660|NCT01801735|469948925|FG000|Overall Study|Death|1|||
130541661|NCT01801735|469948925|FG000|Overall Study|Other, including site closure|19|||
130541662|NCT01435616|469948926|FG000|Overall Study|Adverse Event|39|||
130541663|NCT01435616|469948927|FG001|Overall Study|Adverse Event|21|||
130541664|NCT01435616|469948926|FG000|Overall Study|Death|7|||
130541665|NCT01435616|469948927|FG001|Overall Study|Death|2|||
130541666|NCT01435616|469948926|FG000|Overall Study|Lost to Follow-up|22|||
130541667|NCT01435616|469948927|FG001|Overall Study|Lost to Follow-up|13|||
130541668|NCT01435616|469948926|FG000|Overall Study|Protocol Violation|16|||
130541669|NCT01435616|469948927|FG001|Overall Study|Protocol Violation|13|||
130541670|NCT01435616|469948926|FG000|Overall Study|Withdrawal by Subject|66|||
130541671|NCT01435616|469948927|FG001|Overall Study|Withdrawal by Subject|24|||
130541672|NCT01435616|469948926|FG000|Overall Study|Physician Decision|20|||
130541673|NCT01435616|469948927|FG001|Overall Study|Physician Decision|7|||
130541674|NCT01435616|469948926|FG000|Overall Study|Sponsor Decision|1|||
130541675|NCT01435616|469948927|FG001|Overall Study|Sponsor Decision|0|||
130541676|NCT01528345|469948928|FG000|Overall Study|Adverse Event|10|||
130541677|NCT01528345|469948929|FG001|Overall Study|Adverse Event|1|||
130541678|NCT01528345|469948928|FG000|Overall Study|Death|1|||
130541679|NCT01528345|469948929|FG001|Overall Study|Death|1|||
130541680|NCT01528345|469948928|FG000|Overall Study|Non-compliance with study treatment|1|||
130541681|NCT01528345|469948929|FG001|Overall Study|Non-compliance with study treatment|0|||
130541682|NCT01528345|469948928|FG000|Overall Study|Progressive Disease|26|||
130541683|NCT01528345|469948929|FG001|Overall Study|Progressive Disease|40|||
130541684|NCT01528345|469948928|FG000|Overall Study|Study Terminated by Sponsor|4|||
130541685|NCT01528345|469948929|FG001|Overall Study|Study Terminated by Sponsor|8|||
130541686|NCT01528345|469948928|FG000|Overall Study|Subject/Guardian Decision|5|||
130541687|NCT01528345|469948929|FG001|Overall Study|Subject/Guardian Decision|0|||
130541688|NCT01151410|469948931|FG000|Overall Study|Withdrawal by Subject|3|||
130541689|NCT01151410|469948932|FG001|Overall Study|Withdrawal by Subject|5|||
130541690|NCT01151410|469948931|FG000|Overall Study|Lost to Follow-up|3|||
130541691|NCT01151410|469948932|FG001|Overall Study|Lost to Follow-up|4|||
130541692|NCT01151410|469948931|FG000|Overall Study|Adverse Event|1|||
130541693|NCT01151410|469948932|FG001|Overall Study|Adverse Event|2|||
130541694|NCT01151410|469948931|FG000|Overall Study|Protocol deviation|2|||
130429858|NCT00279201|469535459|FG005|Maintenance|Lost to Follow-up|0|||
130429859|NCT00279201|469535454|FG000|Maintenance|Entry Criteria Exclusion|1|||
130429860|NCT00279201|469535455|FG001|Maintenance|Entry Criteria Exclusion|4|||
130429861|NCT00279201|469535456|FG002|Maintenance|Entry Criteria Exclusion|0|||
130429862|NCT00279201|469535457|FG003|Maintenance|Entry Criteria Exclusion|0|||
130429863|NCT00279201|469535458|FG004|Maintenance|Entry Criteria Exclusion|0|||
130429864|NCT00279201|469535459|FG005|Maintenance|Entry Criteria Exclusion|0|||
130429865|NCT00279201|469535454|FG000|Maintenance|Protocol Violation|16|||
130429866|NCT00279201|469535455|FG001|Maintenance|Protocol Violation|24|||
130429867|NCT00279201|469535456|FG002|Maintenance|Protocol Violation|0|||
130429868|NCT00279201|469535457|FG003|Maintenance|Protocol Violation|0|||
130429869|NCT00279201|469535458|FG004|Maintenance|Protocol Violation|0|||
130429870|NCT00279201|469535459|FG005|Maintenance|Protocol Violation|0|||
130429871|NCT00279201|469535454|FG000|Maintenance|Withdrawal by Subject|18|||
130429872|NCT00279201|469535455|FG001|Maintenance|Withdrawal by Subject|18|||
130429873|NCT00279201|469535456|FG002|Maintenance|Withdrawal by Subject|0|||
130429874|NCT00279201|469535457|FG003|Maintenance|Withdrawal by Subject|0|||
130652267|NCT00344968|470349380|FG002|Overall Study|Lost to Follow-up|37|||
130429875|NCT00279201|469535458|FG004|Maintenance|Withdrawal by Subject|0|||
130429876|NCT00279201|469535459|FG005|Maintenance|Withdrawal by Subject|0|||
130429877|NCT00279201|469535454|FG000|Maintenance|Physician Decision|9|||
130429878|NCT00279201|469535455|FG001|Maintenance|Physician Decision|9|||
130429879|NCT00279201|469535456|FG002|Maintenance|Physician Decision|0|||
130429880|NCT00279201|469535457|FG003|Maintenance|Physician Decision|0|||
130429881|NCT00279201|469535458|FG004|Maintenance|Physician Decision|0|||
130429882|NCT00279201|469535459|FG005|Maintenance|Physician Decision|0|||
130429883|NCT00279201|469535454|FG000|Maintenance|Sponsor Decision|4|||
130429884|NCT00279201|469535455|FG001|Maintenance|Sponsor Decision|0|||
130429885|NCT00279201|469535456|FG002|Maintenance|Sponsor Decision|0|||
130429886|NCT00279201|469535457|FG003|Maintenance|Sponsor Decision|0|||
130429887|NCT00279201|469535458|FG004|Maintenance|Sponsor Decision|0|||
130429888|NCT00279201|469535459|FG005|Maintenance|Sponsor Decision|0|||
130429889|NCT00279201|469535454|FG000|Maintenance|HbA1c>7.5%|123|||
130429890|NCT00279201|469535455|FG001|Maintenance|HbA1c>7.5%|126|||
130429891|NCT00279201|469535456|FG002|Maintenance|HbA1c>7.5%|0|||
130429892|NCT00279201|469535457|FG003|Maintenance|HbA1c>7.5%|0|||
130429893|NCT00279201|469535458|FG004|Maintenance|HbA1c>7.5%|0|||
130429894|NCT00279201|469535459|FG005|Maintenance|HbA1c>7.5%|0|||
130429895|NCT00279201|469535454|FG000|Intensification Addendum|Withdrawal by Subject|0|||
130429896|NCT00279201|469535455|FG001|Intensification Addendum|Withdrawal by Subject|0|||
130429897|NCT00279201|469535456|FG002|Intensification Addendum|Withdrawal by Subject|12|||
130429898|NCT00279201|469535457|FG003|Intensification Addendum|Withdrawal by Subject|14|||
130429899|NCT00279201|469535458|FG004|Intensification Addendum|Withdrawal by Subject|9|||
130429900|NCT00279201|469535459|FG005|Intensification Addendum|Withdrawal by Subject|18|||
130429901|NCT00279201|469535454|FG000|Intensification Addendum|Lost to Follow-up|0|||
130429902|NCT00279201|469535455|FG001|Intensification Addendum|Lost to Follow-up|0|||
130429903|NCT00279201|469535456|FG002|Intensification Addendum|Lost to Follow-up|4|||
130429904|NCT00279201|469535457|FG003|Intensification Addendum|Lost to Follow-up|6|||
130429905|NCT00279201|469535458|FG004|Intensification Addendum|Lost to Follow-up|7|||
130429906|NCT00279201|469535459|FG005|Intensification Addendum|Lost to Follow-up|7|||
130429907|NCT00279201|469535454|FG000|Intensification Addendum|Protocol Violation|0|||
130429908|NCT00279201|469535455|FG001|Intensification Addendum|Protocol Violation|0|||
130429909|NCT00279201|469535456|FG002|Intensification Addendum|Protocol Violation|2|||
130429910|NCT00279201|469535457|FG003|Intensification Addendum|Protocol Violation|2|||
130429911|NCT00279201|469535458|FG004|Intensification Addendum|Protocol Violation|6|||
130429912|NCT00279201|469535459|FG005|Intensification Addendum|Protocol Violation|6|||
130429913|NCT00279201|469535454|FG000|Intensification Addendum|Adverse Event|0|||
130429914|NCT00279201|469535455|FG001|Intensification Addendum|Adverse Event|0|||
130429915|NCT00279201|469535456|FG002|Intensification Addendum|Adverse Event|0|||
130429916|NCT00279201|469535457|FG003|Intensification Addendum|Adverse Event|4|||
130429917|NCT00279201|469535458|FG004|Intensification Addendum|Adverse Event|1|||
130429918|NCT00279201|469535459|FG005|Intensification Addendum|Adverse Event|3|||
130429919|NCT00279201|469535454|FG000|Intensification Addendum|Physician Decision|0|||
130429920|NCT00279201|469535455|FG001|Intensification Addendum|Physician Decision|0|||
130429921|NCT00279201|469535456|FG002|Intensification Addendum|Physician Decision|4|||
130429922|NCT00279201|469535457|FG003|Intensification Addendum|Physician Decision|1|||
130429923|NCT00279201|469535458|FG004|Intensification Addendum|Physician Decision|3|||
130429924|NCT00279201|469535459|FG005|Intensification Addendum|Physician Decision|2|||
130429925|NCT00279201|469535454|FG000|Intensification Addendum|Sponsor Decision|0|||
130429926|NCT00279201|469535455|FG001|Intensification Addendum|Sponsor Decision|0|||
130429927|NCT00279201|469535456|FG002|Intensification Addendum|Sponsor Decision|0|||
130429928|NCT00279201|469535457|FG003|Intensification Addendum|Sponsor Decision|0|||
130429929|NCT00279201|469535458|FG004|Intensification Addendum|Sponsor Decision|1|||
130429930|NCT00279201|469535459|FG005|Intensification Addendum|Sponsor Decision|1|||
130429931|NCT00279201|469535454|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
130429932|NCT00279201|469535455|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
130429933|NCT00279201|469535456|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
130429934|NCT00279201|469535457|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
130429935|NCT00279201|469535458|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
130429936|NCT00279201|469535459|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
130429937|NCT00279201|469535454|FG000|Intensification Addendum|Lack of Efficacy|0|||
130429938|NCT00279201|469535455|FG001|Intensification Addendum|Lack of Efficacy|0|||
130429939|NCT00279201|469535456|FG002|Intensification Addendum|Lack of Efficacy|0|||
130429940|NCT00279201|469535457|FG003|Intensification Addendum|Lack of Efficacy|1|||
130429941|NCT00279201|469535458|FG004|Intensification Addendum|Lack of Efficacy|1|||
130429942|NCT00279201|469535459|FG005|Intensification Addendum|Lack of Efficacy|0|||
130429943|NCT00279201|469535454|FG000|Intensification Addendum|Death|0|||
130429944|NCT00279201|469535455|FG001|Intensification Addendum|Death|0|||
130429945|NCT00279201|469535456|FG002|Intensification Addendum|Death|0|||
130429946|NCT00279201|469535457|FG003|Intensification Addendum|Death|0|||
130429947|NCT00279201|469535458|FG004|Intensification Addendum|Death|1|||
130429948|NCT00279201|469535459|FG005|Intensification Addendum|Death|0|||
130429949|NCT02390531|469535462|FG000|Overall Study|Death|0|||
130429950|NCT02390531|469535463|FG001|Overall Study|Death|2|||
130429951|NCT02390531|469535464|FG002|Overall Study|Death|0|||
130429952|NCT02390531|469535465|FG003|Overall Study|Death|1|||
130541695|NCT01151410|469948932|FG001|Overall Study|Protocol deviation|1|||
130541696|NCT01151410|469948931|FG000|Overall Study|Administrative problems|1|||
130429953|NCT02390531|469535466|FG004|Overall Study|Death|0|||
130429954|NCT02390531|469535467|FG005|Overall Study|Death|0|||
130429955|NCT02390531|469535468|FG006|Overall Study|Death|0|||
130429956|NCT02390531|469535469|FG007|Overall Study|Death|1|||
130429957|NCT02390531|469535462|FG000|Overall Study|Protocol Violation|0|||
130429958|NCT02390531|469535463|FG001|Overall Study|Protocol Violation|0|||
130429959|NCT02390531|469535464|FG002|Overall Study|Protocol Violation|0|||
130541697|NCT01151410|469948932|FG001|Overall Study|Administrative problems|1|||
130541698|NCT01151410|469948931|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130541699|NCT01151410|469948932|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130541700|NCT01151410|469948931|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130541701|NCT01151410|469948932|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130541702|NCT00760474|469948939|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
130541703|NCT00760474|469948940|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
130429960|NCT02390531|469535465|FG003|Overall Study|Protocol Violation|0|||
130429961|NCT02390531|469535466|FG004|Overall Study|Protocol Violation|1|||
130429962|NCT02390531|469535467|FG005|Overall Study|Protocol Violation|0|||
130429963|NCT02390531|469535468|FG006|Overall Study|Protocol Violation|2|||
130429964|NCT02390531|469535469|FG007|Overall Study|Protocol Violation|0|||
130541704|NCT00760474|469948939|FG000|Placebo Washout Period|Other|0|||
130541705|NCT00760474|469948940|FG001|Placebo Washout Period|Other|1|||
130541706|NCT00760474|469948939|FG000|Period 2 (P2)|Lost to Follow-up|1|||
130541707|NCT00760474|469948940|FG001|Period 2 (P2)|Lost to Follow-up|0|||
130541708|NCT00760474|469948939|FG000|Period 2 (P2)|Adverse Event|0|||
130429965|NCT00511875|469535470|FG000|Overall Study|Lost to Follow-up|4|||
130541709|NCT00760474|469948940|FG001|Period 2 (P2)|Adverse Event|1|||
130541710|NCT02217501|469948946|FG000|Overall Study|Death|3|||
130541711|NCT02217501|469948947|FG001|Overall Study|Death|4|||
130541712|NCT00775463|469950590|FG000|Overall Study|Withdrawal by Subject|0|||
130541713|NCT00775463|469950591|FG001|Overall Study|Withdrawal by Subject|1|||
130541714|NCT00775463|469950590|FG000|Overall Study|Adverse Event|7|||
130541715|NCT00775463|469950591|FG001|Overall Study|Adverse Event|9|||
130541716|NCT00775463|469950590|FG000|Overall Study|Protocol Violation|2|||
130541717|NCT00775463|469950591|FG001|Overall Study|Protocol Violation|2|||
130541718|NCT00775463|469950590|FG000|Overall Study|Lost to Follow-up|1|||
130541719|NCT00775463|469950591|FG001|Overall Study|Lost to Follow-up|0|||
130652268|NCT00344968|470349378|FG000|Overall Study|Death|11|||
130429966|NCT00511875|469535471|FG001|Overall Study|Lost to Follow-up|0|||
130429967|NCT00511875|469535470|FG000|Overall Study|Missing variables|1|||
130429968|NCT00511875|469535471|FG001|Overall Study|Missing variables|0|||
130429969|NCT00542880|469535472|FG000|Period 1|Eligibility criteria not fulfilled|2|||
130429970|NCT00542880|469535473|FG001|Period 1|Eligibility criteria not fulfilled|6|||
130429971|NCT00542880|469535472|FG000|Period 1|Adverse Event|2|||
130429972|NCT00542880|469535473|FG001|Period 1|Adverse Event|2|||
130429973|NCT00542880|469535472|FG000|Period 1|Development of study-specific criteria|1|||
130429974|NCT00542880|469535473|FG001|Period 1|Development of study-specific criteria|2|||
130429975|NCT00542880|469535472|FG000|Period 1|Withdrawal by Subject|1|||
130429976|NCT00542880|469535473|FG001|Period 1|Withdrawal by Subject|1|||
130429977|NCT00542880|469535472|FG000|Period 1|Protocol Violation|0|||
130429978|NCT00542880|469535473|FG001|Period 1|Protocol Violation|1|||
130429979|NCT00542880|469535472|FG000|Period 2|Adverse Event|5|||
130429980|NCT00542880|469535473|FG001|Period 2|Adverse Event|7|||
130429981|NCT00542880|469535472|FG000|Period 2|Eligibility not fulfilled|0|||
130429982|NCT00542880|469535473|FG001|Period 2|Eligibility not fulfilled|1|||
130429983|NCT00542880|469535472|FG000|Period 2|Discontinuation criteria|2|||
130429984|NCT00542880|469535473|FG001|Period 2|Discontinuation criteria|0|||
130429985|NCT00542880|469535472|FG000|Period 2|Severe non-compliance|0|||
130429986|NCT00542880|469535473|FG001|Period 2|Severe non-compliance|1|||
130429987|NCT00542880|469535472|FG000|Period 2|Other|0|||
130429988|NCT00542880|469535473|FG001|Period 2|Other|1|||
130429989|NCT00542880|469535472|FG000|Period 3|Adverse Event|0|||
130429990|NCT00542880|469535473|FG001|Period 3|Adverse Event|2|||
130429991|NCT00696384|469535474|FG000|Open Label Phase|Adverse Event|27|||
130429992|NCT00696384|469535475|FG001|Open Label Phase|Adverse Event|0|||
130429993|NCT00696384|469535476|FG002|Open Label Phase|Adverse Event|0|||
130429994|NCT00696384|469535474|FG000|Open Label Phase|Protocol Violation|18|||
130429995|NCT00696384|469535475|FG001|Open Label Phase|Protocol Violation|0|||
130429996|NCT00696384|469535476|FG002|Open Label Phase|Protocol Violation|0|||
130429997|NCT00696384|469535474|FG000|Open Label Phase|Lost to Follow-up|24|||
130429998|NCT00696384|469535475|FG001|Open Label Phase|Lost to Follow-up|0|||
130429999|NCT00696384|469535476|FG002|Open Label Phase|Lost to Follow-up|0|||
130430000|NCT00696384|469535474|FG000|Open Label Phase|Withdrawal by Subject|37|||
130430001|NCT00696384|469535475|FG001|Open Label Phase|Withdrawal by Subject|0|||
130430002|NCT00696384|469535476|FG002|Open Label Phase|Withdrawal by Subject|0|||
130430003|NCT00696384|469535474|FG000|Open Label Phase|Other|6|||
130430004|NCT00696384|469535475|FG001|Open Label Phase|Other|0|||
130430005|NCT00696384|469535476|FG002|Open Label Phase|Other|0|||
130430006|NCT00696384|469535474|FG000|Open Label Phase|Lack of Efficacy|3|||
130430007|NCT00696384|469535475|FG001|Open Label Phase|Lack of Efficacy|0|||
130430008|NCT00696384|469535476|FG002|Open Label Phase|Lack of Efficacy|0|||
130430009|NCT00696384|469535474|FG000|Open Label Phase|Physician Decision|4|||
130541720|NCT00775463|469950590|FG000|Overall Study|Lack of Efficacy|1|||
130541721|NCT00775463|469950591|FG001|Overall Study|Lack of Efficacy|1|||
130541722|NCT01238900|469950592|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
130541723|NCT01238900|469950592|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
130652269|NCT00344968|470349379|FG001|Overall Study|Death|27|||
130430010|NCT00696384|469535475|FG001|Open Label Phase|Physician Decision|0|||
130430011|NCT00696384|469535476|FG002|Open Label Phase|Physician Decision|0|||
130430012|NCT00696384|469535474|FG000|Double Blind Phase|Adverse Event|0|||
130430013|NCT00696384|469535475|FG001|Double Blind Phase|Adverse Event|2|||
130430014|NCT00696384|469535476|FG002|Double Blind Phase|Adverse Event|2|||
130430015|NCT00696384|469535474|FG000|Double Blind Phase|Lost to Follow-up|0|||
130430016|NCT00696384|469535475|FG001|Double Blind Phase|Lost to Follow-up|2|||
130430017|NCT00696384|469535476|FG002|Double Blind Phase|Lost to Follow-up|1|||
130430018|NCT00696384|469535474|FG000|Double Blind Phase|Withdrawal by Subject|0|||
130430019|NCT00696384|469535475|FG001|Double Blind Phase|Withdrawal by Subject|4|||
130430020|NCT00696384|469535476|FG002|Double Blind Phase|Withdrawal by Subject|3|||
130430021|NCT00696384|469535474|FG000|Double Blind Phase|Lack of Efficacy|0|||
130430022|NCT00696384|469535475|FG001|Double Blind Phase|Lack of Efficacy|1|||
130430023|NCT00696384|469535476|FG002|Double Blind Phase|Lack of Efficacy|0|||
130430024|NCT00696384|469535474|FG000|Double Blind Phase|Physician Decision|0|||
130430025|NCT00696384|469535475|FG001|Double Blind Phase|Physician Decision|2|||
130430026|NCT00696384|469535476|FG002|Double Blind Phase|Physician Decision|0|||
130430027|NCT01678131|469535477|FG000|Overall Study|Adverse Event|0|||
130430028|NCT01678131|469535478|FG001|Overall Study|Adverse Event|1|||
130430029|NCT01678131|469535479|FG002|Overall Study|Adverse Event|0|||
130430030|NCT01678131|469535477|FG000|Overall Study|Withdrawal by Subject|0|||
130430031|NCT01678131|469535478|FG001|Overall Study|Withdrawal by Subject|0|||
130430032|NCT01678131|469535479|FG002|Overall Study|Withdrawal by Subject|2|||
130430033|NCT02027402|469535481|FG000|Overall Study|Withdrawal by Subject|4|||
130430034|NCT02027402|469535482|FG001|Overall Study|Withdrawal by Subject|1|||
130430035|NCT00941798|469535486|FG000|Overall Study|Withdrawal by Subject|72|||
130430036|NCT00941798|469535487|FG001|Overall Study|Withdrawal by Subject|74|||
130430037|NCT00941798|469535486|FG000|Overall Study|Adverse Event|43|||
130430038|NCT00941798|469535487|FG001|Overall Study|Adverse Event|23|||
130430039|NCT00941798|469535486|FG000|Overall Study|Lost to Follow-up|29|||
130430040|NCT00941798|469535487|FG001|Overall Study|Lost to Follow-up|23|||
130430041|NCT00941798|469535486|FG000|Overall Study|Protocol Violation|17|||
130430042|NCT00941798|469535487|FG001|Overall Study|Protocol Violation|20|||
130430043|NCT00941798|469535486|FG000|Overall Study|Administrative problems|13|||
130430044|NCT00941798|469535487|FG001|Overall Study|Administrative problems|23|||
130430045|NCT00941798|469535486|FG000|Overall Study|Lack of Efficacy|10|||
130430046|NCT00941798|469535487|FG001|Overall Study|Lack of Efficacy|17|||
130430047|NCT00941798|469535486|FG000|Overall Study|Patient's inability to use device|6|||
130430048|NCT00941798|469535487|FG001|Overall Study|Patient's inability to use device|1|||
130430049|NCT00941798|469535486|FG000|Overall Study|Abnormal test procedure results|3|||
130430050|NCT00941798|469535487|FG001|Overall Study|Abnormal test procedure results|1|||
130430051|NCT00941798|469535486|FG000|Overall Study|Abnormal laboratory values|1|||
130430052|NCT00941798|469535487|FG001|Overall Study|Abnormal laboratory values|2|||
130430053|NCT00941798|469535486|FG000|Overall Study|Death|0|||
130430054|NCT00941798|469535487|FG001|Overall Study|Death|1|||
130430055|NCT03444376|469535492|FG000|Part A|Disease relapse or Progression|1|||
130430056|NCT03444376|469535492|FG000|Part A|Withdrawal by Subject|2|||
130430057|NCT03444376|469535492|FG000|Part A|Adverse Event|1|||
130430058|NCT03444376|469535492|FG000|Part B|Disease relapse or Progression|18|||
130430059|NCT03444376|469535492|FG000|Part B|Withdrawal by Subject|2|||
130430060|NCT03444376|469535492|FG000|Part B|Adverse Event|2|||
130430061|NCT03444376|469535492|FG000|Part B|Physician Decision|1|||
130430062|NCT03444376|469535492|FG000|Part C|Disease relapse or Progression|43|||
130430063|NCT03444376|469535492|FG000|Part C|Withdrawal by Subject|5|||
130430064|NCT03444376|469535492|FG000|Part C|Adverse Event|2|||
130430065|NCT03444376|469535492|FG000|Part C|Physician Decision|2|||
130430066|NCT03444376|469535492|FG000|Part C|Death|1|||
130466687|NCT01538719|469674889|FG000|Overall Study|Lost to Follow-up|2|||
130466688|NCT01538719|469674890|FG001|Overall Study|Lost to Follow-up|0|||
130466689|NCT03664960|469674891|FG000|Overall Study|Adverse Event|0|||
130466690|NCT03664960|469674892|FG001|Overall Study|Adverse Event|3|||
130466691|NCT03664960|469674891|FG000|Overall Study|Lost to Follow-up|3|||
130466692|NCT03664960|469674892|FG001|Overall Study|Lost to Follow-up|2|||
130466693|NCT03664960|469674891|FG000|Overall Study|Physician Decision|1|||
130466694|NCT03664960|469674892|FG001|Overall Study|Physician Decision|0|||
130466695|NCT03664960|469674891|FG000|Overall Study|Withdrawal by Subject|3|||
130466696|NCT03664960|469674892|FG001|Overall Study|Withdrawal by Subject|14|||
130541724|NCT03836716|469950593|FG000|Overall Study|Adverse Event|3|||
130466697|NCT03664960|469674891|FG000|Overall Study|Sponsor Decision|1|||
130466698|NCT03664960|469674892|FG001|Overall Study|Sponsor Decision|1|||
130466699|NCT03664960|469674891|FG000|Overall Study|Other|1|||
130466700|NCT03664960|469674892|FG001|Overall Study|Other|2|||
130466701|NCT04922021|469676351|FG000|Overall Study|Withdrawal by Subject|4|||
130466702|NCT04922021|469676352|FG001|Overall Study|Withdrawal by Subject|10|||
130466703|NCT04922021|469676351|FG000|Overall Study|Adverse Event|2|||
130466704|NCT04922021|469676352|FG001|Overall Study|Adverse Event|2|||
130466705|NCT04922021|469676351|FG000|Overall Study|Lack of Efficacy|0|||
130466706|NCT04922021|469676352|FG001|Overall Study|Lack of Efficacy|1|||
130466707|NCT04922021|469676351|FG000|Overall Study|Multiple reasons|1|||
130430067|NCT03308825|469536453|FG000|Overall Study|Lost to Follow-up|2|||
130430068|NCT03308825|469536454|FG001|Overall Study|Lost to Follow-up|2|||
130430069|NCT03308825|469536455|FG002|Overall Study|Lost to Follow-up|1|||
130430070|NCT03308825|469536456|FG003|Overall Study|Lost to Follow-up|0|||
130430071|NCT03308825|469536453|FG000|Overall Study|Protocol Violation|0|||
130430072|NCT03308825|469536454|FG001|Overall Study|Protocol Violation|2|||
130430073|NCT03308825|469536455|FG002|Overall Study|Protocol Violation|0|||
130430074|NCT03308825|469536456|FG003|Overall Study|Protocol Violation|0|||
130430075|NCT00685945|469536457|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
130430076|NCT03183388|469536458|FG000|Overall Study|Lost to Follow-up|3|||
130430077|NCT03183388|469536459|FG001|Overall Study|Lost to Follow-up|5|||
130430078|NCT03183388|469536458|FG000|Overall Study|Physician Decision|1|||
130430079|NCT03183388|469536459|FG001|Overall Study|Physician Decision|4|||
130430080|NCT03183388|469536458|FG000|Overall Study|Withdrawal by Subject|4|||
130430081|NCT03183388|469536459|FG001|Overall Study|Withdrawal by Subject|1|||
130430082|NCT03183388|469536458|FG000|Overall Study|Moved|1|||
130430083|NCT03183388|469536459|FG001|Overall Study|Moved|0|||
130430084|NCT03183388|469536458|FG000|Overall Study|Met Exclusion Criteria|2|||
130430085|NCT03183388|469536459|FG001|Overall Study|Met Exclusion Criteria|2|||
130430086|NCT03183388|469536458|FG000|Overall Study|COVID Pandemic Related|2|||
130430087|NCT03183388|469536459|FG001|Overall Study|COVID Pandemic Related|4|||
130430088|NCT01728792|469536460|FG000|Overall Study|Withdrawal of Consent|1|||
130430089|NCT01728792|469536461|FG001|Overall Study|Withdrawal of Consent|1|||
130430090|NCT01728792|469536462|FG002|Overall Study|Withdrawal of Consent|0|||
130430091|NCT01728792|469536463|FG003|Overall Study|Withdrawal of Consent|1|||
130430092|NCT01728792|469536464|FG004|Overall Study|Withdrawal of Consent|0|||
130430093|NCT01728792|469536460|FG000|Overall Study|Lost to Follow-up|2|||
130430094|NCT01728792|469536461|FG001|Overall Study|Lost to Follow-up|1|||
130430095|NCT01728792|469536462|FG002|Overall Study|Lost to Follow-up|4|||
130430096|NCT01728792|469536463|FG003|Overall Study|Lost to Follow-up|2|||
130430097|NCT01728792|469536464|FG004|Overall Study|Lost to Follow-up|0|||
130430098|NCT04277455|469536467|FG000|Overall Study|Lost to Follow-up|1|||
130430099|NCT04737109|469536468|FG000|Study Treatment|Disease Progression|5|||
130430100|NCT04737109|469536469|FG001|Study Treatment|Disease Progression|0|||
130430101|NCT04737109|469536470|FG002|Study Treatment|Disease Progression|0|||
130430102|NCT04737109|469536471|FG003|Study Treatment|Disease Progression|0|||
130430103|NCT04737109|469536468|FG000|Study Treatment|Death on study|1|||
130430104|NCT04737109|469536469|FG001|Study Treatment|Death on study|0|||
130430105|NCT04737109|469536470|FG002|Study Treatment|Death on study|0|||
130430106|NCT04737109|469536471|FG003|Study Treatment|Death on study|0|||
130430107|NCT01582789|469536476|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130430108|NCT01582789|469536477|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130430109|NCT02259517|469536478|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
130430110|NCT02259517|469536479|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
130430111|NCT02259517|469536480|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
130430112|NCT02259517|469536478|FG000|Overall Study|Withdrawal by Subject|0|||
130430113|NCT02259517|469536479|FG001|Overall Study|Withdrawal by Subject|0|||
130430114|NCT02259517|469536480|FG002|Overall Study|Withdrawal by Subject|3|||
130430115|NCT02276066|469536481|FG000|Overall Study|Lost to Follow-up|21|||
130430116|NCT02276066|469536482|FG001|Overall Study|Lost to Follow-up|11|||
130430117|NCT01191840|469536490|FG000|Overall Study|withdrew consent|2|||
130430118|NCT01191840|469536491|FG001|Overall Study|withdrew consent|1|||
130430119|NCT01191840|469536490|FG000|Overall Study|Subject discontinued treatment|1|||
130430120|NCT01191840|469536491|FG001|Overall Study|Subject discontinued treatment|2|||
130430121|NCT01191840|469536490|FG000|Overall Study|Lost to Follow-up|4|||
130430122|NCT01191840|469536491|FG001|Overall Study|Lost to Follow-up|6|||
130430123|NCT01191840|469536490|FG000|Overall Study|Non Staph Infection|4|||
130430124|NCT01191840|469536491|FG001|Overall Study|Non Staph Infection|3|||
130430125|NCT01191840|469536490|FG000|Overall Study|ineligible at enrollment|1|||
130430126|NCT01191840|469536491|FG001|Overall Study|ineligible at enrollment|0|||
130430127|NCT01191840|469536490|FG000|Overall Study|IRB approval lapse|0|||
130430128|NCT01191840|469536491|FG001|Overall Study|IRB approval lapse|2|||
130430129|NCT01191840|469536490|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
130430130|NCT01191840|469536491|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
130430131|NCT01191840|469536490|FG000|Overall Study|Withdrawal by Subject|2|||
130430132|NCT01191840|469536491|FG001|Overall Study|Withdrawal by Subject|0|||
130430133|NCT00790452|469536492|FG000|Overall Study|Drug supply issue|1|||
130430134|NCT00790452|469536493|FG001|Overall Study|Drug supply issue|0|||
130430135|NCT01802437|469536494|FG000|Overall Study|Lost to Follow-up|1|||
130430136|NCT01802437|469536495|FG001|Overall Study|Lost to Follow-up|0|||
130430137|NCT01802437|469536494|FG000|Overall Study|Withdrawal by Subject|3|||
130430138|NCT01802437|469536495|FG001|Overall Study|Withdrawal by Subject|4|||
130430139|NCT04082884|469536496|FG000|Overall Study|Withdrawal by Subject|1|||
130430140|NCT00642902|469536504|FG000|Overall Study|Adverse Event|0|||
130430141|NCT00642902|469536505|FG001|Overall Study|Adverse Event|1|||
130430142|NCT00642902|469536506|FG002|Overall Study|Adverse Event|3|||
130541725|NCT03836716|469950593|FG000|Overall Study|Death|22|||
130541726|NCT03836716|469950593|FG000|Overall Study|Withdrawal by Subject|8|||
130541727|NCT03836716|469950593|FG000|Overall Study|Study terminated by sponsor|87|||
130541728|NCT01631227|469950597|FG000|Overall Study|withdrawn consent|27|||
130541729|NCT01631227|469950598|FG001|Overall Study|withdrawn consent|21|||
130541730|NCT01631227|469950597|FG000|Overall Study|Adverse Event|1|||
130541731|NCT01631227|469950598|FG001|Overall Study|Adverse Event|0|||
130541732|NCT01631227|469950597|FG000|Overall Study|administrative|2|||
130541733|NCT01631227|469950598|FG001|Overall Study|administrative|1|||
130541734|NCT00768079|469950601|FG000|Overall Study|Lost to Follow-up|2|||
130541735|NCT00768079|469950602|FG001|Overall Study|Lost to Follow-up|0|||
130541736|NCT00768079|469950603|FG002|Overall Study|Lost to Follow-up|4|||
130541737|NCT00768079|469950601|FG000|Overall Study|Participant incarcerated|0|||
130541738|NCT00768079|469950602|FG001|Overall Study|Participant incarcerated|1|||
130541739|NCT00768079|469950603|FG002|Overall Study|Participant incarcerated|0|||
130541740|NCT01097707|469950604|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130541741|NCT01097707|469950605|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130541742|NCT01097707|469950606|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130541743|NCT01097707|469950607|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130541744|NCT01097707|469950608|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130541745|NCT01097707|469950604|FG000|Overall Study|Adverse Event|4|||
130541746|NCT01097707|469950605|FG001|Overall Study|Adverse Event|2|||
130541747|NCT01097707|469950606|FG002|Overall Study|Adverse Event|3|||
130541748|NCT01097707|469950607|FG003|Overall Study|Adverse Event|1|||
130541749|NCT01097707|469950608|FG004|Overall Study|Adverse Event|3|||
130541750|NCT01097707|469950604|FG000|Overall Study|Entry Criteria Not Met|2|||
130541751|NCT01097707|469950605|FG001|Overall Study|Entry Criteria Not Met|1|||
130541752|NCT01097707|469950606|FG002|Overall Study|Entry Criteria Not Met|1|||
130541753|NCT01097707|469950607|FG003|Overall Study|Entry Criteria Not Met|0|||
130541754|NCT01097707|469950608|FG004|Overall Study|Entry Criteria Not Met|1|||
130541755|NCT01097707|469950604|FG000|Overall Study|Lack of Efficacy|1|||
130652270|NCT00344968|470349380|FG002|Overall Study|Death|31|||
130541756|NCT01097707|469950605|FG001|Overall Study|Lack of Efficacy|0|||
130541757|NCT01097707|469950606|FG002|Overall Study|Lack of Efficacy|0|||
130541758|NCT01097707|469950607|FG003|Overall Study|Lack of Efficacy|1|||
130541759|NCT01097707|469950608|FG004|Overall Study|Lack of Efficacy|0|||
130541760|NCT01097707|469950604|FG000|Overall Study|Lost to Follow-up|1|||
130541761|NCT01097707|469950605|FG001|Overall Study|Lost to Follow-up|1|||
130541762|NCT01097707|469950606|FG002|Overall Study|Lost to Follow-up|2|||
130541763|NCT01097707|469950607|FG003|Overall Study|Lost to Follow-up|0|||
130541764|NCT01097707|469950608|FG004|Overall Study|Lost to Follow-up|3|||
130541765|NCT01097707|469950604|FG000|Overall Study|Protocol Violation|2|||
130541766|NCT01097707|469950605|FG001|Overall Study|Protocol Violation|2|||
130541767|NCT01097707|469950606|FG002|Overall Study|Protocol Violation|3|||
130652271|NCT00344968|470349378|FG000|Overall Study|Other|0|||
130652272|NCT00344968|470349379|FG001|Overall Study|Other|1|||
130541768|NCT01097707|469950607|FG003|Overall Study|Protocol Violation|2|||
130652273|NCT00344968|470349380|FG002|Overall Study|Other|0|||
130652274|NCT03735680|470349381|FG000|Overall Study|Withdrawal by Subject|0|||
130652275|NCT03735680|470349382|FG001|Overall Study|Withdrawal by Subject|1|||
130652276|NCT03735680|470349383|FG002|Overall Study|Withdrawal by Subject|0|||
130652277|NCT03735680|470349384|FG003|Overall Study|Withdrawal by Subject|0|||
130652278|NCT03735680|470349385|FG004|Overall Study|Withdrawal by Subject|0|||
130652279|NCT03735680|470349386|FG005|Overall Study|Withdrawal by Subject|1|||
130207708|NCT01472939|468720981|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207709|NCT01472939|468720982|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207710|NCT01472939|468720983|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
130207711|NCT01472939|468720984|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207712|NCT01472939|468720981|FG000|Overall Study|Prohibited Medication|0|||
130207713|NCT01472939|468720982|FG001|Overall Study|Prohibited Medication|1|||
130207714|NCT01472939|468720983|FG002|Overall Study|Prohibited Medication|0|||
130207715|NCT01472939|468720984|FG003|Overall Study|Prohibited Medication|0|||
130207716|NCT01472939|468720981|FG000|Overall Study|Withdrawal By PI|1|||
130207717|NCT01472939|468720982|FG001|Overall Study|Withdrawal By PI|0|||
130207718|NCT01472939|468720983|FG002|Overall Study|Withdrawal By PI|0|||
130207719|NCT01472939|468720984|FG003|Overall Study|Withdrawal By PI|0|||
130207720|NCT01472939|468720981|FG000|Overall Study|Protocol Violation|3|||
130207721|NCT01472939|468720982|FG001|Overall Study|Protocol Violation|3|||
130207722|NCT01472939|468720983|FG002|Overall Study|Protocol Violation|0|||
130207723|NCT01472939|468720984|FG003|Overall Study|Protocol Violation|1|||
130207724|NCT01472939|468720981|FG000|Overall Study|Withdrawal by Subject|9|||
130207725|NCT01472939|468720982|FG001|Overall Study|Withdrawal by Subject|3|||
130207726|NCT01472939|468720983|FG002|Overall Study|Withdrawal by Subject|1|||
130207727|NCT01472939|468720984|FG003|Overall Study|Withdrawal by Subject|4|||
130207728|NCT00114738|468720985|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
130541769|NCT01097707|469950608|FG004|Overall Study|Protocol Violation|2|||
130541770|NCT01097707|469950604|FG000|Overall Study|Sponsor Decision|31|||
130541771|NCT01097707|469950605|FG001|Overall Study|Sponsor Decision|31|||
130541772|NCT01097707|469950606|FG002|Overall Study|Sponsor Decision|34|||
130541773|NCT01097707|469950607|FG003|Overall Study|Sponsor Decision|35|||
130541774|NCT01097707|469950608|FG004|Overall Study|Sponsor Decision|36|||
130207729|NCT00114738|468720986|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130207730|NCT00114738|468720987|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130207731|NCT00114738|468720985|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
130207732|NCT00114738|468720986|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130207733|NCT00114738|468720987|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130207734|NCT00114738|468720985|FG000|Screening for Randomization|Neuropathy|17|||
130207735|NCT00114738|468720986|FG001|Screening for Randomization|Neuropathy|0|||
130207736|NCT00114738|468720987|FG002|Screening for Randomization|Neuropathy|0|||
130207737|NCT00114738|468720985|FG000|Screening for Randomization|Progressive disease|2|||
130207738|NCT00114738|468720986|FG001|Screening for Randomization|Progressive disease|0|||
130207739|NCT00114738|468720987|FG002|Screening for Randomization|Progressive disease|0|||
130207740|NCT00114738|468720985|FG000|Screening for Randomization|CNS Hemorrhage|1|||
130207741|NCT00114738|468720986|FG001|Screening for Randomization|CNS Hemorrhage|0|||
130207742|NCT00114738|468720987|FG002|Screening for Randomization|CNS Hemorrhage|0|||
130207743|NCT00114738|468720985|FG000|Screening for Randomization|Other|1|||
130207744|NCT00114738|468720986|FG001|Screening for Randomization|Other|0|||
130207745|NCT00114738|468720987|FG002|Screening for Randomization|Other|0|||
130207746|NCT00388297|468720990|FG000|Overall Study|Lost to Follow-up|16|||
130207747|NCT00388297|468720991|FG001|Overall Study|Lost to Follow-up|12|||
130207748|NCT00388297|468720992|FG002|Overall Study|Lost to Follow-up|11|||
130207749|NCT00388297|468720993|FG003|Overall Study|Lost to Follow-up|8|||
130207750|NCT02607280|468720994|FG000|Overall Study|Adverse Event|4|||
130207751|NCT02607280|468720995|FG001|Overall Study|Adverse Event|0|||
130207752|NCT02607280|468720994|FG000|Overall Study|Decrease in CrCl <15|0|||
130207753|NCT02607280|468720995|FG001|Overall Study|Decrease in CrCl <15|1|||
130207754|NCT03435224|468721001|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
130207755|NCT04472026|468721002|FG000|Overall Study|Lost to Follow-up|5|||
130207756|NCT01777295|468721003|FG000|Overall Study|Withdrawal by Subject|2|||
130207757|NCT01777295|468721004|FG001|Overall Study|Withdrawal by Subject|2|||
130207758|NCT01777295|468721003|FG000|Overall Study|Pregnancy|0|||
130207759|NCT01777295|468721004|FG001|Overall Study|Pregnancy|1|||
130207760|NCT01777295|468721003|FG000|Overall Study|Personal problem|1|||
130207761|NCT01777295|468721004|FG001|Overall Study|Personal problem|0|||
130207762|NCT01777295|468721003|FG000|Overall Study|Investigator call for AEs check|1|||
130207763|NCT01777295|468721004|FG001|Overall Study|Investigator call for AEs check|0|||
130207764|NCT01069419|468721005|FG000|Overall Study|Adverse Event|233|||
130207765|NCT01069419|468721005|FG000|Overall Study|Lack of Efficacy|332|||
130207766|NCT01069419|468721005|FG000|Overall Study|Lost to Follow-up|49|||
130207767|NCT01069419|468721005|FG000|Overall Study|Remission of disease|11|||
130207768|NCT01069419|468721005|FG000|Overall Study|Withdrawal by Subject|34|||
130207769|NCT01069419|468721005|FG000|Overall Study|Other Reason|43|||
130207770|NCT01069419|468721005|FG000|Overall Study|Missing termination information|13|||
130207771|NCT04526574|468721006|FG000|Overall Study|Protocol Violation|3|||
130207772|NCT04526574|468721007|FG001|Overall Study|Protocol Violation|1|||
130207773|NCT04526574|468721006|FG000|Overall Study|Withdrawal by Subject|12|||
130541775|NCT01097707|469950604|FG000|Overall Study|Withdrawal by Subject|3|||
130541776|NCT01097707|469950605|FG001|Overall Study|Withdrawal by Subject|6|||
130541777|NCT01097707|469950606|FG002|Overall Study|Withdrawal by Subject|1|||
130541778|NCT01097707|469950607|FG003|Overall Study|Withdrawal by Subject|4|||
130541779|NCT01097707|469950608|FG004|Overall Study|Withdrawal by Subject|3|||
130541780|NCT01097707|469950604|FG000|Overall Study|Reason unknown|0|||
130541781|NCT01097707|469950605|FG001|Overall Study|Reason unknown|0|||
130541782|NCT01097707|469950606|FG002|Overall Study|Reason unknown|0|||
130541783|NCT01097707|469950607|FG003|Overall Study|Reason unknown|0|||
130541784|NCT01097707|469950608|FG004|Overall Study|Reason unknown|1|||
130541785|NCT02207569|469950612|FG000|1-Month|Death|6|||
130207774|NCT04526574|468721007|FG001|Overall Study|Withdrawal by Subject|9|||
130207775|NCT04526574|468721006|FG000|Overall Study|Other|1|||
130207776|NCT04526574|468721007|FG001|Overall Study|Other|2|||
130207777|NCT04526574|468721006|FG000|Overall Study|Adverse Event|1|||
130207778|NCT04526574|468721007|FG001|Overall Study|Adverse Event|1|||
130207779|NCT04526574|468721006|FG000|Overall Study|Death|2|||
130207780|NCT04526574|468721007|FG001|Overall Study|Death|3|||
130207781|NCT04526574|468721006|FG000|Overall Study|Lost to Follow-up|9|||
130541786|NCT02207569|469950612|FG000|1-Month|Withdrawal by Subject|2|||
130541787|NCT02207569|469950612|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
130541788|NCT02207569|469950612|FG000|6-Month|Death|8|||
130541789|NCT02207569|469950612|FG000|6-Month|Withdrawal by Subject|2|||
130541790|NCT02207569|469950612|FG000|12-Month|Death|14|||
130541791|NCT02207569|469950612|FG000|12-Month|Withdrawal by Subject|2|||
130541792|NCT02207569|469950612|FG000|24-Month|Death|23|||
130541793|NCT02207569|469950612|FG000|24-Month|Withdrawal by Subject|3|||
130541794|NCT02207569|469950612|FG000|36-Month|Death|23|||
130541795|NCT02207569|469950612|FG000|36-Month|Withdrawal by Subject|4|||
130541796|NCT02207569|469950612|FG000|48-Month|Death|25|||
130207782|NCT04526574|468721007|FG001|Overall Study|Lost to Follow-up|9|||
130207783|NCT04526574|468721006|FG000|Overall Study|No longer meets eligibility criteria|8|||
130207784|NCT04526574|468721007|FG001|Overall Study|No longer meets eligibility criteria|8|||
130207785|NCT02248974|468721010|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
130207786|NCT02248974|468721011|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
130207787|NCT02248974|468721010|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
130207788|NCT02248974|468721011|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
130207789|NCT02248974|468721010|FG000|1-Day Follow-Up|Enrolled in another study|1|||
130207790|NCT02248974|468721011|FG001|1-Day Follow-Up|Enrolled in another study|0|||
130207791|NCT02248974|468721010|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
130207792|NCT02248974|468721011|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
130207793|NCT02248974|468721010|FG000|1-Week Follow-Up|Enrolled in another study|1|||
130207794|NCT02248974|468721011|FG001|1-Week Follow-Up|Enrolled in another study|1|||
130207795|NCT02248974|468721010|FG000|1-Week Follow-Up|Transferred to another facility|1|||
130207796|NCT02248974|468721011|FG001|1-Week Follow-Up|Transferred to another facility|0|||
130207797|NCT02248974|468721010|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
130207798|NCT02248974|468721011|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
130207799|NCT02248974|468721010|FG000|1-Week Follow-Up|Death|1|||
130207800|NCT02248974|468721011|FG001|1-Week Follow-Up|Death|1|||
130541797|NCT02207569|469950612|FG000|48-Month|Withdrawal by Subject|2|||
130541798|NCT02207569|469950612|FG000|48-Month|Lost to Follow-up|4|||
130541799|NCT02207569|469950612|FG000|60-Month|Death|1|||
130541800|NCT02207569|469950612|FG000|60-Month|Lost to Follow-up|1|||
130541801|NCT02207569|469950612|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
130541802|NCT02207569|469950612|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
130541803|NCT01236534|469950614|FG000|Overall Study|Adverse Event|3|||
130541804|NCT01236534|469950615|FG001|Overall Study|Adverse Event|0|||
130541805|NCT05383508|469950626|FG000|Overall Study|Withdrawal by Subject|1|||
130541806|NCT05383508|469950627|FG001|Overall Study|Withdrawal by Subject|0|||
130541807|NCT05383508|469950628|FG002|Overall Study|Withdrawal by Subject|1|||
130541808|NCT05383508|469950629|FG003|Overall Study|Withdrawal by Subject|1|||
130541809|NCT05383508|469950630|FG004|Overall Study|Withdrawal by Subject|2|||
130541810|NCT05383508|469950631|FG005|Overall Study|Withdrawal by Subject|0|||
130541811|NCT01871805|469950634|FG000|Phase I|Death|7|||
130541812|NCT01871805|469950635|FG001|Phase I|Death|4|||
130541813|NCT01871805|469950636|FG002|Phase I|Death|6|||
130541814|NCT01871805|469950637|FG003|Phase I|Death|2|||
130541815|NCT01871805|469950638|FG004|Phase I|Death|9|||
130541816|NCT01871805|469950639|FG005|Phase I|Death|0|||
130541817|NCT01871805|469950634|FG000|Phase I|Alive in Survival Follow-up|0|||
130541818|NCT01871805|469950635|FG001|Phase I|Alive in Survival Follow-up|2|||
130541819|NCT01871805|469950636|FG002|Phase I|Alive in Survival Follow-up|4|||
130541820|NCT01871805|469950637|FG003|Phase I|Alive in Survival Follow-up|5|||
130652280|NCT03735680|470349381|FG000|Overall Study|Patient unable or unwilling to continue|0|||
130207801|NCT02248974|468721010|FG000|1-Week Follow-Up|Excluded because of age|0|||
130207802|NCT02248974|468721011|FG001|1-Week Follow-Up|Excluded because of age|1|||
130207803|NCT02248974|468721010|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
130207804|NCT02248974|468721011|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
130207805|NCT02248974|468721010|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
130207806|NCT02248974|468721011|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
130207807|NCT02248974|468721010|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
130207808|NCT02248974|468721011|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
130207809|NCT02248974|468721010|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
130207810|NCT02248974|468721011|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
130207811|NCT02248974|468721010|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
130207812|NCT02248974|468721011|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
130207813|NCT02332239|468721012|FG000|Overall Study|Lost to Follow-up|4|||
130207814|NCT02332239|468721013|FG001|Overall Study|Lost to Follow-up|6|||
130207815|NCT00115037|468721014|FG000|Phase1|Lost to Follow-up|16|||
130207816|NCT00115037|468721015|FG001|Phase1|Lost to Follow-up|23|||
130207817|NCT00115037|468721016|FG002|Phase1|Lost to Follow-up|0|||
130207818|NCT00115037|468721017|FG003|Phase1|Lost to Follow-up|0|||
130207819|NCT00115037|468721018|FG004|Phase1|Lost to Follow-up|0|||
130207820|NCT00115037|468721019|FG005|Phase1|Lost to Follow-up|0|||
130207821|NCT00115037|468721014|FG000|Phase1|Withdrawal by Subject|9|||
130207822|NCT00115037|468721015|FG001|Phase1|Withdrawal by Subject|4|||
130207823|NCT00115037|468721016|FG002|Phase1|Withdrawal by Subject|0|||
130207824|NCT00115037|468721017|FG003|Phase1|Withdrawal by Subject|0|||
130207825|NCT00115037|468721018|FG004|Phase1|Withdrawal by Subject|0|||
130207826|NCT00115037|468721019|FG005|Phase1|Withdrawal by Subject|0|||
130207827|NCT00115037|468721014|FG000|Phase2|Death|0|||
130207828|NCT00115037|468721015|FG001|Phase2|Death|0|||
130541821|NCT01871805|469950638|FG004|Phase I|Alive in Survival Follow-up|4|||
130541822|NCT01871805|469950639|FG005|Phase I|Alive in Survival Follow-up|0|||
130541823|NCT01871805|469950634|FG000|Phase I|Lost to Follow-up|0|||
130541824|NCT01871805|469950635|FG001|Phase I|Lost to Follow-up|1|||
130541825|NCT01871805|469950636|FG002|Phase I|Lost to Follow-up|3|||
130541826|NCT01871805|469950637|FG003|Phase I|Lost to Follow-up|0|||
130207829|NCT00115037|468721016|FG002|Phase2|Death|1|||
130207830|NCT00115037|468721017|FG003|Phase2|Death|0|||
130207831|NCT00115037|468721018|FG004|Phase2|Death|0|||
130207832|NCT00115037|468721019|FG005|Phase2|Death|1|||
130207833|NCT00115037|468721014|FG000|Phase2|Withdrawal by Subject|0|||
130207834|NCT00115037|468721015|FG001|Phase2|Withdrawal by Subject|0|||
130207835|NCT00115037|468721016|FG002|Phase2|Withdrawal by Subject|2|||
130207836|NCT00115037|468721017|FG003|Phase2|Withdrawal by Subject|1|||
130207837|NCT00115037|468721018|FG004|Phase2|Withdrawal by Subject|2|||
130207838|NCT00115037|468721019|FG005|Phase2|Withdrawal by Subject|1|||
130207839|NCT00115037|468721014|FG000|Phase2|Lost to Follow-up|0|||
130207840|NCT00115037|468721015|FG001|Phase2|Lost to Follow-up|0|||
130207841|NCT00115037|468721016|FG002|Phase2|Lost to Follow-up|12|||
130207842|NCT00115037|468721017|FG003|Phase2|Lost to Follow-up|14|||
130207843|NCT00115037|468721018|FG004|Phase2|Lost to Follow-up|4|||
130207844|NCT00115037|468721019|FG005|Phase2|Lost to Follow-up|10|||
130207845|NCT00396877|468721020|FG000|Overall Study|Lost to Follow-up|2|||
130207846|NCT00396877|468721021|FG001|Overall Study|Lost to Follow-up|1|||
130207847|NCT00396877|468721020|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
130207848|NCT00396877|468721021|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
130207849|NCT00334802|468721022|FG000|Overall Study|Progressive Disease|2|||
130207850|NCT00334802|468721023|FG001|Overall Study|Progressive Disease|24|||
130207851|NCT00334802|468721022|FG000|Overall Study|Toxicity|1|||
130207852|NCT00334802|468721023|FG001|Overall Study|Toxicity|5|||
130207853|NCT00334802|468721022|FG000|Overall Study|Lack of Efficacy|1|||
130207854|NCT00334802|468721023|FG001|Overall Study|Lack of Efficacy|3|||
130207855|NCT00334802|468721022|FG000|Overall Study|Patient Condition Aggrevated|1|||
130207856|NCT00334802|468721023|FG001|Overall Study|Patient Condition Aggrevated|0|||
130207857|NCT00334802|468721022|FG000|Overall Study|Physician Decision|1|||
130207858|NCT00334802|468721023|FG001|Overall Study|Physician Decision|0|||
130207859|NCT00334802|468721022|FG000|Overall Study|Withdrawal by Subject|0|||
130207860|NCT00334802|468721023|FG001|Overall Study|Withdrawal by Subject|4|||
130207861|NCT00334802|468721022|FG000|Overall Study|Adverse Event|0|||
130207862|NCT00334802|468721023|FG001|Overall Study|Adverse Event|3|||
130207863|NCT00334802|468721022|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
130207864|NCT00334802|468721023|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
130541827|NCT01871805|469950638|FG004|Phase I|Lost to Follow-up|0|||
130541828|NCT01871805|469950639|FG005|Phase I|Lost to Follow-up|0|||
130541829|NCT01871805|469950634|FG000|Phase II|Death|0|||
130541830|NCT01871805|469950635|FG001|Phase II|Death|0|||
130541831|NCT01871805|469950636|FG002|Phase II|Death|0|||
130541832|NCT01871805|469950637|FG003|Phase II|Death|0|||
130541833|NCT01871805|469950638|FG004|Phase II|Death|0|||
130541834|NCT01871805|469950639|FG005|Phase II|Death|45|||
130541835|NCT01871805|469950634|FG000|Phase II|Alive in Survival Follow-up|0|||
130541836|NCT01871805|469950635|FG001|Phase II|Alive in Survival Follow-up|0|||
130541837|NCT01871805|469950636|FG002|Phase II|Alive in Survival Follow-up|0|||
130541838|NCT01871805|469950637|FG003|Phase II|Alive in Survival Follow-up|0|||
130541839|NCT01871805|469950638|FG004|Phase II|Alive in Survival Follow-up|0|||
130541840|NCT01871805|469950639|FG005|Phase II|Alive in Survival Follow-up|29|||
130541841|NCT01871805|469950634|FG000|Phase II|Lost to Follow-up|0|||
130541842|NCT01871805|469950635|FG001|Phase II|Lost to Follow-up|0|||
130541843|NCT01871805|469950636|FG002|Phase II|Lost to Follow-up|0|||
130541844|NCT01871805|469950637|FG003|Phase II|Lost to Follow-up|0|||
130541845|NCT01871805|469950638|FG004|Phase II|Lost to Follow-up|0|||
130541846|NCT01871805|469950639|FG005|Phase II|Lost to Follow-up|13|||
130541847|NCT01157676|469950642|FG000|Randomization|Death|1|||
130541848|NCT01157676|469950643|FG001|Randomization|Death|1|||
130541849|NCT01157676|469950642|FG000|Randomization|unresectable|2|||
130541850|NCT01157676|469950643|FG001|Randomization|unresectable|3|||
130541851|NCT01157676|469950642|FG000|Randomization|Withdrawal by Subject|17|||
130541852|NCT01157676|469950643|FG001|Randomization|Withdrawal by Subject|13|||
130541853|NCT01157676|469950642|FG000|Randomization|Physician Decision|1|||
130541854|NCT01157676|469950643|FG001|Randomization|Physician Decision|0|||
130207865|NCT03436199|468721024|FG000|Overall Study|Adverse Event|15|||
130207866|NCT03436199|468721025|FG001|Overall Study|Adverse Event|40|||
130207867|NCT03436199|468721026|FG002|Overall Study|Adverse Event|7|||
130207868|NCT03436199|468721024|FG000|Overall Study|Withdrawal by Subject|4|||
130207869|NCT03436199|468721025|FG001|Overall Study|Withdrawal by Subject|10|||
130207870|NCT03436199|468721026|FG002|Overall Study|Withdrawal by Subject|3|||
130541855|NCT01157676|469950642|FG000|Surgery|underwent open cystectomy|0|||
130541856|NCT01157676|469950643|FG001|Surgery|underwent open cystectomy|4|||
130207871|NCT03436199|468721024|FG000|Overall Study|Lost to Follow-up|1|||
130207872|NCT03436199|468721025|FG001|Overall Study|Lost to Follow-up|0|||
130207873|NCT03436199|468721026|FG002|Overall Study|Lost to Follow-up|2|||
130207874|NCT03436199|468721024|FG000|Overall Study|Protocol Violation|1|||
130207875|NCT03436199|468721025|FG001|Overall Study|Protocol Violation|1|||
130207876|NCT03436199|468721026|FG002|Overall Study|Protocol Violation|0|||
130541857|NCT01157676|469950642|FG000|Surgery|converted to open procedure|0|||
130541858|NCT01157676|469950643|FG001|Surgery|converted to open procedure|5|||
130541859|NCT01157676|469950642|FG000|Surgery|underwent robotic cystectomy|1|||
130207877|NCT03436199|468721024|FG000|Overall Study|Physician Decision|0|||
130207878|NCT03436199|468721025|FG001|Overall Study|Physician Decision|1|||
130207879|NCT03436199|468721026|FG002|Overall Study|Physician Decision|0|||
130541860|NCT01157676|469950643|FG001|Surgery|underwent robotic cystectomy|0|||
130541861|NCT00468104|469950644|FG000|First Intervention|Protocol Violation|2|||
130541862|NCT00468104|469950645|FG001|First Intervention|Protocol Violation|1|||
130541863|NCT00468104|469950644|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
130541864|NCT00468104|469950645|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
130541865|NCT00468104|469950644|FG000|First Intervention|died within 3 weeks|1|||
130541866|NCT00468104|469950645|FG001|First Intervention|died within 3 weeks|0|||
130541867|NCT00468104|469950644|FG000|First Intervention|malposition/blocked chest tube tube|2|||
130541868|NCT00468104|469950645|FG001|First Intervention|malposition/blocked chest tube tube|0|||
130541869|NCT00468104|469950644|FG000|First Intervention|large lung mass with minimal effusion|1|||
130541870|NCT00468104|469950645|FG001|First Intervention|large lung mass with minimal effusion|0|||
130541871|NCT00468104|469950644|FG000|First Intervention|associated prolonged pneumothorax|1|||
130541872|NCT00468104|469950645|FG001|First Intervention|associated prolonged pneumothorax|0|||
130541873|NCT00468104|469950644|FG000|First Intervention|trapped lung|1|||
130541874|NCT00468104|469950645|FG001|First Intervention|trapped lung|0|||
130541875|NCT00468104|469950644|FG000|Second Intervention|Withdrawal by Subject|5|||
130541876|NCT00468104|469950645|FG001|Second Intervention|Withdrawal by Subject|2|||
130541877|NCT00468104|469950644|FG000|Second Intervention|discarded for malposition of chest tube|0|||
130541878|NCT00468104|469950645|FG001|Second Intervention|discarded for malposition of chest tube|2|||
130541879|NCT04860297|469950650|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
130541880|NCT04860297|469950651|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
130541881|NCT04860297|469950652|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
130541882|NCT04860297|469950653|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
130541883|NCT04860297|469950654|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
130541884|NCT04860297|469950655|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
130541885|NCT04860297|469950656|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
130541886|NCT04860297|469950657|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
130541887|NCT04860297|469950650|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
130541888|NCT04860297|469950651|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
130541889|NCT04860297|469950652|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
130541890|NCT04860297|469950653|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
130541891|NCT04860297|469950654|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
130541892|NCT04860297|469950655|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
130541893|NCT04860297|469950656|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
130541894|NCT04860297|469950657|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
130541895|NCT04860297|469950650|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
130541896|NCT04860297|469950651|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
130541897|NCT04860297|469950652|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
130541898|NCT04860297|469950653|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
130541899|NCT04860297|469950654|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
130541900|NCT04860297|469950655|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
130541901|NCT04860297|469950656|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
130541902|NCT04860297|469950657|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
130207880|NCT03436199|468721024|FG000|Overall Study|Could not return to clinic|1|||
130207881|NCT03436199|468721025|FG001|Overall Study|Could not return to clinic|0|||
130207882|NCT03436199|468721026|FG002|Overall Study|Could not return to clinic|0|||
130207883|NCT03436199|468721024|FG000|Overall Study|Withdrawn per physician|0|||
130207884|NCT03436199|468721025|FG001|Overall Study|Withdrawn per physician|1|||
130207885|NCT03436199|468721026|FG002|Overall Study|Withdrawn per physician|0|||
130207886|NCT00085098|468721027|FG000|Overall Study|Withdrawal by Subject|0|||
130207887|NCT00085098|468721028|FG001|Overall Study|Withdrawal by Subject|1|||
130207888|NCT00085098|468721027|FG000|Overall Study|Ineligible|1|||
130207889|NCT00085098|468721028|FG001|Overall Study|Ineligible|1|||
130207890|NCT03515629|468721029|FG000|Overall Study|Death|0|||
130207891|NCT03515629|468721030|FG001|Overall Study|Death|1|||
130207892|NCT03515629|468721031|FG002|Overall Study|Death|1|||
130207893|NCT03515629|468721029|FG000|Overall Study|Progressive disease|0|||
130207894|NCT03515629|468721030|FG001|Overall Study|Progressive disease|1|||
130541903|NCT04860297|469950650|FG000|Part B (Booster Dose)|Other Than Specified|0|||
130541904|NCT04860297|469950651|FG001|Part B (Booster Dose)|Other Than Specified|0|||
130541905|NCT04860297|469950652|FG002|Part B (Booster Dose)|Other Than Specified|0|||
130541906|NCT04860297|469950653|FG003|Part B (Booster Dose)|Other Than Specified|0|||
130541907|NCT04860297|469950654|FG004|Part B (Booster Dose)|Other Than Specified|0|||
130541908|NCT04860297|469950655|FG005|Part B (Booster Dose)|Other Than Specified|1|||
130541909|NCT04860297|469950656|FG006|Part B (Booster Dose)|Other Than Specified|1|||
130541910|NCT04860297|469950657|FG007|Part B (Booster Dose)|Other Than Specified|0|||
130541911|NCT04860297|469950650|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
130559396|NCT01621542|470016492|FG002|Overall Study|Adverse Event|1|||
130207895|NCT03515629|468721031|FG002|Overall Study|Progressive disease|0|||
130207896|NCT01886781|468721032|FG000|Overall Study|Protocol Violation|5|||
130207897|NCT01886781|468721033|FG001|Overall Study|Protocol Violation|0|||
130541912|NCT04860297|469950651|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
130541913|NCT04860297|469950652|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
130541914|NCT04860297|469950653|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
130541915|NCT04860297|469950654|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
130541916|NCT04860297|469950655|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
130541917|NCT04860297|469950656|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
130541918|NCT04860297|469950657|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
130541919|NCT04860297|469950650|FG000|Part B (Booster Dose)|Death|0|||
130541920|NCT04860297|469950651|FG001|Part B (Booster Dose)|Death|0|||
130541921|NCT04860297|469950652|FG002|Part B (Booster Dose)|Death|0|||
130541922|NCT04860297|469950653|FG003|Part B (Booster Dose)|Death|0|||
130541923|NCT04860297|469950654|FG004|Part B (Booster Dose)|Death|1|||
130541924|NCT04860297|469950655|FG005|Part B (Booster Dose)|Death|2|||
130541925|NCT04860297|469950656|FG006|Part B (Booster Dose)|Death|1|||
130541926|NCT04860297|469950657|FG007|Part B (Booster Dose)|Death|0|||
130541927|NCT04860297|469950650|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
130541928|NCT04860297|469950651|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
130541929|NCT04860297|469950652|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
130541930|NCT04860297|469950653|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
130541931|NCT04860297|469950654|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
130541932|NCT04860297|469950655|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
130541933|NCT04860297|469950656|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
130541934|NCT04860297|469950657|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
130541935|NCT04811131|469950664|FG000|Overall Study|Adverse Event|0|||
130541936|NCT04811131|469950665|FG001|Overall Study|Adverse Event|0|||
130541937|NCT04811131|469950666|FG002|Overall Study|Adverse Event|1|||
130541938|NCT04811131|469950667|FG003|Overall Study|Adverse Event|0|||
130541939|NCT04811131|469950664|FG000|Overall Study|Lack of Efficacy|0|||
130541940|NCT04811131|469950665|FG001|Overall Study|Lack of Efficacy|0|||
130541941|NCT04811131|469950666|FG002|Overall Study|Lack of Efficacy|0|||
130541942|NCT04811131|469950667|FG003|Overall Study|Lack of Efficacy|1|||
130541943|NCT04811131|469950664|FG000|Overall Study|Lost to Follow-up|0|||
130541944|NCT04811131|469950665|FG001|Overall Study|Lost to Follow-up|1|||
130541945|NCT04811131|469950666|FG002|Overall Study|Lost to Follow-up|0|||
130541946|NCT04811131|469950667|FG003|Overall Study|Lost to Follow-up|0|||
130541947|NCT04811131|469950664|FG000|Overall Study|Sponsor request|31|||
130541948|NCT04811131|469950665|FG001|Overall Study|Sponsor request|35|||
130541949|NCT04811131|469950666|FG002|Overall Study|Sponsor request|27|||
130541950|NCT04811131|469950667|FG003|Overall Study|Sponsor request|10|||
130541951|NCT04811131|469950664|FG000|Overall Study|Withdrawal by Subject|3|||
130541952|NCT04811131|469950665|FG001|Overall Study|Withdrawal by Subject|1|||
130541953|NCT04811131|469950666|FG002|Overall Study|Withdrawal by Subject|3|||
130541954|NCT04811131|469950667|FG003|Overall Study|Withdrawal by Subject|1|||
130541955|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|Death|1|||
130541956|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|Death|1|||
130541957|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
130541958|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
130541959|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
130541960|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
130541961|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
130541962|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
130541963|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
130541964|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
130541965|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
130541966|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
130541967|NCT00371683|469950669|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
130541968|NCT00371683|469950670|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
130541969|NCT00371683|469950669|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
130541970|NCT00371683|469950670|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
130541971|NCT00371683|469950669|FG000|Follow-Up Period - Randomized Patients|Death|0|||
130541972|NCT00371683|469950670|FG001|Follow-Up Period - Randomized Patients|Death|2|||
130541973|NCT00371683|469950669|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
130541974|NCT00371683|469950670|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
130541975|NCT00371683|469950669|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
130541976|NCT00371683|469950670|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
130541977|NCT03181789|469950671|FG000|Overall Study|Withdrawal by Subject|0|||
130541978|NCT03181789|469950672|FG001|Overall Study|Withdrawal by Subject|1|||
130541979|NCT03181789|469950673|FG002|Overall Study|Withdrawal by Subject|1|||
130541980|NCT03181789|469950674|FG003|Overall Study|Withdrawal by Subject|0|||
130541981|NCT03181789|469950671|FG000|Overall Study|Lost to Follow-up|7|||
130541982|NCT03181789|469950672|FG001|Overall Study|Lost to Follow-up|1|||
130541983|NCT03181789|469950673|FG002|Overall Study|Lost to Follow-up|0|||
130541984|NCT03181789|469950674|FG003|Overall Study|Lost to Follow-up|0|||
130541985|NCT03181789|469950671|FG000|Overall Study|Participant unable to adhere to visit|0|||
130541986|NCT03181789|469950672|FG001|Overall Study|Participant unable to adhere to visit|1|||
130541987|NCT03181789|469950673|FG002|Overall Study|Participant unable to adhere to visit|0|||
130541988|NCT03181789|469950674|FG003|Overall Study|Participant unable to adhere to visit|0|||
130541989|NCT02624791|469950675|FG000|Overall Study|Withdrawal by Subject|2|||
130541990|NCT02624791|469950676|FG001|Overall Study|Withdrawal by Subject|0|||
130541991|NCT02624791|469950677|FG002|Overall Study|Withdrawal by Subject|0|||
130541992|NCT02624791|469950678|FG003|Overall Study|Withdrawal by Subject|0|||
130541993|NCT02624791|469950679|FG004|Overall Study|Withdrawal by Subject|0|||
130541994|NCT02624791|469950680|FG005|Overall Study|Withdrawal by Subject|0|||
130541995|NCT01131182|469950681|FG000|Overall Study|Withdrawal by Subject|1|||
130541996|NCT01131182|469950682|FG001|Overall Study|Withdrawal by Subject|1|||
130541997|NCT01131182|469950681|FG000|Overall Study|Lost to Follow-up|14|||
130541998|NCT01131182|469950682|FG001|Overall Study|Lost to Follow-up|15|||
130541999|NCT01131182|469950681|FG000|Overall Study|Other Reason|1|||
130542000|NCT01131182|469950682|FG001|Overall Study|Other Reason|0|||
130542001|NCT01146782|469950689|FG000|Screening Cohort|Screen Failure|187|||
130542002|NCT01146782|469950689|FG000|Screening Cohort|Lost to Follow-up|4|||
130542003|NCT01146782|469950689|FG000|Screening Cohort|Physician Decision|1|||
130542004|NCT01146782|469950689|FG000|Screening Cohort|Withdrawal by Subject|29|||
130542005|NCT01146782|469950689|FG000|Safety Cohort|Screen Failure|61|||
130542006|NCT01146782|469950689|FG000|Safety Cohort|Withdrawal by Subject|4|||
130542007|NCT01146782|469950689|FG000|Safety Cohort|Control AHI <5|4|||
130542008|NCT01146782|469950689|FG000|Safety Cohort|TST <4 hrs|14|||
130542009|NCT01146782|469950689|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
130542010|NCT01146782|469950689|FG000|Primary Endpoint Cohort|Physician Decision|1|||
130542011|NCT02656329|469950691|FG000|Overall Study|Lost to Follow-up|2|||
130542012|NCT02656329|469950692|FG001|Overall Study|Lost to Follow-up|3|||
130542013|NCT02656329|469950691|FG000|Overall Study|Withdrawal by Subject|7|||
130542014|NCT02656329|469950692|FG001|Overall Study|Withdrawal by Subject|6|||
130542015|NCT02656329|469950691|FG000|Overall Study|Study termination by Sponsor|150|||
130542016|NCT02656329|469950692|FG001|Overall Study|Study termination by Sponsor|142|||
130542017|NCT02656329|469950691|FG000|Overall Study|Other than specified above|5|||
130542018|NCT02656329|469950692|FG001|Overall Study|Other than specified above|6|||
130542019|NCT01139580|469950693|FG000|Overall Study|Adverse Event|5|||
130542020|NCT01139580|469950694|FG001|Overall Study|Adverse Event|4|||
130542021|NCT01139580|469950693|FG000|Overall Study|Lost to Follow-up|9|||
130542022|NCT01139580|469950694|FG001|Overall Study|Lost to Follow-up|1|||
130542023|NCT01139580|469950693|FG000|Overall Study|Lack of Efficacy|0|||
130542024|NCT01139580|469950694|FG001|Overall Study|Lack of Efficacy|2|||
130542025|NCT01139580|469950693|FG000|Overall Study|Withdrawal by Subject|6|||
130542026|NCT01139580|469950694|FG001|Overall Study|Withdrawal by Subject|9|||
130542027|NCT01139580|469950693|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
130542028|NCT01139580|469950694|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
130542029|NCT01139580|469950693|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
130542030|NCT01139580|469950694|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
130542031|NCT01139580|469950693|FG000|Overall Study|Misrandomized|1|||
130542032|NCT01139580|469950694|FG001|Overall Study|Misrandomized|0|||
130542033|NCT01139580|469950693|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
130542034|NCT01139580|469950694|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
130542035|NCT01139580|469950693|FG000|Overall Study|Participant Randomization in Error|0|||
130542036|NCT01139580|469950694|FG001|Overall Study|Participant Randomization in Error|1|||
130542037|NCT00911768|469950695|FG000|Overall Study|Protocol Violation|5|||
130542038|NCT00911768|469950696|FG001|Overall Study|Protocol Violation|4|||
130542039|NCT00911768|469950695|FG000|Overall Study|Withdrawal by Subject|1|||
130542040|NCT00911768|469950696|FG001|Overall Study|Withdrawal by Subject|0|||
130542041|NCT02842151|469950701|FG000|Overall Study|Adverse Event|1|||
130542042|NCT02842151|469950701|FG000|Overall Study|Subject moved too far away|1|||
130542043|NCT00591851|469950702|FG000|Overall Study|Withdrawal by Subject|3|||
130542044|NCT00591851|469950702|FG000|Overall Study|Adverse Event|2|||
130542045|NCT00591851|469950702|FG000|Overall Study|Progressive Disease|1|||
130542046|NCT02559895|469950703|FG000|Overall Study|Adverse Event|3|||
130542047|NCT02559895|469950704|FG001|Overall Study|Adverse Event|3|||
130542048|NCT02559895|469950705|FG002|Overall Study|Adverse Event|2|||
130542049|NCT02559895|469950706|FG003|Overall Study|Adverse Event|1|||
130542050|NCT02559895|469950703|FG000|Overall Study|Lack of Efficacy|2|||
130542051|NCT02559895|469950704|FG001|Overall Study|Lack of Efficacy|3|||
130542052|NCT02559895|469950705|FG002|Overall Study|Lack of Efficacy|2|||
130542053|NCT02559895|469950706|FG003|Overall Study|Lack of Efficacy|8|||
130542054|NCT02559895|469950703|FG000|Overall Study|Lost to Follow-up|22|||
130542055|NCT02559895|469950704|FG001|Overall Study|Lost to Follow-up|16|||
130542056|NCT02559895|469950705|FG002|Overall Study|Lost to Follow-up|12|||
130542057|NCT02559895|469950706|FG003|Overall Study|Lost to Follow-up|17|||
130542058|NCT02559895|469950703|FG000|Overall Study|Physician Decision|1|||
130542059|NCT02559895|469950704|FG001|Overall Study|Physician Decision|1|||
130542060|NCT02559895|469950705|FG002|Overall Study|Physician Decision|3|||
130542061|NCT02559895|469950706|FG003|Overall Study|Physician Decision|0|||
130542062|NCT02559895|469950703|FG000|Overall Study|Withdrawal by Subject|16|||
130542063|NCT02559895|469950704|FG001|Overall Study|Withdrawal by Subject|9|||
130542064|NCT02559895|469950705|FG002|Overall Study|Withdrawal by Subject|20|||
130542065|NCT02559895|469950706|FG003|Overall Study|Withdrawal by Subject|9|||
130542066|NCT02559895|469950703|FG000|Overall Study|Study Burden|10|||
130542067|NCT02559895|469950704|FG001|Overall Study|Study Burden|16|||
130542068|NCT02559895|469950705|FG002|Overall Study|Study Burden|12|||
130542069|NCT02559895|469950706|FG003|Overall Study|Study Burden|22|||
130542070|NCT02559895|469950703|FG000|Overall Study|Other|1|||
130542071|NCT02559895|469950704|FG001|Overall Study|Other|5|||
130542072|NCT02559895|469950705|FG002|Overall Study|Other|3|||
130542073|NCT02559895|469950706|FG003|Overall Study|Other|3|||
130542074|NCT00867308|469950714|FG000|Overall Study|Death|1|||
130542075|NCT00867308|469950715|FG001|Overall Study|Death|0|||
130542076|NCT00867308|469950714|FG000|Overall Study|Adverse Event|1|||
130542077|NCT00867308|469950715|FG001|Overall Study|Adverse Event|4|||
130542078|NCT00867308|469950714|FG000|Overall Study|Lack of Efficacy|6|||
130542079|NCT00867308|469950715|FG001|Overall Study|Lack of Efficacy|12|||
130542080|NCT00867308|469950714|FG000|Overall Study|Withdrawal by Subject|1|||
130542081|NCT00867308|469950715|FG001|Overall Study|Withdrawal by Subject|2|||
130542082|NCT00604825|469950716|FG000|Overall Study|Adverse Event|2|||
130542083|NCT00604825|469950717|FG001|Overall Study|Adverse Event|6|||
130542084|NCT00604825|469950718|FG002|Overall Study|Adverse Event|7|||
130542085|NCT00604825|469950719|FG003|Overall Study|Adverse Event|4|||
130542086|NCT00604825|469950716|FG000|Overall Study|Lost to Follow-up|0|||
130542087|NCT00604825|469950717|FG001|Overall Study|Lost to Follow-up|3|||
130542088|NCT00604825|469950718|FG002|Overall Study|Lost to Follow-up|1|||
130542089|NCT00604825|469950719|FG003|Overall Study|Lost to Follow-up|0|||
130542090|NCT00604825|469950716|FG000|Overall Study|Protocol Violation|0|||
130542091|NCT00604825|469950717|FG001|Overall Study|Protocol Violation|1|||
130542092|NCT00604825|469950718|FG002|Overall Study|Protocol Violation|0|||
130542093|NCT00604825|469950719|FG003|Overall Study|Protocol Violation|0|||
130542094|NCT00604825|469950716|FG000|Overall Study|Withdrawal by Subject|4|||
130542095|NCT00604825|469950717|FG001|Overall Study|Withdrawal by Subject|3|||
130542096|NCT00604825|469950718|FG002|Overall Study|Withdrawal by Subject|5|||
130542097|NCT00604825|469950719|FG003|Overall Study|Withdrawal by Subject|5|||
130542098|NCT00604825|469950716|FG000|Overall Study|Lack of Efficacy|3|||
130542099|NCT00604825|469950717|FG001|Overall Study|Lack of Efficacy|2|||
130542100|NCT00604825|469950718|FG002|Overall Study|Lack of Efficacy|1|||
130542101|NCT00604825|469950719|FG003|Overall Study|Lack of Efficacy|0|||
130542102|NCT00604825|469950716|FG000|Overall Study|Did not meet eligibility criteria|0|||
130542103|NCT00604825|469950717|FG001|Overall Study|Did not meet eligibility criteria|0|||
130542104|NCT00604825|469950718|FG002|Overall Study|Did not meet eligibility criteria|2|||
130542105|NCT00604825|469950719|FG003|Overall Study|Did not meet eligibility criteria|0|||
130542106|NCT00604825|469950716|FG000|Overall Study|Physician Decision|0|||
130542107|NCT00604825|469950717|FG001|Overall Study|Physician Decision|0|||
130542108|NCT00604825|469950718|FG002|Overall Study|Physician Decision|0|||
130542109|NCT00604825|469950719|FG003|Overall Study|Physician Decision|1|||
130542110|NCT00604825|469950716|FG000|Overall Study|Exclusion criterion met|0|||
130542111|NCT00604825|469950717|FG001|Overall Study|Exclusion criterion met|0|||
130542112|NCT00604825|469950718|FG002|Overall Study|Exclusion criterion met|0|||
130542113|NCT00604825|469950719|FG003|Overall Study|Exclusion criterion met|1|||
130542114|NCT03647488|469952140|FG000|Overall Study|Progressive disease|10|||
130542115|NCT03647488|469952141|FG001|Overall Study|Progressive disease|0|||
130542116|NCT03647488|469952142|FG002|Overall Study|Progressive disease|0|||
130542117|NCT03647488|469952140|FG000|Overall Study|Adverse Event|5|||
130542118|NCT03647488|469952141|FG001|Overall Study|Adverse Event|0|||
130542119|NCT03647488|469952142|FG002|Overall Study|Adverse Event|0|||
130542120|NCT03647488|469952140|FG000|Overall Study|Clinical progression|2|||
130542121|NCT03647488|469952141|FG001|Overall Study|Clinical progression|0|||
130542122|NCT03647488|469952142|FG002|Overall Study|Clinical progression|0|||
130542123|NCT03647488|469952140|FG000|Overall Study|Participant refused to take investigational product|1|||
130542124|NCT03647488|469952141|FG001|Overall Study|Participant refused to take investigational product|0|||
130542125|NCT03647488|469952142|FG002|Overall Study|Participant refused to take investigational product|0|||
130542126|NCT03694275|469952143|FG000|Overall Study|Adverse Event|0|||
130542127|NCT03694275|469952144|FG001|Overall Study|Adverse Event|1|||
130542128|NCT03694275|469952143|FG000|Overall Study|Reason not Specified|0|||
130542129|NCT03694275|469952144|FG001|Overall Study|Reason not Specified|1|||
130542130|NCT03541174|469952145|FG000|Part 1 Double-Blind|Adverse Event|6|||
130542131|NCT03541174|469952146|FG001|Part 1 Double-Blind|Adverse Event|5|||
130542132|NCT03541174|469952147|FG002|Part 1 Double-Blind|Adverse Event|2|||
130207898|NCT01886781|468721032|FG000|Overall Study|Adverse Event|1|||
130542133|NCT03541174|469952148|FG003|Part 1 Double-Blind|Adverse Event|0|||
130542134|NCT03541174|469952149|FG004|Part 1 Double-Blind|Adverse Event|0|||
130542135|NCT03541174|469952150|FG005|Part 1 Double-Blind|Adverse Event|0|||
130542136|NCT03541174|469952145|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
130542137|NCT03541174|469952146|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
130542138|NCT03541174|469952147|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
130542139|NCT03541174|469952148|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
130542140|NCT03541174|469952149|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
130542141|NCT03541174|469952150|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
130542142|NCT03541174|469952145|FG000|Part 1 Double-Blind|Other reasons|3|||
130542143|NCT03541174|469952146|FG001|Part 1 Double-Blind|Other reasons|2|||
130542144|NCT03541174|469952147|FG002|Part 1 Double-Blind|Other reasons|3|||
130542145|NCT03541174|469952148|FG003|Part 1 Double-Blind|Other reasons|0|||
130542146|NCT03541174|469952149|FG004|Part 1 Double-Blind|Other reasons|0|||
130542147|NCT03541174|469952150|FG005|Part 1 Double-Blind|Other reasons|0|||
130542148|NCT03541174|469952145|FG000|Part 2 Single-Blind|Adverse Event|0|||
130542149|NCT03541174|469952146|FG001|Part 2 Single-Blind|Adverse Event|0|||
130542150|NCT03541174|469952147|FG002|Part 2 Single-Blind|Adverse Event|0|||
130542151|NCT03541174|469952148|FG003|Part 2 Single-Blind|Adverse Event|25|||
130542152|NCT03541174|469952149|FG004|Part 2 Single-Blind|Adverse Event|0|||
130542153|NCT03541174|469952150|FG005|Part 2 Single-Blind|Adverse Event|0|||
130542154|NCT03541174|469952145|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
130542155|NCT03541174|469952146|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
130542156|NCT03541174|469952147|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
130542157|NCT03541174|469952148|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
130542158|NCT03541174|469952149|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
130542159|NCT03541174|469952150|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
130542160|NCT03541174|469952145|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
130542161|NCT03541174|469952146|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
130542162|NCT03541174|469952147|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
130542163|NCT03541174|469952148|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
130542164|NCT03541174|469952149|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
130542165|NCT03541174|469952150|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
130542166|NCT03541174|469952145|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
130542167|NCT03541174|469952146|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
130542168|NCT03541174|469952147|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
130542169|NCT03541174|469952148|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
130542170|NCT03541174|469952149|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
130542171|NCT03541174|469952150|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
130542172|NCT03541174|469952145|FG000|Part 2 Single-Blind|Death|0|||
130542173|NCT03541174|469952146|FG001|Part 2 Single-Blind|Death|0|||
130542174|NCT03541174|469952147|FG002|Part 2 Single-Blind|Death|0|||
130542175|NCT03541174|469952148|FG003|Part 2 Single-Blind|Death|5|||
130542176|NCT03541174|469952149|FG004|Part 2 Single-Blind|Death|0|||
130542177|NCT03541174|469952150|FG005|Part 2 Single-Blind|Death|0|||
130542178|NCT03541174|469952145|FG000|Part 2 Single-Blind|Pregnancy|0|||
130542179|NCT03541174|469952146|FG001|Part 2 Single-Blind|Pregnancy|0|||
130542180|NCT03541174|469952147|FG002|Part 2 Single-Blind|Pregnancy|0|||
130542181|NCT03541174|469952148|FG003|Part 2 Single-Blind|Pregnancy|1|||
130542182|NCT03541174|469952149|FG004|Part 2 Single-Blind|Pregnancy|0|||
130542183|NCT03541174|469952150|FG005|Part 2 Single-Blind|Pregnancy|0|||
130542184|NCT03541174|469952145|FG000|Part 2 Single-Blind|Other reasons|0|||
130542185|NCT03541174|469952146|FG001|Part 2 Single-Blind|Other reasons|0|||
130542186|NCT03541174|469952147|FG002|Part 2 Single-Blind|Other reasons|0|||
130542187|NCT03541174|469952148|FG003|Part 2 Single-Blind|Other reasons|32|||
130542188|NCT03541174|469952149|FG004|Part 2 Single-Blind|Other reasons|0|||
130542189|NCT03541174|469952150|FG005|Part 2 Single-Blind|Other reasons|0|||
130542190|NCT03541174|469952145|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
130542191|NCT03541174|469952146|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
130542192|NCT03541174|469952147|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
130542193|NCT03541174|469952148|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
130542194|NCT03541174|469952149|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
130542195|NCT03541174|469952150|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
130542196|NCT03541174|469952145|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
130542197|NCT03541174|469952146|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
130542198|NCT03541174|469952147|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
130542199|NCT03541174|469952148|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
130542200|NCT03541174|469952149|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
130542201|NCT03541174|469952150|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
130542202|NCT03541174|469952145|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
130542203|NCT03541174|469952146|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
130542204|NCT03541174|469952147|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
130542205|NCT03541174|469952148|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
130542206|NCT03541174|469952149|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
130542207|NCT03541174|469952150|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
130542208|NCT03541174|469952145|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
130542209|NCT03541174|469952146|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
130542210|NCT03541174|469952147|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
130542211|NCT03541174|469952148|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
130542212|NCT03541174|469952149|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
130542213|NCT03541174|469952150|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
130542214|NCT03541174|469952145|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
130542215|NCT03541174|469952146|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
130542216|NCT03541174|469952147|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
130542217|NCT03541174|469952148|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
130542218|NCT03541174|469952149|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
130542219|NCT03541174|469952150|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
130542220|NCT02217332|469952153|FG000|Overall Study|Adverse Event|3|||
130542221|NCT02217332|469952153|FG000|Overall Study|Dose interruption >1 month|1|||
130542222|NCT02217332|469952153|FG000|Overall Study|Protocol Violation (eligibility)|1|||
130542223|NCT02217332|469952153|FG000|Overall Study|Withdrawal by Subject|1|||
130542224|NCT02217332|469952153|FG000|Overall Study|Lost to Follow-up|1|||
130542225|NCT02407990|469952154|FG000|Overall Study|Death|2|||
130542226|NCT02407990|469952155|FG001|Overall Study|Death|22|||
130542227|NCT02407990|469952156|FG002|Overall Study|Death|23|||
130542228|NCT02407990|469952157|FG003|Overall Study|Death|7|||
130542229|NCT02407990|469952158|FG004|Overall Study|Death|17|||
130542230|NCT02407990|469952159|FG005|Overall Study|Death|16|||
130542231|NCT02407990|469952160|FG006|Overall Study|Death|10|||
130542232|NCT02407990|469952161|FG007|Overall Study|Death|248|||
130542233|NCT02407990|469952154|FG000|Overall Study|Lost to Follow-up|0|||
130542234|NCT02407990|469952155|FG001|Overall Study|Lost to Follow-up|1|||
130542235|NCT02407990|469952156|FG002|Overall Study|Lost to Follow-up|0|||
130542236|NCT02407990|469952157|FG003|Overall Study|Lost to Follow-up|0|||
130542237|NCT02407990|469952158|FG004|Overall Study|Lost to Follow-up|0|||
130542238|NCT02407990|469952159|FG005|Overall Study|Lost to Follow-up|0|||
130542239|NCT02407990|469952160|FG006|Overall Study|Lost to Follow-up|0|||
130542240|NCT02407990|469952161|FG007|Overall Study|Lost to Follow-up|17|||
130542241|NCT02407990|469952154|FG000|Overall Study|Progressive Disease|0|||
130542242|NCT02407990|469952155|FG001|Overall Study|Progressive Disease|0|||
130542243|NCT02407990|469952156|FG002|Overall Study|Progressive Disease|0|||
130542244|NCT02407990|469952157|FG003|Overall Study|Progressive Disease|0|||
130542245|NCT02407990|469952158|FG004|Overall Study|Progressive Disease|0|||
130542246|NCT02407990|469952159|FG005|Overall Study|Progressive Disease|0|||
130542247|NCT02407990|469952160|FG006|Overall Study|Progressive Disease|0|||
130542248|NCT02407990|469952161|FG007|Overall Study|Progressive Disease|1|||
130542249|NCT02407990|469952154|FG000|Overall Study|Withdrawal by Subject|0|||
130542250|NCT02407990|469952155|FG001|Overall Study|Withdrawal by Subject|0|||
130542251|NCT02407990|469952156|FG002|Overall Study|Withdrawal by Subject|0|||
130542252|NCT02407990|469952157|FG003|Overall Study|Withdrawal by Subject|0|||
130542253|NCT02407990|469952158|FG004|Overall Study|Withdrawal by Subject|1|||
130542254|NCT02407990|469952159|FG005|Overall Study|Withdrawal by Subject|0|||
130542255|NCT02407990|469952160|FG006|Overall Study|Withdrawal by Subject|0|||
130542256|NCT02407990|469952161|FG007|Overall Study|Withdrawal by Subject|30|||
130542257|NCT02407990|469952154|FG000|Overall Study|Study Terminated by Sponsor|1|||
130542258|NCT02407990|469952155|FG001|Overall Study|Study Terminated by Sponsor|3|||
130542259|NCT02407990|469952156|FG002|Overall Study|Study Terminated by Sponsor|3|||
130542260|NCT02407990|469952157|FG003|Overall Study|Study Terminated by Sponsor|0|||
130542261|NCT02407990|469952158|FG004|Overall Study|Study Terminated by Sponsor|3|||
130542262|NCT02407990|469952159|FG005|Overall Study|Study Terminated by Sponsor|4|||
130542263|NCT02407990|469952160|FG006|Overall Study|Study Terminated by Sponsor|3|||
130542264|NCT02407990|469952161|FG007|Overall Study|Study Terminated by Sponsor|37|||
130542265|NCT02407990|469952154|FG000|Overall Study|Logistics|0|||
130542266|NCT02407990|469952155|FG001|Overall Study|Logistics|0|||
130542267|NCT02407990|469952156|FG002|Overall Study|Logistics|0|||
130542268|NCT02407990|469952157|FG003|Overall Study|Logistics|0|||
130542269|NCT02407990|469952158|FG004|Overall Study|Logistics|0|||
130542270|NCT02407990|469952159|FG005|Overall Study|Logistics|0|||
130542271|NCT02407990|469952160|FG006|Overall Study|Logistics|0|||
130542272|NCT02407990|469952161|FG007|Overall Study|Logistics|1|||
130542273|NCT02407990|469952154|FG000|Overall Study|Rolled into long-term extension study|0|||
130542274|NCT02407990|469952155|FG001|Overall Study|Rolled into long-term extension study|0|||
130542275|NCT02407990|469952156|FG002|Overall Study|Rolled into long-term extension study|0|||
130542276|NCT02407990|469952157|FG003|Overall Study|Rolled into long-term extension study|0|||
130542277|NCT02407990|469952158|FG004|Overall Study|Rolled into long-term extension study|0|||
130542278|NCT02407990|469952159|FG005|Overall Study|Rolled into long-term extension study|0|||
130542279|NCT02407990|469952160|FG006|Overall Study|Rolled into long-term extension study|0|||
130542280|NCT02407990|469952161|FG007|Overall Study|Rolled into long-term extension study|1|||
130542281|NCT00852540|469952164|FG000|Overall Study|Adverse Event|10|||
130542282|NCT00852540|469952165|FG001|Overall Study|Adverse Event|3|||
130542283|NCT00852540|469952164|FG000|Overall Study|Lack of Efficacy|15|||
130542284|NCT00852540|469952165|FG001|Overall Study|Lack of Efficacy|3|||
130542285|NCT00852540|469952164|FG000|Overall Study|Protocol Violation|1|||
130542286|NCT00852540|469952165|FG001|Overall Study|Protocol Violation|2|||
130542287|NCT00852540|469952164|FG000|Overall Study|Lost to Follow-up|2|||
130542288|NCT00852540|469952165|FG001|Overall Study|Lost to Follow-up|3|||
130542289|NCT00852540|469952164|FG000|Overall Study|Investigator Discretion|2|||
130542290|NCT00852540|469952165|FG001|Overall Study|Investigator Discretion|3|||
130542291|NCT00852540|469952164|FG000|Overall Study|Withdrawal by Subject|3|||
130542292|NCT00852540|469952165|FG001|Overall Study|Withdrawal by Subject|1|||
130542293|NCT00852540|469952164|FG000|Overall Study|Did Not Receive Study Drug|3|||
130542294|NCT00852540|469952165|FG001|Overall Study|Did Not Receive Study Drug|3|||
130542295|NCT01119105|469952166|FG000|Overall Study|Withdrawal by Subject|1|||
130542296|NCT01119105|469952167|FG001|Overall Study|Withdrawal by Subject|1|||
130542297|NCT01119105|469952168|FG002|Overall Study|Withdrawal by Subject|1|||
130542298|NCT01119105|469952166|FG000|Overall Study|Lost to Follow-up|0|||
130542299|NCT01119105|469952167|FG001|Overall Study|Lost to Follow-up|2|||
130542300|NCT01119105|469952168|FG002|Overall Study|Lost to Follow-up|5|||
130542301|NCT01119105|469952166|FG000|Overall Study|Adverse Event|1|||
130542302|NCT01119105|469952167|FG001|Overall Study|Adverse Event|0|||
130542303|NCT01119105|469952168|FG002|Overall Study|Adverse Event|1|||
130542304|NCT01119105|469952166|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
130542305|NCT01119105|469952167|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
130542306|NCT01119105|469952168|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
130542307|NCT01119105|469952166|FG000|Overall Study|Other|1|||
130542308|NCT01119105|469952167|FG001|Overall Study|Other|1|||
130542309|NCT01119105|469952168|FG002|Overall Study|Other|0|||
130542310|NCT00618618|469952169|FG000|Overall Study|Patient Request|0|||
130542311|NCT00618618|469952170|FG001|Overall Study|Patient Request|0|||
130207899|NCT01886781|468721033|FG001|Overall Study|Adverse Event|0|||
130542312|NCT00618618|469952171|FG002|Overall Study|Patient Request|2|||
130542313|NCT00618618|469952172|FG003|Overall Study|Patient Request|0|||
130542314|NCT00618618|469952169|FG000|Overall Study|Inability to Complete Study Procedures|0|||
130542315|NCT00618618|469952170|FG001|Overall Study|Inability to Complete Study Procedures|1|||
130542316|NCT00618618|469952171|FG002|Overall Study|Inability to Complete Study Procedures|0|||
130542317|NCT00618618|469952172|FG003|Overall Study|Inability to Complete Study Procedures|0|||
130542318|NCT00618618|469952169|FG000|Overall Study|Lost to Follow-up|3|||
130542319|NCT00618618|469952170|FG001|Overall Study|Lost to Follow-up|0|||
130542320|NCT00618618|469952171|FG002|Overall Study|Lost to Follow-up|0|||
130542321|NCT00618618|469952172|FG003|Overall Study|Lost to Follow-up|1|||
130542322|NCT00618618|469952169|FG000|Overall Study|Non-compliance|1|||
130542323|NCT00618618|469952170|FG001|Overall Study|Non-compliance|1|||
130542324|NCT00618618|469952171|FG002|Overall Study|Non-compliance|0|||
130542325|NCT00618618|469952172|FG003|Overall Study|Non-compliance|0|||
130542326|NCT00618618|469952169|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
130542327|NCT00618618|469952170|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
130542328|NCT00618618|469952171|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
130542329|NCT00618618|469952172|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
130542330|NCT00618618|469952169|FG000|Overall Study|Death|0|||
130542331|NCT00618618|469952170|FG001|Overall Study|Death|1|||
130542332|NCT00618618|469952171|FG002|Overall Study|Death|0|||
130542333|NCT00618618|469952172|FG003|Overall Study|Death|0|||
130542334|NCT02929329|469952173|FG000|Overall Study|Withdrawal by Subject|24|||
130542335|NCT02929329|469952174|FG001|Overall Study|Withdrawal by Subject|21|||
130542336|NCT02929329|469952173|FG000|Overall Study|Lost to Follow-up|26|||
130542337|NCT02929329|469952174|FG001|Overall Study|Lost to Follow-up|20|||
130542338|NCT02929329|469952173|FG000|Overall Study|Death|1054|||
130542339|NCT02929329|469952174|FG001|Overall Study|Death|1051|||
130542340|NCT01183234|469952175|FG000|First Intervention|Adverse Event|1|||
130542341|NCT01183234|469952176|FG001|First Intervention|Adverse Event|0|||
130542342|NCT02937454|469952181|FG000|Overall Study|Adverse Event|0|||
130542343|NCT02937454|469952182|FG001|Overall Study|Adverse Event|1|||
130542344|NCT02937454|469952181|FG000|Overall Study|Death|98|||
130542345|NCT02937454|469952182|FG001|Overall Study|Death|95|||
130542346|NCT02937454|469952181|FG000|Overall Study|Lost to Follow-up|1|||
130542347|NCT02937454|469952182|FG001|Overall Study|Lost to Follow-up|1|||
130542348|NCT02937454|469952181|FG000|Overall Study|Physician Decision|0|||
130542349|NCT02937454|469952182|FG001|Overall Study|Physician Decision|1|||
130542350|NCT02937454|469952181|FG000|Overall Study|Protocol Violation|6|||
130542351|NCT02937454|469952182|FG001|Overall Study|Protocol Violation|10|||
130542352|NCT02937454|469952181|FG000|Overall Study|Withdrawal by Subject|27|||
130542353|NCT02937454|469952182|FG001|Overall Study|Withdrawal by Subject|15|||
130542354|NCT02937454|469952181|FG000|Overall Study|Other|8|||
130542355|NCT02937454|469952182|FG001|Overall Study|Other|5|||
130319112|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
130542356|NCT00037830|469952185|FG000|Overall Study|Adverse Event|2|||
130542357|NCT00037830|469952186|FG001|Overall Study|Adverse Event|0|||
130207900|NCT01886781|468721032|FG000|Overall Study|Lost to Follow-up|5|||
130319113|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
130542358|NCT00037830|469952187|FG002|Overall Study|Adverse Event|0|||
130542359|NCT00037830|469952185|FG000|Overall Study|Withdrawal by Subject|4|||
130542360|NCT00037830|469952186|FG001|Overall Study|Withdrawal by Subject|5|||
130542361|NCT00037830|469952187|FG002|Overall Study|Withdrawal by Subject|1|||
130542362|NCT00037830|469952185|FG000|Overall Study|Protocol Violation|2|||
130542363|NCT00037830|469952186|FG001|Overall Study|Protocol Violation|2|||
130542364|NCT00037830|469952187|FG002|Overall Study|Protocol Violation|0|||
130542365|NCT00037830|469952185|FG000|Overall Study|Unrelated Medical Problem|2|||
130542366|NCT00037830|469952186|FG001|Overall Study|Unrelated Medical Problem|0|||
130542367|NCT00037830|469952187|FG002|Overall Study|Unrelated Medical Problem|0|||
130542368|NCT03292432|469952188|FG000|Overall Study|Lost to Follow-up|11|||
130542369|NCT03292432|469952189|FG001|Overall Study|Lost to Follow-up|8|||
130542370|NCT03292432|469952188|FG000|Overall Study|Death|2|||
130542371|NCT03292432|469952189|FG001|Overall Study|Death|1|||
130542372|NCT03292432|469952188|FG000|Overall Study|Withdrawal by Subject|1|||
130542373|NCT03292432|469952189|FG001|Overall Study|Withdrawal by Subject|2|||
130542374|NCT03292432|469952188|FG000|Overall Study|Site closed before any data collected|1|||
130542375|NCT03292432|469952189|FG001|Overall Study|Site closed before any data collected|0|||
130542376|NCT01014143|469952191|FG000|Second Intervention|Lost to Follow-up|2|||
130542377|NCT01014143|469952192|FG001|Second Intervention|Lost to Follow-up|0|||
130542378|NCT01014143|469952193|FG002|Second Intervention|Lost to Follow-up|0|||
130542379|NCT00495586|469952194|FG000|Overall Study|Withdrawal by Subject|4|||
130542380|NCT00495586|469952195|FG001|Overall Study|Withdrawal by Subject|4|||
130542381|NCT02038543|469952196|FG000|Overall Study|Screen Failure|0|||
130542382|NCT02038543|469952197|FG001|Overall Study|Screen Failure|0|||
130542383|NCT02038543|469952198|FG002|Overall Study|Screen Failure|0|||
130542384|NCT02038543|469952199|FG003|Overall Study|Screen Failure|1|||
130542385|NCT02038543|469952196|FG000|Overall Study|Withdrawal by Subject|0|||
130542386|NCT02038543|469952197|FG001|Overall Study|Withdrawal by Subject|0|||
130542387|NCT02038543|469952198|FG002|Overall Study|Withdrawal by Subject|0|||
130542388|NCT02038543|469952199|FG003|Overall Study|Withdrawal by Subject|1|||
130542389|NCT00158860|469952200|FG000|Overall Study|Adverse Event|3|||
130542390|NCT00158860|469952201|FG001|Overall Study|Adverse Event|6|||
130542391|NCT00158860|469952200|FG000|Overall Study|Lost to Follow-up|11|||
130542392|NCT00158860|469952201|FG001|Overall Study|Lost to Follow-up|17|||
130542393|NCT00158860|469952200|FG000|Overall Study|Protocol Violation|8|||
130542394|NCT00158860|469952201|FG001|Overall Study|Protocol Violation|23|||
130542395|NCT00158860|469952200|FG000|Overall Study|Withdrawal by Subject|7|||
130542396|NCT00158860|469952201|FG001|Overall Study|Withdrawal by Subject|17|||
130542397|NCT00158860|469952200|FG000|Overall Study|MOVING OUT OF STATE|1|||
130542398|NCT00158860|469952201|FG001|Overall Study|MOVING OUT OF STATE|0|||
130542399|NCT00158860|469952200|FG000|Overall Study|Pregnancy|3|||
130542400|NCT00158860|469952201|FG001|Overall Study|Pregnancy|3|||
130542401|NCT00158860|469952200|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
130542402|NCT00158860|469952201|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
130542403|NCT00158860|469952200|FG000|Overall Study|SPONSOR REQUEST|0|||
130542404|NCT00158860|469952201|FG001|Overall Study|SPONSOR REQUEST|1|||
130542405|NCT00158860|469952200|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
130542406|NCT00158860|469952201|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
130542407|NCT00158860|469952200|FG000|Overall Study|Closed per sponsor|0|||
130542408|NCT00158860|469952201|FG001|Overall Study|Closed per sponsor|1|||
130542409|NCT01029652|469952202|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
130542410|NCT01029652|469952203|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
130542411|NCT01029652|469952202|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
130542412|NCT01029652|469952203|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
130542413|NCT01029652|469952202|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
130542414|NCT01029652|469952203|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
130542415|NCT01029652|469952202|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
130542416|NCT01029652|469952203|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
130542417|NCT01029652|469952202|FG000|Core Study (0-12 Weeks)|Death|0|||
130542418|NCT01029652|469952203|FG001|Core Study (0-12 Weeks)|Death|1|||
130542419|NCT01029652|469952202|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
130542420|NCT01029652|469952203|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
130542421|NCT01029652|469952202|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
130542422|NCT01029652|469952203|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
130542423|NCT01029652|469952202|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
130542424|NCT01029652|469952203|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
130542425|NCT01029652|469952202|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
130542426|NCT01029652|469952203|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
130542427|NCT01029652|469952202|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
130542428|NCT01029652|469952203|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
130542429|NCT01029652|469952202|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
130542430|NCT01029652|469952203|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
130542431|NCT01029652|469952202|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
130542432|NCT01029652|469952203|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
130542433|NCT02095951|469952204|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
130542434|NCT02095951|469952205|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
130542435|NCT03618823|469952206|FG000|Overall Study|Lost to Follow-up|63|||
130542436|NCT03618823|469952207|FG001|Overall Study|Lost to Follow-up|61|||
130542437|NCT04638920|469952208|FG000|Overall Study|Withdrawal by Subject|5|||
130542438|NCT00964886|469952209|FG000|Overall Study|Lost to Follow-up|2|||
130542439|NCT00964886|469952210|FG001|Overall Study|Lost to Follow-up|2|||
130542440|NCT00964886|469952211|FG002|Overall Study|Lost to Follow-up|6|||
130542441|NCT00964886|469952212|FG003|Overall Study|Lost to Follow-up|4|||
130542442|NCT00964886|469952209|FG000|Overall Study|Withdrawal by Subject|6|||
130542443|NCT00964886|469952210|FG001|Overall Study|Withdrawal by Subject|2|||
130542444|NCT00964886|469952211|FG002|Overall Study|Withdrawal by Subject|5|||
130542445|NCT00964886|469952212|FG003|Overall Study|Withdrawal by Subject|3|||
130542446|NCT00964886|469952209|FG000|Overall Study|Adverse Event|3|||
130542447|NCT00964886|469952210|FG001|Overall Study|Adverse Event|1|||
130542448|NCT00964886|469952211|FG002|Overall Study|Adverse Event|5|||
130542449|NCT00964886|469952212|FG003|Overall Study|Adverse Event|2|||
130542450|NCT00964886|469952209|FG000|Overall Study|Protocol Violation|0|||
130542451|NCT00964886|469952210|FG001|Overall Study|Protocol Violation|2|||
130542452|NCT00964886|469952211|FG002|Overall Study|Protocol Violation|0|||
130542453|NCT00964886|469952212|FG003|Overall Study|Protocol Violation|0|||
130542454|NCT00523640|469952214|FG000|Overall Study|Death|1|||
130542455|NCT03775434|469952216|FG000|Overall Study|Adverse Event|2|||
130542456|NCT03775434|469952216|FG000|Overall Study|Withdrawal by Subject|1|||
130542457|NCT01859988|469952217|FG000|Overall Study|Withdrawal by Subject|6|||
130542458|NCT01859988|469952218|FG001|Overall Study|Withdrawal by Subject|3|||
130542459|NCT01859988|469952219|FG002|Overall Study|Withdrawal by Subject|4|||
130542460|NCT01859988|469952220|FG003|Overall Study|Withdrawal by Subject|3|||
130542461|NCT01859988|469952221|FG004|Overall Study|Withdrawal by Subject|2|||
130542462|NCT01859988|469952222|FG005|Overall Study|Withdrawal by Subject|2|||
130542463|NCT01859988|469952217|FG000|Overall Study|Lack of Efficacy|1|||
130542464|NCT01859988|469952218|FG001|Overall Study|Lack of Efficacy|1|||
130542465|NCT01859988|469952219|FG002|Overall Study|Lack of Efficacy|5|||
130542466|NCT01859988|469952220|FG003|Overall Study|Lack of Efficacy|0|||
130542467|NCT01859988|469952221|FG004|Overall Study|Lack of Efficacy|7|||
130542468|NCT01859988|469952222|FG005|Overall Study|Lack of Efficacy|9|||
130542469|NCT01859988|469952217|FG000|Overall Study|Physician Decision|1|||
130542470|NCT01859988|469952218|FG001|Overall Study|Physician Decision|3|||
130542471|NCT01859988|469952219|FG002|Overall Study|Physician Decision|1|||
130542472|NCT01859988|469952220|FG003|Overall Study|Physician Decision|3|||
130542473|NCT01859988|469952221|FG004|Overall Study|Physician Decision|4|||
130542474|NCT01859988|469952222|FG005|Overall Study|Physician Decision|1|||
130542475|NCT01859988|469952217|FG000|Overall Study|Adverse Event|2|||
130542476|NCT01859988|469952218|FG001|Overall Study|Adverse Event|1|||
130542477|NCT01859988|469952219|FG002|Overall Study|Adverse Event|3|||
130542478|NCT01859988|469952220|FG003|Overall Study|Adverse Event|1|||
130542479|NCT01859988|469952221|FG004|Overall Study|Adverse Event|2|||
130542480|NCT01859988|469952222|FG005|Overall Study|Adverse Event|2|||
130542481|NCT01859988|469952217|FG000|Overall Study|Lost to Follow-up|1|||
130542482|NCT01859988|469952218|FG001|Overall Study|Lost to Follow-up|2|||
130542483|NCT01859988|469952219|FG002|Overall Study|Lost to Follow-up|3|||
130542484|NCT01859988|469952220|FG003|Overall Study|Lost to Follow-up|0|||
130542485|NCT01859988|469952221|FG004|Overall Study|Lost to Follow-up|3|||
130542486|NCT01859988|469952222|FG005|Overall Study|Lost to Follow-up|2|||
130542487|NCT01859988|469952217|FG000|Overall Study|Protocol Violation|0|||
130542488|NCT01859988|469952218|FG001|Overall Study|Protocol Violation|0|||
130542489|NCT01859988|469952219|FG002|Overall Study|Protocol Violation|1|||
130542490|NCT01859988|469952220|FG003|Overall Study|Protocol Violation|0|||
130542491|NCT01859988|469952221|FG004|Overall Study|Protocol Violation|0|||
130542492|NCT01859988|469952222|FG005|Overall Study|Protocol Violation|0|||
130542493|NCT01859988|469952217|FG000|Overall Study|Other than specified above|0|||
130542494|NCT01859988|469952218|FG001|Overall Study|Other than specified above|2|||
130542495|NCT01859988|469952219|FG002|Overall Study|Other than specified above|11|||
130542496|NCT01859988|469952220|FG003|Overall Study|Other than specified above|3|||
130542497|NCT01859988|469952221|FG004|Overall Study|Other than specified above|5|||
130542498|NCT01859988|469952222|FG005|Overall Study|Other than specified above|3|||
130542499|NCT00468559|469952227|FG000|Open-label Treatment Phase|Adverse Event|5|||
130542500|NCT00468559|469952228|FG001|Open-label Treatment Phase|Adverse Event|0|||
130542501|NCT00468559|469952229|FG002|Open-label Treatment Phase|Adverse Event|0|||
130542502|NCT00468559|469952227|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
130542503|NCT00468559|469952228|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
130542504|NCT00468559|469952229|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
130542505|NCT00468559|469952227|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
130542506|NCT00468559|469952228|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130542507|NCT00468559|469952229|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
130542508|NCT00468559|469952227|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
130542509|NCT00468559|469952228|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
130542510|NCT00468559|469952229|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
130207901|NCT01886781|468721033|FG001|Overall Study|Lost to Follow-up|0|||
130542511|NCT00468559|469952227|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
130542512|NCT00468559|469952228|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
130430143|NCT00642902|469536507|FG003|Overall Study|Adverse Event|1|||
130542513|NCT00468559|469952229|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
130207902|NCT01886781|468721032|FG000|Overall Study|Withdrawal by Subject|2|||
130207903|NCT01886781|468721033|FG001|Overall Study|Withdrawal by Subject|1|||
130207904|NCT01886781|468721032|FG000|Overall Study|Worsening of symptoms|1|||
130542514|NCT04602221|469952230|FG000|Overall Study|Discontinuation of trial treatment|0|||
130542515|NCT04602221|469952231|FG001|Overall Study|Discontinuation of trial treatment|0|||
130542516|NCT04602221|469952232|FG002|Overall Study|Discontinuation of trial treatment|1|||
130542517|NCT04602221|469952233|FG003|Overall Study|Discontinuation of trial treatment|0|||
130542518|NCT04602221|469952234|FG004|Overall Study|Discontinuation of trial treatment|0|||
130542519|NCT04602221|469952235|FG005|Overall Study|Discontinuation of trial treatment|0|||
130542520|NCT04602221|469952236|FG006|Overall Study|Discontinuation of trial treatment|0|||
130542521|NCT04602221|469952237|FG007|Overall Study|Discontinuation of trial treatment|0|||
130542522|NCT04602221|469952238|FG008|Overall Study|Discontinuation of trial treatment|0|||
130542523|NCT04602221|469952239|FG009|Overall Study|Discontinuation of trial treatment|0|||
130542524|NCT04602221|469952240|FG010|Overall Study|Discontinuation of trial treatment|0|||
130542525|NCT04602221|469952241|FG011|Overall Study|Discontinuation of trial treatment|0|||
130542526|NCT04602221|469952242|FG012|Overall Study|Discontinuation of trial treatment|0|||
130542527|NCT04602221|469952243|FG013|Overall Study|Discontinuation of trial treatment|0|||
130542528|NCT04602221|469952244|FG014|Overall Study|Discontinuation of trial treatment|0|||
130542529|NCT04602221|469952245|FG015|Overall Study|Discontinuation of trial treatment|0|||
130542530|NCT04602221|469952246|FG016|Overall Study|Discontinuation of trial treatment|0|||
130542531|NCT04602221|469952247|FG017|Overall Study|Discontinuation of trial treatment|0|||
130542532|NCT04602221|469952230|FG000|Overall Study|Other than listed|0|||
130542533|NCT04602221|469952231|FG001|Overall Study|Other than listed|0|||
130542534|NCT04602221|469952232|FG002|Overall Study|Other than listed|0|||
130542535|NCT04602221|469952233|FG003|Overall Study|Other than listed|0|||
130542536|NCT04602221|469952234|FG004|Overall Study|Other than listed|0|||
130542537|NCT04602221|469952235|FG005|Overall Study|Other than listed|0|||
130542538|NCT04602221|469952236|FG006|Overall Study|Other than listed|0|||
130542539|NCT04602221|469952237|FG007|Overall Study|Other than listed|0|||
130542540|NCT04602221|469952238|FG008|Overall Study|Other than listed|0|||
130542541|NCT04602221|469952239|FG009|Overall Study|Other than listed|0|||
130542542|NCT04602221|469952240|FG010|Overall Study|Other than listed|0|||
130542543|NCT04602221|469952241|FG011|Overall Study|Other than listed|0|||
130542544|NCT04602221|469952242|FG012|Overall Study|Other than listed|0|||
130542545|NCT04602221|469952243|FG013|Overall Study|Other than listed|0|||
130542546|NCT04602221|469952244|FG014|Overall Study|Other than listed|0|||
130542547|NCT04602221|469952245|FG015|Overall Study|Other than listed|1|||
130542548|NCT04602221|469952246|FG016|Overall Study|Other than listed|0|||
130542549|NCT04602221|469952247|FG017|Overall Study|Other than listed|1|||
130542550|NCT04602221|469952230|FG000|Overall Study|Withdrawal by Subject|0|||
130542551|NCT04602221|469952231|FG001|Overall Study|Withdrawal by Subject|0|||
130542552|NCT04602221|469952232|FG002|Overall Study|Withdrawal by Subject|0|||
130542553|NCT04602221|469952233|FG003|Overall Study|Withdrawal by Subject|0|||
130542554|NCT04602221|469952234|FG004|Overall Study|Withdrawal by Subject|0|||
130542555|NCT04602221|469952235|FG005|Overall Study|Withdrawal by Subject|0|||
130542556|NCT04602221|469952236|FG006|Overall Study|Withdrawal by Subject|0|||
130542557|NCT04602221|469952237|FG007|Overall Study|Withdrawal by Subject|0|||
130542558|NCT04602221|469952238|FG008|Overall Study|Withdrawal by Subject|0|||
130542559|NCT04602221|469952239|FG009|Overall Study|Withdrawal by Subject|0|||
130542560|NCT04602221|469952240|FG010|Overall Study|Withdrawal by Subject|0|||
130542561|NCT04602221|469952241|FG011|Overall Study|Withdrawal by Subject|0|||
130542562|NCT04602221|469952242|FG012|Overall Study|Withdrawal by Subject|1|||
130542563|NCT04602221|469952243|FG013|Overall Study|Withdrawal by Subject|0|||
130542564|NCT04602221|469952244|FG014|Overall Study|Withdrawal by Subject|0|||
130542565|NCT04602221|469952245|FG015|Overall Study|Withdrawal by Subject|0|||
130542566|NCT04602221|469952246|FG016|Overall Study|Withdrawal by Subject|0|||
130542567|NCT04602221|469952247|FG017|Overall Study|Withdrawal by Subject|0|||
130542568|NCT04602221|469952230|FG000|Overall Study|Lost to Follow-up|0|||
130542569|NCT04602221|469952231|FG001|Overall Study|Lost to Follow-up|0|||
130542570|NCT04602221|469952232|FG002|Overall Study|Lost to Follow-up|0|||
130542571|NCT04602221|469952233|FG003|Overall Study|Lost to Follow-up|0|||
130542572|NCT04602221|469952234|FG004|Overall Study|Lost to Follow-up|0|||
130542573|NCT04602221|469952235|FG005|Overall Study|Lost to Follow-up|1|||
130542574|NCT04602221|469952236|FG006|Overall Study|Lost to Follow-up|0|||
130542575|NCT04602221|469952237|FG007|Overall Study|Lost to Follow-up|0|||
130542576|NCT04602221|469952238|FG008|Overall Study|Lost to Follow-up|0|||
130542577|NCT04602221|469952239|FG009|Overall Study|Lost to Follow-up|0|||
130542578|NCT04602221|469952240|FG010|Overall Study|Lost to Follow-up|0|||
130542579|NCT04602221|469952241|FG011|Overall Study|Lost to Follow-up|0|||
130542580|NCT04602221|469952242|FG012|Overall Study|Lost to Follow-up|0|||
130542581|NCT04602221|469952243|FG013|Overall Study|Lost to Follow-up|0|||
130542582|NCT04602221|469952244|FG014|Overall Study|Lost to Follow-up|0|||
130542583|NCT04602221|469952245|FG015|Overall Study|Lost to Follow-up|0|||
130542584|NCT04602221|469952246|FG016|Overall Study|Lost to Follow-up|0|||
130542585|NCT04602221|469952247|FG017|Overall Study|Lost to Follow-up|0|||
130542586|NCT03538301|469952248|FG000|Overall Study|Adverse Event|1|||
130542587|NCT03538301|469952249|FG001|Overall Study|Adverse Event|4|||
130542588|NCT03538301|469952250|FG002|Overall Study|Adverse Event|4|||
130542589|NCT03538301|469952248|FG000|Overall Study|Death|1|||
130542590|NCT03538301|469952249|FG001|Overall Study|Death|1|||
130542591|NCT03538301|469952250|FG002|Overall Study|Death|0|||
130542592|NCT03538301|469952248|FG000|Overall Study|Physician Decision|0|||
130542593|NCT03538301|469952249|FG001|Overall Study|Physician Decision|1|||
130542594|NCT03538301|469952250|FG002|Overall Study|Physician Decision|0|||
130542595|NCT03538301|469952248|FG000|Overall Study|Protocol Violation|0|||
130542596|NCT03538301|469952249|FG001|Overall Study|Protocol Violation|0|||
130542597|NCT03538301|469952250|FG002|Overall Study|Protocol Violation|1|||
130542598|NCT03538301|469952248|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
130542599|NCT03538301|469952249|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
130542600|NCT03538301|469952250|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
130542601|NCT04540887|469952251|FG000|Overall Study|Withdrawal by Subject|2|||
130542602|NCT00515853|469952252|FG000|Overall Study|Lost to Follow-up|9|||
130542603|NCT00515853|469952253|FG001|Overall Study|Lost to Follow-up|13|||
130542604|NCT00515853|469952252|FG000|Overall Study|Withdrawal by Subject|6|||
130542605|NCT00515853|469952253|FG001|Overall Study|Withdrawal by Subject|4|||
130542606|NCT01262027|469952254|FG000|Overall Study|Adverse Event|1|||
130542607|NCT01262027|469952254|FG000|Overall Study|Withdrawal by Subject|3|||
130542608|NCT01262027|469952254|FG000|Overall Study|Protocol Violation|1|||
130542609|NCT00589121|469952255|FG000|Overall Study|Protocol Violation|2|||
130542610|NCT00589121|469952256|FG001|Overall Study|Protocol Violation|6|||
130542611|NCT00589121|469952255|FG000|Overall Study|No protocol treatment received|0|||
130542612|NCT00589121|469952256|FG001|Overall Study|No protocol treatment received|1|||
130542613|NCT00847808|469952257|FG000|Overall Study|Adverse Event|7|||
130542614|NCT00847808|469952257|FG000|Overall Study|Protocol Violation|1|||
130542615|NCT00847808|469952257|FG000|Overall Study|Lost to Follow-up|1|||
130542616|NCT00847808|469952257|FG000|Overall Study|Withdrawal by Subject|4|||
130542617|NCT00847808|469952257|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
130542618|NCT00847808|469952257|FG000|Overall Study|Participant Took Excluded Medication|1|||
130542619|NCT01758900|469952261|FG000|Overall Study|difficulty for further intubation|7|||
130542620|NCT01758900|469952262|FG001|Overall Study|difficulty for further intubation|8|||
130542621|NCT01892540|469952264|FG000|Overall Study|Did not complete PET/MRI|0|||
130542622|NCT01892540|469952265|FG001|Overall Study|Did not complete PET/MRI|0|||
130542623|NCT01892540|469952266|FG002|Overall Study|Did not complete PET/MRI|2|||
130542624|NCT01892540|469952264|FG000|Overall Study|Did not fit in scanner|0|||
130542625|NCT01892540|469952265|FG001|Overall Study|Did not fit in scanner|0|||
130542626|NCT01892540|469952266|FG002|Overall Study|Did not fit in scanner|1|||
130542627|NCT01370590|469952267|FG000|Period 1|Adverse Event|8|||
130542628|NCT01370590|469952268|FG001|Period 1|Adverse Event|4|||
130542629|NCT01370590|469952267|FG000|Period 1|Lost to Follow-up|2|||
130542630|NCT01370590|469952268|FG001|Period 1|Lost to Follow-up|2|||
130542631|NCT01370590|469952267|FG000|Period 1|Protocol Violation|2|||
130542632|NCT01370590|469952268|FG001|Period 1|Protocol Violation|2|||
130542633|NCT01370590|469952267|FG000|Period 1|Withdrawal by Subject|4|||
130542634|NCT01370590|469952268|FG001|Period 1|Withdrawal by Subject|2|||
130542635|NCT01370590|469952267|FG000|Period 1|Could not access randomization system|0|||
130542636|NCT01370590|469952268|FG001|Period 1|Could not access randomization system|1|||
130542637|NCT01370590|469952267|FG000|Crossover Washout Period|Adverse Event|1|||
130542638|NCT01370590|469952268|FG001|Crossover Washout Period|Adverse Event|4|||
130542639|NCT01370590|469952267|FG000|Crossover Washout Period|Lost to Follow-up|2|||
130542640|NCT01370590|469952268|FG001|Crossover Washout Period|Lost to Follow-up|0|||
130542641|NCT01370590|469952267|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
130542642|NCT01370590|469952268|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
130542643|NCT01370590|469952267|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
130542644|NCT01370590|469952268|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
130542645|NCT01370590|469952267|FG000|Period 2|Adverse Event|0|||
130542646|NCT01370590|469952268|FG001|Period 2|Adverse Event|1|||
130542647|NCT01370590|469952267|FG000|Period 2|Withdrawal by Subject|1|||
130542648|NCT01370590|469952268|FG001|Period 2|Withdrawal by Subject|1|||
130542649|NCT05172050|469952269|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
130542650|NCT05172050|469952270|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
130542651|NCT05172050|469952271|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
130542652|NCT05172050|469952269|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
130542653|NCT05172050|469952270|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
130542654|NCT05172050|469952271|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
130542655|NCT05172050|469952269|FG000|Overall Study|Other|2|||
130542656|NCT05172050|469952270|FG001|Overall Study|Other|2|||
130542657|NCT05172050|469952271|FG002|Overall Study|Other|1|||
130542658|NCT05180500|469952274|FG000|Overall Study|Adverse Event|1|||
130542659|NCT05180500|469952275|FG001|Overall Study|Adverse Event|0|||
130542660|NCT05180500|469952274|FG000|Overall Study|Withdrawal by Subject|2|||
130542661|NCT05180500|469952275|FG001|Overall Study|Withdrawal by Subject|0|||
130542662|NCT04617275|469952276|FG000|Treatment Period|Adverse Event|1|||
130542663|NCT04617275|469952277|FG001|Treatment Period|Adverse Event|6|||
130542664|NCT04617275|469952278|FG002|Treatment Period|Adverse Event|4|||
130542665|NCT04617275|469952279|FG003|Treatment Period|Adverse Event|6|||
130542666|NCT04617275|469952280|FG004|Treatment Period|Adverse Event|7|||
130542667|NCT04617275|469952281|FG005|Treatment Period|Adverse Event|8|||
130542668|NCT04617275|469952282|FG006|Treatment Period|Adverse Event|0|||
130542669|NCT04617275|469952283|FG007|Treatment Period|Adverse Event|12|||
130542670|NCT04617275|469952276|FG000|Treatment Period|Lost to Follow-up|0|||
130542671|NCT04617275|469952277|FG001|Treatment Period|Lost to Follow-up|0|||
130542672|NCT04617275|469952278|FG002|Treatment Period|Lost to Follow-up|2|||
130542673|NCT04617275|469952279|FG003|Treatment Period|Lost to Follow-up|0|||
130542674|NCT04617275|469952280|FG004|Treatment Period|Lost to Follow-up|0|||
130542675|NCT04617275|469952281|FG005|Treatment Period|Lost to Follow-up|3|||
130542676|NCT04617275|469952282|FG006|Treatment Period|Lost to Follow-up|0|||
130542677|NCT04617275|469952283|FG007|Treatment Period|Lost to Follow-up|2|||
130542678|NCT04617275|469952276|FG000|Treatment Period|No longer meets eligibility criteria|0|||
130542679|NCT04617275|469952277|FG001|Treatment Period|No longer meets eligibility criteria|0|||
130542680|NCT04617275|469952278|FG002|Treatment Period|No longer meets eligibility criteria|0|||
130542681|NCT04617275|469952279|FG003|Treatment Period|No longer meets eligibility criteria|1|||
130542682|NCT04617275|469952280|FG004|Treatment Period|No longer meets eligibility criteria|0|||
130542683|NCT04617275|469952281|FG005|Treatment Period|No longer meets eligibility criteria|0|||
130542684|NCT04617275|469952282|FG006|Treatment Period|No longer meets eligibility criteria|0|||
130542685|NCT04617275|469952283|FG007|Treatment Period|No longer meets eligibility criteria|0|||
130542686|NCT04617275|469952276|FG000|Treatment Period|Other|0|||
130542687|NCT04617275|469952277|FG001|Treatment Period|Other|1|||
130542688|NCT04617275|469952278|FG002|Treatment Period|Other|0|||
130542689|NCT04617275|469952279|FG003|Treatment Period|Other|0|||
130542690|NCT04617275|469952280|FG004|Treatment Period|Other|0|||
130542691|NCT04617275|469952281|FG005|Treatment Period|Other|0|||
130542692|NCT04617275|469952282|FG006|Treatment Period|Other|0|||
130542693|NCT04617275|469952283|FG007|Treatment Period|Other|0|||
130542694|NCT04617275|469952276|FG000|Treatment Period|Withdrawal by Subject|2|||
130542695|NCT04617275|469952277|FG001|Treatment Period|Withdrawal by Subject|0|||
130542696|NCT04617275|469952278|FG002|Treatment Period|Withdrawal by Subject|0|||
130542697|NCT04617275|469952279|FG003|Treatment Period|Withdrawal by Subject|2|||
130542698|NCT04617275|469952280|FG004|Treatment Period|Withdrawal by Subject|2|||
130542699|NCT04617275|469952281|FG005|Treatment Period|Withdrawal by Subject|0|||
130542700|NCT04617275|469952282|FG006|Treatment Period|Withdrawal by Subject|1|||
130542701|NCT04617275|469952283|FG007|Treatment Period|Withdrawal by Subject|2|||
130542702|NCT04617275|469952276|FG000|Follow-up Period|Adverse Event|1|||
130542703|NCT04617275|469952277|FG001|Follow-up Period|Adverse Event|1|||
130542704|NCT04617275|469952278|FG002|Follow-up Period|Adverse Event|2|||
130542705|NCT04617275|469952279|FG003|Follow-up Period|Adverse Event|3|||
130542706|NCT04617275|469952280|FG004|Follow-up Period|Adverse Event|4|||
130542707|NCT04617275|469952281|FG005|Follow-up Period|Adverse Event|3|||
130542708|NCT04617275|469952282|FG006|Follow-up Period|Adverse Event|0|||
130542709|NCT04617275|469952283|FG007|Follow-up Period|Adverse Event|3|||
130542710|NCT04617275|469952276|FG000|Follow-up Period|Lost to Follow-up|0|||
130542711|NCT04617275|469952277|FG001|Follow-up Period|Lost to Follow-up|1|||
130542712|NCT04617275|469952278|FG002|Follow-up Period|Lost to Follow-up|2|||
130542713|NCT04617275|469952279|FG003|Follow-up Period|Lost to Follow-up|0|||
130542714|NCT04617275|469952280|FG004|Follow-up Period|Lost to Follow-up|0|||
130542715|NCT04617275|469952281|FG005|Follow-up Period|Lost to Follow-up|4|||
130542716|NCT04617275|469952282|FG006|Follow-up Period|Lost to Follow-up|0|||
130542717|NCT04617275|469952283|FG007|Follow-up Period|Lost to Follow-up|3|||
130542718|NCT04617275|469952276|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
130542719|NCT04617275|469952277|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
130542720|NCT04617275|469952278|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
130542721|NCT04617275|469952279|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
130542722|NCT04617275|469952280|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
130542723|NCT04617275|469952281|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
130542724|NCT04617275|469952282|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
130542725|NCT04617275|469952283|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
130542726|NCT04617275|469952276|FG000|Follow-up Period|Other|0|||
130542727|NCT04617275|469952277|FG001|Follow-up Period|Other|1|||
130542728|NCT04617275|469952278|FG002|Follow-up Period|Other|0|||
130542729|NCT04617275|469952279|FG003|Follow-up Period|Other|0|||
130542730|NCT04617275|469952280|FG004|Follow-up Period|Other|0|||
130542731|NCT04617275|469952281|FG005|Follow-up Period|Other|0|||
130542732|NCT04617275|469952282|FG006|Follow-up Period|Other|0|||
130542733|NCT04617275|469952283|FG007|Follow-up Period|Other|0|||
130542734|NCT04617275|469952276|FG000|Follow-up Period|Withdrawal by Subject|2|||
130542735|NCT04617275|469952277|FG001|Follow-up Period|Withdrawal by Subject|0|||
130542736|NCT04617275|469952278|FG002|Follow-up Period|Withdrawal by Subject|0|||
130542737|NCT04617275|469952279|FG003|Follow-up Period|Withdrawal by Subject|2|||
130542738|NCT04617275|469952280|FG004|Follow-up Period|Withdrawal by Subject|2|||
130542739|NCT04617275|469952281|FG005|Follow-up Period|Withdrawal by Subject|0|||
130542740|NCT04617275|469952282|FG006|Follow-up Period|Withdrawal by Subject|1|||
130542741|NCT04617275|469952283|FG007|Follow-up Period|Withdrawal by Subject|2|||
130542742|NCT04927884|469952287|FG000|Overall Study|Progressive Disease|2|||
130542743|NCT02317432|469952288|FG000|Overall Study|Death|4|||
130542744|NCT02317432|469952289|FG001|Overall Study|Death|1|||
130542745|NCT02317432|469952288|FG000|Overall Study|Lost to Follow-up|0|||
130542746|NCT02317432|469952289|FG001|Overall Study|Lost to Follow-up|5|||
130542747|NCT02317432|469952288|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
130542748|NCT02317432|469952289|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
130542749|NCT05593445|469952290|FG000|12-Week DBVC Period|Adverse Event|1|||
130542750|NCT05593445|469952291|FG001|12-Week DBVC Period|Adverse Event|0|||
130542751|NCT05593445|469952292|FG002|12-Week DBVC Period|Adverse Event|0|||
130542752|NCT05593445|469952293|FG003|12-Week DBVC Period|Adverse Event|0|||
130542753|NCT05593445|469952290|FG000|12-Week DBVC Period|Physician Decision|0|||
130542754|NCT05593445|469952291|FG001|12-Week DBVC Period|Physician Decision|1|||
130542755|NCT05593445|469952292|FG002|12-Week DBVC Period|Physician Decision|0|||
130542756|NCT05593445|469952293|FG003|12-Week DBVC Period|Physician Decision|0|||
130542757|NCT05593445|469952290|FG000|12-Week DBVC Period|Protocol Violation|0|||
130542758|NCT05593445|469952291|FG001|12-Week DBVC Period|Protocol Violation|1|||
130542759|NCT05593445|469952292|FG002|12-Week DBVC Period|Protocol Violation|0|||
130542760|NCT05593445|469952293|FG003|12-Week DBVC Period|Protocol Violation|0|||
130542761|NCT05593445|469952290|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
130542762|NCT05593445|469952291|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
130542763|NCT05593445|469952292|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
130542764|NCT05593445|469952293|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
130542765|NCT05593445|469952290|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
130542766|NCT05593445|469952291|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
130542767|NCT05593445|469952292|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
130542768|NCT05593445|469952293|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
130542769|NCT05593445|469952290|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
130542770|NCT05593445|469952291|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
130542771|NCT05593445|469952292|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
130542772|NCT05593445|469952293|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
130542773|NCT05593445|469952290|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
130542774|NCT05593445|469952291|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
130542775|NCT05593445|469952292|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
130542776|NCT05593445|469952293|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
130542777|NCT05593445|469952290|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130542778|NCT05593445|469952291|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130542779|NCT05593445|469952292|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
130542780|NCT05593445|469952293|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130542781|NCT05559476|469952296|FG000|Overall Study|Adverse Event|2|||
130542782|NCT05559476|469952297|FG001|Overall Study|Adverse Event|0|||
130542783|NCT05559476|469952296|FG000|Overall Study|Lost to Follow-up|13|||
130542784|NCT05559476|469952297|FG001|Overall Study|Lost to Follow-up|12|||
130542785|NCT05559476|469952296|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
130542786|NCT05559476|469952297|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
130542787|NCT05559476|469952296|FG000|Overall Study|Other|0|||
130542788|NCT05559476|469952297|FG001|Overall Study|Other|2|||
130542789|NCT00727311|469952298|FG000|Overall Study|Did not receive drug|316|||
130542790|NCT00727311|469952298|FG000|Overall Study|Missing end of therapy data|205|||
130542791|NCT00727311|469952298|FG000|Overall Study|Adverse Event|58|||
130542792|NCT00727311|469952298|FG000|Overall Study|Lack of Efficacy|242|||
130542793|NCT00727311|469952298|FG000|Overall Study|Lost to Follow-up|73|||
130542794|NCT00727311|469952298|FG000|Overall Study|Withdrawal by Subject|77|||
130542795|NCT00727311|469952298|FG000|Overall Study|Other|97|||
130542796|NCT00727311|469952298|FG000|Overall Study|Multiple reasons|39|||
130542797|NCT03992846|469952299|FG000|Overall Study|Adverse Event|8|||
130542798|NCT03992846|469952300|FG001|Overall Study|Adverse Event|6|||
130542799|NCT03992846|469952301|FG002|Overall Study|Adverse Event|3|||
130542800|NCT03992846|469952299|FG000|Overall Study|Lost to Follow-up|0|||
130542801|NCT03992846|469952300|FG001|Overall Study|Lost to Follow-up|1|||
130542802|NCT03992846|469952301|FG002|Overall Study|Lost to Follow-up|1|||
130542803|NCT03992846|469952299|FG000|Overall Study|Pregnancy|2|||
130542804|NCT03992846|469952300|FG001|Overall Study|Pregnancy|0|||
130542805|NCT03992846|469952301|FG002|Overall Study|Pregnancy|1|||
130542806|NCT03992846|469952299|FG000|Overall Study|Protocol Violation|1|||
130542807|NCT03992846|469952300|FG001|Overall Study|Protocol Violation|2|||
130542808|NCT03992846|469952301|FG002|Overall Study|Protocol Violation|0|||
130542809|NCT03992846|469952299|FG000|Overall Study|Withdrawal by Subject|8|||
130542810|NCT03992846|469952300|FG001|Overall Study|Withdrawal by Subject|10|||
130542811|NCT03992846|469952301|FG002|Overall Study|Withdrawal by Subject|20|||
130542812|NCT03992846|469952299|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
130542813|NCT03992846|469952300|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
130542814|NCT03992846|469952301|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
130542815|NCT04058366|469953771|FG000|Overall Study|Adverse Event|14|||
130542816|NCT04058366|469953771|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
130542817|NCT04058366|469953771|FG000|Overall Study|Commercial drug is available for participants|6|||
130542818|NCT04058366|469953771|FG000|Overall Study|Death|1|||
130542819|NCT04058366|469953771|FG000|Overall Study|Other non-compliance|2|||
130542820|NCT04058366|469953771|FG000|Overall Study|Other|6|||
130542821|NCT00734097|469953772|FG000|Screening|Protocol Violation|12|||
130542822|NCT00734097|469953772|FG000|Screening|Withdrawal by Subject|5|||
130542823|NCT00734097|469953772|FG000|Screening|Lost to Follow-up|2|||
130542824|NCT00734097|469953772|FG000|Screening|Unconfirmed pregnancy|1|||
130542825|NCT00734097|469953772|FG000|Open Label|Lost to Follow-up|7|||
130542826|NCT00734097|469953772|FG000|Open Label|Withdrawal by Subject|5|||
130542827|NCT00734097|469953772|FG000|Open Label|Protocol Violation|4|||
130542828|NCT02233543|469953775|FG000|Period 1|Withdrawal by Subject|1|||
130542829|NCT02233543|469953776|FG001|Period 1|Withdrawal by Subject|0|||
130542830|NCT02233543|469953775|FG000|Period 1|Participants required other treatment.|2|||
130542831|NCT02233543|469953776|FG001|Period 1|Participants required other treatment.|3|||
130542832|NCT02233543|469953775|FG000|Period 2|Adverse Event|1|||
130542833|NCT02233543|469953776|FG001|Period 2|Adverse Event|0|||
130542834|NCT02233543|469953775|FG000|Period 2|Participant required other treatment.|0|||
130542835|NCT02233543|469953776|FG001|Period 2|Participant required other treatment.|1|||
130542836|NCT02233543|469953775|FG000|Period 2|COPD exacerbation|1|||
130542837|NCT02233543|469953776|FG001|Period 2|COPD exacerbation|0|||
130542838|NCT00603304|469953777|FG000|Overall Study|Lost to Follow-up|5|||
130542839|NCT00603304|469953778|FG001|Overall Study|Lost to Follow-up|7|||
130542840|NCT00603304|469953777|FG000|Overall Study|Withdrawal by Subject|8|||
130542841|NCT00603304|469953778|FG001|Overall Study|Withdrawal by Subject|5|||
130542842|NCT00603304|469953777|FG000|Overall Study|Protocol Violation|1|||
130542843|NCT00603304|469953778|FG001|Overall Study|Protocol Violation|0|||
130542844|NCT00603304|469953777|FG000|Overall Study|Adverse Event|4|||
130542845|NCT00603304|469953778|FG001|Overall Study|Adverse Event|2|||
130542846|NCT00603304|469953777|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
130542847|NCT00603304|469953778|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
130542848|NCT00603304|469953777|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
130542849|NCT00603304|469953778|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
130542850|NCT00603304|469953777|FG000|Overall Study|Exclusionary Medication|2|||
130542851|NCT00603304|469953778|FG001|Overall Study|Exclusionary Medication|3|||
130542852|NCT00603304|469953777|FG000|Overall Study|Non-Compliant|0|||
130542853|NCT00603304|469953778|FG001|Overall Study|Non-Compliant|1|||
130542854|NCT00603304|469953777|FG000|Overall Study|Moved Away|0|||
130542855|NCT00603304|469953778|FG001|Overall Study|Moved Away|2|||
130542856|NCT00603304|469953777|FG000|Overall Study|Other|2|||
130542857|NCT00603304|469953778|FG001|Overall Study|Other|0|||
130542858|NCT00603304|469953777|FG000|Overall Study|Patient Decision|2|||
130542859|NCT00603304|469953778|FG001|Overall Study|Patient Decision|0|||
130542860|NCT00616902|469953779|FG000|Overall Study|Termination of study|6|||
130542861|NCT00616902|469953780|FG001|Overall Study|Termination of study|6|||
130542862|NCT03573583|469953781|FG000|Overall Study|Lost to Follow-up|1|||
130542863|NCT03573583|469953782|FG001|Overall Study|Lost to Follow-up|0|||
130542864|NCT03573583|469953781|FG000|Overall Study|Withdrawal by Subject|1|||
130542865|NCT03573583|469953782|FG001|Overall Study|Withdrawal by Subject|1|||
130542866|NCT04343872|469953787|FG000|Overall Study|Lost to Follow-up|6|||
130542867|NCT04343872|469953788|FG001|Overall Study|Lost to Follow-up|3|||
130542868|NCT01850446|469953789|FG000|Overall Study|Lack of Efficacy|1|||
130542869|NCT01850446|469953790|FG001|Overall Study|Lack of Efficacy|0|||
130542870|NCT01850446|469953789|FG000|Overall Study|Withdrawal by Subject|4|||
130542871|NCT01850446|469953790|FG001|Overall Study|Withdrawal by Subject|0|||
130542872|NCT01850446|469953789|FG000|Overall Study|Protocol Violation|0|||
130542873|NCT01850446|469953790|FG001|Overall Study|Protocol Violation|2|||
130542874|NCT00759915|469953791|FG000|Overall Study|Withdrawal by Subject|1|||
130542875|NCT00759915|469953792|FG001|Overall Study|Withdrawal by Subject|0|||
130542876|NCT00759915|469953791|FG000|Overall Study|Adverse Event|0|||
130542877|NCT00759915|469953792|FG001|Overall Study|Adverse Event|1|||
130542878|NCT03730480|469953793|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
130542879|NCT01227577|469953794|FG000|Overall Study|Protocol deviation|3|||
130542880|NCT01227577|469953794|FG000|Overall Study|Death|3|||
130542881|NCT01227577|469953794|FG000|Overall Study|Administrative problems|2|||
130542882|NCT01227577|469953794|FG000|Overall Study|Lost to Follow-up|1|||
130542883|NCT01227577|469953794|FG000|Overall Study|Withdrawal by Subject|4|||
130542884|NCT01227577|469953794|FG000|Overall Study|Lack of Efficacy|5|||
130542885|NCT01227577|469953794|FG000|Overall Study|Adverse Event|17|||
130542886|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
130542887|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
130542888|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
130542889|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
130430144|NCT00642902|469536504|FG000|Overall Study|Lost to Follow-up|1|||
130542890|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
130542891|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
130542892|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
130542893|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
130542894|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
130542895|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
130542896|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
130542897|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
130542898|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
130542899|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
130542900|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
130542901|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
130542902|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
130542903|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
130542904|NCT02480153|469953795|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
130542905|NCT02480153|469953796|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
130542906|NCT02480153|469953797|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
130542907|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
130542908|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
130542909|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
130542910|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
130542911|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
130542912|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
130542913|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
130542914|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
130542915|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
130542916|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
130542917|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
130542918|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
130542919|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
130542920|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
130542921|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
130542922|NCT02480153|469953795|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
130542923|NCT02480153|469953796|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
130542924|NCT02480153|469953797|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
130542925|NCT02480153|469953795|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
130542926|NCT02480153|469953796|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
130542927|NCT02480153|469953797|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
130542928|NCT02480153|469953795|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
130542929|NCT02480153|469953796|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
130542930|NCT02480153|469953797|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
130542931|NCT02480153|469953795|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
130542932|NCT02480153|469953796|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
130542933|NCT02480153|469953797|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
130542934|NCT02480153|469953795|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
130542935|NCT02480153|469953796|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
130542936|NCT02480153|469953797|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
130542937|NCT02480153|469953795|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
130652281|NCT03735680|470349382|FG001|Overall Study|Patient unable or unwilling to continue|0|||
130652282|NCT03735680|470349383|FG002|Overall Study|Patient unable or unwilling to continue|1|||
130652283|NCT03735680|470349384|FG003|Overall Study|Patient unable or unwilling to continue|0|||
130652284|NCT03735680|470349385|FG004|Overall Study|Patient unable or unwilling to continue|0|||
130652285|NCT03735680|470349386|FG005|Overall Study|Patient unable or unwilling to continue|0|||
130652286|NCT01422876|470349388|FG000|Week 24|Lost to Follow-up|1|||
130652287|NCT01422876|470349389|FG001|Week 24|Lost to Follow-up|1|||
130652288|NCT01422876|470349390|FG002|Week 24|Lost to Follow-up|2|||
130652289|NCT01422876|470349391|FG003|Week 24|Lost to Follow-up|4|||
130652290|NCT01422876|470349392|FG004|Week 24|Lost to Follow-up|2|||
130652291|NCT01422876|470349393|FG005|Week 24|Lost to Follow-up|0|||
130652292|NCT01422876|470349394|FG006|Week 24|Lost to Follow-up|1|||
130652293|NCT01422876|470349395|FG007|Week 24|Lost to Follow-up|3|||
130652294|NCT01422876|470349396|FG008|Week 24|Lost to Follow-up|3|||
130652295|NCT01422876|470349397|FG009|Week 24|Lost to Follow-up|4|||
130652296|NCT01422876|470349388|FG000|Week 24|Consent withdrawn|5|||
130652297|NCT01422876|470349389|FG001|Week 24|Consent withdrawn|1|||
130652298|NCT01422876|470349390|FG002|Week 24|Consent withdrawn|3|||
130652299|NCT01422876|470349391|FG003|Week 24|Consent withdrawn|4|||
130652300|NCT01422876|470349392|FG004|Week 24|Consent withdrawn|5|||
130207905|NCT01886781|468721033|FG001|Overall Study|Worsening of symptoms|1|||
130652301|NCT01422876|470349393|FG005|Week 24|Consent withdrawn|6|||
130652302|NCT01422876|470349394|FG006|Week 24|Consent withdrawn|5|||
130207906|NCT00424021|468721034|FG000|NCT00046319 Study Period|Adverse Event|1|||
130207907|NCT00424021|468721035|FG001|NCT00046319 Study Period|Adverse Event|0|||
130207908|NCT00424021|468721036|FG002|NCT00046319 Study Period|Adverse Event|1|||
130207909|NCT00424021|468721037|FG003|NCT00046319 Study Period|Adverse Event|1|||
130652303|NCT01422876|470349395|FG007|Week 24|Consent withdrawn|4|||
130652304|NCT01422876|470349396|FG008|Week 24|Consent withdrawn|3|||
130652305|NCT01422876|470349397|FG009|Week 24|Consent withdrawn|6|||
130652306|NCT01422876|470349388|FG000|Week 24|Death|0|||
130652307|NCT01422876|470349389|FG001|Week 24|Death|1|||
130652308|NCT01422876|470349390|FG002|Week 24|Death|0|||
130652309|NCT01422876|470349391|FG003|Week 24|Death|0|||
130652310|NCT01422876|470349392|FG004|Week 24|Death|0|||
130652311|NCT01422876|470349393|FG005|Week 24|Death|0|||
130652312|NCT01422876|470349394|FG006|Week 24|Death|0|||
130652313|NCT01422876|470349395|FG007|Week 24|Death|0|||
130652314|NCT01422876|470349396|FG008|Week 24|Death|0|||
130542938|NCT02480153|469953796|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
130542939|NCT02480153|469953797|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
130542940|NCT00512317|469953798|FG000|Overall Study|Insufficient clinical response|36|||
130542941|NCT00512317|469953798|FG000|Overall Study|Withdrawal by Subject|23|||
130542942|NCT00512317|469953798|FG000|Overall Study|Sponsor closure of study|21|||
130542943|NCT00512317|469953798|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
130542944|NCT00512317|469953798|FG000|Overall Study|Adverse Event|13|||
130542945|NCT00512317|469953798|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
130542946|NCT00512317|469953798|FG000|Overall Study|Lost to Follow-up|2|||
130542947|NCT00512317|469953798|FG000|Overall Study|Other|2|||
130542948|NCT01639495|469953799|FG000|Overall Study|Lost to Follow-up|6|||
130542949|NCT01639495|469953799|FG000|Overall Study|Consented but didn't have study catheter|4|||
130542950|NCT01639495|469953799|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
130542951|NCT01639495|469953799|FG000|Overall Study|No radiofrequency energy applied|2|||
130542952|NCT01775475|469953800|FG000|Overall Study|Death|3|||
130542953|NCT01775475|469953801|FG001|Overall Study|Death|3|||
130542954|NCT01813929|469953802|FG000|Overall Study|Withdrawal by Subject|0|||
130542955|NCT01813929|469953803|FG001|Overall Study|Withdrawal by Subject|1|||
130542956|NCT00007345|469953804|FG000|Overall Study|Refused further treatment|0|||
130542957|NCT00007345|469953805|FG001|Overall Study|Refused further treatment|7|||
130542958|NCT00007345|469953804|FG000|Overall Study|Switched to alternative treatment|0|||
130542959|NCT00007345|469953805|FG001|Overall Study|Switched to alternative treatment|3|||
130542960|NCT00007345|469953804|FG000|Overall Study|Intercurrent illness|1|||
130542961|NCT00007345|469953805|FG001|Overall Study|Intercurrent illness|0|||
130542962|NCT00007345|469953804|FG000|Overall Study|Death on study|1|||
130542963|NCT00007345|469953805|FG001|Overall Study|Death on study|1|||
130542964|NCT04433585|469953806|FG000|Overall Study|Withdrawal by Subject|15|||
130542965|NCT04433585|469953807|FG001|Overall Study|Withdrawal by Subject|3|||
130542966|NCT04433585|469953808|FG002|Overall Study|Withdrawal by Subject|15|||
130542967|NCT04433585|469953809|FG003|Overall Study|Withdrawal by Subject|6|||
130542968|NCT04433585|469953806|FG000|Overall Study|Adverse Event|10|||
130542969|NCT04433585|469953807|FG001|Overall Study|Adverse Event|4|||
130542970|NCT04433585|469953808|FG002|Overall Study|Adverse Event|1|||
130542971|NCT04433585|469953809|FG003|Overall Study|Adverse Event|0|||
130542972|NCT04433585|469953806|FG000|Overall Study|Due to the conflict in Ukraine|2|||
130542973|NCT04433585|469953807|FG001|Overall Study|Due to the conflict in Ukraine|1|||
130542974|NCT04433585|469953808|FG002|Overall Study|Due to the conflict in Ukraine|1|||
130542975|NCT04433585|469953809|FG003|Overall Study|Due to the conflict in Ukraine|2|||
130542976|NCT04433585|469953806|FG000|Overall Study|Physician Decision|1|||
130542977|NCT04433585|469953807|FG001|Overall Study|Physician Decision|2|||
130542978|NCT04433585|469953808|FG002|Overall Study|Physician Decision|0|||
130542979|NCT04433585|469953809|FG003|Overall Study|Physician Decision|0|||
130542980|NCT04433585|469953806|FG000|Overall Study|Lost to Follow-up|1|||
130542981|NCT04433585|469953807|FG001|Overall Study|Lost to Follow-up|1|||
130542982|NCT04433585|469953808|FG002|Overall Study|Lost to Follow-up|1|||
130542983|NCT04433585|469953809|FG003|Overall Study|Lost to Follow-up|0|||
130542984|NCT04433585|469953806|FG000|Overall Study|Lack of Efficacy|0|||
130542985|NCT04433585|469953807|FG001|Overall Study|Lack of Efficacy|1|||
130542986|NCT04433585|469953808|FG002|Overall Study|Lack of Efficacy|1|||
130542987|NCT04433585|469953809|FG003|Overall Study|Lack of Efficacy|1|||
130542988|NCT04433585|469953806|FG000|Overall Study|Death|0|||
130542989|NCT04433585|469953807|FG001|Overall Study|Death|1|||
130542990|NCT04433585|469953808|FG002|Overall Study|Death|0|||
130542991|NCT04433585|469953809|FG003|Overall Study|Death|0|||
130652315|NCT01422876|470349397|FG009|Week 24|Death|0|||
130652316|NCT01422876|470349388|FG000|Week 52|Lost to Follow-up|3|||
130542992|NCT02074553|469953810|FG000|Intervention Period 1|Family Emergency|0|||
130542993|NCT02074553|469953811|FG001|Intervention Period 1|Family Emergency|0|||
130652317|NCT01422876|470349389|FG001|Week 52|Lost to Follow-up|5|||
130652318|NCT01422876|470349390|FG002|Week 52|Lost to Follow-up|7|||
130652319|NCT01422876|470349391|FG003|Week 52|Lost to Follow-up|5|||
130652320|NCT01422876|470349392|FG004|Week 52|Lost to Follow-up|8|||
130542994|NCT02074553|469953812|FG002|Intervention Period 1|Family Emergency|0|||
130542995|NCT02074553|469953813|FG003|Intervention Period 1|Family Emergency|1|||
130542996|NCT02074553|469953814|FG004|Intervention Period 1|Family Emergency|0|||
130542997|NCT02074553|469953815|FG005|Intervention Period 1|Family Emergency|0|||
130542998|NCT02074553|469953816|FG006|Intervention Period 1|Family Emergency|0|||
130542999|NCT02074553|469953817|FG007|Intervention Period 1|Family Emergency|0|||
130430145|NCT00642902|469536505|FG001|Overall Study|Lost to Follow-up|1|||
130543000|NCT02074553|469953810|FG000|Washout Period 1|Adverse Event|1|||
130543001|NCT02074553|469953811|FG001|Washout Period 1|Adverse Event|0|||
130543002|NCT02074553|469953812|FG002|Washout Period 1|Adverse Event|0|||
130543003|NCT02074553|469953813|FG003|Washout Period 1|Adverse Event|0|||
130543004|NCT02074553|469953814|FG004|Washout Period 1|Adverse Event|0|||
130543005|NCT02074553|469953815|FG005|Washout Period 1|Adverse Event|0|||
130543006|NCT02074553|469953816|FG006|Washout Period 1|Adverse Event|0|||
130543007|NCT02074553|469953817|FG007|Washout Period 1|Adverse Event|0|||
130543008|NCT02074553|469953810|FG000|Washout Period 1|Physician Decision|0|||
130543009|NCT02074553|469953811|FG001|Washout Period 1|Physician Decision|0|||
130543010|NCT02074553|469953812|FG002|Washout Period 1|Physician Decision|0|||
130543011|NCT02074553|469953813|FG003|Washout Period 1|Physician Decision|1|||
130543012|NCT02074553|469953814|FG004|Washout Period 1|Physician Decision|0|||
130543013|NCT02074553|469953815|FG005|Washout Period 1|Physician Decision|0|||
130543014|NCT02074553|469953816|FG006|Washout Period 1|Physician Decision|0|||
130543015|NCT02074553|469953817|FG007|Washout Period 1|Physician Decision|0|||
130543016|NCT02074553|469953810|FG000|Washout Period 1|Other|0|||
130543017|NCT02074553|469953811|FG001|Washout Period 1|Other|0|||
130543018|NCT02074553|469953812|FG002|Washout Period 1|Other|0|||
130543019|NCT02074553|469953813|FG003|Washout Period 1|Other|0|||
130543020|NCT02074553|469953814|FG004|Washout Period 1|Other|0|||
130543021|NCT02074553|469953815|FG005|Washout Period 1|Other|1|||
130543022|NCT02074553|469953816|FG006|Washout Period 1|Other|0|||
130543023|NCT02074553|469953817|FG007|Washout Period 1|Other|0|||
130543024|NCT02074553|469953810|FG000|Washout Period 2|Adverse Event|0|||
130543025|NCT02074553|469953811|FG001|Washout Period 2|Adverse Event|0|||
130543026|NCT02074553|469953812|FG002|Washout Period 2|Adverse Event|0|||
130543027|NCT02074553|469953813|FG003|Washout Period 2|Adverse Event|0|||
130543028|NCT02074553|469953814|FG004|Washout Period 2|Adverse Event|0|||
130543029|NCT02074553|469953815|FG005|Washout Period 2|Adverse Event|0|||
130543030|NCT02074553|469953816|FG006|Washout Period 2|Adverse Event|1|||
130543031|NCT02074553|469953817|FG007|Washout Period 2|Adverse Event|0|||
130543032|NCT02074553|469953810|FG000|Washout Period 2|Physician Decision|0|||
130543033|NCT02074553|469953811|FG001|Washout Period 2|Physician Decision|0|||
130543034|NCT02074553|469953812|FG002|Washout Period 2|Physician Decision|0|||
130543035|NCT02074553|469953813|FG003|Washout Period 2|Physician Decision|0|||
130543036|NCT02074553|469953814|FG004|Washout Period 2|Physician Decision|0|||
130543037|NCT02074553|469953815|FG005|Washout Period 2|Physician Decision|1|||
130543038|NCT02074553|469953816|FG006|Washout Period 2|Physician Decision|0|||
130543039|NCT02074553|469953817|FG007|Washout Period 2|Physician Decision|0|||
130543040|NCT02074553|469953810|FG000|Washout Period 2|Lost to Follow-up|0|||
130543041|NCT02074553|469953811|FG001|Washout Period 2|Lost to Follow-up|0|||
130543042|NCT02074553|469953812|FG002|Washout Period 2|Lost to Follow-up|1|||
130543043|NCT02074553|469953813|FG003|Washout Period 2|Lost to Follow-up|0|||
130543044|NCT02074553|469953814|FG004|Washout Period 2|Lost to Follow-up|0|||
130543045|NCT02074553|469953815|FG005|Washout Period 2|Lost to Follow-up|0|||
130543046|NCT02074553|469953816|FG006|Washout Period 2|Lost to Follow-up|0|||
130543047|NCT02074553|469953817|FG007|Washout Period 2|Lost to Follow-up|0|||
130543048|NCT02074553|469953810|FG000|Washout Period 3|Physician Decision|0|||
130543049|NCT02074553|469953811|FG001|Washout Period 3|Physician Decision|0|||
130543050|NCT02074553|469953812|FG002|Washout Period 3|Physician Decision|0|||
130543051|NCT02074553|469953813|FG003|Washout Period 3|Physician Decision|0|||
130543052|NCT02074553|469953814|FG004|Washout Period 3|Physician Decision|0|||
130543053|NCT02074553|469953815|FG005|Washout Period 3|Physician Decision|0|||
130543054|NCT02074553|469953816|FG006|Washout Period 3|Physician Decision|0|||
130543055|NCT02074553|469953817|FG007|Washout Period 3|Physician Decision|1|||
130543056|NCT01658150|469953818|FG000|Overall Study|Withdrawal by Subject|1|||
130543057|NCT02342743|469953819|FG000|Baseline Period|Withdrawal by Subject|3|||
130543058|NCT02342743|469953819|FG000|Baseline Period|Lost to Follow-up|2|||
130543059|NCT02342743|469953819|FG000|Baseline Period|Change in prophylactic medication|3|||
130543060|NCT02342743|469953819|FG000|Baseline Period|Screening failure regarding baseline|7|||
130543061|NCT02342743|469953819|FG000|Treatment Period|Withdrawal by Subject|2|||
130543062|NCT02342743|469953819|FG000|Treatment Period|Lost to Follow-up|8|||
130543063|NCT02342743|469953819|FG000|Treatment Period|Change in prophylactic medication|1|||
130543064|NCT04875676|469953820|FG000|Overall Study|Lost to Follow-up|1|||
130543065|NCT04875676|469953821|FG001|Overall Study|Lost to Follow-up|0|||
130543066|NCT04875676|469953822|FG002|Overall Study|Lost to Follow-up|0|||
130543067|NCT04187989|469953823|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
130652321|NCT01422876|470349393|FG005|Week 52|Lost to Follow-up|5|||
130652322|NCT01422876|470349394|FG006|Week 52|Lost to Follow-up|5|||
130652323|NCT01422876|470349395|FG007|Week 52|Lost to Follow-up|8|||
130652324|NCT01422876|470349396|FG008|Week 52|Lost to Follow-up|7|||
130652325|NCT01422876|470349397|FG009|Week 52|Lost to Follow-up|8|||
130652326|NCT01422876|470349388|FG000|Week 52|Consent withdrawn|9|||
130652327|NCT01422876|470349389|FG001|Week 52|Consent withdrawn|4|||
130652328|NCT01422876|470349390|FG002|Week 52|Consent withdrawn|6|||
130652329|NCT01422876|470349391|FG003|Week 52|Consent withdrawn|12|||
130652330|NCT01422876|470349392|FG004|Week 52|Consent withdrawn|7|||
130652331|NCT01422876|470349393|FG005|Week 52|Consent withdrawn|12|||
130652332|NCT01422876|470349394|FG006|Week 52|Consent withdrawn|10|||
130652333|NCT01422876|470349395|FG007|Week 52|Consent withdrawn|12|||
130652334|NCT01422876|470349396|FG008|Week 52|Consent withdrawn|13|||
130543068|NCT04187989|469953824|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
130543069|NCT04187989|469953823|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
130652335|NCT01422876|470349397|FG009|Week 52|Consent withdrawn|9|||
130652336|NCT01422876|470349388|FG000|Week 52|Death|0|||
130652337|NCT01422876|470349389|FG001|Week 52|Death|1|||
130652338|NCT01422876|470349390|FG002|Week 52|Death|0|||
130652339|NCT01422876|470349391|FG003|Week 52|Death|1|||
130652340|NCT01422876|470349392|FG004|Week 52|Death|0|||
130652341|NCT01422876|470349393|FG005|Week 52|Death|0|||
130652342|NCT01422876|470349394|FG006|Week 52|Death|1|||
130652343|NCT01422876|470349395|FG007|Week 52|Death|3|||
130652344|NCT01422876|470349396|FG008|Week 52|Death|1|||
130652345|NCT01422876|470349397|FG009|Week 52|Death|0|||
130652346|NCT00536991|470349409|FG000|Overall Study|Withdrawal by Subject|10|||
130543070|NCT04187989|469953824|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
130543071|NCT03646656|469953825|FG000|Overall Study|Lost to Follow-up|1|||
130543072|NCT03646656|469953826|FG001|Overall Study|Lost to Follow-up|0|||
130543073|NCT03646656|469953825|FG000|Overall Study|Withdrawal by Subject|2|||
130543074|NCT03646656|469953826|FG001|Overall Study|Withdrawal by Subject|0|||
130543075|NCT03602066|469953827|FG000|Overall Study|Withdrawal by Subject|2|||
130543076|NCT03602066|469953828|FG001|Overall Study|Withdrawal by Subject|0|||
130543077|NCT03602066|469953827|FG000|Overall Study|Physician Decision|1|||
130543078|NCT03602066|469953828|FG001|Overall Study|Physician Decision|0|||
130543079|NCT00092495|469953829|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
130543080|NCT00092495|469953830|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
130543081|NCT00092495|469953831|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130543082|NCT00092495|469953832|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
130543083|NCT00092495|469953833|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130543084|NCT00092495|469953829|FG000|Base Study Vaccination Period|Extended|0|||
130543085|NCT00092495|469953830|FG001|Base Study Vaccination Period|Extended|0|||
130543086|NCT00092495|469953831|FG002|Base Study Vaccination Period|Extended|0|||
130543087|NCT00092495|469953832|FG003|Base Study Vaccination Period|Extended|1|||
130543088|NCT00092495|469953833|FG004|Base Study Vaccination Period|Extended|0|||
130543089|NCT00092495|469953829|FG000|Base Study Vaccination Period|*Clinical AE|1|||
130543090|NCT00092495|469953830|FG001|Base Study Vaccination Period|*Clinical AE|0|||
130543091|NCT00092495|469953831|FG002|Base Study Vaccination Period|*Clinical AE|1|||
130543092|NCT00092495|469953832|FG003|Base Study Vaccination Period|*Clinical AE|2|||
130543093|NCT00092495|469953833|FG004|Base Study Vaccination Period|*Clinical AE|0|||
130543094|NCT00092495|469953829|FG000|Base Study Vaccination Period|*Other reasons|1|||
130543095|NCT00092495|469953830|FG001|Base Study Vaccination Period|*Other reasons|0|||
130543096|NCT00092495|469953831|FG002|Base Study Vaccination Period|*Other reasons|0|||
130543097|NCT00092495|469953832|FG003|Base Study Vaccination Period|*Other reasons|1|||
130543098|NCT00092495|469953833|FG004|Base Study Vaccination Period|*Other reasons|0|||
130543099|NCT00092495|469953829|FG000|Base Study Vaccination Period|*Pregnancy|0|||
130543100|NCT00092495|469953830|FG001|Base Study Vaccination Period|*Pregnancy|2|||
130543101|NCT00092495|469953831|FG002|Base Study Vaccination Period|*Pregnancy|5|||
130543102|NCT00092495|469953832|FG003|Base Study Vaccination Period|*Pregnancy|7|||
130543103|NCT00092495|469953833|FG004|Base Study Vaccination Period|*Pregnancy|0|||
130543104|NCT00092495|469953829|FG000|Base Study Vaccination Period|Adverse Event|1|||
130543105|NCT00092495|469953830|FG001|Base Study Vaccination Period|Adverse Event|0|||
130543106|NCT00092495|469953831|FG002|Base Study Vaccination Period|Adverse Event|0|||
130543107|NCT00092495|469953832|FG003|Base Study Vaccination Period|Adverse Event|3|||
130543108|NCT00092495|469953833|FG004|Base Study Vaccination Period|Adverse Event|0|||
130543109|NCT00092495|469953829|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
130543110|NCT00092495|469953830|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
130543111|NCT00092495|469953831|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
130543112|NCT00092495|469953832|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
130652347|NCT00536991|470349409|FG000|Overall Study|Physician Decision|1|||
130652348|NCT00536991|470349409|FG000|Overall Study|patient ineligible|2|||
130652349|NCT00054639|470349410|FG000|Overall Study|Lack of Efficacy|1|||
130652350|NCT00054639|470349410|FG000|Overall Study|Physician Decision|1|||
130652351|NCT01600755|470349411|FG000|Overall Study|Withdrawal by Subject|6|||
130430146|NCT00642902|469536506|FG002|Overall Study|Lost to Follow-up|0|||
130543113|NCT00092495|469953833|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130543114|NCT00092495|469953829|FG000|Base Study Vaccination Period|Moved|3|||
130543115|NCT00092495|469953830|FG001|Base Study Vaccination Period|Moved|1|||
130543116|NCT00092495|469953831|FG002|Base Study Vaccination Period|Moved|2|||
130543117|NCT00092495|469953832|FG003|Base Study Vaccination Period|Moved|2|||
130543118|NCT00092495|469953833|FG004|Base Study Vaccination Period|Moved|0|||
130543119|NCT00092495|469953829|FG000|Base Study Vaccination Period|Other|1|||
130543120|NCT00092495|469953830|FG001|Base Study Vaccination Period|Other|1|||
130543121|NCT00092495|469953831|FG002|Base Study Vaccination Period|Other|0|||
130543122|NCT00092495|469953832|FG003|Base Study Vaccination Period|Other|2|||
130543123|NCT00092495|469953833|FG004|Base Study Vaccination Period|Other|0|||
130543124|NCT00092495|469953829|FG000|Base Study Vaccination Period|Pregnancy|2|||
130543125|NCT00092495|469953830|FG001|Base Study Vaccination Period|Pregnancy|0|||
130543126|NCT00092495|469953831|FG002|Base Study Vaccination Period|Pregnancy|0|||
130543127|NCT00092495|469953832|FG003|Base Study Vaccination Period|Pregnancy|0|||
130543128|NCT00092495|469953833|FG004|Base Study Vaccination Period|Pregnancy|0|||
130543129|NCT00092495|469953829|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
130543130|NCT00092495|469953830|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
130543131|NCT00092495|469953831|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
130543132|NCT00092495|469953832|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
130543133|NCT00092495|469953833|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
130543134|NCT00092495|469953829|FG000|Base Study Vaccination Period|Protocol Violation|1|||
130543135|NCT00092495|469953830|FG001|Base Study Vaccination Period|Protocol Violation|0|||
130543136|NCT00092495|469953831|FG002|Base Study Vaccination Period|Protocol Violation|0|||
130543137|NCT00092495|469953832|FG003|Base Study Vaccination Period|Protocol Violation|0|||
130543138|NCT00092495|469953833|FG004|Base Study Vaccination Period|Protocol Violation|0|||
130543139|NCT00092495|469953829|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
130543140|NCT00092495|469953830|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
130543141|NCT00092495|469953831|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
130543142|NCT00092495|469953832|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
130543143|NCT00092495|469953833|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130543144|NCT00092495|469953829|FG000|Base Study Follow-up Period|Extended|0|||
130543145|NCT00092495|469953830|FG001|Base Study Follow-up Period|Extended|0|||
130543146|NCT00092495|469953831|FG002|Base Study Follow-up Period|Extended|1|||
130543147|NCT00092495|469953832|FG003|Base Study Follow-up Period|Extended|2|||
130543148|NCT00092495|469953833|FG004|Base Study Follow-up Period|Extended|0|||
130543149|NCT00092495|469953829|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
130543150|NCT00092495|469953830|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
130543151|NCT00092495|469953831|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
130543152|NCT00092495|469953832|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
130543153|NCT00092495|469953833|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130543154|NCT00092495|469953829|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
130543155|NCT00092495|469953830|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
130543156|NCT00092495|469953831|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130543157|NCT00092495|469953832|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130543158|NCT00092495|469953833|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130543159|NCT00938470|469953840|FG000|Overall Study|Disease Progression|3|||
130543160|NCT00938470|469953841|FG001|Overall Study|Disease Progression|0|||
130543161|NCT00938470|469953840|FG000|Overall Study|Alternate Treatment|1|||
130543162|NCT00938470|469953841|FG001|Overall Study|Alternate Treatment|0|||
130543163|NCT00938470|469953840|FG000|Overall Study|Death|3|||
130543164|NCT00938470|469953841|FG001|Overall Study|Death|2|||
130543165|NCT00938470|469953840|FG000|Overall Study|Other Reason|0|||
130543166|NCT00938470|469953841|FG001|Overall Study|Other Reason|1|||
130543167|NCT00309959|469953846|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
130543168|NCT01004848|469953847|FG000|Overall Study|Lost to Follow-up|55|||
130543169|NCT01004848|469953848|FG001|Overall Study|Lost to Follow-up|45|||
130543170|NCT01621568|469953850|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
130543171|NCT01621568|469953851|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
130543172|NCT01621568|469953850|FG000|Week 5-6 No Treatment|Death|1|||
130543173|NCT01621568|469953851|FG001|Week 5-6 No Treatment|Death|0|||
130543174|NCT02334423|469953852|FG000|Overall Study|Protocol Violation|10|||
130543175|NCT02334423|469953853|FG001|Overall Study|Protocol Violation|3|||
130543176|NCT02930226|469953854|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
130543177|NCT02930226|469953855|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
130543178|NCT02930226|469953856|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
130543179|NCT02930226|469953857|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
130543180|NCT02930226|469953858|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
130543181|NCT02930226|469953859|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
130543182|NCT00652327|469953860|FG000|Overall Study|Adverse Event|0|||
130543183|NCT00652327|469953861|FG001|Overall Study|Adverse Event|2|||
130543184|NCT00652327|469953860|FG000|Overall Study|Lost to Follow-up|0|||
130543185|NCT00652327|469953861|FG001|Overall Study|Lost to Follow-up|3|||
130543186|NCT01076647|469953862|FG000|Overall Study|Adverse Event|4|||
130543187|NCT01076647|469953863|FG001|Overall Study|Adverse Event|1|||
130543188|NCT01076647|469953862|FG000|Overall Study|Lack of Efficacy|0|||
130543189|NCT01076647|469953863|FG001|Overall Study|Lack of Efficacy|1|||
130543190|NCT01076647|469953862|FG000|Overall Study|Protocol Violation|7|||
130543191|NCT01076647|469953863|FG001|Overall Study|Protocol Violation|9|||
130543192|NCT01076647|469953862|FG000|Overall Study|Withdrawal criteria|2|||
130543193|NCT01076647|469953863|FG001|Overall Study|Withdrawal criteria|2|||
130543194|NCT01076647|469953862|FG000|Overall Study|Unclassified|12|||
130543195|NCT01076647|469953863|FG001|Overall Study|Unclassified|12|||
130543196|NCT00564889|469953869|FG000|Overall Study|Death|7|||
130543197|NCT00564889|469953869|FG000|Overall Study|Adverse Event|12|||
130543198|NCT00564889|469953869|FG000|Overall Study|Alternative treatment|3|||
130543199|NCT00564889|469953869|FG000|Overall Study|Disease progression|3|||
130543200|NCT00564889|469953869|FG000|Overall Study|Other, not specified|4|||
130543201|NCT03500159|469953870|FG000|Overall Study|Study Terminated|2|||
130543202|NCT03500159|469953871|FG001|Overall Study|Study Terminated|1|||
130543203|NCT01011387|469953876|FG000|Overall Study|Withdrawal by Subject|3|||
130543204|NCT01011387|469953876|FG000|Overall Study|Adverse Event|2|||
130543205|NCT01011387|469953876|FG000|Overall Study|Protocol Violation|1|||
130543206|NCT01226095|469953877|FG000|Overall Study|Poor compliance|1|||
130543207|NCT02665338|469953879|FG000|Overall Study|Withdrawal by Subject|0|||
130543208|NCT02665338|469953880|FG001|Overall Study|Withdrawal by Subject|1|||
130543209|NCT05326815|469953884|FG000|Overall Study|Withdrawal by Subject|3|||
130543210|NCT05326815|469953884|FG000|Overall Study|Did not complete required labs|6|||
130543211|NCT05326815|469953884|FG000|Overall Study|Screen fail- abnormal labs|5|||
130543212|NCT03562975|469953885|FG000|Overall Study|Death|1|||
130543213|NCT03562975|469953885|FG000|Overall Study|Lost to Follow-up|1|||
130543214|NCT03562975|469953885|FG000|Overall Study|Withdrawal by Subject|1|||
130543215|NCT02545933|469953886|FG000|Overall Study|Adverse Event|3|||
130543216|NCT02545933|469953887|FG001|Overall Study|Adverse Event|0|||
130543217|NCT02545933|469953888|FG002|Overall Study|Adverse Event|0|||
130543218|NCT02545933|469953886|FG000|Overall Study|Withdrawal by Subject|2|||
130543219|NCT02545933|469953887|FG001|Overall Study|Withdrawal by Subject|3|||
130543220|NCT02545933|469953888|FG002|Overall Study|Withdrawal by Subject|3|||
130543221|NCT02545933|469953886|FG000|Overall Study|Protocol Violation|1|||
130543222|NCT02545933|469953887|FG001|Overall Study|Protocol Violation|0|||
130543223|NCT02545933|469953888|FG002|Overall Study|Protocol Violation|1|||
130543224|NCT00935818|469953891|FG000|Overall Study|Withdrawal by Subject|45|||
130543225|NCT00935818|469953892|FG001|Overall Study|Withdrawal by Subject|50|||
130543226|NCT00935818|469953891|FG000|Overall Study|Lost to Follow-up|40|||
130543227|NCT00935818|469953892|FG001|Overall Study|Lost to Follow-up|42|||
130543228|NCT00935818|469953891|FG000|Overall Study|Adverse Event|6|||
130543229|NCT00935818|469953892|FG001|Overall Study|Adverse Event|7|||
130543230|NCT00935818|469953891|FG000|Overall Study|Physician Decision|0|||
130543231|NCT00935818|469953892|FG001|Overall Study|Physician Decision|1|||
130543232|NCT00979134|469953893|FG000|Overall Study|Disease progression|18|||
130543233|NCT00979134|469953894|FG001|Overall Study|Disease progression|2|||
130543234|NCT00979134|469953895|FG002|Overall Study|Disease progression|5|||
130543235|NCT00979134|469953893|FG000|Overall Study|Adverse Event|0|||
130543236|NCT00979134|469953894|FG001|Overall Study|Adverse Event|0|||
130543237|NCT00979134|469953895|FG002|Overall Study|Adverse Event|2|||
130543238|NCT00979134|469953893|FG000|Overall Study|Withdrawal by Subject|1|||
130543239|NCT00979134|469953894|FG001|Overall Study|Withdrawal by Subject|1|||
130543240|NCT00979134|469953895|FG002|Overall Study|Withdrawal by Subject|2|||
130543241|NCT00979134|469953893|FG000|Overall Study|Lost to Follow-up|2|||
130543242|NCT00979134|469953894|FG001|Overall Study|Lost to Follow-up|2|||
130543243|NCT00979134|469953895|FG002|Overall Study|Lost to Follow-up|0|||
130543244|NCT00979134|469953893|FG000|Overall Study|Death|4|||
130543245|NCT00979134|469953894|FG001|Overall Study|Death|0|||
130543246|NCT00979134|469953895|FG002|Overall Study|Death|26|||
130543247|NCT00979134|469953893|FG000|Overall Study|Other|8|||
130543248|NCT00979134|469953894|FG001|Overall Study|Other|1|||
130543249|NCT00979134|469953895|FG002|Overall Study|Other|5|||
130543250|NCT05917470|469953896|FG000|Overall Study|Progressive Disease|1|||
130543251|NCT05917470|469953897|FG001|Overall Study|Progressive Disease|1|||
130543252|NCT05917470|469953898|FG002|Overall Study|Progressive Disease|2|||
130543253|NCT05917470|469953899|FG003|Overall Study|Progressive Disease|3|||
130543254|NCT05917470|469953900|FG004|Overall Study|Progressive Disease|1|||
130543255|NCT05917470|469953901|FG005|Overall Study|Progressive Disease|1|||
130543256|NCT05917470|469953902|FG006|Overall Study|Progressive Disease|0|||
130543257|NCT05917470|469953903|FG007|Overall Study|Progressive Disease|0|||
130543258|NCT05917470|469953896|FG000|Overall Study|Withdrawal by Subject|0|||
130543259|NCT05917470|469953897|FG001|Overall Study|Withdrawal by Subject|0|||
130543260|NCT05917470|469953898|FG002|Overall Study|Withdrawal by Subject|1|||
130543261|NCT05917470|469953899|FG003|Overall Study|Withdrawal by Subject|0|||
130543262|NCT05917470|469953900|FG004|Overall Study|Withdrawal by Subject|0|||
130543263|NCT05917470|469953901|FG005|Overall Study|Withdrawal by Subject|0|||
130543264|NCT05917470|469953902|FG006|Overall Study|Withdrawal by Subject|0|||
130543265|NCT05917470|469953903|FG007|Overall Study|Withdrawal by Subject|0|||
130543266|NCT05917470|469953896|FG000|Overall Study|Sponsor Decision|0|||
130543267|NCT05917470|469953897|FG001|Overall Study|Sponsor Decision|0|||
130543268|NCT05917470|469953898|FG002|Overall Study|Sponsor Decision|1|||
130543269|NCT05917470|469953899|FG003|Overall Study|Sponsor Decision|0|||
130543270|NCT05917470|469953900|FG004|Overall Study|Sponsor Decision|2|||
130543271|NCT05917470|469953901|FG005|Overall Study|Sponsor Decision|1|||
130543272|NCT05917470|469953902|FG006|Overall Study|Sponsor Decision|3|||
130543273|NCT05917470|469953903|FG007|Overall Study|Sponsor Decision|3|||
130543274|NCT05917470|469953896|FG000|Overall Study|Adverse Event|0|||
130543275|NCT05917470|469953897|FG001|Overall Study|Adverse Event|0|||
130543276|NCT05917470|469953898|FG002|Overall Study|Adverse Event|0|||
130543277|NCT05917470|469953899|FG003|Overall Study|Adverse Event|0|||
130543278|NCT05917470|469953900|FG004|Overall Study|Adverse Event|0|||
130543279|NCT05917470|469953901|FG005|Overall Study|Adverse Event|1|||
130543280|NCT05917470|469953902|FG006|Overall Study|Adverse Event|0|||
130543281|NCT05917470|469953903|FG007|Overall Study|Adverse Event|0|||
130543282|NCT01076192|469956683|FG000|Overall Study|Other|197|||
130543283|NCT01034176|469956684|FG000|Overall Study|Physician Decision|2|||
130543284|NCT01034176|469956685|FG001|Overall Study|Physician Decision|0|||
130543285|NCT01034176|469956684|FG000|Overall Study|Withdrawal by Subject|0|||
130543286|NCT01034176|469956685|FG001|Overall Study|Withdrawal by Subject|1|||
130543287|NCT01034176|469956684|FG000|Overall Study|Lost to Follow-up|0|||
130543288|NCT01034176|469956685|FG001|Overall Study|Lost to Follow-up|1|||
130543289|NCT00107120|469956689|FG000|Overall Study|Adverse Event|4|||
130543290|NCT00107120|469956690|FG001|Overall Study|Adverse Event|1|||
130543291|NCT00107120|469956689|FG000|Overall Study|Lack of Efficacy|5|||
130543292|NCT00107120|469956690|FG001|Overall Study|Lack of Efficacy|5|||
130543293|NCT00107120|469956689|FG000|Overall Study|Protocol Violation|3|||
130543294|NCT00107120|469956690|FG001|Overall Study|Protocol Violation|0|||
130543295|NCT00107120|469956689|FG000|Overall Study|Withdrawal by Subject|8|||
130543296|NCT00107120|469956690|FG001|Overall Study|Withdrawal by Subject|9|||
130543297|NCT00107120|469956689|FG000|Overall Study|Lost to Follow-up|8|||
130543298|NCT00107120|469956690|FG001|Overall Study|Lost to Follow-up|6|||
130543299|NCT00107120|469956689|FG000|Overall Study|Pregnancy|0|||
130543300|NCT00107120|469956690|FG001|Overall Study|Pregnancy|1|||
130543301|NCT00107120|469956689|FG000|Overall Study|moving away from site|1|||
130543302|NCT00107120|469956690|FG001|Overall Study|moving away from site|1|||
130543303|NCT00107120|469956689|FG000|Overall Study|death of parent|0|||
130543304|NCT00107120|469956690|FG001|Overall Study|death of parent|1|||
130543305|NCT01635920|469956691|FG000|Overall Study|Adverse Event|1|||
130543306|NCT01635920|469956692|FG001|Overall Study|Adverse Event|0|||
130207910|NCT00424021|468721034|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207911|NCT00424021|468721035|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
130207912|NCT00424021|468721036|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207913|NCT00424021|468721037|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207914|NCT00424021|468721034|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
130207915|NCT00424021|468721035|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
130207916|NCT00424021|468721036|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
130207917|NCT00424021|468721037|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
130207918|NCT00424021|468721034|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
130207919|NCT00424021|468721035|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
130207920|NCT00424021|468721036|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
130207921|NCT00424021|468721037|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
130207922|NCT00424021|468721034|FG000|AMB-220-E Study Period|Adverse Event|1|||
130207923|NCT00424021|468721035|FG001|AMB-220-E Study Period|Adverse Event|1|||
130207924|NCT00424021|468721036|FG002|AMB-220-E Study Period|Adverse Event|3|||
130207925|NCT00424021|468721037|FG003|AMB-220-E Study Period|Adverse Event|7|||
130207926|NCT00424021|468721034|FG000|AMB-220-E Study Period|Death|0|||
130207927|NCT00424021|468721035|FG001|AMB-220-E Study Period|Death|0|||
130207928|NCT00424021|468721036|FG002|AMB-220-E Study Period|Death|1|||
130207929|NCT00424021|468721037|FG003|AMB-220-E Study Period|Death|1|||
130543307|NCT01635920|469956691|FG000|Overall Study|Lost to Follow-up|0|||
130543308|NCT01635920|469956692|FG001|Overall Study|Lost to Follow-up|1|||
130543309|NCT01635920|469956691|FG000|Overall Study|Subject decision|2|||
130543310|NCT01635920|469956692|FG001|Overall Study|Subject decision|0|||
130652352|NCT04621227|470349420|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
130652353|NCT04621227|470349420|FG000|Period 3 (29 Days)|Adverse Event|1|||
130207930|NCT00424021|468721034|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
130207931|NCT00424021|468721035|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
130207932|NCT00424021|468721036|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
130207933|NCT00424021|468721037|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
130543311|NCT00194987|469956693|FG000|Overall Study|Withdrawal by Subject|0|||
130543312|NCT00194987|469956694|FG001|Overall Study|Withdrawal by Subject|3|||
130543313|NCT01664598|469956695|FG000|Overall Study|Sponsor Decision|1|||
130543314|NCT01664598|469956695|FG000|Overall Study|Withdrawal of Informed Consent|4|||
130543315|NCT01664598|469956695|FG000|Overall Study|Adverse Event|1|||
130652354|NCT04621227|470349420|FG000|Period 8 (2 Days)|Adverse Event|1|||
130652355|NCT01548573|470349421|FG000|Overall Study|Death|3|||
130652356|NCT01548573|470349421|FG000|Overall Study|Withdrawal by Subject|2|||
130652357|NCT01366846|470349424|FG000|Overall Study|Withdrawal by Subject|2|||
130652358|NCT01366846|470349425|FG001|Overall Study|Withdrawal by Subject|0|||
130207934|NCT00424021|468721034|FG000|AMB-220-E Study Period|Physician Decision|0|||
130207935|NCT00424021|468721035|FG001|AMB-220-E Study Period|Physician Decision|0|||
130207936|NCT00424021|468721036|FG002|AMB-220-E Study Period|Physician Decision|0|||
130207937|NCT00424021|468721037|FG003|AMB-220-E Study Period|Physician Decision|1|||
130207938|NCT03769194|468721038|FG000|Overall Study|Withdrawal by Subject|0|||
130207939|NCT03769194|468721039|FG001|Overall Study|Withdrawal by Subject|7|||
130207940|NCT03769194|468721040|FG002|Overall Study|Withdrawal by Subject|4|||
130207941|NCT03769194|468721041|FG003|Overall Study|Withdrawal by Subject|1|||
130207942|NCT03769194|468721038|FG000|Overall Study|moved from study area|0|||
130207943|NCT03769194|468721039|FG001|Overall Study|moved from study area|2|||
130207944|NCT03769194|468721040|FG002|Overall Study|moved from study area|1|||
130207945|NCT03769194|468721041|FG003|Overall Study|moved from study area|1|||
130207946|NCT03769194|468721038|FG000|Overall Study|Lost to Follow-up|3|||
130207947|NCT03769194|468721039|FG001|Overall Study|Lost to Follow-up|6|||
130207948|NCT03769194|468721040|FG002|Overall Study|Lost to Follow-up|3|||
130207949|NCT03769194|468721041|FG003|Overall Study|Lost to Follow-up|6|||
130652359|NCT01366846|470349426|FG002|Overall Study|Withdrawal by Subject|0|||
130652360|NCT01366846|470349427|FG003|Overall Study|Withdrawal by Subject|0|||
130652361|NCT01366846|470349424|FG000|Overall Study|Communication Difficulties|1|||
130652362|NCT01366846|470349425|FG001|Overall Study|Communication Difficulties|4|||
130652363|NCT01366846|470349426|FG002|Overall Study|Communication Difficulties|0|||
130652364|NCT01366846|470349427|FG003|Overall Study|Communication Difficulties|1|||
130652365|NCT01366846|470349424|FG000|Overall Study|Scheduling Conflicts|0|||
130652366|NCT01366846|470349425|FG001|Overall Study|Scheduling Conflicts|0|||
130652367|NCT01366846|470349426|FG002|Overall Study|Scheduling Conflicts|1|||
130652368|NCT01366846|470349427|FG003|Overall Study|Scheduling Conflicts|0|||
130652369|NCT00558831|470349428|FG000|Overall Study|Lost to Follow-up|1|||
130652370|NCT00447265|470349429|FG000|Overall Study|Physician Decision|1|||
130652371|NCT00447265|470349430|FG001|Overall Study|Physician Decision|0|||
130652372|NCT02204449|470349433|FG000|Overall Study|Lost to Follow-up|7|||
130652373|NCT02204449|470349434|FG001|Overall Study|Lost to Follow-up|9|||
130652374|NCT02204449|470349433|FG000|Overall Study|Death|0|||
130652375|NCT02204449|470349434|FG001|Overall Study|Death|1|||
130652376|NCT02204449|470349433|FG000|Overall Study|Withdrawal by Subject|0|||
130652377|NCT02204449|470349434|FG001|Overall Study|Withdrawal by Subject|1|||
130652378|NCT00503035|470349435|FG000|Overall Study|Lost to Follow-up|2|||
130652379|NCT00503035|470349435|FG000|Overall Study|Physician Decision|3|||
130652380|NCT00503035|470349435|FG000|Overall Study|Ineligible|15|||
130652381|NCT05028816|470349438|FG000|Overall Study|Lost to Follow-up|5|||
130652382|NCT05028816|470349439|FG001|Overall Study|Lost to Follow-up|3|||
130652383|NCT05028816|470349438|FG000|Overall Study|Withdrawal by Subject|4|||
130652384|NCT05028816|470349439|FG001|Overall Study|Withdrawal by Subject|1|||
130652385|NCT05028816|470349438|FG000|Overall Study|Physician Decision|1|||
130652386|NCT05028816|470349439|FG001|Overall Study|Physician Decision|0|||
130652387|NCT05064436|470349440|FG000|Overall Study|Other Reasons|1|||
130652388|NCT05064436|470349441|FG001|Overall Study|Other Reasons|0|||
130652389|NCT01711736|470349443|FG000|Overall Study|Lost to Follow-up|4|||
130652390|NCT01711736|470349444|FG001|Overall Study|Lost to Follow-up|1|||
130652391|NCT01711736|470349443|FG000|Overall Study|Withdrawal by Subject|6|||
130652392|NCT01711736|470349444|FG001|Overall Study|Withdrawal by Subject|6|||
130652393|NCT01711736|470349443|FG000|Overall Study|Migrated/moved from study area|2|||
130652394|NCT01711736|470349444|FG001|Overall Study|Migrated/moved from study area|1|||
130652395|NCT01342445|470349445|FG000|Overall Study|Experienced side effects|0|||
130652396|NCT01342445|470349446|FG001|Overall Study|Experienced side effects|2|||
130652397|NCT05299359|470349447|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
130652398|NCT05299359|470349448|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
130652399|NCT05299359|470349447|FG000|Main Part: Day 1 up to Day 366|Other|2|||
130652400|NCT05299359|470349448|FG001|Main Part: Day 1 up to Day 366|Other|0|||
130652401|NCT05299359|470349447|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
130652402|NCT05299359|470349448|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
130652403|NCT05299359|470349447|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
130652404|NCT05299359|470349448|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
130652405|NCT05299359|470349447|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
130652406|NCT05299359|470349448|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
130652407|NCT05299359|470349447|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
130652408|NCT05299359|470349448|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
130652409|NCT05299359|470349447|FG000|Extension Part: Day 1 to Day 366|Other|0|||
130207950|NCT03769194|468721038|FG000|Overall Study|other|1|||
130207951|NCT03769194|468721039|FG001|Overall Study|other|3|||
130652410|NCT05299359|470349448|FG001|Extension Part: Day 1 to Day 366|Other|1|||
130652411|NCT03868410|470349451|FG000|Overall Study|Physician Decision|0|||
130652412|NCT03868410|470349452|FG001|Overall Study|Physician Decision|1|||
130652413|NCT01059175|470349453|FG000|Overall Study|Death|17|||
130652414|NCT01059175|470349454|FG001|Overall Study|Death|17|||
130652415|NCT01059175|470349453|FG000|Overall Study|Adverse Event|4|||
130652416|NCT01059175|470349454|FG001|Overall Study|Adverse Event|2|||
130652417|NCT01059175|470349453|FG000|Overall Study|Lost to Follow-up|0|||
130652418|NCT01059175|470349454|FG001|Overall Study|Lost to Follow-up|1|||
130652419|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Adverse Event|4|||
130652420|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Adverse Event|3|||
130652421|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Adverse Event|0|||
130652422|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Adverse Event|0|||
130652423|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Death|24|||
130652424|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Death|9|||
130652425|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Death|0|||
130652426|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Death|0|||
130652427|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
130652428|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
130652429|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
130652430|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
130652431|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Physician Decision|4|||
130652432|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Physician Decision|1|||
130652433|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Physician Decision|0|||
130652434|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Physician Decision|0|||
130652435|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Progressive disease|1|||
130652436|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Progressive disease|0|||
130652437|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Progressive disease|0|||
130652438|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Progressive disease|0|||
130652439|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
130652440|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
130652441|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
130652442|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
130652443|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
130652444|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130652445|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130652446|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130652447|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
130652448|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
130652449|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
130652450|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
130652451|NCT04579666|470349455|FG000|RTP (Up to Week 52)|Other|2|||
130652452|NCT04579666|470349456|FG001|RTP (Up to Week 52)|Other|0|||
130652453|NCT04579666|470349457|FG002|RTP (Up to Week 52)|Other|0|||
130652454|NCT04579666|470349458|FG003|RTP (Up to Week 52)|Other|0|||
130652455|NCT04579666|470349455|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130652456|NCT04579666|470349456|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130652457|NCT04579666|470349457|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
130652458|NCT04579666|470349458|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130652459|NCT04579666|470349455|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
130652460|NCT04579666|470349456|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
130652461|NCT04579666|470349457|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
130652462|NCT04579666|470349458|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
130652463|NCT04579666|470349455|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
130652464|NCT04579666|470349456|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
130652465|NCT04579666|470349457|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
130652466|NCT04579666|470349458|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
130652467|NCT04579666|470349455|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
130652468|NCT04579666|470349456|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
130652469|NCT04579666|470349457|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
130652470|NCT04579666|470349458|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
130652471|NCT04579666|470349455|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
130652472|NCT04579666|470349456|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
130652473|NCT04579666|470349457|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
130652474|NCT04579666|470349458|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
130652475|NCT00643006|470349462|FG000|Overall Study|Lost to Follow-up|5|||
130652476|NCT00643006|470349463|FG001|Overall Study|Lost to Follow-up|4|||
130652477|NCT02506101|470349464|FG000|Overall Study|Transportation issues|1|||
130652478|NCT02506101|470349465|FG001|Overall Study|Transportation issues|0|||
130652479|NCT02506101|470349464|FG000|Overall Study|No enrollment and staff unavailability|1|||
130652480|NCT02506101|470349465|FG001|Overall Study|No enrollment and staff unavailability|0|||
130652481|NCT01151085|470349467|FG000|Overall Study|Lost to Follow-up|31|||
130652482|NCT01151085|470349467|FG000|Overall Study|Protocol Violation|25|||
130652483|NCT01308476|470349468|FG000|Overall Study|Lost to Follow-up|2|||
130652484|NCT01308476|470349469|FG001|Overall Study|Lost to Follow-up|2|||
130652485|NCT01308476|470349468|FG000|Overall Study|Other|1|||
130652486|NCT01308476|470349469|FG001|Overall Study|Other|0|||
130652487|NCT00812968|470349470|FG000|Overall Study|Relapse after erythroid response|6|||
130652488|NCT00812968|470349470|FG000|Overall Study|Disease progression|1|||
130652489|NCT00812968|470349470|FG000|Overall Study|No further treatment required|1|||
130652490|NCT00812968|470349470|FG000|Overall Study|Study closed due to marketing approval|3|||
130652491|NCT01243762|470349478|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130652492|NCT01243762|470349479|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
130652493|NCT01243762|470349480|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130652494|NCT01243762|470349481|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130652495|NCT01243762|470349482|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
130652496|NCT01243762|470349483|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
130652497|NCT01243762|470349484|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130652498|NCT01243762|470349478|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130652499|NCT01243762|470349479|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
130652500|NCT01243762|470349480|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130652501|NCT01243762|470349481|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
130652502|NCT01243762|470349482|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130652503|NCT01243762|470349483|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130652504|NCT01243762|470349484|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130652505|NCT01243762|470349478|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
130652506|NCT01243762|470349479|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
130652507|NCT01243762|470349480|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
130652508|NCT01243762|470349481|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
130652509|NCT01243762|470349482|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
130652510|NCT01243762|470349483|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
130652511|NCT01243762|470349484|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
130652512|NCT01243762|470349478|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652513|NCT01243762|470349479|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
130652514|NCT01243762|470349480|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652515|NCT01243762|470349481|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652516|NCT01243762|470349482|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652517|NCT01243762|470349483|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652518|NCT01243762|470349484|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130652519|NCT01243762|470349478|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130652520|NCT01243762|470349479|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
130652521|NCT01243762|470349480|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130652522|NCT01243762|470349481|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130652523|NCT01243762|470349482|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130652524|NCT01243762|470349483|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130652525|NCT01243762|470349484|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
130652526|NCT01243762|470349478|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
130652527|NCT01243762|470349479|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
130652528|NCT01243762|470349480|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
130652529|NCT01243762|470349481|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
130652530|NCT01243762|470349482|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
130652531|NCT01243762|470349483|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
130652532|NCT01243762|470349484|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
130652533|NCT01243762|470349478|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130652534|NCT01243762|470349479|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
130652535|NCT01243762|470349480|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130652536|NCT01243762|470349481|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130652537|NCT01243762|470349482|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
130652538|NCT01243762|470349483|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130652539|NCT01243762|470349484|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130652540|NCT01243762|470349478|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130652541|NCT01243762|470349479|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130652542|NCT01243762|470349480|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130652543|NCT01243762|470349481|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
130652544|NCT01243762|470349482|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
130652545|NCT01243762|470349483|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130652546|NCT01243762|470349484|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130652547|NCT04196023|470349485|FG000|Overall Study|Withdrawal by Subject|0|||
130652548|NCT04196023|470349486|FG001|Overall Study|Withdrawal by Subject|1|||
130652549|NCT04196023|470349485|FG000|Overall Study|Adverse Event|3|||
130652550|NCT04196023|470349486|FG001|Overall Study|Adverse Event|1|||
130652551|NCT04196023|470349485|FG000|Overall Study|Lost to Follow-up|0|||
130376452|NCT03655691|469343691|FG000|Overall Study|Withdrawal by Subject|1|||
130652552|NCT04196023|470349486|FG001|Overall Study|Lost to Follow-up|1|||
130652553|NCT02985996|470349487|FG000|Overall Study|Withdrawal by Subject|0|||
130652554|NCT02985996|470349488|FG001|Overall Study|Withdrawal by Subject|0|||
130652555|NCT02985996|470349489|FG002|Overall Study|Withdrawal by Subject|1|||
130652556|NCT02985996|470349490|FG003|Overall Study|Withdrawal by Subject|0|||
130652557|NCT02985996|470349491|FG004|Overall Study|Withdrawal by Subject|0|||
130652558|NCT02985996|470349487|FG000|Overall Study|Protocol Violation|0|||
130652559|NCT02985996|470349488|FG001|Overall Study|Protocol Violation|1|||
130652560|NCT02985996|470349489|FG002|Overall Study|Protocol Violation|0|||
130652561|NCT02985996|470349490|FG003|Overall Study|Protocol Violation|0|||
130652562|NCT02985996|470349491|FG004|Overall Study|Protocol Violation|0|||
130652563|NCT00401726|470349492|FG000|Overall Study|Adverse Event|34|||
130652564|NCT00401726|470349493|FG001|Overall Study|Adverse Event|45|||
130652565|NCT00401726|470349492|FG000|Overall Study|Death|0|||
130652566|NCT00401726|470349493|FG001|Overall Study|Death|3|||
130652567|NCT00401726|470349492|FG000|Overall Study|Sponsor Request|0|||
130652568|NCT00401726|470349493|FG001|Overall Study|Sponsor Request|1|||
130652569|NCT00401726|470349492|FG000|Overall Study|Physician Decision|3|||
130652570|NCT00401726|470349493|FG001|Overall Study|Physician Decision|6|||
130652571|NCT00401726|470349492|FG000|Overall Study|Lost to Follow-up|23|||
130652572|NCT00401726|470349493|FG001|Overall Study|Lost to Follow-up|20|||
130652573|NCT00401726|470349492|FG000|Overall Study|Protocol Violation|6|||
130652574|NCT00401726|470349493|FG001|Overall Study|Protocol Violation|3|||
130652575|NCT00401726|470349492|FG000|Overall Study|Withdrawal by Subject|18|||
130652576|NCT00401726|470349493|FG001|Overall Study|Withdrawal by Subject|24|||
130652577|NCT00401726|470349492|FG000|Overall Study|Lack of Efficacy|4|||
130652578|NCT00401726|470349493|FG001|Overall Study|Lack of Efficacy|6|||
130652579|NCT00401726|470349492|FG000|Overall Study|Protocol Deviation|9|||
130652580|NCT00401726|470349493|FG001|Overall Study|Protocol Deviation|4|||
130652581|NCT00442572|470349494|FG000|Overall Study|Relapse|8|||
130652582|NCT00442572|470349495|FG001|Overall Study|Relapse|1|||
130652583|NCT00442572|470349494|FG000|Overall Study|Lost to Follow-up|0|||
130652584|NCT00442572|470349495|FG001|Overall Study|Lost to Follow-up|1|||
130652585|NCT00442572|470349494|FG000|Overall Study|Withdrawal by Subject|0|||
130652586|NCT00442572|470349495|FG001|Overall Study|Withdrawal by Subject|1|||
130652587|NCT01901393|470349496|FG000|Overall Study|Adverse Event|1|||
130652588|NCT01901393|470349497|FG001|Overall Study|Adverse Event|0|||
130652589|NCT04246593|470349498|FG000|Overall Study|Withdrawal by Subject|14|||
130652590|NCT04246593|470349499|FG001|Overall Study|Withdrawal by Subject|13|||
130652591|NCT04246593|470349498|FG000|Overall Study|Lost to Follow-up|124|||
130652592|NCT04246593|470349499|FG001|Overall Study|Lost to Follow-up|71|||
130652593|NCT04246593|470349498|FG000|Overall Study|Moved out of area/became ineligible|3|||
130652594|NCT04246593|470349499|FG001|Overall Study|Moved out of area/became ineligible|1|||
130652595|NCT04246593|470349498|FG000|Overall Study|Reason unknown|4|||
130652596|NCT04246593|470349499|FG001|Overall Study|Reason unknown|2|||
130652597|NCT02369874|470349501|FG000|Overall Study|Lost to Follow-up|2|||
130652598|NCT02369874|470349502|FG001|Overall Study|Lost to Follow-up|2|||
130652599|NCT02369874|470349503|FG002|Overall Study|Lost to Follow-up|2|||
130652600|NCT02369874|470349501|FG000|Overall Study|Withdrawal by Subject|7|||
130652601|NCT02369874|470349502|FG001|Overall Study|Withdrawal by Subject|9|||
130652602|NCT02369874|470349503|FG002|Overall Study|Withdrawal by Subject|27|||
130652603|NCT02369874|470349501|FG000|Overall Study|Miscellaneous|1|||
130652604|NCT02369874|470349502|FG001|Overall Study|Miscellaneous|1|||
130652605|NCT02369874|470349503|FG002|Overall Study|Miscellaneous|0|||
130652606|NCT02369874|470349501|FG000|Overall Study|On Treatment/Off Study|34|||
130652607|NCT02369874|470349502|FG001|Overall Study|On Treatment/Off Study|45|||
130652608|NCT02369874|470349503|FG002|Overall Study|On Treatment/Off Study|32|||
130652609|NCT01049360|470349506|FG000|Period 1|Adverse Event|0|||
130652610|NCT01049360|470349507|FG001|Period 1|Adverse Event|1|||
130652611|NCT01049360|470349508|FG002|Period 1|Adverse Event|0|||
130652612|NCT01049360|470349509|FG003|Period 1|Adverse Event|1|||
130652613|NCT01049360|470349510|FG004|Period 1|Adverse Event|0|||
130652614|NCT01049360|470349511|FG005|Period 1|Adverse Event|0|||
130376453|NCT03655691|469343692|FG001|Overall Study|Withdrawal by Subject|1|||
130652615|NCT01049360|470349512|FG006|Period 1|Adverse Event|0|||
130652616|NCT01049360|470349513|FG007|Period 1|Adverse Event|1|||
130652617|NCT01049360|470349514|FG008|Period 1|Adverse Event|0|||
130652618|NCT01049360|470349515|FG009|Period 1|Adverse Event|0|||
130652619|NCT01049360|470349516|FG010|Period 1|Adverse Event|0|||
130652620|NCT01049360|470349517|FG011|Period 1|Adverse Event|0|||
130652621|NCT01049360|470349518|FG012|Period 1|Adverse Event|1|||
130652622|NCT01049360|470349519|FG013|Period 1|Adverse Event|1|||
130652623|NCT01049360|470349520|FG014|Period 1|Adverse Event|0|||
130652624|NCT01049360|470349521|FG015|Period 1|Adverse Event|0|||
130652625|NCT01049360|470349522|FG016|Period 1|Adverse Event|1|||
130652626|NCT01049360|470349523|FG017|Period 1|Adverse Event|0|||
130652627|NCT01049360|470349524|FG018|Period 1|Adverse Event|1|||
130652628|NCT01049360|470349525|FG019|Period 1|Adverse Event|0|||
130652629|NCT01049360|470349506|FG000|Period 1|Did not meet inc/exc criteria|0|||
130207952|NCT03769194|468721040|FG002|Overall Study|other|0|||
130652630|NCT01049360|470349507|FG001|Period 1|Did not meet inc/exc criteria|0|||
130652631|NCT01049360|470349508|FG002|Period 1|Did not meet inc/exc criteria|0|||
130652632|NCT01049360|470349509|FG003|Period 1|Did not meet inc/exc criteria|0|||
130652633|NCT01049360|470349510|FG004|Period 1|Did not meet inc/exc criteria|0|||
130652634|NCT01049360|470349511|FG005|Period 1|Did not meet inc/exc criteria|0|||
130652635|NCT01049360|470349512|FG006|Period 1|Did not meet inc/exc criteria|0|||
130652636|NCT01049360|470349513|FG007|Period 1|Did not meet inc/exc criteria|1|||
130652637|NCT01049360|470349514|FG008|Period 1|Did not meet inc/exc criteria|1|||
130652638|NCT01049360|470349515|FG009|Period 1|Did not meet inc/exc criteria|0|||
130652639|NCT01049360|470349516|FG010|Period 1|Did not meet inc/exc criteria|0|||
130652640|NCT01049360|470349517|FG011|Period 1|Did not meet inc/exc criteria|0|||
130652641|NCT01049360|470349518|FG012|Period 1|Did not meet inc/exc criteria|0|||
130652642|NCT01049360|470349519|FG013|Period 1|Did not meet inc/exc criteria|0|||
130652643|NCT01049360|470349520|FG014|Period 1|Did not meet inc/exc criteria|0|||
130652644|NCT01049360|470349521|FG015|Period 1|Did not meet inc/exc criteria|0|||
130652645|NCT01049360|470349522|FG016|Period 1|Did not meet inc/exc criteria|0|||
130652646|NCT01049360|470349523|FG017|Period 1|Did not meet inc/exc criteria|0|||
130652647|NCT01049360|470349524|FG018|Period 1|Did not meet inc/exc criteria|0|||
130652648|NCT01049360|470349525|FG019|Period 1|Did not meet inc/exc criteria|0|||
130652649|NCT01049360|470349506|FG000|Period 1|Withdrawal by Subject|0|||
130652650|NCT01049360|470349507|FG001|Period 1|Withdrawal by Subject|0|||
130652651|NCT01049360|470349508|FG002|Period 1|Withdrawal by Subject|0|||
130652652|NCT01049360|470349509|FG003|Period 1|Withdrawal by Subject|0|||
130652653|NCT01049360|470349510|FG004|Period 1|Withdrawal by Subject|0|||
130652654|NCT01049360|470349511|FG005|Period 1|Withdrawal by Subject|0|||
130652655|NCT01049360|470349512|FG006|Period 1|Withdrawal by Subject|0|||
130652656|NCT01049360|470349513|FG007|Period 1|Withdrawal by Subject|0|||
130652657|NCT01049360|470349514|FG008|Period 1|Withdrawal by Subject|1|||
130652658|NCT01049360|470349515|FG009|Period 1|Withdrawal by Subject|0|||
130652659|NCT01049360|470349516|FG010|Period 1|Withdrawal by Subject|1|||
130652660|NCT01049360|470349517|FG011|Period 1|Withdrawal by Subject|0|||
130652661|NCT01049360|470349518|FG012|Period 1|Withdrawal by Subject|1|||
130652662|NCT01049360|470349519|FG013|Period 1|Withdrawal by Subject|0|||
130652663|NCT01049360|470349520|FG014|Period 1|Withdrawal by Subject|0|||
130652664|NCT01049360|470349521|FG015|Period 1|Withdrawal by Subject|0|||
130652665|NCT01049360|470349522|FG016|Period 1|Withdrawal by Subject|0|||
130652666|NCT01049360|470349523|FG017|Period 1|Withdrawal by Subject|0|||
130652667|NCT01049360|470349524|FG018|Period 1|Withdrawal by Subject|0|||
130652668|NCT01049360|470349525|FG019|Period 1|Withdrawal by Subject|0|||
130652669|NCT01049360|470349506|FG000|Period 2|Protocol Violation|0|||
130652670|NCT01049360|470349507|FG001|Period 2|Protocol Violation|0|||
130652671|NCT01049360|470349508|FG002|Period 2|Protocol Violation|0|||
130652672|NCT01049360|470349509|FG003|Period 2|Protocol Violation|1|||
130652673|NCT01049360|470349510|FG004|Period 2|Protocol Violation|0|||
130652674|NCT01049360|470349511|FG005|Period 2|Protocol Violation|0|||
130652675|NCT01049360|470349512|FG006|Period 2|Protocol Violation|0|||
130652676|NCT01049360|470349513|FG007|Period 2|Protocol Violation|0|||
130652677|NCT01049360|470349514|FG008|Period 2|Protocol Violation|0|||
130652678|NCT01049360|470349515|FG009|Period 2|Protocol Violation|0|||
130652679|NCT01049360|470349516|FG010|Period 2|Protocol Violation|0|||
130652680|NCT01049360|470349517|FG011|Period 2|Protocol Violation|0|||
130652681|NCT01049360|470349518|FG012|Period 2|Protocol Violation|0|||
130652682|NCT01049360|470349519|FG013|Period 2|Protocol Violation|0|||
130652683|NCT01049360|470349520|FG014|Period 2|Protocol Violation|1|||
130652684|NCT01049360|470349521|FG015|Period 2|Protocol Violation|1|||
130652685|NCT01049360|470349522|FG016|Period 2|Protocol Violation|0|||
130652686|NCT01049360|470349523|FG017|Period 2|Protocol Violation|0|||
130652687|NCT01049360|470349524|FG018|Period 2|Protocol Violation|0|||
130652688|NCT01049360|470349525|FG019|Period 2|Protocol Violation|0|||
130652689|NCT01049360|470349506|FG000|Period 2|Adverse Event|0|||
130652690|NCT01049360|470349507|FG001|Period 2|Adverse Event|1|||
130652691|NCT01049360|470349508|FG002|Period 2|Adverse Event|0|||
130652692|NCT01049360|470349509|FG003|Period 2|Adverse Event|0|||
130652693|NCT01049360|470349510|FG004|Period 2|Adverse Event|0|||
130652694|NCT01049360|470349511|FG005|Period 2|Adverse Event|0|||
130652695|NCT01049360|470349512|FG006|Period 2|Adverse Event|0|||
130652696|NCT01049360|470349513|FG007|Period 2|Adverse Event|0|||
130652697|NCT01049360|470349514|FG008|Period 2|Adverse Event|1|||
130652698|NCT01049360|470349515|FG009|Period 2|Adverse Event|0|||
130652699|NCT01049360|470349516|FG010|Period 2|Adverse Event|0|||
130652700|NCT01049360|470349517|FG011|Period 2|Adverse Event|0|||
130652701|NCT01049360|470349518|FG012|Period 2|Adverse Event|0|||
130652702|NCT01049360|470349519|FG013|Period 2|Adverse Event|0|||
130652703|NCT01049360|470349520|FG014|Period 2|Adverse Event|0|||
130652704|NCT01049360|470349521|FG015|Period 2|Adverse Event|0|||
130652705|NCT01049360|470349522|FG016|Period 2|Adverse Event|0|||
130652706|NCT01049360|470349523|FG017|Period 2|Adverse Event|0|||
130652707|NCT01049360|470349524|FG018|Period 2|Adverse Event|0|||
130652708|NCT01049360|470349525|FG019|Period 2|Adverse Event|1|||
130652709|NCT01049360|470349506|FG000|Period 2|Withdrawal by Subject|0|||
130652710|NCT01049360|470349507|FG001|Period 2|Withdrawal by Subject|0|||
130652711|NCT01049360|470349508|FG002|Period 2|Withdrawal by Subject|0|||
130652712|NCT01049360|470349509|FG003|Period 2|Withdrawal by Subject|1|||
130652713|NCT01049360|470349510|FG004|Period 2|Withdrawal by Subject|0|||
130652714|NCT01049360|470349511|FG005|Period 2|Withdrawal by Subject|0|||
130652715|NCT01049360|470349512|FG006|Period 2|Withdrawal by Subject|0|||
130652716|NCT01049360|470349513|FG007|Period 2|Withdrawal by Subject|0|||
130652717|NCT01049360|470349514|FG008|Period 2|Withdrawal by Subject|0|||
130652718|NCT01049360|470349515|FG009|Period 2|Withdrawal by Subject|0|||
130652719|NCT01049360|470349516|FG010|Period 2|Withdrawal by Subject|0|||
130652720|NCT01049360|470349517|FG011|Period 2|Withdrawal by Subject|0|||
130652721|NCT01049360|470349518|FG012|Period 2|Withdrawal by Subject|0|||
130652722|NCT01049360|470349519|FG013|Period 2|Withdrawal by Subject|0|||
130652723|NCT01049360|470349520|FG014|Period 2|Withdrawal by Subject|1|||
130652724|NCT01049360|470349521|FG015|Period 2|Withdrawal by Subject|0|||
130652725|NCT01049360|470349522|FG016|Period 2|Withdrawal by Subject|0|||
130652726|NCT01049360|470349523|FG017|Period 2|Withdrawal by Subject|0|||
130207953|NCT03769194|468721041|FG003|Overall Study|other|1|||
130207954|NCT03597022|468721044|FG000|Overall Study|Premature termination of the study|7|||
130207955|NCT03597022|468721045|FG001|Overall Study|Premature termination of the study|7|||
130207956|NCT03597022|468721046|FG002|Overall Study|Premature termination of the study|8|||
130207957|NCT03597022|468721044|FG000|Overall Study|Serious adverse event|1|||
130207958|NCT03597022|468721045|FG001|Overall Study|Serious adverse event|1|||
130207959|NCT03597022|468721046|FG002|Overall Study|Serious adverse event|0|||
130207960|NCT01672294|468721048|FG000|Overall Study|Withdrawal by Subject|4|||
130207961|NCT01672294|468721049|FG001|Overall Study|Withdrawal by Subject|4|||
130207962|NCT01672294|468721050|FG002|Overall Study|Withdrawal by Subject|4|||
130207963|NCT01672294|468721051|FG003|Overall Study|Withdrawal by Subject|4|||
130207964|NCT01672294|468721048|FG000|Overall Study|Excluded by study|1|||
130207965|NCT01672294|468721049|FG001|Overall Study|Excluded by study|1|||
130207966|NCT01672294|468721050|FG002|Overall Study|Excluded by study|0|||
130207967|NCT01672294|468721051|FG003|Overall Study|Excluded by study|0|||
130207968|NCT01672294|468721048|FG000|Overall Study|Lost to Follow-up|1|||
130207969|NCT01672294|468721049|FG001|Overall Study|Lost to Follow-up|16|||
130207970|NCT01672294|468721050|FG002|Overall Study|Lost to Follow-up|7|||
130207971|NCT01672294|468721051|FG003|Overall Study|Lost to Follow-up|9|||
130207972|NCT03887117|468721052|FG000|Overall Study|Discontinued prematurely|0|||
130207973|NCT03887117|468721053|FG001|Overall Study|Discontinued prematurely|1|||
130207974|NCT03887117|468721054|FG002|Overall Study|Discontinued prematurely|1|||
130207975|NCT03887117|468721055|FG003|Overall Study|Discontinued prematurely|2|||
130207976|NCT01739764|468721056|FG000|Overall Study|Adverse Event|0|||
130207977|NCT01739764|468721057|FG001|Overall Study|Adverse Event|3|||
130207978|NCT01739764|468721058|FG002|Overall Study|Adverse Event|4|||
130207979|NCT01739764|468721056|FG000|Overall Study|Death|4|||
130207980|NCT01739764|468721057|FG001|Overall Study|Death|6|||
130652727|NCT01049360|470349524|FG018|Period 2|Withdrawal by Subject|0|||
130207981|NCT01739764|468721058|FG002|Overall Study|Death|38|||
130207982|NCT01739764|468721056|FG000|Overall Study|Lost to Follow-up|0|||
130207983|NCT01739764|468721057|FG001|Overall Study|Lost to Follow-up|0|||
130207984|NCT01739764|468721058|FG002|Overall Study|Lost to Follow-up|5|||
130207985|NCT01739764|468721056|FG000|Overall Study|Non-Compliance|0|||
130207986|NCT01739764|468721057|FG001|Overall Study|Non-Compliance|0|||
130207987|NCT01739764|468721058|FG002|Overall Study|Non-Compliance|1|||
130207988|NCT01739764|468721056|FG000|Overall Study|Multiple Reasons|3|||
130207989|NCT01739764|468721057|FG001|Overall Study|Multiple Reasons|2|||
130207990|NCT01739764|468721058|FG002|Overall Study|Multiple Reasons|3|||
130207991|NCT01739764|468721056|FG000|Overall Study|Physician Decision|2|||
130207992|NCT01739764|468721057|FG001|Overall Study|Physician Decision|2|||
130207993|NCT01739764|468721058|FG002|Overall Study|Physician Decision|4|||
130207994|NCT01739764|468721056|FG000|Overall Study|Progressive Disease|3|||
130207995|NCT01739764|468721057|FG001|Overall Study|Progressive Disease|5|||
130207996|NCT01739764|468721058|FG002|Overall Study|Progressive Disease|16|||
130207997|NCT01739764|468721056|FG000|Overall Study|Protocol Violation|0|||
130207998|NCT01739764|468721057|FG001|Overall Study|Protocol Violation|0|||
130207999|NCT01739764|468721058|FG002|Overall Study|Protocol Violation|2|||
130208000|NCT01739764|468721056|FG000|Overall Study|Study Terminated by Sponsor|8|||
130208001|NCT01739764|468721057|FG001|Overall Study|Study Terminated by Sponsor|13|||
130208002|NCT01739764|468721058|FG002|Overall Study|Study Terminated by Sponsor|26|||
130208003|NCT01739764|468721056|FG000|Overall Study|Withdrawal by Subject|6|||
130208004|NCT01739764|468721057|FG001|Overall Study|Withdrawal by Subject|5|||
130208005|NCT01739764|468721058|FG002|Overall Study|Withdrawal by Subject|27|||
130208006|NCT01389258|468721059|FG000|Overall Study|Lost to Follow-up|5|||
130208007|NCT00926536|468721060|FG000|Overall Study|Physician Decision|1|||
130208008|NCT00926536|468721061|FG001|Overall Study|Physician Decision|2|||
130208009|NCT03013985|468721062|FG000|Overall Study|Protocol Violation|2|||
130208010|NCT03013985|468721063|FG001|Overall Study|Protocol Violation|2|||
130652728|NCT01049360|470349525|FG019|Period 2|Withdrawal by Subject|1|||
130208011|NCT03013985|468721062|FG000|Overall Study|Withdrawal by Subject|14|||
130652729|NCT01049360|470349506|FG000|Period 2|Lack of Efficacy|0|||
130208012|NCT03013985|468721063|FG001|Overall Study|Withdrawal by Subject|17|||
130208013|NCT01080391|468721064|FG000|Overall Study|Randomized but not treated|7|||
130208014|NCT01080391|468721065|FG001|Overall Study|Randomized but not treated|4|||
130208015|NCT01534208|468721066|FG000|Overall Study|Lost to Follow-up|19|||
130652730|NCT01049360|470349507|FG001|Period 2|Lack of Efficacy|0|||
130652731|NCT01049360|470349508|FG002|Period 2|Lack of Efficacy|0|||
130652732|NCT01049360|470349509|FG003|Period 2|Lack of Efficacy|0|||
130652733|NCT01049360|470349510|FG004|Period 2|Lack of Efficacy|0|||
130652734|NCT01049360|470349511|FG005|Period 2|Lack of Efficacy|1|||
130652735|NCT01049360|470349512|FG006|Period 2|Lack of Efficacy|0|||
130652736|NCT01049360|470349513|FG007|Period 2|Lack of Efficacy|0|||
130652737|NCT01049360|470349514|FG008|Period 2|Lack of Efficacy|0|||
130652738|NCT01049360|470349515|FG009|Period 2|Lack of Efficacy|0|||
130652739|NCT01049360|470349516|FG010|Period 2|Lack of Efficacy|0|||
130652740|NCT01049360|470349517|FG011|Period 2|Lack of Efficacy|0|||
130652741|NCT01049360|470349518|FG012|Period 2|Lack of Efficacy|0|||
130652742|NCT01049360|470349519|FG013|Period 2|Lack of Efficacy|0|||
130652743|NCT01049360|470349520|FG014|Period 2|Lack of Efficacy|0|||
130652744|NCT01049360|470349521|FG015|Period 2|Lack of Efficacy|0|||
130652745|NCT01049360|470349522|FG016|Period 2|Lack of Efficacy|0|||
130652746|NCT01049360|470349523|FG017|Period 2|Lack of Efficacy|0|||
130652747|NCT01049360|470349524|FG018|Period 2|Lack of Efficacy|0|||
130652748|NCT01049360|470349525|FG019|Period 2|Lack of Efficacy|0|||
130652749|NCT01049360|470349506|FG000|Period 4|Protocol Violation|0|||
130652750|NCT01049360|470349507|FG001|Period 4|Protocol Violation|0|||
130652751|NCT01049360|470349508|FG002|Period 4|Protocol Violation|0|||
130652752|NCT01049360|470349509|FG003|Period 4|Protocol Violation|0|||
130652753|NCT01049360|470349510|FG004|Period 4|Protocol Violation|0|||
130652754|NCT01049360|470349511|FG005|Period 4|Protocol Violation|0|||
130652755|NCT01049360|470349512|FG006|Period 4|Protocol Violation|0|||
130652756|NCT01049360|470349513|FG007|Period 4|Protocol Violation|0|||
130652757|NCT01049360|470349514|FG008|Period 4|Protocol Violation|0|||
130652758|NCT01049360|470349515|FG009|Period 4|Protocol Violation|0|||
130652759|NCT01049360|470349516|FG010|Period 4|Protocol Violation|0|||
130652760|NCT01049360|470349517|FG011|Period 4|Protocol Violation|0|||
130652761|NCT01049360|470349518|FG012|Period 4|Protocol Violation|0|||
130652762|NCT01049360|470349519|FG013|Period 4|Protocol Violation|0|||
130652763|NCT01049360|470349520|FG014|Period 4|Protocol Violation|0|||
130208016|NCT01534208|468721067|FG001|Overall Study|Lost to Follow-up|14|||
130652764|NCT01049360|470349521|FG015|Period 4|Protocol Violation|0|||
130652765|NCT01049360|470349522|FG016|Period 4|Protocol Violation|0|||
130652766|NCT01049360|470349523|FG017|Period 4|Protocol Violation|1|||
130652767|NCT01049360|470349524|FG018|Period 4|Protocol Violation|0|||
130652768|NCT01049360|470349525|FG019|Period 4|Protocol Violation|0|||
130652769|NCT01049360|470349506|FG000|Period 4|Withdrawal by Subject|0|||
130652770|NCT01049360|470349507|FG001|Period 4|Withdrawal by Subject|0|||
130652771|NCT01049360|470349508|FG002|Period 4|Withdrawal by Subject|0|||
130652772|NCT01049360|470349509|FG003|Period 4|Withdrawal by Subject|1|||
130652773|NCT01049360|470349510|FG004|Period 4|Withdrawal by Subject|0|||
130652774|NCT01049360|470349511|FG005|Period 4|Withdrawal by Subject|0|||
130652775|NCT01049360|470349512|FG006|Period 4|Withdrawal by Subject|0|||
130652776|NCT01049360|470349513|FG007|Period 4|Withdrawal by Subject|0|||
130652777|NCT01049360|470349514|FG008|Period 4|Withdrawal by Subject|0|||
130652778|NCT01049360|470349515|FG009|Period 4|Withdrawal by Subject|0|||
130652779|NCT01049360|470349516|FG010|Period 4|Withdrawal by Subject|0|||
130652780|NCT01049360|470349517|FG011|Period 4|Withdrawal by Subject|0|||
130652781|NCT01049360|470349518|FG012|Period 4|Withdrawal by Subject|0|||
130652782|NCT01049360|470349519|FG013|Period 4|Withdrawal by Subject|0|||
130652783|NCT01049360|470349520|FG014|Period 4|Withdrawal by Subject|0|||
130652784|NCT01049360|470349521|FG015|Period 4|Withdrawal by Subject|0|||
130652785|NCT01049360|470349522|FG016|Period 4|Withdrawal by Subject|0|||
130652786|NCT01049360|470349523|FG017|Period 4|Withdrawal by Subject|0|||
130652787|NCT01049360|470349524|FG018|Period 4|Withdrawal by Subject|0|||
130652788|NCT01049360|470349525|FG019|Period 4|Withdrawal by Subject|0|||
130652789|NCT01012765|470349526|FG000|Treatment Period 1|Adverse Event|1|||
130652790|NCT01012765|470349527|FG001|Treatment Period 1|Adverse Event|0|||
130652791|NCT01012765|470349528|FG002|Treatment Period 1|Adverse Event|1|||
130652792|NCT01012765|470349529|FG003|Treatment Period 1|Adverse Event|0|||
130652793|NCT01012765|470349530|FG004|Treatment Period 1|Adverse Event|0|||
130652794|NCT01012765|470349531|FG005|Treatment Period 1|Adverse Event|0|||
130652795|NCT01012765|470349526|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130652796|NCT01012765|470349527|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130652797|NCT01012765|470349528|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130652798|NCT01012765|470349529|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130652799|NCT01012765|470349530|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130652800|NCT01012765|470349531|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130652801|NCT01012765|470349526|FG000|Treatment Period 1|Administrative problems|0|||
130208017|NCT01534208|468721066|FG000|Overall Study|Withdrawal by Subject|6|||
130652802|NCT01012765|470349527|FG001|Treatment Period 1|Administrative problems|0|||
130652803|NCT01012765|470349528|FG002|Treatment Period 1|Administrative problems|1|||
130652804|NCT01012765|470349529|FG003|Treatment Period 1|Administrative problems|1|||
130652805|NCT01012765|470349530|FG004|Treatment Period 1|Administrative problems|1|||
130652806|NCT01012765|470349531|FG005|Treatment Period 1|Administrative problems|0|||
130652807|NCT01012765|470349526|FG000|Treatment Period 1|Protocol Violation|0|||
130652808|NCT01012765|470349527|FG001|Treatment Period 1|Protocol Violation|0|||
130652809|NCT01012765|470349528|FG002|Treatment Period 1|Protocol Violation|0|||
130652810|NCT01012765|470349529|FG003|Treatment Period 1|Protocol Violation|2|||
130652811|NCT01012765|470349530|FG004|Treatment Period 1|Protocol Violation|1|||
130652812|NCT01012765|470349531|FG005|Treatment Period 1|Protocol Violation|0|||
130652813|NCT01012765|470349526|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130652814|NCT01012765|470349527|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130652815|NCT01012765|470349528|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130652816|NCT01012765|470349529|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130652817|NCT01012765|470349530|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
130652818|NCT01012765|470349531|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130652819|NCT01012765|470349526|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130652820|NCT01012765|470349527|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130652821|NCT01012765|470349528|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130652822|NCT01012765|470349529|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130652823|NCT01012765|470349530|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130652824|NCT01012765|470349531|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130652825|NCT01012765|470349526|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
130652826|NCT01012765|470349527|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
130652827|NCT01012765|470349528|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
130652828|NCT01012765|470349529|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
130652829|NCT01012765|470349530|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
130652830|NCT01012765|470349531|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
130652831|NCT01012765|470349526|FG000|Treatment Period 2|Adverse Event|0|||
130652832|NCT01012765|470349527|FG001|Treatment Period 2|Adverse Event|1|||
130652833|NCT01012765|470349528|FG002|Treatment Period 2|Adverse Event|1|||
130652834|NCT01012765|470349529|FG003|Treatment Period 2|Adverse Event|0|||
130652835|NCT01012765|470349530|FG004|Treatment Period 2|Adverse Event|0|||
130652836|NCT01012765|470349531|FG005|Treatment Period 2|Adverse Event|0|||
130652837|NCT01012765|470349526|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130652838|NCT01012765|470349527|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
130652839|NCT01012765|470349528|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
130652840|NCT01012765|470349529|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130652841|NCT01012765|470349530|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130652842|NCT01012765|470349531|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130652843|NCT01326312|470349532|FG000|Overall Study|Adverse Event|11|||
130652844|NCT01326312|470349533|FG001|Overall Study|Adverse Event|11|||
130652845|NCT01326312|470349534|FG002|Overall Study|Adverse Event|1|||
130652846|NCT01326312|470349532|FG000|Overall Study|Withdrawal by Subject|1|||
130652847|NCT01326312|470349533|FG001|Overall Study|Withdrawal by Subject|2|||
130652848|NCT01326312|470349534|FG002|Overall Study|Withdrawal by Subject|1|||
130652849|NCT01326312|470349532|FG000|Overall Study|Protocol Violation|0|||
130652850|NCT01326312|470349533|FG001|Overall Study|Protocol Violation|1|||
130652851|NCT01326312|470349534|FG002|Overall Study|Protocol Violation|0|||
130652852|NCT01326312|470349532|FG000|Overall Study|Lack of Efficacy|13|||
130652853|NCT01326312|470349533|FG001|Overall Study|Lack of Efficacy|7|||
130652854|NCT01326312|470349534|FG002|Overall Study|Lack of Efficacy|1|||
130652855|NCT01326312|470349532|FG000|Overall Study|Death|1|||
130652856|NCT01326312|470349533|FG001|Overall Study|Death|0|||
130652857|NCT01326312|470349534|FG002|Overall Study|Death|1|||
130652858|NCT01326312|470349532|FG000|Overall Study|progressive disease|0|||
130652859|NCT01326312|470349533|FG001|Overall Study|progressive disease|1|||
130652860|NCT01326312|470349534|FG002|Overall Study|progressive disease|1|||
130652861|NCT01326312|470349532|FG000|Overall Study|Study terminated by Sponsor|8|||
130652862|NCT01326312|470349533|FG001|Overall Study|Study terminated by Sponsor|32|||
130652863|NCT01326312|470349534|FG002|Overall Study|Study terminated by Sponsor|46|||
130652864|NCT01326312|470349532|FG000|Overall Study|Treatment arm terminated|19|||
130652865|NCT01326312|470349533|FG001|Overall Study|Treatment arm terminated|0|||
130652866|NCT01326312|470349534|FG002|Overall Study|Treatment arm terminated|0|||
130652867|NCT01326312|470349532|FG000|Overall Study|QTc > 500|0|||
130652868|NCT01326312|470349533|FG001|Overall Study|QTc > 500|1|||
130652869|NCT01326312|470349534|FG002|Overall Study|QTc > 500|0|||
130652870|NCT00499694|470349535|FG000|Overall Study|Patient never received treatment.|1|||
130720798|NCT00626392|470601520|FG003|Coadministration Period|Protocol Violation|1|||
130720799|NCT00626392|470601521|FG004|Coadministration Period|Protocol Violation|1|||
130720800|NCT00626392|470601522|FG005|Coadministration Period|Protocol Violation|0|||
130720801|NCT00626392|470601517|FG000|Coadministration Period|Other|0|||
130720802|NCT00626392|470601518|FG001|Coadministration Period|Other|2|||
130720803|NCT00626392|470601519|FG002|Coadministration Period|Other|3|||
130720804|NCT00626392|470601520|FG003|Coadministration Period|Other|1|||
130720805|NCT00626392|470601521|FG004|Coadministration Period|Other|1|||
130720806|NCT00626392|470601522|FG005|Coadministration Period|Other|1|||
130720807|NCT01085734|470601527|FG000|Overall Study|Adverse Event|0|||
130720808|NCT01085734|470601528|FG001|Overall Study|Adverse Event|2|||
130720809|NCT01085734|470601527|FG000|Overall Study|Death|1|||
130720810|NCT01085734|470601528|FG001|Overall Study|Death|0|||
130720811|NCT01085734|470601527|FG000|Overall Study|Lost to Follow-up|0|||
130720812|NCT01085734|470601528|FG001|Overall Study|Lost to Follow-up|1|||
130720813|NCT01085734|470601527|FG000|Overall Study|Withdrawal by Subject|0|||
130720814|NCT01085734|470601528|FG001|Overall Study|Withdrawal by Subject|1|||
130652871|NCT01302366|470351309|FG000|Overall Study|patient choice or noncompliance|5|||
130652872|NCT00934661|470351310|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
130652873|NCT00934661|470351311|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
130652874|NCT00467051|470351312|FG000|Overall Study|Adverse Event|2|||
130652875|NCT00761462|470351316|FG000|Treatment|Subjects never received study medication|23|||
130652876|NCT00761462|470351317|FG001|Treatment|Subjects never received study medication|12|||
130652877|NCT00761462|470351316|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
130652878|NCT00761462|470351317|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
130652879|NCT00761462|470351316|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
130652880|NCT00761462|470351317|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
130652881|NCT00761462|470351316|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
130652882|NCT00761462|470351317|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
130652883|NCT01479777|470351318|FG000|Overall Study|Physician Decision|2|||
130652884|NCT01013207|470351322|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
130652885|NCT01541644|470351327|FG000|Overall Study|Withdrawal by Subject|3|||
130652886|NCT02389621|470351328|FG000|Treatment Period|Withdrawal by Subject|1|||
130652887|NCT02389621|470351329|FG001|Treatment Period|Withdrawal by Subject|1|||
130652888|NCT02389621|470351328|FG000|Posttreatment Period|Adverse Event|3|||
130652889|NCT02389621|470351329|FG001|Posttreatment Period|Adverse Event|1|||
130652890|NCT02389621|470351328|FG000|Posttreatment Period|Withdrawal by Subject|3|||
130652891|NCT02389621|470351329|FG001|Posttreatment Period|Withdrawal by Subject|2|||
130652892|NCT02389621|470351328|FG000|Posttreatment Period|Lost to Follow-up|1|||
130652893|NCT02389621|470351329|FG001|Posttreatment Period|Lost to Follow-up|1|||
130652894|NCT02389621|470351328|FG000|Posttreatment Period|Other - Miscellaneous|2|||
130652895|NCT02389621|470351329|FG001|Posttreatment Period|Other - Miscellaneous|0|||
130652896|NCT02957149|470351348|FG000|Overall Study|Withdrawal by Subject|5|||
130652897|NCT00003526|470351349|FG000|Overall Study|Not evaluable|6|||
130652898|NCT04359758|470351356|FG000|Overall Study|Protocol Violation|3|||
130652899|NCT04359758|470351357|FG001|Overall Study|Protocol Violation|2|||
130652900|NCT03358407|470351358|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652901|NCT03358407|470351359|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652902|NCT03358407|470351360|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
130208018|NCT01534208|468721067|FG001|Overall Study|Withdrawal by Subject|20|||
130208019|NCT01534208|468721066|FG000|Overall Study|Adverse Event|15|||
130208020|NCT01534208|468721067|FG001|Overall Study|Adverse Event|8|||
130208021|NCT01534208|468721066|FG000|Overall Study|Physician Decision|2|||
130208022|NCT01534208|468721067|FG001|Overall Study|Physician Decision|0|||
130208023|NCT01534208|468721066|FG000|Overall Study|Lack of Efficacy|0|||
130208024|NCT01534208|468721067|FG001|Overall Study|Lack of Efficacy|3|||
130208025|NCT01534208|468721066|FG000|Overall Study|Protocol Violation|2|||
130208026|NCT01534208|468721067|FG001|Overall Study|Protocol Violation|2|||
130208027|NCT01534208|468721066|FG000|Overall Study|Sponsor decision|4|||
130208028|NCT01534208|468721067|FG001|Overall Study|Sponsor decision|1|||
130208029|NCT01534208|468721066|FG000|Overall Study|Subject relocation|2|||
130208030|NCT01534208|468721067|FG001|Overall Study|Subject relocation|0|||
130208031|NCT01534208|468721066|FG000|Overall Study|Lab assessment|2|||
130208032|NCT01534208|468721067|FG001|Overall Study|Lab assessment|1|||
130208033|NCT01534208|468721066|FG000|Overall Study|Eligibility error|3|||
130208034|NCT01534208|468721067|FG001|Overall Study|Eligibility error|0|||
130208035|NCT01534208|468721066|FG000|Overall Study|PCP decision|1|||
130208036|NCT01534208|468721067|FG001|Overall Study|PCP decision|0|||
130208037|NCT01534208|468721066|FG000|Overall Study|Needed prohibited meds|1|||
130208038|NCT01534208|468721067|FG001|Overall Study|Needed prohibited meds|0|||
130208039|NCT01904903|468721068|FG000|Overall Study|Withdrawal by Subject|1|||
130208040|NCT01260584|468721069|FG000|Period 1|Protocol Violation|0|||
130208041|NCT01260584|468721070|FG001|Period 1|Protocol Violation|0|||
130208042|NCT01260584|468721071|FG002|Period 1|Protocol Violation|1|||
130208043|NCT01260584|468721072|FG003|Period 1|Protocol Violation|1|||
130208044|NCT01260584|468721069|FG000|Period 1|Adverse Event|0|||
130208045|NCT01260584|468721070|FG001|Period 1|Adverse Event|0|||
130208046|NCT01260584|468721071|FG002|Period 1|Adverse Event|1|||
130208047|NCT01260584|468721072|FG003|Period 1|Adverse Event|0|||
130208048|NCT01260584|468721069|FG000|Period 2|Protocol Violation|0|||
130208049|NCT01260584|468721070|FG001|Period 2|Protocol Violation|2|||
130208050|NCT01260584|468721071|FG002|Period 2|Protocol Violation|3|||
130208051|NCT01260584|468721072|FG003|Period 2|Protocol Violation|1|||
130652903|NCT03358407|470351361|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652904|NCT03358407|470351362|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652905|NCT03358407|470351363|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652906|NCT03358407|470351364|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652907|NCT03358407|470351365|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130208052|NCT01260584|468721069|FG000|Period 2|Adverse Event|1|||
130208053|NCT01260584|468721070|FG001|Period 2|Adverse Event|0|||
130208054|NCT01260584|468721071|FG002|Period 2|Adverse Event|2|||
130208055|NCT01260584|468721072|FG003|Period 2|Adverse Event|0|||
130208056|NCT01260584|468721069|FG000|Period 2|Withdrawal by Subject|0|||
130652908|NCT03358407|470351366|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652909|NCT03358407|470351367|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130652910|NCT03358407|470351358|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652911|NCT03358407|470351359|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652912|NCT03358407|470351360|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652913|NCT03358407|470351361|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652914|NCT03358407|470351362|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130652915|NCT03358407|470351363|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652916|NCT03358407|470351364|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652917|NCT03358407|470351365|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652918|NCT03358407|470351366|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652919|NCT03358407|470351367|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652920|NCT03358407|470351358|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652921|NCT03358407|470351359|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652922|NCT03358407|470351360|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652923|NCT03358407|470351361|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652924|NCT03358407|470351362|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652925|NCT03358407|470351363|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
130652926|NCT03358407|470351364|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652927|NCT03358407|470351365|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
130652928|NCT03358407|470351366|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652929|NCT03358407|470351367|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130652930|NCT03358407|470351358|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652931|NCT03358407|470351359|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652932|NCT03358407|470351360|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652933|NCT03358407|470351361|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652934|NCT03358407|470351362|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652935|NCT03358407|470351363|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
130652936|NCT03358407|470351364|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652937|NCT03358407|470351365|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
130652938|NCT03358407|470351366|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652939|NCT03358407|470351367|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130652940|NCT03358407|470351358|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652941|NCT03358407|470351359|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652942|NCT03358407|470351360|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652943|NCT03358407|470351361|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652944|NCT03358407|470351362|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652945|NCT03358407|470351363|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130652946|NCT03358407|470351364|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130652947|NCT03358407|470351365|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652948|NCT03358407|470351366|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652949|NCT03358407|470351367|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130652950|NCT03358407|470351358|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652951|NCT03358407|470351359|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652952|NCT03358407|470351360|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652953|NCT03358407|470351361|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652954|NCT03358407|470351362|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652955|NCT03358407|470351363|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
130652956|NCT03358407|470351364|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
130652957|NCT03358407|470351365|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
130652958|NCT03358407|470351366|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652959|NCT03358407|470351367|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130652960|NCT03605758|470351368|FG000|Overall Study|Lost to Follow-up|2|||
130652961|NCT03605758|470351369|FG001|Overall Study|Lost to Follow-up|1|||
130652962|NCT03605758|470351368|FG000|Overall Study|Illness|0|||
130652963|NCT03605758|470351369|FG001|Overall Study|Illness|1|||
130652964|NCT03605758|470351368|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
130652965|NCT03605758|470351369|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
130652966|NCT04753606|470351370|FG000|Overall Study|Adverse Event|1|||
130652967|NCT04753606|470351371|FG001|Overall Study|Adverse Event|0|||
130652968|NCT04753606|470351372|FG002|Overall Study|Adverse Event|0|||
130652969|NCT00489411|470351373|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
130543316|NCT00686725|469956696|FG000|Overall Study|Adverse Event|1|||
130543317|NCT00686725|469956697|FG001|Overall Study|Adverse Event|1|||
130652970|NCT00489411|470351374|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
130652971|NCT00489411|470351373|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
130652972|NCT00489411|470351374|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
130652973|NCT00489411|470351373|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
130652974|NCT00489411|470351374|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
130652975|NCT00489411|470351373|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
130652976|NCT00489411|470351374|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
130652977|NCT00489411|470351373|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
130652978|NCT00489411|470351374|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
130652979|NCT01283009|470351375|FG000|Overall Study|Death|83|||
130652980|NCT01283009|470351376|FG001|Overall Study|Death|78|||
130652981|NCT01283009|470351375|FG000|Overall Study|Study ended early|23|||
130652982|NCT01283009|470351376|FG001|Overall Study|Study ended early|26|||
130652983|NCT01283009|470351375|FG000|Overall Study|Withdrawal by Subject|10|||
130652984|NCT01283009|470351376|FG001|Overall Study|Withdrawal by Subject|8|||
130652985|NCT01283009|470351375|FG000|Overall Study|Physician Decision|1|||
130652986|NCT01283009|470351376|FG001|Overall Study|Physician Decision|1|||
130652987|NCT01283009|470351375|FG000|Overall Study|Lost to Follow-up|1|||
130652988|NCT01283009|470351376|FG001|Overall Study|Lost to Follow-up|0|||
130652989|NCT01283009|470351375|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
130652990|NCT01283009|470351376|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
130652991|NCT01748162|470351379|FG000|Overall Study|no additional croup episodes to evaluate|2|||
130652992|NCT01748162|470351380|FG001|Overall Study|no additional croup episodes to evaluate|2|||
130652993|NCT01748162|470351379|FG000|Overall Study|participant consented but did not begin|0|||
130652994|NCT01748162|470351380|FG001|Overall Study|participant consented but did not begin|1|||
130652995|NCT01748162|470351379|FG000|Overall Study|reasons not available|3|||
130652996|NCT01748162|470351380|FG001|Overall Study|reasons not available|2|||
130652997|NCT00505765|470351381|FG000|Overall Study|Withdrawal by Subject|1|||
130652998|NCT00505765|470351382|FG001|Overall Study|Withdrawal by Subject|0|||
130652999|NCT00505765|470351383|FG002|Overall Study|Withdrawal by Subject|0|||
130653000|NCT00505765|470351381|FG000|Overall Study|Adverse Event|1|||
130653001|NCT00505765|470351382|FG001|Overall Study|Adverse Event|2|||
130653002|NCT00505765|470351383|FG002|Overall Study|Adverse Event|0|||
130653003|NCT00505765|470351381|FG000|Overall Study|Noncompliance|0|||
130653004|NCT00505765|470351382|FG001|Overall Study|Noncompliance|1|||
130653005|NCT00505765|470351383|FG002|Overall Study|Noncompliance|3|||
130653006|NCT03841331|470351384|FG000|Overall Study|Withdrawal by Subject|4|||
130653007|NCT03841331|470351385|FG001|Overall Study|Withdrawal by Subject|9|||
130653008|NCT03841331|470351384|FG000|Overall Study|Lost to Follow-up|5|||
130653009|NCT03841331|470351385|FG001|Overall Study|Lost to Follow-up|1|||
130653010|NCT02743117|470351386|FG000|Overall Study|Lost to Follow-up|0|||
130653011|NCT02743117|470351387|FG001|Overall Study|Lost to Follow-up|1|||
130653012|NCT02743117|470351386|FG000|Overall Study|Other|1|||
130653013|NCT02743117|470351387|FG001|Overall Study|Other|0|||
130653014|NCT01207219|470351388|FG000|Overall Study|changed diagnosis during study period|5|||
130653015|NCT01207219|470351389|FG001|Overall Study|changed diagnosis during study period|3|||
130653016|NCT01207219|470351390|FG002|Overall Study|changed diagnosis during study period|1|||
130653017|NCT01207219|470351388|FG000|Overall Study|Lost to Follow-up|6|||
130653018|NCT01207219|470351389|FG001|Overall Study|Lost to Follow-up|8|||
130653019|NCT01207219|470351390|FG002|Overall Study|Lost to Follow-up|6|||
130653020|NCT01453296|470351396|FG000|Treatment Period 1|Adverse Event|0|||
130653021|NCT01453296|470351397|FG001|Treatment Period 1|Adverse Event|1|||
130653022|NCT01453296|470351396|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
130653023|NCT01453296|470351397|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
130653024|NCT01453296|470351396|FG000|Treatment Period 2|Adverse Event|1|||
130653025|NCT01453296|470351397|FG001|Treatment Period 2|Adverse Event|0|||
130653026|NCT01453296|470351396|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130653027|NCT01453296|470351397|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130653028|NCT03532048|470351399|FG000|Overall Study|Lost to Follow-up|12|||
130653029|NCT03532048|470351400|FG001|Overall Study|Lost to Follow-up|17|||
130653030|NCT03532048|470351399|FG000|Overall Study|Withdrawal by Subject|7|||
130208057|NCT01260584|468721070|FG001|Period 2|Withdrawal by Subject|1|||
130208058|NCT01260584|468721071|FG002|Period 2|Withdrawal by Subject|0|||
130653031|NCT03532048|470351400|FG001|Overall Study|Withdrawal by Subject|0|||
130653032|NCT04366258|470351401|FG000|Baseline Assessments|Screen Failure|21|||
130653033|NCT04366258|470351401|FG000|Baseline Assessments|Early Termination|3|||
130653034|NCT01725217|470351404|FG000|Overall Study|Withdrawal by Subject|1|||
130653035|NCT01725217|470351405|FG001|Overall Study|Withdrawal by Subject|0|||
130653036|NCT01725217|470351406|FG002|Overall Study|Withdrawal by Subject|0|||
130653037|NCT00308555|470351411|FG000|Overall Study|Withdrawal by Subject|1|||
130653038|NCT00308555|470351412|FG001|Overall Study|Withdrawal by Subject|0|||
130653039|NCT00308555|470351411|FG000|Overall Study|Physician Decision|2|||
130653040|NCT00308555|470351412|FG001|Overall Study|Physician Decision|0|||
130653041|NCT00276458|470351413|FG000|Overall Study|Adverse Event|0|||
130653042|NCT00276458|470351414|FG001|Overall Study|Adverse Event|2|||
130653043|NCT00276458|470351413|FG000|Overall Study|Lost to Follow-up|2|||
130653044|NCT00276458|470351414|FG001|Overall Study|Lost to Follow-up|2|||
130653045|NCT00276458|470351413|FG000|Overall Study|Protocol Violation|4|||
130653046|NCT00276458|470351414|FG001|Overall Study|Protocol Violation|3|||
130653047|NCT03205046|470351420|FG000|Overall Study|Death|10|||
130653048|NCT03205046|470351421|FG001|Overall Study|Death|6|||
130653049|NCT03205046|470351420|FG000|Overall Study|Withdrawal by Subject|1|||
130653050|NCT03205046|470351421|FG001|Overall Study|Withdrawal by Subject|2|||
130653051|NCT03205046|470351420|FG000|Overall Study|Lost to Follow-up|0|||
130653052|NCT03205046|470351421|FG001|Overall Study|Lost to Follow-up|1|||
130653053|NCT03205046|470351420|FG000|Overall Study|Study terminated by sponsor|2|||
130653054|NCT03205046|470351421|FG001|Overall Study|Study terminated by sponsor|1|||
130653055|NCT03253809|470351422|FG000|Overall Study|Unable to obtain study related data|14|||
130653056|NCT04113746|470351423|FG000|Overall Study|Lost to Follow-up|4|||
130653057|NCT04113746|470351424|FG001|Overall Study|Lost to Follow-up|4|||
130653058|NCT02594384|470351425|FG000|Overall Study|Disease Progression|3|||
130653059|NCT02594384|470351426|FG001|Overall Study|Disease Progression|7|||
130653060|NCT02594384|470351427|FG002|Overall Study|Disease Progression|0|||
130653061|NCT02594384|470351428|FG003|Overall Study|Disease Progression|2|||
130653062|NCT02594384|470351429|FG004|Overall Study|Disease Progression|2|||
130653063|NCT02594384|470351430|FG005|Overall Study|Disease Progression|12|||
130653064|NCT02594384|470351431|FG006|Overall Study|Disease Progression|5|||
130653065|NCT02594384|470351432|FG007|Overall Study|Disease Progression|5|||
130653066|NCT02594384|470351425|FG000|Overall Study|Adverse Event|0|||
130653067|NCT02594384|470351426|FG001|Overall Study|Adverse Event|1|||
130653068|NCT02594384|470351427|FG002|Overall Study|Adverse Event|4|||
130653069|NCT02594384|470351428|FG003|Overall Study|Adverse Event|1|||
130653070|NCT02594384|470351429|FG004|Overall Study|Adverse Event|0|||
130653071|NCT02594384|470351430|FG005|Overall Study|Adverse Event|6|||
130653072|NCT02594384|470351431|FG006|Overall Study|Adverse Event|1|||
130653073|NCT02594384|470351432|FG007|Overall Study|Adverse Event|1|||
130653074|NCT02594384|470351425|FG000|Overall Study|Withdrawal by Subject|0|||
130653075|NCT02594384|470351426|FG001|Overall Study|Withdrawal by Subject|0|||
130653076|NCT02594384|470351427|FG002|Overall Study|Withdrawal by Subject|0|||
130653077|NCT02594384|470351428|FG003|Overall Study|Withdrawal by Subject|1|||
130653078|NCT02594384|470351429|FG004|Overall Study|Withdrawal by Subject|0|||
130653079|NCT02594384|470351430|FG005|Overall Study|Withdrawal by Subject|0|||
130653080|NCT02594384|470351431|FG006|Overall Study|Withdrawal by Subject|0|||
130653081|NCT02594384|470351432|FG007|Overall Study|Withdrawal by Subject|1|||
130653082|NCT02594384|470351425|FG000|Overall Study|Physician Decision|0|||
130653083|NCT02594384|470351426|FG001|Overall Study|Physician Decision|0|||
130653084|NCT02594384|470351427|FG002|Overall Study|Physician Decision|0|||
130653085|NCT02594384|470351428|FG003|Overall Study|Physician Decision|0|||
130653086|NCT02594384|470351429|FG004|Overall Study|Physician Decision|0|||
130653087|NCT02594384|470351430|FG005|Overall Study|Physician Decision|1|||
130653088|NCT02594384|470351431|FG006|Overall Study|Physician Decision|2|||
130653089|NCT02594384|470351432|FG007|Overall Study|Physician Decision|0|||
130653090|NCT02594384|470351425|FG000|Overall Study|Progressive Leukocytosis|0|||
130653091|NCT02594384|470351426|FG001|Overall Study|Progressive Leukocytosis|0|||
130653092|NCT02594384|470351427|FG002|Overall Study|Progressive Leukocytosis|1|||
130653093|NCT02594384|470351428|FG003|Overall Study|Progressive Leukocytosis|0|||
130653094|NCT02594384|470351429|FG004|Overall Study|Progressive Leukocytosis|0|||
130653095|NCT02594384|470351430|FG005|Overall Study|Progressive Leukocytosis|0|||
130653096|NCT02594384|470351431|FG006|Overall Study|Progressive Leukocytosis|0|||
130653097|NCT02594384|470351432|FG007|Overall Study|Progressive Leukocytosis|0|||
130653098|NCT02594384|470351425|FG000|Overall Study|Lack of Efficacy|0|||
130653099|NCT02594384|470351426|FG001|Overall Study|Lack of Efficacy|0|||
130653100|NCT02594384|470351427|FG002|Overall Study|Lack of Efficacy|0|||
130653101|NCT02594384|470351428|FG003|Overall Study|Lack of Efficacy|0|||
130653102|NCT02594384|470351429|FG004|Overall Study|Lack of Efficacy|1|||
130653103|NCT02594384|470351430|FG005|Overall Study|Lack of Efficacy|0|||
130653104|NCT02594384|470351431|FG006|Overall Study|Lack of Efficacy|0|||
130653105|NCT02594384|470351432|FG007|Overall Study|Lack of Efficacy|0|||
130653106|NCT02594384|470351425|FG000|Overall Study|Substantial noncompliance|0|||
130653107|NCT02594384|470351426|FG001|Overall Study|Substantial noncompliance|0|||
130653108|NCT02594384|470351427|FG002|Overall Study|Substantial noncompliance|0|||
130653109|NCT02594384|470351428|FG003|Overall Study|Substantial noncompliance|0|||
130653110|NCT02594384|470351429|FG004|Overall Study|Substantial noncompliance|0|||
130653111|NCT02594384|470351430|FG005|Overall Study|Substantial noncompliance|0|||
130653112|NCT02594384|470351431|FG006|Overall Study|Substantial noncompliance|1|||
130653113|NCT02594384|470351432|FG007|Overall Study|Substantial noncompliance|0|||
130653114|NCT04964960|470351435|FG000|Overall Study|Withdrawal by Subject|1|||
130653115|NCT02686749|470351436|FG000|Overall Study|terminated for poor enrollment|2|||
130653116|NCT02686749|470351437|FG001|Overall Study|terminated for poor enrollment|2|||
130653117|NCT00596466|470351445|FG000|Overall Study|Lack of Efficacy|5|||
130653118|NCT00596466|470351445|FG000|Overall Study|Adverse Event|4|||
130653119|NCT00596466|470351445|FG000|Overall Study|Withdrawal by Subject|2|||
130653120|NCT00596466|470351445|FG000|Overall Study|Protocol Violation|2|||
130653121|NCT00596466|470351445|FG000|Overall Study|Unpecified|2|||
130653122|NCT00596466|470351445|FG000|Overall Study|Enrolled, not treated|2|||
130653123|NCT00480077|470351446|FG000|Overall Study|Death|19|||
130653124|NCT00480077|470351447|FG001|Overall Study|Death|15|||
130653125|NCT00480077|470351446|FG000|Overall Study|early exit|12|||
130653126|NCT00480077|470351447|FG001|Overall Study|early exit|11|||
130653127|NCT00262119|470351453|FG000|Overall Study|Lost to Follow-up|38|||
130653128|NCT00262119|470351454|FG001|Overall Study|Lost to Follow-up|51|||
130653129|NCT00262119|470351455|FG002|Overall Study|Lost to Follow-up|42|||
130653130|NCT00262119|470351453|FG000|Overall Study|Death|20|||
130653131|NCT00262119|470351454|FG001|Overall Study|Death|19|||
130653132|NCT00262119|470351455|FG002|Overall Study|Death|16|||
130653133|NCT01683565|470351456|FG000|Overall Study|Lost to Follow-up|2|||
130653134|NCT01683565|470351457|FG001|Overall Study|Lost to Follow-up|0|||
130653135|NCT01683565|470351456|FG000|Overall Study|Discontinued Intervention|1|||
130653136|NCT01683565|470351457|FG001|Overall Study|Discontinued Intervention|1|||
130653137|NCT05261126|470351458|FG000|Overall Study|Death|0|||
130653138|NCT05261126|470351459|FG001|Overall Study|Death|0|||
130653139|NCT05261126|470351460|FG002|Overall Study|Death|1|||
130653140|NCT05261126|470351461|FG003|Overall Study|Death|0|||
130653141|NCT05261126|470351462|FG004|Overall Study|Death|0|||
130653142|NCT05261126|470351458|FG000|Overall Study|Lost to Follow-up|0|||
130653143|NCT05261126|470351459|FG001|Overall Study|Lost to Follow-up|0|||
130653144|NCT05261126|470351460|FG002|Overall Study|Lost to Follow-up|0|||
130653145|NCT05261126|470351461|FG003|Overall Study|Lost to Follow-up|0|||
130653146|NCT05261126|470351462|FG004|Overall Study|Lost to Follow-up|1|||
130653147|NCT05261126|470351458|FG000|Overall Study|Physician Decision|1|||
130653148|NCT05261126|470351459|FG001|Overall Study|Physician Decision|0|||
130653149|NCT05261126|470351460|FG002|Overall Study|Physician Decision|0|||
130653150|NCT05261126|470351461|FG003|Overall Study|Physician Decision|0|||
130653151|NCT05261126|470351462|FG004|Overall Study|Physician Decision|0|||
130653152|NCT05261126|470351458|FG000|Overall Study|Screen Failure|0|||
130653153|NCT05261126|470351459|FG001|Overall Study|Screen Failure|0|||
130653154|NCT05261126|470351460|FG002|Overall Study|Screen Failure|0|||
130653155|NCT05261126|470351461|FG003|Overall Study|Screen Failure|0|||
130653156|NCT05261126|470351462|FG004|Overall Study|Screen Failure|1|||
130653157|NCT05261126|470351458|FG000|Overall Study|Withdrawal by Subject|1|||
130653158|NCT05261126|470351459|FG001|Overall Study|Withdrawal by Subject|0|||
130653159|NCT05261126|470351460|FG002|Overall Study|Withdrawal by Subject|1|||
130653160|NCT05261126|470351461|FG003|Overall Study|Withdrawal by Subject|1|||
130653161|NCT05261126|470351462|FG004|Overall Study|Withdrawal by Subject|0|||
130653162|NCT05261126|470351458|FG000|Overall Study|Not Recorded|0|||
130653163|NCT05261126|470351459|FG001|Overall Study|Not Recorded|0|||
130653164|NCT05261126|470351460|FG002|Overall Study|Not Recorded|0|||
130653165|NCT05261126|470351461|FG003|Overall Study|Not Recorded|1|||
130653166|NCT05261126|470351462|FG004|Overall Study|Not Recorded|0|||
130653167|NCT05570604|470351463|FG000|Overall Study|Lost to Follow-up|1|||
130653168|NCT05570604|470351464|FG001|Overall Study|Lost to Follow-up|5|||
130653169|NCT05570604|470351463|FG000|Overall Study|Illness|2|||
130653170|NCT05570604|470351464|FG001|Overall Study|Illness|2|||
130653171|NCT01463631|470351479|FG000|Overall Study|Withdrawal by Subject|0|||
130653172|NCT01463631|470351480|FG001|Overall Study|Withdrawal by Subject|0|||
130653173|NCT01463631|470351481|FG002|Overall Study|Withdrawal by Subject|0|||
130653174|NCT01463631|470351482|FG003|Overall Study|Withdrawal by Subject|1|||
130653175|NCT01463631|470351479|FG000|Overall Study|Death|0|||
130653176|NCT01463631|470351480|FG001|Overall Study|Death|0|||
130653177|NCT01463631|470351481|FG002|Overall Study|Death|1|||
130653178|NCT01463631|470351482|FG003|Overall Study|Death|0|||
130653179|NCT01463631|470351479|FG000|Overall Study|Progressive Disease|0|||
130653180|NCT01463631|470351480|FG001|Overall Study|Progressive Disease|0|||
130653181|NCT01463631|470351481|FG002|Overall Study|Progressive Disease|0|||
130653182|NCT01463631|470351482|FG003|Overall Study|Progressive Disease|5|||
130653183|NCT05966129|470351483|FG000|Overall Study|Death|1|||
130653184|NCT05966129|470351484|FG001|Overall Study|Death|2|||
130653185|NCT05966129|470351483|FG000|Overall Study|Lost to Follow-up|63|||
130653186|NCT05966129|470351484|FG001|Overall Study|Lost to Follow-up|66|||
130653187|NCT05966129|470351483|FG000|Overall Study|Protocol Violation|1|||
130653188|NCT05966129|470351484|FG001|Overall Study|Protocol Violation|0|||
130653189|NCT05966129|470351483|FG000|Overall Study|Withdrawal by Subject|26|||
130653190|NCT05966129|470351484|FG001|Overall Study|Withdrawal by Subject|25|||
130653191|NCT05966129|470351483|FG000|Overall Study|Surgery not completed|63|||
130208059|NCT01260584|468721072|FG003|Period 2|Withdrawal by Subject|0|||
130653192|NCT05966129|470351484|FG001|Overall Study|Surgery not completed|69|||
130653193|NCT05966129|470351483|FG000|Overall Study|Surgery logistics issue|2|||
130653194|NCT05966129|470351484|FG001|Overall Study|Surgery logistics issue|1|||
130653195|NCT03145207|470351488|FG000|Overall Study|volunteer started taking allergy shots|1|||
130653196|NCT03145207|470351488|FG000|Overall Study|baseline blood pressure high|1|||
130653197|NCT01396434|470351489|FG000|Overall Study|Lost to Follow-up|1|||
130653198|NCT01396434|470351490|FG001|Overall Study|Lost to Follow-up|0|||
130653199|NCT01396434|470351491|FG002|Overall Study|Lost to Follow-up|0|||
130653200|NCT01396434|470351489|FG000|Overall Study|Other|10|||
130653201|NCT01396434|470351490|FG001|Overall Study|Other|0|||
130653202|NCT01396434|470351491|FG002|Overall Study|Other|0|||
130653203|NCT04678557|470351492|FG000|Overall Study|Withdrawal by Subject|1|||
130653204|NCT04678557|470351493|FG001|Overall Study|Withdrawal by Subject|0|||
130653205|NCT04678557|470351492|FG000|Overall Study|Lack of Efficacy|0|||
130653206|NCT04678557|470351493|FG001|Overall Study|Lack of Efficacy|13|||
130653207|NCT04678557|470351492|FG000|Overall Study|Safety Evaluation|0|||
130653208|NCT04678557|470351493|FG001|Overall Study|Safety Evaluation|1|||
130653209|NCT02207413|470351494|FG000|Overall Study|Withdrawal by Subject|1|||
130653210|NCT02207413|470351495|FG001|Overall Study|Withdrawal by Subject|0|||
130653211|NCT02207413|470351496|FG002|Overall Study|Withdrawal by Subject|0|||
130653212|NCT02207413|470351497|FG003|Overall Study|Withdrawal by Subject|0|||
130653213|NCT02207413|470351498|FG004|Overall Study|Withdrawal by Subject|3|||
130653214|NCT02207413|470351499|FG005|Overall Study|Withdrawal by Subject|7|||
130653215|NCT02207413|470351494|FG000|Overall Study|Lost to Follow-up|0|||
130653216|NCT02207413|470351495|FG001|Overall Study|Lost to Follow-up|0|||
130653217|NCT02207413|470351496|FG002|Overall Study|Lost to Follow-up|0|||
130653218|NCT02207413|470351497|FG003|Overall Study|Lost to Follow-up|1|||
130653219|NCT02207413|470351498|FG004|Overall Study|Lost to Follow-up|1|||
130653220|NCT02207413|470351499|FG005|Overall Study|Lost to Follow-up|5|||
130653221|NCT02207413|470351494|FG000|Overall Study|Adverse Event|0|||
130653222|NCT02207413|470351495|FG001|Overall Study|Adverse Event|0|||
130653223|NCT02207413|470351496|FG002|Overall Study|Adverse Event|0|||
130653224|NCT02207413|470351497|FG003|Overall Study|Adverse Event|0|||
130653225|NCT02207413|470351498|FG004|Overall Study|Adverse Event|2|||
130653226|NCT02207413|470351499|FG005|Overall Study|Adverse Event|1|||
130653227|NCT02207413|470351494|FG000|Overall Study|Migrated/moved from study area|0|||
130653228|NCT02207413|470351495|FG001|Overall Study|Migrated/moved from study area|0|||
130653229|NCT02207413|470351496|FG002|Overall Study|Migrated/moved from study area|0|||
130653230|NCT02207413|470351497|FG003|Overall Study|Migrated/moved from study area|0|||
130653231|NCT02207413|470351498|FG004|Overall Study|Migrated/moved from study area|1|||
130653232|NCT02207413|470351499|FG005|Overall Study|Migrated/moved from study area|0|||
130653233|NCT03526549|470353730|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
130653234|NCT03526549|470353731|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
130653235|NCT03526549|470353730|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
130653236|NCT03526549|470353731|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
130653237|NCT03526549|470353730|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
130653238|NCT03526549|470353731|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
130653239|NCT03526549|470353730|FG000|Open-label Phase|Adverse Event|4|||
130653240|NCT03526549|470353731|FG001|Open-label Phase|Adverse Event|0|||
130653241|NCT03526549|470353730|FG000|Open-label Phase|Withdrawal by Subject|54|||
130653242|NCT03526549|470353731|FG001|Open-label Phase|Withdrawal by Subject|0|||
130653243|NCT03526549|470353730|FG000|Open-label Phase|Lost to Follow-up|35|||
130653244|NCT03526549|470353731|FG001|Open-label Phase|Lost to Follow-up|0|||
130653245|NCT03526549|470353730|FG000|Open-label Phase|Other than Specified|5|||
130653246|NCT03526549|470353731|FG001|Open-label Phase|Other than Specified|0|||
130653247|NCT05981365|470353738|FG000|Period 1|Adverse Event|1|||
130653248|NCT05981365|470353739|FG001|Period 1|Adverse Event|0|||
130653249|NCT04780776|470353740|FG000|Titration Week 1-5|Lost to Follow-up|2|||
130653250|NCT04780776|470353741|FG001|Titration Week 1-5|Lost to Follow-up|8|||
130653251|NCT04780776|470353740|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
130653252|NCT04780776|470353741|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
130653253|NCT04780776|470353740|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
130653254|NCT04780776|470353741|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
130653255|NCT03113760|470353742|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
130653256|NCT03113760|470353743|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130653257|NCT03113760|470353744|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130653258|NCT03113760|470353745|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130653259|NCT03113760|470353742|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
130653260|NCT03113760|470353743|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130653261|NCT03113760|470353744|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130653262|NCT03113760|470353745|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130653263|NCT03113760|470353742|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
130653264|NCT03113760|470353743|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
130653265|NCT03113760|470353744|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
130653266|NCT03113760|470353745|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
130653267|NCT03927989|470353746|FG000|Overall Study|Withdrawal by Subject|0|||
130653268|NCT03927989|470353747|FG001|Overall Study|Withdrawal by Subject|1|||
130653269|NCT04640168|470353748|FG000|Overall Study|Withdrawal by Subject|8|||
130653270|NCT04640168|470353749|FG001|Overall Study|Withdrawal by Subject|7|||
130653271|NCT04640168|470353748|FG000|Overall Study|Lost to Follow-up|1|||
130653272|NCT04640168|470353749|FG001|Overall Study|Lost to Follow-up|0|||
130653273|NCT04640168|470353748|FG000|Overall Study|Enrolled but not treated|12|||
130653274|NCT04640168|470353749|FG001|Overall Study|Enrolled but not treated|12|||
130653275|NCT00779857|470353750|FG000|Overall Study|Death|1|||
130653276|NCT00779857|470353750|FG000|Overall Study|Withdrawal by Subject|3|||
130653277|NCT00779857|470353750|FG000|Overall Study|Missed Visit|2|||
130653278|NCT00620776|470353751|FG000|Overall Study|Did not receive treatment|3|||
130653279|NCT00620776|470353752|FG001|Overall Study|Did not receive treatment|5|||
130653280|NCT00620776|470353751|FG000|Overall Study|Adverse Event|2|||
130653281|NCT00620776|470353752|FG001|Overall Study|Adverse Event|3|||
130653282|NCT00620776|470353751|FG000|Overall Study|Lack of Efficacy|2|||
130653283|NCT00620776|470353752|FG001|Overall Study|Lack of Efficacy|1|||
130653284|NCT00620776|470353751|FG000|Overall Study|Lost to Follow-up|2|||
130653285|NCT00620776|470353752|FG001|Overall Study|Lost to Follow-up|5|||
130653286|NCT00620776|470353751|FG000|Overall Study|Withdrawal by Subject|3|||
130653287|NCT00620776|470353752|FG001|Overall Study|Withdrawal by Subject|2|||
130653288|NCT02940392|470353756|FG000|Overall Study|Lost to Follow-up|3|||
130653289|NCT02940392|470353756|FG000|Overall Study|Retreatment|3|||
130653290|NCT02940392|470353756|FG000|Overall Study|Death|2|||
130653291|NCT01023815|470353757|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
130653292|NCT01023815|470353758|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130653293|NCT01023815|470353759|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130653294|NCT01023815|470353760|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130653295|NCT01023815|470353757|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
130653296|NCT01023815|470353758|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
130653297|NCT01023815|470353759|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
130653298|NCT01023815|470353760|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
130653299|NCT01023815|470353757|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
130653300|NCT01023815|470353758|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
130653301|NCT01023815|470353759|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
130653302|NCT01023815|470353760|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
130653303|NCT01023815|470353757|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
130653304|NCT01023815|470353758|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
130653305|NCT01023815|470353759|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
130653306|NCT01023815|470353760|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
130653307|NCT01023815|470353757|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130653308|NCT01023815|470353758|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
130653309|NCT01023815|470353759|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130653310|NCT01023815|470353760|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130653311|NCT03992456|470353763|FG000|Overall Study|Withdrawal by Subject|1|||
130653312|NCT03992456|470353764|FG001|Overall Study|Withdrawal by Subject|0|||
130653313|NCT03992456|470353763|FG000|Overall Study|Disease progression|4|||
130653314|NCT03992456|470353764|FG001|Overall Study|Disease progression|5|||
130653315|NCT03992456|470353763|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
130653316|NCT03992456|470353764|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
130653317|NCT00910000|470353768|FG000|Overall Study|Adverse Event|0|||
130653318|NCT00910000|470353769|FG001|Overall Study|Adverse Event|3|||
130653319|NCT00910000|470353770|FG002|Overall Study|Adverse Event|2|||
130653320|NCT00910000|470353771|FG003|Overall Study|Adverse Event|2|||
130653321|NCT00910000|470353772|FG004|Overall Study|Adverse Event|0|||
130653322|NCT00910000|470353773|FG005|Overall Study|Adverse Event|1|||
130653323|NCT00910000|470353768|FG000|Overall Study|Withdrawal by Subject|0|||
130653324|NCT00910000|470353769|FG001|Overall Study|Withdrawal by Subject|0|||
130653325|NCT00910000|470353770|FG002|Overall Study|Withdrawal by Subject|1|||
130653326|NCT00910000|470353771|FG003|Overall Study|Withdrawal by Subject|0|||
130653327|NCT00910000|470353772|FG004|Overall Study|Withdrawal by Subject|1|||
130653328|NCT00910000|470353773|FG005|Overall Study|Withdrawal by Subject|0|||
130653329|NCT01977625|470353774|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
130653330|NCT01977625|470353775|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130653331|NCT01977625|470353774|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130653332|NCT01977625|470353775|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130653333|NCT03919669|470353777|FG000|Overall Study|Withdrawal by Subject|1|||
130653334|NCT03919669|470353778|FG001|Overall Study|Withdrawal by Subject|0|||
130653335|NCT03919669|470353779|FG002|Overall Study|Withdrawal by Subject|0|||
130653336|NCT03125382|470353780|FG000|Randomization|screening failure|1|||
130653337|NCT03125382|470353781|FG001|Randomization|screening failure|4|||
130653338|NCT03125382|470353782|FG002|Randomization|screening failure|2|||
130653339|NCT03125382|470353783|FG003|Randomization|screening failure|0|||
130653340|NCT03125382|470353780|FG000|Follow-up|Death|1|||
130653341|NCT03125382|470353781|FG001|Follow-up|Death|2|||
130653342|NCT03125382|470353782|FG002|Follow-up|Death|1|||
130653343|NCT03125382|470353783|FG003|Follow-up|Death|2|||
130653344|NCT03125382|470353780|FG000|Follow-up|Lost to Follow-up|1|||
130653345|NCT03125382|470353781|FG001|Follow-up|Lost to Follow-up|4|||
130653346|NCT03125382|470353782|FG002|Follow-up|Lost to Follow-up|3|||
130653347|NCT03125382|470353783|FG003|Follow-up|Lost to Follow-up|1|||
130653348|NCT02319642|470353784|FG000|Overall Study|Adverse Event|2|||
130653349|NCT02319642|470353785|FG001|Overall Study|Adverse Event|4|||
130653350|NCT02319642|470353784|FG000|Overall Study|Lack of Efficacy|1|||
130653351|NCT02319642|470353785|FG001|Overall Study|Lack of Efficacy|1|||
130653352|NCT02319642|470353784|FG000|Overall Study|Withdrawal by Subject|1|||
130653353|NCT02319642|470353785|FG001|Overall Study|Withdrawal by Subject|1|||
130653354|NCT04668066|470353786|FG000|Part 1: Treatment Phase|Adverse Event|0|||
130653355|NCT04668066|470353787|FG001|Part 1: Treatment Phase|Adverse Event|0|||
130653356|NCT04668066|470353788|FG002|Part 1: Treatment Phase|Adverse Event|0|||
130653357|NCT04668066|470353789|FG003|Part 1: Treatment Phase|Adverse Event|0|||
130653358|NCT04668066|470353790|FG004|Part 1: Treatment Phase|Adverse Event|0|||
130653359|NCT04668066|470353791|FG005|Part 1: Treatment Phase|Adverse Event|0|||
130653360|NCT04668066|470353792|FG006|Part 1: Treatment Phase|Adverse Event|0|||
130653361|NCT04668066|470353793|FG007|Part 1: Treatment Phase|Adverse Event|0|||
130653362|NCT04668066|470353794|FG008|Part 1: Treatment Phase|Adverse Event|0|||
130653363|NCT04668066|470353795|FG009|Part 1: Treatment Phase|Adverse Event|0|||
130653364|NCT04668066|470353796|FG010|Part 1: Treatment Phase|Adverse Event|0|||
130653365|NCT04668066|470353797|FG011|Part 1: Treatment Phase|Adverse Event|1|||
130653366|NCT04668066|470353798|FG012|Part 1: Treatment Phase|Adverse Event|1|||
130653367|NCT04668066|470353799|FG013|Part 1: Treatment Phase|Adverse Event|0|||
130653368|NCT04668066|470353800|FG014|Part 1: Treatment Phase|Adverse Event|0|||
130653369|NCT04668066|470353801|FG015|Part 1: Treatment Phase|Adverse Event|0|||
130653370|NCT04668066|470353802|FG016|Part 1: Treatment Phase|Adverse Event|0|||
130653371|NCT04668066|470353803|FG017|Part 1: Treatment Phase|Adverse Event|0|||
130653372|NCT04668066|470353804|FG018|Part 1: Treatment Phase|Adverse Event|0|||
130653373|NCT04668066|470353786|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653374|NCT04668066|470353787|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653375|NCT04668066|470353788|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
130653376|NCT04668066|470353789|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653377|NCT04668066|470353790|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653378|NCT04668066|470353791|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653379|NCT04668066|470353792|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653380|NCT04668066|470353793|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653381|NCT04668066|470353794|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653382|NCT04668066|470353795|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653383|NCT04668066|470353796|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653384|NCT04668066|470353797|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653385|NCT04668066|470353798|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653386|NCT04668066|470353799|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653387|NCT04668066|470353800|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653388|NCT04668066|470353801|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653389|NCT04668066|470353802|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653390|NCT04668066|470353803|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653391|NCT04668066|470353804|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
130653392|NCT04668066|470353786|FG000|Part 1: Treatment Phase|Other|0|||
130653393|NCT04668066|470353787|FG001|Part 1: Treatment Phase|Other|0|||
130653394|NCT04668066|470353788|FG002|Part 1: Treatment Phase|Other|0|||
130653395|NCT04668066|470353789|FG003|Part 1: Treatment Phase|Other|0|||
130653396|NCT04668066|470353790|FG004|Part 1: Treatment Phase|Other|0|||
130653397|NCT04668066|470353791|FG005|Part 1: Treatment Phase|Other|0|||
130653398|NCT04668066|470353792|FG006|Part 1: Treatment Phase|Other|0|||
130653399|NCT04668066|470353793|FG007|Part 1: Treatment Phase|Other|0|||
130653400|NCT04668066|470353794|FG008|Part 1: Treatment Phase|Other|0|||
130653401|NCT04668066|470353795|FG009|Part 1: Treatment Phase|Other|0|||
130653402|NCT04668066|470353796|FG010|Part 1: Treatment Phase|Other|0|||
130653403|NCT04668066|470353797|FG011|Part 1: Treatment Phase|Other|1|||
130653404|NCT04668066|470353798|FG012|Part 1: Treatment Phase|Other|0|||
130653405|NCT04668066|470353799|FG013|Part 1: Treatment Phase|Other|0|||
130653406|NCT04668066|470353800|FG014|Part 1: Treatment Phase|Other|0|||
130653407|NCT04668066|470353801|FG015|Part 1: Treatment Phase|Other|0|||
130653408|NCT04668066|470353802|FG016|Part 1: Treatment Phase|Other|0|||
130653409|NCT04668066|470353803|FG017|Part 1: Treatment Phase|Other|0|||
130653410|NCT04668066|470353804|FG018|Part 1: Treatment Phase|Other|0|||
130653411|NCT04668066|470353786|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653412|NCT04668066|470353787|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653413|NCT04668066|470353788|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653414|NCT04668066|470353789|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653415|NCT04668066|470353790|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653416|NCT04668066|470353791|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653417|NCT04668066|470353792|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653418|NCT04668066|470353793|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653419|NCT04668066|470353794|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653420|NCT04668066|470353795|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653421|NCT04668066|470353796|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653422|NCT04668066|470353797|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653423|NCT04668066|470353798|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
130653424|NCT04668066|470353799|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653425|NCT04668066|470353800|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653426|NCT04668066|470353801|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
130653427|NCT04668066|470353802|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653428|NCT04668066|470353803|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653429|NCT04668066|470353804|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130653430|NCT04668066|470353786|FG000|Part 1: Follow-Up|Adverse Event|0|||
130653431|NCT04668066|470353787|FG001|Part 1: Follow-Up|Adverse Event|0|||
130653432|NCT04668066|470353788|FG002|Part 1: Follow-Up|Adverse Event|0|||
130653433|NCT04668066|470353789|FG003|Part 1: Follow-Up|Adverse Event|0|||
130653434|NCT04668066|470353790|FG004|Part 1: Follow-Up|Adverse Event|0|||
130653435|NCT04668066|470353791|FG005|Part 1: Follow-Up|Adverse Event|0|||
130653436|NCT04668066|470353792|FG006|Part 1: Follow-Up|Adverse Event|0|||
130653437|NCT04668066|470353793|FG007|Part 1: Follow-Up|Adverse Event|0|||
130653438|NCT04668066|470353794|FG008|Part 1: Follow-Up|Adverse Event|0|||
130653439|NCT04668066|470353795|FG009|Part 1: Follow-Up|Adverse Event|0|||
130653440|NCT04668066|470353796|FG010|Part 1: Follow-Up|Adverse Event|0|||
130653441|NCT04668066|470353797|FG011|Part 1: Follow-Up|Adverse Event|1|||
130653442|NCT04668066|470353798|FG012|Part 1: Follow-Up|Adverse Event|0|||
130653443|NCT04668066|470353799|FG013|Part 1: Follow-Up|Adverse Event|0|||
130653444|NCT04668066|470353800|FG014|Part 1: Follow-Up|Adverse Event|0|||
130653445|NCT04668066|470353801|FG015|Part 1: Follow-Up|Adverse Event|0|||
130653446|NCT04668066|470353802|FG016|Part 1: Follow-Up|Adverse Event|0|||
130653447|NCT04668066|470353803|FG017|Part 1: Follow-Up|Adverse Event|0|||
130653448|NCT04668066|470353804|FG018|Part 1: Follow-Up|Adverse Event|0|||
130653449|NCT04668066|470353786|FG000|Part 1: Follow-Up|Other|0|||
130653450|NCT04668066|470353787|FG001|Part 1: Follow-Up|Other|0|||
130653451|NCT04668066|470353788|FG002|Part 1: Follow-Up|Other|0|||
130653452|NCT04668066|470353789|FG003|Part 1: Follow-Up|Other|0|||
130653453|NCT04668066|470353790|FG004|Part 1: Follow-Up|Other|0|||
130653454|NCT04668066|470353791|FG005|Part 1: Follow-Up|Other|0|||
130653455|NCT04668066|470353792|FG006|Part 1: Follow-Up|Other|0|||
130653456|NCT04668066|470353793|FG007|Part 1: Follow-Up|Other|0|||
130653457|NCT04668066|470353794|FG008|Part 1: Follow-Up|Other|0|||
130653458|NCT04668066|470353795|FG009|Part 1: Follow-Up|Other|0|||
130653459|NCT04668066|470353796|FG010|Part 1: Follow-Up|Other|0|||
130653460|NCT04668066|470353797|FG011|Part 1: Follow-Up|Other|1|||
130653461|NCT04668066|470353798|FG012|Part 1: Follow-Up|Other|1|||
130653462|NCT04668066|470353799|FG013|Part 1: Follow-Up|Other|0|||
130653463|NCT04668066|470353800|FG014|Part 1: Follow-Up|Other|0|||
130653464|NCT04668066|470353801|FG015|Part 1: Follow-Up|Other|0|||
130653465|NCT04668066|470353802|FG016|Part 1: Follow-Up|Other|0|||
130653466|NCT04668066|470353803|FG017|Part 1: Follow-Up|Other|0|||
130653467|NCT04668066|470353804|FG018|Part 1: Follow-Up|Other|0|||
130653468|NCT04668066|470353786|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653469|NCT04668066|470353787|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653470|NCT04668066|470353788|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653471|NCT04668066|470353789|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653472|NCT04668066|470353790|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653473|NCT04668066|470353791|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653474|NCT04668066|470353792|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653475|NCT04668066|470353793|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653476|NCT04668066|470353794|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653477|NCT04668066|470353795|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653478|NCT04668066|470353796|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653479|NCT04668066|470353797|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653480|NCT04668066|470353798|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
130653481|NCT04668066|470353799|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653482|NCT04668066|470353800|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653483|NCT04668066|470353801|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
130208060|NCT00586508|468721077|FG000|Overall Study|Progressive disease|52|||
130208061|NCT00586508|468721078|FG001|Overall Study|Progressive disease|8|||
130208062|NCT00586508|468721077|FG000|Overall Study|Death|0|||
130208063|NCT00586508|468721078|FG001|Overall Study|Death|1|||
130208064|NCT00586508|468721077|FG000|Overall Study|Adverse Event|12|||
130208065|NCT00586508|468721078|FG001|Overall Study|Adverse Event|4|||
130208066|NCT00586508|468721077|FG000|Overall Study|Withdrawal by Subject|4|||
130208067|NCT00586508|468721078|FG001|Overall Study|Withdrawal by Subject|0|||
130208068|NCT00561470|468721079|FG000|Overall Study|Adverse Event|74|||
130208069|NCT00561470|468721080|FG001|Overall Study|Adverse Event|163|||
130208070|NCT00561470|468721079|FG000|Overall Study|Disease progression|437|||
130208071|NCT00561470|468721080|FG001|Overall Study|Disease progression|305|||
130208072|NCT00561470|468721079|FG000|Overall Study|poor compliance to protocol|4|||
130208073|NCT00561470|468721080|FG001|Overall Study|poor compliance to protocol|4|||
130653484|NCT04668066|470353802|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653485|NCT04668066|470353803|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653486|NCT04668066|470353804|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
130653487|NCT04668066|470353786|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653488|NCT04668066|470353787|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653489|NCT04668066|470353788|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130208074|NCT00561470|468721079|FG000|Overall Study|Lost to Follow-up|2|||
130208075|NCT00561470|468721080|FG001|Overall Study|Lost to Follow-up|0|||
130208076|NCT00561470|468721079|FG000|Overall Study|Physician Decision|21|||
130208077|NCT00561470|468721080|FG001|Overall Study|Physician Decision|20|||
130208078|NCT00561470|468721079|FG000|Overall Study|Consent Withdrawn|2|||
130208079|NCT00561470|468721080|FG001|Overall Study|Consent Withdrawn|6|||
130208080|NCT00561470|468721079|FG000|Overall Study|Subject request|43|||
130208081|NCT00561470|468721080|FG001|Overall Study|Subject request|77|||
130208082|NCT00561470|468721079|FG000|Overall Study|Metastatic surgery|10|||
130208083|NCT00561470|468721080|FG001|Overall Study|Metastatic surgery|12|||
130208084|NCT00561470|468721079|FG000|Overall Study|Unauthorized procedure|3|||
130208085|NCT00561470|468721080|FG001|Overall Study|Unauthorized procedure|1|||
130208086|NCT00561470|468721079|FG000|Overall Study|Randomized but not treated|5|||
130208087|NCT00561470|468721080|FG001|Overall Study|Randomized but not treated|5|||
130208088|NCT00561470|468721079|FG000|Overall Study|Missed visit window|1|||
130208089|NCT00561470|468721080|FG001|Overall Study|Missed visit window|4|||
130208090|NCT00561470|468721079|FG000|Overall Study|Planning surgery|1|||
130208091|NCT00561470|468721080|FG001|Overall Study|Planning surgery|1|||
130208092|NCT00561470|468721079|FG000|Overall Study|Ongoing Treatment|11|||
130208093|NCT00561470|468721080|FG001|Overall Study|Ongoing Treatment|14|||
130208094|NCT03434249|468721081|FG000|Overall Study|Adverse Event|1|||
130208095|NCT03434249|468721082|FG001|Overall Study|Adverse Event|0|||
130208096|NCT03434249|468721081|FG000|Overall Study|Lost to Follow-up|0|||
130208097|NCT03434249|468721082|FG001|Overall Study|Lost to Follow-up|1|||
130208098|NCT03434249|468721081|FG000|Overall Study|Non-compliance of family|2|||
130208099|NCT03434249|468721082|FG001|Overall Study|Non-compliance of family|1|||
130208100|NCT03434249|468721081|FG000|Overall Study|Difficulties in completing daily diary|2|||
130208101|NCT03434249|468721082|FG001|Overall Study|Difficulties in completing daily diary|1|||
130208102|NCT02918552|468721083|FG000|Overall Study|Failed Pharmacokinetics|1|||
130208103|NCT02918552|468721084|FG001|Overall Study|Failed Pharmacokinetics|0|||
130208104|NCT02918552|468721083|FG000|Overall Study|Withdrawal by Subject|0|||
130208105|NCT02918552|468721084|FG001|Overall Study|Withdrawal by Subject|1|||
130208106|NCT02918552|468721083|FG000|Overall Study|Lost to Follow-up|0|||
130208107|NCT02918552|468721084|FG001|Overall Study|Lost to Follow-up|1|||
130208108|NCT03325894|468721085|FG000|Overall Study|Adverse Event|2|||
130208109|NCT03325894|468721086|FG001|Overall Study|Adverse Event|3|||
130208110|NCT03325894|468721085|FG000|Overall Study|Protocol Violation|1|||
130208111|NCT03325894|468721086|FG001|Overall Study|Protocol Violation|2|||
130208112|NCT03325894|468721085|FG000|Overall Study|Withdrawal by Subject|10|||
130208113|NCT03325894|468721086|FG001|Overall Study|Withdrawal by Subject|6|||
130208114|NCT03325894|468721085|FG000|Overall Study|Lost to Follow-up|4|||
130208115|NCT03325894|468721086|FG001|Overall Study|Lost to Follow-up|9|||
130208116|NCT03325894|468721085|FG000|Overall Study|Lack of Efficacy|8|||
130208117|NCT03325894|468721086|FG001|Overall Study|Lack of Efficacy|14|||
130208118|NCT03325894|468721085|FG000|Overall Study|Study Terminated by Sponsor|38|||
130208119|NCT03325894|468721086|FG001|Overall Study|Study Terminated by Sponsor|43|||
130208120|NCT03325894|468721085|FG000|Overall Study|Other (Not received Treatment)|1|||
130208121|NCT03325894|468721086|FG001|Overall Study|Other (Not received Treatment)|0|||
130208122|NCT04395274|468721087|FG000|Overall Study|Lost to Follow-up|20|||
130208123|NCT04395274|468721088|FG001|Overall Study|Lost to Follow-up|11|||
130208124|NCT04395274|468721087|FG000|Overall Study|Withdrawal by Subject|13|||
130208125|NCT04395274|468721088|FG001|Overall Study|Withdrawal by Subject|10|||
130208126|NCT04395274|468721087|FG000|Overall Study|Moved Abroad|0|||
130208127|NCT04395274|468721088|FG001|Overall Study|Moved Abroad|1|||
130208128|NCT01001598|468721091|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
130208129|NCT01001598|468721091|FG000|Overall Study|Adverse Event|1|||
130208130|NCT02920177|468721096|FG000|Overall Study|Withdrawal by Subject|1|||
130208131|NCT02920177|468721097|FG001|Overall Study|Withdrawal by Subject|1|||
130208132|NCT02920177|468721096|FG000|Overall Study|Physician Decision|1|||
130208133|NCT02920177|468721097|FG001|Overall Study|Physician Decision|0|||
130208134|NCT02920177|468721096|FG000|Overall Study|Lost to Follow-up|0|||
130208135|NCT02920177|468721097|FG001|Overall Study|Lost to Follow-up|1|||
130208136|NCT02054910|468721098|FG000|Overall Study|Lost to Follow-up|4|||
130208137|NCT02054910|468721099|FG001|Overall Study|Lost to Follow-up|1|||
130208138|NCT01096589|468721101|FG000|Overall Study|Adverse Event|2|||
130208139|NCT01096589|468721102|FG001|Overall Study|Adverse Event|1|||
130208140|NCT01096589|468721103|FG002|Overall Study|Adverse Event|2|||
130208141|NCT01096589|468721104|FG003|Overall Study|Adverse Event|1|||
130208142|NCT01096589|468721101|FG000|Overall Study|Withdrawal by Subject|2|||
130208143|NCT01096589|468721102|FG001|Overall Study|Withdrawal by Subject|1|||
130208144|NCT01096589|468721103|FG002|Overall Study|Withdrawal by Subject|1|||
130208145|NCT01096589|468721104|FG003|Overall Study|Withdrawal by Subject|1|||
130653490|NCT04668066|470353789|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130208146|NCT01096589|468721101|FG000|Overall Study|Compliance with protocol|0|||
130653491|NCT04668066|470353790|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653492|NCT04668066|470353791|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653493|NCT04668066|470353792|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130208147|NCT01096589|468721102|FG001|Overall Study|Compliance with protocol|0|||
130208148|NCT01096589|468721103|FG002|Overall Study|Compliance with protocol|1|||
130208149|NCT01096589|468721104|FG003|Overall Study|Compliance with protocol|0|||
130208150|NCT01096589|468721101|FG000|Overall Study|found treatment exhausting|0|||
130208151|NCT01096589|468721102|FG001|Overall Study|found treatment exhausting|0|||
130208152|NCT01096589|468721103|FG002|Overall Study|found treatment exhausting|0|||
130208153|NCT01096589|468721104|FG003|Overall Study|found treatment exhausting|1|||
130208154|NCT03673345|468721105|FG000|Overall Study|Lost to Follow-up|1|||
130208155|NCT03673345|468721106|FG001|Overall Study|Lost to Follow-up|0|||
130208156|NCT03673345|468721107|FG002|Overall Study|Lost to Follow-up|3|||
130208157|NCT03673345|468721108|FG003|Overall Study|Lost to Follow-up|3|||
130208158|NCT03673345|468721109|FG004|Overall Study|Lost to Follow-up|2|||
130208159|NCT03673345|468721110|FG005|Overall Study|Lost to Follow-up|1|||
130208160|NCT03673345|468721111|FG006|Overall Study|Lost to Follow-up|0|||
130208161|NCT03673345|468721112|FG007|Overall Study|Lost to Follow-up|0|||
130208162|NCT03673345|468721105|FG000|Overall Study|Withdrawal by Subject|1|||
130208163|NCT03673345|468721106|FG001|Overall Study|Withdrawal by Subject|0|||
130208164|NCT03673345|468721107|FG002|Overall Study|Withdrawal by Subject|4|||
130208165|NCT03673345|468721108|FG003|Overall Study|Withdrawal by Subject|2|||
130208166|NCT03673345|468721109|FG004|Overall Study|Withdrawal by Subject|0|||
130208167|NCT03673345|468721110|FG005|Overall Study|Withdrawal by Subject|0|||
130208168|NCT03673345|468721111|FG006|Overall Study|Withdrawal by Subject|0|||
130208169|NCT03673345|468721112|FG007|Overall Study|Withdrawal by Subject|0|||
130208170|NCT03673345|468721105|FG000|Overall Study|Physician Decision|0|||
130208171|NCT03673345|468721106|FG001|Overall Study|Physician Decision|0|||
130208172|NCT03673345|468721107|FG002|Overall Study|Physician Decision|2|||
130653494|NCT04668066|470353793|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653495|NCT04668066|470353794|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653496|NCT04668066|470353795|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653497|NCT04668066|470353796|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130208173|NCT03673345|468721108|FG003|Overall Study|Physician Decision|0|||
130208174|NCT03673345|468721109|FG004|Overall Study|Physician Decision|0|||
130208175|NCT03673345|468721110|FG005|Overall Study|Physician Decision|0|||
130208176|NCT03673345|468721111|FG006|Overall Study|Physician Decision|0|||
130208177|NCT03673345|468721112|FG007|Overall Study|Physician Decision|0|||
130208178|NCT01362244|468721113|FG000|Overall Study|Adverse Event|3|||
130208179|NCT01362244|468721114|FG001|Overall Study|Adverse Event|5|||
130208180|NCT01362244|468721113|FG000|Overall Study|Lack of Efficacy|5|||
130208181|NCT01362244|468721114|FG001|Overall Study|Lack of Efficacy|11|||
130208182|NCT01362244|468721113|FG000|Overall Study|Lost to Follow-up|0|||
130208183|NCT01362244|468721114|FG001|Overall Study|Lost to Follow-up|2|||
130208184|NCT01362244|468721113|FG000|Overall Study|Protocol Violation|5|||
130208185|NCT01362244|468721114|FG001|Overall Study|Protocol Violation|1|||
130208186|NCT01362244|468721113|FG000|Overall Study|Withdrawal by Subject|2|||
130208187|NCT01362244|468721114|FG001|Overall Study|Withdrawal by Subject|1|||
130208188|NCT01362244|468721113|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
130208189|NCT01362244|468721114|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
130208190|NCT01362244|468721113|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
130208191|NCT01362244|468721114|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
130316097|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
130316098|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
130316099|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
130316100|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
130316101|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
130316102|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
130316103|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
130316104|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
130316105|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
130316106|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
130653498|NCT04668066|470353797|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653499|NCT04668066|470353798|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653500|NCT04668066|470353799|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653501|NCT04668066|470353800|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653502|NCT04668066|470353801|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653503|NCT04668066|470353802|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653504|NCT04668066|470353803|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130653505|NCT04668066|470353804|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
130653506|NCT04668066|470353786|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653507|NCT04668066|470353787|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653508|NCT04668066|470353788|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653509|NCT04668066|470353789|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653510|NCT04668066|470353790|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653511|NCT04668066|470353791|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653512|NCT04668066|470353792|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653513|NCT04668066|470353793|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653514|NCT04668066|470353794|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
130208192|NCT00908596|468722738|FG000|Overall Study|Other reasons|46|||
130208193|NCT00908596|468722739|FG001|Overall Study|Other reasons|6|||
130208194|NCT00908596|468722740|FG002|Overall Study|Other reasons|2|||
130208195|NCT00908596|468722741|FG003|Overall Study|Other reasons|0|||
130208196|NCT00908596|468722738|FG000|Overall Study|Lost to Follow-up|0|||
130208197|NCT00908596|468722739|FG001|Overall Study|Lost to Follow-up|1|||
130208198|NCT00908596|468722740|FG002|Overall Study|Lost to Follow-up|12|||
130208199|NCT00908596|468722741|FG003|Overall Study|Lost to Follow-up|4|||
130208200|NCT00908596|468722738|FG000|Overall Study|Death|0|||
130208201|NCT00908596|468722739|FG001|Overall Study|Death|5|||
130208202|NCT00908596|468722740|FG002|Overall Study|Death|57|||
130208203|NCT00908596|468722741|FG003|Overall Study|Death|32|||
130208204|NCT00908596|468722738|FG000|Overall Study|Protocol Violation|1|||
130208205|NCT00908596|468722739|FG001|Overall Study|Protocol Violation|0|||
130208206|NCT00908596|468722740|FG002|Overall Study|Protocol Violation|0|||
130208207|NCT00908596|468722741|FG003|Overall Study|Protocol Violation|0|||
130208208|NCT00908596|468722738|FG000|Overall Study|Withdrawal by Subject|0|||
130208209|NCT00908596|468722739|FG001|Overall Study|Withdrawal by Subject|1|||
130208210|NCT00908596|468722740|FG002|Overall Study|Withdrawal by Subject|3|||
130208211|NCT00908596|468722741|FG003|Overall Study|Withdrawal by Subject|1|||
130208212|NCT01709864|468722744|FG000|Overall Study|Physician Decision|0|||
130208213|NCT01709864|468722745|FG001|Overall Study|Physician Decision|1|||
130208214|NCT01709864|468722744|FG000|Overall Study|subject/guardian decision|5|||
130208215|NCT01709864|468722745|FG001|Overall Study|subject/guardian decision|6|||
130208216|NCT01709864|468722744|FG000|Overall Study|Lost to Follow-up|1|||
130208217|NCT01709864|468722745|FG001|Overall Study|Lost to Follow-up|0|||
130208218|NCT01709864|468722744|FG000|Overall Study|non-compliance with study treatment|1|||
130208219|NCT01709864|468722745|FG001|Overall Study|non-compliance with study treatment|1|||
130208220|NCT01709864|468722744|FG000|Overall Study|Adverse Event|0|||
130208221|NCT01709864|468722745|FG001|Overall Study|Adverse Event|2|||
130208222|NCT01709864|468722744|FG000|Overall Study|Death|0|||
130208223|NCT01709864|468722745|FG001|Overall Study|Death|1|||
130208224|NCT02661061|468722748|FG000|Overall Study|Lack of Efficacy|1|||
130208225|NCT02661061|468722749|FG001|Overall Study|Lack of Efficacy|1|||
130208226|NCT02661061|468722748|FG000|Overall Study|Withdrawal by Subject|1|||
130208227|NCT02661061|468722749|FG001|Overall Study|Withdrawal by Subject|1|||
130208228|NCT01492101|468722752|FG000|Overall Study|Death|323|||
130208229|NCT01492101|468722753|FG001|Overall Study|Death|322|||
130208230|NCT01492101|468722752|FG000|Overall Study|Withdrawal by Subject|14|||
130208231|NCT01492101|468722753|FG001|Overall Study|Withdrawal by Subject|18|||
130208232|NCT01492101|468722752|FG000|Overall Study|Lost to Follow-up|0|||
130208233|NCT01492101|468722753|FG001|Overall Study|Lost to Follow-up|2|||
130208234|NCT02696434|468722754|FG000|Overall Study|Adverse Event|3|||
130208235|NCT02696434|468722755|FG001|Overall Study|Adverse Event|1|||
130208236|NCT02696434|468722754|FG000|Overall Study|Lost to Follow-up|5|||
130208237|NCT02696434|468722755|FG001|Overall Study|Lost to Follow-up|4|||
130208238|NCT02696434|468722754|FG000|Overall Study|Withdrawal by Subject|14|||
130208239|NCT02696434|468722755|FG001|Overall Study|Withdrawal by Subject|12|||
130208240|NCT02696434|468722754|FG000|Overall Study|Physician Decision|0|||
130208241|NCT02696434|468722755|FG001|Overall Study|Physician Decision|1|||
130208242|NCT00316914|468722774|FG000|Overall Study|Withdrawal by Subject|5|||
130208243|NCT00316914|468722775|FG001|Overall Study|Withdrawal by Subject|3|||
130208244|NCT00316914|468722774|FG000|Overall Study|Adverse Event|8|||
130208245|NCT00316914|468722775|FG001|Overall Study|Adverse Event|7|||
130208246|NCT00316914|468722774|FG000|Overall Study|Other Problems|6|||
130208247|NCT00316914|468722775|FG001|Overall Study|Other Problems|11|||
130208248|NCT00316914|468722774|FG000|Overall Study|Missing end of treatment documentation|14|||
130208249|NCT00316914|468722775|FG001|Overall Study|Missing end of treatment documentation|15|||
130208250|NCT04105010|468722776|FG000|Overall Study|Death|3|||
130208251|NCT04105010|468722777|FG001|Overall Study|Death|1|||
130208252|NCT04105010|468722778|FG002|Overall Study|Death|1|||
130208253|NCT04105010|468722779|FG003|Overall Study|Death|54|||
130208254|NCT04105010|468722776|FG000|Overall Study|Lost to Follow-up|0|||
130208255|NCT04105010|468722777|FG001|Overall Study|Lost to Follow-up|0|||
130208256|NCT04105010|468722778|FG002|Overall Study|Lost to Follow-up|0|||
130208257|NCT04105010|468722779|FG003|Overall Study|Lost to Follow-up|4|||
130208258|NCT04105010|468722776|FG000|Overall Study|Withdrawal by Subject|8|||
130208259|NCT04105010|468722777|FG001|Overall Study|Withdrawal by Subject|1|||
130208260|NCT04105010|468722778|FG002|Overall Study|Withdrawal by Subject|1|||
130208261|NCT04105010|468722779|FG003|Overall Study|Withdrawal by Subject|4|||
130208262|NCT04105010|468722776|FG000|Overall Study|Other reason|4|||
130208263|NCT04105010|468722777|FG001|Overall Study|Other reason|7|||
130208264|NCT04105010|468722778|FG002|Overall Study|Other reason|0|||
130376454|NCT03655691|469343693|FG002|Overall Study|Withdrawal by Subject|0|||
130208265|NCT04105010|468722779|FG003|Overall Study|Other reason|19|||
130208266|NCT01675154|468722780|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130208267|NCT01675154|468722781|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
130208268|NCT01675154|468722782|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130208269|NCT01675154|468722783|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130653515|NCT04668066|470353795|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653516|NCT04668066|470353796|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653517|NCT04668066|470353797|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653518|NCT04668066|470353798|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653519|NCT04668066|470353799|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653520|NCT04668066|470353800|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653521|NCT04668066|470353801|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653522|NCT04668066|470353802|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653523|NCT04668066|470353803|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
130653524|NCT04668066|470353804|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
130653525|NCT04668066|470353786|FG000|Part 2: Treatment Phase|Other|0|||
130653526|NCT04668066|470353787|FG001|Part 2: Treatment Phase|Other|0|||
130653527|NCT04668066|470353788|FG002|Part 2: Treatment Phase|Other|0|||
130653528|NCT04668066|470353789|FG003|Part 2: Treatment Phase|Other|0|||
130653529|NCT04668066|470353790|FG004|Part 2: Treatment Phase|Other|0|||
130653530|NCT04668066|470353791|FG005|Part 2: Treatment Phase|Other|0|||
130653531|NCT04668066|470353792|FG006|Part 2: Treatment Phase|Other|0|||
130653532|NCT04668066|470353793|FG007|Part 2: Treatment Phase|Other|0|||
130653533|NCT04668066|470353794|FG008|Part 2: Treatment Phase|Other|0|||
130653534|NCT04668066|470353795|FG009|Part 2: Treatment Phase|Other|0|||
130653535|NCT04668066|470353796|FG010|Part 2: Treatment Phase|Other|0|||
130208270|NCT00427999|468722784|FG000|Overall Study|Adverse Event|6|||
130208271|NCT00427999|468722784|FG000|Overall Study|Abnormal laboratory values|1|||
130208272|NCT00427999|468722784|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130653536|NCT04668066|470353797|FG011|Part 2: Treatment Phase|Other|0|||
130653537|NCT04668066|470353798|FG012|Part 2: Treatment Phase|Other|0|||
130653538|NCT04668066|470353799|FG013|Part 2: Treatment Phase|Other|0|||
130208273|NCT00427999|468722784|FG000|Overall Study|Protocol Violation|2|||
130208274|NCT00427999|468722784|FG000|Overall Study|Withdrawal by Subject|9|||
130208275|NCT00427999|468722784|FG000|Overall Study|Death|1|||
130208276|NCT02380859|468722785|FG000|Overall Study|Withdrawal by Subject|2|||
130208277|NCT02380859|468722786|FG001|Overall Study|Withdrawal by Subject|0|||
130208278|NCT02284568|468722787|FG000|Overall Study|Adverse Event|2|||
130208279|NCT02284568|468722788|FG001|Overall Study|Adverse Event|9|||
130208280|NCT02284568|468722789|FG002|Overall Study|Adverse Event|4|||
130208281|NCT02284568|468722787|FG000|Overall Study|Withdrawal by Subject|22|||
130208282|NCT02284568|468722788|FG001|Overall Study|Withdrawal by Subject|21|||
130208283|NCT02284568|468722789|FG002|Overall Study|Withdrawal by Subject|1|||
130208284|NCT02284568|468722787|FG000|Overall Study|Noncompliance with study drug admin|1|||
130208285|NCT02284568|468722788|FG001|Overall Study|Noncompliance with study drug admin|2|||
130208286|NCT02284568|468722789|FG002|Overall Study|Noncompliance with study drug admin|0|||
130208287|NCT02284568|468722787|FG000|Overall Study|Noncompliance|1|||
130208288|NCT02284568|468722788|FG001|Overall Study|Noncompliance|0|||
130208289|NCT02284568|468722789|FG002|Overall Study|Noncompliance|0|||
130208290|NCT02284568|468722787|FG000|Overall Study|Protocol Violation|0|||
130208291|NCT02284568|468722788|FG001|Overall Study|Protocol Violation|1|||
130208292|NCT02284568|468722789|FG002|Overall Study|Protocol Violation|0|||
130208293|NCT02284568|468722787|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
130208294|NCT02284568|468722788|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
130208295|NCT02284568|468722789|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
130208296|NCT02284568|468722787|FG000|Overall Study|Lost to Follow-up|0|||
130208297|NCT02284568|468722788|FG001|Overall Study|Lost to Follow-up|3|||
130208298|NCT02284568|468722789|FG002|Overall Study|Lost to Follow-up|0|||
130208299|NCT02284568|468722787|FG000|Overall Study|Lack of Efficacy|4|||
130208300|NCT02284568|468722788|FG001|Overall Study|Lack of Efficacy|7|||
130208301|NCT02284568|468722789|FG002|Overall Study|Lack of Efficacy|0|||
130208302|NCT02284568|468722787|FG000|Overall Study|Other|1|||
130208303|NCT02284568|468722788|FG001|Overall Study|Other|2|||
130208304|NCT02284568|468722789|FG002|Overall Study|Other|0|||
130208305|NCT02284568|468722787|FG000|Overall Study|Withdrew before taking study drug|0|||
130653539|NCT04668066|470353800|FG014|Part 2: Treatment Phase|Other|0|||
130653540|NCT04668066|470353801|FG015|Part 2: Treatment Phase|Other|0|||
130653541|NCT04668066|470353802|FG016|Part 2: Treatment Phase|Other|0|||
130653542|NCT04668066|470353803|FG017|Part 2: Treatment Phase|Other|0|||
130653543|NCT04668066|470353804|FG018|Part 2: Treatment Phase|Other|1|||
130208306|NCT02284568|468722788|FG001|Overall Study|Withdrew before taking study drug|1|||
130208307|NCT02284568|468722789|FG002|Overall Study|Withdrew before taking study drug|0|||
130208308|NCT05323994|468722790|FG000|Overall Study|Protocol Violation|1|||
130208309|NCT01420679|468722796|FG000|Overall Study|Disease Progression|3|||
130208310|NCT01420679|468722797|FG001|Overall Study|Disease Progression|2|||
130208311|NCT01420679|468722796|FG000|Overall Study|Adverse Event|4|||
130208312|NCT01420679|468722797|FG001|Overall Study|Adverse Event|0|||
130208313|NCT01420679|468722796|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
130208314|NCT01420679|468722797|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
130653544|NCT04668066|470353786|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
130208315|NCT01420679|468722796|FG000|Overall Study|Patient Decision|1|||
130208316|NCT01420679|468722797|FG001|Overall Study|Patient Decision|0|||
130208317|NCT01420679|468722796|FG000|Overall Study|Investigator Decision|1|||
130208318|NCT01420679|468722797|FG001|Overall Study|Investigator Decision|2|||
130319114|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
130319115|NCT00062439|469135412|FG000|Surgery|Physician Decision|4|||
130319116|NCT00062439|469135412|FG000|Surgery|Death|1|||
130319117|NCT00062439|469135412|FG000|Surgery|Adverse Event|2|||
130319118|NCT00062439|469135412|FG000|Consolidation Chemotherapy|Adverse Event|2|||
130319119|NCT01924845|469135413|FG000|Overall Study|Adverse Event|3|||
130319120|NCT01924845|469135413|FG000|Overall Study|Withdrawal by Subject|2|||
130319121|NCT01924845|469135413|FG000|Overall Study|Protocol Violation|1|||
130319122|NCT00001832|469135417|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
130319123|NCT00001832|469135418|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
130319124|NCT00001832|469135419|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
130319125|NCT00001832|469135420|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
130319126|NCT00001832|469135421|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
130319127|NCT00001832|469135422|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
130319128|NCT00001832|469135423|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
130319129|NCT00001832|469135424|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
130319130|NCT00001832|469135425|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
130319131|NCT00001832|469135426|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
130319132|NCT00001832|469135427|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
130319133|NCT00001832|469135428|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
130319134|NCT00001832|469135429|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
130208319|NCT01420679|468722796|FG000|Overall Study|Sponsor Decision|3|||
130208320|NCT01420679|468722797|FG001|Overall Study|Sponsor Decision|3|||
130208321|NCT01420679|468722796|FG000|Overall Study|Other|1|||
130208322|NCT01420679|468722797|FG001|Overall Study|Other|0|||
130208323|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
130208324|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
130208325|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
130208326|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
130208327|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
130208328|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
130208329|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
130208330|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
130208331|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
130208332|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
130208333|NCT03956615|468722799|FG000|Overall Study|No multiple myeloma confirmed|2|||
130208334|NCT03956615|468722799|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
130208335|NCT03956615|468722799|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
130208336|NCT03956615|468722799|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
130208337|NCT03000530|468722808|FG000|Overall Study|Adverse Event|0|||
130208338|NCT03000530|468722809|FG001|Overall Study|Adverse Event|0|||
130208339|NCT03000530|468722810|FG002|Overall Study|Adverse Event|2|||
130208340|NCT03000530|468722808|FG000|Overall Study|Lost to Follow-up|0|||
130208341|NCT03000530|468722809|FG001|Overall Study|Lost to Follow-up|3|||
130208342|NCT03000530|468722810|FG002|Overall Study|Lost to Follow-up|1|||
130208343|NCT03000530|468722808|FG000|Overall Study|Withdrawal by Subject|0|||
130208344|NCT03000530|468722809|FG001|Overall Study|Withdrawal by Subject|2|||
130208345|NCT03000530|468722810|FG002|Overall Study|Withdrawal by Subject|1|||
130208346|NCT00312572|468722814|FG000|Overall Study|Adverse Event|10|||
130208347|NCT00312572|468722815|FG001|Overall Study|Adverse Event|16|||
130208348|NCT00312572|468722814|FG000|Overall Study|Lost to Follow-up|1|||
130208349|NCT00312572|468722815|FG001|Overall Study|Lost to Follow-up|1|||
130208350|NCT00312572|468722814|FG000|Overall Study|Administrative|4|||
130208351|NCT00312572|468722815|FG001|Overall Study|Administrative|2|||
130208352|NCT00312572|468722814|FG000|Overall Study|Lack of Efficacy|1|||
130208353|NCT00312572|468722815|FG001|Overall Study|Lack of Efficacy|2|||
130208354|NCT01430624|468722816|FG000|Overall Study|Lost to Follow-up|23|||
130208355|NCT01430624|468722817|FG001|Overall Study|Lost to Follow-up|29|||
130208356|NCT01430624|468722818|FG002|Overall Study|Lost to Follow-up|27|||
130208357|NCT01430624|468722816|FG000|Overall Study|technical or eligibility|5|||
130208358|NCT01430624|468722817|FG001|Overall Study|technical or eligibility|5|||
130208359|NCT01430624|468722818|FG002|Overall Study|technical or eligibility|2|||
130208360|NCT02614131|468722823|FG000|Overall Study|Withdrawal by Subject|1|||
130208361|NCT02614131|468722824|FG001|Overall Study|Withdrawal by Subject|0|||
130208362|NCT02614131|468722825|FG002|Overall Study|Withdrawal by Subject|0|||
130208363|NCT02614131|468722826|FG003|Overall Study|Withdrawal by Subject|0|||
130208364|NCT02614131|468722827|FG004|Overall Study|Withdrawal by Subject|0|||
130208365|NCT02614131|468722828|FG005|Overall Study|Withdrawal by Subject|0|||
130208366|NCT02614131|468722829|FG006|Overall Study|Withdrawal by Subject|0|||
130208367|NCT02614131|468722823|FG000|Overall Study|Adverse Event|0|||
130208368|NCT02614131|468722824|FG001|Overall Study|Adverse Event|0|||
130208369|NCT02614131|468722825|FG002|Overall Study|Adverse Event|0|||
130208370|NCT02614131|468722826|FG003|Overall Study|Adverse Event|0|||
130208371|NCT02614131|468722827|FG004|Overall Study|Adverse Event|0|||
130208372|NCT02614131|468722828|FG005|Overall Study|Adverse Event|0|||
130208373|NCT02614131|468722829|FG006|Overall Study|Adverse Event|1|||
130208374|NCT01285492|468722834|FG000|Overall Study|Adverse Event|11|||
130208375|NCT01285492|468722835|FG001|Overall Study|Adverse Event|0|||
130208376|NCT01285492|468722834|FG000|Overall Study|Protocol Violation|3|||
130208377|NCT01285492|468722835|FG001|Overall Study|Protocol Violation|0|||
130208378|NCT01285492|468722834|FG000|Overall Study|Withdrawal by Subject|2|||
130208379|NCT01285492|468722835|FG001|Overall Study|Withdrawal by Subject|1|||
130208380|NCT01285492|468722834|FG000|Overall Study|Death|1|||
130208381|NCT01285492|468722835|FG001|Overall Study|Death|0|||
130208382|NCT01797094|468722836|FG000|Overall Study|Adverse Event|1|||
130208383|NCT01797094|468722837|FG001|Overall Study|Adverse Event|1|||
130208384|NCT01797094|468722836|FG000|Overall Study|Personal Reasons|4|||
130208385|NCT01797094|468722837|FG001|Overall Study|Personal Reasons|0|||
130208386|NCT01797094|468722836|FG000|Overall Study|Protocol Violation|0|||
130208387|NCT01797094|468722837|FG001|Overall Study|Protocol Violation|1|||
130208388|NCT01797094|468722836|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130208389|NCT01797094|468722837|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130208390|NCT03217968|468722840|FG000|Overall Study|Withdrawal by Subject|4|||
130208391|NCT03217968|468722840|FG000|Overall Study|Lost to Follow-up|1|||
130208392|NCT03217968|468722840|FG000|Overall Study|Protocol Violation|6|||
130208393|NCT00634049|468722852|FG000|Overall Study|Never received study drug|1|||
130208394|NCT00634049|468722852|FG000|Overall Study|Died prior to receiving study drug|1|||
130208395|NCT00634049|468722852|FG000|Overall Study|Screening failure|1|||
130208396|NCT00314132|468722853|FG000|Overall Study|Lost to Follow-up|3|||
130208397|NCT00314132|468722854|FG001|Overall Study|Lost to Follow-up|13|||
130208398|NCT00314132|468722853|FG000|Overall Study|Withdrawal by Subject|3|||
130208399|NCT00314132|468722854|FG001|Overall Study|Withdrawal by Subject|5|||
130208400|NCT00314132|468722853|FG000|Overall Study|Adverse Event|1|||
130208401|NCT00314132|468722854|FG001|Overall Study|Adverse Event|0|||
130208402|NCT00314132|468722853|FG000|Overall Study|Physician Decision|1|||
130208403|NCT00314132|468722854|FG001|Overall Study|Physician Decision|0|||
130208404|NCT00045734|468722855|FG000|Overall Study|Protocol Violation|1|||
130208405|NCT03482167|468722856|FG000|Allocated to Intervention|Physician Decision|1|||
130208406|NCT03482167|468722857|FG001|Allocated to Intervention|Physician Decision|2|||
130208407|NCT03482167|468722856|FG000|Received Intervention|Adverse Event|3|||
130208408|NCT03482167|468722857|FG001|Received Intervention|Adverse Event|1|||
130208409|NCT03482167|468722856|FG000|Received Intervention|Physician Decision|1|||
130208410|NCT03482167|468722857|FG001|Received Intervention|Physician Decision|1|||
130208411|NCT03482167|468722856|FG000|Received Intervention|Withdrawal by Subject|1|||
130208412|NCT03482167|468722857|FG001|Received Intervention|Withdrawal by Subject|0|||
130208413|NCT05079230|468722868|FG000|Overall Study|Study Terminated by Sponsor|101|||
130208414|NCT05079230|468722869|FG001|Overall Study|Study Terminated by Sponsor|102|||
130208415|NCT05079230|468722868|FG000|Overall Study|Death|72|||
130208416|NCT05079230|468722869|FG001|Overall Study|Death|66|||
130208417|NCT05079230|468722868|FG000|Overall Study|Withdrew Consent|16|||
130208418|NCT05079230|468722869|FG001|Overall Study|Withdrew Consent|18|||
130208419|NCT05079230|468722868|FG000|Overall Study|Lost to Follow-up|0|||
130208420|NCT05079230|468722869|FG001|Overall Study|Lost to Follow-up|3|||
130208421|NCT01524783|468722870|FG000|Blinded Period|Adverse Event|64|||
130208422|NCT01524783|468722871|FG001|Blinded Period|Adverse Event|7|||
130208423|NCT01524783|468722872|FG002|Blinded Period|Adverse Event|0|||
130208424|NCT01524783|468722870|FG000|Blinded Period|Disease Progression|89|||
130208425|NCT01524783|468722871|FG001|Blinded Period|Disease Progression|75|||
130208426|NCT01524783|468722872|FG002|Blinded Period|Disease Progression|0|||
130208427|NCT01524783|468722870|FG000|Blinded Period|Withdrawal by Subject|19|||
130208428|NCT01524783|468722871|FG001|Blinded Period|Withdrawal by Subject|6|||
130208429|NCT01524783|468722872|FG002|Blinded Period|Withdrawal by Subject|0|||
130208430|NCT01524783|468722870|FG000|Blinded Period|Protocol deviation|2|||
130208431|NCT01524783|468722871|FG001|Blinded Period|Protocol deviation|1|||
130208432|NCT01524783|468722872|FG002|Blinded Period|Protocol deviation|0|||
130208433|NCT01524783|468722870|FG000|Blinded Period|Death|5|||
130208434|NCT01524783|468722871|FG001|Blinded Period|Death|2|||
130208435|NCT01524783|468722872|FG002|Blinded Period|Death|0|||
130208436|NCT01524783|468722870|FG000|Open-label Period|Disease progression|13|||
130208437|NCT01524783|468722871|FG001|Open-label Period|Disease progression|0|||
130208438|NCT01524783|468722872|FG002|Open-label Period|Disease progression|2|||
130208439|NCT01524783|468722870|FG000|Open-label Period|Administrative problems|5|||
130208440|NCT01524783|468722871|FG001|Open-label Period|Administrative problems|0|||
130208441|NCT01524783|468722872|FG002|Open-label Period|Administrative problems|2|||
130208442|NCT01524783|468722870|FG000|Open-label Period|Adverse Event|5|||
130208443|NCT01524783|468722871|FG001|Open-label Period|Adverse Event|0|||
130208444|NCT01524783|468722872|FG002|Open-label Period|Adverse Event|1|||
130208445|NCT01524783|468722870|FG000|Open-label Period|Withdrawal by Subject|2|||
130208446|NCT01524783|468722871|FG001|Open-label Period|Withdrawal by Subject|0|||
130208447|NCT01524783|468722872|FG002|Open-label Period|Withdrawal by Subject|1|||
130208448|NCT01524783|468722870|FG000|Open-label Period|Protocol deviation|1|||
130208449|NCT01524783|468722871|FG001|Open-label Period|Protocol deviation|0|||
130653545|NCT04668066|470353787|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653546|NCT04668066|470353788|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653547|NCT04668066|470353789|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653548|NCT04668066|470353790|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653549|NCT04668066|470353791|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653550|NCT04668066|470353792|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653551|NCT04668066|470353793|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653552|NCT04668066|470353794|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653553|NCT04668066|470353795|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653554|NCT04668066|470353796|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653555|NCT04668066|470353797|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653556|NCT04668066|470353798|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653557|NCT04668066|470353799|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653558|NCT04668066|470353800|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653559|NCT04668066|470353801|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653560|NCT04668066|470353802|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653561|NCT04668066|470353803|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
130653562|NCT04668066|470353804|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
130653563|NCT05147311|470353805|FG000|Overall Study|Did not complete survey|2|||
130653564|NCT05147311|470353806|FG001|Overall Study|Did not complete survey|1|||
130653565|NCT05147311|470353805|FG000|Overall Study|Patient too sick|1|||
130653566|NCT05147311|470353806|FG001|Overall Study|Patient too sick|2|||
130653567|NCT05147311|470353805|FG000|Overall Study|Death|0|||
130653568|NCT05147311|470353806|FG001|Overall Study|Death|1|||
130653569|NCT05147311|470353805|FG000|Overall Study|Declined survey|1|||
130653570|NCT05147311|470353806|FG001|Overall Study|Declined survey|0|||
130653571|NCT04505592|470353807|FG000|Overall Study|Death|2|||
130653572|NCT04505592|470353808|FG001|Overall Study|Death|1|||
130653573|NCT01015118|470353813|FG000|Overall Study|Protocol Violation|5|||
130208450|NCT01524783|468722872|FG002|Open-label Period|Protocol deviation|0|||
130208451|NCT05153148|468722875|FG000|Overall Study|Adverse Event|1|||
130208452|NCT05153148|468722876|FG001|Overall Study|Adverse Event|0|||
130208453|NCT05153148|468722877|FG002|Overall Study|Adverse Event|3|||
130208454|NCT05153148|468722878|FG003|Overall Study|Adverse Event|5|||
130208455|NCT05153148|468722875|FG000|Overall Study|Lost to Follow-up|1|||
130208456|NCT05153148|468722876|FG001|Overall Study|Lost to Follow-up|1|||
130208457|NCT05153148|468722877|FG002|Overall Study|Lost to Follow-up|2|||
130653574|NCT01015118|470353814|FG001|Overall Study|Protocol Violation|6|||
130653575|NCT01015118|470353813|FG000|Overall Study|Withdrawal by Subject|103|||
130653576|NCT01015118|470353814|FG001|Overall Study|Withdrawal by Subject|27|||
130653577|NCT01015118|470353813|FG000|Overall Study|Other Adverse Event (AE)|141|||
130653578|NCT01015118|470353814|FG001|Overall Study|Other Adverse Event (AE)|33|||
130653579|NCT01015118|470353813|FG000|Overall Study|Worsening or AE of underlying disease|5|||
130653580|NCT01015118|470353814|FG001|Overall Study|Worsening or AE of underlying disease|4|||
130653581|NCT01015118|470353813|FG000|Overall Study|Progressive disease|364|||
130653582|NCT01015118|470353814|FG001|Overall Study|Progressive disease|229|||
130653583|NCT01015118|470353813|FG000|Overall Study|Not treated|9|||
130653584|NCT01015118|470353814|FG001|Overall Study|Not treated|5|||
130653585|NCT01015118|470353813|FG000|Overall Study|Other than stated above|42|||
130653586|NCT01015118|470353814|FG001|Overall Study|Other than stated above|23|||
130653587|NCT03522506|470353815|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130653588|NCT03522506|470353816|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130653589|NCT03522506|470353817|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130653590|NCT03522506|470353818|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130653591|NCT03522506|470353815|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130653592|NCT03522506|470353816|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130653593|NCT03522506|470353817|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130653594|NCT03522506|470353818|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
130653595|NCT03480243|470353819|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
130653596|NCT03480243|470353819|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
130653597|NCT02388906|470353828|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130653598|NCT02388906|470353829|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130653599|NCT02388906|470353828|FG000|Treatment Period|Disease progression|121|||
130208458|NCT05153148|468722878|FG003|Overall Study|Lost to Follow-up|0|||
130653600|NCT02388906|470353829|FG001|Treatment Period|Disease progression|100|||
130653601|NCT02388906|470353828|FG000|Treatment Period|Study drug toxicity|41|||
130653602|NCT02388906|470353829|FG001|Treatment Period|Study drug toxicity|208|||
130653603|NCT02388906|470353828|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
130208459|NCT05153148|468722875|FG000|Overall Study|Withdrawal by Subject|6|||
130653604|NCT02388906|470353829|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
130208460|NCT05153148|468722876|FG001|Overall Study|Withdrawal by Subject|8|||
130208461|NCT05153148|468722877|FG002|Overall Study|Withdrawal by Subject|6|||
130208462|NCT05153148|468722878|FG003|Overall Study|Withdrawal by Subject|8|||
130653605|NCT02388906|470353828|FG000|Treatment Period|Participant request to stop treatment|5|||
130653606|NCT02388906|470353829|FG001|Treatment Period|Participant request to stop treatment|9|||
130653607|NCT02388906|470353828|FG000|Treatment Period|Participant withdrew consent|2|||
130653608|NCT02388906|470353829|FG001|Treatment Period|Participant withdrew consent|3|||
130653609|NCT02388906|470353828|FG000|Treatment Period|Poor/non-compliance|0|||
130653610|NCT02388906|470353829|FG001|Treatment Period|Poor/non-compliance|1|||
130653611|NCT02388906|470353828|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130653612|NCT02388906|470353829|FG001|Treatment Period|Participant no longer meets study criteria|1|||
130653613|NCT02388906|470353828|FG000|Treatment Period|Other reasons|3|||
130653614|NCT02388906|470353829|FG001|Treatment Period|Other reasons|3|||
130653615|NCT04365387|470353838|FG000|Overall Study|Adverse Event|4|||
130653616|NCT04365387|470353839|FG001|Overall Study|Adverse Event|2|||
130653617|NCT04365387|470353838|FG000|Overall Study|Participants request|14|||
130653618|NCT04365387|470353839|FG001|Overall Study|Participants request|14|||
130653619|NCT04365387|470353838|FG000|Overall Study|Lost to Follow-up|8|||
130208463|NCT05153148|468722875|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208464|NCT05153148|468722876|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208465|NCT05153148|468722877|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
130208466|NCT05153148|468722878|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208467|NCT05153148|468722875|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130653620|NCT04365387|470353839|FG001|Overall Study|Lost to Follow-up|5|||
130653621|NCT04365387|470353838|FG000|Overall Study|Protocol deviation|3|||
130653622|NCT04365387|470353839|FG001|Overall Study|Protocol deviation|4|||
130653623|NCT04365387|470353838|FG000|Overall Study|Participant compliance with visit schedule|1|||
130653624|NCT04365387|470353839|FG001|Overall Study|Participant compliance with visit schedule|0|||
130653625|NCT04365387|470353838|FG000|Overall Study|Participant incarcerated|1|||
130653626|NCT04365387|470353839|FG001|Overall Study|Participant incarcerated|0|||
130653627|NCT04365387|470353838|FG000|Overall Study|Participant moved out of town (relocated)|0|||
130653628|NCT04365387|470353839|FG001|Overall Study|Participant moved out of town (relocated)|1|||
130208468|NCT05153148|468722876|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130208469|NCT05153148|468722877|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130208470|NCT05153148|468722878|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
130208471|NCT05153148|468722875|FG000|Overall Study|Reason not Specified|1|||
130208472|NCT05153148|468722876|FG001|Overall Study|Reason not Specified|1|||
130208473|NCT05153148|468722877|FG002|Overall Study|Reason not Specified|1|||
130208474|NCT05153148|468722878|FG003|Overall Study|Reason not Specified|1|||
130208475|NCT01712334|468722879|FG000|Treatment Period 1|Randomized in Error|0|||
130208476|NCT01712334|468722880|FG001|Treatment Period 1|Randomized in Error|2|||
130208477|NCT01732471|468722881|FG000|Overall Study|Withdrawal by Subject|1|||
130208478|NCT01253174|468722882|FG000|Period 1|Randomized but not treated|0|||
130208479|NCT01253174|468722883|FG001|Period 1|Randomized but not treated|1|||
130208480|NCT01253174|468722884|FG002|Period 1|Randomized but not treated|1|||
130208481|NCT01253174|468722885|FG003|Period 1|Randomized but not treated|0|||
130208482|NCT01253174|468722886|FG004|Period 1|Randomized but not treated|1|||
130208483|NCT01253174|468722887|FG005|Period 1|Randomized but not treated|0|||
130208484|NCT01253174|468722882|FG000|Period 2|Adverse Event|0|||
130208485|NCT01253174|468722883|FG001|Period 2|Adverse Event|0|||
130208486|NCT01253174|468722884|FG002|Period 2|Adverse Event|1|||
130208487|NCT01253174|468722885|FG003|Period 2|Adverse Event|0|||
130208488|NCT01253174|468722886|FG004|Period 2|Adverse Event|0|||
130208489|NCT01253174|468722887|FG005|Period 2|Adverse Event|0|||
130208490|NCT01253174|468722882|FG000|Period 3|Withdrawal by Subject|0|||
130208491|NCT01253174|468722883|FG001|Period 3|Withdrawal by Subject|1|||
130208492|NCT01253174|468722884|FG002|Period 3|Withdrawal by Subject|0|||
130208493|NCT01253174|468722885|FG003|Period 3|Withdrawal by Subject|0|||
130208494|NCT01253174|468722886|FG004|Period 3|Withdrawal by Subject|1|||
130208495|NCT01253174|468722887|FG005|Period 3|Withdrawal by Subject|0|||
130208496|NCT01253174|468722882|FG000|Period 3|Pregnancy|0|||
130208497|NCT01253174|468722883|FG001|Period 3|Pregnancy|0|||
130208498|NCT01253174|468722884|FG002|Period 3|Pregnancy|1|||
130208499|NCT01253174|468722885|FG003|Period 3|Pregnancy|0|||
130208500|NCT01253174|468722886|FG004|Period 3|Pregnancy|0|||
130208501|NCT01253174|468722887|FG005|Period 3|Pregnancy|0|||
130208502|NCT02267135|468722888|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
130208503|NCT02267135|468722889|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
130208504|NCT02267135|468722888|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
130208505|NCT02267135|468722889|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
130208506|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130208507|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130208508|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
130208509|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
130208510|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
130208511|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
130208512|NCT02892513|468722890|FG000|Overall Study|Withdrawal by Subject|0|||
130208513|NCT02892513|468722891|FG001|Overall Study|Withdrawal by Subject|1|||
130653629|NCT04365387|470353838|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
130208514|NCT00900731|468722892|FG000|Overall Study|Adverse Event|31|||
130208515|NCT00900731|468722893|FG001|Overall Study|Adverse Event|27|||
130208516|NCT00900731|468722892|FG000|Overall Study|Withdrawal by Subject|8|||
130653630|NCT04365387|470353839|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
130653631|NCT04365387|470353838|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
130653632|NCT04365387|470353839|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
130653633|NCT05770401|470353840|FG000|Overall Study|Lost to Follow-up|5|||
130653634|NCT05770401|470353841|FG001|Overall Study|Lost to Follow-up|4|||
130653635|NCT00402298|470353842|FG000|Overall Study|Withdrawal by Subject|1|||
130653636|NCT00402298|470353843|FG001|Overall Study|Withdrawal by Subject|0|||
130653637|NCT04784455|470353844|FG000|Overall Study|Death|4|||
130653638|NCT04298229|470353847|FG000|Overall Study|Physician Decision|1|||
130653639|NCT04298229|470353848|FG001|Overall Study|Physician Decision|1|||
130653640|NCT04298229|470353847|FG000|Overall Study|Withdrawal by Subject|1|||
130653641|NCT04298229|470353848|FG001|Overall Study|Withdrawal by Subject|1|||
130653642|NCT04298229|470353847|FG000|Overall Study|Did not receive IV loop diuretics|2|||
130653643|NCT04298229|470353848|FG001|Overall Study|Did not receive IV loop diuretics|0|||
130653644|NCT00071006|470353849|FG000|Overall Study|Lack of Efficacy|7|||
130653645|NCT00071006|470353849|FG000|Overall Study|Adverse Event|1|||
130653646|NCT00071006|470353849|FG000|Overall Study|Withdrawal by Subject|1|||
130653647|NCT00071006|470353849|FG000|Overall Study|Other|3|||
130653648|NCT00859313|470353850|FG000|Overall Study|Lack of Efficacy|2|||
130653649|NCT00859313|470353850|FG000|Overall Study|Adverse Event|1|||
130653650|NCT00859313|470353850|FG000|Overall Study|staff error|1|||
130653651|NCT03901274|470353851|FG000|Overall Study|Lost to Follow-up|120|||
130653652|NCT03901274|470353852|FG001|Overall Study|Lost to Follow-up|124|||
130653653|NCT03901274|470353851|FG000|Overall Study|Withdrawal by Subject|0|||
130653654|NCT03901274|470353852|FG001|Overall Study|Withdrawal by Subject|6|||
130653655|NCT00145119|470353855|FG000|Overall Study|Death|45|||
130653656|NCT04527380|470353856|FG000|Overall Study|Lack of Efficacy|0|||
130653657|NCT04527380|470353857|FG001|Overall Study|Lack of Efficacy|1|||
130653658|NCT04527380|470353856|FG000|Overall Study|Withdrawal by Subject|1|||
130653659|NCT04527380|470353857|FG001|Overall Study|Withdrawal by Subject|0|||
130653660|NCT05048875|470353858|FG000|Overall Study|Withdrawal by Subject|1|||
130653661|NCT05048875|470353859|FG001|Overall Study|Withdrawal by Subject|0|||
130653662|NCT05048875|470353860|FG002|Overall Study|Withdrawal by Subject|0|||
130208517|NCT00900731|468722893|FG001|Overall Study|Withdrawal by Subject|7|||
130208518|NCT00900731|468722892|FG000|Overall Study|Protocol Deviation|8|||
130208519|NCT00900731|468722893|FG001|Overall Study|Protocol Deviation|11|||
130208520|NCT00900731|468722892|FG000|Overall Study|Administrative Problems|5|||
130208521|NCT00900731|468722893|FG001|Overall Study|Administrative Problems|4|||
130208522|NCT00900731|468722892|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
130208523|NCT00900731|468722893|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130208524|NCT00900731|468722892|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
130208525|NCT00900731|468722893|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
130208526|NCT00900731|468722892|FG000|Overall Study|Lost to Follow-up|2|||
130208527|NCT00900731|468722893|FG001|Overall Study|Lost to Follow-up|3|||
130208528|NCT00900731|468722892|FG000|Overall Study|Lack of Efficacy|1|||
130208529|NCT00900731|468722893|FG001|Overall Study|Lack of Efficacy|3|||
130208530|NCT00900731|468722892|FG000|Overall Study|Death|0|||
130208531|NCT00900731|468722893|FG001|Overall Study|Death|2|||
130208532|NCT03806231|468722894|FG000|Overall Study|Physician Decision|1|||
130208533|NCT03806231|468722895|FG001|Overall Study|Physician Decision|0|||
130208534|NCT03806231|468722894|FG000|Overall Study|Withdrawal by Subject|1|||
130208535|NCT03806231|468722895|FG001|Overall Study|Withdrawal by Subject|0|||
130208536|NCT02919267|468722896|FG000|Overall Study|Protocol Violation|0|||
130208537|NCT02919267|468722897|FG001|Overall Study|Protocol Violation|3|||
130208538|NCT02919267|468722898|FG002|Overall Study|Protocol Violation|3|||
130208539|NCT02919267|468722899|FG003|Overall Study|Protocol Violation|4|||
130208540|NCT00628927|468722900|FG000|Overall Study|Problems performing blood draw|6|||
130208541|NCT00628927|468722901|FG001|Overall Study|Problems performing blood draw|0|||
130208542|NCT00628927|468722900|FG000|Overall Study|Lost to Follow-up|1|||
130208543|NCT00628927|468722901|FG001|Overall Study|Lost to Follow-up|0|||
130208544|NCT00628927|468722900|FG000|Overall Study|Equipment failure|1|||
130208545|NCT00628927|468722901|FG001|Overall Study|Equipment failure|0|||
130208546|NCT02093390|468722902|FG000|Overall Study|Withdrawal by Subject|0|||
130208547|NCT02093390|468722903|FG001|Overall Study|Withdrawal by Subject|1|||
130208548|NCT02437188|468725118|FG000|Overall Study|Randomized but did not receive surgery|4|||
130208549|NCT02437188|468725119|FG001|Overall Study|Randomized but did not receive surgery|8|||
130319135|NCT00001832|469135430|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
130208550|NCT02437188|468725118|FG000|Overall Study|Adverse Event|0|||
130208551|NCT02437188|468725119|FG001|Overall Study|Adverse Event|1|||
130208552|NCT01172808|468725120|FG000|Overall Study|Adverse Event|8|||
130653663|NCT05048875|470353861|FG003|Overall Study|Withdrawal by Subject|0|||
130653664|NCT05048875|470353862|FG004|Overall Study|Withdrawal by Subject|0|||
130653665|NCT05048875|470353863|FG005|Overall Study|Withdrawal by Subject|0|||
130653666|NCT05048875|470353864|FG006|Overall Study|Withdrawal by Subject|0|||
130653667|NCT05048875|470353865|FG007|Overall Study|Withdrawal by Subject|0|||
130653668|NCT05048875|470353858|FG000|Overall Study|Adverse Event|0|||
130653669|NCT05048875|470353859|FG001|Overall Study|Adverse Event|0|||
130653670|NCT05048875|470353860|FG002|Overall Study|Adverse Event|0|||
130653671|NCT05048875|470353861|FG003|Overall Study|Adverse Event|1|||
130653672|NCT05048875|470353862|FG004|Overall Study|Adverse Event|0|||
130653673|NCT05048875|470353863|FG005|Overall Study|Adverse Event|0|||
130653674|NCT05048875|470353864|FG006|Overall Study|Adverse Event|0|||
130653675|NCT05048875|470353865|FG007|Overall Study|Adverse Event|0|||
130653676|NCT05437211|470353870|FG000|Overall Study|Patient's decision|1|||
130653677|NCT05437211|470353871|FG001|Overall Study|Patient's decision|1|||
130653678|NCT04411641|470353872|FG000|DB Period|Other|7|||
130653679|NCT04411641|470353873|FG001|DB Period|Other|27|||
130653680|NCT04411641|470353874|FG002|DB Period|Other|0|||
130653681|NCT04411641|470353875|FG003|DB Period|Other|0|||
130653682|NCT04411641|470353872|FG000|DB Period|Withdrawal by Subject|67|||
130653683|NCT04411641|470353873|FG001|DB Period|Withdrawal by Subject|122|||
130653684|NCT04411641|470353874|FG002|DB Period|Withdrawal by Subject|0|||
130653685|NCT04411641|470353875|FG003|DB Period|Withdrawal by Subject|0|||
130653686|NCT04411641|470353872|FG000|DB Period|Progressive disease|76|||
130653687|NCT04411641|470353873|FG001|DB Period|Progressive disease|116|||
130653688|NCT04411641|470353874|FG002|DB Period|Progressive disease|0|||
130653689|NCT04411641|470353875|FG003|DB Period|Progressive disease|0|||
130653690|NCT04411641|470353872|FG000|DB Period|Poor compliance to protocol|1|||
130653691|NCT04411641|470353873|FG001|DB Period|Poor compliance to protocol|5|||
130653692|NCT04411641|470353874|FG002|DB Period|Poor compliance to protocol|0|||
130653693|NCT04411641|470353875|FG003|DB Period|Poor compliance to protocol|0|||
130653694|NCT04411641|470353872|FG000|DB Period|Lack of Efficacy|19|||
130653695|NCT04411641|470353873|FG001|DB Period|Lack of Efficacy|19|||
130653696|NCT04411641|470353874|FG002|DB Period|Lack of Efficacy|0|||
130653697|NCT04411641|470353875|FG003|DB Period|Lack of Efficacy|0|||
130208553|NCT01172808|468725121|FG001|Overall Study|Adverse Event|4|||
130208554|NCT01172808|468725122|FG002|Overall Study|Adverse Event|8|||
130208555|NCT01172808|468725123|FG003|Overall Study|Adverse Event|3|||
130208556|NCT01172808|468725120|FG000|Overall Study|Lack of Efficacy|1|||
130208557|NCT01172808|468725121|FG001|Overall Study|Lack of Efficacy|0|||
130208558|NCT01172808|468725122|FG002|Overall Study|Lack of Efficacy|0|||
130208559|NCT01172808|468725123|FG003|Overall Study|Lack of Efficacy|0|||
130208560|NCT01172808|468725120|FG000|Overall Study|Protocol Violation|2|||
130208561|NCT01172808|468725121|FG001|Overall Study|Protocol Violation|2|||
130208562|NCT01172808|468725122|FG002|Overall Study|Protocol Violation|2|||
130208563|NCT01172808|468725123|FG003|Overall Study|Protocol Violation|0|||
130208564|NCT01172808|468725120|FG000|Overall Study|Lost to Follow-up|0|||
130208565|NCT01172808|468725121|FG001|Overall Study|Lost to Follow-up|1|||
130208566|NCT01172808|468725122|FG002|Overall Study|Lost to Follow-up|1|||
130208567|NCT01172808|468725123|FG003|Overall Study|Lost to Follow-up|3|||
130208568|NCT01172808|468725120|FG000|Overall Study|Withdrawal by Subject|4|||
130208569|NCT01172808|468725121|FG001|Overall Study|Withdrawal by Subject|1|||
130208570|NCT01172808|468725122|FG002|Overall Study|Withdrawal by Subject|3|||
130208571|NCT01172808|468725123|FG003|Overall Study|Withdrawal by Subject|2|||
130208572|NCT01172808|468725120|FG000|Overall Study|Other|6|||
130208573|NCT01172808|468725121|FG001|Overall Study|Other|5|||
130208574|NCT01172808|468725122|FG002|Overall Study|Other|9|||
130208575|NCT01172808|468725123|FG003|Overall Study|Other|7|||
130208576|NCT03246061|468725124|FG000|Overall Study|Still in follow-up|15|||
130208577|NCT03246061|468725125|FG001|Overall Study|Still in follow-up|21|||
130208578|NCT01937715|468725126|FG000|Overall Study|Death|0|||
130208579|NCT01937715|468725127|FG001|Overall Study|Death|0|||
130208580|NCT01937715|468725128|FG002|Overall Study|Death|0|||
130208581|NCT01937715|468725129|FG003|Overall Study|Death|1|||
130208582|NCT01937715|468725130|FG004|Overall Study|Death|0|||
130208583|NCT01937715|468725126|FG000|Overall Study|Withdrawal by Subject|0|||
130208584|NCT01937715|468725127|FG001|Overall Study|Withdrawal by Subject|1|||
130208585|NCT01937715|468725128|FG002|Overall Study|Withdrawal by Subject|0|||
130208586|NCT01937715|468725129|FG003|Overall Study|Withdrawal by Subject|0|||
130653698|NCT04411641|470353872|FG000|DB Period|Adverse Event|13|||
130653699|NCT04411641|470353873|FG001|DB Period|Adverse Event|29|||
130653700|NCT04411641|470353874|FG002|DB Period|Adverse Event|0|||
130208587|NCT01937715|468725130|FG004|Overall Study|Withdrawal by Subject|2|||
130208588|NCT01937715|468725126|FG000|Overall Study|Other|0|||
130208589|NCT01937715|468725127|FG001|Overall Study|Other|0|||
130653701|NCT04411641|470353875|FG003|DB Period|Adverse Event|0|||
130653702|NCT04411641|470353872|FG000|DB Period|Randomized and not treated|2|||
130653703|NCT04411641|470353873|FG001|DB Period|Randomized and not treated|2|||
130208590|NCT01937715|468725128|FG002|Overall Study|Other|0|||
130208591|NCT01937715|468725129|FG003|Overall Study|Other|3|||
130208592|NCT01937715|468725130|FG004|Overall Study|Other|0|||
130208593|NCT02864316|468725131|FG000|Overall Study|Progressive Disease|2|||
130208594|NCT02864316|468725132|FG001|Overall Study|Progressive Disease|1|||
130208595|NCT02864316|468725131|FG000|Overall Study|Adverse Event|0|||
130208596|NCT02864316|468725132|FG001|Overall Study|Adverse Event|1|||
130653704|NCT04411641|470353874|FG002|DB Period|Randomized and not treated|0|||
130653705|NCT04411641|470353875|FG003|DB Period|Randomized and not treated|0|||
130653706|NCT04411641|470353872|FG000|OL|Withdrawal by Subject|0|||
130653707|NCT04411641|470353873|FG001|OL|Withdrawal by Subject|0|||
130653708|NCT04411641|470353874|FG002|OL|Withdrawal by Subject|6|||
130653709|NCT04411641|470353875|FG003|OL|Withdrawal by Subject|17|||
130653710|NCT04411641|470353872|FG000|OL|Progressive disease|0|||
130653711|NCT04411641|470353873|FG001|OL|Progressive disease|0|||
130653712|NCT04411641|470353874|FG002|OL|Progressive disease|1|||
130653713|NCT04411641|470353875|FG003|OL|Progressive disease|2|||
130653714|NCT04411641|470353872|FG000|OL|Poor compliance to protocol|0|||
130653715|NCT04411641|470353873|FG001|OL|Poor compliance to protocol|0|||
130653716|NCT04411641|470353874|FG002|OL|Poor compliance to protocol|1|||
130653717|NCT04411641|470353875|FG003|OL|Poor compliance to protocol|0|||
130653718|NCT04411641|470353872|FG000|OL|Adverse Event|0|||
130653719|NCT04411641|470353873|FG001|OL|Adverse Event|0|||
130653720|NCT04411641|470353874|FG002|OL|Adverse Event|1|||
130653721|NCT04411641|470353875|FG003|OL|Adverse Event|0|||
130653722|NCT04411641|470353872|FG000|OL|Other|0|||
130653723|NCT04411641|470353873|FG001|OL|Other|0|||
130653724|NCT04411641|470353874|FG002|OL|Other|0|||
130653725|NCT04411641|470353875|FG003|OL|Other|6|||
130653726|NCT04410991|470353880|FG000|Overall Study|Poor compliance to protocol|5|||
130653727|NCT04410991|470353881|FG001|Overall Study|Poor compliance to protocol|4|||
130653728|NCT04410991|470353880|FG000|Overall Study|Withdrawal by Subject|59|||
130653729|NCT04410991|470353881|FG001|Overall Study|Withdrawal by Subject|55|||
130653730|NCT04410991|470353880|FG000|Overall Study|Other|10|||
130653731|NCT04410991|470353881|FG001|Overall Study|Other|4|||
130653732|NCT03282123|470353882|FG000|Overall Study|Withdrawal by Subject|5|||
130653733|NCT01195662|470353883|FG000|Double Blind Treatment Period|Adverse Event|4|||
130653734|NCT01195662|470353884|FG001|Double Blind Treatment Period|Adverse Event|1|||
130653735|NCT01195662|470353885|FG002|Double Blind Treatment Period|Adverse Event|2|||
130653736|NCT01195662|470353883|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
130653737|NCT01195662|470353884|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
130653738|NCT01195662|470353885|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
130653739|NCT01195662|470353883|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
130653740|NCT01195662|470353884|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
130653741|NCT01195662|470353885|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
130653742|NCT01195662|470353883|FG000|Double Blind Treatment Period|Administrative reason|2|||
130653743|NCT01195662|470353884|FG001|Double Blind Treatment Period|Administrative reason|1|||
130653744|NCT01195662|470353885|FG002|Double Blind Treatment Period|Administrative reason|1|||
130653745|NCT01195662|470353883|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
130653746|NCT01195662|470353884|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
130653747|NCT01195662|470353885|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
130653748|NCT01195662|470353883|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
130653749|NCT01195662|470353884|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
130653750|NCT01195662|470353885|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
130653751|NCT01195662|470353883|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130653752|NCT01195662|470353884|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130653753|NCT01195662|470353885|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130653754|NCT01195662|470353883|FG000|Double Blind Treatment Period|Non-specified|3|||
130653755|NCT01195662|470353884|FG001|Double Blind Treatment Period|Non-specified|0|||
130653756|NCT01195662|470353885|FG002|Double Blind Treatment Period|Non-specified|0|||
130653757|NCT01195662|470353883|FG000|Double Blind Treatment Period|Missing disposition information|0|||
130653758|NCT01195662|470353884|FG001|Double Blind Treatment Period|Missing disposition information|1|||
130653759|NCT01195662|470353885|FG002|Double Blind Treatment Period|Missing disposition information|1|||
130653760|NCT01195662|470353883|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
130653761|NCT01195662|470353884|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
130653762|NCT01195662|470353885|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
130653763|NCT01195662|470353883|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
130653764|NCT01195662|470353884|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
130653765|NCT01195662|470353885|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
130653766|NCT01215968|470353886|FG000|Overall Study|Adverse Event|0|||
130653767|NCT01215968|470353887|FG001|Overall Study|Adverse Event|2|||
130653768|NCT01215968|470353886|FG000|Overall Study|Protocol Violation|2|||
130653769|NCT01215968|470353887|FG001|Overall Study|Protocol Violation|4|||
130653770|NCT01215968|470353886|FG000|Overall Study|Not received study drug|0|||
130653771|NCT01215968|470353887|FG001|Overall Study|Not received study drug|1|||
130653772|NCT05182840|470353890|FG000|Run-in Period|Not treated|0|||
130653773|NCT05182840|470353891|FG001|Run-in Period|Not treated|1|||
130653774|NCT05182840|470353892|FG002|Run-in Period|Not treated|0|||
130653775|NCT05182840|470353893|FG003|Run-in Period|Not treated|0|||
130653776|NCT05182840|470353894|FG004|Run-in Period|Not treated|0|||
130653777|NCT05182840|470353895|FG005|Run-in Period|Not treated|0|||
130653778|NCT05182840|470353896|FG006|Run-in Period|Not treated|0|||
130653779|NCT05182840|470353897|FG007|Run-in Period|Not treated|0|||
130653780|NCT05182840|470353898|FG008|Run-in Period|Not treated|0|||
130653781|NCT05182840|470353899|FG009|Run-in Period|Not treated|0|||
130653782|NCT05182840|470353890|FG000|Run-in Period|Other reason but not sponsor termination|14|||
130653783|NCT05182840|470353891|FG001|Run-in Period|Other reason but not sponsor termination|18|||
130653784|NCT05182840|470353892|FG002|Run-in Period|Other reason but not sponsor termination|0|||
130653785|NCT05182840|470353893|FG003|Run-in Period|Other reason but not sponsor termination|0|||
130653786|NCT05182840|470353894|FG004|Run-in Period|Other reason but not sponsor termination|0|||
130653787|NCT05182840|470353895|FG005|Run-in Period|Other reason but not sponsor termination|0|||
130653788|NCT05182840|470353896|FG006|Run-in Period|Other reason but not sponsor termination|0|||
130653789|NCT05182840|470353897|FG007|Run-in Period|Other reason but not sponsor termination|0|||
130653790|NCT05182840|470353898|FG008|Run-in Period|Other reason but not sponsor termination|0|||
130653791|NCT05182840|470353899|FG009|Run-in Period|Other reason but not sponsor termination|0|||
130653792|NCT05182840|470353890|FG000|Run-in Period|No reason available|2|||
130653793|NCT05182840|470353891|FG001|Run-in Period|No reason available|2|||
130653794|NCT05182840|470353892|FG002|Run-in Period|No reason available|0|||
130653795|NCT05182840|470353893|FG003|Run-in Period|No reason available|0|||
130653796|NCT05182840|470353894|FG004|Run-in Period|No reason available|0|||
130653797|NCT05182840|470353895|FG005|Run-in Period|No reason available|0|||
130653798|NCT05182840|470353896|FG006|Run-in Period|No reason available|0|||
130653799|NCT05182840|470353897|FG007|Run-in Period|No reason available|0|||
130653800|NCT05182840|470353898|FG008|Run-in Period|No reason available|0|||
130653801|NCT05182840|470353899|FG009|Run-in Period|No reason available|0|||
130653802|NCT05182840|470353890|FG000|Run-in Period|Burden of study procedures|2|||
130653803|NCT05182840|470353891|FG001|Run-in Period|Burden of study procedures|2|||
130653804|NCT05182840|470353892|FG002|Run-in Period|Burden of study procedures|0|||
130653805|NCT05182840|470353893|FG003|Run-in Period|Burden of study procedures|0|||
130653806|NCT05182840|470353894|FG004|Run-in Period|Burden of study procedures|0|||
130653807|NCT05182840|470353895|FG005|Run-in Period|Burden of study procedures|0|||
130653808|NCT05182840|470353896|FG006|Run-in Period|Burden of study procedures|0|||
130653809|NCT05182840|470353897|FG007|Run-in Period|Burden of study procedures|0|||
130653810|NCT05182840|470353898|FG008|Run-in Period|Burden of study procedures|0|||
130653811|NCT05182840|470353899|FG009|Run-in Period|Burden of study procedures|0|||
130653812|NCT05182840|470353890|FG000|Run-in Period|Change of residence|1|||
130653813|NCT05182840|470353891|FG001|Run-in Period|Change of residence|0|||
130653814|NCT05182840|470353892|FG002|Run-in Period|Change of residence|0|||
130653815|NCT05182840|470353893|FG003|Run-in Period|Change of residence|0|||
130653816|NCT05182840|470353894|FG004|Run-in Period|Change of residence|0|||
130653817|NCT05182840|470353895|FG005|Run-in Period|Change of residence|0|||
130653818|NCT05182840|470353896|FG006|Run-in Period|Change of residence|0|||
130653819|NCT05182840|470353897|FG007|Run-in Period|Change of residence|0|||
130653820|NCT05182840|470353898|FG008|Run-in Period|Change of residence|0|||
130653821|NCT05182840|470353899|FG009|Run-in Period|Change of residence|0|||
130653822|NCT05182840|470353890|FG000|Run-in Period|Adverse Event|5|||
130653823|NCT05182840|470353891|FG001|Run-in Period|Adverse Event|5|||
130653824|NCT05182840|470353892|FG002|Run-in Period|Adverse Event|0|||
130653825|NCT05182840|470353893|FG003|Run-in Period|Adverse Event|0|||
130653826|NCT05182840|470353894|FG004|Run-in Period|Adverse Event|0|||
130653827|NCT05182840|470353895|FG005|Run-in Period|Adverse Event|0|||
130653828|NCT05182840|470353896|FG006|Run-in Period|Adverse Event|0|||
130653829|NCT05182840|470353897|FG007|Run-in Period|Adverse Event|0|||
130653830|NCT05182840|470353898|FG008|Run-in Period|Adverse Event|0|||
130653831|NCT05182840|470353899|FG009|Run-in Period|Adverse Event|0|||
130653832|NCT05182840|470353890|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
130653833|NCT05182840|470353891|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
130653834|NCT05182840|470353892|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653835|NCT05182840|470353893|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653836|NCT05182840|470353894|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653837|NCT05182840|470353895|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653838|NCT05182840|470353896|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653839|NCT05182840|470353897|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653840|NCT05182840|470353898|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653841|NCT05182840|470353899|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130653842|NCT05182840|470353890|FG000|Treatment Period|Reason missing|0|||
130653843|NCT05182840|470353891|FG001|Treatment Period|Reason missing|0|||
130653844|NCT05182840|470353892|FG002|Treatment Period|Reason missing|1|||
130653845|NCT05182840|470353893|FG003|Treatment Period|Reason missing|0|||
130653846|NCT05182840|470353894|FG004|Treatment Period|Reason missing|0|||
130208597|NCT01887288|468725133|FG000|Overall Study|The study was terminated and the PI has|16|||
130208598|NCT03114657|468725137|FG000|Overall Study|Adverse Event|9|||
130208599|NCT03114657|468725138|FG001|Overall Study|Adverse Event|6|||
130653847|NCT05182840|470353895|FG005|Treatment Period|Reason missing|0|||
130653848|NCT05182840|470353896|FG006|Treatment Period|Reason missing|0|||
130653849|NCT05182840|470353897|FG007|Treatment Period|Reason missing|0|||
130653850|NCT05182840|470353898|FG008|Treatment Period|Reason missing|0|||
130653851|NCT05182840|470353899|FG009|Treatment Period|Reason missing|0|||
130653852|NCT05182840|470353890|FG000|Treatment Period|Other but not sponsor termination|0|||
130653853|NCT05182840|470353891|FG001|Treatment Period|Other but not sponsor termination|0|||
130653854|NCT05182840|470353892|FG002|Treatment Period|Other but not sponsor termination|8|||
130653855|NCT05182840|470353893|FG003|Treatment Period|Other but not sponsor termination|6|||
130653856|NCT05182840|470353894|FG004|Treatment Period|Other but not sponsor termination|6|||
130653857|NCT05182840|470353895|FG005|Treatment Period|Other but not sponsor termination|7|||
130653858|NCT05182840|470353896|FG006|Treatment Period|Other but not sponsor termination|5|||
130653859|NCT05182840|470353897|FG007|Treatment Period|Other but not sponsor termination|8|||
130653860|NCT05182840|470353898|FG008|Treatment Period|Other but not sponsor termination|7|||
130653861|NCT05182840|470353899|FG009|Treatment Period|Other but not sponsor termination|2|||
130653862|NCT05182840|470353890|FG000|Treatment Period|Protocol deviation|0|||
130653863|NCT05182840|470353891|FG001|Treatment Period|Protocol deviation|0|||
130653864|NCT05182840|470353892|FG002|Treatment Period|Protocol deviation|0|||
130653865|NCT05182840|470353893|FG003|Treatment Period|Protocol deviation|0|||
130653866|NCT05182840|470353894|FG004|Treatment Period|Protocol deviation|0|||
130653867|NCT05182840|470353895|FG005|Treatment Period|Protocol deviation|0|||
130653868|NCT05182840|470353896|FG006|Treatment Period|Protocol deviation|0|||
130653869|NCT05182840|470353897|FG007|Treatment Period|Protocol deviation|0|||
130653870|NCT05182840|470353898|FG008|Treatment Period|Protocol deviation|1|||
130653871|NCT05182840|470353899|FG009|Treatment Period|Protocol deviation|0|||
130653872|NCT05182840|470353890|FG000|Treatment Period|No reason available|0|||
130653873|NCT05182840|470353891|FG001|Treatment Period|No reason available|0|||
130653874|NCT05182840|470353892|FG002|Treatment Period|No reason available|0|||
130653875|NCT05182840|470353893|FG003|Treatment Period|No reason available|1|||
130653876|NCT05182840|470353894|FG004|Treatment Period|No reason available|0|||
130653877|NCT05182840|470353895|FG005|Treatment Period|No reason available|2|||
130653878|NCT05182840|470353896|FG006|Treatment Period|No reason available|0|||
130653879|NCT05182840|470353897|FG007|Treatment Period|No reason available|1|||
130653880|NCT05182840|470353898|FG008|Treatment Period|No reason available|0|||
130653881|NCT05182840|470353899|FG009|Treatment Period|No reason available|0|||
130653882|NCT05182840|470353890|FG000|Treatment Period|Burden of study procedures|0|||
130653883|NCT05182840|470353891|FG001|Treatment Period|Burden of study procedures|0|||
130653884|NCT05182840|470353892|FG002|Treatment Period|Burden of study procedures|0|||
130653885|NCT05182840|470353893|FG003|Treatment Period|Burden of study procedures|0|||
130653886|NCT05182840|470353894|FG004|Treatment Period|Burden of study procedures|1|||
130653887|NCT05182840|470353895|FG005|Treatment Period|Burden of study procedures|0|||
130653888|NCT05182840|470353896|FG006|Treatment Period|Burden of study procedures|0|||
130653889|NCT05182840|470353897|FG007|Treatment Period|Burden of study procedures|0|||
130653890|NCT05182840|470353898|FG008|Treatment Period|Burden of study procedures|0|||
130653891|NCT05182840|470353899|FG009|Treatment Period|Burden of study procedures|0|||
130653892|NCT05182840|470353890|FG000|Treatment Period|Change of residence|0|||
130653893|NCT05182840|470353891|FG001|Treatment Period|Change of residence|0|||
130653894|NCT05182840|470353892|FG002|Treatment Period|Change of residence|0|||
130653895|NCT05182840|470353893|FG003|Treatment Period|Change of residence|0|||
130653896|NCT05182840|470353894|FG004|Treatment Period|Change of residence|0|||
130653897|NCT05182840|470353895|FG005|Treatment Period|Change of residence|1|||
130653898|NCT05182840|470353896|FG006|Treatment Period|Change of residence|0|||
130653899|NCT05182840|470353897|FG007|Treatment Period|Change of residence|0|||
130653900|NCT05182840|470353898|FG008|Treatment Period|Change of residence|0|||
130653901|NCT05182840|470353899|FG009|Treatment Period|Change of residence|0|||
130653902|NCT05182840|470353890|FG000|Treatment Period|Adverse Event|0|||
130653903|NCT05182840|470353891|FG001|Treatment Period|Adverse Event|0|||
130653904|NCT05182840|470353892|FG002|Treatment Period|Adverse Event|4|||
130653905|NCT05182840|470353893|FG003|Treatment Period|Adverse Event|16|||
130653906|NCT05182840|470353894|FG004|Treatment Period|Adverse Event|12|||
130653907|NCT05182840|470353895|FG005|Treatment Period|Adverse Event|6|||
130653908|NCT05182840|470353896|FG006|Treatment Period|Adverse Event|4|||
130653909|NCT05182840|470353897|FG007|Treatment Period|Adverse Event|8|||
130653910|NCT05182840|470353898|FG008|Treatment Period|Adverse Event|16|||
130653911|NCT05182840|470353899|FG009|Treatment Period|Adverse Event|5|||
130653912|NCT05182840|470353890|FG000|Treatment Period|Not treated with study drug|0|||
130653913|NCT05182840|470353891|FG001|Treatment Period|Not treated with study drug|0|||
130653914|NCT05182840|470353892|FG002|Treatment Period|Not treated with study drug|0|||
130653915|NCT05182840|470353893|FG003|Treatment Period|Not treated with study drug|1|||
130653916|NCT05182840|470353894|FG004|Treatment Period|Not treated with study drug|0|||
130653917|NCT05182840|470353895|FG005|Treatment Period|Not treated with study drug|0|||
130653918|NCT05182840|470353896|FG006|Treatment Period|Not treated with study drug|1|||
130653919|NCT05182840|470353897|FG007|Treatment Period|Not treated with study drug|1|||
130720815|NCT01715571|470601529|FG000|Overall Study|Lost to Follow-up|8|||
130653920|NCT05182840|470353898|FG008|Treatment Period|Not treated with study drug|0|||
130653921|NCT05182840|470353899|FG009|Treatment Period|Not treated with study drug|0|||
130653922|NCT02161380|470353900|FG000|Overall Study|Lost to Follow-up|0|||
130653923|NCT02161380|470353901|FG001|Overall Study|Lost to Follow-up|1|||
130653924|NCT02161380|470353902|FG002|Overall Study|Lost to Follow-up|0|||
130653925|NCT02161380|470353903|FG003|Overall Study|Lost to Follow-up|0|||
130653926|NCT04768881|470353912|FG000|Overall Study|Completed Study Follow-up|0|||
130653927|NCT04768881|470353913|FG001|Overall Study|Completed Study Follow-up|2|||
130653928|NCT04768881|470353912|FG000|Overall Study|Death|3|||
130653929|NCT04768881|470353913|FG001|Overall Study|Death|2|||
130653930|NCT04768881|470353912|FG000|Overall Study|Study Terminated by Sponsor|2|||
130653931|NCT04768881|470353913|FG001|Overall Study|Study Terminated by Sponsor|2|||
130653932|NCT04768881|470353912|FG000|Overall Study|Withdrawal by Subject|2|||
130653933|NCT04768881|470353913|FG001|Overall Study|Withdrawal by Subject|0|||
130653934|NCT04768881|470353912|FG000|Overall Study|Other|2|||
130653935|NCT04768881|470353913|FG001|Overall Study|Other|0|||
130653936|NCT01958619|470353914|FG000|Overall Study|Protocol Violation|2|||
130653937|NCT01958619|470353915|FG001|Overall Study|Protocol Violation|0|||
130653938|NCT01958619|470353916|FG002|Overall Study|Protocol Violation|1|||
130653939|NCT01958619|470353917|FG003|Overall Study|Protocol Violation|0|||
130653940|NCT01003691|470353922|FG000|Overall Study|Adverse Event|0|||
130653941|NCT01003691|470353923|FG001|Overall Study|Adverse Event|0|||
130653942|NCT01003691|470353924|FG002|Overall Study|Adverse Event|0|||
130653943|NCT01003691|470353925|FG003|Overall Study|Adverse Event|1|||
130653944|NCT00157820|470353928|FG000|Randomized|Physician Decision|4|||
130653945|NCT00157820|470353929|FG001|Randomized|Physician Decision|2|||
130653946|NCT00157820|470353930|FG002|Randomized|Physician Decision|3|||
130653947|NCT00157820|470353928|FG000|Randomized|Withdrawal by Subject|1|||
130653948|NCT00157820|470353929|FG001|Randomized|Withdrawal by Subject|2|||
130653949|NCT00157820|470353930|FG002|Randomized|Withdrawal by Subject|3|||
130653950|NCT00157820|470353928|FG000|Randomized|Protocol Violation|2|||
130653951|NCT00157820|470353929|FG001|Randomized|Protocol Violation|1|||
130653952|NCT00157820|470353930|FG002|Randomized|Protocol Violation|2|||
130653953|NCT00157820|470353928|FG000|1st 8 Month|Death|7|||
130653954|NCT00157820|470353929|FG001|1st 8 Month|Death|8|||
130653955|NCT00157820|470353930|FG002|1st 8 Month|Death|3|||
130653956|NCT00157820|470353928|FG000|1st 8 Month|Lost to Follow-up|1|||
130653957|NCT00157820|470353929|FG001|1st 8 Month|Lost to Follow-up|2|||
130653958|NCT00157820|470353930|FG002|1st 8 Month|Lost to Follow-up|1|||
130653959|NCT00157820|470353928|FG000|1st 8 Month|Premature cross-over|0|||
130653960|NCT00157820|470353929|FG001|1st 8 Month|Premature cross-over|2|||
130653961|NCT00157820|470353930|FG002|1st 8 Month|Premature cross-over|2|||
130653962|NCT00157820|470353928|FG000|2nd 8 Months|Death|3|||
130653963|NCT00157820|470353929|FG001|2nd 8 Months|Death|1|||
130653964|NCT00157820|470353930|FG002|2nd 8 Months|Death|3|||
130653965|NCT00157820|470353928|FG000|2nd 8 Months|Lost to Follow-up|1|||
130653966|NCT00157820|470353929|FG001|2nd 8 Months|Lost to Follow-up|5|||
130653967|NCT00157820|470353930|FG002|2nd 8 Months|Lost to Follow-up|2|||
130653968|NCT00157820|470353928|FG000|2nd 8 Months|Premature cross-over|1|||
130653969|NCT00157820|470353929|FG001|2nd 8 Months|Premature cross-over|7|||
130653970|NCT00157820|470353930|FG002|2nd 8 Months|Premature cross-over|9|||
130653971|NCT00509223|470355406|FG000|Overall Study|Lost to Follow-up|1|||
130653972|NCT00509223|470355407|FG001|Overall Study|Lost to Follow-up|1|||
130653973|NCT00509223|470355406|FG000|Overall Study|Adverse Event|1|||
130653974|NCT00509223|470355407|FG001|Overall Study|Adverse Event|1|||
130653975|NCT00509223|470355406|FG000|Overall Study|Withdrawal by Subject|25|||
130653976|NCT00509223|470355407|FG001|Overall Study|Withdrawal by Subject|6|||
130653977|NCT00509223|470355406|FG000|Overall Study|Including: subject change of address|5|||
130653978|NCT00509223|470355407|FG001|Overall Study|Including: subject change of address|2|||
130653979|NCT00509223|470355406|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
130653980|NCT00509223|470355407|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
130653981|NCT00437294|470355411|FG000|Overall Study|Adverse Event|5|||
130653982|NCT00437294|470355412|FG001|Overall Study|Adverse Event|4|||
130653983|NCT00437294|470355411|FG000|Overall Study|Death|5|||
130653984|NCT00437294|470355412|FG001|Overall Study|Death|2|||
130653985|NCT00437294|470355411|FG000|Overall Study|Physician Decision|0|||
130653986|NCT00437294|470355412|FG001|Overall Study|Physician Decision|3|||
130653987|NCT00437294|470355411|FG000|Overall Study|Withdrawal by Subject|5|||
130653988|NCT00437294|470355412|FG001|Overall Study|Withdrawal by Subject|0|||
130653989|NCT00437294|470355411|FG000|Overall Study|Progressive Disease|19|||
130653990|NCT00437294|470355412|FG001|Overall Study|Progressive Disease|23|||
130653991|NCT00437294|470355411|FG000|Overall Study|Sponsor Decision|8|||
130653992|NCT00437294|470355412|FG001|Overall Study|Sponsor Decision|9|||
130653993|NCT00437294|470355411|FG000|Overall Study|Protocol Violation|0|||
130653994|NCT00437294|470355412|FG001|Overall Study|Protocol Violation|1|||
130653995|NCT00437294|470355411|FG000|Overall Study|Entry criteria not met|1|||
130653996|NCT00437294|470355412|FG001|Overall Study|Entry criteria not met|1|||
130653997|NCT01300741|470355419|FG000|Overall Study|Lens deposits|1|||
130653998|NCT01300741|470355419|FG000|Overall Study|Lost to Follow-up|1|||
130653999|NCT01300741|470355419|FG000|Overall Study|Discomfort|1|||
130654000|NCT01473602|470355420|FG000|Overall Study|Adverse Event|1|||
130654001|NCT01473602|470355421|FG001|Overall Study|Adverse Event|2|||
130654002|NCT01473602|470355420|FG000|Overall Study|Death|0|||
130654003|NCT01473602|470355421|FG001|Overall Study|Death|1|||
130654004|NCT01473602|470355420|FG000|Overall Study|Lost to Follow-up|1|||
130654005|NCT01473602|470355421|FG001|Overall Study|Lost to Follow-up|1|||
130654006|NCT01473602|470355420|FG000|Overall Study|Withdrawal by Subject|5|||
130654007|NCT01473602|470355421|FG001|Overall Study|Withdrawal by Subject|4|||
130654008|NCT01473602|470355420|FG000|Overall Study|Physician Decision|1|||
130654009|NCT01473602|470355421|FG001|Overall Study|Physician Decision|0|||
130654010|NCT00560573|470355423|FG000|Overall Study|Death|4|||
130654011|NCT00560573|470355424|FG001|Overall Study|Death|1|||
130654012|NCT00560573|470355425|FG002|Overall Study|Death|4|||
130654013|NCT00560573|470355426|FG003|Overall Study|Death|5|||
130654014|NCT00560573|470355427|FG004|Overall Study|Death|1|||
130654015|NCT00560573|470355428|FG005|Overall Study|Death|10|||
130654016|NCT00560573|470355423|FG000|Overall Study|Lost to Follow-up|0|||
130654017|NCT00560573|470355424|FG001|Overall Study|Lost to Follow-up|0|||
130654018|NCT00560573|470355425|FG002|Overall Study|Lost to Follow-up|0|||
130654019|NCT00560573|470355426|FG003|Overall Study|Lost to Follow-up|1|||
130654020|NCT00560573|470355427|FG004|Overall Study|Lost to Follow-up|1|||
130654021|NCT00560573|470355428|FG005|Overall Study|Lost to Follow-up|0|||
130654022|NCT00560573|470355423|FG000|Overall Study|Withdrawal by Subject|0|||
130654023|NCT00560573|470355424|FG001|Overall Study|Withdrawal by Subject|0|||
130654024|NCT00560573|470355425|FG002|Overall Study|Withdrawal by Subject|0|||
130654025|NCT00560573|470355426|FG003|Overall Study|Withdrawal by Subject|1|||
130654026|NCT00560573|470355427|FG004|Overall Study|Withdrawal by Subject|1|||
130654027|NCT00560573|470355428|FG005|Overall Study|Withdrawal by Subject|0|||
130654028|NCT00560573|470355423|FG000|Overall Study|Other|2|||
130654029|NCT00560573|470355424|FG001|Overall Study|Other|2|||
130654030|NCT00560573|470355425|FG002|Overall Study|Other|2|||
130654031|NCT00560573|470355426|FG003|Overall Study|Other|3|||
130654032|NCT00560573|470355427|FG004|Overall Study|Other|3|||
130654033|NCT00560573|470355428|FG005|Overall Study|Other|3|||
130654034|NCT00560573|470355423|FG000|Overall Study|Enrolled, not treated|0|||
130654035|NCT00560573|470355424|FG001|Overall Study|Enrolled, not treated|0|||
130654036|NCT00560573|470355425|FG002|Overall Study|Enrolled, not treated|0|||
130654037|NCT00560573|470355426|FG003|Overall Study|Enrolled, not treated|0|||
130654038|NCT00560573|470355427|FG004|Overall Study|Enrolled, not treated|1|||
130654039|NCT00560573|470355428|FG005|Overall Study|Enrolled, not treated|0|||
130654040|NCT00726882|470355429|FG000|Overall Study|Withdrawal by Subject|5|||
130654041|NCT00726882|470355429|FG000|Overall Study|Lost to Follow-up|7|||
130654042|NCT00726882|470355429|FG000|Overall Study|Other|10|||
130654043|NCT01339273|470355430|FG000|Overall Study|Lost to Follow-up|8|||
130654044|NCT01339273|470355431|FG001|Overall Study|Lost to Follow-up|8|||
130654045|NCT02526017|470355432|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654046|NCT02526017|470355433|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654047|NCT02526017|470355434|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654048|NCT02526017|470355435|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654049|NCT02526017|470355436|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
130654050|NCT02526017|470355437|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654051|NCT02526017|470355438|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654052|NCT02526017|470355439|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654053|NCT02526017|470355440|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130654054|NCT00968539|470355444|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
130654055|NCT00968539|470355445|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130654056|NCT00326118|470355446|FG000|Active Phase|Withdrawal by Subject|4|||
130654057|NCT00326118|470355447|FG001|Active Phase|Withdrawal by Subject|1|||
130654058|NCT00938392|470355448|FG000|Overall Study|Adverse Event|0|||
130654059|NCT00938392|470355449|FG001|Overall Study|Adverse Event|1|||
130654060|NCT00938392|470355448|FG000|Overall Study|Withdrawal by Subject|0|||
130654061|NCT00938392|470355449|FG001|Overall Study|Withdrawal by Subject|1|||
130654062|NCT00938392|470355448|FG000|Overall Study|Lost to Follow-up|2|||
130654063|NCT00938392|470355449|FG001|Overall Study|Lost to Follow-up|2|||
130654064|NCT00290511|470355450|FG000|Overall Study|Adverse Event|1|||
130654065|NCT00290511|470355450|FG000|Overall Study|Death|1|||
130654066|NCT00290511|470355450|FG000|Overall Study|Physician Decision|1|||
130654067|NCT00290511|470355450|FG000|Overall Study|Withdrawal by Subject|1|||
130654068|NCT04341727|470355458|FG000|Overall Study|Withdrawal by Subject|0|||
130654069|NCT04341727|470355459|FG001|Overall Study|Withdrawal by Subject|0|||
130654070|NCT04341727|470355460|FG002|Overall Study|Withdrawal by Subject|1|||
130654071|NCT04341727|470355461|FG003|Overall Study|Withdrawal by Subject|0|||
130654072|NCT04341727|470355458|FG000|Overall Study|Lost to Follow-up|0|||
130654073|NCT04341727|470355459|FG001|Overall Study|Lost to Follow-up|0|||
130654074|NCT04341727|470355460|FG002|Overall Study|Lost to Follow-up|0|||
130654075|NCT04341727|470355461|FG003|Overall Study|Lost to Follow-up|1|||
130720816|NCT04524364|470601530|FG000|Overall Study|Physician Decision|3|||
130208600|NCT03114657|468725137|FG000|Overall Study|Death|4|||
130208601|NCT03114657|468725138|FG001|Overall Study|Death|0|||
130654076|NCT05604521|470355462|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
130654077|NCT05604521|470355463|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
130654078|NCT05604521|470355462|FG000|Overall Study|Adverse Event|1|||
130654079|NCT05604521|470355463|FG001|Overall Study|Adverse Event|0|||
130654080|NCT01491737|470355469|FG000|Overall Study|Withdrawal by Subject|20|||
130654081|NCT01491737|470355470|FG001|Overall Study|Withdrawal by Subject|17|||
130654082|NCT01491737|470355469|FG000|Overall Study|Lost to Follow-up|2|||
130654083|NCT01491737|470355470|FG001|Overall Study|Lost to Follow-up|10|||
130654084|NCT01491737|470355469|FG000|Overall Study|Death|63|||
130208602|NCT03114657|468725137|FG000|Overall Study|Multiple Reasons|1|||
130654085|NCT01491737|470355470|FG001|Overall Study|Death|57|||
130654086|NCT01491737|470355469|FG000|Overall Study|Study Termination by Sponsor|36|||
130654087|NCT01491737|470355470|FG001|Overall Study|Study Termination by Sponsor|36|||
130654088|NCT01491737|470355469|FG000|Overall Study|Reason Not Specified|8|||
130654089|NCT01491737|470355470|FG001|Overall Study|Reason Not Specified|9|||
130654090|NCT01976663|470355471|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
130654091|NCT01976663|470355471|FG000|Overall Study|Personal Reasons|6|||
130654092|NCT01976663|470355471|FG000|Overall Study|Withdrawal by Subject|4|||
130654093|NCT01976663|470355471|FG000|Overall Study|Screen Failure|3|||
130654094|NCT01976663|470355471|FG000|Overall Study|Adverse Event|2|||
130654095|NCT01976663|470355471|FG000|Overall Study|Lost to Follow-up|3|||
130654096|NCT01817764|470355472|FG000|Overall Study|Adverse Event|7|||
130654097|NCT01817764|470355473|FG001|Overall Study|Adverse Event|10|||
130654098|NCT01817764|470355472|FG000|Overall Study|Lack of Efficacy|9|||
130654099|NCT01817764|470355473|FG001|Overall Study|Lack of Efficacy|7|||
130654100|NCT01817764|470355472|FG000|Overall Study|Protocol Violation|7|||
130654101|NCT01817764|470355473|FG001|Overall Study|Protocol Violation|5|||
130654102|NCT01817764|470355472|FG000|Overall Study|Lost to Follow-up|1|||
130654103|NCT01817764|470355473|FG001|Overall Study|Lost to Follow-up|4|||
130654104|NCT01817764|470355472|FG000|Overall Study|Withdrawal by Subject|10|||
130654105|NCT01817764|470355473|FG001|Overall Study|Withdrawal by Subject|12|||
130654106|NCT02255422|470355474|FG000|Overall Study|Withdrawal by Subject|0|||
130654107|NCT02255422|470355475|FG001|Overall Study|Withdrawal by Subject|0|||
130654108|NCT02255422|470355476|FG002|Overall Study|Withdrawal by Subject|0|||
130654109|NCT02255422|470355477|FG003|Overall Study|Withdrawal by Subject|0|||
130654110|NCT02255422|470355478|FG004|Overall Study|Withdrawal by Subject|0|||
130654111|NCT02255422|470355479|FG005|Overall Study|Withdrawal by Subject|0|||
130654112|NCT02255422|470355480|FG006|Overall Study|Withdrawal by Subject|2|||
130654113|NCT02255422|470355474|FG000|Overall Study|Lost to Follow-up|0|||
130654114|NCT02255422|470355475|FG001|Overall Study|Lost to Follow-up|0|||
130654115|NCT02255422|470355476|FG002|Overall Study|Lost to Follow-up|1|||
130654116|NCT02255422|470355477|FG003|Overall Study|Lost to Follow-up|0|||
130654117|NCT02255422|470355478|FG004|Overall Study|Lost to Follow-up|0|||
130654118|NCT02255422|470355479|FG005|Overall Study|Lost to Follow-up|0|||
130654119|NCT02255422|470355480|FG006|Overall Study|Lost to Follow-up|0|||
130654120|NCT00938366|470355483|FG000|Overall Study|Withdrawal by Subject|1|||
130654121|NCT00938366|470355484|FG001|Overall Study|Withdrawal by Subject|0|||
130654122|NCT01250418|470355490|FG000|Overall Study|monitor data failure|1|||
130654123|NCT01250418|470355491|FG001|Overall Study|monitor data failure|1|||
130654124|NCT01761565|470355492|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
130654125|NCT05643573|470355494|FG000|Overall Study|Adverse Event|117|||
130654126|NCT05643573|470355495|FG001|Overall Study|Adverse Event|90|||
130654127|NCT05643573|470355494|FG000|Overall Study|Death|53|||
130654128|NCT05643573|470355495|FG001|Overall Study|Death|57|||
130654129|NCT05643573|470355494|FG000|Overall Study|Lost to Follow-up|6|||
130654130|NCT05643573|470355495|FG001|Overall Study|Lost to Follow-up|3|||
130654131|NCT05643573|470355494|FG000|Overall Study|Other|18|||
130654132|NCT05643573|470355495|FG001|Overall Study|Other|15|||
130654133|NCT05643573|470355494|FG000|Overall Study|Outcome event|64|||
130654134|NCT05643573|470355495|FG001|Overall Study|Outcome event|36|||
130654135|NCT05643573|470355494|FG000|Overall Study|Physician Decision|33|||
130654136|NCT05643573|470355495|FG001|Overall Study|Physician Decision|19|||
130654137|NCT05643573|470355494|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
130654138|NCT05643573|470355495|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
130654139|NCT05643573|470355494|FG000|Overall Study|Site terminated by sponsor|10|||
130654140|NCT05643573|470355495|FG001|Overall Study|Site terminated by sponsor|10|||
130654141|NCT05643573|470355494|FG000|Overall Study|Study terminated by sponsor|1|||
130654142|NCT05643573|470355495|FG001|Overall Study|Study terminated by sponsor|0|||
130654143|NCT05643573|470355494|FG000|Overall Study|Withdrawal by Subject|178|||
130654144|NCT05643573|470355495|FG001|Overall Study|Withdrawal by Subject|130|||
130654145|NCT02268214|470355496|FG000|Overall Study|Subject no longer meets study criteria|0|||
130654146|NCT02268214|470355497|FG001|Overall Study|Subject no longer meets study criteria|2|||
130654147|NCT02268214|470355498|FG002|Overall Study|Subject no longer meets study criteria|0|||
130654148|NCT02268214|470355496|FG000|Overall Study|Pregnancy|2|||
130654149|NCT02268214|470355497|FG001|Overall Study|Pregnancy|2|||
130654150|NCT02268214|470355498|FG002|Overall Study|Pregnancy|1|||
130654151|NCT02268214|470355496|FG000|Overall Study|Lost to Follow-up|3|||
130654152|NCT02268214|470355497|FG001|Overall Study|Lost to Follow-up|3|||
130654153|NCT02268214|470355498|FG002|Overall Study|Lost to Follow-up|4|||
130654154|NCT02268214|470355496|FG000|Overall Study|Lack of Efficacy|1|||
130654155|NCT02268214|470355497|FG001|Overall Study|Lack of Efficacy|0|||
130654156|NCT02268214|470355498|FG002|Overall Study|Lack of Efficacy|2|||
130654157|NCT02268214|470355496|FG000|Overall Study|Adverse Event|11|||
130654158|NCT02268214|470355497|FG001|Overall Study|Adverse Event|14|||
130654159|NCT02268214|470355498|FG002|Overall Study|Adverse Event|9|||
130654160|NCT02268214|470355496|FG000|Overall Study|Withdrawal by Subject|4|||
130654161|NCT02268214|470355497|FG001|Overall Study|Withdrawal by Subject|5|||
130654162|NCT02268214|470355498|FG002|Overall Study|Withdrawal by Subject|10|||
130654163|NCT02268214|470355496|FG000|Overall Study|Subject request to discontinue treatment|10|||
130654164|NCT02268214|470355497|FG001|Overall Study|Subject request to discontinue treatment|8|||
130654165|NCT02268214|470355498|FG002|Overall Study|Subject request to discontinue treatment|6|||
130654166|NCT02268214|470355496|FG000|Overall Study|Poor/non-compliance|2|||
130654167|NCT02268214|470355497|FG001|Overall Study|Poor/non-compliance|1|||
130654168|NCT02268214|470355498|FG002|Overall Study|Poor/non-compliance|2|||
130654169|NCT02268214|470355496|FG000|Overall Study|Other reasons|7|||
130654170|NCT02268214|470355497|FG001|Overall Study|Other reasons|3|||
130654171|NCT02268214|470355498|FG002|Overall Study|Other reasons|3|||
130654172|NCT02268214|470355496|FG000|Overall Study|Not entering long-term period|2|||
130654173|NCT02268214|470355497|FG001|Overall Study|Not entering long-term period|3|||
130654174|NCT02268214|470355498|FG002|Overall Study|Not entering long-term period|5|||
130654175|NCT04342390|470355499|FG000|Overall Study|Lost to Follow-up|3|||
130654176|NCT04342390|470355500|FG001|Overall Study|Lost to Follow-up|0|||
130654177|NCT04089566|470355513|FG000|Overall Study|Death|0|||
130654178|NCT04089566|470355514|FG001|Overall Study|Death|6|||
130654179|NCT04089566|470355515|FG002|Overall Study|Death|10|||
130654180|NCT04089566|470355516|FG003|Overall Study|Death|0|||
130654181|NCT04089566|470355517|FG004|Overall Study|Death|0|||
130654182|NCT04089566|470355518|FG005|Overall Study|Death|0|||
130654183|NCT04089566|470355513|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
130654184|NCT04089566|470355514|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
130654185|NCT04089566|470355515|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
130654186|NCT04089566|470355516|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
130654187|NCT04089566|470355517|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
130654188|NCT04089566|470355518|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
130654189|NCT04089566|470355513|FG000|Overall Study|Reason not Specified|0|||
130654190|NCT04089566|470355514|FG001|Overall Study|Reason not Specified|4|||
130654191|NCT04089566|470355515|FG002|Overall Study|Reason not Specified|4|||
130654192|NCT04089566|470355516|FG003|Overall Study|Reason not Specified|1|||
130654193|NCT04089566|470355517|FG004|Overall Study|Reason not Specified|0|||
130654194|NCT04089566|470355518|FG005|Overall Study|Reason not Specified|0|||
130654195|NCT01083121|470355522|FG000|Overall Study|Use of Humira outside the approved label|81|||
130654196|NCT05403502|470355525|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
130654197|NCT05403502|470355525|FG000|Humalog Lead-In Period|Physician Decision|2|||
130654198|NCT05403502|470355525|FG000|Humalog Lead-In Period|Protocol Violation|1|||
130654199|NCT05403502|470355525|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
130654200|NCT05403502|470355525|FG000|Lyumjev Treatment Period|Physician Decision|2|||
130654201|NCT01054443|470355526|FG000|Overall Study|Withdrawal by Subject|0|||
130654202|NCT01054443|470355527|FG001|Overall Study|Withdrawal by Subject|0|||
130654203|NCT01054443|470355528|FG002|Overall Study|Withdrawal by Subject|0|||
130654204|NCT01054443|470355529|FG003|Overall Study|Withdrawal by Subject|1|||
130654205|NCT00985114|470355530|FG000|Overall Study|Adverse Event|1|||
130654206|NCT00985114|470355531|FG001|Overall Study|Adverse Event|0|||
130654207|NCT00985114|470355530|FG000|Overall Study|Withdrawal by Subject|0|||
130654208|NCT00985114|470355531|FG001|Overall Study|Withdrawal by Subject|2|||
130654209|NCT01119118|470355532|FG000|Overall Study|Adverse Event|1|||
130654210|NCT00167414|470355533|FG000|Overall Study|Death|10|||
130654211|NCT01875731|470355534|FG000|Overall Study|Fail to obtain lab sample|1|||
130654212|NCT01875731|470355535|FG001|Overall Study|Fail to obtain lab sample|0|||
130654213|NCT00223990|470355536|FG000|Overall Study|Moved from area|2|||
130654214|NCT00223990|470355537|FG001|Overall Study|Moved from area|1|||
130654215|NCT00223990|470355536|FG000|Overall Study|Withdrawal by Subject|4|||
130654216|NCT00223990|470355537|FG001|Overall Study|Withdrawal by Subject|8|||
130654217|NCT00223990|470355536|FG000|Overall Study|Lost to Follow-up|1|||
130654218|NCT00223990|470355537|FG001|Overall Study|Lost to Follow-up|0|||
130654219|NCT02674568|470357590|FG000|Overall Study|Withdrawal by Subject|5|||
130654220|NCT02674568|470357590|FG000|Overall Study|Death|303|||
130654221|NCT02674568|470357590|FG000|Overall Study|Physician Decision|2|||
130654222|NCT02674568|470357590|FG000|Overall Study|Lost to Follow-up|9|||
130654223|NCT02674568|470357590|FG000|Overall Study|Other, Not Specified|20|||
130654224|NCT00457249|470357591|FG000|Overall Study|Lost to Follow-up|3|||
130654225|NCT00457249|470357592|FG001|Overall Study|Lost to Follow-up|0|||
130654226|NCT00457249|470357591|FG000|Overall Study|Protocol Violation|4|||
130654227|NCT00457249|470357592|FG001|Overall Study|Protocol Violation|1|||
130654228|NCT00457249|470357591|FG000|Overall Study|Withdrawal by Subject|3|||
130654229|NCT00457249|470357592|FG001|Overall Study|Withdrawal by Subject|1|||
130654230|NCT00457249|470357591|FG000|Overall Study|Serious Adverse Events|2|||
130654231|NCT00457249|470357592|FG001|Overall Study|Serious Adverse Events|0|||
130654232|NCT00396318|470357593|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
130654233|NCT02916056|470357594|FG000|Overall Study|Adverse Event|6|||
130654234|NCT02916056|470357594|FG000|Overall Study|Lost to Follow-up|1|||
130654235|NCT02916056|470357594|FG000|Overall Study|Other|12|||
130654236|NCT02916056|470357594|FG000|Overall Study|Protocol Violation|1|||
130654237|NCT02916056|470357594|FG000|Overall Study|Withdrawal by Subject|8|||
130654238|NCT02916056|470357594|FG000|Overall Study|Study Terminated by Sponsor|269|||
130654239|NCT00124709|470357595|FG000|Overall Study|Randomized but did not take medication|3|||
130654240|NCT00124709|470357596|FG001|Overall Study|Randomized but did not take medication|1|||
130654241|NCT00124709|470357595|FG000|Overall Study|Adverse Event|3|||
130654242|NCT00124709|470357596|FG001|Overall Study|Adverse Event|0|||
130654243|NCT00124709|470357595|FG000|Overall Study|Lack of Efficacy|5|||
130208603|NCT03114657|468725138|FG001|Overall Study|Multiple Reasons|2|||
130208604|NCT03114657|468725137|FG000|Overall Study|Physician Decision|2|||
130208605|NCT03114657|468725138|FG001|Overall Study|Physician Decision|2|||
130208606|NCT03114657|468725137|FG000|Overall Study|Study Terminated By Sponsor|355|||
130208607|NCT03114657|468725138|FG001|Overall Study|Study Terminated By Sponsor|374|||
130208608|NCT03114657|468725137|FG000|Overall Study|Symptomatic Deterioration|0|||
130208609|NCT03114657|468725138|FG001|Overall Study|Symptomatic Deterioration|1|||
130208610|NCT03114657|468725137|FG000|Overall Study|Withdrawal by Subject|28|||
130208611|NCT03114657|468725138|FG001|Overall Study|Withdrawal by Subject|22|||
130208612|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
130208613|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
130208614|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
130208615|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
130208616|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
130208617|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208618|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208619|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208620|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
130208621|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
130208622|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
130208623|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
130208624|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Death|0|||
130208625|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Death|0|||
130654244|NCT00124709|470357596|FG001|Overall Study|Lack of Efficacy|10|||
130654245|NCT00124709|470357595|FG000|Overall Study|Protocol Violation|3|||
130654246|NCT00124709|470357596|FG001|Overall Study|Protocol Violation|5|||
130654247|NCT00124709|470357595|FG000|Overall Study|Withdrawal by Subject|127|||
130654248|NCT00124709|470357596|FG001|Overall Study|Withdrawal by Subject|136|||
130654249|NCT00124709|470357595|FG000|Overall Study|Lost to Follow-up|114|||
130654250|NCT00124709|470357596|FG001|Overall Study|Lost to Follow-up|120|||
130654251|NCT00122954|470357597|FG000|Overall Study|Withdrawal by Subject|2|||
130654252|NCT00122954|470357598|FG001|Overall Study|Withdrawal by Subject|2|||
130654253|NCT00122954|470357597|FG000|Overall Study|Protocol Violation|0|||
130654254|NCT00122954|470357598|FG001|Overall Study|Protocol Violation|1|||
130654255|NCT01728376|470357599|FG000|Overall Study|Adverse Event|1|||
130654256|NCT01728376|470357600|FG001|Overall Study|Adverse Event|1|||
130654257|NCT01728376|470357601|FG002|Overall Study|Adverse Event|1|||
130654258|NCT01728376|470357602|FG003|Overall Study|Adverse Event|1|||
130654259|NCT01728376|470357603|FG004|Overall Study|Adverse Event|1|||
130654260|NCT01728376|470357604|FG005|Overall Study|Adverse Event|0|||
130654261|NCT01728376|470357599|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
130654262|NCT01728376|470357600|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
130654263|NCT01728376|470357601|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
130654264|NCT01728376|470357602|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
130654265|NCT01728376|470357603|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
130654266|NCT01728376|470357604|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
130654267|NCT01728376|470357599|FG000|Overall Study|No relevant bacteria|2|||
130654268|NCT01728376|470357600|FG001|Overall Study|No relevant bacteria|0|||
130654269|NCT01728376|470357601|FG002|Overall Study|No relevant bacteria|0|||
130654270|NCT01728376|470357602|FG003|Overall Study|No relevant bacteria|0|||
130654271|NCT01728376|470357603|FG004|Overall Study|No relevant bacteria|1|||
130654272|NCT01728376|470357604|FG005|Overall Study|No relevant bacteria|1|||
130654273|NCT01728376|470357599|FG000|Overall Study|Did not receive treatment|0|||
130654274|NCT01728376|470357600|FG001|Overall Study|Did not receive treatment|1|||
130654275|NCT01728376|470357601|FG002|Overall Study|Did not receive treatment|0|||
130654276|NCT01728376|470357602|FG003|Overall Study|Did not receive treatment|0|||
130654277|NCT01728376|470357603|FG004|Overall Study|Did not receive treatment|0|||
130654278|NCT01728376|470357604|FG005|Overall Study|Did not receive treatment|0|||
130654279|NCT01728376|470357599|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130654280|NCT01728376|470357600|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130654281|NCT01728376|470357601|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130654282|NCT01728376|470357602|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
130654283|NCT01728376|470357603|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130654284|NCT01728376|470357604|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
130654285|NCT00526162|470357607|FG000|Overall Study|Device not implanted|3|||
130654286|NCT03110107|470357608|FG000|Treatment Period|Disease Progression|3|||
130208626|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Death|1|||
130208627|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Death|0|||
130208628|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208629|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
130208630|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208631|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208632|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
130208633|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
130654287|NCT03110107|470357609|FG001|Treatment Period|Disease Progression|9|||
130654288|NCT03110107|470357610|FG002|Treatment Period|Disease Progression|8|||
130654289|NCT03110107|470357611|FG003|Treatment Period|Disease Progression|11|||
130654290|NCT03110107|470357612|FG004|Treatment Period|Disease Progression|8|||
130654291|NCT03110107|470357613|FG005|Treatment Period|Disease Progression|4|||
130654292|NCT03110107|470357614|FG006|Treatment Period|Disease Progression|6|||
130654293|NCT03110107|470357615|FG007|Treatment Period|Disease Progression|7|||
130654294|NCT03110107|470357616|FG008|Treatment Period|Disease Progression|2|||
130654295|NCT03110107|470357617|FG009|Treatment Period|Disease Progression|10|||
130654296|NCT03110107|470357618|FG010|Treatment Period|Disease Progression|5|||
130654297|NCT03110107|470357619|FG011|Treatment Period|Disease Progression|2|||
130654298|NCT03110107|470357620|FG012|Treatment Period|Disease Progression|0|||
130654299|NCT03110107|470357621|FG013|Treatment Period|Disease Progression|5|||
130654300|NCT03110107|470357622|FG014|Treatment Period|Disease Progression|14|||
130654301|NCT03110107|470357623|FG015|Treatment Period|Disease Progression|14|||
130654302|NCT03110107|470357624|FG016|Treatment Period|Disease Progression|4|||
130654303|NCT03110107|470357625|FG017|Treatment Period|Disease Progression|3|||
130654304|NCT03110107|470357626|FG018|Treatment Period|Disease Progression|16|||
130654305|NCT03110107|470357627|FG019|Treatment Period|Disease Progression|14|||
130654306|NCT03110107|470357628|FG020|Treatment Period|Disease Progression|12|||
130654307|NCT03110107|470357629|FG021|Treatment Period|Disease Progression|16|||
130654308|NCT03110107|470357630|FG022|Treatment Period|Disease Progression|18|||
130654309|NCT03110107|470357631|FG023|Treatment Period|Disease Progression|13|||
130654310|NCT03110107|470357632|FG024|Treatment Period|Disease Progression|16|||
130654311|NCT03110107|470357633|FG025|Treatment Period|Disease Progression|31|||
130654312|NCT03110107|470357608|FG000|Treatment Period|Study drug toxicity|1|||
130654313|NCT03110107|470357609|FG001|Treatment Period|Study drug toxicity|0|||
130654314|NCT03110107|470357610|FG002|Treatment Period|Study drug toxicity|1|||
130654315|NCT03110107|470357611|FG003|Treatment Period|Study drug toxicity|2|||
130654316|NCT03110107|470357612|FG004|Treatment Period|Study drug toxicity|0|||
130654317|NCT03110107|470357613|FG005|Treatment Period|Study drug toxicity|3|||
130654318|NCT03110107|470357614|FG006|Treatment Period|Study drug toxicity|1|||
130654319|NCT03110107|470357615|FG007|Treatment Period|Study drug toxicity|1|||
130654320|NCT03110107|470357616|FG008|Treatment Period|Study drug toxicity|3|||
130654321|NCT03110107|470357617|FG009|Treatment Period|Study drug toxicity|2|||
130654322|NCT03110107|470357618|FG010|Treatment Period|Study drug toxicity|0|||
130654323|NCT03110107|470357619|FG011|Treatment Period|Study drug toxicity|2|||
130654324|NCT03110107|470357620|FG012|Treatment Period|Study drug toxicity|0|||
130654325|NCT03110107|470357621|FG013|Treatment Period|Study drug toxicity|0|||
130654326|NCT03110107|470357622|FG014|Treatment Period|Study drug toxicity|2|||
130654327|NCT03110107|470357623|FG015|Treatment Period|Study drug toxicity|3|||
130654328|NCT03110107|470357624|FG016|Treatment Period|Study drug toxicity|3|||
130654329|NCT03110107|470357625|FG017|Treatment Period|Study drug toxicity|3|||
130654330|NCT03110107|470357626|FG018|Treatment Period|Study drug toxicity|1|||
130654331|NCT03110107|470357627|FG019|Treatment Period|Study drug toxicity|2|||
130654332|NCT03110107|470357628|FG020|Treatment Period|Study drug toxicity|2|||
130654333|NCT03110107|470357629|FG021|Treatment Period|Study drug toxicity|0|||
130654334|NCT03110107|470357630|FG022|Treatment Period|Study drug toxicity|2|||
130654335|NCT03110107|470357631|FG023|Treatment Period|Study drug toxicity|6|||
130654336|NCT03110107|470357632|FG024|Treatment Period|Study drug toxicity|7|||
130654337|NCT03110107|470357633|FG025|Treatment Period|Study drug toxicity|6|||
130654338|NCT03110107|470357608|FG000|Treatment Period|Death|0|||
130654339|NCT03110107|470357609|FG001|Treatment Period|Death|0|||
130654340|NCT03110107|470357610|FG002|Treatment Period|Death|0|||
130654341|NCT03110107|470357611|FG003|Treatment Period|Death|0|||
130654342|NCT03110107|470357612|FG004|Treatment Period|Death|0|||
130654343|NCT03110107|470357613|FG005|Treatment Period|Death|0|||
130654344|NCT03110107|470357614|FG006|Treatment Period|Death|0|||
130654345|NCT03110107|470357615|FG007|Treatment Period|Death|0|||
130654346|NCT03110107|470357616|FG008|Treatment Period|Death|0|||
130654347|NCT03110107|470357617|FG009|Treatment Period|Death|0|||
130654348|NCT03110107|470357618|FG010|Treatment Period|Death|0|||
130654349|NCT03110107|470357619|FG011|Treatment Period|Death|0|||
130654350|NCT03110107|470357620|FG012|Treatment Period|Death|1|||
130654351|NCT03110107|470357621|FG013|Treatment Period|Death|0|||
130654352|NCT03110107|470357622|FG014|Treatment Period|Death|0|||
130654353|NCT03110107|470357623|FG015|Treatment Period|Death|0|||
130654354|NCT03110107|470357624|FG016|Treatment Period|Death|0|||
130654355|NCT03110107|470357625|FG017|Treatment Period|Death|0|||
130654356|NCT03110107|470357626|FG018|Treatment Period|Death|0|||
130654357|NCT03110107|470357627|FG019|Treatment Period|Death|0|||
130654358|NCT03110107|470357628|FG020|Treatment Period|Death|0|||
130654359|NCT03110107|470357629|FG021|Treatment Period|Death|0|||
130654360|NCT03110107|470357630|FG022|Treatment Period|Death|0|||
130654361|NCT03110107|470357631|FG023|Treatment Period|Death|0|||
130654362|NCT03110107|470357632|FG024|Treatment Period|Death|0|||
130654363|NCT03110107|470357633|FG025|Treatment Period|Death|0|||
130654364|NCT03110107|470357608|FG000|Treatment Period|Adverse Event|0|||
130654365|NCT03110107|470357609|FG001|Treatment Period|Adverse Event|0|||
130654366|NCT03110107|470357610|FG002|Treatment Period|Adverse Event|1|||
130654367|NCT03110107|470357611|FG003|Treatment Period|Adverse Event|0|||
130654368|NCT03110107|470357612|FG004|Treatment Period|Adverse Event|0|||
130654369|NCT03110107|470357613|FG005|Treatment Period|Adverse Event|2|||
130654370|NCT03110107|470357614|FG006|Treatment Period|Adverse Event|0|||
130654371|NCT03110107|470357615|FG007|Treatment Period|Adverse Event|2|||
130654372|NCT03110107|470357616|FG008|Treatment Period|Adverse Event|0|||
130654373|NCT03110107|470357617|FG009|Treatment Period|Adverse Event|1|||
130654374|NCT03110107|470357618|FG010|Treatment Period|Adverse Event|0|||
130654375|NCT03110107|470357619|FG011|Treatment Period|Adverse Event|0|||
130654376|NCT03110107|470357620|FG012|Treatment Period|Adverse Event|0|||
130654377|NCT03110107|470357621|FG013|Treatment Period|Adverse Event|0|||
130654378|NCT03110107|470357622|FG014|Treatment Period|Adverse Event|0|||
130654379|NCT03110107|470357623|FG015|Treatment Period|Adverse Event|2|||
130654380|NCT03110107|470357624|FG016|Treatment Period|Adverse Event|0|||
130654381|NCT03110107|470357625|FG017|Treatment Period|Adverse Event|1|||
130654382|NCT03110107|470357626|FG018|Treatment Period|Adverse Event|2|||
130654383|NCT03110107|470357627|FG019|Treatment Period|Adverse Event|1|||
130654384|NCT03110107|470357628|FG020|Treatment Period|Adverse Event|4|||
130654385|NCT03110107|470357629|FG021|Treatment Period|Adverse Event|2|||
130654386|NCT03110107|470357630|FG022|Treatment Period|Adverse Event|2|||
130654387|NCT03110107|470357631|FG023|Treatment Period|Adverse Event|2|||
130654388|NCT03110107|470357632|FG024|Treatment Period|Adverse Event|2|||
130654389|NCT03110107|470357633|FG025|Treatment Period|Adverse Event|4|||
130654390|NCT03110107|470357608|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
130654391|NCT03110107|470357609|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
130654392|NCT03110107|470357610|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
130654393|NCT03110107|470357611|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
130654394|NCT03110107|470357612|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
130654395|NCT03110107|470357613|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
130654396|NCT03110107|470357614|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
130654397|NCT03110107|470357615|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
130654398|NCT03110107|470357616|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
130654399|NCT03110107|470357617|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
130208634|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
130208635|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
130654400|NCT03110107|470357618|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
130654401|NCT03110107|470357619|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
130654402|NCT03110107|470357620|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
130654403|NCT03110107|470357621|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
130654404|NCT03110107|470357622|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
130654405|NCT03110107|470357623|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
130654406|NCT03110107|470357624|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
130654407|NCT03110107|470357625|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
130654408|NCT03110107|470357626|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
130654409|NCT03110107|470357627|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
130654410|NCT03110107|470357628|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
130654411|NCT03110107|470357629|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
130654412|NCT03110107|470357630|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
130654413|NCT03110107|470357631|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
130654414|NCT03110107|470357632|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
130654415|NCT03110107|470357633|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
130654416|NCT03110107|470357608|FG000|Treatment Period|Participant withdrew consent|0|||
130654417|NCT03110107|470357609|FG001|Treatment Period|Participant withdrew consent|0|||
130654418|NCT03110107|470357610|FG002|Treatment Period|Participant withdrew consent|1|||
130654419|NCT03110107|470357611|FG003|Treatment Period|Participant withdrew consent|0|||
130654420|NCT03110107|470357612|FG004|Treatment Period|Participant withdrew consent|4|||
130654421|NCT03110107|470357613|FG005|Treatment Period|Participant withdrew consent|3|||
130654422|NCT03110107|470357614|FG006|Treatment Period|Participant withdrew consent|0|||
130654423|NCT03110107|470357615|FG007|Treatment Period|Participant withdrew consent|0|||
130654424|NCT03110107|470357616|FG008|Treatment Period|Participant withdrew consent|0|||
130654425|NCT03110107|470357617|FG009|Treatment Period|Participant withdrew consent|1|||
130654426|NCT03110107|470357618|FG010|Treatment Period|Participant withdrew consent|0|||
130654427|NCT03110107|470357619|FG011|Treatment Period|Participant withdrew consent|0|||
130654428|NCT03110107|470357620|FG012|Treatment Period|Participant withdrew consent|0|||
130654429|NCT03110107|470357621|FG013|Treatment Period|Participant withdrew consent|0|||
130654430|NCT03110107|470357622|FG014|Treatment Period|Participant withdrew consent|0|||
130654431|NCT03110107|470357623|FG015|Treatment Period|Participant withdrew consent|0|||
130654432|NCT03110107|470357624|FG016|Treatment Period|Participant withdrew consent|0|||
130654433|NCT03110107|470357625|FG017|Treatment Period|Participant withdrew consent|0|||
130654434|NCT03110107|470357626|FG018|Treatment Period|Participant withdrew consent|0|||
130654435|NCT03110107|470357627|FG019|Treatment Period|Participant withdrew consent|1|||
130654436|NCT03110107|470357628|FG020|Treatment Period|Participant withdrew consent|0|||
130654437|NCT03110107|470357629|FG021|Treatment Period|Participant withdrew consent|2|||
130654438|NCT03110107|470357630|FG022|Treatment Period|Participant withdrew consent|0|||
130654439|NCT03110107|470357631|FG023|Treatment Period|Participant withdrew consent|0|||
130654440|NCT03110107|470357632|FG024|Treatment Period|Participant withdrew consent|0|||
130654441|NCT03110107|470357633|FG025|Treatment Period|Participant withdrew consent|2|||
130654442|NCT03110107|470357608|FG000|Treatment Period|Participants no longer meets study criteria|0|||
130654443|NCT03110107|470357609|FG001|Treatment Period|Participants no longer meets study criteria|0|||
130654444|NCT03110107|470357610|FG002|Treatment Period|Participants no longer meets study criteria|0|||
130654445|NCT03110107|470357611|FG003|Treatment Period|Participants no longer meets study criteria|0|||
130654446|NCT03110107|470357612|FG004|Treatment Period|Participants no longer meets study criteria|0|||
130654447|NCT03110107|470357613|FG005|Treatment Period|Participants no longer meets study criteria|0|||
130654448|NCT03110107|470357614|FG006|Treatment Period|Participants no longer meets study criteria|0|||
130654449|NCT03110107|470357615|FG007|Treatment Period|Participants no longer meets study criteria|0|||
130654450|NCT03110107|470357616|FG008|Treatment Period|Participants no longer meets study criteria|0|||
130654451|NCT03110107|470357617|FG009|Treatment Period|Participants no longer meets study criteria|0|||
130654452|NCT03110107|470357618|FG010|Treatment Period|Participants no longer meets study criteria|0|||
130654453|NCT03110107|470357619|FG011|Treatment Period|Participants no longer meets study criteria|0|||
130654454|NCT03110107|470357620|FG012|Treatment Period|Participants no longer meets study criteria|0|||
130654455|NCT03110107|470357621|FG013|Treatment Period|Participants no longer meets study criteria|0|||
130654456|NCT03110107|470357622|FG014|Treatment Period|Participants no longer meets study criteria|0|||
130654457|NCT03110107|470357623|FG015|Treatment Period|Participants no longer meets study criteria|0|||
130654458|NCT03110107|470357624|FG016|Treatment Period|Participants no longer meets study criteria|0|||
130654459|NCT03110107|470357625|FG017|Treatment Period|Participants no longer meets study criteria|0|||
130654460|NCT03110107|470357626|FG018|Treatment Period|Participants no longer meets study criteria|0|||
130654461|NCT03110107|470357627|FG019|Treatment Period|Participants no longer meets study criteria|0|||
130654462|NCT03110107|470357628|FG020|Treatment Period|Participants no longer meets study criteria|0|||
130654463|NCT03110107|470357629|FG021|Treatment Period|Participants no longer meets study criteria|0|||
130654464|NCT03110107|470357630|FG022|Treatment Period|Participants no longer meets study criteria|0|||
130654465|NCT03110107|470357631|FG023|Treatment Period|Participants no longer meets study criteria|1|||
130654466|NCT03110107|470357632|FG024|Treatment Period|Participants no longer meets study criteria|0|||
130720817|NCT04524364|470601531|FG001|Overall Study|Physician Decision|6|||
130720818|NCT04524364|470601530|FG000|Overall Study|Adverse Event|0|||
130720819|NCT04524364|470601531|FG001|Overall Study|Adverse Event|1|||
130208636|NCT01179737|468725140|FG000|Extension|The study was terminated|3|||
130208637|NCT01179737|468725141|FG001|Extension|The study was terminated|0|||
130208638|NCT01179737|468725142|FG002|Extension|The study was terminated|0|||
130208639|NCT01179737|468725143|FG003|Extension|The study was terminated|0|||
130208640|NCT01546038|468725144|FG000|Overall Study|Death|15|||
130208641|NCT01546038|468725145|FG001|Overall Study|Death|6|||
130208642|NCT01546038|468725146|FG002|Overall Study|Death|4|||
130208643|NCT01546038|468725147|FG003|Overall Study|Death|2|||
130208644|NCT01546038|468725148|FG004|Overall Study|Death|9|||
130208645|NCT01546038|468725149|FG005|Overall Study|Death|3|||
130208646|NCT01546038|468725150|FG006|Overall Study|Death|46|||
130208647|NCT01546038|468725151|FG007|Overall Study|Death|76|||
130208648|NCT01546038|468725152|FG008|Overall Study|Death|39|||
130208649|NCT01546038|468725144|FG000|Overall Study|Lost to Follow-up|0|||
130208650|NCT01546038|468725145|FG001|Overall Study|Lost to Follow-up|0|||
130208651|NCT01546038|468725146|FG002|Overall Study|Lost to Follow-up|0|||
130208652|NCT01546038|468725147|FG003|Overall Study|Lost to Follow-up|0|||
130208653|NCT01546038|468725148|FG004|Overall Study|Lost to Follow-up|1|||
130208654|NCT01546038|468725149|FG005|Overall Study|Lost to Follow-up|0|||
130208655|NCT01546038|468725150|FG006|Overall Study|Lost to Follow-up|2|||
130208656|NCT01546038|468725151|FG007|Overall Study|Lost to Follow-up|1|||
130208657|NCT01546038|468725152|FG008|Overall Study|Lost to Follow-up|0|||
130208658|NCT01546038|468725144|FG000|Overall Study|Withdrawal by Subject|1|||
130208659|NCT01546038|468725145|FG001|Overall Study|Withdrawal by Subject|0|||
130319136|NCT00001832|469135431|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
130720820|NCT04524364|470601530|FG000|Overall Study|Investigational device deficiency|0|||
130720821|NCT04524364|470601531|FG001|Overall Study|Investigational device deficiency|1|||
130720822|NCT04524364|470601530|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
130720823|NCT04524364|470601531|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
130720824|NCT04524364|470601530|FG000|Overall Study|Device unavailability|0|||
130720825|NCT04524364|470601531|FG001|Overall Study|Device unavailability|2|||
130720826|NCT04524364|470601530|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
130208660|NCT01546038|468725146|FG002|Overall Study|Withdrawal by Subject|0|||
130208661|NCT01546038|468725147|FG003|Overall Study|Withdrawal by Subject|1|||
130208662|NCT01546038|468725148|FG004|Overall Study|Withdrawal by Subject|0|||
130208663|NCT01546038|468725149|FG005|Overall Study|Withdrawal by Subject|1|||
130208664|NCT01546038|468725150|FG006|Overall Study|Withdrawal by Subject|3|||
130208665|NCT01546038|468725151|FG007|Overall Study|Withdrawal by Subject|3|||
130208666|NCT01546038|468725152|FG008|Overall Study|Withdrawal by Subject|1|||
130208667|NCT01546038|468725144|FG000|Overall Study|: Randomized, not treated|0|||
130208668|NCT01546038|468725145|FG001|Overall Study|: Randomized, not treated|0|||
130208669|NCT01546038|468725146|FG002|Overall Study|: Randomized, not treated|0|||
130208670|NCT01546038|468725147|FG003|Overall Study|: Randomized, not treated|0|||
130208671|NCT01546038|468725148|FG004|Overall Study|: Randomized, not treated|0|||
130208672|NCT01546038|468725149|FG005|Overall Study|: Randomized, not treated|0|||
130208673|NCT01546038|468725150|FG006|Overall Study|: Randomized, not treated|2|||
130208674|NCT01546038|468725151|FG007|Overall Study|: Randomized, not treated|4|||
130208675|NCT01546038|468725152|FG008|Overall Study|: Randomized, not treated|3|||
130208676|NCT04245202|468725153|FG000|Overall Study|Lack of Efficacy|10|||
130208677|NCT04245202|468725154|FG001|Overall Study|Lack of Efficacy|1|||
130208678|NCT02470403|468725155|FG000|Overall Study|Adverse Event|1|||
130208679|NCT02470403|468725156|FG001|Overall Study|Adverse Event|0|||
130208680|NCT02470403|468725157|FG002|Overall Study|Adverse Event|0|||
130208681|NCT02470403|468725158|FG003|Overall Study|Adverse Event|0|||
130208682|NCT02470403|468725159|FG004|Overall Study|Adverse Event|0|||
130208683|NCT02470403|468725155|FG000|Overall Study|Lost to Follow-up|0|||
130208684|NCT02470403|468725156|FG001|Overall Study|Lost to Follow-up|1|||
130208685|NCT02470403|468725157|FG002|Overall Study|Lost to Follow-up|0|||
130208686|NCT02470403|468725158|FG003|Overall Study|Lost to Follow-up|0|||
130208687|NCT02470403|468725159|FG004|Overall Study|Lost to Follow-up|0|||
130208688|NCT02470403|468725155|FG000|Overall Study|Subject/guardian decision|1|||
130208689|NCT02470403|468725156|FG001|Overall Study|Subject/guardian decision|0|||
130208690|NCT02470403|468725157|FG002|Overall Study|Subject/guardian decision|0|||
130208691|NCT02470403|468725158|FG003|Overall Study|Subject/guardian decision|4|||
130208692|NCT02470403|468725159|FG004|Overall Study|Subject/guardian decision|0|||
130208693|NCT00717275|468725160|FG000|Overall Study|Premature study termination.|3|||
130208694|NCT03329248|468725163|FG000|Overall Study|Progressive Disease|6|||
130208695|NCT01254721|468725168|FG000|Overall Study|Lost to Follow-up|0|||
130208696|NCT01254721|468725169|FG001|Overall Study|Lost to Follow-up|4|||
130208697|NCT01254721|468725168|FG000|Overall Study|Lack of Efficacy|4|||
130208698|NCT01254721|468725169|FG001|Overall Study|Lack of Efficacy|2|||
130654467|NCT03110107|470357633|FG025|Treatment Period|Participants no longer meets study criteria|0|||
130208699|NCT01254721|468725168|FG000|Overall Study|Death|0|||
130208700|NCT01254721|468725169|FG001|Overall Study|Death|1|||
130654468|NCT03110107|470357608|FG000|Treatment Period|Other Reasons|0|||
130654469|NCT03110107|470357609|FG001|Treatment Period|Other Reasons|0|||
130654470|NCT03110107|470357610|FG002|Treatment Period|Other Reasons|1|||
130654471|NCT03110107|470357611|FG003|Treatment Period|Other Reasons|1|||
130654472|NCT03110107|470357612|FG004|Treatment Period|Other Reasons|0|||
130654473|NCT03110107|470357613|FG005|Treatment Period|Other Reasons|1|||
130654474|NCT03110107|470357614|FG006|Treatment Period|Other Reasons|0|||
130654475|NCT03110107|470357615|FG007|Treatment Period|Other Reasons|0|||
130654476|NCT03110107|470357616|FG008|Treatment Period|Other Reasons|0|||
130654477|NCT03110107|470357617|FG009|Treatment Period|Other Reasons|0|||
130654478|NCT03110107|470357618|FG010|Treatment Period|Other Reasons|0|||
130654479|NCT03110107|470357619|FG011|Treatment Period|Other Reasons|0|||
130654480|NCT03110107|470357620|FG012|Treatment Period|Other Reasons|0|||
130654481|NCT03110107|470357621|FG013|Treatment Period|Other Reasons|0|||
130654482|NCT03110107|470357622|FG014|Treatment Period|Other Reasons|0|||
130654483|NCT03110107|470357623|FG015|Treatment Period|Other Reasons|0|||
130654484|NCT03110107|470357624|FG016|Treatment Period|Other Reasons|0|||
130654485|NCT03110107|470357625|FG017|Treatment Period|Other Reasons|0|||
130654486|NCT03110107|470357626|FG018|Treatment Period|Other Reasons|0|||
130654487|NCT03110107|470357627|FG019|Treatment Period|Other Reasons|0|||
130654488|NCT03110107|470357628|FG020|Treatment Period|Other Reasons|0|||
130654489|NCT03110107|470357629|FG021|Treatment Period|Other Reasons|0|||
130654490|NCT03110107|470357630|FG022|Treatment Period|Other Reasons|0|||
130654491|NCT03110107|470357631|FG023|Treatment Period|Other Reasons|0|||
130654492|NCT03110107|470357632|FG024|Treatment Period|Other Reasons|1|||
130654493|NCT03110107|470357633|FG025|Treatment Period|Other Reasons|0|||
130654494|NCT01471197|470357636|FG000|Overall Study|Disease Progression|4|||
130654495|NCT01471197|470357637|FG001|Overall Study|Disease Progression|2|||
130654496|NCT01471197|470357636|FG000|Overall Study|Death|1|||
130654497|NCT01471197|470357637|FG001|Overall Study|Death|0|||
130654498|NCT01471197|470357636|FG000|Overall Study|Study Drug Toxicity|1|||
130654499|NCT01471197|470357637|FG001|Overall Study|Study Drug Toxicity|0|||
130654500|NCT03557775|470357643|FG000|Overall Study|Withdrawal by Subject|1|||
130654501|NCT03557775|470357644|FG001|Overall Study|Withdrawal by Subject|2|||
130654502|NCT03557775|470357645|FG002|Overall Study|Withdrawal by Subject|4|||
130654503|NCT03557775|470357643|FG000|Overall Study|Physician Decision|0|||
130208701|NCT01254721|468725168|FG000|Overall Study|technical problum|1|||
130208702|NCT01254721|468725169|FG001|Overall Study|technical problum|0|||
130208703|NCT01254721|468725168|FG000|Overall Study|Adverse Event|2|||
130208704|NCT01254721|468725169|FG001|Overall Study|Adverse Event|3|||
130208705|NCT01254721|468725168|FG000|Overall Study|Withdrawal by Subject|8|||
130208706|NCT01254721|468725169|FG001|Overall Study|Withdrawal by Subject|11|||
130208707|NCT01254721|468725168|FG000|Overall Study|Wrongly randomization|0|||
130208708|NCT01254721|468725169|FG001|Overall Study|Wrongly randomization|1|||
130208709|NCT00987402|468725170|FG000|Overall Study|Insufficient data entry|86|||
130208710|NCT00987402|468725171|FG001|Overall Study|Insufficient data entry|98|||
130208711|NCT01362517|468725172|FG000|Overall Study|Protocol Violation|1|||
130208712|NCT01362517|468725172|FG000|Overall Study|Lost to Follow-up|1|||
130208713|NCT01121536|468725174|FG000|Overall Study|Adverse Event|63|||
130208714|NCT01121536|468725174|FG000|Overall Study|Lack of Efficacy|35|||
130208715|NCT01121536|468725174|FG000|Overall Study|Withdrawal by Subject|65|||
130208716|NCT01121536|468725174|FG000|Overall Study|Protocol Violation|20|||
130208717|NCT01121536|468725174|FG000|Overall Study|Noncompliance with study medication|12|||
130208718|NCT01121536|468725174|FG000|Overall Study|Noncompliance with study procedures|9|||
130208719|NCT01121536|468725174|FG000|Overall Study|Lost to Follow-up|39|||
130208720|NCT01121536|468725174|FG000|Overall Study|Other|118|||
130208721|NCT00568334|468725175|FG000|Overall Study|Withdrawal by Subject|0|||
130208722|NCT00568334|468725176|FG001|Overall Study|Withdrawal by Subject|1|||
130208723|NCT00568334|468725175|FG000|Overall Study|Lost to Follow-up|1|||
130208724|NCT00568334|468725176|FG001|Overall Study|Lost to Follow-up|0|||
130208725|NCT00306787|468725177|FG000|Overall Study|Discontinued without taking study drug|208|||
130208726|NCT00306787|468725178|FG001|Overall Study|Discontinued without taking study drug|215|||
130208727|NCT00306787|468725177|FG000|Overall Study|Adverse Event|1|||
130208728|NCT00306787|468725178|FG001|Overall Study|Adverse Event|1|||
130208729|NCT00306787|468725177|FG000|Overall Study|Lack of Efficacy|1|||
130208730|NCT00306787|468725178|FG001|Overall Study|Lack of Efficacy|0|||
130208731|NCT00306787|468725177|FG000|Overall Study|Protocol Violation|8|||
130208732|NCT00306787|468725178|FG001|Overall Study|Protocol Violation|10|||
130208733|NCT00306787|468725177|FG000|Overall Study|Withdrawal by Subject|2|||
130208734|NCT00306787|468725178|FG001|Overall Study|Withdrawal by Subject|9|||
130208735|NCT00306787|468725177|FG000|Overall Study|Lost to Follow-up|9|||
130208736|NCT00306787|468725178|FG001|Overall Study|Lost to Follow-up|6|||
130208737|NCT00306787|468725177|FG000|Overall Study|Administrative problems|4|||
130208738|NCT00306787|468725178|FG001|Overall Study|Administrative problems|0|||
130208739|NCT00306787|468725177|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130208740|NCT00306787|468725178|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130208741|NCT02273908|468725179|FG000|Overall Study|Adverse Event|16|||
130208742|NCT02273908|468725180|FG001|Overall Study|Adverse Event|0|||
130208743|NCT02273908|468725179|FG000|Overall Study|Lost to Follow-up|10|||
130208744|NCT02273908|468725180|FG001|Overall Study|Lost to Follow-up|1|||
130208745|NCT02273908|468725179|FG000|Overall Study|Did not meet entrance criteria|3|||
130208746|NCT02273908|468725180|FG001|Overall Study|Did not meet entrance criteria|2|||
130208747|NCT02273908|468725179|FG000|Overall Study|Withdrawal by Subject|4|||
130208748|NCT02273908|468725180|FG001|Overall Study|Withdrawal by Subject|2|||
130208749|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
130208750|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208751|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208752|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208753|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208754|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208755|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
130208756|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208757|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208758|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208759|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208760|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208761|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
130208762|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208763|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208764|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208765|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208766|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208767|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208768|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130208769|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
130208770|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130208771|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208772|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208773|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130208774|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
130208775|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
130208776|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
130208777|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
130208778|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130208779|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
130208780|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
130208781|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
130208782|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
130208783|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
130208784|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
130208785|NCT03913104|468725189|FG000|Overall Study|Lost to Follow-up|20|||
130208786|NCT03913104|468725189|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
130208787|NCT03913104|468725189|FG000|Overall Study|Withdrawal by Subject|2|||
130208788|NCT01074255|468725190|FG000|Overall Study|Did not receive EMEND|2|||
130208789|NCT01593254|468725191|FG000|Overall Study|Disease progression|2|||
130208790|NCT01593254|468725192|FG001|Overall Study|Disease progression|7|||
130208791|NCT01593254|468725191|FG000|Overall Study|Study drug toxicity|6|||
130208792|NCT01593254|468725192|FG001|Overall Study|Study drug toxicity|20|||
130208793|NCT01593254|468725191|FG000|Overall Study|Death|3|||
130208794|NCT01593254|468725192|FG001|Overall Study|Death|3|||
130208795|NCT01593254|468725191|FG000|Overall Study|AE unrelated to study drug|0|||
130208796|NCT01593254|468725192|FG001|Overall Study|AE unrelated to study drug|1|||
130208797|NCT01593254|468725191|FG000|Overall Study|participant request to discontinue study treatment|1|||
130376455|NCT01325584|469343696|FG000|Overall Study|Death|1|||
130208798|NCT01593254|468725192|FG001|Overall Study|participant request to discontinue study treatment|3|||
130208799|NCT01593254|468725191|FG000|Overall Study|participant withdrew consent|0|||
130208800|NCT01593254|468725192|FG001|Overall Study|participant withdrew consent|9|||
130208801|NCT01593254|468725191|FG000|Overall Study|lost to follow up|1|||
130208802|NCT01593254|468725192|FG001|Overall Study|lost to follow up|6|||
130208803|NCT01593254|468725191|FG000|Overall Study|maximum clinical benefit|1|||
130208804|NCT01593254|468725192|FG001|Overall Study|maximum clinical benefit|2|||
130208805|NCT01593254|468725191|FG000|Overall Study|Poor/non compliance|1|||
130208806|NCT01593254|468725192|FG001|Overall Study|Poor/non compliance|1|||
130208807|NCT01593254|468725191|FG000|Overall Study|Pregnancy|0|||
130208808|NCT01593254|468725192|FG001|Overall Study|Pregnancy|3|||
130208809|NCT01593254|468725191|FG000|Overall Study|participant no longer meets study criteria|1|||
130208810|NCT01593254|468725192|FG001|Overall Study|participant no longer meets study criteria|1|||
130208811|NCT01593254|468725191|FG000|Overall Study|Admin reason by sponsor|7|||
130208812|NCT01593254|468725192|FG001|Overall Study|Admin reason by sponsor|3|||
130208813|NCT01593254|468725191|FG000|Overall Study|Imatinib treatment failure|2|||
130208814|NCT01593254|468725192|FG001|Overall Study|Imatinib treatment failure|0|||
130208815|NCT01593254|468725191|FG000|Overall Study|Other Reasons|61|||
130208816|NCT01593254|468725192|FG001|Overall Study|Other Reasons|115|||
130208817|NCT01887678|468725193|FG000|Overall Study|Adverse Event|4|||
130208818|NCT01887678|468725194|FG001|Overall Study|Adverse Event|6|||
130208819|NCT01887678|468725193|FG000|Overall Study|Exceeded rescue medication dosage|4|||
130208820|NCT01887678|468725194|FG001|Overall Study|Exceeded rescue medication dosage|5|||
130208821|NCT01887678|468725193|FG000|Overall Study|Withdrawal of consent|3|||
130208822|NCT01887678|468725194|FG001|Overall Study|Withdrawal of consent|4|||
130208823|NCT01887678|468725193|FG000|Overall Study|Lost to Follow-up|4|||
130208824|NCT01887678|468725194|FG001|Overall Study|Lost to Follow-up|2|||
130208825|NCT01887678|468725193|FG000|Overall Study|Deterioration of clinical condition|0|||
130208826|NCT01887678|468725194|FG001|Overall Study|Deterioration of clinical condition|4|||
130208827|NCT01887678|468725193|FG000|Overall Study|Lack of Efficacy|1|||
130208828|NCT01887678|468725194|FG001|Overall Study|Lack of Efficacy|2|||
130208829|NCT01887678|468725193|FG000|Overall Study|Non-compliance|0|||
130208830|NCT01887678|468725194|FG001|Overall Study|Non-compliance|3|||
130208831|NCT01887678|468725193|FG000|Overall Study|Specified|1|||
130208832|NCT01887678|468725194|FG001|Overall Study|Specified|2|||
130208833|NCT00791492|468725195|FG000|Overall Study|Withdrawal by Subject|1|||
130208834|NCT00791492|468725196|FG001|Overall Study|Withdrawal by Subject|2|||
130208835|NCT00791492|468725195|FG000|Overall Study|Liver transplantation|5|||
130208836|NCT00791492|468725196|FG001|Overall Study|Liver transplantation|1|||
130208837|NCT00076999|468725197|FG000|Overall Study|Adverse Event|2|||
130208838|NCT00076999|468725198|FG001|Overall Study|Adverse Event|8|||
130208839|NCT00076999|468725199|FG002|Overall Study|Adverse Event|6|||
130208840|NCT00076999|468725200|FG003|Overall Study|Adverse Event|0|||
130208841|NCT00076999|468725201|FG004|Overall Study|Adverse Event|2|||
130208842|NCT00076999|468725197|FG000|Overall Study|Protocol Violation|0|||
130208843|NCT00076999|468725198|FG001|Overall Study|Protocol Violation|3|||
130208844|NCT00076999|468725199|FG002|Overall Study|Protocol Violation|4|||
130208845|NCT00076999|468725200|FG003|Overall Study|Protocol Violation|0|||
130208846|NCT00076999|468725201|FG004|Overall Study|Protocol Violation|9|||
130208847|NCT00076999|468725197|FG000|Overall Study|Lost to Follow-up|2|||
130208848|NCT00076999|468725198|FG001|Overall Study|Lost to Follow-up|1|||
130208849|NCT00076999|468725199|FG002|Overall Study|Lost to Follow-up|0|||
130208850|NCT00076999|468725200|FG003|Overall Study|Lost to Follow-up|0|||
130208851|NCT00076999|468725201|FG004|Overall Study|Lost to Follow-up|0|||
130208852|NCT00076999|468725197|FG000|Overall Study|Withdrawal by Subject|0|||
130208853|NCT00076999|468725198|FG001|Overall Study|Withdrawal by Subject|4|||
130208854|NCT00076999|468725199|FG002|Overall Study|Withdrawal by Subject|3|||
130208855|NCT00076999|468725200|FG003|Overall Study|Withdrawal by Subject|0|||
130208856|NCT00076999|468725201|FG004|Overall Study|Withdrawal by Subject|1|||
130208857|NCT00076999|468725197|FG000|Overall Study|Other reason (not specified)|8|||
130208858|NCT00076999|468725198|FG001|Overall Study|Other reason (not specified)|8|||
130208859|NCT00076999|468725199|FG002|Overall Study|Other reason (not specified)|4|||
130208860|NCT00076999|468725200|FG003|Overall Study|Other reason (not specified)|1|||
130208861|NCT00076999|468725201|FG004|Overall Study|Other reason (not specified)|13|||
130208862|NCT02603562|468725214|FG000|Overall Study|Lost to Follow-up|1|||
130208863|NCT01380691|468725229|FG000|Washout (7 Days)|Protocol Violation|0|||
130208864|NCT01380691|468725230|FG001|Washout (7 Days)|Protocol Violation|0|||
130208865|NCT01380691|468725231|FG002|Washout (7 Days)|Protocol Violation|0|||
130208866|NCT01380691|468725232|FG003|Washout (7 Days)|Protocol Violation|1|||
130208867|NCT01380691|468725229|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130319137|NCT00001832|469135417|FG000|Treatment Period|Death during treatment|0|||
130208868|NCT01380691|468725230|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
130208869|NCT01380691|468725231|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
130208870|NCT01380691|468725232|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
130208871|NCT01987232|468725233|FG000|Overall Study|Ongoing in Study|0|||
130208872|NCT01987232|468725234|FG001|Overall Study|Ongoing in Study|0|||
130208873|NCT01987232|468725235|FG002|Overall Study|Ongoing in Study|0|||
130208874|NCT01987232|468725236|FG003|Overall Study|Ongoing in Study|1|||
130208875|NCT01987232|468725237|FG004|Overall Study|Ongoing in Study|0|||
130208876|NCT00232596|468725244|FG000|6-Week Titration Phase|Adverse Event|6|||
130208877|NCT00232596|468725245|FG001|6-Week Titration Phase|Adverse Event|19|||
130208878|NCT00232596|468725244|FG000|6-Week Titration Phase|Failed to Return|2|||
130208879|NCT00232596|468725245|FG001|6-Week Titration Phase|Failed to Return|1|||
130208880|NCT00232596|468725244|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
130208881|NCT00232596|468725245|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
130208882|NCT00232596|468725244|FG000|6-Week Titration Phase|Protocol Violation|1|||
130208883|NCT00232596|468725245|FG001|6-Week Titration Phase|Protocol Violation|3|||
130208884|NCT00232596|468725244|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
130208885|NCT00232596|468725245|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
130208886|NCT00232596|468725244|FG000|6-Week Titration Phase|Other|3|||
130208887|NCT00232596|468725245|FG001|6-Week Titration Phase|Other|3|||
130208888|NCT00232596|468725244|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130208889|NCT00232596|468725245|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130208890|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Adverse Event|7|||
130208891|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Adverse Event|22|||
130208892|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
130208893|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
130208894|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
130208895|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
130208896|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Other|1|||
130208897|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Other|3|||
130208898|NCT03426436|468725246|FG000|Overall Study|Incorrect lead placement|12|||
130208899|NCT03426436|468725246|FG000|Overall Study|Withdrawal by Subject|2|||
130208900|NCT03426436|468725246|FG000|Overall Study|Consent issue|1|||
130208901|NCT03426436|468725246|FG000|Overall Study|ECGs not saved|4|||
130208902|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
130208903|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208904|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208905|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208906|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
130208907|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
130208908|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208909|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208910|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208911|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208912|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208913|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208914|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208915|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208916|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208917|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208918|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208919|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208920|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208921|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208922|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208923|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208924|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
130208925|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
130208926|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
130208927|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
130208928|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
130208929|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
130208930|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
130208931|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
130208932|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
130208933|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
130208934|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
130208935|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Other|0|||
130208936|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Other|0|||
130208937|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Other|1|||
130208938|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Other|0|||
130208939|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Other|0|||
130208940|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Other|0|||
130208941|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Other|1|||
130208942|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Other|0|||
130208943|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Other|0|||
130208944|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Other|0|||
130208945|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Other|0|||
130208946|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208947|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208948|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208949|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208950|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208951|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208952|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208953|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
130208954|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
130208955|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
130208956|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
130208957|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208958|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208959|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208960|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208961|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208962|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208963|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208964|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
130208965|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
130208966|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
130208967|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208968|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
130208969|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
130208970|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
130208971|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
130208972|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
130208973|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
130208974|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
130208975|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
130208976|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
130208977|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
130208978|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
130208979|NCT00655681|468725258|FG000|Overall Study|Lost to Follow-up|1|||
130208980|NCT00655681|468725259|FG001|Overall Study|Lost to Follow-up|1|||
130208981|NCT02429310|468725260|FG000|Overall Study|Lost to Follow-up|1|||
130208982|NCT02429310|468725261|FG001|Overall Study|Lost to Follow-up|2|||
130208983|NCT02429310|468725260|FG000|Overall Study|Protocol Violation|1|||
130208984|NCT02429310|468725261|FG001|Overall Study|Protocol Violation|1|||
130208985|NCT00394433|468725262|FG000|Overall Study|Adverse Event|2|||
130208986|NCT00394433|468725262|FG000|Overall Study|Alternative Therapy|1|||
130208987|NCT01554176|468725263|FG000|Treatment Phase|Protocol Violation|1|||
130208988|NCT01554176|468725264|FG001|Treatment Phase|Protocol Violation|2|||
130208989|NCT01554176|468725265|FG002|Treatment Phase|Protocol Violation|0|||
130208990|NCT01554176|468725266|FG003|Treatment Phase|Protocol Violation|0|||
130208991|NCT01554176|468725267|FG004|Treatment Phase|Protocol Violation|0|||
130208992|NCT01554176|468725263|FG000|Treatment Phase|Physician Decision|1|||
130208993|NCT01554176|468725264|FG001|Treatment Phase|Physician Decision|1|||
130208994|NCT01554176|468725265|FG002|Treatment Phase|Physician Decision|0|||
130208995|NCT01554176|468725266|FG003|Treatment Phase|Physician Decision|0|||
130208996|NCT01554176|468725267|FG004|Treatment Phase|Physician Decision|0|||
130208997|NCT01554176|468725263|FG000|Treatment Phase|Lack of Efficacy|0|||
130208998|NCT01554176|468725264|FG001|Treatment Phase|Lack of Efficacy|1|||
130208999|NCT01554176|468725265|FG002|Treatment Phase|Lack of Efficacy|0|||
130209000|NCT01554176|468725266|FG003|Treatment Phase|Lack of Efficacy|0|||
130209001|NCT01554176|468725267|FG004|Treatment Phase|Lack of Efficacy|0|||
130209002|NCT01554176|468725263|FG000|Treatment Phase|Adverse event, non-fatal|1|||
130209003|NCT01554176|468725264|FG001|Treatment Phase|Adverse event, non-fatal|1|||
130319138|NCT00001832|469135418|FG001|Treatment Period|Death during treatment|0|||
130319139|NCT00001832|469135419|FG002|Treatment Period|Death during treatment|0|||
130319140|NCT00001832|469135420|FG003|Treatment Period|Death during treatment|0|||
130319141|NCT00001832|469135421|FG004|Treatment Period|Death during treatment|0|||
130319142|NCT00001832|469135422|FG005|Treatment Period|Death during treatment|1|||
130319143|NCT00001832|469135423|FG006|Treatment Period|Death during treatment|0|||
130319144|NCT00001832|469135424|FG007|Treatment Period|Death during treatment|0|||
130209004|NCT01554176|468725265|FG002|Treatment Phase|Adverse event, non-fatal|0|||
130209005|NCT01554176|468725266|FG003|Treatment Phase|Adverse event, non-fatal|0|||
130209006|NCT01554176|468725267|FG004|Treatment Phase|Adverse event, non-fatal|0|||
130209007|NCT01554176|468725263|FG000|Treatment Phase|Non-compliance with study drug|1|||
130209008|NCT01554176|468725264|FG001|Treatment Phase|Non-compliance with study drug|0|||
130209009|NCT01554176|468725265|FG002|Treatment Phase|Non-compliance with study drug|0|||
130209010|NCT01554176|468725266|FG003|Treatment Phase|Non-compliance with study drug|0|||
130209011|NCT01554176|468725267|FG004|Treatment Phase|Non-compliance with study drug|0|||
130209012|NCT01554176|468725263|FG000|Treatment Phase|Withdrawal by Subject|1|||
130319145|NCT00001832|469135425|FG008|Treatment Period|Death during treatment|0|||
130319146|NCT00001832|469135426|FG009|Treatment Period|Death during treatment|0|||
130319147|NCT00001832|469135427|FG010|Treatment Period|Death during treatment|0|||
130319148|NCT00001832|469135428|FG011|Treatment Period|Death during treatment|0|||
130319149|NCT00001832|469135429|FG012|Treatment Period|Death during treatment|0|||
130319150|NCT00001832|469135430|FG013|Treatment Period|Death during treatment|0|||
130319151|NCT00001832|469135431|FG014|Treatment Period|Death during treatment|0|||
130319152|NCT00001832|469135417|FG000|Treatment Period|Not treated|0|||
130319153|NCT00001832|469135418|FG001|Treatment Period|Not treated|0|||
130319154|NCT00001832|469135419|FG002|Treatment Period|Not treated|0|||
130319155|NCT00001832|469135420|FG003|Treatment Period|Not treated|0|||
130319156|NCT00001832|469135421|FG004|Treatment Period|Not treated|0|||
130319157|NCT00001832|469135422|FG005|Treatment Period|Not treated|0|||
130319158|NCT00001832|469135423|FG006|Treatment Period|Not treated|0|||
130319159|NCT00001832|469135424|FG007|Treatment Period|Not treated|1|||
130319160|NCT00001832|469135425|FG008|Treatment Period|Not treated|0|||
130319161|NCT00001832|469135426|FG009|Treatment Period|Not treated|0|||
130319162|NCT00001832|469135427|FG010|Treatment Period|Not treated|0|||
130319163|NCT00001832|469135428|FG011|Treatment Period|Not treated|0|||
130319164|NCT00001832|469135429|FG012|Treatment Period|Not treated|0|||
130319165|NCT00001832|469135430|FG013|Treatment Period|Not treated|0|||
130319166|NCT00001832|469135431|FG014|Treatment Period|Not treated|0|||
130319167|NCT02546609|469135432|FG000|Overall Study|Withdrawal by Subject|0|||
130319168|NCT02546609|469135433|FG001|Overall Study|Withdrawal by Subject|1|||
130319169|NCT02546609|469135434|FG002|Overall Study|Withdrawal by Subject|2|||
130319170|NCT02546609|469135432|FG000|Overall Study|Adverse Event|0|||
130319171|NCT02546609|469135433|FG001|Overall Study|Adverse Event|6|||
130319172|NCT02546609|469135434|FG002|Overall Study|Adverse Event|1|||
130319173|NCT02546609|469135432|FG000|Overall Study|Protocol Violation|0|||
130319174|NCT02546609|469135433|FG001|Overall Study|Protocol Violation|1|||
130319175|NCT02546609|469135434|FG002|Overall Study|Protocol Violation|1|||
130319176|NCT02546609|469135432|FG000|Overall Study|Lost to Follow-up|2|||
130319177|NCT02546609|469135433|FG001|Overall Study|Lost to Follow-up|3|||
130319178|NCT02546609|469135434|FG002|Overall Study|Lost to Follow-up|1|||
130319179|NCT02546609|469135432|FG000|Overall Study|travel or work schedule restriction|0|||
130319180|NCT02546609|469135433|FG001|Overall Study|travel or work schedule restriction|0|||
130319181|NCT02546609|469135434|FG002|Overall Study|travel or work schedule restriction|2|||
130319182|NCT00914849|469135435|FG000|Overall Study|Withdrawal by Subject|1|||
130319183|NCT00914849|469135436|FG001|Overall Study|Withdrawal by Subject|0|||
130319184|NCT00914849|469135435|FG000|Overall Study|Not eligible|0|||
130319185|NCT00914849|469135436|FG001|Overall Study|Not eligible|1|||
130319186|NCT05106959|469135437|FG000|Overall Study|Lost to Follow-up|1|||
130319187|NCT01292486|469135438|FG000|Overall Study|Protocol Violation|2|||
130319188|NCT01292486|469135438|FG000|Overall Study|Did not meet screening criteria|2|||
130319189|NCT01292486|469135438|FG000|Overall Study|Adverse Event|1|||
130319190|NCT01292486|469135438|FG000|Overall Study|Physician Decision|1|||
130319191|NCT04602390|469135439|FG000|Overall Study|Withdrawal by Subject|0|||
130319192|NCT04602390|469135440|FG001|Overall Study|Withdrawal by Subject|0|||
130319193|NCT04602390|469135441|FG002|Overall Study|Withdrawal by Subject|0|||
130319194|NCT04602390|469135442|FG003|Overall Study|Withdrawal by Subject|0|||
130319195|NCT04602390|469135443|FG004|Overall Study|Withdrawal by Subject|1|||
130319196|NCT04602390|469135444|FG005|Overall Study|Withdrawal by Subject|0|||
130319197|NCT04602390|469135439|FG000|Overall Study|Adverse Event|0|||
130319198|NCT04602390|469135440|FG001|Overall Study|Adverse Event|0|||
130319199|NCT04602390|469135441|FG002|Overall Study|Adverse Event|0|||
130319200|NCT04602390|469135442|FG003|Overall Study|Adverse Event|0|||
130319201|NCT04602390|469135443|FG004|Overall Study|Adverse Event|0|||
130319202|NCT04602390|469135444|FG005|Overall Study|Adverse Event|1|||
130319203|NCT01553084|469135445|FG000|Overall Study|Withdrawal by Subject|15|||
130319204|NCT01553084|469135446|FG001|Overall Study|Withdrawal by Subject|13|||
130319205|NCT01553084|469135447|FG002|Overall Study|Withdrawal by Subject|35|||
130319206|NCT03988400|469135448|FG000|Overall Study|Adverse Event|1|||
130319207|NCT03988400|469135449|FG001|Overall Study|Adverse Event|0|||
130319208|NCT03988400|469135448|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
130319209|NCT03988400|469135449|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
130319210|NCT03988400|469135448|FG000|Overall Study|Lost to Follow-up|0|||
130319211|NCT03988400|469135449|FG001|Overall Study|Lost to Follow-up|1|||
130319212|NCT04201431|469135451|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
130319213|NCT04201431|469135452|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130319214|NCT04201431|469135453|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130319215|NCT01546857|469135454|FG000|Overall Study|Withdrawal by Subject|2|||
130319216|NCT01546857|469135455|FG001|Overall Study|Withdrawal by Subject|3|||
130319217|NCT02358473|469135456|FG000|Overall Study|Disease Progession|6|||
130319218|NCT02358473|469135456|FG000|Overall Study|Adverse Event|3|||
130319219|NCT02358473|469135456|FG000|Overall Study|Withdrawal by Subject|2|||
130209013|NCT01554176|468725264|FG001|Treatment Phase|Withdrawal by Subject|0|||
130209014|NCT01554176|468725265|FG002|Treatment Phase|Withdrawal by Subject|0|||
130209015|NCT01554176|468725266|FG003|Treatment Phase|Withdrawal by Subject|0|||
130209016|NCT01554176|468725267|FG004|Treatment Phase|Withdrawal by Subject|0|||
130209017|NCT01554176|468725263|FG000|Treatment Phase|Lost to Follow-up|3|||
130209018|NCT01554176|468725264|FG001|Treatment Phase|Lost to Follow-up|0|||
130209019|NCT01554176|468725265|FG002|Treatment Phase|Lost to Follow-up|0|||
130209020|NCT01554176|468725266|FG003|Treatment Phase|Lost to Follow-up|0|||
130209021|NCT01554176|468725267|FG004|Treatment Phase|Lost to Follow-up|0|||
130209022|NCT01554176|468725263|FG000|Run-out Phase|Protocol Violation|0|||
130209023|NCT01554176|468725264|FG001|Run-out Phase|Protocol Violation|0|||
130209024|NCT01554176|468725265|FG002|Run-out Phase|Protocol Violation|0|||
130209025|NCT01554176|468725266|FG003|Run-out Phase|Protocol Violation|1|||
130209026|NCT01554176|468725267|FG004|Run-out Phase|Protocol Violation|0|||
130209027|NCT00386425|468725268|FG000|Overall Study|Physician Decision|3|||
130209028|NCT00386425|468725269|FG001|Overall Study|Physician Decision|0|||
130209029|NCT00386425|468725270|FG002|Overall Study|Physician Decision|0|||
130209030|NCT00386425|468725268|FG000|Overall Study|Withdrawal by Subject|0|||
130209031|NCT00386425|468725269|FG001|Overall Study|Withdrawal by Subject|1|||
130209032|NCT00386425|468725270|FG002|Overall Study|Withdrawal by Subject|0|||
130209033|NCT03053427|468725271|FG000|Overall Study|Adverse Event|4|||
130209034|NCT03053427|468725272|FG001|Overall Study|Adverse Event|4|||
130209035|NCT03053427|468725271|FG000|Overall Study|Lack of Efficacy|1|||
130209036|NCT03053427|468725272|FG001|Overall Study|Lack of Efficacy|3|||
130209037|NCT03053427|468725271|FG000|Overall Study|Lost to Follow-up|2|||
130209038|NCT03053427|468725272|FG001|Overall Study|Lost to Follow-up|2|||
130209039|NCT03053427|468725271|FG000|Overall Study|Worsening of the target disease|0|||
130209040|NCT03053427|468725272|FG001|Overall Study|Worsening of the target disease|1|||
130209041|NCT03053427|468725271|FG000|Overall Study|Protocol Deviation|3|||
130209042|NCT03053427|468725272|FG001|Overall Study|Protocol Deviation|3|||
130209043|NCT03053427|468725271|FG000|Overall Study|Withdrawal by Subject|3|||
130209044|NCT03053427|468725272|FG001|Overall Study|Withdrawal by Subject|2|||
130209045|NCT03053427|468725271|FG000|Overall Study|Miscellaneous|0|||
130209046|NCT03053427|468725272|FG001|Overall Study|Miscellaneous|1|||
130209047|NCT02172040|468725276|FG000|Overall Study|Adverse Event|0|||
130209048|NCT02172040|468725277|FG001|Overall Study|Adverse Event|2|||
130209049|NCT02172040|468725278|FG002|Overall Study|Adverse Event|0|||
130209050|NCT02172040|468725279|FG003|Overall Study|Adverse Event|0|||
130209051|NCT02172040|468725276|FG000|Overall Study|Protocol Violation|0|||
130209052|NCT02172040|468725277|FG001|Overall Study|Protocol Violation|1|||
130209053|NCT02172040|468725278|FG002|Overall Study|Protocol Violation|0|||
130209054|NCT02172040|468725279|FG003|Overall Study|Protocol Violation|0|||
130209055|NCT02172040|468725276|FG000|Overall Study|Withdrawal by Subject|0|||
130209056|NCT02172040|468725277|FG001|Overall Study|Withdrawal by Subject|0|||
130209057|NCT02172040|468725278|FG002|Overall Study|Withdrawal by Subject|1|||
130209058|NCT02172040|468725279|FG003|Overall Study|Withdrawal by Subject|0|||
130209059|NCT02172040|468725276|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
130209060|NCT02172040|468725277|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
130209061|NCT02172040|468725278|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
130209062|NCT02172040|468725279|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
130209063|NCT02172040|468725276|FG000|Overall Study|Family emergency abroad|0|||
130209064|NCT02172040|468725277|FG001|Overall Study|Family emergency abroad|0|||
130209065|NCT02172040|468725278|FG002|Overall Study|Family emergency abroad|0|||
130209066|NCT02172040|468725279|FG003|Overall Study|Family emergency abroad|1|||
130209067|NCT01324570|468725286|FG000|Overall Study|Adverse Event|4|||
130209068|NCT01324570|468725287|FG001|Overall Study|Adverse Event|7|||
130209069|NCT01324570|468725286|FG000|Overall Study|Withdrawal by Subject|0|||
130209070|NCT01324570|468725287|FG001|Overall Study|Withdrawal by Subject|3|||
130209071|NCT01324570|468725286|FG000|Overall Study|Lack of Efficacy|0|||
130209072|NCT01324570|468725287|FG001|Overall Study|Lack of Efficacy|1|||
130209073|NCT01324570|468725286|FG000|Overall Study|Confirmed or suspected diversion|0|||
130209074|NCT01324570|468725287|FG001|Overall Study|Confirmed or suspected diversion|1|||
130209075|NCT01324570|468725286|FG000|Overall Study|Administrative|0|||
130209076|NCT01324570|468725287|FG001|Overall Study|Administrative|2|||
130209077|NCT02607306|468725290|FG000|Overall Study|Adverse Event|8|||
130209078|NCT02607306|468725291|FG001|Overall Study|Adverse Event|6|||
130209079|NCT02607306|468725292|FG002|Overall Study|Adverse Event|6|||
130209080|NCT02607306|468725290|FG000|Overall Study|Unclassified|1|||
130209081|NCT02607306|468725291|FG001|Overall Study|Unclassified|4|||
130209082|NCT02607306|468725292|FG002|Overall Study|Unclassified|0|||
130209083|NCT02607306|468725290|FG000|Overall Study|Withdrawal by Subject|8|||
130209084|NCT02607306|468725291|FG001|Overall Study|Withdrawal by Subject|10|||
130209085|NCT02607306|468725292|FG002|Overall Study|Withdrawal by Subject|2|||
130209086|NCT02607306|468725290|FG000|Overall Study|Lack of Efficacy|0|||
130209087|NCT02607306|468725291|FG001|Overall Study|Lack of Efficacy|1|||
130209088|NCT02607306|468725292|FG002|Overall Study|Lack of Efficacy|1|||
130209089|NCT02607306|468725290|FG000|Overall Study|Protocol Violation|4|||
130209090|NCT02607306|468725291|FG001|Overall Study|Protocol Violation|2|||
130209091|NCT02607306|468725292|FG002|Overall Study|Protocol Violation|1|||
130209092|NCT00435019|468725296|FG000|Overall Study|Adverse Event|1|||
130209093|NCT00435019|468725297|FG001|Overall Study|Adverse Event|0|||
130209094|NCT00435019|468725296|FG000|Overall Study|Lack of Efficacy|1|||
130209095|NCT00435019|468725297|FG001|Overall Study|Lack of Efficacy|2|||
130209096|NCT00435019|468725296|FG000|Overall Study|Protocol Violation|3|||
130209097|NCT00435019|468725297|FG001|Overall Study|Protocol Violation|1|||
130209098|NCT00435019|468725296|FG000|Overall Study|Personal reasons for withdrawal|8|||
130209099|NCT00435019|468725297|FG001|Overall Study|Personal reasons for withdrawal|7|||
130209100|NCT01764659|468725303|FG000|Overall Study|Death|1|||
130209101|NCT01764659|468725303|FG000|Overall Study|Physician Decision|1|||
130209102|NCT01298141|468725304|FG000|Overall Study|Adverse Event|3|||
130209103|NCT01298141|468725304|FG000|Overall Study|Refusal of Required Study Procedures|1|||
130209104|NCT01298141|468725304|FG000|Overall Study|Withdrawal by Subject|6|||
130209105|NCT01298141|468725304|FG000|Overall Study|Termination of Study by the Investigator|5|||
130209106|NCT01298141|468725304|FG000|Overall Study|Other|5|||
130209107|NCT01298141|468725304|FG000|Overall Study|Lost to Follow-up|1|||
130209108|NCT01298141|468725304|FG000|Overall Study|Death|6|||
130209109|NCT01298141|468725304|FG000|Overall Study|Not treated|4|||
130209110|NCT01854879|468725308|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
130209111|NCT01854879|468725308|FG000|Overall Study|screen fail|3|||
130209112|NCT01854879|468725308|FG000|Overall Study|incomplete data set|1|||
130209113|NCT01698268|468727169|FG000|Overall Study|Physician Decision|2|||
130209114|NCT01698268|468727170|FG001|Overall Study|Physician Decision|1|||
130209115|NCT00298363|468727171|FG000|Overall Study|Lost to Follow-up|0|||
130209116|NCT00298363|468727172|FG001|Overall Study|Lost to Follow-up|0|||
130209117|NCT00298363|468727173|FG002|Overall Study|Lost to Follow-up|1|||
130209118|NCT00298363|468727171|FG000|Overall Study|Physician Decision|4|||
130209119|NCT00298363|468727172|FG001|Overall Study|Physician Decision|1|||
130209120|NCT00298363|468727173|FG002|Overall Study|Physician Decision|0|||
130209121|NCT00298363|468727171|FG000|Overall Study|Protocol Violation|1|||
130209122|NCT00298363|468727172|FG001|Overall Study|Protocol Violation|1|||
130209123|NCT00298363|468727173|FG002|Overall Study|Protocol Violation|0|||
130209124|NCT00298363|468727171|FG000|Overall Study|Withdrawal by Subject|5|||
130209125|NCT00298363|468727172|FG001|Overall Study|Withdrawal by Subject|1|||
130209126|NCT00298363|468727173|FG002|Overall Study|Withdrawal by Subject|3|||
130209127|NCT00298363|468727171|FG000|Overall Study|Adverse Event|5|||
130209128|NCT00298363|468727172|FG001|Overall Study|Adverse Event|2|||
130209129|NCT00298363|468727173|FG002|Overall Study|Adverse Event|2|||
130209130|NCT00298363|468727171|FG000|Overall Study|Lack of Efficacy|2|||
130209131|NCT00298363|468727172|FG001|Overall Study|Lack of Efficacy|3|||
130209132|NCT00298363|468727173|FG002|Overall Study|Lack of Efficacy|0|||
130209133|NCT04710368|468727174|FG000|Overall Study|Withdrawal by Subject|9|||
130209134|NCT04710368|468727174|FG000|Overall Study|Lost to Follow-up|4|||
130209135|NCT04710368|468727174|FG000|Overall Study|Death|2|||
130209136|NCT04710368|468727174|FG000|Overall Study|Patient preference|11|||
130209137|NCT04710368|468727174|FG000|Overall Study|Treatment discontinuation|1|||
130209138|NCT00135356|468727175|FG000|Overall Study|Adverse Event|6|||
130209139|NCT00135356|468727176|FG001|Overall Study|Adverse Event|2|||
130209140|NCT00135356|468727175|FG000|Overall Study|Lack of Efficacy|2|||
130209141|NCT00135356|468727176|FG001|Overall Study|Lack of Efficacy|0|||
130209142|NCT00135356|468727175|FG000|Overall Study|Lost to Follow-up|3|||
130209143|NCT00135356|468727176|FG001|Overall Study|Lost to Follow-up|1|||
130209144|NCT00135356|468727175|FG000|Overall Study|Surgery for abdominal fat|1|||
130209145|NCT00135356|468727176|FG001|Overall Study|Surgery for abdominal fat|0|||
130209146|NCT00135356|468727175|FG000|Overall Study|Change in antiviral regimen|0|||
130209147|NCT00135356|468727176|FG001|Overall Study|Change in antiviral regimen|1|||
130209148|NCT00135356|468727175|FG000|Overall Study|Poor/noncompliance|1|||
130209149|NCT00135356|468727176|FG001|Overall Study|Poor/noncompliance|1|||
130209150|NCT00135356|468727175|FG000|Overall Study|No longer meets study criteria|2|||
130209151|NCT00135356|468727176|FG001|Overall Study|No longer meets study criteria|0|||
130209152|NCT00135356|468727175|FG000|Overall Study|Withdrawal by Subject|2|||
130209153|NCT00135356|468727176|FG001|Overall Study|Withdrawal by Subject|4|||
130209154|NCT00153816|468727177|FG000|Overall Study|Death|6|||
130209155|NCT00153816|468727178|FG001|Overall Study|Death|5|||
130209156|NCT00153816|468727179|FG002|Overall Study|Death|4|||
130209157|NCT00153816|468727180|FG003|Overall Study|Death|6|||
130209158|NCT00153816|468727181|FG004|Overall Study|Death|0|||
130209159|NCT00153816|468727182|FG005|Overall Study|Death|2|||
130209160|NCT00153816|468727177|FG000|Overall Study|Lost to Follow-up|7|||
130209161|NCT00153816|468727178|FG001|Overall Study|Lost to Follow-up|8|||
130209162|NCT00153816|468727179|FG002|Overall Study|Lost to Follow-up|5|||
130209163|NCT00153816|468727180|FG003|Overall Study|Lost to Follow-up|8|||
130209164|NCT00153816|468727181|FG004|Overall Study|Lost to Follow-up|7|||
130209165|NCT00153816|468727182|FG005|Overall Study|Lost to Follow-up|9|||
130209166|NCT00153816|468727177|FG000|Overall Study|Withdrawal by Subject|9|||
130209167|NCT00153816|468727178|FG001|Overall Study|Withdrawal by Subject|9|||
130209168|NCT00153816|468727179|FG002|Overall Study|Withdrawal by Subject|9|||
130209169|NCT00153816|468727180|FG003|Overall Study|Withdrawal by Subject|4|||
130319220|NCT02358473|469135456|FG000|Overall Study|Physician Decision|2|||
130319221|NCT02240485|469135457|FG000|3 Months Post-admission|Lost to Follow-up|1|||
130319222|NCT02240485|469135458|FG001|3 Months Post-admission|Lost to Follow-up|5|||
130319223|NCT02240485|469135457|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
130319224|NCT02240485|469135458|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
130319225|NCT02240485|469135457|FG000|9 Months Post-admission|Lost to Follow-up|3|||
130319226|NCT02240485|469135458|FG001|9 Months Post-admission|Lost to Follow-up|1|||
130319227|NCT02240485|469135457|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
130319228|NCT02240485|469135458|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
130319229|NCT02240485|469135457|FG000|18 Months Post-admission|Lost to Follow-up|1|||
130319230|NCT02240485|469135458|FG001|18 Months Post-admission|Lost to Follow-up|1|||
130319231|NCT02240485|469135457|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
130319232|NCT02240485|469135458|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
130319233|NCT00953667|469135459|FG000|Overall Study|Lost to Follow-up|11|||
130319234|NCT00953667|469135459|FG000|Overall Study|Physician Decision|35|||
130319235|NCT00953667|469135459|FG000|Overall Study|Withdrawal by Subject|63|||
130319236|NCT00953667|469135459|FG000|Overall Study|Adverse Event|10|||
130319237|NCT00953667|469135459|FG000|Overall Study|poor venous access,unable to draw blood|4|||
130319238|NCT04819945|469135460|FG000|Overall Study|Lost to Follow-up|1|||
130319239|NCT00475670|469135461|FG000|Overall Study|Death|0|||
130319240|NCT00475670|469135462|FG001|Overall Study|Death|1|||
130319241|NCT00475670|469135461|FG000|Overall Study|Lack of Efficacy|3|||
130319242|NCT00475670|469135462|FG001|Overall Study|Lack of Efficacy|34|||
130319243|NCT00475670|469135461|FG000|Overall Study|Refused treatment|0|||
130319244|NCT00475670|469135462|FG001|Overall Study|Refused treatment|2|||
130319245|NCT00475670|469135461|FG000|Overall Study|Failure to Return|0|||
130319246|NCT00475670|469135462|FG001|Overall Study|Failure to Return|1|||
130319247|NCT00475670|469135461|FG000|Overall Study|Other|0|||
130319248|NCT00475670|469135462|FG001|Overall Study|Other|3|||
130319249|NCT04949191|469135463|FG000|Overall Study|Non-compliance with Study Drug|1|||
130319250|NCT04949191|469135464|FG001|Overall Study|Non-compliance with Study Drug|0|||
130319251|NCT04949191|469135465|FG002|Overall Study|Non-compliance with Study Drug|0|||
130319252|NCT04949191|469135466|FG003|Overall Study|Non-compliance with Study Drug|0|||
130319253|NCT04949191|469135463|FG000|Overall Study|Progressive Disease|0|||
130319254|NCT04949191|469135464|FG001|Overall Study|Progressive Disease|1|||
130319255|NCT04949191|469135465|FG002|Overall Study|Progressive Disease|0|||
130319256|NCT04949191|469135466|FG003|Overall Study|Progressive Disease|0|||
130319257|NCT04949191|469135463|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319258|NCT04949191|469135464|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
130319259|NCT04949191|469135465|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319260|NCT04949191|469135466|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319261|NCT04949191|469135463|FG000|Overall Study|Sponsor Terminated Study|0|||
130319262|NCT04949191|469135464|FG001|Overall Study|Sponsor Terminated Study|0|||
130319263|NCT04949191|469135465|FG002|Overall Study|Sponsor Terminated Study|1|||
130319264|NCT04949191|469135466|FG003|Overall Study|Sponsor Terminated Study|1|||
130319265|NCT02913482|469135467|FG000|Overall Study|Death|0|||
130319266|NCT02913482|469135468|FG001|Overall Study|Death|2|||
130319267|NCT02913482|469135469|FG002|Overall Study|Death|2|||
130319268|NCT02913482|469135467|FG000|Overall Study|Progressive Disease|1|||
130319269|NCT02913482|469135468|FG001|Overall Study|Progressive Disease|1|||
130319270|NCT02913482|469135469|FG002|Overall Study|Progressive Disease|1|||
130319271|NCT02913482|469135467|FG000|Overall Study|Reason not specified|0|||
130319272|NCT02913482|469135468|FG001|Overall Study|Reason not specified|0|||
130319273|NCT02913482|469135469|FG002|Overall Study|Reason not specified|1|||
130319274|NCT02913482|469135467|FG000|Overall Study|Withdrawal by Subject|0|||
130319275|NCT02913482|469135468|FG001|Overall Study|Withdrawal by Subject|1|||
130319276|NCT02913482|469135469|FG002|Overall Study|Withdrawal by Subject|1|||
130319277|NCT01046565|469135474|FG000|Overall Study|Adverse Event|2|||
130319278|NCT01046565|469135474|FG000|Overall Study|Withdrawal by Subject|7|||
130319279|NCT00918385|469135475|FG000|Monotherapy|Adverse Event|1|||
130319280|NCT00918385|469135476|FG001|Monotherapy|Adverse Event|6|||
130319281|NCT00918385|469135475|FG000|Monotherapy|Complicating illness|1|||
130319282|NCT00918385|469135476|FG001|Monotherapy|Complicating illness|0|||
130319283|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130319284|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130319285|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130319286|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
130319287|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
130319288|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
130319289|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130319290|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
130319291|NCT00771914|469135479|FG000|Overall Study|Physician Decision|0|||
130319292|NCT00771914|469135480|FG001|Overall Study|Physician Decision|0|||
130319293|NCT00771914|469135481|FG002|Overall Study|Physician Decision|0|||
130319294|NCT00771914|469135482|FG003|Overall Study|Physician Decision|1|||
130319295|NCT00771914|469135479|FG000|Overall Study|Lost to Follow-up|0|||
130319296|NCT00771914|469135480|FG001|Overall Study|Lost to Follow-up|0|||
130319297|NCT00771914|469135481|FG002|Overall Study|Lost to Follow-up|0|||
130319298|NCT00771914|469135482|FG003|Overall Study|Lost to Follow-up|1|||
130319299|NCT02978417|469135485|FG000|Overall Study|Lost to Follow-up|2|||
130319300|NCT02978417|469135486|FG001|Overall Study|Lost to Follow-up|2|||
130319301|NCT03416868|469135494|FG000|Overall Study|Withdrawal by Subject|2|||
130319302|NCT03416868|469135494|FG000|Overall Study|Lost to Follow-up|1|||
130319303|NCT01323582|469135495|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130319304|NCT01323582|469135496|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130319305|NCT01323582|469135495|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
130319306|NCT01323582|469135496|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
130319307|NCT01323582|469135495|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
130319308|NCT01323582|469135496|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
130319309|NCT00960375|469135499|FG000|Overall Study|Lost to Follow-up|20|||
130319310|NCT00960375|469135500|FG001|Overall Study|Lost to Follow-up|22|||
130319311|NCT03557970|469135501|FG000|Overall Study|Study closure|1|||
130319312|NCT03557970|469135502|FG001|Overall Study|Study closure|0|||
130319313|NCT03557970|469135501|FG000|Overall Study|Physician Decision|0|||
130319314|NCT03557970|469135502|FG001|Overall Study|Physician Decision|1|||
130319315|NCT03557970|469135501|FG000|Overall Study|Death|0|||
130319316|NCT03557970|469135502|FG001|Overall Study|Death|1|||
130319317|NCT00112736|469135503|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
130319318|NCT00112736|469135504|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
130319319|NCT01927497|469135505|FG000|Overall Study|Death|0|||
130319320|NCT01927497|469135506|FG001|Overall Study|Death|1|||
130319321|NCT01927497|469135505|FG000|Overall Study|Protocol Violation|2|||
130319322|NCT01927497|469135506|FG001|Overall Study|Protocol Violation|0|||
130319323|NCT03914417|469135507|FG000|Overall Study|Withdrawal by Subject|2|||
130319324|NCT03409796|469137459|FG000|Overall Study|Adverse Event|2|||
130319325|NCT03409796|469137460|FG001|Overall Study|Adverse Event|0|||
130319326|NCT03409796|469137459|FG000|Overall Study|Other|0|||
130319327|NCT03409796|469137460|FG001|Overall Study|Other|1|||
130319328|NCT00740220|469137461|FG000|Overall Study|screen failures (non-COPD patients)|9|||
130319329|NCT01602224|469137462|FG000|Overall Study|Adverse Event|0|||
130319330|NCT01602224|469137463|FG001|Overall Study|Adverse Event|1|||
130319331|NCT01602224|469137464|FG002|Overall Study|Adverse Event|0|||
130319332|NCT01602224|469137462|FG000|Overall Study|Investigator Decison|1|||
130319333|NCT01602224|469137463|FG001|Overall Study|Investigator Decison|0|||
130319334|NCT01602224|469137464|FG002|Overall Study|Investigator Decison|0|||
130319335|NCT01602224|469137462|FG000|Overall Study|Lost to Follow-up|0|||
130319336|NCT01602224|469137463|FG001|Overall Study|Lost to Follow-up|0|||
130319337|NCT01602224|469137464|FG002|Overall Study|Lost to Follow-up|1|||
130319338|NCT01602224|469137462|FG000|Overall Study|Protocol Violation|0|||
130319339|NCT01602224|469137463|FG001|Overall Study|Protocol Violation|1|||
130319340|NCT01602224|469137464|FG002|Overall Study|Protocol Violation|0|||
130319341|NCT01602224|469137462|FG000|Overall Study|Sponsor Decision|2|||
130319342|NCT01602224|469137463|FG001|Overall Study|Sponsor Decision|3|||
130319343|NCT01602224|469137464|FG002|Overall Study|Sponsor Decision|2|||
130319344|NCT01602224|469137462|FG000|Overall Study|Withdrawal by Subject|5|||
130319345|NCT01602224|469137463|FG001|Overall Study|Withdrawal by Subject|3|||
130319346|NCT01602224|469137464|FG002|Overall Study|Withdrawal by Subject|3|||
130319347|NCT01352117|469137465|FG000|Overall Study|Death|15|||
130319348|NCT01352117|469137466|FG001|Overall Study|Death|16|||
130319349|NCT01352117|469137465|FG000|Overall Study|Withdrawal by Subject|1|||
130319350|NCT01352117|469137466|FG001|Overall Study|Withdrawal by Subject|0|||
130319351|NCT01352117|469137465|FG000|Overall Study|Lost to Follow-up|2|||
130319352|NCT01352117|469137466|FG001|Overall Study|Lost to Follow-up|7|||
130319353|NCT01352117|469137465|FG000|Overall Study|Non-adherent to study requirements|1|||
130319354|NCT01352117|469137466|FG001|Overall Study|Non-adherent to study requirements|1|||
130319355|NCT01352117|469137465|FG000|Overall Study|Did not initiate study treatment|1|||
130319356|NCT01352117|469137466|FG001|Overall Study|Did not initiate study treatment|0|||
130319357|NCT01352117|469137465|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
130319358|NCT01352117|469137466|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
130319359|NCT00633477|469137467|FG000|Overall Study|Death|1|||
130319360|NCT00633477|469137468|FG001|Overall Study|Death|0|||
130319361|NCT00633477|469137467|FG000|Overall Study|Randomized but not treated|1|||
130319362|NCT00633477|469137468|FG001|Overall Study|Randomized but not treated|0|||
130319363|NCT00770653|469137472|FG000|Overall Study|Adverse Event|13|||
130319364|NCT00770653|469137473|FG001|Overall Study|Adverse Event|5|||
130319365|NCT00770653|469137472|FG000|Overall Study|Protocol Violation|8|||
130319366|NCT00770653|469137473|FG001|Overall Study|Protocol Violation|6|||
130319367|NCT00770653|469137472|FG000|Overall Study|Withdrawal by Subject|4|||
130319368|NCT00770653|469137473|FG001|Overall Study|Withdrawal by Subject|7|||
130319369|NCT00770653|469137472|FG000|Overall Study|Lack of Compliance|1|||
130319370|NCT00770653|469137473|FG001|Overall Study|Lack of Compliance|4|||
130319371|NCT00770653|469137472|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130319372|NCT00770653|469137473|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130319373|NCT00770653|469137472|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
130319374|NCT00770653|469137473|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
130319375|NCT00770653|469137472|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
130319376|NCT00770653|469137473|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
130319377|NCT00770653|469137472|FG000|Overall Study|Lost to Follow-up|1|||
130319378|NCT00770653|469137473|FG001|Overall Study|Lost to Follow-up|2|||
130319379|NCT00770653|469137472|FG000|Overall Study|Physician Decision|1|||
130319380|NCT00770653|469137473|FG001|Overall Study|Physician Decision|0|||
130319381|NCT04906499|469137479|FG000|Overall Study|Lack of time|1|||
130319382|NCT00179621|469137480|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
130319383|NCT00179621|469137481|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
130319384|NCT00179621|469137482|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
130319385|NCT00179621|469137483|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
130319386|NCT00179621|469137480|FG000|Double-Blind Period|Adverse Event|2|||
130319387|NCT00179621|469137481|FG001|Double-Blind Period|Adverse Event|7|||
130319388|NCT00179621|469137482|FG002|Double-Blind Period|Adverse Event|4|||
130319389|NCT00179621|469137483|FG003|Double-Blind Period|Adverse Event|0|||
130319390|NCT00179621|469137480|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130319391|NCT00179621|469137481|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130319392|NCT00179621|469137482|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130319393|NCT00179621|469137483|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130319394|NCT00179621|469137480|FG000|Double-Blind Period|Death|0|||
130319395|NCT00179621|469137481|FG001|Double-Blind Period|Death|1|||
130319396|NCT00179621|469137482|FG002|Double-Blind Period|Death|2|||
130319397|NCT00179621|469137483|FG003|Double-Blind Period|Death|0|||
130319398|NCT00179621|469137480|FG000|Double-Blind Period|Protocol Violation|1|||
130319399|NCT00179621|469137481|FG001|Double-Blind Period|Protocol Violation|0|||
130319400|NCT00179621|469137482|FG002|Double-Blind Period|Protocol Violation|0|||
130319401|NCT00179621|469137483|FG003|Double-Blind Period|Protocol Violation|0|||
130319402|NCT00179621|469137480|FG000|Double-Blind Period|Other|0|||
130319403|NCT00179621|469137481|FG001|Double-Blind Period|Other|2|||
130319404|NCT00179621|469137482|FG002|Double-Blind Period|Other|2|||
130319405|NCT00179621|469137483|FG003|Double-Blind Period|Other|0|||
130319406|NCT00179621|469137480|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
130319407|NCT00179621|469137481|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
130319408|NCT00179621|469137482|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
130319409|NCT00179621|469137483|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
130319410|NCT00179621|469137480|FG000|Open-Label Period|Adverse Event|0|||
130319411|NCT00179621|469137481|FG001|Open-Label Period|Adverse Event|6|||
130319412|NCT00179621|469137482|FG002|Open-Label Period|Adverse Event|5|||
130319413|NCT00179621|469137483|FG003|Open-Label Period|Adverse Event|6|||
130319414|NCT00179621|469137480|FG000|Open-Label Period|Withdrawal by Subject|0|||
130319415|NCT00179621|469137481|FG001|Open-Label Period|Withdrawal by Subject|2|||
130319416|NCT00179621|469137482|FG002|Open-Label Period|Withdrawal by Subject|2|||
130319417|NCT00179621|469137483|FG003|Open-Label Period|Withdrawal by Subject|2|||
130319418|NCT00179621|469137480|FG000|Open-Label Period|Death|0|||
130319419|NCT00179621|469137481|FG001|Open-Label Period|Death|0|||
130319420|NCT00179621|469137482|FG002|Open-Label Period|Death|1|||
130319421|NCT00179621|469137483|FG003|Open-Label Period|Death|2|||
130319422|NCT00179621|469137480|FG000|Open-Label Period|Other|0|||
130319423|NCT00179621|469137481|FG001|Open-Label Period|Other|1|||
130319424|NCT00179621|469137482|FG002|Open-Label Period|Other|1|||
130319425|NCT00179621|469137483|FG003|Open-Label Period|Other|2|||
130319426|NCT00262860|469137490|FG000|Overall Study|Adverse Event|2|||
130319427|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
130319428|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
130319429|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
130319430|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
130319431|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130319432|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
130319433|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
130319434|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
130319435|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
130319436|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
130319437|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130319438|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
130319439|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
130319440|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
130319441|NCT04124939|469137504|FG000|Overall Study|Lost to Follow-up|1|||
130319442|NCT04124939|469137505|FG001|Overall Study|Lost to Follow-up|3|||
130319443|NCT04235140|469137506|FG000|Overall Study|Adverse Event|2|||
130319444|NCT04235140|469137506|FG000|Overall Study|Lost to Follow-up|1|||
130319445|NCT04235140|469137506|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
130319446|NCT04235140|469137506|FG000|Overall Study|Commercial drug is available for participants|7|||
130319447|NCT00672555|469137508|FG000|Overall Study|Lost to Follow-up|4|||
130319448|NCT00672555|469137508|FG000|Overall Study|Did not want to answer questionnaire|2|||
130319449|NCT00419393|469137509|FG000|Overall Study|Adverse Event|5|||
130319450|NCT00419393|469137509|FG000|Overall Study|Protocol Violation|5|||
130319451|NCT00419393|469137509|FG000|Overall Study|Withdrawal by Subject|7|||
130319452|NCT00419393|469137509|FG000|Overall Study|Other: Sponsor request|3|||
130319453|NCT00419393|469137509|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
130319454|NCT00419393|469137509|FG000|Overall Study|Other: Site closure|1|||
130319455|NCT00419393|469137509|FG000|Overall Study|Other: Other health problems|1|||
130319456|NCT00419393|469137509|FG000|Overall Study|Other: Investigator decision|1|||
130319457|NCT04516746|469137512|FG000|Overall Study|Randomized but not Treated|51|||
130319458|NCT04516746|469137513|FG001|Overall Study|Randomized but not Treated|19|||
130319459|NCT04516746|469137512|FG000|Overall Study|Adverse Event|0|||
130319460|NCT04516746|469137513|FG001|Overall Study|Adverse Event|1|||
130319461|NCT04516746|469137512|FG000|Overall Study|Death|62|||
130319462|NCT04516746|469137513|FG001|Overall Study|Death|32|||
130319463|NCT04516746|469137512|FG000|Overall Study|Lost to Follow-up|3431|||
130319464|NCT04516746|469137513|FG001|Overall Study|Lost to Follow-up|1831|||
130319465|NCT04516746|469137512|FG000|Overall Study|Withdrawal by Subject|1946|||
130319466|NCT04516746|469137513|FG001|Overall Study|Withdrawal by Subject|1696|||
130319467|NCT04516746|469137512|FG000|Overall Study|Physician Decision|10|||
130319468|NCT04516746|469137513|FG001|Overall Study|Physician Decision|8|||
130209170|NCT00153816|468727181|FG004|Overall Study|Withdrawal by Subject|1|||
130209171|NCT00153816|468727182|FG005|Overall Study|Withdrawal by Subject|5|||
130209172|NCT00153816|468727177|FG000|Overall Study|Follow-up exam not done|8|||
130209173|NCT00153816|468727178|FG001|Overall Study|Follow-up exam not done|7|||
130209174|NCT00153816|468727179|FG002|Overall Study|Follow-up exam not done|11|||
130209175|NCT00153816|468727180|FG003|Overall Study|Follow-up exam not done|10|||
130209176|NCT00153816|468727181|FG004|Overall Study|Follow-up exam not done|8|||
130209177|NCT00153816|468727182|FG005|Overall Study|Follow-up exam not done|9|||
130209178|NCT00153816|468727177|FG000|Overall Study|Follow-up exam done, histology missing|2|||
130209179|NCT00153816|468727178|FG001|Overall Study|Follow-up exam done, histology missing|3|||
130209180|NCT00153816|468727179|FG002|Overall Study|Follow-up exam done, histology missing|3|||
130209181|NCT00153816|468727180|FG003|Overall Study|Follow-up exam done, histology missing|3|||
130209182|NCT00153816|468727181|FG004|Overall Study|Follow-up exam done, histology missing|1|||
130209183|NCT00153816|468727182|FG005|Overall Study|Follow-up exam done, histology missing|2|||
130209184|NCT01211483|468727189|FG000|Phase 1b|Death|6|||
130209185|NCT01211483|468727190|FG001|Phase 1b|Death|0|||
130209186|NCT01211483|468727191|FG002|Phase 1b|Death|0|||
130209187|NCT01211483|468727192|FG003|Phase 1b|Death|0|||
130209188|NCT01211483|468727189|FG000|Phase 1b|Withdrawal by Subject|1|||
130209189|NCT01211483|468727190|FG001|Phase 1b|Withdrawal by Subject|0|||
130209190|NCT01211483|468727191|FG002|Phase 1b|Withdrawal by Subject|0|||
130209191|NCT01211483|468727192|FG003|Phase 1b|Withdrawal by Subject|0|||
130209192|NCT01211483|468727189|FG000|Phase 2|Lost to Follow-up|0|||
130209193|NCT01211483|468727190|FG001|Phase 2|Lost to Follow-up|1|||
130209194|NCT01211483|468727191|FG002|Phase 2|Lost to Follow-up|1|||
130209195|NCT01211483|468727192|FG003|Phase 2|Lost to Follow-up|2|||
130209196|NCT01211483|468727189|FG000|Phase 2|Death|0|||
130209197|NCT01211483|468727190|FG001|Phase 2|Death|64|||
130209198|NCT01211483|468727191|FG002|Phase 2|Death|53|||
130209199|NCT01211483|468727192|FG003|Phase 2|Death|53|||
130209200|NCT01211483|468727189|FG000|Phase 2|Withdrawal by Subject|0|||
130209201|NCT01211483|468727190|FG001|Phase 2|Withdrawal by Subject|1|||
130209202|NCT01211483|468727191|FG002|Phase 2|Withdrawal by Subject|10|||
130209203|NCT01211483|468727192|FG003|Phase 2|Withdrawal by Subject|5|||
130209204|NCT01211483|468727189|FG000|Phase 2|Study terminated by Sponsor|0|||
130209205|NCT01211483|468727190|FG001|Phase 2|Study terminated by Sponsor|6|||
130209206|NCT01211483|468727191|FG002|Phase 2|Study terminated by Sponsor|8|||
130209207|NCT01211483|468727192|FG003|Phase 2|Study terminated by Sponsor|11|||
130209208|NCT00460265|468727193|FG000|Overall Study|Lost to Follow-up|14|||
130209209|NCT00460265|468727194|FG001|Overall Study|Lost to Follow-up|15|||
130209210|NCT00460265|468727193|FG000|Overall Study|Physician Decision|1|||
130209211|NCT00460265|468727194|FG001|Overall Study|Physician Decision|2|||
130209212|NCT00460265|468727193|FG000|Overall Study|Withdrawal by Subject|10|||
130319469|NCT04516746|469137512|FG000|Overall Study|Other|35|||
130319470|NCT04516746|469137513|FG001|Overall Study|Other|16|||
130209213|NCT00460265|468727194|FG001|Overall Study|Withdrawal by Subject|25|||
130209214|NCT00460265|468727193|FG000|Overall Study|Ongoing|60|||
130209215|NCT00460265|468727194|FG001|Overall Study|Ongoing|47|||
130209216|NCT02719353|468727195|FG000|First Intervention|Physician Decision|0|||
130209217|NCT02719353|468727196|FG001|First Intervention|Physician Decision|1|||
130209218|NCT01917344|468727198|FG000|Overall Study|Withdrawal by Subject|1|||
130209219|NCT00412217|468727199|FG000|Overall Study|Insufficient Data Available|8|||
130209220|NCT00412217|468727200|FG001|Overall Study|Insufficient Data Available|3|||
130209221|NCT00412217|468727199|FG000|Overall Study|Death|5|||
130209222|NCT00412217|468727200|FG001|Overall Study|Death|4|||
130209223|NCT00412217|468727199|FG000|Overall Study|Disease Progression|2|||
130319471|NCT01751061|469137514|FG000|Overall Study|Death|1|||
130319472|NCT01751061|469137515|FG001|Overall Study|Death|0|||
130319473|NCT01751061|469137514|FG000|Overall Study|patient death|5|||
130319474|NCT01751061|469137515|FG001|Overall Study|patient death|0|||
130319475|NCT01751061|469137514|FG000|Overall Study|Lost to Follow-up|40|||
130319476|NCT01751061|469137515|FG001|Overall Study|Lost to Follow-up|25|||
130319477|NCT01751061|469137514|FG000|Overall Study|patient regained decisional capacity|4|||
130319478|NCT01751061|469137515|FG001|Overall Study|patient regained decisional capacity|8|||
130319479|NCT01751061|469137514|FG000|Overall Study|Withdrawal by Subject|4|||
130319480|NCT01751061|469137515|FG001|Overall Study|Withdrawal by Subject|1|||
130319481|NCT01751061|469137514|FG000|Overall Study|Physician Decision|2|||
130319482|NCT01751061|469137515|FG001|Overall Study|Physician Decision|0|||
130319483|NCT00446849|469137519|FG000|Acute Phase|Lack of Efficacy|64|||
130319484|NCT00446849|469137519|FG000|Acute Phase|Protocol Violation|10|||
130319485|NCT00446849|469137519|FG000|Acute Phase|Consent withdrawn|4|||
130319486|NCT00446849|469137519|FG000|Acute Phase|Lost to Follow-up|2|||
130319487|NCT00446849|469137519|FG000|Acute Phase|Physician Decision|1|||
130319488|NCT00446849|469137519|FG000|Acute Phase|noncompliance|1|||
130319489|NCT00446849|469137519|FG000|Maintenance Phase|Lack of Efficacy|40|||
130319490|NCT00446849|469137519|FG000|Maintenance Phase|Protocol Violation|7|||
130319491|NCT00446849|469137519|FG000|Maintenance Phase|Adverse Event|6|||
130319492|NCT00446849|469137519|FG000|Maintenance Phase|Consent withdrawn|5|||
130319493|NCT00446849|469137519|FG000|Maintenance Phase|Lost to Follow-up|3|||
130319494|NCT00446849|469137519|FG000|Maintenance Phase|Pregnancy|1|||
130319495|NCT00446849|469137519|FG000|Maintenance Phase|noncompliance|2|||
130319496|NCT00446849|469137519|FG000|Maintenance Phase|prohibited medication use|2|||
130319497|NCT00446849|469137519|FG000|Maintenance Phase|antibiotic use|1|||
130319498|NCT00446849|469137519|FG000|Maintenance Phase|study closure|1|||
130319499|NCT00446849|469137519|FG000|Maintenance Phase|hydrocodone use|1|||
130319500|NCT00446849|469137519|FG000|Maintenance Phase|concomitant medication use|1|||
130319501|NCT01194830|469137522|FG000|Overall Study|Adverse Event|3|||
130319502|NCT01194830|469137523|FG001|Overall Study|Adverse Event|2|||
130319503|NCT01194830|469137522|FG000|Overall Study|Protocol Violation|5|||
130319504|NCT01194830|469137523|FG001|Overall Study|Protocol Violation|4|||
130319505|NCT01194830|469137522|FG000|Overall Study|Lost to Follow-up|9|||
130319506|NCT01194830|469137523|FG001|Overall Study|Lost to Follow-up|7|||
130319507|NCT01194830|469137522|FG000|Overall Study|Withdrawal by Subject|2|||
130319508|NCT01194830|469137523|FG001|Overall Study|Withdrawal by Subject|1|||
130319509|NCT01194830|469137522|FG000|Overall Study|Lack of Efficacy|1|||
130319510|NCT01194830|469137523|FG001|Overall Study|Lack of Efficacy|1|||
130319511|NCT01194830|469137522|FG000|Overall Study|Non-compliance issues|4|||
130319512|NCT01194830|469137523|FG001|Overall Study|Non-compliance issues|4|||
130319513|NCT01194830|469137522|FG000|Overall Study|Other Reason|12|||
130319514|NCT01194830|469137523|FG001|Overall Study|Other Reason|8|||
130319515|NCT03115359|469137524|FG000|Overall Study|Withdrawal by Subject|29|||
130319516|NCT03115359|469137525|FG001|Overall Study|Withdrawal by Subject|39|||
130319517|NCT03115359|469137524|FG000|Overall Study|Scheduling conflict|25|||
130319518|NCT03115359|469137525|FG001|Overall Study|Scheduling conflict|23|||
130319519|NCT03115359|469137524|FG000|Overall Study|Personal reasons including health|12|||
130319520|NCT03115359|469137525|FG001|Overall Study|Personal reasons including health|9|||
130319521|NCT03115359|469137524|FG000|Overall Study|Transportation barriers|3|||
130319522|NCT03115359|469137525|FG001|Overall Study|Transportation barriers|0|||
130319523|NCT03115359|469137524|FG000|Overall Study|No longer interested|5|||
130319524|NCT03115359|469137525|FG001|Overall Study|No longer interested|4|||
130319525|NCT03115359|469137524|FG000|Overall Study|No reason provided|45|||
130319526|NCT03115359|469137525|FG001|Overall Study|No reason provided|47|||
130319527|NCT01815918|469137528|FG000|Overall Study|Patient samples not analyzable|3|||
130319528|NCT01815918|469137529|FG001|Overall Study|Patient samples not analyzable|4|||
130319529|NCT01815918|469137528|FG000|Overall Study|Lack of Efficacy|15|||
130319530|NCT01815918|469137529|FG001|Overall Study|Lack of Efficacy|15|||
130319531|NCT03284710|469137532|FG000|Overall Study|Withdrawal by Subject|1|||
130319532|NCT03284710|469137533|FG001|Overall Study|Withdrawal by Subject|0|||
130319533|NCT03284710|469137534|FG002|Overall Study|Withdrawal by Subject|1|||
130319534|NCT03284710|469137535|FG003|Overall Study|Withdrawal by Subject|6|||
130319535|NCT03284710|469137532|FG000|Overall Study|Lost to Follow-up|3|||
130319536|NCT03284710|469137533|FG001|Overall Study|Lost to Follow-up|3|||
130319537|NCT03284710|469137534|FG002|Overall Study|Lost to Follow-up|1|||
130319538|NCT03284710|469137535|FG003|Overall Study|Lost to Follow-up|0|||
130319539|NCT03284710|469137532|FG000|Overall Study|Physician Decision|1|||
130319540|NCT03284710|469137533|FG001|Overall Study|Physician Decision|0|||
130319541|NCT03284710|469137534|FG002|Overall Study|Physician Decision|0|||
130319542|NCT03284710|469137535|FG003|Overall Study|Physician Decision|0|||
130319543|NCT03284710|469137532|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130319544|NCT03284710|469137533|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130319545|NCT03284710|469137534|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130319546|NCT03284710|469137535|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130319547|NCT03284710|469137532|FG000|Overall Study|HIV Infection|0|||
130319548|NCT03284710|469137533|FG001|Overall Study|HIV Infection|2|||
130319549|NCT03284710|469137534|FG002|Overall Study|HIV Infection|2|||
130319550|NCT03284710|469137535|FG003|Overall Study|HIV Infection|1|||
130319551|NCT02814916|469137542|FG000|Overall Study|Withdrawal of consent|0|||
130319552|NCT02814916|469137543|FG001|Overall Study|Withdrawal of consent|2|||
130319553|NCT02814916|469137544|FG002|Overall Study|Withdrawal of consent|0|||
130319554|NCT02814916|469137542|FG000|Overall Study|Lost to Follow-up|0|||
130319555|NCT02814916|469137543|FG001|Overall Study|Lost to Follow-up|1|||
130319556|NCT02814916|469137544|FG002|Overall Study|Lost to Follow-up|0|||
130319557|NCT02814916|469137542|FG000|Overall Study|Other, not specified|0|||
130319558|NCT02814916|469137543|FG001|Overall Study|Other, not specified|1|||
130319559|NCT02814916|469137544|FG002|Overall Study|Other, not specified|0|||
130319560|NCT01706458|469137552|FG000|Overall Study|Physician Decision|3|||
130319561|NCT01706458|469137553|FG001|Overall Study|Physician Decision|4|||
130319562|NCT02384551|469137557|FG000|Overall Study|Lost to Follow-up|13|||
130319563|NCT02384551|469137558|FG001|Overall Study|Lost to Follow-up|14|||
130319564|NCT02384551|469137559|FG002|Overall Study|Lost to Follow-up|14|||
130319565|NCT02384551|469137560|FG003|Overall Study|Lost to Follow-up|14|||
130319566|NCT04742556|469137563|FG000|Overall Study|Withdrawal by Subject|0|||
130319567|NCT04742556|469137564|FG001|Overall Study|Withdrawal by Subject|1|||
130319568|NCT04742556|469137565|FG002|Overall Study|Withdrawal by Subject|0|||
130319569|NCT04742556|469137563|FG000|Overall Study|Adverse Event|0|||
130319570|NCT04742556|469137564|FG001|Overall Study|Adverse Event|0|||
130319571|NCT04742556|469137565|FG002|Overall Study|Adverse Event|2|||
130319572|NCT04742556|469137563|FG000|Overall Study|Clinical disease progression|0|||
130319573|NCT04742556|469137564|FG001|Overall Study|Clinical disease progression|1|||
130319574|NCT04742556|469137565|FG002|Overall Study|Clinical disease progression|2|||
130319575|NCT04742556|469137563|FG000|Overall Study|Objective disease progression|3|||
130319576|NCT04742556|469137564|FG001|Overall Study|Objective disease progression|2|||
130319577|NCT04742556|469137565|FG002|Overall Study|Objective disease progression|4|||
130319578|NCT01903356|469137571|FG000|Overall Study|Lost to Follow-up|7|||
130319579|NCT01903356|469137571|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
130319580|NCT01903356|469137571|FG000|Overall Study|Violated the dosage and administration|3|||
130319581|NCT04196686|469137576|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
130319582|NCT04196686|469137577|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
130319583|NCT03448406|469137579|FG000|Overall Study|Noncompliance of scheduled visits|1|||
130319584|NCT03448406|469137580|FG001|Overall Study|Noncompliance of scheduled visits|2|||
130319585|NCT03448406|469137579|FG000|Overall Study|Withdrawal by Subject|1|||
130319586|NCT03448406|469137580|FG001|Overall Study|Withdrawal by Subject|2|||
130319587|NCT03448406|469137579|FG000|Overall Study|Protocol Violation|1|||
130319588|NCT03448406|469137580|FG001|Overall Study|Protocol Violation|0|||
130319589|NCT03448406|469137579|FG000|Overall Study|Adverse Event|8|||
130319590|NCT03448406|469137580|FG001|Overall Study|Adverse Event|9|||
130319591|NCT02542865|469137588|FG000|Overall Study|Identified as screen failure|1|||
130319592|NCT02542865|469137589|FG001|Overall Study|Identified as screen failure|0|||
130319593|NCT02542865|469137588|FG000|Overall Study|Withdrawal by Subject|16|||
130319594|NCT02542865|469137589|FG001|Overall Study|Withdrawal by Subject|0|||
130319595|NCT00083889|469137591|FG000|Overall Study|Adverse Event|76|||
130319596|NCT00083889|469137592|FG001|Overall Study|Adverse Event|86|||
130319597|NCT00083889|469137591|FG000|Overall Study|Protocol Violation|2|||
130319598|NCT00083889|469137592|FG001|Overall Study|Protocol Violation|2|||
130319599|NCT00083889|469137591|FG000|Overall Study|Withdrawal by Subject|22|||
130319600|NCT00083889|469137592|FG001|Overall Study|Withdrawal by Subject|24|||
130319601|NCT00083889|469137591|FG000|Overall Study|Lack of Efficacy|240|||
130319602|NCT00083889|469137592|FG001|Overall Study|Lack of Efficacy|219|||
130319603|NCT00083889|469137591|FG000|Overall Study|Decision of sponsor|32|||
130319604|NCT00083889|469137592|FG001|Overall Study|Decision of sponsor|4|||
130319605|NCT00083889|469137591|FG000|Overall Study|Randomized: did not take study drug|0|||
130319606|NCT00083889|469137592|FG001|Overall Study|Randomized: did not take study drug|15|||
130319607|NCT00083889|469137591|FG000|Overall Study|Completed on marketed sunitinub|3|||
130319608|NCT00083889|469137592|FG001|Overall Study|Completed on marketed sunitinub|0|||
130319609|NCT00083889|469137591|FG000|Overall Study|Crossover to SU011248|0|||
130319610|NCT00083889|469137592|FG001|Overall Study|Crossover to SU011248|25|||
130319611|NCT05135871|469137594|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
130319612|NCT05135871|469137595|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319613|NCT05135871|469137596|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319614|NCT05135871|469137597|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319615|NCT03836625|469137601|FG000|Overall Study|Lost to Follow-up|9|||
130319616|NCT03836625|469137602|FG001|Overall Study|Lost to Follow-up|9|||
130319617|NCT03836625|469137601|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
130319618|NCT03836625|469137602|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
130319619|NCT03836625|469137601|FG000|Overall Study|Death|0|||
130319620|NCT03836625|469137602|FG001|Overall Study|Death|1|||
130319621|NCT03836625|469137601|FG000|Overall Study|Refused follow-up|0|||
130319622|NCT03836625|469137602|FG001|Overall Study|Refused follow-up|1|||
130319623|NCT01247324|469137607|FG000|Overall Study|Death|6|||
130319624|NCT01247324|469137608|FG001|Overall Study|Death|10|||
130319625|NCT01247324|469137607|FG000|Overall Study|Physician Decision|2|||
130319626|NCT01247324|469137608|FG001|Overall Study|Physician Decision|3|||
130319627|NCT01247324|469137607|FG000|Overall Study|Non-compliance with study drug|3|||
130319628|NCT01247324|469137608|FG001|Overall Study|Non-compliance with study drug|0|||
130319629|NCT01247324|469137607|FG000|Overall Study|Lack of Efficacy|24|||
130319630|NCT01247324|469137608|FG001|Overall Study|Lack of Efficacy|14|||
130319631|NCT01247324|469137607|FG000|Overall Study|Non-compliance|3|||
130319632|NCT01247324|469137608|FG001|Overall Study|Non-compliance|2|||
130319633|NCT01247324|469137607|FG000|Overall Study|Pregnancy|5|||
130319634|NCT01247324|469137608|FG001|Overall Study|Pregnancy|10|||
130319635|NCT01247324|469137607|FG000|Overall Study|Protocol Violation|1|||
130319636|NCT01247324|469137608|FG001|Overall Study|Protocol Violation|1|||
130319637|NCT01247324|469137607|FG000|Overall Study|Reason not specified|42|||
130319638|NCT01247324|469137608|FG001|Overall Study|Reason not specified|32|||
130319639|NCT01247324|469137607|FG000|Overall Study|Consent withdrawn by participant|41|||
130319640|NCT01247324|469137608|FG001|Overall Study|Consent withdrawn by participant|56|||
130319641|NCT01247324|469137607|FG000|Overall Study|Adverse Event|49|||
130319642|NCT01247324|469137608|FG001|Overall Study|Adverse Event|35|||
130319643|NCT01247324|469137607|FG000|Overall Study|Lost to Follow-up|3|||
130319644|NCT01247324|469137608|FG001|Overall Study|Lost to Follow-up|6|||
130319645|NCT01247324|469137607|FG000|Overall Study|Study Terminated by Sponsor|4|||
130319646|NCT01247324|469137608|FG001|Overall Study|Study Terminated by Sponsor|1|||
130319647|NCT01247324|469137607|FG000|Overall Study|Missing|2|||
130319648|NCT01247324|469137608|FG001|Overall Study|Missing|1|||
130319649|NCT03035032|469139621|FG000|Overall Study|Adverse Event|2|||
130319650|NCT03035032|469139621|FG000|Overall Study|Death|9|||
130319651|NCT03035032|469139621|FG000|Overall Study|Lost to Follow-up|1|||
130319652|NCT03035032|469139621|FG000|Overall Study|Progressive Disease|22|||
130319653|NCT03035032|469139621|FG000|Overall Study|Protocol Violation|2|||
130319654|NCT03035032|469139621|FG000|Overall Study|Withdrawal by Subject|2|||
130319655|NCT03035032|469139621|FG000|Overall Study|Physician Decision|5|||
130319656|NCT00836589|469139622|FG000|Overall Study|Lost to Follow-up|246|||
130319657|NCT00836589|469139622|FG000|Overall Study|Death|429|||
130319658|NCT00836589|469139622|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
130319659|NCT02399215|469139644|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
130319660|NCT02399215|469139644|FG000|Overall Study|Withdrawal by Subject|1|||
130319661|NCT04529083|469139645|FG000|Overall Study|Withdrawal by Subject|3|||
130319662|NCT01176032|469139649|FG000|Overall Study|Adverse Event|1|||
130319663|NCT01176032|469139650|FG001|Overall Study|Adverse Event|0|||
130319664|NCT01176032|469139649|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130319665|NCT01176032|469139650|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130319666|NCT01176032|469139649|FG000|Overall Study|Protocol Violation|1|||
130319667|NCT01176032|469139650|FG001|Overall Study|Protocol Violation|0|||
130319668|NCT01176032|469139649|FG000|Overall Study|Informed consent withdrawn|3|||
130319669|NCT01176032|469139650|FG001|Overall Study|Informed consent withdrawn|0|||
130319670|NCT01176032|469139649|FG000|Overall Study|Other|1|||
130319671|NCT01176032|469139650|FG001|Overall Study|Other|0|||
130319672|NCT01469221|469139651|FG000|Double Blind Phase|Protocol Violation|1|||
130319673|NCT01469221|469139652|FG001|Double Blind Phase|Protocol Violation|0|||
130319674|NCT01469221|469139653|FG002|Double Blind Phase|Protocol Violation|0|||
130319675|NCT01469221|469139651|FG000|Double Blind Phase|Physician Decision|1|||
130319676|NCT01469221|469139652|FG001|Double Blind Phase|Physician Decision|1|||
130319677|NCT01469221|469139653|FG002|Double Blind Phase|Physician Decision|0|||
130319678|NCT01469221|469139651|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
130319679|NCT01469221|469139652|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
130319680|NCT01469221|469139653|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
130319681|NCT03186209|469139659|FG000|Overall Study|Withdrawal by Subject|11|||
130319682|NCT03186209|469139660|FG001|Overall Study|Withdrawal by Subject|22|||
130319683|NCT03186209|469139659|FG000|Overall Study|Pregnancy|1|||
130319684|NCT03186209|469139660|FG001|Overall Study|Pregnancy|0|||
130319685|NCT03186209|469139659|FG000|Overall Study|Adverse Event|4|||
130319686|NCT03186209|469139660|FG001|Overall Study|Adverse Event|0|||
130319687|NCT03186209|469139659|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
130319688|NCT03186209|469139660|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
130319689|NCT03186209|469139659|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
130319690|NCT03186209|469139660|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
130319691|NCT03186209|469139659|FG000|Overall Study|Fail to meet randomization criteria|0|||
130319692|NCT03186209|469139660|FG001|Overall Study|Fail to meet randomization criteria|1|||
130319693|NCT03186209|469139659|FG000|Overall Study|Lost to Follow-up|0|||
130319694|NCT03186209|469139660|FG001|Overall Study|Lost to Follow-up|1|||
130319695|NCT04739982|469139666|FG000|Overall Study|Lost to Follow-up|176|||
130319696|NCT04739982|469139667|FG001|Overall Study|Lost to Follow-up|65|||
130319697|NCT04739982|469139666|FG000|Overall Study|Withdrawal by Subject|19|||
130319698|NCT04739982|469139667|FG001|Overall Study|Withdrawal by Subject|0|||
130319699|NCT04739982|469139666|FG000|Overall Study|Protocol Violation|0|||
130319700|NCT04739982|469139667|FG001|Overall Study|Protocol Violation|5|||
130319701|NCT04079296|469139668|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319702|NCT04079296|469139669|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319703|NCT04079296|469139670|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319704|NCT04079296|469139671|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130319705|NCT04079296|469139672|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130319706|NCT04079296|469139668|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319707|NCT04079296|469139669|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319708|NCT04079296|469139670|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319709|NCT04079296|469139671|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130319710|NCT04079296|469139672|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130319711|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319712|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319713|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319714|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319715|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
130319716|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319717|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319718|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319719|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319720|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
130319721|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319722|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319723|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319724|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
130319725|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319726|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319727|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319728|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319729|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
130319730|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
130319731|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319732|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319733|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319734|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
130319735|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
130319736|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Death|0|||
130319737|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Death|0|||
130319738|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Death|0|||
130319739|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Death|1|||
130319740|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Death|0|||
130319741|NCT01346358|469139685|FG000|Overall Study|Withdrawal by Subject|1|||
130319742|NCT01346358|469139686|FG001|Overall Study|Withdrawal by Subject|0|||
130319743|NCT01346358|469139687|FG002|Overall Study|Withdrawal by Subject|1|||
130319744|NCT01346358|469139688|FG003|Overall Study|Withdrawal by Subject|1|||
130319745|NCT01346358|469139689|FG004|Overall Study|Withdrawal by Subject|0|||
130319746|NCT01346358|469139690|FG005|Overall Study|Withdrawal by Subject|2|||
130319747|NCT01346358|469139691|FG006|Overall Study|Withdrawal by Subject|1|||
130319748|NCT01346358|469139692|FG007|Overall Study|Withdrawal by Subject|1|||
130319749|NCT01346358|469139693|FG008|Overall Study|Withdrawal by Subject|1|||
130319750|NCT01346358|469139685|FG000|Overall Study|Adverse Event|1|||
130319751|NCT01346358|469139686|FG001|Overall Study|Adverse Event|0|||
130319752|NCT01346358|469139687|FG002|Overall Study|Adverse Event|0|||
130319753|NCT01346358|469139688|FG003|Overall Study|Adverse Event|0|||
130319754|NCT01346358|469139689|FG004|Overall Study|Adverse Event|1|||
130319755|NCT01346358|469139690|FG005|Overall Study|Adverse Event|0|||
130319756|NCT01346358|469139691|FG006|Overall Study|Adverse Event|0|||
130319757|NCT01346358|469139692|FG007|Overall Study|Adverse Event|0|||
130319758|NCT01346358|469139693|FG008|Overall Study|Adverse Event|1|||
130319759|NCT01346358|469139685|FG000|Overall Study|Non-Compliance|0|||
130319760|NCT01346358|469139686|FG001|Overall Study|Non-Compliance|0|||
130319761|NCT01346358|469139687|FG002|Overall Study|Non-Compliance|0|||
130319762|NCT01346358|469139688|FG003|Overall Study|Non-Compliance|0|||
130319763|NCT01346358|469139689|FG004|Overall Study|Non-Compliance|0|||
130319764|NCT01346358|469139690|FG005|Overall Study|Non-Compliance|0|||
130319765|NCT01346358|469139691|FG006|Overall Study|Non-Compliance|0|||
130319766|NCT01346358|469139692|FG007|Overall Study|Non-Compliance|2|||
130319767|NCT01346358|469139693|FG008|Overall Study|Non-Compliance|0|||
130319768|NCT01346358|469139685|FG000|Overall Study|Physician Decision|0|||
130319769|NCT01346358|469139686|FG001|Overall Study|Physician Decision|1|||
130319770|NCT01346358|469139687|FG002|Overall Study|Physician Decision|0|||
130319771|NCT01346358|469139688|FG003|Overall Study|Physician Decision|0|||
130319772|NCT01346358|469139689|FG004|Overall Study|Physician Decision|0|||
130319773|NCT01346358|469139690|FG005|Overall Study|Physician Decision|0|||
130319774|NCT01346358|469139691|FG006|Overall Study|Physician Decision|0|||
130319775|NCT01346358|469139692|FG007|Overall Study|Physician Decision|1|||
130319776|NCT01346358|469139693|FG008|Overall Study|Physician Decision|1|||
130319777|NCT05058365|469139696|FG000|Overall Study|Migration|1|||
130319778|NCT05058365|469139697|FG001|Overall Study|Migration|1|||
130319779|NCT00702702|469139698|FG000|Overall Study|Study prematurely terminated|56|||
130319780|NCT04038359|469139699|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
130319781|NCT04038359|469139700|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
130319782|NCT04038359|469139699|FG000|Overall Study|Death|8|||
130319783|NCT04038359|469139700|FG001|Overall Study|Death|7|||
130319784|NCT04038359|469139699|FG000|Overall Study|Lost to Follow-up|3|||
130319785|NCT04038359|469139700|FG001|Overall Study|Lost to Follow-up|0|||
130319786|NCT04038359|469139699|FG000|Overall Study|Participant Moved|1|||
130319787|NCT04038359|469139700|FG001|Overall Study|Participant Moved|0|||
130319788|NCT04038359|469139699|FG000|Overall Study|Withdrawal by Subject|4|||
130319789|NCT04038359|469139700|FG001|Overall Study|Withdrawal by Subject|3|||
130319790|NCT04038359|469139699|FG000|Overall Study|Physician Decision|3|||
130319791|NCT04038359|469139700|FG001|Overall Study|Physician Decision|2|||
130319792|NCT04038359|469139699|FG000|Overall Study|Adverse Event|0|||
130319793|NCT04038359|469139700|FG001|Overall Study|Adverse Event|2|||
130319794|NCT04038359|469139699|FG000|Overall Study|Progressive Disease|0|||
130319795|NCT04038359|469139700|FG001|Overall Study|Progressive Disease|1|||
130319796|NCT02004236|469139701|FG000|Overall Study|Lack of Efficacy|0|||
130319797|NCT02004236|469139702|FG001|Overall Study|Lack of Efficacy|0|||
130319798|NCT02004236|469139703|FG002|Overall Study|Lack of Efficacy|16|||
130319799|NCT05121766|469139704|FG000|Overall Study|Covid reinfection|3|||
130319800|NCT05121766|469139705|FG001|Overall Study|Covid reinfection|0|||
130319801|NCT05121766|469139704|FG000|Overall Study|Withdrawal by Subject|3|||
130319802|NCT05121766|469139705|FG001|Overall Study|Withdrawal by Subject|1|||
130319803|NCT05121766|469139704|FG000|Overall Study|Adverse Event|2|||
130319804|NCT05121766|469139705|FG001|Overall Study|Adverse Event|4|||
130319805|NCT05121766|469139704|FG000|Overall Study|Lost to Follow-up|0|||
130319806|NCT05121766|469139705|FG001|Overall Study|Lost to Follow-up|1|||
130319807|NCT03259230|469139707|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
130319808|NCT03259230|469139708|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
130319809|NCT01033240|469139709|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
130319810|NCT01033240|469139710|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
130319811|NCT01033240|469139711|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
130319812|NCT01033240|469139709|FG000|Overall Study|Death|2|||
130319813|NCT01033240|469139710|FG001|Overall Study|Death|0|||
130319814|NCT01033240|469139711|FG002|Overall Study|Death|0|||
130319815|NCT01033240|469139709|FG000|Overall Study|Withdrew Consent|2|||
130319816|NCT01033240|469139710|FG001|Overall Study|Withdrew Consent|9|||
130319817|NCT01033240|469139711|FG002|Overall Study|Withdrew Consent|2|||
130319818|NCT01033240|469139709|FG000|Overall Study|Disease Progression|35|||
130319819|NCT01033240|469139710|FG001|Overall Study|Disease Progression|32|||
130319820|NCT01033240|469139711|FG002|Overall Study|Disease Progression|41|||
130319821|NCT01033240|469139709|FG000|Overall Study|Investigator Discretion|0|||
130319822|NCT01033240|469139710|FG001|Overall Study|Investigator Discretion|0|||
130319823|NCT01033240|469139711|FG002|Overall Study|Investigator Discretion|2|||
130319824|NCT01033240|469139709|FG000|Overall Study|Other|0|||
130319825|NCT01033240|469139710|FG001|Overall Study|Other|1|||
130319826|NCT01033240|469139711|FG002|Overall Study|Other|2|||
130319827|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
130319828|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
130319829|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
130319830|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
130319831|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
130319832|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
130319833|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
130319834|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
130319835|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
130319836|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
130319837|NCT02960217|469139713|FG000|Open-Label Extension Phase|Adverse Event|1|||
130319838|NCT02960217|469139714|FG001|Open-Label Extension Phase|Adverse Event|0|||
130319839|NCT02960217|469139713|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
130319840|NCT02960217|469139714|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
130319841|NCT02960217|469139713|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
130319842|NCT02960217|469139714|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
130319843|NCT02960217|469139713|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
130319844|NCT02960217|469139714|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
130319845|NCT00625131|469139715|FG000|Overall Study|Lost to Follow-up|3|||
130319846|NCT00625131|469139716|FG001|Overall Study|Lost to Follow-up|2|||
130319847|NCT00625131|469139717|FG002|Overall Study|Lost to Follow-up|0|||
130319848|NCT00625131|469139715|FG000|Overall Study|Withdrawal by Subject|1|||
130319849|NCT00625131|469139716|FG001|Overall Study|Withdrawal by Subject|0|||
130319850|NCT00625131|469139717|FG002|Overall Study|Withdrawal by Subject|5|||
130319851|NCT00918281|469139720|FG000|Overall Study|Physician Decision|29|||
130319852|NCT01743469|469139721|FG000|Active Treatment Phase|Adverse Event|10|||
130319853|NCT01743469|469139722|FG001|Active Treatment Phase|Adverse Event|5|||
130319854|NCT01743469|469139723|FG002|Active Treatment Phase|Adverse Event|8|||
130319855|NCT01743469|469139724|FG003|Active Treatment Phase|Adverse Event|1|||
130319856|NCT01743469|469139721|FG000|Active Treatment Phase|Disease Progression|40|||
130319857|NCT01743469|469139722|FG001|Active Treatment Phase|Disease Progression|47|||
130319858|NCT01743469|469139723|FG002|Active Treatment Phase|Disease Progression|30|||
130319859|NCT01743469|469139724|FG003|Active Treatment Phase|Disease Progression|20|||
130319860|NCT01743469|469139721|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
130319861|NCT01743469|469139722|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
130319862|NCT01743469|469139723|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
130319863|NCT01743469|469139724|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
130319864|NCT01743469|469139721|FG000|Active Treatment Phase|Missing|1|||
130319865|NCT01743469|469139722|FG001|Active Treatment Phase|Missing|0|||
130319866|NCT01743469|469139723|FG002|Active Treatment Phase|Missing|0|||
130319867|NCT01743469|469139724|FG003|Active Treatment Phase|Missing|0|||
130319868|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130319869|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130319870|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130319871|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130319872|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Death|43|||
130319873|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Death|47|||
130319874|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Death|22|||
130319875|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Death|16|||
130319876|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130319877|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130319878|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130319879|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130319880|NCT00317473|469139725|FG000|Overall Study|Withdrawal by Subject|2|||
130319881|NCT00317473|469139726|FG001|Overall Study|Withdrawal by Subject|1|||
130319882|NCT00317473|469139727|FG002|Overall Study|Withdrawal by Subject|2|||
130319883|NCT00317473|469139728|FG003|Overall Study|Withdrawal by Subject|1|||
130319884|NCT00317473|469139729|FG004|Overall Study|Withdrawal by Subject|3|||
130319885|NCT00317473|469139730|FG005|Overall Study|Withdrawal by Subject|1|||
130319886|NCT00317473|469139725|FG000|Overall Study|Relocation|1|||
130319887|NCT00317473|469139726|FG001|Overall Study|Relocation|0|||
130319888|NCT00317473|469139727|FG002|Overall Study|Relocation|1|||
130319889|NCT00317473|469139728|FG003|Overall Study|Relocation|1|||
130319890|NCT00317473|469139729|FG004|Overall Study|Relocation|5|||
130319891|NCT00317473|469139730|FG005|Overall Study|Relocation|2|||
130319892|NCT00317473|469139725|FG000|Overall Study|Death|1|||
130319893|NCT00317473|469139726|FG001|Overall Study|Death|0|||
130319894|NCT00317473|469139727|FG002|Overall Study|Death|0|||
130319895|NCT00317473|469139728|FG003|Overall Study|Death|0|||
130319896|NCT00317473|469139729|FG004|Overall Study|Death|0|||
130319897|NCT00317473|469139730|FG005|Overall Study|Death|0|||
130319898|NCT00317473|469139725|FG000|Overall Study|Other|0|||
130319899|NCT00317473|469139726|FG001|Overall Study|Other|2|||
130319900|NCT00317473|469139727|FG002|Overall Study|Other|0|||
130319901|NCT00317473|469139728|FG003|Overall Study|Other|0|||
130319902|NCT00317473|469139729|FG004|Overall Study|Other|0|||
130319903|NCT00317473|469139730|FG005|Overall Study|Other|0|||
130319904|NCT00388349|469139731|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
130319905|NCT00388349|469139732|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
130319906|NCT00168844|469139733|FG000|Overall Study|Adverse Event|31|||
130319907|NCT00168844|469139734|FG001|Overall Study|Adverse Event|32|||
130319908|NCT00168844|469139735|FG002|Overall Study|Adverse Event|48|||
130319909|NCT00168844|469139733|FG000|Overall Study|Lost to Follow-up|4|||
130319910|NCT00168844|469139734|FG001|Overall Study|Lost to Follow-up|5|||
130319911|NCT00168844|469139735|FG002|Overall Study|Lost to Follow-up|11|||
130319912|NCT00168844|469139733|FG000|Overall Study|Withdrawal by Subject|12|||
130319913|NCT00168844|469139734|FG001|Overall Study|Withdrawal by Subject|9|||
130319914|NCT00168844|469139735|FG002|Overall Study|Withdrawal by Subject|19|||
130319915|NCT00168844|469139733|FG000|Overall Study|Protocol Violation|2|||
130319916|NCT00168844|469139734|FG001|Overall Study|Protocol Violation|2|||
130319917|NCT00168844|469139735|FG002|Overall Study|Protocol Violation|4|||
130319918|NCT00168844|469139733|FG000|Overall Study|Other|6|||
130319919|NCT00168844|469139734|FG001|Overall Study|Other|7|||
130319920|NCT00168844|469139735|FG002|Overall Study|Other|9|||
130319921|NCT02138890|469139744|FG000|Overall Study|Adverse Event|1|||
130319922|NCT02138890|469139745|FG001|Overall Study|Adverse Event|0|||
130319923|NCT01446159|469139748|FG000|Overall Study|Withdrawal by Subject|1|||
130319924|NCT01446159|469139749|FG001|Overall Study|Withdrawal by Subject|0|||
130319925|NCT01446159|469139750|FG002|Overall Study|Withdrawal by Subject|14|||
130319926|NCT01446159|469139751|FG003|Overall Study|Withdrawal by Subject|11|||
130319927|NCT01446159|469139748|FG000|Overall Study|Lost to Follow-up|0|||
130319928|NCT01446159|469139749|FG001|Overall Study|Lost to Follow-up|0|||
130319929|NCT01446159|469139750|FG002|Overall Study|Lost to Follow-up|1|||
130319930|NCT01446159|469139751|FG003|Overall Study|Lost to Follow-up|2|||
130319931|NCT01446159|469139748|FG000|Overall Study|Death|2|||
130319932|NCT01446159|469139749|FG001|Overall Study|Death|3|||
130319933|NCT01446159|469139750|FG002|Overall Study|Death|43|||
130319934|NCT01446159|469139751|FG003|Overall Study|Death|36|||
130319935|NCT01446159|469139748|FG000|Overall Study|Other|0|||
130319936|NCT01446159|469139749|FG001|Overall Study|Other|0|||
130319937|NCT01446159|469139750|FG002|Overall Study|Other|13|||
130319938|NCT01446159|469139751|FG003|Overall Study|Other|13|||
130319939|NCT00537394|469139752|FG000|First Year of Follow-up|Death|7|||
130319940|NCT00537394|469139753|FG001|First Year of Follow-up|Death|0|||
130319941|NCT00537394|469139754|FG002|First Year of Follow-up|Death|0|||
130319942|NCT00537394|469139752|FG000|First Year of Follow-up|Severe debilitation|1|||
130319943|NCT00537394|469139753|FG001|First Year of Follow-up|Severe debilitation|0|||
130319944|NCT00537394|469139754|FG002|First Year of Follow-up|Severe debilitation|1|||
130319945|NCT00537394|469139752|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
130319946|NCT00537394|469139753|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
130319947|NCT00537394|469139754|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
130319948|NCT00537394|469139752|FG000|First Year of Follow-up|Lost to Follow-up|1|||
130319949|NCT00537394|469139753|FG001|First Year of Follow-up|Lost to Follow-up|5|||
130319950|NCT00537394|469139754|FG002|First Year of Follow-up|Lost to Follow-up|1|||
130319951|NCT00537394|469139752|FG000|2nd Year of Follow-up|Death|4|||
130319952|NCT00537394|469139753|FG001|2nd Year of Follow-up|Death|1|||
130319953|NCT00537394|469139754|FG002|2nd Year of Follow-up|Death|2|||
130319954|NCT00537394|469139752|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
130319955|NCT00537394|469139753|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
130319956|NCT00537394|469139754|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
130319957|NCT00537394|469139752|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
130319958|NCT00537394|469139753|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
130319959|NCT00537394|469139754|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
130319960|NCT00537394|469139752|FG000|2nd Year of Follow-up|Clinic site closure|1|||
130319961|NCT00537394|469139753|FG001|2nd Year of Follow-up|Clinic site closure|0|||
130319962|NCT00537394|469139754|FG002|2nd Year of Follow-up|Clinic site closure|0|||
130319963|NCT00685165|469139756|FG000|Washout Period of 14 Days|Adverse Event|1|||
130319964|NCT00685165|469139757|FG001|Washout Period of 14 Days|Adverse Event|0|||
130319965|NCT00795535|469139765|FG000|Overall Study|incomplete data and technical problems|20|||
130319966|NCT00556075|469139766|FG000|Overall Study|Lost to Follow-up|3|||
130319967|NCT00556075|469139767|FG001|Overall Study|Lost to Follow-up|0|||
130319968|NCT00556075|469139768|FG002|Overall Study|Lost to Follow-up|3|||
130319969|NCT00556075|469139766|FG000|Overall Study|Withdrawal by Subject|3|||
130319970|NCT00556075|469139767|FG001|Overall Study|Withdrawal by Subject|3|||
130319971|NCT00556075|469139768|FG002|Overall Study|Withdrawal by Subject|0|||
130319972|NCT00556075|469139766|FG000|Overall Study|Protocol Violation|1|||
130319973|NCT00556075|469139767|FG001|Overall Study|Protocol Violation|1|||
130319974|NCT00556075|469139768|FG002|Overall Study|Protocol Violation|3|||
130319975|NCT00556075|469139766|FG000|Overall Study|Not eligible|1|||
130319976|NCT00556075|469139767|FG001|Overall Study|Not eligible|1|||
130319977|NCT00556075|469139768|FG002|Overall Study|Not eligible|2|||
130319978|NCT00556075|469139766|FG000|Overall Study|Adverse Event|1|||
130319979|NCT00556075|469139767|FG001|Overall Study|Adverse Event|2|||
130319980|NCT00556075|469139768|FG002|Overall Study|Adverse Event|0|||
130319981|NCT00556075|469139766|FG000|Overall Study|Personal issues|4|||
130319982|NCT00556075|469139767|FG001|Overall Study|Personal issues|1|||
130319983|NCT00556075|469139768|FG002|Overall Study|Personal issues|0|||
130319984|NCT00556075|469139766|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130319985|NCT00556075|469139767|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
130319986|NCT00556075|469139768|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130319987|NCT02485691|469139769|FG000|Overall Study|Adverse Event|25|||
130319988|NCT02485691|469139770|FG001|Overall Study|Adverse Event|11|||
130319989|NCT02485691|469139769|FG000|Overall Study|Poor compliance to protocol|0|||
130319990|NCT02485691|469139770|FG001|Overall Study|Poor compliance to protocol|1|||
130319991|NCT02485691|469139769|FG000|Overall Study|Disease progression|57|||
130319992|NCT02485691|469139770|FG001|Overall Study|Disease progression|92|||
130319993|NCT02485691|469139769|FG000|Overall Study|Investigator's decision|23|||
130319994|NCT02485691|469139770|FG001|Overall Study|Investigator's decision|5|||
130319995|NCT02485691|469139769|FG000|Overall Study|Participant's request|13|||
130319996|NCT02485691|469139770|FG001|Overall Study|Participant's request|6|||
130319997|NCT02485691|469139769|FG000|Overall Study|Other reason|8|||
130319998|NCT02485691|469139770|FG001|Overall Study|Other reason|9|||
130319999|NCT02485691|469139769|FG000|Overall Study|Randomized and not treated|3|||
130320000|NCT02485691|469139770|FG001|Overall Study|Randomized and not treated|2|||
130320001|NCT01420861|469139771|FG000|Overall Study|Adverse Event|2|||
130320002|NCT01420861|469139771|FG000|Overall Study|Study terminated by Sponsor|7|||
130320003|NCT01420861|469139771|FG000|Overall Study|Screen failure|7|||
130320004|NCT01420861|469139771|FG000|Overall Study|Randomized not Treated|2|||
130320005|NCT04764162|469139772|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
130320006|NCT04764162|469139773|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
130209224|NCT00412217|468727200|FG001|Overall Study|Disease Progression|3|||
130320007|NCT03361137|469139774|FG000|Overall Study|Reason not specified|1|||
130320008|NCT03361137|469139775|FG001|Overall Study|Reason not specified|0|||
130320009|NCT03361137|469139776|FG002|Overall Study|Reason not specified|0|||
130320010|NCT03361137|469139777|FG003|Overall Study|Reason not specified|0|||
130320011|NCT03361137|469139778|FG004|Overall Study|Reason not specified|0|||
130320012|NCT03413891|469139779|FG000|Overall Study|Lost to Follow-up|2|||
130320013|NCT03413891|469139780|FG001|Overall Study|Lost to Follow-up|1|||
130320014|NCT03413891|469139779|FG000|Overall Study|Protocol Violation|0|||
130320015|NCT03413891|469139780|FG001|Overall Study|Protocol Violation|1|||
130320016|NCT04905134|469139783|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
130320017|NCT04905134|469139783|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
130320018|NCT03009058|469139784|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
130320019|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320020|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
130320021|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320022|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320023|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320024|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320025|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
130320026|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320027|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320028|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320029|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320030|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
130320031|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320032|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320033|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320034|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130320035|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130320036|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
130320037|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
130320038|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
130320039|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130320040|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
130320041|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130320042|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130320043|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130320044|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
130320045|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
130320046|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
130320047|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
130320048|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
130320049|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320050|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
130320051|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320052|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320053|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
130320054|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320055|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320056|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130320057|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320058|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130320059|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320060|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320061|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130320062|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320063|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130320064|NCT01486966|469139792|FG000|Overall Study|Adverse Event|0|||
130320065|NCT01486966|469139793|FG001|Overall Study|Adverse Event|1|||
130320066|NCT01486966|469139792|FG000|Overall Study|Withdrawal by Subject|0|||
130320067|NCT01486966|469139793|FG001|Overall Study|Withdrawal by Subject|1|||
130320068|NCT02153086|469141810|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
130320069|NCT02153086|469141810|FG000|Overall Study|Other|2|||
130320070|NCT01317472|469141811|FG000|Overall Study|Withdrawal by Subject|1|||
130320071|NCT01317472|469141812|FG001|Overall Study|Withdrawal by Subject|0|||
130320072|NCT01317472|469141811|FG000|Overall Study|Unrelated hospitalization|1|||
130320073|NCT01317472|469141812|FG001|Overall Study|Unrelated hospitalization|0|||
130320074|NCT05546476|469141813|FG000|Period 1: Part A|Adverse Event|2|||
130320075|NCT05546476|469141814|FG001|Period 1: Part A|Adverse Event|0|||
130320076|NCT05546476|469141815|FG002|Period 1: Part A|Adverse Event|0|||
130320077|NCT05546476|469141816|FG003|Period 1: Part A|Adverse Event|1|||
130320078|NCT05546476|469141813|FG000|Period 1: Part A|Death|4|||
130320079|NCT05546476|469141814|FG001|Period 1: Part A|Death|4|||
130320080|NCT05546476|469141815|FG002|Period 1: Part A|Death|5|||
130320081|NCT05546476|469141816|FG003|Period 1: Part A|Death|6|||
130320082|NCT05546476|469141813|FG000|Period 1: Part A|Lack of Efficacy|0|||
130320083|NCT05546476|469141814|FG001|Period 1: Part A|Lack of Efficacy|0|||
130320084|NCT05546476|469141815|FG002|Period 1: Part A|Lack of Efficacy|0|||
130320085|NCT05546476|469141816|FG003|Period 1: Part A|Lack of Efficacy|1|||
130320086|NCT05546476|469141813|FG000|Period 1: Part A|Lost to Follow-up|0|||
130320087|NCT05546476|469141814|FG001|Period 1: Part A|Lost to Follow-up|0|||
130320088|NCT05546476|469141815|FG002|Period 1: Part A|Lost to Follow-up|0|||
130320089|NCT05546476|469141816|FG003|Period 1: Part A|Lost to Follow-up|1|||
130320090|NCT05546476|469141813|FG000|Period 1: Part A|Physician Decision|1|||
130320091|NCT05546476|469141814|FG001|Period 1: Part A|Physician Decision|0|||
130320092|NCT05546476|469141815|FG002|Period 1: Part A|Physician Decision|0|||
130320093|NCT05546476|469141816|FG003|Period 1: Part A|Physician Decision|0|||
130320094|NCT05546476|469141813|FG000|Period 1: Part A|Progressive disease|3|||
130320095|NCT05546476|469141814|FG001|Period 1: Part A|Progressive disease|5|||
130320096|NCT05546476|469141815|FG002|Period 1: Part A|Progressive disease|0|||
130320097|NCT05546476|469141816|FG003|Period 1: Part A|Progressive disease|1|||
130320098|NCT05546476|469141813|FG000|Period 1: Part A|Withdrawal by Subject|1|||
130320099|NCT05546476|469141814|FG001|Period 1: Part A|Withdrawal by Subject|1|||
130320100|NCT05546476|469141815|FG002|Period 1: Part A|Withdrawal by Subject|1|||
130320101|NCT05546476|469141816|FG003|Period 1: Part A|Withdrawal by Subject|2|||
130320102|NCT05546476|469141813|FG000|Period 1: Part A|Global deterioration of health status|2|||
130320103|NCT05546476|469141814|FG001|Period 1: Part A|Global deterioration of health status|2|||
130320104|NCT05546476|469141815|FG002|Period 1: Part A|Global deterioration of health status|1|||
130320105|NCT05546476|469141816|FG003|Period 1: Part A|Global deterioration of health status|4|||
130320106|NCT05546476|469141813|FG000|Period 1: Part A|Other: Unspecified|0|||
130320107|NCT05546476|469141814|FG001|Period 1: Part A|Other: Unspecified|2|||
130320108|NCT05546476|469141815|FG002|Period 1: Part A|Other: Unspecified|0|||
130320109|NCT05546476|469141816|FG003|Period 1: Part A|Other: Unspecified|0|||
130320110|NCT05546476|469141813|FG000|Period 2: Part B|Ongoing|26|||
130320111|NCT05546476|469141814|FG001|Period 2: Part B|Ongoing|27|||
130320112|NCT05546476|469141815|FG002|Period 2: Part B|Ongoing|35|||
130320113|NCT05546476|469141816|FG003|Period 2: Part B|Ongoing|29|||
130320114|NCT02953652|469141817|FG000|Overall Study|Adverse Event|18|||
130320115|NCT02953652|469141817|FG000|Overall Study|Withdrawal by Subject|6|||
130320116|NCT02953652|469141817|FG000|Overall Study|Protocol Violation|1|||
130320117|NCT02953652|469141817|FG000|Overall Study|Disease Progression|27|||
130320118|NCT00772538|469141818|FG000|Overall Study|Adverse Event|6|||
130320119|NCT00772538|469141819|FG001|Overall Study|Adverse Event|6|||
130320120|NCT00772538|469141818|FG000|Overall Study|Protocol Violation|3|||
130320121|NCT00772538|469141819|FG001|Overall Study|Protocol Violation|3|||
130320122|NCT00772538|469141818|FG000|Overall Study|Lost to Follow-up|1|||
130320123|NCT00772538|469141819|FG001|Overall Study|Lost to Follow-up|1|||
130320124|NCT00772538|469141818|FG000|Overall Study|Withdrawal by Subject|3|||
130320125|NCT00772538|469141819|FG001|Overall Study|Withdrawal by Subject|8|||
130320126|NCT00772538|469141818|FG000|Overall Study|Lack of Efficacy|0|||
130320127|NCT00772538|469141819|FG001|Overall Study|Lack of Efficacy|1|||
130320128|NCT00772538|469141818|FG000|Overall Study|Other|7|||
130320129|NCT00772538|469141819|FG001|Overall Study|Other|7|||
130320130|NCT00713609|469141822|FG000|Overall Study|Adverse Event|2|||
130320131|NCT00713609|469141823|FG001|Overall Study|Adverse Event|0|||
130320132|NCT00713609|469141824|FG002|Overall Study|Adverse Event|2|||
130320133|NCT00713609|469141825|FG003|Overall Study|Adverse Event|2|||
130320134|NCT00713609|469141826|FG004|Overall Study|Adverse Event|3|||
130320135|NCT00713609|469141827|FG005|Overall Study|Adverse Event|1|||
130320136|NCT00713609|469141822|FG000|Overall Study|Lost to Follow-up|5|||
130320137|NCT00713609|469141823|FG001|Overall Study|Lost to Follow-up|7|||
130320138|NCT00713609|469141824|FG002|Overall Study|Lost to Follow-up|5|||
130320139|NCT00713609|469141825|FG003|Overall Study|Lost to Follow-up|5|||
130320140|NCT00713609|469141826|FG004|Overall Study|Lost to Follow-up|7|||
130320141|NCT00713609|469141827|FG005|Overall Study|Lost to Follow-up|0|||
130320142|NCT00713609|469141822|FG000|Overall Study|Lack of Efficacy|1|||
130320143|NCT00713609|469141823|FG001|Overall Study|Lack of Efficacy|3|||
130320144|NCT00713609|469141824|FG002|Overall Study|Lack of Efficacy|0|||
130320145|NCT00713609|469141825|FG003|Overall Study|Lack of Efficacy|0|||
130320146|NCT00713609|469141826|FG004|Overall Study|Lack of Efficacy|1|||
130320147|NCT00713609|469141827|FG005|Overall Study|Lack of Efficacy|0|||
130320148|NCT00713609|469141822|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
130320149|NCT00713609|469141823|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
130320150|NCT00713609|469141824|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
130320151|NCT00713609|469141825|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
130320152|NCT00713609|469141826|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
130320153|NCT00713609|469141827|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
130320154|NCT00713609|469141822|FG000|Overall Study|Withdrawal by Subject|6|||
130320155|NCT00713609|469141823|FG001|Overall Study|Withdrawal by Subject|1|||
130320156|NCT00713609|469141824|FG002|Overall Study|Withdrawal by Subject|5|||
130320157|NCT00713609|469141825|FG003|Overall Study|Withdrawal by Subject|1|||
130320158|NCT00713609|469141826|FG004|Overall Study|Withdrawal by Subject|5|||
130320159|NCT00713609|469141827|FG005|Overall Study|Withdrawal by Subject|7|||
130320160|NCT00713609|469141822|FG000|Overall Study|Protocol Violation|6|||
130320161|NCT00713609|469141823|FG001|Overall Study|Protocol Violation|3|||
130320162|NCT00713609|469141824|FG002|Overall Study|Protocol Violation|1|||
130320163|NCT00713609|469141825|FG003|Overall Study|Protocol Violation|1|||
130320164|NCT00713609|469141826|FG004|Overall Study|Protocol Violation|2|||
130320165|NCT00713609|469141827|FG005|Overall Study|Protocol Violation|0|||
130320166|NCT03780452|469141831|FG000|Overall Study|Screening failure|2|||
130320167|NCT01001221|469141832|FG000|Overall Study|Adverse Event|1|||
130320168|NCT01001221|469141833|FG001|Overall Study|Adverse Event|2|||
130320169|NCT01001221|469141834|FG002|Overall Study|Adverse Event|0|||
130320170|NCT01001221|469141835|FG003|Overall Study|Adverse Event|2|||
130320171|NCT01001221|469141836|FG004|Overall Study|Adverse Event|0|||
130320172|NCT01001221|469141832|FG000|Overall Study|Disease progression|3|||
130320173|NCT01001221|469141833|FG001|Overall Study|Disease progression|2|||
130320174|NCT01001221|469141834|FG002|Overall Study|Disease progression|2|||
130320175|NCT01001221|469141835|FG003|Overall Study|Disease progression|4|||
130543318|NCT00686725|469956696|FG000|Overall Study|Progressive Disease|17|||
130543319|NCT00686725|469956697|FG001|Overall Study|Progressive Disease|23|||
130543320|NCT00686725|469956696|FG000|Overall Study|Lost to Follow-up|7|||
130543321|NCT00686725|469956697|FG001|Overall Study|Lost to Follow-up|5|||
130543322|NCT00686725|469956696|FG000|Overall Study|Death|6|||
130543323|NCT00686725|469956697|FG001|Overall Study|Death|3|||
130543324|NCT00686725|469956696|FG000|Overall Study|Withdrawal by Subject|13|||
130543325|NCT00686725|469956697|FG001|Overall Study|Withdrawal by Subject|4|||
130543326|NCT00686725|469956696|FG000|Overall Study|Protocol Violation|1|||
130543327|NCT00686725|469956697|FG001|Overall Study|Protocol Violation|3|||
130543328|NCT00686725|469956696|FG000|Overall Study|Other|1|||
130543329|NCT00686725|469956697|FG001|Overall Study|Other|3|||
130543330|NCT02630693|469956701|FG000|Overall Study|No receive treatment|0|||
130543331|NCT02630693|469956702|FG001|Overall Study|No receive treatment|1|||
130543332|NCT01639560|469956703|FG000|Overall Study|Withdrawal by Subject|9|||
130543333|NCT01639560|469956704|FG001|Overall Study|Withdrawal by Subject|14|||
130543334|NCT01639560|469956703|FG000|Overall Study|Lack of Efficacy|1|||
130543335|NCT01639560|469956704|FG001|Overall Study|Lack of Efficacy|2|||
130543336|NCT01639560|469956703|FG000|Overall Study|Lost to Follow-up|9|||
130543337|NCT01639560|469956704|FG001|Overall Study|Lost to Follow-up|11|||
130543338|NCT01639560|469956703|FG000|Overall Study|Adverse Event|0|||
130543339|NCT01639560|469956704|FG001|Overall Study|Adverse Event|2|||
130543340|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
130543341|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130543342|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130543343|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130543344|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130543345|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130543346|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
130543347|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
130543348|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
130543349|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
130543350|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
130543351|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
130320176|NCT01001221|469141836|FG004|Overall Study|Disease progression|0|||
130320177|NCT01001221|469141832|FG000|Overall Study|Other|1|||
130320178|NCT01001221|469141833|FG001|Overall Study|Other|1|||
130320179|NCT01001221|469141834|FG002|Overall Study|Other|0|||
130543352|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
130543353|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
130543354|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
130543355|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
130543356|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
130320180|NCT01001221|469141835|FG003|Overall Study|Other|0|||
130320181|NCT01001221|469141836|FG004|Overall Study|Other|0|||
130320182|NCT01001221|469141832|FG000|Overall Study|Not treated; protocol exclusion|0|||
130320183|NCT01001221|469141833|FG001|Overall Study|Not treated; protocol exclusion|0|||
130320184|NCT01001221|469141834|FG002|Overall Study|Not treated; protocol exclusion|1|||
130320185|NCT01001221|469141835|FG003|Overall Study|Not treated; protocol exclusion|0|||
130320186|NCT01001221|469141836|FG004|Overall Study|Not treated; protocol exclusion|0|||
130320187|NCT02388269|469141837|FG000|Overall Study|Adverse Event|2|||
130320188|NCT02388269|469141838|FG001|Overall Study|Adverse Event|0|||
130430147|NCT00642902|469536507|FG003|Overall Study|Lost to Follow-up|0|||
130430148|NCT00642902|469536504|FG000|Overall Study|Lack of Efficacy|0|||
130430149|NCT00642902|469536505|FG001|Overall Study|Lack of Efficacy|3|||
130430150|NCT00642902|469536506|FG002|Overall Study|Lack of Efficacy|3|||
130430151|NCT00642902|469536507|FG003|Overall Study|Lack of Efficacy|0|||
130430152|NCT00642902|469536504|FG000|Overall Study|Death|1|||
130430153|NCT00642902|469536505|FG001|Overall Study|Death|0|||
130430154|NCT00642902|469536506|FG002|Overall Study|Death|0|||
130430155|NCT00642902|469536507|FG003|Overall Study|Death|0|||
130430156|NCT00642902|469536504|FG000|Overall Study|Premature termination of clinical trial|37|||
130430157|NCT00642902|469536505|FG001|Overall Study|Premature termination of clinical trial|32|||
130430158|NCT00642902|469536506|FG002|Overall Study|Premature termination of clinical trial|35|||
130430159|NCT00642902|469536507|FG003|Overall Study|Premature termination of clinical trial|35|||
130430160|NCT00642902|469536504|FG000|Overall Study|Randomized, but not treated|0|||
130430161|NCT00642902|469536505|FG001|Overall Study|Randomized, but not treated|0|||
130430162|NCT00642902|469536506|FG002|Overall Study|Randomized, but not treated|1|||
130430163|NCT00642902|469536507|FG003|Overall Study|Randomized, but not treated|0|||
130430164|NCT00642902|469536504|FG000|Overall Study|Other|1|||
130430165|NCT00642902|469536505|FG001|Overall Study|Other|5|||
130430166|NCT00642902|469536506|FG002|Overall Study|Other|1|||
130430167|NCT00642902|469536507|FG003|Overall Study|Other|4|||
130430168|NCT03953898|469536508|FG000|Overall Study|Lack of Efficacy|8|||
130430169|NCT03953898|469536508|FG000|Overall Study|Death|3|||
130430170|NCT03953898|469536508|FG000|Overall Study|Withdrawal by Subject|2|||
130430171|NCT03953898|469536508|FG000|Overall Study|Adverse Event|1|||
130430172|NCT01538472|469536510|FG000|Overall Study|Disease Progression|3|||
130430173|NCT01538472|469536510|FG000|Overall Study|Death|1|||
130430174|NCT02309112|469536511|FG000|Overall Study|Withdrawal by Subject|1|||
130430175|NCT02309112|469536512|FG001|Overall Study|Withdrawal by Subject|0|||
130430176|NCT02309112|469536513|FG002|Overall Study|Withdrawal by Subject|1|||
130430177|NCT02309112|469536511|FG000|Overall Study|Lost to Follow-up|0|||
130430178|NCT02309112|469536512|FG001|Overall Study|Lost to Follow-up|1|||
130430179|NCT02309112|469536513|FG002|Overall Study|Lost to Follow-up|0|||
130430180|NCT01376323|469536515|FG000|Overall Study|Adverse Event|1|||
130430181|NCT01376323|469536516|FG001|Overall Study|Adverse Event|0|||
130430182|NCT01376323|469536517|FG002|Overall Study|Adverse Event|0|||
130430183|NCT01376323|469536518|FG003|Overall Study|Adverse Event|2|||
130430184|NCT01376323|469536519|FG004|Overall Study|Adverse Event|0|||
130430185|NCT01376323|469536515|FG000|Overall Study|Lost to Follow-up|0|||
130430186|NCT01376323|469536516|FG001|Overall Study|Lost to Follow-up|0|||
130430187|NCT01376323|469536517|FG002|Overall Study|Lost to Follow-up|0|||
130430188|NCT01376323|469536518|FG003|Overall Study|Lost to Follow-up|2|||
130430189|NCT01376323|469536519|FG004|Overall Study|Lost to Follow-up|0|||
130430190|NCT01376323|469536515|FG000|Overall Study|Physician Decision|1|||
130430191|NCT01376323|469536516|FG001|Overall Study|Physician Decision|0|||
130430192|NCT01376323|469536517|FG002|Overall Study|Physician Decision|2|||
130430193|NCT01376323|469536518|FG003|Overall Study|Physician Decision|1|||
130430194|NCT01376323|469536519|FG004|Overall Study|Physician Decision|1|||
130430195|NCT01376323|469536515|FG000|Overall Study|Withdrawal by Subject|0|||
130430196|NCT01376323|469536516|FG001|Overall Study|Withdrawal by Subject|1|||
130430197|NCT01376323|469536517|FG002|Overall Study|Withdrawal by Subject|1|||
130430198|NCT01376323|469536518|FG003|Overall Study|Withdrawal by Subject|0|||
130430199|NCT01376323|469536519|FG004|Overall Study|Withdrawal by Subject|0|||
130430200|NCT04681729|469536520|FG000|Overall Study|Lack of Efficacy|2|||
130430201|NCT04681729|469536521|FG001|Overall Study|Lack of Efficacy|2|||
130543357|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
130430202|NCT04681729|469536520|FG000|Overall Study|Withdrawal by Subject|8|||
130430203|NCT04681729|469536521|FG001|Overall Study|Withdrawal by Subject|9|||
130430204|NCT00499863|469536523|FG000|Overall Study|Lack of Efficacy|21|||
130430205|NCT00499863|469536524|FG001|Overall Study|Lack of Efficacy|27|||
130430206|NCT00499863|469536523|FG000|Overall Study|Protocol Violation|12|||
130430207|NCT00499863|469536524|FG001|Overall Study|Protocol Violation|7|||
130430208|NCT00499863|469536523|FG000|Overall Study|Withdrawal by Subject|6|||
130430209|NCT00499863|469536524|FG001|Overall Study|Withdrawal by Subject|4|||
130430210|NCT00499863|469536523|FG000|Overall Study|Adverse Event|8|||
130430211|NCT00499863|469536524|FG001|Overall Study|Adverse Event|2|||
130430212|NCT00499863|469536523|FG000|Overall Study|Sponsor decision|2|||
130430213|NCT00499863|469536524|FG001|Overall Study|Sponsor decision|2|||
130430214|NCT00499863|469536523|FG000|Overall Study|Lost to Follow-up|1|||
130430215|NCT00499863|469536524|FG001|Overall Study|Lost to Follow-up|1|||
130430216|NCT03759834|469536525|FG000|Overall Study|Withdrawal by Subject|1|||
130430217|NCT05701995|469536526|FG000|Pre-Treatment|Randomization Error|1|||
130430218|NCT05701995|469536527|FG001|Pre-Treatment|Randomization Error|1|||
130430219|NCT05701995|469536526|FG000|Treatment|Withdrawal by Subject|8|||
130430220|NCT05701995|469536527|FG001|Treatment|Withdrawal by Subject|4|||
130430221|NCT05701995|469536526|FG000|Treatment|Lost to Follow-up|2|||
130430222|NCT05701995|469536527|FG001|Treatment|Lost to Follow-up|3|||
130430223|NCT05701995|469536526|FG000|Treatment|Adverse Event|3|||
130430224|NCT05701995|469536527|FG001|Treatment|Adverse Event|1|||
130430225|NCT05701995|469536526|FG000|Treatment|Other Reason|1|||
130430226|NCT05701995|469536527|FG001|Treatment|Other Reason|1|||
130430227|NCT05701995|469536526|FG000|Treatment|Death|1|||
130430228|NCT05701995|469536527|FG001|Treatment|Death|0|||
130430229|NCT05701995|469536526|FG000|Treatment|Physician Decision|0|||
130430230|NCT05701995|469536527|FG001|Treatment|Physician Decision|1|||
130430231|NCT03483038|469536528|FG000|Overall Study|Subjects still in follow-up|18|||
130430232|NCT00504426|469536529|FG000|Overall Study|Adverse Event|0|||
130430233|NCT00504426|469536530|FG001|Overall Study|Adverse Event|0|||
130430234|NCT00504426|469536531|FG002|Overall Study|Adverse Event|2|||
130430235|NCT00504426|469536532|FG003|Overall Study|Adverse Event|0|||
130430236|NCT00504426|469536529|FG000|Overall Study|Protocol Violation|1|||
130430237|NCT00504426|469536530|FG001|Overall Study|Protocol Violation|1|||
130430238|NCT00504426|469536531|FG002|Overall Study|Protocol Violation|2|||
130430239|NCT00504426|469536532|FG003|Overall Study|Protocol Violation|0|||
130430240|NCT00504426|469536529|FG000|Overall Study|Withdrawal by Subject|2|||
130430241|NCT00504426|469536530|FG001|Overall Study|Withdrawal by Subject|0|||
130430242|NCT00504426|469536531|FG002|Overall Study|Withdrawal by Subject|0|||
130430243|NCT00504426|469536532|FG003|Overall Study|Withdrawal by Subject|0|||
130430244|NCT03988166|469536535|FG000|Overall Study|Lost to Follow-up|2|||
130430245|NCT03988166|469536535|FG000|Overall Study|Death|1|||
130430246|NCT03248375|469536536|FG000|Overall Study|Lost to Follow-up|5|||
130430247|NCT00633464|469536537|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
130430248|NCT00633464|469536538|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
130430249|NCT00633464|469536537|FG000|Overall Study|Never Treated (Randomized in error)|0|||
130430250|NCT00633464|469536538|FG001|Overall Study|Never Treated (Randomized in error)|1|||
130430251|NCT02612064|469536539|FG000|Overall Study|Withdrawal by Subject|1|||
130430252|NCT02612064|469536540|FG001|Overall Study|Withdrawal by Subject|1|||
130430253|NCT02612064|469536539|FG000|Overall Study|Other|0|||
130430254|NCT02612064|469536540|FG001|Overall Study|Other|2|||
130430255|NCT01669798|469536541|FG000|Overall Study|Physician Decision|5|||
130430256|NCT04179721|469536545|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
130430257|NCT04179721|469536546|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
130430258|NCT04179721|469536545|FG000|Overall Study|Lost to Follow-up|0|||
130430259|NCT04179721|469536546|FG001|Overall Study|Lost to Follow-up|1|||
130430260|NCT00112580|469536547|FG000|Overall Study|Adverse Event|1|||
130430261|NCT00112580|469536548|FG001|Overall Study|Adverse Event|2|||
130430262|NCT00112580|469536547|FG000|Overall Study|Disease progression|5|||
130430263|NCT00112580|469536548|FG001|Overall Study|Disease progression|16|||
130430264|NCT00112580|469536547|FG000|Overall Study|Participant withdrew consent|2|||
130430265|NCT00112580|469536548|FG001|Overall Study|Participant withdrew consent|1|||
130430266|NCT05619003|469536549|FG000|Overall Study|Adverse Event|1|||
130430267|NCT01679301|469537663|FG000|Screening Period|screen failure|3|||
130430268|NCT01679301|469537664|FG001|Screening Period|screen failure|0|||
130430269|NCT01679301|469537665|FG002|Screening Period|screen failure|0|||
130430270|NCT01529008|469537666|FG000|Bone Marrow Harvesting|Physician Decision|1|||
130430271|NCT01529008|469537667|FG001|Bone Marrow Harvesting|Physician Decision|1|||
130430272|NCT01529008|469537666|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
130430273|NCT01529008|469537667|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
130430274|NCT01529008|469537666|FG000|Treatment|Adverse Event|6|||
130430275|NCT01529008|469537667|FG001|Treatment|Adverse Event|0|||
130430276|NCT01529008|469537666|FG000|Treatment|Other|3|||
130430277|NCT01529008|469537667|FG001|Treatment|Other|1|||
130430278|NCT01529008|469537666|FG000|Efficacy Analysis|Protocol Violation|2|||
130430279|NCT01529008|469537667|FG001|Efficacy Analysis|Protocol Violation|0|||
130430280|NCT01529008|469537666|FG000|Efficacy Analysis|Physician Decision|0|||
130430281|NCT01529008|469537667|FG001|Efficacy Analysis|Physician Decision|1|||
130430282|NCT01529008|469537666|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
130430283|NCT01529008|469537667|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
130430284|NCT01382602|469537668|FG000|Overall Study|Protocol Violation|0|||
130430285|NCT01382602|469537669|FG001|Overall Study|Protocol Violation|3|||
130430286|NCT01382602|469537668|FG000|Overall Study|Withdrawal by Subject|0|||
130430287|NCT01382602|469537669|FG001|Overall Study|Withdrawal by Subject|1|||
130430288|NCT01682213|469537672|FG000|Overall Study|Withdrawal by Subject|2|||
130320189|NCT02388269|469141839|FG002|Overall Study|Adverse Event|0|||
130320190|NCT02388269|469141837|FG000|Overall Study|Withdrawal by Subject|1|||
130320191|NCT02388269|469141838|FG001|Overall Study|Withdrawal by Subject|2|||
130320192|NCT02388269|469141839|FG002|Overall Study|Withdrawal by Subject|0|||
130320193|NCT02388269|469141837|FG000|Overall Study|less than 50% stimulations|1|||
130320194|NCT02388269|469141838|FG001|Overall Study|less than 50% stimulations|0|||
130320195|NCT02388269|469141839|FG002|Overall Study|less than 50% stimulations|0|||
130320196|NCT02388269|469141837|FG000|Overall Study|no diary data|3|||
130320197|NCT02388269|469141838|FG001|Overall Study|no diary data|0|||
130320198|NCT02388269|469141839|FG002|Overall Study|no diary data|0|||
130320199|NCT02388269|469141837|FG000|Overall Study|Protocol Violation|2|||
130320200|NCT02388269|469141838|FG001|Overall Study|Protocol Violation|0|||
130320201|NCT02388269|469141839|FG002|Overall Study|Protocol Violation|0|||
130320202|NCT02388269|469141837|FG000|Overall Study|Screen Failure|0|||
130320203|NCT02388269|469141838|FG001|Overall Study|Screen Failure|0|||
130320204|NCT02388269|469141839|FG002|Overall Study|Screen Failure|10|||
130320205|NCT01791244|469141841|FG000|Overall Study|Adverse Event|5|||
130320206|NCT01791244|469141842|FG001|Overall Study|Adverse Event|7|||
130320207|NCT01791244|469141841|FG000|Overall Study|Insufficient clinical response|10|||
130320208|NCT01791244|469141842|FG001|Overall Study|Insufficient clinical response|10|||
130320209|NCT01791244|469141841|FG000|Overall Study|Laboratory Abnormality|0|||
130320210|NCT01791244|469141842|FG001|Overall Study|Laboratory Abnormality|1|||
130320211|NCT01383928|469141843|FG000|Overall Study|Initiation of ASCT|2|||
130320212|NCT01383928|469141844|FG001|Overall Study|Initiation of ASCT|1|||
130320213|NCT01383928|469141845|FG002|Overall Study|Initiation of ASCT|18|||
130320214|NCT01383928|469141843|FG000|Overall Study|Adverse Event|1|||
130320215|NCT01383928|469141844|FG001|Overall Study|Adverse Event|2|||
130320216|NCT01383928|469141845|FG002|Overall Study|Adverse Event|8|||
130320217|NCT01383928|469141843|FG000|Overall Study|Other|1|||
130320218|NCT01383928|469141844|FG001|Overall Study|Other|3|||
130320219|NCT01383928|469141845|FG002|Overall Study|Other|4|||
130320220|NCT01383928|469141843|FG000|Overall Study|Progressive Disease|1|||
130320221|NCT01383928|469141844|FG001|Overall Study|Progressive Disease|1|||
130320222|NCT01383928|469141845|FG002|Overall Study|Progressive Disease|5|||
130320223|NCT01383928|469141843|FG000|Overall Study|Withdrawal by Subject|0|||
130320224|NCT01383928|469141844|FG001|Overall Study|Withdrawal by Subject|0|||
130320225|NCT01383928|469141845|FG002|Overall Study|Withdrawal by Subject|4|||
130320226|NCT01383928|469141843|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
130320227|NCT01383928|469141844|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130320228|NCT01383928|469141845|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130320229|NCT01149096|469141847|FG000|Overall Study|Lost to Follow-up|0|||
130320230|NCT01149096|469141848|FG001|Overall Study|Lost to Follow-up|1|||
130320231|NCT03651765|469141850|FG000|Overall Study|Adverse Event|6|||
130320232|NCT03651765|469141850|FG000|Overall Study|Lack of Efficacy|18|||
130320233|NCT03651765|469141850|FG000|Overall Study|Lost to Follow-up|5|||
130320234|NCT03651765|469141850|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130320235|NCT03651765|469141850|FG000|Overall Study|Physician Decision|6|||
130320236|NCT03651765|469141850|FG000|Overall Study|Pregnancy|1|||
130320237|NCT03651765|469141850|FG000|Overall Study|Discontinued by Sponsor|40|||
130320238|NCT03651765|469141850|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
130320239|NCT03651765|469141850|FG000|Overall Study|Withdrawal by Subject|24|||
130320240|NCT03651765|469141850|FG000|Overall Study|Miscellaneous|6|||
130320241|NCT00703014|469141858|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
130320242|NCT00703014|469141859|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
130320243|NCT00703014|469141860|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320244|NCT00703014|469141861|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320245|NCT00703014|469141858|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320246|NCT00703014|469141859|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320247|NCT00703014|469141860|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
130320248|NCT00703014|469141861|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
130320249|NCT05468814|469141864|FG000|Overall Study|Lost to Follow-up|5|||
130320250|NCT05468814|469141865|FG001|Overall Study|Lost to Follow-up|6|||
130320251|NCT04716426|469141866|FG000|Overall Study|Vaccination|1|||
130320252|NCT04716426|469141867|FG001|Overall Study|Vaccination|1|||
130320253|NCT04716426|469141866|FG000|Overall Study|Contamination|1|||
130320254|NCT04716426|469141867|FG001|Overall Study|Contamination|0|||
130320255|NCT03668873|469141869|FG000|Overall Study|Lost to Follow-up|6|||
130320256|NCT03668873|469141870|FG001|Overall Study|Lost to Follow-up|3|||
130320257|NCT01521117|469141871|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
130320258|NCT01521117|469141872|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130320259|NCT01521117|469141871|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
130320260|NCT01521117|469141872|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
130209225|NCT00412217|468727199|FG000|Overall Study|Investigator Decision|1|||
130430289|NCT00742079|469537673|FG000|Overall Study|Lost to Follow-up|0|||
130430290|NCT00742079|469537674|FG001|Overall Study|Lost to Follow-up|1|||
130430291|NCT01264380|469537675|FG000|Period C|Disease Progression|0|||
130430292|NCT01264380|469537676|FG001|Period C|Disease Progression|0|||
130430293|NCT01264380|469537677|FG002|Period C|Disease Progression|4|||
130430294|NCT01264380|469537675|FG000|Period C|Death|0|||
130430295|NCT01264380|469537676|FG001|Period C|Death|0|||
130430296|NCT01264380|469537677|FG002|Period C|Death|2|||
130430297|NCT01264380|469537675|FG000|Period C|Follow-up for survival status|0|||
130430298|NCT01264380|469537676|FG001|Period C|Follow-up for survival status|0|||
130430299|NCT01264380|469537677|FG002|Period C|Follow-up for survival status|6|||
130430300|NCT01264380|469537675|FG000|Period C|Withdrawal by Subject|0|||
130320261|NCT01521117|469141871|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130320262|NCT01521117|469141872|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
130320263|NCT00784563|469141873|FG000|Years 1 & 2|Withdrawal by Subject|3|||
130320264|NCT00784563|469141874|FG001|Years 1 & 2|Withdrawal by Subject|2|||
130320265|NCT00784563|469141875|FG002|Years 1 & 2|Withdrawal by Subject|0|||
130320266|NCT00784563|469141873|FG000|Years 1 & 2|Adverse Event|0|||
130320267|NCT00784563|469141874|FG001|Years 1 & 2|Adverse Event|3|||
130320268|NCT00784563|469141875|FG002|Years 1 & 2|Adverse Event|0|||
130320269|NCT00784563|469141873|FG000|Year 3|Withdrawal by Subject|0|||
130320270|NCT00784563|469141874|FG001|Year 3|Withdrawal by Subject|0|||
130320271|NCT00784563|469141875|FG002|Year 3|Withdrawal by Subject|2|||
130320272|NCT00784563|469141873|FG000|Year 3|Adverse Event|0|||
130320273|NCT00784563|469141874|FG001|Year 3|Adverse Event|0|||
130320274|NCT00784563|469141875|FG002|Year 3|Adverse Event|1|||
130430301|NCT01264380|469537676|FG001|Period C|Withdrawal by Subject|0|||
130209226|NCT00412217|468727200|FG001|Overall Study|Investigator Decision|0|||
130209227|NCT00412217|468727199|FG000|Overall Study|Withdrawal by Subject|2|||
130209228|NCT00412217|468727200|FG001|Overall Study|Withdrawal by Subject|0|||
130320275|NCT00374140|469141882|FG000|Overall Study|Lost to Follow-up|1|||
130430302|NCT01264380|469537677|FG002|Period C|Withdrawal by Subject|1|||
130430303|NCT01264380|469537675|FG000|Period C|Adverse Event|0|||
130430304|NCT01264380|469537676|FG001|Period C|Adverse Event|0|||
130430305|NCT01264380|469537677|FG002|Period C|Adverse Event|1|||
130430306|NCT01147822|469537678|FG000|Overall Study|Lost to Follow-up|14|||
130430307|NCT01147822|469537679|FG001|Overall Study|Lost to Follow-up|6|||
130430308|NCT01147822|469537678|FG000|Overall Study|Withdrawal by Subject|10|||
130430309|NCT01147822|469537679|FG001|Overall Study|Withdrawal by Subject|16|||
130430310|NCT01147822|469537678|FG000|Overall Study|Physician Decision|9|||
130430311|NCT01147822|469537679|FG001|Overall Study|Physician Decision|8|||
130430312|NCT01147822|469537678|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
130430313|NCT01147822|469537679|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
130430314|NCT01147822|469537678|FG000|Overall Study|Protocol Violation|1|||
130430315|NCT01147822|469537679|FG001|Overall Study|Protocol Violation|1|||
130430316|NCT00429663|469537682|FG000|Overall Study|Lost to Follow-up|24|||
130430317|NCT00429663|469537683|FG001|Overall Study|Lost to Follow-up|31|||
130430318|NCT00429663|469537682|FG000|Overall Study|Physician Decision|6|||
130430319|NCT00429663|469537683|FG001|Overall Study|Physician Decision|3|||
130430320|NCT00429663|469537682|FG000|Overall Study|Withdrawal by Subject|2|||
130430321|NCT00429663|469537683|FG001|Overall Study|Withdrawal by Subject|5|||
130430322|NCT00429663|469537682|FG000|Overall Study|Death|4|||
130430323|NCT00429663|469537683|FG001|Overall Study|Death|0|||
130430324|NCT03261271|469537689|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
130430325|NCT03261271|469537690|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
130430326|NCT01932697|469537691|FG000|Overall Study|Received a different amount of tx|1|||
130430327|NCT01932697|469537692|FG001|Overall Study|Received a different amount of tx|0|||
130430328|NCT01932697|469537691|FG000|Overall Study|Ineligible|1|||
130430329|NCT01932697|469537692|FG001|Overall Study|Ineligible|0|||
130430330|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
130430331|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
130430332|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
130430333|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
130430334|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
130430335|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
130430336|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
130430337|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130430338|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130430339|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130430340|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
130430341|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
130430342|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130430343|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130430344|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130430345|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
130430346|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
130430347|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130430348|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130430349|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130430350|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Death|2|||
130430351|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Death|2|||
130430352|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Death|0|||
130430353|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Death|0|||
130430354|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Death|0|||
130430355|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
130430356|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
130430357|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
130430358|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
130430359|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
130430360|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130430361|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
130430362|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130430363|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130430364|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130430365|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
130430366|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
130430367|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130430368|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130430369|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130430370|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
130430371|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130430372|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130430373|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130430374|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130430375|NCT03420781|469537693|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
130430376|NCT03420781|469537694|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130430377|NCT03420781|469537695|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130430378|NCT03420781|469537696|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130430379|NCT03420781|469537697|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130430380|NCT03420781|469537693|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130430381|NCT03420781|469537694|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130430382|NCT03420781|469537695|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130430383|NCT03420781|469537696|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
130430384|NCT03420781|469537697|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130430385|NCT03420781|469537693|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130430386|NCT03420781|469537694|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130430387|NCT03420781|469537695|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130430388|NCT03420781|469537696|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130430389|NCT03420781|469537697|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
130430390|NCT03420781|469537693|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
130430391|NCT03420781|469537694|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
130430392|NCT03420781|469537695|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
130430393|NCT03420781|469537696|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
130430394|NCT03420781|469537697|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
130430395|NCT00246337|469537698|FG000|Overall Study|Lost to Follow-up|3|||
130430396|NCT00246337|469537699|FG001|Overall Study|Lost to Follow-up|0|||
130430397|NCT00246337|469537700|FG002|Overall Study|Lost to Follow-up|0|||
130430398|NCT00246337|469537701|FG003|Overall Study|Lost to Follow-up|0|||
130430399|NCT00246337|469537702|FG004|Overall Study|Lost to Follow-up|2|||
130430400|NCT00246337|469537703|FG005|Overall Study|Lost to Follow-up|2|||
130430401|NCT00246337|469537704|FG006|Overall Study|Lost to Follow-up|1|||
130430402|NCT00246337|469537705|FG007|Overall Study|Lost to Follow-up|2|||
130430403|NCT00246337|469537706|FG008|Overall Study|Lost to Follow-up|0|||
130430404|NCT00246337|469537698|FG000|Overall Study|Protocol Violation|1|||
130430405|NCT00246337|469537699|FG001|Overall Study|Protocol Violation|0|||
130430406|NCT00246337|469537700|FG002|Overall Study|Protocol Violation|0|||
130430407|NCT00246337|469537701|FG003|Overall Study|Protocol Violation|0|||
130430408|NCT00246337|469537702|FG004|Overall Study|Protocol Violation|1|||
130430409|NCT00246337|469537703|FG005|Overall Study|Protocol Violation|0|||
130430410|NCT00246337|469537704|FG006|Overall Study|Protocol Violation|1|||
130430411|NCT00246337|469537705|FG007|Overall Study|Protocol Violation|1|||
130430412|NCT00246337|469537706|FG008|Overall Study|Protocol Violation|0|||
130430413|NCT00246337|469537698|FG000|Overall Study|Withdrawal by Subject|2|||
130430414|NCT00246337|469537699|FG001|Overall Study|Withdrawal by Subject|0|||
130430415|NCT00246337|469537700|FG002|Overall Study|Withdrawal by Subject|0|||
130430416|NCT00246337|469537701|FG003|Overall Study|Withdrawal by Subject|0|||
130430417|NCT00246337|469537702|FG004|Overall Study|Withdrawal by Subject|0|||
130430418|NCT00246337|469537703|FG005|Overall Study|Withdrawal by Subject|0|||
130430419|NCT00246337|469537704|FG006|Overall Study|Withdrawal by Subject|1|||
130430420|NCT00246337|469537705|FG007|Overall Study|Withdrawal by Subject|1|||
130430421|NCT00246337|469537706|FG008|Overall Study|Withdrawal by Subject|0|||
130430422|NCT00246337|469537698|FG000|Overall Study|Lack of Qualifying Event|8|||
130430423|NCT00246337|469537699|FG001|Overall Study|Lack of Qualifying Event|2|||
130430424|NCT00246337|469537700|FG002|Overall Study|Lack of Qualifying Event|1|||
130430425|NCT00246337|469537701|FG003|Overall Study|Lack of Qualifying Event|1|||
130430426|NCT00246337|469537702|FG004|Overall Study|Lack of Qualifying Event|1|||
130430427|NCT00246337|469537703|FG005|Overall Study|Lack of Qualifying Event|3|||
130430428|NCT00246337|469537704|FG006|Overall Study|Lack of Qualifying Event|3|||
130430429|NCT00246337|469537705|FG007|Overall Study|Lack of Qualifying Event|2|||
130430430|NCT00246337|469537706|FG008|Overall Study|Lack of Qualifying Event|5|||
130430431|NCT00246337|469537698|FG000|Overall Study|Site Terminated|10|||
130430432|NCT00246337|469537699|FG001|Overall Study|Site Terminated|0|||
130430433|NCT00246337|469537700|FG002|Overall Study|Site Terminated|0|||
130430434|NCT00246337|469537701|FG003|Overall Study|Site Terminated|0|||
130430435|NCT00246337|469537702|FG004|Overall Study|Site Terminated|0|||
130430436|NCT00246337|469537703|FG005|Overall Study|Site Terminated|7|||
130430437|NCT00246337|469537704|FG006|Overall Study|Site Terminated|1|||
130430438|NCT00246337|469537705|FG007|Overall Study|Site Terminated|6|||
130430439|NCT00246337|469537706|FG008|Overall Study|Site Terminated|2|||
130430440|NCT00246337|469537698|FG000|Overall Study|Abnormal baseline lab values|7|||
130430441|NCT00246337|469537699|FG001|Overall Study|Abnormal baseline lab values|0|||
130430442|NCT00246337|469537700|FG002|Overall Study|Abnormal baseline lab values|2|||
130430443|NCT00246337|469537701|FG003|Overall Study|Abnormal baseline lab values|0|||
130430444|NCT00246337|469537702|FG004|Overall Study|Abnormal baseline lab values|0|||
130430445|NCT00246337|469537703|FG005|Overall Study|Abnormal baseline lab values|2|||
130430446|NCT00246337|469537704|FG006|Overall Study|Abnormal baseline lab values|2|||
130430447|NCT00246337|469537705|FG007|Overall Study|Abnormal baseline lab values|0|||
130430448|NCT00246337|469537706|FG008|Overall Study|Abnormal baseline lab values|4|||
130430449|NCT00246337|469537698|FG000|Overall Study|Overwhelmed|0|||
130430450|NCT00246337|469537699|FG001|Overall Study|Overwhelmed|0|||
130430451|NCT00246337|469537700|FG002|Overall Study|Overwhelmed|0|||
130430452|NCT00246337|469537701|FG003|Overall Study|Overwhelmed|0|||
130430453|NCT00246337|469537702|FG004|Overall Study|Overwhelmed|0|||
130430454|NCT00246337|469537703|FG005|Overall Study|Overwhelmed|1|||
130430455|NCT00246337|469537704|FG006|Overall Study|Overwhelmed|0|||
130430456|NCT00246337|469537705|FG007|Overall Study|Overwhelmed|0|||
130430457|NCT00246337|469537706|FG008|Overall Study|Overwhelmed|0|||
130430458|NCT00246337|469537698|FG000|Overall Study|Protocol Violator|1|||
130430459|NCT00246337|469537699|FG001|Overall Study|Protocol Violator|0|||
130430460|NCT00246337|469537700|FG002|Overall Study|Protocol Violator|0|||
130430461|NCT00246337|469537701|FG003|Overall Study|Protocol Violator|0|||
130430462|NCT00246337|469537702|FG004|Overall Study|Protocol Violator|0|||
130430463|NCT00246337|469537703|FG005|Overall Study|Protocol Violator|0|||
130430464|NCT00246337|469537704|FG006|Overall Study|Protocol Violator|0|||
130430465|NCT00246337|469537705|FG007|Overall Study|Protocol Violator|0|||
130430466|NCT00246337|469537706|FG008|Overall Study|Protocol Violator|0|||
130430467|NCT00246337|469537698|FG000|Overall Study|Reported as completing trial in error|0|||
130430468|NCT00246337|469537699|FG001|Overall Study|Reported as completing trial in error|0|||
130430469|NCT00246337|469537700|FG002|Overall Study|Reported as completing trial in error|0|||
130430470|NCT00246337|469537701|FG003|Overall Study|Reported as completing trial in error|0|||
130430471|NCT00246337|469537702|FG004|Overall Study|Reported as completing trial in error|0|||
130430472|NCT00246337|469537703|FG005|Overall Study|Reported as completing trial in error|0|||
130430473|NCT00246337|469537704|FG006|Overall Study|Reported as completing trial in error|0|||
130430474|NCT00246337|469537705|FG007|Overall Study|Reported as completing trial in error|1|||
130430475|NCT00246337|469537706|FG008|Overall Study|Reported as completing trial in error|0|||
130430476|NCT01226511|469537711|FG000|Acute Treatment Period|Adverse Event|7|||
130430477|NCT01226511|469537712|FG001|Acute Treatment Period|Adverse Event|6|||
130430478|NCT01226511|469537711|FG000|Acute Treatment Period|Lack of Efficacy|2|||
130430479|NCT01226511|469537712|FG001|Acute Treatment Period|Lack of Efficacy|1|||
130430480|NCT01226511|469537711|FG000|Acute Treatment Period|Lost to Follow-up|3|||
130430481|NCT01226511|469537712|FG001|Acute Treatment Period|Lost to Follow-up|6|||
130430482|NCT01226511|469537711|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
130430483|NCT01226511|469537712|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
130430484|NCT01226511|469537711|FG000|Acute Treatment Period|Protocol Violation|5|||
130430485|NCT01226511|469537712|FG001|Acute Treatment Period|Protocol Violation|5|||
130430486|NCT01226511|469537711|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
130430487|NCT01226511|469537712|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
130430488|NCT01226511|469537711|FG000|Extension Treatment Period|Adverse Event|8|||
130430489|NCT01226511|469537712|FG001|Extension Treatment Period|Adverse Event|8|||
130430490|NCT01226511|469537711|FG000|Extension Treatment Period|Lack of Efficacy|3|||
130430491|NCT01226511|469537712|FG001|Extension Treatment Period|Lack of Efficacy|2|||
130430492|NCT01226511|469537711|FG000|Extension Treatment Period|Lost to Follow-up|4|||
130430493|NCT01226511|469537712|FG001|Extension Treatment Period|Lost to Follow-up|3|||
130430494|NCT01226511|469537711|FG000|Extension Treatment Period|Protocol Violation|2|||
130430495|NCT01226511|469537712|FG001|Extension Treatment Period|Protocol Violation|2|||
130430496|NCT01226511|469537711|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130543358|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
130430497|NCT01226511|469537712|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
130430498|NCT01226511|469537711|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
130430499|NCT01226511|469537712|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
130430500|NCT01226511|469537711|FG000|Extension Treatment Period|Sponsor Decision|1|||
130430501|NCT01226511|469537712|FG001|Extension Treatment Period|Sponsor Decision|1|||
130543359|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130543360|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130543361|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130543362|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130543363|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130543364|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
130543365|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
130543366|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
130543367|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
130543368|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
130543369|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
130543370|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
130543371|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
130543372|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
130543373|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
130543374|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
130543375|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
130543376|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
130430502|NCT01226511|469537711|FG000|Taper Period|Adverse Event|1|||
130430503|NCT01226511|469537712|FG001|Taper Period|Adverse Event|0|||
130430504|NCT01226511|469537711|FG000|Taper Period|Lost to Follow-up|2|||
130430505|NCT01226511|469537712|FG001|Taper Period|Lost to Follow-up|2|||
130430506|NCT01226511|469537711|FG000|Taper Period|Protocol Violation|1|||
130430507|NCT01226511|469537712|FG001|Taper Period|Protocol Violation|0|||
130430508|NCT01226511|469537711|FG000|Taper Period|Parent/Caregiver Decision|1|||
130430509|NCT01226511|469537712|FG001|Taper Period|Parent/Caregiver Decision|1|||
130559397|NCT01621542|470016493|FG003|Overall Study|Adverse Event|3|||
130430510|NCT02696564|469537713|FG000|Overall Study|Death|1|||
130430511|NCT02696564|469537714|FG001|Overall Study|Death|2|||
130209229|NCT00412217|468727199|FG000|Overall Study|Lost to Follow-up|1|||
130209230|NCT00412217|468727200|FG001|Overall Study|Lost to Follow-up|4|||
130209231|NCT00412217|468727199|FG000|Overall Study|Study Terminated by Sponsor|26|||
130209232|NCT00412217|468727200|FG001|Overall Study|Study Terminated by Sponsor|33|||
130209233|NCT00412217|468727199|FG000|Overall Study|Other|1|||
130209234|NCT00412217|468727200|FG001|Overall Study|Other|1|||
130209235|NCT01398410|468727202|FG000|Overall Study|Adverse Event|12|||
130209236|NCT01398410|468727203|FG001|Overall Study|Adverse Event|16|||
130209237|NCT01398410|468727202|FG000|Overall Study|Participants Choice|8|||
130209238|NCT01398410|468727203|FG001|Overall Study|Participants Choice|11|||
130209239|NCT01398410|468727202|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
130209240|NCT01398410|468727203|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
130209241|NCT01398410|468727202|FG000|Overall Study|Other|36|||
130209242|NCT01398410|468727203|FG001|Overall Study|Other|29|||
130209243|NCT03209518|468727206|FG000|Overall Study|Case Report Forms Uncollected|1|||
130209244|NCT03209518|468727206|FG000|Overall Study|Protocol Deviation|1|||
130209245|NCT00236899|468727207|FG000|Overall Study|Adverse Event (Study Related)|1|||
130209246|NCT00236899|468727208|FG001|Overall Study|Adverse Event (Study Related)|1|||
130209247|NCT00236899|468727209|FG002|Overall Study|Adverse Event (Study Related)|2|||
130209248|NCT00236899|468727210|FG003|Overall Study|Adverse Event (Study Related)|1|||
130209249|NCT00236899|468727207|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
130209250|NCT00236899|468727208|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
130209251|NCT00236899|468727209|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
130209252|NCT00236899|468727210|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
130209253|NCT00236899|468727207|FG000|Overall Study|Death (Study Disease)|1|||
130209254|NCT00236899|468727208|FG001|Overall Study|Death (Study Disease)|4|||
130209255|NCT00236899|468727209|FG002|Overall Study|Death (Study Disease)|0|||
130209256|NCT00236899|468727210|FG003|Overall Study|Death (Study Disease)|0|||
130209257|NCT00236899|468727207|FG000|Overall Study|Death (Not Study Related)|2|||
130209258|NCT00236899|468727208|FG001|Overall Study|Death (Not Study Related)|0|||
130209259|NCT00236899|468727209|FG002|Overall Study|Death (Not Study Related)|0|||
130209260|NCT00236899|468727210|FG003|Overall Study|Death (Not Study Related)|0|||
130209261|NCT00236899|468727207|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
130209262|NCT00236899|468727208|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
130209263|NCT00236899|468727209|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
130209264|NCT00236899|468727210|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
130209265|NCT00236899|468727207|FG000|Overall Study|Lost to Follow-up|0|||
130209266|NCT00236899|468727208|FG001|Overall Study|Lost to Follow-up|1|||
130209267|NCT00236899|468727209|FG002|Overall Study|Lost to Follow-up|0|||
130209268|NCT00236899|468727210|FG003|Overall Study|Lost to Follow-up|0|||
130209269|NCT00236899|468727207|FG000|Overall Study|Entry Criteria Exclusion|0|||
130209270|NCT00236899|468727208|FG001|Overall Study|Entry Criteria Exclusion|1|||
130209271|NCT00236899|468727209|FG002|Overall Study|Entry Criteria Exclusion|1|||
130209272|NCT00236899|468727210|FG003|Overall Study|Entry Criteria Exclusion|0|||
130209273|NCT00236899|468727207|FG000|Overall Study|Protocol Violation|1|||
130209274|NCT00236899|468727208|FG001|Overall Study|Protocol Violation|0|||
130209275|NCT00236899|468727209|FG002|Overall Study|Protocol Violation|0|||
130209276|NCT00236899|468727210|FG003|Overall Study|Protocol Violation|0|||
130209277|NCT00236899|468727207|FG000|Overall Study|Withdrawal by Subject|6|||
130209278|NCT00236899|468727208|FG001|Overall Study|Withdrawal by Subject|4|||
130209279|NCT00236899|468727209|FG002|Overall Study|Withdrawal by Subject|5|||
130209280|NCT00236899|468727210|FG003|Overall Study|Withdrawal by Subject|2|||
130209281|NCT00236899|468727207|FG000|Overall Study|Physician Decision|7|||
130209282|NCT00236899|468727208|FG001|Overall Study|Physician Decision|8|||
130209283|NCT00236899|468727209|FG002|Overall Study|Physician Decision|7|||
130209284|NCT00236899|468727210|FG003|Overall Study|Physician Decision|6|||
130209285|NCT00236899|468727207|FG000|Overall Study|Satisfactory Response|2|||
130209286|NCT00236899|468727208|FG001|Overall Study|Satisfactory Response|0|||
130209287|NCT00236899|468727209|FG002|Overall Study|Satisfactory Response|0|||
130209288|NCT00236899|468727210|FG003|Overall Study|Satisfactory Response|1|||
130209289|NCT00236899|468727207|FG000|Overall Study|Lack of Efficacy|18|||
130209290|NCT00236899|468727208|FG001|Overall Study|Lack of Efficacy|18|||
130209291|NCT00236899|468727209|FG002|Overall Study|Lack of Efficacy|25|||
130209292|NCT00236899|468727210|FG003|Overall Study|Lack of Efficacy|23|||
130209293|NCT03379792|468727211|FG000|Overall Study|Physician Decision|0|||
130209294|NCT03379792|468727212|FG001|Overall Study|Physician Decision|0|||
130209295|NCT03379792|468727213|FG002|Overall Study|Physician Decision|0|||
130209296|NCT03379792|468727214|FG003|Overall Study|Physician Decision|1|||
130209297|NCT03379792|468727215|FG004|Overall Study|Physician Decision|0|||
130209298|NCT03379792|468727216|FG005|Overall Study|Physician Decision|0|||
130209299|NCT03379792|468727211|FG000|Overall Study|Withdrawal by Subject|0|||
130209300|NCT03379792|468727212|FG001|Overall Study|Withdrawal by Subject|0|||
130209301|NCT03379792|468727213|FG002|Overall Study|Withdrawal by Subject|0|||
130209302|NCT03379792|468727214|FG003|Overall Study|Withdrawal by Subject|0|||
130209303|NCT03379792|468727215|FG004|Overall Study|Withdrawal by Subject|1|||
130209304|NCT03379792|468727216|FG005|Overall Study|Withdrawal by Subject|1|||
130209305|NCT02854605|468727219|FG000|Overall Study|Adverse Event|1|||
130209306|NCT02854605|468727220|FG001|Overall Study|Adverse Event|5|||
130209307|NCT02854605|468727221|FG002|Overall Study|Adverse Event|2|||
130209308|NCT02854605|468727219|FG000|Overall Study|Lost to Follow-up|0|||
130430512|NCT02696564|469537713|FG000|Overall Study|Withdrawal by Subject|3|||
130430513|NCT02696564|469537714|FG001|Overall Study|Withdrawal by Subject|2|||
130430514|NCT02696564|469537713|FG000|Overall Study|Lost to Follow-up|3|||
130430515|NCT02696564|469537714|FG001|Overall Study|Lost to Follow-up|3|||
130430516|NCT02696564|469537713|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
130430517|NCT02696564|469537714|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
130430518|NCT02696564|469537713|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
130430519|NCT02696564|469537714|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
130430520|NCT02696564|469537713|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
130430521|NCT02696564|469537714|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
130430522|NCT02696564|469537713|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
130430523|NCT02696564|469537714|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
130430524|NCT02696564|469537713|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
130430525|NCT02696564|469537714|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
130430526|NCT01337986|469537715|FG000|Overall Study|Adverse Event|2|||
130430527|NCT01337986|469537716|FG001|Overall Study|Adverse Event|2|||
130430528|NCT01337986|469537715|FG000|Overall Study|Lost to Follow-up|1|||
130430529|NCT01337986|469537716|FG001|Overall Study|Lost to Follow-up|0|||
130430530|NCT01337986|469537715|FG000|Overall Study|Protocol Violation|0|||
130430531|NCT01337986|469537716|FG001|Overall Study|Protocol Violation|3|||
130430532|NCT01520402|469537717|FG000|Overall Study|Withdrawal by Subject|2|||
130430533|NCT01520402|469537717|FG000|Overall Study|Physician Decision|3|||
130430534|NCT01722162|469537719|FG000|Overall Study|Withdrawal by Subject|1|||
130430535|NCT01722162|469537720|FG001|Overall Study|Withdrawal by Subject|1|||
130430536|NCT01722162|469537719|FG000|Overall Study|Found ineligible|1|||
130430537|NCT01722162|469537720|FG001|Overall Study|Found ineligible|0|||
130430538|NCT01722162|469537719|FG000|Overall Study|Unrelated to study adverse event|2|||
130430539|NCT01722162|469537720|FG001|Overall Study|Unrelated to study adverse event|2|||
130430540|NCT01722162|469537719|FG000|Overall Study|Adverse Event|1|||
130430541|NCT01722162|469537720|FG001|Overall Study|Adverse Event|1|||
130430542|NCT01722162|469537719|FG000|Overall Study|Insurance denial post enrollment|0|||
130430543|NCT01722162|469537720|FG001|Overall Study|Insurance denial post enrollment|1|||
130430544|NCT01722162|469537719|FG000|Overall Study|Noncompliance|0|||
130430545|NCT01722162|469537720|FG001|Overall Study|Noncompliance|1|||
130430546|NCT03124199|469537721|FG000|Overall Study|Lost to Follow-up|4|||
130430547|NCT03170375|469537722|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
130430548|NCT03170375|469537723|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
130430549|NCT03170375|469537724|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
130543377|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
130543378|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
130543379|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
130543380|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
130543381|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
130543382|NCT01160289|469956705|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
130543383|NCT01160289|469956706|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
130543384|NCT01160289|469956707|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
130654504|NCT03557775|470357644|FG001|Overall Study|Physician Decision|1|||
130654505|NCT03557775|470357645|FG002|Overall Study|Physician Decision|0|||
130654506|NCT03426995|470357646|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130209309|NCT02854605|468727220|FG001|Overall Study|Lost to Follow-up|2|||
130209310|NCT02854605|468727221|FG002|Overall Study|Lost to Follow-up|0|||
130209311|NCT02854605|468727219|FG000|Overall Study|Withdrew Consent|1|||
130209312|NCT02854605|468727220|FG001|Overall Study|Withdrew Consent|0|||
130654507|NCT03426995|470357647|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654508|NCT03426995|470357648|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
130654509|NCT03426995|470357649|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654510|NCT03426995|470357650|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654511|NCT03426995|470357651|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654512|NCT03426995|470357652|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654513|NCT03426995|470357653|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654514|NCT03426995|470357654|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654515|NCT03426995|470357655|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654516|NCT03426995|470357656|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654517|NCT03426995|470357657|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654518|NCT03426995|470357658|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130543385|NCT01160289|469956708|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
130543386|NCT01160289|469956709|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
130543387|NCT01160289|469956710|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
130543388|NCT01160289|469956705|FG000|Post-Randomization Period|Adverse Event|0|||
130543389|NCT01160289|469956706|FG001|Post-Randomization Period|Adverse Event|4|||
130543390|NCT01160289|469956707|FG002|Post-Randomization Period|Adverse Event|4|||
130543391|NCT01160289|469956708|FG003|Post-Randomization Period|Adverse Event|2|||
130543392|NCT01160289|469956709|FG004|Post-Randomization Period|Adverse Event|0|||
130543393|NCT01160289|469956710|FG005|Post-Randomization Period|Adverse Event|0|||
130543394|NCT01160289|469956705|FG000|Post-Randomization Period|Death|0|||
130543395|NCT01160289|469956706|FG001|Post-Randomization Period|Death|0|||
130543396|NCT01160289|469956707|FG002|Post-Randomization Period|Death|0|||
130543397|NCT01160289|469956708|FG003|Post-Randomization Period|Death|1|||
130543398|NCT01160289|469956709|FG004|Post-Randomization Period|Death|0|||
130543399|NCT01160289|469956710|FG005|Post-Randomization Period|Death|0|||
130543400|NCT01160289|469956705|FG000|Post-Randomization Period|Lack of Efficacy|0|||
130543401|NCT01160289|469956706|FG001|Post-Randomization Period|Lack of Efficacy|1|||
130543402|NCT01160289|469956707|FG002|Post-Randomization Period|Lack of Efficacy|0|||
130543403|NCT01160289|469956708|FG003|Post-Randomization Period|Lack of Efficacy|3|||
130543404|NCT01160289|469956709|FG004|Post-Randomization Period|Lack of Efficacy|0|||
130543405|NCT01160289|469956710|FG005|Post-Randomization Period|Lack of Efficacy|0|||
130543406|NCT01160289|469956705|FG000|Post-Randomization Period|Lost to Follow-up|0|||
130543407|NCT01160289|469956706|FG001|Post-Randomization Period|Lost to Follow-up|3|||
130543408|NCT01160289|469956707|FG002|Post-Randomization Period|Lost to Follow-up|2|||
130543409|NCT01160289|469956708|FG003|Post-Randomization Period|Lost to Follow-up|5|||
130543410|NCT01160289|469956709|FG004|Post-Randomization Period|Lost to Follow-up|3|||
130543411|NCT01160289|469956710|FG005|Post-Randomization Period|Lost to Follow-up|4|||
130543412|NCT01160289|469956705|FG000|Post-Randomization Period|Physician Decision|0|||
130543413|NCT01160289|469956706|FG001|Post-Randomization Period|Physician Decision|0|||
130543414|NCT01160289|469956707|FG002|Post-Randomization Period|Physician Decision|1|||
130543415|NCT01160289|469956708|FG003|Post-Randomization Period|Physician Decision|0|||
130543416|NCT01160289|469956709|FG004|Post-Randomization Period|Physician Decision|0|||
130543417|NCT01160289|469956710|FG005|Post-Randomization Period|Physician Decision|0|||
130543418|NCT01160289|469956705|FG000|Post-Randomization Period|Protocol Violation|0|||
130543419|NCT01160289|469956706|FG001|Post-Randomization Period|Protocol Violation|4|||
130543420|NCT01160289|469956707|FG002|Post-Randomization Period|Protocol Violation|2|||
130543421|NCT01160289|469956708|FG003|Post-Randomization Period|Protocol Violation|0|||
130543422|NCT01160289|469956709|FG004|Post-Randomization Period|Protocol Violation|1|||
130543423|NCT01160289|469956710|FG005|Post-Randomization Period|Protocol Violation|3|||
130543424|NCT01160289|469956705|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
130543425|NCT01160289|469956706|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
130543426|NCT01160289|469956707|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
130543427|NCT01160289|469956708|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
130543428|NCT01160289|469956709|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
130543429|NCT01160289|469956710|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
130543430|NCT01160289|469956705|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
130543431|NCT01160289|469956706|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
130543432|NCT01160289|469956707|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
130543433|NCT01160289|469956708|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
130543434|NCT01160289|469956709|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
130543435|NCT01160289|469956710|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
130543436|NCT01160289|469956705|FG000|Post-Randomization Period|Sponsor Decision|0|||
130543437|NCT01160289|469956706|FG001|Post-Randomization Period|Sponsor Decision|1|||
130543438|NCT01160289|469956707|FG002|Post-Randomization Period|Sponsor Decision|0|||
130559398|NCT01621542|470016494|FG004|Overall Study|Adverse Event|0|||
130543439|NCT01160289|469956708|FG003|Post-Randomization Period|Sponsor Decision|0|||
130543440|NCT01160289|469956709|FG004|Post-Randomization Period|Sponsor Decision|0|||
130543441|NCT01160289|469956710|FG005|Post-Randomization Period|Sponsor Decision|0|||
130543442|NCT01156792|469956712|FG000|Overall Study|Adverse Event|1|||
130543443|NCT01156792|469956712|FG000|Overall Study|Lack of Efficacy|36|||
130543444|NCT01156792|469956712|FG000|Overall Study|Protocol Violation|6|||
130543445|NCT01156792|469956712|FG000|Overall Study|Lost to Follow-up|3|||
130543446|NCT01156792|469956712|FG000|Overall Study|Physician Decision|3|||
130543447|NCT01156792|469956712|FG000|Overall Study|Withdrawal by Subject|9|||
130543448|NCT01156792|469956712|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
130543449|NCT01474434|469956713|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
130543450|NCT01474434|469956714|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
130543451|NCT01474434|469956715|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
130543452|NCT01474434|469956716|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
130543453|NCT01474434|469956713|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
130543454|NCT01474434|469956714|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
130559399|NCT01621542|470016495|FG005|Overall Study|Adverse Event|0|||
130543455|NCT01474434|469956715|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
130543456|NCT01474434|469956716|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
130543457|NCT01474434|469956713|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
130543458|NCT01474434|469956714|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
130543459|NCT01474434|469956715|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
130543460|NCT01474434|469956716|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
130543461|NCT00993668|469956717|FG000|Single-Blind Period|Adverse Event|1|||
130543462|NCT00993668|469956718|FG001|Single-Blind Period|Adverse Event|1|||
130543463|NCT00993668|469956717|FG000|Single-Blind Period|Lack of Efficacy|0|||
130543464|NCT00993668|469956718|FG001|Single-Blind Period|Lack of Efficacy|1|||
130543465|NCT00993668|469956717|FG000|Single-Blind Period|Lost to Follow-up|3|||
130543466|NCT00993668|469956718|FG001|Single-Blind Period|Lost to Follow-up|1|||
130543467|NCT00993668|469956717|FG000|Open-Label Period|Adverse Event|9|||
130543468|NCT00993668|469956718|FG001|Open-Label Period|Adverse Event|8|||
130543469|NCT00993668|469956717|FG000|Open-Label Period|Lack of Efficacy|4|||
130543470|NCT00993668|469956718|FG001|Open-Label Period|Lack of Efficacy|3|||
130543471|NCT00993668|469956717|FG000|Open-Label Period|Withdrawal by Subject|4|||
130543472|NCT00993668|469956718|FG001|Open-Label Period|Withdrawal by Subject|3|||
130543473|NCT00993668|469956717|FG000|Open-Label Period|Lost to Follow-up|6|||
130543474|NCT00993668|469956718|FG001|Open-Label Period|Lost to Follow-up|1|||
130543475|NCT03606668|469956721|FG000|Overall Study|Screen Failure|1|||
130543476|NCT03606668|469956721|FG000|Overall Study|Lost to Follow-up|1|||
130543477|NCT02057523|469956725|FG000|Overall Study|Withdrawal by Subject|1|||
130543478|NCT02057523|469956725|FG000|Overall Study|Lack of Efficacy|1|||
130209313|NCT02854605|468727221|FG002|Overall Study|Withdrew Consent|1|||
130320276|NCT00374140|469141882|FG000|Overall Study|Protocol Violation|1|||
130209314|NCT02854605|468727219|FG000|Overall Study|Investigator's Discretion|1|||
130209315|NCT02854605|468727220|FG001|Overall Study|Investigator's Discretion|0|||
130209316|NCT02854605|468727221|FG002|Overall Study|Investigator's Discretion|0|||
130209317|NCT02854605|468727219|FG000|Overall Study|Protocol Violation|0|||
130209318|NCT02854605|468727220|FG001|Overall Study|Protocol Violation|0|||
130209319|NCT02854605|468727221|FG002|Overall Study|Protocol Violation|1|||
130209320|NCT01897571|468727224|FG000|Overall Study|Lost to Follow-up|3|||
130209321|NCT01897571|468727225|FG001|Overall Study|Lost to Follow-up|0|||
130209322|NCT01897571|468727226|FG002|Overall Study|Lost to Follow-up|0|||
130209323|NCT01897571|468727227|FG003|Overall Study|Lost to Follow-up|0|||
130209324|NCT01897571|468727228|FG004|Overall Study|Lost to Follow-up|2|||
130209325|NCT01897571|468727229|FG005|Overall Study|Lost to Follow-up|0|||
130209326|NCT01897571|468727230|FG006|Overall Study|Lost to Follow-up|0|||
130209327|NCT01897571|468727231|FG007|Overall Study|Lost to Follow-up|0|||
130209328|NCT01897571|468727232|FG008|Overall Study|Lost to Follow-up|1|||
130209329|NCT01897571|468727233|FG009|Overall Study|Lost to Follow-up|2|||
130209330|NCT01897571|468727234|FG010|Overall Study|Lost to Follow-up|4|||
130209331|NCT01897571|468727224|FG000|Overall Study|Withdrawal by Subject|0|||
130209332|NCT01897571|468727225|FG001|Overall Study|Withdrawal by Subject|0|||
130209333|NCT01897571|468727226|FG002|Overall Study|Withdrawal by Subject|0|||
130209334|NCT01897571|468727227|FG003|Overall Study|Withdrawal by Subject|0|||
130209335|NCT01897571|468727228|FG004|Overall Study|Withdrawal by Subject|0|||
130209336|NCT01897571|468727229|FG005|Overall Study|Withdrawal by Subject|0|||
130209337|NCT01897571|468727230|FG006|Overall Study|Withdrawal by Subject|0|||
130209338|NCT01897571|468727231|FG007|Overall Study|Withdrawal by Subject|1|||
130209339|NCT01897571|468727232|FG008|Overall Study|Withdrawal by Subject|4|||
130209340|NCT01897571|468727233|FG009|Overall Study|Withdrawal by Subject|3|||
130209341|NCT01897571|468727234|FG010|Overall Study|Withdrawal by Subject|1|||
130209342|NCT01897571|468727224|FG000|Overall Study|Other|1|||
130209343|NCT01897571|468727225|FG001|Overall Study|Other|0|||
130209344|NCT01897571|468727226|FG002|Overall Study|Other|0|||
130209345|NCT01897571|468727227|FG003|Overall Study|Other|3|||
130209346|NCT01897571|468727228|FG004|Overall Study|Other|3|||
130209347|NCT01897571|468727229|FG005|Overall Study|Other|4|||
130209348|NCT01897571|468727230|FG006|Overall Study|Other|7|||
130209349|NCT01897571|468727231|FG007|Overall Study|Other|0|||
130209350|NCT01897571|468727232|FG008|Overall Study|Other|0|||
130209351|NCT01897571|468727233|FG009|Overall Study|Other|0|||
130209352|NCT01897571|468727234|FG010|Overall Study|Other|0|||
130209353|NCT01897571|468727224|FG000|Overall Study|Enrolled in rollover study|0|||
130209354|NCT01897571|468727225|FG001|Overall Study|Enrolled in rollover study|0|||
130209355|NCT01897571|468727226|FG002|Overall Study|Enrolled in rollover study|0|||
130209356|NCT01897571|468727227|FG003|Overall Study|Enrolled in rollover study|0|||
130209357|NCT01897571|468727228|FG004|Overall Study|Enrolled in rollover study|0|||
130209358|NCT01897571|468727229|FG005|Overall Study|Enrolled in rollover study|0|||
130209359|NCT01897571|468727230|FG006|Overall Study|Enrolled in rollover study|0|||
130209360|NCT01897571|468727231|FG007|Overall Study|Enrolled in rollover study|9|||
130209361|NCT01897571|468727232|FG008|Overall Study|Enrolled in rollover study|7|||
130209362|NCT01897571|468727233|FG009|Overall Study|Enrolled in rollover study|9|||
130209363|NCT01897571|468727234|FG010|Overall Study|Enrolled in rollover study|1|||
130209364|NCT01897571|468727224|FG000|Overall Study|Death|2|||
130209365|NCT01897571|468727225|FG001|Overall Study|Death|2|||
130209366|NCT01897571|468727226|FG002|Overall Study|Death|3|||
130209367|NCT01897571|468727227|FG003|Overall Study|Death|6|||
130209368|NCT01897571|468727228|FG004|Overall Study|Death|7|||
130209369|NCT01897571|468727229|FG005|Overall Study|Death|9|||
130209370|NCT01897571|468727230|FG006|Overall Study|Death|5|||
130209371|NCT01897571|468727231|FG007|Overall Study|Death|22|||
130209372|NCT01897571|468727232|FG008|Overall Study|Death|23|||
130209373|NCT01897571|468727233|FG009|Overall Study|Death|129|||
130209374|NCT01897571|468727234|FG010|Overall Study|Death|59|||
130209375|NCT00089635|468727236|FG000|Overall Study|Adverse Event|2|||
130209376|NCT00089635|468727236|FG000|Overall Study|Death|17|||
130209377|NCT00089635|468727236|FG000|Overall Study|Disease Progression|12|||
130209378|NCT00089635|468727236|FG000|Overall Study|Lost to Follow-up|3|||
130209379|NCT00089635|468727236|FG000|Overall Study|Withdrawal by Subject|6|||
130209380|NCT00089635|468727236|FG000|Overall Study|Ineligibility determined|1|||
130209381|NCT00089635|468727236|FG000|Overall Study|Other|2|||
130209382|NCT02943785|468727238|FG000|Overall Study|Adverse Event|112|||
130209383|NCT02943785|468727239|FG001|Overall Study|Adverse Event|97|||
130209384|NCT02943785|468727238|FG000|Overall Study|Withdrawal by Subject|63|||
130209385|NCT02943785|468727239|FG001|Overall Study|Withdrawal by Subject|126|||
130209386|NCT02943785|468727238|FG000|Overall Study|Physician Decision|23|||
130209387|NCT02943785|468727239|FG001|Overall Study|Physician Decision|47|||
130209388|NCT02943785|468727238|FG000|Overall Study|Death|46|||
130209389|NCT02943785|468727239|FG001|Overall Study|Death|46|||
130209390|NCT02943785|468727238|FG000|Overall Study|Lost to Follow-up|1|||
130209391|NCT02943785|468727239|FG001|Overall Study|Lost to Follow-up|0|||
130209392|NCT02943785|468727238|FG000|Overall Study|Other|16|||
130209393|NCT02943785|468727239|FG001|Overall Study|Other|19|||
130209394|NCT02943785|468727238|FG000|Overall Study|Did not receive any study medication|21|||
130209395|NCT02943785|468727239|FG001|Overall Study|Did not receive any study medication|28|||
130209396|NCT00821015|468727242|FG000|Overall Study|Lost to Follow-up|12|||
130209397|NCT03170609|468727243|FG000|Overall Study|Death|0|||
130209398|NCT03170609|468727244|FG001|Overall Study|Death|0|||
130209399|NCT03170609|468727245|FG002|Overall Study|Death|1|||
130209400|NCT03170609|468727246|FG003|Overall Study|Death|0|||
130209401|NCT03170609|468727247|FG004|Overall Study|Death|0|||
130209402|NCT03170609|468727248|FG005|Overall Study|Death|0|||
130209403|NCT03170609|468727249|FG006|Overall Study|Death|0|||
130209404|NCT03170609|468727243|FG000|Overall Study|Withdrawal by Subject|1|||
130209405|NCT03170609|468727244|FG001|Overall Study|Withdrawal by Subject|2|||
130209406|NCT03170609|468727245|FG002|Overall Study|Withdrawal by Subject|0|||
130209407|NCT03170609|468727246|FG003|Overall Study|Withdrawal by Subject|0|||
130209408|NCT03170609|468727247|FG004|Overall Study|Withdrawal by Subject|0|||
130209409|NCT03170609|468727248|FG005|Overall Study|Withdrawal by Subject|0|||
130209410|NCT03170609|468727249|FG006|Overall Study|Withdrawal by Subject|1|||
130209411|NCT03170609|468727243|FG000|Overall Study|Lost to Follow-up|1|||
130209412|NCT03170609|468727244|FG001|Overall Study|Lost to Follow-up|0|||
130209413|NCT03170609|468727245|FG002|Overall Study|Lost to Follow-up|5|||
130209414|NCT03170609|468727246|FG003|Overall Study|Lost to Follow-up|2|||
130209415|NCT03170609|468727247|FG004|Overall Study|Lost to Follow-up|1|||
130209416|NCT03170609|468727248|FG005|Overall Study|Lost to Follow-up|1|||
130209417|NCT03170609|468727249|FG006|Overall Study|Lost to Follow-up|0|||
130209418|NCT03170609|468727243|FG000|Overall Study|Other|1|||
130209419|NCT03170609|468727244|FG001|Overall Study|Other|0|||
130209420|NCT03170609|468727245|FG002|Overall Study|Other|0|||
130209421|NCT03170609|468727246|FG003|Overall Study|Other|0|||
130209422|NCT03170609|468727247|FG004|Overall Study|Other|0|||
130209423|NCT03170609|468727248|FG005|Overall Study|Other|1|||
130209424|NCT03170609|468727249|FG006|Overall Study|Other|0|||
130209425|NCT01281956|468727250|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
130209426|NCT01281956|468727251|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
130209427|NCT01857102|468727264|FG000|Period 1|No longer meets Eligibility Criteria|0|||
130209428|NCT01857102|468727265|FG001|Period 1|No longer meets Eligibility Criteria|2|||
130209429|NCT01857102|468727264|FG000|Period 1|Lost to Follow-up|0|||
130209430|NCT01857102|468727265|FG001|Period 1|Lost to Follow-up|3|||
130209431|NCT01857102|468727264|FG000|Period 1|Unsatisfactory Lens Fit|1|||
130209432|NCT01857102|468727265|FG001|Period 1|Unsatisfactory Lens Fit|0|||
130209433|NCT01857102|468727264|FG000|Period 1|Unsatisfactory Visual Response|1|||
130209434|NCT01857102|468727265|FG001|Period 1|Unsatisfactory Visual Response|0|||
130209435|NCT01857102|468727264|FG000|Period 1|Physician Decision|1|||
130209436|NCT01857102|468727265|FG001|Period 1|Physician Decision|0|||
130209437|NCT01857102|468727264|FG000|Period 2|Lens Discomfort|1|||
130209438|NCT01857102|468727265|FG001|Period 2|Lens Discomfort|0|||
130209439|NCT01857102|468727264|FG000|Period 2|Unsatisfactory Lens Fit|1|||
130209440|NCT01857102|468727265|FG001|Period 2|Unsatisfactory Lens Fit|0|||
130209441|NCT01490697|468727266|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
130209442|NCT01490697|468727267|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
130209443|NCT00090584|468727268|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
130209444|NCT00090584|468727269|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
130209445|NCT00090584|468727268|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
130209446|NCT00090584|468727269|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
130209447|NCT02117713|468727278|FG000|Week 48|Adverse Event|4|||
130209448|NCT02117713|468727278|FG000|Week 48|Withdrawal by caregiver|2|||
130209449|NCT02117713|468727278|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
130209450|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
130209451|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
130209452|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
130209453|NCT02028169|468727280|FG000|Overall Study|Lost to Follow-up|21|||
130430550|NCT03170375|469537722|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
130209454|NCT02028169|468727280|FG000|Overall Study|Lack of Efficacy|2|||
130209455|NCT02028169|468727280|FG000|Overall Study|Withdrawal by Subject|2|||
130209456|NCT02028169|468727280|FG000|Overall Study|Adverse Event|1|||
130209457|NCT02028169|468727280|FG000|Overall Study|Cessation of Drug|1|||
130209458|NCT02028169|468727280|FG000|Overall Study|Concomitant Medication Usage|1|||
130209459|NCT04907227|468727281|FG000|Overall Study|Death|12|||
130209460|NCT04907227|468727282|FG001|Overall Study|Death|8|||
130209461|NCT04907227|468727281|FG000|Overall Study|Withdrawal by Subject|2|||
130209462|NCT04907227|468727282|FG001|Overall Study|Withdrawal by Subject|2|||
130209463|NCT04907227|468727281|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
130209464|NCT04907227|468727282|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130209465|NCT04907227|468727281|FG000|Overall Study|Sponsor Decision|25|||
130209466|NCT04907227|468727282|FG001|Overall Study|Sponsor Decision|30|||
130209467|NCT04907227|468727281|FG000|Overall Study|Physician Decision|1|||
130209468|NCT04907227|468727282|FG001|Overall Study|Physician Decision|0|||
130209469|NCT02208050|468727283|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
130209470|NCT02208050|468727284|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
130209471|NCT00432276|468727286|FG000|Overall Study|Hyperglycemic Rescue|44|||
130209472|NCT00432276|468727287|FG001|Overall Study|Hyperglycemic Rescue|87|||
130209473|NCT00432276|468727286|FG000|Overall Study|Adverse Event|13|||
130209474|NCT00432276|468727287|FG001|Overall Study|Adverse Event|16|||
130209475|NCT00432276|468727286|FG000|Overall Study|Protocol Violation|25|||
130209476|NCT00432276|468727287|FG001|Overall Study|Protocol Violation|20|||
130209477|NCT00432276|468727286|FG000|Overall Study|Lost to Follow-up|6|||
130209478|NCT00432276|468727287|FG001|Overall Study|Lost to Follow-up|2|||
130209479|NCT00432276|468727286|FG000|Overall Study|Withdrawal by Subject|25|||
130209480|NCT00432276|468727287|FG001|Overall Study|Withdrawal by Subject|20|||
130209481|NCT00432276|468727286|FG000|Overall Study|Physician Decision|6|||
130209482|NCT00432276|468727287|FG001|Overall Study|Physician Decision|8|||
130209483|NCT00432276|468727286|FG000|Overall Study|Other|2|||
130209484|NCT00432276|468727287|FG001|Overall Study|Other|3|||
130209485|NCT00467961|468727288|FG000|Overall Study|Technical Failures|5|||
130209486|NCT00467961|468727288|FG000|Overall Study|Disease Progression|2|||
130209487|NCT05249127|468727289|FG000|Overall Study|Protocol Violation|13|||
130209488|NCT05249127|468727289|FG000|Overall Study|Physician Decision|4|||
130209489|NCT05249127|468727289|FG000|Overall Study|Withdrawal by Subject|2|||
130209490|NCT05249127|468727289|FG000|Overall Study|Participant Non-compliance|1|||
130209491|NCT02073565|468727291|FG000|Cohort A|Withdrawal by Subject|1|||
130209492|NCT02073565|468727292|FG001|Cohort A|Withdrawal by Subject|0|||
130209493|NCT02073565|468727291|FG000|Cohort B|Withdrawal by Subject|1|||
130209494|NCT02073565|468727292|FG001|Cohort B|Withdrawal by Subject|2|||
130209495|NCT02073565|468727291|FG000|Cohort C|Withdrawal by Subject|0|||
130209496|NCT02073565|468727292|FG001|Cohort C|Withdrawal by Subject|2|||
130209497|NCT02073565|468727291|FG000|Cohort C|Lost to Follow-up|0|||
130209498|NCT02073565|468727292|FG001|Cohort C|Lost to Follow-up|2|||
130209499|NCT03168919|468727295|FG000|Overall Study|Withdrawal by Subject|2|||
130209500|NCT01085136|468727296|FG000|Part A|Other Adverse event|223|||
130209501|NCT01085136|468727297|FG001|Part A|Other Adverse event|0|||
130209502|NCT01085136|468727298|FG002|Part A|Other Adverse event|0|||
130209503|NCT01085136|468727296|FG000|Part A|Protocol Violation|3|||
130209504|NCT01085136|468727297|FG001|Part A|Protocol Violation|0|||
130209505|NCT01085136|468727298|FG002|Part A|Protocol Violation|0|||
130209506|NCT01085136|468727296|FG000|Part A|Lost to Follow-up|3|||
130209507|NCT01085136|468727297|FG001|Part A|Lost to Follow-up|0|||
130209508|NCT01085136|468727298|FG002|Part A|Lost to Follow-up|0|||
130209509|NCT01085136|468727296|FG000|Part A|Refusal to continue trial medication|64|||
130209510|NCT01085136|468727297|FG001|Part A|Refusal to continue trial medication|0|||
130209511|NCT01085136|468727298|FG002|Part A|Refusal to continue trial medication|0|||
130209512|NCT01085136|468727296|FG000|Part A|Other reason not defined above|30|||
130209513|NCT01085136|468727297|FG001|Part A|Other reason not defined above|0|||
130209514|NCT01085136|468727298|FG002|Part A|Other reason not defined above|0|||
130209515|NCT01085136|468727296|FG000|Part B|Other AE|0|||
130209516|NCT01085136|468727297|FG001|Part B|Other AE|29|||
130209517|NCT01085136|468727298|FG002|Part B|Other AE|8|||
130209518|NCT01085136|468727296|FG000|Part B|Refusal to continue trial medication|0|||
130209519|NCT01085136|468727297|FG001|Part B|Refusal to continue trial medication|12|||
130209520|NCT01085136|468727298|FG002|Part B|Refusal to continue trial medication|7|||
130209521|NCT01085136|468727296|FG000|Part B|Not treated|0|||
130209522|NCT01085136|468727297|FG001|Part B|Not treated|4|||
130209523|NCT01085136|468727298|FG002|Part B|Not treated|8|||
130430551|NCT03170375|469537723|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
130209524|NCT01085136|468727296|FG000|Part B|Other reason not defined above|0|||
130209525|NCT01085136|468727297|FG001|Part B|Other reason not defined above|6|||
130209526|NCT01085136|468727298|FG002|Part B|Other reason not defined above|3|||
130209527|NCT02678000|468727300|FG000|PART 2|Adverse Event|0|||
130209528|NCT02678000|468727301|FG001|PART 2|Adverse Event|0|||
130209529|NCT02678000|468727302|FG002|PART 2|Adverse Event|2|||
130209530|NCT02678000|468727303|FG003|PART 2|Adverse Event|1|||
130209531|NCT02678000|468727304|FG004|PART 2|Adverse Event|0|||
130209532|NCT02678000|468727300|FG000|PART 2|Withdrawal by Subject|0|||
130209533|NCT02678000|468727301|FG001|PART 2|Withdrawal by Subject|0|||
130209534|NCT02678000|468727302|FG002|PART 2|Withdrawal by Subject|1|||
130209535|NCT02678000|468727303|FG003|PART 2|Withdrawal by Subject|0|||
130209536|NCT02678000|468727304|FG004|PART 2|Withdrawal by Subject|0|||
130209537|NCT02360475|468727306|FG000|Overall Study|Lost to Follow-up|4|||
130209538|NCT02360475|468727307|FG001|Overall Study|Lost to Follow-up|12|||
130209539|NCT02360475|468727308|FG002|Overall Study|Lost to Follow-up|6|||
130209540|NCT02360475|468727309|FG003|Overall Study|Lost to Follow-up|4|||
130209541|NCT02360475|468727306|FG000|Overall Study|Withdrawal by Subject|0|||
130209542|NCT02360475|468727307|FG001|Overall Study|Withdrawal by Subject|1|||
130209543|NCT02360475|468727308|FG002|Overall Study|Withdrawal by Subject|2|||
130209544|NCT02360475|468727309|FG003|Overall Study|Withdrawal by Subject|0|||
130209545|NCT02360475|468727306|FG000|Overall Study|Migrated/moved from study area|0|||
130209546|NCT02360475|468727307|FG001|Overall Study|Migrated/moved from study area|0|||
130209547|NCT02360475|468727308|FG002|Overall Study|Migrated/moved from study area|0|||
130209548|NCT02360475|468727309|FG003|Overall Study|Migrated/moved from study area|1|||
130209549|NCT03759366|468727311|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
130209550|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
130209551|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
130209552|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
130209553|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
130209554|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
130209555|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
130209556|NCT04226495|468727312|FG000|Overall Study|Withdrawal by Subject|3|||
130209557|NCT04226495|468727313|FG001|Overall Study|Withdrawal by Subject|3|||
130209558|NCT04226495|468727312|FG000|Overall Study|PI discretion|3|||
130209559|NCT04226495|468727313|FG001|Overall Study|PI discretion|4|||
130209560|NCT00539032|468727314|FG000|Overall Study|Withdrawal by Subject|2|||
130209561|NCT00539032|468727315|FG001|Overall Study|Withdrawal by Subject|1|||
130209562|NCT01210352|468727316|FG000|Overall Study|Adverse Event|0|||
130209563|NCT01210352|468727317|FG001|Overall Study|Adverse Event|0|||
130209564|NCT01210352|468727318|FG002|Overall Study|Adverse Event|0|||
130209565|NCT01210352|468727319|FG003|Overall Study|Adverse Event|0|||
130430552|NCT03170375|469537724|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
130466708|NCT04922021|469676352|FG001|Overall Study|Multiple reasons|0|||
130209566|NCT01210352|468727320|FG004|Overall Study|Adverse Event|0|||
130209567|NCT01210352|468727321|FG005|Overall Study|Adverse Event|0|||
130430553|NCT00763958|469537727|FG000|Overall Study|did not meet final criteria|4|||
130430554|NCT00763958|469537728|FG001|Overall Study|did not meet final criteria|4|||
130430555|NCT00763958|469537727|FG000|Overall Study|Lost to Follow-up|10|||
130430556|NCT00763958|469537728|FG001|Overall Study|Lost to Follow-up|2|||
130430557|NCT00763958|469537727|FG000|Overall Study|Believed they were receiving placebo|0|||
130430558|NCT00763958|469537728|FG001|Overall Study|Believed they were receiving placebo|5|||
130430559|NCT02535364|469537736|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
130430560|NCT02535364|469537736|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
130430561|NCT02535364|469537736|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
130430562|NCT02535364|469537736|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
130430563|NCT02535364|469537736|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
130430564|NCT02535364|469537736|FG000|Part B Screening|Death|2|||
130430565|NCT02535364|469537736|FG000|Part B Screening|Physician Decision|1|||
130430566|NCT02535364|469537736|FG000|Part B Screening|Withdrawal by Subject|1|||
130430567|NCT02535364|469537736|FG000|Part B Screening|Adverse Event|1|||
130430568|NCT02535364|469537736|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
130430569|NCT02535364|469537736|FG000|Study Treatment|Death|1|||
130430570|NCT02535364|469537736|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
130430571|NCT02535364|469537736|FG000|12-Month Follow-up Period|Disease progression|22|||
130430572|NCT02535364|469537736|FG000|12-Month Follow-up Period|Death|5|||
130430573|NCT02535364|469537736|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
130430574|NCT02535364|469537736|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
130430575|NCT02535364|469537736|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
130430576|NCT00571701|469537737|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
130430577|NCT00571701|469537738|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
130430578|NCT00571701|469537737|FG000|First Intervention 12 Months|Death|1|||
130430579|NCT00571701|469537738|FG001|First Intervention 12 Months|Death|0|||
130430580|NCT00571701|469537737|FG000|Second Intervention 12 Months|Adverse Event|0|||
130430581|NCT00571701|469537738|FG001|Second Intervention 12 Months|Adverse Event|1|||
130430582|NCT00571701|469537737|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
130430583|NCT00571701|469537738|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
130430584|NCT04766086|469537742|FG000|Overall Study|Lost to Follow-up|3|||
130430585|NCT04766086|469537743|FG001|Overall Study|Lost to Follow-up|5|||
130430586|NCT04766086|469537744|FG002|Overall Study|Lost to Follow-up|3|||
130430587|NCT04766086|469537742|FG000|Overall Study|Withdrawal by Subject|1|||
130430588|NCT04766086|469537743|FG001|Overall Study|Withdrawal by Subject|1|||
130430589|NCT04766086|469537744|FG002|Overall Study|Withdrawal by Subject|2|||
130430590|NCT04766086|469537742|FG000|Overall Study|Other|0|||
130430591|NCT04766086|469537743|FG001|Overall Study|Other|0|||
130430592|NCT04766086|469537744|FG002|Overall Study|Other|1|||
130430593|NCT03815019|469537745|FG000|Overall Study|Withdrawal by Subject|6|||
130430594|NCT03815019|469537746|FG001|Overall Study|Withdrawal by Subject|8|||
130430595|NCT01320943|469537747|FG000|Overall Study|Lost to Follow-up|1|||
130430596|NCT01320943|469537748|FG001|Overall Study|Lost to Follow-up|0|||
130430597|NCT01320943|469537747|FG000|Overall Study|Physician Decision|0|||
130430598|NCT01320943|469537748|FG001|Overall Study|Physician Decision|1|||
130430599|NCT01320943|469537747|FG000|Overall Study|Randomized but not Treated|0|||
130430600|NCT01320943|469537748|FG001|Overall Study|Randomized but not Treated|1|||
130430601|NCT03937219|469537749|FG000|Overall Study|Death|223|||
130430602|NCT03937219|469537750|FG001|Overall Study|Death|211|||
130430603|NCT03937219|469537749|FG000|Overall Study|Withdrawal by Subject|17|||
130430604|NCT03937219|469537750|FG001|Overall Study|Withdrawal by Subject|25|||
130430605|NCT03937219|469537749|FG000|Overall Study|Lost to Follow-up|3|||
130209568|NCT01210352|468727322|FG006|Overall Study|Adverse Event|0|||
130209569|NCT01210352|468727323|FG007|Overall Study|Adverse Event|2|||
130209570|NCT01210352|468727324|FG008|Overall Study|Adverse Event|1|||
130209571|NCT01210352|468727316|FG000|Overall Study|Lack of Efficacy|0|||
130209572|NCT01210352|468727317|FG001|Overall Study|Lack of Efficacy|0|||
130209573|NCT01210352|468727318|FG002|Overall Study|Lack of Efficacy|0|||
130209574|NCT01210352|468727319|FG003|Overall Study|Lack of Efficacy|0|||
130209575|NCT01210352|468727320|FG004|Overall Study|Lack of Efficacy|0|||
130209576|NCT01210352|468727321|FG005|Overall Study|Lack of Efficacy|0|||
130209577|NCT01210352|468727322|FG006|Overall Study|Lack of Efficacy|1|||
130209578|NCT01210352|468727323|FG007|Overall Study|Lack of Efficacy|0|||
130209579|NCT01210352|468727324|FG008|Overall Study|Lack of Efficacy|0|||
130209580|NCT01210352|468727316|FG000|Overall Study|Physician Decision|0|||
130209581|NCT01210352|468727317|FG001|Overall Study|Physician Decision|0|||
130209582|NCT01210352|468727318|FG002|Overall Study|Physician Decision|0|||
130209583|NCT01210352|468727319|FG003|Overall Study|Physician Decision|0|||
130209584|NCT01210352|468727320|FG004|Overall Study|Physician Decision|0|||
130209585|NCT01210352|468727321|FG005|Overall Study|Physician Decision|0|||
130209586|NCT01210352|468727322|FG006|Overall Study|Physician Decision|0|||
130209587|NCT01210352|468727323|FG007|Overall Study|Physician Decision|1|||
130209588|NCT01210352|468727324|FG008|Overall Study|Physician Decision|2|||
130209589|NCT01210352|468727316|FG000|Overall Study|Withdrawal by Subject|0|||
130209590|NCT01210352|468727317|FG001|Overall Study|Withdrawal by Subject|0|||
130209591|NCT01210352|468727318|FG002|Overall Study|Withdrawal by Subject|1|||
130209592|NCT01210352|468727319|FG003|Overall Study|Withdrawal by Subject|0|||
130209593|NCT01210352|468727320|FG004|Overall Study|Withdrawal by Subject|0|||
130209594|NCT01210352|468727321|FG005|Overall Study|Withdrawal by Subject|0|||
130209595|NCT01210352|468727322|FG006|Overall Study|Withdrawal by Subject|1|||
130209596|NCT01210352|468727323|FG007|Overall Study|Withdrawal by Subject|0|||
130209597|NCT01210352|468727324|FG008|Overall Study|Withdrawal by Subject|1|||
130209598|NCT01210352|468727316|FG000|Overall Study|Patient Discharged Early|0|||
130209599|NCT01210352|468727317|FG001|Overall Study|Patient Discharged Early|0|||
130209600|NCT01210352|468727318|FG002|Overall Study|Patient Discharged Early|1|||
130209601|NCT01210352|468727319|FG003|Overall Study|Patient Discharged Early|0|||
130209602|NCT01210352|468727320|FG004|Overall Study|Patient Discharged Early|0|||
130209603|NCT01210352|468727321|FG005|Overall Study|Patient Discharged Early|0|||
130209604|NCT01210352|468727322|FG006|Overall Study|Patient Discharged Early|0|||
130209605|NCT01210352|468727323|FG007|Overall Study|Patient Discharged Early|0|||
130209606|NCT01210352|468727324|FG008|Overall Study|Patient Discharged Early|0|||
130209607|NCT00422292|468727325|FG000|Overall Study|Serious adverse events|1|||
130209608|NCT00422292|468727326|FG001|Overall Study|Serious adverse events|4|||
130209609|NCT00422292|468727327|FG002|Overall Study|Serious adverse events|0|||
130430606|NCT03937219|469537750|FG001|Overall Study|Lost to Follow-up|4|||
130430607|NCT00532155|469537751|FG000|Overall Study|Adverse Event|66|||
130430608|NCT00532155|469537752|FG001|Overall Study|Adverse Event|123|||
130430609|NCT00532155|469537751|FG000|Overall Study|Lack of Efficacy|332|||
130430610|NCT00532155|469537752|FG001|Overall Study|Lack of Efficacy|255|||
130430611|NCT00532155|469537751|FG000|Overall Study|Protocol Violation|1|||
130430612|NCT00532155|469537752|FG001|Overall Study|Protocol Violation|3|||
130430613|NCT00532155|469537751|FG000|Overall Study|Lost to Follow-up|2|||
130430614|NCT00532155|469537752|FG001|Overall Study|Lost to Follow-up|0|||
130430615|NCT00532155|469537751|FG000|Overall Study|Physician Decision|16|||
130430616|NCT00532155|469537752|FG001|Overall Study|Physician Decision|15|||
130430617|NCT00532155|469537751|FG000|Overall Study|Withdrawal by Subject|23|||
130430618|NCT00532155|469537752|FG001|Overall Study|Withdrawal by Subject|44|||
130430619|NCT00532155|469537751|FG000|Overall Study|Consent withdrawn|5|||
130430620|NCT00532155|469537752|FG001|Overall Study|Consent withdrawn|7|||
130430621|NCT00532155|469537751|FG000|Overall Study|Moved|1|||
130209610|NCT00422292|468727328|FG003|Overall Study|Serious adverse events|0|||
130209611|NCT00422292|468727325|FG000|Overall Study|Adverse Event|1|||
130209612|NCT00422292|468727326|FG001|Overall Study|Adverse Event|0|||
130209613|NCT00422292|468727327|FG002|Overall Study|Adverse Event|1|||
130209614|NCT00422292|468727328|FG003|Overall Study|Adverse Event|0|||
130209615|NCT00422292|468727325|FG000|Overall Study|Protocol Violation|4|||
130209616|NCT00422292|468727326|FG001|Overall Study|Protocol Violation|25|||
130209617|NCT00422292|468727327|FG002|Overall Study|Protocol Violation|8|||
130209618|NCT00422292|468727328|FG003|Overall Study|Protocol Violation|5|||
130209619|NCT00422292|468727325|FG000|Overall Study|Lost to Follow-up|6|||
130209620|NCT00422292|468727326|FG001|Overall Study|Lost to Follow-up|12|||
130209621|NCT00422292|468727327|FG002|Overall Study|Lost to Follow-up|6|||
130209622|NCT00422292|468727328|FG003|Overall Study|Lost to Follow-up|6|||
130209623|NCT00422292|468727325|FG000|Overall Study|Withdrawal by Subject|6|||
130209624|NCT00422292|468727326|FG001|Overall Study|Withdrawal by Subject|25|||
130209625|NCT00422292|468727327|FG002|Overall Study|Withdrawal by Subject|7|||
130209626|NCT00422292|468727328|FG003|Overall Study|Withdrawal by Subject|13|||
130430622|NCT00532155|469537752|FG001|Overall Study|Moved|0|||
130430623|NCT00532155|469537751|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
130430624|NCT00532155|469537752|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
130430625|NCT00532155|469537751|FG000|Overall Study|Occurence of a second cancer|0|||
130430626|NCT00532155|469537752|FG001|Overall Study|Occurence of a second cancer|1|||
130430627|NCT00532155|469537751|FG000|Overall Study|Occurence of a secondary cancer|0|||
130430628|NCT00532155|469537752|FG001|Overall Study|Occurence of a secondary cancer|1|||
130430629|NCT00532155|469537751|FG000|Overall Study|Promotor ended study|1|||
130430630|NCT00532155|469537752|FG001|Overall Study|Promotor ended study|0|||
130430631|NCT00532155|469537751|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
130209627|NCT02440854|468727329|FG000|Overall Study|Relocation of patient|1|||
130209628|NCT02440854|468727329|FG000|Overall Study|Death|6|||
130209629|NCT02440854|468727329|FG000|Overall Study|Lost to Follow-up|10|||
130209630|NCT02440854|468727329|FG000|Overall Study|Afatinib discontinuation|46|||
130209631|NCT02440854|468727329|FG000|Overall Study|stopped study at earlier timepoint|14|||
130209632|NCT02440854|468727329|FG000|Overall Study|Study medication not received|1|||
130209633|NCT02440854|468727329|FG000|Overall Study|Violation of inclusion criteria|2|||
130209634|NCT03338569|468727330|FG000|Overall Study|Physician Decision|8|||
130209635|NCT03338569|468727331|FG001|Overall Study|Physician Decision|3|||
130430632|NCT00532155|469537752|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
130430633|NCT00532155|469537751|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
130543479|NCT02399254|469956729|FG000|Overall Study|Physician Decision|2|||
130209636|NCT03338569|468727330|FG000|Overall Study|Withdrawal by Subject|0|||
130209637|NCT03338569|468727331|FG001|Overall Study|Withdrawal by Subject|1|||
130209638|NCT03338569|468727330|FG000|Overall Study|Lost to Follow-up|0|||
130209639|NCT03338569|468727331|FG001|Overall Study|Lost to Follow-up|1|||
130209640|NCT02243046|468727332|FG000|Overall Study|Lost to Follow-up|1|||
130209641|NCT02243046|468727333|FG001|Overall Study|Lost to Follow-up|1|||
130209642|NCT02243046|468727334|FG002|Overall Study|Lost to Follow-up|4|||
130209643|NCT02669082|468727335|FG000|Overall Study|Adverse Event|1|||
130209644|NCT04852276|468727336|FG000|Overall Study|Death|2|||
130209645|NCT04852276|468727337|FG001|Overall Study|Death|0|||
130209646|NCT04852276|468727336|FG000|Overall Study|Lost to Follow-up|15|||
130209647|NCT04852276|468727337|FG001|Overall Study|Lost to Follow-up|9|||
130209648|NCT04852276|468727336|FG000|Overall Study|Withdrawal by Subject|26|||
130209649|NCT04852276|468727337|FG001|Overall Study|Withdrawal by Subject|6|||
130430634|NCT00532155|469537752|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
130430635|NCT00532155|469537751|FG000|Overall Study|Study stopped|1|||
130430636|NCT00532155|469537752|FG001|Overall Study|Study stopped|0|||
130430637|NCT00532155|469537751|FG000|Overall Study|Study terminated by sponsor|1|||
130430638|NCT00532155|469537752|FG001|Overall Study|Study terminated by sponsor|0|||
130430639|NCT00532155|469537751|FG000|Overall Study|Study termination stop further treatment|4|||
130430640|NCT00532155|469537752|FG001|Overall Study|Study termination stop further treatment|0|||
130430641|NCT00532155|469537751|FG000|Overall Study|Did not receive study medication|2|||
130430642|NCT00532155|469537752|FG001|Overall Study|Did not receive study medication|6|||
130430643|NCT02134925|469537753|FG000|Overall Study|Withdrawal by Subject|1|||
130430644|NCT02134925|469537754|FG001|Overall Study|Withdrawal by Subject|0|||
130430645|NCT02134925|469537753|FG000|Overall Study|Cancel|1|||
130430646|NCT02134925|469537754|FG001|Overall Study|Cancel|6|||
130430647|NCT04987762|469537755|FG000|Overall Study|Study was Terminated by Sponsor|103|||
130430648|NCT02158884|469537760|FG000|Baseline Assessment|Missed performance assessment|3|||
130430649|NCT02158884|469537760|FG000|Baseline Assessment|Missed SMFA|1|||
130430650|NCT02158884|469537760|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
130430651|NCT02158884|469537760|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
130430652|NCT02158884|469537760|FG000|6 Month Assessment|Missed SMFA|20|||
130430653|NCT02158884|469537760|FG000|12 Month Assessment|Missed SMFA|17|||
130430654|NCT00316173|469537763|FG000|Run-in Phase|Adverse Event|1|||
130430655|NCT00316173|469537764|FG001|Run-in Phase|Adverse Event|0|||
130430656|NCT00316173|469537763|FG000|Run-in Phase|Protocol Violation|1|||
130430657|NCT00316173|469537764|FG001|Run-in Phase|Protocol Violation|0|||
130430658|NCT00316173|469537763|FG000|Run-in Phase|Study Follow-up Stopped|5|||
130430659|NCT00316173|469537764|FG001|Run-in Phase|Study Follow-up Stopped|0|||
130430660|NCT00316173|469537763|FG000|Treatment Phase|Adverse Event|0|||
130430661|NCT00316173|469537764|FG001|Treatment Phase|Adverse Event|1|||
130430662|NCT00316173|469537763|FG000|Treatment Phase|Lack of Efficacy|0|||
130430663|NCT00316173|469537764|FG001|Treatment Phase|Lack of Efficacy|3|||
130430664|NCT00316173|469537763|FG000|Treatment Phase|Lost to Follow-up|0|||
130430665|NCT00316173|469537764|FG001|Treatment Phase|Lost to Follow-up|3|||
130430666|NCT00316173|469537763|FG000|Treatment Phase|Withdrawal by Subject|0|||
130430667|NCT00316173|469537764|FG001|Treatment Phase|Withdrawal by Subject|1|||
130430668|NCT00316173|469537763|FG000|Treatment Phase|Study Follow-up Stopped|0|||
130430669|NCT00316173|469537764|FG001|Treatment Phase|Study Follow-up Stopped|34|||
130430670|NCT03764072|469537765|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130430671|NCT03764072|469537766|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130430672|NCT03764072|469537767|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130430673|NCT03764072|469537768|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130430674|NCT03764072|469537769|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130430675|NCT03764072|469537770|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130430676|NCT03764072|469537765|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
130430677|NCT03764072|469537766|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
130430678|NCT03764072|469537767|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
130430679|NCT03764072|469537768|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
130430680|NCT03764072|469537769|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
130430681|NCT03764072|469537770|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
130209650|NCT02824562|468729191|FG000|Overall Study|Lost to Follow-up|3|||
130430682|NCT03764072|469537765|FG000|Overall Study|Lost to Follow-up|0|||
130430683|NCT03764072|469537766|FG001|Overall Study|Lost to Follow-up|0|||
130430684|NCT03764072|469537767|FG002|Overall Study|Lost to Follow-up|0|||
130430685|NCT03764072|469537768|FG003|Overall Study|Lost to Follow-up|0|||
130430686|NCT03764072|469537769|FG004|Overall Study|Lost to Follow-up|1|||
130430687|NCT03764072|469537770|FG005|Overall Study|Lost to Follow-up|0|||
130430688|NCT00558064|469537771|FG000|Overall Study|Adverse Event|3|||
130209651|NCT02824562|468729192|FG001|Overall Study|Lost to Follow-up|4|||
130209652|NCT02824562|468729191|FG000|Overall Study|Death|0|||
130209653|NCT02824562|468729192|FG001|Overall Study|Death|1|||
130209654|NCT02168777|468729193|FG000|Overall Study|Withdrawal by Subject|1|||
130209655|NCT02168777|468729194|FG001|Overall Study|Withdrawal by Subject|0|||
130209656|NCT02168777|468729195|FG002|Overall Study|Withdrawal by Subject|2|||
130209657|NCT02168777|468729193|FG000|Overall Study|Adverse Event|1|||
130209658|NCT02168777|468729194|FG001|Overall Study|Adverse Event|0|||
130209659|NCT02168777|468729195|FG002|Overall Study|Adverse Event|1|||
130209660|NCT02168777|468729193|FG000|Overall Study|Disease recurrence|0|||
130209661|NCT02168777|468729194|FG001|Overall Study|Disease recurrence|0|||
130209662|NCT02168777|468729195|FG002|Overall Study|Disease recurrence|1|||
130430689|NCT00558064|469537772|FG001|Overall Study|Adverse Event|2|||
130430690|NCT00558064|469537771|FG000|Overall Study|Lack of Efficacy|0|||
130430691|NCT00558064|469537772|FG001|Overall Study|Lack of Efficacy|1|||
130430692|NCT00558064|469537771|FG000|Overall Study|Protocol Violation|1|||
130430693|NCT00558064|469537772|FG001|Overall Study|Protocol Violation|0|||
130430694|NCT00558064|469537771|FG000|Overall Study|Lost to Follow-up|0|||
130430695|NCT00558064|469537772|FG001|Overall Study|Lost to Follow-up|1|||
130430696|NCT00558064|469537771|FG000|Overall Study|Withdrawal by Subject|0|||
130430697|NCT00558064|469537772|FG001|Overall Study|Withdrawal by Subject|1|||
130430698|NCT00558064|469537771|FG000|Overall Study|No visit within allowance period|1|||
130430699|NCT00558064|469537772|FG001|Overall Study|No visit within allowance period|0|||
130430700|NCT00982930|469537775|FG000|Overall Study|Adverse Event|1|||
130430701|NCT00982930|469537775|FG000|Overall Study|Withdrawal by Subject|1|||
130430702|NCT00982930|469537775|FG000|Overall Study|Administrative Problems|2|||
130430703|NCT01489189|469537776|FG000|Overall Study|Withdrawal by Subject|20|||
130430704|NCT01489189|469537777|FG001|Overall Study|Withdrawal by Subject|23|||
130430705|NCT01489189|469537776|FG000|Overall Study|Death|10|||
130430706|NCT01489189|469537777|FG001|Overall Study|Death|8|||
130430707|NCT01489189|469537776|FG000|Overall Study|Missed Visit|1|||
130430708|NCT01489189|469537777|FG001|Overall Study|Missed Visit|4|||
130430709|NCT05597722|469537778|FG000|Overall Study|Study was terminated|6|||
130430710|NCT05597722|469537779|FG001|Overall Study|Study was terminated|1|||
130430711|NCT00404495|469537780|FG000|Overall Study|Death|37|||
130430712|NCT00404495|469537781|FG001|Overall Study|Death|11|||
130430713|NCT00404495|469537780|FG000|Overall Study|Lost to Follow-up|5|||
130430714|NCT00404495|469537781|FG001|Overall Study|Lost to Follow-up|0|||
130430715|NCT00404495|469537780|FG000|Overall Study|Other|1|||
130430716|NCT00404495|469537781|FG001|Overall Study|Other|0|||
130430717|NCT00404495|469537780|FG000|Overall Study|Withdrawal by Subject|1|||
130430718|NCT00404495|469537781|FG001|Overall Study|Withdrawal by Subject|0|||
130430719|NCT04108000|469537782|FG000|Overall Study|Death of patient|1|||
130430720|NCT04108000|469537783|FG001|Overall Study|Death of patient|0|||
130430721|NCT04108000|469537784|FG002|Overall Study|Death of patient|1|||
130430722|NCT04108000|469537785|FG003|Overall Study|Death of patient|0|||
130430723|NCT04108000|469537782|FG000|Overall Study|Withdrawal by Subject|2|||
130430724|NCT04108000|469537783|FG001|Overall Study|Withdrawal by Subject|2|||
130430725|NCT04108000|469537784|FG002|Overall Study|Withdrawal by Subject|0|||
130430726|NCT04108000|469537785|FG003|Overall Study|Withdrawal by Subject|0|||
130430727|NCT04108000|469537782|FG000|Overall Study|Death of surrogate partner|0|||
130430728|NCT04108000|469537783|FG001|Overall Study|Death of surrogate partner|1|||
130430729|NCT04108000|469537784|FG002|Overall Study|Death of surrogate partner|0|||
130430730|NCT04108000|469537785|FG003|Overall Study|Death of surrogate partner|1|||
130430731|NCT03750006|469537789|FG000|Overall Study|Withdrawal by Subject|8|||
130430732|NCT03750006|469537789|FG000|Overall Study|COVID PANDEMIC|11|||
130430733|NCT03881696|469537790|FG000|Overall Study|Adverse Event|2|||
130430734|NCT03881696|469537791|FG001|Overall Study|Adverse Event|0|||
130209663|NCT02168777|468729193|FG000|Overall Study|Radiological disease progression|0|||
130209664|NCT02168777|468729194|FG001|Overall Study|Radiological disease progression|5|||
130209665|NCT02168777|468729195|FG002|Overall Study|Radiological disease progression|5|||
130209666|NCT02168777|468729193|FG000|Overall Study|Clinical disease progression|0|||
130209667|NCT02168777|468729194|FG001|Overall Study|Clinical disease progression|1|||
130209668|NCT02168777|468729195|FG002|Overall Study|Clinical disease progression|2|||
130209669|NCT02168777|468729193|FG000|Overall Study|Other reason|0|||
130209670|NCT02168777|468729194|FG001|Overall Study|Other reason|1|||
130430735|NCT03881696|469537790|FG000|Overall Study|Withdrawal by Subject|2|||
130430736|NCT03881696|469537791|FG001|Overall Study|Withdrawal by Subject|0|||
130430737|NCT03881696|469537790|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
130430738|NCT03881696|469537791|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
130430739|NCT03881696|469537790|FG000|Overall Study|Failure to meet continuation criteria|1|||
130430740|NCT03881696|469537791|FG001|Overall Study|Failure to meet continuation criteria|0|||
130430741|NCT02044848|469539281|FG000|Overall Study|Administrative Problems|2|||
130430742|NCT02044848|469539282|FG001|Overall Study|Administrative Problems|3|||
130430743|NCT01493960|469539283|FG000|Overall Study|Adverse Event|0|||
130430744|NCT01493960|469539284|FG001|Overall Study|Adverse Event|1|||
130430745|NCT01493960|469539283|FG000|Overall Study|Lack of Efficacy|15|||
130430746|NCT01493960|469539284|FG001|Overall Study|Lack of Efficacy|9|||
130654519|NCT03426995|470357659|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130209671|NCT02168777|468729195|FG002|Overall Study|Other reason|0|||
130209672|NCT05243563|468729196|FG000|Overall Study|Withdrawal by Subject|1|||
130430747|NCT01493960|469539283|FG000|Overall Study|Protocol Violation|3|||
130209673|NCT05243563|468729197|FG001|Overall Study|Withdrawal by Subject|0|||
130209674|NCT05243563|468729196|FG000|Overall Study|Physician Decision|1|||
130209675|NCT05243563|468729197|FG001|Overall Study|Physician Decision|0|||
130209676|NCT02474355|468729201|FG000|Overall Study|Other|43|||
130209677|NCT02474355|468729201|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
130209678|NCT02474355|468729201|FG000|Overall Study|Lost to Follow-up|98|||
130209679|NCT02474355|468729201|FG000|Overall Study|Withdrawal by Subject|124|||
130209680|NCT02474355|468729201|FG000|Overall Study|Death|1361|||
130209681|NCT01066793|468729202|FG000|Overall Study|Death|4|||
130209682|NCT01066793|468729203|FG001|Overall Study|Death|1|||
130209683|NCT01066793|468729204|FG002|Overall Study|Death|1|||
130209684|NCT01066793|468729205|FG003|Overall Study|Death|0|||
130209685|NCT01066793|468729206|FG004|Overall Study|Death|0|||
130209686|NCT01066793|468729207|FG005|Overall Study|Death|0|||
130209687|NCT01066793|468729202|FG000|Overall Study|Lack of Efficacy|2|||
130209688|NCT01066793|468729203|FG001|Overall Study|Lack of Efficacy|1|||
130209689|NCT01066793|468729204|FG002|Overall Study|Lack of Efficacy|0|||
130209690|NCT01066793|468729205|FG003|Overall Study|Lack of Efficacy|0|||
130209691|NCT01066793|468729206|FG004|Overall Study|Lack of Efficacy|0|||
130209692|NCT01066793|468729207|FG005|Overall Study|Lack of Efficacy|0|||
130209693|NCT01066793|468729202|FG000|Overall Study|Lost to Follow-up|180|||
130209694|NCT01066793|468729203|FG001|Overall Study|Lost to Follow-up|39|||
130209695|NCT01066793|468729204|FG002|Overall Study|Lost to Follow-up|82|||
130209696|NCT01066793|468729205|FG003|Overall Study|Lost to Follow-up|16|||
130209697|NCT01066793|468729206|FG004|Overall Study|Lost to Follow-up|0|||
130209698|NCT01066793|468729207|FG005|Overall Study|Lost to Follow-up|1|||
130209699|NCT01066793|468729202|FG000|Overall Study|Physician Decision|3|||
130209700|NCT01066793|468729203|FG001|Overall Study|Physician Decision|0|||
130209701|NCT01066793|468729204|FG002|Overall Study|Physician Decision|0|||
130209702|NCT01066793|468729205|FG003|Overall Study|Physician Decision|0|||
130209703|NCT01066793|468729206|FG004|Overall Study|Physician Decision|0|||
130209704|NCT01066793|468729207|FG005|Overall Study|Physician Decision|0|||
130209705|NCT01066793|468729202|FG000|Overall Study|Protocol Violation|3|||
130209706|NCT01066793|468729203|FG001|Overall Study|Protocol Violation|2|||
130209707|NCT01066793|468729204|FG002|Overall Study|Protocol Violation|2|||
130209708|NCT01066793|468729205|FG003|Overall Study|Protocol Violation|0|||
130209709|NCT01066793|468729206|FG004|Overall Study|Protocol Violation|0|||
130209710|NCT01066793|468729207|FG005|Overall Study|Protocol Violation|0|||
130209711|NCT01066793|468729202|FG000|Overall Study|Withdrawal by Subject|7|||
130209712|NCT01066793|468729203|FG001|Overall Study|Withdrawal by Subject|4|||
130209713|NCT01066793|468729204|FG002|Overall Study|Withdrawal by Subject|1|||
130209714|NCT01066793|468729205|FG003|Overall Study|Withdrawal by Subject|0|||
130209715|NCT01066793|468729206|FG004|Overall Study|Withdrawal by Subject|0|||
130209716|NCT01066793|468729207|FG005|Overall Study|Withdrawal by Subject|0|||
130209717|NCT01066793|468729202|FG000|Overall Study|Early Termination|3|||
130209718|NCT01066793|468729203|FG001|Overall Study|Early Termination|0|||
130209719|NCT01066793|468729204|FG002|Overall Study|Early Termination|0|||
130209720|NCT01066793|468729205|FG003|Overall Study|Early Termination|0|||
130209721|NCT01066793|468729206|FG004|Overall Study|Early Termination|0|||
130209722|NCT01066793|468729207|FG005|Overall Study|Early Termination|0|||
130209723|NCT01066793|468729202|FG000|Overall Study|Lab test not done|7|||
130209724|NCT01066793|468729203|FG001|Overall Study|Lab test not done|0|||
130209725|NCT01066793|468729204|FG002|Overall Study|Lab test not done|0|||
130209726|NCT01066793|468729205|FG003|Overall Study|Lab test not done|1|||
130209727|NCT01066793|468729206|FG004|Overall Study|Lab test not done|0|||
130209728|NCT01066793|468729207|FG005|Overall Study|Lab test not done|0|||
130209729|NCT01066793|468729202|FG000|Overall Study|Miscellaneous|4|||
130209730|NCT01066793|468729203|FG001|Overall Study|Miscellaneous|5|||
130209731|NCT01066793|468729204|FG002|Overall Study|Miscellaneous|6|||
130209732|NCT01066793|468729205|FG003|Overall Study|Miscellaneous|0|||
130209733|NCT01066793|468729206|FG004|Overall Study|Miscellaneous|0|||
130209734|NCT01066793|468729207|FG005|Overall Study|Miscellaneous|0|||
130209735|NCT01066793|468729202|FG000|Overall Study|Non-responders|104|||
130430748|NCT01493960|469539284|FG001|Overall Study|Protocol Violation|0|||
130209736|NCT01066793|468729203|FG001|Overall Study|Non-responders|5|||
130209737|NCT01066793|468729204|FG002|Overall Study|Non-responders|11|||
130209738|NCT01066793|468729205|FG003|Overall Study|Non-responders|25|||
130209739|NCT01066793|468729206|FG004|Overall Study|Non-responders|0|||
130209740|NCT01066793|468729207|FG005|Overall Study|Non-responders|0|||
130209741|NCT01066793|468729202|FG000|Overall Study|Other|15|||
130209742|NCT01066793|468729203|FG001|Overall Study|Other|5|||
130209743|NCT01066793|468729204|FG002|Overall Study|Other|6|||
130209744|NCT01066793|468729205|FG003|Overall Study|Other|2|||
130209745|NCT01066793|468729206|FG004|Overall Study|Other|0|||
130209746|NCT01066793|468729207|FG005|Overall Study|Other|0|||
130209747|NCT01066793|468729202|FG000|Overall Study|Relapse|20|||
130209748|NCT01066793|468729203|FG001|Overall Study|Relapse|8|||
130209749|NCT01066793|468729204|FG002|Overall Study|Relapse|2|||
130209750|NCT01066793|468729205|FG003|Overall Study|Relapse|3|||
130209751|NCT01066793|468729206|FG004|Overall Study|Relapse|0|||
130209752|NCT01066793|468729207|FG005|Overall Study|Relapse|0|||
130209753|NCT01066793|468729202|FG000|Overall Study|Result Not Available|1|||
130209754|NCT01066793|468729203|FG001|Overall Study|Result Not Available|0|||
130430749|NCT01493960|469539283|FG000|Overall Study|Withdrawal by Subject|10|||
130430750|NCT01493960|469539284|FG001|Overall Study|Withdrawal by Subject|4|||
130430751|NCT01493960|469539283|FG000|Overall Study|Non-specified|4|||
130430752|NCT01493960|469539284|FG001|Overall Study|Non-specified|4|||
130430753|NCT01160484|469539293|FG000|Overall Study|Lack of Efficacy|9|||
130430754|NCT01160484|469539293|FG000|Overall Study|Adverse Event|6|||
130430755|NCT01160484|469539293|FG000|Overall Study|Withdrawal by Subject|2|||
130430756|NCT01160484|469539293|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
130430757|NCT00803101|469539294|FG000|Overall Study|Death / Serious Adverse Event|4|||
130430758|NCT00803101|469539295|FG001|Overall Study|Death / Serious Adverse Event|6|||
130430759|NCT00803101|469539294|FG000|Overall Study|Withdrawal by Subject|6|||
130430760|NCT00803101|469539295|FG001|Overall Study|Withdrawal by Subject|4|||
130430761|NCT00803101|469539294|FG000|Overall Study|Lost to Follow-up|2|||
130430762|NCT00803101|469539295|FG001|Overall Study|Lost to Follow-up|2|||
130430763|NCT00803101|469539294|FG000|Overall Study|Protocol Violation|1|||
130430764|NCT00803101|469539295|FG001|Overall Study|Protocol Violation|7|||
130430765|NCT00803101|469539294|FG000|Overall Study|Surgery finished outside protocol window|1|||
130430766|NCT00803101|469539295|FG001|Overall Study|Surgery finished outside protocol window|1|||
130430767|NCT00803101|469539294|FG000|Overall Study|Patient died outside SAE report period|1|||
130430768|NCT00803101|469539295|FG001|Overall Study|Patient died outside SAE report period|0|||
130430769|NCT00803101|469539294|FG000|Overall Study|Patient did not attend scheduled visit|2|||
130430770|NCT00803101|469539295|FG001|Overall Study|Patient did not attend scheduled visit|1|||
130430771|NCT00803101|469539294|FG000|Overall Study|Patient did not have surgery|1|||
130430772|NCT00803101|469539295|FG001|Overall Study|Patient did not have surgery|1|||
130430773|NCT01782742|469539296|FG000|Double-blind Treatment Phase|Adverse Event|1|||
130430774|NCT01782742|469539297|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130430775|NCT02026232|469539302|FG000|Overall Study|incomplete visit/missing data|3|||
130430776|NCT02026232|469539303|FG001|Overall Study|incomplete visit/missing data|2|||
130430777|NCT00332332|469539304|FG000|Overall Study|Adverse Event|13|||
130430778|NCT00332332|469539304|FG000|Overall Study|Death|1|||
130430779|NCT00332332|469539304|FG000|Overall Study|Withdrawal by Subject|8|||
130430780|NCT00332332|469539304|FG000|Overall Study|Physician Decision|1|||
130430781|NCT00332332|469539304|FG000|Overall Study|Lost to Follow-up|3|||
130430782|NCT00332332|469539304|FG000|Overall Study|Protocol deviation|4|||
130430783|NCT00332332|469539304|FG000|Overall Study|Noncompliance|2|||
130430784|NCT00332332|469539304|FG000|Overall Study|Disease progression|2|||
130430785|NCT00332332|469539304|FG000|Overall Study|Other|18|||
130430786|NCT00332332|469539304|FG000|Overall Study|Did not receive study treatment|16|||
130430787|NCT02790073|469539305|FG000|Overall Study|Death|1|||
130430788|NCT02790073|469539305|FG000|Overall Study|Withdrawal from HD|1|||
130430789|NCT02790073|469539305|FG000|Overall Study|Withdrawal by Subject|1|||
130430790|NCT01392300|469539310|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
130430791|NCT01392300|469539311|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
130430792|NCT01392300|469539312|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
130430793|NCT01392300|469539310|FG000|Main Period (MP)|Withdrawal by Subject|5|||
130430794|NCT01392300|469539311|FG001|Main Period (MP)|Withdrawal by Subject|1|||
130430795|NCT01392300|469539312|FG002|Main Period (MP)|Withdrawal by Subject|0|||
130430796|NCT01392300|469539310|FG000|Main Period (MP)|Lost to Follow-up|3|||
130430797|NCT01392300|469539311|FG001|Main Period (MP)|Lost to Follow-up|3|||
130430798|NCT01392300|469539312|FG002|Main Period (MP)|Lost to Follow-up|0|||
130430799|NCT01392300|469539310|FG000|Main Period (MP)|Non-compliance|1|||
130430800|NCT01392300|469539311|FG001|Main Period (MP)|Non-compliance|0|||
130430801|NCT01392300|469539312|FG002|Main Period (MP)|Non-compliance|0|||
130430802|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
130430803|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
130430804|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
130430805|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
130430806|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
130430807|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
130430808|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
130430809|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
130430810|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
130430811|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Death|0|||
130430812|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Death|0|||
130430813|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Death|4|||
130430814|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
130430815|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
130430816|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
130430817|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
130430818|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
130720913|NCT00620555|470601559|FG000|Overall Study|Visit failure against planned|1|||
130209755|NCT01066793|468729204|FG002|Overall Study|Result Not Available|0|||
130209756|NCT01066793|468729205|FG003|Overall Study|Result Not Available|0|||
130209757|NCT01066793|468729206|FG004|Overall Study|Result Not Available|0|||
130209758|NCT01066793|468729207|FG005|Overall Study|Result Not Available|0|||
130209759|NCT01066793|468729202|FG000|Overall Study|Treatment Interrupted|1|||
130209760|NCT01066793|468729203|FG001|Overall Study|Treatment Interrupted|1|||
130209761|NCT01066793|468729204|FG002|Overall Study|Treatment Interrupted|0|||
130209762|NCT01066793|468729205|FG003|Overall Study|Treatment Interrupted|0|||
130209763|NCT01066793|468729206|FG004|Overall Study|Treatment Interrupted|0|||
130209764|NCT01066793|468729207|FG005|Overall Study|Treatment Interrupted|0|||
130209765|NCT01066793|468729202|FG000|Overall Study|Treatment Never Started|18|||
130209766|NCT01066793|468729203|FG001|Overall Study|Treatment Never Started|5|||
130209767|NCT01066793|468729204|FG002|Overall Study|Treatment Never Started|4|||
130209768|NCT01066793|468729205|FG003|Overall Study|Treatment Never Started|1|||
130209769|NCT01066793|468729206|FG004|Overall Study|Treatment Never Started|0|||
130209770|NCT01066793|468729207|FG005|Overall Study|Treatment Never Started|0|||
130209771|NCT01066793|468729202|FG000|Overall Study|Treatment Stopped|2|||
130209772|NCT01066793|468729203|FG001|Overall Study|Treatment Stopped|1|||
130209773|NCT01066793|468729204|FG002|Overall Study|Treatment Stopped|0|||
130209774|NCT01066793|468729205|FG003|Overall Study|Treatment Stopped|1|||
130209775|NCT01066793|468729206|FG004|Overall Study|Treatment Stopped|0|||
130430819|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
130430820|NCT01392300|469539310|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
130430821|NCT01392300|469539311|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
130430822|NCT01392300|469539312|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
130430823|NCT05056870|469539317|FG000|Period 1|Site COVID-19 Related|3|||
130430824|NCT05056870|469539318|FG001|Period 1|Site COVID-19 Related|3|||
130430825|NCT05056870|469539317|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130430826|NCT05056870|469539318|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130430827|NCT05056870|469539317|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130430828|NCT05056870|469539318|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130430829|NCT05056870|469539317|FG000|Period 2|COVID-19 Related|1|||
130430830|NCT05056870|469539318|FG001|Period 2|COVID-19 Related|0|||
130430831|NCT05056870|469539317|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130430832|NCT05056870|469539318|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130430833|NCT00676130|469539319|FG000|Overall Study|Lost to Follow-up|0|||
130430834|NCT00676130|469539320|FG001|Overall Study|Lost to Follow-up|1|||
130430835|NCT00676130|469539319|FG000|Overall Study|Found ineligible|3|||
130430836|NCT00676130|469539320|FG001|Overall Study|Found ineligible|2|||
130430837|NCT00676130|469539319|FG000|Overall Study|Withdrawal by Subject|0|||
130430838|NCT00676130|469539320|FG001|Overall Study|Withdrawal by Subject|1|||
130430839|NCT01181726|469539323|FG000|First Intervention|Adverse Event|1|||
130430840|NCT01181726|469539324|FG001|First Intervention|Adverse Event|0|||
130430841|NCT01114204|469539326|FG000|Overall Study|Adverse Event|3|||
130430842|NCT01114204|469539327|FG001|Overall Study|Adverse Event|2|||
130430843|NCT01114204|469539326|FG000|Overall Study|Lost to Follow-up|1|||
130430844|NCT01114204|469539327|FG001|Overall Study|Lost to Follow-up|0|||
130430845|NCT01114204|469539326|FG000|Overall Study|Withdrawal by Subject|10|||
130430846|NCT01114204|469539327|FG001|Overall Study|Withdrawal by Subject|6|||
130430847|NCT01114204|469539326|FG000|Overall Study|Death|1|||
130430848|NCT01114204|469539327|FG001|Overall Study|Death|0|||
130430849|NCT01114204|469539326|FG000|Overall Study|Other-Personal reasons|2|||
130430850|NCT01114204|469539327|FG001|Overall Study|Other-Personal reasons|0|||
130430851|NCT01114204|469539326|FG000|Overall Study|Other-Medical monitor request|1|||
130430852|NCT01114204|469539327|FG001|Overall Study|Other-Medical monitor request|0|||
130430853|NCT01114204|469539326|FG000|Overall Study|Other-Participant request|2|||
130430854|NCT01114204|469539327|FG001|Overall Study|Other-Participant request|0|||
130430855|NCT01114204|469539326|FG000|Overall Study|Other-Protocol Violation|1|||
130430856|NCT01114204|469539327|FG001|Overall Study|Other-Protocol Violation|0|||
130430857|NCT00674570|469539328|FG000|Overall Study|Withdrawal by Subject|0|||
130430858|NCT00674570|469539329|FG001|Overall Study|Withdrawal by Subject|2|||
130430859|NCT00674570|469539330|FG002|Overall Study|Withdrawal by Subject|0|||
130430860|NCT03633929|469539331|FG000|Overall Study|Lost to Follow-up|1|||
130430861|NCT03633929|469539331|FG000|Overall Study|Did not login to software. Did not participate|3|||
130430862|NCT04461795|469539332|FG000|Overall Study|Lost to Follow-up|2|||
130430863|NCT04461795|469539332|FG000|Overall Study|Withdrawal by Subject|2|||
130430864|NCT04461795|469539332|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
130209776|NCT01066793|468729207|FG005|Overall Study|Treatment Stopped|0|||
130209777|NCT01911793|468729209|FG000|Overall Study|Physician Decision|1|||
130430865|NCT02798211|469539336|FG000|Period 1|Adverse Event|1|||
130430866|NCT02798211|469539337|FG001|Period 1|Adverse Event|1|||
130430867|NCT02798211|469539338|FG002|Period 1|Adverse Event|0|||
130209778|NCT01911793|468729210|FG001|Overall Study|Physician Decision|5|||
130209779|NCT03334422|468729211|FG000|Overall Study|Adverse Event|1|||
130209780|NCT03334422|468729212|FG001|Overall Study|Adverse Event|3|||
130209781|NCT03334422|468729213|FG002|Overall Study|Adverse Event|2|||
130430868|NCT02798211|469539339|FG003|Period 1|Adverse Event|0|||
130430869|NCT02798211|469539340|FG004|Period 1|Adverse Event|0|||
130430870|NCT02798211|469539341|FG005|Period 1|Adverse Event|0|||
130430871|NCT02798211|469539336|FG000|Period 1|Lost to Follow-up|2|||
130430872|NCT02798211|469539337|FG001|Period 1|Lost to Follow-up|1|||
130430873|NCT02798211|469539338|FG002|Period 1|Lost to Follow-up|0|||
130430874|NCT02798211|469539339|FG003|Period 1|Lost to Follow-up|0|||
130430875|NCT02798211|469539340|FG004|Period 1|Lost to Follow-up|0|||
130430876|NCT02798211|469539341|FG005|Period 1|Lost to Follow-up|0|||
130430877|NCT02798211|469539336|FG000|Period 1|Protocol Violation|0|||
130430878|NCT02798211|469539337|FG001|Period 1|Protocol Violation|0|||
130430879|NCT02798211|469539338|FG002|Period 1|Protocol Violation|2|||
130430880|NCT02798211|469539339|FG003|Period 1|Protocol Violation|0|||
130430881|NCT02798211|469539340|FG004|Period 1|Protocol Violation|0|||
130430882|NCT02798211|469539341|FG005|Period 1|Protocol Violation|0|||
130430883|NCT02798211|469539336|FG000|Period 1|Withdrawal by Subject|1|||
130430884|NCT02798211|469539337|FG001|Period 1|Withdrawal by Subject|1|||
130430885|NCT02798211|469539338|FG002|Period 1|Withdrawal by Subject|0|||
130430886|NCT02798211|469539339|FG003|Period 1|Withdrawal by Subject|0|||
130430887|NCT02798211|469539340|FG004|Period 1|Withdrawal by Subject|0|||
130430888|NCT02798211|469539341|FG005|Period 1|Withdrawal by Subject|0|||
130430889|NCT02798211|469539336|FG000|Period 1|Death|0|||
130430890|NCT02798211|469539337|FG001|Period 1|Death|0|||
130430891|NCT02798211|469539338|FG002|Period 1|Death|1|||
130430892|NCT02798211|469539339|FG003|Period 1|Death|0|||
130430893|NCT02798211|469539340|FG004|Period 1|Death|0|||
130430894|NCT02798211|469539341|FG005|Period 1|Death|0|||
130430895|NCT02798211|469539336|FG000|Period 1|Withdrawal of Informed Consent|2|||
130430896|NCT02798211|469539337|FG001|Period 1|Withdrawal of Informed Consent|7|||
130430897|NCT02798211|469539338|FG002|Period 1|Withdrawal of Informed Consent|3|||
130430898|NCT02798211|469539339|FG003|Period 1|Withdrawal of Informed Consent|0|||
130430899|NCT02798211|469539340|FG004|Period 1|Withdrawal of Informed Consent|0|||
130430900|NCT02798211|469539341|FG005|Period 1|Withdrawal of Informed Consent|0|||
130430901|NCT02798211|469539336|FG000|Period 2|Withdrawal by Subject|2|||
130430902|NCT02798211|469539337|FG001|Period 2|Withdrawal by Subject|0|||
130430903|NCT02798211|469539338|FG002|Period 2|Withdrawal by Subject|0|||
130430904|NCT02798211|469539339|FG003|Period 2|Withdrawal by Subject|0|||
130430905|NCT02798211|469539340|FG004|Period 2|Withdrawal by Subject|2|||
130430906|NCT02798211|469539341|FG005|Period 2|Withdrawal by Subject|2|||
130430907|NCT02798211|469539336|FG000|Period 2|Adverse Event|5|||
130430908|NCT02798211|469539337|FG001|Period 2|Adverse Event|0|||
130430909|NCT02798211|469539338|FG002|Period 2|Adverse Event|0|||
130430910|NCT02798211|469539339|FG003|Period 2|Adverse Event|0|||
130430911|NCT02798211|469539340|FG004|Period 2|Adverse Event|1|||
130430912|NCT02798211|469539341|FG005|Period 2|Adverse Event|0|||
130430913|NCT02798211|469539336|FG000|Period 2|Lack of Efficacy|1|||
130430914|NCT02798211|469539337|FG001|Period 2|Lack of Efficacy|0|||
130430915|NCT02798211|469539338|FG002|Period 2|Lack of Efficacy|0|||
130430916|NCT02798211|469539339|FG003|Period 2|Lack of Efficacy|1|||
130430917|NCT02798211|469539340|FG004|Period 2|Lack of Efficacy|0|||
130430918|NCT02798211|469539341|FG005|Period 2|Lack of Efficacy|1|||
130430919|NCT02798211|469539336|FG000|Period 2|Lost to Follow-up|3|||
130430920|NCT02798211|469539337|FG001|Period 2|Lost to Follow-up|0|||
130430921|NCT02798211|469539338|FG002|Period 2|Lost to Follow-up|0|||
130430922|NCT02798211|469539339|FG003|Period 2|Lost to Follow-up|0|||
130430923|NCT02798211|469539340|FG004|Period 2|Lost to Follow-up|2|||
130430924|NCT02798211|469539341|FG005|Period 2|Lost to Follow-up|0|||
130430925|NCT02798211|469539336|FG000|Period 2|Physician Decision|1|||
130430926|NCT02798211|469539337|FG001|Period 2|Physician Decision|0|||
130430927|NCT02798211|469539338|FG002|Period 2|Physician Decision|0|||
130430928|NCT02798211|469539339|FG003|Period 2|Physician Decision|1|||
130430929|NCT02798211|469539340|FG004|Period 2|Physician Decision|1|||
130430930|NCT02798211|469539341|FG005|Period 2|Physician Decision|0|||
130430931|NCT02798211|469539336|FG000|Period 2|Pregnancy|0|||
130430932|NCT02798211|469539337|FG001|Period 2|Pregnancy|0|||
130430933|NCT02798211|469539338|FG002|Period 2|Pregnancy|0|||
130430934|NCT02798211|469539339|FG003|Period 2|Pregnancy|2|||
130430935|NCT02798211|469539340|FG004|Period 2|Pregnancy|0|||
130430936|NCT02798211|469539341|FG005|Period 2|Pregnancy|0|||
130430937|NCT02798211|469539336|FG000|Period 2|Technical problems|1|||
130430938|NCT02798211|469539337|FG001|Period 2|Technical problems|0|||
130430939|NCT02798211|469539338|FG002|Period 2|Technical problems|0|||
130430940|NCT02798211|469539339|FG003|Period 2|Technical problems|1|||
130430941|NCT02798211|469539340|FG004|Period 2|Technical problems|0|||
130430942|NCT02798211|469539341|FG005|Period 2|Technical problems|0|||
130430943|NCT02798211|469539336|FG000|Period 2|Withdrawal of Informed Consent|1|||
130430944|NCT02798211|469539337|FG001|Period 2|Withdrawal of Informed Consent|0|||
130430945|NCT02798211|469539338|FG002|Period 2|Withdrawal of Informed Consent|0|||
130430946|NCT02798211|469539339|FG003|Period 2|Withdrawal of Informed Consent|2|||
130430947|NCT02798211|469539340|FG004|Period 2|Withdrawal of Informed Consent|2|||
130430948|NCT02798211|469539341|FG005|Period 2|Withdrawal of Informed Consent|3|||
130430949|NCT05292534|469539342|FG000|Overall Study|Protocol Violation|3|||
130430950|NCT05292534|469539343|FG001|Overall Study|Protocol Violation|4|||
130430951|NCT05292534|469539342|FG000|Overall Study|Withdrawal by Subject|0|||
130430952|NCT05292534|469539343|FG001|Overall Study|Withdrawal by Subject|1|||
130430953|NCT01982435|469539344|FG000|Overall Study|Adverse Event|1|||
130430954|NCT01982435|469539345|FG001|Overall Study|Adverse Event|0|||
130430955|NCT03086018|469539346|FG000|Final Testing for End of Trial|Adverse Event|1|||
130430956|NCT03086018|469539346|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
130430957|NCT01892345|469539347|FG000|Overall Study|Adverse Event|0|||
130430958|NCT01892345|469539348|FG001|Overall Study|Adverse Event|2|||
130430959|NCT01892345|469539347|FG000|Overall Study|Death|1|||
130430960|NCT01892345|469539348|FG001|Overall Study|Death|0|||
130430961|NCT01892345|469539347|FG000|Overall Study|Lost to Follow-up|3|||
130430962|NCT01892345|469539348|FG001|Overall Study|Lost to Follow-up|0|||
130430963|NCT01892345|469539347|FG000|Overall Study|Withdrawal by Subject|12|||
130430964|NCT01892345|469539348|FG001|Overall Study|Withdrawal by Subject|1|||
130430965|NCT02748694|469539349|FG000|Overall Study|Voluntary Withdrawal|0|||
130430966|NCT02748694|469539350|FG001|Overall Study|Voluntary Withdrawal|0|||
130430967|NCT02748694|469539351|FG002|Overall Study|Voluntary Withdrawal|0|||
130430968|NCT02748694|469539352|FG003|Overall Study|Voluntary Withdrawal|0|||
130430969|NCT02748694|469539353|FG004|Overall Study|Voluntary Withdrawal|0|||
130430970|NCT02748694|469539354|FG005|Overall Study|Voluntary Withdrawal|0|||
130430971|NCT02748694|469539355|FG006|Overall Study|Voluntary Withdrawal|0|||
130430972|NCT02748694|469539356|FG007|Overall Study|Voluntary Withdrawal|0|||
130430973|NCT02748694|469539357|FG008|Overall Study|Voluntary Withdrawal|0|||
130430974|NCT02748694|469539358|FG009|Overall Study|Voluntary Withdrawal|0|||
130430975|NCT02748694|469539359|FG010|Overall Study|Voluntary Withdrawal|0|||
130430976|NCT02748694|469539360|FG011|Overall Study|Voluntary Withdrawal|0|||
130430977|NCT02748694|469539361|FG012|Overall Study|Voluntary Withdrawal|0|||
130430978|NCT02748694|469539362|FG013|Overall Study|Voluntary Withdrawal|0|||
130430979|NCT02748694|469539363|FG014|Overall Study|Voluntary Withdrawal|2|||
130430980|NCT01473381|469539364|FG000|Overall Study|Adverse Event|8|||
130430981|NCT01473381|469539365|FG001|Overall Study|Adverse Event|20|||
130430982|NCT01473381|469539366|FG002|Overall Study|Adverse Event|25|||
130430983|NCT01473381|469539367|FG003|Overall Study|Adverse Event|17|||
130430984|NCT01473381|469539364|FG000|Overall Study|Insufficient Therapeutic Response|10|||
130430985|NCT01473381|469539365|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130209782|NCT03334422|468729214|FG003|Overall Study|Adverse Event|2|||
130209783|NCT03334422|468729211|FG000|Overall Study|Lack of Efficacy|10|||
130209784|NCT03334422|468729212|FG001|Overall Study|Lack of Efficacy|2|||
130209785|NCT03334422|468729213|FG002|Overall Study|Lack of Efficacy|7|||
130209786|NCT03334422|468729214|FG003|Overall Study|Lack of Efficacy|3|||
130209787|NCT03334422|468729211|FG000|Overall Study|Withdrawal by Subject|8|||
130209788|NCT03334422|468729212|FG001|Overall Study|Withdrawal by Subject|3|||
130209789|NCT03334422|468729213|FG002|Overall Study|Withdrawal by Subject|1|||
130209790|NCT03334422|468729214|FG003|Overall Study|Withdrawal by Subject|0|||
130209791|NCT03334422|468729211|FG000|Overall Study|Lost to Follow-up|0|||
130209792|NCT03334422|468729212|FG001|Overall Study|Lost to Follow-up|0|||
130209793|NCT03334422|468729213|FG002|Overall Study|Lost to Follow-up|0|||
130209794|NCT03334422|468729214|FG003|Overall Study|Lost to Follow-up|1|||
130209795|NCT03334422|468729211|FG000|Overall Study|Inability to obtain laboratory samples|0|||
130209796|NCT03334422|468729212|FG001|Overall Study|Inability to obtain laboratory samples|1|||
130209797|NCT03334422|468729213|FG002|Overall Study|Inability to obtain laboratory samples|0|||
130209798|NCT03334422|468729214|FG003|Overall Study|Inability to obtain laboratory samples|0|||
130209799|NCT03334422|468729211|FG000|Overall Study|Pregnancy|0|||
130209800|NCT03334422|468729212|FG001|Overall Study|Pregnancy|1|||
130209801|NCT03334422|468729213|FG002|Overall Study|Pregnancy|0|||
130209802|NCT03334422|468729214|FG003|Overall Study|Pregnancy|0|||
130209803|NCT03774394|468729215|FG000|Overall Study|Withdrawal by Subject|2|||
130209804|NCT03774394|468729216|FG001|Overall Study|Withdrawal by Subject|0|||
130209805|NCT02697916|468729217|FG000|Overall Study|Death|357|||
130209806|NCT02697916|468729218|FG001|Overall Study|Death|315|||
130209807|NCT02697916|468729217|FG000|Overall Study|Withdrawal by Subject|221|||
130209808|NCT02697916|468729218|FG001|Overall Study|Withdrawal by Subject|393|||
130209809|NCT01313221|468729221|FG000|Overall Study|Protocol Violation|0|||
130209810|NCT01313221|468729222|FG001|Overall Study|Protocol Violation|1|||
130209811|NCT01313221|468729223|FG002|Overall Study|Protocol Violation|1|||
130209812|NCT01313221|468729221|FG000|Overall Study|Non-compliance|3|||
130209813|NCT01313221|468729222|FG001|Overall Study|Non-compliance|0|||
130209814|NCT01313221|468729223|FG002|Overall Study|Non-compliance|2|||
130209815|NCT01313221|468729221|FG000|Overall Study|Withdrawal by Subject|2|||
130209816|NCT01313221|468729222|FG001|Overall Study|Withdrawal by Subject|3|||
130209817|NCT01313221|468729223|FG002|Overall Study|Withdrawal by Subject|5|||
130209818|NCT01313221|468729221|FG000|Overall Study|Requirement for alternative therapy|0|||
130209819|NCT01313221|468729222|FG001|Overall Study|Requirement for alternative therapy|1|||
130209820|NCT01313221|468729223|FG002|Overall Study|Requirement for alternative therapy|1|||
130209821|NCT01313221|468729221|FG000|Overall Study|Lost to Follow-up|6|||
130209822|NCT01313221|468729222|FG001|Overall Study|Lost to Follow-up|3|||
130209823|NCT01313221|468729223|FG002|Overall Study|Lost to Follow-up|1|||
130209824|NCT01313221|468729221|FG000|Overall Study|Other|1|||
130209825|NCT01313221|468729222|FG001|Overall Study|Other|0|||
130209826|NCT01313221|468729223|FG002|Overall Study|Other|0|||
130209827|NCT01313221|468729221|FG000|Overall Study|Adverse Event|0|||
130209828|NCT01313221|468729222|FG001|Overall Study|Adverse Event|0|||
130209829|NCT01313221|468729223|FG002|Overall Study|Adverse Event|7|||
130209830|NCT01313221|468729221|FG000|Overall Study|Disease progression|0|||
130209831|NCT01313221|468729222|FG001|Overall Study|Disease progression|0|||
130209832|NCT01313221|468729223|FG002|Overall Study|Disease progression|2|||
130209833|NCT01313221|468729221|FG000|Overall Study|Physician Decision|0|||
130209834|NCT01313221|468729222|FG001|Overall Study|Physician Decision|0|||
130209835|NCT01313221|468729223|FG002|Overall Study|Physician Decision|2|||
130209836|NCT01313221|468729221|FG000|Overall Study|Pregnancy|0|||
130430986|NCT01473381|469539366|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130430987|NCT01473381|469539367|FG003|Overall Study|Insufficient Therapeutic Response|3|||
130430988|NCT01473381|469539364|FG000|Overall Study|Protocol Violation|17|||
130209837|NCT01313221|468729222|FG001|Overall Study|Pregnancy|0|||
130209838|NCT01313221|468729223|FG002|Overall Study|Pregnancy|2|||
130209839|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209840|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
130209841|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209842|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209843|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209844|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209845|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209846|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
130209847|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
130209848|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209849|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209850|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209851|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130209852|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
130209853|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130209854|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
130209855|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209856|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209857|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209858|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
130209859|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
130209860|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
130209861|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130209862|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130209863|NCT01533688|468729231|FG000|Overall Study|Withdrawal by Subject|5|||
130209864|NCT01533688|468729232|FG001|Overall Study|Withdrawal by Subject|4|||
130209865|NCT01533688|468729233|FG002|Overall Study|Withdrawal by Subject|3|||
130209866|NCT01533688|468729231|FG000|Overall Study|Medically unstable|1|||
130209867|NCT01533688|468729232|FG001|Overall Study|Medically unstable|3|||
130209868|NCT01533688|468729233|FG002|Overall Study|Medically unstable|3|||
130209869|NCT01533688|468729231|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
130209870|NCT01533688|468729232|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
130209871|NCT01533688|468729233|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
130209872|NCT02509078|468729238|FG000|Overall Study|Protocol Violation|1|||
130209873|NCT02509078|468729239|FG001|Overall Study|Protocol Violation|1|||
130209874|NCT00253370|468729240|FG000|Overall Study|Adverse Event|18|||
130209875|NCT00253370|468729240|FG000|Overall Study|Disease progression|13|||
130209876|NCT00253370|468729240|FG000|Overall Study|Death|2|||
130209877|NCT00253370|468729240|FG000|Overall Study|Withdrawal by Subject|6|||
130209878|NCT00253370|468729240|FG000|Overall Study|Non-protocol therapy|1|||
130209879|NCT00253370|468729240|FG000|Overall Study|Physician Decision|1|||
130209880|NCT00253370|468729240|FG000|Overall Study|Protocol Violation|1|||
130209881|NCT00253370|468729240|FG000|Overall Study|Abdominal pain due to disease|1|||
130209882|NCT05916131|468729241|FG000|Overall Study|Lost to Follow-up|0|||
130209883|NCT05916131|468729242|FG001|Overall Study|Lost to Follow-up|0|||
130209884|NCT05916131|468729243|FG002|Overall Study|Lost to Follow-up|1|||
130209885|NCT05916131|468729244|FG003|Overall Study|Lost to Follow-up|0|||
130209886|NCT00904839|468729247|FG000|Overall Study|Adverse Event|0|||
130209887|NCT00904839|468729248|FG001|Overall Study|Adverse Event|5|||
130209888|NCT00904839|468729249|FG002|Overall Study|Adverse Event|4|||
130209889|NCT00904839|468729247|FG000|Overall Study|Protocol Violation|0|||
130209890|NCT00904839|468729248|FG001|Overall Study|Protocol Violation|1|||
130209891|NCT00904839|468729249|FG002|Overall Study|Protocol Violation|1|||
130209892|NCT00904839|468729247|FG000|Overall Study|Lost to Follow-up|0|||
130209893|NCT00904839|468729248|FG001|Overall Study|Lost to Follow-up|1|||
130209894|NCT00904839|468729249|FG002|Overall Study|Lost to Follow-up|2|||
130209895|NCT00904839|468729247|FG000|Overall Study|Withdrawal by Subject|0|||
130209896|NCT00904839|468729248|FG001|Overall Study|Withdrawal by Subject|2|||
130209897|NCT00904839|468729249|FG002|Overall Study|Withdrawal by Subject|0|||
130209898|NCT00904839|468729247|FG000|Overall Study|Not treated|1|||
130209899|NCT00904839|468729248|FG001|Overall Study|Not treated|0|||
130209900|NCT00904839|468729249|FG002|Overall Study|Not treated|1|||
130209901|NCT00904839|468729247|FG000|Overall Study|Other than above|0|||
130209902|NCT00904839|468729248|FG001|Overall Study|Other than above|9|||
130209903|NCT00904839|468729249|FG002|Overall Study|Other than above|7|||
130209904|NCT00553358|468729252|FG000|Overall Study|Randomized but did not receive treatment|3|||
130209905|NCT00553358|468729253|FG001|Overall Study|Randomized but did not receive treatment|3|||
130209906|NCT00553358|468729254|FG002|Overall Study|Randomized but did not receive treatment|1|||
130209907|NCT00553358|468729252|FG000|Overall Study|Lost to Follow-up|22|||
130209908|NCT00553358|468729253|FG001|Overall Study|Lost to Follow-up|26|||
130209909|NCT00553358|468729254|FG002|Overall Study|Lost to Follow-up|18|||
130209910|NCT00553358|468729252|FG000|Overall Study|Withdrew completely|23|||
130209911|NCT00553358|468729253|FG001|Overall Study|Withdrew completely|33|||
130209912|NCT00553358|468729254|FG002|Overall Study|Withdrew completely|34|||
130209913|NCT00553358|468729252|FG000|Overall Study|Died during clinical follow-up|25|||
130209914|NCT00553358|468729253|FG001|Overall Study|Died during clinical follow-up|29|||
130209915|NCT00553358|468729254|FG002|Overall Study|Died during clinical follow-up|32|||
130209916|NCT00553358|468729252|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
130209917|NCT00553358|468729253|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130209918|NCT00553358|468729254|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130209919|NCT00553358|468729252|FG000|Overall Study|Died after clinical follow-up ended|1|||
130209920|NCT00553358|468729253|FG001|Overall Study|Died after clinical follow-up ended|2|||
130209921|NCT00553358|468729254|FG002|Overall Study|Died after clinical follow-up ended|0|||
130209922|NCT00553358|468729252|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209923|NCT00553358|468729253|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209924|NCT00553358|468729254|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209925|NCT05268016|468729256|FG000|Overall Study|Unacceptable toxicity or AE|2|||
130209926|NCT05268016|468729257|FG001|Overall Study|Unacceptable toxicity or AE|2|||
130209927|NCT05268016|468729258|FG002|Overall Study|Unacceptable toxicity or AE|4|||
130209928|NCT05268016|468729259|FG003|Overall Study|Unacceptable toxicity or AE|3|||
130209929|NCT05268016|468729260|FG004|Overall Study|Unacceptable toxicity or AE|1|||
130209930|NCT05268016|468729256|FG000|Overall Study|Withdrawal by Subject|1|||
130209931|NCT05268016|468729257|FG001|Overall Study|Withdrawal by Subject|3|||
130209932|NCT05268016|468729258|FG002|Overall Study|Withdrawal by Subject|2|||
130209933|NCT05268016|468729259|FG003|Overall Study|Withdrawal by Subject|2|||
130209934|NCT05268016|468729260|FG004|Overall Study|Withdrawal by Subject|1|||
130209935|NCT05268016|468729256|FG000|Overall Study|Lost to Follow-up|4|||
130209936|NCT05268016|468729257|FG001|Overall Study|Lost to Follow-up|7|||
130209937|NCT05268016|468729258|FG002|Overall Study|Lost to Follow-up|1|||
130209938|NCT05268016|468729259|FG003|Overall Study|Lost to Follow-up|3|||
130209939|NCT05268016|468729260|FG004|Overall Study|Lost to Follow-up|5|||
130209940|NCT05268016|468729256|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130209941|NCT05268016|468729257|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209942|NCT05268016|468729258|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209943|NCT05268016|468729259|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130209944|NCT05268016|468729260|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209945|NCT05268016|468729256|FG000|Overall Study|Lack of Efficacy|0|||
130209946|NCT05268016|468729257|FG001|Overall Study|Lack of Efficacy|0|||
130209947|NCT05268016|468729258|FG002|Overall Study|Lack of Efficacy|0|||
130209948|NCT05268016|468729259|FG003|Overall Study|Lack of Efficacy|0|||
130209949|NCT05268016|468729260|FG004|Overall Study|Lack of Efficacy|4|||
130209950|NCT05268016|468729256|FG000|Overall Study|Physician Decision|0|||
130209951|NCT05268016|468729257|FG001|Overall Study|Physician Decision|0|||
130209952|NCT05268016|468729258|FG002|Overall Study|Physician Decision|0|||
130209953|NCT05268016|468729259|FG003|Overall Study|Physician Decision|1|||
130209954|NCT05268016|468729260|FG004|Overall Study|Physician Decision|0|||
130209955|NCT05268016|468729256|FG000|Overall Study|Other|1|||
130209956|NCT05268016|468729257|FG001|Overall Study|Other|0|||
130209957|NCT05268016|468729258|FG002|Overall Study|Other|1|||
130209958|NCT05268016|468729259|FG003|Overall Study|Other|2|||
130209959|NCT05268016|468729260|FG004|Overall Study|Other|0|||
130209960|NCT00404924|468729261|FG000|Overall Study|Adverse Event|75|||
130209961|NCT00404924|468729262|FG001|Overall Study|Adverse Event|16|||
130209962|NCT00404924|468729261|FG000|Overall Study|Condition under investigation worsened|475|||
130209963|NCT00404924|468729262|FG001|Overall Study|Condition under investigation worsened|264|||
130209964|NCT00404924|468729261|FG000|Overall Study|Lost to Follow-up|1|||
130209965|NCT00404924|468729262|FG001|Overall Study|Lost to Follow-up|1|||
130209966|NCT00404924|468729261|FG000|Overall Study|Withdrawal by Subject|26|||
130209967|NCT00404924|468729262|FG001|Overall Study|Withdrawal by Subject|13|||
130209968|NCT00404924|468729261|FG000|Overall Study|Other|25|||
130209969|NCT00404924|468729262|FG001|Overall Study|Other|11|||
130209970|NCT00404924|468729261|FG000|Overall Study|Randomised but not received treatment|1|||
130209971|NCT00404924|468729262|FG001|Overall Study|Randomised but not received treatment|1|||
130209972|NCT00187278|468729271|FG000|Overall Study|Protocol Violation|10|||
130209973|NCT00187278|468729272|FG001|Overall Study|Protocol Violation|13|||
130209974|NCT00803205|468729273|FG000|Overall Study|Adverse Event|7|||
130209975|NCT00803205|468729274|FG001|Overall Study|Adverse Event|2|||
130209976|NCT00803205|468729273|FG000|Overall Study|Lost to Follow-up|1|||
130209977|NCT00803205|468729274|FG001|Overall Study|Lost to Follow-up|0|||
130209978|NCT00803205|468729273|FG000|Overall Study|Withdrawal by Subject|9|||
130209979|NCT00803205|468729274|FG001|Overall Study|Withdrawal by Subject|9|||
130209980|NCT00803205|468729273|FG000|Overall Study|Physician Decision|1|||
130209981|NCT00803205|468729274|FG001|Overall Study|Physician Decision|0|||
130209982|NCT00803205|468729273|FG000|Overall Study|Protocol Violation|1|||
130209983|NCT00803205|468729274|FG001|Overall Study|Protocol Violation|1|||
130209984|NCT00803205|468729273|FG000|Overall Study|Medical Monitor Decision|1|||
130209985|NCT00803205|468729274|FG001|Overall Study|Medical Monitor Decision|0|||
130209986|NCT00803205|468729273|FG000|Overall Study|Acquired a Lung Infection|0|||
130209987|NCT00803205|468729274|FG001|Overall Study|Acquired a Lung Infection|1|||
130209988|NCT00803205|468729273|FG000|Overall Study|Sponsor Decision|0|||
130209989|NCT00803205|468729274|FG001|Overall Study|Sponsor Decision|1|||
130209990|NCT02735096|468729276|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
130209991|NCT00270231|468729277|FG000|First Intervention|Lost to Follow-up|1|||
130209992|NCT00270231|468729278|FG001|First Intervention|Lost to Follow-up|1|||
130209993|NCT00270231|468729277|FG000|Washout Period|Lost to Follow-up|1|||
130209994|NCT00270231|468729278|FG001|Washout Period|Lost to Follow-up|0|||
130209995|NCT00270231|468729277|FG000|Second Intervention|Lost to Follow-up|0|||
130209996|NCT00270231|468729278|FG001|Second Intervention|Lost to Follow-up|1|||
130209997|NCT00379808|468729279|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
130209998|NCT00379808|468729280|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
130209999|NCT04299048|468729285|FG000|Overall Study|Death|1|||
130210000|NCT04299048|468729285|FG000|Overall Study|Global deterioration of health status|2|||
130210001|NCT04299048|468729285|FG000|Overall Study|Enrolled and not treated|1|||
130210002|NCT00508157|468729288|FG000|Overall Study|Adverse Event|0|||
130210003|NCT00508157|468729289|FG001|Overall Study|Adverse Event|1|||
130210004|NCT00508157|468729288|FG000|Overall Study|Subject Withdrew Consent|1|||
130210005|NCT00508157|468729289|FG001|Overall Study|Subject Withdrew Consent|0|||
130210006|NCT00508157|468729288|FG000|Overall Study|Lost to Follow-up|1|||
130210007|NCT00508157|468729289|FG001|Overall Study|Lost to Follow-up|0|||
130210008|NCT00508157|468729288|FG000|Overall Study|Subject no longer met study criteria|0|||
130210009|NCT00508157|468729289|FG001|Overall Study|Subject no longer met study criteria|1|||
130210010|NCT00508157|468729288|FG000|Overall Study|Other known cause|0|||
130210011|NCT00508157|468729289|FG001|Overall Study|Other known cause|1|||
130210012|NCT02069093|468729290|FG000|Overall Study|Disease progression|14|||
130210013|NCT02069093|468729290|FG000|Overall Study|New cancer therapy|1|||
130210014|NCT02069093|468729290|FG000|Overall Study|Death|1|||
130210015|NCT02069093|468729290|FG000|Overall Study|Administrative problems|1|||
130210016|NCT02069093|468729290|FG000|Overall Study|Withdrawal by Subject|2|||
130210017|NCT02069093|468729290|FG000|Overall Study|Abnormal laboratory values|1|||
130210018|NCT02069093|468729290|FG000|Overall Study|Adverse Event|10|||
130210019|NCT03564795|468729291|FG000|Overall Study|Withdrawal by Subject|3|||
130210020|NCT03564795|468729291|FG000|Overall Study|Lost to Follow-up|6|||
130210021|NCT03564795|468729291|FG000|Overall Study|Physician Decision|2|||
130210022|NCT02906033|468729292|FG000|Baseline|Protocol Violation|37|||
130210023|NCT02906033|468729293|FG001|Baseline|Protocol Violation|33|||
130210024|NCT02906033|468729292|FG000|Follow-up|Lost to Follow-up|46|||
130210025|NCT02906033|468729293|FG001|Follow-up|Lost to Follow-up|62|||
130210026|NCT01333956|468729304|FG000|Overall Study|Lost to Follow-up|1|||
130210027|NCT01333956|468729305|FG001|Overall Study|Lost to Follow-up|2|||
130210028|NCT01333956|468729306|FG002|Overall Study|Lost to Follow-up|0|||
130210029|NCT01333956|468729307|FG003|Overall Study|Lost to Follow-up|1|||
130210030|NCT01333956|468729304|FG000|Overall Study|Unable to complete study procedure|1|||
130210031|NCT01333956|468729305|FG001|Overall Study|Unable to complete study procedure|0|||
130210032|NCT01333956|468729306|FG002|Overall Study|Unable to complete study procedure|0|||
130210033|NCT01333956|468729307|FG003|Overall Study|Unable to complete study procedure|1|||
130210034|NCT01333956|468729304|FG000|Overall Study|Withdrawal by Subject|0|||
130210035|NCT01333956|468729305|FG001|Overall Study|Withdrawal by Subject|2|||
130210036|NCT01333956|468729306|FG002|Overall Study|Withdrawal by Subject|1|||
130210037|NCT01333956|468729307|FG003|Overall Study|Withdrawal by Subject|0|||
130210038|NCT02240069|468729308|FG000|Overall Study|Withdrawal by Subject|5|||
130430989|NCT01473381|469539365|FG001|Overall Study|Protocol Violation|23|||
130430990|NCT01473381|469539366|FG002|Overall Study|Protocol Violation|19|||
130430991|NCT01473381|469539367|FG003|Overall Study|Protocol Violation|17|||
130430992|NCT01473381|469539364|FG000|Overall Study|Withdrawal of Consent|20|||
130210039|NCT02240069|468729309|FG001|Overall Study|Withdrawal by Subject|5|||
130210040|NCT02240069|468729310|FG002|Overall Study|Withdrawal by Subject|2|||
130210041|NCT03723070|468729311|FG000|Overall Study|Lost to Follow-up|2|||
130210042|NCT03723070|468729311|FG000|Overall Study|Physician Decision|1|||
130430993|NCT01473381|469539365|FG001|Overall Study|Withdrawal of Consent|21|||
130210043|NCT03723070|468729311|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
130430994|NCT01473381|469539366|FG002|Overall Study|Withdrawal of Consent|20|||
130430995|NCT01473381|469539367|FG003|Overall Study|Withdrawal of Consent|26|||
130430996|NCT01473381|469539364|FG000|Overall Study|Lost to Follow-up|25|||
130430997|NCT01473381|469539365|FG001|Overall Study|Lost to Follow-up|28|||
130430998|NCT01473381|469539366|FG002|Overall Study|Lost to Follow-up|35|||
130430999|NCT01473381|469539367|FG003|Overall Study|Lost to Follow-up|23|||
130431000|NCT01473381|469539364|FG000|Overall Study|Other Reasons|0|||
130431001|NCT01473381|469539365|FG001|Overall Study|Other Reasons|0|||
130431002|NCT01473381|469539366|FG002|Overall Study|Other Reasons|1|||
130431003|NCT01473381|469539367|FG003|Overall Study|Other Reasons|3|||
130431004|NCT02487810|469539368|FG000|Overall Study|Withdrawal by Subject|1|||
130431005|NCT02487810|469539369|FG001|Overall Study|Withdrawal by Subject|0|||
130431006|NCT01889186|469539370|FG000|Overall Study|Adverse event- not related to progression|18|||
130431007|NCT01889186|469539371|FG001|Overall Study|Adverse event- not related to progression|5|||
130431008|NCT01889186|469539370|FG000|Overall Study|Adverse event- related to progression|7|||
130431009|NCT01889186|469539371|FG001|Overall Study|Adverse event- related to progression|2|||
130431010|NCT01889186|469539370|FG000|Overall Study|COVID-19 logistical restrictions|1|||
130431011|NCT01889186|469539371|FG001|Overall Study|COVID-19 logistical restrictions|0|||
130431012|NCT01889186|469539370|FG000|Overall Study|Investigator request|1|||
130431013|NCT01889186|469539371|FG001|Overall Study|Investigator request|1|||
130431014|NCT01889186|469539370|FG000|Overall Study|Progressive disease- Richter's|12|||
130431015|NCT01889186|469539371|FG001|Overall Study|Progressive disease- Richter's|7|||
130431016|NCT01889186|469539370|FG000|Overall Study|Progressive disease per protocol|46|||
130431017|NCT01889186|469539371|FG001|Overall Study|Progressive disease per protocol|17|||
130431018|NCT01889186|469539370|FG000|Overall Study|Stem cell transplant|2|||
130431019|NCT01889186|469539371|FG001|Overall Study|Stem cell transplant|1|||
130431020|NCT01889186|469539370|FG000|Overall Study|Withdrew consent|2|||
130431021|NCT01889186|469539371|FG001|Overall Study|Withdrew consent|3|||
130431022|NCT01889186|469539370|FG000|Overall Study|Other, not specified|18|||
130431023|NCT01889186|469539371|FG001|Overall Study|Other, not specified|15|||
130431024|NCT03056534|469539379|FG000|Overall Study|Participant withdrew consent|8|||
130431025|NCT03056534|469539379|FG000|Overall Study|Participant not able to return|6|||
130431026|NCT03056534|469539379|FG000|Overall Study|Lost to Follow-up|37|||
130431027|NCT03056534|469539379|FG000|Overall Study|Investigator judgment|1|||
130431028|NCT03056534|469539379|FG000|Overall Study|Death|4|||
130431029|NCT03056534|469539379|FG000|Overall Study|Adverse Event|1|||
130431030|NCT03056534|469539379|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
130431031|NCT01313286|469539386|FG000|Period 1|Withdrawal by Subject|2|||
130431032|NCT01313286|469539387|FG001|Period 1|Withdrawal by Subject|0|||
130431033|NCT00654901|469539388|FG000|Overall Study|Lost to Follow-up|1|||
130431034|NCT00654901|469539389|FG001|Overall Study|Lost to Follow-up|0|||
130431035|NCT00654901|469539390|FG002|Overall Study|Lost to Follow-up|1|||
130431036|NCT00654901|469539391|FG003|Overall Study|Lost to Follow-up|0|||
130431037|NCT00654901|469539388|FG000|Overall Study|Withdrawal by Subject|3|||
130431038|NCT00654901|469539389|FG001|Overall Study|Withdrawal by Subject|0|||
130431039|NCT00654901|469539390|FG002|Overall Study|Withdrawal by Subject|1|||
130431040|NCT00654901|469539391|FG003|Overall Study|Withdrawal by Subject|0|||
130431041|NCT04241094|469539399|FG000|Overall Study|Dropped out of treatment|4|||
130431042|NCT04241094|469539399|FG000|Overall Study|Ineligible after clinical assessment|2|||
130431043|NCT04241094|469539399|FG000|Overall Study|Lost to Follow-up|2|||
130431044|NCT02332590|469539400|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
130431045|NCT02332590|469539401|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
130431046|NCT02332590|469539400|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
130431047|NCT02332590|469539401|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
130431048|NCT02332590|469539400|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
130431049|NCT02332590|469539401|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
130431050|NCT02332590|469539400|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
130431051|NCT02332590|469539401|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
130431052|NCT02332590|469539400|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
130431053|NCT02332590|469539401|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
130431054|NCT02332590|469539400|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
130431055|NCT02332590|469539401|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
130431056|NCT02332590|469539400|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
130431057|NCT02332590|469539401|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
130431058|NCT02332590|469539400|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
130431059|NCT02332590|469539401|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
130431060|NCT02332590|469539400|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
130431061|NCT02332590|469539401|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
130431062|NCT04739761|469539415|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
130431063|NCT04739761|469539416|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
130431064|NCT04739761|469539415|FG000|Overall Study|By complete response from the participant|1|||
130431065|NCT04739761|469539416|FG001|Overall Study|By complete response from the participant|0|||
130431066|NCT04739761|469539415|FG000|Overall Study|Lost to Follow-up|3|||
130431067|NCT04739761|469539416|FG001|Overall Study|Lost to Follow-up|3|||
130431068|NCT04739761|469539415|FG000|Overall Study|Death|13|||
130210044|NCT00474786|468729312|FG000|Overall Study|Not Meeting Study Criteria|0|||
130210045|NCT00474786|468729313|FG001|Overall Study|Not Meeting Study Criteria|1|||
130210046|NCT00474786|468729312|FG000|Overall Study|Investigator Request|2|||
130210047|NCT00474786|468729313|FG001|Overall Study|Investigator Request|1|||
130210048|NCT00474786|468729312|FG000|Overall Study|Death|189|||
130210049|NCT00474786|468729313|FG001|Overall Study|Death|170|||
130210050|NCT00474786|468729312|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
130210051|NCT00474786|468729313|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
130210052|NCT00474786|468729312|FG000|Overall Study|Lost to Follow-up|4|||
130210053|NCT00474786|468729313|FG001|Overall Study|Lost to Follow-up|7|||
130210054|NCT00474786|468729312|FG000|Overall Study|Protocol Violation|2|||
130210055|NCT00474786|468729313|FG001|Overall Study|Protocol Violation|0|||
130210056|NCT00474786|468729312|FG000|Overall Study|Withdrawal by Subject|15|||
130210057|NCT00474786|468729313|FG001|Overall Study|Withdrawal by Subject|15|||
130210058|NCT00474786|468729312|FG000|Overall Study|Other|5|||
130210059|NCT00474786|468729313|FG001|Overall Study|Other|0|||
130210060|NCT03646305|468729316|FG000|Overall Study|Lost to Follow-up|4|||
130210061|NCT03646305|468729317|FG001|Overall Study|Lost to Follow-up|2|||
130210062|NCT03646305|468729318|FG002|Overall Study|Lost to Follow-up|2|||
130210063|NCT03646305|468729319|FG003|Overall Study|Lost to Follow-up|1|||
130210064|NCT03646305|468729316|FG000|Overall Study|Withdrawal by Subject|1|||
130210065|NCT03646305|468729317|FG001|Overall Study|Withdrawal by Subject|0|||
130210066|NCT03646305|468729318|FG002|Overall Study|Withdrawal by Subject|0|||
130210067|NCT03646305|468729319|FG003|Overall Study|Withdrawal by Subject|1|||
130210068|NCT03417024|468729320|FG000|Overall Study|Study Termination prior to follow-up|11|||
130210069|NCT03417024|468729320|FG000|Overall Study|Physician Decision|2|||
130210070|NCT02195427|468729321|FG000|Overall Study|Did not consent to study extension|13|||
130210071|NCT02195427|468729322|FG001|Overall Study|Did not consent to study extension|9|||
130210072|NCT02195427|468729321|FG000|Overall Study|Withdrawal by Subject|4|||
130210073|NCT02195427|468729322|FG001|Overall Study|Withdrawal by Subject|2|||
130210074|NCT02195427|468729321|FG000|Overall Study|Lost to Follow-up|0|||
130210075|NCT02195427|468729322|FG001|Overall Study|Lost to Follow-up|1|||
130210076|NCT02195427|468729321|FG000|Overall Study|Protocol Violation|7|||
130210077|NCT02195427|468729322|FG001|Overall Study|Protocol Violation|14|||
130210078|NCT02195427|468729321|FG000|Overall Study|Conditional re-treatment at W52|2|||
130210079|NCT02195427|468729322|FG001|Overall Study|Conditional re-treatment at W52|1|||
130210080|NCT02655419|468729323|FG000|Overall Study|Enrolled but not treated|1|||
130210081|NCT02655419|468729324|FG001|Overall Study|Enrolled but not treated|5|||
130210082|NCT02655419|468729323|FG000|Overall Study|Withdrawal by Subject|4|||
130210083|NCT02655419|468729324|FG001|Overall Study|Withdrawal by Subject|1|||
130210084|NCT02655419|468729323|FG000|Overall Study|Other|0|||
130210085|NCT02655419|468729324|FG001|Overall Study|Other|1|||
130210086|NCT00207727|468729325|FG000|Overall Study|Withdrawal by Subject|0|||
130210087|NCT00207727|468729326|FG001|Overall Study|Withdrawal by Subject|0|||
130210088|NCT00207727|468729327|FG002|Overall Study|Withdrawal by Subject|0|||
130210089|NCT00207727|468729328|FG003|Overall Study|Withdrawal by Subject|0|||
130210090|NCT00207727|468729329|FG004|Overall Study|Withdrawal by Subject|1|||
130210091|NCT00207727|468729325|FG000|Overall Study|Lost to Follow-up|0|||
130210092|NCT00207727|468729326|FG001|Overall Study|Lost to Follow-up|1|||
130210093|NCT00207727|468729327|FG002|Overall Study|Lost to Follow-up|0|||
130210094|NCT00207727|468729328|FG003|Overall Study|Lost to Follow-up|0|||
130210095|NCT00207727|468729329|FG004|Overall Study|Lost to Follow-up|0|||
130210096|NCT00207727|468729325|FG000|Overall Study|Other|38|||
130210097|NCT00207727|468729326|FG001|Overall Study|Other|41|||
130210098|NCT00207727|468729327|FG002|Overall Study|Other|41|||
130210099|NCT00207727|468729328|FG003|Overall Study|Other|37|||
130210100|NCT00207727|468729329|FG004|Overall Study|Other|33|||
130210101|NCT00463840|468729334|FG000|Overall Study|Disease progression|7|||
130210102|NCT00463840|468729334|FG000|Overall Study|Withdrawal by Subject|2|||
130210103|NCT00463840|468729334|FG000|Overall Study|Adverse Event|3|||
130210104|NCT01653327|468729335|FG000|Overall Study|Withdrawal by Subject|1|||
130210105|NCT04607980|468729336|FG000|Overall Study|Adverse Event|3|||
130210106|NCT04607980|468729337|FG001|Overall Study|Adverse Event|4|||
130210107|NCT04607980|468729336|FG000|Overall Study|Death|0|||
130210108|NCT04607980|468729337|FG001|Overall Study|Death|1|||
130210109|NCT04607980|468729336|FG000|Overall Study|Withdrawal by Subject|2|||
130210110|NCT04607980|468729337|FG001|Overall Study|Withdrawal by Subject|5|||
130210111|NCT04607980|468729336|FG000|Overall Study|Lost to Follow-up|4|||
130210112|NCT04607980|468729337|FG001|Overall Study|Lost to Follow-up|8|||
130210113|NCT04607980|468729336|FG000|Overall Study|Protocol Violation|0|||
130210114|NCT04607980|468729337|FG001|Overall Study|Protocol Violation|3|||
130210115|NCT04607980|468729336|FG000|Overall Study|Other|3|||
130210116|NCT04607980|468729337|FG001|Overall Study|Other|0|||
130210117|NCT04767529|468730688|FG000|Overall Study|Adverse Event|0|||
130210118|NCT04767529|468730689|FG001|Overall Study|Adverse Event|4|||
130210119|NCT04767529|468730690|FG002|Overall Study|Adverse Event|3|||
130210120|NCT04767529|468730688|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
130210121|NCT04767529|468730689|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130376456|NCT00887978|469343697|FG000|Overall Study|Adverse Event|18|||
130210122|NCT04767529|468730690|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130210123|NCT04767529|468730688|FG000|Overall Study|Required use of a prohibited medication|0|||
130210124|NCT04767529|468730689|FG001|Overall Study|Required use of a prohibited medication|1|||
130210125|NCT04767529|468730690|FG002|Overall Study|Required use of a prohibited medication|0|||
130210126|NCT04767529|468730688|FG000|Overall Study|Withdrawal by Subject|7|||
130210127|NCT04767529|468730689|FG001|Overall Study|Withdrawal by Subject|5|||
130210128|NCT04767529|468730690|FG002|Overall Study|Withdrawal by Subject|4|||
130210129|NCT04767529|468730688|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
130210130|NCT04767529|468730689|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
130210131|NCT04767529|468730690|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
130210132|NCT04767529|468730688|FG000|Overall Study|Lost to Follow-up|0|||
130210133|NCT04767529|468730689|FG001|Overall Study|Lost to Follow-up|2|||
130210134|NCT04767529|468730690|FG002|Overall Study|Lost to Follow-up|3|||
130210135|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130210136|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210137|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210138|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210139|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210140|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210141|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210142|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210143|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
130210144|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210145|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210146|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210147|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210148|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130210149|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210150|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210151|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210152|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210153|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210154|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
130210155|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210156|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210157|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210158|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210159|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210160|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210161|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210162|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210163|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210164|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130210165|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210166|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210167|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130210168|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210169|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210170|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130210171|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210172|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210173|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210174|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210175|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
130210176|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210177|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210178|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210179|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210180|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210181|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130210182|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210183|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210184|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210185|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210186|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210187|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130654520|NCT03426995|470357660|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130431069|NCT04739761|469539416|FG001|Overall Study|Death|13|||
130431070|NCT04739761|469539415|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
130543480|NCT02292927|469956730|FG000|Overall Study|Protocol Violation|13|||
130543481|NCT02292927|469956731|FG001|Overall Study|Protocol Violation|7|||
130543482|NCT01656733|469956735|FG000|Overall Study|No permission to collect birth outcomes|0|||
130543483|NCT01656733|469956736|FG001|Overall Study|No permission to collect birth outcomes|1|||
130543484|NCT01656733|469956735|FG000|Overall Study|Delivery at another hospital|0|||
130543485|NCT01656733|469956736|FG001|Overall Study|Delivery at another hospital|2|||
130543486|NCT01656733|469956735|FG000|Overall Study|Spontaneous abortion|0|||
130543487|NCT01656733|469956736|FG001|Overall Study|Spontaneous abortion|1|||
130543488|NCT00682890|469956740|FG000|Overall Study|Lost to Follow-up|1|||
130543489|NCT00682890|469956741|FG001|Overall Study|Lost to Follow-up|1|||
130543490|NCT00682890|469956740|FG000|Overall Study|subject moved away|0|||
130543491|NCT00682890|469956741|FG001|Overall Study|subject moved away|1|||
130543492|NCT00682890|469956740|FG000|Overall Study|heavy menstrual bleeding|1|||
130543493|NCT00682890|469956741|FG001|Overall Study|heavy menstrual bleeding|0|||
130543494|NCT03545503|469956742|FG000|Overall Study|Protocol Violation|14|||
130543495|NCT03545503|469956743|FG001|Overall Study|Protocol Violation|16|||
130543496|NCT02224690|469956746|FG000|Overall Study|Adverse Event|8|||
130543497|NCT02224690|469956747|FG001|Overall Study|Adverse Event|1|||
130543498|NCT02224690|469956746|FG000|Overall Study|Met Withdrawal Criteria|4|||
130543499|NCT02224690|469956747|FG001|Overall Study|Met Withdrawal Criteria|0|||
130543500|NCT02224690|469956746|FG000|Overall Study|Use of G-tube|1|||
130543501|NCT02224690|469956747|FG001|Overall Study|Use of G-tube|0|||
130543502|NCT02224690|469956746|FG000|Overall Study|Did not meet eligibility criteria|1|||
130543503|NCT02224690|469956747|FG001|Overall Study|Did not meet eligibility criteria|0|||
130543504|NCT00141219|469956748|FG000|Overall Study|Protocol violations|5|||
130543505|NCT00141219|469956749|FG001|Overall Study|Protocol violations|4|||
130543506|NCT00141219|469956748|FG000|Overall Study|Adverse Event|8|||
130543507|NCT00141219|469956749|FG001|Overall Study|Adverse Event|6|||
130543508|NCT00141219|469956748|FG000|Overall Study|Lack of Efficacy|5|||
130543509|NCT00141219|469956749|FG001|Overall Study|Lack of Efficacy|4|||
130543510|NCT00141219|469956748|FG000|Overall Study|Withdrawal by Subject|6|||
130543511|NCT00141219|469956749|FG001|Overall Study|Withdrawal by Subject|2|||
130543512|NCT00122460|469956751|FG000|Overall Study|investigational study phase ongoing|7|||
130543513|NCT00122460|469956752|FG001|Overall Study|investigational study phase ongoing|1|||
130543514|NCT02595073|469956753|FG000|Overall Study|Progressive Disease|0|||
130543515|NCT02595073|469956754|FG001|Overall Study|Progressive Disease|1|||
130543516|NCT02595073|469956753|FG000|Overall Study|Protocol Violation|2|||
130543517|NCT02595073|469956754|FG001|Overall Study|Protocol Violation|0|||
130543518|NCT02962960|469956755|FG000|Overall Study|Withdrawal by Subject|1|||
130543519|NCT02962960|469956756|FG001|Overall Study|Withdrawal by Subject|1|||
130543520|NCT02962960|469956757|FG002|Overall Study|Withdrawal by Subject|0|||
130543521|NCT02962960|469956755|FG000|Overall Study|Adverse Event|1|||
130543522|NCT02962960|469956756|FG001|Overall Study|Adverse Event|1|||
130543523|NCT02962960|469956757|FG002|Overall Study|Adverse Event|0|||
130543524|NCT02962960|469956755|FG000|Overall Study|Protocol Violation|1|||
130543525|NCT02962960|469956756|FG001|Overall Study|Protocol Violation|0|||
130543526|NCT02962960|469956757|FG002|Overall Study|Protocol Violation|0|||
130543527|NCT01605019|469956758|FG000|Overall Study|pt did not meet transplant endpoint|3|||
130543528|NCT01605019|469956759|FG001|Overall Study|pt did not meet transplant endpoint|0|||
130543529|NCT01451827|469956760|FG000|Overall Study|Adverse Event|2|||
130543530|NCT01451827|469956761|FG001|Overall Study|Adverse Event|0|||
130543531|NCT01451827|469956762|FG002|Overall Study|Adverse Event|1|||
130543532|NCT01451827|469956763|FG003|Overall Study|Adverse Event|1|||
130543533|NCT01451827|469956760|FG000|Overall Study|Protocol deviation|1|||
130543534|NCT01451827|469956761|FG001|Overall Study|Protocol deviation|0|||
130543535|NCT01451827|469956762|FG002|Overall Study|Protocol deviation|0|||
130543536|NCT01451827|469956763|FG003|Overall Study|Protocol deviation|0|||
130543537|NCT01451827|469956760|FG000|Overall Study|Lost to Follow-up|0|||
130543538|NCT01451827|469956761|FG001|Overall Study|Lost to Follow-up|3|||
130543539|NCT01451827|469956762|FG002|Overall Study|Lost to Follow-up|0|||
130543540|NCT01451827|469956763|FG003|Overall Study|Lost to Follow-up|2|||
130543541|NCT01451827|469956760|FG000|Overall Study|Participant met withdrawal criteria|0|||
130543542|NCT01451827|469956761|FG001|Overall Study|Participant met withdrawal criteria|2|||
130543543|NCT01451827|469956762|FG002|Overall Study|Participant met withdrawal criteria|0|||
130543544|NCT01451827|469956763|FG003|Overall Study|Participant met withdrawal criteria|0|||
130543545|NCT01451827|469956760|FG000|Overall Study|Withdrawal by Subject|0|||
130543546|NCT01451827|469956761|FG001|Overall Study|Withdrawal by Subject|0|||
130543547|NCT01451827|469956762|FG002|Overall Study|Withdrawal by Subject|1|||
130543548|NCT01451827|469956763|FG003|Overall Study|Withdrawal by Subject|1|||
130543549|NCT02424734|469956764|FG000|Overall Study|Treatment stopped to be discharged home|2|||
130543550|NCT02424734|469956765|FG001|Overall Study|Treatment stopped to be discharged home|2|||
130543551|NCT02424734|469956766|FG002|Overall Study|Treatment stopped to be discharged home|0|||
130543552|NCT01642251|469956767|FG000|Overall Study|Progressive disease|0|||
130543553|NCT01642251|469956768|FG001|Overall Study|Progressive disease|0|||
130210188|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210189|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210190|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210191|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210192|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210193|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210194|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210195|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
130210196|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210197|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210198|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210199|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210200|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210201|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210202|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210203|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210204|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210205|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210206|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
130210207|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210208|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
130210209|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210210|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210211|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210212|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210213|NCT01716520|468730691|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210214|NCT01716520|468730692|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210215|NCT01716520|468730693|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210216|NCT01716520|468730694|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210217|NCT01716520|468730695|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210218|NCT01716520|468730696|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
130210219|NCT01716520|468730691|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210220|NCT01716520|468730692|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210221|NCT01716520|468730693|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130210222|NCT01716520|468730694|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210223|NCT01716520|468730695|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210224|NCT01716520|468730696|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210225|NCT01937884|468730700|FG000|Overall Study|Withdrawal by Subject|1|||
130210226|NCT01937884|468730701|FG001|Overall Study|Withdrawal by Subject|0|||
130210227|NCT00004088|468730702|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
130210228|NCT00004088|468730702|FG000|Overall Study|Withdrawal by Subject|1|||
130210229|NCT00004088|468730702|FG000|Overall Study|Protocol Violation|3|||
130210230|NCT00004088|468730702|FG000|Overall Study|Physician Decision|1|||
130210231|NCT02636699|468730709|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
130210232|NCT02636699|468730710|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
130210233|NCT02636699|468730711|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
130210234|NCT02636699|468730709|FG000|Screening Period|Withdrawal by Subject|0|||
130210235|NCT02636699|468730710|FG001|Screening Period|Withdrawal by Subject|0|||
130210236|NCT02636699|468730711|FG002|Screening Period|Withdrawal by Subject|23|||
130210237|NCT02636699|468730709|FG000|Screening Period|Adverse Event|0|||
130210238|NCT02636699|468730710|FG001|Screening Period|Adverse Event|0|||
130210239|NCT02636699|468730711|FG002|Screening Period|Adverse Event|1|||
130210240|NCT02636699|468730709|FG000|Screening Period|Other not specified|0|||
130210241|NCT02636699|468730710|FG001|Screening Period|Other not specified|0|||
130210242|NCT02636699|468730711|FG002|Screening Period|Other not specified|3|||
130210243|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
130210244|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
130210245|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
130210246|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130210247|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130210248|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
130210249|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
130210250|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130210251|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130210252|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
130210253|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
130210254|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
130210255|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
130210256|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
130210257|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
130210258|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Other|3|||
130210259|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Other|1|||
130210260|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Other|0|||
130210261|NCT00981058|468730714|FG000|Overall Study|Progressive Disease|38|||
130210262|NCT00981058|468730715|FG001|Overall Study|Progressive Disease|31|||
130210263|NCT00981058|468730714|FG000|Overall Study|Lost to Follow-up|3|||
130210264|NCT00981058|468730715|FG001|Overall Study|Lost to Follow-up|2|||
130210265|NCT00981058|468730714|FG000|Overall Study|Physician Decision|4|||
130210266|NCT00981058|468730715|FG001|Overall Study|Physician Decision|5|||
130210267|NCT00981058|468730714|FG000|Overall Study|Randomization Error|0|||
130210268|NCT00981058|468730715|FG001|Overall Study|Randomization Error|1|||
130210269|NCT00981058|468730714|FG000|Overall Study|Withdrawal by Subject|24|||
130210270|NCT00981058|468730715|FG001|Overall Study|Withdrawal by Subject|22|||
130210271|NCT02667587|468730716|FG000|Pre-Treatment|Not reported|1|||
130210272|NCT02667587|468730717|FG001|Pre-Treatment|Not reported|0|||
130210273|NCT02667587|468730716|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130210274|NCT02667587|468730717|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
130210275|NCT02667587|468730716|FG000|Pre-Treatment|Participant withdrew consent|0|||
130210276|NCT02667587|468730717|FG001|Pre-Treatment|Participant withdrew consent|1|||
130210277|NCT02667587|468730716|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130210278|NCT02667587|468730717|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130210279|NCT02667587|468730716|FG000|End of Treatment|Disease Progression|193|||
130210280|NCT02667587|468730717|FG001|End of Treatment|Disease Progression|226|||
130210281|NCT02667587|468730716|FG000|End of Treatment|Study Drug Toxicity|75|||
130210282|NCT02667587|468730717|FG001|End of Treatment|Study Drug Toxicity|19|||
130210283|NCT02667587|468730716|FG000|End of Treatment|Death|2|||
130210284|NCT02667587|468730717|FG001|End of Treatment|Death|1|||
130210285|NCT02667587|468730716|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
130210286|NCT02667587|468730717|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
130210287|NCT02667587|468730716|FG000|End of Treatment|participant request to discontinue treatment|33|||
130210288|NCT02667587|468730717|FG001|End of Treatment|participant request to discontinue treatment|35|||
130210289|NCT02667587|468730716|FG000|End of Treatment|participant withdrew consent|5|||
130210290|NCT02667587|468730717|FG001|End of Treatment|participant withdrew consent|6|||
130210291|NCT02667587|468730716|FG000|End of Treatment|Lost to Follow-up|1|||
130210292|NCT02667587|468730717|FG001|End of Treatment|Lost to Follow-up|2|||
130210293|NCT02667587|468730716|FG000|End of Treatment|maximum clinical benefit|4|||
130210294|NCT02667587|468730717|FG001|End of Treatment|maximum clinical benefit|4|||
130210295|NCT02667587|468730716|FG000|End of Treatment|poor or non compliant|0|||
130210296|NCT02667587|468730717|FG001|End of Treatment|poor or non compliant|1|||
130210297|NCT02667587|468730716|FG000|End of Treatment|participant no longer meets study criteria|1|||
130210298|NCT02667587|468730717|FG001|End of Treatment|participant no longer meets study criteria|1|||
130210299|NCT02667587|468730716|FG000|End of Treatment|administrative reason by sponsor|1|||
130210300|NCT02667587|468730717|FG001|End of Treatment|administrative reason by sponsor|29|||
130210301|NCT02667587|468730716|FG000|End of Treatment|other reasonse|21|||
130210302|NCT02667587|468730717|FG001|End of Treatment|other reasonse|10|||
130210303|NCT02305446|468730724|FG000|Overall Study|Adverse Event|1|||
130210304|NCT01636947|468730725|FG000|Overall Study|Not Treated|2|||
130210305|NCT01636947|468730726|FG001|Overall Study|Not Treated|2|||
130210306|NCT01636947|468730725|FG000|Overall Study|Lost to Follow-up|4|||
130210307|NCT01636947|468730726|FG001|Overall Study|Lost to Follow-up|0|||
130210308|NCT01636947|468730725|FG000|Overall Study|Protocol Violation|1|||
130210309|NCT01636947|468730726|FG001|Overall Study|Protocol Violation|1|||
130210310|NCT01636947|468730725|FG000|Overall Study|Withdrawal by Subject|3|||
130210311|NCT01636947|468730726|FG001|Overall Study|Withdrawal by Subject|3|||
130210312|NCT01636947|468730725|FG000|Overall Study|Adverse Event|1|||
130210313|NCT01636947|468730726|FG001|Overall Study|Adverse Event|1|||
130210314|NCT01636947|468730725|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130210315|NCT01636947|468730726|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
130210316|NCT00957424|468730727|FG000|Overall Study|Lost to Follow-up|19|||
130210317|NCT00957424|468730727|FG000|Overall Study|Protocol Violation|3|||
130210318|NCT00957424|468730727|FG000|Overall Study|Withdrawal by Subject|1|||
130210319|NCT05182606|468730734|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
130210320|NCT01167634|468730737|FG000|Overall Study|Lost to Follow-up|1|||
130210321|NCT01167634|468730738|FG001|Overall Study|Lost to Follow-up|3|||
130210322|NCT01167634|468730739|FG002|Overall Study|Lost to Follow-up|3|||
130210323|NCT01167634|468730740|FG003|Overall Study|Lost to Follow-up|4|||
130210324|NCT01167634|468730737|FG000|Overall Study|Withdrawal by Subject|1|||
130210325|NCT01167634|468730738|FG001|Overall Study|Withdrawal by Subject|1|||
130210326|NCT01167634|468730739|FG002|Overall Study|Withdrawal by Subject|0|||
130210327|NCT01167634|468730740|FG003|Overall Study|Withdrawal by Subject|0|||
130210328|NCT00438256|468730741|FG000|Overall Study|Ineligible for Resection|2|||
130210329|NCT00438256|468730742|FG001|Overall Study|Ineligible for Resection|1|||
130210330|NCT00438256|468730743|FG002|Overall Study|Ineligible for Resection|1|||
130210331|NCT00438256|468730744|FG003|Overall Study|Ineligible for Resection|7|||
130210332|NCT00438256|468730741|FG000|Overall Study|Excluded final Diagnosis|0|||
130210333|NCT00438256|468730742|FG001|Overall Study|Excluded final Diagnosis|0|||
130210334|NCT00438256|468730743|FG002|Overall Study|Excluded final Diagnosis|0|||
130210335|NCT00438256|468730744|FG003|Overall Study|Excluded final Diagnosis|2|||
130210336|NCT01133288|468730745|FG000|Eligibility Assessment|met exclusion criteria|5|||
130210337|NCT01133288|468730745|FG000|Intervention Allocation|study terminated|2|||
130210338|NCT00369161|468730746|FG000|Overall Study|Adverse Event|15|||
130210339|NCT00369161|468730747|FG001|Overall Study|Adverse Event|13|||
130210340|NCT00369161|468730746|FG000|Overall Study|Abnormal laboratory value|0|||
130210341|NCT00369161|468730747|FG001|Overall Study|Abnormal laboratory value|1|||
130210342|NCT00369161|468730746|FG000|Overall Study|Lack of Efficacy|3|||
130210343|NCT00369161|468730747|FG001|Overall Study|Lack of Efficacy|1|||
130210344|NCT00369161|468730746|FG000|Overall Study|Protocol Violation|0|||
130210345|NCT00369161|468730747|FG001|Overall Study|Protocol Violation|2|||
130210346|NCT00369161|468730746|FG000|Overall Study|Withdrawal by Subject|2|||
130210347|NCT00369161|468730747|FG001|Overall Study|Withdrawal by Subject|3|||
130210348|NCT00369161|468730746|FG000|Overall Study|Death|1|||
130210349|NCT00369161|468730747|FG001|Overall Study|Death|2|||
130210350|NCT00369161|468730746|FG000|Overall Study|Graft loss|4|||
130210351|NCT00369161|468730747|FG001|Overall Study|Graft loss|0|||
130210352|NCT00369161|468730746|FG000|Overall Study|Administrative Problem|2|||
130210353|NCT00369161|468730747|FG001|Overall Study|Administrative Problem|2|||
130210354|NCT02147067|468730750|FG000|Overall Study|Withdrawal by Subject|2|||
130210355|NCT02147067|468730751|FG001|Overall Study|Withdrawal by Subject|2|||
130210356|NCT02603107|468730752|FG000|Randomized Phase|Withdrew consent|8|||
130210357|NCT02603107|468730753|FG001|Randomized Phase|Withdrew consent|15|||
130210358|NCT02603107|468730752|FG000|Randomized Phase|Lost to Follow-up|1|||
130210359|NCT02603107|468730753|FG001|Randomized Phase|Lost to Follow-up|3|||
130210360|NCT02603107|468730752|FG000|Randomized Phase|Adverse Event|2|||
130210361|NCT02603107|468730753|FG001|Randomized Phase|Adverse Event|0|||
130210362|NCT02603107|468730752|FG000|Randomized Phase|Death|1|||
130210363|NCT02603107|468730753|FG001|Randomized Phase|Death|1|||
130210364|NCT02603107|468730752|FG000|Randomized Phase|Non-compliance with study drug|1|||
130210365|NCT02603107|468730753|FG001|Randomized Phase|Non-compliance with study drug|1|||
130210366|NCT02603107|468730752|FG000|Randomized Phase|Investigator's discretion|0|||
130210367|NCT02603107|468730753|FG001|Randomized Phase|Investigator's discretion|1|||
130210368|NCT02603107|468730752|FG000|Randomized Phase|Lack of Efficacy|1|||
130210369|NCT02603107|468730753|FG001|Randomized Phase|Lack of Efficacy|0|||
130210370|NCT02603107|468730752|FG000|Randomized Phase|Protocol Violation|1|||
130210371|NCT02603107|468730753|FG001|Randomized Phase|Protocol Violation|0|||
130210372|NCT02603107|468730752|FG000|Optional Extension Phase|Lost to Follow-up|3|||
130210373|NCT02603107|468730753|FG001|Optional Extension Phase|Lost to Follow-up|3|||
130210374|NCT02603107|468730752|FG000|Optional Extension Phase|Withdrew consent|3|||
130210375|NCT02603107|468730753|FG001|Optional Extension Phase|Withdrew consent|2|||
130210376|NCT02603107|468730752|FG000|Optional Extension Phase|Investigator's discretion|2|||
130210377|NCT02603107|468730753|FG001|Optional Extension Phase|Investigator's discretion|2|||
130210378|NCT02603107|468730752|FG000|Optional Extension Phase|Pregnancy|0|||
130210379|NCT02603107|468730753|FG001|Optional Extension Phase|Pregnancy|3|||
130210380|NCT02603107|468730752|FG000|Optional Extension Phase|Adverse Event|0|||
130210381|NCT02603107|468730753|FG001|Optional Extension Phase|Adverse Event|2|||
130210382|NCT02603107|468730752|FG000|Optional Extension Phase|Not treated in extension phase|0|||
130210383|NCT02603107|468730753|FG001|Optional Extension Phase|Not treated in extension phase|1|||
130210384|NCT02603107|468730752|FG000|Optional Extension Phase|Protocol Violation|1|||
130210385|NCT02603107|468730753|FG001|Optional Extension Phase|Protocol Violation|0|||
130210386|NCT01404949|468730754|FG000|Overall Study|Not Treated|1|||
130210387|NCT03411902|468730755|FG000|Overall Study|Lost to Follow-up|3|||
130210388|NCT03411902|468730756|FG001|Overall Study|Lost to Follow-up|0|||
130210389|NCT00419159|468730757|FG000|Overall Study|Adverse Event|7|||
130210390|NCT00419159|468730758|FG001|Overall Study|Adverse Event|15|||
130210391|NCT00419159|468730757|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130210392|NCT00419159|468730758|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130210393|NCT00419159|468730757|FG000|Overall Study|Subject's no longer requires study drug|0|||
130210394|NCT00419159|468730758|FG001|Overall Study|Subject's no longer requires study drug|1|||
130210395|NCT00419159|468730757|FG000|Overall Study|Protocol Violation|1|||
130210396|NCT00419159|468730758|FG001|Overall Study|Protocol Violation|0|||
130210397|NCT00419159|468730757|FG000|Overall Study|Withdrawal by Subject|10|||
130210398|NCT00419159|468730758|FG001|Overall Study|Withdrawal by Subject|3|||
130210399|NCT00419159|468730757|FG000|Overall Study|Lost to Follow-up|0|||
130210400|NCT00419159|468730758|FG001|Overall Study|Lost to Follow-up|1|||
130210401|NCT00419159|468730757|FG000|Overall Study|Death|2|||
130210402|NCT00419159|468730758|FG001|Overall Study|Death|2|||
130210403|NCT00419159|468730757|FG000|Overall Study|Disease progression|79|||
130210404|NCT00419159|468730758|FG001|Overall Study|Disease progression|76|||
130210405|NCT01017601|468730759|FG000|Overall Study|Disease Progression|12|||
130210406|NCT01017601|468730760|FG001|Overall Study|Disease Progression|12|||
130210407|NCT01017601|468730759|FG000|Overall Study|Withdrawal by Subject|0|||
130210408|NCT01017601|468730760|FG001|Overall Study|Withdrawal by Subject|1|||
130210409|NCT00574795|468730762|FG000|Infant Series|Withdrawal by Subject|2|||
130210410|NCT00574795|468730762|FG000|Infant Series|Protocol Violation|2|||
130210411|NCT00574795|468730762|FG000|Infant Series|Adverse Event|1|||
130210412|NCT00574795|468730762|FG000|After Infant Series|Withdrawal by Subject|1|||
130210413|NCT00574795|468730762|FG000|After Infant Series|Adverse Event|2|||
130210414|NCT00574795|468730762|FG000|Toddler Dose|Withdrawal by Subject|1|||
130210415|NCT02638259|468730763|FG000|Treatment Period 1|Adverse Event|1|||
130210416|NCT02638259|468730764|FG001|Treatment Period 1|Adverse Event|5|||
130210417|NCT02638259|468730763|FG000|Treatment Period 1|Death|0|||
130210418|NCT02638259|468730764|FG001|Treatment Period 1|Death|1|||
130210419|NCT02638259|468730763|FG000|Treatment Period 1|Lack of Efficacy|0|||
130210420|NCT02638259|468730764|FG001|Treatment Period 1|Lack of Efficacy|1|||
130210421|NCT02638259|468730763|FG000|Treatment Period 1|Protocol Violation|0|||
130210422|NCT02638259|468730764|FG001|Treatment Period 1|Protocol Violation|3|||
130210423|NCT02638259|468730763|FG000|Treatment Period 1|Withdrawal by Subject|4|||
130210424|NCT02638259|468730764|FG001|Treatment Period 1|Withdrawal by Subject|6|||
130210425|NCT02638259|468730763|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
130210426|NCT02638259|468730764|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
130210427|NCT02638259|468730763|FG000|Treatment Period 2|Adverse Event|5|||
130210428|NCT02638259|468730764|FG001|Treatment Period 2|Adverse Event|4|||
130210429|NCT02638259|468730763|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130210430|NCT02638259|468730764|FG001|Treatment Period 2|Withdrawal by Subject|7|||
130210431|NCT01706575|468730765|FG000|Overall Study|Participant Withdrew Consent|4|||
130210432|NCT01706575|468730765|FG000|Overall Study|Lost to Follow-up|2|||
130210433|NCT01706575|468730765|FG000|Overall Study|Started but not Treated|6|||
130210434|NCT01094782|468730766|FG000|Overall Study|Withdrawal by Subject|5|||
130210435|NCT01094782|468730767|FG001|Overall Study|Withdrawal by Subject|5|||
130210436|NCT01094782|468730768|FG002|Overall Study|Withdrawal by Subject|1|||
130210437|NCT01094782|468730769|FG003|Overall Study|Withdrawal by Subject|5|||
130210438|NCT01094782|468730770|FG004|Overall Study|Withdrawal by Subject|5|||
130210439|NCT01094782|468730771|FG005|Overall Study|Withdrawal by Subject|0|||
130210440|NCT01094782|468730766|FG000|Overall Study|Lost to Follow-up|1|||
130210441|NCT01094782|468730767|FG001|Overall Study|Lost to Follow-up|0|||
130210442|NCT01094782|468730768|FG002|Overall Study|Lost to Follow-up|0|||
130210443|NCT01094782|468730769|FG003|Overall Study|Lost to Follow-up|2|||
130210444|NCT01094782|468730770|FG004|Overall Study|Lost to Follow-up|1|||
130210445|NCT01094782|468730771|FG005|Overall Study|Lost to Follow-up|4|||
130210446|NCT01094782|468730766|FG000|Overall Study|Positive Drug Screen|2|||
130210447|NCT01094782|468730767|FG001|Overall Study|Positive Drug Screen|2|||
130210448|NCT01094782|468730768|FG002|Overall Study|Positive Drug Screen|1|||
130210449|NCT01094782|468730769|FG003|Overall Study|Positive Drug Screen|1|||
130210450|NCT01094782|468730770|FG004|Overall Study|Positive Drug Screen|3|||
130210451|NCT01094782|468730771|FG005|Overall Study|Positive Drug Screen|2|||
130210452|NCT01094782|468730766|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
130210453|NCT01094782|468730767|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
130210454|NCT01094782|468730768|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
130210455|NCT01094782|468730769|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
130210456|NCT01094782|468730770|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
130210457|NCT01094782|468730771|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
130210458|NCT01094782|468730766|FG000|Overall Study|Unable to Complete Questionnaires|0|||
130210459|NCT01094782|468730767|FG001|Overall Study|Unable to Complete Questionnaires|1|||
130210460|NCT01094782|468730768|FG002|Overall Study|Unable to Complete Questionnaires|0|||
130210461|NCT01094782|468730769|FG003|Overall Study|Unable to Complete Questionnaires|0|||
130210462|NCT01094782|468730770|FG004|Overall Study|Unable to Complete Questionnaires|0|||
130210463|NCT01094782|468730771|FG005|Overall Study|Unable to Complete Questionnaires|0|||
130210464|NCT01094782|468730766|FG000|Overall Study|Healthy Subject Had Pain|0|||
130210465|NCT01094782|468730767|FG001|Overall Study|Healthy Subject Had Pain|1|||
130210466|NCT01094782|468730768|FG002|Overall Study|Healthy Subject Had Pain|0|||
130210467|NCT01094782|468730769|FG003|Overall Study|Healthy Subject Had Pain|0|||
130210468|NCT01094782|468730770|FG004|Overall Study|Healthy Subject Had Pain|0|||
130210469|NCT01094782|468730771|FG005|Overall Study|Healthy Subject Had Pain|0|||
130210470|NCT01094782|468730766|FG000|Overall Study|Hypertension|0|||
130210471|NCT01094782|468730767|FG001|Overall Study|Hypertension|0|||
130210472|NCT01094782|468730768|FG002|Overall Study|Hypertension|1|||
130210473|NCT01094782|468730769|FG003|Overall Study|Hypertension|0|||
130210474|NCT01094782|468730770|FG004|Overall Study|Hypertension|0|||
130210475|NCT01094782|468730771|FG005|Overall Study|Hypertension|0|||
130210476|NCT01094782|468730766|FG000|Overall Study|Wrong Pain Condition|0|||
130210477|NCT01094782|468730767|FG001|Overall Study|Wrong Pain Condition|0|||
130210478|NCT01094782|468730768|FG002|Overall Study|Wrong Pain Condition|0|||
130210479|NCT01094782|468730769|FG003|Overall Study|Wrong Pain Condition|2|||
130210480|NCT01094782|468730770|FG004|Overall Study|Wrong Pain Condition|1|||
130210481|NCT01094782|468730771|FG005|Overall Study|Wrong Pain Condition|1|||
130210482|NCT01094782|468730766|FG000|Overall Study|Recent Interventional Injection|0|||
130210483|NCT01094782|468730767|FG001|Overall Study|Recent Interventional Injection|0|||
130210484|NCT01094782|468730768|FG002|Overall Study|Recent Interventional Injection|0|||
130210485|NCT01094782|468730769|FG003|Overall Study|Recent Interventional Injection|0|||
130210486|NCT01094782|468730770|FG004|Overall Study|Recent Interventional Injection|0|||
130210487|NCT01094782|468730771|FG005|Overall Study|Recent Interventional Injection|1|||
130210488|NCT01094782|468730766|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210489|NCT01094782|468730767|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210490|NCT01094782|468730768|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210491|NCT01094782|468730769|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210492|NCT01094782|468730770|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
130210493|NCT01094782|468730771|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210494|NCT01094782|468730766|FG000|Overall Study|Noncompliance With Study Schedule|0|||
130210495|NCT01094782|468730767|FG001|Overall Study|Noncompliance With Study Schedule|0|||
130210496|NCT01094782|468730768|FG002|Overall Study|Noncompliance With Study Schedule|0|||
130210497|NCT01094782|468730769|FG003|Overall Study|Noncompliance With Study Schedule|1|||
130210498|NCT01094782|468730770|FG004|Overall Study|Noncompliance With Study Schedule|0|||
130210499|NCT01094782|468730771|FG005|Overall Study|Noncompliance With Study Schedule|0|||
130210500|NCT00957905|468730772|FG000|Part B|Not Treated|0|||
130210501|NCT00957905|468730773|FG001|Part B|Not Treated|1|||
130210502|NCT00957905|468730772|FG000|Part B|Physician Decision|0|||
130210503|NCT00957905|468730773|FG001|Part B|Physician Decision|1|||
130210504|NCT00957905|468730772|FG000|Part B|Death|0|||
130210505|NCT00957905|468730773|FG001|Part B|Death|1|||
130210506|NCT00957905|468730772|FG000|Part B|Protocol Violation|0|||
130210507|NCT00957905|468730773|FG001|Part B|Protocol Violation|1|||
130210508|NCT02073656|468730790|FG000|Primary Study|Lost to Follow-up|6|||
130210509|NCT02073656|468730790|FG000|Primary Study|Death|1|||
130210510|NCT02073656|468730790|FG000|Primary Study|Withdrew Consent|1|||
130210511|NCT02536781|468730793|FG000|Overall Study|Lost to Follow-up|2|||
130210512|NCT02536781|468730794|FG001|Overall Study|Lost to Follow-up|0|||
130210513|NCT03423147|468730795|FG000|Overall Study|Lost to Follow-up|5|||
130210514|NCT03423147|468730796|FG001|Overall Study|Lost to Follow-up|8|||
130210515|NCT03423147|468730795|FG000|Overall Study|Withdrawal by Subject|1|||
130210516|NCT03423147|468730796|FG001|Overall Study|Withdrawal by Subject|0|||
130210517|NCT03423147|468730795|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
130210518|NCT03423147|468730796|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
130210519|NCT03423147|468730795|FG000|Overall Study|Age < 18|1|||
130210520|NCT03423147|468730796|FG001|Overall Study|Age < 18|0|||
130210521|NCT03423147|468730795|FG000|Overall Study|No Trial of Labor|0|||
130210522|NCT03423147|468730796|FG001|Overall Study|No Trial of Labor|1|||
130376457|NCT00887978|469343698|FG001|Overall Study|Adverse Event|5|||
130210523|NCT01048099|468730797|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
130210524|NCT01048099|468730797|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
130210525|NCT02258334|468730800|FG000|Overall Study|Adverse Event|1|||
130210526|NCT02258334|468730801|FG001|Overall Study|Adverse Event|0|||
130210527|NCT02258334|468730802|FG002|Overall Study|Adverse Event|0|||
130210528|NCT02258334|468730803|FG003|Overall Study|Adverse Event|0|||
130210529|NCT01969084|468730804|FG000|Overall Study|Adverse Event|0|||
130210530|NCT01969084|468730805|FG001|Overall Study|Adverse Event|1|||
130210531|NCT00862459|468730808|FG000|Overall Study|Lost to Follow-up|1|||
130210532|NCT00862459|468730809|FG001|Overall Study|Lost to Follow-up|2|||
130210533|NCT00862459|468730810|FG002|Overall Study|Lost to Follow-up|2|||
130210534|NCT00862459|468730808|FG000|Overall Study|Protocol Violation|1|||
130210535|NCT00862459|468730809|FG001|Overall Study|Protocol Violation|0|||
130210536|NCT00862459|468730810|FG002|Overall Study|Protocol Violation|0|||
130210537|NCT00862459|468730808|FG000|Overall Study|Withdrawal by Subject|1|||
130210538|NCT00862459|468730809|FG001|Overall Study|Withdrawal by Subject|1|||
130210539|NCT00862459|468730810|FG002|Overall Study|Withdrawal by Subject|3|||
130210540|NCT00862459|468730808|FG000|Overall Study|Adverse Event|0|||
130210541|NCT00862459|468730809|FG001|Overall Study|Adverse Event|1|||
130210542|NCT00862459|468730810|FG002|Overall Study|Adverse Event|0|||
130210543|NCT00862459|468730808|FG000|Overall Study|Personal reasons|1|||
130210544|NCT00862459|468730809|FG001|Overall Study|Personal reasons|0|||
130210545|NCT00862459|468730810|FG002|Overall Study|Personal reasons|0|||
130210546|NCT00862459|468730808|FG000|Overall Study|Operation|1|||
130210547|NCT00862459|468730809|FG001|Overall Study|Operation|1|||
130210548|NCT00862459|468730810|FG002|Overall Study|Operation|0|||
130210549|NCT00862459|468730808|FG000|Overall Study|Intravenous (IV) site problems|1|||
130210550|NCT00862459|468730809|FG001|Overall Study|Intravenous (IV) site problems|0|||
130210551|NCT00862459|468730810|FG002|Overall Study|Intravenous (IV) site problems|1|||
130210552|NCT00862459|468730808|FG000|Overall Study|Unable to hold still for imaging|0|||
130210553|NCT00862459|468730809|FG001|Overall Study|Unable to hold still for imaging|1|||
130210554|NCT00862459|468730810|FG002|Overall Study|Unable to hold still for imaging|0|||
130210555|NCT00862459|468730808|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130210556|NCT00862459|468730809|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130210557|NCT00862459|468730810|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130210558|NCT00862459|468730808|FG000|Overall Study|Administrative problems|0|||
130210559|NCT00862459|468730809|FG001|Overall Study|Administrative problems|1|||
130210560|NCT00862459|468730810|FG002|Overall Study|Administrative problems|0|||
130210561|NCT04015518|468730815|FG000|Overall Study|Adverse Event|6|||
130210562|NCT04015518|468730816|FG001|Overall Study|Adverse Event|1|||
130210563|NCT04015518|468730817|FG002|Overall Study|Adverse Event|1|||
130210564|NCT04015518|468730818|FG003|Overall Study|Adverse Event|3|||
130210565|NCT04015518|468730819|FG004|Overall Study|Adverse Event|3|||
130210566|NCT04015518|468730815|FG000|Overall Study|Lack of Efficacy|1|||
130210567|NCT04015518|468730816|FG001|Overall Study|Lack of Efficacy|0|||
130210568|NCT04015518|468730817|FG002|Overall Study|Lack of Efficacy|1|||
130210569|NCT04015518|468730818|FG003|Overall Study|Lack of Efficacy|0|||
130210570|NCT04015518|468730819|FG004|Overall Study|Lack of Efficacy|4|||
130210571|NCT04015518|468730815|FG000|Overall Study|Lost to Follow-up|0|||
130210572|NCT04015518|468730816|FG001|Overall Study|Lost to Follow-up|0|||
130210573|NCT04015518|468730817|FG002|Overall Study|Lost to Follow-up|0|||
130210574|NCT04015518|468730818|FG003|Overall Study|Lost to Follow-up|0|||
130210575|NCT04015518|468730819|FG004|Overall Study|Lost to Follow-up|1|||
130210576|NCT04015518|468730815|FG000|Overall Study|Withdrawal by Subject|0|||
130210577|NCT04015518|468730816|FG001|Overall Study|Withdrawal by Subject|1|||
130210578|NCT04015518|468730817|FG002|Overall Study|Withdrawal by Subject|0|||
130210579|NCT04015518|468730818|FG003|Overall Study|Withdrawal by Subject|1|||
130210580|NCT04015518|468730819|FG004|Overall Study|Withdrawal by Subject|1|||
130210581|NCT04015518|468730815|FG000|Overall Study|Patient did not come for consecutive visits|0|||
130210582|NCT04015518|468730816|FG001|Overall Study|Patient did not come for consecutive visits|1|||
130210583|NCT04015518|468730817|FG002|Overall Study|Patient did not come for consecutive visits|0|||
130210584|NCT04015518|468730818|FG003|Overall Study|Patient did not come for consecutive visits|0|||
130210585|NCT04015518|468730819|FG004|Overall Study|Patient did not come for consecutive visits|0|||
130210586|NCT04015518|468730815|FG000|Overall Study|not willing to travel due to Covid-19|0|||
130210587|NCT04015518|468730816|FG001|Overall Study|not willing to travel due to Covid-19|0|||
130210588|NCT04015518|468730817|FG002|Overall Study|not willing to travel due to Covid-19|1|||
130210589|NCT04015518|468730818|FG003|Overall Study|not willing to travel due to Covid-19|0|||
130210590|NCT04015518|468730819|FG004|Overall Study|not willing to travel due to Covid-19|0|||
130210591|NCT04015518|468730815|FG000|Overall Study|Patient wants to discontinue treatment|0|||
130210592|NCT04015518|468730816|FG001|Overall Study|Patient wants to discontinue treatment|0|||
130210593|NCT04015518|468730817|FG002|Overall Study|Patient wants to discontinue treatment|0|||
130210594|NCT04015518|468730818|FG003|Overall Study|Patient wants to discontinue treatment|1|||
130210595|NCT04015518|468730819|FG004|Overall Study|Patient wants to discontinue treatment|0|||
130466709|NCT02544074|469676362|FG000|Overall Study|Withdrawal by Subject|0|||
130543554|NCT01642251|469956769|FG002|Overall Study|Progressive disease|3|||
130543555|NCT01642251|469956770|FG003|Overall Study|Progressive disease|3|||
130543556|NCT01642251|469956767|FG000|Overall Study|Adverse Event|0|||
130543557|NCT01642251|469956768|FG001|Overall Study|Adverse Event|0|||
130543558|NCT01642251|469956769|FG002|Overall Study|Adverse Event|5|||
130543559|NCT01642251|469956770|FG003|Overall Study|Adverse Event|4|||
130543560|NCT01642251|469956767|FG000|Overall Study|Death|0|||
130543561|NCT01642251|469956768|FG001|Overall Study|Death|0|||
130543562|NCT01642251|469956769|FG002|Overall Study|Death|1|||
130543563|NCT01642251|469956770|FG003|Overall Study|Death|3|||
130543564|NCT01642251|469956767|FG000|Overall Study|Withdrawal by Subject|0|||
130543565|NCT01642251|469956768|FG001|Overall Study|Withdrawal by Subject|0|||
130543566|NCT01642251|469956769|FG002|Overall Study|Withdrawal by Subject|1|||
130543567|NCT01642251|469956770|FG003|Overall Study|Withdrawal by Subject|3|||
130543568|NCT01642251|469956767|FG000|Overall Study|Alternative therapy|0|||
130543569|NCT01642251|469956768|FG001|Overall Study|Alternative therapy|0|||
130543570|NCT01642251|469956769|FG002|Overall Study|Alternative therapy|0|||
130543571|NCT01642251|469956770|FG003|Overall Study|Alternative therapy|2|||
130543572|NCT01642251|469956767|FG000|Overall Study|Other complicating disease|0|||
130543573|NCT01642251|469956768|FG001|Overall Study|Other complicating disease|0|||
130543574|NCT01642251|469956769|FG002|Overall Study|Other complicating disease|1|||
130543575|NCT01642251|469956770|FG003|Overall Study|Other complicating disease|0|||
130543576|NCT01642251|469956767|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
130543577|NCT01642251|469956768|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
130543578|NCT01642251|469956769|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
130543579|NCT01642251|469956770|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
130543580|NCT00752557|469956771|FG000|Overall Study|Withdrawal by Subject|4|||
130543581|NCT00752557|469956772|FG001|Overall Study|Withdrawal by Subject|3|||
130543582|NCT00752557|469956773|FG002|Overall Study|Withdrawal by Subject|3|||
130543583|NCT00752557|469956771|FG000|Overall Study|Unspecified resaons|0|||
130543584|NCT00752557|469956772|FG001|Overall Study|Unspecified resaons|2|||
130543585|NCT00752557|469956773|FG002|Overall Study|Unspecified resaons|2|||
130543586|NCT00752557|469956771|FG000|Overall Study|Lost to Follow-up|1|||
130543587|NCT00752557|469956772|FG001|Overall Study|Lost to Follow-up|0|||
130543588|NCT00752557|469956773|FG002|Overall Study|Lost to Follow-up|1|||
130543589|NCT00470366|469956774|FG000|Overall Study|Adverse Event|3|||
130543590|NCT00470366|469956774|FG000|Overall Study|Poor compliance|1|||
130543591|NCT02996474|469956775|FG000|Overall Study|Physician Decision|5|||
130543592|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
130543593|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
130543594|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
130543595|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
130543596|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
130543597|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
130543598|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
130543599|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
130543600|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
130543601|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
130543602|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
130543603|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
130543604|NCT04493502|469956776|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
130543605|NCT04493502|469956777|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
130543606|NCT04493502|469956776|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
130543607|NCT04493502|469956777|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
130543608|NCT04493502|469956776|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
130543609|NCT04493502|469956777|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
130543610|NCT04493502|469956776|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
130543611|NCT04493502|469956777|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
130543612|NCT04493502|469956776|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
130543613|NCT04493502|469956777|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
130543614|NCT04493502|469956776|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
130543615|NCT04493502|469956777|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
130543616|NCT04493502|469956776|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
130543617|NCT04493502|469956777|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
130654521|NCT03426995|470357661|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654522|NCT03426995|470357662|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654523|NCT03426995|470357663|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654524|NCT03426995|470357664|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130654525|NCT03426995|470357646|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654526|NCT03426995|470357647|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654527|NCT03426995|470357648|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130210596|NCT04015518|468730815|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
130210597|NCT04015518|468730816|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
130210598|NCT04015518|468730817|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
130210599|NCT04015518|468730818|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
130210600|NCT04015518|468730819|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
130210601|NCT04015518|468730815|FG000|Overall Study|Pregnancy|0|||
130210602|NCT04015518|468730816|FG001|Overall Study|Pregnancy|0|||
130210603|NCT04015518|468730817|FG002|Overall Study|Pregnancy|0|||
130210604|NCT04015518|468730818|FG003|Overall Study|Pregnancy|0|||
130210605|NCT04015518|468730819|FG004|Overall Study|Pregnancy|1|||
130210606|NCT04015518|468730815|FG000|Overall Study|Personal reasons|1|||
130210607|NCT04015518|468730816|FG001|Overall Study|Personal reasons|0|||
130210608|NCT04015518|468730817|FG002|Overall Study|Personal reasons|0|||
130210609|NCT04015518|468730818|FG003|Overall Study|Personal reasons|0|||
130210610|NCT04015518|468730819|FG004|Overall Study|Personal reasons|1|||
130210611|NCT04015518|468730815|FG000|Overall Study|Withdrew consent|1|||
130210612|NCT04015518|468730816|FG001|Overall Study|Withdrew consent|0|||
130210613|NCT04015518|468730817|FG002|Overall Study|Withdrew consent|0|||
130210614|NCT04015518|468730818|FG003|Overall Study|Withdrew consent|0|||
130210615|NCT04015518|468730819|FG004|Overall Study|Withdrew consent|0|||
130210616|NCT04015518|468730815|FG000|Overall Study|Prostate carcinoma|1|||
130210617|NCT04015518|468730816|FG001|Overall Study|Prostate carcinoma|0|||
130210618|NCT04015518|468730817|FG002|Overall Study|Prostate carcinoma|0|||
130210619|NCT04015518|468730818|FG003|Overall Study|Prostate carcinoma|0|||
130210620|NCT04015518|468730819|FG004|Overall Study|Prostate carcinoma|0|||
130210621|NCT04015518|468730815|FG000|Overall Study|Could not keep appointments due to work|1|||
130210622|NCT04015518|468730816|FG001|Overall Study|Could not keep appointments due to work|0|||
130210623|NCT04015518|468730817|FG002|Overall Study|Could not keep appointments due to work|0|||
130210624|NCT04015518|468730818|FG003|Overall Study|Could not keep appointments due to work|0|||
130210625|NCT04015518|468730819|FG004|Overall Study|Could not keep appointments due to work|0|||
130210626|NCT00505661|468730820|FG000|Overall Study|Not Eligible|4|||
130210627|NCT01738191|468730821|FG000|Overall Study|Withdrawal by Subject|4|||
130210628|NCT01738191|468730822|FG001|Overall Study|Withdrawal by Subject|1|||
130210629|NCT02109445|468730825|FG000|Overall Study|Symptomatic deterioration|2|||
130210630|NCT02109445|468730825|FG000|Overall Study|Adverse Event|1|||
130210631|NCT03089853|468732398|FG000|Overall Study|Lost to Follow-up|2|||
130210632|NCT03089853|468732399|FG001|Overall Study|Lost to Follow-up|1|||
130210633|NCT02578940|468732400|FG000|Overall Study|Screening failure|5|||
130210634|NCT02578940|468732400|FG000|Overall Study|Lost to Follow-up|1|||
130210635|NCT04591015|468732403|FG000|Overall Study|Death|6|||
130210636|NCT04591015|468732404|FG001|Overall Study|Death|4|||
130210637|NCT04591015|468732403|FG000|Overall Study|Withdrawal by Subject|6|||
130210638|NCT04591015|468732404|FG001|Overall Study|Withdrawal by Subject|3|||
130210639|NCT04591015|468732403|FG000|Overall Study|Lost to Follow-up|16|||
130210640|NCT04591015|468732404|FG001|Overall Study|Lost to Follow-up|11|||
130210641|NCT02686814|468732405|FG000|Overall Study|Physician Decision|14|||
130210642|NCT02686814|468732405|FG000|Overall Study|Withdrawal by Subject|4|||
130210643|NCT02686814|468732405|FG000|Overall Study|Death|1|||
130210644|NCT00290693|468732406|FG000|Overall Study|Withdrawal by Subject|2|||
130210645|NCT02907619|468732407|FG000|Overall Study|Study terminated by sponsor|18|||
130210646|NCT02907619|468732408|FG001|Overall Study|Study terminated by sponsor|18|||
130210647|NCT02907619|468732409|FG002|Overall Study|Study terminated by sponsor|19|||
130210648|NCT02907619|468732407|FG000|Overall Study|Death|0|||
130210649|NCT02907619|468732408|FG001|Overall Study|Death|0|||
130210650|NCT02907619|468732409|FG002|Overall Study|Death|1|||
130210651|NCT02907619|468732407|FG000|Overall Study|Withdrawal by Subject|1|||
130210652|NCT02907619|468732408|FG001|Overall Study|Withdrawal by Subject|1|||
130210653|NCT02907619|468732409|FG002|Overall Study|Withdrawal by Subject|0|||
130210654|NCT02907619|468732407|FG000|Overall Study|Other|0|||
130210655|NCT02907619|468732408|FG001|Overall Study|Other|1|||
130210656|NCT02907619|468732409|FG002|Overall Study|Other|0|||
130210657|NCT01908582|468732410|FG000|Period 2|Physician Decision|1|||
130210658|NCT01908582|468732410|FG000|Period 2|Withdrawal by Subject|1|||
130210659|NCT03484403|468732412|FG000|Overall Study|Withdrawal by Subject|6|||
130210660|NCT03484403|468732413|FG001|Overall Study|Withdrawal by Subject|4|||
130210661|NCT02722746|468732427|FG000|Overall Study|Withdrawal by Subject|0|||
130210662|NCT02722746|468732428|FG001|Overall Study|Withdrawal by Subject|1|||
130210663|NCT02722746|468732429|FG002|Overall Study|Withdrawal by Subject|0|||
130210664|NCT02722746|468732427|FG000|Overall Study|Protocol Violation|8|||
130210665|NCT02722746|468732428|FG001|Overall Study|Protocol Violation|4|||
130210666|NCT02722746|468732429|FG002|Overall Study|Protocol Violation|6|||
130210667|NCT01134263|468732430|FG000|Overall Study|Serious adverse event|2|||
130210668|NCT01134263|468732431|FG001|Overall Study|Serious adverse event|1|||
130210669|NCT01134263|468732432|FG002|Overall Study|Serious adverse event|1|||
130210670|NCT01134263|468732433|FG003|Overall Study|Serious adverse event|1|||
130210671|NCT01134263|468732434|FG004|Overall Study|Serious adverse event|1|||
130210672|NCT01134263|468732430|FG000|Overall Study|Other adverse event|1|||
130210673|NCT01134263|468732431|FG001|Overall Study|Other adverse event|2|||
130210674|NCT01134263|468732432|FG002|Overall Study|Other adverse event|5|||
130210675|NCT01134263|468732433|FG003|Overall Study|Other adverse event|3|||
130210676|NCT01134263|468732434|FG004|Overall Study|Other adverse event|0|||
130210677|NCT01134263|468732430|FG000|Overall Study|Protocol Violation|8|||
130210678|NCT01134263|468732431|FG001|Overall Study|Protocol Violation|7|||
130210679|NCT01134263|468732432|FG002|Overall Study|Protocol Violation|2|||
130210680|NCT01134263|468732433|FG003|Overall Study|Protocol Violation|4|||
130210681|NCT01134263|468732434|FG004|Overall Study|Protocol Violation|2|||
130210682|NCT01134263|468732430|FG000|Overall Study|Lost to Follow-up|4|||
130210683|NCT01134263|468732431|FG001|Overall Study|Lost to Follow-up|3|||
130210684|NCT01134263|468732432|FG002|Overall Study|Lost to Follow-up|5|||
130210685|NCT01134263|468732433|FG003|Overall Study|Lost to Follow-up|3|||
130210686|NCT01134263|468732434|FG004|Overall Study|Lost to Follow-up|1|||
130210687|NCT01134263|468732430|FG000|Overall Study|Withdrawal by Subject|8|||
130210688|NCT01134263|468732431|FG001|Overall Study|Withdrawal by Subject|6|||
130210689|NCT01134263|468732432|FG002|Overall Study|Withdrawal by Subject|16|||
130210690|NCT01134263|468732433|FG003|Overall Study|Withdrawal by Subject|7|||
130210691|NCT01134263|468732434|FG004|Overall Study|Withdrawal by Subject|5|||
130210692|NCT01134263|468732430|FG000|Overall Study|Enrolled, but not treated|1|||
130210693|NCT01134263|468732431|FG001|Overall Study|Enrolled, but not treated|1|||
130210694|NCT01134263|468732432|FG002|Overall Study|Enrolled, but not treated|0|||
130210695|NCT01134263|468732433|FG003|Overall Study|Enrolled, but not treated|1|||
130210696|NCT01134263|468732434|FG004|Overall Study|Enrolled, but not treated|0|||
130210697|NCT01955109|468732440|FG000|Overall Study|Adverse Event|2|||
130210698|NCT01955109|468732441|FG001|Overall Study|Adverse Event|0|||
130210699|NCT01955109|468732440|FG000|Overall Study|Participant unwilling to continue|35|||
130210700|NCT01955109|468732441|FG001|Overall Study|Participant unwilling to continue|7|||
130210701|NCT01955109|468732440|FG000|Overall Study|Physician Decision|2|||
130210702|NCT01955109|468732441|FG001|Overall Study|Physician Decision|0|||
130210703|NCT01955109|468732440|FG000|Overall Study|Lost to Follow-up|3|||
130210704|NCT01955109|468732441|FG001|Overall Study|Lost to Follow-up|1|||
130210705|NCT01955109|468732440|FG000|Overall Study|Non-compliance|3|||
130210706|NCT01955109|468732441|FG001|Overall Study|Non-compliance|1|||
130210707|NCT00750919|468732452|FG000|Overall Study|Adverse Event|9|||
130210708|NCT00750919|468732452|FG000|Overall Study|Withdrawal by Subject|1|||
130210709|NCT00750919|468732452|FG000|Overall Study|Lack of Efficacy|8|||
130210710|NCT00750919|468732452|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
130210711|NCT00750919|468732452|FG000|Overall Study|Other|36|||
130210712|NCT02912455|468732458|FG000|Overall Study|Withdrawal by Subject|0|||
130210713|NCT02912455|468732459|FG001|Overall Study|Withdrawal by Subject|1|||
130210714|NCT02912455|468732458|FG000|Overall Study|Lack of Efficacy|0|||
130210715|NCT02912455|468732459|FG001|Overall Study|Lack of Efficacy|1|||
130210716|NCT02912455|468732458|FG000|Overall Study|Lost to Follow-up|2|||
130210717|NCT02912455|468732459|FG001|Overall Study|Lost to Follow-up|1|||
130210718|NCT01810783|468732464|FG000|Overall Study|Adverse Event|32|||
130210719|NCT01810783|468732464|FG000|Overall Study|Withdrawal by Subject|22|||
130210720|NCT01810783|468732464|FG000|Overall Study|Lack of Efficacy|12|||
130210721|NCT01810783|468732464|FG000|Overall Study|Lost to Follow-up|10|||
130210722|NCT01810783|468732464|FG000|Overall Study|Protocol Violation|5|||
130210723|NCT01810783|468732464|FG000|Overall Study|Non-compliance with IMP|4|||
130210724|NCT01810783|468732464|FG000|Overall Study|Adminstrative or other reason(s)|23|||
130210725|NCT01810783|468732464|FG000|Overall Study|Enrolled, not treated|1|||
130210726|NCT02134353|468732465|FG000|Overall Study|Adverse Event|10|||
130210727|NCT02134353|468732466|FG001|Overall Study|Adverse Event|6|||
130210728|NCT02134353|468732465|FG000|Overall Study|Lost to Follow-up|1|||
130210729|NCT02134353|468732466|FG001|Overall Study|Lost to Follow-up|1|||
130210730|NCT02134353|468732465|FG000|Overall Study|Lack of Efficacy|2|||
130210731|NCT02134353|468732466|FG001|Overall Study|Lack of Efficacy|1|||
130210732|NCT02134353|468732465|FG000|Overall Study|Withdrawal by Subject|12|||
130210733|NCT02134353|468732466|FG001|Overall Study|Withdrawal by Subject|13|||
130210734|NCT02134353|468732465|FG000|Overall Study|Death|0|||
130210735|NCT02134353|468732466|FG001|Overall Study|Death|1|||
130320277|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130320278|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130320279|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
130210736|NCT02134353|468732465|FG000|Overall Study|Pregnancy|0|||
130210737|NCT02134353|468732466|FG001|Overall Study|Pregnancy|1|||
130320280|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
130320281|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130210738|NCT02134353|468732465|FG000|Overall Study|Relocation|1|||
130210739|NCT02134353|468732466|FG001|Overall Study|Relocation|0|||
130210740|NCT02134353|468732465|FG000|Overall Study|Other - Patient's Choice|0|||
130210741|NCT02134353|468732466|FG001|Overall Study|Other - Patient's Choice|1|||
130210742|NCT00477607|468732467|FG000|Overall Study|Lost to Follow-up|7|||
130210743|NCT00477607|468732468|FG001|Overall Study|Lost to Follow-up|7|||
130210744|NCT00358956|468732469|FG000|Overall Study|Adverse Event|3|||
130210745|NCT00358956|468732469|FG000|Overall Study|condition under investigation worsened|4|||
130210746|NCT00358956|468732469|FG000|Overall Study|Withdrawal by Subject|1|||
130210747|NCT04776018|468732470|FG000|Overall Study|Death|0|||
130210748|NCT04776018|468732471|FG001|Overall Study|Death|1|||
130210749|NCT04776018|468732472|FG002|Overall Study|Death|4|||
130210750|NCT04776018|468732473|FG003|Overall Study|Death|1|||
130210751|NCT04776018|468732474|FG004|Overall Study|Death|4|||
130210752|NCT04776018|468732475|FG005|Overall Study|Death|0|||
130210753|NCT04776018|468732476|FG006|Overall Study|Death|0|||
130210754|NCT04776018|468732470|FG000|Overall Study|Study terminated by sponsor|2|||
130210755|NCT04776018|468732471|FG001|Overall Study|Study terminated by sponsor|1|||
130210756|NCT04776018|468732472|FG002|Overall Study|Study terminated by sponsor|4|||
130210757|NCT04776018|468732473|FG003|Overall Study|Study terminated by sponsor|0|||
130210758|NCT04776018|468732474|FG004|Overall Study|Study terminated by sponsor|3|||
130210759|NCT04776018|468732475|FG005|Overall Study|Study terminated by sponsor|0|||
130210760|NCT04776018|468732476|FG006|Overall Study|Study terminated by sponsor|0|||
130210761|NCT04776018|468732470|FG000|Overall Study|Withdrawal by Subject|1|||
130210762|NCT04776018|468732471|FG001|Overall Study|Withdrawal by Subject|0|||
130210763|NCT04776018|468732472|FG002|Overall Study|Withdrawal by Subject|0|||
130210764|NCT04776018|468732473|FG003|Overall Study|Withdrawal by Subject|2|||
130210765|NCT04776018|468732474|FG004|Overall Study|Withdrawal by Subject|1|||
130210766|NCT04776018|468732475|FG005|Overall Study|Withdrawal by Subject|0|||
130210767|NCT04776018|468732476|FG006|Overall Study|Withdrawal by Subject|0|||
130210768|NCT04776018|468732470|FG000|Overall Study|Other|0|||
130210769|NCT04776018|468732471|FG001|Overall Study|Other|1|||
130210770|NCT04776018|468732472|FG002|Overall Study|Other|1|||
130210771|NCT04776018|468732473|FG003|Overall Study|Other|0|||
130210772|NCT04776018|468732474|FG004|Overall Study|Other|0|||
130210773|NCT04776018|468732475|FG005|Overall Study|Other|0|||
130210774|NCT04776018|468732476|FG006|Overall Study|Other|0|||
130210775|NCT04776018|468732470|FG000|Overall Study|Lost to Follow-up|0|||
130210776|NCT04776018|468732471|FG001|Overall Study|Lost to Follow-up|0|||
130210777|NCT04776018|468732472|FG002|Overall Study|Lost to Follow-up|1|||
130210778|NCT04776018|468732473|FG003|Overall Study|Lost to Follow-up|0|||
130210779|NCT04776018|468732474|FG004|Overall Study|Lost to Follow-up|0|||
130210780|NCT04776018|468732475|FG005|Overall Study|Lost to Follow-up|0|||
130210781|NCT04776018|468732476|FG006|Overall Study|Lost to Follow-up|0|||
130210782|NCT02908074|468732477|FG000|Overall Study|sponsor/ICON decision|0|||
130210783|NCT02908074|468732478|FG001|Overall Study|sponsor/ICON decision|0|||
130210784|NCT02908074|468732479|FG002|Overall Study|sponsor/ICON decision|1|||
130210785|NCT02908074|468732480|FG003|Overall Study|sponsor/ICON decision|0|||
130210786|NCT02908074|468732481|FG004|Overall Study|sponsor/ICON decision|0|||
130210787|NCT02908074|468732482|FG005|Overall Study|sponsor/ICON decision|0|||
130210788|NCT02908074|468732477|FG000|Overall Study|Protocol Violation|0|||
130210789|NCT02908074|468732478|FG001|Overall Study|Protocol Violation|1|||
130210790|NCT02908074|468732479|FG002|Overall Study|Protocol Violation|0|||
130210791|NCT02908074|468732480|FG003|Overall Study|Protocol Violation|0|||
130210792|NCT02908074|468732481|FG004|Overall Study|Protocol Violation|0|||
130210793|NCT02908074|468732482|FG005|Overall Study|Protocol Violation|0|||
130210794|NCT02908074|468732477|FG000|Overall Study|Adverse Event|5|||
130210795|NCT02908074|468732478|FG001|Overall Study|Adverse Event|2|||
130210796|NCT02908074|468732479|FG002|Overall Study|Adverse Event|0|||
130210797|NCT02908074|468732480|FG003|Overall Study|Adverse Event|0|||
130210798|NCT02908074|468732481|FG004|Overall Study|Adverse Event|1|||
130210799|NCT02908074|468732482|FG005|Overall Study|Adverse Event|0|||
130210800|NCT02908074|468732477|FG000|Overall Study|AESI|1|||
130210801|NCT02908074|468732478|FG001|Overall Study|AESI|0|||
130210802|NCT02908074|468732479|FG002|Overall Study|AESI|1|||
130210803|NCT02908074|468732480|FG003|Overall Study|AESI|0|||
130210804|NCT02908074|468732481|FG004|Overall Study|AESI|1|||
130210805|NCT02908074|468732482|FG005|Overall Study|AESI|0|||
130210806|NCT02908074|468732477|FG000|Overall Study|Discontinuation criteria per protocol|0|||
130210807|NCT02908074|468732478|FG001|Overall Study|Discontinuation criteria per protocol|0|||
130210808|NCT02908074|468732479|FG002|Overall Study|Discontinuation criteria per protocol|1|||
130210809|NCT02908074|468732480|FG003|Overall Study|Discontinuation criteria per protocol|0|||
130210810|NCT02908074|468732481|FG004|Overall Study|Discontinuation criteria per protocol|0|||
130210811|NCT02908074|468732482|FG005|Overall Study|Discontinuation criteria per protocol|1|||
130210812|NCT02908074|468732477|FG000|Overall Study|Withdrawal by Subject|3|||
130210813|NCT02908074|468732478|FG001|Overall Study|Withdrawal by Subject|2|||
130210814|NCT02908074|468732479|FG002|Overall Study|Withdrawal by Subject|2|||
130210815|NCT02908074|468732480|FG003|Overall Study|Withdrawal by Subject|2|||
130210816|NCT02908074|468732481|FG004|Overall Study|Withdrawal by Subject|2|||
130210817|NCT02908074|468732482|FG005|Overall Study|Withdrawal by Subject|2|||
130210818|NCT02908074|468732477|FG000|Overall Study|Lost to Follow-up|0|||
130210819|NCT02908074|468732478|FG001|Overall Study|Lost to Follow-up|1|||
130210820|NCT02908074|468732479|FG002|Overall Study|Lost to Follow-up|1|||
130210821|NCT02908074|468732480|FG003|Overall Study|Lost to Follow-up|1|||
130210822|NCT02908074|468732481|FG004|Overall Study|Lost to Follow-up|0|||
130210823|NCT02908074|468732482|FG005|Overall Study|Lost to Follow-up|1|||
130210824|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
130210825|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
130210826|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
130210827|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130210828|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130210829|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
130210830|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
130210831|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
130210832|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
130210833|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
130210834|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
130210835|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
130210836|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
130210837|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
130210838|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
130210839|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
130210840|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
130210841|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
130210842|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130210843|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130210844|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
130210845|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130210846|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130210847|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
130210848|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130210849|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130210850|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
130210851|NCT03755518|468732492|FG000|Overall Study|Lack of Efficacy|10|||
130210852|NCT03755518|468732492|FG000|Overall Study|Adverse Event|7|||
130210853|NCT03755518|468732492|FG000|Overall Study|Study Terminated by Sponsor|5|||
130210854|NCT03755518|468732492|FG000|Overall Study|Death|1|||
130210855|NCT03755518|468732492|FG000|Overall Study|Withdrawal by Subject|3|||
130210856|NCT03755518|468732492|FG000|Overall Study|Progressive Disease|4|||
130210857|NCT03755518|468732492|FG000|Overall Study|Bone Marrow Transplant|4|||
130210858|NCT03755518|468732492|FG000|Overall Study|Physicians Decision|1|||
130210859|NCT03755518|468732492|FG000|Overall Study|Relapse|1|||
130210860|NCT03755518|468732492|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
130210861|NCT03755518|468732492|FG000|Overall Study|Withdrawal by PI|1|||
130210862|NCT03172364|468732493|FG000|Overall Study|Adverse Event|1|||
130210863|NCT03172364|468732494|FG001|Overall Study|Adverse Event|1|||
130210864|NCT03172364|468732493|FG000|Overall Study|Protocol Violation|1|||
130210865|NCT03172364|468732494|FG001|Overall Study|Protocol Violation|0|||
130210866|NCT02732327|468732495|FG000|Overall Study|Protocol Violation|0|||
130210867|NCT02732327|468732496|FG001|Overall Study|Protocol Violation|1|||
130210868|NCT04503668|468732497|FG000|Overall Study|Incomplete data|4|||
130210869|NCT04503668|468732498|FG001|Overall Study|Incomplete data|3|||
130210870|NCT04503668|468732497|FG000|Overall Study|Withdrawal by Subject|1|||
130210871|NCT04503668|468732498|FG001|Overall Study|Withdrawal by Subject|1|||
130210872|NCT04503668|468732497|FG000|Overall Study|Adverse Event|2|||
130210873|NCT04503668|468732498|FG001|Overall Study|Adverse Event|0|||
130210874|NCT00603382|468732499|FG000|Overall Study|Adverse Event|0|||
130210875|NCT00603382|468732500|FG001|Overall Study|Adverse Event|1|||
130210876|NCT00603382|468732501|FG002|Overall Study|Adverse Event|1|||
130210877|NCT00603382|468732502|FG003|Overall Study|Adverse Event|2|||
130210878|NCT00603382|468732503|FG004|Overall Study|Adverse Event|1|||
130210879|NCT00603382|468732504|FG005|Overall Study|Adverse Event|2|||
130210880|NCT00603382|468732499|FG000|Overall Study|Lack of Efficacy|14|||
130210881|NCT00603382|468732500|FG001|Overall Study|Lack of Efficacy|9|||
130210882|NCT00603382|468732501|FG002|Overall Study|Lack of Efficacy|3|||
130210883|NCT00603382|468732502|FG003|Overall Study|Lack of Efficacy|6|||
130210884|NCT00603382|468732503|FG004|Overall Study|Lack of Efficacy|6|||
130210885|NCT00603382|468732504|FG005|Overall Study|Lack of Efficacy|11|||
130210886|NCT00603382|468732499|FG000|Overall Study|Protocol Violation|1|||
130210887|NCT00603382|468732500|FG001|Overall Study|Protocol Violation|0|||
130210888|NCT00603382|468732501|FG002|Overall Study|Protocol Violation|1|||
130210889|NCT00603382|468732502|FG003|Overall Study|Protocol Violation|2|||
130210890|NCT00603382|468732503|FG004|Overall Study|Protocol Violation|1|||
130210891|NCT00603382|468732504|FG005|Overall Study|Protocol Violation|0|||
130210892|NCT00603382|468732499|FG000|Overall Study|Lost to Follow-up|0|||
130210893|NCT00603382|468732500|FG001|Overall Study|Lost to Follow-up|1|||
130210894|NCT00603382|468732501|FG002|Overall Study|Lost to Follow-up|1|||
130210895|NCT00603382|468732502|FG003|Overall Study|Lost to Follow-up|1|||
130210896|NCT00603382|468732503|FG004|Overall Study|Lost to Follow-up|0|||
130210897|NCT00603382|468732504|FG005|Overall Study|Lost to Follow-up|1|||
130210898|NCT00603382|468732499|FG000|Overall Study|Physician Decision|0|||
130210899|NCT00603382|468732500|FG001|Overall Study|Physician Decision|0|||
130210900|NCT00603382|468732501|FG002|Overall Study|Physician Decision|2|||
130210901|NCT00603382|468732502|FG003|Overall Study|Physician Decision|0|||
130210902|NCT00603382|468732503|FG004|Overall Study|Physician Decision|1|||
130210903|NCT00603382|468732504|FG005|Overall Study|Physician Decision|3|||
130210904|NCT00603382|468732499|FG000|Overall Study|Withdrawal by Subject|3|||
130210905|NCT00603382|468732500|FG001|Overall Study|Withdrawal by Subject|3|||
130210906|NCT00603382|468732501|FG002|Overall Study|Withdrawal by Subject|1|||
130210907|NCT00603382|468732502|FG003|Overall Study|Withdrawal by Subject|1|||
130210908|NCT00603382|468732503|FG004|Overall Study|Withdrawal by Subject|0|||
130210909|NCT00603382|468732504|FG005|Overall Study|Withdrawal by Subject|1|||
130210910|NCT03403621|468732505|FG000|Overall Study|Withdrawal by Subject|2|||
130210911|NCT03403621|468732506|FG001|Overall Study|Withdrawal by Subject|2|||
130210912|NCT00583102|468732507|FG000|Overall Study|Adverse Event|3|||
130210913|NCT03611582|468732510|FG000|Overall Study|Adverse Event|26|||
130210914|NCT03611582|468732511|FG001|Overall Study|Adverse Event|6|||
130210915|NCT03611582|468732510|FG000|Overall Study|Protocol Violation|0|||
130210916|NCT03611582|468732511|FG001|Overall Study|Protocol Violation|1|||
130210917|NCT03611582|468732510|FG000|Overall Study|Pregnancy|1|||
130210918|NCT03611582|468732511|FG001|Overall Study|Pregnancy|2|||
130210919|NCT03611582|468732510|FG000|Overall Study|Lack of Efficacy|0|||
130210920|NCT03611582|468732511|FG001|Overall Study|Lack of Efficacy|1|||
130210921|NCT03611582|468732510|FG000|Overall Study|At the discretion of the investigator|1|||
130210922|NCT03611582|468732511|FG001|Overall Study|At the discretion of the investigator|0|||
130210923|NCT03611582|468732510|FG000|Overall Study|Safety concern as judged by the investigator|1|||
130210924|NCT03611582|468732511|FG001|Overall Study|Safety concern as judged by the investigator|2|||
130210925|NCT03611582|468732510|FG000|Overall Study|Withdrawal by Subject|4|||
130210926|NCT03611582|468732511|FG001|Overall Study|Withdrawal by Subject|3|||
130210927|NCT03611582|468732510|FG000|Overall Study|Lost to Follow-up|18|||
130210928|NCT03611582|468732511|FG001|Overall Study|Lost to Follow-up|7|||
130210929|NCT03611582|468732510|FG000|Overall Study|other|17|||
130210930|NCT03611582|468732511|FG001|Overall Study|other|16|||
130210931|NCT01783821|468732512|FG000|Overall Study|Screen Failure|1|||
130210932|NCT01783821|468732513|FG001|Overall Study|Screen Failure|1|||
130210933|NCT02333383|468732516|FG000|Overall Study|Adalimumab discontinuation|21|||
130210934|NCT02333383|468732516|FG000|Overall Study|Lost to Follow-up|15|||
130210935|NCT02333383|468732516|FG000|Overall Study|Withdrawal by Subject|3|||
130210936|NCT02333383|468732516|FG000|Overall Study|Transfer to another hospital|2|||
130210937|NCT04459598|468732517|FG000|Overall Study|Adverse Event|1|||
130210938|NCT04459598|468732518|FG001|Overall Study|Adverse Event|1|||
130210939|NCT01907217|468732519|FG000|Overall Study|Withdrawal by Subject|0|||
130210940|NCT01907217|468732520|FG001|Overall Study|Withdrawal by Subject|2|||
130210941|NCT01078298|468732521|FG000|Overall Study|Lost to Follow-up|12|||
130210942|NCT01078298|468732522|FG001|Overall Study|Lost to Follow-up|13|||
130210943|NCT01078298|468732521|FG000|Overall Study|Withdrawal by Subject|31|||
130210944|NCT01078298|468732522|FG001|Overall Study|Withdrawal by Subject|33|||
130210945|NCT01078298|468732521|FG000|Overall Study|Protocol Violation|6|||
130210946|NCT01078298|468732522|FG001|Overall Study|Protocol Violation|6|||
130210947|NCT01078298|468732521|FG000|Overall Study|Adverse Event|6|||
130210948|NCT01078298|468732522|FG001|Overall Study|Adverse Event|5|||
130210949|NCT01078298|468732521|FG000|Overall Study|Death|2|||
130210950|NCT01078298|468732522|FG001|Overall Study|Death|0|||
130210951|NCT01078298|468732521|FG000|Overall Study|Did not meet entrance criteria|0|||
130210952|NCT01078298|468732522|FG001|Overall Study|Did not meet entrance criteria|1|||
130210953|NCT01078298|468732521|FG000|Overall Study|Other|24|||
130210954|NCT01078298|468732522|FG001|Overall Study|Other|32|||
130210955|NCT00866333|468732524|FG000|Overall Study|Withdrawal of consent|0|||
130210956|NCT00866333|468732525|FG001|Overall Study|Withdrawal of consent|1|||
130210957|NCT00866333|468732526|FG002|Overall Study|Withdrawal of consent|2|||
130210958|NCT00866333|468732524|FG000|Overall Study|Reason not Specified|3|||
130210959|NCT00866333|468732525|FG001|Overall Study|Reason not Specified|1|||
130210960|NCT00866333|468732526|FG002|Overall Study|Reason not Specified|1|||
130210961|NCT00866333|468732524|FG000|Overall Study|Study Terminated by Sponsor|2|||
130210962|NCT00866333|468732525|FG001|Overall Study|Study Terminated by Sponsor|5|||
130210963|NCT00866333|468732526|FG002|Overall Study|Study Terminated by Sponsor|9|||
130210964|NCT00350779|468732528|FG000|Overall Study|Adverse Event|4|||
130210965|NCT00350779|468732529|FG001|Overall Study|Adverse Event|2|||
130210966|NCT00350779|468732528|FG000|Overall Study|Lack of Efficacy|0|||
130210967|NCT00350779|468732529|FG001|Overall Study|Lack of Efficacy|4|||
130210968|NCT00350779|468732528|FG000|Overall Study|Lost to Follow-up|2|||
130210969|NCT00350779|468732529|FG001|Overall Study|Lost to Follow-up|0|||
130210970|NCT00350779|468732528|FG000|Overall Study|Physician Decision|2|||
130210971|NCT00350779|468732529|FG001|Overall Study|Physician Decision|4|||
130210972|NCT00350779|468732528|FG000|Overall Study|Protocol Violation|3|||
130210973|NCT00350779|468732529|FG001|Overall Study|Protocol Violation|1|||
130210974|NCT00350779|468732528|FG000|Overall Study|Withdrawal by Subject|9|||
130210975|NCT00350779|468732529|FG001|Overall Study|Withdrawal by Subject|8|||
130210976|NCT00350779|468732528|FG000|Overall Study|Patient Moved|2|||
130210977|NCT00350779|468732529|FG001|Overall Study|Patient Moved|1|||
130543618|NCT00540046|469956778|FG000|Overall Study|Lost to Follow-up|33|||
130543619|NCT00540046|469956779|FG001|Overall Study|Lost to Follow-up|23|||
130543620|NCT02891837|469956780|FG000|Overall Study|Lost to Follow-up|2|||
130543621|NCT02891837|469956781|FG001|Overall Study|Lost to Follow-up|0|||
130543622|NCT02891837|469956780|FG000|Overall Study|Withdrawal by Subject|1|||
130543623|NCT02891837|469956781|FG001|Overall Study|Withdrawal by Subject|0|||
130543624|NCT02751320|469956789|FG000|Overall Study|Adverse Event|2|||
130543625|NCT02751320|469956789|FG000|Overall Study|Withdrawal by Subject|1|||
130543626|NCT01021215|469956790|FG000|Overall Study|Lost to Follow-up|3|||
130543627|NCT01021215|469956791|FG001|Overall Study|Lost to Follow-up|0|||
130543628|NCT02549196|469956792|FG000|Overall Study|Protocol Violation|0|||
130543629|NCT02549196|469956793|FG001|Overall Study|Protocol Violation|0|||
130543630|NCT02549196|469956794|FG002|Overall Study|Protocol Violation|0|||
130543631|NCT02549196|469956795|FG003|Overall Study|Protocol Violation|1|||
130543632|NCT02549196|469956792|FG000|Overall Study|Withdrawal by Subject|1|||
130543633|NCT02549196|469956793|FG001|Overall Study|Withdrawal by Subject|0|||
130543634|NCT02549196|469956794|FG002|Overall Study|Withdrawal by Subject|1|||
130543635|NCT02549196|469956795|FG003|Overall Study|Withdrawal by Subject|0|||
130543636|NCT00185965|469956796|FG000|Overall Study|Adverse Event|0|||
130543637|NCT00185965|469956797|FG001|Overall Study|Adverse Event|1|||
130543638|NCT01103362|469956800|FG000|Overall Study|study terminated|596|||
130543639|NCT02533531|469956801|FG000|Overall Study|Device did not turn on|1|||
130543640|NCT02047903|469956802|FG000|Overall Study|Adverse Event|14|||
130543641|NCT02047903|469956802|FG000|Overall Study|Serious adverse event|10|||
130543642|NCT02047903|469956802|FG000|Overall Study|Withdrawal by Subject|16|||
130543643|NCT02047903|469956802|FG000|Overall Study|Lost to Follow-up|4|||
130543644|NCT02047903|469956802|FG000|Overall Study|Reason not listed|6|||
130543645|NCT02047903|469956802|FG000|Overall Study|Not Treated|9|||
130543646|NCT01014533|469956803|FG000|Overall Study|Protocol Violation|3|||
130543647|NCT01014533|469956804|FG001|Overall Study|Protocol Violation|2|||
130543648|NCT01014533|469956803|FG000|Overall Study|Withdrawal by Subject|2|||
130543649|NCT01014533|469956804|FG001|Overall Study|Withdrawal by Subject|0|||
130543650|NCT01014533|469956803|FG000|Overall Study|unable to come to appointment|0|||
130543651|NCT01014533|469956804|FG001|Overall Study|unable to come to appointment|3|||
130543652|NCT00296400|469956808|FG000|Overall Study|Adverse Event|7|||
130543653|NCT00296400|469956809|FG001|Overall Study|Adverse Event|7|||
130543654|NCT00296400|469956810|FG002|Overall Study|Adverse Event|7|||
130543655|NCT00296400|469956808|FG000|Overall Study|Withdrawal by Subject|5|||
130543656|NCT00296400|469956809|FG001|Overall Study|Withdrawal by Subject|6|||
130543657|NCT00296400|469956810|FG002|Overall Study|Withdrawal by Subject|2|||
130543658|NCT00296400|469956808|FG000|Overall Study|Incorrect enrollment|2|||
130543659|NCT00296400|469956809|FG001|Overall Study|Incorrect enrollment|0|||
130543660|NCT00296400|469956810|FG002|Overall Study|Incorrect enrollment|0|||
130543661|NCT00296400|469956808|FG000|Overall Study|Protocol Violation|1|||
130543662|NCT00296400|469956809|FG001|Overall Study|Protocol Violation|1|||
130543663|NCT00296400|469956810|FG002|Overall Study|Protocol Violation|1|||
130543664|NCT00296400|469956808|FG000|Overall Study|Lost to Follow-up|1|||
130543665|NCT00296400|469956809|FG001|Overall Study|Lost to Follow-up|1|||
130543666|NCT00296400|469956810|FG002|Overall Study|Lost to Follow-up|2|||
130543667|NCT00296400|469956808|FG000|Overall Study|Study specific discontinuation criteria|0|||
130543668|NCT00296400|469956809|FG001|Overall Study|Study specific discontinuation criteria|0|||
130543669|NCT00296400|469956810|FG002|Overall Study|Study specific discontinuation criteria|1|||
130543670|NCT00296400|469956808|FG000|Overall Study|Visit 10 was performed earlier|0|||
130543671|NCT00296400|469956809|FG001|Overall Study|Visit 10 was performed earlier|1|||
130543672|NCT00296400|469956810|FG002|Overall Study|Visit 10 was performed earlier|0|||
130543673|NCT00296400|469956808|FG000|Overall Study|Pregnancy|1|||
130543674|NCT00296400|469956809|FG001|Overall Study|Pregnancy|2|||
130543675|NCT00296400|469956810|FG002|Overall Study|Pregnancy|0|||
130543676|NCT00412061|469956812|FG000|Double Blind Phase|Disease Progression|101|||
130543677|NCT00412061|469956813|FG001|Double Blind Phase|Disease Progression|154|||
130543678|NCT00412061|469956812|FG000|Double Blind Phase|Adverse Event|61|||
130543679|NCT00412061|469956813|FG001|Double Blind Phase|Adverse Event|16|||
130543680|NCT00412061|469956812|FG000|Double Blind Phase|Final Primary Analysis|26|||
130543681|NCT00412061|469956813|FG001|Double Blind Phase|Final Primary Analysis|14|||
130543682|NCT00412061|469956812|FG000|Double Blind Phase|Withdrawal by Subject|18|||
130543683|NCT00412061|469956813|FG001|Double Blind Phase|Withdrawal by Subject|20|||
130543684|NCT00412061|469956812|FG000|Double Blind Phase|Death|6|||
130543685|NCT00412061|469956813|FG001|Double Blind Phase|Death|3|||
130543686|NCT00412061|469956812|FG000|Double Blind Phase|Protocol Violation|3|||
130543687|NCT00412061|469956813|FG001|Double Blind Phase|Protocol Violation|4|||
130543688|NCT00412061|469956812|FG000|Double Blind Phase|New Cander Therapy|1|||
130543689|NCT00412061|469956813|FG001|Double Blind Phase|New Cander Therapy|1|||
130543690|NCT00412061|469956812|FG000|Double Blind Phase|Lost to Follow-up|0|||
130543691|NCT00412061|469956813|FG001|Double Blind Phase|Lost to Follow-up|1|||
130543692|NCT00412061|469956812|FG000|Open Label Phase|Disease Progression|0|||
130543693|NCT00412061|469956813|FG001|Open Label Phase|Disease Progression|86|||
130543694|NCT00412061|469956812|FG000|Open Label Phase|Adverse Event|0|||
130543695|NCT00412061|469956813|FG001|Open Label Phase|Adverse Event|46|||
130431071|NCT04739761|469539416|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
130431072|NCT04739761|469539415|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
130431073|NCT04739761|469539416|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
130431074|NCT04739761|469539415|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
130431075|NCT04739761|469539416|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
130210978|NCT00350779|468732528|FG000|Overall Study|Non-compliance with study procedures|0|||
130210979|NCT00350779|468732529|FG001|Overall Study|Non-compliance with study procedures|1|||
130210980|NCT02012959|468732530|FG000|Treatment Phase A|Adverse Event|2|||
130210981|NCT02012959|468732531|FG001|Treatment Phase A|Adverse Event|0|||
130210982|NCT02012959|468732532|FG002|Treatment Phase A|Adverse Event|0|||
130210983|NCT02012959|468732533|FG003|Treatment Phase A|Adverse Event|0|||
130210984|NCT02012959|468732534|FG004|Treatment Phase A|Adverse Event|0|||
130210985|NCT00642954|468733568|FG000|Overall Study|Progressive Disease|3|||
130210986|NCT00642954|468733569|FG001|Overall Study|Progressive Disease|3|||
130210987|NCT00642954|468733570|FG002|Overall Study|Progressive Disease|3|||
130210988|NCT00642954|468733571|FG003|Overall Study|Progressive Disease|3|||
130210989|NCT00642954|468733572|FG004|Overall Study|Progressive Disease|9|||
130210990|NCT00642954|468733568|FG000|Overall Study|Withdrawal by Subject|0|||
130210991|NCT00642954|468733569|FG001|Overall Study|Withdrawal by Subject|0|||
130210992|NCT00642954|468733570|FG002|Overall Study|Withdrawal by Subject|0|||
130210993|NCT00642954|468733571|FG003|Overall Study|Withdrawal by Subject|0|||
130210994|NCT00642954|468733572|FG004|Overall Study|Withdrawal by Subject|1|||
130210995|NCT00642954|468733568|FG000|Overall Study|Adverse Event|1|||
130210996|NCT00642954|468733569|FG001|Overall Study|Adverse Event|1|||
130210997|NCT00642954|468733570|FG002|Overall Study|Adverse Event|0|||
130210998|NCT00642954|468733571|FG003|Overall Study|Adverse Event|0|||
130210999|NCT00642954|468733572|FG004|Overall Study|Adverse Event|6|||
130211000|NCT00441363|468733573|FG000|Overall Study|Adverse Event|4|||
130211001|NCT00441363|468733574|FG001|Overall Study|Adverse Event|2|||
130211002|NCT00441363|468733573|FG000|Overall Study|Withdrawal by Subject|3|||
130211003|NCT00441363|468733574|FG001|Overall Study|Withdrawal by Subject|4|||
130211004|NCT00441363|468733573|FG000|Overall Study|Physician Decision|6|||
130211005|NCT00441363|468733574|FG001|Overall Study|Physician Decision|7|||
130211006|NCT00441363|468733573|FG000|Overall Study|Lost to Follow-up|2|||
130211007|NCT00441363|468733574|FG001|Overall Study|Lost to Follow-up|2|||
130211008|NCT00441363|468733573|FG000|Overall Study|Other|2|||
130211009|NCT00441363|468733574|FG001|Overall Study|Other|0|||
130211010|NCT01663857|468733577|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
130211011|NCT01663857|468733578|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
130211012|NCT01663857|468733579|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
130211013|NCT01663857|468733580|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
130211014|NCT01663857|468733577|FG000|Overall Study|Lost to Follow-up|0|||
130211015|NCT01663857|468733578|FG001|Overall Study|Lost to Follow-up|0|||
130211016|NCT01663857|468733579|FG002|Overall Study|Lost to Follow-up|3|||
130211017|NCT01663857|468733580|FG003|Overall Study|Lost to Follow-up|1|||
130211018|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
130211019|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
130211020|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
130211021|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
130211022|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130211023|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130211024|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
130211025|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
130211026|NCT04114656|468733581|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130211027|NCT04114656|468733582|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130211028|NCT03052920|468733583|FG000|Overall Study|Withdrawal by Subject|1|||
130211029|NCT03326518|468733589|FG000|Overall Study|Protocol Violation|1|||
130211030|NCT03326518|468733590|FG001|Overall Study|Protocol Violation|0|||
130211031|NCT03326518|468733591|FG002|Overall Study|Protocol Violation|0|||
130211032|NCT03326518|468733589|FG000|Overall Study|Withdrawal by Subject|1|||
130211033|NCT03326518|468733590|FG001|Overall Study|Withdrawal by Subject|0|||
130211034|NCT03326518|468733591|FG002|Overall Study|Withdrawal by Subject|0|||
130211035|NCT03326518|468733589|FG000|Overall Study|Lost to Follow-up|1|||
130211036|NCT03326518|468733590|FG001|Overall Study|Lost to Follow-up|0|||
130211037|NCT03326518|468733591|FG002|Overall Study|Lost to Follow-up|1|||
130211038|NCT01375374|468733594|FG000|Overall Study|Adverse Event|1|||
130211039|NCT02065518|468733595|FG000|Overall Study|Lost to Follow-up|3|||
130211040|NCT02065518|468733596|FG001|Overall Study|Lost to Follow-up|4|||
130211041|NCT02065518|468733597|FG002|Overall Study|Lost to Follow-up|0|||
130211042|NCT02065518|468733598|FG003|Overall Study|Lost to Follow-up|3|||
130211043|NCT02065518|468733595|FG000|Overall Study|Withdrawal by Subject|3|||
130211044|NCT02065518|468733596|FG001|Overall Study|Withdrawal by Subject|4|||
130211045|NCT02065518|468733597|FG002|Overall Study|Withdrawal by Subject|9|||
130211046|NCT02065518|468733598|FG003|Overall Study|Withdrawal by Subject|2|||
130211047|NCT04849416|468733599|FG000|Overall Study|Ongoing Treatment|12|||
130211048|NCT04849416|468733600|FG001|Overall Study|Ongoing Treatment|5|||
130211049|NCT04849416|468733601|FG002|Overall Study|Ongoing Treatment|3|||
130211050|NCT04849416|468733599|FG000|Overall Study|On Post-Treatment Follow-up|8|||
130211051|NCT04849416|468733600|FG001|Overall Study|On Post-Treatment Follow-up|9|||
130211052|NCT04849416|468733601|FG002|Overall Study|On Post-Treatment Follow-up|10|||
130211053|NCT04849416|468733599|FG000|Overall Study|Withdrawal by Subject|0|||
130211054|NCT04849416|468733600|FG001|Overall Study|Withdrawal by Subject|0|||
130211055|NCT04849416|468733601|FG002|Overall Study|Withdrawal by Subject|1|||
130211056|NCT04849416|468733599|FG000|Overall Study|Lost to Follow-up|1|||
130211057|NCT04849416|468733600|FG001|Overall Study|Lost to Follow-up|0|||
130211058|NCT04849416|468733601|FG002|Overall Study|Lost to Follow-up|0|||
130211059|NCT01038752|468733611|FG000|Overall Study|Tumor Progression|2|||
130211060|NCT01038752|468733612|FG001|Overall Study|Tumor Progression|2|||
130211061|NCT01038752|468733611|FG000|Overall Study|Lost to Follow-up|3|||
130211062|NCT01038752|468733612|FG001|Overall Study|Lost to Follow-up|3|||
130211063|NCT04165135|468733613|FG000|Overall Study|Protocol Violation|10|||
130211064|NCT04165135|468733613|FG000|Overall Study|Participants withdrawal of consent|5|||
130211065|NCT01618916|468733614|FG000|Overall Study|Adverse Event|1|||
130211066|NCT01618916|468733615|FG001|Overall Study|Adverse Event|0|||
130211067|NCT01618916|468733616|FG002|Overall Study|Adverse Event|0|||
130211068|NCT01618916|468733617|FG003|Overall Study|Adverse Event|0|||
130211069|NCT01618916|468733618|FG004|Overall Study|Adverse Event|0|||
130211070|NCT01618916|468733619|FG005|Overall Study|Adverse Event|0|||
130211071|NCT01618916|468733614|FG000|Overall Study|Withdrawal by Subject|0|||
130211072|NCT01618916|468733615|FG001|Overall Study|Withdrawal by Subject|1|||
130211073|NCT01618916|468733616|FG002|Overall Study|Withdrawal by Subject|1|||
130211074|NCT01618916|468733617|FG003|Overall Study|Withdrawal by Subject|0|||
130211075|NCT01618916|468733618|FG004|Overall Study|Withdrawal by Subject|1|||
130211076|NCT01618916|468733619|FG005|Overall Study|Withdrawal by Subject|0|||
130211077|NCT01618916|468733614|FG000|Overall Study|Lost to Follow-up|1|||
130211078|NCT01618916|468733615|FG001|Overall Study|Lost to Follow-up|0|||
130211079|NCT01618916|468733616|FG002|Overall Study|Lost to Follow-up|0|||
130211080|NCT01618916|468733617|FG003|Overall Study|Lost to Follow-up|2|||
130211081|NCT01618916|468733618|FG004|Overall Study|Lost to Follow-up|0|||
130211082|NCT01618916|468733619|FG005|Overall Study|Lost to Follow-up|0|||
130211083|NCT04521114|468733620|FG000|Overall Study|Lost to Follow-up|1|||
130211084|NCT04521114|468733621|FG001|Overall Study|Lost to Follow-up|2|||
130211085|NCT04521114|468733622|FG002|Overall Study|Lost to Follow-up|0|||
130211086|NCT04521114|468733620|FG000|Overall Study|Withdrawal by Subject|1|||
130211087|NCT04521114|468733621|FG001|Overall Study|Withdrawal by Subject|2|||
130211088|NCT04521114|468733622|FG002|Overall Study|Withdrawal by Subject|2|||
130211089|NCT04521114|468733620|FG000|Overall Study|Adverse Event|1|||
130211090|NCT04521114|468733621|FG001|Overall Study|Adverse Event|0|||
130211091|NCT04521114|468733622|FG002|Overall Study|Adverse Event|0|||
130211092|NCT04521114|468733620|FG000|Overall Study|Sponsor Wish|1|||
130211093|NCT04521114|468733621|FG001|Overall Study|Sponsor Wish|0|||
130211094|NCT04521114|468733622|FG002|Overall Study|Sponsor Wish|0|||
130211095|NCT04521114|468733620|FG000|Overall Study|Withdrawal of Consent|2|||
130211096|NCT04521114|468733621|FG001|Overall Study|Withdrawal of Consent|2|||
130211097|NCT04521114|468733622|FG002|Overall Study|Withdrawal of Consent|0|||
130211098|NCT01084538|468733630|FG000|Overall Study|Drug not available|30|||
130211099|NCT01084538|468733630|FG000|Overall Study|Adverse Event|9|||
130211100|NCT01084538|468733630|FG000|Overall Study|Kidney transplant|6|||
130211101|NCT01084538|468733630|FG000|Overall Study|Serious Adverse Event|3|||
130211102|NCT01084538|468733630|FG000|Overall Study|Lack of effectiveness|2|||
130211103|NCT01084538|468733630|FG000|Overall Study|Patient noncompliance|2|||
130211104|NCT01084538|468733630|FG000|Overall Study|Hyperphosphatemia|2|||
130211105|NCT01084538|468733630|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
130211106|NCT01084538|468733630|FG000|Overall Study|Change of residence|2|||
130211107|NCT01084538|468733630|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
130211108|NCT01084538|468733630|FG000|Overall Study|Reason unknown|8|||
130211109|NCT01625689|468733635|FG000|Overall Study|Migration|2|||
130211110|NCT01625689|468733636|FG001|Overall Study|Migration|1|||
130211111|NCT00106639|468733637|FG000|Overall Study|Adverse Event|3|||
130211112|NCT00106639|468733638|FG001|Overall Study|Adverse Event|4|||
130211113|NCT00106639|468733639|FG002|Overall Study|Adverse Event|1|||
130211114|NCT00106639|468733637|FG000|Overall Study|Protocol Violation|0|||
130211115|NCT00106639|468733638|FG001|Overall Study|Protocol Violation|1|||
130211116|NCT00106639|468733639|FG002|Overall Study|Protocol Violation|0|||
130211117|NCT00106639|468733637|FG000|Overall Study|Withdrawal by Subject|0|||
130211118|NCT00106639|468733638|FG001|Overall Study|Withdrawal by Subject|1|||
130211119|NCT00106639|468733639|FG002|Overall Study|Withdrawal by Subject|0|||
130211120|NCT00106639|468733637|FG000|Overall Study|Participant defaulted|0|||
130211121|NCT00106639|468733638|FG001|Overall Study|Participant defaulted|1|||
130211122|NCT00106639|468733639|FG002|Overall Study|Participant defaulted|1|||
130211123|NCT01210144|468733643|FG000|Overall Study|Lack of ovarian response|1|||
130211124|NCT01210144|468733644|FG001|Overall Study|Lack of ovarian response|0|||
130211125|NCT01210144|468733643|FG000|Overall Study|No fertilization|1|||
130211126|NCT01210144|468733644|FG001|Overall Study|No fertilization|0|||
130211127|NCT01210144|468733643|FG000|Overall Study|No transfer|1|||
130211128|NCT01210144|468733644|FG001|Overall Study|No transfer|0|||
130211129|NCT00494221|468733645|FG000|Overall Study|Death|15|||
130211130|NCT00494221|468733646|FG001|Overall Study|Death|9|||
130211131|NCT00494221|468733647|FG002|Overall Study|Death|14|||
130211132|NCT00494221|468733645|FG000|Overall Study|Withdrawal by Subject|1|||
130211133|NCT00494221|468733646|FG001|Overall Study|Withdrawal by Subject|2|||
130211134|NCT00494221|468733647|FG002|Overall Study|Withdrawal by Subject|0|||
130211135|NCT01714609|468733652|FG000|Overall Study|Protocol Violation|1|||
130211136|NCT01714609|468733653|FG001|Overall Study|Protocol Violation|0|||
130211137|NCT00630747|468733654|FG000|Overall Study|Death|1|||
130211138|NCT00630747|468733654|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
130211139|NCT00630747|468733654|FG000|Overall Study|Returned to country of origin|1|||
130211140|NCT02306694|468733657|FG000|Overall Study|Withdrawal by Subject|3|||
130211141|NCT02306694|468733657|FG000|Overall Study|Lost to Follow-up|1|||
130211142|NCT03782974|468733658|FG000|Overall Study|Withdrawal by Subject|7|||
130211143|NCT03782974|468733659|FG001|Overall Study|Withdrawal by Subject|7|||
130211144|NCT03782974|468733658|FG000|Overall Study|Pregnancy|1|||
130211145|NCT03782974|468733659|FG001|Overall Study|Pregnancy|0|||
130211146|NCT00395642|468733660|FG000|Overall Study|Death|4|||
130211147|NCT00395642|468733660|FG000|Overall Study|Lost to Follow-up|1|||
130211148|NCT00395642|468733660|FG000|Overall Study|Physician Decision|7|||
130211149|NCT00395642|468733660|FG000|Overall Study|Withdrawal by Subject|1|||
130211150|NCT00659776|468733670|FG000|Overall Study|Withdrawal by Subject|12|||
130211151|NCT00659776|468733671|FG001|Overall Study|Withdrawal by Subject|2|||
130211152|NCT00659776|468733672|FG002|Overall Study|Withdrawal by Subject|0|||
130211153|NCT01180049|468733673|FG000|Overall Study|Other|9|||
130211154|NCT01180049|468733674|FG001|Overall Study|Other|7|||
130211155|NCT01180049|468733673|FG000|Overall Study|Lost to Follow-up|8|||
130211156|NCT01180049|468733674|FG001|Overall Study|Lost to Follow-up|6|||
130211157|NCT01180049|468733673|FG000|Overall Study|Death|36|||
130211158|NCT01180049|468733674|FG001|Overall Study|Death|35|||
130211159|NCT01905592|468733677|FG000|Overall Study|Disease Progression|51|||
130211160|NCT01905592|468733678|FG001|Overall Study|Disease Progression|110|||
130211161|NCT01905592|468733677|FG000|Overall Study|Toxicity|1|||
130211162|NCT01905592|468733678|FG001|Overall Study|Toxicity|16|||
130211163|NCT01905592|468733677|FG000|Overall Study|Physician Decision|0|||
130211164|NCT01905592|468733678|FG001|Overall Study|Physician Decision|2|||
130211165|NCT01905592|468733677|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
130211166|NCT01905592|468733678|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
130211167|NCT01905592|468733677|FG000|Overall Study|Protocol Violation|0|||
130211168|NCT01905592|468733678|FG001|Overall Study|Protocol Violation|1|||
130211169|NCT01905592|468733677|FG000|Overall Study|Sponsor's decision|1|||
130211170|NCT01905592|468733678|FG001|Overall Study|Sponsor's decision|1|||
130211171|NCT01905592|468733677|FG000|Overall Study|Not treated|7|||
130211172|NCT01905592|468733678|FG001|Overall Study|Not treated|3|||
130431076|NCT04739761|469539415|FG000|Overall Study|Adverse Event|0|||
130431077|NCT04739761|469539416|FG001|Overall Study|Adverse Event|3|||
130431078|NCT04739761|469539415|FG000|Overall Study|Participant decision|1|||
130431079|NCT04739761|469539416|FG001|Overall Study|Participant decision|0|||
130431080|NCT04739761|469539415|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
130431081|NCT04739761|469539416|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
130431082|NCT04739761|469539415|FG000|Overall Study|Participant immediately started next line of treatment|1|||
130431083|NCT04739761|469539416|FG001|Overall Study|Participant immediately started next line of treatment|0|||
130431084|NCT04739761|469539415|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
130431085|NCT04739761|469539416|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
130431086|NCT04739761|469539415|FG000|Overall Study|Lack of clinical benefit|1|||
130431087|NCT04739761|469539416|FG001|Overall Study|Lack of clinical benefit|0|||
130431088|NCT04739761|469539415|FG000|Overall Study|Disease progression|5|||
130431089|NCT04739761|469539416|FG001|Overall Study|Disease progression|5|||
130431090|NCT04739761|469539415|FG000|Overall Study|Withdrawal by Subject|14|||
130543696|NCT00412061|469956812|FG000|Open Label Phase|Withdrawal by Subject|0|||
130211173|NCT01905592|468733677|FG000|Overall Study|Withdrawal by Subject|10|||
130211174|NCT01905592|468733678|FG001|Overall Study|Withdrawal by Subject|2|||
130211175|NCT03015194|468735477|FG000|Overall Study|Death|10|||
130211176|NCT03015194|468735477|FG000|Overall Study|Withdrawal by Subject|2|||
130211177|NCT00433017|468735479|FG000|Overall Study|Adverse Event|5|||
130211178|NCT00433017|468735480|FG001|Overall Study|Adverse Event|3|||
130211179|NCT00433017|468735479|FG000|Overall Study|Withdrawal by Subject|4|||
130211180|NCT00433017|468735480|FG001|Overall Study|Withdrawal by Subject|5|||
130211181|NCT00433017|468735479|FG000|Overall Study|Lost to Follow-up|3|||
130211182|NCT00433017|468735480|FG001|Overall Study|Lost to Follow-up|4|||
130211183|NCT00433017|468735479|FG000|Overall Study|Administrative problems|80|||
130431091|NCT04739761|469539416|FG001|Overall Study|Withdrawal by Subject|13|||
130431092|NCT04739761|469539415|FG000|Overall Study|Protocol Violation|1|||
130431093|NCT04739761|469539416|FG001|Overall Study|Protocol Violation|0|||
130431094|NCT04739761|469539415|FG000|Overall Study|Physician Decision|2|||
130431095|NCT04739761|469539416|FG001|Overall Study|Physician Decision|0|||
130431096|NCT01061333|469539418|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
130431097|NCT01061333|469539419|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
130431098|NCT00058422|469540618|FG000|Overall Study|Not treated|2|||
130431099|NCT00185640|469540619|FG000|Overall Study|Not Eligible|4|||
130431100|NCT00185640|469540619|FG000|Overall Study|Withdrawal by Subject|3|||
130431101|NCT00185640|469540619|FG000|Overall Study|Death|138|||
130431102|NCT02287584|469540620|FG000|the Double-blind Phase|Adverse Event|17|||
130431103|NCT02287584|469540621|FG001|the Double-blind Phase|Adverse Event|17|||
130431104|NCT02287584|469540622|FG002|the Double-blind Phase|Adverse Event|12|||
130431105|NCT02287584|469540623|FG003|the Double-blind Phase|Adverse Event|0|||
130431106|NCT02287584|469540624|FG004|the Double-blind Phase|Adverse Event|0|||
130431107|NCT02287584|469540625|FG005|the Double-blind Phase|Adverse Event|0|||
130431108|NCT02287584|469540620|FG000|the Double-blind Phase|Lack of Efficacy|18|||
130431109|NCT02287584|469540621|FG001|the Double-blind Phase|Lack of Efficacy|8|||
130431110|NCT02287584|469540622|FG002|the Double-blind Phase|Lack of Efficacy|8|||
130431111|NCT02287584|469540623|FG003|the Double-blind Phase|Lack of Efficacy|0|||
130431112|NCT02287584|469540624|FG004|the Double-blind Phase|Lack of Efficacy|0|||
130431113|NCT02287584|469540625|FG005|the Double-blind Phase|Lack of Efficacy|0|||
130431114|NCT02287584|469540620|FG000|the Double-blind Phase|Lost to Follow-up|0|||
130431115|NCT02287584|469540621|FG001|the Double-blind Phase|Lost to Follow-up|1|||
130431116|NCT02287584|469540622|FG002|the Double-blind Phase|Lost to Follow-up|1|||
130431117|NCT02287584|469540623|FG003|the Double-blind Phase|Lost to Follow-up|0|||
130431118|NCT02287584|469540624|FG004|the Double-blind Phase|Lost to Follow-up|0|||
130431119|NCT02287584|469540625|FG005|the Double-blind Phase|Lost to Follow-up|0|||
130431120|NCT02287584|469540620|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
130431121|NCT02287584|469540621|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
130431122|NCT02287584|469540622|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
130431123|NCT02287584|469540623|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
130431124|NCT02287584|469540624|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
130431125|NCT02287584|469540625|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
130431126|NCT02287584|469540620|FG000|the Double-blind Phase|Pregnancy|0|||
130431127|NCT02287584|469540621|FG001|the Double-blind Phase|Pregnancy|1|||
130431128|NCT02287584|469540622|FG002|the Double-blind Phase|Pregnancy|0|||
130431129|NCT02287584|469540623|FG003|the Double-blind Phase|Pregnancy|0|||
130431130|NCT02287584|469540624|FG004|the Double-blind Phase|Pregnancy|0|||
130431131|NCT02287584|469540625|FG005|the Double-blind Phase|Pregnancy|0|||
130431132|NCT02287584|469540620|FG000|the Double-blind Phase|Protocol Violation|0|||
130431133|NCT02287584|469540621|FG001|the Double-blind Phase|Protocol Violation|3|||
130431134|NCT02287584|469540622|FG002|the Double-blind Phase|Protocol Violation|0|||
130431135|NCT02287584|469540623|FG003|the Double-blind Phase|Protocol Violation|0|||
130431136|NCT02287584|469540624|FG004|the Double-blind Phase|Protocol Violation|0|||
130431137|NCT02287584|469540625|FG005|the Double-blind Phase|Protocol Violation|0|||
130431138|NCT02287584|469540620|FG000|the Double-blind Phase|other reasons|0|||
130431139|NCT02287584|469540621|FG001|the Double-blind Phase|other reasons|0|||
130431140|NCT02287584|469540622|FG002|the Double-blind Phase|other reasons|1|||
130431141|NCT02287584|469540623|FG003|the Double-blind Phase|other reasons|0|||
130431142|NCT02287584|469540624|FG004|the Double-blind Phase|other reasons|0|||
130431143|NCT02287584|469540625|FG005|the Double-blind Phase|other reasons|0|||
130431144|NCT02287584|469540620|FG000|the Open-label Phase|Did not receive drug|0|||
130431145|NCT02287584|469540621|FG001|the Open-label Phase|Did not receive drug|0|||
130431146|NCT02287584|469540622|FG002|the Open-label Phase|Did not receive drug|0|||
130431147|NCT02287584|469540623|FG003|the Open-label Phase|Did not receive drug|7|||
130431148|NCT02287584|469540624|FG004|the Open-label Phase|Did not receive drug|6|||
130431149|NCT02287584|469540625|FG005|the Open-label Phase|Did not receive drug|4|||
130431150|NCT02287584|469540620|FG000|the Open-label Phase|Adverse Event|0|||
130431151|NCT02287584|469540621|FG001|the Open-label Phase|Adverse Event|0|||
130431152|NCT02287584|469540622|FG002|the Open-label Phase|Adverse Event|0|||
130431153|NCT02287584|469540623|FG003|the Open-label Phase|Adverse Event|15|||
130431154|NCT02287584|469540624|FG004|the Open-label Phase|Adverse Event|12|||
130431155|NCT02287584|469540625|FG005|the Open-label Phase|Adverse Event|16|||
130431156|NCT02287584|469540620|FG000|the Open-label Phase|Lack of Efficacy|0|||
130431157|NCT02287584|469540621|FG001|the Open-label Phase|Lack of Efficacy|0|||
130431158|NCT02287584|469540622|FG002|the Open-label Phase|Lack of Efficacy|0|||
130431159|NCT02287584|469540623|FG003|the Open-label Phase|Lack of Efficacy|8|||
130431160|NCT02287584|469540624|FG004|the Open-label Phase|Lack of Efficacy|3|||
130431161|NCT02287584|469540625|FG005|the Open-label Phase|Lack of Efficacy|7|||
130431162|NCT02287584|469540620|FG000|the Open-label Phase|Lost to Follow-up|0|||
130431163|NCT02287584|469540621|FG001|the Open-label Phase|Lost to Follow-up|0|||
130431164|NCT02287584|469540622|FG002|the Open-label Phase|Lost to Follow-up|0|||
130431165|NCT02287584|469540623|FG003|the Open-label Phase|Lost to Follow-up|4|||
130431166|NCT02287584|469540624|FG004|the Open-label Phase|Lost to Follow-up|1|||
130431167|NCT02287584|469540625|FG005|the Open-label Phase|Lost to Follow-up|2|||
130431168|NCT02287584|469540620|FG000|the Open-label Phase|Withdrawal by Subject|0|||
130431169|NCT02287584|469540621|FG001|the Open-label Phase|Withdrawal by Subject|0|||
130431170|NCT02287584|469540622|FG002|the Open-label Phase|Withdrawal by Subject|0|||
130431171|NCT02287584|469540623|FG003|the Open-label Phase|Withdrawal by Subject|18|||
130431172|NCT02287584|469540624|FG004|the Open-label Phase|Withdrawal by Subject|29|||
130431173|NCT02287584|469540625|FG005|the Open-label Phase|Withdrawal by Subject|21|||
130431174|NCT02287584|469540620|FG000|the Open-label Phase|non-compliance|0|||
130431175|NCT02287584|469540621|FG001|the Open-label Phase|non-compliance|0|||
130431176|NCT02287584|469540622|FG002|the Open-label Phase|non-compliance|0|||
130431177|NCT02287584|469540623|FG003|the Open-label Phase|non-compliance|2|||
130431178|NCT02287584|469540624|FG004|the Open-label Phase|non-compliance|5|||
130431179|NCT02287584|469540625|FG005|the Open-label Phase|non-compliance|1|||
130431180|NCT02287584|469540620|FG000|the Open-label Phase|other reasons|0|||
130431181|NCT02287584|469540621|FG001|the Open-label Phase|other reasons|0|||
130431182|NCT02287584|469540622|FG002|the Open-label Phase|other reasons|0|||
130431183|NCT02287584|469540623|FG003|the Open-label Phase|other reasons|3|||
130431184|NCT02287584|469540624|FG004|the Open-label Phase|other reasons|6|||
130431185|NCT02287584|469540625|FG005|the Open-label Phase|other reasons|6|||
130431186|NCT03430063|469540629|FG000|Overall Study|Adverse Event|0|||
130431187|NCT03430063|469540630|FG001|Overall Study|Adverse Event|1|||
130431188|NCT03430063|469540631|FG002|Overall Study|Adverse Event|0|||
130431189|NCT03430063|469540629|FG000|Overall Study|Death|3|||
130431190|NCT03430063|469540630|FG001|Overall Study|Death|2|||
130431191|NCT03430063|469540631|FG002|Overall Study|Death|3|||
130431192|NCT03430063|469540629|FG000|Overall Study|Lost to Follow-up|0|||
130431193|NCT03430063|469540630|FG001|Overall Study|Lost to Follow-up|1|||
130431194|NCT03430063|469540631|FG002|Overall Study|Lost to Follow-up|0|||
130431195|NCT03430063|469540629|FG000|Overall Study|Withdrawal by Subject|0|||
130431196|NCT03430063|469540630|FG001|Overall Study|Withdrawal by Subject|0|||
130431197|NCT03430063|469540631|FG002|Overall Study|Withdrawal by Subject|1|||
130431198|NCT03430063|469540629|FG000|Overall Study|Withdrawal of consent|3|||
130431199|NCT03430063|469540630|FG001|Overall Study|Withdrawal of consent|1|||
130431200|NCT03430063|469540631|FG002|Overall Study|Withdrawal of consent|2|||
130431201|NCT03430063|469540629|FG000|Overall Study|Progressive disease|1|||
130431202|NCT03430063|469540630|FG001|Overall Study|Progressive disease|2|||
130431203|NCT03430063|469540631|FG002|Overall Study|Progressive disease|1|||
130431204|NCT03430063|469540629|FG000|Overall Study|Other un-specified|1|||
130431205|NCT03430063|469540630|FG001|Overall Study|Other un-specified|1|||
130431206|NCT03430063|469540631|FG002|Overall Study|Other un-specified|0|||
130431207|NCT03430063|469540629|FG000|Overall Study|Randomized, but never treated|0|||
130431208|NCT03430063|469540630|FG001|Overall Study|Randomized, but never treated|0|||
130431209|NCT03430063|469540631|FG002|Overall Study|Randomized, but never treated|1|||
130431210|NCT01782872|469540633|FG000|Overall Study|Protocol Violation|0|||
130431211|NCT01782872|469540634|FG001|Overall Study|Protocol Violation|0|||
130431212|NCT01782872|469540635|FG002|Overall Study|Protocol Violation|0|||
130431213|NCT01782872|469540636|FG003|Overall Study|Protocol Violation|1|||
130431214|NCT01782872|469540633|FG000|Overall Study|Withdrawal by Subject|0|||
130431215|NCT01782872|469540634|FG001|Overall Study|Withdrawal by Subject|1|||
130431216|NCT01782872|469540635|FG002|Overall Study|Withdrawal by Subject|0|||
130431217|NCT01782872|469540636|FG003|Overall Study|Withdrawal by Subject|0|||
130431218|NCT04026165|469540640|FG000|Run-in Placebo Period|Enrollment Error|13|||
130431219|NCT04026165|469540641|FG001|Run-in Placebo Period|Enrollment Error|0|||
130431220|NCT04026165|469540642|FG002|Run-in Placebo Period|Enrollment Error|0|||
130431221|NCT04026165|469540643|FG003|Run-in Placebo Period|Enrollment Error|0|||
130431222|NCT04026165|469540640|FG000|Run-in Placebo Period|Run-in Failure|4|||
130431223|NCT04026165|469540641|FG001|Run-in Placebo Period|Run-in Failure|0|||
130431224|NCT04026165|469540642|FG002|Run-in Placebo Period|Run-in Failure|0|||
130431225|NCT04026165|469540643|FG003|Run-in Placebo Period|Run-in Failure|0|||
130431226|NCT04026165|469540640|FG000|Run-in Placebo Period|Protocol Violation|2|||
130431227|NCT04026165|469540641|FG001|Run-in Placebo Period|Protocol Violation|0|||
130431228|NCT04026165|469540642|FG002|Run-in Placebo Period|Protocol Violation|0|||
130431229|NCT04026165|469540643|FG003|Run-in Placebo Period|Protocol Violation|0|||
130431230|NCT04026165|469540640|FG000|Run-in Placebo Period|Withdrew Consent|2|||
130431231|NCT04026165|469540641|FG001|Run-in Placebo Period|Withdrew Consent|0|||
130431232|NCT04026165|469540642|FG002|Run-in Placebo Period|Withdrew Consent|0|||
130431233|NCT04026165|469540643|FG003|Run-in Placebo Period|Withdrew Consent|0|||
130431234|NCT04026165|469540640|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
130431235|NCT04026165|469540641|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130431236|NCT04026165|469540642|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130431237|NCT04026165|469540643|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130431238|NCT04026165|469540640|FG000|Run-in SEL Period|Run-in Failure|0|||
130431239|NCT04026165|469540641|FG001|Run-in SEL Period|Run-in Failure|26|||
130431240|NCT04026165|469540642|FG002|Run-in SEL Period|Run-in Failure|0|||
130431241|NCT04026165|469540643|FG003|Run-in SEL Period|Run-in Failure|0|||
130431242|NCT04026165|469540640|FG000|Run-in SEL Period|Withdrew Consent|0|||
130431243|NCT04026165|469540641|FG001|Run-in SEL Period|Withdrew Consent|10|||
130431244|NCT04026165|469540642|FG002|Run-in SEL Period|Withdrew Consent|0|||
130431245|NCT04026165|469540643|FG003|Run-in SEL Period|Withdrew Consent|0|||
130431246|NCT04026165|469540640|FG000|Run-in SEL Period|Enrollment Error|0|||
130431247|NCT04026165|469540641|FG001|Run-in SEL Period|Enrollment Error|4|||
130431248|NCT04026165|469540642|FG002|Run-in SEL Period|Enrollment Error|0|||
130431249|NCT04026165|469540643|FG003|Run-in SEL Period|Enrollment Error|0|||
130431250|NCT04026165|469540640|FG000|Run-in SEL Period|Protocol Violation|0|||
130431251|NCT04026165|469540641|FG001|Run-in SEL Period|Protocol Violation|3|||
130431252|NCT04026165|469540642|FG002|Run-in SEL Period|Protocol Violation|0|||
130431253|NCT04026165|469540643|FG003|Run-in SEL Period|Protocol Violation|0|||
130431254|NCT04026165|469540640|FG000|Run-in SEL Period|Investigator's Discretion|0|||
130431255|NCT04026165|469540641|FG001|Run-in SEL Period|Investigator's Discretion|2|||
130431256|NCT04026165|469540642|FG002|Run-in SEL Period|Investigator's Discretion|0|||
130431257|NCT04026165|469540643|FG003|Run-in SEL Period|Investigator's Discretion|0|||
130431258|NCT04026165|469540640|FG000|Run-in SEL Period|Death|0|||
130431259|NCT04026165|469540641|FG001|Run-in SEL Period|Death|1|||
130431260|NCT04026165|469540642|FG002|Run-in SEL Period|Death|0|||
130431261|NCT04026165|469540643|FG003|Run-in SEL Period|Death|0|||
130431262|NCT04026165|469540640|FG000|Randomized Period|Withdrew Consent|0|||
130431263|NCT04026165|469540641|FG001|Randomized Period|Withdrew Consent|0|||
130431264|NCT04026165|469540642|FG002|Randomized Period|Withdrew Consent|5|||
130431265|NCT04026165|469540643|FG003|Randomized Period|Withdrew Consent|8|||
130431266|NCT04026165|469540640|FG000|Randomized Period|Death|0|||
130431267|NCT04026165|469540641|FG001|Randomized Period|Death|0|||
130431268|NCT04026165|469540642|FG002|Randomized Period|Death|5|||
130431269|NCT04026165|469540643|FG003|Randomized Period|Death|7|||
130431270|NCT04026165|469540640|FG000|Randomized Period|Investigator's Discretion|0|||
130431271|NCT04026165|469540641|FG001|Randomized Period|Investigator's Discretion|0|||
130431272|NCT04026165|469540642|FG002|Randomized Period|Investigator's Discretion|2|||
130431273|NCT04026165|469540643|FG003|Randomized Period|Investigator's Discretion|2|||
130431274|NCT04026165|469540640|FG000|Randomized Period|Lost to Follow-up|0|||
130431275|NCT04026165|469540641|FG001|Randomized Period|Lost to Follow-up|0|||
130431276|NCT04026165|469540642|FG002|Randomized Period|Lost to Follow-up|2|||
130431277|NCT04026165|469540643|FG003|Randomized Period|Lost to Follow-up|2|||
130431278|NCT00441701|469540644|FG000|Overall Study|Adverse Event|3|||
130431279|NCT00441701|469540645|FG001|Overall Study|Adverse Event|2|||
130431280|NCT00441701|469540646|FG002|Overall Study|Adverse Event|1|||
130431281|NCT00441701|469540647|FG003|Overall Study|Adverse Event|0|||
130431282|NCT00441701|469540648|FG004|Overall Study|Adverse Event|2|||
130431283|NCT00441701|469540649|FG005|Overall Study|Adverse Event|2|||
130431284|NCT00441701|469540650|FG006|Overall Study|Adverse Event|0|||
130431285|NCT00441701|469540651|FG007|Overall Study|Adverse Event|0|||
130431286|NCT00441701|469540652|FG008|Overall Study|Adverse Event|0|||
130431287|NCT00441701|469540653|FG009|Overall Study|Adverse Event|0|||
130431288|NCT00441701|469540644|FG000|Overall Study|Lack of Efficacy|2|||
130431289|NCT00441701|469540645|FG001|Overall Study|Lack of Efficacy|0|||
130431290|NCT00441701|469540646|FG002|Overall Study|Lack of Efficacy|2|||
130431291|NCT00441701|469540647|FG003|Overall Study|Lack of Efficacy|2|||
130431292|NCT00441701|469540648|FG004|Overall Study|Lack of Efficacy|0|||
130431293|NCT00441701|469540649|FG005|Overall Study|Lack of Efficacy|1|||
130431294|NCT00441701|469540650|FG006|Overall Study|Lack of Efficacy|0|||
130431295|NCT00441701|469540651|FG007|Overall Study|Lack of Efficacy|0|||
130431296|NCT00441701|469540652|FG008|Overall Study|Lack of Efficacy|0|||
130431297|NCT00441701|469540653|FG009|Overall Study|Lack of Efficacy|0|||
130431298|NCT00441701|469540644|FG000|Overall Study|Withdrawal by Subject|0|||
130431299|NCT00441701|469540645|FG001|Overall Study|Withdrawal by Subject|2|||
130431300|NCT00441701|469540646|FG002|Overall Study|Withdrawal by Subject|1|||
130431301|NCT00441701|469540647|FG003|Overall Study|Withdrawal by Subject|1|||
130431302|NCT00441701|469540648|FG004|Overall Study|Withdrawal by Subject|0|||
130431303|NCT00441701|469540649|FG005|Overall Study|Withdrawal by Subject|0|||
130431304|NCT00441701|469540650|FG006|Overall Study|Withdrawal by Subject|0|||
130431305|NCT00441701|469540651|FG007|Overall Study|Withdrawal by Subject|0|||
130431306|NCT00441701|469540652|FG008|Overall Study|Withdrawal by Subject|0|||
130431307|NCT00441701|469540653|FG009|Overall Study|Withdrawal by Subject|0|||
130431308|NCT00077064|469540654|FG000|Overall Study|Adverse Event|0|||
130431309|NCT00077064|469540655|FG001|Overall Study|Adverse Event|4|||
130431310|NCT00077064|469540654|FG000|Overall Study|Patient refusal|0|||
130431311|NCT00077064|469540655|FG001|Overall Study|Patient refusal|2|||
130431312|NCT04710927|469540656|FG000|Overall Study|Lost to Follow-up|7|||
130431313|NCT04710927|469540657|FG001|Overall Study|Lost to Follow-up|6|||
130431314|NCT04710927|469540658|FG002|Overall Study|Lost to Follow-up|5|||
130431315|NCT00621543|469540659|FG000|Overall Study|Lost to Follow-up|23|||
130431316|NCT02007434|469540661|FG000|Overall Study|Lost to Follow-up|0|||
130431317|NCT02007434|469540662|FG001|Overall Study|Lost to Follow-up|1|||
130431318|NCT02007434|469540663|FG002|Overall Study|Lost to Follow-up|0|||
130431319|NCT02007434|469540664|FG003|Overall Study|Lost to Follow-up|0|||
130431320|NCT02007434|469540665|FG004|Overall Study|Lost to Follow-up|0|||
130431321|NCT02007434|469540666|FG005|Overall Study|Lost to Follow-up|0|||
130431322|NCT02007434|469540667|FG006|Overall Study|Lost to Follow-up|0|||
130431323|NCT02007434|469540668|FG007|Overall Study|Lost to Follow-up|0|||
130431324|NCT02007434|469540661|FG000|Overall Study|Non-compliance|1|||
130431325|NCT02007434|469540662|FG001|Overall Study|Non-compliance|0|||
130431326|NCT02007434|469540663|FG002|Overall Study|Non-compliance|1|||
130431327|NCT02007434|469540664|FG003|Overall Study|Non-compliance|0|||
130431328|NCT02007434|469540665|FG004|Overall Study|Non-compliance|0|||
130431329|NCT02007434|469540666|FG005|Overall Study|Non-compliance|0|||
130431330|NCT02007434|469540667|FG006|Overall Study|Non-compliance|0|||
130431331|NCT02007434|469540668|FG007|Overall Study|Non-compliance|0|||
130431332|NCT01287611|469540669|FG000|Overall Study|Lost to Follow-up|29|||
130431333|NCT01287611|469540670|FG001|Overall Study|Lost to Follow-up|16|||
130431334|NCT01287611|469540669|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
130431335|NCT01287611|469540670|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
130431336|NCT02192970|469540673|FG000|Overall Study|Lost to Follow-up|6|||
130431337|NCT02192970|469540674|FG001|Overall Study|Lost to Follow-up|0|||
130431338|NCT04074590|469540675|FG000|Overall Study|Adverse Event|1|||
130431339|NCT04074590|469540676|FG001|Overall Study|Adverse Event|0|||
130431340|NCT04074590|469540675|FG000|Overall Study|Physician Decision|1|||
130431341|NCT04074590|469540676|FG001|Overall Study|Physician Decision|0|||
130431342|NCT04074590|469540675|FG000|Overall Study|Withdrawal by Subject|2|||
130431343|NCT04074590|469540676|FG001|Overall Study|Withdrawal by Subject|0|||
130431344|NCT03745222|469540687|FG000|Overall Study|Withdrawal by Subject|0|||
130431345|NCT03745222|469540688|FG001|Overall Study|Withdrawal by Subject|1|||
130431346|NCT03745222|469540689|FG002|Overall Study|Withdrawal by Subject|0|||
130431347|NCT03299686|469540690|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
130431348|NCT03299686|469540691|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
130431349|NCT03299686|469540690|FG000|Treatment Epoch|Physician Decision|1|||
130431350|NCT03299686|469540691|FG001|Treatment Epoch|Physician Decision|0|||
130431351|NCT03299686|469540690|FG000|Treatment Epoch|Adverse Event|8|||
130431352|NCT03299686|469540691|FG001|Treatment Epoch|Adverse Event|4|||
130431353|NCT03299686|469540690|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
130431354|NCT03299686|469540691|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
130431355|NCT02709005|469540692|FG000|Overall Study|Lost to Follow-up|1|||
130431356|NCT02709005|469540693|FG001|Overall Study|Lost to Follow-up|1|||
130431357|NCT02709005|469540692|FG000|Overall Study|Withdrawal by Subject|3|||
130431358|NCT02709005|469540693|FG001|Overall Study|Withdrawal by Subject|0|||
130431359|NCT00691132|469540694|FG000|Overall Study|Adverse Event|2|||
130431360|NCT00691132|469540695|FG001|Overall Study|Adverse Event|3|||
130431361|NCT00691132|469540694|FG000|Overall Study|Withdrawal by Subject|10|||
130431362|NCT00691132|469540695|FG001|Overall Study|Withdrawal by Subject|10|||
130431363|NCT01959347|469540696|FG000|Overall Study|Protocol Violation|9|||
130431364|NCT01959347|469540697|FG001|Overall Study|Protocol Violation|7|||
130431365|NCT03954743|469540698|FG000|Overall Study|Adverse Event|1|||
130431366|NCT03954743|469540699|FG001|Overall Study|Adverse Event|0|||
130431367|NCT03954743|469540698|FG000|Overall Study|Lost to Follow-up|6|||
130431368|NCT03954743|469540699|FG001|Overall Study|Lost to Follow-up|4|||
130431369|NCT03954743|469540698|FG000|Overall Study|Protocol Violation|1|||
130431370|NCT03954743|469540699|FG001|Overall Study|Protocol Violation|0|||
130431371|NCT03954743|469540698|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
130431372|NCT03954743|469540699|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
130431373|NCT03954743|469540698|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130431374|NCT03954743|469540699|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130431375|NCT01282801|469540702|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
130431376|NCT01282801|469540703|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
130431377|NCT02387996|469540706|FG000|Overall Study|Disease Progression|167|||
130431378|NCT02387996|469540706|FG000|Overall Study|Study Drug Toxicity|31|||
130431379|NCT02387996|469540706|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
130431380|NCT02387996|469540706|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
130431381|NCT02387996|469540706|FG000|Overall Study|Subject Withdrew Consent|5|||
130431382|NCT02387996|469540706|FG000|Overall Study|Lost to Follow-up|1|||
130431383|NCT02387996|469540706|FG000|Overall Study|Poor/Non-Compliance|1|||
130431384|NCT02387996|469540706|FG000|Overall Study|Other Reasons|5|||
130431385|NCT02387996|469540706|FG000|Overall Study|Death|1|||
130431386|NCT01060553|469540707|FG000|Overall Study|Lost to Follow-up|3|||
130431387|NCT01060553|469540708|FG001|Overall Study|Lost to Follow-up|5|||
130431388|NCT01060553|469540707|FG000|Overall Study|Withdrawal by Subject|5|||
130431389|NCT01060553|469540708|FG001|Overall Study|Withdrawal by Subject|5|||
130431390|NCT01060553|469540707|FG000|Overall Study|Lack of Efficacy|1|||
130431391|NCT01060553|469540708|FG001|Overall Study|Lack of Efficacy|0|||
130431392|NCT04707196|469540711|FG000|Overall Study|Withdrawal by Subject|9|||
130431393|NCT04707196|469540712|FG001|Overall Study|Withdrawal by Subject|6|||
130431394|NCT04707196|469540711|FG000|Overall Study|Lost to Follow-up|1|||
130431395|NCT04707196|469540712|FG001|Overall Study|Lost to Follow-up|0|||
130431396|NCT04707196|469540711|FG000|Overall Study|Protocol Violation|4|||
130431397|NCT04707196|469540712|FG001|Overall Study|Protocol Violation|1|||
130431398|NCT04707196|469540711|FG000|Overall Study|Adverse Event|2|||
130431399|NCT04707196|469540712|FG001|Overall Study|Adverse Event|2|||
130431400|NCT04707196|469540711|FG000|Overall Study|Death|3|||
130431401|NCT04707196|469540712|FG001|Overall Study|Death|1|||
130431402|NCT04707196|469540711|FG000|Overall Study|Non-compliance with study drug|1|||
130431403|NCT04707196|469540712|FG001|Overall Study|Non-compliance with study drug|0|||
130431404|NCT04707196|469540711|FG000|Overall Study|Progressive disease|9|||
130431405|NCT04707196|469540712|FG001|Overall Study|Progressive disease|10|||
130431406|NCT01862796|469540713|FG000|Overall Study|Prohibited medications|0|||
130431407|NCT01862796|469540714|FG001|Overall Study|Prohibited medications|0|||
130431408|NCT01862796|469540715|FG002|Overall Study|Prohibited medications|1|||
130431409|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
130431410|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
130431411|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
130431412|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
130431413|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
130431414|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
130431415|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
130431416|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Physician Decision|4|||
130431417|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Physician Decision|1|||
130431418|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Physician Decision|3|||
130431419|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Physician Decision|0|||
130431420|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Physician Decision|0|||
130431421|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Physician Decision|1|||
130431422|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Physician Decision|0|||
130431423|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Other|0|||
130431424|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Other|1|||
130431425|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Other|0|||
130431426|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Other|0|||
130431427|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Other|0|||
130431428|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Other|0|||
130431429|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Other|0|||
130431430|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431431|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431432|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431433|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431434|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431435|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130431436|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
130431437|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
130431438|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
130431439|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
130431440|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
130431441|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
130431442|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
130431443|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
130431444|NCT05375955|469540723|FG000|Treatment (12 Weeks)|Pregnancy|0|||
130431445|NCT05375955|469540724|FG001|Treatment (12 Weeks)|Pregnancy|0|||
130431446|NCT05375955|469540725|FG002|Treatment (12 Weeks)|Pregnancy|1|||
130431447|NCT05375955|469540726|FG003|Treatment (12 Weeks)|Pregnancy|0|||
130431448|NCT05375955|469540727|FG004|Treatment (12 Weeks)|Pregnancy|0|||
130431449|NCT05375955|469540728|FG005|Treatment (12 Weeks)|Pregnancy|0|||
130431450|NCT05375955|469540729|FG006|Treatment (12 Weeks)|Pregnancy|0|||
130431451|NCT05375955|469540723|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431452|NCT05375955|469540724|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431453|NCT05375955|469540725|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
130431454|NCT05375955|469540726|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431455|NCT05375955|469540727|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431456|NCT05375955|469540728|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431457|NCT05375955|469540729|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130431458|NCT05375955|469540723|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130431459|NCT05375955|469540724|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130431460|NCT05375955|469540725|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130431461|NCT05375955|469540726|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130431462|NCT05375955|469540727|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130431463|NCT05375955|469540728|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130431464|NCT05375955|469540729|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130431465|NCT05375955|469540723|FG000|Follow-up (up to 5 Weeks)|Other|0|||
130431466|NCT05375955|469540724|FG001|Follow-up (up to 5 Weeks)|Other|1|||
130431467|NCT05375955|469540725|FG002|Follow-up (up to 5 Weeks)|Other|0|||
130431468|NCT05375955|469540726|FG003|Follow-up (up to 5 Weeks)|Other|0|||
130431469|NCT05375955|469540727|FG004|Follow-up (up to 5 Weeks)|Other|0|||
130431470|NCT05375955|469540728|FG005|Follow-up (up to 5 Weeks)|Other|0|||
130431471|NCT05375955|469540729|FG006|Follow-up (up to 5 Weeks)|Other|0|||
130431472|NCT05375955|469540723|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
130431473|NCT05375955|469540724|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130431474|NCT05375955|469540725|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
130431475|NCT05375955|469540726|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130431476|NCT05375955|469540727|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130431477|NCT05375955|469540728|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130431478|NCT05375955|469540729|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130431479|NCT05375955|469540723|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130431480|NCT05375955|469540724|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
130431481|NCT05375955|469540725|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130431482|NCT05375955|469540726|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
130431483|NCT05375955|469540727|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130431484|NCT05375955|469540728|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130431485|NCT05375955|469540729|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
130431486|NCT00728962|469540735|FG000|Implant Placement Surgery|Adverse Event|8|||
130431487|NCT00728962|469540735|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
130431488|NCT00728962|469540735|FG000|Implant Placement Surgery|Protocol Violation|1|||
130431489|NCT00728962|469540735|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
130431490|NCT00728962|469540735|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
130431491|NCT04954586|469540736|FG000|Overall Study|Withdrawal by Subject|5|||
130431492|NCT02063828|469540737|FG000|Overall Study|Withdrawal by Subject|4|||
130431493|NCT02063828|469540738|FG001|Overall Study|Withdrawal by Subject|6|||
130431494|NCT02063828|469540739|FG002|Overall Study|Withdrawal by Subject|3|||
130431495|NCT02063828|469540737|FG000|Overall Study|Death|0|||
130431496|NCT02063828|469540738|FG001|Overall Study|Death|0|||
130431497|NCT02063828|469540739|FG002|Overall Study|Death|1|||
130431498|NCT00733980|469540742|FG000|Overall Study|Adverse Event|5|||
130431499|NCT00733980|469540743|FG001|Overall Study|Adverse Event|2|||
130431500|NCT00733980|469540742|FG000|Overall Study|Lack of Efficacy|0|||
130431501|NCT00733980|469540743|FG001|Overall Study|Lack of Efficacy|1|||
130431502|NCT00733980|469540742|FG000|Overall Study|Protocol Violation|2|||
130431503|NCT00733980|469540743|FG001|Overall Study|Protocol Violation|1|||
130431504|NCT00733980|469540742|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
130431505|NCT00733980|469540743|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
130431506|NCT00733980|469540742|FG000|Overall Study|Lost to Follow-up|6|||
130431507|NCT00733980|469540743|FG001|Overall Study|Lost to Follow-up|11|||
130431508|NCT00733980|469540742|FG000|Overall Study|Physician Decision|2|||
130431509|NCT00733980|469540743|FG001|Overall Study|Physician Decision|3|||
130431510|NCT00733980|469540742|FG000|Overall Study|Withdrawal by Subject|6|||
130431511|NCT00733980|469540743|FG001|Overall Study|Withdrawal by Subject|2|||
130431512|NCT02010632|469540744|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
130431513|NCT02010632|469540745|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
130431514|NCT06387472|469540749|FG000|Overall Study|Withdrawal by Subject|1|||
130431515|NCT06387472|469540749|FG000|Overall Study|Lost to Follow-up|2|||
130431516|NCT06387472|469540749|FG000|Overall Study|Physician Decision|1|||
130431517|NCT01679236|469543199|FG000|Overall Study|Lost to Follow-up|15|||
130431518|NCT01679236|469543200|FG001|Overall Study|Lost to Follow-up|15|||
130431519|NCT00975221|469543202|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
130431520|NCT00975221|469543203|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
130431521|NCT00975221|469543202|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
130431522|NCT00975221|469543203|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
130431523|NCT00975221|469543202|FG000|Titration Phase (Weeks 1-12)|Other|0|||
130431524|NCT00975221|469543203|FG001|Titration Phase (Weeks 1-12)|Other|1|||
130431525|NCT00975221|469543202|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
130431526|NCT00975221|469543203|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
130431527|NCT00975221|469543202|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
130431528|NCT00975221|469543203|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
130431529|NCT00975221|469543202|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
130431530|NCT00975221|469543203|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
130431531|NCT03935217|469543204|FG000|Overall Study|Adverse Event|1|||
130431532|NCT03935217|469543205|FG001|Overall Study|Adverse Event|0|||
130431533|NCT03935217|469543204|FG000|Overall Study|Lost to Follow-up|0|||
130431534|NCT03935217|469543205|FG001|Overall Study|Lost to Follow-up|1|||
130431535|NCT03935217|469543204|FG000|Overall Study|Withdrawal by Subject|0|||
130431536|NCT03935217|469543205|FG001|Overall Study|Withdrawal by Subject|2|||
130431537|NCT03559218|469543206|FG000|Overall Study|Withdrawal by Subject|1|||
130431538|NCT03559218|469543207|FG001|Overall Study|Withdrawal by Subject|0|||
130431539|NCT03237858|469543213|FG000|Overall Study|Death|19|||
130431540|NCT03237858|469543213|FG000|Overall Study|Withdrawal by Subject|37|||
130431541|NCT01862991|469543215|FG000|Overall Study|Lost to Follow-up|2|||
130431542|NCT01862991|469543216|FG001|Overall Study|Lost to Follow-up|1|||
130431543|NCT01862991|469543217|FG002|Overall Study|Lost to Follow-up|1|||
130431544|NCT01862991|469543215|FG000|Overall Study|Protocol Violation|1|||
130431545|NCT01862991|469543216|FG001|Overall Study|Protocol Violation|0|||
130431546|NCT01862991|469543217|FG002|Overall Study|Protocol Violation|0|||
130431547|NCT04858802|469543218|FG000|Overall Study|Lost to Follow-up|1|||
130431548|NCT04858802|469543219|FG001|Overall Study|Lost to Follow-up|1|||
130431549|NCT04858802|469543218|FG000|Overall Study|Withdrawal by Subject|1|||
130431550|NCT04858802|469543219|FG001|Overall Study|Withdrawal by Subject|1|||
130431551|NCT01108458|469543220|FG000|Overall Study|Withdrawal by Subject|1|||
130431552|NCT04170686|469543221|FG000|Screening|Physician Decision|12|||
130431553|NCT04170686|469543222|FG001|Screening|Physician Decision|13|||
130431554|NCT04170686|469543221|FG000|Randomization and Treatment|Lost to Follow-up|26|||
130431555|NCT04170686|469543222|FG001|Randomization and Treatment|Lost to Follow-up|15|||
130431556|NCT03328143|469543223|FG000|Overall Study|Declined|3|||
130431557|NCT03328143|469543223|FG000|Overall Study|Required increased sedation|4|||
130431558|NCT03328143|469543223|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
130431559|NCT03328143|469543223|FG000|Overall Study|Surgery cancelled|1|||
130431560|NCT02305381|469543224|FG000|Overall Study|Unclassified|5|||
130431561|NCT02305381|469543225|FG001|Overall Study|Unclassified|5|||
130431562|NCT02305381|469543226|FG002|Overall Study|Unclassified|7|||
130431563|NCT02487498|469543230|FG000|Period: Period 1|Adverse Event|2|||
130431564|NCT02487498|469543231|FG001|Period: Period 1|Adverse Event|4|||
130431565|NCT02487498|469543230|FG000|Period: Period 1|Subject/guardian decision|2|||
130431566|NCT02487498|469543231|FG001|Period: Period 1|Subject/guardian decision|4|||
130431567|NCT02487498|469543230|FG000|Period: Period 1|Lost to Follow-up|0|||
130431568|NCT02487498|469543231|FG001|Period: Period 1|Lost to Follow-up|2|||
130431569|NCT02487498|469543230|FG000|Period: Period 1|Lack of Efficacy|1|||
130431570|NCT02487498|469543231|FG001|Period: Period 1|Lack of Efficacy|0|||
130431571|NCT02487498|469543230|FG000|Period: Period 1|Physician Decision|0|||
130431572|NCT02487498|469543231|FG001|Period: Period 1|Physician Decision|1|||
130431573|NCT02487498|469543230|FG000|Period: Period 1|Protocol deviation|1|||
130431574|NCT02487498|469543231|FG001|Period: Period 1|Protocol deviation|0|||
130431575|NCT02487498|469543230|FG000|Period: Washout|Subject/guardian decision|0|||
130431576|NCT02487498|469543231|FG001|Period: Washout|Subject/guardian decision|5|||
130431577|NCT02487498|469543230|FG000|Period: Washout|Lack of Efficacy|1|||
130431578|NCT02487498|469543231|FG001|Period: Washout|Lack of Efficacy|1|||
130431579|NCT02487498|469543230|FG000|Period: Washout|Physician Decision|1|||
130431580|NCT02487498|469543231|FG001|Period: Washout|Physician Decision|0|||
130431581|NCT02487498|469543230|FG000|Period: Washout|Non-compliance with study treatment|0|||
130431582|NCT02487498|469543231|FG001|Period: Washout|Non-compliance with study treatment|1|||
130431583|NCT02487498|469543230|FG000|Period: Period 2|Adverse Event|2|||
130431584|NCT02487498|469543231|FG001|Period: Period 2|Adverse Event|2|||
130431585|NCT02487498|469543230|FG000|Period: Period 2|Subject/guardian decision|2|||
130431586|NCT02487498|469543231|FG001|Period: Period 2|Subject/guardian decision|1|||
130431587|NCT02487498|469543230|FG000|Period: Period 2|Lost to Follow-up|1|||
130431588|NCT02487498|469543231|FG001|Period: Period 2|Lost to Follow-up|1|||
130431589|NCT02487498|469543230|FG000|Period: Period 2|Death|0|||
130431590|NCT02487498|469543231|FG001|Period: Period 2|Death|1|||
130431591|NCT02487498|469543230|FG000|Period: Period 2|Physician Decision|1|||
130431592|NCT02487498|469543231|FG001|Period: Period 2|Physician Decision|0|||
130431593|NCT05044325|469543232|FG000|Part A:Treatment Period 1|Adverse Event|0|||
130431594|NCT05044325|469543233|FG001|Part A:Treatment Period 1|Adverse Event|0|||
130431595|NCT05044325|469543234|FG002|Part A:Treatment Period 1|Adverse Event|0|||
130431596|NCT05044325|469543235|FG003|Part A:Treatment Period 1|Adverse Event|0|||
130431597|NCT05044325|469543236|FG004|Part A:Treatment Period 1|Adverse Event|0|||
130431598|NCT05044325|469543237|FG005|Part A:Treatment Period 1|Adverse Event|1|||
130431599|NCT05044325|469543238|FG006|Part A:Treatment Period 1|Adverse Event|0|||
130431600|NCT05044325|469543239|FG007|Part A:Treatment Period 1|Adverse Event|1|||
130431601|NCT05044325|469543240|FG008|Part A:Treatment Period 1|Adverse Event|0|||
130431602|NCT05044325|469543241|FG009|Part A:Treatment Period 1|Adverse Event|0|||
130431603|NCT05044325|469543232|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431604|NCT05044325|469543233|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431605|NCT05044325|469543234|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431606|NCT05044325|469543235|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
130431607|NCT05044325|469543236|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
130431608|NCT05044325|469543237|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
130431609|NCT05044325|469543238|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431610|NCT05044325|469543239|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431611|NCT05044325|469543240|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431612|NCT05044325|469543241|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130431613|NCT05044325|469543232|FG000|Part A:Treatment Period 1|Physician Decision|0|||
130431614|NCT05044325|469543233|FG001|Part A:Treatment Period 1|Physician Decision|0|||
130431615|NCT05044325|469543234|FG002|Part A:Treatment Period 1|Physician Decision|0|||
130431616|NCT05044325|469543235|FG003|Part A:Treatment Period 1|Physician Decision|0|||
130431617|NCT05044325|469543236|FG004|Part A:Treatment Period 1|Physician Decision|0|||
130559400|NCT01621542|470016490|FG000|Overall Study|Death|0|||
130431618|NCT05044325|469543237|FG005|Part A:Treatment Period 1|Physician Decision|0|||
130431619|NCT05044325|469543238|FG006|Part A:Treatment Period 1|Physician Decision|1|||
130431620|NCT05044325|469543239|FG007|Part A:Treatment Period 1|Physician Decision|0|||
130431621|NCT05044325|469543240|FG008|Part A:Treatment Period 1|Physician Decision|0|||
130431622|NCT05044325|469543241|FG009|Part A:Treatment Period 1|Physician Decision|0|||
130431623|NCT05044325|469543232|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431624|NCT05044325|469543233|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431625|NCT05044325|469543234|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
130431626|NCT05044325|469543235|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431627|NCT05044325|469543236|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431628|NCT05044325|469543237|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431629|NCT05044325|469543238|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431630|NCT05044325|469543239|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431631|NCT05044325|469543240|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431632|NCT05044325|469543241|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130431633|NCT05044325|469543232|FG000|Part A:Treatment Period 2|Adverse Event|0|||
130431634|NCT05044325|469543233|FG001|Part A:Treatment Period 2|Adverse Event|1|||
130431635|NCT05044325|469543234|FG002|Part A:Treatment Period 2|Adverse Event|0|||
130431636|NCT05044325|469543235|FG003|Part A:Treatment Period 2|Adverse Event|0|||
130431637|NCT05044325|469543236|FG004|Part A:Treatment Period 2|Adverse Event|1|||
130431638|NCT05044325|469543237|FG005|Part A:Treatment Period 2|Adverse Event|1|||
130431639|NCT05044325|469543238|FG006|Part A:Treatment Period 2|Adverse Event|0|||
130431640|NCT05044325|469543239|FG007|Part A:Treatment Period 2|Adverse Event|0|||
130431641|NCT05044325|469543240|FG008|Part A:Treatment Period 2|Adverse Event|0|||
130431642|NCT05044325|469543241|FG009|Part A:Treatment Period 2|Adverse Event|0|||
130431643|NCT05044325|469543232|FG000|Part A:Treatment Period 2|Physician Decision|0|||
130431644|NCT05044325|469543233|FG001|Part A:Treatment Period 2|Physician Decision|0|||
130431645|NCT05044325|469543234|FG002|Part A:Treatment Period 2|Physician Decision|0|||
130431646|NCT05044325|469543235|FG003|Part A:Treatment Period 2|Physician Decision|0|||
130431647|NCT05044325|469543236|FG004|Part A:Treatment Period 2|Physician Decision|0|||
130431648|NCT05044325|469543237|FG005|Part A:Treatment Period 2|Physician Decision|1|||
130431649|NCT05044325|469543238|FG006|Part A:Treatment Period 2|Physician Decision|0|||
130431650|NCT05044325|469543239|FG007|Part A:Treatment Period 2|Physician Decision|0|||
130431651|NCT05044325|469543240|FG008|Part A:Treatment Period 2|Physician Decision|0|||
130431652|NCT05044325|469543241|FG009|Part A:Treatment Period 2|Physician Decision|0|||
130431653|NCT05044325|469543232|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431654|NCT05044325|469543233|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431655|NCT05044325|469543234|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431656|NCT05044325|469543235|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
130431657|NCT05044325|469543236|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
130431658|NCT05044325|469543237|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431659|NCT05044325|469543238|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431660|NCT05044325|469543239|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431661|NCT05044325|469543240|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431662|NCT05044325|469543241|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130431663|NCT00755222|469543242|FG000|Overall Study|Withdrawal by Subject|4|||
130431664|NCT00755222|469543243|FG001|Overall Study|Withdrawal by Subject|2|||
130431665|NCT00755222|469543242|FG000|Overall Study|Adverse Event|2|||
130431666|NCT00755222|469543243|FG001|Overall Study|Adverse Event|0|||
130431667|NCT00755222|469543242|FG000|Overall Study|Protocol Violation|2|||
130431668|NCT00755222|469543243|FG001|Overall Study|Protocol Violation|0|||
130431669|NCT02243202|469543244|FG000|Overall Study|Adverse Event|5|||
130431670|NCT02243202|469543245|FG001|Overall Study|Adverse Event|6|||
130431671|NCT02243202|469543246|FG002|Overall Study|Adverse Event|10|||
130431672|NCT02243202|469543247|FG003|Overall Study|Adverse Event|4|||
130431673|NCT02243202|469543244|FG000|Overall Study|Lost to Follow-up|9|||
130431674|NCT02243202|469543245|FG001|Overall Study|Lost to Follow-up|9|||
130431675|NCT02243202|469543246|FG002|Overall Study|Lost to Follow-up|14|||
130431676|NCT02243202|469543247|FG003|Overall Study|Lost to Follow-up|11|||
130431677|NCT02243202|469543244|FG000|Overall Study|Protocol Violation|3|||
130431678|NCT02243202|469543245|FG001|Overall Study|Protocol Violation|1|||
130431679|NCT02243202|469543246|FG002|Overall Study|Protocol Violation|2|||
130431680|NCT02243202|469543247|FG003|Overall Study|Protocol Violation|1|||
130431681|NCT02243202|469543244|FG000|Overall Study|Withdrawal by Subject|7|||
130431682|NCT02243202|469543245|FG001|Overall Study|Withdrawal by Subject|6|||
130431683|NCT02243202|469543246|FG002|Overall Study|Withdrawal by Subject|4|||
130431684|NCT02243202|469543247|FG003|Overall Study|Withdrawal by Subject|4|||
130431685|NCT02243202|469543244|FG000|Overall Study|Other|1|||
130543697|NCT00412061|469956813|FG001|Open Label Phase|Withdrawal by Subject|15|||
130543698|NCT00412061|469956812|FG000|Open Label Phase|Administrative Problems|0|||
130211184|NCT00433017|468735480|FG001|Overall Study|Administrative problems|86|||
130211185|NCT00433017|468735479|FG000|Overall Study|Protocol Violation|1|||
130431686|NCT02243202|469543245|FG001|Overall Study|Other|3|||
130431687|NCT02243202|469543246|FG002|Overall Study|Other|1|||
130431688|NCT02243202|469543247|FG003|Overall Study|Other|2|||
130431689|NCT02243202|469543244|FG000|Overall Study|Randomized but not received treatment|0|||
130431690|NCT02243202|469543245|FG001|Overall Study|Randomized but not received treatment|0|||
130431691|NCT02243202|469543246|FG002|Overall Study|Randomized but not received treatment|0|||
130431692|NCT02243202|469543247|FG003|Overall Study|Randomized but not received treatment|1|||
130431693|NCT02013388|469543254|FG000|Overall Study|work emergency|1|||
130431694|NCT02013388|469543255|FG001|Overall Study|work emergency|0|||
130431695|NCT02013388|469543256|FG002|Overall Study|work emergency|0|||
130431696|NCT02013388|469543257|FG003|Overall Study|work emergency|0|||
130431697|NCT02013388|469543258|FG004|Overall Study|work emergency|1|||
130431698|NCT02013388|469543259|FG005|Overall Study|work emergency|0|||
130431699|NCT02013388|469543260|FG006|Overall Study|work emergency|0|||
130431700|NCT02013388|469543261|FG007|Overall Study|work emergency|0|||
130431701|NCT04207840|469543262|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
130431702|NCT04207840|469543263|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
130431703|NCT04207840|469543264|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
130431704|NCT04207840|469543262|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
130431705|NCT04207840|469543263|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
130431706|NCT04207840|469543264|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
130431707|NCT03243422|469543265|FG000|Overall Study|Death|20|||
130431708|NCT03243422|469543266|FG001|Overall Study|Death|21|||
130431709|NCT03243422|469543265|FG000|Overall Study|Lost to Follow-up|9|||
130431710|NCT03243422|469543266|FG001|Overall Study|Lost to Follow-up|21|||
130431711|NCT03243422|469543265|FG000|Overall Study|Withdrawal by Subject|22|||
130431712|NCT03243422|469543266|FG001|Overall Study|Withdrawal by Subject|8|||
130431713|NCT02173054|469543267|FG000|Overall Study|lack of compliance|1|||
130431714|NCT02173054|469543268|FG001|Overall Study|lack of compliance|0|||
130431715|NCT02173054|469543269|FG002|Overall Study|lack of compliance|0|||
130431716|NCT02173054|469543267|FG000|Overall Study|Withdrawal by Subject|0|||
130431717|NCT02173054|469543268|FG001|Overall Study|Withdrawal by Subject|0|||
130431718|NCT02173054|469543269|FG002|Overall Study|Withdrawal by Subject|1|||
130431719|NCT00991341|469543279|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
130431720|NCT00991341|469543280|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
130431721|NCT00991341|469543279|FG000|Overall Study|Death|3|||
130431722|NCT00991341|469543280|FG001|Overall Study|Death|0|||
130431723|NCT00991341|469543279|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
130431724|NCT00991341|469543280|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
130431725|NCT00991341|469543279|FG000|Overall Study|Physician Decision|1|||
130431726|NCT00991341|469543280|FG001|Overall Study|Physician Decision|2|||
130431727|NCT00991341|469543279|FG000|Overall Study|Withdrawal by Subject|3|||
130431728|NCT00991341|469543280|FG001|Overall Study|Withdrawal by Subject|4|||
130431729|NCT01330316|469543296|FG000|Overall Study|Adverse Event|2|||
130431730|NCT01330316|469543297|FG001|Overall Study|Adverse Event|2|||
130431731|NCT01330316|469543296|FG000|Overall Study|Lack of Efficacy|0|||
130431732|NCT01330316|469543297|FG001|Overall Study|Lack of Efficacy|10|||
130431733|NCT01330316|469543296|FG000|Overall Study|Lost to Follow-up|0|||
130431734|NCT01330316|469543297|FG001|Overall Study|Lost to Follow-up|1|||
130431735|NCT01330316|469543296|FG000|Overall Study|Withdrawal by Subject|0|||
130431736|NCT01330316|469543297|FG001|Overall Study|Withdrawal by Subject|1|||
130431737|NCT01330316|469543296|FG000|Overall Study|other than above|0|||
130431738|NCT01330316|469543297|FG001|Overall Study|other than above|1|||
130431739|NCT00215540|469543298|FG000|Overall Study|Withdrew from study medication|1|||
130431740|NCT00215540|469543299|FG001|Overall Study|Withdrew from study medication|0|||
130431741|NCT00215540|469543300|FG002|Overall Study|Withdrew from study medication|0|||
130431742|NCT03010462|469543301|FG000|Overall Study|Withdrawal by Subject|3|||
130431743|NCT03010462|469543302|FG001|Overall Study|Withdrawal by Subject|1|||
130431744|NCT03145766|469543303|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130431745|NCT03145766|469543304|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130431746|NCT03145766|469543305|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
130431747|NCT03145766|469543306|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130431748|NCT03145766|469543307|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
130431749|NCT03145766|469543303|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
130431750|NCT03145766|469543304|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
130431751|NCT03145766|469543305|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
130431752|NCT03145766|469543306|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
130431753|NCT03145766|469543307|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
130431754|NCT03145766|469543303|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
130431755|NCT03145766|469543304|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
130431756|NCT03145766|469543305|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
130431757|NCT03145766|469543306|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
130431758|NCT03145766|469543307|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
130431759|NCT03145766|469543303|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
130431760|NCT03145766|469543304|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130431761|NCT03145766|469543305|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130431762|NCT03145766|469543306|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130431763|NCT03145766|469543307|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
130431764|NCT03145766|469543303|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
130431765|NCT03145766|469543304|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130431766|NCT03145766|469543305|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130431767|NCT03145766|469543306|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
130431768|NCT03145766|469543307|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130431769|NCT03145766|469543303|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
130431770|NCT03145766|469543304|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
130431771|NCT03145766|469543305|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
130431772|NCT03145766|469543306|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
130431773|NCT03145766|469543307|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
130431774|NCT03145766|469543303|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130431775|NCT03145766|469543304|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130431776|NCT03145766|469543305|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130431777|NCT03145766|469543306|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
130431778|NCT03145766|469543307|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
130431779|NCT02799472|469543311|FG000|Overall Study|Withdrawal by Subject|2|||
130431780|NCT02799472|469543312|FG001|Overall Study|Withdrawal by Subject|4|||
130431781|NCT02799472|469543311|FG000|Overall Study|Lack of Efficacy|2|||
130431782|NCT02799472|469543312|FG001|Overall Study|Lack of Efficacy|0|||
130431783|NCT02799472|469543311|FG000|Overall Study|Lost to Follow-up|0|||
130431784|NCT02799472|469543312|FG001|Overall Study|Lost to Follow-up|1|||
130431785|NCT02801669|469543313|FG000|Overall Study|Death|66|||
130431786|NCT02801669|469543314|FG001|Overall Study|Death|69|||
130431787|NCT02801669|469543313|FG000|Overall Study|Withdrawal by Subject|81|||
130431788|NCT02801669|469543314|FG001|Overall Study|Withdrawal by Subject|77|||
130431789|NCT02801669|469543313|FG000|Overall Study|Other|4|||
130431790|NCT02801669|469543314|FG001|Overall Study|Other|6|||
130431791|NCT01492686|469543316|FG000|Double-blind Phase|Adverse Event|0|||
130431792|NCT01492686|469543317|FG001|Double-blind Phase|Adverse Event|2|||
130431793|NCT01492686|469543316|FG000|Double-blind Phase|Physician Decision|0|||
130431794|NCT01492686|469543317|FG001|Double-blind Phase|Physician Decision|1|||
130431795|NCT01492686|469543316|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130431796|NCT01492686|469543317|FG001|Double-blind Phase|Withdrawal by Subject|2|||
130431797|NCT01492686|469543316|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
130431798|NCT01492686|469543317|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
130431799|NCT01492686|469543316|FG000|Open-label Phase|Adverse Event|1|||
130431800|NCT01492686|469543317|FG001|Open-label Phase|Adverse Event|2|||
130431801|NCT01492686|469543316|FG000|Open-label Phase|Physician Decision|1|||
130431802|NCT01492686|469543317|FG001|Open-label Phase|Physician Decision|0|||
130431803|NCT01492686|469543316|FG000|Open-label Phase|Withdrawal by Subject|6|||
130431804|NCT01492686|469543317|FG001|Open-label Phase|Withdrawal by Subject|7|||
130431805|NCT01492686|469543316|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
130431806|NCT01492686|469543317|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
130431807|NCT01153269|469543328|FG000|Overall Study|Withdrawal by Subject|1|||
130431808|NCT01153269|469543328|FG000|Overall Study|Antiretroviral therapy break|1|||
130431809|NCT03541044|469543329|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
130431810|NCT03541044|469543330|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
130431811|NCT03541044|469543329|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
130431812|NCT03541044|469543330|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
130431813|NCT02635724|469543331|FG000|Overall Study|Withdrawal by Subject|0|||
130431814|NCT02635724|469543332|FG001|Overall Study|Withdrawal by Subject|1|||
130431815|NCT02635724|469543333|FG002|Overall Study|Withdrawal by Subject|0|||
130431816|NCT00860067|469543334|FG000|Overall Study|Lost to Follow-up|46|||
130431817|NCT00860067|469543335|FG001|Overall Study|Lost to Follow-up|9|||
130431818|NCT00860067|469543336|FG002|Overall Study|Lost to Follow-up|9|||
130431819|NCT00860067|469543334|FG000|Overall Study|Withdrawal by Subject|4|||
130431820|NCT00860067|469543335|FG001|Overall Study|Withdrawal by Subject|0|||
130431821|NCT00860067|469543336|FG002|Overall Study|Withdrawal by Subject|0|||
130431822|NCT00860067|469543334|FG000|Overall Study|Pregnancy|1|||
130431823|NCT00860067|469543335|FG001|Overall Study|Pregnancy|0|||
130431824|NCT00860067|469543336|FG002|Overall Study|Pregnancy|0|||
130431825|NCT02424591|469543341|FG000|Overall Study|Protocol Violation|2|||
130543699|NCT00412061|469956813|FG001|Open Label Phase|Administrative Problems|13|||
130431826|NCT02424591|469543342|FG001|Overall Study|Protocol Violation|3|||
130431827|NCT01446796|469543343|FG000|Overall Study|Withdrawal by Subject|1|||
130431828|NCT01446796|469543344|FG001|Overall Study|Withdrawal by Subject|0|||
130431829|NCT01498822|469543345|FG000|Overall Study|Protocol Violation|8|||
130431830|NCT01498822|469543346|FG001|Overall Study|Protocol Violation|4|||
130431831|NCT01498822|469543345|FG000|Overall Study|Other Reason|5|||
130431832|NCT01498822|469543346|FG001|Overall Study|Other Reason|2|||
130431833|NCT01498822|469543345|FG000|Overall Study|Lack of Efficacy|7|||
130431834|NCT01498822|469543346|FG001|Overall Study|Lack of Efficacy|2|||
130431835|NCT01498822|469543345|FG000|Overall Study|AE, non-serious non-fatal|8|||
130431836|NCT01498822|469543346|FG001|Overall Study|AE, non-serious non-fatal|17|||
130431837|NCT01498822|469543345|FG000|Overall Study|SAE, non-fatal|2|||
130431838|NCT01498822|469543346|FG001|Overall Study|SAE, non-fatal|2|||
130431839|NCT01498822|469543345|FG000|Overall Study|Adverse Event, serious fatal|1|||
130431840|NCT01498822|469543346|FG001|Overall Study|Adverse Event, serious fatal|1|||
130431841|NCT01498822|469543345|FG000|Overall Study|Withdrawal by Subject|15|||
130431842|NCT01498822|469543346|FG001|Overall Study|Withdrawal by Subject|25|||
130431843|NCT01498822|469543345|FG000|Overall Study|Lost to Follow-up|8|||
130431844|NCT01498822|469543346|FG001|Overall Study|Lost to Follow-up|3|||
130431845|NCT01674621|469543351|FG000|Overall Study|Adverse Event|3|||
130431846|NCT01674621|469543352|FG001|Overall Study|Adverse Event|2|||
130431847|NCT01674621|469543353|FG002|Overall Study|Adverse Event|5|||
130431848|NCT01674621|469543354|FG003|Overall Study|Adverse Event|5|||
130431849|NCT01674621|469543355|FG004|Overall Study|Adverse Event|1|||
130431850|NCT01674621|469543351|FG000|Overall Study|Inability to Complete Study Procedures|0|||
130431851|NCT01674621|469543352|FG001|Overall Study|Inability to Complete Study Procedures|0|||
130431852|NCT01674621|469543353|FG002|Overall Study|Inability to Complete Study Procedures|0|||
130431853|NCT01674621|469543354|FG003|Overall Study|Inability to Complete Study Procedures|0|||
130431854|NCT01674621|469543355|FG004|Overall Study|Inability to Complete Study Procedures|2|||
130431855|NCT01674621|469543351|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130431856|NCT01674621|469543352|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130431857|NCT01674621|469543353|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130431858|NCT01674621|469543354|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
130431859|NCT01674621|469543355|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130431860|NCT01674621|469543351|FG000|Overall Study|Withdrawal by Subject|2|||
130431861|NCT01674621|469543352|FG001|Overall Study|Withdrawal by Subject|5|||
130431862|NCT01674621|469543353|FG002|Overall Study|Withdrawal by Subject|2|||
130431863|NCT01674621|469543354|FG003|Overall Study|Withdrawal by Subject|0|||
130431864|NCT01674621|469543355|FG004|Overall Study|Withdrawal by Subject|1|||
130431865|NCT01674621|469543351|FG000|Overall Study|Other than specified|0|||
130431866|NCT01674621|469543352|FG001|Overall Study|Other than specified|1|||
130431867|NCT01674621|469543353|FG002|Overall Study|Other than specified|0|||
130431868|NCT01674621|469543354|FG003|Overall Study|Other than specified|0|||
130431869|NCT01674621|469543355|FG004|Overall Study|Other than specified|2|||
130431870|NCT01148862|469543358|FG000|Second Intervention|Withdrawal by Subject|0|||
130431871|NCT01148862|469543359|FG001|Second Intervention|Withdrawal by Subject|2|||
130431872|NCT01597505|469543363|FG000|Overall Study|Physician Decision|5|||
130431873|NCT01597505|469543364|FG001|Overall Study|Physician Decision|0|||
130431874|NCT01597505|469543363|FG000|Overall Study|Adverse Event|19|||
130431875|NCT01597505|469543364|FG001|Overall Study|Adverse Event|7|||
130431876|NCT01597505|469543363|FG000|Overall Study|Lost to Follow-up|4|||
130431877|NCT01597505|469543364|FG001|Overall Study|Lost to Follow-up|2|||
130431878|NCT01597505|469543363|FG000|Overall Study|Withdrawal by Subject|10|||
130431879|NCT01597505|469543364|FG001|Overall Study|Withdrawal by Subject|18|||
130431880|NCT01597505|469543363|FG000|Overall Study|Other|5|||
130431881|NCT01597505|469543364|FG001|Overall Study|Other|6|||
130431882|NCT01597505|469543363|FG000|Overall Study|Missing|1|||
130431883|NCT01597505|469543364|FG001|Overall Study|Missing|0|||
130431884|NCT05454410|469543365|FG000|Overall Study|Withdrawal by Subject|0|||
130431885|NCT05454410|469543366|FG001|Overall Study|Withdrawal by Subject|0|||
130431886|NCT05454410|469543367|FG002|Overall Study|Withdrawal by Subject|1|||
130431887|NCT05454410|469543368|FG003|Overall Study|Withdrawal by Subject|1|||
130431888|NCT05004688|469543379|FG000|Overall Study|Protocol Violation|7|||
130431889|NCT05004688|469543379|FG000|Overall Study|Physician Decision|2|||
130431890|NCT05004688|469543379|FG000|Overall Study|Withdrawal by Subject|2|||
130431891|NCT00895622|469543380|FG000|Overall Study|Protocol Violation|5|||
130431892|NCT00895622|469543381|FG001|Overall Study|Protocol Violation|4|||
130431893|NCT00895622|469543382|FG002|Overall Study|Protocol Violation|4|||
130431894|NCT00779779|469543385|FG000|Overall Study|Adverse Event|1|||
130543700|NCT00412061|469956812|FG000|Open Label Phase|Death|0|||
130431895|NCT00779779|469543385|FG000|Overall Study|Protocol Violation|14|||
130431896|NCT00779779|469543385|FG000|Overall Study|Withdrawal by Subject|4|||
130431897|NCT00779779|469543385|FG000|Overall Study|Lost to Follow-up|5|||
130431898|NCT02552238|469543388|FG000|Overall Study|Withdrawal by Subject|2|||
130431899|NCT02552238|469543388|FG000|Overall Study|Adverse Event|2|||
130431900|NCT05158296|469543391|FG000|Overall Study|Sponsor Decision|2|||
130543701|NCT00412061|469956813|FG001|Open Label Phase|Death|7|||
130543702|NCT00412061|469956812|FG000|Open Label Phase|Lost to Follow-up|0|||
130431901|NCT05158296|469543392|FG001|Overall Study|Sponsor Decision|3|||
130431902|NCT05158296|469543393|FG002|Overall Study|Sponsor Decision|2|||
130431903|NCT02036645|469543394|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431904|NCT02036645|469543395|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431905|NCT02036645|469543396|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431906|NCT02036645|469543397|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431907|NCT02036645|469543398|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431908|NCT02036645|469543399|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431909|NCT02036645|469543400|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
130431910|NCT02036645|469543401|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431911|NCT02036645|469543402|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431912|NCT02036645|469543403|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431913|NCT02036645|469543404|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431914|NCT02036645|469543405|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130431915|NCT02036645|469543394|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431916|NCT02036645|469543395|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431917|NCT02036645|469543396|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431918|NCT02036645|469543397|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
130431919|NCT02036645|469543398|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431920|NCT02036645|469543399|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431921|NCT02036645|469543400|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431922|NCT02036645|469543401|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431923|NCT02036645|469543402|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431924|NCT02036645|469543403|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431925|NCT02036645|469543404|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431926|NCT02036645|469543405|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130431927|NCT02404389|469543409|FG000|Overall Study|Adverse Event|1|||
130431928|NCT02404389|469543410|FG001|Overall Study|Adverse Event|0|||
130431929|NCT02404389|469543411|FG002|Overall Study|Adverse Event|1|||
130431930|NCT02404389|469543412|FG003|Overall Study|Adverse Event|0|||
130431931|NCT02404389|469543413|FG004|Overall Study|Adverse Event|2|||
130431932|NCT02404389|469543409|FG000|Overall Study|Subject/guardian decision|1|||
130431933|NCT02404389|469543410|FG001|Overall Study|Subject/guardian decision|0|||
130431934|NCT02404389|469543411|FG002|Overall Study|Subject/guardian decision|0|||
130431935|NCT02404389|469543412|FG003|Overall Study|Subject/guardian decision|1|||
130431936|NCT02404389|469543413|FG004|Overall Study|Subject/guardian decision|1|||
130431937|NCT03324880|469543417|FG000|Overall Study|Adverse Event|0|||
130431938|NCT03324880|469543418|FG001|Overall Study|Adverse Event|2|||
130431939|NCT03324880|469543417|FG000|Overall Study|Withdrawal by Subject|2|||
130431940|NCT03324880|469543418|FG001|Overall Study|Withdrawal by Subject|2|||
130431941|NCT03324880|469543417|FG000|Overall Study|Lost to Follow-up|0|||
130431942|NCT03324880|469543418|FG001|Overall Study|Lost to Follow-up|1|||
130431943|NCT03324880|469543417|FG000|Overall Study|Product Recall|0|||
130431944|NCT03324880|469543418|FG001|Overall Study|Product Recall|1|||
130431945|NCT00652938|469543419|FG000|Overall Study|Adverse Event|1|||
130431946|NCT00652938|469543420|FG001|Overall Study|Adverse Event|0|||
130431947|NCT00652938|469543421|FG002|Overall Study|Adverse Event|2|||
130431948|NCT00652938|469543419|FG000|Overall Study|Withdrawal by Subject|0|||
130431949|NCT00652938|469543420|FG001|Overall Study|Withdrawal by Subject|6|||
130431950|NCT00652938|469543421|FG002|Overall Study|Withdrawal by Subject|1|||
130431951|NCT00652938|469543419|FG000|Overall Study|Lost to Follow-up|0|||
130431952|NCT00652938|469543420|FG001|Overall Study|Lost to Follow-up|0|||
130431953|NCT00652938|469543421|FG002|Overall Study|Lost to Follow-up|2|||
130431954|NCT00652938|469543419|FG000|Overall Study|fear of blood sampling|0|||
130431955|NCT00652938|469543420|FG001|Overall Study|fear of blood sampling|1|||
130431956|NCT00652938|469543421|FG002|Overall Study|fear of blood sampling|0|||
130431957|NCT01412801|469543422|FG000|Overall Study|Death|0|||
130431958|NCT01412801|469543423|FG001|Overall Study|Death|1|||
130431959|NCT01412801|469543424|FG002|Overall Study|Death|0|||
130431960|NCT01412801|469543425|FG003|Overall Study|Death|4|||
130431961|NCT01412801|469543426|FG004|Overall Study|Death|2|||
130431962|NCT01412801|469543427|FG005|Overall Study|Death|2|||
130431963|NCT01412801|469543422|FG000|Overall Study|Lost to Follow-up|1|||
130431964|NCT01412801|469543423|FG001|Overall Study|Lost to Follow-up|2|||
130431965|NCT01412801|469543424|FG002|Overall Study|Lost to Follow-up|4|||
130431966|NCT01412801|469543425|FG003|Overall Study|Lost to Follow-up|0|||
130431967|NCT01412801|469543426|FG004|Overall Study|Lost to Follow-up|1|||
130431968|NCT01412801|469543427|FG005|Overall Study|Lost to Follow-up|1|||
130431969|NCT01412801|469543422|FG000|Overall Study|Withdrawal by Subject|3|||
130543703|NCT00412061|469956813|FG001|Open Label Phase|Lost to Follow-up|2|||
130431970|NCT01412801|469543423|FG001|Overall Study|Withdrawal by Subject|2|||
130543704|NCT00412061|469956812|FG000|Open Label Phase|New Cancer Therapy|0|||
130543705|NCT00412061|469956813|FG001|Open Label Phase|New Cancer Therapy|1|||
130431971|NCT01412801|469543424|FG002|Overall Study|Withdrawal by Subject|1|||
130431972|NCT01412801|469543425|FG003|Overall Study|Withdrawal by Subject|0|||
130431973|NCT01412801|469543426|FG004|Overall Study|Withdrawal by Subject|0|||
130431974|NCT01412801|469543427|FG005|Overall Study|Withdrawal by Subject|0|||
130431975|NCT01412801|469543422|FG000|Overall Study|Relocated to another area|0|||
130431976|NCT01412801|469543423|FG001|Overall Study|Relocated to another area|0|||
130431977|NCT01412801|469543424|FG002|Overall Study|Relocated to another area|2|||
130431978|NCT01412801|469543425|FG003|Overall Study|Relocated to another area|0|||
130431979|NCT01412801|469543426|FG004|Overall Study|Relocated to another area|0|||
130431980|NCT01412801|469543427|FG005|Overall Study|Relocated to another area|0|||
130431981|NCT00116272|469543428|FG000|Overall Study|Lost to Follow-up|11|||
130431982|NCT00116272|469543429|FG001|Overall Study|Lost to Follow-up|6|||
130431983|NCT01547299|469543432|FG000|Overall Study|Withdrawal by Subject|2|||
130431984|NCT01547299|469543433|FG001|Overall Study|Withdrawal by Subject|2|||
130431985|NCT01576718|469543434|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
130431986|NCT01576718|469543435|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431987|NCT01576718|469543436|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431988|NCT01576718|469543437|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431989|NCT01576718|469543438|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431990|NCT01576718|469543439|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431991|NCT01576718|469543440|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130431992|NCT01576718|469543434|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
130431993|NCT01576718|469543435|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431994|NCT01576718|469543436|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431995|NCT01576718|469543437|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431996|NCT01576718|469543438|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431997|NCT01576718|469543439|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431998|NCT01576718|469543440|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130431999|NCT01576718|469543434|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
130432000|NCT01576718|469543435|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432001|NCT01576718|469543436|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432002|NCT01576718|469543437|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432003|NCT01576718|469543438|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432004|NCT01576718|469543439|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432005|NCT01576718|469543440|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130432006|NCT01576718|469543434|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
130432007|NCT01576718|469543435|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432008|NCT01576718|469543436|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432009|NCT01576718|469543437|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432010|NCT01576718|469543438|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432011|NCT01576718|469543439|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432012|NCT01576718|469543440|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130432013|NCT01576718|469543434|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
130432014|NCT01576718|469543435|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432015|NCT01576718|469543436|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432016|NCT01576718|469543437|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432017|NCT01576718|469543438|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432018|NCT01576718|469543439|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432019|NCT01576718|469543440|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130432020|NCT01576718|469543434|FG000|Treatment Period|Adverse Event|0|||
130432021|NCT01576718|469543435|FG001|Treatment Period|Adverse Event|1|||
130432022|NCT01576718|469543436|FG002|Treatment Period|Adverse Event|1|||
130432023|NCT01576718|469543437|FG003|Treatment Period|Adverse Event|1|||
130432024|NCT01576718|469543438|FG004|Treatment Period|Adverse Event|1|||
130432025|NCT01576718|469543439|FG005|Treatment Period|Adverse Event|1|||
130432026|NCT01576718|469543440|FG006|Treatment Period|Adverse Event|0|||
130432027|NCT01576718|469543434|FG000|Treatment Period|Withdrawal by Subject|0|||
130432028|NCT01576718|469543435|FG001|Treatment Period|Withdrawal by Subject|1|||
130432029|NCT01576718|469543436|FG002|Treatment Period|Withdrawal by Subject|1|||
130432030|NCT01576718|469543437|FG003|Treatment Period|Withdrawal by Subject|0|||
130432031|NCT01576718|469543438|FG004|Treatment Period|Withdrawal by Subject|2|||
130432032|NCT01576718|469543439|FG005|Treatment Period|Withdrawal by Subject|4|||
130432033|NCT01576718|469543440|FG006|Treatment Period|Withdrawal by Subject|2|||
130432034|NCT01576718|469543434|FG000|Treatment Period|Physician Decision|0|||
130432035|NCT01576718|469543435|FG001|Treatment Period|Physician Decision|1|||
130432036|NCT01576718|469543436|FG002|Treatment Period|Physician Decision|1|||
130432037|NCT01576718|469543437|FG003|Treatment Period|Physician Decision|1|||
130432038|NCT01576718|469543438|FG004|Treatment Period|Physician Decision|1|||
130432039|NCT01576718|469543439|FG005|Treatment Period|Physician Decision|0|||
130432040|NCT01576718|469543440|FG006|Treatment Period|Physician Decision|0|||
130432041|NCT01576718|469543434|FG000|Treatment Period|Protocol Violation|0|||
130432042|NCT01576718|469543435|FG001|Treatment Period|Protocol Violation|5|||
130432043|NCT01576718|469543436|FG002|Treatment Period|Protocol Violation|4|||
130432044|NCT01576718|469543437|FG003|Treatment Period|Protocol Violation|10|||
130432045|NCT01576718|469543438|FG004|Treatment Period|Protocol Violation|6|||
130432046|NCT01576718|469543439|FG005|Treatment Period|Protocol Violation|8|||
130432047|NCT01576718|469543440|FG006|Treatment Period|Protocol Violation|12|||
130432048|NCT01576718|469543434|FG000|Treatment Period|Sponsor request|0|||
130432049|NCT01576718|469543435|FG001|Treatment Period|Sponsor request|1|||
130432050|NCT01576718|469543436|FG002|Treatment Period|Sponsor request|0|||
130432051|NCT01576718|469543437|FG003|Treatment Period|Sponsor request|0|||
130432052|NCT01576718|469543438|FG004|Treatment Period|Sponsor request|0|||
130432053|NCT01576718|469543439|FG005|Treatment Period|Sponsor request|1|||
130432054|NCT01576718|469543440|FG006|Treatment Period|Sponsor request|0|||
130432055|NCT01576718|469543434|FG000|Treatment Period|Met stopping criteria|0|||
130432056|NCT01576718|469543435|FG001|Treatment Period|Met stopping criteria|16|||
130432057|NCT01576718|469543436|FG002|Treatment Period|Met stopping criteria|13|||
130432058|NCT01576718|469543437|FG003|Treatment Period|Met stopping criteria|19|||
130432059|NCT01576718|469543438|FG004|Treatment Period|Met stopping criteria|16|||
130432060|NCT01576718|469543439|FG005|Treatment Period|Met stopping criteria|33|||
130432061|NCT01576718|469543440|FG006|Treatment Period|Met stopping criteria|15|||
130432062|NCT01576718|469543434|FG000|Treatment Period|Lost to Follow-up|0|||
130432063|NCT01576718|469543435|FG001|Treatment Period|Lost to Follow-up|0|||
130432064|NCT01576718|469543436|FG002|Treatment Period|Lost to Follow-up|0|||
130432065|NCT01576718|469543437|FG003|Treatment Period|Lost to Follow-up|0|||
130432066|NCT01576718|469543438|FG004|Treatment Period|Lost to Follow-up|1|||
130432067|NCT01576718|469543439|FG005|Treatment Period|Lost to Follow-up|0|||
130432068|NCT01576718|469543440|FG006|Treatment Period|Lost to Follow-up|0|||
130432069|NCT01576718|469543434|FG000|Treatment Period|Noncompliance to study medication|0|||
130432070|NCT01576718|469543435|FG001|Treatment Period|Noncompliance to study medication|0|||
130432071|NCT01576718|469543436|FG002|Treatment Period|Noncompliance to study medication|0|||
130432072|NCT01576718|469543437|FG003|Treatment Period|Noncompliance to study medication|0|||
130432073|NCT01576718|469543438|FG004|Treatment Period|Noncompliance to study medication|0|||
130432074|NCT01576718|469543439|FG005|Treatment Period|Noncompliance to study medication|1|||
130432075|NCT01576718|469543440|FG006|Treatment Period|Noncompliance to study medication|1|||
130432076|NCT00045708|469545850|FG000|Phase 1|early progressive disease|0|||
130432077|NCT00045708|469545851|FG001|Phase 1|early progressive disease|1|||
130432078|NCT00045708|469545852|FG002|Phase 1|early progressive disease|0|||
130432079|NCT00284141|469545853|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
130432080|NCT00284141|469545853|FG000|Overall Study|Adverse Event|19|||
130432081|NCT00284141|469545853|FG000|Overall Study|Participant's request|9|||
130432082|NCT00284141|469545853|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
130432083|NCT00284141|469545853|FG000|Overall Study|Clinical deterioration / death|2|||
130432084|NCT00284141|469545853|FG000|Overall Study|General decline|1|||
130432085|NCT00284141|469545853|FG000|Overall Study|Pneumonia|1|||
130432086|NCT00284141|469545853|FG000|Overall Study|Did not take study medication|2|||
130432087|NCT00284141|469545853|FG000|Overall Study|Ongoing treatment|2|||
130432088|NCT04382924|469545859|FG000|Overall Study|Death|2|||
130432089|NCT04382924|469545860|FG001|Overall Study|Death|5|||
130432090|NCT04382924|469545861|FG002|Overall Study|Death|4|||
130432091|NCT04382924|469545859|FG000|Overall Study|Protocol Violation|0|||
130432092|NCT04382924|469545860|FG001|Overall Study|Protocol Violation|1|||
130432093|NCT04382924|469545861|FG002|Overall Study|Protocol Violation|1|||
130432094|NCT04382924|469545859|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
130432095|NCT04382924|469545860|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
130432096|NCT04382924|469545861|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
130432097|NCT04382924|469545859|FG000|Overall Study|Withdrawal by Subject|6|||
130432098|NCT04382924|469545860|FG001|Overall Study|Withdrawal by Subject|3|||
130432099|NCT04382924|469545861|FG002|Overall Study|Withdrawal by Subject|6|||
130432100|NCT01559454|469545862|FG000|Overall Study|Lost to Follow-up|3|||
130432101|NCT01559454|469545863|FG001|Overall Study|Lost to Follow-up|2|||
130432102|NCT01559454|469545862|FG000|Overall Study|Withdrawal by Subject|0|||
130432103|NCT01559454|469545863|FG001|Overall Study|Withdrawal by Subject|1|||
130432104|NCT01559454|469545862|FG000|Overall Study|Physician Decision|0|||
130432105|NCT01559454|469545863|FG001|Overall Study|Physician Decision|1|||
130432106|NCT01559454|469545862|FG000|Overall Study|Protocol Violation|0|||
130432107|NCT01559454|469545863|FG001|Overall Study|Protocol Violation|1|||
130432108|NCT01559454|469545862|FG000|Overall Study|Lack of Efficacy|0|||
130432109|NCT01559454|469545863|FG001|Overall Study|Lack of Efficacy|1|||
130432110|NCT02207725|469545864|FG000|Overall Study|Did Not Receive Treatment|0|||
130432111|NCT02207725|469545865|FG001|Overall Study|Did Not Receive Treatment|1|||
130432112|NCT02207725|469545866|FG002|Overall Study|Did Not Receive Treatment|1|||
130432113|NCT02207725|469545867|FG003|Overall Study|Did Not Receive Treatment|1|||
130432114|NCT01966003|469545868|FG000|Overall Study|Death|43|||
130432115|NCT01966003|469545869|FG001|Overall Study|Death|36|||
130432116|NCT01966003|469545868|FG000|Overall Study|Protocol Violation|6|||
130432117|NCT01966003|469545869|FG001|Overall Study|Protocol Violation|4|||
130432118|NCT01966003|469545868|FG000|Overall Study|Lost to Follow-up|4|||
130432119|NCT01966003|469545869|FG001|Overall Study|Lost to Follow-up|3|||
130432120|NCT01966003|469545868|FG000|Overall Study|Physician Decision|12|||
130432121|NCT01966003|469545869|FG001|Overall Study|Physician Decision|13|||
130432122|NCT01966003|469545868|FG000|Overall Study|Withdrawal by Subject|29|||
130432123|NCT01966003|469545869|FG001|Overall Study|Withdrawal by Subject|19|||
130432124|NCT01966003|469545868|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
130432125|NCT01966003|469545869|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
130432126|NCT01966003|469545868|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
130432127|NCT01966003|469545869|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
130432128|NCT01966003|469545868|FG000|Overall Study|Other|1|||
130432129|NCT01966003|469545869|FG001|Overall Study|Other|1|||
130432130|NCT00615264|469545872|FG000|Overall Study|Withdrawal by Subject|17|||
130432131|NCT00615264|469545873|FG001|Overall Study|Withdrawal by Subject|19|||
130432132|NCT00615264|469545872|FG000|Overall Study|Lost to Follow-up|6|||
130432133|NCT00615264|469545873|FG001|Overall Study|Lost to Follow-up|13|||
130432134|NCT00615264|469545872|FG000|Overall Study|Adverse Event|8|||
130432135|NCT00615264|469545873|FG001|Overall Study|Adverse Event|5|||
130432136|NCT00615264|469545872|FG000|Overall Study|Death|1|||
130432137|NCT00615264|469545873|FG001|Overall Study|Death|1|||
130432138|NCT00615264|469545872|FG000|Overall Study|Protocol Violation|11|||
130432139|NCT00615264|469545873|FG001|Overall Study|Protocol Violation|7|||
130432140|NCT00615264|469545872|FG000|Overall Study|Not defined|7|||
130432141|NCT00615264|469545873|FG001|Overall Study|Not defined|4|||
130432142|NCT00615264|469545872|FG000|Overall Study|Dermal Hypersensitivity|0|||
130211186|NCT00433017|468735480|FG001|Overall Study|Protocol Violation|0|||
130211187|NCT00433017|468735479|FG000|Overall Study|Death|2|||
130211188|NCT00433017|468735480|FG001|Overall Study|Death|2|||
130211189|NCT00433017|468735479|FG000|Overall Study|Subject no longer requires study drug|1|||
130211190|NCT00433017|468735480|FG001|Overall Study|Subject no longer requires study drug|1|||
130211191|NCT01108237|468735483|FG000|Overall Study|No alignment data|2|||
130211192|NCT01108237|468735484|FG001|Overall Study|No alignment data|15|||
130211193|NCT01108237|468735483|FG000|Overall Study|Did not meet criteria for analysis|7|||
130211194|NCT01108237|468735484|FG001|Overall Study|Did not meet criteria for analysis|0|||
130211195|NCT00564278|468735486|FG000|Overall Study|Lost to Follow-up|35|||
130211196|NCT00564278|468735487|FG001|Overall Study|Lost to Follow-up|33|||
130211197|NCT00564278|468735486|FG000|Overall Study|Physician Decision|1|||
130211198|NCT00564278|468735487|FG001|Overall Study|Physician Decision|2|||
130211199|NCT00564278|468735486|FG000|Overall Study|Withdrawal by Subject|11|||
130211200|NCT00564278|468735487|FG001|Overall Study|Withdrawal by Subject|7|||
130211201|NCT06439095|468735488|FG000|Overall Study|Lost to Follow-up|2|||
130211202|NCT03341936|468735489|FG000|Overall Study|Ineligible|1|||
130211203|NCT03341936|468735489|FG000|Overall Study|Disease Progression|2|||
130211204|NCT03341936|468735489|FG000|Overall Study|Withdrew Consent|4|||
130211205|NCT03341936|468735489|FG000|Overall Study|Non-Compliance|1|||
130211206|NCT03341936|468735489|FG000|Overall Study|Physician Decision|1|||
130211207|NCT03341936|468735489|FG000|Overall Study|Withdrawal by Subject|1|||
130211208|NCT03341936|468735489|FG000|Overall Study|Other|1|||
130211209|NCT02368886|468735490|FG000|Overall Study|Cancel|1|||
130211210|NCT02368886|468735491|FG001|Overall Study|Cancel|1|||
130211211|NCT02368886|468735492|FG002|Overall Study|Cancel|1|||
130211212|NCT02368886|468735493|FG003|Overall Study|Cancel|3|||
130211213|NCT02368886|468735490|FG000|Overall Study|Ineligible|0|||
130211214|NCT02368886|468735491|FG001|Overall Study|Ineligible|0|||
130211215|NCT02368886|468735492|FG002|Overall Study|Ineligible|0|||
130211216|NCT02368886|468735493|FG003|Overall Study|Ineligible|1|||
130211217|NCT02131636|468735498|FG000|Overall Study|Personal Reasons|4|||
130211218|NCT02131636|468735499|FG001|Overall Study|Personal Reasons|4|||
130211219|NCT02131636|468735498|FG000|Overall Study|Lost to Follow-up|4|||
130211220|NCT02131636|468735499|FG001|Overall Study|Lost to Follow-up|0|||
130211221|NCT02131636|468735498|FG000|Overall Study|Adverse Event|4|||
130211222|NCT02131636|468735499|FG001|Overall Study|Adverse Event|1|||
130211223|NCT02173379|468735500|FG000|Overall Study|Lost to Follow-up|89|||
130211224|NCT02173379|468735501|FG001|Overall Study|Lost to Follow-up|81|||
130211225|NCT02173379|468735500|FG000|Overall Study|Withdrawal by Subject|24|||
130211226|NCT02173379|468735501|FG001|Overall Study|Withdrawal by Subject|29|||
130211227|NCT02173379|468735500|FG000|Overall Study|Physician Decision|8|||
130211228|NCT02173379|468735501|FG001|Overall Study|Physician Decision|8|||
130211229|NCT02173379|468735500|FG000|Overall Study|Death|75|||
130211230|NCT02173379|468735501|FG001|Overall Study|Death|72|||
130211231|NCT02173379|468735500|FG000|Overall Study|Other Reason|1|||
130211232|NCT02173379|468735501|FG001|Overall Study|Other Reason|0|||
130211233|NCT00715520|468735506|FG000|Overall Study|Screen failure|8|||
130432143|NCT00615264|469545873|FG001|Overall Study|Dermal Hypersensitivity|3|||
130432144|NCT04415151|469545880|FG000|Overall Study|Death|1|||
130432145|NCT04415151|469545881|FG001|Overall Study|Death|1|||
130432146|NCT04415151|469545880|FG000|Overall Study|Withdrawal by Subject|1|||
130432147|NCT04415151|469545881|FG001|Overall Study|Withdrawal by Subject|0|||
130211234|NCT00715520|468735507|FG001|Overall Study|Screen failure|1|||
130211235|NCT00715520|468735508|FG002|Overall Study|Screen failure|1|||
130211236|NCT00715520|468735506|FG000|Overall Study|Withdrawal by Subject|2|||
130432148|NCT00638235|469545887|FG000|Overall Study|Lost to Follow-up|31|||
130432149|NCT00638235|469545888|FG001|Overall Study|Lost to Follow-up|3|||
130432150|NCT00638235|469545889|FG002|Overall Study|Lost to Follow-up|18|||
130432151|NCT00638235|469545890|FG003|Overall Study|Lost to Follow-up|10|||
130432152|NCT00638235|469545891|FG004|Overall Study|Lost to Follow-up|13|||
130432153|NCT00638235|469545892|FG005|Overall Study|Lost to Follow-up|26|||
130432154|NCT00638235|469545893|FG006|Overall Study|Lost to Follow-up|0|||
130432155|NCT00638235|469545894|FG007|Overall Study|Lost to Follow-up|1|||
130432156|NCT00638235|469545895|FG008|Overall Study|Lost to Follow-up|18|||
130432157|NCT03505476|469545898|FG000|Overall Study|Physician Decision|18|||
130432158|NCT03505476|469545898|FG000|Overall Study|Device Malfunctioned|101|||
130432159|NCT03505476|469545898|FG000|Overall Study|Data Corrupt|6|||
130432160|NCT03505476|469545898|FG000|Overall Study|Device application insufficiant|3|||
130432161|NCT02228395|469545903|FG000|First Intervention Period|No longer willing to participate|1|||
130432162|NCT02228395|469545904|FG001|First Intervention Period|No longer willing to participate|0|||
130432163|NCT02228395|469545905|FG002|First Intervention Period|No longer willing to participate|0|||
130432164|NCT02228395|469545903|FG000|First Intervention Period|Unable to comply with study dates|0|||
130432165|NCT02228395|469545904|FG001|First Intervention Period|Unable to comply with study dates|1|||
130432166|NCT02228395|469545905|FG002|First Intervention Period|Unable to comply with study dates|1|||
130432167|NCT00659984|469545906|FG000|Overall Study|Adverse Event|1|||
130432168|NCT02569437|469545909|FG000|Overall Study|Lost to Follow-up|12|||
130432169|NCT02569437|469545910|FG001|Overall Study|Lost to Follow-up|14|||
130432170|NCT00985985|469545914|FG000|Overall Study|Adverse Event|4|||
130432171|NCT00985985|469545915|FG001|Overall Study|Adverse Event|2|||
130432172|NCT00985985|469545916|FG002|Overall Study|Adverse Event|2|||
130432173|NCT00985985|469545917|FG003|Overall Study|Adverse Event|2|||
130432174|NCT00985985|469545914|FG000|Overall Study|Lost to Follow-up|4|||
130432175|NCT00985985|469545915|FG001|Overall Study|Lost to Follow-up|11|||
130432176|NCT00985985|469545916|FG002|Overall Study|Lost to Follow-up|2|||
130432177|NCT00985985|469545917|FG003|Overall Study|Lost to Follow-up|3|||
130432178|NCT00985985|469545914|FG000|Overall Study|Protocol Violation|1|||
130432179|NCT00985985|469545915|FG001|Overall Study|Protocol Violation|2|||
130432180|NCT00985985|469545916|FG002|Overall Study|Protocol Violation|0|||
130432181|NCT00985985|469545917|FG003|Overall Study|Protocol Violation|1|||
130432182|NCT00985985|469545914|FG000|Overall Study|Lack of Efficacy|5|||
130432183|NCT00985985|469545915|FG001|Overall Study|Lack of Efficacy|6|||
130432184|NCT00985985|469545916|FG002|Overall Study|Lack of Efficacy|1|||
130432185|NCT00985985|469545917|FG003|Overall Study|Lack of Efficacy|3|||
130432186|NCT00985985|469545914|FG000|Overall Study|Withdrawal by Subject|4|||
130432187|NCT00985985|469545915|FG001|Overall Study|Withdrawal by Subject|2|||
130432188|NCT00985985|469545916|FG002|Overall Study|Withdrawal by Subject|2|||
130432189|NCT00985985|469545917|FG003|Overall Study|Withdrawal by Subject|2|||
130432190|NCT00985985|469545914|FG000|Overall Study|Other Reason|6|||
130432191|NCT00985985|469545915|FG001|Overall Study|Other Reason|1|||
130432192|NCT00985985|469545916|FG002|Overall Study|Other Reason|4|||
130432193|NCT00985985|469545917|FG003|Overall Study|Other Reason|2|||
130432194|NCT02255357|469545920|FG000|Overall Study|Physician Decision|10|||
130432195|NCT02255357|469545921|FG001|Overall Study|Physician Decision|24|||
130432196|NCT00509236|469545922|FG000|Overall Study|Adverse Event|7|||
130432197|NCT00509236|469545923|FG001|Overall Study|Adverse Event|9|||
130432198|NCT00509236|469545922|FG000|Overall Study|Withdrawal by Subject|5|||
130432199|NCT00509236|469545923|FG001|Overall Study|Withdrawal by Subject|10|||
130432200|NCT00509236|469545922|FG000|Overall Study|Protocol Violation|3|||
130432201|NCT00509236|469545923|FG001|Overall Study|Protocol Violation|0|||
130432202|NCT00509236|469545922|FG000|Overall Study|Excluded Medication|1|||
130432203|NCT00509236|469545923|FG001|Overall Study|Excluded Medication|1|||
130432204|NCT00509236|469545922|FG000|Overall Study|Scheduled Kidney Transplant|1|||
130432205|NCT00509236|469545923|FG001|Overall Study|Scheduled Kidney Transplant|0|||
130432206|NCT00927355|469545924|FG000|Overall Study|Adverse Event|1|||
130432207|NCT00927355|469545925|FG001|Overall Study|Adverse Event|1|||
130432208|NCT00792103|469545926|FG000|Overall Study|Enrolled, not treated|15|||
130432209|NCT00792103|469545926|FG000|Overall Study|Lost to Follow-up|17|||
130432210|NCT00792103|469545926|FG000|Overall Study|Adverse Event|25|||
130432211|NCT00792103|469545926|FG000|Overall Study|Withdrawal by Subject|52|||
130432212|NCT00792103|469545926|FG000|Overall Study|Protocol Violation|10|||
130432213|NCT00792103|469545926|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
130432214|NCT01572389|469545928|FG000|Overall Study|Death|1|||
130432215|NCT01572389|469545929|FG001|Overall Study|Death|3|||
130432216|NCT01572389|469545928|FG000|Overall Study|Withdrawal by Subject|14|||
130432217|NCT01572389|469545929|FG001|Overall Study|Withdrawal by Subject|2|||
130432218|NCT01572389|469545928|FG000|Overall Study|Lost to Follow-up|25|||
130432219|NCT01572389|469545929|FG001|Overall Study|Lost to Follow-up|14|||
130432220|NCT01572389|469545928|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
130432221|NCT01572389|469545929|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
130432222|NCT01287520|469545930|FG000|Overall Study|Adverse Event|2|||
130432223|NCT01287520|469545931|FG001|Overall Study|Adverse Event|2|||
130432224|NCT01287520|469545932|FG002|Overall Study|Adverse Event|2|||
130432225|NCT01287520|469545933|FG003|Overall Study|Adverse Event|1|||
130432226|NCT01287520|469545934|FG004|Overall Study|Adverse Event|1|||
130432227|NCT01287520|469545935|FG005|Overall Study|Adverse Event|2|||
130432228|NCT01287520|469545936|FG006|Overall Study|Adverse Event|0|||
130432229|NCT01287520|469545937|FG007|Overall Study|Adverse Event|2|||
130432230|NCT01287520|469545938|FG008|Overall Study|Adverse Event|0|||
130432231|NCT01287520|469545930|FG000|Overall Study|Physician Decision|1|||
130432232|NCT01287520|469545931|FG001|Overall Study|Physician Decision|1|||
130432233|NCT01287520|469545932|FG002|Overall Study|Physician Decision|2|||
130432234|NCT01287520|469545933|FG003|Overall Study|Physician Decision|0|||
130432235|NCT01287520|469545934|FG004|Overall Study|Physician Decision|1|||
130432236|NCT01287520|469545935|FG005|Overall Study|Physician Decision|1|||
130432237|NCT01287520|469545936|FG006|Overall Study|Physician Decision|0|||
130432238|NCT01287520|469545937|FG007|Overall Study|Physician Decision|1|||
130432239|NCT01287520|469545938|FG008|Overall Study|Physician Decision|0|||
130432240|NCT01287520|469545930|FG000|Overall Study|Progressive disease|0|||
130432241|NCT01287520|469545931|FG001|Overall Study|Progressive disease|4|||
130432242|NCT01287520|469545932|FG002|Overall Study|Progressive disease|1|||
130432243|NCT01287520|469545933|FG003|Overall Study|Progressive disease|6|||
130432244|NCT01287520|469545934|FG004|Overall Study|Progressive disease|1|||
130432245|NCT01287520|469545935|FG005|Overall Study|Progressive disease|0|||
130432246|NCT01287520|469545936|FG006|Overall Study|Progressive disease|2|||
130432247|NCT01287520|469545937|FG007|Overall Study|Progressive disease|2|||
130432248|NCT01287520|469545938|FG008|Overall Study|Progressive disease|4|||
130432249|NCT01287520|469545930|FG000|Overall Study|Withdrawal by Subject|0|||
130432250|NCT01287520|469545931|FG001|Overall Study|Withdrawal by Subject|0|||
130432251|NCT01287520|469545932|FG002|Overall Study|Withdrawal by Subject|0|||
130432252|NCT01287520|469545933|FG003|Overall Study|Withdrawal by Subject|0|||
130432253|NCT01287520|469545934|FG004|Overall Study|Withdrawal by Subject|0|||
130432254|NCT01287520|469545935|FG005|Overall Study|Withdrawal by Subject|1|||
130432255|NCT01287520|469545936|FG006|Overall Study|Withdrawal by Subject|0|||
130432256|NCT01287520|469545937|FG007|Overall Study|Withdrawal by Subject|0|||
130432257|NCT01287520|469545938|FG008|Overall Study|Withdrawal by Subject|1|||
130432258|NCT03587142|469545939|FG000|Overall Study|Lost to Follow-up|5|||
130432259|NCT03587142|469545940|FG001|Overall Study|Lost to Follow-up|3|||
130432260|NCT03587142|469545939|FG000|Overall Study|Did not complete the f4 visit|3|||
130432261|NCT03587142|469545940|FG001|Overall Study|Did not complete the f4 visit|7|||
130432262|NCT02768662|469545941|FG000|Overall Study|Adverse Event|1|||
130432263|NCT02768662|469545941|FG000|Overall Study|Lost to Follow-up|4|||
130432264|NCT02768662|469545941|FG000|Overall Study|Withdrawal by Subject|3|||
130432265|NCT02768662|469545941|FG000|Overall Study|Study terminated by Sponsor|78|||
130432266|NCT03673462|469545942|FG000|Overall Study|Adverse Event|11|||
130432267|NCT03673462|469545943|FG001|Overall Study|Adverse Event|1|||
130432268|NCT03673462|469545942|FG000|Overall Study|Protocol Violation|25|||
130432269|NCT03673462|469545943|FG001|Overall Study|Protocol Violation|11|||
130432270|NCT03673462|469545942|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
130432271|NCT03673462|469545943|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
130432272|NCT03673462|469545942|FG000|Overall Study|Lost to Follow-up|102|||
130432273|NCT03673462|469545943|FG001|Overall Study|Lost to Follow-up|19|||
130432274|NCT01800201|469545944|FG000|Overall Study|Withdrawal by Subject|2|||
130432275|NCT01800201|469545945|FG001|Overall Study|Withdrawal by Subject|0|||
130432276|NCT01800201|469545944|FG000|Overall Study|patient privacy concerns|1|||
130432277|NCT01800201|469545945|FG001|Overall Study|patient privacy concerns|1|||
130432278|NCT01800201|469545944|FG000|Overall Study|did not want to use device|0|||
130432279|NCT01800201|469545945|FG001|Overall Study|did not want to use device|1|||
130432280|NCT01800201|469545944|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
130432281|NCT01800201|469545945|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
130432282|NCT00708435|469545946|FG000|Overall Study|Death / Serious Adverse Event|10|||
130432283|NCT00708435|469545947|FG001|Overall Study|Death / Serious Adverse Event|5|||
130432284|NCT00708435|469545946|FG000|Overall Study|Lost to Follow-up|9|||
130432285|NCT00708435|469545947|FG001|Overall Study|Lost to Follow-up|4|||
130432286|NCT00708435|469545946|FG000|Overall Study|Withdrawal by Subject|3|||
130432287|NCT00708435|469545947|FG001|Overall Study|Withdrawal by Subject|7|||
130432288|NCT00708435|469545946|FG000|Overall Study|Adverse Event|1|||
130432289|NCT00708435|469545947|FG001|Overall Study|Adverse Event|0|||
130432290|NCT00708435|469545946|FG000|Overall Study|Protocol Violation|0|||
130432291|NCT00708435|469545947|FG001|Overall Study|Protocol Violation|1|||
130432292|NCT00708435|469545946|FG000|Overall Study|Intervention by primary care physician|1|||
130432293|NCT00708435|469545947|FG001|Overall Study|Intervention by primary care physician|0|||
130432294|NCT00708435|469545946|FG000|Overall Study|Refused hospitalization|1|||
130432295|NCT00708435|469545947|FG001|Overall Study|Refused hospitalization|0|||
130432296|NCT05061537|469545953|FG000|Treatment Phase|Progressive disease|0|||
130432297|NCT05061537|469545954|FG001|Treatment Phase|Progressive disease|1|||
130432298|NCT05061537|469545955|FG002|Treatment Phase|Progressive disease|2|||
130432299|NCT05061537|469545956|FG003|Treatment Phase|Progressive disease|0|||
130432300|NCT05061537|469545957|FG004|Treatment Phase|Progressive disease|0|||
130432301|NCT05061537|469545953|FG000|Treatment Phase|Adverse Event|0|||
130432302|NCT05061537|469545954|FG001|Treatment Phase|Adverse Event|0|||
130432303|NCT05061537|469545955|FG002|Treatment Phase|Adverse Event|2|||
130432304|NCT05061537|469545956|FG003|Treatment Phase|Adverse Event|0|||
130432305|NCT05061537|469545957|FG004|Treatment Phase|Adverse Event|0|||
130432306|NCT05061537|469545953|FG000|Treatment Phase|Global deterioration of health status|0|||
130432307|NCT05061537|469545954|FG001|Treatment Phase|Global deterioration of health status|1|||
130432308|NCT05061537|469545955|FG002|Treatment Phase|Global deterioration of health status|0|||
130432309|NCT05061537|469545956|FG003|Treatment Phase|Global deterioration of health status|0|||
130432310|NCT05061537|469545957|FG004|Treatment Phase|Global deterioration of health status|0|||
130432311|NCT05061537|469545953|FG000|Follow up|Other|2|||
130432312|NCT05061537|469545954|FG001|Follow up|Other|0|||
130432313|NCT05061537|469545955|FG002|Follow up|Other|2|||
130432314|NCT05061537|469545956|FG003|Follow up|Other|0|||
130432315|NCT05061537|469545957|FG004|Follow up|Other|0|||
130432316|NCT05061537|469545953|FG000|Follow up|Study terminated by sponsor|0|||
130432317|NCT05061537|469545954|FG001|Follow up|Study terminated by sponsor|0|||
130432318|NCT05061537|469545955|FG002|Follow up|Study terminated by sponsor|2|||
130432319|NCT05061537|469545956|FG003|Follow up|Study terminated by sponsor|0|||
130432320|NCT05061537|469545957|FG004|Follow up|Study terminated by sponsor|0|||
130432321|NCT05061537|469545953|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
130432322|NCT05061537|469545954|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
130432323|NCT05061537|469545955|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
130432324|NCT05061537|469545956|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
130432325|NCT05061537|469545957|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
130432326|NCT05061537|469545953|FG000|Long-term Follow-up|Death|0|||
130432327|NCT05061537|469545954|FG001|Long-term Follow-up|Death|1|||
130432328|NCT05061537|469545955|FG002|Long-term Follow-up|Death|0|||
130432329|NCT05061537|469545956|FG003|Long-term Follow-up|Death|0|||
130432330|NCT05061537|469545957|FG004|Long-term Follow-up|Death|0|||
130432331|NCT03502616|469545958|FG000|Up to Week 16|Withdrawal by Subject|1|||
130432332|NCT03502616|469545959|FG001|Up to Week 16|Withdrawal by Subject|2|||
130432333|NCT03502616|469545958|FG000|Up to Week 16|Lost to Follow-up|0|||
130432334|NCT03502616|469545959|FG001|Up to Week 16|Lost to Follow-up|1|||
130432335|NCT03502616|469545958|FG000|Up to Week 16|Randomized, but not treated|1|||
130432336|NCT03502616|469545959|FG001|Up to Week 16|Randomized, but not treated|0|||
130432337|NCT03502616|469545958|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
130432338|NCT03502616|469545959|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
130432339|NCT03502616|469545958|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
130432340|NCT03502616|469545959|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
130432341|NCT03724396|469545962|FG000|Overall Study|Lost to Follow-up|1|||
130432342|NCT03724396|469545963|FG001|Overall Study|Lost to Follow-up|1|||
130432343|NCT03724396|469545962|FG000|Overall Study|Withdrawal by Subject|1|||
130432344|NCT03724396|469545963|FG001|Overall Study|Withdrawal by Subject|0|||
130432345|NCT03879408|469545964|FG000|Overall Study|Lost to Follow-up|0|||
130432346|NCT03879408|469545965|FG001|Overall Study|Lost to Follow-up|3|||
130432347|NCT03879408|469545966|FG002|Overall Study|Lost to Follow-up|2|||
130432348|NCT03879408|469545967|FG003|Overall Study|Lost to Follow-up|1|||
130432349|NCT03879408|469545968|FG004|Overall Study|Lost to Follow-up|0|||
130432350|NCT03879408|469545964|FG000|Overall Study|Withdrawal by Subject|2|||
130432351|NCT03879408|469545965|FG001|Overall Study|Withdrawal by Subject|1|||
130432352|NCT03879408|469545966|FG002|Overall Study|Withdrawal by Subject|1|||
130432353|NCT03879408|469545967|FG003|Overall Study|Withdrawal by Subject|0|||
130432354|NCT03879408|469545968|FG004|Overall Study|Withdrawal by Subject|1|||
130432355|NCT01490125|469545969|FG000|Period I|Adverse Event|4|||
130432356|NCT01490125|469545970|FG001|Period I|Adverse Event|1|||
130432357|NCT01490125|469545971|FG002|Period I|Adverse Event|1|||
130432358|NCT01490125|469545972|FG003|Period I|Adverse Event|3|||
130432359|NCT01490125|469545973|FG004|Period I|Adverse Event|2|||
130432360|NCT01490125|469545974|FG005|Period I|Adverse Event|4|||
130432361|NCT01490125|469545969|FG000|Period I|Protocol Violation|1|||
130432362|NCT01490125|469545970|FG001|Period I|Protocol Violation|1|||
130432363|NCT01490125|469545971|FG002|Period I|Protocol Violation|1|||
130432364|NCT01490125|469545972|FG003|Period I|Protocol Violation|1|||
130432365|NCT01490125|469545973|FG004|Period I|Protocol Violation|0|||
130432366|NCT01490125|469545974|FG005|Period I|Protocol Violation|0|||
130432367|NCT01490125|469545969|FG000|Period I|Withdrawal by Subject|1|||
130432368|NCT01490125|469545970|FG001|Period I|Withdrawal by Subject|3|||
130432369|NCT01490125|469545971|FG002|Period I|Withdrawal by Subject|2|||
130432370|NCT01490125|469545972|FG003|Period I|Withdrawal by Subject|1|||
130432371|NCT01490125|469545973|FG004|Period I|Withdrawal by Subject|2|||
130432372|NCT01490125|469545974|FG005|Period I|Withdrawal by Subject|1|||
130432373|NCT01490125|469545969|FG000|Period II|Adverse Event|2|||
130432374|NCT01490125|469545970|FG001|Period II|Adverse Event|3|||
130432375|NCT01490125|469545971|FG002|Period II|Adverse Event|2|||
130432376|NCT01490125|469545972|FG003|Period II|Adverse Event|2|||
130432377|NCT01490125|469545973|FG004|Period II|Adverse Event|4|||
130432378|NCT01490125|469545974|FG005|Period II|Adverse Event|2|||
130559401|NCT01621542|470016491|FG001|Overall Study|Death|1|||
130432379|NCT01490125|469545969|FG000|Period II|Protocol Violation|0|||
130432380|NCT01490125|469545970|FG001|Period II|Protocol Violation|0|||
130432381|NCT01490125|469545971|FG002|Period II|Protocol Violation|1|||
130432382|NCT01490125|469545972|FG003|Period II|Protocol Violation|1|||
130432383|NCT01490125|469545973|FG004|Period II|Protocol Violation|0|||
130432384|NCT01490125|469545974|FG005|Period II|Protocol Violation|0|||
130432385|NCT01490125|469545969|FG000|Period II|Lost to Follow-up|0|||
130432386|NCT01490125|469545970|FG001|Period II|Lost to Follow-up|1|||
130432387|NCT01490125|469545971|FG002|Period II|Lost to Follow-up|0|||
130432388|NCT01490125|469545972|FG003|Period II|Lost to Follow-up|0|||
130432389|NCT01490125|469545973|FG004|Period II|Lost to Follow-up|0|||
130432390|NCT01490125|469545974|FG005|Period II|Lost to Follow-up|0|||
130432391|NCT01490125|469545969|FG000|Period II|Withdrawal by Subject|1|||
130432392|NCT01490125|469545970|FG001|Period II|Withdrawal by Subject|0|||
130432393|NCT01490125|469545971|FG002|Period II|Withdrawal by Subject|0|||
130432394|NCT01490125|469545972|FG003|Period II|Withdrawal by Subject|0|||
130432395|NCT01490125|469545973|FG004|Period II|Withdrawal by Subject|0|||
130432396|NCT01490125|469545974|FG005|Period II|Withdrawal by Subject|0|||
130432397|NCT01490125|469545969|FG000|Period III|Adverse Event|3|||
130432398|NCT01490125|469545970|FG001|Period III|Adverse Event|1|||
130432399|NCT01490125|469545971|FG002|Period III|Adverse Event|0|||
130432400|NCT01490125|469545972|FG003|Period III|Adverse Event|1|||
130432401|NCT01490125|469545973|FG004|Period III|Adverse Event|0|||
130432402|NCT01490125|469545974|FG005|Period III|Adverse Event|0|||
130432403|NCT01490125|469545969|FG000|Period III|Death|0|||
130432404|NCT01490125|469545970|FG001|Period III|Death|0|||
130432405|NCT01490125|469545971|FG002|Period III|Death|0|||
130432406|NCT01490125|469545972|FG003|Period III|Death|1|||
130432407|NCT01490125|469545973|FG004|Period III|Death|0|||
130432408|NCT01490125|469545974|FG005|Period III|Death|0|||
130432409|NCT01490125|469545969|FG000|Period III|Lack of Efficacy|0|||
130432410|NCT01490125|469545970|FG001|Period III|Lack of Efficacy|0|||
130432411|NCT01490125|469545971|FG002|Period III|Lack of Efficacy|0|||
130432412|NCT01490125|469545972|FG003|Period III|Lack of Efficacy|0|||
130432413|NCT01490125|469545973|FG004|Period III|Lack of Efficacy|1|||
130432414|NCT01490125|469545974|FG005|Period III|Lack of Efficacy|0|||
130432415|NCT02237508|469545976|FG000|Overall Study|Withdrawal by Subject|0|||
130432416|NCT02237508|469545977|FG001|Overall Study|Withdrawal by Subject|2|||
130432417|NCT02237508|469545978|FG002|Overall Study|Withdrawal by Subject|0|||
130432418|NCT02237508|469545979|FG003|Overall Study|Withdrawal by Subject|1|||
130432419|NCT02237508|469545980|FG004|Overall Study|Withdrawal by Subject|0|||
130432420|NCT02237508|469545981|FG005|Overall Study|Withdrawal by Subject|1|||
130432421|NCT02237508|469545982|FG006|Overall Study|Withdrawal by Subject|1|||
130432422|NCT02237508|469545983|FG007|Overall Study|Withdrawal by Subject|0|||
130432423|NCT02237508|469545984|FG008|Overall Study|Withdrawal by Subject|1|||
130432424|NCT02237508|469545985|FG009|Overall Study|Withdrawal by Subject|0|||
130432425|NCT02237508|469545976|FG000|Overall Study|Physician Decision|0|||
130432426|NCT02237508|469545977|FG001|Overall Study|Physician Decision|1|||
130432427|NCT02237508|469545978|FG002|Overall Study|Physician Decision|0|||
130432428|NCT02237508|469545979|FG003|Overall Study|Physician Decision|0|||
130432429|NCT02237508|469545980|FG004|Overall Study|Physician Decision|0|||
130432430|NCT02237508|469545981|FG005|Overall Study|Physician Decision|0|||
130432431|NCT02237508|469545982|FG006|Overall Study|Physician Decision|0|||
130432432|NCT02237508|469545983|FG007|Overall Study|Physician Decision|0|||
130432433|NCT02237508|469545984|FG008|Overall Study|Physician Decision|0|||
130432434|NCT02237508|469545985|FG009|Overall Study|Physician Decision|0|||
130432435|NCT02237508|469545976|FG000|Overall Study|Protocol Violation|0|||
130432436|NCT02237508|469545977|FG001|Overall Study|Protocol Violation|0|||
130432437|NCT02237508|469545978|FG002|Overall Study|Protocol Violation|1|||
130432438|NCT02237508|469545979|FG003|Overall Study|Protocol Violation|0|||
130432439|NCT02237508|469545980|FG004|Overall Study|Protocol Violation|0|||
130432440|NCT02237508|469545981|FG005|Overall Study|Protocol Violation|0|||
130432441|NCT02237508|469545982|FG006|Overall Study|Protocol Violation|0|||
130432442|NCT02237508|469545983|FG007|Overall Study|Protocol Violation|0|||
130432443|NCT02237508|469545984|FG008|Overall Study|Protocol Violation|0|||
130432444|NCT02237508|469545985|FG009|Overall Study|Protocol Violation|0|||
130432445|NCT04000594|469545986|FG000|Overall Study|Withdrawal by Subject|1|||
130432446|NCT04000594|469545987|FG001|Overall Study|Withdrawal by Subject|0|||
130432447|NCT04000594|469545988|FG002|Overall Study|Withdrawal by Subject|0|||
130432448|NCT04522180|469545989|FG000|Overall Study|Investigator judgement|3|||
130432449|NCT04522180|469545990|FG001|Overall Study|Investigator judgement|4|||
130432450|NCT04522180|469545989|FG000|Overall Study|Voluntary withdrawal|1|||
130432451|NCT04522180|469545990|FG001|Overall Study|Voluntary withdrawal|0|||
130432452|NCT04522180|469545989|FG000|Overall Study|Pregnancy|0|||
130432453|NCT04522180|469545990|FG001|Overall Study|Pregnancy|1|||
130432454|NCT04522180|469545989|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
130432455|NCT04522180|469545990|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
130432456|NCT04522180|469545989|FG000|Overall Study|Reason not specified|8|||
130432457|NCT04522180|469545990|FG001|Overall Study|Reason not specified|5|||
130543706|NCT01942590|469956815|FG000|Overall Study|Withdrawal by Subject|0|||
130432458|NCT05807919|469545991|FG000|Overall Study|Received antibiotics - excluded|0|||
130432459|NCT05807919|469545992|FG001|Overall Study|Received antibiotics - excluded|1|||
130432460|NCT05807919|469545991|FG000|Overall Study|Withdrawal by Subject|0|||
130432461|NCT05807919|469545992|FG001|Overall Study|Withdrawal by Subject|3|||
130432462|NCT05807919|469545991|FG000|Overall Study|Adverse Event|1|||
130432463|NCT05807919|469545992|FG001|Overall Study|Adverse Event|1|||
130432464|NCT01905046|469545993|FG000|Months 13-24|Withdrawal by Subject|10|||
130432465|NCT01905046|469545994|FG001|Months 13-24|Withdrawal by Subject|10|||
130432466|NCT01905046|469545993|FG000|Months 13-24|Adverse Event|3|||
130432467|NCT01905046|469545994|FG001|Months 13-24|Adverse Event|2|||
130432468|NCT01905046|469545993|FG000|Months 13-24|Protocol Violation|3|||
130432469|NCT01905046|469545994|FG001|Months 13-24|Protocol Violation|3|||
130432470|NCT01905046|469545993|FG000|Months 13-24|Physician Decision|1|||
130432471|NCT01905046|469545994|FG001|Months 13-24|Physician Decision|0|||
130432472|NCT03489057|469545999|FG000|Overall Study|Lost to Follow-up|16|||
130432473|NCT03489057|469546000|FG001|Overall Study|Lost to Follow-up|16|||
130432474|NCT03489057|469546001|FG002|Overall Study|Lost to Follow-up|14|||
130432475|NCT03489057|469546002|FG003|Overall Study|Lost to Follow-up|14|||
130432476|NCT03489057|469545999|FG000|Overall Study|Withdrawal by Subject|12|||
130432477|NCT03489057|469546000|FG001|Overall Study|Withdrawal by Subject|12|||
130432478|NCT03489057|469546001|FG002|Overall Study|Withdrawal by Subject|8|||
130432479|NCT03489057|469546002|FG003|Overall Study|Withdrawal by Subject|8|||
130432480|NCT03489057|469545999|FG000|Overall Study|Protocol Violation|7|||
130432481|NCT03489057|469546000|FG001|Overall Study|Protocol Violation|7|||
130432482|NCT03489057|469546001|FG002|Overall Study|Protocol Violation|2|||
130432483|NCT03489057|469546002|FG003|Overall Study|Protocol Violation|2|||
130432484|NCT01368900|469546005|FG000|Overall Study|Lost to Follow-up|7|||
130432485|NCT04027348|469546008|FG000|Overall Study|Adverse Event|2|||
130432486|NCT02487472|469546009|FG000|Overall Study|Did not complete telephonic interviews|9|||
130432487|NCT02487472|469546009|FG000|Overall Study|Other|2|||
130432488|NCT02034708|469546012|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
130432489|NCT02034708|469546013|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
130432490|NCT02034708|469546012|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
130432491|NCT02034708|469546013|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
130432492|NCT02034708|469546012|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
130432493|NCT02034708|469546013|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
130432494|NCT02034708|469546012|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
130432495|NCT02034708|469546013|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
130432496|NCT01552954|469546014|FG000|Overall Study|Adverse Event|1|||
130432497|NCT01552954|469546015|FG001|Overall Study|Adverse Event|2|||
130432498|NCT01552954|469546014|FG000|Overall Study|Lost to Follow-up|1|||
130432499|NCT01552954|469546015|FG001|Overall Study|Lost to Follow-up|1|||
130432500|NCT01552954|469546014|FG000|Overall Study|Withdrawal by Subject|1|||
130432501|NCT01552954|469546015|FG001|Overall Study|Withdrawal by Subject|1|||
130432502|NCT01552954|469546014|FG000|Overall Study|Protocol Violation|1|||
130432503|NCT01552954|469546015|FG001|Overall Study|Protocol Violation|2|||
130432504|NCT01552954|469546014|FG000|Overall Study|diagnosed DM|1|||
130432505|NCT01552954|469546015|FG001|Overall Study|diagnosed DM|0|||
130432506|NCT04843930|469546016|FG000|Randomization|Withdrawal by Subject|6|||
130432507|NCT04843930|469546017|FG001|Randomization|Withdrawal by Subject|6|||
130432508|NCT04843930|469546018|FG002|Randomization|Withdrawal by Subject|0|||
130432509|NCT04843930|469546019|FG003|Randomization|Withdrawal by Subject|0|||
130432510|NCT04843930|469546016|FG000|Week 6 Assessment|Adverse Event|3|||
130432511|NCT04843930|469546017|FG001|Week 6 Assessment|Adverse Event|0|||
130432512|NCT04843930|469546018|FG002|Week 6 Assessment|Adverse Event|0|||
130432513|NCT04843930|469546019|FG003|Week 6 Assessment|Adverse Event|0|||
130432514|NCT04843930|469546016|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
130432515|NCT04843930|469546017|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
130432516|NCT04843930|469546018|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
130432517|NCT04843930|469546019|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
130432518|NCT04843930|469546016|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
130432519|NCT04843930|469546017|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
130432520|NCT04843930|469546018|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
130432521|NCT04843930|469546019|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
130432522|NCT01931735|469546020|FG000|Randomized Phase|Lost to Follow-up|2|||
130432523|NCT01931735|469546021|FG001|Randomized Phase|Lost to Follow-up|2|||
130432524|NCT01931735|469546022|FG002|Randomized Phase|Lost to Follow-up|5|||
130432525|NCT01931735|469546023|FG003|Randomized Phase|Lost to Follow-up|0|||
130432526|NCT01931735|469546020|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
130432527|NCT01931735|469546021|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
130432528|NCT01931735|469546022|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
130432529|NCT01931735|469546023|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
130432530|NCT01931735|469546020|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130432531|NCT01931735|469546021|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130432532|NCT01931735|469546022|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130432533|NCT01931735|469546023|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
130432534|NCT02719990|469546024|FG000|Overall Study|Physician Decision|2|||
130432535|NCT02719990|469546024|FG000|Overall Study|Withdrawal by Subject|2|||
130432536|NCT02719990|469546024|FG000|Overall Study|Study Terminated By Sponsor|32|||
130432537|NCT01833143|469546028|FG000|Overall Study|Not Treated|1|||
130559402|NCT01621542|470016492|FG002|Overall Study|Death|0|||
130543707|NCT01942590|469956816|FG001|Overall Study|Withdrawal by Subject|1|||
130320282|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130320283|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
130320284|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
130320285|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
130320286|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
130320287|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
130320288|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
130320289|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
130320290|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
130320291|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
130320292|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
130320293|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Death|2|||
130320294|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Death|1|||
130320295|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
130320296|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
130320297|NCT00617734|469141885|FG000|Overall Study|Withdrew Consent|2|||
130320298|NCT00617734|469141886|FG001|Overall Study|Withdrew Consent|0|||
130320299|NCT00617734|469141885|FG000|Overall Study|Adverse Event|4|||
130320300|NCT00617734|469141886|FG001|Overall Study|Adverse Event|1|||
130320301|NCT00617734|469141885|FG000|Overall Study|Protocol Violation|1|||
130320302|NCT00617734|469141886|FG001|Overall Study|Protocol Violation|0|||
130320303|NCT00617734|469141885|FG000|Overall Study|Found Ineligible After Randomization|1|||
130320304|NCT00617734|469141886|FG001|Overall Study|Found Ineligible After Randomization|4|||
130320305|NCT00617734|469141885|FG000|Overall Study|Lost to Follow-up|0|||
130320306|NCT00617734|469141886|FG001|Overall Study|Lost to Follow-up|1|||
130320307|NCT01844765|469141887|FG000|Overall Study|Adverse Event|6|||
130320308|NCT01844765|469141888|FG001|Overall Study|Adverse Event|8|||
130320309|NCT01844765|469141887|FG000|Overall Study|Withdrawal by Subject|2|||
130320310|NCT01844765|469141888|FG001|Overall Study|Withdrawal by Subject|3|||
130320311|NCT01844765|469141887|FG000|Overall Study|Disease progression|1|||
130320312|NCT01844765|469141888|FG001|Overall Study|Disease progression|0|||
130320313|NCT01844765|469141887|FG000|Overall Study|Administrative problems|3|||
130320314|NCT01844765|469141888|FG001|Overall Study|Administrative problems|4|||
130320315|NCT01844765|469141887|FG000|Overall Study|Protocol deviation|2|||
130320316|NCT01844765|469141888|FG001|Overall Study|Protocol deviation|0|||
130320317|NCT01844765|469141887|FG000|Overall Study|Untreated|1|||
130320318|NCT01844765|469141888|FG001|Overall Study|Untreated|0|||
130320319|NCT03221556|469141890|FG000|Allocation|post-randomization exclusion|0|||
130320320|NCT03221556|469141891|FG001|Allocation|post-randomization exclusion|1|||
130320321|NCT03221556|469141890|FG000|Follow-Up|Withdrawal by Subject|0|||
130320322|NCT03221556|469141891|FG001|Follow-Up|Withdrawal by Subject|1|||
130320323|NCT00506350|469141892|FG000|Overall Study|Serious Adverse Event|1|||
130320324|NCT00506350|469141893|FG001|Overall Study|Serious Adverse Event|0|||
130320325|NCT00506350|469141894|FG002|Overall Study|Serious Adverse Event|0|||
130320326|NCT00506350|469141895|FG003|Overall Study|Serious Adverse Event|0|||
130320327|NCT00506350|469141896|FG004|Overall Study|Serious Adverse Event|0|||
130320328|NCT00506350|469141897|FG005|Overall Study|Serious Adverse Event|0|||
130320329|NCT00506350|469141898|FG006|Overall Study|Serious Adverse Event|0|||
130320330|NCT00506350|469141899|FG007|Overall Study|Serious Adverse Event|0|||
130320331|NCT00506350|469141900|FG008|Overall Study|Serious Adverse Event|0|||
130320332|NCT00506350|469141892|FG000|Overall Study|Adverse Event|0|||
130320333|NCT00506350|469141893|FG001|Overall Study|Adverse Event|0|||
130320334|NCT00506350|469141894|FG002|Overall Study|Adverse Event|0|||
130320335|NCT00506350|469141895|FG003|Overall Study|Adverse Event|0|||
130320336|NCT00506350|469141896|FG004|Overall Study|Adverse Event|0|||
130320337|NCT00506350|469141897|FG005|Overall Study|Adverse Event|0|||
130320338|NCT00506350|469141898|FG006|Overall Study|Adverse Event|0|||
130320339|NCT00506350|469141899|FG007|Overall Study|Adverse Event|1|||
130320340|NCT00506350|469141900|FG008|Overall Study|Adverse Event|1|||
130320341|NCT00506350|469141892|FG000|Overall Study|Protocol Violation|0|||
130320342|NCT00506350|469141893|FG001|Overall Study|Protocol Violation|0|||
130320343|NCT00506350|469141894|FG002|Overall Study|Protocol Violation|1|||
130320344|NCT00506350|469141895|FG003|Overall Study|Protocol Violation|0|||
130320345|NCT00506350|469141896|FG004|Overall Study|Protocol Violation|0|||
130320346|NCT00506350|469141897|FG005|Overall Study|Protocol Violation|0|||
130320347|NCT00506350|469141898|FG006|Overall Study|Protocol Violation|1|||
130320348|NCT00506350|469141899|FG007|Overall Study|Protocol Violation|0|||
130320349|NCT00506350|469141900|FG008|Overall Study|Protocol Violation|0|||
130320350|NCT00506350|469141892|FG000|Overall Study|Withdrawal by Subject|0|||
130320351|NCT00506350|469141893|FG001|Overall Study|Withdrawal by Subject|1|||
130320352|NCT00506350|469141894|FG002|Overall Study|Withdrawal by Subject|1|||
130320353|NCT00506350|469141895|FG003|Overall Study|Withdrawal by Subject|1|||
130320354|NCT00506350|469141896|FG004|Overall Study|Withdrawal by Subject|4|||
130320355|NCT00506350|469141897|FG005|Overall Study|Withdrawal by Subject|1|||
130432538|NCT03995784|469546029|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
130432539|NCT02202434|469547700|FG000|Overall Study|Death|70|||
130432540|NCT02202434|469547701|FG001|Overall Study|Death|39|||
130432541|NCT02202434|469547702|FG002|Overall Study|Death|13|||
130432542|NCT02202434|469547703|FG003|Overall Study|Death|27|||
130432543|NCT02202434|469547700|FG000|Overall Study|Lost to Follow-up|1|||
130432544|NCT02202434|469547701|FG001|Overall Study|Lost to Follow-up|1|||
130432545|NCT02202434|469547702|FG002|Overall Study|Lost to Follow-up|1|||
130432546|NCT02202434|469547703|FG003|Overall Study|Lost to Follow-up|0|||
130432547|NCT02202434|469547700|FG000|Overall Study|Physician Decision|2|||
130432548|NCT02202434|469547701|FG001|Overall Study|Physician Decision|3|||
130432549|NCT02202434|469547702|FG002|Overall Study|Physician Decision|0|||
130432550|NCT02202434|469547703|FG003|Overall Study|Physician Decision|0|||
130432551|NCT02202434|469547700|FG000|Overall Study|Withdrawal by Subject|13|||
130432552|NCT02202434|469547701|FG001|Overall Study|Withdrawal by Subject|14|||
130432553|NCT02202434|469547702|FG002|Overall Study|Withdrawal by Subject|1|||
130432554|NCT02202434|469547703|FG003|Overall Study|Withdrawal by Subject|4|||
130432555|NCT02202434|469547700|FG000|Overall Study|Completed Study|1|||
130432556|NCT02202434|469547701|FG001|Overall Study|Completed Study|0|||
130432557|NCT02202434|469547702|FG002|Overall Study|Completed Study|0|||
130432558|NCT02202434|469547703|FG003|Overall Study|Completed Study|0|||
130432559|NCT02202434|469547700|FG000|Overall Study|Visit Missed|21|||
130432560|NCT02202434|469547701|FG001|Overall Study|Visit Missed|12|||
130432561|NCT02202434|469547702|FG002|Overall Study|Visit Missed|0|||
130432562|NCT02202434|469547703|FG003|Overall Study|Visit Missed|5|||
130432563|NCT02202434|469547700|FG000|Overall Study|Other|1|||
130432564|NCT02202434|469547701|FG001|Overall Study|Other|0|||
130432565|NCT02202434|469547702|FG002|Overall Study|Other|0|||
130432566|NCT02202434|469547703|FG003|Overall Study|Other|1|||
130432567|NCT03610737|469547706|FG000|Overall Study|Withdrawal by Subject|1|||
130432568|NCT03610737|469547707|FG001|Overall Study|Withdrawal by Subject|5|||
130432569|NCT03610737|469547706|FG000|Overall Study|Death|1|||
130432570|NCT03610737|469547707|FG001|Overall Study|Death|0|||
130432571|NCT03610737|469547706|FG000|Overall Study|Not treated|5|||
130432572|NCT03610737|469547707|FG001|Overall Study|Not treated|2|||
130432573|NCT03610737|469547706|FG000|Overall Study|Missed Visit|1|||
130432574|NCT03610737|469547707|FG001|Overall Study|Missed Visit|2|||
130432575|NCT00369681|469547709|FG000|Overall Study|Death|1|||
130432576|NCT02991482|469547710|FG000|Overall Study|Disease progression|56|||
130432577|NCT02991482|469547711|FG001|Overall Study|Disease progression|47|||
130432578|NCT02991482|469547710|FG000|Overall Study|Death|4|||
130432579|NCT02991482|469547711|FG001|Overall Study|Death|4|||
130432580|NCT02991482|469547710|FG000|Overall Study|Adverse Event|1|||
130432581|NCT02991482|469547711|FG001|Overall Study|Adverse Event|6|||
130432582|NCT02991482|469547710|FG000|Overall Study|Patient decision|1|||
130432583|NCT02991482|469547711|FG001|Overall Study|Patient decision|1|||
130432584|NCT02991482|469547710|FG000|Overall Study|Physician Decision|0|||
130432585|NCT02991482|469547711|FG001|Overall Study|Physician Decision|6|||
130432586|NCT02991482|469547710|FG000|Overall Study|Clinical deterioration|1|||
130432587|NCT02991482|469547711|FG001|Overall Study|Clinical deterioration|0|||
130432588|NCT02991482|469547710|FG000|Overall Study|Patient feeling too unwell|1|||
130432589|NCT02991482|469547711|FG001|Overall Study|Patient feeling too unwell|0|||
130432590|NCT02991482|469547710|FG000|Overall Study|Worsening of performance status|0|||
130432591|NCT02991482|469547711|FG001|Overall Study|Worsening of performance status|1|||
130432592|NCT02991482|469547710|FG000|Overall Study|Death prior to study drug initiation|1|||
130432593|NCT02991482|469547711|FG001|Overall Study|Death prior to study drug initiation|0|||
130432594|NCT02991482|469547710|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
130432595|NCT02991482|469547711|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
130432596|NCT02396537|469547718|FG000|Overall Study|Protocol Violation|0|||
130432597|NCT02396537|469547719|FG001|Overall Study|Protocol Violation|1|||
130432598|NCT00871403|469547720|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
130432599|NCT00871403|469547721|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
130432600|NCT00871403|469547722|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
130432601|NCT00871403|469547720|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
130432602|NCT00871403|469547721|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
130432603|NCT00871403|469547722|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
130432604|NCT00871403|469547720|FG000|Combination Treatment Phase|Adverse Event|0|||
130432605|NCT00871403|469547721|FG001|Combination Treatment Phase|Adverse Event|17|||
130432606|NCT00871403|469547722|FG002|Combination Treatment Phase|Adverse Event|2|||
130432607|NCT00871403|469547720|FG000|Combination Treatment Phase|Disease Progression|0|||
130432608|NCT00871403|469547721|FG001|Combination Treatment Phase|Disease Progression|8|||
130543708|NCT01942590|469956815|FG000|Overall Study|Adverse Event|1|||
130543709|NCT01942590|469956816|FG001|Overall Study|Adverse Event|0|||
130543710|NCT02433340|469956820|FG000|Overall Study|Adverse Event|0|||
130543711|NCT02433340|469956821|FG001|Overall Study|Adverse Event|0|||
130432609|NCT00871403|469547722|FG002|Combination Treatment Phase|Disease Progression|5|||
130432610|NCT00871403|469547720|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
130432611|NCT00871403|469547721|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
130432612|NCT00871403|469547722|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
130432613|NCT00871403|469547720|FG000|Combination Treatment Phase|Physician Decision|0|||
130432614|NCT00871403|469547721|FG001|Combination Treatment Phase|Physician Decision|1|||
130432615|NCT00871403|469547722|FG002|Combination Treatment Phase|Physician Decision|3|||
130432616|NCT00871403|469547720|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
130432617|NCT00871403|469547721|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
130432618|NCT00871403|469547722|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
130432619|NCT00871403|469547720|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
130432620|NCT00871403|469547721|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
130432621|NCT00871403|469547722|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
130432622|NCT04887948|469547723|FG000|Overall Study|Death|1|||
130432623|NCT04887948|469547724|FG001|Overall Study|Death|0|||
130432624|NCT04887948|469547725|FG002|Overall Study|Death|0|||
130432625|NCT04887948|469547723|FG000|Overall Study|Lost to Follow-up|1|||
130432626|NCT04887948|469547724|FG001|Overall Study|Lost to Follow-up|0|||
130432627|NCT04887948|469547725|FG002|Overall Study|Lost to Follow-up|3|||
130432628|NCT04887948|469547723|FG000|Overall Study|Physician Decision|0|||
130432629|NCT04887948|469547724|FG001|Overall Study|Physician Decision|4|||
130432630|NCT04887948|469547725|FG002|Overall Study|Physician Decision|1|||
130432631|NCT04887948|469547723|FG000|Overall Study|Protocol Violation|1|||
130432632|NCT04887948|469547724|FG001|Overall Study|Protocol Violation|1|||
130432633|NCT04887948|469547725|FG002|Overall Study|Protocol Violation|0|||
130432634|NCT04887948|469547723|FG000|Overall Study|Withdrawal by Subject|0|||
130432635|NCT04887948|469547724|FG001|Overall Study|Withdrawal by Subject|6|||
130432636|NCT04887948|469547725|FG002|Overall Study|Withdrawal by Subject|1|||
130432637|NCT04887948|469547723|FG000|Overall Study|No longer met eligibility criteria|1|||
130432638|NCT04887948|469547724|FG001|Overall Study|No longer met eligibility criteria|2|||
130432639|NCT04887948|469547725|FG002|Overall Study|No longer met eligibility criteria|1|||
130432640|NCT04887948|469547723|FG000|Overall Study|Other|2|||
130211237|NCT00715520|468735507|FG001|Overall Study|Withdrawal by Subject|0|||
130211238|NCT00715520|468735508|FG002|Overall Study|Withdrawal by Subject|1|||
130211239|NCT02290925|468735510|FG000|First Period of Three Months|Lost to Follow-up|2|||
130211240|NCT02290925|468735511|FG001|First Period of Three Months|Lost to Follow-up|1|||
130211241|NCT02290925|468735510|FG000|First Period of Three Months|Death|1|||
130211242|NCT02290925|468735511|FG001|First Period of Three Months|Death|0|||
130211243|NCT02290925|468735510|FG000|First Period of Three Months|Insulin Started|1|||
130211244|NCT02290925|468735511|FG001|First Period of Three Months|Insulin Started|1|||
130211245|NCT02290925|468735510|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
130211246|NCT02290925|468735511|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
130211247|NCT02290925|468735510|FG000|Second Period of 3 Months|insulin started|0|||
130211248|NCT02290925|468735511|FG001|Second Period of 3 Months|insulin started|1|||
130211249|NCT04942210|468735512|FG000|Overall Study|Adverse Event|0|||
130211250|NCT04942210|468735513|FG001|Overall Study|Adverse Event|1|||
130211251|NCT04942210|468735512|FG000|Overall Study|Protocol Deviation|4|||
130211252|NCT04942210|468735513|FG001|Overall Study|Protocol Deviation|1|||
130211253|NCT04942210|468735512|FG000|Overall Study|Withdrawal by Subject|5|||
130432641|NCT04887948|469547724|FG001|Overall Study|Other|1|||
130432642|NCT04887948|469547725|FG002|Overall Study|Other|1|||
130432643|NCT00787319|469547729|FG000|Overall Study|Lost to Follow-up|2|||
130432644|NCT00787319|469547729|FG000|Overall Study|Withdrawal by Subject|15|||
130432645|NCT00787319|469547729|FG000|Overall Study|Adverse Event|3|||
130432646|NCT00787319|469547729|FG000|Overall Study|Objective progression or relapse|30|||
130432647|NCT00787319|469547729|FG000|Overall Study|Lack of Efficacy|1|||
130432648|NCT00787319|469547729|FG000|Overall Study|Budget exhausted/exceeded|1|||
130432649|NCT00787319|469547729|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
130432650|NCT00787319|469547729|FG000|Overall Study|No health insurance reimbursement|2|||
130432651|NCT00787319|469547729|FG000|Overall Study|Stabilized disease findings|3|||
130432652|NCT00787319|469547729|FG000|Overall Study|Inactive disease|5|||
130543712|NCT02433340|469956822|FG002|Overall Study|Adverse Event|1|||
130543713|NCT02433340|469956823|FG003|Overall Study|Adverse Event|0|||
130543714|NCT02433340|469956820|FG000|Overall Study|Withdrawal by Subject|1|||
130543715|NCT02433340|469956821|FG001|Overall Study|Withdrawal by Subject|0|||
130543716|NCT02433340|469956822|FG002|Overall Study|Withdrawal by Subject|1|||
130543717|NCT02433340|469956823|FG003|Overall Study|Withdrawal by Subject|2|||
130543718|NCT02433340|469956820|FG000|Overall Study|Lost to Follow-up|0|||
130543719|NCT02433340|469956821|FG001|Overall Study|Lost to Follow-up|1|||
130543720|NCT02433340|469956822|FG002|Overall Study|Lost to Follow-up|0|||
130543721|NCT02433340|469956823|FG003|Overall Study|Lost to Follow-up|0|||
130543722|NCT02433340|469956820|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
130543723|NCT02433340|469956821|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
130543724|NCT02433340|469956822|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
130543725|NCT02433340|469956823|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
130543726|NCT02433340|469956820|FG000|Overall Study|Other|0|||
130211254|NCT04942210|468735513|FG001|Overall Study|Withdrawal by Subject|2|||
130211255|NCT04942210|468735512|FG000|Overall Study|Lost to Follow-up|16|||
130211256|NCT04942210|468735513|FG001|Overall Study|Lost to Follow-up|7|||
130211257|NCT04942210|468735512|FG000|Overall Study|Ongoing at the time of DBL date|60|||
130211258|NCT04942210|468735513|FG001|Overall Study|Ongoing at the time of DBL date|25|||
130211259|NCT04942210|468735512|FG000|Overall Study|Randomized but did not receive vaccination|3|||
130211260|NCT04942210|468735513|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130211261|NCT05697627|468735514|FG000|Overall Study|Adverse Event|1|||
130211262|NCT02570750|468735515|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
130211263|NCT02570750|468735516|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
130211264|NCT02570750|468735515|FG000|Overall Study|Protocol deviation|4|||
130211265|NCT02570750|468735516|FG001|Overall Study|Protocol deviation|2|||
130211266|NCT02570750|468735515|FG000|Overall Study|Withdrawal by Subject|5|||
130211267|NCT02570750|468735516|FG001|Overall Study|Withdrawal by Subject|0|||
130211268|NCT02570750|468735515|FG000|Overall Study|Lost to Follow-up|2|||
130211269|NCT02570750|468735516|FG001|Overall Study|Lost to Follow-up|2|||
130211270|NCT02570750|468735515|FG000|Overall Study|Adverse Event|2|||
130211271|NCT02570750|468735516|FG001|Overall Study|Adverse Event|1|||
130211272|NCT04122625|468735517|FG000|Part A (up to 2.92 Years)|Death|2|||
130211273|NCT04122625|468735518|FG001|Part A (up to 2.92 Years)|Death|4|||
130211274|NCT04122625|468735519|FG002|Part A (up to 2.92 Years)|Death|0|||
130211275|NCT04122625|468735520|FG003|Part A (up to 2.92 Years)|Death|0|||
130211276|NCT04122625|468735521|FG004|Part A (up to 2.92 Years)|Death|0|||
130211277|NCT04122625|468735522|FG005|Part A (up to 2.92 Years)|Death|0|||
130211278|NCT04122625|468735517|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211279|NCT04122625|468735518|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211280|NCT04122625|468735519|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130211281|NCT04122625|468735520|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130211282|NCT04122625|468735521|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
130211283|NCT04122625|468735522|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211284|NCT04122625|468735517|FG000|Part B (up to 2.33 Years)|Death|0|||
130211285|NCT04122625|468735518|FG001|Part B (up to 2.33 Years)|Death|0|||
130211286|NCT04122625|468735519|FG002|Part B (up to 2.33 Years)|Death|5|||
130211287|NCT04122625|468735520|FG003|Part B (up to 2.33 Years)|Death|7|||
130211288|NCT04122625|468735521|FG004|Part B (up to 2.33 Years)|Death|6|||
130211289|NCT04122625|468735522|FG005|Part B (up to 2.33 Years)|Death|7|||
130211290|NCT01410240|468735523|FG000|Overall Study|Physician Decision|0|||
130211291|NCT01410240|468735524|FG001|Overall Study|Physician Decision|0|||
130211292|NCT01410240|468735525|FG002|Overall Study|Physician Decision|1|||
130211293|NCT01410240|468735523|FG000|Overall Study|Missed week 6 assessments|1|||
130211294|NCT01410240|468735524|FG001|Overall Study|Missed week 6 assessments|1|||
130211295|NCT01410240|468735525|FG002|Overall Study|Missed week 6 assessments|1|||
130211296|NCT02776670|468735526|FG000|Overall Study|Adverse Event|0|||
130211297|NCT02776670|468735527|FG001|Overall Study|Adverse Event|2|||
130211298|NCT02776670|468735526|FG000|Overall Study|Protocol Violation|0|||
130211299|NCT02776670|468735527|FG001|Overall Study|Protocol Violation|2|||
130211300|NCT02776670|468735526|FG000|Overall Study|Withdrawal by Subject|0|||
130211301|NCT02776670|468735527|FG001|Overall Study|Withdrawal by Subject|1|||
130211302|NCT02776670|468735526|FG000|Overall Study|Other - Reason not given|0|||
130211303|NCT02776670|468735527|FG001|Overall Study|Other - Reason not given|1|||
130211304|NCT02697591|468735530|FG000|Overall Study|Lost to Follow-up|0|||
130211305|NCT02697591|468735531|FG001|Overall Study|Lost to Follow-up|0|||
130211306|NCT02697591|468735532|FG002|Overall Study|Lost to Follow-up|0|||
130211307|NCT02697591|468735533|FG003|Overall Study|Lost to Follow-up|0|||
130211308|NCT02697591|468735534|FG004|Overall Study|Lost to Follow-up|0|||
130211309|NCT02697591|468735535|FG005|Overall Study|Lost to Follow-up|1|||
130211310|NCT02697591|468735536|FG006|Overall Study|Lost to Follow-up|1|||
130211311|NCT02697591|468735537|FG007|Overall Study|Lost to Follow-up|0|||
130211312|NCT02697591|468735538|FG008|Overall Study|Lost to Follow-up|0|||
130211313|NCT02697591|468735539|FG009|Overall Study|Lost to Follow-up|1|||
130211314|NCT02697591|468735530|FG000|Overall Study|Withdrawal by Subject|1|||
130211315|NCT02697591|468735531|FG001|Overall Study|Withdrawal by Subject|1|||
130211316|NCT02697591|468735532|FG002|Overall Study|Withdrawal by Subject|2|||
130432653|NCT02312856|469547730|FG000|Overall Study|Death|1|||
130432654|NCT02312856|469547730|FG000|Overall Study|Lost to Follow-up|3|||
130432655|NCT01932294|469547731|FG000|Overall Study|Death|43|||
130211317|NCT02697591|468735533|FG003|Overall Study|Withdrawal by Subject|1|||
130432656|NCT01932294|469547731|FG000|Overall Study|Lost to Follow-up|8|||
130432657|NCT01932294|469547731|FG000|Overall Study|VAD Implantation|20|||
130211318|NCT02697591|468735534|FG004|Overall Study|Withdrawal by Subject|7|||
130211319|NCT02697591|468735535|FG005|Overall Study|Withdrawal by Subject|6|||
130211320|NCT02697591|468735536|FG006|Overall Study|Withdrawal by Subject|9|||
130211321|NCT02697591|468735537|FG007|Overall Study|Withdrawal by Subject|1|||
130211322|NCT02697591|468735538|FG008|Overall Study|Withdrawal by Subject|6|||
130211323|NCT02697591|468735539|FG009|Overall Study|Withdrawal by Subject|10|||
130211324|NCT02697591|468735530|FG000|Overall Study|Physician Decision|1|||
130211325|NCT02697591|468735531|FG001|Overall Study|Physician Decision|0|||
130211326|NCT02697591|468735532|FG002|Overall Study|Physician Decision|0|||
130211327|NCT02697591|468735533|FG003|Overall Study|Physician Decision|0|||
130211328|NCT02697591|468735534|FG004|Overall Study|Physician Decision|1|||
130211329|NCT02697591|468735535|FG005|Overall Study|Physician Decision|2|||
130211330|NCT02697591|468735536|FG006|Overall Study|Physician Decision|0|||
130211331|NCT02697591|468735537|FG007|Overall Study|Physician Decision|0|||
130211332|NCT02697591|468735538|FG008|Overall Study|Physician Decision|1|||
130211333|NCT02697591|468735539|FG009|Overall Study|Physician Decision|1|||
130211334|NCT02697591|468735530|FG000|Overall Study|Death|2|||
130211335|NCT02697591|468735531|FG001|Overall Study|Death|3|||
130211336|NCT02697591|468735532|FG002|Overall Study|Death|1|||
130211337|NCT02697591|468735533|FG003|Overall Study|Death|1|||
130211338|NCT02697591|468735534|FG004|Overall Study|Death|4|||
130211339|NCT02697591|468735535|FG005|Overall Study|Death|5|||
130211340|NCT02697591|468735536|FG006|Overall Study|Death|3|||
130211341|NCT02697591|468735537|FG007|Overall Study|Death|1|||
130211342|NCT02697591|468735538|FG008|Overall Study|Death|1|||
130211343|NCT02697591|468735539|FG009|Overall Study|Death|5|||
130211344|NCT02697591|468735530|FG000|Overall Study|Reason not Specified|0|||
130211345|NCT02697591|468735531|FG001|Overall Study|Reason not Specified|0|||
130211346|NCT02697591|468735532|FG002|Overall Study|Reason not Specified|0|||
130211347|NCT02697591|468735533|FG003|Overall Study|Reason not Specified|1|||
130211348|NCT02697591|468735534|FG004|Overall Study|Reason not Specified|1|||
130211349|NCT02697591|468735535|FG005|Overall Study|Reason not Specified|2|||
130211350|NCT02697591|468735536|FG006|Overall Study|Reason not Specified|3|||
130211351|NCT02697591|468735537|FG007|Overall Study|Reason not Specified|1|||
130211352|NCT02697591|468735538|FG008|Overall Study|Reason not Specified|1|||
130211353|NCT02697591|468735539|FG009|Overall Study|Reason not Specified|3|||
130211354|NCT04379700|468735544|FG000|Overall Study|Withdrawal by Subject|10|||
130211355|NCT04379700|468735544|FG000|Overall Study|Screen Fail|4|||
130211356|NCT04379700|468735544|FG000|Overall Study|Lost to Follow-up|3|||
130211357|NCT00592592|468735545|FG000|Overall Study|Patient found ineligible upon chart review|1|||
130211358|NCT00530790|468735546|FG000|Overall Study|Adverse Event|2|||
130211359|NCT00530790|468735546|FG000|Overall Study|Withdrawal by Subject|2|||
130211360|NCT00530790|468735546|FG000|Overall Study|Physician Decision|1|||
130211361|NCT05053035|468735547|FG000|Overall Study|Withdrawal by Subject|1|||
130211362|NCT05053035|468735548|FG001|Overall Study|Withdrawal by Subject|0|||
130211363|NCT00938587|468735551|FG000|Overall Study|Adverse Event|2|||
130211364|NCT00938587|468735552|FG001|Overall Study|Adverse Event|0|||
130211365|NCT00938587|468735553|FG002|Overall Study|Adverse Event|0|||
130211366|NCT00938587|468735554|FG003|Overall Study|Adverse Event|2|||
130211367|NCT00938587|468735551|FG000|Overall Study|Did not meet entrance criteria|0|||
130211368|NCT00938587|468735552|FG001|Overall Study|Did not meet entrance criteria|0|||
130211369|NCT00938587|468735553|FG002|Overall Study|Did not meet entrance criteria|1|||
130211370|NCT00938587|468735554|FG003|Overall Study|Did not meet entrance criteria|0|||
130211371|NCT00938587|468735551|FG000|Overall Study|Withdrawal by Subject|1|||
130211372|NCT00938587|468735552|FG001|Overall Study|Withdrawal by Subject|1|||
130211373|NCT00938587|468735553|FG002|Overall Study|Withdrawal by Subject|0|||
130211374|NCT00938587|468735554|FG003|Overall Study|Withdrawal by Subject|0|||
130211375|NCT02191046|468735558|FG000|Overall Study|low compliance|5|||
130211376|NCT02191046|468735559|FG001|Overall Study|low compliance|1|||
130211377|NCT00048997|468735562|FG000|Overall Study|Protocol Violation|7|||
130211378|NCT00048997|468735563|FG001|Overall Study|Protocol Violation|2|||
130211379|NCT00048997|468735562|FG000|Overall Study|Withdrawal by Subject|6|||
130211380|NCT00048997|468735563|FG001|Overall Study|Withdrawal by Subject|1|||
130211381|NCT02819440|468735564|FG000|Overall Study|Adverse Event|3|||
130211382|NCT02819440|468735565|FG001|Overall Study|Adverse Event|1|||
130211383|NCT02819440|468735564|FG000|Overall Study|Lost to Follow-up|1|||
130211384|NCT02819440|468735565|FG001|Overall Study|Lost to Follow-up|3|||
130211385|NCT02819440|468735564|FG000|Overall Study|Withdrawal by Subject|9|||
130211386|NCT02819440|468735565|FG001|Overall Study|Withdrawal by Subject|8|||
130211387|NCT00575510|468735568|FG000|Overall Study|Lost to Follow-up|4|||
130211388|NCT00575510|468735569|FG001|Overall Study|Lost to Follow-up|6|||
130211389|NCT00575510|468735570|FG002|Overall Study|Lost to Follow-up|9|||
130211390|NCT00575510|468735568|FG000|Overall Study|Withdrawal by Subject|1|||
130211391|NCT00575510|468735569|FG001|Overall Study|Withdrawal by Subject|0|||
130211392|NCT00575510|468735570|FG002|Overall Study|Withdrawal by Subject|0|||
130211393|NCT00575510|468735568|FG000|Overall Study|Clinic Called Patient|7|||
130211394|NCT00575510|468735569|FG001|Overall Study|Clinic Called Patient|7|||
130211395|NCT00575510|468735570|FG002|Overall Study|Clinic Called Patient|7|||
130211396|NCT00575510|468735568|FG000|Overall Study|Pregnancy|0|||
130211397|NCT00575510|468735569|FG001|Overall Study|Pregnancy|0|||
130432658|NCT01932294|469547731|FG000|Overall Study|Heart Transplantation|16|||
130211398|NCT00575510|468735570|FG002|Overall Study|Pregnancy|1|||
130211399|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
130211400|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
130211401|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Adverse Event|1|||
130211402|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Adverse Event|2|||
130211403|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Physician Decision|1|||
130211404|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Physician Decision|0|||
130211405|NCT02697734|468735575|FG000|Optional Extension Phase|Adverse Event|5|||
130211406|NCT02697734|468735576|FG001|Optional Extension Phase|Adverse Event|1|||
130211407|NCT02697734|468735575|FG000|Optional Extension Phase|Physician Decision|0|||
130211408|NCT02697734|468735576|FG001|Optional Extension Phase|Physician Decision|1|||
130211409|NCT02651688|468735577|FG000|Overall Study|Non-compliance|0|||
130211410|NCT02651688|468735578|FG001|Overall Study|Non-compliance|0|||
130211411|NCT02651688|468735579|FG002|Overall Study|Non-compliance|1|||
130211412|NCT02651688|468735577|FG000|Overall Study|Principal Investigator (PI) decision|0|||
130211413|NCT02651688|468735578|FG001|Overall Study|Principal Investigator (PI) decision|2|||
130211414|NCT02651688|468735579|FG002|Overall Study|Principal Investigator (PI) decision|0|||
130211415|NCT02651688|468735577|FG000|Overall Study|Lost to Follow-up|1|||
130211416|NCT02651688|468735578|FG001|Overall Study|Lost to Follow-up|3|||
130211417|NCT02651688|468735579|FG002|Overall Study|Lost to Follow-up|0|||
130211418|NCT02651688|468735577|FG000|Overall Study|Withdrawal by Subject|1|||
130211419|NCT02651688|468735578|FG001|Overall Study|Withdrawal by Subject|0|||
130211420|NCT02651688|468735579|FG002|Overall Study|Withdrawal by Subject|2|||
130211421|NCT00731731|468735580|FG000|Overall Study|Protocol Violation|0|||
130211422|NCT00731731|468735581|FG001|Overall Study|Protocol Violation|0|||
130211423|NCT00731731|468735582|FG002|Overall Study|Protocol Violation|1|||
130211424|NCT00731731|468735580|FG000|Overall Study|Cancel prior to treatment|0|||
130211425|NCT00731731|468735581|FG001|Overall Study|Cancel prior to treatment|0|||
130211426|NCT00731731|468735582|FG002|Overall Study|Cancel prior to treatment|2|||
130211427|NCT03970200|468735583|FG000|Overall Study|Death|2|||
130211428|NCT03970200|468735584|FG001|Overall Study|Death|2|||
130211429|NCT03970200|468735585|FG002|Overall Study|Death|1|||
130211430|NCT03970200|468735583|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
130211431|NCT03970200|468735584|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
130211432|NCT03970200|468735585|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
130211433|NCT01693185|468735586|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
130211434|NCT01693185|468735587|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
130211435|NCT01429441|468735588|FG000|Overall Study|Adverse Event|5|||
130211436|NCT01429441|468735589|FG001|Overall Study|Adverse Event|1|||
130211437|NCT01429441|468735588|FG000|Overall Study|Death|0|||
130211438|NCT01429441|468735589|FG001|Overall Study|Death|2|||
130211439|NCT01429441|468735588|FG000|Overall Study|Lost to Follow-up|5|||
130211440|NCT01429441|468735589|FG001|Overall Study|Lost to Follow-up|2|||
130211441|NCT01429441|468735588|FG000|Overall Study|Physician Decision|1|||
130211442|NCT01429441|468735589|FG001|Overall Study|Physician Decision|0|||
130211443|NCT01429441|468735588|FG000|Overall Study|Withdrawal by Subject|27|||
130211444|NCT01429441|468735589|FG001|Overall Study|Withdrawal by Subject|18|||
130211445|NCT02279745|468735590|FG000|Overall Study|Adverse Event|7|||
130211446|NCT02279745|468735590|FG000|Overall Study|Death|6|||
130211447|NCT02279745|468735590|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
130211448|NCT02279745|468735590|FG000|Overall Study|Withdrawal by Subject|2|||
130211449|NCT02279745|468735590|FG000|Overall Study|Pregnancy|1|||
130211450|NCT02279745|468735590|FG000|Overall Study|Study Non-compliance|1|||
130211451|NCT02279745|468735590|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
130211452|NCT00380718|468735591|FG000|Overall Study|Adverse Event|1|||
130211453|NCT00380718|468735591|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
130211454|NCT01606748|468735592|FG000|Overall Study|Adverse Event|1|||
130211455|NCT01606748|468735593|FG001|Overall Study|Adverse Event|0|||
130211456|NCT01606748|468735592|FG000|Overall Study|Progressive Disease|1|||
130211457|NCT01606748|468735593|FG001|Overall Study|Progressive Disease|0|||
130211458|NCT01606748|468735592|FG000|Overall Study|Withdrawal by Subject|1|||
130211459|NCT01606748|468735593|FG001|Overall Study|Withdrawal by Subject|0|||
130211460|NCT03742258|468735597|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
130211461|NCT03742258|468735598|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
130211462|NCT03742258|468735599|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
130211463|NCT03742258|468735597|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130211464|NCT03742258|468735598|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130211465|NCT03742258|468735599|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
130211466|NCT03742258|468735597|FG000|Survival Follow-Up|Still in Follow-up|0|||
130211467|NCT03742258|468735598|FG001|Survival Follow-Up|Still in Follow-up|0|||
130211468|NCT03742258|468735599|FG002|Survival Follow-Up|Still in Follow-up|2|||
130211469|NCT02083653|468735600|FG000|Overall Study|Randomized but not Treated|0|||
130211470|NCT02083653|468735601|FG001|Overall Study|Randomized but not Treated|2|||
130211471|NCT02083653|468735602|FG002|Overall Study|Randomized but not Treated|7|||
130211472|NCT02083653|468735600|FG000|Overall Study|Adverse Event|12|||
130211473|NCT02083653|468735601|FG001|Overall Study|Adverse Event|5|||
130211474|NCT02083653|468735602|FG002|Overall Study|Adverse Event|4|||
130320356|NCT00506350|469141898|FG006|Overall Study|Withdrawal by Subject|1|||
130320357|NCT00506350|469141899|FG007|Overall Study|Withdrawal by Subject|2|||
130320358|NCT00506350|469141900|FG008|Overall Study|Withdrawal by Subject|0|||
130320359|NCT00506350|469141892|FG000|Overall Study|Lost to Follow-up|1|||
130320360|NCT00506350|469141893|FG001|Overall Study|Lost to Follow-up|1|||
130320361|NCT00506350|469141894|FG002|Overall Study|Lost to Follow-up|1|||
130211475|NCT02083653|468735600|FG000|Overall Study|Lost to Follow-up|1|||
130211476|NCT02083653|468735601|FG001|Overall Study|Lost to Follow-up|0|||
130211477|NCT02083653|468735602|FG002|Overall Study|Lost to Follow-up|0|||
130211478|NCT02083653|468735600|FG000|Overall Study|Death|2|||
130211479|NCT02083653|468735601|FG001|Overall Study|Death|2|||
130211480|NCT02083653|468735602|FG002|Overall Study|Death|2|||
130211481|NCT02083653|468735600|FG000|Overall Study|Progressive Disease|65|||
130211482|NCT02083653|468735601|FG001|Overall Study|Progressive Disease|73|||
130211483|NCT02083653|468735602|FG002|Overall Study|Progressive Disease|63|||
130211484|NCT02083653|468735600|FG000|Overall Study|Withdrawal by Subject|2|||
130211485|NCT02083653|468735601|FG001|Overall Study|Withdrawal by Subject|1|||
130211486|NCT02083653|468735602|FG002|Overall Study|Withdrawal by Subject|2|||
130211487|NCT02083653|468735600|FG000|Overall Study|Other Events|0|||
130211488|NCT02083653|468735601|FG001|Overall Study|Other Events|2|||
130211489|NCT02083653|468735602|FG002|Overall Study|Other Events|2|||
130211490|NCT02083653|468735600|FG000|Overall Study|Reason Missing|0|||
130211491|NCT02083653|468735601|FG001|Overall Study|Reason Missing|0|||
130211492|NCT02083653|468735602|FG002|Overall Study|Reason Missing|4|||
130211493|NCT03084315|468735603|FG000|Overall Study|Lost to Follow-up|8|||
130211494|NCT03084315|468735604|FG001|Overall Study|Lost to Follow-up|7|||
130211495|NCT03084315|468735603|FG000|Overall Study|Withdrawal by Subject|2|||
130211496|NCT03084315|468735604|FG001|Overall Study|Withdrawal by Subject|2|||
130211497|NCT01952080|468735606|FG000|Overall Study|Withdrawal by Subject|0|||
130211498|NCT01952080|468735607|FG001|Overall Study|Withdrawal by Subject|0|||
130211499|NCT01952080|468735608|FG002|Overall Study|Withdrawal by Subject|0|||
130211500|NCT01952080|468735609|FG003|Overall Study|Withdrawal by Subject|1|||
130211501|NCT01952080|468735606|FG000|Overall Study|Protocol Non-compliance|0|||
130211502|NCT01952080|468735607|FG001|Overall Study|Protocol Non-compliance|1|||
130211503|NCT01952080|468735608|FG002|Overall Study|Protocol Non-compliance|0|||
130211504|NCT01952080|468735609|FG003|Overall Study|Protocol Non-compliance|0|||
130211505|NCT00564395|468735610|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
130211506|NCT00564395|468735611|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
130211507|NCT00564395|468735610|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
130211508|NCT00564395|468735611|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
130211509|NCT00594386|468735613|FG000|Overall Study|Major protocol violation|2|||
130211510|NCT00594386|468735613|FG000|Overall Study|Lack of Efficacy|12|||
130211511|NCT00594386|468735613|FG000|Overall Study|Adverse Event|68|||
130211512|NCT00594386|468735613|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
130211513|NCT00594386|468735613|FG000|Overall Study|Subject withdrew consent|35|||
130211514|NCT00594386|468735613|FG000|Overall Study|Study ended per sponsor|115|||
130211515|NCT00594386|468735613|FG000|Overall Study|Lost to Follow-up|6|||
130211516|NCT00594386|468735613|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
130211517|NCT00594386|468735613|FG000|Overall Study|Other: Subject moved to Seattle|1|||
130211518|NCT00594386|468735613|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
130211519|NCT00594386|468735613|FG000|Overall Study|Other: Study terminated per investigator|2|||
130211520|NCT00594386|468735613|FG000|Overall Study|Other: Sponsor closure of study|1|||
130211521|NCT00594386|468735613|FG000|Overall Study|Other: Site terminated participation|1|||
130211522|NCT00594386|468735613|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
130211523|NCT00594386|468735613|FG000|Overall Study|Other: Loss of drivers license|1|||
130211524|NCT00094536|468735614|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
130211525|NCT00094536|468735614|FG000|Treatment and Follow-up|Adverse Event|4|||
130211526|NCT00094536|468735614|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
130211527|NCT00094536|468735614|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
130211528|NCT00094536|468735614|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
130211529|NCT00094536|468735614|FG000|Treatment and Follow-up|Subject non-compliance|9|||
130211530|NCT00094536|468735614|FG000|Treatment and Follow-up|Unable to attend visits|1|||
130211531|NCT01687283|468737431|FG000|Overall Study|Adverse Event|11|||
130211532|NCT01687283|468737432|FG001|Overall Study|Adverse Event|4|||
130211533|NCT01687283|468737431|FG000|Overall Study|Lack of Efficacy|3|||
130211534|NCT01687283|468737432|FG001|Overall Study|Lack of Efficacy|1|||
130211535|NCT01687283|468737431|FG000|Overall Study|Protocol Violation|1|||
130211536|NCT01687283|468737432|FG001|Overall Study|Protocol Violation|3|||
130211537|NCT01687283|468737431|FG000|Overall Study|protocol defined stopping criteria|8|||
130211538|NCT01687283|468737432|FG001|Overall Study|protocol defined stopping criteria|10|||
130211539|NCT01687283|468737431|FG000|Overall Study|Lost to Follow-up|1|||
130211540|NCT01687283|468737432|FG001|Overall Study|Lost to Follow-up|1|||
130211541|NCT01687283|468737431|FG000|Overall Study|Investigator discretion|2|||
130211542|NCT01687283|468737432|FG001|Overall Study|Investigator discretion|0|||
130211543|NCT01687283|468737431|FG000|Overall Study|Withdrawal by Subject|9|||
130211544|NCT01687283|468737432|FG001|Overall Study|Withdrawal by Subject|8|||
130211545|NCT01744483|468737433|FG000|Overall Study|Death|9|||
130211546|NCT01744483|468737434|FG001|Overall Study|Death|4|||
130211547|NCT01744483|468737435|FG002|Overall Study|Death|11|||
130211548|NCT01744483|468737433|FG000|Overall Study|Lost to Follow-up|8|||
130211549|NCT01744483|468737434|FG001|Overall Study|Lost to Follow-up|9|||
130211550|NCT01744483|468737435|FG002|Overall Study|Lost to Follow-up|11|||
130211551|NCT01744483|468737433|FG000|Overall Study|Protocol Violation|1|||
130211552|NCT01744483|468737434|FG001|Overall Study|Protocol Violation|2|||
130211553|NCT01744483|468737435|FG002|Overall Study|Protocol Violation|1|||
130211554|NCT01744483|468737433|FG000|Overall Study|Withdrawal by Subject|4|||
130211555|NCT01744483|468737434|FG001|Overall Study|Withdrawal by Subject|6|||
130211556|NCT01744483|468737435|FG002|Overall Study|Withdrawal by Subject|2|||
130211557|NCT01744483|468737433|FG000|Overall Study|No ICU Admit|5|||
130211558|NCT01744483|468737434|FG001|Overall Study|No ICU Admit|1|||
130211559|NCT01744483|468737435|FG002|Overall Study|No ICU Admit|2|||
130211560|NCT01744483|468737433|FG000|Overall Study|Routed to OSH|2|||
130211561|NCT01744483|468737434|FG001|Overall Study|Routed to OSH|0|||
130211562|NCT01744483|468737435|FG002|Overall Study|Routed to OSH|1|||
130211563|NCT03041467|468737436|FG000|Overall Study|Death|46|||
130211564|NCT03041467|468737437|FG001|Overall Study|Death|39|||
130211565|NCT03041467|468737436|FG000|Overall Study|Withdrawal by Subject|36|||
130211566|NCT03041467|468737437|FG001|Overall Study|Withdrawal by Subject|37|||
130211567|NCT03041467|468737436|FG000|Overall Study|Lost to Follow-up|6|||
130211568|NCT03041467|468737437|FG001|Overall Study|Lost to Follow-up|8|||
130211569|NCT03041467|468737436|FG000|Overall Study|Declined consent for study extension|21|||
130211570|NCT03041467|468737437|FG001|Overall Study|Declined consent for study extension|33|||
130211571|NCT03041467|468737436|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
130211572|NCT03041467|468737437|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
130211573|NCT01190189|468737438|FG000|Overall Study|Lost to Follow-up|4|||
130211574|NCT01190189|468737438|FG000|Overall Study|Withdrawal by Subject|1|||
130211575|NCT01190189|468737438|FG000|Overall Study|Migrated/moved from study area|1|||
130211576|NCT02732015|468737439|FG000|Overall Study|Lost to Follow-up|0|||
130211577|NCT02732015|468737440|FG001|Overall Study|Lost to Follow-up|1|||
130211578|NCT01980628|468737441|FG000|Overall Study|Adverse Event|12|||
130211579|NCT01980628|468737441|FG000|Overall Study|Physician Decision|5|||
130211580|NCT01980628|468737441|FG000|Overall Study|Withdrawal by Subject|4|||
130211581|NCT01980628|468737441|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
130211582|NCT02469168|468737443|FG000|Overall Study|Trial closed|1|||
130211583|NCT02469168|468737444|FG001|Overall Study|Trial closed|0|||
130211584|NCT03959488|468737447|FG000|Season 1|Other|6|||
130211585|NCT03959488|468737448|FG001|Season 1|Other|7|||
130211586|NCT03959488|468737449|FG002|Season 1|Other|0|||
130211587|NCT03959488|468737450|FG003|Season 1|Other|0|||
130211588|NCT03959488|468737451|FG004|Season 1|Other|0|||
130211589|NCT03959488|468737447|FG000|Season 1|Withdrawal by parent/guardian|43|||
130211590|NCT03959488|468737448|FG001|Season 1|Withdrawal by parent/guardian|28|||
130211591|NCT03959488|468737449|FG002|Season 1|Withdrawal by parent/guardian|0|||
130211592|NCT03959488|468737450|FG003|Season 1|Withdrawal by parent/guardian|0|||
130211593|NCT03959488|468737451|FG004|Season 1|Withdrawal by parent/guardian|0|||
130211594|NCT03959488|468737447|FG000|Season 1|Due to COVID-19 pandemic|2|||
130211595|NCT03959488|468737448|FG001|Season 1|Due to COVID-19 pandemic|3|||
130211596|NCT03959488|468737449|FG002|Season 1|Due to COVID-19 pandemic|0|||
130211597|NCT03959488|468737450|FG003|Season 1|Due to COVID-19 pandemic|0|||
130211598|NCT03959488|468737451|FG004|Season 1|Due to COVID-19 pandemic|0|||
130211599|NCT03959488|468737447|FG000|Season 1|Lost to Follow-up|17|||
130211600|NCT03959488|468737448|FG001|Season 1|Lost to Follow-up|7|||
130211601|NCT03959488|468737449|FG002|Season 1|Lost to Follow-up|0|||
130211602|NCT03959488|468737450|FG003|Season 1|Lost to Follow-up|0|||
130211603|NCT03959488|468737451|FG004|Season 1|Lost to Follow-up|0|||
130211604|NCT03959488|468737447|FG000|Season 1|Death|5|||
130211605|NCT03959488|468737448|FG001|Season 1|Death|1|||
130211606|NCT03959488|468737449|FG002|Season 1|Death|0|||
130211607|NCT03959488|468737450|FG003|Season 1|Death|0|||
130211608|NCT03959488|468737451|FG004|Season 1|Death|0|||
130211609|NCT03959488|468737447|FG000|Season 2|Other|0|||
130211610|NCT03959488|468737448|FG001|Season 2|Other|0|||
130211611|NCT03959488|468737449|FG002|Season 2|Other|2|||
130211612|NCT03959488|468737450|FG003|Season 2|Other|0|||
130211613|NCT03959488|468737451|FG004|Season 2|Other|0|||
130211614|NCT03959488|468737447|FG000|Season 2|Withdrawal by parent/guardian|0|||
130211615|NCT03959488|468737448|FG001|Season 2|Withdrawal by parent/guardian|0|||
130211616|NCT03959488|468737449|FG002|Season 2|Withdrawal by parent/guardian|3|||
130211617|NCT03959488|468737450|FG003|Season 2|Withdrawal by parent/guardian|1|||
130211618|NCT03959488|468737451|FG004|Season 2|Withdrawal by parent/guardian|1|||
130211619|NCT03959488|468737447|FG000|Season 2|Lost to Follow-up|0|||
130211620|NCT03959488|468737448|FG001|Season 2|Lost to Follow-up|0|||
130211621|NCT03959488|468737449|FG002|Season 2|Lost to Follow-up|1|||
130211622|NCT03959488|468737450|FG003|Season 2|Lost to Follow-up|0|||
130211623|NCT03959488|468737451|FG004|Season 2|Lost to Follow-up|1|||
130211624|NCT01760447|468737452|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130211625|NCT01760447|468737453|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130211626|NCT01760447|468737454|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
130211627|NCT01760447|468737455|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
130211628|NCT01760447|468737452|FG000|Weeks 0-20|Withdrawal by Subject|2|||
130211629|NCT01760447|468737453|FG001|Weeks 0-20|Withdrawal by Subject|0|||
130211630|NCT01760447|468737454|FG002|Weeks 0-20|Withdrawal by Subject|1|||
130211631|NCT01760447|468737455|FG003|Weeks 0-20|Withdrawal by Subject|0|||
130211632|NCT01760447|468737452|FG000|Weeks 0-20|Lost to Follow-up|1|||
130211633|NCT01760447|468737453|FG001|Weeks 0-20|Lost to Follow-up|0|||
130211634|NCT01760447|468737454|FG002|Weeks 0-20|Lost to Follow-up|1|||
130211635|NCT01760447|468737455|FG003|Weeks 0-20|Lost to Follow-up|1|||
130211636|NCT01760447|468737452|FG000|Weeks 0-20|Randomized but not treated|0|||
130211637|NCT01760447|468737453|FG001|Weeks 0-20|Randomized but not treated|0|||
130211638|NCT01760447|468737454|FG002|Weeks 0-20|Randomized but not treated|2|||
130211639|NCT01760447|468737455|FG003|Weeks 0-20|Randomized but not treated|0|||
130211640|NCT01760447|468737452|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211641|NCT01760447|468737453|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211642|NCT01760447|468737454|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211643|NCT01760447|468737455|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
130211644|NCT01760447|468737452|FG000|Weeks 20-54|Withdrawal by Subject|2|||
130211645|NCT01760447|468737453|FG001|Weeks 20-54|Withdrawal by Subject|1|||
130211646|NCT01760447|468737454|FG002|Weeks 20-54|Withdrawal by Subject|1|||
130211647|NCT01760447|468737455|FG003|Weeks 20-54|Withdrawal by Subject|2|||
130211648|NCT01760447|468737452|FG000|Weeks 20-54|Lost to Follow-up|0|||
130211649|NCT01760447|468737453|FG001|Weeks 20-54|Lost to Follow-up|0|||
130211650|NCT01760447|468737454|FG002|Weeks 20-54|Lost to Follow-up|1|||
130211651|NCT01760447|468737455|FG003|Weeks 20-54|Lost to Follow-up|2|||
130211652|NCT00255840|468737458|FG000|Overall Study|Lost to Follow-up|10|||
130211653|NCT00255840|468737459|FG001|Overall Study|Lost to Follow-up|14|||
130211654|NCT00255840|468737458|FG000|Overall Study|Discontinued intervention|53|||
130211655|NCT00255840|468737459|FG001|Overall Study|Discontinued intervention|56|||
130211656|NCT04278924|468737461|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130211657|NCT04278924|468737462|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130211658|NCT04278924|468737463|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211659|NCT04278924|468737464|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
130211660|NCT04278924|468737465|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211661|NCT04278924|468737466|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211662|NCT04278924|468737467|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211663|NCT04278924|468737461|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211664|NCT04278924|468737462|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
130211665|NCT04278924|468737463|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211666|NCT04278924|468737464|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211667|NCT04278924|468737465|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211668|NCT04278924|468737466|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211669|NCT04278924|468737467|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211670|NCT06226649|468737468|FG000|Overall Study|Withdrawal by Subject|4|||
130211671|NCT06226649|468737469|FG001|Overall Study|Withdrawal by Subject|1|||
130211672|NCT04847232|468737470|FG000|Overall Study|Death|123|||
130211673|NCT04847232|468737471|FG001|Overall Study|Death|115|||
130211674|NCT04847232|468737470|FG000|Overall Study|Lost to Follow-up|3|||
130211675|NCT04847232|468737471|FG001|Overall Study|Lost to Follow-up|10|||
130211676|NCT04847232|468737470|FG000|Overall Study|Withdrawal by Subject|73|||
130211677|NCT04847232|468737471|FG001|Overall Study|Withdrawal by Subject|101|||
130211678|NCT04847232|468737470|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
130211679|NCT04847232|468737471|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
130211680|NCT00631163|468737472|FG000|Number of Participants in Year 1|Adverse Event|12|||
130211681|NCT00631163|468737472|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
130211682|NCT00631163|468737472|FG000|Number of Participants in Year 1|Death|6|||
130211683|NCT00631163|468737472|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
130211684|NCT00631163|468737472|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
130211685|NCT00631163|468737472|FG000|Number of Participants in Year 1|Administrative problems|6|||
130211686|NCT00631163|468737472|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
130211687|NCT00631163|468737472|FG000|Number of Participants in Year 2|Adverse Event|1|||
130211688|NCT00631163|468737472|FG000|Number of Participants in Year 2|Protocol Violation|1|||
130211689|NCT00631163|468737472|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
130211690|NCT04348500|468737475|FG000|Overall Study|Death|2|||
130211691|NCT04348500|468737476|FG001|Overall Study|Death|2|||
130211692|NCT04348500|468737475|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
130211693|NCT04348500|468737476|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
130211694|NCT03699540|468737477|FG000|Overall Study|Lost to Follow-up|1|||
130211695|NCT00624832|468737480|FG000|Overall Study|Adverse Event|0|||
130211696|NCT00624832|468737481|FG001|Overall Study|Adverse Event|1|||
130211697|NCT00624832|468737482|FG002|Overall Study|Adverse Event|0|||
130211698|NCT00624832|468737483|FG003|Overall Study|Adverse Event|1|||
130211699|NCT00624832|468737480|FG000|Overall Study|Abnormal Laboratory Value|2|||
130211700|NCT00624832|468737481|FG001|Overall Study|Abnormal Laboratory Value|0|||
130211701|NCT00624832|468737482|FG002|Overall Study|Abnormal Laboratory Value|0|||
130211702|NCT00624832|468737483|FG003|Overall Study|Abnormal Laboratory Value|0|||
130211703|NCT02700698|468737484|FG000|Overall Study|Withdrawal by Subject|1|||
130211704|NCT02700698|468737485|FG001|Overall Study|Withdrawal by Subject|0|||
130211705|NCT03517449|468737492|FG000|Overall Study|Death|184|||
130211706|NCT03517449|468737493|FG001|Overall Study|Death|236|||
130211707|NCT03517449|468737492|FG000|Overall Study|Lost to Follow-up|0|||
130211708|NCT03517449|468737493|FG001|Overall Study|Lost to Follow-up|2|||
130211709|NCT03517449|468737492|FG000|Overall Study|Withdrawal by Subject|7|||
130211710|NCT03517449|468737493|FG001|Overall Study|Withdrawal by Subject|26|||
130211711|NCT03517449|468737492|FG000|Overall Study|Participants Ongoing|220|||
130211712|NCT03517449|468737493|FG001|Overall Study|Participants Ongoing|152|||
130211713|NCT02005627|468737498|FG000|Overall Study|Lost to Follow-up|1|||
130211714|NCT02005627|468737499|FG001|Overall Study|Lost to Follow-up|2|||
130211715|NCT02005627|468737498|FG000|Overall Study|Withdrawal by Subject|1|||
130211716|NCT02005627|468737499|FG001|Overall Study|Withdrawal by Subject|2|||
130211717|NCT00548249|468737500|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
130211718|NCT00548249|468737501|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211719|NCT00548249|468737502|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211720|NCT00548249|468737503|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
130211721|NCT00548249|468737504|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211722|NCT00548249|468737500|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
130211723|NCT00548249|468737501|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130211724|NCT00548249|468737502|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
130211725|NCT00548249|468737503|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130211726|NCT00548249|468737504|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
130211727|NCT00548249|468737500|FG000|Overall Study|Protocol Violation|1|||
130211728|NCT00548249|468737501|FG001|Overall Study|Protocol Violation|1|||
130211729|NCT00548249|468737502|FG002|Overall Study|Protocol Violation|4|||
130211730|NCT00548249|468737503|FG003|Overall Study|Protocol Violation|0|||
130211731|NCT00548249|468737504|FG004|Overall Study|Protocol Violation|3|||
130211732|NCT00548249|468737500|FG000|Overall Study|Miscellaneous|2|||
130211733|NCT00548249|468737501|FG001|Overall Study|Miscellaneous|3|||
130211734|NCT00548249|468737502|FG002|Overall Study|Miscellaneous|2|||
130211735|NCT00548249|468737503|FG003|Overall Study|Miscellaneous|0|||
130211736|NCT00548249|468737504|FG004|Overall Study|Miscellaneous|2|||
130211737|NCT00548249|468737500|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130211738|NCT00548249|468737501|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130211739|NCT00548249|468737502|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
130211740|NCT00548249|468737503|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
130211741|NCT00548249|468737504|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
130211742|NCT00548249|468737500|FG000|Overall Study|Adverse Event|2|||
130211743|NCT00548249|468737501|FG001|Overall Study|Adverse Event|2|||
130211744|NCT00548249|468737502|FG002|Overall Study|Adverse Event|0|||
130211745|NCT00548249|468737503|FG003|Overall Study|Adverse Event|1|||
130211746|NCT00548249|468737504|FG004|Overall Study|Adverse Event|1|||
130211747|NCT00548249|468737500|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130211748|NCT00548249|468737501|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130211749|NCT00548249|468737502|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
130211750|NCT00548249|468737503|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
130211751|NCT00548249|468737504|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
130211752|NCT00548249|468737500|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130211753|NCT00548249|468737501|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130211754|NCT00548249|468737502|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
130211755|NCT00548249|468737503|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130211756|NCT00548249|468737504|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130211757|NCT00548249|468737500|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211758|NCT00548249|468737501|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211759|NCT00548249|468737502|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211760|NCT00548249|468737503|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211761|NCT00548249|468737504|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
130211762|NCT00548249|468737500|FG000|Overall Study|Prolonged hospitalization|0|||
130211763|NCT00548249|468737501|FG001|Overall Study|Prolonged hospitalization|0|||
130211764|NCT00548249|468737502|FG002|Overall Study|Prolonged hospitalization|2|||
130211765|NCT00548249|468737503|FG003|Overall Study|Prolonged hospitalization|1|||
130432659|NCT01932294|469547731|FG000|Overall Study|Transferred to other hospitals|12|||
130432660|NCT03075904|469547733|FG000|Overall Study|Physician Decision|3|||
130432661|NCT03075904|469547733|FG000|Overall Study|Need for Medication not Permitted|1|||
130211766|NCT00548249|468737504|FG004|Overall Study|Prolonged hospitalization|0|||
130211767|NCT00548249|468737500|FG000|Overall Study|Withdrawal by Subject|2|||
130211768|NCT00548249|468737501|FG001|Overall Study|Withdrawal by Subject|0|||
130211769|NCT00548249|468737502|FG002|Overall Study|Withdrawal by Subject|0|||
130211770|NCT00548249|468737503|FG003|Overall Study|Withdrawal by Subject|0|||
130211771|NCT00548249|468737504|FG004|Overall Study|Withdrawal by Subject|0|||
130211772|NCT00548249|468737500|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211773|NCT00548249|468737501|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130432662|NCT01691521|469547734|FG000|Overall Study|Adverse Event|4|||
130432663|NCT01691521|469547735|FG001|Overall Study|Adverse Event|0|||
130211774|NCT00548249|468737502|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211775|NCT00548249|468737503|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211776|NCT00548249|468737504|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130211777|NCT00548249|468737500|FG000|Overall Study|Sponsor's request|0|||
130211778|NCT00548249|468737501|FG001|Overall Study|Sponsor's request|0|||
130211779|NCT00548249|468737502|FG002|Overall Study|Sponsor's request|0|||
130211780|NCT00548249|468737503|FG003|Overall Study|Sponsor's request|1|||
130211781|NCT00548249|468737504|FG004|Overall Study|Sponsor's request|0|||
130211782|NCT03003000|468737505|FG000|Overall Study|Adverse Event|1|||
130211783|NCT03003000|468737506|FG001|Overall Study|Adverse Event|2|||
130211784|NCT03003000|468737507|FG002|Overall Study|Adverse Event|3|||
130211785|NCT03003000|468737505|FG000|Overall Study|Lack of Efficacy|1|||
130211786|NCT03003000|468737506|FG001|Overall Study|Lack of Efficacy|0|||
130211787|NCT03003000|468737507|FG002|Overall Study|Lack of Efficacy|0|||
130211788|NCT03003000|468737505|FG000|Overall Study|Non-compliant with protocol|0|||
130211789|NCT03003000|468737506|FG001|Overall Study|Non-compliant with protocol|1|||
130211790|NCT03003000|468737507|FG002|Overall Study|Non-compliant with protocol|1|||
130211791|NCT03003000|468737505|FG000|Overall Study|Refused to continue medication|2|||
130211792|NCT03003000|468737506|FG001|Overall Study|Refused to continue medication|0|||
130211793|NCT03003000|468737507|FG002|Overall Study|Refused to continue medication|0|||
130211794|NCT03003000|468737505|FG000|Overall Study|Other than listed|1|||
130211795|NCT03003000|468737506|FG001|Overall Study|Other than listed|1|||
130211796|NCT03003000|468737507|FG002|Overall Study|Other than listed|1|||
130211797|NCT04933617|468737509|FG000|Dose Escalation|Early closure of study|0|||
130211798|NCT04933617|468737510|FG001|Dose Escalation|Early closure of study|3|||
130211799|NCT04933617|468737511|FG002|Dose Escalation|Early closure of study|0|||
130211800|NCT04933617|468737512|FG003|Dose Escalation|Early closure of study|0|||
130211801|NCT04933617|468737513|FG004|Dose Escalation|Early closure of study|0|||
130211802|NCT03760458|468737514|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130211803|NCT03760458|468737515|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130211804|NCT03760458|468737516|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211805|NCT03760458|468737517|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211806|NCT03760458|468737518|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211807|NCT02007278|468737532|FG000|Overall Study|Failure to comply with an eligibility|0|||
130211808|NCT02007278|468737533|FG001|Overall Study|Failure to comply with an eligibility|1|||
130211809|NCT02007278|468737532|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
130211810|NCT02007278|468737533|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
130211811|NCT02007278|468737532|FG000|Overall Study|Incorrect medication administration|1|||
130211812|NCT02007278|468737533|FG001|Overall Study|Incorrect medication administration|0|||
130211813|NCT02007278|468737532|FG000|Overall Study|Mis-randomization|1|||
130211814|NCT02007278|468737533|FG001|Overall Study|Mis-randomization|1|||
130211815|NCT00002525|468737534|FG000|Overall Study|Adverse Event|36|||
130211816|NCT00002525|468737535|FG001|Overall Study|Adverse Event|0|||
130211817|NCT00002525|468737534|FG000|Overall Study|Death|5|||
130211818|NCT00002525|468737535|FG001|Overall Study|Death|0|||
130211819|NCT00002525|468737534|FG000|Overall Study|Withdrawal by Subject|11|||
130211820|NCT00002525|468737535|FG001|Overall Study|Withdrawal by Subject|0|||
130211821|NCT00002525|468737534|FG000|Overall Study|Start non-protocol therapy|1|||
130211822|NCT00002525|468737535|FG001|Overall Study|Start non-protocol therapy|0|||
130211823|NCT00002525|468737534|FG000|Overall Study|Other complicating disease|1|||
130211824|NCT00002525|468737535|FG001|Overall Study|Other complicating disease|0|||
130211825|NCT00002525|468737534|FG000|Overall Study|Duke's A, B1, D disease|92|||
130211826|NCT00002525|468737535|FG001|Overall Study|Duke's A, B1, D disease|0|||
130211827|NCT00002525|468737534|FG000|Overall Study|Error|6|||
130211828|NCT00002525|468737535|FG001|Overall Study|Error|0|||
130211829|NCT00002525|468737534|FG000|Overall Study|Other|26|||
130211830|NCT00002525|468737535|FG001|Overall Study|Other|0|||
130211831|NCT00002525|468737534|FG000|Overall Study|Never start protocol therapy|8|||
130211832|NCT00002525|468737535|FG001|Overall Study|Never start protocol therapy|0|||
130211833|NCT02886884|468737536|FG000|Follow-up|Withdrawal by Subject|0|||
130211834|NCT02886884|468737537|FG001|Follow-up|Withdrawal by Subject|0|||
130211835|NCT02886884|468737538|FG002|Follow-up|Withdrawal by Subject|0|||
130211836|NCT02886884|468737539|FG003|Follow-up|Withdrawal by Subject|1|||
130211837|NCT03230838|468737540|FG000|Overall Study|Withdrawal by Subject|3|||
130211838|NCT03230838|468737541|FG001|Overall Study|Withdrawal by Subject|0|||
130432664|NCT01691521|469547736|FG002|Overall Study|Adverse Event|1|||
130432665|NCT01691521|469547734|FG000|Overall Study|Lack of Efficacy|1|||
130211839|NCT03230838|468737540|FG000|Overall Study|Temperature excursion|1|||
130211840|NCT03230838|468737541|FG001|Overall Study|Temperature excursion|0|||
130211841|NCT00435188|468737547|FG000|Overall Study|Death|1|||
130211842|NCT00435188|468737548|FG001|Overall Study|Death|6|||
130211843|NCT00435188|468737547|FG000|Overall Study|Withdrawal by Subject|16|||
130211844|NCT00435188|468737548|FG001|Overall Study|Withdrawal by Subject|11|||
130211845|NCT00435188|468737547|FG000|Overall Study|Lost to Follow-up|5|||
130211846|NCT00435188|468737548|FG001|Overall Study|Lost to Follow-up|6|||
130432666|NCT01691521|469547735|FG001|Overall Study|Lack of Efficacy|1|||
130432667|NCT01691521|469547736|FG002|Overall Study|Lack of Efficacy|2|||
130432668|NCT01691521|469547734|FG000|Overall Study|Protocol Violation|0|||
130432669|NCT01691521|469547735|FG001|Overall Study|Protocol Violation|3|||
130432670|NCT01691521|469547736|FG002|Overall Study|Protocol Violation|0|||
130432671|NCT01691521|469547734|FG000|Overall Study|Lost to Follow-up|0|||
130432672|NCT01691521|469547735|FG001|Overall Study|Lost to Follow-up|2|||
130432673|NCT01691521|469547736|FG002|Overall Study|Lost to Follow-up|2|||
130432674|NCT01691521|469547734|FG000|Overall Study|Physician Decision|2|||
130432675|NCT01691521|469547735|FG001|Overall Study|Physician Decision|1|||
130432676|NCT01691521|469547736|FG002|Overall Study|Physician Decision|0|||
130432677|NCT01691521|469547734|FG000|Overall Study|Withdrawal by Subject|5|||
130432678|NCT01691521|469547735|FG001|Overall Study|Withdrawal by Subject|9|||
130432679|NCT01691521|469547736|FG002|Overall Study|Withdrawal by Subject|4|||
130432680|NCT00770432|469547740|FG000|Overall Study|Other|4|||
130432681|NCT00770432|469547741|FG001|Overall Study|Other|6|||
130432682|NCT00770432|469547740|FG000|Overall Study|Non-compliance|0|||
130432683|NCT00770432|469547741|FG001|Overall Study|Non-compliance|1|||
130432684|NCT00312702|469547742|FG000|Immunization Phase|Lost to Follow-up|0|||
130432685|NCT00312702|469547743|FG001|Immunization Phase|Lost to Follow-up|1|||
130432686|NCT00312702|469547744|FG002|Immunization Phase|Lost to Follow-up|0|||
130432687|NCT00988221|469547747|FG000|Part I|Adverse Event|0|||
130432688|NCT00988221|469547748|FG001|Part I|Adverse Event|1|||
130432689|NCT00988221|469547749|FG002|Part I|Adverse Event|2|||
130432690|NCT00988221|469547750|FG003|Part I|Adverse Event|0|||
130432691|NCT00988221|469547747|FG000|Part I|Insufficient Therapeutic Response|4|||
130432692|NCT00988221|469547748|FG001|Part I|Insufficient Therapeutic Response|6|||
130432693|NCT00988221|469547749|FG002|Part I|Insufficient Therapeutic Response|5|||
130432694|NCT00988221|469547750|FG003|Part I|Insufficient Therapeutic Response|0|||
130432695|NCT00988221|469547747|FG000|Part I|Refused Treatment|0|||
130432696|NCT00988221|469547748|FG001|Part I|Refused Treatment|2|||
130432697|NCT00988221|469547749|FG002|Part I|Refused Treatment|1|||
130432698|NCT00988221|469547750|FG003|Part I|Refused Treatment|0|||
130432699|NCT00988221|469547747|FG000|Part I|Lost to Follow-up|0|||
130432700|NCT00988221|469547748|FG001|Part I|Lost to Follow-up|1|||
130432701|NCT00988221|469547749|FG002|Part I|Lost to Follow-up|0|||
130432702|NCT00988221|469547750|FG003|Part I|Lost to Follow-up|0|||
130432703|NCT00988221|469547747|FG000|Part II|Adverse Event|1|||
130432704|NCT00988221|469547748|FG001|Part II|Adverse Event|0|||
130432705|NCT00988221|469547749|FG002|Part II|Adverse Event|0|||
130432706|NCT00988221|469547750|FG003|Part II|Adverse Event|1|||
130432707|NCT00988221|469547747|FG000|Part II|Withdrawal by Subject|0|||
130432708|NCT00988221|469547748|FG001|Part II|Withdrawal by Subject|0|||
130432709|NCT00988221|469547749|FG002|Part II|Withdrawal by Subject|2|||
130432710|NCT00988221|469547750|FG003|Part II|Withdrawal by Subject|2|||
130432711|NCT00988221|469547747|FG000|Part II|Reason not Specified|0|||
130432712|NCT00988221|469547748|FG001|Part II|Reason not Specified|0|||
130432713|NCT00988221|469547749|FG002|Part II|Reason not Specified|1|||
130432714|NCT00988221|469547750|FG003|Part II|Reason not Specified|0|||
130432715|NCT00988221|469547747|FG000|Part III|Adverse Event|1|||
130432716|NCT00988221|469547748|FG001|Part III|Adverse Event|0|||
130432717|NCT00988221|469547749|FG002|Part III|Adverse Event|1|||
130432718|NCT00988221|469547750|FG003|Part III|Adverse Event|0|||
130432719|NCT00988221|469547747|FG000|Part III|Insufficient Therapeutic Response|0|||
130432720|NCT00988221|469547748|FG001|Part III|Insufficient Therapeutic Response|1|||
130432721|NCT00988221|469547749|FG002|Part III|Insufficient Therapeutic Response|1|||
130432722|NCT00988221|469547750|FG003|Part III|Insufficient Therapeutic Response|0|||
130432723|NCT00988221|469547747|FG000|Part III|Refused Treatment|0|||
130432724|NCT00988221|469547748|FG001|Part III|Refused Treatment|0|||
130432725|NCT00988221|469547749|FG002|Part III|Refused Treatment|1|||
130432726|NCT00988221|469547750|FG003|Part III|Refused Treatment|0|||
130432727|NCT02756832|469547753|FG000|Overall Study|Lost for Observation after Baseline|6|||
130432728|NCT02756832|469547753|FG000|Overall Study|Lost for Observation|13|||
130432729|NCT02756832|469547753|FG000|Overall Study|Patient's Unwillingness|12|||
130432730|NCT02756832|469547753|FG000|Overall Study|Insufficient Efficacy|2|||
130432731|NCT02756832|469547753|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
130432732|NCT02756832|469547753|FG000|Overall Study|Reason not Specified|9|||
130432733|NCT02756832|469547753|FG000|Overall Study|Protocol Deviation|10|||
130432734|NCT01364597|469547754|FG000|Overall Study|Adverse Event|4|||
130432735|NCT01364597|469547755|FG001|Overall Study|Adverse Event|5|||
130432736|NCT01364597|469547756|FG002|Overall Study|Adverse Event|16|||
130432737|NCT01364597|469547757|FG003|Overall Study|Adverse Event|7|||
130432738|NCT01364597|469547754|FG000|Overall Study|Lack of Efficacy|4|||
130432739|NCT01364597|469547755|FG001|Overall Study|Lack of Efficacy|4|||
130432740|NCT01364597|469547756|FG002|Overall Study|Lack of Efficacy|23|||
130432741|NCT01364597|469547757|FG003|Overall Study|Lack of Efficacy|8|||
130432742|NCT01364597|469547754|FG000|Overall Study|Protocol Violation|0|||
130432743|NCT01364597|469547755|FG001|Overall Study|Protocol Violation|0|||
130432744|NCT01364597|469547756|FG002|Overall Study|Protocol Violation|2|||
130432745|NCT01364597|469547757|FG003|Overall Study|Protocol Violation|0|||
130432746|NCT01364597|469547754|FG000|Overall Study|Lost to Follow-up|0|||
130211847|NCT01915771|468737549|FG000|Day 1|Withdrawal by Subject|1|||
130211848|NCT01915771|468737549|FG000|Day 15|Withdrawal by Subject|1|||
130211849|NCT03420222|468737552|FG000|Overall Study|Withdrawal by Subject|5|||
130211850|NCT03420222|468737553|FG001|Overall Study|Withdrawal by Subject|0|||
130211851|NCT03420222|468737552|FG000|Overall Study|Physician Decision|0|||
130211852|NCT03420222|468737553|FG001|Overall Study|Physician Decision|1|||
130211853|NCT02334384|468737554|FG000|Overall Study|Lost to Follow-up|1|||
130211854|NCT02334384|468737555|FG001|Overall Study|Lost to Follow-up|1|||
130211855|NCT00055497|468737556|FG000|Overall Study|Adverse Event|1|||
130211856|NCT00055497|468737557|FG001|Overall Study|Adverse Event|1|||
130211857|NCT00055497|468737558|FG002|Overall Study|Adverse Event|1|||
130211858|NCT00055497|468737559|FG003|Overall Study|Adverse Event|28|||
130211859|NCT00055497|468737556|FG000|Overall Study|Withdrawal by Subject|3|||
130211860|NCT00055497|468737557|FG001|Overall Study|Withdrawal by Subject|1|||
130211861|NCT00055497|468737558|FG002|Overall Study|Withdrawal by Subject|1|||
130211862|NCT00055497|468737559|FG003|Overall Study|Withdrawal by Subject|15|||
130211863|NCT00055497|468737556|FG000|Overall Study|Lost to Follow-up|0|||
130211864|NCT00055497|468737557|FG001|Overall Study|Lost to Follow-up|1|||
130211865|NCT00055497|468737558|FG002|Overall Study|Lost to Follow-up|0|||
130211866|NCT00055497|468737559|FG003|Overall Study|Lost to Follow-up|5|||
130211867|NCT00055497|468737556|FG000|Overall Study|Protocol Violation|0|||
130211868|NCT00055497|468737557|FG001|Overall Study|Protocol Violation|0|||
130211869|NCT00055497|468737558|FG002|Overall Study|Protocol Violation|0|||
130211870|NCT00055497|468737559|FG003|Overall Study|Protocol Violation|3|||
130211871|NCT00055497|468737556|FG000|Overall Study|Lack of Efficacy|1|||
130211872|NCT00055497|468737557|FG001|Overall Study|Lack of Efficacy|0|||
130211873|NCT00055497|468737558|FG002|Overall Study|Lack of Efficacy|0|||
130211874|NCT00055497|468737559|FG003|Overall Study|Lack of Efficacy|27|||
130211875|NCT00055497|468737556|FG000|Overall Study|Administrative Reasons|0|||
130211876|NCT00055497|468737557|FG001|Overall Study|Administrative Reasons|0|||
130211877|NCT00055497|468737558|FG002|Overall Study|Administrative Reasons|0|||
130211878|NCT00055497|468737559|FG003|Overall Study|Administrative Reasons|1|||
130211879|NCT00055497|468737556|FG000|Overall Study|Other|0|||
130211880|NCT00055497|468737557|FG001|Overall Study|Other|0|||
130211881|NCT00055497|468737558|FG002|Overall Study|Other|0|||
130211882|NCT00055497|468737559|FG003|Overall Study|Other|11|||
130211883|NCT00048165|468737560|FG000|Completed 6 Months Study|Administration/Other|8|||
130211884|NCT00048165|468737561|FG001|Completed 6 Months Study|Administration/Other|8|||
130211885|NCT00048165|468737560|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
130211886|NCT00048165|468737561|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
130211887|NCT00048165|468737560|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
130211888|NCT00048165|468737561|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
130211889|NCT00048165|468737560|FG000|Completed 6 Months Study|Death|12|||
130211890|NCT00048165|468737561|FG001|Completed 6 Months Study|Death|6|||
130211891|NCT00048165|468737560|FG000|Completed 6 Months Study|Insufficient therapy|1|||
130211892|NCT00048165|468737561|FG001|Completed 6 Months Study|Insufficient therapy|4|||
130211893|NCT00048165|468737560|FG000|Completed 6 Months Study|Other violation|4|||
130211894|NCT00048165|468737561|FG001|Completed 6 Months Study|Other violation|6|||
130211895|NCT00048165|468737560|FG000|Completed 6 Months Study|Refused treatment|5|||
130211896|NCT00048165|468737561|FG001|Completed 6 Months Study|Refused treatment|5|||
130211897|NCT00048165|468737560|FG000|Completed 6 Months Study|Violation criteria|0|||
130211898|NCT00048165|468737561|FG001|Completed 6 Months Study|Violation criteria|2|||
130211899|NCT00048165|468737560|FG000|Completed 6 Months Study|Did not receive study drug|6|||
130211900|NCT00048165|468737561|FG001|Completed 6 Months Study|Did not receive study drug|6|||
130211901|NCT00048165|468737560|FG000|Completed 12 Months Study|Administration/Other|0|||
130211902|NCT00048165|468737561|FG001|Completed 12 Months Study|Administration/Other|2|||
130211903|NCT00048165|468737560|FG000|Completed 12 Months Study|Death|2|||
130211904|NCT00048165|468737561|FG001|Completed 12 Months Study|Death|1|||
130211905|NCT00048165|468737560|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
130211906|NCT00048165|468737561|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
130211907|NCT02112877|468737562|FG000|Overall Study|Withdrawal by Subject|1|||
130211908|NCT02112877|468737563|FG001|Overall Study|Withdrawal by Subject|7|||
130211909|NCT02112877|468737562|FG000|Overall Study|Visit Missed|1|||
130211910|NCT02112877|468737563|FG001|Overall Study|Visit Missed|6|||
130211911|NCT00621517|468737574|FG000|Overall Study|Lost to Follow-up|3|||
130211912|NCT00621517|468737575|FG001|Overall Study|Lost to Follow-up|3|||
130211913|NCT00621517|468737574|FG000|Overall Study|Withdrawal by Subject|3|||
130211914|NCT00621517|468737575|FG001|Overall Study|Withdrawal by Subject|4|||
130543727|NCT02433340|469956821|FG001|Overall Study|Other|1|||
130543728|NCT02433340|469956822|FG002|Overall Study|Other|0|||
130543729|NCT02433340|469956823|FG003|Overall Study|Other|0|||
130211915|NCT00621517|468737574|FG000|Overall Study|Adverse Event|1|||
130211916|NCT00621517|468737575|FG001|Overall Study|Adverse Event|0|||
130211917|NCT00073008|468737576|FG000|Overall Study|Missing|6|||
130211918|NCT00073008|468737577|FG001|Overall Study|Missing|6|||
130211919|NCT00073008|468737576|FG000|Overall Study|Withdrawal by Subject|2|||
130211920|NCT00073008|468737577|FG001|Overall Study|Withdrawal by Subject|2|||
130211921|NCT00073008|468737576|FG000|Overall Study|Lost to Follow-up|1|||
130211922|NCT00073008|468737577|FG001|Overall Study|Lost to Follow-up|3|||
130211923|NCT00073008|468737576|FG000|Overall Study|Death|46|||
130211924|NCT00073008|468737577|FG001|Overall Study|Death|47|||
130211925|NCT00073008|468737576|FG000|Overall Study|"Other selected on Case Report Form"|7|||
130211926|NCT00073008|468737577|FG001|Overall Study|"Other selected on Case Report Form"|5|||
130211927|NCT02669667|468737578|FG000|Overall Study|Lost to Follow-up|0|||
130211928|NCT02669667|468737579|FG001|Overall Study|Lost to Follow-up|0|||
130211929|NCT02669667|468737580|FG002|Overall Study|Lost to Follow-up|0|||
130211930|NCT02669667|468737581|FG003|Overall Study|Lost to Follow-up|0|||
130211931|NCT02669667|468737582|FG004|Overall Study|Lost to Follow-up|0|||
130211932|NCT02669667|468737583|FG005|Overall Study|Lost to Follow-up|1|||
130211933|NCT02669667|468737584|FG006|Overall Study|Lost to Follow-up|0|||
130211934|NCT02839876|468737585|FG000|Overall Study|Protocol Violation|10|||
130211935|NCT02839876|468737586|FG001|Overall Study|Protocol Violation|11|||
130211936|NCT01156051|468737589|FG000|Overall Study|Lost to Follow-up|1|||
130211937|NCT01156051|468737590|FG001|Overall Study|Lost to Follow-up|0|||
130211938|NCT01156051|468737589|FG000|Overall Study|patient not compliant with protocol|0|||
130211939|NCT01156051|468737590|FG001|Overall Study|patient not compliant with protocol|1|||
130211940|NCT02071082|468737597|FG000|Overall Study|Enrolled and Never Treated|1|||
130211941|NCT02071082|468737598|FG001|Overall Study|Enrolled and Never Treated|1|||
130211942|NCT02071082|468737597|FG000|Overall Study|Adverse Event|0|||
130211943|NCT02071082|468737598|FG001|Overall Study|Adverse Event|1|||
130211944|NCT02071082|468737597|FG000|Overall Study|Withdrew Consent|0|||
130211945|NCT02071082|468737598|FG001|Overall Study|Withdrew Consent|4|||
130211946|NCT02071082|468737597|FG000|Overall Study|Lost to Follow-up|1|||
130211947|NCT02071082|468737598|FG001|Overall Study|Lost to Follow-up|1|||
130211948|NCT00958412|468737602|FG000|Overall Study|Study prematurely terminated|18|||
130211949|NCT02227368|468739383|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
130211950|NCT02227368|468739384|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
130211951|NCT02227368|468739383|FG000|Overall Study|Lost to Follow-up|1|||
130211952|NCT02227368|468739384|FG001|Overall Study|Lost to Follow-up|0|||
130211953|NCT02227368|468739383|FG000|Overall Study|Adverse Event|1|||
130211954|NCT02227368|468739384|FG001|Overall Study|Adverse Event|0|||
130211955|NCT02510820|468739388|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130211956|NCT02510820|468739389|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130211957|NCT02510820|468739388|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130211958|NCT02510820|468739389|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130211959|NCT03046056|468739390|FG000|Overall Study|Non-responder at Week 10|6|||
130211960|NCT03046056|468739391|FG001|Overall Study|Non-responder at Week 10|6|||
130211961|NCT03046056|468739392|FG002|Overall Study|Non-responder at Week 10|4|||
130211962|NCT03046056|468739390|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
130211963|NCT03046056|468739391|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
130211964|NCT03046056|468739392|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
130432747|NCT01364597|469547755|FG001|Overall Study|Lost to Follow-up|0|||
130432748|NCT01364597|469547756|FG002|Overall Study|Lost to Follow-up|5|||
130432749|NCT01364597|469547757|FG003|Overall Study|Lost to Follow-up|3|||
130432750|NCT01364597|469547754|FG000|Overall Study|Withdrawal by Subject|4|||
130432751|NCT01364597|469547755|FG001|Overall Study|Withdrawal by Subject|1|||
130432752|NCT01364597|469547756|FG002|Overall Study|Withdrawal by Subject|18|||
130211965|NCT03046056|468739390|FG000|Overall Study|Adverse Event|1|||
130211966|NCT03046056|468739391|FG001|Overall Study|Adverse Event|5|||
130211967|NCT03046056|468739392|FG002|Overall Study|Adverse Event|0|||
130211968|NCT03046056|468739390|FG000|Overall Study|Non-compliance With Study Drug|0|||
130211969|NCT03046056|468739391|FG001|Overall Study|Non-compliance With Study Drug|0|||
130211970|NCT03046056|468739392|FG002|Overall Study|Non-compliance With Study Drug|2|||
130211971|NCT03046056|468739390|FG000|Overall Study|Protocol Violation|1|||
130211972|NCT03046056|468739391|FG001|Overall Study|Protocol Violation|1|||
130211973|NCT03046056|468739392|FG002|Overall Study|Protocol Violation|0|||
130432753|NCT01364597|469547757|FG003|Overall Study|Withdrawal by Subject|6|||
130432754|NCT01364597|469547754|FG000|Overall Study|Non compliance|1|||
130432755|NCT01364597|469547755|FG001|Overall Study|Non compliance|0|||
130559403|NCT01621542|470016493|FG003|Overall Study|Death|0|||
130211974|NCT03046056|468739390|FG000|Overall Study|Investigator's Discretion|0|||
130211975|NCT03046056|468739391|FG001|Overall Study|Investigator's Discretion|1|||
130211976|NCT03046056|468739392|FG002|Overall Study|Investigator's Discretion|0|||
130211977|NCT03046056|468739390|FG000|Overall Study|Withdrew Consent|1|||
130211978|NCT03046056|468739391|FG001|Overall Study|Withdrew Consent|0|||
130211979|NCT03046056|468739392|FG002|Overall Study|Withdrew Consent|0|||
130211980|NCT02913105|468739393|FG000|Overall Study|Adverse Event|11|||
130211981|NCT02913105|468739394|FG001|Overall Study|Adverse Event|0|||
130211982|NCT02913105|468739395|FG002|Overall Study|Adverse Event|4|||
130211983|NCT02913105|468739393|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130320362|NCT00506350|469141895|FG003|Overall Study|Lost to Follow-up|1|||
130432756|NCT01364597|469547756|FG002|Overall Study|Non compliance|1|||
130432757|NCT01364597|469547757|FG003|Overall Study|Non compliance|0|||
130432758|NCT01364597|469547754|FG000|Overall Study|Lack of compliance|1|||
130211984|NCT02913105|468739394|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130211985|NCT02913105|468739395|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130211986|NCT02913105|468739393|FG000|Overall Study|Reason Not Specified|3|||
130211987|NCT02913105|468739394|FG001|Overall Study|Reason Not Specified|1|||
130211988|NCT02913105|468739395|FG002|Overall Study|Reason Not Specified|1|||
130211989|NCT02913105|468739393|FG000|Overall Study|Physician Decision|1|||
130211990|NCT02913105|468739394|FG001|Overall Study|Physician Decision|1|||
130211991|NCT02913105|468739395|FG002|Overall Study|Physician Decision|0|||
130211992|NCT02913105|468739393|FG000|Overall Study|Withdrawal by Subject|0|||
130211993|NCT02913105|468739394|FG001|Overall Study|Withdrawal by Subject|3|||
130211994|NCT02913105|468739395|FG002|Overall Study|Withdrawal by Subject|1|||
130211995|NCT01317004|468739396|FG000|Overall Study|Withdrawal by Subject|1|||
130211996|NCT01317004|468739397|FG001|Overall Study|Withdrawal by Subject|4|||
130211997|NCT01317004|468739396|FG000|Overall Study|Protocol Violation|0|||
130211998|NCT01317004|468739397|FG001|Overall Study|Protocol Violation|2|||
130211999|NCT01317004|468739396|FG000|Overall Study|Adverse Event|3|||
130212000|NCT01317004|468739397|FG001|Overall Study|Adverse Event|3|||
130212001|NCT01859949|468739403|FG000|Overall Study|Family Matters|0|||
130212002|NCT01859949|468739404|FG001|Overall Study|Family Matters|1|||
130212003|NCT01859949|468739403|FG000|Overall Study|Physician Decision|2|||
130212004|NCT01859949|468739404|FG001|Overall Study|Physician Decision|4|||
130212005|NCT01859949|468739403|FG000|Overall Study|Withdrawal by Subject|11|||
130212006|NCT01859949|468739404|FG001|Overall Study|Withdrawal by Subject|10|||
130212007|NCT01859949|468739403|FG000|Overall Study|Protocol Violation|1|||
130212008|NCT01859949|468739404|FG001|Overall Study|Protocol Violation|1|||
130212009|NCT01859949|468739403|FG000|Overall Study|Adverse Event|0|||
130212010|NCT01859949|468739404|FG001|Overall Study|Adverse Event|1|||
130212011|NCT01890759|468739405|FG000|Overall Study|Protocol Violation|0|||
130212012|NCT01890759|468739406|FG001|Overall Study|Protocol Violation|2|||
130212013|NCT01890759|468739405|FG000|Overall Study|Lost to Follow-up|0|||
130212014|NCT01890759|468739406|FG001|Overall Study|Lost to Follow-up|2|||
130212015|NCT01890759|468739405|FG000|Overall Study|Withdrawal by Subject|2|||
130212016|NCT01890759|468739406|FG001|Overall Study|Withdrawal by Subject|8|||
130212017|NCT01344759|468739407|FG000|Overall Study|Patients failed to reach sedation level|0|||
130212018|NCT01344759|468739408|FG001|Overall Study|Patients failed to reach sedation level|2|||
130212019|NCT01153009|468739409|FG000|Overall Study|Adverse Event|4|||
130212020|NCT01153009|468739410|FG001|Overall Study|Adverse Event|14|||
130212021|NCT01153009|468739411|FG002|Overall Study|Adverse Event|14|||
130212022|NCT01153009|468739412|FG003|Overall Study|Adverse Event|10|||
130212023|NCT01153009|468739409|FG000|Overall Study|Lack of Efficacy|9|||
130212024|NCT01153009|468739410|FG001|Overall Study|Lack of Efficacy|0|||
130212025|NCT01153009|468739411|FG002|Overall Study|Lack of Efficacy|2|||
130212026|NCT01153009|468739412|FG003|Overall Study|Lack of Efficacy|1|||
130212027|NCT01153009|468739409|FG000|Overall Study|Noncompliance with Study Medication|1|||
130212028|NCT01153009|468739410|FG001|Overall Study|Noncompliance with Study Medication|3|||
130212029|NCT01153009|468739411|FG002|Overall Study|Noncompliance with Study Medication|4|||
130212030|NCT01153009|468739412|FG003|Overall Study|Noncompliance with Study Medication|1|||
130212031|NCT01153009|468739409|FG000|Overall Study|Protocol Deviations|4|||
130212032|NCT01153009|468739410|FG001|Overall Study|Protocol Deviations|3|||
130212033|NCT01153009|468739411|FG002|Overall Study|Protocol Deviations|3|||
130212034|NCT01153009|468739412|FG003|Overall Study|Protocol Deviations|2|||
130212035|NCT01153009|468739409|FG000|Overall Study|Withdrawal of Consent|5|||
130212036|NCT01153009|468739410|FG001|Overall Study|Withdrawal of Consent|5|||
130212037|NCT01153009|468739411|FG002|Overall Study|Withdrawal of Consent|4|||
130212038|NCT01153009|468739412|FG003|Overall Study|Withdrawal of Consent|6|||
130212039|NCT01153009|468739409|FG000|Overall Study|Lost to Follow-up|8|||
130212040|NCT01153009|468739410|FG001|Overall Study|Lost to Follow-up|8|||
130212041|NCT01153009|468739411|FG002|Overall Study|Lost to Follow-up|11|||
130212042|NCT01153009|468739412|FG003|Overall Study|Lost to Follow-up|15|||
130432759|NCT01364597|469547755|FG001|Overall Study|Lack of compliance|0|||
130432760|NCT01364597|469547756|FG002|Overall Study|Lack of compliance|0|||
130432761|NCT01364597|469547757|FG003|Overall Study|Lack of compliance|0|||
130212043|NCT01153009|468739409|FG000|Overall Study|Other|1|||
130212044|NCT01153009|468739410|FG001|Overall Study|Other|1|||
130212045|NCT01153009|468739411|FG002|Overall Study|Other|3|||
130212046|NCT01153009|468739412|FG003|Overall Study|Other|2|||
130212047|NCT04494425|468739417|FG000|Overall Study|Death|160|||
130212048|NCT04494425|468739418|FG001|Overall Study|Death|166|||
130212049|NCT04494425|468739417|FG000|Overall Study|Withdrawal by Subject|10|||
130212050|NCT04494425|468739418|FG001|Overall Study|Withdrawal by Subject|40|||
130212051|NCT04494425|468739417|FG000|Overall Study|Other|1|||
130212052|NCT04494425|468739418|FG001|Overall Study|Other|1|||
130212053|NCT04494425|468739417|FG000|Overall Study|Ongoing at the time of PCD|265|||
130212054|NCT04494425|468739418|FG001|Overall Study|Ongoing at the time of PCD|223|||
130212055|NCT01270321|468739420|FG000|Overall Study|Death|3|||
130212056|NCT01270321|468739421|FG001|Overall Study|Death|1|||
130212057|NCT01270321|468739422|FG002|Overall Study|Death|4|||
130212058|NCT01270321|468739420|FG000|Overall Study|Adverse Event|7|||
130432762|NCT01364597|469547754|FG000|Overall Study|End of treatment epilepsy|1|||
130212059|NCT01270321|468739421|FG001|Overall Study|Adverse Event|9|||
130212060|NCT01270321|468739422|FG002|Overall Study|Adverse Event|5|||
130212061|NCT04003623|468739426|FG000|Overall Study|Withdrawal by Subject|1|||
130212062|NCT04003623|468739427|FG001|Overall Study|Withdrawal by Subject|0|||
130212063|NCT00703326|468739429|FG000|Overall Study|Lost to Follow-up|47|||
130212064|NCT00703326|468739430|FG001|Overall Study|Lost to Follow-up|18|||
130212065|NCT00703326|468739429|FG000|Overall Study|Withdrawal by Subject|54|||
130212066|NCT00703326|468739430|FG001|Overall Study|Withdrawal by Subject|20|||
130212067|NCT00703326|468739429|FG000|Overall Study|Adverse Event|1|||
130212068|NCT00703326|468739430|FG001|Overall Study|Adverse Event|0|||
130212069|NCT01393106|468739433|FG000|Overall Study|Adverse Event|3|||
130212070|NCT01393106|468739433|FG000|Overall Study|Withdrawal by Subject|1|||
130212071|NCT01393106|468739433|FG000|Overall Study|Lack of Efficacy|1|||
130212072|NCT05437640|468739436|FG000|Washout (1 Week)|Adverse Event|1|||
130212073|NCT05437640|468739437|FG001|Washout (1 Week)|Adverse Event|0|||
130212074|NCT04228965|468739440|FG000|Overall Study|Lost to Follow-up|26|||
130212075|NCT04228965|468739441|FG001|Overall Study|Lost to Follow-up|11|||
130212076|NCT04228965|468739440|FG000|Overall Study|Withdrawal by Subject|18|||
130212077|NCT04228965|468739441|FG001|Overall Study|Withdrawal by Subject|5|||
130212078|NCT00734656|468739444|FG000|Lab Session 1|Withdrawal by Subject|2|||
130212079|NCT00734656|468739445|FG001|Lab Session 1|Withdrawal by Subject|0|||
130212080|NCT00734656|468739446|FG002|Lab Session 1|Withdrawal by Subject|0|||
130212081|NCT00734656|468739447|FG003|Lab Session 1|Withdrawal by Subject|0|||
130212082|NCT00734656|468739444|FG000|Washout 1|Withdrawal by Subject|1|||
130212083|NCT00734656|468739445|FG001|Washout 1|Withdrawal by Subject|5|||
130212084|NCT00734656|468739446|FG002|Washout 1|Withdrawal by Subject|2|||
130212085|NCT00734656|468739447|FG003|Washout 1|Withdrawal by Subject|3|||
130212086|NCT00734656|468739444|FG000|Lab Session 2|Withdrawal by Subject|1|||
130212087|NCT00734656|468739445|FG001|Lab Session 2|Withdrawal by Subject|0|||
130212088|NCT00734656|468739446|FG002|Lab Session 2|Withdrawal by Subject|0|||
130212089|NCT00734656|468739447|FG003|Lab Session 2|Withdrawal by Subject|1|||
130212090|NCT00734656|468739444|FG000|Washout 2|Withdrawal by Subject|1|||
130212091|NCT00734656|468739445|FG001|Washout 2|Withdrawal by Subject|1|||
130212092|NCT00734656|468739446|FG002|Washout 2|Withdrawal by Subject|1|||
130212093|NCT00734656|468739447|FG003|Washout 2|Withdrawal by Subject|0|||
130212094|NCT00734656|468739444|FG000|Washout 3|Withdrawal by Subject|1|||
130212095|NCT00734656|468739445|FG001|Washout 3|Withdrawal by Subject|0|||
130212096|NCT00734656|468739446|FG002|Washout 3|Withdrawal by Subject|0|||
130212097|NCT00734656|468739447|FG003|Washout 3|Withdrawal by Subject|1|||
130212098|NCT00734656|468739444|FG000|Lab Session 4|Withdrawal by Subject|0|||
130212099|NCT00734656|468739445|FG001|Lab Session 4|Withdrawal by Subject|0|||
130212100|NCT00734656|468739446|FG002|Lab Session 4|Withdrawal by Subject|0|||
130212101|NCT00734656|468739447|FG003|Lab Session 4|Withdrawal by Subject|1|||
130212102|NCT03214679|468739449|FG000|Overall Study|Lost to Follow-up|12|||
130212103|NCT03214679|468739450|FG001|Overall Study|Lost to Follow-up|14|||
130212104|NCT03214679|468739449|FG000|Overall Study|not eligible|2|||
130212105|NCT03214679|468739450|FG001|Overall Study|not eligible|0|||
130212106|NCT01754766|468739456|FG000|Overall Study|Personal reasons|1|||
130212107|NCT01754766|468739457|FG001|Overall Study|Personal reasons|1|||
130212108|NCT01754766|468739458|FG002|Overall Study|Personal reasons|0|||
130212109|NCT01709409|468739461|FG000|Overall Study|Protocol Violation|1|||
130212110|NCT01709409|468739462|FG001|Overall Study|Protocol Violation|0|||
130212111|NCT02412878|468739463|FG000|Overall Study|Withdrawal by Subject|19|||
130212112|NCT02412878|468739464|FG001|Overall Study|Withdrawal by Subject|10|||
130212113|NCT02412878|468739463|FG000|Overall Study|Lost to Follow-up|2|||
130212114|NCT02412878|468739464|FG001|Overall Study|Lost to Follow-up|3|||
130212115|NCT04571385|468739465|FG000|Overall Study|Participant non-compliance|1|||
130212116|NCT04571385|468739466|FG001|Overall Study|Participant non-compliance|0|||
130212117|NCT04571385|468739467|FG002|Overall Study|Participant non-compliance|0|||
130212118|NCT04571385|468739465|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130212119|NCT04571385|468739466|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
130212120|NCT04571385|468739467|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130212121|NCT04571385|468739465|FG000|Overall Study|Screen failure|0|||
130212122|NCT04571385|468739466|FG001|Overall Study|Screen failure|0|||
130212123|NCT04571385|468739467|FG002|Overall Study|Screen failure|1|||
130212124|NCT02263729|468739468|FG000|Overall Study|Lost to Follow-up|1|||
130212125|NCT02263729|468739469|FG001|Overall Study|Lost to Follow-up|1|||
130432763|NCT01364597|469547755|FG001|Overall Study|End of treatment epilepsy|0|||
130212126|NCT01212159|468739470|FG000|Overall Study|Withdrawal by Subject|12|||
130212127|NCT01212159|468739471|FG001|Overall Study|Withdrawal by Subject|12|||
130212128|NCT01306214|468739472|FG000|Overall Study|Death|0|||
130212129|NCT01306214|468739473|FG001|Overall Study|Death|0|||
130212130|NCT01306214|468739474|FG002|Overall Study|Death|1|||
130212131|NCT01306214|468739472|FG000|Overall Study|Lost to Follow-up|3|||
130212132|NCT01306214|468739473|FG001|Overall Study|Lost to Follow-up|5|||
130212133|NCT01306214|468739474|FG002|Overall Study|Lost to Follow-up|4|||
130212134|NCT01306214|468739472|FG000|Overall Study|Withdrawal by Subject|24|||
130212135|NCT01306214|468739473|FG001|Overall Study|Withdrawal by Subject|22|||
130212136|NCT01306214|468739474|FG002|Overall Study|Withdrawal by Subject|16|||
130212137|NCT01306214|468739472|FG000|Overall Study|Not treated|1|||
130212138|NCT01306214|468739473|FG001|Overall Study|Not treated|1|||
130212139|NCT01306214|468739474|FG002|Overall Study|Not treated|1|||
130212140|NCT01026818|468739475|FG000|Screening Period|Entry Criteria Not Met|105|||
130212141|NCT01026818|468739476|FG001|Screening Period|Entry Criteria Not Met|0|||
130212142|NCT01026818|468739477|FG002|Screening Period|Entry Criteria Not Met|0|||
130212143|NCT01026818|468739478|FG003|Screening Period|Entry Criteria Not Met|0|||
130212144|NCT01026818|468739475|FG000|Screening Period|Withdrawal by Subject|49|||
130212145|NCT01026818|468739476|FG001|Screening Period|Withdrawal by Subject|0|||
130212146|NCT01026818|468739477|FG002|Screening Period|Withdrawal by Subject|0|||
130212147|NCT01026818|468739478|FG003|Screening Period|Withdrawal by Subject|0|||
130212148|NCT01026818|468739475|FG000|Screening Period|Protocol Deviation|3|||
130212149|NCT01026818|468739476|FG001|Screening Period|Protocol Deviation|0|||
130212150|NCT01026818|468739477|FG002|Screening Period|Protocol Deviation|0|||
130212151|NCT01026818|468739478|FG003|Screening Period|Protocol Deviation|0|||
130212152|NCT01026818|468739475|FG000|Screening Period|Adverse Event|2|||
130212153|NCT01026818|468739476|FG001|Screening Period|Adverse Event|0|||
130212154|NCT01026818|468739477|FG002|Screening Period|Adverse Event|0|||
130212155|NCT01026818|468739478|FG003|Screening Period|Adverse Event|0|||
130212156|NCT01026818|468739475|FG000|Screening Period|Physician Decision|1|||
130212157|NCT01026818|468739476|FG001|Screening Period|Physician Decision|0|||
130212158|NCT01026818|468739477|FG002|Screening Period|Physician Decision|0|||
130212159|NCT01026818|468739478|FG003|Screening Period|Physician Decision|0|||
130212160|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
130212161|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
130212162|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
130212163|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
130212164|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
130212165|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
130212166|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130212167|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130212168|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
130212169|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
130212170|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
130212171|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
130212172|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130212173|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
130212174|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130212175|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
130212176|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
130212177|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
130212178|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
130212179|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
130212180|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130212181|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130212182|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
130212183|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
130212184|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
130212185|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130212186|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
130212187|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130212188|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
130212189|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130212190|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
130212191|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130212192|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212193|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
130212194|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212195|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212196|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130212197|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
130212198|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130212199|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
130212200|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130212201|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130212202|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130212203|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130212204|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212205|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
130212206|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212207|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212208|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130212209|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
130212210|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
130212211|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130212212|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212213|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212214|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212215|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
130212216|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212217|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
130212218|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212219|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212220|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212221|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
130212222|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212223|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212224|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
130212225|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130212226|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
130212227|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130212228|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
130212229|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130212230|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
130212231|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130212232|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130212233|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
130212234|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130212235|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
130212236|NCT01031004|468739479|FG000|Overall Study|Protocol Violation|0|||
130212237|NCT01031004|468739480|FG001|Overall Study|Protocol Violation|1|||
130212238|NCT01031004|468739479|FG000|Overall Study|Lost to Follow-up|1|||
130212239|NCT01031004|468739480|FG001|Overall Study|Lost to Follow-up|0|||
130212240|NCT01641471|468739481|FG000|Overall Study|Withdrawal by Subject|19|||
130212241|NCT01641471|468739482|FG001|Overall Study|Withdrawal by Subject|19|||
130212242|NCT01641471|468739481|FG000|Overall Study|Lost to Follow-up|2|||
130212243|NCT01641471|468739482|FG001|Overall Study|Lost to Follow-up|4|||
130212244|NCT01641471|468739481|FG000|Overall Study|Protocol Violation|2|||
130212245|NCT01641471|468739482|FG001|Overall Study|Protocol Violation|4|||
130212246|NCT04575584|468739486|FG000|Overall Study|Death|6|||
130212247|NCT04575584|468739487|FG001|Overall Study|Death|4|||
130212248|NCT04575584|468739488|FG002|Overall Study|Death|6|||
130212249|NCT04575584|468739489|FG003|Overall Study|Death|2|||
130212250|NCT04575584|468739490|FG004|Overall Study|Death|0|||
130212251|NCT04575584|468739491|FG005|Overall Study|Death|0|||
130212252|NCT04575584|468739486|FG000|Overall Study|Lost to Follow-up|1|||
130212253|NCT04575584|468739487|FG001|Overall Study|Lost to Follow-up|1|||
130212254|NCT04575584|468739488|FG002|Overall Study|Lost to Follow-up|1|||
130212255|NCT04575584|468739489|FG003|Overall Study|Lost to Follow-up|1|||
130212256|NCT04575584|468739490|FG004|Overall Study|Lost to Follow-up|0|||
130212257|NCT04575584|468739491|FG005|Overall Study|Lost to Follow-up|0|||
130212258|NCT04575584|468739486|FG000|Overall Study|Physician Decision|0|||
130212259|NCT04575584|468739487|FG001|Overall Study|Physician Decision|1|||
130212260|NCT04575584|468739488|FG002|Overall Study|Physician Decision|1|||
130212261|NCT04575584|468739489|FG003|Overall Study|Physician Decision|1|||
130212262|NCT04575584|468739490|FG004|Overall Study|Physician Decision|0|||
130212263|NCT04575584|468739491|FG005|Overall Study|Physician Decision|0|||
130212264|NCT04575584|468739486|FG000|Overall Study|Withdrawal by Subject|7|||
130212265|NCT04575584|468739487|FG001|Overall Study|Withdrawal by Subject|9|||
130212266|NCT04575584|468739488|FG002|Overall Study|Withdrawal by Subject|5|||
130212267|NCT04575584|468739489|FG003|Overall Study|Withdrawal by Subject|3|||
130212268|NCT04575584|468739490|FG004|Overall Study|Withdrawal by Subject|0|||
130212269|NCT04575584|468739491|FG005|Overall Study|Withdrawal by Subject|0|||
130212270|NCT04575584|468739486|FG000|Overall Study|Not recorded|0|||
130212271|NCT04575584|468739487|FG001|Overall Study|Not recorded|0|||
130212272|NCT04575584|468739488|FG002|Overall Study|Not recorded|0|||
130212273|NCT04575584|468739489|FG003|Overall Study|Not recorded|1|||
130212274|NCT04575584|468739490|FG004|Overall Study|Not recorded|0|||
130212275|NCT04575584|468739491|FG005|Overall Study|Not recorded|0|||
130212276|NCT03488563|468739492|FG000|Overall Study|Lost to Follow-up|7|||
130212277|NCT03488563|468739493|FG001|Overall Study|Lost to Follow-up|6|||
130212278|NCT03488563|468739494|FG002|Overall Study|Lost to Follow-up|7|||
130320363|NCT00506350|469141896|FG004|Overall Study|Lost to Follow-up|2|||
130212279|NCT03488563|468739492|FG000|Overall Study|Withdrawal by Subject|8|||
130212280|NCT03488563|468739493|FG001|Overall Study|Withdrawal by Subject|7|||
130212281|NCT03488563|468739494|FG002|Overall Study|Withdrawal by Subject|7|||
130212282|NCT03488563|468739492|FG000|Overall Study|Physician Decision|0|||
130212283|NCT03488563|468739493|FG001|Overall Study|Physician Decision|0|||
130212284|NCT03488563|468739494|FG002|Overall Study|Physician Decision|1|||
130212285|NCT03488563|468739492|FG000|Overall Study|Protocol Violation|3|||
130212286|NCT03488563|468739493|FG001|Overall Study|Protocol Violation|2|||
130212287|NCT03488563|468739494|FG002|Overall Study|Protocol Violation|6|||
130212288|NCT03488563|468739492|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
130212289|NCT03488563|468739493|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130212290|NCT03488563|468739494|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130212291|NCT03488563|468739492|FG000|Overall Study|Use of prohibited medication|2|||
130212292|NCT03488563|468739493|FG001|Overall Study|Use of prohibited medication|0|||
130212293|NCT03488563|468739494|FG002|Overall Study|Use of prohibited medication|0|||
130212294|NCT03488563|468739492|FG000|Overall Study|Adverse Event|1|||
130212295|NCT03488563|468739493|FG001|Overall Study|Adverse Event|0|||
130212296|NCT03488563|468739494|FG002|Overall Study|Adverse Event|1|||
130212297|NCT03488563|468739492|FG000|Overall Study|Subject returned for ET visit|0|||
130212298|NCT03488563|468739493|FG001|Overall Study|Subject returned for ET visit|1|||
130212299|NCT03488563|468739494|FG002|Overall Study|Subject returned for ET visit|0|||
130212300|NCT03488563|468739492|FG000|Overall Study|Sponsor's decision|0|||
130212301|NCT03488563|468739493|FG001|Overall Study|Sponsor's decision|0|||
130212302|NCT03488563|468739494|FG002|Overall Study|Sponsor's decision|1|||
130212303|NCT02769312|468739507|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130212304|NCT02769312|468739508|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130212305|NCT02769312|468739507|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
130212306|NCT02769312|468739508|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
130212307|NCT02769312|468739507|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
130212308|NCT02769312|468739508|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
130212309|NCT02769312|468739507|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
130212310|NCT02769312|468739508|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
130212311|NCT02769312|468739507|FG000|Follow-up|Lost to Follow-up|1|||
130212312|NCT02769312|468739508|FG001|Follow-up|Lost to Follow-up|1|||
130212313|NCT02815267|468739509|FG000|Double-Blind Phase|Adverse Event|0|||
130212314|NCT02815267|468739510|FG001|Double-Blind Phase|Adverse Event|3|||
130212315|NCT02815267|468739509|FG000|Double-Blind Phase|Lost to Follow-up|17|||
130212316|NCT02815267|468739510|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130212317|NCT02815267|468739509|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
130212318|NCT02815267|468739510|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
130212319|NCT02815267|468739509|FG000|Double-Blind Phase|Protocol Violation|3|||
130212320|NCT02815267|468739510|FG001|Double-Blind Phase|Protocol Violation|2|||
130212321|NCT02815267|468739509|FG000|Double-Blind Phase|Site withdrawal|1|||
130212322|NCT02815267|468739510|FG001|Double-Blind Phase|Site withdrawal|6|||
130212323|NCT02815267|468739509|FG000|Double-Blind Phase|Received a disallowed medication|1|||
130212324|NCT02815267|468739510|FG001|Double-Blind Phase|Received a disallowed medication|1|||
130212325|NCT02815267|468739509|FG000|Open-Label Phase|Adverse Event|1|||
130212326|NCT02815267|468739510|FG001|Open-Label Phase|Adverse Event|1|||
130212327|NCT02815267|468739509|FG000|Open-Label Phase|Lost to Follow-up|23|||
130212328|NCT02815267|468739510|FG001|Open-Label Phase|Lost to Follow-up|9|||
130212329|NCT02815267|468739509|FG000|Open-Label Phase|Withdrawal by Subject|24|||
130212330|NCT02815267|468739510|FG001|Open-Label Phase|Withdrawal by Subject|13|||
130212331|NCT02815267|468739509|FG000|Open-Label Phase|Protocol Violation|0|||
130212332|NCT02815267|468739510|FG001|Open-Label Phase|Protocol Violation|1|||
130212333|NCT02815267|468739509|FG000|Open-Label Phase|Administrative|21|||
130212334|NCT02815267|468739510|FG001|Open-Label Phase|Administrative|12|||
130212335|NCT02815267|468739509|FG000|Open-Label Phase|Other|2|||
130212336|NCT02815267|468739510|FG001|Open-Label Phase|Other|5|||
130212337|NCT03594955|468739511|FG000|Overall Study|Adverse Event|1|||
130212338|NCT03594955|468739511|FG000|Overall Study|Progressive disease|5|||
130212339|NCT03594955|468739511|FG000|Overall Study|Sponsor's decision|1|||
130212340|NCT05600036|468739514|FG000|Overall Study|Adverse Event|0|||
130212341|NCT05600036|468739515|FG001|Overall Study|Adverse Event|2|||
130212342|NCT05600036|468739516|FG002|Overall Study|Adverse Event|1|||
130212343|NCT05600036|468739517|FG003|Overall Study|Adverse Event|0|||
130212344|NCT05600036|468739518|FG004|Overall Study|Adverse Event|1|||
130212345|NCT05600036|468739519|FG005|Overall Study|Adverse Event|0|||
130212346|NCT05600036|468739514|FG000|Overall Study|Lost to Follow-up|0|||
130212347|NCT05600036|468739515|FG001|Overall Study|Lost to Follow-up|2|||
130212348|NCT05600036|468739516|FG002|Overall Study|Lost to Follow-up|1|||
130212349|NCT05600036|468739517|FG003|Overall Study|Lost to Follow-up|1|||
130212350|NCT05600036|468739518|FG004|Overall Study|Lost to Follow-up|0|||
130212351|NCT05600036|468739519|FG005|Overall Study|Lost to Follow-up|0|||
130212352|NCT05600036|468739514|FG000|Overall Study|Protocol Violation|0|||
130212353|NCT05600036|468739515|FG001|Overall Study|Protocol Violation|0|||
130212354|NCT05600036|468739516|FG002|Overall Study|Protocol Violation|2|||
130212355|NCT05600036|468739517|FG003|Overall Study|Protocol Violation|0|||
130212356|NCT05600036|468739518|FG004|Overall Study|Protocol Violation|0|||
130212357|NCT05600036|468739519|FG005|Overall Study|Protocol Violation|0|||
130212358|NCT05600036|468739514|FG000|Overall Study|Withdrawal by Subject|0|||
130212359|NCT05600036|468739515|FG001|Overall Study|Withdrawal by Subject|1|||
130212360|NCT05600036|468739516|FG002|Overall Study|Withdrawal by Subject|2|||
130212361|NCT05600036|468739517|FG003|Overall Study|Withdrawal by Subject|0|||
130212362|NCT05600036|468739518|FG004|Overall Study|Withdrawal by Subject|3|||
130212363|NCT05600036|468739519|FG005|Overall Study|Withdrawal by Subject|5|||
130212364|NCT05600036|468739514|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212365|NCT05600036|468739515|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212366|NCT05600036|468739516|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212367|NCT05600036|468739517|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
130212368|NCT05600036|468739518|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212369|NCT05600036|468739519|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212370|NCT05600036|468739514|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212371|NCT05600036|468739515|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
130212372|NCT05600036|468739516|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212373|NCT05600036|468739517|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212374|NCT05600036|468739518|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212375|NCT05600036|468739519|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212376|NCT05600036|468739514|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212377|NCT05600036|468739515|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212378|NCT05600036|468739516|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212379|NCT05600036|468739517|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
130212380|NCT05600036|468739518|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212381|NCT05600036|468739519|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212382|NCT02714036|468739520|FG000|Overall Study|Adverse Event|9|||
130212383|NCT02714036|468739521|FG001|Overall Study|Adverse Event|2|||
130212384|NCT02714036|468739520|FG000|Overall Study|Withdrawal by Subject|3|||
130212385|NCT02714036|468739521|FG001|Overall Study|Withdrawal by Subject|2|||
130212386|NCT01006590|468739522|FG000|Overall Study|Adverse Event|2|||
130212387|NCT01006590|468739523|FG001|Overall Study|Adverse Event|3|||
130212388|NCT01006590|468739522|FG000|Overall Study|Death|1|||
130212389|NCT01006590|468739523|FG001|Overall Study|Death|1|||
130212390|NCT01006590|468739522|FG000|Overall Study|Lost to Follow-up|1|||
130212391|NCT01006590|468739523|FG001|Overall Study|Lost to Follow-up|1|||
130212392|NCT01006590|468739522|FG000|Overall Study|Protocol Violation|1|||
130212393|NCT01006590|468739523|FG001|Overall Study|Protocol Violation|0|||
130212394|NCT01006590|468739522|FG000|Overall Study|Withdrawal by Subject|4|||
130212395|NCT01006590|468739523|FG001|Overall Study|Withdrawal by Subject|2|||
130212396|NCT01006590|468739522|FG000|Overall Study|Study specific discontinuation criteria|16|||
130212397|NCT01006590|468739523|FG001|Overall Study|Study specific discontinuation criteria|23|||
130212398|NCT01006590|468739522|FG000|Overall Study|Other|3|||
130212399|NCT01006590|468739523|FG001|Overall Study|Other|2|||
130212400|NCT03332095|468739524|FG000|Overall Study|Lost to Follow-up|1|||
130212401|NCT03332095|468739525|FG001|Overall Study|Lost to Follow-up|0|||
130212402|NCT03332095|468739524|FG000|Overall Study|Pregnancy|0|||
130212403|NCT03332095|468739525|FG001|Overall Study|Pregnancy|1|||
130212404|NCT00703118|468739526|FG000|Overall Study|Adverse Event|1|||
130212405|NCT00703118|468739527|FG001|Overall Study|Adverse Event|2|||
130212406|NCT00703118|468739528|FG002|Overall Study|Adverse Event|2|||
130212407|NCT00703118|468739526|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
130212408|NCT00703118|468739527|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
130212409|NCT00703118|468739528|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
130212410|NCT00703118|468739526|FG000|Overall Study|Lost to Follow-up|6|||
130212411|NCT00703118|468739527|FG001|Overall Study|Lost to Follow-up|4|||
130212412|NCT00703118|468739528|FG002|Overall Study|Lost to Follow-up|4|||
130212413|NCT00703118|468739526|FG000|Overall Study|Withdrawal by Subject|8|||
130212414|NCT00703118|468739527|FG001|Overall Study|Withdrawal by Subject|7|||
130212415|NCT00703118|468739528|FG002|Overall Study|Withdrawal by Subject|13|||
130212416|NCT00703118|468739526|FG000|Overall Study|Other|0|||
130212417|NCT00703118|468739527|FG001|Overall Study|Other|0|||
130212418|NCT00703118|468739528|FG002|Overall Study|Other|1|||
130212419|NCT00431067|468739529|FG000|Overall Study|Other Adverse Event|9|||
130212420|NCT00431067|468739529|FG000|Overall Study|Progressive disease|30|||
130212421|NCT00431067|468739529|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
130432764|NCT01364597|469547756|FG002|Overall Study|End of treatment epilepsy|0|||
130432765|NCT01364597|469547757|FG003|Overall Study|End of treatment epilepsy|0|||
130432766|NCT01364597|469547754|FG000|Overall Study|No Seizures|1|||
130432767|NCT01364597|469547755|FG001|Overall Study|No Seizures|0|||
130432768|NCT01364597|469547756|FG002|Overall Study|No Seizures|0|||
130212422|NCT00830518|468739539|FG000|Overall Study|Progressive Disease|18|||
130212423|NCT00830518|468739540|FG001|Overall Study|Progressive Disease|8|||
130212424|NCT00830518|468739539|FG000|Overall Study|Symptomatic Deterioration|4|||
130212425|NCT00830518|468739540|FG001|Overall Study|Symptomatic Deterioration|1|||
130212426|NCT00830518|468739539|FG000|Overall Study|Adverse Event|14|||
130212427|NCT00830518|468739540|FG001|Overall Study|Adverse Event|1|||
130212428|NCT00830518|468739539|FG000|Overall Study|Withdrawal by Patient|2|||
130212429|NCT00830518|468739540|FG001|Overall Study|Withdrawal by Patient|0|||
130212430|NCT00830518|468739539|FG000|Overall Study|Reason not Specified|8|||
130212431|NCT00830518|468739540|FG001|Overall Study|Reason not Specified|1|||
130212432|NCT02155322|468739545|FG000|Overall Study|Adverse Event|1|||
130212433|NCT02155322|468739545|FG000|Overall Study|Physician Decision|1|||
130212434|NCT02155322|468739545|FG000|Overall Study|Relapse/Recurrence|8|||
130212435|NCT02155322|468739545|FG000|Overall Study|Withdrawal by Subject|4|||
130212436|NCT03337048|468739549|FG000|Overall Study|Withdrawal by Subject|2|||
130212437|NCT03337048|468739550|FG001|Overall Study|Withdrawal by Subject|0|||
130212438|NCT03337048|468739551|FG002|Overall Study|Withdrawal by Subject|0|||
130212439|NCT02791438|468739552|FG000|Treatment Period|Adverse Event|1|||
130212440|NCT02791438|468739553|FG001|Treatment Period|Adverse Event|0|||
130212441|NCT02791438|468739552|FG000|Treatment Period|Withdrawal by Subject|0|||
130212442|NCT02791438|468739553|FG001|Treatment Period|Withdrawal by Subject|1|||
130212443|NCT02791438|468739552|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130212444|NCT02791438|468739553|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
130212445|NCT00394771|468739554|FG000|Overall Study|Did not meet protocol requirements|1|||
130212446|NCT00394771|468739555|FG001|Overall Study|Did not meet protocol requirements|0|||
130212447|NCT00394771|468739556|FG002|Overall Study|Did not meet protocol requirements|2|||
130212448|NCT00394771|468739557|FG003|Overall Study|Did not meet protocol requirements|0|||
130212449|NCT00394771|468739554|FG000|Overall Study|Protocol Violation|2|||
130212450|NCT00394771|468739555|FG001|Overall Study|Protocol Violation|4|||
130212451|NCT00394771|468739556|FG002|Overall Study|Protocol Violation|9|||
130212452|NCT00394771|468739557|FG003|Overall Study|Protocol Violation|7|||
130212453|NCT00394771|468739554|FG000|Overall Study|Withdrawal by Subject|10|||
130212454|NCT00394771|468739555|FG001|Overall Study|Withdrawal by Subject|6|||
130212455|NCT00394771|468739556|FG002|Overall Study|Withdrawal by Subject|8|||
130212456|NCT00394771|468739557|FG003|Overall Study|Withdrawal by Subject|12|||
130212457|NCT00394771|468739554|FG000|Overall Study|Adverse Event|10|||
130212458|NCT00394771|468739555|FG001|Overall Study|Adverse Event|5|||
130212459|NCT00394771|468739556|FG002|Overall Study|Adverse Event|12|||
130212460|NCT00394771|468739557|FG003|Overall Study|Adverse Event|8|||
130212461|NCT00394771|468739554|FG000|Overall Study|Participant pregnant|0|||
130212462|NCT00394771|468739555|FG001|Overall Study|Participant pregnant|1|||
130212463|NCT00394771|468739556|FG002|Overall Study|Participant pregnant|2|||
130212464|NCT00394771|468739557|FG003|Overall Study|Participant pregnant|2|||
130212465|NCT00394771|468739554|FG000|Overall Study|Lost to Follow-up|15|||
130212466|NCT00394771|468739555|FG001|Overall Study|Lost to Follow-up|15|||
130212467|NCT00394771|468739556|FG002|Overall Study|Lost to Follow-up|13|||
130212468|NCT00394771|468739557|FG003|Overall Study|Lost to Follow-up|10|||
130212469|NCT00394771|468739554|FG000|Overall Study|Other|3|||
130212470|NCT00394771|468739555|FG001|Overall Study|Other|3|||
130212471|NCT00394771|468739556|FG002|Overall Study|Other|1|||
130212472|NCT00394771|468739557|FG003|Overall Study|Other|0|||
130212473|NCT00586898|468739562|FG000|Overall Study|Adverse Event|1|||
130212474|NCT00586898|468739562|FG000|Overall Study|Patiemt Non-compliance|1|||
130212475|NCT00586898|468739562|FG000|Overall Study|Evaluable for Toxicity Only|5|||
130212476|NCT02494401|468739564|FG000|Overall Study|Lost to Follow-up|22|||
130212477|NCT02494401|468739565|FG001|Overall Study|Lost to Follow-up|25|||
130212478|NCT02494401|468739564|FG000|Overall Study|Withdrawal by Subject|3|||
130212479|NCT02494401|468739565|FG001|Overall Study|Withdrawal by Subject|2|||
130212480|NCT00385827|468741115|FG000|Part 1|Adverse Event|1|||
130212481|NCT00385827|468741116|FG001|Part 1|Adverse Event|0|||
130212482|NCT00385827|468741117|FG002|Part 1|Adverse Event|0|||
130212483|NCT00385827|468741115|FG000|Part 1|Death|2|||
130212484|NCT00385827|468741116|FG001|Part 1|Death|0|||
130212485|NCT00385827|468741117|FG002|Part 1|Death|0|||
130212486|NCT00385827|468741115|FG000|Part 1|Lack of Efficacy|5|||
130212487|NCT00385827|468741116|FG001|Part 1|Lack of Efficacy|0|||
130212488|NCT00385827|468741117|FG002|Part 1|Lack of Efficacy|0|||
130212489|NCT00385827|468741115|FG000|Part 1|Other|1|||
130212490|NCT00385827|468741116|FG001|Part 1|Other|0|||
130212491|NCT00385827|468741117|FG002|Part 1|Other|0|||
130212492|NCT00385827|468741115|FG000|Part 2|Adverse Event|0|||
130212493|NCT00385827|468741116|FG001|Part 2|Adverse Event|6|||
130212494|NCT00385827|468741117|FG002|Part 2|Adverse Event|10|||
130212495|NCT00385827|468741115|FG000|Part 2|Death|0|||
130212496|NCT00385827|468741116|FG001|Part 2|Death|0|||
130212497|NCT00385827|468741117|FG002|Part 2|Death|2|||
130212498|NCT00385827|468741115|FG000|Part 2|Lack of Efficacy|0|||
130212499|NCT00385827|468741116|FG001|Part 2|Lack of Efficacy|14|||
130212500|NCT00385827|468741117|FG002|Part 2|Lack of Efficacy|13|||
130212501|NCT00385827|468741115|FG000|Part 2|Randomized but not treated|0|||
130212502|NCT00385827|468741116|FG001|Part 2|Randomized but not treated|2|||
130212503|NCT00385827|468741117|FG002|Part 2|Randomized but not treated|2|||
130212504|NCT00385827|468741115|FG000|Part 2|Other|0|||
130212505|NCT00385827|468741116|FG001|Part 2|Other|11|||
130212506|NCT00385827|468741117|FG002|Part 2|Other|21|||
130212507|NCT00410072|468741118|FG000|Day 1 to Week 48|Adverse Event|1|||
130212508|NCT00410072|468741119|FG001|Day 1 to Week 48|Adverse Event|2|||
130212509|NCT00410072|468741118|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
130212510|NCT00410072|468741119|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
130212511|NCT00410072|468741118|FG000|Day 1 to Week 48|Other|0|||
130212512|NCT00410072|468741119|FG001|Day 1 to Week 48|Other|1|||
130212513|NCT00410072|468741118|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
130212514|NCT00410072|468741119|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
130212515|NCT00410072|468741118|FG000|Day 1 to Week 48|Pregnancy|0|||
130212516|NCT00410072|468741119|FG001|Day 1 to Week 48|Pregnancy|2|||
130212517|NCT00410072|468741118|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
130212518|NCT00410072|468741119|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
130212519|NCT00410072|468741118|FG000|After Week 48 to Week 96|Adverse Event|1|||
130212520|NCT00410072|468741119|FG001|After Week 48 to Week 96|Adverse Event|2|||
130212521|NCT00410072|468741118|FG000|After Week 48 to Week 96|Death|0|||
130212522|NCT00410072|468741119|FG001|After Week 48 to Week 96|Death|1|||
130212523|NCT00410072|468741118|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
130212524|NCT00410072|468741119|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
130212525|NCT00410072|468741118|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
130212526|NCT00410072|468741119|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
130212527|NCT00410072|468741118|FG000|After Week 48 to Week 96|Other|2|||
130212528|NCT00410072|468741119|FG001|After Week 48 to Week 96|Other|0|||
130212529|NCT00410072|468741118|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
130212530|NCT00410072|468741119|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
130212531|NCT00410072|468741118|FG000|After Week 48 to Week 96|Pregnancy|0|||
130212532|NCT00410072|468741119|FG001|After Week 48 to Week 96|Pregnancy|2|||
130212533|NCT00410072|468741118|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
130212534|NCT00410072|468741119|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
130212535|NCT03307837|468741120|FG000|Overall Study|Withdrawal by Subject|0|||
130212536|NCT03307837|468741121|FG001|Overall Study|Withdrawal by Subject|0|||
130212537|NCT03307837|468741122|FG002|Overall Study|Withdrawal by Subject|1|||
130212538|NCT03307837|468741123|FG003|Overall Study|Withdrawal by Subject|0|||
130212539|NCT03307837|468741124|FG004|Overall Study|Withdrawal by Subject|0|||
130212540|NCT03307837|468741125|FG005|Overall Study|Withdrawal by Subject|1|||
130212541|NCT03307837|468741120|FG000|Overall Study|Lost to Follow-up|1|||
130212542|NCT03307837|468741121|FG001|Overall Study|Lost to Follow-up|1|||
130212543|NCT03307837|468741122|FG002|Overall Study|Lost to Follow-up|0|||
130212544|NCT03307837|468741123|FG003|Overall Study|Lost to Follow-up|0|||
130212545|NCT03307837|468741124|FG004|Overall Study|Lost to Follow-up|0|||
130212546|NCT03307837|468741125|FG005|Overall Study|Lost to Follow-up|1|||
130212547|NCT00904917|468741126|FG000|Overall Study|Lost to Follow-up|2|||
130212548|NCT00904917|468741127|FG001|Overall Study|Lost to Follow-up|2|||
130212549|NCT00904917|468741128|FG002|Overall Study|Lost to Follow-up|2|||
130212550|NCT00904917|468741129|FG003|Overall Study|Lost to Follow-up|2|||
130212551|NCT03915626|468741130|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
130212552|NCT02190721|468741138|FG000|Overall Study|Patient was out of the city|0|||
130212553|NCT02190721|468741139|FG001|Overall Study|Patient was out of the city|1|||
130212554|NCT02190721|468741140|FG002|Overall Study|Patient was out of the city|0|||
130212555|NCT05025332|468741142|FG000|Screening|Screen failure|12|||
130212556|NCT05025332|468741142|FG000|Treatment & Follow Up|Protocol Violation|1|||
130212557|NCT05025332|468741142|FG000|Treatment & Follow Up|Adverse Event|4|||
130212558|NCT01928199|468741143|FG000|Overall Study|Lost to Follow-up|2|||
130212559|NCT01928199|468741144|FG001|Overall Study|Lost to Follow-up|1|||
130212560|NCT01928199|468741143|FG000|Overall Study|Withdrawal by Subject|3|||
130212561|NCT01928199|468741144|FG001|Overall Study|Withdrawal by Subject|5|||
130212562|NCT01502956|468741145|FG000|Overall Study|Death|0|||
130212563|NCT01502956|468741146|FG001|Overall Study|Death|2|||
130212564|NCT01502956|468741145|FG000|Overall Study|Lost to Follow-up|14|||
130212565|NCT01502956|468741146|FG001|Overall Study|Lost to Follow-up|11|||
130212566|NCT01502956|468741145|FG000|Overall Study|Physician Decision|2|||
130212567|NCT01502956|468741146|FG001|Overall Study|Physician Decision|3|||
130212568|NCT01502956|468741145|FG000|Overall Study|Withdrawal by Subject|8|||
130212569|NCT01502956|468741146|FG001|Overall Study|Withdrawal by Subject|10|||
130212570|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
130212571|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
130212572|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
130212573|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130212574|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
130212575|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130212576|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
130212577|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130212578|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130212579|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130212580|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130212581|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
130212582|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
130212583|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
130212584|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
130212585|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130212586|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130212587|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
130212588|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
130212589|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130212590|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130212591|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212592|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212593|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212594|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
130212595|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
130212596|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
130212597|NCT02634801|468741149|FG000|Follow-up Period|Lost to Follow-up|3|||
130212598|NCT02634801|468741150|FG001|Follow-up Period|Lost to Follow-up|1|||
130212599|NCT02634801|468741151|FG002|Follow-up Period|Lost to Follow-up|2|||
130212600|NCT02634801|468741149|FG000|Follow-up Period|Physician Decision|0|||
130212601|NCT02634801|468741150|FG001|Follow-up Period|Physician Decision|0|||
130212602|NCT02634801|468741151|FG002|Follow-up Period|Physician Decision|1|||
130212603|NCT02634801|468741149|FG000|Follow-up Period|Withdrawal by Subject|1|||
130212604|NCT02634801|468741150|FG001|Follow-up Period|Withdrawal by Subject|2|||
130212605|NCT02634801|468741151|FG002|Follow-up Period|Withdrawal by Subject|5|||
130212606|NCT02634801|468741149|FG000|Follow-up Period|Adverse Event|1|||
130212607|NCT02634801|468741150|FG001|Follow-up Period|Adverse Event|5|||
130212608|NCT02634801|468741151|FG002|Follow-up Period|Adverse Event|0|||
130212609|NCT02626000|468741152|FG000|Overall Study|Decision by Sponsor|1|||
130212610|NCT02626000|468741152|FG000|Overall Study|Death|29|||
130212611|NCT03539484|468741153|FG000|Overall Study|Death|1|||
130212612|NCT03539484|468741154|FG001|Overall Study|Death|0|||
130212613|NCT03539484|468741155|FG002|Overall Study|Death|0|||
130212614|NCT03539484|468741156|FG003|Overall Study|Death|2|||
130212615|NCT03539484|468741157|FG004|Overall Study|Death|8|||
130212616|NCT03539484|468741158|FG005|Overall Study|Death|3|||
130212617|NCT03539484|468741159|FG006|Overall Study|Death|0|||
130212618|NCT03539484|468741153|FG000|Overall Study|Lost to Follow-up|0|||
130212619|NCT03539484|468741154|FG001|Overall Study|Lost to Follow-up|1|||
130212620|NCT03539484|468741155|FG002|Overall Study|Lost to Follow-up|0|||
130212621|NCT03539484|468741156|FG003|Overall Study|Lost to Follow-up|0|||
130212622|NCT03539484|468741157|FG004|Overall Study|Lost to Follow-up|1|||
130212623|NCT03539484|468741158|FG005|Overall Study|Lost to Follow-up|0|||
130212624|NCT03539484|468741159|FG006|Overall Study|Lost to Follow-up|0|||
130212625|NCT03539484|468741153|FG000|Overall Study|Withdrawal by Subject|0|||
130212626|NCT03539484|468741154|FG001|Overall Study|Withdrawal by Subject|0|||
130212627|NCT03539484|468741155|FG002|Overall Study|Withdrawal by Subject|0|||
130212628|NCT03539484|468741156|FG003|Overall Study|Withdrawal by Subject|0|||
130212629|NCT03539484|468741157|FG004|Overall Study|Withdrawal by Subject|2|||
130212630|NCT03539484|468741158|FG005|Overall Study|Withdrawal by Subject|0|||
130212631|NCT03539484|468741159|FG006|Overall Study|Withdrawal by Subject|1|||
130212632|NCT03539484|468741153|FG000|Overall Study|Study Terminated by Sponsor|0|||
130212633|NCT03539484|468741154|FG001|Overall Study|Study Terminated by Sponsor|0|||
130212634|NCT03539484|468741155|FG002|Overall Study|Study Terminated by Sponsor|1|||
130212635|NCT03539484|468741156|FG003|Overall Study|Study Terminated by Sponsor|1|||
130212636|NCT03539484|468741157|FG004|Overall Study|Study Terminated by Sponsor|2|||
130212637|NCT03539484|468741158|FG005|Overall Study|Study Terminated by Sponsor|2|||
130212638|NCT03539484|468741159|FG006|Overall Study|Study Terminated by Sponsor|1|||
130212639|NCT02476916|468741160|FG000|Core Period|Adverse Event|2|||
130212640|NCT02476916|468741161|FG001|Core Period|Adverse Event|2|||
130212641|NCT02476916|468741160|FG000|Core Period|Investigator decision|1|||
130432769|NCT01364597|469547757|FG003|Overall Study|No Seizures|0|||
130212642|NCT02476916|468741161|FG001|Core Period|Investigator decision|1|||
130212643|NCT02476916|468741160|FG000|Core Period|Withdrawal by Subject|3|||
130212644|NCT02476916|468741161|FG001|Core Period|Withdrawal by Subject|0|||
130212645|NCT02476916|468741160|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
130212646|NCT02476916|468741161|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
130212647|NCT02476916|468741160|FG000|Extension Period|On Treatment|12|||
130212648|NCT02476916|468741161|FG001|Extension Period|On Treatment|17|||
130212649|NCT06010732|468741162|FG000|Crossover Period 1|Protocol Violation|0|||
130212650|NCT06010732|468741163|FG001|Crossover Period 1|Protocol Violation|0|||
130212651|NCT06010732|468741164|FG002|Crossover Period 1|Protocol Violation|1|||
130212652|NCT06010732|468741165|FG003|Crossover Period 1|Protocol Violation|0|||
130212653|NCT06010732|468741166|FG004|Crossover Period 1|Protocol Violation|1|||
130212654|NCT06010732|468741167|FG005|Crossover Period 1|Protocol Violation|0|||
130212655|NCT06010732|468741162|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212656|NCT06010732|468741163|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
130212657|NCT06010732|468741164|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212658|NCT06010732|468741165|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212659|NCT06010732|468741166|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212660|NCT06010732|468741167|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212661|NCT06010732|468741162|FG000|Crossover Period 2|Adverse Event|0|||
130212662|NCT06010732|468741163|FG001|Crossover Period 2|Adverse Event|1|||
130212663|NCT06010732|468741164|FG002|Crossover Period 2|Adverse Event|0|||
130212664|NCT06010732|468741165|FG003|Crossover Period 2|Adverse Event|0|||
130212665|NCT06010732|468741166|FG004|Crossover Period 2|Adverse Event|0|||
130212666|NCT06010732|468741167|FG005|Crossover Period 2|Adverse Event|0|||
130212667|NCT06010732|468741162|FG000|Crossover Period 2|broken denture|0|||
130212668|NCT06010732|468741163|FG001|Crossover Period 2|broken denture|0|||
130212669|NCT06010732|468741164|FG002|Crossover Period 2|broken denture|1|||
130212670|NCT06010732|468741165|FG003|Crossover Period 2|broken denture|0|||
130212671|NCT06010732|468741166|FG004|Crossover Period 2|broken denture|0|||
130212672|NCT06010732|468741167|FG005|Crossover Period 2|broken denture|0|||
130212673|NCT04401202|468741168|FG000|Overall Study|Lost to Follow-up|2|||
130212674|NCT04401202|468741169|FG001|Overall Study|Lost to Follow-up|2|||
130212675|NCT04401202|468741168|FG000|Overall Study|Adverse Event|0|||
130212676|NCT04401202|468741169|FG001|Overall Study|Adverse Event|1|||
130212677|NCT04401202|468741168|FG000|Overall Study|Hospitalized|4|||
130212678|NCT04401202|468741169|FG001|Overall Study|Hospitalized|1|||
130212679|NCT00329745|468741172|FG000|Overall Study|Protocol Violation|1|||
130212680|NCT00329745|468741173|FG001|Overall Study|Protocol Violation|0|||
130212681|NCT00329745|468741172|FG000|Overall Study|Withdrawal by Subject|0|||
130212682|NCT00329745|468741173|FG001|Overall Study|Withdrawal by Subject|1|||
130212683|NCT00329745|468741172|FG000|Overall Study|Lost to Follow-up|86|||
130212684|NCT00329745|468741173|FG001|Overall Study|Lost to Follow-up|101|||
130212685|NCT01597492|468741174|FG000|Overall Study|Withdrawal by Subject|1|||
130212686|NCT01597492|468741175|FG001|Overall Study|Withdrawal by Subject|2|||
130212687|NCT01597492|468741174|FG000|Overall Study|Adverse Event|3|||
130212688|NCT01597492|468741175|FG001|Overall Study|Adverse Event|0|||
130212689|NCT01597492|468741174|FG000|Overall Study|Lost to Follow-up|0|||
130212690|NCT01597492|468741175|FG001|Overall Study|Lost to Follow-up|2|||
130212691|NCT01597492|468741174|FG000|Overall Study|Other Reason|2|||
130212692|NCT01597492|468741175|FG001|Overall Study|Other Reason|0|||
130212693|NCT01939223|468741179|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
130212694|NCT01939223|468741180|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
130212695|NCT01939223|468741179|FG000|Overall Study|Disease recurrence (radiological)|1|||
130212696|NCT01939223|468741180|FG001|Overall Study|Disease recurrence (radiological)|3|||
130212697|NCT01939223|468741179|FG000|Overall Study|Study stopped by Sponsor|5|||
130212698|NCT01939223|468741180|FG001|Overall Study|Study stopped by Sponsor|7|||
130212699|NCT01939223|468741179|FG000|Overall Study|Withdrawal by Subject|6|||
130212700|NCT01939223|468741180|FG001|Overall Study|Withdrawal by Subject|0|||
130212701|NCT03624569|468741181|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130212702|NCT03624569|468741182|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130212703|NCT03624569|468741181|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
130212704|NCT03624569|468741182|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
130212705|NCT01557517|468741183|FG000|Overall Study|Death|1|||
130212706|NCT01557517|468741184|FG001|Overall Study|Death|0|||
130212707|NCT01557517|468741183|FG000|Overall Study|Refused further treatment|0|||
130212708|NCT01557517|468741184|FG001|Overall Study|Refused further treatment|2|||
130212709|NCT01557517|468741183|FG000|Overall Study|Adverse Event|0|||
130212710|NCT01557517|468741184|FG001|Overall Study|Adverse Event|2|||
130212711|NCT01557517|468741183|FG000|Overall Study|Pt declined before treatment started|1|||
130212712|NCT01557517|468741184|FG001|Overall Study|Pt declined before treatment started|0|||
130212713|NCT01204918|468741195|FG000|Overall Study|Withdrawal by Subject|4|||
130212714|NCT01204918|468741196|FG001|Overall Study|Withdrawal by Subject|10|||
130212715|NCT01204918|468741197|FG002|Overall Study|Withdrawal by Subject|5|||
130212716|NCT01853696|468741200|FG000|Overall Study|Withdrawal by Subject|1|||
130212717|NCT01853696|468741201|FG001|Overall Study|Withdrawal by Subject|1|||
130212718|NCT01853696|468741200|FG000|Overall Study|Lost to Follow-up|5|||
130432770|NCT01364597|469547754|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
130212719|NCT01853696|468741201|FG001|Overall Study|Lost to Follow-up|4|||
130212720|NCT00849290|468741204|FG000|Overall Study|Adverse Event|3|||
130212721|NCT00849290|468741204|FG000|Overall Study|Death|14|||
130212722|NCT00849290|468741204|FG000|Overall Study|Withdrawal by Subject|11|||
130212723|NCT00849290|468741204|FG000|Overall Study|Lost to Follow-up|2|||
130212724|NCT00849290|468741204|FG000|Overall Study|Protocol Violation|5|||
130212725|NCT00849290|468741204|FG000|Overall Study|Disease Progression|20|||
130212726|NCT01119846|468741209|FG000|Overall Study|Adverse Event|1|||
130432771|NCT01364597|469547755|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
130212727|NCT01119846|468741210|FG001|Overall Study|Adverse Event|0|||
130212728|NCT01119846|468741211|FG002|Overall Study|Adverse Event|6|||
130212729|NCT01119846|468741209|FG000|Overall Study|Physician Decision|1|||
130212730|NCT01119846|468741210|FG001|Overall Study|Physician Decision|0|||
130212731|NCT01119846|468741211|FG002|Overall Study|Physician Decision|0|||
130212732|NCT01119846|468741209|FG000|Overall Study|Protocol Violation|0|||
130212733|NCT01119846|468741210|FG001|Overall Study|Protocol Violation|0|||
130212734|NCT01119846|468741211|FG002|Overall Study|Protocol Violation|1|||
130212735|NCT01119846|468741209|FG000|Overall Study|Withdrawal by Subject|0|||
130212736|NCT01119846|468741210|FG001|Overall Study|Withdrawal by Subject|0|||
130212737|NCT01119846|468741211|FG002|Overall Study|Withdrawal by Subject|4|||
130212738|NCT03304184|468741216|FG000|Overall Study|Withdrawal by Subject|1|||
130212739|NCT03304184|468741217|FG001|Overall Study|Withdrawal by Subject|2|||
130212740|NCT01605825|468741222|FG000|Overall Study|Adverse Event|4|||
130432772|NCT01364597|469547756|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
130432773|NCT01364597|469547757|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
130432774|NCT01364597|469547754|FG000|Overall Study|Cure|1|||
130432775|NCT01364597|469547755|FG001|Overall Study|Cure|0|||
130432776|NCT01364597|469547756|FG002|Overall Study|Cure|0|||
130432777|NCT01364597|469547757|FG003|Overall Study|Cure|0|||
130432778|NCT01364597|469547754|FG000|Overall Study|Patient was moving|0|||
130432779|NCT01364597|469547755|FG001|Overall Study|Patient was moving|1|||
130432780|NCT01364597|469547756|FG002|Overall Study|Patient was moving|0|||
130432781|NCT01364597|469547757|FG003|Overall Study|Patient was moving|0|||
130432782|NCT01364597|469547754|FG000|Overall Study|Seizures resolved|0|||
130212741|NCT01605825|468741223|FG001|Overall Study|Adverse Event|2|||
130212742|NCT01605825|468741222|FG000|Overall Study|Withdrawal by Subject|0|||
130212743|NCT01605825|468741223|FG001|Overall Study|Withdrawal by Subject|1|||
130212744|NCT01605825|468741222|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
130212745|NCT01605825|468741223|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
130212746|NCT01605825|468741222|FG000|Overall Study|Non-Compliance with Protocol|3|||
130212747|NCT01605825|468741223|FG001|Overall Study|Non-Compliance with Protocol|0|||
130212748|NCT03244618|468741228|FG000|Overall Study|Lost to Follow-up|3|||
130212749|NCT03244618|468741229|FG001|Overall Study|Lost to Follow-up|4|||
130212750|NCT03244618|468741228|FG000|Overall Study|Protocol Violation|4|||
130212751|NCT03244618|468741229|FG001|Overall Study|Protocol Violation|3|||
130212752|NCT03244618|468741228|FG000|Overall Study|Withdrawal by Subject|0|||
130212753|NCT03244618|468741229|FG001|Overall Study|Withdrawal by Subject|2|||
130212754|NCT00913770|468741231|FG000|Overall Study|Unable to contact|24|||
130212755|NCT00913770|468741232|FG001|Overall Study|Unable to contact|19|||
130212756|NCT00913770|468741233|FG002|Overall Study|Unable to contact|13|||
130212757|NCT00913770|468741231|FG000|Overall Study|Refused|11|||
130212758|NCT00913770|468741232|FG001|Overall Study|Refused|10|||
130212759|NCT00913770|468741233|FG002|Overall Study|Refused|8|||
130212760|NCT03816007|468741236|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
130212761|NCT03816007|468741237|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
130212762|NCT03816007|468741236|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
130212763|NCT03816007|468741237|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
130212764|NCT03816007|468741236|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130212765|NCT03816007|468741237|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130212766|NCT01926197|468741238|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
130212767|NCT01926197|468741239|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
130212768|NCT01926197|468741238|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
130212769|NCT01926197|468741239|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
130212770|NCT01428115|468741241|FG000|Overall Study|Lack of Efficacy|3|||
130212771|NCT01428115|468741241|FG000|Overall Study|Lost to Follow-up|10|||
130212772|NCT01428115|468741241|FG000|Overall Study|Pregnancy|1|||
130212773|NCT01428115|468741241|FG000|Overall Study|Protocol Violation|3|||
130212774|NCT01428115|468741241|FG000|Overall Study|Withdrawal by Subject|4|||
130212775|NCT02620384|468741242|FG000|Overall Study|Adverse Event|2|||
130212776|NCT02620384|468741243|FG001|Overall Study|Adverse Event|1|||
130212777|NCT02620384|468741242|FG000|Overall Study|Discharged prior to 2nd dose|2|||
130212778|NCT02620384|468741243|FG001|Overall Study|Discharged prior to 2nd dose|5|||
130212779|NCT02620384|468741242|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
130432783|NCT01364597|469547755|FG001|Overall Study|Seizures resolved|0|||
130212780|NCT02620384|468741243|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
130212781|NCT02101359|468741244|FG000|Overall Study|Not included|23|||
130212782|NCT02101359|468741245|FG001|Overall Study|Not included|13|||
130212783|NCT02101359|468741244|FG000|Overall Study|Withdrawal by Subject|5|||
130212784|NCT02101359|468741245|FG001|Overall Study|Withdrawal by Subject|4|||
130212785|NCT02101359|468741244|FG000|Overall Study|Lost to Follow-up|1|||
130212786|NCT02101359|468741245|FG001|Overall Study|Lost to Follow-up|0|||
130212787|NCT02101359|468741244|FG000|Overall Study|Protocol Violation|0|||
130212788|NCT02101359|468741245|FG001|Overall Study|Protocol Violation|2|||
130432784|NCT01364597|469547756|FG002|Overall Study|Seizures resolved|1|||
130432785|NCT01364597|469547757|FG003|Overall Study|Seizures resolved|0|||
130432786|NCT01364597|469547754|FG000|Overall Study|Patient became seizure-free after surgery|0|||
130212789|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
130212790|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212791|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212792|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130212793|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130212794|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
130212795|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
130212796|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212797|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212798|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212799|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212800|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212801|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212802|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212803|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212804|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212805|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212806|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212807|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212808|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212809|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212810|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212811|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212812|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212813|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212814|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212815|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212816|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212817|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
130212818|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212819|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212820|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212821|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212822|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212823|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212824|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212825|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212826|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212827|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212828|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212829|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212830|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212831|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
130212832|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
130212833|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
130212834|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
130212835|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
130212836|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
130212837|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
130212838|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
130212839|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
130212840|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
130212841|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
130212842|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
130212843|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
130212844|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
130212845|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
130212846|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
130212847|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
130212848|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
130212849|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
130212850|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
130212851|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
130212852|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
130212853|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
130212854|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
130212855|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
130212856|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
130212857|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
130212858|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
130212859|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212860|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212861|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212862|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212863|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212864|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212865|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212866|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212867|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212868|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212869|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212870|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212871|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212872|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212873|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212874|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212875|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212876|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212877|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212878|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212879|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212880|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212881|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212882|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212883|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212884|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212885|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212886|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212887|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212888|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212889|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212890|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212891|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212892|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212893|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212894|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212895|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130212896|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212897|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
130212898|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212899|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212900|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130212901|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212902|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212903|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212904|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212905|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212906|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212907|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212908|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212909|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
130212910|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212911|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212912|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212913|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
130212914|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
130212915|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
130212916|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
130432787|NCT01364597|469547755|FG001|Overall Study|Patient became seizure-free after surgery|0|||
130432788|NCT01364597|469547756|FG002|Overall Study|Patient became seizure-free after surgery|1|||
130212917|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
130212918|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
130212919|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
130212920|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
130212921|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
130212922|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
130212923|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
130212924|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
130212925|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
130212926|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
130212927|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
130212928|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
130212929|NCT00966355|468741261|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
130212930|NCT00966355|468741262|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
130212931|NCT00966355|468741263|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
130212932|NCT00966355|468741261|FG000|Overall Study|newly diagnosed advanced HCC|11|||
130212933|NCT00966355|468741262|FG001|Overall Study|newly diagnosed advanced HCC|12|||
130212934|NCT00966355|468741263|FG002|Overall Study|newly diagnosed advanced HCC|10|||
130212935|NCT00966355|468741261|FG000|Overall Study|Lost to Follow-up|5|||
130212936|NCT00966355|468741262|FG001|Overall Study|Lost to Follow-up|4|||
130212937|NCT00966355|468741263|FG002|Overall Study|Lost to Follow-up|3|||
130212938|NCT01421147|468742909|FG000|Treatment Period|Adverse Event|2|||
130212939|NCT01421147|468742910|FG001|Treatment Period|Adverse Event|3|||
130212940|NCT01421147|468742909|FG000|Treatment Period|Lost to Follow-up|2|||
130212941|NCT01421147|468742910|FG001|Treatment Period|Lost to Follow-up|1|||
130212942|NCT01421147|468742909|FG000|Treatment Period|Physician Decision|2|||
130212943|NCT01421147|468742910|FG001|Treatment Period|Physician Decision|2|||
130212944|NCT01421147|468742909|FG000|Treatment Period|Withdrawal by Subject|10|||
130212945|NCT01421147|468742910|FG001|Treatment Period|Withdrawal by Subject|5|||
130212946|NCT01421147|468742909|FG000|Extension Period|Adverse Event|0|||
130212947|NCT01421147|468742910|FG001|Extension Period|Adverse Event|2|||
130212948|NCT01421147|468742909|FG000|Extension Period|Death|0|||
130212949|NCT01421147|468742910|FG001|Extension Period|Death|1|||
130212950|NCT01421147|468742909|FG000|Extension Period|Lost to Follow-up|2|||
130212951|NCT01421147|468742910|FG001|Extension Period|Lost to Follow-up|5|||
130212952|NCT01421147|468742909|FG000|Extension Period|Physician Decision|1|||
130212953|NCT01421147|468742910|FG001|Extension Period|Physician Decision|0|||
130212954|NCT01421147|468742909|FG000|Extension Period|Withdrawal by Subject|5|||
130212955|NCT01421147|468742910|FG001|Extension Period|Withdrawal by Subject|3|||
130212956|NCT02155309|468742914|FG000|Overall Study|Protocol Violation|0|||
130212957|NCT02155309|468742915|FG001|Overall Study|Protocol Violation|0|||
130212958|NCT02155309|468742916|FG002|Overall Study|Protocol Violation|1|||
130212959|NCT04676152|468742917|FG000|Overall Study|screen fail|9|||
130212960|NCT00662311|468742929|FG000|Overall Study|Respiratory Infection|1|||
130212961|NCT00662311|468742930|FG001|Overall Study|Respiratory Infection|0|||
130212962|NCT00662311|468742931|FG002|Overall Study|Respiratory Infection|0|||
130212963|NCT01467271|468742932|FG000|Overall Study|Death|84|||
130212964|NCT01467271|468742932|FG000|Overall Study|Lost to Follow-up|83|||
130212965|NCT01467271|468742932|FG000|Overall Study|Retraction of patient's consent|21|||
130212966|NCT01467271|468742932|FG000|Overall Study|Other reason|14|||
130212967|NCT02335346|468742951|FG000|Overall Study|Adverse Event|11|||
130212968|NCT02335346|468742951|FG000|Overall Study|Withdrawal by Subject|1|||
130212969|NCT01548768|468742952|FG000|Overall Study|Withdrawal by Subject|0|||
130212970|NCT01548768|468742953|FG001|Overall Study|Withdrawal by Subject|2|||
130212971|NCT01548768|468742954|FG002|Overall Study|Withdrawal by Subject|1|||
130212972|NCT01548768|468742955|FG003|Overall Study|Withdrawal by Subject|0|||
130212973|NCT01548768|468742952|FG000|Overall Study|Physician Decision|1|||
130212974|NCT01548768|468742953|FG001|Overall Study|Physician Decision|0|||
130212975|NCT01548768|468742954|FG002|Overall Study|Physician Decision|0|||
130212976|NCT01548768|468742955|FG003|Overall Study|Physician Decision|0|||
130212977|NCT01548768|468742952|FG000|Overall Study|Adverse Event|0|||
130212978|NCT01548768|468742953|FG001|Overall Study|Adverse Event|0|||
130212979|NCT01548768|468742954|FG002|Overall Study|Adverse Event|0|||
130212980|NCT01548768|468742955|FG003|Overall Study|Adverse Event|1|||
130212981|NCT01548768|468742952|FG000|Overall Study|Non-Compliance|0|||
130212982|NCT01548768|468742953|FG001|Overall Study|Non-Compliance|0|||
130212983|NCT01548768|468742954|FG002|Overall Study|Non-Compliance|0|||
130212984|NCT01548768|468742955|FG003|Overall Study|Non-Compliance|3|||
130212985|NCT03300050|468742956|FG000|Overall Study|Lost to Follow-up|2|||
130212986|NCT03300050|468742957|FG001|Overall Study|Lost to Follow-up|1|||
130212987|NCT03300050|468742958|FG002|Overall Study|Lost to Follow-up|0|||
130212988|NCT03300050|468742959|FG003|Overall Study|Lost to Follow-up|0|||
130212989|NCT03300050|468742960|FG004|Overall Study|Lost to Follow-up|1|||
130212990|NCT03300050|468742956|FG000|Overall Study|Withdrawal by Subject|1|||
130212991|NCT03300050|468742957|FG001|Overall Study|Withdrawal by Subject|1|||
130212992|NCT03300050|468742958|FG002|Overall Study|Withdrawal by Subject|1|||
130543730|NCT01178385|469956824|FG000|Overall Study|Withdrawal by Subject|2|||
130543731|NCT01178385|469956825|FG001|Overall Study|Withdrawal by Subject|0|||
130212993|NCT03300050|468742959|FG003|Overall Study|Withdrawal by Subject|0|||
130212994|NCT03300050|468742960|FG004|Overall Study|Withdrawal by Subject|0|||
130212995|NCT03300050|468742956|FG000|Overall Study|Death|0|||
130212996|NCT03300050|468742957|FG001|Overall Study|Death|0|||
130212997|NCT03300050|468742958|FG002|Overall Study|Death|1|||
130212998|NCT03300050|468742959|FG003|Overall Study|Death|0|||
130212999|NCT03300050|468742960|FG004|Overall Study|Death|0|||
130213000|NCT03300050|468742956|FG000|Overall Study|Not Eligible at Randomization|0|||
130213001|NCT03300050|468742957|FG001|Overall Study|Not Eligible at Randomization|0|||
130213002|NCT03300050|468742958|FG002|Overall Study|Not Eligible at Randomization|1|||
130213003|NCT03300050|468742959|FG003|Overall Study|Not Eligible at Randomization|1|||
130213004|NCT03300050|468742960|FG004|Overall Study|Not Eligible at Randomization|0|||
130213005|NCT02178358|468742974|FG000|Overall Study|Withdrawal by Subject|0|||
130213006|NCT02178358|468742975|FG001|Overall Study|Withdrawal by Subject|2|||
130213007|NCT02178358|468742976|FG002|Overall Study|Withdrawal by Subject|2|||
130213008|NCT02178358|468742974|FG000|Overall Study|Lost to Follow-up|1|||
130213009|NCT02178358|468742975|FG001|Overall Study|Lost to Follow-up|0|||
130213010|NCT02178358|468742976|FG002|Overall Study|Lost to Follow-up|0|||
130213011|NCT01066663|468742977|FG000|Overall Study|Adverse Event|0|||
130213012|NCT01066663|468742978|FG001|Overall Study|Adverse Event|0|||
130213013|NCT01066663|468742979|FG002|Overall Study|Adverse Event|1|||
130213014|NCT02985021|468742980|FG000|Overall Study|Inability to comply with study procedures|1|||
130213015|NCT01090050|468742981|FG000|Overall Study|Lost to Follow-up|0|||
130213016|NCT01090050|468742982|FG001|Overall Study|Lost to Follow-up|1|||
130213017|NCT01090050|468742981|FG000|Overall Study|Lack of Efficacy|1|||
130213018|NCT01090050|468742982|FG001|Overall Study|Lack of Efficacy|5|||
130213019|NCT01090050|468742981|FG000|Overall Study|Physician Decision|0|||
130213020|NCT01090050|468742982|FG001|Overall Study|Physician Decision|1|||
130213021|NCT02232061|468742983|FG000|Overall Study|Administrative problems|1|||
130213022|NCT02232061|468742983|FG000|Overall Study|Withdrawal by Subject|1|||
130213023|NCT00560703|468742985|FG000|Overall Study|Adverse Event|0|||
130213024|NCT00560703|468742986|FG001|Overall Study|Adverse Event|2|||
130213025|NCT00560703|468742985|FG000|Overall Study|Protocol Violation|0|||
130213026|NCT00560703|468742986|FG001|Overall Study|Protocol Violation|2|||
130213027|NCT00560703|468742985|FG000|Overall Study|Withdrawal by Subject|0|||
130213028|NCT00560703|468742986|FG001|Overall Study|Withdrawal by Subject|1|||
130213029|NCT00560703|468742985|FG000|Overall Study|non-compliance|0|||
130213030|NCT00560703|468742986|FG001|Overall Study|non-compliance|1|||
130213031|NCT00790556|468742988|FG000|Treatment Period 1|Physician Decision|1|||
130213032|NCT00790556|468742989|FG001|Treatment Period 1|Physician Decision|0|||
130213033|NCT00790556|468742988|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130213034|NCT00790556|468742989|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130213035|NCT00339833|468742992|FG000|Overall Study|Withdrawal by Subject|1|||
130213036|NCT00339833|468742993|FG001|Overall Study|Withdrawal by Subject|2|||
130213037|NCT00339833|468742992|FG000|Overall Study|toothache|0|||
130213038|NCT00339833|468742993|FG001|Overall Study|toothache|1|||
130213039|NCT00339833|468742992|FG000|Overall Study|indigestion|0|||
130213040|NCT00339833|468742993|FG001|Overall Study|indigestion|1|||
130213041|NCT00339833|468742992|FG000|Overall Study|Chest pain|0|||
130213042|NCT00339833|468742993|FG001|Overall Study|Chest pain|1|||
130213043|NCT00339833|468742992|FG000|Overall Study|minor infection|0|||
130213044|NCT00339833|468742993|FG001|Overall Study|minor infection|1|||
130213045|NCT00339833|468742992|FG000|Overall Study|Poor venous access|2|||
130213046|NCT00339833|468742993|FG001|Overall Study|Poor venous access|2|||
130213047|NCT00339833|468742992|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
130213048|NCT00339833|468742993|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
130213049|NCT00339833|468742992|FG000|Overall Study|Error in data records|1|||
130213050|NCT00339833|468742993|FG001|Overall Study|Error in data records|0|||
130213051|NCT00482170|468742996|FG000|Overall Study|Adverse Event|5|||
130213052|NCT00482170|468742997|FG001|Overall Study|Adverse Event|14|||
130213053|NCT00482170|468742996|FG000|Overall Study|Withdrawal by Subject|6|||
130213054|NCT00482170|468742997|FG001|Overall Study|Withdrawal by Subject|1|||
130213055|NCT00482170|468742996|FG000|Overall Study|Protocol Violation|2|||
130213056|NCT00482170|468742997|FG001|Overall Study|Protocol Violation|3|||
130213057|NCT00482170|468742996|FG000|Overall Study|Lost to Follow-up|2|||
130213058|NCT00482170|468742997|FG001|Overall Study|Lost to Follow-up|0|||
130213059|NCT00482170|468742996|FG000|Overall Study|Unspecified reason|0|||
130213060|NCT00482170|468742997|FG001|Overall Study|Unspecified reason|2|||
130213061|NCT00162097|468742998|FG000|Overall Study|Participant no longer met study criteria|0|||
130213062|NCT00162097|468742999|FG001|Overall Study|Participant no longer met study criteria|0|||
130213063|NCT00162097|468743000|FG002|Overall Study|Participant no longer met study criteria|0|||
130213064|NCT00162097|468743001|FG003|Overall Study|Participant no longer met study criteria|1|||
130213065|NCT03585712|468743004|FG000|Treatment Period 1|Protocol Violation|1|||
130213066|NCT03585712|468743005|FG001|Treatment Period 1|Protocol Violation|0|||
130213067|NCT03585712|468743006|FG002|Treatment Period 1|Protocol Violation|0|||
130213068|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
130213069|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
130213070|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
130213071|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130213072|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
130213073|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130213074|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
130213075|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
130213076|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
130213077|NCT03004924|468743013|FG000|Overall Study|Adverse Event|6|||
130213078|NCT03004924|468743014|FG001|Overall Study|Adverse Event|5|||
130213079|NCT03004924|468743015|FG002|Overall Study|Adverse Event|10|||
130432789|NCT01364597|469547757|FG003|Overall Study|Patient became seizure-free after surgery|0|||
130432790|NCT01364597|469547754|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
130432791|NCT01364597|469547755|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
130432792|NCT01364597|469547756|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
130543732|NCT01688830|469956828|FG000|Overall Study|Lost to Follow-up|0|||
130213080|NCT03004924|468743013|FG000|Overall Study|Protocol Violation|4|||
130213081|NCT03004924|468743014|FG001|Overall Study|Protocol Violation|0|||
130213082|NCT03004924|468743015|FG002|Overall Study|Protocol Violation|1|||
130213083|NCT03004924|468743013|FG000|Overall Study|Withdrawal by Subject|5|||
130213084|NCT03004924|468743014|FG001|Overall Study|Withdrawal by Subject|3|||
130213085|NCT03004924|468743015|FG002|Overall Study|Withdrawal by Subject|5|||
130213086|NCT03004924|468743013|FG000|Overall Study|Lost to Follow-up|6|||
130213087|NCT03004924|468743014|FG001|Overall Study|Lost to Follow-up|1|||
130213088|NCT03004924|468743015|FG002|Overall Study|Lost to Follow-up|4|||
130213089|NCT03004924|468743013|FG000|Overall Study|Lack of Efficacy|2|||
130213090|NCT03004924|468743014|FG001|Overall Study|Lack of Efficacy|4|||
130213091|NCT03004924|468743015|FG002|Overall Study|Lack of Efficacy|2|||
130213092|NCT03004924|468743013|FG000|Overall Study|Physician Decision|1|||
130213093|NCT03004924|468743014|FG001|Overall Study|Physician Decision|0|||
130213094|NCT03004924|468743015|FG002|Overall Study|Physician Decision|1|||
130213095|NCT03004924|468743013|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130213096|NCT03004924|468743014|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130213097|NCT03004924|468743015|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130213098|NCT03004924|468743013|FG000|Overall Study|Screen Failure|1|||
130213099|NCT03004924|468743014|FG001|Overall Study|Screen Failure|0|||
130213100|NCT03004924|468743015|FG002|Overall Study|Screen Failure|0|||
130213101|NCT03004924|468743013|FG000|Overall Study|Pregnancy|0|||
130213102|NCT03004924|468743014|FG001|Overall Study|Pregnancy|1|||
130213103|NCT03004924|468743015|FG002|Overall Study|Pregnancy|0|||
130213104|NCT03004924|468743013|FG000|Overall Study|Terminated by Sponsor|0|||
130213105|NCT03004924|468743014|FG001|Overall Study|Terminated by Sponsor|0|||
130213106|NCT03004924|468743015|FG002|Overall Study|Terminated by Sponsor|1|||
130213107|NCT03004924|468743013|FG000|Overall Study|Missed Study Visit|0|||
130213108|NCT03004924|468743014|FG001|Overall Study|Missed Study Visit|0|||
130213109|NCT03004924|468743015|FG002|Overall Study|Missed Study Visit|2|||
130213110|NCT03004924|468743013|FG000|Overall Study|HSV1 Positive|1|||
130213111|NCT03004924|468743014|FG001|Overall Study|HSV1 Positive|0|||
130213112|NCT03004924|468743015|FG002|Overall Study|HSV1 Positive|0|||
130213113|NCT01280682|468743016|FG000|Overall Study|Lost to Follow-up|0|||
130213114|NCT01280682|468743017|FG001|Overall Study|Lost to Follow-up|6|||
130213115|NCT01280682|468743016|FG000|Overall Study|Withdrawal by Subject|0|||
130213116|NCT01280682|468743017|FG001|Overall Study|Withdrawal by Subject|7|||
130213117|NCT00269477|468743020|FG000|Overall Study|Protocol Violation|5|||
130213118|NCT00269477|468743021|FG001|Overall Study|Protocol Violation|5|||
130213119|NCT00269477|468743022|FG002|Overall Study|Protocol Violation|1|||
130213120|NCT00269477|468743023|FG003|Overall Study|Protocol Violation|0|||
130213121|NCT00269477|468743020|FG000|Overall Study|Missed post-vaccination blood draw|0|||
130213122|NCT00269477|468743021|FG001|Overall Study|Missed post-vaccination blood draw|1|||
130213123|NCT00269477|468743022|FG002|Overall Study|Missed post-vaccination blood draw|0|||
130213124|NCT00269477|468743023|FG003|Overall Study|Missed post-vaccination blood draw|0|||
130213125|NCT01964716|468743030|FG000|Overall Study|Withdrawal by Subject|2|||
130213126|NCT01964716|468743031|FG001|Overall Study|Withdrawal by Subject|3|||
130213127|NCT01964716|468743030|FG000|Overall Study|Lost to Follow-up|1|||
130213128|NCT01964716|468743031|FG001|Overall Study|Lost to Follow-up|2|||
130213129|NCT01964716|468743030|FG000|Overall Study|No longer met eligibility criteria|1|||
130213130|NCT01964716|468743031|FG001|Overall Study|No longer met eligibility criteria|1|||
130213131|NCT01964716|468743030|FG000|Overall Study|Death|1|||
130213132|NCT01964716|468743031|FG001|Overall Study|Death|0|||
130213133|NCT01464619|468743032|FG000|Overall Study|Lost to Follow-up|3|||
130213134|NCT01464619|468743033|FG001|Overall Study|Lost to Follow-up|4|||
130213135|NCT00080483|468743038|FG000|Overall Study|Lost to Follow-up|1|||
130213136|NCT00080483|468743039|FG001|Overall Study|Lost to Follow-up|1|||
130213137|NCT00080483|468743038|FG000|Overall Study|Physician Decision|1|||
130213138|NCT00080483|468743039|FG001|Overall Study|Physician Decision|1|||
130213139|NCT04527978|468743040|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130213140|NCT04527978|468743041|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130213141|NCT01370616|468743042|FG000|Overall Study|Adverse Event|11|||
130213142|NCT01370616|468743043|FG001|Overall Study|Adverse Event|16|||
130213143|NCT01370616|468743042|FG000|Overall Study|Death|1|||
130213144|NCT01370616|468743043|FG001|Overall Study|Death|0|||
130213145|NCT01370616|468743042|FG000|Overall Study|Lack of Efficacy|6|||
130213146|NCT01370616|468743043|FG001|Overall Study|Lack of Efficacy|2|||
130213147|NCT01370616|468743042|FG000|Overall Study|Lost to Follow-up|0|||
130213148|NCT01370616|468743043|FG001|Overall Study|Lost to Follow-up|3|||
130213149|NCT01370616|468743042|FG000|Overall Study|Physician Decision|6|||
130213150|NCT01370616|468743043|FG001|Overall Study|Physician Decision|6|||
130213151|NCT01370616|468743042|FG000|Overall Study|Progressive Disease|0|||
130213152|NCT01370616|468743043|FG001|Overall Study|Progressive Disease|1|||
130213153|NCT01370616|468743042|FG000|Overall Study|Recovery|1|||
130213154|NCT01370616|468743043|FG001|Overall Study|Recovery|0|||
130213155|NCT01370616|468743042|FG000|Overall Study|Technical Problems|3|||
130213156|NCT01370616|468743043|FG001|Overall Study|Technical Problems|5|||
130213157|NCT01370616|468743042|FG000|Overall Study|Withdrawal by Subject|34|||
130213158|NCT01370616|468743043|FG001|Overall Study|Withdrawal by Subject|34|||
130213159|NCT02324699|468743044|FG000|Overall Study|study terminated|1|||
130213160|NCT01578499|468743047|FG000|Overall Study|Reason not Specified|0|||
130213161|NCT01578499|468743048|FG001|Overall Study|Reason not Specified|1|||
130213162|NCT01578499|468743047|FG000|Overall Study|Lost to Follow-up|2|||
130213163|NCT01578499|468743048|FG001|Overall Study|Lost to Follow-up|1|||
130213164|NCT01578499|468743047|FG000|Overall Study|Withdrawal by Subject|10|||
130213165|NCT01578499|468743048|FG001|Overall Study|Withdrawal by Subject|16|||
130213166|NCT01578499|468743047|FG000|Overall Study|Death|20|||
130213167|NCT01578499|468743048|FG001|Overall Study|Death|25|||
130213168|NCT01578499|468743047|FG000|Overall Study|Died and End of Study Page not Completed|2|||
130213169|NCT01578499|468743048|FG001|Overall Study|Died and End of Study Page not Completed|0|||
130213170|NCT02670382|468743049|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
130213171|NCT02670382|468743050|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
130213172|NCT03469999|468743053|FG000|Overall Study|Lost to Follow-up|2|||
130213173|NCT01863732|468743054|FG000|Overall Study|Adverse Event|2|||
130213174|NCT01863732|468743055|FG001|Overall Study|Adverse Event|0|||
130213175|NCT01863732|468743056|FG002|Overall Study|Adverse Event|3|||
130213176|NCT01863732|468743057|FG003|Overall Study|Adverse Event|3|||
130213177|NCT01863732|468743054|FG000|Overall Study|Lack of Efficacy|1|||
130213178|NCT01863732|468743055|FG001|Overall Study|Lack of Efficacy|0|||
130213179|NCT01863732|468743056|FG002|Overall Study|Lack of Efficacy|2|||
130213180|NCT01863732|468743057|FG003|Overall Study|Lack of Efficacy|1|||
130213181|NCT01863732|468743054|FG000|Overall Study|Lost to Follow-up|2|||
130213182|NCT01863732|468743055|FG001|Overall Study|Lost to Follow-up|2|||
130213183|NCT01863732|468743056|FG002|Overall Study|Lost to Follow-up|1|||
130213184|NCT01863732|468743057|FG003|Overall Study|Lost to Follow-up|1|||
130213185|NCT01863732|468743054|FG000|Overall Study|Physician Decision|1|||
130213186|NCT01863732|468743055|FG001|Overall Study|Physician Decision|0|||
130213187|NCT01863732|468743056|FG002|Overall Study|Physician Decision|1|||
130213188|NCT01863732|468743057|FG003|Overall Study|Physician Decision|0|||
130213189|NCT01863732|468743054|FG000|Overall Study|Pregnancy|0|||
130213190|NCT01863732|468743055|FG001|Overall Study|Pregnancy|0|||
130213191|NCT01863732|468743056|FG002|Overall Study|Pregnancy|0|||
130213192|NCT01863732|468743057|FG003|Overall Study|Pregnancy|1|||
130213193|NCT01863732|468743054|FG000|Overall Study|Technical problems|0|||
130213194|NCT01863732|468743055|FG001|Overall Study|Technical problems|1|||
130213195|NCT01863732|468743056|FG002|Overall Study|Technical problems|1|||
130213196|NCT01863732|468743057|FG003|Overall Study|Technical problems|0|||
130213197|NCT01863732|468743054|FG000|Overall Study|Subject/guardian decision|6|||
130213198|NCT01863732|468743055|FG001|Overall Study|Subject/guardian decision|9|||
130213199|NCT01863732|468743056|FG002|Overall Study|Subject/guardian decision|3|||
130213200|NCT01863732|468743057|FG003|Overall Study|Subject/guardian decision|1|||
130213201|NCT01863732|468743054|FG000|Overall Study|Death|1|||
130213202|NCT01863732|468743055|FG001|Overall Study|Death|0|||
130213203|NCT01863732|468743056|FG002|Overall Study|Death|0|||
130213204|NCT01863732|468743057|FG003|Overall Study|Death|1|||
130213205|NCT00460746|468743058|FG000|Overall Study|Adverse Event|1|||
130213206|NCT00460746|468743058|FG000|Overall Study|Lost to Follow-up|1|||
130213207|NCT00636961|468743064|FG000|Period 1|Administrative problems|1|||
130213208|NCT00636961|468743065|FG001|Period 1|Administrative problems|1|||
130213209|NCT00636961|468743064|FG000|Period 2|Adverse Event|1|||
130213210|NCT00636961|468743065|FG001|Period 2|Adverse Event|0|||
130213211|NCT02223364|468743066|FG000|Overall Study|Protocol Violation|3|||
130213212|NCT02223364|468743067|FG001|Overall Study|Protocol Violation|0|||
130213213|NCT02223364|468743068|FG002|Overall Study|Protocol Violation|3|||
130213214|NCT02223364|468743066|FG000|Overall Study|subject expired before surgery|1|||
130213215|NCT02223364|468743067|FG001|Overall Study|subject expired before surgery|0|||
130213216|NCT02223364|468743068|FG002|Overall Study|subject expired before surgery|0|||
130213217|NCT02223364|468743066|FG000|Overall Study|Physician Decision|1|||
130213218|NCT02223364|468743067|FG001|Overall Study|Physician Decision|0|||
130213219|NCT02223364|468743068|FG002|Overall Study|Physician Decision|0|||
130213220|NCT00742027|468743069|FG000|Overall Study|Disease Progression|76|||
130213221|NCT00742027|468743069|FG000|Overall Study|New Cancer Therapy|19|||
130320364|NCT00506350|469141897|FG005|Overall Study|Lost to Follow-up|1|||
130213222|NCT00742027|468743069|FG000|Overall Study|Withdrawal by Subject|18|||
130213223|NCT00742027|468743069|FG000|Overall Study|Death|7|||
130213224|NCT00742027|468743069|FG000|Overall Study|Lost to Follow-up|4|||
130213225|NCT00742027|468743069|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
130213226|NCT00742027|468743069|FG000|Overall Study|Missing|2|||
130213227|NCT00742027|468743069|FG000|Overall Study|Administrative Problems|1|||
130213228|NCT00171158|468744560|FG000|Core Study|Death|27|||
130213229|NCT00171158|468744560|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
130213230|NCT00171158|468744560|FG000|Core Study|Protocol Violation|4|||
130213231|NCT00171158|468744560|FG000|Core Study|Administrative problems|1|||
130213232|NCT00171158|468744560|FG000|Core Study|Adverse event, non-fatal|21|||
130213233|NCT00171158|468744560|FG000|Core Study|Consent withdrawn by subject|6|||
130213234|NCT00171158|468744560|FG000|Core Study|No longer required drug (BMT)|14|||
130213235|NCT00171158|468744560|FG000|Core Study|Abnormal Laboratory Values|2|||
130213236|NCT00171158|468744560|FG000|Core Study|Lost to Follow-up|1|||
130213237|NCT00171158|468744560|FG000|E2 Extension|Other|7|||
130213238|NCT03536663|468744563|FG000|Endexo|Protocol Violation|1|||
130213239|NCT00762034|468744564|FG000|Induction Period|Protocol Violation|1|||
130213240|NCT00762034|468744565|FG001|Induction Period|Protocol Violation|2|||
130213241|NCT00762034|468744564|FG000|Induction Period|Entry Criterion Not Met|12|||
130213242|NCT00762034|468744565|FG001|Induction Period|Entry Criterion Not Met|11|||
130213243|NCT00762034|468744564|FG000|Induction Period|Adverse Event|27|||
130213244|NCT00762034|468744565|FG001|Induction Period|Adverse Event|38|||
130213245|NCT00762034|468744564|FG000|Induction Period|Lost to Follow-up|1|||
130213246|NCT00762034|468744565|FG001|Induction Period|Lost to Follow-up|1|||
130213247|NCT00762034|468744564|FG000|Induction Period|Progressive Disease|73|||
130213248|NCT00762034|468744565|FG001|Induction Period|Progressive Disease|55|||
130213249|NCT00762034|468744564|FG000|Induction Period|Physician Decision|21|||
130213250|NCT00762034|468744565|FG001|Induction Period|Physician Decision|20|||
130213251|NCT00762034|468744564|FG000|Induction Period|Withdrawal by Subject|15|||
130213252|NCT00762034|468744565|FG001|Induction Period|Withdrawal by Subject|19|||
130213253|NCT00762034|468744564|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
130213254|NCT00762034|468744565|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
130213255|NCT00762034|468744564|FG000|Induction Period|Deaths Due to Study Disease|9|||
130213256|NCT00762034|468744565|FG001|Induction Period|Deaths Due to Study Disease|9|||
130213257|NCT00762034|468744564|FG000|Maintenance Period|Protocol Violation|1|||
130213258|NCT00762034|468744565|FG001|Maintenance Period|Protocol Violation|3|||
130213259|NCT00762034|468744564|FG000|Maintenance Period|Entry Criterion Not Met|0|||
130213260|NCT00762034|468744565|FG001|Maintenance Period|Entry Criterion Not Met|2|||
130213261|NCT00762034|468744564|FG000|Maintenance Period|Adverse Event|42|||
130213262|NCT00762034|468744565|FG001|Maintenance Period|Adverse Event|26|||
130213263|NCT00762034|468744564|FG000|Maintenance Period|Progressive Disease|186|||
130213264|NCT00762034|468744565|FG001|Maintenance Period|Progressive Disease|224|||
130213265|NCT00762034|468744564|FG000|Maintenance Period|Physician Decision|25|||
130213266|NCT00762034|468744565|FG001|Maintenance Period|Physician Decision|20|||
130213267|NCT00762034|468744564|FG000|Maintenance Period|Withdrawal by Subject|34|||
130213268|NCT00762034|468744565|FG001|Maintenance Period|Withdrawal by Subject|14|||
130213269|NCT00762034|468744564|FG000|Maintenance Period|Death not due to study disease|2|||
130213270|NCT00762034|468744565|FG001|Maintenance Period|Death not due to study disease|5|||
130213271|NCT00762034|468744564|FG000|Maintenance Period|Death due to study disease|3|||
130213272|NCT00762034|468744565|FG001|Maintenance Period|Death due to study disease|3|||
130213273|NCT00762034|468744564|FG000|Maintenance Period|Other|1|||
130213274|NCT00762034|468744565|FG001|Maintenance Period|Other|1|||
130213275|NCT02442206|468744566|FG000|Period 1|Adverse Event|1|||
130213276|NCT02442206|468744567|FG001|Period 1|Adverse Event|1|||
130213277|NCT02442206|468744566|FG000|Period 1|withdrew consent|0|||
130213278|NCT02442206|468744567|FG001|Period 1|withdrew consent|1|||
130213279|NCT02442206|468744566|FG000|Period 1|COPD exacerbation|0|||
130213280|NCT02442206|468744567|FG001|Period 1|COPD exacerbation|1|||
130213281|NCT02442206|468744566|FG000|Period 2|Adverse Event|1|||
130213282|NCT02442206|468744567|FG001|Period 2|Adverse Event|0|||
130213283|NCT00497146|468744568|FG000|Treatment Period|Adverse Event|6|||
130213284|NCT00497146|468744569|FG001|Treatment Period|Adverse Event|2|||
130213285|NCT00497146|468744568|FG000|Treatment Period|Withdrawal by Subject|5|||
130213286|NCT00497146|468744569|FG001|Treatment Period|Withdrawal by Subject|9|||
130213287|NCT00497146|468744568|FG000|Treatment Period|Lost to Follow-up|1|||
130213288|NCT00497146|468744569|FG001|Treatment Period|Lost to Follow-up|3|||
130213289|NCT00497146|468744568|FG000|Treatment Period|Required dialysis|4|||
130213290|NCT00497146|468744569|FG001|Treatment Period|Required dialysis|1|||
130213291|NCT00497146|468744568|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
130213292|NCT00497146|468744569|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
130213293|NCT00497146|468744568|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
130213294|NCT00497146|468744569|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
130213295|NCT00497146|468744568|FG000|Treatment Period|Other Reason|2|||
130213296|NCT00497146|468744569|FG001|Treatment Period|Other Reason|3|||
130213297|NCT00497146|468744568|FG000|Long-term Follow-up Period|Adverse Event|2|||
130213298|NCT00497146|468744569|FG001|Long-term Follow-up Period|Adverse Event|2|||
130213299|NCT00497146|468744568|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
130213300|NCT00497146|468744569|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
130213301|NCT00497146|468744568|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
130213302|NCT00497146|468744569|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
130213303|NCT00497146|468744568|FG000|Long-term Follow-up Period|Other|0|||
130213304|NCT00497146|468744569|FG001|Long-term Follow-up Period|Other|1|||
130213305|NCT01471444|468744570|FG000|Overall Study|Physician Decision|3|||
130213306|NCT01471444|468744571|FG001|Overall Study|Physician Decision|2|||
130213307|NCT01471444|468744570|FG000|Overall Study|Withdrawal by Subject|0|||
130213308|NCT01471444|468744571|FG001|Overall Study|Withdrawal by Subject|1|||
130213309|NCT01299896|468744574|FG000|Overall Study|Withdrawal by Subject|1|||
130213310|NCT01299896|468744575|FG001|Overall Study|Withdrawal by Subject|7|||
130213311|NCT01299896|468744574|FG000|Overall Study|Lost to Follow-up|0|||
130213312|NCT01299896|468744575|FG001|Overall Study|Lost to Follow-up|11|||
130213313|NCT02107313|468744576|FG000|Overall Study|One participant did not do the FED cohor|0|||
130213314|NCT02107313|468744577|FG001|Overall Study|One participant did not do the FED cohor|1|||
130213315|NCT00582426|468744588|FG000|Overall Study|Lost to Follow-up|0|||
130213316|NCT00582426|468744589|FG001|Overall Study|Lost to Follow-up|2|||
130213317|NCT00582426|468744588|FG000|Overall Study|Adverse Event|4|||
130213318|NCT00582426|468744589|FG001|Overall Study|Adverse Event|2|||
130213319|NCT00582426|468744588|FG000|Overall Study|Protocol Violation|6|||
130213320|NCT00582426|468744589|FG001|Overall Study|Protocol Violation|2|||
130213321|NCT00582426|468744588|FG000|Overall Study|Death|4|||
130213322|NCT00582426|468744589|FG001|Overall Study|Death|3|||
130213323|NCT00582426|468744588|FG000|Overall Study|Withdrawal by Subject|3|||
130213324|NCT00582426|468744589|FG001|Overall Study|Withdrawal by Subject|2|||
130213325|NCT00582426|468744588|FG000|Overall Study|Disease Progression|2|||
130213326|NCT00582426|468744589|FG001|Overall Study|Disease Progression|2|||
130213327|NCT00582426|468744588|FG000|Overall Study|Use of illicit drugs|1|||
130213328|NCT00582426|468744589|FG001|Overall Study|Use of illicit drugs|0|||
130213329|NCT02164318|468744590|FG000|Overall Study|Withdrawal by Subject|0|||
130213330|NCT02164318|468744591|FG001|Overall Study|Withdrawal by Subject|1|||
130213331|NCT02164318|468744592|FG002|Overall Study|Withdrawal by Subject|0|||
130213332|NCT02164318|468744593|FG003|Overall Study|Withdrawal by Subject|1|||
130213333|NCT04126317|468744597|FG000|Overall Study|Adverse Event|0|||
130213334|NCT04126317|468744598|FG001|Overall Study|Adverse Event|1|||
130213335|NCT04126317|468744597|FG000|Overall Study|Withdrawal by Subject|4|||
130213336|NCT04126317|468744598|FG001|Overall Study|Withdrawal by Subject|1|||
130213337|NCT03297021|468744600|FG000|Overall Study|Incomplete/illegible data sheet|4|||
130213338|NCT03297021|468744601|FG001|Overall Study|Incomplete/illegible data sheet|2|||
130213339|NCT03297021|468744602|FG002|Overall Study|Incomplete/illegible data sheet|3|||
130213340|NCT03297021|468744600|FG000|Overall Study|Missing Post-Op Data|1|||
130213341|NCT03297021|468744601|FG001|Overall Study|Missing Post-Op Data|2|||
130213342|NCT03297021|468744602|FG002|Overall Study|Missing Post-Op Data|1|||
130213343|NCT00948922|468744604|FG000|Overall Study|Did not start study treatment|2|||
130213344|NCT00948922|468744605|FG001|Overall Study|Did not start study treatment|5|||
130213345|NCT00948922|468744606|FG002|Overall Study|Did not start study treatment|0|||
130213346|NCT00948922|468744604|FG000|Overall Study|Withdrawal by Subject|0|||
130213347|NCT00948922|468744605|FG001|Overall Study|Withdrawal by Subject|2|||
130213348|NCT00948922|468744606|FG002|Overall Study|Withdrawal by Subject|1|||
130213349|NCT00948922|468744604|FG000|Overall Study|Death|3|||
130213350|NCT00948922|468744605|FG001|Overall Study|Death|0|||
130213351|NCT00948922|468744606|FG002|Overall Study|Death|0|||
130213352|NCT00948922|468744604|FG000|Overall Study|Disease progression|0|||
130213353|NCT00948922|468744605|FG001|Overall Study|Disease progression|1|||
130213354|NCT00948922|468744606|FG002|Overall Study|Disease progression|0|||
130213355|NCT00948922|468744604|FG000|Overall Study|Insurance issues|1|||
130213356|NCT00948922|468744605|FG001|Overall Study|Insurance issues|0|||
130213357|NCT00948922|468744606|FG002|Overall Study|Insurance issues|0|||
130213358|NCT00948922|468744604|FG000|Overall Study|Transplant eligibility issues|2|||
130213359|NCT00948922|468744605|FG001|Overall Study|Transplant eligibility issues|3|||
130213360|NCT00948922|468744606|FG002|Overall Study|Transplant eligibility issues|0|||
130213361|NCT00948922|468744604|FG000|Overall Study|Not evaluable at time of analysis|0|||
130213362|NCT00948922|468744605|FG001|Overall Study|Not evaluable at time of analysis|3|||
130213363|NCT00948922|468744606|FG002|Overall Study|Not evaluable at time of analysis|0|||
130213364|NCT02095197|468744607|FG000|Overall Study|Lost to Follow-up|0|||
130213365|NCT02095197|468744608|FG001|Overall Study|Lost to Follow-up|3|||
130213366|NCT02829047|468744612|FG000|Overall Study|Withdrawal by Subject|1|||
130213367|NCT03077607|468744614|FG000|Period 1 (15 Days)|Adverse Event|1|||
130213368|NCT03077607|468744615|FG001|Period 1 (15 Days)|Adverse Event|0|||
130213369|NCT03077607|468744614|FG000|Period 1 (15 Days)|Death|1|||
130213370|NCT03077607|468744615|FG001|Period 1 (15 Days)|Death|0|||
130213371|NCT03077607|468744614|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
130213372|NCT03077607|468744615|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
130213373|NCT03077607|468744614|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130320365|NCT00506350|469141898|FG006|Overall Study|Lost to Follow-up|0|||
130432793|NCT01364597|469547757|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
130432794|NCT01364597|469547754|FG000|Overall Study|Patient cured from Epilepsy|0|||
130432795|NCT01364597|469547755|FG001|Overall Study|Patient cured from Epilepsy|0|||
130432796|NCT01364597|469547756|FG002|Overall Study|Patient cured from Epilepsy|1|||
130432797|NCT01364597|469547757|FG003|Overall Study|Patient cured from Epilepsy|0|||
130432798|NCT01364597|469547754|FG000|Overall Study|Investigator decision|0|||
130432799|NCT01364597|469547755|FG001|Overall Study|Investigator decision|0|||
130432800|NCT01364597|469547756|FG002|Overall Study|Investigator decision|1|||
130432801|NCT01364597|469547757|FG003|Overall Study|Investigator decision|0|||
130432802|NCT01364597|469547754|FG000|Overall Study|Sponsor recommended discontinuation|0|||
130432803|NCT01364597|469547755|FG001|Overall Study|Sponsor recommended discontinuation|0|||
130432804|NCT01364597|469547756|FG002|Overall Study|Sponsor recommended discontinuation|0|||
130432805|NCT01364597|469547757|FG003|Overall Study|Sponsor recommended discontinuation|1|||
130432806|NCT01364597|469547754|FG000|Overall Study|Parents went abroad with the patient|0|||
130432807|NCT01364597|469547755|FG001|Overall Study|Parents went abroad with the patient|0|||
130432808|NCT01364597|469547756|FG002|Overall Study|Parents went abroad with the patient|1|||
130432809|NCT01364597|469547757|FG003|Overall Study|Parents went abroad with the patient|0|||
130432810|NCT01364597|469547754|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
130432811|NCT01364597|469547755|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
130432812|NCT01364597|469547756|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
130432813|NCT01364597|469547757|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
130432814|NCT01364597|469547754|FG000|Overall Study|BRV administration dropout|0|||
130432815|NCT01364597|469547755|FG001|Overall Study|BRV administration dropout|0|||
130432816|NCT01364597|469547756|FG002|Overall Study|BRV administration dropout|1|||
130432817|NCT01364597|469547757|FG003|Overall Study|BRV administration dropout|0|||
130432818|NCT01364597|469547754|FG000|Overall Study|Dropout|0|||
130432819|NCT01364597|469547755|FG001|Overall Study|Dropout|0|||
130432820|NCT01364597|469547756|FG002|Overall Study|Dropout|3|||
130432821|NCT01364597|469547757|FG003|Overall Study|Dropout|1|||
130432822|NCT01364597|469547754|FG000|Overall Study|Unreliable subject|0|||
130432823|NCT01364597|469547755|FG001|Overall Study|Unreliable subject|0|||
130432824|NCT01364597|469547756|FG002|Overall Study|Unreliable subject|0|||
130432825|NCT01364597|469547757|FG003|Overall Study|Unreliable subject|1|||
130432826|NCT01364597|469547754|FG000|Overall Study|Other|0|||
130432827|NCT01364597|469547755|FG001|Overall Study|Other|0|||
130432828|NCT01364597|469547756|FG002|Overall Study|Other|0|||
130432829|NCT01364597|469547757|FG003|Overall Study|Other|1|||
130432830|NCT04581200|469547767|FG000|Overall Study|Lost to Follow-up|6|||
130432831|NCT04581200|469547768|FG001|Overall Study|Lost to Follow-up|5|||
130432832|NCT03579290|469547771|FG000|Overall Study|Lost to Follow-up|9|||
130432833|NCT03131960|469547772|FG000|Overall Study|Adverse Event|0|||
130432834|NCT03131960|469547773|FG001|Overall Study|Adverse Event|1|||
130432835|NCT01781390|469547774|FG000|Overall Study|Withdrawal of Consent|0|||
130432836|NCT01781390|469547775|FG001|Overall Study|Withdrawal of Consent|3|||
130432837|NCT01781390|469547776|FG002|Overall Study|Withdrawal of Consent|1|||
130432838|NCT01781390|469547774|FG000|Overall Study|Lost to Follow-up|1|||
130432839|NCT01781390|469547775|FG001|Overall Study|Lost to Follow-up|1|||
130432840|NCT01781390|469547776|FG002|Overall Study|Lost to Follow-up|1|||
130213374|NCT03077607|468744615|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130213375|NCT01658904|468744617|FG000|Overall Study|Principal Investigator discretion|2|||
130213376|NCT01658904|468744618|FG001|Overall Study|Principal Investigator discretion|0|||
130213377|NCT01658904|468744619|FG002|Overall Study|Principal Investigator discretion|0|||
130213378|NCT01603394|468744629|FG000|Overall Study|Adverse Event|1|||
130213379|NCT04399538|468744631|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
130213380|NCT04399538|468744632|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
130213381|NCT04399538|468744633|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
130213382|NCT04399538|468744634|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
130213383|NCT04399538|468744635|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
130213384|NCT04399538|468744631|FG000|Double-Blind Treatment|Adverse Event|0|||
130213385|NCT04399538|468744632|FG001|Double-Blind Treatment|Adverse Event|0|||
130213386|NCT04399538|468744633|FG002|Double-Blind Treatment|Adverse Event|0|||
130213387|NCT04399538|468744634|FG003|Double-Blind Treatment|Adverse Event|0|||
130213388|NCT04399538|468744635|FG004|Double-Blind Treatment|Adverse Event|1|||
130213389|NCT04399538|468744631|FG000|Follow-Up|Adverse Event|0|||
130213390|NCT04399538|468744632|FG001|Follow-Up|Adverse Event|0|||
130213391|NCT04399538|468744633|FG002|Follow-Up|Adverse Event|0|||
130213392|NCT04399538|468744634|FG003|Follow-Up|Adverse Event|0|||
130213393|NCT04399538|468744635|FG004|Follow-Up|Adverse Event|1|||
130213394|NCT04399538|468744631|FG000|Follow-Up|Withdrawal by Subject|0|||
130432841|NCT01781390|469547774|FG000|Overall Study|Adverse Event|1|||
130432842|NCT01781390|469547775|FG001|Overall Study|Adverse Event|2|||
130432843|NCT01781390|469547776|FG002|Overall Study|Adverse Event|1|||
130432844|NCT01781390|469547774|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
130432845|NCT01781390|469547775|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
130213395|NCT04399538|468744632|FG001|Follow-Up|Withdrawal by Subject|0|||
130432846|NCT01781390|469547776|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
130432847|NCT00622713|469547779|FG000|Overall Study|Adverse Event|35|||
130432848|NCT00622713|469547779|FG000|Overall Study|Administrative problems|4|||
130432849|NCT00622713|469547779|FG000|Overall Study|Withdrawal by Subject|11|||
130432850|NCT00622713|469547779|FG000|Overall Study|Lost to Follow-up|5|||
130432851|NCT00622713|469547779|FG000|Overall Study|Death|2|||
130432852|NCT00622713|469547779|FG000|Overall Study|Subject no longer required study drug|1|||
130432853|NCT00622713|469547779|FG000|Overall Study|Did not meet eligibility criteria|1|||
130432854|NCT04404478|469547783|FG000|Overall Study|Withdrawal by Subject|1|||
130432855|NCT04404478|469547784|FG001|Overall Study|Withdrawal by Subject|3|||
130432856|NCT03485911|469547785|FG000|Part 1|Perceived lack of efficacy|1|||
130432857|NCT03485911|469547786|FG001|Part 1|Perceived lack of efficacy|1|||
130432858|NCT03485911|469547787|FG002|Part 1|Perceived lack of efficacy|2|||
130432859|NCT03485911|469547788|FG003|Part 1|Perceived lack of efficacy|0|||
130432860|NCT03485911|469547785|FG000|Part 1|Subject withdrew consent|0|||
130432861|NCT03485911|469547786|FG001|Part 1|Subject withdrew consent|1|||
130432862|NCT03485911|469547787|FG002|Part 1|Subject withdrew consent|0|||
130432863|NCT03485911|469547788|FG003|Part 1|Subject withdrew consent|1|||
130432864|NCT03485911|469547785|FG000|Part 1|Lab abnormalities/AEs|3|||
130432865|NCT03485911|469547786|FG001|Part 1|Lab abnormalities/AEs|1|||
130432866|NCT03485911|469547787|FG002|Part 1|Lab abnormalities/AEs|1|||
130432867|NCT03485911|469547788|FG003|Part 1|Lab abnormalities/AEs|0|||
130432868|NCT03485911|469547785|FG000|Part 1|Withdrew Consent prior to dosing|0|||
130432869|NCT03485911|469547786|FG001|Part 1|Withdrew Consent prior to dosing|0|||
130432870|NCT03485911|469547787|FG002|Part 1|Withdrew Consent prior to dosing|0|||
130432871|NCT03485911|469547788|FG003|Part 1|Withdrew Consent prior to dosing|1|||
130432872|NCT03485911|469547785|FG000|Part 1|Other NOS|0|||
130432873|NCT03485911|469547786|FG001|Part 1|Other NOS|0|||
130432874|NCT03485911|469547787|FG002|Part 1|Other NOS|0|||
130432875|NCT03485911|469547788|FG003|Part 1|Other NOS|1|||
130432876|NCT03485911|469547785|FG000|Part 2|Perceived lack of efficacy|5|||
130432877|NCT03485911|469547786|FG001|Part 2|Perceived lack of efficacy|3|||
130432878|NCT03485911|469547787|FG002|Part 2|Perceived lack of efficacy|0|||
130432879|NCT03485911|469547788|FG003|Part 2|Perceived lack of efficacy|2|||
130432880|NCT03485911|469547785|FG000|Part 2|Subject withdrew consent|1|||
130432881|NCT03485911|469547786|FG001|Part 2|Subject withdrew consent|0|||
130432882|NCT03485911|469547787|FG002|Part 2|Subject withdrew consent|2|||
130432883|NCT03485911|469547788|FG003|Part 2|Subject withdrew consent|1|||
130432884|NCT03485911|469547785|FG000|Part 2|Lab abnormalities/AEs|1|||
130432885|NCT03485911|469547786|FG001|Part 2|Lab abnormalities/AEs|2|||
130432886|NCT03485911|469547787|FG002|Part 2|Lab abnormalities/AEs|0|||
130432887|NCT03485911|469547788|FG003|Part 2|Lab abnormalities/AEs|0|||
130432888|NCT03485911|469547785|FG000|Part 2|Other NOS|0|||
130432889|NCT03485911|469547786|FG001|Part 2|Other NOS|1|||
130432890|NCT03485911|469547787|FG002|Part 2|Other NOS|0|||
130432891|NCT03485911|469547788|FG003|Part 2|Other NOS|0|||
130432892|NCT03485911|469547785|FG000|Part 2|Intercurrent illness/new medical condition|1|||
130432893|NCT03485911|469547786|FG001|Part 2|Intercurrent illness/new medical condition|0|||
130432894|NCT03485911|469547787|FG002|Part 2|Intercurrent illness/new medical condition|0|||
130432895|NCT03485911|469547788|FG003|Part 2|Intercurrent illness/new medical condition|0|||
130432896|NCT03485911|469547785|FG000|Part 2|Investigator judgement|1|||
130432897|NCT03485911|469547786|FG001|Part 2|Investigator judgement|0|||
130432898|NCT03485911|469547787|FG002|Part 2|Investigator judgement|0|||
130432899|NCT03485911|469547788|FG003|Part 2|Investigator judgement|0|||
130432900|NCT03485911|469547785|FG000|Part 3|Perceived lack of efficacy|2|||
130432901|NCT03485911|469547786|FG001|Part 3|Perceived lack of efficacy|2|||
130432902|NCT03485911|469547787|FG002|Part 3|Perceived lack of efficacy|2|||
130432903|NCT03485911|469547788|FG003|Part 3|Perceived lack of efficacy|0|||
130432904|NCT03485911|469547785|FG000|Part 3|Subject withdrew consent|1|||
130432905|NCT03485911|469547786|FG001|Part 3|Subject withdrew consent|4|||
130432906|NCT03485911|469547787|FG002|Part 3|Subject withdrew consent|0|||
130432907|NCT03485911|469547788|FG003|Part 3|Subject withdrew consent|1|||
130432908|NCT03485911|469547785|FG000|Part 3|Lab abnormalities/AEs|1|||
130432909|NCT03485911|469547786|FG001|Part 3|Lab abnormalities/AEs|1|||
130432910|NCT03485911|469547787|FG002|Part 3|Lab abnormalities/AEs|0|||
130432911|NCT03485911|469547788|FG003|Part 3|Lab abnormalities/AEs|2|||
130432912|NCT03485911|469547785|FG000|Part 3|Other NOS|1|||
130432913|NCT03485911|469547786|FG001|Part 3|Other NOS|1|||
130432914|NCT03485911|469547787|FG002|Part 3|Other NOS|0|||
130432915|NCT03485911|469547788|FG003|Part 3|Other NOS|0|||
130432916|NCT03485911|469547785|FG000|Part 3|Intercurrent illness/new medical condition|0|||
130432917|NCT03485911|469547786|FG001|Part 3|Intercurrent illness/new medical condition|1|||
130432918|NCT03485911|469547787|FG002|Part 3|Intercurrent illness/new medical condition|1|||
130432919|NCT03485911|469547788|FG003|Part 3|Intercurrent illness/new medical condition|0|||
130432920|NCT03485911|469547785|FG000|Part 3|Sponsor discontinuation|1|||
130432921|NCT03485911|469547786|FG001|Part 3|Sponsor discontinuation|0|||
130432922|NCT03485911|469547787|FG002|Part 3|Sponsor discontinuation|0|||
130432923|NCT03485911|469547788|FG003|Part 3|Sponsor discontinuation|0|||
130432924|NCT03485911|469547785|FG000|Part 3|Berotralstat provided by alternative means|13|||
130432925|NCT03485911|469547786|FG001|Part 3|Berotralstat provided by alternative means|13|||
130432926|NCT03485911|469547787|FG002|Part 3|Berotralstat provided by alternative means|7|||
130432927|NCT03485911|469547788|FG003|Part 3|Berotralstat provided by alternative means|7|||
130432928|NCT03528174|469547793|FG000|Overall Study|Adverse Event|1|||
130432929|NCT03528174|469547793|FG000|Overall Study|sensors dislodged|1|||
130432930|NCT03002038|469547794|FG000|Overall Study|Adverse Event|3|||
130432931|NCT03002038|469547795|FG001|Overall Study|Adverse Event|1|||
130432932|NCT03002038|469547794|FG000|Overall Study|Withdrawal by Subject|8|||
130432933|NCT03002038|469547795|FG001|Overall Study|Withdrawal by Subject|4|||
130432934|NCT03002038|469547794|FG000|Overall Study|Immigration to another region|0|||
130432935|NCT03002038|469547795|FG001|Overall Study|Immigration to another region|2|||
130432936|NCT00979602|469547804|FG000|Overall Study|Serious Adverse Event|5|||
130432937|NCT00979602|469547805|FG001|Overall Study|Serious Adverse Event|3|||
130432938|NCT00979602|469547804|FG000|Overall Study|Protocol Violation|3|||
130432939|NCT00979602|469547805|FG001|Overall Study|Protocol Violation|0|||
130432940|NCT00979602|469547804|FG000|Overall Study|Withdrawal by Subject|31|||
130432941|NCT00979602|469547805|FG001|Overall Study|Withdrawal by Subject|25|||
130432942|NCT00979602|469547804|FG000|Overall Study|Lost to Follow-up|100|||
130432943|NCT00979602|469547805|FG001|Overall Study|Lost to Follow-up|96|||
130432944|NCT00979602|469547804|FG000|Overall Study|Migrated/moved from study area|3|||
130432945|NCT00979602|469547805|FG001|Overall Study|Migrated/moved from study area|6|||
130432946|NCT00979602|469547804|FG000|Overall Study|Others|3|||
130432947|NCT00979602|469547805|FG001|Overall Study|Others|3|||
130432948|NCT02904902|469547806|FG000|Overall Study|Withdrawal by Subject|1|||
130432949|NCT02712398|469547807|FG000|Overall Study|Withdrawal by Subject|6|||
130432950|NCT02712398|469547807|FG000|Overall Study|Lost to Follow-up|6|||
130432951|NCT02712398|469547807|FG000|Overall Study|Sponsor Decision|1|||
130432952|NCT02712398|469547807|FG000|Overall Study|Physician Decision|1|||
130432953|NCT02712398|469547807|FG000|Overall Study|Death|2|||
130432954|NCT02712398|469547807|FG000|Overall Study|Re-operation|21|||
130432955|NCT01719237|469547808|FG000|Overall Study|Physician Decision|0|||
130432956|NCT01719237|469547809|FG001|Overall Study|Physician Decision|1|||
130432957|NCT00782496|469547818|FG000|Overall Study|Lost to Follow-up|14|||
130432958|NCT00782496|469547819|FG001|Overall Study|Lost to Follow-up|15|||
130432959|NCT00990340|469547822|FG000|First 14-day Treatment|Not Compliant|2|||
130432960|NCT00990340|469547823|FG001|First 14-day Treatment|Not Compliant|1|||
130432961|NCT00990340|469547822|FG000|First 14-day Treatment|Lost to Follow-up|2|||
130432962|NCT00990340|469547823|FG001|First 14-day Treatment|Lost to Follow-up|1|||
130432963|NCT00990340|469547822|FG000|First 14-day Treatment|Protocol Violation|2|||
130432964|NCT00990340|469547823|FG001|First 14-day Treatment|Protocol Violation|2|||
130432965|NCT01987817|469547825|FG000|Overall Study|Adverse Event|4|||
130432966|NCT01987817|469547826|FG001|Overall Study|Adverse Event|0|||
130432967|NCT01987817|469547825|FG000|Overall Study|Withdrawal by Subject|1|||
130432968|NCT01987817|469547826|FG001|Overall Study|Withdrawal by Subject|1|||
130432969|NCT01987817|469547825|FG000|Overall Study|Physician Decision|1|||
130432970|NCT01987817|469547826|FG001|Overall Study|Physician Decision|0|||
130432971|NCT02070484|469547827|FG000|Overall Study|Withdrawal by Subject|1|||
130432972|NCT02070484|469547828|FG001|Overall Study|Withdrawal by Subject|0|||
130432973|NCT00682643|469547829|FG000|Overall Study|Adverse Event|12|||
130432974|NCT00682643|469547830|FG001|Overall Study|Adverse Event|23|||
130432975|NCT00682643|469547829|FG000|Overall Study|Lack of Efficacy|2|||
130432976|NCT00682643|469547830|FG001|Overall Study|Lack of Efficacy|0|||
130432977|NCT00682643|469547829|FG000|Overall Study|Protocol Violation|38|||
130213396|NCT04399538|468744633|FG002|Follow-Up|Withdrawal by Subject|0|||
130213397|NCT04399538|468744634|FG003|Follow-Up|Withdrawal by Subject|2|||
130213398|NCT04399538|468744635|FG004|Follow-Up|Withdrawal by Subject|0|||
130213399|NCT01215435|468744636|FG000|Overall Study|Adverse Event|1|||
130213400|NCT01215435|468744637|FG001|Overall Study|Adverse Event|0|||
130213401|NCT01215435|468744636|FG000|Overall Study|Protocol Violation|2|||
130213402|NCT01215435|468744637|FG001|Overall Study|Protocol Violation|0|||
130213403|NCT01215435|468744636|FG000|Overall Study|Withdrawal Criteria|8|||
130213404|NCT01215435|468744637|FG001|Overall Study|Withdrawal Criteria|11|||
130213405|NCT01215435|468744636|FG000|Overall Study|Lost to Follow-up|3|||
130213406|NCT01215435|468744637|FG001|Overall Study|Lost to Follow-up|0|||
130213407|NCT01215435|468744636|FG000|Overall Study|Unclassified|5|||
130213408|NCT01215435|468744637|FG001|Overall Study|Unclassified|5|||
130432978|NCT00682643|469547830|FG001|Overall Study|Protocol Violation|76|||
130432979|NCT00682643|469547829|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130432980|NCT00682643|469547830|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130432981|NCT00682643|469547829|FG000|Overall Study|Lost to Follow-up|1|||
130432982|NCT00682643|469547830|FG001|Overall Study|Lost to Follow-up|6|||
130432983|NCT00682643|469547829|FG000|Overall Study|Physician Decision|2|||
130432984|NCT00682643|469547830|FG001|Overall Study|Physician Decision|6|||
130213409|NCT00840034|468744638|FG000|Acute Treatment Phase|Adverse Event|6|||
130213410|NCT00840034|468744639|FG001|Acute Treatment Phase|Adverse Event|8|||
130213411|NCT00840034|468744638|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130432985|NCT00682643|469547829|FG000|Overall Study|Withdrawal by Subject|19|||
130432986|NCT00682643|469547830|FG001|Overall Study|Withdrawal by Subject|53|||
130432987|NCT00682643|469547829|FG000|Overall Study|Did Not Receive Study Drug|1|||
130213412|NCT00840034|468744639|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
130213413|NCT00840034|468744638|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
130213414|NCT00840034|468744639|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
130432988|NCT00682643|469547830|FG001|Overall Study|Did Not Receive Study Drug|1|||
130432989|NCT01852058|469547833|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
130432990|NCT01852058|469547834|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432991|NCT01852058|469547835|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432992|NCT01852058|469547836|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432993|NCT01852058|469547837|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432994|NCT01852058|469547838|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432995|NCT01852058|469547839|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432996|NCT01852058|469547840|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130543733|NCT01688830|469956829|FG001|Overall Study|Lost to Follow-up|0|||
130543734|NCT01688830|469956830|FG002|Overall Study|Lost to Follow-up|0|||
130543735|NCT01688830|469956831|FG003|Overall Study|Lost to Follow-up|0|||
130543736|NCT01688830|469956832|FG004|Overall Study|Lost to Follow-up|0|||
130543737|NCT01688830|469956833|FG005|Overall Study|Lost to Follow-up|0|||
130543738|NCT01688830|469956834|FG006|Overall Study|Lost to Follow-up|0|||
130543739|NCT01688830|469956835|FG007|Overall Study|Lost to Follow-up|0|||
130543740|NCT01688830|469956836|FG008|Overall Study|Lost to Follow-up|0|||
130543741|NCT01688830|469956837|FG009|Overall Study|Lost to Follow-up|0|||
130543742|NCT01688830|469956838|FG010|Overall Study|Lost to Follow-up|1|||
130543743|NCT01688830|469956839|FG011|Overall Study|Lost to Follow-up|0|||
130543744|NCT01688830|469956840|FG012|Overall Study|Lost to Follow-up|0|||
130543745|NCT01688830|469956841|FG013|Overall Study|Lost to Follow-up|0|||
130543746|NCT01688830|469956842|FG014|Overall Study|Lost to Follow-up|0|||
130543747|NCT01688830|469956843|FG015|Overall Study|Lost to Follow-up|0|||
130543748|NCT01688830|469956844|FG016|Overall Study|Lost to Follow-up|0|||
130543749|NCT01688830|469956845|FG017|Overall Study|Lost to Follow-up|0|||
130543750|NCT01688830|469956846|FG018|Overall Study|Lost to Follow-up|0|||
130543751|NCT01688830|469956847|FG019|Overall Study|Lost to Follow-up|0|||
130543752|NCT01688830|469956848|FG020|Overall Study|Lost to Follow-up|0|||
130543753|NCT04822597|469956849|FG000|Overall Study|Withdrawal by Subject|0|||
130543754|NCT04822597|469956850|FG001|Overall Study|Withdrawal by Subject|1|||
130543755|NCT04822597|469956851|FG002|Overall Study|Withdrawal by Subject|1|||
130543756|NCT04822597|469956852|FG003|Overall Study|Withdrawal by Subject|0|||
130543757|NCT04822597|469956849|FG000|Overall Study|Physician Decision|0|||
130543758|NCT04822597|469956850|FG001|Overall Study|Physician Decision|0|||
130543759|NCT04822597|469956851|FG002|Overall Study|Physician Decision|1|||
130543760|NCT04822597|469956852|FG003|Overall Study|Physician Decision|1|||
130543761|NCT04822597|469956849|FG000|Overall Study|Subject withdrawn after enrollment|0|||
130543762|NCT04822597|469956850|FG001|Overall Study|Subject withdrawn after enrollment|1|||
130543763|NCT04822597|469956851|FG002|Overall Study|Subject withdrawn after enrollment|0|||
130543764|NCT04822597|469956852|FG003|Overall Study|Subject withdrawn after enrollment|1|||
130543765|NCT04822597|469956849|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
130213415|NCT00840034|468744638|FG000|Acute Treatment Phase|Physician Decision|0|||
130213416|NCT00840034|468744639|FG001|Acute Treatment Phase|Physician Decision|1|||
130213417|NCT00840034|468744638|FG000|Acute Treatment Phase|Protocol Violation|2|||
130213418|NCT00840034|468744639|FG001|Acute Treatment Phase|Protocol Violation|4|||
130213419|NCT00840034|468744638|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
130213420|NCT00840034|468744639|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
130213421|NCT00840034|468744638|FG000|Taper Phase|Adverse Event|1|||
130213422|NCT00840034|468744639|FG001|Taper Phase|Adverse Event|0|||
130213423|NCT00840034|468744638|FG000|Taper Phase|Lost to Follow-up|1|||
130213424|NCT00840034|468744639|FG001|Taper Phase|Lost to Follow-up|1|||
130213425|NCT00840034|468744638|FG000|Taper Phase|Withdrawal by Subject|1|||
130213426|NCT00840034|468744639|FG001|Taper Phase|Withdrawal by Subject|1|||
130213427|NCT02179749|468744652|FG000|Overall Study|Adverse Event|0|||
130213428|NCT02179749|468744653|FG001|Overall Study|Adverse Event|0|||
130213429|NCT02179749|468744654|FG002|Overall Study|Adverse Event|1|||
130213430|NCT02179749|468744652|FG000|Overall Study|Withdrawal by Subject|0|||
130213431|NCT02179749|468744653|FG001|Overall Study|Withdrawal by Subject|0|||
130213432|NCT02179749|468744654|FG002|Overall Study|Withdrawal by Subject|1|||
130543766|NCT04822597|469956850|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
130543767|NCT04822597|469956851|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
130543768|NCT04822597|469956852|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
130543769|NCT01285609|469956853|FG000|Randomized|Progressive Disease|41|||
130543770|NCT01285609|469956854|FG001|Randomized|Progressive Disease|61|||
130543771|NCT01285609|469956853|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
130543772|NCT01285609|469956854|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
130543773|NCT01285609|469956853|FG000|Randomized|Study Drug Toxicity|13|||
130213433|NCT02756364|468744655|FG000|Overall Study|Site Terminated by Sponsor|24|||
130213434|NCT02756364|468744656|FG001|Overall Study|Site Terminated by Sponsor|30|||
130213435|NCT02756364|468744657|FG002|Overall Study|Site Terminated by Sponsor|21|||
130213436|NCT02756364|468744655|FG000|Overall Study|Death|20|||
130543774|NCT01285609|469956854|FG001|Randomized|Study Drug Toxicity|14|||
130543775|NCT01285609|469956853|FG000|Randomized|Death|5|||
130543776|NCT01285609|469956854|FG001|Randomized|Death|7|||
130543777|NCT01285609|469956853|FG000|Randomized|Withdrawal by Subject|8|||
130543778|NCT01285609|469956854|FG001|Randomized|Withdrawal by Subject|11|||
130543779|NCT01285609|469956853|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
130543780|NCT01285609|469956854|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
130543781|NCT01285609|469956853|FG000|Randomized|Undisclosed Reasons|1|||
130213437|NCT02756364|468744656|FG001|Overall Study|Death|15|||
130543782|NCT01285609|469956854|FG001|Randomized|Undisclosed Reasons|0|||
130213438|NCT02756364|468744657|FG002|Overall Study|Death|18|||
130213439|NCT02756364|468744655|FG000|Overall Study|Withdrawal by Patient|2|||
130213440|NCT02756364|468744656|FG001|Overall Study|Withdrawal by Patient|1|||
130213441|NCT02756364|468744657|FG002|Overall Study|Withdrawal by Patient|8|||
130213442|NCT02756364|468744655|FG000|Overall Study|Lost to Follow-up|0|||
130213443|NCT02756364|468744656|FG001|Overall Study|Lost to Follow-up|1|||
130213444|NCT02756364|468744657|FG002|Overall Study|Lost to Follow-up|1|||
130213445|NCT00793546|468744658|FG000|Overall Study|Death|3|||
130213446|NCT00793546|468744659|FG001|Overall Study|Death|0|||
130213447|NCT00793546|468744658|FG000|Overall Study|Lost to Follow-up|1|||
130213448|NCT00793546|468744659|FG001|Overall Study|Lost to Follow-up|0|||
130213449|NCT00793546|468744658|FG000|Overall Study|Withdrawal by Subject|1|||
130213450|NCT00793546|468744659|FG001|Overall Study|Withdrawal by Subject|1|||
130213451|NCT00793546|468744658|FG000|Overall Study|Study Terminated by Sponsor|8|||
130213452|NCT00793546|468744659|FG001|Overall Study|Study Terminated by Sponsor|27|||
130213453|NCT00793546|468744658|FG000|Overall Study|Other|1|||
130213454|NCT00793546|468744659|FG001|Overall Study|Other|0|||
130213455|NCT01841567|468744660|FG000|Overall Study|Adverse Event|3|||
130213456|NCT01416155|468744661|FG000|Overall Study|Adverse Event|8|||
130213457|NCT01416155|468744661|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
130213458|NCT01416155|468744661|FG000|Overall Study|Withdrawal by Subject|33|||
130213459|NCT01416155|468744661|FG000|Overall Study|Investigator decision|8|||
130213460|NCT01416155|468744661|FG000|Overall Study|Other|7|||
130213461|NCT01573754|468744667|FG000|Overall Study|Noncompliance or remission not achieved|3|||
130213462|NCT01573754|468744668|FG001|Overall Study|Noncompliance or remission not achieved|15|||
130213463|NCT00829829|468744669|FG000|Overall Study|Protocol Violation|0|||
130213464|NCT00829829|468744670|FG001|Overall Study|Protocol Violation|3|||
130213465|NCT00829829|468744671|FG002|Overall Study|Protocol Violation|0|||
130213466|NCT00829829|468744669|FG000|Overall Study|Adverse Event|4|||
130213467|NCT00829829|468744670|FG001|Overall Study|Adverse Event|4|||
130213468|NCT00829829|468744671|FG002|Overall Study|Adverse Event|3|||
130213469|NCT00829829|468744669|FG000|Overall Study|Withdrawal by Subject|8|||
130213470|NCT00829829|468744670|FG001|Overall Study|Withdrawal by Subject|4|||
130213471|NCT00829829|468744671|FG002|Overall Study|Withdrawal by Subject|2|||
130213472|NCT00829829|468744669|FG000|Overall Study|Decision by the Sponsor|1|||
130213473|NCT00829829|468744670|FG001|Overall Study|Decision by the Sponsor|0|||
130213474|NCT00829829|468744671|FG002|Overall Study|Decision by the Sponsor|2|||
130213475|NCT00829829|468744669|FG000|Overall Study|Lost to Follow-up|7|||
130213476|NCT00829829|468744670|FG001|Overall Study|Lost to Follow-up|3|||
130213477|NCT00829829|468744671|FG002|Overall Study|Lost to Follow-up|3|||
130213478|NCT00829829|468744669|FG000|Overall Study|Other than specified above|2|||
130213479|NCT00829829|468744670|FG001|Overall Study|Other than specified above|2|||
130213480|NCT00829829|468744671|FG002|Overall Study|Other than specified above|1|||
130213481|NCT02984267|468744672|FG000|Overall Study|Protocol Violation|1|||
130213482|NCT02984267|468744673|FG001|Overall Study|Protocol Violation|0|||
130213483|NCT02984267|468744672|FG000|Overall Study|Withdrawal by Subject|0|||
130213484|NCT02984267|468744673|FG001|Overall Study|Withdrawal by Subject|1|||
130213485|NCT03597139|468744674|FG000|Overall Study|Adverse Event|3|||
130213486|NCT03597139|468744675|FG001|Overall Study|Adverse Event|0|||
130213487|NCT03597139|468744674|FG000|Overall Study|Protocol Non-compliance|1|||
130213488|NCT03597139|468744675|FG001|Overall Study|Protocol Non-compliance|0|||
130213489|NCT00520767|468744676|FG000|Overall Study|Death|2|||
130213490|NCT00382109|468744679|FG000|Overall Study|Adverse Event|3|||
130213491|NCT00382109|468744680|FG001|Overall Study|Adverse Event|0|||
130213492|NCT00382109|468744679|FG000|Overall Study|Physician Decision|6|||
130213493|NCT00382109|468744680|FG001|Overall Study|Physician Decision|1|||
130213494|NCT00382109|468744679|FG000|Overall Study|Withdrawal by Subject|1|||
130213495|NCT00382109|468744680|FG001|Overall Study|Withdrawal by Subject|0|||
130213496|NCT00382109|468744679|FG000|Overall Study|ineligible|2|||
130213497|NCT00382109|468744680|FG001|Overall Study|ineligible|0|||
130213498|NCT00382109|468744679|FG000|Overall Study|Other|0|||
130213499|NCT00382109|468744680|FG001|Overall Study|Other|2|||
130213500|NCT00382109|468744679|FG000|Overall Study|consent withdrawal|0|||
130213501|NCT00382109|468744680|FG001|Overall Study|consent withdrawal|1|||
130213502|NCT01249833|468744681|FG000|Overall Study|Lost to Follow-up|0|||
130213503|NCT01249833|468744682|FG001|Overall Study|Lost to Follow-up|1|||
130213504|NCT03796676|468744683|FG000|Overall Study|Adverse Event|2|||
130213505|NCT03796676|468744684|FG001|Overall Study|Adverse Event|1|||
130543783|NCT01285609|469956853|FG000|Randomized|Randomized but not Treated|4|||
130543784|NCT01285609|469956854|FG001|Randomized|Randomized but not Treated|4|||
130543785|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
130543786|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
130543787|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
130543788|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
130543789|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
130543790|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
130543791|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
130543792|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
130543793|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Death|11|||
130543794|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Death|3|||
130543795|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
130543796|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
130543797|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Not Reported|0|||
130543798|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Not Reported|2|||
130543799|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
130543800|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
130543801|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
130543802|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
130543803|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
130543804|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
130543805|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
130543806|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
130543807|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
130543808|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
130543809|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
130543810|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
130543811|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
130543812|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
130543813|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
130543814|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
130543815|NCT01285609|469956853|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
130543816|NCT01285609|469956854|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
130543817|NCT01285609|469956853|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
130543818|NCT01285609|469956854|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
130543819|NCT03616977|469956861|FG000|Period 1|Physician Decision|0|||
130543820|NCT03616977|469956862|FG001|Period 1|Physician Decision|1|||
130543821|NCT03616977|469956861|FG000|Period 3|Adverse Event|1|||
130543822|NCT03616977|469956862|FG001|Period 3|Adverse Event|1|||
130543823|NCT00925132|469956863|FG000|Overall Study|Withdrawal by Subject|2|||
130543824|NCT00925132|469956864|FG001|Overall Study|Withdrawal by Subject|0|||
130213506|NCT03796676|468744685|FG002|Overall Study|Adverse Event|2|||
130213507|NCT03796676|468744683|FG000|Overall Study|Lost to Follow-up|2|||
130213508|NCT03796676|468744684|FG001|Overall Study|Lost to Follow-up|1|||
130213509|NCT03796676|468744685|FG002|Overall Study|Lost to Follow-up|0|||
130213510|NCT03796676|468744683|FG000|Overall Study|Protocol Violation|0|||
130213511|NCT03796676|468744684|FG001|Overall Study|Protocol Violation|0|||
130213512|NCT03796676|468744685|FG002|Overall Study|Protocol Violation|1|||
130213513|NCT03796676|468744683|FG000|Overall Study|Withdrawal by Subject|1|||
130213514|NCT03796676|468744684|FG001|Overall Study|Withdrawal by Subject|1|||
130213515|NCT03796676|468744685|FG002|Overall Study|Withdrawal by Subject|0|||
130213516|NCT03796676|468744683|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
130213517|NCT03796676|468744684|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130213518|NCT03796676|468744685|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130213519|NCT00248833|468744689|FG000|Overall Study|Adverse Event|2|||
130213520|NCT00248833|468744690|FG001|Overall Study|Adverse Event|0|||
130213521|NCT00248833|468744691|FG002|Overall Study|Adverse Event|0|||
130213522|NCT00248833|468744689|FG000|Overall Study|Withdrawal by Subject|0|||
130213523|NCT00248833|468744690|FG001|Overall Study|Withdrawal by Subject|1|||
130213524|NCT00248833|468744691|FG002|Overall Study|Withdrawal by Subject|1|||
130213525|NCT00248833|468744689|FG000|Overall Study|Lost to Follow-up|1|||
130213526|NCT00248833|468744690|FG001|Overall Study|Lost to Follow-up|1|||
130213527|NCT00248833|468744691|FG002|Overall Study|Lost to Follow-up|1|||
130213528|NCT00248833|468744689|FG000|Overall Study|Other|0|||
130213529|NCT00248833|468744690|FG001|Overall Study|Other|1|||
130543825|NCT00925132|469956865|FG002|Overall Study|Withdrawal by Subject|0|||
130543826|NCT00925132|469956866|FG003|Overall Study|Withdrawal by Subject|0|||
130543827|NCT00925132|469956867|FG004|Overall Study|Withdrawal by Subject|1|||
130213530|NCT00248833|468744691|FG002|Overall Study|Other|0|||
130213531|NCT01900899|468744692|FG000|Overall Study|Withdrawal by Subject|7|||
130543828|NCT00925132|469956863|FG000|Overall Study|Removed due to disease progression|0|||
130543829|NCT00925132|469956864|FG001|Overall Study|Removed due to disease progression|0|||
130543830|NCT00925132|469956865|FG002|Overall Study|Removed due to disease progression|0|||
130543831|NCT00925132|469956866|FG003|Overall Study|Removed due to disease progression|0|||
130543832|NCT00925132|469956867|FG004|Overall Study|Removed due to disease progression|4|||
130543833|NCT02502799|469958492|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
130543834|NCT02502799|469958493|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
130543835|NCT02502799|469958494|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
130543836|NCT02502799|469958495|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
130543837|NCT02502799|469958492|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
130543838|NCT02502799|469958493|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
130543839|NCT02502799|469958494|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
130543840|NCT02502799|469958495|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
130543841|NCT02502799|469958492|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
130543842|NCT02502799|469958493|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
130543843|NCT02502799|469958494|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
130543844|NCT02502799|469958495|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
130543845|NCT02502799|469958492|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
130543846|NCT02502799|469958493|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
130543847|NCT02502799|469958494|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
130543848|NCT02502799|469958495|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
130543849|NCT02502799|469958492|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
130543850|NCT02502799|469958493|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
130543851|NCT02502799|469958494|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
130543852|NCT02502799|469958495|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
130543853|NCT05087979|469958499|FG000|Overall Study|Converted to general anesthesia|1|||
130543854|NCT05087979|469958500|FG001|Overall Study|Converted to general anesthesia|0|||
130543855|NCT02915302|469958501|FG000|Overall Study|Adverse Event|3|||
130543856|NCT02915302|469958502|FG001|Overall Study|Adverse Event|0|||
130543857|NCT02915302|469958501|FG000|Overall Study|Protocol Violation|20|||
130543858|NCT02915302|469958502|FG001|Overall Study|Protocol Violation|27|||
130543859|NCT02915302|469958501|FG000|Overall Study|Lost to Follow-up|19|||
130543860|NCT02915302|469958502|FG001|Overall Study|Lost to Follow-up|22|||
130543861|NCT02915302|469958501|FG000|Overall Study|Withdrawal by Subject|22|||
130543862|NCT02915302|469958502|FG001|Overall Study|Withdrawal by Subject|29|||
130543863|NCT02915302|469958501|FG000|Overall Study|Other|1|||
130543864|NCT02915302|469958502|FG001|Overall Study|Other|0|||
130543865|NCT03527173|469958503|FG000|Overall Study|Lost to Follow-up|4|||
130543866|NCT03527173|469958504|FG001|Overall Study|Lost to Follow-up|2|||
130543867|NCT03527173|469958503|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
130543868|NCT03527173|469958504|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
130543869|NCT03527173|469958503|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130543870|NCT03527173|469958504|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
130543871|NCT03527173|469958503|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130543872|NCT03527173|469958504|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130543873|NCT02134977|469958505|FG000|Overall Study|Protocol Deviation|102|||
130543874|NCT04097301|469958506|FG000|Overall Study|Death|1|||
130543875|NCT04097301|469958506|FG000|Overall Study|Withdrawal by Subject|1|||
130543876|NCT04097301|469958506|FG000|Overall Study|Screening Failure|5|||
130543877|NCT01773291|469958507|FG000|Overall Study|Protocol Violation|1|||
130543878|NCT01773291|469958508|FG001|Overall Study|Protocol Violation|0|||
130543879|NCT01773291|469958509|FG002|Overall Study|Protocol Violation|0|||
130543880|NCT01773291|469958507|FG000|Overall Study|Withdrawal by Subject|0|||
130543881|NCT01773291|469958508|FG001|Overall Study|Withdrawal by Subject|0|||
130543882|NCT01773291|469958509|FG002|Overall Study|Withdrawal by Subject|1|||
130543883|NCT00203476|469958510|FG000|Overall Study|Lost to Follow-up|1|||
130543884|NCT00203476|469958511|FG001|Overall Study|Lost to Follow-up|0|||
130543885|NCT00203476|469958512|FG002|Overall Study|Lost to Follow-up|0|||
130543886|NCT00203476|469958510|FG000|Overall Study|Withdrawal by Subject|0|||
130543887|NCT00203476|469958511|FG001|Overall Study|Withdrawal by Subject|1|||
130543888|NCT00203476|469958512|FG002|Overall Study|Withdrawal by Subject|0|||
130543889|NCT01190514|469958513|FG000|First Intervention (Period 1)|Adverse Event|1|||
130543890|NCT01190514|469958514|FG001|First Intervention (Period 1)|Adverse Event|0|||
130543891|NCT01190514|469958515|FG002|First Intervention (Period 1)|Adverse Event|0|||
130543892|NCT01190514|469958516|FG003|First Intervention (Period 1)|Adverse Event|0|||
130543893|NCT01190514|469958513|FG000|Third Intervention (Period 3)|Adverse Event|1|||
130543894|NCT01190514|469958514|FG001|Third Intervention (Period 3)|Adverse Event|0|||
130543895|NCT01190514|469958515|FG002|Third Intervention (Period 3)|Adverse Event|0|||
130543896|NCT01190514|469958516|FG003|Third Intervention (Period 3)|Adverse Event|0|||
130543897|NCT03241225|469958519|FG000|Overall Study|Lost to Follow-up|2|||
130213532|NCT01900899|468744693|FG001|Overall Study|Withdrawal by Subject|1|||
130432997|NCT01852058|469547841|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432998|NCT01852058|469547842|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130432999|NCT01852058|469547843|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130433000|NCT01852058|469547844|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130433001|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433002|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433003|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433004|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433005|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
130433006|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433007|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433008|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433009|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433010|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433011|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433012|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130433013|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433014|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433015|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433016|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433017|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
130433018|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
130433019|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433020|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433021|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433022|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433023|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433024|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130433025|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433026|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433027|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433028|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433029|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
130433030|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433031|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433032|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433033|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433034|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433035|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433036|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130433037|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433038|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433039|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433040|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433041|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
130433042|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
130433043|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433044|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433045|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433046|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433047|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433048|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130433049|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433050|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433051|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433052|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
130433053|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433054|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433055|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433056|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433057|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433058|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130213533|NCT01900899|468744692|FG000|Overall Study|Migrated from study area|2|||
130213534|NCT01900899|468744693|FG001|Overall Study|Migrated from study area|0|||
130213535|NCT00723697|468744696|FG000|Overall Study|Physician questionnaires not received|2|||
130213536|NCT00723697|468744696|FG000|Overall Study|Missing Informed Consent Form|10|||
130213537|NCT00723697|468744696|FG000|Overall Study|Other exclusion criteria applied|6|||
130213538|NCT00467558|468744699|FG000|Overall Study|Lost to Follow-up|2|||
130213539|NCT00467558|468744700|FG001|Overall Study|Lost to Follow-up|0|||
130213540|NCT05188729|468744701|FG000|Overall Study|Withdrawal by Subject|0|||
130213541|NCT05188729|468744702|FG001|Overall Study|Withdrawal by Subject|0|||
130213542|NCT05188729|468744703|FG002|Overall Study|Withdrawal by Subject|0|||
130213543|NCT05188729|468744704|FG003|Overall Study|Withdrawal by Subject|0|||
130213544|NCT05188729|468744705|FG004|Overall Study|Withdrawal by Subject|0|||
130213545|NCT05188729|468744706|FG005|Overall Study|Withdrawal by Subject|0|||
130213546|NCT05188729|468744707|FG006|Overall Study|Withdrawal by Subject|0|||
130213547|NCT05188729|468744708|FG007|Overall Study|Withdrawal by Subject|0|||
130213548|NCT05188729|468744709|FG008|Overall Study|Withdrawal by Subject|0|||
130213549|NCT05188729|468744710|FG009|Overall Study|Withdrawal by Subject|1|||
130213550|NCT05188729|468744711|FG010|Overall Study|Withdrawal by Subject|0|||
130213551|NCT05188729|468744712|FG011|Overall Study|Withdrawal by Subject|0|||
130213552|NCT05188729|468744713|FG012|Overall Study|Withdrawal by Subject|0|||
130213553|NCT05188729|468744701|FG000|Overall Study|Lost to Follow-up|0|||
130213554|NCT05188729|468744702|FG001|Overall Study|Lost to Follow-up|0|||
130213555|NCT05188729|468744703|FG002|Overall Study|Lost to Follow-up|0|||
130213556|NCT05188729|468744704|FG003|Overall Study|Lost to Follow-up|0|||
130213557|NCT05188729|468744705|FG004|Overall Study|Lost to Follow-up|0|||
130213558|NCT05188729|468744706|FG005|Overall Study|Lost to Follow-up|0|||
130213559|NCT05188729|468744707|FG006|Overall Study|Lost to Follow-up|0|||
130320366|NCT00506350|469141899|FG007|Overall Study|Lost to Follow-up|0|||
130320367|NCT00506350|469141900|FG008|Overall Study|Lost to Follow-up|2|||
130320368|NCT00506350|469141892|FG000|Overall Study|Medical Reason|0|||
130320369|NCT00506350|469141893|FG001|Overall Study|Medical Reason|0|||
130320370|NCT00506350|469141894|FG002|Overall Study|Medical Reason|0|||
130320371|NCT00506350|469141895|FG003|Overall Study|Medical Reason|0|||
130320372|NCT00506350|469141896|FG004|Overall Study|Medical Reason|1|||
130320373|NCT00506350|469141897|FG005|Overall Study|Medical Reason|0|||
130320374|NCT00506350|469141898|FG006|Overall Study|Medical Reason|0|||
130320375|NCT00506350|469141899|FG007|Overall Study|Medical Reason|0|||
130320376|NCT00506350|469141900|FG008|Overall Study|Medical Reason|0|||
130320377|NCT00506350|469141892|FG000|Overall Study|Other|1|||
130320378|NCT00506350|469141893|FG001|Overall Study|Other|1|||
130320379|NCT00506350|469141894|FG002|Overall Study|Other|3|||
130320380|NCT00506350|469141895|FG003|Overall Study|Other|0|||
130320381|NCT00506350|469141896|FG004|Overall Study|Other|3|||
130320382|NCT00506350|469141897|FG005|Overall Study|Other|0|||
130320383|NCT00506350|469141898|FG006|Overall Study|Other|0|||
130320384|NCT00506350|469141899|FG007|Overall Study|Other|2|||
130320385|NCT00506350|469141900|FG008|Overall Study|Other|2|||
130320386|NCT01691794|469141901|FG000|Overall Study|Poor/Non-Compliance|1|||
130320387|NCT01691794|469141902|FG001|Overall Study|Poor/Non-Compliance|4|||
130320388|NCT01691794|469141903|FG002|Overall Study|Poor/Non-Compliance|1|||
130320389|NCT01691794|469141901|FG000|Overall Study|Death|0|||
130320390|NCT01691794|469141902|FG001|Overall Study|Death|0|||
130320391|NCT01691794|469141903|FG002|Overall Study|Death|1|||
130320392|NCT01691794|469141901|FG000|Overall Study|Lack of Efficacy|0|||
130320393|NCT01691794|469141902|FG001|Overall Study|Lack of Efficacy|7|||
130320394|NCT01691794|469141903|FG002|Overall Study|Lack of Efficacy|1|||
130320395|NCT01691794|469141901|FG000|Overall Study|Participant request to discontinue|0|||
130320396|NCT01691794|469141902|FG001|Overall Study|Participant request to discontinue|1|||
130320397|NCT01691794|469141903|FG002|Overall Study|Participant request to discontinue|0|||
130320398|NCT01691794|469141901|FG000|Overall Study|Adverse Event|0|||
130320399|NCT01691794|469141902|FG001|Overall Study|Adverse Event|1|||
130320400|NCT01691794|469141903|FG002|Overall Study|Adverse Event|1|||
130320401|NCT01691794|469141901|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
130320402|NCT01691794|469141902|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
130320403|NCT01691794|469141903|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
130320404|NCT01691794|469141901|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
130320405|NCT01691794|469141902|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
130320406|NCT01691794|469141903|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
130320407|NCT04972786|469141904|FG000|First Intervention (1 Day)|Adverse Event|1|||
130320408|NCT04972786|469141905|FG001|First Intervention (1 Day)|Adverse Event|0|||
130320409|NCT00844844|469141906|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
130320410|NCT00844844|469141906|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
130320411|NCT00844844|469141906|FG000|Extension Treatment Period|Adverse Event|2|||
130320412|NCT00844844|469141906|FG000|Post Treatment Period|Withdrawal by Subject|1|||
130320413|NCT03905096|469141907|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
130320414|NCT03905096|469141908|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
130320415|NCT02016781|469141910|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
130433059|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433060|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130433061|NCT01852058|469547833|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433062|NCT01852058|469547834|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433063|NCT01852058|469547835|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433064|NCT01852058|469547836|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433065|NCT01852058|469547837|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
130433066|NCT01852058|469547838|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
130433067|NCT01852058|469547839|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433068|NCT01852058|469547840|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433069|NCT01852058|469547841|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433070|NCT01852058|469547842|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433071|NCT01852058|469547843|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433072|NCT01852058|469547844|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130433073|NCT01852058|469547833|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433074|NCT01852058|469547834|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433075|NCT01852058|469547835|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433076|NCT01852058|469547836|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433077|NCT01852058|469547837|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433078|NCT01852058|469547838|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433079|NCT01852058|469547839|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433080|NCT01852058|469547840|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
130433081|NCT01852058|469547841|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433082|NCT01852058|469547842|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433083|NCT01852058|469547843|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433084|NCT01852058|469547844|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130433085|NCT01852058|469547833|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433086|NCT01852058|469547834|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433087|NCT01852058|469547835|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433088|NCT01852058|469547836|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433089|NCT01852058|469547837|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433090|NCT01852058|469547838|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433091|NCT01852058|469547839|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433092|NCT01852058|469547840|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433093|NCT01852058|469547841|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
130433094|NCT01852058|469547842|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433095|NCT01852058|469547843|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433096|NCT01852058|469547844|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130433097|NCT00622180|469547845|FG000|Overall Study|Lost to Follow-up|1|||
130433098|NCT00622180|469547846|FG001|Overall Study|Lost to Follow-up|2|||
130433099|NCT01353222|469547849|FG000|Overall Study|Death|30|||
130433100|NCT01353222|469547850|FG001|Overall Study|Death|30|||
130433101|NCT01353222|469547849|FG000|Overall Study|Withdrawal by Subject|8|||
130433102|NCT01353222|469547850|FG001|Overall Study|Withdrawal by Subject|5|||
130433103|NCT01353222|469547849|FG000|Overall Study|Study Terminated|31|||
130433104|NCT01353222|469547850|FG001|Overall Study|Study Terminated|37|||
130433105|NCT01353222|469547849|FG000|Overall Study|Site closed research department|1|||
130433106|NCT01353222|469547850|FG001|Overall Study|Site closed research department|0|||
130433107|NCT02636270|469547851|FG000|Overall Study|Adverse Event|1|||
130433108|NCT02636270|469547852|FG001|Overall Study|Adverse Event|0|||
130433109|NCT02636270|469547853|FG002|Overall Study|Adverse Event|0|||
130433110|NCT02636270|469547851|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
130433111|NCT02636270|469547852|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
130433112|NCT02636270|469547853|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
130433113|NCT01119898|469547854|FG000|Overall Study|Adverse Event|4|||
130433114|NCT01119898|469547855|FG001|Overall Study|Adverse Event|5|||
130433115|NCT01119898|469547854|FG000|Overall Study|Withdrawal by Subject|1|||
130433116|NCT01119898|469547855|FG001|Overall Study|Withdrawal by Subject|4|||
130433117|NCT01119898|469547854|FG000|Overall Study|Lack of Efficacy|0|||
130433118|NCT01119898|469547855|FG001|Overall Study|Lack of Efficacy|2|||
130433119|NCT01119898|469547854|FG000|Overall Study|Protocol Violation|1|||
130433120|NCT01119898|469547855|FG001|Overall Study|Protocol Violation|1|||
130433121|NCT01119898|469547854|FG000|Overall Study|Medical procedure|1|||
130433122|NCT01119898|469547855|FG001|Overall Study|Medical procedure|0|||
130433123|NCT01119898|469547854|FG000|Overall Study|Randomized in error did not participate|1|||
130433124|NCT01119898|469547855|FG001|Overall Study|Randomized in error did not participate|0|||
130543898|NCT03241225|469958520|FG001|Overall Study|Lost to Follow-up|1|||
130543899|NCT03241225|469958519|FG000|Overall Study|Protocol Violation|4|||
130543900|NCT03241225|469958520|FG001|Overall Study|Protocol Violation|1|||
130543901|NCT03241225|469958519|FG000|Overall Study|Withdrawal by Subject|1|||
130543902|NCT03241225|469958520|FG001|Overall Study|Withdrawal by Subject|0|||
130543903|NCT01970345|469958523|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
130543904|NCT01970345|469958524|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
130543905|NCT01970345|469958523|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
130543906|NCT01970345|469958524|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
130543907|NCT03932812|469958531|FG000|Overall Study|Lost to Follow-up|12|||
130543908|NCT03932812|469958532|FG001|Overall Study|Lost to Follow-up|14|||
130543909|NCT03932812|469958531|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
130543910|NCT03932812|469958532|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
130543911|NCT02585232|469958537|FG000|Overall Study|Lost to Follow-up|8|||
130543912|NCT02585232|469958538|FG001|Overall Study|Lost to Follow-up|8|||
130543913|NCT02585232|469958537|FG000|Overall Study|Withdrawal by Subject|4|||
130543914|NCT02585232|469958538|FG001|Overall Study|Withdrawal by Subject|8|||
130543915|NCT03215810|469958539|FG000|Overall Study|Still responding to nivolumab|1|||
130543916|NCT03215810|469958539|FG000|Overall Study|Insufficient TIL growth|1|||
130543917|NCT03215810|469958539|FG000|Overall Study|Decline in performance status|1|||
130543918|NCT03215810|469958539|FG000|Overall Study|Withdrawal by Subject|1|||
130543919|NCT02313233|469958540|FG000|Overall Study|Withdrawal by Subject|1|||
130543920|NCT02313233|469958541|FG001|Overall Study|Withdrawal by Subject|2|||
130543921|NCT02313233|469958540|FG000|Overall Study|Administrative reason|1|||
130543922|NCT02313233|469958541|FG001|Overall Study|Administrative reason|1|||
130543923|NCT02679573|469958544|FG000|Overall Study|Adverse Event|13|||
130543924|NCT02679573|469958545|FG001|Overall Study|Adverse Event|6|||
130543925|NCT02679573|469958544|FG000|Overall Study|Lack of Efficacy|12|||
130543926|NCT02679573|469958545|FG001|Overall Study|Lack of Efficacy|15|||
130543927|NCT02679573|469958544|FG000|Overall Study|Could not complete required study visits|6|||
130543928|NCT02679573|469958545|FG001|Overall Study|Could not complete required study visits|2|||
130543929|NCT02679573|469958544|FG000|Overall Study|Withdrawal by Subject|2|||
130543930|NCT02679573|469958545|FG001|Overall Study|Withdrawal by Subject|9|||
130543931|NCT02679573|469958544|FG000|Overall Study|Death|2|||
130543932|NCT02679573|469958545|FG001|Overall Study|Death|0|||
130543933|NCT02679573|469958544|FG000|Overall Study|Physician Decision|2|||
130543934|NCT02679573|469958545|FG001|Overall Study|Physician Decision|4|||
130543935|NCT02679573|469958544|FG000|Overall Study|Lost to Follow-up|0|||
130543936|NCT02679573|469958545|FG001|Overall Study|Lost to Follow-up|3|||
130543937|NCT01506609|469958546|FG000|Overall Study|Adverse Event Related to Progression|0|||
130543938|NCT01506609|469958547|FG001|Overall Study|Adverse Event Related to Progression|0|||
130543939|NCT01506609|469958548|FG002|Overall Study|Adverse Event Related to Progression|0|||
130543940|NCT01506609|469958549|FG003|Overall Study|Adverse Event Related to Progression|3|||
130543941|NCT01506609|469958550|FG004|Overall Study|Adverse Event Related to Progression|7|||
130543942|NCT01506609|469958551|FG005|Overall Study|Adverse Event Related to Progression|3|||
130543943|NCT01506609|469958546|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
130543944|NCT01506609|469958547|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
130543945|NCT01506609|469958548|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
130543946|NCT01506609|469958549|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
130543947|NCT01506609|469958550|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
130543948|NCT01506609|469958551|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
130543949|NCT01506609|469958546|FG000|Overall Study|Withdrawal by Subject|0|||
130543950|NCT01506609|469958547|FG001|Overall Study|Withdrawal by Subject|0|||
130543951|NCT01506609|469958548|FG002|Overall Study|Withdrawal by Subject|0|||
130543952|NCT01506609|469958549|FG003|Overall Study|Withdrawal by Subject|9|||
130543953|NCT01506609|469958550|FG004|Overall Study|Withdrawal by Subject|7|||
130543954|NCT01506609|469958551|FG005|Overall Study|Withdrawal by Subject|7|||
130543955|NCT01506609|469958546|FG000|Overall Study|Lost to Follow-up|0|||
130543956|NCT01506609|469958547|FG001|Overall Study|Lost to Follow-up|0|||
130543957|NCT01506609|469958548|FG002|Overall Study|Lost to Follow-up|0|||
130543958|NCT01506609|469958549|FG003|Overall Study|Lost to Follow-up|1|||
130543959|NCT01506609|469958550|FG004|Overall Study|Lost to Follow-up|2|||
130543960|NCT01506609|469958551|FG005|Overall Study|Lost to Follow-up|0|||
130543961|NCT01506609|469958546|FG000|Overall Study|Sponsor Discontinued Study|0|||
130543962|NCT01506609|469958547|FG001|Overall Study|Sponsor Discontinued Study|0|||
130543963|NCT01506609|469958548|FG002|Overall Study|Sponsor Discontinued Study|0|||
130543964|NCT01506609|469958549|FG003|Overall Study|Sponsor Discontinued Study|2|||
130543965|NCT01506609|469958550|FG004|Overall Study|Sponsor Discontinued Study|2|||
130543966|NCT01506609|469958551|FG005|Overall Study|Sponsor Discontinued Study|0|||
130543967|NCT01506609|469958546|FG000|Overall Study|Progressive Disease per Protocol|1|||
130543968|NCT01506609|469958547|FG001|Overall Study|Progressive Disease per Protocol|0|||
130543969|NCT01506609|469958548|FG002|Overall Study|Progressive Disease per Protocol|0|||
130543970|NCT01506609|469958549|FG003|Overall Study|Progressive Disease per Protocol|64|||
130559404|NCT01621542|470016494|FG004|Overall Study|Death|0|||
130213560|NCT05188729|468744708|FG007|Overall Study|Lost to Follow-up|0|||
130213561|NCT05188729|468744709|FG008|Overall Study|Lost to Follow-up|0|||
130213562|NCT05188729|468744710|FG009|Overall Study|Lost to Follow-up|0|||
130213563|NCT05188729|468744711|FG010|Overall Study|Lost to Follow-up|1|||
130213564|NCT05188729|468744712|FG011|Overall Study|Lost to Follow-up|1|||
130213565|NCT05188729|468744713|FG012|Overall Study|Lost to Follow-up|0|||
130213566|NCT03084302|468746844|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
130213567|NCT03084302|468746844|FG000|Overall Study|No valid objective monitor data|6|||
130213568|NCT00929994|468746845|FG000|Overall Study|Withdrawal by Subject|1|||
130213569|NCT00929994|468746845|FG000|Overall Study|medical issue unrelated to intervention|4|||
130213570|NCT00929994|468746845|FG000|Overall Study|employment|1|||
130213571|NCT01214668|468746846|FG000|Overall Study|Adverse Event|0|||
130213572|NCT01214668|468746847|FG001|Overall Study|Adverse Event|1|||
130213573|NCT01214668|468746848|FG002|Overall Study|Adverse Event|0|||
130213574|NCT01214668|468746849|FG003|Overall Study|Adverse Event|2|||
130213575|NCT01214668|468746850|FG004|Overall Study|Adverse Event|1|||
130213576|NCT01214668|468746851|FG005|Overall Study|Adverse Event|1|||
130213577|NCT01214668|468746846|FG000|Overall Study|Death|0|||
130213578|NCT01214668|468746847|FG001|Overall Study|Death|0|||
130213579|NCT01214668|468746848|FG002|Overall Study|Death|1|||
130213580|NCT01214668|468746849|FG003|Overall Study|Death|0|||
130213581|NCT01214668|468746850|FG004|Overall Study|Death|0|||
130213582|NCT01214668|468746851|FG005|Overall Study|Death|0|||
130213583|NCT01214668|468746846|FG000|Overall Study|Progressive Disease|4|||
130213584|NCT01214668|468746847|FG001|Overall Study|Progressive Disease|2|||
130213585|NCT01214668|468746848|FG002|Overall Study|Progressive Disease|5|||
130213586|NCT01214668|468746849|FG003|Overall Study|Progressive Disease|4|||
130213587|NCT01214668|468746850|FG004|Overall Study|Progressive Disease|4|||
130213588|NCT01214668|468746851|FG005|Overall Study|Progressive Disease|5|||
130213589|NCT01214668|468746846|FG000|Overall Study|Withdrawal by Subject|0|||
130213590|NCT01214668|468746847|FG001|Overall Study|Withdrawal by Subject|0|||
130213591|NCT01214668|468746848|FG002|Overall Study|Withdrawal by Subject|0|||
130213592|NCT01214668|468746849|FG003|Overall Study|Withdrawal by Subject|0|||
130213593|NCT01214668|468746850|FG004|Overall Study|Withdrawal by Subject|1|||
130213594|NCT01214668|468746851|FG005|Overall Study|Withdrawal by Subject|0|||
130213595|NCT01964989|468746852|FG000|Overall Study|Protocol Violation|3|||
130213596|NCT01964989|468746853|FG001|Overall Study|Protocol Violation|4|||
130213597|NCT01964989|468746852|FG000|Overall Study|Administrative Reason|103|||
130213598|NCT01964989|468746853|FG001|Overall Study|Administrative Reason|95|||
130213599|NCT01964989|468746852|FG000|Overall Study|Adverse Event|0|||
130213600|NCT01964989|468746853|FG001|Overall Study|Adverse Event|1|||
130213601|NCT01964989|468746852|FG000|Overall Study|Death|1|||
130213602|NCT01964989|468746853|FG001|Overall Study|Death|3|||
130213603|NCT01964989|468746852|FG000|Overall Study|Withdrawal by Subject|156|||
130213604|NCT01964989|468746853|FG001|Overall Study|Withdrawal by Subject|160|||
130213605|NCT01964989|468746852|FG000|Overall Study|Lost to Follow-up|254|||
130213606|NCT01964989|468746853|FG001|Overall Study|Lost to Follow-up|232|||
130213607|NCT01964989|468746852|FG000|Overall Study|Other|267|||
130213608|NCT01964989|468746853|FG001|Overall Study|Other|252|||
130213609|NCT00424593|468746854|FG000|Acute Double-Blind Period|Adverse Event|16|||
130213610|NCT00424593|468746855|FG001|Acute Double-Blind Period|Adverse Event|7|||
130213611|NCT00424593|468746854|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
130213612|NCT00424593|468746855|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
130213613|NCT00424593|468746854|FG000|Acute Double-Blind Period|Protocol Violation|2|||
130213614|NCT00424593|468746855|FG001|Acute Double-Blind Period|Protocol Violation|2|||
130213615|NCT00424593|468746854|FG000|Acute Double-Blind Period|Physician Decision|1|||
130213616|NCT00424593|468746855|FG001|Acute Double-Blind Period|Physician Decision|2|||
130213617|NCT00424593|468746854|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
130213618|NCT00424593|468746855|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
130213619|NCT00424593|468746854|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
130213620|NCT00424593|468746855|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
130213621|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
130213622|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
130213623|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Adverse Event|18|||
130213624|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Adverse Event|0|||
130213625|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
130213626|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
130213627|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
130213628|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
130213629|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
130213630|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
130213631|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Physician Decision|3|||
130213632|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Physician Decision|0|||
130213633|NCT01796301|468746856|FG000|Overall Study|Withdrawal by Subject|15|||
130543971|NCT01506609|469958550|FG004|Overall Study|Progressive Disease per Protocol|57|||
130543972|NCT01506609|469958551|FG005|Overall Study|Progressive Disease per Protocol|74|||
130543973|NCT01506609|469958546|FG000|Overall Study|Other, Not Specified|0|||
130543974|NCT01506609|469958547|FG001|Overall Study|Other, Not Specified|0|||
130543975|NCT01506609|469958548|FG002|Overall Study|Other, Not Specified|0|||
130543976|NCT01506609|469958549|FG003|Overall Study|Other, Not Specified|10|||
130543977|NCT01506609|469958550|FG004|Overall Study|Other, Not Specified|7|||
130543978|NCT01506609|469958551|FG005|Overall Study|Other, Not Specified|3|||
130543979|NCT01506609|469958546|FG000|Overall Study|Missing / Unknown Reason|1|||
130543980|NCT01506609|469958547|FG001|Overall Study|Missing / Unknown Reason|0|||
130543981|NCT01506609|469958548|FG002|Overall Study|Missing / Unknown Reason|1|||
130543982|NCT01506609|469958549|FG003|Overall Study|Missing / Unknown Reason|4|||
130543983|NCT01506609|469958550|FG004|Overall Study|Missing / Unknown Reason|4|||
130543984|NCT01506609|469958551|FG005|Overall Study|Missing / Unknown Reason|2|||
130543985|NCT01502631|469958552|FG000|Overall Study|Adverse Event|5|||
130543986|NCT01502631|469958553|FG001|Overall Study|Adverse Event|8|||
130543987|NCT01502631|469958552|FG000|Overall Study|Lost to Follow-up|2|||
130543988|NCT01502631|469958553|FG001|Overall Study|Lost to Follow-up|2|||
130543989|NCT01502631|469958552|FG000|Overall Study|Participant withdrew consent|2|||
130543990|NCT01502631|469958553|FG001|Overall Study|Participant withdrew consent|4|||
130543991|NCT01502631|469958552|FG000|Overall Study|Participant non-compliant|1|||
130543992|NCT01502631|469958553|FG001|Overall Study|Participant non-compliant|0|||
130543993|NCT01502631|469958552|FG000|Overall Study|Investigator's decision|0|||
130543994|NCT01502631|469958553|FG001|Overall Study|Investigator's decision|1|||
130543995|NCT01502631|469958552|FG000|Overall Study|Other|10|||
130543996|NCT01502631|469958553|FG001|Overall Study|Other|5|||
130543997|NCT01293487|469958554|FG000|Overall Study|Lost to Follow-up|0|||
130543998|NCT01293487|469958555|FG001|Overall Study|Lost to Follow-up|0|||
130543999|NCT01293487|469958556|FG002|Overall Study|Lost to Follow-up|0|||
130544000|NCT01293487|469958557|FG003|Overall Study|Lost to Follow-up|1|||
130544001|NCT01293487|469958558|FG004|Overall Study|Lost to Follow-up|0|||
130544002|NCT01293487|469958559|FG005|Overall Study|Lost to Follow-up|0|||
130544003|NCT01293487|469958560|FG006|Overall Study|Lost to Follow-up|0|||
130544004|NCT01293487|469958561|FG007|Overall Study|Lost to Follow-up|0|||
130544005|NCT01293487|469958554|FG000|Overall Study|Withdrawal by Subject|0|||
130544006|NCT01293487|469958555|FG001|Overall Study|Withdrawal by Subject|0|||
130544007|NCT01293487|469958556|FG002|Overall Study|Withdrawal by Subject|0|||
130544008|NCT01293487|469958557|FG003|Overall Study|Withdrawal by Subject|0|||
130544009|NCT01293487|469958558|FG004|Overall Study|Withdrawal by Subject|0|||
130544010|NCT01293487|469958559|FG005|Overall Study|Withdrawal by Subject|0|||
130544011|NCT01293487|469958560|FG006|Overall Study|Withdrawal by Subject|0|||
130544012|NCT01293487|469958561|FG007|Overall Study|Withdrawal by Subject|2|||
130544013|NCT00395460|469958563|FG000|Overall Study|Withdrawal by Subject|1|||
130544014|NCT00395460|469958564|FG001|Overall Study|Withdrawal by Subject|0|||
130544015|NCT04223830|469958570|FG000|Overall Study|Lost to Follow-up|9|||
130544016|NCT04223830|469958570|FG000|Overall Study|Adverse Event|1|||
130544017|NCT00862719|469958571|FG000|Overall Study|Disease Progression|5|||
130544018|NCT00862719|469958572|FG001|Overall Study|Disease Progression|0|||
130544019|NCT00862719|469958573|FG002|Overall Study|Disease Progression|1|||
130544020|NCT00862719|469958574|FG003|Overall Study|Disease Progression|0|||
130544021|NCT00862719|469958571|FG000|Overall Study|Death|5|||
130544022|NCT00862719|469958572|FG001|Overall Study|Death|6|||
130544023|NCT00862719|469958573|FG002|Overall Study|Death|1|||
130544024|NCT00862719|469958574|FG003|Overall Study|Death|1|||
130544025|NCT00862719|469958571|FG000|Overall Study|Engraftment failure|0|||
130544026|NCT00862719|469958572|FG001|Overall Study|Engraftment failure|0|||
130544027|NCT00862719|469958573|FG002|Overall Study|Engraftment failure|1|||
130544028|NCT00862719|469958574|FG003|Overall Study|Engraftment failure|0|||
130544029|NCT00862719|469958571|FG000|Overall Study|Veno-Occlusive Disease|0|||
130544030|NCT00862719|469958572|FG001|Overall Study|Veno-Occlusive Disease|0|||
130544031|NCT00862719|469958573|FG002|Overall Study|Veno-Occlusive Disease|1|||
130544032|NCT00862719|469958574|FG003|Overall Study|Veno-Occlusive Disease|0|||
130544033|NCT00324116|469958575|FG000|Overall Study|Adverse Event|5|||
130544034|NCT00324116|469958575|FG000|Overall Study|Lack of Efficacy|17|||
130544035|NCT00324116|469958575|FG000|Overall Study|Withdrawal by Subject|5|||
130544036|NCT00324116|469958575|FG000|Overall Study|Other|5|||
130544037|NCT01806623|469958576|FG000|Overall Study|Withdrawal by Subject|1|||
130544038|NCT01806623|469958576|FG000|Overall Study|Adverse Event|1|||
130544039|NCT01806623|469958576|FG000|Overall Study|Did not meet the inclusion criteria|56|||
130544040|NCT01737827|469958577|FG000|Overall Study|Adverse Event|3|||
130544041|NCT01737827|469958578|FG001|Overall Study|Adverse Event|6|||
130544042|NCT01737827|469958579|FG002|Overall Study|Adverse Event|0|||
130544043|NCT01737827|469958577|FG000|Overall Study|Lost to Follow-up|0|||
130544044|NCT01737827|469958578|FG001|Overall Study|Lost to Follow-up|1|||
130544045|NCT01737827|469958579|FG002|Overall Study|Lost to Follow-up|0|||
130544046|NCT01737827|469958577|FG000|Overall Study|Physician Decision|0|||
130544047|NCT01737827|469958578|FG001|Overall Study|Physician Decision|2|||
130544048|NCT01737827|469958579|FG002|Overall Study|Physician Decision|0|||
130544049|NCT01737827|469958577|FG000|Overall Study|Progressive Disease|5|||
130544050|NCT01737827|469958578|FG001|Overall Study|Progressive Disease|16|||
130544051|NCT01737827|469958579|FG002|Overall Study|Progressive Disease|2|||
130544052|NCT01737827|469958577|FG000|Overall Study|Study Terminated by Sponsor|0|||
130544053|NCT01737827|469958578|FG001|Overall Study|Study Terminated by Sponsor|1|||
130544054|NCT01737827|469958579|FG002|Overall Study|Study Terminated by Sponsor|0|||
130544055|NCT01737827|469958577|FG000|Overall Study|Subject/Guardian Decision|0|||
130544056|NCT01737827|469958578|FG001|Overall Study|Subject/Guardian Decision|2|||
130544057|NCT01737827|469958579|FG002|Overall Study|Subject/Guardian Decision|0|||
130544058|NCT01964924|469958580|FG000|Trametinib Monotherapy|Progression|19|||
130544059|NCT01964924|469958581|FG001|Trametinib Monotherapy|Progression|0|||
130544060|NCT01153958|469958582|FG000|Overall Study|Study Terminated|36|||
130544061|NCT01153958|469958583|FG001|Overall Study|Study Terminated|32|||
130544062|NCT02971761|469958584|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
130544063|NCT01034163|469958585|FG000|Overall Study|Treatment completed as per protocol|8|||
130544064|NCT01034163|469958586|FG001|Overall Study|Treatment completed as per protocol|7|||
130544065|NCT01034163|469958585|FG000|Overall Study|Withdrawal by Subject|8|||
130544066|NCT01034163|469958586|FG001|Overall Study|Withdrawal by Subject|2|||
130544067|NCT01034163|469958585|FG000|Overall Study|Protocol deviation|1|||
130544068|NCT01034163|469958586|FG001|Overall Study|Protocol deviation|0|||
130544069|NCT01034163|469958585|FG000|Overall Study|Disease progression|3|||
130544070|NCT01034163|469958586|FG001|Overall Study|Disease progression|4|||
130544071|NCT01034163|469958585|FG000|Overall Study|Adverse Event|6|||
130544072|NCT01034163|469958586|FG001|Overall Study|Adverse Event|0|||
130544073|NCT01034163|469958585|FG000|Overall Study|Administrative problems|0|||
130544074|NCT01034163|469958586|FG001|Overall Study|Administrative problems|1|||
130544075|NCT01034163|469958585|FG000|Overall Study|Abnormal laboratory value|1|||
130544076|NCT01034163|469958586|FG001|Overall Study|Abnormal laboratory value|0|||
130544077|NCT00116753|469958587|FG000|Overall Study|Adverse Event|16|||
130544078|NCT00116753|469958588|FG001|Overall Study|Adverse Event|10|||
130544079|NCT00116753|469958589|FG002|Overall Study|Adverse Event|7|||
130544080|NCT00116753|469958587|FG000|Overall Study|Withdrawal by Subject|11|||
130544081|NCT00116753|469958588|FG001|Overall Study|Withdrawal by Subject|12|||
130544082|NCT00116753|469958589|FG002|Overall Study|Withdrawal by Subject|8|||
130544083|NCT00116753|469958587|FG000|Overall Study|Lost to Follow-up|0|||
130544084|NCT00116753|469958588|FG001|Overall Study|Lost to Follow-up|2|||
130544085|NCT00116753|469958589|FG002|Overall Study|Lost to Follow-up|1|||
130544086|NCT00116753|469958587|FG000|Overall Study|Protocol Violation|0|||
130544087|NCT00116753|469958588|FG001|Overall Study|Protocol Violation|0|||
130544088|NCT00116753|469958589|FG002|Overall Study|Protocol Violation|1|||
130544089|NCT00116753|469958587|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
130544090|NCT00116753|469958588|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
130544091|NCT00116753|469958589|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
130544092|NCT00116753|469958587|FG000|Overall Study|Disease Progression|3|||
130544093|NCT00116753|469958588|FG001|Overall Study|Disease Progression|4|||
130544094|NCT00116753|469958589|FG002|Overall Study|Disease Progression|3|||
130544095|NCT00116753|469958587|FG000|Overall Study|Abnormal Echocardiogram|0|||
130544096|NCT00116753|469958588|FG001|Overall Study|Abnormal Echocardiogram|0|||
130544097|NCT00116753|469958589|FG002|Overall Study|Abnormal Echocardiogram|1|||
130544098|NCT00116753|469958587|FG000|Overall Study|Progressive Parkinson's Disease|1|||
130544099|NCT00116753|469958588|FG001|Overall Study|Progressive Parkinson's Disease|0|||
130544100|NCT00116753|469958589|FG002|Overall Study|Progressive Parkinson's Disease|0|||
130544101|NCT00116753|469958587|FG000|Overall Study|Dosing Error|0|||
130544102|NCT00116753|469958588|FG001|Overall Study|Dosing Error|1|||
130544103|NCT00116753|469958589|FG002|Overall Study|Dosing Error|0|||
130544104|NCT00528645|469958590|FG000|Overall Study|Adverse Event|3|||
130544105|NCT01445301|469958591|FG000|Overall Study|Adverse Event|15|||
130544106|NCT01445301|469958592|FG001|Overall Study|Adverse Event|25|||
130544107|NCT01445301|469958593|FG002|Overall Study|Adverse Event|4|||
130544108|NCT01445301|469958591|FG000|Overall Study|Lack of Efficacy|0|||
130544109|NCT01445301|469958592|FG001|Overall Study|Lack of Efficacy|1|||
130544110|NCT01445301|469958593|FG002|Overall Study|Lack of Efficacy|0|||
130544111|NCT01445301|469958591|FG000|Overall Study|Protocol Violation|1|||
130544112|NCT01445301|469958592|FG001|Overall Study|Protocol Violation|0|||
130544113|NCT01445301|469958593|FG002|Overall Study|Protocol Violation|0|||
130544114|NCT01445301|469958591|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
130544115|NCT01445301|469958592|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
130544116|NCT01445301|469958593|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
130544117|NCT01445301|469958591|FG000|Overall Study|Physician Decision|0|||
130544118|NCT01445301|469958592|FG001|Overall Study|Physician Decision|2|||
130544119|NCT01445301|469958593|FG002|Overall Study|Physician Decision|0|||
130544120|NCT01445301|469958591|FG000|Overall Study|Withdrawal by Subject|5|||
130544121|NCT01445301|469958592|FG001|Overall Study|Withdrawal by Subject|6|||
130544122|NCT01445301|469958593|FG002|Overall Study|Withdrawal by Subject|4|||
130544123|NCT02150343|469958598|FG000|Overall Study|Adverse Event|2|||
130544124|NCT02150343|469958599|FG001|Overall Study|Adverse Event|0|||
130544125|NCT02150343|469958600|FG002|Overall Study|Adverse Event|1|||
130544126|NCT02150343|469958601|FG003|Overall Study|Adverse Event|1|||
130544127|NCT02150343|469958598|FG000|Overall Study|Withdrawal by Subject|13|||
130544128|NCT02150343|469958599|FG001|Overall Study|Withdrawal by Subject|10|||
130544129|NCT02150343|469958600|FG002|Overall Study|Withdrawal by Subject|9|||
130544130|NCT02150343|469958601|FG003|Overall Study|Withdrawal by Subject|4|||
130544131|NCT02150343|469958598|FG000|Overall Study|Lost to Follow-up|4|||
130544132|NCT02150343|469958599|FG001|Overall Study|Lost to Follow-up|4|||
130544133|NCT02150343|469958600|FG002|Overall Study|Lost to Follow-up|2|||
130544134|NCT02150343|469958601|FG003|Overall Study|Lost to Follow-up|3|||
130544135|NCT02150343|469958598|FG000|Overall Study|Other|2|||
130544136|NCT02150343|469958599|FG001|Overall Study|Other|6|||
130544137|NCT02150343|469958600|FG002|Overall Study|Other|0|||
130544138|NCT02150343|469958601|FG003|Overall Study|Other|2|||
130544139|NCT02729753|469958602|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
130544140|NCT02729753|469958603|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
130544141|NCT01090427|469958604|FG000|After Controlled Period|Death|0|||
130544142|NCT01090427|469958605|FG001|After Controlled Period|Death|0|||
130544143|NCT01090427|469958606|FG002|After Controlled Period|Death|0|||
130544144|NCT01090427|469958607|FG003|After Controlled Period|Death|0|||
130544145|NCT01090427|469958608|FG004|After Controlled Period|Death|0|||
130544146|NCT01090427|469958609|FG005|After Controlled Period|Death|1|||
130544147|NCT01090427|469958610|FG006|After Controlled Period|Death|0|||
130544148|NCT01090427|469958604|FG000|After Controlled Period|Lack of Efficacy|0|||
130544149|NCT01090427|469958605|FG001|After Controlled Period|Lack of Efficacy|0|||
130544150|NCT01090427|469958606|FG002|After Controlled Period|Lack of Efficacy|0|||
130544151|NCT01090427|469958607|FG003|After Controlled Period|Lack of Efficacy|0|||
130544152|NCT01090427|469958608|FG004|After Controlled Period|Lack of Efficacy|0|||
130544153|NCT01090427|469958609|FG005|After Controlled Period|Lack of Efficacy|3|||
130544154|NCT01090427|469958610|FG006|After Controlled Period|Lack of Efficacy|2|||
130544155|NCT01090427|469958604|FG000|After Controlled Period|Adverse Event|0|||
130544156|NCT01090427|469958605|FG001|After Controlled Period|Adverse Event|0|||
130544157|NCT01090427|469958606|FG002|After Controlled Period|Adverse Event|0|||
130544158|NCT01090427|469958607|FG003|After Controlled Period|Adverse Event|2|||
130544159|NCT01090427|469958608|FG004|After Controlled Period|Adverse Event|0|||
130544160|NCT01090427|469958609|FG005|After Controlled Period|Adverse Event|1|||
130544161|NCT01090427|469958610|FG006|After Controlled Period|Adverse Event|0|||
130544162|NCT01200589|469958611|FG000|Overall Study|Withdrawal by Subject|13|||
130544163|NCT01200589|469958612|FG001|Overall Study|Withdrawal by Subject|11|||
130544164|NCT01200589|469958611|FG000|Overall Study|Physician Decision|2|||
130544165|NCT01200589|469958612|FG001|Overall Study|Physician Decision|2|||
130544166|NCT01200589|469958611|FG000|Overall Study|Lost to Follow-up|5|||
130544167|NCT01200589|469958612|FG001|Overall Study|Lost to Follow-up|4|||
130544168|NCT01200589|469958611|FG000|Overall Study|Study terminated|170|||
130544169|NCT01200589|469958612|FG001|Overall Study|Study terminated|172|||
130544170|NCT00439231|469958613|FG000|Overall Study|Lack of Efficacy|28|||
130544171|NCT01605916|469958614|FG000|Overall Study|Adverse Event|1|||
130544172|NCT01605916|469958615|FG001|Overall Study|Adverse Event|0|||
130544173|NCT01605916|469958616|FG002|Overall Study|Adverse Event|0|||
130544174|NCT01605916|469958617|FG003|Overall Study|Adverse Event|1|||
130544175|NCT01605916|469958618|FG004|Overall Study|Adverse Event|0|||
130320416|NCT02016781|469141911|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
130544176|NCT01605916|469958614|FG000|Overall Study|Lack of Efficacy|2|||
130544177|NCT01605916|469958615|FG001|Overall Study|Lack of Efficacy|3|||
130544178|NCT01605916|469958616|FG002|Overall Study|Lack of Efficacy|3|||
130544179|NCT01605916|469958617|FG003|Overall Study|Lack of Efficacy|5|||
130544180|NCT01605916|469958618|FG004|Overall Study|Lack of Efficacy|4|||
130544181|NCT01605916|469958614|FG000|Overall Study|Withdrawal by Subject|1|||
130544182|NCT01605916|469958615|FG001|Overall Study|Withdrawal by Subject|1|||
130544183|NCT01605916|469958616|FG002|Overall Study|Withdrawal by Subject|0|||
130544184|NCT01605916|469958617|FG003|Overall Study|Withdrawal by Subject|0|||
130320417|NCT02016781|469141910|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
130320418|NCT02016781|469141911|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
130320419|NCT02016781|469141910|FG000|Final Database Lock|Withdrawal by Subject|2|||
130544185|NCT01605916|469958618|FG004|Overall Study|Withdrawal by Subject|2|||
130544186|NCT02689518|469958621|FG000|Overall Study|Withdrawal by Subject|3|||
130544187|NCT03265938|469958627|FG000|Overall Study|Withdrawal by Subject|1|||
130544188|NCT03265938|469958627|FG000|Overall Study|Physician Decision|1|||
130544189|NCT03265938|469958627|FG000|Overall Study|friable mass|6|||
130544190|NCT02679508|469958628|FG000|Healing Phase|Protocol Violation|1|||
130544191|NCT02679508|469958629|FG001|Healing Phase|Protocol Violation|1|||
130544192|NCT02679508|469958628|FG000|Healing Phase|Lost to Follow-up|1|||
130544193|NCT02679508|469958629|FG001|Healing Phase|Lost to Follow-up|0|||
130544194|NCT02679508|469958628|FG000|Maintenance Phase|Adverse Event|12|||
130544195|NCT02679508|469958629|FG001|Maintenance Phase|Adverse Event|2|||
130544196|NCT02679508|469958628|FG000|Maintenance Phase|Lost to Follow-up|0|||
130544197|NCT02679508|469958629|FG001|Maintenance Phase|Lost to Follow-up|1|||
130544198|NCT02679508|469958628|FG000|Maintenance Phase|Withdrawal by Subject|15|||
130544199|NCT02679508|469958629|FG001|Maintenance Phase|Withdrawal by Subject|8|||
130544200|NCT02679508|469958628|FG000|Maintenance Phase|Other|5|||
130544201|NCT02679508|469958629|FG001|Maintenance Phase|Other|4|||
130544202|NCT03143166|469958630|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
130544203|NCT03683823|469958631|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
130544204|NCT03683823|469958632|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
130544205|NCT03683823|469958631|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
130544206|NCT03683823|469958632|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
130544207|NCT03683823|469958631|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
130544208|NCT03683823|469958632|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
130544209|NCT01323972|469958634|FG000|Overall Study|Withdrawal by Subject|1|||
130544210|NCT01323972|469958635|FG001|Overall Study|Withdrawal by Subject|0|||
130544211|NCT01323972|469958636|FG002|Overall Study|Withdrawal by Subject|1|||
130544212|NCT01323972|469958637|FG003|Overall Study|Withdrawal by Subject|0|||
130544213|NCT01323972|469958634|FG000|Overall Study|Migrated/moved from study area|1|||
130544214|NCT01323972|469958635|FG001|Overall Study|Migrated/moved from study area|2|||
130544215|NCT01323972|469958636|FG002|Overall Study|Migrated/moved from study area|0|||
130544216|NCT01323972|469958637|FG003|Overall Study|Migrated/moved from study area|0|||
130544217|NCT01323972|469958634|FG000|Overall Study|Lost to Follow-up|0|||
130544218|NCT01323972|469958635|FG001|Overall Study|Lost to Follow-up|1|||
130544219|NCT01323972|469958636|FG002|Overall Study|Lost to Follow-up|1|||
130544220|NCT01323972|469958637|FG003|Overall Study|Lost to Follow-up|1|||
130544221|NCT05000931|469958646|FG000|Overall Study|Lost to Follow-up|1|||
130544222|NCT03141905|469958647|FG000|Overall Study|Death|3|||
130544223|NCT03141905|469958648|FG001|Overall Study|Death|2|||
130544224|NCT03141905|469958647|FG000|Overall Study|Withdrawal by Subject|1|||
130544225|NCT03141905|469958648|FG001|Overall Study|Withdrawal by Subject|0|||
130544226|NCT03141905|469958647|FG000|Overall Study|Lost to Follow-up|3|||
130544227|NCT03141905|469958648|FG001|Overall Study|Lost to Follow-up|7|||
130544228|NCT03141905|469958647|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
130544229|NCT03141905|469958648|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
130544230|NCT00812331|469960457|FG000|Overall Study|Adverse Event|1|||
130544231|NCT00812331|469960458|FG001|Overall Study|Adverse Event|0|||
130544232|NCT00812331|469960459|FG002|Overall Study|Adverse Event|0|||
130544233|NCT00812331|469960460|FG003|Overall Study|Adverse Event|0|||
130544234|NCT00812331|469960461|FG004|Overall Study|Adverse Event|0|||
130544235|NCT01506453|469960462|FG000|Overall Study|Withdrawal prior to treatment|0|||
130544236|NCT01506453|469960463|FG001|Overall Study|Withdrawal prior to treatment|2|||
130544237|NCT00055601|469960466|FG000|Overall Study|Protocol Violation|1|||
130544238|NCT00055601|469960467|FG001|Overall Study|Protocol Violation|1|||
130544239|NCT00055601|469960466|FG000|Overall Study|No protocol treatment received|1|||
130544240|NCT00055601|469960467|FG001|Overall Study|No protocol treatment received|1|||
130544241|NCT00117845|469960468|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
130544242|NCT01022268|469960469|FG000|Overall Study|Withdrawal by Subject|1|||
130544243|NCT01022268|469960470|FG001|Overall Study|Withdrawal by Subject|0|||
130544244|NCT01022268|469960469|FG000|Overall Study|Withdrawal by Subject|1|||
130544245|NCT01022268|469960470|FG001|Overall Study|Withdrawal by Subject|0|||
130544246|NCT00910689|469960471|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
130544247|NCT00910689|469960472|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
130544248|NCT00910689|469960473|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
130544249|NCT00910689|469960474|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
130544250|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
130544251|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
130544252|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
130544253|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
130544254|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
130544255|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
130544256|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
130544257|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
130544258|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
130544259|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
130544260|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
130544261|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
130544262|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
130544263|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
130544264|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
130544265|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
130544266|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
130544267|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
130544268|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
130544269|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
130544270|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
130544271|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
130544272|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
130544273|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
130544274|NCT00910689|469960471|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
130544275|NCT00910689|469960472|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
130544276|NCT00910689|469960473|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
130544277|NCT00910689|469960474|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
130544278|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
130544279|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
130544280|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
130544281|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
130544282|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
130544283|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
130544284|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
130544285|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
130544286|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
130544287|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
130544288|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
130544289|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
130544290|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
130544291|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
130544292|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
130544293|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
130544294|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
130544295|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
130544296|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
130544297|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
130544298|NCT00910689|469960471|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
130544299|NCT00910689|469960472|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
130544300|NCT00910689|469960473|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
130544301|NCT00910689|469960474|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
130544302|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
130544303|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
130544304|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
130544305|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
130544306|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
130544307|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
130544308|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
130544309|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
130544310|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
130544311|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
130544312|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
130544313|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
130544314|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
130544315|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
130544316|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
130544317|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
130544318|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
130544319|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
130544320|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
130544321|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
130544322|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
130544323|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
130544324|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
130544325|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
130544326|NCT00910689|469960471|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
130544327|NCT00910689|469960472|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
130544328|NCT00910689|469960473|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
130544329|NCT00910689|469960474|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
130544330|NCT03207009|469960475|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
130544331|NCT02924428|469960476|FG000|Overall Study|Adverse Event|1|||
130544332|NCT02924428|469960477|FG001|Overall Study|Adverse Event|0|||
130544333|NCT02924428|469960476|FG000|Overall Study|Physician Decision|1|||
130544334|NCT02924428|469960477|FG001|Overall Study|Physician Decision|0|||
130544335|NCT02924428|469960476|FG000|Overall Study|Lost to Follow-up|2|||
130544336|NCT02924428|469960477|FG001|Overall Study|Lost to Follow-up|4|||
130544337|NCT02924428|469960476|FG000|Overall Study|Pregnancy|0|||
130544338|NCT02924428|469960477|FG001|Overall Study|Pregnancy|1|||
130544339|NCT02680002|469960478|FG000|Overall Study|Lost to Follow-up|5|||
130544340|NCT02680002|469960479|FG001|Overall Study|Lost to Follow-up|1|||
130544341|NCT02680002|469960480|FG002|Overall Study|Lost to Follow-up|4|||
130544342|NCT02680002|469960481|FG003|Overall Study|Lost to Follow-up|2|||
130544343|NCT02680002|469960482|FG004|Overall Study|Lost to Follow-up|0|||
130544344|NCT02680002|469960483|FG005|Overall Study|Lost to Follow-up|2|||
130544345|NCT02680002|469960478|FG000|Overall Study|Physician Decision|5|||
130544346|NCT02680002|469960479|FG001|Overall Study|Physician Decision|1|||
130544347|NCT02680002|469960480|FG002|Overall Study|Physician Decision|1|||
130544348|NCT02680002|469960481|FG003|Overall Study|Physician Decision|1|||
130544349|NCT02680002|469960482|FG004|Overall Study|Physician Decision|1|||
130544350|NCT02680002|469960483|FG005|Overall Study|Physician Decision|1|||
130544351|NCT02680002|469960478|FG000|Overall Study|Protocol Violation|1|||
130544352|NCT02680002|469960479|FG001|Overall Study|Protocol Violation|0|||
130544353|NCT02680002|469960480|FG002|Overall Study|Protocol Violation|1|||
130544354|NCT02680002|469960481|FG003|Overall Study|Protocol Violation|0|||
130544355|NCT02680002|469960482|FG004|Overall Study|Protocol Violation|1|||
130544356|NCT02680002|469960483|FG005|Overall Study|Protocol Violation|2|||
130544357|NCT02680002|469960478|FG000|Overall Study|Withdrawal by Subject|0|||
130544358|NCT02680002|469960479|FG001|Overall Study|Withdrawal by Subject|0|||
130544359|NCT02680002|469960480|FG002|Overall Study|Withdrawal by Subject|1|||
130544360|NCT02680002|469960481|FG003|Overall Study|Withdrawal by Subject|0|||
130544361|NCT02680002|469960482|FG004|Overall Study|Withdrawal by Subject|2|||
130544362|NCT02680002|469960483|FG005|Overall Study|Withdrawal by Subject|2|||
130544363|NCT02680002|469960478|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
130544364|NCT02680002|469960479|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
130544365|NCT02680002|469960480|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
130544366|NCT02680002|469960481|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
130544367|NCT02680002|469960482|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
130544368|NCT02680002|469960483|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
130544369|NCT02680002|469960478|FG000|Overall Study|Other|0|||
130544370|NCT02680002|469960479|FG001|Overall Study|Other|1|||
130544371|NCT02680002|469960480|FG002|Overall Study|Other|0|||
130544372|NCT02680002|469960481|FG003|Overall Study|Other|0|||
130544373|NCT02680002|469960482|FG004|Overall Study|Other|1|||
130544374|NCT02680002|469960483|FG005|Overall Study|Other|0|||
130544375|NCT02680002|469960478|FG000|Overall Study|Adverse Event|0|||
130544376|NCT02680002|469960479|FG001|Overall Study|Adverse Event|0|||
130544377|NCT02680002|469960480|FG002|Overall Study|Adverse Event|0|||
130544378|NCT02680002|469960481|FG003|Overall Study|Adverse Event|0|||
130544379|NCT02680002|469960482|FG004|Overall Study|Adverse Event|1|||
130544380|NCT02680002|469960483|FG005|Overall Study|Adverse Event|2|||
130544381|NCT01248780|469960490|FG000|Overall Study|Lack of Efficacy|2|||
130544382|NCT01248780|469960491|FG001|Overall Study|Lack of Efficacy|0|||
130544383|NCT01248780|469960490|FG000|Overall Study|Lost to Follow-up|0|||
130544384|NCT01248780|469960491|FG001|Overall Study|Lost to Follow-up|1|||
130544385|NCT01248780|469960490|FG000|Overall Study|Death|0|||
130544386|NCT01248780|469960491|FG001|Overall Study|Death|1|||
130544387|NCT01248780|469960490|FG000|Overall Study|Adverse Event|2|||
130544388|NCT01248780|469960491|FG001|Overall Study|Adverse Event|7|||
130544389|NCT01248780|469960490|FG000|Overall Study|Protocol Violation|1|||
130544390|NCT01248780|469960491|FG001|Overall Study|Protocol Violation|1|||
130544391|NCT01248780|469960490|FG000|Overall Study|Withdrawal by Subject|4|||
130544392|NCT01248780|469960491|FG001|Overall Study|Withdrawal by Subject|4|||
130544393|NCT01248780|469960490|FG000|Overall Study|Not treated|0|||
130544394|NCT01248780|469960491|FG001|Overall Study|Not treated|1|||
130544395|NCT03064035|469960492|FG000|Overall Study|Did not receive allocated intervention|4|||
130544396|NCT03064035|469960493|FG001|Overall Study|Did not receive allocated intervention|2|||
130544397|NCT03064035|469960492|FG000|Overall Study|Lost to Follow-up|1|||
130544398|NCT03064035|469960493|FG001|Overall Study|Lost to Follow-up|1|||
130544399|NCT03103763|469960494|FG000|Overall Study|Death|15|||
130544400|NCT03103763|469960495|FG001|Overall Study|Death|5|||
130544401|NCT03103763|469960496|FG002|Overall Study|Death|5|||
130544402|NCT03103763|469960494|FG000|Overall Study|Withdrawal by Subject|0|||
130544403|NCT03103763|469960495|FG001|Overall Study|Withdrawal by Subject|3|||
130544404|NCT03103763|469960496|FG002|Overall Study|Withdrawal by Subject|2|||
130544405|NCT04279392|469960497|FG000|Overall Study|Physician Decision|1|||
130544406|NCT04279392|469960498|FG001|Overall Study|Physician Decision|0|||
130544407|NCT04101318|469960505|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
130544408|NCT04101318|469960506|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
130544409|NCT04101318|469960505|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
130544410|NCT04101318|469960506|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
130544411|NCT04101318|469960505|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
130544412|NCT04101318|469960506|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
130544413|NCT00558259|469960507|FG000|Overall Study|Adverse Event|50|||
130544414|NCT00558259|469960508|FG001|Overall Study|Adverse Event|81|||
130544415|NCT00558259|469960507|FG000|Overall Study|Protocol Violation|9|||
130544416|NCT00558259|469960508|FG001|Overall Study|Protocol Violation|5|||
130544417|NCT00558259|469960507|FG000|Overall Study|Withdrawal by Subject|12|||
130544418|NCT00558259|469960508|FG001|Overall Study|Withdrawal by Subject|13|||
130544419|NCT04289051|469960509|FG000|Overall Study|Lost to Follow-up|0|||
130544420|NCT04289051|469960510|FG001|Overall Study|Lost to Follow-up|0|||
130544421|NCT04289051|469960511|FG002|Overall Study|Lost to Follow-up|2|||
130544422|NCT01901341|469960512|FG000|Overall Study|Adverse Event|4|||
130544423|NCT01901341|469960513|FG001|Overall Study|Adverse Event|2|||
130544424|NCT01901341|469960512|FG000|Overall Study|Lack of Efficacy|0|||
130544425|NCT01901341|469960513|FG001|Overall Study|Lack of Efficacy|2|||
130544426|NCT01901341|469960512|FG000|Overall Study|Lost to Follow-up|0|||
130544427|NCT01901341|469960513|FG001|Overall Study|Lost to Follow-up|1|||
130544428|NCT01901341|469960512|FG000|Overall Study|Protocol Violation|2|||
130544429|NCT01901341|469960513|FG001|Overall Study|Protocol Violation|0|||
130544430|NCT01901341|469960512|FG000|Overall Study|Study Terminated by Sponsor|13|||
130544431|NCT01901341|469960513|FG001|Overall Study|Study Terminated by Sponsor|15|||
130544432|NCT01901341|469960512|FG000|Overall Study|Withdrawal by Subject|1|||
130544433|NCT01901341|469960513|FG001|Overall Study|Withdrawal by Subject|1|||
130544434|NCT02966301|469960514|FG000|Overall Study|Death|2|||
130544435|NCT02966301|469960514|FG000|Overall Study|Withdrawal by Subject|1|||
130544436|NCT00370331|469960516|FG000|Overall Study|Adverse Event|4|||
130544437|NCT00370331|469960517|FG001|Overall Study|Adverse Event|13|||
130544438|NCT00370331|469960516|FG000|Overall Study|Withdrawal by Subject|2|||
130544439|NCT00370331|469960517|FG001|Overall Study|Withdrawal by Subject|4|||
130544440|NCT00370331|469960516|FG000|Overall Study|Lost to Follow-up|0|||
130544441|NCT00370331|469960517|FG001|Overall Study|Lost to Follow-up|3|||
130544442|NCT00370331|469960516|FG000|Overall Study|Lack of Efficacy|0|||
130544443|NCT00370331|469960517|FG001|Overall Study|Lack of Efficacy|1|||
130544444|NCT00370331|469960516|FG000|Overall Study|Non-compliance|0|||
130544445|NCT00370331|469960517|FG001|Overall Study|Non-compliance|1|||
130544446|NCT00370331|469960516|FG000|Overall Study|Protocol Violation|1|||
130544447|NCT00370331|469960517|FG001|Overall Study|Protocol Violation|1|||
130544448|NCT01874431|469960518|FG000|Overall Study|Physician Decision|0|||
130544449|NCT01874431|469960519|FG001|Overall Study|Physician Decision|0|||
130544450|NCT01874431|469960520|FG002|Overall Study|Physician Decision|1|||
130544451|NCT01874431|469960521|FG003|Overall Study|Physician Decision|0|||
130544452|NCT01874431|469960522|FG004|Overall Study|Physician Decision|0|||
130544453|NCT01874431|469960523|FG005|Overall Study|Physician Decision|0|||
130544454|NCT01874431|469960524|FG006|Overall Study|Physician Decision|0|||
130544455|NCT01874431|469960525|FG007|Overall Study|Physician Decision|0|||
130544456|NCT01874431|469960518|FG000|Overall Study|Adverse Event|5|||
130544457|NCT01874431|469960519|FG001|Overall Study|Adverse Event|4|||
130544458|NCT01874431|469960520|FG002|Overall Study|Adverse Event|6|||
130544459|NCT01874431|469960521|FG003|Overall Study|Adverse Event|5|||
130544460|NCT01874431|469960522|FG004|Overall Study|Adverse Event|2|||
130544461|NCT01874431|469960523|FG005|Overall Study|Adverse Event|8|||
130544462|NCT01874431|469960524|FG006|Overall Study|Adverse Event|2|||
130544463|NCT01874431|469960525|FG007|Overall Study|Adverse Event|3|||
130544464|NCT01874431|469960518|FG000|Overall Study|Protocol Violation|1|||
130544465|NCT01874431|469960519|FG001|Overall Study|Protocol Violation|1|||
130544466|NCT01874431|469960520|FG002|Overall Study|Protocol Violation|1|||
130544467|NCT01874431|469960521|FG003|Overall Study|Protocol Violation|0|||
130544468|NCT01874431|469960522|FG004|Overall Study|Protocol Violation|3|||
130544469|NCT01874431|469960523|FG005|Overall Study|Protocol Violation|2|||
130544470|NCT01874431|469960524|FG006|Overall Study|Protocol Violation|1|||
130544471|NCT01874431|469960525|FG007|Overall Study|Protocol Violation|1|||
130544472|NCT01874431|469960518|FG000|Overall Study|Non-compliance|0|||
130544473|NCT01874431|469960519|FG001|Overall Study|Non-compliance|0|||
130544474|NCT01874431|469960520|FG002|Overall Study|Non-compliance|0|||
130544475|NCT01874431|469960521|FG003|Overall Study|Non-compliance|0|||
130544476|NCT01874431|469960522|FG004|Overall Study|Non-compliance|1|||
130544477|NCT01874431|469960523|FG005|Overall Study|Non-compliance|0|||
130544478|NCT01874431|469960524|FG006|Overall Study|Non-compliance|1|||
130544479|NCT01874431|469960525|FG007|Overall Study|Non-compliance|0|||
130544480|NCT01874431|469960518|FG000|Overall Study|Logistical difficulties|0|||
130544481|NCT01874431|469960519|FG001|Overall Study|Logistical difficulties|0|||
130544482|NCT01874431|469960520|FG002|Overall Study|Logistical difficulties|0|||
130544483|NCT01874431|469960521|FG003|Overall Study|Logistical difficulties|0|||
130544484|NCT01874431|469960522|FG004|Overall Study|Logistical difficulties|0|||
130544485|NCT01874431|469960523|FG005|Overall Study|Logistical difficulties|0|||
130544486|NCT01874431|469960524|FG006|Overall Study|Logistical difficulties|1|||
130544487|NCT01874431|469960525|FG007|Overall Study|Logistical difficulties|0|||
130544488|NCT01874431|469960518|FG000|Overall Study|Withdrawal by Subject|0|||
130544489|NCT01874431|469960519|FG001|Overall Study|Withdrawal by Subject|0|||
130544490|NCT01874431|469960520|FG002|Overall Study|Withdrawal by Subject|1|||
130544491|NCT01874431|469960521|FG003|Overall Study|Withdrawal by Subject|2|||
130544492|NCT01874431|469960522|FG004|Overall Study|Withdrawal by Subject|1|||
130544493|NCT01874431|469960523|FG005|Overall Study|Withdrawal by Subject|1|||
130544494|NCT01874431|469960524|FG006|Overall Study|Withdrawal by Subject|3|||
130544495|NCT01874431|469960525|FG007|Overall Study|Withdrawal by Subject|0|||
130544496|NCT01874431|469960518|FG000|Overall Study|Sponsor decision|0|||
130544497|NCT01874431|469960519|FG001|Overall Study|Sponsor decision|0|||
130544498|NCT01874431|469960520|FG002|Overall Study|Sponsor decision|0|||
130320420|NCT02016781|469141911|FG001|Final Database Lock|Withdrawal by Subject|1|||
130320421|NCT02016781|469141910|FG000|Final Database Lock|Lost to Follow-up|11|||
130320422|NCT02016781|469141911|FG001|Final Database Lock|Lost to Follow-up|4|||
130320423|NCT02016781|469141910|FG000|Final Database Lock|Missing data|0|||
130320424|NCT02016781|469141911|FG001|Final Database Lock|Missing data|3|||
130320425|NCT04886154|469141912|FG000|Overall Study|Adverse Event|0|||
130320426|NCT04886154|469141913|FG001|Overall Study|Adverse Event|0|||
130320427|NCT04886154|469141914|FG002|Overall Study|Adverse Event|0|||
130320428|NCT04886154|469141915|FG003|Overall Study|Adverse Event|0|||
130320429|NCT04886154|469141916|FG004|Overall Study|Adverse Event|1|||
130320430|NCT04886154|469141917|FG005|Overall Study|Adverse Event|0|||
130320431|NCT04886154|469141918|FG006|Overall Study|Adverse Event|0|||
130320432|NCT04886154|469141919|FG007|Overall Study|Adverse Event|1|||
130320433|NCT04886154|469141920|FG008|Overall Study|Adverse Event|1|||
130320434|NCT04886154|469141921|FG009|Overall Study|Adverse Event|0|||
130320435|NCT04886154|469141922|FG010|Overall Study|Adverse Event|0|||
130320436|NCT04886154|469141923|FG011|Overall Study|Adverse Event|1|||
130320437|NCT04886154|469141924|FG012|Overall Study|Adverse Event|0|||
130320438|NCT04886154|469141925|FG013|Overall Study|Adverse Event|0|||
130320439|NCT04886154|469141926|FG014|Overall Study|Adverse Event|3|||
130320440|NCT04886154|469141912|FG000|Overall Study|Lost to Follow-up|1|||
130320441|NCT04886154|469141913|FG001|Overall Study|Lost to Follow-up|0|||
130320442|NCT04886154|469141914|FG002|Overall Study|Lost to Follow-up|2|||
130320443|NCT04886154|469141915|FG003|Overall Study|Lost to Follow-up|0|||
130320444|NCT04886154|469141916|FG004|Overall Study|Lost to Follow-up|17|||
130320445|NCT04886154|469141917|FG005|Overall Study|Lost to Follow-up|7|||
130320446|NCT04886154|469141918|FG006|Overall Study|Lost to Follow-up|8|||
130320447|NCT04886154|469141919|FG007|Overall Study|Lost to Follow-up|7|||
130320448|NCT04886154|469141920|FG008|Overall Study|Lost to Follow-up|8|||
130320449|NCT04886154|469141921|FG009|Overall Study|Lost to Follow-up|0|||
130320450|NCT04886154|469141922|FG010|Overall Study|Lost to Follow-up|2|||
130320451|NCT04886154|469141923|FG011|Overall Study|Lost to Follow-up|0|||
130320452|NCT04886154|469141924|FG012|Overall Study|Lost to Follow-up|0|||
130320453|NCT04886154|469141925|FG013|Overall Study|Lost to Follow-up|0|||
130320454|NCT04886154|469141926|FG014|Overall Study|Lost to Follow-up|0|||
130320455|NCT04886154|469141912|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320456|NCT04886154|469141913|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320457|NCT04886154|469141914|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320458|NCT04886154|469141915|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320459|NCT04886154|469141916|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320460|NCT04886154|469141917|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130544499|NCT01874431|469960521|FG003|Overall Study|Sponsor decision|0|||
130544500|NCT01874431|469960522|FG004|Overall Study|Sponsor decision|1|||
130544501|NCT01874431|469960523|FG005|Overall Study|Sponsor decision|0|||
130544502|NCT01874431|469960524|FG006|Overall Study|Sponsor decision|0|||
130320461|NCT04886154|469141918|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
130320462|NCT04886154|469141919|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320463|NCT04886154|469141920|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320464|NCT04886154|469141921|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320465|NCT04886154|469141922|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320466|NCT04886154|469141923|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320467|NCT04886154|469141924|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320468|NCT04886154|469141925|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320469|NCT04886154|469141926|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320470|NCT04886154|469141912|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320471|NCT04886154|469141913|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320472|NCT04886154|469141914|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320473|NCT04886154|469141915|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320474|NCT04886154|469141916|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130320475|NCT04886154|469141917|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320476|NCT04886154|469141918|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130320477|NCT04886154|469141919|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130320478|NCT04886154|469141920|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320479|NCT04886154|469141921|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130544503|NCT01874431|469960525|FG007|Overall Study|Sponsor decision|0|||
130544504|NCT01874431|469960518|FG000|Overall Study|Lost to Follow-up|0|||
130544505|NCT01874431|469960519|FG001|Overall Study|Lost to Follow-up|0|||
130544506|NCT01874431|469960520|FG002|Overall Study|Lost to Follow-up|1|||
130544507|NCT01874431|469960521|FG003|Overall Study|Lost to Follow-up|0|||
130320480|NCT04886154|469141922|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320481|NCT04886154|469141923|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320482|NCT04886154|469141924|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320483|NCT04886154|469141925|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130544508|NCT01874431|469960522|FG004|Overall Study|Lost to Follow-up|0|||
130544509|NCT01874431|469960523|FG005|Overall Study|Lost to Follow-up|0|||
130544510|NCT01874431|469960524|FG006|Overall Study|Lost to Follow-up|0|||
130544511|NCT01874431|469960525|FG007|Overall Study|Lost to Follow-up|0|||
130544512|NCT01981473|469960526|FG000|Overall Study|Incorrect diagnosis of RA|0|||
130544513|NCT01981473|469960527|FG001|Overall Study|Incorrect diagnosis of RA|0|||
130544514|NCT01981473|469960528|FG002|Overall Study|Incorrect diagnosis of RA|1|||
130544515|NCT01981473|469960526|FG000|Overall Study|Received treatment for < 6 months|0|||
130544516|NCT01981473|469960527|FG001|Overall Study|Received treatment for < 6 months|0|||
130544517|NCT01981473|469960528|FG002|Overall Study|Received treatment for < 6 months|1|||
130544518|NCT01981473|469960526|FG000|Overall Study|Received treatment for >24 months|2|||
130544519|NCT01981473|469960527|FG001|Overall Study|Received treatment for >24 months|0|||
130544520|NCT01981473|469960528|FG002|Overall Study|Received treatment for >24 months|6|||
130544521|NCT00545051|469960532|FG000|Overall Study|Adverse Event|7|||
130544522|NCT00545051|469960533|FG001|Overall Study|Adverse Event|3|||
130544523|NCT00545051|469960532|FG000|Overall Study|Death|1|||
130544524|NCT00545051|469960533|FG001|Overall Study|Death|0|||
130544525|NCT00545051|469960532|FG000|Overall Study|Violation of inclusion/exclusion|0|||
130544526|NCT00545051|469960533|FG001|Overall Study|Violation of inclusion/exclusion|2|||
130544527|NCT00545051|469960532|FG000|Overall Study|Protocol Violation|1|||
130544528|NCT00545051|469960533|FG001|Overall Study|Protocol Violation|0|||
130544529|NCT00545051|469960532|FG000|Overall Study|Withdrawal by Subject|0|||
130544530|NCT00545051|469960533|FG001|Overall Study|Withdrawal by Subject|1|||
130544531|NCT00545051|469960532|FG000|Overall Study|Administrative reasons|0|||
130544532|NCT00545051|469960533|FG001|Overall Study|Administrative reasons|1|||
130544533|NCT01888900|469960534|FG000|Overall Study|failed treatment|0|||
130544534|NCT01888900|469960535|FG001|Overall Study|failed treatment|2|||
130544535|NCT03271021|469960539|FG000|Overall Study|Adverse Event|3|||
130544536|NCT03271021|469960540|FG001|Overall Study|Adverse Event|2|||
130544537|NCT03271021|469960539|FG000|Overall Study|Withdrawal by Subject|36|||
130544538|NCT03271021|469960540|FG001|Overall Study|Withdrawal by Subject|53|||
130544539|NCT03271021|469960539|FG000|Overall Study|Lost to Follow-up|34|||
130544540|NCT03271021|469960540|FG001|Overall Study|Lost to Follow-up|39|||
130544541|NCT03271021|469960539|FG000|Overall Study|Protocol Violation|6|||
130544542|NCT03271021|469960540|FG001|Overall Study|Protocol Violation|4|||
130544543|NCT03271021|469960539|FG000|Overall Study|Abnormal Lab Results|1|||
130544544|NCT03271021|469960540|FG001|Overall Study|Abnormal Lab Results|0|||
130544545|NCT03271021|469960539|FG000|Overall Study|Miscellaneous|9|||
130544546|NCT03271021|469960540|FG001|Overall Study|Miscellaneous|8|||
130544547|NCT02257567|469960547|FG000|Overall Study|Adverse Event|0|||
130544548|NCT02257567|469960548|FG001|Overall Study|Adverse Event|0|||
130544549|NCT02257567|469960549|FG002|Overall Study|Adverse Event|0|||
130544550|NCT02257567|469960550|FG003|Overall Study|Adverse Event|1|||
130544551|NCT02257567|469960551|FG004|Overall Study|Adverse Event|1|||
130544552|NCT02257567|469960552|FG005|Overall Study|Adverse Event|0|||
130544553|NCT02257567|469960553|FG006|Overall Study|Adverse Event|0|||
130544554|NCT02257567|469960554|FG007|Overall Study|Adverse Event|0|||
130544555|NCT02257567|469960555|FG008|Overall Study|Adverse Event|1|||
130544556|NCT02257567|469960556|FG009|Overall Study|Adverse Event|0|||
130544557|NCT02257567|469960557|FG010|Overall Study|Adverse Event|0|||
130544558|NCT02257567|469960547|FG000|Overall Study|Death|2|||
130544559|NCT02257567|469960548|FG001|Overall Study|Death|2|||
130544560|NCT02257567|469960549|FG002|Overall Study|Death|2|||
130544561|NCT02257567|469960550|FG003|Overall Study|Death|4|||
130544562|NCT02257567|469960551|FG004|Overall Study|Death|15|||
130544563|NCT02257567|469960552|FG005|Overall Study|Death|11|||
130544564|NCT02257567|469960553|FG006|Overall Study|Death|26|||
130544565|NCT02257567|469960554|FG007|Overall Study|Death|30|||
130544566|NCT02257567|469960555|FG008|Overall Study|Death|2|||
130544567|NCT02257567|469960556|FG009|Overall Study|Death|18|||
130544568|NCT02257567|469960557|FG010|Overall Study|Death|65|||
130544569|NCT02257567|469960547|FG000|Overall Study|Lost to Follow-up|0|||
130544570|NCT02257567|469960548|FG001|Overall Study|Lost to Follow-up|0|||
130544571|NCT02257567|469960549|FG002|Overall Study|Lost to Follow-up|0|||
130544572|NCT02257567|469960550|FG003|Overall Study|Lost to Follow-up|0|||
130544573|NCT02257567|469960551|FG004|Overall Study|Lost to Follow-up|2|||
130544574|NCT02257567|469960552|FG005|Overall Study|Lost to Follow-up|2|||
130544575|NCT02257567|469960553|FG006|Overall Study|Lost to Follow-up|0|||
130544576|NCT02257567|469960554|FG007|Overall Study|Lost to Follow-up|0|||
130544577|NCT02257567|469960555|FG008|Overall Study|Lost to Follow-up|0|||
130544578|NCT02257567|469960556|FG009|Overall Study|Lost to Follow-up|1|||
130544579|NCT02257567|469960557|FG010|Overall Study|Lost to Follow-up|1|||
130544580|NCT02257567|469960547|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544581|NCT02257567|469960548|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544582|NCT02257567|469960549|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544583|NCT02257567|469960550|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544584|NCT02257567|469960551|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
130544585|NCT02257567|469960552|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544586|NCT02257567|469960553|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
130544587|NCT02257567|469960554|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544588|NCT02257567|469960555|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544589|NCT02257567|469960556|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544590|NCT02257567|469960557|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130544591|NCT02257567|469960547|FG000|Overall Study|Physician Decision|0|||
130544592|NCT02257567|469960548|FG001|Overall Study|Physician Decision|0|||
130544593|NCT02257567|469960549|FG002|Overall Study|Physician Decision|0|||
130544594|NCT02257567|469960550|FG003|Overall Study|Physician Decision|0|||
130544595|NCT02257567|469960551|FG004|Overall Study|Physician Decision|0|||
130544596|NCT02257567|469960552|FG005|Overall Study|Physician Decision|0|||
130544597|NCT02257567|469960553|FG006|Overall Study|Physician Decision|0|||
130544598|NCT02257567|469960554|FG007|Overall Study|Physician Decision|2|||
130544599|NCT02257567|469960555|FG008|Overall Study|Physician Decision|0|||
130544600|NCT02257567|469960556|FG009|Overall Study|Physician Decision|1|||
130544601|NCT02257567|469960557|FG010|Overall Study|Physician Decision|0|||
130544602|NCT02257567|469960547|FG000|Overall Study|Withdrawal by Subject|0|||
130544603|NCT02257567|469960548|FG001|Overall Study|Withdrawal by Subject|0|||
130544604|NCT02257567|469960549|FG002|Overall Study|Withdrawal by Subject|2|||
130544605|NCT02257567|469960550|FG003|Overall Study|Withdrawal by Subject|0|||
130544606|NCT02257567|469960551|FG004|Overall Study|Withdrawal by Subject|0|||
130544607|NCT02257567|469960552|FG005|Overall Study|Withdrawal by Subject|6|||
130544608|NCT02257567|469960553|FG006|Overall Study|Withdrawal by Subject|6|||
130544609|NCT02257567|469960554|FG007|Overall Study|Withdrawal by Subject|6|||
130544610|NCT02257567|469960555|FG008|Overall Study|Withdrawal by Subject|1|||
130544611|NCT02257567|469960556|FG009|Overall Study|Withdrawal by Subject|1|||
130544612|NCT02257567|469960557|FG010|Overall Study|Withdrawal by Subject|10|||
130544613|NCT01065844|469960566|FG000|Overall Study|Adverse Event|5|||
130544614|NCT02084056|469960574|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
130544615|NCT02084056|469960575|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130544616|NCT02084056|469960576|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130544617|NCT02084056|469960577|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130544618|NCT02084056|469960574|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
130544619|NCT02084056|469960575|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130544620|NCT02084056|469960576|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130544621|NCT02084056|469960577|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130544622|NCT00190749|469960578|FG000|Overall Study|Lost to Follow-up|8|||
130544623|NCT00190749|469960579|FG001|Overall Study|Lost to Follow-up|11|||
130544624|NCT00190749|469960578|FG000|Overall Study|Withdrawal by Subject|10|||
130544625|NCT00190749|469960579|FG001|Overall Study|Withdrawal by Subject|6|||
130544626|NCT00190749|469960578|FG000|Overall Study|Protocol Violation|5|||
130544627|NCT00190749|469960579|FG001|Overall Study|Protocol Violation|4|||
130544628|NCT00190749|469960578|FG000|Overall Study|Adverse Event|0|||
130544629|NCT00190749|469960579|FG001|Overall Study|Adverse Event|5|||
130544630|NCT00190749|469960578|FG000|Overall Study|Lack of Efficacy|2|||
130544631|NCT00190749|469960579|FG001|Overall Study|Lack of Efficacy|3|||
130544632|NCT00190749|469960578|FG000|Overall Study|Reason Not Specified|0|||
130544633|NCT00190749|469960579|FG001|Overall Study|Reason Not Specified|2|||
130544634|NCT00190749|469960578|FG000|Overall Study|Sponsor Decision|1|||
130544635|NCT00190749|469960579|FG001|Overall Study|Sponsor Decision|0|||
130544636|NCT01154010|469960580|FG000|Overall Study|Lost to Follow-up|0|||
130544637|NCT01154010|469960581|FG001|Overall Study|Lost to Follow-up|1|||
130544638|NCT03814187|469960582|FG000|Overall Study|Sponsor's Administrative Decision|0|||
130544639|NCT03814187|469960583|FG001|Overall Study|Sponsor's Administrative Decision|0|||
130544640|NCT03814187|469960584|FG002|Overall Study|Sponsor's Administrative Decision|272|||
130544641|NCT03814187|469960582|FG000|Overall Study|Death|80|||
130544642|NCT03814187|469960583|FG001|Overall Study|Death|81|||
130544643|NCT03814187|469960584|FG002|Overall Study|Death|4|||
130544644|NCT03814187|469960582|FG000|Overall Study|Withdrew Consent|77|||
130544645|NCT03814187|469960583|FG001|Overall Study|Withdrew Consent|78|||
130544646|NCT03814187|469960584|FG002|Overall Study|Withdrew Consent|2|||
130544647|NCT03814187|469960582|FG000|Overall Study|Lost to Follow-up|47|||
130544648|NCT03814187|469960583|FG001|Overall Study|Lost to Follow-up|52|||
130544649|NCT03814187|469960584|FG002|Overall Study|Lost to Follow-up|1|||
130544650|NCT03814187|469960582|FG000|Overall Study|Adverse Event|22|||
130544651|NCT03814187|469960583|FG001|Overall Study|Adverse Event|23|||
130544652|NCT03814187|469960584|FG002|Overall Study|Adverse Event|0|||
130544653|NCT03814187|469960582|FG000|Overall Study|Physician Decision|7|||
130544654|NCT03814187|469960583|FG001|Overall Study|Physician Decision|4|||
130544655|NCT03814187|469960584|FG002|Overall Study|Physician Decision|2|||
130544656|NCT03814187|469960582|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
130376458|NCT00887978|469343697|FG000|Overall Study|Clinical Worsening|4|||
130544657|NCT03814187|469960583|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
130544658|NCT03814187|469960584|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
130544659|NCT03814187|469960582|FG000|Overall Study|Other reasons|34|||
130544660|NCT03814187|469960583|FG001|Overall Study|Other reasons|40|||
130544661|NCT03814187|469960584|FG002|Overall Study|Other reasons|2|||
130544662|NCT00825825|469960585|FG000|First Medication Period (14 Days)|Adverse Event|1|||
130544663|NCT00825825|469960586|FG001|First Medication Period (14 Days)|Adverse Event|0|||
130544664|NCT00825825|469960587|FG002|First Medication Period (14 Days)|Adverse Event|0|||
130544665|NCT00825825|469960588|FG003|First Medication Period (14 Days)|Adverse Event|0|||
130544666|NCT00825825|469960589|FG004|First Medication Period (14 Days)|Adverse Event|0|||
130544667|NCT00825825|469960590|FG005|First Medication Period (14 Days)|Adverse Event|1|||
130544668|NCT00825825|469960585|FG000|First Medication Period (14 Days)|Physician Decision|2|||
130544669|NCT00825825|469960586|FG001|First Medication Period (14 Days)|Physician Decision|0|||
130544670|NCT00825825|469960587|FG002|First Medication Period (14 Days)|Physician Decision|1|||
130544671|NCT00825825|469960588|FG003|First Medication Period (14 Days)|Physician Decision|0|||
130544672|NCT00825825|469960589|FG004|First Medication Period (14 Days)|Physician Decision|0|||
130544673|NCT00825825|469960590|FG005|First Medication Period (14 Days)|Physician Decision|1|||
130544674|NCT00825825|469960585|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
130544675|NCT00825825|469960586|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
130544676|NCT00825825|469960587|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
130544677|NCT00825825|469960588|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
130544678|NCT00825825|469960589|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
130544679|NCT00825825|469960590|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
130544680|NCT00825825|469960585|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
130544681|NCT00825825|469960586|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
130544682|NCT00825825|469960587|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
130544683|NCT00825825|469960588|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
130544684|NCT00825825|469960589|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
130544685|NCT00825825|469960590|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
130544686|NCT00825825|469960585|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
130544687|NCT00825825|469960586|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
130544688|NCT00825825|469960587|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
130544689|NCT00825825|469960588|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
130544690|NCT00825825|469960589|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
130544691|NCT00825825|469960590|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
130544692|NCT00825825|469960585|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
130544693|NCT00825825|469960586|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
130544694|NCT00825825|469960587|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
130544695|NCT00825825|469960588|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
130544696|NCT00825825|469960589|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
130544697|NCT00825825|469960590|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
130544698|NCT00825825|469960585|FG000|Third Medication Period (14 Days)|poor data quality|0|||
130544699|NCT00825825|469960586|FG001|Third Medication Period (14 Days)|poor data quality|1|||
130544700|NCT00825825|469960587|FG002|Third Medication Period (14 Days)|poor data quality|0|||
130544701|NCT00825825|469960588|FG003|Third Medication Period (14 Days)|poor data quality|0|||
130544702|NCT00825825|469960589|FG004|Third Medication Period (14 Days)|poor data quality|0|||
130544703|NCT00825825|469960590|FG005|Third Medication Period (14 Days)|poor data quality|0|||
130544704|NCT01920854|469960594|FG000|Overall Study|Withdrawal by Subject|1|||
130544705|NCT01920854|469960595|FG001|Overall Study|Withdrawal by Subject|0|||
130544706|NCT01920854|469960596|FG002|Overall Study|Withdrawal by Subject|0|||
130544707|NCT01920854|469960597|FG003|Overall Study|Withdrawal by Subject|0|||
130544708|NCT01920854|469960598|FG004|Overall Study|Withdrawal by Subject|1|||
130544709|NCT01920854|469960599|FG005|Overall Study|Withdrawal by Subject|0|||
130544710|NCT01920854|469960600|FG006|Overall Study|Withdrawal by Subject|1|||
130544711|NCT00757783|469960601|FG000|Overall Study|Adverse Event|0|||
130544712|NCT00757783|469960602|FG001|Overall Study|Adverse Event|2|||
130544713|NCT00757783|469960601|FG000|Overall Study|Lost to Follow-up|1|||
130544714|NCT00757783|469960602|FG001|Overall Study|Lost to Follow-up|1|||
130544715|NCT00757783|469960601|FG000|Overall Study|Protocol Violation|1|||
130544716|NCT00757783|469960602|FG001|Overall Study|Protocol Violation|0|||
130544717|NCT00757783|469960601|FG000|Overall Study|Withdrawal by Subject|2|||
130544718|NCT00757783|469960602|FG001|Overall Study|Withdrawal by Subject|1|||
130544719|NCT00757783|469960601|FG000|Overall Study|Other|1|||
130544720|NCT00757783|469960602|FG001|Overall Study|Other|2|||
130544721|NCT02008877|469960605|FG000|Overall Study|Inevaluable|0|||
130544722|NCT02008877|469960606|FG001|Overall Study|Inevaluable|1|||
130544723|NCT02008877|469960607|FG002|Overall Study|Inevaluable|0|||
130544724|NCT01049217|469960608|FG000|Overall Study|Adverse Event|2|||
130544725|NCT01049217|469960609|FG001|Overall Study|Adverse Event|1|||
130544726|NCT01049217|469960608|FG000|Overall Study|Lack of Efficacy|1|||
130544727|NCT01049217|469960609|FG001|Overall Study|Lack of Efficacy|1|||
130544728|NCT01049217|469960608|FG000|Overall Study|Lost to Follow-up|3|||
130544729|NCT01049217|469960609|FG001|Overall Study|Lost to Follow-up|8|||
130544730|NCT01049217|469960608|FG000|Overall Study|Withdrawal by Subject|4|||
130544731|NCT01049217|469960609|FG001|Overall Study|Withdrawal by Subject|3|||
130544732|NCT01049217|469960608|FG000|Overall Study|Protocol Violation|1|||
130544733|NCT01049217|469960609|FG001|Overall Study|Protocol Violation|3|||
130544734|NCT01049217|469960608|FG000|Overall Study|Pregnancy|1|||
130544735|NCT01049217|469960609|FG001|Overall Study|Pregnancy|0|||
130544736|NCT01049217|469960608|FG000|Overall Study|Study Terminated by Sponsor|43|||
130544737|NCT01049217|469960609|FG001|Overall Study|Study Terminated by Sponsor|43|||
130544738|NCT01049217|469960608|FG000|Overall Study|Other|1|||
130544739|NCT01049217|469960609|FG001|Overall Study|Other|2|||
130544740|NCT01049217|469960608|FG000|Overall Study|Randomized but not Treated|0|||
130544741|NCT01049217|469960609|FG001|Overall Study|Randomized but not Treated|2|||
130544742|NCT02412371|469960610|FG000|Overall Study|Withdrawal by Subject|0|||
130544743|NCT02412371|469960611|FG001|Overall Study|Withdrawal by Subject|2|||
130544744|NCT02412371|469960612|FG002|Overall Study|Withdrawal by Subject|0|||
130544745|NCT02412371|469960613|FG003|Overall Study|Withdrawal by Subject|1|||
130544746|NCT02412371|469960614|FG004|Overall Study|Withdrawal by Subject|1|||
130544747|NCT02412371|469960615|FG005|Overall Study|Withdrawal by Subject|0|||
130544748|NCT02412371|469960610|FG000|Overall Study|Sponsor Discontinued Study|1|||
130544749|NCT02412371|469960611|FG001|Overall Study|Sponsor Discontinued Study|4|||
130544750|NCT02412371|469960612|FG002|Overall Study|Sponsor Discontinued Study|6|||
130544751|NCT02412371|469960613|FG003|Overall Study|Sponsor Discontinued Study|4|||
130544752|NCT02412371|469960614|FG004|Overall Study|Sponsor Discontinued Study|5|||
130544753|NCT02412371|469960615|FG005|Overall Study|Sponsor Discontinued Study|0|||
130544754|NCT02412371|469960610|FG000|Overall Study|Death|4|||
130544755|NCT02412371|469960611|FG001|Overall Study|Death|2|||
130544756|NCT02412371|469960612|FG002|Overall Study|Death|1|||
130544757|NCT02412371|469960613|FG003|Overall Study|Death|3|||
130544758|NCT02412371|469960614|FG004|Overall Study|Death|5|||
130544759|NCT02412371|469960615|FG005|Overall Study|Death|2|||
130544760|NCT02412371|469960610|FG000|Overall Study|Other|2|||
130544761|NCT02412371|469960611|FG001|Overall Study|Other|1|||
130544762|NCT02412371|469960612|FG002|Overall Study|Other|0|||
130544763|NCT02412371|469960613|FG003|Overall Study|Other|0|||
130544764|NCT02412371|469960614|FG004|Overall Study|Other|1|||
130544765|NCT02412371|469960615|FG005|Overall Study|Other|3|||
130544766|NCT02495792|469960616|FG000|Overall Study|Lost to Follow-up|5|||
130544767|NCT02495792|469960617|FG001|Overall Study|Lost to Follow-up|9|||
130544768|NCT02495792|469960616|FG000|Overall Study|Protocol Violation|32|||
130544769|NCT02495792|469960617|FG001|Overall Study|Protocol Violation|31|||
130544770|NCT02053792|469960618|FG000|Overall Study|Physician Decision|0|||
130544771|NCT02053792|469960619|FG001|Overall Study|Physician Decision|1|||
130544772|NCT02053792|469960618|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
130544773|NCT02053792|469960619|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
130320484|NCT04886154|469141926|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130544774|NCT02053792|469960618|FG000|Overall Study|Lack of Efficacy|1|||
130544775|NCT02053792|469960619|FG001|Overall Study|Lack of Efficacy|0|||
130544776|NCT02053792|469960618|FG000|Overall Study|Adverse Event|1|||
130544777|NCT02053792|469960619|FG001|Overall Study|Adverse Event|0|||
130544778|NCT02053792|469960618|FG000|Overall Study|Withdrawal by Subject|2|||
130544779|NCT02053792|469960619|FG001|Overall Study|Withdrawal by Subject|2|||
130544780|NCT02053792|469960618|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
130544781|NCT02053792|469960619|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
130544782|NCT02053792|469960618|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
130544783|NCT02053792|469960619|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
130544784|NCT01028027|469960620|FG000|Overall Study|Lost to Follow-up|4|||
130544785|NCT01028027|469960621|FG001|Overall Study|Lost to Follow-up|1|||
130544786|NCT01028027|469960620|FG000|Overall Study|Withdrawal by Subject|5|||
130544787|NCT01028027|469960621|FG001|Overall Study|Withdrawal by Subject|3|||
130544788|NCT01028027|469960620|FG000|Overall Study|Adverse Event|4|||
130320485|NCT04886154|469141912|FG000|Overall Study|Other, Not Specified|0|||
130320486|NCT04886154|469141913|FG001|Overall Study|Other, Not Specified|0|||
130544789|NCT01028027|469960621|FG001|Overall Study|Adverse Event|7|||
130544790|NCT01028027|469960620|FG000|Overall Study|Protocol Violation|3|||
130544791|NCT01028027|469960621|FG001|Overall Study|Protocol Violation|1|||
130544792|NCT01028027|469960620|FG000|Overall Study|Lack of Efficacy|0|||
130544793|NCT01028027|469960621|FG001|Overall Study|Lack of Efficacy|1|||
130544794|NCT03149549|469960622|FG000|Study Discontinuation--Treatment Period|Death|0|||
130544795|NCT03149549|469960623|FG001|Study Discontinuation--Treatment Period|Death|0|||
130544796|NCT03149549|469960624|FG002|Study Discontinuation--Treatment Period|Death|0|||
130544797|NCT03149549|469960625|FG003|Study Discontinuation--Treatment Period|Death|1|||
130544798|NCT03149549|469960626|FG004|Study Discontinuation--Treatment Period|Death|2|||
130544799|NCT03149549|469960627|FG005|Study Discontinuation--Treatment Period|Death|1|||
130544800|NCT03149549|469960628|FG006|Study Discontinuation--Treatment Period|Death|1|||
130544801|NCT03149549|469960629|FG007|Study Discontinuation--Treatment Period|Death|2|||
130544802|NCT03149549|469960630|FG008|Study Discontinuation--Treatment Period|Death|4|||
130544803|NCT03149549|469960631|FG009|Study Discontinuation--Treatment Period|Death|1|||
130544804|NCT03149549|469960632|FG010|Study Discontinuation--Treatment Period|Death|0|||
130544805|NCT03149549|469960633|FG011|Study Discontinuation--Treatment Period|Death|0|||
130544806|NCT03149549|469960634|FG012|Study Discontinuation--Treatment Period|Death|1|||
130544807|NCT03149549|469960622|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544808|NCT03149549|469960623|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544809|NCT03149549|469960624|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544810|NCT03149549|469960625|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544811|NCT03149549|469960626|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544812|NCT03149549|469960627|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544813|NCT03149549|469960628|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544814|NCT03149549|469960629|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
130544815|NCT03149549|469960630|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544816|NCT03149549|469960631|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544817|NCT03149549|469960632|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544818|NCT03149549|469960633|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130544819|NCT03149549|469960634|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
130544820|NCT03149549|469960622|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544821|NCT03149549|469960623|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544822|NCT03149549|469960624|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544823|NCT03149549|469960625|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
130544824|NCT03149549|469960626|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
130544825|NCT03149549|469960627|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
130544826|NCT03149549|469960628|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
130544827|NCT03149549|469960629|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544828|NCT03149549|469960630|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
130544829|NCT03149549|469960631|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544830|NCT03149549|469960632|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544831|NCT03149549|469960633|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544832|NCT03149549|469960634|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130544833|NCT03149549|469960622|FG000|Study Discontinuation--Treatment Period|Other|0|||
130544834|NCT03149549|469960623|FG001|Study Discontinuation--Treatment Period|Other|0|||
130544835|NCT03149549|469960624|FG002|Study Discontinuation--Treatment Period|Other|0|||
130544836|NCT03149549|469960625|FG003|Study Discontinuation--Treatment Period|Other|0|||
130544837|NCT03149549|469960626|FG004|Study Discontinuation--Treatment Period|Other|0|||
130544838|NCT03149549|469960627|FG005|Study Discontinuation--Treatment Period|Other|0|||
130544839|NCT03149549|469960628|FG006|Study Discontinuation--Treatment Period|Other|0|||
130544840|NCT03149549|469960629|FG007|Study Discontinuation--Treatment Period|Other|1|||
130544841|NCT03149549|469960630|FG008|Study Discontinuation--Treatment Period|Other|0|||
130544842|NCT03149549|469960631|FG009|Study Discontinuation--Treatment Period|Other|1|||
130544843|NCT03149549|469960632|FG010|Study Discontinuation--Treatment Period|Other|0|||
130544844|NCT03149549|469960633|FG011|Study Discontinuation--Treatment Period|Other|0|||
130544845|NCT03149549|469960634|FG012|Study Discontinuation--Treatment Period|Other|0|||
130544846|NCT03149549|469960622|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544847|NCT03149549|469960623|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544848|NCT03149549|469960624|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544849|NCT03149549|469960625|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544850|NCT03149549|469960626|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544851|NCT03149549|469960627|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
130544852|NCT03149549|469960628|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
130544853|NCT03149549|469960629|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544854|NCT03149549|469960630|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
130544855|NCT03149549|469960631|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544856|NCT03149549|469960632|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544857|NCT03149549|469960633|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544858|NCT03149549|469960634|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130544859|NCT03149549|469960622|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544860|NCT03149549|469960623|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544861|NCT03149549|469960624|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544862|NCT03149549|469960625|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544863|NCT03149549|469960626|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
130544864|NCT03149549|469960627|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130559405|NCT01621542|470016495|FG005|Overall Study|Death|0|||
130320487|NCT04886154|469141914|FG002|Overall Study|Other, Not Specified|0|||
130544865|NCT03149549|469960628|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544866|NCT03149549|469960629|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
130544867|NCT03149549|469960630|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
130544868|NCT03149549|469960631|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544869|NCT03149549|469960632|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
130544870|NCT03149549|469960633|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
130544871|NCT03149549|469960634|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
130544872|NCT03149549|469960622|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544873|NCT03149549|469960623|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544874|NCT03149549|469960624|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544875|NCT03149549|469960625|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544876|NCT03149549|469960626|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
130544877|NCT03149549|469960627|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544878|NCT03149549|469960628|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544879|NCT03149549|469960629|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
130544880|NCT03149549|469960630|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
130544881|NCT03149549|469960631|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
130544882|NCT03149549|469960632|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
130544883|NCT03149549|469960633|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
130544884|NCT03149549|469960634|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
130544885|NCT03149549|469960622|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
130544886|NCT03149549|469960623|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
130544887|NCT03149549|469960624|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
130544888|NCT03149549|469960625|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
130544889|NCT03149549|469960626|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
130544890|NCT03149549|469960627|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
130544891|NCT03149549|469960628|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
130544892|NCT03149549|469960629|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
130544893|NCT03149549|469960630|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
130544894|NCT03149549|469960631|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
130544895|NCT03149549|469960632|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
130544896|NCT03149549|469960633|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
130544897|NCT03149549|469960634|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
130544898|NCT03149549|469960622|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
130544899|NCT03149549|469960623|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
130544900|NCT03149549|469960624|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
130544901|NCT03149549|469960625|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
130544902|NCT03149549|469960626|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
130544903|NCT03149549|469960627|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
130544904|NCT03149549|469960628|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
130544905|NCT03149549|469960629|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
130544906|NCT03149549|469960630|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
130544907|NCT03149549|469960631|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
130544908|NCT03149549|469960632|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
130544909|NCT03149549|469960633|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
130544910|NCT03149549|469960634|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
130544911|NCT00153062|469962915|FG000|Overall Study|Death|360|||
130544912|NCT00153062|469962916|FG001|Overall Study|Death|352|||
130544913|NCT00153062|469962917|FG002|Overall Study|Death|369|||
130544914|NCT00153062|469962918|FG003|Overall Study|Death|365|||
130544915|NCT00153062|469962915|FG000|Overall Study|Withdrawal by Subject|14|||
130544916|NCT00153062|469962916|FG001|Overall Study|Withdrawal by Subject|30|||
130544917|NCT00153062|469962917|FG002|Overall Study|Withdrawal by Subject|27|||
130544918|NCT00153062|469962918|FG003|Overall Study|Withdrawal by Subject|28|||
130544919|NCT00153062|469962915|FG000|Overall Study|Lost to Follow-up|12|||
130544920|NCT00153062|469962916|FG001|Overall Study|Lost to Follow-up|20|||
130544921|NCT00153062|469962917|FG002|Overall Study|Lost to Follow-up|15|||
130544922|NCT00153062|469962918|FG003|Overall Study|Lost to Follow-up|16|||
130544923|NCT00153062|469962915|FG000|Overall Study|Adverse Event|0|||
130544924|NCT00153062|469962916|FG001|Overall Study|Adverse Event|1|||
130544925|NCT00153062|469962917|FG002|Overall Study|Adverse Event|1|||
130544926|NCT00153062|469962918|FG003|Overall Study|Adverse Event|0|||
130544927|NCT00153062|469962915|FG000|Overall Study|Protocol Violation|0|||
130544928|NCT00153062|469962916|FG001|Overall Study|Protocol Violation|2|||
130544929|NCT00153062|469962917|FG002|Overall Study|Protocol Violation|1|||
130544930|NCT00153062|469962918|FG003|Overall Study|Protocol Violation|1|||
130544931|NCT00153062|469962915|FG000|Overall Study|No disposition data available|1|||
130544932|NCT00153062|469962916|FG001|Overall Study|No disposition data available|1|||
130544933|NCT00153062|469962917|FG002|Overall Study|No disposition data available|1|||
130544934|NCT00153062|469962918|FG003|Overall Study|No disposition data available|1|||
130544935|NCT00153062|469962915|FG000|Overall Study|Other|0|||
130544936|NCT00153062|469962916|FG001|Overall Study|Other|0|||
130544937|NCT00153062|469962917|FG002|Overall Study|Other|1|||
130544938|NCT00153062|469962918|FG003|Overall Study|Other|0|||
130544939|NCT00275262|469962925|FG000|Overall Study|Adverse Event|2|||
130544940|NCT00275262|469962926|FG001|Overall Study|Adverse Event|0|||
130544941|NCT00275262|469962925|FG000|Overall Study|Disease progression|2|||
130544942|NCT00275262|469962926|FG001|Overall Study|Disease progression|5|||
130544943|NCT00275262|469962925|FG000|Overall Study|Lost to Follow-up|0|||
130544944|NCT00275262|469962926|FG001|Overall Study|Lost to Follow-up|2|||
130544945|NCT00275262|469962925|FG000|Overall Study|Protocol Violation|0|||
130544946|NCT00275262|469962926|FG001|Overall Study|Protocol Violation|2|||
130544947|NCT00275262|469962925|FG000|Overall Study|Death|1|||
130544948|NCT00275262|469962926|FG001|Overall Study|Death|0|||
130544949|NCT00275262|469962925|FG000|Overall Study|Started Chemotherapy|1|||
130544950|NCT00275262|469962926|FG001|Overall Study|Started Chemotherapy|0|||
130544951|NCT01589237|469962939|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
130544952|NCT01589237|469962940|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
130544953|NCT01589237|469962941|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
130544954|NCT01589237|469962942|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
130544955|NCT01589237|469962939|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
130544956|NCT01589237|469962940|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
130544957|NCT01589237|469962941|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
130544958|NCT01589237|469962942|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
130544959|NCT01589237|469962939|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
130544960|NCT01589237|469962940|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
130544961|NCT01589237|469962941|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
130544962|NCT01589237|469962942|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
130544963|NCT01589237|469962939|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
130544964|NCT01589237|469962940|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
130544965|NCT01589237|469962941|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
130544966|NCT01589237|469962942|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
130544967|NCT02594163|469962943|FG000|Treatment Period|Progressive disease|2|||
130544968|NCT02594163|469962944|FG001|Treatment Period|Progressive disease|3|||
130544969|NCT02594163|469962943|FG000|Treatment Period|Adverse Event|1|||
130544970|NCT02594163|469962944|FG001|Treatment Period|Adverse Event|5|||
130544971|NCT02594163|469962943|FG000|Treatment Period|Physician Decision|1|||
130544972|NCT02594163|469962944|FG001|Treatment Period|Physician Decision|3|||
130544973|NCT02594163|469962943|FG000|Treatment Period|Study termination by sponsor|2|||
130544974|NCT02594163|469962944|FG001|Treatment Period|Study termination by sponsor|1|||
130544975|NCT02594163|469962943|FG000|Treatment Period|Other, Non-AE|1|||
130544976|NCT02594163|469962944|FG001|Treatment Period|Other, Non-AE|0|||
130544977|NCT02594163|469962943|FG000|Follow-up Period|Withdrawal by Subject|0|||
130544978|NCT02594163|469962944|FG001|Follow-up Period|Withdrawal by Subject|1|||
130544979|NCT02594163|469962943|FG000|Follow-up Period|Study Termination by Sponsor|6|||
130544980|NCT02594163|469962944|FG001|Follow-up Period|Study Termination by Sponsor|4|||
130544981|NCT02594163|469962943|FG000|Follow-up Period|Lost to Follow-up|1|||
130544982|NCT02594163|469962944|FG001|Follow-up Period|Lost to Follow-up|0|||
130544983|NCT02594163|469962943|FG000|Follow-up Period|Death|2|||
130544984|NCT02594163|469962944|FG001|Follow-up Period|Death|5|||
130544985|NCT02594163|469962943|FG000|Follow-up Period|Adverse Event|0|||
130544986|NCT02594163|469962944|FG001|Follow-up Period|Adverse Event|1|||
130544987|NCT02594163|469962943|FG000|Follow-up Period|Progressive Disease|2|||
130544988|NCT02594163|469962944|FG001|Follow-up Period|Progressive Disease|0|||
130544989|NCT02594163|469962943|FG000|Follow-up Period|Physician Decision|0|||
130544990|NCT02594163|469962944|FG001|Follow-up Period|Physician Decision|1|||
130544991|NCT01290029|469962947|FG000|Overall Study|Other|2|||
130544992|NCT00189488|469962948|FG000|Overall Study|Ineligibility determined|1|||
130544993|NCT00189488|469962949|FG001|Overall Study|Ineligibility determined|0|||
130544994|NCT00189488|469962948|FG000|Overall Study|Protocol deviation|2|||
130544995|NCT00189488|469962949|FG001|Overall Study|Protocol deviation|1|||
130544996|NCT00189488|469962948|FG000|Overall Study|Adverse Event|2|||
130544997|NCT00189488|469962949|FG001|Overall Study|Adverse Event|1|||
130544998|NCT00189488|469962948|FG000|Overall Study|Withdrawal by Subject|2|||
130544999|NCT00189488|469962949|FG001|Overall Study|Withdrawal by Subject|6|||
130545000|NCT00189488|469962948|FG000|Overall Study|Disease progression|2|||
130545001|NCT00189488|469962949|FG001|Overall Study|Disease progression|4|||
130545002|NCT00189488|469962948|FG000|Overall Study|Administrative Decision|0|||
130545003|NCT00189488|469962949|FG001|Overall Study|Administrative Decision|2|||
130545004|NCT00189488|469962948|FG000|Overall Study|Death|5|||
130213634|NCT01796301|468746857|FG001|Overall Study|Withdrawal by Subject|15|||
130213635|NCT01796301|468746856|FG000|Overall Study|Lost to Follow-up|3|||
130545005|NCT00189488|469962949|FG001|Overall Study|Death|8|||
130545006|NCT00189488|469962948|FG000|Overall Study|Other|1|||
130545007|NCT00189488|469962949|FG001|Overall Study|Other|0|||
130545008|NCT00484289|469962955|FG000|Long Term Phase|Adverse Event|1|||
130545009|NCT00484289|469962956|FG001|Long Term Phase|Adverse Event|17|||
130545010|NCT00484289|469962957|FG002|Long Term Phase|Adverse Event|5|||
130545011|NCT00484289|469962955|FG000|Long Term Phase|Withdrawal by Subject|0|||
130545012|NCT00484289|469962956|FG001|Long Term Phase|Withdrawal by Subject|7|||
130545013|NCT00484289|469962957|FG002|Long Term Phase|Withdrawal by Subject|6|||
130545014|NCT00484289|469962955|FG000|Long Term Phase|Inadequate response|2|||
130545015|NCT00484289|469962956|FG001|Long Term Phase|Inadequate response|7|||
130545016|NCT00484289|469962957|FG002|Long Term Phase|Inadequate response|4|||
130545017|NCT00484289|469962955|FG000|Long Term Phase|Other Reason|0|||
130545018|NCT00484289|469962956|FG001|Long Term Phase|Other Reason|5|||
130545019|NCT00484289|469962957|FG002|Long Term Phase|Other Reason|1|||
130545020|NCT00484289|469962955|FG000|Post Marketing Phase|Adverse Event|0|||
130545021|NCT00484289|469962956|FG001|Post Marketing Phase|Adverse Event|1|||
130545022|NCT00484289|469962957|FG002|Post Marketing Phase|Adverse Event|0|||
130545023|NCT02349425|469962958|FG000|Period 1|Adverse Event|1|||
130545024|NCT02349425|469962959|FG001|Period 1|Adverse Event|1|||
130545025|NCT02349425|469962960|FG002|Period 1|Adverse Event|0|||
130545026|NCT02349425|469962961|FG003|Period 1|Adverse Event|0|||
130545027|NCT02349425|469962958|FG000|Period 2|Adverse Event|0|||
130545028|NCT02349425|469962959|FG001|Period 2|Adverse Event|1|||
130545029|NCT02349425|469962960|FG002|Period 2|Adverse Event|1|||
130545030|NCT02349425|469962961|FG003|Period 2|Adverse Event|0|||
130545031|NCT01877837|469962962|FG000|Overall Study|Lost to Follow-up|1|||
130545032|NCT01877837|469962962|FG000|Overall Study|Ineligible|4|||
130545033|NCT00645801|469962964|FG000|Overall Study|unclear if patient took all the medication.|1|||
130545034|NCT00645801|469962965|FG001|Overall Study|unclear if patient took all the medication.|0|||
130545035|NCT00645801|469962964|FG000|Overall Study|Lost to Follow-up|19|||
130545036|NCT00645801|469962965|FG001|Overall Study|Lost to Follow-up|15|||
130545037|NCT00705679|469962966|FG000|Overall Study|Adverse Event|1|||
130545038|NCT00705679|469962967|FG001|Overall Study|Adverse Event|1|||
130545039|NCT00705679|469962968|FG002|Overall Study|Adverse Event|0|||
130545040|NCT00705679|469962969|FG003|Overall Study|Adverse Event|0|||
130545041|NCT00705679|469962970|FG004|Overall Study|Adverse Event|0|||
130545042|NCT00705679|469962966|FG000|Overall Study|Death|0|||
130545043|NCT00705679|469962967|FG001|Overall Study|Death|0|||
130545044|NCT00705679|469962968|FG002|Overall Study|Death|3|||
130545045|NCT00705679|469962969|FG003|Overall Study|Death|2|||
130545046|NCT00705679|469962970|FG004|Overall Study|Death|1|||
130545047|NCT00705679|469962966|FG000|Overall Study|Lost to Follow-up|32|||
130545048|NCT00705679|469962967|FG001|Overall Study|Lost to Follow-up|60|||
130545049|NCT00705679|469962968|FG002|Overall Study|Lost to Follow-up|44|||
130545050|NCT00705679|469962969|FG003|Overall Study|Lost to Follow-up|30|||
130545051|NCT00705679|469962970|FG004|Overall Study|Lost to Follow-up|35|||
130545052|NCT00705679|469962966|FG000|Overall Study|Physician Decision|0|||
130545053|NCT00705679|469962967|FG001|Overall Study|Physician Decision|1|||
130545054|NCT00705679|469962968|FG002|Overall Study|Physician Decision|0|||
130545055|NCT00705679|469962969|FG003|Overall Study|Physician Decision|1|||
130545056|NCT00705679|469962970|FG004|Overall Study|Physician Decision|0|||
130545057|NCT00705679|469962966|FG000|Overall Study|Withdrawal by Subject|32|||
130545058|NCT00705679|469962967|FG001|Overall Study|Withdrawal by Subject|77|||
130545059|NCT00705679|469962968|FG002|Overall Study|Withdrawal by Subject|68|||
130545060|NCT00705679|469962969|FG003|Overall Study|Withdrawal by Subject|47|||
130545061|NCT00705679|469962970|FG004|Overall Study|Withdrawal by Subject|33|||
130545062|NCT01143038|469962975|FG000|Overall Study|Withdrawal by Subject|4|||
130545063|NCT01143038|469962975|FG000|Overall Study|Requirement for alternative therapy|5|||
130545064|NCT01143038|469962975|FG000|Overall Study|Adverse Event|3|||
130545065|NCT01143038|469962975|FG000|Overall Study|Lost to Follow-up|2|||
130545066|NCT01143038|469962975|FG000|Overall Study|Protocol Deviation|1|||
130545067|NCT01143038|469962975|FG000|Overall Study|Death|1|||
130545068|NCT01346475|469962979|FG000|First Intervention|Lost to Follow-up|4|||
130545069|NCT01346475|469962980|FG001|First Intervention|Lost to Follow-up|3|||
130545070|NCT01171807|469962981|FG000|Overall Study|Treatment failure|2|||
130545071|NCT01171807|469962982|FG001|Overall Study|Treatment failure|4|||
130545072|NCT01171807|469962981|FG000|Overall Study|Non compliance|1|||
130545073|NCT01171807|469962982|FG001|Overall Study|Non compliance|0|||
130545074|NCT01171807|469962981|FG000|Overall Study|Lost to Follow-up|3|||
130545075|NCT01171807|469962982|FG001|Overall Study|Lost to Follow-up|0|||
130545076|NCT02874924|469962983|FG000|Overall Study|Adverse Event|2|||
130545077|NCT02874924|469962984|FG001|Overall Study|Adverse Event|0|||
130545078|NCT02874924|469962985|FG002|Overall Study|Adverse Event|0|||
130213636|NCT01796301|468746857|FG001|Overall Study|Lost to Follow-up|3|||
130213637|NCT01796301|468746856|FG000|Overall Study|Death|0|||
130213638|NCT01796301|468746857|FG001|Overall Study|Death|1|||
130213639|NCT01796301|468746856|FG000|Overall Study|Decision by Sponsor|0|||
130213640|NCT01796301|468746857|FG001|Overall Study|Decision by Sponsor|1|||
130213641|NCT00667563|468746858|FG000|Overall Study|Protocol Violation|24|||
130213642|NCT02187029|468746860|FG000|Overall Study|Adverse Event|0|||
130213643|NCT02187029|468746861|FG001|Overall Study|Adverse Event|1|||
130213644|NCT02187029|468746862|FG002|Overall Study|Adverse Event|1|||
130545079|NCT02874924|469962983|FG000|Overall Study|Withdrawal by Subject|1|||
130545080|NCT02874924|469962984|FG001|Overall Study|Withdrawal by Subject|0|||
130545081|NCT02874924|469962985|FG002|Overall Study|Withdrawal by Subject|0|||
130320488|NCT04886154|469141915|FG003|Overall Study|Other, Not Specified|0|||
130320489|NCT04886154|469141916|FG004|Overall Study|Other, Not Specified|11|||
130320490|NCT04886154|469141917|FG005|Overall Study|Other, Not Specified|8|||
130320491|NCT04886154|469141918|FG006|Overall Study|Other, Not Specified|9|||
130320492|NCT04886154|469141919|FG007|Overall Study|Other, Not Specified|10|||
130320493|NCT04886154|469141920|FG008|Overall Study|Other, Not Specified|6|||
130320494|NCT04886154|469141921|FG009|Overall Study|Other, Not Specified|1|||
130320495|NCT04886154|469141922|FG010|Overall Study|Other, Not Specified|1|||
130320496|NCT04886154|469141923|FG011|Overall Study|Other, Not Specified|2|||
130320497|NCT04886154|469141924|FG012|Overall Study|Other, Not Specified|1|||
130320498|NCT04886154|469141925|FG013|Overall Study|Other, Not Specified|2|||
130320499|NCT04886154|469141926|FG014|Overall Study|Other, Not Specified|3|||
130320500|NCT02336282|469141941|FG000|Overall Study|Unrelated illness|1|||
130320501|NCT02336282|469141941|FG000|Overall Study|Uncomfortable with technology|1|||
130320502|NCT02336282|469141941|FG000|Overall Study|Lost to Follow-up|1|||
130320503|NCT02336282|469141941|FG000|Overall Study|Not enough time to complete sessions|2|||
130320504|NCT03724942|469141943|FG000|Overall Study|Adverse Event|20|||
130320505|NCT03724942|469141944|FG001|Overall Study|Adverse Event|14|||
130213645|NCT02187029|468746863|FG003|Overall Study|Adverse Event|0|||
130213646|NCT02187029|468746860|FG000|Overall Study|Study Terminated by Sponsor|0|||
130213647|NCT02187029|468746861|FG001|Overall Study|Study Terminated by Sponsor|0|||
130213648|NCT02187029|468746862|FG002|Overall Study|Study Terminated by Sponsor|10|||
130213649|NCT02187029|468746863|FG003|Overall Study|Study Terminated by Sponsor|3|||
130213650|NCT02187029|468746860|FG000|Overall Study|Withdrawal by Subject|1|||
130213651|NCT02187029|468746861|FG001|Overall Study|Withdrawal by Subject|0|||
130213652|NCT02187029|468746862|FG002|Overall Study|Withdrawal by Subject|0|||
130213653|NCT02187029|468746863|FG003|Overall Study|Withdrawal by Subject|0|||
130213654|NCT03042910|468746864|FG000|Overall Study|Adverse Event|1|||
130213655|NCT03042910|468746864|FG000|Overall Study|Disease Progression|2|||
130213656|NCT03042910|468746864|FG000|Overall Study|Withdrawal by Subject|3|||
130213657|NCT03042910|468746864|FG000|Overall Study|Enrolled but not treated|1|||
130545082|NCT02029846|469962988|FG000|Overall Study|n=1 each arm|1|||
130545083|NCT02029846|469962989|FG001|Overall Study|n=1 each arm|1|||
130545084|NCT00642772|469962993|FG000|Overall Study|Lost to Follow-up|3|||
130545085|NCT00642772|469962993|FG000|Overall Study|Withdrawal by Subject|7|||
130545086|NCT00903006|469962994|FG000|Overall Study|Withdrawal by Subject|2|||
130545087|NCT00903006|469962995|FG001|Overall Study|Withdrawal by Subject|0|||
130545088|NCT00903006|469962996|FG002|Overall Study|Withdrawal by Subject|0|||
130545089|NCT00903006|469962997|FG003|Overall Study|Withdrawal by Subject|0|||
130545090|NCT00903006|469962994|FG000|Overall Study|Progressive Disease|0|||
130213658|NCT02756819|468746868|FG000|Overall Study|Lost for observation|23|||
130213659|NCT02756819|468746868|FG000|Overall Study|Patient's unwillingness|16|||
130213660|NCT02756819|468746868|FG000|Overall Study|Insufficient efficacy|2|||
130213661|NCT02756819|468746868|FG000|Overall Study|Adverse Event|2|||
130213662|NCT02756819|468746868|FG000|Overall Study|Reason not Specified|9|||
130213663|NCT01491841|468746870|FG000|Overall Study|Screen Failure|10|||
130213664|NCT01491841|468746870|FG000|Overall Study|Withdrawal by Subject|1|||
130213665|NCT02933528|468746871|FG000|Overall Study|Lost to Follow-up|2|||
130213666|NCT01301079|468746872|FG000|Overall Study|Lost to Follow-up|2|||
130213667|NCT01301079|468746873|FG001|Overall Study|Lost to Follow-up|2|||
130213668|NCT00264290|468746877|FG000|Intervention (8 Weeks)|Adverse Event|1|||
130213669|NCT00264290|468746878|FG001|Intervention (8 Weeks)|Adverse Event|0|||
130213670|NCT02496039|468746879|FG000|Overall Study|Adverse Event|3|||
130213671|NCT02496039|468746879|FG000|Overall Study|Protocol Violation|1|||
130213672|NCT04472494|468746880|FG000|Pre-treatment|Other reasons|2|||
130213673|NCT04472494|468746881|FG001|Pre-treatment|Other reasons|0|||
130213674|NCT04472494|468746880|FG000|Treatment|Death|5|||
130213675|NCT04472494|468746881|FG001|Treatment|Death|2|||
130213676|NCT04472494|468746880|FG000|Treatment|Hospital discharge|1|||
130545091|NCT00903006|469962995|FG001|Overall Study|Progressive Disease|3|||
130545092|NCT00903006|469962996|FG002|Overall Study|Progressive Disease|1|||
130213677|NCT04472494|468746881|FG001|Treatment|Hospital discharge|1|||
130213678|NCT00571103|468746882|FG000|Overall Study|Withdrawal by Subject|1|||
130213679|NCT00571103|468746882|FG000|Overall Study|Lost to Follow-up|1|||
130213680|NCT01308463|468746883|FG000|Overall Study|Study Discontinued|23|||
130213681|NCT01308463|468746883|FG000|Overall Study|Death|4|||
130213682|NCT01308463|468746883|FG000|Overall Study|Revision|2|||
130213683|NCT02784288|468746884|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
130213684|NCT02734862|468746885|FG000|Part A|Death|3|||
130213685|NCT02734862|468746886|FG001|Part A|Death|4|||
130213686|NCT02734862|468746887|FG002|Part A|Death|6|||
130320506|NCT03724942|469141943|FG000|Overall Study|Lack of Efficacy|0|||
130320507|NCT03724942|469141944|FG001|Overall Study|Lack of Efficacy|1|||
130545093|NCT00903006|469962997|FG003|Overall Study|Progressive Disease|0|||
130545094|NCT04275089|469962998|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
130213687|NCT02734862|468746885|FG000|Part A|Lost to Follow-up|2|||
130213688|NCT02734862|468746886|FG001|Part A|Lost to Follow-up|1|||
130213689|NCT02734862|468746887|FG002|Part A|Lost to Follow-up|1|||
130213690|NCT02734862|468746885|FG000|Part A|Withdrawal by Subject|1|||
130213691|NCT02734862|468746886|FG001|Part A|Withdrawal by Subject|1|||
130213692|NCT02734862|468746887|FG002|Part A|Withdrawal by Subject|2|||
130213693|NCT02734862|468746885|FG000|Part A|Physician Decision|2|||
130213694|NCT02734862|468746886|FG001|Part A|Physician Decision|0|||
130213695|NCT02734862|468746887|FG002|Part A|Physician Decision|1|||
130213696|NCT02734862|468746885|FG000|Part A|Adverse Event|2|||
130213697|NCT02734862|468746886|FG001|Part A|Adverse Event|0|||
130213698|NCT02734862|468746887|FG002|Part A|Adverse Event|1|||
130213699|NCT02734862|468746885|FG000|Part A|Noncompliance|1|||
130213700|NCT02734862|468746886|FG001|Part A|Noncompliance|1|||
130213701|NCT02734862|468746887|FG002|Part A|Noncompliance|0|||
130213702|NCT02734862|468746885|FG000|Part A|Other|1|||
130213703|NCT02734862|468746886|FG001|Part A|Other|1|||
130213704|NCT02734862|468746887|FG002|Part A|Other|3|||
130213705|NCT02734862|468746885|FG000|Part B|Death|8|||
130213706|NCT02734862|468746886|FG001|Part B|Death|3|||
130213707|NCT02734862|468746887|FG002|Part B|Death|5|||
130213708|NCT02734862|468746885|FG000|Part B|Lost to Follow-up|2|||
130213709|NCT02734862|468746886|FG001|Part B|Lost to Follow-up|2|||
130213710|NCT02734862|468746887|FG002|Part B|Lost to Follow-up|0|||
130213711|NCT02734862|468746885|FG000|Part B|Withdrawal by Subject|3|||
130213712|NCT02734862|468746886|FG001|Part B|Withdrawal by Subject|1|||
130213713|NCT02734862|468746887|FG002|Part B|Withdrawal by Subject|0|||
130213714|NCT02734862|468746885|FG000|Part B|Other|0|||
130213715|NCT02734862|468746886|FG001|Part B|Other|1|||
130213716|NCT02734862|468746887|FG002|Part B|Other|0|||
130213717|NCT02131233|468746888|FG000|Overall Study|Not Treated|2|||
130213718|NCT02131233|468746889|FG001|Overall Study|Not Treated|3|||
130213719|NCT02131233|468746888|FG000|Overall Study|Adverse Event|7|||
130213720|NCT02131233|468746889|FG001|Overall Study|Adverse Event|6|||
130213721|NCT02131233|468746888|FG000|Overall Study|Death|0|||
130213722|NCT02131233|468746889|FG001|Overall Study|Death|1|||
130213723|NCT02131233|468746888|FG000|Overall Study|Lack of Efficacy|6|||
130213724|NCT02131233|468746889|FG001|Overall Study|Lack of Efficacy|3|||
130213725|NCT02131233|468746888|FG000|Overall Study|Lost to Follow-up|14|||
130213726|NCT02131233|468746889|FG001|Overall Study|Lost to Follow-up|13|||
130213727|NCT02131233|468746888|FG000|Overall Study|Non-Compliance With Study Drug|8|||
130213728|NCT02131233|468746889|FG001|Overall Study|Non-Compliance With Study Drug|5|||
130213729|NCT02131233|468746888|FG000|Overall Study|Physician Decision|7|||
130213730|NCT02131233|468746889|FG001|Overall Study|Physician Decision|0|||
130213731|NCT02131233|468746888|FG000|Overall Study|Pregnancy|4|||
130213732|NCT02131233|468746889|FG001|Overall Study|Pregnancy|0|||
130320508|NCT03724942|469141943|FG000|Overall Study|Physician Decision|5|||
130320509|NCT03724942|469141944|FG001|Overall Study|Physician Decision|2|||
130320510|NCT03724942|469141943|FG000|Overall Study|Protocol Violation|1|||
130213733|NCT02131233|468746888|FG000|Overall Study|Withdrawal by Subject|18|||
130213734|NCT02131233|468746889|FG001|Overall Study|Withdrawal by Subject|11|||
130213735|NCT04399889|468746898|FG000|Overall Study|Death|5|||
130213736|NCT04399889|468746899|FG001|Overall Study|Death|1|||
130213737|NCT04399889|468746900|FG002|Overall Study|Death|1|||
130213738|NCT00217581|468746901|FG000|Overall Study|Withdrawal by Subject|1|||
130320511|NCT03724942|469141944|FG001|Overall Study|Protocol Violation|0|||
130320512|NCT03724942|469141943|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
130320513|NCT03724942|469141944|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
130320514|NCT03724942|469141943|FG000|Overall Study|Withdrawal by Legal Representative|3|||
130320515|NCT03724942|469141944|FG001|Overall Study|Withdrawal by Legal Representative|0|||
130320516|NCT00668148|469141958|FG000|Overall Study|Adverse Event|5|||
130320517|NCT00668148|469141958|FG000|Overall Study|Subject Non-compliance|1|||
130545095|NCT03038438|469963001|FG000|Overall Study|Death|3|||
130320518|NCT00668148|469141958|FG000|Overall Study|Progressive Disease Before Treatment|2|||
130545096|NCT03038438|469963001|FG000|Overall Study|Lost to Follow-up|8|||
130320519|NCT00668148|469141958|FG000|Overall Study|Withdrawal of Consent|2|||
130320520|NCT04875975|469141961|FG000|Overall Study|Adverse Event|1|||
130320521|NCT04875975|469141962|FG001|Overall Study|Adverse Event|2|||
130213739|NCT01005901|468746902|FG000|Overall Study|Withdrawal by Subject|38|||
130213740|NCT01005901|468746903|FG001|Overall Study|Withdrawal by Subject|14|||
130213741|NCT01005901|468746902|FG000|Overall Study|Adverse Event|30|||
130213742|NCT01005901|468746903|FG001|Overall Study|Adverse Event|16|||
130213743|NCT01005901|468746902|FG000|Overall Study|Administrative problems|21|||
130213744|NCT01005901|468746903|FG001|Overall Study|Administrative problems|13|||
130213745|NCT01005901|468746902|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130213746|NCT01005901|468746903|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130213747|NCT01005901|468746902|FG000|Overall Study|Protocol Violation|4|||
130213748|NCT01005901|468746903|FG001|Overall Study|Protocol Violation|3|||
130213749|NCT01005901|468746902|FG000|Overall Study|Death|2|||
130213750|NCT01005901|468746903|FG001|Overall Study|Death|3|||
130213751|NCT01005901|468746902|FG000|Overall Study|Lost to Follow-up|1|||
130320522|NCT04875975|469141961|FG000|Overall Study|Lack of Efficacy|2|||
130320523|NCT04875975|469141962|FG001|Overall Study|Lack of Efficacy|2|||
130320524|NCT04875975|469141961|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
130320525|NCT04875975|469141962|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
130320526|NCT04875975|469141961|FG000|Overall Study|Relapse With Insults|0|||
130320527|NCT04875975|469141962|FG001|Overall Study|Relapse With Insults|1|||
130320528|NCT04875975|469141961|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
130320529|NCT04875975|469141962|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
130320530|NCT05472090|469141963|FG000|Overall Study|Adverse Event|2|||
130320531|NCT05472090|469141964|FG001|Overall Study|Adverse Event|3|||
130320532|NCT05472090|469141963|FG000|Overall Study|Lack of Efficacy|1|||
130320533|NCT05472090|469141964|FG001|Overall Study|Lack of Efficacy|0|||
130320534|NCT05472090|469141963|FG000|Overall Study|Physician Decision|1|||
130320535|NCT05472090|469141964|FG001|Overall Study|Physician Decision|0|||
130320536|NCT05472090|469141963|FG000|Overall Study|Withdrawal by Subject|2|||
130320537|NCT05472090|469141964|FG001|Overall Study|Withdrawal by Subject|0|||
130320538|NCT05472090|469141963|FG000|Overall Study|Lost to Follow-up|0|||
130320539|NCT05472090|469141964|FG001|Overall Study|Lost to Follow-up|3|||
130320540|NCT01350999|469141966|FG000|Overall Study|Adverse Event|4|||
130320541|NCT01350999|469141967|FG001|Overall Study|Adverse Event|9|||
130320542|NCT01350999|469141968|FG002|Overall Study|Adverse Event|10|||
130320543|NCT01350999|469141966|FG000|Overall Study|Voluntary withdrawal|3|||
130320544|NCT01350999|469141967|FG001|Overall Study|Voluntary withdrawal|4|||
130320545|NCT01350999|469141968|FG002|Overall Study|Voluntary withdrawal|6|||
130320546|NCT01350999|469141966|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
130320547|NCT01350999|469141967|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
130320548|NCT01350999|469141968|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
130320549|NCT01766050|469144021|FG000|Overall Study|Adverse Event|1|||
130320550|NCT01766050|469144021|FG000|Overall Study|Lost to Follow-up|1|||
130320551|NCT01766050|469144021|FG000|Overall Study|Withdrawal by Subject|2|||
130320552|NCT00089297|469144023|FG000|Overall Study|Adverse Event|9|||
130320553|NCT00089297|469144023|FG000|Overall Study|Death|1|||
130320554|NCT00089297|469144023|FG000|Overall Study|Withdrawal by Subject|12|||
130320555|NCT00089297|469144023|FG000|Overall Study|Disease progression|2|||
130320556|NCT00089297|469144023|FG000|Overall Study|Ineligible|11|||
130320557|NCT00089297|469144023|FG000|Overall Study|Secondary malignancy|1|||
130320558|NCT00089297|469144023|FG000|Overall Study|IRB approval not ready|1|||
130320559|NCT00089297|469144023|FG000|Overall Study|Non-compliance|1|||
130320560|NCT01910298|469144026|FG000|Overall Study|Adverse Event|1|||
130320561|NCT01910298|469144027|FG001|Overall Study|Adverse Event|0|||
130320562|NCT01910298|469144026|FG000|Overall Study|Withdrawal by Subject|2|||
130320563|NCT01910298|469144027|FG001|Overall Study|Withdrawal by Subject|7|||
130320564|NCT01910298|469144026|FG000|Overall Study|Protocol Deviation|0|||
130320565|NCT01910298|469144027|FG001|Overall Study|Protocol Deviation|5|||
130320566|NCT01910298|469144026|FG000|Overall Study|Lost to Follow-up|1|||
130320567|NCT01910298|469144027|FG001|Overall Study|Lost to Follow-up|1|||
130320568|NCT01910298|469144026|FG000|Overall Study|Study Terminated by Sponsor|1|||
130320569|NCT01910298|469144027|FG001|Overall Study|Study Terminated by Sponsor|17|||
130320570|NCT01910298|469144026|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130320571|NCT01910298|469144027|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130320572|NCT03037385|469144030|FG000|Overall Study|Adverse Event|0|||
130320573|NCT03037385|469144031|FG001|Overall Study|Adverse Event|0|||
130320574|NCT03037385|469144032|FG002|Overall Study|Adverse Event|1|||
130320575|NCT03037385|469144033|FG003|Overall Study|Adverse Event|0|||
130320576|NCT03037385|469144034|FG004|Overall Study|Adverse Event|0|||
130320577|NCT03037385|469144035|FG005|Overall Study|Adverse Event|0|||
130320578|NCT03037385|469144036|FG006|Overall Study|Adverse Event|0|||
130320579|NCT03037385|469144037|FG007|Overall Study|Adverse Event|0|||
130320580|NCT03037385|469144038|FG008|Overall Study|Adverse Event|0|||
130320581|NCT03037385|469144039|FG009|Overall Study|Adverse Event|6|||
130320582|NCT03037385|469144030|FG000|Overall Study|Death|1|||
130320583|NCT03037385|469144031|FG001|Overall Study|Death|4|||
130320584|NCT03037385|469144032|FG002|Overall Study|Death|2|||
130320585|NCT03037385|469144033|FG003|Overall Study|Death|2|||
130320586|NCT03037385|469144034|FG004|Overall Study|Death|5|||
130320587|NCT03037385|469144035|FG005|Overall Study|Death|2|||
130320588|NCT03037385|469144036|FG006|Overall Study|Death|1|||
130320589|NCT03037385|469144037|FG007|Overall Study|Death|4|||
130320590|NCT03037385|469144038|FG008|Overall Study|Death|3|||
130320591|NCT03037385|469144039|FG009|Overall Study|Death|240|||
130320592|NCT03037385|469144030|FG000|Overall Study|Initiation of Another Therapy|1|||
130320593|NCT03037385|469144031|FG001|Overall Study|Initiation of Another Therapy|0|||
130320594|NCT03037385|469144032|FG002|Overall Study|Initiation of Another Therapy|0|||
130320595|NCT03037385|469144033|FG003|Overall Study|Initiation of Another Therapy|0|||
130320596|NCT03037385|469144034|FG004|Overall Study|Initiation of Another Therapy|0|||
130320597|NCT03037385|469144035|FG005|Overall Study|Initiation of Another Therapy|0|||
130320598|NCT03037385|469144036|FG006|Overall Study|Initiation of Another Therapy|0|||
130320599|NCT03037385|469144037|FG007|Overall Study|Initiation of Another Therapy|1|||
130320600|NCT03037385|469144038|FG008|Overall Study|Initiation of Another Therapy|0|||
130320601|NCT03037385|469144039|FG009|Overall Study|Initiation of Another Therapy|2|||
130320602|NCT03037385|469144030|FG000|Overall Study|Lost to Follow-up|0|||
130320603|NCT03037385|469144031|FG001|Overall Study|Lost to Follow-up|0|||
130320604|NCT03037385|469144032|FG002|Overall Study|Lost to Follow-up|0|||
130320605|NCT03037385|469144033|FG003|Overall Study|Lost to Follow-up|0|||
130320606|NCT03037385|469144034|FG004|Overall Study|Lost to Follow-up|0|||
130320607|NCT03037385|469144035|FG005|Overall Study|Lost to Follow-up|1|||
130320608|NCT03037385|469144036|FG006|Overall Study|Lost to Follow-up|0|||
130320609|NCT03037385|469144037|FG007|Overall Study|Lost to Follow-up|0|||
130320610|NCT03037385|469144038|FG008|Overall Study|Lost to Follow-up|0|||
130320611|NCT03037385|469144039|FG009|Overall Study|Lost to Follow-up|16|||
130320612|NCT03037385|469144030|FG000|Overall Study|Physician Decision|0|||
130320613|NCT03037385|469144031|FG001|Overall Study|Physician Decision|0|||
130320614|NCT03037385|469144032|FG002|Overall Study|Physician Decision|0|||
130320615|NCT03037385|469144033|FG003|Overall Study|Physician Decision|0|||
130320616|NCT03037385|469144034|FG004|Overall Study|Physician Decision|0|||
130320617|NCT03037385|469144035|FG005|Overall Study|Physician Decision|0|||
130320618|NCT03037385|469144036|FG006|Overall Study|Physician Decision|0|||
130320619|NCT03037385|469144037|FG007|Overall Study|Physician Decision|0|||
130320620|NCT03037385|469144038|FG008|Overall Study|Physician Decision|0|||
130320621|NCT03037385|469144039|FG009|Overall Study|Physician Decision|1|||
130320622|NCT03037385|469144030|FG000|Overall Study|Progressive Disease|0|||
130320623|NCT03037385|469144031|FG001|Overall Study|Progressive Disease|1|||
130320624|NCT03037385|469144032|FG002|Overall Study|Progressive Disease|1|||
130320625|NCT03037385|469144033|FG003|Overall Study|Progressive Disease|5|||
130320626|NCT03037385|469144034|FG004|Overall Study|Progressive Disease|2|||
130320627|NCT03037385|469144035|FG005|Overall Study|Progressive Disease|0|||
130320628|NCT03037385|469144036|FG006|Overall Study|Progressive Disease|1|||
130320629|NCT03037385|469144037|FG007|Overall Study|Progressive Disease|0|||
130320630|NCT03037385|469144038|FG008|Overall Study|Progressive Disease|0|||
130320631|NCT03037385|469144039|FG009|Overall Study|Progressive Disease|30|||
130320632|NCT03037385|469144030|FG000|Overall Study|Withdrawal by Subject|0|||
130320633|NCT03037385|469144031|FG001|Overall Study|Withdrawal by Subject|0|||
130320634|NCT03037385|469144032|FG002|Overall Study|Withdrawal by Subject|1|||
130320635|NCT03037385|469144033|FG003|Overall Study|Withdrawal by Subject|2|||
130320636|NCT03037385|469144034|FG004|Overall Study|Withdrawal by Subject|1|||
130320637|NCT03037385|469144035|FG005|Overall Study|Withdrawal by Subject|3|||
130320638|NCT03037385|469144036|FG006|Overall Study|Withdrawal by Subject|0|||
130320639|NCT03037385|469144037|FG007|Overall Study|Withdrawal by Subject|0|||
130320640|NCT03037385|469144038|FG008|Overall Study|Withdrawal by Subject|0|||
130320641|NCT03037385|469144039|FG009|Overall Study|Withdrawal by Subject|52|||
130320642|NCT03037385|469144030|FG000|Overall Study|Reason Not Specified|0|||
130320643|NCT03037385|469144031|FG001|Overall Study|Reason Not Specified|1|||
130320644|NCT03037385|469144032|FG002|Overall Study|Reason Not Specified|0|||
130320645|NCT03037385|469144033|FG003|Overall Study|Reason Not Specified|4|||
130320646|NCT03037385|469144034|FG004|Overall Study|Reason Not Specified|3|||
130320647|NCT03037385|469144035|FG005|Overall Study|Reason Not Specified|6|||
130320648|NCT03037385|469144036|FG006|Overall Study|Reason Not Specified|2|||
130320649|NCT03037385|469144037|FG007|Overall Study|Reason Not Specified|0|||
130320650|NCT03037385|469144038|FG008|Overall Study|Reason Not Specified|1|||
130320651|NCT03037385|469144039|FG009|Overall Study|Reason Not Specified|181|||
130320652|NCT04515771|469144044|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
130320653|NCT04515771|469144045|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
130320654|NCT04515771|469144044|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
130320655|NCT04515771|469144045|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
130320656|NCT04515771|469144044|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
130320657|NCT04515771|469144045|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
130320658|NCT01021020|469144046|FG000|Period I|Protocol Violation|1|||
130320659|NCT01021020|469144046|FG000|Period I|Withdrawal by Subject|1|||
130320660|NCT01021020|469144046|FG000|14 Day Washout Period A|Physician Decision|1|||
130320661|NCT00948246|469144049|FG000|Overall Study|Lost to Follow-up|11|||
130545097|NCT03038438|469963001|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
130545098|NCT03038438|469963001|FG000|Overall Study|Withdrawal by Subject|5|||
130320662|NCT00948246|469144049|FG000|Overall Study|Adverse Event|11|||
130320663|NCT00948246|469144049|FG000|Overall Study|Death|1|||
130320664|NCT00948246|469144049|FG000|Overall Study|Withdrawal by Subject|1|||
130545099|NCT03038438|469963001|FG000|Overall Study|No 36-Month Follow-Up|18|||
130320665|NCT03598036|469144052|FG000|Overall Study|Withdrawal by Subject|1|||
130320666|NCT03598036|469144053|FG001|Overall Study|Withdrawal by Subject|0|||
130320667|NCT04199351|469144054|FG000|Overall Study|Decision by sponsor|0|||
130320668|NCT04199351|469144055|FG001|Overall Study|Decision by sponsor|0|||
130320669|NCT04199351|469144056|FG002|Overall Study|Decision by sponsor|0|||
130320670|NCT04199351|469144057|FG003|Overall Study|Decision by sponsor|2|||
130320671|NCT04199351|469144058|FG004|Overall Study|Decision by sponsor|0|||
130320672|NCT04199351|469144059|FG005|Overall Study|Decision by sponsor|0|||
130320673|NCT04199351|469144060|FG006|Overall Study|Decision by sponsor|0|||
130320674|NCT04199351|469144061|FG007|Overall Study|Decision by sponsor|0|||
130320675|NCT04199351|469144062|FG008|Overall Study|Decision by sponsor|0|||
130320676|NCT04199351|469144063|FG009|Overall Study|Decision by sponsor|6|||
130320677|NCT04199351|469144054|FG000|Overall Study|Lost to Follow-up|0|||
130320678|NCT04199351|469144055|FG001|Overall Study|Lost to Follow-up|0|||
130320679|NCT04199351|469144056|FG002|Overall Study|Lost to Follow-up|1|||
130320680|NCT04199351|469144057|FG003|Overall Study|Lost to Follow-up|0|||
130320681|NCT04199351|469144058|FG004|Overall Study|Lost to Follow-up|0|||
130320682|NCT04199351|469144059|FG005|Overall Study|Lost to Follow-up|1|||
130320683|NCT04199351|469144060|FG006|Overall Study|Lost to Follow-up|0|||
130320684|NCT04199351|469144061|FG007|Overall Study|Lost to Follow-up|0|||
130320685|NCT04199351|469144062|FG008|Overall Study|Lost to Follow-up|0|||
130320686|NCT04199351|469144063|FG009|Overall Study|Lost to Follow-up|0|||
130320687|NCT04199351|469144054|FG000|Overall Study|Withdrawal by Subject|0|||
130320688|NCT04199351|469144055|FG001|Overall Study|Withdrawal by Subject|1|||
130320689|NCT04199351|469144056|FG002|Overall Study|Withdrawal by Subject|0|||
130320690|NCT04199351|469144057|FG003|Overall Study|Withdrawal by Subject|0|||
130320691|NCT04199351|469144058|FG004|Overall Study|Withdrawal by Subject|1|||
130320692|NCT04199351|469144059|FG005|Overall Study|Withdrawal by Subject|4|||
130320693|NCT04199351|469144060|FG006|Overall Study|Withdrawal by Subject|2|||
130320694|NCT04199351|469144061|FG007|Overall Study|Withdrawal by Subject|0|||
130320695|NCT04199351|469144062|FG008|Overall Study|Withdrawal by Subject|3|||
130320696|NCT04199351|469144063|FG009|Overall Study|Withdrawal by Subject|0|||
130320697|NCT01838694|469144064|FG000|Overall Study|Adverse Event|0|||
130320698|NCT01838694|469144065|FG001|Overall Study|Adverse Event|1|||
130320699|NCT03623243|469144066|FG000|Overall Study|Adverse Event|15|||
130320700|NCT03623243|469144066|FG000|Overall Study|Guardian Decision|1|||
130320701|NCT03623243|469144066|FG000|Overall Study|New Therapy for Study Indication|1|||
130320702|NCT03623243|469144066|FG000|Overall Study|Protocol Deviation|3|||
130320703|NCT03623243|469144066|FG000|Overall Study|Physician Decision|4|||
130320704|NCT03623243|469144066|FG000|Overall Study|Patient Decision|15|||
130320705|NCT02177695|469144070|FG000|ITT Analysis|Ineligible|5|||
130320706|NCT02177695|469144071|FG001|ITT Analysis|Ineligible|5|||
130320707|NCT02177695|469144070|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
130320708|NCT02177695|469144071|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
130320709|NCT02177695|469144070|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
130320710|NCT02177695|469144071|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
130320711|NCT02177695|469144070|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130320712|NCT02177695|469144071|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130320713|NCT00979901|469144072|FG000|Overall Study|Adverse Event|1|||
130320714|NCT00979901|469144073|FG001|Overall Study|Adverse Event|3|||
130320715|NCT00979901|469144074|FG002|Overall Study|Adverse Event|9|||
130320716|NCT00979901|469144075|FG003|Overall Study|Adverse Event|2|||
130320717|NCT00979901|469144072|FG000|Overall Study|Lack of Efficacy|8|||
130320718|NCT00979901|469144073|FG001|Overall Study|Lack of Efficacy|4|||
130320719|NCT00979901|469144074|FG002|Overall Study|Lack of Efficacy|9|||
130320720|NCT00979901|469144075|FG003|Overall Study|Lack of Efficacy|0|||
130320721|NCT00979901|469144072|FG000|Overall Study|Lost to Follow-up|1|||
130320722|NCT00979901|469144073|FG001|Overall Study|Lost to Follow-up|1|||
130320723|NCT00979901|469144074|FG002|Overall Study|Lost to Follow-up|2|||
130320724|NCT00979901|469144075|FG003|Overall Study|Lost to Follow-up|0|||
130320725|NCT00979901|469144072|FG000|Overall Study|Protocol Violation|2|||
130320726|NCT00979901|469144073|FG001|Overall Study|Protocol Violation|2|||
130320727|NCT00979901|469144074|FG002|Overall Study|Protocol Violation|7|||
130320728|NCT00979901|469144075|FG003|Overall Study|Protocol Violation|1|||
130320729|NCT00979901|469144072|FG000|Overall Study|Withdrawal by Subject|2|||
130320730|NCT00979901|469144073|FG001|Overall Study|Withdrawal by Subject|1|||
130320731|NCT00979901|469144074|FG002|Overall Study|Withdrawal by Subject|1|||
130320732|NCT00979901|469144075|FG003|Overall Study|Withdrawal by Subject|1|||
130320733|NCT00979901|469144072|FG000|Overall Study|Noncompliance|1|||
130320734|NCT00979901|469144073|FG001|Overall Study|Noncompliance|0|||
130320735|NCT00979901|469144074|FG002|Overall Study|Noncompliance|0|||
130320736|NCT00979901|469144075|FG003|Overall Study|Noncompliance|0|||
130320737|NCT00979901|469144072|FG000|Overall Study|out-of-state|1|||
130320738|NCT00979901|469144073|FG001|Overall Study|out-of-state|0|||
130320739|NCT00979901|469144074|FG002|Overall Study|out-of-state|0|||
130320740|NCT00979901|469144075|FG003|Overall Study|out-of-state|0|||
130320741|NCT00979901|469144072|FG000|Overall Study|vacation|1|||
130320742|NCT00979901|469144073|FG001|Overall Study|vacation|0|||
130320743|NCT00979901|469144074|FG002|Overall Study|vacation|0|||
130320744|NCT00979901|469144075|FG003|Overall Study|vacation|0|||
130320745|NCT00979901|469144072|FG000|Overall Study|elevated lab values pre-randomization|1|||
130320746|NCT00979901|469144073|FG001|Overall Study|elevated lab values pre-randomization|0|||
130320747|NCT00979901|469144074|FG002|Overall Study|elevated lab values pre-randomization|0|||
130320748|NCT00979901|469144075|FG003|Overall Study|elevated lab values pre-randomization|0|||
130320749|NCT00979901|469144072|FG000|Overall Study|Discontinued in Error|0|||
130320750|NCT00979901|469144073|FG001|Overall Study|Discontinued in Error|1|||
130376459|NCT00887978|469343698|FG001|Overall Study|Clinical Worsening|4|||
130320751|NCT00979901|469144074|FG002|Overall Study|Discontinued in Error|0|||
130320752|NCT00979901|469144075|FG003|Overall Study|Discontinued in Error|0|||
130320753|NCT00979901|469144072|FG000|Overall Study|Left Country|0|||
130320754|NCT00979901|469144073|FG001|Overall Study|Left Country|0|||
130320755|NCT00979901|469144074|FG002|Overall Study|Left Country|1|||
130320756|NCT00979901|469144075|FG003|Overall Study|Left Country|0|||
130320757|NCT00979901|469144072|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320758|NCT00979901|469144073|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320759|NCT00979901|469144074|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320760|NCT00979901|469144075|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
130320761|NCT02182895|469144086|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
130320762|NCT02182895|469144087|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
130320763|NCT00286468|469144088|FG000|Overall Study|Hyperglycemic Rescue|28|||
130320764|NCT00286468|469144089|FG001|Overall Study|Hyperglycemic Rescue|30|||
130320765|NCT00286468|469144090|FG002|Overall Study|Hyperglycemic Rescue|31|||
130320766|NCT00286468|469144088|FG000|Overall Study|Adverse Event|2|||
130320767|NCT00286468|469144089|FG001|Overall Study|Adverse Event|6|||
130320768|NCT00286468|469144090|FG002|Overall Study|Adverse Event|4|||
130320769|NCT00286468|469144088|FG000|Overall Study|Protocol Violation|0|||
130320770|NCT00286468|469144089|FG001|Overall Study|Protocol Violation|3|||
130320771|NCT00286468|469144090|FG002|Overall Study|Protocol Violation|1|||
130320772|NCT00286468|469144088|FG000|Overall Study|Lost to Follow-up|1|||
130320773|NCT00286468|469144089|FG001|Overall Study|Lost to Follow-up|1|||
130320774|NCT00286468|469144090|FG002|Overall Study|Lost to Follow-up|2|||
130320775|NCT00286468|469144088|FG000|Overall Study|Withdrawal by Subject|3|||
130320776|NCT00286468|469144089|FG001|Overall Study|Withdrawal by Subject|8|||
130320777|NCT00286468|469144090|FG002|Overall Study|Withdrawal by Subject|11|||
130320778|NCT00286468|469144088|FG000|Overall Study|Physician Decision|3|||
130320779|NCT00286468|469144089|FG001|Overall Study|Physician Decision|2|||
130320780|NCT00286468|469144090|FG002|Overall Study|Physician Decision|1|||
130320781|NCT03305666|469144091|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
130320782|NCT03305666|469144092|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
130320783|NCT02230410|469144094|FG000|Overall Study|Screen Failure|3|||
130320784|NCT02587221|469144099|FG000|Overall Study|Adverse Event|3|||
130320785|NCT02587221|469144100|FG001|Overall Study|Adverse Event|3|||
130320786|NCT02587221|469144099|FG000|Overall Study|Death|33|||
130320787|NCT02587221|469144100|FG001|Overall Study|Death|34|||
130320788|NCT02587221|469144099|FG000|Overall Study|Withdrawal by Subject|66|||
130320789|NCT02587221|469144100|FG001|Overall Study|Withdrawal by Subject|61|||
130320790|NCT02587221|469144099|FG000|Overall Study|Lost to Follow-up|21|||
130320791|NCT02587221|469144100|FG001|Overall Study|Lost to Follow-up|19|||
130320792|NCT02587221|469144099|FG000|Overall Study|Protocol Violation|6|||
130320793|NCT02587221|469144100|FG001|Overall Study|Protocol Violation|5|||
130320794|NCT02587221|469144099|FG000|Overall Study|Other Reason or Unspecified|2|||
130320795|NCT02587221|469144100|FG001|Overall Study|Other Reason or Unspecified|1|||
130320796|NCT02242942|469144105|FG000|Overall Study|Death|17|||
130320797|NCT02242942|469144106|FG001|Overall Study|Death|20|||
130320798|NCT02242942|469144107|FG002|Overall Study|Death|2|||
130320799|NCT02242942|469144105|FG000|Overall Study|Physician Decision|1|||
130320800|NCT02242942|469144106|FG001|Overall Study|Physician Decision|0|||
130320801|NCT02242942|469144107|FG002|Overall Study|Physician Decision|0|||
130320802|NCT02242942|469144105|FG000|Overall Study|Withdrawal by Subject|8|||
130320803|NCT02242942|469144106|FG001|Overall Study|Withdrawal by Subject|10|||
130320804|NCT02242942|469144107|FG002|Overall Study|Withdrawal by Subject|0|||
130320805|NCT02242942|469144105|FG000|Overall Study|On-going in Study|190|||
130320806|NCT02242942|469144106|FG001|Overall Study|On-going in Study|186|||
130320807|NCT02242942|469144107|FG002|Overall Study|On-going in Study|11|||
130320808|NCT00551759|469144108|FG000|Overall Study|Adverse Event|7|||
130320809|NCT00551759|469144108|FG000|Overall Study|Death|5|||
130320810|NCT00551759|469144108|FG000|Overall Study|Ineligible|1|||
130320811|NCT01451606|469144113|FG000|Overall Study|Withdrawal by Subject|4|||
130320812|NCT01451606|469144114|FG001|Overall Study|Withdrawal by Subject|3|||
130320813|NCT02163538|469144117|FG000|Overall Study|Protocol Violation|1|||
130320814|NCT02163538|469144118|FG001|Overall Study|Protocol Violation|0|||
130320815|NCT02163538|469144117|FG000|Overall Study|Physician Decision|0|||
130320816|NCT02163538|469144118|FG001|Overall Study|Physician Decision|1|||
130320817|NCT01283139|469144119|FG000|Overall Study|Lost to Follow-up|5|||
130320818|NCT01283139|469144120|FG001|Overall Study|Lost to Follow-up|2|||
130320819|NCT01283139|469144121|FG002|Overall Study|Lost to Follow-up|3|||
130320820|NCT01283139|469144122|FG003|Overall Study|Lost to Follow-up|1|||
130320821|NCT01283139|469144119|FG000|Overall Study|Withdrawal by Subject|8|||
130320822|NCT01283139|469144120|FG001|Overall Study|Withdrawal by Subject|8|||
130320823|NCT01283139|469144121|FG002|Overall Study|Withdrawal by Subject|6|||
130433125|NCT01806584|469547856|FG000|Overall Study|Adverse Event|2|||
130320824|NCT01283139|469144122|FG003|Overall Study|Withdrawal by Subject|8|||
130320825|NCT01283139|469144119|FG000|Overall Study|Death|2|||
130320826|NCT01283139|469144120|FG001|Overall Study|Death|0|||
130320827|NCT01283139|469144121|FG002|Overall Study|Death|2|||
130320828|NCT01283139|469144122|FG003|Overall Study|Death|2|||
130320829|NCT01283139|469144119|FG000|Overall Study|Lack of Efficacy|1|||
130545100|NCT03625895|469963002|FG000|Overall Study|Protocol Violation|585|||
130545101|NCT00577473|469963005|FG000|Overall Study|Protocol Violation|1|||
130545102|NCT00577473|469963006|FG001|Overall Study|Protocol Violation|4|||
130545103|NCT00577473|469963005|FG000|Overall Study|Adverse Event|8|||
130545104|NCT00577473|469963006|FG001|Overall Study|Adverse Event|5|||
130545105|NCT00577473|469963005|FG000|Overall Study|Withdrawal by Subject|2|||
130545106|NCT00577473|469963006|FG001|Overall Study|Withdrawal by Subject|6|||
130545107|NCT00577473|469963005|FG000|Overall Study|Physician Decision|2|||
130545108|NCT00577473|469963006|FG001|Overall Study|Physician Decision|2|||
130545109|NCT00577473|469963005|FG000|Overall Study|Lack of Efficacy|8|||
130545110|NCT00577473|469963006|FG001|Overall Study|Lack of Efficacy|7|||
130545111|NCT02884908|469963007|FG000|Overall Study|Lost to Follow-up|13|||
130213752|NCT01005901|468746903|FG001|Overall Study|Lost to Follow-up|2|||
130213753|NCT01005901|468746902|FG000|Overall Study|Patient's inability to use the device|1|||
130213754|NCT01005901|468746903|FG001|Overall Study|Patient's inability to use the device|1|||
130213755|NCT01005901|468746902|FG000|Overall Study|No longer requires study drug|0|||
130213756|NCT01005901|468746903|FG001|Overall Study|No longer requires study drug|1|||
130213757|NCT00760487|468746904|FG000|Overall Study|Unilateral implantation|3|||
130213758|NCT06360588|468746905|FG000|Overall Study|Adverse Event|3|||
130213759|NCT06360588|468746905|FG000|Overall Study|Death|2|||
130213760|NCT06360588|468746905|FG000|Overall Study|Disease Progression|14|||
130213761|NCT06360588|468746905|FG000|Overall Study|Withdrawal by Subject|1|||
130213762|NCT06360588|468746905|FG000|Overall Study|Lack of Efficacy|1|||
130213763|NCT06360588|468746905|FG000|Overall Study|Ineligible|1|||
130213764|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
130213765|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
130213766|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
130213767|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130213768|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130213769|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
130213770|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
130213771|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
130213772|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130213773|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130213774|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
130213775|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130213776|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130213777|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130213778|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130213779|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130213780|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213781|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130213782|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213783|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213784|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213785|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
130213786|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213787|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213788|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213789|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
130213790|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
130213791|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
130213792|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
130213793|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
130213794|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130213795|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
130213796|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130213797|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130213798|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130213799|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213800|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213801|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
130213802|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213803|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213804|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213805|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130545112|NCT02884908|469963008|FG001|Overall Study|Lost to Follow-up|18|||
130545113|NCT00232544|469963015|FG000|Overall Study|Lost to Follow-up|20|||
130545114|NCT00232544|469963016|FG001|Overall Study|Lost to Follow-up|15|||
130545115|NCT00986973|469963020|FG000|Overall Study|Withdrawn by study team|1|||
130545116|NCT01465347|469963021|FG000|Overall Study|Withdrawal by Subject|1|||
130545117|NCT01465347|469963022|FG001|Overall Study|Withdrawal by Subject|1|||
130545118|NCT01465347|469963021|FG000|Overall Study|Physician Decision|0|||
130545119|NCT01465347|469963022|FG001|Overall Study|Physician Decision|1|||
130320830|NCT01283139|469144120|FG001|Overall Study|Lack of Efficacy|2|||
130320831|NCT01283139|469144121|FG002|Overall Study|Lack of Efficacy|2|||
130320832|NCT01283139|469144122|FG003|Overall Study|Lack of Efficacy|1|||
130320833|NCT01283139|469144119|FG000|Overall Study|Early termination due to AE/SAE|1|||
130320834|NCT01283139|469144120|FG001|Overall Study|Early termination due to AE/SAE|1|||
130320835|NCT01283139|469144121|FG002|Overall Study|Early termination due to AE/SAE|0|||
130320836|NCT01283139|469144122|FG003|Overall Study|Early termination due to AE/SAE|0|||
130320837|NCT01283139|469144119|FG000|Overall Study|Participant's refusal to continue|0|||
130320838|NCT01283139|469144120|FG001|Overall Study|Participant's refusal to continue|3|||
130545120|NCT01465347|469963021|FG000|Overall Study|Admitted to hospice|0|||
130545121|NCT01465347|469963022|FG001|Overall Study|Admitted to hospice|1|||
130545122|NCT02413333|469963023|FG000|Period 1|Adverse Event|1|||
130545123|NCT02413333|469963024|FG001|Period 1|Adverse Event|0|||
130320839|NCT01283139|469144121|FG002|Overall Study|Participant's refusal to continue|1|||
130320840|NCT01283139|469144122|FG003|Overall Study|Participant's refusal to continue|1|||
130320841|NCT01283139|469144119|FG000|Overall Study|Pregnancy|0|||
130320842|NCT01283139|469144120|FG001|Overall Study|Pregnancy|1|||
130320843|NCT01283139|469144121|FG002|Overall Study|Pregnancy|1|||
130320844|NCT01283139|469144122|FG003|Overall Study|Pregnancy|0|||
130320845|NCT01283139|469144119|FG000|Overall Study|Missed follow-up visit|0|||
130320846|NCT01283139|469144120|FG001|Overall Study|Missed follow-up visit|1|||
130320847|NCT01283139|469144121|FG002|Overall Study|Missed follow-up visit|2|||
130320848|NCT01283139|469144122|FG003|Overall Study|Missed follow-up visit|2|||
130320849|NCT01283139|469144119|FG000|Overall Study|Participant randomized in error|0|||
130320850|NCT01283139|469144120|FG001|Overall Study|Participant randomized in error|0|||
130320851|NCT01283139|469144121|FG002|Overall Study|Participant randomized in error|1|||
130320852|NCT01283139|469144122|FG003|Overall Study|Participant randomized in error|0|||
130320853|NCT00762164|469144123|FG000|Overall Study|Lost to Follow-up|1|||
130320854|NCT00762164|469144124|FG001|Overall Study|Lost to Follow-up|1|||
130320855|NCT00762164|469144123|FG000|Overall Study|Discontinued medication|2|||
130320856|NCT00762164|469144124|FG001|Overall Study|Discontinued medication|0|||
130320857|NCT00762164|469144123|FG000|Overall Study|Withdrawal by Subject|0|||
130320858|NCT00762164|469144124|FG001|Overall Study|Withdrawal by Subject|1|||
130320859|NCT02954536|469144125|FG000|Overall Study|Adverse Event|2|||
130320860|NCT02954536|469144125|FG000|Overall Study|Death|12|||
130320861|NCT00604565|469144133|FG000|Overall Study|Study terminated|0|||
130320862|NCT00604565|469144134|FG001|Overall Study|Study terminated|3|||
130320863|NCT04292535|469144136|FG000|Overall Study|Withdrawal by Subject|0|||
130320864|NCT04292535|469144137|FG001|Overall Study|Withdrawal by Subject|0|||
130320865|NCT04292535|469144138|FG002|Overall Study|Withdrawal by Subject|0|||
130320866|NCT04292535|469144139|FG003|Overall Study|Withdrawal by Subject|0|||
130320867|NCT04292535|469144140|FG004|Overall Study|Withdrawal by Subject|0|||
130320868|NCT04292535|469144141|FG005|Overall Study|Withdrawal by Subject|0|||
130320869|NCT04292535|469144142|FG006|Overall Study|Withdrawal by Subject|0|||
130320870|NCT04292535|469144143|FG007|Overall Study|Withdrawal by Subject|1|||
130320871|NCT04292535|469144144|FG008|Overall Study|Withdrawal by Subject|0|||
130320872|NCT04292535|469144145|FG009|Overall Study|Withdrawal by Subject|0|||
130320873|NCT04292535|469144146|FG010|Overall Study|Withdrawal by Subject|0|||
130320874|NCT04292535|469144147|FG011|Overall Study|Withdrawal by Subject|0|||
130320875|NCT04292535|469144148|FG012|Overall Study|Withdrawal by Subject|0|||
130320876|NCT04292535|469144149|FG013|Overall Study|Withdrawal by Subject|0|||
130320877|NCT04292535|469144136|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320878|NCT04292535|469144137|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130545124|NCT02413333|469963023|FG000|Period 1|Reason Not Specified|0|||
130545125|NCT02413333|469963024|FG001|Period 1|Reason Not Specified|1|||
130545126|NCT02413333|469963023|FG000|Period 2|Protocol Deviation|1|||
130320879|NCT04292535|469144138|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320880|NCT04292535|469144139|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320881|NCT04292535|469144140|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130545127|NCT02413333|469963024|FG001|Period 2|Protocol Deviation|0|||
130545128|NCT01590082|469963025|FG000|Overall Study|Withdrawal by Subject|1|||
130545129|NCT01590082|469963026|FG001|Overall Study|Withdrawal by Subject|0|||
130545130|NCT01590082|469963025|FG000|Overall Study|Ineligible|1|||
130320882|NCT04292535|469144141|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320883|NCT04292535|469144142|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320884|NCT04292535|469144143|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130545131|NCT01590082|469963026|FG001|Overall Study|Ineligible|0|||
130320885|NCT04292535|469144144|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320886|NCT04292535|469144145|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320887|NCT04292535|469144146|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320888|NCT04292535|469144147|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320889|NCT04292535|469144148|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130320890|NCT04292535|469144149|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130320891|NCT04292535|469144136|FG000|Overall Study|Report of Dizziness|0|||
130320892|NCT04292535|469144137|FG001|Overall Study|Report of Dizziness|0|||
130320893|NCT04292535|469144138|FG002|Overall Study|Report of Dizziness|0|||
130320894|NCT04292535|469144139|FG003|Overall Study|Report of Dizziness|0|||
130320895|NCT04292535|469144140|FG004|Overall Study|Report of Dizziness|0|||
130320896|NCT04292535|469144141|FG005|Overall Study|Report of Dizziness|0|||
130320897|NCT04292535|469144142|FG006|Overall Study|Report of Dizziness|0|||
130320898|NCT04292535|469144143|FG007|Overall Study|Report of Dizziness|0|||
130320899|NCT04292535|469144144|FG008|Overall Study|Report of Dizziness|0|||
130320900|NCT04292535|469144145|FG009|Overall Study|Report of Dizziness|0|||
130320901|NCT04292535|469144146|FG010|Overall Study|Report of Dizziness|0|||
130320902|NCT04292535|469144147|FG011|Overall Study|Report of Dizziness|0|||
130320903|NCT04292535|469144148|FG012|Overall Study|Report of Dizziness|0|||
130320904|NCT04292535|469144149|FG013|Overall Study|Report of Dizziness|1|||
130320905|NCT04292535|469144136|FG000|Overall Study|Equipment Failure|0|||
130320906|NCT04292535|469144137|FG001|Overall Study|Equipment Failure|0|||
130320907|NCT04292535|469144138|FG002|Overall Study|Equipment Failure|0|||
130320908|NCT04292535|469144139|FG003|Overall Study|Equipment Failure|0|||
130320909|NCT04292535|469144140|FG004|Overall Study|Equipment Failure|0|||
130320910|NCT04292535|469144141|FG005|Overall Study|Equipment Failure|0|||
130320911|NCT04292535|469144142|FG006|Overall Study|Equipment Failure|0|||
130320912|NCT04292535|469144143|FG007|Overall Study|Equipment Failure|0|||
130320913|NCT04292535|469144144|FG008|Overall Study|Equipment Failure|0|||
130320914|NCT04292535|469144145|FG009|Overall Study|Equipment Failure|0|||
130320915|NCT04292535|469144146|FG010|Overall Study|Equipment Failure|0|||
130320916|NCT04292535|469144147|FG011|Overall Study|Equipment Failure|1|||
130320917|NCT04292535|469144148|FG012|Overall Study|Equipment Failure|0|||
130320918|NCT04292535|469144149|FG013|Overall Study|Equipment Failure|0|||
130320919|NCT00517296|469144150|FG000|Overall Study|Withdrawal by Subject|1|||
130320920|NCT00517296|469144151|FG001|Overall Study|Withdrawal by Subject|0|||
130320921|NCT04609319|469144153|FG000|Overall Study|Death|64|||
130320922|NCT04609319|469144154|FG001|Overall Study|Death|49|||
130320923|NCT04609319|469144155|FG002|Overall Study|Death|1|||
130320924|NCT04609319|469144153|FG000|Overall Study|Withdrawal of consent|15|||
130320925|NCT04609319|469144154|FG001|Overall Study|Withdrawal of consent|3|||
130320926|NCT04609319|469144155|FG002|Overall Study|Withdrawal of consent|0|||
130320927|NCT04609319|469144153|FG000|Overall Study|Lost to Follow-up|20|||
130320928|NCT04609319|469144154|FG001|Overall Study|Lost to Follow-up|33|||
130320929|NCT04609319|469144155|FG002|Overall Study|Lost to Follow-up|0|||
130320930|NCT04609319|469144153|FG000|Overall Study|Alive until end of follow-up|60|||
130320931|NCT04609319|469144154|FG001|Overall Study|Alive until end of follow-up|53|||
130320932|NCT04609319|469144155|FG002|Overall Study|Alive until end of follow-up|1|||
130320933|NCT01253291|469144156|FG000|Overall Study|Withdrawal by Subject|1|||
130320934|NCT01253291|469144157|FG001|Overall Study|Withdrawal by Subject|1|||
130320935|NCT01253291|469144158|FG002|Overall Study|Withdrawal by Subject|0|||
130320936|NCT01253291|469144159|FG003|Overall Study|Withdrawal by Subject|0|||
130320937|NCT01253291|469144160|FG004|Overall Study|Withdrawal by Subject|0|||
130320938|NCT01253291|469144156|FG000|Overall Study|Adverse Event|0|||
130320939|NCT01253291|469144157|FG001|Overall Study|Adverse Event|1|||
130320940|NCT01253291|469144158|FG002|Overall Study|Adverse Event|0|||
130320941|NCT01253291|469144159|FG003|Overall Study|Adverse Event|0|||
130320942|NCT01253291|469144160|FG004|Overall Study|Adverse Event|0|||
130320943|NCT01253291|469144156|FG000|Overall Study|Lack of Efficacy|1|||
130320944|NCT01253291|469144157|FG001|Overall Study|Lack of Efficacy|0|||
130320945|NCT01253291|469144158|FG002|Overall Study|Lack of Efficacy|0|||
130320946|NCT01253291|469144159|FG003|Overall Study|Lack of Efficacy|0|||
130320947|NCT01253291|469144160|FG004|Overall Study|Lack of Efficacy|0|||
130320948|NCT01253291|469144156|FG000|Overall Study|Physician Decision|2|||
130320949|NCT01253291|469144157|FG001|Overall Study|Physician Decision|0|||
130320950|NCT01253291|469144158|FG002|Overall Study|Physician Decision|0|||
130320951|NCT01253291|469144159|FG003|Overall Study|Physician Decision|0|||
130320952|NCT01253291|469144160|FG004|Overall Study|Physician Decision|2|||
130320953|NCT02234843|469144169|FG000|Overall Study|Death|1|||
130320954|NCT02234843|469144170|FG001|Overall Study|Death|0|||
130320955|NCT02234843|469144171|FG002|Overall Study|Death|0|||
130320956|NCT02234843|469144172|FG003|Overall Study|Death|0|||
130320957|NCT02234843|469144173|FG004|Overall Study|Death|0|||
130320958|NCT02234843|469144174|FG005|Overall Study|Death|0|||
130320959|NCT02234843|469144175|FG006|Overall Study|Death|0|||
130320960|NCT02234843|469144176|FG007|Overall Study|Death|0|||
130320961|NCT02234843|469144177|FG008|Overall Study|Death|0|||
130320962|NCT02234843|469144178|FG009|Overall Study|Death|0|||
130320963|NCT02234843|469144169|FG000|Overall Study|Protocol Violation|1|||
130320964|NCT02234843|469144170|FG001|Overall Study|Protocol Violation|0|||
130320965|NCT02234843|469144171|FG002|Overall Study|Protocol Violation|1|||
130320966|NCT02234843|469144172|FG003|Overall Study|Protocol Violation|0|||
130320967|NCT02234843|469144173|FG004|Overall Study|Protocol Violation|0|||
130320968|NCT02234843|469144174|FG005|Overall Study|Protocol Violation|0|||
130320969|NCT02234843|469144175|FG006|Overall Study|Protocol Violation|0|||
130320970|NCT02234843|469144176|FG007|Overall Study|Protocol Violation|0|||
130320971|NCT02234843|469144177|FG008|Overall Study|Protocol Violation|0|||
130320972|NCT02234843|469144178|FG009|Overall Study|Protocol Violation|0|||
130320973|NCT02234843|469144169|FG000|Overall Study|Efficacy outcome reached|2|||
130320974|NCT02234843|469144170|FG001|Overall Study|Efficacy outcome reached|0|||
130320975|NCT02234843|469144171|FG002|Overall Study|Efficacy outcome reached|0|||
130320976|NCT02234843|469144172|FG003|Overall Study|Efficacy outcome reached|0|||
130320977|NCT02234843|469144173|FG004|Overall Study|Efficacy outcome reached|0|||
130320978|NCT02234843|469144174|FG005|Overall Study|Efficacy outcome reached|2|||
130320979|NCT02234843|469144175|FG006|Overall Study|Efficacy outcome reached|0|||
130320980|NCT02234843|469144176|FG007|Overall Study|Efficacy outcome reached|0|||
130320981|NCT02234843|469144177|FG008|Overall Study|Efficacy outcome reached|0|||
130320982|NCT02234843|469144178|FG009|Overall Study|Efficacy outcome reached|0|||
130320983|NCT02234843|469144169|FG000|Overall Study|Patient convenience|2|||
130320984|NCT02234843|469144170|FG001|Overall Study|Patient convenience|0|||
130320985|NCT02234843|469144171|FG002|Overall Study|Patient convenience|0|||
130320986|NCT02234843|469144172|FG003|Overall Study|Patient convenience|0|||
130320987|NCT02234843|469144173|FG004|Overall Study|Patient convenience|0|||
130320988|NCT02234843|469144174|FG005|Overall Study|Patient convenience|1|||
130320989|NCT02234843|469144175|FG006|Overall Study|Patient convenience|0|||
130320990|NCT02234843|469144176|FG007|Overall Study|Patient convenience|0|||
130320991|NCT02234843|469144177|FG008|Overall Study|Patient convenience|0|||
130320992|NCT02234843|469144178|FG009|Overall Study|Patient convenience|0|||
130320993|NCT02234843|469144169|FG000|Overall Study|Withdrawal by Subject|5|||
130320994|NCT02234843|469144170|FG001|Overall Study|Withdrawal by Subject|1|||
130320995|NCT02234843|469144171|FG002|Overall Study|Withdrawal by Subject|1|||
130320996|NCT02234843|469144172|FG003|Overall Study|Withdrawal by Subject|0|||
130320997|NCT02234843|469144173|FG004|Overall Study|Withdrawal by Subject|0|||
130320998|NCT02234843|469144174|FG005|Overall Study|Withdrawal by Subject|7|||
130320999|NCT02234843|469144175|FG006|Overall Study|Withdrawal by Subject|0|||
130321000|NCT02234843|469144176|FG007|Overall Study|Withdrawal by Subject|0|||
130321001|NCT02234843|469144177|FG008|Overall Study|Withdrawal by Subject|0|||
130321002|NCT02234843|469144178|FG009|Overall Study|Withdrawal by Subject|0|||
130321003|NCT02234843|469144169|FG000|Overall Study|Recovery|1|||
130321004|NCT02234843|469144170|FG001|Overall Study|Recovery|0|||
130321005|NCT02234843|469144171|FG002|Overall Study|Recovery|0|||
130321006|NCT02234843|469144172|FG003|Overall Study|Recovery|0|||
130321007|NCT02234843|469144173|FG004|Overall Study|Recovery|0|||
130321008|NCT02234843|469144174|FG005|Overall Study|Recovery|0|||
130321009|NCT02234843|469144175|FG006|Overall Study|Recovery|0|||
130321010|NCT02234843|469144176|FG007|Overall Study|Recovery|0|||
130321011|NCT02234843|469144177|FG008|Overall Study|Recovery|0|||
130321012|NCT02234843|469144178|FG009|Overall Study|Recovery|0|||
130321013|NCT02234843|469144169|FG000|Overall Study|Other|0|||
130321014|NCT02234843|469144170|FG001|Overall Study|Other|2|||
130321015|NCT02234843|469144171|FG002|Overall Study|Other|0|||
130321016|NCT02234843|469144172|FG003|Overall Study|Other|1|||
130321017|NCT02234843|469144173|FG004|Overall Study|Other|0|||
130321018|NCT02234843|469144174|FG005|Overall Study|Other|1|||
130321019|NCT02234843|469144175|FG006|Overall Study|Other|0|||
130321020|NCT02234843|469144176|FG007|Overall Study|Other|1|||
130321021|NCT02234843|469144177|FG008|Overall Study|Other|0|||
130321022|NCT02234843|469144178|FG009|Overall Study|Other|0|||
130321023|NCT02234843|469144169|FG000|Overall Study|Physician Decision|4|||
130321024|NCT02234843|469144170|FG001|Overall Study|Physician Decision|1|||
130321025|NCT02234843|469144171|FG002|Overall Study|Physician Decision|0|||
130321026|NCT02234843|469144172|FG003|Overall Study|Physician Decision|1|||
130321027|NCT02234843|469144173|FG004|Overall Study|Physician Decision|0|||
130321028|NCT02234843|469144174|FG005|Overall Study|Physician Decision|0|||
130321029|NCT02234843|469144175|FG006|Overall Study|Physician Decision|0|||
130321030|NCT02234843|469144176|FG007|Overall Study|Physician Decision|1|||
130321031|NCT02234843|469144177|FG008|Overall Study|Physician Decision|0|||
130321032|NCT02234843|469144178|FG009|Overall Study|Physician Decision|0|||
130321033|NCT02234843|469144169|FG000|Overall Study|Adverse Event|5|||
130321034|NCT02234843|469144170|FG001|Overall Study|Adverse Event|1|||
130321035|NCT02234843|469144171|FG002|Overall Study|Adverse Event|1|||
130321036|NCT02234843|469144172|FG003|Overall Study|Adverse Event|3|||
130321037|NCT02234843|469144173|FG004|Overall Study|Adverse Event|2|||
130321038|NCT02234843|469144174|FG005|Overall Study|Adverse Event|1|||
130321039|NCT02234843|469144175|FG006|Overall Study|Adverse Event|0|||
130321040|NCT02234843|469144176|FG007|Overall Study|Adverse Event|0|||
130321041|NCT02234843|469144177|FG008|Overall Study|Adverse Event|1|||
130321042|NCT02234843|469144178|FG009|Overall Study|Adverse Event|0|||
130321043|NCT02234843|469144169|FG000|Overall Study|Non-compliance with study drug|1|||
130321044|NCT02234843|469144170|FG001|Overall Study|Non-compliance with study drug|0|||
130321045|NCT02234843|469144171|FG002|Overall Study|Non-compliance with study drug|0|||
130321046|NCT02234843|469144172|FG003|Overall Study|Non-compliance with study drug|0|||
130321047|NCT02234843|469144173|FG004|Overall Study|Non-compliance with study drug|0|||
130321048|NCT02234843|469144174|FG005|Overall Study|Non-compliance with study drug|1|||
130321049|NCT02234843|469144175|FG006|Overall Study|Non-compliance with study drug|1|||
130321050|NCT02234843|469144176|FG007|Overall Study|Non-compliance with study drug|0|||
130321051|NCT02234843|469144177|FG008|Overall Study|Non-compliance with study drug|0|||
130321052|NCT02234843|469144178|FG009|Overall Study|Non-compliance with study drug|0|||
130321053|NCT02234843|469144169|FG000|Overall Study|Lost to Follow-up|0|||
130321054|NCT02234843|469144170|FG001|Overall Study|Lost to Follow-up|1|||
130321055|NCT02234843|469144171|FG002|Overall Study|Lost to Follow-up|0|||
130321056|NCT02234843|469144172|FG003|Overall Study|Lost to Follow-up|0|||
130321057|NCT02234843|469144173|FG004|Overall Study|Lost to Follow-up|0|||
130321058|NCT02234843|469144174|FG005|Overall Study|Lost to Follow-up|0|||
130321059|NCT02234843|469144175|FG006|Overall Study|Lost to Follow-up|1|||
130321060|NCT02234843|469144176|FG007|Overall Study|Lost to Follow-up|0|||
130321061|NCT02234843|469144177|FG008|Overall Study|Lost to Follow-up|0|||
130321062|NCT02234843|469144178|FG009|Overall Study|Lost to Follow-up|0|||
130321063|NCT01607957|469144181|FG000|Overall Study|Not treated|1|||
130321064|NCT01607957|469144182|FG001|Overall Study|Not treated|1|||
130321065|NCT01607957|469144181|FG000|Overall Study|Death|367|||
130321066|NCT01607957|469144182|FG001|Overall Study|Death|211|||
130321067|NCT01607957|469144181|FG000|Overall Study|Lost to Follow-up|3|||
130321068|NCT01607957|469144182|FG001|Overall Study|Lost to Follow-up|3|||
130321069|NCT01607957|469144181|FG000|Overall Study|Participant refusal|1|||
130321070|NCT01607957|469144182|FG001|Overall Study|Participant refusal|0|||
130321071|NCT00945009|469144185|FG000|Overall Study|Lack of Efficacy|10|||
130321072|NCT00945009|469144186|FG001|Overall Study|Lack of Efficacy|0|||
130321073|NCT00945009|469144187|FG002|Overall Study|Lack of Efficacy|0|||
130321074|NCT00945009|469144185|FG000|Overall Study|Physician Decision|21|||
130321075|NCT00945009|469144186|FG001|Overall Study|Physician Decision|4|||
130321076|NCT00945009|469144187|FG002|Overall Study|Physician Decision|3|||
130321077|NCT00945009|469144185|FG000|Overall Study|Protocol Violation|6|||
130321078|NCT00945009|469144186|FG001|Overall Study|Protocol Violation|1|||
130321079|NCT00945009|469144187|FG002|Overall Study|Protocol Violation|0|||
130321080|NCT00945009|469144185|FG000|Overall Study|Withdrawal by Subject|1|||
130321081|NCT00945009|469144186|FG001|Overall Study|Withdrawal by Subject|0|||
130321082|NCT00945009|469144187|FG002|Overall Study|Withdrawal by Subject|0|||
130321083|NCT00945009|469144185|FG000|Overall Study|Ineligible|6|||
130321084|NCT00945009|469144186|FG001|Overall Study|Ineligible|1|||
130321085|NCT00945009|469144187|FG002|Overall Study|Ineligible|0|||
130321086|NCT00945009|469144185|FG000|Overall Study|Inevaluable|0|||
130321087|NCT00945009|469144186|FG001|Overall Study|Inevaluable|1|||
130321088|NCT00945009|469144187|FG002|Overall Study|Inevaluable|0|||
130321089|NCT00945009|469144185|FG000|Overall Study|Refusal of further protocol|1|||
130321090|NCT00945009|469144186|FG001|Overall Study|Refusal of further protocol|0|||
130321091|NCT00945009|469144187|FG002|Overall Study|Refusal of further protocol|0|||
130321092|NCT03919773|469144188|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
130321093|NCT03919773|469144189|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
130321094|NCT03919773|469144188|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
130321095|NCT03919773|469144189|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
130321096|NCT04659044|469144190|FG000|Induction|Physician Decision|1|||
130321097|NCT04659044|469144190|FG000|Induction|Adverse Event|2|||
130321098|NCT04966013|469144191|FG000|Overall Study|Withdrawal by Subject|0|||
130321099|NCT04966013|469144192|FG001|Overall Study|Withdrawal by Subject|2|||
130321100|NCT04966013|469144193|FG002|Overall Study|Withdrawal by Subject|1|||
130321101|NCT04966013|469144191|FG000|Overall Study|Adverse Event|2|||
130321102|NCT04966013|469144192|FG001|Overall Study|Adverse Event|1|||
130321103|NCT04966013|469144193|FG002|Overall Study|Adverse Event|1|||
130321104|NCT03518086|469144194|FG000|Overall Study|Adverse Event|23|||
130321105|NCT03518086|469144195|FG001|Overall Study|Adverse Event|15|||
130321106|NCT03518086|469144196|FG002|Overall Study|Adverse Event|3|||
130321107|NCT03518086|469144197|FG003|Overall Study|Adverse Event|2|||
130321108|NCT03518086|469144194|FG000|Overall Study|Withdrawal by Subject|8|||
130545132|NCT02414932|469963027|FG000|Overall Study|Withdrawal by Subject|2|||
130321109|NCT03518086|469144195|FG001|Overall Study|Withdrawal by Subject|5|||
130321110|NCT03518086|469144196|FG002|Overall Study|Withdrawal by Subject|1|||
130321111|NCT03518086|469144197|FG003|Overall Study|Withdrawal by Subject|0|||
130321112|NCT03518086|469144194|FG000|Overall Study|Lack of Efficacy|5|||
130545133|NCT02414932|469963028|FG001|Overall Study|Withdrawal by Subject|3|||
130545134|NCT02414932|469963027|FG000|Overall Study|Adverse Event|1|||
130321113|NCT03518086|469144195|FG001|Overall Study|Lack of Efficacy|5|||
130321114|NCT03518086|469144196|FG002|Overall Study|Lack of Efficacy|0|||
130321115|NCT03518086|469144197|FG003|Overall Study|Lack of Efficacy|2|||
130321116|NCT03518086|469144194|FG000|Overall Study|Protocol Violation|1|||
130321117|NCT03518086|469144195|FG001|Overall Study|Protocol Violation|5|||
130545135|NCT02414932|469963028|FG001|Overall Study|Adverse Event|0|||
130321118|NCT03518086|469144196|FG002|Overall Study|Protocol Violation|1|||
130321119|NCT03518086|469144197|FG003|Overall Study|Protocol Violation|3|||
130321120|NCT03518086|469144194|FG000|Overall Study|Lost to Follow-up|0|||
130321121|NCT03518086|469144195|FG001|Overall Study|Lost to Follow-up|3|||
130321122|NCT03518086|469144196|FG002|Overall Study|Lost to Follow-up|0|||
130321123|NCT03518086|469144197|FG003|Overall Study|Lost to Follow-up|0|||
130321124|NCT03518086|469144194|FG000|Overall Study|Insufficient Diary Data|0|||
130321125|NCT03518086|469144195|FG001|Overall Study|Insufficient Diary Data|2|||
130321126|NCT03518086|469144196|FG002|Overall Study|Insufficient Diary Data|0|||
130321127|NCT03518086|469144197|FG003|Overall Study|Insufficient Diary Data|0|||
130321128|NCT03518086|469144194|FG000|Overall Study|Non- compliance to Protocol|0|||
130321129|NCT03518086|469144195|FG001|Overall Study|Non- compliance to Protocol|1|||
130321130|NCT03518086|469144196|FG002|Overall Study|Non- compliance to Protocol|0|||
130321131|NCT03518086|469144197|FG003|Overall Study|Non- compliance to Protocol|0|||
130321132|NCT03518086|469144194|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
130321133|NCT03518086|469144195|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
130321134|NCT03518086|469144196|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
130321135|NCT03518086|469144197|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
130321136|NCT03518086|469144194|FG000|Overall Study|Site Terminated by Sponsor|0|||
130321137|NCT03518086|469144195|FG001|Overall Study|Site Terminated by Sponsor|1|||
130321138|NCT03518086|469144196|FG002|Overall Study|Site Terminated by Sponsor|0|||
130321139|NCT03518086|469144197|FG003|Overall Study|Site Terminated by Sponsor|0|||
130321140|NCT03518086|469144194|FG000|Overall Study|Pregnancy|0|||
130321141|NCT03518086|469144195|FG001|Overall Study|Pregnancy|0|||
130321142|NCT03518086|469144196|FG002|Overall Study|Pregnancy|0|||
130321143|NCT03518086|469144197|FG003|Overall Study|Pregnancy|2|||
130321144|NCT05967260|469144198|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
130321145|NCT05967260|469144199|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
130321146|NCT02994108|469145669|FG000|Intervention Messages|Withdrawal by Subject|2|||
130321147|NCT02994108|469145670|FG001|Intervention Messages|Withdrawal by Subject|0|||
130321148|NCT02994108|469145669|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
130321149|NCT02994108|469145670|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
130321150|NCT02994108|469145669|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
130321151|NCT02994108|469145670|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
130321152|NCT02994108|469145669|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
130321153|NCT02994108|469145670|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
130321154|NCT02081677|469145671|FG000|Overall Study|Adverse Event|0|||
130321155|NCT02081677|469145672|FG001|Overall Study|Adverse Event|0|||
130321156|NCT02081677|469145673|FG002|Overall Study|Adverse Event|1|||
130321157|NCT02081677|469145674|FG003|Overall Study|Adverse Event|0|||
130321158|NCT02081677|469145671|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321159|NCT02081677|469145672|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321160|NCT02081677|469145673|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130321161|NCT02081677|469145674|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321162|NCT02081677|469145671|FG000|Overall Study|Not comfortable with lens care system|1|||
130321163|NCT02081677|469145672|FG001|Overall Study|Not comfortable with lens care system|0|||
130321164|NCT02081677|469145673|FG002|Overall Study|Not comfortable with lens care system|0|||
130321165|NCT02081677|469145674|FG003|Overall Study|Not comfortable with lens care system|0|||
130321166|NCT02081677|469145671|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130321167|NCT02081677|469145672|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130321168|NCT02081677|469145673|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
130321169|NCT02081677|469145674|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
130321170|NCT01097668|469145675|FG000|Overall Study|Withdrawal by Subject|1|||
130321171|NCT01097668|469145676|FG001|Overall Study|Withdrawal by Subject|2|||
130321172|NCT01097668|469145675|FG000|Overall Study|Lost to Follow-up|1|||
130321173|NCT01097668|469145676|FG001|Overall Study|Lost to Follow-up|0|||
130321174|NCT04607668|469145681|FG000|Overall Study|Death|49|||
130321175|NCT04607668|469145682|FG001|Overall Study|Death|26|||
130321176|NCT04607668|469145681|FG000|Overall Study|Lost to Follow-up|3|||
130321177|NCT04607668|469145682|FG001|Overall Study|Lost to Follow-up|4|||
130321178|NCT04607668|469145681|FG000|Overall Study|Study terminated by Sponsor|92|||
130321179|NCT04607668|469145682|FG001|Overall Study|Study terminated by Sponsor|114|||
130321180|NCT04607668|469145681|FG000|Overall Study|Withdrawal by Subject|12|||
130321181|NCT04607668|469145682|FG001|Overall Study|Withdrawal by Subject|11|||
130321182|NCT04607668|469145681|FG000|Overall Study|Other, unspecified|8|||
130545136|NCT01210664|469963030|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
130545137|NCT01210664|469963031|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
130321183|NCT04607668|469145682|FG001|Overall Study|Other, unspecified|7|||
130321184|NCT00474487|469145683|FG000|Overall Study|Withdrawal by Subject|6|||
130321185|NCT00474487|469145684|FG001|Overall Study|Withdrawal by Subject|0|||
130321186|NCT00474487|469145685|FG002|Overall Study|Withdrawal by Subject|0|||
130321187|NCT00474487|469145686|FG003|Overall Study|Withdrawal by Subject|0|||
130321188|NCT00474487|469145683|FG000|Overall Study|Lost to Follow-up|20|||
130321189|NCT00474487|469145684|FG001|Overall Study|Lost to Follow-up|1|||
130321190|NCT00474487|469145685|FG002|Overall Study|Lost to Follow-up|7|||
130545138|NCT01210664|469963032|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
130321191|NCT00474487|469145686|FG003|Overall Study|Lost to Follow-up|0|||
130321192|NCT00474487|469145683|FG000|Overall Study|Inappropriate enrollment|4|||
130321193|NCT00474487|469145684|FG001|Overall Study|Inappropriate enrollment|0|||
130321194|NCT00474487|469145685|FG002|Overall Study|Inappropriate enrollment|7|||
130321195|NCT00474487|469145686|FG003|Overall Study|Inappropriate enrollment|0|||
130321196|NCT00474487|469145683|FG000|Overall Study|Death|0|||
130321197|NCT00474487|469145684|FG001|Overall Study|Death|1|||
130321198|NCT00474487|469145685|FG002|Overall Study|Death|0|||
130321199|NCT00474487|469145686|FG003|Overall Study|Death|0|||
130321200|NCT01428258|469145687|FG000|Intervention 1|Withdrawal by Subject|2|||
130321201|NCT01428258|469145688|FG001|Intervention 1|Withdrawal by Subject|0|||
130321202|NCT02766023|469145689|FG000|Overall Study|Lost to Follow-up|23|||
130321203|NCT02766023|469145690|FG001|Overall Study|Lost to Follow-up|11|||
130321204|NCT02766023|469145689|FG000|Overall Study|Pregnancy|1|||
130321205|NCT02766023|469145690|FG001|Overall Study|Pregnancy|0|||
130321206|NCT02766023|469145689|FG000|Overall Study|Adverse Event|1|||
130321207|NCT02766023|469145690|FG001|Overall Study|Adverse Event|0|||
130321208|NCT02766023|469145689|FG000|Overall Study|Withdrawal by Subject|4|||
130321209|NCT02766023|469145690|FG001|Overall Study|Withdrawal by Subject|5|||
130321210|NCT02766023|469145689|FG000|Overall Study|Physician Decision|1|||
130321211|NCT02766023|469145690|FG001|Overall Study|Physician Decision|0|||
130321212|NCT02766023|469145689|FG000|Overall Study|Not Eligible at Enrollment|0|||
130321213|NCT02766023|469145690|FG001|Overall Study|Not Eligible at Enrollment|1|||
130321214|NCT01488045|469145691|FG000|Overall Study|Withdrawal by Subject|6|||
130321215|NCT01488045|469145692|FG001|Overall Study|Withdrawal by Subject|11|||
130321216|NCT01488045|469145691|FG000|Overall Study|Failure to present for colonoscopy|3|||
130321217|NCT01488045|469145692|FG001|Overall Study|Failure to present for colonoscopy|6|||
130321218|NCT01488045|469145691|FG000|Overall Study|Failure to report exclusion criteria|0|||
130321219|NCT01488045|469145692|FG001|Overall Study|Failure to report exclusion criteria|1|||
130321220|NCT05365217|469145694|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130321221|NCT05365217|469145695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130321222|NCT00656513|469145699|FG000|Overall Study|Protocol Violation|1|||
130321223|NCT00656513|469145700|FG001|Overall Study|Protocol Violation|0|||
130321224|NCT00656513|469145701|FG002|Overall Study|Protocol Violation|2|||
130321225|NCT00656513|469145699|FG000|Overall Study|Withdrawal by Subject|0|||
130321226|NCT00656513|469145700|FG001|Overall Study|Withdrawal by Subject|11|||
130321227|NCT00656513|469145701|FG002|Overall Study|Withdrawal by Subject|4|||
130321228|NCT00656513|469145699|FG000|Overall Study|Death|0|||
130321229|NCT00656513|469145700|FG001|Overall Study|Death|0|||
130321230|NCT00656513|469145701|FG002|Overall Study|Death|1|||
130321231|NCT00656513|469145699|FG000|Overall Study|Missing data|0|||
130321232|NCT00656513|469145700|FG001|Overall Study|Missing data|11|||
130321233|NCT00656513|469145701|FG002|Overall Study|Missing data|9|||
130321234|NCT00656513|469145699|FG000|Overall Study|Incomplete treatment|3|||
130321235|NCT00656513|469145700|FG001|Overall Study|Incomplete treatment|0|||
130321236|NCT00656513|469145701|FG002|Overall Study|Incomplete treatment|0|||
130321237|NCT00656513|469145699|FG000|Overall Study|Treatment completed outside of timeframe|0|||
130321238|NCT00656513|469145700|FG001|Overall Study|Treatment completed outside of timeframe|3|||
130321239|NCT00656513|469145701|FG002|Overall Study|Treatment completed outside of timeframe|1|||
130321240|NCT00656513|469145699|FG000|Overall Study|Missing baseline form|0|||
130321241|NCT00656513|469145700|FG001|Overall Study|Missing baseline form|5|||
130321242|NCT00656513|469145701|FG002|Overall Study|Missing baseline form|5|||
130321243|NCT03405792|469145702|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
130321244|NCT03405792|469145703|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
130321245|NCT03405792|469145702|FG000|Overall Study|o Did not receive pembrolizumab|1|||
130321246|NCT03405792|469145703|FG001|Overall Study|o Did not receive pembrolizumab|0|||
130321247|NCT03962491|469145704|FG000|Overall Study|Lost to Follow-up|4|||
130321248|NCT03962491|469145705|FG001|Overall Study|Lost to Follow-up|5|||
130321249|NCT03882021|469145708|FG000|Enrollment|Procedure aborted/cancelled|2|||
130321250|NCT03882021|469145708|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
130321251|NCT03882021|469145708|FG000|Enrollment to 3-Month|Death|1|||
130321252|NCT03882021|469145708|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
130321253|NCT03882021|469145708|FG000|Enrollment to 3-Month|Missed Visit|4|||
130321254|NCT03882021|469145708|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
130321255|NCT03882021|469145708|FG000|6-Month to 12-Month Visit|Death|1|||
130559406|NCT01621542|470016490|FG000|Overall Study|Physician Decision|1|||
130321256|NCT03882021|469145708|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
130321257|NCT03796728|469145712|FG000|Overall Study|Lost to Follow-up|8|||
130321258|NCT03796728|469145712|FG000|Overall Study|Reason not Specified|16|||
130321259|NCT00333775|469145713|FG000|Overall Study|Death|144|||
130321260|NCT00333775|469145714|FG001|Overall Study|Death|149|||
130321261|NCT00333775|469145715|FG002|Overall Study|Death|143|||
130321262|NCT00333775|469145713|FG000|Overall Study|In Follow-up When Study Stopped|87|||
130321263|NCT00333775|469145714|FG001|Overall Study|In Follow-up When Study Stopped|92|||
130321264|NCT00333775|469145715|FG002|Overall Study|In Follow-up When Study Stopped|96|||
130321265|NCT00333775|469145713|FG000|Overall Study|Lost to Follow-up|10|||
130321266|NCT00333775|469145714|FG001|Overall Study|Lost to Follow-up|7|||
130321267|NCT00333775|469145715|FG002|Overall Study|Lost to Follow-up|8|||
130321268|NCT02476617|469145719|FG000|Overall Study|Adverse Event|1|||
130321269|NCT02476617|469145719|FG000|Overall Study|Lost to Follow-up|1|||
130321270|NCT03486912|469145720|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321271|NCT03486912|469145721|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
130321272|NCT03486912|469145722|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321273|NCT03486912|469145723|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321274|NCT03486912|469145720|FG000|Treatment Period|Withdrawal by Subject|3|||
130321275|NCT03486912|469145721|FG001|Treatment Period|Withdrawal by Subject|3|||
130321276|NCT03486912|469145722|FG002|Treatment Period|Withdrawal by Subject|3|||
130321277|NCT03486912|469145723|FG003|Treatment Period|Withdrawal by Subject|2|||
130321278|NCT03486912|469145720|FG000|Treatment Period|Other Reasons|0|||
130321279|NCT03486912|469145721|FG001|Treatment Period|Other Reasons|2|||
130321280|NCT03486912|469145722|FG002|Treatment Period|Other Reasons|1|||
130321281|NCT03486912|469145723|FG003|Treatment Period|Other Reasons|1|||
130321282|NCT03486912|469145720|FG000|Treatment Period|Adverse Event|0|||
130321283|NCT03486912|469145721|FG001|Treatment Period|Adverse Event|1|||
130321284|NCT03486912|469145722|FG002|Treatment Period|Adverse Event|1|||
130321285|NCT03486912|469145723|FG003|Treatment Period|Adverse Event|0|||
130321286|NCT03486912|469145720|FG000|Treatment Period|Lost to Follow-up|1|||
130321287|NCT03486912|469145721|FG001|Treatment Period|Lost to Follow-up|0|||
130321288|NCT03486912|469145722|FG002|Treatment Period|Lost to Follow-up|0|||
130321289|NCT03486912|469145723|FG003|Treatment Period|Lost to Follow-up|2|||
130321290|NCT02491684|469145724|FG000|Treatment Phase|Adverse Event|2|||
130321291|NCT02491684|469145725|FG001|Treatment Phase|Adverse Event|2|||
130321292|NCT02491684|469145724|FG000|Treatment Phase|Incorrect randomisation|1|||
130321293|NCT02491684|469145725|FG001|Treatment Phase|Incorrect randomisation|0|||
130321294|NCT02491684|469145724|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
130321295|NCT02491684|469145725|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
130321296|NCT01263769|469145728|FG000|Overall Study|Non-Compliant with treatment|1|||
130321297|NCT04842747|469145733|FG000|Overall Study|Withdrawal by Subject|6|||
130321298|NCT04842747|469145734|FG001|Overall Study|Withdrawal by Subject|2|||
130321299|NCT04842747|469145733|FG000|Overall Study|Lost to Follow-up|1|||
130321300|NCT04842747|469145734|FG001|Overall Study|Lost to Follow-up|2|||
130321301|NCT04842747|469145733|FG000|Overall Study|Physician Decision|1|||
130321302|NCT04842747|469145734|FG001|Overall Study|Physician Decision|0|||
130321303|NCT04842747|469145733|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
130321304|NCT04842747|469145734|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
130321305|NCT02559622|469145735|FG000|Overall Study|Progressive disease|0|||
130321306|NCT02559622|469145736|FG001|Overall Study|Progressive disease|1|||
130321307|NCT02559622|469145737|FG002|Overall Study|Progressive disease|0|||
130321308|NCT02559622|469145738|FG003|Overall Study|Progressive disease|0|||
130321309|NCT02559622|469145735|FG000|Overall Study|Adverse Event|0|||
130321310|NCT02559622|469145736|FG001|Overall Study|Adverse Event|2|||
130321311|NCT02559622|469145737|FG002|Overall Study|Adverse Event|2|||
130321312|NCT02559622|469145738|FG003|Overall Study|Adverse Event|2|||
130321313|NCT02559622|469145735|FG000|Overall Study|Patient/guardian decision|1|||
130321314|NCT02559622|469145736|FG001|Overall Study|Patient/guardian decision|2|||
130321315|NCT02559622|469145737|FG002|Overall Study|Patient/guardian decision|0|||
130321316|NCT02559622|469145738|FG003|Overall Study|Patient/guardian decision|1|||
130321317|NCT04011540|469145744|FG000|Overall Study|Lost to Follow-up|9|||
130321318|NCT04011540|469145745|FG001|Overall Study|Lost to Follow-up|6|||
130321319|NCT03019406|469145746|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
130321320|NCT03019406|469145747|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
130321321|NCT03019406|469145748|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
130321322|NCT03019406|469145749|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
130321323|NCT01339832|469145752|FG000|Overall Study|Lost to Follow-up|3|||
130321324|NCT01339832|469145752|FG000|Overall Study|Death|11|||
130321325|NCT00468169|469145753|FG000|Overall Study|Withdrawal by Subject|1|||
130321326|NCT00468169|469145754|FG001|Overall Study|Withdrawal by Subject|0|||
130321327|NCT00231816|469145755|FG000|Overall Study|Adverse Event|1|||
130321328|NCT00231816|469145756|FG001|Overall Study|Adverse Event|0|||
130321329|NCT00231816|469145755|FG000|Overall Study|Lost to Follow-up|8|||
130545139|NCT01210664|469963033|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
130545140|NCT01210664|469963030|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
130545141|NCT01210664|469963031|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
130321330|NCT00231816|469145756|FG001|Overall Study|Lost to Follow-up|5|||
130321331|NCT00231816|469145755|FG000|Overall Study|Protocol Violation|2|||
130321332|NCT00231816|469145756|FG001|Overall Study|Protocol Violation|3|||
130321333|NCT00231816|469145755|FG000|Overall Study|Withdrawal by Subject|3|||
130321334|NCT00231816|469145756|FG001|Overall Study|Withdrawal by Subject|3|||
130321335|NCT00231816|469145755|FG000|Overall Study|Other|2|||
130321336|NCT00231816|469145756|FG001|Overall Study|Other|1|||
130321337|NCT01126749|469145761|FG000|Phase 1b|Other|0|||
130321338|NCT01126749|469145762|FG001|Phase 1b|Other|1|||
130321339|NCT01126749|469145763|FG002|Phase 1b|Other|0|||
130321340|NCT01126749|469145764|FG003|Phase 1b|Other|0|||
130321341|NCT01126749|469145761|FG000|Phase 1b|Withdrawal by Subject|0|||
130321342|NCT01126749|469145762|FG001|Phase 1b|Withdrawal by Subject|1|||
130321343|NCT01126749|469145763|FG002|Phase 1b|Withdrawal by Subject|0|||
130321344|NCT01126749|469145764|FG003|Phase 1b|Withdrawal by Subject|0|||
130321345|NCT01126749|469145761|FG000|Phase 1b|Death|3|||
130321346|NCT01126749|469145762|FG001|Phase 1b|Death|4|||
130321347|NCT01126749|469145763|FG002|Phase 1b|Death|0|||
130321348|NCT01126749|469145764|FG003|Phase 1b|Death|0|||
130321349|NCT01126749|469145761|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130321350|NCT01126749|469145762|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130321351|NCT01126749|469145763|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
130321352|NCT01126749|469145764|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
130321353|NCT01126749|469145761|FG000|Phase 2|Study Termination by Sponsor|0|||
130321354|NCT01126749|469145762|FG001|Phase 2|Study Termination by Sponsor|0|||
130321355|NCT01126749|469145763|FG002|Phase 2|Study Termination by Sponsor|12|||
130321356|NCT01126749|469145764|FG003|Phase 2|Study Termination by Sponsor|6|||
130321357|NCT01126749|469145761|FG000|Phase 2|Other|0|||
130321358|NCT01126749|469145762|FG001|Phase 2|Other|0|||
130321359|NCT01126749|469145763|FG002|Phase 2|Other|4|||
130321360|NCT01126749|469145764|FG003|Phase 2|Other|2|||
130321361|NCT01126749|469145761|FG000|Phase 2|Withdrawal by Subject|0|||
130321362|NCT01126749|469145762|FG001|Phase 2|Withdrawal by Subject|0|||
130321363|NCT01126749|469145763|FG002|Phase 2|Withdrawal by Subject|0|||
130321364|NCT01126749|469145764|FG003|Phase 2|Withdrawal by Subject|2|||
130321365|NCT01126749|469145761|FG000|Phase 2|Lost to Follow-up|0|||
130321366|NCT01126749|469145762|FG001|Phase 2|Lost to Follow-up|0|||
130321367|NCT01126749|469145763|FG002|Phase 2|Lost to Follow-up|0|||
130321368|NCT01126749|469145764|FG003|Phase 2|Lost to Follow-up|1|||
130321369|NCT01126749|469145761|FG000|Phase 2|Death|0|||
130321370|NCT01126749|469145762|FG001|Phase 2|Death|0|||
130321371|NCT01126749|469145763|FG002|Phase 2|Death|22|||
130321372|NCT01126749|469145764|FG003|Phase 2|Death|22|||
130321373|NCT01126749|469145761|FG000|Phase 2|Adverse Event|0|||
130321374|NCT01126749|469145762|FG001|Phase 2|Adverse Event|0|||
130321375|NCT01126749|469145763|FG002|Phase 2|Adverse Event|0|||
130321376|NCT01126749|469145764|FG003|Phase 2|Adverse Event|1|||
130321377|NCT02183675|469145766|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321378|NCT02183675|469145767|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321379|NCT02183675|469145768|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321380|NCT02183675|469145769|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321381|NCT02183675|469145770|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321382|NCT02183675|469145771|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
130321383|NCT01614249|469145776|FG000|Overall Study|Lost to Follow-up|11|||
130321384|NCT01614249|469145777|FG001|Overall Study|Lost to Follow-up|23|||
130321385|NCT05498649|469145778|FG000|Overall Study|Lost to Follow-up|1|||
130321386|NCT02946580|469145782|FG000|Overall Study|Withdrawal by Subject|1|||
130321387|NCT02946580|469145783|FG001|Overall Study|Withdrawal by Subject|2|||
130321388|NCT02946580|469145782|FG000|Overall Study|Adverse Event|0|||
130321389|NCT02946580|469145783|FG001|Overall Study|Adverse Event|2|||
130321390|NCT02946580|469145782|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
130321391|NCT02946580|469145783|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
130321392|NCT02761330|469145784|FG000|Treatment Week 1|Withdrawal by Subject|0|||
130321393|NCT02761330|469145785|FG001|Treatment Week 1|Withdrawal by Subject|0|||
130321394|NCT02761330|469145786|FG002|Treatment Week 1|Withdrawal by Subject|0|||
130321395|NCT02761330|469145787|FG003|Treatment Week 1|Withdrawal by Subject|1|||
130321396|NCT02761330|469145788|FG004|Treatment Week 1|Withdrawal by Subject|0|||
130321397|NCT02761330|469145789|FG005|Treatment Week 1|Withdrawal by Subject|1|||
130321398|NCT03043313|469145792|FG000|Overall Study|Withdrawal by Subject|5|||
130321399|NCT03043313|469145793|FG001|Overall Study|Withdrawal by Subject|1|||
130321400|NCT03043313|469145794|FG002|Overall Study|Withdrawal by Subject|1|||
130321401|NCT03043313|469145792|FG000|Overall Study|Lost to Follow-up|1|||
130321402|NCT03043313|469145793|FG001|Overall Study|Lost to Follow-up|1|||
130321403|NCT03043313|469145794|FG002|Overall Study|Lost to Follow-up|0|||
130321404|NCT03043313|469145792|FG000|Overall Study|Death|28|||
130321405|NCT03043313|469145793|FG001|Overall Study|Death|26|||
130321406|NCT03043313|469145794|FG002|Overall Study|Death|17|||
130321407|NCT03043313|469145792|FG000|Overall Study|Participation terminated by sponsor|11|||
130321408|NCT03043313|469145793|FG001|Overall Study|Participation terminated by sponsor|13|||
130321409|NCT03043313|469145794|FG002|Overall Study|Participation terminated by sponsor|13|||
130321412|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130321413|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130321414|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130321415|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130321416|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
130321417|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321418|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321419|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321420|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321421|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
130321422|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321423|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321424|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321425|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
130321426|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321427|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321428|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130321429|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130321430|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
130321431|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
130321432|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130321433|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130321434|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
130321435|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
130321436|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130321437|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130321438|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
130321439|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
130321440|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130321441|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130321442|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
130321443|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
130545142|NCT01210664|469963032|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
130545143|NCT01210664|469963033|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
130545144|NCT01210664|469963030|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
130545145|NCT01210664|469963031|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
130545146|NCT01210664|469963032|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
130545147|NCT01210664|469963033|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
130545148|NCT01853644|469963034|FG000|Registration and Treatment Start|Did not start treatment|1|||
130545149|NCT01853644|469963034|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
130545150|NCT01853644|469963034|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
130545151|NCT01853644|469963034|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
130545152|NCT01853644|469963034|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
130545153|NCT01853644|469963034|FG000|Continued Treatment After First Response|Adverse Event|2|||
130559407|NCT01621542|470016491|FG001|Overall Study|Physician Decision|0|||
130321444|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130321445|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130321446|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
130321447|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
130321448|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321449|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321450|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321451|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
130321452|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130321453|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130321454|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
130321455|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
130321456|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321457|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321458|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321459|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
130321460|NCT01576341|469145801|FG000|Overall Study|Withdrawal by Subject|24|||
130321461|NCT01576341|469145801|FG000|Overall Study|Adverse Event|10|||
130321462|NCT01576341|469145801|FG000|Overall Study|Death|21|||
130321463|NCT01576341|469145801|FG000|Overall Study|Physician Decision|2|||
130321464|NCT01576341|469145801|FG000|Overall Study|Lost to Follow-up|2|||
130321465|NCT01576341|469145801|FG000|Overall Study|Kidney transplantation|10|||
130321466|NCT01576341|469145801|FG000|Overall Study|Protocol Violation|12|||
130321467|NCT01576341|469145801|FG000|Overall Study|Other|12|||
130321468|NCT03341299|469145802|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321469|NCT03341299|469145803|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321470|NCT03341299|469145804|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
130321471|NCT03341299|469145805|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321472|NCT00791934|469145807|FG000|Overall Study|Withdrawal by Subject|2|||
130321473|NCT00791934|469145807|FG000|Overall Study|Did not consent for extended follow-up|13|||
130321474|NCT02018562|469145809|FG000|Overall Study|Withdrawal by Subject|2|||
130321475|NCT02018562|469145810|FG001|Overall Study|Withdrawal by Subject|0|||
130321476|NCT02018562|469145809|FG000|Overall Study|Discharged prior to study completion|1|||
130321477|NCT02018562|469145810|FG001|Overall Study|Discharged prior to study completion|0|||
130321478|NCT05194124|469145811|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321479|NCT05194124|469145812|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321480|NCT05194124|469145813|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321481|NCT05194124|469145814|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
130321482|NCT05194124|469145815|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321483|NCT05194124|469145816|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
130321484|NCT05194124|469145817|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321485|NCT05194124|469145818|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321486|NCT05194124|469145819|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321487|NCT05194124|469145820|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321488|NCT05194124|469145811|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321489|NCT05194124|469145812|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321490|NCT05194124|469145813|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321491|NCT05194124|469145814|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321492|NCT05194124|469145815|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321493|NCT05194124|469145816|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321494|NCT05194124|469145817|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321495|NCT05194124|469145818|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321496|NCT05194124|469145819|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321497|NCT05194124|469145820|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
130321498|NCT03642873|469145821|FG000|Third Intervention (1 Day)|Screen failure|0|||
130321499|NCT03642873|469145822|FG001|Third Intervention (1 Day)|Screen failure|0|||
130321500|NCT03642873|469145823|FG002|Third Intervention (1 Day)|Screen failure|0|||
130321501|NCT03642873|469145824|FG003|Third Intervention (1 Day)|Screen failure|0|||
130321502|NCT03642873|469145825|FG004|Third Intervention (1 Day)|Screen failure|1|||
130321503|NCT03642873|469145826|FG005|Third Intervention (1 Day)|Screen failure|0|||
130545154|NCT01853644|469963034|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
130545155|NCT02891408|469963035|FG000|Overall Study|Lost to Follow-up|0|||
130545156|NCT02891408|469963036|FG001|Overall Study|Lost to Follow-up|0|||
130545157|NCT02891408|469963037|FG002|Overall Study|Lost to Follow-up|1|||
130545158|NCT02891408|469963038|FG003|Overall Study|Lost to Follow-up|0|||
130545159|NCT02891408|469963039|FG004|Overall Study|Lost to Follow-up|0|||
130321504|NCT03589859|469145833|FG000|Overall Study|Withdrawal by Subject|0|||
130321505|NCT03589859|469145834|FG001|Overall Study|Withdrawal by Subject|6|||
130321506|NCT03253393|469145839|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
130321507|NCT03253393|469145840|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
130321508|NCT03253393|469145841|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
130321509|NCT00248625|469147507|FG000|Overall Study|Withdrawal by Subject|0|||
130321510|NCT00248625|469147508|FG001|Overall Study|Withdrawal by Subject|2|||
130321511|NCT02443688|469147511|FG000|Overall Study|Adverse Event|2|||
130321512|NCT02443688|469147512|FG001|Overall Study|Adverse Event|3|||
130321513|NCT02443688|469147513|FG002|Overall Study|Adverse Event|2|||
130321514|NCT02443688|469147511|FG000|Overall Study|Lost to Follow-up|1|||
130321515|NCT02443688|469147512|FG001|Overall Study|Lost to Follow-up|0|||
130321516|NCT02443688|469147513|FG002|Overall Study|Lost to Follow-up|0|||
130321517|NCT02443688|469147511|FG000|Overall Study|Physician Decision|3|||
130321518|NCT02443688|469147512|FG001|Overall Study|Physician Decision|0|||
130321519|NCT02443688|469147513|FG002|Overall Study|Physician Decision|1|||
130321520|NCT02443688|469147511|FG000|Overall Study|Pregnancy|0|||
130321521|NCT02443688|469147512|FG001|Overall Study|Pregnancy|0|||
130321522|NCT02443688|469147513|FG002|Overall Study|Pregnancy|1|||
130321523|NCT02443688|469147511|FG000|Overall Study|Withdrawal by Subject|3|||
130321524|NCT02443688|469147512|FG001|Overall Study|Withdrawal by Subject|3|||
130321525|NCT02443688|469147513|FG002|Overall Study|Withdrawal by Subject|4|||
130213806|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213807|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213808|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
130213809|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213810|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213811|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130213812|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130213813|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213814|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130213815|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130213816|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
130213817|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213818|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213819|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213820|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
130213821|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213822|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213823|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213824|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213825|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213826|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
130213827|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
130213828|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213829|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213830|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213831|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130321526|NCT02443688|469147511|FG000|Overall Study|Non-compliance with study drug|1|||
130321527|NCT02443688|469147512|FG001|Overall Study|Non-compliance with study drug|2|||
130321528|NCT02443688|469147513|FG002|Overall Study|Non-compliance with study drug|4|||
130433126|NCT01806584|469547857|FG001|Overall Study|Adverse Event|1|||
130433127|NCT01806584|469547856|FG000|Overall Study|Death|1|||
130433128|NCT01806584|469547857|FG001|Overall Study|Death|0|||
130433129|NCT01806584|469547856|FG000|Overall Study|Lost to Follow-up|0|||
130433130|NCT01806584|469547857|FG001|Overall Study|Lost to Follow-up|2|||
130433131|NCT01806584|469547856|FG000|Overall Study|Study terminated by sponsor|9|||
130433132|NCT01806584|469547857|FG001|Overall Study|Study terminated by sponsor|14|||
130433133|NCT01806584|469547856|FG000|Overall Study|Withdrawal by Subject|1|||
130433134|NCT01806584|469547857|FG001|Overall Study|Withdrawal by Subject|1|||
130433135|NCT01806584|469547856|FG000|Overall Study|Other unspecified|1|||
130433136|NCT01806584|469547857|FG001|Overall Study|Other unspecified|0|||
130433137|NCT04398537|469547864|FG000|Overall Study|Physician Decision|10|||
130433138|NCT04398537|469547865|FG001|Overall Study|Physician Decision|15|||
130433139|NCT04503096|469550348|FG000|Overall Study|Withdrawal by Subject|3|||
130433140|NCT01480596|469550349|FG000|Overall Study|Adverse Event|3|||
130433141|NCT01480596|469550350|FG001|Overall Study|Adverse Event|0|||
130433142|NCT01480596|469550349|FG000|Overall Study|MG exacerbation or change in medication|2|||
130433143|NCT01480596|469550350|FG001|Overall Study|MG exacerbation or change in medication|2|||
130433144|NCT02281760|469550351|FG000|Overall Study|Withdrawal by Subject|1|||
130433145|NCT01453348|469550352|FG000|Overall Study|Death|0|||
130321529|NCT02443688|469147511|FG000|Overall Study|Sponsor Request|2|||
130321530|NCT02443688|469147512|FG001|Overall Study|Sponsor Request|1|||
130321531|NCT02443688|469147513|FG002|Overall Study|Sponsor Request|0|||
130321532|NCT03182374|469147514|FG000|Overall Study|Lost to Follow-up|3|||
130321533|NCT03182374|469147515|FG001|Overall Study|Lost to Follow-up|2|||
130321534|NCT03182374|469147514|FG000|Overall Study|Lack of Efficacy|8|||
130321535|NCT03182374|469147515|FG001|Overall Study|Lack of Efficacy|14|||
130321536|NCT03182374|469147514|FG000|Overall Study|Withdrawal by Subject|1|||
130321537|NCT03182374|469147515|FG001|Overall Study|Withdrawal by Subject|1|||
130321538|NCT03182374|469147514|FG000|Overall Study|exit for non-compliance|1|||
130321539|NCT03182374|469147515|FG001|Overall Study|exit for non-compliance|1|||
130545160|NCT02891408|469963040|FG005|Overall Study|Lost to Follow-up|0|||
130545161|NCT02891408|469963041|FG006|Overall Study|Lost to Follow-up|0|||
130545162|NCT01054170|469963042|FG000|Overall Study|Protocol Violation|1|||
130545163|NCT01054170|469963043|FG001|Overall Study|Protocol Violation|0|||
130545164|NCT01054170|469963042|FG000|Overall Study|Withdrawal by Subject|3|||
130545165|NCT01054170|469963043|FG001|Overall Study|Withdrawal by Subject|2|||
130545166|NCT01054170|469963042|FG000|Overall Study|Adverse Event|0|||
130545167|NCT01054170|469963043|FG001|Overall Study|Adverse Event|4|||
130545168|NCT00709852|469963044|FG000|Period 1|Adverse Event|2|||
130545169|NCT00709852|469963045|FG001|Period 1|Adverse Event|0|||
130545170|NCT00709852|469963044|FG000|Period 1|Withdrawal by Subject|4|||
130545171|NCT00709852|469963045|FG001|Period 1|Withdrawal by Subject|2|||
130545172|NCT00709852|469963044|FG000|Period 1|Protocol Violation|1|||
130545173|NCT00709852|469963045|FG001|Period 1|Protocol Violation|0|||
130545174|NCT00709852|469963044|FG000|Period 1|Defective scanner|0|||
130545175|NCT00709852|469963045|FG001|Period 1|Defective scanner|1|||
130545176|NCT00709852|469963044|FG000|Period 1|Lost to Follow-up|1|||
130545177|NCT00709852|469963045|FG001|Period 1|Lost to Follow-up|0|||
130545178|NCT00709852|469963044|FG000|Period 2|Protocol Violation|4|||
130545179|NCT00709852|469963045|FG001|Period 2|Protocol Violation|1|||
130545180|NCT00709852|469963044|FG000|Period 2|Adverse Event|1|||
130545181|NCT00709852|469963045|FG001|Period 2|Adverse Event|1|||
130545182|NCT00709852|469963044|FG000|Period 2|Lost to Follow-up|1|||
130545183|NCT00709852|469963045|FG001|Period 2|Lost to Follow-up|0|||
130545184|NCT00709852|469963044|FG000|Period 2|No 72-hour follow-up|3|||
130545185|NCT00709852|469963045|FG001|Period 2|No 72-hour follow-up|0|||
130545186|NCT02951767|469963046|FG000|Overall Study|Study Terminated By Sponsor|9|||
130545187|NCT02951767|469963046|FG000|Overall Study|Withdrawal by Subject|11|||
130545188|NCT02951767|469963046|FG000|Overall Study|Death|96|||
130545189|NCT02951767|469963046|FG000|Overall Study|Lost to Follow-up|2|||
130545190|NCT02951767|469963046|FG000|Overall Study|Physician Decision|1|||
130545191|NCT01442779|469963047|FG000|Overall Study|Withdrawal by Subject|3|||
130545192|NCT01442779|469963047|FG000|Overall Study|Death|3|||
130545193|NCT01442779|469963047|FG000|Overall Study|Non-compliance|1|||
130545194|NCT01048671|469963048|FG000|Overall Study|Protocol Violation|0|||
130545195|NCT01048671|469963049|FG001|Overall Study|Protocol Violation|1|||
130545196|NCT01048671|469963050|FG002|Overall Study|Protocol Violation|1|||
130545197|NCT05249829|469963051|FG000|Overall Study|Participant Relocation|0|||
130545198|NCT05249829|469963052|FG001|Overall Study|Participant Relocation|1|||
130545199|NCT05249829|469963053|FG002|Overall Study|Participant Relocation|2|||
130545200|NCT05249829|469963054|FG003|Overall Study|Participant Relocation|2|||
130545201|NCT05249829|469963051|FG000|Overall Study|Withdrawal by Subject|9|||
130545202|NCT05249829|469963052|FG001|Overall Study|Withdrawal by Subject|17|||
130545203|NCT05249829|469963053|FG002|Overall Study|Withdrawal by Subject|40|||
130545204|NCT05249829|469963054|FG003|Overall Study|Withdrawal by Subject|35|||
130545205|NCT05249829|469963051|FG000|Overall Study|Physician Decision|1|||
130545206|NCT05249829|469963052|FG001|Overall Study|Physician Decision|0|||
130545207|NCT05249829|469963053|FG002|Overall Study|Physician Decision|0|||
130545208|NCT05249829|469963054|FG003|Overall Study|Physician Decision|0|||
130545209|NCT05249829|469963051|FG000|Overall Study|Lost to Follow-up|16|||
130545210|NCT05249829|469963052|FG001|Overall Study|Lost to Follow-up|16|||
130545211|NCT05249829|469963053|FG002|Overall Study|Lost to Follow-up|57|||
130321540|NCT03182374|469147514|FG000|Overall Study|one subject was randomized but not treated|1|||
130321541|NCT03182374|469147515|FG001|Overall Study|one subject was randomized but not treated|0|||
130321542|NCT03182374|469147514|FG000|Overall Study|Other reasons|0|||
130321543|NCT03182374|469147515|FG001|Overall Study|Other reasons|3|||
130545212|NCT05249829|469963054|FG003|Overall Study|Lost to Follow-up|60|||
130545213|NCT05249829|469963051|FG000|Overall Study|Adverse Event|2|||
130545214|NCT05249829|469963052|FG001|Overall Study|Adverse Event|2|||
130545215|NCT05249829|469963053|FG002|Overall Study|Adverse Event|2|||
130545216|NCT05249829|469963054|FG003|Overall Study|Adverse Event|2|||
130545217|NCT05249829|469963051|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
130545218|NCT05249829|469963052|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
130545219|NCT05249829|469963053|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
130545220|NCT05249829|469963054|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
130321544|NCT03085095|469147516|FG000|Overall Study|Adverse Event|23|||
130545221|NCT05249829|469963051|FG000|Overall Study|Protocol Violation|2|||
130545222|NCT05249829|469963052|FG001|Overall Study|Protocol Violation|0|||
130545223|NCT05249829|469963053|FG002|Overall Study|Protocol Violation|5|||
130545224|NCT05249829|469963054|FG003|Overall Study|Protocol Violation|3|||
130545225|NCT05249829|469963051|FG000|Overall Study|Death|0|||
130545226|NCT05249829|469963052|FG001|Overall Study|Death|1|||
130545227|NCT05249829|469963053|FG002|Overall Study|Death|2|||
130545228|NCT05249829|469963054|FG003|Overall Study|Death|4|||
130545229|NCT00513604|469963055|FG000|Overall Study|Not treated|2|||
130545230|NCT00513604|469963056|FG001|Overall Study|Not treated|0|||
130321545|NCT03085095|469147517|FG001|Overall Study|Adverse Event|8|||
130321546|NCT03085095|469147516|FG000|Overall Study|Protocol Violation|0|||
130321547|NCT03085095|469147517|FG001|Overall Study|Protocol Violation|1|||
130321548|NCT03085095|469147516|FG000|Overall Study|Lost to Follow-up|2|||
130321549|NCT03085095|469147517|FG001|Overall Study|Lost to Follow-up|1|||
130321550|NCT03085095|469147516|FG000|Overall Study|Withdrawal by Subject|17|||
130321551|NCT03085095|469147517|FG001|Overall Study|Withdrawal by Subject|6|||
130321552|NCT03085095|469147516|FG000|Overall Study|Physician Decision|9|||
130321553|NCT03085095|469147517|FG001|Overall Study|Physician Decision|3|||
130321554|NCT03085095|469147516|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
130321555|NCT03085095|469147517|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
130321556|NCT03085095|469147516|FG000|Overall Study|Did not Receive Study Drug|2|||
130321557|NCT03085095|469147517|FG001|Overall Study|Did not Receive Study Drug|2|||
130321558|NCT03085095|469147516|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
130321559|NCT03085095|469147517|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
130321560|NCT00408317|469147518|FG000|First Intervention Period|Adverse Event|0|||
130321561|NCT00408317|469147519|FG001|First Intervention Period|Adverse Event|1|||
130321562|NCT00408317|469147518|FG000|Second Intervention Period|Adverse Event|2|||
130321563|NCT00408317|469147519|FG001|Second Intervention Period|Adverse Event|0|||
130321564|NCT00408317|469147518|FG000|Second Intervention Period|Protocol Violation|0|||
130321565|NCT00408317|469147519|FG001|Second Intervention Period|Protocol Violation|1|||
130321566|NCT00408317|469147518|FG000|Second Intervention Period|Withdrawal of consent|0|||
130321567|NCT00408317|469147519|FG001|Second Intervention Period|Withdrawal of consent|1|||
130321568|NCT03822117|469147520|FG000|Overall Study|Death|18|||
130321569|NCT03822117|469147521|FG001|Overall Study|Death|17|||
130321570|NCT03822117|469147522|FG002|Overall Study|Death|12|||
130321571|NCT03822117|469147523|FG003|Overall Study|Death|4|||
130321572|NCT03822117|469147520|FG000|Overall Study|Lost to Follow-up|1|||
130321573|NCT03822117|469147521|FG001|Overall Study|Lost to Follow-up|2|||
130321574|NCT03822117|469147522|FG002|Overall Study|Lost to Follow-up|3|||
130321575|NCT03822117|469147523|FG003|Overall Study|Lost to Follow-up|0|||
130321576|NCT03822117|469147520|FG000|Overall Study|Study Terminated by Sponsor|25|||
130321577|NCT03822117|469147521|FG001|Overall Study|Study Terminated by Sponsor|11|||
130321578|NCT03822117|469147522|FG002|Overall Study|Study Terminated by Sponsor|6|||
130321579|NCT03822117|469147523|FG003|Overall Study|Study Terminated by Sponsor|0|||
130321580|NCT03822117|469147520|FG000|Overall Study|Withdrawal by Subject|4|||
130321581|NCT03822117|469147521|FG001|Overall Study|Withdrawal by Subject|0|||
130321582|NCT03822117|469147522|FG002|Overall Study|Withdrawal by Subject|3|||
130321583|NCT03822117|469147523|FG003|Overall Study|Withdrawal by Subject|0|||
130321584|NCT03822117|469147520|FG000|Overall Study|Disease Progression|1|||
130321585|NCT03822117|469147521|FG001|Overall Study|Disease Progression|2|||
130321586|NCT03822117|469147522|FG002|Overall Study|Disease Progression|1|||
130321587|NCT03822117|469147523|FG003|Overall Study|Disease Progression|0|||
130321588|NCT03822117|469147520|FG000|Overall Study|Never Returned to Hospital|0|||
130321589|NCT03822117|469147521|FG001|Overall Study|Never Returned to Hospital|0|||
130321590|NCT03822117|469147522|FG002|Overall Study|Never Returned to Hospital|1|||
130321591|NCT03822117|469147523|FG003|Overall Study|Never Returned to Hospital|0|||
130321592|NCT01074502|469147524|FG000|Overall Study|Withdrawal by Subject|1|||
130321593|NCT03198715|469147525|FG000|Overall Study|Death|0|||
130321594|NCT03198715|469147526|FG001|Overall Study|Death|0|||
130321595|NCT03198715|469147527|FG002|Overall Study|Death|1|||
130321596|NCT03198715|469147528|FG003|Overall Study|Death|0|||
130321597|NCT03198715|469147529|FG004|Overall Study|Death|2|||
130321598|NCT03198715|469147525|FG000|Overall Study|Other|0|||
130321599|NCT03198715|469147526|FG001|Overall Study|Other|1|||
130321600|NCT03198715|469147527|FG002|Overall Study|Other|1|||
130321601|NCT03198715|469147528|FG003|Overall Study|Other|0|||
130545231|NCT00513604|469963057|FG002|Overall Study|Not treated|1|||
130321602|NCT03198715|469147529|FG004|Overall Study|Other|0|||
130321603|NCT00616759|469147530|FG000|Overall Study|Physician Decision|2|||
130321604|NCT00616759|469147531|FG001|Overall Study|Physician Decision|0|||
130321605|NCT00616759|469147530|FG000|Overall Study|Withdrawal by Subject|1|||
130321606|NCT00616759|469147531|FG001|Overall Study|Withdrawal by Subject|2|||
130321607|NCT00726063|469147535|FG000|Overall Study|Adverse Event|9|||
130321608|NCT00726063|469147536|FG001|Overall Study|Adverse Event|7|||
130321609|NCT02007096|469147537|FG000|Overall Study|medication not available|2|||
130321610|NCT02007096|469147538|FG001|Overall Study|medication not available|0|||
130321611|NCT02007096|469147537|FG000|Overall Study|did not inject saline|0|||
130321612|NCT02007096|469147538|FG001|Overall Study|did not inject saline|3|||
130545232|NCT00513604|469963058|FG003|Overall Study|Not treated|0|||
130545233|NCT00513604|469963059|FG004|Overall Study|Not treated|0|||
130321613|NCT02007096|469147537|FG000|Overall Study|did not follow postoperative protocol|8|||
130321614|NCT02007096|469147538|FG001|Overall Study|did not follow postoperative protocol|11|||
130321615|NCT02007096|469147537|FG000|Overall Study|converted to open surgery|1|||
130321616|NCT02007096|469147538|FG001|Overall Study|converted to open surgery|1|||
130321617|NCT02007096|469147537|FG000|Overall Study|no mesh placed|0|||
130321618|NCT02007096|469147538|FG001|Overall Study|no mesh placed|1|||
130321619|NCT05176314|469147540|FG000|Overall Study|Lost to Follow-up|2|||
130321620|NCT05176314|469147540|FG000|Overall Study|Physician Decision|1|||
130321621|NCT05176314|469147540|FG000|Overall Study|Adverse Event|1|||
130321622|NCT01231984|469147541|FG000|Study Period 1|Withdrawal by Subject|0|||
130321623|NCT01231984|469147542|FG001|Study Period 1|Withdrawal by Subject|0|||
130321624|NCT01231984|469147543|FG002|Study Period 1|Withdrawal by Subject|0|||
130321625|NCT01231984|469147544|FG003|Study Period 1|Withdrawal by Subject|1|||
130321626|NCT01231984|469147541|FG000|Study Period 1|Lost to Follow-up|1|||
130321627|NCT01231984|469147542|FG001|Study Period 1|Lost to Follow-up|1|||
130321628|NCT01231984|469147543|FG002|Study Period 1|Lost to Follow-up|1|||
130321629|NCT01231984|469147544|FG003|Study Period 1|Lost to Follow-up|0|||
130321630|NCT01231984|469147541|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321631|NCT01231984|469147542|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321632|NCT01231984|469147543|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321633|NCT01231984|469147544|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321634|NCT01231984|469147541|FG000|Study Period 1|Screen Failure|0|||
130321635|NCT01231984|469147542|FG001|Study Period 1|Screen Failure|0|||
130321636|NCT01231984|469147543|FG002|Study Period 1|Screen Failure|0|||
130321637|NCT01231984|469147544|FG003|Study Period 1|Screen Failure|1|||
130321638|NCT01231984|469147541|FG000|Study Period 1|Non-compliance with study requirements|5|||
130321639|NCT01231984|469147542|FG001|Study Period 1|Non-compliance with study requirements|0|||
130321640|NCT01231984|469147543|FG002|Study Period 1|Non-compliance with study requirements|2|||
130321641|NCT01231984|469147544|FG003|Study Period 1|Non-compliance with study requirements|1|||
130321642|NCT01231984|469147541|FG000|Study Period 1|Protocol Violation|3|||
130321643|NCT01231984|469147542|FG001|Study Period 1|Protocol Violation|4|||
130321644|NCT01231984|469147543|FG002|Study Period 1|Protocol Violation|2|||
130321645|NCT01231984|469147544|FG003|Study Period 1|Protocol Violation|3|||
130321646|NCT01231984|469147541|FG000|Study Period 1|Adverse Event|1|||
130321647|NCT01231984|469147542|FG001|Study Period 1|Adverse Event|0|||
130321648|NCT01231984|469147543|FG002|Study Period 1|Adverse Event|0|||
130321649|NCT01231984|469147544|FG003|Study Period 1|Adverse Event|0|||
130321650|NCT01231984|469147541|FG000|Study Period 1|Other|0|||
130321651|NCT01231984|469147542|FG001|Study Period 1|Other|0|||
130321652|NCT01231984|469147543|FG002|Study Period 1|Other|0|||
130321653|NCT01231984|469147544|FG003|Study Period 1|Other|1|||
130321654|NCT01231984|469147541|FG000|Study Period 2|Withdrawal by Subject|1|||
130321655|NCT01231984|469147542|FG001|Study Period 2|Withdrawal by Subject|1|||
130321656|NCT01231984|469147543|FG002|Study Period 2|Withdrawal by Subject|0|||
130545234|NCT00513604|469963055|FG000|Overall Study|Death during treatment|0|||
130545235|NCT00513604|469963056|FG001|Overall Study|Death during treatment|3|||
130545236|NCT00513604|469963057|FG002|Overall Study|Death during treatment|2|||
130545237|NCT00513604|469963058|FG003|Overall Study|Death during treatment|0|||
130545238|NCT00513604|469963059|FG004|Overall Study|Death during treatment|0|||
130545239|NCT00196976|469963060|FG000|Primary Study|Migrated from study area|0|||
130545240|NCT00196976|469963061|FG001|Primary Study|Migrated from study area|0|||
130545241|NCT00196976|469963062|FG002|Primary Study|Migrated from study area|0|||
130545242|NCT00196976|469963063|FG003|Primary Study|Migrated from study area|0|||
130545243|NCT00196976|469963064|FG004|Primary Study|Migrated from study area|0|||
130545244|NCT00196976|469963065|FG005|Primary Study|Migrated from study area|0|||
130545245|NCT00196976|469963066|FG006|Primary Study|Migrated from study area|0|||
130545246|NCT00196976|469963067|FG007|Primary Study|Migrated from study area|1|||
130545247|NCT00196976|469963068|FG008|Primary Study|Migrated from study area|0|||
130321657|NCT01231984|469147544|FG003|Study Period 2|Withdrawal by Subject|0|||
130321658|NCT01231984|469147541|FG000|Study Period 2|Lost to Follow-up|1|||
130321659|NCT01231984|469147542|FG001|Study Period 2|Lost to Follow-up|0|||
130321660|NCT01231984|469147543|FG002|Study Period 2|Lost to Follow-up|0|||
130545248|NCT00196976|469963069|FG009|Primary Study|Migrated from study area|0|||
130321661|NCT01231984|469147544|FG003|Study Period 2|Lost to Follow-up|3|||
130321662|NCT01231984|469147541|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321663|NCT01231984|469147542|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321664|NCT01231984|469147543|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
130321665|NCT01231984|469147544|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321666|NCT02923726|469147549|FG000|Overall Study|Death|196|||
130321667|NCT02923726|469147550|FG001|Overall Study|Death|175|||
130321668|NCT02923726|469147549|FG000|Overall Study|Withdrawal by Subject|337|||
130321669|NCT02923726|469147550|FG001|Overall Study|Withdrawal by Subject|307|||
130545249|NCT00196976|469963070|FG010|Primary Study|Migrated from study area|0|||
130545250|NCT00196976|469963071|FG011|Primary Study|Migrated from study area|0|||
130545251|NCT00196976|469963072|FG012|Primary Study|Migrated from study area|0|||
130545252|NCT00196976|469963073|FG013|Primary Study|Migrated from study area|0|||
130321670|NCT01680341|469147553|FG000|Overall Study|Adverse Event|3|||
130321671|NCT01680341|469147554|FG001|Overall Study|Adverse Event|2|||
130321672|NCT01680341|469147553|FG000|Overall Study|Unclassified|18|||
130321673|NCT01680341|469147554|FG001|Overall Study|Unclassified|15|||
130545253|NCT00196976|469963060|FG000|Primary Study|Protocol Violation|0|||
130545254|NCT00196976|469963061|FG001|Primary Study|Protocol Violation|1|||
130545255|NCT00196976|469963062|FG002|Primary Study|Protocol Violation|1|||
130545256|NCT00196976|469963063|FG003|Primary Study|Protocol Violation|0|||
130321674|NCT00481832|469147555|FG000|Enrollment|Physician Decision|8|||
130321675|NCT00481832|469147555|FG000|Enrollment|Unable to collect enough stem cells|2|||
130321676|NCT00481832|469147555|FG000|Inter-transplant Period|Adverse Event|4|||
130321677|NCT00481832|469147555|FG000|Inter-transplant Period|Death|3|||
130321678|NCT00481832|469147555|FG000|Inter-transplant Period|Physician Decision|4|||
130321679|NCT00481832|469147555|FG000|Inter-transplant Period|Disease relapse|11|||
130321680|NCT00481832|469147555|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
130321681|NCT02558894|469147558|FG000|Overall Study|Death; any cause, entire study duration|28|||
130321682|NCT02558894|469147559|FG001|Overall Study|Death; any cause, entire study duration|31|||
130321683|NCT02558894|469147558|FG000|Overall Study|Withdrawal by Subject|2|||
130321684|NCT02558894|469147559|FG001|Overall Study|Withdrawal by Subject|1|||
130321685|NCT02558894|469147558|FG000|Overall Study|Closure of Part A|2|||
130321686|NCT02558894|469147559|FG001|Overall Study|Closure of Part A|1|||
130321687|NCT02992288|469147560|FG000|Overall Study|Adverse Event|8|||
130321688|NCT02992288|469147561|FG001|Overall Study|Adverse Event|2|||
130321689|NCT02992288|469147562|FG002|Overall Study|Adverse Event|2|||
130321690|NCT02992288|469147563|FG003|Overall Study|Adverse Event|2|||
130321691|NCT02992288|469147564|FG004|Overall Study|Adverse Event|2|||
130545257|NCT00196976|469963064|FG004|Primary Study|Protocol Violation|0|||
130545258|NCT00196976|469963065|FG005|Primary Study|Protocol Violation|0|||
130545259|NCT00196976|469963066|FG006|Primary Study|Protocol Violation|0|||
130545260|NCT00196976|469963067|FG007|Primary Study|Protocol Violation|0|||
130545261|NCT00196976|469963068|FG008|Primary Study|Protocol Violation|0|||
130545262|NCT00196976|469963069|FG009|Primary Study|Protocol Violation|0|||
130545263|NCT00196976|469963070|FG010|Primary Study|Protocol Violation|0|||
130545264|NCT00196976|469963071|FG011|Primary Study|Protocol Violation|0|||
130545265|NCT00196976|469963072|FG012|Primary Study|Protocol Violation|0|||
130545266|NCT00196976|469963073|FG013|Primary Study|Protocol Violation|0|||
130545267|NCT00196976|469963060|FG000|Primary Study|Withdrawal by Subject|1|||
130545268|NCT00196976|469963061|FG001|Primary Study|Withdrawal by Subject|0|||
130545269|NCT00196976|469963062|FG002|Primary Study|Withdrawal by Subject|1|||
130545270|NCT00196976|469963063|FG003|Primary Study|Withdrawal by Subject|1|||
130545271|NCT00196976|469963064|FG004|Primary Study|Withdrawal by Subject|2|||
130545272|NCT00196976|469963065|FG005|Primary Study|Withdrawal by Subject|1|||
130545273|NCT00196976|469963066|FG006|Primary Study|Withdrawal by Subject|0|||
130545274|NCT00196976|469963067|FG007|Primary Study|Withdrawal by Subject|0|||
130545275|NCT00196976|469963068|FG008|Primary Study|Withdrawal by Subject|0|||
130545276|NCT00196976|469963069|FG009|Primary Study|Withdrawal by Subject|1|||
130545277|NCT00196976|469963070|FG010|Primary Study|Withdrawal by Subject|0|||
130545278|NCT00196976|469963071|FG011|Primary Study|Withdrawal by Subject|0|||
130545279|NCT00196976|469963072|FG012|Primary Study|Withdrawal by Subject|0|||
130545280|NCT00196976|469963073|FG013|Primary Study|Withdrawal by Subject|0|||
130545281|NCT00196976|469963060|FG000|Primary Study|Lost to Follow-up|0|||
130545282|NCT00196976|469963061|FG001|Primary Study|Lost to Follow-up|0|||
130545283|NCT00196976|469963062|FG002|Primary Study|Lost to Follow-up|0|||
130545284|NCT00196976|469963063|FG003|Primary Study|Lost to Follow-up|0|||
130545285|NCT00196976|469963064|FG004|Primary Study|Lost to Follow-up|1|||
130545286|NCT00196976|469963065|FG005|Primary Study|Lost to Follow-up|1|||
130545287|NCT00196976|469963066|FG006|Primary Study|Lost to Follow-up|0|||
130545288|NCT00196976|469963067|FG007|Primary Study|Lost to Follow-up|2|||
130545289|NCT00196976|469963068|FG008|Primary Study|Lost to Follow-up|0|||
130545290|NCT00196976|469963069|FG009|Primary Study|Lost to Follow-up|0|||
130545291|NCT00196976|469963070|FG010|Primary Study|Lost to Follow-up|0|||
130545292|NCT00196976|469963071|FG011|Primary Study|Lost to Follow-up|0|||
130545293|NCT00196976|469963072|FG012|Primary Study|Lost to Follow-up|0|||
130545294|NCT00196976|469963073|FG013|Primary Study|Lost to Follow-up|0|||
130321692|NCT02992288|469147565|FG005|Overall Study|Adverse Event|7|||
130545295|NCT00196976|469963060|FG000|Primary Study|Other|0|||
130545296|NCT00196976|469963061|FG001|Primary Study|Other|0|||
130321693|NCT02992288|469147560|FG000|Overall Study|Non-compliance with study drug|0|||
130321694|NCT02992288|469147561|FG001|Overall Study|Non-compliance with study drug|1|||
130321695|NCT02992288|469147562|FG002|Overall Study|Non-compliance with study drug|1|||
130545297|NCT00196976|469963062|FG002|Primary Study|Other|2|||
130545298|NCT00196976|469963063|FG003|Primary Study|Other|0|||
130545299|NCT00196976|469963064|FG004|Primary Study|Other|0|||
130545300|NCT00196976|469963065|FG005|Primary Study|Other|0|||
130545301|NCT00196976|469963066|FG006|Primary Study|Other|0|||
130545302|NCT00196976|469963067|FG007|Primary Study|Other|0|||
130545303|NCT00196976|469963068|FG008|Primary Study|Other|0|||
130545304|NCT00196976|469963069|FG009|Primary Study|Other|0|||
130545305|NCT00196976|469963070|FG010|Primary Study|Other|0|||
130545306|NCT00196976|469963071|FG011|Primary Study|Other|0|||
130545307|NCT00196976|469963072|FG012|Primary Study|Other|0|||
130545308|NCT00196976|469963073|FG013|Primary Study|Other|0|||
130545309|NCT00196976|469963060|FG000|Booster Study|Withdrawal by Subject|0|||
130545310|NCT00196976|469963061|FG001|Booster Study|Withdrawal by Subject|0|||
130545311|NCT00196976|469963062|FG002|Booster Study|Withdrawal by Subject|0|||
130545312|NCT00196976|469963063|FG003|Booster Study|Withdrawal by Subject|0|||
130545313|NCT00196976|469963064|FG004|Booster Study|Withdrawal by Subject|0|||
130545314|NCT00196976|469963065|FG005|Booster Study|Withdrawal by Subject|0|||
130545315|NCT00196976|469963066|FG006|Booster Study|Withdrawal by Subject|0|||
130545316|NCT00196976|469963067|FG007|Booster Study|Withdrawal by Subject|0|||
130545317|NCT00196976|469963068|FG008|Booster Study|Withdrawal by Subject|0|||
130321696|NCT02992288|469147563|FG003|Overall Study|Non-compliance with study drug|0|||
130321697|NCT02992288|469147564|FG004|Overall Study|Non-compliance with study drug|1|||
130321698|NCT02992288|469147565|FG005|Overall Study|Non-compliance with study drug|0|||
130321699|NCT02992288|469147560|FG000|Overall Study|Physician Decision|3|||
130321700|NCT02992288|469147561|FG001|Overall Study|Physician Decision|0|||
130321701|NCT02992288|469147562|FG002|Overall Study|Physician Decision|1|||
130321702|NCT02992288|469147563|FG003|Overall Study|Physician Decision|0|||
130321703|NCT02992288|469147564|FG004|Overall Study|Physician Decision|0|||
130321704|NCT02992288|469147565|FG005|Overall Study|Physician Decision|1|||
130545318|NCT00196976|469963069|FG009|Booster Study|Withdrawal by Subject|0|||
130545319|NCT00196976|469963070|FG010|Booster Study|Withdrawal by Subject|1|||
130321705|NCT02992288|469147560|FG000|Overall Study|Death|2|||
130545320|NCT00196976|469963071|FG011|Booster Study|Withdrawal by Subject|0|||
130545321|NCT00196976|469963072|FG012|Booster Study|Withdrawal by Subject|0|||
130321706|NCT02992288|469147561|FG001|Overall Study|Death|0|||
130321707|NCT02992288|469147562|FG002|Overall Study|Death|2|||
130321708|NCT02992288|469147563|FG003|Overall Study|Death|1|||
130321709|NCT02992288|469147564|FG004|Overall Study|Death|2|||
130321710|NCT02992288|469147565|FG005|Overall Study|Death|0|||
130321711|NCT02992288|469147560|FG000|Overall Study|Lost to Follow-up|0|||
130321712|NCT02992288|469147561|FG001|Overall Study|Lost to Follow-up|0|||
130321713|NCT02992288|469147562|FG002|Overall Study|Lost to Follow-up|0|||
130321714|NCT02992288|469147563|FG003|Overall Study|Lost to Follow-up|1|||
130321715|NCT02992288|469147564|FG004|Overall Study|Lost to Follow-up|0|||
130321716|NCT02992288|469147565|FG005|Overall Study|Lost to Follow-up|0|||
130321717|NCT02992288|469147560|FG000|Overall Study|Protocol Violation|0|||
130321718|NCT02992288|469147561|FG001|Overall Study|Protocol Violation|0|||
130321719|NCT02992288|469147562|FG002|Overall Study|Protocol Violation|0|||
130321720|NCT02992288|469147563|FG003|Overall Study|Protocol Violation|0|||
130321721|NCT02992288|469147564|FG004|Overall Study|Protocol Violation|0|||
130545322|NCT00196976|469963073|FG013|Booster Study|Withdrawal by Subject|0|||
130545323|NCT00196976|469963060|FG000|Booster Study|Lost to Follow-up|0|||
130545324|NCT00196976|469963061|FG001|Booster Study|Lost to Follow-up|0|||
130545325|NCT00196976|469963062|FG002|Booster Study|Lost to Follow-up|0|||
130321722|NCT02992288|469147565|FG005|Overall Study|Protocol Violation|1|||
130321723|NCT02992288|469147560|FG000|Overall Study|Withdrawal by Subject|4|||
130321724|NCT02992288|469147561|FG001|Overall Study|Withdrawal by Subject|2|||
130321725|NCT02992288|469147562|FG002|Overall Study|Withdrawal by Subject|1|||
130321726|NCT02992288|469147563|FG003|Overall Study|Withdrawal by Subject|5|||
130321727|NCT02992288|469147564|FG004|Overall Study|Withdrawal by Subject|3|||
130545326|NCT00196976|469963063|FG003|Booster Study|Lost to Follow-up|0|||
130545327|NCT00196976|469963064|FG004|Booster Study|Lost to Follow-up|0|||
130545328|NCT00196976|469963065|FG005|Booster Study|Lost to Follow-up|0|||
130545329|NCT00196976|469963066|FG006|Booster Study|Lost to Follow-up|0|||
130545330|NCT00196976|469963067|FG007|Booster Study|Lost to Follow-up|0|||
130545331|NCT00196976|469963068|FG008|Booster Study|Lost to Follow-up|0|||
130545332|NCT00196976|469963069|FG009|Booster Study|Lost to Follow-up|0|||
130545333|NCT00196976|469963070|FG010|Booster Study|Lost to Follow-up|1|||
130545334|NCT00196976|469963071|FG011|Booster Study|Lost to Follow-up|2|||
130545335|NCT00196976|469963072|FG012|Booster Study|Lost to Follow-up|0|||
130545336|NCT00196976|469963073|FG013|Booster Study|Lost to Follow-up|0|||
130545337|NCT01535560|469963075|FG000|Overall Study|Adverse Event|12|||
130545338|NCT01535560|469963076|FG001|Overall Study|Adverse Event|7|||
130545339|NCT01535560|469963075|FG000|Overall Study|Lost to Follow-up|1|||
130321728|NCT02992288|469147565|FG005|Overall Study|Withdrawal by Subject|4|||
130321729|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
130321730|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
130321731|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
130545340|NCT01535560|469963076|FG001|Overall Study|Lost to Follow-up|3|||
130545341|NCT01535560|469963075|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
130321732|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
130321733|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
130321734|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321735|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321736|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
130545342|NCT01535560|469963076|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
130545343|NCT01535560|469963075|FG000|Overall Study|Treatment Failure|21|||
130545344|NCT01535560|469963076|FG001|Overall Study|Treatment Failure|83|||
130545345|NCT01535560|469963075|FG000|Overall Study|Other|0|||
130545346|NCT01535560|469963076|FG001|Overall Study|Other|1|||
130545347|NCT01535560|469963075|FG000|Overall Study|Randomized in Error|0|||
130545348|NCT01535560|469963076|FG001|Overall Study|Randomized in Error|1|||
130321737|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321738|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130545349|NCT02009761|469963077|FG000|Overall Study|Adverse Event|4|||
130545350|NCT02842827|469963080|FG000|Overall Study|Adverse Event|0|||
130545351|NCT02842827|469963081|FG001|Overall Study|Adverse Event|1|||
130545352|NCT02842827|469963082|FG002|Overall Study|Adverse Event|0|||
130321739|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
130321740|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
130321741|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
130321742|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
130321743|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
130321744|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Other|1|||
130321745|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Other|5|||
130321746|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Other|0|||
130321747|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Other|2|||
130321748|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Other|3|||
130321749|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
130321750|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
130321751|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
130321752|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
130321753|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
130321754|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321755|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
130321756|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321757|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
130321758|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321759|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321760|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
130321761|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
130545353|NCT02842827|469963083|FG003|Overall Study|Adverse Event|1|||
130545354|NCT02842827|469963084|FG004|Overall Study|Adverse Event|0|||
130545355|NCT02842827|469963085|FG005|Overall Study|Adverse Event|1|||
130545356|NCT02842827|469963086|FG006|Overall Study|Adverse Event|0|||
130545357|NCT02842827|469963087|FG007|Overall Study|Adverse Event|0|||
130545358|NCT02842827|469963080|FG000|Overall Study|Death|1|||
130545359|NCT02842827|469963081|FG001|Overall Study|Death|0|||
130545360|NCT02842827|469963082|FG002|Overall Study|Death|2|||
130545361|NCT02842827|469963083|FG003|Overall Study|Death|3|||
130545362|NCT02842827|469963084|FG004|Overall Study|Death|2|||
130545363|NCT02842827|469963085|FG005|Overall Study|Death|1|||
130545364|NCT02842827|469963086|FG006|Overall Study|Death|0|||
130545365|NCT02842827|469963087|FG007|Overall Study|Death|4|||
130545366|NCT02842827|469963080|FG000|Overall Study|Physician Decision|1|||
130545367|NCT02842827|469963081|FG001|Overall Study|Physician Decision|3|||
130545368|NCT02842827|469963082|FG002|Overall Study|Physician Decision|0|||
130545369|NCT02842827|469963083|FG003|Overall Study|Physician Decision|0|||
130545370|NCT02842827|469963084|FG004|Overall Study|Physician Decision|1|||
130545371|NCT02842827|469963085|FG005|Overall Study|Physician Decision|4|||
130545372|NCT02842827|469963086|FG006|Overall Study|Physician Decision|2|||
130321762|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321763|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321764|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
130321765|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
130321766|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
130321767|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
130545373|NCT02842827|469963087|FG007|Overall Study|Physician Decision|1|||
130545374|NCT02842827|469963080|FG000|Overall Study|Protocol Defined Disease Progression|0|||
130545375|NCT02842827|469963081|FG001|Overall Study|Protocol Defined Disease Progression|0|||
130321768|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
130321769|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
130321770|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
130321771|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
130545376|NCT02842827|469963082|FG002|Overall Study|Protocol Defined Disease Progression|0|||
130545377|NCT02842827|469963083|FG003|Overall Study|Protocol Defined Disease Progression|0|||
130321772|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
130321773|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
130545378|NCT02842827|469963084|FG004|Overall Study|Protocol Defined Disease Progression|0|||
130545379|NCT02842827|469963085|FG005|Overall Study|Protocol Defined Disease Progression|1|||
130545380|NCT02842827|469963086|FG006|Overall Study|Protocol Defined Disease Progression|0|||
130545381|NCT02842827|469963087|FG007|Overall Study|Protocol Defined Disease Progression|0|||
130559408|NCT01621542|470016492|FG002|Overall Study|Physician Decision|1|||
130321774|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Other|0|||
130321775|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Other|1|||
130321776|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Other|0|||
130321777|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Other|1|||
130321778|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Other|0|||
130321779|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Not treated|0|||
130321780|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Not treated|0|||
130321781|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Not treated|2|||
130321782|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Not treated|0|||
130321783|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Not treated|0|||
130321784|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130321785|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
130321786|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130321787|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130321788|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130321789|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
130321790|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
130321791|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
130321792|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
130321793|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
130321794|NCT00499486|469147574|FG000|Overall Study|Withdrawal by Subject|16|||
130321795|NCT00087152|469147575|FG000|Overall Study|Ineligible|6|||
130321796|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
130321797|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130321798|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130321799|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
130321800|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130321801|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130321802|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
130321803|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130321804|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130321805|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
130321806|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130321807|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130321808|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
130321809|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130321810|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130321811|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Other|119|||
130321812|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Other|0|||
130321813|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Other|0|||
130321814|NCT01436149|469147577|FG000|Randomized Phase|Adverse Event|9|||
130321815|NCT01436149|469147578|FG001|Randomized Phase|Adverse Event|10|||
130321816|NCT01436149|469147579|FG002|Randomized Phase|Adverse Event|11|||
130321817|NCT01436149|469147577|FG000|Randomized Phase|Protocol Violation|4|||
130321818|NCT01436149|469147578|FG001|Randomized Phase|Protocol Violation|5|||
130321819|NCT01436149|469147579|FG002|Randomized Phase|Protocol Violation|0|||
130321820|NCT01436149|469147577|FG000|Randomized Phase|Withdrawal by Subject|16|||
130321821|NCT01436149|469147578|FG001|Randomized Phase|Withdrawal by Subject|10|||
130321822|NCT01436149|469147579|FG002|Randomized Phase|Withdrawal by Subject|10|||
130321823|NCT01436149|469147577|FG000|Randomized Phase|Lost to Follow-up|34|||
130321824|NCT01436149|469147578|FG001|Randomized Phase|Lost to Follow-up|5|||
130321825|NCT01436149|469147579|FG002|Randomized Phase|Lost to Follow-up|6|||
130321826|NCT01436149|469147577|FG000|Randomized Phase|Lack of Efficacy|0|||
130321827|NCT01436149|469147578|FG001|Randomized Phase|Lack of Efficacy|0|||
130321828|NCT01436149|469147579|FG002|Randomized Phase|Lack of Efficacy|1|||
130321829|NCT01436149|469147577|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130321830|NCT01436149|469147578|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130321831|NCT01436149|469147579|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130321832|NCT01436149|469147577|FG000|Randomized Phase|Other|12|||
130321833|NCT01436149|469147578|FG001|Randomized Phase|Other|5|||
130321834|NCT01436149|469147579|FG002|Randomized Phase|Other|11|||
130321835|NCT01643668|469147583|FG000|Overall Study|Death|1|||
130321836|NCT00322881|469147584|FG000|Overall Study|Death|2|||
130321837|NCT00322881|469147584|FG000|Overall Study|Adverse Event|1|||
130321838|NCT00322881|469147584|FG000|Overall Study|Disease Progression|2|||
130321839|NCT00561652|469147585|FG000|Overall Study|Withdrawal by Subject|0|||
130321840|NCT00561652|469147586|FG001|Overall Study|Withdrawal by Subject|1|||
130321841|NCT02285855|469147589|FG000|Overall Study|Withdrawal by Subject|2|||
130321842|NCT02285855|469147590|FG001|Overall Study|Withdrawal by Subject|1|||
130321843|NCT02718898|469147591|FG000|Blinded Treatment Period|Adverse Event|5|||
130321844|NCT02718898|469147592|FG001|Blinded Treatment Period|Adverse Event|1|||
130321845|NCT02718898|469147593|FG002|Blinded Treatment Period|Adverse Event|0|||
130321846|NCT02718898|469147594|FG003|Blinded Treatment Period|Adverse Event|0|||
130321847|NCT02718898|469147595|FG004|Blinded Treatment Period|Adverse Event|0|||
130321848|NCT02718898|469147596|FG005|Blinded Treatment Period|Adverse Event|0|||
130321849|NCT02718898|469147597|FG006|Blinded Treatment Period|Adverse Event|0|||
130321850|NCT02718898|469147591|FG000|Blinded Treatment Period|Physician Decision|1|||
130321851|NCT02718898|469147592|FG001|Blinded Treatment Period|Physician Decision|0|||
130321852|NCT02718898|469147593|FG002|Blinded Treatment Period|Physician Decision|0|||
130321853|NCT02718898|469147594|FG003|Blinded Treatment Period|Physician Decision|0|||
130321854|NCT02718898|469147595|FG004|Blinded Treatment Period|Physician Decision|0|||
130321855|NCT02718898|469147596|FG005|Blinded Treatment Period|Physician Decision|0|||
130321856|NCT02718898|469147597|FG006|Blinded Treatment Period|Physician Decision|0|||
130321857|NCT02718898|469147591|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130321858|NCT02718898|469147592|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
130321859|NCT02718898|469147593|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
130321860|NCT02718898|469147594|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
130321861|NCT02718898|469147595|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
130321862|NCT02718898|469147596|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
130321863|NCT02718898|469147597|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
130321864|NCT02718898|469147591|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
130321865|NCT02718898|469147592|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
130321866|NCT02718898|469147593|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
130321867|NCT02718898|469147594|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
130321868|NCT02718898|469147595|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
130321869|NCT02718898|469147596|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
130321870|NCT02718898|469147597|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
130321871|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321872|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321873|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130321874|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130321875|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321876|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321877|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321878|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321879|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321880|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321881|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
130321882|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321883|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321884|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321885|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321886|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321887|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130321888|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
130321889|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321890|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321891|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321892|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321893|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321894|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
130321895|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
130321896|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321897|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321898|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321899|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321900|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321901|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321902|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
130321903|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321904|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321905|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321906|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321907|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321908|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321909|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
130321910|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130545382|NCT02842827|469963080|FG000|Overall Study|Participant Withdrawal of Consent|1|||
130545383|NCT02842827|469963081|FG001|Overall Study|Participant Withdrawal of Consent|2|||
130321911|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130559409|NCT01621542|470016493|FG003|Overall Study|Physician Decision|13|||
130321912|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321913|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
130321914|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
130321915|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
130321916|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
130321917|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
130321918|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
130321919|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
130321920|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321921|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321922|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321923|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321924|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130321925|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
130321926|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130321927|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321928|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321929|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321930|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321931|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321932|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
130321933|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
130321934|NCT04484961|469147598|FG000|Overall Study|Lost to Follow-up|9|||
130321935|NCT04484961|469147599|FG001|Overall Study|Lost to Follow-up|9|||
130321936|NCT01667900|469147600|FG000|Part B|Death|0|||
130321937|NCT01667900|469147601|FG001|Part B|Death|0|||
130321938|NCT01667900|469147602|FG002|Part B|Death|0|||
130321939|NCT01667900|469147603|FG003|Part B|Death|0|||
130321940|NCT01667900|469147604|FG004|Part B|Death|0|||
130321941|NCT01667900|469147605|FG005|Part B|Death|0|||
130321942|NCT01667900|469147606|FG006|Part B|Death|0|||
130321943|NCT01667900|469147607|FG007|Part B|Death|0|||
130321944|NCT01667900|469147608|FG008|Part B|Death|0|||
130321945|NCT01667900|469147609|FG009|Part B|Death|0|||
130321946|NCT01667900|469147610|FG010|Part B|Death|0|||
130321947|NCT01667900|469147611|FG011|Part B|Death|0|||
130321948|NCT01667900|469147612|FG012|Part B|Death|0|||
130321949|NCT01667900|469147613|FG013|Part B|Death|0|||
130321950|NCT01667900|469147614|FG014|Part B|Death|0|||
130321951|NCT01667900|469147615|FG015|Part B|Death|0|||
130321952|NCT01667900|469147616|FG016|Part B|Death|1|||
130321953|NCT01667900|469147617|FG017|Part B|Death|0|||
130321954|NCT01667900|469147618|FG018|Part B|Death|0|||
130321955|NCT01667900|469147619|FG019|Part B|Death|0|||
130321956|NCT00976274|469147621|FG000|Overall Study|Lost to Follow-up|5|||
130321957|NCT00976274|469147622|FG001|Overall Study|Lost to Follow-up|5|||
130321958|NCT00976274|469147621|FG000|Overall Study|Withdrawal by Subject|1|||
130321959|NCT00976274|469147622|FG001|Overall Study|Withdrawal by Subject|1|||
130321960|NCT00976274|469147621|FG000|Overall Study|Physician Decision|1|||
130321961|NCT00976274|469147622|FG001|Overall Study|Physician Decision|2|||
130321962|NCT00627393|469147625|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
130321963|NCT00627393|469147626|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
130321964|NCT00627393|469147625|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
130321965|NCT00627393|469147626|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
130321966|NCT00627393|469147625|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
130321967|NCT00627393|469147626|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
130321968|NCT00627393|469147625|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
130321969|NCT00627393|469147626|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
130321970|NCT00004563|469147627|FG000|Overall Study|Withdrawal by Subject|20|||
130321971|NCT00004563|469147628|FG001|Overall Study|Withdrawal by Subject|16|||
130321972|NCT00004563|469147627|FG000|Overall Study|Lack of Efficacy|3|||
130321973|NCT00004563|469147628|FG001|Overall Study|Lack of Efficacy|5|||
130545384|NCT02842827|469963082|FG002|Overall Study|Participant Withdrawal of Consent|2|||
130321974|NCT00004563|469147627|FG000|Overall Study|Death|2|||
130321975|NCT00004563|469147628|FG001|Overall Study|Death|3|||
130321976|NCT03337308|469147629|FG000|Overall Study|Adverse Event|2|||
130321977|NCT03337308|469147630|FG001|Overall Study|Adverse Event|3|||
130321978|NCT03337308|469147631|FG002|Overall Study|Adverse Event|3|||
130321979|NCT03337308|469147632|FG003|Overall Study|Adverse Event|1|||
130321980|NCT03337308|469147629|FG000|Overall Study|Lost to Follow-up|1|||
130321981|NCT03337308|469147630|FG001|Overall Study|Lost to Follow-up|2|||
130321982|NCT03337308|469147631|FG002|Overall Study|Lost to Follow-up|0|||
130545385|NCT02842827|469963083|FG003|Overall Study|Participant Withdrawal of Consent|2|||
130321983|NCT03337308|469147632|FG003|Overall Study|Lost to Follow-up|0|||
130321984|NCT03337308|469147629|FG000|Overall Study|Withdrawal by Subject|2|||
130321985|NCT03337308|469147630|FG001|Overall Study|Withdrawal by Subject|1|||
130321986|NCT03337308|469147631|FG002|Overall Study|Withdrawal by Subject|2|||
130321987|NCT03337308|469147632|FG003|Overall Study|Withdrawal by Subject|1|||
130321988|NCT03337308|469147629|FG000|Overall Study|Protocol Violation|0|||
130545386|NCT02842827|469963084|FG004|Overall Study|Participant Withdrawal of Consent|2|||
130545387|NCT02842827|469963085|FG005|Overall Study|Participant Withdrawal of Consent|1|||
130545388|NCT02842827|469963086|FG006|Overall Study|Participant Withdrawal of Consent|2|||
130545389|NCT02842827|469963087|FG007|Overall Study|Participant Withdrawal of Consent|1|||
130545390|NCT02372136|469963090|FG000|Overall Study|Death|3|||
130545391|NCT02372136|469963091|FG001|Overall Study|Death|1|||
130545392|NCT00985946|469963092|FG000|Overall Study|Lost to Follow-up|6|||
130545393|NCT00985946|469963092|FG000|Overall Study|Withdrawal by Subject|1|||
130545394|NCT02471833|469963093|FG000|Overall Study|Lost to Follow-up|1|||
130545395|NCT02471833|469963094|FG001|Overall Study|Lost to Follow-up|0|||
130545396|NCT02471833|469963095|FG002|Overall Study|Lost to Follow-up|0|||
130545397|NCT02471833|469963093|FG000|Overall Study|Withdrawal by Subject|2|||
130545398|NCT02471833|469963094|FG001|Overall Study|Withdrawal by Subject|1|||
130545399|NCT02471833|469963095|FG002|Overall Study|Withdrawal by Subject|5|||
130321989|NCT03337308|469147630|FG001|Overall Study|Protocol Violation|1|||
130321990|NCT03337308|469147631|FG002|Overall Study|Protocol Violation|0|||
130321991|NCT03337308|469147632|FG003|Overall Study|Protocol Violation|0|||
130321992|NCT01056822|469147633|FG000|Overall Study|Adverse Event|0|||
130321993|NCT01056822|469147634|FG001|Overall Study|Adverse Event|1|||
130321994|NCT01056822|469147633|FG000|Overall Study|Protocol Violation|6|||
130321995|NCT01056822|469147634|FG001|Overall Study|Protocol Violation|5|||
130321996|NCT01056822|469147633|FG000|Overall Study|Withdrawal by Subject|1|||
130321997|NCT01056822|469147634|FG001|Overall Study|Withdrawal by Subject|1|||
130321998|NCT01056822|469147633|FG000|Overall Study|Lost to Follow-up|1|||
130321999|NCT01056822|469147634|FG001|Overall Study|Lost to Follow-up|0|||
130322000|NCT04528641|469147637|FG000|Overall Study|Withdrawal by Subject|0|||
130322001|NCT04528641|469147638|FG001|Overall Study|Withdrawal by Subject|0|||
130322002|NCT04528641|469147639|FG002|Overall Study|Withdrawal by Subject|0|||
130322003|NCT04528641|469147640|FG003|Overall Study|Withdrawal by Subject|1|||
130322004|NCT04528641|469147641|FG004|Overall Study|Withdrawal by Subject|0|||
130322005|NCT04528641|469147642|FG005|Overall Study|Withdrawal by Subject|1|||
130322006|NCT04366349|469147643|FG000|Overall Study|Withdrawal by Subject|1|||
130322007|NCT04366349|469147644|FG001|Overall Study|Withdrawal by Subject|0|||
130322008|NCT04366349|469147645|FG002|Overall Study|Withdrawal by Subject|0|||
130322009|NCT04366349|469147646|FG003|Overall Study|Withdrawal by Subject|0|||
130322010|NCT04366349|469147647|FG004|Overall Study|Withdrawal by Subject|0|||
130322011|NCT04366349|469147648|FG005|Overall Study|Withdrawal by Subject|0|||
130322012|NCT02783690|469147654|FG000|Overall Study|Withdrawal by Subject|3|||
130322013|NCT02783690|469147655|FG001|Overall Study|Withdrawal by Subject|3|||
130322014|NCT03474588|469147656|FG000|Overall Study|Withdrawal by Subject|4|||
130322015|NCT03474588|469147657|FG001|Overall Study|Withdrawal by Subject|3|||
130322016|NCT03474588|469147656|FG000|Overall Study|Death|0|||
130322017|NCT03474588|469147657|FG001|Overall Study|Death|1|||
130322018|NCT00626106|469147663|FG000|Overall Study|Withdrawal by Subject|2|||
130322019|NCT00626106|469147664|FG001|Overall Study|Withdrawal by Subject|1|||
130322020|NCT00626106|469147663|FG000|Overall Study|Lost to Follow-up|1|||
130322021|NCT00626106|469147664|FG001|Overall Study|Lost to Follow-up|4|||
130322022|NCT00626106|469147663|FG000|Overall Study|Death|64|||
130322023|NCT00626106|469147664|FG001|Overall Study|Death|19|||
130322024|NCT05417438|469147665|FG000|Overall Study|Withdrawal by Subject|3|||
130322025|NCT02702492|469147668|FG000|Overall Study|Disease progression|3|||
130545400|NCT02673515|469963096|FG000|Overall Study|Lack of motivation|2|||
130545401|NCT02673515|469963097|FG001|Overall Study|Lack of motivation|1|||
130545402|NCT00490724|469963099|FG000|Period I|Physician Decision|0|||
130545403|NCT00490724|469963100|FG001|Period I|Physician Decision|0|||
130545404|NCT00490724|469963101|FG002|Period I|Physician Decision|1|||
130545405|NCT00490724|469963099|FG000|Period II|Treatment Discontinuation|3|||
130545406|NCT00490724|469963100|FG001|Period II|Treatment Discontinuation|1|||
130545407|NCT00490724|469963101|FG002|Period II|Treatment Discontinuation|3|||
130545408|NCT00994682|469963102|FG000|Double Bilnd|Withdrawal by Subject|5|||
130545409|NCT00994682|469963103|FG001|Double Bilnd|Withdrawal by Subject|6|||
130545410|NCT00994682|469963102|FG000|Double Bilnd|Lost to Follow-up|3|||
130545411|NCT00994682|469963103|FG001|Double Bilnd|Lost to Follow-up|3|||
130545412|NCT00994682|469963102|FG000|Double Bilnd|Adverse Event|1|||
130322026|NCT02702492|469147669|FG001|Overall Study|Disease progression|3|||
130322027|NCT02702492|469147670|FG002|Overall Study|Disease progression|2|||
130322028|NCT02702492|469147671|FG003|Overall Study|Disease progression|4|||
130322029|NCT02702492|469147672|FG004|Overall Study|Disease progression|4|||
130545413|NCT00994682|469963103|FG001|Double Bilnd|Adverse Event|0|||
130545414|NCT00994682|469963102|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
130545415|NCT00994682|469963103|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
130545416|NCT00994682|469963102|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
130322030|NCT02702492|469147673|FG005|Overall Study|Disease progression|1|||
130322031|NCT02702492|469147674|FG006|Overall Study|Disease progression|2|||
130322032|NCT02702492|469147675|FG007|Overall Study|Disease progression|8|||
130322033|NCT02702492|469147676|FG008|Overall Study|Disease progression|5|||
130322034|NCT02702492|469147677|FG009|Overall Study|Disease progression|1|||
130322035|NCT02702492|469147678|FG010|Overall Study|Disease progression|0|||
130322036|NCT02702492|469147679|FG011|Overall Study|Disease progression|3|||
130322037|NCT02702492|469147680|FG012|Overall Study|Disease progression|2|||
130322038|NCT02702492|469147668|FG000|Overall Study|Clinical progression|0|||
130322039|NCT02702492|469147669|FG001|Overall Study|Clinical progression|0|||
130322040|NCT02702492|469147670|FG002|Overall Study|Clinical progression|2|||
130322041|NCT02702492|469147671|FG003|Overall Study|Clinical progression|1|||
130322042|NCT02702492|469147672|FG004|Overall Study|Clinical progression|0|||
130322043|NCT02702492|469147673|FG005|Overall Study|Clinical progression|2|||
130322044|NCT02702492|469147674|FG006|Overall Study|Clinical progression|1|||
130322045|NCT02702492|469147675|FG007|Overall Study|Clinical progression|4|||
130322046|NCT02702492|469147676|FG008|Overall Study|Clinical progression|0|||
130322047|NCT02702492|469147677|FG009|Overall Study|Clinical progression|0|||
130322048|NCT02702492|469147678|FG010|Overall Study|Clinical progression|1|||
130322049|NCT02702492|469147679|FG011|Overall Study|Clinical progression|2|||
130322050|NCT02702492|469147680|FG012|Overall Study|Clinical progression|0|||
130322051|NCT02702492|469147668|FG000|Overall Study|Adverse Event|0|||
130322052|NCT02702492|469147669|FG001|Overall Study|Adverse Event|0|||
130322053|NCT02702492|469147670|FG002|Overall Study|Adverse Event|1|||
130322054|NCT02702492|469147671|FG003|Overall Study|Adverse Event|2|||
130322055|NCT02702492|469147672|FG004|Overall Study|Adverse Event|1|||
130322056|NCT02702492|469147673|FG005|Overall Study|Adverse Event|0|||
130322057|NCT02702492|469147674|FG006|Overall Study|Adverse Event|1|||
130322058|NCT02702492|469147675|FG007|Overall Study|Adverse Event|0|||
130322059|NCT02702492|469147676|FG008|Overall Study|Adverse Event|2|||
130322060|NCT02702492|469147677|FG009|Overall Study|Adverse Event|0|||
130322061|NCT02702492|469147678|FG010|Overall Study|Adverse Event|0|||
130322062|NCT02702492|469147679|FG011|Overall Study|Adverse Event|0|||
130322063|NCT02702492|469147680|FG012|Overall Study|Adverse Event|1|||
130322064|NCT02702492|469147668|FG000|Overall Study|Other|0|||
130322065|NCT02702492|469147669|FG001|Overall Study|Other|0|||
130322066|NCT02702492|469147670|FG002|Overall Study|Other|0|||
130322067|NCT02702492|469147671|FG003|Overall Study|Other|0|||
130322068|NCT02702492|469147672|FG004|Overall Study|Other|0|||
130322069|NCT02702492|469147673|FG005|Overall Study|Other|0|||
130322070|NCT02702492|469147674|FG006|Overall Study|Other|0|||
130322071|NCT02702492|469147675|FG007|Overall Study|Other|0|||
130322072|NCT02702492|469147676|FG008|Overall Study|Other|0|||
130322073|NCT02702492|469147677|FG009|Overall Study|Other|0|||
130322074|NCT02702492|469147678|FG010|Overall Study|Other|0|||
130322075|NCT02702492|469147679|FG011|Overall Study|Other|0|||
130322076|NCT02702492|469147680|FG012|Overall Study|Other|1|||
130322077|NCT00781768|469149030|FG000|Overall Study|Not transplanted.|0|||
130322078|NCT00781768|469149031|FG001|Overall Study|Not transplanted.|2|||
130322079|NCT00079417|469149040|FG000|Overall Study|Physician Decision|2|||
130322080|NCT00079417|469149040|FG000|Overall Study|Ineligible|7|||
130322081|NCT02458313|469149041|FG000|Overall Study|Withdrawal by Subject|6|||
130322082|NCT02458313|469149042|FG001|Overall Study|Withdrawal by Subject|8|||
130322083|NCT02458313|469149041|FG000|Overall Study|Excluded for motion during MRI|1|||
130322084|NCT02458313|469149042|FG001|Overall Study|Excluded for motion during MRI|2|||
130322085|NCT00904969|469149043|FG000|Overall Study|Lost to Follow-up|4|||
130322086|NCT00904969|469149043|FG000|Overall Study|Withdrawal by Subject|3|||
130322087|NCT00904969|469149043|FG000|Overall Study|Additional Treatments|11|||
130322088|NCT00904969|469149043|FG000|Overall Study|Case Aborted; Subject Exited|1|||
130322089|NCT00199381|469149050|FG000|Overall Study|Withdrawal by Subject|38|||
130322090|NCT00199381|469149050|FG000|Overall Study|Adverse Event|73|||
130322091|NCT00199381|469149050|FG000|Overall Study|Protocol Violation|6|||
130322092|NCT00199381|469149050|FG000|Overall Study|Lack of Efficacy|27|||
130322093|NCT00199381|469149050|FG000|Overall Study|Not including due to early termination|37|||
130322094|NCT00199381|469149050|FG000|Overall Study|Study termination by Sponsor|323|||
130322095|NCT00385671|469149052|FG000|Overall Study|Adverse Event|14|||
130322096|NCT00385671|469149053|FG001|Overall Study|Adverse Event|27|||
130322097|NCT00385671|469149054|FG002|Overall Study|Adverse Event|18|||
130545417|NCT00994682|469963103|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
130322098|NCT00385671|469149052|FG000|Overall Study|Lack of Efficacy|5|||
130322099|NCT00385671|469149053|FG001|Overall Study|Lack of Efficacy|9|||
130322100|NCT00385671|469149054|FG002|Overall Study|Lack of Efficacy|5|||
130322101|NCT00385671|469149052|FG000|Overall Study|Lost to Follow-up|6|||
130322102|NCT00385671|469149053|FG001|Overall Study|Lost to Follow-up|6|||
130322103|NCT00385671|469149054|FG002|Overall Study|Lost to Follow-up|5|||
130545418|NCT00994682|469963102|FG000|Pioglitazone Open Label|Physician Decision|6|||
130322104|NCT00385671|469149052|FG000|Overall Study|Physician Decision|2|||
130322105|NCT00385671|469149053|FG001|Overall Study|Physician Decision|1|||
130322106|NCT00385671|469149054|FG002|Overall Study|Physician Decision|2|||
130322107|NCT00385671|469149052|FG000|Overall Study|Protocol Violation|5|||
130322108|NCT00385671|469149053|FG001|Overall Study|Protocol Violation|2|||
130322109|NCT00385671|469149054|FG002|Overall Study|Protocol Violation|1|||
130322110|NCT00385671|469149052|FG000|Overall Study|Sponsor Decision|2|||
130322111|NCT00385671|469149053|FG001|Overall Study|Sponsor Decision|2|||
130322112|NCT00385671|469149054|FG002|Overall Study|Sponsor Decision|1|||
130322113|NCT00385671|469149052|FG000|Overall Study|Withdrawal by Subject|4|||
130322114|NCT00385671|469149053|FG001|Overall Study|Withdrawal by Subject|4|||
130322115|NCT00385671|469149054|FG002|Overall Study|Withdrawal by Subject|4|||
130322116|NCT00303069|469149055|FG000|Overall Study|Lost to Follow-up|1|||
130322117|NCT00303069|469149056|FG001|Overall Study|Lost to Follow-up|0|||
130322118|NCT00303069|469149057|FG002|Overall Study|Lost to Follow-up|0|||
130322119|NCT00303069|469149058|FG003|Overall Study|Lost to Follow-up|2|||
130322120|NCT00303069|469149055|FG000|Overall Study|subject moved|1|||
130322121|NCT00303069|469149056|FG001|Overall Study|subject moved|0|||
130322122|NCT00303069|469149057|FG002|Overall Study|subject moved|0|||
130322123|NCT00303069|469149058|FG003|Overall Study|subject moved|0|||
130322124|NCT00303069|469149055|FG000|Overall Study|Recruitment into Army Reserves|0|||
130322125|NCT00303069|469149056|FG001|Overall Study|Recruitment into Army Reserves|0|||
130322126|NCT00303069|469149057|FG002|Overall Study|Recruitment into Army Reserves|1|||
130322127|NCT00303069|469149058|FG003|Overall Study|Recruitment into Army Reserves|0|||
130322128|NCT00751296|469149059|FG000|Overall Study|Adverse Event|2|||
130322129|NCT01775501|469149060|FG000|Overall Study|Discontinued prior to treatment|1|||
130322130|NCT01280903|469149064|FG000|Overall Study|Lost to Follow-up|23|||
130322131|NCT01280903|469149065|FG001|Overall Study|Lost to Follow-up|16|||
130322132|NCT03453164|469149066|FG000|Overall Study|Lack of Efficacy|16|||
130322133|NCT03453164|469149066|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
130322134|NCT03007966|469149069|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
130322135|NCT03007966|469149070|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
130322136|NCT03459079|469149071|FG000|Overall Study|Adverse Event|4|||
130322137|NCT03459079|469149072|FG001|Overall Study|Adverse Event|2|||
130322138|NCT03459079|469149073|FG002|Overall Study|Adverse Event|0|||
130322139|NCT03459079|469149071|FG000|Overall Study|Withdrawal by Subject|2|||
130322140|NCT03459079|469149072|FG001|Overall Study|Withdrawal by Subject|2|||
130322141|NCT03459079|469149073|FG002|Overall Study|Withdrawal by Subject|0|||
130322142|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
130322143|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
130322144|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
130322145|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Death|9|||
130322146|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Death|0|||
130322147|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Death|0|||
130322148|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
130322149|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130322150|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130322151|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
130322152|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
130322153|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
130322154|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Other|135|||
130322155|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Other|0|||
130322156|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Other|0|||
130322157|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
130322158|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
130322159|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
130322160|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
130322161|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
130322162|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
130322163|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
130322164|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130322165|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130322166|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Other|3|||
130322167|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Other|0|||
130322168|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Other|0|||
130322169|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
130322170|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130322171|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130322172|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130322173|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
130322174|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130322175|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
130322176|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
130322177|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
130322178|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
130322179|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
130322180|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
130322181|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130322182|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130322183|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
130322184|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130322185|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
130322186|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130545419|NCT00994682|469963103|FG001|Pioglitazone Open Label|Physician Decision|1|||
130545420|NCT00903682|469963104|FG000|Overall Study|Adverse Event|6|||
130545421|NCT00903682|469963105|FG001|Overall Study|Adverse Event|13|||
130545422|NCT00903682|469963104|FG000|Overall Study|Lost to Follow-up|1|||
130545423|NCT00903682|469963105|FG001|Overall Study|Lost to Follow-up|0|||
130545424|NCT00903682|469963104|FG000|Overall Study|Withdrawal by Subject|5|||
130545425|NCT00903682|469963105|FG001|Overall Study|Withdrawal by Subject|0|||
130545426|NCT00903682|469963104|FG000|Overall Study|Pregnancy|0|||
130545427|NCT00903682|469963105|FG001|Overall Study|Pregnancy|1|||
130545428|NCT00903682|469963104|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
130545429|NCT00903682|469963105|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
130545430|NCT00903682|469963104|FG000|Overall Study|Subject Non-Compliant|1|||
130322187|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
130322188|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
130322189|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
130322190|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130322191|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
130322192|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130322193|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
130322194|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
130322195|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
130322196|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130322197|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
130322198|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130322199|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130322200|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130322201|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130322202|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130322203|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130322204|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
130322205|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130322206|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130322207|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130322208|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322209|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322210|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322211|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
130322212|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
130322213|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
130322214|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
130322215|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
130322216|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130322217|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130322218|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130322219|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130322220|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322221|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
130322222|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322223|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322224|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322225|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
130322226|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322227|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322228|NCT04026113|469149081|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
130322229|NCT04026113|469149082|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
130545431|NCT00903682|469963105|FG001|Overall Study|Subject Non-Compliant|0|||
130322230|NCT04026113|469149083|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
130545432|NCT00903682|469963104|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
130545433|NCT00903682|469963105|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
130545434|NCT00903682|469963104|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
130545435|NCT00903682|469963105|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
130213832|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
130213833|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130213834|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130213835|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213836|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213837|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213838|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213839|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213840|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213841|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130213842|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
130213843|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130213844|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213845|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213846|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213847|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
130213848|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
130213849|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
130213850|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213851|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213852|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213853|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213854|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130213855|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130213856|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213857|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213858|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213859|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
130213860|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
130213861|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
130213862|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213863|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213864|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213865|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130213866|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
130213867|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130213868|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213869|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213870|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213871|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213872|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213873|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
130213874|NCT03836209|468746918|FG000|Overall Study|Adverse Event|5|||
130213875|NCT03836209|468746919|FG001|Overall Study|Adverse Event|2|||
130213876|NCT03836209|468746918|FG000|Overall Study|Death|4|||
130213877|NCT03836209|468746919|FG001|Overall Study|Death|1|||
130213878|NCT03836209|468746918|FG000|Overall Study|Lack of Efficacy|7|||
130213879|NCT03836209|468746919|FG001|Overall Study|Lack of Efficacy|10|||
130213880|NCT03836209|468746918|FG000|Overall Study|Physician Decision|7|||
130213881|NCT03836209|468746919|FG001|Overall Study|Physician Decision|11|||
130213882|NCT03836209|468746918|FG000|Overall Study|Protocol Violation|0|||
130213883|NCT03836209|468746919|FG001|Overall Study|Protocol Violation|3|||
130213884|NCT03836209|468746918|FG000|Overall Study|Withdrawal by Subject|2|||
130213885|NCT03836209|468746919|FG001|Overall Study|Withdrawal by Subject|10|||
130213886|NCT03836209|468746918|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
130213887|NCT03836209|468746919|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
130213888|NCT03739710|468746920|FG000|Overall Study|Screen Failed|81|||
130213889|NCT01753115|468746921|FG000|Overall Study|Lost to Follow-up|3|||
130213890|NCT01753115|468746922|FG001|Overall Study|Lost to Follow-up|6|||
130213891|NCT01753115|468746923|FG002|Overall Study|Lost to Follow-up|8|||
130213892|NCT01753115|468746921|FG000|Overall Study|Withdrawal by Subject|6|||
130213893|NCT01753115|468746922|FG001|Overall Study|Withdrawal by Subject|5|||
130213894|NCT01753115|468746923|FG002|Overall Study|Withdrawal by Subject|6|||
130213895|NCT01753115|468746921|FG000|Overall Study|Subject non-compliant|3|||
130213896|NCT01753115|468746922|FG001|Overall Study|Subject non-compliant|3|||
130213897|NCT01753115|468746923|FG002|Overall Study|Subject non-compliant|0|||
130322231|NCT04026113|469149084|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
130322232|NCT04613362|469149085|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130322233|NCT04613362|469149086|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130322234|NCT04613362|469149085|FG000|6 Month Follow-up|Lost to Follow-up|0|||
130322235|NCT04613362|469149086|FG001|6 Month Follow-up|Lost to Follow-up|1|||
130322236|NCT02218372|469149087|FG000|Overall Study|Adverse Event|1|||
130322237|NCT02218372|469149088|FG001|Overall Study|Adverse Event|1|||
130322238|NCT02218372|469149087|FG000|Overall Study|Miscellaneous|2|||
130322239|NCT02218372|469149088|FG001|Overall Study|Miscellaneous|1|||
130322240|NCT02218372|469149087|FG000|Overall Study|Randomized but did not receive treatment|2|||
130322241|NCT02218372|469149088|FG001|Overall Study|Randomized but did not receive treatment|3|||
130322242|NCT02218372|469149087|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130322243|NCT02218372|469149088|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130322244|NCT00074711|469149097|FG000|Overall Study|Withdrawal by Subject|1|||
130322245|NCT00074711|469149098|FG001|Overall Study|Withdrawal by Subject|1|||
130322246|NCT00074711|469149097|FG000|Overall Study|Lost to Follow-up|10|||
130322247|NCT00074711|469149098|FG001|Overall Study|Lost to Follow-up|8|||
130322248|NCT00074711|469149097|FG000|Overall Study|Participant stopped study drug|4|||
130322249|NCT00074711|469149098|FG001|Overall Study|Participant stopped study drug|6|||
130322250|NCT00671658|469149099|FG000|Overall Study|Physician Decision|5|||
130322251|NCT01921205|469149100|FG000|Overall Study|Adverse Event|12|||
130322252|NCT01921205|469149101|FG001|Overall Study|Adverse Event|7|||
130322253|NCT01921205|469149100|FG000|Overall Study|Lack of Efficacy|1|||
130322254|NCT01921205|469149101|FG001|Overall Study|Lack of Efficacy|0|||
130322255|NCT01921205|469149100|FG000|Overall Study|Protocol Violation|1|||
130322256|NCT01921205|469149101|FG001|Overall Study|Protocol Violation|3|||
130322257|NCT01921205|469149100|FG000|Overall Study|Lost to Follow-up|1|||
130322258|NCT01921205|469149101|FG001|Overall Study|Lost to Follow-up|1|||
130322259|NCT01921205|469149100|FG000|Overall Study|Withdrawal by Subject|6|||
130322260|NCT01921205|469149101|FG001|Overall Study|Withdrawal by Subject|5|||
130322261|NCT01921205|469149100|FG000|Overall Study|Use Of Prohibited Medication|0|||
130322262|NCT01921205|469149101|FG001|Overall Study|Use Of Prohibited Medication|1|||
130322263|NCT01921205|469149100|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
130322264|NCT01921205|469149101|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
130322265|NCT01921205|469149100|FG000|Overall Study|Non Compliance Of The Parent|0|||
130322266|NCT01921205|469149101|FG001|Overall Study|Non Compliance Of The Parent|1|||
130545436|NCT00932113|469965370|FG000|Overall Study|Lost to Follow-up|1|||
130545437|NCT00932113|469965371|FG001|Overall Study|Lost to Follow-up|0|||
130545438|NCT01403610|469965372|FG000|Overall Study|Withdrawal by Subject|2|||
130545439|NCT01403610|469965373|FG001|Overall Study|Withdrawal by Subject|0|||
130545440|NCT01403610|469965374|FG002|Overall Study|Withdrawal by Subject|0|||
130545441|NCT01403610|469965375|FG003|Overall Study|Withdrawal by Subject|0|||
130545442|NCT01403610|469965372|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
130545443|NCT01403610|469965373|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
130545444|NCT01403610|469965374|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
130545445|NCT01403610|469965375|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
130545446|NCT00896051|469965379|FG000|Overall Study|Adverse Event|2|||
130545447|NCT00896051|469965380|FG001|Overall Study|Adverse Event|1|||
130545448|NCT00896051|469965379|FG000|Overall Study|Lost to Follow-up|3|||
130545449|NCT00896051|469965380|FG001|Overall Study|Lost to Follow-up|2|||
130545450|NCT00896051|469965379|FG000|Overall Study|Withdrawal by Subject|3|||
130545451|NCT00896051|469965380|FG001|Overall Study|Withdrawal by Subject|2|||
130545452|NCT00896051|469965379|FG000|Overall Study|Subject noncompliant|1|||
130545453|NCT00896051|469965380|FG001|Overall Study|Subject noncompliant|3|||
130545454|NCT00896051|469965379|FG000|Overall Study|Other|1|||
130545455|NCT00896051|469965380|FG001|Overall Study|Other|1|||
130545456|NCT02935452|469965381|FG000|Overall Study|work and life commintment|3|||
130545457|NCT02935452|469965382|FG001|Overall Study|work and life commintment|1|||
130545458|NCT00876928|469965383|FG000|Overall Study|Lost to Follow-up|2|||
130545459|NCT00876928|469965384|FG001|Overall Study|Lost to Follow-up|5|||
130545460|NCT00876928|469965383|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
130545461|NCT00876928|469965384|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
130545462|NCT02336178|469965385|FG000|Overall Study|Lost to Follow-up|1|||
130545463|NCT02336178|469965385|FG000|Overall Study|Protocol Violation|1|||
130545464|NCT02336178|469965385|FG000|Overall Study|Withdrawal by Subject|1|||
130545465|NCT02336178|469965385|FG000|Overall Study|Other|1|||
130322267|NCT01921205|469149100|FG000|Overall Study|Non Compliance Of Child|0|||
130322268|NCT01921205|469149101|FG001|Overall Study|Non Compliance Of Child|1|||
130322269|NCT01527149|469149103|FG000|Overall Study|Death|2|||
130322270|NCT03125395|469149104|FG000|Overall Study|Adverse Event|2|||
130322271|NCT03125395|469149104|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130322272|NCT03125395|469149104|FG000|Overall Study|Physician Decision|2|||
130322273|NCT03125395|469149104|FG000|Overall Study|Commercial drug is available|5|||
130376460|NCT00887978|469343697|FG000|Overall Study|Death|2|||
130545466|NCT00618982|469965386|FG000|Overall Study|Adverse Event|23|||
130545467|NCT00618982|469965386|FG000|Overall Study|Withdrawal by Subject|1|||
130545468|NCT00618982|469965386|FG000|Overall Study|Protocol Violation|1|||
130545469|NCT00618982|469965386|FG000|Overall Study|ongoing, still treated with study med.|25|||
130545470|NCT01776541|469965389|FG000|Overall Study|Administrative Reason|6|||
130545471|NCT01776541|469965390|FG001|Overall Study|Administrative Reason|2|||
130545472|NCT01776541|469965389|FG000|Overall Study|Death|4|||
130545473|NCT01776541|469965390|FG001|Overall Study|Death|0|||
130545474|NCT01776541|469965389|FG000|Overall Study|Lost to Follow-up|27|||
130545475|NCT01776541|469965390|FG001|Overall Study|Lost to Follow-up|48|||
130545476|NCT01776541|469965389|FG000|Overall Study|Unclassified|5|||
130545477|NCT01776541|469965390|FG001|Overall Study|Unclassified|4|||
130545478|NCT01776541|469965389|FG000|Overall Study|Protocol Violation|2|||
130545479|NCT01776541|469965390|FG001|Overall Study|Protocol Violation|1|||
130545480|NCT01776541|469965389|FG000|Overall Study|Withdrawal by Subject|12|||
130545481|NCT01776541|469965390|FG001|Overall Study|Withdrawal by Subject|20|||
130545482|NCT00156819|469965391|FG000|Overall Study|Lost to Follow-up|1|||
130545483|NCT00156819|469965392|FG001|Overall Study|Lost to Follow-up|1|||
130545484|NCT00156819|469965393|FG002|Overall Study|Lost to Follow-up|3|||
130545485|NCT02090959|469965394|FG000|Overall Study|Withdrawal by Subject|10|||
130545486|NCT02090959|469965394|FG000|Overall Study|Adverse Event|1|||
130545487|NCT02090959|469965394|FG000|Overall Study|Investigator decision|2|||
130545488|NCT02090959|469965394|FG000|Overall Study|Study termination|6|||
130545489|NCT02090959|469965394|FG000|Overall Study|Enrolled but not treated|1|||
130545490|NCT02090959|469965394|FG000|Overall Study|Transfer for compassionate use medicine|4|||
130545491|NCT02090959|469965394|FG000|Overall Study|Move to medical need program|3|||
130545492|NCT02090959|469965394|FG000|Overall Study|Entered in to other study|34|||
130545493|NCT02090959|469965394|FG000|Overall Study|Switched to commercial supply|88|||
130545494|NCT02090959|469965394|FG000|Overall Study|Other than specified|2|||
130545495|NCT00522873|469965397|FG000|Overall Study|Adverse Event|41|||
130545496|NCT00522873|469965398|FG001|Overall Study|Adverse Event|26|||
130545497|NCT00522873|469965397|FG000|Overall Study|Withdrawal by Subject|20|||
130545498|NCT00522873|469965398|FG001|Overall Study|Withdrawal by Subject|9|||
130545499|NCT00522873|469965397|FG000|Overall Study|Protocol Violation|14|||
130545500|NCT00522873|469965398|FG001|Overall Study|Protocol Violation|4|||
130545501|NCT00522873|469965397|FG000|Overall Study|Lost to Follow-up|11|||
130545502|NCT00522873|469965398|FG001|Overall Study|Lost to Follow-up|3|||
130545503|NCT00522873|469965397|FG000|Overall Study|Personal Reasons|8|||
130545504|NCT00522873|469965398|FG001|Overall Study|Personal Reasons|1|||
130545505|NCT00522873|469965397|FG000|Overall Study|Medication Errors|1|||
130213898|NCT01753115|468746921|FG000|Overall Study|Used excluded drug|0|||
130213899|NCT01753115|468746922|FG001|Overall Study|Used excluded drug|1|||
130213900|NCT01753115|468746923|FG002|Overall Study|Used excluded drug|0|||
130213901|NCT01424241|468746926|FG000|Overall Study|Withdrawal by Subject|1|||
130213902|NCT01424241|468746926|FG000|Overall Study|Time constraints|2|||
130213903|NCT00496587|468746927|FG000|Overall Study|Adverse Event|2|||
130213904|NCT00496587|468746927|FG000|Overall Study|Progressive Disease|24|||
130213905|NCT00496587|468746927|FG000|Overall Study|Withdrawal by Subject|2|||
130213906|NCT00496587|468746927|FG000|Overall Study|Death|1|||
130213907|NCT00496587|468746927|FG000|Overall Study|Complications unrelated|2|||
130213908|NCT05259917|468746933|FG000|Overall Study|Protocol Violation|0|||
130213909|NCT05259917|468746934|FG001|Overall Study|Protocol Violation|0|||
130213910|NCT05259917|468746935|FG002|Overall Study|Protocol Violation|1|||
130213911|NCT05259917|468746936|FG003|Overall Study|Protocol Violation|0|||
130213912|NCT05259917|468746937|FG004|Overall Study|Protocol Violation|0|||
130213913|NCT05259917|468746938|FG005|Overall Study|Protocol Violation|0|||
130213914|NCT05259917|468746933|FG000|Overall Study|Lost to Follow-up|0|||
130213915|NCT05259917|468746934|FG001|Overall Study|Lost to Follow-up|0|||
130213916|NCT05259917|468746935|FG002|Overall Study|Lost to Follow-up|1|||
130213917|NCT05259917|468746936|FG003|Overall Study|Lost to Follow-up|0|||
130213918|NCT05259917|468746937|FG004|Overall Study|Lost to Follow-up|0|||
130213919|NCT05259917|468746938|FG005|Overall Study|Lost to Follow-up|1|||
130213920|NCT05259917|468746933|FG000|Overall Study|Physician Decision|0|||
130213921|NCT05259917|468746934|FG001|Overall Study|Physician Decision|1|||
130213922|NCT05259917|468746935|FG002|Overall Study|Physician Decision|0|||
130213923|NCT05259917|468746936|FG003|Overall Study|Physician Decision|0|||
130213924|NCT05259917|468746937|FG004|Overall Study|Physician Decision|0|||
130213925|NCT05259917|468746938|FG005|Overall Study|Physician Decision|0|||
130213926|NCT05259917|468746933|FG000|Overall Study|Withdrawal by Subject|0|||
130213927|NCT05259917|468746934|FG001|Overall Study|Withdrawal by Subject|1|||
130213928|NCT05259917|468746935|FG002|Overall Study|Withdrawal by Subject|0|||
130213929|NCT05259917|468746936|FG003|Overall Study|Withdrawal by Subject|0|||
130545506|NCT00522873|469965398|FG001|Overall Study|Medication Errors|1|||
130545507|NCT00522873|469965397|FG000|Overall Study|Never Received Medication|1|||
130545508|NCT00522873|469965398|FG001|Overall Study|Never Received Medication|0|||
130213930|NCT05259917|468746937|FG004|Overall Study|Withdrawal by Subject|1|||
130213931|NCT05259917|468746938|FG005|Overall Study|Withdrawal by Subject|1|||
130545509|NCT00822172|469965401|FG000|Overall Study|Adverse Event|10|||
130545510|NCT00822172|469965402|FG001|Overall Study|Adverse Event|12|||
130213932|NCT05259917|468746933|FG000|Overall Study|Trial Termination by Sponsor|7|||
130213933|NCT05259917|468746934|FG001|Overall Study|Trial Termination by Sponsor|2|||
130545511|NCT00822172|469965401|FG000|Overall Study|Death|1|||
130322274|NCT01780506|469149105|FG000|Double-Blind Phase|Randomized but not Treated|3|||
130322275|NCT01780506|469149106|FG001|Double-Blind Phase|Randomized but not Treated|2|||
130322276|NCT01780506|469149105|FG000|Double-Blind Phase|Adverse Event|4|||
130322277|NCT01780506|469149106|FG001|Double-Blind Phase|Adverse Event|14|||
130322278|NCT01780506|469149105|FG000|Double-Blind Phase|Death|1|||
130322279|NCT01780506|469149106|FG001|Double-Blind Phase|Death|2|||
130322280|NCT01780506|469149105|FG000|Double-Blind Phase|Pregnancy|2|||
130322281|NCT01780506|469149106|FG001|Double-Blind Phase|Pregnancy|1|||
130322282|NCT01780506|469149105|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130322283|NCT01780506|469149106|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130322284|NCT01780506|469149105|FG000|Double-Blind Phase|Investigator's Discretion|5|||
130322285|NCT01780506|469149106|FG001|Double-Blind Phase|Investigator's Discretion|2|||
130322286|NCT01780506|469149105|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130322287|NCT01780506|469149106|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130322288|NCT01780506|469149105|FG000|Double-Blind Phase|Protocol Violation|4|||
130322289|NCT01780506|469149106|FG001|Double-Blind Phase|Protocol Violation|3|||
130322290|NCT01780506|469149105|FG000|Double-Blind Phase|Withdrew Consent|23|||
130322291|NCT01780506|469149106|FG001|Double-Blind Phase|Withdrew Consent|24|||
130322292|NCT01780506|469149105|FG000|Double-Blind Phase|Lost to Follow-up|23|||
130322293|NCT01780506|469149106|FG001|Double-Blind Phase|Lost to Follow-up|26|||
130322294|NCT01780506|469149105|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
130322295|NCT01780506|469149106|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
130322296|NCT05236270|469149107|FG000|Overall Study|Lost to Follow-up|3|||
130322297|NCT05236270|469149108|FG001|Overall Study|Lost to Follow-up|2|||
130322298|NCT05236270|469149109|FG002|Overall Study|Lost to Follow-up|0|||
130322299|NCT05236270|469149110|FG003|Overall Study|Lost to Follow-up|0|||
130322300|NCT05236270|469149111|FG004|Overall Study|Lost to Follow-up|2|||
130322301|NCT05236270|469149112|FG005|Overall Study|Lost to Follow-up|0|||
130322302|NCT05236270|469149113|FG006|Overall Study|Lost to Follow-up|1|||
130322303|NCT05236270|469149114|FG007|Overall Study|Lost to Follow-up|3|||
130322304|NCT01499940|469149115|FG000|Overall Study|Study was withdrawn before completion.|9|||
130322305|NCT03279081|469149117|FG000|Overall Study|Withdrawal by Subject|12|||
130322306|NCT03279081|469149118|FG001|Overall Study|Withdrawal by Subject|20|||
130322307|NCT03279081|469149117|FG000|Overall Study|Physician Decision|4|||
130322308|NCT03279081|469149118|FG001|Overall Study|Physician Decision|1|||
130322309|NCT03279081|469149117|FG000|Overall Study|Lost to Follow-up|8|||
130322310|NCT03279081|469149118|FG001|Overall Study|Lost to Follow-up|8|||
130322311|NCT03279081|469149117|FG000|Overall Study|Death|0|||
130322312|NCT03279081|469149118|FG001|Overall Study|Death|1|||
130322313|NCT03279081|469149117|FG000|Overall Study|Adverse Event|1|||
130322314|NCT03279081|469149118|FG001|Overall Study|Adverse Event|0|||
130322315|NCT03279081|469149117|FG000|Overall Study|Reason not Specified|14|||
130322316|NCT03279081|469149118|FG001|Overall Study|Reason not Specified|4|||
130322317|NCT03521570|469149119|FG000|Overall Study|Not eligible|11|||
130322318|NCT03253796|469149130|FG000|Period 1: Run-In|Adverse Event|4|||
130322319|NCT03253796|469149131|FG001|Period 1: Run-In|Adverse Event|0|||
130322320|NCT03253796|469149132|FG002|Period 1: Run-In|Adverse Event|0|||
130322321|NCT03253796|469149133|FG003|Period 1: Run-In|Adverse Event|0|||
130322322|NCT03253796|469149134|FG004|Period 1: Run-In|Adverse Event|0|||
130322323|NCT03253796|469149130|FG000|Period 1: Run-In|Lack of Efficacy|1|||
130322324|NCT03253796|469149131|FG001|Period 1: Run-In|Lack of Efficacy|0|||
130322325|NCT03253796|469149132|FG002|Period 1: Run-In|Lack of Efficacy|0|||
130322326|NCT03253796|469149133|FG003|Period 1: Run-In|Lack of Efficacy|0|||
130322327|NCT03253796|469149134|FG004|Period 1: Run-In|Lack of Efficacy|0|||
130322328|NCT03253796|469149130|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
130322329|NCT03253796|469149131|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
130322330|NCT03253796|469149132|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
130322331|NCT03253796|469149133|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
130322332|NCT03253796|469149134|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
130322333|NCT03253796|469149130|FG000|Period 1: Run-In|Protocol Violation|5|||
130322334|NCT03253796|469149131|FG001|Period 1: Run-In|Protocol Violation|0|||
130322335|NCT03253796|469149132|FG002|Period 1: Run-In|Protocol Violation|0|||
130322336|NCT03253796|469149133|FG003|Period 1: Run-In|Protocol Violation|0|||
130322337|NCT03253796|469149134|FG004|Period 1: Run-In|Protocol Violation|0|||
130322338|NCT03253796|469149130|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
130322339|NCT03253796|469149131|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
130322340|NCT03253796|469149132|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
130322341|NCT03253796|469149133|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
130322342|NCT03253796|469149134|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
130322343|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322344|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322345|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
130322346|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322347|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322348|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322349|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322350|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
130322351|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322352|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322353|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130545512|NCT00822172|469965402|FG001|Overall Study|Death|0|||
130213934|NCT05259917|468746935|FG002|Overall Study|Trial Termination by Sponsor|3|||
130213935|NCT05259917|468746936|FG003|Overall Study|Trial Termination by Sponsor|5|||
130213936|NCT05259917|468746937|FG004|Overall Study|Trial Termination by Sponsor|11|||
130213937|NCT05259917|468746938|FG005|Overall Study|Trial Termination by Sponsor|4|||
130213938|NCT05259917|468746933|FG000|Overall Study|Other|1|||
130213939|NCT05259917|468746934|FG001|Overall Study|Other|0|||
130213940|NCT05259917|468746935|FG002|Overall Study|Other|2|||
130213941|NCT05259917|468746936|FG003|Overall Study|Other|0|||
130213942|NCT05259917|468746937|FG004|Overall Study|Other|0|||
130213943|NCT05259917|468746938|FG005|Overall Study|Other|0|||
130213944|NCT02383355|468746941|FG000|Overall Study|Adverse Event|2|||
130213945|NCT02383355|468746942|FG001|Overall Study|Adverse Event|0|||
130213946|NCT01146561|468746944|FG000|Overall Study|Withdrawal by Subject|1|||
130213947|NCT01146561|468746944|FG000|Overall Study|Lost to Follow-up|1|||
130213948|NCT03628716|468746945|FG000|Overall Study|Adverse Event|1|||
130213949|NCT03628716|468746946|FG001|Overall Study|Adverse Event|1|||
130213950|NCT03628716|468746945|FG000|Overall Study|Death|1|||
130213951|NCT03628716|468746946|FG001|Overall Study|Death|0|||
130213952|NCT03628716|468746945|FG000|Overall Study|Lack of Efficacy|15|||
130213953|NCT03628716|468746946|FG001|Overall Study|Lack of Efficacy|20|||
130213954|NCT03628716|468746945|FG000|Overall Study|Withdrawal by Subject|1|||
130213955|NCT03628716|468746946|FG001|Overall Study|Withdrawal by Subject|2|||
130213956|NCT03628716|468746945|FG000|Overall Study|Study Terminated by Sponsor|1|||
130213957|NCT03628716|468746946|FG001|Overall Study|Study Terminated by Sponsor|0|||
130213958|NCT00856843|468746947|FG000|Overall Study|Withdrawal by Subject|1|||
130213959|NCT00856843|468746948|FG001|Overall Study|Withdrawal by Subject|5|||
130213960|NCT00856843|468746947|FG000|Overall Study|Lack of Efficacy|1|||
130213961|NCT00856843|468746948|FG001|Overall Study|Lack of Efficacy|0|||
130213962|NCT01994902|468746949|FG000|Test Period 1|Withdrawal by Subject|3|||
130213963|NCT01994902|468746950|FG001|Test Period 1|Withdrawal by Subject|0|||
130213964|NCT01994902|468746949|FG000|Test Period 1|device deficiency with adverse event|0|||
130213965|NCT01994902|468746950|FG001|Test Period 1|device deficiency with adverse event|1|||
130213966|NCT01994902|468746949|FG000|Test Period 1|Adverse Event|2|||
130213967|NCT01994902|468746950|FG001|Test Period 1|Adverse Event|1|||
130213968|NCT01994902|468746949|FG000|Test Period 1|Lack of Efficacy|0|||
130213969|NCT01994902|468746950|FG001|Test Period 1|Lack of Efficacy|1|||
130213970|NCT01994902|468746949|FG000|Test Period 1|bag too small|1|||
130213971|NCT01994902|468746950|FG001|Test Period 1|bag too small|0|||
130213972|NCT01994902|468746949|FG000|Test Period 2|Withdrawal by Subject|0|||
130213973|NCT01994902|468746950|FG001|Test Period 2|Withdrawal by Subject|2|||
130213974|NCT01994902|468746949|FG000|Test Period 2|Lack of Efficacy|0|||
130213975|NCT01994902|468746950|FG001|Test Period 2|Lack of Efficacy|1|||
130213976|NCT01994902|468746949|FG000|Test Period 2|Other|0|||
130213977|NCT01994902|468746950|FG001|Test Period 2|Other|3|||
130213978|NCT02717442|468746952|FG000|Overall Study|Study Terminated by Sponsor|31|||
130213979|NCT02717442|468746953|FG001|Overall Study|Study Terminated by Sponsor|29|||
130213980|NCT02717442|468746952|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
130213981|NCT02717442|468746953|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
130213982|NCT02717442|468746952|FG000|Overall Study|Other - Not Specified|2|||
130213983|NCT02717442|468746953|FG001|Overall Study|Other - Not Specified|0|||
130213984|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
130213985|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213986|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213987|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213988|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213989|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213990|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213991|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213992|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213993|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130213994|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130213995|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130213996|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
130213997|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130213998|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
130213999|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
130545513|NCT00822172|469965401|FG000|Overall Study|Lost to Follow-up|3|||
130214000|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130376461|NCT00887978|469343698|FG001|Overall Study|Death|3|||
130322354|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130322355|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
130322356|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
130322357|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130322358|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322359|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322360|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
130545514|NCT00822172|469965402|FG001|Overall Study|Lost to Follow-up|1|||
130545515|NCT00822172|469965401|FG000|Overall Study|Withdrawal by Subject|1|||
130545516|NCT00822172|469965402|FG001|Overall Study|Withdrawal by Subject|4|||
130545517|NCT00822172|469965401|FG000|Overall Study|site closed|0|||
130545518|NCT00822172|469965402|FG001|Overall Study|site closed|1|||
130545519|NCT00822172|469965401|FG000|Overall Study|Other|0|||
130545520|NCT00822172|469965402|FG001|Overall Study|Other|1|||
130545521|NCT00700258|469965403|FG000|Overall Study|Premature discontinuation of documentation|136|||
130545522|NCT00700258|469965403|FG000|Overall Study|Type of study end not documented|1|||
130545523|NCT00700258|469965403|FG000|Overall Study|Lost to Follow-up|81|||
130545524|NCT00700258|469965403|FG000|Overall Study|Premature discontinuation of therapy|1013|||
130545525|NCT00738582|469965407|FG000|Combination Therapy|Completed Combination Therapy|1|||
130545526|NCT00738582|469965408|FG001|Combination Therapy|Completed Combination Therapy|0|||
130545527|NCT00738582|469965407|FG000|Combination Therapy|Physician Decision|1|||
130545528|NCT00738582|469965408|FG001|Combination Therapy|Physician Decision|0|||
130545529|NCT00738582|469965407|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
130545530|NCT00738582|469965408|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
130545531|NCT00738582|469965407|FG000|Combination Therapy|Other|5|||
130545532|NCT00738582|469965408|FG001|Combination Therapy|Other|0|||
130545533|NCT00738582|469965407|FG000|Combination Therapy|Adverse Event|16|||
130545534|NCT00738582|469965408|FG001|Combination Therapy|Adverse Event|0|||
130545535|NCT00738582|469965407|FG000|Combination Therapy|Progressive Disease|9|||
130545536|NCT00738582|469965408|FG001|Combination Therapy|Progressive Disease|0|||
130545537|NCT00738582|469965407|FG000|Maintenance Therapy|Other|0|||
130545538|NCT00738582|469965408|FG001|Maintenance Therapy|Other|2|||
130545539|NCT00738582|469965407|FG000|Maintenance Therapy|Adverse Event|0|||
130545540|NCT00738582|469965408|FG001|Maintenance Therapy|Adverse Event|6|||
130545541|NCT00738582|469965407|FG000|Maintenance Therapy|Progressive Disease|0|||
130545542|NCT00738582|469965408|FG001|Maintenance Therapy|Progressive Disease|47|||
130545543|NCT00738582|469965407|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
130545544|NCT00738582|469965408|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
130545545|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
130545546|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
130545547|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
130545548|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
130545549|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
130545550|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
130545551|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
130545552|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
130545553|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
130545554|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
130545555|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
130545556|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
130545557|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
130545558|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
130322361|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322362|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322363|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
130322364|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
130322365|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
130322366|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
130322367|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
130545559|NCT00757588|469965409|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
130545560|NCT00757588|469965410|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
130545561|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
130545562|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
130545563|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
130545564|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
130545565|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
130545566|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
130545567|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
130545568|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
130545569|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
130545570|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
130545571|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
130545572|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
130545573|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
130545574|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
130545575|NCT00757588|469965409|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
130545576|NCT00757588|469965410|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
130545577|NCT01052103|469965411|FG000|Overall Study|Adverse Event|10|||
130545578|NCT01052103|469965412|FG001|Overall Study|Adverse Event|6|||
130545579|NCT01052103|469965411|FG000|Overall Study|Entry Criteria Not Met|3|||
130545580|NCT01052103|469965412|FG001|Overall Study|Entry Criteria Not Met|1|||
130545581|NCT01052103|469965411|FG000|Overall Study|Lost to Follow-up|3|||
130545582|NCT01052103|469965412|FG001|Overall Study|Lost to Follow-up|5|||
130545583|NCT01052103|469965411|FG000|Overall Study|Protocol Violation|10|||
130545584|NCT01052103|469965412|FG001|Overall Study|Protocol Violation|4|||
130545585|NCT01052103|469965411|FG000|Overall Study|Scheduling conflict|2|||
130545586|NCT01052103|469965412|FG001|Overall Study|Scheduling conflict|1|||
130545587|NCT01052103|469965411|FG000|Overall Study|Sponsor Decision|2|||
130545588|NCT01052103|469965412|FG001|Overall Study|Sponsor Decision|0|||
130545589|NCT01052103|469965411|FG000|Overall Study|Withdrawal by Subject|3|||
130545590|NCT01052103|469965412|FG001|Overall Study|Withdrawal by Subject|6|||
130545591|NCT01052103|469965411|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130545592|NCT01052103|469965412|FG001|Overall Study|Perceived Lack of Efficacy|0|||
130545593|NCT00799513|469965416|FG000|Overall Study|Physician Decision|1|||
130545594|NCT00799513|469965416|FG000|Overall Study|Adverse Event|1|||
130545595|NCT05398237|469965419|FG000|Overall Study|Withdrawal by Subject|1|||
130545596|NCT00666679|469965420|FG000|First Intervention|Lost to Follow-up|1|||
130545597|NCT00666679|469965421|FG001|First Intervention|Lost to Follow-up|0|||
130545598|NCT00666679|469965420|FG000|First Intervention|Protocol Violation|1|||
130545599|NCT00666679|469965421|FG001|First Intervention|Protocol Violation|0|||
130545600|NCT00666679|469965420|FG000|First Intervention|Withdrawal by Subject|1|||
130545601|NCT00666679|469965421|FG001|First Intervention|Withdrawal by Subject|0|||
130545602|NCT00666679|469965420|FG000|First Intervention|Randomized did not start treatment|1|||
130545603|NCT00666679|469965421|FG001|First Intervention|Randomized did not start treatment|1|||
130545604|NCT00666679|469965420|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
130545605|NCT00666679|469965421|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
130545606|NCT00666679|469965420|FG000|Washout Period of 1 Week|Protocol Violation|0|||
130545607|NCT00666679|469965421|FG001|Washout Period of 1 Week|Protocol Violation|1|||
130545608|NCT00666679|469965420|FG000|Second Intervention|Adverse Event|1|||
130545609|NCT00666679|469965421|FG001|Second Intervention|Adverse Event|0|||
130545610|NCT00666679|469965420|FG000|Second Intervention|Death|0|||
130545611|NCT00666679|469965421|FG001|Second Intervention|Death|1|||
130545612|NCT05062759|469965427|FG000|Overall Study|Death|0|||
130545613|NCT05062759|469965428|FG001|Overall Study|Death|1|||
130545614|NCT05062759|469965427|FG000|Overall Study|Lost to Follow-up|1|||
130545615|NCT05062759|469965428|FG001|Overall Study|Lost to Follow-up|0|||
130545616|NCT01248065|469965429|FG000|Overall Study|Lost to Follow-up|3|||
130545617|NCT01248065|469965430|FG001|Overall Study|Lost to Follow-up|5|||
130545618|NCT01248065|469965429|FG000|Overall Study|Withdrawal by Subject|14|||
130545619|NCT01248065|469965430|FG001|Overall Study|Withdrawal by Subject|11|||
130545620|NCT01248065|469965429|FG000|Overall Study|Adverse Event|3|||
130545621|NCT01248065|469965430|FG001|Overall Study|Adverse Event|0|||
130545622|NCT01248065|469965429|FG000|Overall Study|Third treatment failure event|3|||
130545623|NCT01248065|469965430|FG001|Overall Study|Third treatment failure event|1|||
130545624|NCT01248065|469965429|FG000|Overall Study|Other|3|||
130545625|NCT01248065|469965430|FG001|Overall Study|Other|5|||
130545626|NCT02781844|469965434|FG000|Treatment Period 1|Adverse Event|0|||
130545627|NCT02781844|469965435|FG001|Treatment Period 1|Adverse Event|0|||
130545628|NCT02781844|469965436|FG002|Treatment Period 1|Adverse Event|0|||
130214001|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130214002|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
130545629|NCT02781844|469965437|FG003|Treatment Period 1|Adverse Event|0|||
130545630|NCT02781844|469965438|FG004|Treatment Period 1|Adverse Event|0|||
130545631|NCT02781844|469965439|FG005|Treatment Period 1|Adverse Event|1|||
130545632|NCT02781844|469965440|FG006|Treatment Period 1|Adverse Event|0|||
130545633|NCT02781844|469965441|FG007|Treatment Period 1|Adverse Event|0|||
130545634|NCT02518490|469965444|FG000|Overall Study|Withdrawal by Subject|1|||
130545635|NCT02518490|469965445|FG001|Overall Study|Withdrawal by Subject|1|||
130545636|NCT03010176|469965446|FG000|Overall Study|Death|21|||
130545637|NCT03010176|469965447|FG001|Overall Study|Death|35|||
130545638|NCT03010176|469965448|FG002|Overall Study|Death|19|||
130545639|NCT03010176|469965449|FG003|Overall Study|Death|19|||
130214003|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
130545640|NCT03010176|469965450|FG004|Overall Study|Death|14|||
130545641|NCT03010176|469965451|FG005|Overall Study|Death|0|||
130545642|NCT03010176|469965446|FG000|Overall Study|Lost to Follow-up|0|||
130545643|NCT03010176|469965447|FG001|Overall Study|Lost to Follow-up|0|||
130545644|NCT03010176|469965448|FG002|Overall Study|Lost to Follow-up|0|||
130545645|NCT03010176|469965449|FG003|Overall Study|Lost to Follow-up|0|||
130545646|NCT03010176|469965450|FG004|Overall Study|Lost to Follow-up|1|||
130545647|NCT03010176|469965451|FG005|Overall Study|Lost to Follow-up|0|||
130545648|NCT03010176|469965446|FG000|Overall Study|Physician Decision|0|||
130545649|NCT03010176|469965447|FG001|Overall Study|Physician Decision|4|||
130545650|NCT03010176|469965448|FG002|Overall Study|Physician Decision|0|||
130545651|NCT03010176|469965449|FG003|Overall Study|Physician Decision|1|||
130545652|NCT03010176|469965450|FG004|Overall Study|Physician Decision|0|||
130545653|NCT03010176|469965451|FG005|Overall Study|Physician Decision|0|||
130545654|NCT03010176|469965446|FG000|Overall Study|Sponsor Decision|0|||
130545655|NCT03010176|469965447|FG001|Overall Study|Sponsor Decision|4|||
130545656|NCT03010176|469965448|FG002|Overall Study|Sponsor Decision|4|||
130545657|NCT03010176|469965449|FG003|Overall Study|Sponsor Decision|1|||
130545658|NCT03010176|469965450|FG004|Overall Study|Sponsor Decision|6|||
130545659|NCT03010176|469965451|FG005|Overall Study|Sponsor Decision|0|||
130545660|NCT03010176|469965446|FG000|Overall Study|Withdrawal by Subject|11|||
130545661|NCT03010176|469965447|FG001|Overall Study|Withdrawal by Subject|9|||
130545662|NCT03010176|469965448|FG002|Overall Study|Withdrawal by Subject|3|||
130545663|NCT03010176|469965449|FG003|Overall Study|Withdrawal by Subject|0|||
130545664|NCT03010176|469965450|FG004|Overall Study|Withdrawal by Subject|4|||
130545665|NCT03010176|469965451|FG005|Overall Study|Withdrawal by Subject|0|||
130545666|NCT04256629|469965454|FG000|Overall Study|Adverse Event|0|||
130545667|NCT04256629|469965455|FG001|Overall Study|Adverse Event|0|||
130545668|NCT04256629|469965456|FG002|Overall Study|Adverse Event|0|||
130545669|NCT04256629|469965457|FG003|Overall Study|Adverse Event|0|||
130545670|NCT04256629|469965458|FG004|Overall Study|Adverse Event|0|||
130545671|NCT04256629|469965459|FG005|Overall Study|Adverse Event|1|||
130545672|NCT04256629|469965454|FG000|Overall Study|Protocol Violation|0|||
130545673|NCT04256629|469965455|FG001|Overall Study|Protocol Violation|1|||
130545674|NCT04256629|469965456|FG002|Overall Study|Protocol Violation|0|||
130545675|NCT04256629|469965457|FG003|Overall Study|Protocol Violation|0|||
130545676|NCT04256629|469965458|FG004|Overall Study|Protocol Violation|0|||
130545677|NCT04256629|469965459|FG005|Overall Study|Protocol Violation|0|||
130545678|NCT00321373|469965460|FG000|Overall Study|Adverse Event|0|||
130545679|NCT00321373|469965461|FG001|Overall Study|Adverse Event|0|||
130545680|NCT00321373|469965462|FG002|Overall Study|Adverse Event|1|||
130545681|NCT00321373|469965460|FG000|Overall Study|Lost to Follow-up|1|||
130545682|NCT00321373|469965461|FG001|Overall Study|Lost to Follow-up|0|||
130545683|NCT00321373|469965462|FG002|Overall Study|Lost to Follow-up|1|||
130545684|NCT00321373|469965460|FG000|Overall Study|Withdrawal by Subject|1|||
130545685|NCT00321373|469965461|FG001|Overall Study|Withdrawal by Subject|0|||
130545686|NCT00321373|469965462|FG002|Overall Study|Withdrawal by Subject|0|||
130545687|NCT00321373|469965460|FG000|Overall Study|Other|0|||
130545688|NCT00321373|469965461|FG001|Overall Study|Other|0|||
130545689|NCT00321373|469965462|FG002|Overall Study|Other|1|||
130545690|NCT01383499|469965463|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
130545691|NCT01383499|469965464|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130545692|NCT01383499|469965465|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130545693|NCT01383499|469965466|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130545694|NCT01774487|469965467|FG000|Overall Study|Did not tolerate taste|4|||
130545695|NCT01774487|469965468|FG001|Overall Study|Did not tolerate taste|4|||
130545696|NCT00346632|469965469|FG000|Overall Study|Progressive Disease|2|||
130545697|NCT00346632|469965470|FG001|Overall Study|Progressive Disease|2|||
130545698|NCT00346632|469965471|FG002|Overall Study|Progressive Disease|4|||
130545699|NCT00346632|469965472|FG003|Overall Study|Progressive Disease|3|||
130545700|NCT00346632|469965473|FG004|Overall Study|Progressive Disease|3|||
130545701|NCT00346632|469965474|FG005|Overall Study|Progressive Disease|1|||
130545702|NCT00346632|469965475|FG006|Overall Study|Progressive Disease|2|||
130545703|NCT00346632|469965476|FG007|Overall Study|Progressive Disease|2|||
130545704|NCT00346632|469965477|FG008|Overall Study|Progressive Disease|2|||
130545705|NCT00346632|469965478|FG009|Overall Study|Progressive Disease|2|||
130545706|NCT00346632|469965469|FG000|Overall Study|Adverse Event|0|||
130322368|NCT03253796|469149130|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130545707|NCT00346632|469965470|FG001|Overall Study|Adverse Event|0|||
130545708|NCT00346632|469965471|FG002|Overall Study|Adverse Event|0|||
130545709|NCT00346632|469965472|FG003|Overall Study|Adverse Event|0|||
130545710|NCT00346632|469965473|FG004|Overall Study|Adverse Event|1|||
130545711|NCT00346632|469965474|FG005|Overall Study|Adverse Event|1|||
130545712|NCT00346632|469965475|FG006|Overall Study|Adverse Event|1|||
130545713|NCT00346632|469965476|FG007|Overall Study|Adverse Event|0|||
130545714|NCT00346632|469965477|FG008|Overall Study|Adverse Event|0|||
130545715|NCT00346632|469965478|FG009|Overall Study|Adverse Event|0|||
130545716|NCT00346632|469965469|FG000|Overall Study|Death|0|||
130322369|NCT03253796|469149131|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130545717|NCT00346632|469965470|FG001|Overall Study|Death|0|||
130545718|NCT00346632|469965471|FG002|Overall Study|Death|1|||
130545719|NCT00346632|469965472|FG003|Overall Study|Death|0|||
130545720|NCT00346632|469965473|FG004|Overall Study|Death|0|||
130545721|NCT00346632|469965474|FG005|Overall Study|Death|0|||
130545722|NCT00346632|469965475|FG006|Overall Study|Death|0|||
130545723|NCT00346632|469965476|FG007|Overall Study|Death|0|||
130545724|NCT00346632|469965477|FG008|Overall Study|Death|0|||
130545725|NCT00346632|469965478|FG009|Overall Study|Death|0|||
130545726|NCT00346632|469965469|FG000|Overall Study|Protocol Violation|0|||
130545727|NCT00346632|469965470|FG001|Overall Study|Protocol Violation|0|||
130545728|NCT00346632|469965471|FG002|Overall Study|Protocol Violation|0|||
130545729|NCT00346632|469965472|FG003|Overall Study|Protocol Violation|0|||
130545730|NCT00346632|469965473|FG004|Overall Study|Protocol Violation|0|||
130545731|NCT00346632|469965474|FG005|Overall Study|Protocol Violation|0|||
130545732|NCT00346632|469965475|FG006|Overall Study|Protocol Violation|1|||
130545733|NCT00346632|469965476|FG007|Overall Study|Protocol Violation|0|||
130545734|NCT00346632|469965477|FG008|Overall Study|Protocol Violation|0|||
130545735|NCT00346632|469965478|FG009|Overall Study|Protocol Violation|0|||
130545736|NCT00346632|469965469|FG000|Overall Study|Withdrawal by Subject|0|||
130545737|NCT00346632|469965470|FG001|Overall Study|Withdrawal by Subject|0|||
130545738|NCT00346632|469965471|FG002|Overall Study|Withdrawal by Subject|0|||
130545739|NCT00346632|469965472|FG003|Overall Study|Withdrawal by Subject|0|||
130545740|NCT00346632|469965473|FG004|Overall Study|Withdrawal by Subject|0|||
130545741|NCT00346632|469965474|FG005|Overall Study|Withdrawal by Subject|0|||
130545742|NCT00346632|469965475|FG006|Overall Study|Withdrawal by Subject|1|||
130545743|NCT00346632|469965476|FG007|Overall Study|Withdrawal by Subject|0|||
130545744|NCT00346632|469965477|FG008|Overall Study|Withdrawal by Subject|0|||
130545745|NCT00346632|469965478|FG009|Overall Study|Withdrawal by Subject|0|||
130545746|NCT00346632|469965469|FG000|Overall Study|Switched to alternative treatment|0|||
130545747|NCT00346632|469965470|FG001|Overall Study|Switched to alternative treatment|0|||
130545748|NCT00346632|469965471|FG002|Overall Study|Switched to alternative treatment|1|||
130545749|NCT00346632|469965472|FG003|Overall Study|Switched to alternative treatment|0|||
130545750|NCT00346632|469965473|FG004|Overall Study|Switched to alternative treatment|0|||
130545751|NCT00346632|469965474|FG005|Overall Study|Switched to alternative treatment|0|||
130545752|NCT00346632|469965475|FG006|Overall Study|Switched to alternative treatment|0|||
130545753|NCT00346632|469965476|FG007|Overall Study|Switched to alternative treatment|0|||
130545754|NCT00346632|469965477|FG008|Overall Study|Switched to alternative treatment|0|||
130545755|NCT00346632|469965478|FG009|Overall Study|Switched to alternative treatment|0|||
130545756|NCT00346632|469965469|FG000|Overall Study|Not Stated|1|||
130545757|NCT00346632|469965470|FG001|Overall Study|Not Stated|1|||
130545758|NCT00346632|469965471|FG002|Overall Study|Not Stated|0|||
130545759|NCT00346632|469965472|FG003|Overall Study|Not Stated|0|||
130545760|NCT00346632|469965473|FG004|Overall Study|Not Stated|0|||
130545761|NCT00346632|469965474|FG005|Overall Study|Not Stated|0|||
130545762|NCT00346632|469965475|FG006|Overall Study|Not Stated|0|||
130545763|NCT00346632|469965476|FG007|Overall Study|Not Stated|2|||
130545764|NCT00346632|469965477|FG008|Overall Study|Not Stated|2|||
130545765|NCT00346632|469965478|FG009|Overall Study|Not Stated|1|||
130545766|NCT00918580|469965479|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
130545767|NCT00918580|469965479|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
130545768|NCT00918580|469965479|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
130545769|NCT00918580|469965479|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
130545770|NCT00918580|469965479|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
130545771|NCT00918580|469965479|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
130545772|NCT00918580|469965479|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
130545773|NCT01079663|469965480|FG000|Overall Study|Adverse Event|0|||
130545774|NCT01079663|469965481|FG001|Overall Study|Adverse Event|2|||
130545775|NCT01079663|469965480|FG000|Overall Study|Protocol Violation|0|||
130545776|NCT01079663|469965481|FG001|Overall Study|Protocol Violation|2|||
130545777|NCT00297232|469965482|FG000|Overall Study|Lack of Efficacy|7|||
130545778|NCT00297232|469965482|FG000|Overall Study|Lost to Follow-up|10|||
130545779|NCT00297232|469965482|FG000|Overall Study|Adverse Event|63|||
130545780|NCT00297232|469965482|FG000|Overall Study|Voluntary Withdrawal|120|||
130545781|NCT00297232|469965482|FG000|Overall Study|Subject was Noncompliant|9|||
130545782|NCT00297232|469965482|FG000|Overall Study|Death|9|||
130545783|NCT00297232|469965482|FG000|Overall Study|Anti-natalizumab Positive|8|||
130545784|NCT00297232|469965482|FG000|Overall Study|Switched to Commercial Tysabri|22|||
130545785|NCT00297232|469965482|FG000|Overall Study|Disease Progression|8|||
130545786|NCT00297232|469965482|FG000|Overall Study|Fear of PML|10|||
130545787|NCT00297232|469965482|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
130545788|NCT00297232|469965482|FG000|Overall Study|Miscellaneous|5|||
130545789|NCT00297232|469965482|FG000|Overall Study|Sponsor Decision|34|||
130545790|NCT00297232|469965482|FG000|Overall Study|Subject Relocated|7|||
130545791|NCT00297232|469965482|FG000|Overall Study|Subject Withdrew Consent|37|||
130545792|NCT00297232|469965482|FG000|Overall Study|Persistently Positive Antibodies|11|||
130545793|NCT00297232|469965482|FG000|Overall Study|Investigator Withdrew From Program|19|||
130545794|NCT00297232|469965482|FG000|Overall Study|Did Not Enroll to Week 264|34|||
130545795|NCT00297232|469965482|FG000|Overall Study|Did Not Enroll to Week 480|17|||
130545796|NCT00297232|469965482|FG000|Overall Study|No data available after Week 264|161|||
130545797|NCT00297232|469965482|FG000|Overall Study|Other|1|||
130545798|NCT00946101|469965483|FG000|Overall Study|Lost to Follow-up|2|||
130545799|NCT00946101|469965484|FG001|Overall Study|Lost to Follow-up|1|||
130545800|NCT00946101|469965483|FG000|Overall Study|Withdrawal of consent|2|||
130545801|NCT00946101|469965484|FG001|Overall Study|Withdrawal of consent|0|||
130545802|NCT00946101|469965483|FG000|Overall Study|Physician Decision|0|||
130545803|NCT00946101|469965484|FG001|Overall Study|Physician Decision|1|||
130545804|NCT00552240|469965490|FG000|Overall Study|Adverse Event|9|||
130545805|NCT00552240|469965491|FG001|Overall Study|Adverse Event|9|||
130545806|NCT00552240|469965490|FG000|Overall Study|Protocol Violation|1|||
130545807|NCT00552240|469965491|FG001|Overall Study|Protocol Violation|1|||
130545808|NCT00552240|469965490|FG000|Overall Study|Lost to Follow-up|5|||
130545809|NCT00552240|469965491|FG001|Overall Study|Lost to Follow-up|6|||
130545810|NCT00552240|469965490|FG000|Overall Study|Withdrawal by Subject|2|||
130545811|NCT00552240|469965491|FG001|Overall Study|Withdrawal by Subject|2|||
130545812|NCT00552240|469965490|FG000|Overall Study|Lack of Efficacy|6|||
130545813|NCT00552240|469965491|FG001|Overall Study|Lack of Efficacy|0|||
130545814|NCT00552240|469965490|FG000|Overall Study|Other|1|||
130545815|NCT00552240|469965491|FG001|Overall Study|Other|0|||
130545816|NCT02783768|469965493|FG000|Overall Study|Lost to Follow-up|1|||
130545817|NCT02783768|469965494|FG001|Overall Study|Lost to Follow-up|0|||
130545818|NCT02476279|469965495|FG000|Overall Study|Lost to Follow-up|1|||
130545819|NCT02476279|469965496|FG001|Overall Study|Lost to Follow-up|1|||
130545820|NCT01323647|469965497|FG000|Overall Study|Migrated/moved from study area|2|||
130545821|NCT01323647|469965498|FG001|Overall Study|Migrated/moved from study area|0|||
130545822|NCT01323647|469965497|FG000|Overall Study|Withdrawal by Subject|5|||
130545823|NCT01323647|469965498|FG001|Overall Study|Withdrawal by Subject|0|||
130545824|NCT01323647|469965497|FG000|Overall Study|Lost to Follow-up|2|||
130545825|NCT01323647|469965498|FG001|Overall Study|Lost to Follow-up|0|||
130545826|NCT01236339|469965501|FG000|Overall Study|Termination of study by sponsor|11|||
130545827|NCT01236339|469965502|FG001|Overall Study|Termination of study by sponsor|13|||
130545828|NCT02054741|469965503|FG000|Overall Study|Protocol Violation|13|||
130545829|NCT02054741|469965504|FG001|Overall Study|Protocol Violation|2|||
130545830|NCT02054741|469965503|FG000|Overall Study|Withdrawal by Subject|10|||
130545831|NCT02054741|469965504|FG001|Overall Study|Withdrawal by Subject|5|||
130545832|NCT02054741|469965503|FG000|Overall Study|Death|94|||
130545833|NCT02054741|469965504|FG001|Overall Study|Death|90|||
130545834|NCT02054741|469965503|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
130545835|NCT02054741|469965504|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
130545836|NCT01945060|469965505|FG000|Overall Study|Lost to follow up|1|||
130545837|NCT01945060|469965506|FG001|Overall Study|Lost to follow up|0|||
130545838|NCT01945060|469965505|FG000|Overall Study|Distress related to IV access|0|||
130545839|NCT01945060|469965506|FG001|Overall Study|Distress related to IV access|1|||
130545840|NCT00402597|469965507|FG000|Overall Study|Death|15|||
130545841|NCT00402597|469965508|FG001|Overall Study|Death|7|||
130545842|NCT00402597|469965509|FG002|Overall Study|Death|6|||
130545843|NCT00402597|469965510|FG003|Overall Study|Death|4|||
130545844|NCT00402597|469965511|FG004|Overall Study|Death|6|||
130545845|NCT00402597|469965507|FG000|Overall Study|Adverse Event|81|||
130545846|NCT00402597|469965508|FG001|Overall Study|Adverse Event|18|||
130545847|NCT00402597|469965509|FG002|Overall Study|Adverse Event|106|||
130545848|NCT00402597|469965510|FG003|Overall Study|Adverse Event|39|||
130545849|NCT00402597|469965511|FG004|Overall Study|Adverse Event|71|||
130545850|NCT00402597|469965507|FG000|Overall Study|Lost to Follow-up|8|||
130545851|NCT00402597|469965508|FG001|Overall Study|Lost to Follow-up|1|||
130545852|NCT00402597|469965509|FG002|Overall Study|Lost to Follow-up|8|||
130545853|NCT00402597|469965510|FG003|Overall Study|Lost to Follow-up|2|||
130545854|NCT00402597|469965511|FG004|Overall Study|Lost to Follow-up|3|||
130214004|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
130214005|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
130214006|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130214007|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
130214008|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130214009|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
130214010|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
130545855|NCT00402597|469965507|FG000|Overall Study|Withdrawal by Subject|57|||
130545856|NCT00402597|469965508|FG001|Overall Study|Withdrawal by Subject|16|||
130214011|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
130545857|NCT00402597|469965509|FG002|Overall Study|Withdrawal by Subject|65|||
130545858|NCT00402597|469965510|FG003|Overall Study|Withdrawal by Subject|15|||
130545859|NCT00402597|469965511|FG004|Overall Study|Withdrawal by Subject|24|||
130545860|NCT00402597|469965507|FG000|Overall Study|reason not specified|30|||
130545861|NCT00402597|469965508|FG001|Overall Study|reason not specified|4|||
130545862|NCT00402597|469965509|FG002|Overall Study|reason not specified|27|||
130559410|NCT01621542|470016494|FG004|Overall Study|Physician Decision|3|||
130545863|NCT00402597|469965510|FG003|Overall Study|reason not specified|14|||
130545864|NCT00402597|469965511|FG004|Overall Study|reason not specified|20|||
130545865|NCT02319525|469965513|FG000|Overall Study|Withdrawal by Subject|2|||
130545866|NCT02319525|469965514|FG001|Overall Study|Withdrawal by Subject|1|||
130545867|NCT00938860|469965515|FG000|Overall Study|Adverse Event|2|||
130545868|NCT00938860|469965516|FG001|Overall Study|Adverse Event|1|||
130545869|NCT00938860|469965515|FG000|Overall Study|Abnormal laboratory values|2|||
130545870|NCT00938860|469965516|FG001|Overall Study|Abnormal laboratory values|2|||
130545871|NCT00938860|469965515|FG000|Overall Study|Withdrawal by Subject|11|||
130545872|NCT00938860|469965516|FG001|Overall Study|Withdrawal by Subject|8|||
130545873|NCT00938860|469965515|FG000|Overall Study|Lost to Follow-up|4|||
130545874|NCT00938860|469965516|FG001|Overall Study|Lost to Follow-up|4|||
130545875|NCT00938860|469965515|FG000|Overall Study|Administration problems|2|||
130545876|NCT00938860|469965516|FG001|Overall Study|Administration problems|0|||
130545877|NCT00938860|469965515|FG000|Overall Study|Death|1|||
130545878|NCT00938860|469965516|FG001|Overall Study|Death|1|||
130545879|NCT00938860|469965515|FG000|Overall Study|Protocol Violation|3|||
130545880|NCT00938860|469965516|FG001|Overall Study|Protocol Violation|1|||
130545881|NCT00577577|469965518|FG000|Overall Study|Adverse Event|3|||
130545882|NCT00577577|469965519|FG001|Overall Study|Adverse Event|2|||
130545883|NCT00577577|469965518|FG000|Overall Study|Lost to Follow-up|1|||
130545884|NCT00577577|469965519|FG001|Overall Study|Lost to Follow-up|0|||
130545885|NCT00577577|469965518|FG000|Overall Study|Protocol Violation|0|||
130545886|NCT00577577|469965519|FG001|Overall Study|Protocol Violation|3|||
130545887|NCT00577577|469965518|FG000|Overall Study|Transportation|1|||
130545888|NCT00577577|469965519|FG001|Overall Study|Transportation|0|||
130545889|NCT00906945|469965524|FG000|Overall Study|Found to be not eligible|0|||
130545890|NCT00906945|469965525|FG001|Overall Study|Found to be not eligible|0|||
130545891|NCT00906945|469965526|FG002|Overall Study|Found to be not eligible|0|||
130545892|NCT00906945|469965527|FG003|Overall Study|Found to be not eligible|1|||
130545893|NCT00906945|469965528|FG004|Overall Study|Found to be not eligible|1|||
130545894|NCT00906945|469965529|FG005|Overall Study|Found to be not eligible|1|||
130545895|NCT00906945|469965524|FG000|Overall Study|Physician Decision|0|||
130545896|NCT00906945|469965525|FG001|Overall Study|Physician Decision|0|||
130545897|NCT00906945|469965526|FG002|Overall Study|Physician Decision|0|||
130545898|NCT00906945|469965527|FG003|Overall Study|Physician Decision|0|||
130545899|NCT00906945|469965528|FG004|Overall Study|Physician Decision|0|||
130545900|NCT00906945|469965529|FG005|Overall Study|Physician Decision|1|||
130545901|NCT03965351|469965535|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130545902|NCT03965351|469965536|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
130545903|NCT03965351|469965535|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
130545904|NCT03965351|469965536|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
130545905|NCT00943111|469965539|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
130545906|NCT00943111|469965540|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
130545907|NCT00943111|469965541|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
130545908|NCT00943111|469965539|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
130545909|NCT00943111|469965540|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
130545910|NCT00943111|469965541|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
130545911|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
130545912|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
130545913|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
130545914|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
130545915|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
130545916|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
130545917|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
130545918|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
130545919|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
130545920|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
130545921|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
130545922|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
130545923|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
130545924|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
130545925|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
130545926|NCT00943111|469965539|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
130545927|NCT00943111|469965540|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
130545928|NCT00943111|469965541|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
130433146|NCT01453348|469550353|FG001|Overall Study|Death|0|||
130545929|NCT04227704|469965545|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
130545930|NCT04227704|469965546|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
130545931|NCT04227704|469965547|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
130545932|NCT04227704|469965545|FG000|Overall Study|due to C/S being cancelled|1|||
130545933|NCT04227704|469965546|FG001|Overall Study|due to C/S being cancelled|0|||
130545934|NCT04227704|469965547|FG002|Overall Study|due to C/S being cancelled|0|||
130545935|NCT03432260|469965554|FG000|Overall Study|Lost to Follow-up|1|||
130545936|NCT03432260|469965555|FG001|Overall Study|Lost to Follow-up|1|||
130545937|NCT03432260|469965556|FG002|Overall Study|Lost to Follow-up|0|||
130545938|NCT03432260|469965557|FG003|Overall Study|Lost to Follow-up|0|||
130545939|NCT03432260|469965558|FG004|Overall Study|Lost to Follow-up|1|||
130545940|NCT01775124|469965560|FG000|Core Period|Disease Progression|0|||
130545941|NCT01775124|469965561|FG001|Core Period|Disease Progression|1|||
130545942|NCT01775124|469965560|FG000|Core Period|Physician Decision|1|||
130545943|NCT01775124|469965561|FG001|Core Period|Physician Decision|1|||
130545944|NCT01775124|469965560|FG000|Core Period|Death|0|||
130545945|NCT01775124|469965561|FG001|Core Period|Death|1|||
130545946|NCT01775124|469965560|FG000|Core Period|Administrative problems|1|||
130545947|NCT01775124|469965561|FG001|Core Period|Administrative problems|0|||
130545948|NCT01775124|469965560|FG000|Core Period|Withdrawal by Subject|4|||
130545949|NCT01775124|469965561|FG001|Core Period|Withdrawal by Subject|2|||
130545950|NCT01775124|469965560|FG000|Core Period|Adverse Event|5|||
130545951|NCT01775124|469965561|FG001|Core Period|Adverse Event|5|||
130545952|NCT01775124|469965560|FG000|Extension Period|Adverse Event|3|||
130545953|NCT01775124|469965561|FG001|Extension Period|Adverse Event|2|||
130545954|NCT01775124|469965560|FG000|Extension Period|Physician Decision|0|||
130545955|NCT01775124|469965561|FG001|Extension Period|Physician Decision|2|||
130545956|NCT01775124|469965560|FG000|Extension Period|Administrative problems|0|||
130545957|NCT01775124|469965561|FG001|Extension Period|Administrative problems|1|||
130545958|NCT01775124|469965560|FG000|Extension Period|Lost to Follow-up|0|||
130545959|NCT01775124|469965561|FG001|Extension Period|Lost to Follow-up|1|||
130545960|NCT01775124|469965560|FG000|Extension Period|Withdrawal by Subject|9|||
130545961|NCT01775124|469965561|FG001|Extension Period|Withdrawal by Subject|12|||
130545962|NCT00031551|469967672|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
130545963|NCT00031551|469967673|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
130545964|NCT00409773|469967674|FG000|Overall Study|Adverse Event|3|||
130545965|NCT00409773|469967675|FG001|Overall Study|Adverse Event|4|||
130545966|NCT00409773|469967676|FG002|Overall Study|Adverse Event|4|||
130545967|NCT00409773|469967677|FG003|Overall Study|Adverse Event|2|||
130545968|NCT00409773|469967678|FG004|Overall Study|Adverse Event|6|||
130545969|NCT00409773|469967674|FG000|Overall Study|Lost to Follow-up|6|||
130545970|NCT00409773|469967675|FG001|Overall Study|Lost to Follow-up|1|||
130545971|NCT00409773|469967676|FG002|Overall Study|Lost to Follow-up|2|||
130545972|NCT00409773|469967677|FG003|Overall Study|Lost to Follow-up|3|||
130545973|NCT00409773|469967678|FG004|Overall Study|Lost to Follow-up|1|||
130545974|NCT00409773|469967674|FG000|Overall Study|Physician Decision|0|||
130545975|NCT00409773|469967675|FG001|Overall Study|Physician Decision|0|||
130545976|NCT00409773|469967676|FG002|Overall Study|Physician Decision|0|||
130545977|NCT00409773|469967677|FG003|Overall Study|Physician Decision|2|||
130545978|NCT00409773|469967678|FG004|Overall Study|Physician Decision|0|||
130545979|NCT00409773|469967674|FG000|Overall Study|Protocol Violation|0|||
130545980|NCT00409773|469967675|FG001|Overall Study|Protocol Violation|2|||
130545981|NCT00409773|469967676|FG002|Overall Study|Protocol Violation|3|||
130545982|NCT00409773|469967677|FG003|Overall Study|Protocol Violation|3|||
130545983|NCT00409773|469967678|FG004|Overall Study|Protocol Violation|1|||
130545984|NCT00409773|469967674|FG000|Overall Study|Withdrawal by Subject|0|||
130545985|NCT00409773|469967675|FG001|Overall Study|Withdrawal by Subject|0|||
130545986|NCT00409773|469967676|FG002|Overall Study|Withdrawal by Subject|0|||
130545987|NCT00409773|469967677|FG003|Overall Study|Withdrawal by Subject|2|||
130545988|NCT00409773|469967678|FG004|Overall Study|Withdrawal by Subject|1|||
130545989|NCT00409773|469967674|FG000|Overall Study|Lack of Eligibility|0|||
130545990|NCT00409773|469967675|FG001|Overall Study|Lack of Eligibility|0|||
130545991|NCT00409773|469967676|FG002|Overall Study|Lack of Eligibility|0|||
130545992|NCT00409773|469967677|FG003|Overall Study|Lack of Eligibility|0|||
130545993|NCT00409773|469967678|FG004|Overall Study|Lack of Eligibility|1|||
130545994|NCT02359877|469967679|FG000|Overall Study|Withdrawal by Subject|1|||
130545995|NCT02359877|469967680|FG001|Overall Study|Withdrawal by Subject|0|||
130545996|NCT02359877|469967681|FG002|Overall Study|Withdrawal by Subject|0|||
130545997|NCT02359877|469967682|FG003|Overall Study|Withdrawal by Subject|2|||
130322370|NCT03253796|469149132|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130322371|NCT03253796|469149133|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130545998|NCT02359877|469967679|FG000|Overall Study|Adverse Event|0|||
130545999|NCT02359877|469967680|FG001|Overall Study|Adverse Event|0|||
130546000|NCT02359877|469967681|FG002|Overall Study|Adverse Event|0|||
130546001|NCT02359877|469967682|FG003|Overall Study|Adverse Event|1|||
130546002|NCT01919814|469967683|FG000|Overall Study|Adverse Event|1|||
130546003|NCT01919814|469967684|FG001|Overall Study|Adverse Event|0|||
130546004|NCT01919814|469967683|FG000|Overall Study|Protocol Violation|1|||
130546005|NCT01919814|469967684|FG001|Overall Study|Protocol Violation|0|||
130546006|NCT01919814|469967683|FG000|Overall Study|Withdrawal by Subject|1|||
130546007|NCT01919814|469967684|FG001|Overall Study|Withdrawal by Subject|0|||
130546008|NCT02164383|469967685|FG000|Overall Study|Lost to Follow-up|1|||
130546009|NCT02164383|469967686|FG001|Overall Study|Lost to Follow-up|0|||
130546010|NCT02831387|469967688|FG000|Overall Study|Withdrawal by Subject|1|||
130546011|NCT02831387|469967689|FG001|Overall Study|Withdrawal by Subject|1|||
130546012|NCT02831387|469967688|FG000|Overall Study|Discontinued due to stock recovery|0|||
130546013|NCT02831387|469967689|FG001|Overall Study|Discontinued due to stock recovery|1|||
130546014|NCT00192647|469967690|FG000|Overall Study|Death|1|||
130546015|NCT00192647|469967691|FG001|Overall Study|Death|1|||
130546016|NCT00192647|469967690|FG000|Overall Study|Adverse Event|35|||
130546017|NCT00192647|469967691|FG001|Overall Study|Adverse Event|29|||
130546018|NCT00192647|469967690|FG000|Overall Study|Laboratory Test Abnormality|4|||
130546019|NCT00192647|469967691|FG001|Overall Study|Laboratory Test Abnormality|2|||
130546020|NCT00192647|469967690|FG000|Overall Study|Insufficient Therapeutic Response|53|||
130546021|NCT00192647|469967691|FG001|Overall Study|Insufficient Therapeutic Response|83|||
130546022|NCT00192647|469967690|FG000|Overall Study|Entry Criteria Violation|6|||
130546023|NCT00192647|469967691|FG001|Overall Study|Entry Criteria Violation|6|||
130546024|NCT00192647|469967690|FG000|Overall Study|Protocol Violation|3|||
130546025|NCT00192647|469967691|FG001|Overall Study|Protocol Violation|1|||
130546026|NCT00192647|469967690|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
130546027|NCT00192647|469967691|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
130546028|NCT00192647|469967690|FG000|Overall Study|Failure to Return|11|||
130546029|NCT00192647|469967691|FG001|Overall Study|Failure to Return|13|||
130546030|NCT00192647|469967690|FG000|Overall Study|Other/Administrative|5|||
130546031|NCT00192647|469967691|FG001|Overall Study|Other/Administrative|3|||
130546032|NCT01828073|469967692|FG000|Overall Study|Lost to Follow-up|1|||
130546033|NCT01828073|469967693|FG001|Overall Study|Lost to Follow-up|2|||
130546034|NCT00690443|469967694|FG000|Overall Study|Adverse Event|1|||
130546035|NCT00690443|469967695|FG001|Overall Study|Adverse Event|2|||
130546036|NCT01350336|469967696|FG000|Overall Study|Lost to Follow-up|31|||
130546037|NCT01350336|469967696|FG000|Overall Study|Withdrawal by Subject|14|||
130546038|NCT01350336|469967696|FG000|Overall Study|Physician Decision|8|||
130546039|NCT01350336|469967696|FG000|Overall Study|Death|4|||
130546040|NCT02079610|469967699|FG000|Overall Study|Withdrawal by Subject|1|||
130546041|NCT02079610|469967700|FG001|Overall Study|Withdrawal by Subject|1|||
130546042|NCT01111474|469967704|FG000|Overall Study|Lost to Follow-up|12|||
130546043|NCT01016977|469967705|FG000|Overall Study|Lost to Follow-up|1|||
130546044|NCT01016977|469967706|FG001|Overall Study|Lost to Follow-up|0|||
130546045|NCT01016977|469967705|FG000|Overall Study|Withdrawal by Subject|2|||
130546046|NCT01016977|469967706|FG001|Overall Study|Withdrawal by Subject|2|||
130546047|NCT00477334|469967707|FG000|Overall Study|Discontinued prior to taking study drug|106|||
130546048|NCT00477334|469967708|FG001|Overall Study|Discontinued prior to taking study drug|53|||
130546049|NCT00477334|469967707|FG000|Overall Study|Adverse Event|1|||
130546050|NCT00477334|469967708|FG001|Overall Study|Adverse Event|2|||
130546051|NCT00477334|469967707|FG000|Overall Study|Withdrawal by Subject|2|||
130546052|NCT00477334|469967708|FG001|Overall Study|Withdrawal by Subject|1|||
130546053|NCT00477334|469967707|FG000|Overall Study|Lost to Follow-up|15|||
130546054|NCT00477334|469967708|FG001|Overall Study|Lost to Follow-up|4|||
130546055|NCT00477334|469967707|FG000|Overall Study|Administrative Problems|39|||
130546056|NCT00477334|469967708|FG001|Overall Study|Administrative Problems|15|||
130546057|NCT00477334|469967707|FG000|Overall Study|Protocol Violation|7|||
130546058|NCT00477334|469967708|FG001|Overall Study|Protocol Violation|1|||
130546059|NCT02354508|469967710|FG000|Period 1: Core Phase|Adverse Event|1|||
130546060|NCT02354508|469967711|FG001|Period 1: Core Phase|Adverse Event|1|||
130546061|NCT02354508|469967712|FG002|Period 1: Core Phase|Adverse Event|2|||
130546062|NCT02354508|469967710|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
130546063|NCT02354508|469967711|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
130546064|NCT02354508|469967712|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
130546065|NCT02354508|469967710|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
130546066|NCT02354508|469967711|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
130546067|NCT02354508|469967712|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
130546068|NCT02354508|469967710|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
130546069|NCT02354508|469967711|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
130546070|NCT02354508|469967712|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
130546071|NCT02354508|469967710|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
130546072|NCT02354508|469967711|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
130546073|NCT02354508|469967712|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
130546074|NCT02354508|469967710|FG000|Period 2: Extension Phase|Physician Decision|5|||
130546075|NCT02354508|469967711|FG001|Period 2: Extension Phase|Physician Decision|0|||
130546076|NCT02354508|469967712|FG002|Period 2: Extension Phase|Physician Decision|1|||
130546077|NCT02354508|469967710|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
130546078|NCT02354508|469967711|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
130546079|NCT02354508|469967712|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
130546080|NCT02354508|469967710|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
130546081|NCT02354508|469967711|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
130546082|NCT02354508|469967712|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
130546083|NCT02354508|469967710|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
130546084|NCT02354508|469967711|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
130546085|NCT02354508|469967712|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
130546086|NCT03587974|469967713|FG000|Overall Study|caregiver demented, care recipient died|3|||
130546087|NCT03587974|469967714|FG001|Overall Study|caregiver demented, care recipient died|3|||
130546088|NCT03587974|469967713|FG000|Overall Study|Withdrawal by Subject|2|||
130546089|NCT03587974|469967714|FG001|Overall Study|Withdrawal by Subject|1|||
130546090|NCT04447846|469967715|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
130546091|NCT00461032|469967716|FG000|Overall Study|Adverse Event|5|||
130546092|NCT00461032|469967717|FG001|Overall Study|Adverse Event|6|||
130546093|NCT00461032|469967716|FG000|Overall Study|Lack of Efficacy|5|||
130546094|NCT00461032|469967717|FG001|Overall Study|Lack of Efficacy|1|||
130546095|NCT00461032|469967716|FG000|Overall Study|Lost to Follow-up|7|||
130546096|NCT00461032|469967717|FG001|Overall Study|Lost to Follow-up|12|||
130546097|NCT00461032|469967716|FG000|Overall Study|Protocol Violation|4|||
130546098|NCT00461032|469967717|FG001|Overall Study|Protocol Violation|4|||
130546099|NCT00461032|469967716|FG000|Overall Study|Withdrawal by Subject|7|||
130546100|NCT00461032|469967717|FG001|Overall Study|Withdrawal by Subject|15|||
130546101|NCT00461032|469967716|FG000|Overall Study|Patient Moved or Relocated|2|||
130546102|NCT00461032|469967717|FG001|Overall Study|Patient Moved or Relocated|1|||
130546103|NCT00461032|469967716|FG000|Overall Study|Other|7|||
130546104|NCT00461032|469967717|FG001|Overall Study|Other|5|||
130546105|NCT03486457|469967720|FG000|Up to Month 3|Adverse Event|2|||
130546106|NCT03486457|469967721|FG001|Up to Month 3|Adverse Event|5|||
130546107|NCT03486457|469967720|FG000|Up to Month 3|Lack of Efficacy|1|||
130546108|NCT03486457|469967721|FG001|Up to Month 3|Lack of Efficacy|0|||
130546109|NCT03486457|469967720|FG000|Up to Month 3|Withdrawal by Subject|1|||
130546110|NCT03486457|469967721|FG001|Up to Month 3|Withdrawal by Subject|0|||
130546111|NCT03486457|469967720|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
130546112|NCT03486457|469967721|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
130546113|NCT03486457|469967720|FG000|Up to Month 3|Other|1|||
130546114|NCT03486457|469967721|FG001|Up to Month 3|Other|0|||
130546115|NCT03486457|469967720|FG000|Month 3 to Month 6|Adverse Event|2|||
130546116|NCT03486457|469967721|FG001|Month 3 to Month 6|Adverse Event|0|||
130546117|NCT03486457|469967720|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
130546118|NCT03486457|469967721|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
130546119|NCT03486457|469967720|FG000|Month 3 to Month 6|Pregnancy|0|||
130546120|NCT03486457|469967721|FG001|Month 3 to Month 6|Pregnancy|1|||
130546121|NCT03486457|469967720|FG000|Month 3 to Month 6|Other|1|||
130546122|NCT03486457|469967721|FG001|Month 3 to Month 6|Other|0|||
130546123|NCT00372229|469967722|FG000|Study Phase|Graft loss|0|||
130546124|NCT00372229|469967723|FG001|Study Phase|Graft loss|3|||
130546125|NCT00372229|469967722|FG000|Study Phase|Protocol Violation|3|||
130546126|NCT00372229|469967723|FG001|Study Phase|Protocol Violation|4|||
130546127|NCT00372229|469967722|FG000|Study Phase|Consent withdrawn|16|||
130546128|NCT00372229|469967723|FG001|Study Phase|Consent withdrawn|14|||
130546129|NCT00372229|469967722|FG000|Study Phase|Refused treatment/did not cooperate|3|||
130546130|NCT00372229|469967723|FG001|Study Phase|Refused treatment/did not cooperate|1|||
130546131|NCT00372229|469967722|FG000|Study Phase|Death|3|||
130546132|NCT00372229|469967723|FG001|Study Phase|Death|2|||
130546133|NCT00372229|469967722|FG000|Study Phase|Reason not specified|3|||
130546134|NCT00372229|469967723|FG001|Study Phase|Reason not specified|2|||
130546135|NCT00372229|469967722|FG000|Study Phase|Lost to Follow-up|3|||
130546136|NCT00372229|469967723|FG001|Study Phase|Lost to Follow-up|3|||
130546137|NCT00372229|469967722|FG000|Follow-Up Phase|Graft loss|8|||
130546138|NCT00372229|469967723|FG001|Follow-Up Phase|Graft loss|7|||
130546139|NCT00372229|469967722|FG000|Follow-Up Phase|Consent withdrawn|13|||
130546140|NCT00372229|469967723|FG001|Follow-Up Phase|Consent withdrawn|19|||
130546141|NCT00372229|469967722|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
130546142|NCT00372229|469967723|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
130546143|NCT00372229|469967722|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
130546144|NCT00372229|469967723|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
130546145|NCT00372229|469967722|FG000|Follow-Up Phase|Death|9|||
130546146|NCT00372229|469967723|FG001|Follow-Up Phase|Death|12|||
130546147|NCT00372229|469967722|FG000|Follow-Up Phase|Administrative|1|||
130546148|NCT00372229|469967723|FG001|Follow-Up Phase|Administrative|0|||
130546149|NCT00372229|469967722|FG000|Follow-Up Phase|Reason not specified|2|||
130546150|NCT00372229|469967723|FG001|Follow-Up Phase|Reason not specified|3|||
130546151|NCT00372229|469967722|FG000|Follow-Up Phase|Lost to Follow-up|12|||
130546152|NCT00372229|469967723|FG001|Follow-Up Phase|Lost to Follow-up|10|||
130546153|NCT01878214|469967724|FG000|Overall Study|Withdrawal by Subject|18|||
130546154|NCT01878214|469967725|FG001|Overall Study|Withdrawal by Subject|7|||
130546155|NCT01878214|469967724|FG000|Overall Study|Death|0|||
130546156|NCT01878214|469967725|FG001|Overall Study|Death|1|||
130546157|NCT01878214|469967724|FG000|Overall Study|Lost to Follow-up|35|||
130546158|NCT01878214|469967725|FG001|Overall Study|Lost to Follow-up|36|||
130546159|NCT00093808|469967728|FG000|Overall Study|Cancel participation before receiving tx|1|||
130546160|NCT00093808|469967728|FG000|Overall Study|Protocol Violation|1|||
130546161|NCT02647866|469967729|FG000|Overall Study|Adverse Event|0|||
130546162|NCT02647866|469967730|FG001|Overall Study|Adverse Event|0|||
130546163|NCT02647866|469967731|FG002|Overall Study|Adverse Event|2|||
130546164|NCT02647866|469967732|FG003|Overall Study|Adverse Event|2|||
130546165|NCT02647866|469967733|FG004|Overall Study|Adverse Event|1|||
130546166|NCT02647866|469967729|FG000|Overall Study|Disease Worsening|3|||
130546167|NCT02647866|469967730|FG001|Overall Study|Disease Worsening|1|||
130546168|NCT02647866|469967731|FG002|Overall Study|Disease Worsening|0|||
130546169|NCT02647866|469967732|FG003|Overall Study|Disease Worsening|0|||
130546170|NCT02647866|469967733|FG004|Overall Study|Disease Worsening|1|||
130546171|NCT02647866|469967729|FG000|Overall Study|Withdrawal by Subject|1|||
130546172|NCT02647866|469967730|FG001|Overall Study|Withdrawal by Subject|1|||
130546173|NCT02647866|469967731|FG002|Overall Study|Withdrawal by Subject|2|||
130546174|NCT02647866|469967732|FG003|Overall Study|Withdrawal by Subject|4|||
130546175|NCT02647866|469967733|FG004|Overall Study|Withdrawal by Subject|4|||
130546176|NCT02647866|469967729|FG000|Overall Study|Physician Decision|0|||
130546177|NCT02647866|469967730|FG001|Overall Study|Physician Decision|1|||
130546178|NCT02647866|469967731|FG002|Overall Study|Physician Decision|1|||
130546179|NCT02647866|469967732|FG003|Overall Study|Physician Decision|0|||
130546180|NCT02647866|469967733|FG004|Overall Study|Physician Decision|2|||
130546181|NCT02647866|469967729|FG000|Overall Study|Death|0|||
130546182|NCT02647866|469967730|FG001|Overall Study|Death|1|||
130546183|NCT02647866|469967731|FG002|Overall Study|Death|0|||
130546184|NCT02647866|469967732|FG003|Overall Study|Death|0|||
130546185|NCT02647866|469967733|FG004|Overall Study|Death|0|||
130546186|NCT02647866|469967729|FG000|Overall Study|Subject moved to different country|1|||
130546187|NCT02647866|469967730|FG001|Overall Study|Subject moved to different country|0|||
130546188|NCT02647866|469967731|FG002|Overall Study|Subject moved to different country|0|||
130546189|NCT02647866|469967732|FG003|Overall Study|Subject moved to different country|0|||
130546190|NCT02647866|469967733|FG004|Overall Study|Subject moved to different country|0|||
130546191|NCT01415531|469967737|FG000|Overall Study|Adverse Event|7|||
130546192|NCT01415531|469967738|FG001|Overall Study|Adverse Event|10|||
130546193|NCT01415531|469967737|FG000|Overall Study|Lack of Efficacy|3|||
130546194|NCT01415531|469967738|FG001|Overall Study|Lack of Efficacy|2|||
130546195|NCT01415531|469967737|FG000|Overall Study|Protocol Violation|0|||
130546196|NCT01415531|469967738|FG001|Overall Study|Protocol Violation|1|||
130546197|NCT01415531|469967737|FG000|Overall Study|Withdrawal by Subject|5|||
130546198|NCT01415531|469967738|FG001|Overall Study|Withdrawal by Subject|4|||
130546199|NCT01415531|469967737|FG000|Overall Study|Lost to Follow-up|6|||
130546200|NCT01415531|469967738|FG001|Overall Study|Lost to Follow-up|14|||
130546201|NCT01415531|469967737|FG000|Overall Study|Lack of Compliance|1|||
130546202|NCT01415531|469967738|FG001|Overall Study|Lack of Compliance|4|||
130546203|NCT01415531|469967737|FG000|Overall Study|Other Reasons|3|||
130546204|NCT01415531|469967738|FG001|Overall Study|Other Reasons|2|||
130546205|NCT02344004|469967740|FG000|Overall Study|Adverse Event|11|||
130546206|NCT02344004|469967741|FG001|Overall Study|Adverse Event|1|||
130546207|NCT02344004|469967740|FG000|Overall Study|Death|9|||
130546208|NCT02344004|469967741|FG001|Overall Study|Death|7|||
130546209|NCT02344004|469967740|FG000|Overall Study|Physician Decision|4|||
130546210|NCT02344004|469967741|FG001|Overall Study|Physician Decision|1|||
130546211|NCT02344004|469967740|FG000|Overall Study|Withdrawal by Subject|22|||
130546212|NCT02344004|469967741|FG001|Overall Study|Withdrawal by Subject|5|||
130546213|NCT02344004|469967740|FG000|Overall Study|Rescue Medication|2|||
130546214|NCT02344004|469967741|FG001|Overall Study|Rescue Medication|0|||
130546215|NCT02344004|469967740|FG000|Overall Study|Other Not Specified|12|||
130546216|NCT02344004|469967741|FG001|Overall Study|Other Not Specified|0|||
130546217|NCT02344004|469967740|FG000|Overall Study|Protocol Violation|1|||
130546218|NCT02344004|469967741|FG001|Overall Study|Protocol Violation|0|||
130546219|NCT00598273|469967744|FG000|Overall Study|Adverse Event|4|||
130546220|NCT00598273|469967745|FG001|Overall Study|Adverse Event|5|||
130546221|NCT00598273|469967746|FG002|Overall Study|Adverse Event|2|||
130546222|NCT00598273|469967744|FG000|Overall Study|Death|6|||
130546223|NCT00598273|469967745|FG001|Overall Study|Death|12|||
130546224|NCT00598273|469967746|FG002|Overall Study|Death|8|||
130546225|NCT00598273|469967744|FG000|Overall Study|Lost to Follow-up|8|||
130546226|NCT00598273|469967745|FG001|Overall Study|Lost to Follow-up|3|||
130433147|NCT01453348|469550354|FG002|Overall Study|Death|1|||
130546227|NCT00598273|469967746|FG002|Overall Study|Lost to Follow-up|5|||
130546228|NCT00598273|469967744|FG000|Overall Study|Physician Decision|0|||
130546229|NCT00598273|469967745|FG001|Overall Study|Physician Decision|0|||
130546230|NCT00598273|469967746|FG002|Overall Study|Physician Decision|1|||
130546231|NCT00598273|469967744|FG000|Overall Study|Withdrawal by Subject|12|||
130546232|NCT00598273|469967745|FG001|Overall Study|Withdrawal by Subject|10|||
130546233|NCT00598273|469967746|FG002|Overall Study|Withdrawal by Subject|10|||
130546234|NCT00598273|469967744|FG000|Overall Study|Noncompliance|3|||
130546235|NCT00598273|469967745|FG001|Overall Study|Noncompliance|2|||
130546236|NCT00598273|469967746|FG002|Overall Study|Noncompliance|3|||
130546237|NCT00598273|469967744|FG000|Overall Study|Relocation|0|||
130546238|NCT00598273|469967745|FG001|Overall Study|Relocation|2|||
130546239|NCT00598273|469967746|FG002|Overall Study|Relocation|4|||
130546240|NCT00598273|469967744|FG000|Overall Study|Renal transplant|1|||
130546241|NCT00598273|469967745|FG001|Overall Study|Renal transplant|0|||
130546242|NCT00598273|469967746|FG002|Overall Study|Renal transplant|1|||
130546243|NCT00598273|469967744|FG000|Overall Study|Site elected to close|1|||
130546244|NCT00598273|469967745|FG001|Overall Study|Site elected to close|0|||
130546245|NCT00598273|469967746|FG002|Overall Study|Site elected to close|0|||
130546246|NCT00598273|469967744|FG000|Overall Study|Started dialysis|6|||
130546247|NCT00598273|469967745|FG001|Overall Study|Started dialysis|4|||
130546248|NCT00598273|469967746|FG002|Overall Study|Started dialysis|5|||
130546249|NCT03426605|469967747|FG000|Overall Study|AML relapse or progression|2|||
130546250|NCT03426605|469967748|FG001|Overall Study|AML relapse or progression|1|||
130546251|NCT03426605|469967749|FG002|Overall Study|AML relapse or progression|2|||
130546252|NCT03426605|469967750|FG003|Overall Study|AML relapse or progression|2|||
130546253|NCT03426605|469967747|FG000|Overall Study|Treatment failure|3|||
130546254|NCT03426605|469967748|FG001|Overall Study|Treatment failure|2|||
130546255|NCT03426605|469967749|FG002|Overall Study|Treatment failure|0|||
130546256|NCT03426605|469967750|FG003|Overall Study|Treatment failure|0|||
130546257|NCT03426605|469967747|FG000|Overall Study|Adverse Event|1|||
130546258|NCT03426605|469967748|FG001|Overall Study|Adverse Event|0|||
130546259|NCT03426605|469967749|FG002|Overall Study|Adverse Event|1|||
130546260|NCT03426605|469967750|FG003|Overall Study|Adverse Event|1|||
130546261|NCT03426605|469967747|FG000|Overall Study|Withdrawal by Subject|0|||
130546262|NCT03426605|469967748|FG001|Overall Study|Withdrawal by Subject|0|||
130546263|NCT03426605|469967749|FG002|Overall Study|Withdrawal by Subject|1|||
130546264|NCT03426605|469967750|FG003|Overall Study|Withdrawal by Subject|1|||
130546265|NCT00609765|469967756|FG000|Overall Study|Study ended prior to 12 months|1|||
130546266|NCT02649946|469967763|FG000|Overall Study|Withdrawal by Subject|1|||
130546267|NCT02649946|469967764|FG001|Overall Study|Withdrawal by Subject|1|||
130546268|NCT02649946|469967763|FG000|Overall Study|Death|7|||
130546269|NCT02649946|469967764|FG001|Overall Study|Death|9|||
130546270|NCT02649946|469967763|FG000|Overall Study|Physician Decision|1|||
130546271|NCT02649946|469967764|FG001|Overall Study|Physician Decision|0|||
130546272|NCT02649946|469967763|FG000|Overall Study|Lost to Follow-up|2|||
130546273|NCT02649946|469967764|FG001|Overall Study|Lost to Follow-up|1|||
130546274|NCT02649946|469967763|FG000|Overall Study|Erroneously enrolled|1|||
130546275|NCT02649946|469967764|FG001|Overall Study|Erroneously enrolled|0|||
130546276|NCT02649946|469967763|FG000|Overall Study|Missed 6-month follow-up visit|0|||
130546277|NCT02649946|469967764|FG001|Overall Study|Missed 6-month follow-up visit|4|||
130546278|NCT00950950|469967765|FG000|Overall Study|Adverse Event|1|||
130546279|NCT00950950|469967766|FG001|Overall Study|Adverse Event|0|||
130546280|NCT00950950|469967765|FG000|Overall Study|Withdrawal by Subject|0|||
130546281|NCT00950950|469967766|FG001|Overall Study|Withdrawal by Subject|1|||
130546282|NCT01047293|469967772|FG000|Overall Study|DLT criteria not fulfilled|1|||
130546283|NCT01047293|469967773|FG001|Overall Study|DLT criteria not fulfilled|1|||
130546284|NCT01047293|469967774|FG002|Overall Study|DLT criteria not fulfilled|0|||
130546285|NCT01047293|469967775|FG003|Overall Study|DLT criteria not fulfilled|0|||
130546286|NCT02054520|469967776|FG000|Overall Study|Adverse Event|1|||
130546287|NCT02054520|469967777|FG001|Overall Study|Adverse Event|4|||
130546288|NCT02054520|469967778|FG002|Overall Study|Adverse Event|2|||
130546289|NCT02054520|469967779|FG003|Overall Study|Adverse Event|1|||
130546290|NCT02054520|469967780|FG004|Overall Study|Adverse Event|1|||
130546291|NCT02054520|469967781|FG005|Overall Study|Adverse Event|0|||
130214012|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130214013|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214014|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214015|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214016|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214017|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214018|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214019|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130214020|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214021|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214022|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214023|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
130322372|NCT03253796|469149134|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
130546292|NCT02054520|469967776|FG000|Overall Study|Lack of Efficacy|7|||
130546293|NCT02054520|469967777|FG001|Overall Study|Lack of Efficacy|0|||
130546294|NCT02054520|469967778|FG002|Overall Study|Lack of Efficacy|2|||
130546295|NCT02054520|469967779|FG003|Overall Study|Lack of Efficacy|1|||
130546296|NCT02054520|469967780|FG004|Overall Study|Lack of Efficacy|3|||
130546297|NCT02054520|469967781|FG005|Overall Study|Lack of Efficacy|2|||
130546298|NCT02054520|469967776|FG000|Overall Study|Withdrawal by Subject|1|||
130546299|NCT02054520|469967777|FG001|Overall Study|Withdrawal by Subject|0|||
130546300|NCT02054520|469967778|FG002|Overall Study|Withdrawal by Subject|0|||
130546301|NCT02054520|469967779|FG003|Overall Study|Withdrawal by Subject|2|||
130546302|NCT02054520|469967780|FG004|Overall Study|Withdrawal by Subject|1|||
130546303|NCT02054520|469967781|FG005|Overall Study|Withdrawal by Subject|0|||
130546304|NCT02054520|469967776|FG000|Overall Study|Physician Decision|0|||
130546305|NCT02054520|469967777|FG001|Overall Study|Physician Decision|1|||
130546306|NCT02054520|469967778|FG002|Overall Study|Physician Decision|0|||
130546307|NCT02054520|469967779|FG003|Overall Study|Physician Decision|1|||
130546308|NCT02054520|469967780|FG004|Overall Study|Physician Decision|0|||
130546309|NCT02054520|469967781|FG005|Overall Study|Physician Decision|1|||
130546310|NCT02054520|469967776|FG000|Overall Study|Study terminated by Sponsor|0|||
130546311|NCT02054520|469967777|FG001|Overall Study|Study terminated by Sponsor|0|||
130546312|NCT02054520|469967778|FG002|Overall Study|Study terminated by Sponsor|2|||
130546313|NCT02054520|469967779|FG003|Overall Study|Study terminated by Sponsor|1|||
130546314|NCT02054520|469967780|FG004|Overall Study|Study terminated by Sponsor|0|||
130546315|NCT02054520|469967781|FG005|Overall Study|Study terminated by Sponsor|0|||
130546316|NCT01272804|469967782|FG000|Overall Study|Adverse Event|1|||
130546317|NCT01272804|469967783|FG001|Overall Study|Adverse Event|0|||
130546318|NCT01272804|469967784|FG002|Overall Study|Adverse Event|0|||
130546319|NCT01272804|469967785|FG003|Overall Study|Adverse Event|0|||
130546320|NCT01272804|469967786|FG004|Overall Study|Adverse Event|2|||
130546321|NCT01272804|469967787|FG005|Overall Study|Adverse Event|1|||
130546322|NCT02318797|469967788|FG000|Overall Study|Death|3|||
130546323|NCT02318797|469967789|FG001|Overall Study|Death|6|||
130546324|NCT02318797|469967788|FG000|Overall Study|Lost to Follow-up|85|||
130546325|NCT02318797|469967789|FG001|Overall Study|Lost to Follow-up|96|||
130546326|NCT02308020|469967792|FG000|Overall Study|Lost to Follow-up|1|||
130546327|NCT02308020|469967793|FG001|Overall Study|Lost to Follow-up|7|||
130546328|NCT02308020|469967794|FG002|Overall Study|Lost to Follow-up|0|||
130546329|NCT02308020|469967795|FG003|Overall Study|Lost to Follow-up|0|||
130546330|NCT02308020|469967796|FG004|Overall Study|Lost to Follow-up|1|||
130546331|NCT02308020|469967797|FG005|Overall Study|Lost to Follow-up|2|||
130546332|NCT02308020|469967792|FG000|Overall Study|Sponsor Decision|0|||
130546333|NCT02308020|469967793|FG001|Overall Study|Sponsor Decision|8|||
130546334|NCT02308020|469967794|FG002|Overall Study|Sponsor Decision|0|||
130546335|NCT02308020|469967795|FG003|Overall Study|Sponsor Decision|2|||
130546336|NCT02308020|469967796|FG004|Overall Study|Sponsor Decision|2|||
130546337|NCT02308020|469967797|FG005|Overall Study|Sponsor Decision|1|||
130546338|NCT02308020|469967792|FG000|Overall Study|Withdrawal by Subject|3|||
130546339|NCT02308020|469967793|FG001|Overall Study|Withdrawal by Subject|5|||
130546340|NCT02308020|469967794|FG002|Overall Study|Withdrawal by Subject|3|||
130546341|NCT02308020|469967795|FG003|Overall Study|Withdrawal by Subject|2|||
130546342|NCT02308020|469967796|FG004|Overall Study|Withdrawal by Subject|1|||
130546343|NCT02308020|469967797|FG005|Overall Study|Withdrawal by Subject|2|||
130546344|NCT03333837|469967798|FG000|Overall Study|Adverse Event|2|||
130546345|NCT03333837|469967799|FG001|Overall Study|Adverse Event|1|||
130546346|NCT03333837|469967800|FG002|Overall Study|Adverse Event|1|||
130546347|NCT03333837|469967801|FG003|Overall Study|Adverse Event|1|||
130546348|NCT03333837|469967802|FG004|Overall Study|Adverse Event|0|||
130546349|NCT03333837|469967798|FG000|Overall Study|Caregiver withdrew|0|||
130546350|NCT03333837|469967799|FG001|Overall Study|Caregiver withdrew|2|||
130546351|NCT03333837|469967800|FG002|Overall Study|Caregiver withdrew|1|||
130546352|NCT03333837|469967801|FG003|Overall Study|Caregiver withdrew|0|||
130546353|NCT03333837|469967802|FG004|Overall Study|Caregiver withdrew|0|||
130546354|NCT03333837|469967798|FG000|Overall Study|Withdrawal by Subject|0|||
130546355|NCT03333837|469967799|FG001|Overall Study|Withdrawal by Subject|0|||
130546356|NCT03333837|469967800|FG002|Overall Study|Withdrawal by Subject|1|||
130546357|NCT03333837|469967801|FG003|Overall Study|Withdrawal by Subject|1|||
130546358|NCT03333837|469967802|FG004|Overall Study|Withdrawal by Subject|3|||
130546359|NCT03333837|469967798|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
130546360|NCT03333837|469967799|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
130546361|NCT03333837|469967800|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
130546362|NCT03333837|469967801|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
130546363|NCT03333837|469967802|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
130546364|NCT04217590|469967803|FG000|Overall Study|Other|1|||
130546365|NCT04217590|469967804|FG001|Overall Study|Other|1|||
130546366|NCT04217590|469967803|FG000|Overall Study|Withdrawal by Subject|3|||
130546367|NCT04217590|469967804|FG001|Overall Study|Withdrawal by Subject|1|||
130546368|NCT04217590|469967803|FG000|Overall Study|Death|0|||
130546369|NCT04217590|469967804|FG001|Overall Study|Death|1|||
130546370|NCT02232243|469967805|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
130546371|NCT02232243|469967806|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
130546372|NCT02232243|469967807|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
130546373|NCT00704405|469967808|FG000|Overall Study (NC Population)|Adverse Event|1|||
130546374|NCT00704405|469967809|FG001|Overall Study (NC Population)|Adverse Event|0|||
130546375|NCT00704405|469967810|FG002|Overall Study (NC Population)|Adverse Event|0|||
130214024|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130322373|NCT01075243|469149138|FG000|Overall Study|Lost to Follow-up|5|||
130546376|NCT00704405|469967811|FG003|Overall Study (NC Population)|Adverse Event|0|||
130546377|NCT00704405|469967812|FG004|Overall Study (NC Population)|Adverse Event|0|||
130546378|NCT00704405|469967808|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
130546379|NCT00704405|469967809|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
130546380|NCT00704405|469967810|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
130546381|NCT00704405|469967811|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
130546382|NCT00704405|469967812|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
130546383|NCT00704405|469967808|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
130546384|NCT00704405|469967809|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
130546385|NCT00704405|469967810|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
130546386|NCT00704405|469967811|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
130546387|NCT00704405|469967812|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
130546388|NCT00704405|469967808|FG000|Overall Study (NC Population)|Other|0|||
130546389|NCT00704405|469967809|FG001|Overall Study (NC Population)|Other|0|||
130546390|NCT00704405|469967810|FG002|Overall Study (NC Population)|Other|0|||
130546391|NCT00704405|469967811|FG003|Overall Study (NC Population)|Other|0|||
130546392|NCT00704405|469967812|FG004|Overall Study (NC Population)|Other|1|||
130546393|NCT00704405|469967808|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
130546394|NCT00704405|469967809|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
130546395|NCT00704405|469967810|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
130546396|NCT00704405|469967811|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
130546397|NCT00704405|469967812|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
130546398|NCT00704405|469967808|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
130546399|NCT00704405|469967809|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
130546400|NCT00704405|469967810|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
130546401|NCT00704405|469967811|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
130546402|NCT00704405|469967812|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
130546403|NCT01395888|469967813|FG000|2-week Run-in Period|Adverse Event|2|||
130546404|NCT01395888|469967814|FG001|2-week Run-in Period|Adverse Event|0|||
130546405|NCT01395888|469967815|FG002|2-week Run-in Period|Adverse Event|0|||
130546406|NCT01395888|469967813|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
130546407|NCT01395888|469967814|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
130546408|NCT01395888|469967815|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
130546409|NCT01395888|469967813|FG000|2-week Run-in Period|Lost to Follow-up|1|||
130546410|NCT01395888|469967814|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130546411|NCT01395888|469967815|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130546412|NCT01395888|469967813|FG000|2-week Run-in Period|Protocol Violation|2|||
130546413|NCT01395888|469967814|FG001|2-week Run-in Period|Protocol Violation|0|||
130546414|NCT01395888|469967815|FG002|2-week Run-in Period|Protocol Violation|0|||
130546415|NCT01395888|469967813|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
130546416|NCT01395888|469967814|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130546417|NCT01395888|469967815|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130546418|NCT01395888|469967813|FG000|Treatment Period (TP)|Adverse Event|0|||
130546419|NCT01395888|469967814|FG001|Treatment Period (TP)|Adverse Event|7|||
130546420|NCT01395888|469967815|FG002|Treatment Period (TP)|Adverse Event|6|||
130546421|NCT01395888|469967813|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
130546422|NCT01395888|469967814|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
130546423|NCT01395888|469967815|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
130546424|NCT01395888|469967813|FG000|Treatment Period (TP)|Protocol Violation|0|||
130546425|NCT01395888|469967814|FG001|Treatment Period (TP)|Protocol Violation|1|||
130546426|NCT01395888|469967815|FG002|Treatment Period (TP)|Protocol Violation|5|||
130546427|NCT01395888|469967813|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
130546428|NCT01395888|469967814|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
130546429|NCT01395888|469967815|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
130546430|NCT01395888|469967813|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
130546431|NCT01395888|469967814|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
130546432|NCT01395888|469967815|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
130546433|NCT03218397|469967816|FG000|Overall Study|Prior positive blood culture|8|||
130546434|NCT03218397|469967817|FG001|Overall Study|Prior positive blood culture|13|||
130546435|NCT03218397|469967816|FG000|Overall Study|Comfort care|8|||
130546436|NCT03218397|469967817|FG001|Overall Study|Comfort care|5|||
130546437|NCT03218397|469967816|FG000|Overall Study|Comfort care and positive blood culture|1|||
130546438|NCT03218397|469967817|FG001|Overall Study|Comfort care and positive blood culture|0|||
130546439|NCT03218397|469967816|FG000|Overall Study|Comfort care and mixed culture|0|||
130546440|NCT03218397|469967817|FG001|Overall Study|Comfort care and mixed culture|1|||
130546441|NCT03218397|469967816|FG000|Overall Study|Mixed culture|2|||
130546442|NCT03218397|469967817|FG001|Overall Study|Mixed culture|2|||
130546443|NCT03218397|469967816|FG000|Overall Study|Inaccessible hospital records|2|||
130546444|NCT03218397|469967817|FG001|Overall Study|Inaccessible hospital records|5|||
130546445|NCT03218397|469967816|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
130546446|NCT03218397|469967817|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
130546447|NCT03218397|469967816|FG000|Overall Study|Randomized during laboratory off hours|2|||
130546448|NCT03218397|469967817|FG001|Overall Study|Randomized during laboratory off hours|1|||
130546449|NCT02859324|469967818|FG000|Overall Study|Death|4|||
130546450|NCT02859324|469967819|FG001|Overall Study|Death|6|||
130546451|NCT02859324|469967820|FG002|Overall Study|Death|5|||
130546452|NCT02859324|469967818|FG000|Overall Study|Other reasons|3|||
130546453|NCT02859324|469967819|FG001|Overall Study|Other reasons|3|||
130546454|NCT02859324|469967820|FG002|Overall Study|Other reasons|0|||
130546455|NCT01796548|469967821|FG000|Overall Study|Lost to Follow-up|1|||
130546456|NCT01796548|469967821|FG000|Overall Study|Other|2|||
130546457|NCT01946438|469967822|FG000|Overall Study|Adverse Event|0|||
130546458|NCT01946438|469967823|FG001|Overall Study|Adverse Event|0|||
130322374|NCT01075243|469149139|FG001|Overall Study|Lost to Follow-up|2|||
130546459|NCT01946438|469967824|FG002|Overall Study|Adverse Event|0|||
130546460|NCT01946438|469967825|FG003|Overall Study|Adverse Event|1|||
130546461|NCT01946438|469967822|FG000|Overall Study|Serious Adverse event|1|||
130546462|NCT01946438|469967823|FG001|Overall Study|Serious Adverse event|0|||
130546463|NCT01946438|469967824|FG002|Overall Study|Serious Adverse event|0|||
130546464|NCT01946438|469967825|FG003|Overall Study|Serious Adverse event|0|||
130546465|NCT01946438|469967822|FG000|Overall Study|Protocol Violation|0|||
130546466|NCT01946438|469967823|FG001|Overall Study|Protocol Violation|0|||
130546467|NCT01946438|469967824|FG002|Overall Study|Protocol Violation|1|||
130546468|NCT01946438|469967825|FG003|Overall Study|Protocol Violation|0|||
130546469|NCT01946438|469967822|FG000|Overall Study|Withdrawal by Subject|1|||
130546470|NCT01946438|469967823|FG001|Overall Study|Withdrawal by Subject|0|||
130546471|NCT01946438|469967824|FG002|Overall Study|Withdrawal by Subject|0|||
130546472|NCT01946438|469967825|FG003|Overall Study|Withdrawal by Subject|0|||
130546473|NCT03169101|469967828|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
130546474|NCT03169101|469967829|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
130546475|NCT03169101|469967830|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
130546476|NCT03169101|469967831|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
130546477|NCT02641496|469967832|FG000|Overall Study|Lost to Follow-up|13|||
130546478|NCT02641496|469967833|FG001|Overall Study|Lost to Follow-up|12|||
130546479|NCT02641496|469967832|FG000|Overall Study|Withdrawal by Subject|1|||
130546480|NCT02641496|469967833|FG001|Overall Study|Withdrawal by Subject|0|||
130546481|NCT02523599|469967834|FG000|Overall Study|Adverse Event|1|||
130546482|NCT02523599|469967835|FG001|Overall Study|Adverse Event|0|||
130546483|NCT02523599|469967834|FG000|Overall Study|Physician Decision|1|||
130546484|NCT02523599|469967835|FG001|Overall Study|Physician Decision|0|||
130546485|NCT02523599|469967834|FG000|Overall Study|Lost to Follow-up|4|||
130546486|NCT02523599|469967835|FG001|Overall Study|Lost to Follow-up|1|||
130546487|NCT02523599|469967834|FG000|Overall Study|Did not return for Day 30 visit|2|||
130546488|NCT02523599|469967835|FG001|Overall Study|Did not return for Day 30 visit|0|||
130546489|NCT00790751|469967838|FG000|Overall Study|Protocol non-compliance|16|||
130546490|NCT00790751|469967839|FG001|Overall Study|Protocol non-compliance|16|||
130546491|NCT00790751|469967840|FG002|Overall Study|Protocol non-compliance|10|||
130546492|NCT00790751|469967841|FG003|Overall Study|Protocol non-compliance|11|||
130546493|NCT00790751|469967838|FG000|Overall Study|Lost to Follow-up|4|||
130546494|NCT00790751|469967839|FG001|Overall Study|Lost to Follow-up|9|||
130546495|NCT00790751|469967840|FG002|Overall Study|Lost to Follow-up|4|||
130546496|NCT00790751|469967841|FG003|Overall Study|Lost to Follow-up|5|||
130546497|NCT00790751|469967838|FG000|Overall Study|Adverse Event|5|||
130546498|NCT00790751|469967839|FG001|Overall Study|Adverse Event|3|||
130546499|NCT00790751|469967840|FG002|Overall Study|Adverse Event|5|||
130546500|NCT00790751|469967841|FG003|Overall Study|Adverse Event|4|||
130546501|NCT00790751|469967838|FG000|Overall Study|Requirement for restricted medication|0|||
130546502|NCT00790751|469967839|FG001|Overall Study|Requirement for restricted medication|2|||
130546503|NCT00790751|469967840|FG002|Overall Study|Requirement for restricted medication|0|||
130546504|NCT00790751|469967841|FG003|Overall Study|Requirement for restricted medication|0|||
130546505|NCT00790751|469967838|FG000|Overall Study|Death|0|||
130546506|NCT00790751|469967839|FG001|Overall Study|Death|0|||
130546507|NCT00790751|469967840|FG002|Overall Study|Death|1|||
130546508|NCT00790751|469967841|FG003|Overall Study|Death|0|||
130546509|NCT00790751|469967838|FG000|Overall Study|Physician Decision|0|||
130546510|NCT00790751|469967839|FG001|Overall Study|Physician Decision|0|||
130546511|NCT00790751|469967840|FG002|Overall Study|Physician Decision|0|||
130546512|NCT00790751|469967841|FG003|Overall Study|Physician Decision|1|||
130546513|NCT00112047|469967842|FG000|Randomized Phase|Lost to Follow-up|26|||
130546514|NCT00112047|469967843|FG001|Randomized Phase|Lost to Follow-up|33|||
130546515|NCT00112047|469967842|FG000|Randomized Phase|Adverse Event|10|||
130546516|NCT00112047|469967843|FG001|Randomized Phase|Adverse Event|10|||
130546517|NCT00112047|469967842|FG000|Randomized Phase|Withrawal of consent|10|||
130322375|NCT01075243|469149140|FG002|Overall Study|Lost to Follow-up|0|||
130546518|NCT00112047|469967843|FG001|Randomized Phase|Withrawal of consent|18|||
130546519|NCT00112047|469967842|FG000|Randomized Phase|Sub-optimal virological response|3|||
130546520|NCT00112047|469967843|FG001|Randomized Phase|Sub-optimal virological response|13|||
130546521|NCT00112047|469967842|FG000|Randomized Phase|Noncompliance|8|||
130546522|NCT00112047|469967843|FG001|Randomized Phase|Noncompliance|4|||
130546523|NCT00112047|469967842|FG000|Randomized Phase|Protocol Violation|2|||
130546524|NCT00112047|469967843|FG001|Randomized Phase|Protocol Violation|0|||
130546525|NCT00112047|469967842|FG000|Randomized Phase|Pregnancy|3|||
130546526|NCT00112047|469967843|FG001|Randomized Phase|Pregnancy|1|||
130546527|NCT00112047|469967842|FG000|Randomized Phase|Death|1|||
130546528|NCT00112047|469967843|FG001|Randomized Phase|Death|3|||
130546529|NCT00112047|469967842|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
130546530|NCT00112047|469967843|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
130546531|NCT00112047|469967842|FG000|Randomized Phase|Inability to swallow pills|0|||
130546532|NCT00112047|469967843|FG001|Randomized Phase|Inability to swallow pills|1|||
130546533|NCT00112047|469967842|FG000|Randomized Phase|Incarceration|3|||
130546534|NCT00112047|469967843|FG001|Randomized Phase|Incarceration|2|||
130546535|NCT00112047|469967842|FG000|Randomized Phase|Moved out of State|0|||
130546536|NCT00112047|469967843|FG001|Randomized Phase|Moved out of State|1|||
130546537|NCT00112047|469967842|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
130546538|NCT00112047|469967843|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
130546539|NCT00112047|469967842|FG000|Randomized Phase|High Hepatitis B DNA|0|||
130546540|NCT00112047|469967843|FG001|Randomized Phase|High Hepatitis B DNA|1|||
130546541|NCT00112047|469967842|FG000|Atripla Phase|Adverse Event|2|||
130546542|NCT00112047|469967843|FG001|Atripla Phase|Adverse Event|1|||
130546543|NCT00112047|469967842|FG000|Atripla Phase|Lost to Follow-up|5|||
130546544|NCT00112047|469967843|FG001|Atripla Phase|Lost to Follow-up|7|||
130546545|NCT00112047|469967842|FG000|Atripla Phase|Pregnancy|0|||
130546546|NCT00112047|469967843|FG001|Atripla Phase|Pregnancy|1|||
130546547|NCT00112047|469967842|FG000|Atripla Phase|Death|0|||
130546548|NCT00112047|469967843|FG001|Atripla Phase|Death|2|||
130546549|NCT00112047|469967842|FG000|Atripla Phase|Withdrew consent|7|||
130546550|NCT00112047|469967843|FG001|Atripla Phase|Withdrew consent|7|||
130546551|NCT00112047|469967842|FG000|Atripla Phase|Sub-optimal virological response|0|||
130546552|NCT00112047|469967843|FG001|Atripla Phase|Sub-optimal virological response|1|||
130546553|NCT00112047|469967842|FG000|Atripla Phase|Non-compliance|1|||
130546554|NCT00112047|469967843|FG001|Atripla Phase|Non-compliance|0|||
130546555|NCT00112047|469967842|FG000|Atripla Phase|Other|3|||
130546556|NCT00112047|469967843|FG001|Atripla Phase|Other|1|||
130546557|NCT01307579|469967844|FG000|Overall Study|Death|3|||
130546558|NCT01307579|469967845|FG001|Overall Study|Death|6|||
130546559|NCT01307579|469967844|FG000|Overall Study|Physician Decision|26|||
130546560|NCT01307579|469967845|FG001|Overall Study|Physician Decision|29|||
130546561|NCT01307579|469967844|FG000|Overall Study|Withdrawal by Subject|7|||
130546562|NCT01307579|469967845|FG001|Overall Study|Withdrawal by Subject|3|||
130546563|NCT01307579|469967844|FG000|Overall Study|Institutional diagnosis of IFD|21|||
130546564|NCT01307579|469967845|FG001|Overall Study|Institutional diagnosis of IFD|36|||
130546565|NCT01307579|469967844|FG000|Overall Study|Begin conditioning for HSCT|42|||
130546566|NCT01307579|469967845|FG001|Overall Study|Begin conditioning for HSCT|44|||
130546567|NCT01307579|469967844|FG000|Overall Study|Refractory or relapsed AML|38|||
130546568|NCT01307579|469967845|FG001|Overall Study|Refractory or relapsed AML|23|||
130546569|NCT01307579|469967844|FG000|Overall Study|Ineligible|3|||
130546570|NCT01307579|469967845|FG001|Overall Study|Ineligible|4|||
130546571|NCT02502097|469969811|FG000|Period 1|Adverse Event|0|||
130546572|NCT02502097|469969812|FG001|Period 1|Adverse Event|0|||
130546573|NCT02502097|469969813|FG002|Period 1|Adverse Event|1|||
130546574|NCT02502097|469969814|FG003|Period 1|Adverse Event|0|||
130546575|NCT02502097|469969811|FG000|Wash Out Period|Adverse Event|0|||
130546576|NCT02502097|469969812|FG001|Wash Out Period|Adverse Event|1|||
130546577|NCT02502097|469969813|FG002|Wash Out Period|Adverse Event|1|||
130546578|NCT02502097|469969814|FG003|Wash Out Period|Adverse Event|1|||
130546579|NCT02502097|469969811|FG000|Period 2|Adverse Event|0|||
130546580|NCT02502097|469969812|FG001|Period 2|Adverse Event|0|||
130546581|NCT02502097|469969813|FG002|Period 2|Adverse Event|1|||
130546582|NCT02502097|469969814|FG003|Period 2|Adverse Event|0|||
130546583|NCT02186223|469969815|FG000|Overall Study|Not eligible for device placement|6|||
130546584|NCT02186223|469969815|FG000|Overall Study|Unable to obtain femoral access|3|||
130546585|NCT02186223|469969815|FG000|Overall Study|Death|3|||
130546586|NCT02186223|469969815|FG000|Overall Study|Device in place less than 48 hours|9|||
130546587|NCT01201317|469969816|FG000|Overall Study|Withdrawal by Subject|5|||
130546588|NCT01201317|469969817|FG001|Overall Study|Withdrawal by Subject|0|||
130546589|NCT01201317|469969818|FG002|Overall Study|Withdrawal by Subject|3|||
130546590|NCT01201317|469969816|FG000|Overall Study|Adverse Event|2|||
130546591|NCT01201317|469969817|FG001|Overall Study|Adverse Event|2|||
130546592|NCT01201317|469969818|FG002|Overall Study|Adverse Event|2|||
130546593|NCT01201317|469969816|FG000|Overall Study|Screen failure|1|||
130546594|NCT01201317|469969817|FG001|Overall Study|Screen failure|1|||
130546595|NCT01201317|469969818|FG002|Overall Study|Screen failure|0|||
130546596|NCT01201317|469969816|FG000|Overall Study|Protocol Violation|0|||
130546597|NCT01201317|469969817|FG001|Overall Study|Protocol Violation|1|||
130546598|NCT01201317|469969818|FG002|Overall Study|Protocol Violation|1|||
130546599|NCT01201317|469969816|FG000|Overall Study|Death|0|||
130546600|NCT01201317|469969817|FG001|Overall Study|Death|1|||
130546601|NCT01201317|469969818|FG002|Overall Study|Death|0|||
130559411|NCT01621542|470016495|FG005|Overall Study|Physician Decision|1|||
130322376|NCT01075243|469149138|FG000|Overall Study|Withdrawal by Subject|1|||
130322377|NCT01075243|469149139|FG001|Overall Study|Withdrawal by Subject|1|||
130322378|NCT01075243|469149140|FG002|Overall Study|Withdrawal by Subject|0|||
130322379|NCT03094416|469149143|FG000|Run-in|Screening failure|8|||
130322380|NCT03094416|469149143|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
130322381|NCT03094416|469149143|FG000|Run-in|Withdrawal by Subject|3|||
130322382|NCT03094416|469149143|FG000|Treatment Period|Withdrawal by Subject|2|||
130322383|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
130322384|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
130322385|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
130322386|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
130322387|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
130322388|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
130322389|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
130322390|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
130322391|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
130322392|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
130322393|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
130322394|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
130322395|NCT01668784|469149144|FG000|Treatment Period|Disease Progression|316|||
130322396|NCT01668784|469149145|FG001|Treatment Period|Disease Progression|293|||
130322397|NCT01668784|469149144|FG000|Treatment Period|Study Drug Toxicity|46|||
130322398|NCT01668784|469149145|FG001|Treatment Period|Study Drug Toxicity|53|||
130322399|NCT01668784|469149144|FG000|Treatment Period|Death|1|||
130322400|NCT01668784|469149145|FG001|Treatment Period|Death|1|||
130322401|NCT01668784|469149144|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130322402|NCT01668784|469149145|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130322403|NCT01668784|469149144|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
130322404|NCT01668784|469149145|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
130322405|NCT01668784|469149144|FG000|Treatment Period|Withdrawal by Subject|5|||
130322406|NCT01668784|469149145|FG001|Treatment Period|Withdrawal by Subject|3|||
130322407|NCT01668784|469149144|FG000|Treatment Period|Maximal Clinical Benefit|3|||
130322408|NCT01668784|469149145|FG001|Treatment Period|Maximal Clinical Benefit|3|||
130322409|NCT01668784|469149144|FG000|Treatment Period|Other|2|||
130322410|NCT01668784|469149145|FG001|Treatment Period|Other|8|||
130322411|NCT01668784|469149144|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
130322412|NCT01668784|469149145|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
130322413|NCT03804528|469149153|FG000|Overall Study|Time Commitment|18|||
130322414|NCT03804528|469149153|FG000|Overall Study|Health Reasons|5|||
130322415|NCT04607005|469149154|FG000|Overall Study|Adverse Event|0|||
130322416|NCT04607005|469149155|FG001|Overall Study|Adverse Event|1|||
130322417|NCT04607005|469149154|FG000|Overall Study|Lack of Efficacy|1|||
130322418|NCT04607005|469149155|FG001|Overall Study|Lack of Efficacy|6|||
130322419|NCT04607005|469149154|FG000|Overall Study|Withdrawal by Subject|4|||
130322420|NCT04607005|469149155|FG001|Overall Study|Withdrawal by Subject|9|||
130322421|NCT04607005|469149154|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
130322422|NCT04607005|469149155|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
130322423|NCT02331134|469149156|FG000|Overall Study|Withdrawal by Subject|1|||
130322424|NCT04825574|469149158|FG000|Overall Study|Commercial treatment became available|1|||
130322425|NCT04825574|469149158|FG000|Overall Study|Disease progression|1|||
130322426|NCT04272242|469149161|FG000|Overall Study|Withdrawal by Subject|3|||
130322427|NCT04272242|469149161|FG000|Overall Study|Lost to Follow-up|1|||
130322428|NCT04272242|469149161|FG000|Overall Study|Adverse Event|1|||
130322429|NCT04944992|469151267|FG000|Overall Study|Lost to Follow-up|1|||
130322430|NCT04944992|469151268|FG001|Overall Study|Lost to Follow-up|1|||
130322431|NCT04944992|469151267|FG000|Overall Study|Physician Decision|1|||
130322432|NCT04944992|469151268|FG001|Overall Study|Physician Decision|0|||
130322433|NCT04944992|469151267|FG000|Overall Study|Withdrawal by Subject|6|||
130322434|NCT04944992|469151268|FG001|Overall Study|Withdrawal by Subject|1|||
130322435|NCT01295814|469151269|FG000|Overall Study|Lack of Efficacy|0|||
130322436|NCT01295814|469151270|FG001|Overall Study|Lack of Efficacy|2|||
130322437|NCT01295814|469151269|FG000|Overall Study|Withdrawal by Subject|2|||
130322438|NCT01295814|469151270|FG001|Overall Study|Withdrawal by Subject|0|||
130322439|NCT03414983|469151271|FG000|Pre-Treatment|Other reasons|1|||
130322440|NCT03414983|469151272|FG001|Pre-Treatment|Other reasons|0|||
130322441|NCT03414983|469151271|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130322442|NCT03414983|469151272|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
130322443|NCT03414983|469151271|FG000|Pre-Treatment|Participant withdrew consent|1|||
130322444|NCT03414983|469151272|FG001|Pre-Treatment|Participant withdrew consent|3|||
130546602|NCT01201317|469969816|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130546603|NCT01201317|469969817|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130546604|NCT01201317|469969818|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130546605|NCT01201317|469969816|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
130546606|NCT01201317|469969817|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
130546607|NCT01201317|469969818|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
130546608|NCT01201317|469969816|FG000|Overall Study|Decrease in renal function|0|||
130546609|NCT01201317|469969817|FG001|Overall Study|Decrease in renal function|1|||
130546610|NCT01201317|469969818|FG002|Overall Study|Decrease in renal function|0|||
130546611|NCT01201317|469969816|FG000|Overall Study|Lack of Efficacy|1|||
130546612|NCT01201317|469969817|FG001|Overall Study|Lack of Efficacy|0|||
130546613|NCT01201317|469969818|FG002|Overall Study|Lack of Efficacy|0|||
130546614|NCT01201317|469969816|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
130546615|NCT01201317|469969817|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
130546616|NCT01201317|469969818|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
130546617|NCT00252733|469969819|FG000|Overall Study|Withdrawal by Subject|73|||
130546618|NCT00252733|469969820|FG001|Overall Study|Withdrawal by Subject|67|||
130546619|NCT00252733|469969819|FG000|Overall Study|Death|7|||
130546620|NCT00252733|469969820|FG001|Overall Study|Death|5|||
130546621|NCT00252733|469969819|FG000|Overall Study|Lost to Follow-up|12|||
130546622|NCT00252733|469969820|FG001|Overall Study|Lost to Follow-up|6|||
130546623|NCT00252733|469969819|FG000|Overall Study|Multiple Reasons|14|||
130546624|NCT00252733|469969820|FG001|Overall Study|Multiple Reasons|14|||
130546625|NCT01491672|469969821|FG000|Overall Study|Lost to Follow-up|0|||
130546626|NCT01491672|469969822|FG001|Overall Study|Lost to Follow-up|4|||
130546627|NCT01491672|469969823|FG002|Overall Study|Lost to Follow-up|1|||
130546628|NCT01491672|469969821|FG000|Overall Study|Withdrawal by Subject|6|||
130546629|NCT01491672|469969822|FG001|Overall Study|Withdrawal by Subject|7|||
130546630|NCT01491672|469969823|FG002|Overall Study|Withdrawal by Subject|0|||
130546631|NCT01491672|469969821|FG000|Overall Study|Adverse Event|8|||
130546632|NCT01491672|469969822|FG001|Overall Study|Adverse Event|10|||
130546633|NCT01491672|469969823|FG002|Overall Study|Adverse Event|4|||
130546634|NCT01491672|469969821|FG000|Overall Study|Disease progression|42|||
130546635|NCT01491672|469969822|FG001|Overall Study|Disease progression|34|||
130546636|NCT01491672|469969823|FG002|Overall Study|Disease progression|6|||
130546637|NCT01491672|469969821|FG000|Overall Study|Protocol deviation|0|||
130546638|NCT01491672|469969822|FG001|Overall Study|Protocol deviation|1|||
130546639|NCT01491672|469969823|FG002|Overall Study|Protocol deviation|0|||
130546640|NCT01491672|469969821|FG000|Overall Study|Death|0|||
130546641|NCT01491672|469969822|FG001|Overall Study|Death|4|||
130546642|NCT01491672|469969823|FG002|Overall Study|Death|0|||
130546643|NCT03310268|469969827|FG000|Overall Study|(Not specified)|1|||
130546644|NCT03310268|469969828|FG001|Overall Study|(Not specified)|5|||
130546645|NCT03310268|469969829|FG002|Overall Study|(Not specified)|0|||
130546646|NCT00706433|469969832|FG000|Overall Study|Lost to Follow-up|3|||
130546647|NCT00706433|469969833|FG001|Overall Study|Lost to Follow-up|1|||
130546648|NCT00706433|469969834|FG002|Overall Study|Lost to Follow-up|6|||
130546649|NCT00706433|469969835|FG003|Overall Study|Lost to Follow-up|0|||
130546650|NCT00706433|469969832|FG000|Overall Study|Withdrawal by Subject|1|||
130546651|NCT00706433|469969833|FG001|Overall Study|Withdrawal by Subject|2|||
130546652|NCT00706433|469969834|FG002|Overall Study|Withdrawal by Subject|3|||
130546653|NCT00706433|469969835|FG003|Overall Study|Withdrawal by Subject|1|||
130546654|NCT00706433|469969832|FG000|Overall Study|Adverse Event|0|||
130546655|NCT00706433|469969833|FG001|Overall Study|Adverse Event|0|||
130546656|NCT00706433|469969834|FG002|Overall Study|Adverse Event|1|||
130546657|NCT00706433|469969835|FG003|Overall Study|Adverse Event|0|||
130546658|NCT00706433|469969832|FG000|Overall Study|Protocol Violation|1|||
130546659|NCT00706433|469969833|FG001|Overall Study|Protocol Violation|0|||
130546660|NCT00706433|469969834|FG002|Overall Study|Protocol Violation|0|||
130546661|NCT00706433|469969835|FG003|Overall Study|Protocol Violation|0|||
130546662|NCT00706433|469969832|FG000|Overall Study|new job|0|||
130546663|NCT00706433|469969833|FG001|Overall Study|new job|0|||
130546664|NCT00706433|469969834|FG002|Overall Study|new job|0|||
130546665|NCT00706433|469969835|FG003|Overall Study|new job|1|||
130546666|NCT01236365|469969836|FG000|Overall Study|Lost to Follow-up|0|||
130546667|NCT01236365|469969837|FG001|Overall Study|Lost to Follow-up|2|||
130546668|NCT01236365|469969836|FG000|Overall Study|Moved Out of State|1|||
130546669|NCT01236365|469969837|FG001|Overall Study|Moved Out of State|0|||
130546670|NCT01236365|469969836|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
130546671|NCT01236365|469969837|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
130546672|NCT00717067|469969838|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
130546673|NCT00717067|469969839|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
130546674|NCT00717067|469969840|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
130546675|NCT00717067|469969841|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
130546676|NCT00717067|469969842|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
130546677|NCT02808143|469969843|FG000|Maintenance Phase|Disease recurrence|1|||
130546678|NCT02808143|469969844|FG001|Maintenance Phase|Disease recurrence|3|||
130546679|NCT02808143|469969843|FG000|Maintenance Phase|Disease progression|1|||
130546680|NCT02808143|469969844|FG001|Maintenance Phase|Disease progression|2|||
130546681|NCT02808143|469969843|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
130546682|NCT02808143|469969844|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
130546683|NCT02808143|469969843|FG000|Survival Follow-Up|Disease recurrence|0|||
130546684|NCT02808143|469969844|FG001|Survival Follow-Up|Disease recurrence|2|||
130546685|NCT02808143|469969843|FG000|Survival Follow-Up|Adverse Event|0|||
130546686|NCT02808143|469969844|FG001|Survival Follow-Up|Adverse Event|1|||
130546687|NCT02808143|469969843|FG000|Survival Follow-Up|Death|1|||
130546688|NCT02808143|469969844|FG001|Survival Follow-Up|Death|0|||
130546689|NCT04964388|469969845|FG000|Overall Study|Lost to Follow-up|3|||
130546690|NCT04964388|469969846|FG001|Overall Study|Lost to Follow-up|2|||
130546691|NCT01689337|469969847|FG000|Overall Study|Study Discontinuation|1|||
130546692|NCT03406260|469969848|FG000|Period 1|Adverse Event|0|||
130546693|NCT03406260|469969849|FG001|Period 1|Adverse Event|0|||
130546694|NCT03406260|469969850|FG002|Period 1|Adverse Event|0|||
130546695|NCT03406260|469969851|FG003|Period 1|Adverse Event|0|||
130546696|NCT03406260|469969852|FG004|Period 1|Adverse Event|1|||
130546697|NCT03406260|469969853|FG005|Period 1|Adverse Event|0|||
130546698|NCT00871780|469969854|FG000|Overall Study|Enrolled But Not Treated|6|||
130546699|NCT00871780|469969854|FG000|Overall Study|Withdrawal by Subject|9|||
130546700|NCT00871780|469969854|FG000|Overall Study|Adverse Event|6|||
130546701|NCT00871780|469969854|FG000|Overall Study|Voluntary Discontinuation|4|||
130546702|NCT00871780|469969854|FG000|Overall Study|Death|1|||
130546703|NCT00871780|469969854|FG000|Overall Study|Physician Decision|1|||
130546704|NCT00069108|469969859|FG000|Overall Study|Withdrawal by Subject|5|||
130546705|NCT00069108|469969860|FG001|Overall Study|Withdrawal by Subject|9|||
130546706|NCT00069108|469969859|FG000|Overall Study|Adverse Event|64|||
130546707|NCT00069108|469969860|FG001|Overall Study|Adverse Event|42|||
130546708|NCT00069108|469969859|FG000|Overall Study|Death|6|||
130546709|NCT00069108|469969860|FG001|Overall Study|Death|6|||
130546710|NCT00069108|469969859|FG000|Overall Study|Administration|15|||
130546711|NCT00069108|469969860|FG001|Overall Study|Administration|4|||
130546712|NCT00069108|469969859|FG000|Overall Study|Insufficient therapy|117|||
130546713|NCT00069108|469969860|FG001|Overall Study|Insufficient therapy|144|||
130546714|NCT00069108|469969859|FG000|Overall Study|Violation criteria|1|||
130546715|NCT00069108|469969860|FG001|Overall Study|Violation criteria|4|||
130546716|NCT00069108|469969859|FG000|Overall Study|Refused treatment|5|||
130546717|NCT00069108|469969860|FG001|Overall Study|Refused treatment|10|||
130546718|NCT02208999|469969862|FG000|Overall Study|Lost to Follow-up|1|||
130546719|NCT00319839|469969863|FG000|Overall Study|Adverse Event|5|||
130546720|NCT00319839|469969863|FG000|Overall Study|Withdrawal by Subject|1|||
130546721|NCT00262951|469969864|FG000|Overall Study|Progressive disease/relapse|3|||
130546722|NCT00262951|469969864|FG000|Overall Study|Adverse Event|7|||
130546723|NCT00262951|469969864|FG000|Overall Study|Death|1|||
130546724|NCT00262951|469969864|FG000|Overall Study|Withdrawal by Subject|1|||
130546725|NCT00262951|469969864|FG000|Overall Study|Alternative treatment|3|||
130546726|NCT00262951|469969864|FG000|Overall Study|Off treatment for other disease|1|||
130546727|NCT01577745|469969865|FG000|Overall Study|Withdrawal by Subject|0|||
130546728|NCT01577745|469969866|FG001|Overall Study|Withdrawal by Subject|1|||
130546729|NCT01577745|469969867|FG002|Overall Study|Withdrawal by Subject|0|||
130546730|NCT01577745|469969868|FG003|Overall Study|Withdrawal by Subject|3|||
130546731|NCT01577745|469969869|FG004|Overall Study|Withdrawal by Subject|2|||
130546732|NCT01577745|469969870|FG005|Overall Study|Withdrawal by Subject|0|||
130546733|NCT01577745|469969865|FG000|Overall Study|Death|3|||
130546734|NCT01577745|469969866|FG001|Overall Study|Death|2|||
130546735|NCT01577745|469969867|FG002|Overall Study|Death|2|||
130546736|NCT01577745|469969868|FG003|Overall Study|Death|1|||
130546737|NCT01577745|469969869|FG004|Overall Study|Death|1|||
130546738|NCT01577745|469969870|FG005|Overall Study|Death|3|||
130546739|NCT01577745|469969865|FG000|Overall Study|Physician Decision|0|||
130546740|NCT01577745|469969866|FG001|Overall Study|Physician Decision|0|||
130546741|NCT01577745|469969867|FG002|Overall Study|Physician Decision|0|||
130546742|NCT01577745|469969868|FG003|Overall Study|Physician Decision|1|||
130546743|NCT01577745|469969869|FG004|Overall Study|Physician Decision|1|||
130546744|NCT01577745|469969870|FG005|Overall Study|Physician Decision|0|||
130546745|NCT01577745|469969865|FG000|Overall Study|Lost to Follow-up|0|||
130546746|NCT01577745|469969866|FG001|Overall Study|Lost to Follow-up|0|||
130546747|NCT01577745|469969867|FG002|Overall Study|Lost to Follow-up|0|||
130546748|NCT01577745|469969868|FG003|Overall Study|Lost to Follow-up|0|||
130546749|NCT01577745|469969869|FG004|Overall Study|Lost to Follow-up|0|||
130546750|NCT01577745|469969870|FG005|Overall Study|Lost to Follow-up|1|||
130546751|NCT01577745|469969865|FG000|Overall Study|Alternative Therapy|0|||
130546752|NCT01577745|469969866|FG001|Overall Study|Alternative Therapy|0|||
130546753|NCT01577745|469969867|FG002|Overall Study|Alternative Therapy|0|||
130546754|NCT01577745|469969868|FG003|Overall Study|Alternative Therapy|1|||
130546755|NCT01577745|469969869|FG004|Overall Study|Alternative Therapy|1|||
130546756|NCT01577745|469969870|FG005|Overall Study|Alternative Therapy|0|||
130546757|NCT02483585|469969871|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
130546758|NCT02483585|469969872|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
130546759|NCT02483585|469969871|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
130546760|NCT02483585|469969872|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
130546761|NCT02483585|469969871|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
130546762|NCT02483585|469969872|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
130546763|NCT02483585|469969871|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
130546764|NCT02483585|469969872|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
130546765|NCT02483585|469969871|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
130546766|NCT02483585|469969872|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
130546767|NCT02483585|469969871|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
130546768|NCT02483585|469969872|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
130546769|NCT02483585|469969871|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
130546770|NCT02483585|469969872|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
130546771|NCT00825916|469969874|FG000|Overall Study|Lost to Follow-up|4|||
130546772|NCT00825916|469969875|FG001|Overall Study|Lost to Follow-up|2|||
130546773|NCT00825916|469969876|FG002|Overall Study|Lost to Follow-up|1|||
130546774|NCT01324440|469969880|FG000|Overall Study|Subject moved|0|||
130546775|NCT01324440|469969881|FG001|Overall Study|Subject moved|1|||
130546776|NCT00394082|469969884|FG000|Overall Study|Unacceptable toxicity|15|||
130546777|NCT00394082|469969884|FG000|Overall Study|Adverse Event|4|||
130546778|NCT00394082|469969884|FG000|Overall Study|Physician Decision|4|||
130546779|NCT00394082|469969884|FG000|Overall Study|Withdrawal by Subject|2|||
130546780|NCT00394082|469969884|FG000|Overall Study|Other|1|||
130546781|NCT00903630|469969885|FG000|Phase 2|Adverse Event|0|||
130546782|NCT00903630|469969886|FG001|Phase 2|Adverse Event|0|||
130546783|NCT00903630|469969887|FG002|Phase 2|Adverse Event|1|||
130546784|NCT02325557|469969888|FG000|Overall Study|Progressive disease|1|||
130546785|NCT02325557|469969889|FG001|Overall Study|Progressive disease|0|||
130546786|NCT02325557|469969890|FG002|Overall Study|Progressive disease|0|||
130546787|NCT02325557|469969891|FG003|Overall Study|Progressive disease|0|||
130546788|NCT02325557|469969888|FG000|Overall Study|Withdrawal by Subject|4|||
130546789|NCT02325557|469969889|FG001|Overall Study|Withdrawal by Subject|0|||
130546790|NCT02325557|469969890|FG002|Overall Study|Withdrawal by Subject|0|||
130546791|NCT02325557|469969891|FG003|Overall Study|Withdrawal by Subject|15|||
130546792|NCT02325557|469969888|FG000|Overall Study|Death|5|||
130546793|NCT02325557|469969889|FG001|Overall Study|Death|1|||
130546794|NCT02325557|469969890|FG002|Overall Study|Death|1|||
130546795|NCT02325557|469969891|FG003|Overall Study|Death|16|||
130546796|NCT02325557|469969888|FG000|Overall Study|Lost to Follow-up|0|||
130546797|NCT02325557|469969889|FG001|Overall Study|Lost to Follow-up|0|||
130546798|NCT02325557|469969890|FG002|Overall Study|Lost to Follow-up|1|||
130546799|NCT02325557|469969891|FG003|Overall Study|Lost to Follow-up|1|||
130546800|NCT02325557|469969888|FG000|Overall Study|Other|0|||
130546801|NCT02325557|469969889|FG001|Overall Study|Other|0|||
130546802|NCT02325557|469969890|FG002|Overall Study|Other|0|||
130546803|NCT02325557|469969891|FG003|Overall Study|Other|5|||
130546804|NCT01136772|469969894|FG000|Overall Study|Adverse Event|15|||
130546805|NCT01136772|469969895|FG001|Overall Study|Adverse Event|14|||
130546806|NCT01136772|469969894|FG000|Overall Study|Lack of Efficacy|42|||
130546807|NCT01136772|469969895|FG001|Overall Study|Lack of Efficacy|39|||
130546808|NCT01136772|469969894|FG000|Overall Study|Administrative|14|||
130546809|NCT01136772|469969895|FG001|Overall Study|Administrative|12|||
130546810|NCT01136772|469969894|FG000|Overall Study|Withdrawal by Subject|33|||
130546811|NCT01136772|469969895|FG001|Overall Study|Withdrawal by Subject|36|||
130546812|NCT01136772|469969894|FG000|Overall Study|Did not receive injection|10|||
130546813|NCT01136772|469969895|FG001|Overall Study|Did not receive injection|7|||
130546814|NCT01136772|469969894|FG000|Overall Study|Did not follow up after first injection|2|||
130546815|NCT01136772|469969895|FG001|Overall Study|Did not follow up after first injection|2|||
130546816|NCT01602562|469969901|FG000|Overall Study|Adverse Event|3|||
130546817|NCT01602562|469969902|FG001|Overall Study|Adverse Event|1|||
130546818|NCT01602562|469969901|FG000|Overall Study|Physician Decision|1|||
130546819|NCT01602562|469969902|FG001|Overall Study|Physician Decision|1|||
130546820|NCT01602562|469969901|FG000|Overall Study|Withdrawal by Subject|1|||
130546821|NCT01602562|469969902|FG001|Overall Study|Withdrawal by Subject|1|||
130546822|NCT03881553|469969903|FG000|Overall Study|Discharged prior to participation|1|||
130546823|NCT03881553|469969904|FG001|Overall Study|Discharged prior to participation|1|||
130546824|NCT03881553|469969905|FG002|Overall Study|Discharged prior to participation|0|||
130546825|NCT03881553|469969903|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
130546826|NCT03881553|469969904|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
130546827|NCT03881553|469969905|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
130214025|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
130214026|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214027|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214028|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214029|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130214030|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214031|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130546828|NCT01959516|469969906|FG000|Epoch 1|Adverse Event|4|||
130546829|NCT01959516|469969907|FG001|Epoch 1|Adverse Event|1|||
130546830|NCT01959516|469969906|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
130546831|NCT01959516|469969907|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
130546832|NCT01959516|469969906|FG000|Epoch 1|Subject withdrew consent|3|||
130546833|NCT01959516|469969907|FG001|Epoch 1|Subject withdrew consent|2|||
130546834|NCT01959516|469969906|FG000|Epoch 1|Administrative problems|1|||
130546835|NCT01959516|469969907|FG001|Epoch 1|Administrative problems|0|||
130546836|NCT01959516|469969906|FG000|Epoch 1|Use of prohibited treatment|1|||
130546837|NCT01959516|469969907|FG001|Epoch 1|Use of prohibited treatment|0|||
130546838|NCT01959516|469969906|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
130546839|NCT01959516|469969907|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
130546840|NCT01959516|469969906|FG000|Epoch 1|Protocol deviation|0|||
130546841|NCT01959516|469969907|FG001|Epoch 1|Protocol deviation|1|||
130546842|NCT01959516|469969906|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
130546843|NCT01959516|469969907|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
130546844|NCT01959516|469969906|FG000|Epoch 2|Subject withdrew consent|1|||
130546845|NCT01959516|469969907|FG001|Epoch 2|Subject withdrew consent|0|||
130546846|NCT01959516|469969906|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
130546847|NCT01959516|469969907|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
130546848|NCT01477333|469969908|FG000|Overall Study|Adverse Event|1|||
130546849|NCT01477333|469969908|FG000|Overall Study|Withdrawal by Subject|1|||
130546850|NCT01477333|469969908|FG000|Overall Study|Clinical Deterioration|1|||
130546851|NCT00928746|469969912|FG000|Overall Study|Adverse Event|2|||
130546852|NCT00928746|469969912|FG000|Overall Study|Protocol Violation|1|||
130546853|NCT00928746|469969912|FG000|Overall Study|Withdrawal by Subject|1|||
130546854|NCT00928746|469969912|FG000|Overall Study|Other|2|||
130546855|NCT02581631|469969914|FG000|Overall Study|Disease progression|29|||
130546856|NCT02581631|469969915|FG001|Overall Study|Disease progression|19|||
130546857|NCT02581631|469969916|FG002|Overall Study|Disease progression|13|||
130546858|NCT02581631|469969917|FG003|Overall Study|Disease progression|5|||
130546859|NCT02581631|469969918|FG004|Overall Study|Disease progression|8|||
130546860|NCT02581631|469969914|FG000|Overall Study|Study drug toxicity|4|||
130546861|NCT02581631|469969915|FG001|Overall Study|Study drug toxicity|6|||
130546862|NCT02581631|469969916|FG002|Overall Study|Study drug toxicity|7|||
130546863|NCT02581631|469969917|FG003|Overall Study|Study drug toxicity|0|||
130546864|NCT02581631|469969918|FG004|Overall Study|Study drug toxicity|3|||
130546865|NCT02581631|469969914|FG000|Overall Study|AE unrelated to study drug|3|||
130546866|NCT02581631|469969915|FG001|Overall Study|AE unrelated to study drug|1|||
130546867|NCT02581631|469969916|FG002|Overall Study|AE unrelated to study drug|1|||
130546868|NCT02581631|469969917|FG003|Overall Study|AE unrelated to study drug|0|||
130546869|NCT02581631|469969918|FG004|Overall Study|AE unrelated to study drug|2|||
130546870|NCT02581631|469969914|FG000|Overall Study|Request to discontinue|1|||
130546871|NCT02581631|469969915|FG001|Overall Study|Request to discontinue|0|||
130546872|NCT02581631|469969916|FG002|Overall Study|Request to discontinue|3|||
130546873|NCT02581631|469969917|FG003|Overall Study|Request to discontinue|0|||
130546874|NCT02581631|469969918|FG004|Overall Study|Request to discontinue|1|||
130546875|NCT02581631|469969914|FG000|Overall Study|participant withdrew consent|3|||
130546876|NCT02581631|469969915|FG001|Overall Study|participant withdrew consent|0|||
130546877|NCT02581631|469969916|FG002|Overall Study|participant withdrew consent|1|||
130546878|NCT02581631|469969917|FG003|Overall Study|participant withdrew consent|0|||
130546879|NCT02581631|469969918|FG004|Overall Study|participant withdrew consent|0|||
130546880|NCT02581631|469969914|FG000|Overall Study|Maximum clinical benefit|1|||
130546881|NCT02581631|469969915|FG001|Overall Study|Maximum clinical benefit|7|||
130546882|NCT02581631|469969916|FG002|Overall Study|Maximum clinical benefit|1|||
130546883|NCT02581631|469969917|FG003|Overall Study|Maximum clinical benefit|3|||
130546884|NCT02581631|469969918|FG004|Overall Study|Maximum clinical benefit|13|||
130546885|NCT02581631|469969914|FG000|Overall Study|Other Reasons|1|||
130546886|NCT02581631|469969915|FG001|Overall Study|Other Reasons|0|||
130546887|NCT02581631|469969916|FG002|Overall Study|Other Reasons|2|||
130546888|NCT02581631|469969917|FG003|Overall Study|Other Reasons|2|||
130546889|NCT02581631|469969918|FG004|Overall Study|Other Reasons|3|||
130546890|NCT02581631|469969914|FG000|Overall Study|Poor/Non-Compliance|0|||
130546891|NCT02581631|469969915|FG001|Overall Study|Poor/Non-Compliance|0|||
130546892|NCT02581631|469969916|FG002|Overall Study|Poor/Non-Compliance|1|||
130546893|NCT02581631|469969917|FG003|Overall Study|Poor/Non-Compliance|0|||
130546894|NCT02581631|469969918|FG004|Overall Study|Poor/Non-Compliance|0|||
130546895|NCT00336895|469969919|FG000|Overall Study|diarrhea|1|||
130546896|NCT00336895|469969919|FG000|Overall Study|nausea and upset stomach|1|||
130546897|NCT00336895|469969919|FG000|Overall Study|Physician Decision|1|||
130546898|NCT00336895|469969919|FG000|Overall Study|screen failed|1|||
130546899|NCT02481947|469969920|FG000|Overall Study|Withdrawal by Subject|24|||
130546900|NCT02481947|469969921|FG001|Overall Study|Withdrawal by Subject|10|||
130546901|NCT02481947|469969920|FG000|Overall Study|Lost to Follow-up|11|||
130546902|NCT02481947|469969921|FG001|Overall Study|Lost to Follow-up|5|||
130546903|NCT02481947|469969920|FG000|Overall Study|Adverse Event|6|||
130546904|NCT02481947|469969921|FG001|Overall Study|Adverse Event|11|||
130546905|NCT02481947|469969920|FG000|Overall Study|Physician Decision|4|||
130546906|NCT02481947|469969921|FG001|Overall Study|Physician Decision|5|||
130546907|NCT02481947|469969920|FG000|Overall Study|Protocol Violation|1|||
130546908|NCT02481947|469969921|FG001|Overall Study|Protocol Violation|5|||
130546909|NCT01815138|469969922|FG000|Overall Study|Withdrawal by Subject|0|||
130546910|NCT01815138|469969923|FG001|Overall Study|Withdrawal by Subject|1|||
130546911|NCT01815138|469969922|FG000|Overall Study|Physician Decision|8|||
130546912|NCT01815138|469969923|FG001|Overall Study|Physician Decision|5|||
130546913|NCT03426267|469969924|FG000|Overall Study|Physician Decision|1|||
130546914|NCT03426267|469969925|FG001|Overall Study|Physician Decision|4|||
130546915|NCT03426267|469969924|FG000|Overall Study|Lost to Follow-up|1|||
130546916|NCT03426267|469969925|FG001|Overall Study|Lost to Follow-up|0|||
130546917|NCT03426267|469969924|FG000|Overall Study|Withdrawal by Subject|4|||
130546918|NCT03426267|469969925|FG001|Overall Study|Withdrawal by Subject|10|||
130546919|NCT03426267|469969924|FG000|Overall Study|Protocol Violation|1|||
130546920|NCT03426267|469969925|FG001|Overall Study|Protocol Violation|3|||
130546921|NCT03426267|469969924|FG000|Overall Study|Adverse Event|9|||
130546922|NCT03426267|469969925|FG001|Overall Study|Adverse Event|27|||
130546923|NCT03426267|469969924|FG000|Overall Study|Prohibited Treatment Intake|2|||
130546924|NCT03426267|469969925|FG001|Overall Study|Prohibited Treatment Intake|3|||
130546925|NCT03426267|469969924|FG000|Overall Study|Lack of Efficacy|0|||
130546926|NCT03426267|469969925|FG001|Overall Study|Lack of Efficacy|25|||
130546927|NCT03426267|469969924|FG000|Overall Study|other|3|||
130546928|NCT03426267|469969925|FG001|Overall Study|other|0|||
130546929|NCT03801915|469969927|FG000|Overall Study|Screen failure|0|||
130546930|NCT03801915|469969928|FG001|Overall Study|Screen failure|0|||
130546931|NCT03801915|469969929|FG002|Overall Study|Screen failure|1|||
130546932|NCT03801915|469969927|FG000|Overall Study|Ineligible|1|||
130546933|NCT03801915|469969928|FG001|Overall Study|Ineligible|0|||
130546934|NCT03801915|469969929|FG002|Overall Study|Ineligible|0|||
130546935|NCT03801915|469969927|FG000|Overall Study|Physician Decision|2|||
130546936|NCT03801915|469969928|FG001|Overall Study|Physician Decision|1|||
130546937|NCT03801915|469969929|FG002|Overall Study|Physician Decision|0|||
130546938|NCT02003573|469969942|FG000|Overall Study|Progressive disease|2|||
130546939|NCT02003573|469969943|FG001|Overall Study|Progressive disease|0|||
130546940|NCT02003573|469969944|FG002|Overall Study|Progressive disease|1|||
130546941|NCT02003573|469969942|FG000|Overall Study|Other Adverse event|0|||
130546942|NCT02003573|469969943|FG001|Overall Study|Other Adverse event|1|||
130546943|NCT02003573|469969944|FG002|Overall Study|Other Adverse event|1|||
130546944|NCT02003573|469969942|FG000|Overall Study|Refuse to take trial medication|0|||
130546945|NCT02003573|469969943|FG001|Overall Study|Refuse to take trial medication|1|||
130546946|NCT02003573|469969944|FG002|Overall Study|Refuse to take trial medication|1|||
130546947|NCT02003573|469969942|FG000|Overall Study|Other than specified|1|||
130546948|NCT02003573|469969943|FG001|Overall Study|Other than specified|2|||
130546949|NCT02003573|469969944|FG002|Overall Study|Other than specified|3|||
130546950|NCT00928018|469969951|FG000|Overall Study|Withdrawal by Subject|1|||
130546951|NCT00928018|469969952|FG001|Overall Study|Withdrawal by Subject|0|||
130546952|NCT00126503|469969953|FG000|Overall Study|disease progression|23|||
130546953|NCT00126503|469969954|FG001|Overall Study|disease progression|14|||
130546954|NCT00126503|469969953|FG000|Overall Study|Withdrawal by Subject|0|||
130546955|NCT00126503|469969954|FG001|Overall Study|Withdrawal by Subject|1|||
130546956|NCT00126503|469969953|FG000|Overall Study|alternative therapy|1|||
130546957|NCT00126503|469969954|FG001|Overall Study|alternative therapy|1|||
130546958|NCT00126503|469969953|FG000|Overall Study|other complicating disease|4|||
130546959|NCT00126503|469969954|FG001|Overall Study|other complicating disease|1|||
130546960|NCT00126503|469969953|FG000|Overall Study|Death|3|||
130546961|NCT00126503|469969954|FG001|Overall Study|Death|0|||
130546962|NCT00126503|469969953|FG000|Overall Study|Adverse Event|13|||
130546963|NCT00126503|469969954|FG001|Overall Study|Adverse Event|3|||
130546964|NCT00126503|469969953|FG000|Overall Study|non-compliant|1|||
130546965|NCT00126503|469969954|FG001|Overall Study|non-compliant|0|||
130546966|NCT00126503|469969953|FG000|Overall Study|Physician Decision|2|||
130546967|NCT00126503|469969954|FG001|Overall Study|Physician Decision|1|||
130546968|NCT02457559|469969955|FG000|Overall Study|Progressive Disease|1|||
130546969|NCT02457559|469969956|FG001|Overall Study|Progressive Disease|2|||
130546970|NCT02457559|469969957|FG002|Overall Study|Progressive Disease|3|||
130546971|NCT02457559|469969958|FG003|Overall Study|Progressive Disease|0|||
130546972|NCT02457559|469969959|FG004|Overall Study|Progressive Disease|0|||
130546973|NCT02457559|469969960|FG005|Overall Study|Progressive Disease|2|||
130546974|NCT02457559|469969961|FG006|Overall Study|Progressive Disease|1|||
130546975|NCT02457559|469969962|FG007|Overall Study|Progressive Disease|0|||
130546976|NCT02457559|469969963|FG008|Overall Study|Progressive Disease|1|||
130546977|NCT02457559|469969964|FG009|Overall Study|Progressive Disease|1|||
130546978|NCT02457559|469969965|FG010|Overall Study|Progressive Disease|1|||
130546979|NCT02457559|469969955|FG000|Overall Study|Investigator's Discretion|0|||
130546980|NCT02457559|469969956|FG001|Overall Study|Investigator's Discretion|0|||
130546981|NCT02457559|469969957|FG002|Overall Study|Investigator's Discretion|2|||
130546982|NCT02457559|469969958|FG003|Overall Study|Investigator's Discretion|0|||
130546983|NCT02457559|469969959|FG004|Overall Study|Investigator's Discretion|1|||
130546984|NCT02457559|469969960|FG005|Overall Study|Investigator's Discretion|0|||
130546985|NCT02457559|469969961|FG006|Overall Study|Investigator's Discretion|1|||
130546986|NCT02457559|469969962|FG007|Overall Study|Investigator's Discretion|0|||
130546987|NCT02457559|469969963|FG008|Overall Study|Investigator's Discretion|1|||
130546988|NCT02457559|469969964|FG009|Overall Study|Investigator's Discretion|0|||
130546989|NCT02457559|469969965|FG010|Overall Study|Investigator's Discretion|1|||
130546990|NCT02457559|469969955|FG000|Overall Study|Adverse Event|0|||
130546991|NCT02457559|469969956|FG001|Overall Study|Adverse Event|1|||
130546992|NCT02457559|469969957|FG002|Overall Study|Adverse Event|2|||
130546993|NCT02457559|469969958|FG003|Overall Study|Adverse Event|0|||
130546994|NCT02457559|469969959|FG004|Overall Study|Adverse Event|0|||
130546995|NCT02457559|469969960|FG005|Overall Study|Adverse Event|0|||
130546996|NCT02457559|469969961|FG006|Overall Study|Adverse Event|0|||
130546997|NCT02457559|469969962|FG007|Overall Study|Adverse Event|0|||
130546998|NCT02457559|469969963|FG008|Overall Study|Adverse Event|0|||
130546999|NCT02457559|469969964|FG009|Overall Study|Adverse Event|0|||
130547000|NCT02457559|469969965|FG010|Overall Study|Adverse Event|0|||
130547001|NCT02457559|469969955|FG000|Overall Study|Reason not Specified|1|||
130547002|NCT02457559|469969956|FG001|Overall Study|Reason not Specified|0|||
130547003|NCT02457559|469969957|FG002|Overall Study|Reason not Specified|0|||
130547004|NCT02457559|469969958|FG003|Overall Study|Reason not Specified|0|||
130547005|NCT02457559|469969959|FG004|Overall Study|Reason not Specified|0|||
130547006|NCT02457559|469969960|FG005|Overall Study|Reason not Specified|0|||
130547007|NCT02457559|469969961|FG006|Overall Study|Reason not Specified|0|||
130547008|NCT02457559|469969962|FG007|Overall Study|Reason not Specified|0|||
130547009|NCT02457559|469969963|FG008|Overall Study|Reason not Specified|0|||
130547010|NCT02457559|469969964|FG009|Overall Study|Reason not Specified|2|||
130547011|NCT02457559|469969965|FG010|Overall Study|Reason not Specified|0|||
130547012|NCT02457559|469969955|FG000|Overall Study|Death|0|||
130547013|NCT02457559|469969956|FG001|Overall Study|Death|0|||
130547014|NCT02457559|469969957|FG002|Overall Study|Death|0|||
130547015|NCT02457559|469969958|FG003|Overall Study|Death|0|||
130547016|NCT02457559|469969959|FG004|Overall Study|Death|0|||
130547017|NCT02457559|469969960|FG005|Overall Study|Death|0|||
130547018|NCT02457559|469969961|FG006|Overall Study|Death|0|||
130547019|NCT02457559|469969962|FG007|Overall Study|Death|0|||
130547020|NCT02457559|469969963|FG008|Overall Study|Death|1|||
130547021|NCT02457559|469969964|FG009|Overall Study|Death|1|||
130547022|NCT02457559|469969965|FG010|Overall Study|Death|0|||
130547023|NCT00998335|469969966|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
130547024|NCT00998335|469969967|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
130547025|NCT02374671|469969968|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
130547026|NCT02374671|469969969|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
130547027|NCT02374671|469969970|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
130547028|NCT02374671|469969968|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
130547029|NCT02374671|469969969|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
130547030|NCT02374671|469969970|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
130547031|NCT02374671|469969968|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
130547032|NCT02374671|469969969|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
130547033|NCT02374671|469969970|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
130547034|NCT02374671|469969968|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
130547035|NCT02374671|469969969|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
130547036|NCT02374671|469969970|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
130547037|NCT02374671|469969968|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
130547038|NCT02374671|469969969|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
130547039|NCT02374671|469969970|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
130547040|NCT05330312|469969975|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
130547041|NCT05330312|469969976|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
130547042|NCT05330312|469969977|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
130547043|NCT05330312|469969975|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
130547044|NCT05330312|469969976|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
130547045|NCT05330312|469969977|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
130547046|NCT05330312|469969975|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
130547047|NCT05330312|469969976|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
130547048|NCT05330312|469969977|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
130547049|NCT05330312|469969975|FG000|Pivotal Investigation - Part 2|Death|1|||
130547050|NCT05330312|469969976|FG001|Pivotal Investigation - Part 2|Death|4|||
130547051|NCT05330312|469969977|FG002|Pivotal Investigation - Part 2|Death|0|||
130547052|NCT01078454|469969980|FG000|Overall Study|Adverse Event|1|||
130547053|NCT01078454|469969981|FG001|Overall Study|Adverse Event|1|||
130547054|NCT01078454|469969980|FG000|Overall Study|Death|0|||
130547055|NCT01078454|469969981|FG001|Overall Study|Death|1|||
130547056|NCT00346268|469971436|FG000|Overall Study|Adverse Event|1|||
130547057|NCT00346268|469971437|FG001|Overall Study|Adverse Event|0|||
130547058|NCT00346268|469971436|FG000|Overall Study|Protocol Violation|1|||
130547059|NCT00346268|469971437|FG001|Overall Study|Protocol Violation|0|||
130547060|NCT00346268|469971436|FG000|Overall Study|Participant refused|0|||
130547061|NCT00346268|469971437|FG001|Overall Study|Participant refused|3|||
130547062|NCT01036763|469971438|FG000|Overall Study|Adverse Event|25|||
130547063|NCT01036763|469971438|FG000|Overall Study|Lost to Follow-up|28|||
130547064|NCT01036763|469971438|FG000|Overall Study|Other reason (not specified)|40|||
130547065|NCT00743275|469971439|FG000|Overall Study|Protocol Violation|0|||
130547066|NCT00743275|469971440|FG001|Overall Study|Protocol Violation|1|||
130547067|NCT01672723|469971441|FG000|First Intervention|Adverse Event|3|||
130547068|NCT01672723|469971442|FG001|First Intervention|Adverse Event|0|||
130547069|NCT03536143|469971451|FG000|Overall Study|Early termination, Sponsor decision|1|||
130547070|NCT01174160|469971452|FG000|Overall Study|Adverse Event|1|||
130547071|NCT01174160|469971453|FG001|Overall Study|Adverse Event|0|||
130547072|NCT01174160|469971452|FG000|Overall Study|Lost to Follow-up|1|||
130547073|NCT01174160|469971453|FG001|Overall Study|Lost to Follow-up|0|||
130547074|NCT01174160|469971452|FG000|Overall Study|Physician Decision|1|||
130547075|NCT01174160|469971453|FG001|Overall Study|Physician Decision|0|||
130547076|NCT01174160|469971452|FG000|Overall Study|Protocol Violation|4|||
130547077|NCT01174160|469971453|FG001|Overall Study|Protocol Violation|6|||
130322445|NCT03414983|469151271|FG000|Treatment|Participant withdrew consent|4|||
130322446|NCT03414983|469151272|FG001|Treatment|Participant withdrew consent|3|||
130322447|NCT03414983|469151271|FG000|Treatment|Participant request to discontinue study treatment|8|||
130322448|NCT03414983|469151272|FG001|Treatment|Participant request to discontinue study treatment|10|||
130322449|NCT03414983|469151271|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
130322450|NCT03414983|469151272|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
130322451|NCT03414983|469151271|FG000|Treatment|Death|0|||
130547078|NCT01174160|469971452|FG000|Overall Study|Withdrawal by Subject|1|||
130547079|NCT01174160|469971453|FG001|Overall Study|Withdrawal by Subject|0|||
130547080|NCT02527343|469971454|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
130547081|NCT02527343|469971455|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
130547082|NCT02527343|469971456|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
130547083|NCT02527343|469971457|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
130547084|NCT02527343|469971458|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
130547085|NCT02527343|469971459|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
130547086|NCT02527343|469971454|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
130547087|NCT02527343|469971455|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
130547088|NCT02527343|469971456|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
130547089|NCT02527343|469971457|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
130547090|NCT02527343|469971458|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
130547091|NCT02527343|469971459|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
130547092|NCT02527343|469971454|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130547093|NCT02527343|469971455|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
130547094|NCT02527343|469971456|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130547095|NCT02527343|469971457|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130547096|NCT02527343|469971458|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130547097|NCT02527343|469971459|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130547098|NCT02527343|469971454|FG000|RT Period: Weeks 1 to 52|Other|4|||
130547099|NCT02527343|469971455|FG001|RT Period: Weeks 1 to 52|Other|3|||
130547100|NCT02527343|469971456|FG002|RT Period: Weeks 1 to 52|Other|0|||
130547101|NCT02527343|469971457|FG003|RT Period: Weeks 1 to 52|Other|0|||
130547102|NCT02527343|469971458|FG004|RT Period: Weeks 1 to 52|Other|0|||
130547103|NCT02527343|469971459|FG005|RT Period: Weeks 1 to 52|Other|0|||
130547104|NCT02527343|469971454|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
130547105|NCT02527343|469971455|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
130547106|NCT02527343|469971456|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
130547107|NCT02527343|469971457|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
130547108|NCT02527343|469971458|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
130547109|NCT02527343|469971459|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
130547110|NCT02527343|469971454|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
130547111|NCT02527343|469971455|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
130547112|NCT02527343|469971456|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
130547113|NCT02527343|469971457|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
130547114|NCT02527343|469971458|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
130547115|NCT02527343|469971459|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
130547116|NCT02527343|469971454|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
130547117|NCT02527343|469971455|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
130547118|NCT02527343|469971456|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
130547119|NCT02527343|469971457|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
130547120|NCT02527343|469971458|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
130547121|NCT02527343|469971459|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
130547122|NCT02527343|469971454|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
130322452|NCT03414983|469151272|FG001|Treatment|Death|1|||
130322453|NCT03414983|469151271|FG000|Treatment|Study Drug Toxicity|10|||
130322454|NCT03414983|469151272|FG001|Treatment|Study Drug Toxicity|5|||
130322455|NCT03414983|469151271|FG000|Treatment|Disease Progression|75|||
130547123|NCT02527343|469971455|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
130547124|NCT02527343|469971456|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
130547125|NCT02527343|469971457|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
130547126|NCT02527343|469971458|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
130547127|NCT02527343|469971459|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
130547128|NCT02527343|469971454|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130547129|NCT02527343|469971455|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130547130|NCT02527343|469971456|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130547131|NCT02527343|469971457|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130547132|NCT02527343|469971458|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
130547133|NCT02527343|469971459|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
130547134|NCT02527343|469971454|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
130547135|NCT02527343|469971455|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
130547136|NCT02527343|469971456|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
130547137|NCT02527343|469971457|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
130547138|NCT02527343|469971458|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
130547139|NCT02527343|469971459|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
130547140|NCT02527343|469971454|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
130547141|NCT02527343|469971455|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
130547142|NCT02527343|469971456|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
130547143|NCT02527343|469971457|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
130547144|NCT02527343|469971458|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
130547145|NCT02527343|469971459|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
130547146|NCT02527343|469971454|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130547147|NCT02527343|469971455|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130547148|NCT02527343|469971456|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130547149|NCT02527343|469971457|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130547150|NCT02527343|469971458|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
130547151|NCT02527343|469971459|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130547152|NCT02527343|469971454|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
130547153|NCT02527343|469971455|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
130547154|NCT02527343|469971456|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
130547155|NCT02527343|469971457|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
130547156|NCT02527343|469971458|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
130547157|NCT02527343|469971459|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
130547158|NCT00701220|469971460|FG000|Overall Study|Withdrawal by Subject|0|||
130547159|NCT00701220|469971461|FG001|Overall Study|Withdrawal by Subject|2|||
130547160|NCT00701220|469971460|FG000|Overall Study|Protocol Violation|2|||
130547161|NCT00701220|469971461|FG001|Overall Study|Protocol Violation|0|||
130547162|NCT00440999|469971462|FG000|Overall Study|Adverse Event|0|||
130547163|NCT00440999|469971463|FG001|Overall Study|Adverse Event|2|||
130547164|NCT00440999|469971462|FG000|Overall Study|Lack of Efficacy|6|||
130547165|NCT00440999|469971463|FG001|Overall Study|Lack of Efficacy|7|||
130547166|NCT00440999|469971462|FG000|Overall Study|Lost to Follow-up|19|||
130547167|NCT00440999|469971463|FG001|Overall Study|Lost to Follow-up|12|||
130547168|NCT00440999|469971462|FG000|Overall Study|Protocol Violation|1|||
130547169|NCT00440999|469971463|FG001|Overall Study|Protocol Violation|0|||
130547170|NCT00440999|469971462|FG000|Overall Study|Withdrawal by Subject|2|||
130547171|NCT00440999|469971463|FG001|Overall Study|Withdrawal by Subject|5|||
130547172|NCT00440999|469971462|FG000|Overall Study|Subjets missed the visit|1|||
130547173|NCT00440999|469971463|FG001|Overall Study|Subjets missed the visit|0|||
130547174|NCT00440999|469971462|FG000|Overall Study|Mixed infection at entry|1|||
130547175|NCT00440999|469971463|FG001|Overall Study|Mixed infection at entry|0|||
130547176|NCT00440999|469971462|FG000|Overall Study|P. falciparum malaria|5|||
130547177|NCT00440999|469971463|FG001|Overall Study|P. falciparum malaria|14|||
130547178|NCT00440999|469971462|FG000|Overall Study|Subj left hosp without inform staff|0|||
130547179|NCT00440999|469971463|FG001|Overall Study|Subj left hosp without inform staff|1|||
130547180|NCT04745026|469971464|FG000|Overall Study|Physician Decision|1|||
130547181|NCT04745026|469971465|FG001|Overall Study|Physician Decision|0|||
130547182|NCT04745026|469971464|FG000|Overall Study|Adverse Event|2|||
130322456|NCT03414983|469151272|FG001|Treatment|Disease Progression|29|||
130322457|NCT03414983|469151271|FG000|Treatment|Not reported|1|||
130322458|NCT03414983|469151272|FG001|Treatment|Not reported|0|||
130322459|NCT03414983|469151271|FG000|Treatment|Other reasons|3|||
130547183|NCT04745026|469971465|FG001|Overall Study|Adverse Event|2|||
130547184|NCT04745026|469971464|FG000|Overall Study|Protocol Violation|1|||
130322460|NCT03414983|469151272|FG001|Treatment|Other reasons|2|||
130322461|NCT03414983|469151271|FG000|Treatment|Poor/non-compliance|2|||
130322462|NCT03414983|469151272|FG001|Treatment|Poor/non-compliance|0|||
130547185|NCT04745026|469971465|FG001|Overall Study|Protocol Violation|3|||
130547186|NCT04745026|469971464|FG000|Overall Study|Lost to Follow-up|4|||
130547187|NCT04745026|469971465|FG001|Overall Study|Lost to Follow-up|3|||
130547188|NCT04745026|469971464|FG000|Overall Study|Withdrawal by Subject|5|||
130547189|NCT04745026|469971465|FG001|Overall Study|Withdrawal by Subject|5|||
130547190|NCT04426851|469971466|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
130547191|NCT04426851|469971467|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
130547192|NCT04426851|469971466|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
130547193|NCT04426851|469971467|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
130547194|NCT03256851|469971468|FG000|Overall Study|Withdrawal by Subject|1|||
130547195|NCT03256851|469971469|FG001|Overall Study|Withdrawal by Subject|0|||
130547196|NCT01990560|469971470|FG000|Overall Study|Withdrawal by Subject|1|||
130547197|NCT01778023|469971471|FG000|Overall Study|Withdrawal by Subject|0|||
130547198|NCT01778023|469971472|FG001|Overall Study|Withdrawal by Subject|3|||
130547199|NCT01098097|469971473|FG000|Overall Study|Adverse Event|17|||
130547200|NCT01098097|469971473|FG000|Overall Study|Lost to Follow-up|18|||
130547201|NCT01098097|469971473|FG000|Overall Study|Status unknown|16|||
130547202|NCT01098097|469971473|FG000|Overall Study|No reason reported|31|||
130547203|NCT00966277|469971476|FG000|Overall Study|Withdrawal by Subject|3|||
130547204|NCT00966277|469971477|FG001|Overall Study|Withdrawal by Subject|0|||
130547205|NCT00966277|469971476|FG000|Overall Study|Ineligible|1|||
130547206|NCT00966277|469971477|FG001|Overall Study|Ineligible|3|||
130547207|NCT00966277|469971476|FG000|Overall Study|Treatment Plan Changed|0|||
130547208|NCT00966277|469971477|FG001|Overall Study|Treatment Plan Changed|1|||
130547209|NCT01488487|469971478|FG000|Overall Study|Adverse Event|6|||
130547210|NCT01488487|469971478|FG000|Overall Study|Death|1|||
130547211|NCT01488487|469971478|FG000|Overall Study|Withdrawal by Subject|2|||
130547212|NCT02004353|469971483|FG000|Overall Study|Voluntary participation|1334|||
130547213|NCT00819390|469971484|FG000|Overall Study|Lost to Follow-up|1|||
130547214|NCT00819390|469971485|FG001|Overall Study|Lost to Follow-up|1|||
130547215|NCT00819390|469971486|FG002|Overall Study|Lost to Follow-up|0|||
130547216|NCT00819390|469971487|FG003|Overall Study|Lost to Follow-up|0|||
130547217|NCT00819390|469971484|FG000|Overall Study|Withdrawal by Subject|2|||
130547218|NCT00819390|469971485|FG001|Overall Study|Withdrawal by Subject|0|||
130547219|NCT00819390|469971486|FG002|Overall Study|Withdrawal by Subject|0|||
130547220|NCT00819390|469971487|FG003|Overall Study|Withdrawal by Subject|0|||
130547221|NCT00819390|469971484|FG000|Overall Study|Adverse Event|0|||
130547222|NCT00819390|469971485|FG001|Overall Study|Adverse Event|0|||
130547223|NCT00819390|469971486|FG002|Overall Study|Adverse Event|1|||
130547224|NCT00819390|469971487|FG003|Overall Study|Adverse Event|0|||
130547225|NCT01211288|469971494|FG000|Overall Study|Lost to Follow-up|1|||
130547226|NCT01211288|469971495|FG001|Overall Study|Lost to Follow-up|1|||
130547227|NCT01270971|469971496|FG000|Overall Study|Withdrawal by Subject|24|||
130547228|NCT01270971|469971497|FG001|Overall Study|Withdrawal by Subject|11|||
130547229|NCT01270971|469971496|FG000|Overall Study|Lost to Follow-up|18|||
130547230|NCT01270971|469971497|FG001|Overall Study|Lost to Follow-up|5|||
130547231|NCT01270971|469971496|FG000|Overall Study|Adverse Event|1|||
130547232|NCT01270971|469971497|FG001|Overall Study|Adverse Event|2|||
130547233|NCT01270971|469971496|FG000|Overall Study|Non compliance|2|||
130547234|NCT01270971|469971497|FG001|Overall Study|Non compliance|2|||
130547235|NCT01270971|469971496|FG000|Overall Study|Non-specific|7|||
130547236|NCT01270971|469971497|FG001|Overall Study|Non-specific|3|||
130547237|NCT01588496|469971501|FG000|Overall Study|Withdrawal by Subject|0|||
130547238|NCT01588496|469971502|FG001|Overall Study|Withdrawal by Subject|1|||
130547239|NCT01588496|469971503|FG002|Overall Study|Withdrawal by Subject|0|||
130547240|NCT01551212|469971504|FG000|Overall Study|Graft loss/Retransplantation|0|||
130547241|NCT01551212|469971505|FG001|Overall Study|Graft loss/Retransplantation|1|||
130547242|NCT01551212|469971504|FG000|Overall Study|Administrative problems|1|||
130547243|NCT01551212|469971505|FG001|Overall Study|Administrative problems|2|||
130547244|NCT01551212|469971504|FG000|Overall Study|Lost to Follow-up|0|||
130547245|NCT01551212|469971505|FG001|Overall Study|Lost to Follow-up|1|||
130547246|NCT01551212|469971504|FG000|Overall Study|Protocol Violation|0|||
130547247|NCT01551212|469971505|FG001|Overall Study|Protocol Violation|1|||
130547248|NCT01551212|469971504|FG000|Overall Study|Withdrawal by Subject|0|||
130547249|NCT01551212|469971505|FG001|Overall Study|Withdrawal by Subject|7|||
130547250|NCT01551212|469971504|FG000|Overall Study|Death|2|||
130547251|NCT01551212|469971505|FG001|Overall Study|Death|4|||
130547252|NCT01551212|469971504|FG000|Overall Study|Never Received Study Treatment|2|||
130547253|NCT01551212|469971505|FG001|Overall Study|Never Received Study Treatment|4|||
130547254|NCT00705523|469971506|FG000|Overall Study|Lost to Follow-up|2|||
130547255|NCT00705523|469971507|FG001|Overall Study|Lost to Follow-up|3|||
130547256|NCT01013285|469971509|FG000|Overall Study|Death|48|||
130547257|NCT01013285|469971510|FG001|Overall Study|Death|89|||
130547258|NCT02112708|469971513|FG000|Baseline|Physician Decision|16|||
130547259|NCT02112708|469971514|FG001|Baseline|Physician Decision|11|||
130547260|NCT02112708|469971513|FG000|Baseline|Lost to Follow-up|12|||
130547261|NCT02112708|469971514|FG001|Baseline|Lost to Follow-up|0|||
130547262|NCT02112708|469971513|FG000|4 Month|Death|0|||
130547263|NCT02112708|469971514|FG001|4 Month|Death|1|||
130547264|NCT02112708|469971513|FG000|4 Month|Withdrawal by Subject|12|||
130547265|NCT02112708|469971514|FG001|4 Month|Withdrawal by Subject|0|||
130547266|NCT01242800|469971515|FG000|Overall Study|Patient refusal|0|||
130547267|NCT01242800|469971516|FG001|Overall Study|Patient refusal|10|||
130547268|NCT01242800|469971515|FG000|Overall Study|Physician Decision|0|||
130547269|NCT01242800|469971516|FG001|Overall Study|Physician Decision|1|||
130547270|NCT01242800|469971515|FG000|Overall Study|Disease progression|0|||
130547271|NCT01242800|469971516|FG001|Overall Study|Disease progression|3|||
130547272|NCT01242800|469971515|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
130547273|NCT01242800|469971516|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
130547274|NCT01242800|469971515|FG000|Overall Study|Reasons not reported|0|||
130547275|NCT01242800|469971516|FG001|Overall Study|Reasons not reported|4|||
130547276|NCT00953745|469971517|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
130547277|NCT00953745|469971518|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
130547278|NCT00953745|469971517|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
130547279|NCT00953745|469971518|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
130547280|NCT00953745|469971517|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
130547281|NCT00953745|469971518|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
130547282|NCT00953745|469971517|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
130547283|NCT00953745|469971518|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
130547284|NCT00953745|469971517|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
130547285|NCT00953745|469971518|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
130547286|NCT00953745|469971517|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
130547287|NCT00953745|469971518|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
130547288|NCT02640157|469971522|FG000|Overall Study|Adverse Event|2|||
130547289|NCT02640157|469971523|FG001|Overall Study|Adverse Event|2|||
130547290|NCT02640157|469971524|FG002|Overall Study|Adverse Event|1|||
130547291|NCT02640157|469971522|FG000|Overall Study|Withdrew consent|2|||
130547292|NCT02640157|469971523|FG001|Overall Study|Withdrew consent|0|||
130547293|NCT02640157|469971524|FG002|Overall Study|Withdrew consent|2|||
130547294|NCT02640157|469971522|FG000|Overall Study|Lost to Follow-up|9|||
130547295|NCT02640157|469971523|FG001|Overall Study|Lost to Follow-up|2|||
130547296|NCT02640157|469971524|FG002|Overall Study|Lost to Follow-up|7|||
130547297|NCT02640157|469971522|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
130547298|NCT02640157|469971523|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
130547299|NCT02640157|469971524|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
130547300|NCT01679405|469971526|FG000|Overall Study|Death|2|||
130547301|NCT01679405|469971527|FG001|Overall Study|Death|5|||
130547302|NCT04677179|469971528|FG000|Induction Treatment Period|Adverse Event|1|||
130547303|NCT04677179|469971529|FG001|Induction Treatment Period|Adverse Event|0|||
130547304|NCT04677179|469971530|FG002|Induction Treatment Period|Adverse Event|0|||
130547305|NCT04677179|469971531|FG003|Induction Treatment Period|Adverse Event|0|||
130547306|NCT04677179|469971532|FG004|Induction Treatment Period|Adverse Event|0|||
130547307|NCT04677179|469971533|FG005|Induction Treatment Period|Adverse Event|0|||
130547308|NCT04677179|469971534|FG006|Induction Treatment Period|Adverse Event|0|||
130547309|NCT04677179|469971535|FG007|Induction Treatment Period|Adverse Event|0|||
130547310|NCT04677179|469971536|FG008|Induction Treatment Period|Adverse Event|0|||
130547311|NCT04677179|469971537|FG009|Induction Treatment Period|Adverse Event|0|||
130547312|NCT04677179|469971528|FG000|Induction Treatment Period|Physician Decision|1|||
130547313|NCT04677179|469971529|FG001|Induction Treatment Period|Physician Decision|0|||
130547314|NCT04677179|469971530|FG002|Induction Treatment Period|Physician Decision|1|||
130547315|NCT04677179|469971531|FG003|Induction Treatment Period|Physician Decision|0|||
130547316|NCT04677179|469971532|FG004|Induction Treatment Period|Physician Decision|0|||
130547317|NCT04677179|469971533|FG005|Induction Treatment Period|Physician Decision|0|||
130547318|NCT04677179|469971534|FG006|Induction Treatment Period|Physician Decision|0|||
130547319|NCT04677179|469971535|FG007|Induction Treatment Period|Physician Decision|0|||
130547320|NCT04677179|469971536|FG008|Induction Treatment Period|Physician Decision|0|||
130547321|NCT04677179|469971537|FG009|Induction Treatment Period|Physician Decision|0|||
130547322|NCT04677179|469971528|FG000|Induction Treatment Period|Protocol Violation|0|||
130547323|NCT04677179|469971529|FG001|Induction Treatment Period|Protocol Violation|1|||
130547324|NCT04677179|469971530|FG002|Induction Treatment Period|Protocol Violation|0|||
130547325|NCT04677179|469971531|FG003|Induction Treatment Period|Protocol Violation|0|||
130547326|NCT04677179|469971532|FG004|Induction Treatment Period|Protocol Violation|0|||
130547327|NCT04677179|469971533|FG005|Induction Treatment Period|Protocol Violation|0|||
130547328|NCT04677179|469971534|FG006|Induction Treatment Period|Protocol Violation|0|||
130547329|NCT04677179|469971535|FG007|Induction Treatment Period|Protocol Violation|0|||
130547330|NCT04677179|469971536|FG008|Induction Treatment Period|Protocol Violation|0|||
130547331|NCT04677179|469971537|FG009|Induction Treatment Period|Protocol Violation|0|||
130547332|NCT04677179|469971528|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
130547333|NCT04677179|469971529|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
130547334|NCT04677179|469971530|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
130547335|NCT04677179|469971531|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
130547336|NCT04677179|469971532|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
130547337|NCT04677179|469971533|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
130547338|NCT04677179|469971534|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
130547339|NCT04677179|469971535|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
130547340|NCT04677179|469971536|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
130547341|NCT04677179|469971537|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
130547342|NCT04677179|469971528|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
130547343|NCT04677179|469971529|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
130547344|NCT04677179|469971530|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
130547345|NCT04677179|469971531|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
130547346|NCT04677179|469971532|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
130547347|NCT04677179|469971533|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
130547348|NCT04677179|469971534|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
130547349|NCT04677179|469971535|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
130547350|NCT04677179|469971536|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
130547351|NCT04677179|469971537|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
130547352|NCT04677179|469971528|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
130547353|NCT04677179|469971529|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
130547354|NCT04677179|469971530|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
130547355|NCT04677179|469971531|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
130547356|NCT04677179|469971532|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
130547357|NCT04677179|469971533|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
130547358|NCT04677179|469971534|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
130547359|NCT04677179|469971535|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
130547360|NCT04677179|469971536|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
130547361|NCT04677179|469971537|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
130547362|NCT04677179|469971528|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547363|NCT04677179|469971529|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547364|NCT04677179|469971530|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547365|NCT04677179|469971531|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
130547366|NCT04677179|469971532|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547367|NCT04677179|469971533|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547368|NCT04677179|469971534|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547369|NCT04677179|469971535|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547370|NCT04677179|469971536|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547371|NCT04677179|469971537|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
130547372|NCT04677179|469971528|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547373|NCT04677179|469971529|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547374|NCT04677179|469971530|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547375|NCT04677179|469971531|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
130547376|NCT04677179|469971532|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
130547377|NCT04677179|469971533|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
130547378|NCT04677179|469971534|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547379|NCT04677179|469971535|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547380|NCT04677179|469971536|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547381|NCT04677179|469971537|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
130547382|NCT04677179|469971528|FG000|Extension Treatment Period|Lack of Efficacy|0|||
130547383|NCT04677179|469971529|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130547384|NCT04677179|469971530|FG002|Extension Treatment Period|Lack of Efficacy|0|||
130547385|NCT04677179|469971531|FG003|Extension Treatment Period|Lack of Efficacy|0|||
130547386|NCT04677179|469971532|FG004|Extension Treatment Period|Lack of Efficacy|0|||
130547387|NCT04677179|469971533|FG005|Extension Treatment Period|Lack of Efficacy|0|||
130547388|NCT04677179|469971534|FG006|Extension Treatment Period|Lack of Efficacy|6|||
130547389|NCT04677179|469971535|FG007|Extension Treatment Period|Lack of Efficacy|0|||
130547390|NCT04677179|469971536|FG008|Extension Treatment Period|Lack of Efficacy|0|||
130547391|NCT04677179|469971537|FG009|Extension Treatment Period|Lack of Efficacy|0|||
130547392|NCT04677179|469971528|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
130547393|NCT04677179|469971529|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130547394|NCT04677179|469971530|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130547395|NCT04677179|469971531|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
130547396|NCT04677179|469971532|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
130547397|NCT04677179|469971533|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
130547398|NCT04677179|469971534|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
130547399|NCT04677179|469971535|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
130547400|NCT04677179|469971536|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
130547401|NCT04677179|469971537|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
130547402|NCT04677179|469971528|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
130547403|NCT04677179|469971529|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
130547404|NCT04677179|469971530|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
130547405|NCT04677179|469971531|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
130547406|NCT04677179|469971532|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
130547407|NCT04677179|469971533|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
130547408|NCT04677179|469971534|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
130547409|NCT04677179|469971535|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
130547410|NCT04677179|469971536|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
130547411|NCT04677179|469971537|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
130547412|NCT04677179|469971528|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
130547413|NCT04677179|469971529|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
130547414|NCT04677179|469971530|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
130547415|NCT04677179|469971531|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
130547416|NCT04677179|469971532|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
130547417|NCT04677179|469971533|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
130547418|NCT04677179|469971534|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
130547419|NCT04677179|469971535|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
130547420|NCT04677179|469971536|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
130547421|NCT04677179|469971537|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
130547422|NCT04677179|469971528|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547423|NCT04677179|469971529|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547424|NCT04677179|469971530|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547425|NCT04677179|469971531|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547426|NCT04677179|469971532|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547427|NCT04677179|469971533|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547428|NCT04677179|469971534|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547429|NCT04677179|469971535|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
130547430|NCT04677179|469971536|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
130547431|NCT04677179|469971537|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130547432|NCT04677179|469971528|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547433|NCT04677179|469971529|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547434|NCT04677179|469971530|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547435|NCT04677179|469971531|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547436|NCT04677179|469971532|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547437|NCT04677179|469971533|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547438|NCT04677179|469971534|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547439|NCT04677179|469971535|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
130547440|NCT04677179|469971536|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547441|NCT04677179|469971537|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130547442|NCT04677179|469971528|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547443|NCT04677179|469971529|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547444|NCT04677179|469971530|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547445|NCT04677179|469971531|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547446|NCT04677179|469971532|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547447|NCT04677179|469971533|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547448|NCT04677179|469971534|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547449|NCT04677179|469971535|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
130547450|NCT04677179|469971536|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
130547451|NCT04677179|469971537|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130547452|NCT04677179|469971528|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547453|NCT04677179|469971529|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547454|NCT04677179|469971530|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547455|NCT04677179|469971531|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547456|NCT04677179|469971532|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547457|NCT04677179|469971533|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547458|NCT04677179|469971534|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130547459|NCT04677179|469971535|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
130547460|NCT04677179|469971536|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
130547461|NCT04677179|469971537|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
130547462|NCT03866473|469971541|FG000|Phase 1|Death|1|||
130547463|NCT03866473|469971542|FG001|Phase 1|Death|0|||
130547464|NCT03866473|469971541|FG000|Phase 2|Death|0|||
130547465|NCT03866473|469971542|FG001|Phase 2|Death|2|||
130547466|NCT03866473|469971541|FG000|Phase 2|Dropped|1|||
130547467|NCT03866473|469971542|FG001|Phase 2|Dropped|1|||
130547468|NCT03866473|469971541|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
130547469|NCT03866473|469971542|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
130547470|NCT03110185|469971544|FG000|Overall Study|Death|0|||
130547471|NCT03110185|469971545|FG001|Overall Study|Death|1|||
130547472|NCT03110185|469971544|FG000|Overall Study|Withdrawal by Subject|2|||
130547473|NCT03110185|469971545|FG001|Overall Study|Withdrawal by Subject|7|||
130547474|NCT03110185|469971544|FG000|Overall Study|Time Constraints|0|||
130547475|NCT03110185|469971545|FG001|Overall Study|Time Constraints|6|||
130547476|NCT03110185|469971544|FG000|Overall Study|Conflict with care|5|||
130547477|NCT03110185|469971545|FG001|Overall Study|Conflict with care|12|||
130547478|NCT03110185|469971544|FG000|Overall Study|Protocol Violation|1|||
130547479|NCT03110185|469971545|FG001|Overall Study|Protocol Violation|4|||
130547480|NCT03110185|469971544|FG000|Overall Study|MRI Incompatible|2|||
130547481|NCT03110185|469971545|FG001|Overall Study|MRI Incompatible|0|||
130547482|NCT03110185|469971544|FG000|Overall Study|Patient Refusal|0|||
130547483|NCT03110185|469971545|FG001|Overall Study|Patient Refusal|1|||
130547484|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
130547485|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
130547486|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
130547487|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
130547488|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
130547489|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
130547490|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
130547491|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
130547492|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
130547493|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
130547494|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
130547495|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
130547496|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
130547497|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
130547498|NCT00600886|469971546|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
130547499|NCT00600886|469971547|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
130547500|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
130547501|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
130547502|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
130547503|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
130547504|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
130547505|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
130547506|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
130547507|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
130547508|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
130547509|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
130547510|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
130547511|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
130547512|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Death|1|||
130547513|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Death|1|||
130547514|NCT00600886|469971546|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
130547515|NCT00600886|469971547|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
130547516|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
130547517|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
130547518|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
130547519|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
130547520|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
130547521|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
130547522|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
130547523|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
130547524|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
130547525|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
130547526|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
130547527|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
130547528|NCT00600886|469971546|FG000|Extension - After Crossover (CAS)|Death|1|||
130547529|NCT00600886|469971547|FG001|Extension - After Crossover (CAS)|Death|0|||
130547530|NCT03075410|469971548|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
130547531|NCT03075410|469971549|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547532|NCT03075410|469971550|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
130547533|NCT03075410|469971551|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547534|NCT03075410|469971552|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547535|NCT03075410|469971553|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547536|NCT03075410|469971554|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547537|NCT03075410|469971555|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547538|NCT03075410|469971556|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
130547539|NCT03075410|469971548|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
130547540|NCT03075410|469971549|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547541|NCT03075410|469971550|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547542|NCT03075410|469971551|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547543|NCT03075410|469971552|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547544|NCT03075410|469971553|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547545|NCT03075410|469971554|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547546|NCT03075410|469971555|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547547|NCT03075410|469971556|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130547548|NCT01427751|469971557|FG000|Overall Study|Adverse Event|18|||
130547549|NCT01427751|469971558|FG001|Overall Study|Adverse Event|2|||
130547550|NCT01427751|469971557|FG000|Overall Study|No further treatment benefit expected|5|||
130547551|NCT01427751|469971558|FG001|Overall Study|No further treatment benefit expected|1|||
130547552|NCT01427751|469971557|FG000|Overall Study|Lost to Follow-up|3|||
130547553|NCT01427751|469971558|FG001|Overall Study|Lost to Follow-up|1|||
130547554|NCT01427751|469971557|FG000|Overall Study|Withdrawal of consent|2|||
130547555|NCT01427751|469971558|FG001|Overall Study|Withdrawal of consent|2|||
130547556|NCT01427751|469971557|FG000|Overall Study|Protocol Violation|6|||
130547557|NCT01427751|469971558|FG001|Overall Study|Protocol Violation|4|||
130547558|NCT01427751|469971557|FG000|Overall Study|Death|2|||
130547559|NCT01427751|469971558|FG001|Overall Study|Death|0|||
130547560|NCT01427751|469971557|FG000|Overall Study|Other miscellaneous reasons|6|||
130547561|NCT01427751|469971558|FG001|Overall Study|Other miscellaneous reasons|4|||
130547562|NCT03534284|469971569|FG000|Overall Study|Death|2|||
130547563|NCT03534284|469971570|FG001|Overall Study|Death|3|||
130547564|NCT03534284|469971571|FG002|Overall Study|Death|3|||
130547565|NCT03534284|469971569|FG000|Overall Study|Withdrawal by Subject|5|||
130547566|NCT03534284|469971570|FG001|Overall Study|Withdrawal by Subject|0|||
130547567|NCT03534284|469971571|FG002|Overall Study|Withdrawal by Subject|0|||
130547568|NCT04737187|469971572|FG000|Overall Study|Switched to marketed drug|32|||
130547569|NCT04737187|469971573|FG001|Overall Study|Switched to marketed drug|4|||
130547570|NCT04737187|469971572|FG000|Overall Study|Radiological Progressive Disease|145|||
130547571|NCT04737187|469971573|FG001|Overall Study|Radiological Progressive Disease|146|||
130547572|NCT04737187|469971572|FG000|Overall Study|Clinical Progressive Disease|20|||
130547573|NCT04737187|469971573|FG001|Overall Study|Clinical Progressive Disease|20|||
130547574|NCT04737187|469971572|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
130547575|NCT04737187|469971573|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
130547576|NCT04737187|469971572|FG000|Overall Study|Adverse Event|16|||
130547577|NCT04737187|469971573|FG001|Overall Study|Adverse Event|16|||
130547578|NCT04737187|469971572|FG000|Overall Study|Physician Decision|2|||
130547579|NCT04737187|469971573|FG001|Overall Study|Physician Decision|0|||
130547580|NCT04737187|469971572|FG000|Overall Study|Withdrawal by Subject|5|||
130547581|NCT04737187|469971573|FG001|Overall Study|Withdrawal by Subject|8|||
130547582|NCT03756129|469971574|FG000|Overall Study|Adverse Event|1|||
130547583|NCT03756129|469971575|FG001|Overall Study|Adverse Event|1|||
130547584|NCT03756129|469971576|FG002|Overall Study|Adverse Event|0|||
130547585|NCT03756129|469971577|FG003|Overall Study|Adverse Event|2|||
130547586|NCT03756129|469971578|FG004|Overall Study|Adverse Event|0|||
130547587|NCT03756129|469971579|FG005|Overall Study|Adverse Event|0|||
130547588|NCT03756129|469971574|FG000|Overall Study|Withdrawal by Subject|2|||
130547589|NCT03756129|469971575|FG001|Overall Study|Withdrawal by Subject|1|||
130547590|NCT03756129|469971576|FG002|Overall Study|Withdrawal by Subject|3|||
130547591|NCT03756129|469971577|FG003|Overall Study|Withdrawal by Subject|1|||
130547592|NCT03756129|469971578|FG004|Overall Study|Withdrawal by Subject|1|||
130547593|NCT03756129|469971579|FG005|Overall Study|Withdrawal by Subject|3|||
130547594|NCT03756129|469971574|FG000|Overall Study|Lost to Follow-up|0|||
130547595|NCT03756129|469971575|FG001|Overall Study|Lost to Follow-up|0|||
130547596|NCT03756129|469971576|FG002|Overall Study|Lost to Follow-up|0|||
130547597|NCT03756129|469971577|FG003|Overall Study|Lost to Follow-up|0|||
130547598|NCT03756129|469971578|FG004|Overall Study|Lost to Follow-up|0|||
130547599|NCT03756129|469971579|FG005|Overall Study|Lost to Follow-up|1|||
130547600|NCT03756129|469971574|FG000|Overall Study|Physician Decision|0|||
130547601|NCT03756129|469971575|FG001|Overall Study|Physician Decision|0|||
130547602|NCT03756129|469971576|FG002|Overall Study|Physician Decision|0|||
130547603|NCT03756129|469971577|FG003|Overall Study|Physician Decision|0|||
130547604|NCT03756129|469971578|FG004|Overall Study|Physician Decision|0|||
130547605|NCT03756129|469971579|FG005|Overall Study|Physician Decision|1|||
130547606|NCT05195489|469973388|FG000|Overall Study|Lost to Follow-up|1|||
130547607|NCT05195489|469973389|FG001|Overall Study|Lost to Follow-up|0|||
130547608|NCT05195489|469973388|FG000|Overall Study|Protocol Violation|0|||
130547609|NCT05195489|469973389|FG001|Overall Study|Protocol Violation|2|||
130547610|NCT05195489|469973388|FG000|Overall Study|Withdrawal by Subject|1|||
130322463|NCT03414983|469151271|FG000|Treatment|Maximum clinical benefit|5|||
130547611|NCT05195489|469973389|FG001|Overall Study|Withdrawal by Subject|1|||
130547612|NCT05195489|469973388|FG000|Overall Study|Removed|0|||
130547613|NCT05195489|469973389|FG001|Overall Study|Removed|1|||
130547614|NCT04812548|469973391|FG000|Overall Study|Adverse Event|2|||
130547615|NCT04812548|469973392|FG001|Overall Study|Adverse Event|7|||
130547616|NCT04812548|469973391|FG000|Overall Study|HSCT Planned|2|||
130547617|NCT04812548|469973392|FG001|Overall Study|HSCT Planned|3|||
130547618|NCT04812548|469973391|FG000|Overall Study|Progressive Disease|0|||
130547619|NCT04812548|469973392|FG001|Overall Study|Progressive Disease|2|||
130547620|NCT04812548|469973391|FG000|Overall Study|Death|0|||
130547621|NCT04812548|469973392|FG001|Overall Study|Death|1|||
130547622|NCT04812548|469973391|FG000|Overall Study|Post Study Access to Treatment|0|||
130547623|NCT04812548|469973392|FG001|Overall Study|Post Study Access to Treatment|1|||
130547624|NCT04812548|469973391|FG000|Overall Study|Withdrawal by Subject|0|||
130547625|NCT04812548|469973392|FG001|Overall Study|Withdrawal by Subject|1|||
130547626|NCT04812548|469973391|FG000|Overall Study|Physician Decision|1|||
130547627|NCT04812548|469973392|FG001|Overall Study|Physician Decision|0|||
130547628|NCT03184870|469973393|FG000|Initial Treatment|Death|6|||
130547629|NCT03184870|469973394|FG001|Initial Treatment|Death|6|||
130547630|NCT03184870|469973395|FG002|Initial Treatment|Death|8|||
130547631|NCT03184870|469973396|FG003|Initial Treatment|Death|8|||
130547632|NCT03184870|469973397|FG004|Initial Treatment|Death|6|||
130547633|NCT03184870|469973398|FG005|Initial Treatment|Death|6|||
130547634|NCT03184870|469973399|FG006|Initial Treatment|Death|6|||
130547635|NCT03184870|469973400|FG007|Initial Treatment|Death|7|||
130547636|NCT03184870|469973401|FG008|Initial Treatment|Death|1|||
130547637|NCT03184870|469973402|FG009|Initial Treatment|Death|2|||
130547638|NCT03184870|469973403|FG010|Initial Treatment|Death|26|||
130547639|NCT03184870|469973404|FG011|Initial Treatment|Death|28|||
130547640|NCT03184870|469973405|FG012|Initial Treatment|Death|10|||
130547641|NCT03184870|469973406|FG013|Initial Treatment|Death|33|||
130547642|NCT03184870|469973407|FG014|Initial Treatment|Death|34|||
130547643|NCT03184870|469973408|FG015|Initial Treatment|Death|26|||
130547644|NCT03184870|469973409|FG016|Initial Treatment|Death|20|||
130547645|NCT03184870|469973410|FG017|Initial Treatment|Death|18|||
130547646|NCT03184870|469973393|FG000|Initial Treatment|Other Reasons|2|||
130547647|NCT03184870|469973394|FG001|Initial Treatment|Other Reasons|2|||
130547648|NCT03184870|469973395|FG002|Initial Treatment|Other Reasons|0|||
130547649|NCT03184870|469973396|FG003|Initial Treatment|Other Reasons|1|||
130547650|NCT03184870|469973397|FG004|Initial Treatment|Other Reasons|0|||
130547651|NCT03184870|469973398|FG005|Initial Treatment|Other Reasons|0|||
130547652|NCT03184870|469973399|FG006|Initial Treatment|Other Reasons|0|||
130547653|NCT03184870|469973400|FG007|Initial Treatment|Other Reasons|2|||
130547654|NCT03184870|469973401|FG008|Initial Treatment|Other Reasons|0|||
130547655|NCT03184870|469973402|FG009|Initial Treatment|Other Reasons|0|||
130547656|NCT03184870|469973403|FG010|Initial Treatment|Other Reasons|4|||
130547657|NCT03184870|469973404|FG011|Initial Treatment|Other Reasons|2|||
130547658|NCT03184870|469973405|FG012|Initial Treatment|Other Reasons|2|||
130547659|NCT03184870|469973406|FG013|Initial Treatment|Other Reasons|0|||
130547660|NCT03184870|469973407|FG014|Initial Treatment|Other Reasons|0|||
130547661|NCT03184870|469973408|FG015|Initial Treatment|Other Reasons|1|||
130547662|NCT03184870|469973409|FG016|Initial Treatment|Other Reasons|0|||
130547663|NCT03184870|469973410|FG017|Initial Treatment|Other Reasons|2|||
130547664|NCT03184870|469973393|FG000|Initial Treatment|Lost to Follow-up|2|||
130547665|NCT03184870|469973394|FG001|Initial Treatment|Lost to Follow-up|0|||
130547666|NCT03184870|469973395|FG002|Initial Treatment|Lost to Follow-up|0|||
130547667|NCT03184870|469973396|FG003|Initial Treatment|Lost to Follow-up|1|||
130547668|NCT03184870|469973397|FG004|Initial Treatment|Lost to Follow-up|1|||
130547669|NCT03184870|469973398|FG005|Initial Treatment|Lost to Follow-up|1|||
130547670|NCT03184870|469973399|FG006|Initial Treatment|Lost to Follow-up|0|||
130547671|NCT03184870|469973400|FG007|Initial Treatment|Lost to Follow-up|2|||
130547672|NCT03184870|469973401|FG008|Initial Treatment|Lost to Follow-up|0|||
130547673|NCT03184870|469973402|FG009|Initial Treatment|Lost to Follow-up|0|||
130547674|NCT03184870|469973403|FG010|Initial Treatment|Lost to Follow-up|2|||
130547675|NCT03184870|469973404|FG011|Initial Treatment|Lost to Follow-up|0|||
130547676|NCT03184870|469973405|FG012|Initial Treatment|Lost to Follow-up|2|||
130547677|NCT03184870|469973406|FG013|Initial Treatment|Lost to Follow-up|2|||
130547678|NCT03184870|469973407|FG014|Initial Treatment|Lost to Follow-up|0|||
130547679|NCT03184870|469973408|FG015|Initial Treatment|Lost to Follow-up|0|||
130547680|NCT03184870|469973409|FG016|Initial Treatment|Lost to Follow-up|2|||
130547681|NCT03184870|469973410|FG017|Initial Treatment|Lost to Follow-up|2|||
130547682|NCT03184870|469973393|FG000|Initial Treatment|Withdrawal by Subject|0|||
130547683|NCT03184870|469973394|FG001|Initial Treatment|Withdrawal by Subject|0|||
130547684|NCT03184870|469973395|FG002|Initial Treatment|Withdrawal by Subject|2|||
130547685|NCT03184870|469973396|FG003|Initial Treatment|Withdrawal by Subject|1|||
130547686|NCT03184870|469973397|FG004|Initial Treatment|Withdrawal by Subject|1|||
130547687|NCT03184870|469973398|FG005|Initial Treatment|Withdrawal by Subject|0|||
130547688|NCT03184870|469973399|FG006|Initial Treatment|Withdrawal by Subject|1|||
130547689|NCT03184870|469973400|FG007|Initial Treatment|Withdrawal by Subject|0|||
130547690|NCT03184870|469973401|FG008|Initial Treatment|Withdrawal by Subject|0|||
130547691|NCT03184870|469973402|FG009|Initial Treatment|Withdrawal by Subject|0|||
130547692|NCT03184870|469973403|FG010|Initial Treatment|Withdrawal by Subject|0|||
130547693|NCT03184870|469973404|FG011|Initial Treatment|Withdrawal by Subject|2|||
130547694|NCT03184870|469973405|FG012|Initial Treatment|Withdrawal by Subject|3|||
130547695|NCT03184870|469973406|FG013|Initial Treatment|Withdrawal by Subject|0|||
130547696|NCT03184870|469973407|FG014|Initial Treatment|Withdrawal by Subject|1|||
130547697|NCT03184870|469973408|FG015|Initial Treatment|Withdrawal by Subject|5|||
130547698|NCT03184870|469973409|FG016|Initial Treatment|Withdrawal by Subject|2|||
130547699|NCT03184870|469973410|FG017|Initial Treatment|Withdrawal by Subject|2|||
130547700|NCT03184870|469973393|FG000|Initial Treatment|Moved to crossover treatment|0|||
130547701|NCT03184870|469973394|FG001|Initial Treatment|Moved to crossover treatment|0|||
130547702|NCT03184870|469973395|FG002|Initial Treatment|Moved to crossover treatment|0|||
130547703|NCT03184870|469973396|FG003|Initial Treatment|Moved to crossover treatment|0|||
130547704|NCT03184870|469973397|FG004|Initial Treatment|Moved to crossover treatment|0|||
130547705|NCT03184870|469973398|FG005|Initial Treatment|Moved to crossover treatment|0|||
130547706|NCT03184870|469973399|FG006|Initial Treatment|Moved to crossover treatment|0|||
130547707|NCT03184870|469973400|FG007|Initial Treatment|Moved to crossover treatment|0|||
130547708|NCT03184870|469973401|FG008|Initial Treatment|Moved to crossover treatment|0|||
130547709|NCT03184870|469973402|FG009|Initial Treatment|Moved to crossover treatment|0|||
130547710|NCT03184870|469973403|FG010|Initial Treatment|Moved to crossover treatment|0|||
130547711|NCT03184870|469973404|FG011|Initial Treatment|Moved to crossover treatment|0|||
130547712|NCT03184870|469973405|FG012|Initial Treatment|Moved to crossover treatment|9|||
130547713|NCT03184870|469973406|FG013|Initial Treatment|Moved to crossover treatment|0|||
130547714|NCT03184870|469973407|FG014|Initial Treatment|Moved to crossover treatment|0|||
130547715|NCT03184870|469973408|FG015|Initial Treatment|Moved to crossover treatment|0|||
130547716|NCT03184870|469973409|FG016|Initial Treatment|Moved to crossover treatment|0|||
130547717|NCT03184870|469973410|FG017|Initial Treatment|Moved to crossover treatment|0|||
130547718|NCT03184870|469973393|FG000|Crossover Treatment|Other reasons|0|||
130547719|NCT03184870|469973394|FG001|Crossover Treatment|Other reasons|0|||
130547720|NCT03184870|469973395|FG002|Crossover Treatment|Other reasons|0|||
130547721|NCT03184870|469973396|FG003|Crossover Treatment|Other reasons|0|||
130547722|NCT03184870|469973397|FG004|Crossover Treatment|Other reasons|0|||
130547723|NCT03184870|469973398|FG005|Crossover Treatment|Other reasons|0|||
130547724|NCT03184870|469973399|FG006|Crossover Treatment|Other reasons|0|||
130547725|NCT03184870|469973400|FG007|Crossover Treatment|Other reasons|0|||
130547726|NCT03184870|469973401|FG008|Crossover Treatment|Other reasons|0|||
130547727|NCT03184870|469973402|FG009|Crossover Treatment|Other reasons|0|||
130547728|NCT03184870|469973403|FG010|Crossover Treatment|Other reasons|0|||
130547729|NCT03184870|469973404|FG011|Crossover Treatment|Other reasons|0|||
130547730|NCT03184870|469973405|FG012|Crossover Treatment|Other reasons|0|||
130547731|NCT03184870|469973406|FG013|Crossover Treatment|Other reasons|0|||
130547732|NCT03184870|469973407|FG014|Crossover Treatment|Other reasons|0|||
130547733|NCT03184870|469973408|FG015|Crossover Treatment|Other reasons|0|||
130547734|NCT03184870|469973409|FG016|Crossover Treatment|Other reasons|0|||
130547735|NCT03184870|469973410|FG017|Crossover Treatment|Other reasons|2|||
130547736|NCT03184870|469973393|FG000|Crossover Treatment|Death|0|||
130547737|NCT03184870|469973394|FG001|Crossover Treatment|Death|0|||
130547738|NCT03184870|469973395|FG002|Crossover Treatment|Death|0|||
130547739|NCT03184870|469973396|FG003|Crossover Treatment|Death|0|||
130547740|NCT03184870|469973397|FG004|Crossover Treatment|Death|0|||
130547741|NCT03184870|469973398|FG005|Crossover Treatment|Death|0|||
130547742|NCT03184870|469973399|FG006|Crossover Treatment|Death|0|||
130547743|NCT03184870|469973400|FG007|Crossover Treatment|Death|0|||
130547744|NCT03184870|469973401|FG008|Crossover Treatment|Death|0|||
130547745|NCT03184870|469973402|FG009|Crossover Treatment|Death|0|||
130547746|NCT03184870|469973403|FG010|Crossover Treatment|Death|0|||
130547747|NCT03184870|469973404|FG011|Crossover Treatment|Death|0|||
130547748|NCT03184870|469973405|FG012|Crossover Treatment|Death|0|||
130547749|NCT03184870|469973406|FG013|Crossover Treatment|Death|0|||
130547750|NCT03184870|469973407|FG014|Crossover Treatment|Death|0|||
130547751|NCT03184870|469973408|FG015|Crossover Treatment|Death|0|||
130547752|NCT03184870|469973409|FG016|Crossover Treatment|Death|0|||
130547753|NCT03184870|469973410|FG017|Crossover Treatment|Death|7|||
130547754|NCT03786783|469973412|FG000|Overall Study|Death|1|||
130547755|NCT03786783|469973412|FG000|Overall Study|Physician Decision|6|||
130547756|NCT03786783|469973412|FG000|Overall Study|Withdrawal by Subject|2|||
130547757|NCT03786783|469973412|FG000|Overall Study|Disease Progression|7|||
130547758|NCT03786783|469973412|FG000|Overall Study|Patient/Parent Refusal|4|||
130547759|NCT04363801|469973413|FG000|Overall Study|Death|18|||
130547760|NCT04363801|469973414|FG001|Overall Study|Death|14|||
130547761|NCT04363801|469973415|FG002|Overall Study|Death|16|||
130547762|NCT04363801|469973416|FG003|Overall Study|Death|48|||
130547763|NCT04363801|469973417|FG004|Overall Study|Death|38|||
130547764|NCT04363801|469973413|FG000|Overall Study|Withdrawal by Subject|1|||
130547765|NCT04363801|469973414|FG001|Overall Study|Withdrawal by Subject|6|||
130547766|NCT04363801|469973415|FG002|Overall Study|Withdrawal by Subject|1|||
130547767|NCT04363801|469973416|FG003|Overall Study|Withdrawal by Subject|4|||
130547768|NCT04363801|469973417|FG004|Overall Study|Withdrawal by Subject|14|||
130547769|NCT04363801|469973413|FG000|Overall Study|Sponsor Decision|6|||
130547770|NCT04363801|469973414|FG001|Overall Study|Sponsor Decision|4|||
130547771|NCT04363801|469973415|FG002|Overall Study|Sponsor Decision|10|||
130547772|NCT04363801|469973416|FG003|Overall Study|Sponsor Decision|33|||
130547773|NCT04363801|469973417|FG004|Overall Study|Sponsor Decision|32|||
130547774|NCT04363801|469973413|FG000|Overall Study|Lost to Follow-up|0|||
130547775|NCT04363801|469973414|FG001|Overall Study|Lost to Follow-up|0|||
130547776|NCT04363801|469973415|FG002|Overall Study|Lost to Follow-up|1|||
130547777|NCT04363801|469973416|FG003|Overall Study|Lost to Follow-up|0|||
130547778|NCT04363801|469973417|FG004|Overall Study|Lost to Follow-up|1|||
130547779|NCT06336603|469973420|FG000|Overall Study|Withdrawal by Subject|1|||
130547780|NCT06336603|469973420|FG000|Overall Study|Lost to Follow-up|2|||
130547781|NCT04776148|469973421|FG000|Overall Study|Death|249|||
130547782|NCT04776148|469973422|FG001|Overall Study|Death|260|||
130547783|NCT04776148|469973421|FG000|Overall Study|Lost to Follow-up|0|||
130547784|NCT04776148|469973422|FG001|Overall Study|Lost to Follow-up|1|||
130547785|NCT04776148|469973421|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130547786|NCT04776148|469973422|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130547787|NCT04776148|469973421|FG000|Overall Study|Withdrawal by Subject|3|||
130547788|NCT04776148|469973422|FG001|Overall Study|Withdrawal by Subject|4|||
130547789|NCT04776148|469973421|FG000|Overall Study|Sponsor Decision|30|||
130547790|NCT04776148|469973422|FG001|Overall Study|Sponsor Decision|15|||
130547791|NCT02563522|469973423|FG000|Overall Study|Adverse Event|2|||
130547792|NCT02563522|469973424|FG001|Overall Study|Adverse Event|3|||
130547793|NCT02563522|469973423|FG000|Overall Study|Lost to Follow-up|1|||
130547794|NCT02563522|469973424|FG001|Overall Study|Lost to Follow-up|0|||
130547795|NCT02563522|469973423|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
130547796|NCT02563522|469973424|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
130547797|NCT00824161|469973425|FG000|Overall Study|Withdrawal by Subject|1|||
130547798|NCT00824161|469973425|FG000|Overall Study|Screen Failure|1|||
130547799|NCT04874415|469973426|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547800|NCT04874415|469973427|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547801|NCT04874415|469973428|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547802|NCT04874415|469973429|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547803|NCT04874415|469973430|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547804|NCT04874415|469973431|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547805|NCT04874415|469973432|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
130547806|NCT04874415|469973433|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547807|NCT04874415|469973434|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
130547808|NCT04874415|469973435|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
130547809|NCT04874415|469973436|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547810|NCT04874415|469973437|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
130547811|NCT04874415|469973438|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
130547812|NCT04874415|469973439|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
130547813|NCT04874415|469973440|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
130547814|NCT04874415|469973441|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
130547815|NCT04874415|469973426|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547816|NCT04874415|469973427|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547817|NCT04874415|469973428|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547818|NCT04874415|469973429|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547819|NCT04874415|469973430|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547820|NCT04874415|469973431|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547821|NCT04874415|469973432|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547822|NCT04874415|469973433|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547823|NCT04874415|469973434|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547824|NCT04874415|469973435|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
130547825|NCT04874415|469973436|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547826|NCT04874415|469973437|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547827|NCT04874415|469973438|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547828|NCT04874415|469973439|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547829|NCT04874415|469973440|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
130547830|NCT04874415|469973441|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
130547831|NCT04874415|469973426|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547832|NCT04874415|469973427|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547833|NCT04874415|469973428|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547834|NCT04874415|469973429|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547835|NCT04874415|469973430|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
130547836|NCT04874415|469973431|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547837|NCT04874415|469973432|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547838|NCT04874415|469973433|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547839|NCT04874415|469973434|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547840|NCT04874415|469973435|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547841|NCT04874415|469973436|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547842|NCT04874415|469973437|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547843|NCT04874415|469973438|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547844|NCT04874415|469973439|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547845|NCT04874415|469973440|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547846|NCT04874415|469973441|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
130547847|NCT01312857|469973442|FG000|Overall Study|Adverse Event|1|||
130547848|NCT01312857|469973443|FG001|Overall Study|Adverse Event|1|||
130547849|NCT01312857|469973442|FG000|Overall Study|Lost to Follow-up|2|||
130547850|NCT01312857|469973443|FG001|Overall Study|Lost to Follow-up|0|||
130547851|NCT01312857|469973442|FG000|Overall Study|Physician Decision|3|||
130547852|NCT01312857|469973443|FG001|Overall Study|Physician Decision|0|||
130547853|NCT01312857|469973442|FG000|Overall Study|Withdrawal by Subject|2|||
130547854|NCT01312857|469973443|FG001|Overall Study|Withdrawal by Subject|0|||
130547855|NCT04882995|469973444|FG000|Overall Study|Withdrawal by Subject|1|||
130547856|NCT04882995|469973445|FG001|Overall Study|Withdrawal by Subject|2|||
130547857|NCT04882995|469973444|FG000|Overall Study|Protocol Violation|4|||
130547858|NCT04882995|469973445|FG001|Overall Study|Protocol Violation|4|||
130547859|NCT04882995|469973444|FG000|Overall Study|Surgery postponed due to COVID|1|||
130547860|NCT04882995|469973445|FG001|Overall Study|Surgery postponed due to COVID|1|||
130547861|NCT02572882|469973446|FG000|Overall Study|Withdrawal by Subject|1|||
130547862|NCT02572882|469973446|FG000|Overall Study|Participant received kidney transplant|1|||
130547863|NCT04371198|469973447|FG000|Overall Study|inadequate sample|4|||
130547864|NCT04754477|469973448|FG000|Overall Study|Withdrawal by Subject|1|||
130547865|NCT01590017|469973449|FG000|Overall Study|Adverse Event|1|||
130547866|NCT01590017|469973449|FG000|Overall Study|Withdrawal by Subject|1|||
130547867|NCT01590017|469973449|FG000|Overall Study|Lack of Efficacy|1|||
130547868|NCT01590017|469973449|FG000|Overall Study|Physician Decision|1|||
130547869|NCT01347762|469973450|FG000|Overall Study|Lost to Follow-up|0|||
130547870|NCT01347762|469973451|FG001|Overall Study|Lost to Follow-up|1|||
130547871|NCT01347762|469973452|FG002|Overall Study|Lost to Follow-up|6|||
130547872|NCT01347762|469973453|FG003|Overall Study|Lost to Follow-up|5|||
130547873|NCT01347762|469973450|FG000|Overall Study|Withdrawal by Subject|4|||
130547874|NCT01347762|469973451|FG001|Overall Study|Withdrawal by Subject|1|||
130547875|NCT01347762|469973452|FG002|Overall Study|Withdrawal by Subject|3|||
130547876|NCT01347762|469973453|FG003|Overall Study|Withdrawal by Subject|3|||
130547877|NCT03235284|469973454|FG000|Overall Study|Adverse Event|1|||
130547878|NCT03235284|469973455|FG001|Overall Study|Adverse Event|2|||
130547879|NCT03235284|469973456|FG002|Overall Study|Adverse Event|1|||
130547880|NCT01382706|469973459|FG000|Overall Study|Adverse Event|1|||
130547881|NCT01382706|469973459|FG000|Overall Study|Withdrawal by Subject|1|||
130547882|NCT05559099|469973460|FG000|Overall Study|Death|5|||
130547883|NCT05559099|469973461|FG001|Overall Study|Death|4|||
130547884|NCT05559099|469973460|FG000|Overall Study|Lost to Follow-up|0|||
130547885|NCT05559099|469973461|FG001|Overall Study|Lost to Follow-up|2|||
130547886|NCT05559099|469973460|FG000|Overall Study|Adverse Event|1|||
130547887|NCT05559099|469973461|FG001|Overall Study|Adverse Event|1|||
130547888|NCT04018092|469973462|FG000|Overall Study|Withdrawal by Subject|1|||
130547889|NCT04018092|469973463|FG001|Overall Study|Withdrawal by Subject|1|||
130547890|NCT04018092|469973462|FG000|Overall Study|Withdrawal by Subject|1|||
130547891|NCT04018092|469973463|FG001|Overall Study|Withdrawal by Subject|1|||
130547892|NCT05218499|469973464|FG000|Overall Study|Not treated|1|||
130547893|NCT05218499|469973465|FG001|Overall Study|Not treated|1|||
130547894|NCT05218499|469973466|FG002|Overall Study|Not treated|8|||
130547895|NCT05218499|469973464|FG000|Overall Study|Death|2|||
130547896|NCT05218499|469973465|FG001|Overall Study|Death|0|||
130547897|NCT05218499|469973466|FG002|Overall Study|Death|0|||
130547898|NCT05218499|469973464|FG000|Overall Study|Other than listed|3|||
130547899|NCT05218499|469973465|FG001|Overall Study|Other than listed|7|||
130547900|NCT05218499|469973466|FG002|Overall Study|Other than listed|10|||
130322464|NCT03414983|469151272|FG001|Treatment|Maximum clinical benefit|9|||
130322465|NCT03414983|469151271|FG000|Treatment|Lost to Follow-up|0|||
130322466|NCT03414983|469151272|FG001|Treatment|Lost to Follow-up|1|||
130322467|NCT03414983|469151271|FG000|Treatment|Administrative reasons by sponsor|1|||
130322468|NCT03414983|469151272|FG001|Treatment|Administrative reasons by sponsor|0|||
130322469|NCT00092417|469151273|FG000|Overall Study|Lost to Follow-up|2|||
130547901|NCT05218499|469973464|FG000|Overall Study|Protocol deviation|5|||
130547902|NCT05218499|469973465|FG001|Overall Study|Protocol deviation|6|||
130547903|NCT05218499|469973466|FG002|Overall Study|Protocol deviation|4|||
130547904|NCT05218499|469973464|FG000|Overall Study|Technical problems|0|||
130547905|NCT05218499|469973465|FG001|Overall Study|Technical problems|1|||
130547906|NCT05218499|469973466|FG002|Overall Study|Technical problems|0|||
130547907|NCT05218499|469973464|FG000|Overall Study|Burden of trial procedures|0|||
130547908|NCT05218499|469973465|FG001|Overall Study|Burden of trial procedures|1|||
130547909|NCT05218499|469973466|FG002|Overall Study|Burden of trial procedures|2|||
130322470|NCT00092417|469151274|FG001|Overall Study|Lost to Follow-up|0|||
130322471|NCT00092417|469151273|FG000|Overall Study|Withdrawal by Subject|2|||
130547910|NCT05218499|469973464|FG000|Overall Study|Clinical disease progression|6|||
130547911|NCT05218499|469973465|FG001|Overall Study|Clinical disease progression|6|||
130547912|NCT05218499|469973466|FG002|Overall Study|Clinical disease progression|11|||
130547913|NCT05218499|469973464|FG000|Overall Study|Objective disease progression|44|||
130547914|NCT05218499|469973465|FG001|Overall Study|Objective disease progression|61|||
130547915|NCT05218499|469973466|FG002|Overall Study|Objective disease progression|42|||
130547916|NCT05218499|469973464|FG000|Overall Study|Adverse Event|11|||
130547917|NCT05218499|469973465|FG001|Overall Study|Adverse Event|36|||
130547918|NCT05218499|469973466|FG002|Overall Study|Adverse Event|9|||
130547919|NCT05218499|469973464|FG000|Overall Study|On treatment at time of snapshot|18|||
130547920|NCT05218499|469973465|FG001|Overall Study|On treatment at time of snapshot|29|||
130547921|NCT05218499|469973466|FG002|Overall Study|On treatment at time of snapshot|0|||
130547922|NCT04055090|469973467|FG000|Overall Study|screen failure|1|||
130547923|NCT04055090|469973468|FG001|Overall Study|screen failure|0|||
130547924|NCT04055090|469973467|FG000|Overall Study|Withdrawal by Subject|1|||
130547925|NCT04055090|469973468|FG001|Overall Study|Withdrawal by Subject|0|||
130547926|NCT04572841|469973472|FG000|Overall Study|Adverse Event|1|||
130547927|NCT04572841|469973473|FG001|Overall Study|Adverse Event|1|||
130547928|NCT04572841|469973472|FG000|Overall Study|Withdrawal by Subject|2|||
130547929|NCT04572841|469973473|FG001|Overall Study|Withdrawal by Subject|1|||
130547930|NCT06469242|469973474|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
130547931|NCT06469242|469973475|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
130547932|NCT06469242|469973474|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
130547933|NCT06469242|469973475|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
130547934|NCT05041101|469973476|FG000|Overall Study|Adverse Event|1|||
130547935|NCT05041101|469973477|FG001|Overall Study|Adverse Event|0|||
130547936|NCT05041101|469973478|FG002|Overall Study|Adverse Event|0|||
130547937|NCT05041101|469973476|FG000|Overall Study|Diease Progression|5|||
130547938|NCT05041101|469973477|FG001|Overall Study|Diease Progression|0|||
130547939|NCT05041101|469973478|FG002|Overall Study|Diease Progression|0|||
130547940|NCT01205152|469973479|FG000|Overall Study|Death|1|||
130547941|NCT00249002|469973480|FG000|Overall Study|Adverse Event|2|||
130547942|NCT00249002|469973480|FG000|Overall Study|Study cancellation|3|||
130547943|NCT00249002|469973480|FG000|Overall Study|Other|2|||
130547944|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
130547945|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
130547946|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
130547947|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
130547948|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
130547949|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
130547950|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
130547951|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547952|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547953|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547954|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547955|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
130547956|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547957|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130547958|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547959|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547960|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547961|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547962|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
130547963|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547964|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
130547965|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130547966|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130547967|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130547968|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
130547969|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
130547970|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130547971|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130547972|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
130547973|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
130547974|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
130547975|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
130547976|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
130547977|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
130547978|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
130547979|NCT04494256|469973481|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
130322472|NCT00092417|469151274|FG001|Overall Study|Withdrawal by Subject|1|||
130547980|NCT04494256|469973482|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
130547981|NCT04494256|469973483|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
130547982|NCT04494256|469973484|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
130547983|NCT04494256|469973485|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
130547984|NCT04494256|469973486|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
130547985|NCT04494256|469973487|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
130547986|NCT04494256|469973481|FG000|Part 2: Open Label Period|Death|0|||
130547987|NCT04494256|469973482|FG001|Part 2: Open Label Period|Death|0|||
130547988|NCT04494256|469973483|FG002|Part 2: Open Label Period|Death|0|||
130547989|NCT04494256|469973484|FG003|Part 2: Open Label Period|Death|0|||
130547990|NCT04494256|469973485|FG004|Part 2: Open Label Period|Death|0|||
130547991|NCT04494256|469973486|FG005|Part 2: Open Label Period|Death|4|||
130547992|NCT04494256|469973487|FG006|Part 2: Open Label Period|Death|2|||
130547993|NCT04494256|469973481|FG000|Part 2: Open Label Period|Adverse Event|0|||
130547994|NCT04494256|469973482|FG001|Part 2: Open Label Period|Adverse Event|0|||
130547995|NCT04494256|469973483|FG002|Part 2: Open Label Period|Adverse Event|0|||
130547996|NCT04494256|469973484|FG003|Part 2: Open Label Period|Adverse Event|0|||
130547997|NCT04494256|469973485|FG004|Part 2: Open Label Period|Adverse Event|0|||
130547998|NCT04494256|469973486|FG005|Part 2: Open Label Period|Adverse Event|0|||
130547999|NCT04494256|469973487|FG006|Part 2: Open Label Period|Adverse Event|2|||
130548000|NCT04494256|469973481|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
130548001|NCT04494256|469973482|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
130548002|NCT04494256|469973483|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
130548003|NCT04494256|469973484|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
130548004|NCT04494256|469973485|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
130548005|NCT04494256|469973486|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
130548006|NCT04494256|469973487|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
130548007|NCT04494256|469973481|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548008|NCT04494256|469973482|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548009|NCT04494256|469973483|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548010|NCT04494256|469973484|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548011|NCT04494256|469973485|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548012|NCT04494256|469973486|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130548013|NCT04494256|469973487|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
130548014|NCT04494256|469973481|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
130548015|NCT04494256|469973482|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
130548016|NCT04494256|469973483|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
130548017|NCT04494256|469973484|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
130548018|NCT04494256|469973485|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
130548019|NCT04494256|469973486|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
130548020|NCT04494256|469973487|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
130548021|NCT04494256|469973481|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130548022|NCT04494256|469973482|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130548023|NCT04494256|469973483|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130548024|NCT04494256|469973484|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130548025|NCT04494256|469973485|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130548026|NCT04494256|469973486|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
130548027|NCT04494256|469973487|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
130548028|NCT04494256|469973481|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
130548029|NCT04494256|469973482|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
130548030|NCT04494256|469973483|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
130548031|NCT04494256|469973484|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
130548032|NCT04494256|469973485|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
130548033|NCT04494256|469973486|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
130548034|NCT04494256|469973487|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
130548035|NCT00986674|469973488|FG000|Overall Study|Lack of Efficacy|28|||
130548036|NCT00986674|469973489|FG001|Overall Study|Lack of Efficacy|25|||
130548037|NCT00986674|469973490|FG002|Overall Study|Lack of Efficacy|23|||
130548038|NCT00986674|469973488|FG000|Overall Study|Adverse Event|4|||
130548039|NCT00986674|469973489|FG001|Overall Study|Adverse Event|8|||
130548040|NCT00986674|469973490|FG002|Overall Study|Adverse Event|9|||
130548041|NCT00986674|469973488|FG000|Overall Study|Death|5|||
130548042|NCT00986674|469973489|FG001|Overall Study|Death|0|||
130548043|NCT00986674|469973490|FG002|Overall Study|Death|4|||
130548044|NCT00986674|469973488|FG000|Overall Study|Withdrawal by Subject|6|||
130548045|NCT00986674|469973489|FG001|Overall Study|Withdrawal by Subject|2|||
130548046|NCT00986674|469973490|FG002|Overall Study|Withdrawal by Subject|1|||
130548047|NCT00986674|469973488|FG000|Overall Study|alternative therapy|0|||
130548048|NCT00986674|469973489|FG001|Overall Study|alternative therapy|0|||
130548049|NCT00986674|469973490|FG002|Overall Study|alternative therapy|1|||
130548050|NCT00986674|469973488|FG000|Overall Study|not start protocol therapy|4|||
130548051|NCT00986674|469973489|FG001|Overall Study|not start protocol therapy|3|||
130548052|NCT00986674|469973490|FG002|Overall Study|not start protocol therapy|1|||
130548053|NCT00986674|469973488|FG000|Overall Study|unknown/not specify|0|||
130548054|NCT00986674|469973489|FG001|Overall Study|unknown/not specify|7|||
130548055|NCT00986674|469973490|FG002|Overall Study|unknown/not specify|9|||
130548056|NCT02128542|469973491|FG000|Overall Study|Lost to Follow-up|3|||
130548057|NCT02128542|469973492|FG001|Overall Study|Lost to Follow-up|0|||
130548058|NCT02128542|469973491|FG000|Overall Study|Withdrew Consent|1|||
130548059|NCT02128542|469973492|FG001|Overall Study|Withdrew Consent|0|||
130548060|NCT02513303|469973493|FG000|Overall Study|Withdrawal by Subject|9|||
130548061|NCT02513303|469973494|FG001|Overall Study|Withdrawal by Subject|7|||
130548062|NCT02513303|469973495|FG002|Overall Study|Withdrawal by Subject|2|||
130548063|NCT02513303|469973493|FG000|Overall Study|Lost to Follow-up|2|||
130548064|NCT02513303|469973494|FG001|Overall Study|Lost to Follow-up|4|||
130548065|NCT02513303|469973495|FG002|Overall Study|Lost to Follow-up|0|||
130548066|NCT02513303|469973493|FG000|Overall Study|Adverse Event|0|||
130548067|NCT02513303|469973494|FG001|Overall Study|Adverse Event|1|||
130548068|NCT02513303|469973495|FG002|Overall Study|Adverse Event|0|||
130548069|NCT02513303|469973493|FG000|Overall Study|Physician Decision|1|||
130548070|NCT02513303|469973494|FG001|Overall Study|Physician Decision|1|||
130548071|NCT02513303|469973495|FG002|Overall Study|Physician Decision|0|||
130548072|NCT02513303|469973493|FG000|Overall Study|Death|8|||
130548073|NCT02513303|469973494|FG001|Overall Study|Death|4|||
130548074|NCT02513303|469973495|FG002|Overall Study|Death|2|||
130548075|NCT06338462|469973499|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
130548076|NCT03816332|469973500|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
130322473|NCT00092417|469151273|FG000|Overall Study|Other|1|||
130548077|NCT03816332|469973500|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
130548078|NCT04689828|469973501|FG000|Overall Study|Subject decision|5|||
130548079|NCT04689828|469973502|FG001|Overall Study|Subject decision|5|||
130548080|NCT04689828|469973501|FG000|Overall Study|Adverse Event|12|||
130548081|NCT04689828|469973502|FG001|Overall Study|Adverse Event|12|||
130548082|NCT04689828|469973501|FG000|Overall Study|Physician Decision|24|||
130548083|NCT04689828|469973502|FG001|Overall Study|Physician Decision|32|||
130548084|NCT04689828|469973501|FG000|Overall Study|Progressive disease|54|||
130548085|NCT04689828|469973502|FG001|Overall Study|Progressive disease|173|||
130548086|NCT04689828|469973501|FG000|Overall Study|Death|0|||
130548087|NCT04689828|469973502|FG001|Overall Study|Death|1|||
130548088|NCT04689828|469973501|FG000|Overall Study|Lost to Follow-up|1|||
130548089|NCT04689828|469973502|FG001|Overall Study|Lost to Follow-up|0|||
130548090|NCT04689828|469973501|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
130548091|NCT04689828|469973502|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
130548092|NCT04689828|469973501|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
130548093|NCT04689828|469973502|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
130548094|NCT04689828|469973501|FG000|Overall Study|Participants not treated|7|||
130548095|NCT04689828|469973502|FG001|Overall Study|Participants not treated|2|||
130548096|NCT05182125|469973505|FG000|Overall Study|Withdrawal by Subject|0|||
130548097|NCT05182125|469973506|FG001|Overall Study|Withdrawal by Subject|0|||
130548098|NCT05182125|469973507|FG002|Overall Study|Withdrawal by Subject|0|||
130548099|NCT05182125|469973508|FG003|Overall Study|Withdrawal by Subject|0|||
130548100|NCT05182125|469973509|FG004|Overall Study|Withdrawal by Subject|2|||
130548101|NCT05182125|469973510|FG005|Overall Study|Withdrawal by Subject|0|||
130548102|NCT05182125|469973505|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
130548103|NCT05182125|469973506|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
130548104|NCT05182125|469973507|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
130548105|NCT05182125|469973508|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
130548106|NCT05182125|469973509|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
130548107|NCT05182125|469973510|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
130548108|NCT05182125|469973505|FG000|Overall Study|Death|0|||
130548109|NCT05182125|469973506|FG001|Overall Study|Death|0|||
130548110|NCT05182125|469973507|FG002|Overall Study|Death|0|||
130548111|NCT05182125|469973508|FG003|Overall Study|Death|0|||
130548112|NCT05182125|469973509|FG004|Overall Study|Death|1|||
130548113|NCT05182125|469973510|FG005|Overall Study|Death|0|||
130548114|NCT03464097|469973515|FG000|Overall Study|Withdrawal by Subject|15|||
130548115|NCT03464097|469973516|FG001|Overall Study|Withdrawal by Subject|13|||
130548116|NCT03464097|469973517|FG002|Overall Study|Withdrawal by Subject|11|||
130548117|NCT03464097|469973515|FG000|Overall Study|Study terminated by sponsor|47|||
130548118|NCT03464097|469973516|FG001|Overall Study|Study terminated by sponsor|44|||
130548119|NCT03464097|469973517|FG002|Overall Study|Study terminated by sponsor|40|||
130548120|NCT03464097|469973515|FG000|Overall Study|Pregnancy|0|||
130548121|NCT03464097|469973516|FG001|Overall Study|Pregnancy|1|||
130548122|NCT03464097|469973517|FG002|Overall Study|Pregnancy|0|||
130548123|NCT03464097|469973515|FG000|Overall Study|Other reasons|5|||
130548124|NCT03464097|469973516|FG001|Overall Study|Other reasons|12|||
130548125|NCT03464097|469973517|FG002|Overall Study|Other reasons|14|||
130548126|NCT03464097|469973515|FG000|Overall Study|Lost to Follow-up|0|||
130548127|NCT03464097|469973516|FG001|Overall Study|Lost to Follow-up|1|||
130548128|NCT03464097|469973517|FG002|Overall Study|Lost to Follow-up|1|||
130548129|NCT03464097|469973515|FG000|Overall Study|Lack of Efficacy|11|||
130548130|NCT03464097|469973516|FG001|Overall Study|Lack of Efficacy|18|||
130548131|NCT03464097|469973517|FG002|Overall Study|Lack of Efficacy|30|||
130548132|NCT03464097|469973515|FG000|Overall Study|Death|1|||
130548133|NCT03464097|469973516|FG001|Overall Study|Death|0|||
130548134|NCT03464097|469973517|FG002|Overall Study|Death|0|||
130548135|NCT03464097|469973515|FG000|Overall Study|Adverse Event|13|||
130548136|NCT03464097|469973516|FG001|Overall Study|Adverse Event|6|||
130548137|NCT03464097|469973517|FG002|Overall Study|Adverse Event|8|||
130548138|NCT03035201|469973518|FG000|Overall Study|Death|9|||
130548139|NCT03035201|469973519|FG001|Overall Study|Death|12|||
130548140|NCT03035201|469973520|FG002|Overall Study|Death|9|||
130548141|NCT03035201|469973521|FG003|Overall Study|Death|10|||
130548142|NCT03035201|469973518|FG000|Overall Study|Withdrawal by Subject|51|||
130548143|NCT03035201|469973519|FG001|Overall Study|Withdrawal by Subject|49|||
130548144|NCT03035201|469973520|FG002|Overall Study|Withdrawal by Subject|37|||
130548145|NCT03035201|469973521|FG003|Overall Study|Withdrawal by Subject|46|||
130548146|NCT03035201|469973518|FG000|Overall Study|Lost to Follow-up|67|||
130548147|NCT03035201|469973519|FG001|Overall Study|Lost to Follow-up|51|||
130548148|NCT03035201|469973520|FG002|Overall Study|Lost to Follow-up|64|||
130548149|NCT03035201|469973521|FG003|Overall Study|Lost to Follow-up|69|||
130548150|NCT05445843|469973522|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
130548151|NCT05445843|469973523|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
130548152|NCT05445843|469973522|FG000|Overall Study|Progressive disease|17|||
130548153|NCT05445843|469973523|FG001|Overall Study|Progressive disease|9|||
130548154|NCT05445843|469973522|FG000|Overall Study|Physician Decision|16|||
130548155|NCT05445843|469973523|FG001|Overall Study|Physician Decision|4|||
130548156|NCT05445843|469973522|FG000|Overall Study|Death|6|||
130548157|NCT05445843|469973523|FG001|Overall Study|Death|3|||
130548158|NCT05445843|469973522|FG000|Overall Study|Subject decision|6|||
130548159|NCT05445843|469973523|FG001|Overall Study|Subject decision|2|||
130548160|NCT05445843|469973522|FG000|Overall Study|Adverse Event|2|||
130548161|NCT05445843|469973523|FG001|Overall Study|Adverse Event|0|||
130548162|NCT04469270|469973524|FG000|Overall Study|Adverse Event|2|||
130548163|NCT04469270|469973525|FG001|Overall Study|Adverse Event|0|||
130548164|NCT04469270|469973524|FG000|Overall Study|Lost to Follow-up|4|||
130548165|NCT04469270|469973525|FG001|Overall Study|Lost to Follow-up|3|||
130548166|NCT04469270|469973524|FG000|Overall Study|Withdrawal by Subject|7|||
130548167|NCT04469270|469973525|FG001|Overall Study|Withdrawal by Subject|3|||
130548168|NCT04469270|469973524|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
130548169|NCT04469270|469973525|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
130548170|NCT04469270|469973524|FG000|Overall Study|missing|1|||
130548171|NCT04469270|469973525|FG001|Overall Study|missing|0|||
130548172|NCT04576455|469973526|FG000|Overall Study|Ongoing in the Study|48|||
130548173|NCT04576455|469973527|FG001|Overall Study|Ongoing in the Study|58|||
130548174|NCT04576455|469973526|FG000|Overall Study|Death|83|||
130548175|NCT04576455|469973527|FG001|Overall Study|Death|77|||
130548176|NCT04576455|469973526|FG000|Overall Study|Lost to Follow-up|4|||
130548177|NCT04576455|469973527|FG001|Overall Study|Lost to Follow-up|5|||
130548178|NCT04576455|469973526|FG000|Overall Study|Withdrawal by Subject|16|||
130548179|NCT04576455|469973527|FG001|Overall Study|Withdrawal by Subject|12|||
130548180|NCT02186847|469973528|FG000|Overall Study|Protocol Violation|3|||
130548181|NCT02186847|469973529|FG001|Overall Study|Protocol Violation|0|||
130548182|NCT03319849|469973530|FG000|Overall Study|Adverse Event|1|||
130548183|NCT03319849|469973531|FG001|Overall Study|Adverse Event|0|||
130548184|NCT03319849|469973530|FG000|Overall Study|Physician Decision|0|||
130548185|NCT03319849|469973531|FG001|Overall Study|Physician Decision|1|||
130322474|NCT00092417|469151274|FG001|Overall Study|Other|0|||
130548186|NCT03319849|469973530|FG000|Overall Study|Withdrawal by Subject|0|||
130548187|NCT03319849|469973531|FG001|Overall Study|Withdrawal by Subject|1|||
130548188|NCT03319849|469973530|FG000|Overall Study|COVID-19|0|||
130548189|NCT03319849|469973531|FG001|Overall Study|COVID-19|1|||
130548190|NCT03319849|469973530|FG000|Overall Study|Other|1|||
130548191|NCT03319849|469973531|FG001|Overall Study|Other|2|||
130548192|NCT03319849|469973530|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
130548193|NCT03319849|469973531|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
130548194|NCT03319849|469973530|FG000|Overall Study|Lost to Follow-up|0|||
130548195|NCT03319849|469973531|FG001|Overall Study|Lost to Follow-up|2|||
130548196|NCT02254278|469973532|FG000|Overall Study|Protocol Violation|1|||
130548197|NCT02254278|469973533|FG001|Overall Study|Protocol Violation|1|||
130548198|NCT05774197|469973536|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
130548199|NCT03727438|469973541|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
130548200|NCT03727438|469973542|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
130548201|NCT03727438|469973541|FG000|Intervention Period|Excluded (health)|1|||
130548202|NCT03727438|469973542|FG001|Intervention Period|Excluded (health)|0|||
130548203|NCT03727438|469973541|FG000|Intervention Period|Withdrawal by Subject|3|||
130548204|NCT03727438|469973542|FG001|Intervention Period|Withdrawal by Subject|1|||
130548205|NCT03727438|469973541|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
130548206|NCT03727438|469973542|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
130548207|NCT03727438|469973541|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
130548208|NCT03727438|469973542|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
130548209|NCT03727438|469973541|FG000|8 Week Assessment|Withdrawal by Subject|6|||
130548210|NCT03727438|469973542|FG001|8 Week Assessment|Withdrawal by Subject|1|||
130548211|NCT03727438|469973541|FG000|6 mo Assessment|did not complete assessment|10|||
130548212|NCT03727438|469973542|FG001|6 mo Assessment|did not complete assessment|11|||
130548213|NCT04647253|469973543|FG000|Overall Study|Death ≤ 365 Days|16|||
130548214|NCT04647253|469973544|FG001|Overall Study|Death ≤ 365 Days|7|||
130548215|NCT04647253|469973543|FG000|Overall Study|Physician Decision|0|||
130548216|NCT04647253|469973544|FG001|Overall Study|Physician Decision|1|||
130548217|NCT04647253|469973543|FG000|Overall Study|Withdrawal by Subject|7|||
130548218|NCT04647253|469973544|FG001|Overall Study|Withdrawal by Subject|2|||
130548219|NCT04647253|469973543|FG000|Overall Study|Missed 12-Month Visit|9|||
130548220|NCT04647253|469973544|FG001|Overall Study|Missed 12-Month Visit|7|||
130548221|NCT04647253|469973543|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
130548222|NCT04647253|469973544|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
130548223|NCT06729606|469973547|FG000|Overall Study|Adverse Event|0|||
130548224|NCT06729606|469973548|FG001|Overall Study|Adverse Event|2|||
130548225|NCT06729606|469973547|FG000|Overall Study|Death|1|||
130548226|NCT06729606|469973548|FG001|Overall Study|Death|0|||
130548227|NCT06729606|469973547|FG000|Overall Study|Physician Decision|0|||
130548228|NCT06729606|469973548|FG001|Overall Study|Physician Decision|1|||
130548229|NCT06729606|469973547|FG000|Overall Study|Withdrawal by Subject|2|||
130548230|NCT06729606|469973548|FG001|Overall Study|Withdrawal by Subject|4|||
130548231|NCT04873232|469973549|FG000|Overall Study|Lost to Follow-up|1|||
130548232|NCT04873232|469973550|FG001|Overall Study|Lost to Follow-up|4|||
130548233|NCT04873232|469973549|FG000|Overall Study|Withdrawal by Subject|1|||
130548234|NCT04873232|469973550|FG001|Overall Study|Withdrawal by Subject|0|||
130548235|NCT05437510|469973551|FG000|Overall Study|Adverse Event|2|||
130548236|NCT05437510|469973552|FG001|Overall Study|Adverse Event|1|||
130548237|NCT05437510|469973551|FG000|Overall Study|Protocol Deviation|1|||
130548238|NCT05437510|469973552|FG001|Overall Study|Protocol Deviation|6|||
130548239|NCT05437510|469973551|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
130548240|NCT05437510|469973552|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
130548241|NCT05437510|469973551|FG000|Overall Study|Lost to Follow-up|265|||
130548242|NCT05437510|469973552|FG001|Overall Study|Lost to Follow-up|358|||
130548243|NCT00250679|469974679|FG000|Overall Study|Adverse Event|12|||
130548244|NCT00250679|469974680|FG001|Overall Study|Adverse Event|15|||
130548245|NCT00250679|469974681|FG002|Overall Study|Adverse Event|16|||
130548246|NCT00250679|469974679|FG000|Overall Study|Protocol Violation|2|||
130548247|NCT00250679|469974680|FG001|Overall Study|Protocol Violation|4|||
130548248|NCT00250679|469974681|FG002|Overall Study|Protocol Violation|3|||
130548249|NCT00250679|469974679|FG000|Overall Study|Withdrawal by Subject|15|||
130548250|NCT00250679|469974680|FG001|Overall Study|Withdrawal by Subject|18|||
130548251|NCT00250679|469974681|FG002|Overall Study|Withdrawal by Subject|15|||
130548252|NCT00250679|469974679|FG000|Overall Study|Lost to Follow-up|3|||
130548253|NCT00250679|469974680|FG001|Overall Study|Lost to Follow-up|4|||
130548254|NCT00250679|469974681|FG002|Overall Study|Lost to Follow-up|2|||
130548255|NCT00250679|469974679|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
130548256|NCT00250679|469974680|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
130548257|NCT00250679|469974681|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
130548258|NCT00250679|469974679|FG000|Overall Study|Lack of Efficacy|0|||
130548259|NCT00250679|469974680|FG001|Overall Study|Lack of Efficacy|1|||
130548260|NCT00250679|469974681|FG002|Overall Study|Lack of Efficacy|3|||
130548261|NCT00250679|469974679|FG000|Overall Study|Technical Holter issues|1|||
130548262|NCT00250679|469974680|FG001|Overall Study|Technical Holter issues|0|||
130548263|NCT00250679|469974681|FG002|Overall Study|Technical Holter issues|2|||
130548264|NCT00250679|469974679|FG000|Overall Study|Moved|1|||
130548265|NCT00250679|469974680|FG001|Overall Study|Moved|1|||
130548266|NCT00250679|469974681|FG002|Overall Study|Moved|0|||
130548267|NCT00250679|469974679|FG000|Overall Study|Non-compliance|1|||
130548268|NCT00250679|469974680|FG001|Overall Study|Non-compliance|1|||
130548269|NCT00250679|469974681|FG002|Overall Study|Non-compliance|0|||
130548270|NCT00250679|469974679|FG000|Overall Study|various single events: hip surgery,diary|3|||
130548271|NCT00250679|469974680|FG001|Overall Study|various single events: hip surgery,diary|1|||
130548272|NCT00250679|469974681|FG002|Overall Study|various single events: hip surgery,diary|1|||
130548273|NCT00448279|469974683|FG000|Overall Study|Lost to Follow-up|2|||
130548274|NCT00448279|469974684|FG001|Overall Study|Lost to Follow-up|2|||
130548275|NCT00448279|469974683|FG000|Overall Study|Adverse Event|1|||
130548276|NCT00448279|469974684|FG001|Overall Study|Adverse Event|1|||
130548277|NCT00448279|469974683|FG000|Overall Study|Disease progression|16|||
130548278|NCT00448279|469974684|FG001|Overall Study|Disease progression|18|||
130548279|NCT00448279|469974683|FG000|Overall Study|Withdrawal by Subject|4|||
130548280|NCT00448279|469974684|FG001|Overall Study|Withdrawal by Subject|3|||
130548281|NCT00448279|469974683|FG000|Overall Study|Other|6|||
130548282|NCT00448279|469974684|FG001|Overall Study|Other|4|||
130548283|NCT00448279|469974683|FG000|Overall Study|Protocol Violation|0|||
130548284|NCT00448279|469974684|FG001|Overall Study|Protocol Violation|1|||
130548285|NCT03907410|469974685|FG000|Overall Study|Lost to Follow-up|4|||
130548286|NCT03907410|469974686|FG001|Overall Study|Lost to Follow-up|1|||
130548287|NCT03907410|469974687|FG002|Overall Study|Lost to Follow-up|1|||
130548288|NCT03907410|469974685|FG000|Overall Study|Lost to follow-up and research burden|0|||
130548289|NCT03907410|469974686|FG001|Overall Study|Lost to follow-up and research burden|0|||
130548290|NCT03907410|469974687|FG002|Overall Study|Lost to follow-up and research burden|1|||
130548291|NCT03718533|469974688|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
130548292|NCT03718533|469974688|FG000|Overall Study|Protocol deviation|1|||
130548293|NCT03718533|469974688|FG000|Overall Study|Disease progression|1|||
130548294|NCT03718533|469974688|FG000|Overall Study|Relapse|1|||
130548295|NCT03718533|469974688|FG000|Overall Study|Physician Decision|2|||
130548296|NCT03718533|469974688|FG000|Overall Study|Physician Decision and Adverse Event|1|||
130548297|NCT05754333|469974689|FG000|Overall Study|Miscellaneous|3|||
130548298|NCT05754333|469974690|FG001|Overall Study|Miscellaneous|0|||
130548299|NCT05754333|469974691|FG002|Overall Study|Miscellaneous|0|||
130548300|NCT05754333|469974692|FG003|Overall Study|Miscellaneous|0|||
130548301|NCT05754333|469974689|FG000|Overall Study|Lost to Follow-up|2|||
130548302|NCT05754333|469974690|FG001|Overall Study|Lost to Follow-up|1|||
130548303|NCT05754333|469974691|FG002|Overall Study|Lost to Follow-up|0|||
130548304|NCT05754333|469974692|FG003|Overall Study|Lost to Follow-up|1|||
130548305|NCT01853137|469974695|FG000|Overall Study|Lost to Follow-up|4|||
130548306|NCT01853137|469974696|FG001|Overall Study|Lost to Follow-up|1|||
130548307|NCT01037244|469974697|FG000|Overall Study|Adverse Event|3|||
130548308|NCT01037244|469974698|FG001|Overall Study|Adverse Event|2|||
130548309|NCT01037244|469974699|FG002|Overall Study|Adverse Event|6|||
130548310|NCT01037244|469974700|FG003|Overall Study|Adverse Event|3|||
130548311|NCT01037244|469974697|FG000|Overall Study|Lack of Efficacy|1|||
130548312|NCT01037244|469974698|FG001|Overall Study|Lack of Efficacy|1|||
130548313|NCT01037244|469974699|FG002|Overall Study|Lack of Efficacy|0|||
130548314|NCT01037244|469974700|FG003|Overall Study|Lack of Efficacy|1|||
130548315|NCT01037244|469974697|FG000|Overall Study|Lost to Follow-up|3|||
130548316|NCT01037244|469974698|FG001|Overall Study|Lost to Follow-up|3|||
130548317|NCT01037244|469974699|FG002|Overall Study|Lost to Follow-up|4|||
130548318|NCT01037244|469974700|FG003|Overall Study|Lost to Follow-up|4|||
130548319|NCT01037244|469974697|FG000|Overall Study|Withdrawal by Subject|1|||
130548320|NCT01037244|469974698|FG001|Overall Study|Withdrawal by Subject|5|||
130548321|NCT01037244|469974699|FG002|Overall Study|Withdrawal by Subject|3|||
130548322|NCT01037244|469974700|FG003|Overall Study|Withdrawal by Subject|5|||
130548323|NCT01037244|469974697|FG000|Overall Study|Partner Withdrew Consent|2|||
130548324|NCT01037244|469974698|FG001|Overall Study|Partner Withdrew Consent|1|||
130548325|NCT01037244|469974699|FG002|Overall Study|Partner Withdrew Consent|0|||
130548326|NCT01037244|469974700|FG003|Overall Study|Partner Withdrew Consent|0|||
130548327|NCT01037244|469974697|FG000|Overall Study|Various|3|||
130548328|NCT01037244|469974698|FG001|Overall Study|Various|2|||
130548329|NCT01037244|469974699|FG002|Overall Study|Various|1|||
130548330|NCT01037244|469974700|FG003|Overall Study|Various|1|||
130548331|NCT01411215|469974701|FG000|Overall Study|Adverse Event|1|||
130548332|NCT01411215|469974702|FG001|Overall Study|Adverse Event|2|||
130548333|NCT01411215|469974701|FG000|Overall Study|Lack of Efficacy|2|||
130322475|NCT03780244|469151285|FG000|Overall Study|Lost to Follow-up|1|||
130548334|NCT01411215|469974702|FG001|Overall Study|Lack of Efficacy|4|||
130548335|NCT01411215|469974701|FG000|Overall Study|Lost to Follow-up|12|||
130548336|NCT01411215|469974702|FG001|Overall Study|Lost to Follow-up|18|||
130548337|NCT01411215|469974701|FG000|Overall Study|Did not meet entrance criteria|0|||
130548338|NCT01411215|469974702|FG001|Overall Study|Did not meet entrance criteria|1|||
130548339|NCT01411215|469974701|FG000|Overall Study|Study terminated by sponsor|2|||
130548340|NCT01411215|469974702|FG001|Overall Study|Study terminated by sponsor|15|||
130548341|NCT01411215|469974701|FG000|Overall Study|Protocol Violation|3|||
130548342|NCT01411215|469974702|FG001|Overall Study|Protocol Violation|5|||
130548343|NCT01411215|469974701|FG000|Overall Study|Withdrawal by Subject|34|||
130548344|NCT01411215|469974702|FG001|Overall Study|Withdrawal by Subject|21|||
130322476|NCT03780244|469151286|FG001|Overall Study|Lost to Follow-up|0|||
130322477|NCT00804908|469151289|FG000|Overall Study|Other|115|||
130548345|NCT01411215|469974701|FG000|Overall Study|Other|12|||
130548346|NCT01411215|469974702|FG001|Overall Study|Other|17|||
130548347|NCT01411215|469974701|FG000|Overall Study|Screen failure|0|||
130548348|NCT01411215|469974702|FG001|Overall Study|Screen failure|1|||
130548349|NCT00848926|469974703|FG000|Treatment Period|Progressive disease|45|||
130548350|NCT00848926|469974703|FG000|Treatment Period|Adverse Event|20|||
130548351|NCT00848926|469974703|FG000|Treatment Period|Physician Decision|12|||
130548352|NCT00848926|469974703|FG000|Treatment Period|Withdrawal by Subject|7|||
130548353|NCT00848926|469974703|FG000|Follow-up Period|Lost to Follow-up|7|||
130548354|NCT00848926|469974703|FG000|Follow-up Period|Withdrawal by Subject|3|||
130548355|NCT00848926|469974703|FG000|Follow-up Period|Other|2|||
130548356|NCT04025580|469974704|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
130548357|NCT04025580|469974705|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
130548358|NCT04025580|469974706|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
130548359|NCT04507126|469974707|FG000|Overall Study|Withdrawal by Subject|1|||
130548360|NCT04507126|469974707|FG000|Overall Study|Protocol Violation|2|||
130548361|NCT04507126|469974707|FG000|Overall Study|Physician Decision|1|||
130548362|NCT02924064|469974708|FG000|Overall Study|Adverse Event|2|||
130548363|NCT02924064|469974709|FG001|Overall Study|Adverse Event|2|||
130548364|NCT02924064|469974708|FG000|Overall Study|Lost to Follow-up|0|||
130548365|NCT02924064|469974709|FG001|Overall Study|Lost to Follow-up|2|||
130548366|NCT02924064|469974708|FG000|Overall Study|Physician Decision|0|||
130548367|NCT02924064|469974709|FG001|Overall Study|Physician Decision|2|||
130548368|NCT02924064|469974708|FG000|Overall Study|Protocol Violation|1|||
130548369|NCT02924064|469974709|FG001|Overall Study|Protocol Violation|3|||
130548370|NCT02924064|469974708|FG000|Overall Study|Withdrawal by Subject|4|||
130548371|NCT02924064|469974709|FG001|Overall Study|Withdrawal by Subject|5|||
130548372|NCT02924064|469974708|FG000|Overall Study|Other|17|||
130548373|NCT02924064|469974709|FG001|Overall Study|Other|29|||
130548374|NCT01249274|469974712|FG000|Overall Study|Lost to Follow-up|3|||
130548375|NCT01249274|469974713|FG001|Overall Study|Lost to Follow-up|4|||
130548376|NCT01249274|469974712|FG000|Overall Study|Received inpatient substance treatment|1|||
130548377|NCT01249274|469974713|FG001|Overall Study|Received inpatient substance treatment|2|||
130548378|NCT00138671|469974714|FG000|Overall Study|Death|0|||
130548379|NCT00138671|469974715|FG001|Overall Study|Death|3|||
130548380|NCT00138671|469974714|FG000|Overall Study|Adverse Event|6|||
130548381|NCT00138671|469974715|FG001|Overall Study|Adverse Event|3|||
130548382|NCT00138671|469974714|FG000|Overall Study|Lost to Follow-up|1|||
130548383|NCT00138671|469974715|FG001|Overall Study|Lost to Follow-up|2|||
130548384|NCT00138671|469974714|FG000|Overall Study|Withdrawal by Subject|3|||
130548385|NCT00138671|469974715|FG001|Overall Study|Withdrawal by Subject|5|||
130548386|NCT00138671|469974714|FG000|Overall Study|Other|3|||
130548387|NCT00138671|469974715|FG001|Overall Study|Other|3|||
130548388|NCT01952054|469974716|FG000|Overall Study|Physician Decision|1|||
130548389|NCT01100034|469974717|FG000|Overall Study|Lost to Follow-up|11|||
130548390|NCT01100034|469974717|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
130548391|NCT01100034|469974717|FG000|Overall Study|Withdrawal by Subject|4|||
130548392|NCT01100034|469974717|FG000|Overall Study|Sponsor decision|21|||
130548393|NCT01100034|469974717|FG000|Overall Study|Participated in another clinical trial|1|||
130548394|NCT01100034|469974717|FG000|Overall Study|Participants moved to another hospital|4|||
130548395|NCT01100034|469974717|FG000|Overall Study|Site closed due to non-responsiveness|1|||
130548396|NCT01831856|469974718|FG000|Overall Study|Adverse Event|5|||
130548397|NCT01831856|469974719|FG001|Overall Study|Adverse Event|8|||
130548398|NCT01831856|469974718|FG000|Overall Study|Lack of Efficacy|13|||
130548399|NCT01831856|469974719|FG001|Overall Study|Lack of Efficacy|11|||
130548400|NCT01831856|469974718|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
130548401|NCT01831856|469974719|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
130548402|NCT01498653|469974720|FG000|Overall Study|Adverse Event|2|||
130548403|NCT01498653|469974721|FG001|Overall Study|Adverse Event|2|||
130548404|NCT01498653|469974720|FG000|Overall Study|Lack of Efficacy|12|||
130548405|NCT01498653|469974721|FG001|Overall Study|Lack of Efficacy|26|||
130548406|NCT01498653|469974720|FG000|Overall Study|Protocol Violation|0|||
130548407|NCT01498653|469974721|FG001|Overall Study|Protocol Violation|4|||
130548408|NCT01498653|469974720|FG000|Overall Study|Lost to Follow-up|1|||
130548409|NCT01498653|469974721|FG001|Overall Study|Lost to Follow-up|0|||
130548410|NCT01498653|469974720|FG000|Overall Study|Physician Decision|2|||
130548411|NCT01498653|469974721|FG001|Overall Study|Physician Decision|0|||
130548412|NCT01498653|469974720|FG000|Overall Study|Withdrawal by Subject|2|||
130548413|NCT01498653|469974721|FG001|Overall Study|Withdrawal by Subject|3|||
130548414|NCT05208866|469974722|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
130548415|NCT02070588|469974723|FG000|Overall Study|Withdrawal by Subject|29|||
130548416|NCT02070588|469974724|FG001|Overall Study|Withdrawal by Subject|1|||
130548417|NCT02070588|469974725|FG002|Overall Study|Withdrawal by Subject|0|||
130548418|NCT02070588|469974723|FG000|Overall Study|Writhdrawal due to early termination|9|||
130548419|NCT02070588|469974724|FG001|Overall Study|Writhdrawal due to early termination|0|||
130548420|NCT02070588|469974725|FG002|Overall Study|Writhdrawal due to early termination|0|||
130322478|NCT00804908|469151290|FG001|Overall Study|Other|116|||
130548421|NCT02070588|469974723|FG000|Overall Study|Adverse Event|1|||
130548422|NCT02070588|469974724|FG001|Overall Study|Adverse Event|0|||
130548423|NCT02070588|469974725|FG002|Overall Study|Adverse Event|0|||
130548424|NCT02216357|469974728|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
130548425|NCT02216357|469974729|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
130548426|NCT00836095|469974730|FG000|Overall Study|Physician Decision|0|||
130548427|NCT00836095|469974731|FG001|Overall Study|Physician Decision|3|||
130548428|NCT04620811|469974734|FG000|Overall Study|Withdrawal by Subject|18|||
130548429|NCT04620811|469974735|FG001|Overall Study|Withdrawal by Subject|15|||
130548430|NCT04620811|469974734|FG000|Overall Study|Adverse Event|6|||
130548431|NCT04620811|469974735|FG001|Overall Study|Adverse Event|11|||
130548432|NCT04620811|469974734|FG000|Overall Study|Lost to Follow-up|4|||
130548433|NCT04620811|469974735|FG001|Overall Study|Lost to Follow-up|8|||
130548434|NCT04620811|469974734|FG000|Overall Study|Physician Decision|1|||
130548435|NCT04620811|469974735|FG001|Overall Study|Physician Decision|4|||
130548436|NCT04620811|469974734|FG000|Overall Study|Sponsor Decision|0|||
130548437|NCT04620811|469974735|FG001|Overall Study|Sponsor Decision|1|||
130548438|NCT04620811|469974734|FG000|Overall Study|Elevation of ALT or AST|1|||
130548439|NCT04620811|469974735|FG001|Overall Study|Elevation of ALT or AST|0|||
130548440|NCT04620811|469974734|FG000|Overall Study|Other|3|||
130548441|NCT04620811|469974735|FG001|Overall Study|Other|5|||
130548442|NCT01078675|469974736|FG000|Overall Study|Withdrawal by Subject|7|||
130548443|NCT01078675|469974737|FG001|Overall Study|Withdrawal by Subject|3|||
130548444|NCT01078675|469974736|FG000|Overall Study|Protocol Violation|56|||
130548445|NCT01078675|469974737|FG001|Overall Study|Protocol Violation|0|||
130548446|NCT01078675|469974736|FG000|Overall Study|Provided in CRF for specific reasons|2|||
130548447|NCT01078675|469974737|FG001|Overall Study|Provided in CRF for specific reasons|3|||
130548448|NCT01078675|469974736|FG000|Overall Study|Adverse Event|3|||
130548449|NCT01078675|469974737|FG001|Overall Study|Adverse Event|0|||
130548450|NCT01759368|469974740|FG000|Overall Study|Lost to Follow-up|1|||
130548451|NCT01759368|469974741|FG001|Overall Study|Lost to Follow-up|0|||
130548452|NCT01191268|469974742|FG000|Overall Study|Withdrawal by Subject|19|||
130548453|NCT01191268|469974743|FG001|Overall Study|Withdrawal by Subject|25|||
130548454|NCT01191268|469974744|FG002|Overall Study|Withdrawal by Subject|21|||
130548455|NCT01191268|469974742|FG000|Overall Study|Adverse Event|21|||
130548456|NCT01191268|469974743|FG001|Overall Study|Adverse Event|13|||
130548457|NCT01191268|469974744|FG002|Overall Study|Adverse Event|8|||
130548458|NCT01191268|469974742|FG000|Overall Study|Physician Decision|6|||
130548459|NCT01191268|469974743|FG001|Overall Study|Physician Decision|8|||
130548460|NCT01191268|469974744|FG002|Overall Study|Physician Decision|9|||
130548461|NCT01191268|469974742|FG000|Overall Study|Lost to Follow-up|8|||
130548462|NCT01191268|469974743|FG001|Overall Study|Lost to Follow-up|5|||
130548463|NCT01191268|469974744|FG002|Overall Study|Lost to Follow-up|9|||
130548464|NCT01191268|469974742|FG000|Overall Study|Entry Criteria Not Met|3|||
130548465|NCT01191268|469974743|FG001|Overall Study|Entry Criteria Not Met|1|||
130548466|NCT01191268|469974744|FG002|Overall Study|Entry Criteria Not Met|1|||
130548467|NCT01191268|469974742|FG000|Overall Study|Death|0|||
130548468|NCT01191268|469974743|FG001|Overall Study|Death|1|||
130548469|NCT01191268|469974744|FG002|Overall Study|Death|3|||
130548470|NCT01191268|469974742|FG000|Overall Study|Protocol Violation|1|||
130548471|NCT01191268|469974743|FG001|Overall Study|Protocol Violation|0|||
130548472|NCT01191268|469974744|FG002|Overall Study|Protocol Violation|1|||
130548473|NCT01191268|469974742|FG000|Overall Study|Sponsor Decision|0|||
130548474|NCT01191268|469974743|FG001|Overall Study|Sponsor Decision|2|||
130548475|NCT01191268|469974744|FG002|Overall Study|Sponsor Decision|0|||
130548476|NCT02294227|469974747|FG000|Overall Study|Death|0|||
130548477|NCT02294227|469974748|FG001|Overall Study|Death|0|||
130548478|NCT02294227|469974749|FG002|Overall Study|Death|1|||
130548479|NCT02294227|469974747|FG000|Overall Study|Subject/Guardian Decision|6|||
130548480|NCT02294227|469974748|FG001|Overall Study|Subject/Guardian Decision|3|||
130548481|NCT02294227|469974749|FG002|Overall Study|Subject/Guardian Decision|7|||
130548482|NCT02294227|469974747|FG000|Overall Study|Physician Decision|1|||
130548483|NCT02294227|469974748|FG001|Overall Study|Physician Decision|2|||
130548484|NCT02294227|469974749|FG002|Overall Study|Physician Decision|1|||
130548485|NCT02294227|469974747|FG000|Overall Study|Lost to Follow-up|1|||
130548486|NCT02294227|469974748|FG001|Overall Study|Lost to Follow-up|0|||
130548487|NCT02294227|469974749|FG002|Overall Study|Lost to Follow-up|0|||
130548488|NCT02294227|469974747|FG000|Overall Study|Lack of Efficacy|11|||
130548489|NCT02294227|469974748|FG001|Overall Study|Lack of Efficacy|12|||
130548490|NCT02294227|469974749|FG002|Overall Study|Lack of Efficacy|8|||
130548491|NCT02294227|469974747|FG000|Overall Study|Adverse Event|6|||
130548492|NCT02294227|469974748|FG001|Overall Study|Adverse Event|8|||
130548493|NCT02294227|469974749|FG002|Overall Study|Adverse Event|2|||
130548494|NCT01768637|469974752|FG000|Overall Study|Lost to Follow-up|2|||
130548495|NCT01768637|469974753|FG001|Overall Study|Lost to Follow-up|7|||
130548496|NCT01768637|469974752|FG000|Overall Study|Difficult blood draw|1|||
130548497|NCT01768637|469974753|FG001|Overall Study|Difficult blood draw|0|||
130548498|NCT00899548|469974754|FG000|Overall Study|Physician Decision|3|||
130548499|NCT00511472|469974755|FG000|Overall Study|Clinical Adverse Event|1|||
130548500|NCT00511472|469974756|FG001|Overall Study|Clinical Adverse Event|2|||
130548501|NCT00511472|469974755|FG000|Overall Study|Laboratory Adverse Event|0|||
130548502|NCT00511472|469974756|FG001|Overall Study|Laboratory Adverse Event|2|||
130548503|NCT00511472|469974755|FG000|Overall Study|Not reported|2|||
130548504|NCT00511472|469974756|FG001|Overall Study|Not reported|2|||
130548505|NCT02709096|469974757|FG000|Overall Study|non-compliance|1|||
130548506|NCT02709096|469974758|FG001|Overall Study|non-compliance|1|||
130548507|NCT02427464|469974760|FG000|Overall Study|Adverse Event|6|||
130548508|NCT02427464|469974761|FG001|Overall Study|Adverse Event|1|||
130548509|NCT02427464|469974760|FG000|Overall Study|Lost to Follow-up|16|||
130548510|NCT02427464|469974761|FG001|Overall Study|Lost to Follow-up|5|||
130548511|NCT02427464|469974760|FG000|Overall Study|Physician Decision|2|||
130548512|NCT02427464|469974761|FG001|Overall Study|Physician Decision|0|||
130548513|NCT02427464|469974760|FG000|Overall Study|Withdrawal by Subject|10|||
130548514|NCT02427464|469974761|FG001|Overall Study|Withdrawal by Subject|8|||
130548515|NCT02427464|469974760|FG000|Overall Study|Noncompliance|16|||
130548516|NCT02427464|469974761|FG001|Overall Study|Noncompliance|10|||
130548517|NCT03164564|469974764|FG000|Overall Study|Death|3|||
130548518|NCT03164564|469974765|FG001|Overall Study|Death|0|||
130548519|NCT03164564|469974764|FG000|Overall Study|Withdrawal by Subject|20|||
130548520|NCT03164564|469974765|FG001|Overall Study|Withdrawal by Subject|15|||
130548521|NCT03164564|469974764|FG000|Overall Study|Lost to Follow-up|2|||
130548522|NCT03164564|469974765|FG001|Overall Study|Lost to Follow-up|0|||
130548523|NCT03164564|469974764|FG000|Overall Study|Physician Decision|0|||
130548524|NCT03164564|469974765|FG001|Overall Study|Physician Decision|1|||
130548525|NCT03164564|469974764|FG000|Overall Study|Adverse Event|0|||
130548526|NCT03164564|469974765|FG001|Overall Study|Adverse Event|1|||
130548527|NCT03164564|469974764|FG000|Overall Study|Ongoing|1586|||
130548528|NCT03164564|469974765|FG001|Overall Study|Ongoing|1586|||
130548529|NCT05959629|469974768|FG000|Overall Study|partially necrotic/technical issues|2|||
130322479|NCT00804908|469151291|FG002|Overall Study|Other|114|||
130322480|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
130322481|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
130322482|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
130322483|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
130322484|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
130548530|NCT05959629|469974769|FG001|Overall Study|partially necrotic/technical issues|2|||
130548531|NCT03573401|469974770|FG000|Overall Study|Withdrawal by Subject|2|||
130548532|NCT03573401|469974771|FG001|Overall Study|Withdrawal by Subject|0|||
130548533|NCT03573401|469974770|FG000|Overall Study|Subject non-compliance with study schedule|1|||
130548534|NCT03573401|469974771|FG001|Overall Study|Subject non-compliance with study schedule|0|||
130548535|NCT03573401|469974770|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
130548536|NCT03573401|469974771|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
130548537|NCT03573401|469974770|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
130548538|NCT03573401|469974771|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
130548539|NCT03938545|469976333|FG000|Overall Study|Lost to Follow-up|0|||
130548540|NCT03938545|469976334|FG001|Overall Study|Lost to Follow-up|0|||
130548541|NCT03938545|469976335|FG002|Overall Study|Lost to Follow-up|0|||
130548542|NCT03938545|469976336|FG003|Overall Study|Lost to Follow-up|1|||
130548543|NCT03938545|469976333|FG000|Overall Study|Non-compliance with study drug|0|||
130548544|NCT03938545|469976334|FG001|Overall Study|Non-compliance with study drug|0|||
130548545|NCT03938545|469976335|FG002|Overall Study|Non-compliance with study drug|1|||
130548546|NCT03938545|469976336|FG003|Overall Study|Non-compliance with study drug|0|||
130548547|NCT03938545|469976333|FG000|Overall Study|Pregnancy|1|||
130548548|NCT03938545|469976334|FG001|Overall Study|Pregnancy|0|||
130548549|NCT03938545|469976335|FG002|Overall Study|Pregnancy|0|||
130548550|NCT03938545|469976336|FG003|Overall Study|Pregnancy|0|||
130548551|NCT03938545|469976333|FG000|Overall Study|Study terminated by sponsor|6|||
130548552|NCT03938545|469976334|FG001|Overall Study|Study terminated by sponsor|4|||
130548553|NCT03938545|469976335|FG002|Overall Study|Study terminated by sponsor|2|||
130548554|NCT03938545|469976336|FG003|Overall Study|Study terminated by sponsor|4|||
130548555|NCT03938545|469976333|FG000|Overall Study|Withdrawal by Subject|0|||
130548556|NCT03938545|469976334|FG001|Overall Study|Withdrawal by Subject|1|||
130548557|NCT03938545|469976335|FG002|Overall Study|Withdrawal by Subject|0|||
130548558|NCT03938545|469976336|FG003|Overall Study|Withdrawal by Subject|0|||
130548559|NCT03938545|469976333|FG000|Overall Study|Adverse Event|1|||
130548560|NCT03938545|469976334|FG001|Overall Study|Adverse Event|0|||
130548561|NCT03938545|469976335|FG002|Overall Study|Adverse Event|0|||
130548562|NCT03938545|469976336|FG003|Overall Study|Adverse Event|0|||
130548563|NCT01060540|469976337|FG000|Overall Study|Withdrawal by Subject|10|||
130548564|NCT01060540|469976338|FG001|Overall Study|Withdrawal by Subject|20|||
130548565|NCT01060540|469976337|FG000|Overall Study|Lost to Follow-up|52|||
130322485|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
130322486|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
130322487|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
130322488|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
130548566|NCT01060540|469976338|FG001|Overall Study|Lost to Follow-up|43|||
130548567|NCT01060540|469976337|FG000|Overall Study|Death|2|||
130548568|NCT01060540|469976338|FG001|Overall Study|Death|1|||
130548569|NCT01060540|469976337|FG000|Overall Study|Physician Decision|0|||
130548570|NCT01060540|469976338|FG001|Overall Study|Physician Decision|1|||
130548571|NCT01222507|469976339|FG000|Overall Study|Physician Decision|1|||
130548572|NCT01222507|469976339|FG000|Overall Study|Withdrawal by Subject|1|||
130548573|NCT02647320|469976340|FG000|Overall Study|Adverse Event|0|||
130548574|NCT02647320|469976341|FG001|Overall Study|Adverse Event|1|||
130548575|NCT02647320|469976342|FG002|Overall Study|Adverse Event|3|||
130548576|NCT02647320|469976343|FG003|Overall Study|Adverse Event|2|||
130548577|NCT02647320|469976344|FG004|Overall Study|Adverse Event|1|||
130548578|NCT02647320|469976340|FG000|Overall Study|Protocol Violation|0|||
130548579|NCT02647320|469976341|FG001|Overall Study|Protocol Violation|0|||
130548580|NCT02647320|469976342|FG002|Overall Study|Protocol Violation|3|||
130548581|NCT02647320|469976343|FG003|Overall Study|Protocol Violation|0|||
130548582|NCT02647320|469976344|FG004|Overall Study|Protocol Violation|0|||
130548583|NCT02647320|469976340|FG000|Overall Study|Withdrawal by Subject|7|||
130548584|NCT02647320|469976341|FG001|Overall Study|Withdrawal by Subject|4|||
130548585|NCT02647320|469976342|FG002|Overall Study|Withdrawal by Subject|2|||
130548586|NCT02647320|469976343|FG003|Overall Study|Withdrawal by Subject|2|||
130548587|NCT02647320|469976344|FG004|Overall Study|Withdrawal by Subject|7|||
130548588|NCT02647320|469976340|FG000|Overall Study|Persistent hyperglycemia|0|||
130548589|NCT02647320|469976341|FG001|Overall Study|Persistent hyperglycemia|1|||
130548590|NCT02647320|469976342|FG002|Overall Study|Persistent hyperglycemia|1|||
130548591|NCT02647320|469976343|FG003|Overall Study|Persistent hyperglycemia|1|||
130548592|NCT02647320|469976344|FG004|Overall Study|Persistent hyperglycemia|1|||
130548593|NCT02647320|469976340|FG000|Overall Study|Study terminated by sponsor|1|||
130548594|NCT02647320|469976341|FG001|Overall Study|Study terminated by sponsor|1|||
130548595|NCT02647320|469976342|FG002|Overall Study|Study terminated by sponsor|1|||
130548596|NCT02647320|469976343|FG003|Overall Study|Study terminated by sponsor|1|||
130548597|NCT02647320|469976344|FG004|Overall Study|Study terminated by sponsor|2|||
130548598|NCT02647320|469976340|FG000|Overall Study|Reason not provided|0|||
130548599|NCT02647320|469976341|FG001|Overall Study|Reason not provided|0|||
130548600|NCT02647320|469976342|FG002|Overall Study|Reason not provided|1|||
130548601|NCT02647320|469976343|FG003|Overall Study|Reason not provided|0|||
130548602|NCT02647320|469976344|FG004|Overall Study|Reason not provided|2|||
130548603|NCT02647320|469976340|FG000|Overall Study|Lost to Follow-up|1|||
130548604|NCT02647320|469976341|FG001|Overall Study|Lost to Follow-up|1|||
130548605|NCT02647320|469976342|FG002|Overall Study|Lost to Follow-up|0|||
130548606|NCT02647320|469976343|FG003|Overall Study|Lost to Follow-up|0|||
130548607|NCT02647320|469976344|FG004|Overall Study|Lost to Follow-up|0|||
130548608|NCT02647320|469976340|FG000|Overall Study|Develop anemia|1|||
130548609|NCT02647320|469976341|FG001|Overall Study|Develop anemia|0|||
130548610|NCT02647320|469976342|FG002|Overall Study|Develop anemia|0|||
130548611|NCT02647320|469976343|FG003|Overall Study|Develop anemia|0|||
130548612|NCT02647320|469976344|FG004|Overall Study|Develop anemia|0|||
130548613|NCT02647320|469976340|FG000|Overall Study|Lack of Efficacy|0|||
130548614|NCT02647320|469976341|FG001|Overall Study|Lack of Efficacy|0|||
130548615|NCT02647320|469976342|FG002|Overall Study|Lack of Efficacy|0|||
130548616|NCT02647320|469976343|FG003|Overall Study|Lack of Efficacy|1|||
130548617|NCT02647320|469976344|FG004|Overall Study|Lack of Efficacy|0|||
130548618|NCT02647320|469976340|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
130548619|NCT02647320|469976341|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
130548620|NCT02647320|469976342|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
130548621|NCT02647320|469976343|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
130548622|NCT02647320|469976344|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
130548623|NCT00596427|469976348|FG000|Overall Study|Withdrawal by Subject|2|||
130548624|NCT00596427|469976349|FG001|Overall Study|Withdrawal by Subject|2|||
130548625|NCT00596427|469976348|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
130548626|NCT00596427|469976349|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
130548627|NCT00596427|469976348|FG000|Overall Study|Protocol Violation|1|||
130548628|NCT00596427|469976349|FG001|Overall Study|Protocol Violation|0|||
130548629|NCT00320541|469976350|FG000|Overall Study|Adverse Event|21|||
130548630|NCT00320541|469976351|FG001|Overall Study|Adverse Event|19|||
130548631|NCT00320541|469976350|FG000|Overall Study|Protocol Violation|0|||
130548632|NCT00320541|469976351|FG001|Overall Study|Protocol Violation|1|||
130548633|NCT00320541|469976350|FG000|Overall Study|Withdrawal by Subject|12|||
130548634|NCT00320541|469976351|FG001|Overall Study|Withdrawal by Subject|16|||
130548635|NCT00320541|469976350|FG000|Overall Study|Physician Decision|9|||
130548636|NCT00320541|469976351|FG001|Overall Study|Physician Decision|13|||
130548637|NCT00320541|469976350|FG000|Overall Study|Other|3|||
130548638|NCT00320541|469976351|FG001|Overall Study|Other|4|||
130548639|NCT00320541|469976350|FG000|Overall Study|Sponsor Decision|2|||
130548640|NCT00320541|469976351|FG001|Overall Study|Sponsor Decision|1|||
130548641|NCT00320541|469976350|FG000|Overall Study|Death due to Study Disease|1|||
130548642|NCT00320541|469976351|FG001|Overall Study|Death due to Study Disease|3|||
130548643|NCT00320541|469976350|FG000|Overall Study|Death due to Adverse Event(s)|1|||
130548644|NCT00320541|469976351|FG001|Overall Study|Death due to Adverse Event(s)|0|||
130548645|NCT00320541|469976350|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
130548646|NCT00320541|469976351|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
130548647|NCT03057977|469976354|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
130548648|NCT03057977|469976355|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
130548649|NCT03057977|469976354|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
130548650|NCT03057977|469976355|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
130548651|NCT03057977|469976354|FG000|Discontinuation From Treatment|Protocol Violation|6|||
130548652|NCT03057977|469976355|FG001|Discontinuation From Treatment|Protocol Violation|5|||
130548653|NCT03057977|469976354|FG000|Discontinuation From Treatment|Not treated|4|||
130548654|NCT03057977|469976355|FG001|Discontinuation From Treatment|Not treated|0|||
130548655|NCT03057977|469976354|FG000|Discontinuation From Treatment|Adverse Event|343|||
130548656|NCT03057977|469976355|FG001|Discontinuation From Treatment|Adverse Event|337|||
130548657|NCT03057977|469976354|FG000|Discontinuation From Treatment|Reason Unknown|0|||
130548658|NCT03057977|469976355|FG001|Discontinuation From Treatment|Reason Unknown|1|||
130548659|NCT03057977|469976354|FG000|Discontinuation From Treatment|Personal Reasons|1|||
130548660|NCT03057977|469976355|FG001|Discontinuation From Treatment|Personal Reasons|1|||
130548661|NCT03057977|469976354|FG000|Discontinuation From Treatment|Unblinded medication|1|||
130548662|NCT03057977|469976355|FG001|Discontinuation From Treatment|Unblinded medication|0|||
130548663|NCT03057977|469976354|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
130548664|NCT03057977|469976355|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
130548665|NCT03057977|469976354|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
130548666|NCT03057977|469976355|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
130548667|NCT03057977|469976354|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
130548668|NCT03057977|469976355|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
130548669|NCT03057977|469976354|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
130548670|NCT03057977|469976355|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
130548671|NCT03057977|469976354|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
130548672|NCT03057977|469976355|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
130548673|NCT03057977|469976354|FG000|Discontinuation From Treatment|Not attending study visit|3|||
130548674|NCT03057977|469976355|FG001|Discontinuation From Treatment|Not attending study visit|10|||
130548675|NCT03057977|469976354|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
130548676|NCT03057977|469976355|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
130548677|NCT03057977|469976354|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
130548678|NCT03057977|469976355|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
130548679|NCT03057977|469976354|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
130548680|NCT03057977|469976355|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
130548681|NCT03057977|469976354|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
130548682|NCT03057977|469976355|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
130548683|NCT03057977|469976354|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
130548684|NCT03057977|469976355|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
130548685|NCT02401867|469976356|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
130548686|NCT02401867|469976356|FG000|Analysis|Cervical assay could not be conducted|9|||
130548687|NCT01650246|469976357|FG000|Overall Study|Adverse Event|23|||
130548688|NCT01650246|469976357|FG000|Overall Study|Protocol Violation|5|||
130548689|NCT01650246|469976357|FG000|Overall Study|Sponsor terminated study|53|||
130548690|NCT01650246|469976357|FG000|Overall Study|Lost to Follow-up|5|||
130548691|NCT01650246|469976357|FG000|Overall Study|Withdrawal by Subject|26|||
130548692|NCT01650246|469976357|FG000|Overall Study|Death|1|||
130548693|NCT01650246|469976357|FG000|Overall Study|Lack of Efficacy|30|||
130548694|NCT00953407|469976358|FG000|Overall Study|Failed inclusion criteria|1|||
130548695|NCT00953407|469976359|FG001|Overall Study|Failed inclusion criteria|1|||
130548696|NCT00953407|469976360|FG002|Overall Study|Failed inclusion criteria|1|||
130548697|NCT00953407|469976361|FG003|Overall Study|Failed inclusion criteria|1|||
130548698|NCT00953407|469976362|FG004|Overall Study|Failed inclusion criteria|1|||
130548699|NCT00953407|469976358|FG000|Overall Study|Lost to Follow-up|0|||
130548700|NCT00953407|469976359|FG001|Overall Study|Lost to Follow-up|0|||
130548701|NCT00953407|469976360|FG002|Overall Study|Lost to Follow-up|0|||
130548702|NCT00953407|469976361|FG003|Overall Study|Lost to Follow-up|1|||
130548703|NCT00953407|469976362|FG004|Overall Study|Lost to Follow-up|0|||
130548704|NCT03435497|469976364|FG000|Overall Study|Lost to Follow-up|1|||
130548705|NCT03435497|469976365|FG001|Overall Study|Lost to Follow-up|0|||
130548706|NCT03435497|469976364|FG000|Overall Study|Death|1|||
130548707|NCT03435497|469976365|FG001|Overall Study|Death|0|||
130548708|NCT03435497|469976364|FG000|Overall Study|Withdrawal by Subject|0|||
130548709|NCT03435497|469976365|FG001|Overall Study|Withdrawal by Subject|4|||
130548710|NCT03435497|469976364|FG000|Overall Study|Wrong survey administered|0|||
130548711|NCT03435497|469976365|FG001|Overall Study|Wrong survey administered|2|||
130548712|NCT02795429|469976366|FG000|Overall Study|Adverse Event|1|||
130548713|NCT02795429|469976367|FG001|Overall Study|Adverse Event|2|||
130548714|NCT02795429|469976368|FG002|Overall Study|Adverse Event|1|||
130548715|NCT02795429|469976369|FG003|Overall Study|Adverse Event|2|||
130548716|NCT02795429|469976370|FG004|Overall Study|Adverse Event|1|||
130548717|NCT02795429|469976366|FG000|Overall Study|Death|1|||
130548718|NCT02795429|469976367|FG001|Overall Study|Death|0|||
130548719|NCT02795429|469976368|FG002|Overall Study|Death|1|||
130548720|NCT02795429|469976369|FG003|Overall Study|Death|2|||
130548721|NCT02795429|469976370|FG004|Overall Study|Death|1|||
130548722|NCT02795429|469976366|FG000|Overall Study|Physician Decision|0|||
130548723|NCT02795429|469976367|FG001|Overall Study|Physician Decision|0|||
130548724|NCT02795429|469976368|FG002|Overall Study|Physician Decision|2|||
130548725|NCT02795429|469976369|FG003|Overall Study|Physician Decision|1|||
130548726|NCT02795429|469976370|FG004|Overall Study|Physician Decision|5|||
130548727|NCT02795429|469976366|FG000|Overall Study|Progressive disease|3|||
130548728|NCT02795429|469976367|FG001|Overall Study|Progressive disease|7|||
130548729|NCT02795429|469976368|FG002|Overall Study|Progressive disease|6|||
130548730|NCT02795429|469976369|FG003|Overall Study|Progressive disease|26|||
130548731|NCT02795429|469976370|FG004|Overall Study|Progressive disease|20|||
130548732|NCT02795429|469976366|FG000|Overall Study|Subject/guardian decision|1|||
130548733|NCT02795429|469976367|FG001|Overall Study|Subject/guardian decision|1|||
130548734|NCT02795429|469976368|FG002|Overall Study|Subject/guardian decision|1|||
130548735|NCT02795429|469976369|FG003|Overall Study|Subject/guardian decision|1|||
130548736|NCT02795429|469976370|FG004|Overall Study|Subject/guardian decision|3|||
130548737|NCT00701779|469976371|FG000|Overall Study|Adverse Event|6|||
130548738|NCT00701779|469976371|FG000|Overall Study|Lost to Follow-up|1|||
130548739|NCT00701779|469976371|FG000|Overall Study|Withdrawal by Subject|2|||
130548740|NCT01640054|469976374|FG000|Overall Study|Study-specific disc criteria|1|||
130548741|NCT01640054|469976374|FG000|Overall Study|Lack of Efficacy|3|||
130548742|NCT01640054|469976374|FG000|Overall Study|Adverse Event|2|||
130548743|NCT05220254|469976376|FG000|Overall Study|Withdrawal by Subject|4|||
130548744|NCT05220254|469976376|FG000|Overall Study|Removed due to ineligibility|1|||
130548745|NCT05220254|469976376|FG000|Overall Study|Lost to Follow-up|7|||
130548746|NCT01557283|469976377|FG000|Overall Study|Lost to Follow-up|7|||
130548747|NCT01557283|469976377|FG000|Overall Study|Non-responder|19|||
130548748|NCT01557283|469976377|FG000|Overall Study|Adverse Event|7|||
130548749|NCT01557283|469976377|FG000|Overall Study|Lack of Efficacy|1|||
130548750|NCT01557283|469976377|FG000|Overall Study|Non-compliance|1|||
130548751|NCT01557283|469976377|FG000|Overall Study|Withdrawal by Subject|1|||
130548752|NCT01557283|469976377|FG000|Overall Study|Participant's weight too high for dose|1|||
130548753|NCT01557283|469976377|FG000|Overall Study|Worsening of psoriasis|1|||
130548754|NCT01557283|469976377|FG000|Overall Study|Other|6|||
130548755|NCT03645057|469976378|FG000|Randomization to Baseline|Lost to Follow-up|1|||
130548756|NCT03645057|469976379|FG001|Randomization to Baseline|Lost to Follow-up|0|||
130548757|NCT03645057|469976380|FG002|Randomization to Baseline|Lost to Follow-up|1|||
130548758|NCT03645057|469976381|FG003|Randomization to Baseline|Lost to Follow-up|0|||
130548759|NCT03645057|469976378|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
130548760|NCT03645057|469976379|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
130548761|NCT03645057|469976380|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
130548762|NCT03645057|469976381|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
130548763|NCT03645057|469976378|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
130548764|NCT03645057|469976379|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
130548765|NCT03645057|469976380|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
130548766|NCT03645057|469976381|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
130548767|NCT03645057|469976378|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
130548768|NCT03645057|469976379|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
130548769|NCT03645057|469976380|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
130548770|NCT03645057|469976381|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
130548771|NCT01873495|469976382|FG000|Overall Study|Withdrawal by Subject|1|||
130548772|NCT01873495|469976382|FG000|Overall Study|Physician Decision|3|||
130548773|NCT01873495|469976382|FG000|Overall Study|Adverse Event|1|||
130548774|NCT01873495|469976382|FG000|Overall Study|Removed for Transplantation|1|||
130548775|NCT01873495|469976382|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
130548776|NCT01206777|469976383|FG000|Overall Study|Death|1|||
130548777|NCT01206777|469976383|FG000|Overall Study|Adverse Event|1|||
130548778|NCT02080221|469976384|FG000|Overall Study|Withdrawal by Subject|1|||
130548779|NCT02080221|469976384|FG000|Overall Study|Clinical Progression of Disease|1|||
130548780|NCT00842985|469976389|FG000|Screening|Did not meet entrance requirements|27|||
130548781|NCT00842985|469976389|FG000|First Intervention|Withdrawal by Subject|3|||
130548782|NCT00842985|469976389|FG000|First Intervention|Protocol Violation|3|||
130548783|NCT00842985|469976389|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
130548784|NCT00842985|469976389|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
130548785|NCT01000636|469976390|FG000|Overall Study|Withdrawal by Subject|1|||
130548786|NCT01000636|469976390|FG000|Overall Study|Adverse Event|1|||
130548787|NCT03451162|469976391|FG000|Overall Study|Lost to Follow-up|1|||
130548788|NCT03451162|469976392|FG001|Overall Study|Lost to Follow-up|0|||
130548789|NCT03451162|469976393|FG002|Overall Study|Lost to Follow-up|0|||
130548790|NCT03451162|469976394|FG003|Overall Study|Lost to Follow-up|0|||
130548791|NCT03451162|469976395|FG004|Overall Study|Lost to Follow-up|0|||
130548792|NCT03451162|469976391|FG000|Overall Study|Physician Decision|0|||
130548793|NCT03451162|469976392|FG001|Overall Study|Physician Decision|1|||
130548794|NCT03451162|469976393|FG002|Overall Study|Physician Decision|0|||
130548795|NCT03451162|469976394|FG003|Overall Study|Physician Decision|0|||
130548796|NCT03451162|469976395|FG004|Overall Study|Physician Decision|0|||
130548797|NCT03451162|469976391|FG000|Overall Study|Withdrawal by Subject|1|||
130548798|NCT03451162|469976392|FG001|Overall Study|Withdrawal by Subject|1|||
130548799|NCT03451162|469976393|FG002|Overall Study|Withdrawal by Subject|0|||
130548800|NCT03451162|469976394|FG003|Overall Study|Withdrawal by Subject|0|||
130548801|NCT03451162|469976395|FG004|Overall Study|Withdrawal by Subject|0|||
130548802|NCT03305731|469976396|FG000|Overall Study|Protocol Violation|1|||
130548803|NCT03658668|469976397|FG000|Overall Study|Time Commitment|1|||
130548804|NCT03658668|469976398|FG001|Overall Study|Time Commitment|1|||
130548805|NCT01127139|469976399|FG000|Overall Study|Adverse Event|40|||
130548806|NCT01127139|469976399|FG000|Overall Study|Incompliance|12|||
130548807|NCT01127139|469976399|FG000|Overall Study|Lack of Efficacy|4|||
130548808|NCT01127139|469976399|FG000|Overall Study|Reason not specified|1|||
130548809|NCT04964414|469976403|FG000|Overall Study|Lost to Follow-up|10|||
130548810|NCT04964414|469976404|FG001|Overall Study|Lost to Follow-up|8|||
130548811|NCT04964414|469976403|FG000|Overall Study|Withdrawal by Subject|1|||
130548812|NCT04964414|469976404|FG001|Overall Study|Withdrawal by Subject|1|||
130548813|NCT01718353|469976405|FG000|Overall Study|Lost to Follow-up|0|||
130548814|NCT01718353|469976406|FG001|Overall Study|Lost to Follow-up|1|||
130548815|NCT01718353|469976405|FG000|Overall Study|Principal Investigator's Decision|10|||
130548816|NCT01718353|469976406|FG001|Overall Study|Principal Investigator's Decision|4|||
130548817|NCT01718353|469976405|FG000|Overall Study|Randomized but not treated|2|||
130548818|NCT01718353|469976406|FG001|Overall Study|Randomized but not treated|0|||
130548819|NCT00455325|469976407|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
130548820|NCT00455325|469976408|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
130548821|NCT00455325|469976409|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
130548822|NCT00455325|469976410|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
130548823|NCT00455325|469976407|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
130548824|NCT00455325|469976408|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
130548825|NCT00455325|469976409|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
130548826|NCT00455325|469976410|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
130548827|NCT00455325|469976407|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
130548828|NCT00455325|469976408|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
130548829|NCT00455325|469976409|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
130548830|NCT00455325|469976410|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
130548831|NCT00455325|469976407|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
130548832|NCT00455325|469976408|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
130548833|NCT00455325|469976409|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
130548834|NCT00455325|469976410|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
130548835|NCT00455325|469976407|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
130548836|NCT00455325|469976408|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
130548837|NCT00455325|469976409|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
130548838|NCT00455325|469976410|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
130548839|NCT00455325|469976407|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
130548840|NCT00455325|469976408|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
130548841|NCT00455325|469976409|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
130548842|NCT00455325|469976410|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
130548843|NCT00455325|469976407|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
130548844|NCT00455325|469976408|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
130548845|NCT00455325|469976409|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
130548846|NCT00455325|469976410|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
130548847|NCT02745392|469976419|FG000|Overall Study|Lost to Follow-up|0|||
130548848|NCT02745392|469976420|FG001|Overall Study|Lost to Follow-up|1|||
130548849|NCT02745392|469976421|FG002|Overall Study|Lost to Follow-up|0|||
130548850|NCT02745392|469976422|FG003|Overall Study|Lost to Follow-up|0|||
130548851|NCT01691768|469976423|FG000|Overall Study|Death|0|||
130548852|NCT01691768|469976424|FG001|Overall Study|Death|2|||
130548853|NCT01691768|469976423|FG000|Overall Study|Lost to Follow-up|4|||
130548854|NCT01691768|469976424|FG001|Overall Study|Lost to Follow-up|3|||
130548855|NCT01691768|469976423|FG000|Overall Study|Withdrawal by Subject|10|||
130548856|NCT01691768|469976424|FG001|Overall Study|Withdrawal by Subject|9|||
130548857|NCT01691768|469976423|FG000|Overall Study|Relocated|0|||
130322489|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
130548858|NCT01691768|469976424|FG001|Overall Study|Relocated|1|||
130322490|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
130548859|NCT01691768|469976423|FG000|Overall Study|Investigator decision|1|||
130548860|NCT01691768|469976424|FG001|Overall Study|Investigator decision|1|||
130548861|NCT01959334|469976425|FG000|Second Dose|Adverse Event|1|||
130548862|NCT01959334|469976426|FG001|Second Dose|Adverse Event|0|||
130548863|NCT01959334|469976425|FG000|Third Dose|Adverse Event|0|||
130548864|NCT01959334|469976426|FG001|Third Dose|Adverse Event|1|||
130548865|NCT00887432|469976427|FG000|Overall Study|Start Excluded Therapy|3|||
130548866|NCT00887432|469976428|FG001|Overall Study|Start Excluded Therapy|0|||
130548867|NCT00887432|469976427|FG000|Overall Study|Did not complete treatment|6|||
130548868|NCT00887432|469976428|FG001|Overall Study|Did not complete treatment|8|||
130548869|NCT00887432|469976427|FG000|Overall Study|Protocol Violation|2|||
130548870|NCT00887432|469976428|FG001|Overall Study|Protocol Violation|3|||
130548871|NCT00887432|469976427|FG000|Overall Study|Withdrawal by Subject|3|||
130548872|NCT00887432|469976428|FG001|Overall Study|Withdrawal by Subject|2|||
130548873|NCT00887432|469976427|FG000|Overall Study|Lost to Follow-up|1|||
130548874|NCT00887432|469976428|FG001|Overall Study|Lost to Follow-up|0|||
130548875|NCT00887432|469976427|FG000|Overall Study|No reason provided|0|||
130548876|NCT00887432|469976428|FG001|Overall Study|No reason provided|1|||
130548877|NCT04781387|469976429|FG000|Overall Study|Withdrawal by Subject|1|||
130548878|NCT04781387|469976430|FG001|Overall Study|Withdrawal by Subject|0|||
130548879|NCT04781387|469976431|FG002|Overall Study|Withdrawal by Subject|1|||
130548880|NCT04781387|469976429|FG000|Overall Study|Lost to Follow-up|1|||
130548881|NCT04781387|469976430|FG001|Overall Study|Lost to Follow-up|0|||
130548882|NCT04781387|469976431|FG002|Overall Study|Lost to Follow-up|0|||
130548883|NCT01636960|469976434|FG000|Induction Phase|Adverse Event|2|||
130548884|NCT01636960|469976434|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
130548885|NCT01636960|469976434|FG000|Maintenance Phase|Adverse Event|3|||
130548886|NCT01636960|469976434|FG000|Maintenance Phase|Progressive disease|1|||
130548887|NCT01209780|469976435|FG000|Overall Study|Adverse Event|0|||
130548888|NCT01209780|469976436|FG001|Overall Study|Adverse Event|1|||
130548889|NCT01209780|469976437|FG002|Overall Study|Adverse Event|0|||
130548890|NCT01209780|469976438|FG003|Overall Study|Adverse Event|0|||
130548891|NCT01209780|469976439|FG004|Overall Study|Adverse Event|0|||
130548892|NCT01209780|469976435|FG000|Overall Study|Withdrawal by Subject|9|||
130548893|NCT01209780|469976436|FG001|Overall Study|Withdrawal by Subject|2|||
130548894|NCT01209780|469976437|FG002|Overall Study|Withdrawal by Subject|1|||
130548895|NCT01209780|469976438|FG003|Overall Study|Withdrawal by Subject|1|||
130548896|NCT01209780|469976439|FG004|Overall Study|Withdrawal by Subject|0|||
130548897|NCT01209780|469976435|FG000|Overall Study|Lost to Follow-up|17|||
130548898|NCT01209780|469976436|FG001|Overall Study|Lost to Follow-up|12|||
130548899|NCT01209780|469976437|FG002|Overall Study|Lost to Follow-up|3|||
130548900|NCT01209780|469976438|FG003|Overall Study|Lost to Follow-up|9|||
130548901|NCT01209780|469976439|FG004|Overall Study|Lost to Follow-up|4|||
130548902|NCT01209780|469976435|FG000|Overall Study|Protocol Violation|0|||
130548903|NCT01209780|469976436|FG001|Overall Study|Protocol Violation|1|||
130548904|NCT01209780|469976437|FG002|Overall Study|Protocol Violation|0|||
130548905|NCT01209780|469976438|FG003|Overall Study|Protocol Violation|0|||
130548906|NCT01209780|469976439|FG004|Overall Study|Protocol Violation|0|||
130548907|NCT01209780|469976435|FG000|Overall Study|Inappropriate enrollment|0|||
130548908|NCT01209780|469976436|FG001|Overall Study|Inappropriate enrollment|2|||
130548909|NCT01209780|469976437|FG002|Overall Study|Inappropriate enrollment|0|||
130548910|NCT01209780|469976438|FG003|Overall Study|Inappropriate enrollment|0|||
130548911|NCT01209780|469976439|FG004|Overall Study|Inappropriate enrollment|1|||
130548912|NCT00505284|469976445|FG000|Overall Study|Adverse Event|3|||
130548913|NCT00505284|469976446|FG001|Overall Study|Adverse Event|7|||
130548914|NCT00505284|469976447|FG002|Overall Study|Adverse Event|9|||
130548915|NCT00505284|469976448|FG003|Overall Study|Adverse Event|14|||
130548916|NCT00505284|469976449|FG004|Overall Study|Adverse Event|22|||
130548917|NCT00505284|469976445|FG000|Overall Study|Protocol Violation|0|||
130548918|NCT00505284|469976446|FG001|Overall Study|Protocol Violation|1|||
130548919|NCT00505284|469976447|FG002|Overall Study|Protocol Violation|1|||
130548920|NCT00505284|469976448|FG003|Overall Study|Protocol Violation|0|||
130548921|NCT00505284|469976449|FG004|Overall Study|Protocol Violation|0|||
130548922|NCT00505284|469976445|FG000|Overall Study|Withdrawal by Subject|2|||
130548923|NCT00505284|469976446|FG001|Overall Study|Withdrawal by Subject|6|||
130548924|NCT00505284|469976447|FG002|Overall Study|Withdrawal by Subject|1|||
130548925|NCT00505284|469976448|FG003|Overall Study|Withdrawal by Subject|0|||
130548926|NCT00505284|469976449|FG004|Overall Study|Withdrawal by Subject|6|||
130548927|NCT00505284|469976445|FG000|Overall Study|Lack of Efficacy|0|||
130548928|NCT00505284|469976446|FG001|Overall Study|Lack of Efficacy|1|||
130548929|NCT00505284|469976447|FG002|Overall Study|Lack of Efficacy|1|||
130548930|NCT00505284|469976448|FG003|Overall Study|Lack of Efficacy|1|||
130548931|NCT00505284|469976449|FG004|Overall Study|Lack of Efficacy|1|||
130548932|NCT00505284|469976445|FG000|Overall Study|Physician Decision|0|||
130548933|NCT00505284|469976446|FG001|Overall Study|Physician Decision|1|||
130548934|NCT00505284|469976447|FG002|Overall Study|Physician Decision|0|||
130548935|NCT00505284|469976448|FG003|Overall Study|Physician Decision|0|||
130548936|NCT00505284|469976449|FG004|Overall Study|Physician Decision|0|||
130548937|NCT00505284|469976445|FG000|Overall Study|Other|5|||
130548938|NCT00505284|469976446|FG001|Overall Study|Other|0|||
130548939|NCT00505284|469976447|FG002|Overall Study|Other|0|||
130548940|NCT00505284|469976448|FG003|Overall Study|Other|4|||
130548941|NCT00505284|469976449|FG004|Overall Study|Other|4|||
130548942|NCT01275131|469976450|FG000|Period 1|Withdrawal by Subject|1|||
130548943|NCT01275131|469976451|FG001|Period 1|Withdrawal by Subject|0|||
130548944|NCT01275131|469976452|FG002|Period 1|Withdrawal by Subject|3|||
130548945|NCT01275131|469976453|FG003|Period 1|Withdrawal by Subject|2|||
130322491|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
130322492|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
130322493|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
130322494|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
130322495|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
130322496|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Reason missing|2|||
130322497|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Reason missing|0|||
130322498|NCT02220920|469151295|FG000|Overall Study|Adverse Event|1|||
130322499|NCT02220920|469151296|FG001|Overall Study|Adverse Event|0|||
130322500|NCT02220920|469151295|FG000|Overall Study|Lack of Efficacy|0|||
130548946|NCT01275131|469976450|FG000|Period 1|Physician Decision|1|||
130322501|NCT02220920|469151296|FG001|Overall Study|Lack of Efficacy|1|||
130322502|NCT02220920|469151295|FG000|Overall Study|Withdrawal by Subject|1|||
130322503|NCT02220920|469151296|FG001|Overall Study|Withdrawal by Subject|0|||
130322504|NCT02220920|469151295|FG000|Overall Study|Conflict with the stopping criteria|1|||
130322505|NCT02220920|469151296|FG001|Overall Study|Conflict with the stopping criteria|2|||
130322506|NCT01112917|469151297|FG000|Overall Study|Death|2|||
130322507|NCT01112917|469151298|FG001|Overall Study|Death|11|||
130322508|NCT01112917|469151297|FG000|Overall Study|Lost to Follow-up|1|||
130322509|NCT01112917|469151298|FG001|Overall Study|Lost to Follow-up|1|||
130322510|NCT01112917|469151297|FG000|Overall Study|Withdrawal by Subject|1|||
130322511|NCT01112917|469151298|FG001|Overall Study|Withdrawal by Subject|3|||
130322512|NCT01112917|469151297|FG000|Overall Study|Unable to Convert Filter|3|||
130322513|NCT01112917|469151298|FG001|Overall Study|Unable to Convert Filter|0|||
130322514|NCT02177123|469151299|FG000|Overall Study|Lost to Follow-up|6|||
130322515|NCT02177123|469151299|FG000|Overall Study|Withdrawal by Subject|4|||
130322516|NCT02177123|469151299|FG000|Overall Study|Adverse Event|4|||
130322517|NCT02177123|469151299|FG000|Overall Study|Physician Decision|3|||
130322518|NCT02177123|469151299|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
130322519|NCT02177123|469151299|FG000|Overall Study|Excluded for medical reasons|2|||
130322520|NCT02177123|469151299|FG000|Overall Study|Death|1|||
130322521|NCT02177123|469151299|FG000|Overall Study|Other|1|||
130322522|NCT02177123|469151299|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
130322523|NCT06271993|469151306|FG000|Overall Study|Not reactive to histamine|5|||
130322524|NCT06271993|469151307|FG001|Overall Study|Not reactive to histamine|5|||
130322525|NCT06271993|469151308|FG002|Overall Study|Not reactive to histamine|5|||
130322526|NCT03103542|469151309|FG000|Overall Study|Physician Decision|2|||
130322527|NCT03103542|469151309|FG000|Overall Study|Adverse Event|2|||
130322528|NCT03103542|469151309|FG000|Overall Study|Other|2|||
130322529|NCT03103542|469151309|FG000|Overall Study|Withdrawal by Subject|1|||
130322530|NCT03566511|469151310|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
130322531|NCT03566511|469151311|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
130322532|NCT02939287|469151317|FG000|Overall Study|met exclusion criteria|1|||
130322533|NCT02939287|469151318|FG001|Overall Study|met exclusion criteria|1|||
130322534|NCT02939287|469151319|FG002|Overall Study|met exclusion criteria|1|||
130322535|NCT02939287|469151317|FG000|Overall Study|Did not complete survey|2|||
130322536|NCT02939287|469151318|FG001|Overall Study|Did not complete survey|2|||
130322537|NCT02939287|469151319|FG002|Overall Study|Did not complete survey|0|||
130322538|NCT02939287|469151317|FG000|Overall Study|Withdrawal by Subject|1|||
130322539|NCT02939287|469151318|FG001|Overall Study|Withdrawal by Subject|1|||
130322540|NCT02939287|469151319|FG002|Overall Study|Withdrawal by Subject|0|||
130322541|NCT00981656|469151320|FG000|Overall Study|Protocol Violation|1|||
130322542|NCT00981656|469151320|FG000|Overall Study|Did not start protocol treatment|2|||
130322543|NCT00687596|469151321|FG000|Overall Study|Adverse Event (AE)|10|||
130322544|NCT00687596|469151322|FG001|Overall Study|Adverse Event (AE)|3|||
130322545|NCT00687596|469151321|FG000|Overall Study|Radiological Disease Progression|6|||
130548947|NCT01275131|469976451|FG001|Period 1|Physician Decision|0|||
130548948|NCT01275131|469976452|FG002|Period 1|Physician Decision|0|||
130548949|NCT01275131|469976453|FG003|Period 1|Physician Decision|0|||
130548950|NCT01275131|469976450|FG000|Period 2 (Crossover)|Adverse Event|0|||
130548951|NCT01275131|469976451|FG001|Period 2 (Crossover)|Adverse Event|1|||
130548952|NCT01275131|469976452|FG002|Period 2 (Crossover)|Adverse Event|0|||
130548953|NCT01275131|469976453|FG003|Period 2 (Crossover)|Adverse Event|0|||
130548954|NCT01275131|469976450|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
130548955|NCT01275131|469976451|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
130548956|NCT01275131|469976452|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
130548957|NCT01275131|469976453|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
130322546|NCT00687596|469151322|FG001|Overall Study|Radiological Disease Progression|2|||
130322547|NCT00687596|469151321|FG000|Overall Study|Clinical Disease Progression|1|||
130548958|NCT00731120|469976454|FG000|Overall Study|Adverse Event|7|||
130322548|NCT00687596|469151322|FG001|Overall Study|Clinical Disease Progression|3|||
130322549|NCT00687596|469151321|FG000|Overall Study|Investigator Discretion|3|||
130322550|NCT00687596|469151322|FG001|Overall Study|Investigator Discretion|1|||
130548959|NCT00731120|469976455|FG001|Overall Study|Adverse Event|6|||
130548960|NCT00731120|469976456|FG002|Overall Study|Adverse Event|8|||
130548961|NCT00731120|469976454|FG000|Overall Study|Lack of Efficacy|4|||
130548962|NCT00731120|469976455|FG001|Overall Study|Lack of Efficacy|5|||
130548963|NCT00731120|469976456|FG002|Overall Study|Lack of Efficacy|4|||
130548964|NCT00731120|469976454|FG000|Overall Study|Noncompliance with Study Drug|3|||
130548965|NCT00731120|469976455|FG001|Overall Study|Noncompliance with Study Drug|3|||
130548966|NCT00731120|469976456|FG002|Overall Study|Noncompliance with Study Drug|1|||
130548967|NCT00731120|469976454|FG000|Overall Study|Protocol Deviations|1|||
130548968|NCT00731120|469976455|FG001|Overall Study|Protocol Deviations|6|||
130548969|NCT00731120|469976456|FG002|Overall Study|Protocol Deviations|1|||
130548970|NCT00731120|469976454|FG000|Overall Study|Withdrawal of Consent|13|||
130548971|NCT00731120|469976455|FG001|Overall Study|Withdrawal of Consent|8|||
130548972|NCT00731120|469976456|FG002|Overall Study|Withdrawal of Consent|4|||
130548973|NCT00731120|469976454|FG000|Overall Study|Lost to Follow-up|10|||
130548974|NCT00731120|469976455|FG001|Overall Study|Lost to Follow-up|15|||
130548975|NCT00731120|469976456|FG002|Overall Study|Lost to Follow-up|17|||
130548976|NCT00731120|469976454|FG000|Overall Study|Other|4|||
130548977|NCT00731120|469976455|FG001|Overall Study|Other|0|||
130548978|NCT00731120|469976456|FG002|Overall Study|Other|1|||
130548979|NCT02434939|469976460|FG000|Overall Study|Lack of Efficacy|34|||
130548980|NCT02434939|469976461|FG001|Overall Study|Lack of Efficacy|48|||
130548981|NCT02434939|469976460|FG000|Overall Study|Withdrawal by Subject|3|||
130548982|NCT02434939|469976461|FG001|Overall Study|Withdrawal by Subject|0|||
130548983|NCT02434939|469976460|FG000|Overall Study|Adverse Event|0|||
130548984|NCT02434939|469976461|FG001|Overall Study|Adverse Event|1|||
130548985|NCT00069238|469976464|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
130548986|NCT00069238|469976465|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
130548987|NCT00069238|469976466|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
130548988|NCT00069238|469976464|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
130548989|NCT00069238|469976465|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
130548990|NCT00069238|469976466|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
130548991|NCT00069238|469976464|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
130548992|NCT00069238|469976465|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
130548993|NCT00069238|469976466|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
130548994|NCT01001832|469976467|FG000|Short-term Period|Adverse Event|2|||
130548995|NCT01001832|469976468|FG001|Short-term Period|Adverse Event|3|||
130548996|NCT01001832|469976467|FG000|Long-term Period|Adverse Event|2|||
130548997|NCT01001832|469976468|FG001|Long-term Period|Adverse Event|1|||
130548998|NCT01001832|469976467|FG000|Long-term Period|Withdrawal by Subject|1|||
130548999|NCT01001832|469976468|FG001|Long-term Period|Withdrawal by Subject|0|||
130549000|NCT01001832|469976467|FG000|Long-term Period|Lack of Efficacy|0|||
130549001|NCT01001832|469976468|FG001|Long-term Period|Lack of Efficacy|2|||
130549002|NCT01001832|469976467|FG000|Long-term Period|Other|1|||
130549003|NCT01001832|469976468|FG001|Long-term Period|Other|2|||
130549004|NCT01001832|469976467|FG000|Follow-up Period|Withdrawal by Subject|1|||
130549005|NCT01001832|469976468|FG001|Follow-up Period|Withdrawal by Subject|0|||
130549006|NCT01001832|469976467|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
130549007|NCT01001832|469976468|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
130549008|NCT01001832|469976467|FG000|Follow-up Period|Other|2|||
130549009|NCT01001832|469976468|FG001|Follow-up Period|Other|1|||
130549010|NCT01575028|469976475|FG000|Overall Study|Physician Decision|0|||
130549011|NCT01575028|469976476|FG001|Overall Study|Physician Decision|1|||
130549012|NCT01328717|469977664|FG000|Overall Study|Adverse Event|1|||
130549013|NCT03440320|469977665|FG000|Overall Study|Withdrawal by Subject|0|||
130549014|NCT03440320|469977666|FG001|Overall Study|Withdrawal by Subject|1|||
130549015|NCT01912456|469977667|FG000|Period 1|Physician Decision|0|||
130549016|NCT01912456|469977668|FG001|Period 1|Physician Decision|0|||
130549017|NCT01912456|469977669|FG002|Period 1|Physician Decision|1|||
130549018|NCT01912456|469977670|FG003|Period 1|Physician Decision|0|||
130549019|NCT01912456|469977667|FG000|Period 1|non-compliance|1|||
130549020|NCT01912456|469977668|FG001|Period 1|non-compliance|0|||
130549021|NCT01912456|469977669|FG002|Period 1|non-compliance|0|||
130549022|NCT01912456|469977670|FG003|Period 1|non-compliance|1|||
130549023|NCT01912456|469977667|FG000|Period 1|Adverse Event|1|||
130549024|NCT01912456|469977668|FG001|Period 1|Adverse Event|0|||
130549025|NCT01912456|469977669|FG002|Period 1|Adverse Event|0|||
130549026|NCT01912456|469977670|FG003|Period 1|Adverse Event|1|||
130549027|NCT01912456|469977667|FG000|Period 1|Withdrawal by Subject|0|||
130549028|NCT01912456|469977668|FG001|Period 1|Withdrawal by Subject|1|||
130549029|NCT01912456|469977669|FG002|Period 1|Withdrawal by Subject|1|||
130549030|NCT01912456|469977670|FG003|Period 1|Withdrawal by Subject|1|||
130549031|NCT01912456|469977667|FG000|Period 2|Lack of Efficacy|0|||
130549032|NCT01912456|469977668|FG001|Period 2|Lack of Efficacy|2|||
130549033|NCT01912456|469977669|FG002|Period 2|Lack of Efficacy|0|||
130322551|NCT00687596|469151321|FG000|Overall Study|Sponsor Terminated Study|6|||
130549034|NCT01912456|469977670|FG003|Period 2|Lack of Efficacy|0|||
130549035|NCT01912456|469977667|FG000|Period 2|Adverse Event|0|||
130549036|NCT01912456|469977668|FG001|Period 2|Adverse Event|0|||
130549037|NCT01912456|469977669|FG002|Period 2|Adverse Event|0|||
130549038|NCT01912456|469977670|FG003|Period 2|Adverse Event|1|||
130549039|NCT01201343|469977671|FG000|Overall Study|Adverse Event|6|||
130549040|NCT01201343|469977671|FG000|Overall Study|Withdrawal by Subject|5|||
130549041|NCT01201343|469977671|FG000|Overall Study|Lost to Follow-up|2|||
130549042|NCT01201343|469977671|FG000|Overall Study|Lack of Efficacy|2|||
130549043|NCT01201343|469977671|FG000|Overall Study|Participant wrongly included in trial|1|||
130549044|NCT01201343|469977671|FG000|Overall Study|Randomized, not treated|3|||
130549045|NCT00001962|469977674|FG000|Overall Study|Lack of Efficacy|18|||
130549046|NCT00001962|469977674|FG000|Overall Study|Lack of Accrual|6|||
130322552|NCT00687596|469151322|FG001|Overall Study|Sponsor Terminated Study|17|||
130322553|NCT03406780|469151323|FG000|Overall Study|Withdrawal by Subject|1|||
130322554|NCT03406780|469151324|FG001|Overall Study|Withdrawal by Subject|1|||
130322555|NCT03406780|469151323|FG000|Overall Study|Other|0|||
130322556|NCT03406780|469151324|FG001|Overall Study|Other|2|||
130322557|NCT03466658|469151327|FG000|Overall Study|Withdrawal by Subject|3|||
130322558|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322559|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322560|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322561|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322562|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322563|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322564|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322565|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322566|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322567|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322568|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322569|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322570|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
130322571|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322572|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322573|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322574|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322575|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
130322576|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322577|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322578|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322579|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322580|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322581|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130322582|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322583|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130322584|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322585|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322586|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322587|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322588|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
130322589|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322590|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322591|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322592|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322593|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322594|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322595|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
130322596|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130549047|NCT00001962|469977674|FG000|Overall Study|Death|1|||
130549048|NCT00001962|469977674|FG000|Overall Study|Lost to Follow-up|2|||
130549049|NCT00001962|469977674|FG000|Overall Study|Adverse Event|1|||
130549050|NCT01440374|469977675|FG000|Part 1: Open-label Phase|Adverse Event|5|||
130549051|NCT01440374|469977676|FG001|Part 1: Open-label Phase|Adverse Event|0|||
130549052|NCT01440374|469977677|FG002|Part 1: Open-label Phase|Adverse Event|0|||
130549053|NCT01440374|469977678|FG003|Part 1: Open-label Phase|Adverse Event|0|||
130549054|NCT01440374|469977675|FG000|Part 1: Open-label Phase|Physician Decision|1|||
130549055|NCT01440374|469977676|FG001|Part 1: Open-label Phase|Physician Decision|0|||
130549056|NCT01440374|469977677|FG002|Part 1: Open-label Phase|Physician Decision|0|||
130549057|NCT01440374|469977678|FG003|Part 1: Open-label Phase|Physician Decision|0|||
130549058|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
130549059|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
130549060|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
130549061|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
130549062|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
130549063|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
130549064|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
130549065|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
130549066|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
130549067|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
130549068|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
130549069|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
130549070|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
130549071|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
130549072|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
130549073|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
130549074|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
130549075|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
130549076|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
130549077|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
130549078|NCT01440374|469977675|FG000|Part 2; Double-blind Phase|Not treated|0|||
130549079|NCT01440374|469977676|FG001|Part 2; Double-blind Phase|Not treated|0|||
130549080|NCT01440374|469977677|FG002|Part 2; Double-blind Phase|Not treated|1|||
130549081|NCT01440374|469977678|FG003|Part 2; Double-blind Phase|Not treated|0|||
130549082|NCT01440374|469977675|FG000|Part 3: Extension|Withdrawal by Subject|0|||
130549083|NCT01440374|469977676|FG001|Part 3: Extension|Withdrawal by Subject|0|||
130549084|NCT01440374|469977677|FG002|Part 3: Extension|Withdrawal by Subject|0|||
130549085|NCT01440374|469977678|FG003|Part 3: Extension|Withdrawal by Subject|5|||
130549086|NCT01440374|469977675|FG000|Part 3: Extension|Adverse Event|0|||
130549087|NCT01440374|469977676|FG001|Part 3: Extension|Adverse Event|0|||
130549088|NCT01440374|469977677|FG002|Part 3: Extension|Adverse Event|0|||
130549089|NCT01440374|469977678|FG003|Part 3: Extension|Adverse Event|13|||
130549090|NCT01440374|469977675|FG000|Part 3: Extension|Physician Decision|0|||
130549091|NCT01440374|469977676|FG001|Part 3: Extension|Physician Decision|0|||
130549092|NCT01440374|469977677|FG002|Part 3: Extension|Physician Decision|0|||
130549093|NCT01440374|469977678|FG003|Part 3: Extension|Physician Decision|14|||
130549094|NCT01177722|469977687|FG000|Overall Study|Serious Adverse Event|0|||
130549095|NCT01177722|469977688|FG001|Overall Study|Serious Adverse Event|0|||
130549096|NCT01177722|469977689|FG002|Overall Study|Serious Adverse Event|1|||
130549097|NCT01177722|469977690|FG003|Overall Study|Serious Adverse Event|0|||
130549098|NCT01177722|469977687|FG000|Overall Study|Protocol Violation|0|||
130549099|NCT01177722|469977688|FG001|Overall Study|Protocol Violation|0|||
130549100|NCT01177722|469977689|FG002|Overall Study|Protocol Violation|1|||
130549101|NCT01177722|469977690|FG003|Overall Study|Protocol Violation|0|||
130549102|NCT01177722|469977687|FG000|Overall Study|Lost to Follow-up|3|||
130549103|NCT01177722|469977688|FG001|Overall Study|Lost to Follow-up|4|||
130549104|NCT01177722|469977689|FG002|Overall Study|Lost to Follow-up|3|||
130549105|NCT01177722|469977690|FG003|Overall Study|Lost to Follow-up|1|||
130549106|NCT01177722|469977687|FG000|Overall Study|Withdrawal by Subject|10|||
130549107|NCT01177722|469977688|FG001|Overall Study|Withdrawal by Subject|6|||
130549108|NCT01177722|469977689|FG002|Overall Study|Withdrawal by Subject|4|||
130549109|NCT01177722|469977690|FG003|Overall Study|Withdrawal by Subject|6|||
130549110|NCT03442985|469977695|FG000|Overall Study|Sponsor Request|55|||
130549111|NCT03442985|469977696|FG001|Overall Study|Sponsor Request|60|||
130549112|NCT03442985|469977697|FG002|Overall Study|Sponsor Request|54|||
130549113|NCT03442985|469977695|FG000|Overall Study|Lost to Follow-up|5|||
130549114|NCT03442985|469977696|FG001|Overall Study|Lost to Follow-up|2|||
130549115|NCT03442985|469977697|FG002|Overall Study|Lost to Follow-up|7|||
130549116|NCT03442985|469977695|FG000|Overall Study|Withdrawal by Subject|2|||
130549117|NCT03442985|469977696|FG001|Overall Study|Withdrawal by Subject|3|||
130549118|NCT03442985|469977697|FG002|Overall Study|Withdrawal by Subject|4|||
130549119|NCT03442985|469977695|FG000|Overall Study|Adverse Event|0|||
130549120|NCT03442985|469977696|FG001|Overall Study|Adverse Event|1|||
130549121|NCT03442985|469977697|FG002|Overall Study|Adverse Event|0|||
130549122|NCT01716117|469977698|FG000|Overall Study|Death|5|||
130549123|NCT01716117|469977699|FG001|Overall Study|Death|2|||
130549124|NCT01716117|469977698|FG000|Overall Study|Withdrawal by Subject|2|||
130549125|NCT01716117|469977699|FG001|Overall Study|Withdrawal by Subject|0|||
130549126|NCT01386788|469977703|FG000|Overall Study|Lost to Follow-up|2|||
130549127|NCT02986334|469977704|FG000|Overall Study|Withdrawal by Subject|0|||
130549128|NCT02986334|469977705|FG001|Overall Study|Withdrawal by Subject|1|||
130549129|NCT02986334|469977706|FG002|Overall Study|Withdrawal by Subject|2|||
130549130|NCT02986334|469977704|FG000|Overall Study|Lost to Follow-up|1|||
130549131|NCT02986334|469977705|FG001|Overall Study|Lost to Follow-up|2|||
130549132|NCT02986334|469977706|FG002|Overall Study|Lost to Follow-up|1|||
130549133|NCT02986334|469977704|FG000|Overall Study|Adverse Event|0|||
130549134|NCT02986334|469977705|FG001|Overall Study|Adverse Event|2|||
130549135|NCT02986334|469977706|FG002|Overall Study|Adverse Event|1|||
130549136|NCT02986334|469977704|FG000|Overall Study|non compliance in phone ratings|2|||
130549137|NCT02986334|469977705|FG001|Overall Study|non compliance in phone ratings|1|||
130549138|NCT02986334|469977706|FG002|Overall Study|non compliance in phone ratings|2|||
130549139|NCT02986334|469977704|FG000|Overall Study|undisclosed comorbidities|0|||
130549140|NCT02986334|469977705|FG001|Overall Study|undisclosed comorbidities|1|||
130549141|NCT02986334|469977706|FG002|Overall Study|undisclosed comorbidities|1|||
130549142|NCT00120406|469977707|FG000|Overall Study|Death|9|||
130549143|NCT00120406|469977708|FG001|Overall Study|Death|4|||
130549144|NCT00120406|469977707|FG000|Overall Study|Withdrawal by Subject|5|||
130549145|NCT00120406|469977708|FG001|Overall Study|Withdrawal by Subject|7|||
130549146|NCT00120406|469977707|FG000|Overall Study|Lost to Follow-up|5|||
130549147|NCT00120406|469977708|FG001|Overall Study|Lost to Follow-up|2|||
130549148|NCT00120406|469977707|FG000|Overall Study|received non-study stent|0|||
130549149|NCT00120406|469977708|FG001|Overall Study|received non-study stent|2|||
130549150|NCT00120406|469977707|FG000|Overall Study|patient moved but has not withdrawn|0|||
130549151|NCT00120406|469977708|FG001|Overall Study|patient moved but has not withdrawn|1|||
130549152|NCT01295034|469977709|FG000|Overall Study|Lost to Follow-up|5|||
130549153|NCT01295034|469977710|FG001|Overall Study|Lost to Follow-up|5|||
130549154|NCT01313637|469977716|FG000|Overall Study|Adverse Event|17|||
130549155|NCT01313637|469977717|FG001|Overall Study|Adverse Event|24|||
130549156|NCT01313637|469977718|FG002|Overall Study|Adverse Event|25|||
130549157|NCT01313637|469977719|FG003|Overall Study|Adverse Event|18|||
130549158|NCT01313637|469977716|FG000|Overall Study|Lack of Efficacy|44|||
130549159|NCT01313637|469977717|FG001|Overall Study|Lack of Efficacy|38|||
130549160|NCT01313637|469977718|FG002|Overall Study|Lack of Efficacy|37|||
130549161|NCT01313637|469977719|FG003|Overall Study|Lack of Efficacy|24|||
130549162|NCT01313637|469977716|FG000|Overall Study|Protocol Violation|4|||
130549163|NCT01313637|469977717|FG001|Overall Study|Protocol Violation|3|||
130549164|NCT01313637|469977718|FG002|Overall Study|Protocol Violation|11|||
130549165|NCT01313637|469977719|FG003|Overall Study|Protocol Violation|5|||
130549166|NCT01313637|469977716|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
130549167|NCT01313637|469977717|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
130549168|NCT01313637|469977718|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
130549169|NCT01313637|469977719|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
130549170|NCT01313637|469977716|FG000|Overall Study|Lost to Follow-up|0|||
130549171|NCT01313637|469977717|FG001|Overall Study|Lost to Follow-up|2|||
130549172|NCT01313637|469977718|FG002|Overall Study|Lost to Follow-up|1|||
130549173|NCT01313637|469977719|FG003|Overall Study|Lost to Follow-up|3|||
130549174|NCT01313637|469977716|FG000|Overall Study|Withdrawal by Subject|11|||
130549175|NCT01313637|469977717|FG001|Overall Study|Withdrawal by Subject|13|||
130549176|NCT01313637|469977718|FG002|Overall Study|Withdrawal by Subject|18|||
130549177|NCT01313637|469977719|FG003|Overall Study|Withdrawal by Subject|15|||
130549178|NCT04218084|469977721|FG000|Overall Study|Adverse Event|7|||
130549179|NCT04218084|469977722|FG001|Overall Study|Adverse Event|2|||
130549180|NCT04218084|469977721|FG000|Overall Study|Withdrawal of Consent|4|||
130549181|NCT04218084|469977722|FG001|Overall Study|Withdrawal of Consent|5|||
130549182|NCT04218084|469977721|FG000|Overall Study|Physician Decision|1|||
130549183|NCT04218084|469977722|FG001|Overall Study|Physician Decision|1|||
130549184|NCT04218084|469977721|FG000|Overall Study|Lost to Follow-up|1|||
130549185|NCT04218084|469977722|FG001|Overall Study|Lost to Follow-up|1|||
130549186|NCT04218084|469977721|FG000|Overall Study|Non-compliance with study drug|1|||
130549187|NCT04218084|469977722|FG001|Overall Study|Non-compliance with study drug|1|||
130549188|NCT04218084|469977721|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
130549189|NCT04218084|469977722|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
130549190|NCT04218084|469977721|FG000|Overall Study|Other|0|||
130549191|NCT04218084|469977722|FG001|Overall Study|Other|1|||
130549192|NCT04218084|469977721|FG000|Overall Study|Ongoing at data cut-off date|62|||
130549193|NCT04218084|469977722|FG001|Overall Study|Ongoing at data cut-off date|58|||
130549194|NCT05580588|469977723|FG000|Overall Study|Lack of Efficacy|12|||
130549195|NCT00211185|469977726|FG000|Overall Study|Death|2|||
130549196|NCT00211185|469977726|FG000|Overall Study|Disease progression|7|||
130549197|NCT00211185|469977726|FG000|Overall Study|Withdrawal by Subject|6|||
130549198|NCT00211185|469977726|FG000|Overall Study|Physician Decision|5|||
130549199|NCT00712673|469977727|FG000|Overall Study|Adverse Event|3|||
130549200|NCT00712673|469977728|FG001|Overall Study|Adverse Event|3|||
130549201|NCT00712673|469977729|FG002|Overall Study|Adverse Event|21|||
130549202|NCT00712673|469977730|FG003|Overall Study|Adverse Event|26|||
130549203|NCT00712673|469977727|FG000|Overall Study|Lack of Efficacy|2|||
130549204|NCT00712673|469977728|FG001|Overall Study|Lack of Efficacy|8|||
130549205|NCT00712673|469977729|FG002|Overall Study|Lack of Efficacy|8|||
130549206|NCT00712673|469977730|FG003|Overall Study|Lack of Efficacy|6|||
130549207|NCT00712673|469977727|FG000|Overall Study|Poor Compliance to Protocol|3|||
130549208|NCT00712673|469977728|FG001|Overall Study|Poor Compliance to Protocol|3|||
130549209|NCT00712673|469977729|FG002|Overall Study|Poor Compliance to Protocol|4|||
130549210|NCT00712673|469977730|FG003|Overall Study|Poor Compliance to Protocol|16|||
130549211|NCT00712673|469977727|FG000|Overall Study|Lost to Follow-up|1|||
130549212|NCT00712673|469977728|FG001|Overall Study|Lost to Follow-up|0|||
130549213|NCT00712673|469977729|FG002|Overall Study|Lost to Follow-up|2|||
130549214|NCT00712673|469977730|FG003|Overall Study|Lost to Follow-up|0|||
130549215|NCT00712673|469977727|FG000|Overall Study|Withdrawal by Subject|6|||
130549216|NCT00712673|469977728|FG001|Overall Study|Withdrawal by Subject|7|||
130549217|NCT00712673|469977729|FG002|Overall Study|Withdrawal by Subject|15|||
130549218|NCT00712673|469977730|FG003|Overall Study|Withdrawal by Subject|20|||
130549219|NCT00712673|469977727|FG000|Overall Study|Familial and Personal Reasons|5|||
130549220|NCT00712673|469977728|FG001|Overall Study|Familial and Personal Reasons|0|||
130549221|NCT00712673|469977729|FG002|Overall Study|Familial and Personal Reasons|5|||
130549222|NCT00712673|469977730|FG003|Overall Study|Familial and Personal Reasons|2|||
130549223|NCT00712673|469977727|FG000|Overall Study|Investigator's Decision|1|||
130549224|NCT00712673|469977728|FG001|Overall Study|Investigator's Decision|0|||
130549225|NCT00712673|469977729|FG002|Overall Study|Investigator's Decision|0|||
130549226|NCT00712673|469977730|FG003|Overall Study|Investigator's Decision|0|||
130549227|NCT00712673|469977727|FG000|Overall Study|Protocol Violation|0|||
130549228|NCT00712673|469977728|FG001|Overall Study|Protocol Violation|0|||
130549229|NCT00712673|469977729|FG002|Overall Study|Protocol Violation|2|||
130549230|NCT00712673|469977730|FG003|Overall Study|Protocol Violation|0|||
130549231|NCT03603028|469977731|FG000|Overall Study|Withdrawal by Subject|1|||
130549232|NCT01768117|469977736|FG000|Overall Study|Lost to Follow-up|1|||
130549233|NCT01768117|469977736|FG000|Overall Study|Withdrawal by Subject|2|||
130549234|NCT01768117|469977736|FG000|Overall Study|Protocol Violation|3|||
130549235|NCT01580969|469977739|FG000|Overall Study|Physician Decision|3|||
130549236|NCT01580969|469977740|FG001|Overall Study|Physician Decision|0|||
130549237|NCT01580969|469977741|FG002|Overall Study|Physician Decision|0|||
130549238|NCT02076178|469977747|FG000|Oral Phase|Adverse Event|0|||
130549239|NCT02076178|469977748|FG001|Oral Phase|Adverse Event|7|||
130549240|NCT02076178|469977747|FG000|Oral Phase|Withdrawal by Subject|0|||
130549241|NCT02076178|469977748|FG001|Oral Phase|Withdrawal by Subject|4|||
130549242|NCT02076178|469977747|FG000|Oral Phase|Physician Decision|0|||
130549243|NCT02076178|469977748|FG001|Oral Phase|Physician Decision|1|||
130549244|NCT02076178|469977747|FG000|Injection Phase|Protocol defined stopping criteria|1|||
130549245|NCT02076178|469977748|FG001|Injection Phase|Protocol defined stopping criteria|0|||
130549246|NCT02076178|469977747|FG000|Injection Phase|Withdrawal by Subject|0|||
130549247|NCT02076178|469977748|FG001|Injection Phase|Withdrawal by Subject|3|||
130549248|NCT02076178|469977747|FG000|Injection Phase|Physician Decision|0|||
130549249|NCT02076178|469977748|FG001|Injection Phase|Physician Decision|3|||
130549250|NCT02076178|469977747|FG000|Injection Phase|Lost to Follow-up|0|||
130549251|NCT02076178|469977748|FG001|Injection Phase|Lost to Follow-up|1|||
130549252|NCT00710021|469977749|FG000|Overall Study|Lost to Follow-up|1|||
130549253|NCT00710021|469977750|FG001|Overall Study|Lost to Follow-up|0|||
130549254|NCT00710021|469977751|FG002|Overall Study|Lost to Follow-up|0|||
130549255|NCT00710021|469977749|FG000|Overall Study|Subject's Decision|0|||
130549256|NCT00710021|469977750|FG001|Overall Study|Subject's Decision|1|||
130549257|NCT00710021|469977751|FG002|Overall Study|Subject's Decision|0|||
130549258|NCT00710021|469977749|FG000|Overall Study|Subject misrandomized|0|||
130549259|NCT00710021|469977750|FG001|Overall Study|Subject misrandomized|1|||
130549260|NCT00710021|469977751|FG002|Overall Study|Subject misrandomized|1|||
130549261|NCT00710021|469977749|FG000|Overall Study|Physician Decision|0|||
130549262|NCT00710021|469977750|FG001|Overall Study|Physician Decision|1|||
130549263|NCT00710021|469977751|FG002|Overall Study|Physician Decision|0|||
130549264|NCT03581825|469977752|FG000|Period 1|Lens Discomfort|1|||
130549265|NCT03581825|469977753|FG001|Period 1|Lens Discomfort|0|||
130549266|NCT03581825|469977752|FG000|Period 2|Unsatisfactory Vision to Test|0|||
130549267|NCT03581825|469977753|FG001|Period 2|Unsatisfactory Vision to Test|1|||
130549268|NCT00511901|469977754|FG000|Overall Study|Withdrawal by Subject|1|||
130549269|NCT00511901|469977755|FG001|Overall Study|Withdrawal by Subject|3|||
130549270|NCT02447172|469977756|FG000|Overall Study|Adverse Event|11|||
130549271|NCT02447172|469977757|FG001|Overall Study|Adverse Event|8|||
130549272|NCT02447172|469977758|FG002|Overall Study|Adverse Event|7|||
130549273|NCT02447172|469977756|FG000|Overall Study|Death|3|||
130549274|NCT02447172|469977757|FG001|Overall Study|Death|1|||
130549275|NCT02447172|469977758|FG002|Overall Study|Death|0|||
130549276|NCT02447172|469977756|FG000|Overall Study|Protocol Violation|2|||
130549277|NCT02447172|469977757|FG001|Overall Study|Protocol Violation|1|||
130549278|NCT02447172|469977758|FG002|Overall Study|Protocol Violation|2|||
130549279|NCT02447172|469977756|FG000|Overall Study|Lost to Follow-up|7|||
130549280|NCT02447172|469977757|FG001|Overall Study|Lost to Follow-up|4|||
130549281|NCT02447172|469977758|FG002|Overall Study|Lost to Follow-up|4|||
130549282|NCT02447172|469977756|FG000|Overall Study|Withdrawal by Subject|5|||
130549283|NCT02447172|469977757|FG001|Overall Study|Withdrawal by Subject|1|||
130549284|NCT02447172|469977758|FG002|Overall Study|Withdrawal by Subject|3|||
130549285|NCT02447172|469977756|FG000|Overall Study|protocol specific treatment unrelated|3|||
130549286|NCT02447172|469977757|FG001|Overall Study|protocol specific treatment unrelated|0|||
130549287|NCT02447172|469977758|FG002|Overall Study|protocol specific treatment unrelated|2|||
130549288|NCT00529958|469977761|FG000|2-Year Follow-up|Lost to Follow-up|1|||
130549289|NCT00529958|469977762|FG001|2-Year Follow-up|Lost to Follow-up|2|||
130549290|NCT00529958|469977763|FG002|2-Year Follow-up|Lost to Follow-up|2|||
130549291|NCT00529958|469977761|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
130549292|NCT00529958|469977762|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
130549293|NCT00529958|469977763|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
130549294|NCT00529958|469977761|FG000|5-Year Follow-up|Lost to Follow-up|2|||
130549295|NCT00529958|469977762|FG001|5-Year Follow-up|Lost to Follow-up|3|||
130322597|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322598|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
130322599|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322600|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322601|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322602|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
130322603|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322604|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322605|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322606|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322607|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322608|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322609|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
130322610|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322611|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322612|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
130322613|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322614|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322615|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322616|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130322617|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322618|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322619|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130322620|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322621|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322622|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322623|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322624|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322625|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322626|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322627|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
130322628|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322629|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322630|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322631|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322632|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322633|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322634|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
130322635|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130549296|NCT00529958|469977763|FG002|5-Year Follow-up|Lost to Follow-up|1|||
130549297|NCT00529958|469977761|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
130214032|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214033|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214034|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130214035|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214036|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214037|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214038|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
130214039|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214040|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214041|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130214042|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214043|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214044|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214045|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130214046|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214047|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130214048|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130214049|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
130214050|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130214051|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130322636|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322637|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322638|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322639|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322640|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322641|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
130322642|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322643|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322644|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322645|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322646|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322647|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322648|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
130322649|NCT00456846|469151335|FG000|Overall Study|Adverse Event|2|||
130322650|NCT00456846|469151336|FG001|Overall Study|Adverse Event|15|||
130322651|NCT00456846|469151335|FG000|Overall Study|Physician Decision|11|||
130322652|NCT00456846|469151336|FG001|Overall Study|Physician Decision|6|||
130322653|NCT00456846|469151335|FG000|Overall Study|Protocol Deviation|2|||
130322654|NCT00456846|469151336|FG001|Overall Study|Protocol Deviation|0|||
130322655|NCT00456846|469151335|FG000|Overall Study|Participant Discretion|1|||
130322656|NCT00456846|469151336|FG001|Overall Study|Participant Discretion|5|||
130322657|NCT00456846|469151335|FG000|Overall Study|Other|0|||
130322658|NCT00456846|469151336|FG001|Overall Study|Other|2|||
130322659|NCT03044106|469151337|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130322660|NCT03044106|469151338|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
130322661|NCT01748292|469151339|FG000|Overall Study|Adverse Event|2|||
130322662|NCT01748292|469151340|FG001|Overall Study|Adverse Event|4|||
130322663|NCT01748292|469151339|FG000|Overall Study|Lost to Follow-up|0|||
130322664|NCT01748292|469151340|FG001|Overall Study|Lost to Follow-up|3|||
130322665|NCT01748292|469151339|FG000|Overall Study|Death|0|||
130322666|NCT01748292|469151340|FG001|Overall Study|Death|3|||
130322667|NCT01748292|469151339|FG000|Overall Study|Withdrawal by Subject|0|||
130322668|NCT01748292|469151340|FG001|Overall Study|Withdrawal by Subject|2|||
130322669|NCT03379818|469151341|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
130322670|NCT03379818|469151342|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
130322671|NCT03379818|469151341|FG000|Overall Study|Withdrawal by Subject|2|||
130322672|NCT03379818|469151342|FG001|Overall Study|Withdrawal by Subject|3|||
130322673|NCT03379818|469151341|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
130322674|NCT03379818|469151342|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
130322675|NCT03199976|469151344|FG000|Overall Study|Lack of Efficacy|3|||
130322676|NCT03199976|469151345|FG001|Overall Study|Lack of Efficacy|6|||
130322677|NCT03199976|469151346|FG002|Overall Study|Lack of Efficacy|13|||
130322678|NCT03199976|469151344|FG000|Overall Study|Withdrawal by Subject|1|||
130322679|NCT03199976|469151345|FG001|Overall Study|Withdrawal by Subject|0|||
130322680|NCT03199976|469151346|FG002|Overall Study|Withdrawal by Subject|0|||
130322681|NCT03199976|469151344|FG000|Overall Study|Lost to Follow-up|0|||
130322682|NCT03199976|469151345|FG001|Overall Study|Lost to Follow-up|1|||
130322683|NCT03199976|469151346|FG002|Overall Study|Lost to Follow-up|1|||
130322684|NCT04030143|469151354|FG000|Overall Study|Adverse Event|5|||
130322685|NCT04030143|469151355|FG001|Overall Study|Adverse Event|10|||
130322686|NCT04030143|469151354|FG000|Overall Study|Lost to Follow-up|3|||
130322687|NCT04030143|469151355|FG001|Overall Study|Lost to Follow-up|7|||
130322688|NCT04030143|469151354|FG000|Overall Study|Protocol Deviation|2|||
130322689|NCT04030143|469151355|FG001|Overall Study|Protocol Deviation|2|||
130322690|NCT04030143|469151354|FG000|Overall Study|Withdrawal by Subject|16|||
130322691|NCT04030143|469151355|FG001|Overall Study|Withdrawal by Subject|18|||
130322692|NCT04030143|469151354|FG000|Overall Study|Physician Decision|1|||
130322693|NCT04030143|469151355|FG001|Overall Study|Physician Decision|1|||
130322694|NCT04030143|469151354|FG000|Overall Study|Due to Covid-19|2|||
130322695|NCT04030143|469151355|FG001|Overall Study|Due to Covid-19|3|||
130322696|NCT04030143|469151354|FG000|Overall Study|Not Due to Covid-19|1|||
130322697|NCT04030143|469151355|FG001|Overall Study|Not Due to Covid-19|1|||
130322698|NCT00412984|469151357|FG000|Overall Study|Death|331|||
130322699|NCT00412984|469151358|FG001|Overall Study|Death|349|||
130322700|NCT00412984|469151357|FG000|Overall Study|Adverse Event|679|||
130322701|NCT00412984|469151358|FG001|Overall Study|Adverse Event|738|||
130322702|NCT00412984|469151357|FG000|Overall Study|Withdrawal by Subject|921|||
130322703|NCT00412984|469151358|FG001|Overall Study|Withdrawal by Subject|989|||
130322704|NCT00412984|469151357|FG000|Overall Study|Lost to Follow-up|51|||
130322705|NCT00412984|469151358|FG001|Overall Study|Lost to Follow-up|39|||
130322706|NCT00412984|469151357|FG000|Overall Study|Poor/Noncompliance|57|||
130322707|NCT00412984|469151358|FG001|Overall Study|Poor/Noncompliance|77|||
130322708|NCT00412984|469151357|FG000|Overall Study|Pregnancy|1|||
130322709|NCT00412984|469151358|FG001|Overall Study|Pregnancy|0|||
130322710|NCT00412984|469151357|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
130322711|NCT00412984|469151358|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
130322712|NCT00412984|469151357|FG000|Overall Study|Administrative Reason by Sponsor|11|||
130322713|NCT00412984|469151358|FG001|Overall Study|Administrative Reason by Sponsor|8|||
130322714|NCT00412984|469151357|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
130322715|NCT00412984|469151358|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
130322716|NCT00412984|469151357|FG000|Overall Study|Other Reason|80|||
130322717|NCT00412984|469151358|FG001|Overall Study|Other Reason|92|||
130322718|NCT00412984|469151357|FG000|Overall Study|Not Reported|11|||
130322719|NCT00412984|469151358|FG001|Overall Study|Not Reported|12|||
130322720|NCT02383576|469151359|FG000|Overall Study|Death|53|||
130322721|NCT02383576|469151360|FG001|Overall Study|Death|33|||
130322722|NCT02383576|469151359|FG000|Overall Study|Lost to Follow-up|7|||
130322723|NCT02383576|469151360|FG001|Overall Study|Lost to Follow-up|1|||
130322724|NCT02383576|469151359|FG000|Overall Study|Withdrew Consent|1|||
130322725|NCT02383576|469151360|FG001|Overall Study|Withdrew Consent|6|||
130322726|NCT02383576|469151359|FG000|Overall Study|Investigator's Decision|0|||
130322727|NCT02383576|469151360|FG001|Overall Study|Investigator's Decision|1|||
130322728|NCT02383576|469151359|FG000|Overall Study|Administrative/Other|2|||
130322729|NCT02383576|469151360|FG001|Overall Study|Administrative/Other|4|||
130322730|NCT04218240|469151361|FG000|Overall Study|Withdrawal by Subject|6|||
130322731|NCT04218240|469151362|FG001|Overall Study|Withdrawal by Subject|0|||
130322732|NCT04218240|469151361|FG000|Overall Study|Lack of Efficacy|24|||
130322733|NCT04218240|469151362|FG001|Overall Study|Lack of Efficacy|19|||
130322734|NCT04218240|469151361|FG000|Overall Study|Physician Decision|0|||
130322735|NCT04218240|469151362|FG001|Overall Study|Physician Decision|1|||
130322736|NCT04218240|469151361|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
130322737|NCT04218240|469151362|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
130322738|NCT04914364|469151363|FG000|Overall Study|No longer eligible for study|1|||
130322739|NCT04914364|469151363|FG000|Overall Study|Lost to Follow-up|2|||
130322740|NCT04097678|469151364|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
130322741|NCT04097678|469151365|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
130322742|NCT03694678|469151366|FG000|Overall Study|Withdrawal by Subject|2|||
130322743|NCT03694678|469151367|FG001|Overall Study|Withdrawal by Subject|0|||
130322744|NCT03694678|469151366|FG000|Overall Study|Lost to Follow-up|2|||
130322745|NCT03694678|469151367|FG001|Overall Study|Lost to Follow-up|3|||
130322746|NCT02435212|469151368|FG000|Core Phase|Adverse Event|8|||
130322747|NCT02435212|469151369|FG001|Core Phase|Adverse Event|5|||
130322748|NCT02435212|469151368|FG000|Core Phase|Withdrawal by Subject|3|||
130322749|NCT02435212|469151369|FG001|Core Phase|Withdrawal by Subject|0|||
130322750|NCT02435212|469151368|FG000|Core Phase|Withdrawal by parent/guardian|9|||
130322751|NCT02435212|469151369|FG001|Core Phase|Withdrawal by parent/guardian|4|||
130322752|NCT02435212|469151368|FG000|Core Phase|Protocol Violation|1|||
130322753|NCT02435212|469151369|FG001|Core Phase|Protocol Violation|2|||
130322754|NCT02435212|469151368|FG000|Core Phase|Physician Decision|3|||
130322755|NCT02435212|469151369|FG001|Core Phase|Physician Decision|0|||
130322756|NCT02435212|469151368|FG000|Core Phase|Lost to Follow-up|0|||
130322757|NCT02435212|469151369|FG001|Core Phase|Lost to Follow-up|1|||
130322758|NCT02435212|469151368|FG000|Core Phase|Lack of Efficacy|0|||
130322759|NCT02435212|469151369|FG001|Core Phase|Lack of Efficacy|1|||
130549298|NCT00529958|469977762|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
130549299|NCT00529958|469977763|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
130549300|NCT03316300|469977764|FG000|Overall Study|Withdrawal by Subject|3|||
130549301|NCT03316300|469977765|FG001|Overall Study|Withdrawal by Subject|2|||
130549302|NCT03316300|469977764|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
130549303|NCT03316300|469977765|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
130549304|NCT03316300|469977764|FG000|Overall Study|Adverse Event|1|||
130549305|NCT03316300|469977765|FG001|Overall Study|Adverse Event|0|||
130549306|NCT03316300|469977764|FG000|Overall Study|COVID-19|0|||
130549307|NCT03316300|469977765|FG001|Overall Study|COVID-19|1|||
130549308|NCT01315353|469977766|FG000|Overall Study|Death|2|||
130549309|NCT01315353|469977767|FG001|Overall Study|Death|1|||
130549310|NCT01315353|469977768|FG002|Overall Study|Death|0|||
130549311|NCT01315353|469977766|FG000|Overall Study|Withdrawal by Subject|2|||
130549312|NCT01315353|469977767|FG001|Overall Study|Withdrawal by Subject|6|||
130549313|NCT01315353|469977768|FG002|Overall Study|Withdrawal by Subject|1|||
130549314|NCT01315353|469977766|FG000|Overall Study|Lost to Follow-up|13|||
130549315|NCT01315353|469977767|FG001|Overall Study|Lost to Follow-up|6|||
130549316|NCT01315353|469977768|FG002|Overall Study|Lost to Follow-up|6|||
130549317|NCT01315353|469977766|FG000|Overall Study|Unwilling to adhere to requirements|5|||
130549318|NCT01315353|469977767|FG001|Overall Study|Unwilling to adhere to requirements|5|||
130549319|NCT01315353|469977768|FG002|Overall Study|Unwilling to adhere to requirements|4|||
130322760|NCT02435212|469151368|FG000|Core Phase|Recovery|1|||
130322761|NCT02435212|469151369|FG001|Core Phase|Recovery|0|||
130322762|NCT02435212|469151368|FG000|Optional Extension Phase|Adverse Event|3|||
130322763|NCT02435212|469151369|FG001|Optional Extension Phase|Adverse Event|9|||
130549320|NCT01315353|469977766|FG000|Overall Study|Site closing|7|||
130549321|NCT01315353|469977767|FG001|Overall Study|Site closing|4|||
130549322|NCT01315353|469977768|FG002|Overall Study|Site closing|0|||
130322764|NCT02435212|469151368|FG000|Optional Extension Phase|Physician Decision|6|||
130322765|NCT02435212|469151369|FG001|Optional Extension Phase|Physician Decision|8|||
130322766|NCT02435212|469151368|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
130322767|NCT02435212|469151369|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
130322768|NCT02435212|469151368|FG000|Optional Extension Phase|Lack of Efficacy|2|||
130322769|NCT02435212|469151369|FG001|Optional Extension Phase|Lack of Efficacy|3|||
130322770|NCT02435212|469151368|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
130322771|NCT02435212|469151369|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
130322772|NCT02435212|469151368|FG000|Optional Extension Phase|Protocol Violation|0|||
130322773|NCT02435212|469151369|FG001|Optional Extension Phase|Protocol Violation|1|||
130322774|NCT02435212|469151368|FG000|Optional Extension Phase|Recovery|1|||
130322775|NCT02435212|469151369|FG001|Optional Extension Phase|Recovery|1|||
130322776|NCT02435212|469151368|FG000|Optional Extension Phase|Death|1|||
130322777|NCT02435212|469151369|FG001|Optional Extension Phase|Death|0|||
130322778|NCT02435212|469151368|FG000|Optional Extension Phase|Technical problems|2|||
130322779|NCT02435212|469151369|FG001|Optional Extension Phase|Technical problems|0|||
130322780|NCT05966142|469151379|FG000|Overall Study|Death|3|||
130322781|NCT05966142|469151380|FG001|Overall Study|Death|3|||
130322782|NCT05966142|469151379|FG000|Overall Study|Lost to Follow-up|55|||
130322783|NCT05966142|469151380|FG001|Overall Study|Lost to Follow-up|52|||
130322784|NCT05966142|469151379|FG000|Overall Study|Physician Decision|1|||
130322785|NCT05966142|469151380|FG001|Overall Study|Physician Decision|0|||
130322786|NCT05966142|469151379|FG000|Overall Study|Withdrawal by Subject|9|||
130322787|NCT05966142|469151380|FG001|Overall Study|Withdrawal by Subject|8|||
130322788|NCT05966142|469151379|FG000|Overall Study|Duplicate Enrollment|1|||
130322789|NCT05966142|469151380|FG001|Overall Study|Duplicate Enrollment|0|||
130322790|NCT05966142|469151379|FG000|Overall Study|Study Logistical Reason|1|||
130322791|NCT05966142|469151380|FG001|Overall Study|Study Logistical Reason|0|||
130322792|NCT05966142|469151379|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
130322793|NCT05966142|469151380|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
130322794|NCT04852302|469151386|FG000|Overall Study|Withdrawal by Subject|2|||
130322795|NCT04852302|469151386|FG000|Overall Study|Did not complete CALM therapy.|2|||
130322796|NCT04711850|469151387|FG000|Overall Study|Graft loss|2|||
130322797|NCT04711850|469151388|FG001|Overall Study|Graft loss|1|||
130322798|NCT04711850|469151387|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
130322799|NCT04711850|469151388|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
130322800|NCT04711850|469151387|FG000|Overall Study|Study terminated by sponsor|5|||
130322801|NCT04711850|469151388|FG001|Overall Study|Study terminated by sponsor|3|||
130549323|NCT01315353|469977766|FG000|Overall Study|Taken off study by site in error|0|||
130549324|NCT01315353|469977767|FG001|Overall Study|Taken off study by site in error|1|||
130549325|NCT01315353|469977768|FG002|Overall Study|Taken off study by site in error|0|||
130549326|NCT01315353|469977766|FG000|Overall Study|Inadvertent randomization/assignment|0|||
130549327|NCT01315353|469977767|FG001|Overall Study|Inadvertent randomization/assignment|0|||
130549328|NCT01315353|469977768|FG002|Overall Study|Inadvertent randomization/assignment|2|||
130549329|NCT03567434|469977769|FG000|Overall Study|Lost to Follow-up|1|||
130549330|NCT03567434|469977770|FG001|Overall Study|Lost to Follow-up|3|||
130549331|NCT02881957|469977773|FG000|Overall Study|Comfort care|0|||
130549332|NCT02881957|469977774|FG001|Overall Study|Comfort care|1|||
130549333|NCT02881957|469977773|FG000|Overall Study|Concurrent trial enrollment|0|||
130549334|NCT02881957|469977774|FG001|Overall Study|Concurrent trial enrollment|1|||
130549335|NCT02881957|469977773|FG000|Overall Study|Discharged within 48 hours|0|||
130549336|NCT02881957|469977774|FG001|Overall Study|Discharged within 48 hours|1|||
130549337|NCT02881957|469977773|FG000|Overall Study|Withdrawal by Subject|2|||
130549338|NCT02881957|469977774|FG001|Overall Study|Withdrawal by Subject|1|||
130549339|NCT02881957|469977773|FG000|Overall Study|Protocol Violation|1|||
130549340|NCT02881957|469977774|FG001|Overall Study|Protocol Violation|0|||
130549341|NCT03705832|469977776|FG000|Overall Study|Physician Decision|0|||
130549342|NCT03705832|469977777|FG001|Overall Study|Physician Decision|1|||
130549343|NCT03705832|469977776|FG000|Overall Study|Withdrawal by Subject|1|||
130549344|NCT03705832|469977777|FG001|Overall Study|Withdrawal by Subject|0|||
130549345|NCT01050790|469977778|FG000|Overall Study|Adverse Event|1|||
130322802|NCT04711850|469151387|FG000|Overall Study|Sponsor decision|0|||
130322803|NCT04711850|469151388|FG001|Overall Study|Sponsor decision|2|||
130322804|NCT03267277|469151389|FG000|Overall Study|Withdrawal by Subject|1|||
130322805|NCT04849364|469151390|FG000|Overall Study|Eligibility criteria not meet|0|||
130322806|NCT04849364|469151391|FG001|Overall Study|Eligibility criteria not meet|1|||
130549346|NCT01880528|469977779|FG000|Overall Study|Other|1|||
130549347|NCT01880528|469977780|FG001|Overall Study|Other|1|||
130322807|NCT04849364|469151392|FG002|Overall Study|Eligibility criteria not meet|0|||
130322808|NCT04531176|469151403|FG000|Overall Study|Study was stopped early|24|||
130322809|NCT04531176|469151404|FG001|Overall Study|Study was stopped early|26|||
130322810|NCT04531176|469151405|FG002|Overall Study|Study was stopped early|24|||
130549348|NCT01439360|469977781|FG000|Overall Study|Adverse Event|4|||
130549349|NCT01439360|469977782|FG001|Overall Study|Adverse Event|16|||
130549350|NCT01439360|469977781|FG000|Overall Study|Lost to Follow-up|43|||
130322811|NCT00528112|469151406|FG000|Treatment up to 3 Years|Adverse Event|313|||
130322812|NCT00528112|469151407|FG001|Treatment up to 3 Years|Adverse Event|278|||
130322813|NCT00528112|469151406|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
130322814|NCT00528112|469151407|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
130322815|NCT00528112|469151406|FG000|Treatment up to 3 Years|Protocol Violation|16|||
130322816|NCT00528112|469151407|FG001|Treatment up to 3 Years|Protocol Violation|16|||
130322817|NCT00528112|469151406|FG000|Treatment up to 3 Years|Death|0|||
130322818|NCT00528112|469151407|FG001|Treatment up to 3 Years|Death|1|||
130322819|NCT00528112|469151406|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
130322820|NCT00528112|469151407|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
130322821|NCT00528112|469151406|FG000|Treatment up to 3 Years|Pregnancy|9|||
130322822|NCT00528112|469151407|FG001|Treatment up to 3 Years|Pregnancy|10|||
130322823|NCT00528112|469151406|FG000|Treatment up to 3 Years|Other reasons|186|||
130322824|NCT00528112|469151407|FG001|Treatment up to 3 Years|Other reasons|186|||
130322825|NCT00528112|469151406|FG000|Extension Phase|Withdrawal by Subject|0|||
130322826|NCT00528112|469151407|FG001|Extension Phase|Withdrawal by Subject|3|||
130322827|NCT00528112|469151406|FG000|Extension Phase|Other reasons|0|||
130322828|NCT00528112|469151407|FG001|Extension Phase|Other reasons|100|||
130322829|NCT00528112|469151406|FG000|Extension Phase|Pregnancy|0|||
130322830|NCT00528112|469151407|FG001|Extension Phase|Pregnancy|3|||
130322831|NCT00528112|469151406|FG000|Extension Phase|Lost to Follow-up|0|||
130322832|NCT00528112|469151407|FG001|Extension Phase|Lost to Follow-up|12|||
130322833|NCT00528112|469151406|FG000|Extension Phase|Death|0|||
130322834|NCT00528112|469151407|FG001|Extension Phase|Death|1|||
130322835|NCT00528112|469151406|FG000|Extension Phase|Adverse Event|0|||
130322836|NCT00528112|469151407|FG001|Extension Phase|Adverse Event|36|||
130322837|NCT00528112|469151406|FG000|Extension Phase|Protocol Violation|0|||
130322838|NCT00528112|469151407|FG001|Extension Phase|Protocol Violation|2|||
130322839|NCT00894803|469151408|FG000|Overall Study|Death|20|||
130322840|NCT00894803|469151409|FG001|Overall Study|Death|4|||
130322841|NCT00894803|469151408|FG000|Overall Study|Lost to Follow-up|0|||
130322842|NCT00894803|469151409|FG001|Overall Study|Lost to Follow-up|1|||
130322843|NCT01345240|469151411|FG000|Overall Study|Adverse Event|3|||
130322844|NCT01345240|469151412|FG001|Overall Study|Adverse Event|5|||
130322845|NCT01345240|469151413|FG002|Overall Study|Adverse Event|4|||
130322846|NCT01345240|469151414|FG003|Overall Study|Adverse Event|2|||
130322847|NCT01345240|469151415|FG004|Overall Study|Adverse Event|1|||
130322848|NCT01345240|469151411|FG000|Overall Study|Lost to Follow-up|8|||
130322849|NCT01345240|469151412|FG001|Overall Study|Lost to Follow-up|9|||
130322850|NCT01345240|469151413|FG002|Overall Study|Lost to Follow-up|14|||
130322851|NCT01345240|469151414|FG003|Overall Study|Lost to Follow-up|7|||
130322852|NCT01345240|469151415|FG004|Overall Study|Lost to Follow-up|9|||
130322853|NCT01502293|469151416|FG000|Overall Study|Progressive Disease|20|||
130322854|NCT01502293|469151417|FG001|Overall Study|Progressive Disease|12|||
130322855|NCT01502293|469151418|FG002|Overall Study|Progressive Disease|2|||
130322856|NCT01502293|469151416|FG000|Overall Study|Withdrawal by Subject|3|||
130322857|NCT01502293|469151417|FG001|Overall Study|Withdrawal by Subject|3|||
130322858|NCT01502293|469151418|FG002|Overall Study|Withdrawal by Subject|1|||
130322859|NCT01502293|469151416|FG000|Overall Study|Adverse Event|0|||
130322860|NCT01502293|469151417|FG001|Overall Study|Adverse Event|2|||
130322861|NCT01502293|469151418|FG002|Overall Study|Adverse Event|0|||
130322862|NCT01502293|469151416|FG000|Overall Study|Reason Not Specified|2|||
130322863|NCT01502293|469151417|FG001|Overall Study|Reason Not Specified|0|||
130322864|NCT01502293|469151418|FG002|Overall Study|Reason Not Specified|0|||
130322865|NCT01502293|469151416|FG000|Overall Study|Physician Decision|0|||
130322866|NCT01502293|469151417|FG001|Overall Study|Physician Decision|0|||
130322867|NCT01502293|469151418|FG002|Overall Study|Physician Decision|1|||
130322868|NCT00774046|469151421|FG000|Screening|Not eligible|56|||
130322869|NCT00774046|469151421|FG000|Enrollment|Desired other therapy/refused|28|||
130322870|NCT00774046|469151421|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
130322871|NCT02246530|469151423|FG000|Overall Study|Lost to Follow-up|4|||
130322872|NCT02246530|469151424|FG001|Overall Study|Lost to Follow-up|0|||
130322873|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
130322874|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322875|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322876|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322877|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322878|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322879|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322880|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322881|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322882|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322883|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322884|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322885|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322886|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322887|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322888|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322889|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322890|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130322891|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322892|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322893|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322894|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322895|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322896|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322897|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130322898|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322899|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322900|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322901|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322902|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322903|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322904|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322905|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322906|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130322907|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322908|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322909|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130322910|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322911|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322912|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322913|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322914|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322915|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322916|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322917|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322918|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322919|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322920|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322921|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322922|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322923|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322924|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322925|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322926|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322927|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
130322928|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322929|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322930|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322931|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322932|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322933|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322934|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322935|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322936|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322937|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322938|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322939|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322940|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322941|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322942|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322943|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322944|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322945|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322946|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322947|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130549351|NCT01439360|469977782|FG001|Overall Study|Lost to Follow-up|58|||
130549352|NCT01439360|469977781|FG000|Overall Study|Others|10|||
130549353|NCT01439360|469977782|FG001|Overall Study|Others|5|||
130322948|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322949|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130322950|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322951|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130322952|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322953|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322954|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322955|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322956|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322957|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322958|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322959|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322960|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322961|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322962|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322963|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322964|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322965|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322966|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322967|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322968|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
130322969|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322970|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322971|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322972|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322973|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322974|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322975|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322976|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322977|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322978|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322979|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322980|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322981|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322982|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
130322983|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322984|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322985|NCT01824836|469151441|FG000|Overall Study|Adverse Event|48|||
130322986|NCT01824836|469151441|FG000|Overall Study|Withdrawal by Subject|63|||
130322987|NCT01824836|469151441|FG000|Overall Study|Other complicating disease|116|||
130322988|NCT01824836|469151441|FG000|Overall Study|Disease progression|5|||
130322989|NCT01824836|469151441|FG000|Overall Study|Alternative therapy|2|||
130322990|NCT01824836|469151441|FG000|Overall Study|Depression|1|||
130322991|NCT01824836|469151441|FG000|Overall Study|Non-compliance|3|||
130322992|NCT01824836|469151441|FG000|Overall Study|Patient regained ovarian function|3|||
130322993|NCT01824836|469151441|FG000|Overall Study|Lost to Follow-up|8|||
130322994|NCT01824836|469151441|FG000|Overall Study|Physician Decision|2|||
130322995|NCT01824836|469151441|FG000|Overall Study|Research office was closed|3|||
130322996|NCT01824836|469151441|FG000|Overall Study|Relocation|3|||
130322997|NCT01824836|469151441|FG000|Overall Study|Insurance-related issue|1|||
130322998|NCT01824836|469151441|FG000|Overall Study|Transportation issue|1|||
130322999|NCT01824836|469151441|FG000|Overall Study|Patient transferred care|1|||
130323000|NCT01824836|469151441|FG000|Overall Study|Unknown reasons|4|||
130323001|NCT01824836|469151441|FG000|Overall Study|Never started treatment|16|||
130323002|NCT02608684|469153504|FG000|Overall Study|Physician Decision|2|||
130323003|NCT02608684|469153504|FG000|Overall Study|Withdrawal by Subject|1|||
130323004|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130549354|NCT01439360|469977781|FG000|Overall Study|Protocol Violation|1|||
130549355|NCT01439360|469977782|FG001|Overall Study|Protocol Violation|0|||
130549356|NCT01439360|469977781|FG000|Overall Study|Withdrawal by Subject|140|||
130549357|NCT01439360|469977782|FG001|Overall Study|Withdrawal by Subject|129|||
130549358|NCT00345293|469977783|FG000|Overall Study|Unable to access line for sample|1|||
130549359|NCT00345293|469977784|FG001|Overall Study|Unable to access line for sample|0|||
130549360|NCT00345293|469977783|FG000|Overall Study|Withdrawal by Subject|1|||
130549361|NCT00345293|469977784|FG001|Overall Study|Withdrawal by Subject|0|||
130549362|NCT01786174|469979240|FG000|Overall Study|Discontinued Study Drug|2|||
130549363|NCT01786174|469979241|FG001|Overall Study|Discontinued Study Drug|0|||
130549364|NCT04281004|469979250|FG000|Overall Study|Physician Decision|1|||
130549365|NCT04281004|469979251|FG001|Overall Study|Physician Decision|0|||
130549366|NCT03628898|469979252|FG000|Overall Study|Device deficiency|1|||
130549367|NCT01217957|469979253|FG000|Phase 1|Withdrawal by Patient|1|||
130549368|NCT01217957|469979254|FG001|Phase 1|Withdrawal by Patient|0|||
130549369|NCT01217957|469979255|FG002|Phase 1|Withdrawal by Patient|1|||
130549370|NCT01217957|469979256|FG003|Phase 1|Withdrawal by Patient|1|||
130549371|NCT01217957|469979257|FG004|Phase 1|Withdrawal by Patient|0|||
130549372|NCT01217957|469979253|FG000|Phase 2|Withdrawal by Patient|0|||
130549373|NCT01217957|469979254|FG001|Phase 2|Withdrawal by Patient|0|||
130549374|NCT01217957|469979255|FG002|Phase 2|Withdrawal by Patient|0|||
130549375|NCT01217957|469979256|FG003|Phase 2|Withdrawal by Patient|0|||
130549376|NCT01217957|469979257|FG004|Phase 2|Withdrawal by Patient|1|||
130549377|NCT01620255|469979260|FG000|Overall Study|Withdrawal by Subject|4|||
130549378|NCT01620255|469979261|FG001|Overall Study|Withdrawal by Subject|1|||
130549379|NCT01620255|469979262|FG002|Overall Study|Withdrawal by Subject|1|||
130549380|NCT01620255|469979263|FG003|Overall Study|Withdrawal by Subject|2|||
130549381|NCT01620255|469979264|FG004|Overall Study|Withdrawal by Subject|4|||
130549382|NCT01620255|469979260|FG000|Overall Study|Participant underwent fecal transplant|0|||
130549383|NCT01620255|469979261|FG001|Overall Study|Participant underwent fecal transplant|0|||
130549384|NCT01620255|469979262|FG002|Overall Study|Participant underwent fecal transplant|1|||
130549385|NCT01620255|469979263|FG003|Overall Study|Participant underwent fecal transplant|0|||
130549386|NCT01620255|469979264|FG004|Overall Study|Participant underwent fecal transplant|0|||
130549387|NCT01620255|469979260|FG000|Overall Study|Non-compliance|0|||
130549388|NCT01620255|469979261|FG001|Overall Study|Non-compliance|1|||
130549389|NCT01620255|469979262|FG002|Overall Study|Non-compliance|0|||
130549390|NCT01620255|469979263|FG003|Overall Study|Non-compliance|0|||
130549391|NCT01620255|469979264|FG004|Overall Study|Non-compliance|0|||
130549392|NCT01620255|469979260|FG000|Overall Study|Adverse Event|0|||
130549393|NCT01620255|469979261|FG001|Overall Study|Adverse Event|4|||
130549394|NCT01620255|469979262|FG002|Overall Study|Adverse Event|0|||
130549395|NCT01620255|469979263|FG003|Overall Study|Adverse Event|1|||
130549396|NCT01620255|469979264|FG004|Overall Study|Adverse Event|1|||
130549397|NCT01620255|469979260|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
130549398|NCT01620255|469979261|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
130549399|NCT01620255|469979262|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
130549400|NCT01620255|469979263|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
130549401|NCT01620255|469979264|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
130549402|NCT01155375|469979276|FG000|Overall Study|Adverse Event|1|||
130549403|NCT01155375|469979277|FG001|Overall Study|Adverse Event|0|||
130549404|NCT00762970|469979281|FG000|Overall Study|Withdrawal by Subject|7|||
130549405|NCT00762970|469979282|FG001|Overall Study|Withdrawal by Subject|4|||
130549406|NCT00762970|469979283|FG002|Overall Study|Withdrawal by Subject|0|||
130549407|NCT00762970|469979281|FG000|Overall Study|Protocol Violation|3|||
130549408|NCT00762970|469979282|FG001|Overall Study|Protocol Violation|1|||
130214052|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130214053|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
130549409|NCT00762970|469979283|FG002|Overall Study|Protocol Violation|1|||
130549410|NCT00762970|469979281|FG000|Overall Study|Lost to Follow-up|1|||
130549411|NCT00762970|469979282|FG001|Overall Study|Lost to Follow-up|2|||
130549412|NCT00762970|469979283|FG002|Overall Study|Lost to Follow-up|0|||
130549413|NCT00762970|469979281|FG000|Overall Study|Difficulty of handling lens|1|||
130549414|NCT00762970|469979282|FG001|Overall Study|Difficulty of handling lens|2|||
130549415|NCT00762970|469979283|FG002|Overall Study|Difficulty of handling lens|0|||
130549416|NCT01480674|469979284|FG000|Overall Study|Death|23|||
130549417|NCT01480674|469979284|FG000|Overall Study|Lost to Follow-up|2|||
130549418|NCT01480674|469979284|FG000|Overall Study|visit not done|10|||
130549419|NCT03818204|469979285|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549420|NCT03818204|469979286|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549421|NCT03818204|469979287|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549422|NCT03818204|469979288|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549423|NCT03818204|469979289|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
130549424|NCT03818204|469979290|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549425|NCT03818204|469979291|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549426|NCT03818204|469979292|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549427|NCT03818204|469979293|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549428|NCT03818204|469979294|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549429|NCT03818204|469979295|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549430|NCT03818204|469979296|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549431|NCT03818204|469979297|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549432|NCT03818204|469979298|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
130549433|NCT03818204|469979299|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549434|NCT03818204|469979300|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549435|NCT03818204|469979301|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549436|NCT03818204|469979302|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549437|NCT03818204|469979303|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
130549438|NCT03818204|469979285|FG000|Overall Study|Physician Decision|0|||
130549439|NCT03818204|469979286|FG001|Overall Study|Physician Decision|0|||
130549440|NCT03818204|469979287|FG002|Overall Study|Physician Decision|0|||
130549441|NCT03818204|469979288|FG003|Overall Study|Physician Decision|0|||
130549442|NCT03818204|469979289|FG004|Overall Study|Physician Decision|0|||
130549443|NCT03818204|469979290|FG005|Overall Study|Physician Decision|0|||
130549444|NCT03818204|469979291|FG006|Overall Study|Physician Decision|0|||
130549445|NCT03818204|469979292|FG007|Overall Study|Physician Decision|0|||
130549446|NCT03818204|469979293|FG008|Overall Study|Physician Decision|0|||
130549447|NCT03818204|469979294|FG009|Overall Study|Physician Decision|0|||
130549448|NCT03818204|469979295|FG010|Overall Study|Physician Decision|0|||
130549449|NCT03818204|469979296|FG011|Overall Study|Physician Decision|0|||
130549450|NCT03818204|469979297|FG012|Overall Study|Physician Decision|0|||
130549451|NCT03818204|469979298|FG013|Overall Study|Physician Decision|0|||
130549452|NCT03818204|469979299|FG014|Overall Study|Physician Decision|1|||
130549453|NCT03818204|469979300|FG015|Overall Study|Physician Decision|0|||
130549454|NCT03818204|469979301|FG016|Overall Study|Physician Decision|0|||
130549455|NCT03818204|469979302|FG017|Overall Study|Physician Decision|0|||
130549456|NCT03818204|469979303|FG018|Overall Study|Physician Decision|0|||
130549457|NCT00887250|469979304|FG000|Overall Study|Adverse Event|3|||
130549458|NCT00887250|469979305|FG001|Overall Study|Adverse Event|0|||
130549459|NCT00887250|469979306|FG002|Overall Study|Adverse Event|7|||
130549460|NCT00887250|469979304|FG000|Overall Study|Lack of Efficacy|9|||
130549461|NCT00887250|469979305|FG001|Overall Study|Lack of Efficacy|6|||
130549462|NCT00887250|469979306|FG002|Overall Study|Lack of Efficacy|1|||
130549463|NCT00887250|469979304|FG000|Overall Study|Lost to Follow-up|2|||
130549464|NCT00887250|469979305|FG001|Overall Study|Lost to Follow-up|3|||
130549465|NCT00887250|469979306|FG002|Overall Study|Lost to Follow-up|1|||
130549466|NCT00887250|469979304|FG000|Overall Study|Protocol Violation|2|||
130549467|NCT00887250|469979305|FG001|Overall Study|Protocol Violation|2|||
130549468|NCT00887250|469979306|FG002|Overall Study|Protocol Violation|1|||
130549469|NCT00887250|469979304|FG000|Overall Study|Withdrawal by Subject|2|||
130549470|NCT00887250|469979305|FG001|Overall Study|Withdrawal by Subject|1|||
130549471|NCT00887250|469979306|FG002|Overall Study|Withdrawal by Subject|2|||
130549472|NCT00887250|469979304|FG000|Overall Study|Patient uncooperative|0|||
130549473|NCT00887250|469979305|FG001|Overall Study|Patient uncooperative|0|||
130549474|NCT00887250|469979306|FG002|Overall Study|Patient uncooperative|1|||
130549475|NCT03864146|469979307|FG000|Overall Study|Lost to Follow-up|14|||
130549476|NCT03864146|469979308|FG001|Overall Study|Lost to Follow-up|23|||
130549477|NCT03864146|469979307|FG000|Overall Study|Withdrawal by Subject|3|||
130549478|NCT03864146|469979308|FG001|Overall Study|Withdrawal by Subject|2|||
130549479|NCT01933113|469979309|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
130549480|NCT00879762|469979310|FG000|Overall Study|Lost to Follow-up|3|||
130549481|NCT00879762|469979311|FG001|Overall Study|Lost to Follow-up|1|||
130549482|NCT04981366|469979312|FG000|Overall Study|Withdrawal by Subject|5|||
130549483|NCT04981366|469979313|FG001|Overall Study|Withdrawal by Subject|4|||
130549484|NCT04981366|469979314|FG002|Overall Study|Withdrawal by Subject|8|||
130549485|NCT04981366|469979312|FG000|Overall Study|Health issues unrelated to the trial|1|||
130549486|NCT04981366|469979313|FG001|Overall Study|Health issues unrelated to the trial|2|||
130549487|NCT04981366|469979314|FG002|Overall Study|Health issues unrelated to the trial|0|||
130549488|NCT00881608|469979315|FG000|Overall Study|Study prematurely terminated|11|||
130549489|NCT03214094|469979316|FG000|Overall Study|Case Report Forms Uncollected|14|||
130549490|NCT03214094|469979316|FG000|Overall Study|Protocol Deviation|46|||
130549491|NCT00795951|469979322|FG000|Overall Study|Lost to Follow-up|1|||
130549492|NCT00795951|469979322|FG000|Overall Study|Withdrawal by Subject|1|||
130549493|NCT00690820|469979323|FG000|Period 1|Withdrawal by Subject|0|||
130549494|NCT00690820|469979324|FG001|Period 1|Withdrawal by Subject|1|||
130549495|NCT00846391|469979326|FG000|Overall Study|Physician Decision|0|||
130549496|NCT00846391|469979327|FG001|Overall Study|Physician Decision|0|||
130549497|NCT00846391|469979328|FG002|Overall Study|Physician Decision|1|||
130549498|NCT00846391|469979326|FG000|Overall Study|Study Terminated by Sponsor|1|||
130549499|NCT00846391|469979327|FG001|Overall Study|Study Terminated by Sponsor|2|||
130549500|NCT00846391|469979328|FG002|Overall Study|Study Terminated by Sponsor|2|||
130549501|NCT04634825|469979330|FG000|Overall Study|Death|10|||
130549502|NCT04634825|469979331|FG001|Overall Study|Death|3|||
130549503|NCT04634825|469979330|FG000|Overall Study|Lost to Follow-up|1|||
130549504|NCT04634825|469979331|FG001|Overall Study|Lost to Follow-up|0|||
130549505|NCT04634825|469979330|FG000|Overall Study|Study terminated by sponsor|35|||
130549506|NCT04634825|469979331|FG001|Overall Study|Study terminated by sponsor|11|||
130549507|NCT04634825|469979330|FG000|Overall Study|Withdrawal by Subject|2|||
130549508|NCT04634825|469979331|FG001|Overall Study|Withdrawal by Subject|0|||
130549509|NCT01337115|469979338|FG000|Overall Study|Protocol Violation|2|||
130549510|NCT01337115|469979339|FG001|Overall Study|Protocol Violation|0|||
130549511|NCT00551460|469979345|FG000|Overall Study|Adverse Event|1|||
130549512|NCT00551460|469979345|FG000|Overall Study|Withdrawal by Subject|1|||
130323005|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
130323006|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130323007|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130323008|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
130323009|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
130323010|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
130549513|NCT00551460|469979345|FG000|Overall Study|Physician Decision|1|||
130549514|NCT00551460|469979345|FG000|Overall Study|Death|7|||
130549515|NCT00551460|469979345|FG000|Overall Study|Ineligible|4|||
130549516|NCT00551460|469979345|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
130549517|NCT01745848|469979346|FG000|Overall Study|Adverse Event|6|||
130549518|NCT00679627|469979347|FG000|Overall Study|Death|41|||
130549519|NCT00679627|469979348|FG001|Overall Study|Death|29|||
130549520|NCT00679627|469979347|FG000|Overall Study|Adverse Event|43|||
130549521|NCT00679627|469979348|FG001|Overall Study|Adverse Event|53|||
130549522|NCT00679627|469979347|FG000|Overall Study|Withdrawal by Subject|168|||
130549523|NCT00679627|469979348|FG001|Overall Study|Withdrawal by Subject|172|||
130549524|NCT00679627|469979347|FG000|Overall Study|Lost to Follow-up|22|||
130549525|NCT00679627|469979348|FG001|Overall Study|Lost to Follow-up|26|||
130549526|NCT00679627|469979347|FG000|Overall Study|Early Study Closure|425|||
130549527|NCT00679627|469979348|FG001|Overall Study|Early Study Closure|405|||
130549528|NCT00448123|469979349|FG000|Overall Study|Lost to Follow-up|9|||
130549529|NCT00448123|469979350|FG001|Overall Study|Lost to Follow-up|6|||
130549530|NCT00448123|469979349|FG000|Overall Study|Physician Decision|6|||
130549531|NCT00448123|469979350|FG001|Overall Study|Physician Decision|6|||
130549532|NCT02027623|469979352|FG000|Overall Study|Lost to Follow-up|3|||
130549533|NCT02027623|469979353|FG001|Overall Study|Lost to Follow-up|3|||
130549534|NCT02027623|469979352|FG000|Overall Study|Withdrawal by Subject|6|||
130549535|NCT02027623|469979353|FG001|Overall Study|Withdrawal by Subject|9|||
130549536|NCT01886378|469979354|FG000|Overall Study|Adverse Event|1|||
130549537|NCT01886378|469979354|FG000|Overall Study|Withdrawal by Subject|4|||
130549538|NCT01079741|469979355|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
130549539|NCT01079741|469979356|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
130549540|NCT01079741|469979357|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
130549541|NCT01079741|469979358|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
130549542|NCT01079741|469979359|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
130549543|NCT01079741|469979355|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
130549544|NCT01079741|469979356|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
130549545|NCT01079741|469979357|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
130549546|NCT01079741|469979358|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
130549547|NCT01079741|469979359|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
130549548|NCT00446992|469979360|FG000|Overall Study|Adverse Event|11|||
130549549|NCT00446992|469979360|FG000|Overall Study|Lost to Follow-up|5|||
130549550|NCT03021954|469979365|FG000|Overall Study|Lost to Follow-up|10|||
130549551|NCT03021954|469979366|FG001|Overall Study|Lost to Follow-up|43|||
130549552|NCT03021954|469979365|FG000|Overall Study|Subjects had avulsion trauma|4|||
130549553|NCT03021954|469979366|FG001|Overall Study|Subjects had avulsion trauma|1|||
130549554|NCT01536015|469979371|FG000|Overall Study|Adverse Event|1|||
130549555|NCT01536015|469979372|FG001|Overall Study|Adverse Event|4|||
130549556|NCT01536015|469979371|FG000|Overall Study|Lost to Follow-up|0|||
130549557|NCT01536015|469979372|FG001|Overall Study|Lost to Follow-up|1|||
130549558|NCT01536015|469979371|FG000|Overall Study|Inclusion Criterion not met|2|||
130549559|NCT01536015|469979372|FG001|Overall Study|Inclusion Criterion not met|0|||
130549560|NCT01536015|469979371|FG000|Overall Study|Study closure|5|||
130549561|NCT01536015|469979372|FG001|Overall Study|Study closure|5|||
130549562|NCT01668667|469979374|FG000|Overall Study|Adverse Event|3|||
130549563|NCT01668667|469979375|FG001|Overall Study|Adverse Event|6|||
130549564|NCT01668667|469979376|FG002|Overall Study|Adverse Event|4|||
130549565|NCT01668667|469979377|FG003|Overall Study|Adverse Event|4|||
130549566|NCT01668667|469979374|FG000|Overall Study|Lack of Efficacy|3|||
130549567|NCT01668667|469979375|FG001|Overall Study|Lack of Efficacy|2|||
130549568|NCT01668667|469979376|FG002|Overall Study|Lack of Efficacy|2|||
130549569|NCT01668667|469979377|FG003|Overall Study|Lack of Efficacy|3|||
130549570|NCT01668667|469979374|FG000|Overall Study|Protocol Violation|6|||
130549571|NCT01668667|469979375|FG001|Overall Study|Protocol Violation|10|||
130549572|NCT01668667|469979376|FG002|Overall Study|Protocol Violation|12|||
130549573|NCT01668667|469979377|FG003|Overall Study|Protocol Violation|5|||
130549574|NCT01668667|469979374|FG000|Overall Study|Lost to Follow-up|9|||
130549575|NCT01668667|469979375|FG001|Overall Study|Lost to Follow-up|4|||
130549576|NCT01668667|469979376|FG002|Overall Study|Lost to Follow-up|7|||
130549577|NCT01668667|469979377|FG003|Overall Study|Lost to Follow-up|6|||
130549578|NCT01668667|469979374|FG000|Overall Study|Physician Decision|3|||
130549579|NCT01668667|469979375|FG001|Overall Study|Physician Decision|0|||
130549580|NCT01668667|469979376|FG002|Overall Study|Physician Decision|1|||
130549581|NCT01668667|469979377|FG003|Overall Study|Physician Decision|0|||
130549582|NCT01668667|469979374|FG000|Overall Study|Withdrawal by Subject|7|||
130549583|NCT01668667|469979375|FG001|Overall Study|Withdrawal by Subject|4|||
130549584|NCT01668667|469979376|FG002|Overall Study|Withdrawal by Subject|5|||
130549585|NCT01668667|469979377|FG003|Overall Study|Withdrawal by Subject|5|||
130549586|NCT03343301|469979378|FG000|Overall Study|Withdrawal by Subject|1|||
130549587|NCT03343301|469979379|FG001|Overall Study|Withdrawal by Subject|1|||
130549588|NCT03343301|469979378|FG000|Overall Study|Death|0|||
130549589|NCT03343301|469979379|FG001|Overall Study|Death|2|||
130549590|NCT03343301|469979378|FG000|Overall Study|Other|0|||
130549591|NCT03343301|469979379|FG001|Overall Study|Other|6|||
130549592|NCT03343301|469979378|FG000|Overall Study|Missing|2|||
130549593|NCT03343301|469979379|FG001|Overall Study|Missing|0|||
130549594|NCT01013597|469979388|FG000|Overall Study|Withdrawal by Subject|1|||
130549595|NCT00427895|469979389|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549596|NCT00427895|469979390|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549597|NCT00427895|469979391|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549598|NCT00427895|469979392|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
130549599|NCT00427895|469979393|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549600|NCT00427895|469979394|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549601|NCT00427895|469979395|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549602|NCT00427895|469979396|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
130549603|NCT00427895|469979389|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549604|NCT00427895|469979390|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549605|NCT00427895|469979391|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549606|NCT00427895|469979392|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549607|NCT00427895|469979393|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549608|NCT00427895|469979394|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549609|NCT00427895|469979395|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
130549610|NCT00427895|469979396|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
130549611|NCT00427895|469979389|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549612|NCT00427895|469979390|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549613|NCT00427895|469979391|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549614|NCT00427895|469979392|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549615|NCT00427895|469979393|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549616|NCT00427895|469979394|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549617|NCT00427895|469979395|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
130549618|NCT00427895|469979396|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
130549619|NCT00427895|469979389|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
130549620|NCT00427895|469979390|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
130323011|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
130323012|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130323013|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
130549621|NCT00427895|469979391|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
130549622|NCT00427895|469979392|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
130323014|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130323015|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130549623|NCT00427895|469979393|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
130549624|NCT00427895|469979394|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
130549625|NCT00427895|469979395|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
130549626|NCT00427895|469979396|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
130549627|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
130549628|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
130549629|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
130549630|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
130549631|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
130549632|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
130549633|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
130323016|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
130323017|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
130323018|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
130323019|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
130323020|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Death|0|||
130323021|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Death|0|||
130549634|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
130549635|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
130549636|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
130549637|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
130549638|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
130549639|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
130549640|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
130549641|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
130549642|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
130549643|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
130549644|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
130549645|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549646|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549647|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549648|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549649|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549650|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
130549651|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
130549652|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
130549653|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
130549654|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
130549655|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
130549656|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
130549657|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
130549658|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
130549659|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549660|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549661|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549662|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
130549663|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549664|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549665|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549666|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
130549667|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
130214054|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130214055|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130214056|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130214057|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130214058|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130214059|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214060|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
130214061|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130214062|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
130214063|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214064|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214065|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130214066|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130214067|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130214068|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130214069|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
130214070|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
130214071|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130214072|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
130214073|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130214074|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130214075|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130214076|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214077|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214078|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
130214079|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
130214080|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130214081|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130214082|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214083|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214084|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214085|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214086|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214087|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130549668|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
130549669|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
130549670|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
130549671|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
130549672|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
130549673|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
130549674|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
130549675|NCT00427895|469979389|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549676|NCT00427895|469979390|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549677|NCT00427895|469979391|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
130549678|NCT00427895|469979392|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
130549679|NCT00427895|469979393|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549680|NCT00427895|469979394|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549681|NCT00427895|469979395|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549682|NCT00427895|469979396|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
130549683|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
130549684|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
130549685|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
130549686|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
130549687|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
130549688|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
130549689|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
130549690|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
130549691|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
130549692|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
130549693|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
130549694|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
130549695|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
130549696|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
130549697|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
130549698|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
130549699|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
130549700|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
130549701|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
130549702|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
130549703|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
130549704|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
130549705|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
130549706|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
130549707|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549708|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
130549709|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549710|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549711|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549712|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549713|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549714|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
130549715|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Death|1|||
130549716|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Death|0|||
130549717|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Death|0|||
130549718|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Death|0|||
130549719|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Death|0|||
130549720|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Death|0|||
130549721|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Death|0|||
130549722|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Death|0|||
130549723|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549724|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549725|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
130549726|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
130549727|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549728|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549729|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549730|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
130549731|NCT00427895|469979389|FG000|Vax 1/Year 1 Follow-up|Other|0|||
130549732|NCT00427895|469979390|FG001|Vax 1/Year 1 Follow-up|Other|0|||
130549733|NCT00427895|469979391|FG002|Vax 1/Year 1 Follow-up|Other|0|||
130549734|NCT00427895|469979392|FG003|Vax 1/Year 1 Follow-up|Other|2|||
130549735|NCT00427895|469979393|FG004|Vax 1/Year 1 Follow-up|Other|0|||
130549736|NCT00427895|469979394|FG005|Vax 1/Year 1 Follow-up|Other|0|||
130549737|NCT00427895|469979395|FG006|Vax 1/Year 1 Follow-up|Other|0|||
130549738|NCT00427895|469979396|FG007|Vax 1/Year 1 Follow-up|Other|0|||
130549739|NCT00427895|469979389|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
130549740|NCT00427895|469979390|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
130549741|NCT00427895|469979391|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
130549742|NCT00427895|469979392|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
130549743|NCT00427895|469979393|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
130549744|NCT00427895|469979394|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
130549745|NCT00427895|469979395|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
130549746|NCT00427895|469979396|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
130549747|NCT02390245|469979397|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
130549748|NCT02390245|469979398|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
130549749|NCT02390245|469979399|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
130549750|NCT02390245|469979397|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
130549751|NCT02390245|469979398|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
130549752|NCT02390245|469979399|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
130549753|NCT00655486|469981214|FG000|Overall Study|Adverse Event|10|||
130549754|NCT00655486|469981214|FG000|Overall Study|Lack of Efficacy|8|||
130549755|NCT00655486|469981214|FG000|Overall Study|Withdrawal by Subject|4|||
130549756|NCT00655486|469981214|FG000|Overall Study|Protocol Violation|1|||
130549757|NCT00655486|469981214|FG000|Overall Study|Unsatisfactory compliance|2|||
130549758|NCT00655486|469981214|FG000|Overall Study|Other: Pregnancy|1|||
130549759|NCT00655486|469981214|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
130549760|NCT00655486|469981214|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
130549761|NCT02768870|469981225|FG000|Overall Study|Death|1|||
130549762|NCT02768870|469981225|FG000|Overall Study|Reoperation|6|||
130549763|NCT02768870|469981225|FG000|Overall Study|Lost to Follow-up|1|||
130549764|NCT02768870|469981225|FG000|Overall Study|Exit|4|||
130549765|NCT03401229|469981226|FG000|Overall Study|Lost to Follow-up|2|||
130549766|NCT03401229|469981227|FG001|Overall Study|Lost to Follow-up|1|||
130549767|NCT03401229|469981226|FG000|Overall Study|Other|1|||
130549768|NCT03401229|469981227|FG001|Overall Study|Other|3|||
130549769|NCT03401229|469981226|FG000|Overall Study|Adverse Event|8|||
130549770|NCT03401229|469981227|FG001|Overall Study|Adverse Event|6|||
130549771|NCT03401229|469981226|FG000|Overall Study|Withdrawal by Subject|29|||
130549772|NCT03401229|469981227|FG001|Overall Study|Withdrawal by Subject|26|||
130549773|NCT03401229|469981226|FG000|Overall Study|COVID-19|0|||
130549774|NCT03401229|469981227|FG001|Overall Study|COVID-19|1|||
130549775|NCT02963610|469981228|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
130549776|NCT01774110|469981229|FG000|Overall Study|Lost to Follow-up|7|||
130549777|NCT00640016|469981230|FG000|Overall Study|Withdrawal by Subject|0|||
130549778|NCT00640016|469981231|FG001|Overall Study|Withdrawal by Subject|1|||
130549779|NCT00640016|469981232|FG002|Overall Study|Withdrawal by Subject|0|||
130549780|NCT00640016|469981233|FG003|Overall Study|Withdrawal by Subject|0|||
130549781|NCT00640016|469981230|FG000|Overall Study|Study termination|2|||
130549782|NCT00640016|469981231|FG001|Overall Study|Study termination|1|||
130549783|NCT00640016|469981232|FG002|Overall Study|Study termination|3|||
130549784|NCT00640016|469981233|FG003|Overall Study|Study termination|2|||
130549785|NCT00640016|469981230|FG000|Overall Study|Adverse Event|0|||
130549786|NCT00640016|469981231|FG001|Overall Study|Adverse Event|0|||
130549787|NCT00640016|469981232|FG002|Overall Study|Adverse Event|0|||
130549788|NCT00640016|469981233|FG003|Overall Study|Adverse Event|1|||
130549789|NCT01122862|469981234|FG000|Period 1|Protocol Violation|0|||
130549790|NCT01122862|469981235|FG001|Period 1|Protocol Violation|1|||
130549791|NCT01122862|469981236|FG002|Period 1|Protocol Violation|0|||
130549792|NCT01122862|469981234|FG000|Period 2|Adverse Event|0|||
130549793|NCT01122862|469981235|FG001|Period 2|Adverse Event|0|||
130549794|NCT01122862|469981236|FG002|Period 2|Adverse Event|1|||
130549795|NCT02699983|469981239|FG000|Overall Study|Withdrawal by Subject|1|||
130549796|NCT02699983|469981240|FG001|Overall Study|Withdrawal by Subject|0|||
130549797|NCT03575143|469981241|FG000|Overall Study|Lost to Follow-up|0|||
130549798|NCT03575143|469981242|FG001|Overall Study|Lost to Follow-up|0|||
130549799|NCT03575143|469981243|FG002|Overall Study|Lost to Follow-up|4|||
130549800|NCT03575143|469981241|FG000|Overall Study|Withdrawal by Subject|0|||
130549801|NCT03575143|469981242|FG001|Overall Study|Withdrawal by Subject|0|||
130549802|NCT03575143|469981243|FG002|Overall Study|Withdrawal by Subject|5|||
130549803|NCT03575143|469981241|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
130549804|NCT03575143|469981242|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
130549805|NCT03575143|469981243|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
130549806|NCT01287065|469981246|FG000|Treatment Period 1|Adverse Event|0|||
130549807|NCT01287065|469981247|FG001|Treatment Period 1|Adverse Event|0|||
130549808|NCT01287065|469981248|FG002|Treatment Period 1|Adverse Event|0|||
130549809|NCT01287065|469981249|FG003|Treatment Period 1|Adverse Event|0|||
130549810|NCT01287065|469981250|FG004|Treatment Period 1|Adverse Event|1|||
130549811|NCT01287065|469981251|FG005|Treatment Period 1|Adverse Event|0|||
130549812|NCT01287065|469981246|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130549813|NCT01287065|469981247|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130549814|NCT01287065|469981248|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130549815|NCT01287065|469981249|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130323022|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Death|43|||
130549816|NCT01287065|469981250|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130549817|NCT01287065|469981251|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130549818|NCT02875977|469981252|FG000|Overall Study|Lost to Follow-up|42|||
130549819|NCT02875977|469981253|FG001|Overall Study|Lost to Follow-up|29|||
130549820|NCT01259726|469981254|FG000|Overall Study|Death|1|||
130549821|NCT01259726|469981255|FG001|Overall Study|Death|0|||
130549822|NCT01259726|469981256|FG002|Overall Study|Death|0|||
130549823|NCT01259726|469981257|FG003|Overall Study|Death|0|||
130549824|NCT01259726|469981254|FG000|Overall Study|Physician Decision|2|||
130549825|NCT01259726|469981255|FG001|Overall Study|Physician Decision|0|||
130549826|NCT01259726|469981256|FG002|Overall Study|Physician Decision|1|||
130549827|NCT01259726|469981257|FG003|Overall Study|Physician Decision|1|||
130549828|NCT01259726|469981254|FG000|Overall Study|Withdrawal by Subject|1|||
130549829|NCT01259726|469981255|FG001|Overall Study|Withdrawal by Subject|3|||
130549830|NCT01259726|469981256|FG002|Overall Study|Withdrawal by Subject|2|||
130549831|NCT01259726|469981257|FG003|Overall Study|Withdrawal by Subject|1|||
130549832|NCT01259726|469981254|FG000|Overall Study|Lost to Follow-up|1|||
130549833|NCT01259726|469981255|FG001|Overall Study|Lost to Follow-up|1|||
130549834|NCT01259726|469981256|FG002|Overall Study|Lost to Follow-up|1|||
130549835|NCT01259726|469981257|FG003|Overall Study|Lost to Follow-up|3|||
130549836|NCT03421431|469981265|FG000|Overall Study|Adverse Event|2|||
130549837|NCT03421431|469981266|FG001|Overall Study|Adverse Event|1|||
130549838|NCT03421431|469981267|FG002|Overall Study|Adverse Event|12|||
130549839|NCT03421431|469981265|FG000|Overall Study|Lost to Follow-up|1|||
130549840|NCT03421431|469981266|FG001|Overall Study|Lost to Follow-up|1|||
130549841|NCT03421431|469981267|FG002|Overall Study|Lost to Follow-up|1|||
130549842|NCT03421431|469981265|FG000|Overall Study|Withdrawal by Subject|3|||
130549843|NCT03421431|469981266|FG001|Overall Study|Withdrawal by Subject|2|||
130549844|NCT03421431|469981267|FG002|Overall Study|Withdrawal by Subject|1|||
130549845|NCT03421431|469981265|FG000|Overall Study|Protocol Violation|0|||
130549846|NCT03421431|469981266|FG001|Overall Study|Protocol Violation|1|||
130549847|NCT03421431|469981267|FG002|Overall Study|Protocol Violation|0|||
130549848|NCT03421431|469981265|FG000|Overall Study|Participant met Stopping Rules|0|||
130549849|NCT03421431|469981266|FG001|Overall Study|Participant met Stopping Rules|1|||
130549850|NCT03421431|469981267|FG002|Overall Study|Participant met Stopping Rules|0|||
130549851|NCT00141726|469981268|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
130549852|NCT00235326|469981276|FG000|Overall Study|Lost to Follow-up|746|||
130549853|NCT00235326|469981277|FG001|Overall Study|Lost to Follow-up|1400|||
130549854|NCT01790126|469981278|FG000|Overall Study|PSA Progression|12|||
130549855|NCT01790126|469981279|FG001|Overall Study|PSA Progression|16|||
130549856|NCT01790126|469981280|FG002|Overall Study|PSA Progression|16|||
130549857|NCT01790126|469981278|FG000|Overall Study|Other|5|||
130549858|NCT01790126|469981279|FG001|Overall Study|Other|4|||
130549859|NCT01790126|469981280|FG002|Overall Study|Other|8|||
130549860|NCT01790126|469981278|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
130549861|NCT01790126|469981279|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
130549862|NCT01790126|469981280|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
130549863|NCT01790126|469981278|FG000|Overall Study|Withdrawal by Physician|1|||
130549864|NCT01790126|469981279|FG001|Overall Study|Withdrawal by Physician|1|||
130549865|NCT01790126|469981280|FG002|Overall Study|Withdrawal by Physician|2|||
130549866|NCT01790126|469981278|FG000|Overall Study|Withdrawal by Subject|3|||
130549867|NCT01790126|469981279|FG001|Overall Study|Withdrawal by Subject|1|||
130549868|NCT01790126|469981280|FG002|Overall Study|Withdrawal by Subject|2|||
130549869|NCT01790126|469981278|FG000|Overall Study|Lost to Follow-up|1|||
130549870|NCT01790126|469981279|FG001|Overall Study|Lost to Follow-up|0|||
130549871|NCT01790126|469981280|FG002|Overall Study|Lost to Follow-up|1|||
130549872|NCT01790126|469981278|FG000|Overall Study|Adverse Event|0|||
130549873|NCT01790126|469981279|FG001|Overall Study|Adverse Event|2|||
130323023|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Death|44|||
130323024|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130323025|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130549874|NCT01790126|469981280|FG002|Overall Study|Adverse Event|0|||
130323026|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
130549875|NCT01790126|469981278|FG000|Overall Study|Death|2|||
130549876|NCT01790126|469981279|FG001|Overall Study|Death|0|||
130549877|NCT01790126|469981280|FG002|Overall Study|Death|0|||
130549878|NCT01790126|469981278|FG000|Overall Study|Radiographic Progression|3|||
130549879|NCT01790126|469981279|FG001|Overall Study|Radiographic Progression|1|||
130549880|NCT01790126|469981280|FG002|Overall Study|Radiographic Progression|0|||
130549881|NCT01128738|469981281|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
130549882|NCT01128738|469981282|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
130549883|NCT01128738|469981281|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
130549884|NCT01128738|469981282|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
130549885|NCT01128738|469981281|FG000|Second TP|Lost to Follow-up|0|||
130549886|NCT01128738|469981282|FG001|Second TP|Lost to Follow-up|1|||
130549887|NCT01128738|469981281|FG000|Second TP|Withdrawal by Subject|0|||
130549888|NCT01128738|469981282|FG001|Second TP|Withdrawal by Subject|2|||
130549889|NCT01178671|469981283|FG000|Overall Study|Adverse Event|4|||
130549890|NCT01178671|469981284|FG001|Overall Study|Adverse Event|6|||
130549891|NCT01178671|469981283|FG000|Overall Study|Protocol Violation|1|||
130549892|NCT01178671|469981284|FG001|Overall Study|Protocol Violation|1|||
130549893|NCT01178671|469981283|FG000|Overall Study|Lack of Efficacy|0|||
130549894|NCT01178671|469981284|FG001|Overall Study|Lack of Efficacy|1|||
130549895|NCT01178671|469981283|FG000|Overall Study|Lost to Follow-up|3|||
130549896|NCT01178671|469981284|FG001|Overall Study|Lost to Follow-up|1|||
130549897|NCT01178671|469981283|FG000|Overall Study|Physician Decision|4|||
130549898|NCT01178671|469981284|FG001|Overall Study|Physician Decision|6|||
130549899|NCT02435966|469981285|FG000|Overall Study|Withdrawal by Subject|0|||
130549900|NCT02435966|469981286|FG001|Overall Study|Withdrawal by Subject|1|||
130549901|NCT02435966|469981287|FG002|Overall Study|Withdrawal by Subject|0|||
130549902|NCT01211197|469981291|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130549903|NCT01211197|469981292|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130549904|NCT01211197|469981293|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130549905|NCT01211197|469981294|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130549906|NCT01211197|469981295|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130549907|NCT01211197|469981296|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130549908|NCT01211197|469981291|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
130549909|NCT01211197|469981292|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
130549910|NCT01211197|469981293|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
130549911|NCT01211197|469981294|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
130549912|NCT01211197|469981295|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
130549913|NCT01211197|469981296|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
130549914|NCT00406653|469981301|FG000|Induction Period|Adverse Event|1|||
130549915|NCT00406653|469981302|FG001|Induction Period|Adverse Event|10|||
130549916|NCT00406653|469981303|FG002|Induction Period|Adverse Event|4|||
130549917|NCT00406653|469981304|FG003|Induction Period|Adverse Event|11|||
130549918|NCT00406653|469981305|FG004|Induction Period|Adverse Event|0|||
130549919|NCT00406653|469981306|FG005|Induction Period|Adverse Event|0|||
130549920|NCT00406653|469981307|FG006|Induction Period|Adverse Event|0|||
130549921|NCT00406653|469981301|FG000|Induction Period|Lack of Efficacy|11|||
130549922|NCT00406653|469981302|FG001|Induction Period|Lack of Efficacy|14|||
130549923|NCT00406653|469981303|FG002|Induction Period|Lack of Efficacy|8|||
130549924|NCT00406653|469981304|FG003|Induction Period|Lack of Efficacy|10|||
130549925|NCT00406653|469981305|FG004|Induction Period|Lack of Efficacy|0|||
130549926|NCT00406653|469981306|FG005|Induction Period|Lack of Efficacy|0|||
130549927|NCT00406653|469981307|FG006|Induction Period|Lack of Efficacy|0|||
130549928|NCT00406653|469981301|FG000|Induction Period|Lost to Follow-up|0|||
130549929|NCT00406653|469981302|FG001|Induction Period|Lost to Follow-up|2|||
130549930|NCT00406653|469981303|FG002|Induction Period|Lost to Follow-up|0|||
130549931|NCT00406653|469981304|FG003|Induction Period|Lost to Follow-up|0|||
130549932|NCT00406653|469981305|FG004|Induction Period|Lost to Follow-up|0|||
130549933|NCT00406653|469981306|FG005|Induction Period|Lost to Follow-up|0|||
130549934|NCT00406653|469981307|FG006|Induction Period|Lost to Follow-up|0|||
130549935|NCT00406653|469981301|FG000|Induction Period|Withdrawal of Consent|2|||
130549936|NCT00406653|469981302|FG001|Induction Period|Withdrawal of Consent|5|||
130549937|NCT00406653|469981303|FG002|Induction Period|Withdrawal of Consent|1|||
130549938|NCT00406653|469981304|FG003|Induction Period|Withdrawal of Consent|2|||
130549939|NCT00406653|469981305|FG004|Induction Period|Withdrawal of Consent|0|||
130549940|NCT00406653|469981306|FG005|Induction Period|Withdrawal of Consent|0|||
130549941|NCT00406653|469981307|FG006|Induction Period|Withdrawal of Consent|0|||
130549942|NCT00406653|469981301|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549943|NCT00406653|469981302|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549944|NCT00406653|469981303|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549945|NCT00406653|469981304|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
130549946|NCT00406653|469981305|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549947|NCT00406653|469981306|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549948|NCT00406653|469981307|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
130549949|NCT00406653|469981301|FG000|Induction Period|Pregnancy|1|||
130549950|NCT00406653|469981302|FG001|Induction Period|Pregnancy|0|||
130549951|NCT00406653|469981303|FG002|Induction Period|Pregnancy|0|||
130549952|NCT00406653|469981304|FG003|Induction Period|Pregnancy|0|||
130549953|NCT00406653|469981305|FG004|Induction Period|Pregnancy|0|||
130549954|NCT00406653|469981306|FG005|Induction Period|Pregnancy|0|||
130549955|NCT00406653|469981307|FG006|Induction Period|Pregnancy|0|||
130549956|NCT00406653|469981301|FG000|Induction Period|Declined participation but followup done|0|||
130549957|NCT00406653|469981302|FG001|Induction Period|Declined participation but followup done|2|||
130549958|NCT00406653|469981303|FG002|Induction Period|Declined participation but followup done|1|||
130549959|NCT00406653|469981304|FG003|Induction Period|Declined participation but followup done|1|||
130549960|NCT00406653|469981305|FG004|Induction Period|Declined participation but followup done|0|||
130549961|NCT00406653|469981306|FG005|Induction Period|Declined participation but followup done|0|||
130549962|NCT00406653|469981307|FG006|Induction Period|Declined participation but followup done|0|||
130549963|NCT00406653|469981301|FG000|Induction Period|Given prohibited drug|0|||
130549964|NCT00406653|469981302|FG001|Induction Period|Given prohibited drug|1|||
130549965|NCT00406653|469981303|FG002|Induction Period|Given prohibited drug|2|||
130549966|NCT00406653|469981304|FG003|Induction Period|Given prohibited drug|0|||
130549967|NCT00406653|469981305|FG004|Induction Period|Given prohibited drug|0|||
130549968|NCT00406653|469981306|FG005|Induction Period|Given prohibited drug|0|||
130549969|NCT00406653|469981307|FG006|Induction Period|Given prohibited drug|0|||
130549970|NCT00406653|469981301|FG000|Induction Period|Incarcerated|0|||
130549971|NCT00406653|469981302|FG001|Induction Period|Incarcerated|0|||
130549972|NCT00406653|469981303|FG002|Induction Period|Incarcerated|1|||
130549973|NCT00406653|469981304|FG003|Induction Period|Incarcerated|0|||
130549974|NCT00406653|469981305|FG004|Induction Period|Incarcerated|0|||
130549975|NCT00406653|469981306|FG005|Induction Period|Incarcerated|0|||
130549976|NCT00406653|469981307|FG006|Induction Period|Incarcerated|0|||
130549977|NCT00406653|469981301|FG000|Induction Period|Patient relocated|0|||
130549978|NCT00406653|469981302|FG001|Induction Period|Patient relocated|0|||
130549979|NCT00406653|469981303|FG002|Induction Period|Patient relocated|1|||
130549980|NCT00406653|469981304|FG003|Induction Period|Patient relocated|0|||
130549981|NCT00406653|469981305|FG004|Induction Period|Patient relocated|0|||
130549982|NCT00406653|469981306|FG005|Induction Period|Patient relocated|0|||
130549983|NCT00406653|469981307|FG006|Induction Period|Patient relocated|0|||
130549984|NCT00406653|469981301|FG000|Maintenance Period|Adverse Event|0|||
130549985|NCT00406653|469981302|FG001|Maintenance Period|Adverse Event|0|||
130549986|NCT00406653|469981303|FG002|Maintenance Period|Adverse Event|0|||
130323027|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130549987|NCT00406653|469981304|FG003|Maintenance Period|Adverse Event|0|||
130549988|NCT00406653|469981305|FG004|Maintenance Period|Adverse Event|1|||
130549989|NCT00406653|469981306|FG005|Maintenance Period|Adverse Event|1|||
130549990|NCT00406653|469981307|FG006|Maintenance Period|Adverse Event|0|||
130549991|NCT00406653|469981301|FG000|Maintenance Period|Lack of Efficacy|0|||
130549992|NCT00406653|469981302|FG001|Maintenance Period|Lack of Efficacy|0|||
130549993|NCT00406653|469981303|FG002|Maintenance Period|Lack of Efficacy|0|||
130549994|NCT00406653|469981304|FG003|Maintenance Period|Lack of Efficacy|0|||
130549995|NCT00406653|469981305|FG004|Maintenance Period|Lack of Efficacy|20|||
130549996|NCT00406653|469981306|FG005|Maintenance Period|Lack of Efficacy|26|||
130549997|NCT00406653|469981307|FG006|Maintenance Period|Lack of Efficacy|0|||
130549998|NCT00406653|469981301|FG000|Maintenance Period|Lost to Follow-up|0|||
130549999|NCT00406653|469981302|FG001|Maintenance Period|Lost to Follow-up|0|||
130550000|NCT00406653|469981303|FG002|Maintenance Period|Lost to Follow-up|0|||
130550001|NCT00406653|469981304|FG003|Maintenance Period|Lost to Follow-up|0|||
130550002|NCT00406653|469981305|FG004|Maintenance Period|Lost to Follow-up|2|||
130550003|NCT00406653|469981306|FG005|Maintenance Period|Lost to Follow-up|1|||
130550004|NCT00406653|469981307|FG006|Maintenance Period|Lost to Follow-up|0|||
130550005|NCT00406653|469981301|FG000|Maintenance Period|Withdrawal of Consent|0|||
130550006|NCT00406653|469981302|FG001|Maintenance Period|Withdrawal of Consent|0|||
130550007|NCT00406653|469981303|FG002|Maintenance Period|Withdrawal of Consent|0|||
130550008|NCT00406653|469981304|FG003|Maintenance Period|Withdrawal of Consent|0|||
130550009|NCT00406653|469981305|FG004|Maintenance Period|Withdrawal of Consent|2|||
130550010|NCT00406653|469981306|FG005|Maintenance Period|Withdrawal of Consent|0|||
130550011|NCT00406653|469981307|FG006|Maintenance Period|Withdrawal of Consent|0|||
130550012|NCT00406653|469981301|FG000|Maintenance Period|Pregnancy|0|||
130550013|NCT00406653|469981302|FG001|Maintenance Period|Pregnancy|0|||
130550014|NCT00406653|469981303|FG002|Maintenance Period|Pregnancy|0|||
130550015|NCT00406653|469981304|FG003|Maintenance Period|Pregnancy|0|||
130550016|NCT00406653|469981305|FG004|Maintenance Period|Pregnancy|0|||
130550017|NCT00406653|469981306|FG005|Maintenance Period|Pregnancy|1|||
130550018|NCT00406653|469981307|FG006|Maintenance Period|Pregnancy|0|||
130550019|NCT00406653|469981301|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
130550020|NCT00406653|469981302|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
130550021|NCT00406653|469981303|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
130550022|NCT00406653|469981304|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
130550023|NCT00406653|469981305|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
130550024|NCT00406653|469981306|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
130550025|NCT00406653|469981307|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
130550026|NCT00406653|469981301|FG000|Maintenance Period|Error in disease score evaluation|0|||
130550027|NCT00406653|469981302|FG001|Maintenance Period|Error in disease score evaluation|0|||
130550028|NCT00406653|469981303|FG002|Maintenance Period|Error in disease score evaluation|0|||
130550029|NCT00406653|469981304|FG003|Maintenance Period|Error in disease score evaluation|0|||
130550030|NCT00406653|469981305|FG004|Maintenance Period|Error in disease score evaluation|1|||
130550031|NCT00406653|469981306|FG005|Maintenance Period|Error in disease score evaluation|0|||
130550032|NCT00406653|469981307|FG006|Maintenance Period|Error in disease score evaluation|0|||
130550033|NCT00406653|469981301|FG000|Open-Label Period|Death|0|||
130550034|NCT00406653|469981302|FG001|Open-Label Period|Death|0|||
130550035|NCT00406653|469981303|FG002|Open-Label Period|Death|0|||
130550036|NCT00406653|469981304|FG003|Open-Label Period|Death|0|||
130550037|NCT00406653|469981305|FG004|Open-Label Period|Death|0|||
130550038|NCT00406653|469981306|FG005|Open-Label Period|Death|0|||
130550039|NCT00406653|469981307|FG006|Open-Label Period|Death|1|||
130550040|NCT00406653|469981301|FG000|Open-Label Period|Adverse Event|0|||
130550041|NCT00406653|469981302|FG001|Open-Label Period|Adverse Event|0|||
130550042|NCT00406653|469981303|FG002|Open-Label Period|Adverse Event|0|||
130550043|NCT00406653|469981304|FG003|Open-Label Period|Adverse Event|0|||
130550044|NCT00406653|469981305|FG004|Open-Label Period|Adverse Event|0|||
130550045|NCT00406653|469981306|FG005|Open-Label Period|Adverse Event|0|||
130550046|NCT00406653|469981307|FG006|Open-Label Period|Adverse Event|18|||
130550047|NCT00406653|469981301|FG000|Open-Label Period|Lack of Efficacy|0|||
130550048|NCT00406653|469981302|FG001|Open-Label Period|Lack of Efficacy|0|||
130550049|NCT00406653|469981303|FG002|Open-Label Period|Lack of Efficacy|0|||
130550050|NCT00406653|469981304|FG003|Open-Label Period|Lack of Efficacy|0|||
130550051|NCT00406653|469981305|FG004|Open-Label Period|Lack of Efficacy|0|||
130550052|NCT00406653|469981306|FG005|Open-Label Period|Lack of Efficacy|0|||
130550053|NCT00406653|469981307|FG006|Open-Label Period|Lack of Efficacy|160|||
130550054|NCT00406653|469981301|FG000|Open-Label Period|Lost to Follow-up|0|||
130550055|NCT00406653|469981302|FG001|Open-Label Period|Lost to Follow-up|0|||
130550056|NCT00406653|469981303|FG002|Open-Label Period|Lost to Follow-up|0|||
130550057|NCT00406653|469981304|FG003|Open-Label Period|Lost to Follow-up|0|||
130550058|NCT00406653|469981305|FG004|Open-Label Period|Lost to Follow-up|0|||
130550059|NCT00406653|469981306|FG005|Open-Label Period|Lost to Follow-up|0|||
130550060|NCT00406653|469981307|FG006|Open-Label Period|Lost to Follow-up|6|||
130550061|NCT00406653|469981301|FG000|Open-Label Period|Withdrawal of Consent|0|||
130550062|NCT00406653|469981302|FG001|Open-Label Period|Withdrawal of Consent|0|||
130550063|NCT00406653|469981303|FG002|Open-Label Period|Withdrawal of Consent|0|||
130550064|NCT00406653|469981304|FG003|Open-Label Period|Withdrawal of Consent|0|||
130550065|NCT00406653|469981305|FG004|Open-Label Period|Withdrawal of Consent|0|||
130550066|NCT00406653|469981306|FG005|Open-Label Period|Withdrawal of Consent|0|||
130550067|NCT00406653|469981307|FG006|Open-Label Period|Withdrawal of Consent|11|||
130550068|NCT00406653|469981301|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550069|NCT00406653|469981302|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550070|NCT00406653|469981303|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550071|NCT00406653|469981304|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550072|NCT00406653|469981305|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550073|NCT00406653|469981306|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
130550074|NCT00406653|469981307|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
130550075|NCT00406653|469981301|FG000|Open-Label Period|Pregnancy|0|||
130550076|NCT00406653|469981302|FG001|Open-Label Period|Pregnancy|0|||
130550077|NCT00406653|469981303|FG002|Open-Label Period|Pregnancy|0|||
130550078|NCT00406653|469981304|FG003|Open-Label Period|Pregnancy|0|||
130550079|NCT00406653|469981305|FG004|Open-Label Period|Pregnancy|0|||
130550080|NCT00406653|469981306|FG005|Open-Label Period|Pregnancy|0|||
130550081|NCT00406653|469981307|FG006|Open-Label Period|Pregnancy|2|||
130550082|NCT00406653|469981301|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
130550083|NCT00406653|469981302|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
130550084|NCT00406653|469981303|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
130550085|NCT00406653|469981304|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
130550086|NCT00406653|469981305|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
130550087|NCT00406653|469981306|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
130550088|NCT00406653|469981307|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
130550089|NCT00406653|469981301|FG000|Open-Label Period|Declined participation but followup done|0|||
130550090|NCT00406653|469981302|FG001|Open-Label Period|Declined participation but followup done|0|||
130550091|NCT00406653|469981303|FG002|Open-Label Period|Declined participation but followup done|0|||
130550092|NCT00406653|469981304|FG003|Open-Label Period|Declined participation but followup done|0|||
130550093|NCT00406653|469981305|FG004|Open-Label Period|Declined participation but followup done|0|||
130550094|NCT00406653|469981306|FG005|Open-Label Period|Declined participation but followup done|0|||
130550095|NCT00406653|469981307|FG006|Open-Label Period|Declined participation but followup done|8|||
130550096|NCT00406653|469981301|FG000|Open-Label Period|Discontinued by Sponsor|0|||
130550097|NCT00406653|469981302|FG001|Open-Label Period|Discontinued by Sponsor|0|||
130550098|NCT00406653|469981303|FG002|Open-Label Period|Discontinued by Sponsor|0|||
130550099|NCT00406653|469981304|FG003|Open-Label Period|Discontinued by Sponsor|0|||
130550100|NCT00406653|469981305|FG004|Open-Label Period|Discontinued by Sponsor|0|||
130550101|NCT00406653|469981306|FG005|Open-Label Period|Discontinued by Sponsor|0|||
130550102|NCT00406653|469981307|FG006|Open-Label Period|Discontinued by Sponsor|1|||
130550103|NCT00406653|469981301|FG000|Open-Label Period|Refused followup|0|||
130550104|NCT00406653|469981302|FG001|Open-Label Period|Refused followup|0|||
130550105|NCT00406653|469981303|FG002|Open-Label Period|Refused followup|0|||
130550106|NCT00406653|469981304|FG003|Open-Label Period|Refused followup|0|||
130550107|NCT00406653|469981305|FG004|Open-Label Period|Refused followup|0|||
130550108|NCT00406653|469981306|FG005|Open-Label Period|Refused followup|0|||
130550109|NCT00406653|469981307|FG006|Open-Label Period|Refused followup|1|||
130550110|NCT00818649|469981308|FG000|Overall Study|Declining performance status|2|||
130323028|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
130323029|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
130323030|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
130323031|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
130323032|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130323033|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130323034|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
130323035|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
130323036|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323037|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323038|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323039|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
130323040|NCT02318706|469153509|FG000|Double-blind Phase|Adverse Event|7|||
130323041|NCT02318706|469153510|FG001|Double-blind Phase|Adverse Event|4|||
130323042|NCT02318706|469153511|FG002|Double-blind Phase|Adverse Event|3|||
130323043|NCT02318706|469153512|FG003|Double-blind Phase|Adverse Event|10|||
130323044|NCT02318706|469153513|FG004|Double-blind Phase|Adverse Event|0|||
130323045|NCT02318706|469153509|FG000|Double-blind Phase|Lost to Follow-up|1|||
130323046|NCT02318706|469153510|FG001|Double-blind Phase|Lost to Follow-up|0|||
130323047|NCT02318706|469153511|FG002|Double-blind Phase|Lost to Follow-up|0|||
130323048|NCT02318706|469153512|FG003|Double-blind Phase|Lost to Follow-up|0|||
130323049|NCT02318706|469153513|FG004|Double-blind Phase|Lost to Follow-up|0|||
130323050|NCT02318706|469153509|FG000|Double-blind Phase|Protocol Violation|4|||
130323051|NCT02318706|469153510|FG001|Double-blind Phase|Protocol Violation|2|||
130323052|NCT02318706|469153511|FG002|Double-blind Phase|Protocol Violation|4|||
130323053|NCT02318706|469153512|FG003|Double-blind Phase|Protocol Violation|3|||
130323054|NCT02318706|469153513|FG004|Double-blind Phase|Protocol Violation|0|||
130323055|NCT02318706|469153509|FG000|Double-blind Phase|Withdrawal by Subject|9|||
130323056|NCT02318706|469153510|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130323057|NCT02318706|469153511|FG002|Double-blind Phase|Withdrawal by Subject|7|||
130323058|NCT02318706|469153512|FG003|Double-blind Phase|Withdrawal by Subject|10|||
130323059|NCT02318706|469153513|FG004|Double-blind Phase|Withdrawal by Subject|0|||
130323060|NCT02318706|469153509|FG000|Double-blind Phase|Other|4|||
130323061|NCT02318706|469153510|FG001|Double-blind Phase|Other|1|||
130323062|NCT02318706|469153511|FG002|Double-blind Phase|Other|2|||
130323063|NCT02318706|469153512|FG003|Double-blind Phase|Other|1|||
130323064|NCT02318706|469153513|FG004|Double-blind Phase|Other|0|||
130323065|NCT02318706|469153509|FG000|Double-blind Phase|Death|0|||
130323066|NCT02318706|469153510|FG001|Double-blind Phase|Death|0|||
130323067|NCT02318706|469153511|FG002|Double-blind Phase|Death|2|||
130323068|NCT02318706|469153512|FG003|Double-blind Phase|Death|0|||
130323069|NCT02318706|469153513|FG004|Double-blind Phase|Death|0|||
130550111|NCT00818649|469981308|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
130550112|NCT00818649|469981308|FG000|Overall Study|Adverse Event|1|||
130550113|NCT03513588|469981309|FG000|Overall Study|Lost to Follow-up|0|||
130550114|NCT03513588|469981310|FG001|Overall Study|Lost to Follow-up|1|||
130550115|NCT03513588|469981311|FG002|Overall Study|Lost to Follow-up|1|||
130550116|NCT03513588|469981309|FG000|Overall Study|Study dosing paused by sponsor|1|||
130550117|NCT03513588|469981310|FG001|Overall Study|Study dosing paused by sponsor|1|||
130550118|NCT03513588|469981311|FG002|Overall Study|Study dosing paused by sponsor|0|||
130550119|NCT03513588|469981309|FG000|Overall Study|Death|0|||
130550120|NCT03513588|469981310|FG001|Overall Study|Death|0|||
130550121|NCT03513588|469981311|FG002|Overall Study|Death|1|||
130550122|NCT00940108|469981312|FG000|Overall Study|Adverse Event|2|||
130550123|NCT00940108|469981313|FG001|Overall Study|Adverse Event|4|||
130550124|NCT00940108|469981314|FG002|Overall Study|Adverse Event|0|||
130550125|NCT00940108|469981315|FG003|Overall Study|Adverse Event|2|||
130550126|NCT00940108|469981312|FG000|Overall Study|Withdrew Consent|2|||
130550127|NCT00940108|469981313|FG001|Overall Study|Withdrew Consent|1|||
130550128|NCT00940108|469981314|FG002|Overall Study|Withdrew Consent|0|||
130550129|NCT00940108|469981315|FG003|Overall Study|Withdrew Consent|1|||
130550130|NCT00940108|469981312|FG000|Overall Study|Dose 2 contraindicated|1|||
130550131|NCT00940108|469981313|FG001|Overall Study|Dose 2 contraindicated|1|||
130550132|NCT00940108|469981314|FG002|Overall Study|Dose 2 contraindicated|0|||
130550133|NCT00940108|469981315|FG003|Overall Study|Dose 2 contraindicated|1|||
130550134|NCT00940108|469981312|FG000|Overall Study|Declined further vaccination|0|||
130550135|NCT00940108|469981313|FG001|Overall Study|Declined further vaccination|1|||
130550136|NCT00940108|469981314|FG002|Overall Study|Declined further vaccination|3|||
130323070|NCT02318706|469153509|FG000|Open-label Extension Phase|Adverse Event|0|||
130323071|NCT02318706|469153510|FG001|Open-label Extension Phase|Adverse Event|0|||
130323072|NCT02318706|469153511|FG002|Open-label Extension Phase|Adverse Event|0|||
130323073|NCT02318706|469153512|FG003|Open-label Extension Phase|Adverse Event|0|||
130323074|NCT02318706|469153513|FG004|Open-label Extension Phase|Adverse Event|21|||
130323075|NCT02318706|469153509|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
130550137|NCT00940108|469981315|FG003|Overall Study|Declined further vaccination|0|||
130550138|NCT00940108|469981312|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
130550139|NCT00940108|469981313|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
130550140|NCT00940108|469981314|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
130550141|NCT00940108|469981315|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
130550142|NCT00940108|469981312|FG000|Overall Study|Viral illness after Dose 1|0|||
130550143|NCT00940108|469981313|FG001|Overall Study|Viral illness after Dose 1|1|||
130550144|NCT00940108|469981314|FG002|Overall Study|Viral illness after Dose 1|0|||
130550145|NCT00940108|469981315|FG003|Overall Study|Viral illness after Dose 1|0|||
130550146|NCT00940108|469981312|FG000|Overall Study|Diagnosed with H1N1|0|||
130550147|NCT00940108|469981313|FG001|Overall Study|Diagnosed with H1N1|0|||
130550148|NCT00940108|469981314|FG002|Overall Study|Diagnosed with H1N1|0|||
130550149|NCT00940108|469981315|FG003|Overall Study|Diagnosed with H1N1|1|||
130550150|NCT02075541|469981319|FG000|Overall Study|Serious Adverse Event|1|||
130550151|NCT02075541|469981320|FG001|Overall Study|Serious Adverse Event|4|||
130550152|NCT02075541|469981319|FG000|Overall Study|Protocol Violation|1|||
130550153|NCT02075541|469981320|FG001|Overall Study|Protocol Violation|0|||
130550154|NCT02075541|469981319|FG000|Overall Study|Withdrawal by Subject|1|||
130550155|NCT02075541|469981320|FG001|Overall Study|Withdrawal by Subject|3|||
130550156|NCT02075541|469981319|FG000|Overall Study|Sponsor study termination|0|||
130550157|NCT02075541|469981320|FG001|Overall Study|Sponsor study termination|1|||
130550158|NCT02075541|469981319|FG000|Overall Study|Other- unable to perform study procedure|1|||
130550159|NCT02075541|469981320|FG001|Overall Study|Other- unable to perform study procedure|0|||
130550160|NCT01142596|469981322|FG000|Overall Study|Withdrawal by Subject|9|||
130550161|NCT01142596|469981323|FG001|Overall Study|Withdrawal by Subject|35|||
130550162|NCT01142596|469981322|FG000|Overall Study|Adverse Event|8|||
130550163|NCT01142596|469981323|FG001|Overall Study|Adverse Event|35|||
130550164|NCT01142596|469981322|FG000|Overall Study|Lack of Efficacy|5|||
130550165|NCT01142596|469981323|FG001|Overall Study|Lack of Efficacy|9|||
130550166|NCT01142596|469981322|FG000|Overall Study|Lost to Follow-up|2|||
130550167|NCT01142596|469981323|FG001|Overall Study|Lost to Follow-up|3|||
130550168|NCT01142596|469981322|FG000|Overall Study|Other reason (not specified)|5|||
130550169|NCT01142596|469981323|FG001|Overall Study|Other reason (not specified)|4|||
130550170|NCT00585195|469981326|FG000|Overall Study|Adverse Event|0|||
130550171|NCT00585195|469981327|FG001|Overall Study|Adverse Event|0|||
130550172|NCT00585195|469981328|FG002|Overall Study|Adverse Event|0|||
130214088|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214089|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214090|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214091|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214092|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214093|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214094|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214095|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214096|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
130214097|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
130214098|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214099|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214100|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214101|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214102|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214103|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214104|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214105|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214106|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214107|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214108|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214109|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214110|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214111|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214112|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130214113|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214114|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
130550173|NCT00585195|469981329|FG003|Overall Study|Adverse Event|0|||
130550174|NCT00585195|469981330|FG004|Overall Study|Adverse Event|2|||
130550175|NCT00585195|469981331|FG005|Overall Study|Adverse Event|1|||
130550176|NCT00585195|469981332|FG006|Overall Study|Adverse Event|0|||
130550177|NCT00585195|469981333|FG007|Overall Study|Adverse Event|1|||
130550178|NCT00585195|469981334|FG008|Overall Study|Adverse Event|0|||
130550179|NCT00585195|469981335|FG009|Overall Study|Adverse Event|0|||
130550180|NCT00585195|469981336|FG010|Overall Study|Adverse Event|3|||
130550181|NCT00585195|469981337|FG011|Overall Study|Adverse Event|0|||
130550182|NCT00585195|469981338|FG012|Overall Study|Adverse Event|8|||
130550183|NCT00585195|469981339|FG013|Overall Study|Adverse Event|6|||
130550184|NCT00585195|469981340|FG014|Overall Study|Adverse Event|4|||
130550185|NCT00585195|469981341|FG015|Overall Study|Adverse Event|1|||
130550186|NCT00585195|469981342|FG016|Overall Study|Adverse Event|14|||
130550187|NCT00585195|469981343|FG017|Overall Study|Adverse Event|9|||
130550188|NCT00585195|469981344|FG018|Overall Study|Adverse Event|2|||
130550189|NCT00585195|469981345|FG019|Overall Study|Adverse Event|3|||
130550190|NCT00585195|469981346|FG020|Overall Study|Adverse Event|1|||
130550191|NCT00585195|469981326|FG000|Overall Study|Progressive Disease|2|||
130550192|NCT00585195|469981327|FG001|Overall Study|Progressive Disease|2|||
130550193|NCT00585195|469981328|FG002|Overall Study|Progressive Disease|5|||
130550194|NCT00585195|469981329|FG003|Overall Study|Progressive Disease|4|||
130550195|NCT00585195|469981330|FG004|Overall Study|Progressive Disease|6|||
130550196|NCT00585195|469981331|FG005|Overall Study|Progressive Disease|4|||
130550197|NCT00585195|469981332|FG006|Overall Study|Progressive Disease|6|||
130550198|NCT00585195|469981333|FG007|Overall Study|Progressive Disease|3|||
130550199|NCT00585195|469981334|FG008|Overall Study|Progressive Disease|0|||
130550200|NCT00585195|469981335|FG009|Overall Study|Progressive Disease|5|||
130550201|NCT00585195|469981336|FG010|Overall Study|Progressive Disease|2|||
130550202|NCT00585195|469981337|FG011|Overall Study|Progressive Disease|25|||
130550203|NCT00585195|469981338|FG012|Overall Study|Progressive Disease|29|||
130550204|NCT00585195|469981339|FG013|Overall Study|Progressive Disease|26|||
130550205|NCT00585195|469981340|FG014|Overall Study|Progressive Disease|21|||
130550206|NCT00585195|469981341|FG015|Overall Study|Progressive Disease|12|||
130550207|NCT00585195|469981342|FG016|Overall Study|Progressive Disease|94|||
130550208|NCT00585195|469981343|FG017|Overall Study|Progressive Disease|42|||
130550209|NCT00585195|469981344|FG018|Overall Study|Progressive Disease|4|||
130550210|NCT00585195|469981345|FG019|Overall Study|Progressive Disease|9|||
130550211|NCT00585195|469981346|FG020|Overall Study|Progressive Disease|8|||
130550212|NCT00585195|469981326|FG000|Overall Study|Withdrawal by Subject|1|||
130550213|NCT00585195|469981327|FG001|Overall Study|Withdrawal by Subject|1|||
130550214|NCT00585195|469981328|FG002|Overall Study|Withdrawal by Subject|2|||
130550215|NCT00585195|469981329|FG003|Overall Study|Withdrawal by Subject|2|||
130550216|NCT00585195|469981330|FG004|Overall Study|Withdrawal by Subject|0|||
130550217|NCT00585195|469981331|FG005|Overall Study|Withdrawal by Subject|0|||
130550218|NCT00585195|469981332|FG006|Overall Study|Withdrawal by Subject|0|||
130550219|NCT00585195|469981333|FG007|Overall Study|Withdrawal by Subject|1|||
130550220|NCT00585195|469981334|FG008|Overall Study|Withdrawal by Subject|0|||
130550221|NCT00585195|469981335|FG009|Overall Study|Withdrawal by Subject|0|||
130550222|NCT00585195|469981336|FG010|Overall Study|Withdrawal by Subject|3|||
130550223|NCT00585195|469981337|FG011|Overall Study|Withdrawal by Subject|8|||
130550224|NCT00585195|469981338|FG012|Overall Study|Withdrawal by Subject|15|||
130550225|NCT00585195|469981339|FG013|Overall Study|Withdrawal by Subject|0|||
130550226|NCT00585195|469981340|FG014|Overall Study|Withdrawal by Subject|3|||
130550227|NCT00585195|469981341|FG015|Overall Study|Withdrawal by Subject|0|||
130550228|NCT00585195|469981342|FG016|Overall Study|Withdrawal by Subject|7|||
130550229|NCT00585195|469981343|FG017|Overall Study|Withdrawal by Subject|1|||
130550230|NCT00585195|469981344|FG018|Overall Study|Withdrawal by Subject|2|||
130550231|NCT00585195|469981345|FG019|Overall Study|Withdrawal by Subject|2|||
130550232|NCT00585195|469981346|FG020|Overall Study|Withdrawal by Subject|0|||
130550233|NCT00585195|469981326|FG000|Overall Study|Other|0|||
130550234|NCT00585195|469981327|FG001|Overall Study|Other|1|||
130550235|NCT00585195|469981328|FG002|Overall Study|Other|1|||
130550236|NCT00585195|469981329|FG003|Overall Study|Other|1|||
130550237|NCT00585195|469981330|FG004|Overall Study|Other|0|||
130550238|NCT00585195|469981331|FG005|Overall Study|Other|1|||
130550239|NCT00585195|469981332|FG006|Overall Study|Other|0|||
130550240|NCT00585195|469981333|FG007|Overall Study|Other|0|||
130550241|NCT00585195|469981334|FG008|Overall Study|Other|2|||
130550242|NCT00585195|469981335|FG009|Overall Study|Other|1|||
130550243|NCT00585195|469981336|FG010|Overall Study|Other|0|||
130323076|NCT02318706|469153510|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130550244|NCT00585195|469981337|FG011|Overall Study|Other|19|||
130550245|NCT00585195|469981338|FG012|Overall Study|Other|24|||
130550246|NCT00585195|469981339|FG013|Overall Study|Other|7|||
130550247|NCT00585195|469981340|FG014|Overall Study|Other|11|||
130550248|NCT00585195|469981341|FG015|Overall Study|Other|3|||
130550249|NCT00585195|469981342|FG016|Overall Study|Other|28|||
130550250|NCT00585195|469981343|FG017|Overall Study|Other|12|||
130550251|NCT00585195|469981344|FG018|Overall Study|Other|10|||
130550252|NCT00585195|469981345|FG019|Overall Study|Other|4|||
130550253|NCT00585195|469981346|FG020|Overall Study|Other|2|||
130550254|NCT00585195|469981326|FG000|Overall Study|Randomized not treated|0|||
130550255|NCT00585195|469981327|FG001|Overall Study|Randomized not treated|0|||
130550256|NCT00585195|469981328|FG002|Overall Study|Randomized not treated|1|||
130550257|NCT00585195|469981329|FG003|Overall Study|Randomized not treated|0|||
130550258|NCT00585195|469981330|FG004|Overall Study|Randomized not treated|1|||
130550259|NCT00585195|469981331|FG005|Overall Study|Randomized not treated|0|||
130550260|NCT00585195|469981332|FG006|Overall Study|Randomized not treated|1|||
130550261|NCT00585195|469981333|FG007|Overall Study|Randomized not treated|0|||
130550262|NCT00585195|469981334|FG008|Overall Study|Randomized not treated|0|||
130550263|NCT00585195|469981335|FG009|Overall Study|Randomized not treated|0|||
130550264|NCT00585195|469981336|FG010|Overall Study|Randomized not treated|2|||
130550265|NCT00585195|469981337|FG011|Overall Study|Randomized not treated|0|||
130550266|NCT00585195|469981338|FG012|Overall Study|Randomized not treated|0|||
130550267|NCT00585195|469981339|FG013|Overall Study|Randomized not treated|0|||
130550268|NCT00585195|469981340|FG014|Overall Study|Randomized not treated|0|||
130550269|NCT00585195|469981341|FG015|Overall Study|Randomized not treated|1|||
130550270|NCT00585195|469981342|FG016|Overall Study|Randomized not treated|0|||
130550271|NCT00585195|469981343|FG017|Overall Study|Randomized not treated|1|||
130550272|NCT00585195|469981344|FG018|Overall Study|Randomized not treated|3|||
130550273|NCT00585195|469981345|FG019|Overall Study|Randomized not treated|0|||
130550274|NCT00585195|469981346|FG020|Overall Study|Randomized not treated|2|||
130550275|NCT00585195|469981326|FG000|Overall Study|Death|0|||
130550276|NCT00585195|469981327|FG001|Overall Study|Death|0|||
130323077|NCT02318706|469153511|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
130550277|NCT00585195|469981328|FG002|Overall Study|Death|0|||
130550278|NCT00585195|469981329|FG003|Overall Study|Death|0|||
130550279|NCT00585195|469981330|FG004|Overall Study|Death|0|||
130550280|NCT00585195|469981331|FG005|Overall Study|Death|0|||
130550281|NCT00585195|469981332|FG006|Overall Study|Death|0|||
130550282|NCT00585195|469981333|FG007|Overall Study|Death|0|||
130550283|NCT00585195|469981334|FG008|Overall Study|Death|1|||
130550284|NCT00585195|469981335|FG009|Overall Study|Death|0|||
130550285|NCT00585195|469981336|FG010|Overall Study|Death|1|||
130550286|NCT00585195|469981337|FG011|Overall Study|Death|1|||
130550287|NCT00585195|469981338|FG012|Overall Study|Death|7|||
130550288|NCT00585195|469981339|FG013|Overall Study|Death|2|||
130550289|NCT00585195|469981340|FG014|Overall Study|Death|8|||
130550290|NCT00585195|469981341|FG015|Overall Study|Death|2|||
130550291|NCT00585195|469981342|FG016|Overall Study|Death|11|||
130550292|NCT00585195|469981343|FG017|Overall Study|Death|0|||
130550293|NCT00585195|469981344|FG018|Overall Study|Death|0|||
130550294|NCT00585195|469981345|FG019|Overall Study|Death|0|||
130550295|NCT00585195|469981346|FG020|Overall Study|Death|1|||
130550296|NCT00585195|469981326|FG000|Overall Study|Lost to Follow-up|0|||
130550297|NCT00585195|469981327|FG001|Overall Study|Lost to Follow-up|0|||
130550298|NCT00585195|469981328|FG002|Overall Study|Lost to Follow-up|0|||
130550299|NCT00585195|469981329|FG003|Overall Study|Lost to Follow-up|0|||
130550300|NCT00585195|469981330|FG004|Overall Study|Lost to Follow-up|0|||
130550301|NCT00585195|469981331|FG005|Overall Study|Lost to Follow-up|0|||
130550302|NCT00585195|469981332|FG006|Overall Study|Lost to Follow-up|0|||
130550303|NCT00585195|469981333|FG007|Overall Study|Lost to Follow-up|0|||
130550304|NCT00585195|469981334|FG008|Overall Study|Lost to Follow-up|0|||
130550305|NCT00585195|469981335|FG009|Overall Study|Lost to Follow-up|0|||
130550306|NCT00585195|469981336|FG010|Overall Study|Lost to Follow-up|0|||
130550307|NCT00585195|469981337|FG011|Overall Study|Lost to Follow-up|0|||
130323078|NCT02318706|469153512|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
130323079|NCT02318706|469153513|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
130323080|NCT02318706|469153509|FG000|Open-label Extension Phase|Death|0|||
130323081|NCT02318706|469153510|FG001|Open-label Extension Phase|Death|0|||
130323082|NCT02318706|469153511|FG002|Open-label Extension Phase|Death|0|||
130323083|NCT02318706|469153512|FG003|Open-label Extension Phase|Death|0|||
130323084|NCT02318706|469153513|FG004|Open-label Extension Phase|Death|1|||
130323085|NCT02318706|469153509|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
130323086|NCT02318706|469153510|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130323087|NCT02318706|469153511|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
130323088|NCT02318706|469153512|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
130323089|NCT02318706|469153513|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
130323090|NCT00755183|469153516|FG000|Overall Study|Adverse Event|5|||
130550308|NCT00585195|469981338|FG012|Overall Study|Lost to Follow-up|1|||
130550309|NCT00585195|469981339|FG013|Overall Study|Lost to Follow-up|0|||
130550310|NCT00585195|469981340|FG014|Overall Study|Lost to Follow-up|0|||
130550311|NCT00585195|469981341|FG015|Overall Study|Lost to Follow-up|0|||
130550312|NCT00585195|469981342|FG016|Overall Study|Lost to Follow-up|0|||
130550313|NCT00585195|469981343|FG017|Overall Study|Lost to Follow-up|2|||
130550314|NCT00585195|469981344|FG018|Overall Study|Lost to Follow-up|0|||
130550315|NCT00585195|469981345|FG019|Overall Study|Lost to Follow-up|0|||
130550316|NCT00585195|469981346|FG020|Overall Study|Lost to Follow-up|0|||
130323091|NCT00755183|469153517|FG001|Overall Study|Adverse Event|2|||
130323092|NCT00755183|469153516|FG000|Overall Study|Protocol Violation|0|||
130550317|NCT00585195|469981326|FG000|Overall Study|Site Terminated by Sponsor|0|||
130550318|NCT00585195|469981327|FG001|Overall Study|Site Terminated by Sponsor|0|||
130550319|NCT00585195|469981328|FG002|Overall Study|Site Terminated by Sponsor|0|||
130550320|NCT00585195|469981329|FG003|Overall Study|Site Terminated by Sponsor|0|||
130550321|NCT00585195|469981330|FG004|Overall Study|Site Terminated by Sponsor|0|||
130550322|NCT00585195|469981331|FG005|Overall Study|Site Terminated by Sponsor|0|||
130550323|NCT00585195|469981332|FG006|Overall Study|Site Terminated by Sponsor|0|||
130550324|NCT00585195|469981333|FG007|Overall Study|Site Terminated by Sponsor|0|||
130550325|NCT00585195|469981334|FG008|Overall Study|Site Terminated by Sponsor|0|||
130550326|NCT00585195|469981335|FG009|Overall Study|Site Terminated by Sponsor|0|||
130550327|NCT00585195|469981336|FG010|Overall Study|Site Terminated by Sponsor|0|||
130550328|NCT00585195|469981337|FG011|Overall Study|Site Terminated by Sponsor|0|||
130550329|NCT00585195|469981338|FG012|Overall Study|Site Terminated by Sponsor|1|||
130550330|NCT00585195|469981339|FG013|Overall Study|Site Terminated by Sponsor|0|||
130550331|NCT00585195|469981340|FG014|Overall Study|Site Terminated by Sponsor|0|||
130550332|NCT00585195|469981341|FG015|Overall Study|Site Terminated by Sponsor|0|||
130550333|NCT00585195|469981342|FG016|Overall Study|Site Terminated by Sponsor|0|||
130550334|NCT00585195|469981343|FG017|Overall Study|Site Terminated by Sponsor|0|||
130550335|NCT00585195|469981344|FG018|Overall Study|Site Terminated by Sponsor|0|||
130550336|NCT00585195|469981345|FG019|Overall Study|Site Terminated by Sponsor|0|||
130550337|NCT00585195|469981346|FG020|Overall Study|Site Terminated by Sponsor|0|||
130550338|NCT00585195|469981326|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
130550339|NCT00585195|469981327|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
130550340|NCT00585195|469981328|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
130550341|NCT00585195|469981329|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
130550342|NCT00585195|469981330|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
130550343|NCT00585195|469981331|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
130550344|NCT00585195|469981332|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
130550345|NCT00585195|469981333|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
130550346|NCT00585195|469981334|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
130550347|NCT00585195|469981335|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
130550348|NCT00585195|469981336|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
130550349|NCT00585195|469981337|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
130323093|NCT00755183|469153517|FG001|Overall Study|Protocol Violation|1|||
130323094|NCT00755183|469153516|FG000|Overall Study|Withdrawal by Subject|0|||
130323095|NCT00755183|469153517|FG001|Overall Study|Withdrawal by Subject|2|||
130323096|NCT00755183|469153516|FG000|Overall Study|Administrative|2|||
130323097|NCT00755183|469153517|FG001|Overall Study|Administrative|1|||
130323098|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
130323099|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
130323100|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
130323101|NCT00992108|469153526|FG000|Overall Study|Lost to Follow-up|0|||
130323102|NCT00992108|469153527|FG001|Overall Study|Lost to Follow-up|1|||
130550350|NCT00585195|469981338|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
130550351|NCT00585195|469981339|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
130550352|NCT00585195|469981340|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
130550353|NCT00585195|469981341|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
130550354|NCT00585195|469981342|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
130550355|NCT00585195|469981343|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
130550356|NCT00585195|469981344|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
130550357|NCT00585195|469981345|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
130550358|NCT00585195|469981346|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
130550359|NCT02796560|469981347|FG000|Overall Study|Adverse Event|2|||
130550360|NCT02796560|469981348|FG001|Overall Study|Adverse Event|0|||
130550361|NCT02796560|469981347|FG000|Overall Study|Withdrawal by Subject|2|||
130550362|NCT02796560|469981348|FG001|Overall Study|Withdrawal by Subject|2|||
130550363|NCT02533570|469981349|FG000|Overall Study|Adverse Event|0|||
130550364|NCT02533570|469981350|FG001|Overall Study|Adverse Event|1|||
130550365|NCT02533570|469981351|FG002|Overall Study|Adverse Event|1|||
130550366|NCT04002401|469981353|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
130550367|NCT04002401|469981353|FG000|Overall Study|Death|10|||
130550368|NCT04002401|469981353|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
130550369|NCT04002401|469981353|FG000|Overall Study|Enrolled but Never Treated|1|||
130550370|NCT04002401|469981353|FG000|Overall Study|Lost to Follow-up|1|||
130550371|NCT00423930|469981354|FG000|Overall Study|Withdrawal by Subject|2|||
130550372|NCT02656823|469981355|FG000|Overall Study|Adverse Event|3|||
130550373|NCT02656823|469981355|FG000|Overall Study|Lost to Follow-up|2|||
130550374|NCT01009580|469981360|FG000|Overall Study|Adverse Event|4|||
130550375|NCT01009580|469981361|FG001|Overall Study|Adverse Event|4|||
130550376|NCT01009580|469981360|FG000|Overall Study|Lack of Efficacy|0|||
130550377|NCT01009580|469981361|FG001|Overall Study|Lack of Efficacy|1|||
130550378|NCT01009580|469981360|FG000|Overall Study|Protocol Violation|2|||
130550379|NCT01009580|469981361|FG001|Overall Study|Protocol Violation|3|||
130550380|NCT01009580|469981360|FG000|Overall Study|Withdrawal Criteria|4|||
130550381|NCT01009580|469981361|FG001|Overall Study|Withdrawal Criteria|6|||
130323103|NCT04639245|469153528|FG000|Overall Study|Death|1|||
130323104|NCT01702311|469153529|FG000|Overall Study|Withdrawal by Subject|3|||
130323105|NCT01702311|469153530|FG001|Overall Study|Withdrawal by Subject|2|||
130550382|NCT01009580|469981360|FG000|Overall Study|Unclassified|17|||
130323106|NCT01702311|469153529|FG000|Overall Study|Discharge less than 24 hours|10|||
130550383|NCT01009580|469981361|FG001|Overall Study|Unclassified|21|||
130550384|NCT05269355|469981365|FG000|Overall Study|Progressive Disease|104|||
130323107|NCT01702311|469153530|FG001|Overall Study|Discharge less than 24 hours|7|||
130323108|NCT01702311|469153529|FG000|Overall Study|Physician Decision|3|||
130323109|NCT01702311|469153530|FG001|Overall Study|Physician Decision|4|||
130323110|NCT04106557|469153534|FG000|Overall Study|Physician Decision|0|||
130323111|NCT04106557|469153535|FG001|Overall Study|Physician Decision|1|||
130323112|NCT04106557|469153536|FG002|Overall Study|Physician Decision|0|||
130323113|NCT04106557|469153534|FG000|Overall Study|Protocol Violation|0|||
130323114|NCT04106557|469153535|FG001|Overall Study|Protocol Violation|1|||
130323115|NCT04106557|469153536|FG002|Overall Study|Protocol Violation|0|||
130323116|NCT01209689|469153537|FG000|Overall Study|Insufficient Therapeutic Response|7|||
130323117|NCT01209689|469153538|FG001|Overall Study|Insufficient Therapeutic Response|2|||
130323118|NCT01209689|469153537|FG000|Overall Study|Refused Treatment|8|||
130323119|NCT01209689|469153538|FG001|Overall Study|Refused Treatment|3|||
130323120|NCT01209689|469153537|FG000|Overall Study|Adverse Event|4|||
130323121|NCT01209689|469153538|FG001|Overall Study|Adverse Event|0|||
130323122|NCT01209689|469153537|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130323123|NCT01209689|469153538|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130323124|NCT01209689|469153537|FG000|Overall Study|Failure to Return|3|||
130323125|NCT01209689|469153538|FG001|Overall Study|Failure to Return|0|||
130550385|NCT05269355|469981366|FG001|Overall Study|Progressive Disease|68|||
130550386|NCT05269355|469981365|FG000|Overall Study|Study Terminated by Sponsor|87|||
130550387|NCT05269355|469981366|FG001|Overall Study|Study Terminated by Sponsor|29|||
130550388|NCT05269355|469981365|FG000|Overall Study|Adverse Event|15|||
130550389|NCT05269355|469981366|FG001|Overall Study|Adverse Event|8|||
130550390|NCT05269355|469981365|FG000|Overall Study|Withdrawal by Subject|18|||
130550391|NCT05269355|469981366|FG001|Overall Study|Withdrawal by Subject|5|||
130550392|NCT05269355|469981365|FG000|Overall Study|Physician Decision|6|||
130550393|NCT05269355|469981366|FG001|Overall Study|Physician Decision|4|||
130550394|NCT05269355|469981365|FG000|Overall Study|Death|3|||
130550395|NCT05269355|469981366|FG001|Overall Study|Death|5|||
130550396|NCT05269355|469981365|FG000|Overall Study|Other Than Specified|5|||
130550397|NCT05269355|469981366|FG001|Overall Study|Other Than Specified|1|||
130550398|NCT05269355|469981365|FG000|Overall Study|Randomized But Not Treated|1|||
130550399|NCT05269355|469981366|FG001|Overall Study|Randomized But Not Treated|0|||
130550400|NCT00081497|469981367|FG000|Overall Study|Adverse Event|2|||
130550401|NCT00081497|469981368|FG001|Overall Study|Adverse Event|0|||
130550402|NCT00081497|469981367|FG000|Overall Study|Death|0|||
130550403|NCT00081497|469981368|FG001|Overall Study|Death|1|||
130550404|NCT00081497|469981367|FG000|Overall Study|Withdrawal by Subject|1|||
130550405|NCT00081497|469981368|FG001|Overall Study|Withdrawal by Subject|0|||
130550406|NCT00081497|469981367|FG000|Overall Study|Non-compliance|0|||
130550407|NCT00081497|469981368|FG001|Overall Study|Non-compliance|1|||
130550408|NCT00959647|469981370|FG000|Overall Study|Adverse Event|2|||
130550409|NCT00959647|469981370|FG000|Overall Study|Progressive disease|6|||
130550410|NCT00959647|469981370|FG000|Overall Study|Study terminated by sponsor|4|||
130550411|NCT00959647|469981370|FG000|Overall Study|Withdrawal by Subject|7|||
130550412|NCT01340196|469983237|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
130550413|NCT00171704|469983240|FG000|Overall Study|Adverse Event|24|||
130550414|NCT00171704|469983241|FG001|Overall Study|Adverse Event|33|||
130550415|NCT00171704|469983240|FG000|Overall Study|Disease Progression|14|||
130550416|NCT00171704|469983241|FG001|Overall Study|Disease Progression|9|||
130550417|NCT00171704|469983240|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
130550418|NCT00171704|469983241|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
130550419|NCT00171704|469983240|FG000|Overall Study|Administrative Problems|2|||
130550420|NCT00171704|469983241|FG001|Overall Study|Administrative Problems|1|||
130550421|NCT00171704|469983240|FG000|Overall Study|Death|2|||
130550422|NCT00171704|469983241|FG001|Overall Study|Death|2|||
130550423|NCT00171704|469983240|FG000|Overall Study|Withdrawal by Subject|1|||
130550424|NCT00171704|469983241|FG001|Overall Study|Withdrawal by Subject|3|||
130550425|NCT00171704|469983240|FG000|Overall Study|Protocol Violation|0|||
130550426|NCT00171704|469983241|FG001|Overall Study|Protocol Violation|1|||
130550427|NCT02141984|469983242|FG000|Overall Study|Lack of Efficacy|2|||
130550428|NCT00816400|469983246|FG000|Overall Study|Death|2|||
130550429|NCT00816400|469983247|FG001|Overall Study|Death|3|||
130323126|NCT01209689|469153537|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
130323127|NCT01209689|469153538|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
130323128|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130550430|NCT00816400|469983248|FG002|Overall Study|Death|3|||
130550431|NCT00816400|469983249|FG003|Overall Study|Death|3|||
130550432|NCT00816400|469983250|FG004|Overall Study|Death|2|||
130550433|NCT00816400|469983251|FG005|Overall Study|Death|3|||
130550434|NCT00816400|469983252|FG006|Overall Study|Death|2|||
130550435|NCT00816400|469983253|FG007|Overall Study|Death|5|||
130550436|NCT00816400|469983254|FG008|Overall Study|Death|6|||
130323129|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130550437|NCT00816400|469983246|FG000|Overall Study|In hospice care at the end of the study|0|||
130550438|NCT00816400|469983247|FG001|Overall Study|In hospice care at the end of the study|0|||
130323130|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
130323131|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130323132|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130323133|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130323134|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130323135|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323136|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323137|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130323138|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130323139|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
130323140|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323141|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323142|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323143|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323144|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130323145|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130323146|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130323147|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323148|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130323149|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130323150|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
130323151|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
130323152|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130323153|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323154|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323155|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323156|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323157|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323158|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130323159|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323160|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130323161|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323162|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323163|NCT03175367|469153539|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323164|NCT03175367|469153540|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323165|NCT03175367|469153541|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323166|NCT03175367|469153542|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323167|NCT03175367|469153543|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323168|NCT03175367|469153544|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323169|NCT03175367|469153545|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
130323170|NCT03175367|469153539|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323171|NCT03175367|469153540|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323172|NCT03175367|469153541|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323173|NCT03175367|469153542|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323174|NCT03175367|469153543|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323175|NCT03175367|469153544|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
130323176|NCT03175367|469153545|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130323177|NCT02151058|469153547|FG000|Overall Study|Withdrawal by Subject|1|||
130323178|NCT02151058|469153548|FG001|Overall Study|Withdrawal by Subject|1|||
130323179|NCT02151058|469153549|FG002|Overall Study|Withdrawal by Subject|3|||
130323180|NCT02151058|469153547|FG000|Overall Study|Lost to Follow-up|1|||
130323181|NCT02151058|469153548|FG001|Overall Study|Lost to Follow-up|0|||
130323182|NCT02151058|469153549|FG002|Overall Study|Lost to Follow-up|2|||
130323183|NCT03829228|469153550|FG000|Overall Study|Protocol Violation|1|||
130323184|NCT03337477|469153551|FG000|Overall Study|not categorized into the listed ones|11|||
130323185|NCT03337477|469153552|FG001|Overall Study|not categorized into the listed ones|9|||
130323186|NCT03337477|469153551|FG000|Overall Study|Withdrawal by Subject|0|||
130323187|NCT03337477|469153552|FG001|Overall Study|Withdrawal by Subject|1|||
130323188|NCT03337477|469153551|FG000|Overall Study|Death|0|||
130323189|NCT03337477|469153552|FG001|Overall Study|Death|1|||
130323190|NCT03337477|469153551|FG000|Overall Study|Lost to Follow-up|0|||
130323191|NCT03337477|469153552|FG001|Overall Study|Lost to Follow-up|2|||
130323192|NCT01462370|469153559|FG000|Overall Study|Lack of Qualifying Event|1|||
130323193|NCT01462370|469153560|FG001|Overall Study|Lack of Qualifying Event|1|||
130323194|NCT01462370|469153559|FG000|Overall Study|Physician Decision|0|||
130323195|NCT01462370|469153560|FG001|Overall Study|Physician Decision|1|||
130323196|NCT01462370|469153559|FG000|Overall Study|Withdrawal by Subject|0|||
130323197|NCT01462370|469153560|FG001|Overall Study|Withdrawal by Subject|3|||
130550439|NCT00816400|469983248|FG002|Overall Study|In hospice care at the end of the study|2|||
130550440|NCT00816400|469983249|FG003|Overall Study|In hospice care at the end of the study|0|||
130550441|NCT00816400|469983250|FG004|Overall Study|In hospice care at the end of the study|0|||
130550442|NCT00816400|469983251|FG005|Overall Study|In hospice care at the end of the study|0|||
130550443|NCT00816400|469983252|FG006|Overall Study|In hospice care at the end of the study|0|||
130550444|NCT00816400|469983253|FG007|Overall Study|In hospice care at the end of the study|0|||
130550445|NCT00816400|469983254|FG008|Overall Study|In hospice care at the end of the study|0|||
130550446|NCT00081770|469983255|FG000|Overall Study|Adverse Event|130|||
130550447|NCT00081770|469983256|FG001|Overall Study|Adverse Event|98|||
130550448|NCT00081770|469983257|FG002|Overall Study|Adverse Event|136|||
130550449|NCT00081770|469983255|FG000|Overall Study|Lack of Efficacy|262|||
130550450|NCT00081770|469983256|FG001|Overall Study|Lack of Efficacy|357|||
130550451|NCT00081770|469983257|FG002|Overall Study|Lack of Efficacy|211|||
130550452|NCT00081770|469983255|FG000|Overall Study|Lost to Follow-up|45|||
130550453|NCT00081770|469983256|FG001|Overall Study|Lost to Follow-up|34|||
130550454|NCT00081770|469983257|FG002|Overall Study|Lost to Follow-up|45|||
130550455|NCT00081770|469983255|FG000|Overall Study|Protocol Violation|15|||
130550456|NCT00081770|469983256|FG001|Overall Study|Protocol Violation|10|||
130550457|NCT00081770|469983257|FG002|Overall Study|Protocol Violation|10|||
130550458|NCT00081770|469983255|FG000|Overall Study|Withdrawal by Subject|45|||
130550459|NCT00081770|469983256|FG001|Overall Study|Withdrawal by Subject|40|||
130550460|NCT00081770|469983257|FG002|Overall Study|Withdrawal by Subject|42|||
130550461|NCT00081770|469983255|FG000|Overall Study|Did not meet protocol eligibility|2|||
130550462|NCT00081770|469983256|FG001|Overall Study|Did not meet protocol eligibility|0|||
130550463|NCT00081770|469983257|FG002|Overall Study|Did not meet protocol eligibility|3|||
130550464|NCT00081770|469983255|FG000|Overall Study|Administrative|1|||
130550465|NCT00081770|469983256|FG001|Overall Study|Administrative|0|||
130550466|NCT00081770|469983257|FG002|Overall Study|Administrative|1|||
130550467|NCT00081770|469983255|FG000|Overall Study|Other|2|||
130550468|NCT00081770|469983256|FG001|Overall Study|Other|7|||
130550469|NCT00081770|469983257|FG002|Overall Study|Other|8|||
130550470|NCT00601419|469983258|FG000|Overall Study|Lost to Follow-up|3|||
130550471|NCT00601419|469983258|FG000|Overall Study|Missed Visits|1|||
130550472|NCT01614197|469983259|FG000|Overall Study|Withdrawal by Subject|0|||
130550473|NCT01614197|469983260|FG001|Overall Study|Withdrawal by Subject|1|||
130550474|NCT01614197|469983261|FG002|Overall Study|Withdrawal by Subject|0|||
130550475|NCT01614197|469983262|FG003|Overall Study|Withdrawal by Subject|0|||
130550476|NCT02245672|469983263|FG000|Overall Study|Adverse Event|4|||
130550477|NCT02245672|469983264|FG001|Overall Study|Adverse Event|4|||
130550478|NCT02245672|469983265|FG002|Overall Study|Adverse Event|4|||
130550479|NCT02245672|469983263|FG000|Overall Study|Lost to Follow-up|3|||
130550480|NCT02245672|469983264|FG001|Overall Study|Lost to Follow-up|5|||
130550481|NCT02245672|469983265|FG002|Overall Study|Lost to Follow-up|1|||
130550482|NCT02245672|469983263|FG000|Overall Study|Withdrawal by Subject|6|||
130550483|NCT02245672|469983264|FG001|Overall Study|Withdrawal by Subject|3|||
130214115|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130214116|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
130214117|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130214118|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130214119|NCT02772809|468746968|FG000|Overall Study|not completed some tasks|6|||
130214120|NCT00534105|468746969|FG000|Overall Study|Lost to Follow-up|23|||
130214121|NCT00534105|468746970|FG001|Overall Study|Lost to Follow-up|39|||
130214122|NCT02774005|468746971|FG000|Overall Study|Adverse Event|8|||
130214123|NCT02774005|468746971|FG000|Overall Study|Withdrawal by Subject|23|||
130214124|NCT02774005|468746971|FG000|Overall Study|Lost to Follow-up|7|||
130214125|NCT02774005|468746971|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
130214126|NCT02774005|468746971|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
130214127|NCT02774005|468746971|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
130214128|NCT02774005|468746971|FG000|Overall Study|Death|1|||
130214129|NCT02774005|468746971|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
130214130|NCT02774005|468746971|FG000|Overall Study|Lack of compliance with study medication|4|||
130214131|NCT02774005|468746971|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
130214132|NCT02774005|468746971|FG000|Overall Study|another study|1|||
130323198|NCT00853307|469153561|FG000|Overall Study|Adverse Event|1|||
130550484|NCT02245672|469983265|FG002|Overall Study|Withdrawal by Subject|0|||
130550485|NCT02245672|469983263|FG000|Overall Study|Randomized in error (not treated)|0|||
130550486|NCT02245672|469983264|FG001|Overall Study|Randomized in error (not treated)|1|||
130550487|NCT02245672|469983265|FG002|Overall Study|Randomized in error (not treated)|0|||
130550488|NCT00971932|469983266|FG000|Overall Study|Withdrawal by Subject|1|||
130550489|NCT00971932|469983266|FG000|Overall Study|Investigator's decision|2|||
130550490|NCT00971932|469983266|FG000|Overall Study|Ongoing|4|||
130550491|NCT01765192|469983269|FG000|Treatment Period 1|Adverse Event|0|||
130550492|NCT01765192|469983270|FG001|Treatment Period 1|Adverse Event|1|||
130550493|NCT01765192|469983269|FG000|Washout Period|Voluntary Withdrawal|1|||
130550494|NCT01765192|469983270|FG001|Washout Period|Voluntary Withdrawal|1|||
130323199|NCT00853307|469153562|FG001|Overall Study|Adverse Event|2|||
130323200|NCT00853307|469153561|FG000|Overall Study|Withdrawal by Subject|1|||
130323201|NCT00853307|469153562|FG001|Overall Study|Withdrawal by Subject|2|||
130323202|NCT00853307|469153561|FG000|Overall Study|Reason Not Specified|0|||
130550495|NCT01765192|469983269|FG000|Washout Period|Reason not specified|1|||
130550496|NCT01765192|469983270|FG001|Washout Period|Reason not specified|0|||
130550497|NCT01765192|469983269|FG000|Treatment Period 2|Reason not specified|0|||
130550498|NCT01765192|469983270|FG001|Treatment Period 2|Reason not specified|2|||
130550499|NCT01765192|469983269|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
130550500|NCT01765192|469983270|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
130550501|NCT00876694|469983275|FG000|Overall Study|Adverse Event|10|||
130550502|NCT00876694|469983276|FG001|Overall Study|Adverse Event|7|||
130550503|NCT00876694|469983275|FG000|Overall Study|Subject withdrew consent|6|||
130550504|NCT00876694|469983276|FG001|Overall Study|Subject withdrew consent|4|||
130550505|NCT00876694|469983275|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130550506|NCT00876694|469983276|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130550507|NCT00876694|469983275|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130550508|NCT00876694|469983276|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130550509|NCT00876694|469983275|FG000|Overall Study|Administrative problems|1|||
130550510|NCT00876694|469983276|FG001|Overall Study|Administrative problems|1|||
130550511|NCT00876694|469983275|FG000|Overall Study|Death|1|||
130550512|NCT00876694|469983276|FG001|Overall Study|Death|0|||
130550513|NCT00288509|469983277|FG000|Treatment Cycle 1|Adverse Event|1|||
130550514|NCT00288509|469983277|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
130550515|NCT00288509|469983277|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
130550516|NCT00288509|469983277|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
130550517|NCT00288509|469983277|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
130550518|NCT00288509|469983277|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
130550519|NCT00288509|469983277|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
130550520|NCT00288509|469983277|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
130550521|NCT00288509|469983277|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
130550522|NCT00288509|469983277|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
130550523|NCT00288509|469983277|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
130550524|NCT00288509|469983277|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
130550525|NCT00288509|469983277|FG000|Treatment Cycle 4|Physician Decision|4|||
130550526|NCT00288509|469983277|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
130550527|NCT02349451|469983282|FG000|Overall Study|Withdrawal by Subject|0|||
130550528|NCT02349451|469983283|FG001|Overall Study|Withdrawal by Subject|1|||
130550529|NCT02349451|469983284|FG002|Overall Study|Withdrawal by Subject|2|||
130550530|NCT02349451|469983285|FG003|Overall Study|Withdrawal by Subject|1|||
130550531|NCT05116046|469983288|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130550532|NCT05116046|469983289|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130550533|NCT05116046|469983290|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130550534|NCT05116046|469983288|FG000|Overall Study|Study terminated by sponsor|14|||
130550535|NCT05116046|469983289|FG001|Overall Study|Study terminated by sponsor|16|||
130550536|NCT05116046|469983290|FG002|Overall Study|Study terminated by sponsor|1|||
130550537|NCT02683941|469983291|FG000|Double-blind Phase|Adverse Event|0|||
130550538|NCT02683941|469983292|FG001|Double-blind Phase|Adverse Event|1|||
130550539|NCT02683941|469983291|FG000|Double-blind Phase|Withdrawal by Subject|4|||
130550540|NCT02683941|469983292|FG001|Double-blind Phase|Withdrawal by Subject|2|||
130550541|NCT02683941|469983291|FG000|Double-blind Phase|Lost to Follow-up|1|||
130323203|NCT00853307|469153562|FG001|Overall Study|Reason Not Specified|1|||
130323204|NCT00473564|469153563|FG000|Overall Study|robot surgery aborted in OR|23|||
130323205|NCT00674817|469153564|FG000|Period 1|Withdrawal by Subject|2|||
130323206|NCT00674817|469153564|FG000|Period 1|Protocol Violation|1|||
130323207|NCT00674817|469153564|FG000|Period 3|Adverse Event|1|||
130323208|NCT00674817|469153564|FG000|Period 3|Protocol Violation|1|||
130323209|NCT00674817|469153564|FG000|Period 4|Adverse Event|1|||
130323210|NCT00837434|469153566|FG000|Overall Study|Physician Decision|3|||
130323211|NCT00837434|469153567|FG001|Overall Study|Physician Decision|0|||
130323212|NCT00837434|469153566|FG000|Overall Study|Lost to Follow-up|1|||
130323213|NCT00837434|469153567|FG001|Overall Study|Lost to Follow-up|1|||
130323214|NCT00837434|469153566|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
130323215|NCT00837434|469153567|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
130323216|NCT00837434|469153566|FG000|Overall Study|Noncompliant|2|||
130550542|NCT02683941|469983292|FG001|Double-blind Phase|Lost to Follow-up|0|||
130550543|NCT02683941|469983291|FG000|Double-blind Phase|Disease Progression|5|||
130550544|NCT02683941|469983292|FG001|Double-blind Phase|Disease Progression|2|||
130550545|NCT02683941|469983291|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
130550546|NCT02683941|469983292|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
130550547|NCT02683941|469983291|FG000|Open-label Treatment Phase|Disease Progression|1|||
130550548|NCT02683941|469983292|FG001|Open-label Treatment Phase|Disease Progression|2|||
130323217|NCT00837434|469153567|FG001|Overall Study|Noncompliant|0|||
130323218|NCT00837434|469153566|FG000|Overall Study|Baseline assessments not done in time|1|||
130323219|NCT00837434|469153567|FG001|Overall Study|Baseline assessments not done in time|0|||
130323220|NCT00837434|469153566|FG000|Overall Study|Unable to obtain study drug|1|||
130323221|NCT00837434|469153567|FG001|Overall Study|Unable to obtain study drug|0|||
130323222|NCT00459316|469153568|FG000|Steps 1 & 2|Other eligibility failure|1|||
130323223|NCT00459316|469153569|FG001|Steps 1 & 2|Other eligibility failure|1|||
130323224|NCT00459316|469153570|FG002|Steps 1 & 2|Other eligibility failure|0|||
130323225|NCT00459316|469153568|FG000|Steps 1 & 2|Death|1|||
130323226|NCT00459316|469153569|FG001|Steps 1 & 2|Death|1|||
130323227|NCT00459316|469153570|FG002|Steps 1 & 2|Death|0|||
130323228|NCT00459316|469153568|FG000|Steps 1 & 2|Not able to get to clinic|7|||
130323229|NCT00459316|469153569|FG001|Steps 1 & 2|Not able to get to clinic|4|||
130323230|NCT00459316|469153570|FG002|Steps 1 & 2|Not able to get to clinic|0|||
130323231|NCT00459316|469153568|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
130323232|NCT00459316|469153569|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
130323233|NCT00459316|469153570|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
130323234|NCT00459316|469153568|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
130323235|NCT00459316|469153569|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
130323236|NCT00459316|469153570|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
130323237|NCT00459316|469153568|FG000|Steps 1 & 2|Lost to Follow-up|5|||
130323238|NCT00459316|469153569|FG001|Steps 1 & 2|Lost to Follow-up|0|||
130323239|NCT00459316|469153570|FG002|Steps 1 & 2|Lost to Follow-up|2|||
130323240|NCT00459316|469153568|FG000|Step 3|Withdrawal by Subject|3|||
130323241|NCT00459316|469153569|FG001|Step 3|Withdrawal by Subject|0|||
130323242|NCT00459316|469153570|FG002|Step 3|Withdrawal by Subject|1|||
130323243|NCT01614886|469153571|FG000|Overall Study|Adverse Event|15|||
130323244|NCT01614886|469153572|FG001|Overall Study|Adverse Event|20|||
130323245|NCT01614886|469153571|FG000|Overall Study|Withdrawal by Subject|4|||
130323246|NCT01614886|469153572|FG001|Overall Study|Withdrawal by Subject|4|||
130323247|NCT01614886|469153571|FG000|Overall Study|Death|1|||
130323248|NCT01614886|469153572|FG001|Overall Study|Death|0|||
130323249|NCT01614886|469153571|FG000|Overall Study|Protocol deviation|0|||
130323250|NCT01614886|469153572|FG001|Overall Study|Protocol deviation|2|||
130323251|NCT01207414|469153574|FG000|Overall Study|Adverse Event|25|||
130323252|NCT01207414|469153575|FG001|Overall Study|Adverse Event|39|||
130323253|NCT01207414|469153574|FG000|Overall Study|Abnormal test procedure results|0|||
130323254|NCT01207414|469153575|FG001|Overall Study|Abnormal test procedure results|1|||
130323255|NCT01207414|469153574|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130323256|NCT01207414|469153575|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130323257|NCT01207414|469153574|FG000|Overall Study|Patient withdrew consent|14|||
130323258|NCT01207414|469153575|FG001|Overall Study|Patient withdrew consent|11|||
130550549|NCT02683941|469983291|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
130550550|NCT02683941|469983292|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
130550551|NCT02683941|469983291|FG000|Open-label Treatment Phase|Other|1|||
130550552|NCT02683941|469983292|FG001|Open-label Treatment Phase|Other|0|||
130550553|NCT02683941|469983291|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
130550554|NCT02683941|469983292|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
130550555|NCT02683941|469983291|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
130550556|NCT02683941|469983292|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
130550557|NCT02683941|469983291|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
130550558|NCT02683941|469983292|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
130550559|NCT02683941|469983291|FG000|Open-label Follow-up Phase|Other|8|||
130550560|NCT02683941|469983292|FG001|Open-label Follow-up Phase|Other|1|||
130550561|NCT00261846|469983293|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
130550562|NCT00261846|469983294|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
130550563|NCT00261846|469983295|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
130550564|NCT00261846|469983296|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550565|NCT00261846|469983297|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550566|NCT00261846|469983298|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550567|NCT00261846|469983299|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550568|NCT00261846|469983300|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550569|NCT00261846|469983301|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550570|NCT00261846|469983302|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550571|NCT00261846|469983303|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550572|NCT00261846|469983304|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130550573|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550574|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130323259|NCT01207414|469153574|FG000|Overall Study|Lost to Follow-up|15|||
130323260|NCT01207414|469153575|FG001|Overall Study|Lost to Follow-up|17|||
130323261|NCT01207414|469153574|FG000|Overall Study|Administrative problems|1|||
130323262|NCT01207414|469153575|FG001|Overall Study|Administrative problems|1|||
130323263|NCT01207414|469153574|FG000|Overall Study|Protocol deviation|12|||
130323264|NCT01207414|469153575|FG001|Overall Study|Protocol deviation|9|||
130323265|NCT01207414|469153574|FG000|Overall Study|Randomized in error|1|||
130550575|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550576|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
130550577|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550578|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550579|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550580|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550581|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
130550582|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550583|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550584|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
130550585|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550586|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550587|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550588|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
130550589|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
130550590|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
130550591|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
130550592|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
130550593|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550594|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
130550595|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550596|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
130550597|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550598|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550599|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550600|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
130550601|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
130550602|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550603|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
130550604|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550605|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
130550606|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
130550607|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
130550608|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
130550609|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
130550610|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
130550611|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
130550612|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
130550613|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
130550614|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
130550615|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
130550616|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
130550617|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
130550618|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
130550619|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
130550620|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
130550621|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
130550622|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
130550623|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
130550624|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
130550625|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
130550626|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
130550627|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
130550628|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
130550629|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
130550630|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
130550631|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
130550632|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
130550633|NCT00261846|469983293|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
130550634|NCT00261846|469983294|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
130550635|NCT00261846|469983295|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
130550636|NCT00261846|469983296|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
130550637|NCT00261846|469983297|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
130550638|NCT00261846|469983298|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
130550639|NCT00261846|469983299|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
130550640|NCT00261846|469983300|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
130550641|NCT00261846|469983301|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
130550642|NCT00261846|469983302|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
130550643|NCT00261846|469983303|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
130550644|NCT00261846|469983304|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
130550645|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
130550646|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
130550647|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Death|0|||
130550648|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Death|2|||
130550649|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
130550650|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
130550651|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
130550652|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
130550653|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
130550654|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
130323266|NCT01207414|469153575|FG001|Overall Study|Randomized in error|0|||
130323267|NCT03697252|469153578|FG000|Overall Study|Adverse Event|3|||
130323268|NCT03697252|469153579|FG001|Overall Study|Adverse Event|2|||
130323269|NCT03697252|469153578|FG000|Overall Study|Withdrawal by Subject|14|||
130323270|NCT03697252|469153579|FG001|Overall Study|Withdrawal by Subject|14|||
130323271|NCT03697252|469153578|FG000|Overall Study|Lost to Follow-up|0|||
130323272|NCT03697252|469153579|FG001|Overall Study|Lost to Follow-up|1|||
130323273|NCT03697252|469153578|FG000|Overall Study|Physician Decision|1|||
130323274|NCT03697252|469153579|FG001|Overall Study|Physician Decision|1|||
130323275|NCT03697252|469153578|FG000|Overall Study|Other|0|||
130323276|NCT03697252|469153579|FG001|Overall Study|Other|1|||
130323277|NCT02340026|469153580|FG000|Treatment Phase|Withdrawal by Subject|2|||
130323278|NCT02340026|469153581|FG001|Treatment Phase|Withdrawal by Subject|2|||
130323279|NCT02340026|469153580|FG000|Follow-up Phase|Lost to Follow-up|1|||
130323280|NCT02340026|469153581|FG001|Follow-up Phase|Lost to Follow-up|0|||
130323281|NCT02738801|469153593|FG000|Overall Study|Adverse Event|1|||
130323282|NCT02738801|469153594|FG001|Overall Study|Adverse Event|1|||
130323283|NCT02738801|469153593|FG000|Overall Study|Withdrawal by Subject|0|||
130323284|NCT02738801|469153594|FG001|Overall Study|Withdrawal by Subject|1|||
130323285|NCT00888134|469153609|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
130323286|NCT00888134|469153609|FG000|Follow-up|being followed for long-term survival|1|||
130323287|NCT01488890|469153612|FG000|Overall Study|Serious adverse event|2|||
130323288|NCT01488890|469153613|FG001|Overall Study|Serious adverse event|0|||
130323289|NCT01488890|469153614|FG002|Overall Study|Serious adverse event|0|||
130323290|NCT01488890|469153615|FG003|Overall Study|Serious adverse event|0|||
130323291|NCT01488890|469153612|FG000|Overall Study|Protocol Violation|3|||
130323292|NCT01488890|469153613|FG001|Overall Study|Protocol Violation|0|||
130323293|NCT01488890|469153614|FG002|Overall Study|Protocol Violation|4|||
130323294|NCT01488890|469153615|FG003|Overall Study|Protocol Violation|0|||
130323295|NCT01488890|469153612|FG000|Overall Study|Lost to Follow-up|13|||
130323296|NCT01488890|469153613|FG001|Overall Study|Lost to Follow-up|10|||
130323297|NCT01488890|469153614|FG002|Overall Study|Lost to Follow-up|20|||
130323298|NCT01488890|469153615|FG003|Overall Study|Lost to Follow-up|3|||
130323299|NCT01488890|469153612|FG000|Overall Study|Withdrawal by Subject|14|||
130323300|NCT01488890|469153613|FG001|Overall Study|Withdrawal by Subject|10|||
130323301|NCT01488890|469153614|FG002|Overall Study|Withdrawal by Subject|11|||
130323302|NCT01488890|469153615|FG003|Overall Study|Withdrawal by Subject|2|||
130323303|NCT05712460|469153616|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323304|NCT05712460|469153617|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323305|NCT05712460|469153618|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323306|NCT05712460|469153619|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323307|NCT05712460|469153620|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323308|NCT05712460|469153621|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323309|NCT05712460|469153622|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323310|NCT05712460|469153623|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
130323311|NCT05712460|469153624|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323312|NCT05712460|469153625|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323313|NCT05712460|469153626|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323314|NCT05712460|469153627|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323315|NCT00829426|469153632|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130323316|NCT00829426|469153633|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130323317|NCT05135767|469153636|FG000|Baseline|Lost to Follow-up|1|||
130323318|NCT05135767|469153637|FG001|Baseline|Lost to Follow-up|1|||
130550655|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
130550656|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
130323319|NCT05135767|469153636|FG000|Baseline|Withdrawal by Subject|0|||
130323320|NCT05135767|469153637|FG001|Baseline|Withdrawal by Subject|2|||
130323321|NCT05135767|469153636|FG000|Active Study Phase|Lost to Follow-up|2|||
130323322|NCT05135767|469153637|FG001|Active Study Phase|Lost to Follow-up|0|||
130323323|NCT02260934|469153643|FG000|Overall Study|Lost to Follow-up|2|||
130550657|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
130323324|NCT02260934|469153644|FG001|Overall Study|Lost to Follow-up|1|||
130323325|NCT02260934|469153643|FG000|Overall Study|Withdrawal by Subject|0|||
130323326|NCT02260934|469153644|FG001|Overall Study|Withdrawal by Subject|2|||
130323327|NCT02260934|469153643|FG000|Overall Study|Participant Relocated|1|||
130323328|NCT02260934|469153644|FG001|Overall Study|Participant Relocated|0|||
130550658|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
130550659|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
130550660|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
130550661|NCT00343252|469983305|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
130550662|NCT00343252|469983306|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
130550663|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
130550664|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
130550665|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Death|3|||
130550666|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Death|3|||
130550667|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
130550668|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
130550669|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
130550670|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
130550671|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
130550672|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
130550673|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
130550674|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
130550675|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
130550676|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
130550677|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
130550678|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
130550679|NCT00343252|469983305|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
130550680|NCT00343252|469983306|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
130550681|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
130550682|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
130550683|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Death|4|||
130550684|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Death|5|||
130550685|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
130550686|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
130550687|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
130550688|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
130550689|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
130550690|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
130550691|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
130550692|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
130550693|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
130550694|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
130550695|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
130550696|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
130550697|NCT00343252|469983305|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
130550698|NCT00343252|469983306|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
130550699|NCT01740323|469983307|FG000|Overall Study|Adverse Event|1|||
130214133|NCT02774005|468746971|FG000|Overall Study|cardiologist imposed travel restriction|1|||
130214134|NCT03275389|468746975|FG000|Overall Study|Lost to Follow-up|10|||
130214135|NCT03275389|468746976|FG001|Overall Study|Lost to Follow-up|10|||
130214136|NCT03275389|468746977|FG002|Overall Study|Lost to Follow-up|19|||
130214137|NCT03275389|468746978|FG003|Overall Study|Lost to Follow-up|12|||
130214138|NCT03275389|468746979|FG004|Overall Study|Lost to Follow-up|11|||
130214139|NCT03275389|468746980|FG005|Overall Study|Lost to Follow-up|12|||
130214140|NCT03275389|468746981|FG006|Overall Study|Lost to Follow-up|21|||
130214141|NCT03275389|468746982|FG007|Overall Study|Lost to Follow-up|15|||
130214142|NCT03275389|468746983|FG008|Overall Study|Lost to Follow-up|12|||
130214143|NCT03275389|468746984|FG009|Overall Study|Lost to Follow-up|14|||
130214144|NCT03275389|468746975|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214145|NCT03275389|468746976|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214146|NCT03275389|468746977|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214147|NCT03275389|468746978|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214148|NCT03275389|468746979|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214149|NCT03275389|468746980|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130214150|NCT03275389|468746981|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214151|NCT03275389|468746982|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214152|NCT03275389|468746983|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214153|NCT03275389|468746984|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130214154|NCT03275389|468746975|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130214155|NCT03275389|468746976|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130214156|NCT03275389|468746977|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130214157|NCT03275389|468746978|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
130323329|NCT02260934|469153643|FG000|Overall Study|Site error|0|||
130550700|NCT01740323|469983308|FG001|Overall Study|Adverse Event|0|||
130550701|NCT01740323|469983307|FG000|Overall Study|Randomized but did not take study drug|1|||
130550702|NCT01740323|469983308|FG001|Overall Study|Randomized but did not take study drug|0|||
130550703|NCT01054846|469983309|FG000|Overall Study|Lost to Follow-up|76|||
130550704|NCT01054846|469983310|FG001|Overall Study|Lost to Follow-up|17|||
130550705|NCT02446886|469983311|FG000|Overall Study|Adverse Event|1|||
130550706|NCT02446886|469983312|FG001|Overall Study|Adverse Event|3|||
130550707|NCT02446886|469983311|FG000|Overall Study|Withdrawal by Subject|1|||
130550708|NCT02446886|469983312|FG001|Overall Study|Withdrawal by Subject|1|||
130550709|NCT00928447|469983313|FG000|Overall Study|Withdrawal by Subject|1|||
130550710|NCT00928447|469983313|FG000|Overall Study|Investigator's decision|1|||
130550711|NCT01259284|469983318|FG000|Overall Study|Study Termination|2|||
130550712|NCT01259284|469983319|FG001|Overall Study|Study Termination|0|||
130550713|NCT01259284|469983320|FG002|Overall Study|Study Termination|0|||
130550714|NCT01971203|469983322|FG000|Overall Study|Protocol Violation|3|||
130550715|NCT01971203|469983323|FG001|Overall Study|Protocol Violation|2|||
130550716|NCT01971203|469983322|FG000|Overall Study|Withdrawal by Subject|5|||
130550717|NCT01971203|469983323|FG001|Overall Study|Withdrawal by Subject|6|||
130323330|NCT02260934|469153644|FG001|Overall Study|Site error|1|||
130323331|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
130323332|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
130323333|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
130323334|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
130323335|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
130323336|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
130323337|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
130323338|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
130323339|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130323340|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130323341|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
130323342|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
130323343|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
130323344|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
130323345|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130323346|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130323347|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
130323348|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
130323349|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
130323350|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
130323351|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
130323352|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
130323353|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Other|6|||
130323354|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Other|8|||
130323355|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
130323356|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
130323357|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
130323358|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
130323359|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
130323360|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
130323361|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
130323362|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
130323363|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
130323364|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
130323365|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
130323366|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
130323367|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Death|0|||
130323368|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Death|2|||
130323369|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
130323370|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
130323371|NCT03597347|469153651|FG000|Overall Study|Withdrawal by Subject|1|||
130323372|NCT03597347|469153652|FG001|Overall Study|Withdrawal by Subject|1|||
130323373|NCT03597347|469153653|FG002|Overall Study|Withdrawal by Subject|0|||
130323374|NCT03597347|469153651|FG000|Overall Study|Withdrawal due to Covid-19|3|||
130323375|NCT03597347|469153652|FG001|Overall Study|Withdrawal due to Covid-19|0|||
130323376|NCT03597347|469153653|FG002|Overall Study|Withdrawal due to Covid-19|0|||
130323377|NCT03597347|469153651|FG000|Overall Study|Sponsor decision to terminate study|3|||
130323378|NCT03597347|469153652|FG001|Overall Study|Sponsor decision to terminate study|2|||
130550718|NCT01971203|469983322|FG000|Overall Study|Adverse Event|1|||
130550719|NCT01971203|469983323|FG001|Overall Study|Adverse Event|0|||
130550720|NCT03353350|469983324|FG000|30-week Core Treatment Period|Protocol Violation|1|||
130550721|NCT03353350|469983325|FG001|30-week Core Treatment Period|Protocol Violation|1|||
130550722|NCT03353350|469983326|FG002|30-week Core Treatment Period|Protocol Violation|1|||
130550723|NCT03353350|469983327|FG003|30-week Core Treatment Period|Protocol Violation|0|||
130550724|NCT03353350|469983324|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
130550725|NCT03353350|469983325|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
130550726|NCT03353350|469983326|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
130550727|NCT03353350|469983327|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
130550728|NCT03353350|469983324|FG000|30-week Core Treatment Period|Adverse Event|0|||
130550729|NCT03353350|469983325|FG001|30-week Core Treatment Period|Adverse Event|4|||
130550730|NCT03353350|469983326|FG002|30-week Core Treatment Period|Adverse Event|2|||
130550731|NCT03353350|469983327|FG003|30-week Core Treatment Period|Adverse Event|3|||
130550732|NCT03353350|469983324|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
130550733|NCT03353350|469983325|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
130550734|NCT03353350|469983326|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
130550735|NCT03353350|469983327|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
130550736|NCT03353350|469983324|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
130550737|NCT03353350|469983325|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
130550738|NCT03353350|469983326|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
130550739|NCT03353350|469983327|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
130550740|NCT03353350|469983324|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
130550741|NCT03353350|469983325|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
130550742|NCT03353350|469983326|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
130550743|NCT03353350|469983327|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
130550744|NCT03353350|469983324|FG000|26-week Treatment Extension Period|Adverse Event|1|||
130550745|NCT03353350|469983325|FG001|26-week Treatment Extension Period|Adverse Event|0|||
130550746|NCT03353350|469983326|FG002|26-week Treatment Extension Period|Adverse Event|0|||
130550747|NCT03353350|469983327|FG003|26-week Treatment Extension Period|Adverse Event|1|||
130550748|NCT03353350|469983324|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
130550749|NCT03353350|469983325|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
130550750|NCT03353350|469983326|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
130550751|NCT03353350|469983327|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
130550752|NCT00807235|469983328|FG000|Overall Study|Adverse Event|1|||
130550753|NCT00807235|469983329|FG001|Overall Study|Adverse Event|0|||
130550754|NCT01012713|469983330|FG000|Overall Study|Lack of Efficacy|3|||
130550755|NCT00985153|469983331|FG000|Overall Study|Lost to Follow-up|16|||
130550756|NCT00985153|469983332|FG001|Overall Study|Lost to Follow-up|19|||
130550757|NCT00985153|469983333|FG002|Overall Study|Lost to Follow-up|17|||
130550758|NCT00985153|469983334|FG003|Overall Study|Lost to Follow-up|20|||
130550759|NCT00985153|469983331|FG000|Overall Study|Protocol Violation|3|||
130550760|NCT00985153|469983332|FG001|Overall Study|Protocol Violation|2|||
130550761|NCT00985153|469983333|FG002|Overall Study|Protocol Violation|4|||
130550762|NCT00985153|469983334|FG003|Overall Study|Protocol Violation|3|||
130550763|NCT00985153|469983331|FG000|Overall Study|Withdrawal by Subject|6|||
130550764|NCT00985153|469983332|FG001|Overall Study|Withdrawal by Subject|11|||
130550765|NCT00985153|469983333|FG002|Overall Study|Withdrawal by Subject|11|||
130550766|NCT00985153|469983334|FG003|Overall Study|Withdrawal by Subject|10|||
130550767|NCT00985153|469983331|FG000|Overall Study|Missed One or More Bleeds|7|||
130550768|NCT00985153|469983332|FG001|Overall Study|Missed One or More Bleeds|7|||
130550769|NCT00985153|469983333|FG002|Overall Study|Missed One or More Bleeds|8|||
130550770|NCT00985153|469983334|FG003|Overall Study|Missed One or More Bleeds|10|||
130550771|NCT00985153|469983331|FG000|Overall Study|Incomplete Safety Follow-up|3|||
130550772|NCT00985153|469983332|FG001|Overall Study|Incomplete Safety Follow-up|5|||
130550773|NCT00985153|469983333|FG002|Overall Study|Incomplete Safety Follow-up|4|||
130550774|NCT00985153|469983334|FG003|Overall Study|Incomplete Safety Follow-up|4|||
130550775|NCT03370471|469983336|FG000|Overall Study|Withdrawal by Subject|6|||
130550776|NCT03370471|469983337|FG001|Overall Study|Withdrawal by Subject|1|||
130550777|NCT03370471|469983336|FG000|Overall Study|Unable to access veins for blood draw|0|||
130214158|NCT03275389|468746979|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214159|NCT03275389|468746980|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214160|NCT03275389|468746981|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130550778|NCT03370471|469983337|FG001|Overall Study|Unable to access veins for blood draw|1|||
130550779|NCT03370471|469983336|FG000|Overall Study|Screen fail|1|||
130214161|NCT03275389|468746982|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214162|NCT03275389|468746983|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130214163|NCT03275389|468746984|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130214164|NCT03275389|468746975|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214165|NCT03275389|468746976|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130214166|NCT03275389|468746977|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214167|NCT03275389|468746978|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130214168|NCT03275389|468746979|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214169|NCT03275389|468746980|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130550780|NCT03370471|469983337|FG001|Overall Study|Screen fail|0|||
130550781|NCT01765179|469983338|FG000|Overall Study|Adverse Event|3|||
130214170|NCT03275389|468746981|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130214171|NCT03275389|468746982|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214172|NCT03275389|468746983|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214173|NCT03275389|468746984|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214174|NCT03275389|468746975|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214175|NCT03275389|468746976|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214176|NCT03275389|468746977|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130214177|NCT03275389|468746978|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214178|NCT03275389|468746979|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214179|NCT03275389|468746980|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214180|NCT03275389|468746981|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214181|NCT03275389|468746982|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214182|NCT03275389|468746983|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214183|NCT03275389|468746984|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130214184|NCT03275389|468746975|FG000|Overall Study|Other|0|||
130214185|NCT03275389|468746976|FG001|Overall Study|Other|4|||
130214186|NCT03275389|468746977|FG002|Overall Study|Other|3|||
130214187|NCT03275389|468746978|FG003|Overall Study|Other|2|||
130214188|NCT03275389|468746979|FG004|Overall Study|Other|2|||
130214189|NCT03275389|468746980|FG005|Overall Study|Other|2|||
130214190|NCT03275389|468746981|FG006|Overall Study|Other|0|||
130214191|NCT03275389|468746982|FG007|Overall Study|Other|0|||
130214192|NCT03275389|468746983|FG008|Overall Study|Other|1|||
130214193|NCT03275389|468746984|FG009|Overall Study|Other|0|||
130214194|NCT00978341|468746985|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
130214195|NCT00978341|468746986|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
130214196|NCT00448812|468746987|FG000|Year 2|Missed visit but remained in study|4|||
130214197|NCT00448812|468746988|FG001|Year 2|Missed visit but remained in study|1|||
130214198|NCT00448812|468746987|FG000|Year 3|Withdrawal by Subject|1|||
130214199|NCT00448812|468746988|FG001|Year 3|Withdrawal by Subject|3|||
130214200|NCT00448812|468746987|FG000|Year 3|Lost to Follow-up|1|||
130214201|NCT00448812|468746988|FG001|Year 3|Lost to Follow-up|0|||
130214202|NCT00448812|468746987|FG000|Year 3|Missed visit but remained in study|2|||
130214203|NCT00448812|468746988|FG001|Year 3|Missed visit but remained in study|0|||
130214204|NCT00448812|468746987|FG000|Year 5|Missed visit but remained in study|1|||
130214205|NCT00448812|468746988|FG001|Year 5|Missed visit but remained in study|0|||
130214206|NCT03035916|468746989|FG000|Overall Study|Puncture failed|0|||
130214207|NCT03035916|468746990|FG001|Overall Study|Puncture failed|2|||
130214208|NCT03035916|468746991|FG002|Overall Study|Puncture failed|0|||
130214209|NCT03885999|468746992|FG000|Overall Study|Adverse Event|1|||
130214210|NCT02452554|468746993|FG000|Overall Study|Death|2|||
130214211|NCT02452554|468746994|FG001|Overall Study|Death|1|||
130214212|NCT02452554|468746995|FG002|Overall Study|Death|0|||
130214213|NCT02452554|468746996|FG003|Overall Study|Death|0|||
130214214|NCT02452554|468746997|FG004|Overall Study|Death|0|||
130214215|NCT02452554|468746998|FG005|Overall Study|Death|0|||
130214216|NCT02452554|468746993|FG000|Overall Study|Lack of Efficacy|13|||
130214217|NCT02452554|468746994|FG001|Overall Study|Lack of Efficacy|14|||
130214218|NCT02452554|468746995|FG002|Overall Study|Lack of Efficacy|9|||
130214219|NCT02452554|468746996|FG003|Overall Study|Lack of Efficacy|1|||
130214220|NCT02452554|468746997|FG004|Overall Study|Lack of Efficacy|5|||
130214221|NCT02452554|468746998|FG005|Overall Study|Lack of Efficacy|8|||
130214222|NCT02452554|468746993|FG000|Overall Study|Physician Decision|0|||
130214223|NCT02452554|468746994|FG001|Overall Study|Physician Decision|1|||
130214224|NCT02452554|468746995|FG002|Overall Study|Physician Decision|0|||
130214225|NCT02452554|468746996|FG003|Overall Study|Physician Decision|0|||
130214226|NCT02452554|468746997|FG004|Overall Study|Physician Decision|0|||
130214227|NCT02452554|468746998|FG005|Overall Study|Physician Decision|0|||
130214228|NCT02452554|468746993|FG000|Overall Study|Withdrawal by Subject|1|||
130214229|NCT02452554|468746994|FG001|Overall Study|Withdrawal by Subject|0|||
130214230|NCT02452554|468746995|FG002|Overall Study|Withdrawal by Subject|2|||
130214231|NCT02452554|468746996|FG003|Overall Study|Withdrawal by Subject|0|||
130214232|NCT02452554|468746997|FG004|Overall Study|Withdrawal by Subject|0|||
130214233|NCT02452554|468746998|FG005|Overall Study|Withdrawal by Subject|1|||
130214234|NCT02452554|468746993|FG000|Overall Study|Ineligible|0|||
130214235|NCT02452554|468746994|FG001|Overall Study|Ineligible|1|||
130214236|NCT02452554|468746995|FG002|Overall Study|Ineligible|0|||
130214237|NCT02452554|468746996|FG003|Overall Study|Ineligible|0|||
130214238|NCT02452554|468746997|FG004|Overall Study|Ineligible|0|||
130214239|NCT02452554|468746998|FG005|Overall Study|Ineligible|0|||
130214240|NCT02452554|468746993|FG000|Overall Study|Never Received Treatment|1|||
130214241|NCT02452554|468746994|FG001|Overall Study|Never Received Treatment|0|||
130214242|NCT02452554|468746995|FG002|Overall Study|Never Received Treatment|0|||
130214243|NCT02452554|468746996|FG003|Overall Study|Never Received Treatment|0|||
130214244|NCT02452554|468746997|FG004|Overall Study|Never Received Treatment|0|||
130214245|NCT02452554|468746998|FG005|Overall Study|Never Received Treatment|0|||
130323379|NCT03597347|469153653|FG002|Overall Study|Sponsor decision to terminate study|4|||
130323380|NCT00107653|469153654|FG000|Overall Study|Adverse Event|24|||
130323381|NCT00107653|469153655|FG001|Overall Study|Adverse Event|43|||
130323382|NCT00107653|469153654|FG000|Overall Study|Insufficient Therapeutic Response|25|||
130323383|NCT00107653|469153655|FG001|Overall Study|Insufficient Therapeutic Response|11|||
130323384|NCT00107653|469153654|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130323385|NCT00107653|469153655|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130323386|NCT00107653|469153654|FG000|Overall Study|Protocol Violation|1|||
130323387|NCT00107653|469153655|FG001|Overall Study|Protocol Violation|0|||
130323388|NCT00107653|469153654|FG000|Overall Study|Withdrawal by Subject|12|||
130323389|NCT00107653|469153655|FG001|Overall Study|Withdrawal by Subject|13|||
130323390|NCT00107653|469153654|FG000|Overall Study|Lost to Follow-up|13|||
130323391|NCT00107653|469153655|FG001|Overall Study|Lost to Follow-up|5|||
130323392|NCT00107653|469153654|FG000|Overall Study|Administrative Reasons|3|||
130323393|NCT00107653|469153655|FG001|Overall Study|Administrative Reasons|3|||
130323394|NCT02532517|469153659|FG000|Overall Study|Did not complete 24-Month visit|4|||
130323395|NCT02532517|469153659|FG000|Overall Study|Failed Angiographic eligibility|1|||
130323396|NCT02532517|469153659|FG000|Overall Study|Lost to Follow-up|4|||
130323397|NCT02532517|469153659|FG000|Overall Study|Withdrawal by Subject|4|||
130323398|NCT02532517|469153659|FG000|Overall Study|Death|4|||
130323399|NCT03312231|469153660|FG000|Overall Study|Lost to Follow-up|2|||
130323400|NCT03312231|469153661|FG001|Overall Study|Lost to Follow-up|6|||
130323401|NCT03312231|469153662|FG002|Overall Study|Lost to Follow-up|1|||
130323402|NCT03312231|469153663|FG003|Overall Study|Lost to Follow-up|3|||
130323403|NCT03312231|469153664|FG004|Overall Study|Lost to Follow-up|1|||
130323404|NCT03312231|469153660|FG000|Overall Study|Withdrawal by Subject|0|||
130323405|NCT03312231|469153661|FG001|Overall Study|Withdrawal by Subject|3|||
130323406|NCT03312231|469153662|FG002|Overall Study|Withdrawal by Subject|1|||
130323407|NCT03312231|469153663|FG003|Overall Study|Withdrawal by Subject|0|||
130323408|NCT03312231|469153664|FG004|Overall Study|Withdrawal by Subject|0|||
130323409|NCT03312231|469153660|FG000|Overall Study|Death|0|||
130323410|NCT03312231|469153661|FG001|Overall Study|Death|1|||
130323411|NCT03312231|469153662|FG002|Overall Study|Death|1|||
130323412|NCT03312231|469153663|FG003|Overall Study|Death|0|||
130323413|NCT03312231|469153664|FG004|Overall Study|Death|0|||
130323414|NCT03312231|469153660|FG000|Overall Study|Study Vaccination not Received|1|||
130323415|NCT03312231|469153661|FG001|Overall Study|Study Vaccination not Received|1|||
130323416|NCT03312231|469153662|FG002|Overall Study|Study Vaccination not Received|1|||
130323417|NCT03312231|469153663|FG003|Overall Study|Study Vaccination not Received|0|||
130323418|NCT03312231|469153664|FG004|Overall Study|Study Vaccination not Received|0|||
130323419|NCT03157830|469153665|FG000|Overall Study|Lost to Follow-up|1|||
130323420|NCT03157830|469153665|FG000|Overall Study|Withdrawal by Subject|1|||
130323421|NCT03694353|469153667|FG000|Overall Study|Withdrawal by Subject|1|||
130323422|NCT03694353|469153667|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
130323423|NCT05720897|469153668|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
130323424|NCT05720897|469153669|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
130323425|NCT00400179|469153670|FG000|Overall Study|Adverse Event|2|||
130323426|NCT00400179|469153671|FG001|Overall Study|Adverse Event|2|||
130323427|NCT00400179|469153670|FG000|Overall Study|Death|1|||
130323428|NCT00400179|469153671|FG001|Overall Study|Death|2|||
130323429|NCT00400179|469153670|FG000|Overall Study|Withdrew Consent|1|||
130323430|NCT00400179|469153671|FG001|Overall Study|Withdrew Consent|5|||
130323431|NCT00400179|469153670|FG000|Overall Study|Disease progression|1|||
130323432|NCT00400179|469153671|FG001|Overall Study|Disease progression|1|||
130323433|NCT00400179|469153670|FG000|Overall Study|Intercurrent illness|0|||
130323434|NCT00400179|469153671|FG001|Overall Study|Intercurrent illness|1|||
130323435|NCT00400179|469153670|FG000|Overall Study|Investigator judgment|0|||
130323436|NCT00400179|469153671|FG001|Overall Study|Investigator judgment|1|||
130323437|NCT00400179|469153670|FG000|Overall Study|Randomization error/patient ineligible|1|||
130323438|NCT00400179|469153671|FG001|Overall Study|Randomization error/patient ineligible|6|||
130323439|NCT04780061|469153672|FG000|Overall Study|Withdrawal by Subject|5|||
130323440|NCT04780061|469153673|FG001|Overall Study|Withdrawal by Subject|8|||
130323441|NCT04780061|469153672|FG000|Overall Study|Adverse Event|2|||
130550782|NCT01765179|469983338|FG000|Overall Study|Lost to Follow-up|5|||
130323442|NCT04780061|469153673|FG001|Overall Study|Adverse Event|2|||
130323443|NCT04780061|469153672|FG000|Overall Study|Lost to Follow-up|1|||
130323444|NCT04780061|469153673|FG001|Overall Study|Lost to Follow-up|5|||
130323445|NCT05523089|469153674|FG000|Overall Study|Withdrawal by Subject|1|||
130323446|NCT05523089|469153675|FG001|Overall Study|Withdrawal by Subject|0|||
130323447|NCT05523089|469153676|FG002|Overall Study|Withdrawal by Subject|0|||
130323448|NCT05523089|469153674|FG000|Overall Study|Lost to Follow-up|1|||
130323449|NCT05523089|469153675|FG001|Overall Study|Lost to Follow-up|0|||
130323450|NCT05523089|469153676|FG002|Overall Study|Lost to Follow-up|0|||
130323451|NCT02681523|469153677|FG000|Overall Study|Adverse Event|1|||
130323452|NCT02681523|469153677|FG000|Overall Study|Patient Non-compliance|1|||
130550783|NCT01765179|469983338|FG000|Overall Study|Non-compliance with study drug|2|||
130550784|NCT01765179|469983338|FG000|Overall Study|Protocol Violation|1|||
130550785|NCT01765179|469983338|FG000|Overall Study|Withdrawal by Subject|8|||
130550786|NCT01765179|469983338|FG000|Overall Study|Hematocrit >54%|3|||
130550787|NCT01765179|469983338|FG000|Overall Study|prohibited med|1|||
130550788|NCT01765179|469983338|FG000|Overall Study|Out of country unable to finish study|1|||
130550789|NCT01765179|469983338|FG000|Overall Study|lack of venous access|1|||
130550790|NCT01765179|469983338|FG000|Overall Study|work conflict|1|||
130550791|NCT01765179|469983338|FG000|Overall Study|Ca elevated 10.6|1|||
130550792|NCT00392327|469983339|FG000|Overall Study|Death|1|||
130550793|NCT00392327|469983340|FG001|Overall Study|Death|0|||
130550794|NCT00392327|469983341|FG002|Overall Study|Death|1|||
130550795|NCT00392327|469983342|FG003|Overall Study|Death|0|||
130550796|NCT00392327|469983343|FG004|Overall Study|Death|0|||
130550797|NCT00392327|469983344|FG005|Overall Study|Death|0|||
130323453|NCT01456039|469155485|FG000|Phase 1 (First Step)|Disease Progression|1|||
130323454|NCT01456039|469155486|FG001|Phase 1 (First Step)|Disease Progression|1|||
130323455|NCT01456039|469155487|FG002|Phase 1 (First Step)|Disease Progression|0|||
130550798|NCT00392327|469983345|FG006|Overall Study|Death|0|||
130550799|NCT00392327|469983346|FG007|Overall Study|Death|0|||
130550800|NCT00392327|469983339|FG000|Overall Study|Lack of Efficacy|8|||
130550801|NCT00392327|469983340|FG001|Overall Study|Lack of Efficacy|8|||
130550802|NCT00392327|469983341|FG002|Overall Study|Lack of Efficacy|9|||
130550803|NCT00392327|469983342|FG003|Overall Study|Lack of Efficacy|6|||
130550804|NCT00392327|469983343|FG004|Overall Study|Lack of Efficacy|3|||
130550805|NCT00392327|469983344|FG005|Overall Study|Lack of Efficacy|3|||
130550806|NCT00392327|469983345|FG006|Overall Study|Lack of Efficacy|3|||
130550807|NCT00392327|469983346|FG007|Overall Study|Lack of Efficacy|3|||
130550808|NCT00392327|469983339|FG000|Overall Study|Physician Decision|3|||
130550809|NCT00392327|469983340|FG001|Overall Study|Physician Decision|5|||
130550810|NCT00392327|469983341|FG002|Overall Study|Physician Decision|2|||
130550811|NCT00392327|469983342|FG003|Overall Study|Physician Decision|2|||
130550812|NCT00392327|469983343|FG004|Overall Study|Physician Decision|0|||
130550813|NCT00392327|469983344|FG005|Overall Study|Physician Decision|1|||
130550814|NCT00392327|469983345|FG006|Overall Study|Physician Decision|5|||
130550815|NCT00392327|469983346|FG007|Overall Study|Physician Decision|3|||
130550816|NCT00392327|469983339|FG000|Overall Study|Protocol Violation|0|||
130550817|NCT00392327|469983340|FG001|Overall Study|Protocol Violation|0|||
130550818|NCT00392327|469983341|FG002|Overall Study|Protocol Violation|1|||
130550819|NCT00392327|469983342|FG003|Overall Study|Protocol Violation|0|||
130550820|NCT00392327|469983343|FG004|Overall Study|Protocol Violation|0|||
130550821|NCT00392327|469983344|FG005|Overall Study|Protocol Violation|0|||
130550822|NCT00392327|469983345|FG006|Overall Study|Protocol Violation|0|||
130550823|NCT00392327|469983346|FG007|Overall Study|Protocol Violation|0|||
130550824|NCT00392327|469983339|FG000|Overall Study|Withdrawal by Subject|3|||
130550825|NCT00392327|469983340|FG001|Overall Study|Withdrawal by Subject|2|||
130550826|NCT00392327|469983341|FG002|Overall Study|Withdrawal by Subject|4|||
130550827|NCT00392327|469983342|FG003|Overall Study|Withdrawal by Subject|6|||
130323456|NCT01456039|469155485|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
130323457|NCT01456039|469155486|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
130323458|NCT01456039|469155487|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
130323459|NCT01456039|469155485|FG000|Phase 1 (First Step)|Adverse Event|0|||
130323460|NCT01456039|469155486|FG001|Phase 1 (First Step)|Adverse Event|3|||
130323461|NCT01456039|469155487|FG002|Phase 1 (First Step)|Adverse Event|0|||
130323462|NCT01456039|469155485|FG000|Phase 1 (First Step)|Other|0|||
130323463|NCT01456039|469155486|FG001|Phase 1 (First Step)|Other|1|||
130323464|NCT01456039|469155487|FG002|Phase 1 (First Step)|Other|0|||
130323465|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Disease Progression|0|||
130323466|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Disease Progression|0|||
130323467|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Disease Progression|17|||
130323468|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Adverse Event|0|||
130323469|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Adverse Event|0|||
130323470|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Adverse Event|10|||
130550828|NCT00392327|469983343|FG004|Overall Study|Withdrawal by Subject|0|||
130550829|NCT00392327|469983344|FG005|Overall Study|Withdrawal by Subject|1|||
130550830|NCT00392327|469983345|FG006|Overall Study|Withdrawal by Subject|1|||
130550831|NCT00392327|469983346|FG007|Overall Study|Withdrawal by Subject|5|||
130550832|NCT00392327|469983339|FG000|Overall Study|Ineligible|0|||
130550833|NCT00392327|469983340|FG001|Overall Study|Ineligible|4|||
130550834|NCT00392327|469983341|FG002|Overall Study|Ineligible|3|||
130550835|NCT00392327|469983342|FG003|Overall Study|Ineligible|2|||
130550836|NCT00392327|469983343|FG004|Overall Study|Ineligible|0|||
130323471|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
130550837|NCT00392327|469983344|FG005|Overall Study|Ineligible|0|||
130550838|NCT00392327|469983345|FG006|Overall Study|Ineligible|0|||
130550839|NCT00392327|469983346|FG007|Overall Study|Ineligible|0|||
130550840|NCT04508023|469983347|FG000|Overall Study|Withdrawal by Subject|1|||
130550841|NCT04508023|469983348|FG001|Overall Study|Withdrawal by Subject|2|||
130550842|NCT00178126|469983349|FG000|Overall Study|Lost to Follow-up|21|||
130550843|NCT00178126|469983350|FG001|Overall Study|Lost to Follow-up|21|||
130550844|NCT00178126|469983349|FG000|Overall Study|did not receive intervention|4|||
130550845|NCT00178126|469983350|FG001|Overall Study|did not receive intervention|6|||
130550846|NCT02988622|469983351|FG000|Overall Study|Lost to Follow-up|17|||
130550847|NCT03562247|469983355|FG000|Overall Study|Lost to Follow-up|3|||
130550848|NCT03562247|469983356|FG001|Overall Study|Lost to Follow-up|1|||
130550849|NCT03562247|469983357|FG002|Overall Study|Lost to Follow-up|1|||
130550850|NCT01204398|469983358|FG000|Overall Study|Adverse Event|1|||
130550851|NCT00983931|469983359|FG000|14 Day Washout Period|Physician Decision|1|||
130550852|NCT01281969|469983362|FG000|Overall Study|not randomized didn't meet criteria|0|||
130550853|NCT01281969|469983363|FG001|Overall Study|not randomized didn't meet criteria|0|||
130550854|NCT01281969|469983364|FG002|Overall Study|not randomized didn't meet criteria|7|||
130550855|NCT01281969|469983362|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
130550856|NCT01281969|469983363|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
130550857|NCT01281969|469983364|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
130550858|NCT01281969|469983362|FG000|Overall Study|not randomized, child consent not given|0|||
130550859|NCT01281969|469983363|FG001|Overall Study|not randomized, child consent not given|0|||
130550860|NCT01281969|469983364|FG002|Overall Study|not randomized, child consent not given|2|||
130550861|NCT01201265|469983369|FG000|Overall Study|Death|14|||
130550862|NCT01201265|469983369|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130550863|NCT01201265|469983369|FG000|Overall Study|Lost to Follow-up|10|||
130550864|NCT01201265|469983369|FG000|Overall Study|Withdrawal by Subject|7|||
130550865|NCT01201265|469983369|FG000|Overall Study|Disease Progression|4|||
130550866|NCT04640077|469983370|FG000|Period 1|Withdrawal by Subject|4|||
130550867|NCT04640077|469983371|FG001|Period 1|Withdrawal by Subject|5|||
130550868|NCT04640077|469983372|FG002|Period 1|Withdrawal by Subject|0|||
130550869|NCT04640077|469983370|FG000|Period 1|Adverse Event|1|||
130550870|NCT04640077|469983371|FG001|Period 1|Adverse Event|1|||
130550871|NCT04640077|469983372|FG002|Period 1|Adverse Event|0|||
130550872|NCT04640077|469983370|FG000|Period 1|Screen Failure|2|||
130550873|NCT04640077|469983371|FG001|Period 1|Screen Failure|0|||
130550874|NCT04640077|469983372|FG002|Period 1|Screen Failure|0|||
130550875|NCT04640077|469983370|FG000|Period 2|Withdrawal by Subject|0|||
130550876|NCT04640077|469983371|FG001|Period 2|Withdrawal by Subject|0|||
130550877|NCT04640077|469983372|FG002|Period 2|Withdrawal by Subject|18|||
130550878|NCT04640077|469983370|FG000|Period 2|Adverse Event|0|||
130550879|NCT04640077|469983371|FG001|Period 2|Adverse Event|0|||
130550880|NCT04640077|469983372|FG002|Period 2|Adverse Event|6|||
130550881|NCT04640077|469983370|FG000|Period 2|Lost to Follow-up|0|||
130550882|NCT04640077|469983371|FG001|Period 2|Lost to Follow-up|0|||
130550883|NCT04640077|469983372|FG002|Period 2|Lost to Follow-up|2|||
130550884|NCT04640077|469983370|FG000|Period 2|Death|0|||
130550885|NCT04640077|469983371|FG001|Period 2|Death|0|||
130550886|NCT04640077|469983372|FG002|Period 2|Death|2|||
130550887|NCT04640077|469983370|FG000|Period 2|Progressive Disease|0|||
130550888|NCT04640077|469983371|FG001|Period 2|Progressive Disease|0|||
130550889|NCT04640077|469983372|FG002|Period 2|Progressive Disease|1|||
130550890|NCT04640077|469983370|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
130550891|NCT04640077|469983371|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
130550892|NCT04640077|469983372|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
130550893|NCT01257425|469983373|FG000|Overall Study|Lack of Efficacy|3|||
130550894|NCT01257425|469983374|FG001|Overall Study|Lack of Efficacy|3|||
130550895|NCT01257425|469983373|FG000|Overall Study|Adverse Event|1|||
130550896|NCT01257425|469983374|FG001|Overall Study|Adverse Event|1|||
130550897|NCT01257425|469983373|FG000|Overall Study|Protocol Violation|1|||
130550898|NCT01257425|469983374|FG001|Overall Study|Protocol Violation|1|||
130550899|NCT01257425|469983373|FG000|Overall Study|Withdrawal by Subject|0|||
130550900|NCT01257425|469983374|FG001|Overall Study|Withdrawal by Subject|1|||
130550901|NCT01257425|469983373|FG000|Overall Study|Death|1|||
130550902|NCT01257425|469983374|FG001|Overall Study|Death|0|||
130550903|NCT01182194|469983375|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130550904|NCT01182194|469983376|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
130550905|NCT00368992|469983378|FG000|Overall Study|Ineligible|5|||
130550906|NCT00368992|469983378|FG000|Overall Study|Refused treatment|3|||
130550907|NCT00368992|469983378|FG000|Overall Study|Lack of Efficacy|63|||
130550908|NCT00368992|469983378|FG000|Overall Study|Adverse Event|26|||
130550909|NCT00368992|469983378|FG000|Overall Study|Death|4|||
130550910|NCT00368992|469983378|FG000|Overall Study|Other|9|||
130550911|NCT02668185|469983379|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
130550912|NCT02668185|469983380|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
130550913|NCT02668185|469983379|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
130550914|NCT02668185|469983380|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
130550915|NCT02668185|469983379|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
130550916|NCT02668185|469983380|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
130550917|NCT02668185|469983379|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
130214246|NCT02749799|468746999|FG000|Overall Study|Adverse Event|2|||
130550918|NCT02668185|469983380|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
130550919|NCT00723021|469983385|FG000|Intervention Period 4|Adverse Event|0|||
130550920|NCT00723021|469983386|FG001|Intervention Period 4|Adverse Event|0|||
130550921|NCT00723021|469983387|FG002|Intervention Period 4|Adverse Event|0|||
130550922|NCT00723021|469983388|FG003|Intervention Period 4|Adverse Event|0|||
130550923|NCT00723021|469983389|FG004|Intervention Period 4|Adverse Event|1|||
130550924|NCT00770341|469983391|FG000|Overall Study|Did not meet eligibility criteria|1|||
130550925|NCT00770341|469983392|FG001|Overall Study|Did not meet eligibility criteria|0|||
130550926|NCT00770341|469983393|FG002|Overall Study|Did not meet eligibility criteria|0|||
130550927|NCT00770341|469983391|FG000|Overall Study|Withdrawal by Subject|0|||
130550928|NCT00770341|469983392|FG001|Overall Study|Withdrawal by Subject|1|||
130550929|NCT00770341|469983393|FG002|Overall Study|Withdrawal by Subject|0|||
130550930|NCT00770341|469983391|FG000|Overall Study|Clinical Adverse Event|3|||
130550931|NCT00770341|469983392|FG001|Overall Study|Clinical Adverse Event|1|||
130550932|NCT00770341|469983393|FG002|Overall Study|Clinical Adverse Event|2|||
130550933|NCT00770341|469983391|FG000|Overall Study|Laboratory adverse event|3|||
130550934|NCT00770341|469983392|FG001|Overall Study|Laboratory adverse event|3|||
130550935|NCT00770341|469983393|FG002|Overall Study|Laboratory adverse event|0|||
130550936|NCT00770341|469983391|FG000|Overall Study|Lack of Efficacy|3|||
130550937|NCT00770341|469983392|FG001|Overall Study|Lack of Efficacy|0|||
130550938|NCT00770341|469983393|FG002|Overall Study|Lack of Efficacy|1|||
130550939|NCT00770341|469983391|FG000|Overall Study|Other|1|||
130550940|NCT00770341|469983392|FG001|Overall Study|Other|0|||
130550941|NCT00770341|469983393|FG002|Overall Study|Other|0|||
130550942|NCT00770341|469983391|FG000|Overall Study|Not treated|1|||
130550943|NCT00770341|469983392|FG001|Overall Study|Not treated|0|||
130550944|NCT00770341|469983393|FG002|Overall Study|Not treated|0|||
130550945|NCT00960531|469983399|FG000|Overall Study|Lack of Efficacy|1|||
130550946|NCT00960531|469983400|FG001|Overall Study|Lack of Efficacy|0|||
130550947|NCT00960531|469983401|FG002|Overall Study|Lack of Efficacy|0|||
130550948|NCT00960531|469983402|FG003|Overall Study|Lack of Efficacy|0|||
130550949|NCT00960531|469983403|FG004|Overall Study|Lack of Efficacy|0|||
130550950|NCT00960531|469983404|FG005|Overall Study|Lack of Efficacy|0|||
130550951|NCT00960531|469983405|FG006|Overall Study|Lack of Efficacy|0|||
130550952|NCT00960531|469983406|FG007|Overall Study|Lack of Efficacy|0|||
130550953|NCT00960531|469983407|FG008|Overall Study|Lack of Efficacy|0|||
130550954|NCT00960531|469983408|FG009|Overall Study|Lack of Efficacy|0|||
130550955|NCT00960531|469983399|FG000|Overall Study|Withdrawal by Subject|1|||
130550956|NCT00960531|469983400|FG001|Overall Study|Withdrawal by Subject|0|||
130550957|NCT00960531|469983401|FG002|Overall Study|Withdrawal by Subject|5|||
130550958|NCT00960531|469983402|FG003|Overall Study|Withdrawal by Subject|2|||
130550959|NCT00960531|469983403|FG004|Overall Study|Withdrawal by Subject|0|||
130550960|NCT00960531|469983404|FG005|Overall Study|Withdrawal by Subject|0|||
130550961|NCT00960531|469983405|FG006|Overall Study|Withdrawal by Subject|2|||
130550962|NCT00960531|469983406|FG007|Overall Study|Withdrawal by Subject|0|||
130550963|NCT00960531|469983407|FG008|Overall Study|Withdrawal by Subject|1|||
130550964|NCT00960531|469983408|FG009|Overall Study|Withdrawal by Subject|0|||
130550965|NCT00960531|469983399|FG000|Overall Study|Caregiver Request|2|||
130550966|NCT00960531|469983400|FG001|Overall Study|Caregiver Request|0|||
130550967|NCT00960531|469983401|FG002|Overall Study|Caregiver Request|6|||
130550968|NCT00960531|469983402|FG003|Overall Study|Caregiver Request|5|||
130550969|NCT00960531|469983403|FG004|Overall Study|Caregiver Request|0|||
130550970|NCT00960531|469983404|FG005|Overall Study|Caregiver Request|2|||
130214247|NCT02749799|468746999|FG000|Overall Study|Lost to Follow-up|4|||
130214248|NCT02749799|468746999|FG000|Overall Study|Protocol Violation|1|||
130214249|NCT02749799|468746999|FG000|Overall Study|Withdrawal by Subject|1|||
130214250|NCT03749109|468747000|FG000|Overall Study|Adverse Event|2|||
130214251|NCT03749109|468747001|FG001|Overall Study|Adverse Event|0|||
130214252|NCT02636439|468747004|FG000|Overall Study|Adverse Event|2|||
130214253|NCT02636439|468747005|FG001|Overall Study|Adverse Event|2|||
130214254|NCT02636439|468747004|FG000|Overall Study|Lost to Follow-up|1|||
130214255|NCT02636439|468747005|FG001|Overall Study|Lost to Follow-up|0|||
130214256|NCT02636439|468747004|FG000|Overall Study|Non-compliance|1|||
130214257|NCT02636439|468747005|FG001|Overall Study|Non-compliance|1|||
130214258|NCT02636439|468747004|FG000|Overall Study|Personal reasons|2|||
130214259|NCT02636439|468747005|FG001|Overall Study|Personal reasons|0|||
130214260|NCT02075008|468748942|FG000|Overall Study|Technical problems|1|||
130214261|NCT02075008|468748942|FG000|Overall Study|Pregnancy|1|||
130214262|NCT02075008|468748942|FG000|Overall Study|Physician Decision|1|||
130214263|NCT02075008|468748942|FG000|Overall Study|Lost to Follow-up|1|||
130550971|NCT00960531|469983405|FG006|Overall Study|Caregiver Request|3|||
130550972|NCT00960531|469983406|FG007|Overall Study|Caregiver Request|1|||
130214264|NCT02075008|468748942|FG000|Overall Study|Lack of Efficacy|1|||
130214265|NCT02075008|468748942|FG000|Overall Study|Death|1|||
130214266|NCT02075008|468748942|FG000|Overall Study|Adverse Event|5|||
130214267|NCT02075008|468748942|FG000|Overall Study|Withdrawal by Subject|6|||
130214268|NCT02075008|468748942|FG000|Overall Study|Study terminated by Sponsor|159|||
130214269|NCT00660595|468748943|FG000|Overall Study|Lost to Follow-up|0|||
130214270|NCT00660595|468748944|FG001|Overall Study|Lost to Follow-up|1|||
130550973|NCT00960531|469983407|FG008|Overall Study|Caregiver Request|3|||
130550974|NCT00960531|469983408|FG009|Overall Study|Caregiver Request|0|||
130550975|NCT00960531|469983399|FG000|Overall Study|Investigator Request|0|||
130550976|NCT00960531|469983400|FG001|Overall Study|Investigator Request|0|||
130550977|NCT00960531|469983401|FG002|Overall Study|Investigator Request|1|||
130550978|NCT00960531|469983402|FG003|Overall Study|Investigator Request|0|||
130550979|NCT00960531|469983403|FG004|Overall Study|Investigator Request|0|||
130550980|NCT00960531|469983404|FG005|Overall Study|Investigator Request|0|||
130550981|NCT00960531|469983405|FG006|Overall Study|Investigator Request|0|||
130550982|NCT00960531|469983406|FG007|Overall Study|Investigator Request|0|||
130550983|NCT00960531|469983407|FG008|Overall Study|Investigator Request|0|||
130550984|NCT00960531|469983408|FG009|Overall Study|Investigator Request|0|||
130550985|NCT00960531|469983399|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
130550986|NCT00960531|469983400|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130550987|NCT00960531|469983401|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
130550988|NCT00960531|469983402|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130550989|NCT00960531|469983403|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
130550990|NCT00960531|469983404|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
130550991|NCT00960531|469983405|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
130550992|NCT00960531|469983406|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
130550993|NCT00960531|469983407|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
130550994|NCT00960531|469983408|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
130550995|NCT00960531|469983399|FG000|Overall Study|Lost to Follow-up|0|||
130550996|NCT00960531|469983400|FG001|Overall Study|Lost to Follow-up|0|||
130550997|NCT00960531|469983401|FG002|Overall Study|Lost to Follow-up|1|||
130550998|NCT00960531|469983402|FG003|Overall Study|Lost to Follow-up|0|||
130550999|NCT00960531|469983403|FG004|Overall Study|Lost to Follow-up|0|||
130551000|NCT00960531|469983404|FG005|Overall Study|Lost to Follow-up|0|||
130551001|NCT00960531|469983405|FG006|Overall Study|Lost to Follow-up|1|||
130551002|NCT00960531|469983406|FG007|Overall Study|Lost to Follow-up|0|||
130551003|NCT00960531|469983407|FG008|Overall Study|Lost to Follow-up|0|||
130551004|NCT00960531|469983408|FG009|Overall Study|Lost to Follow-up|0|||
130551005|NCT00960531|469983399|FG000|Overall Study|Failed to Return|2|||
130551006|NCT00960531|469983400|FG001|Overall Study|Failed to Return|0|||
130551007|NCT00960531|469983401|FG002|Overall Study|Failed to Return|0|||
130551008|NCT00960531|469983402|FG003|Overall Study|Failed to Return|0|||
130551009|NCT00960531|469983403|FG004|Overall Study|Failed to Return|0|||
130551010|NCT00960531|469983404|FG005|Overall Study|Failed to Return|0|||
130551011|NCT00960531|469983405|FG006|Overall Study|Failed to Return|0|||
130551012|NCT00960531|469983406|FG007|Overall Study|Failed to Return|2|||
130551013|NCT00960531|469983407|FG008|Overall Study|Failed to Return|0|||
130551014|NCT00960531|469983408|FG009|Overall Study|Failed to Return|0|||
130551015|NCT00960531|469983399|FG000|Overall Study|Adverse Event (AE)|2|||
130551016|NCT00960531|469983400|FG001|Overall Study|Adverse Event (AE)|0|||
130551017|NCT00960531|469983401|FG002|Overall Study|Adverse Event (AE)|0|||
130551018|NCT00960531|469983402|FG003|Overall Study|Adverse Event (AE)|0|||
130551019|NCT00960531|469983403|FG004|Overall Study|Adverse Event (AE)|0|||
130551020|NCT00960531|469983404|FG005|Overall Study|Adverse Event (AE)|1|||
130551021|NCT00960531|469983405|FG006|Overall Study|Adverse Event (AE)|2|||
130551022|NCT00960531|469983406|FG007|Overall Study|Adverse Event (AE)|0|||
130551023|NCT00960531|469983407|FG008|Overall Study|Adverse Event (AE)|2|||
130551024|NCT00960531|469983408|FG009|Overall Study|Adverse Event (AE)|0|||
130551025|NCT00960531|469983399|FG000|Overall Study|Reason not Specified|2|||
130551026|NCT00960531|469983400|FG001|Overall Study|Reason not Specified|1|||
130214271|NCT00660595|468748943|FG000|Overall Study|Did not consent to participate in study|12|||
130214272|NCT00660595|468748944|FG001|Overall Study|Did not consent to participate in study|8|||
130214273|NCT00660595|468748943|FG000|Overall Study|Participant left hospital|1|||
130214274|NCT00660595|468748944|FG001|Overall Study|Participant left hospital|0|||
130214275|NCT00660595|468748943|FG000|Overall Study|Non Specified reasons|5|||
130214276|NCT00660595|468748944|FG001|Overall Study|Non Specified reasons|0|||
130214277|NCT05205005|468748945|FG000|Overall Study|Withdrawal by Subject|1|||
130214278|NCT05205005|468748946|FG001|Overall Study|Withdrawal by Subject|0|||
130214279|NCT05205005|468748945|FG000|Overall Study|Adverse Event|1|||
130214280|NCT05205005|468748946|FG001|Overall Study|Adverse Event|0|||
130551027|NCT00960531|469983401|FG002|Overall Study|Reason not Specified|13|||
130551028|NCT00960531|469983402|FG003|Overall Study|Reason not Specified|1|||
130551029|NCT00960531|469983403|FG004|Overall Study|Reason not Specified|2|||
130551030|NCT00960531|469983404|FG005|Overall Study|Reason not Specified|0|||
130551031|NCT00960531|469983405|FG006|Overall Study|Reason not Specified|16|||
130551032|NCT00960531|469983406|FG007|Overall Study|Reason not Specified|0|||
130551033|NCT00960531|469983407|FG008|Overall Study|Reason not Specified|8|||
130551034|NCT00960531|469983408|FG009|Overall Study|Reason not Specified|1|||
130551035|NCT01163916|469983411|FG000|Overall Study|Withdrawal by Subject|2|||
130551036|NCT01163916|469983412|FG001|Overall Study|Withdrawal by Subject|0|||
130551037|NCT01163916|469983413|FG002|Overall Study|Withdrawal by Subject|2|||
130551038|NCT01163916|469983411|FG000|Overall Study|Adverse Event|2|||
130551039|NCT01163916|469983412|FG001|Overall Study|Adverse Event|0|||
130551040|NCT01163916|469983413|FG002|Overall Study|Adverse Event|1|||
130551041|NCT01163916|469983411|FG000|Overall Study|Lack of Efficacy|2|||
130551042|NCT01163916|469983412|FG001|Overall Study|Lack of Efficacy|0|||
130551043|NCT01163916|469983413|FG002|Overall Study|Lack of Efficacy|1|||
130551044|NCT01163916|469983411|FG000|Overall Study|Other|24|||
130551045|NCT01163916|469983412|FG001|Overall Study|Other|4|||
130551046|NCT01163916|469983413|FG002|Overall Study|Other|16|||
130551047|NCT00883051|469983414|FG000|Overall Study|Lost to Follow-up|0|||
130551048|NCT00883051|469983415|FG001|Overall Study|Lost to Follow-up|0|||
130551049|NCT00883051|469983416|FG002|Overall Study|Lost to Follow-up|0|||
130551050|NCT00883051|469983417|FG003|Overall Study|Lost to Follow-up|0|||
130551051|NCT00883051|469983418|FG004|Overall Study|Lost to Follow-up|1|||
130551052|NCT00883051|469983414|FG000|Overall Study|Did not use study medication|24|||
130551053|NCT00883051|469983415|FG001|Overall Study|Did not use study medication|22|||
130551054|NCT00883051|469983416|FG002|Overall Study|Did not use study medication|29|||
130551055|NCT00883051|469983417|FG003|Overall Study|Did not use study medication|29|||
130551056|NCT00883051|469983418|FG004|Overall Study|Did not use study medication|17|||
130551057|NCT02337751|469983419|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
130551058|NCT02337751|469983420|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130551059|NCT02337751|469983419|FG000|Overall Study|Voluntary Withdrawal|6|||
130551060|NCT02337751|469983420|FG001|Overall Study|Voluntary Withdrawal|8|||
130551061|NCT02337751|469983419|FG000|Overall Study|Lack of Efficacy|2|||
130551062|NCT02337751|469983420|FG001|Overall Study|Lack of Efficacy|5|||
130551063|NCT02337751|469983419|FG000|Overall Study|Investigator's Judgement|1|||
130551064|NCT02337751|469983420|FG001|Overall Study|Investigator's Judgement|0|||
130551065|NCT01910181|469983427|FG000|Overall Study|Death|37|||
130551066|NCT01910181|469983427|FG000|Overall Study|Lost to Follow-up|3|||
130551067|NCT01910181|469983427|FG000|Overall Study|Study Terminated by Sponsor|6|||
130551068|NCT01215422|469986292|FG000|Overall Study|Relocation|1|||
130551069|NCT01215422|469986293|FG001|Overall Study|Relocation|0|||
130551070|NCT01215422|469986294|FG002|Overall Study|Relocation|0|||
130551071|NCT01215422|469986295|FG003|Overall Study|Relocation|0|||
130551072|NCT01215422|469986292|FG000|Overall Study|Failed intubations|0|||
130551073|NCT01215422|469986293|FG001|Overall Study|Failed intubations|0|||
130551074|NCT01215422|469986294|FG002|Overall Study|Failed intubations|3|||
130551075|NCT01215422|469986295|FG003|Overall Study|Failed intubations|8|||
130551076|NCT01215422|469986292|FG000|Overall Study|Did not complete all intubations|7|||
130551077|NCT01215422|469986293|FG001|Overall Study|Did not complete all intubations|0|||
130551078|NCT01215422|469986294|FG002|Overall Study|Did not complete all intubations|0|||
130551079|NCT01215422|469986295|FG003|Overall Study|Did not complete all intubations|0|||
130551080|NCT04142450|469986300|FG000|Overall Study|Screen Failure|1|||
130551081|NCT04142450|469986300|FG000|Overall Study|Lost to Follow-up|1|||
130551082|NCT02544217|469986301|FG000|Overall Study|Withdrawal by Subject|1|||
130551083|NCT02544217|469986302|FG001|Overall Study|Withdrawal by Subject|1|||
130551084|NCT02544217|469986303|FG002|Overall Study|Withdrawal by Subject|0|||
130551085|NCT02544217|469986304|FG003|Overall Study|Withdrawal by Subject|0|||
130551086|NCT02544217|469986305|FG004|Overall Study|Withdrawal by Subject|0|||
130551087|NCT02544217|469986306|FG005|Overall Study|Withdrawal by Subject|0|||
130551088|NCT04335812|469986307|FG000|Overall Study|Withdrawal by Subject|1|||
130551089|NCT04335812|469986308|FG001|Overall Study|Withdrawal by Subject|3|||
130551090|NCT04335812|469986307|FG000|Overall Study|Lost to Follow-up|12|||
130551091|NCT04335812|469986308|FG001|Overall Study|Lost to Follow-up|12|||
130551092|NCT04335812|469986307|FG000|Overall Study|Did not engage in the intervention|22|||
130551093|NCT04335812|469986308|FG001|Overall Study|Did not engage in the intervention|18|||
130551094|NCT02901041|469986319|FG000|Overall Study|Withdrawal by PI|4|||
130551095|NCT02901041|469986320|FG001|Overall Study|Withdrawal by PI|8|||
130551096|NCT02901041|469986319|FG000|Overall Study|Withdrawal by Subject|7|||
130551097|NCT02901041|469986320|FG001|Overall Study|Withdrawal by Subject|3|||
130551098|NCT00975507|469986324|FG000|Overall Study|Adverse Event|1|||
130551099|NCT00975507|469986325|FG001|Overall Study|Adverse Event|0|||
130551100|NCT00975507|469986324|FG000|Overall Study|Lost to Follow-up|7|||
130551101|NCT00975507|469986325|FG001|Overall Study|Lost to Follow-up|1|||
130551102|NCT00975507|469986324|FG000|Overall Study|Protocol Violation|2|||
130551103|NCT00975507|469986325|FG001|Overall Study|Protocol Violation|0|||
130551104|NCT00975507|469986324|FG000|Overall Study|Withdrawal by Subject|10|||
130551105|NCT00975507|469986325|FG001|Overall Study|Withdrawal by Subject|3|||
130551106|NCT03249714|469986326|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
130551107|NCT03249714|469986327|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
130551108|NCT03249714|469986326|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
130551109|NCT03249714|469986327|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
130551110|NCT03249714|469986326|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
130551111|NCT03249714|469986327|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
130551112|NCT03249714|469986326|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
130551113|NCT03249714|469986327|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
130551114|NCT01112306|469986335|FG000|Overall Study|Death|175|||
130551115|NCT01112306|469986335|FG000|Overall Study|Lost to Follow-up|9|||
130551116|NCT01112306|469986335|FG000|Overall Study|Withdrawal by Subject|31|||
130551117|NCT01112306|469986335|FG000|Overall Study|Other|70|||
130551118|NCT01607554|469986339|FG000|Overall Study|Disease progression|2|||
130551119|NCT03952806|469986340|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
130551120|NCT03952806|469986341|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
130551121|NCT03952806|469986340|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
130551122|NCT03952806|469986341|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
130551123|NCT03952806|469986340|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
130551124|NCT03952806|469986341|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
130551125|NCT03952806|469986340|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
130551126|NCT03952806|469986341|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
130551127|NCT03952806|469986340|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
130551128|NCT03952806|469986341|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
130551129|NCT03952806|469986340|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
130551130|NCT03952806|469986341|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
130551131|NCT03952806|469986340|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
130551132|NCT03952806|469986341|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
130551133|NCT03952806|469986340|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
130551134|NCT03952806|469986341|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
130551135|NCT03952806|469986340|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
130551136|NCT03952806|469986341|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
130551137|NCT03952806|469986340|FG000|OLE Phase (48 Weeks)|Other|16|||
130551138|NCT03952806|469986341|FG001|OLE Phase (48 Weeks)|Other|13|||
130551139|NCT00655863|469986342|FG000|Overall Study|Lost to Follow-up|0|||
130551140|NCT00655863|469986343|FG001|Overall Study|Lost to Follow-up|0|||
130551141|NCT00655863|469986344|FG002|Overall Study|Lost to Follow-up|1|||
130551142|NCT01138007|469986345|FG000|Overall Study|Adverse Event|4|||
130551143|NCT01138007|469986346|FG001|Overall Study|Adverse Event|12|||
130551144|NCT01138007|469986347|FG002|Overall Study|Adverse Event|9|||
130551145|NCT01138007|469986345|FG000|Overall Study|Lack of Efficacy|2|||
130551146|NCT01138007|469986346|FG001|Overall Study|Lack of Efficacy|0|||
130551147|NCT01138007|469986347|FG002|Overall Study|Lack of Efficacy|6|||
130551148|NCT01138007|469986345|FG000|Overall Study|Protocol Violation|2|||
130551149|NCT01138007|469986346|FG001|Overall Study|Protocol Violation|3|||
130551150|NCT01138007|469986347|FG002|Overall Study|Protocol Violation|2|||
130551151|NCT01138007|469986345|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
130551152|NCT01138007|469986346|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
130551153|NCT01138007|469986347|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
130551154|NCT01138007|469986345|FG000|Overall Study|Lost to Follow-up|3|||
130551155|NCT01138007|469986346|FG001|Overall Study|Lost to Follow-up|3|||
130551156|NCT01138007|469986347|FG002|Overall Study|Lost to Follow-up|5|||
130551157|NCT01138007|469986345|FG000|Overall Study|Physician Decision|0|||
130551158|NCT01138007|469986346|FG001|Overall Study|Physician Decision|5|||
130551159|NCT01138007|469986347|FG002|Overall Study|Physician Decision|3|||
130551160|NCT01138007|469986345|FG000|Overall Study|Withdrawal by Subject|5|||
130551161|NCT01138007|469986346|FG001|Overall Study|Withdrawal by Subject|6|||
130551162|NCT01138007|469986347|FG002|Overall Study|Withdrawal by Subject|15|||
130551163|NCT04661878|469986348|FG000|Overall Study|Lost to Follow-up|6|||
130551164|NCT04661878|469986349|FG001|Overall Study|Lost to Follow-up|5|||
130551165|NCT04442737|469986354|FG000|Overall Study|Lost to Follow-up|1|||
130551166|NCT04442737|469986355|FG001|Overall Study|Lost to Follow-up|3|||
130551167|NCT04442737|469986354|FG000|Overall Study|Withdrawal by Subject|3|||
130551168|NCT04442737|469986355|FG001|Overall Study|Withdrawal by Subject|2|||
130551169|NCT04442737|469986354|FG000|Overall Study|Adverse Event|3|||
130551170|NCT04442737|469986355|FG001|Overall Study|Adverse Event|2|||
130551171|NCT04442737|469986354|FG000|Overall Study|Death|0|||
130551172|NCT04442737|469986355|FG001|Overall Study|Death|1|||
130551173|NCT04442737|469986354|FG000|Overall Study|Protocol Violation|0|||
130551174|NCT04442737|469986355|FG001|Overall Study|Protocol Violation|2|||
130551175|NCT04442737|469986354|FG000|Overall Study|Other|1|||
130551176|NCT04442737|469986355|FG001|Overall Study|Other|1|||
130551177|NCT00744523|469986356|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
130551178|NCT00744523|469986357|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
130551179|NCT05333224|469986358|FG000|Overall Study - Infants|Lost to Follow-up|1|||
130551180|NCT05333224|469986359|FG001|Overall Study - Infants|Lost to Follow-up|1|||
130551181|NCT00063154|469986360|FG000|Overall Study|Disease progression|27|||
130551182|NCT00063154|469986360|FG000|Overall Study|Adverse Event|2|||
130551183|NCT00063154|469986360|FG000|Overall Study|Physician Decision|10|||
130551184|NCT00063154|469986360|FG000|Overall Study|Death|3|||
130551185|NCT00063154|469986360|FG000|Overall Study|Reason unspecified|1|||
130551186|NCT00063154|469986360|FG000|Overall Study|Did not receive treatment|8|||
130551187|NCT01978262|469986361|FG000|Overall Study|Withdrawal by Subject|9|||
130551188|NCT01978262|469986361|FG000|Overall Study|Lost to Follow-up|2|||
130551189|NCT00325039|469986363|FG000|Overall Study|Lost to Follow-up|18|||
130551190|NCT00325039|469986364|FG001|Overall Study|Lost to Follow-up|14|||
130551191|NCT01009203|469986365|FG000|Overall Study|Withdrawal by Subject|1|||
130551192|NCT01009203|469986365|FG000|Overall Study|Adverse Event|5|||
130551193|NCT01009203|469986365|FG000|Overall Study|Treatment-unrelated death|1|||
130551194|NCT02974088|469986366|FG000|Overall Study|Lost to Follow-up|0|||
130551195|NCT02974088|469986367|FG001|Overall Study|Lost to Follow-up|2|||
130551196|NCT02974088|469986366|FG000|Overall Study|Adverse Event|0|||
130551197|NCT02974088|469986367|FG001|Overall Study|Adverse Event|1|||
130551198|NCT00892723|469986368|FG000|Overall Study|Lost to Follow-up|1|||
130551199|NCT00892723|469986369|FG001|Overall Study|Lost to Follow-up|3|||
130551200|NCT00892723|469986370|FG002|Overall Study|Lost to Follow-up|1|||
130551201|NCT00892723|469986368|FG000|Overall Study|Withdrawal by Subject|1|||
130551202|NCT00892723|469986369|FG001|Overall Study|Withdrawal by Subject|1|||
130551203|NCT00892723|469986370|FG002|Overall Study|Withdrawal by Subject|1|||
130551204|NCT00150969|469986373|FG000|24 Month Main Study|Adverse Event|3|||
130551205|NCT00150969|469986374|FG001|24 Month Main Study|Adverse Event|4|||
130551206|NCT00150969|469986373|FG000|24 Month Main Study|Death|1|||
130551207|NCT00150969|469986374|FG001|24 Month Main Study|Death|1|||
130551208|NCT00150969|469986373|FG000|24 Month Main Study|Lack of Efficacy|1|||
130551209|NCT00150969|469986374|FG001|24 Month Main Study|Lack of Efficacy|8|||
130551210|NCT00150969|469986373|FG000|24 Month Main Study|Lost to Follow-up|3|||
130551211|NCT00150969|469986374|FG001|24 Month Main Study|Lost to Follow-up|2|||
130551212|NCT00150969|469986373|FG000|24 Month Main Study|Protocol Violation|4|||
130551213|NCT00150969|469986374|FG001|24 Month Main Study|Protocol Violation|2|||
130551214|NCT00150969|469986373|FG000|24 Month Main Study|Withdrawal by Subject|7|||
130551215|NCT00150969|469986374|FG001|24 Month Main Study|Withdrawal by Subject|4|||
130551216|NCT00150969|469986373|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
130551217|NCT00150969|469986374|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
130551218|NCT00150969|469986373|FG000|24-48 Month Extension|Lack of Efficacy|0|||
130551219|NCT00150969|469986374|FG001|24-48 Month Extension|Lack of Efficacy|1|||
130551220|NCT00150969|469986373|FG000|24-48 Month Extension|Adverse Event|1|||
130551221|NCT00150969|469986374|FG001|24-48 Month Extension|Adverse Event|3|||
130551222|NCT00150969|469986373|FG000|24-48 Month Extension|Other Reason|81|||
130551223|NCT00150969|469986374|FG001|24-48 Month Extension|Other Reason|91|||
130551224|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
130551225|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
130551226|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
130551227|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
130551228|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
130551229|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
130551230|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
130551231|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
130551232|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
130551233|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
130551234|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
130551235|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
130551236|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
130551237|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
130551238|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
130551239|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
130551240|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
130551241|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
130551242|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
130551243|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
130551244|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
130551245|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
130551246|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
130551247|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
130551248|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
130551249|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
130551250|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
130551251|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
130551252|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
130551253|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
130551254|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Other|10|||
130551255|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Other|7|||
130551256|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Other|8|||
130551257|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Other|8|||
130551258|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Other|0|||
130551259|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
130551260|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
130551261|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
130551262|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
130551263|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
130551264|NCT00615836|469986375|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
130551265|NCT00615836|469986376|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
130551266|NCT00615836|469986377|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
130551267|NCT00615836|469986378|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
130551268|NCT00615836|469986379|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
130551269|NCT01313689|469986380|FG000|24-Week Randomization 1|Adverse Event|10|||
130551270|NCT01313689|469986381|FG001|24-Week Randomization 1|Adverse Event|5|||
130551271|NCT01313689|469986382|FG002|24-Week Randomization 1|Adverse Event|0|||
130551272|NCT01313689|469986383|FG003|24-Week Randomization 1|Adverse Event|0|||
130551273|NCT01313689|469986384|FG004|24-Week Randomization 1|Adverse Event|0|||
130551274|NCT01313689|469986380|FG000|24-Week Randomization 1|Physician Decision|4|||
130551275|NCT01313689|469986381|FG001|24-Week Randomization 1|Physician Decision|5|||
130551276|NCT01313689|469986382|FG002|24-Week Randomization 1|Physician Decision|0|||
130551277|NCT01313689|469986383|FG003|24-Week Randomization 1|Physician Decision|0|||
130551278|NCT01313689|469986384|FG004|24-Week Randomization 1|Physician Decision|0|||
130551279|NCT01313689|469986380|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
130551280|NCT01313689|469986381|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
130551281|NCT01313689|469986382|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
130551282|NCT01313689|469986383|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
130551283|NCT01313689|469986384|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
130551284|NCT01313689|469986380|FG000|24-Week Randomization 2|Adverse Event|0|||
130551285|NCT01313689|469986381|FG001|24-Week Randomization 2|Adverse Event|0|||
130551286|NCT01313689|469986382|FG002|24-Week Randomization 2|Adverse Event|2|||
130551287|NCT01313689|469986383|FG003|24-Week Randomization 2|Adverse Event|0|||
130551288|NCT01313689|469986384|FG004|24-Week Randomization 2|Adverse Event|8|||
130551289|NCT01313689|469986380|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
130551290|NCT01313689|469986381|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
130551291|NCT01313689|469986382|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
130551292|NCT01313689|469986383|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
130551293|NCT01313689|469986384|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
130551294|NCT01313689|469986380|FG000|24-Week Randomization 2|Physician Decision|0|||
130214281|NCT01763203|468748953|FG000|Overall Study|Death|4|||
130214282|NCT01763203|468748954|FG001|Overall Study|Death|7|||
130214283|NCT01763203|468748953|FG000|Overall Study|Lost to Follow-up|12|||
130214284|NCT01763203|468748954|FG001|Overall Study|Lost to Follow-up|12|||
130214285|NCT01763203|468748953|FG000|Overall Study|Withdrawal by Subject|8|||
130214286|NCT01763203|468748954|FG001|Overall Study|Withdrawal by Subject|12|||
130214287|NCT01763203|468748953|FG000|Overall Study|Moved out of study region|7|||
130214288|NCT01763203|468748954|FG001|Overall Study|Moved out of study region|10|||
130214289|NCT01763203|468748953|FG000|Overall Study|Physician Decision|2|||
130214290|NCT01763203|468748954|FG001|Overall Study|Physician Decision|1|||
130214291|NCT02187861|468748955|FG000|Overall Study|Adverse Event|2|||
130214292|NCT02187861|468748956|FG001|Overall Study|Adverse Event|1|||
130214293|NCT02187861|468748957|FG002|Overall Study|Adverse Event|2|||
130214294|NCT02187861|468748958|FG003|Overall Study|Adverse Event|1|||
130214295|NCT02187861|468748955|FG000|Overall Study|Death|0|||
130214296|NCT02187861|468748956|FG001|Overall Study|Death|3|||
130214297|NCT02187861|468748957|FG002|Overall Study|Death|1|||
130214298|NCT02187861|468748958|FG003|Overall Study|Death|2|||
130214299|NCT02187861|468748955|FG000|Overall Study|Physician Decision|0|||
130214300|NCT02187861|468748956|FG001|Overall Study|Physician Decision|1|||
130214301|NCT02187861|468748957|FG002|Overall Study|Physician Decision|0|||
130214302|NCT02187861|468748958|FG003|Overall Study|Physician Decision|3|||
130214303|NCT02187861|468748955|FG000|Overall Study|Progressive Disease|4|||
130214304|NCT02187861|468748956|FG001|Overall Study|Progressive Disease|42|||
130214305|NCT02187861|468748957|FG002|Overall Study|Progressive Disease|19|||
130214306|NCT02187861|468748958|FG003|Overall Study|Progressive Disease|22|||
130214307|NCT02187861|468748955|FG000|Overall Study|Withdrawal by Subject|0|||
130214308|NCT02187861|468748956|FG001|Overall Study|Withdrawal by Subject|0|||
130214309|NCT02187861|468748957|FG002|Overall Study|Withdrawal by Subject|3|||
130214310|NCT02187861|468748958|FG003|Overall Study|Withdrawal by Subject|3|||
130214311|NCT02187861|468748955|FG000|Overall Study|Other|0|||
130214312|NCT02187861|468748956|FG001|Overall Study|Other|1|||
130214313|NCT02187861|468748957|FG002|Overall Study|Other|7|||
130551295|NCT01313689|469986381|FG001|24-Week Randomization 2|Physician Decision|0|||
130551296|NCT01313689|469986382|FG002|24-Week Randomization 2|Physician Decision|0|||
130551297|NCT01313689|469986383|FG003|24-Week Randomization 2|Physician Decision|0|||
130551298|NCT01313689|469986384|FG004|24-Week Randomization 2|Physician Decision|4|||
130551299|NCT00687973|469986385|FG000|Overall Study|Adverse Event|18|||
130214314|NCT02187861|468748958|FG003|Overall Study|Other|1|||
130214315|NCT02757625|468748960|FG000|Overall Study|Investigator's discretion|0|||
130214316|NCT02757625|468748961|FG001|Overall Study|Investigator's discretion|0|||
130214317|NCT02757625|468748962|FG002|Overall Study|Investigator's discretion|1|||
130214318|NCT02757625|468748963|FG003|Overall Study|Investigator's discretion|0|||
130551300|NCT00687973|469986386|FG001|Overall Study|Adverse Event|28|||
130551301|NCT00687973|469986385|FG000|Overall Study|Lack of Efficacy|2|||
130551302|NCT00687973|469986386|FG001|Overall Study|Lack of Efficacy|3|||
130551303|NCT00687973|469986385|FG000|Overall Study|Protocol Violation|1|||
130551304|NCT00687973|469986386|FG001|Overall Study|Protocol Violation|2|||
130551305|NCT00687973|469986385|FG000|Overall Study|Administrative Reasons|0|||
130551306|NCT00687973|469986386|FG001|Overall Study|Administrative Reasons|2|||
130551307|NCT00687973|469986385|FG000|Overall Study|Withdrawal by Subject|3|||
130551308|NCT00687973|469986386|FG001|Overall Study|Withdrawal by Subject|3|||
130551309|NCT01007448|469986387|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
130551310|NCT01007448|469986388|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
130551311|NCT01007448|469986387|FG000|Overall Study|Staph Skin Infection Flare|1|||
130551312|NCT01007448|469986388|FG001|Overall Study|Staph Skin Infection Flare|0|||
130551313|NCT01007448|469986387|FG000|Overall Study|Participant Leaving the Country|1|||
130551314|NCT01007448|469986388|FG001|Overall Study|Participant Leaving the Country|0|||
130551315|NCT01007448|469986387|FG000|Overall Study|Participant Given Prohibited Medication|1|||
130551316|NCT01007448|469986388|FG001|Overall Study|Participant Given Prohibited Medication|0|||
130551317|NCT01007448|469986387|FG000|Overall Study|Progressive Disease|1|||
130551318|NCT01007448|469986388|FG001|Overall Study|Progressive Disease|2|||
130551319|NCT01007448|469986387|FG000|Overall Study|Lack of Efficacy|2|||
130551320|NCT01007448|469986388|FG001|Overall Study|Lack of Efficacy|0|||
130551321|NCT01007448|469986387|FG000|Overall Study|Withdrawal by Subject|2|||
130551322|NCT01007448|469986388|FG001|Overall Study|Withdrawal by Subject|3|||
130551323|NCT01007448|469986387|FG000|Overall Study|Adverse Event|1|||
130551324|NCT01007448|469986388|FG001|Overall Study|Adverse Event|4|||
130551325|NCT02121834|469986390|FG000|Overall Study|Protocol Violation|0|||
130551326|NCT02121834|469986391|FG001|Overall Study|Protocol Violation|1|||
130551327|NCT02121834|469986392|FG002|Overall Study|Protocol Violation|0|||
130551328|NCT02121834|469986393|FG003|Overall Study|Protocol Violation|0|||
130551329|NCT02121834|469986394|FG004|Overall Study|Protocol Violation|0|||
130551330|NCT02121834|469986395|FG005|Overall Study|Protocol Violation|0|||
130551331|NCT02121834|469986396|FG006|Overall Study|Protocol Violation|0|||
130551332|NCT02121834|469986390|FG000|Overall Study|Withdrawal by Subject|0|||
130551333|NCT02121834|469986391|FG001|Overall Study|Withdrawal by Subject|1|||
130551334|NCT02121834|469986392|FG002|Overall Study|Withdrawal by Subject|1|||
130551335|NCT02121834|469986393|FG003|Overall Study|Withdrawal by Subject|0|||
130551336|NCT02121834|469986394|FG004|Overall Study|Withdrawal by Subject|0|||
130551337|NCT02121834|469986395|FG005|Overall Study|Withdrawal by Subject|0|||
130551338|NCT02121834|469986396|FG006|Overall Study|Withdrawal by Subject|0|||
130551339|NCT02121834|469986390|FG000|Overall Study|Lost to Follow-up|0|||
130551340|NCT02121834|469986391|FG001|Overall Study|Lost to Follow-up|0|||
130551341|NCT02121834|469986392|FG002|Overall Study|Lost to Follow-up|1|||
130551342|NCT02121834|469986393|FG003|Overall Study|Lost to Follow-up|0|||
130551343|NCT02121834|469986394|FG004|Overall Study|Lost to Follow-up|0|||
130551344|NCT02121834|469986395|FG005|Overall Study|Lost to Follow-up|0|||
130551345|NCT02121834|469986396|FG006|Overall Study|Lost to Follow-up|0|||
130551346|NCT02019927|469986399|FG000|Overall Study|Lost to Follow-up|2|||
130551347|NCT02019927|469986400|FG001|Overall Study|Lost to Follow-up|4|||
130551348|NCT02019927|469986401|FG002|Overall Study|Lost to Follow-up|1|||
130551349|NCT02019927|469986402|FG003|Overall Study|Lost to Follow-up|2|||
130551350|NCT02019927|469986403|FG004|Overall Study|Lost to Follow-up|3|||
130551351|NCT02019927|469986404|FG005|Overall Study|Lost to Follow-up|1|||
130551352|NCT01423253|469986413|FG000|Overall Study|Adverse Event|2|||
130551353|NCT01423253|469986413|FG000|Overall Study|Lack of Efficacy|2|||
130551354|NCT01423253|469986413|FG000|Overall Study|Lost to Follow-up|1|||
130551355|NCT01423253|469986413|FG000|Overall Study|Protocol Violation|2|||
130551356|NCT01423253|469986413|FG000|Overall Study|Withdrawal by Subject|2|||
130551357|NCT00307125|469986416|FG000|Screening Phase|Adverse Event|1|||
130551358|NCT00307125|469986417|FG001|Screening Phase|Adverse Event|0|||
130551359|NCT00307125|469986418|FG002|Screening Phase|Adverse Event|0|||
130551360|NCT00307125|469986416|FG000|Screening Phase|Protocol Violation|27|||
130551361|NCT00307125|469986417|FG001|Screening Phase|Protocol Violation|0|||
130551362|NCT00307125|469986418|FG002|Screening Phase|Protocol Violation|0|||
130551363|NCT00307125|469986416|FG000|Screening Phase|Lost to Follow-up|87|||
130551364|NCT00307125|469986417|FG001|Screening Phase|Lost to Follow-up|0|||
130551365|NCT00307125|469986418|FG002|Screening Phase|Lost to Follow-up|0|||
130551366|NCT00307125|469986416|FG000|Screening Phase|Death|10|||
130551367|NCT00307125|469986417|FG001|Screening Phase|Death|0|||
130551368|NCT00307125|469986418|FG002|Screening Phase|Death|0|||
130551369|NCT00307125|469986416|FG000|Screening Phase|Withdrawal by Subject|77|||
130551370|NCT00307125|469986417|FG001|Screening Phase|Withdrawal by Subject|0|||
130551371|NCT00307125|469986418|FG002|Screening Phase|Withdrawal by Subject|0|||
130551372|NCT00307125|469986416|FG000|Screening Phase|Physician Decision|26|||
130551373|NCT00307125|469986417|FG001|Screening Phase|Physician Decision|0|||
130551374|NCT00307125|469986418|FG002|Screening Phase|Physician Decision|0|||
130551375|NCT00307125|469986416|FG000|Screening Phase|Sponsor Decision|4|||
130551376|NCT00307125|469986417|FG001|Screening Phase|Sponsor Decision|0|||
130551377|NCT00307125|469986418|FG002|Screening Phase|Sponsor Decision|0|||
130551378|NCT00307125|469986416|FG000|Screening Phase|Study Terminated|17|||
130551379|NCT00307125|469986417|FG001|Screening Phase|Study Terminated|0|||
130551380|NCT00307125|469986418|FG002|Screening Phase|Study Terminated|0|||
130551381|NCT00307125|469986416|FG000|Screening Phase|Graft Loss|3|||
130551382|NCT00307125|469986417|FG001|Screening Phase|Graft Loss|0|||
130551383|NCT00307125|469986418|FG002|Screening Phase|Graft Loss|0|||
130551384|NCT00307125|469986416|FG000|Screening Phase|Graft Failure|8|||
130551385|NCT00307125|469986417|FG001|Screening Phase|Graft Failure|0|||
130551386|NCT00307125|469986418|FG002|Screening Phase|Graft Failure|0|||
130551387|NCT00307125|469986416|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
130551388|NCT00307125|469986417|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
130551389|NCT00307125|469986418|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
130551390|NCT00307125|469986416|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
130551391|NCT00307125|469986417|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
130551392|NCT00307125|469986418|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
130551393|NCT00307125|469986416|FG000|Screening Phase|Moved or transferred facilities|34|||
130551394|NCT00307125|469986417|FG001|Screening Phase|Moved or transferred facilities|0|||
130551395|NCT00307125|469986418|FG002|Screening Phase|Moved or transferred facilities|0|||
130551396|NCT00307125|469986416|FG000|Screening Phase|Received Pancreas Transplant|8|||
130551397|NCT00307125|469986417|FG001|Screening Phase|Received Pancreas Transplant|0|||
130551398|NCT00307125|469986418|FG002|Screening Phase|Received Pancreas Transplant|0|||
130551399|NCT00307125|469986416|FG000|Screening Phase|Ineligible for pilot|4|||
130551400|NCT00307125|469986417|FG001|Screening Phase|Ineligible for pilot|0|||
130551401|NCT00307125|469986418|FG002|Screening Phase|Ineligible for pilot|0|||
130551402|NCT00307125|469986416|FG000|Screening Phase|Try to get pregnant|1|||
130551403|NCT00307125|469986417|FG001|Screening Phase|Try to get pregnant|0|||
130551404|NCT00307125|469986418|FG002|Screening Phase|Try to get pregnant|0|||
130551405|NCT00307125|469986416|FG000|Screening Phase|Developed acute leukemia|1|||
130551406|NCT00307125|469986417|FG001|Screening Phase|Developed acute leukemia|0|||
130551407|NCT00307125|469986418|FG002|Screening Phase|Developed acute leukemia|0|||
130551408|NCT00307125|469986416|FG000|Screening Phase|Metastatic colon cancer|1|||
130551409|NCT00307125|469986417|FG001|Screening Phase|Metastatic colon cancer|0|||
130551410|NCT00307125|469986418|FG002|Screening Phase|Metastatic colon cancer|0|||
130551411|NCT00307125|469986416|FG000|Screening Phase|Malignancy|1|||
130551412|NCT00307125|469986417|FG001|Screening Phase|Malignancy|0|||
130551413|NCT00307125|469986418|FG002|Screening Phase|Malignancy|0|||
130551414|NCT00307125|469986416|FG000|Screening Phase|PAK|1|||
130551415|NCT00307125|469986417|FG001|Screening Phase|PAK|0|||
130551416|NCT00307125|469986418|FG002|Screening Phase|PAK|0|||
130551417|NCT00307125|469986416|FG000|Screening Phase|Ineligible|1|||
130551418|NCT00307125|469986417|FG001|Screening Phase|Ineligible|0|||
130551419|NCT00307125|469986418|FG002|Screening Phase|Ineligible|0|||
130551420|NCT00307125|469986416|FG000|Screening Phase|Screen Error|1|||
130551421|NCT00307125|469986417|FG001|Screening Phase|Screen Error|0|||
130551422|NCT00307125|469986418|FG002|Screening Phase|Screen Error|0|||
130551423|NCT00307125|469986416|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
130551424|NCT00307125|469986417|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
130551425|NCT00307125|469986418|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
130551426|NCT00307125|469986416|FG000|Screening Phase|AMR and treated with rituximab|1|||
130551427|NCT00307125|469986417|FG001|Screening Phase|AMR and treated with rituximab|0|||
130551428|NCT00307125|469986418|FG002|Screening Phase|AMR and treated with rituximab|0|||
130551429|NCT00307125|469986416|FG000|Screening Phase|Coronary artery bypass|1|||
130551430|NCT00307125|469986417|FG001|Screening Phase|Coronary artery bypass|0|||
130551431|NCT00307125|469986418|FG002|Screening Phase|Coronary artery bypass|0|||
130551432|NCT00307125|469986416|FG000|Pilot Phase|Lost to Follow-up|0|||
130551433|NCT00307125|469986417|FG001|Pilot Phase|Lost to Follow-up|1|||
130551434|NCT00307125|469986418|FG002|Pilot Phase|Lost to Follow-up|0|||
130551435|NCT00307125|469986416|FG000|Pilot Phase|Withdrawal by Subject|0|||
130551436|NCT00307125|469986417|FG001|Pilot Phase|Withdrawal by Subject|1|||
130551437|NCT00307125|469986418|FG002|Pilot Phase|Withdrawal by Subject|1|||
130551438|NCT00051363|469986419|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
130551439|NCT00051363|469986420|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
130551440|NCT00051363|469986419|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
130551441|NCT00051363|469986420|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
130551442|NCT00051363|469986419|FG000|Overall Study|Death|2|||
130551443|NCT00051363|469986420|FG001|Overall Study|Death|2|||
130551444|NCT00051363|469986419|FG000|Overall Study|Excluded Pre-Randomization|2|||
130551445|NCT00051363|469986420|FG001|Overall Study|Excluded Pre-Randomization|5|||
130551446|NCT00147823|469986423|FG000|Overall Study|Lost to Follow-up|6|||
130551447|NCT00147823|469986424|FG001|Overall Study|Lost to Follow-up|12|||
130551448|NCT00147823|469986423|FG000|Overall Study|Physician Decision|1|||
130551449|NCT00147823|469986424|FG001|Overall Study|Physician Decision|0|||
130551450|NCT00147823|469986423|FG000|Overall Study|Withdrawal by Subject|0|||
130551451|NCT00147823|469986424|FG001|Overall Study|Withdrawal by Subject|1|||
130551452|NCT00147823|469986423|FG000|Overall Study|Did not receive vitoss due to infection|6|||
130214319|NCT02757625|468748960|FG000|Overall Study|Adverse Event|0|||
130214320|NCT02757625|468748961|FG001|Overall Study|Adverse Event|0|||
130214321|NCT02757625|468748962|FG002|Overall Study|Adverse Event|1|||
130214322|NCT02757625|468748963|FG003|Overall Study|Adverse Event|0|||
130214323|NCT04854057|468748964|FG000|Overall Study|Adverse Event|0|||
130551453|NCT00147823|469986424|FG001|Overall Study|Did not receive vitoss due to infection|2|||
130214324|NCT04854057|468748965|FG001|Overall Study|Adverse Event|1|||
130214325|NCT03519919|468748966|FG000|Overall Study|Withdrawal by Subject|1|||
130214326|NCT03519919|468748966|FG000|Overall Study|Lack of Efficacy|1|||
130214327|NCT03519919|468748966|FG000|Overall Study|Screen Failure|1|||
130214328|NCT00645671|468748967|FG000|Overall Study|Protocol Violation|1|||
130214329|NCT00645671|468748968|FG001|Overall Study|Protocol Violation|0|||
130214330|NCT00645671|468748967|FG000|Overall Study|Withdrawal by Subject|0|||
130214331|NCT00645671|468748968|FG001|Overall Study|Withdrawal by Subject|4|||
130214332|NCT00645671|468748967|FG000|Overall Study|Adverse Event|0|||
130214333|NCT00645671|468748968|FG001|Overall Study|Adverse Event|1|||
130214334|NCT00645671|468748967|FG000|Overall Study|Physician Decision|0|||
130214335|NCT00645671|468748968|FG001|Overall Study|Physician Decision|1|||
130214336|NCT05114564|468748969|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
130214337|NCT05114564|468748970|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
130214338|NCT05114564|468748969|FG000|First Intervention|Adverse Event|0|||
130214339|NCT05114564|468748970|FG001|First Intervention|Adverse Event|1|||
130214340|NCT00493311|468748971|FG000|Overall Study|Need for rescue medication|2|||
130214341|NCT00493311|468748972|FG001|Overall Study|Need for rescue medication|2|||
130214342|NCT02779075|468748973|FG000|Overall Study|Withdrawal by Subject|1|||
130214343|NCT02779075|468748974|FG001|Overall Study|Withdrawal by Subject|3|||
130214344|NCT02779075|468748973|FG000|Overall Study|IV lost during 2nd study|1|||
130214345|NCT02779075|468748974|FG001|Overall Study|IV lost during 2nd study|0|||
130214346|NCT01951573|468748975|FG000|Washout Period|Adverse Event|0|||
130214347|NCT01951573|468748976|FG001|Washout Period|Adverse Event|1|||
130214348|NCT00707980|468748977|FG000|Overall Study|Adverse Event|49|||
130214349|NCT00707980|468748977|FG000|Overall Study|Lack of Efficacy|35|||
130214350|NCT00707980|468748977|FG000|Overall Study|Non-Compliance with Study Drug|28|||
130214351|NCT00707980|468748977|FG000|Overall Study|Protocol Deviations|19|||
130214352|NCT00707980|468748977|FG000|Overall Study|Withdrawal of Consent|81|||
130214353|NCT00707980|468748977|FG000|Overall Study|Lost to Follow-up|59|||
130214354|NCT00707980|468748977|FG000|Overall Study|Other|39|||
130214355|NCT01909973|468748978|FG000|Overall Study|Lost to Follow-up|1|||
130214356|NCT01909973|468748979|FG001|Overall Study|Lost to Follow-up|0|||
130214357|NCT00460239|468748980|FG000|Overall Study|Physician Decision|0|||
130214358|NCT00460239|468748981|FG001|Overall Study|Physician Decision|1|||
130214359|NCT00460239|468748982|FG002|Overall Study|Physician Decision|0|||
130214360|NCT00460239|468748983|FG003|Overall Study|Physician Decision|0|||
130214361|NCT00460239|468748984|FG004|Overall Study|Physician Decision|0|||
130214362|NCT00460239|468748985|FG005|Overall Study|Physician Decision|2|||
130214363|NCT00460239|468748986|FG006|Overall Study|Physician Decision|0|||
130214364|NCT00460239|468748987|FG007|Overall Study|Physician Decision|0|||
130214365|NCT00460239|468748988|FG008|Overall Study|Physician Decision|0|||
130214366|NCT00460239|468748980|FG000|Overall Study|Withdrawal by Subject|0|||
130214367|NCT00460239|468748981|FG001|Overall Study|Withdrawal by Subject|0|||
130214368|NCT00460239|468748982|FG002|Overall Study|Withdrawal by Subject|0|||
130214369|NCT00460239|468748983|FG003|Overall Study|Withdrawal by Subject|0|||
130214370|NCT00460239|468748984|FG004|Overall Study|Withdrawal by Subject|0|||
130214371|NCT00460239|468748985|FG005|Overall Study|Withdrawal by Subject|1|||
130214372|NCT00460239|468748986|FG006|Overall Study|Withdrawal by Subject|0|||
130214373|NCT00460239|468748987|FG007|Overall Study|Withdrawal by Subject|0|||
130214374|NCT00460239|468748988|FG008|Overall Study|Withdrawal by Subject|0|||
130214375|NCT04217317|468749016|FG000|Overall Study|Lack of Efficacy|4|||
130214376|NCT04217317|468749016|FG000|Overall Study|Physician Decision|1|||
130214377|NCT04313400|468749020|FG000|Overall Study|Withdrawal by Subject|0|||
130214378|NCT04313400|468749021|FG001|Overall Study|Withdrawal by Subject|0|||
130214379|NCT04313400|468749022|FG002|Overall Study|Withdrawal by Subject|0|||
130214380|NCT04313400|468749023|FG003|Overall Study|Withdrawal by Subject|0|||
130551454|NCT01032382|469986425|FG000|Overall Study|Disease dissemination|1|||
130551455|NCT01032382|469986426|FG001|Overall Study|Disease dissemination|1|||
130551456|NCT01032382|469986425|FG000|Overall Study|Treatment failure|3|||
130551457|NCT01032382|469986426|FG001|Overall Study|Treatment failure|1|||
130551458|NCT01032382|469986425|FG000|Overall Study|Index lesion relapse|1|||
130551459|NCT01032382|469986426|FG001|Overall Study|Index lesion relapse|3|||
130214381|NCT04313400|468749024|FG004|Overall Study|Withdrawal by Subject|0|||
130214382|NCT04313400|468749025|FG005|Overall Study|Withdrawal by Subject|4|||
130214383|NCT04313400|468749026|FG006|Overall Study|Withdrawal by Subject|1|||
130214384|NCT04313400|468749020|FG000|Overall Study|Adverse Event|0|||
130214385|NCT04313400|468749021|FG001|Overall Study|Adverse Event|0|||
130214386|NCT04313400|468749022|FG002|Overall Study|Adverse Event|0|||
130214387|NCT04313400|468749023|FG003|Overall Study|Adverse Event|0|||
130214388|NCT04313400|468749024|FG004|Overall Study|Adverse Event|0|||
130551460|NCT00412971|469986427|FG000|Overall Study|Lost to Follow-up|17|||
130551461|NCT00412971|469986428|FG001|Overall Study|Lost to Follow-up|9|||
130551462|NCT00412971|469986427|FG000|Overall Study|Protocol Violation|13|||
130551463|NCT00412971|469986428|FG001|Overall Study|Protocol Violation|1|||
130551464|NCT02571049|469986429|FG000|Screening|Did not meet entry criteria|2|||
130551465|NCT02571049|469986430|FG001|Screening|Did not meet entry criteria|2|||
130551466|NCT02571049|469986429|FG000|Randomization|No migraine attack|0|||
130551467|NCT02571049|469986430|FG001|Randomization|No migraine attack|1|||
130551468|NCT02571049|469986429|FG000|Randomization|Adverse Event|0|||
130551469|NCT02571049|469986430|FG001|Randomization|Adverse Event|1|||
130551470|NCT01055262|469986431|FG000|Overall Study|Adverse Event|5|||
130551471|NCT01055262|469986431|FG000|Overall Study|Protocol Violation|3|||
130551472|NCT01055262|469986431|FG000|Overall Study|Uncooperativeness|1|||
130551473|NCT00561951|469986432|FG000|Overall Study|Adverse Event|11|||
130551474|NCT00561951|469986433|FG001|Overall Study|Adverse Event|14|||
130551475|NCT00561951|469986434|FG002|Overall Study|Adverse Event|14|||
130551476|NCT00561951|469986432|FG000|Overall Study|Lack of Efficacy|5|||
130551477|NCT00561951|469986433|FG001|Overall Study|Lack of Efficacy|3|||
130551478|NCT00561951|469986434|FG002|Overall Study|Lack of Efficacy|2|||
130551479|NCT00561951|469986432|FG000|Overall Study|Lost to Follow-up|1|||
130551480|NCT00561951|469986433|FG001|Overall Study|Lost to Follow-up|1|||
130551481|NCT00561951|469986434|FG002|Overall Study|Lost to Follow-up|0|||
130551482|NCT00561951|469986432|FG000|Overall Study|Withdrawal by Subject|10|||
130551483|NCT00561951|469986433|FG001|Overall Study|Withdrawal by Subject|9|||
130551484|NCT00561951|469986434|FG002|Overall Study|Withdrawal by Subject|10|||
130214389|NCT04313400|468749025|FG005|Overall Study|Adverse Event|1|||
130214390|NCT04313400|468749026|FG006|Overall Study|Adverse Event|0|||
130214391|NCT04313400|468749020|FG000|Overall Study|Lost to Follow-up|0|||
130214392|NCT04313400|468749021|FG001|Overall Study|Lost to Follow-up|0|||
130214393|NCT04313400|468749022|FG002|Overall Study|Lost to Follow-up|0|||
130214394|NCT04313400|468749023|FG003|Overall Study|Lost to Follow-up|0|||
130214395|NCT04313400|468749024|FG004|Overall Study|Lost to Follow-up|0|||
130214396|NCT04313400|468749025|FG005|Overall Study|Lost to Follow-up|1|||
130214397|NCT04313400|468749026|FG006|Overall Study|Lost to Follow-up|0|||
130214398|NCT00770913|468749029|FG000|Overall Study|Adverse Event|1|||
130214399|NCT00770913|468749030|FG001|Overall Study|Adverse Event|3|||
130214400|NCT00770913|468749031|FG002|Overall Study|Adverse Event|6|||
130214401|NCT00770913|468749029|FG000|Overall Study|Refusal to continue participation|6|||
130214402|NCT00770913|468749030|FG001|Overall Study|Refusal to continue participation|4|||
130214403|NCT00770913|468749031|FG002|Overall Study|Refusal to continue participation|5|||
130214404|NCT00770913|468749029|FG000|Overall Study|Physician Decision|0|||
130214405|NCT00770913|468749030|FG001|Overall Study|Physician Decision|1|||
130214406|NCT00770913|468749031|FG002|Overall Study|Physician Decision|1|||
130214407|NCT00770913|468749029|FG000|Overall Study|Protocol Violation|3|||
130214408|NCT00770913|468749030|FG001|Overall Study|Protocol Violation|0|||
130214409|NCT00770913|468749031|FG002|Overall Study|Protocol Violation|1|||
130214410|NCT00770913|468749029|FG000|Overall Study|Incorrect drug was allocated|1|||
130214411|NCT00770913|468749030|FG001|Overall Study|Incorrect drug was allocated|0|||
130214412|NCT00770913|468749031|FG002|Overall Study|Incorrect drug was allocated|0|||
130214413|NCT00359294|468749032|FG000|Overall Study|Progressive disease|1|||
130214414|NCT00359294|468749033|FG001|Overall Study|Progressive disease|1|||
130214415|NCT00359294|468749034|FG002|Overall Study|Progressive disease|2|||
130214416|NCT00359294|468749035|FG003|Overall Study|Progressive disease|3|||
130214417|NCT00359294|468749036|FG004|Overall Study|Progressive disease|2|||
130214418|NCT00359294|468749032|FG000|Overall Study|Withdrawal by Subject|0|||
130214419|NCT00359294|468749033|FG001|Overall Study|Withdrawal by Subject|0|||
130214420|NCT00359294|468749034|FG002|Overall Study|Withdrawal by Subject|0|||
130214421|NCT00359294|468749035|FG003|Overall Study|Withdrawal by Subject|0|||
130214422|NCT00359294|468749036|FG004|Overall Study|Withdrawal by Subject|1|||
130214423|NCT00359294|468749032|FG000|Overall Study|Not treated|0|||
130214424|NCT00359294|468749033|FG001|Overall Study|Not treated|0|||
130214425|NCT00359294|468749034|FG002|Overall Study|Not treated|0|||
130214426|NCT00359294|468749035|FG003|Overall Study|Not treated|1|||
130214427|NCT00359294|468749036|FG004|Overall Study|Not treated|0|||
130214428|NCT00359294|468749032|FG000|Overall Study|Physician Decision|0|||
130214429|NCT00359294|468749033|FG001|Overall Study|Physician Decision|0|||
130214430|NCT00359294|468749034|FG002|Overall Study|Physician Decision|1|||
130214431|NCT00359294|468749035|FG003|Overall Study|Physician Decision|0|||
130214432|NCT00359294|468749036|FG004|Overall Study|Physician Decision|0|||
130551485|NCT00561951|469986432|FG000|Overall Study|Protocol Violation|4|||
130551486|NCT00561951|469986433|FG001|Overall Study|Protocol Violation|3|||
130551487|NCT00561951|469986434|FG002|Overall Study|Protocol Violation|4|||
130214433|NCT01808222|468749037|FG000|Overall Study|mpMR scan was not performed|1|||
130214434|NCT00524680|468749040|FG000|Overall Study|progression|0|||
130214435|NCT00524680|468749041|FG001|Overall Study|progression|0|||
130551488|NCT00561951|469986432|FG000|Overall Study|Physician Decision|1|||
130551489|NCT00561951|469986433|FG001|Overall Study|Physician Decision|0|||
130551490|NCT00561951|469986434|FG002|Overall Study|Physician Decision|0|||
130214436|NCT00524680|468749042|FG002|Overall Study|progression|0|||
130214437|NCT00524680|468749043|FG003|Overall Study|progression|1|||
130551491|NCT00561951|469986432|FG000|Overall Study|Pregnancy|0|||
130551492|NCT00561951|469986433|FG001|Overall Study|Pregnancy|1|||
130551493|NCT00561951|469986434|FG002|Overall Study|Pregnancy|0|||
130551494|NCT00561951|469986432|FG000|Overall Study|Meet Withdrawal Criterion|0|||
130551495|NCT00561951|469986433|FG001|Overall Study|Meet Withdrawal Criterion|1|||
130551496|NCT00561951|469986434|FG002|Overall Study|Meet Withdrawal Criterion|1|||
130551497|NCT00561951|469986432|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
130551498|NCT00561951|469986433|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
130551499|NCT00561951|469986434|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
130551500|NCT01596621|469986446|FG000|Overall Study|Death|4|||
130551501|NCT01596621|469986446|FG000|Overall Study|Withdrawal by Subject|9|||
130551502|NCT01596621|469986446|FG000|Overall Study|Disease Progression|49|||
130551503|NCT01596621|469986446|FG000|Overall Study|Lost to Follow-up|3|||
130551504|NCT01596621|469986446|FG000|Overall Study|Other than specified|13|||
130551505|NCT00421707|469986455|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
130551506|NCT00421707|469986456|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
130551507|NCT00421707|469986455|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
130551508|NCT00421707|469986456|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
130551509|NCT00421707|469986455|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
130551510|NCT00421707|469986456|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
130551511|NCT00421707|469986455|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
130551512|NCT00421707|469986456|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
130551513|NCT00421707|469986455|FG000|Period 2: Washout|Adverse Event|1|||
130551514|NCT00421707|469986456|FG001|Period 2: Washout|Adverse Event|1|||
130551515|NCT00421707|469986455|FG000|Period 2: Washout|Withdrawal by Subject|0|||
130551516|NCT00421707|469986456|FG001|Period 2: Washout|Withdrawal by Subject|1|||
130551517|NCT00421707|469986455|FG000|Period 2: Washout|Lost to Follow-up|0|||
130551518|NCT00421707|469986456|FG001|Period 2: Washout|Lost to Follow-up|1|||
130551519|NCT00421707|469986455|FG000|Period 2: Washout|Other: Pregnancy|0|||
130551520|NCT00421707|469986456|FG001|Period 2: Washout|Other: Pregnancy|1|||
130551521|NCT00421707|469986455|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
130551522|NCT00421707|469986456|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
130551523|NCT00421707|469986455|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
130551524|NCT00421707|469986456|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
130551525|NCT00421707|469986455|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
130551526|NCT00421707|469986456|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
130551527|NCT03261700|469986457|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
130551528|NCT03261700|469986458|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
130551529|NCT01723254|469986459|FG000|Overall Study|Conflict with work schedule|0|||
130551530|NCT01723254|469986460|FG001|Overall Study|Conflict with work schedule|0|||
130654528|NCT03426995|470357649|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654529|NCT03426995|470357650|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654530|NCT03426995|470357651|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
130654531|NCT03426995|470357652|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654532|NCT03426995|470357653|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654533|NCT03426995|470357654|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654534|NCT03426995|470357655|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654535|NCT03426995|470357656|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654536|NCT03426995|470357657|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654537|NCT03426995|470357658|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654538|NCT03426995|470357659|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654539|NCT03426995|470357660|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654540|NCT03426995|470357661|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654541|NCT03426995|470357662|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654542|NCT03426995|470357663|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654543|NCT03426995|470357664|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130654544|NCT03426995|470357646|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654545|NCT03426995|470357647|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654546|NCT03426995|470357648|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654547|NCT03426995|470357649|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654548|NCT03426995|470357650|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
130654549|NCT03426995|470357651|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
130654550|NCT03426995|470357652|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654551|NCT03426995|470357653|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654552|NCT03426995|470357654|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654553|NCT03426995|470357655|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654554|NCT03426995|470357656|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654555|NCT03426995|470357657|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654556|NCT03426995|470357658|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654557|NCT03426995|470357659|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654558|NCT03426995|470357660|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654559|NCT03426995|470357661|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654560|NCT03426995|470357662|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654561|NCT03426995|470357663|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654562|NCT03426995|470357664|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130654563|NCT03426995|470357646|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654564|NCT03426995|470357647|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654565|NCT03426995|470357648|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654566|NCT03426995|470357649|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654567|NCT03426995|470357650|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654568|NCT03426995|470357651|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654569|NCT03426995|470357652|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654570|NCT03426995|470357653|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654571|NCT03426995|470357654|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654572|NCT03426995|470357655|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654573|NCT03426995|470357656|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
130654574|NCT03426995|470357657|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654575|NCT03426995|470357658|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654576|NCT03426995|470357659|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654577|NCT03426995|470357660|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654578|NCT03426995|470357661|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654579|NCT03426995|470357662|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654580|NCT03426995|470357663|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654581|NCT03426995|470357664|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130654582|NCT03426995|470357646|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654583|NCT03426995|470357647|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654584|NCT03426995|470357648|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654585|NCT03426995|470357649|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654586|NCT03426995|470357650|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654587|NCT03426995|470357651|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654588|NCT03426995|470357652|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654589|NCT03426995|470357653|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
130654590|NCT03426995|470357654|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654591|NCT03426995|470357655|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654592|NCT03426995|470357656|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654593|NCT03426995|470357657|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654594|NCT03426995|470357658|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654595|NCT03426995|470357659|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654596|NCT03426995|470357660|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654597|NCT03426995|470357661|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654598|NCT03426995|470357662|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654599|NCT03426995|470357663|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654600|NCT03426995|470357664|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130654601|NCT03426995|470357646|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654602|NCT03426995|470357647|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654603|NCT03426995|470357648|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654604|NCT03426995|470357649|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654605|NCT03426995|470357650|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654606|NCT03426995|470357651|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654607|NCT03426995|470357652|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654608|NCT03426995|470357653|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654609|NCT03426995|470357654|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130214438|NCT00524680|468749040|FG000|Overall Study|Adverse Event|2|||
130214439|NCT00524680|468749041|FG001|Overall Study|Adverse Event|0|||
130214440|NCT00524680|468749042|FG002|Overall Study|Adverse Event|0|||
130551531|NCT01723254|469986461|FG002|Overall Study|Conflict with work schedule|0|||
130551532|NCT01723254|469986462|FG003|Overall Study|Conflict with work schedule|0|||
130551533|NCT01723254|469986463|FG004|Overall Study|Conflict with work schedule|0|||
130551534|NCT01723254|469986464|FG005|Overall Study|Conflict with work schedule|0|||
130214441|NCT00524680|468749043|FG003|Overall Study|Adverse Event|1|||
130214442|NCT00524680|468749040|FG000|Overall Study|Other|0|||
130214443|NCT00524680|468749041|FG001|Overall Study|Other|1|||
130214444|NCT00524680|468749042|FG002|Overall Study|Other|2|||
130551535|NCT01723254|469986465|FG006|Overall Study|Conflict with work schedule|0|||
130551536|NCT01723254|469986466|FG007|Overall Study|Conflict with work schedule|1|||
130551537|NCT01723254|469986459|FG000|Overall Study|Personal issues|0|||
130551538|NCT01723254|469986460|FG001|Overall Study|Personal issues|0|||
130551539|NCT01723254|469986461|FG002|Overall Study|Personal issues|0|||
130551540|NCT01723254|469986462|FG003|Overall Study|Personal issues|0|||
130551541|NCT01723254|469986463|FG004|Overall Study|Personal issues|0|||
130551542|NCT01723254|469986464|FG005|Overall Study|Personal issues|1|||
130551543|NCT01723254|469986465|FG006|Overall Study|Personal issues|0|||
130551544|NCT01723254|469986466|FG007|Overall Study|Personal issues|0|||
130551545|NCT01723254|469986459|FG000|Overall Study|No longer have time to participate|0|||
130551546|NCT01723254|469986460|FG001|Overall Study|No longer have time to participate|0|||
130551547|NCT01723254|469986461|FG002|Overall Study|No longer have time to participate|0|||
130551548|NCT01723254|469986462|FG003|Overall Study|No longer have time to participate|1|||
130551549|NCT01723254|469986463|FG004|Overall Study|No longer have time to participate|0|||
130551550|NCT01723254|469986464|FG005|Overall Study|No longer have time to participate|0|||
130551551|NCT01723254|469986465|FG006|Overall Study|No longer have time to participate|0|||
130551552|NCT01723254|469986466|FG007|Overall Study|No longer have time to participate|0|||
130551553|NCT01723254|469986459|FG000|Overall Study|Move/Left to another country/city|0|||
130551554|NCT01723254|469986460|FG001|Overall Study|Move/Left to another country/city|0|||
130551555|NCT01723254|469986461|FG002|Overall Study|Move/Left to another country/city|2|||
130551556|NCT01723254|469986462|FG003|Overall Study|Move/Left to another country/city|1|||
130551557|NCT01723254|469986463|FG004|Overall Study|Move/Left to another country/city|1|||
130551558|NCT01723254|469986464|FG005|Overall Study|Move/Left to another country/city|0|||
130551559|NCT01723254|469986465|FG006|Overall Study|Move/Left to another country/city|0|||
130551560|NCT01723254|469986466|FG007|Overall Study|Move/Left to another country/city|0|||
130551561|NCT01723254|469986459|FG000|Overall Study|Protocol Violation|0|||
130551562|NCT01723254|469986460|FG001|Overall Study|Protocol Violation|1|||
130551563|NCT01723254|469986461|FG002|Overall Study|Protocol Violation|0|||
130551564|NCT01723254|469986462|FG003|Overall Study|Protocol Violation|0|||
130551565|NCT01723254|469986463|FG004|Overall Study|Protocol Violation|0|||
130551566|NCT01723254|469986464|FG005|Overall Study|Protocol Violation|0|||
130551567|NCT01723254|469986465|FG006|Overall Study|Protocol Violation|0|||
130551568|NCT01723254|469986466|FG007|Overall Study|Protocol Violation|0|||
130551569|NCT01723254|469986459|FG000|Overall Study|Withdrawal by Subject|1|||
130551570|NCT01723254|469986460|FG001|Overall Study|Withdrawal by Subject|2|||
130551571|NCT01723254|469986461|FG002|Overall Study|Withdrawal by Subject|1|||
130551572|NCT01723254|469986462|FG003|Overall Study|Withdrawal by Subject|0|||
130551573|NCT01723254|469986463|FG004|Overall Study|Withdrawal by Subject|1|||
130551574|NCT01723254|469986464|FG005|Overall Study|Withdrawal by Subject|1|||
130551575|NCT01723254|469986465|FG006|Overall Study|Withdrawal by Subject|1|||
130551576|NCT01723254|469986466|FG007|Overall Study|Withdrawal by Subject|2|||
130551577|NCT01074216|469986467|FG000|Overall Study|Physician Decision|1|||
130551578|NCT01074216|469986467|FG000|Overall Study|Not Treated|12|||
130551579|NCT04223856|469986470|FG000|Overall Study|Progressive disease|153|||
130551580|NCT04223856|469986471|FG001|Overall Study|Progressive disease|73|||
130551581|NCT04223856|469986470|FG000|Overall Study|Adverse Event|97|||
130551582|NCT04223856|469986471|FG001|Overall Study|Adverse Event|62|||
130551583|NCT04223856|469986470|FG000|Overall Study|Physician Decision|9|||
130551584|NCT04223856|469986471|FG001|Overall Study|Physician Decision|28|||
130551585|NCT04223856|469986470|FG000|Overall Study|Withdrawal by Subject|22|||
130551586|NCT04223856|469986471|FG001|Overall Study|Withdrawal by Subject|24|||
130551587|NCT04223856|469986470|FG000|Overall Study|Other|7|||
130551588|NCT04223856|469986471|FG001|Overall Study|Other|2|||
130551589|NCT04223856|469986470|FG000|Overall Study|Randomized but not treated|2|||
130551590|NCT04223856|469986471|FG001|Overall Study|Randomized but not treated|11|||
130551591|NCT04223856|469986470|FG000|Overall Study|On-treatment|144|||
130551592|NCT04223856|469986471|FG001|Overall Study|On-treatment|0|||
130551593|NCT03226275|469986472|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
130551594|NCT03226275|469986473|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
130551595|NCT03226275|469986474|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
130551596|NCT03226275|469986475|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
130551597|NCT03226275|469986472|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
130551598|NCT03226275|469986473|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
130654610|NCT03426995|470357655|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654611|NCT03426995|470357656|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654612|NCT03426995|470357657|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654613|NCT03426995|470357658|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654614|NCT03426995|470357659|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654615|NCT03426995|470357660|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
130551599|NCT03226275|469986474|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
130551600|NCT03226275|469986475|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
130551601|NCT00294554|469988051|FG000|Overall Study|Lack of Efficacy|0|||
130551602|NCT00294554|469988052|FG001|Overall Study|Lack of Efficacy|1|||
130551603|NCT00294554|469988051|FG000|Overall Study|Physician Decision|0|||
130551604|NCT00294554|469988052|FG001|Overall Study|Physician Decision|1|||
130551605|NCT00462865|469988053|FG000|Overall Study|Adverse Event|1|||
130551606|NCT02864381|469988054|FG000|Overall Study|Death|58|||
130551607|NCT02864381|469988055|FG001|Overall Study|Death|61|||
130551608|NCT02864381|469988054|FG000|Overall Study|Withdrew Consent|5|||
130551609|NCT02864381|469988055|FG001|Overall Study|Withdrew Consent|6|||
130323472|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
130323473|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
130323474|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
130323475|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
130654616|NCT03426995|470357661|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
130654617|NCT03426995|470357662|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654618|NCT03426995|470357663|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130654619|NCT03426995|470357664|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130323476|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
130323477|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Other|0|||
130323478|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Other|0|||
130323479|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Other|1|||
130323480|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
130323481|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
130323482|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
130323483|NCT00335777|469155488|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
130323484|NCT00335777|469155488|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
130323485|NCT00371150|469155491|FG000|Overall Study|Lost to Follow-up|3|||
130323486|NCT00371150|469155492|FG001|Overall Study|Lost to Follow-up|2|||
130323487|NCT00124943|469155495|FG000|Phase II|Adverse Event|0|||
130323488|NCT00124943|469155496|FG001|Phase II|Adverse Event|2|||
130323489|NCT00124943|469155497|FG002|Phase II|Adverse Event|0|||
130323490|NCT00124943|469155498|FG003|Phase II|Adverse Event|1|||
130323491|NCT00124943|469155495|FG000|Phase II|Protocol Violation|0|||
130323492|NCT00124943|469155496|FG001|Phase II|Protocol Violation|0|||
130323493|NCT00124943|469155497|FG002|Phase II|Protocol Violation|0|||
130654620|NCT03426995|470357646|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654621|NCT03426995|470357647|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654622|NCT03426995|470357648|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654623|NCT03426995|470357649|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654624|NCT03426995|470357650|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654625|NCT03426995|470357651|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130551610|NCT02864381|469988054|FG000|Overall Study|Reason Unknown|7|||
130551611|NCT02864381|469988055|FG001|Overall Study|Reason Unknown|3|||
130551612|NCT02864381|469988054|FG000|Overall Study|Lost to Follow-up|1|||
130551613|NCT02864381|469988055|FG001|Overall Study|Lost to Follow-up|1|||
130323494|NCT00124943|469155498|FG003|Phase II|Protocol Violation|1|||
130323495|NCT00124943|469155495|FG000|Phase II|Lost to Follow-up|0|||
130323496|NCT00124943|469155496|FG001|Phase II|Lost to Follow-up|0|||
130323497|NCT00124943|469155497|FG002|Phase II|Lost to Follow-up|0|||
130323498|NCT00124943|469155498|FG003|Phase II|Lost to Follow-up|1|||
130551614|NCT02864381|469988054|FG000|Overall Study|Investigator's Discretion|1|||
130551615|NCT02864381|469988055|FG001|Overall Study|Investigator's Discretion|0|||
130551616|NCT02864381|469988054|FG000|Overall Study|Protocol Violation|0|||
130551617|NCT02864381|469988055|FG001|Overall Study|Protocol Violation|1|||
130551618|NCT01146054|469988058|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
130551619|NCT01146054|469988058|FG000|Overall Study|Rapid tumor progression|2|||
130551620|NCT01146054|469988058|FG000|Overall Study|Other illness precluded treatment|2|||
130551621|NCT01146054|469988058|FG000|Overall Study|Lost to Follow-up|1|||
130551622|NCT03840486|469988059|FG000|Overall Study|Withdrawal by Subject|0|||
130551623|NCT03840486|469988060|FG001|Overall Study|Withdrawal by Subject|1|||
130551624|NCT03840486|469988061|FG002|Overall Study|Withdrawal by Subject|0|||
130551625|NCT03840486|469988062|FG003|Overall Study|Withdrawal by Subject|0|||
130551626|NCT03840486|469988063|FG004|Overall Study|Withdrawal by Subject|0|||
130551627|NCT03840486|469988064|FG005|Overall Study|Withdrawal by Subject|0|||
130654626|NCT03426995|470357652|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654627|NCT03426995|470357653|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654628|NCT03426995|470357654|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654629|NCT03426995|470357655|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654630|NCT03426995|470357656|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654631|NCT03426995|470357657|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654632|NCT03426995|470357658|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654633|NCT03426995|470357659|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654634|NCT03426995|470357660|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
130654635|NCT03426995|470357661|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
130654636|NCT03426995|470357662|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654637|NCT03426995|470357663|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130654638|NCT03426995|470357664|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130551628|NCT03840486|469988065|FG006|Overall Study|Withdrawal by Subject|0|||
130551629|NCT03840486|469988066|FG007|Overall Study|Withdrawal by Subject|0|||
130551630|NCT03840486|469988067|FG008|Overall Study|Withdrawal by Subject|0|||
130323499|NCT00124943|469155495|FG000|Phase II|Withdrawal by Subject|0|||
130654639|NCT04410978|470357670|FG000|Overall Study|Poor compliance to protocol|2|||
130551631|NCT03840486|469988068|FG009|Overall Study|Withdrawal by Subject|0|||
130551632|NCT03840486|469988069|FG010|Overall Study|Withdrawal by Subject|0|||
130551633|NCT03840486|469988070|FG011|Overall Study|Withdrawal by Subject|0|||
130551634|NCT01139021|469988075|FG000|Overall Study|Adverse Event|0|||
130551635|NCT01139021|469988076|FG001|Overall Study|Adverse Event|0|||
130551636|NCT01139021|469988077|FG002|Overall Study|Adverse Event|0|||
130551637|NCT01139021|469988078|FG003|Overall Study|Adverse Event|0|||
130551638|NCT01139021|469988079|FG004|Overall Study|Adverse Event|1|||
130551639|NCT01139021|469988080|FG005|Overall Study|Adverse Event|0|||
130551640|NCT01139021|469988075|FG000|Overall Study|Lost to Follow-up|0|||
130551641|NCT01139021|469988076|FG001|Overall Study|Lost to Follow-up|0|||
130551642|NCT01139021|469988077|FG002|Overall Study|Lost to Follow-up|0|||
130551643|NCT01139021|469988078|FG003|Overall Study|Lost to Follow-up|0|||
130654640|NCT04410978|470357671|FG001|Overall Study|Poor compliance to protocol|4|||
130654641|NCT04410978|470357670|FG000|Overall Study|Withdrawal by Subject|64|||
130654642|NCT04410978|470357671|FG001|Overall Study|Withdrawal by Subject|66|||
130654643|NCT04410978|470357670|FG000|Overall Study|Other|6|||
130654644|NCT04410978|470357671|FG001|Overall Study|Other|7|||
130654645|NCT04410978|470357670|FG000|Overall Study|Missing study status|1|||
130654646|NCT04410978|470357671|FG001|Overall Study|Missing study status|0|||
130654647|NCT05153629|470357673|FG000|Overall Study|Withdrawal by Subject|0|||
130654648|NCT05153629|470357674|FG001|Overall Study|Withdrawal by Subject|2|||
130654649|NCT03743571|470357680|FG000|Overall Study|Withdrawal by Subject|1|||
130654650|NCT03743571|470357681|FG001|Overall Study|Withdrawal by Subject|1|||
130654651|NCT03743571|470357680|FG000|Overall Study|Lost to Follow-up|1|||
130654652|NCT03743571|470357681|FG001|Overall Study|Lost to Follow-up|2|||
130654653|NCT04115488|470357682|FG000|Overall Study|Adverse Event|8|||
130654654|NCT04115488|470357683|FG001|Overall Study|Adverse Event|4|||
130654655|NCT04115488|470357682|FG000|Overall Study|Withdrawal by Subject|3|||
130654656|NCT04115488|470357683|FG001|Overall Study|Withdrawal by Subject|6|||
130654657|NCT04115488|470357682|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
130654658|NCT04115488|470357683|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
130654659|NCT04115488|470357682|FG000|Overall Study|Patient 's location change|1|||
130654660|NCT04115488|470357683|FG001|Overall Study|Patient 's location change|0|||
130654661|NCT04115488|470357682|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
130654662|NCT04115488|470357683|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
130654663|NCT00885677|470357684|FG000|Overall Study|Death|40|||
130654664|NCT00885677|470357685|FG001|Overall Study|Death|34|||
130654665|NCT00885677|470357684|FG000|Overall Study|Lost to Follow-up|15|||
130654666|NCT00885677|470357685|FG001|Overall Study|Lost to Follow-up|13|||
130654667|NCT00885677|470357684|FG000|Overall Study|Protocol Violation|54|||
130654668|NCT00885677|470357685|FG001|Overall Study|Protocol Violation|54|||
130654669|NCT00885677|470357684|FG000|Overall Study|premature study closure|41|||
130654670|NCT00885677|470357685|FG001|Overall Study|premature study closure|44|||
130654671|NCT00885677|470357684|FG000|Overall Study|device/lead revision or replacement|7|||
130654672|NCT00885677|470357685|FG001|Overall Study|device/lead revision or replacement|6|||
130654673|NCT00885677|470357684|FG000|Overall Study|Heart transplantation|1|||
130654674|NCT00885677|470357685|FG001|Overall Study|Heart transplantation|0|||
130654675|NCT00885677|470357684|FG000|Overall Study|Inclusion/exclusion not met|25|||
130654676|NCT00885677|470357685|FG001|Overall Study|Inclusion/exclusion not met|27|||
130654677|NCT00972309|470357686|FG000|Overall Study|Switched to alternative treatment|0|||
130654678|NCT00972309|470357687|FG001|Overall Study|Switched to alternative treatment|2|||
130654679|NCT00972309|470357686|FG000|Overall Study|Refused further treatment|0|||
130654680|NCT00972309|470357687|FG001|Overall Study|Refused further treatment|1|||
130654681|NCT00972309|470357686|FG000|Overall Study|Late determination of ineligibility|0|||
130654682|NCT00972309|470357687|FG001|Overall Study|Late determination of ineligibility|1|||
130654683|NCT00972309|470357686|FG000|Overall Study|Second malignancy|1|||
130654684|NCT00972309|470357687|FG001|Overall Study|Second malignancy|1|||
130654685|NCT00972309|470357686|FG000|Overall Study|Visa issues|0|||
130654686|NCT00972309|470357687|FG001|Overall Study|Visa issues|1|||
130654687|NCT00972309|470357686|FG000|Overall Study|Secondary cancer (SCC)|0|||
130654688|NCT00972309|470357687|FG001|Overall Study|Secondary cancer (SCC)|1|||
130654689|NCT00972309|470357686|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
130654690|NCT00972309|470357687|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
130654691|NCT00972309|470357686|FG000|Overall Study|Lost to Follow-up|1|||
130654692|NCT00972309|470357687|FG001|Overall Study|Lost to Follow-up|1|||
130654693|NCT00972309|470357686|FG000|Overall Study|Disease progression on study|10|||
130654694|NCT00972309|470357687|FG001|Overall Study|Disease progression on study|4|||
130654695|NCT00948896|470357689|FG000|Randomization to 24 Months of Age|Death|1|||
130654696|NCT00948896|470357690|FG001|Randomization to 24 Months of Age|Death|0|||
130654697|NCT00948896|470357691|FG002|Randomization to 24 Months of Age|Death|0|||
130654698|NCT00948896|470357692|FG003|Randomization to 24 Months of Age|Death|0|||
130654699|NCT00948896|470357693|FG004|Randomization to 24 Months of Age|Death|2|||
130551644|NCT01139021|469988079|FG004|Overall Study|Lost to Follow-up|2|||
130551645|NCT01139021|469988080|FG005|Overall Study|Lost to Follow-up|0|||
130654700|NCT00948896|470357694|FG005|Randomization to 24 Months of Age|Death|1|||
130654701|NCT00948896|470357695|FG006|Randomization to 24 Months of Age|Death|2|||
130654702|NCT00948896|470357696|FG007|Randomization to 24 Months of Age|Death|1|||
130654703|NCT00948896|470357689|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
130654704|NCT00948896|470357690|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
130654705|NCT00948896|470357691|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
130654706|NCT00948896|470357692|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
130654707|NCT00948896|470357693|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130654708|NCT00948896|470357694|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
130654709|NCT00948896|470357695|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130654710|NCT00948896|470357696|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130654711|NCT00948896|470357689|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
130654712|NCT00948896|470357690|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
130654713|NCT00948896|470357691|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
130654714|NCT00948896|470357692|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
130654715|NCT00948896|470357693|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130654716|NCT00948896|470357694|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130654717|NCT00948896|470357695|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
130654718|NCT00948896|470357696|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130654719|NCT00948896|470357689|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
130654720|NCT00948896|470357690|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
130654721|NCT00948896|470357691|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
130654722|NCT00948896|470357692|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
130654723|NCT00948896|470357693|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
130654724|NCT00948896|470357694|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
130654725|NCT00948896|470357695|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
130654726|NCT00948896|470357696|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
130654727|NCT00948896|470357689|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130654728|NCT00948896|470357690|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
130654729|NCT00948896|470357691|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
130654730|NCT00948896|470357692|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
130654731|NCT00948896|470357693|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130654732|NCT00948896|470357694|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
130654733|NCT00948896|470357695|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130654734|NCT00948896|470357696|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130654735|NCT00948896|470357689|FG000|24 Months of Age to 36 Months of Age|Death|0|||
130654736|NCT00948896|470357690|FG001|24 Months of Age to 36 Months of Age|Death|2|||
130654737|NCT00948896|470357691|FG002|24 Months of Age to 36 Months of Age|Death|2|||
130654738|NCT00948896|470357692|FG003|24 Months of Age to 36 Months of Age|Death|0|||
130654739|NCT00948896|470357693|FG004|24 Months of Age to 36 Months of Age|Death|0|||
130654740|NCT00948896|470357694|FG005|24 Months of Age to 36 Months of Age|Death|1|||
130654741|NCT00948896|470357695|FG006|24 Months of Age to 36 Months of Age|Death|0|||
130654742|NCT00948896|470357696|FG007|24 Months of Age to 36 Months of Age|Death|0|||
130654743|NCT00948896|470357689|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130654744|NCT00948896|470357690|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130323500|NCT00124943|469155496|FG001|Phase II|Withdrawal by Subject|0|||
130323501|NCT00124943|469155497|FG002|Phase II|Withdrawal by Subject|0|||
130323502|NCT00124943|469155498|FG003|Phase II|Withdrawal by Subject|2|||
130323503|NCT00321620|469155499|FG000|Overall Study|Death|269|||
130654745|NCT00948896|470357691|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130654746|NCT00948896|470357692|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130654747|NCT00948896|470357693|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130214445|NCT00524680|468749043|FG003|Overall Study|Other|3|||
130214446|NCT00524680|468749040|FG000|Overall Study|Withdrawal by Subject|1|||
130214447|NCT00524680|468749041|FG001|Overall Study|Withdrawal by Subject|0|||
130214448|NCT00524680|468749042|FG002|Overall Study|Withdrawal by Subject|1|||
130214449|NCT00524680|468749043|FG003|Overall Study|Withdrawal by Subject|1|||
130214450|NCT03124537|468749044|FG000|Overall Study|Lost to Follow-up|3|||
130214451|NCT03124537|468749045|FG001|Overall Study|Lost to Follow-up|5|||
130214452|NCT03124537|468749044|FG000|Overall Study|App Crash, Incomplete Data|7|||
130214453|NCT03124537|468749045|FG001|Overall Study|App Crash, Incomplete Data|8|||
130214454|NCT03681184|468749046|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
130214455|NCT03681184|468749047|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
130214456|NCT01607346|468749050|FG000|Overall Study|Adverse Event|3|||
130214457|NCT01098162|468749051|FG000|Overall Study|Adverse Event|37|||
130214458|NCT01098162|468749051|FG000|Overall Study|Lack of Efficacy|4|||
130214459|NCT01098162|468749051|FG000|Overall Study|Wish of Patient|7|||
130214460|NCT01098162|468749051|FG000|Overall Study|Lost to Follow-up|9|||
130323504|NCT00321620|469155500|FG001|Overall Study|Death|294|||
130654748|NCT00948896|470357694|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130654749|NCT00948896|470357695|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130654750|NCT00948896|470357696|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130654751|NCT00948896|470357689|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
130654752|NCT00948896|470357690|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130654753|NCT00948896|470357691|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
130654754|NCT00948896|470357692|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130654755|NCT00948896|470357693|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
130654756|NCT00948896|470357694|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130654757|NCT00948896|470357695|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130654758|NCT00948896|470357696|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130214461|NCT01098162|468749051|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
130214462|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
130214463|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
130214464|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
130214465|NCT01098162|468749051|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
130214466|NCT01098162|468749051|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
130214467|NCT01098162|468749051|FG000|Overall Study|Other Reason|1|||
130214468|NCT01098162|468749051|FG000|Overall Study|Reason Unknown|26|||
130214469|NCT00625183|468749052|FG000|Overall Study|Disease Progression|1|||
130214470|NCT04318132|468749053|FG000|Overall Study|Protocol Violation|0|||
130214471|NCT04318132|468749054|FG001|Overall Study|Protocol Violation|0|||
130214472|NCT04318132|468749055|FG002|Overall Study|Protocol Violation|3|||
130214473|NCT04318132|468749056|FG003|Overall Study|Protocol Violation|0|||
130214474|NCT04424914|468749057|FG000|Overall Study|Other|0|||
130214475|NCT04424914|468749058|FG001|Overall Study|Other|0|||
130214476|NCT04424914|468749059|FG002|Overall Study|Other|28|||
130214477|NCT04424914|468749057|FG000|Overall Study|Withdrawal by Subject|3|||
130214478|NCT04424914|468749058|FG001|Overall Study|Withdrawal by Subject|0|||
130214479|NCT04424914|468749059|FG002|Overall Study|Withdrawal by Subject|0|||
130214480|NCT04424914|468749057|FG000|Overall Study|Study terminated by sponsor|23|||
130214481|NCT04424914|468749058|FG001|Overall Study|Study terminated by sponsor|7|||
130214482|NCT04424914|468749059|FG002|Overall Study|Study terminated by sponsor|0|||
130214483|NCT04424914|468749057|FG000|Overall Study|Lost to Follow-up|0|||
130214484|NCT04424914|468749058|FG001|Overall Study|Lost to Follow-up|0|||
130214485|NCT04424914|468749059|FG002|Overall Study|Lost to Follow-up|1|||
130214486|NCT04424914|468749057|FG000|Overall Study|Death|3|||
130214487|NCT04424914|468749058|FG001|Overall Study|Death|1|||
130214488|NCT04424914|468749059|FG002|Overall Study|Death|0|||
130214489|NCT01778751|468749064|FG000|Overall Study|Lost to Follow-up|1|||
130214490|NCT01778751|468749065|FG001|Overall Study|Lost to Follow-up|0|||
130214491|NCT01778751|468749064|FG000|Overall Study|Withdrawal by Subject|0|||
130214492|NCT01778751|468749065|FG001|Overall Study|Withdrawal by Subject|2|||
130214493|NCT01778751|468749064|FG000|Overall Study|Transfered care|1|||
130214494|NCT01778751|468749065|FG001|Overall Study|Transfered care|0|||
130214495|NCT02685072|468749073|FG000|Treatment Period|Lost to Follow-up|12|||
130214496|NCT02685072|468749074|FG001|Treatment Period|Lost to Follow-up|6|||
130214497|NCT02685072|468749073|FG000|Treatment Period|Withdrawal by Subject|1|||
130214498|NCT02685072|468749074|FG001|Treatment Period|Withdrawal by Subject|3|||
130214499|NCT02685072|468749073|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
130214500|NCT02685072|468749074|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
130214501|NCT02634710|468749075|FG000|Overall Study|Death|4|||
130214502|NCT02432144|468749079|FG000|Overall Study|Participant Non-Compliance|1|||
130214503|NCT01451554|468749080|FG000|Overall Study|Withdrawal by Subject|14|||
130214504|NCT01451554|468749081|FG001|Overall Study|Withdrawal by Subject|9|||
130214505|NCT01402986|468749082|FG000|Overall Study|Withdrawal by Subject|7|||
130214506|NCT01402986|468749083|FG001|Overall Study|Withdrawal by Subject|10|||
130214507|NCT01402986|468749084|FG002|Overall Study|Withdrawal by Subject|7|||
130214508|NCT01402986|468749085|FG003|Overall Study|Withdrawal by Subject|13|||
130214509|NCT01402986|468749082|FG000|Overall Study|Death|0|||
130214510|NCT01402986|468749083|FG001|Overall Study|Death|0|||
130214511|NCT01402986|468749084|FG002|Overall Study|Death|0|||
130214512|NCT01402986|468749085|FG003|Overall Study|Death|2|||
130214513|NCT01402986|468749082|FG000|Overall Study|Lost to Follow-up|0|||
130214514|NCT01402986|468749083|FG001|Overall Study|Lost to Follow-up|0|||
130214515|NCT01402986|468749084|FG002|Overall Study|Lost to Follow-up|0|||
130214516|NCT01402986|468749085|FG003|Overall Study|Lost to Follow-up|1|||
130214517|NCT01402986|468749082|FG000|Overall Study|Other|2|||
130214518|NCT01402986|468749083|FG001|Overall Study|Other|5|||
130214519|NCT01402986|468749084|FG002|Overall Study|Other|1|||
130214520|NCT01402986|468749085|FG003|Overall Study|Other|6|||
130214521|NCT02427802|468749086|FG000|Overall Study|Adverse Event|11|||
130214522|NCT02427802|468749087|FG001|Overall Study|Adverse Event|3|||
130214523|NCT02427802|468749088|FG002|Overall Study|Adverse Event|7|||
130214524|NCT02427802|468749086|FG000|Overall Study|Death|0|||
130214525|NCT02427802|468749087|FG001|Overall Study|Death|4|||
130214526|NCT02427802|468749088|FG002|Overall Study|Death|1|||
130654759|NCT00948896|470357689|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654760|NCT00948896|470357690|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654761|NCT00948896|470357691|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
130654762|NCT00948896|470357692|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654763|NCT00948896|470357693|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654764|NCT00948896|470357694|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
130654765|NCT00948896|470357695|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654766|NCT00948896|470357696|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130654767|NCT00948896|470357689|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654768|NCT00948896|470357690|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654769|NCT00948896|470357691|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654770|NCT00948896|470357692|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
130654771|NCT00948896|470357693|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654772|NCT00948896|470357694|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654773|NCT00948896|470357695|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130214527|NCT02427802|468749086|FG000|Overall Study|Lost to Follow-up|13|||
130214528|NCT02427802|468749087|FG001|Overall Study|Lost to Follow-up|8|||
130214529|NCT02427802|468749088|FG002|Overall Study|Lost to Follow-up|8|||
130214530|NCT02427802|468749086|FG000|Overall Study|Physician Decision|4|||
130214531|NCT02427802|468749087|FG001|Overall Study|Physician Decision|2|||
130214532|NCT02427802|468749088|FG002|Overall Study|Physician Decision|4|||
130214533|NCT02427802|468749086|FG000|Overall Study|Withdrawal by Subject|10|||
130214534|NCT02427802|468749087|FG001|Overall Study|Withdrawal by Subject|5|||
130214535|NCT02427802|468749088|FG002|Overall Study|Withdrawal by Subject|11|||
130214536|NCT02427802|468749086|FG000|Overall Study|Protocol Violation|3|||
130214537|NCT02427802|468749087|FG001|Overall Study|Protocol Violation|1|||
130214538|NCT02427802|468749088|FG002|Overall Study|Protocol Violation|1|||
130214539|NCT02427802|468749086|FG000|Overall Study|protocol specific treatment unrelated|18|||
130214540|NCT02427802|468749087|FG001|Overall Study|protocol specific treatment unrelated|11|||
130214541|NCT02427802|468749088|FG002|Overall Study|protocol specific treatment unrelated|11|||
130214542|NCT01085084|468749089|FG000|Overall Study|Withdrawal by Subject|1|||
130214543|NCT01085084|468749090|FG001|Overall Study|Withdrawal by Subject|0|||
130214544|NCT01085084|468749091|FG002|Overall Study|Withdrawal by Subject|0|||
130214545|NCT01085084|468749089|FG000|Overall Study|Lost to Follow-up|2|||
130214546|NCT01085084|468749090|FG001|Overall Study|Lost to Follow-up|1|||
130214547|NCT01085084|468749091|FG002|Overall Study|Lost to Follow-up|1|||
130214548|NCT01085084|468749089|FG000|Overall Study|Adverse Event|4|||
130214549|NCT01085084|468749090|FG001|Overall Study|Adverse Event|3|||
130214550|NCT01085084|468749091|FG002|Overall Study|Adverse Event|6|||
130214551|NCT01085084|468749089|FG000|Overall Study|Treatment Failure|0|||
130214552|NCT01085084|468749090|FG001|Overall Study|Treatment Failure|1|||
130214553|NCT01085084|468749091|FG002|Overall Study|Treatment Failure|2|||
130214554|NCT02634983|468749092|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
130214555|NCT02634983|468749093|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
130214556|NCT02070978|468749094|FG000|Overall Study|Adverse Event|6|||
130214557|NCT02070978|468749095|FG001|Overall Study|Adverse Event|2|||
130214558|NCT02070978|468749096|FG002|Overall Study|Adverse Event|0|||
130214559|NCT02070978|468749094|FG000|Overall Study|Lost to Follow-up|1|||
130214560|NCT02070978|468749095|FG001|Overall Study|Lost to Follow-up|3|||
130214561|NCT02070978|468749096|FG002|Overall Study|Lost to Follow-up|4|||
130214562|NCT02070978|468749094|FG000|Overall Study|Withdrawal by Subject|3|||
130214563|NCT02070978|468749095|FG001|Overall Study|Withdrawal by Subject|5|||
130214564|NCT02070978|468749096|FG002|Overall Study|Withdrawal by Subject|3|||
130214565|NCT02070978|468749094|FG000|Overall Study|Protocol Violation|1|||
130214566|NCT02070978|468749095|FG001|Overall Study|Protocol Violation|0|||
130214567|NCT02070978|468749096|FG002|Overall Study|Protocol Violation|3|||
130214568|NCT02070978|468749094|FG000|Overall Study|Lack of Efficacy|0|||
130214569|NCT02070978|468749095|FG001|Overall Study|Lack of Efficacy|1|||
130214570|NCT02070978|468749096|FG002|Overall Study|Lack of Efficacy|0|||
130214571|NCT02070978|468749094|FG000|Overall Study|Death|0|||
130214572|NCT02070978|468749095|FG001|Overall Study|Death|0|||
130214573|NCT02070978|468749096|FG002|Overall Study|Death|2|||
130214574|NCT02070978|468749094|FG000|Overall Study|Un-specified|3|||
130214575|NCT02070978|468749095|FG001|Overall Study|Un-specified|2|||
130214576|NCT02070978|468749096|FG002|Overall Study|Un-specified|2|||
130214577|NCT02070978|468749094|FG000|Overall Study|Terminated by Sponsor|33|||
130214578|NCT02070978|468749095|FG001|Overall Study|Terminated by Sponsor|40|||
130214579|NCT02070978|468749096|FG002|Overall Study|Terminated by Sponsor|39|||
130214580|NCT03951753|468749097|FG000|Overall Study|Adverse Event|1|||
130214581|NCT03951753|468749098|FG001|Overall Study|Adverse Event|0|||
130214582|NCT03951753|468749099|FG002|Overall Study|Adverse Event|3|||
130214583|NCT03951753|468749097|FG000|Overall Study|Withdrawal by Subject|3|||
130214584|NCT03951753|468749098|FG001|Overall Study|Withdrawal by Subject|1|||
130214585|NCT03951753|468749099|FG002|Overall Study|Withdrawal by Subject|0|||
130654774|NCT00948896|470357696|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130654775|NCT03795233|470357697|FG000|Overall Study|Withdrawal by Subject|2|||
130654776|NCT03795233|470357698|FG001|Overall Study|Withdrawal by Subject|1|||
130654777|NCT03795233|470357697|FG000|Overall Study|Lost to Follow-up|1|||
130654778|NCT03795233|470357698|FG001|Overall Study|Lost to Follow-up|0|||
130654779|NCT03795233|470357697|FG000|Overall Study|Death|1|||
130654780|NCT03795233|470357698|FG001|Overall Study|Death|0|||
130654781|NCT01593761|470357710|FG000|Overall Study|Lost to Follow-up|1|||
130654782|NCT01593761|470357710|FG000|Overall Study|culture negative for MRSA at baseline|5|||
130654783|NCT01593761|470357710|FG000|Overall Study|positive for hepatitis C virus|1|||
130654784|NCT01593761|470357710|FG000|Overall Study|secondary cellulitis|1|||
130654785|NCT01869959|470357715|FG000|Randomization Period|Physician Decision|0|||
130654786|NCT01869959|470357716|FG001|Randomization Period|Physician Decision|0|||
130654787|NCT01869959|470357717|FG002|Randomization Period|Physician Decision|0|||
130654788|NCT01869959|470357718|FG003|Randomization Period|Physician Decision|0|||
130654789|NCT01869959|470357719|FG004|Randomization Period|Physician Decision|1|||
130654790|NCT01869959|470357715|FG000|Treatment Period|Adverse Event|1|||
130654791|NCT01869959|470357716|FG001|Treatment Period|Adverse Event|0|||
130654792|NCT01869959|470357717|FG002|Treatment Period|Adverse Event|3|||
130654793|NCT01869959|470357718|FG003|Treatment Period|Adverse Event|1|||
130654794|NCT01869959|470357719|FG004|Treatment Period|Adverse Event|0|||
130654795|NCT01869959|470357715|FG000|Treatment Period|Sponsor decision|0|||
130654796|NCT01869959|470357716|FG001|Treatment Period|Sponsor decision|1|||
130654797|NCT01869959|470357717|FG002|Treatment Period|Sponsor decision|0|||
130654798|NCT01869959|470357718|FG003|Treatment Period|Sponsor decision|1|||
130654799|NCT01869959|470357719|FG004|Treatment Period|Sponsor decision|0|||
130654800|NCT01869959|470357715|FG000|Treatment Period|Withdrawal by Subject|0|||
130654801|NCT01869959|470357716|FG001|Treatment Period|Withdrawal by Subject|1|||
130654802|NCT01869959|470357717|FG002|Treatment Period|Withdrawal by Subject|0|||
130654803|NCT01869959|470357718|FG003|Treatment Period|Withdrawal by Subject|0|||
130654804|NCT01869959|470357719|FG004|Treatment Period|Withdrawal by Subject|0|||
130654805|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
130654806|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
130654807|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
130654808|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
130654809|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
130654810|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
130654811|NCT00828009|470357720|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
130654812|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
130654813|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
130654814|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Death|1|||
130654815|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
130654816|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
130654817|NCT00828009|470357720|FG000|Step 2 - Maintenance Therapy|Other|1|||
130654818|NCT02576951|470357726|FG000|Overall Study|Lost to Follow-up|0|||
130654819|NCT02576951|470357727|FG001|Overall Study|Lost to Follow-up|0|||
130654820|NCT02576951|470357728|FG002|Overall Study|Lost to Follow-up|2|||
130654821|NCT02576951|470357729|FG003|Overall Study|Lost to Follow-up|2|||
130654822|NCT02576951|470357726|FG000|Overall Study|Withdrawal by Subject|1|||
130654823|NCT02576951|470357727|FG001|Overall Study|Withdrawal by Subject|0|||
130654824|NCT02576951|470357728|FG002|Overall Study|Withdrawal by Subject|0|||
130654825|NCT02576951|470357729|FG003|Overall Study|Withdrawal by Subject|2|||
130654826|NCT02576951|470357726|FG000|Overall Study|Protocol Violation|0|||
130654827|NCT02576951|470357727|FG001|Overall Study|Protocol Violation|0|||
130654828|NCT02576951|470357728|FG002|Overall Study|Protocol Violation|0|||
130654829|NCT02576951|470357729|FG003|Overall Study|Protocol Violation|1|||
130654830|NCT00563706|470359522|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
130654831|NCT00563706|470359523|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130654832|NCT00563706|470359524|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130654833|NCT00563706|470359525|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130654834|NCT00563706|470359526|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130654835|NCT00563706|470359527|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130654836|NCT00563706|470359528|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130654837|NCT00563706|470359529|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130654838|NCT00563706|470359530|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
130654839|NCT00563706|470359522|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130654840|NCT00563706|470359523|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130654841|NCT00563706|470359524|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130654842|NCT00563706|470359525|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
130654843|NCT00563706|470359526|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130654844|NCT00563706|470359527|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130654845|NCT00563706|470359528|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130214586|NCT03951753|468749097|FG000|Overall Study|Lost to Follow-up|0|||
130654846|NCT00563706|470359529|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
130654847|NCT00563706|470359530|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130654848|NCT00563706|470359522|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
130654849|NCT00563706|470359523|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130654850|NCT00563706|470359524|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
130654851|NCT00563706|470359525|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
130654852|NCT00563706|470359526|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
130654853|NCT00563706|470359527|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130654854|NCT00563706|470359528|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
130654855|NCT00563706|470359529|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
130654856|NCT00563706|470359530|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130654857|NCT00563706|470359522|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
130654858|NCT00563706|470359523|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654859|NCT00563706|470359524|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654860|NCT00563706|470359525|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654861|NCT00563706|470359526|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654862|NCT00563706|470359527|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654863|NCT00563706|470359528|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654864|NCT00563706|470359529|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
130654865|NCT00563706|470359530|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130654866|NCT00563706|470359522|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654867|NCT00563706|470359523|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654868|NCT00563706|470359524|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654869|NCT00563706|470359525|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654870|NCT00563706|470359526|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654871|NCT00563706|470359527|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654872|NCT00563706|470359528|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130654873|NCT00563706|470359529|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
130654874|NCT00563706|470359530|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
130654875|NCT03280628|470359531|FG000|Overall Study|Lost to Follow-up|8|||
130654876|NCT03280628|470359532|FG001|Overall Study|Lost to Follow-up|6|||
130654877|NCT03280628|470359533|FG002|Overall Study|Lost to Follow-up|11|||
130654878|NCT00700115|470359542|FG000|Overall Study|Withdrawal by Subject|1|||
130654879|NCT00700115|470359543|FG001|Overall Study|Withdrawal by Subject|0|||
130654880|NCT00700115|470359542|FG000|Overall Study|Lost to Follow-up|0|||
130654881|NCT00700115|470359543|FG001|Overall Study|Lost to Follow-up|1|||
130654882|NCT02503215|470359544|FG000|Overall Study|Unable to wear compression stockings|1|||
130654883|NCT02503215|470359544|FG000|Overall Study|Unable to use positive airway pressure|2|||
130654884|NCT02983305|470359549|FG000|Overall Study|incomplete data|2|||
130654885|NCT02983305|470359550|FG001|Overall Study|incomplete data|0|||
130654886|NCT00822237|470359551|FG000|Dose 1 Vaccination|Not vaccinated|3|||
130654887|NCT00822237|470359552|FG001|Dose 1 Vaccination|Not vaccinated|0|||
130654888|NCT00822237|470359551|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
130654889|NCT00822237|470359552|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
130654890|NCT00822237|470359551|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
130654891|NCT00822237|470359552|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
130654892|NCT00822237|470359551|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
130654893|NCT00822237|470359552|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
130654894|NCT00822237|470359551|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
130654895|NCT00822237|470359552|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
130654896|NCT03433482|470359553|FG000|Overall Study|Lost to Follow-up|1|||
130654897|NCT03433482|470359554|FG001|Overall Study|Lost to Follow-up|0|||
130654898|NCT03433482|470359555|FG002|Overall Study|Lost to Follow-up|1|||
130654899|NCT03433482|470359556|FG003|Overall Study|Lost to Follow-up|1|||
130654900|NCT03433482|470359553|FG000|Overall Study|Withdrawal by Subject|0|||
130654901|NCT03433482|470359554|FG001|Overall Study|Withdrawal by Subject|0|||
130323505|NCT00321620|469155499|FG000|Overall Study|Withdrawal by Subject|164|||
130323506|NCT00321620|469155500|FG001|Overall Study|Withdrawal by Subject|147|||
130654902|NCT03433482|470359555|FG002|Overall Study|Withdrawal by Subject|1|||
130323507|NCT00321620|469155499|FG000|Overall Study|Disease progression|113|||
130323508|NCT00321620|469155500|FG001|Overall Study|Disease progression|117|||
130323509|NCT00321620|469155499|FG000|Overall Study|Adverse Event|43|||
130323510|NCT00321620|469155500|FG001|Overall Study|Adverse Event|56|||
130323511|NCT00321620|469155499|FG000|Overall Study|Lost to Follow-up|13|||
130323512|NCT00321620|469155500|FG001|Overall Study|Lost to Follow-up|9|||
130323513|NCT00321620|469155499|FG000|Overall Study|Physician Decision|4|||
130323514|NCT00321620|469155500|FG001|Overall Study|Physician Decision|1|||
130323515|NCT00321620|469155499|FG000|Overall Study|Noncompliance|14|||
130323516|NCT00321620|469155500|FG001|Overall Study|Noncompliance|7|||
130323517|NCT00321620|469155499|FG000|Overall Study|Protocol deviation|4|||
130654903|NCT03433482|470359556|FG003|Overall Study|Withdrawal by Subject|0|||
130654904|NCT03433482|470359553|FG000|Overall Study|Unknown reason|0|||
130654905|NCT03433482|470359554|FG001|Overall Study|Unknown reason|0|||
130654906|NCT03433482|470359555|FG002|Overall Study|Unknown reason|2|||
130654907|NCT03433482|470359556|FG003|Overall Study|Unknown reason|0|||
130654908|NCT01646268|470359557|FG000|Overall Study|Adverse Event|6|||
130654909|NCT01646268|470359558|FG001|Overall Study|Adverse Event|7|||
130654910|NCT01646268|470359557|FG000|Overall Study|Lack of Efficacy|1|||
130654911|NCT01646268|470359558|FG001|Overall Study|Lack of Efficacy|3|||
130654912|NCT01646268|470359557|FG000|Overall Study|Protocol Violation|0|||
130654913|NCT01646268|470359558|FG001|Overall Study|Protocol Violation|1|||
130654914|NCT01646268|470359557|FG000|Overall Study|Withdrawal by Subject|2|||
130654915|NCT01646268|470359558|FG001|Overall Study|Withdrawal by Subject|5|||
130654916|NCT01646268|470359557|FG000|Overall Study|Other|2|||
130654917|NCT01646268|470359558|FG001|Overall Study|Other|0|||
130654918|NCT01519635|470359563|FG000|Overall Study|Withdrawal by Subject|0|||
130654919|NCT01519635|470359564|FG001|Overall Study|Withdrawal by Subject|1|||
130654920|NCT01519635|470359563|FG000|Overall Study|No possibility to put a catheter|1|||
130654921|NCT01519635|470359564|FG001|Overall Study|No possibility to put a catheter|2|||
130654922|NCT02325414|470359565|FG000|Overall Study|Withdrawal by Subject|3|||
130654923|NCT02325414|470359566|FG001|Overall Study|Withdrawal by Subject|1|||
130654924|NCT02325414|470359565|FG000|Overall Study|Lost to Follow-up|5|||
130654925|NCT02325414|470359566|FG001|Overall Study|Lost to Follow-up|5|||
130654926|NCT00347776|470359567|FG000|1.5 Month Follow-up|Death|2|||
130654927|NCT00347776|470359568|FG001|1.5 Month Follow-up|Death|0|||
130654928|NCT00347776|470359569|FG002|1.5 Month Follow-up|Death|0|||
130654929|NCT00347776|470359567|FG000|1.5 Month Follow-up|reached the endpoint|12|||
130654930|NCT00347776|470359568|FG001|1.5 Month Follow-up|reached the endpoint|8|||
130654931|NCT00347776|470359569|FG002|1.5 Month Follow-up|reached the endpoint|12|||
130654932|NCT00347776|470359567|FG000|6 Month Follow-up|Death|2|||
130654933|NCT00347776|470359568|FG001|6 Month Follow-up|Death|1|||
130654934|NCT00347776|470359569|FG002|6 Month Follow-up|Death|3|||
130654935|NCT00347776|470359567|FG000|6 Month Follow-up|reached endpont|20|||
130323518|NCT00321620|469155500|FG001|Overall Study|Protocol deviation|3|||
130323519|NCT00321620|469155499|FG000|Overall Study|Ineligibility determined|2|||
130323520|NCT00321620|469155500|FG001|Overall Study|Ineligibility determined|3|||
130323521|NCT00321620|469155499|FG000|Overall Study|Participant request|75|||
130323522|NCT00321620|469155500|FG001|Overall Study|Participant request|52|||
130323523|NCT00321620|469155499|FG000|Overall Study|Other|42|||
130323524|NCT00321620|469155500|FG001|Overall Study|Other|33|||
130323525|NCT03304626|469155503|FG000|Overall Study|Adverse Event|1|||
130323526|NCT03304626|469155504|FG001|Overall Study|Adverse Event|0|||
130323527|NCT03304626|469155503|FG000|Overall Study|Lack of Efficacy|1|||
130323528|NCT03304626|469155504|FG001|Overall Study|Lack of Efficacy|1|||
130323529|NCT04385277|469155505|FG000|Overall Study|Physician Decision|2|||
130323530|NCT04385277|469155505|FG000|Overall Study|Ineligible|1|||
130323531|NCT04385277|469155505|FG000|Overall Study|Patient/Parent Refusal|2|||
130323532|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
130323533|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323534|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323535|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323536|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323537|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323538|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
130654936|NCT00347776|470359568|FG001|6 Month Follow-up|reached endpont|12|||
130654937|NCT00347776|470359569|FG002|6 Month Follow-up|reached endpont|15|||
130654938|NCT00347776|470359567|FG000|12 Month Follow-up|Lost to Follow-up|7|||
130654939|NCT00347776|470359568|FG001|12 Month Follow-up|Lost to Follow-up|6|||
130654940|NCT00347776|470359569|FG002|12 Month Follow-up|Lost to Follow-up|6|||
130654941|NCT00347776|470359567|FG000|12 Month Follow-up|Death|3|||
130654942|NCT00347776|470359568|FG001|12 Month Follow-up|Death|4|||
130654943|NCT00347776|470359569|FG002|12 Month Follow-up|Death|4|||
130654944|NCT00347776|470359567|FG000|12 Month Follow-up|Reached endpoint|13|||
130654945|NCT00347776|470359568|FG001|12 Month Follow-up|Reached endpoint|6|||
130654946|NCT00347776|470359569|FG002|12 Month Follow-up|Reached endpoint|9|||
130654947|NCT00594568|470359570|FG000|Initial Treatment|Adverse Event|51|||
130654948|NCT00594568|470359571|FG001|Initial Treatment|Adverse Event|121|||
130654949|NCT00594568|470359572|FG002|Initial Treatment|Adverse Event|144|||
130654950|NCT00594568|470359570|FG000|Initial Treatment|Death|6|||
130654951|NCT00594568|470359571|FG001|Initial Treatment|Death|11|||
130654952|NCT00594568|470359572|FG002|Initial Treatment|Death|15|||
130654953|NCT00594568|470359570|FG000|Initial Treatment|Lost to Follow-up|4|||
130654954|NCT00594568|470359571|FG001|Initial Treatment|Lost to Follow-up|1|||
130323539|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323540|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
130654955|NCT00594568|470359572|FG002|Initial Treatment|Lost to Follow-up|4|||
130654956|NCT00594568|470359570|FG000|Initial Treatment|Physician Decision|3|||
130654957|NCT00594568|470359571|FG001|Initial Treatment|Physician Decision|2|||
130214587|NCT03951753|468749098|FG001|Overall Study|Lost to Follow-up|0|||
130214588|NCT03951753|468749099|FG002|Overall Study|Lost to Follow-up|1|||
130214589|NCT03178851|468749100|FG000|Overall Study|Death|48|||
130214590|NCT03178851|468749101|FG001|Overall Study|Death|2|||
130214591|NCT03178851|468749102|FG002|Overall Study|Death|25|||
130214592|NCT03178851|468749100|FG000|Overall Study|Withdrawal by Subject|8|||
130214593|NCT03178851|468749101|FG001|Overall Study|Withdrawal by Subject|0|||
130214594|NCT03178851|468749102|FG002|Overall Study|Withdrawal by Subject|0|||
130214595|NCT03178851|468749100|FG000|Overall Study|Lost to Follow-up|5|||
130214596|NCT03178851|468749101|FG001|Overall Study|Lost to Follow-up|2|||
130214597|NCT03178851|468749102|FG002|Overall Study|Lost to Follow-up|0|||
130214598|NCT03178851|468749100|FG000|Overall Study|Adverse Event|0|||
130214599|NCT03178851|468749101|FG001|Overall Study|Adverse Event|0|||
130214600|NCT03178851|468749102|FG002|Overall Study|Adverse Event|1|||
130214601|NCT03178851|468749100|FG000|Overall Study|Study Termination by Sponsor|31|||
130214602|NCT03178851|468749101|FG001|Overall Study|Study Termination by Sponsor|7|||
130214603|NCT03178851|468749102|FG002|Overall Study|Study Termination by Sponsor|26|||
130214604|NCT02669043|468749107|FG000|Overall Study|Didn't meet I/E criteria|4|||
130214605|NCT02552888|468749110|FG000|Overall Study|Lost to Follow-up|1|||
130214606|NCT02552888|468749111|FG001|Overall Study|Lost to Follow-up|1|||
130214607|NCT00401193|468751584|FG000|Overall Study|Adverse Event|1|||
130214608|NCT00401193|468751585|FG001|Overall Study|Adverse Event|3|||
130214609|NCT00401193|468751586|FG002|Overall Study|Adverse Event|1|||
130214610|NCT00401193|468751584|FG000|Overall Study|Protocol Violation|3|||
130214611|NCT00401193|468751585|FG001|Overall Study|Protocol Violation|1|||
130214612|NCT00401193|468751586|FG002|Overall Study|Protocol Violation|1|||
130214613|NCT00401193|468751584|FG000|Overall Study|Lost to Follow-up|6|||
130214614|NCT00401193|468751585|FG001|Overall Study|Lost to Follow-up|5|||
130214615|NCT00401193|468751586|FG002|Overall Study|Lost to Follow-up|1|||
130214616|NCT00401193|468751584|FG000|Overall Study|Withdrawal by Subject|2|||
130214617|NCT00401193|468751585|FG001|Overall Study|Withdrawal by Subject|0|||
130214618|NCT00401193|468751586|FG002|Overall Study|Withdrawal by Subject|1|||
130214619|NCT00401193|468751584|FG000|Overall Study|Other Event|3|||
130214620|NCT00401193|468751585|FG001|Overall Study|Other Event|2|||
130214621|NCT00401193|468751586|FG002|Overall Study|Other Event|2|||
130214622|NCT00398216|468751587|FG000|Overall Study|Adverse Event|4|||
130214623|NCT00398216|468751588|FG001|Overall Study|Adverse Event|2|||
130214624|NCT00398216|468751589|FG002|Overall Study|Adverse Event|5|||
130214625|NCT00398216|468751590|FG003|Overall Study|Adverse Event|7|||
130214626|NCT00398216|468751591|FG004|Overall Study|Adverse Event|2|||
130214627|NCT00398216|468751587|FG000|Overall Study|Protocol Violation|2|||
130214628|NCT00398216|468751588|FG001|Overall Study|Protocol Violation|4|||
130214629|NCT00398216|468751589|FG002|Overall Study|Protocol Violation|5|||
130214630|NCT00398216|468751590|FG003|Overall Study|Protocol Violation|7|||
130214631|NCT00398216|468751591|FG004|Overall Study|Protocol Violation|5|||
130214632|NCT00398216|468751587|FG000|Overall Study|Lost to Follow-up|1|||
130214633|NCT00398216|468751588|FG001|Overall Study|Lost to Follow-up|6|||
130214634|NCT00398216|468751589|FG002|Overall Study|Lost to Follow-up|4|||
130214635|NCT00398216|468751590|FG003|Overall Study|Lost to Follow-up|4|||
130214636|NCT00398216|468751591|FG004|Overall Study|Lost to Follow-up|1|||
130214637|NCT00398216|468751587|FG000|Overall Study|Death|0|||
130214638|NCT00398216|468751588|FG001|Overall Study|Death|3|||
130214639|NCT00398216|468751589|FG002|Overall Study|Death|0|||
130214640|NCT00398216|468751590|FG003|Overall Study|Death|0|||
130214641|NCT00398216|468751591|FG004|Overall Study|Death|0|||
130214642|NCT00398216|468751587|FG000|Overall Study|Withdrawal by Subject|1|||
130214643|NCT00398216|468751588|FG001|Overall Study|Withdrawal by Subject|0|||
130214644|NCT00398216|468751589|FG002|Overall Study|Withdrawal by Subject|3|||
130214645|NCT00398216|468751590|FG003|Overall Study|Withdrawal by Subject|1|||
130214646|NCT00398216|468751591|FG004|Overall Study|Withdrawal by Subject|2|||
130214647|NCT00398216|468751587|FG000|Overall Study|administrative reasons|3|||
130214648|NCT00398216|468751588|FG001|Overall Study|administrative reasons|4|||
130214649|NCT00398216|468751589|FG002|Overall Study|administrative reasons|4|||
130214650|NCT00398216|468751590|FG003|Overall Study|administrative reasons|3|||
130214651|NCT00398216|468751591|FG004|Overall Study|administrative reasons|3|||
130214652|NCT00398216|468751587|FG000|Overall Study|entrance criteria|0|||
130214653|NCT00398216|468751588|FG001|Overall Study|entrance criteria|0|||
130214654|NCT00398216|468751589|FG002|Overall Study|entrance criteria|0|||
130214655|NCT00398216|468751590|FG003|Overall Study|entrance criteria|0|||
130214656|NCT00398216|468751591|FG004|Overall Study|entrance criteria|2|||
130214657|NCT00376532|468751592|FG000|Overall Study|Lack sufficient blood sample|6|||
130214658|NCT00376532|468751593|FG001|Overall Study|Lack sufficient blood sample|6|||
130214659|NCT04227405|468751594|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
130214660|NCT04227405|468751595|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
130551646|NCT01139021|469988075|FG000|Overall Study|Protocol Violation|1|||
130551647|NCT01139021|469988076|FG001|Overall Study|Protocol Violation|0|||
130551648|NCT01139021|469988077|FG002|Overall Study|Protocol Violation|0|||
130551649|NCT01139021|469988078|FG003|Overall Study|Protocol Violation|0|||
130551650|NCT01139021|469988079|FG004|Overall Study|Protocol Violation|2|||
130654958|NCT00594568|470359572|FG002|Initial Treatment|Physician Decision|4|||
130654959|NCT00594568|470359570|FG000|Initial Treatment|Protocol Violation|2|||
130654960|NCT00594568|470359571|FG001|Initial Treatment|Protocol Violation|2|||
130654961|NCT00594568|470359572|FG002|Initial Treatment|Protocol Violation|5|||
130654962|NCT00594568|470359570|FG000|Initial Treatment|Withdrawal by Subject|25|||
130654963|NCT00594568|470359571|FG001|Initial Treatment|Withdrawal by Subject|31|||
130654964|NCT00594568|470359572|FG002|Initial Treatment|Withdrawal by Subject|46|||
130323541|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323542|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
130654965|NCT00594568|470359570|FG000|Initial Treatment|Sponsor decision|193|||
130654966|NCT00594568|470359571|FG001|Initial Treatment|Sponsor decision|142|||
130654967|NCT00594568|470359572|FG002|Initial Treatment|Sponsor decision|147|||
130654968|NCT00594568|470359570|FG000|Initial Treatment|Caregiver decision|21|||
130654969|NCT00594568|470359571|FG001|Initial Treatment|Caregiver decision|36|||
130654970|NCT00594568|470359572|FG002|Initial Treatment|Caregiver decision|36|||
130654971|NCT00594568|470359570|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
130654972|NCT00594568|470359571|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
130654973|NCT00594568|470359572|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
130654974|NCT00594568|470359570|FG000|Initial Treatment|Entry criteria exclusion|0|||
130654975|NCT00594568|470359571|FG001|Initial Treatment|Entry criteria exclusion|1|||
130654976|NCT00594568|470359572|FG002|Initial Treatment|Entry criteria exclusion|1|||
130654977|NCT00594568|470359570|FG000|Delayed Start|Death|0|||
130654978|NCT00594568|470359571|FG001|Delayed Start|Death|0|||
130654979|NCT00594568|470359572|FG002|Delayed Start|Death|1|||
130654980|NCT00594568|470359570|FG000|Delayed Start|Adverse Event|12|||
130654981|NCT00594568|470359571|FG001|Delayed Start|Adverse Event|2|||
130654982|NCT00594568|470359572|FG002|Delayed Start|Adverse Event|2|||
130654983|NCT00594568|470359570|FG000|Delayed Start|Withdrawal by Subject|4|||
130654984|NCT00594568|470359571|FG001|Delayed Start|Withdrawal by Subject|3|||
130654985|NCT00594568|470359572|FG002|Delayed Start|Withdrawal by Subject|0|||
130654986|NCT00594568|470359570|FG000|Delayed Start|Physician Decision|0|||
130654987|NCT00594568|470359571|FG001|Delayed Start|Physician Decision|0|||
130654988|NCT00594568|470359572|FG002|Delayed Start|Physician Decision|1|||
130654989|NCT00594568|470359570|FG000|Delayed Start|Lost to Follow-up|0|||
130654990|NCT00594568|470359571|FG001|Delayed Start|Lost to Follow-up|0|||
130654991|NCT00594568|470359572|FG002|Delayed Start|Lost to Follow-up|1|||
130654992|NCT00594568|470359570|FG000|Delayed Start|Caregiver Decision|5|||
130654993|NCT00594568|470359571|FG001|Delayed Start|Caregiver Decision|6|||
130654994|NCT00594568|470359572|FG002|Delayed Start|Caregiver Decision|2|||
130654995|NCT00594568|470359570|FG000|Delayed Start|Sponsor Decision|77|||
130654996|NCT00594568|470359571|FG001|Delayed Start|Sponsor Decision|66|||
130654997|NCT00594568|470359572|FG002|Delayed Start|Sponsor Decision|59|||
130654998|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
130654999|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
130655000|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
130655001|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
130655002|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130655003|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130655004|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
130655005|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
130655006|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
130655007|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
130323543|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323544|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323545|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323546|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323547|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323548|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130323549|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323550|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130655008|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
130655009|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
130655010|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
130655011|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
130655012|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
130655013|NCT00594568|470359570|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
130655014|NCT00594568|470359571|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
130655015|NCT00594568|470359572|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
130655016|NCT00299546|470359573|FG000|Overall Study|Death|3|||
130655017|NCT00299546|470359574|FG001|Overall Study|Death|2|||
130655018|NCT00299546|470359575|FG002|Overall Study|Death|0|||
130655019|NCT00299546|470359573|FG000|Overall Study|Lost to Follow-up|2|||
130655020|NCT00299546|470359574|FG001|Overall Study|Lost to Follow-up|2|||
130323551|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130323552|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323553|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323554|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323555|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323556|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130655021|NCT00299546|470359575|FG002|Overall Study|Lost to Follow-up|5|||
130655022|NCT00299546|470359573|FG000|Overall Study|Adverse Event|37|||
130655023|NCT00299546|470359574|FG001|Overall Study|Adverse Event|22|||
130655024|NCT00299546|470359575|FG002|Overall Study|Adverse Event|27|||
130655025|NCT00299546|470359573|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
130655026|NCT00299546|470359574|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
130655027|NCT00299546|470359575|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
130655028|NCT00299546|470359573|FG000|Overall Study|Other|24|||
130655029|NCT00299546|470359574|FG001|Overall Study|Other|26|||
130655030|NCT00299546|470359575|FG002|Overall Study|Other|19|||
130655031|NCT00299546|470359573|FG000|Overall Study|Not treated|0|||
130655032|NCT00299546|470359574|FG001|Overall Study|Not treated|1|||
130655033|NCT00299546|470359575|FG002|Overall Study|Not treated|1|||
130655034|NCT03099265|470359576|FG000|Overall Study|Adverse Event|1|||
130655035|NCT00518531|470359580|FG000|Treatment Period 1|Adverse Event|5|||
130655036|NCT00518531|470359581|FG001|Treatment Period 1|Adverse Event|0|||
130655037|NCT00518531|470359580|FG000|Treatment Period 1|Lost to Follow-up|5|||
130655038|NCT00518531|470359581|FG001|Treatment Period 1|Lost to Follow-up|3|||
130655039|NCT00518531|470359580|FG000|Treatment Period 1|Physician Decision|1|||
130655040|NCT00518531|470359581|FG001|Treatment Period 1|Physician Decision|0|||
130655041|NCT00518531|470359580|FG000|Treatment Period 1|Protocol Violation|2|||
130655042|NCT00518531|470359581|FG001|Treatment Period 1|Protocol Violation|0|||
130655043|NCT00518531|470359580|FG000|Treatment Period 1|Withdrawal by Subject|4|||
130655044|NCT00518531|470359581|FG001|Treatment Period 1|Withdrawal by Subject|6|||
130655045|NCT00518531|470359580|FG000|Treatment Period 1|Early crossover|1|||
130655046|NCT00518531|470359581|FG001|Treatment Period 1|Early crossover|3|||
130655047|NCT00518531|470359580|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130655048|NCT00518531|470359581|FG001|Treatment Period 2|Withdrawal by Subject|8|||
130655049|NCT00518531|470359580|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
130655050|NCT00518531|470359581|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
130655051|NCT00518531|470359580|FG000|Treatment Period 2|Adverse Event|1|||
130655052|NCT00518531|470359581|FG001|Treatment Period 2|Adverse Event|7|||
130655053|NCT00518531|470359580|FG000|Treatment Period 2|Protocol-specified criteria|0|||
130655054|NCT00518531|470359581|FG001|Treatment Period 2|Protocol-specified criteria|1|||
130655055|NCT00518531|470359580|FG000|Treatment Period 2|Non-compliance|1|||
130655056|NCT00518531|470359581|FG001|Treatment Period 2|Non-compliance|2|||
130655057|NCT00602927|470359584|FG000|Period 1: 13 Days|Protocol Violation|2|||
130655058|NCT00602927|470359585|FG001|Period 1: 13 Days|Protocol Violation|4|||
130655059|NCT00602927|470359584|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
130655060|NCT00602927|470359585|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
130655061|NCT00602927|470359584|FG000|Period 1: 13 Days|Time|1|||
130655062|NCT00602927|470359585|FG001|Period 1: 13 Days|Time|0|||
130655063|NCT00602927|470359584|FG000|Period 1: 13 Days|Claustrophobia|0|||
130655064|NCT00602927|470359585|FG001|Period 1: 13 Days|Claustrophobia|1|||
130655065|NCT00602927|470359584|FG000|Period 2: 14 Days|Protocol Violation|0|||
130655066|NCT00602927|470359585|FG001|Period 2: 14 Days|Protocol Violation|2|||
130655067|NCT00602927|470359584|FG000|Period 3: 13 Days|Protocol Violation|0|||
130655068|NCT00602927|470359585|FG001|Period 3: 13 Days|Protocol Violation|1|||
130655069|NCT00602927|470359584|FG000|Period 3: 13 Days|MRI data quality|2|||
130655070|NCT00602927|470359585|FG001|Period 3: 13 Days|MRI data quality|2|||
130655071|NCT04311411|470359589|FG000|Overall Study|Adverse Event|2|||
130655072|NCT04311411|470359590|FG001|Overall Study|Adverse Event|3|||
130655073|NCT04311411|470359591|FG002|Overall Study|Adverse Event|2|||
130655074|NCT04311411|470359589|FG000|Overall Study|Withdrawal by Subject|3|||
130655075|NCT04311411|470359590|FG001|Overall Study|Withdrawal by Subject|3|||
130655076|NCT04311411|470359591|FG002|Overall Study|Withdrawal by Subject|0|||
130655077|NCT03722849|470359595|FG000|Overall Study|Withdrawal by Subject|1|||
130655078|NCT03722849|470359596|FG001|Overall Study|Withdrawal by Subject|1|||
130655079|NCT04888377|470359597|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
130655080|NCT04888377|470359598|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
130655081|NCT04888377|470359597|FG000|Overall Study|Physician Decision|6|||
130655082|NCT04888377|470359598|FG001|Overall Study|Physician Decision|6|||
130655083|NCT04888377|470359597|FG000|Overall Study|Withdrawal by Subject|7|||
130655084|NCT04888377|470359598|FG001|Overall Study|Withdrawal by Subject|3|||
130655085|NCT05279807|470359599|FG000|Overall Study|Withdrawal by Subject|1|||
130655086|NCT05279807|470359600|FG001|Overall Study|Withdrawal by Subject|0|||
130655087|NCT05279807|470359599|FG000|Overall Study|Adverse Event|0|||
130323557|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
130655088|NCT05279807|470359600|FG001|Overall Study|Adverse Event|1|||
130655089|NCT05279807|470359599|FG000|Overall Study|Laboratory Abnormal Results|1|||
130655090|NCT05279807|470359600|FG001|Overall Study|Laboratory Abnormal Results|0|||
130655091|NCT05993299|470359601|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
130655092|NCT05993299|470359601|FG000|Overall Study|Ongoing|4|||
130655093|NCT05644756|470359602|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
130655094|NCT05644756|470359602|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
130655095|NCT03985982|470359603|FG000|Double-Blind Phase|Lost to Follow-up|4|||
130655096|NCT03985982|470359604|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130655097|NCT03985982|470359605|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130655098|NCT03985982|470359603|FG000|Double-Blind Phase|Physician Decision|1|||
130655099|NCT03985982|470359604|FG001|Double-Blind Phase|Physician Decision|0|||
130655100|NCT03985982|470359605|FG002|Double-Blind Phase|Physician Decision|0|||
130655101|NCT03985982|470359603|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
130655102|NCT03985982|470359604|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130655103|NCT03985982|470359605|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130655104|NCT03985982|470359603|FG000|Double-Blind Phase|COVID-19|1|||
130655105|NCT03985982|470359604|FG001|Double-Blind Phase|COVID-19|0|||
130655106|NCT03985982|470359605|FG002|Double-Blind Phase|COVID-19|0|||
130655107|NCT03985982|470359603|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
130655108|NCT03985982|470359604|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
130655109|NCT03985982|470359605|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
130655110|NCT03985982|470359603|FG000|Open-Label Phase|Lost to Follow-up|0|||
130655111|NCT03985982|470359604|FG001|Open-Label Phase|Lost to Follow-up|0|||
130655112|NCT03985982|470359605|FG002|Open-Label Phase|Lost to Follow-up|13|||
130655113|NCT03985982|470359603|FG000|Open-Label Phase|Physician Decision|0|||
130655114|NCT03985982|470359604|FG001|Open-Label Phase|Physician Decision|0|||
130655115|NCT03985982|470359605|FG002|Open-Label Phase|Physician Decision|2|||
130655116|NCT03985982|470359603|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130655117|NCT03985982|470359604|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130655118|NCT03985982|470359605|FG002|Open-Label Phase|Withdrawal by Subject|11|||
130655119|NCT00478933|470359610|FG000|Overall Study|Protocol Violation|22|||
130655120|NCT00478933|470359610|FG000|Overall Study|Informed consent not verified|3|||
130655121|NCT00478933|470359610|FG000|Overall Study|Inadequate data available|53|||
130655122|NCT03772574|470359611|FG000|Overall Study|Protocol Violation|2|||
130655123|NCT03772574|470359612|FG001|Overall Study|Protocol Violation|0|||
130655124|NCT03772574|470359613|FG002|Overall Study|Protocol Violation|0|||
130323558|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323559|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323560|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
130655125|NCT03772574|470359611|FG000|Overall Study|Discomfort|0|||
130655126|NCT03772574|470359612|FG001|Overall Study|Discomfort|5|||
130655127|NCT03772574|470359613|FG002|Overall Study|Discomfort|4|||
130655128|NCT03586427|470359619|FG000|Overall Study|Lost to Follow-up|0|||
130655129|NCT03586427|470359620|FG001|Overall Study|Lost to Follow-up|3|||
130655130|NCT03586427|470359621|FG002|Overall Study|Lost to Follow-up|1|||
130655131|NCT03586427|470359622|FG003|Overall Study|Lost to Follow-up|3|||
130655132|NCT03586427|470359623|FG004|Overall Study|Lost to Follow-up|3|||
130655133|NCT03586427|470359619|FG000|Overall Study|Withdrawal by Subject|0|||
130655134|NCT03586427|470359620|FG001|Overall Study|Withdrawal by Subject|1|||
130655135|NCT03586427|470359621|FG002|Overall Study|Withdrawal by Subject|2|||
130655136|NCT03586427|470359622|FG003|Overall Study|Withdrawal by Subject|1|||
130655137|NCT03586427|470359623|FG004|Overall Study|Withdrawal by Subject|1|||
130655138|NCT03586427|470359619|FG000|Overall Study|Adverse Event|0|||
130655139|NCT03586427|470359620|FG001|Overall Study|Adverse Event|0|||
130655140|NCT03586427|470359621|FG002|Overall Study|Adverse Event|1|||
130655141|NCT03586427|470359622|FG003|Overall Study|Adverse Event|0|||
130655142|NCT03586427|470359623|FG004|Overall Study|Adverse Event|0|||
130655143|NCT03586427|470359619|FG000|Overall Study|Protocol Violation|0|||
130655144|NCT03586427|470359620|FG001|Overall Study|Protocol Violation|0|||
130655145|NCT03586427|470359621|FG002|Overall Study|Protocol Violation|1|||
130655146|NCT03586427|470359622|FG003|Overall Study|Protocol Violation|0|||
130655147|NCT03586427|470359623|FG004|Overall Study|Protocol Violation|1|||
130655148|NCT03586427|470359619|FG000|Overall Study|Noncompliance with study drug|0|||
130655149|NCT03586427|470359620|FG001|Overall Study|Noncompliance with study drug|0|||
130323561|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323562|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323563|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323564|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323565|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
130323566|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323567|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323568|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323569|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323570|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323571|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
130323572|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323573|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323574|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323575|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323576|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323577|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323578|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
130323579|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323580|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323581|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323582|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323583|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323584|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323585|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
130323586|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323587|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323588|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323589|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323590|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130655150|NCT03586427|470359621|FG002|Overall Study|Noncompliance with study drug|1|||
130655151|NCT03586427|470359622|FG003|Overall Study|Noncompliance with study drug|0|||
130323591|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323592|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
130323593|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323594|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323595|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323596|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323597|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323598|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323599|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
130323600|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323601|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323602|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323603|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323604|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323605|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323606|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
130323607|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130655152|NCT03586427|470359623|FG004|Overall Study|Noncompliance with study drug|0|||
130655153|NCT03193996|470359624|FG000|Overall Study|Withdrawal by Subject|4|||
130655154|NCT03193996|470359624|FG000|Overall Study|Lost to Follow-up|4|||
130655155|NCT03193996|470359624|FG000|Overall Study|Physician Decision|2|||
130655156|NCT03193996|470359624|FG000|Overall Study|Pregnancy|1|||
130323608|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323609|NCT03041038|469155540|FG000|Overall Study|Withdrawal by Subject|4|||
130323610|NCT03041038|469155541|FG001|Overall Study|Withdrawal by Subject|0|||
130323611|NCT03041038|469155540|FG000|Overall Study|Lost to Follow-up|1|||
130323612|NCT03041038|469155541|FG001|Overall Study|Lost to Follow-up|1|||
130655157|NCT03193996|470359624|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
130655158|NCT03193996|470359624|FG000|Overall Study|Complicating disease|1|||
130655159|NCT00494234|470359625|FG000|Overall Study|Withdrawal by Subject|1|||
130655160|NCT00494234|470359626|FG001|Overall Study|Withdrawal by Subject|0|||
130655161|NCT00494234|470359625|FG000|Overall Study|Disease progression|11|||
130655162|NCT00494234|470359626|FG001|Overall Study|Disease progression|8|||
130655163|NCT00494234|470359625|FG000|Overall Study|Death|2|||
130655164|NCT00494234|470359626|FG001|Overall Study|Death|1|||
130655165|NCT00423137|470359627|FG000|Overall Study|Lost to Follow-up|0|||
130655166|NCT00423137|470359628|FG001|Overall Study|Lost to Follow-up|0|||
130655167|NCT00423137|470359629|FG002|Overall Study|Lost to Follow-up|1|||
130655168|NCT00423137|470359630|FG003|Overall Study|Lost to Follow-up|0|||
130655169|NCT00423137|470359627|FG000|Overall Study|Protocol Violation|0|||
130655170|NCT00423137|470359628|FG001|Overall Study|Protocol Violation|0|||
130655171|NCT00423137|470359629|FG002|Overall Study|Protocol Violation|0|||
130655172|NCT00423137|470359630|FG003|Overall Study|Protocol Violation|1|||
130655173|NCT00423137|470359627|FG000|Overall Study|Adverse Event Study disease worse|1|||
130655174|NCT00423137|470359628|FG001|Overall Study|Adverse Event Study disease worse|0|||
130655175|NCT00423137|470359629|FG002|Overall Study|Adverse Event Study disease worse|3|||
130655176|NCT00423137|470359630|FG003|Overall Study|Adverse Event Study disease worse|1|||
130655177|NCT00423137|470359627|FG000|Overall Study|Adverse Event Other|0|||
130655178|NCT00423137|470359628|FG001|Overall Study|Adverse Event Other|0|||
130655179|NCT00423137|470359629|FG002|Overall Study|Adverse Event Other|2|||
130655180|NCT00423137|470359630|FG003|Overall Study|Adverse Event Other|0|||
130655181|NCT00593385|470359635|FG000|Overall Study|Death|14|||
130655182|NCT00593385|470359635|FG000|Overall Study|Lost to Follow-up|17|||
130655183|NCT00593385|470359635|FG000|Overall Study|Withdrawal by Subject|9|||
130655184|NCT00348348|470359636|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
130655185|NCT00348348|470359637|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
130655186|NCT00348348|470359636|FG000|Overall Study|Lack of Efficacy|1|||
130655187|NCT00348348|470359637|FG001|Overall Study|Lack of Efficacy|1|||
130655188|NCT00348348|470359636|FG000|Overall Study|Lost to Follow-up|8|||
130655189|NCT00348348|470359637|FG001|Overall Study|Lost to Follow-up|10|||
130655190|NCT00348348|470359636|FG000|Overall Study|Withdrawal by Subject|4|||
130655191|NCT00348348|470359637|FG001|Overall Study|Withdrawal by Subject|1|||
130214661|NCT04227405|468751594|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
130214662|NCT04227405|468751595|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
130214663|NCT04227405|468751594|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
130214664|NCT04227405|468751595|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
130214665|NCT02207400|468751596|FG000|Overall Study|Adverse Event|1|||
130214666|NCT02207400|468751597|FG001|Overall Study|Adverse Event|1|||
130214667|NCT02207400|468751596|FG000|Overall Study|Lost to Follow-up|6|||
130214668|NCT02207400|468751597|FG001|Overall Study|Lost to Follow-up|7|||
130214669|NCT02207400|468751596|FG000|Overall Study|Protocol Violation|1|||
130214670|NCT02207400|468751597|FG001|Overall Study|Protocol Violation|1|||
130214671|NCT02207400|468751596|FG000|Overall Study|Withdrawal by Subject|8|||
130214672|NCT02207400|468751597|FG001|Overall Study|Withdrawal by Subject|4|||
130214673|NCT02207400|468751596|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
130214674|NCT02207400|468751597|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
130214675|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
130214676|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214677|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
130214678|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214679|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214680|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214681|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214682|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214683|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214684|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214685|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214686|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214687|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
130214688|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214689|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130655192|NCT00348348|470359636|FG000|Overall Study|Other|7|||
130655193|NCT00348348|470359637|FG001|Overall Study|Other|4|||
130655194|NCT00348348|470359636|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
130655195|NCT00348348|470359637|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
130655196|NCT00348348|470359636|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
130655197|NCT00348348|470359637|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
130655198|NCT00348348|470359636|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
130655199|NCT00348348|470359637|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
130655200|NCT00348348|470359636|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
130655201|NCT00348348|470359637|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
130655202|NCT00348348|470359636|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
130655203|NCT00348348|470359637|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
130655204|NCT00348348|470359636|FG000|Overall Study|Adverse event probably related to study|1|||
130655205|NCT00348348|470359637|FG001|Overall Study|Adverse event probably related to study|0|||
130655206|NCT00924313|470359638|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
130655207|NCT01298362|470359639|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
130655208|NCT01298362|470359640|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
130655209|NCT01012609|470359643|FG000|Overall Study|Withdrawal by Subject|1|||
130655210|NCT01012609|470359644|FG001|Overall Study|Withdrawal by Subject|1|||
130655211|NCT00924820|470359647|FG000|Overall Study|Death|2|||
130655212|NCT00924820|470359647|FG000|Overall Study|Ineligible, Screen Failure|5|||
130655213|NCT04983589|470359648|FG000|Overall Study|Withdrawal by Subject|0|||
130655214|NCT04983589|470359649|FG001|Overall Study|Withdrawal by Subject|3|||
130655215|NCT04983589|470359648|FG000|Overall Study|COVID-19 Infection|1|||
130655216|NCT04983589|470359649|FG001|Overall Study|COVID-19 Infection|0|||
130655217|NCT04983589|470359648|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
130655218|NCT04983589|470359649|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
130655219|NCT00762073|470359654|FG000|Overall Study|Lack of Efficacy|1|||
130655220|NCT00762073|470359655|FG001|Overall Study|Lack of Efficacy|1|||
130655221|NCT00762073|470359656|FG002|Overall Study|Lack of Efficacy|0|||
130655222|NCT00762073|470359657|FG003|Overall Study|Lack of Efficacy|0|||
130655223|NCT00762073|470359654|FG000|Overall Study|Adverse Event|1|||
130655224|NCT00762073|470359655|FG001|Overall Study|Adverse Event|0|||
130323613|NCT03041038|469155540|FG000|Overall Study|Protocol Violation|1|||
130323614|NCT03041038|469155541|FG001|Overall Study|Protocol Violation|1|||
130323615|NCT03331315|469155542|FG000|Overall Study|Physician Decision|18|||
130323616|NCT03331315|469155543|FG001|Overall Study|Physician Decision|14|||
130323617|NCT01709721|469155544|FG000|Open Label Phase|Withdrawal by Subject|0|||
130323618|NCT01709721|469155545|FG001|Open Label Phase|Withdrawal by Subject|0|||
130323619|NCT01709721|469155546|FG002|Open Label Phase|Withdrawal by Subject|5|||
130323620|NCT01709721|469155544|FG000|Open Label Phase|Adverse Event|0|||
130323621|NCT01709721|469155545|FG001|Open Label Phase|Adverse Event|0|||
130323622|NCT01709721|469155546|FG002|Open Label Phase|Adverse Event|8|||
130323623|NCT01709721|469155544|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
130323624|NCT01709721|469155545|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
130323625|NCT01709721|469155546|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
130323626|NCT01709721|469155544|FG000|Open Label Phase|Investigator Decision|0|||
130323627|NCT01709721|469155545|FG001|Open Label Phase|Investigator Decision|0|||
130323628|NCT01709721|469155546|FG002|Open Label Phase|Investigator Decision|1|||
130323629|NCT01709721|469155544|FG000|Open Label Phase|Sponsor Decision|0|||
130323630|NCT01709721|469155545|FG001|Open Label Phase|Sponsor Decision|0|||
130323631|NCT01709721|469155546|FG002|Open Label Phase|Sponsor Decision|2|||
130323632|NCT01709721|469155544|FG000|Open Label Phase|Protocol Violation|0|||
130323633|NCT01709721|469155545|FG001|Open Label Phase|Protocol Violation|0|||
130323634|NCT01709721|469155546|FG002|Open Label Phase|Protocol Violation|1|||
130323635|NCT01709721|469155544|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130323636|NCT01709721|469155545|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130323637|NCT01709721|469155546|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
130323638|NCT01709721|469155544|FG000|Open Label Phase|Inadequate Pain Control|0|||
130323639|NCT01709721|469155545|FG001|Open Label Phase|Inadequate Pain Control|0|||
130323640|NCT01709721|469155546|FG002|Open Label Phase|Inadequate Pain Control|37|||
130323641|NCT01709721|469155544|FG000|Open Label Phase|Other, Specify in text field in database|0|||
130323642|NCT01709721|469155545|FG001|Open Label Phase|Other, Specify in text field in database|0|||
130323643|NCT01709721|469155546|FG002|Open Label Phase|Other, Specify in text field in database|14|||
130323644|NCT01709721|469155544|FG000|Randomized Phase|Adverse Event|0|||
130323645|NCT01709721|469155545|FG001|Randomized Phase|Adverse Event|1|||
130323646|NCT01709721|469155546|FG002|Randomized Phase|Adverse Event|0|||
130323647|NCT01709721|469155544|FG000|Randomized Phase|Lost to Follow-up|1|||
130323648|NCT01709721|469155545|FG001|Randomized Phase|Lost to Follow-up|0|||
130323649|NCT01709721|469155546|FG002|Randomized Phase|Lost to Follow-up|0|||
130323650|NCT01709721|469155544|FG000|Randomized Phase|Inadequate Pain Control|1|||
130323651|NCT01709721|469155545|FG001|Randomized Phase|Inadequate Pain Control|2|||
130323652|NCT01709721|469155546|FG002|Randomized Phase|Inadequate Pain Control|0|||
130655225|NCT00762073|470359656|FG002|Overall Study|Adverse Event|1|||
130655226|NCT00762073|470359657|FG003|Overall Study|Adverse Event|1|||
130655227|NCT00762073|470359654|FG000|Overall Study|Significant Subject Noncompliance|0|||
130655228|NCT00762073|470359655|FG001|Overall Study|Significant Subject Noncompliance|1|||
130655229|NCT00762073|470359656|FG002|Overall Study|Significant Subject Noncompliance|0|||
130323653|NCT01709721|469155544|FG000|Randomized Phase|Other, Specify text field in database|1|||
130323654|NCT01709721|469155545|FG001|Randomized Phase|Other, Specify text field in database|3|||
130323655|NCT01709721|469155546|FG002|Randomized Phase|Other, Specify text field in database|0|||
130323656|NCT00360230|469155549|FG000|Overall Study|Withdrawal by Subject|1|||
130323657|NCT00360230|469155550|FG001|Overall Study|Withdrawal by Subject|1|||
130323658|NCT00360230|469155551|FG002|Overall Study|Withdrawal by Subject|0|||
130323659|NCT00360230|469155552|FG003|Overall Study|Withdrawal by Subject|1|||
130655230|NCT00762073|470359657|FG003|Overall Study|Significant Subject Noncompliance|1|||
130655231|NCT00762073|470359654|FG000|Overall Study|Withdrawal by Subject|1|||
130655232|NCT00762073|470359655|FG001|Overall Study|Withdrawal by Subject|2|||
130655233|NCT00762073|470359656|FG002|Overall Study|Withdrawal by Subject|1|||
130655234|NCT00762073|470359657|FG003|Overall Study|Withdrawal by Subject|1|||
130655235|NCT00762073|470359654|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
130655236|NCT00762073|470359655|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
130655237|NCT00762073|470359656|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
130655238|NCT00762073|470359657|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
130655239|NCT00491322|470359659|FG000|Overall Study|Protocol Violation|1|||
130655240|NCT00491322|470359660|FG001|Overall Study|Protocol Violation|0|||
130655241|NCT00491322|470359659|FG000|Overall Study|Pregnancy|0|||
130655242|NCT00491322|470359660|FG001|Overall Study|Pregnancy|1|||
130655243|NCT00455923|470359661|FG000|Overall Study|Pregnancy|0|||
130655244|NCT00455923|470359662|FG001|Overall Study|Pregnancy|2|||
130655245|NCT00455923|470359661|FG000|Overall Study|Other|3|||
130655246|NCT00455923|470359662|FG001|Overall Study|Other|1|||
130655247|NCT00483119|470359663|FG000|Overall Study|Adverse Event|0|||
130655248|NCT00483119|470359664|FG001|Overall Study|Adverse Event|1|||
130655249|NCT00483119|470359663|FG000|Overall Study|Physician Decision|1|||
130655250|NCT00483119|470359664|FG001|Overall Study|Physician Decision|0|||
130655251|NCT02279888|470359665|FG000|Overall Study|Death|326|||
130655252|NCT02279888|470359665|FG000|Overall Study|Withdrawal by Subject|38|||
130655253|NCT02279888|470359665|FG000|Overall Study|Lost to Follow-up|21|||
130655254|NCT02279888|470359665|FG000|Overall Study|Physician Decision|62|||
130655255|NCT02279888|470359665|FG000|Overall Study|Subject Non-compliance|43|||
130655256|NCT02279888|470359665|FG000|Overall Study|Not implanted|14|||
130655257|NCT02279888|470359665|FG000|Overall Study|Visit not performed|26|||
130655258|NCT05939388|470359667|FG000|Overall Study|Lost to Follow-up|1|||
130655259|NCT00602667|470359668|FG000|Overall Study|Still on Therapy|0|||
130655260|NCT00602667|470359669|FG001|Overall Study|Still on Therapy|2|||
130655261|NCT00602667|470359670|FG002|Overall Study|Still on Therapy|2|||
130655262|NCT00602667|470359668|FG000|Overall Study|Death|0|||
130655263|NCT00602667|470359669|FG001|Overall Study|Death|1|||
130655264|NCT00602667|470359670|FG002|Overall Study|Death|1|||
130655265|NCT00602667|470359668|FG000|Overall Study|Family request|3|||
130655266|NCT00602667|470359669|FG001|Overall Study|Family request|25|||
130655267|NCT00602667|470359670|FG002|Overall Study|Family request|6|||
130655268|NCT00602667|470359668|FG000|Overall Study|Excessive toxicity|1|||
130655269|NCT00602667|470359669|FG001|Overall Study|Excessive toxicity|1|||
130655270|NCT00602667|470359670|FG002|Overall Study|Excessive toxicity|0|||
130655271|NCT00602667|470359668|FG000|Overall Study|Second malignancy|0|||
130655272|NCT00602667|470359669|FG001|Overall Study|Second malignancy|1|||
130655273|NCT00602667|470359670|FG002|Overall Study|Second malignancy|0|||
130655274|NCT00602667|470359668|FG000|Overall Study|Physician Decision|2|||
130655275|NCT00602667|470359669|FG001|Overall Study|Physician Decision|3|||
130655276|NCT00602667|470359670|FG002|Overall Study|Physician Decision|8|||
130655277|NCT00602667|470359668|FG000|Overall Study|Progressive disease|13|||
130655278|NCT00602667|470359669|FG001|Overall Study|Progressive disease|48|||
130655279|NCT00602667|470359670|FG002|Overall Study|Progressive disease|45|||
130655280|NCT00602667|470359668|FG000|Overall Study|Progressive disease prior to therapy|0|||
130655281|NCT00602667|470359669|FG001|Overall Study|Progressive disease prior to therapy|0|||
130655282|NCT00602667|470359670|FG002|Overall Study|Progressive disease prior to therapy|1|||
130655283|NCT01361308|470360851|FG000|Overall Study|Withdrawal by Subject|9|||
130655284|NCT01361308|470360852|FG001|Overall Study|Withdrawal by Subject|13|||
130655285|NCT01361308|470360851|FG000|Overall Study|Physician Decision|3|||
130655286|NCT01361308|470360852|FG001|Overall Study|Physician Decision|3|||
130655287|NCT01361308|470360851|FG000|Overall Study|Lack of Efficacy|2|||
130655288|NCT01361308|470360852|FG001|Overall Study|Lack of Efficacy|0|||
130655289|NCT01361308|470360851|FG000|Overall Study|Protocol Violation|1|||
130655290|NCT01361308|470360852|FG001|Overall Study|Protocol Violation|0|||
130655291|NCT01361308|470360851|FG000|Overall Study|Lost to Follow-up|5|||
130655292|NCT01361308|470360852|FG001|Overall Study|Lost to Follow-up|4|||
130655293|NCT01361308|470360851|FG000|Overall Study|Adverse Event|8|||
130655294|NCT01361308|470360852|FG001|Overall Study|Adverse Event|4|||
130655295|NCT01361308|470360851|FG000|Overall Study|Eligibility Criteria Not Met|2|||
130655296|NCT01361308|470360852|FG001|Overall Study|Eligibility Criteria Not Met|3|||
130655297|NCT01361308|470360851|FG000|Overall Study|Failed C-SSRS|5|||
130655298|NCT01361308|470360852|FG001|Overall Study|Failed C-SSRS|2|||
130655299|NCT01361308|470360851|FG000|Overall Study|Other|0|||
130655300|NCT01361308|470360852|FG001|Overall Study|Other|1|||
130655301|NCT03839693|470360857|FG000|Overall Study|Lost to Follow-up|0|||
130655302|NCT03839693|470360858|FG001|Overall Study|Lost to Follow-up|2|||
130655303|NCT03839693|470360859|FG002|Overall Study|Lost to Follow-up|2|||
130655304|NCT03839693|470360857|FG000|Overall Study|Withdrawal by Subject|1|||
130655305|NCT03839693|470360858|FG001|Overall Study|Withdrawal by Subject|0|||
130655306|NCT03839693|470360859|FG002|Overall Study|Withdrawal by Subject|2|||
130655307|NCT03839693|470360857|FG000|Overall Study|subject moved out of the area|1|||
130655308|NCT03839693|470360858|FG001|Overall Study|subject moved out of the area|0|||
130655309|NCT03839693|470360859|FG002|Overall Study|subject moved out of the area|0|||
130655310|NCT02856282|470360865|FG000|Overall Study|Withdrawal by Subject|1|||
130655311|NCT00057330|470360866|FG000|Overall Study|Adverse Event|9|||
130655312|NCT00057330|470360867|FG001|Overall Study|Adverse Event|12|||
130655313|NCT00057330|470360866|FG000|Overall Study|Death|1|||
130655314|NCT00057330|470360867|FG001|Overall Study|Death|0|||
130655315|NCT00057330|470360866|FG000|Overall Study|Protocol Violation|1|||
130655316|NCT00057330|470360867|FG001|Overall Study|Protocol Violation|1|||
130655317|NCT00057330|470360866|FG000|Overall Study|Withdrawal by Subject|115|||
130655318|NCT00057330|470360867|FG001|Overall Study|Withdrawal by Subject|84|||
130655319|NCT00057330|470360866|FG000|Overall Study|Lost to Follow-up|745|||
130655320|NCT00057330|470360867|FG001|Overall Study|Lost to Follow-up|617|||
130655321|NCT00057330|470360866|FG000|Overall Study|Physician Decision|1|||
130655322|NCT00057330|470360867|FG001|Overall Study|Physician Decision|0|||
130655323|NCT00057330|470360866|FG000|Overall Study|Other|260|||
130655324|NCT00057330|470360867|FG001|Overall Study|Other|206|||
130655325|NCT02074982|470360868|FG000|Overall Study|Adverse Event|15|||
130655326|NCT02074982|470360869|FG001|Overall Study|Adverse Event|7|||
130655327|NCT02074982|470360868|FG000|Overall Study|Lack of Efficacy|6|||
130655328|NCT02074982|470360869|FG001|Overall Study|Lack of Efficacy|1|||
130655329|NCT02074982|470360868|FG000|Overall Study|Lost to Follow-up|9|||
130655330|NCT02074982|470360869|FG001|Overall Study|Lost to Follow-up|10|||
130655331|NCT02074982|470360868|FG000|Overall Study|Non-compliance with study treatment|0|||
130655332|NCT02074982|470360869|FG001|Overall Study|Non-compliance with study treatment|2|||
130655333|NCT02074982|470360868|FG000|Overall Study|Physician Decision|1|||
130655334|NCT02074982|470360869|FG001|Overall Study|Physician Decision|1|||
130655335|NCT02074982|470360868|FG000|Overall Study|Pregnancy|1|||
130655336|NCT02074982|470360869|FG001|Overall Study|Pregnancy|2|||
130655337|NCT02074982|470360868|FG000|Overall Study|Protocol deviation|4|||
130655338|NCT02074982|470360869|FG001|Overall Study|Protocol deviation|3|||
130655339|NCT02074982|470360868|FG000|Overall Study|Technical problems|0|||
130655340|NCT02074982|470360869|FG001|Overall Study|Technical problems|2|||
130655341|NCT02074982|470360868|FG000|Overall Study|Subject/guardian decision|15|||
130655342|NCT02074982|470360869|FG001|Overall Study|Subject/guardian decision|24|||
130655343|NCT02074982|470360868|FG000|Overall Study|Death|0|||
130655344|NCT02074982|470360869|FG001|Overall Study|Death|2|||
130655345|NCT00183170|470360884|FG000|First Intervention|Did not complete study|1|||
130655346|NCT00183170|470360885|FG001|First Intervention|Did not complete study|0|||
130655347|NCT00183170|470360884|FG000|First Intervention|Did not meet targeted BrAC|1|||
130655348|NCT00183170|470360885|FG001|First Intervention|Did not meet targeted BrAC|0|||
130655349|NCT00183170|470360884|FG000|Washout 1 Week|Did not complete study|6|||
130655350|NCT00183170|470360885|FG001|Washout 1 Week|Did not complete study|8|||
130655351|NCT00183170|470360884|FG000|Second Intervention|Did not complete study|1|||
130655352|NCT00183170|470360885|FG001|Second Intervention|Did not complete study|0|||
130655353|NCT00183170|470360884|FG000|Second Intervention|Did not meet targeted BrAC|0|||
130655354|NCT00183170|470360885|FG001|Second Intervention|Did not meet targeted BrAC|2|||
130655355|NCT00761969|470360886|FG000|Overall Study|Death|112|||
130655356|NCT00761969|470360887|FG001|Overall Study|Death|47|||
130655357|NCT00761969|470360886|FG000|Overall Study|Lost to Follow-up|88|||
130655358|NCT00761969|470360887|FG001|Overall Study|Lost to Follow-up|93|||
130655359|NCT01353586|470360888|FG000|Overall Study|Procedure terminated prior to ablation|3|||
130655360|NCT01353586|470360889|FG001|Overall Study|Procedure terminated prior to ablation|0|||
130655361|NCT01353586|470360888|FG000|Overall Study|Never had insertion of study catheter|4|||
130655362|NCT01353586|470360889|FG001|Overall Study|Never had insertion of study catheter|1|||
130655363|NCT01353586|470360888|FG000|Overall Study|Neurological exam not done|0|||
130655364|NCT01353586|470360889|FG001|Overall Study|Neurological exam not done|1|||
130655365|NCT00585468|470360890|FG000|First Intervention|Withdrawal by Subject|1|||
130655366|NCT00585468|470360891|FG001|First Intervention|Withdrawal by Subject|1|||
130655367|NCT00978120|470360892|FG000|Overall Study|Death|0|||
130655368|NCT00978120|470360893|FG001|Overall Study|Death|0|||
130655369|NCT00978120|470360894|FG002|Overall Study|Death|0|||
130655370|NCT00978120|470360895|FG003|Overall Study|Death|1|||
130655371|NCT00978120|470360892|FG000|Overall Study|Lost to Follow-up|0|||
130655372|NCT00978120|470360893|FG001|Overall Study|Lost to Follow-up|0|||
130655373|NCT00978120|470360894|FG002|Overall Study|Lost to Follow-up|3|||
130655374|NCT00978120|470360895|FG003|Overall Study|Lost to Follow-up|0|||
130655375|NCT00978120|470360892|FG000|Overall Study|Withdrawal by Subject|2|||
130655376|NCT00978120|470360893|FG001|Overall Study|Withdrawal by Subject|0|||
130655377|NCT00978120|470360894|FG002|Overall Study|Withdrawal by Subject|0|||
130655378|NCT00978120|470360895|FG003|Overall Study|Withdrawal by Subject|0|||
130655379|NCT00978120|470360892|FG000|Overall Study|Moved out of state|0|||
130655380|NCT00978120|470360893|FG001|Overall Study|Moved out of state|0|||
130655381|NCT00978120|470360894|FG002|Overall Study|Moved out of state|0|||
130655382|NCT00978120|470360895|FG003|Overall Study|Moved out of state|1|||
130655383|NCT01068418|470360904|FG000|Overall Study|Physician Decision|12|||
130655384|NCT03155269|470360905|FG000|Overall Study|Withdrawal by Subject|4|||
130655385|NCT03155269|470360906|FG001|Overall Study|Withdrawal by Subject|5|||
130655386|NCT03155269|470360905|FG000|Overall Study|Lost to Follow-up|1|||
130655387|NCT03155269|470360906|FG001|Overall Study|Lost to Follow-up|2|||
130655388|NCT00943826|470360907|FG000|Concurrent Phase|Adverse Event|50|||
130655389|NCT00943826|470360908|FG001|Concurrent Phase|Adverse Event|27|||
130655390|NCT00943826|470360907|FG000|Concurrent Phase|Withdrew consent|3|||
130655391|NCT00943826|470360908|FG001|Concurrent Phase|Withdrew consent|7|||
130655392|NCT00943826|470360907|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
130655393|NCT00943826|470360908|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
130655394|NCT00943826|470360907|FG000|Concurrent Phase|Administrative reasons|2|||
130655395|NCT00943826|470360908|FG001|Concurrent Phase|Administrative reasons|1|||
130655396|NCT00943826|470360907|FG000|Concurrent Phase|Protocol Violation|1|||
130655397|NCT00943826|470360908|FG001|Concurrent Phase|Protocol Violation|0|||
130655398|NCT00943826|470360907|FG000|Maintenance Phase|Adverse Event|31|||
130655399|NCT00943826|470360908|FG001|Maintenance Phase|Adverse Event|30|||
130655400|NCT00943826|470360907|FG000|Maintenance Phase|Withdrew consent|2|||
130655401|NCT00943826|470360908|FG001|Maintenance Phase|Withdrew consent|4|||
130655402|NCT00943826|470360907|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
130655403|NCT00943826|470360908|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
130655404|NCT00943826|470360907|FG000|Maintenance Phase|Administrative reasons|4|||
130655405|NCT00943826|470360908|FG001|Maintenance Phase|Administrative reasons|1|||
130655406|NCT00943826|470360907|FG000|Maintenance Phase|Failure to return|0|||
130655407|NCT00943826|470360908|FG001|Maintenance Phase|Failure to return|1|||
130655408|NCT00943826|470360907|FG000|Monotherapy Phase|Adverse Event|42|||
130655409|NCT00943826|470360908|FG001|Monotherapy Phase|Adverse Event|5|||
130655410|NCT00943826|470360907|FG000|Monotherapy Phase|Administrative reasons|11|||
130655411|NCT00943826|470360908|FG001|Monotherapy Phase|Administrative reasons|5|||
130655412|NCT00943826|470360907|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
130655413|NCT00943826|470360908|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
130655414|NCT00943826|470360907|FG000|Monotherapy Phase|Withdrew Consent|2|||
130655415|NCT00943826|470360908|FG001|Monotherapy Phase|Withdrew Consent|3|||
130655416|NCT00943826|470360907|FG000|Monotherapy Phase|Failure to return|2|||
130655417|NCT00943826|470360908|FG001|Monotherapy Phase|Failure to return|1|||
130655418|NCT00943826|470360907|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
130323660|NCT00360230|469155553|FG004|Overall Study|Withdrawal by Subject|1|||
130323661|NCT00360230|469155554|FG005|Overall Study|Withdrawal by Subject|1|||
130323662|NCT00360230|469155555|FG006|Overall Study|Withdrawal by Subject|0|||
130323663|NCT00360230|469155549|FG000|Overall Study|Migrated|4|||
130323664|NCT00360230|469155550|FG001|Overall Study|Migrated|1|||
130323665|NCT00360230|469155551|FG002|Overall Study|Migrated|3|||
130323666|NCT00360230|469155552|FG003|Overall Study|Migrated|1|||
130655419|NCT00943826|470360908|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
130655420|NCT00943826|470360907|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
130655421|NCT00943826|470360908|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
130655422|NCT00943826|470360907|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
130655423|NCT00943826|470360908|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
130655424|NCT00943826|470360907|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
130655425|NCT00943826|470360908|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
130655426|NCT00326625|470360909|FG000|Overall Study|Adverse Event|20|||
130655427|NCT00326625|470360910|FG001|Overall Study|Adverse Event|9|||
130655428|NCT00326625|470360909|FG000|Overall Study|Withdrawal by Subject|15|||
130655429|NCT00326625|470360910|FG001|Overall Study|Withdrawal by Subject|12|||
130655430|NCT00326625|470360909|FG000|Overall Study|Death|18|||
130655431|NCT00326625|470360910|FG001|Overall Study|Death|16|||
130655432|NCT00326625|470360909|FG000|Overall Study|Lost to Follow-up|1|||
130655433|NCT00326625|470360910|FG001|Overall Study|Lost to Follow-up|0|||
130655434|NCT00326625|470360909|FG000|Overall Study|prescheduled medical intervention|0|||
130655435|NCT00326625|470360910|FG001|Overall Study|prescheduled medical intervention|1|||
130323667|NCT00360230|469155553|FG004|Overall Study|Migrated|4|||
130323668|NCT00360230|469155554|FG005|Overall Study|Migrated|1|||
130323669|NCT00360230|469155555|FG006|Overall Study|Migrated|1|||
130323670|NCT00360230|469155549|FG000|Overall Study|Other|1|||
130655436|NCT01265875|470360916|FG000|Overall Study|Uncooperative/unreliable|1|||
130655437|NCT05275673|470360917|FG000|Overall Study|Study Termination by Sponsor|2|||
130655438|NCT05275673|470360918|FG001|Overall Study|Study Termination by Sponsor|3|||
130655439|NCT05275673|470360917|FG000|Overall Study|Death|1|||
130655440|NCT05275673|470360918|FG001|Overall Study|Death|0|||
130655441|NCT05275673|470360917|FG000|Overall Study|Withdrawal by Subject|1|||
130655442|NCT05275673|470360918|FG001|Overall Study|Withdrawal by Subject|0|||
130655443|NCT02331680|470360921|FG000|Overall Study|Adverse Event|3|||
130323671|NCT00360230|469155550|FG001|Overall Study|Other|0|||
130655444|NCT02331680|470360922|FG001|Overall Study|Adverse Event|0|||
130655445|NCT02331680|470360923|FG002|Overall Study|Adverse Event|2|||
130323672|NCT00360230|469155551|FG002|Overall Study|Other|0|||
130323673|NCT00360230|469155552|FG003|Overall Study|Other|0|||
130655446|NCT02331680|470360921|FG000|Overall Study|Physician Decision|1|||
130323674|NCT00360230|469155553|FG004|Overall Study|Other|0|||
130323675|NCT00360230|469155554|FG005|Overall Study|Other|0|||
130323676|NCT00360230|469155555|FG006|Overall Study|Other|0|||
130323677|NCT00360230|469155549|FG000|Overall Study|Protocol Violation|0|||
130323678|NCT00360230|469155550|FG001|Overall Study|Protocol Violation|0|||
130323679|NCT00360230|469155551|FG002|Overall Study|Protocol Violation|0|||
130323680|NCT00360230|469155552|FG003|Overall Study|Protocol Violation|0|||
130323681|NCT00360230|469155553|FG004|Overall Study|Protocol Violation|0|||
130323682|NCT00360230|469155554|FG005|Overall Study|Protocol Violation|1|||
130323683|NCT00360230|469155555|FG006|Overall Study|Protocol Violation|0|||
130323684|NCT00360230|469155549|FG000|Overall Study|Death|0|||
130323685|NCT00360230|469155550|FG001|Overall Study|Death|1|||
130323686|NCT00360230|469155551|FG002|Overall Study|Death|0|||
130323687|NCT00360230|469155552|FG003|Overall Study|Death|0|||
130323688|NCT00360230|469155553|FG004|Overall Study|Death|0|||
130323689|NCT00360230|469155554|FG005|Overall Study|Death|1|||
130323690|NCT00360230|469155555|FG006|Overall Study|Death|1|||
130323691|NCT00581308|469155556|FG000|Pre Discharge|Lost to Follow-up|1|||
130323692|NCT00581308|469155556|FG000|Pre Discharge|Device Removed|1|||
130323693|NCT00581308|469155556|FG000|Month 1|Lost to Follow-up|3|||
130323694|NCT00581308|469155556|FG000|Month 1|Withdrawal by Subject|2|||
130323695|NCT00581308|469155556|FG000|Month 1|Device Removed|2|||
130323696|NCT00581308|469155556|FG000|Month 1|Uknown|1|||
130323697|NCT00581308|469155556|FG000|Month 6|Lost to Follow-up|1|||
130323698|NCT00581308|469155556|FG000|Month 6|Withdrawal by Subject|2|||
130323699|NCT00581308|469155556|FG000|Month 12|Death|1|||
130323700|NCT00581308|469155556|FG000|Month 12|Lost to Follow-up|14|||
130323701|NCT00581308|469155556|FG000|Month 12|Withdrawal by Subject|3|||
130323702|NCT00581308|469155556|FG000|Month 12|Device Removed|1|||
130323703|NCT00581308|469155556|FG000|Month 12|Other|1|||
130323704|NCT03219723|469155557|FG000|Overall Study|Case Report Forms Uncollected|6|||
130323705|NCT03219723|469155557|FG000|Overall Study|Protocol Deviation|4|||
130323706|NCT01527370|469155560|FG000|Overall Study|Withdrawal by Subject|4|||
130323707|NCT01527370|469155560|FG000|Overall Study|Physician Decision|1|||
130323708|NCT01527370|469155560|FG000|Overall Study|Death|1|||
130323709|NCT02057250|469155561|FG000|AID Assessment Phase|Adverse Event|3|||
130323710|NCT02057250|469155562|FG001|AID Assessment Phase|Adverse Event|2|||
130323711|NCT02057250|469155563|FG002|AID Assessment Phase|Adverse Event|6|||
130323712|NCT02057250|469155564|FG003|AID Assessment Phase|Adverse Event|1|||
130323713|NCT02057250|469155565|FG004|AID Assessment Phase|Adverse Event|0|||
130323714|NCT02057250|469155561|FG000|AID Assessment Phase|Other than specified above|1|||
130323715|NCT02057250|469155562|FG001|AID Assessment Phase|Other than specified above|1|||
130323716|NCT02057250|469155563|FG002|AID Assessment Phase|Other than specified above|1|||
130323717|NCT02057250|469155564|FG003|AID Assessment Phase|Other than specified above|1|||
130323718|NCT02057250|469155565|FG004|AID Assessment Phase|Other than specified above|0|||
130323719|NCT02057250|469155561|FG000|Extension Phase|Adverse Event|0|||
130323720|NCT02057250|469155562|FG001|Extension Phase|Adverse Event|0|||
130323721|NCT02057250|469155563|FG002|Extension Phase|Adverse Event|0|||
130323722|NCT02057250|469155564|FG003|Extension Phase|Adverse Event|0|||
130323723|NCT02057250|469155565|FG004|Extension Phase|Adverse Event|15|||
130323724|NCT02057250|469155561|FG000|Extension Phase|Lack of Efficacy|0|||
130323725|NCT02057250|469155562|FG001|Extension Phase|Lack of Efficacy|0|||
130323726|NCT02057250|469155563|FG002|Extension Phase|Lack of Efficacy|0|||
130323727|NCT02057250|469155564|FG003|Extension Phase|Lack of Efficacy|0|||
130323728|NCT02057250|469155565|FG004|Extension Phase|Lack of Efficacy|10|||
130323729|NCT02057250|469155561|FG000|Extension Phase|Entered in this period but not treated|0|||
130323730|NCT02057250|469155562|FG001|Extension Phase|Entered in this period but not treated|0|||
130323731|NCT02057250|469155563|FG002|Extension Phase|Entered in this period but not treated|0|||
130323732|NCT02057250|469155564|FG003|Extension Phase|Entered in this period but not treated|0|||
130323733|NCT02057250|469155565|FG004|Extension Phase|Entered in this period but not treated|4|||
130323734|NCT02057250|469155561|FG000|Extension Phase|Other than specified above|0|||
130323735|NCT02057250|469155562|FG001|Extension Phase|Other than specified above|0|||
130323736|NCT02057250|469155563|FG002|Extension Phase|Other than specified above|0|||
130323737|NCT02057250|469155564|FG003|Extension Phase|Other than specified above|0|||
130323738|NCT02057250|469155565|FG004|Extension Phase|Other than specified above|7|||
130323739|NCT01435382|469155567|FG000|Overall Study|Lost to Follow-up|1|||
130323740|NCT01435382|469155568|FG001|Overall Study|Lost to Follow-up|0|||
130323741|NCT01435382|469155569|FG002|Overall Study|Lost to Follow-up|1|||
130323742|NCT01435382|469155570|FG003|Overall Study|Lost to Follow-up|0|||
130323743|NCT01435382|469155567|FG000|Overall Study|Withdrawal by Subject|0|||
130323744|NCT01435382|469155568|FG001|Overall Study|Withdrawal by Subject|2|||
130323745|NCT01435382|469155569|FG002|Overall Study|Withdrawal by Subject|0|||
130323746|NCT01435382|469155570|FG003|Overall Study|Withdrawal by Subject|1|||
130323747|NCT02435992|469155571|FG000|Overall Study|non compliance with protocol|2|||
130323748|NCT02435992|469155572|FG001|Overall Study|non compliance with protocol|0|||
130323749|NCT02435992|469155573|FG002|Overall Study|non compliance with protocol|1|||
130323750|NCT02435992|469155574|FG003|Overall Study|non compliance with protocol|0|||
130323751|NCT02435992|469155575|FG004|Overall Study|non compliance with protocol|0|||
130323752|NCT02435992|469155571|FG000|Overall Study|Adverse Event|11|||
130323753|NCT02435992|469155572|FG001|Overall Study|Adverse Event|6|||
130655447|NCT02331680|470360922|FG001|Overall Study|Physician Decision|1|||
130655448|NCT02331680|470360923|FG002|Overall Study|Physician Decision|2|||
130655449|NCT02331680|470360921|FG000|Overall Study|Withdrawal by Subject|0|||
130655450|NCT02331680|470360922|FG001|Overall Study|Withdrawal by Subject|1|||
130655451|NCT02331680|470360923|FG002|Overall Study|Withdrawal by Subject|2|||
130655452|NCT02331680|470360921|FG000|Overall Study|Met withdrawal criteria|2|||
130655453|NCT02331680|470360922|FG001|Overall Study|Met withdrawal criteria|2|||
130655454|NCT02331680|470360923|FG002|Overall Study|Met withdrawal criteria|5|||
130655455|NCT02331680|470360921|FG000|Overall Study|Non-compliance with study drug|0|||
130655456|NCT02331680|470360922|FG001|Overall Study|Non-compliance with study drug|0|||
130655457|NCT02331680|470360923|FG002|Overall Study|Non-compliance with study drug|1|||
130655458|NCT02331680|470360921|FG000|Overall Study|Protocol Violation|0|||
130655459|NCT02331680|470360922|FG001|Overall Study|Protocol Violation|0|||
130655460|NCT02331680|470360923|FG002|Overall Study|Protocol Violation|3|||
130655461|NCT02335411|470360924|FG000|Overall Study|Death|223|||
130655462|NCT02335411|470360925|FG001|Overall Study|Death|22|||
130655463|NCT02335411|470360926|FG002|Overall Study|Death|26|||
130655464|NCT02335411|470360924|FG000|Overall Study|Physician Decision|3|||
130655465|NCT02335411|470360925|FG001|Overall Study|Physician Decision|0|||
130655466|NCT02335411|470360926|FG002|Overall Study|Physician Decision|0|||
130655467|NCT02335411|470360924|FG000|Overall Study|Protocol Violation|1|||
130655468|NCT02335411|470360925|FG001|Overall Study|Protocol Violation|0|||
130655469|NCT02335411|470360926|FG002|Overall Study|Protocol Violation|0|||
130655470|NCT02335411|470360924|FG000|Overall Study|Withdrawal by Subject|11|||
130655471|NCT02335411|470360925|FG001|Overall Study|Withdrawal by Subject|0|||
130655472|NCT02335411|470360926|FG002|Overall Study|Withdrawal by Subject|3|||
130655473|NCT02335411|470360924|FG000|Overall Study|Sponsor Decision|12|||
130655474|NCT02335411|470360925|FG001|Overall Study|Sponsor Decision|3|||
130655475|NCT02335411|470360926|FG002|Overall Study|Sponsor Decision|2|||
130655476|NCT02335411|470360924|FG000|Overall Study|Adverse Event|9|||
130655477|NCT02335411|470360925|FG001|Overall Study|Adverse Event|0|||
130655478|NCT02335411|470360926|FG002|Overall Study|Adverse Event|0|||
130655479|NCT01891669|470360927|FG000|Overall Study|Death|0|||
130655480|NCT01891669|470360928|FG001|Overall Study|Death|0|||
130655481|NCT01891669|470360929|FG002|Overall Study|Death|0|||
130655482|NCT01891669|470360930|FG003|Overall Study|Death|0|||
130655483|NCT01891669|470360931|FG004|Overall Study|Death|0|||
130655484|NCT01891669|470360932|FG005|Overall Study|Death|0|||
130655485|NCT01891669|470360933|FG006|Overall Study|Death|0|||
130655486|NCT01891669|470360934|FG007|Overall Study|Death|1|||
130655487|NCT01891669|470360935|FG008|Overall Study|Death|0|||
130655488|NCT01891669|470360936|FG009|Overall Study|Death|1|||
130655489|NCT01891669|470360927|FG000|Overall Study|Withdrawal by Subject|1|||
130655490|NCT01891669|470360928|FG001|Overall Study|Withdrawal by Subject|1|||
130655491|NCT01891669|470360929|FG002|Overall Study|Withdrawal by Subject|0|||
130655492|NCT01891669|470360930|FG003|Overall Study|Withdrawal by Subject|0|||
130655493|NCT01891669|470360931|FG004|Overall Study|Withdrawal by Subject|0|||
130655494|NCT01891669|470360932|FG005|Overall Study|Withdrawal by Subject|0|||
130655495|NCT01891669|470360933|FG006|Overall Study|Withdrawal by Subject|1|||
130655496|NCT01891669|470360934|FG007|Overall Study|Withdrawal by Subject|2|||
130655497|NCT01891669|470360935|FG008|Overall Study|Withdrawal by Subject|1|||
130655498|NCT01891669|470360936|FG009|Overall Study|Withdrawal by Subject|1|||
130655499|NCT01891669|470360927|FG000|Overall Study|Other|1|||
130655500|NCT01891669|470360928|FG001|Overall Study|Other|0|||
130655501|NCT01891669|470360929|FG002|Overall Study|Other|0|||
130655502|NCT01891669|470360930|FG003|Overall Study|Other|0|||
130655503|NCT01891669|470360931|FG004|Overall Study|Other|0|||
130655504|NCT01891669|470360932|FG005|Overall Study|Other|0|||
130655505|NCT01891669|470360933|FG006|Overall Study|Other|0|||
130655506|NCT01891669|470360934|FG007|Overall Study|Other|1|||
130655507|NCT01891669|470360935|FG008|Overall Study|Other|0|||
130655508|NCT01891669|470360936|FG009|Overall Study|Other|0|||
130655509|NCT03075826|470360937|FG000|Overall Study|Withdrawal by Subject|1|||
130655510|NCT03075826|470360937|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
130655511|NCT00650806|470360938|FG000|Overall Study|Adverse Event|0|||
130655512|NCT00650806|470360939|FG001|Overall Study|Adverse Event|5|||
130655513|NCT00650806|470360940|FG002|Overall Study|Adverse Event|3|||
130655514|NCT00650806|470360941|FG003|Overall Study|Adverse Event|4|||
130655515|NCT00650806|470360938|FG000|Overall Study|Lost to Follow-up|7|||
130655516|NCT00650806|470360939|FG001|Overall Study|Lost to Follow-up|6|||
130655517|NCT00650806|470360940|FG002|Overall Study|Lost to Follow-up|11|||
130655518|NCT00650806|470360941|FG003|Overall Study|Lost to Follow-up|10|||
130655519|NCT00650806|470360938|FG000|Overall Study|Protocol Violation|0|||
130323754|NCT02435992|469155573|FG002|Overall Study|Adverse Event|12|||
130655520|NCT00650806|470360939|FG001|Overall Study|Protocol Violation|0|||
130655521|NCT00650806|470360940|FG002|Overall Study|Protocol Violation|0|||
130655522|NCT00650806|470360941|FG003|Overall Study|Protocol Violation|1|||
130655523|NCT00650806|470360938|FG000|Overall Study|Pregnancy|0|||
130655524|NCT00650806|470360939|FG001|Overall Study|Pregnancy|0|||
130655525|NCT00650806|470360940|FG002|Overall Study|Pregnancy|0|||
130655526|NCT00650806|470360941|FG003|Overall Study|Pregnancy|1|||
130655527|NCT00650806|470360938|FG000|Overall Study|Withdrawal by Subject|7|||
130655528|NCT00650806|470360939|FG001|Overall Study|Withdrawal by Subject|5|||
130655529|NCT00650806|470360940|FG002|Overall Study|Withdrawal by Subject|8|||
130655530|NCT00650806|470360941|FG003|Overall Study|Withdrawal by Subject|6|||
130655531|NCT00650806|470360938|FG000|Overall Study|Noncompliance with study drug regimen|1|||
130655532|NCT00650806|470360939|FG001|Overall Study|Noncompliance with study drug regimen|1|||
130655533|NCT00650806|470360940|FG002|Overall Study|Noncompliance with study drug regimen|0|||
130655534|NCT00650806|470360941|FG003|Overall Study|Noncompliance with study drug regimen|0|||
130655535|NCT00650806|470360938|FG000|Overall Study|Study terminated by sponsor|2|||
130655536|NCT00650806|470360939|FG001|Overall Study|Study terminated by sponsor|3|||
130655537|NCT00650806|470360940|FG002|Overall Study|Study terminated by sponsor|5|||
130655538|NCT00650806|470360941|FG003|Overall Study|Study terminated by sponsor|4|||
130655539|NCT00650806|470360938|FG000|Overall Study|Other|1|||
130655540|NCT00650806|470360939|FG001|Overall Study|Other|1|||
130655541|NCT00650806|470360940|FG002|Overall Study|Other|2|||
130655542|NCT00650806|470360941|FG003|Overall Study|Other|0|||
130655543|NCT04456998|470360942|FG000|Overall Study|Adverse Event|0|||
130655544|NCT04456998|470360943|FG001|Overall Study|Adverse Event|4|||
130655545|NCT04456998|470360942|FG000|Overall Study|Protocol Deviation|0|||
130655546|NCT04456998|470360943|FG001|Overall Study|Protocol Deviation|1|||
130655547|NCT04456998|470360942|FG000|Overall Study|Withdrawal by Subject|0|||
130655548|NCT04456998|470360943|FG001|Overall Study|Withdrawal by Subject|1|||
130655549|NCT04882085|470360947|FG000|Overall Study|Death|6|||
130655550|NCT04882085|470360948|FG001|Overall Study|Death|9|||
130655551|NCT04882085|470360947|FG000|Overall Study|Withdrawal by Subject|0|||
130655552|NCT04882085|470360948|FG001|Overall Study|Withdrawal by Subject|3|||
130655553|NCT04882085|470360947|FG000|Overall Study|Randomized not treated|1|||
130655554|NCT04882085|470360948|FG001|Overall Study|Randomized not treated|0|||
130655555|NCT00965562|470360949|FG000|Overall Study|Lost to Follow-up|1|||
130655556|NCT00965562|470360950|FG001|Overall Study|Lost to Follow-up|2|||
130655557|NCT00965562|470360951|FG002|Overall Study|Lost to Follow-up|3|||
130655558|NCT00965562|470360949|FG000|Overall Study|Withdrawal by Subject|2|||
130655559|NCT00965562|470360950|FG001|Overall Study|Withdrawal by Subject|2|||
130655560|NCT00965562|470360951|FG002|Overall Study|Withdrawal by Subject|0|||
130655561|NCT03792633|470360956|FG000|Overall Study|Alternative Treatment|17|||
130655562|NCT03792633|470360957|FG001|Overall Study|Alternative Treatment|19|||
130655563|NCT03792633|470360956|FG000|Overall Study|Death|2|||
130655564|NCT03792633|470360957|FG001|Overall Study|Death|0|||
130655565|NCT03792633|470360956|FG000|Overall Study|Disease progression|8|||
130655566|NCT03792633|470360957|FG001|Overall Study|Disease progression|9|||
130655567|NCT03792633|470360956|FG000|Overall Study|Lost to Follow-up|1|||
130655568|NCT03792633|470360957|FG001|Overall Study|Lost to Follow-up|1|||
130655569|NCT03792633|470360956|FG000|Overall Study|Screen fail|1|||
130655570|NCT03792633|470360957|FG001|Overall Study|Screen fail|0|||
130655571|NCT03792633|470360956|FG000|Overall Study|Second malignancy|0|||
130655572|NCT03792633|470360957|FG001|Overall Study|Second malignancy|1|||
130655573|NCT03179462|470360959|FG000|Overall Study|screening failure|1|||
130655574|NCT03179462|470360960|FG001|Overall Study|screening failure|2|||
130655575|NCT03179462|470360961|FG002|Overall Study|screening failure|0|||
130655576|NCT00816166|470360962|FG000|Overall Study|Lost to Follow-up|6|||
130655577|NCT00816166|470360963|FG001|Overall Study|Lost to Follow-up|10|||
130655578|NCT00816166|470360962|FG000|Overall Study|Death|4|||
130655579|NCT00816166|470360963|FG001|Overall Study|Death|2|||
130655580|NCT01843660|470360969|FG000|Overall Study|Other|30|||
130655581|NCT00209560|470360970|FG000|Overall Study|Lack of Efficacy|1|||
130655582|NCT00209560|470360971|FG001|Overall Study|Lack of Efficacy|0|||
130655583|NCT00795886|470360972|FG000|Overall Study|Death|10|||
130655584|NCT00526227|470360983|FG000|Overall Study|Device not implanted|1|||
130655585|NCT00526227|470360983|FG000|Overall Study|Death|1|||
130655586|NCT01721369|470360986|FG000|Overall Study|Not initial etiological diagnosis|12|||
130655587|NCT01100073|470362604|FG000|Overall Study|Lack of Efficacy|4|||
130655588|NCT01100073|470362604|FG000|Overall Study|Insufficient Tolerability|21|||
130655589|NCT01100073|470362604|FG000|Overall Study|Withdrawal by Subject|13|||
130655590|NCT01100073|470362604|FG000|Overall Study|Lost to Follow-up|39|||
130655591|NCT01100073|470362604|FG000|Overall Study|Lack of effect + patient's wish|2|||
130655592|NCT01100073|470362604|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
130323755|NCT02435992|469155574|FG003|Overall Study|Adverse Event|0|||
130655593|NCT01100073|470362604|FG000|Overall Study|Other|8|||
130655594|NCT01100073|470362604|FG000|Overall Study|Missing|5|||
130655595|NCT01656850|470362605|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
130655596|NCT01656850|470362606|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
130655597|NCT00698009|470362615|FG000|Overall Study|Withdrawal by Subject|1|||
130655598|NCT04633434|470362620|FG000|Overall Study|Lost to Follow-up|32|||
130655599|NCT04633434|470362621|FG001|Overall Study|Lost to Follow-up|32|||
130655600|NCT00627094|470362634|FG000|Overall Study|Adverse Event|8|||
130655601|NCT00627094|470362635|FG001|Overall Study|Adverse Event|7|||
130655602|NCT00627094|470362634|FG000|Overall Study|Lost to Follow-up|1|||
130655603|NCT00627094|470362635|FG001|Overall Study|Lost to Follow-up|0|||
130655604|NCT00627094|470362634|FG000|Overall Study|Withdrawal by Subject|1|||
130655605|NCT00627094|470362635|FG001|Overall Study|Withdrawal by Subject|1|||
130655606|NCT00627094|470362634|FG000|Overall Study|ulcer healed|1|||
130655607|NCT00627094|470362635|FG001|Overall Study|ulcer healed|7|||
130323756|NCT02435992|469155575|FG004|Overall Study|Adverse Event|0|||
130655608|NCT00627094|470362634|FG000|Overall Study|Other reason|1|||
130655609|NCT00627094|470362635|FG001|Overall Study|Other reason|0|||
130655610|NCT04637815|470362645|FG000|Overall Study|Death|1|||
130655611|NCT04637815|470362646|FG001|Overall Study|Death|0|||
130655612|NCT04637815|470362645|FG000|Overall Study|Lost to Follow-up|5|||
130655613|NCT04637815|470362646|FG001|Overall Study|Lost to Follow-up|2|||
130655614|NCT00877799|470362648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
130655615|NCT00877799|470362649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
130655616|NCT00877799|470362650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
130323757|NCT02435992|469155571|FG000|Overall Study|Lack of Efficacy|4|||
130323758|NCT02435992|469155572|FG001|Overall Study|Lack of Efficacy|10|||
130323759|NCT02435992|469155573|FG002|Overall Study|Lack of Efficacy|9|||
130323760|NCT02435992|469155574|FG003|Overall Study|Lack of Efficacy|0|||
130323761|NCT02435992|469155575|FG004|Overall Study|Lack of Efficacy|0|||
130323762|NCT02435992|469155571|FG000|Overall Study|Withdrawal by Subject|10|||
130323763|NCT02435992|469155572|FG001|Overall Study|Withdrawal by Subject|8|||
130323764|NCT02435992|469155573|FG002|Overall Study|Withdrawal by Subject|20|||
130323765|NCT02435992|469155574|FG003|Overall Study|Withdrawal by Subject|0|||
130323766|NCT02435992|469155575|FG004|Overall Study|Withdrawal by Subject|0|||
130323767|NCT02435992|469155571|FG000|Overall Study|Other Reason|1|||
130323768|NCT02435992|469155572|FG001|Overall Study|Other Reason|0|||
130323769|NCT02435992|469155573|FG002|Overall Study|Other Reason|0|||
130323770|NCT02435992|469155574|FG003|Overall Study|Other Reason|0|||
130323771|NCT02435992|469155575|FG004|Overall Study|Other Reason|0|||
130323772|NCT02435992|469155571|FG000|Overall Study|Physician Decision|0|||
130323773|NCT02435992|469155572|FG001|Overall Study|Physician Decision|0|||
130323774|NCT02435992|469155573|FG002|Overall Study|Physician Decision|1|||
130323775|NCT02435992|469155574|FG003|Overall Study|Physician Decision|0|||
130323776|NCT02435992|469155575|FG004|Overall Study|Physician Decision|0|||
130323777|NCT00260533|469155576|FG000|Overall Study|Other|3|||
130323778|NCT00260533|469155577|FG001|Overall Study|Other|3|||
130323779|NCT01761877|469155578|FG000|Overall Study|Adverse Event|7|||
130323780|NCT01761877|469155579|FG001|Overall Study|Adverse Event|0|||
130323781|NCT01761877|469155578|FG000|Overall Study|Withdrawal by Subject|6|||
130323782|NCT01761877|469155579|FG001|Overall Study|Withdrawal by Subject|4|||
130323783|NCT01761877|469155578|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
130323784|NCT01761877|469155579|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
130323785|NCT01761877|469155578|FG000|Overall Study|Death|0|||
130323786|NCT01761877|469155579|FG001|Overall Study|Death|1|||
130323787|NCT01761877|469155578|FG000|Overall Study|MRI intolerant|1|||
130323788|NCT01761877|469155579|FG001|Overall Study|MRI intolerant|6|||
130323789|NCT01310777|469155581|FG000|Overall Study|Adverse Event|23|||
130323790|NCT01310777|469155582|FG001|Overall Study|Adverse Event|1|||
130323791|NCT01310777|469155583|FG002|Overall Study|Adverse Event|15|||
130323792|NCT01310777|469155581|FG000|Overall Study|Lost to Follow-up|0|||
130551651|NCT01139021|469988080|FG005|Overall Study|Protocol Violation|0|||
130551652|NCT01139021|469988075|FG000|Overall Study|Withdrawal by Subject|0|||
130551653|NCT01139021|469988076|FG001|Overall Study|Withdrawal by Subject|0|||
130551654|NCT01139021|469988077|FG002|Overall Study|Withdrawal by Subject|0|||
130551655|NCT01139021|469988078|FG003|Overall Study|Withdrawal by Subject|1|||
130551656|NCT01139021|469988079|FG004|Overall Study|Withdrawal by Subject|4|||
130551657|NCT01139021|469988080|FG005|Overall Study|Withdrawal by Subject|0|||
130551658|NCT03588728|469988081|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
130655617|NCT00877799|470362651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
130323793|NCT01310777|469155582|FG001|Overall Study|Lost to Follow-up|4|||
130323794|NCT01310777|469155583|FG002|Overall Study|Lost to Follow-up|1|||
130323795|NCT01310777|469155581|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
130323796|NCT01310777|469155582|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
130323797|NCT01310777|469155583|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
130323798|NCT01310777|469155581|FG000|Overall Study|Inadequate Control of IOP|5|||
130323799|NCT01310777|469155582|FG001|Overall Study|Inadequate Control of IOP|7|||
130323800|NCT01310777|469155583|FG002|Overall Study|Inadequate Control of IOP|10|||
130323801|NCT01310777|469155581|FG000|Overall Study|Other|4|||
130323802|NCT01310777|469155582|FG001|Overall Study|Other|1|||
130323803|NCT01310777|469155583|FG002|Overall Study|Other|2|||
130323804|NCT02461758|469155585|FG000|Overall Study|Lost to Follow-up|0|||
130323805|NCT02461758|469155586|FG001|Overall Study|Lost to Follow-up|1|||
130323806|NCT02461758|469155587|FG002|Overall Study|Lost to Follow-up|1|||
130323807|NCT02461758|469155588|FG003|Overall Study|Lost to Follow-up|0|||
130323808|NCT01210313|469155594|FG000|Overall Study|Withdrawal by Subject|3|||
130323809|NCT01210313|469155594|FG000|Overall Study|Adverse Event|2|||
130323810|NCT01210313|469155594|FG000|Overall Study|Distant recurrence|4|||
130551659|NCT03588728|469988082|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
130551660|NCT03588728|469988083|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
130655618|NCT00877799|470362652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
130655619|NCT00877799|470362648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
130655620|NCT00877799|470362649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
130655621|NCT00877799|470362650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
130655622|NCT00877799|470362651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
130655623|NCT00877799|470362652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
130655624|NCT00877799|470362648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130655625|NCT00877799|470362649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
130655626|NCT00877799|470362650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130655627|NCT00877799|470362651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130655628|NCT00877799|470362652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130655629|NCT00877799|470362648|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130655630|NCT00877799|470362649|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130655631|NCT00877799|470362650|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130655632|NCT00877799|470362651|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
130655633|NCT00877799|470362652|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130655634|NCT00877799|470362648|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130655635|NCT00877799|470362649|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130655636|NCT00877799|470362650|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130655637|NCT00877799|470362651|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
130655638|NCT00877799|470362652|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
130655639|NCT04054011|470362653|FG000|Overall Study|COVID|3|||
130655640|NCT00669110|470362654|FG000|Overall Study|Adverse Event|4|||
130655641|NCT00669110|470362655|FG001|Overall Study|Adverse Event|3|||
130655642|NCT00669110|470362654|FG000|Overall Study|Caregiver request|3|||
130655643|NCT00669110|470362655|FG001|Overall Study|Caregiver request|2|||
130655644|NCT00669110|470362654|FG000|Overall Study|Physician Decision|0|||
130655645|NCT00669110|470362655|FG001|Overall Study|Physician Decision|1|||
130655646|NCT00669110|470362654|FG000|Overall Study|Lost to Follow-up|1|||
130655647|NCT00669110|470362655|FG001|Overall Study|Lost to Follow-up|0|||
130655648|NCT00669110|470362654|FG000|Overall Study|Protocol Violation|0|||
130655649|NCT00669110|470362655|FG001|Overall Study|Protocol Violation|5|||
130655650|NCT00669110|470362654|FG000|Overall Study|Withdrawal by Subject|0|||
130655651|NCT00669110|470362655|FG001|Overall Study|Withdrawal by Subject|2|||
130655652|NCT01870921|470362656|FG000|Overall Study|Subject decision|80|||
130655653|NCT01870921|470362656|FG000|Overall Study|Severe non-compliance to protocol|7|||
130655654|NCT01870921|470362656|FG000|Overall Study|Subject Lost to Follow up|2|||
130655655|NCT01870921|470362656|FG000|Overall Study|Other|1|||
130655656|NCT04409509|470362659|FG000|Overall Study|Failure to meet randomization requirement|1|||
130655657|NCT04409509|470362660|FG001|Overall Study|Failure to meet randomization requirement|0|||
130655658|NCT04409509|470362659|FG000|Overall Study|Adverse Event|0|||
130655659|NCT04409509|470362660|FG001|Overall Study|Adverse Event|1|||
130655660|NCT04409509|470362659|FG000|Overall Study|Death|11|||
130655661|NCT04409509|470362660|FG001|Overall Study|Death|10|||
130655662|NCT04409509|470362659|FG000|Overall Study|Non-compliance with study drug|0|||
130655663|NCT04409509|470362660|FG001|Overall Study|Non-compliance with study drug|1|||
130655664|NCT04409509|470362659|FG000|Overall Study|Lost to Follow-up|0|||
130655665|NCT04409509|470362660|FG001|Overall Study|Lost to Follow-up|3|||
130655666|NCT04409509|470362659|FG000|Overall Study|Withdrawal by Subject|0|||
130655667|NCT04409509|470362660|FG001|Overall Study|Withdrawal by Subject|3|||
130655668|NCT04409509|470362659|FG000|Overall Study|Randomized by mistake|0|||
130655669|NCT04409509|470362660|FG001|Overall Study|Randomized by mistake|1|||
130655670|NCT04409509|470362659|FG000|Overall Study|Other|1|||
130655671|NCT04409509|470362660|FG001|Overall Study|Other|1|||
130655672|NCT03707145|470362661|FG000|Overall Study|Lost to Follow-up|0|||
130655673|NCT03707145|470362662|FG001|Overall Study|Lost to Follow-up|1|||
130655674|NCT03707145|470362663|FG002|Overall Study|Lost to Follow-up|1|||
130655675|NCT03707145|470362664|FG003|Overall Study|Lost to Follow-up|0|||
130655676|NCT04455620|470362668|FG000|Overall Study|Withdrawal by Subject|0|||
130655677|NCT04455620|470362669|FG001|Overall Study|Withdrawal by Subject|0|||
130655678|NCT04455620|470362670|FG002|Overall Study|Withdrawal by Subject|2|||
130214690|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214691|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214692|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214693|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214694|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214695|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
130214696|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
130214697|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
130214698|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130655679|NCT04455620|470362671|FG003|Overall Study|Withdrawal by Subject|0|||
130323811|NCT01210313|469155594|FG000|Overall Study|Non-compliance|7|||
130323812|NCT01710345|469155603|FG000|Overall Study|Adverse Event|0|||
130323813|NCT01710345|469155604|FG001|Overall Study|Adverse Event|2|||
130323814|NCT01710345|469155605|FG002|Overall Study|Adverse Event|0|||
130323815|NCT01710345|469155603|FG000|Overall Study|Lack of Efficacy|2|||
130323816|NCT01710345|469155604|FG001|Overall Study|Lack of Efficacy|3|||
130323817|NCT01710345|469155605|FG002|Overall Study|Lack of Efficacy|1|||
130323818|NCT01710345|469155603|FG000|Overall Study|Drug Dosing Error|1|||
130323819|NCT01710345|469155604|FG001|Overall Study|Drug Dosing Error|0|||
130323820|NCT01710345|469155605|FG002|Overall Study|Drug Dosing Error|0|||
130323821|NCT04298697|469155609|FG000|Overall Study|Lost to Follow-up|5|||
130323822|NCT04298697|469155610|FG001|Overall Study|Lost to Follow-up|5|||
130323823|NCT04298697|469155611|FG002|Overall Study|Lost to Follow-up|1|||
130323824|NCT04298697|469155612|FG003|Overall Study|Lost to Follow-up|0|||
130323825|NCT04298697|469155609|FG000|Overall Study|Withdrawal by Subject|0|||
130323826|NCT04298697|469155610|FG001|Overall Study|Withdrawal by Subject|3|||
130323827|NCT04298697|469155611|FG002|Overall Study|Withdrawal by Subject|2|||
130323828|NCT04298697|469155612|FG003|Overall Study|Withdrawal by Subject|3|||
130323829|NCT00449696|469155613|FG000|Overall Study|Other Treatment Required|6|||
130323830|NCT00449696|469155614|FG001|Overall Study|Other Treatment Required|1|||
130323831|NCT00449696|469155613|FG000|Overall Study|Withdrawal by Subject|5|||
130323832|NCT00449696|469155614|FG001|Overall Study|Withdrawal by Subject|5|||
130323833|NCT00449696|469155613|FG000|Overall Study|Lost to Follow-up|2|||
130323834|NCT00449696|469155614|FG001|Overall Study|Lost to Follow-up|3|||
130323835|NCT00449696|469155613|FG000|Overall Study|Others|7|||
130323836|NCT00449696|469155614|FG001|Overall Study|Others|0|||
130323837|NCT01903460|469155615|FG000|Overall Study|Adverse Event|0|||
130323838|NCT01903460|469155616|FG001|Overall Study|Adverse Event|0|||
130323839|NCT01903460|469155617|FG002|Overall Study|Adverse Event|0|||
130323840|NCT01903460|469155618|FG003|Overall Study|Adverse Event|1|||
130323841|NCT04973449|469155619|FG000|Overall Study|Withdrawal by Subject|3|||
130323842|NCT04973449|469155620|FG001|Overall Study|Withdrawal by Subject|3|||
130323843|NCT04973449|469155621|FG002|Overall Study|Withdrawal by Subject|2|||
130323844|NCT04973449|469155622|FG003|Overall Study|Withdrawal by Subject|5|||
130323845|NCT04973449|469155623|FG004|Overall Study|Withdrawal by Subject|5|||
130323846|NCT04973449|469155624|FG005|Overall Study|Withdrawal by Subject|4|||
130323847|NCT04973449|469155625|FG006|Overall Study|Withdrawal by Subject|7|||
130655680|NCT04455620|470362672|FG004|Overall Study|Withdrawal by Subject|1|||
130655681|NCT04455620|470362668|FG000|Overall Study|Lost to Follow-up|0|||
130655682|NCT04455620|470362669|FG001|Overall Study|Lost to Follow-up|0|||
130655683|NCT04455620|470362670|FG002|Overall Study|Lost to Follow-up|1|||
130655684|NCT04455620|470362671|FG003|Overall Study|Lost to Follow-up|1|||
130655685|NCT04455620|470362672|FG004|Overall Study|Lost to Follow-up|0|||
130655686|NCT04455620|470362668|FG000|Overall Study|Death|1|||
130655687|NCT04455620|470362669|FG001|Overall Study|Death|6|||
130655688|NCT04455620|470362670|FG002|Overall Study|Death|20|||
130655689|NCT04455620|470362671|FG003|Overall Study|Death|1|||
130655690|NCT04455620|470362672|FG004|Overall Study|Death|7|||
130655691|NCT04455620|470362668|FG000|Overall Study|Study Termination|0|||
130655692|NCT04455620|470362669|FG001|Overall Study|Study Termination|2|||
130655693|NCT04455620|470362670|FG002|Overall Study|Study Termination|1|||
130655694|NCT04455620|470362671|FG003|Overall Study|Study Termination|0|||
130655695|NCT04455620|470362672|FG004|Overall Study|Study Termination|6|||
130655696|NCT00400985|470362673|FG000|Overall Study|Withdrawal by Subject|5|||
130655697|NCT00400985|470362673|FG000|Overall Study|system modification|8|||
130655698|NCT00400985|470362673|FG000|Overall Study|Death|30|||
130655699|NCT00400985|470362673|FG000|Overall Study|Lost to Follow-up|9|||
130655700|NCT04636437|470362676|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
130655701|NCT04636437|470362677|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
130655702|NCT04636437|470362678|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
130655703|NCT04636437|470362676|FG000|Overall Study|Started weight loss drug/program|2|||
130655704|NCT04636437|470362677|FG001|Overall Study|Started weight loss drug/program|1|||
130655705|NCT04636437|470362678|FG002|Overall Study|Started weight loss drug/program|1|||
130655706|NCT04636437|470362676|FG000|Overall Study|Lost to Follow-up|3|||
130655707|NCT04636437|470362677|FG001|Overall Study|Lost to Follow-up|1|||
130655708|NCT04636437|470362678|FG002|Overall Study|Lost to Follow-up|4|||
130655709|NCT04636437|470362676|FG000|Overall Study|Participant or physician decision|3|||
130655710|NCT04636437|470362677|FG001|Overall Study|Participant or physician decision|1|||
130323848|NCT04973449|469155626|FG007|Overall Study|Withdrawal by Subject|5|||
130323849|NCT04973449|469155619|FG000|Overall Study|Lost to Follow-up|15|||
130323850|NCT04973449|469155620|FG001|Overall Study|Lost to Follow-up|16|||
130323851|NCT04973449|469155621|FG002|Overall Study|Lost to Follow-up|16|||
130323852|NCT04973449|469155622|FG003|Overall Study|Lost to Follow-up|13|||
130323853|NCT04973449|469155623|FG004|Overall Study|Lost to Follow-up|5|||
130323854|NCT04973449|469155624|FG005|Overall Study|Lost to Follow-up|6|||
130323855|NCT04973449|469155625|FG006|Overall Study|Lost to Follow-up|10|||
130655711|NCT04636437|470362678|FG002|Overall Study|Participant or physician decision|1|||
130323856|NCT04973449|469155626|FG007|Overall Study|Lost to Follow-up|6|||
130655712|NCT02851069|470362679|FG000|Overall Study|Failure to Return|3|||
130655713|NCT02851069|470362679|FG000|Overall Study|Other|3|||
130655714|NCT00352664|470362686|FG000|Overall Study|Withdrawal by Subject|7|||
130655715|NCT00352664|470362687|FG001|Overall Study|Withdrawal by Subject|0|||
130655716|NCT03539952|470362690|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
130655717|NCT03539952|470362691|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
130655718|NCT03539952|470362690|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
130655719|NCT03539952|470362691|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
130655720|NCT03539952|470362690|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
130655721|NCT03539952|470362691|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
130655722|NCT03539952|470362690|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
130655723|NCT03539952|470362691|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
130655724|NCT03539952|470362690|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
130655725|NCT03539952|470362691|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
130655726|NCT03539952|470362690|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
130655727|NCT03539952|470362691|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
130655728|NCT03539952|470362690|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
130655729|NCT03539952|470362691|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
130655730|NCT03075215|470362692|FG000|12-Month Primary Endpoint|Death|152|||
130655731|NCT03075215|470362692|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
130655732|NCT03075215|470362692|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
130655733|NCT03075215|470362692|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
130655734|NCT01233284|470362693|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
130655735|NCT01233284|470362694|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130655736|NCT01233284|470362695|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130655737|NCT01233284|470362696|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130655738|NCT01233284|470362697|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130655739|NCT01233284|470362693|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130655740|NCT01233284|470362694|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
130655741|NCT01233284|470362695|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130655742|NCT01233284|470362696|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130655743|NCT01233284|470362697|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130655744|NCT01233284|470362693|FG000|Period 1 (4 Weeks)|Other|0|||
130655745|NCT01233284|470362694|FG001|Period 1 (4 Weeks)|Other|0|||
130655746|NCT01233284|470362695|FG002|Period 1 (4 Weeks)|Other|1|||
130655747|NCT01233284|470362696|FG003|Period 1 (4 Weeks)|Other|0|||
130655748|NCT01233284|470362697|FG004|Period 1 (4 Weeks)|Other|0|||
130655749|NCT01233284|470362693|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130655750|NCT01233284|470362694|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130655751|NCT01233284|470362695|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
130655752|NCT01233284|470362696|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130655753|NCT01233284|470362697|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130655754|NCT01233284|470362693|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130655755|NCT01233284|470362694|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130655756|NCT01233284|470362695|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
130655757|NCT01233284|470362696|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130655758|NCT01233284|470362697|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130655759|NCT01233284|470362693|FG000|Period 3 (4 Weeks)|Other|0|||
130655760|NCT01233284|470362694|FG001|Period 3 (4 Weeks)|Other|0|||
130655761|NCT01233284|470362695|FG002|Period 3 (4 Weeks)|Other|0|||
130655762|NCT01233284|470362696|FG003|Period 3 (4 Weeks)|Other|1|||
130655763|NCT01233284|470362697|FG004|Period 3 (4 Weeks)|Other|0|||
130655764|NCT01233284|470362693|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
130655765|NCT01233284|470362694|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
130655766|NCT01233284|470362695|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
130655767|NCT01233284|470362696|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
130655768|NCT01233284|470362697|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
130655769|NCT01233284|470362693|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130655770|NCT01233284|470362694|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130655771|NCT01233284|470362695|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130655772|NCT01233284|470362696|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
130655773|NCT01233284|470362697|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130655774|NCT02756182|470362698|FG000|Overall Study|StudyTechnical Difficulties|4|||
130655775|NCT01058707|470362699|FG000|Overall Study|Disease Progression|15|||
130655776|NCT01058707|470362700|FG001|Overall Study|Disease Progression|20|||
130655777|NCT01058707|470362701|FG002|Overall Study|Disease Progression|20|||
130655778|NCT01058707|470362702|FG003|Overall Study|Disease Progression|15|||
130655779|NCT01058707|470362703|FG004|Overall Study|Disease Progression|23|||
130655780|NCT01058707|470362704|FG005|Overall Study|Disease Progression|10|||
130655781|NCT01058707|470362705|FG006|Overall Study|Disease Progression|12|||
130655782|NCT01058707|470362699|FG000|Overall Study|Adverse Event|11|||
130655783|NCT01058707|470362700|FG001|Overall Study|Adverse Event|4|||
130655784|NCT01058707|470362701|FG002|Overall Study|Adverse Event|7|||
130655785|NCT01058707|470362702|FG003|Overall Study|Adverse Event|6|||
130655786|NCT01058707|470362703|FG004|Overall Study|Adverse Event|7|||
130655787|NCT01058707|470362704|FG005|Overall Study|Adverse Event|3|||
130655788|NCT01058707|470362705|FG006|Overall Study|Adverse Event|1|||
130655789|NCT01058707|470362699|FG000|Overall Study|Subject Decision|5|||
130655790|NCT01058707|470362700|FG001|Overall Study|Subject Decision|3|||
130655791|NCT01058707|470362701|FG002|Overall Study|Subject Decision|3|||
130655792|NCT01058707|470362702|FG003|Overall Study|Subject Decision|1|||
130655793|NCT01058707|470362703|FG004|Overall Study|Subject Decision|2|||
130655794|NCT01058707|470362704|FG005|Overall Study|Subject Decision|3|||
130655795|NCT01058707|470362705|FG006|Overall Study|Subject Decision|6|||
130655796|NCT01058707|470362699|FG000|Overall Study|Lost to Follow-up|0|||
130655797|NCT01058707|470362700|FG001|Overall Study|Lost to Follow-up|0|||
130655798|NCT01058707|470362701|FG002|Overall Study|Lost to Follow-up|1|||
130655799|NCT01058707|470362702|FG003|Overall Study|Lost to Follow-up|0|||
130655800|NCT01058707|470362703|FG004|Overall Study|Lost to Follow-up|0|||
130655801|NCT01058707|470362704|FG005|Overall Study|Lost to Follow-up|0|||
130655802|NCT01058707|470362705|FG006|Overall Study|Lost to Follow-up|0|||
130655803|NCT01058707|470362699|FG000|Overall Study|Reason Not Specified|0|||
130655804|NCT01058707|470362700|FG001|Overall Study|Reason Not Specified|3|||
130655805|NCT01058707|470362701|FG002|Overall Study|Reason Not Specified|2|||
130655806|NCT01058707|470362702|FG003|Overall Study|Reason Not Specified|0|||
130655807|NCT01058707|470362703|FG004|Overall Study|Reason Not Specified|7|||
130655808|NCT01058707|470362704|FG005|Overall Study|Reason Not Specified|1|||
130655809|NCT01058707|470362705|FG006|Overall Study|Reason Not Specified|7|||
130655810|NCT01821391|470362706|FG000|Overall Study|Adverse Event|1|||
130655811|NCT01821391|470362707|FG001|Overall Study|Adverse Event|0|||
130655812|NCT02146365|470362708|FG000|Overall Study|Lost to Follow-up|2|||
130655813|NCT02146365|470362709|FG001|Overall Study|Lost to Follow-up|1|||
130655814|NCT02146365|470362710|FG002|Overall Study|Lost to Follow-up|3|||
130655815|NCT02146365|470362711|FG003|Overall Study|Lost to Follow-up|3|||
130655816|NCT02146365|470362712|FG004|Overall Study|Lost to Follow-up|1|||
130655817|NCT02146365|470362713|FG005|Overall Study|Lost to Follow-up|1|||
130655818|NCT02146365|470362714|FG006|Overall Study|Lost to Follow-up|0|||
130655819|NCT02146365|470362715|FG007|Overall Study|Lost to Follow-up|1|||
130655820|NCT02146365|470362708|FG000|Overall Study|Withdrawal by Subject|1|||
130655821|NCT02146365|470362709|FG001|Overall Study|Withdrawal by Subject|2|||
130655822|NCT02146365|470362710|FG002|Overall Study|Withdrawal by Subject|1|||
130655823|NCT02146365|470362711|FG003|Overall Study|Withdrawal by Subject|5|||
130655824|NCT02146365|470362712|FG004|Overall Study|Withdrawal by Subject|1|||
130655825|NCT02146365|470362713|FG005|Overall Study|Withdrawal by Subject|0|||
130655826|NCT02146365|470362714|FG006|Overall Study|Withdrawal by Subject|0|||
130655827|NCT02146365|470362715|FG007|Overall Study|Withdrawal by Subject|0|||
130655828|NCT02146365|470362708|FG000|Overall Study|Unable to Comply with Protocol|0|||
130655829|NCT02146365|470362709|FG001|Overall Study|Unable to Comply with Protocol|1|||
130655830|NCT02146365|470362710|FG002|Overall Study|Unable to Comply with Protocol|1|||
130655831|NCT02146365|470362711|FG003|Overall Study|Unable to Comply with Protocol|0|||
130655832|NCT02146365|470362712|FG004|Overall Study|Unable to Comply with Protocol|0|||
130655833|NCT02146365|470362713|FG005|Overall Study|Unable to Comply with Protocol|0|||
130655834|NCT02146365|470362714|FG006|Overall Study|Unable to Comply with Protocol|0|||
130655835|NCT02146365|470362715|FG007|Overall Study|Unable to Comply with Protocol|0|||
130655836|NCT02146365|470362708|FG000|Overall Study|Other|1|||
130655837|NCT02146365|470362709|FG001|Overall Study|Other|0|||
130655838|NCT02146365|470362710|FG002|Overall Study|Other|2|||
130655839|NCT02146365|470362711|FG003|Overall Study|Other|1|||
130655840|NCT02146365|470362712|FG004|Overall Study|Other|0|||
130655841|NCT02146365|470362713|FG005|Overall Study|Other|0|||
130655842|NCT02146365|470362714|FG006|Overall Study|Other|0|||
130655843|NCT02146365|470362715|FG007|Overall Study|Other|0|||
130655844|NCT01977482|470362717|FG000|Overall Study|Adverse Event|0|||
130655845|NCT01977482|470362718|FG001|Overall Study|Adverse Event|1|||
130655846|NCT01977482|470362719|FG002|Overall Study|Adverse Event|1|||
130655847|NCT01977482|470362720|FG003|Overall Study|Adverse Event|0|||
130655848|NCT01977482|470362721|FG004|Overall Study|Adverse Event|2|||
130655849|NCT01977482|470362722|FG005|Overall Study|Adverse Event|0|||
130655850|NCT01977482|470362717|FG000|Overall Study|Lost to Follow-up|1|||
130655851|NCT01977482|470362718|FG001|Overall Study|Lost to Follow-up|0|||
130655852|NCT01977482|470362719|FG002|Overall Study|Lost to Follow-up|0|||
130655853|NCT01977482|470362720|FG003|Overall Study|Lost to Follow-up|0|||
130655854|NCT01977482|470362721|FG004|Overall Study|Lost to Follow-up|0|||
130655855|NCT01977482|470362722|FG005|Overall Study|Lost to Follow-up|0|||
130655856|NCT01977482|470362717|FG000|Overall Study|Physician Decision|0|||
130655857|NCT01977482|470362718|FG001|Overall Study|Physician Decision|1|||
130655858|NCT01977482|470362719|FG002|Overall Study|Physician Decision|0|||
130655859|NCT01977482|470362720|FG003|Overall Study|Physician Decision|0|||
130323857|NCT04973449|469155619|FG000|Overall Study|Death|1|||
130655860|NCT01977482|470362721|FG004|Overall Study|Physician Decision|0|||
130655861|NCT01977482|470362722|FG005|Overall Study|Physician Decision|0|||
130655862|NCT01977482|470362717|FG000|Overall Study|Protocol Violation|0|||
130655863|NCT01977482|470362718|FG001|Overall Study|Protocol Violation|0|||
130655864|NCT01977482|470362719|FG002|Overall Study|Protocol Violation|1|||
130655865|NCT01977482|470362720|FG003|Overall Study|Protocol Violation|0|||
130655866|NCT01977482|470362721|FG004|Overall Study|Protocol Violation|0|||
130655867|NCT01977482|470362722|FG005|Overall Study|Protocol Violation|0|||
130655868|NCT01977482|470362717|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130655869|NCT01977482|470362718|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
130655870|NCT01977482|470362719|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
130655871|NCT01977482|470362720|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
130655872|NCT01977482|470362721|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130655873|NCT01977482|470362722|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130655874|NCT01977482|470362717|FG000|Overall Study|Withdrawal by Subject|2|||
130655875|NCT01977482|470362718|FG001|Overall Study|Withdrawal by Subject|4|||
130655876|NCT01977482|470362719|FG002|Overall Study|Withdrawal by Subject|1|||
130655877|NCT01977482|470362720|FG003|Overall Study|Withdrawal by Subject|3|||
130655878|NCT01977482|470362721|FG004|Overall Study|Withdrawal by Subject|1|||
130655879|NCT01977482|470362722|FG005|Overall Study|Withdrawal by Subject|5|||
130655880|NCT05554471|470362723|FG000|Overall Study|Physician Decision|2|||
130655881|NCT05554471|470362724|FG001|Overall Study|Physician Decision|1|||
130655882|NCT05554471|470362723|FG000|Overall Study|Lost to Follow-up|2|||
130655883|NCT05554471|470362724|FG001|Overall Study|Lost to Follow-up|1|||
130655884|NCT05554471|470362723|FG000|Overall Study|Death|0|||
130655885|NCT05554471|470362724|FG001|Overall Study|Death|1|||
130655886|NCT04880850|470362727|FG000|Overall Study|Death|2|||
130655887|NCT04880850|470362728|FG001|Overall Study|Death|1|||
130655888|NCT04880850|470362727|FG000|Overall Study|Lost to Follow-up|3|||
130655889|NCT04880850|470362728|FG001|Overall Study|Lost to Follow-up|6|||
130655890|NCT04880850|470362727|FG000|Overall Study|Physician Decision|2|||
130655891|NCT04880850|470362728|FG001|Overall Study|Physician Decision|1|||
130655892|NCT04880850|470362727|FG000|Overall Study|Withdrawal by Subject|9|||
130655893|NCT04880850|470362728|FG001|Overall Study|Withdrawal by Subject|10|||
130655894|NCT01608321|470362729|FG000|Overall Study|Withdrawal by Subject|1|||
130655895|NCT01608321|470362730|FG001|Overall Study|Withdrawal by Subject|0|||
130655896|NCT03417102|470362731|FG000|Overall Study|Adverse Event|0|||
130655897|NCT03417102|470362732|FG001|Overall Study|Adverse Event|1|||
130655898|NCT03417102|470362731|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
130655899|NCT03417102|470362732|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
130655900|NCT03417102|470362731|FG000|Overall Study|Other|0|||
130655901|NCT03417102|470362732|FG001|Overall Study|Other|1|||
130655902|NCT02062385|470362733|FG000|Overall Study|Adverse Event|19|||
130655903|NCT02062385|470362734|FG001|Overall Study|Adverse Event|13|||
130655904|NCT02062385|470362735|FG002|Overall Study|Adverse Event|1|||
130655905|NCT02062385|470362736|FG003|Overall Study|Adverse Event|0|||
130655906|NCT02062385|470362733|FG000|Overall Study|Protocol Violation|1|||
130655907|NCT02062385|470362734|FG001|Overall Study|Protocol Violation|0|||
130655908|NCT02062385|470362735|FG002|Overall Study|Protocol Violation|0|||
130655909|NCT02062385|470362736|FG003|Overall Study|Protocol Violation|0|||
130655910|NCT02062385|470362733|FG000|Overall Study|Incomplete EPI by database lock|2|||
130655911|NCT02062385|470362734|FG001|Overall Study|Incomplete EPI by database lock|0|||
130655912|NCT02062385|470362735|FG002|Overall Study|Incomplete EPI by database lock|0|||
130655913|NCT02062385|470362736|FG003|Overall Study|Incomplete EPI by database lock|0|||
130655914|NCT02062385|470362733|FG000|Overall Study|Moved|10|||
130655915|NCT02062385|470362734|FG001|Overall Study|Moved|11|||
130655916|NCT02062385|470362735|FG002|Overall Study|Moved|1|||
130655917|NCT02062385|470362736|FG003|Overall Study|Moved|0|||
130655918|NCT02062385|470362733|FG000|Overall Study|Withdrawn by parent/guardian|46|||
130655919|NCT02062385|470362734|FG001|Overall Study|Withdrawn by parent/guardian|41|||
130655920|NCT02062385|470362735|FG002|Overall Study|Withdrawn by parent/guardian|9|||
130655921|NCT02062385|470362736|FG003|Overall Study|Withdrawn by parent/guardian|8|||
130655922|NCT02062385|470362733|FG000|Overall Study|Death|0|||
130655923|NCT02062385|470362734|FG001|Overall Study|Death|0|||
130655924|NCT02062385|470362735|FG002|Overall Study|Death|0|||
130655925|NCT02062385|470362736|FG003|Overall Study|Death|1|||
130655926|NCT02062385|470362733|FG000|Overall Study|Lost to Follow-up|0|||
130655927|NCT02062385|470362734|FG001|Overall Study|Lost to Follow-up|0|||
130655928|NCT02062385|470362735|FG002|Overall Study|Lost to Follow-up|1|||
130655929|NCT02062385|470362736|FG003|Overall Study|Lost to Follow-up|0|||
130655930|NCT03222856|470362739|FG000|Overall Study|Adverse Event|6|||
130655931|NCT03222856|470362739|FG000|Overall Study|Death|1|||
130655932|NCT00706901|470364207|FG000|Overall Study|Lost to Follow-up|2|||
130655933|NCT00706901|470364208|FG001|Overall Study|Lost to Follow-up|3|||
130655934|NCT00706901|470364209|FG002|Overall Study|Lost to Follow-up|2|||
130655935|NCT00706901|470364207|FG000|Overall Study|Withdrawal by Subject|4|||
130655936|NCT00706901|470364208|FG001|Overall Study|Withdrawal by Subject|2|||
130655937|NCT00706901|470364209|FG002|Overall Study|Withdrawal by Subject|5|||
130655938|NCT00706901|470364207|FG000|Overall Study|In Jail|1|||
130655939|NCT00706901|470364208|FG001|Overall Study|In Jail|0|||
130655940|NCT00706901|470364209|FG002|Overall Study|In Jail|1|||
130655941|NCT00706901|470364207|FG000|Overall Study|Death|1|||
130655942|NCT00706901|470364208|FG001|Overall Study|Death|0|||
130655943|NCT00706901|470364209|FG002|Overall Study|Death|0|||
130655944|NCT04478994|470364210|FG000|Overall Study|Withdrawal by Subject|1|||
130655945|NCT04478994|470364211|FG001|Overall Study|Withdrawal by Subject|1|||
130655946|NCT01118949|470364214|FG000|Overall Study|Adverse Event|5|||
130655947|NCT01118949|470364214|FG000|Overall Study|Withdrawal by Subject|4|||
130655948|NCT03255226|470364215|FG000|Overall Study|Adverse Event|2|||
130655949|NCT03255226|470364215|FG000|Overall Study|Physician Decision|3|||
130655950|NCT03255226|470364215|FG000|Overall Study|Withdrawal by Subject|1|||
130655951|NCT03255226|470364215|FG000|Overall Study|Serum or blood sodium increased|4|||
130655952|NCT03255226|470364215|FG000|Overall Study|Serum or blood potassium increased|4|||
130655953|NCT00685763|470364217|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
130655954|NCT00685763|470364217|FG000|Overall Study|Protocol Violation|1|||
130655955|NCT01741259|470364218|FG000|Overall Study|Protocol Violation|6|||
130655956|NCT01741259|470364219|FG001|Overall Study|Protocol Violation|4|||
130655957|NCT01741259|470364218|FG000|Overall Study|Withdrawal by Subject|0|||
130655958|NCT01741259|470364219|FG001|Overall Study|Withdrawal by Subject|2|||
130655959|NCT00798707|470364220|FG000|Overall Study|Adverse Event|6|||
130655960|NCT00798707|470364221|FG001|Overall Study|Adverse Event|8|||
130655961|NCT00798707|470364222|FG002|Overall Study|Adverse Event|8|||
130655962|NCT00798707|470364220|FG000|Overall Study|Failed to return|2|||
130655963|NCT00798707|470364221|FG001|Overall Study|Failed to return|2|||
130655964|NCT00798707|470364222|FG002|Overall Study|Failed to return|0|||
130655965|NCT00798707|470364220|FG000|Overall Study|Investigator|0|||
130655966|NCT00798707|470364221|FG001|Overall Study|Investigator|1|||
130655967|NCT00798707|470364222|FG002|Overall Study|Investigator|2|||
130655968|NCT00798707|470364220|FG000|Overall Study|Lack of Efficacy|2|||
130655969|NCT00798707|470364221|FG001|Overall Study|Lack of Efficacy|2|||
130655970|NCT00798707|470364222|FG002|Overall Study|Lack of Efficacy|1|||
130655971|NCT00798707|470364220|FG000|Overall Study|Lost to Follow-up|5|||
130655972|NCT00798707|470364221|FG001|Overall Study|Lost to Follow-up|6|||
130655973|NCT00798707|470364222|FG002|Overall Study|Lost to Follow-up|6|||
130655974|NCT00798707|470364220|FG000|Overall Study|Other|0|||
130655975|NCT00798707|470364221|FG001|Overall Study|Other|1|||
130655976|NCT00798707|470364222|FG002|Overall Study|Other|0|||
130655977|NCT00798707|470364220|FG000|Overall Study|Protocol Violation|4|||
130655978|NCT00798707|470364221|FG001|Overall Study|Protocol Violation|0|||
130655979|NCT00798707|470364222|FG002|Overall Study|Protocol Violation|2|||
130655980|NCT00798707|470364220|FG000|Overall Study|Withdrawal by Subject|3|||
130655981|NCT00798707|470364221|FG001|Overall Study|Withdrawal by Subject|8|||
130655982|NCT00798707|470364222|FG002|Overall Study|Withdrawal by Subject|2|||
130655983|NCT00798707|470364220|FG000|Overall Study|Randomized not treated|4|||
130655984|NCT00798707|470364221|FG001|Overall Study|Randomized not treated|5|||
130655985|NCT00798707|470364222|FG002|Overall Study|Randomized not treated|1|||
130655986|NCT02094573|470364223|FG000|Overall Study|Adverse Event|4|||
130655987|NCT02094573|470364224|FG001|Overall Study|Adverse Event|14|||
130655988|NCT02094573|470364223|FG000|Overall Study|Clinical Progressive Disease|9|||
130655989|NCT02094573|470364224|FG001|Overall Study|Clinical Progressive Disease|13|||
130655990|NCT02094573|470364223|FG000|Overall Study|Death|11|||
130655991|NCT02094573|470364224|FG001|Overall Study|Death|3|||
130655992|NCT02094573|470364223|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
130655993|NCT02094573|470364224|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
130655994|NCT02094573|470364223|FG000|Overall Study|Non-compliance with Study Drug|1|||
130655995|NCT02094573|470364224|FG001|Overall Study|Non-compliance with Study Drug|1|||
130655996|NCT02094573|470364223|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
130655997|NCT02094573|470364224|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
130655998|NCT02094573|470364223|FG000|Overall Study|Physician Decision|4|||
130655999|NCT02094573|470364224|FG001|Overall Study|Physician Decision|4|||
130656000|NCT02094573|470364223|FG000|Overall Study|Site Terminated by Sponsor|10|||
130656001|NCT02094573|470364224|FG001|Overall Study|Site Terminated by Sponsor|17|||
130656002|NCT02094573|470364223|FG000|Overall Study|Withdrawal by Subject|6|||
130656003|NCT02094573|470364224|FG001|Overall Study|Withdrawal by Subject|8|||
130656004|NCT02094573|470364223|FG000|Overall Study|Randomized but not Treated|3|||
130656005|NCT02094573|470364224|FG001|Overall Study|Randomized but not Treated|0|||
130656006|NCT00929201|470364225|FG000|Period 1|Withdrawal by Subject|0|||
130656007|NCT00929201|470364226|FG001|Period 1|Withdrawal by Subject|1|||
130656008|NCT04242264|470364229|FG000|Overall Study|Lost to Follow-up|2|||
130656009|NCT04242264|470364230|FG001|Overall Study|Lost to Follow-up|2|||
130656010|NCT04242264|470364231|FG002|Overall Study|Lost to Follow-up|1|||
130656011|NCT04242264|470364232|FG003|Overall Study|Lost to Follow-up|1|||
130656012|NCT04242264|470364229|FG000|Overall Study|Withdrawal by Subject|1|||
130656013|NCT04242264|470364230|FG001|Overall Study|Withdrawal by Subject|0|||
130656014|NCT04242264|470364231|FG002|Overall Study|Withdrawal by Subject|0|||
130656015|NCT04242264|470364232|FG003|Overall Study|Withdrawal by Subject|0|||
130656016|NCT00471237|470364236|FG000|Overall Study|Adverse Event|6|||
130656017|NCT00471237|470364237|FG001|Overall Study|Adverse Event|5|||
130656018|NCT00471237|470364238|FG002|Overall Study|Adverse Event|4|||
130656019|NCT00471237|470364239|FG003|Overall Study|Adverse Event|8|||
130656020|NCT00471237|470364240|FG004|Overall Study|Adverse Event|7|||
130656021|NCT00471237|470364241|FG005|Overall Study|Adverse Event|5|||
130656022|NCT00471237|470364242|FG006|Overall Study|Adverse Event|0|||
130656023|NCT00471237|470364236|FG000|Overall Study|Lost to Follow-up|1|||
130656024|NCT00471237|470364237|FG001|Overall Study|Lost to Follow-up|1|||
130656025|NCT00471237|470364238|FG002|Overall Study|Lost to Follow-up|0|||
130656026|NCT00471237|470364239|FG003|Overall Study|Lost to Follow-up|2|||
130656027|NCT00471237|470364240|FG004|Overall Study|Lost to Follow-up|3|||
130656028|NCT00471237|470364241|FG005|Overall Study|Lost to Follow-up|0|||
130656029|NCT00471237|470364242|FG006|Overall Study|Lost to Follow-up|0|||
130656030|NCT00471237|470364236|FG000|Overall Study|Protocol Violation|3|||
130656031|NCT00471237|470364237|FG001|Overall Study|Protocol Violation|6|||
130656032|NCT00471237|470364238|FG002|Overall Study|Protocol Violation|3|||
130656033|NCT00471237|470364239|FG003|Overall Study|Protocol Violation|2|||
130656034|NCT00471237|470364240|FG004|Overall Study|Protocol Violation|2|||
130656035|NCT00471237|470364241|FG005|Overall Study|Protocol Violation|4|||
130656036|NCT00471237|470364242|FG006|Overall Study|Protocol Violation|1|||
130656037|NCT00471237|470364236|FG000|Overall Study|Withdrawal by Subject|8|||
130656038|NCT00471237|470364237|FG001|Overall Study|Withdrawal by Subject|6|||
130656039|NCT00471237|470364238|FG002|Overall Study|Withdrawal by Subject|5|||
130656040|NCT00471237|470364239|FG003|Overall Study|Withdrawal by Subject|8|||
130656041|NCT00471237|470364240|FG004|Overall Study|Withdrawal by Subject|7|||
130656042|NCT00471237|470364241|FG005|Overall Study|Withdrawal by Subject|4|||
130656043|NCT00471237|470364242|FG006|Overall Study|Withdrawal by Subject|2|||
130656044|NCT00471237|470364236|FG000|Overall Study|Sponsor terminated study|20|||
130656045|NCT00471237|470364237|FG001|Overall Study|Sponsor terminated study|23|||
130656046|NCT00471237|470364238|FG002|Overall Study|Sponsor terminated study|19|||
130656047|NCT00471237|470364239|FG003|Overall Study|Sponsor terminated study|22|||
130656048|NCT00471237|470364240|FG004|Overall Study|Sponsor terminated study|18|||
130656049|NCT00471237|470364241|FG005|Overall Study|Sponsor terminated study|24|||
130656050|NCT00471237|470364242|FG006|Overall Study|Sponsor terminated study|0|||
130656051|NCT00471237|470364236|FG000|Overall Study|Non-compliance|0|||
130656052|NCT00471237|470364237|FG001|Overall Study|Non-compliance|1|||
130656053|NCT00471237|470364238|FG002|Overall Study|Non-compliance|0|||
130656054|NCT00471237|470364239|FG003|Overall Study|Non-compliance|1|||
130656055|NCT00471237|470364240|FG004|Overall Study|Non-compliance|0|||
130656056|NCT00471237|470364241|FG005|Overall Study|Non-compliance|0|||
130656057|NCT00471237|470364242|FG006|Overall Study|Non-compliance|0|||
130656058|NCT00471237|470364236|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
130656059|NCT00471237|470364237|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
130656060|NCT00471237|470364238|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
130656061|NCT00471237|470364239|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
130656062|NCT00471237|470364240|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
130656063|NCT00471237|470364241|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
130656064|NCT00471237|470364242|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
130656065|NCT00471237|470364236|FG000|Overall Study|Early stopping due to non-efficacy|1|||
130656066|NCT00471237|470364237|FG001|Overall Study|Early stopping due to non-efficacy|0|||
130656067|NCT00471237|470364238|FG002|Overall Study|Early stopping due to non-efficacy|0|||
130656068|NCT00471237|470364239|FG003|Overall Study|Early stopping due to non-efficacy|0|||
130656069|NCT00471237|470364240|FG004|Overall Study|Early stopping due to non-efficacy|1|||
130656070|NCT00471237|470364241|FG005|Overall Study|Early stopping due to non-efficacy|0|||
130656071|NCT00471237|470364242|FG006|Overall Study|Early stopping due to non-efficacy|0|||
130656072|NCT00471237|470364236|FG000|Overall Study|Participant planned to travel to abraod|1|||
130656073|NCT00471237|470364237|FG001|Overall Study|Participant planned to travel to abraod|0|||
130656074|NCT00471237|470364238|FG002|Overall Study|Participant planned to travel to abraod|0|||
130656075|NCT00471237|470364239|FG003|Overall Study|Participant planned to travel to abraod|0|||
130656076|NCT00471237|470364240|FG004|Overall Study|Participant planned to travel to abraod|0|||
130656077|NCT00471237|470364241|FG005|Overall Study|Participant planned to travel to abraod|1|||
130656078|NCT00471237|470364242|FG006|Overall Study|Participant planned to travel to abraod|0|||
130656079|NCT00471237|470364236|FG000|Overall Study|High parathyroid hormone|0|||
130656080|NCT00471237|470364237|FG001|Overall Study|High parathyroid hormone|0|||
130656081|NCT00471237|470364238|FG002|Overall Study|High parathyroid hormone|1|||
130656082|NCT00471237|470364239|FG003|Overall Study|High parathyroid hormone|0|||
130656083|NCT00471237|470364240|FG004|Overall Study|High parathyroid hormone|0|||
130656084|NCT00471237|470364241|FG005|Overall Study|High parathyroid hormone|0|||
130656085|NCT00471237|470364242|FG006|Overall Study|High parathyroid hormone|0|||
130656086|NCT00471237|470364236|FG000|Overall Study|Participant lost medication|0|||
130656087|NCT00471237|470364237|FG001|Overall Study|Participant lost medication|0|||
130656088|NCT00471237|470364238|FG002|Overall Study|Participant lost medication|0|||
130656089|NCT00471237|470364239|FG003|Overall Study|Participant lost medication|0|||
130656090|NCT00471237|470364240|FG004|Overall Study|Participant lost medication|1|||
130656091|NCT00471237|470364241|FG005|Overall Study|Participant lost medication|0|||
130656092|NCT00471237|470364242|FG006|Overall Study|Participant lost medication|0|||
130656093|NCT00471237|470364236|FG000|Overall Study|Administration of prohibited medicine|0|||
130656094|NCT00471237|470364237|FG001|Overall Study|Administration of prohibited medicine|0|||
130656095|NCT00471237|470364238|FG002|Overall Study|Administration of prohibited medicine|0|||
130323858|NCT04973449|469155620|FG001|Overall Study|Death|0|||
130656096|NCT00471237|470364239|FG003|Overall Study|Administration of prohibited medicine|0|||
130656097|NCT00471237|470364240|FG004|Overall Study|Administration of prohibited medicine|1|||
130656098|NCT00471237|470364241|FG005|Overall Study|Administration of prohibited medicine|0|||
130656099|NCT00471237|470364242|FG006|Overall Study|Administration of prohibited medicine|0|||
130656100|NCT00471237|470364236|FG000|Overall Study|Participant shifted residence|0|||
130656101|NCT00471237|470364237|FG001|Overall Study|Participant shifted residence|0|||
130656102|NCT00471237|470364238|FG002|Overall Study|Participant shifted residence|0|||
130656103|NCT00471237|470364239|FG003|Overall Study|Participant shifted residence|0|||
130656104|NCT00471237|470364240|FG004|Overall Study|Participant shifted residence|1|||
130656105|NCT00471237|470364241|FG005|Overall Study|Participant shifted residence|0|||
130656106|NCT00471237|470364242|FG006|Overall Study|Participant shifted residence|0|||
130656107|NCT00471237|470364236|FG000|Overall Study|Participant's decision|0|||
130656108|NCT00471237|470364237|FG001|Overall Study|Participant's decision|0|||
130656109|NCT00471237|470364238|FG002|Overall Study|Participant's decision|0|||
130656110|NCT00471237|470364239|FG003|Overall Study|Participant's decision|0|||
130656111|NCT00471237|470364240|FG004|Overall Study|Participant's decision|0|||
130656112|NCT00471237|470364241|FG005|Overall Study|Participant's decision|1|||
130656113|NCT00471237|470364242|FG006|Overall Study|Participant's decision|0|||
130656114|NCT01605370|470364243|FG000|Overall Study|Adverse Event|1|||
130656115|NCT01605370|470364244|FG001|Overall Study|Adverse Event|0|||
130656116|NCT00578448|470364245|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
130656117|NCT00578448|470364245|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
130656118|NCT00578448|470364245|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
130656119|NCT00578448|470364245|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
130656120|NCT01976104|470364246|FG000|Overall Study|Adverse Event|0|||
130656121|NCT01976104|470364247|FG001|Overall Study|Adverse Event|0|||
130656122|NCT01976104|470364248|FG002|Overall Study|Adverse Event|1|||
130656123|NCT01976104|470364249|FG003|Overall Study|Adverse Event|0|||
130656124|NCT01976104|470364246|FG000|Overall Study|Lost to Follow-up|3|||
130656125|NCT01976104|470364247|FG001|Overall Study|Lost to Follow-up|0|||
130656126|NCT01976104|470364248|FG002|Overall Study|Lost to Follow-up|1|||
130656127|NCT01976104|470364249|FG003|Overall Study|Lost to Follow-up|1|||
130656128|NCT01976104|470364246|FG000|Overall Study|Subject Choice|0|||
130656129|NCT01976104|470364247|FG001|Overall Study|Subject Choice|1|||
130656130|NCT01976104|470364248|FG002|Overall Study|Subject Choice|0|||
130656131|NCT01976104|470364249|FG003|Overall Study|Subject Choice|1|||
130656132|NCT01976104|470364246|FG000|Overall Study|Withdrawal by Subject|3|||
130656133|NCT01976104|470364247|FG001|Overall Study|Withdrawal by Subject|0|||
130656134|NCT01976104|470364248|FG002|Overall Study|Withdrawal by Subject|0|||
130656135|NCT01976104|470364249|FG003|Overall Study|Withdrawal by Subject|1|||
130656136|NCT01976104|470364246|FG000|Overall Study|Other|0|||
130656137|NCT01976104|470364247|FG001|Overall Study|Other|1|||
130656138|NCT01976104|470364248|FG002|Overall Study|Other|0|||
130656139|NCT01976104|470364249|FG003|Overall Study|Other|0|||
130656140|NCT01317199|470364250|FG000|Dose-escalation Phase 1|Physician Decision|5|||
130656141|NCT01317199|470364251|FG001|Dose-escalation Phase 1|Physician Decision|0|||
130656142|NCT01317199|470364252|FG002|Dose-escalation Phase 1|Physician Decision|0|||
130656143|NCT01317199|470364253|FG003|Dose-escalation Phase 1|Physician Decision|0|||
130656144|NCT01317199|470364250|FG000|Dose-escalation Phase 1|Disease progression|1|||
130656145|NCT01317199|470364251|FG001|Dose-escalation Phase 1|Disease progression|0|||
130656146|NCT01317199|470364252|FG002|Dose-escalation Phase 1|Disease progression|0|||
130656147|NCT01317199|470364253|FG003|Dose-escalation Phase 1|Disease progression|0|||
130656148|NCT01317199|470364250|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
130656149|NCT01317199|470364251|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130656150|NCT01317199|470364252|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130656151|NCT01317199|470364253|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130656152|NCT01317199|470364250|FG000|Randomized Phase 2|Disease progression|0|||
130656153|NCT01317199|470364251|FG001|Randomized Phase 2|Disease progression|3|||
130656154|NCT01317199|470364252|FG002|Randomized Phase 2|Disease progression|7|||
130656155|NCT01317199|470364253|FG003|Randomized Phase 2|Disease progression|5|||
130656156|NCT01317199|470364250|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
130656157|NCT01317199|470364251|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
130656158|NCT01317199|470364252|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
130656159|NCT01317199|470364253|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
130656160|NCT01317199|470364250|FG000|Randomized Phase 2|Adverse Event|0|||
130656161|NCT01317199|470364251|FG001|Randomized Phase 2|Adverse Event|0|||
130656162|NCT01317199|470364252|FG002|Randomized Phase 2|Adverse Event|0|||
130656163|NCT01317199|470364253|FG003|Randomized Phase 2|Adverse Event|1|||
130656164|NCT01317199|470364250|FG000|Randomized Phase 2|Comorbidities|0|||
130656165|NCT01317199|470364251|FG001|Randomized Phase 2|Comorbidities|2|||
130656166|NCT01317199|470364252|FG002|Randomized Phase 2|Comorbidities|2|||
130656167|NCT01317199|470364253|FG003|Randomized Phase 2|Comorbidities|2|||
130656168|NCT01317199|470364250|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
130656169|NCT01317199|470364251|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
130323859|NCT04973449|469155621|FG002|Overall Study|Death|0|||
130323860|NCT04973449|469155622|FG003|Overall Study|Death|0|||
130323861|NCT04973449|469155623|FG004|Overall Study|Death|0|||
130323862|NCT04973449|469155624|FG005|Overall Study|Death|1|||
130323863|NCT04973449|469155625|FG006|Overall Study|Death|0|||
130323864|NCT04973449|469155626|FG007|Overall Study|Death|0|||
130323865|NCT04973449|469155619|FG000|Overall Study|Other|1|||
130656170|NCT01317199|470364252|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
130656171|NCT01317199|470364253|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
130656172|NCT01317199|470364250|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
130656173|NCT01317199|470364251|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
130656174|NCT01317199|470364252|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
130656175|NCT01317199|470364253|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
130656176|NCT01317199|470364250|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
130656177|NCT01317199|470364251|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
130656178|NCT01317199|470364252|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
130656179|NCT01317199|470364253|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
130656180|NCT01317199|470364250|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
130656181|NCT01317199|470364251|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
130656182|NCT01317199|470364252|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
130656183|NCT01317199|470364253|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
130656184|NCT01353209|470364254|FG000|Overall Study|Adverse Event|1|||
130656185|NCT01353209|470364255|FG001|Overall Study|Adverse Event|1|||
130656186|NCT01301625|470364261|FG000|Overall Study|Death|5|||
130656187|NCT01301625|470364261|FG000|Overall Study|Not Due|21|||
130656188|NCT01301625|470364261|FG000|Overall Study|Expected|8|||
130656189|NCT01301625|470364261|FG000|Overall Study|Lost to Follow-up|1|||
130656190|NCT03237325|470364264|FG000|Overall Study|Lost to Follow-up|3|||
130656191|NCT03237325|470364265|FG001|Overall Study|Lost to Follow-up|5|||
130656192|NCT03237325|470364264|FG000|Overall Study|Physician Decision|2|||
130656193|NCT03237325|470364265|FG001|Overall Study|Physician Decision|4|||
130656194|NCT03237325|470364264|FG000|Overall Study|Withdrawal by Subject|9|||
130656195|NCT03237325|470364265|FG001|Overall Study|Withdrawal by Subject|12|||
130656196|NCT03237325|470364264|FG000|Overall Study|Noncompliance with Study Procedures|1|||
130656197|NCT03237325|470364265|FG001|Overall Study|Noncompliance with Study Procedures|1|||
130656198|NCT03237325|470364264|FG000|Overall Study|Termination by Sponsor|0|||
130656199|NCT03237325|470364265|FG001|Overall Study|Termination by Sponsor|1|||
130656200|NCT03237325|470364264|FG000|Overall Study|Reason other than described|0|||
130656201|NCT03237325|470364265|FG001|Overall Study|Reason other than described|2|||
130656202|NCT02684370|470364267|FG000|Part A|Adverse Event|2|||
130656203|NCT02684370|470364268|FG001|Part A|Adverse Event|0|||
130656204|NCT02684370|470364269|FG002|Part A|Adverse Event|1|||
130656205|NCT02684370|470364270|FG003|Part A|Adverse Event|0|||
130656206|NCT02684370|470364271|FG004|Part A|Adverse Event|0|||
130656207|NCT02684370|470364272|FG005|Part A|Adverse Event|0|||
130656208|NCT02684370|470364267|FG000|Part A|Lost to Follow-up|1|||
130656209|NCT02684370|470364268|FG001|Part A|Lost to Follow-up|1|||
130656210|NCT02684370|470364269|FG002|Part A|Lost to Follow-up|0|||
130656211|NCT02684370|470364270|FG003|Part A|Lost to Follow-up|0|||
130656212|NCT02684370|470364271|FG004|Part A|Lost to Follow-up|0|||
130656213|NCT02684370|470364272|FG005|Part A|Lost to Follow-up|0|||
130656214|NCT02684370|470364267|FG000|Part A|Subject Withdrawal|1|||
130656215|NCT02684370|470364268|FG001|Part A|Subject Withdrawal|0|||
130656216|NCT02684370|470364269|FG002|Part A|Subject Withdrawal|3|||
130656217|NCT02684370|470364270|FG003|Part A|Subject Withdrawal|0|||
130656218|NCT02684370|470364271|FG004|Part A|Subject Withdrawal|0|||
130656219|NCT02684370|470364272|FG005|Part A|Subject Withdrawal|0|||
130656220|NCT02684370|470364267|FG000|Part A|Other|0|||
130656221|NCT02684370|470364268|FG001|Part A|Other|0|||
130656222|NCT02684370|470364269|FG002|Part A|Other|1|||
130656223|NCT02684370|470364270|FG003|Part A|Other|0|||
130656224|NCT02684370|470364271|FG004|Part A|Other|0|||
130656225|NCT02684370|470364272|FG005|Part A|Other|0|||
130656226|NCT02684370|470364267|FG000|Part B|Adverse Event|0|||
130656227|NCT02684370|470364268|FG001|Part B|Adverse Event|0|||
130656228|NCT02684370|470364269|FG002|Part B|Adverse Event|0|||
130656229|NCT02684370|470364270|FG003|Part B|Adverse Event|0|||
130656230|NCT02684370|470364271|FG004|Part B|Adverse Event|2|||
130656231|NCT02684370|470364272|FG005|Part B|Adverse Event|1|||
130656232|NCT02684370|470364267|FG000|Part B|Lost to Follow-up|0|||
130656233|NCT02684370|470364268|FG001|Part B|Lost to Follow-up|0|||
130656234|NCT02684370|470364269|FG002|Part B|Lost to Follow-up|0|||
130323866|NCT04973449|469155620|FG001|Overall Study|Other|1|||
130323867|NCT04973449|469155621|FG002|Overall Study|Other|2|||
130656235|NCT02684370|470364270|FG003|Part B|Lost to Follow-up|1|||
130656236|NCT02684370|470364271|FG004|Part B|Lost to Follow-up|2|||
130656237|NCT02684370|470364272|FG005|Part B|Lost to Follow-up|5|||
130656238|NCT02684370|470364267|FG000|Part B|Subject Withdrawal|0|||
130656239|NCT02684370|470364268|FG001|Part B|Subject Withdrawal|0|||
130656240|NCT02684370|470364269|FG002|Part B|Subject Withdrawal|0|||
130656241|NCT02684370|470364270|FG003|Part B|Subject Withdrawal|1|||
130656242|NCT02684370|470364271|FG004|Part B|Subject Withdrawal|1|||
130656243|NCT02684370|470364272|FG005|Part B|Subject Withdrawal|2|||
130656244|NCT04221373|470364273|FG000|Overall Study|Physician Decision|4|||
130656245|NCT04221373|470364274|FG001|Overall Study|Physician Decision|0|||
130656246|NCT00138658|470364277|FG000|Overall Study|Adverse Event|23|||
130656247|NCT00138658|470364277|FG000|Overall Study|Death|1|||
130323868|NCT04973449|469155622|FG003|Overall Study|Other|1|||
130323869|NCT04973449|469155623|FG004|Overall Study|Other|4|||
130323870|NCT04973449|469155624|FG005|Overall Study|Other|0|||
130323871|NCT04973449|469155625|FG006|Overall Study|Other|2|||
130323872|NCT04973449|469155626|FG007|Overall Study|Other|2|||
130323873|NCT00521079|469155627|FG000|Overall Study|Adverse Event|7|||
130323874|NCT00521079|469155628|FG001|Overall Study|Adverse Event|1|||
130323875|NCT00521079|469155627|FG000|Overall Study|Lost to Follow-up|2|||
130323876|NCT00521079|469155628|FG001|Overall Study|Lost to Follow-up|1|||
130323877|NCT00521079|469155627|FG000|Overall Study|Withdrawal by Subject|5|||
130323878|NCT00521079|469155628|FG001|Overall Study|Withdrawal by Subject|3|||
130323879|NCT01506596|469155630|FG000|Overall Study|ineligible pathology|1|||
130323880|NCT00888173|469155631|FG000|Overall Study|Wrong Primary|1|||
130323881|NCT00888173|469155631|FG000|Overall Study|Ineligible: required test not done|1|||
130323882|NCT00651742|469155645|FG000|Overall Study|Objective Disease Progression|22|||
130323883|NCT00651742|469155645|FG000|Overall Study|Toxicity|3|||
130323884|NCT00651742|469155645|FG000|Overall Study|Investigator Judgment|1|||
130323885|NCT00651742|469155645|FG000|Overall Study|Withdrawal of Consent|1|||
130323886|NCT00651742|469155645|FG000|Overall Study|Enrolled but not treated|1|||
130323887|NCT04050553|469155646|FG000|Period 1|Physician Decision|2|||
130323888|NCT04050553|469155647|FG001|Period 1|Physician Decision|2|||
130323889|NCT04050553|469155646|FG000|Period 1|Adverse Event|1|||
130323890|NCT04050553|469155647|FG001|Period 1|Adverse Event|1|||
130323891|NCT04050553|469155646|FG000|Period 1|Withdrawal by Subject|0|||
130323892|NCT04050553|469155647|FG001|Period 1|Withdrawal by Subject|1|||
130323893|NCT04050553|469155646|FG000|Wash-out|Adverse Event|0|||
130323894|NCT04050553|469155647|FG001|Wash-out|Adverse Event|1|||
130323895|NCT04050553|469155646|FG000|Wash-out|Withdrawal by Subject|0|||
130323896|NCT04050553|469155647|FG001|Wash-out|Withdrawal by Subject|1|||
130323897|NCT02638220|469155648|FG000|Overall Study|Lost to Follow-up|6|||
130323898|NCT02638220|469155648|FG000|Overall Study|Withdrawal by Subject|3|||
130323899|NCT02638220|469155648|FG000|Overall Study|Physician Decision|1|||
130323900|NCT02638220|469155648|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
130323901|NCT04323124|469155653|FG000|Overall Study|Adverse Event|0|||
130323902|NCT04323124|469155654|FG001|Overall Study|Adverse Event|0|||
130323903|NCT04323124|469155655|FG002|Overall Study|Adverse Event|0|||
130323904|NCT04323124|469155656|FG003|Overall Study|Adverse Event|0|||
130323905|NCT04323124|469155657|FG004|Overall Study|Adverse Event|0|||
130323906|NCT04323124|469155658|FG005|Overall Study|Adverse Event|1|||
130323907|NCT04323124|469155659|FG006|Overall Study|Adverse Event|0|||
130323908|NCT04323124|469155660|FG007|Overall Study|Adverse Event|1|||
130323909|NCT04323124|469155661|FG008|Overall Study|Adverse Event|1|||
130323910|NCT04323124|469155662|FG009|Overall Study|Adverse Event|0|||
130323911|NCT04323124|469155663|FG010|Overall Study|Adverse Event|0|||
130323912|NCT04323124|469155664|FG011|Overall Study|Adverse Event|0|||
130323913|NCT04323124|469155665|FG012|Overall Study|Adverse Event|0|||
130323914|NCT04323124|469155666|FG013|Overall Study|Adverse Event|0|||
130323915|NCT04323124|469155667|FG014|Overall Study|Adverse Event|0|||
130323916|NCT04323124|469155653|FG000|Overall Study|Other|0|||
130323917|NCT04323124|469155654|FG001|Overall Study|Other|0|||
130323918|NCT04323124|469155655|FG002|Overall Study|Other|0|||
130323919|NCT04323124|469155656|FG003|Overall Study|Other|0|||
130656248|NCT00138658|470364277|FG000|Overall Study|Disease Progression|21|||
130656249|NCT00138658|470364277|FG000|Overall Study|Physician Decision|11|||
130656250|NCT00138658|470364277|FG000|Overall Study|Withdrawal by Subject|5|||
130323920|NCT04323124|469155657|FG004|Overall Study|Other|1|||
130323921|NCT04323124|469155658|FG005|Overall Study|Other|0|||
130323922|NCT04323124|469155659|FG006|Overall Study|Other|0|||
130323923|NCT04323124|469155660|FG007|Overall Study|Other|0|||
130323924|NCT04323124|469155661|FG008|Overall Study|Other|1|||
130323925|NCT04323124|469155662|FG009|Overall Study|Other|0|||
130323926|NCT04323124|469155663|FG010|Overall Study|Other|0|||
130656251|NCT03733301|470364280|FG000|Overall Study|Screen Fail|1|||
130656252|NCT03733301|470364281|FG001|Overall Study|Screen Fail|0|||
130656253|NCT03733301|470364282|FG002|Overall Study|Screen Fail|0|||
130323927|NCT04323124|469155664|FG011|Overall Study|Other|0|||
130656254|NCT03733301|470364280|FG000|Overall Study|Non-compliance|1|||
130323928|NCT04323124|469155665|FG012|Overall Study|Other|0|||
130323929|NCT04323124|469155666|FG013|Overall Study|Other|0|||
130323930|NCT04323124|469155667|FG014|Overall Study|Other|0|||
130323931|NCT04323124|469155653|FG000|Overall Study|Coming from a red zone (COVID)|0|||
130323932|NCT04323124|469155654|FG001|Overall Study|Coming from a red zone (COVID)|0|||
130323933|NCT04323124|469155655|FG002|Overall Study|Coming from a red zone (COVID)|0|||
130323934|NCT04323124|469155656|FG003|Overall Study|Coming from a red zone (COVID)|0|||
130656255|NCT03733301|470364281|FG001|Overall Study|Non-compliance|0|||
130656256|NCT03733301|470364282|FG002|Overall Study|Non-compliance|0|||
130656257|NCT03733301|470364280|FG000|Overall Study|Lack of Efficacy|2|||
130656258|NCT03733301|470364281|FG001|Overall Study|Lack of Efficacy|3|||
130656259|NCT03733301|470364282|FG002|Overall Study|Lack of Efficacy|0|||
130656260|NCT03733301|470364280|FG000|Overall Study|Adverse Event|0|||
130656261|NCT03733301|470364281|FG001|Overall Study|Adverse Event|1|||
130656262|NCT03733301|470364282|FG002|Overall Study|Adverse Event|3|||
130656263|NCT03733301|470364280|FG000|Overall Study|Withdrawal by Subject|3|||
130656264|NCT03733301|470364281|FG001|Overall Study|Withdrawal by Subject|5|||
130656265|NCT03733301|470364282|FG002|Overall Study|Withdrawal by Subject|1|||
130656266|NCT00337727|470364285|FG000|Overall Study|Adverse Event|5|||
130656267|NCT00337727|470364286|FG001|Overall Study|Adverse Event|3|||
130656268|NCT00337727|470364285|FG000|Overall Study|Lost to Follow-up|5|||
130656269|NCT00337727|470364286|FG001|Overall Study|Lost to Follow-up|4|||
130656270|NCT00337727|470364285|FG000|Overall Study|Physician Decision|1|||
130656271|NCT00337727|470364286|FG001|Overall Study|Physician Decision|0|||
130656272|NCT00337727|470364285|FG000|Overall Study|Protocol Violation|4|||
130656273|NCT00337727|470364286|FG001|Overall Study|Protocol Violation|0|||
130656274|NCT00337727|470364285|FG000|Overall Study|Withdrawal by Subject|3|||
130656275|NCT00337727|470364286|FG001|Overall Study|Withdrawal by Subject|5|||
130656276|NCT00320801|470364287|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
130656277|NCT00320801|470364288|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130656278|NCT00320801|470364289|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130656279|NCT00320801|470364290|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
130656280|NCT00320801|470364287|FG000|Open-label Run-in Period|Adverse Event|33|||
130656281|NCT00320801|470364288|FG001|Open-label Run-in Period|Adverse Event|0|||
130656282|NCT00320801|470364289|FG002|Open-label Run-in Period|Adverse Event|0|||
130656283|NCT00320801|470364290|FG003|Open-label Run-in Period|Adverse Event|0|||
130656284|NCT00320801|470364287|FG000|Open-label Run-in Period|Administrative|10|||
130656285|NCT00320801|470364288|FG001|Open-label Run-in Period|Administrative|0|||
130656286|NCT00320801|470364289|FG002|Open-label Run-in Period|Administrative|0|||
130656287|NCT00320801|470364290|FG003|Open-label Run-in Period|Administrative|0|||
130656288|NCT00320801|470364287|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
130656289|NCT00320801|470364288|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130656290|NCT00320801|470364289|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130656291|NCT00320801|470364290|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
130656292|NCT00320801|470364287|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
130656293|NCT00320801|470364288|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130656294|NCT00320801|470364289|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130656295|NCT00320801|470364290|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
130656296|NCT00320801|470364287|FG000|Open-label Run-in Period|Did not qualify|1|||
130656297|NCT00320801|470364288|FG001|Open-label Run-in Period|Did not qualify|0|||
130656298|NCT00320801|470364289|FG002|Open-label Run-in Period|Did not qualify|0|||
130656299|NCT00320801|470364290|FG003|Open-label Run-in Period|Did not qualify|0|||
130656300|NCT00320801|470364287|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130656301|NCT00320801|470364288|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130656302|NCT00320801|470364289|FG002|Double-blind Phase|Withdrawal by Subject|1|||
130656303|NCT00320801|470364290|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130656304|NCT00320801|470364287|FG000|Double-blind Phase|Adverse Event|0|||
130656305|NCT00320801|470364288|FG001|Double-blind Phase|Adverse Event|2|||
130656306|NCT00320801|470364289|FG002|Double-blind Phase|Adverse Event|8|||
130656307|NCT00320801|470364290|FG003|Double-blind Phase|Adverse Event|0|||
130656308|NCT00320801|470364287|FG000|Double-blind Phase|Administrative|0|||
130656309|NCT00320801|470364288|FG001|Double-blind Phase|Administrative|0|||
130656310|NCT00320801|470364289|FG002|Double-blind Phase|Administrative|4|||
130656311|NCT00320801|470364290|FG003|Double-blind Phase|Administrative|0|||
130656312|NCT00320801|470364287|FG000|Double-blind Phase|Lack of Efficacy|0|||
130656313|NCT00320801|470364288|FG001|Double-blind Phase|Lack of Efficacy|9|||
130656314|NCT00320801|470364289|FG002|Double-blind Phase|Lack of Efficacy|1|||
130656315|NCT00320801|470364290|FG003|Double-blind Phase|Lack of Efficacy|0|||
130656316|NCT00320801|470364287|FG000|Extension Phase|Withdrawal by Subject|0|||
130656317|NCT00320801|470364288|FG001|Extension Phase|Withdrawal by Subject|0|||
130656318|NCT00320801|470364289|FG002|Extension Phase|Withdrawal by Subject|0|||
130656319|NCT00320801|470364290|FG003|Extension Phase|Withdrawal by Subject|6|||
130656320|NCT00320801|470364287|FG000|Extension Phase|Adverse Event|0|||
130656321|NCT00320801|470364288|FG001|Extension Phase|Adverse Event|0|||
130656322|NCT00320801|470364289|FG002|Extension Phase|Adverse Event|0|||
130656323|NCT00320801|470364290|FG003|Extension Phase|Adverse Event|8|||
130656324|NCT00320801|470364287|FG000|Extension Phase|Administrative|0|||
130656325|NCT00320801|470364288|FG001|Extension Phase|Administrative|0|||
130656326|NCT00320801|470364289|FG002|Extension Phase|Administrative|0|||
130656327|NCT00320801|470364290|FG003|Extension Phase|Administrative|29|||
130656328|NCT00320801|470364287|FG000|Extension Phase|Lack of Efficacy|0|||
130656329|NCT00320801|470364288|FG001|Extension Phase|Lack of Efficacy|0|||
130656330|NCT00320801|470364289|FG002|Extension Phase|Lack of Efficacy|0|||
130656331|NCT00320801|470364290|FG003|Extension Phase|Lack of Efficacy|2|||
130656332|NCT00320801|470364287|FG000|Extension Phase|Lost to Follow-up|0|||
130656333|NCT00320801|470364288|FG001|Extension Phase|Lost to Follow-up|0|||
130656334|NCT00320801|470364289|FG002|Extension Phase|Lost to Follow-up|0|||
130656335|NCT00320801|470364290|FG003|Extension Phase|Lost to Follow-up|3|||
130656336|NCT00577031|470364291|FG000|Overall Study|Adverse Event|52|||
130656337|NCT00577031|470364291|FG000|Overall Study|Progression of disease|93|||
130656338|NCT00577031|470364291|FG000|Overall Study|Protocol Violation|5|||
130656339|NCT00577031|470364291|FG000|Overall Study|Participant withdrew consent|13|||
130656340|NCT00577031|470364291|FG000|Overall Study|Participant non-compliance|5|||
130656341|NCT00577031|470364291|FG000|Overall Study|Need for surgery|17|||
130656342|NCT00577031|470364291|FG000|Overall Study|Medical decision|14|||
130656343|NCT00577031|470364291|FG000|Overall Study|Death|6|||
130656344|NCT06067191|470364292|FG000|Overall Study|Withdrawal by Subject|0|||
130656345|NCT06067191|470364293|FG001|Overall Study|Withdrawal by Subject|1|||
130656346|NCT04764669|470364295|FG000|Overall Study|Adverse Event|1|||
130656347|NCT04764669|470364296|FG001|Overall Study|Adverse Event|0|||
130656348|NCT04764669|470364297|FG002|Overall Study|Adverse Event|1|||
130656349|NCT04764669|470364298|FG003|Overall Study|Adverse Event|0|||
130656350|NCT04764669|470364295|FG000|Overall Study|Subject Choice|0|||
130656351|NCT04764669|470364296|FG001|Overall Study|Subject Choice|0|||
130656352|NCT04764669|470364297|FG002|Overall Study|Subject Choice|1|||
130656353|NCT04764669|470364298|FG003|Overall Study|Subject Choice|0|||
130656354|NCT04764669|470364295|FG000|Overall Study|Withdrawal by Subject|2|||
130656355|NCT04764669|470364296|FG001|Overall Study|Withdrawal by Subject|0|||
130656356|NCT04764669|470364297|FG002|Overall Study|Withdrawal by Subject|0|||
130656357|NCT04764669|470364298|FG003|Overall Study|Withdrawal by Subject|0|||
130656358|NCT00807040|470364299|FG000|Overall Study|Death|24|||
130656359|NCT00807040|470364300|FG001|Overall Study|Death|29|||
130656360|NCT00807040|470364299|FG000|Overall Study|Withdrawal by Subject|8|||
130656361|NCT00807040|470364300|FG001|Overall Study|Withdrawal by Subject|6|||
130656362|NCT00807040|470364299|FG000|Overall Study|Lost to Follow-up|4|||
130656363|NCT00807040|470364300|FG001|Overall Study|Lost to Follow-up|6|||
130656364|NCT00625846|470364301|FG000|Overall Study|Withdrawal by Subject|2|||
130656365|NCT00625846|470364302|FG001|Overall Study|Withdrawal by Subject|0|||
130656366|NCT00625846|470364303|FG002|Overall Study|Withdrawal by Subject|1|||
130656367|NCT00625846|470364304|FG003|Overall Study|Withdrawal by Subject|2|||
130656368|NCT01067339|470364311|FG000|Overall Study|Withdrawal by Subject|6|||
130656369|NCT01067339|470364312|FG001|Overall Study|Withdrawal by Subject|5|||
130656370|NCT00890409|470364313|FG000|Overall Study|Lost to Follow-up|20|||
130656371|NCT00890409|470364314|FG001|Overall Study|Lost to Follow-up|21|||
130656372|NCT00769132|470364316|FG000|Period 1|Adverse Event|1|||
130656373|NCT00769132|470364317|FG001|Period 1|Adverse Event|0|||
130656374|NCT00769132|470364318|FG002|Period 1|Adverse Event|0|||
130656375|NCT00769132|470364319|FG003|Period 1|Adverse Event|1|||
130656376|NCT00769132|470364316|FG000|Period 2|Withdrawal by Subject|0|||
130656377|NCT00769132|470364317|FG001|Period 2|Withdrawal by Subject|0|||
130656378|NCT00769132|470364318|FG002|Period 2|Withdrawal by Subject|0|||
130656379|NCT00769132|470364319|FG003|Period 2|Withdrawal by Subject|1|||
130656380|NCT00769132|470364316|FG000|Period 3|Withdrawal by Subject|1|||
130656381|NCT00769132|470364317|FG001|Period 3|Withdrawal by Subject|0|||
130656382|NCT00769132|470364318|FG002|Period 3|Withdrawal by Subject|0|||
130656383|NCT00769132|470364319|FG003|Period 3|Withdrawal by Subject|0|||
130656384|NCT00769132|470364316|FG000|Period 4|Withdrawal by Subject|0|||
130656385|NCT00769132|470364317|FG001|Period 4|Withdrawal by Subject|1|||
130656386|NCT00769132|470364318|FG002|Period 4|Withdrawal by Subject|0|||
130656387|NCT00769132|470364319|FG003|Period 4|Withdrawal by Subject|0|||
130656388|NCT00557830|470364323|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
130656389|NCT00557830|470364324|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
130656390|NCT00557830|470364325|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
130656391|NCT00557830|470364323|FG000|Screening Treatment Phase|Adverse Event|2|||
130656392|NCT00557830|470364324|FG001|Screening Treatment Phase|Adverse Event|0|||
130656393|NCT00557830|470364325|FG002|Screening Treatment Phase|Adverse Event|0|||
130656394|NCT00557830|470364323|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
130656395|NCT00557830|470364324|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
130656396|NCT00557830|470364325|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
130656397|NCT00538473|470364326|FG000|Overall Study|Adverse Event|1|||
130656398|NCT00538473|470364327|FG001|Overall Study|Adverse Event|0|||
130656399|NCT01833897|470364328|FG000|Overall Study|Lack of Efficacy|1|||
130656400|NCT00127192|470364329|FG000|Overall Study|Adverse Event|0|||
130656401|NCT00127192|470364330|FG001|Overall Study|Adverse Event|1|||
130656402|NCT00127192|470364331|FG002|Overall Study|Adverse Event|1|||
130656403|NCT00127192|470364332|FG003|Overall Study|Adverse Event|1|||
130656404|NCT00127192|470364333|FG004|Overall Study|Adverse Event|0|||
130656405|NCT00127192|470364329|FG000|Overall Study|Lack of Efficacy|2|||
130656406|NCT00127192|470364330|FG001|Overall Study|Lack of Efficacy|0|||
130656407|NCT00127192|470364331|FG002|Overall Study|Lack of Efficacy|0|||
130656408|NCT00127192|470364332|FG003|Overall Study|Lack of Efficacy|0|||
130656409|NCT00127192|470364333|FG004|Overall Study|Lack of Efficacy|2|||
130656410|NCT00127192|470364329|FG000|Overall Study|Withdrawal by Subject|0|||
130656411|NCT00127192|470364330|FG001|Overall Study|Withdrawal by Subject|0|||
130656412|NCT00127192|470364331|FG002|Overall Study|Withdrawal by Subject|1|||
130323935|NCT04323124|469155657|FG004|Overall Study|Coming from a red zone (COVID)|1|||
130323936|NCT04323124|469155658|FG005|Overall Study|Coming from a red zone (COVID)|1|||
130323937|NCT04323124|469155659|FG006|Overall Study|Coming from a red zone (COVID)|0|||
130323938|NCT04323124|469155660|FG007|Overall Study|Coming from a red zone (COVID)|0|||
130323939|NCT04323124|469155661|FG008|Overall Study|Coming from a red zone (COVID)|0|||
130323940|NCT04323124|469155662|FG009|Overall Study|Coming from a red zone (COVID)|0|||
130323941|NCT04323124|469155663|FG010|Overall Study|Coming from a red zone (COVID)|0|||
130323942|NCT04323124|469155664|FG011|Overall Study|Coming from a red zone (COVID)|0|||
130656413|NCT00127192|470364332|FG003|Overall Study|Withdrawal by Subject|0|||
130656414|NCT00127192|470364333|FG004|Overall Study|Withdrawal by Subject|3|||
130656415|NCT00127192|470364329|FG000|Overall Study|Adverse event in pre-treatment period|1|||
130656416|NCT00127192|470364330|FG001|Overall Study|Adverse event in pre-treatment period|0|||
130656417|NCT00127192|470364331|FG002|Overall Study|Adverse event in pre-treatment period|0|||
130656418|NCT00127192|470364332|FG003|Overall Study|Adverse event in pre-treatment period|0|||
130656419|NCT00127192|470364333|FG004|Overall Study|Adverse event in pre-treatment period|0|||
130656420|NCT00077766|470364334|FG000|Overall Study|Adverse Event|1|||
130656421|NCT00077766|470364335|FG001|Overall Study|Adverse Event|1|||
130656422|NCT00077766|470364334|FG000|Overall Study|Withdrawal by Subject|4|||
130656423|NCT00077766|470364335|FG001|Overall Study|Withdrawal by Subject|3|||
130656424|NCT00077766|470364334|FG000|Overall Study|Death|12|||
130656425|NCT00077766|470364335|FG001|Overall Study|Death|10|||
130656426|NCT00077766|470364334|FG000|Overall Study|Lost to Follow-up|2|||
130656427|NCT00077766|470364335|FG001|Overall Study|Lost to Follow-up|0|||
130656428|NCT00077766|470364334|FG000|Overall Study|Protocol Violation|1|||
130656429|NCT00077766|470364335|FG001|Overall Study|Protocol Violation|0|||
130656430|NCT00077766|470364334|FG000|Overall Study|Kidney Transplantation|9|||
130656431|NCT00077766|470364335|FG001|Overall Study|Kidney Transplantation|5|||
130656432|NCT00077766|470364334|FG000|Overall Study|Transplantation|5|||
130656433|NCT00077766|470364335|FG001|Overall Study|Transplantation|1|||
130656434|NCT00077766|470364334|FG000|Overall Study|Investigators Discretion|1|||
130656435|NCT00077766|470364335|FG001|Overall Study|Investigators Discretion|0|||
130656436|NCT00077766|470364334|FG000|Overall Study|Participant's decision|1|||
130656437|NCT00077766|470364335|FG001|Overall Study|Participant's decision|0|||
130656438|NCT00077766|470364334|FG000|Overall Study|Dialysis Discontinued|1|||
130656439|NCT00077766|470364335|FG001|Overall Study|Dialysis Discontinued|0|||
130656440|NCT00077766|470364334|FG000|Overall Study|Dialysis|0|||
130656441|NCT00077766|470364335|FG001|Overall Study|Dialysis|1|||
130656442|NCT00077766|470364334|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
130656443|NCT00077766|470364335|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
130656444|NCT00077766|470364334|FG000|Overall Study|Started Nocturnal Dialysis|0|||
130656445|NCT00077766|470364335|FG001|Overall Study|Started Nocturnal Dialysis|1|||
130656446|NCT00077766|470364334|FG000|Overall Study|Stop Dialysis|0|||
130656447|NCT00077766|470364335|FG001|Overall Study|Stop Dialysis|1|||
130656448|NCT00077766|470364334|FG000|Overall Study|Participants Vacation|2|||
130656449|NCT00077766|470364335|FG001|Overall Study|Participants Vacation|1|||
130656450|NCT01886105|470364336|FG000|Overall Study|Lack of Efficacy|3|||
130656451|NCT03843775|470364337|FG000|Overall Study|Adverse Event|1|||
130656452|NCT03843775|470364338|FG001|Overall Study|Adverse Event|1|||
130656453|NCT03843775|470364337|FG000|Overall Study|Lack of Efficacy|2|||
130656454|NCT03843775|470364338|FG001|Overall Study|Lack of Efficacy|6|||
130656455|NCT03843775|470364337|FG000|Overall Study|Withdrawal by Subject|0|||
130656456|NCT03843775|470364338|FG001|Overall Study|Withdrawal by Subject|1|||
130656457|NCT04150107|470364341|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
130656458|NCT04150107|470364342|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
130656459|NCT04150107|470364341|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
130656460|NCT04150107|470364342|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
130656461|NCT02184988|470364347|FG000|Overall Study|Pregnancy|2|||
130656462|NCT02184988|470364347|FG000|Overall Study|Adverse Event|2|||
130656463|NCT02184988|470364347|FG000|Overall Study|moving away/travelling/unable to complet|6|||
130323943|NCT04323124|469155665|FG012|Overall Study|Coming from a red zone (COVID)|0|||
130323944|NCT04323124|469155666|FG013|Overall Study|Coming from a red zone (COVID)|0|||
130323945|NCT04323124|469155667|FG014|Overall Study|Coming from a red zone (COVID)|0|||
130656464|NCT02184988|470364347|FG000|Overall Study|work scheduling issues|4|||
130656465|NCT02184988|470364347|FG000|Overall Study|various other reasons|9|||
130323946|NCT04323124|469155653|FG000|Overall Study|No longer meets eligibility criteria|0|||
130656466|NCT02184988|470364347|FG000|Overall Study|Lost to Follow-up|32|||
130323947|NCT04323124|469155654|FG001|Overall Study|No longer meets eligibility criteria|0|||
130656467|NCT03188991|470364348|FG000|Overall Study|Withdrawal by Subject|0|||
130656468|NCT03188991|470364349|FG001|Overall Study|Withdrawal by Subject|0|||
130656469|NCT03188991|470364350|FG002|Overall Study|Withdrawal by Subject|0|||
130656470|NCT03188991|470364351|FG003|Overall Study|Withdrawal by Subject|1|||
130656471|NCT01319994|470365731|FG000|Overall Study|Protocol Violation|7|||
130656472|NCT01319994|470365732|FG001|Overall Study|Protocol Violation|6|||
130656473|NCT01340794|470365733|FG000|Overall Study|Withdrawal by Subject|0|||
130656474|NCT01340794|470365734|FG001|Overall Study|Withdrawal by Subject|1|||
130656475|NCT01035229|470365742|FG000|Overall Study|Adverse Event|61|||
130656476|NCT01035229|470365743|FG001|Overall Study|Adverse Event|14|||
130656477|NCT01035229|470365742|FG000|Overall Study|Withdrawal by Subject|20|||
130656478|NCT01035229|470365743|FG001|Overall Study|Withdrawal by Subject|7|||
130656479|NCT01035229|470365742|FG000|Overall Study|Lost to Follow-up|1|||
130656480|NCT01035229|470365743|FG001|Overall Study|Lost to Follow-up|0|||
130656481|NCT01035229|470365742|FG000|Overall Study|Administrative problems|1|||
130656482|NCT01035229|470365743|FG001|Overall Study|Administrative problems|1|||
130656483|NCT01035229|470365742|FG000|Overall Study|Death|13|||
130656484|NCT01035229|470365743|FG001|Overall Study|Death|5|||
130656485|NCT01035229|470365742|FG000|Overall Study|New cancer therapy|2|||
130656486|NCT01035229|470365743|FG001|Overall Study|New cancer therapy|0|||
130656487|NCT01035229|470365742|FG000|Overall Study|Protocol Violation|0|||
130656488|NCT01035229|470365743|FG001|Overall Study|Protocol Violation|2|||
130656489|NCT01035229|470365742|FG000|Overall Study|Sponsor's decision to end study|3|||
130656490|NCT01035229|470365743|FG001|Overall Study|Sponsor's decision to end study|3|||
130656491|NCT01035229|470365742|FG000|Overall Study|Disease Progression|261|||
130656492|NCT01035229|470365743|FG001|Overall Study|Disease Progression|152|||
130656493|NCT03256526|470365747|FG000|Overall Study|Adverse Event|1|||
130656494|NCT03256526|470365748|FG001|Overall Study|Adverse Event|0|||
130656495|NCT03256526|470365749|FG002|Overall Study|Adverse Event|1|||
130656496|NCT03256526|470365747|FG000|Overall Study|Lost to Follow-up|1|||
130656497|NCT03256526|470365748|FG001|Overall Study|Lost to Follow-up|0|||
130656498|NCT03256526|470365749|FG002|Overall Study|Lost to Follow-up|2|||
130656499|NCT02875340|470365750|FG000|Overall Study|Death|2|||
130656500|NCT02875340|470365750|FG000|Overall Study|Withdrawal by Subject|2|||
130656501|NCT02875340|470365750|FG000|Overall Study|Physician Decision|3|||
130656502|NCT02875340|470365750|FG000|Overall Study|Adverse Event|1|||
130656503|NCT01160770|470365751|FG000|Overall Study|Adverse Event|10|||
130656504|NCT01160770|470365751|FG000|Overall Study|Protocol Violation|2|||
130656505|NCT01160770|470365751|FG000|Overall Study|Subject/parent/caregiver request|33|||
130656506|NCT01160770|470365751|FG000|Overall Study|Physician Decision|1|||
130656507|NCT01160770|470365751|FG000|Overall Study|Lost to Follow-up|7|||
130656508|NCT01160770|470365751|FG000|Overall Study|Study termination or sponsor request|1|||
130656509|NCT01160770|470365751|FG000|Overall Study|Death|9|||
130656510|NCT01160770|470365751|FG000|Overall Study|Lack of Efficacy|15|||
130656511|NCT01160770|470365751|FG000|Overall Study|Other Reasons|1|||
130656512|NCT03457727|470365752|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130656513|NCT03457727|470365753|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130656514|NCT03457727|470365754|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130656515|NCT03457727|470365755|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
130656516|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
130656517|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130656518|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130656519|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130656520|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
130656521|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
130656522|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
130656523|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
130656524|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
130656525|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130656526|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130656527|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130656528|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
130656529|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
130656530|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
130656531|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
130656532|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
130656533|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130656534|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130656535|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130656536|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
130656537|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
130656538|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
130656539|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
130656540|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
130656541|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130656542|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130656543|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130656544|NCT01299272|470365761|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
130656545|NCT01299272|470365762|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
130656546|NCT01299272|470365763|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
130656547|NCT01299272|470365764|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
130323948|NCT04323124|469155655|FG002|Overall Study|No longer meets eligibility criteria|0|||
130323949|NCT04323124|469155656|FG003|Overall Study|No longer meets eligibility criteria|0|||
130323950|NCT04323124|469155657|FG004|Overall Study|No longer meets eligibility criteria|0|||
130323951|NCT04323124|469155658|FG005|Overall Study|No longer meets eligibility criteria|0|||
130323952|NCT04323124|469155659|FG006|Overall Study|No longer meets eligibility criteria|0|||
130656548|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130656549|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
130323953|NCT04323124|469155660|FG007|Overall Study|No longer meets eligibility criteria|1|||
130323954|NCT04323124|469155661|FG008|Overall Study|No longer meets eligibility criteria|0|||
130323955|NCT04323124|469155662|FG009|Overall Study|No longer meets eligibility criteria|0|||
130323956|NCT04323124|469155663|FG010|Overall Study|No longer meets eligibility criteria|0|||
130323957|NCT04323124|469155664|FG011|Overall Study|No longer meets eligibility criteria|0|||
130323958|NCT04323124|469155665|FG012|Overall Study|No longer meets eligibility criteria|0|||
130323959|NCT04323124|469155666|FG013|Overall Study|No longer meets eligibility criteria|1|||
130323960|NCT04323124|469155667|FG014|Overall Study|No longer meets eligibility criteria|1|||
130323961|NCT04323124|469155653|FG000|Overall Study|Study terminated by sponsor|0|||
130323962|NCT04323124|469155654|FG001|Overall Study|Study terminated by sponsor|0|||
130323963|NCT04323124|469155655|FG002|Overall Study|Study terminated by sponsor|0|||
130323964|NCT04323124|469155656|FG003|Overall Study|Study terminated by sponsor|0|||
130323965|NCT04323124|469155657|FG004|Overall Study|Study terminated by sponsor|0|||
130323966|NCT04323124|469155658|FG005|Overall Study|Study terminated by sponsor|0|||
130323967|NCT04323124|469155659|FG006|Overall Study|Study terminated by sponsor|0|||
130323968|NCT04323124|469155660|FG007|Overall Study|Study terminated by sponsor|0|||
130323969|NCT04323124|469155661|FG008|Overall Study|Study terminated by sponsor|0|||
130323970|NCT04323124|469155662|FG009|Overall Study|Study terminated by sponsor|0|||
130323971|NCT04323124|469155663|FG010|Overall Study|Study terminated by sponsor|0|||
130323972|NCT04323124|469155664|FG011|Overall Study|Study terminated by sponsor|2|||
130323973|NCT04323124|469155665|FG012|Overall Study|Study terminated by sponsor|1|||
130323974|NCT04323124|469155666|FG013|Overall Study|Study terminated by sponsor|0|||
130323975|NCT04323124|469155667|FG014|Overall Study|Study terminated by sponsor|0|||
130323976|NCT00489307|469155668|FG000|Overall Study|Death|1|||
130323977|NCT00489307|469155669|FG001|Overall Study|Death|1|||
130323978|NCT00489307|469155668|FG000|Overall Study|Lost to Follow-up|2|||
130323979|NCT00489307|469155669|FG001|Overall Study|Lost to Follow-up|2|||
130323980|NCT00489307|469155668|FG000|Overall Study|Physician Decision|1|||
130323981|NCT00489307|469155669|FG001|Overall Study|Physician Decision|0|||
130323982|NCT00489307|469155668|FG000|Overall Study|Withdrawal by Subject|2|||
130323983|NCT00489307|469155669|FG001|Overall Study|Withdrawal by Subject|4|||
130323984|NCT00489307|469155668|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
130323985|NCT00489307|469155669|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
130323986|NCT00489307|469155668|FG000|Overall Study|Surgery after assignment|1|||
130323987|NCT00489307|469155669|FG001|Overall Study|Surgery after assignment|0|||
130323988|NCT00489307|469155668|FG000|Overall Study|Did not fill up the forms|2|||
130323989|NCT00489307|469155669|FG001|Overall Study|Did not fill up the forms|1|||
130323990|NCT00489307|469155668|FG000|Overall Study|Patient or family refusal|5|||
130323991|NCT00489307|469155669|FG001|Overall Study|Patient or family refusal|9|||
130323992|NCT03204188|469155672|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
130323993|NCT03204188|469155672|FG000|Immunotherapy Phase (1 Year)|Death|1|||
130323994|NCT03204188|469155672|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
130323995|NCT03204188|469155672|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
130323996|NCT01520506|469156991|FG000|Overall Study|Missed Visit|4|||
130323997|NCT01520506|469156991|FG000|Overall Study|Lost to Follow-up|1|||
130323998|NCT01520506|469156991|FG000|Overall Study|Withdrawal by Subject|1|||
130323999|NCT00425269|469156992|FG000|Overall Study|Pregnancy|5|||
130324000|NCT00425269|469156993|FG001|Overall Study|Pregnancy|7|||
130324001|NCT00425269|469156992|FG000|Overall Study|Lost to Follow-up|9|||
130324002|NCT00425269|469156993|FG001|Overall Study|Lost to Follow-up|9|||
130324003|NCT00425269|469156992|FG000|Overall Study|moved or medical reason|5|||
130324004|NCT00425269|469156993|FG001|Overall Study|moved or medical reason|4|||
130324005|NCT01084655|469156998|FG000|Overall Study|Radiographic disease progression|3|||
130324006|NCT01084655|469156999|FG001|Overall Study|Radiographic disease progression|2|||
130324007|NCT01084655|469157000|FG002|Overall Study|Radiographic disease progression|8|||
130324008|NCT01084655|469156998|FG000|Overall Study|Withdrawal by Subject|1|||
130656550|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130324009|NCT01084655|469156999|FG001|Overall Study|Withdrawal by Subject|0|||
130324010|NCT01084655|469157000|FG002|Overall Study|Withdrawal by Subject|4|||
130324011|NCT01084655|469156998|FG000|Overall Study|Adverse Event|2|||
130324012|NCT01084655|469156999|FG001|Overall Study|Adverse Event|1|||
130324013|NCT01084655|469157000|FG002|Overall Study|Adverse Event|2|||
130324014|NCT01084655|469156998|FG000|Overall Study|Other|0|||
130324015|NCT01084655|469156999|FG001|Overall Study|Other|3|||
130656551|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130324016|NCT01084655|469157000|FG002|Overall Study|Other|2|||
130324017|NCT01084655|469156998|FG000|Overall Study|Symptomatic deterioration|0|||
130324018|NCT01084655|469156999|FG001|Overall Study|Symptomatic deterioration|0|||
130324019|NCT01084655|469157000|FG002|Overall Study|Symptomatic deterioration|2|||
130324020|NCT01084655|469156998|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130324021|NCT01084655|469156999|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130324022|NCT01084655|469157000|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
130324023|NCT00535496|469157001|FG000|Overall Study|Lost to Follow-up|0|||
130324024|NCT00535496|469157002|FG001|Overall Study|Lost to Follow-up|1|||
130324025|NCT00535496|469157003|FG002|Overall Study|Lost to Follow-up|0|||
130324026|NCT00535496|469157004|FG003|Overall Study|Lost to Follow-up|0|||
130324027|NCT00535496|469157001|FG000|Overall Study|Not treated with sugammadex|0|||
130324028|NCT00535496|469157002|FG001|Overall Study|Not treated with sugammadex|1|||
130324029|NCT00535496|469157003|FG002|Overall Study|Not treated with sugammadex|0|||
130324030|NCT00535496|469157004|FG003|Overall Study|Not treated with sugammadex|0|||
130324031|NCT02326155|469157005|FG000|Overall Study|Adverse Event|21|||
130324032|NCT02326155|469157006|FG001|Overall Study|Adverse Event|5|||
130324033|NCT02326155|469157005|FG000|Overall Study|Death|3|||
130324034|NCT02326155|469157006|FG001|Overall Study|Death|0|||
130324035|NCT02326155|469157005|FG000|Overall Study|Lack of Efficacy|49|||
130324036|NCT02326155|469157006|FG001|Overall Study|Lack of Efficacy|5|||
130324037|NCT02326155|469157005|FG000|Overall Study|Lost to Follow-up|14|||
130324038|NCT02326155|469157006|FG001|Overall Study|Lost to Follow-up|3|||
130324039|NCT02326155|469157005|FG000|Overall Study|Protocol Violation|2|||
130324040|NCT02326155|469157006|FG001|Overall Study|Protocol Violation|0|||
130324041|NCT02326155|469157005|FG000|Overall Study|Withdrawal by Subject|34|||
130324042|NCT02326155|469157006|FG001|Overall Study|Withdrawal by Subject|11|||
130324043|NCT02326155|469157005|FG000|Overall Study|Disease progression|37|||
130324044|NCT02326155|469157006|FG001|Overall Study|Disease progression|4|||
130324045|NCT02326155|469157005|FG000|Overall Study|Study close|188|||
130324046|NCT02326155|469157006|FG001|Overall Study|Study close|21|||
130324047|NCT02326155|469157005|FG000|Overall Study|except for study close|46|||
130324048|NCT02326155|469157006|FG001|Overall Study|except for study close|13|||
130324049|NCT05024032|469157007|FG000|Overall Study|Withdrawal by Subject|0|||
130324050|NCT05024032|469157008|FG001|Overall Study|Withdrawal by Subject|3|||
130324051|NCT05024032|469157009|FG002|Overall Study|Withdrawal by Subject|4|||
130324052|NCT05024032|469157007|FG000|Overall Study|Adverse Event|0|||
130324053|NCT05024032|469157008|FG001|Overall Study|Adverse Event|1|||
130324054|NCT05024032|469157009|FG002|Overall Study|Adverse Event|0|||
130324055|NCT05024032|469157007|FG000|Overall Study|Protocol Deviation|1|||
130324056|NCT05024032|469157008|FG001|Overall Study|Protocol Deviation|0|||
130324057|NCT05024032|469157009|FG002|Overall Study|Protocol Deviation|0|||
130324058|NCT03714672|469157012|FG000|Overall Study|Adverse Event|0|||
130324059|NCT03714672|469157013|FG001|Overall Study|Adverse Event|0|||
130324060|NCT03714672|469157014|FG002|Overall Study|Adverse Event|3|||
130324061|NCT03714672|469157015|FG003|Overall Study|Adverse Event|0|||
130324062|NCT03714672|469157012|FG000|Overall Study|Physician Decision|0|||
130656552|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130656553|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
130656554|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130656555|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130656556|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
130656557|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
130656558|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
130656559|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
130656560|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130656561|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
130656562|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130656563|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130656564|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130656565|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
130656566|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130324063|NCT03714672|469157013|FG001|Overall Study|Physician Decision|1|||
130324064|NCT03714672|469157014|FG002|Overall Study|Physician Decision|0|||
130324065|NCT03714672|469157015|FG003|Overall Study|Physician Decision|0|||
130324066|NCT03714672|469157012|FG000|Overall Study|Other Reason|1|||
130324067|NCT03714672|469157013|FG001|Overall Study|Other Reason|2|||
130324068|NCT03714672|469157014|FG002|Overall Study|Other Reason|1|||
130324069|NCT03714672|469157015|FG003|Overall Study|Other Reason|1|||
130324070|NCT03714672|469157012|FG000|Overall Study|Lost to Follow-up|1|||
130324071|NCT03714672|469157013|FG001|Overall Study|Lost to Follow-up|1|||
130324072|NCT03714672|469157014|FG002|Overall Study|Lost to Follow-up|0|||
130324073|NCT03714672|469157015|FG003|Overall Study|Lost to Follow-up|0|||
130324074|NCT02345070|469157016|FG000|Overall Study|Adverse Event|12|||
130324075|NCT02345070|469157017|FG001|Overall Study|Adverse Event|8|||
130324076|NCT02345070|469157018|FG002|Overall Study|Adverse Event|16|||
130324077|NCT02345070|469157016|FG000|Overall Study|Poor compliance to protocol|2|||
130324078|NCT02345070|469157017|FG001|Overall Study|Poor compliance to protocol|0|||
130324079|NCT02345070|469157018|FG002|Overall Study|Poor compliance to protocol|0|||
130324080|NCT02345070|469157016|FG000|Overall Study|Other than specified above|6|||
130324081|NCT02345070|469157017|FG001|Overall Study|Other than specified above|3|||
130324082|NCT02345070|469157018|FG002|Overall Study|Other than specified above|7|||
130324083|NCT02379728|469157019|FG000|Overall Study|Lost to Follow-up|1|||
130324084|NCT02379728|469157020|FG001|Overall Study|Lost to Follow-up|0|||
130324085|NCT02379728|469157021|FG002|Overall Study|Lost to Follow-up|3|||
130324086|NCT02379728|469157022|FG003|Overall Study|Lost to Follow-up|0|||
130324087|NCT02379728|469157019|FG000|Overall Study|Withdrawal by Subject|5|||
130324088|NCT02379728|469157020|FG001|Overall Study|Withdrawal by Subject|0|||
130324089|NCT02379728|469157021|FG002|Overall Study|Withdrawal by Subject|5|||
130324090|NCT02379728|469157022|FG003|Overall Study|Withdrawal by Subject|3|||
130324091|NCT02379728|469157019|FG000|Overall Study|Protocol Violation|0|||
130324092|NCT02379728|469157020|FG001|Overall Study|Protocol Violation|0|||
130324093|NCT02379728|469157021|FG002|Overall Study|Protocol Violation|2|||
130324094|NCT02379728|469157022|FG003|Overall Study|Protocol Violation|0|||
130324095|NCT05101122|469157023|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
130324096|NCT05101122|469157023|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
130324097|NCT05101122|469157023|FG000|AD313 80/5|Withdrawal by Subject|1|||
130656567|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130656568|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130656569|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
130656570|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130656571|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130656572|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130656573|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
130656574|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130656575|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130656576|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130656577|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
130656578|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130656579|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130656580|NCT01299272|470365761|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
130324098|NCT05101122|469157023|FG000|AD313 80/10|Physician Decision|1|||
130324099|NCT04945733|469157026|FG000|Overall Study|Physician Decision|1|||
130324100|NCT04945733|469157027|FG001|Overall Study|Physician Decision|3|||
130324101|NCT04945733|469157028|FG002|Overall Study|Physician Decision|0|||
130324102|NCT04945733|469157026|FG000|Overall Study|Withdrawal by Subject|3|||
130324103|NCT04945733|469157027|FG001|Overall Study|Withdrawal by Subject|3|||
130656581|NCT01299272|470365762|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
130656582|NCT01299272|470365763|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
130656583|NCT01299272|470365764|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
130656584|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
130324104|NCT04945733|469157028|FG002|Overall Study|Withdrawal by Subject|0|||
130551661|NCT03588728|469988084|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
130551662|NCT03588728|469988081|FG000|Overall Study|Lab shut down due to COVID-19|0|||
130551663|NCT03588728|469988082|FG001|Overall Study|Lab shut down due to COVID-19|0|||
130551664|NCT03588728|469988083|FG002|Overall Study|Lab shut down due to COVID-19|0|||
130551665|NCT03588728|469988084|FG003|Overall Study|Lab shut down due to COVID-19|1|||
130551666|NCT03588728|469988081|FG000|Overall Study|multiple technical issues|1|||
130551667|NCT03588728|469988082|FG001|Overall Study|multiple technical issues|0|||
130551668|NCT03588728|469988083|FG002|Overall Study|multiple technical issues|0|||
130551669|NCT03588728|469988084|FG003|Overall Study|multiple technical issues|0|||
130551670|NCT03588728|469988081|FG000|Overall Study|Hospitalized for COVID|1|||
130551671|NCT03588728|469988082|FG001|Overall Study|Hospitalized for COVID|0|||
130551672|NCT03588728|469988083|FG002|Overall Study|Hospitalized for COVID|0|||
130551673|NCT03588728|469988084|FG003|Overall Study|Hospitalized for COVID|0|||
130551674|NCT03588728|469988081|FG000|Overall Study|Schedule change unable to attend sessions|1|||
130551675|NCT03588728|469988082|FG001|Overall Study|Schedule change unable to attend sessions|0|||
130551676|NCT03588728|469988083|FG002|Overall Study|Schedule change unable to attend sessions|0|||
130551677|NCT03588728|469988084|FG003|Overall Study|Schedule change unable to attend sessions|0|||
130656585|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
130656586|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
130551678|NCT02027701|469988085|FG000|Overall Study|Adverse Event|3|||
130551679|NCT02027701|469988085|FG000|Overall Study|Lack of Efficacy|8|||
130324105|NCT05660577|469157031|FG000|Overall Study|Discontinued|9|||
130324106|NCT03363841|469157034|FG000|Overall Study|Adverse Event|1|||
130324107|NCT03363841|469157034|FG000|Overall Study|Withdrawal by Subject|1|||
130551680|NCT02027701|469988085|FG000|Overall Study|Physician Decision|2|||
130551681|NCT02027701|469988085|FG000|Overall Study|Withdrawal by Subject|3|||
130656587|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
130656588|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
130656589|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
130656590|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
130656591|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
130656592|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
130656593|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
130656594|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
130656595|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
130656596|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
130656597|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
130656598|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
130656599|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
130656600|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
130656601|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
130656602|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
130656603|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
130656604|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
130656605|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
130656606|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
130656607|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
130656608|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
130656609|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
130656610|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
130656611|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
130656612|NCT01299272|470365761|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
130656613|NCT01299272|470365762|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
130656614|NCT01299272|470365763|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
130656615|NCT01299272|470365764|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
130656616|NCT00464308|470365765|FG000|Overall Study|Adverse Event|22|||
130656617|NCT00464308|470365766|FG001|Overall Study|Adverse Event|27|||
130656618|NCT00464308|470365767|FG002|Overall Study|Adverse Event|16|||
130656619|NCT00464308|470365765|FG000|Overall Study|Lost to Follow-up|29|||
130656620|NCT00464308|470365766|FG001|Overall Study|Lost to Follow-up|19|||
130656621|NCT00464308|470365767|FG002|Overall Study|Lost to Follow-up|20|||
130656622|NCT00464308|470365765|FG000|Overall Study|Patient discontinued and other reasons|17|||
130656623|NCT00464308|470365766|FG001|Overall Study|Patient discontinued and other reasons|17|||
130656624|NCT00464308|470365767|FG002|Overall Study|Patient discontinued and other reasons|23|||
130656625|NCT00464308|470365765|FG000|Overall Study|Physician Decision|1|||
130656626|NCT00464308|470365766|FG001|Overall Study|Physician Decision|0|||
130656627|NCT00464308|470365767|FG002|Overall Study|Physician Decision|0|||
130656628|NCT01513759|470365768|FG000|Overall Study|Protocol Violation|4|||
130656629|NCT01513759|470365768|FG000|Overall Study|Death during catheter placement|1|||
130656630|NCT03606109|470365769|FG000|Overall Study|Lost to Follow-up|2|||
130656631|NCT03606109|470365770|FG001|Overall Study|Lost to Follow-up|1|||
130656632|NCT00630994|470365771|FG000|Overall Study|Adverse Event|1|||
130656633|NCT00630994|470365771|FG000|Overall Study|Disease Progression|1|||
130656634|NCT00630994|470365771|FG000|Overall Study|Lack of Efficacy|1|||
130656635|NCT00630994|470365771|FG000|Overall Study|Other|1|||
130656636|NCT03669640|470365772|FG000|Overall Study|Study Terminated by Sponsor|0|||
130656637|NCT03669640|470365773|FG001|Overall Study|Study Terminated by Sponsor|0|||
130656638|NCT03669640|470365774|FG002|Overall Study|Study Terminated by Sponsor|0|||
130656639|NCT03669640|470365775|FG003|Overall Study|Study Terminated by Sponsor|0|||
130656640|NCT03669640|470365776|FG004|Overall Study|Study Terminated by Sponsor|1|||
130656641|NCT03669640|470365777|FG005|Overall Study|Study Terminated by Sponsor|0|||
130656642|NCT03669640|470365772|FG000|Overall Study|Lost to Follow-up|0|||
130656643|NCT03669640|470365773|FG001|Overall Study|Lost to Follow-up|0|||
130656644|NCT03669640|470365774|FG002|Overall Study|Lost to Follow-up|2|||
130656645|NCT03669640|470365775|FG003|Overall Study|Lost to Follow-up|0|||
130656646|NCT03669640|470365776|FG004|Overall Study|Lost to Follow-up|0|||
130656647|NCT03669640|470365777|FG005|Overall Study|Lost to Follow-up|0|||
130656648|NCT03669640|470365772|FG000|Overall Study|Death|0|||
130656649|NCT03669640|470365773|FG001|Overall Study|Death|0|||
130656650|NCT03669640|470365774|FG002|Overall Study|Death|1|||
130656651|NCT03669640|470365775|FG003|Overall Study|Death|0|||
130656652|NCT03669640|470365776|FG004|Overall Study|Death|0|||
130656653|NCT03669640|470365777|FG005|Overall Study|Death|0|||
130656654|NCT03669640|470365772|FG000|Overall Study|Withdrawal by Subject|1|||
130656655|NCT03669640|470365773|FG001|Overall Study|Withdrawal by Subject|2|||
130656656|NCT03669640|470365774|FG002|Overall Study|Withdrawal by Subject|1|||
130656657|NCT03669640|470365775|FG003|Overall Study|Withdrawal by Subject|0|||
130656658|NCT03669640|470365776|FG004|Overall Study|Withdrawal by Subject|1|||
130324108|NCT03363841|469157034|FG000|Overall Study|Death|7|||
130324109|NCT03363841|469157034|FG000|Overall Study|Physician Decision|1|||
130324110|NCT00886379|469157037|FG000|Overall Study|Transferred Schools|0|||
130324111|NCT00886379|469157038|FG001|Overall Study|Transferred Schools|0|||
130324112|NCT00886379|469157039|FG002|Overall Study|Transferred Schools|2|||
130324113|NCT00886379|469157040|FG003|Overall Study|Transferred Schools|1|||
130324114|NCT00886379|469157041|FG004|Overall Study|Transferred Schools|1|||
130324115|NCT00886379|469157037|FG000|Overall Study|Final blood draw not obtained|3|||
130324116|NCT00886379|469157038|FG001|Overall Study|Final blood draw not obtained|3|||
130324117|NCT00886379|469157039|FG002|Overall Study|Final blood draw not obtained|4|||
130324118|NCT00886379|469157040|FG003|Overall Study|Final blood draw not obtained|2|||
130324119|NCT00886379|469157041|FG004|Overall Study|Final blood draw not obtained|2|||
130324120|NCT04558125|469157042|FG000|Overall Study|Death|1|||
130324121|NCT03137381|469157043|FG000|Overall Study|Adverse Event|3|||
130324122|NCT03137381|469157044|FG001|Overall Study|Adverse Event|0|||
130324123|NCT03137381|469157045|FG002|Overall Study|Adverse Event|2|||
130324124|NCT03137381|469157046|FG003|Overall Study|Adverse Event|0|||
130324125|NCT03137381|469157043|FG000|Overall Study|Lost to Follow-up|2|||
130324126|NCT03137381|469157044|FG001|Overall Study|Lost to Follow-up|1|||
130324127|NCT03137381|469157045|FG002|Overall Study|Lost to Follow-up|1|||
130324128|NCT03137381|469157046|FG003|Overall Study|Lost to Follow-up|0|||
130324129|NCT03137381|469157043|FG000|Overall Study|Protocol deviation|1|||
130324130|NCT03137381|469157044|FG001|Overall Study|Protocol deviation|1|||
130324131|NCT03137381|469157045|FG002|Overall Study|Protocol deviation|0|||
130324132|NCT03137381|469157046|FG003|Overall Study|Protocol deviation|1|||
130324133|NCT03137381|469157043|FG000|Overall Study|Withdrawal by Investigator|0|||
130324134|NCT03137381|469157044|FG001|Overall Study|Withdrawal by Investigator|1|||
130324135|NCT03137381|469157045|FG002|Overall Study|Withdrawal by Investigator|1|||
130656659|NCT03669640|470365777|FG005|Overall Study|Withdrawal by Subject|3|||
130656660|NCT03669640|470365772|FG000|Overall Study|Protocol Violation|1|||
130656661|NCT03669640|470365773|FG001|Overall Study|Protocol Violation|0|||
130656662|NCT03669640|470365774|FG002|Overall Study|Protocol Violation|0|||
130656663|NCT03669640|470365775|FG003|Overall Study|Protocol Violation|0|||
130656664|NCT03669640|470365776|FG004|Overall Study|Protocol Violation|0|||
130656665|NCT03669640|470365777|FG005|Overall Study|Protocol Violation|0|||
130656666|NCT03669640|470365772|FG000|Overall Study|Physician Decision|0|||
130656667|NCT03669640|470365773|FG001|Overall Study|Physician Decision|2|||
130656668|NCT03669640|470365774|FG002|Overall Study|Physician Decision|0|||
130656669|NCT03669640|470365775|FG003|Overall Study|Physician Decision|0|||
130656670|NCT03669640|470365776|FG004|Overall Study|Physician Decision|0|||
130656671|NCT03669640|470365777|FG005|Overall Study|Physician Decision|0|||
130656672|NCT03669640|470365772|FG000|Overall Study|Disease Relapse|1|||
130656673|NCT03669640|470365773|FG001|Overall Study|Disease Relapse|0|||
130656674|NCT03669640|470365774|FG002|Overall Study|Disease Relapse|0|||
130656675|NCT03669640|470365775|FG003|Overall Study|Disease Relapse|0|||
130656676|NCT03669640|470365776|FG004|Overall Study|Disease Relapse|0|||
130656677|NCT03669640|470365777|FG005|Overall Study|Disease Relapse|0|||
130656678|NCT03669640|470365772|FG000|Overall Study|Adverse Event|2|||
130656679|NCT03669640|470365773|FG001|Overall Study|Adverse Event|1|||
130656680|NCT03669640|470365774|FG002|Overall Study|Adverse Event|0|||
130656681|NCT03669640|470365775|FG003|Overall Study|Adverse Event|0|||
130656682|NCT03669640|470365776|FG004|Overall Study|Adverse Event|1|||
130656683|NCT03669640|470365777|FG005|Overall Study|Adverse Event|0|||
130656684|NCT03533608|470365778|FG000|Overall Study|Withdrawal by Subject|3|||
130656685|NCT03533608|470365778|FG000|Overall Study|Physician Decision|2|||
130656686|NCT03286426|470365779|FG000|Overall Study|Physician Decision|3|||
130656687|NCT03514121|470365780|FG000|Overall Study|Withdrawal by Subject|0|||
130656688|NCT03514121|470365781|FG001|Overall Study|Withdrawal by Subject|0|||
130656689|NCT03514121|470365782|FG002|Overall Study|Withdrawal by Subject|0|||
130656690|NCT03514121|470365783|FG003|Overall Study|Withdrawal by Subject|0|||
130656691|NCT03514121|470365784|FG004|Overall Study|Withdrawal by Subject|1|||
130656692|NCT03514121|470365785|FG005|Overall Study|Withdrawal by Subject|2|||
130656693|NCT03514121|470365786|FG006|Overall Study|Withdrawal by Subject|1|||
130656694|NCT03514121|470365787|FG007|Overall Study|Withdrawal by Subject|1|||
130324136|NCT03137381|469157046|FG003|Overall Study|Withdrawal by Investigator|0|||
130656695|NCT03514121|470365788|FG008|Overall Study|Withdrawal by Subject|7|||
130324137|NCT03137381|469157043|FG000|Overall Study|Withdrawal by Subject|3|||
130324138|NCT03137381|469157044|FG001|Overall Study|Withdrawal by Subject|4|||
130324139|NCT03137381|469157045|FG002|Overall Study|Withdrawal by Subject|3|||
130656696|NCT03514121|470365789|FG009|Overall Study|Withdrawal by Subject|2|||
130656697|NCT03514121|470365780|FG000|Overall Study|Death|0|||
130324140|NCT03137381|469157046|FG003|Overall Study|Withdrawal by Subject|0|||
130324141|NCT03137381|469157043|FG000|Overall Study|Pregnancy|0|||
130656698|NCT03514121|470365781|FG001|Overall Study|Death|0|||
130656699|NCT03514121|470365782|FG002|Overall Study|Death|0|||
130656700|NCT03514121|470365783|FG003|Overall Study|Death|0|||
130656701|NCT03514121|470365784|FG004|Overall Study|Death|0|||
130656702|NCT03514121|470365785|FG005|Overall Study|Death|3|||
130656703|NCT03514121|470365786|FG006|Overall Study|Death|2|||
130656704|NCT03514121|470365787|FG007|Overall Study|Death|1|||
130324142|NCT03137381|469157044|FG001|Overall Study|Pregnancy|0|||
130324143|NCT03137381|469157045|FG002|Overall Study|Pregnancy|1|||
130324144|NCT03137381|469157046|FG003|Overall Study|Pregnancy|0|||
130324145|NCT01980017|469157051|FG000|Overall Study|Lost to Follow-up|30|||
130324146|NCT01980017|469157052|FG001|Overall Study|Lost to Follow-up|21|||
130324147|NCT01980017|469157051|FG000|Overall Study|Death|0|||
130324148|NCT01980017|469157052|FG001|Overall Study|Death|1|||
130324149|NCT00910650|469157053|FG000|Overall Study|Death|2|||
130324150|NCT03367793|469157054|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324151|NCT03367793|469157055|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324152|NCT03367793|469157056|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
130324153|NCT03367793|469157057|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324154|NCT03367793|469157058|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324155|NCT03367793|469157059|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324156|NCT00423579|469157060|FG000|Overall Study|Lost to Follow-up|3|||
130324157|NCT00423579|469157061|FG001|Overall Study|Lost to Follow-up|0|||
130324158|NCT00423579|469157060|FG000|Overall Study|Protocol Violation|1|||
130324159|NCT00423579|469157061|FG001|Overall Study|Protocol Violation|3|||
130324160|NCT00423579|469157060|FG000|Overall Study|Diagnosis of diabetes|0|||
130324161|NCT00423579|469157061|FG001|Overall Study|Diagnosis of diabetes|1|||
130324162|NCT00106704|469157064|FG000|Overall Study|Adverse Event|10|||
130324163|NCT00106704|469157065|FG001|Overall Study|Adverse Event|7|||
130324164|NCT00106704|469157064|FG000|Overall Study|Death|2|||
130656705|NCT03514121|470365788|FG008|Overall Study|Death|26|||
130656706|NCT03514121|470365789|FG009|Overall Study|Death|3|||
130656707|NCT03514121|470365780|FG000|Overall Study|Lost to Follow-up|0|||
130656708|NCT03514121|470365781|FG001|Overall Study|Lost to Follow-up|0|||
130656709|NCT03514121|470365782|FG002|Overall Study|Lost to Follow-up|1|||
130656710|NCT03514121|470365783|FG003|Overall Study|Lost to Follow-up|0|||
130656711|NCT03514121|470365784|FG004|Overall Study|Lost to Follow-up|0|||
130656712|NCT03514121|470365785|FG005|Overall Study|Lost to Follow-up|0|||
130656713|NCT03514121|470365786|FG006|Overall Study|Lost to Follow-up|0|||
130656714|NCT03514121|470365787|FG007|Overall Study|Lost to Follow-up|0|||
130656715|NCT03514121|470365788|FG008|Overall Study|Lost to Follow-up|1|||
130656716|NCT03514121|470365789|FG009|Overall Study|Lost to Follow-up|0|||
130656717|NCT03514121|470365780|FG000|Overall Study|Adverse Event|0|||
130656718|NCT03514121|470365781|FG001|Overall Study|Adverse Event|0|||
130656719|NCT03514121|470365782|FG002|Overall Study|Adverse Event|0|||
130656720|NCT03514121|470365783|FG003|Overall Study|Adverse Event|0|||
130656721|NCT03514121|470365784|FG004|Overall Study|Adverse Event|0|||
130656722|NCT03514121|470365785|FG005|Overall Study|Adverse Event|0|||
130656723|NCT03514121|470365786|FG006|Overall Study|Adverse Event|1|||
130656724|NCT03514121|470365787|FG007|Overall Study|Adverse Event|0|||
130656725|NCT03514121|470365788|FG008|Overall Study|Adverse Event|0|||
130656726|NCT03514121|470365789|FG009|Overall Study|Adverse Event|0|||
130656727|NCT03514121|470365780|FG000|Overall Study|Other|0|||
130656728|NCT03514121|470365781|FG001|Overall Study|Other|1|||
130656729|NCT03514121|470365782|FG002|Overall Study|Other|1|||
130656730|NCT03514121|470365783|FG003|Overall Study|Other|0|||
130656731|NCT03514121|470365784|FG004|Overall Study|Other|1|||
130656732|NCT03514121|470365785|FG005|Overall Study|Other|2|||
130656733|NCT03514121|470365786|FG006|Overall Study|Other|3|||
130656734|NCT03514121|470365787|FG007|Overall Study|Other|2|||
130656735|NCT03514121|470365788|FG008|Overall Study|Other|7|||
130656736|NCT03514121|470365789|FG009|Overall Study|Other|3|||
130656737|NCT03514121|470365780|FG000|Overall Study|Study termination by Sponsor|0|||
130324165|NCT00106704|469157065|FG001|Overall Study|Death|1|||
130324166|NCT00106704|469157064|FG000|Overall Study|Lack of Efficacy|67|||
130656738|NCT03514121|470365781|FG001|Overall Study|Study termination by Sponsor|0|||
130656739|NCT03514121|470365782|FG002|Overall Study|Study termination by Sponsor|0|||
130656740|NCT03514121|470365783|FG003|Overall Study|Study termination by Sponsor|0|||
130656741|NCT03514121|470365784|FG004|Overall Study|Study termination by Sponsor|0|||
130324167|NCT00106704|469157065|FG001|Overall Study|Lack of Efficacy|69|||
130324168|NCT00106704|469157064|FG000|Overall Study|Lost to Follow-up|7|||
130324169|NCT00106704|469157065|FG001|Overall Study|Lost to Follow-up|3|||
130324170|NCT00106704|469157064|FG000|Overall Study|Pregnancy|1|||
130324171|NCT00106704|469157065|FG001|Overall Study|Pregnancy|0|||
130324172|NCT00106704|469157064|FG000|Overall Study|Protocol Violation|4|||
130324173|NCT00106704|469157065|FG001|Overall Study|Protocol Violation|7|||
130324174|NCT00106704|469157064|FG000|Overall Study|Withdrawal by Subject|14|||
130324175|NCT00106704|469157065|FG001|Overall Study|Withdrawal by Subject|21|||
130656742|NCT03514121|470365785|FG005|Overall Study|Study termination by Sponsor|0|||
130656743|NCT03514121|470365786|FG006|Overall Study|Study termination by Sponsor|0|||
130656744|NCT03514121|470365787|FG007|Overall Study|Study termination by Sponsor|0|||
130656745|NCT03514121|470365788|FG008|Overall Study|Study termination by Sponsor|11|||
130656746|NCT03514121|470365789|FG009|Overall Study|Study termination by Sponsor|3|||
130656747|NCT03514121|470365780|FG000|Overall Study|Investigator decision|0|||
130656748|NCT03514121|470365781|FG001|Overall Study|Investigator decision|0|||
130656749|NCT03514121|470365782|FG002|Overall Study|Investigator decision|0|||
130324176|NCT00106704|469157064|FG000|Overall Study|Patient moved|1|||
130324177|NCT00106704|469157065|FG001|Overall Study|Patient moved|0|||
130324178|NCT00106704|469157064|FG000|Overall Study|Site terminated|0|||
130324179|NCT00106704|469157065|FG001|Overall Study|Site terminated|1|||
130324180|NCT00106704|469157064|FG000|Overall Study|Planned major surgery|1|||
130324181|NCT00106704|469157065|FG001|Overall Study|Planned major surgery|0|||
130324182|NCT00106704|469157064|FG000|Overall Study|Patient Received Glycemic Medication|22|||
130324183|NCT00106704|469157065|FG001|Overall Study|Patient Received Glycemic Medication|41|||
130324184|NCT00106704|469157064|FG000|Overall Study|Unable to re-enter US|1|||
130324185|NCT00106704|469157065|FG001|Overall Study|Unable to re-enter US|0|||
130324186|NCT00106704|469157064|FG000|Overall Study|Laboratory test|1|||
130324187|NCT00106704|469157065|FG001|Overall Study|Laboratory test|1|||
130324188|NCT02224560|469157066|FG000|Overall Study|Protocol Deviation|1|||
130324189|NCT02224560|469157067|FG001|Overall Study|Protocol Deviation|0|||
130324190|NCT02224560|469157068|FG002|Overall Study|Protocol Deviation|0|||
130324191|NCT02224560|469157066|FG000|Overall Study|Withdrawal by Subject|2|||
130324192|NCT02224560|469157067|FG001|Overall Study|Withdrawal by Subject|0|||
130324193|NCT02224560|469157068|FG002|Overall Study|Withdrawal by Subject|1|||
130324194|NCT02224560|469157066|FG000|Overall Study|Met Withdrawal Criteria|1|||
130324195|NCT02224560|469157067|FG001|Overall Study|Met Withdrawal Criteria|0|||
130324196|NCT02224560|469157068|FG002|Overall Study|Met Withdrawal Criteria|0|||
130324197|NCT02224560|469157066|FG000|Overall Study|Adverse Event|4|||
130324198|NCT02224560|469157067|FG001|Overall Study|Adverse Event|1|||
130324199|NCT02224560|469157068|FG002|Overall Study|Adverse Event|1|||
130324200|NCT02224560|469157066|FG000|Overall Study|Withdrawn by Investigator|1|||
130324201|NCT02224560|469157067|FG001|Overall Study|Withdrawn by Investigator|1|||
130324202|NCT02224560|469157068|FG002|Overall Study|Withdrawn by Investigator|0|||
130324203|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
130324204|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
130324205|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
130324206|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
130324207|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
130324208|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
130324209|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
130324210|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
130324211|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
130324212|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
130324213|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
130324214|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
130324215|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
130324216|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
130324217|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
130324218|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
130324219|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
130324220|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
130324221|NCT03773978|469157071|FG000|DBW Period|Adverse Event|2|||
130324222|NCT03773978|469157072|FG001|DBW Period|Adverse Event|2|||
130324223|NCT03773978|469157071|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
130324224|NCT03773978|469157072|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
130324225|NCT03773978|469157071|FG000|DBW Period|Withdrawal by Subject|2|||
130324226|NCT03773978|469157072|FG001|DBW Period|Withdrawal by Subject|1|||
130324227|NCT03773978|469157071|FG000|DBW Period|Due to epidemic or pandemic|5|||
130324228|NCT03773978|469157072|FG001|DBW Period|Due to epidemic or pandemic|6|||
130324229|NCT03773978|469157071|FG000|DBW Period|Study team decision|1|||
130324230|NCT03773978|469157072|FG001|DBW Period|Study team decision|0|||
130324231|NCT01033019|469157073|FG000|Overall Study|Withdrawal by Subject|1|||
130324232|NCT01033019|469157074|FG001|Overall Study|Withdrawal by Subject|0|||
130324233|NCT03224819|469157080|FG000|Overall Study|Withdrawal by Subject|0|||
130324234|NCT03224819|469157081|FG001|Overall Study|Withdrawal by Subject|0|||
130324235|NCT03224819|469157082|FG002|Overall Study|Withdrawal by Subject|0|||
130324236|NCT03224819|469157083|FG003|Overall Study|Withdrawal by Subject|0|||
130324237|NCT03224819|469157084|FG004|Overall Study|Withdrawal by Subject|0|||
130324238|NCT03224819|469157085|FG005|Overall Study|Withdrawal by Subject|0|||
130324239|NCT03224819|469157086|FG006|Overall Study|Withdrawal by Subject|0|||
130324240|NCT03224819|469157087|FG007|Overall Study|Withdrawal by Subject|0|||
130324241|NCT03224819|469157088|FG008|Overall Study|Withdrawal by Subject|0|||
130324242|NCT03224819|469157089|FG009|Overall Study|Withdrawal by Subject|0|||
130324243|NCT03224819|469157090|FG010|Overall Study|Withdrawal by Subject|0|||
130324244|NCT03224819|469157091|FG011|Overall Study|Withdrawal by Subject|0|||
130324245|NCT03224819|469157092|FG012|Overall Study|Withdrawal by Subject|1|||
130656750|NCT03514121|470365783|FG003|Overall Study|Investigator decision|0|||
130656751|NCT03514121|470365784|FG004|Overall Study|Investigator decision|0|||
130324246|NCT03224819|469157093|FG013|Overall Study|Withdrawal by Subject|0|||
130324247|NCT03224819|469157080|FG000|Overall Study|Sponsor Decision|0|||
130324248|NCT03224819|469157081|FG001|Overall Study|Sponsor Decision|0|||
130324249|NCT03224819|469157082|FG002|Overall Study|Sponsor Decision|0|||
130324250|NCT03224819|469157083|FG003|Overall Study|Sponsor Decision|1|||
130324251|NCT03224819|469157084|FG004|Overall Study|Sponsor Decision|1|||
130324252|NCT03224819|469157085|FG005|Overall Study|Sponsor Decision|2|||
130324253|NCT03224819|469157086|FG006|Overall Study|Sponsor Decision|1|||
130324254|NCT03224819|469157087|FG007|Overall Study|Sponsor Decision|1|||
130324255|NCT03224819|469157088|FG008|Overall Study|Sponsor Decision|1|||
130324256|NCT03224819|469157089|FG009|Overall Study|Sponsor Decision|2|||
130324257|NCT03224819|469157090|FG010|Overall Study|Sponsor Decision|1|||
130324258|NCT03224819|469157091|FG011|Overall Study|Sponsor Decision|1|||
130324259|NCT03224819|469157092|FG012|Overall Study|Sponsor Decision|1|||
130324260|NCT03224819|469157093|FG013|Overall Study|Sponsor Decision|0|||
130324261|NCT03224819|469157080|FG000|Overall Study|Lost to Follow-up|0|||
130324262|NCT03224819|469157081|FG001|Overall Study|Lost to Follow-up|0|||
130324263|NCT03224819|469157082|FG002|Overall Study|Lost to Follow-up|0|||
130324264|NCT03224819|469157083|FG003|Overall Study|Lost to Follow-up|0|||
130324265|NCT03224819|469157084|FG004|Overall Study|Lost to Follow-up|0|||
130324266|NCT03224819|469157085|FG005|Overall Study|Lost to Follow-up|0|||
130324267|NCT03224819|469157086|FG006|Overall Study|Lost to Follow-up|0|||
130324268|NCT03224819|469157087|FG007|Overall Study|Lost to Follow-up|0|||
130324269|NCT03224819|469157088|FG008|Overall Study|Lost to Follow-up|1|||
130324270|NCT03224819|469157089|FG009|Overall Study|Lost to Follow-up|0|||
130324271|NCT03224819|469157090|FG010|Overall Study|Lost to Follow-up|0|||
130324272|NCT03224819|469157091|FG011|Overall Study|Lost to Follow-up|0|||
130324273|NCT03224819|469157092|FG012|Overall Study|Lost to Follow-up|0|||
130324274|NCT03224819|469157093|FG013|Overall Study|Lost to Follow-up|0|||
130324275|NCT03224819|469157080|FG000|Overall Study|Death|0|||
130324276|NCT03224819|469157081|FG001|Overall Study|Death|1|||
130324277|NCT03224819|469157082|FG002|Overall Study|Death|0|||
130324278|NCT03224819|469157083|FG003|Overall Study|Death|0|||
130324279|NCT03224819|469157084|FG004|Overall Study|Death|0|||
130324280|NCT03224819|469157085|FG005|Overall Study|Death|0|||
130324281|NCT03224819|469157086|FG006|Overall Study|Death|0|||
130324282|NCT03224819|469157087|FG007|Overall Study|Death|1|||
130324283|NCT03224819|469157088|FG008|Overall Study|Death|0|||
130324284|NCT03224819|469157089|FG009|Overall Study|Death|0|||
130324285|NCT03224819|469157090|FG010|Overall Study|Death|0|||
130324286|NCT03224819|469157091|FG011|Overall Study|Death|1|||
130324287|NCT03224819|469157092|FG012|Overall Study|Death|0|||
130324288|NCT03224819|469157093|FG013|Overall Study|Death|0|||
130324289|NCT01535040|469157100|FG000|Overall Study|Physician Decision|0|||
130324290|NCT01535040|469157101|FG001|Overall Study|Physician Decision|1|||
130324291|NCT01535040|469157100|FG000|Overall Study|Withdrawal by Subject|13|||
130324292|NCT01535040|469157101|FG001|Overall Study|Withdrawal by Subject|10|||
130324293|NCT01535040|469157100|FG000|Overall Study|Never Started|9|||
130324294|NCT01535040|469157101|FG001|Overall Study|Never Started|4|||
130324295|NCT01535040|469157100|FG000|Overall Study|Toxicity|7|||
130324296|NCT01535040|469157101|FG001|Overall Study|Toxicity|5|||
130324297|NCT01535040|469157100|FG000|Overall Study|Multiple Reasons|1|||
130324298|NCT01535040|469157101|FG001|Overall Study|Multiple Reasons|1|||
130324299|NCT01074970|469157103|FG000|Overall Study|Never Treated|0|||
130656752|NCT03514121|470365785|FG005|Overall Study|Investigator decision|0|||
130656753|NCT03514121|470365786|FG006|Overall Study|Investigator decision|0|||
130656754|NCT03514121|470365787|FG007|Overall Study|Investigator decision|0|||
130656755|NCT03514121|470365788|FG008|Overall Study|Investigator decision|1|||
130656756|NCT03514121|470365789|FG009|Overall Study|Investigator decision|0|||
130656757|NCT05553600|470365790|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
130656758|NCT05553600|470365791|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
130656759|NCT05553600|470365792|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
130656760|NCT05553600|470365793|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
130324300|NCT01074970|469157104|FG001|Overall Study|Never Treated|0|||
130324301|NCT01074970|469157105|FG002|Overall Study|Never Treated|8|||
130324302|NCT01074970|469157106|FG003|Overall Study|Never Treated|1|||
130324303|NCT01074970|469157103|FG000|Overall Study|Adverse Event|1|||
130324304|NCT01074970|469157104|FG001|Overall Study|Adverse Event|0|||
130324305|NCT01074970|469157105|FG002|Overall Study|Adverse Event|4|||
130324306|NCT01074970|469157106|FG003|Overall Study|Adverse Event|3|||
130324307|NCT01074970|469157103|FG000|Overall Study|Disease progression during treatment|3|||
130324308|NCT01074970|469157104|FG001|Overall Study|Disease progression during treatment|1|||
130324309|NCT01074970|469157105|FG002|Overall Study|Disease progression during treatment|2|||
130324310|NCT01074970|469157106|FG003|Overall Study|Disease progression during treatment|9|||
130324311|NCT01074970|469157103|FG000|Overall Study|Lost to Follow-up|0|||
130324312|NCT01074970|469157104|FG001|Overall Study|Lost to Follow-up|0|||
130324313|NCT01074970|469157105|FG002|Overall Study|Lost to Follow-up|1|||
130324314|NCT01074970|469157106|FG003|Overall Study|Lost to Follow-up|0|||
130324315|NCT01074970|469157103|FG000|Overall Study|Withdrawal by Subject|0|||
130324316|NCT01074970|469157104|FG001|Overall Study|Withdrawal by Subject|0|||
130324317|NCT01074970|469157105|FG002|Overall Study|Withdrawal by Subject|6|||
130656761|NCT05553600|470365790|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
130656762|NCT05553600|470365791|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
130656763|NCT05553600|470365792|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
130656764|NCT05553600|470365793|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
130656765|NCT05553600|470365790|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130656766|NCT05553600|470365791|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130656767|NCT05553600|470365792|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130656768|NCT05553600|470365793|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
130656769|NCT05553600|470365790|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
130656770|NCT05553600|470365791|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
130656771|NCT05553600|470365792|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
130656772|NCT05553600|470365793|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
130656773|NCT05553600|470365790|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
130656774|NCT05553600|470365791|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
130656775|NCT05553600|470365792|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
130656776|NCT05553600|470365793|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
130656777|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130656778|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130656779|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
130656780|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130656781|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
130656782|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
130656783|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
130656784|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
130656785|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
130656786|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
130656787|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
130656788|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
130656789|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
130656790|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
130656791|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
130656792|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
130656793|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
130656794|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
130656795|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
130656796|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
130656797|NCT05553600|470365790|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
130656798|NCT05553600|470365791|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
130656799|NCT05553600|470365792|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
130656800|NCT05553600|470365793|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
130656801|NCT05553600|470365790|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
130656802|NCT05553600|470365791|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
130656803|NCT05553600|470365792|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
130656804|NCT05553600|470365793|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
130656805|NCT04930536|470365794|FG000|Overall Study|Adverse Event|1|||
130656806|NCT04930536|470365795|FG001|Overall Study|Adverse Event|0|||
130656807|NCT04930536|470365794|FG000|Overall Study|Disease Progression|2|||
130656808|NCT04930536|470365795|FG001|Overall Study|Disease Progression|0|||
130656809|NCT04930536|470365794|FG000|Overall Study|Patient Decision|4|||
130656810|NCT04930536|470365795|FG001|Overall Study|Patient Decision|2|||
130656811|NCT04930536|470365794|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
130656812|NCT04930536|470365795|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
130656813|NCT01432600|470365796|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
130656814|NCT01432600|470365797|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
130656815|NCT01432600|470365798|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
130656816|NCT03286400|470365802|FG000|Overall Study|Death|10|||
130656817|NCT03286400|470365802|FG000|Overall Study|Lost to Follow-up|10|||
130656818|NCT03286400|470365802|FG000|Overall Study|Physician Decision|1|||
130656819|NCT03286400|470365802|FG000|Overall Study|Scheduling difficulty|4|||
130656820|NCT00826176|470365805|FG000|Overall Study|Lost to Follow-up|1|||
130656821|NCT00826176|470365806|FG001|Overall Study|Lost to Follow-up|0|||
130656822|NCT00826176|470365805|FG000|Overall Study|Subject Withdrew Consent|3|||
130656823|NCT00826176|470365806|FG001|Overall Study|Subject Withdrew Consent|0|||
130656824|NCT00826176|470365805|FG000|Overall Study|Administrative|9|||
130656825|NCT00826176|470365806|FG001|Overall Study|Administrative|0|||
130656826|NCT00297882|470365812|FG000|Day 14|Lack of Efficacy|12|||
130656827|NCT00297882|470365813|FG001|Day 14|Lack of Efficacy|49|||
130324318|NCT01074970|469157106|FG003|Overall Study|Withdrawal by Subject|4|||
130324319|NCT00734149|469157107|FG000|Overall Study|Withdrawal by Subject|1|||
130324320|NCT05430854|469157108|FG000|Overall Study|Trial terminated by Sponsor|39|||
130324321|NCT05430854|469157109|FG001|Overall Study|Trial terminated by Sponsor|50|||
130324322|NCT05430854|469157110|FG002|Overall Study|Trial terminated by Sponsor|46|||
130324323|NCT05430854|469157108|FG000|Overall Study|Withdrawal by Subject|0|||
130324324|NCT05430854|469157109|FG001|Overall Study|Withdrawal by Subject|3|||
130324325|NCT05430854|469157110|FG002|Overall Study|Withdrawal by Subject|0|||
130324326|NCT04314284|469157111|FG000|Overall Study|Withdrawal by Subject|4|||
130324327|NCT04314284|469157112|FG001|Overall Study|Withdrawal by Subject|7|||
130324328|NCT04314284|469157111|FG000|Overall Study|Consented but did not complete survey|0|||
130324329|NCT04314284|469157112|FG001|Overall Study|Consented but did not complete survey|6|||
130324330|NCT01652235|469157115|FG000|Overall Study|Death|9|||
130324331|NCT01652235|469157115|FG000|Overall Study|Lost to Follow-up|5|||
130324332|NCT01652235|469157115|FG000|Overall Study|Withdrawal by Subject|2|||
130324333|NCT02023086|469157118|FG000|Overall Study|Withdrawal by Subject|2|||
130324334|NCT02023086|469157119|FG001|Overall Study|Withdrawal by Subject|0|||
130324335|NCT03472885|469157120|FG000|24-Week Treatment Period|Adverse Event|1|||
130324336|NCT02201953|469157121|FG000|Overall Study|Randomized but Never Treated|1|||
130324337|NCT02201953|469157122|FG001|Overall Study|Randomized but Never Treated|5|||
130324338|NCT02201953|469157121|FG000|Overall Study|Lack of Efficacy|9|||
130324339|NCT02201953|469157122|FG001|Overall Study|Lack of Efficacy|30|||
130324340|NCT02201953|469157121|FG000|Overall Study|Lost to Follow-up|8|||
130324341|NCT02201953|469157122|FG001|Overall Study|Lost to Follow-up|8|||
130324342|NCT02201953|469157121|FG000|Overall Study|Withdrew Consent|2|||
130324343|NCT02201953|469157122|FG001|Overall Study|Withdrew Consent|5|||
130324344|NCT02201953|469157121|FG000|Overall Study|Adverse Event|0|||
130324345|NCT02201953|469157122|FG001|Overall Study|Adverse Event|5|||
130324346|NCT02201953|469157121|FG000|Overall Study|Death|0|||
130324347|NCT02201953|469157122|FG001|Overall Study|Death|3|||
130324348|NCT01615939|469158630|FG000|Overall Study|Lost to Follow-up|5|||
130324349|NCT01615939|469158631|FG001|Overall Study|Lost to Follow-up|0|||
130324350|NCT02892344|469158635|FG000|Overall Study|Protocol deviation|3|||
130324351|NCT02892344|469158636|FG001|Overall Study|Protocol deviation|4|||
130324352|NCT02892344|469158635|FG000|Overall Study|Adverse Event|1|||
130324353|NCT02892344|469158636|FG001|Overall Study|Adverse Event|8|||
130324354|NCT02892344|469158635|FG000|Overall Study|Lost to Follow-up|0|||
130324355|NCT02892344|469158636|FG001|Overall Study|Lost to Follow-up|1|||
130324356|NCT02892344|469158635|FG000|Overall Study|Non-compliance with study treatment|0|||
130324357|NCT02892344|469158636|FG001|Overall Study|Non-compliance with study treatment|1|||
130324358|NCT02892344|469158635|FG000|Overall Study|Physician Decision|0|||
130324359|NCT02892344|469158636|FG001|Overall Study|Physician Decision|2|||
130324360|NCT02892344|469158635|FG000|Overall Study|Subject/guardian decision|0|||
130324361|NCT02892344|469158636|FG001|Overall Study|Subject/guardian decision|4|||
130324362|NCT02892344|469158635|FG000|Overall Study|Technical problems|0|||
130324363|NCT02892344|469158636|FG001|Overall Study|Technical problems|1|||
130324364|NCT03591406|469158638|FG000|Overall Study|Adverse Event|5|||
130324365|NCT03591406|469158639|FG001|Overall Study|Adverse Event|3|||
130324366|NCT03591406|469158638|FG000|Overall Study|Protocol Violation|2|||
130324367|NCT03591406|469158639|FG001|Overall Study|Protocol Violation|1|||
130324368|NCT03591406|469158638|FG000|Overall Study|Withdrawal by Subject|0|||
130324369|NCT03591406|469158639|FG001|Overall Study|Withdrawal by Subject|5|||
130324370|NCT01083771|469158640|FG000|Overall Study|non-compliant|2|||
130656828|NCT00297882|470365812|FG000|Day 28|Lost to Follow-up|13|||
130656829|NCT00297882|470365813|FG001|Day 28|Lost to Follow-up|23|||
130656830|NCT00297882|470365812|FG000|Day 28|Lack of Efficacy|3|||
130656831|NCT00297882|470365813|FG001|Day 28|Lack of Efficacy|0|||
130656832|NCT04484805|470365814|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
130656833|NCT04484805|470365815|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
130656834|NCT04484805|470365814|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
130656835|NCT04484805|470365815|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
130656836|NCT02116309|470365817|FG000|Overall Study|Lost to Follow-up|0|||
130324371|NCT01083771|469158640|FG000|Overall Study|Withdrawal by Subject|3|||
130324372|NCT02066181|469158641|FG000|Overall Study|Withdrawal by Subject|1|||
130324373|NCT02066181|469158642|FG001|Overall Study|Withdrawal by Subject|1|||
130324374|NCT00939393|469158645|FG000|Overall Study|Withdrawal by Subject|1|||
130324375|NCT00939393|469158646|FG001|Overall Study|Withdrawal by Subject|0|||
130324376|NCT00939393|469158645|FG000|Overall Study|Lost to Follow-up|3|||
130324377|NCT00939393|469158646|FG001|Overall Study|Lost to Follow-up|0|||
130324378|NCT02851615|469158647|FG000|Overall Study|Cognitive Issue|1|||
130324379|NCT02851615|469158648|FG001|Overall Study|Cognitive Issue|0|||
130324380|NCT02851615|469158647|FG000|Overall Study|Lost to Follow-up|0|||
130656837|NCT02116309|470365818|FG001|Overall Study|Lost to Follow-up|1|||
130324381|NCT02851615|469158648|FG001|Overall Study|Lost to Follow-up|4|||
130324382|NCT01747876|469158658|FG000|Overall Study|Adverse Event|1|||
130324383|NCT01747876|469158659|FG001|Overall Study|Adverse Event|0|||
130324384|NCT01747876|469158660|FG002|Overall Study|Adverse Event|2|||
130324385|NCT01747876|469158658|FG000|Overall Study|Withdrawal by Subject|0|||
130324386|NCT01747876|469158659|FG001|Overall Study|Withdrawal by Subject|1|||
130324387|NCT01747876|469158660|FG002|Overall Study|Withdrawal by Subject|1|||
130324388|NCT01747876|469158658|FG000|Overall Study|Disease progression|4|||
130324389|NCT01747876|469158659|FG001|Overall Study|Disease progression|13|||
130324390|NCT01747876|469158660|FG002|Overall Study|Disease progression|8|||
130324391|NCT01747876|469158658|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
130324392|NCT01747876|469158659|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
130324393|NCT01747876|469158660|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
130324394|NCT03131219|469158663|FG000|Initial Evaluation Period|Adverse Event|2|||
130324395|NCT03131219|469158664|FG001|Initial Evaluation Period|Adverse Event|0|||
130324396|NCT03131219|469158663|FG000|Initial Evaluation Period|Protocol Violation|1|||
130324397|NCT03131219|469158664|FG001|Initial Evaluation Period|Protocol Violation|0|||
130324398|NCT03131219|469158663|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
130324399|NCT03131219|469158664|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
130324400|NCT03131219|469158663|FG000|Initial Evaluation Period|Physician Decision|1|||
130324401|NCT03131219|469158664|FG001|Initial Evaluation Period|Physician Decision|0|||
130324402|NCT03131219|469158663|FG000|Extension Period|Physician Decision|1|||
130324403|NCT03131219|469158664|FG001|Extension Period|Physician Decision|0|||
130324404|NCT01391546|469158667|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
130324405|NCT01391546|469158668|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
130324406|NCT02156076|469158669|FG000|Treatment Period|no longer meets study criteria|0|||
130324407|NCT02156076|469158670|FG001|Treatment Period|no longer meets study criteria|0|||
130324408|NCT02156076|469158671|FG002|Treatment Period|no longer meets study criteria|1|||
130324409|NCT02156076|469158672|FG003|Treatment Period|no longer meets study criteria|0|||
130324410|NCT02156076|469158669|FG000|Treatment Period|Poor/non-compliance|0|||
130324411|NCT02156076|469158670|FG001|Treatment Period|Poor/non-compliance|1|||
130324412|NCT02156076|469158671|FG002|Treatment Period|Poor/non-compliance|0|||
130324413|NCT02156076|469158672|FG003|Treatment Period|Poor/non-compliance|0|||
130324414|NCT02156076|469158669|FG000|Treatment Period|Lost to Follow-up|0|||
130324415|NCT02156076|469158670|FG001|Treatment Period|Lost to Follow-up|0|||
130324416|NCT02156076|469158671|FG002|Treatment Period|Lost to Follow-up|0|||
130324417|NCT02156076|469158672|FG003|Treatment Period|Lost to Follow-up|1|||
130324418|NCT02156076|469158669|FG000|Treatment Period|Withdrawal by Subject|0|||
130324419|NCT02156076|469158670|FG001|Treatment Period|Withdrawal by Subject|0|||
130324420|NCT02156076|469158671|FG002|Treatment Period|Withdrawal by Subject|1|||
130324421|NCT02156076|469158672|FG003|Treatment Period|Withdrawal by Subject|0|||
130324422|NCT02156076|469158669|FG000|Treatment Period|Subject request to discontinue treatment|0|||
130324423|NCT02156076|469158670|FG001|Treatment Period|Subject request to discontinue treatment|1|||
130324424|NCT02156076|469158671|FG002|Treatment Period|Subject request to discontinue treatment|0|||
130324425|NCT02156076|469158672|FG003|Treatment Period|Subject request to discontinue treatment|0|||
130324426|NCT02156076|469158669|FG000|Treatment Period|Adverse Event|0|||
130324427|NCT02156076|469158670|FG001|Treatment Period|Adverse Event|0|||
130324428|NCT02156076|469158671|FG002|Treatment Period|Adverse Event|0|||
130324429|NCT02156076|469158672|FG003|Treatment Period|Adverse Event|1|||
130324430|NCT02156076|469158669|FG000|Follow-up Period|Withdrawal by Subject|1|||
130324431|NCT02156076|469158670|FG001|Follow-up Period|Withdrawal by Subject|0|||
130324432|NCT02156076|469158671|FG002|Follow-up Period|Withdrawal by Subject|0|||
130324433|NCT02156076|469158672|FG003|Follow-up Period|Withdrawal by Subject|0|||
130324434|NCT00003475|469158673|FG000|Overall Study|Not evaluable|13|||
130324435|NCT01498068|469158677|FG000|Overall Study|Withdrawal by Subject|1|||
130324436|NCT01498068|469158678|FG001|Overall Study|Withdrawal by Subject|1|||
130324437|NCT01353898|469158680|FG000|Overall Study|Study site terminated|0|||
130324438|NCT01353898|469158681|FG001|Overall Study|Study site terminated|0|||
130324439|NCT01353898|469158682|FG002|Overall Study|Study site terminated|0|||
130324440|NCT01353898|469158683|FG003|Overall Study|Study site terminated|0|||
130324441|NCT01353898|469158684|FG004|Overall Study|Study site terminated|0|||
130324442|NCT01353898|469158685|FG005|Overall Study|Study site terminated|1|||
130324443|NCT03558737|469158686|FG000|Overall Study|Death|1|||
130551682|NCT02982187|469988086|FG000|Overall Study|Withdrawal by Subject|0|||
130551683|NCT02982187|469988087|FG001|Overall Study|Withdrawal by Subject|0|||
130551684|NCT02982187|469988088|FG002|Overall Study|Withdrawal by Subject|0|||
130551685|NCT02982187|469988089|FG003|Overall Study|Withdrawal by Subject|0|||
130551686|NCT02982187|469988090|FG004|Overall Study|Withdrawal by Subject|0|||
130551687|NCT02982187|469988091|FG005|Overall Study|Withdrawal by Subject|0|||
130551688|NCT02982187|469988092|FG006|Overall Study|Withdrawal by Subject|1|||
130551689|NCT02982187|469988093|FG007|Overall Study|Withdrawal by Subject|0|||
130551690|NCT00887679|469988094|FG000|Overall Study|Withdrawal by Subject|1|||
130551691|NCT00887679|469988094|FG000|Overall Study|Lost to Follow-up|4|||
130551692|NCT00887679|469988094|FG000|Overall Study|Physician Decision|5|||
130551693|NCT02168842|469988095|FG000|Overall Study|Withdrawal by Subject|5|||
130656838|NCT00848965|470365819|FG000|Overall Study|Adverse Event|1|||
130656839|NCT00848965|470365819|FG000|Overall Study|Withdrawal by Subject|1|||
130656840|NCT03710824|470365820|FG000|Overall Study|Withdrawal by Subject|1|||
130656841|NCT03710824|470365820|FG000|Overall Study|Lost to Follow-up|3|||
130656842|NCT03710824|470365820|FG000|Overall Study|Adverse Event|25|||
130656843|NCT03710824|470365820|FG000|Overall Study|Treatment discontinuation|2|||
130656844|NCT02329834|470365821|FG000|Overall Study|Physician Decision|1|||
130656845|NCT02329834|470365822|FG001|Overall Study|Physician Decision|0|||
130656846|NCT05102162|470365827|FG000|Overall Study|Withdrawal by Subject|3|||
130656847|NCT05102162|470365828|FG001|Overall Study|Withdrawal by Subject|0|||
130656848|NCT05102162|470365827|FG000|Overall Study|Baseline cultures negative|4|||
130656849|NCT05102162|470365828|FG001|Overall Study|Baseline cultures negative|2|||
130656850|NCT05102162|470365827|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
130656851|NCT05102162|470365828|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
130656852|NCT05102162|470365827|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
130656853|NCT05102162|470365828|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
130656854|NCT01165424|470365829|FG000|Overall Study|Clinical adverse experiences|1|||
130656855|NCT01165424|470365829|FG000|Overall Study|Laboratory adverse experiences|1|||
130656856|NCT01165424|470365829|FG000|Overall Study|Did not meet entry criteria|1|||
130656857|NCT01165424|470365829|FG000|Overall Study|Participant moved (relocated)|1|||
130656858|NCT02181673|470365830|FG000|Up to Week 24|Adverse Event|2|||
130656859|NCT02181673|470365831|FG001|Up to Week 24|Adverse Event|0|||
130656860|NCT02181673|470365832|FG002|Up to Week 24|Adverse Event|3|||
130656861|NCT02181673|470365830|FG000|Up to Week 24|Death|1|||
130656862|NCT02181673|470365831|FG001|Up to Week 24|Death|0|||
130656863|NCT02181673|470365832|FG002|Up to Week 24|Death|0|||
130656864|NCT02181673|470365830|FG000|Up to Week 24|Lack of Efficacy|1|||
130656865|NCT02181673|470365831|FG001|Up to Week 24|Lack of Efficacy|0|||
130656866|NCT02181673|470365832|FG002|Up to Week 24|Lack of Efficacy|0|||
130324444|NCT03558737|469158687|FG001|Overall Study|Death|1|||
130324445|NCT01318915|469158688|FG000|Overall Study|Lost to Follow-up|1|||
130324446|NCT00453206|469158690|FG000|Overall Study|Death|1|||
130656867|NCT02181673|470365830|FG000|Up to Week 24|Lost to Follow-up|1|||
130656868|NCT02181673|470365831|FG001|Up to Week 24|Lost to Follow-up|0|||
130656869|NCT02181673|470365832|FG002|Up to Week 24|Lost to Follow-up|0|||
130656870|NCT02181673|470365830|FG000|Up to Week 24|Physician Decision|0|||
130656871|NCT02181673|470365831|FG001|Up to Week 24|Physician Decision|0|||
130324447|NCT05386329|469158691|FG000|Overall Study|Lost to Follow-up|3|||
130324448|NCT03041181|469158693|FG000|Overall Study|Disease Progression|1|||
130324449|NCT03041181|469158694|FG001|Overall Study|Disease Progression|2|||
130324450|NCT03104868|469158695|FG000|6 Week Follow up|Lost to Follow-up|5|||
130324451|NCT03104868|469158696|FG001|6 Week Follow up|Lost to Follow-up|8|||
130324452|NCT03104868|469158695|FG000|6 Week Follow up|Death|1|||
130324453|NCT03104868|469158696|FG001|6 Week Follow up|Death|1|||
130324454|NCT03104868|469158695|FG000|6 Week Follow up|Withdrawal by Subject|7|||
130324455|NCT03104868|469158696|FG001|6 Week Follow up|Withdrawal by Subject|6|||
130324456|NCT03104868|469158695|FG000|6 Week Follow up|Completed Later Timepoint|24|||
130324457|NCT03104868|469158696|FG001|6 Week Follow up|Completed Later Timepoint|22|||
130324458|NCT03104868|469158695|FG000|6 Month Follow up|Lost to Follow-up|2|||
130324459|NCT03104868|469158696|FG001|6 Month Follow up|Lost to Follow-up|2|||
130324460|NCT03104868|469158695|FG000|6 Month Follow up|Death|0|||
130324461|NCT03104868|469158696|FG001|6 Month Follow up|Death|1|||
130324462|NCT03104868|469158695|FG000|6 Month Follow up|Completed Later Timepoint|22|||
130324463|NCT03104868|469158696|FG001|6 Month Follow up|Completed Later Timepoint|32|||
130324464|NCT03104868|469158695|FG000|12 Month Follow up|Lost to Follow-up|1|||
130324465|NCT03104868|469158696|FG001|12 Month Follow up|Lost to Follow-up|2|||
130324466|NCT03104868|469158695|FG000|12 Month Follow up|Death|0|||
130324467|NCT03104868|469158696|FG001|12 Month Follow up|Death|1|||
130324468|NCT03104868|469158695|FG000|12 Month Follow up|Withdrawal by Subject|0|||
130324469|NCT03104868|469158696|FG001|12 Month Follow up|Withdrawal by Subject|3|||
130324470|NCT03104868|469158695|FG000|12 Month Follow up|Completed Later Timepoint|32|||
130324471|NCT03104868|469158696|FG001|12 Month Follow up|Completed Later Timepoint|29|||
130324472|NCT03104868|469158695|FG000|18 Month Follow up|Lost to Follow-up|7|||
130324473|NCT03104868|469158696|FG001|18 Month Follow up|Lost to Follow-up|11|||
130324474|NCT03104868|469158695|FG000|18 Month Follow up|Death|2|||
130324475|NCT03104868|469158696|FG001|18 Month Follow up|Death|1|||
130324476|NCT03104868|469158695|FG000|18 Month Follow up|Withdrawal by Subject|1|||
130324477|NCT03104868|469158696|FG001|18 Month Follow up|Withdrawal by Subject|2|||
130656872|NCT02181673|470365832|FG002|Up to Week 24|Physician Decision|3|||
130656873|NCT02181673|470365830|FG000|Up to Week 24|Withdrawal by Subject|10|||
130656874|NCT02181673|470365831|FG001|Up to Week 24|Withdrawal by Subject|0|||
130656875|NCT02181673|470365832|FG002|Up to Week 24|Withdrawal by Subject|1|||
130656876|NCT02181673|470365830|FG000|Up to Week 24|Other|2|||
130656877|NCT02181673|470365831|FG001|Up to Week 24|Other|0|||
130656878|NCT02181673|470365832|FG002|Up to Week 24|Other|3|||
130656879|NCT02181673|470365830|FG000|Up to Week 24|Randomized not Treated|0|||
130324478|NCT03104868|469158695|FG000|18 Month Follow up|Graft Loss|1|||
130324479|NCT03104868|469158696|FG001|18 Month Follow up|Graft Loss|1|||
130324480|NCT03104868|469158695|FG000|18 Month Follow up|Completed Later Timepoint|19|||
130324481|NCT03104868|469158696|FG001|18 Month Follow up|Completed Later Timepoint|20|||
130324482|NCT03104868|469158695|FG000|24 Month Follow up|Lost to Follow-up|15|||
130324483|NCT03104868|469158696|FG001|24 Month Follow up|Lost to Follow-up|16|||
130324484|NCT03104868|469158695|FG000|24 Month Follow up|Death|3|||
130324485|NCT03104868|469158696|FG001|24 Month Follow up|Death|2|||
130324486|NCT03104868|469158695|FG000|24 Month Follow up|Withdrawal by Subject|1|||
130324487|NCT03104868|469158696|FG001|24 Month Follow up|Withdrawal by Subject|0|||
130324488|NCT03104868|469158695|FG000|24 Month Follow up|Graft Loss|2|||
130324489|NCT03104868|469158696|FG001|24 Month Follow up|Graft Loss|0|||
130324490|NCT03050801|469158699|FG000|Experiment 1|Lost to Follow-up|0|||
130324491|NCT03050801|469158700|FG001|Experiment 1|Lost to Follow-up|1|||
130324492|NCT03050801|469158701|FG002|Experiment 1|Lost to Follow-up|0|||
130324493|NCT03050801|469158702|FG003|Experiment 1|Lost to Follow-up|0|||
130324494|NCT03050801|469158703|FG004|Experiment 1|Lost to Follow-up|0|||
130324495|NCT03050801|469158704|FG005|Experiment 1|Lost to Follow-up|0|||
130324496|NCT03050801|469158699|FG000|Experiment 1|Physician Decision|0|||
130324497|NCT03050801|469158700|FG001|Experiment 1|Physician Decision|3|||
130324498|NCT03050801|469158701|FG002|Experiment 1|Physician Decision|0|||
130324499|NCT03050801|469158702|FG003|Experiment 1|Physician Decision|0|||
130324500|NCT03050801|469158703|FG004|Experiment 1|Physician Decision|0|||
130324501|NCT03050801|469158704|FG005|Experiment 1|Physician Decision|0|||
130324502|NCT03050801|469158699|FG000|Experiment 1|Change of experimental design|0|||
130324503|NCT03050801|469158700|FG001|Experiment 1|Change of experimental design|3|||
130324504|NCT03050801|469158701|FG002|Experiment 1|Change of experimental design|0|||
130324505|NCT03050801|469158702|FG003|Experiment 1|Change of experimental design|0|||
130324506|NCT03050801|469158703|FG004|Experiment 1|Change of experimental design|0|||
130324507|NCT03050801|469158704|FG005|Experiment 1|Change of experimental design|0|||
130324508|NCT03050801|469158699|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324509|NCT03050801|469158700|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324510|NCT03050801|469158701|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
130324511|NCT03050801|469158702|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324512|NCT03050801|469158703|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324513|NCT03050801|469158704|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324514|NCT03050801|469158699|FG000|Experiment 2|Lost to Follow-up|0|||
130324515|NCT03050801|469158700|FG001|Experiment 2|Lost to Follow-up|0|||
130324516|NCT03050801|469158701|FG002|Experiment 2|Lost to Follow-up|0|||
130324517|NCT03050801|469158702|FG003|Experiment 2|Lost to Follow-up|1|||
130324518|NCT03050801|469158703|FG004|Experiment 2|Lost to Follow-up|1|||
130324519|NCT03050801|469158704|FG005|Experiment 2|Lost to Follow-up|0|||
130324520|NCT03050801|469158699|FG000|Experiment 2|Physician Decision|0|||
130324521|NCT03050801|469158700|FG001|Experiment 2|Physician Decision|0|||
130324522|NCT03050801|469158701|FG002|Experiment 2|Physician Decision|0|||
130324523|NCT03050801|469158702|FG003|Experiment 2|Physician Decision|0|||
130324524|NCT03050801|469158703|FG004|Experiment 2|Physician Decision|1|||
130324525|NCT03050801|469158704|FG005|Experiment 2|Physician Decision|0|||
130324526|NCT03050801|469158699|FG000|Experiment 2|Pregnancy|0|||
130324527|NCT03050801|469158700|FG001|Experiment 2|Pregnancy|0|||
130324528|NCT03050801|469158701|FG002|Experiment 2|Pregnancy|0|||
130324529|NCT03050801|469158702|FG003|Experiment 2|Pregnancy|0|||
130324530|NCT03050801|469158703|FG004|Experiment 2|Pregnancy|1|||
130324531|NCT03050801|469158704|FG005|Experiment 2|Pregnancy|0|||
130324532|NCT03050801|469158699|FG000|Experiment 2|Withdrawal by Subject|0|||
130324533|NCT03050801|469158700|FG001|Experiment 2|Withdrawal by Subject|0|||
130324534|NCT03050801|469158701|FG002|Experiment 2|Withdrawal by Subject|0|||
130324535|NCT03050801|469158702|FG003|Experiment 2|Withdrawal by Subject|1|||
130324536|NCT03050801|469158703|FG004|Experiment 2|Withdrawal by Subject|0|||
130324537|NCT03050801|469158704|FG005|Experiment 2|Withdrawal by Subject|0|||
130324538|NCT03050801|469158699|FG000|Experiment 2|Poor data quality|0|||
130324539|NCT03050801|469158700|FG001|Experiment 2|Poor data quality|0|||
130324540|NCT03050801|469158701|FG002|Experiment 2|Poor data quality|0|||
130324541|NCT03050801|469158702|FG003|Experiment 2|Poor data quality|4|||
130324542|NCT03050801|469158703|FG004|Experiment 2|Poor data quality|1|||
130324543|NCT03050801|469158704|FG005|Experiment 2|Poor data quality|0|||
130324544|NCT03050801|469158699|FG000|Experiment 2|Discomfort during stimulation|0|||
130551694|NCT02168842|469988096|FG001|Overall Study|Withdrawal by Subject|3|||
130551695|NCT02168842|469988095|FG000|Overall Study|Lost to Follow-up|0|||
130551696|NCT02168842|469988096|FG001|Overall Study|Lost to Follow-up|2|||
130551697|NCT02168842|469988095|FG000|Overall Study|Death|2|||
130551698|NCT02168842|469988096|FG001|Overall Study|Death|1|||
130324545|NCT03050801|469158700|FG001|Experiment 2|Discomfort during stimulation|0|||
130324546|NCT03050801|469158701|FG002|Experiment 2|Discomfort during stimulation|0|||
130324547|NCT03050801|469158702|FG003|Experiment 2|Discomfort during stimulation|0|||
130324548|NCT03050801|469158703|FG004|Experiment 2|Discomfort during stimulation|0|||
130324549|NCT03050801|469158704|FG005|Experiment 2|Discomfort during stimulation|2|||
130324550|NCT00005780|469158705|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
130551699|NCT02168842|469988095|FG000|Overall Study|Physician Decision|1|||
130324551|NCT03600909|469158706|FG000|Overall Study|Not treated|0|||
130324552|NCT03600909|469158707|FG001|Overall Study|Not treated|3|||
130324553|NCT03600909|469158708|FG002|Overall Study|Not treated|0|||
130324554|NCT02651675|469158709|FG000|Overall Study|Death|0|||
130324555|NCT02651675|469158710|FG001|Overall Study|Death|0|||
130324556|NCT02651675|469158711|FG002|Overall Study|Death|1|||
130324557|NCT03674411|469158712|FG000|Overall Study|Non-treatment|4|||
130324558|NCT04408989|469158713|FG000|Overall Study|Lost to Follow-up|0|||
130324559|NCT04408989|469158714|FG001|Overall Study|Lost to Follow-up|0|||
130324560|NCT04408989|469158715|FG002|Overall Study|Lost to Follow-up|1|||
130324561|NCT04408989|469158713|FG000|Overall Study|Withdrawal by Subject|0|||
130324562|NCT04408989|469158714|FG001|Overall Study|Withdrawal by Subject|0|||
130324563|NCT04408989|469158715|FG002|Overall Study|Withdrawal by Subject|2|||
130324564|NCT02694185|469158716|FG000|Overall Study|Withdrawal by Subject|45|||
130324565|NCT02694185|469158717|FG001|Overall Study|Withdrawal by Subject|0|||
130324566|NCT05082857|469158718|FG000|Overall Study|participants relocated and could not continue|2|||
130324567|NCT05082857|469158719|FG001|Overall Study|participants relocated and could not continue|1|||
130324568|NCT05082857|469158718|FG000|Overall Study|Lost to Follow-up|1|||
130324569|NCT05082857|469158719|FG001|Overall Study|Lost to Follow-up|3|||
130324570|NCT04363320|469158720|FG000|Overall Study|Lost to Follow-up|43|||
130324571|NCT04363320|469158721|FG001|Overall Study|Lost to Follow-up|42|||
130324572|NCT04363320|469158722|FG002|Overall Study|Lost to Follow-up|24|||
130324573|NCT04363320|469158723|FG003|Overall Study|Lost to Follow-up|29|||
130324574|NCT04363320|469158720|FG000|Overall Study|Death|0|||
130324575|NCT04363320|469158721|FG001|Overall Study|Death|0|||
130324576|NCT04363320|469158722|FG002|Overall Study|Death|1|||
130324577|NCT04363320|469158723|FG003|Overall Study|Death|0|||
130324578|NCT05632211|469158724|FG000|Overall Study|Withdrawal by Subject|2|||
130324579|NCT05632211|469158725|FG001|Overall Study|Withdrawal by Subject|0|||
130324580|NCT05632211|469158726|FG002|Overall Study|Withdrawal by Subject|2|||
130324581|NCT05632211|469158724|FG000|Overall Study|Other reasons|1|||
130324582|NCT05632211|469158725|FG001|Overall Study|Other reasons|1|||
130324583|NCT05632211|469158726|FG002|Overall Study|Other reasons|1|||
130324584|NCT04672239|469158727|FG000|Week 2 Survey|Failed survey check items|1|||
130324585|NCT04672239|469158728|FG001|Week 2 Survey|Failed survey check items|2|||
130324586|NCT04672239|469158729|FG002|Week 2 Survey|Failed survey check items|3|||
130324587|NCT04672239|469158727|FG000|Week 2 Survey|Partially completed survey|7|||
130324588|NCT04672239|469158728|FG001|Week 2 Survey|Partially completed survey|1|||
130324589|NCT04672239|469158729|FG002|Week 2 Survey|Partially completed survey|4|||
130324590|NCT04672239|469158727|FG000|Week 2 Survey|Withdrawal by Subject|0|||
130324591|NCT04672239|469158728|FG001|Week 2 Survey|Withdrawal by Subject|1|||
130324592|NCT04672239|469158729|FG002|Week 2 Survey|Withdrawal by Subject|0|||
130324593|NCT04672239|469158727|FG000|Week 2 Survey|Lost to Follow-up|3|||
130324594|NCT04672239|469158728|FG001|Week 2 Survey|Lost to Follow-up|2|||
130324595|NCT04672239|469158729|FG002|Week 2 Survey|Lost to Follow-up|5|||
130324596|NCT04672239|469158727|FG000|Week 6 Survey|Failed survey check items|2|||
130324597|NCT04672239|469158728|FG001|Week 6 Survey|Failed survey check items|2|||
130324598|NCT04672239|469158729|FG002|Week 6 Survey|Failed survey check items|2|||
130324599|NCT04672239|469158727|FG000|Week 6 Survey|Partially completed survey|3|||
130324600|NCT04672239|469158728|FG001|Week 6 Survey|Partially completed survey|3|||
130324601|NCT04672239|469158729|FG002|Week 6 Survey|Partially completed survey|2|||
130324602|NCT04672239|469158727|FG000|Week 6 Survey|Withdrawal by Subject|1|||
130324603|NCT04672239|469158728|FG001|Week 6 Survey|Withdrawal by Subject|1|||
130324604|NCT04672239|469158729|FG002|Week 6 Survey|Withdrawal by Subject|1|||
130324605|NCT04672239|469158727|FG000|Week 6 Survey|Withdrawn by PI|0|||
130324606|NCT04672239|469158728|FG001|Week 6 Survey|Withdrawn by PI|1|||
130324607|NCT04672239|469158729|FG002|Week 6 Survey|Withdrawn by PI|0|||
130324608|NCT04672239|469158727|FG000|Week 6 Survey|Lost to Follow-up|12|||
130324609|NCT04672239|469158728|FG001|Week 6 Survey|Lost to Follow-up|2|||
130324610|NCT04672239|469158729|FG002|Week 6 Survey|Lost to Follow-up|5|||
130324611|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
130324612|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
130324613|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
130324614|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
130551700|NCT02168842|469988096|FG001|Overall Study|Physician Decision|2|||
130551701|NCT01026454|469988099|FG000|Second Intervention|Pregnancy|1|||
130551702|NCT01026454|469988100|FG001|Second Intervention|Pregnancy|1|||
130551703|NCT00394953|469988103|FG000|First Treatment Period|Adverse Event|1|||
130551704|NCT00394953|469988104|FG001|First Treatment Period|Adverse Event|2|||
130551705|NCT00394953|469988103|FG000|First Treatment Period|Death|6|||
130551706|NCT00394953|469988104|FG001|First Treatment Period|Death|7|||
130324615|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
130551707|NCT00394953|469988103|FG000|First Treatment Period|Lack of Efficacy|1|||
130324616|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
130324617|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
130324618|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130551708|NCT00394953|469988104|FG001|First Treatment Period|Lack of Efficacy|1|||
130324619|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130324620|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
130324621|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
130324622|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
130324623|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
130324624|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
130324625|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
130324626|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
130324627|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
130324628|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
130324629|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
130324630|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
130324631|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
130324632|NCT04606134|469158730|FG000|Overall Study|Adverse Event|0|||
130324633|NCT04606134|469158731|FG001|Overall Study|Adverse Event|1|||
130324634|NCT01099267|469158733|FG000|MDS-003 Study|Adverse Event|37|||
130324635|NCT01099267|469158733|FG000|MDS-003 Study|Lack of Efficacy|52|||
130324636|NCT01099267|469158733|FG000|MDS-003 Study|Withdrawal by Subject|8|||
130324637|NCT01099267|469158733|FG000|MDS-003 Study|Lost to Follow-up|1|||
130551709|NCT00394953|469988103|FG000|First Treatment Period|Withdrawal by Subject|6|||
130551710|NCT00394953|469988104|FG001|First Treatment Period|Withdrawal by Subject|3|||
130551711|NCT00394953|469988103|FG000|First Treatment Period|Lost to Follow-up|0|||
130551712|NCT00394953|469988104|FG001|First Treatment Period|Lost to Follow-up|1|||
130551713|NCT00394953|469988103|FG000|First Treatment Period|Renal transplant|11|||
130551714|NCT00394953|469988104|FG001|First Treatment Period|Renal transplant|7|||
130551715|NCT00394953|469988103|FG000|First Treatment Period|Not defined|4|||
130551716|NCT00394953|469988104|FG001|First Treatment Period|Not defined|1|||
130551717|NCT00394953|469988103|FG000|Second Treatment Period|Adverse Event|2|||
130551718|NCT00394953|469988104|FG001|Second Treatment Period|Adverse Event|5|||
130551719|NCT00394953|469988103|FG000|Second Treatment Period|Death|8|||
130551720|NCT00394953|469988104|FG001|Second Treatment Period|Death|4|||
130551721|NCT00394953|469988103|FG000|Second Treatment Period|Lack of Efficacy|9|||
130551722|NCT00394953|469988104|FG001|Second Treatment Period|Lack of Efficacy|47|||
130551723|NCT00394953|469988103|FG000|Second Treatment Period|Withdrawal by Subject|3|||
130551724|NCT00394953|469988104|FG001|Second Treatment Period|Withdrawal by Subject|3|||
130551725|NCT00394953|469988103|FG000|Second Treatment Period|Lost to Follow-up|0|||
130551726|NCT00394953|469988104|FG001|Second Treatment Period|Lost to Follow-up|1|||
130551727|NCT00394953|469988103|FG000|Second Treatment Period|Renal transplant|4|||
130551728|NCT00394953|469988104|FG001|Second Treatment Period|Renal transplant|6|||
130551729|NCT00394953|469988103|FG000|Second Treatment Period|Not defined|3|||
130551730|NCT00394953|469988104|FG001|Second Treatment Period|Not defined|8|||
130551731|NCT03181451|469988108|FG000|Overall Study|Adverse Event|0|||
130551732|NCT03181451|469988109|FG001|Overall Study|Adverse Event|1|||
130551733|NCT03181451|469988110|FG002|Overall Study|Adverse Event|0|||
130551734|NCT03181451|469988108|FG000|Overall Study|Withdrawal by Subject|0|||
130551735|NCT03181451|469988109|FG001|Overall Study|Withdrawal by Subject|1|||
130551736|NCT03181451|469988110|FG002|Overall Study|Withdrawal by Subject|0|||
130551737|NCT02196714|469988114|FG000|Overall Study|Protocol Violation|0|||
130551738|NCT02196714|469988115|FG001|Overall Study|Protocol Violation|0|||
130551739|NCT02196714|469988116|FG002|Overall Study|Protocol Violation|1|||
130551740|NCT02196714|469988117|FG003|Overall Study|Protocol Violation|0|||
130551741|NCT01592864|469988119|FG000|Overall Study|Withdrawal by Subject|0|||
130551742|NCT01592864|469988120|FG001|Overall Study|Withdrawal by Subject|1|||
130551743|NCT01326533|469988128|FG000|Overall Study|Lost to Follow-up|2|||
130551744|NCT01326533|469988129|FG001|Overall Study|Lost to Follow-up|0|||
130551745|NCT01326533|469988128|FG000|Overall Study|Withdrawal by Subject|1|||
130551746|NCT01326533|469988129|FG001|Overall Study|Withdrawal by Subject|0|||
130551747|NCT01326533|469988128|FG000|Overall Study|Adverse Event|1|||
130551748|NCT01326533|469988129|FG001|Overall Study|Adverse Event|0|||
130551749|NCT04079803|469988130|FG000|Overall Study|Withdrawal by Subject|0|||
130551750|NCT04079803|469988131|FG001|Overall Study|Withdrawal by Subject|0|||
130551751|NCT04079803|469988132|FG002|Overall Study|Withdrawal by Subject|1|||
130551752|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
130551753|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
130551754|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
130551755|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
130324638|NCT01099267|469158733|FG000|MDS-003 Study|Death|11|||
130551756|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
130551757|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
130324639|NCT01099267|469158733|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
130551758|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
130551759|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
130551760|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
130551761|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
130324640|NCT01099267|469158733|FG000|MDS-003 Study|Disease Progression|7|||
130324641|NCT01099267|469158733|FG000|MDS-003 Study|Investigator Decision|2|||
130324642|NCT01099267|469158733|FG000|MDS-003 Study|Non-Compliance|2|||
130324643|NCT01099267|469158733|FG000|MDS-003 Study|Loss of Response|1|||
130324644|NCT01099267|469158733|FG000|MDS-003 Study|Secondary Malign Disease|1|||
130324645|NCT01838395|469158741|FG000|Overall Study|Withdrawal by Subject|0|||
130324646|NCT01838395|469158742|FG001|Overall Study|Withdrawal by Subject|0|||
130324647|NCT01838395|469158743|FG002|Overall Study|Withdrawal by Subject|0|||
130324648|NCT01838395|469158744|FG003|Overall Study|Withdrawal by Subject|0|||
130324649|NCT01838395|469158745|FG004|Overall Study|Withdrawal by Subject|1|||
130324650|NCT01838395|469158746|FG005|Overall Study|Withdrawal by Subject|0|||
130324651|NCT01838395|469158741|FG000|Overall Study|Death|0|||
130324652|NCT01838395|469158742|FG001|Overall Study|Death|0|||
130324653|NCT01838395|469158743|FG002|Overall Study|Death|1|||
130324654|NCT01838395|469158744|FG003|Overall Study|Death|0|||
130324655|NCT01838395|469158745|FG004|Overall Study|Death|0|||
130324656|NCT01838395|469158746|FG005|Overall Study|Death|0|||
130324657|NCT01838395|469158741|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324658|NCT01838395|469158742|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
130324659|NCT01838395|469158743|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324660|NCT01838395|469158744|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324661|NCT01838395|469158745|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324662|NCT01838395|469158746|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324663|NCT03866577|469158747|FG000|Overall Study|Protocol Violation|0|||
130324664|NCT03866577|469158748|FG001|Overall Study|Protocol Violation|0|||
130324665|NCT03866577|469158749|FG002|Overall Study|Protocol Violation|0|||
130324666|NCT03866577|469158750|FG003|Overall Study|Protocol Violation|0|||
130324667|NCT03866577|469158751|FG004|Overall Study|Protocol Violation|0|||
130324668|NCT03866577|469158752|FG005|Overall Study|Protocol Violation|0|||
130324669|NCT03866577|469158753|FG006|Overall Study|Protocol Violation|0|||
130324670|NCT03866577|469158754|FG007|Overall Study|Protocol Violation|0|||
130324671|NCT03866577|469158755|FG008|Overall Study|Protocol Violation|0|||
130324672|NCT03866577|469158756|FG009|Overall Study|Protocol Violation|0|||
130324673|NCT03866577|469158757|FG010|Overall Study|Protocol Violation|0|||
130324674|NCT03866577|469158758|FG011|Overall Study|Protocol Violation|1|||
130324675|NCT03866577|469158759|FG012|Overall Study|Protocol Violation|0|||
130324676|NCT03866577|469158747|FG000|Overall Study|Withdrawal by Subject|0|||
130324677|NCT03866577|469158748|FG001|Overall Study|Withdrawal by Subject|0|||
130324678|NCT03866577|469158749|FG002|Overall Study|Withdrawal by Subject|0|||
130324679|NCT03866577|469158750|FG003|Overall Study|Withdrawal by Subject|0|||
130324680|NCT03866577|469158751|FG004|Overall Study|Withdrawal by Subject|0|||
130324681|NCT03866577|469158752|FG005|Overall Study|Withdrawal by Subject|0|||
130324682|NCT03866577|469158753|FG006|Overall Study|Withdrawal by Subject|0|||
130324683|NCT03866577|469158754|FG007|Overall Study|Withdrawal by Subject|0|||
130324684|NCT03866577|469158755|FG008|Overall Study|Withdrawal by Subject|1|||
130324685|NCT03866577|469158756|FG009|Overall Study|Withdrawal by Subject|1|||
130324686|NCT03866577|469158757|FG010|Overall Study|Withdrawal by Subject|0|||
130324687|NCT03866577|469158758|FG011|Overall Study|Withdrawal by Subject|0|||
130324688|NCT03866577|469158759|FG012|Overall Study|Withdrawal by Subject|0|||
130324689|NCT03866577|469158747|FG000|Overall Study|Not qualified for IVIg infusion|0|||
130324690|NCT03866577|469158748|FG001|Overall Study|Not qualified for IVIg infusion|0|||
130324691|NCT03866577|469158749|FG002|Overall Study|Not qualified for IVIg infusion|0|||
130324692|NCT03866577|469158750|FG003|Overall Study|Not qualified for IVIg infusion|0|||
130324693|NCT03866577|469158751|FG004|Overall Study|Not qualified for IVIg infusion|0|||
130324694|NCT03866577|469158752|FG005|Overall Study|Not qualified for IVIg infusion|0|||
130324695|NCT03866577|469158753|FG006|Overall Study|Not qualified for IVIg infusion|0|||
130324696|NCT03866577|469158754|FG007|Overall Study|Not qualified for IVIg infusion|0|||
130324697|NCT03866577|469158755|FG008|Overall Study|Not qualified for IVIg infusion|0|||
130324698|NCT03866577|469158756|FG009|Overall Study|Not qualified for IVIg infusion|1|||
130324699|NCT03866577|469158757|FG010|Overall Study|Not qualified for IVIg infusion|0|||
130324700|NCT03866577|469158758|FG011|Overall Study|Not qualified for IVIg infusion|0|||
130324701|NCT03866577|469158759|FG012|Overall Study|Not qualified for IVIg infusion|0|||
130324702|NCT04825678|469158760|FG000|Overall Study|Decision by Sponsor|2|||
130324703|NCT04825678|469158761|FG001|Overall Study|Decision by Sponsor|3|||
130324704|NCT04825678|469158760|FG000|Overall Study|Withdrawal of Consent From Study|7|||
130324705|NCT04825678|469158761|FG001|Overall Study|Withdrawal of Consent From Study|9|||
130324706|NCT04825678|469158760|FG000|Overall Study|Lost to Follow-up|3|||
130324707|NCT04825678|469158761|FG001|Overall Study|Lost to Follow-up|4|||
130324708|NCT04825678|469158760|FG000|Overall Study|Never Received Investigational Product|1|||
130324709|NCT04825678|469158761|FG001|Overall Study|Never Received Investigational Product|1|||
130324710|NCT05530252|469158762|FG000|Overall Study|Lost to Follow-up|1|||
130324711|NCT05530252|469158763|FG001|Overall Study|Lost to Follow-up|1|||
130324712|NCT05530252|469158764|FG002|Overall Study|Lost to Follow-up|1|||
130324713|NCT03043794|469158770|FG000|Overall Study|Lost to Follow-up|1|||
130551762|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
130214699|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214700|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214701|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214702|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214703|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214704|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214705|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214706|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
130214707|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214708|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214709|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214710|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214711|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214712|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214713|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214714|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214715|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214716|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130214717|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214718|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214719|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214720|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214721|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214722|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214723|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214724|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214725|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214726|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214727|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
130214728|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214729|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214730|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214731|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214732|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214733|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214734|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214735|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
130214736|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
130214737|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
130214738|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214739|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214740|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214741|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214742|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214743|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214744|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214745|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214746|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214747|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214748|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
130214749|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214750|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
130214751|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214752|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214753|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214754|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214755|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214756|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214757|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214758|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
130551763|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
130324714|NCT05565742|469158771|FG000|Overall Study|Withdrawal by Subject|0|||
130324715|NCT05565742|469158772|FG001|Overall Study|Withdrawal by Subject|0|||
130324716|NCT05565742|469158773|FG002|Overall Study|Withdrawal by Subject|2|||
130324717|NCT05565742|469158774|FG003|Overall Study|Withdrawal by Subject|2|||
130324718|NCT05565742|469158775|FG004|Overall Study|Withdrawal by Subject|2|||
130324719|NCT05565742|469158771|FG000|Overall Study|Death|1|||
130324720|NCT05565742|469158772|FG001|Overall Study|Death|0|||
130324721|NCT05565742|469158773|FG002|Overall Study|Death|0|||
130324722|NCT05565742|469158774|FG003|Overall Study|Death|0|||
130551764|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
130551765|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
130551766|NCT01294683|469988133|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
130551767|NCT01294683|469988134|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
130551768|NCT01294683|469988133|FG000|Post Crossover (Period III)|Adverse Event|6|||
130551769|NCT01294683|469988134|FG001|Post Crossover (Period III)|Adverse Event|6|||
130551770|NCT01294683|469988133|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
130551771|NCT01294683|469988134|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
130551772|NCT01294683|469988133|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
130656880|NCT02181673|470365831|FG001|Up to Week 24|Randomized not Treated|0|||
130656881|NCT02181673|470365832|FG002|Up to Week 24|Randomized not Treated|1|||
130656882|NCT02181673|470365830|FG000|Week 24-Week 60|Adverse Event|0|||
130656883|NCT02181673|470365831|FG001|Week 24-Week 60|Adverse Event|4|||
130656884|NCT02181673|470365832|FG002|Week 24-Week 60|Adverse Event|10|||
130214759|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130214760|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
130214761|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214762|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214763|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214764|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214765|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214766|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214767|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214768|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214769|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
130214770|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214771|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214772|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214773|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214774|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214775|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214776|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214777|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214778|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214779|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214780|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
130214781|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214782|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214783|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214784|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214785|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214786|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214787|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214788|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
130214789|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214790|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214791|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214792|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214793|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214794|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214795|NCT02757352|468751600|FG000|Follow-Up Period|Adverse Event|0|||
130214796|NCT02757352|468751601|FG001|Follow-Up Period|Adverse Event|0|||
130214797|NCT02757352|468751602|FG002|Follow-Up Period|Adverse Event|0|||
130214798|NCT02757352|468751603|FG003|Follow-Up Period|Adverse Event|0|||
130214799|NCT02757352|468751604|FG004|Follow-Up Period|Adverse Event|0|||
130214800|NCT02757352|468751605|FG005|Follow-Up Period|Adverse Event|0|||
130324723|NCT05565742|469158775|FG004|Overall Study|Death|0|||
130324724|NCT05565742|469158771|FG000|Overall Study|Participant Travelled Abroad|0|||
130656885|NCT02181673|470365830|FG000|Week 24-Week 60|Other|0|||
130656886|NCT02181673|470365831|FG001|Week 24-Week 60|Other|2|||
130656887|NCT02181673|470365832|FG002|Week 24-Week 60|Other|1|||
130324725|NCT05565742|469158772|FG001|Overall Study|Participant Travelled Abroad|0|||
130324726|NCT05565742|469158773|FG002|Overall Study|Participant Travelled Abroad|0|||
130324727|NCT05565742|469158774|FG003|Overall Study|Participant Travelled Abroad|0|||
130324728|NCT05565742|469158775|FG004|Overall Study|Participant Travelled Abroad|1|||
130324729|NCT04163341|469158776|FG000|Overall Study|Withdrawal by Subject|2|||
130324730|NCT04163341|469158777|FG001|Overall Study|Withdrawal by Subject|0|||
130324731|NCT04163341|469158776|FG000|Overall Study|Lost to Follow-up|3|||
130324732|NCT04163341|469158777|FG001|Overall Study|Lost to Follow-up|4|||
130324733|NCT02855125|469158778|FG000|Overall Study|Withdrawal by Subject|2|||
130324734|NCT02855125|469158779|FG001|Overall Study|Withdrawal by Subject|2|||
130324735|NCT02855125|469158778|FG000|Overall Study|Clinical Disease Progression|5|||
130324736|NCT02855125|469158779|FG001|Overall Study|Clinical Disease Progression|4|||
130324737|NCT02855125|469158778|FG000|Overall Study|Radiologic Disease Progression|36|||
130324738|NCT02855125|469158779|FG001|Overall Study|Radiologic Disease Progression|39|||
130324739|NCT02855125|469158778|FG000|Overall Study|Adverse Event|11|||
130324740|NCT02855125|469158779|FG001|Overall Study|Adverse Event|7|||
130324741|NCT02855125|469158778|FG000|Overall Study|Physician Decision|1|||
130324742|NCT02855125|469158779|FG001|Overall Study|Physician Decision|0|||
130324743|NCT02855125|469158778|FG000|Overall Study|On Treatment|9|||
130324744|NCT02855125|469158779|FG001|Overall Study|On Treatment|11|||
130324745|NCT02855125|469158778|FG000|Overall Study|Randomized but not treated|0|||
130324746|NCT02855125|469158779|FG001|Overall Study|Randomized but not treated|1|||
130324747|NCT04467905|469158780|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
130324748|NCT04467905|469158781|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
130324749|NCT04467905|469158782|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
130324750|NCT04467905|469158780|FG000|Overall Study|Conversion to SR|0|||
130324751|NCT04467905|469158781|FG001|Overall Study|Conversion to SR|0|||
130324752|NCT04467905|469158782|FG002|Overall Study|Conversion to SR|3|||
130324753|NCT04467905|469158780|FG000|Overall Study|Technical issue with Holter ECG|0|||
130324754|NCT04467905|469158781|FG001|Overall Study|Technical issue with Holter ECG|0|||
130324755|NCT04467905|469158782|FG002|Overall Study|Technical issue with Holter ECG|3|||
130324756|NCT04467905|469158780|FG000|Overall Study|Hemodynamic instability|0|||
130324757|NCT04467905|469158781|FG001|Overall Study|Hemodynamic instability|0|||
130324758|NCT04467905|469158782|FG002|Overall Study|Hemodynamic instability|1|||
130324759|NCT04467905|469158780|FG000|Overall Study|Site misinterpretation of protocol|0|||
130324760|NCT04467905|469158781|FG001|Overall Study|Site misinterpretation of protocol|0|||
130324761|NCT04467905|469158782|FG002|Overall Study|Site misinterpretation of protocol|1|||
130324762|NCT04586205|469158787|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
130324763|NCT04586205|469158788|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
130433148|NCT01453348|469550352|FG000|Overall Study|Withdrawal by Subject|0|||
130433149|NCT01453348|469550353|FG001|Overall Study|Withdrawal by Subject|1|||
130433150|NCT01453348|469550354|FG002|Overall Study|Withdrawal by Subject|0|||
130433151|NCT01453348|469550352|FG000|Overall Study|Protocol Violation|1|||
130433152|NCT01453348|469550353|FG001|Overall Study|Protocol Violation|0|||
130433153|NCT01453348|469550354|FG002|Overall Study|Protocol Violation|0|||
130433154|NCT00954733|469550359|FG000|Overall Study|blood gas machine did not work|1|||
130433155|NCT01216163|469550362|FG000|Overall Study|Withdrawal by Subject|1|||
130433156|NCT01216163|469550363|FG001|Overall Study|Withdrawal by Subject|1|||
130433157|NCT01216163|469550364|FG002|Overall Study|Withdrawal by Subject|0|||
130433158|NCT02914314|469550365|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130433159|NCT02914314|469550366|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130433160|NCT02914314|469550367|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130433161|NCT02914314|469550368|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
130433162|NCT02914314|469550365|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130551773|NCT01294683|469988134|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
130551774|NCT01294683|469988133|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
130551775|NCT01294683|469988134|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
130551776|NCT01881750|469988135|FG000|Overall Study|Changes in concomitant therapies|2|||
130433163|NCT02914314|469550366|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130433164|NCT02914314|469550367|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130551777|NCT01881750|469988136|FG001|Overall Study|Changes in concomitant therapies|3|||
130551778|NCT01881750|469988135|FG000|Overall Study|Lost to Follow-up|0|||
130324782|NCT01586364|469160689|FG000|Overall Study|Withdrawal by Subject|40|||
130324783|NCT01586364|469160689|FG000|Overall Study|Adverse Event|37|||
130551779|NCT01881750|469988136|FG001|Overall Study|Lost to Follow-up|1|||
130324784|NCT01586364|469160689|FG000|Overall Study|Lost to Follow-up|17|||
130324785|NCT01586364|469160689|FG000|Overall Study|Protocol Violation|16|||
130324786|NCT01586364|469160689|FG000|Overall Study|Lack of Efficacy|1|||
130324787|NCT01586364|469160689|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
130324788|NCT01586364|469160689|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
130324789|NCT01586364|469160689|FG000|Overall Study|Other-Site closure due to PI illness|1|||
130324790|NCT01586364|469160689|FG000|Overall Study|Other-PI discretion, site closing|2|||
130551780|NCT00926211|469988138|FG000|Overall Study|Lost to Follow-up|1|||
130214801|NCT02757352|468751606|FG006|Follow-Up Period|Adverse Event|1|||
130214802|NCT02757352|468751607|FG007|Follow-Up Period|Adverse Event|0|||
130214803|NCT02757352|468751608|FG008|Follow-Up Period|Adverse Event|2|||
130214804|NCT02757352|468751609|FG009|Follow-Up Period|Adverse Event|0|||
130214805|NCT02757352|468751600|FG000|Follow-Up Period|Lost to Follow-up|0|||
130214806|NCT02757352|468751601|FG001|Follow-Up Period|Lost to Follow-up|0|||
130214807|NCT02757352|468751602|FG002|Follow-Up Period|Lost to Follow-up|0|||
130214808|NCT02757352|468751603|FG003|Follow-Up Period|Lost to Follow-up|0|||
130214809|NCT02757352|468751604|FG004|Follow-Up Period|Lost to Follow-up|0|||
130214810|NCT02757352|468751605|FG005|Follow-Up Period|Lost to Follow-up|0|||
130214811|NCT02757352|468751606|FG006|Follow-Up Period|Lost to Follow-up|0|||
130214812|NCT02757352|468751607|FG007|Follow-Up Period|Lost to Follow-up|0|||
130214813|NCT02757352|468751608|FG008|Follow-Up Period|Lost to Follow-up|1|||
130214814|NCT02757352|468751609|FG009|Follow-Up Period|Lost to Follow-up|0|||
130214815|NCT02757352|468751600|FG000|Follow-Up Period|Lack of Efficacy|0|||
130214816|NCT02757352|468751601|FG001|Follow-Up Period|Lack of Efficacy|0|||
130214817|NCT02757352|468751602|FG002|Follow-Up Period|Lack of Efficacy|0|||
130214818|NCT02757352|468751603|FG003|Follow-Up Period|Lack of Efficacy|0|||
130214819|NCT02757352|468751604|FG004|Follow-Up Period|Lack of Efficacy|0|||
130214820|NCT02757352|468751605|FG005|Follow-Up Period|Lack of Efficacy|0|||
130214821|NCT02757352|468751606|FG006|Follow-Up Period|Lack of Efficacy|0|||
130214822|NCT02757352|468751607|FG007|Follow-Up Period|Lack of Efficacy|0|||
130214823|NCT02757352|468751608|FG008|Follow-Up Period|Lack of Efficacy|1|||
130214824|NCT02757352|468751609|FG009|Follow-Up Period|Lack of Efficacy|1|||
130214825|NCT02757352|468751600|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130214826|NCT02757352|468751601|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130214827|NCT02757352|468751602|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130214828|NCT02757352|468751603|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130214829|NCT02757352|468751604|FG004|Follow-Up Period|Withdrawal by Subject|0|||
130214830|NCT02757352|468751605|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130214831|NCT02757352|468751606|FG006|Follow-Up Period|Withdrawal by Subject|0|||
130214832|NCT02757352|468751607|FG007|Follow-Up Period|Withdrawal by Subject|1|||
130214833|NCT02757352|468751608|FG008|Follow-Up Period|Withdrawal by Subject|6|||
130214834|NCT02757352|468751609|FG009|Follow-Up Period|Withdrawal by Subject|2|||
130214835|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
130214836|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214837|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214838|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214839|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
130214840|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214841|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214842|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214843|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
130214844|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
130214845|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
130214846|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
130214847|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
130214848|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214849|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214850|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214851|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
130214852|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
130214853|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
130214854|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
130214855|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214856|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214857|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214858|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
130214859|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214860|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214861|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214862|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
130214863|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214864|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214865|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
130214866|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214867|NCT00802672|468751620|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
130214868|NCT00802672|468751621|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
130214869|NCT00802672|468751622|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
130214870|NCT00802672|468751620|FG000|Overall Study|Adverse Event|1|||
130214871|NCT00802672|468751621|FG001|Overall Study|Adverse Event|1|||
130324791|NCT01586364|469160689|FG000|Overall Study|Other-Not specified|1|||
130324792|NCT02121535|469160690|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
130324793|NCT02121535|469160691|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
130324794|NCT02121535|469160690|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
130324795|NCT02121535|469160691|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
130324796|NCT00091949|469160692|FG000|Overall Study|Withdrawal by Subject|117|||
130324797|NCT00091949|469160693|FG001|Overall Study|Withdrawal by Subject|110|||
130324798|NCT00091949|469160692|FG000|Overall Study|Lost to Follow-up|58|||
130324799|NCT00091949|469160693|FG001|Overall Study|Lost to Follow-up|41|||
130324800|NCT02083354|469160694|FG000|Overall Study|Withdrawal by Subject|9|||
130324801|NCT02083354|469160694|FG000|Overall Study|Lost to Follow-up|1|||
130324802|NCT02083354|469160694|FG000|Overall Study|Adverse Event|3|||
130324803|NCT02083354|469160694|FG000|Overall Study|Disease progression|46|||
130324804|NCT02083354|469160694|FG000|Overall Study|Study closed/terminated|5|||
130324805|NCT04328077|469160695|FG000|Overall Study|Lost to Follow-up|0|||
130324806|NCT04328077|469160696|FG001|Overall Study|Lost to Follow-up|1|||
130324807|NCT04328077|469160697|FG002|Overall Study|Lost to Follow-up|0|||
130324808|NCT04328077|469160698|FG003|Overall Study|Lost to Follow-up|0|||
130324809|NCT04328077|469160695|FG000|Overall Study|Withdrawal by Subject|0|||
130324810|NCT04328077|469160696|FG001|Overall Study|Withdrawal by Subject|1|||
130324811|NCT04328077|469160697|FG002|Overall Study|Withdrawal by Subject|1|||
130324812|NCT04328077|469160698|FG003|Overall Study|Withdrawal by Subject|3|||
130324813|NCT02419001|469160709|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
130324814|NCT02419001|469160710|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
130324815|NCT00313014|469160711|FG000|Overall Study|Withdrawal by Subject|11|||
130324816|NCT00313014|469160712|FG001|Overall Study|Withdrawal by Subject|7|||
130324817|NCT00313014|469160713|FG002|Overall Study|Withdrawal by Subject|5|||
130324818|NCT00313014|469160711|FG000|Overall Study|Adverse Event|14|||
130324819|NCT00313014|469160712|FG001|Overall Study|Adverse Event|29|||
130324820|NCT00313014|469160713|FG002|Overall Study|Adverse Event|16|||
130324821|NCT00313014|469160711|FG000|Overall Study|Lost to Follow-up|7|||
130324822|NCT00313014|469160712|FG001|Overall Study|Lost to Follow-up|6|||
130324823|NCT00313014|469160713|FG002|Overall Study|Lost to Follow-up|10|||
130324824|NCT00313014|469160711|FG000|Overall Study|Administrative|9|||
130324825|NCT00313014|469160712|FG001|Overall Study|Administrative|6|||
130324826|NCT00313014|469160713|FG002|Overall Study|Administrative|14|||
130324827|NCT00313014|469160711|FG000|Overall Study|Lack of Efficacy|52|||
130324828|NCT00313014|469160712|FG001|Overall Study|Lack of Efficacy|25|||
130324829|NCT00313014|469160713|FG002|Overall Study|Lack of Efficacy|16|||
130324830|NCT01198795|469160716|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
130324831|NCT01198795|469160716|FG000|Overall Study|Withdrawal by Subject|17|||
130324832|NCT01198795|469160716|FG000|Overall Study|Lost to Follow-up|15|||
130324833|NCT01198795|469160716|FG000|Overall Study|Adverse Event|9|||
130324834|NCT01198795|469160716|FG000|Overall Study|Lack of Efficacy|5|||
130324835|NCT01198795|469160716|FG000|Overall Study|Protocol Violation|2|||
130324836|NCT01198795|469160716|FG000|Overall Study|Other Reason|4|||
130324837|NCT00744497|469160717|FG000|Overall Study|Withdrawal by Subject|21|||
130324838|NCT00744497|469160718|FG001|Overall Study|Withdrawal by Subject|18|||
130324839|NCT00744497|469160717|FG000|Overall Study|Death|11|||
130324840|NCT00744497|469160718|FG001|Overall Study|Death|9|||
130324841|NCT00744497|469160717|FG000|Overall Study|Lost to Follow-up|4|||
130324842|NCT00744497|469160718|FG001|Overall Study|Lost to Follow-up|2|||
130324843|NCT00744497|469160717|FG000|Overall Study|Poor compliance/noncompliance|9|||
130324844|NCT00744497|469160718|FG001|Overall Study|Poor compliance/noncompliance|5|||
130324845|NCT00744497|469160717|FG000|Overall Study|No longer meets study criteria|7|||
130324846|NCT00744497|469160718|FG001|Overall Study|No longer meets study criteria|3|||
130324847|NCT00744497|469160717|FG000|Overall Study|Administrative Reason By Sponsor|25|||
130324848|NCT00744497|469160718|FG001|Overall Study|Administrative Reason By Sponsor|8|||
130324849|NCT00744497|469160717|FG000|Overall Study|Disease progression|312|||
130324850|NCT00744497|469160718|FG001|Overall Study|Disease progression|219|||
130324851|NCT00744497|469160717|FG000|Overall Study|Study drug toxicity|68|||
130324852|NCT00744497|469160718|FG001|Overall Study|Study drug toxicity|141|||
130551781|NCT01323634|469988141|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
130324853|NCT00744497|469160717|FG000|Overall Study|Adverse event unrelated to study drug|78|||
130324854|NCT00744497|469160718|FG001|Overall Study|Adverse event unrelated to study drug|122|||
130324855|NCT00744497|469160717|FG000|Overall Study|Patient requested to stop study drug|65|||
130324856|NCT00744497|469160718|FG001|Overall Study|Patient requested to stop study drug|80|||
130324857|NCT00744497|469160717|FG000|Overall Study|Maximum clinical benefit|141|||
130324858|NCT00744497|469160718|FG001|Overall Study|Maximum clinical benefit|142|||
130324859|NCT00744497|469160717|FG000|Overall Study|Not defined|19|||
130324860|NCT00744497|469160718|FG001|Overall Study|Not defined|13|||
130324861|NCT04154904|469160753|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
130324862|NCT04154904|469160754|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
130324863|NCT04154904|469160755|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
130324864|NCT00936715|469160756|FG000|Overall Study|Investigators Discretion|1|||
130324865|NCT00936715|469160756|FG000|Overall Study|Protocol Violation|1|||
130324866|NCT00936715|469160756|FG000|Overall Study|Safety or Tolerability Reasons|4|||
130324867|NCT03819114|469160757|FG000|Overall Study|Protocol Violation|0|||
130324868|NCT03819114|469160758|FG001|Overall Study|Protocol Violation|1|||
130324869|NCT03819114|469160759|FG002|Overall Study|Protocol Violation|1|||
130324870|NCT03819114|469160760|FG003|Overall Study|Protocol Violation|0|||
130324871|NCT03819114|469160757|FG000|Overall Study|Lost to Follow-up|0|||
130324872|NCT03819114|469160758|FG001|Overall Study|Lost to Follow-up|0|||
130324873|NCT03819114|469160759|FG002|Overall Study|Lost to Follow-up|1|||
130324874|NCT03819114|469160760|FG003|Overall Study|Lost to Follow-up|0|||
130324875|NCT01744977|469160761|FG000|Overall Study|Withdrawal by Subject|1|||
130324876|NCT01744977|469160762|FG001|Overall Study|Withdrawal by Subject|2|||
130324877|NCT01744977|469160761|FG000|Overall Study|Death|2|||
130324878|NCT01744977|469160762|FG001|Overall Study|Death|3|||
130324879|NCT01744977|469160761|FG000|Overall Study|Lost to Follow-up|2|||
130324880|NCT01744977|469160762|FG001|Overall Study|Lost to Follow-up|0|||
130324881|NCT01744977|469160761|FG000|Overall Study|No longer meets inclusion|6|||
130324882|NCT01744977|469160762|FG001|Overall Study|No longer meets inclusion|0|||
130324883|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324884|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
130324885|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324886|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324887|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324888|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324889|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324890|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324891|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324892|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324893|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324894|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324895|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324896|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324897|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
130324898|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324899|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324900|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324901|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324902|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324903|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324904|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324905|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324906|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324907|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324908|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324909|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
130324910|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324911|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324912|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324913|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324914|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324915|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324916|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324917|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324918|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324919|NCT04225897|469160770|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324920|NCT04225897|469160771|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324921|NCT04225897|469160772|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130214872|NCT00802672|468751622|FG002|Overall Study|Adverse Event|1|||
130214873|NCT00802672|468751620|FG000|Overall Study|Protocol Violation|2|||
130214874|NCT00802672|468751621|FG001|Overall Study|Protocol Violation|1|||
130214875|NCT00802672|468751622|FG002|Overall Study|Protocol Violation|1|||
130214876|NCT00802672|468751620|FG000|Overall Study|Lost to Follow-up|5|||
130214877|NCT00802672|468751621|FG001|Overall Study|Lost to Follow-up|5|||
130214878|NCT00802672|468751622|FG002|Overall Study|Lost to Follow-up|3|||
130214879|NCT00802672|468751620|FG000|Overall Study|Withdrawal by Subject|1|||
130214880|NCT00802672|468751621|FG001|Overall Study|Withdrawal by Subject|1|||
130214881|NCT00802672|468751622|FG002|Overall Study|Withdrawal by Subject|2|||
130214882|NCT00802672|468751620|FG000|Overall Study|other|3|||
130214883|NCT00802672|468751621|FG001|Overall Study|other|1|||
130214884|NCT00802672|468751622|FG002|Overall Study|other|2|||
130324922|NCT04225897|469160773|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324923|NCT04225897|469160774|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324924|NCT04225897|469160775|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324925|NCT04225897|469160776|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324926|NCT04225897|469160777|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
130324927|NCT04225897|469160778|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324928|NCT04225897|469160779|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324929|NCT04225897|469160780|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324930|NCT04225897|469160781|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324931|NCT02703597|469160782|FG000|Assignment to Baseline|Lost to Follow-up|17|||
130324932|NCT02703597|469160783|FG001|Assignment to Baseline|Lost to Follow-up|16|||
130324933|NCT02703597|469160782|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
130324934|NCT02703597|469160783|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
130324935|NCT02703597|469160782|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
130324936|NCT02703597|469160783|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
130324937|NCT02703597|469160782|FG000|First Post-test to First Follow-up|Site drop out|0|||
130324938|NCT02703597|469160783|FG001|First Post-test to First Follow-up|Site drop out|58|||
130324939|NCT02703597|469160782|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
130324940|NCT02703597|469160783|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
130324941|NCT02703597|469160782|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
130324942|NCT02703597|469160783|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
130324943|NCT02703597|469160782|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
130324944|NCT02703597|469160783|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
130324945|NCT02131259|469160784|FG000|Overall Study|Progressive disease|751|||
130324946|NCT02131259|469160784|FG000|Overall Study|Adverse Event|341|||
130324947|NCT02131259|469160784|FG000|Overall Study|Lost to Follow-up|7|||
130324948|NCT02131259|469160784|FG000|Overall Study|Relocation|32|||
130324949|NCT02131259|469160784|FG000|Overall Study|Other|63|||
130324950|NCT02131259|469160784|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
130324951|NCT02131259|469160784|FG000|Overall Study|Progressive disease/relocation|1|||
130324952|NCT02131259|469160784|FG000|Overall Study|Progressive disease/other|2|||
130324953|NCT02131259|469160784|FG000|Overall Study|AE/lost to follow-up|1|||
130324954|NCT02131259|469160784|FG000|Overall Study|AE/other|1|||
130324955|NCT02131259|469160784|FG000|Overall Study|Progressive disease/AE/other|1|||
130324956|NCT02131259|469160784|FG000|Overall Study|Missing|3|||
130324957|NCT02796170|469160785|FG000|Overall Study|Lost to Follow-up|3|||
130324958|NCT02796170|469160786|FG001|Overall Study|Lost to Follow-up|0|||
130324959|NCT03818321|469160789|FG000|Overall Study|Withdrawal by Subject|1|||
130324960|NCT03818321|469160790|FG001|Overall Study|Withdrawal by Subject|2|||
130324961|NCT01867671|469160791|FG000|Overall Study|Adverse Event|5|||
130324962|NCT01867671|469160792|FG001|Overall Study|Adverse Event|3|||
130324963|NCT01867671|469160791|FG000|Overall Study|Anaphylaxis|0|||
130324964|NCT01867671|469160792|FG001|Overall Study|Anaphylaxis|1|||
130324965|NCT01867671|469160791|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
130214885|NCT01616758|468751624|FG000|Overall Study|Adverse Event|1|||
130214886|NCT01616758|468751624|FG000|Overall Study|Withdrawal by Subject|2|||
130214887|NCT01616758|468751624|FG000|Overall Study|Disease progression|18|||
130214888|NCT01616758|468751624|FG000|Overall Study|Study termination by Sponsor|1|||
130214889|NCT03026283|468751625|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
130214890|NCT03026283|468751626|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
130214891|NCT03026283|468751627|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
130214892|NCT03026283|468751628|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
130214893|NCT03026283|468751629|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
130214894|NCT03026283|468751630|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
130214895|NCT03026283|468751631|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
130214896|NCT03026283|468751632|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
130214897|NCT03026283|468751625|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
130214898|NCT03026283|468751626|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
130214899|NCT03026283|468751627|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
130214900|NCT03026283|468751628|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
130214901|NCT03026283|468751629|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
130214902|NCT03026283|468751630|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
130214903|NCT03026283|468751631|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
130214904|NCT03026283|468751632|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
130214905|NCT03026283|468751625|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214906|NCT03026283|468751626|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
130214907|NCT03026283|468751627|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214908|NCT03026283|468751628|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214909|NCT03026283|468751629|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130324966|NCT01867671|469160792|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
130324967|NCT01867671|469160791|FG000|Overall Study|Lost to Follow-up|0|||
130324968|NCT01867671|469160792|FG001|Overall Study|Lost to Follow-up|1|||
130324969|NCT01867671|469160791|FG000|Overall Study|Non-compliance with Study Drug|1|||
130324970|NCT01867671|469160792|FG001|Overall Study|Non-compliance with Study Drug|2|||
130324971|NCT01867671|469160791|FG000|Overall Study|Withdrawal by Subject|21|||
130324972|NCT01867671|469160792|FG001|Overall Study|Withdrawal by Subject|21|||
130324973|NCT01523366|469160793|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130324974|NCT01523366|469160794|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130324975|NCT01523366|469160793|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
130324976|NCT01523366|469160794|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
130324977|NCT04543279|469160799|FG000|Overall Study|Withdrawal by Subject|1|||
130324978|NCT04543279|469160800|FG001|Overall Study|Withdrawal by Subject|0|||
130324979|NCT04543279|469160799|FG000|Overall Study|Adverse Event|1|||
130324980|NCT04543279|469160800|FG001|Overall Study|Adverse Event|0|||
130324981|NCT04543279|469160799|FG000|Overall Study|Physician Decision|1|||
130324982|NCT04543279|469160800|FG001|Overall Study|Physician Decision|0|||
130324983|NCT05249582|469160804|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
130324984|NCT05249582|469160805|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
130324985|NCT05249582|469160804|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
130324986|NCT05249582|469160805|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
130324987|NCT05249582|469160804|FG000|Overall Study|Declined to use virtual reality headset|1|||
130324988|NCT05249582|469160805|FG001|Overall Study|Declined to use virtual reality headset|0|||
130324989|NCT03675126|469160806|FG000|Overall Study|Study Terminated by Sponsor|9|||
130324990|NCT03675126|469160806|FG000|Overall Study|Death|2|||
130324991|NCT03675126|469160806|FG000|Overall Study|Withdrawal by Subject|4|||
130324992|NCT00001959|469160807|FG000|Overall Study|newly diagnosed colon cancer|1|||
130324993|NCT00001959|469160807|FG000|Overall Study|disabling sedation|1|||
130324994|NCT00001959|469160807|FG000|Overall Study|non-compliance|1|||
130324995|NCT04189952|469160809|FG000|Follow-up Period|Death|1|||
130324996|NCT04189952|469160809|FG000|Follow-up Period|Withdrawal by Subject|1|||
130324997|NCT01052493|469160810|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
130324998|NCT01052493|469160811|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130324999|NCT01052493|469160812|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130325000|NCT00283296|469160814|FG000|Overall Study|in-home trial not completed|5|||
130325001|NCT02158442|469160817|FG000|Overall Study|Withdrawal by Subject|1|||
130325002|NCT02158442|469160818|FG001|Overall Study|Withdrawal by Subject|0|||
130325003|NCT02158442|469160817|FG000|Overall Study|Perfusion staff not available|1|||
130325004|NCT02158442|469160818|FG001|Overall Study|Perfusion staff not available|0|||
130325005|NCT00632229|469160826|FG000|Overall Study|Adverse Event|6|||
130325006|NCT00632229|469160827|FG001|Overall Study|Adverse Event|0|||
130214910|NCT03026283|468751630|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214911|NCT03026283|468751631|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214912|NCT03026283|468751632|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214913|NCT03026283|468751625|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214914|NCT03026283|468751626|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214915|NCT03026283|468751627|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
130214916|NCT03026283|468751628|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214917|NCT03026283|468751629|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214918|NCT03026283|468751630|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214919|NCT03026283|468751631|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214920|NCT03026283|468751632|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214921|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214922|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214923|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214924|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
130214925|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
130214926|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214927|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214928|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214929|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214930|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214931|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214932|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
130214933|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130214934|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130214935|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214936|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130325007|NCT00632229|469160826|FG000|Overall Study|Lost to Follow-up|0|||
130325008|NCT00632229|469160827|FG001|Overall Study|Lost to Follow-up|3|||
130325009|NCT00632229|469160826|FG000|Overall Study|Lack of Efficacy|0|||
130325010|NCT00632229|469160827|FG001|Overall Study|Lack of Efficacy|2|||
130325011|NCT00632229|469160826|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
130656888|NCT02181673|470365830|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
130656889|NCT02181673|470365831|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
130656890|NCT02181673|470365832|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
130656891|NCT02181673|470365830|FG000|Week 24-Week 60|Pregnancy|0|||
130656892|NCT02181673|470365831|FG001|Week 24-Week 60|Pregnancy|0|||
130656893|NCT02181673|470365832|FG002|Week 24-Week 60|Pregnancy|1|||
130656894|NCT02181673|470365830|FG000|Week 24-Week 60|Lack of Efficacy|0|||
130656895|NCT02181673|470365831|FG001|Week 24-Week 60|Lack of Efficacy|0|||
130656896|NCT02181673|470365832|FG002|Week 24-Week 60|Lack of Efficacy|1|||
130656897|NCT02181673|470365830|FG000|Week 24-Week 60|Lost to Follow-up|0|||
130656898|NCT02181673|470365831|FG001|Week 24-Week 60|Lost to Follow-up|0|||
130656899|NCT02181673|470365832|FG002|Week 24-Week 60|Lost to Follow-up|1|||
130656900|NCT02181673|470365830|FG000|Week 24-Week 60|Physician Decision|0|||
130656901|NCT02181673|470365831|FG001|Week 24-Week 60|Physician Decision|0|||
130656902|NCT02181673|470365832|FG002|Week 24-Week 60|Physician Decision|1|||
130656903|NCT00433771|470365833|FG000|Overall Study|screen fail|14|||
130656904|NCT00433771|470365833|FG000|Overall Study|Treated and later found to be ineligible|2|||
130656905|NCT00433771|470365833|FG000|Overall Study|Death|2|||
130656906|NCT00433771|470365833|FG000|Overall Study|Failure to deploy stent|1|||
130656907|NCT02230332|470365836|FG000|Overall Study|Adverse Event|2|||
130325012|NCT00632229|469160827|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
130325013|NCT00474812|469160834|FG000|Overall Study|Withdrawal by Subject|5|||
130325014|NCT00474812|469160834|FG000|Overall Study|No Initiation of treatment|2|||
130325015|NCT00737672|469160841|FG000|Overall Study|Graft Abandonment|48|||
130325016|NCT00737672|469160842|FG001|Overall Study|Graft Abandonment|56|||
130325017|NCT00737672|469160841|FG000|Overall Study|Death|23|||
130325018|NCT00737672|469160842|FG001|Overall Study|Death|22|||
130325019|NCT00737672|469160841|FG000|Overall Study|Withdrawal by Subject|1|||
130325020|NCT00737672|469160842|FG001|Overall Study|Withdrawal by Subject|2|||
130325021|NCT00737672|469160841|FG000|Overall Study|Lost to Follow-up|1|||
130325022|NCT00737672|469160842|FG001|Overall Study|Lost to Follow-up|0|||
130325023|NCT00737672|469160841|FG000|Overall Study|Miscellaneous|7|||
130325024|NCT00737672|469160842|FG001|Overall Study|Miscellaneous|1|||
130325025|NCT00737672|469160841|FG000|Overall Study|Physician Decision|0|||
130325026|NCT00737672|469160842|FG001|Overall Study|Physician Decision|2|||
130325027|NCT04123470|469160844|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
130325028|NCT04123470|469160845|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130325029|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
130325030|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
130325031|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
130325032|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
130325033|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
130325034|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
130325035|NCT05408429|469160857|FG000|Overall Study|Lost to Follow-up|1|||
130325036|NCT05408429|469160858|FG001|Overall Study|Lost to Follow-up|1|||
130325037|NCT05408429|469160859|FG002|Overall Study|Lost to Follow-up|0|||
130325038|NCT05408429|469160857|FG000|Overall Study|Withdrawal by Subject|5|||
130325039|NCT05408429|469160858|FG001|Overall Study|Withdrawal by Subject|0|||
130325040|NCT05408429|469160859|FG002|Overall Study|Withdrawal by Subject|1|||
130325041|NCT05972993|469160861|FG000|Overall Study|Lost to Follow-up|2|||
130325042|NCT05972993|469160862|FG001|Overall Study|Lost to Follow-up|0|||
130325043|NCT05972993|469160863|FG002|Overall Study|Lost to Follow-up|1|||
130325044|NCT05972993|469160864|FG003|Overall Study|Lost to Follow-up|0|||
130325045|NCT05972993|469160865|FG004|Overall Study|Lost to Follow-up|0|||
130325046|NCT05972993|469160866|FG005|Overall Study|Lost to Follow-up|0|||
130325047|NCT05972993|469160867|FG006|Overall Study|Lost to Follow-up|0|||
130325048|NCT05972993|469160868|FG007|Overall Study|Lost to Follow-up|2|||
130325049|NCT05972993|469160869|FG008|Overall Study|Lost to Follow-up|0|||
130325050|NCT03818256|469160872|FG000|Overall Study|Withdrawal by Subject|2|||
130325051|NCT03818256|469160873|FG001|Overall Study|Withdrawal by Subject|2|||
130325052|NCT03818256|469160872|FG000|Overall Study|Adverse Event|3|||
130325053|NCT03818256|469160873|FG001|Overall Study|Adverse Event|1|||
130325054|NCT03818256|469160872|FG000|Overall Study|Lost to Follow-up|0|||
130325055|NCT03818256|469160873|FG001|Overall Study|Lost to Follow-up|5|||
130325056|NCT03818256|469160872|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
130325057|NCT03818256|469160873|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
130656908|NCT02230332|470365837|FG001|Overall Study|Adverse Event|1|||
130656909|NCT02230332|470365836|FG000|Overall Study|Lost to Follow-up|1|||
130325058|NCT03818256|469160872|FG000|Overall Study|Not reporting for scheduled visits|1|||
130656910|NCT02230332|470365837|FG001|Overall Study|Lost to Follow-up|0|||
130325059|NCT03818256|469160873|FG001|Overall Study|Not reporting for scheduled visits|0|||
130325060|NCT03818256|469160872|FG000|Overall Study|Non-compliant with investigational product|1|||
130325061|NCT03818256|469160873|FG001|Overall Study|Non-compliant with investigational product|0|||
130325062|NCT00911170|469160874|FG000|Treatment Period|Randomized in error|1|||
130325063|NCT00911170|469160875|FG001|Treatment Period|Randomized in error|1|||
130325064|NCT00911170|469160874|FG000|Treatment Period|Ineligibility determined|1|||
130325065|NCT00911170|469160875|FG001|Treatment Period|Ineligibility determined|3|||
130325066|NCT00911170|469160874|FG000|Treatment Period|Protocol deviation|1|||
130325067|NCT00911170|469160875|FG001|Treatment Period|Protocol deviation|2|||
130325068|NCT00911170|469160874|FG000|Treatment Period|Adverse Event|9|||
130325069|NCT00911170|469160875|FG001|Treatment Period|Adverse Event|10|||
130325070|NCT00911170|469160874|FG000|Treatment Period|Withdrawal by Subject|4|||
130325071|NCT00911170|469160875|FG001|Treatment Period|Withdrawal by Subject|4|||
130325072|NCT00911170|469160874|FG000|Treatment Period|Disease progression|0|||
130325073|NCT00911170|469160875|FG001|Treatment Period|Disease progression|2|||
130325074|NCT00911170|469160874|FG000|Treatment Period|Physician Decision|5|||
130325075|NCT00911170|469160875|FG001|Treatment Period|Physician Decision|5|||
130325076|NCT00911170|469160874|FG000|Treatment Period|Lost to Follow-up|0|||
130325077|NCT00911170|469160875|FG001|Treatment Period|Lost to Follow-up|1|||
130325078|NCT00911170|469160874|FG000|Treatment Period|Death|6|||
130325079|NCT00911170|469160875|FG001|Treatment Period|Death|9|||
130325080|NCT00911170|469160874|FG000|Long Term Follow-Up|Continuing in study|274|||
130325081|NCT00911170|469160875|FG001|Long Term Follow-Up|Continuing in study|269|||
130325082|NCT00911170|469160874|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
130325083|NCT00911170|469160875|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
130325084|NCT00911170|469160874|FG000|Long Term Follow-Up|Physician Decision|5|||
130325085|NCT00911170|469160875|FG001|Long Term Follow-Up|Physician Decision|4|||
130325086|NCT00911170|469160874|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
130325087|NCT00911170|469160875|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
130325088|NCT00911170|469160874|FG000|Long Term Follow-Up|Death|116|||
130325089|NCT00911170|469160875|FG001|Long Term Follow-Up|Death|121|||
130325090|NCT02514083|469160876|FG000|Overall Study|Adverse Event|1|||
130325091|NCT04226742|469163656|FG000|Overall Study|Lost to Follow-up|16|||
130325092|NCT04226742|469163657|FG001|Overall Study|Lost to Follow-up|13|||
130325093|NCT04226742|469163656|FG000|Overall Study|Withdrawal by Subject|5|||
130325094|NCT04226742|469163657|FG001|Overall Study|Withdrawal by Subject|3|||
130325095|NCT02492763|469163658|FG000|Overall Study|Withdrawal by Subject|0|||
130325096|NCT02492763|469163659|FG001|Overall Study|Withdrawal by Subject|2|||
130325097|NCT02492763|469163660|FG002|Overall Study|Withdrawal by Subject|1|||
130325098|NCT02492763|469163661|FG003|Overall Study|Withdrawal by Subject|0|||
130325099|NCT02492763|469163658|FG000|Overall Study|Adverse Event|3|||
130325100|NCT02492763|469163659|FG001|Overall Study|Adverse Event|1|||
130325101|NCT02492763|469163660|FG002|Overall Study|Adverse Event|1|||
130325102|NCT02492763|469163661|FG003|Overall Study|Adverse Event|2|||
130325103|NCT02492763|469163658|FG000|Overall Study|Death|0|||
130325104|NCT02492763|469163659|FG001|Overall Study|Death|0|||
130325105|NCT02492763|469163660|FG002|Overall Study|Death|1|||
130325106|NCT02492763|469163661|FG003|Overall Study|Death|0|||
130325107|NCT02492763|469163658|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325108|NCT02492763|469163659|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
130325109|NCT02492763|469163660|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325110|NCT02492763|469163661|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325111|NCT02492763|469163658|FG000|Overall Study|Lost to Follow-up|0|||
130325112|NCT02492763|469163659|FG001|Overall Study|Lost to Follow-up|0|||
130325113|NCT02492763|469163660|FG002|Overall Study|Lost to Follow-up|1|||
130325114|NCT02492763|469163661|FG003|Overall Study|Lost to Follow-up|0|||
130325115|NCT02492763|469163658|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130325116|NCT02492763|469163659|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130325117|NCT02492763|469163660|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130325118|NCT02492763|469163661|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130325119|NCT02492763|469163658|FG000|Overall Study|Screen Failure|0|||
130325120|NCT02492763|469163659|FG001|Overall Study|Screen Failure|0|||
130325121|NCT02492763|469163660|FG002|Overall Study|Screen Failure|0|||
130325122|NCT02492763|469163661|FG003|Overall Study|Screen Failure|1|||
130325123|NCT02492763|469163658|FG000|Overall Study|Study Terminated by Sponsor|13|||
130325124|NCT02492763|469163659|FG001|Overall Study|Study Terminated by Sponsor|10|||
130325125|NCT02492763|469163660|FG002|Overall Study|Study Terminated by Sponsor|6|||
130325126|NCT02492763|469163661|FG003|Overall Study|Study Terminated by Sponsor|10|||
130325127|NCT01337960|469163662|FG000|Overall Study|Lost to Follow-up|1|||
130325128|NCT01337960|469163663|FG001|Overall Study|Lost to Follow-up|0|||
130325129|NCT01337960|469163664|FG002|Overall Study|Lost to Follow-up|0|||
130325130|NCT01337960|469163662|FG000|Overall Study|Withdrawal by Subject|1|||
130325131|NCT01337960|469163663|FG001|Overall Study|Withdrawal by Subject|0|||
130325132|NCT01337960|469163664|FG002|Overall Study|Withdrawal by Subject|0|||
130325133|NCT01772316|469163665|FG000|Overall Study|Serious adverse event|1|||
130325134|NCT01772316|469163665|FG000|Overall Study|Inform consent withdrawn|1|||
130325135|NCT01772316|469163665|FG000|Overall Study|Withdrawn by sponsor decision|5|||
130325136|NCT00914316|469163669|FG000|Phase 1|Physician Decision|4|||
130325137|NCT00914316|469163670|FG001|Phase 1|Physician Decision|0|||
130325138|NCT00914316|469163671|FG002|Phase 1|Physician Decision|1|||
130656911|NCT02230332|470365836|FG000|Overall Study|Protocol Violation|1|||
130656912|NCT02230332|470365837|FG001|Overall Study|Protocol Violation|0|||
130656913|NCT01036594|470365839|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
130656914|NCT01036594|470365840|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
130656915|NCT01036594|470365839|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
130325139|NCT00914316|469163672|FG003|Phase 1|Physician Decision|2|||
130325140|NCT00914316|469163669|FG000|Phase 1|Withdrawal by Subject|0|||
130325141|NCT00914316|469163670|FG001|Phase 1|Withdrawal by Subject|2|||
130325142|NCT00914316|469163671|FG002|Phase 1|Withdrawal by Subject|4|||
130325143|NCT00914316|469163672|FG003|Phase 1|Withdrawal by Subject|0|||
130656916|NCT01036594|470365840|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
130214937|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214938|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214939|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214940|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
130214941|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214942|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
130214943|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214944|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214945|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214946|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214947|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214948|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
130214949|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214950|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214951|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214952|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214953|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214954|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214955|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214956|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214957|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
130214958|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
130214959|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214960|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214961|NCT03782571|468751633|FG000|Period 1|Withdrawal by Subject|1|||
130214962|NCT03782571|468751634|FG001|Period 1|Withdrawal by Subject|0|||
130214963|NCT03782571|468751635|FG002|Period 1|Withdrawal by Subject|0|||
130214964|NCT03782571|468751636|FG003|Period 1|Withdrawal by Subject|0|||
130214965|NCT03782571|468751633|FG000|Period 3|Subject Unable to Attend V5|1|||
130214966|NCT03782571|468751634|FG001|Period 3|Subject Unable to Attend V5|0|||
130214967|NCT03782571|468751635|FG002|Period 3|Subject Unable to Attend V5|0|||
130214968|NCT03782571|468751636|FG003|Period 3|Subject Unable to Attend V5|0|||
130214969|NCT03782571|468751633|FG000|Period 3|Adverse Event|1|||
130214970|NCT03782571|468751634|FG001|Period 3|Adverse Event|0|||
130214971|NCT03782571|468751635|FG002|Period 3|Adverse Event|0|||
130214972|NCT03782571|468751636|FG003|Period 3|Adverse Event|0|||
130214973|NCT02090283|468751646|FG000|Overall Study|Withdrawal by Subject|6|||
130214974|NCT02090283|468751647|FG001|Overall Study|Withdrawal by Subject|6|||
130214975|NCT02090283|468751648|FG002|Overall Study|Withdrawal by Subject|6|||
130214976|NCT02090283|468751646|FG000|Overall Study|Sponsor Terminated Study|6|||
130214977|NCT02090283|468751647|FG001|Overall Study|Sponsor Terminated Study|6|||
130214978|NCT02090283|468751648|FG002|Overall Study|Sponsor Terminated Study|1|||
130214979|NCT02090283|468751646|FG000|Overall Study|Lost to Follow-up|2|||
130214980|NCT02090283|468751647|FG001|Overall Study|Lost to Follow-up|2|||
130214981|NCT02090283|468751648|FG002|Overall Study|Lost to Follow-up|3|||
130214982|NCT02090283|468751646|FG000|Overall Study|Adverse Event|1|||
130214983|NCT02090283|468751647|FG001|Overall Study|Adverse Event|1|||
130214984|NCT02090283|468751648|FG002|Overall Study|Adverse Event|0|||
130214985|NCT02090283|468751646|FG000|Overall Study|Protocol Violation|2|||
130214986|NCT02090283|468751647|FG001|Overall Study|Protocol Violation|0|||
130214987|NCT02090283|468751648|FG002|Overall Study|Protocol Violation|0|||
130214988|NCT01411319|468751656|FG000|Overall Study|Lost to Follow-up|1|||
130214989|NCT02499263|468751657|FG000|Overall Study|Lost to Follow-up|9|||
130325144|NCT00914316|469163669|FG000|Phase 1|Adverse Event|1|||
130325145|NCT00914316|469163670|FG001|Phase 1|Adverse Event|0|||
130214990|NCT02499263|468751657|FG000|Overall Study|Participant's withdrawal of consent|4|||
130214991|NCT02499263|468751657|FG000|Overall Study|Lack of Efficacy|22|||
130214992|NCT02499263|468751657|FG000|Overall Study|investigator's judgment|12|||
130214993|NCT02499263|468751657|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
130325146|NCT00914316|469163671|FG002|Phase 1|Adverse Event|0|||
130325147|NCT00914316|469163672|FG003|Phase 1|Adverse Event|0|||
130325148|NCT00914316|469163669|FG000|Phase 2|Withdrawal by Subject|1|||
130325149|NCT00914316|469163670|FG001|Phase 2|Withdrawal by Subject|0|||
130325150|NCT00914316|469163671|FG002|Phase 2|Withdrawal by Subject|1|||
130325151|NCT00914316|469163672|FG003|Phase 2|Withdrawal by Subject|0|||
130325152|NCT01759446|469163674|FG000|Overall Study|Protocol Violation|1|||
130325153|NCT01759446|469163675|FG001|Overall Study|Protocol Violation|0|||
130325154|NCT01759446|469163676|FG002|Overall Study|Protocol Violation|1|||
130325155|NCT01759446|469163677|FG003|Overall Study|Protocol Violation|0|||
130325156|NCT01759446|469163678|FG004|Overall Study|Protocol Violation|0|||
130325157|NCT01759446|469163674|FG000|Overall Study|Withdrawal by Subject|0|||
130325158|NCT01759446|469163675|FG001|Overall Study|Withdrawal by Subject|1|||
130325159|NCT01759446|469163676|FG002|Overall Study|Withdrawal by Subject|0|||
130325160|NCT01759446|469163677|FG003|Overall Study|Withdrawal by Subject|1|||
130325161|NCT01759446|469163678|FG004|Overall Study|Withdrawal by Subject|0|||
130325162|NCT01213472|469163686|FG000|Overall Study|Recurrence/Progressive disease|25|||
130325163|NCT01213472|469163686|FG000|Overall Study|Withdrawal by Subject|1|||
130325164|NCT01213472|469163686|FG000|Overall Study|Physician Decision|1|||
130325165|NCT02085460|469163687|FG000|Overall Study|Adverse Event|2|||
130325166|NCT02085460|469163688|FG001|Overall Study|Adverse Event|2|||
130325167|NCT02085460|469163689|FG002|Overall Study|Adverse Event|1|||
130325168|NCT02085460|469163687|FG000|Overall Study|Physician Decision|1|||
130325169|NCT02085460|469163688|FG001|Overall Study|Physician Decision|1|||
130325170|NCT02085460|469163689|FG002|Overall Study|Physician Decision|2|||
130325171|NCT02085460|469163687|FG000|Overall Study|Withdrawal by Subject|11|||
130325172|NCT02085460|469163688|FG001|Overall Study|Withdrawal by Subject|5|||
130325173|NCT02085460|469163689|FG002|Overall Study|Withdrawal by Subject|7|||
130325174|NCT01285323|469163690|FG000|Overall Study|Adverse Event|9|||
130325175|NCT01285323|469163691|FG001|Overall Study|Adverse Event|8|||
130325176|NCT01285323|469163690|FG000|Overall Study|Lack of Efficacy|4|||
130325177|NCT01285323|469163691|FG001|Overall Study|Lack of Efficacy|2|||
130325178|NCT01285323|469163690|FG000|Overall Study|Withdrawal by Subject|15|||
130325179|NCT01285323|469163691|FG001|Overall Study|Withdrawal by Subject|11|||
130325180|NCT01285323|469163690|FG000|Overall Study|Protocol Violation|1|||
130325181|NCT01285323|469163691|FG001|Overall Study|Protocol Violation|2|||
130325182|NCT01285323|469163690|FG000|Overall Study|Non-compliance with study procedures|2|||
130325183|NCT01285323|469163691|FG001|Overall Study|Non-compliance with study procedures|3|||
130325184|NCT01285323|469163690|FG000|Overall Study|Lost to Follow-up|1|||
130325185|NCT01285323|469163691|FG001|Overall Study|Lost to Follow-up|1|||
130325186|NCT01285323|469163690|FG000|Overall Study|Other|1|||
130325187|NCT01285323|469163691|FG001|Overall Study|Other|3|||
130325188|NCT00763035|469163692|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
130325189|NCT00763035|469163693|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
130325190|NCT00763035|469163692|FG000|First Intervention|Adverse Event|0|||
130325191|NCT00763035|469163693|FG001|First Intervention|Adverse Event|1|||
130325192|NCT00763035|469163692|FG000|Second Intervention|Adverse Event|1|||
130325193|NCT00763035|469163693|FG001|Second Intervention|Adverse Event|0|||
130325194|NCT00763035|469163692|FG000|Second Intervention|Physician Decision|2|||
130325195|NCT00763035|469163693|FG001|Second Intervention|Physician Decision|0|||
130325196|NCT02606643|469163694|FG000|Overall Study|did not meet inclusion criteria|1|||
130325197|NCT02606643|469163695|FG001|Overall Study|did not meet inclusion criteria|3|||
130325198|NCT04313244|469163701|FG000|Overall Study|Withdrawal of Consent|3|||
130325199|NCT04313244|469163702|FG001|Overall Study|Withdrawal of Consent|3|||
130325200|NCT04313244|469163701|FG000|Overall Study|Met Exclusion Criteria|1|||
130325201|NCT04313244|469163702|FG001|Overall Study|Met Exclusion Criteria|0|||
130325202|NCT04313244|469163701|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
130325203|NCT04313244|469163702|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
130325204|NCT01472289|469163705|FG000|Overall Study|Death|2|||
130325205|NCT00907335|469163706|FG000|Overall Study|Withdrawal by Subject|2|||
130325206|NCT00907335|469163707|FG001|Overall Study|Withdrawal by Subject|0|||
130325207|NCT00907335|469163706|FG000|Overall Study|Adverse Event|4|||
130325208|NCT00907335|469163707|FG001|Overall Study|Adverse Event|1|||
130325209|NCT00907335|469163706|FG000|Overall Study|Lost to Follow-up|2|||
130325210|NCT00907335|469163707|FG001|Overall Study|Lost to Follow-up|0|||
130325211|NCT03879772|469163708|FG000|Overall Study|Adverse Event|2|||
130325212|NCT03879772|469163709|FG001|Overall Study|Adverse Event|2|||
130325213|NCT03879772|469163710|FG002|Overall Study|Adverse Event|3|||
130325214|NCT03879772|469163711|FG003|Overall Study|Adverse Event|4|||
130325215|NCT03879772|469163712|FG004|Overall Study|Adverse Event|3|||
130325216|NCT03879772|469163708|FG000|Overall Study|Treatment Failure|1|||
130325217|NCT03879772|469163709|FG001|Overall Study|Treatment Failure|0|||
130325218|NCT03879772|469163710|FG002|Overall Study|Treatment Failure|0|||
130325219|NCT03879772|469163711|FG003|Overall Study|Treatment Failure|2|||
130325220|NCT03879772|469163712|FG004|Overall Study|Treatment Failure|1|||
130325221|NCT03879772|469163708|FG000|Overall Study|Lost to Follow-up|0|||
130325222|NCT03879772|469163709|FG001|Overall Study|Lost to Follow-up|0|||
130325223|NCT03879772|469163710|FG002|Overall Study|Lost to Follow-up|0|||
130325224|NCT03879772|469163711|FG003|Overall Study|Lost to Follow-up|0|||
130656917|NCT01036594|470365839|FG000|Week 12 Evaluation|Adverse Event|5|||
130656918|NCT01036594|470365840|FG001|Week 12 Evaluation|Adverse Event|0|||
130656919|NCT01036594|470365839|FG000|Week 12 Evaluation|Physician Decision|1|||
130656920|NCT01036594|470365840|FG001|Week 12 Evaluation|Physician Decision|0|||
130656921|NCT01036594|470365839|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
130656922|NCT01036594|470365840|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
130656923|NCT01036594|470365839|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
130656924|NCT01036594|470365840|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
130656925|NCT01036594|470365839|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
130656926|NCT01036594|470365840|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
130656927|NCT01036594|470365839|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
130656928|NCT01036594|470365840|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
130656929|NCT01036594|470365839|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
130656930|NCT01036594|470365840|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
130656931|NCT03664024|470365845|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
130656932|NCT03664024|470365845|FG000|Overall Study|Lost to Follow-up|2|||
130656933|NCT03664024|470365845|FG000|Overall Study|Withdrawal by Subject|2|||
130656934|NCT03664024|470365845|FG000|Overall Study|Death|80|||
130656935|NCT00227591|470365846|FG000|Overall Study|Withdrawal by Subject|1|||
130656936|NCT02057549|470365850|FG000|Overall Study|Lost to Follow-up|1|||
130656937|NCT02057549|470365851|FG001|Overall Study|Lost to Follow-up|0|||
130656938|NCT02057549|470365850|FG000|Overall Study|Physician Decision|1|||
130656939|NCT02057549|470365851|FG001|Overall Study|Physician Decision|0|||
130656940|NCT02057549|470365850|FG000|Overall Study|Withdrawal by Subject|1|||
130656941|NCT02057549|470365851|FG001|Overall Study|Withdrawal by Subject|0|||
130656942|NCT01418365|470365852|FG000|First Intervention|Withdrawal by Subject|0|||
130656943|NCT01418365|470365853|FG001|First Intervention|Withdrawal by Subject|1|||
130656944|NCT01418365|470365852|FG000|First Intervention|Non-compliance|1|||
130656945|NCT01418365|470365853|FG001|First Intervention|Non-compliance|0|||
130656946|NCT01418365|470365852|FG000|Second Intervention|Withdrawal by Subject|0|||
130656947|NCT01418365|470365853|FG001|Second Intervention|Withdrawal by Subject|1|||
130656948|NCT03505606|470367177|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
130656949|NCT03505606|470367178|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
130656950|NCT03505606|470367179|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
130656951|NCT03505606|470367177|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
130656952|NCT03505606|470367178|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
130656953|NCT03505606|470367179|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
130656954|NCT03505606|470367177|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
130656955|NCT03505606|470367178|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
130656956|NCT03505606|470367179|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
130656957|NCT03505606|470367177|FG000|Overall Study|Poor compliance with refractive correction|0|||
130656958|NCT03505606|470367178|FG001|Overall Study|Poor compliance with refractive correction|0|||
130656959|NCT03505606|470367179|FG002|Overall Study|Poor compliance with refractive correction|1|||
130656960|NCT03505606|470367177|FG000|Overall Study|Insufficient anisometropia|0|||
130656961|NCT03505606|470367178|FG001|Overall Study|Insufficient anisometropia|0|||
130656962|NCT03505606|470367179|FG002|Overall Study|Insufficient anisometropia|2|||
130656963|NCT03505606|470367177|FG000|Overall Study|Ectopia Lentis|0|||
130656964|NCT03505606|470367178|FG001|Overall Study|Ectopia Lentis|0|||
130656965|NCT03505606|470367179|FG002|Overall Study|Ectopia Lentis|1|||
130656966|NCT03505606|470367177|FG000|Overall Study|alternation of amblyopic eye|0|||
130656967|NCT03505606|470367178|FG001|Overall Study|alternation of amblyopic eye|1|||
130656968|NCT03505606|470367179|FG002|Overall Study|alternation of amblyopic eye|0|||
130656969|NCT02087865|470367181|FG000|Overall Study|Withdrawal by Subject|6|||
130656970|NCT02087865|470367182|FG001|Overall Study|Withdrawal by Subject|0|||
130656971|NCT02087865|470367183|FG002|Overall Study|Withdrawal by Subject|1|||
130656972|NCT02087865|470367181|FG000|Overall Study|Lost to Follow-up|0|||
130656973|NCT02087865|470367182|FG001|Overall Study|Lost to Follow-up|0|||
130656974|NCT02087865|470367183|FG002|Overall Study|Lost to Follow-up|1|||
130656975|NCT02087865|470367181|FG000|Overall Study|Drug Non-compliance|0|||
130656976|NCT02087865|470367182|FG001|Overall Study|Drug Non-compliance|2|||
130325225|NCT03879772|469163712|FG004|Overall Study|Lost to Follow-up|1|||
130656977|NCT02087865|470367183|FG002|Overall Study|Drug Non-compliance|0|||
130656978|NCT02087865|470367181|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
130656979|NCT02087865|470367182|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
130656980|NCT02087865|470367183|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
130325226|NCT03879772|469163708|FG000|Overall Study|Withdrawal by Subject|0|||
130656981|NCT01392469|470367186|FG000|Overall Study|Adverse Event|2|||
130656982|NCT01392469|470367186|FG000|Overall Study|Withdrawal by Subject|1|||
130656983|NCT01392469|470367186|FG000|Overall Study|Protocol Violation|1|||
130656984|NCT00648739|470367189|FG000|Overall Study|Adverse Event|1|||
130656985|NCT00648739|470367190|FG001|Overall Study|Adverse Event|0|||
130656986|NCT00648739|470367191|FG002|Overall Study|Adverse Event|1|||
130325227|NCT03879772|469163709|FG001|Overall Study|Withdrawal by Subject|1|||
130325228|NCT03879772|469163710|FG002|Overall Study|Withdrawal by Subject|3|||
130325229|NCT03879772|469163711|FG003|Overall Study|Withdrawal by Subject|1|||
130325230|NCT03879772|469163712|FG004|Overall Study|Withdrawal by Subject|1|||
130325231|NCT03879772|469163708|FG000|Overall Study|Protocol Violation|0|||
130325232|NCT03879772|469163709|FG001|Overall Study|Protocol Violation|0|||
130325233|NCT03879772|469163710|FG002|Overall Study|Protocol Violation|3|||
130325234|NCT03879772|469163711|FG003|Overall Study|Protocol Violation|1|||
130325235|NCT03879772|469163712|FG004|Overall Study|Protocol Violation|2|||
130325236|NCT03879772|469163708|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
130325237|NCT03879772|469163709|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
130325238|NCT03879772|469163710|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
130325239|NCT03879772|469163711|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
130325240|NCT03879772|469163712|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
130325241|NCT00930046|469163713|FG000|Overall Study|Wound catheter malfunctioned|1|||
130325242|NCT00930046|469163714|FG001|Overall Study|Wound catheter malfunctioned|2|||
130325243|NCT02161016|469163715|FG000|Overall Study|withdrawn by IRB|1|||
130325244|NCT02531802|469163716|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
130325245|NCT02531802|469163717|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
130325246|NCT02531802|469163718|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
130325247|NCT02531802|469163719|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
130325248|NCT02531802|469163720|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
130325249|NCT02531802|469163721|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
130325250|NCT02531802|469163722|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
130325251|NCT02531802|469163723|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
130325252|NCT02531802|469163724|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
130325253|NCT02531802|469163725|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
130325254|NCT02531802|469163726|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
130325255|NCT02531802|469163727|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
130656987|NCT00648739|470367192|FG003|Overall Study|Adverse Event|2|||
130656988|NCT00648739|470367193|FG004|Overall Study|Adverse Event|1|||
130656989|NCT00648739|470367194|FG005|Overall Study|Adverse Event|0|||
130325256|NCT02531802|469163728|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
130325257|NCT02531802|469163729|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
130325258|NCT02531802|469163730|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
130325259|NCT02531802|469163731|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
130325260|NCT02531802|469163732|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
130656990|NCT00648739|470367195|FG006|Overall Study|Adverse Event|0|||
130656991|NCT00648739|470367189|FG000|Overall Study|Withdrawal by Subject|1|||
130656992|NCT00648739|470367190|FG001|Overall Study|Withdrawal by Subject|0|||
130656993|NCT00648739|470367191|FG002|Overall Study|Withdrawal by Subject|1|||
130656994|NCT00648739|470367192|FG003|Overall Study|Withdrawal by Subject|0|||
130656995|NCT00648739|470367193|FG004|Overall Study|Withdrawal by Subject|0|||
130214994|NCT02499263|468751657|FG000|Overall Study|Participant's decision|3|||
130214995|NCT02499263|468751657|FG000|Overall Study|Pregnancy|1|||
130214996|NCT01148459|468751676|FG000|Overall Study|Serious Adverse Event|5|||
130214997|NCT01148459|468751677|FG001|Overall Study|Serious Adverse Event|4|||
130214998|NCT01148459|468751676|FG000|Overall Study|Withdrawal by Subject|1|||
130214999|NCT01148459|468751677|FG001|Overall Study|Withdrawal by Subject|0|||
130215000|NCT01148459|468751676|FG000|Overall Study|Migrated/moved from study area|3|||
130215001|NCT01148459|468751677|FG001|Overall Study|Migrated/moved from study area|6|||
130215002|NCT01148459|468751676|FG000|Overall Study|Lost to Follow-up|2|||
130215003|NCT01148459|468751677|FG001|Overall Study|Lost to Follow-up|0|||
130215004|NCT01148459|468751676|FG000|Overall Study|Refusal|1|||
130215005|NCT01148459|468751677|FG001|Overall Study|Refusal|0|||
130215006|NCT01148459|468751676|FG000|Overall Study|Failure to comply with study procedures|0|||
130215007|NCT01148459|468751677|FG001|Overall Study|Failure to comply with study procedures|1|||
130215008|NCT00694356|468751678|FG000|Overall Study|Adverse Event|1|||
130215009|NCT00694356|468751679|FG001|Overall Study|Adverse Event|0|||
130215010|NCT00694356|468751680|FG002|Overall Study|Adverse Event|0|||
130215011|NCT00694356|468751678|FG000|Overall Study|Progressive Disease|2|||
130215012|NCT00694356|468751679|FG001|Overall Study|Progressive Disease|6|||
130215013|NCT00694356|468751680|FG002|Overall Study|Progressive Disease|6|||
130215014|NCT01152996|468751681|FG000|Overall Study|Withdrawal by Subject|142|||
130215015|NCT01152996|468751681|FG000|Overall Study|Adverse Event|115|||
130215016|NCT01152996|468751681|FG000|Overall Study|Lost to Follow-up|112|||
130215017|NCT01152996|468751681|FG000|Overall Study|Lack of Efficacy|68|||
130215018|NCT01152996|468751681|FG000|Overall Study|Noncompliance|41|||
130215019|NCT01152996|468751681|FG000|Overall Study|Other|36|||
130215020|NCT01152996|468751681|FG000|Overall Study|Protocol Violation|22|||
130215021|NCT01152996|468751681|FG000|Overall Study|Elevated liver enzymes|1|||
130215022|NCT02072941|468751682|FG000|Overall Study|Withdrawal by Subject|29|||
130215023|NCT02072941|468751683|FG001|Overall Study|Withdrawal by Subject|21|||
130551782|NCT01323634|469988142|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
130551783|NCT01323634|469988143|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
130215024|NCT02072941|468751682|FG000|Overall Study|Lost to Follow-up|4|||
130215025|NCT02072941|468751683|FG001|Overall Study|Lost to Follow-up|4|||
130215026|NCT02072941|468751682|FG000|Overall Study|Death|3|||
130215027|NCT02072941|468751683|FG001|Overall Study|Death|2|||
130215028|NCT02072941|468751682|FG000|Overall Study|Removed by Study Staff|2|||
130215029|NCT02072941|468751683|FG001|Overall Study|Removed by Study Staff|2|||
130215030|NCT03224624|468751693|FG000|Overall Study|Lost to Follow-up|9|||
130215031|NCT03224624|468751694|FG001|Overall Study|Lost to Follow-up|4|||
130215032|NCT03224624|468751693|FG000|Overall Study|Death|1|||
130215033|NCT03224624|468751694|FG001|Overall Study|Death|0|||
130215034|NCT01884545|468751695|FG000|Overall Study|Lost to Follow-up|6|||
130215035|NCT01884545|468751696|FG001|Overall Study|Lost to Follow-up|4|||
130215036|NCT01884545|468751697|FG002|Overall Study|Lost to Follow-up|9|||
130215037|NCT01884545|468751698|FG003|Overall Study|Lost to Follow-up|4|||
130215038|NCT01884545|468751695|FG000|Overall Study|Patient withdrawn|7|||
130215039|NCT01884545|468751696|FG001|Overall Study|Patient withdrawn|12|||
130215040|NCT01884545|468751697|FG002|Overall Study|Patient withdrawn|5|||
130215041|NCT01884545|468751698|FG003|Overall Study|Patient withdrawn|5|||
130215042|NCT01884545|468751695|FG000|Overall Study|Non-adherence|0|||
130215043|NCT01884545|468751696|FG001|Overall Study|Non-adherence|2|||
130215044|NCT01884545|468751697|FG002|Overall Study|Non-adherence|0|||
130215045|NCT01884545|468751698|FG003|Overall Study|Non-adherence|0|||
130215046|NCT02782377|468751699|FG000|Overall Study|Physician Decision|5|||
130215047|NCT02521792|468751700|FG000|Overall Study|Study Terminated|6|||
130215048|NCT01188668|468751701|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
130215049|NCT01188668|468751701|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
130215050|NCT01188668|468751701|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
130215051|NCT00303472|468751702|FG000|Treatment Period|Adverse Event|0|||
130215052|NCT00303472|468751703|FG001|Treatment Period|Adverse Event|0|||
130215053|NCT00303472|468751704|FG002|Treatment Period|Adverse Event|0|||
130215054|NCT00303472|468751705|FG003|Treatment Period|Adverse Event|0|||
130215055|NCT00303472|468751706|FG004|Treatment Period|Adverse Event|1|||
130215056|NCT00303472|468751707|FG005|Treatment Period|Adverse Event|0|||
130215057|NCT00303472|468751708|FG006|Treatment Period|Adverse Event|0|||
130215058|NCT00303472|468751702|FG000|Treatment Period|Death|0|||
130215059|NCT00303472|468751703|FG001|Treatment Period|Death|0|||
130215060|NCT00303472|468751704|FG002|Treatment Period|Death|0|||
130215061|NCT00303472|468751705|FG003|Treatment Period|Death|1|||
130215062|NCT00303472|468751706|FG004|Treatment Period|Death|0|||
130215063|NCT00303472|468751707|FG005|Treatment Period|Death|0|||
130215064|NCT00303472|468751708|FG006|Treatment Period|Death|1|||
130215065|NCT00303472|468751702|FG000|Treatment Period|Withdrawal by Subject|0|||
130215066|NCT00303472|468751703|FG001|Treatment Period|Withdrawal by Subject|0|||
130215067|NCT00303472|468751704|FG002|Treatment Period|Withdrawal by Subject|0|||
130215068|NCT00303472|468751705|FG003|Treatment Period|Withdrawal by Subject|1|||
130215069|NCT00303472|468751706|FG004|Treatment Period|Withdrawal by Subject|0|||
130215070|NCT00303472|468751707|FG005|Treatment Period|Withdrawal by Subject|1|||
130215071|NCT00303472|468751708|FG006|Treatment Period|Withdrawal by Subject|0|||
130215072|NCT00303472|468751702|FG000|Treatment Period|Other|0|||
130215073|NCT00303472|468751703|FG001|Treatment Period|Other|0|||
130215074|NCT00303472|468751704|FG002|Treatment Period|Other|0|||
130215075|NCT00303472|468751705|FG003|Treatment Period|Other|0|||
130215076|NCT00303472|468751706|FG004|Treatment Period|Other|1|||
130215077|NCT00303472|468751707|FG005|Treatment Period|Other|0|||
130215078|NCT00303472|468751708|FG006|Treatment Period|Other|1|||
130215079|NCT00303472|468751702|FG000|Treatment Period|Disease Progression (to AML)|0|||
130215080|NCT00303472|468751703|FG001|Treatment Period|Disease Progression (to AML)|0|||
130215081|NCT00303472|468751704|FG002|Treatment Period|Disease Progression (to AML)|0|||
130215082|NCT00303472|468751705|FG003|Treatment Period|Disease Progression (to AML)|0|||
130215083|NCT00303472|468751706|FG004|Treatment Period|Disease Progression (to AML)|1|||
130215084|NCT00303472|468751707|FG005|Treatment Period|Disease Progression (to AML)|0|||
130215085|NCT00303472|468751708|FG006|Treatment Period|Disease Progression (to AML)|0|||
130215086|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Adverse Event|1|||
130215087|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Adverse Event|0|||
130215088|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Adverse Event|1|||
130215089|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Adverse Event|0|||
130215090|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Adverse Event|0|||
130215091|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Adverse Event|0|||
130215092|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Adverse Event|0|||
130215093|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Death|2|||
130215094|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Death|0|||
130215095|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Death|1|||
130215096|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Death|0|||
130325261|NCT02531802|469163733|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
130325262|NCT02531802|469163734|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
130325263|NCT02531802|469163735|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
130325264|NCT02531802|469163736|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
130325265|NCT02531802|469163716|FG000|Received Vaccination 2|Physician Decision|0|||
130325266|NCT02531802|469163717|FG001|Received Vaccination 2|Physician Decision|0|||
130325267|NCT02531802|469163718|FG002|Received Vaccination 2|Physician Decision|0|||
130325268|NCT02531802|469163719|FG003|Received Vaccination 2|Physician Decision|0|||
130325269|NCT02531802|469163720|FG004|Received Vaccination 2|Physician Decision|0|||
130325270|NCT02531802|469163721|FG005|Received Vaccination 2|Physician Decision|1|||
130325271|NCT02531802|469163722|FG006|Received Vaccination 2|Physician Decision|0|||
130325272|NCT02531802|469163723|FG007|Received Vaccination 2|Physician Decision|0|||
130325273|NCT02531802|469163724|FG008|Received Vaccination 2|Physician Decision|0|||
130325274|NCT02531802|469163725|FG009|Received Vaccination 2|Physician Decision|2|||
130325275|NCT02531802|469163726|FG010|Received Vaccination 2|Physician Decision|0|||
130325276|NCT02531802|469163727|FG011|Received Vaccination 2|Physician Decision|0|||
130325277|NCT02531802|469163728|FG012|Received Vaccination 2|Physician Decision|0|||
130325278|NCT02531802|469163729|FG013|Received Vaccination 2|Physician Decision|1|||
130325279|NCT02531802|469163730|FG014|Received Vaccination 2|Physician Decision|0|||
130325280|NCT02531802|469163731|FG015|Received Vaccination 2|Physician Decision|0|||
130325281|NCT02531802|469163732|FG016|Received Vaccination 2|Physician Decision|0|||
130325282|NCT02531802|469163733|FG017|Received Vaccination 2|Physician Decision|1|||
130325283|NCT02531802|469163734|FG018|Received Vaccination 2|Physician Decision|0|||
130325284|NCT02531802|469163735|FG019|Received Vaccination 2|Physician Decision|0|||
130325285|NCT02531802|469163736|FG020|Received Vaccination 2|Physician Decision|0|||
130325286|NCT02531802|469163716|FG000|Received Vaccination 2|Adverse Event|0|||
130325287|NCT02531802|469163717|FG001|Received Vaccination 2|Adverse Event|0|||
130325288|NCT02531802|469163718|FG002|Received Vaccination 2|Adverse Event|0|||
130325289|NCT02531802|469163719|FG003|Received Vaccination 2|Adverse Event|0|||
130325290|NCT02531802|469163720|FG004|Received Vaccination 2|Adverse Event|0|||
130325291|NCT02531802|469163721|FG005|Received Vaccination 2|Adverse Event|2|||
130325292|NCT02531802|469163722|FG006|Received Vaccination 2|Adverse Event|0|||
130325293|NCT02531802|469163723|FG007|Received Vaccination 2|Adverse Event|0|||
130325294|NCT02531802|469163724|FG008|Received Vaccination 2|Adverse Event|0|||
130325295|NCT02531802|469163725|FG009|Received Vaccination 2|Adverse Event|0|||
130325296|NCT02531802|469163726|FG010|Received Vaccination 2|Adverse Event|0|||
130325297|NCT02531802|469163727|FG011|Received Vaccination 2|Adverse Event|0|||
130325298|NCT02531802|469163728|FG012|Received Vaccination 2|Adverse Event|0|||
130325299|NCT02531802|469163729|FG013|Received Vaccination 2|Adverse Event|0|||
130325300|NCT02531802|469163730|FG014|Received Vaccination 2|Adverse Event|0|||
130325301|NCT02531802|469163731|FG015|Received Vaccination 2|Adverse Event|0|||
130325302|NCT02531802|469163732|FG016|Received Vaccination 2|Adverse Event|0|||
130325303|NCT02531802|469163733|FG017|Received Vaccination 2|Adverse Event|2|||
130325304|NCT02531802|469163734|FG018|Received Vaccination 2|Adverse Event|1|||
130325305|NCT02531802|469163735|FG019|Received Vaccination 2|Adverse Event|0|||
130325306|NCT02531802|469163736|FG020|Received Vaccination 2|Adverse Event|1|||
130325307|NCT02531802|469163716|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130325308|NCT02531802|469163717|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130325309|NCT02531802|469163718|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130325310|NCT02531802|469163719|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130325311|NCT02531802|469163720|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130325312|NCT02531802|469163721|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130325313|NCT02531802|469163722|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130325314|NCT02531802|469163723|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
130325315|NCT02531802|469163724|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
130325316|NCT02531802|469163725|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
130325317|NCT02531802|469163726|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
130325318|NCT02531802|469163727|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
130325319|NCT02531802|469163728|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
130325320|NCT02531802|469163729|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
130325321|NCT02531802|469163730|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
130325322|NCT02531802|469163731|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
130325323|NCT02531802|469163732|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
130325324|NCT02531802|469163733|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
130325325|NCT02531802|469163734|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
130325326|NCT02531802|469163735|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
130325327|NCT02531802|469163736|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
130325328|NCT03345784|469163739|FG000|Overall Study|Withdrawal by Subject|2|||
130325329|NCT03345784|469163740|FG001|Overall Study|Withdrawal by Subject|1|||
130325330|NCT04798196|469163741|FG000|Overall Study|Lost to Follow-up|3|||
130656996|NCT00648739|470367194|FG005|Overall Study|Withdrawal by Subject|2|||
130656997|NCT00648739|470367195|FG006|Overall Study|Withdrawal by Subject|0|||
130656998|NCT00648739|470367189|FG000|Overall Study|Lack of Efficacy|0|||
130325331|NCT04798196|469163742|FG001|Overall Study|Lost to Follow-up|1|||
130325332|NCT04798196|469163743|FG002|Overall Study|Lost to Follow-up|3|||
130325333|NCT00728689|469163752|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
130325334|NCT00728689|469163753|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
130325335|NCT00929695|469163754|FG000|Overall Study|Death|2|||
130325336|NCT00929695|469163755|FG001|Overall Study|Death|1|||
130325337|NCT00929695|469163754|FG000|Overall Study|Withdrawal by Subject|0|||
130325338|NCT00929695|469163755|FG001|Overall Study|Withdrawal by Subject|2|||
130325339|NCT00929695|469163754|FG000|Overall Study|discharge home|4|||
130325340|NCT00929695|469163755|FG001|Overall Study|discharge home|3|||
130325341|NCT00929695|469163754|FG000|Overall Study|incorrect stratification|2|||
130325342|NCT00929695|469163755|FG001|Overall Study|incorrect stratification|0|||
130325343|NCT03216226|469163756|FG000|Overall Study|Adverse Event|3|||
130325344|NCT03216226|469163757|FG001|Overall Study|Adverse Event|0|||
130325345|NCT03216226|469163756|FG000|Overall Study|Protocol Violation|1|||
130325346|NCT03216226|469163757|FG001|Overall Study|Protocol Violation|3|||
130325347|NCT03216226|469163756|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
130325348|NCT03216226|469163757|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
130325349|NCT03216226|469163756|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
130325350|NCT03216226|469163757|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
130325351|NCT03216226|469163756|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
130325352|NCT03216226|469163757|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
130325353|NCT00887809|469163758|FG000|Overall Study|Patient Not Treated|3|||
130325354|NCT00887809|469163759|FG001|Overall Study|Patient Not Treated|0|||
130325355|NCT00887809|469163758|FG000|Overall Study|Death|1|||
130325356|NCT00887809|469163759|FG001|Overall Study|Death|0|||
130325357|NCT01352715|469163762|FG000|Overall Study|Death|3|||
130325358|NCT01352715|469163763|FG001|Overall Study|Death|3|||
130325359|NCT01352715|469163762|FG000|Overall Study|Lost to Follow-up|5|||
130325360|NCT01352715|469163763|FG001|Overall Study|Lost to Follow-up|7|||
130325361|NCT01352715|469163762|FG000|Overall Study|Withdrawal by Subject|4|||
130325362|NCT01352715|469163763|FG001|Overall Study|Withdrawal by Subject|8|||
130325363|NCT01352715|469163762|FG000|Overall Study|site closure|16|||
130325364|NCT01352715|469163763|FG001|Overall Study|site closure|15|||
130325365|NCT01352715|469163762|FG000|Overall Study|no final visit in closeout period|15|||
130325366|NCT01352715|469163763|FG001|Overall Study|no final visit in closeout period|12|||
130325367|NCT01352715|469163762|FG000|Overall Study|major ineligibility|2|||
130325368|NCT01352715|469163763|FG001|Overall Study|major ineligibility|1|||
130325369|NCT04596267|469163764|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
130325370|NCT04596267|469163765|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
130325371|NCT04596267|469163764|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
130325372|NCT04596267|469163765|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
130325373|NCT00071058|469163766|FG000|Overall Study|brain tumor-removed from study|1|||
130325374|NCT04109547|469163767|FG000|Overall Study|Withdrawal by Subject|3|||
130325375|NCT04109547|469163768|FG001|Overall Study|Withdrawal by Subject|2|||
130325376|NCT04109547|469163769|FG002|Overall Study|Withdrawal by Subject|6|||
130325377|NCT04109547|469163770|FG003|Overall Study|Withdrawal by Subject|6|||
130325378|NCT04109547|469163767|FG000|Overall Study|Lost to Follow-up|0|||
130325379|NCT04109547|469163768|FG001|Overall Study|Lost to Follow-up|0|||
130325380|NCT04109547|469163769|FG002|Overall Study|Lost to Follow-up|0|||
130325381|NCT04109547|469163770|FG003|Overall Study|Lost to Follow-up|1|||
130325382|NCT04109547|469163767|FG000|Overall Study|Physician Decision|1|||
130325383|NCT04109547|469163768|FG001|Overall Study|Physician Decision|2|||
130325384|NCT04109547|469163769|FG002|Overall Study|Physician Decision|0|||
130325385|NCT04109547|469163770|FG003|Overall Study|Physician Decision|0|||
130325386|NCT01550003|469163771|FG000|Overall Study|Adverse Event|0|||
130325387|NCT01550003|469163772|FG001|Overall Study|Adverse Event|9|||
130325388|NCT01550003|469163773|FG002|Overall Study|Adverse Event|15|||
130325389|NCT01550003|469163771|FG000|Overall Study|Lack of Efficacy|4|||
130325390|NCT01550003|469163772|FG001|Overall Study|Lack of Efficacy|11|||
130325391|NCT01550003|469163773|FG002|Overall Study|Lack of Efficacy|15|||
130325392|NCT01550003|469163771|FG000|Overall Study|Protocol Violation|0|||
130325393|NCT01550003|469163772|FG001|Overall Study|Protocol Violation|3|||
130325394|NCT01550003|469163773|FG002|Overall Study|Protocol Violation|2|||
130325395|NCT01550003|469163771|FG000|Overall Study|Lost to Follow-up|1|||
130325396|NCT01550003|469163772|FG001|Overall Study|Lost to Follow-up|4|||
130325397|NCT01550003|469163773|FG002|Overall Study|Lost to Follow-up|8|||
130325398|NCT01550003|469163771|FG000|Overall Study|Consent withdrawn|2|||
130325399|NCT01550003|469163772|FG001|Overall Study|Consent withdrawn|11|||
130325400|NCT01550003|469163773|FG002|Overall Study|Consent withdrawn|23|||
130325401|NCT01550003|469163771|FG000|Overall Study|Missing|1|||
130325402|NCT01550003|469163772|FG001|Overall Study|Missing|0|||
130325403|NCT01550003|469163773|FG002|Overall Study|Missing|2|||
130325404|NCT01550003|469163771|FG000|Overall Study|Study closure as announced by sponsor|7|||
130656999|NCT00648739|470367190|FG001|Overall Study|Lack of Efficacy|0|||
130215097|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Death|0|||
130215098|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Death|0|||
130657000|NCT00648739|470367191|FG002|Overall Study|Lack of Efficacy|0|||
130215099|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Death|0|||
130215100|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215101|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215102|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215103|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
130215104|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215105|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215106|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215107|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Physician Decision|0|||
130215108|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Physician Decision|4|||
130215109|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Physician Decision|2|||
130215110|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Physician Decision|3|||
130215111|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Physician Decision|2|||
130215112|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Physician Decision|0|||
130215113|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Physician Decision|0|||
130215114|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215115|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215116|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215117|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
130215118|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215119|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215120|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215121|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Other|0|||
130215122|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Other|2|||
130215123|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Other|4|||
130215124|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Other|2|||
130215125|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Other|1|||
130215126|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Other|0|||
130215127|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Other|0|||
130215128|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130215129|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215130|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215131|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215132|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215133|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130215134|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215135|NCT02937636|468751709|FG000|Overall Study|Other (Not specified)|3|||
130215136|NCT02937636|468751710|FG001|Overall Study|Other (Not specified)|2|||
130215137|NCT03383692|468751723|FG000|Overall Study|Progressive disease as per RECIST|3|||
130215138|NCT03383692|468751724|FG001|Overall Study|Progressive disease as per RECIST|3|||
130215139|NCT03383692|468751723|FG000|Overall Study|Clinical progression|0|||
130215140|NCT03383692|468751724|FG001|Overall Study|Clinical progression|1|||
130215141|NCT03383692|468751723|FG000|Overall Study|Adverse Event|3|||
130215142|NCT03383692|468751724|FG001|Overall Study|Adverse Event|0|||
130215143|NCT00893971|468751725|FG000|Overall Study|Physician Decision|3|||
130215144|NCT02453256|468751726|FG000|Double Blind Period|Death|1|||
130215145|NCT02453256|468751727|FG001|Double Blind Period|Death|1|||
130215146|NCT02453256|468751726|FG000|Double Blind Period|Adverse Event|3|||
130215147|NCT02453256|468751727|FG001|Double Blind Period|Adverse Event|2|||
130215148|NCT02453256|468751726|FG000|Double Blind Period|Withdrawal by Subject|9|||
130215149|NCT02453256|468751727|FG001|Double Blind Period|Withdrawal by Subject|5|||
130215150|NCT02453256|468751726|FG000|Double Blind Period|Other|0|||
130215151|NCT02453256|468751727|FG001|Double Blind Period|Other|1|||
130215152|NCT02453256|468751726|FG000|Open Label Period|Adverse Event|1|||
130215153|NCT02453256|468751727|FG001|Open Label Period|Adverse Event|3|||
130215154|NCT02453256|468751726|FG000|Open Label Period|Death|0|||
130215155|NCT02453256|468751727|FG001|Open Label Period|Death|1|||
130215156|NCT02453256|468751726|FG000|Open Label Period|Lost to Follow-up|1|||
130215157|NCT02453256|468751727|FG001|Open Label Period|Lost to Follow-up|0|||
130215158|NCT02453256|468751726|FG000|Open Label Period|Other|0|||
130215159|NCT02453256|468751727|FG001|Open Label Period|Other|2|||
130215160|NCT02453256|468751726|FG000|Open Label Period|Withdrawal by Subject|5|||
130215161|NCT02453256|468751727|FG001|Open Label Period|Withdrawal by Subject|1|||
130215162|NCT01366638|468751728|FG000|Overall Study|Withdrawal by Subject|0|||
130215163|NCT01366638|468751729|FG001|Overall Study|Withdrawal by Subject|0|||
130215164|NCT01366638|468751730|FG002|Overall Study|Withdrawal by Subject|6|||
130215165|NCT01366638|468751728|FG000|Overall Study|Other|1|||
130215166|NCT01366638|468751729|FG001|Overall Study|Other|0|||
130215167|NCT01366638|468751730|FG002|Overall Study|Other|0|||
130657001|NCT00648739|470367192|FG003|Overall Study|Lack of Efficacy|0|||
130325405|NCT01550003|469163772|FG001|Overall Study|Study closure as announced by sponsor|6|||
130325406|NCT01550003|469163773|FG002|Overall Study|Study closure as announced by sponsor|24|||
130325407|NCT01550003|469163771|FG000|Overall Study|Protocol Noncompliance|1|||
130325408|NCT01550003|469163772|FG001|Overall Study|Protocol Noncompliance|0|||
130325409|NCT01550003|469163773|FG002|Overall Study|Protocol Noncompliance|0|||
130325410|NCT01550003|469163771|FG000|Overall Study|Study closure|0|||
130325411|NCT01550003|469163772|FG001|Overall Study|Study closure|1|||
130325412|NCT01550003|469163773|FG002|Overall Study|Study closure|1|||
130325413|NCT01550003|469163771|FG000|Overall Study|Patient reached adulthood|0|||
130325414|NCT01550003|469163772|FG001|Overall Study|Patient reached adulthood|1|||
130325415|NCT01550003|469163773|FG002|Overall Study|Patient reached adulthood|0|||
130325416|NCT01550003|469163771|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
130325417|NCT01550003|469163772|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
130325418|NCT01550003|469163773|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
130325419|NCT01550003|469163771|FG000|Overall Study|Sponsor's order|0|||
130325420|NCT01550003|469163772|FG001|Overall Study|Sponsor's order|3|||
130325421|NCT01550003|469163773|FG002|Overall Study|Sponsor's order|3|||
130325422|NCT01550003|469163771|FG000|Overall Study|Sponsor's decision|1|||
130325423|NCT01550003|469163772|FG001|Overall Study|Sponsor's decision|5|||
130325424|NCT01550003|469163773|FG002|Overall Study|Sponsor's decision|4|||
130325425|NCT01550003|469163771|FG000|Overall Study|Subject mother passed away|0|||
130325426|NCT01550003|469163772|FG001|Overall Study|Subject mother passed away|1|||
130325427|NCT01550003|469163773|FG002|Overall Study|Subject mother passed away|0|||
130325428|NCT01550003|469163771|FG000|Overall Study|Discontinuation|0|||
130325429|NCT01550003|469163772|FG001|Overall Study|Discontinuation|1|||
130325430|NCT01550003|469163773|FG002|Overall Study|Discontinuation|0|||
130325431|NCT01550003|469163771|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
130325432|NCT01550003|469163772|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
130325433|NCT01550003|469163773|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
130325434|NCT01550003|469163771|FG000|Overall Study|Site closure|0|||
130325435|NCT01550003|469163772|FG001|Overall Study|Site closure|2|||
130325436|NCT01550003|469163773|FG002|Overall Study|Site closure|0|||
130325437|NCT01550003|469163771|FG000|Overall Study|Pregnancy|0|||
130325438|NCT01550003|469163772|FG001|Overall Study|Pregnancy|1|||
130325439|NCT01550003|469163773|FG002|Overall Study|Pregnancy|0|||
130325440|NCT01550003|469163771|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
130325441|NCT01550003|469163772|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
130325442|NCT01550003|469163773|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
130325443|NCT01550003|469163771|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
130325444|NCT01550003|469163772|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
130325445|NCT01550003|469163773|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
130325446|NCT01550003|469163771|FG000|Overall Study|Switching to adult rheumatologist|0|||
130325447|NCT01550003|469163772|FG001|Overall Study|Switching to adult rheumatologist|0|||
130325448|NCT01550003|469163773|FG002|Overall Study|Switching to adult rheumatologist|1|||
130325449|NCT01550003|469163771|FG000|Overall Study|Patient transition to adult care|0|||
130325450|NCT01550003|469163772|FG001|Overall Study|Patient transition to adult care|0|||
130325451|NCT01550003|469163773|FG002|Overall Study|Patient transition to adult care|1|||
130325452|NCT01550003|469163771|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
130325453|NCT01550003|469163772|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
130325454|NCT01550003|469163773|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
130325455|NCT01550003|469163771|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
130325456|NCT01550003|469163772|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
130325457|NCT01550003|469163773|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
130325458|NCT01550003|469163771|FG000|Overall Study|Per Sponsor request|1|||
130657002|NCT00648739|470367193|FG004|Overall Study|Lack of Efficacy|1|||
130657003|NCT00648739|470367194|FG005|Overall Study|Lack of Efficacy|2|||
130325459|NCT01550003|469163772|FG001|Overall Study|Per Sponsor request|0|||
130325460|NCT01550003|469163773|FG002|Overall Study|Per Sponsor request|1|||
130325461|NCT01550003|469163771|FG000|Overall Study|Patient not compliance|0|||
130325462|NCT01550003|469163772|FG001|Overall Study|Patient not compliance|0|||
130325463|NCT01550003|469163773|FG002|Overall Study|Patient not compliance|1|||
130325464|NCT01550003|469163771|FG000|Overall Study|Non-compliance|0|||
130325465|NCT01550003|469163772|FG001|Overall Study|Non-compliance|0|||
130325466|NCT01550003|469163773|FG002|Overall Study|Non-compliance|1|||
130325467|NCT01550003|469163771|FG000|Overall Study|Study closed|0|||
130325468|NCT01550003|469163772|FG001|Overall Study|Study closed|1|||
130325469|NCT01550003|469163773|FG002|Overall Study|Study closed|0|||
130325470|NCT01550003|469163771|FG000|Overall Study|Transitioned to adult rheumatology|0|||
130325471|NCT01550003|469163772|FG001|Overall Study|Transitioned to adult rheumatology|0|||
130657004|NCT00648739|470367195|FG006|Overall Study|Lack of Efficacy|0|||
130325472|NCT01550003|469163773|FG002|Overall Study|Transitioned to adult rheumatology|1|||
130657005|NCT00648739|470367189|FG000|Overall Study|Investigator Considered it Advisable|0|||
130657006|NCT00648739|470367190|FG001|Overall Study|Investigator Considered it Advisable|0|||
130325473|NCT01656408|469163774|FG000|Overall Study|Adverse Event|0|||
130325474|NCT01656408|469163775|FG001|Overall Study|Adverse Event|0|||
130325475|NCT01656408|469163776|FG002|Overall Study|Adverse Event|1|||
130325476|NCT01656408|469163777|FG003|Overall Study|Adverse Event|0|||
130325477|NCT01656408|469163778|FG004|Overall Study|Adverse Event|0|||
130325478|NCT01656408|469163779|FG005|Overall Study|Adverse Event|1|||
130325479|NCT01656408|469163780|FG006|Overall Study|Adverse Event|1|||
130325480|NCT01656408|469163781|FG007|Overall Study|Adverse Event|0|||
130325481|NCT01656408|469163782|FG008|Overall Study|Adverse Event|1|||
130325482|NCT01656408|469163783|FG009|Overall Study|Adverse Event|0|||
130325483|NCT01656408|469163774|FG000|Overall Study|Physician Decision|1|||
130325484|NCT01656408|469163775|FG001|Overall Study|Physician Decision|0|||
130325485|NCT01656408|469163776|FG002|Overall Study|Physician Decision|1|||
130325486|NCT01656408|469163777|FG003|Overall Study|Physician Decision|0|||
130325487|NCT01656408|469163778|FG004|Overall Study|Physician Decision|1|||
130325488|NCT01656408|469163779|FG005|Overall Study|Physician Decision|1|||
130325489|NCT01656408|469163780|FG006|Overall Study|Physician Decision|0|||
130325490|NCT01656408|469163781|FG007|Overall Study|Physician Decision|1|||
130325491|NCT01656408|469163782|FG008|Overall Study|Physician Decision|1|||
130325492|NCT01656408|469163783|FG009|Overall Study|Physician Decision|3|||
130325493|NCT00871975|469163784|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
130325494|NCT00871975|469163784|FG000|Overall Study|Catheters could not be inserted|1|||
130325495|NCT00871975|469163784|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
130325496|NCT00871975|469163784|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
130325497|NCT00870740|469163785|FG000|Overall Study|Adverse Event|2|||
130325498|NCT00870740|469163786|FG001|Overall Study|Adverse Event|1|||
130325499|NCT00870740|469163787|FG002|Overall Study|Adverse Event|3|||
130325500|NCT00870740|469163788|FG003|Overall Study|Adverse Event|2|||
130325501|NCT00870740|469163789|FG004|Overall Study|Adverse Event|1|||
130325502|NCT00870740|469163790|FG005|Overall Study|Adverse Event|6|||
130325503|NCT00870740|469163785|FG000|Overall Study|Consent Withdrawn|6|||
130325504|NCT00870740|469163786|FG001|Overall Study|Consent Withdrawn|3|||
130325505|NCT00870740|469163787|FG002|Overall Study|Consent Withdrawn|4|||
130325506|NCT00870740|469163788|FG003|Overall Study|Consent Withdrawn|6|||
130325507|NCT00870740|469163789|FG004|Overall Study|Consent Withdrawn|6|||
130325508|NCT00870740|469163790|FG005|Overall Study|Consent Withdrawn|5|||
130325509|NCT00870740|469163785|FG000|Overall Study|Investigator Decision|2|||
130325510|NCT00870740|469163786|FG001|Overall Study|Investigator Decision|0|||
130325511|NCT00870740|469163787|FG002|Overall Study|Investigator Decision|1|||
130325512|NCT00870740|469163788|FG003|Overall Study|Investigator Decision|0|||
130325513|NCT00870740|469163789|FG004|Overall Study|Investigator Decision|0|||
130325514|NCT00870740|469163790|FG005|Overall Study|Investigator Decision|0|||
130325515|NCT00870740|469163785|FG000|Overall Study|Subject Non-compliance|0|||
130325516|NCT00870740|469163786|FG001|Overall Study|Subject Non-compliance|0|||
130325517|NCT00870740|469163787|FG002|Overall Study|Subject Non-compliance|0|||
130325518|NCT00870740|469163788|FG003|Overall Study|Subject Non-compliance|0|||
130657007|NCT00648739|470367191|FG002|Overall Study|Investigator Considered it Advisable|0|||
130657008|NCT00648739|470367192|FG003|Overall Study|Investigator Considered it Advisable|0|||
130657009|NCT00648739|470367193|FG004|Overall Study|Investigator Considered it Advisable|0|||
130657010|NCT00648739|470367194|FG005|Overall Study|Investigator Considered it Advisable|1|||
130657011|NCT00648739|470367195|FG006|Overall Study|Investigator Considered it Advisable|1|||
130657012|NCT00648739|470367189|FG000|Overall Study|Death|0|||
130657013|NCT00648739|470367190|FG001|Overall Study|Death|1|||
130657014|NCT00648739|470367191|FG002|Overall Study|Death|0|||
130657015|NCT00648739|470367192|FG003|Overall Study|Death|0|||
130215168|NCT01237327|468751731|FG000|Overall Study|Protocol Violation: Core Study|1|||
130215169|NCT01237327|468751732|FG001|Overall Study|Protocol Violation: Core Study|0|||
130215170|NCT01237327|468751731|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
130215171|NCT01237327|468751732|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
130215172|NCT01237327|468751731|FG000|Overall Study|Progression of Disease: Core Study|18|||
130215173|NCT01237327|468751732|FG001|Overall Study|Progression of Disease: Core Study|22|||
130215174|NCT01237327|468751731|FG000|Overall Study|Progression of Disease: Extension Study|15|||
130215175|NCT01237327|468751732|FG001|Overall Study|Progression of Disease: Extension Study|13|||
130215176|NCT01237327|468751731|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
130215177|NCT01237327|468751732|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
130215178|NCT01237327|468751731|FG000|Overall Study|Withdrawal by Subject|1|||
130215179|NCT01237327|468751732|FG001|Overall Study|Withdrawal by Subject|3|||
130215180|NCT01237327|468751731|FG000|Overall Study|Lost to Follow-up|3|||
130215181|NCT01237327|468751732|FG001|Overall Study|Lost to Follow-up|0|||
130215182|NCT02483572|468751735|FG000|Overall Study|Withdrawal by Subject|1|||
130215183|NCT02483572|468751736|FG001|Overall Study|Withdrawal by Subject|0|||
130215184|NCT02483572|468751735|FG000|Overall Study|Lost to Follow-up|1|||
130325519|NCT00870740|469163789|FG004|Overall Study|Subject Non-compliance|0|||
130325520|NCT00870740|469163790|FG005|Overall Study|Subject Non-compliance|1|||
130325521|NCT00870740|469163785|FG000|Overall Study|Death|0|||
130325522|NCT00870740|469163786|FG001|Overall Study|Death|0|||
130325523|NCT00870740|469163787|FG002|Overall Study|Death|0|||
130325524|NCT00870740|469163788|FG003|Overall Study|Death|0|||
130325525|NCT00870740|469163789|FG004|Overall Study|Death|1|||
130325526|NCT00870740|469163790|FG005|Overall Study|Death|0|||
130325527|NCT00870740|469163785|FG000|Overall Study|Other|2|||
130325528|NCT00870740|469163786|FG001|Overall Study|Other|5|||
130325529|NCT00870740|469163787|FG002|Overall Study|Other|2|||
130325530|NCT00870740|469163788|FG003|Overall Study|Other|4|||
130325531|NCT00870740|469163789|FG004|Overall Study|Other|3|||
130325532|NCT00870740|469163790|FG005|Overall Study|Other|5|||
130325533|NCT03592186|469163791|FG000|Overall Study|Withdrawal by Subject|1|||
130325534|NCT03592186|469163792|FG001|Overall Study|Withdrawal by Subject|0|||
130325535|NCT03592186|469163791|FG000|Overall Study|Lost to Follow-up|16|||
130325536|NCT03592186|469163792|FG001|Overall Study|Lost to Follow-up|11|||
130325537|NCT00307801|469163795|FG000|Overall Study|Adverse Event|12|||
130325538|NCT00307801|469163796|FG001|Overall Study|Adverse Event|4|||
130325539|NCT00307801|469163795|FG000|Overall Study|Withdrawal by Subject|9|||
130325540|NCT00307801|469163796|FG001|Overall Study|Withdrawal by Subject|4|||
130325541|NCT00307801|469163795|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
130325542|NCT00307801|469163796|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
130325543|NCT00307801|469163795|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
130325544|NCT00307801|469163796|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
130325545|NCT00307801|469163795|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
130325546|NCT00307801|469163796|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
130325547|NCT00307801|469163795|FG000|Overall Study|Wrong Randomization|1|||
130325548|NCT00307801|469163796|FG001|Overall Study|Wrong Randomization|0|||
130325549|NCT00307801|469163795|FG000|Overall Study|Lack of Efficacy|0|||
130325550|NCT00307801|469163796|FG001|Overall Study|Lack of Efficacy|2|||
130325551|NCT00307801|469163795|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
130325552|NCT00307801|469163796|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
130325553|NCT00307801|469163795|FG000|Overall Study|Frustration with e-diary|1|||
130325554|NCT00307801|469163796|FG001|Overall Study|Frustration with e-diary|0|||
130325555|NCT00307801|469163795|FG000|Overall Study|Protocol Violation|3|||
130325556|NCT00307801|469163796|FG001|Overall Study|Protocol Violation|2|||
130325557|NCT00307801|469163795|FG000|Overall Study|No reason specified|2|||
130325558|NCT00307801|469163796|FG001|Overall Study|No reason specified|0|||
130325559|NCT00307801|469163795|FG000|Overall Study|Pregnancy|0|||
130325560|NCT00307801|469163796|FG001|Overall Study|Pregnancy|1|||
130325561|NCT00551642|469163799|FG000|Treatment Period|Protocol Deviation|6|||
130325562|NCT00551642|469163800|FG001|Treatment Period|Protocol Deviation|11|||
130325563|NCT00551642|469163799|FG000|Treatment Period|Delivery device failure|1|||
130325564|NCT00551642|469163800|FG001|Treatment Period|Delivery device failure|3|||
130325565|NCT00551642|469163799|FG000|Treatment Period|Physician Decision|0|||
130325566|NCT00551642|469163800|FG001|Treatment Period|Physician Decision|1|||
130325567|NCT00551642|469163799|FG000|Treatment Period|Death|33|||
130325568|NCT00551642|469163800|FG001|Treatment Period|Death|31|||
130325569|NCT00551642|469163799|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
130325570|NCT00551642|469163800|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
130325571|NCT00551642|469163799|FG000|Treatment Period|Adverse Event|15|||
130325572|NCT00551642|469163800|FG001|Treatment Period|Adverse Event|12|||
130325573|NCT00551642|469163799|FG000|Treatment Period|Withdrawal by Subject|2|||
130325574|NCT00551642|469163800|FG001|Treatment Period|Withdrawal by Subject|1|||
130325575|NCT03011099|469163804|FG000|Overall Study|Withdrawal by Subject|0|||
130325576|NCT03011099|469163805|FG001|Overall Study|Withdrawal by Subject|2|||
130325577|NCT02668653|469163808|FG000|Overall Study|Refractory disease|41|||
130325578|NCT02668653|469163809|FG001|Overall Study|Refractory disease|70|||
130325579|NCT02668653|469163808|FG000|Overall Study|Relapse|44|||
130325580|NCT02668653|469163809|FG001|Overall Study|Relapse|65|||
130325581|NCT02668653|469163808|FG000|Overall Study|Adverse Event|58|||
130325582|NCT02668653|469163809|FG001|Overall Study|Adverse Event|23|||
130325583|NCT02668653|469163808|FG000|Overall Study|Subject decision to stop study drug|25|||
130325584|NCT02668653|469163809|FG001|Overall Study|Subject decision to stop study drug|23|||
130325585|NCT02668653|469163808|FG000|Overall Study|Other reasons not specified|16|||
130325586|NCT02668653|469163809|FG001|Overall Study|Other reasons not specified|11|||
130325587|NCT02668653|469163808|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
130325588|NCT02668653|469163809|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
130325589|NCT02668653|469163808|FG000|Overall Study|Investigator decision|10|||
130325590|NCT02668653|469163809|FG001|Overall Study|Investigator decision|7|||
130325591|NCT02668653|469163808|FG000|Overall Study|Failure to meet continuation criteria|5|||
130325592|NCT02668653|469163809|FG001|Overall Study|Failure to meet continuation criteria|12|||
130325593|NCT02668653|469163808|FG000|Overall Study|Lost to Follow-up|1|||
130325594|NCT02668653|469163809|FG001|Overall Study|Lost to Follow-up|0|||
130325595|NCT02668653|469163808|FG000|Overall Study|Pregnancy|0|||
130325596|NCT02668653|469163809|FG001|Overall Study|Pregnancy|1|||
130325597|NCT02668653|469163808|FG000|Overall Study|Death|0|||
130325598|NCT02668653|469163809|FG001|Overall Study|Death|1|||
130325599|NCT01294553|469163810|FG000|Overall Study|Duplicated Participants|1|||
130325600|NCT01294553|469163810|FG000|Overall Study|Protocol Violation|268|||
130325601|NCT01217229|469163811|FG000|Overall Study|Adverse Event|1|||
130325602|NCT01217229|469163811|FG000|Overall Study|Disease progression, deterioration|2|||
130325603|NCT01217229|469163811|FG000|Overall Study|Disease progression, Cheson criteria|14|||
130325604|NCT01217229|469163811|FG000|Overall Study|Protocol Violation|1|||
130325605|NCT01217229|469163811|FG000|Overall Study|Disease progression not confirmed|2|||
130325606|NCT00926237|469163812|FG000|Overall Study|Withdrawal by Subject|2|||
130325607|NCT00926237|469163813|FG001|Overall Study|Withdrawal by Subject|1|||
130325608|NCT00577889|469163814|FG000|Overall Study|Withdrawal by Subject|1|||
130325609|NCT00577889|469163815|FG001|Overall Study|Withdrawal by Subject|0|||
130325610|NCT00577889|469163816|FG002|Overall Study|Withdrawal by Subject|0|||
130325611|NCT02667119|469163817|FG000|Overall Study|Lost to Follow-up|3|||
130325612|NCT02667119|469163818|FG001|Overall Study|Lost to Follow-up|0|||
130325613|NCT03783078|469163821|FG000|Overall Study|Death|31|||
130325614|NCT03783078|469163821|FG000|Overall Study|Sponsor Decision|23|||
130325615|NCT03783078|469163821|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130325616|NCT02059278|469163823|FG000|Overall Study|Adverse Event|1|||
130325617|NCT02059278|469163824|FG001|Overall Study|Adverse Event|1|||
130325618|NCT02059278|469163823|FG000|Overall Study|Lost to Follow-up|1|||
130325619|NCT02059278|469163824|FG001|Overall Study|Lost to Follow-up|0|||
130325620|NCT02059278|469163823|FG000|Overall Study|Withdrawal by Subject|0|||
130325621|NCT02059278|469163824|FG001|Overall Study|Withdrawal by Subject|3|||
130325622|NCT02059278|469163823|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
130325623|NCT02059278|469163824|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
130325624|NCT00541658|469163825|FG000|Overall Study|Adverse Event|28|||
130325625|NCT00541658|469163826|FG001|Overall Study|Adverse Event|37|||
130325626|NCT00541658|469163827|FG002|Overall Study|Adverse Event|25|||
130325627|NCT00541658|469163825|FG000|Overall Study|Physician Decision|0|||
130325628|NCT00541658|469163826|FG001|Overall Study|Physician Decision|0|||
130325629|NCT00541658|469163827|FG002|Overall Study|Physician Decision|4|||
130325630|NCT00541658|469163825|FG000|Overall Study|Lost to Follow-up|3|||
130325631|NCT00541658|469163826|FG001|Overall Study|Lost to Follow-up|3|||
130325632|NCT00541658|469163827|FG002|Overall Study|Lost to Follow-up|6|||
130215185|NCT02483572|468751736|FG001|Overall Study|Lost to Follow-up|0|||
130215186|NCT02483572|468751735|FG000|Overall Study|Physician Decision|0|||
130215187|NCT02483572|468751736|FG001|Overall Study|Physician Decision|1|||
130215188|NCT04811664|468751737|FG000|Overall Study|Lost to Follow-up|78|||
130215189|NCT04811664|468751738|FG001|Overall Study|Lost to Follow-up|125|||
130215190|NCT04811664|468751739|FG002|Overall Study|Lost to Follow-up|46|||
130215191|NCT04811664|468751737|FG000|Overall Study|Withdrawal by Subject|39|||
130215192|NCT04811664|468751738|FG001|Overall Study|Withdrawal by Subject|76|||
130215193|NCT04811664|468751739|FG002|Overall Study|Withdrawal by Subject|12|||
130215194|NCT04811664|468751737|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
130215195|NCT04811664|468751738|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
130215196|NCT04811664|468751739|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
130215197|NCT04811664|468751737|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
130215198|NCT04811664|468751738|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
130215199|NCT04811664|468751739|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
130215200|NCT04811664|468751737|FG000|Overall Study|Protocol Violation|0|||
130215201|NCT04811664|468751738|FG001|Overall Study|Protocol Violation|5|||
130215202|NCT04811664|468751739|FG002|Overall Study|Protocol Violation|11|||
130215203|NCT04811664|468751737|FG000|Overall Study|Study Terminated by Sponsor|4|||
130215204|NCT04811664|468751738|FG001|Overall Study|Study Terminated by Sponsor|3|||
130215205|NCT04811664|468751739|FG002|Overall Study|Study Terminated by Sponsor|34|||
130215206|NCT04811664|468751737|FG000|Overall Study|Early Study Closure|3|||
130215207|NCT04811664|468751738|FG001|Overall Study|Early Study Closure|7|||
130215208|NCT04811664|468751739|FG002|Overall Study|Early Study Closure|79|||
130215209|NCT04811664|468751737|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
130215210|NCT04811664|468751738|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
130215211|NCT04811664|468751739|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
130215212|NCT05052697|468751740|FG000|Substudy A|Lost to Follow-up|0|||
130215213|NCT05052697|468751741|FG001|Substudy A|Lost to Follow-up|0|||
130215214|NCT05052697|468751742|FG002|Substudy A|Lost to Follow-up|0|||
130215215|NCT05052697|468751743|FG003|Substudy A|Lost to Follow-up|0|||
130215216|NCT05052697|468751744|FG004|Substudy A|Lost to Follow-up|0|||
130215217|NCT05052697|468751745|FG005|Substudy A|Lost to Follow-up|1|||
130215218|NCT05052697|468751746|FG006|Substudy A|Lost to Follow-up|0|||
130215219|NCT05052697|468751747|FG007|Substudy A|Lost to Follow-up|0|||
130215220|NCT05052697|468751748|FG008|Substudy A|Lost to Follow-up|0|||
130215221|NCT05052697|468751749|FG009|Substudy A|Lost to Follow-up|0|||
130215222|NCT05052697|468751750|FG010|Substudy A|Lost to Follow-up|0|||
130215223|NCT05052697|468751751|FG011|Substudy A|Lost to Follow-up|0|||
130215224|NCT05052697|468751752|FG012|Substudy A|Lost to Follow-up|0|||
130215225|NCT05052697|468751753|FG013|Substudy A|Lost to Follow-up|0|||
130215226|NCT05052697|468751754|FG014|Substudy A|Lost to Follow-up|0|||
130215227|NCT05052697|468751755|FG015|Substudy A|Lost to Follow-up|2|||
130325633|NCT00541658|469163825|FG000|Overall Study|Protocol Violation|0|||
130325634|NCT00541658|469163826|FG001|Overall Study|Protocol Violation|1|||
130325635|NCT00541658|469163827|FG002|Overall Study|Protocol Violation|1|||
130325636|NCT00541658|469163825|FG000|Overall Study|Withdrawal by Subject|28|||
130325637|NCT00541658|469163826|FG001|Overall Study|Withdrawal by Subject|32|||
130325638|NCT00541658|469163827|FG002|Overall Study|Withdrawal by Subject|32|||
130325639|NCT00541658|469163825|FG000|Overall Study|Took No Study Drug|1|||
130325640|NCT00541658|469163826|FG001|Overall Study|Took No Study Drug|0|||
130325641|NCT00541658|469163827|FG002|Overall Study|Took No Study Drug|0|||
130325642|NCT04482647|469163833|FG000|Overall Study|Time constraints|2|||
130325643|NCT04482647|469163833|FG000|Overall Study|Health issues|1|||
130325644|NCT04482647|469163833|FG000|Overall Study|Death in the family|1|||
130325645|NCT04482647|469163833|FG000|Overall Study|Disliked the intervention|1|||
130325646|NCT04482647|469163833|FG000|Overall Study|No reasons specified|7|||
130325647|NCT02484391|469163834|FG000|Overall Study|Lack of Efficacy|15|||
130325648|NCT02484391|469163835|FG001|Overall Study|Lack of Efficacy|14|||
130325649|NCT02484391|469163836|FG002|Overall Study|Lack of Efficacy|3|||
130325650|NCT02484391|469163834|FG000|Overall Study|Lost to Follow-up|0|||
130325651|NCT02484391|469163835|FG001|Overall Study|Lost to Follow-up|0|||
130325652|NCT02484391|469163836|FG002|Overall Study|Lost to Follow-up|2|||
130325653|NCT02484391|469163834|FG000|Overall Study|Physician Decision|1|||
130325654|NCT02484391|469163835|FG001|Overall Study|Physician Decision|3|||
130325655|NCT02484391|469163836|FG002|Overall Study|Physician Decision|0|||
130325656|NCT02484391|469163834|FG000|Overall Study|Went to Transplant|5|||
130325657|NCT02484391|469163835|FG001|Overall Study|Went to Transplant|3|||
130325658|NCT02484391|469163836|FG002|Overall Study|Went to Transplant|2|||
130325659|NCT02594124|469163837|FG000|Overall Study|Adverse Event|0|||
130657016|NCT00648739|470367193|FG004|Overall Study|Death|0|||
130325660|NCT02594124|469163838|FG001|Overall Study|Adverse Event|5|||
130325661|NCT02594124|469163839|FG002|Overall Study|Adverse Event|8|||
130325662|NCT02594124|469163840|FG003|Overall Study|Adverse Event|1|||
130325663|NCT02594124|469163841|FG004|Overall Study|Adverse Event|0|||
130325664|NCT02594124|469163842|FG005|Overall Study|Adverse Event|0|||
130325665|NCT02594124|469163843|FG006|Overall Study|Adverse Event|2|||
130325666|NCT02594124|469163844|FG007|Overall Study|Adverse Event|2|||
130325667|NCT02594124|469163845|FG008|Overall Study|Adverse Event|0|||
130325668|NCT02594124|469163837|FG000|Overall Study|Withdrawal by Subject|2|||
130325669|NCT02594124|469163838|FG001|Overall Study|Withdrawal by Subject|3|||
130325670|NCT02594124|469163839|FG002|Overall Study|Withdrawal by Subject|5|||
130325671|NCT02594124|469163840|FG003|Overall Study|Withdrawal by Subject|1|||
130325672|NCT02594124|469163841|FG004|Overall Study|Withdrawal by Subject|8|||
130325673|NCT02594124|469163842|FG005|Overall Study|Withdrawal by Subject|4|||
130325674|NCT02594124|469163843|FG006|Overall Study|Withdrawal by Subject|13|||
130325675|NCT02594124|469163844|FG007|Overall Study|Withdrawal by Subject|19|||
130325676|NCT02594124|469163845|FG008|Overall Study|Withdrawal by Subject|0|||
130325677|NCT02594124|469163837|FG000|Overall Study|Physician Decision|0|||
130325678|NCT02594124|469163838|FG001|Overall Study|Physician Decision|2|||
130325679|NCT02594124|469163839|FG002|Overall Study|Physician Decision|0|||
130325680|NCT02594124|469163840|FG003|Overall Study|Physician Decision|0|||
130325681|NCT02594124|469163841|FG004|Overall Study|Physician Decision|0|||
130325682|NCT02594124|469163842|FG005|Overall Study|Physician Decision|0|||
130325683|NCT02594124|469163843|FG006|Overall Study|Physician Decision|0|||
130325684|NCT02594124|469163844|FG007|Overall Study|Physician Decision|1|||
130325685|NCT02594124|469163845|FG008|Overall Study|Physician Decision|0|||
130325686|NCT02594124|469163837|FG000|Overall Study|Commercial drug|0|||
130325687|NCT02594124|469163838|FG001|Overall Study|Commercial drug|1|||
130325688|NCT02594124|469163839|FG002|Overall Study|Commercial drug|6|||
130657017|NCT00648739|470367194|FG005|Overall Study|Death|0|||
130325689|NCT02594124|469163840|FG003|Overall Study|Commercial drug|3|||
130325690|NCT02594124|469163841|FG004|Overall Study|Commercial drug|0|||
130325691|NCT02594124|469163842|FG005|Overall Study|Commercial drug|0|||
130325692|NCT02594124|469163843|FG006|Overall Study|Commercial drug|7|||
130325693|NCT02594124|469163844|FG007|Overall Study|Commercial drug|11|||
130657018|NCT00648739|470367195|FG006|Overall Study|Death|0|||
130325694|NCT02594124|469163845|FG008|Overall Study|Commercial drug|2|||
130325695|NCT02594124|469163837|FG000|Overall Study|Reason Not Specified|1|||
130325696|NCT02594124|469163838|FG001|Overall Study|Reason Not Specified|3|||
130325697|NCT02594124|469163839|FG002|Overall Study|Reason Not Specified|4|||
130325698|NCT02594124|469163840|FG003|Overall Study|Reason Not Specified|0|||
130325699|NCT02594124|469163841|FG004|Overall Study|Reason Not Specified|0|||
130325700|NCT02594124|469163842|FG005|Overall Study|Reason Not Specified|1|||
130325701|NCT02594124|469163843|FG006|Overall Study|Reason Not Specified|1|||
130325702|NCT02594124|469163844|FG007|Overall Study|Reason Not Specified|6|||
130325703|NCT02594124|469163845|FG008|Overall Study|Reason Not Specified|1|||
130325704|NCT01899040|469163850|FG000|Overall Study|Randomized in error|0|||
130325705|NCT01899040|469163851|FG001|Overall Study|Randomized in error|1|||
130325706|NCT01899040|469163852|FG002|Overall Study|Randomized in error|1|||
130325707|NCT01899040|469163850|FG000|Overall Study|Adverse Event|3|||
130325708|NCT01899040|469163851|FG001|Overall Study|Adverse Event|1|||
130325709|NCT01899040|469163852|FG002|Overall Study|Adverse Event|2|||
130325710|NCT01899040|469163850|FG000|Overall Study|Unspecified reasons|4|||
130325711|NCT01899040|469163851|FG001|Overall Study|Unspecified reasons|4|||
130325712|NCT01899040|469163852|FG002|Overall Study|Unspecified reasons|0|||
130325713|NCT01899040|469163850|FG000|Overall Study|Compliance issues|1|||
130325714|NCT01899040|469163851|FG001|Overall Study|Compliance issues|2|||
130325715|NCT01899040|469163852|FG002|Overall Study|Compliance issues|0|||
130325716|NCT00905164|469163858|FG000|Period 1|Protocol Violation|0|||
130325717|NCT00905164|469163859|FG001|Period 1|Protocol Violation|1|||
130325718|NCT01256788|469165847|FG000|Overall Study|Lost to Follow-up|5|||
130325719|NCT01256788|469165848|FG001|Overall Study|Lost to Follow-up|8|||
130325720|NCT01256788|469165849|FG002|Overall Study|Lost to Follow-up|3|||
130325721|NCT03312634|469165850|FG000|Overall Study|Adverse Event|11|||
130325722|NCT03312634|469165851|FG001|Overall Study|Adverse Event|0|||
130325723|NCT03312634|469165850|FG000|Overall Study|Sponsor request|2|||
130325724|NCT03312634|469165851|FG001|Overall Study|Sponsor request|0|||
130325725|NCT03312634|469165850|FG000|Overall Study|Withdrawal by Subject|31|||
130325726|NCT03312634|469165851|FG001|Overall Study|Withdrawal by Subject|9|||
130325727|NCT03312634|469165850|FG000|Overall Study|Enrolled in an interventional study|0|||
130325728|NCT03312634|469165851|FG001|Overall Study|Enrolled in an interventional study|52|||
130325729|NCT03312634|469165850|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
130325730|NCT03312634|469165851|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
130325731|NCT03312634|469165850|FG000|Overall Study|Death|0|||
130325732|NCT03312634|469165851|FG001|Overall Study|Death|1|||
130325733|NCT03312634|469165850|FG000|Overall Study|Non-compliance|0|||
130325734|NCT03312634|469165851|FG001|Overall Study|Non-compliance|2|||
130325735|NCT03312634|469165850|FG000|Overall Study|Lost to Follow-up|0|||
130325736|NCT03312634|469165851|FG001|Overall Study|Lost to Follow-up|1|||
130325737|NCT03312634|469165850|FG000|Overall Study|Enrolled into non-interventional study|0|||
130325738|NCT03312634|469165851|FG001|Overall Study|Enrolled into non-interventional study|5|||
130325739|NCT03312634|469165850|FG000|Overall Study|Worsening clinical condition|0|||
130325740|NCT03312634|469165851|FG001|Overall Study|Worsening clinical condition|1|||
130325741|NCT03312634|469165850|FG000|Overall Study|Participant did not want to travel|0|||
130325742|NCT03312634|469165851|FG001|Overall Study|Participant did not want to travel|1|||
130325743|NCT03312634|469165850|FG000|Overall Study|Physician Decision|1|||
130325744|NCT03312634|469165851|FG001|Overall Study|Physician Decision|0|||
130325745|NCT03312634|469165850|FG000|Overall Study|Other|13|||
130325746|NCT03312634|469165851|FG001|Overall Study|Other|0|||
130325747|NCT05366738|469165852|FG000|Overall Study|Adverse Event|0|||
130325748|NCT05366738|469165853|FG001|Overall Study|Adverse Event|1|||
130325749|NCT05366738|469165854|FG002|Overall Study|Adverse Event|0|||
130325750|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
130325751|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
130325752|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
130325753|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
130325754|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
130325755|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
130325756|NCT00906204|469165857|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130325757|NCT00906204|469165858|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130325758|NCT00906204|469165857|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
130325759|NCT00906204|469165858|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
130325760|NCT05291520|469165859|FG000|Overall Study|Lost to Follow-up|0|||
130325761|NCT05291520|469165860|FG001|Overall Study|Lost to Follow-up|0|||
130325762|NCT05291520|469165861|FG002|Overall Study|Lost to Follow-up|1|||
130325763|NCT01347112|469165862|FG000|Overall Study|Withdrawal by Subject|1|||
130325764|NCT01347112|469165863|FG001|Overall Study|Withdrawal by Subject|7|||
130325765|NCT01347112|469165862|FG000|Overall Study|Lost to Follow-up|3|||
130325766|NCT01347112|469165863|FG001|Overall Study|Lost to Follow-up|5|||
130657019|NCT00648739|470367189|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
130657020|NCT00648739|470367190|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
130657021|NCT00648739|470367191|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
130657022|NCT00648739|470367192|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
130657023|NCT00648739|470367193|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
130657024|NCT00648739|470367194|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
130657025|NCT00648739|470367195|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
130657026|NCT00648739|470367189|FG000|Overall Study|Follow-up Visits Not Completed|0|||
130325767|NCT00696072|469165866|FG000|Overall Study|continuing active treatment|10|||
130325768|NCT00696072|469165867|FG001|Overall Study|continuing active treatment|13|||
130325769|NCT00696072|469165866|FG000|Overall Study|Adverse Event|10|||
130325770|NCT00696072|469165867|FG001|Overall Study|Adverse Event|6|||
130325771|NCT00696072|469165866|FG000|Overall Study|Patient Request|3|||
130325772|NCT00696072|469165867|FG001|Overall Study|Patient Request|7|||
130325773|NCT00696072|469165866|FG000|Overall Study|Investigator Request|1|||
130325774|NCT00696072|469165867|FG001|Overall Study|Investigator Request|4|||
130325775|NCT00696072|469165866|FG000|Overall Study|Sponsor Request|0|||
130325776|NCT00696072|469165867|FG001|Overall Study|Sponsor Request|1|||
130325777|NCT00696072|469165866|FG000|Overall Study|Disease Progression|32|||
130325778|NCT00696072|469165867|FG001|Overall Study|Disease Progression|30|||
130325779|NCT00696072|469165866|FG000|Overall Study|Non-specified|1|||
130325780|NCT00696072|469165867|FG001|Overall Study|Non-specified|2|||
130325781|NCT01597596|469165868|FG000|Overall Study|Study terminated by sponsor|1|||
130325782|NCT01597596|469165869|FG001|Overall Study|Study terminated by sponsor|0|||
130325783|NCT01597596|469165868|FG000|Overall Study|Physician Decision|0|||
130325784|NCT01597596|469165869|FG001|Overall Study|Physician Decision|1|||
130325785|NCT02141295|469165884|FG000|Overall Study|Adverse Event|1|||
130325786|NCT02141295|469165885|FG001|Overall Study|Adverse Event|18|||
130325787|NCT02141295|469165886|FG002|Overall Study|Adverse Event|11|||
130325788|NCT02141295|469165884|FG000|Overall Study|Physician Decision|2|||
130325789|NCT02141295|469165885|FG001|Overall Study|Physician Decision|19|||
130325790|NCT02141295|469165886|FG002|Overall Study|Physician Decision|14|||
130325791|NCT02141295|469165884|FG000|Overall Study|Study terminated by sponsor|0|||
130325792|NCT02141295|469165885|FG001|Overall Study|Study terminated by sponsor|6|||
130325793|NCT02141295|469165886|FG002|Overall Study|Study terminated by sponsor|6|||
130325794|NCT02141295|469165884|FG000|Overall Study|Non-compliance|0|||
130325795|NCT02141295|469165885|FG001|Overall Study|Non-compliance|1|||
130325796|NCT02141295|469165886|FG002|Overall Study|Non-compliance|0|||
130325797|NCT02141295|469165884|FG000|Overall Study|Progressive disease|3|||
130325798|NCT02141295|469165885|FG001|Overall Study|Progressive disease|32|||
130325799|NCT02141295|469165886|FG002|Overall Study|Progressive disease|50|||
130325800|NCT02141295|469165884|FG000|Overall Study|Reason not specified|0|||
130325801|NCT02141295|469165885|FG001|Overall Study|Reason not specified|9|||
130325802|NCT02141295|469165886|FG002|Overall Study|Reason not specified|10|||
130325803|NCT02141295|469165884|FG000|Overall Study|Withdrawal by Subject|0|||
130325804|NCT02141295|469165885|FG001|Overall Study|Withdrawal by Subject|9|||
130325805|NCT02141295|469165886|FG002|Overall Study|Withdrawal by Subject|4|||
130325806|NCT01710501|469165887|FG000|Overall Study|Lost to Follow-up|2|||
130325807|NCT01710501|469165888|FG001|Overall Study|Lost to Follow-up|0|||
130325808|NCT01710501|469165889|FG002|Overall Study|Lost to Follow-up|0|||
130325809|NCT02536976|469165890|FG000|Overall Study|Physician Decision|0|||
130325810|NCT02536976|469165891|FG001|Overall Study|Physician Decision|1|||
130325811|NCT01671319|469165894|FG000|Overall Study|Withdrawal by Subject|1|||
130325812|NCT01389596|469165895|FG000|Overall Study|Protocol Violation|3|||
130325813|NCT01389596|469165896|FG001|Overall Study|Protocol Violation|4|||
130325814|NCT01389596|469165897|FG002|Overall Study|Protocol Violation|3|||
130325815|NCT01389596|469165895|FG000|Overall Study|Withdrawal by Subject|1|||
130325816|NCT01389596|469165896|FG001|Overall Study|Withdrawal by Subject|2|||
130325817|NCT01389596|469165897|FG002|Overall Study|Withdrawal by Subject|2|||
130325818|NCT01389596|469165895|FG000|Overall Study|Insufficient Clinical Response|3|||
130325819|NCT01389596|469165896|FG001|Overall Study|Insufficient Clinical Response|4|||
130325820|NCT01389596|469165897|FG002|Overall Study|Insufficient Clinical Response|5|||
130325821|NCT01389596|469165895|FG000|Overall Study|Adverse Event|1|||
130325822|NCT01389596|469165896|FG001|Overall Study|Adverse Event|4|||
130325823|NCT01389596|469165897|FG002|Overall Study|Adverse Event|0|||
130325824|NCT01389596|469165895|FG000|Overall Study|Death|0|||
130325825|NCT01389596|469165896|FG001|Overall Study|Death|1|||
130325826|NCT01389596|469165897|FG002|Overall Study|Death|0|||
130325827|NCT01389596|469165895|FG000|Overall Study|Other Unspecified|2|||
130325828|NCT01389596|469165896|FG001|Overall Study|Other Unspecified|1|||
130325829|NCT01389596|469165897|FG002|Overall Study|Other Unspecified|0|||
130325830|NCT01709084|469165898|FG000|Overall Study|Lost to Follow-up|4|||
130325831|NCT01709084|469165899|FG001|Overall Study|Lost to Follow-up|7|||
130325832|NCT01709084|469165898|FG000|Overall Study|Withdrawal by Subject|2|||
130325833|NCT01709084|469165899|FG001|Overall Study|Withdrawal by Subject|2|||
130325834|NCT01709084|469165898|FG000|Overall Study|Adverse Event|5|||
130657027|NCT00648739|470367190|FG001|Overall Study|Follow-up Visits Not Completed|1|||
130325835|NCT01709084|469165899|FG001|Overall Study|Adverse Event|0|||
130325836|NCT01709084|469165898|FG000|Overall Study|Other|5|||
130325837|NCT01709084|469165899|FG001|Overall Study|Other|3|||
130325838|NCT01709084|469165898|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
130657028|NCT00648739|470367191|FG002|Overall Study|Follow-up Visits Not Completed|0|||
130657029|NCT00648739|470367192|FG003|Overall Study|Follow-up Visits Not Completed|0|||
130657030|NCT00648739|470367193|FG004|Overall Study|Follow-up Visits Not Completed|0|||
130325839|NCT01709084|469165899|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
130325840|NCT01709084|469165898|FG000|Overall Study|Not Treated|0|||
130325841|NCT01709084|469165899|FG001|Overall Study|Not Treated|2|||
130325842|NCT02144610|469165900|FG000|Overall Study|Physician Decision|1|||
130325843|NCT02144610|469165901|FG001|Overall Study|Physician Decision|0|||
130325844|NCT02144610|469165900|FG000|Overall Study|Withdrawal by Subject|1|||
130325845|NCT02144610|469165901|FG001|Overall Study|Withdrawal by Subject|5|||
130325846|NCT02144610|469165900|FG000|Overall Study|Death|2|||
130325847|NCT02144610|469165901|FG001|Overall Study|Death|2|||
130325848|NCT02144610|469165900|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
130325849|NCT02144610|469165901|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
130325850|NCT02144610|469165900|FG000|Overall Study|Other|0|||
130325851|NCT02144610|469165901|FG001|Overall Study|Other|1|||
130325852|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
130325853|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325854|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325855|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325856|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325857|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130215228|NCT05052697|468751756|FG016|Substudy A|Lost to Follow-up|0|||
130215229|NCT05052697|468751757|FG017|Substudy A|Lost to Follow-up|0|||
130215230|NCT05052697|468751758|FG018|Substudy A|Lost to Follow-up|0|||
130215231|NCT05052697|468751759|FG019|Substudy A|Lost to Follow-up|0|||
130215232|NCT05052697|468751760|FG020|Substudy A|Lost to Follow-up|0|||
130215233|NCT05052697|468751761|FG021|Substudy A|Lost to Follow-up|0|||
130215234|NCT05052697|468751762|FG022|Substudy A|Lost to Follow-up|0|||
130215235|NCT05052697|468751763|FG023|Substudy A|Lost to Follow-up|0|||
130215236|NCT05052697|468751764|FG024|Substudy A|Lost to Follow-up|0|||
130215237|NCT05052697|468751765|FG025|Substudy A|Lost to Follow-up|0|||
130215238|NCT05052697|468751766|FG026|Substudy A|Lost to Follow-up|0|||
130215239|NCT05052697|468751767|FG027|Substudy A|Lost to Follow-up|0|||
130215240|NCT05052697|468751768|FG028|Substudy A|Lost to Follow-up|0|||
130215241|NCT05052697|468751769|FG029|Substudy A|Lost to Follow-up|0|||
130215242|NCT05052697|468751770|FG030|Substudy A|Lost to Follow-up|0|||
130215243|NCT05052697|468751771|FG031|Substudy A|Lost to Follow-up|0|||
130215244|NCT05052697|468751772|FG032|Substudy A|Lost to Follow-up|0|||
130215245|NCT05052697|468751773|FG033|Substudy A|Lost to Follow-up|0|||
130215246|NCT05052697|468751740|FG000|Substudy A|No longer met eligibility criteria|0|||
130215247|NCT05052697|468751741|FG001|Substudy A|No longer met eligibility criteria|0|||
130215248|NCT05052697|468751742|FG002|Substudy A|No longer met eligibility criteria|0|||
130215249|NCT05052697|468751743|FG003|Substudy A|No longer met eligibility criteria|0|||
130215250|NCT05052697|468751744|FG004|Substudy A|No longer met eligibility criteria|0|||
130215251|NCT05052697|468751745|FG005|Substudy A|No longer met eligibility criteria|0|||
130215252|NCT05052697|468751746|FG006|Substudy A|No longer met eligibility criteria|0|||
130215253|NCT05052697|468751747|FG007|Substudy A|No longer met eligibility criteria|0|||
130215254|NCT05052697|468751748|FG008|Substudy A|No longer met eligibility criteria|0|||
130215255|NCT05052697|468751749|FG009|Substudy A|No longer met eligibility criteria|0|||
130215256|NCT05052697|468751750|FG010|Substudy A|No longer met eligibility criteria|0|||
130215257|NCT05052697|468751751|FG011|Substudy A|No longer met eligibility criteria|0|||
130215258|NCT05052697|468751752|FG012|Substudy A|No longer met eligibility criteria|0|||
130215259|NCT05052697|468751753|FG013|Substudy A|No longer met eligibility criteria|1|||
130215260|NCT05052697|468751754|FG014|Substudy A|No longer met eligibility criteria|0|||
130215261|NCT05052697|468751755|FG015|Substudy A|No longer met eligibility criteria|0|||
130215262|NCT05052697|468751756|FG016|Substudy A|No longer met eligibility criteria|0|||
130215263|NCT05052697|468751757|FG017|Substudy A|No longer met eligibility criteria|0|||
130215264|NCT05052697|468751758|FG018|Substudy A|No longer met eligibility criteria|0|||
130215265|NCT05052697|468751759|FG019|Substudy A|No longer met eligibility criteria|0|||
130215266|NCT05052697|468751760|FG020|Substudy A|No longer met eligibility criteria|0|||
130215267|NCT05052697|468751761|FG021|Substudy A|No longer met eligibility criteria|0|||
130215268|NCT05052697|468751762|FG022|Substudy A|No longer met eligibility criteria|0|||
130215269|NCT05052697|468751763|FG023|Substudy A|No longer met eligibility criteria|0|||
130215270|NCT05052697|468751764|FG024|Substudy A|No longer met eligibility criteria|0|||
130215271|NCT05052697|468751765|FG025|Substudy A|No longer met eligibility criteria|0|||
130215272|NCT05052697|468751766|FG026|Substudy A|No longer met eligibility criteria|0|||
130215273|NCT05052697|468751767|FG027|Substudy A|No longer met eligibility criteria|0|||
130215274|NCT05052697|468751768|FG028|Substudy A|No longer met eligibility criteria|0|||
130215275|NCT05052697|468751769|FG029|Substudy A|No longer met eligibility criteria|0|||
130215276|NCT05052697|468751770|FG030|Substudy A|No longer met eligibility criteria|0|||
130215277|NCT05052697|468751771|FG031|Substudy A|No longer met eligibility criteria|0|||
130215278|NCT05052697|468751772|FG032|Substudy A|No longer met eligibility criteria|0|||
130215279|NCT05052697|468751773|FG033|Substudy A|No longer met eligibility criteria|0|||
130215280|NCT05052697|468751740|FG000|Substudy A|Not vaccinated|0|||
130215281|NCT05052697|468751741|FG001|Substudy A|Not vaccinated|0|||
130215282|NCT05052697|468751742|FG002|Substudy A|Not vaccinated|0|||
130215283|NCT05052697|468751743|FG003|Substudy A|Not vaccinated|1|||
130215284|NCT05052697|468751744|FG004|Substudy A|Not vaccinated|0|||
130215285|NCT05052697|468751745|FG005|Substudy A|Not vaccinated|0|||
130215286|NCT05052697|468751746|FG006|Substudy A|Not vaccinated|0|||
130215287|NCT05052697|468751747|FG007|Substudy A|Not vaccinated|0|||
130215288|NCT05052697|468751748|FG008|Substudy A|Not vaccinated|1|||
130215289|NCT05052697|468751749|FG009|Substudy A|Not vaccinated|0|||
130215290|NCT05052697|468751750|FG010|Substudy A|Not vaccinated|0|||
130215291|NCT05052697|468751751|FG011|Substudy A|Not vaccinated|0|||
130215292|NCT05052697|468751752|FG012|Substudy A|Not vaccinated|0|||
130325858|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325859|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
130325860|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325861|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325862|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325863|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325864|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325865|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325866|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
130325867|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325868|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325869|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325870|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325871|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325872|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325873|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130325874|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325875|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325876|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325877|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325878|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325879|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325880|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
130325881|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325882|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325883|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325884|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325885|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325886|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325887|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
130325888|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325889|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325890|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325891|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325892|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325893|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325894|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130325895|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
130325896|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
130325897|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
130325898|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
130325899|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
130325900|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
130325901|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325902|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325903|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130325904|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130325905|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325906|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130325907|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325908|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130325909|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130325910|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
130325911|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
130325912|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
130325913|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130325914|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130325915|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130325916|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130325917|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130325918|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130325919|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130325920|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
130551784|NCT01323634|469988141|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
130215293|NCT05052697|468751753|FG013|Substudy A|Not vaccinated|0|||
130215294|NCT05052697|468751754|FG014|Substudy A|Not vaccinated|0|||
130215295|NCT05052697|468751755|FG015|Substudy A|Not vaccinated|0|||
130215296|NCT05052697|468751756|FG016|Substudy A|Not vaccinated|0|||
130215297|NCT05052697|468751757|FG017|Substudy A|Not vaccinated|0|||
130215298|NCT05052697|468751758|FG018|Substudy A|Not vaccinated|0|||
130215299|NCT05052697|468751759|FG019|Substudy A|Not vaccinated|0|||
130215300|NCT05052697|468751760|FG020|Substudy A|Not vaccinated|0|||
130215301|NCT05052697|468751761|FG021|Substudy A|Not vaccinated|0|||
130215302|NCT05052697|468751762|FG022|Substudy A|Not vaccinated|0|||
130215303|NCT05052697|468751763|FG023|Substudy A|Not vaccinated|0|||
130215304|NCT05052697|468751764|FG024|Substudy A|Not vaccinated|0|||
130215305|NCT05052697|468751765|FG025|Substudy A|Not vaccinated|0|||
130215306|NCT05052697|468751766|FG026|Substudy A|Not vaccinated|0|||
130215307|NCT05052697|468751767|FG027|Substudy A|Not vaccinated|0|||
130215308|NCT05052697|468751768|FG028|Substudy A|Not vaccinated|0|||
130215309|NCT05052697|468751769|FG029|Substudy A|Not vaccinated|0|||
130215310|NCT05052697|468751770|FG030|Substudy A|Not vaccinated|0|||
130215311|NCT05052697|468751771|FG031|Substudy A|Not vaccinated|0|||
130215312|NCT05052697|468751772|FG032|Substudy A|Not vaccinated|0|||
130215313|NCT05052697|468751773|FG033|Substudy A|Not vaccinated|0|||
130215314|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215315|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215316|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215317|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215318|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215319|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215320|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215321|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215322|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215323|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215324|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215325|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215326|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215327|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215328|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215329|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215330|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215331|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215332|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215333|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215334|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215335|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215336|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
130215337|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215338|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215339|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215340|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215341|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215342|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215343|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215344|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215345|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215346|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215347|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215348|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215349|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215350|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215351|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215352|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215353|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215354|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215355|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215356|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215357|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215358|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215359|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215360|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
130325921|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130325922|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
130325923|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325924|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130325925|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325926|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325927|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
130325928|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130325929|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325930|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325931|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130325932|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325933|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325934|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325935|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130325936|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325937|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130325938|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130325939|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325940|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325941|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130325942|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130325943|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130325944|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
130325945|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325946|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
130325947|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
130325948|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325949|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325950|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130325951|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
130325952|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130325953|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130325954|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
130325955|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130325956|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
130325957|NCT00214201|469165910|FG000|Overall Study|Withdrawal by Subject|2|||
130325958|NCT00214201|469165911|FG001|Overall Study|Withdrawal by Subject|0|||
130325959|NCT00214201|469165910|FG000|Overall Study|Death|0|||
130325960|NCT00214201|469165911|FG001|Overall Study|Death|2|||
130325961|NCT01399372|469165915|FG000|Overall Study|Protocol Violation|3|||
130325962|NCT01399372|469165916|FG001|Overall Study|Protocol Violation|1|||
130325963|NCT01432730|469165917|FG000|Period 1|Adverse Event|2|||
130325964|NCT01432730|469165918|FG001|Period 1|Adverse Event|0|||
130325965|NCT01432730|469165917|FG000|Period 2|Adverse Event|0|||
130325966|NCT01432730|469165918|FG001|Period 2|Adverse Event|4|||
130325967|NCT01421719|469165923|FG000|Overall Study|Withdrawal by Subject|4|||
130325968|NCT01124006|469165924|FG000|Overall Study|Withdrawal by Subject|2|||
130325969|NCT01124006|469165925|FG001|Overall Study|Withdrawal by Subject|2|||
130325970|NCT01124006|469165926|FG002|Overall Study|Withdrawal by Subject|0|||
130325971|NCT01124006|469165924|FG000|Overall Study|Lost to Follow-up|1|||
130325972|NCT01124006|469165925|FG001|Overall Study|Lost to Follow-up|0|||
130325973|NCT01124006|469165926|FG002|Overall Study|Lost to Follow-up|1|||
130325974|NCT01124006|469165924|FG000|Overall Study|Other|0|||
130325975|NCT01124006|469165925|FG001|Overall Study|Other|0|||
130325976|NCT01124006|469165926|FG002|Overall Study|Other|1|||
130325977|NCT01712399|469165932|FG000|Overall Study|Lost to Follow-up|1|||
130325978|NCT01712399|469165932|FG000|Overall Study|Withdrawal by Subject|39|||
130325979|NCT01712399|469165932|FG000|Overall Study|Death|1|||
130325980|NCT01712399|469165932|FG000|Overall Study|Adverse Event|11|||
130325981|NCT01712399|469165932|FG000|Overall Study|Study closure|345|||
130325982|NCT01942837|469165933|FG000|Overall Study|Death|1|||
130325983|NCT01942837|469165933|FG000|Overall Study|Symptomatic or radiographic progression|49|||
130325984|NCT01942837|469165933|FG000|Overall Study|Adverse Event|6|||
130657031|NCT00648739|470367194|FG005|Overall Study|Follow-up Visits Not Completed|0|||
130657032|NCT00648739|470367195|FG006|Overall Study|Follow-up Visits Not Completed|0|||
130325985|NCT01942837|469165933|FG000|Overall Study|Physician Decision|3|||
130325986|NCT01942837|469165933|FG000|Overall Study|Withdrawal by Subject|2|||
130325987|NCT01942837|469165933|FG000|Overall Study|Intercurrent Illness|1|||
130657033|NCT00564486|470367200|FG000|Overall Study|Adverse Event|0|||
130325988|NCT01942837|469165933|FG000|Overall Study|On treatment|3|||
130325989|NCT01942837|469165933|FG000|Overall Study|Never initiate the treatment|2|||
130325990|NCT01298648|469165934|FG000|Overall Study|Withdrawal by Subject|2|||
130325991|NCT01298648|469165934|FG000|Overall Study|Lost to Follow-up|21|||
130325992|NCT01803607|469165939|FG000|Overall Study|Adverse Event|5|||
130325993|NCT01803607|469165940|FG001|Overall Study|Adverse Event|3|||
130325994|NCT01803607|469165939|FG000|Overall Study|Lack of Efficacy|0|||
130325995|NCT01803607|469165940|FG001|Overall Study|Lack of Efficacy|1|||
130325996|NCT01803607|469165939|FG000|Overall Study|Protocol Violation|3|||
130325997|NCT01803607|469165940|FG001|Overall Study|Protocol Violation|2|||
130325998|NCT01803607|469165939|FG000|Overall Study|Study terminated by sponsor|54|||
130325999|NCT01803607|469165940|FG001|Overall Study|Study terminated by sponsor|56|||
130326000|NCT01803607|469165939|FG000|Overall Study|Withdrawal by Subject|6|||
130326001|NCT01803607|469165940|FG001|Overall Study|Withdrawal by Subject|5|||
130326002|NCT02038933|469165952|FG000|Overall Study|Disease progression|104|||
130326003|NCT02038933|469165952|FG000|Overall Study|Study drug toxicity|6|||
130326004|NCT02038933|469165952|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130326005|NCT02038933|469165952|FG000|Overall Study|Participant request to discontinue treatment|2|||
130326006|NCT02038933|469165952|FG000|Overall Study|Lost to Follow-up|1|||
130326007|NCT02038933|469165952|FG000|Overall Study|Other reasons|2|||
130326008|NCT03250273|469165953|FG000|Overall Study|Disease Progression|2|||
130326009|NCT03250273|469165954|FG001|Overall Study|Disease Progression|11|||
130326010|NCT03250273|469165953|FG000|Overall Study|Death|0|||
130326011|NCT03250273|469165954|FG001|Overall Study|Death|1|||
130326012|NCT01774721|469165957|FG000|Overall Study|Death|133|||
130326013|NCT01774721|469165958|FG001|Overall Study|Death|152|||
130326014|NCT01774721|469165957|FG000|Overall Study|Withdrawal by Subject|20|||
130326015|NCT01774721|469165958|FG001|Overall Study|Withdrawal by Subject|14|||
130326016|NCT01774721|469165957|FG000|Overall Study|Lost to Follow-up|6|||
130326017|NCT01774721|469165958|FG001|Overall Study|Lost to Follow-up|7|||
130326018|NCT01774721|469165957|FG000|Overall Study|Did not meet eligibility criteria|0|||
130326019|NCT01774721|469165958|FG001|Overall Study|Did not meet eligibility criteria|3|||
130326020|NCT01774721|469165957|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
130326021|NCT01774721|469165958|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
130326022|NCT01774721|469165957|FG000|Overall Study|Study terminated by sponsor|5|||
130326023|NCT01774721|469165958|FG001|Overall Study|Study terminated by sponsor|0|||
130326024|NCT01774721|469165957|FG000|Overall Study|Disease progression|5|||
130326025|NCT01774721|469165958|FG001|Overall Study|Disease progression|0|||
130326026|NCT02399163|469165960|FG000|Overall Study|Adverse Event|2|||
130326027|NCT02399163|469165960|FG000|Overall Study|Protocol Deviation|2|||
130326028|NCT02399163|469165960|FG000|Overall Study|Withdrawal by Participant|5|||
130326029|NCT04646044|469165962|FG000|Overall Study|Lost to Follow-up|0|||
130326030|NCT04646044|469165963|FG001|Overall Study|Lost to Follow-up|0|||
130326031|NCT04646044|469165964|FG002|Overall Study|Lost to Follow-up|1|||
130326032|NCT04646044|469165965|FG003|Overall Study|Lost to Follow-up|0|||
130326033|NCT04646044|469165962|FG000|Overall Study|Withdrawal by Subject|0|||
130326034|NCT04646044|469165963|FG001|Overall Study|Withdrawal by Subject|1|||
130326035|NCT04646044|469165964|FG002|Overall Study|Withdrawal by Subject|0|||
130326036|NCT04646044|469165965|FG003|Overall Study|Withdrawal by Subject|0|||
130326037|NCT01907854|469165966|FG000|Overall Study|Protocol Violation|1|||
130326038|NCT01907854|469165967|FG001|Overall Study|Protocol Violation|1|||
130326039|NCT01907854|469165966|FG000|Overall Study|Withdrawal by Subject|9|||
130326040|NCT01907854|469165967|FG001|Overall Study|Withdrawal by Subject|7|||
130326041|NCT01907854|469165966|FG000|Overall Study|Lost to Follow-up|2|||
130326042|NCT01907854|469165967|FG001|Overall Study|Lost to Follow-up|2|||
130326043|NCT01907854|469165966|FG000|Overall Study|Unclassified|4|||
130326044|NCT01907854|469165967|FG001|Overall Study|Unclassified|3|||
130326045|NCT02215252|469165968|FG000|Overall Study|Adverse Event|1|||
130326046|NCT02215252|469165969|FG001|Overall Study|Adverse Event|5|||
130326047|NCT02215252|469165970|FG002|Overall Study|Adverse Event|2|||
130326048|NCT02215252|469165968|FG000|Overall Study|Lost to Follow-up|0|||
130326049|NCT02215252|469165969|FG001|Overall Study|Lost to Follow-up|0|||
130326050|NCT02215252|469165970|FG002|Overall Study|Lost to Follow-up|1|||
130326051|NCT02215252|469165968|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
130326052|NCT02215252|469165969|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
130326053|NCT02215252|469165970|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
130326054|NCT02215252|469165968|FG000|Overall Study|Protocol Violation|0|||
130326055|NCT02215252|469165969|FG001|Overall Study|Protocol Violation|1|||
130326056|NCT02215252|469165970|FG002|Overall Study|Protocol Violation|0|||
130326057|NCT02215252|469165968|FG000|Overall Study|Withdrawal by Subject|1|||
130326058|NCT02215252|469165969|FG001|Overall Study|Withdrawal by Subject|0|||
130551785|NCT01323634|469988142|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
130551786|NCT01323634|469988143|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
130551787|NCT01323634|469988141|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
130551788|NCT01323634|469988142|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130551789|NCT01323634|469988143|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130326059|NCT02215252|469165970|FG002|Overall Study|Withdrawal by Subject|0|||
130326060|NCT02215252|469165968|FG000|Overall Study|Other|0|||
130326061|NCT02215252|469165969|FG001|Overall Study|Other|1|||
130326062|NCT02215252|469165970|FG002|Overall Study|Other|1|||
130326063|NCT02633306|469165971|FG000|Overall Study|Withdrawal by Subject|3|||
130326064|NCT03910244|469165972|FG000|Overall Study|Adverse Event|14|||
130326065|NCT03910244|469165973|FG001|Overall Study|Adverse Event|0|||
130326066|NCT03910244|469165972|FG000|Overall Study|Death|1|||
130326067|NCT03910244|469165973|FG001|Overall Study|Death|0|||
130326068|NCT03910244|469165972|FG000|Overall Study|Lost to Follow-up|0|||
130326069|NCT03910244|469165973|FG001|Overall Study|Lost to Follow-up|2|||
130326070|NCT03910244|469165972|FG000|Overall Study|Joint withdrawal decision|1|||
130326071|NCT03910244|469165973|FG001|Overall Study|Joint withdrawal decision|0|||
130326072|NCT03910244|469165972|FG000|Overall Study|Study Terminated by Sponsor|7|||
130326073|NCT03910244|469165973|FG001|Overall Study|Study Terminated by Sponsor|4|||
130326074|NCT03910244|469165972|FG000|Overall Study|Physician Decision|1|||
130326075|NCT03910244|469165973|FG001|Overall Study|Physician Decision|0|||
130326076|NCT03910244|469165972|FG000|Overall Study|Protocol Violation|1|||
130326077|NCT03910244|469165973|FG001|Overall Study|Protocol Violation|0|||
130326078|NCT03910244|469165972|FG000|Overall Study|Withdrawal by Subject|7|||
130326079|NCT03910244|469165973|FG001|Overall Study|Withdrawal by Subject|2|||
130326080|NCT00803569|469165975|FG000|Overall Study|Progressive Disease|3|||
130326081|NCT00803569|469165975|FG000|Overall Study|Noncompliance|1|||
130326082|NCT04004988|469165976|FG000|Period 1|Physician Decision|2|||
130326083|NCT04004988|469165977|FG001|Period 1|Physician Decision|0|||
130326084|NCT04004988|469165976|FG000|Period 1|Withdrawal by Subject|0|||
130326085|NCT04004988|469165977|FG001|Period 1|Withdrawal by Subject|1|||
130326086|NCT04004988|469165976|FG000|Period 1|Adverse Event|1|||
130326087|NCT04004988|469165977|FG001|Period 1|Adverse Event|2|||
130326088|NCT01598532|469165978|FG000|Overall Study|Lost to Follow-up|3|||
130326089|NCT01598532|469165978|FG000|Overall Study|Did not meet inclusion criteria|8|||
130326090|NCT00912808|469165979|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
130326091|NCT00912808|469165980|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130326092|NCT00912808|469165979|FG000|Washout|Withdrawal by Subject|0|||
130326093|NCT00912808|469165980|FG001|Washout|Withdrawal by Subject|1|||
130326094|NCT00912808|469165979|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130326095|NCT00912808|469165980|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
130326096|NCT00912808|469165979|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
130326097|NCT00912808|469165980|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130326098|NCT03873116|469165981|FG000|Part 1|Study drug discontinuation due to rash|0|||
130326099|NCT03873116|469165982|FG001|Part 1|Study drug discontinuation due to rash|0|||
130326100|NCT03873116|469165983|FG002|Part 1|Study drug discontinuation due to rash|0|||
130326101|NCT03873116|469165984|FG003|Part 1|Study drug discontinuation due to rash|0|||
130326102|NCT03873116|469165985|FG004|Part 1|Study drug discontinuation due to rash|0|||
130326103|NCT03873116|469165986|FG005|Part 1|Study drug discontinuation due to rash|1|||
130326104|NCT03873116|469165981|FG000|Part 2|Withdrawal by Subject|0|||
130326105|NCT03873116|469165982|FG001|Part 2|Withdrawal by Subject|0|||
130326106|NCT03873116|469165983|FG002|Part 2|Withdrawal by Subject|1|||
130326107|NCT03873116|469165984|FG003|Part 2|Withdrawal by Subject|0|||
130326108|NCT03873116|469165985|FG004|Part 2|Withdrawal by Subject|0|||
130326109|NCT03873116|469165986|FG005|Part 2|Withdrawal by Subject|0|||
130326110|NCT03873116|469165981|FG000|Part 2|Lab abnormality or AE|0|||
130326111|NCT03873116|469165982|FG001|Part 2|Lab abnormality or AE|0|||
130326112|NCT03873116|469165983|FG002|Part 2|Lab abnormality or AE|0|||
130326113|NCT03873116|469165984|FG003|Part 2|Lab abnormality or AE|0|||
130326114|NCT03873116|469165985|FG004|Part 2|Lab abnormality or AE|1|||
130326115|NCT03873116|469165986|FG005|Part 2|Lab abnormality or AE|0|||
130326116|NCT03873116|469165981|FG000|Part 3|Withdrawal by Subject|0|||
130326117|NCT03873116|469165982|FG001|Part 3|Withdrawal by Subject|0|||
130326118|NCT03873116|469165983|FG002|Part 3|Withdrawal by Subject|0|||
130326119|NCT03873116|469165984|FG003|Part 3|Withdrawal by Subject|0|||
130326120|NCT03873116|469165985|FG004|Part 3|Withdrawal by Subject|1|||
130326121|NCT03873116|469165986|FG005|Part 3|Withdrawal by Subject|0|||
130326122|NCT04682366|469165987|FG000|Overall Study|Lost to Follow-up|1|||
130326123|NCT04682366|469165988|FG001|Overall Study|Lost to Follow-up|1|||
130326124|NCT00702221|469165989|FG000|Overall Study|Adverse Event|4|||
130326125|NCT00702221|469165990|FG001|Overall Study|Adverse Event|3|||
130326126|NCT02000440|469165995|FG000|Overall Study|Adverse Event|3|||
130326127|NCT02000440|469165995|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
130326128|NCT03995368|469165996|FG000|Overall Study|Lost to Follow-up|1|||
130326129|NCT03995368|469165997|FG001|Overall Study|Lost to Follow-up|4|||
130326130|NCT03995368|469165998|FG002|Overall Study|Lost to Follow-up|1|||
130326131|NCT03995368|469165996|FG000|Overall Study|Did not meet inclusion criteria|1|||
130326132|NCT03995368|469165997|FG001|Overall Study|Did not meet inclusion criteria|6|||
130326133|NCT03995368|469165998|FG002|Overall Study|Did not meet inclusion criteria|3|||
130326134|NCT03995368|469165996|FG000|Overall Study|Withdrawal by Subject|0|||
130657034|NCT00564486|470367201|FG001|Overall Study|Adverse Event|1|||
130326135|NCT03995368|469165997|FG001|Overall Study|Withdrawal by Subject|1|||
130657035|NCT00564486|470367202|FG002|Overall Study|Adverse Event|0|||
130657036|NCT00564486|470367203|FG003|Overall Study|Adverse Event|0|||
130657037|NCT00564486|470367200|FG000|Overall Study|Withdrawal by Subject|4|||
130657038|NCT00564486|470367201|FG001|Overall Study|Withdrawal by Subject|0|||
130657039|NCT00564486|470367202|FG002|Overall Study|Withdrawal by Subject|0|||
130215361|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215362|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215363|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215364|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215365|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
130215366|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215367|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215368|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215369|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215370|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215371|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215372|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215373|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215374|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215375|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215376|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215377|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215378|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215379|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215380|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215381|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215382|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215383|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215384|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215385|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215386|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215387|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215388|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215389|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215390|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215391|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215392|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215393|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215394|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215395|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215396|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215397|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215398|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215399|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215400|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215401|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
130215402|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215403|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215404|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215405|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215406|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215407|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215408|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215409|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215410|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215411|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215412|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215413|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215414|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215415|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215416|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215417|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215418|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215419|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215420|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215421|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130326136|NCT03995368|469165998|FG002|Overall Study|Withdrawal by Subject|1|||
130326137|NCT03755934|469165999|FG000|Overall Study|Adverse Event|4|||
130326138|NCT03755934|469166000|FG001|Overall Study|Adverse Event|1|||
130657040|NCT00564486|470367203|FG003|Overall Study|Withdrawal by Subject|5|||
130657041|NCT00564486|470367200|FG000|Overall Study|Subject refused to have blood drawn|0|||
130326139|NCT03755934|469166001|FG002|Overall Study|Adverse Event|1|||
130326140|NCT03755934|469166002|FG003|Overall Study|Adverse Event|3|||
130326141|NCT03755934|469165999|FG000|Overall Study|Physician Decision|2|||
130326142|NCT03755934|469166000|FG001|Overall Study|Physician Decision|0|||
130326143|NCT03755934|469166001|FG002|Overall Study|Physician Decision|0|||
130326144|NCT03755934|469166002|FG003|Overall Study|Physician Decision|1|||
130326145|NCT03755934|469165999|FG000|Overall Study|Withdrawal by Subject|5|||
130326146|NCT03755934|469166000|FG001|Overall Study|Withdrawal by Subject|0|||
130326147|NCT03755934|469166001|FG002|Overall Study|Withdrawal by Subject|0|||
130326148|NCT03755934|469166002|FG003|Overall Study|Withdrawal by Subject|1|||
130326149|NCT03755934|469165999|FG000|Overall Study|Other|3|||
130326150|NCT03755934|469166000|FG001|Overall Study|Other|1|||
130326151|NCT03755934|469166001|FG002|Overall Study|Other|3|||
130326152|NCT03755934|469166002|FG003|Overall Study|Other|1|||
130326153|NCT00361296|469166006|FG000|Overall Study|Physician Decision|1|||
130326154|NCT00361296|469166006|FG000|Overall Study|Lack of Efficacy|2|||
130326155|NCT00198822|469166007|FG000|Overall Study|Lost to Follow-up|14|||
130326156|NCT00198822|469166008|FG001|Overall Study|Lost to Follow-up|20|||
130326157|NCT00198822|469166009|FG002|Overall Study|Lost to Follow-up|21|||
130326158|NCT02420821|469166011|FG000|Overall Study|Lost to Follow-up|6|||
130326159|NCT02420821|469166012|FG001|Overall Study|Lost to Follow-up|6|||
130326160|NCT02420821|469166011|FG000|Overall Study|Non-compliance|0|||
130326161|NCT02420821|469166012|FG001|Overall Study|Non-compliance|2|||
130326162|NCT02420821|469166011|FG000|Overall Study|Physician Decision|6|||
130326163|NCT02420821|469166012|FG001|Overall Study|Physician Decision|2|||
130326164|NCT02420821|469166011|FG000|Overall Study|Withdrawal by Subject|32|||
130326165|NCT02420821|469166012|FG001|Overall Study|Withdrawal by Subject|25|||
130326166|NCT02420821|469166011|FG000|Overall Study|Death|270|||
130326167|NCT02420821|469166012|FG001|Overall Study|Death|263|||
130326168|NCT02420821|469166011|FG000|Overall Study|Study Terminated By Sponsor|145|||
130326169|NCT02420821|469166012|FG001|Overall Study|Study Terminated By Sponsor|149|||
130326170|NCT02420821|469166011|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
130326171|NCT02420821|469166012|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
130326172|NCT02420821|469166011|FG000|Overall Study|Adverse Event|0|||
130326173|NCT02420821|469166012|FG001|Overall Study|Adverse Event|1|||
130326174|NCT02420821|469166011|FG000|Overall Study|Protinuria|0|||
130326175|NCT02420821|469166012|FG001|Overall Study|Protinuria|1|||
130326176|NCT02420821|469166011|FG000|Overall Study|Progressive Disease|1|||
130326177|NCT02420821|469166012|FG001|Overall Study|Progressive Disease|1|||
130326178|NCT02420821|469166011|FG000|Overall Study|Disease Progression|0|||
130326179|NCT02420821|469166012|FG001|Overall Study|Disease Progression|1|||
130326180|NCT02420821|469166011|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
130326181|NCT02420821|469166012|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
130326182|NCT04322526|469166014|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
130326183|NCT04322526|469166015|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130326184|NCT04322526|469166014|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130326185|NCT04322526|469166015|FG001|Washout (1 Week)|Lost to Follow-up|2|||
130326186|NCT00993967|469166016|FG000|Overall Study|Adverse Event|8|||
130326187|NCT00993967|469166016|FG000|Overall Study|Death|1|||
130326188|NCT00993967|469166016|FG000|Overall Study|Lost to Follow-up|14|||
130326189|NCT00993967|469166016|FG000|Overall Study|Withdrawal by Subject|36|||
130326190|NCT00993967|469166016|FG000|Overall Study|Protocol Violation|2|||
130326191|NCT02760498|469166017|FG000|Overall Study|Adverse Event|3|||
130657042|NCT00564486|470367201|FG001|Overall Study|Subject refused to have blood drawn|0|||
130657043|NCT00564486|470367202|FG002|Overall Study|Subject refused to have blood drawn|1|||
130657044|NCT00564486|470367203|FG003|Overall Study|Subject refused to have blood drawn|0|||
130657045|NCT00564486|470367200|FG000|Overall Study|Lost to Follow-up|3|||
130657046|NCT00564486|470367201|FG001|Overall Study|Lost to Follow-up|0|||
130657047|NCT00564486|470367202|FG002|Overall Study|Lost to Follow-up|2|||
130657048|NCT00564486|470367203|FG003|Overall Study|Lost to Follow-up|2|||
130657049|NCT03862807|470367208|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
130657050|NCT04362761|470367209|FG000|Part A (48 Weeks)|Adverse Event|2|||
130657051|NCT04362761|470367209|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
130657052|NCT04362761|470367209|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
130657053|NCT04362761|470367209|FG000|Part A (48 Weeks)|Other|5|||
130657054|NCT04362761|470367209|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
130657055|NCT04362761|470367209|FG000|Part B (86 Weeks)|Other|4|||
130657056|NCT00684645|470367210|FG000|Overall Study|Death|2|||
130657057|NCT00684645|470367210|FG000|Overall Study|Progressive disease|67|||
130326192|NCT02760498|469166018|FG001|Overall Study|Adverse Event|3|||
130326193|NCT02760498|469166019|FG002|Overall Study|Adverse Event|1|||
130326194|NCT02760498|469166020|FG003|Overall Study|Adverse Event|1|||
130326195|NCT02760498|469166021|FG004|Overall Study|Adverse Event|0|||
130326196|NCT02760498|469166022|FG005|Overall Study|Adverse Event|6|||
130326197|NCT02760498|469166017|FG000|Overall Study|Death|7|||
130326198|NCT02760498|469166018|FG001|Overall Study|Death|5|||
130657058|NCT00684645|470367210|FG000|Overall Study|Adverse Event|27|||
130657059|NCT00684645|470367210|FG000|Overall Study|Lost to Follow-up|3|||
130326199|NCT02760498|469166019|FG002|Overall Study|Death|5|||
130326200|NCT02760498|469166020|FG003|Overall Study|Death|7|||
130326201|NCT02760498|469166021|FG004|Overall Study|Death|0|||
130326202|NCT02760498|469166022|FG005|Overall Study|Death|23|||
130326203|NCT02760498|469166017|FG000|Overall Study|Lost to Follow-up|0|||
130326204|NCT02760498|469166018|FG001|Overall Study|Lost to Follow-up|0|||
130326205|NCT02760498|469166019|FG002|Overall Study|Lost to Follow-up|0|||
130326206|NCT02760498|469166020|FG003|Overall Study|Lost to Follow-up|0|||
130326207|NCT02760498|469166021|FG004|Overall Study|Lost to Follow-up|0|||
130326208|NCT02760498|469166022|FG005|Overall Study|Lost to Follow-up|3|||
130326209|NCT02760498|469166017|FG000|Overall Study|Non-compliance with study drug|0|||
130326210|NCT02760498|469166018|FG001|Overall Study|Non-compliance with study drug|2|||
130326211|NCT02760498|469166019|FG002|Overall Study|Non-compliance with study drug|0|||
130326212|NCT02760498|469166020|FG003|Overall Study|Non-compliance with study drug|0|||
130326213|NCT02760498|469166021|FG004|Overall Study|Non-compliance with study drug|0|||
130326214|NCT02760498|469166022|FG005|Overall Study|Non-compliance with study drug|0|||
130326215|NCT02760498|469166017|FG000|Overall Study|Participant decision|1|||
130326216|NCT02760498|469166018|FG001|Overall Study|Participant decision|4|||
130326217|NCT02760498|469166019|FG002|Overall Study|Participant decision|2|||
130326218|NCT02760498|469166020|FG003|Overall Study|Participant decision|2|||
130326219|NCT02760498|469166021|FG004|Overall Study|Participant decision|1|||
130326220|NCT02760498|469166022|FG005|Overall Study|Participant decision|6|||
130326221|NCT02760498|469166017|FG000|Overall Study|Sponsor decision|0|||
130326222|NCT02760498|469166018|FG001|Overall Study|Sponsor decision|0|||
130326223|NCT02760498|469166019|FG002|Overall Study|Sponsor decision|0|||
130326224|NCT02760498|469166020|FG003|Overall Study|Sponsor decision|3|||
130326225|NCT02760498|469166021|FG004|Overall Study|Sponsor decision|0|||
130326226|NCT02760498|469166022|FG005|Overall Study|Sponsor decision|0|||
130326227|NCT02760498|469166017|FG000|Overall Study|Physician Decision|3|||
130326228|NCT02760498|469166018|FG001|Overall Study|Physician Decision|4|||
130326229|NCT02760498|469166019|FG002|Overall Study|Physician Decision|1|||
130326230|NCT02760498|469166020|FG003|Overall Study|Physician Decision|4|||
130326231|NCT02760498|469166021|FG004|Overall Study|Physician Decision|0|||
130326232|NCT02760498|469166022|FG005|Overall Study|Physician Decision|2|||
130326233|NCT02760498|469166017|FG000|Overall Study|Disease progression|21|||
130326234|NCT02760498|469166018|FG001|Overall Study|Disease progression|19|||
130326235|NCT02760498|469166019|FG002|Overall Study|Disease progression|20|||
130326236|NCT02760498|469166020|FG003|Overall Study|Disease progression|18|||
130326237|NCT02760498|469166021|FG004|Overall Study|Disease progression|4|||
130326238|NCT02760498|469166022|FG005|Overall Study|Disease progression|55|||
130326239|NCT02760498|469166017|FG000|Overall Study|Withdrawal by Subject|4|||
130326240|NCT02760498|469166018|FG001|Overall Study|Withdrawal by Subject|7|||
130326241|NCT02760498|469166019|FG002|Overall Study|Withdrawal by Subject|5|||
130326242|NCT02760498|469166020|FG003|Overall Study|Withdrawal by Subject|1|||
130326243|NCT02760498|469166021|FG004|Overall Study|Withdrawal by Subject|0|||
130326244|NCT02760498|469166022|FG005|Overall Study|Withdrawal by Subject|6|||
130326245|NCT02760498|469166017|FG000|Overall Study|Other than specified|1|||
130326246|NCT02760498|469166018|FG001|Overall Study|Other than specified|6|||
130326247|NCT02760498|469166019|FG002|Overall Study|Other than specified|0|||
130326248|NCT02760498|469166020|FG003|Overall Study|Other than specified|3|||
130326249|NCT02760498|469166021|FG004|Overall Study|Other than specified|1|||
130326250|NCT02760498|469166022|FG005|Overall Study|Other than specified|0|||
130326251|NCT02760498|469166017|FG000|Overall Study|Not treated|0|||
130326252|NCT02760498|469166018|FG001|Overall Study|Not treated|0|||
130326253|NCT02760498|469166019|FG002|Overall Study|Not treated|0|||
130326254|NCT02760498|469166020|FG003|Overall Study|Not treated|0|||
130326255|NCT02760498|469166021|FG004|Overall Study|Not treated|0|||
130657060|NCT00684645|470367210|FG000|Overall Study|Other|15|||
130657061|NCT02525627|470367224|FG000|Overall Study|Revision|1|||
130657062|NCT02525627|470367225|FG001|Overall Study|Revision|1|||
130657063|NCT02525627|470367224|FG000|Overall Study|Withdrawal by Subject|1|||
130657064|NCT02525627|470367225|FG001|Overall Study|Withdrawal by Subject|2|||
130657065|NCT02525627|470367224|FG000|Overall Study|Death|1|||
130326256|NCT02760498|469166022|FG005|Overall Study|Not treated|2|||
130326257|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130326258|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130326259|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
130326260|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
130326261|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Adverse Event|2|||
130326262|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Adverse Event|5|||
130326263|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Adverse Event|1|||
130326264|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Adverse Event|2|||
130326265|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Death|13|||
130326266|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Death|17|||
130326267|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Death|1|||
130326268|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Death|0|||
130326269|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
130657066|NCT02525627|470367225|FG001|Overall Study|Death|0|||
130657067|NCT02525627|470367224|FG000|Overall Study|Site terminated|11|||
130326270|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
130326271|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
130326272|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
130326273|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Disease Progression|2|||
130326274|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Disease Progression|0|||
130326275|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Disease Progression|0|||
130326276|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Disease Progression|0|||
130326277|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
130326278|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
130326279|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
130326280|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
130326281|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130326282|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130326283|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130326284|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130326285|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
130326286|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
130326287|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
130326288|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
130326289|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Participant Decision|9|||
130326290|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Participant Decision|12|||
130326291|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Participant Decision|1|||
130326292|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Participant Decision|1|||
130326293|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
130326294|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
130326295|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
130657068|NCT02525627|470367225|FG001|Overall Study|Site terminated|10|||
130657069|NCT03746080|470367226|FG000|Overall Study|In follow up|2|||
130657070|NCT03746080|470367226|FG000|Overall Study|Death|15|||
130657071|NCT01473589|470367227|FG000|Overall Study|Adverse Event|1|||
130657072|NCT01473589|470367228|FG001|Overall Study|Adverse Event|1|||
130657073|NCT01473589|470367227|FG000|Overall Study|Death|2|||
130657074|NCT01473589|470367228|FG001|Overall Study|Death|0|||
130657075|NCT01473589|470367227|FG000|Overall Study|Lost to Follow-up|2|||
130657076|NCT01473589|470367228|FG001|Overall Study|Lost to Follow-up|2|||
130326296|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
130326297|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
130326298|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
130551790|NCT01323634|469988141|FG000|2-week Run-in Period|Physician Decision|5|||
130551791|NCT01323634|469988142|FG001|2-week Run-in Period|Physician Decision|0|||
130551792|NCT01323634|469988143|FG002|2-week Run-in Period|Physician Decision|0|||
130551793|NCT01323634|469988141|FG000|2-week Run-in Period|Protocol Violation|1|||
130551794|NCT01323634|469988142|FG001|2-week Run-in Period|Protocol Violation|0|||
130551795|NCT01323634|469988143|FG002|2-week Run-in Period|Protocol Violation|0|||
130551796|NCT01323634|469988141|FG000|2-week Run-in Period|Adverse Event|1|||
130551797|NCT01323634|469988142|FG001|2-week Run-in Period|Adverse Event|0|||
130551798|NCT01323634|469988143|FG002|2-week Run-in Period|Adverse Event|0|||
130551799|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130551800|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
130551801|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
130551802|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130551803|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130551804|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
130551805|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130551806|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
130551807|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
130551808|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130551809|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130551810|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130551811|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
130551812|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
130551813|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
130551814|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130551815|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
130551816|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
130551817|NCT01323634|469988141|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
130551818|NCT01323634|469988142|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
130551819|NCT01323634|469988143|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
130657077|NCT01473589|470367227|FG000|Overall Study|Protocol Violation|1|||
130657078|NCT01473589|470367228|FG001|Overall Study|Protocol Violation|0|||
130657079|NCT01473589|470367227|FG000|Overall Study|Withdrawal by Subject|5|||
130326299|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130326300|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130326301|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326302|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
130326303|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326304|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326305|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130326306|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130326307|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130326308|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130326309|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
130326310|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
130326311|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130326312|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130326313|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
130326314|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326315|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326316|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326317|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
130326318|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
130326319|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130326320|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130326321|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
130326322|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
130326323|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130326324|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130326325|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
130657080|NCT01473589|470367228|FG001|Overall Study|Withdrawal by Subject|11|||
130657081|NCT01473589|470367227|FG000|Overall Study|Physician Decision|0|||
130657082|NCT01473589|470367228|FG001|Overall Study|Physician Decision|1|||
130657083|NCT01473589|470367227|FG000|Overall Study|Entry criteria not met|0|||
130657084|NCT01473589|470367228|FG001|Overall Study|Entry criteria not met|1|||
130326326|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326327|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326328|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326329|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
130326330|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
130326331|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130326332|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130326333|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
130326334|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326335|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326336|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326337|NCT02002598|469166031|FG000|Dose Level 1|Withdrawal by Subject|1|||
130326338|NCT02002598|469166032|FG001|Dose Level 1|Withdrawal by Subject|0|||
130326339|NCT02002598|469166033|FG002|Dose Level 1|Withdrawal by Subject|0|||
130326340|NCT02002598|469166034|FG003|Dose Level 1|Withdrawal by Subject|0|||
130326341|NCT02002598|469166035|FG004|Dose Level 1|Withdrawal by Subject|0|||
130657085|NCT01819467|470367229|FG000|Overall Study|Physician Decision|20|||
130657086|NCT01819467|470367230|FG001|Overall Study|Physician Decision|9|||
130657087|NCT01607398|470367234|FG000|Overall Study|Adverse Event|0|||
130657088|NCT01607398|470367235|FG001|Overall Study|Adverse Event|2|||
130657089|NCT01607398|470367234|FG000|Overall Study|Severe COPD|2|||
130657090|NCT01607398|470367235|FG001|Overall Study|Severe COPD|0|||
130657091|NCT04139642|470367249|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
130657092|NCT04139642|470367250|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
130657093|NCT02871921|470367254|FG000|Overall Study|Withdrawal by Subject|34|||
130657094|NCT02871921|470367255|FG001|Overall Study|Withdrawal by Subject|27|||
130657095|NCT02871921|470367256|FG002|Overall Study|Withdrawal by Subject|27|||
130657096|NCT02871921|470367257|FG003|Overall Study|Withdrawal by Subject|30|||
130657097|NCT02353572|470367258|FG000|Overall Study|Withdrawal by Subject|1|||
130657098|NCT02353572|470367258|FG000|Overall Study|Study terminated|2|||
130657099|NCT03159611|470367263|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
130657100|NCT03159611|470367264|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
130657101|NCT03159611|470367263|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
130657102|NCT03159611|470367264|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
130657103|NCT03159611|470367263|FG000|Overall Study|Protocol Violation|7|||
130657104|NCT03159611|470367264|FG001|Overall Study|Protocol Violation|4|||
130657105|NCT03159611|470367263|FG000|Overall Study|Adverse Event|1|||
130657106|NCT03159611|470367264|FG001|Overall Study|Adverse Event|0|||
130657107|NCT03159611|470367263|FG000|Overall Study|Withdrawal by Subject|1|||
130657108|NCT03159611|470367264|FG001|Overall Study|Withdrawal by Subject|1|||
130657109|NCT03159611|470367263|FG000|Overall Study|Non-compliance with protocol requirement|3|||
130657110|NCT03159611|470367264|FG001|Overall Study|Non-compliance with protocol requirement|2|||
130657111|NCT03159611|470367263|FG000|Overall Study|Inability to perform procedures|1|||
130657112|NCT03159611|470367264|FG001|Overall Study|Inability to perform procedures|0|||
130657113|NCT00518011|470367265|FG000|Overall Study|Death|1|||
130657114|NCT00518011|470367266|FG001|Overall Study|Death|1|||
130657115|NCT00518011|470367265|FG000|Overall Study|Adverse Event|2|||
130657116|NCT00518011|470367266|FG001|Overall Study|Adverse Event|3|||
130657117|NCT00518011|470367265|FG000|Overall Study|Disease Progression|2|||
130657118|NCT00518011|470367266|FG001|Overall Study|Disease Progression|2|||
130657119|NCT00518011|470367265|FG000|Overall Study|Other Reasons|3|||
130657120|NCT00518011|470367266|FG001|Overall Study|Other Reasons|2|||
130657121|NCT00518011|470367265|FG000|Overall Study|Withdrawal by Subject|1|||
130657122|NCT00518011|470367266|FG001|Overall Study|Withdrawal by Subject|0|||
130657123|NCT02596009|470367267|FG000|Overall Study|Administrative problems|0|||
130657124|NCT02596009|470367268|FG001|Overall Study|Administrative problems|1|||
130657125|NCT02596009|470367269|FG002|Overall Study|Administrative problems|0|||
130657126|NCT02596009|470367270|FG003|Overall Study|Administrative problems|0|||
130657127|NCT02596009|470367271|FG004|Overall Study|Administrative problems|0|||
130657128|NCT02596009|470367272|FG005|Overall Study|Administrative problems|0|||
130657129|NCT03930615|470367273|FG000|Overall Study|Death|9|||
130657130|NCT03930615|470367274|FG001|Overall Study|Death|3|||
130657131|NCT03930615|470367273|FG000|Overall Study|Lost to Follow-up|1|||
130657132|NCT03930615|470367274|FG001|Overall Study|Lost to Follow-up|2|||
130657133|NCT03930615|470367273|FG000|Overall Study|Physician Decision|3|||
130657134|NCT03930615|470367274|FG001|Overall Study|Physician Decision|4|||
130657135|NCT03930615|470367273|FG000|Overall Study|Withdrawal by Subject|13|||
130657136|NCT03930615|470367274|FG001|Overall Study|Withdrawal by Subject|2|||
130657137|NCT03930615|470367273|FG000|Overall Study|Not treated|1|||
130657138|NCT03930615|470367274|FG001|Overall Study|Not treated|1|||
130657139|NCT03644927|470367279|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
130657140|NCT03644927|470367280|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
130657141|NCT00956813|470367284|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
130657142|NCT00956813|470367285|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
130657143|NCT00956813|470367284|FG000|Flaxseed and Placebo|Ineligible|3|||
130657144|NCT00956813|470367285|FG001|Flaxseed and Placebo|Ineligible|1|||
130657145|NCT04797637|470367286|FG000|Overall Study|Lost to Follow-up|23|||
130657146|NCT04797637|470367287|FG001|Overall Study|Lost to Follow-up|32|||
130657147|NCT04797637|470367286|FG000|Overall Study|Withdrawal by Subject|0|||
130657148|NCT04797637|470367287|FG001|Overall Study|Withdrawal by Subject|1|||
130657149|NCT03917654|470367290|FG000|Year 1|Withdrawal by Subject|1|||
130657150|NCT03917654|470367291|FG001|Year 1|Withdrawal by Subject|0|||
130657151|NCT03917654|470367292|FG002|Year 1|Withdrawal by Subject|0|||
130657152|NCT03917654|470367293|FG003|Year 1|Withdrawal by Subject|0|||
130657153|NCT03917654|470367294|FG004|Year 1|Withdrawal by Subject|0|||
130657154|NCT03917654|470367295|FG005|Year 1|Withdrawal by Subject|1|||
130657155|NCT03917654|470367296|FG006|Year 1|Withdrawal by Subject|6|||
130657156|NCT03917654|470367297|FG007|Year 1|Withdrawal by Subject|2|||
130657157|NCT03917654|470367298|FG008|Year 1|Withdrawal by Subject|5|||
130657158|NCT03917654|470367299|FG009|Year 1|Withdrawal by Subject|3|||
130657159|NCT03917654|470367300|FG010|Year 1|Withdrawal by Subject|1|||
130657160|NCT03917654|470367301|FG011|Year 1|Withdrawal by Subject|0|||
130657161|NCT03917654|470367290|FG000|Year 1|Travel|0|||
130657162|NCT03917654|470367291|FG001|Year 1|Travel|1|||
130657163|NCT03917654|470367292|FG002|Year 1|Travel|1|||
130657164|NCT03917654|470367293|FG003|Year 1|Travel|0|||
130326342|NCT02628873|469166036|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
130326343|NCT02628873|469166037|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
130326344|NCT02628873|469166036|FG000|Second Test (1 Hour)|Physician Decision|1|||
130326345|NCT02628873|469166037|FG001|Second Test (1 Hour)|Physician Decision|0|||
130326346|NCT02195518|469166038|FG000|Overall Study|Adverse Event|1|||
130326347|NCT02195518|469166038|FG000|Overall Study|Protocol Violation|4|||
130326348|NCT02195518|469166038|FG000|Overall Study|Pregnancy|2|||
130657165|NCT03917654|470367294|FG004|Year 1|Travel|4|||
130657166|NCT03917654|470367295|FG005|Year 1|Travel|4|||
130657167|NCT03917654|470367296|FG006|Year 1|Travel|10|||
130657168|NCT03917654|470367297|FG007|Year 1|Travel|8|||
130657169|NCT03917654|470367298|FG008|Year 1|Travel|2|||
130657170|NCT03917654|470367299|FG009|Year 1|Travel|5|||
130657171|NCT03917654|470367300|FG010|Year 1|Travel|3|||
130657172|NCT03917654|470367301|FG011|Year 1|Travel|3|||
130657173|NCT03917654|470367290|FG000|Year 1|Subject moved away from site|0|||
130657174|NCT03917654|470367291|FG001|Year 1|Subject moved away from site|1|||
130657175|NCT03917654|470367292|FG002|Year 1|Subject moved away from site|0|||
130657176|NCT03917654|470367293|FG003|Year 1|Subject moved away from site|0|||
130657177|NCT03917654|470367294|FG004|Year 1|Subject moved away from site|0|||
130657178|NCT03917654|470367295|FG005|Year 1|Subject moved away from site|0|||
130657179|NCT03917654|470367296|FG006|Year 1|Subject moved away from site|1|||
130657180|NCT03917654|470367297|FG007|Year 1|Subject moved away from site|2|||
130215422|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215423|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215424|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215425|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215426|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215427|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215428|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215429|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215430|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215431|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215432|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215433|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215434|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215435|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215436|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215437|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215438|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215439|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215440|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215441|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215442|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215443|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215444|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215445|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215446|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215447|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215448|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215449|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215450|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215451|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215452|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215453|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215454|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215455|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215456|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215457|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215458|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215459|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215460|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215461|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215462|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215463|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215464|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215465|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215466|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215467|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215468|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215469|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215470|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215471|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215472|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215473|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215474|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215475|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215476|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215477|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215478|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
130215479|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215480|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215481|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215482|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215483|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130657181|NCT03917654|470367298|FG008|Year 1|Subject moved away from site|1|||
130657182|NCT03917654|470367299|FG009|Year 1|Subject moved away from site|0|||
130657183|NCT03917654|470367300|FG010|Year 1|Subject moved away from site|0|||
130657184|NCT03917654|470367301|FG011|Year 1|Subject moved away from site|3|||
130657185|NCT03917654|470367290|FG000|Year 1|Spouse/Family member request|0|||
130657186|NCT03917654|470367291|FG001|Year 1|Spouse/Family member request|0|||
130657187|NCT03917654|470367292|FG002|Year 1|Spouse/Family member request|1|||
130657188|NCT03917654|470367293|FG003|Year 1|Spouse/Family member request|0|||
130657189|NCT03917654|470367294|FG004|Year 1|Spouse/Family member request|1|||
130657190|NCT03917654|470367295|FG005|Year 1|Spouse/Family member request|0|||
130657191|NCT03917654|470367296|FG006|Year 1|Spouse/Family member request|0|||
130657192|NCT03917654|470367297|FG007|Year 1|Spouse/Family member request|2|||
130657193|NCT03917654|470367298|FG008|Year 1|Spouse/Family member request|0|||
130657194|NCT03917654|470367299|FG009|Year 1|Spouse/Family member request|0|||
130657195|NCT03917654|470367300|FG010|Year 1|Spouse/Family member request|0|||
130657196|NCT03917654|470367301|FG011|Year 1|Spouse/Family member request|1|||
130657197|NCT03917654|470367290|FG000|Year 1|Death|0|||
130657198|NCT03917654|470367291|FG001|Year 1|Death|0|||
130657199|NCT03917654|470367292|FG002|Year 1|Death|0|||
130326349|NCT02195518|469166038|FG000|Overall Study|Withdrawal by Subject|1|||
130326350|NCT02195518|469166038|FG000|Overall Study|Lost to Follow-up|1|||
130326351|NCT01281124|469167775|FG000|Overall Study|Death|1|||
130326352|NCT03038100|469167776|FG000|Overall Study|Death|289|||
130326353|NCT03038100|469167777|FG001|Overall Study|Death|272|||
130326354|NCT03038100|469167776|FG000|Overall Study|Lost to Follow-up|9|||
130326355|NCT03038100|469167777|FG001|Overall Study|Lost to Follow-up|10|||
130657200|NCT03917654|470367293|FG003|Year 1|Death|0|||
130657201|NCT03917654|470367294|FG004|Year 1|Death|0|||
130326356|NCT03038100|469167776|FG000|Overall Study|Protocol Deviation|1|||
130657202|NCT03917654|470367295|FG005|Year 1|Death|0|||
130657203|NCT03917654|470367296|FG006|Year 1|Death|0|||
130657204|NCT03917654|470367297|FG007|Year 1|Death|0|||
130657205|NCT03917654|470367298|FG008|Year 1|Death|1|||
130657206|NCT03917654|470367299|FG009|Year 1|Death|1|||
130657207|NCT03917654|470367300|FG010|Year 1|Death|0|||
130657208|NCT03917654|470367301|FG011|Year 1|Death|0|||
130657209|NCT03917654|470367290|FG000|Year 1|Lost to Follow-up|0|||
130657210|NCT03917654|470367291|FG001|Year 1|Lost to Follow-up|0|||
130657211|NCT03917654|470367292|FG002|Year 1|Lost to Follow-up|0|||
130657212|NCT03917654|470367293|FG003|Year 1|Lost to Follow-up|0|||
130657213|NCT03917654|470367294|FG004|Year 1|Lost to Follow-up|0|||
130657214|NCT03917654|470367295|FG005|Year 1|Lost to Follow-up|0|||
130657215|NCT03917654|470367296|FG006|Year 1|Lost to Follow-up|2|||
130326357|NCT03038100|469167777|FG001|Overall Study|Protocol Deviation|4|||
130326358|NCT03038100|469167776|FG000|Overall Study|Withdrawal by Subject|45|||
130326359|NCT03038100|469167777|FG001|Overall Study|Withdrawal by Subject|51|||
130326360|NCT03038100|469167776|FG000|Overall Study|Study Terminated By Sponsor|305|||
130326361|NCT03038100|469167777|FG001|Overall Study|Study Terminated By Sponsor|311|||
130326362|NCT03038100|469167776|FG000|Overall Study|Physician Decision|1|||
130326363|NCT03038100|469167777|FG001|Overall Study|Physician Decision|3|||
130326364|NCT02392624|469167778|FG000|Overall Study|Withdrawal by Subject|15|||
130326365|NCT02392624|469167779|FG001|Overall Study|Withdrawal by Subject|12|||
130326366|NCT02392624|469167780|FG002|Overall Study|Withdrawal by Subject|9|||
130326367|NCT02392624|469167778|FG000|Overall Study|Adverse Event|4|||
130326368|NCT02392624|469167779|FG001|Overall Study|Adverse Event|1|||
130326369|NCT02392624|469167780|FG002|Overall Study|Adverse Event|2|||
130326370|NCT02392624|469167778|FG000|Overall Study|Pregnancy|1|||
130326371|NCT02392624|469167779|FG001|Overall Study|Pregnancy|0|||
130326372|NCT02392624|469167780|FG002|Overall Study|Pregnancy|0|||
130326373|NCT02392624|469167778|FG000|Overall Study|Protocol Violation|0|||
130657216|NCT03917654|470367297|FG007|Year 1|Lost to Follow-up|0|||
130657217|NCT03917654|470367298|FG008|Year 1|Lost to Follow-up|0|||
130657218|NCT03917654|470367299|FG009|Year 1|Lost to Follow-up|0|||
130657219|NCT03917654|470367300|FG010|Year 1|Lost to Follow-up|0|||
130657220|NCT03917654|470367301|FG011|Year 1|Lost to Follow-up|0|||
130657221|NCT03917654|470367290|FG000|Year 1|Missed visits|0|||
130657222|NCT03917654|470367291|FG001|Year 1|Missed visits|0|||
130326374|NCT02392624|469167779|FG001|Overall Study|Protocol Violation|0|||
130326375|NCT02392624|469167780|FG002|Overall Study|Protocol Violation|1|||
130326376|NCT02392624|469167778|FG000|Overall Study|Sponsor/Investigator Decision|2|||
130326377|NCT02392624|469167779|FG001|Overall Study|Sponsor/Investigator Decision|1|||
130326378|NCT02392624|469167780|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130326379|NCT02392624|469167778|FG000|Overall Study|Other|49|||
130326380|NCT02392624|469167779|FG001|Overall Study|Other|1|||
130657223|NCT03917654|470367292|FG002|Year 1|Missed visits|0|||
130657224|NCT03917654|470367293|FG003|Year 1|Missed visits|0|||
130657225|NCT03917654|470367294|FG004|Year 1|Missed visits|0|||
130657226|NCT03917654|470367295|FG005|Year 1|Missed visits|0|||
130657227|NCT03917654|470367296|FG006|Year 1|Missed visits|0|||
130657228|NCT03917654|470367297|FG007|Year 1|Missed visits|0|||
130657229|NCT03917654|470367298|FG008|Year 1|Missed visits|0|||
130657230|NCT03917654|470367299|FG009|Year 1|Missed visits|0|||
130657231|NCT03917654|470367300|FG010|Year 1|Missed visits|1|||
130326381|NCT02392624|469167780|FG002|Overall Study|Other|1|||
130326382|NCT00706238|469167781|FG000|Overall Study|Disease progression|4|||
130326383|NCT00706238|469167781|FG000|Overall Study|Other|1|||
130326384|NCT03841604|469167786|FG000|Overall Study|Withdrawal by Subject|3|||
130326385|NCT03841604|469167787|FG001|Overall Study|Withdrawal by Subject|1|||
130326386|NCT03841604|469167786|FG000|Overall Study|Adverse Event|4|||
130326387|NCT03841604|469167787|FG001|Overall Study|Adverse Event|2|||
130326388|NCT03841604|469167786|FG000|Overall Study|Physician Decision|1|||
130326389|NCT03841604|469167787|FG001|Overall Study|Physician Decision|0|||
130326390|NCT03877510|469167790|FG000|Overall Study|Death|6|||
130326391|NCT03877510|469167790|FG000|Overall Study|Lost to Follow-up|2|||
130326392|NCT03877510|469167790|FG000|Overall Study|Non-compliance with study drug|2|||
130326393|NCT03877510|469167790|FG000|Overall Study|Lack of Efficacy|14|||
130326394|NCT03877510|469167790|FG000|Overall Study|Adverse Event|20|||
130326395|NCT03877510|469167790|FG000|Overall Study|Withdrawal by Subject|22|||
130326396|NCT03877510|469167790|FG000|Overall Study|Miscellaneous|1|||
130326397|NCT01417377|469167791|FG000|Overall Study|Lost to Follow-up|12|||
130326398|NCT01417377|469167791|FG000|Overall Study|Enrolled, but not treated|1|||
130326399|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
130326400|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130326401|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
130326402|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
130326403|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
130326404|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130326405|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130326406|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
130326407|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
130326408|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
130326409|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
130326410|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
130326411|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
130326412|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
130326413|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
130326414|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
130326415|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130326416|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
130326417|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
130326418|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
130326419|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
130326420|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
130326421|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
130326422|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
130326423|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
130326424|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
130326425|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
130326426|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
130326427|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326428|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326429|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326430|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326431|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326432|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326433|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
130326434|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326435|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326436|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326437|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130551820|NCT05056987|469988144|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
130551821|NCT05056987|469988145|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
130551822|NCT05056987|469988144|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
130551823|NCT05056987|469988145|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
130551824|NCT02409368|469988146|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
130551825|NCT02409368|469988147|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
130551826|NCT02409368|469988148|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
130551827|NCT02409368|469988149|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
130551828|NCT02409368|469988146|FG000|ECOG Reclassification|Death|1|||
130657232|NCT03917654|470367301|FG011|Year 1|Missed visits|1|||
130326438|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326439|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130551829|NCT02409368|469988147|FG001|ECOG Reclassification|Death|5|||
130326440|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326441|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Transplant|0|||
130326442|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Transplant|1|||
130657233|NCT03917654|470367290|FG000|Year 1|Pregnancy|0|||
130657234|NCT03917654|470367291|FG001|Year 1|Pregnancy|0|||
130657235|NCT03917654|470367292|FG002|Year 1|Pregnancy|0|||
130657236|NCT03917654|470367293|FG003|Year 1|Pregnancy|0|||
130657237|NCT03917654|470367294|FG004|Year 1|Pregnancy|0|||
130657238|NCT03917654|470367295|FG005|Year 1|Pregnancy|0|||
130657239|NCT03917654|470367296|FG006|Year 1|Pregnancy|0|||
130657240|NCT03917654|470367297|FG007|Year 1|Pregnancy|1|||
130657241|NCT03917654|470367298|FG008|Year 1|Pregnancy|0|||
130657242|NCT03917654|470367299|FG009|Year 1|Pregnancy|1|||
130657243|NCT03917654|470367300|FG010|Year 1|Pregnancy|0|||
130657244|NCT03917654|470367301|FG011|Year 1|Pregnancy|0|||
130657245|NCT03917654|470367290|FG000|Year 2|Travel|1|||
130657246|NCT03917654|470367291|FG001|Year 2|Travel|0|||
130657247|NCT03917654|470367292|FG002|Year 2|Travel|0|||
130657248|NCT03917654|470367293|FG003|Year 2|Travel|0|||
130657249|NCT03917654|470367294|FG004|Year 2|Travel|1|||
130657250|NCT03917654|470367295|FG005|Year 2|Travel|1|||
130657251|NCT03917654|470367296|FG006|Year 2|Travel|2|||
130657252|NCT03917654|470367297|FG007|Year 2|Travel|1|||
130657253|NCT03917654|470367298|FG008|Year 2|Travel|0|||
130657254|NCT03917654|470367299|FG009|Year 2|Travel|1|||
130657255|NCT03917654|470367300|FG010|Year 2|Travel|0|||
130657256|NCT03917654|470367301|FG011|Year 2|Travel|1|||
130657257|NCT03917654|470367290|FG000|Year 2|Married|1|||
130657258|NCT03917654|470367291|FG001|Year 2|Married|0|||
130657259|NCT03917654|470367292|FG002|Year 2|Married|0|||
130657260|NCT03917654|470367293|FG003|Year 2|Married|0|||
130657261|NCT03917654|470367294|FG004|Year 2|Married|0|||
130657262|NCT03917654|470367295|FG005|Year 2|Married|0|||
130657263|NCT03917654|470367296|FG006|Year 2|Married|1|||
130657264|NCT03917654|470367297|FG007|Year 2|Married|1|||
130657265|NCT03917654|470367298|FG008|Year 2|Married|0|||
130215484|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215485|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215486|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215487|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215488|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215489|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215490|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215491|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215492|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215493|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215494|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215495|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215496|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215497|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215498|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215499|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215500|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215501|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215502|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215503|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215504|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215505|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215506|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215507|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215508|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215509|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215510|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215511|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215512|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130215513|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130215514|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130215515|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130215516|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
130215517|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215518|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215519|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215520|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215521|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215522|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215523|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215524|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215525|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215526|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215527|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130326443|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Transplant|0|||
130326444|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Transplant|0|||
130326445|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Transplant|0|||
130326446|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Transplant|1|||
130326447|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Transplant|0|||
130326448|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Transplant|0|||
130657266|NCT03917654|470367299|FG009|Year 2|Married|0|||
130657267|NCT03917654|470367300|FG010|Year 2|Married|0|||
130657268|NCT03917654|470367301|FG011|Year 2|Married|0|||
130657269|NCT03917654|470367290|FG000|Year 2|Subject moved away from site|1|||
130657270|NCT03917654|470367291|FG001|Year 2|Subject moved away from site|0|||
130657271|NCT03917654|470367292|FG002|Year 2|Subject moved away from site|0|||
130657272|NCT03917654|470367293|FG003|Year 2|Subject moved away from site|0|||
130657273|NCT03917654|470367294|FG004|Year 2|Subject moved away from site|1|||
130657274|NCT03917654|470367295|FG005|Year 2|Subject moved away from site|0|||
130657275|NCT03917654|470367296|FG006|Year 2|Subject moved away from site|2|||
130657276|NCT03917654|470367297|FG007|Year 2|Subject moved away from site|3|||
130657277|NCT03917654|470367298|FG008|Year 2|Subject moved away from site|0|||
130326449|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Transplant|0|||
130326450|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Transplant|0|||
130326451|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Transplant|0|||
130326452|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Transplant|0|||
130326453|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Transplant|0|||
130326454|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Transplant|0|||
130551830|NCT02409368|469988148|FG002|ECOG Reclassification|Death|0|||
130551831|NCT02409368|469988149|FG003|ECOG Reclassification|Death|0|||
130551832|NCT02409368|469988146|FG000|ECOG Reclassification|Disease Progression|113|||
130551833|NCT02409368|469988147|FG001|ECOG Reclassification|Disease Progression|382|||
130551834|NCT02409368|469988148|FG002|ECOG Reclassification|Disease Progression|70|||
130551835|NCT02409368|469988149|FG003|ECOG Reclassification|Disease Progression|1|||
130551836|NCT02409368|469988146|FG000|ECOG Reclassification|Lost to Follow-up|1|||
130551837|NCT02409368|469988147|FG001|ECOG Reclassification|Lost to Follow-up|5|||
130551838|NCT02409368|469988148|FG002|ECOG Reclassification|Lost to Follow-up|0|||
130551839|NCT02409368|469988149|FG003|ECOG Reclassification|Lost to Follow-up|0|||
130551840|NCT02409368|469988146|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
130551841|NCT02409368|469988147|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
130551842|NCT02409368|469988148|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
130551843|NCT02409368|469988149|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
130551844|NCT02409368|469988146|FG000|ECOG Reclassification|Poor/non-compliance|0|||
130551845|NCT02409368|469988147|FG001|ECOG Reclassification|Poor/non-compliance|3|||
130551846|NCT02409368|469988148|FG002|ECOG Reclassification|Poor/non-compliance|2|||
130551847|NCT02409368|469988149|FG003|ECOG Reclassification|Poor/non-compliance|0|||
130551848|NCT02409368|469988146|FG000|ECOG Reclassification|Study drug toxicity|17|||
130551849|NCT02409368|469988147|FG001|ECOG Reclassification|Study drug toxicity|42|||
130551850|NCT02409368|469988148|FG002|ECOG Reclassification|Study drug toxicity|7|||
130551851|NCT02409368|469988149|FG003|ECOG Reclassification|Study drug toxicity|0|||
130551852|NCT02409368|469988146|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
130551853|NCT02409368|469988147|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
130551854|NCT02409368|469988148|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
130551855|NCT02409368|469988149|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
130551856|NCT02409368|469988146|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
130551857|NCT02409368|469988147|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
130551858|NCT02409368|469988148|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
130551859|NCT02409368|469988149|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
130551860|NCT02409368|469988146|FG000|ECOG Reclassification|Participant withdrew consent|2|||
130551861|NCT02409368|469988147|FG001|ECOG Reclassification|Participant withdrew consent|3|||
130551862|NCT02409368|469988148|FG002|ECOG Reclassification|Participant withdrew consent|4|||
130551863|NCT02409368|469988149|FG003|ECOG Reclassification|Participant withdrew consent|0|||
130551864|NCT02409368|469988146|FG000|ECOG Reclassification|Other Reasons|5|||
130551865|NCT02409368|469988147|FG001|ECOG Reclassification|Other Reasons|26|||
130551866|NCT02409368|469988148|FG002|ECOG Reclassification|Other Reasons|2|||
130551867|NCT02409368|469988149|FG003|ECOG Reclassification|Other Reasons|0|||
130551868|NCT02409368|469988146|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
130551869|NCT02409368|469988147|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
130551870|NCT02409368|469988148|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
130551871|NCT02409368|469988149|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
130551872|NCT01585987|469988150|FG000|Randomized|Withdrawal by Subject|0|||
130551873|NCT01585987|469988151|FG001|Randomized|Withdrawal by Subject|4|||
130551874|NCT01585987|469988150|FG000|Randomized|No longer met criteria|0|||
130657278|NCT03917654|470367299|FG009|Year 2|Subject moved away from site|2|||
130657279|NCT03917654|470367300|FG010|Year 2|Subject moved away from site|0|||
130326455|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
130326456|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
130657280|NCT03917654|470367301|FG011|Year 2|Subject moved away from site|1|||
130657281|NCT03917654|470367290|FG000|Year 2|Year 2 Screening failure|0|||
130657282|NCT03917654|470367291|FG001|Year 2|Year 2 Screening failure|1|||
130657283|NCT03917654|470367292|FG002|Year 2|Year 2 Screening failure|0|||
130657284|NCT03917654|470367293|FG003|Year 2|Year 2 Screening failure|0|||
130657285|NCT03917654|470367294|FG004|Year 2|Year 2 Screening failure|2|||
130657286|NCT03917654|470367295|FG005|Year 2|Year 2 Screening failure|0|||
130657287|NCT03917654|470367296|FG006|Year 2|Year 2 Screening failure|4|||
130657288|NCT03917654|470367297|FG007|Year 2|Year 2 Screening failure|3|||
130657289|NCT03917654|470367298|FG008|Year 2|Year 2 Screening failure|10|||
130657290|NCT03917654|470367299|FG009|Year 2|Year 2 Screening failure|2|||
130657291|NCT03917654|470367300|FG010|Year 2|Year 2 Screening failure|1|||
130657292|NCT03917654|470367301|FG011|Year 2|Year 2 Screening failure|1|||
130657293|NCT03917654|470367290|FG000|Year 2|Death|0|||
130657294|NCT03917654|470367291|FG001|Year 2|Death|0|||
130657295|NCT03917654|470367292|FG002|Year 2|Death|0|||
130657296|NCT03917654|470367293|FG003|Year 2|Death|0|||
130657297|NCT03917654|470367294|FG004|Year 2|Death|0|||
130657298|NCT03917654|470367295|FG005|Year 2|Death|1|||
130657299|NCT03917654|470367296|FG006|Year 2|Death|0|||
130657300|NCT03917654|470367297|FG007|Year 2|Death|0|||
130657301|NCT03917654|470367298|FG008|Year 2|Death|1|||
130657302|NCT03917654|470367299|FG009|Year 2|Death|1|||
130657303|NCT03917654|470367300|FG010|Year 2|Death|0|||
130657304|NCT03917654|470367301|FG011|Year 2|Death|0|||
130657305|NCT03917654|470367290|FG000|Year 2|Withdrawal by Subject|0|||
130551875|NCT01585987|469988151|FG001|Randomized|No longer met criteria|2|||
130551876|NCT01585987|469988150|FG000|Treated|Disease Progression|39|||
130551877|NCT01585987|469988151|FG001|Treated|Disease Progression|36|||
130551878|NCT01585987|469988150|FG000|Treated|Study Drug Toxicity|9|||
130551879|NCT01585987|469988151|FG001|Treated|Study Drug Toxicity|5|||
130551880|NCT01585987|469988150|FG000|Treated|Adverse Event|3|||
130551881|NCT01585987|469988151|FG001|Treated|Adverse Event|0|||
130551882|NCT01585987|469988150|FG000|Treated|Withdrawal by Subject|1|||
130551883|NCT01585987|469988151|FG001|Treated|Withdrawal by Subject|2|||
130551884|NCT01585987|469988150|FG000|Treated|Death|1|||
130551885|NCT01585987|469988151|FG001|Treated|Death|0|||
130551886|NCT01585987|469988150|FG000|Treated|Lost to Follow-up|0|||
130551887|NCT01585987|469988151|FG001|Treated|Lost to Follow-up|1|||
130551888|NCT01585987|469988150|FG000|Treated|Maximum Clinical Benefit|0|||
130551889|NCT01585987|469988151|FG001|Treated|Maximum Clinical Benefit|1|||
130551890|NCT01585987|469988150|FG000|Treated|Non-Specified|1|||
130551891|NCT01585987|469988151|FG001|Treated|Non-Specified|2|||
130551892|NCT01585987|469988150|FG000|Treated|Subject Request|0|||
130551893|NCT01585987|469988151|FG001|Treated|Subject Request|1|||
130551894|NCT01585987|469988150|FG000|Treated|Poor/Non-Compliance|0|||
130551895|NCT01585987|469988151|FG001|Treated|Poor/Non-Compliance|1|||
130551896|NCT02041520|469988152|FG000|Overall Study|Adverse Event|2|||
130551897|NCT02041520|469988153|FG001|Overall Study|Adverse Event|1|||
130551898|NCT02041520|469988152|FG000|Overall Study|Withdrawal by Subject|3|||
130551899|NCT02041520|469988153|FG001|Overall Study|Withdrawal by Subject|4|||
130551900|NCT02041520|469988152|FG000|Overall Study|Protocol Violation|1|||
130551901|NCT02041520|469988153|FG001|Overall Study|Protocol Violation|0|||
130551902|NCT02041520|469988152|FG000|Overall Study|Lost to Follow-up|0|||
130551903|NCT02041520|469988153|FG001|Overall Study|Lost to Follow-up|1|||
130551904|NCT02041520|469988152|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
130551905|NCT02041520|469988153|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
130551906|NCT00413972|469988159|FG000|Overall Study|Adverse Event|2|||
130551907|NCT00413972|469988160|FG001|Overall Study|Adverse Event|1|||
130551908|NCT00413972|469988161|FG002|Overall Study|Adverse Event|0|||
130551909|NCT00413972|469988162|FG003|Overall Study|Adverse Event|0|||
130551910|NCT00413972|469988159|FG000|Overall Study|Lost to Follow-up|1|||
130551911|NCT00413972|469988160|FG001|Overall Study|Lost to Follow-up|2|||
130551912|NCT00413972|469988161|FG002|Overall Study|Lost to Follow-up|1|||
130551913|NCT00413972|469988162|FG003|Overall Study|Lost to Follow-up|0|||
130551914|NCT00413972|469988159|FG000|Overall Study|Withdrawal by Subject|4|||
130551915|NCT00413972|469988160|FG001|Overall Study|Withdrawal by Subject|5|||
130551916|NCT00413972|469988161|FG002|Overall Study|Withdrawal by Subject|7|||
130551917|NCT00413972|469988162|FG003|Overall Study|Withdrawal by Subject|2|||
130551918|NCT00413972|469988159|FG000|Overall Study|Protocol Violation|0|||
130551919|NCT00413972|469988160|FG001|Overall Study|Protocol Violation|0|||
130551920|NCT00413972|469988161|FG002|Overall Study|Protocol Violation|2|||
130551921|NCT00413972|469988162|FG003|Overall Study|Protocol Violation|0|||
130551922|NCT00413972|469988159|FG000|Overall Study|Other|0|||
130551923|NCT00413972|469988160|FG001|Overall Study|Other|0|||
130551924|NCT00413972|469988161|FG002|Overall Study|Other|0|||
130551925|NCT00413972|469988162|FG003|Overall Study|Other|1|||
130657306|NCT03917654|470367291|FG001|Year 2|Withdrawal by Subject|0|||
130657307|NCT03917654|470367292|FG002|Year 2|Withdrawal by Subject|0|||
130657308|NCT03917654|470367293|FG003|Year 2|Withdrawal by Subject|0|||
130657309|NCT03917654|470367294|FG004|Year 2|Withdrawal by Subject|0|||
130657310|NCT03917654|470367295|FG005|Year 2|Withdrawal by Subject|0|||
130657311|NCT03917654|470367296|FG006|Year 2|Withdrawal by Subject|3|||
130326457|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
130326458|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
130326459|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
130326460|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
130326461|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
130326462|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
130326463|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
130326464|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
130326465|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
130326466|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
130326467|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
130326468|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
130326469|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
130326470|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
130326471|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
130326472|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
130326473|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
130326474|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
130326475|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
130326476|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
130326477|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
130326478|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
130326479|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
130326480|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
130326481|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
130326482|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
130326483|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
130326484|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
130326485|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
130326486|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
130326487|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
130326488|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
130326489|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
130326490|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
130326491|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
130326492|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
130326493|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
130326494|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
130326495|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
130326496|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
130326497|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
130326498|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
130326499|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
130326500|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
130326501|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
130326502|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
130326503|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
130326504|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
130326505|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
130551926|NCT01759407|469988163|FG000|Overall Study|Protocol Violation|0|||
130551927|NCT01759407|469988164|FG001|Overall Study|Protocol Violation|2|||
130551928|NCT03737474|469988165|FG000|Overall Study|Adverse Event|18|||
130551929|NCT03737474|469988166|FG001|Overall Study|Adverse Event|48|||
130551930|NCT03737474|469988165|FG000|Overall Study|Lack of Efficacy|1|||
130551931|NCT03737474|469988166|FG001|Overall Study|Lack of Efficacy|3|||
130551932|NCT03737474|469988165|FG000|Overall Study|Protocol Violation|0|||
130551933|NCT03737474|469988166|FG001|Overall Study|Protocol Violation|8|||
130551934|NCT03737474|469988165|FG000|Overall Study|Withdrawal by Subject|5|||
130551935|NCT03737474|469988166|FG001|Overall Study|Withdrawal by Subject|20|||
130551936|NCT03737474|469988165|FG000|Overall Study|Non-compliance With Study Drug|0|||
130551937|NCT03737474|469988166|FG001|Overall Study|Non-compliance With Study Drug|1|||
130551938|NCT03737474|469988165|FG000|Overall Study|Physician Decision|1|||
130551939|NCT03737474|469988166|FG001|Overall Study|Physician Decision|4|||
130551940|NCT02513745|469988167|FG000|Overall Study|Criteria at time of surgery not met.|3|||
130551941|NCT02513745|469988168|FG001|Overall Study|Criteria at time of surgery not met.|3|||
130551942|NCT02678247|469988169|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
130657312|NCT03917654|470367297|FG007|Year 2|Withdrawal by Subject|0|||
130551943|NCT02678247|469988170|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
130326506|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
130326507|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
130326508|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
130326509|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
130326510|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
130657313|NCT03917654|470367298|FG008|Year 2|Withdrawal by Subject|2|||
130657314|NCT03917654|470367299|FG009|Year 2|Withdrawal by Subject|5|||
130657315|NCT03917654|470367300|FG010|Year 2|Withdrawal by Subject|0|||
130657316|NCT03917654|470367301|FG011|Year 2|Withdrawal by Subject|0|||
130657317|NCT03917654|470367290|FG000|Year 2|Spouse/family member request|0|||
130657318|NCT03917654|470367291|FG001|Year 2|Spouse/family member request|0|||
130657319|NCT03917654|470367292|FG002|Year 2|Spouse/family member request|0|||
130657320|NCT03917654|470367293|FG003|Year 2|Spouse/family member request|0|||
130657321|NCT03917654|470367294|FG004|Year 2|Spouse/family member request|0|||
130657322|NCT03917654|470367295|FG005|Year 2|Spouse/family member request|0|||
130657323|NCT03917654|470367296|FG006|Year 2|Spouse/family member request|1|||
130657324|NCT03917654|470367297|FG007|Year 2|Spouse/family member request|0|||
130657325|NCT03917654|470367298|FG008|Year 2|Spouse/family member request|0|||
130657326|NCT03917654|470367299|FG009|Year 2|Spouse/family member request|0|||
130657327|NCT03917654|470367300|FG010|Year 2|Spouse/family member request|0|||
130657328|NCT03917654|470367301|FG011|Year 2|Spouse/family member request|0|||
130657329|NCT03917654|470367290|FG000|Year 2|Lost to Follow-up|0|||
130657330|NCT03917654|470367291|FG001|Year 2|Lost to Follow-up|0|||
130657331|NCT03917654|470367292|FG002|Year 2|Lost to Follow-up|0|||
130657332|NCT03917654|470367293|FG003|Year 2|Lost to Follow-up|0|||
130657333|NCT03917654|470367294|FG004|Year 2|Lost to Follow-up|0|||
130657334|NCT03917654|470367295|FG005|Year 2|Lost to Follow-up|0|||
130657335|NCT03917654|470367296|FG006|Year 2|Lost to Follow-up|1|||
130657336|NCT03917654|470367297|FG007|Year 2|Lost to Follow-up|0|||
130657337|NCT03917654|470367298|FG008|Year 2|Lost to Follow-up|1|||
130657338|NCT03917654|470367299|FG009|Year 2|Lost to Follow-up|0|||
130657339|NCT03917654|470367300|FG010|Year 2|Lost to Follow-up|0|||
130657340|NCT03917654|470367301|FG011|Year 2|Lost to Follow-up|1|||
130657341|NCT03917654|470367290|FG000|Year 2|Adverse Event|0|||
130657342|NCT03917654|470367291|FG001|Year 2|Adverse Event|0|||
130657343|NCT03917654|470367292|FG002|Year 2|Adverse Event|0|||
130657344|NCT03917654|470367293|FG003|Year 2|Adverse Event|0|||
130657345|NCT03917654|470367294|FG004|Year 2|Adverse Event|0|||
130657346|NCT03917654|470367295|FG005|Year 2|Adverse Event|0|||
130657347|NCT03917654|470367296|FG006|Year 2|Adverse Event|0|||
130657348|NCT03917654|470367297|FG007|Year 2|Adverse Event|0|||
130657349|NCT03917654|470367298|FG008|Year 2|Adverse Event|0|||
130657350|NCT03917654|470367299|FG009|Year 2|Adverse Event|1|||
130657351|NCT03917654|470367300|FG010|Year 2|Adverse Event|0|||
130657352|NCT03917654|470367301|FG011|Year 2|Adverse Event|0|||
130657353|NCT00905437|470367304|FG000|Overall Study|Adverse Event|3|||
130657354|NCT00905437|470367305|FG001|Overall Study|Adverse Event|2|||
130657355|NCT00905437|470367304|FG000|Overall Study|Lost to Follow-up|0|||
130657356|NCT00905437|470367305|FG001|Overall Study|Lost to Follow-up|1|||
130657357|NCT00905437|470367304|FG000|Overall Study|Withdrawal by Subject|0|||
130657358|NCT00905437|470367305|FG001|Overall Study|Withdrawal by Subject|1|||
130657359|NCT00905437|470367304|FG000|Overall Study|Other|5|||
130657360|NCT00905437|470367305|FG001|Overall Study|Other|6|||
130657361|NCT01306968|470367308|FG000|Overall Study|Lost to Follow-up|1|||
130657362|NCT01306968|470367309|FG001|Overall Study|Lost to Follow-up|1|||
130657363|NCT01306968|470367310|FG002|Overall Study|Lost to Follow-up|0|||
130657364|NCT01306968|470367311|FG003|Overall Study|Lost to Follow-up|0|||
130657365|NCT01306968|470367308|FG000|Overall Study|Physician Decision|0|||
130657366|NCT01306968|470367309|FG001|Overall Study|Physician Decision|1|||
130657367|NCT01306968|470367310|FG002|Overall Study|Physician Decision|0|||
130657368|NCT01306968|470367311|FG003|Overall Study|Physician Decision|0|||
130657369|NCT01306968|470367308|FG000|Overall Study|Relocated and left active duty|0|||
130657370|NCT01306968|470367309|FG001|Overall Study|Relocated and left active duty|1|||
130657371|NCT01306968|470367310|FG002|Overall Study|Relocated and left active duty|1|||
130657372|NCT01306968|470367311|FG003|Overall Study|Relocated and left active duty|1|||
130657373|NCT01306968|470367308|FG000|Overall Study|Withdrew - time commitment|0|||
130657374|NCT01306968|470367309|FG001|Overall Study|Withdrew - time commitment|0|||
130657375|NCT01306968|470367310|FG002|Overall Study|Withdrew - time commitment|0|||
130657376|NCT01306968|470367311|FG003|Overall Study|Withdrew - time commitment|2|||
130657377|NCT01306968|470367308|FG000|Overall Study|Withdrew over privacy concerns|0|||
130657378|NCT01306968|470367309|FG001|Overall Study|Withdrew over privacy concerns|0|||
130657379|NCT01306968|470367310|FG002|Overall Study|Withdrew over privacy concerns|0|||
130657380|NCT01306968|470367311|FG003|Overall Study|Withdrew over privacy concerns|1|||
130657381|NCT03252015|470367312|FG000|Overall Study|Withdrawal by Subject|0|||
130657382|NCT03252015|470367313|FG001|Overall Study|Withdrawal by Subject|1|||
130657383|NCT03252015|470367314|FG002|Overall Study|Withdrawal by Subject|1|||
130657384|NCT03252015|470367315|FG003|Overall Study|Withdrawal by Subject|0|||
130657385|NCT03252015|470367312|FG000|Overall Study|Adverse Event|1|||
130657386|NCT03252015|470367313|FG001|Overall Study|Adverse Event|0|||
130657387|NCT03252015|470367314|FG002|Overall Study|Adverse Event|0|||
130657388|NCT03252015|470367315|FG003|Overall Study|Adverse Event|1|||
130657389|NCT00690573|470367327|FG000|Overall Study|Lack of Efficacy|8|||
130657390|NCT00690573|470367327|FG000|Overall Study|Withdrawal by Subject|1|||
130657391|NCT04502862|470367328|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
130326511|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326512|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326513|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326514|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326515|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326516|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326517|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326518|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
130326519|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326520|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
130326521|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
130326522|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326523|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326524|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326525|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326526|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326527|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326528|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326529|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326530|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326531|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326532|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
130326533|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326534|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
130326535|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326536|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326537|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326538|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326539|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326540|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326541|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326542|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326543|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326544|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326545|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326546|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
130326547|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326548|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326549|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326550|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326551|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326552|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326553|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Transplant|0|||
130326554|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Transplant|0|||
130326555|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Transplant|0|||
130326556|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Transplant|0|||
130326557|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Transplant|0|||
130326558|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Transplant|0|||
130326559|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Transplant|0|||
130326560|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Transplant|0|||
130326561|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Transplant|0|||
130326562|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Transplant|4|||
130326563|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Transplant|2|||
130326564|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Transplant|0|||
130326565|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Transplant|0|||
130326566|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Transplant|0|||
130326567|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
130657392|NCT04502862|470367329|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
130657393|NCT04502862|470367328|FG000|Overall Study|Withdrawal by Subject|1|||
130657394|NCT04502862|470367329|FG001|Overall Study|Withdrawal by Subject|0|||
130657395|NCT04502862|470367328|FG000|Overall Study|Adverse Event|1|||
130657396|NCT04502862|470367329|FG001|Overall Study|Adverse Event|1|||
130657397|NCT01808508|470369229|FG000|Overall Study|Lost to Follow-up|1|||
130326568|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
130326569|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
130326570|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
130326571|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
130326572|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
130326573|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
130657398|NCT01808508|470369230|FG001|Overall Study|Lost to Follow-up|0|||
130326574|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
130326575|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
130326576|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
130326577|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
130326578|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
130326579|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
130326580|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
130326581|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
130326582|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
130326583|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
130326584|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
130326585|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
130326586|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
130326587|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
130326588|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
130326589|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
130326590|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
130326591|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
130326592|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
130326593|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
130326594|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
130326595|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326596|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326597|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326598|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326599|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326600|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326601|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326602|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326603|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326604|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326605|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326606|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
130326607|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326608|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326609|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326610|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326611|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326612|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326613|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326614|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326615|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326616|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326617|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326618|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326619|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326620|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
130326621|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326622|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326623|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326624|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326625|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326626|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326627|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326628|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326629|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326630|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326631|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326632|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326633|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326634|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
130326635|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326636|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326637|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
130657399|NCT01808508|470369231|FG002|Overall Study|Lost to Follow-up|0|||
130657400|NCT01017731|470369232|FG000|Overall Study|Lost to Follow-up|2|||
130326638|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
130326639|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
130326640|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
130326641|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
130326642|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
130326643|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
130657401|NCT01017731|470369232|FG000|Overall Study|Withdrawal by Subject|3|||
130657402|NCT01017731|470369232|FG000|Overall Study|Physician Decision|2|||
130326644|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
130326645|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
130326646|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
130326647|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
130326648|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
130326649|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
130326650|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
130326651|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326652|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326653|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326654|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326655|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130657403|NCT01017731|470369232|FG000|Overall Study|Adverse Event|1|||
130657404|NCT05378269|470369233|FG000|Overall Study|Protocol Violation|1|||
130657405|NCT05378269|470369234|FG001|Overall Study|Protocol Violation|0|||
130657406|NCT05378269|470369235|FG002|Overall Study|Protocol Violation|2|||
130657407|NCT05378269|470369236|FG003|Overall Study|Protocol Violation|0|||
130657408|NCT05378269|470369237|FG004|Overall Study|Protocol Violation|0|||
130657409|NCT00242567|470369240|FG000|Overall Study|Adverse Event|70|||
130657410|NCT00242567|470369241|FG001|Overall Study|Adverse Event|43|||
130657411|NCT00242567|470369240|FG000|Overall Study|Disease Progression|17|||
130657412|NCT00242567|470369241|FG001|Overall Study|Disease Progression|22|||
130657413|NCT00242567|470369240|FG000|Overall Study|Symptomatic deterioration|9|||
130657414|NCT00242567|470369241|FG001|Overall Study|Symptomatic deterioration|3|||
130657415|NCT00242567|470369240|FG000|Overall Study|Lack of Efficacy|2|||
130657416|NCT00242567|470369241|FG001|Overall Study|Lack of Efficacy|2|||
130657417|NCT00242567|470369240|FG000|Overall Study|Lost to Follow-up|9|||
130657418|NCT00242567|470369241|FG001|Overall Study|Lost to Follow-up|19|||
130657419|NCT00242567|470369240|FG000|Overall Study|Withdrawal by Subject|33|||
130657420|NCT00242567|470369241|FG001|Overall Study|Withdrawal by Subject|28|||
130657421|NCT00242567|470369240|FG000|Overall Study|Protocol Violation|12|||
130657422|NCT00242567|470369241|FG001|Overall Study|Protocol Violation|12|||
130657423|NCT00242567|470369240|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
130657424|NCT00242567|470369241|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
130657425|NCT00242567|470369240|FG000|Overall Study|Other|14|||
130657426|NCT00242567|470369241|FG001|Overall Study|Other|9|||
130657427|NCT01721200|470369242|FG000|Overall Study|Lost to Follow-up|3|||
130657428|NCT01721200|470369243|FG001|Overall Study|Lost to Follow-up|5|||
130657429|NCT03926728|470369244|FG000|Overall Study|Withdrawal by Subject|0|||
130657430|NCT03926728|470369245|FG001|Overall Study|Withdrawal by Subject|1|||
130657431|NCT03926728|470369246|FG002|Overall Study|Withdrawal by Subject|1|||
130657432|NCT03926728|470369247|FG003|Overall Study|Withdrawal by Subject|0|||
130657433|NCT03926728|470369248|FG004|Overall Study|Withdrawal by Subject|0|||
130657434|NCT03926728|470369249|FG005|Overall Study|Withdrawal by Subject|1|||
130657435|NCT03926728|470369250|FG006|Overall Study|Withdrawal by Subject|1|||
130657436|NCT03926728|470369251|FG007|Overall Study|Withdrawal by Subject|0|||
130657437|NCT03926728|470369252|FG008|Overall Study|Withdrawal by Subject|0|||
130657438|NCT03926728|470369253|FG009|Overall Study|Withdrawal by Subject|1|||
130657439|NCT03926728|470369254|FG010|Overall Study|Withdrawal by Subject|0|||
130657440|NCT03926728|470369255|FG011|Overall Study|Withdrawal by Subject|0|||
130657441|NCT03079869|470369258|FG000|Overall Study|Adverse Event|6|||
130657442|NCT03079869|470369259|FG001|Overall Study|Adverse Event|8|||
130657443|NCT03079869|470369258|FG000|Overall Study|Withdrawal by Subject|4|||
130657444|NCT03079869|470369259|FG001|Overall Study|Withdrawal by Subject|1|||
130657445|NCT03079869|470369258|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
130657446|NCT03079869|470369259|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
130657447|NCT02411110|470369260|FG000|Treatment Period 1|Adverse Event|4|||
130657448|NCT02411110|470369261|FG001|Treatment Period 1|Adverse Event|2|||
130657449|NCT02411110|470369260|FG000|Treatment Period 1|Lost to Follow-up|1|||
130657450|NCT02411110|470369261|FG001|Treatment Period 1|Lost to Follow-up|0|||
130657451|NCT02411110|470369260|FG000|Treatment Period 1|Personal Reasons|2|||
130657452|NCT02411110|470369261|FG001|Treatment Period 1|Personal Reasons|5|||
130326656|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326657|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326658|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326659|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130657453|NCT02411110|470369260|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
130657454|NCT02411110|470369261|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
130657455|NCT02411110|470369260|FG000|Treatment Period 2|Adverse Event|1|||
130326660|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326661|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326662|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326663|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
130657456|NCT02411110|470369261|FG001|Treatment Period 2|Adverse Event|0|||
130657457|NCT02411110|470369260|FG000|Treatment Period 2|Lost to Follow-up|0|||
130326664|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130657458|NCT02411110|470369261|FG001|Treatment Period 2|Lost to Follow-up|2|||
130657459|NCT02411110|470369260|FG000|Treatment Period 2|Personal Reasons|0|||
130657460|NCT02411110|470369261|FG001|Treatment Period 2|Personal Reasons|2|||
130657461|NCT00539006|470369270|FG000|Pre-treatment|Other|0|||
130657462|NCT00539006|470369271|FG001|Pre-treatment|Other|1|||
130657463|NCT00539006|470369272|FG002|Pre-treatment|Other|0|||
130657464|NCT00539006|470369273|FG003|Pre-treatment|Other|0|||
130657465|NCT00539006|470369270|FG000|Treatment Period 1|Lost to Follow-up|0|||
130657466|NCT00539006|470369271|FG001|Treatment Period 1|Lost to Follow-up|0|||
130657467|NCT00539006|470369272|FG002|Treatment Period 1|Lost to Follow-up|1|||
130657468|NCT00539006|470369273|FG003|Treatment Period 1|Lost to Follow-up|0|||
130657469|NCT00539006|470369270|FG000|Treatment Period 1|Protocol Violation|0|||
130326665|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326666|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326667|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326668|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326669|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326670|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326671|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326672|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326673|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326674|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326675|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326676|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326677|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
130326678|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
130326679|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326680|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326681|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326682|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326683|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326684|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326685|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326686|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326687|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326688|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326689|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326690|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326691|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
130326692|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
130326693|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326694|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326695|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326696|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326697|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326698|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326699|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326700|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326701|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326702|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326703|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326704|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326705|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
130326706|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
130326707|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326708|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326709|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326710|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326711|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326712|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326713|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326714|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326715|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326716|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326717|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130657470|NCT00539006|470369271|FG001|Treatment Period 1|Protocol Violation|0|||
130657471|NCT00539006|470369272|FG002|Treatment Period 1|Protocol Violation|1|||
130657472|NCT00539006|470369273|FG003|Treatment Period 1|Protocol Violation|0|||
130326718|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326719|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
130326720|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326721|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326722|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326723|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326724|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326725|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326726|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326727|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326728|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326729|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326730|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326731|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326732|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326733|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
130326734|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326735|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326736|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326737|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326738|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326739|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326740|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326741|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326742|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326743|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326744|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326745|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326746|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326747|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
130326748|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326749|NCT02085161|469167807|FG000|Overall Study|Not Treated|1|||
130326750|NCT02085161|469167808|FG001|Overall Study|Not Treated|0|||
130326751|NCT02085161|469167809|FG002|Overall Study|Not Treated|0|||
130326752|NCT02085161|469167810|FG003|Overall Study|Not Treated|0|||
130326753|NCT02085161|469167807|FG000|Overall Study|Adverse Event|8|||
130326754|NCT02085161|469167808|FG001|Overall Study|Adverse Event|5|||
130326755|NCT02085161|469167809|FG002|Overall Study|Adverse Event|4|||
130326756|NCT02085161|469167810|FG003|Overall Study|Adverse Event|5|||
130326757|NCT02085161|469167807|FG000|Overall Study|Protocol Violation|0|||
130326758|NCT02085161|469167808|FG001|Overall Study|Protocol Violation|1|||
130326759|NCT02085161|469167809|FG002|Overall Study|Protocol Violation|0|||
130326760|NCT02085161|469167810|FG003|Overall Study|Protocol Violation|1|||
130326761|NCT02085161|469167807|FG000|Overall Study|Withdrawal by Subject|2|||
130326762|NCT02085161|469167808|FG001|Overall Study|Withdrawal by Subject|4|||
130326763|NCT02085161|469167809|FG002|Overall Study|Withdrawal by Subject|0|||
130326764|NCT02085161|469167810|FG003|Overall Study|Withdrawal by Subject|3|||
130326765|NCT02085161|469167807|FG000|Overall Study|Other Reason|1|||
130326766|NCT02085161|469167808|FG001|Overall Study|Other Reason|0|||
130326767|NCT02085161|469167809|FG002|Overall Study|Other Reason|1|||
130326768|NCT02085161|469167810|FG003|Overall Study|Other Reason|1|||
130326769|NCT01936870|469167813|FG000|Overall Study|No Visit After Treatment|176|||
130326770|NCT01936870|469167813|FG000|Overall Study|Protocol Violation|12|||
130326771|NCT01936870|469167813|FG000|Overall Study|No Drug Administration|1|||
130326772|NCT00628108|469167824|FG000|Overall Study|Adverse Event|0|||
130326773|NCT00628108|469167825|FG001|Overall Study|Adverse Event|3|||
130326774|NCT00628108|469167824|FG000|Overall Study|Withdrawal by Subject|1|||
130326775|NCT00628108|469167825|FG001|Overall Study|Withdrawal by Subject|0|||
130326776|NCT03848832|469167826|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130326777|NCT03848832|469167827|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130326778|NCT03848832|469167828|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
130657473|NCT00539006|470369270|FG000|Treatment Period 1|Lack of Efficacy|0|||
130326779|NCT03848832|469167826|FG000|Overall Study|Withdrawal by Subject|0|||
130657474|NCT00539006|470369271|FG001|Treatment Period 1|Lack of Efficacy|0|||
130657475|NCT00539006|470369272|FG002|Treatment Period 1|Lack of Efficacy|0|||
130326780|NCT03848832|469167827|FG001|Overall Study|Withdrawal by Subject|0|||
130657476|NCT00539006|470369273|FG003|Treatment Period 1|Lack of Efficacy|1|||
130657477|NCT00539006|470369270|FG000|Washout|Adverse Event|2|||
130326781|NCT03848832|469167828|FG002|Overall Study|Withdrawal by Subject|1|||
130326782|NCT03848832|469167826|FG000|Overall Study|Withdrawal (Covid-19)|0|||
130326783|NCT03848832|469167827|FG001|Overall Study|Withdrawal (Covid-19)|2|||
130657478|NCT00539006|470369271|FG001|Washout|Adverse Event|1|||
130326784|NCT03848832|469167828|FG002|Overall Study|Withdrawal (Covid-19)|0|||
130326785|NCT03848832|469167826|FG000|Overall Study|Physician Decision|2|||
130326786|NCT03848832|469167827|FG001|Overall Study|Physician Decision|1|||
130326787|NCT03848832|469167828|FG002|Overall Study|Physician Decision|3|||
130326788|NCT03848832|469167826|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130326789|NCT03848832|469167827|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130326790|NCT03848832|469167828|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
130326791|NCT03848832|469167826|FG000|Overall Study|Adverse Event|1|||
130326792|NCT03848832|469167827|FG001|Overall Study|Adverse Event|0|||
130326793|NCT03848832|469167828|FG002|Overall Study|Adverse Event|0|||
130326794|NCT01760733|469167829|FG000|Waiting List|Death|18|||
130326795|NCT01760733|469167829|FG000|Waiting List|Removed from waiting list|41|||
130326796|NCT01760733|469167829|FG000|Waiting List|Not received a transplant yet|13|||
130326797|NCT01760733|469167829|FG000|Transplanted|Not reached 10 years post transplant|184|||
130326798|NCT01760733|469167829|FG000|Transplanted|Death|26|||
130326799|NCT01760733|469167829|FG000|Transplanted|Graft loss|7|||
130326800|NCT02404025|469167831|FG000|Overall Study|Adverse Event|1|||
130326801|NCT02404025|469167831|FG000|Overall Study|Lack of Efficacy|3|||
130326802|NCT03938259|469167833|FG000|Overall Study|unable to establish baseline for ventilation|1|||
130326803|NCT03938259|469167834|FG001|Overall Study|unable to establish baseline for ventilation|1|||
130326804|NCT01746901|469167837|FG000|Naloxone Challenge Phase|Adverse Event|2|||
130326805|NCT01746901|469167838|FG001|Naloxone Challenge Phase|Adverse Event|0|||
130326806|NCT01746901|469167839|FG002|Naloxone Challenge Phase|Adverse Event|0|||
130326807|NCT01746901|469167840|FG003|Naloxone Challenge Phase|Adverse Event|0|||
130326808|NCT01746901|469167841|FG004|Naloxone Challenge Phase|Adverse Event|0|||
130326809|NCT01746901|469167842|FG005|Naloxone Challenge Phase|Adverse Event|0|||
130326810|NCT01746901|469167843|FG006|Naloxone Challenge Phase|Adverse Event|0|||
130326811|NCT01746901|469167844|FG007|Naloxone Challenge Phase|Adverse Event|0|||
130326812|NCT01746901|469167845|FG008|Naloxone Challenge Phase|Adverse Event|0|||
130326813|NCT01746901|469167837|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
130326814|NCT01746901|469167838|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326815|NCT01746901|469167839|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326816|NCT01746901|469167840|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326817|NCT01746901|469167841|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326818|NCT01746901|469167842|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326819|NCT01746901|469167843|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326820|NCT01746901|469167844|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326821|NCT01746901|469167845|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326822|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326823|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130326824|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326825|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326826|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326827|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326828|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326829|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326830|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326831|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326832|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
130326833|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
130326834|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130551944|NCT02678247|469988169|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
130551945|NCT02678247|469988170|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
130551946|NCT02678247|469988169|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
130551947|NCT02678247|469988170|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
130551948|NCT02678247|469988169|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
130551949|NCT02678247|469988170|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
130551950|NCT02678247|469988169|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
130326835|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326836|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326837|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326838|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326839|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326840|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326841|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
130326842|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
130326843|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326844|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326845|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326846|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326847|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326848|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326849|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326850|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130326851|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130326852|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326853|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326854|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326855|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326856|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326857|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326858|NCT01746901|469167837|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
130326859|NCT01746901|469167838|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
130326860|NCT01746901|469167839|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
130657479|NCT00539006|470369272|FG002|Washout|Adverse Event|0|||
130657480|NCT00539006|470369273|FG003|Washout|Adverse Event|0|||
130657481|NCT00539006|470369270|FG000|Washout|Protocol Violation|1|||
130657482|NCT00539006|470369271|FG001|Washout|Protocol Violation|1|||
130657483|NCT00539006|470369272|FG002|Washout|Protocol Violation|0|||
130657484|NCT00539006|470369273|FG003|Washout|Protocol Violation|0|||
130657485|NCT00539006|470369270|FG000|Washout|Withdrawal by Subject|0|||
130657486|NCT00539006|470369271|FG001|Washout|Withdrawal by Subject|2|||
130657487|NCT00539006|470369272|FG002|Washout|Withdrawal by Subject|0|||
130657488|NCT00539006|470369273|FG003|Washout|Withdrawal by Subject|0|||
130657489|NCT00539006|470369270|FG000|Washout|Failed to meet continuation criteria|16|||
130657490|NCT00539006|470369271|FG001|Washout|Failed to meet continuation criteria|5|||
130657491|NCT00539006|470369272|FG002|Washout|Failed to meet continuation criteria|14|||
130657492|NCT00539006|470369273|FG003|Washout|Failed to meet continuation criteria|6|||
130657493|NCT00539006|470369270|FG000|Washout|Other|1|||
130657494|NCT00539006|470369271|FG001|Washout|Other|1|||
130657495|NCT00539006|470369272|FG002|Washout|Other|2|||
130657496|NCT00539006|470369273|FG003|Washout|Other|3|||
130657497|NCT00539006|470369270|FG000|Treatment Period 2|Protocol Violation|1|||
130657498|NCT00539006|470369271|FG001|Treatment Period 2|Protocol Violation|0|||
130657499|NCT00539006|470369272|FG002|Treatment Period 2|Protocol Violation|0|||
130657500|NCT00539006|470369273|FG003|Treatment Period 2|Protocol Violation|0|||
130657501|NCT00539006|470369270|FG000|Treatment Period 2|Other|0|||
130657502|NCT00539006|470369271|FG001|Treatment Period 2|Other|1|||
130657503|NCT00539006|470369272|FG002|Treatment Period 2|Other|0|||
130657504|NCT00539006|470369273|FG003|Treatment Period 2|Other|0|||
130657505|NCT00244881|470369277|FG000|Overall Study|Withdrawal by Subject|3|||
130657506|NCT01102972|470369278|FG000|Overall Study|Adverse Event|8|||
130657507|NCT01102972|470369279|FG001|Overall Study|Adverse Event|2|||
130657508|NCT01102972|470369278|FG000|Overall Study|Lack of Efficacy|2|||
130657509|NCT01102972|470369279|FG001|Overall Study|Lack of Efficacy|1|||
130657510|NCT01102972|470369278|FG000|Overall Study|Protocol Violation|1|||
130657511|NCT01102972|470369279|FG001|Overall Study|Protocol Violation|0|||
130657512|NCT01102972|470369278|FG000|Overall Study|Lost to Follow-up|10|||
130657513|NCT01102972|470369279|FG001|Overall Study|Lost to Follow-up|5|||
130657514|NCT01102972|470369278|FG000|Overall Study|Investigator Discretion|2|||
130657515|NCT01102972|470369279|FG001|Overall Study|Investigator Discretion|0|||
130657516|NCT01102972|470369278|FG000|Overall Study|Withdrawal by Subject|6|||
130657517|NCT01102972|470369279|FG001|Overall Study|Withdrawal by Subject|6|||
130657518|NCT01856257|470369283|FG000|Overall Study|Death|2|||
130657519|NCT01856257|470369284|FG001|Overall Study|Death|0|||
130657520|NCT01856257|470369285|FG002|Overall Study|Death|0|||
130657521|NCT01856257|470369286|FG003|Overall Study|Death|0|||
130657522|NCT01856257|470369283|FG000|Overall Study|Physician Decision|0|||
130657523|NCT01856257|470369284|FG001|Overall Study|Physician Decision|0|||
130657524|NCT01856257|470369285|FG002|Overall Study|Physician Decision|0|||
130657525|NCT01856257|470369286|FG003|Overall Study|Physician Decision|1|||
130657526|NCT01856257|470369283|FG000|Overall Study|Withdrawal by Subject|1|||
130657527|NCT01856257|470369284|FG001|Overall Study|Withdrawal by Subject|1|||
130657528|NCT01856257|470369285|FG002|Overall Study|Withdrawal by Subject|0|||
130657529|NCT01856257|470369286|FG003|Overall Study|Withdrawal by Subject|0|||
130657530|NCT01856257|470369283|FG000|Overall Study|Donor complication|0|||
130326861|NCT01746901|469167840|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
130657531|NCT01856257|470369284|FG001|Overall Study|Donor complication|0|||
130657532|NCT01856257|470369285|FG002|Overall Study|Donor complication|0|||
130657533|NCT01856257|470369286|FG003|Overall Study|Donor complication|1|||
130326862|NCT01746901|469167841|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
130657534|NCT04527549|470369287|FG000|Overall Study|Withdrawal by Subject|1|||
130657535|NCT04527549|470369288|FG001|Overall Study|Withdrawal by Subject|1|||
130657536|NCT02325739|470369289|FG000|Phase I Part|Adverse Event|1|||
130657537|NCT02325739|470369290|FG001|Phase I Part|Adverse Event|0|||
130657538|NCT02325739|470369291|FG002|Phase I Part|Adverse Event|1|||
130657539|NCT02325739|470369292|FG003|Phase I Part|Adverse Event|2|||
130326863|NCT01746901|469167842|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
130326864|NCT01746901|469167843|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
130326865|NCT01746901|469167844|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
130326866|NCT01746901|469167845|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
130326867|NCT01746901|469167837|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326868|NCT01746901|469167838|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326869|NCT01746901|469167839|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326870|NCT01746901|469167840|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326871|NCT01746901|469167841|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326872|NCT01746901|469167842|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326873|NCT01746901|469167843|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326874|NCT01746901|469167844|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
130326875|NCT01746901|469167845|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326876|NCT01746901|469167837|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326877|NCT01746901|469167838|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326878|NCT01746901|469167839|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326879|NCT01746901|469167840|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326880|NCT01746901|469167841|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326881|NCT01746901|469167842|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
130326882|NCT01746901|469167843|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
130326883|NCT01746901|469167844|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326884|NCT01746901|469167845|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326885|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326886|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326887|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326888|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
130326889|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326890|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326891|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326892|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326893|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326894|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326895|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326896|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326897|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326898|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326899|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130326900|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326901|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326902|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130326903|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326904|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326905|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326906|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326907|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326908|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326909|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130326910|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326911|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130326912|NCT03594110|469167849|FG000|Interventional Part|Participant concerned about study treatment|23|||
130326913|NCT03594110|469167850|FG001|Interventional Part|Participant concerned about study treatment|28|||
130326914|NCT03594110|469167849|FG000|Interventional Part|Doctor advice|38|||
130326915|NCT03594110|469167850|FG001|Interventional Part|Doctor advice|40|||
130326916|NCT03594110|469167849|FG000|Interventional Part|Participants' wish|89|||
130326917|NCT03594110|469167850|FG001|Interventional Part|Participants' wish|68|||
130326918|NCT03594110|469167849|FG000|Interventional Part|Adverse event-non-fatal events|119|||
130326919|NCT03594110|469167850|FG001|Interventional Part|Adverse event-non-fatal events|116|||
130326920|NCT03594110|469167849|FG000|Interventional Part|Study drug stopped, reason missing|336|||
130326921|NCT03594110|469167850|FG001|Interventional Part|Study drug stopped, reason missing|294|||
130326922|NCT03594110|469167849|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
130326923|NCT03594110|469167850|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
130326924|NCT03594110|469167849|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
130326925|NCT03594110|469167850|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
130326926|NCT03594110|469167849|FG000|Interventional Part|Contraindicated drug started|32|||
130326927|NCT03594110|469167850|FG001|Interventional Part|Contraindicated drug started|18|||
130326928|NCT03594110|469167849|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
130326929|NCT03594110|469167850|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
130326930|NCT03594110|469167849|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
130326931|NCT03594110|469167850|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
130326932|NCT03594110|469167849|FG000|Non-interventional Part|Withdrawal by Subject|3|||
130326933|NCT03594110|469167850|FG001|Non-interventional Part|Withdrawal by Subject|4|||
130326934|NCT03594110|469167849|FG000|Non-interventional Part|Lost to Follow-up|45|||
130326935|NCT03594110|469167850|FG001|Non-interventional Part|Lost to Follow-up|41|||
130326936|NCT05029362|469167851|FG000|Overall Study|Lost to Follow-up|9|||
130326937|NCT00684021|469167857|FG000|Overall Study|MRI Contraindicated|1|||
130326938|NCT00684021|469167858|FG001|Overall Study|MRI Contraindicated|1|||
130326939|NCT00684021|469167859|FG002|Overall Study|MRI Contraindicated|1|||
130326940|NCT00684021|469167860|FG003|Overall Study|MRI Contraindicated|0|||
130326941|NCT00684021|469167857|FG000|Overall Study|MRI not performed|0|||
130326942|NCT00684021|469167858|FG001|Overall Study|MRI not performed|1|||
130326943|NCT00684021|469167859|FG002|Overall Study|MRI not performed|1|||
130326944|NCT00684021|469167860|FG003|Overall Study|MRI not performed|2|||
130326945|NCT00684021|469167857|FG000|Overall Study|Death|1|||
130326946|NCT00684021|469167858|FG001|Overall Study|Death|0|||
130326947|NCT00684021|469167859|FG002|Overall Study|Death|0|||
130326948|NCT00684021|469167860|FG003|Overall Study|Death|0|||
130326949|NCT04041414|469167861|FG000|Overall Study|Lost to Follow-up|1|||
130326950|NCT04041414|469167862|FG001|Overall Study|Lost to Follow-up|2|||
130326951|NCT02900378|469167863|FG000|Randomization (Visit 2)|Adverse Event|14|||
130326952|NCT02900378|469167864|FG001|Randomization (Visit 2)|Adverse Event|11|||
130326953|NCT02900378|469167863|FG000|Randomization (Visit 2)|Death|1|||
130326954|NCT02900378|469167864|FG001|Randomization (Visit 2)|Death|4|||
130326955|NCT02900378|469167863|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
130326956|NCT02900378|469167864|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
130326957|NCT02900378|469167863|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130326958|NCT02900378|469167864|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130326959|NCT02900378|469167863|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
130326960|NCT02900378|469167864|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
130326961|NCT02900378|469167863|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
130326962|NCT02900378|469167864|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
130326963|NCT02900378|469167863|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
130326964|NCT02900378|469167864|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
130326965|NCT01690143|469167868|FG000|Overall Study|Withdrawal by Subject|1|||
130326966|NCT01409707|469167877|FG000|Overall Study|Withdrawal by Subject|5|||
130326967|NCT01409707|469167878|FG001|Overall Study|Withdrawal by Subject|17|||
130326968|NCT01409707|469167879|FG002|Overall Study|Withdrawal by Subject|16|||
130326969|NCT01658436|469167880|FG000|Overall Study|Adverse Event|6|||
130326970|NCT01658436|469167881|FG001|Overall Study|Adverse Event|5|||
130326971|NCT01658436|469167880|FG000|Overall Study|Physician Decision|1|||
130326972|NCT01658436|469167881|FG001|Overall Study|Physician Decision|0|||
130326973|NCT01658436|469167880|FG000|Overall Study|Progressive disease|12|||
130326974|NCT01658436|469167881|FG001|Overall Study|Progressive disease|4|||
130326975|NCT01658436|469167880|FG000|Overall Study|Study terminated by sponsor|0|||
130326976|NCT01658436|469167881|FG001|Overall Study|Study terminated by sponsor|1|||
130326977|NCT01658436|469167880|FG000|Overall Study|Subject/guardian decision|0|||
130326978|NCT01658436|469167881|FG001|Overall Study|Subject/guardian decision|1|||
130326979|NCT01658436|469167880|FG000|Overall Study|Death|1|||
130326980|NCT01658436|469167881|FG001|Overall Study|Death|0|||
130326981|NCT00686712|469167882|FG000|Overall Study|Protocol Violation|8|||
130326982|NCT00686712|469167883|FG001|Overall Study|Protocol Violation|8|||
130326983|NCT00686712|469167884|FG002|Overall Study|Protocol Violation|10|||
130326984|NCT00686712|469167882|FG000|Overall Study|Lost to Follow-up|1|||
130326985|NCT00686712|469167883|FG001|Overall Study|Lost to Follow-up|2|||
130326986|NCT00686712|469167884|FG002|Overall Study|Lost to Follow-up|3|||
130326987|NCT00686712|469167882|FG000|Overall Study|Adverse Event|1|||
130326988|NCT00686712|469167883|FG001|Overall Study|Adverse Event|1|||
130326989|NCT00686712|469167884|FG002|Overall Study|Adverse Event|0|||
130326990|NCT03987503|469167885|FG000|Overall Study|Lost to Follow-up|20|||
130326991|NCT03987503|469167885|FG000|Overall Study|Withdrawal by Subject|2|||
130326992|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
130326993|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
130326994|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
130326995|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
130326996|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
130326997|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
130657540|NCT02325739|470369293|FG004|Phase I Part|Adverse Event|3|||
130326998|NCT01929317|469167886|FG000|Long-term Phase|Adverse Event|5|||
130326999|NCT01929317|469167887|FG001|Long-term Phase|Adverse Event|1|||
130327000|NCT01929317|469167886|FG000|Long-term Phase|Physician Decision|3|||
130657541|NCT02325739|470369294|FG005|Phase I Part|Adverse Event|1|||
130327001|NCT01929317|469167887|FG001|Long-term Phase|Physician Decision|0|||
130657542|NCT02325739|470369295|FG006|Phase I Part|Adverse Event|0|||
130657543|NCT02325739|470369296|FG007|Phase I Part|Adverse Event|2|||
130657544|NCT02325739|470369297|FG008|Phase I Part|Adverse Event|0|||
130657545|NCT02325739|470369298|FG009|Phase I Part|Adverse Event|0|||
130657546|NCT02325739|470369299|FG010|Phase I Part|Adverse Event|0|||
130657547|NCT02325739|470369289|FG000|Phase I Part|Progressive disease|9|||
130657548|NCT02325739|470369290|FG001|Phase I Part|Progressive disease|6|||
130657549|NCT02325739|470369291|FG002|Phase I Part|Progressive disease|3|||
130657550|NCT02325739|470369292|FG003|Phase I Part|Progressive disease|23|||
130657551|NCT02325739|470369293|FG004|Phase I Part|Progressive disease|14|||
130657552|NCT02325739|470369294|FG005|Phase I Part|Progressive disease|6|||
130657553|NCT02325739|470369295|FG006|Phase I Part|Progressive disease|6|||
130657554|NCT02325739|470369296|FG007|Phase I Part|Progressive disease|3|||
130657555|NCT02325739|470369297|FG008|Phase I Part|Progressive disease|0|||
130657556|NCT02325739|470369298|FG009|Phase I Part|Progressive disease|0|||
130657557|NCT02325739|470369299|FG010|Phase I Part|Progressive disease|0|||
130657558|NCT02325739|470369289|FG000|Phase I Part|Subject/guardian decision|1|||
130657559|NCT02325739|470369290|FG001|Phase I Part|Subject/guardian decision|0|||
130657560|NCT02325739|470369291|FG002|Phase I Part|Subject/guardian decision|1|||
130657561|NCT02325739|470369292|FG003|Phase I Part|Subject/guardian decision|1|||
130657562|NCT02325739|470369293|FG004|Phase I Part|Subject/guardian decision|0|||
130657563|NCT02325739|470369294|FG005|Phase I Part|Subject/guardian decision|0|||
130657564|NCT02325739|470369295|FG006|Phase I Part|Subject/guardian decision|0|||
130657565|NCT02325739|470369296|FG007|Phase I Part|Subject/guardian decision|1|||
130657566|NCT02325739|470369297|FG008|Phase I Part|Subject/guardian decision|0|||
130657567|NCT02325739|470369298|FG009|Phase I Part|Subject/guardian decision|0|||
130657568|NCT02325739|470369299|FG010|Phase I Part|Subject/guardian decision|0|||
130657569|NCT02325739|470369289|FG000|Phase I Part|Death|0|||
130657570|NCT02325739|470369290|FG001|Phase I Part|Death|0|||
130657571|NCT02325739|470369291|FG002|Phase I Part|Death|0|||
130657572|NCT02325739|470369292|FG003|Phase I Part|Death|0|||
130657573|NCT02325739|470369293|FG004|Phase I Part|Death|2|||
130657574|NCT02325739|470369294|FG005|Phase I Part|Death|0|||
130657575|NCT02325739|470369295|FG006|Phase I Part|Death|0|||
130657576|NCT02325739|470369296|FG007|Phase I Part|Death|0|||
130657577|NCT02325739|470369297|FG008|Phase I Part|Death|0|||
130657578|NCT02325739|470369298|FG009|Phase I Part|Death|0|||
130657579|NCT02325739|470369299|FG010|Phase I Part|Death|0|||
130657580|NCT02325739|470369289|FG000|Phase II Part|Adverse Event|0|||
130657581|NCT02325739|470369290|FG001|Phase II Part|Adverse Event|0|||
130657582|NCT02325739|470369291|FG002|Phase II Part|Adverse Event|0|||
130657583|NCT02325739|470369292|FG003|Phase II Part|Adverse Event|0|||
130657584|NCT02325739|470369293|FG004|Phase II Part|Adverse Event|0|||
130657585|NCT02325739|470369294|FG005|Phase II Part|Adverse Event|0|||
130657586|NCT02325739|470369295|FG006|Phase II Part|Adverse Event|0|||
130657587|NCT02325739|470369296|FG007|Phase II Part|Adverse Event|0|||
130657588|NCT02325739|470369297|FG008|Phase II Part|Adverse Event|4|||
130657589|NCT02325739|470369298|FG009|Phase II Part|Adverse Event|5|||
130657590|NCT02325739|470369299|FG010|Phase II Part|Adverse Event|1|||
130657591|NCT02325739|470369289|FG000|Phase II Part|Physician Decision|0|||
130657592|NCT02325739|470369290|FG001|Phase II Part|Physician Decision|0|||
130657593|NCT02325739|470369291|FG002|Phase II Part|Physician Decision|0|||
130657594|NCT02325739|470369292|FG003|Phase II Part|Physician Decision|0|||
130657595|NCT02325739|470369293|FG004|Phase II Part|Physician Decision|0|||
130657596|NCT02325739|470369294|FG005|Phase II Part|Physician Decision|0|||
130657597|NCT02325739|470369295|FG006|Phase II Part|Physician Decision|0|||
130657598|NCT02325739|470369296|FG007|Phase II Part|Physician Decision|0|||
130657599|NCT02325739|470369297|FG008|Phase II Part|Physician Decision|0|||
130657600|NCT02325739|470369298|FG009|Phase II Part|Physician Decision|1|||
130657601|NCT02325739|470369299|FG010|Phase II Part|Physician Decision|0|||
130657602|NCT02325739|470369289|FG000|Phase II Part|Progressive disease|0|||
130657603|NCT02325739|470369290|FG001|Phase II Part|Progressive disease|0|||
130657604|NCT02325739|470369291|FG002|Phase II Part|Progressive disease|0|||
130657605|NCT02325739|470369292|FG003|Phase II Part|Progressive disease|0|||
130657606|NCT02325739|470369293|FG004|Phase II Part|Progressive disease|0|||
130657607|NCT02325739|470369294|FG005|Phase II Part|Progressive disease|0|||
130657608|NCT02325739|470369295|FG006|Phase II Part|Progressive disease|0|||
130657609|NCT02325739|470369296|FG007|Phase II Part|Progressive disease|0|||
130657610|NCT02325739|470369297|FG008|Phase II Part|Progressive disease|22|||
130657611|NCT02325739|470369298|FG009|Phase II Part|Progressive disease|29|||
130657612|NCT02325739|470369299|FG010|Phase II Part|Progressive disease|18|||
130657613|NCT02325739|470369289|FG000|Phase II Part|Subject/guardian decision|0|||
130657614|NCT02325739|470369290|FG001|Phase II Part|Subject/guardian decision|0|||
130327002|NCT01929317|469167886|FG000|Long-term Phase|Withdrawal by Subject|4|||
130657615|NCT02325739|470369291|FG002|Phase II Part|Subject/guardian decision|0|||
130657616|NCT02325739|470369292|FG003|Phase II Part|Subject/guardian decision|0|||
130657617|NCT02325739|470369293|FG004|Phase II Part|Subject/guardian decision|0|||
130657618|NCT02325739|470369294|FG005|Phase II Part|Subject/guardian decision|0|||
130657619|NCT02325739|470369295|FG006|Phase II Part|Subject/guardian decision|0|||
130327003|NCT01929317|469167887|FG001|Long-term Phase|Withdrawal by Subject|0|||
130327004|NCT01929317|469167886|FG000|Long-term Phase|Protocol Violation|1|||
130327005|NCT01929317|469167887|FG001|Long-term Phase|Protocol Violation|0|||
130327006|NCT01929317|469167886|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
130327007|NCT01929317|469167887|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
130327008|NCT01929317|469167886|FG000|Long-term Phase|Study Closed/Terminated|5|||
130327009|NCT01929317|469167887|FG001|Long-term Phase|Study Closed/Terminated|3|||
130327010|NCT01523756|469167888|FG000|Baseline Period|Adverse Event|0|||
130327011|NCT01523756|469167889|FG001|Baseline Period|Adverse Event|1|||
130327012|NCT01523756|469167888|FG000|Test Period 1|Adverse Event|1|||
130327013|NCT01523756|469167889|FG001|Test Period 1|Adverse Event|0|||
130327014|NCT01523756|469167888|FG000|Test Period 2|Withdrawal by Subject|0|||
130327015|NCT01523756|469167889|FG001|Test Period 2|Withdrawal by Subject|1|||
130327016|NCT00515619|469167890|FG000|Overall Study|Adverse Event|34|||
130327017|NCT00515619|469167890|FG000|Overall Study|Lack of Efficacy|92|||
130327018|NCT00515619|469167890|FG000|Overall Study|Withdrawal by Subject|66|||
130327019|NCT00515619|469167890|FG000|Overall Study|Protocol Violation|3|||
130327020|NCT00515619|469167890|FG000|Overall Study|Lost to Follow-up|4|||
130327021|NCT00515619|469167890|FG000|Overall Study|Unsatisfactory compliance|6|||
130327022|NCT00515619|469167890|FG000|Overall Study|Other: Site discontinuing trials|2|||
130327023|NCT00515619|469167890|FG000|Overall Study|Other: Subject cannot attend visits|2|||
130327024|NCT00515619|469167890|FG000|Overall Study|Other: Subject required surgery|1|||
130327025|NCT00515619|469167890|FG000|Overall Study|Other: Subject moved to another country|1|||
130657620|NCT02325739|470369296|FG007|Phase II Part|Subject/guardian decision|0|||
130327026|NCT00515619|469167890|FG000|Overall Study|Other: Investigator decision|1|||
130327027|NCT00515619|469167890|FG000|Overall Study|Other: Subject became pregnant|1|||
130327028|NCT00515619|469167890|FG000|Overall Study|Other: Request from sponsor|1|||
130327029|NCT00515619|469167890|FG000|Overall Study|Other: Drug available on license|1|||
130327030|NCT00515619|469167890|FG000|Overall Study|Other: Subject interested in other AED|1|||
130327031|NCT01467960|469167891|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327032|NCT01467960|469167892|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327033|NCT01467960|469167893|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327034|NCT01467960|469167894|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327035|NCT01467960|469167895|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327036|NCT01467960|469167896|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327037|NCT01588522|469167897|FG000|Overall Study|Withdrawal by Subject|1|||
130327038|NCT01588522|469167898|FG001|Overall Study|Withdrawal by Subject|5|||
130327039|NCT01588522|469167899|FG002|Overall Study|Withdrawal by Subject|3|||
130327040|NCT01588522|469167900|FG003|Overall Study|Withdrawal by Subject|1|||
130327041|NCT01588522|469167901|FG004|Overall Study|Withdrawal by Subject|2|||
130327042|NCT01588522|469167902|FG005|Overall Study|Withdrawal by Subject|0|||
130657621|NCT02325739|470369297|FG008|Phase II Part|Subject/guardian decision|4|||
130657622|NCT02325739|470369298|FG009|Phase II Part|Subject/guardian decision|1|||
130657623|NCT02325739|470369299|FG010|Phase II Part|Subject/guardian decision|1|||
130657624|NCT00530621|470369308|FG000|Overall Study|Adverse Event|11|||
130657625|NCT00530621|470369309|FG001|Overall Study|Adverse Event|8|||
130657626|NCT00530621|470369308|FG000|Overall Study|Physician Decision|2|||
130657627|NCT00530621|470369309|FG001|Overall Study|Physician Decision|4|||
130657628|NCT00530621|470369308|FG000|Overall Study|Progressive Disease (PD)|47|||
130657629|NCT00530621|470369309|FG001|Overall Study|Progressive Disease (PD)|40|||
130657630|NCT00530621|470369308|FG000|Overall Study|Sponsor Decision|12|||
130657631|NCT00530621|470369309|FG001|Overall Study|Sponsor Decision|15|||
130657632|NCT00530621|470369308|FG000|Overall Study|Subject Decision|4|||
130657633|NCT00530621|470369309|FG001|Overall Study|Subject Decision|7|||
130657634|NCT00530621|470369308|FG000|Overall Study|Death|3|||
130657635|NCT00530621|470369309|FG001|Overall Study|Death|6|||
130657636|NCT00530621|470369308|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
130657637|NCT00530621|470369309|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
130657638|NCT03409328|470369310|FG000|Overall Study|Lost to Follow-up|6|||
130657639|NCT03409328|470369311|FG001|Overall Study|Lost to Follow-up|3|||
130657640|NCT02998645|470369312|FG000|Treatment Period 1|Adverse Event|6|||
130657641|NCT02998645|470369312|FG000|Treatment Period 1|Death|5|||
130657642|NCT02998645|470369312|FG000|Treatment Period 1|Technical Problems|4|||
130327043|NCT01588522|469167897|FG000|Overall Study|Lack of Efficacy|0|||
130657643|NCT02998645|470369312|FG000|Treatment Period 1|Lack of Efficacy|2|||
130657644|NCT02998645|470369312|FG000|Treatment Period 1|Progressive disease|1|||
130657645|NCT02998645|470369312|FG000|Treatment Period 1|Subject/guardian decision|1|||
130327044|NCT01588522|469167898|FG001|Overall Study|Lack of Efficacy|0|||
130327045|NCT01588522|469167899|FG002|Overall Study|Lack of Efficacy|0|||
130327046|NCT01588522|469167900|FG003|Overall Study|Lack of Efficacy|0|||
130327047|NCT01588522|469167901|FG004|Overall Study|Lack of Efficacy|1|||
130327048|NCT01588522|469167902|FG005|Overall Study|Lack of Efficacy|0|||
130327049|NCT01588522|469167897|FG000|Overall Study|Adverse Event|0|||
130327050|NCT01588522|469167898|FG001|Overall Study|Adverse Event|0|||
130327051|NCT01588522|469167899|FG002|Overall Study|Adverse Event|0|||
130215528|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215529|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215530|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215531|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215532|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215533|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215534|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215535|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215536|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215537|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215538|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215539|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215540|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215541|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215542|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215543|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215544|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215545|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215546|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215547|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215548|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215549|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215550|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
130215551|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215552|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215553|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215554|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215555|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215556|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215557|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215558|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215559|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215560|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215561|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215562|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215563|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215564|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215565|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215566|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215567|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215568|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215569|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215570|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215571|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215572|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215573|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215574|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215575|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215576|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215577|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215578|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215579|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215580|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130215581|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
130215582|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130215583|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215584|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215585|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215586|NCT01289574|468751774|FG000|Overall Study|Lack of Efficacy|4|||
130215587|NCT01289574|468751775|FG001|Overall Study|Lack of Efficacy|0|||
130215588|NCT01289574|468751776|FG002|Overall Study|Lack of Efficacy|1|||
130215589|NCT01289574|468751774|FG000|Overall Study|Lost to Follow-up|2|||
130215590|NCT01289574|468751775|FG001|Overall Study|Lost to Follow-up|0|||
130215591|NCT01289574|468751776|FG002|Overall Study|Lost to Follow-up|1|||
130215592|NCT01289574|468751774|FG000|Overall Study|Withdrawal by Subject|1|||
130215593|NCT01289574|468751775|FG001|Overall Study|Withdrawal by Subject|1|||
130215594|NCT01289574|468751776|FG002|Overall Study|Withdrawal by Subject|1|||
130327052|NCT01588522|469167900|FG003|Overall Study|Adverse Event|1|||
130327053|NCT01588522|469167901|FG004|Overall Study|Adverse Event|0|||
130327054|NCT01588522|469167902|FG005|Overall Study|Adverse Event|0|||
130327055|NCT01588522|469167897|FG000|Overall Study|Grade 2 alopecia|1|||
130327056|NCT01588522|469167898|FG001|Overall Study|Grade 2 alopecia|0|||
130327057|NCT01588522|469167899|FG002|Overall Study|Grade 2 alopecia|0|||
130327058|NCT01588522|469167900|FG003|Overall Study|Grade 2 alopecia|0|||
130327059|NCT01588522|469167901|FG004|Overall Study|Grade 2 alopecia|0|||
130327060|NCT01588522|469167902|FG005|Overall Study|Grade 2 alopecia|0|||
130327061|NCT01588522|469167897|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
130327062|NCT01588522|469167898|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
130327063|NCT01588522|469167899|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
130327064|NCT01588522|469167900|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
130327065|NCT01588522|469167901|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
130327066|NCT01588522|469167902|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
130327067|NCT01588522|469167897|FG000|Overall Study|Taken off taxane-based regimen|0|||
130327068|NCT01588522|469167898|FG001|Overall Study|Taken off taxane-based regimen|0|||
130327069|NCT01588522|469167899|FG002|Overall Study|Taken off taxane-based regimen|0|||
130327070|NCT01588522|469167900|FG003|Overall Study|Taken off taxane-based regimen|1|||
130327071|NCT01588522|469167901|FG004|Overall Study|Taken off taxane-based regimen|0|||
130327072|NCT01588522|469167902|FG005|Overall Study|Taken off taxane-based regimen|0|||
130327073|NCT01588522|469167897|FG000|Overall Study|Did not initiate chemotherapy|0|||
130327074|NCT01588522|469167898|FG001|Overall Study|Did not initiate chemotherapy|0|||
130327075|NCT01588522|469167899|FG002|Overall Study|Did not initiate chemotherapy|0|||
130327076|NCT01588522|469167900|FG003|Overall Study|Did not initiate chemotherapy|0|||
130657646|NCT02998645|470369312|FG000|Treatment Period 2|Lack of Efficacy|5|||
130327077|NCT01588522|469167901|FG004|Overall Study|Did not initiate chemotherapy|1|||
130327078|NCT01588522|469167902|FG005|Overall Study|Did not initiate chemotherapy|0|||
130327079|NCT04949490|469167905|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327080|NCT04949490|469167906|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327081|NCT04949490|469167907|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327082|NCT04949490|469167908|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
130327083|NCT04949490|469167909|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327084|NCT04949490|469167910|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327085|NCT04949490|469167905|FG000|Group A and Group B|Withdrawal by Subject|0|||
130327086|NCT04949490|469167906|FG001|Group A and Group B|Withdrawal by Subject|0|||
130327087|NCT04949490|469167907|FG002|Group A and Group B|Withdrawal by Subject|1|||
130327088|NCT04949490|469167908|FG003|Group A and Group B|Withdrawal by Subject|0|||
130327089|NCT04949490|469167909|FG004|Group A and Group B|Withdrawal by Subject|0|||
130327090|NCT04949490|469167910|FG005|Group A and Group B|Withdrawal by Subject|0|||
130327091|NCT04949490|469167905|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327092|NCT04949490|469167906|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327093|NCT04949490|469167907|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327094|NCT04949490|469167908|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327095|NCT04949490|469167909|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327096|NCT04949490|469167910|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
130327097|NCT04949490|469167905|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327098|NCT04949490|469167906|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327099|NCT04949490|469167907|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327100|NCT04949490|469167908|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130657647|NCT02998645|470369312|FG000|Treatment Period 2|Adverse Event|2|||
130657648|NCT02998645|470369312|FG000|Treatment Period 2|Progressive disease|2|||
130657649|NCT02998645|470369312|FG000|Treatment Period 2|Physician Decision|1|||
130657650|NCT04611152|470369316|FG000|Overall Study|Adverse Event|9|||
130657651|NCT04611152|470369317|FG001|Overall Study|Adverse Event|8|||
130657652|NCT04611152|470369316|FG000|Overall Study|Non-compliance with study schedule|1|||
130657653|NCT04611152|470369317|FG001|Overall Study|Non-compliance with study schedule|3|||
130657654|NCT04611152|470369316|FG000|Overall Study|Withdrawal by Subject|5|||
130657655|NCT04611152|470369317|FG001|Overall Study|Withdrawal by Subject|6|||
130657656|NCT04611152|470369316|FG000|Overall Study|Lost to Follow-up|11|||
130657657|NCT04611152|470369317|FG001|Overall Study|Lost to Follow-up|2|||
130657658|NCT00605839|470369322|FG000|Overall Study|Protocol Violation|1|||
130657659|NCT00605839|470369323|FG001|Overall Study|Protocol Violation|0|||
130657660|NCT00605839|470369324|FG002|Overall Study|Protocol Violation|0|||
130657661|NCT01023022|470369325|FG000|Overall Study|Death|5|||
130657662|NCT01023022|470369325|FG000|Overall Study|Lost to Follow-up|7|||
130657663|NCT01023022|470369325|FG000|Overall Study|due to technical issues|2|||
130657664|NCT03728257|470369326|FG000|Overall Study|Death|3|||
130657665|NCT03728257|470369327|FG001|Overall Study|Death|0|||
130327101|NCT04949490|469167909|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
130327102|NCT04949490|469167910|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130657666|NCT01329562|470369330|FG000|Overall Study|Protocol Violation|5|||
130327103|NCT02017405|469167911|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327104|NCT02017405|469167912|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327105|NCT02017405|469167913|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327106|NCT02017405|469167914|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327107|NCT02017405|469167915|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327108|NCT02017405|469167916|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
130327109|NCT02017405|469167911|FG000|Open-label Phase|Adverse Event|1|||
130327110|NCT02017405|469167912|FG001|Open-label Phase|Adverse Event|1|||
130327111|NCT02017405|469167913|FG002|Open-label Phase|Adverse Event|0|||
130327112|NCT02017405|469167914|FG003|Open-label Phase|Adverse Event|0|||
130327113|NCT02017405|469167915|FG004|Open-label Phase|Adverse Event|0|||
130327114|NCT02017405|469167916|FG005|Open-label Phase|Adverse Event|0|||
130327115|NCT02864394|469167918|FG000|Overall Study|Death|184|||
130327116|NCT02864394|469167919|FG001|Overall Study|Death|189|||
130327117|NCT02864394|469167918|FG000|Overall Study|Lost to Follow-up|0|||
130327118|NCT02864394|469167919|FG001|Overall Study|Lost to Follow-up|2|||
130327119|NCT02864394|469167918|FG000|Overall Study|Sponsor Decision|26|||
130327120|NCT02864394|469167919|FG001|Overall Study|Sponsor Decision|11|||
130327121|NCT02864394|469167918|FG000|Overall Study|Withdrawal by Subject|3|||
130327122|NCT02864394|469167919|FG001|Overall Study|Withdrawal by Subject|10|||
130327123|NCT04730804|469167924|FG000|Overall Study|Physician Decision|0|||
130327124|NCT04730804|469167925|FG001|Overall Study|Physician Decision|0|||
130327125|NCT04730804|469167926|FG002|Overall Study|Physician Decision|0|||
130327126|NCT04730804|469167927|FG003|Overall Study|Physician Decision|0|||
130327127|NCT04730804|469167928|FG004|Overall Study|Physician Decision|0|||
130327128|NCT04730804|469167929|FG005|Overall Study|Physician Decision|1|||
130327129|NCT04730804|469167924|FG000|Overall Study|Withdrawal by Subject|0|||
130327130|NCT04730804|469167925|FG001|Overall Study|Withdrawal by Subject|0|||
130327131|NCT04730804|469167926|FG002|Overall Study|Withdrawal by Subject|0|||
130327132|NCT04730804|469167927|FG003|Overall Study|Withdrawal by Subject|0|||
130327133|NCT04730804|469167928|FG004|Overall Study|Withdrawal by Subject|1|||
130327134|NCT04730804|469167929|FG005|Overall Study|Withdrawal by Subject|2|||
130327135|NCT00554216|469169479|FG000|Overall Study|Lost to Follow-up|92|||
130327136|NCT00554216|469169480|FG001|Overall Study|Lost to Follow-up|31|||
130327137|NCT00554216|469169481|FG002|Overall Study|Lost to Follow-up|63|||
130327138|NCT00554216|469169479|FG000|Overall Study|Adverse Event|16|||
130327139|NCT00554216|469169480|FG001|Overall Study|Adverse Event|16|||
130327140|NCT00554216|469169481|FG002|Overall Study|Adverse Event|36|||
130327141|NCT00554216|469169479|FG000|Overall Study|Withdrawal by Subject|92|||
130327142|NCT00554216|469169480|FG001|Overall Study|Withdrawal by Subject|31|||
130327143|NCT00554216|469169481|FG002|Overall Study|Withdrawal by Subject|43|||
130327144|NCT00554216|469169479|FG000|Overall Study|Non compliance|10|||
130327145|NCT00554216|469169480|FG001|Overall Study|Non compliance|4|||
130327146|NCT00554216|469169481|FG002|Overall Study|Non compliance|5|||
130327147|NCT00554216|469169479|FG000|Overall Study|Pregnancy|2|||
130327148|NCT00554216|469169480|FG001|Overall Study|Pregnancy|1|||
130327149|NCT00554216|469169481|FG002|Overall Study|Pregnancy|14|||
130327150|NCT00554216|469169479|FG000|Overall Study|Restricted med|3|||
130327151|NCT00554216|469169480|FG001|Overall Study|Restricted med|1|||
130327152|NCT00554216|469169481|FG002|Overall Study|Restricted med|1|||
130327153|NCT00554216|469169479|FG000|Overall Study|Other|12|||
130327154|NCT00554216|469169480|FG001|Overall Study|Other|7|||
130327155|NCT00554216|469169481|FG002|Overall Study|Other|10|||
130327156|NCT00554216|469169479|FG000|Overall Study|Lack of Efficacy|15|||
130327157|NCT00554216|469169480|FG001|Overall Study|Lack of Efficacy|3|||
130327158|NCT00554216|469169481|FG002|Overall Study|Lack of Efficacy|0|||
130327159|NCT00463567|469169488|FG000|Overall Study|Adverse Event|29|||
130327160|NCT00463567|469169489|FG001|Overall Study|Adverse Event|26|||
130327161|NCT00463567|469169490|FG002|Overall Study|Adverse Event|17|||
130327162|NCT00463567|469169491|FG003|Overall Study|Adverse Event|46|||
130657667|NCT01329562|470369331|FG001|Overall Study|Protocol Violation|3|||
130657668|NCT01329562|470369330|FG000|Overall Study|Lost to Follow-up|1|||
130327163|NCT00463567|469169492|FG004|Overall Study|Adverse Event|10|||
130657669|NCT01329562|470369331|FG001|Overall Study|Lost to Follow-up|1|||
130327164|NCT00463567|469169493|FG005|Overall Study|Adverse Event|10|||
130657670|NCT01329562|470369330|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
130327165|NCT00463567|469169494|FG006|Overall Study|Adverse Event|4|||
130327166|NCT00463567|469169488|FG000|Overall Study|Withdrawal by Subject|29|||
130327167|NCT00463567|469169489|FG001|Overall Study|Withdrawal by Subject|22|||
130327168|NCT00463567|469169490|FG002|Overall Study|Withdrawal by Subject|20|||
130327169|NCT00463567|469169491|FG003|Overall Study|Withdrawal by Subject|37|||
130657671|NCT01329562|470369331|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
130657672|NCT01329562|470369330|FG000|Overall Study|Physician Decision|0|||
130327170|NCT00463567|469169492|FG004|Overall Study|Withdrawal by Subject|6|||
130327171|NCT00463567|469169493|FG005|Overall Study|Withdrawal by Subject|5|||
130327172|NCT00463567|469169494|FG006|Overall Study|Withdrawal by Subject|1|||
130327173|NCT00463567|469169488|FG000|Overall Study|Protocol Deviation|13|||
130657673|NCT01329562|470369331|FG001|Overall Study|Physician Decision|1|||
130327174|NCT00463567|469169489|FG001|Overall Study|Protocol Deviation|9|||
130327175|NCT00463567|469169490|FG002|Overall Study|Protocol Deviation|14|||
130327176|NCT00463567|469169491|FG003|Overall Study|Protocol Deviation|11|||
130327177|NCT00463567|469169492|FG004|Overall Study|Protocol Deviation|1|||
130327178|NCT00463567|469169493|FG005|Overall Study|Protocol Deviation|1|||
130327179|NCT00463567|469169494|FG006|Overall Study|Protocol Deviation|2|||
130327180|NCT00463567|469169488|FG000|Overall Study|Lost to Follow-up|12|||
130327181|NCT00463567|469169489|FG001|Overall Study|Lost to Follow-up|6|||
130327182|NCT00463567|469169490|FG002|Overall Study|Lost to Follow-up|13|||
130327183|NCT00463567|469169491|FG003|Overall Study|Lost to Follow-up|8|||
130327184|NCT00463567|469169492|FG004|Overall Study|Lost to Follow-up|1|||
130327185|NCT00463567|469169493|FG005|Overall Study|Lost to Follow-up|1|||
130327186|NCT00463567|469169494|FG006|Overall Study|Lost to Follow-up|1|||
130327187|NCT00463567|469169488|FG000|Overall Study|Administrative problems|5|||
130327188|NCT00463567|469169489|FG001|Overall Study|Administrative problems|3|||
130327189|NCT00463567|469169490|FG002|Overall Study|Administrative problems|6|||
130327190|NCT00463567|469169491|FG003|Overall Study|Administrative problems|9|||
130327191|NCT00463567|469169492|FG004|Overall Study|Administrative problems|3|||
130327192|NCT00463567|469169493|FG005|Overall Study|Administrative problems|2|||
130327193|NCT00463567|469169494|FG006|Overall Study|Administrative problems|2|||
130327194|NCT00463567|469169488|FG000|Overall Study|Lack of Efficacy|4|||
130327195|NCT00463567|469169489|FG001|Overall Study|Lack of Efficacy|9|||
130327196|NCT00463567|469169490|FG002|Overall Study|Lack of Efficacy|9|||
130327197|NCT00463567|469169491|FG003|Overall Study|Lack of Efficacy|17|||
130327198|NCT00463567|469169492|FG004|Overall Study|Lack of Efficacy|1|||
130327199|NCT00463567|469169493|FG005|Overall Study|Lack of Efficacy|0|||
130327200|NCT00463567|469169494|FG006|Overall Study|Lack of Efficacy|1|||
130327201|NCT00463567|469169488|FG000|Overall Study|Abnormal lab value(s)|1|||
130327202|NCT00463567|469169489|FG001|Overall Study|Abnormal lab value(s)|1|||
130327203|NCT00463567|469169490|FG002|Overall Study|Abnormal lab value(s)|2|||
130327204|NCT00463567|469169491|FG003|Overall Study|Abnormal lab value(s)|1|||
130327205|NCT00463567|469169492|FG004|Overall Study|Abnormal lab value(s)|1|||
130327206|NCT00463567|469169493|FG005|Overall Study|Abnormal lab value(s)|0|||
130327207|NCT00463567|469169494|FG006|Overall Study|Abnormal lab value(s)|0|||
130327208|NCT00463567|469169488|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130327209|NCT00463567|469169489|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130327210|NCT00463567|469169490|FG002|Overall Study|Abnormal test procedure result(s)|6|||
130327211|NCT00463567|469169491|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130327212|NCT00463567|469169492|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130327213|NCT00463567|469169493|FG005|Overall Study|Abnormal test procedure result(s)|2|||
130327214|NCT00463567|469169494|FG006|Overall Study|Abnormal test procedure result(s)|0|||
130327215|NCT00463567|469169488|FG000|Overall Study|Death|1|||
130327216|NCT00463567|469169489|FG001|Overall Study|Death|0|||
130327217|NCT00463567|469169490|FG002|Overall Study|Death|2|||
130327218|NCT00463567|469169491|FG003|Overall Study|Death|0|||
130327219|NCT00463567|469169492|FG004|Overall Study|Death|0|||
130327220|NCT00463567|469169493|FG005|Overall Study|Death|0|||
130327221|NCT00463567|469169494|FG006|Overall Study|Death|0|||
130327222|NCT01524796|469169496|FG000|Overall Study|Adverse Event|13|||
130327223|NCT01524796|469169496|FG000|Overall Study|Lack of Efficacy|3|||
130327224|NCT01524796|469169496|FG000|Overall Study|Lost to Follow-up|1|||
130327225|NCT01524796|469169496|FG000|Overall Study|The price|1|||
130327226|NCT01524796|469169496|FG000|Overall Study|Withdrawal by Subject|4|||
130327227|NCT01524796|469169496|FG000|Overall Study|Move|1|||
130327228|NCT01524796|469169496|FG000|Overall Study|Deterioration of pains|1|||
130327229|NCT01524796|469169496|FG000|Overall Study|Gall stone surgery|1|||
130327230|NCT01524796|469169496|FG000|Overall Study|Nervous about confidentiality|1|||
130657674|NCT03128931|470369332|FG000|Overall Study|Physician Decision|1|||
130657675|NCT03128931|470369332|FG000|Overall Study|Equipment Issues|3|||
130657676|NCT04993339|470369333|FG000|Overall Study|Lost to Follow-up|0|||
130657677|NCT04993339|470369334|FG001|Overall Study|Lost to Follow-up|1|||
130327231|NCT01524796|469169496|FG000|Overall Study|Switch to carbamazapine|1|||
130327232|NCT01524796|469169496|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
130327233|NCT00956007|469169499|FG000|Overall Study|Protocol Violation|27|||
130327234|NCT00956007|469169500|FG001|Overall Study|Protocol Violation|23|||
130327235|NCT03774576|469169501|FG000|Period 2|Adverse Event|1|||
130327236|NCT00927953|469169502|FG000|Overall Study|Death|2|||
130327237|NCT00927953|469169503|FG001|Overall Study|Death|1|||
130327238|NCT01249261|469169516|FG000|Overall Study|Withdrawal by Subject|1|||
130327239|NCT01249261|469169517|FG001|Overall Study|Withdrawal by Subject|0|||
130327240|NCT00482053|469169521|FG000|Inter-treatment Period|Disease progression|1|||
130657678|NCT04993339|470369333|FG000|Overall Study|no MRI scan|3|||
130657679|NCT04993339|470369334|FG001|Overall Study|no MRI scan|1|||
130215595|NCT01289574|468751774|FG000|Overall Study|Adverse Event|0|||
130327241|NCT01055197|469169527|FG000|Overall Study|Protocol Violation|7|||
130327242|NCT01055197|469169528|FG001|Overall Study|Protocol Violation|2|||
130327243|NCT01055197|469169527|FG000|Overall Study|Withdrawal by Subject|2|||
130327244|NCT01055197|469169528|FG001|Overall Study|Withdrawal by Subject|0|||
130327245|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
130327246|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
130327247|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
130327248|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130327249|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130327250|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
130327251|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130327252|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130327253|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
130327254|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327255|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327256|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327257|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
130327258|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
130327259|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
130327260|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
130327261|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
130327262|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
130327263|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
130327264|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
130327265|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
130327266|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
130327267|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
130327268|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
130327269|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130327270|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
130327271|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
130327272|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130327273|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130327274|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130327275|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130327276|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130327277|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
130327278|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130327279|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130327280|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
130327281|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130327282|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
130327283|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130327284|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130327285|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
130327286|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130327287|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130327288|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
130327289|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130327290|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
130327291|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
130327292|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
130327293|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130327294|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130327295|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
130327296|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
130327297|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
130327298|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
130327299|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130327300|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130327301|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
130327302|NCT01967940|469169535|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327303|NCT01967940|469169536|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327304|NCT01967940|469169537|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327305|NCT01967940|469169538|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
130327306|NCT01967940|469169535|FG000|Part 2|Adverse Event|0|||
130657680|NCT00061568|470369337|FG000|Overall Study|Lost to Follow-up|12|||
130327307|NCT01967940|469169536|FG001|Part 2|Adverse Event|0|||
130327308|NCT01967940|469169537|FG002|Part 2|Adverse Event|0|||
130327309|NCT01967940|469169538|FG003|Part 2|Adverse Event|1|||
130327310|NCT01967940|469169535|FG000|Part 2|Unknown Reason|0|||
130327311|NCT01967940|469169536|FG001|Part 2|Unknown Reason|0|||
130327312|NCT01967940|469169537|FG002|Part 2|Unknown Reason|0|||
130327313|NCT01967940|469169538|FG003|Part 2|Unknown Reason|1|||
130327314|NCT01663103|469169539|FG000|Overall Study|Withdrawal by Subject|1|||
130327315|NCT01663103|469169540|FG001|Overall Study|Withdrawal by Subject|2|||
130327316|NCT01663103|469169539|FG000|Overall Study|Adverse Event|1|||
130327317|NCT01663103|469169540|FG001|Overall Study|Adverse Event|0|||
130327318|NCT01663103|469169539|FG000|Overall Study|dog bite|1|||
130327319|NCT01663103|469169540|FG001|Overall Study|dog bite|0|||
130327320|NCT03113487|469169545|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
130327321|NCT03777982|469169546|FG000|Overall Study|Physician Decision|0|||
130327322|NCT03777982|469169547|FG001|Overall Study|Physician Decision|1|||
130327323|NCT00391586|469169551|FG000|Overall Study|Progressive disease|13|||
130327324|NCT00391586|469169551|FG000|Overall Study|Adverse Event|5|||
130327325|NCT00391586|469169551|FG000|Overall Study|Physician Decision|2|||
130327326|NCT00391586|469169551|FG000|Overall Study|Death|4|||
130327327|NCT00904982|469169552|FG000|Overall Study|Withdrawal by Subject|2|||
130327328|NCT00904982|469169553|FG001|Overall Study|Withdrawal by Subject|0|||
130327329|NCT00904982|469169554|FG002|Overall Study|Withdrawal by Subject|0|||
130327330|NCT00904982|469169555|FG003|Overall Study|Withdrawal by Subject|0|||
130327331|NCT02072668|469169556|FG000|Second Intervention|Lost to Follow-up|1|||
130327332|NCT02072668|469169557|FG001|Second Intervention|Lost to Follow-up|0|||
130327333|NCT03058146|469169558|FG000|Overall Study|Withdrawal by Subject|4|||
130327334|NCT03058146|469169559|FG001|Overall Study|Withdrawal by Subject|1|||
130327335|NCT03058146|469169558|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
130327336|NCT03058146|469169559|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
130327337|NCT00771758|469169564|FG000|Overall Study|Adverse Event|2|||
130327338|NCT00771758|469169565|FG001|Overall Study|Adverse Event|8|||
130327339|NCT00771758|469169566|FG002|Overall Study|Adverse Event|1|||
130327340|NCT00771758|469169564|FG000|Overall Study|Lack of Efficacy|0|||
130327341|NCT00771758|469169565|FG001|Overall Study|Lack of Efficacy|2|||
130327342|NCT00771758|469169566|FG002|Overall Study|Lack of Efficacy|1|||
130327343|NCT00771758|469169564|FG000|Overall Study|Lost to Follow-up|1|||
130327344|NCT00771758|469169565|FG001|Overall Study|Lost to Follow-up|0|||
130327345|NCT00771758|469169566|FG002|Overall Study|Lost to Follow-up|0|||
130327346|NCT00771758|469169564|FG000|Overall Study|Protocol Violation|1|||
130327347|NCT00771758|469169565|FG001|Overall Study|Protocol Violation|0|||
130327348|NCT00771758|469169566|FG002|Overall Study|Protocol Violation|0|||
130327349|NCT00771758|469169564|FG000|Overall Study|Withdrawal by Subject|1|||
130327350|NCT00771758|469169565|FG001|Overall Study|Withdrawal by Subject|0|||
130327351|NCT00771758|469169566|FG002|Overall Study|Withdrawal by Subject|0|||
130327352|NCT00771758|469169564|FG000|Overall Study|Other|3|||
130327353|NCT00771758|469169565|FG001|Overall Study|Other|2|||
130327354|NCT00771758|469169566|FG002|Overall Study|Other|0|||
130327355|NCT03067077|469169567|FG000|Overall Study|Did not receive surgery|4|||
130327356|NCT03067077|469169568|FG001|Overall Study|Did not receive surgery|5|||
130327357|NCT03067077|469169567|FG000|Overall Study|Lost to Follow-up|3|||
130327358|NCT03067077|469169568|FG001|Overall Study|Lost to Follow-up|2|||
130327359|NCT00935584|469169571|FG000|Overall Study|Withdrawal by Subject|9|||
130327360|NCT00935584|469169572|FG001|Overall Study|Withdrawal by Subject|0|||
130327361|NCT00935584|469169571|FG000|Overall Study|Death|3|||
130327362|NCT00935584|469169572|FG001|Overall Study|Death|0|||
130327363|NCT00935584|469169571|FG000|Overall Study|Lost to Follow-up|8|||
130327364|NCT00935584|469169572|FG001|Overall Study|Lost to Follow-up|0|||
130327365|NCT00935584|469169571|FG000|Overall Study|No show|9|||
130327366|NCT00935584|469169572|FG001|Overall Study|No show|0|||
130327367|NCT00935584|469169571|FG000|Overall Study|Relocated|3|||
130327368|NCT00935584|469169572|FG001|Overall Study|Relocated|0|||
130327369|NCT00935584|469169571|FG000|Overall Study|Patient changed provider|3|||
130327370|NCT00935584|469169572|FG001|Overall Study|Patient changed provider|0|||
130327371|NCT00935584|469169571|FG000|Overall Study|Provider dropped out of study|14|||
130327372|NCT00935584|469169572|FG001|Overall Study|Provider dropped out of study|4|||
130327373|NCT00687193|469169573|FG000|Overall Study|Adverse Event|0|||
130327374|NCT00687193|469169574|FG001|Overall Study|Adverse Event|1|||
130327375|NCT00687193|469169575|FG002|Overall Study|Adverse Event|2|||
130327376|NCT00687193|469169576|FG003|Overall Study|Adverse Event|3|||
130327377|NCT00687193|469169577|FG004|Overall Study|Adverse Event|0|||
130327378|NCT00687193|469169578|FG005|Overall Study|Adverse Event|2|||
130215596|NCT01289574|468751775|FG001|Overall Study|Adverse Event|1|||
130327379|NCT00687193|469169573|FG000|Overall Study|Lack of Efficacy|1|||
130327380|NCT00687193|469169574|FG001|Overall Study|Lack of Efficacy|1|||
130327381|NCT00687193|469169575|FG002|Overall Study|Lack of Efficacy|0|||
130327382|NCT00687193|469169576|FG003|Overall Study|Lack of Efficacy|0|||
130327383|NCT00687193|469169577|FG004|Overall Study|Lack of Efficacy|0|||
130327384|NCT00687193|469169578|FG005|Overall Study|Lack of Efficacy|2|||
130327385|NCT00687193|469169573|FG000|Overall Study|Protocol Violation|1|||
130327386|NCT00687193|469169574|FG001|Overall Study|Protocol Violation|2|||
130327387|NCT00687193|469169575|FG002|Overall Study|Protocol Violation|0|||
130327388|NCT00687193|469169576|FG003|Overall Study|Protocol Violation|1|||
130327389|NCT00687193|469169577|FG004|Overall Study|Protocol Violation|2|||
130327390|NCT00687193|469169578|FG005|Overall Study|Protocol Violation|0|||
130657681|NCT00061568|470369338|FG001|Overall Study|Lost to Follow-up|0|||
130327391|NCT04986904|469169579|FG000|Overall Study|Lost to Follow-up|11|||
130327392|NCT04986904|469169579|FG000|Overall Study|Withdrawal by Subject|1|||
130327393|NCT03435211|469169580|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
130327394|NCT03863080|469169581|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327395|NCT03863080|469169582|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327396|NCT03863080|469169583|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
130327397|NCT03863080|469169584|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327398|NCT03863080|469169581|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327399|NCT03863080|469169582|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327400|NCT03863080|469169583|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327401|NCT03863080|469169584|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
130327402|NCT03863080|469169581|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327403|NCT03863080|469169582|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327404|NCT03863080|469169583|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327405|NCT03863080|469169584|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
130327406|NCT01342211|469169585|FG000|Overall Study|Lost to Follow-up|0|||
130327407|NCT01342211|469169586|FG001|Overall Study|Lost to Follow-up|0|||
130327408|NCT01342211|469169587|FG002|Overall Study|Lost to Follow-up|0|||
130327409|NCT01342211|469169588|FG003|Overall Study|Lost to Follow-up|1|||
130327410|NCT01342211|469169589|FG004|Overall Study|Lost to Follow-up|0|||
130327411|NCT01342211|469169585|FG000|Overall Study|Adverse Event|0|||
130327412|NCT01342211|469169586|FG001|Overall Study|Adverse Event|0|||
130327413|NCT01342211|469169587|FG002|Overall Study|Adverse Event|0|||
130327414|NCT01342211|469169588|FG003|Overall Study|Adverse Event|0|||
130327415|NCT01342211|469169589|FG004|Overall Study|Adverse Event|1|||
130327416|NCT01342211|469169585|FG000|Overall Study|Withdrawal by Subject|0|||
130327417|NCT01342211|469169586|FG001|Overall Study|Withdrawal by Subject|0|||
130327418|NCT01342211|469169587|FG002|Overall Study|Withdrawal by Subject|0|||
130327419|NCT01342211|469169588|FG003|Overall Study|Withdrawal by Subject|1|||
130327420|NCT01342211|469169589|FG004|Overall Study|Withdrawal by Subject|0|||
130327421|NCT01342211|469169585|FG000|Overall Study|Randomized, but not Treated|0|||
130327422|NCT01342211|469169586|FG001|Overall Study|Randomized, but not Treated|2|||
130327423|NCT01342211|469169587|FG002|Overall Study|Randomized, but not Treated|0|||
130327424|NCT01342211|469169588|FG003|Overall Study|Randomized, but not Treated|0|||
130327425|NCT01342211|469169589|FG004|Overall Study|Randomized, but not Treated|1|||
130327426|NCT01648751|469169607|FG000|Overall Study|Withdrawal by Subject|2|||
130327427|NCT01648751|469169608|FG001|Overall Study|Withdrawal by Subject|3|||
130327428|NCT05673876|469169611|FG000|Overall Study|Death|3|||
130327429|NCT05673876|469169612|FG001|Overall Study|Death|1|||
130327430|NCT05673876|469169611|FG000|Overall Study|Study Terminated by Sponsor|0|||
130327431|NCT05673876|469169612|FG001|Overall Study|Study Terminated by Sponsor|1|||
130327432|NCT05673876|469169611|FG000|Overall Study|Physician Decision|0|||
130327433|NCT05673876|469169612|FG001|Overall Study|Physician Decision|1|||
130327434|NCT03205423|469169615|FG000|Overall Study|Personal|1|||
130327435|NCT03205423|469169616|FG001|Overall Study|Personal|1|||
130327436|NCT03205423|469169615|FG000|Overall Study|Physician Decision|0|||
130327437|NCT03205423|469169616|FG001|Overall Study|Physician Decision|2|||
130327438|NCT02749422|469169619|FG000|Overall Study|Lost to Follow-up|0|||
130327439|NCT02749422|469169620|FG001|Overall Study|Lost to Follow-up|2|||
130327440|NCT02749422|469169619|FG000|Overall Study|Ineligible|0|||
130327441|NCT02749422|469169620|FG001|Overall Study|Ineligible|1|||
130327442|NCT05786651|469169623|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
130327443|NCT04390763|469169624|FG000|Safety run-in Part|Adverse Event|4|||
130327444|NCT04390763|469169625|FG001|Safety run-in Part|Adverse Event|0|||
130327445|NCT04390763|469169626|FG002|Safety run-in Part|Adverse Event|0|||
130327446|NCT04390763|469169627|FG003|Safety run-in Part|Adverse Event|0|||
130327447|NCT04390763|469169624|FG000|Safety run-in Part|Physician Decision|1|||
130327448|NCT04390763|469169625|FG001|Safety run-in Part|Physician Decision|0|||
130327449|NCT04390763|469169626|FG002|Safety run-in Part|Physician Decision|0|||
130657682|NCT00061568|470369337|FG000|Overall Study|Death|6|||
130657683|NCT00061568|470369338|FG001|Overall Study|Death|0|||
130657684|NCT00061568|470369337|FG000|Overall Study|Withdrawal by Subject|1|||
130327450|NCT04390763|469169627|FG003|Safety run-in Part|Physician Decision|0|||
130327451|NCT04390763|469169624|FG000|Safety run-in Part|Progressive Disease|6|||
130327452|NCT04390763|469169625|FG001|Safety run-in Part|Progressive Disease|0|||
130327453|NCT04390763|469169626|FG002|Safety run-in Part|Progressive Disease|0|||
130327454|NCT04390763|469169627|FG003|Safety run-in Part|Progressive Disease|0|||
130327455|NCT04390763|469169624|FG000|Randomized Part|Adverse Event|0|||
130327456|NCT04390763|469169625|FG001|Randomized Part|Adverse Event|11|||
130657685|NCT00061568|470369338|FG001|Overall Study|Withdrawal by Subject|0|||
130327457|NCT04390763|469169626|FG002|Randomized Part|Adverse Event|5|||
130327458|NCT04390763|469169627|FG003|Randomized Part|Adverse Event|5|||
130327459|NCT04390763|469169624|FG000|Randomized Part|Death|0|||
130327460|NCT04390763|469169625|FG001|Randomized Part|Death|3|||
130327461|NCT04390763|469169626|FG002|Randomized Part|Death|4|||
130327462|NCT04390763|469169627|FG003|Randomized Part|Death|2|||
130327463|NCT04390763|469169624|FG000|Randomized Part|Physician Decision|0|||
130327464|NCT04390763|469169625|FG001|Randomized Part|Physician Decision|2|||
130327465|NCT04390763|469169626|FG002|Randomized Part|Physician Decision|2|||
130327466|NCT04390763|469169627|FG003|Randomized Part|Physician Decision|9|||
130327467|NCT04390763|469169624|FG000|Randomized Part|Progressive Disease|0|||
130657686|NCT01381068|470369339|FG000|Overall Study|Death|1|||
130657687|NCT01381068|470369340|FG001|Overall Study|Death|0|||
130657688|NCT01071278|470369341|FG000|Overall Study|Premature Discontinuation|254|||
130657689|NCT01071278|470369341|FG000|Overall Study|Completion Status Unknown|459|||
130657690|NCT00903409|470369342|FG000|Overall Study|Adverse Event|11|||
130657691|NCT00903409|470369343|FG001|Overall Study|Adverse Event|9|||
130327468|NCT04390763|469169625|FG001|Randomized Part|Progressive Disease|24|||
130327469|NCT04390763|469169626|FG002|Randomized Part|Progressive Disease|31|||
130327470|NCT04390763|469169627|FG003|Randomized Part|Progressive Disease|23|||
130327471|NCT04390763|469169624|FG000|Randomized Part|Study terminated by sponsor|0|||
130327472|NCT04390763|469169625|FG001|Randomized Part|Study terminated by sponsor|1|||
130327473|NCT04390763|469169626|FG002|Randomized Part|Study terminated by sponsor|0|||
130327474|NCT04390763|469169627|FG003|Randomized Part|Study terminated by sponsor|0|||
130327475|NCT04390763|469169624|FG000|Randomized Part|Participant Decision|0|||
130327476|NCT04390763|469169625|FG001|Randomized Part|Participant Decision|5|||
130327477|NCT04390763|469169626|FG002|Randomized Part|Participant Decision|7|||
130327478|NCT04390763|469169627|FG003|Randomized Part|Participant Decision|6|||
130327479|NCT04390763|469169624|FG000|Randomized Part|Not treated|0|||
130327480|NCT04390763|469169625|FG001|Randomized Part|Not treated|4|||
130327481|NCT04390763|469169626|FG002|Randomized Part|Not treated|2|||
130327482|NCT04390763|469169627|FG003|Randomized Part|Not treated|7|||
130327483|NCT04721977|469169633|FG000|Overall Study|Death|15|||
130327484|NCT04721977|469169633|FG000|Overall Study|Ongoing|51|||
130327485|NCT00777153|469171533|FG000|Overall Study|Lost to Follow-up|1|||
130327486|NCT00777153|469171534|FG001|Overall Study|Lost to Follow-up|1|||
130327487|NCT00777153|469171535|FG002|Overall Study|Lost to Follow-up|0|||
130327488|NCT00777153|469171533|FG000|Overall Study|Death|85|||
130327489|NCT00777153|469171534|FG001|Overall Study|Death|73|||
130327490|NCT00777153|469171535|FG002|Overall Study|Death|33|||
130327491|NCT00777153|469171533|FG000|Overall Study|Withdrawal by Subject|3|||
130327492|NCT00777153|469171534|FG001|Overall Study|Withdrawal by Subject|4|||
130327493|NCT00777153|469171535|FG002|Overall Study|Withdrawal by Subject|3|||
130657692|NCT00903409|470369342|FG000|Overall Study|Non-compliance with Protocol|1|||
130657693|NCT00903409|470369343|FG001|Overall Study|Non-compliance with Protocol|1|||
130657694|NCT00903409|470369342|FG000|Overall Study|Laboratory Abnormality|2|||
130657695|NCT00903409|470369343|FG001|Overall Study|Laboratory Abnormality|0|||
130657696|NCT00903409|470369342|FG000|Overall Study|Withdrawal by Subject|8|||
130657697|NCT00903409|470369343|FG001|Overall Study|Withdrawal by Subject|8|||
130657698|NCT00903409|470369342|FG000|Overall Study|Other|2|||
130657699|NCT00903409|470369343|FG001|Overall Study|Other|3|||
130657700|NCT00903409|470369342|FG000|Overall Study|Lost to Follow-up|2|||
130657701|NCT00903409|470369343|FG001|Overall Study|Lost to Follow-up|6|||
130657702|NCT00797316|470369344|FG000|Overall Study|Administrative problems|1|||
130657703|NCT00797316|470369345|FG001|Overall Study|Administrative problems|0|||
130657704|NCT00797316|470369344|FG000|Overall Study|Adverse Event|5|||
130657705|NCT00797316|470369345|FG001|Overall Study|Adverse Event|3|||
130657706|NCT00797316|470369344|FG000|Overall Study|Lost to Follow-up|4|||
130657707|NCT00797316|470369345|FG001|Overall Study|Lost to Follow-up|8|||
130657708|NCT00797316|470369344|FG000|Overall Study|Protocol Deviation|1|||
130657709|NCT00797316|470369345|FG001|Overall Study|Protocol Deviation|2|||
130215597|NCT01289574|468751776|FG002|Overall Study|Adverse Event|0|||
130215598|NCT01289574|468751774|FG000|Overall Study|Subject wanted alternate treatment|0|||
130215599|NCT01289574|468751775|FG001|Overall Study|Subject wanted alternate treatment|1|||
130327494|NCT00777153|469171533|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130327495|NCT00777153|469171534|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
130327496|NCT00777153|469171535|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130327497|NCT02079246|469171537|FG000|OLEX|Withdrawal before treatment|1|||
130327498|NCT02079246|469171538|FG001|OLEX|Withdrawal before treatment|0|||
130327499|NCT02079246|469171537|FG000|OLEX|Death|11|||
130327500|NCT02079246|469171538|FG001|OLEX|Death|0|||
130657710|NCT00797316|470369344|FG000|Overall Study|Patient withdrew consent|12|||
130657711|NCT00797316|470369345|FG001|Overall Study|Patient withdrew consent|6|||
130657712|NCT00797316|470369344|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130657713|NCT00797316|470369345|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130215600|NCT01289574|468751776|FG002|Overall Study|Subject wanted alternate treatment|0|||
130215601|NCT00262002|468751777|FG000|Overall Study|Adverse Event|2|||
130327501|NCT02079246|469171537|FG000|OLEX|Adverse Event|66|||
130327502|NCT02079246|469171538|FG001|OLEX|Adverse Event|0|||
130327503|NCT02079246|469171537|FG000|OLEX|Withdrawal by Subject|60|||
130327504|NCT02079246|469171538|FG001|OLEX|Withdrawal by Subject|0|||
130327505|NCT02079246|469171537|FG000|OLEX|Lost to Follow-up|6|||
130327506|NCT02079246|469171538|FG001|OLEX|Lost to Follow-up|0|||
130657714|NCT03239340|470369352|FG000|Overall Study|Other|26|||
130657715|NCT03239340|470369352|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
130657716|NCT03239340|470369352|FG000|Overall Study|Death|40|||
130657717|NCT03239340|470369352|FG000|Overall Study|Lost to Follow-up|2|||
130327507|NCT02079246|469171537|FG000|OLEX|Protocol Violation|6|||
130327508|NCT02079246|469171538|FG001|OLEX|Protocol Violation|0|||
130327509|NCT02079246|469171537|FG000|OLEX|Lack of Efficacy|3|||
130327510|NCT02079246|469171538|FG001|OLEX|Lack of Efficacy|0|||
130327511|NCT02079246|469171537|FG000|OLEX|Results of the lead-in studies|58|||
130327512|NCT02079246|469171538|FG001|OLEX|Results of the lead-in studies|0|||
130327513|NCT02079246|469171537|FG000|OLEX|Other: Disallowed medication|8|||
130327514|NCT02079246|469171538|FG001|OLEX|Other: Disallowed medication|0|||
130327515|NCT02079246|469171537|FG000|OLEX|Other: Insufficient compliance|2|||
130327516|NCT02079246|469171538|FG001|OLEX|Other: Insufficient compliance|0|||
130327517|NCT02079246|469171537|FG000|OLEX|Other: Caregiver unavailable|3|||
130327518|NCT02079246|469171538|FG001|OLEX|Other: Caregiver unavailable|0|||
130327519|NCT02079246|469171537|FG000|OLEX|Other: Coordinator decision|1|||
130327520|NCT02079246|469171538|FG001|OLEX|Other: Coordinator decision|0|||
130327521|NCT02079246|469171537|FG000|OLEX|Other: Worsening of condition|1|||
130327522|NCT02079246|469171538|FG001|OLEX|Other: Worsening of condition|0|||
130327523|NCT02079246|469171537|FG000|OLEX|Other: Moved to nursing home|1|||
130327524|NCT02079246|469171538|FG001|OLEX|Other: Moved to nursing home|0|||
130327525|NCT02079246|469171537|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
130327526|NCT02079246|469171538|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
130327527|NCT02079246|469171537|FG000|OLEX-MEM|Adverse Event|0|||
130327528|NCT02079246|469171538|FG001|OLEX-MEM|Adverse Event|6|||
130327529|NCT02079246|469171537|FG000|OLEX-MEM|Withdrawal by Subject|0|||
130327530|NCT02079246|469171538|FG001|OLEX-MEM|Withdrawal by Subject|7|||
130327531|NCT02079246|469171537|FG000|OLEX-MEM|Protocol Violation|0|||
130327532|NCT02079246|469171538|FG001|OLEX-MEM|Protocol Violation|2|||
130327533|NCT02079246|469171537|FG000|OLEX-MEM|Lost to Follow-up|0|||
130327534|NCT02079246|469171538|FG001|OLEX-MEM|Lost to Follow-up|1|||
130327535|NCT02079246|469171537|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
130327536|NCT02079246|469171538|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
130327537|NCT03077412|469171539|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
130327538|NCT03077412|469171540|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
130327539|NCT03077412|469171541|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
130327540|NCT03077412|469171539|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
130327541|NCT03077412|469171540|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
130327542|NCT03077412|469171541|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
130327543|NCT03077412|469171539|FG000|Overall Study|Adverse Event|1|||
130327544|NCT03077412|469171540|FG001|Overall Study|Adverse Event|2|||
130327545|NCT03077412|469171541|FG002|Overall Study|Adverse Event|2|||
130327546|NCT03077412|469171539|FG000|Overall Study|Investigator's Discretion|0|||
130327547|NCT03077412|469171540|FG001|Overall Study|Investigator's Discretion|1|||
130657718|NCT03239340|470369352|FG000|Overall Study|Physician Decision|16|||
130657719|NCT03239340|470369352|FG000|Overall Study|Withdrawal by Subject|27|||
130657720|NCT03868059|470369354|FG000|Overall Study|Adverse Event|3|||
130657721|NCT03868059|470369354|FG000|Overall Study|Lost to Follow-up|3|||
130657722|NCT03868059|470369354|FG000|Overall Study|Withdrawal by Subject|6|||
130657723|NCT02061293|470369355|FG000|Overall Study|Elevated Blood Pressure|1|||
130657724|NCT02061293|470369356|FG001|Overall Study|Elevated Blood Pressure|1|||
130657725|NCT04066894|470369357|FG000|Overall Study|Lack of Efficacy|1|||
130657726|NCT04066894|470369357|FG000|Overall Study|Screen Failure|1|||
130657727|NCT01283282|470369363|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
130657728|NCT01283282|470369364|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
130657729|NCT01283282|470369363|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
130657730|NCT01283282|470369364|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
130657731|NCT01283282|470369363|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
130657732|NCT01283282|470369364|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
130657733|NCT00777920|470369365|FG000|Overall Study|Adverse Event|39|||
130327548|NCT03077412|469171541|FG002|Overall Study|Investigator's Discretion|1|||
130327549|NCT03077412|469171539|FG000|Overall Study|Withdrew Consent|0|||
130327550|NCT03077412|469171540|FG001|Overall Study|Withdrew Consent|2|||
130657734|NCT00777920|470369365|FG000|Overall Study|Withdrawal of Consent|4|||
130657735|NCT00777920|470369365|FG000|Overall Study|Lost to Follow-up|1|||
130657736|NCT00777920|470369365|FG000|Overall Study|Investigator's discretion|1|||
130657737|NCT00777920|470369365|FG000|Overall Study|Clinical status did not improve|1|||
130657738|NCT00777920|470369365|FG000|Overall Study|Other, not specified|4|||
130327551|NCT03077412|469171541|FG002|Overall Study|Withdrew Consent|0|||
130327552|NCT02266888|469171542|FG000|Overall Study|Death|2|||
130327553|NCT02266888|469171543|FG001|Overall Study|Death|2|||
130327554|NCT02266888|469171544|FG002|Overall Study|Death|4|||
130327555|NCT02266888|469171545|FG003|Overall Study|Death|2|||
130327556|NCT02266888|469171542|FG000|Overall Study|Physician Decision|0|||
130327557|NCT02266888|469171543|FG001|Overall Study|Physician Decision|1|||
130657739|NCT00483717|470369366|FG000|Overall Study|Protocol Violation|5|||
130657740|NCT00483717|470369367|FG001|Overall Study|Protocol Violation|7|||
130657741|NCT00483717|470369366|FG000|Overall Study|Time of dosing missing|1|||
130657742|NCT00483717|470369367|FG001|Overall Study|Time of dosing missing|1|||
130657743|NCT00483717|470369366|FG000|Overall Study|No treatment for migraine|16|||
130657744|NCT00483717|470369367|FG001|Overall Study|No treatment for migraine|13|||
130657745|NCT00483717|470369366|FG000|Overall Study|Lost to Follow-up|1|||
130657746|NCT00483717|470369367|FG001|Overall Study|Lost to Follow-up|0|||
130657747|NCT00483717|470369366|FG000|Overall Study|Withdrawal by Subject|1|||
130657748|NCT00483717|470369367|FG001|Overall Study|Withdrawal by Subject|0|||
130657749|NCT00909857|470369368|FG000|Overall Study|Withdrawal by Subject|6|||
130657750|NCT00909857|470369369|FG001|Overall Study|Withdrawal by Subject|10|||
130657751|NCT00909857|470369368|FG000|Overall Study|Adverse Event|5|||
130657752|NCT00909857|470369369|FG001|Overall Study|Adverse Event|5|||
130657753|NCT00909857|470369368|FG000|Overall Study|Lost to Follow-up|2|||
130657754|NCT00909857|470369369|FG001|Overall Study|Lost to Follow-up|5|||
130657755|NCT00909857|470369368|FG000|Overall Study|Protocol Violation|2|||
130657756|NCT00909857|470369369|FG001|Overall Study|Protocol Violation|1|||
130657757|NCT00909857|470369368|FG000|Overall Study|Pregnancy|1|||
130657758|NCT00909857|470369369|FG001|Overall Study|Pregnancy|0|||
130657759|NCT00909857|470369368|FG000|Overall Study|Other|1|||
130657760|NCT00909857|470369369|FG001|Overall Study|Other|0|||
130657761|NCT00909857|470369368|FG000|Overall Study|Did not receive study medication|19|||
130657762|NCT00909857|470369369|FG001|Overall Study|Did not receive study medication|24|||
130327558|NCT02266888|469171544|FG002|Overall Study|Physician Decision|2|||
130327559|NCT02266888|469171545|FG003|Overall Study|Physician Decision|2|||
130327560|NCT02266888|469171542|FG000|Overall Study|Study Terminated|5|||
130327561|NCT02266888|469171543|FG001|Overall Study|Study Terminated|1|||
130327562|NCT02266888|469171544|FG002|Overall Study|Study Terminated|0|||
130327563|NCT02266888|469171545|FG003|Overall Study|Study Terminated|0|||
130327564|NCT02266888|469171542|FG000|Overall Study|No Longer Eligible|0|||
130327565|NCT02266888|469171543|FG001|Overall Study|No Longer Eligible|0|||
130327566|NCT02266888|469171544|FG002|Overall Study|No Longer Eligible|0|||
130327567|NCT02266888|469171545|FG003|Overall Study|No Longer Eligible|2|||
130327568|NCT02266888|469171542|FG000|Overall Study|Randomization Closed|0|||
130327569|NCT02266888|469171543|FG001|Overall Study|Randomization Closed|0|||
130327570|NCT02266888|469171544|FG002|Overall Study|Randomization Closed|4|||
130327571|NCT02266888|469171545|FG003|Overall Study|Randomization Closed|0|||
130327572|NCT02266888|469171542|FG000|Overall Study|Personnel unavailable at transplant|0|||
130327573|NCT02266888|469171543|FG001|Overall Study|Personnel unavailable at transplant|0|||
130327574|NCT02266888|469171544|FG002|Overall Study|Personnel unavailable at transplant|0|||
130327575|NCT02266888|469171545|FG003|Overall Study|Personnel unavailable at transplant|1|||
130327576|NCT02266888|469171542|FG000|Overall Study|Transfer of care|0|||
130327577|NCT02266888|469171543|FG001|Overall Study|Transfer of care|0|||
130327578|NCT02266888|469171544|FG002|Overall Study|Transfer of care|1|||
130327579|NCT02266888|469171545|FG003|Overall Study|Transfer of care|0|||
130327580|NCT02351856|469171546|FG000|Overall Study|Adverse Event|2|||
130327581|NCT02351856|469171546|FG000|Overall Study|Physician Decision|5|||
130327582|NCT02351856|469171546|FG000|Overall Study|Study terminated by sponsor|1|||
130327583|NCT01458392|469171547|FG000|Overall Study|Death|2|||
130327584|NCT01458392|469171548|FG001|Overall Study|Death|11|||
130327585|NCT01458392|469171549|FG002|Overall Study|Death|22|||
130327586|NCT01458392|469171547|FG000|Overall Study|At the discretion of the sponsor|0|||
130327587|NCT01458392|469171548|FG001|Overall Study|At the discretion of the sponsor|2|||
130327588|NCT01458392|469171549|FG002|Overall Study|At the discretion of the sponsor|7|||
130327589|NCT01458392|469171547|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
130327590|NCT01458392|469171548|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
130327591|NCT01458392|469171549|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
130327592|NCT01193244|469171552|FG000|Overall Study|Withdrawal by Subject|79|||
130327593|NCT01193244|469171553|FG001|Overall Study|Withdrawal by Subject|97|||
130327594|NCT01193244|469171552|FG000|Overall Study|Other|303|||
130327595|NCT01193244|469171553|FG001|Overall Study|Other|278|||
130327596|NCT01193244|469171552|FG000|Overall Study|Lost to Follow-up|6|||
130327597|NCT01193244|469171553|FG001|Overall Study|Lost to Follow-up|15|||
130657763|NCT03878108|470369370|FG000|Overall Study|Adverse Event|1|||
130657764|NCT03878108|470369371|FG001|Overall Study|Adverse Event|0|||
130657765|NCT01682681|470369372|FG000|Overall Study|Lack of Efficacy|62|||
130657766|NCT01682681|470369372|FG000|Overall Study|Withdrawal by Subject|1|||
130327598|NCT03763877|469171563|FG000|Overall Study|Withdrawal by Subject|3|||
130327599|NCT03763877|469171564|FG001|Overall Study|Withdrawal by Subject|1|||
130327600|NCT03763877|469171565|FG002|Overall Study|Withdrawal by Subject|3|||
130327601|NCT03763877|469171566|FG003|Overall Study|Withdrawal by Subject|4|||
130327602|NCT03763877|469171563|FG000|Overall Study|Adverse Event|1|||
130327603|NCT03763877|469171564|FG001|Overall Study|Adverse Event|1|||
130657767|NCT01682681|470369372|FG000|Overall Study|Moved to other hospital|10|||
130657768|NCT01682681|470369372|FG000|Overall Study|Lost to Follow-up|174|||
130657769|NCT01682681|470369372|FG000|Overall Study|Adverse Event|46|||
130327604|NCT03763877|469171565|FG002|Overall Study|Adverse Event|3|||
130327605|NCT03763877|469171566|FG003|Overall Study|Adverse Event|1|||
130327606|NCT03763877|469171563|FG000|Overall Study|Protocol Violation|1|||
130327607|NCT03763877|469171564|FG001|Overall Study|Protocol Violation|1|||
130327608|NCT03763877|469171565|FG002|Overall Study|Protocol Violation|0|||
130327609|NCT03763877|469171566|FG003|Overall Study|Protocol Violation|0|||
130327610|NCT03763877|469171563|FG000|Overall Study|Lost to Follow-up|0|||
130327611|NCT03763877|469171564|FG001|Overall Study|Lost to Follow-up|1|||
130327612|NCT03763877|469171565|FG002|Overall Study|Lost to Follow-up|1|||
130327613|NCT03763877|469171566|FG003|Overall Study|Lost to Follow-up|0|||
130327614|NCT03040336|469171567|FG000|Overall Study|Death|1|||
130327615|NCT03040336|469171568|FG001|Overall Study|Death|0|||
130327616|NCT03040336|469171567|FG000|Overall Study|Withdrawal by Subject|2|||
130327617|NCT03040336|469171568|FG001|Overall Study|Withdrawal by Subject|3|||
130327618|NCT00068692|469171573|FG000|Step 1: Registration|Disese progression/relapse|5|||
130327619|NCT00068692|469171574|FG001|Step 1: Registration|Disese progression/relapse|0|||
130327620|NCT00068692|469171575|FG002|Step 1: Registration|Disese progression/relapse|0|||
130327621|NCT00068692|469171576|FG003|Step 1: Registration|Disese progression/relapse|0|||
130327622|NCT00068692|469171577|FG004|Step 1: Registration|Disese progression/relapse|0|||
130327623|NCT00068692|469171578|FG005|Step 1: Registration|Disese progression/relapse|0|||
130327624|NCT00068692|469171579|FG006|Step 1: Registration|Disese progression/relapse|0|||
130327625|NCT00068692|469171580|FG007|Step 1: Registration|Disese progression/relapse|0|||
130327626|NCT00068692|469171573|FG000|Step 1: Registration|Adverse Event|7|||
130327627|NCT00068692|469171574|FG001|Step 1: Registration|Adverse Event|0|||
130327628|NCT00068692|469171575|FG002|Step 1: Registration|Adverse Event|0|||
130327629|NCT00068692|469171576|FG003|Step 1: Registration|Adverse Event|0|||
130327630|NCT00068692|469171577|FG004|Step 1: Registration|Adverse Event|0|||
130327631|NCT00068692|469171578|FG005|Step 1: Registration|Adverse Event|0|||
130327632|NCT00068692|469171579|FG006|Step 1: Registration|Adverse Event|0|||
130327633|NCT00068692|469171580|FG007|Step 1: Registration|Adverse Event|0|||
130327634|NCT00068692|469171573|FG000|Step 1: Registration|Death|1|||
130327635|NCT00068692|469171574|FG001|Step 1: Registration|Death|0|||
130327636|NCT00068692|469171575|FG002|Step 1: Registration|Death|0|||
130327637|NCT00068692|469171576|FG003|Step 1: Registration|Death|0|||
130327638|NCT00068692|469171577|FG004|Step 1: Registration|Death|0|||
130327639|NCT00068692|469171578|FG005|Step 1: Registration|Death|0|||
130327640|NCT00068692|469171579|FG006|Step 1: Registration|Death|0|||
130327641|NCT00068692|469171580|FG007|Step 1: Registration|Death|0|||
130327642|NCT00068692|469171573|FG000|Step 1: Registration|Withdrawal by Subject|11|||
130327643|NCT00068692|469171574|FG001|Step 1: Registration|Withdrawal by Subject|0|||
130327644|NCT00068692|469171575|FG002|Step 1: Registration|Withdrawal by Subject|0|||
130327645|NCT00068692|469171576|FG003|Step 1: Registration|Withdrawal by Subject|0|||
130327646|NCT00068692|469171577|FG004|Step 1: Registration|Withdrawal by Subject|0|||
130327647|NCT00068692|469171578|FG005|Step 1: Registration|Withdrawal by Subject|0|||
130327648|NCT00068692|469171579|FG006|Step 1: Registration|Withdrawal by Subject|0|||
130327649|NCT00068692|469171580|FG007|Step 1: Registration|Withdrawal by Subject|0|||
130327650|NCT00068692|469171573|FG000|Step 1: Registration|Alternative therapy|2|||
130327651|NCT00068692|469171574|FG001|Step 1: Registration|Alternative therapy|0|||
130327652|NCT00068692|469171575|FG002|Step 1: Registration|Alternative therapy|0|||
130327653|NCT00068692|469171576|FG003|Step 1: Registration|Alternative therapy|0|||
130327654|NCT00068692|469171577|FG004|Step 1: Registration|Alternative therapy|0|||
130327655|NCT00068692|469171578|FG005|Step 1: Registration|Alternative therapy|0|||
130327656|NCT00068692|469171579|FG006|Step 1: Registration|Alternative therapy|0|||
130327657|NCT00068692|469171580|FG007|Step 1: Registration|Alternative therapy|0|||
130327658|NCT00068692|469171573|FG000|Step 1: Registration|Complicating disease|2|||
130327659|NCT00068692|469171574|FG001|Step 1: Registration|Complicating disease|0|||
130327660|NCT00068692|469171575|FG002|Step 1: Registration|Complicating disease|0|||
130327661|NCT00068692|469171576|FG003|Step 1: Registration|Complicating disease|0|||
130327662|NCT00068692|469171577|FG004|Step 1: Registration|Complicating disease|0|||
130327663|NCT00068692|469171578|FG005|Step 1: Registration|Complicating disease|0|||
130327664|NCT00068692|469171579|FG006|Step 1: Registration|Complicating disease|0|||
130327665|NCT00068692|469171580|FG007|Step 1: Registration|Complicating disease|0|||
130327666|NCT00068692|469171573|FG000|Step 1: Registration|Protocol Violation|1|||
130327667|NCT00068692|469171574|FG001|Step 1: Registration|Protocol Violation|0|||
130327668|NCT00068692|469171575|FG002|Step 1: Registration|Protocol Violation|0|||
130327669|NCT00068692|469171576|FG003|Step 1: Registration|Protocol Violation|0|||
130327670|NCT00068692|469171577|FG004|Step 1: Registration|Protocol Violation|0|||
130327671|NCT00068692|469171578|FG005|Step 1: Registration|Protocol Violation|0|||
130327672|NCT00068692|469171579|FG006|Step 1: Registration|Protocol Violation|0|||
130327673|NCT00068692|469171580|FG007|Step 1: Registration|Protocol Violation|0|||
130327674|NCT00068692|469171573|FG000|Step 1: Registration|Not eligible|6|||
130327675|NCT00068692|469171574|FG001|Step 1: Registration|Not eligible|0|||
130327676|NCT00068692|469171575|FG002|Step 1: Registration|Not eligible|0|||
130327677|NCT00068692|469171576|FG003|Step 1: Registration|Not eligible|0|||
130327678|NCT00068692|469171577|FG004|Step 1: Registration|Not eligible|0|||
130327679|NCT00068692|469171578|FG005|Step 1: Registration|Not eligible|0|||
130327680|NCT00068692|469171579|FG006|Step 1: Registration|Not eligible|0|||
130327681|NCT00068692|469171580|FG007|Step 1: Registration|Not eligible|0|||
130327682|NCT00068692|469171573|FG000|Step 1: Registration|Other|2|||
130327683|NCT00068692|469171574|FG001|Step 1: Registration|Other|0|||
130327684|NCT00068692|469171575|FG002|Step 1: Registration|Other|0|||
130327685|NCT00068692|469171576|FG003|Step 1: Registration|Other|0|||
130327686|NCT00068692|469171577|FG004|Step 1: Registration|Other|0|||
130327687|NCT00068692|469171578|FG005|Step 1: Registration|Other|0|||
130327688|NCT00068692|469171579|FG006|Step 1: Registration|Other|0|||
130327689|NCT00068692|469171580|FG007|Step 1: Registration|Other|0|||
130327690|NCT00068692|469171573|FG000|Step 1: Registration|Not start protocol therapy|3|||
130327691|NCT00068692|469171574|FG001|Step 1: Registration|Not start protocol therapy|0|||
130327692|NCT00068692|469171575|FG002|Step 1: Registration|Not start protocol therapy|0|||
130327693|NCT00068692|469171576|FG003|Step 1: Registration|Not start protocol therapy|0|||
130327694|NCT00068692|469171577|FG004|Step 1: Registration|Not start protocol therapy|0|||
130327695|NCT00068692|469171578|FG005|Step 1: Registration|Not start protocol therapy|0|||
130327696|NCT00068692|469171579|FG006|Step 1: Registration|Not start protocol therapy|0|||
130327697|NCT00068692|469171580|FG007|Step 1: Registration|Not start protocol therapy|0|||
130327698|NCT00068692|469171573|FG000|Step 1: Registration|Registered but not randomized|0|||
130327699|NCT00068692|469171574|FG001|Step 1: Registration|Registered but not randomized|1|||
130327700|NCT00068692|469171575|FG002|Step 1: Registration|Registered but not randomized|0|||
130327701|NCT00068692|469171576|FG003|Step 1: Registration|Registered but not randomized|0|||
130327702|NCT00068692|469171577|FG004|Step 1: Registration|Registered but not randomized|0|||
130327703|NCT00068692|469171578|FG005|Step 1: Registration|Registered but not randomized|0|||
130327704|NCT00068692|469171579|FG006|Step 1: Registration|Registered but not randomized|0|||
130327705|NCT00068692|469171580|FG007|Step 1: Registration|Registered but not randomized|0|||
130327706|NCT00068692|469171573|FG000|Step 2: Randomization|Disesae progression/replase|0|||
130327707|NCT00068692|469171574|FG001|Step 2: Randomization|Disesae progression/replase|0|||
130327708|NCT00068692|469171575|FG002|Step 2: Randomization|Disesae progression/replase|1|||
130327709|NCT00068692|469171576|FG003|Step 2: Randomization|Disesae progression/replase|1|||
130327710|NCT00068692|469171577|FG004|Step 2: Randomization|Disesae progression/replase|0|||
130327711|NCT00068692|469171578|FG005|Step 2: Randomization|Disesae progression/replase|0|||
130327712|NCT00068692|469171579|FG006|Step 2: Randomization|Disesae progression/replase|0|||
130327713|NCT00068692|469171580|FG007|Step 2: Randomization|Disesae progression/replase|0|||
130327714|NCT00068692|469171573|FG000|Step 2: Randomization|Adverse Event|0|||
130327715|NCT00068692|469171574|FG001|Step 2: Randomization|Adverse Event|0|||
130327716|NCT00068692|469171575|FG002|Step 2: Randomization|Adverse Event|4|||
130327717|NCT00068692|469171576|FG003|Step 2: Randomization|Adverse Event|2|||
130327718|NCT00068692|469171577|FG004|Step 2: Randomization|Adverse Event|2|||
130327719|NCT00068692|469171578|FG005|Step 2: Randomization|Adverse Event|3|||
130327720|NCT00068692|469171579|FG006|Step 2: Randomization|Adverse Event|4|||
130327721|NCT00068692|469171580|FG007|Step 2: Randomization|Adverse Event|4|||
130327722|NCT00068692|469171573|FG000|Step 2: Randomization|Death|0|||
130327723|NCT00068692|469171574|FG001|Step 2: Randomization|Death|0|||
130327724|NCT00068692|469171575|FG002|Step 2: Randomization|Death|0|||
130327725|NCT00068692|469171576|FG003|Step 2: Randomization|Death|0|||
130327726|NCT00068692|469171577|FG004|Step 2: Randomization|Death|1|||
130327727|NCT00068692|469171578|FG005|Step 2: Randomization|Death|0|||
130327728|NCT00068692|469171579|FG006|Step 2: Randomization|Death|0|||
130327729|NCT00068692|469171580|FG007|Step 2: Randomization|Death|1|||
130327730|NCT00068692|469171573|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
130327731|NCT00068692|469171574|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
130327732|NCT00068692|469171575|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
130327733|NCT00068692|469171576|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
130215602|NCT00262002|468751778|FG001|Overall Study|Adverse Event|1|||
130215603|NCT00262002|468751779|FG002|Overall Study|Adverse Event|0|||
130215604|NCT00262002|468751780|FG003|Overall Study|Adverse Event|0|||
130215605|NCT00262002|468751781|FG004|Overall Study|Adverse Event|0|||
130215606|NCT00262002|468751782|FG005|Overall Study|Adverse Event|1|||
130215607|NCT00262002|468751783|FG006|Overall Study|Adverse Event|0|||
130215608|NCT00262002|468751777|FG000|Overall Study|Withdrawal by Subject|4|||
130215609|NCT00262002|468751778|FG001|Overall Study|Withdrawal by Subject|2|||
130327734|NCT00068692|469171577|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
130327735|NCT00068692|469171578|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
130327736|NCT00068692|469171579|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
130327737|NCT00068692|469171580|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
130327738|NCT00068692|469171573|FG000|Step 2: Randomization|alternative therapy|0|||
130327739|NCT00068692|469171574|FG001|Step 2: Randomization|alternative therapy|0|||
130327740|NCT00068692|469171575|FG002|Step 2: Randomization|alternative therapy|0|||
130327741|NCT00068692|469171576|FG003|Step 2: Randomization|alternative therapy|1|||
130327742|NCT00068692|469171577|FG004|Step 2: Randomization|alternative therapy|1|||
130327743|NCT00068692|469171578|FG005|Step 2: Randomization|alternative therapy|0|||
130327744|NCT00068692|469171579|FG006|Step 2: Randomization|alternative therapy|0|||
130327745|NCT00068692|469171580|FG007|Step 2: Randomization|alternative therapy|0|||
130327746|NCT00068692|469171573|FG000|Step 2: Randomization|Physician Decision|0|||
130327747|NCT00068692|469171574|FG001|Step 2: Randomization|Physician Decision|0|||
130327748|NCT00068692|469171575|FG002|Step 2: Randomization|Physician Decision|0|||
130327749|NCT00068692|469171576|FG003|Step 2: Randomization|Physician Decision|1|||
130327750|NCT00068692|469171577|FG004|Step 2: Randomization|Physician Decision|1|||
130327751|NCT00068692|469171578|FG005|Step 2: Randomization|Physician Decision|0|||
130327752|NCT00068692|469171579|FG006|Step 2: Randomization|Physician Decision|0|||
130327753|NCT00068692|469171580|FG007|Step 2: Randomization|Physician Decision|0|||
130327754|NCT00068692|469171573|FG000|Step 2: Randomization|Other|0|||
130327755|NCT00068692|469171574|FG001|Step 2: Randomization|Other|0|||
130327756|NCT00068692|469171575|FG002|Step 2: Randomization|Other|0|||
130327757|NCT00068692|469171576|FG003|Step 2: Randomization|Other|1|||
130327758|NCT00068692|469171577|FG004|Step 2: Randomization|Other|0|||
130327759|NCT00068692|469171578|FG005|Step 2: Randomization|Other|1|||
130327760|NCT00068692|469171579|FG006|Step 2: Randomization|Other|0|||
130327761|NCT00068692|469171580|FG007|Step 2: Randomization|Other|0|||
130327762|NCT00068692|469171573|FG000|Step 2: Randomization|never start protocol therapy|0|||
130327763|NCT00068692|469171574|FG001|Step 2: Randomization|never start protocol therapy|0|||
130327764|NCT00068692|469171575|FG002|Step 2: Randomization|never start protocol therapy|1|||
130327765|NCT00068692|469171576|FG003|Step 2: Randomization|never start protocol therapy|0|||
130327766|NCT00068692|469171577|FG004|Step 2: Randomization|never start protocol therapy|1|||
130327767|NCT00068692|469171578|FG005|Step 2: Randomization|never start protocol therapy|0|||
130327768|NCT00068692|469171579|FG006|Step 2: Randomization|never start protocol therapy|0|||
130327769|NCT00068692|469171580|FG007|Step 2: Randomization|never start protocol therapy|0|||
130327770|NCT00248040|469171585|FG000|Overall Study|transplantectomy|2|||
130327771|NCT00248040|469171586|FG001|Overall Study|transplantectomy|1|||
130327772|NCT00248040|469171587|FG002|Overall Study|transplantectomy|3|||
130327773|NCT00248040|469171585|FG000|Overall Study|transplant cancelled post treat start|1|||
130657770|NCT01682681|470369372|FG000|Overall Study|tapering of topiramate|5|||
130657771|NCT01682681|470369372|FG000|Overall Study|Other|21|||
130657772|NCT01682681|470369372|FG000|Overall Study|Low compliance|13|||
130657773|NCT00975000|470369373|FG000|Overall Study|Other|1|||
130657774|NCT00975000|470369374|FG001|Overall Study|Other|0|||
130657775|NCT00975000|470369373|FG000|Overall Study|Adverse Event|1|||
130657776|NCT00975000|470369374|FG001|Overall Study|Adverse Event|1|||
130657777|NCT00975000|470369373|FG000|Overall Study|Withdrawal by Subject|2|||
130657778|NCT00975000|470369374|FG001|Overall Study|Withdrawal by Subject|2|||
130657779|NCT00975000|470369373|FG000|Overall Study|Lost to Follow-up|0|||
130657780|NCT00975000|470369374|FG001|Overall Study|Lost to Follow-up|1|||
130657781|NCT00975000|470369373|FG000|Overall Study|Protocol-specified Criteria|1|||
130657782|NCT00975000|470369374|FG001|Overall Study|Protocol-specified Criteria|0|||
130657783|NCT00975000|470369373|FG000|Overall Study|Non-compliance|0|||
130657784|NCT00975000|470369374|FG001|Overall Study|Non-compliance|1|||
130657785|NCT01126359|470369375|FG000|First Intervention (20-minutes)|Physician Decision|0|||
130657786|NCT01126359|470369376|FG001|First Intervention (20-minutes)|Physician Decision|1|||
130657787|NCT00902486|470369377|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130657788|NCT00902486|470369378|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
130657789|NCT00902486|470369379|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
130657790|NCT00902486|470369380|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130657791|NCT00902486|470369381|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130657792|NCT00902486|470369382|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
130657793|NCT00902486|470369377|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
130657794|NCT00902486|470369378|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130657795|NCT00902486|470369379|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130657796|NCT00902486|470369380|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130657797|NCT00902486|470369381|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130657798|NCT00902486|470369382|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
130657799|NCT00902486|470369377|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130657800|NCT00902486|470369378|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130657801|NCT00902486|470369379|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130657802|NCT00902486|470369380|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130657803|NCT00902486|470369381|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
130657804|NCT00902486|470369382|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
130657805|NCT00902486|470369377|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130657806|NCT00902486|470369378|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130657807|NCT00902486|470369379|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130657808|NCT00902486|470369380|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
130327774|NCT00248040|469171586|FG001|Overall Study|transplant cancelled post treat start|0|||
130327775|NCT00248040|469171587|FG002|Overall Study|transplant cancelled post treat start|0|||
130327776|NCT00248040|469171585|FG000|Overall Study|Death|0|||
130327777|NCT00248040|469171586|FG001|Overall Study|Death|0|||
130327778|NCT00248040|469171587|FG002|Overall Study|Death|1|||
130327779|NCT00711191|469171593|FG000|Overall Study|Adverse Event|1|||
130657809|NCT00902486|470369381|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130327780|NCT00711191|469171594|FG001|Overall Study|Adverse Event|1|||
130327781|NCT00711191|469171595|FG002|Overall Study|Adverse Event|2|||
130327782|NCT00711191|469171593|FG000|Overall Study|Objective progression or relapse|2|||
130327783|NCT00711191|469171594|FG001|Overall Study|Objective progression or relapse|3|||
130327784|NCT00711191|469171595|FG002|Overall Study|Objective progression or relapse|7|||
130327785|NCT00711191|469171593|FG000|Overall Study|Withdrawal by Subject|0|||
130327786|NCT00711191|469171594|FG001|Overall Study|Withdrawal by Subject|1|||
130327787|NCT00711191|469171595|FG002|Overall Study|Withdrawal by Subject|3|||
130327788|NCT00602472|469171596|FG000|Overall Study|Adverse Event|5|||
130327789|NCT00602472|469171597|FG001|Overall Study|Adverse Event|23|||
130327790|NCT00602472|469171596|FG000|Overall Study|Protocol Violation|4|||
130327791|NCT00602472|469171597|FG001|Overall Study|Protocol Violation|19|||
130327792|NCT00602472|469171596|FG000|Overall Study|Withdrawal by Subject|8|||
130327793|NCT00602472|469171597|FG001|Overall Study|Withdrawal by Subject|14|||
130327794|NCT00602472|469171596|FG000|Overall Study|Other incl. lack of efficacy|4|||
130327795|NCT00602472|469171597|FG001|Overall Study|Other incl. lack of efficacy|2|||
130327796|NCT03038880|469171598|FG000|Overall Study|Death|1|||
130327797|NCT03038880|469171599|FG001|Overall Study|Death|2|||
130327798|NCT03038880|469171600|FG002|Overall Study|Death|0|||
130327799|NCT03038880|469171598|FG000|Overall Study|Physician Decision|2|||
130327800|NCT03038880|469171599|FG001|Overall Study|Physician Decision|1|||
130327801|NCT03038880|469171600|FG002|Overall Study|Physician Decision|0|||
130327802|NCT01002339|469171601|FG000|Overall Study|Withdrawal by Subject|0|||
130327803|NCT01002339|469171602|FG001|Overall Study|Withdrawal by Subject|1|||
130327804|NCT01002339|469171603|FG002|Overall Study|Withdrawal by Subject|0|||
130327805|NCT01002339|469171601|FG000|Overall Study|Incorrect treatment assignment|0|||
130327806|NCT01002339|469171602|FG001|Overall Study|Incorrect treatment assignment|0|||
130327807|NCT01002339|469171603|FG002|Overall Study|Incorrect treatment assignment|1|||
130327808|NCT01002339|469171601|FG000|Overall Study|Protocol Violation|0|||
130327809|NCT01002339|469171602|FG001|Overall Study|Protocol Violation|0|||
130327810|NCT01002339|469171603|FG002|Overall Study|Protocol Violation|2|||
130327811|NCT01002339|469171601|FG000|Overall Study|Lung cancer detected before transplant|0|||
130327812|NCT01002339|469171602|FG001|Overall Study|Lung cancer detected before transplant|0|||
130327813|NCT01002339|469171603|FG002|Overall Study|Lung cancer detected before transplant|1|||
130327814|NCT01002339|469171601|FG000|Overall Study|Randomized. Not transplanted|0|||
130327815|NCT01002339|469171602|FG001|Overall Study|Randomized. Not transplanted|0|||
130327816|NCT01002339|469171603|FG002|Overall Study|Randomized. Not transplanted|1|||
130327817|NCT02118961|469171604|FG000|Overall Study|Withdrawal by Subject|1|||
130327818|NCT02118961|469171605|FG001|Overall Study|Withdrawal by Subject|0|||
130327819|NCT00790842|469171606|FG000|Dose Level 1|Adverse Event|1|||
130327820|NCT00790842|469171607|FG001|Dose Level 1|Adverse Event|0|||
130327821|NCT00790842|469171608|FG002|Dose Level 1|Adverse Event|0|||
130327822|NCT00790842|469171609|FG003|Dose Level 1|Adverse Event|2|||
130327823|NCT00790842|469171610|FG004|Dose Level 1|Adverse Event|0|||
130327824|NCT00790842|469171611|FG005|Dose Level 1|Adverse Event|0|||
130327825|NCT00790842|469171612|FG006|Dose Level 1|Adverse Event|0|||
130327826|NCT00790842|469171613|FG007|Dose Level 1|Adverse Event|1|||
130327827|NCT00790842|469171614|FG008|Dose Level 1|Adverse Event|0|||
130327828|NCT00790842|469171615|FG009|Dose Level 1|Adverse Event|0|||
130657810|NCT00902486|470369382|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130657811|NCT00902486|470369377|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130657812|NCT00902486|470369378|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130657813|NCT00902486|470369379|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130657814|NCT00902486|470369380|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
130657815|NCT00902486|470369381|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130657816|NCT00902486|470369382|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130657817|NCT00902486|470369377|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130657818|NCT00902486|470369378|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130657819|NCT00902486|470369379|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130657820|NCT00902486|470369380|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130657821|NCT00902486|470369381|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
130657822|NCT00902486|470369382|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
130657823|NCT00902486|470369377|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130657824|NCT00902486|470369378|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130327829|NCT00790842|469171616|FG010|Dose Level 1|Adverse Event|0|||
130327830|NCT00790842|469171606|FG000|Dose Level 1|Physician Decision|1|||
130327831|NCT00790842|469171607|FG001|Dose Level 1|Physician Decision|0|||
130327832|NCT00790842|469171608|FG002|Dose Level 1|Physician Decision|0|||
130327833|NCT00790842|469171609|FG003|Dose Level 1|Physician Decision|0|||
130327834|NCT00790842|469171610|FG004|Dose Level 1|Physician Decision|0|||
130327835|NCT00790842|469171611|FG005|Dose Level 1|Physician Decision|0|||
130327836|NCT00790842|469171612|FG006|Dose Level 1|Physician Decision|0|||
130327837|NCT00790842|469171613|FG007|Dose Level 1|Physician Decision|1|||
130327838|NCT00790842|469171614|FG008|Dose Level 1|Physician Decision|0|||
130327839|NCT00790842|469171615|FG009|Dose Level 1|Physician Decision|0|||
130327840|NCT00790842|469171616|FG010|Dose Level 1|Physician Decision|0|||
130327841|NCT00790842|469171606|FG000|Dose Level 1|Withdrawal by Subject|1|||
130327842|NCT00790842|469171607|FG001|Dose Level 1|Withdrawal by Subject|0|||
130327843|NCT00790842|469171608|FG002|Dose Level 1|Withdrawal by Subject|0|||
130327844|NCT00790842|469171609|FG003|Dose Level 1|Withdrawal by Subject|0|||
130327845|NCT00790842|469171610|FG004|Dose Level 1|Withdrawal by Subject|0|||
130327846|NCT00790842|469171611|FG005|Dose Level 1|Withdrawal by Subject|0|||
130327847|NCT00790842|469171612|FG006|Dose Level 1|Withdrawal by Subject|0|||
130327848|NCT00790842|469171613|FG007|Dose Level 1|Withdrawal by Subject|0|||
130327849|NCT00790842|469171614|FG008|Dose Level 1|Withdrawal by Subject|0|||
130327850|NCT00790842|469171615|FG009|Dose Level 1|Withdrawal by Subject|0|||
130327851|NCT00790842|469171616|FG010|Dose Level 1|Withdrawal by Subject|0|||
130327852|NCT00790842|469171606|FG000|Dose Level 2|Death|0|||
130327853|NCT00790842|469171607|FG001|Dose Level 2|Death|1|||
130327854|NCT00790842|469171608|FG002|Dose Level 2|Death|0|||
130327855|NCT00790842|469171609|FG003|Dose Level 2|Death|0|||
130327856|NCT00790842|469171610|FG004|Dose Level 2|Death|1|||
130327857|NCT00790842|469171611|FG005|Dose Level 2|Death|0|||
130327858|NCT00790842|469171612|FG006|Dose Level 2|Death|0|||
130327859|NCT00790842|469171613|FG007|Dose Level 2|Death|0|||
130327860|NCT00790842|469171614|FG008|Dose Level 2|Death|0|||
130327861|NCT00790842|469171615|FG009|Dose Level 2|Death|0|||
130327862|NCT00790842|469171616|FG010|Dose Level 2|Death|0|||
130327863|NCT00790842|469171606|FG000|Dose Level 2|Physician Decision|0|||
130327864|NCT00790842|469171607|FG001|Dose Level 2|Physician Decision|1|||
130327865|NCT00790842|469171608|FG002|Dose Level 2|Physician Decision|0|||
130327866|NCT00790842|469171609|FG003|Dose Level 2|Physician Decision|0|||
130327867|NCT00790842|469171610|FG004|Dose Level 2|Physician Decision|0|||
130327868|NCT00790842|469171611|FG005|Dose Level 2|Physician Decision|0|||
130327869|NCT00790842|469171612|FG006|Dose Level 2|Physician Decision|0|||
130327870|NCT00790842|469171613|FG007|Dose Level 2|Physician Decision|0|||
130327871|NCT00790842|469171614|FG008|Dose Level 2|Physician Decision|0|||
130327872|NCT00790842|469171615|FG009|Dose Level 2|Physician Decision|0|||
130327873|NCT00790842|469171616|FG010|Dose Level 2|Physician Decision|0|||
130327874|NCT00790842|469171606|FG000|Dose Level 2|Withdrawal by Subject|0|||
130327875|NCT00790842|469171607|FG001|Dose Level 2|Withdrawal by Subject|1|||
130327876|NCT00790842|469171608|FG002|Dose Level 2|Withdrawal by Subject|0|||
130327877|NCT00790842|469171609|FG003|Dose Level 2|Withdrawal by Subject|0|||
130327878|NCT00790842|469171610|FG004|Dose Level 2|Withdrawal by Subject|0|||
130327879|NCT00790842|469171611|FG005|Dose Level 2|Withdrawal by Subject|0|||
130327880|NCT00790842|469171612|FG006|Dose Level 2|Withdrawal by Subject|0|||
130327881|NCT00790842|469171613|FG007|Dose Level 2|Withdrawal by Subject|0|||
130327882|NCT00790842|469171614|FG008|Dose Level 2|Withdrawal by Subject|0|||
130327883|NCT00790842|469171615|FG009|Dose Level 2|Withdrawal by Subject|0|||
130657825|NCT00902486|470369379|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
130657826|NCT00902486|470369380|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
130657827|NCT00902486|470369381|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130657828|NCT00902486|470369382|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130657829|NCT00902486|470369377|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130657830|NCT00902486|470369378|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130657831|NCT00902486|470369379|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130657832|NCT00902486|470369380|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130657833|NCT00902486|470369381|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130657834|NCT00902486|470369382|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
130657835|NCT00902486|470369377|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130657836|NCT00902486|470369378|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130657837|NCT00902486|470369379|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130657838|NCT00902486|470369380|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
130657839|NCT00902486|470369381|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130657840|NCT00902486|470369382|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130327884|NCT00790842|469171616|FG010|Dose Level 2|Withdrawal by Subject|0|||
130327885|NCT00790842|469171606|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327886|NCT00790842|469171607|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327887|NCT00790842|469171608|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327888|NCT00790842|469171609|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327889|NCT00790842|469171610|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327890|NCT00790842|469171611|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327891|NCT00790842|469171612|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327892|NCT00790842|469171613|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327893|NCT00790842|469171614|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
130327894|NCT00790842|469171615|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327895|NCT00790842|469171616|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327896|NCT00790842|469171606|FG000|Dose Level 3|Adverse Event|0|||
130327897|NCT00790842|469171607|FG001|Dose Level 3|Adverse Event|0|||
130327898|NCT00790842|469171608|FG002|Dose Level 3|Adverse Event|1|||
130327899|NCT00790842|469171609|FG003|Dose Level 3|Adverse Event|0|||
130327900|NCT00790842|469171610|FG004|Dose Level 3|Adverse Event|0|||
130327901|NCT00790842|469171611|FG005|Dose Level 3|Adverse Event|0|||
130327902|NCT00790842|469171612|FG006|Dose Level 3|Adverse Event|0|||
130327903|NCT00790842|469171613|FG007|Dose Level 3|Adverse Event|0|||
130327904|NCT00790842|469171614|FG008|Dose Level 3|Adverse Event|0|||
130327905|NCT00790842|469171615|FG009|Dose Level 3|Adverse Event|0|||
130327906|NCT00790842|469171616|FG010|Dose Level 3|Adverse Event|0|||
130327907|NCT00790842|469171606|FG000|Dose Level 3|Withdrawal by Subject|0|||
130327908|NCT00790842|469171607|FG001|Dose Level 3|Withdrawal by Subject|0|||
130327909|NCT00790842|469171608|FG002|Dose Level 3|Withdrawal by Subject|3|||
130327910|NCT00790842|469171609|FG003|Dose Level 3|Withdrawal by Subject|0|||
130327911|NCT00790842|469171610|FG004|Dose Level 3|Withdrawal by Subject|0|||
130327912|NCT00790842|469171611|FG005|Dose Level 3|Withdrawal by Subject|0|||
130327913|NCT00790842|469171612|FG006|Dose Level 3|Withdrawal by Subject|0|||
130327914|NCT00790842|469171613|FG007|Dose Level 3|Withdrawal by Subject|0|||
130327915|NCT00790842|469171614|FG008|Dose Level 3|Withdrawal by Subject|0|||
130327916|NCT00790842|469171615|FG009|Dose Level 3|Withdrawal by Subject|2|||
130327917|NCT00790842|469171616|FG010|Dose Level 3|Withdrawal by Subject|0|||
130327918|NCT00790842|469171606|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327919|NCT00790842|469171607|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327920|NCT00790842|469171608|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327921|NCT00790842|469171609|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327922|NCT00790842|469171610|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327923|NCT00790842|469171611|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
130327924|NCT00790842|469171612|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130551951|NCT02678247|469988170|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
130551952|NCT02678247|469988169|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
130551953|NCT02678247|469988170|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
130551954|NCT01209143|469988171|FG000|Overall Study|Adverse Event|2|||
130551955|NCT01209143|469988172|FG001|Overall Study|Adverse Event|1|||
130551956|NCT01209143|469988171|FG000|Overall Study|Death|0|||
130551957|NCT01209143|469988172|FG001|Overall Study|Death|1|||
130551958|NCT01209143|469988171|FG000|Overall Study|Physician Decision|3|||
130551959|NCT01209143|469988172|FG001|Overall Study|Physician Decision|1|||
130551960|NCT01209143|469988171|FG000|Overall Study|Lost to Follow-up|1|||
130551961|NCT01209143|469988172|FG001|Overall Study|Lost to Follow-up|0|||
130551962|NCT01209143|469988171|FG000|Overall Study|Withdrawal by Subject|2|||
130551963|NCT01209143|469988172|FG001|Overall Study|Withdrawal by Subject|1|||
130551964|NCT01209143|469988171|FG000|Overall Study|Disease progression|11|||
130551965|NCT01209143|469988172|FG001|Overall Study|Disease progression|16|||
130551966|NCT01145755|469988173|FG000|Overall Study|Adverse Event|2|||
130551967|NCT01145755|469988174|FG001|Overall Study|Adverse Event|4|||
130551968|NCT01145755|469988175|FG002|Overall Study|Adverse Event|2|||
130551969|NCT01145755|469988173|FG000|Overall Study|Withdrawal by Subject|2|||
130551970|NCT01145755|469988174|FG001|Overall Study|Withdrawal by Subject|2|||
130551971|NCT01145755|469988175|FG002|Overall Study|Withdrawal by Subject|2|||
130551972|NCT01145755|469988173|FG000|Overall Study|Lost to Follow-up|2|||
130551973|NCT01145755|469988174|FG001|Overall Study|Lost to Follow-up|3|||
130551974|NCT01145755|469988175|FG002|Overall Study|Lost to Follow-up|1|||
130551975|NCT01145755|469988173|FG000|Overall Study|Protocol Violation|0|||
130551976|NCT01145755|469988174|FG001|Overall Study|Protocol Violation|3|||
130551977|NCT01145755|469988175|FG002|Overall Study|Protocol Violation|1|||
130551978|NCT01145755|469988173|FG000|Overall Study|Study Closure|14|||
130551979|NCT01145755|469988174|FG001|Overall Study|Study Closure|14|||
130551980|NCT01145755|469988175|FG002|Overall Study|Study Closure|17|||
130551981|NCT01145755|469988173|FG000|Overall Study|Lack of Efficacy|0|||
130551982|NCT01145755|469988174|FG001|Overall Study|Lack of Efficacy|1|||
130551983|NCT01145755|469988175|FG002|Overall Study|Lack of Efficacy|0|||
130551984|NCT01145755|469988173|FG000|Overall Study|Patient could not swollow medication|0|||
130551985|NCT01145755|469988174|FG001|Overall Study|Patient could not swollow medication|0|||
130215610|NCT00262002|468751779|FG002|Overall Study|Withdrawal by Subject|0|||
130327925|NCT00790842|469171613|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327926|NCT00790842|469171614|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327927|NCT00790842|469171615|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130551986|NCT01145755|469988175|FG002|Overall Study|Patient could not swollow medication|1|||
130551987|NCT01145755|469988173|FG000|Overall Study|Withdrawal by Subject|0|||
130551988|NCT01145755|469988174|FG001|Overall Study|Withdrawal by Subject|0|||
130551989|NCT01145755|469988175|FG002|Overall Study|Withdrawal by Subject|1|||
130551990|NCT01145755|469988173|FG000|Overall Study|Positive urine ethanol|0|||
130551991|NCT01145755|469988174|FG001|Overall Study|Positive urine ethanol|1|||
130551992|NCT01145755|469988175|FG002|Overall Study|Positive urine ethanol|0|||
130327928|NCT00790842|469171616|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327929|NCT00790842|469171606|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327930|NCT00790842|469171607|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327931|NCT00790842|469171608|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
130327932|NCT00790842|469171609|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327933|NCT00790842|469171610|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327934|NCT00790842|469171611|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327935|NCT00790842|469171612|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327936|NCT00790842|469171613|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327937|NCT00790842|469171614|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327938|NCT00790842|469171615|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327939|NCT00790842|469171616|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327940|NCT00790842|469171606|FG000|Dose Level 4|Adverse Event|0|||
130327941|NCT00790842|469171607|FG001|Dose Level 4|Adverse Event|0|||
130327942|NCT00790842|469171608|FG002|Dose Level 4|Adverse Event|0|||
130327943|NCT00790842|469171609|FG003|Dose Level 4|Adverse Event|0|||
130327944|NCT00790842|469171610|FG004|Dose Level 4|Adverse Event|0|||
130327945|NCT00790842|469171611|FG005|Dose Level 4|Adverse Event|0|||
130327946|NCT00790842|469171612|FG006|Dose Level 4|Adverse Event|1|||
130327947|NCT00790842|469171613|FG007|Dose Level 4|Adverse Event|0|||
130327948|NCT00790842|469171614|FG008|Dose Level 4|Adverse Event|0|||
130327949|NCT00790842|469171615|FG009|Dose Level 4|Adverse Event|0|||
130327950|NCT00790842|469171616|FG010|Dose Level 4|Adverse Event|0|||
130327951|NCT00790842|469171606|FG000|Dose Level 4|Physician Decision|0|||
130327952|NCT00790842|469171607|FG001|Dose Level 4|Physician Decision|0|||
130327953|NCT00790842|469171608|FG002|Dose Level 4|Physician Decision|0|||
130327954|NCT00790842|469171609|FG003|Dose Level 4|Physician Decision|0|||
130327955|NCT00790842|469171610|FG004|Dose Level 4|Physician Decision|0|||
130327956|NCT00790842|469171611|FG005|Dose Level 4|Physician Decision|0|||
130327957|NCT00790842|469171612|FG006|Dose Level 4|Physician Decision|1|||
130327958|NCT00790842|469171613|FG007|Dose Level 4|Physician Decision|0|||
130327959|NCT00790842|469171614|FG008|Dose Level 4|Physician Decision|0|||
130327960|NCT00790842|469171615|FG009|Dose Level 4|Physician Decision|0|||
130327961|NCT00790842|469171616|FG010|Dose Level 4|Physician Decision|1|||
130327962|NCT00790842|469171606|FG000|Dose Level 4|Withdrawal by Subject|0|||
130327963|NCT00790842|469171607|FG001|Dose Level 4|Withdrawal by Subject|0|||
130327964|NCT00790842|469171608|FG002|Dose Level 4|Withdrawal by Subject|0|||
130327965|NCT00790842|469171609|FG003|Dose Level 4|Withdrawal by Subject|0|||
130327966|NCT00790842|469171610|FG004|Dose Level 4|Withdrawal by Subject|0|||
130327967|NCT00790842|469171611|FG005|Dose Level 4|Withdrawal by Subject|0|||
130327968|NCT00790842|469171612|FG006|Dose Level 4|Withdrawal by Subject|0|||
130327969|NCT00790842|469171613|FG007|Dose Level 4|Withdrawal by Subject|0|||
130327970|NCT00790842|469171614|FG008|Dose Level 4|Withdrawal by Subject|0|||
130327971|NCT00790842|469171615|FG009|Dose Level 4|Withdrawal by Subject|0|||
130327972|NCT00790842|469171616|FG010|Dose Level 4|Withdrawal by Subject|1|||
130327973|NCT00790842|469171606|FG000|Expansion Cohort|Adverse Event|0|||
130327974|NCT00790842|469171607|FG001|Expansion Cohort|Adverse Event|0|||
130327975|NCT00790842|469171608|FG002|Expansion Cohort|Adverse Event|0|||
130327976|NCT00790842|469171609|FG003|Expansion Cohort|Adverse Event|0|||
130327977|NCT00790842|469171610|FG004|Expansion Cohort|Adverse Event|0|||
130327978|NCT00790842|469171611|FG005|Expansion Cohort|Adverse Event|0|||
130327979|NCT00790842|469171612|FG006|Expansion Cohort|Adverse Event|1|||
130327980|NCT00790842|469171613|FG007|Expansion Cohort|Adverse Event|0|||
130327981|NCT00790842|469171614|FG008|Expansion Cohort|Adverse Event|0|||
130327982|NCT00790842|469171615|FG009|Expansion Cohort|Adverse Event|0|||
130327983|NCT00790842|469171616|FG010|Expansion Cohort|Adverse Event|0|||
130327984|NCT00790842|469171606|FG000|Expansion Cohort|Death|0|||
130327985|NCT00790842|469171607|FG001|Expansion Cohort|Death|0|||
130327986|NCT00790842|469171608|FG002|Expansion Cohort|Death|2|||
130327987|NCT00790842|469171609|FG003|Expansion Cohort|Death|0|||
130327988|NCT00790842|469171610|FG004|Expansion Cohort|Death|0|||
130327989|NCT00790842|469171611|FG005|Expansion Cohort|Death|0|||
130327990|NCT00790842|469171612|FG006|Expansion Cohort|Death|0|||
130327991|NCT00790842|469171613|FG007|Expansion Cohort|Death|0|||
130327992|NCT00790842|469171614|FG008|Expansion Cohort|Death|0|||
130327993|NCT00790842|469171615|FG009|Expansion Cohort|Death|0|||
130327994|NCT00790842|469171616|FG010|Expansion Cohort|Death|0|||
130327995|NCT00790842|469171606|FG000|Expansion Cohort|Physician Decision|0|||
130327996|NCT00790842|469171607|FG001|Expansion Cohort|Physician Decision|0|||
130327997|NCT00790842|469171608|FG002|Expansion Cohort|Physician Decision|1|||
130327998|NCT00790842|469171609|FG003|Expansion Cohort|Physician Decision|0|||
130327999|NCT00790842|469171610|FG004|Expansion Cohort|Physician Decision|0|||
130328000|NCT00790842|469171611|FG005|Expansion Cohort|Physician Decision|0|||
130328001|NCT00790842|469171612|FG006|Expansion Cohort|Physician Decision|0|||
130328002|NCT00790842|469171613|FG007|Expansion Cohort|Physician Decision|0|||
130328003|NCT00790842|469171614|FG008|Expansion Cohort|Physician Decision|0|||
130328004|NCT00790842|469171615|FG009|Expansion Cohort|Physician Decision|0|||
130328005|NCT00790842|469171616|FG010|Expansion Cohort|Physician Decision|0|||
130328006|NCT00790842|469171606|FG000|Expansion Cohort|Withdrawal by Subject|0|||
130328007|NCT00790842|469171607|FG001|Expansion Cohort|Withdrawal by Subject|0|||
130328008|NCT00790842|469171608|FG002|Expansion Cohort|Withdrawal by Subject|3|||
130328009|NCT00790842|469171609|FG003|Expansion Cohort|Withdrawal by Subject|0|||
130328010|NCT00790842|469171610|FG004|Expansion Cohort|Withdrawal by Subject|0|||
130328011|NCT00790842|469171611|FG005|Expansion Cohort|Withdrawal by Subject|0|||
130328012|NCT00790842|469171612|FG006|Expansion Cohort|Withdrawal by Subject|0|||
130328013|NCT00790842|469171613|FG007|Expansion Cohort|Withdrawal by Subject|0|||
130328014|NCT00790842|469171614|FG008|Expansion Cohort|Withdrawal by Subject|0|||
130328015|NCT00790842|469171615|FG009|Expansion Cohort|Withdrawal by Subject|0|||
130328016|NCT00790842|469171616|FG010|Expansion Cohort|Withdrawal by Subject|0|||
130328017|NCT00790842|469171606|FG000|Expansion Cohort|Study Closure|0|||
130328018|NCT00790842|469171607|FG001|Expansion Cohort|Study Closure|0|||
130328019|NCT00790842|469171608|FG002|Expansion Cohort|Study Closure|1|||
130328020|NCT00790842|469171609|FG003|Expansion Cohort|Study Closure|0|||
130328021|NCT00790842|469171610|FG004|Expansion Cohort|Study Closure|0|||
130328022|NCT00790842|469171611|FG005|Expansion Cohort|Study Closure|0|||
130328023|NCT00790842|469171612|FG006|Expansion Cohort|Study Closure|0|||
130328024|NCT00790842|469171613|FG007|Expansion Cohort|Study Closure|0|||
130328025|NCT00790842|469171614|FG008|Expansion Cohort|Study Closure|0|||
130328026|NCT00790842|469171615|FG009|Expansion Cohort|Study Closure|0|||
130328027|NCT00790842|469171616|FG010|Expansion Cohort|Study Closure|0|||
130328028|NCT00419952|469171617|FG000|Overall Study|Adverse Event|8|||
130328029|NCT00419952|469171618|FG001|Overall Study|Adverse Event|10|||
130328030|NCT00419952|469171617|FG000|Overall Study|Withdrawal by Subject|44|||
130328031|NCT00419952|469171618|FG001|Overall Study|Withdrawal by Subject|43|||
130328032|NCT00419952|469171617|FG000|Overall Study|Lost to Follow-up|43|||
130328033|NCT00419952|469171618|FG001|Overall Study|Lost to Follow-up|34|||
130328034|NCT00419952|469171617|FG000|Overall Study|Protocol Violation|32|||
130328035|NCT00419952|469171618|FG001|Overall Study|Protocol Violation|24|||
130328036|NCT00419952|469171617|FG000|Overall Study|Pregnancy|4|||
130328037|NCT00419952|469171618|FG001|Overall Study|Pregnancy|2|||
130328038|NCT00419952|469171617|FG000|Overall Study|Physician Decision|1|||
130328039|NCT00419952|469171618|FG001|Overall Study|Physician Decision|3|||
130328040|NCT00419952|469171617|FG000|Overall Study|Incorrectly enrolled|10|||
130328041|NCT00419952|469171618|FG001|Overall Study|Incorrectly enrolled|3|||
130328042|NCT00419952|469171617|FG000|Overall Study|Intake of prohibited medication|2|||
130328043|NCT00419952|469171618|FG001|Overall Study|Intake of prohibited medication|2|||
130328044|NCT00419952|469171617|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
130328045|NCT00419952|469171618|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
130328046|NCT00419952|469171617|FG000|Overall Study|Diary or medication non-compliance|2|||
130328047|NCT00419952|469171618|FG001|Overall Study|Diary or medication non-compliance|4|||
130328048|NCT00419952|469171617|FG000|Overall Study|Abnormal ECG|1|||
130328049|NCT00419952|469171618|FG001|Overall Study|Abnormal ECG|0|||
130328050|NCT03126591|469171619|FG000|Overall Study|Death|6|||
130328051|NCT03126591|469171620|FG001|Overall Study|Death|3|||
130328052|NCT03126591|469171621|FG002|Overall Study|Death|17|||
130328053|NCT03126591|469171619|FG000|Overall Study|Progressive Disease|0|||
130328054|NCT03126591|469171620|FG001|Overall Study|Progressive Disease|1|||
130328055|NCT03126591|469171621|FG002|Overall Study|Progressive Disease|2|||
130328056|NCT03126591|469171619|FG000|Overall Study|Terminated by Sponsor|0|||
130657841|NCT00902486|470369377|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130657842|NCT00902486|470369378|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130657843|NCT00902486|470369379|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
130328057|NCT03126591|469171620|FG001|Overall Study|Terminated by Sponsor|1|||
130328058|NCT03126591|469171621|FG002|Overall Study|Terminated by Sponsor|4|||
130328059|NCT03126591|469171619|FG000|Overall Study|Withdrawal by Subject|1|||
130328060|NCT03126591|469171620|FG001|Overall Study|Withdrawal by Subject|1|||
130328061|NCT03126591|469171621|FG002|Overall Study|Withdrawal by Subject|4|||
130328062|NCT02158546|469171622|FG000|Overall Study|Physician Decision|0|||
130328063|NCT02158546|469171623|FG001|Overall Study|Physician Decision|1|||
130328064|NCT02158546|469171624|FG002|Overall Study|Physician Decision|0|||
130328065|NCT02158546|469171625|FG003|Overall Study|Physician Decision|0|||
130328066|NCT02158546|469171622|FG000|Overall Study|Non-compliance|0|||
130328067|NCT02158546|469171623|FG001|Overall Study|Non-compliance|1|||
130328068|NCT02158546|469171624|FG002|Overall Study|Non-compliance|0|||
130328069|NCT02158546|469171625|FG003|Overall Study|Non-compliance|1|||
130328070|NCT02158546|469171622|FG000|Overall Study|Failure to meet eligibility criteria|0|||
130215611|NCT00262002|468751780|FG003|Overall Study|Withdrawal by Subject|1|||
130328071|NCT02158546|469171623|FG001|Overall Study|Failure to meet eligibility criteria|1|||
130328072|NCT02158546|469171624|FG002|Overall Study|Failure to meet eligibility criteria|0|||
130328073|NCT02158546|469171625|FG003|Overall Study|Failure to meet eligibility criteria|0|||
130328074|NCT02158546|469171622|FG000|Overall Study|Lack of Efficacy|1|||
130328075|NCT02158546|469171623|FG001|Overall Study|Lack of Efficacy|1|||
130328076|NCT02158546|469171624|FG002|Overall Study|Lack of Efficacy|0|||
130328077|NCT02158546|469171625|FG003|Overall Study|Lack of Efficacy|0|||
130328078|NCT02158546|469171622|FG000|Overall Study|Adverse Event|2|||
130328079|NCT02158546|469171623|FG001|Overall Study|Adverse Event|2|||
130657844|NCT00902486|470369380|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130657845|NCT00902486|470369381|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130657846|NCT00902486|470369382|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130657847|NCT00902486|470369377|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
130657848|NCT00902486|470369378|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
130657849|NCT00902486|470369379|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
130657850|NCT00902486|470369380|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
130657851|NCT00902486|470369381|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
130657852|NCT00902486|470369382|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
130657853|NCT02332655|470369383|FG000|Overall Study|Lack of Efficacy|1|||
130657854|NCT01298661|470369384|FG000|Overall Study|Withdrawal by Subject|2|||
130657855|NCT01298661|470369385|FG001|Overall Study|Withdrawal by Subject|0|||
130657856|NCT01298661|470369386|FG002|Overall Study|Withdrawal by Subject|2|||
130657857|NCT01525407|470369387|FG000|Overall Study|Change in recipient treatment plan|2|||
130657858|NCT01525407|470369388|FG001|Overall Study|Change in recipient treatment plan|2|||
130657859|NCT01525407|470369387|FG000|Overall Study|Withdrawal by Subject|0|||
130657860|NCT01525407|470369388|FG001|Overall Study|Withdrawal by Subject|1|||
130657861|NCT01525407|470369387|FG000|Overall Study|Transplant was delayed|0|||
130657862|NCT01525407|470369388|FG001|Overall Study|Transplant was delayed|1|||
130657863|NCT01525407|470369387|FG000|Overall Study|Delay in Transplant|1|||
130657864|NCT01525407|470369388|FG001|Overall Study|Delay in Transplant|0|||
130657865|NCT02729545|470370984|FG000|Overall Study|Pregnancy|1|||
130657866|NCT02729545|470370985|FG001|Overall Study|Pregnancy|1|||
130657867|NCT02729545|470370984|FG000|Overall Study|Lost to Follow-up|0|||
130657868|NCT02729545|470370985|FG001|Overall Study|Lost to Follow-up|1|||
130657869|NCT02729545|470370984|FG000|Overall Study|Withdrawal by Subject|2|||
130657870|NCT02729545|470370985|FG001|Overall Study|Withdrawal by Subject|3|||
130657871|NCT00398632|470370986|FG000|Overall Study|Withdrawal by Subject|1|||
130657872|NCT00398632|470370986|FG000|Overall Study|Lack of Efficacy|1|||
130657873|NCT00366678|470370989|FG000|Infant Series|Withdrawal by Subject|8|||
130657874|NCT00366678|470370990|FG001|Infant Series|Withdrawal by Subject|6|||
130657875|NCT00366678|470370991|FG002|Infant Series|Withdrawal by Subject|0|||
130657876|NCT00366678|470370989|FG000|Infant Series|Protocol Violation|4|||
130657877|NCT00366678|470370990|FG001|Infant Series|Protocol Violation|3|||
130657878|NCT00366678|470370991|FG002|Infant Series|Protocol Violation|0|||
130657879|NCT00366678|470370989|FG000|Infant Series|Failed to return|1|||
130657880|NCT00366678|470370990|FG001|Infant Series|Failed to return|1|||
130657881|NCT00366678|470370991|FG002|Infant Series|Failed to return|0|||
130657882|NCT00366678|470370989|FG000|Infant Series|Adverse Event|1|||
130657883|NCT00366678|470370990|FG001|Infant Series|Adverse Event|0|||
130657884|NCT00366678|470370991|FG002|Infant Series|Adverse Event|0|||
130657885|NCT00366678|470370989|FG000|After Infant|Withdrawal by Subject|8|||
130657886|NCT00366678|470370990|FG001|After Infant|Withdrawal by Subject|4|||
130657887|NCT00366678|470370991|FG002|After Infant|Withdrawal by Subject|0|||
130657888|NCT00366678|470370989|FG000|After Infant|Lost to Follow-up|2|||
130657889|NCT00366678|470370990|FG001|After Infant|Lost to Follow-up|1|||
130328080|NCT02158546|469171624|FG002|Overall Study|Adverse Event|0|||
130328081|NCT02158546|469171625|FG003|Overall Study|Adverse Event|0|||
130328082|NCT02158546|469171622|FG000|Overall Study|Withdrawal by Subject|6|||
130328083|NCT02158546|469171623|FG001|Overall Study|Withdrawal by Subject|2|||
130328084|NCT02158546|469171624|FG002|Overall Study|Withdrawal by Subject|1|||
130328085|NCT02158546|469171625|FG003|Overall Study|Withdrawal by Subject|0|||
130328086|NCT02158546|469171622|FG000|Overall Study|Lost to Follow-up|5|||
130328087|NCT02158546|469171623|FG001|Overall Study|Lost to Follow-up|4|||
130328088|NCT02158546|469171624|FG002|Overall Study|Lost to Follow-up|0|||
130328089|NCT02158546|469171625|FG003|Overall Study|Lost to Follow-up|1|||
130328090|NCT02158546|469171622|FG000|Overall Study|Site Excluded|5|||
130328091|NCT02158546|469171623|FG001|Overall Study|Site Excluded|5|||
130328092|NCT02158546|469171624|FG002|Overall Study|Site Excluded|3|||
130328093|NCT02158546|469171625|FG003|Overall Study|Site Excluded|4|||
130328094|NCT02351817|469171626|FG000|Period 1|Adverse Event|1|||
130328095|NCT02351817|469171627|FG001|Period 1|Adverse Event|2|||
130657890|NCT00366678|470370991|FG002|After Infant|Lost to Follow-up|0|||
130657891|NCT00366678|470370989|FG000|After Infant|Failed to return|5|||
130657892|NCT00366678|470370990|FG001|After Infant|Failed to return|5|||
130657893|NCT00366678|470370991|FG002|After Infant|Failed to return|0|||
130657894|NCT00366678|470370989|FG000|After Infant|Adverse Event|1|||
130657895|NCT00366678|470370990|FG001|After Infant|Adverse Event|0|||
130657896|NCT00366678|470370991|FG002|After Infant|Adverse Event|0|||
130657897|NCT00366678|470370989|FG000|After Infant|Protocol Violation|1|||
130657898|NCT00366678|470370990|FG001|After Infant|Protocol Violation|0|||
130657899|NCT00366678|470370991|FG002|After Infant|Protocol Violation|0|||
130657900|NCT00366678|470370989|FG000|Toddler Dose|Protocol Violation|2|||
130328096|NCT02351817|469171626|FG000|Period 1|Lack of Efficacy|0|||
130328097|NCT02351817|469171627|FG001|Period 1|Lack of Efficacy|1|||
130328098|NCT02351817|469171626|FG000|Period 2|Adverse Event|0|||
130328099|NCT02351817|469171627|FG001|Period 2|Adverse Event|2|||
130657901|NCT00366678|470370990|FG001|Toddler Dose|Protocol Violation|1|||
130657902|NCT00366678|470370991|FG002|Toddler Dose|Protocol Violation|0|||
130657903|NCT00366678|470370989|FG000|Toddler Dose|Failed to return|1|||
130657904|NCT00366678|470370990|FG001|Toddler Dose|Failed to return|0|||
130657905|NCT00366678|470370991|FG002|Toddler Dose|Failed to return|0|||
130657906|NCT00366678|470370989|FG000|Toddler Dose|Withdrawal by Subject|1|||
130657907|NCT00366678|470370990|FG001|Toddler Dose|Withdrawal by Subject|0|||
130657908|NCT00366678|470370991|FG002|Toddler Dose|Withdrawal by Subject|0|||
130657909|NCT00366678|470370989|FG000|Toddler Dose|protocol deviation|1|||
130657910|NCT00366678|470370990|FG001|Toddler Dose|protocol deviation|0|||
130657911|NCT00366678|470370991|FG002|Toddler Dose|protocol deviation|0|||
130657912|NCT04292171|470370992|FG000|Overall Study|Pharmacy error|2|||
130657913|NCT04292171|470370993|FG001|Overall Study|Pharmacy error|0|||
130657914|NCT04292171|470370992|FG000|Overall Study|Delivered prior to procedure|0|||
130657915|NCT04292171|470370993|FG001|Overall Study|Delivered prior to procedure|1|||
130657916|NCT03976076|470370994|FG000|Overall Study|Withdrawal by Subject|2|||
130657917|NCT03292731|470370995|FG000|Overall Study|Protocol Violation|4|||
130657918|NCT03292731|470370996|FG001|Overall Study|Protocol Violation|11|||
130657919|NCT03292731|470370997|FG002|Overall Study|Protocol Violation|1|||
130657920|NCT01965431|470370998|FG000|Overall Study|Adverse Event|0|||
130657921|NCT01965431|470370999|FG001|Overall Study|Adverse Event|1|||
130657922|NCT01965431|470371000|FG002|Overall Study|Adverse Event|0|||
130657923|NCT01965431|470371001|FG003|Overall Study|Adverse Event|0|||
130657924|NCT01965431|470371002|FG004|Overall Study|Adverse Event|0|||
130657925|NCT01965431|470371003|FG005|Overall Study|Adverse Event|0|||
130657926|NCT01965431|470370998|FG000|Overall Study|Other than stated above|6|||
130657927|NCT01965431|470370999|FG001|Overall Study|Other than stated above|5|||
130657928|NCT01965431|470371000|FG002|Overall Study|Other than stated above|6|||
130657929|NCT01965431|470371001|FG003|Overall Study|Other than stated above|6|||
130657930|NCT01965431|470371002|FG004|Overall Study|Other than stated above|6|||
130657931|NCT01965431|470371003|FG005|Overall Study|Other than stated above|6|||
130657932|NCT01803464|470371008|FG000|Overall Study|Incomplete data|0|||
130657933|NCT01803464|470371009|FG001|Overall Study|Incomplete data|0|||
130657934|NCT01803464|470371010|FG002|Overall Study|Incomplete data|4|||
130657935|NCT01803464|470371011|FG003|Overall Study|Incomplete data|0|||
130657936|NCT01803464|470371008|FG000|Overall Study|Withdrawal by Subject|1|||
130657937|NCT01803464|470371009|FG001|Overall Study|Withdrawal by Subject|0|||
130657938|NCT01803464|470371010|FG002|Overall Study|Withdrawal by Subject|0|||
130657939|NCT01803464|470371011|FG003|Overall Study|Withdrawal by Subject|0|||
130657940|NCT02860039|470371017|FG000|Overall Study|Death|4|||
130657941|NCT02860039|470371018|FG001|Overall Study|Death|0|||
130657942|NCT02860039|470371017|FG000|Overall Study|Lost to Follow-up|2|||
130657943|NCT02860039|470371018|FG001|Overall Study|Lost to Follow-up|2|||
130657944|NCT02860039|470371017|FG000|Overall Study|Protocol Violation|3|||
130657945|NCT02860039|470371018|FG001|Overall Study|Protocol Violation|1|||
130657946|NCT02860039|470371017|FG000|Overall Study|Withdrawal by Subject|1|||
130657947|NCT02860039|470371018|FG001|Overall Study|Withdrawal by Subject|0|||
130657948|NCT02860039|470371017|FG000|Overall Study|Not otherwise eligible|1|||
130657949|NCT02860039|470371018|FG001|Overall Study|Not otherwise eligible|1|||
130657950|NCT01360021|470371019|FG000|Overall Study|Eligibility criteria + other|2|||
130657951|NCT01360021|470371020|FG001|Overall Study|Eligibility criteria + other|1|||
130657952|NCT01360021|470371021|FG002|Overall Study|Eligibility criteria + other|1|||
130657953|NCT01360021|470371019|FG000|Overall Study|Protocol Violation|0|||
130657954|NCT01360021|470371020|FG001|Overall Study|Protocol Violation|0|||
130657955|NCT01360021|470371021|FG002|Overall Study|Protocol Violation|1|||
130657956|NCT01360021|470371019|FG000|Overall Study|Withdrawal by Subject|4|||
130657957|NCT01360021|470371020|FG001|Overall Study|Withdrawal by Subject|0|||
130657958|NCT01360021|470371021|FG002|Overall Study|Withdrawal by Subject|2|||
130657959|NCT01360021|470371019|FG000|Overall Study|Adverse Event|2|||
130657960|NCT01360021|470371020|FG001|Overall Study|Adverse Event|3|||
130657961|NCT01360021|470371021|FG002|Overall Study|Adverse Event|3|||
130657962|NCT01257737|470371023|FG000|Overall Study|Lost to Follow-up|1|||
130657963|NCT01257737|470371024|FG001|Overall Study|Lost to Follow-up|2|||
130657964|NCT01257737|470371023|FG000|Overall Study|Liver transplant|1|||
130657965|NCT01257737|470371024|FG001|Overall Study|Liver transplant|0|||
130657966|NCT01257737|470371023|FG000|Overall Study|Relocation out of the country|0|||
130657967|NCT01257737|470371024|FG001|Overall Study|Relocation out of the country|1|||
130657968|NCT01257737|470371023|FG000|Overall Study|Withdrew from study|0|||
130657969|NCT01257737|470371024|FG001|Overall Study|Withdrew from study|1|||
130657970|NCT03170271|470371028|FG000|Overall Study|Adverse Event|7|||
130657971|NCT03170271|470371029|FG001|Overall Study|Adverse Event|2|||
130657972|NCT03170271|470371028|FG000|Overall Study|Lost to Follow-up|0|||
130657973|NCT03170271|470371029|FG001|Overall Study|Lost to Follow-up|1|||
130657974|NCT03170271|470371028|FG000|Overall Study|Physician Decision|1|||
130657975|NCT03170271|470371029|FG001|Overall Study|Physician Decision|0|||
130657976|NCT03170271|470371028|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
130657977|NCT03170271|470371029|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
130657978|NCT03170271|470371028|FG000|Overall Study|Withdrawal by Subject|17|||
130328100|NCT02351817|469171626|FG000|Period 2|Protocol Violation|1|||
130328101|NCT02351817|469171627|FG001|Period 2|Protocol Violation|0|||
130328102|NCT02488915|469171630|FG000|Overall Study|Death|21|||
130328103|NCT02488915|469171630|FG000|Overall Study|Lost to Follow-up|4|||
130328104|NCT02488915|469171630|FG000|Overall Study|Withdrawal by Subject|1|||
130328105|NCT02976038|469171631|FG000|Overall Study|Physician Decision|22|||
130328106|NCT02976038|469171631|FG000|Overall Study|Withdrawal by Subject|3|||
130328107|NCT02976038|469171631|FG000|Overall Study|Lost to Follow-up|2|||
130328108|NCT02976038|469171631|FG000|Overall Study|Adverse Event|1|||
130328109|NCT01046396|469171632|FG000|Overall Study|Withdrawal by Subject|5|||
130328110|NCT01208207|469171633|FG000|Part I|Adverse Event|19|||
130328111|NCT01208207|469171634|FG001|Part I|Adverse Event|2|||
130657979|NCT03170271|470371029|FG001|Overall Study|Withdrawal by Subject|5|||
130657980|NCT03170271|470371028|FG000|Overall Study|Other|2|||
130657981|NCT03170271|470371029|FG001|Overall Study|Other|2|||
130657982|NCT03170271|470371028|FG000|Overall Study|Randomized in error|4|||
130657983|NCT03170271|470371029|FG001|Overall Study|Randomized in error|0|||
130657984|NCT03123120|470371033|FG000|Overall Study|Lost to Follow-up|0|||
130328112|NCT01208207|469171635|FG002|Part I|Adverse Event|6|||
130328113|NCT01208207|469171636|FG003|Part I|Adverse Event|0|||
130328114|NCT01208207|469171637|FG004|Part I|Adverse Event|0|||
130328115|NCT01208207|469171638|FG005|Part I|Adverse Event|0|||
130328116|NCT01208207|469171639|FG006|Part I|Adverse Event|0|||
130328117|NCT01208207|469171633|FG000|Part I|Lack of Efficacy|21|||
130328118|NCT01208207|469171634|FG001|Part I|Lack of Efficacy|3|||
130328119|NCT01208207|469171635|FG002|Part I|Lack of Efficacy|2|||
130328120|NCT01208207|469171636|FG003|Part I|Lack of Efficacy|0|||
130328121|NCT01208207|469171637|FG004|Part I|Lack of Efficacy|0|||
130657985|NCT03123120|470371034|FG001|Overall Study|Lost to Follow-up|1|||
130657986|NCT03123120|470371033|FG000|Overall Study|Withdrawal by Subject|0|||
130657987|NCT03123120|470371034|FG001|Overall Study|Withdrawal by Subject|1|||
130657988|NCT00203892|470371035|FG000|Overall Study|Physician Decision|1|||
130657989|NCT00203892|470371036|FG001|Overall Study|Physician Decision|2|||
130657990|NCT00203892|470371037|FG002|Overall Study|Physician Decision|0|||
130657991|NCT00203892|470371035|FG000|Overall Study|Death|1|||
130657992|NCT00203892|470371036|FG001|Overall Study|Death|0|||
130657993|NCT00203892|470371037|FG002|Overall Study|Death|0|||
130657994|NCT00806416|470371038|FG000|Period 1 - Part I|Adverse Event|0|||
130657995|NCT00806416|470371039|FG001|Period 1 - Part I|Adverse Event|1|||
130657996|NCT00806416|470371040|FG002|Period 1 - Part I|Adverse Event|0|||
130657997|NCT00806416|470371041|FG003|Period 1 - Part I|Adverse Event|0|||
130657998|NCT00806416|470371038|FG000|Period 1 - Part I|Lost to Follow-up|0|||
130657999|NCT00806416|470371039|FG001|Period 1 - Part I|Lost to Follow-up|2|||
130658000|NCT00806416|470371040|FG002|Period 1 - Part I|Lost to Follow-up|0|||
130658001|NCT00806416|470371041|FG003|Period 1 - Part I|Lost to Follow-up|0|||
130658002|NCT00806416|470371038|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
130658003|NCT00806416|470371039|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
130658004|NCT00806416|470371040|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
130658005|NCT00806416|470371041|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
130658006|NCT00806416|470371038|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
130658007|NCT00806416|470371039|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
130658008|NCT00806416|470371040|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
130658009|NCT00806416|470371041|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
130658010|NCT01244516|470371046|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
130328122|NCT01208207|469171638|FG005|Part I|Lack of Efficacy|0|||
130328123|NCT01208207|469171639|FG006|Part I|Lack of Efficacy|0|||
130328124|NCT01208207|469171633|FG000|Part I|Lost to Follow-up|6|||
130328125|NCT01208207|469171634|FG001|Part I|Lost to Follow-up|1|||
130328126|NCT01208207|469171635|FG002|Part I|Lost to Follow-up|0|||
130328127|NCT01208207|469171636|FG003|Part I|Lost to Follow-up|0|||
130328128|NCT01208207|469171637|FG004|Part I|Lost to Follow-up|0|||
130328129|NCT01208207|469171638|FG005|Part I|Lost to Follow-up|0|||
130328130|NCT01208207|469171639|FG006|Part I|Lost to Follow-up|0|||
130328131|NCT01208207|469171633|FG000|Part I|Non-Compliance With Study Drug|1|||
130658011|NCT01244516|470371047|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
130658012|NCT01244516|470371048|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
130658013|NCT01244516|470371046|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
130658014|NCT01244516|470371047|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
130328132|NCT01208207|469171634|FG001|Part I|Non-Compliance With Study Drug|0|||
130328133|NCT01208207|469171635|FG002|Part I|Non-Compliance With Study Drug|1|||
130328134|NCT01208207|469171636|FG003|Part I|Non-Compliance With Study Drug|0|||
130328135|NCT01208207|469171637|FG004|Part I|Non-Compliance With Study Drug|0|||
130328136|NCT01208207|469171638|FG005|Part I|Non-Compliance With Study Drug|0|||
130328137|NCT01208207|469171639|FG006|Part I|Non-Compliance With Study Drug|0|||
130328138|NCT01208207|469171633|FG000|Part I|Physician Decision|0|||
130328139|NCT01208207|469171634|FG001|Part I|Physician Decision|1|||
130328140|NCT01208207|469171635|FG002|Part I|Physician Decision|0|||
130658015|NCT01244516|470371048|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
130658016|NCT01244516|470371046|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
130658017|NCT01244516|470371047|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
130658018|NCT01244516|470371048|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
130658019|NCT01244516|470371046|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
130658020|NCT01244516|470371047|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
130658021|NCT01244516|470371048|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
130658022|NCT01244516|470371046|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
130658023|NCT01244516|470371047|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
130658024|NCT01244516|470371048|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
130658025|NCT01244516|470371046|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
130658026|NCT01244516|470371047|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
130658027|NCT01244516|470371048|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
130658028|NCT01244516|470371046|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
130658029|NCT01244516|470371047|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
130658030|NCT01244516|470371048|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
130658031|NCT03345485|470371051|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
130658032|NCT03345485|470371052|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
130658033|NCT03345485|470371053|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
130658034|NCT03345485|470371054|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
130658035|NCT03345485|470371055|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
130658036|NCT03345485|470371056|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
130658037|NCT03345485|470371057|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
130658038|NCT03345485|470371058|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
130658039|NCT03345485|470371059|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
130658040|NCT03345485|470371060|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
130658041|NCT03345485|470371061|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
130658042|NCT03345485|470371062|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
130658043|NCT03345485|470371063|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
130658044|NCT03359473|470371064|FG000|Overall Study|Adverse Event|0|||
130658045|NCT03359473|470371065|FG001|Overall Study|Adverse Event|2|||
130658046|NCT03359473|470371066|FG002|Overall Study|Adverse Event|5|||
130658047|NCT03359473|470371067|FG003|Overall Study|Adverse Event|3|||
130658048|NCT03359473|470371064|FG000|Overall Study|Lost to Follow-up|0|||
130658049|NCT03359473|470371065|FG001|Overall Study|Lost to Follow-up|1|||
130658050|NCT03359473|470371066|FG002|Overall Study|Lost to Follow-up|0|||
130658051|NCT03359473|470371067|FG003|Overall Study|Lost to Follow-up|0|||
130658052|NCT03359473|470371064|FG000|Overall Study|Physician Decision|0|||
130658053|NCT03359473|470371065|FG001|Overall Study|Physician Decision|1|||
130658054|NCT03359473|470371066|FG002|Overall Study|Physician Decision|0|||
130658055|NCT03359473|470371067|FG003|Overall Study|Physician Decision|1|||
130658056|NCT03359473|470371064|FG000|Overall Study|Withdrawal by Subject|1|||
130658057|NCT03359473|470371065|FG001|Overall Study|Withdrawal by Subject|2|||
130658058|NCT03359473|470371066|FG002|Overall Study|Withdrawal by Subject|1|||
130658059|NCT03359473|470371067|FG003|Overall Study|Withdrawal by Subject|0|||
130658060|NCT03359473|470371064|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130658061|NCT03359473|470371065|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130658062|NCT03359473|470371066|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130658063|NCT03359473|470371067|FG003|Overall Study|Protocol-defined stopping criteria|1|||
130658064|NCT05302414|470371068|FG000|Pretest to Posttest|Lost to Follow-up|12|||
130658065|NCT05302414|470371069|FG001|Pretest to Posttest|Lost to Follow-up|8|||
130658066|NCT05302414|470371070|FG002|Pretest to Posttest|Lost to Follow-up|8|||
130658067|NCT05302414|470371068|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130658068|NCT05302414|470371069|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130658069|NCT05302414|470371070|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130658070|NCT01610284|470371071|FG000|Randomization Phase|Adverse Event|1|||
130658071|NCT01610284|470371072|FG001|Randomization Phase|Adverse Event|0|||
130658072|NCT01610284|470371071|FG000|Randomization Phase|Physician Decision|1|||
130658073|NCT01610284|470371072|FG001|Randomization Phase|Physician Decision|1|||
130658074|NCT01610284|470371071|FG000|Randomization Phase|Death|0|||
130658075|NCT01610284|470371072|FG001|Randomization Phase|Death|1|||
130658076|NCT01610284|470371071|FG000|Treatment Phase|Adverse Event|80|||
130658077|NCT01610284|470371072|FG001|Treatment Phase|Adverse Event|12|||
130658078|NCT01610284|470371071|FG000|Treatment Phase|Lost to Follow-up|1|||
130658079|NCT01610284|470371072|FG001|Treatment Phase|Lost to Follow-up|0|||
130658080|NCT01610284|470371071|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
130658081|NCT01610284|470371072|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
130658082|NCT01610284|470371071|FG000|Treatment Phase|Physician Decision|27|||
130658083|NCT01610284|470371072|FG001|Treatment Phase|Physician Decision|24|||
130658084|NCT01610284|470371071|FG000|Treatment Phase|Progressive Disease|377|||
130658085|NCT01610284|470371072|FG001|Treatment Phase|Progressive Disease|486|||
130658086|NCT01610284|470371071|FG000|Treatment Phase|Protocol Deviation|2|||
130658087|NCT01610284|470371072|FG001|Treatment Phase|Protocol Deviation|3|||
130658088|NCT01610284|470371071|FG000|Treatment Phase|Study terminated by Sponsor|18|||
130658089|NCT01610284|470371072|FG001|Treatment Phase|Study terminated by Sponsor|15|||
130658090|NCT01610284|470371071|FG000|Treatment Phase|Subject/Guardian Decision|55|||
130658091|NCT01610284|470371072|FG001|Treatment Phase|Subject/Guardian Decision|23|||
130658092|NCT01610284|470371071|FG000|Treatment Phase|Death|6|||
130658093|NCT01610284|470371072|FG001|Treatment Phase|Death|5|||
130658094|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
130658095|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130658096|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
130658097|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
130328141|NCT01208207|469171636|FG003|Part I|Physician Decision|0|||
130328142|NCT01208207|469171637|FG004|Part I|Physician Decision|0|||
130328143|NCT01208207|469171638|FG005|Part I|Physician Decision|0|||
130328144|NCT01208207|469171639|FG006|Part I|Physician Decision|0|||
130328145|NCT01208207|469171633|FG000|Part I|Progressive Disease|1|||
130658098|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
130658099|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
130658100|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
130658101|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130658102|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
130658103|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
130658104|NCT01610284|470371071|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
130658105|NCT01610284|470371072|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
130658106|NCT01125358|470371078|FG000|Overall Study|Adverse Event|3|||
130658107|NCT01125358|470371079|FG001|Overall Study|Adverse Event|0|||
130658108|NCT01125358|470371080|FG002|Overall Study|Adverse Event|0|||
130658109|NCT01125358|470371081|FG003|Overall Study|Adverse Event|2|||
130658110|NCT01125358|470371078|FG000|Overall Study|Perceived Lack of Efficacy|6|||
130658111|NCT01125358|470371079|FG001|Overall Study|Perceived Lack of Efficacy|3|||
130658112|NCT01125358|470371080|FG002|Overall Study|Perceived Lack of Efficacy|7|||
130658113|NCT01125358|470371081|FG003|Overall Study|Perceived Lack of Efficacy|4|||
130658114|NCT01125358|470371078|FG000|Overall Study|Protocol Violation|1|||
130658115|NCT01125358|470371079|FG001|Overall Study|Protocol Violation|0|||
130658116|NCT01125358|470371080|FG002|Overall Study|Protocol Violation|0|||
130658117|NCT01125358|470371081|FG003|Overall Study|Protocol Violation|0|||
130658118|NCT01125358|470371078|FG000|Overall Study|Sponsor Decision|0|||
130658119|NCT01125358|470371079|FG001|Overall Study|Sponsor Decision|0|||
130658120|NCT01125358|470371080|FG002|Overall Study|Sponsor Decision|1|||
130658121|NCT01125358|470371081|FG003|Overall Study|Sponsor Decision|1|||
130658122|NCT01125358|470371078|FG000|Overall Study|Withdrawal by Subject|2|||
130658123|NCT01125358|470371079|FG001|Overall Study|Withdrawal by Subject|1|||
130658124|NCT01125358|470371080|FG002|Overall Study|Withdrawal by Subject|1|||
130658125|NCT01125358|470371081|FG003|Overall Study|Withdrawal by Subject|1|||
130658126|NCT01157065|470371082|FG000|Overall Study|Death|0|||
130328146|NCT01208207|469171634|FG001|Part I|Progressive Disease|0|||
130658127|NCT01157065|470371083|FG001|Overall Study|Death|1|||
130658128|NCT01060007|470371084|FG000|Overall Study|Withdrawal by Subject|1|||
130658129|NCT01060007|470371084|FG000|Overall Study|Inevaluable for response at surgery|3|||
130658130|NCT05168657|470371085|FG000|Overall Study|Adverse Event|0|||
130658131|NCT05168657|470371086|FG001|Overall Study|Adverse Event|0|||
130658132|NCT05168657|470371087|FG002|Overall Study|Adverse Event|1|||
130658133|NCT05168657|470371088|FG003|Overall Study|Adverse Event|0|||
130658134|NCT05168657|470371089|FG004|Overall Study|Adverse Event|0|||
130328147|NCT01208207|469171635|FG002|Part I|Progressive Disease|0|||
130328148|NCT01208207|469171636|FG003|Part I|Progressive Disease|0|||
130328149|NCT01208207|469171637|FG004|Part I|Progressive Disease|0|||
130328150|NCT01208207|469171638|FG005|Part I|Progressive Disease|0|||
130328151|NCT01208207|469171639|FG006|Part I|Progressive Disease|0|||
130328152|NCT01208207|469171633|FG000|Part I|Protocol Violation|8|||
130328153|NCT01208207|469171634|FG001|Part I|Protocol Violation|0|||
130328154|NCT01208207|469171635|FG002|Part I|Protocol Violation|2|||
130328155|NCT01208207|469171636|FG003|Part I|Protocol Violation|0|||
130328156|NCT01208207|469171637|FG004|Part I|Protocol Violation|0|||
130328157|NCT01208207|469171638|FG005|Part I|Protocol Violation|0|||
130328158|NCT01208207|469171639|FG006|Part I|Protocol Violation|0|||
130328159|NCT01208207|469171633|FG000|Part I|Withdrawal by Subject|14|||
130328160|NCT01208207|469171634|FG001|Part I|Withdrawal by Subject|4|||
130328161|NCT01208207|469171635|FG002|Part I|Withdrawal by Subject|4|||
130328162|NCT01208207|469171636|FG003|Part I|Withdrawal by Subject|0|||
130328163|NCT01208207|469171637|FG004|Part I|Withdrawal by Subject|0|||
130328164|NCT01208207|469171638|FG005|Part I|Withdrawal by Subject|0|||
130328165|NCT01208207|469171639|FG006|Part I|Withdrawal by Subject|0|||
130658135|NCT05168657|470371090|FG005|Overall Study|Adverse Event|0|||
130658136|NCT05168657|470371091|FG006|Overall Study|Adverse Event|0|||
130658137|NCT05168657|470371092|FG007|Overall Study|Adverse Event|0|||
130328166|NCT01208207|469171633|FG000|Part II|Withdrawal by Subject|0|||
130328167|NCT01208207|469171634|FG001|Part II|Withdrawal by Subject|0|||
130328168|NCT01208207|469171635|FG002|Part II|Withdrawal by Subject|0|||
130328169|NCT01208207|469171636|FG003|Part II|Withdrawal by Subject|10|||
130328170|NCT01208207|469171637|FG004|Part II|Withdrawal by Subject|9|||
130658138|NCT04935931|470371093|FG000|Overall Study|Withdrawal by Subject|1|||
130658139|NCT00424632|470371096|FG000|Overall Study|Death|0|||
130658140|NCT00424632|470371097|FG001|Overall Study|Death|0|||
130658141|NCT00424632|470371098|FG002|Overall Study|Death|0|||
130658142|NCT00424632|470371099|FG003|Overall Study|Death|0|||
130658143|NCT00424632|470371100|FG004|Overall Study|Death|0|||
130658144|NCT00424632|470371101|FG005|Overall Study|Death|2|||
130658145|NCT00424632|470371102|FG006|Overall Study|Death|0|||
130658146|NCT00424632|470371103|FG007|Overall Study|Death|0|||
130658147|NCT00424632|470371104|FG008|Overall Study|Death|0|||
130658148|NCT00424632|470371105|FG009|Overall Study|Death|0|||
130658149|NCT00424632|470371096|FG000|Overall Study|Adverse Event|0|||
130658150|NCT00424632|470371097|FG001|Overall Study|Adverse Event|0|||
130658151|NCT00424632|470371098|FG002|Overall Study|Adverse Event|0|||
130658152|NCT00424632|470371099|FG003|Overall Study|Adverse Event|0|||
130658153|NCT00424632|470371100|FG004|Overall Study|Adverse Event|0|||
130658154|NCT00424632|470371101|FG005|Overall Study|Adverse Event|0|||
130658155|NCT00424632|470371102|FG006|Overall Study|Adverse Event|0|||
130658156|NCT00424632|470371103|FG007|Overall Study|Adverse Event|0|||
130658157|NCT00424632|470371104|FG008|Overall Study|Adverse Event|3|||
130658158|NCT00424632|470371105|FG009|Overall Study|Adverse Event|2|||
130658159|NCT00424632|470371096|FG000|Overall Study|Global deterioration of health status|0|||
130658160|NCT00424632|470371097|FG001|Overall Study|Global deterioration of health status|0|||
130658161|NCT00424632|470371098|FG002|Overall Study|Global deterioration of health status|0|||
130658162|NCT00424632|470371099|FG003|Overall Study|Global deterioration of health status|1|||
130658163|NCT00424632|470371100|FG004|Overall Study|Global deterioration of health status|1|||
130658164|NCT00424632|470371101|FG005|Overall Study|Global deterioration of health status|0|||
130658165|NCT00424632|470371102|FG006|Overall Study|Global deterioration of health status|0|||
130658166|NCT00424632|470371103|FG007|Overall Study|Global deterioration of health status|0|||
130658167|NCT00424632|470371104|FG008|Overall Study|Global deterioration of health status|0|||
130658168|NCT00424632|470371105|FG009|Overall Study|Global deterioration of health status|0|||
130658169|NCT00424632|470371096|FG000|Overall Study|Objective progression or relapse|1|||
130658170|NCT00424632|470371097|FG001|Overall Study|Objective progression or relapse|1|||
130658171|NCT00424632|470371098|FG002|Overall Study|Objective progression or relapse|1|||
130658172|NCT00424632|470371099|FG003|Overall Study|Objective progression or relapse|2|||
130658173|NCT00424632|470371100|FG004|Overall Study|Objective progression or relapse|2|||
130658174|NCT00424632|470371101|FG005|Overall Study|Objective progression or relapse|13|||
130658175|NCT00424632|470371102|FG006|Overall Study|Objective progression or relapse|7|||
130658176|NCT00424632|470371103|FG007|Overall Study|Objective progression or relapse|3|||
130658177|NCT00424632|470371104|FG008|Overall Study|Objective progression or relapse|12|||
130658178|NCT00424632|470371105|FG009|Overall Study|Objective progression or relapse|4|||
130658179|NCT00424632|470371096|FG000|Overall Study|Other|0|||
130658180|NCT00424632|470371097|FG001|Overall Study|Other|0|||
130658181|NCT00424632|470371098|FG002|Overall Study|Other|0|||
130658182|NCT00424632|470371099|FG003|Overall Study|Other|1|||
130658183|NCT00424632|470371100|FG004|Overall Study|Other|0|||
130658184|NCT00424632|470371101|FG005|Overall Study|Other|0|||
130658185|NCT00424632|470371102|FG006|Overall Study|Other|0|||
130658186|NCT00424632|470371103|FG007|Overall Study|Other|0|||
130658187|NCT00424632|470371104|FG008|Overall Study|Other|1|||
130658188|NCT00424632|470371105|FG009|Overall Study|Other|0|||
130658189|NCT00445458|470371110|FG000|Overall Study|Disease Progression|3|||
130658190|NCT00445458|470371111|FG001|Overall Study|Disease Progression|4|||
130658191|NCT00445458|470371112|FG002|Overall Study|Disease Progression|54|||
130658192|NCT00445458|470371113|FG003|Overall Study|Disease Progression|27|||
130658193|NCT00445458|470371110|FG000|Overall Study|Withdrawal by Subject|0|||
130658194|NCT00445458|470371111|FG001|Overall Study|Withdrawal by Subject|0|||
130658195|NCT00445458|470371112|FG002|Overall Study|Withdrawal by Subject|7|||
130658196|NCT00445458|470371113|FG003|Overall Study|Withdrawal by Subject|0|||
130658197|NCT00445458|470371110|FG000|Overall Study|Adverse Event|0|||
130658198|NCT00445458|470371111|FG001|Overall Study|Adverse Event|0|||
130658199|NCT00445458|470371112|FG002|Overall Study|Adverse Event|3|||
130658200|NCT00445458|470371113|FG003|Overall Study|Adverse Event|0|||
130658201|NCT00445458|470371110|FG000|Overall Study|Death|0|||
130658202|NCT00445458|470371111|FG001|Overall Study|Death|1|||
130658203|NCT00445458|470371112|FG002|Overall Study|Death|2|||
130658204|NCT00445458|470371113|FG003|Overall Study|Death|0|||
130658205|NCT00445458|470371110|FG000|Overall Study|Physician Decision|0|||
130658206|NCT00445458|470371111|FG001|Overall Study|Physician Decision|0|||
130658207|NCT00445458|470371112|FG002|Overall Study|Physician Decision|1|||
130658208|NCT00445458|470371113|FG003|Overall Study|Physician Decision|1|||
130658209|NCT00445458|470371110|FG000|Overall Study|Surgery|0|||
130658210|NCT00445458|470371111|FG001|Overall Study|Surgery|0|||
130658211|NCT00445458|470371112|FG002|Overall Study|Surgery|1|||
130658212|NCT00445458|470371113|FG003|Overall Study|Surgery|0|||
130658213|NCT01071083|470371116|FG000|Overall Study|Adverse Event|1|||
130658214|NCT01071083|470371117|FG001|Overall Study|Adverse Event|0|||
130658215|NCT01071083|470371118|FG002|Overall Study|Adverse Event|1|||
130658216|NCT01071083|470371119|FG003|Overall Study|Adverse Event|0|||
130658217|NCT01071083|470371120|FG004|Overall Study|Adverse Event|1|||
130658218|NCT01071083|470371116|FG000|Overall Study|Withdrawal by Subject|3|||
130658219|NCT01071083|470371117|FG001|Overall Study|Withdrawal by Subject|0|||
130658220|NCT01071083|470371118|FG002|Overall Study|Withdrawal by Subject|2|||
130658221|NCT01071083|470371119|FG003|Overall Study|Withdrawal by Subject|0|||
130658222|NCT01071083|470371120|FG004|Overall Study|Withdrawal by Subject|3|||
130658223|NCT01071083|470371116|FG000|Overall Study|Physician Decision|1|||
130658224|NCT01071083|470371117|FG001|Overall Study|Physician Decision|0|||
130658225|NCT01071083|470371118|FG002|Overall Study|Physician Decision|0|||
130658226|NCT01071083|470371119|FG003|Overall Study|Physician Decision|1|||
130658227|NCT01071083|470371120|FG004|Overall Study|Physician Decision|1|||
130658228|NCT01071083|470371116|FG000|Overall Study|Early Rescue|1|||
130658229|NCT01071083|470371117|FG001|Overall Study|Early Rescue|0|||
130658230|NCT01071083|470371118|FG002|Overall Study|Early Rescue|0|||
130658231|NCT01071083|470371119|FG003|Overall Study|Early Rescue|0|||
130658232|NCT01071083|470371120|FG004|Overall Study|Early Rescue|1|||
130658233|NCT01071083|470371116|FG000|Overall Study|Subject Moved|0|||
130658234|NCT01071083|470371117|FG001|Overall Study|Subject Moved|1|||
130658235|NCT01071083|470371118|FG002|Overall Study|Subject Moved|0|||
130658236|NCT01071083|470371119|FG003|Overall Study|Subject Moved|0|||
130658237|NCT01071083|470371120|FG004|Overall Study|Subject Moved|0|||
130658238|NCT01071083|470371116|FG000|Overall Study|Images Not Usable (Motion)|0|||
130658239|NCT01071083|470371117|FG001|Overall Study|Images Not Usable (Motion)|1|||
130658240|NCT01071083|470371118|FG002|Overall Study|Images Not Usable (Motion)|0|||
130658241|NCT01071083|470371119|FG003|Overall Study|Images Not Usable (Motion)|0|||
130658242|NCT01071083|470371120|FG004|Overall Study|Images Not Usable (Motion)|0|||
130658243|NCT01071083|470371116|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130658244|NCT01071083|470371117|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130658245|NCT01071083|470371118|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
130658246|NCT01071083|470371119|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
130658247|NCT01071083|470371120|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
130658248|NCT01071083|470371116|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
130658249|NCT01071083|470371117|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
130658250|NCT01071083|470371118|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
130658251|NCT01071083|470371119|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
130658252|NCT01071083|470371120|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
130658253|NCT01071083|470371116|FG000|Overall Study|Subject Refused to Continue|1|||
130658254|NCT01071083|470371117|FG001|Overall Study|Subject Refused to Continue|0|||
130658255|NCT01071083|470371118|FG002|Overall Study|Subject Refused to Continue|0|||
130658256|NCT01071083|470371119|FG003|Overall Study|Subject Refused to Continue|0|||
130658257|NCT01071083|470371120|FG004|Overall Study|Subject Refused to Continue|0|||
130658258|NCT00728988|470371123|FG000|Overall Study|Not Treated|2|||
130658259|NCT00728988|470371124|FG001|Overall Study|Not Treated|2|||
130658260|NCT00728988|470371123|FG000|Overall Study|Death|1|||
130658261|NCT00728988|470371124|FG001|Overall Study|Death|1|||
130658262|NCT00728988|470371123|FG000|Overall Study|Adverse Event|3|||
130658263|NCT00728988|470371124|FG001|Overall Study|Adverse Event|2|||
130658264|NCT00728988|470371123|FG000|Overall Study|Other|85|||
130658265|NCT00728988|470371124|FG001|Overall Study|Other|77|||
130658266|NCT00728988|470371123|FG000|Overall Study|Withdrawal by Subject|2|||
130658267|NCT00728988|470371124|FG001|Overall Study|Withdrawal by Subject|6|||
130658268|NCT03319368|470371128|FG000|Overall Study|Discharge swabs not collected from resident|57|||
130658269|NCT03319368|470371129|FG001|Overall Study|Discharge swabs not collected from resident|46|||
130658270|NCT03000075|470371130|FG000|Part A|Adverse Event|4|||
130658271|NCT03000075|470371131|FG001|Part A|Adverse Event|0|||
130658272|NCT03000075|470371132|FG002|Part A|Adverse Event|0|||
130658273|NCT03000075|470371133|FG003|Part A|Adverse Event|0|||
130658274|NCT03000075|470371134|FG004|Part A|Adverse Event|0|||
130658275|NCT03000075|470371135|FG005|Part A|Adverse Event|0|||
130658276|NCT03000075|470371136|FG006|Part A|Adverse Event|0|||
130658277|NCT03000075|470371130|FG000|Part B|Not dosed due to AE|0|||
130658278|NCT03000075|470371131|FG001|Part B|Not dosed due to AE|0|||
130658279|NCT03000075|470371132|FG002|Part B|Not dosed due to AE|0|||
130658280|NCT03000075|470371133|FG003|Part B|Not dosed due to AE|0|||
130658281|NCT03000075|470371134|FG004|Part B|Not dosed due to AE|0|||
130658282|NCT03000075|470371135|FG005|Part B|Not dosed due to AE|2|||
130658283|NCT03000075|470371136|FG006|Part B|Not dosed due to AE|1|||
130658284|NCT03000075|470371130|FG000|Part B|Adverse Event|0|||
130658285|NCT03000075|470371131|FG001|Part B|Adverse Event|0|||
130658286|NCT03000075|470371132|FG002|Part B|Adverse Event|0|||
130658287|NCT03000075|470371133|FG003|Part B|Adverse Event|0|||
130658288|NCT03000075|470371134|FG004|Part B|Adverse Event|1|||
130658289|NCT03000075|470371135|FG005|Part B|Adverse Event|0|||
130658290|NCT03000075|470371136|FG006|Part B|Adverse Event|0|||
130658291|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
130658292|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
130658293|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Death|5|||
130658294|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Death|2|||
130658295|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
130658296|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
130658297|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
130658298|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
130658299|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
130658300|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
130658301|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Relapse|1|||
130658302|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Relapse|0|||
130658303|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
130658304|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
130658305|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
130658306|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
130658307|NCT00111007|470371137|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
130658308|NCT00111007|470371138|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
130658309|NCT00111007|470371137|FG000|Active Follow-up|Adverse Event|1|||
130658310|NCT00111007|470371138|FG001|Active Follow-up|Adverse Event|0|||
130658311|NCT00111007|470371137|FG000|Active Follow-up|Death|2|||
130658312|NCT00111007|470371138|FG001|Active Follow-up|Death|0|||
130658313|NCT00111007|470371137|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
130658314|NCT00111007|470371138|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
130658315|NCT00111007|470371137|FG000|Long Term Follow-up|Death|34|||
130658316|NCT00111007|470371138|FG001|Long Term Follow-up|Death|39|||
130658317|NCT00111007|470371137|FG000|Long Term Follow-up|Lost to Follow-up|1|||
130328171|NCT01208207|469171638|FG005|Part II|Withdrawal by Subject|3|||
130328172|NCT01208207|469171639|FG006|Part II|Withdrawal by Subject|5|||
130328173|NCT01208207|469171633|FG000|Part II|Adverse Event|0|||
130328174|NCT01208207|469171634|FG001|Part II|Adverse Event|0|||
130328175|NCT01208207|469171635|FG002|Part II|Adverse Event|0|||
130328176|NCT01208207|469171636|FG003|Part II|Adverse Event|5|||
130328177|NCT01208207|469171637|FG004|Part II|Adverse Event|9|||
130328178|NCT01208207|469171638|FG005|Part II|Adverse Event|4|||
130328179|NCT01208207|469171639|FG006|Part II|Adverse Event|2|||
130328180|NCT01208207|469171633|FG000|Part II|Lack of Efficacy|0|||
130328181|NCT01208207|469171634|FG001|Part II|Lack of Efficacy|0|||
130328182|NCT01208207|469171635|FG002|Part II|Lack of Efficacy|0|||
130328183|NCT01208207|469171636|FG003|Part II|Lack of Efficacy|6|||
130328184|NCT01208207|469171637|FG004|Part II|Lack of Efficacy|4|||
130328185|NCT01208207|469171638|FG005|Part II|Lack of Efficacy|3|||
130328186|NCT01208207|469171639|FG006|Part II|Lack of Efficacy|3|||
130328187|NCT01208207|469171633|FG000|Part II|Lost to Follow-up|0|||
130328188|NCT01208207|469171634|FG001|Part II|Lost to Follow-up|0|||
130328189|NCT01208207|469171635|FG002|Part II|Lost to Follow-up|0|||
130328190|NCT01208207|469171636|FG003|Part II|Lost to Follow-up|4|||
130328191|NCT01208207|469171637|FG004|Part II|Lost to Follow-up|0|||
130328192|NCT01208207|469171638|FG005|Part II|Lost to Follow-up|2|||
130328193|NCT01208207|469171639|FG006|Part II|Lost to Follow-up|1|||
130328194|NCT01208207|469171633|FG000|Part II|Non-Compliance With Study Drug|0|||
130328195|NCT01208207|469171634|FG001|Part II|Non-Compliance With Study Drug|0|||
130328196|NCT01208207|469171635|FG002|Part II|Non-Compliance With Study Drug|0|||
130328197|NCT01208207|469171636|FG003|Part II|Non-Compliance With Study Drug|4|||
130328198|NCT01208207|469171637|FG004|Part II|Non-Compliance With Study Drug|1|||
130328199|NCT01208207|469171638|FG005|Part II|Non-Compliance With Study Drug|1|||
130328200|NCT01208207|469171639|FG006|Part II|Non-Compliance With Study Drug|0|||
130328201|NCT01208207|469171633|FG000|Part II|Physician Decision|0|||
130328202|NCT01208207|469171634|FG001|Part II|Physician Decision|0|||
130328203|NCT01208207|469171635|FG002|Part II|Physician Decision|0|||
130328204|NCT01208207|469171636|FG003|Part II|Physician Decision|1|||
130328205|NCT01208207|469171637|FG004|Part II|Physician Decision|0|||
130328206|NCT01208207|469171638|FG005|Part II|Physician Decision|2|||
130328207|NCT01208207|469171639|FG006|Part II|Physician Decision|0|||
130328208|NCT01208207|469171633|FG000|Part II|Protocol Violation|0|||
130328209|NCT01208207|469171634|FG001|Part II|Protocol Violation|0|||
130328210|NCT01208207|469171635|FG002|Part II|Protocol Violation|0|||
130328211|NCT01208207|469171636|FG003|Part II|Protocol Violation|1|||
130658318|NCT00111007|470371138|FG001|Long Term Follow-up|Lost to Follow-up|1|||
130658319|NCT00111007|470371137|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
130658320|NCT00111007|470371138|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
130328212|NCT01208207|469171637|FG004|Part II|Protocol Violation|0|||
130328213|NCT01208207|469171638|FG005|Part II|Protocol Violation|0|||
130328214|NCT01208207|469171639|FG006|Part II|Protocol Violation|0|||
130328215|NCT01208207|469171633|FG000|Part II|Technical Problems|0|||
130328216|NCT01208207|469171634|FG001|Part II|Technical Problems|0|||
130328217|NCT01208207|469171635|FG002|Part II|Technical Problems|0|||
130328218|NCT01208207|469171636|FG003|Part II|Technical Problems|1|||
130328219|NCT01208207|469171637|FG004|Part II|Technical Problems|0|||
130328220|NCT01208207|469171638|FG005|Part II|Technical Problems|1|||
130328221|NCT01208207|469171639|FG006|Part II|Technical Problems|0|||
130328222|NCT00724698|469171640|FG000|Overall Study|Adverse Event|9|||
130328223|NCT00724698|469171640|FG000|Overall Study|Failure of Therapy|4|||
130328224|NCT00724698|469171640|FG000|Overall Study|Poor Compliance|16|||
130328225|NCT00724698|469171640|FG000|Overall Study|Lost to Follow-up|36|||
130328226|NCT00724698|469171640|FG000|Overall Study|No Info|25|||
130328227|NCT02177032|469171643|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
130328228|NCT02177032|469171644|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
130658321|NCT00111007|470371137|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
130328229|NCT02177032|469171645|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130328230|NCT02177032|469171646|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
130328231|NCT02177032|469171643|FG000|Overall Study|Lost to Follow-up|0|||
130328232|NCT02177032|469171644|FG001|Overall Study|Lost to Follow-up|2|||
130328233|NCT02177032|469171645|FG002|Overall Study|Lost to Follow-up|0|||
130328234|NCT02177032|469171646|FG003|Overall Study|Lost to Follow-up|0|||
130328235|NCT02177032|469171643|FG000|Overall Study|OTHER|2|||
130328236|NCT02177032|469171644|FG001|Overall Study|OTHER|0|||
130328237|NCT02177032|469171645|FG002|Overall Study|OTHER|1|||
130328238|NCT02177032|469171646|FG003|Overall Study|OTHER|0|||
130328239|NCT02177032|469171643|FG000|Overall Study|Withdrawal by Subject|1|||
130328240|NCT02177032|469171644|FG001|Overall Study|Withdrawal by Subject|0|||
130328241|NCT02177032|469171645|FG002|Overall Study|Withdrawal by Subject|1|||
130328242|NCT02177032|469171646|FG003|Overall Study|Withdrawal by Subject|0|||
130328243|NCT00665652|469171647|FG000|Overall Study|Adverse Event|4|||
130328244|NCT00665652|469171647|FG000|Overall Study|Death|1|||
130328245|NCT00665652|469171647|FG000|Overall Study|No longer met inclusion criteria.|1|||
130328246|NCT02556177|469171650|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
130328247|NCT02556177|469171651|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
130328248|NCT00389610|469171658|FG000|Overall Study|Disease Progression|0|||
130328249|NCT00389610|469171659|FG001|Overall Study|Disease Progression|19|||
130328250|NCT00389610|469171658|FG000|Overall Study|Death|0|||
130328251|NCT00389610|469171659|FG001|Overall Study|Death|1|||
130328252|NCT00389610|469171658|FG000|Overall Study|Physician Decision|0|||
130328253|NCT00389610|469171659|FG001|Overall Study|Physician Decision|1|||
130328254|NCT00389610|469171658|FG000|Overall Study|Withdrawal by Subject|0|||
130328255|NCT00389610|469171659|FG001|Overall Study|Withdrawal by Subject|1|||
130328256|NCT03131570|469171660|FG000|Overall Study|Adverse Event|1|||
130328257|NCT03131570|469171661|FG001|Overall Study|Adverse Event|0|||
130328258|NCT00830440|469171662|FG000|Overall Study|Protocol Violation|1|||
130328259|NCT00830440|469171663|FG001|Overall Study|Protocol Violation|0|||
130328260|NCT00830440|469171662|FG000|Overall Study|Withdrawal by Subject|1|||
130328261|NCT00830440|469171663|FG001|Overall Study|Withdrawal by Subject|0|||
130328262|NCT00830440|469171662|FG000|Overall Study|unsuccessful procedure|4|||
130328263|NCT00830440|469171663|FG001|Overall Study|unsuccessful procedure|0|||
130328264|NCT00830440|469171662|FG000|Overall Study|Adverse Event|2|||
130328265|NCT00830440|469171663|FG001|Overall Study|Adverse Event|0|||
130658322|NCT00111007|470371138|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
130658323|NCT00111007|470371137|FG000|Long Term Follow-up|Missing|10|||
130658324|NCT00111007|470371138|FG001|Long Term Follow-up|Missing|3|||
130658325|NCT00824993|470371139|FG000|Overall Study|Withdrawal by Subject|1|||
130658326|NCT00824993|470371140|FG001|Overall Study|Withdrawal by Subject|1|||
130658327|NCT00824993|470371139|FG000|Overall Study|Malignancy Relapse|9|||
130658328|NCT00824993|470371140|FG001|Overall Study|Malignancy Relapse|10|||
130658329|NCT00824993|470371139|FG000|Overall Study|Rapid Bone Loss|0|||
130658330|NCT00824993|470371140|FG001|Overall Study|Rapid Bone Loss|1|||
130658331|NCT00824993|470371139|FG000|Overall Study|Non-Compliant|2|||
130658332|NCT00824993|470371140|FG001|Overall Study|Non-Compliant|1|||
130658333|NCT00824993|470371139|FG000|Overall Study|Insurance Issue|2|||
130658334|NCT00824993|470371140|FG001|Overall Study|Insurance Issue|1|||
130658335|NCT00824993|470371139|FG000|Overall Study|Death|0|||
130658336|NCT00824993|470371140|FG001|Overall Study|Death|3|||
130658337|NCT00440193|470371141|FG000|Treatment Period|Adverse Event|74|||
130328266|NCT00942604|469171669|FG000|Overall Study|Protocol Violation|1|||
130328267|NCT00942604|469171670|FG001|Overall Study|Protocol Violation|1|||
130328268|NCT00942604|469171669|FG000|Overall Study|Adverse Event|0|||
130328269|NCT00942604|469171670|FG001|Overall Study|Adverse Event|1|||
130328270|NCT00942604|469171669|FG000|Overall Study|Withdrawal by Subject|0|||
130328271|NCT00942604|469171670|FG001|Overall Study|Withdrawal by Subject|1|||
130328272|NCT00942604|469171669|FG000|Overall Study|Patient relocation|1|||
130328273|NCT00942604|469171670|FG001|Overall Study|Patient relocation|1|||
130328274|NCT01188343|469171671|FG000|Overall Study|Not vaccinated|0|||
130328275|NCT01188343|469171672|FG001|Overall Study|Not vaccinated|2|||
130658338|NCT00440193|470371142|FG001|Treatment Period|Adverse Event|67|||
130658339|NCT00440193|470371141|FG000|Treatment Period|Death|19|||
130658340|NCT00440193|470371142|FG001|Treatment Period|Death|22|||
130658341|NCT00440193|470371141|FG000|Treatment Period|Lack of Efficacy|0|||
130658342|NCT00440193|470371142|FG001|Treatment Period|Lack of Efficacy|1|||
130658343|NCT00440193|470371141|FG000|Treatment Period|Lost to Follow-up|12|||
130328276|NCT01188343|469171673|FG002|Overall Study|Not vaccinated|1|||
130328277|NCT01188343|469171671|FG000|Overall Study|Withdrawal by Subject|1|||
130328278|NCT01188343|469171672|FG001|Overall Study|Withdrawal by Subject|24|||
130658344|NCT00440193|470371142|FG001|Treatment Period|Lost to Follow-up|18|||
130551993|NCT01139658|469988183|FG000|Overall Study|Adverse Event|10|||
130551994|NCT01139658|469988184|FG001|Overall Study|Adverse Event|27|||
130551995|NCT01139658|469988183|FG000|Overall Study|Lack of Efficacy|15|||
130551996|NCT01139658|469988184|FG001|Overall Study|Lack of Efficacy|7|||
130551997|NCT01139658|469988183|FG000|Overall Study|Withdrawal by Subject|2|||
130551998|NCT01139658|469988184|FG001|Overall Study|Withdrawal by Subject|4|||
130551999|NCT01139658|469988183|FG000|Overall Study|No documentation of treatment|1|||
130552000|NCT01139658|469988184|FG001|Overall Study|No documentation of treatment|0|||
130552001|NCT01139658|469988183|FG000|Overall Study|Other|28|||
130552002|NCT01139658|469988184|FG001|Overall Study|Other|75|||
130552003|NCT00753272|469988190|FG000|Overall Study|Adverse Event|878|||
130552004|NCT00753272|469988191|FG001|Overall Study|Adverse Event|869|||
130552005|NCT00753272|469988190|FG000|Overall Study|Protocol Violation|28|||
130552006|NCT00753272|469988191|FG001|Overall Study|Protocol Violation|46|||
130552007|NCT00753272|469988190|FG000|Overall Study|Withdrawal by Subject|2481|||
130552008|NCT00753272|469988191|FG001|Overall Study|Withdrawal by Subject|2407|||
130552009|NCT00753272|469988190|FG000|Overall Study|Lost to Follow-up|491|||
130552010|NCT00753272|469988191|FG001|Overall Study|Lost to Follow-up|497|||
130552011|NCT00753272|469988190|FG000|Overall Study|Other|1104|||
130552012|NCT00753272|469988191|FG001|Overall Study|Other|1088|||
130552013|NCT00026208|469988192|FG000|Overall Study|Complications of auto accident|1|||
130552014|NCT00026208|469988193|FG001|Overall Study|Complications of auto accident|0|||
130552015|NCT02225353|469988194|FG000|Overall Study|Lost to Follow-up|0|||
130552016|NCT02225353|469988195|FG001|Overall Study|Lost to Follow-up|1|||
130552017|NCT02225353|469988196|FG002|Overall Study|Lost to Follow-up|3|||
130552018|NCT02225353|469988194|FG000|Overall Study|Protocol Violation|4|||
130552019|NCT02225353|469988195|FG001|Overall Study|Protocol Violation|5|||
130552020|NCT02225353|469988196|FG002|Overall Study|Protocol Violation|12|||
130552021|NCT03604523|469988197|FG000|Overall Study|Physician Decision|1|||
130552022|NCT03604523|469988198|FG001|Overall Study|Physician Decision|0|||
130552023|NCT03442114|469988202|FG000|Overall Study|Lost to Follow-up|13|||
130552024|NCT03442114|469988203|FG001|Overall Study|Lost to Follow-up|13|||
130552025|NCT03442114|469988202|FG000|Overall Study|Physician Decision|2|||
130552026|NCT03442114|469988203|FG001|Overall Study|Physician Decision|2|||
130552027|NCT03442114|469988202|FG000|Overall Study|Protocol Violation|0|||
130552028|NCT03442114|469988203|FG001|Overall Study|Protocol Violation|2|||
130552029|NCT03442114|469988202|FG000|Overall Study|Withdrawal by Subject|1|||
130552030|NCT03442114|469988203|FG001|Overall Study|Withdrawal by Subject|3|||
130552031|NCT03442114|469988202|FG000|Overall Study|Guardianship Change|0|||
130552032|NCT03442114|469988203|FG001|Overall Study|Guardianship Change|1|||
130552033|NCT02903368|469988204|FG000|Part 1|Adverse Event|3|||
130552034|NCT02903368|469988205|FG001|Part 1|Adverse Event|0|||
130552035|NCT02903368|469988206|FG002|Part 1|Adverse Event|0|||
130552036|NCT02903368|469988207|FG003|Part 1|Adverse Event|0|||
130552037|NCT02903368|469988204|FG000|Part 1|Withdrawal by Subject|1|||
130552038|NCT02903368|469988205|FG001|Part 1|Withdrawal by Subject|0|||
130552039|NCT02903368|469988206|FG002|Part 1|Withdrawal by Subject|0|||
130552040|NCT02903368|469988207|FG003|Part 1|Withdrawal by Subject|0|||
130552041|NCT02903368|469988204|FG000|Part 2|Adverse Event|0|||
130552042|NCT02903368|469988205|FG001|Part 2|Adverse Event|0|||
130552043|NCT02903368|469988206|FG002|Part 2|Adverse Event|5|||
130552044|NCT02903368|469988207|FG003|Part 2|Adverse Event|0|||
130552045|NCT02903368|469988204|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
130552046|NCT02903368|469988205|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
130552047|NCT02903368|469988206|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
130552048|NCT02903368|469988207|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
130552049|NCT02903368|469988204|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
130552050|NCT02903368|469988205|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
130552051|NCT02903368|469988206|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
130552052|NCT02903368|469988207|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
130552053|NCT02903368|469988204|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
130552054|NCT02903368|469988205|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
130552055|NCT02903368|469988206|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
130552056|NCT02903368|469988207|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
130552057|NCT02382016|469990106|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
130552058|NCT02382016|469990107|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
130552059|NCT02382016|469990106|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
130552060|NCT02382016|469990107|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
130552061|NCT02382016|469990106|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
130552062|NCT02382016|469990107|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
130552063|NCT02382016|469990106|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
130552064|NCT02382016|469990107|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
130552065|NCT02382016|469990106|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
130658345|NCT00440193|470371141|FG000|Treatment Period|Physician Decision|3|||
130658346|NCT00440193|470371142|FG001|Treatment Period|Physician Decision|6|||
130658347|NCT00440193|470371141|FG000|Treatment Period|Protocol Violation|16|||
130658348|NCT00440193|470371142|FG001|Treatment Period|Protocol Violation|19|||
130658349|NCT00440193|470371141|FG000|Treatment Period|Withdrawal by Subject|36|||
130658350|NCT00440193|470371142|FG001|Treatment Period|Withdrawal by Subject|77|||
130658351|NCT00440193|470371141|FG000|Treatment Period|Clinical endpoint reached|28|||
130328279|NCT01188343|469171673|FG002|Overall Study|Withdrawal by Subject|0|||
130328280|NCT01143246|469171674|FG000|Overall Study|Adverse Event|24|||
130328281|NCT01143246|469171675|FG001|Overall Study|Adverse Event|28|||
130328282|NCT01143246|469171674|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
130552066|NCT02382016|469990107|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
130552067|NCT02382016|469990106|FG000|Open-label (OL) Treatment Period|Death|4|||
130552068|NCT02382016|469990107|FG001|Open-label (OL) Treatment Period|Death|0|||
130552069|NCT02382016|469990106|FG000|OL Extension Period|Physician Decision|3|||
130552070|NCT02382016|469990107|FG001|OL Extension Period|Physician Decision|0|||
130552071|NCT02382016|469990106|FG000|OL Extension Period|Death|2|||
130552072|NCT02382016|469990107|FG001|OL Extension Period|Death|0|||
130552073|NCT02382016|469990106|FG000|OL Extension Period|Withdrawal by Subject|1|||
130552074|NCT02382016|469990107|FG001|OL Extension Period|Withdrawal by Subject|0|||
130552075|NCT00084266|469990108|FG000|Overall Study|Death|42|||
130552076|NCT00084266|469990109|FG001|Overall Study|Death|39|||
130552077|NCT00084266|469990108|FG000|Overall Study|Adverse Event|8|||
130552078|NCT00084266|469990109|FG001|Overall Study|Adverse Event|5|||
130552079|NCT00084266|469990108|FG000|Overall Study|Lack of Efficacy|2|||
130552080|NCT00084266|469990109|FG001|Overall Study|Lack of Efficacy|4|||
130552081|NCT00084266|469990108|FG000|Overall Study|Lost to Follow-up|5|||
130552082|NCT00084266|469990109|FG001|Overall Study|Lost to Follow-up|3|||
130552083|NCT00084266|469990108|FG000|Overall Study|Participant not willing to participate|3|||
130552084|NCT00084266|469990109|FG001|Overall Study|Participant not willing to participate|8|||
130552085|NCT00084266|469990108|FG000|Overall Study|Other|360|||
130552086|NCT00084266|469990109|FG001|Overall Study|Other|344|||
130552087|NCT00084266|469990108|FG000|Overall Study|Randomized not treated|21|||
130552088|NCT00084266|469990109|FG001|Overall Study|Randomized not treated|20|||
130552089|NCT00730171|469990110|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
130552090|NCT00730171|469990110|FG000|Overall Study|Adverse Event|193|||
130552091|NCT00730171|469990110|FG000|Overall Study|Protocol Violation|48|||
130552092|NCT00730171|469990110|FG000|Overall Study|Withdrawal by Subject|202|||
130552093|NCT00730171|469990110|FG000|Overall Study|Lost to Follow-up|121|||
130552094|NCT00730171|469990110|FG000|Overall Study|Insufficient Therapeutic Response|141|||
130552095|NCT00730171|469990110|FG000|Overall Study|Other|61|||
130552096|NCT01729156|469990111|FG000|Overall Study|Withdrawal by Subject|1|||
130552097|NCT01729156|469990112|FG001|Overall Study|Withdrawal by Subject|0|||
130552098|NCT01729156|469990113|FG002|Overall Study|Withdrawal by Subject|0|||
130552099|NCT02952001|469990116|FG000|Overall Study|Adverse Event|3|||
130552100|NCT02952001|469990117|FG001|Overall Study|Adverse Event|0|||
130552101|NCT02952001|469990116|FG000|Overall Study|Prohibited therapy|10|||
130552102|NCT02952001|469990117|FG001|Overall Study|Prohibited therapy|3|||
130552103|NCT02952001|469990116|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
130552104|NCT02952001|469990117|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
130552105|NCT00937833|469990118|FG000|Overall Study|Protocol Violation|1|||
130552106|NCT00937833|469990119|FG001|Overall Study|Protocol Violation|2|||
130552107|NCT00937833|469990118|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
130552108|NCT00937833|469990119|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
130552109|NCT00937833|469990118|FG000|Overall Study|Lost to Follow-up|10|||
130552110|NCT00937833|469990119|FG001|Overall Study|Lost to Follow-up|8|||
130552111|NCT00937833|469990118|FG000|Overall Study|Withdrawal by Subject|4|||
130552112|NCT00937833|469990119|FG001|Overall Study|Withdrawal by Subject|6|||
130552113|NCT03278106|469990121|FG000|Overall Study|No protocol treatment|1|||
130552114|NCT00818389|469990122|FG000|Overall Study|Death|1|||
130552115|NCT00818389|469990123|FG001|Overall Study|Death|3|||
130552116|NCT00818389|469990122|FG000|Overall Study|ALS Disease Progression|1|||
130552117|NCT00818389|469990123|FG001|Overall Study|ALS Disease Progression|0|||
130552118|NCT00818389|469990122|FG000|Overall Study|Withdrawal by Subject|2|||
130552119|NCT00818389|469990123|FG001|Overall Study|Withdrawal by Subject|2|||
130552120|NCT00818389|469990122|FG000|Overall Study|Adverse Event|0|||
130552121|NCT00818389|469990123|FG001|Overall Study|Adverse Event|1|||
130552122|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
130552123|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
130552124|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
130552125|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
130552126|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
130552127|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
130552128|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
130328283|NCT01143246|469171675|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
130658352|NCT00440193|470371142|FG001|Treatment Period|Clinical endpoint reached|25|||
130658353|NCT00440193|470371141|FG000|Treatment Period|Study terminated by sponsor|102|||
130658354|NCT00440193|470371142|FG001|Treatment Period|Study terminated by sponsor|94|||
130658355|NCT00440193|470371141|FG000|Treatment Period|Protocol driven decision point|2|||
130658356|NCT00440193|470371142|FG001|Treatment Period|Protocol driven decision point|2|||
130658357|NCT00440193|470371141|FG000|Treatment Period|Switch to commercial drug|0|||
130658358|NCT00440193|470371142|FG001|Treatment Period|Switch to commercial drug|2|||
130658359|NCT00440193|470371141|FG000|Treatment Period|Technical problems|1|||
130658360|NCT00440193|470371142|FG001|Treatment Period|Technical problems|1|||
130658361|NCT00440193|470371141|FG000|Treatment Period|Participant convenience|5|||
130658362|NCT00440193|470371142|FG001|Treatment Period|Participant convenience|2|||
130658363|NCT00440193|470371141|FG000|Treatment Period|Participant did not receive treatment|7|||
130658364|NCT00440193|470371142|FG001|Treatment Period|Participant did not receive treatment|13|||
130658365|NCT00440193|470371141|FG000|Treatment Period|Site closed by investigator|0|||
130658366|NCT00440193|470371142|FG001|Treatment Period|Site closed by investigator|2|||
130658367|NCT00440193|470371141|FG000|Observational Period|Adverse Event|2|||
130658368|NCT00440193|470371142|FG001|Observational Period|Adverse Event|2|||
130658369|NCT00440193|470371141|FG000|Observational Period|Death|15|||
130658370|NCT00440193|470371142|FG001|Observational Period|Death|20|||
130658371|NCT00440193|470371141|FG000|Observational Period|Lost to Follow-up|12|||
130658372|NCT00440193|470371142|FG001|Observational Period|Lost to Follow-up|8|||
130658373|NCT00440193|470371141|FG000|Observational Period|Protocol Violation|1|||
130658374|NCT00440193|470371142|FG001|Observational Period|Protocol Violation|0|||
130658375|NCT00440193|470371141|FG000|Observational Period|Withdrawal by Subject|11|||
130658376|NCT00440193|470371142|FG001|Observational Period|Withdrawal by Subject|8|||
130658377|NCT00440193|470371141|FG000|Observational Period|Physician Decision|1|||
130658378|NCT00440193|470371142|FG001|Observational Period|Physician Decision|0|||
130658379|NCT00440193|470371141|FG000|Observational Period|Clinical endpoint reached|1|||
130658380|NCT00440193|470371142|FG001|Observational Period|Clinical endpoint reached|0|||
130658381|NCT00440193|470371141|FG000|Observational Period|Participant convenience|2|||
130658382|NCT00440193|470371142|FG001|Observational Period|Participant convenience|0|||
130658383|NCT02864953|470371145|FG000|Overall Study|Adverse Event|22|||
130658384|NCT02864953|470371146|FG001|Overall Study|Adverse Event|19|||
130658385|NCT02864953|470371145|FG000|Overall Study|Withdrawal by Subject|1|||
130658386|NCT02864953|470371146|FG001|Overall Study|Withdrawal by Subject|0|||
130658387|NCT02864953|470371145|FG000|Overall Study|Physician Decision|4|||
130658388|NCT02864953|470371146|FG001|Overall Study|Physician Decision|2|||
130658389|NCT02864953|470371145|FG000|Overall Study|Death|3|||
130658390|NCT02864953|470371146|FG001|Overall Study|Death|13|||
130658391|NCT02864953|470371145|FG000|Overall Study|Reason not specified|14|||
130658392|NCT02864953|470371146|FG001|Overall Study|Reason not specified|12|||
130658393|NCT02864953|470371145|FG000|Overall Study|Withdrew Prior to Dosing|9|||
130658394|NCT02864953|470371146|FG001|Overall Study|Withdrew Prior to Dosing|8|||
130658395|NCT00621309|470371147|FG000|Overall Study|Withdrawal by Subject|2|||
130658396|NCT00621309|470371148|FG001|Overall Study|Withdrawal by Subject|0|||
130658397|NCT00621309|470371149|FG002|Overall Study|Withdrawal by Subject|1|||
130658398|NCT00621309|470371150|FG003|Overall Study|Withdrawal by Subject|1|||
130658399|NCT00621309|470371151|FG004|Overall Study|Withdrawal by Subject|1|||
130658400|NCT00621309|470371152|FG005|Overall Study|Withdrawal by Subject|1|||
130658401|NCT02949219|470371158|FG000|Overall Study|Withdrawal by Subject|1|||
130658402|NCT03494816|470371159|FG000|Overall Study|Protocol Violation|2|||
130658403|NCT03494816|470371159|FG000|Overall Study|Physician Decision|2|||
130658404|NCT03494816|470371159|FG000|Overall Study|Did not start trial treatment|1|||
130658405|NCT03494816|470371159|FG000|Overall Study|Adverse Event|1|||
130658406|NCT02392377|470371162|FG000|Overall Study|Withdrawal by Subject|0|||
130658407|NCT02392377|470371163|FG001|Overall Study|Withdrawal by Subject|1|||
130658408|NCT03205163|470371164|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
130658409|NCT03205163|470371165|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
130658410|NCT02545868|470373017|FG000|Overall Study|Lack of Efficacy|1|||
130658411|NCT02545868|470373018|FG001|Overall Study|Lack of Efficacy|1|||
130658412|NCT02545868|470373019|FG002|Overall Study|Lack of Efficacy|0|||
130658413|NCT02545868|470373017|FG000|Overall Study|Lost to Follow-up|1|||
130658414|NCT02545868|470373018|FG001|Overall Study|Lost to Follow-up|5|||
130658415|NCT02545868|470373019|FG002|Overall Study|Lost to Follow-up|1|||
130658416|NCT02545868|470373017|FG000|Overall Study|Non-compliance|1|||
130658417|NCT02545868|470373018|FG001|Overall Study|Non-compliance|1|||
130658418|NCT02545868|470373019|FG002|Overall Study|Non-compliance|1|||
130658419|NCT02545868|470373017|FG000|Overall Study|Treatment change|21|||
130658420|NCT02545868|470373018|FG001|Overall Study|Treatment change|19|||
130658421|NCT02545868|470373019|FG002|Overall Study|Treatment change|22|||
130658422|NCT02545868|470373017|FG000|Overall Study|Physician Decision|1|||
130658423|NCT02545868|470373018|FG001|Overall Study|Physician Decision|1|||
130658424|NCT02545868|470373019|FG002|Overall Study|Physician Decision|1|||
130658425|NCT02545868|470373017|FG000|Overall Study|Withdrawal by Subject|6|||
130658426|NCT02545868|470373018|FG001|Overall Study|Withdrawal by Subject|7|||
130658427|NCT02545868|470373019|FG002|Overall Study|Withdrawal by Subject|9|||
130658428|NCT04465916|470373024|FG000|Overall Study|Withdrawal by Subject|0|||
130658429|NCT04465916|470373025|FG001|Overall Study|Withdrawal by Subject|1|||
130658430|NCT01325701|470373027|FG000|Overall Study|Adverse Event|12|||
130658431|NCT01325701|470373028|FG001|Overall Study|Adverse Event|0|||
130658432|NCT01325701|470373027|FG000|Overall Study|Protocol Violation|1|||
130658433|NCT01325701|470373028|FG001|Overall Study|Protocol Violation|0|||
130658434|NCT01325701|470373027|FG000|Overall Study|Physician Decision|2|||
130658435|NCT01325701|470373028|FG001|Overall Study|Physician Decision|2|||
130658436|NCT01325701|470373027|FG000|Overall Study|Withdrawal by Subject|2|||
130658437|NCT01325701|470373028|FG001|Overall Study|Withdrawal by Subject|1|||
130658438|NCT01325701|470373027|FG000|Overall Study|Rollerover Extension Study|4|||
130658439|NCT01325701|470373028|FG001|Overall Study|Rollerover Extension Study|0|||
130658440|NCT00388674|470373035|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
130658441|NCT00388674|470373036|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
130658442|NCT00388674|470373035|FG000|Initial Treatment|Adverse Event|22|||
130658443|NCT00388674|470373036|FG001|Initial Treatment|Adverse Event|87|||
130658444|NCT00388674|470373035|FG000|Initial Treatment|Death|215|||
130658445|NCT00388674|470373036|FG001|Initial Treatment|Death|216|||
130658446|NCT00388674|470373035|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
130328284|NCT01143246|469171674|FG000|Overall Study|Lost to Follow-up|0|||
130328285|NCT01143246|469171675|FG001|Overall Study|Lost to Follow-up|1|||
130328286|NCT01143246|469171674|FG000|Overall Study|Death|16|||
130328287|NCT01143246|469171675|FG001|Overall Study|Death|15|||
130328288|NCT01143246|469171674|FG000|Overall Study|Reason not Specified|3|||
130328289|NCT01143246|469171675|FG001|Overall Study|Reason not Specified|5|||
130328290|NCT05567783|469171676|FG000|Overall Study|Death|2|||
130328291|NCT05567783|469171677|FG001|Overall Study|Death|3|||
130328292|NCT05567783|469171678|FG002|Overall Study|Death|0|||
130328293|NCT05567783|469171676|FG000|Overall Study|Lost to Follow-up|25|||
130328294|NCT05567783|469171677|FG001|Overall Study|Lost to Follow-up|19|||
130328295|NCT05567783|469171678|FG002|Overall Study|Lost to Follow-up|17|||
130328296|NCT05567783|469171676|FG000|Overall Study|Physician Decision|10|||
130328297|NCT05567783|469171677|FG001|Overall Study|Physician Decision|7|||
130328298|NCT05567783|469171678|FG002|Overall Study|Physician Decision|9|||
130328299|NCT05567783|469171676|FG000|Overall Study|Study Terminated by Sponsor|924|||
130328300|NCT05567783|469171677|FG001|Overall Study|Study Terminated by Sponsor|937|||
130328301|NCT05567783|469171678|FG002|Overall Study|Study Terminated by Sponsor|941|||
130328302|NCT05567783|469171676|FG000|Overall Study|Withdrawal by Subject|23|||
130328303|NCT05567783|469171677|FG001|Overall Study|Withdrawal by Subject|27|||
130658447|NCT00388674|470373036|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
130658448|NCT00388674|470373035|FG000|Initial Treatment|HCC|12|||
130658449|NCT00388674|470373036|FG001|Initial Treatment|HCC|20|||
130658450|NCT00388674|470373035|FG000|Initial Treatment|Lost to Follow-up|526|||
130658451|NCT00388674|470373036|FG001|Initial Treatment|Lost to Follow-up|624|||
130658452|NCT00388674|470373035|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
130658453|NCT00388674|470373036|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
130658454|NCT00388674|470373035|FG000|Initial Treatment|Never Treated with Study Medication|1|||
130658455|NCT00388674|470373036|FG001|Initial Treatment|Never Treated with Study Medication|7|||
130658456|NCT00388674|470373035|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
130658457|NCT00388674|470373036|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
130658458|NCT00388674|470373035|FG000|Initial Treatment|Not Defined|125|||
130658459|NCT00388674|470373036|FG001|Initial Treatment|Not Defined|172|||
130658460|NCT00388674|470373035|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
130658461|NCT00388674|470373036|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
130658462|NCT00388674|470373035|FG000|Initial Treatment|Pregnancy|26|||
130658463|NCT00388674|470373036|FG001|Initial Treatment|Pregnancy|16|||
130658464|NCT00388674|470373035|FG000|Initial Treatment|Study Drug Toxicity|5|||
130658465|NCT00388674|470373036|FG001|Initial Treatment|Study Drug Toxicity|92|||
130658466|NCT00388674|470373035|FG000|Initial Treatment|Participant Request|501|||
130658467|NCT00388674|470373036|FG001|Initial Treatment|Participant Request|673|||
130658468|NCT00388674|470373035|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
130328304|NCT05567783|469171678|FG002|Overall Study|Withdrawal by Subject|24|||
130658469|NCT00388674|470373036|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
130658470|NCT00388674|470373035|FG000|Initial Treatment|Not Reported|10|||
130658471|NCT00388674|470373036|FG001|Initial Treatment|Not Reported|12|||
130658472|NCT00388674|470373035|FG000|End of Study|Administrative Reason By Sponsor|299|||
130328305|NCT05567783|469171676|FG000|Overall Study|Incarcerated|1|||
130328306|NCT05567783|469171677|FG001|Overall Study|Incarcerated|0|||
130658473|NCT00388674|470373036|FG001|End of Study|Administrative Reason By Sponsor|253|||
130658474|NCT00388674|470373035|FG000|End of Study|Death|239|||
130658475|NCT00388674|470373036|FG001|End of Study|Death|262|||
130328307|NCT05567783|469171678|FG002|Overall Study|Incarcerated|0|||
130328308|NCT05567783|469171676|FG000|Overall Study|Participant randomized in error|4|||
130328309|NCT05567783|469171677|FG001|Overall Study|Participant randomized in error|2|||
130328310|NCT05567783|469171678|FG002|Overall Study|Participant randomized in error|2|||
130658476|NCT00388674|470373035|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
130658477|NCT00388674|470373036|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
130328311|NCT03944577|469171684|FG000|Overall Study|Adverse Event|3|||
130328312|NCT04119414|469171685|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
130328313|NCT01352793|469171689|FG000|Overall Study|Lost to Follow-up|289|||
130328314|NCT01352793|469171690|FG001|Overall Study|Lost to Follow-up|125|||
130328315|NCT01352793|469171689|FG000|Overall Study|Withdrawal by Subject|120|||
130328316|NCT01352793|469171690|FG001|Overall Study|Withdrawal by Subject|55|||
130328317|NCT01352793|469171689|FG000|Overall Study|Protocol Violation|44|||
130328318|NCT01352793|469171690|FG001|Overall Study|Protocol Violation|23|||
130328319|NCT01352793|469171689|FG000|Overall Study|Adverse Event|44|||
130328320|NCT01352793|469171690|FG001|Overall Study|Adverse Event|10|||
130328321|NCT01352793|469171689|FG000|Overall Study|Physician Decision|1|||
130328322|NCT01352793|469171690|FG001|Overall Study|Physician Decision|0|||
130328323|NCT01352793|469171689|FG000|Overall Study|Pregnancy|26|||
130328324|NCT01352793|469171690|FG001|Overall Study|Pregnancy|8|||
130328325|NCT01352793|469171689|FG000|Overall Study|Other|25|||
130328326|NCT01352793|469171690|FG001|Overall Study|Other|7|||
130328327|NCT01352793|469171689|FG000|Overall Study|Medication error|2|||
130328328|NCT01352793|469171690|FG001|Overall Study|Medication error|2|||
130328329|NCT01352793|469171689|FG000|Overall Study|Death|1|||
130328330|NCT01352793|469171690|FG001|Overall Study|Death|0|||
130328331|NCT01352793|469171689|FG000|Overall Study|Randomized but not vaccinated|8|||
130328332|NCT01352793|469171690|FG001|Overall Study|Randomized but not vaccinated|0|||
130328333|NCT01352793|469171689|FG000|Overall Study|No longer meets eligibility criteria|25|||
130328334|NCT01352793|469171690|FG001|Overall Study|No longer meets eligibility criteria|15|||
130328335|NCT01716234|469171695|FG000|Overall Study|Protocol Violation|0|||
130328336|NCT01716234|469171696|FG001|Overall Study|Protocol Violation|0|||
130328337|NCT01716234|469171697|FG002|Overall Study|Protocol Violation|0|||
130328338|NCT01716234|469171698|FG003|Overall Study|Protocol Violation|1|||
130328339|NCT01716234|469171699|FG004|Overall Study|Protocol Violation|1|||
130328340|NCT01716234|469171700|FG005|Overall Study|Protocol Violation|1|||
130328341|NCT01716234|469171701|FG006|Overall Study|Protocol Violation|0|||
130328342|NCT01716234|469171695|FG000|Overall Study|Lack of Efficacy|0|||
130328343|NCT01716234|469171696|FG001|Overall Study|Lack of Efficacy|0|||
130328344|NCT01716234|469171697|FG002|Overall Study|Lack of Efficacy|0|||
130328345|NCT01716234|469171698|FG003|Overall Study|Lack of Efficacy|1|||
130328346|NCT01716234|469171699|FG004|Overall Study|Lack of Efficacy|0|||
130328347|NCT01716234|469171700|FG005|Overall Study|Lack of Efficacy|0|||
130328348|NCT01716234|469171701|FG006|Overall Study|Lack of Efficacy|0|||
130328349|NCT01716234|469171695|FG000|Overall Study|Did not meet protocol eligibility|0|||
130328350|NCT01716234|469171696|FG001|Overall Study|Did not meet protocol eligibility|0|||
130328351|NCT01716234|469171697|FG002|Overall Study|Did not meet protocol eligibility|1|||
130328352|NCT01716234|469171698|FG003|Overall Study|Did not meet protocol eligibility|0|||
130328353|NCT01716234|469171699|FG004|Overall Study|Did not meet protocol eligibility|0|||
130328354|NCT01716234|469171700|FG005|Overall Study|Did not meet protocol eligibility|4|||
130328355|NCT01716234|469171701|FG006|Overall Study|Did not meet protocol eligibility|0|||
130328356|NCT01716234|469171695|FG000|Overall Study|Adverse Event|7|||
130328357|NCT01716234|469171696|FG001|Overall Study|Adverse Event|10|||
130328358|NCT01716234|469171697|FG002|Overall Study|Adverse Event|2|||
130328359|NCT01716234|469171698|FG003|Overall Study|Adverse Event|8|||
130328360|NCT01716234|469171699|FG004|Overall Study|Adverse Event|3|||
130328361|NCT01716234|469171700|FG005|Overall Study|Adverse Event|6|||
130328362|NCT01716234|469171701|FG006|Overall Study|Adverse Event|0|||
130328363|NCT01716234|469171695|FG000|Overall Study|Withdrawal by Subject|3|||
130328364|NCT01716234|469171696|FG001|Overall Study|Withdrawal by Subject|0|||
130328365|NCT01716234|469171697|FG002|Overall Study|Withdrawal by Subject|2|||
130328366|NCT01716234|469171698|FG003|Overall Study|Withdrawal by Subject|2|||
130328367|NCT01716234|469171699|FG004|Overall Study|Withdrawal by Subject|1|||
130328368|NCT01716234|469171700|FG005|Overall Study|Withdrawal by Subject|3|||
130328369|NCT01716234|469171701|FG006|Overall Study|Withdrawal by Subject|0|||
130658478|NCT00388674|470373035|FG000|End of Study|HCC|8|||
130658479|NCT00388674|470373036|FG001|End of Study|HCC|7|||
130658480|NCT00388674|470373035|FG000|End of Study|Lost to Follow-up|587|||
130658481|NCT00388674|470373036|FG001|End of Study|Lost to Follow-up|715|||
130658482|NCT00388674|470373035|FG000|End of Study|Malignancy (Non-HCC)|1|||
130328370|NCT03326713|469171703|FG000|Overall Study|Death|2|||
130328371|NCT03326713|469171704|FG001|Overall Study|Death|1|||
130328372|NCT03326713|469171705|FG002|Overall Study|Death|0|||
130658483|NCT00388674|470373036|FG001|End of Study|Malignancy (Non-HCC)|1|||
130658484|NCT00388674|470373035|FG000|End of Study|Non-Study Related Comorbidities|3|||
130658485|NCT00388674|470373036|FG001|End of Study|Non-Study Related Comorbidities|4|||
130658486|NCT00388674|470373035|FG000|End of Study|Not Defined|135|||
130658487|NCT00388674|470373036|FG001|End of Study|Not Defined|214|||
130658488|NCT00388674|470373035|FG000|End of Study|Participant Withdrew Consent|437|||
130658489|NCT00388674|470373036|FG001|End of Study|Participant Withdrew Consent|673|||
130328373|NCT03326713|469171703|FG000|Overall Study|Lost to Follow-up|20|||
130328374|NCT03326713|469171704|FG001|Overall Study|Lost to Follow-up|21|||
130328375|NCT03326713|469171705|FG002|Overall Study|Lost to Follow-up|33|||
130328376|NCT03326713|469171703|FG000|Overall Study|Withdrawal by Subject|1|||
130328377|NCT03326713|469171704|FG001|Overall Study|Withdrawal by Subject|2|||
130658490|NCT00388674|470373035|FG000|End of Study|No Off-Treatment Status Data|22|||
130658491|NCT00388674|470373036|FG001|End of Study|No Off-Treatment Status Data|30|||
130658492|NCT00388674|470373035|FG000|End of Study|Not Reported|0|||
130658493|NCT00388674|470373036|FG001|End of Study|Not Reported|1|||
130328378|NCT03326713|469171705|FG002|Overall Study|Withdrawal by Subject|11|||
130328379|NCT03326713|469171703|FG000|Overall Study|Found Ineligible|11|||
130328380|NCT03326713|469171704|FG001|Overall Study|Found Ineligible|11|||
130328381|NCT03326713|469171705|FG002|Overall Study|Found Ineligible|8|||
130328382|NCT01394016|469171708|FG000|Overall Study|Progressive Disease|2|||
130328383|NCT01394016|469171709|FG001|Overall Study|Progressive Disease|0|||
130328384|NCT01394016|469171710|FG002|Overall Study|Progressive Disease|0|||
130328385|NCT01394016|469171711|FG003|Overall Study|Progressive Disease|0|||
130328386|NCT01394016|469171712|FG004|Overall Study|Progressive Disease|0|||
130328387|NCT01394016|469171713|FG005|Overall Study|Progressive Disease|0|||
130328388|NCT01394016|469171714|FG006|Overall Study|Progressive Disease|0|||
130328389|NCT01394016|469171715|FG007|Overall Study|Progressive Disease|0|||
130328390|NCT01394016|469171716|FG008|Overall Study|Progressive Disease|0|||
130328391|NCT01394016|469171717|FG009|Overall Study|Progressive Disease|0|||
130328392|NCT01394016|469171718|FG010|Overall Study|Progressive Disease|0|||
130328393|NCT01394016|469171719|FG011|Overall Study|Progressive Disease|0|||
130328394|NCT01394016|469171720|FG012|Overall Study|Progressive Disease|0|||
130328395|NCT01394016|469171721|FG013|Overall Study|Progressive Disease|0|||
130328396|NCT01394016|469171722|FG014|Overall Study|Progressive Disease|0|||
130328397|NCT01394016|469171723|FG015|Overall Study|Progressive Disease|0|||
130328398|NCT01394016|469171724|FG016|Overall Study|Progressive Disease|0|||
130328399|NCT01394016|469171725|FG017|Overall Study|Progressive Disease|0|||
130328400|NCT01394016|469171726|FG018|Overall Study|Progressive Disease|0|||
130328401|NCT01394016|469171708|FG000|Overall Study|Withdrawal by Subject|0|||
130328402|NCT01394016|469171709|FG001|Overall Study|Withdrawal by Subject|0|||
130328403|NCT01394016|469171710|FG002|Overall Study|Withdrawal by Subject|0|||
130328404|NCT01394016|469171711|FG003|Overall Study|Withdrawal by Subject|0|||
130328405|NCT01394016|469171712|FG004|Overall Study|Withdrawal by Subject|0|||
130328406|NCT01394016|469171713|FG005|Overall Study|Withdrawal by Subject|0|||
130328407|NCT01394016|469171714|FG006|Overall Study|Withdrawal by Subject|0|||
130328408|NCT01394016|469171715|FG007|Overall Study|Withdrawal by Subject|1|||
130328409|NCT01394016|469171716|FG008|Overall Study|Withdrawal by Subject|1|||
130328410|NCT01394016|469171717|FG009|Overall Study|Withdrawal by Subject|1|||
130328411|NCT01394016|469171718|FG010|Overall Study|Withdrawal by Subject|4|||
130328412|NCT01394016|469171719|FG011|Overall Study|Withdrawal by Subject|0|||
130328413|NCT01394016|469171720|FG012|Overall Study|Withdrawal by Subject|0|||
130328414|NCT01394016|469171721|FG013|Overall Study|Withdrawal by Subject|3|||
130328415|NCT01394016|469171722|FG014|Overall Study|Withdrawal by Subject|1|||
130328416|NCT01394016|469171723|FG015|Overall Study|Withdrawal by Subject|3|||
130328417|NCT01394016|469171724|FG016|Overall Study|Withdrawal by Subject|1|||
130658494|NCT00568776|470373037|FG000|Overall Study|Adverse Event|8|||
130658495|NCT00568776|470373038|FG001|Overall Study|Adverse Event|8|||
130328418|NCT01394016|469171725|FG017|Overall Study|Withdrawal by Subject|1|||
130328419|NCT01394016|469171726|FG018|Overall Study|Withdrawal by Subject|2|||
130328420|NCT01394016|469171708|FG000|Overall Study|Adverse Event|0|||
130328421|NCT01394016|469171709|FG001|Overall Study|Adverse Event|0|||
130328422|NCT01394016|469171710|FG002|Overall Study|Adverse Event|0|||
130328423|NCT01394016|469171711|FG003|Overall Study|Adverse Event|0|||
130328424|NCT01394016|469171712|FG004|Overall Study|Adverse Event|0|||
130328425|NCT01394016|469171713|FG005|Overall Study|Adverse Event|0|||
130658496|NCT00568776|470373039|FG002|Overall Study|Adverse Event|10|||
130658497|NCT00568776|470373040|FG003|Overall Study|Adverse Event|8|||
130658498|NCT00568776|470373037|FG000|Overall Study|Death|0|||
130658499|NCT00568776|470373038|FG001|Overall Study|Death|1|||
130658500|NCT00568776|470373039|FG002|Overall Study|Death|4|||
130658501|NCT00568776|470373040|FG003|Overall Study|Death|3|||
130328426|NCT01394016|469171714|FG006|Overall Study|Adverse Event|0|||
130658502|NCT00568776|470373037|FG000|Overall Study|Physician Decision|0|||
130658503|NCT00568776|470373038|FG001|Overall Study|Physician Decision|2|||
130658504|NCT00568776|470373039|FG002|Overall Study|Physician Decision|0|||
130215612|NCT00262002|468751781|FG004|Overall Study|Withdrawal by Subject|2|||
130215613|NCT00262002|468751782|FG005|Overall Study|Withdrawal by Subject|2|||
130328427|NCT01394016|469171715|FG007|Overall Study|Adverse Event|0|||
130328428|NCT01394016|469171716|FG008|Overall Study|Adverse Event|0|||
130328429|NCT01394016|469171717|FG009|Overall Study|Adverse Event|1|||
130328430|NCT01394016|469171718|FG010|Overall Study|Adverse Event|0|||
130328431|NCT01394016|469171719|FG011|Overall Study|Adverse Event|0|||
130328432|NCT01394016|469171720|FG012|Overall Study|Adverse Event|0|||
130328433|NCT01394016|469171721|FG013|Overall Study|Adverse Event|0|||
130658505|NCT00568776|470373040|FG003|Overall Study|Physician Decision|0|||
130658506|NCT00568776|470373037|FG000|Overall Study|Lack of Efficacy|2|||
130658507|NCT00568776|470373038|FG001|Overall Study|Lack of Efficacy|2|||
130215614|NCT00262002|468751783|FG006|Overall Study|Withdrawal by Subject|2|||
130328434|NCT01394016|469171722|FG014|Overall Study|Adverse Event|0|||
130328435|NCT01394016|469171723|FG015|Overall Study|Adverse Event|0|||
130658508|NCT00568776|470373039|FG002|Overall Study|Lack of Efficacy|2|||
130658509|NCT00568776|470373040|FG003|Overall Study|Lack of Efficacy|4|||
130658510|NCT00568776|470373037|FG000|Overall Study|Lost to Follow-up|1|||
130658511|NCT00568776|470373038|FG001|Overall Study|Lost to Follow-up|1|||
130658512|NCT00568776|470373039|FG002|Overall Study|Lost to Follow-up|1|||
130658513|NCT00568776|470373040|FG003|Overall Study|Lost to Follow-up|1|||
130658514|NCT00568776|470373037|FG000|Overall Study|Protocol Violation|1|||
130658515|NCT00568776|470373038|FG001|Overall Study|Protocol Violation|0|||
130658516|NCT00568776|470373039|FG002|Overall Study|Protocol Violation|1|||
130658517|NCT00568776|470373040|FG003|Overall Study|Protocol Violation|1|||
130658518|NCT00568776|470373037|FG000|Overall Study|Withdrawal by Subject|13|||
130658519|NCT00568776|470373038|FG001|Overall Study|Withdrawal by Subject|15|||
130658520|NCT00568776|470373039|FG002|Overall Study|Withdrawal by Subject|13|||
130658521|NCT00568776|470373040|FG003|Overall Study|Withdrawal by Subject|7|||
130658522|NCT00568776|470373037|FG000|Overall Study|Loss of Caregiver|0|||
130658523|NCT00568776|470373038|FG001|Overall Study|Loss of Caregiver|2|||
130658524|NCT00568776|470373039|FG002|Overall Study|Loss of Caregiver|1|||
130658525|NCT00568776|470373040|FG003|Overall Study|Loss of Caregiver|2|||
130658526|NCT00568776|470373037|FG000|Overall Study|Sponsor Decision|2|||
130658527|NCT00568776|470373038|FG001|Overall Study|Sponsor Decision|2|||
130658528|NCT00568776|470373039|FG002|Overall Study|Sponsor Decision|41|||
130215615|NCT00262002|468751777|FG000|Overall Study|Lost to Follow-up|2|||
130328436|NCT01394016|469171724|FG016|Overall Study|Adverse Event|1|||
130328437|NCT01394016|469171725|FG017|Overall Study|Adverse Event|1|||
130328438|NCT01394016|469171726|FG018|Overall Study|Adverse Event|0|||
130328439|NCT01394016|469171708|FG000|Overall Study|Sponsor Decision|0|||
130328440|NCT01394016|469171709|FG001|Overall Study|Sponsor Decision|0|||
130328441|NCT01394016|469171710|FG002|Overall Study|Sponsor Decision|0|||
130328442|NCT01394016|469171711|FG003|Overall Study|Sponsor Decision|0|||
130328443|NCT01394016|469171712|FG004|Overall Study|Sponsor Decision|0|||
130328444|NCT01394016|469171713|FG005|Overall Study|Sponsor Decision|0|||
130328445|NCT01394016|469171714|FG006|Overall Study|Sponsor Decision|0|||
130328446|NCT01394016|469171715|FG007|Overall Study|Sponsor Decision|0|||
130328447|NCT01394016|469171716|FG008|Overall Study|Sponsor Decision|0|||
130328448|NCT01394016|469171717|FG009|Overall Study|Sponsor Decision|0|||
130328449|NCT01394016|469171718|FG010|Overall Study|Sponsor Decision|0|||
130328450|NCT01394016|469171719|FG011|Overall Study|Sponsor Decision|0|||
130328451|NCT01394016|469171720|FG012|Overall Study|Sponsor Decision|1|||
130328452|NCT01394016|469171721|FG013|Overall Study|Sponsor Decision|0|||
130328453|NCT01394016|469171722|FG014|Overall Study|Sponsor Decision|0|||
130328454|NCT01394016|469171723|FG015|Overall Study|Sponsor Decision|0|||
130328455|NCT01394016|469171724|FG016|Overall Study|Sponsor Decision|0|||
130328456|NCT01394016|469171725|FG017|Overall Study|Sponsor Decision|0|||
130328457|NCT01394016|469171726|FG018|Overall Study|Sponsor Decision|0|||
130328458|NCT01394016|469171708|FG000|Overall Study|Lost to Follow-up|0|||
130328459|NCT01394016|469171709|FG001|Overall Study|Lost to Follow-up|0|||
130328460|NCT01394016|469171710|FG002|Overall Study|Lost to Follow-up|0|||
130328461|NCT01394016|469171711|FG003|Overall Study|Lost to Follow-up|0|||
130328462|NCT01394016|469171712|FG004|Overall Study|Lost to Follow-up|0|||
130328463|NCT01394016|469171713|FG005|Overall Study|Lost to Follow-up|0|||
130328464|NCT01394016|469171714|FG006|Overall Study|Lost to Follow-up|0|||
130328465|NCT01394016|469171715|FG007|Overall Study|Lost to Follow-up|0|||
130328466|NCT01394016|469171716|FG008|Overall Study|Lost to Follow-up|0|||
130328467|NCT01394016|469171717|FG009|Overall Study|Lost to Follow-up|0|||
130328468|NCT01394016|469171718|FG010|Overall Study|Lost to Follow-up|0|||
130328469|NCT01394016|469171719|FG011|Overall Study|Lost to Follow-up|0|||
130328470|NCT01394016|469171720|FG012|Overall Study|Lost to Follow-up|0|||
130328471|NCT01394016|469171721|FG013|Overall Study|Lost to Follow-up|0|||
130328472|NCT01394016|469171722|FG014|Overall Study|Lost to Follow-up|0|||
130328473|NCT01394016|469171723|FG015|Overall Study|Lost to Follow-up|0|||
130328474|NCT01394016|469171724|FG016|Overall Study|Lost to Follow-up|0|||
130328475|NCT01394016|469171725|FG017|Overall Study|Lost to Follow-up|0|||
130328476|NCT01394016|469171726|FG018|Overall Study|Lost to Follow-up|1|||
130328477|NCT03534804|469171727|FG000|Overall Study|Withdrawal by Subject|1|||
130328478|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
130328479|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
130328480|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
130328481|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
130328482|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
130328483|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
130328484|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130328485|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
130658529|NCT00568776|470373040|FG003|Overall Study|Sponsor Decision|42|||
130658530|NCT00568776|470373037|FG000|Overall Study|Miscellaeneous|3|||
130658531|NCT00568776|470373038|FG001|Overall Study|Miscellaeneous|3|||
130658532|NCT00568776|470373039|FG002|Overall Study|Miscellaeneous|1|||
130658533|NCT00568776|470373040|FG003|Overall Study|Miscellaeneous|4|||
130328486|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130328487|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Other|0|||
130328488|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Other|1|||
130658534|NCT01005680|470373041|FG000|Overall Study|Lost to Follow-up|4|||
130658535|NCT01005680|470373042|FG001|Overall Study|Lost to Follow-up|6|||
130658536|NCT01005680|470373041|FG000|Overall Study|Withdrawal by Subject|1|||
130658537|NCT01005680|470373042|FG001|Overall Study|Withdrawal by Subject|4|||
130658538|NCT01005680|470373041|FG000|Overall Study|Physician Decision|1|||
130658539|NCT01005680|470373042|FG001|Overall Study|Physician Decision|1|||
130658540|NCT00996632|470373043|FG000|Overall Study|Physician Decision|0|||
130658541|NCT00996632|470373044|FG001|Overall Study|Physician Decision|0|||
130658542|NCT02118896|470373057|FG000|Overall Study|Death|4|||
130658543|NCT02118896|470373058|FG001|Overall Study|Death|0|||
130658544|NCT02118896|470373059|FG002|Overall Study|Death|4|||
130658545|NCT02118896|470373060|FG003|Overall Study|Death|6|||
130658546|NCT02118896|470373061|FG004|Overall Study|Death|3|||
130658547|NCT02118896|470373062|FG005|Overall Study|Death|1|||
130658548|NCT02118896|470373063|FG006|Overall Study|Death|0|||
130658549|NCT02118896|470373064|FG007|Overall Study|Death|0|||
130658550|NCT02118896|470373065|FG008|Overall Study|Death|0|||
130658551|NCT02118896|470373066|FG009|Overall Study|Death|0|||
130658552|NCT02118896|470373057|FG000|Overall Study|Adverse Event|5|||
130658553|NCT02118896|470373058|FG001|Overall Study|Adverse Event|4|||
130658554|NCT02118896|470373059|FG002|Overall Study|Adverse Event|4|||
130658555|NCT02118896|470373060|FG003|Overall Study|Adverse Event|5|||
130658556|NCT02118896|470373061|FG004|Overall Study|Adverse Event|5|||
130328489|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Other|0|||
130328490|NCT00174187|469171728|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130328491|NCT00174187|469171729|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130328492|NCT00174187|469171730|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
130328493|NCT00174187|469171728|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130328494|NCT00174187|469171729|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130328495|NCT00174187|469171730|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
130328496|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130328497|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130328498|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
130328499|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130328500|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130328501|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
130328502|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Other|0|||
130328503|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Other|0|||
130328504|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Other|5|||
130328505|NCT00759941|469171731|FG000|Overall Study|Use of medication|1|||
130328506|NCT00759941|469171732|FG001|Overall Study|Use of medication|0|||
130328507|NCT00759941|469171731|FG000|Overall Study|Adverse Event|1|||
130328508|NCT00759941|469171732|FG001|Overall Study|Adverse Event|0|||
130328509|NCT00759941|469171731|FG000|Overall Study|Exited in error by site|1|||
130328510|NCT00759941|469171732|FG001|Overall Study|Exited in error by site|1|||
130328511|NCT06078124|469171733|FG000|Overall Study|Lost to Follow-up|14|||
130328512|NCT06078124|469171734|FG001|Overall Study|Lost to Follow-up|14|||
130328513|NCT01198977|469171735|FG000|Overall Study|Lost to Follow-up|1|||
130328514|NCT01198977|469171736|FG001|Overall Study|Lost to Follow-up|0|||
130328515|NCT01285557|469171737|FG000|Overall Study|Death|173|||
130328516|NCT01285557|469171738|FG001|Overall Study|Death|90|||
130328517|NCT01285557|469171737|FG000|Overall Study|Lost to Follow-up|6|||
130328518|NCT01285557|469171738|FG001|Overall Study|Lost to Follow-up|2|||
130328519|NCT01285557|469171737|FG000|Overall Study|Withdrew Consent|6|||
130328520|NCT01285557|469171738|FG001|Overall Study|Withdrew Consent|1|||
130328521|NCT01285557|469171737|FG000|Overall Study|Sponsor Study Termination|23|||
130328522|NCT01285557|469171738|FG001|Overall Study|Sponsor Study Termination|13|||
130328523|NCT01285557|469171737|FG000|Overall Study|Randomized but not treated|1|||
130328524|NCT01285557|469171738|FG001|Overall Study|Randomized but not treated|1|||
130328525|NCT01285557|469171737|FG000|Overall Study|Study follow-up ongoing|28|||
130328526|NCT01285557|469171738|FG001|Overall Study|Study follow-up ongoing|14|||
130328527|NCT01285557|469171737|FG000|Overall Study|Sponsor Decision|2|||
130328528|NCT01285557|469171738|FG001|Overall Study|Sponsor Decision|1|||
130328529|NCT03467750|469171739|FG000|Overall Study|Surgery canceled|1|||
130328530|NCT03467750|469171740|FG001|Overall Study|Surgery canceled|0|||
130328531|NCT03467750|469171739|FG000|Overall Study|Protocol Violation|1|||
130328532|NCT03467750|469171740|FG001|Overall Study|Protocol Violation|1|||
130328533|NCT03467750|469171739|FG000|Overall Study|Withdrawal by Subject|0|||
130328534|NCT03467750|469171740|FG001|Overall Study|Withdrawal by Subject|1|||
130328535|NCT04922216|469171743|FG000|Overall Study|Withdrawal by Subject|0|||
130328536|NCT04922216|469171744|FG001|Overall Study|Withdrawal by Subject|1|||
130658557|NCT02118896|470373062|FG005|Overall Study|Adverse Event|9|||
130658558|NCT02118896|470373063|FG006|Overall Study|Adverse Event|1|||
130658559|NCT02118896|470373064|FG007|Overall Study|Adverse Event|1|||
130658560|NCT02118896|470373065|FG008|Overall Study|Adverse Event|4|||
130658561|NCT02118896|470373066|FG009|Overall Study|Adverse Event|0|||
130658562|NCT02118896|470373057|FG000|Overall Study|Consent withdrawn|2|||
130658563|NCT02118896|470373058|FG001|Overall Study|Consent withdrawn|0|||
130658564|NCT02118896|470373059|FG002|Overall Study|Consent withdrawn|3|||
130328537|NCT04922216|469171745|FG002|Overall Study|Withdrawal by Subject|0|||
130328538|NCT04922216|469171746|FG003|Overall Study|Withdrawal by Subject|0|||
130328539|NCT04922216|469171747|FG004|Overall Study|Withdrawal by Subject|0|||
130328540|NCT04922216|469171748|FG005|Overall Study|Withdrawal by Subject|0|||
130328541|NCT04922216|469171749|FG006|Overall Study|Withdrawal by Subject|0|||
130328542|NCT04922216|469171750|FG007|Overall Study|Withdrawal by Subject|2|||
130328543|NCT04922216|469171751|FG008|Overall Study|Withdrawal by Subject|0|||
130328544|NCT04922216|469171752|FG009|Overall Study|Withdrawal by Subject|0|||
130328545|NCT04922216|469171753|FG010|Overall Study|Withdrawal by Subject|0|||
130328546|NCT04922216|469171754|FG011|Overall Study|Withdrawal by Subject|0|||
130328547|NCT04922216|469171755|FG012|Overall Study|Withdrawal by Subject|1|||
130328548|NCT04922216|469171756|FG013|Overall Study|Withdrawal by Subject|1|||
130328549|NCT04922216|469171757|FG014|Overall Study|Withdrawal by Subject|1|||
130328550|NCT04922216|469171758|FG015|Overall Study|Withdrawal by Subject|0|||
130328551|NCT04922216|469171759|FG016|Overall Study|Withdrawal by Subject|0|||
130328552|NCT04922216|469171760|FG017|Overall Study|Withdrawal by Subject|1|||
130328553|NCT04922216|469171761|FG018|Overall Study|Withdrawal by Subject|1|||
130328554|NCT04922216|469171762|FG019|Overall Study|Withdrawal by Subject|1|||
130328555|NCT04922216|469171763|FG020|Overall Study|Withdrawal by Subject|1|||
130328556|NCT04922216|469171764|FG021|Overall Study|Withdrawal by Subject|0|||
130328557|NCT04922216|469171765|FG022|Overall Study|Withdrawal by Subject|0|||
130328558|NCT04922216|469171766|FG023|Overall Study|Withdrawal by Subject|2|||
130328559|NCT04922216|469171767|FG024|Overall Study|Withdrawal by Subject|0|||
130328560|NCT04922216|469171768|FG025|Overall Study|Withdrawal by Subject|0|||
130328561|NCT04922216|469171769|FG026|Overall Study|Withdrawal by Subject|1|||
130328562|NCT04922216|469171770|FG027|Overall Study|Withdrawal by Subject|0|||
130328563|NCT04922216|469171771|FG028|Overall Study|Withdrawal by Subject|0|||
130328564|NCT04922216|469171772|FG029|Overall Study|Withdrawal by Subject|0|||
130328565|NCT04922216|469171773|FG030|Overall Study|Withdrawal by Subject|1|||
130328566|NCT04922216|469171774|FG031|Overall Study|Withdrawal by Subject|0|||
130328567|NCT04922216|469171743|FG000|Overall Study|Lost to Follow-up|1|||
130328568|NCT04922216|469171744|FG001|Overall Study|Lost to Follow-up|0|||
130328569|NCT04922216|469171745|FG002|Overall Study|Lost to Follow-up|2|||
130328570|NCT04922216|469171746|FG003|Overall Study|Lost to Follow-up|0|||
130328571|NCT04922216|469171747|FG004|Overall Study|Lost to Follow-up|0|||
130328572|NCT04922216|469171748|FG005|Overall Study|Lost to Follow-up|2|||
130328573|NCT04922216|469171749|FG006|Overall Study|Lost to Follow-up|0|||
130328574|NCT04922216|469171750|FG007|Overall Study|Lost to Follow-up|1|||
130328575|NCT04922216|469171751|FG008|Overall Study|Lost to Follow-up|1|||
130328576|NCT04922216|469171752|FG009|Overall Study|Lost to Follow-up|2|||
130328577|NCT04922216|469171753|FG010|Overall Study|Lost to Follow-up|2|||
130328578|NCT04922216|469171754|FG011|Overall Study|Lost to Follow-up|1|||
130328579|NCT04922216|469171755|FG012|Overall Study|Lost to Follow-up|1|||
130328580|NCT04922216|469171756|FG013|Overall Study|Lost to Follow-up|0|||
130328581|NCT04922216|469171757|FG014|Overall Study|Lost to Follow-up|1|||
130328582|NCT04922216|469171758|FG015|Overall Study|Lost to Follow-up|0|||
130328583|NCT04922216|469171759|FG016|Overall Study|Lost to Follow-up|0|||
130328584|NCT04922216|469171760|FG017|Overall Study|Lost to Follow-up|2|||
130328585|NCT04922216|469171761|FG018|Overall Study|Lost to Follow-up|1|||
130328586|NCT04922216|469171762|FG019|Overall Study|Lost to Follow-up|0|||
130328587|NCT04922216|469171763|FG020|Overall Study|Lost to Follow-up|1|||
130328588|NCT04922216|469171764|FG021|Overall Study|Lost to Follow-up|0|||
130328589|NCT04922216|469171765|FG022|Overall Study|Lost to Follow-up|2|||
130328590|NCT04922216|469171766|FG023|Overall Study|Lost to Follow-up|1|||
130328591|NCT04922216|469171767|FG024|Overall Study|Lost to Follow-up|0|||
130328592|NCT04922216|469171768|FG025|Overall Study|Lost to Follow-up|2|||
130328593|NCT04922216|469171769|FG026|Overall Study|Lost to Follow-up|0|||
130658565|NCT02118896|470373060|FG003|Overall Study|Consent withdrawn|4|||
130658566|NCT02118896|470373061|FG004|Overall Study|Consent withdrawn|1|||
130658567|NCT02118896|470373062|FG005|Overall Study|Consent withdrawn|4|||
130658568|NCT02118896|470373063|FG006|Overall Study|Consent withdrawn|0|||
130658569|NCT02118896|470373064|FG007|Overall Study|Consent withdrawn|0|||
130658570|NCT02118896|470373065|FG008|Overall Study|Consent withdrawn|0|||
130658571|NCT02118896|470373066|FG009|Overall Study|Consent withdrawn|0|||
130328594|NCT04922216|469171770|FG027|Overall Study|Lost to Follow-up|0|||
130328595|NCT04922216|469171771|FG028|Overall Study|Lost to Follow-up|1|||
130328596|NCT04922216|469171772|FG029|Overall Study|Lost to Follow-up|0|||
130328597|NCT04922216|469171773|FG030|Overall Study|Lost to Follow-up|2|||
130328598|NCT04922216|469171774|FG031|Overall Study|Lost to Follow-up|1|||
130328599|NCT04145349|469173325|FG000|Overall Study|Withdrawal by Subject|3|||
130658572|NCT02118896|470373057|FG000|Overall Study|Non-compliance|2|||
130658573|NCT02118896|470373058|FG001|Overall Study|Non-compliance|1|||
130658574|NCT02118896|470373059|FG002|Overall Study|Non-compliance|1|||
130658575|NCT02118896|470373060|FG003|Overall Study|Non-compliance|5|||
130328600|NCT04145349|469173326|FG001|Overall Study|Withdrawal by Subject|0|||
130328601|NCT04145349|469173325|FG000|Overall Study|Lost to Follow-up|0|||
130328602|NCT04145349|469173326|FG001|Overall Study|Lost to Follow-up|1|||
130328603|NCT04145349|469173325|FG000|Overall Study|On study treatment (Ongoing)|0|||
130328604|NCT04145349|469173326|FG001|Overall Study|On study treatment (Ongoing)|1|||
130328605|NCT01148979|469173336|FG000|Overall Study|Lost to Follow-up|0|||
130328606|NCT01148979|469173337|FG001|Overall Study|Lost to Follow-up|1|||
130328607|NCT01646125|469173338|FG000|Overall Study|Untreated|2|||
130328608|NCT01646125|469173339|FG001|Overall Study|Untreated|5|||
130328609|NCT01646125|469173338|FG000|Overall Study|Adverse Event|2|||
130328610|NCT01646125|469173339|FG001|Overall Study|Adverse Event|1|||
130328611|NCT01646125|469173338|FG000|Overall Study|Death|1|||
130328612|NCT01646125|469173339|FG001|Overall Study|Death|1|||
130328613|NCT01646125|469173338|FG000|Overall Study|Physician Decision|1|||
130328614|NCT01646125|469173339|FG001|Overall Study|Physician Decision|3|||
130328615|NCT01646125|469173338|FG000|Overall Study|Progressive disease|22|||
130328616|NCT01646125|469173339|FG001|Overall Study|Progressive disease|16|||
130328617|NCT01646125|469173338|FG000|Overall Study|Study terminated by sponsor|2|||
130328618|NCT01646125|469173339|FG001|Overall Study|Study terminated by sponsor|1|||
130328619|NCT01646125|469173338|FG000|Overall Study|Subject/Guardian decision|1|||
130328620|NCT01646125|469173339|FG001|Overall Study|Subject/Guardian decision|1|||
130328621|NCT00775190|469173340|FG000|Overall Study|Lost to Follow-up|2|||
130328622|NCT00775190|469173341|FG001|Overall Study|Lost to Follow-up|3|||
130328623|NCT00775190|469173340|FG000|Overall Study|Withdrawal by Subject|1|||
130328624|NCT00775190|469173341|FG001|Overall Study|Withdrawal by Subject|2|||
130328625|NCT00775190|469173340|FG000|Overall Study|Protocol Violation|1|||
130328626|NCT00775190|469173341|FG001|Overall Study|Protocol Violation|0|||
130328627|NCT04610281|469173346|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
130328628|NCT04610281|469173347|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
130328629|NCT00918255|469173349|FG000|Overall Study|Adverse Event|1|||
130328630|NCT00918255|469173350|FG001|Overall Study|Adverse Event|0|||
130328631|NCT00918255|469173351|FG002|Overall Study|Adverse Event|0|||
130328632|NCT00918255|469173349|FG000|Overall Study|Withdrawal by Subject|1|||
130328633|NCT00918255|469173350|FG001|Overall Study|Withdrawal by Subject|0|||
130328634|NCT00918255|469173351|FG002|Overall Study|Withdrawal by Subject|2|||
130328635|NCT00918255|469173349|FG000|Overall Study|Lack of Efficacy|1|||
130328636|NCT00918255|469173350|FG001|Overall Study|Lack of Efficacy|0|||
130328637|NCT00918255|469173351|FG002|Overall Study|Lack of Efficacy|0|||
130328638|NCT00918255|469173349|FG000|Overall Study|Lost to Follow-up|1|||
130328639|NCT00918255|469173350|FG001|Overall Study|Lost to Follow-up|0|||
130328640|NCT00918255|469173351|FG002|Overall Study|Lost to Follow-up|2|||
130328641|NCT00918255|469173349|FG000|Overall Study|Exceeded allowed number of interventions|0|||
130328642|NCT00918255|469173350|FG001|Overall Study|Exceeded allowed number of interventions|0|||
130328643|NCT00918255|469173351|FG002|Overall Study|Exceeded allowed number of interventions|1|||
130328644|NCT00918255|469173349|FG000|Overall Study|Non-compliance|1|||
130658576|NCT02118896|470373061|FG004|Overall Study|Non-compliance|0|||
130658577|NCT02118896|470373062|FG005|Overall Study|Non-compliance|1|||
130658578|NCT02118896|470373063|FG006|Overall Study|Non-compliance|0|||
130658579|NCT02118896|470373064|FG007|Overall Study|Non-compliance|1|||
130658580|NCT02118896|470373065|FG008|Overall Study|Non-compliance|0|||
130658581|NCT02118896|470373066|FG009|Overall Study|Non-compliance|0|||
130658582|NCT02118896|470373057|FG000|Overall Study|Pregnancy|1|||
130658583|NCT02118896|470373058|FG001|Overall Study|Pregnancy|1|||
130658584|NCT02118896|470373059|FG002|Overall Study|Pregnancy|0|||
130658585|NCT02118896|470373060|FG003|Overall Study|Pregnancy|0|||
130658586|NCT02118896|470373061|FG004|Overall Study|Pregnancy|1|||
130658587|NCT02118896|470373062|FG005|Overall Study|Pregnancy|3|||
130658588|NCT02118896|470373063|FG006|Overall Study|Pregnancy|1|||
130658589|NCT02118896|470373064|FG007|Overall Study|Pregnancy|0|||
130658590|NCT02118896|470373065|FG008|Overall Study|Pregnancy|0|||
130658591|NCT02118896|470373066|FG009|Overall Study|Pregnancy|0|||
130658592|NCT02118896|470373057|FG000|Overall Study|Lost to Follow-up|1|||
130658593|NCT02118896|470373058|FG001|Overall Study|Lost to Follow-up|2|||
130658594|NCT02118896|470373059|FG002|Overall Study|Lost to Follow-up|1|||
130658595|NCT02118896|470373060|FG003|Overall Study|Lost to Follow-up|0|||
130658596|NCT02118896|470373061|FG004|Overall Study|Lost to Follow-up|2|||
130658597|NCT02118896|470373062|FG005|Overall Study|Lost to Follow-up|1|||
130215616|NCT00262002|468751778|FG001|Overall Study|Lost to Follow-up|0|||
130658598|NCT02118896|470373063|FG006|Overall Study|Lost to Follow-up|0|||
130658599|NCT02118896|470373064|FG007|Overall Study|Lost to Follow-up|0|||
130215617|NCT00262002|468751779|FG002|Overall Study|Lost to Follow-up|0|||
130658600|NCT02118896|470373065|FG008|Overall Study|Lost to Follow-up|0|||
130215618|NCT00262002|468751780|FG003|Overall Study|Lost to Follow-up|2|||
130328645|NCT00918255|469173350|FG001|Overall Study|Non-compliance|0|||
130328646|NCT00918255|469173351|FG002|Overall Study|Non-compliance|0|||
130328647|NCT00918255|469173349|FG000|Overall Study|Investigator discretion|1|||
130328648|NCT00918255|469173350|FG001|Overall Study|Investigator discretion|0|||
130328649|NCT00918255|469173351|FG002|Overall Study|Investigator discretion|0|||
130328650|NCT03557034|469173352|FG000|Overall Study|Withdrawal by Subject|1|||
130328651|NCT03557034|469173353|FG001|Overall Study|Withdrawal by Subject|0|||
130328652|NCT00719472|469173354|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
130658601|NCT02118896|470373066|FG009|Overall Study|Lost to Follow-up|0|||
130658602|NCT02118896|470373057|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
130658603|NCT02118896|470373058|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
130658604|NCT02118896|470373059|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
130658605|NCT02118896|470373060|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
130658606|NCT02118896|470373061|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
130658607|NCT02118896|470373062|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
130658608|NCT02118896|470373063|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130658609|NCT02118896|470373064|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130658610|NCT02118896|470373065|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130658611|NCT02118896|470373066|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
130658612|NCT02118896|470373057|FG000|Overall Study|Prohibited medication|0|||
130658613|NCT02118896|470373058|FG001|Overall Study|Prohibited medication|0|||
130658614|NCT02118896|470373059|FG002|Overall Study|Prohibited medication|0|||
130658615|NCT02118896|470373060|FG003|Overall Study|Prohibited medication|0|||
130658616|NCT02118896|470373061|FG004|Overall Study|Prohibited medication|1|||
130658617|NCT02118896|470373062|FG005|Overall Study|Prohibited medication|3|||
130658618|NCT02118896|470373063|FG006|Overall Study|Prohibited medication|0|||
130658619|NCT02118896|470373064|FG007|Overall Study|Prohibited medication|0|||
130658620|NCT02118896|470373065|FG008|Overall Study|Prohibited medication|0|||
130658621|NCT02118896|470373066|FG009|Overall Study|Prohibited medication|0|||
130658622|NCT02118896|470373057|FG000|Overall Study|Miscellaneous|1|||
130658623|NCT02118896|470373058|FG001|Overall Study|Miscellaneous|2|||
130658624|NCT02118896|470373059|FG002|Overall Study|Miscellaneous|0|||
130658625|NCT02118896|470373060|FG003|Overall Study|Miscellaneous|2|||
130658626|NCT02118896|470373061|FG004|Overall Study|Miscellaneous|0|||
130658627|NCT02118896|470373062|FG005|Overall Study|Miscellaneous|4|||
130658628|NCT02118896|470373063|FG006|Overall Study|Miscellaneous|0|||
130658629|NCT02118896|470373064|FG007|Overall Study|Miscellaneous|0|||
130658630|NCT02118896|470373065|FG008|Overall Study|Miscellaneous|0|||
130658631|NCT02118896|470373066|FG009|Overall Study|Miscellaneous|0|||
130658632|NCT03901352|470373067|FG000|Double-blind Phase|Adverse Event|6|||
130658633|NCT03901352|470373068|FG001|Double-blind Phase|Adverse Event|4|||
130658634|NCT03901352|470373067|FG000|Double-blind Phase|Death|1|||
130658635|NCT03901352|470373068|FG001|Double-blind Phase|Death|0|||
130658636|NCT03901352|470373067|FG000|Double-blind Phase|Lack of Efficacy|0|||
130658637|NCT03901352|470373068|FG001|Double-blind Phase|Lack of Efficacy|1|||
130658638|NCT03901352|470373067|FG000|Double-blind Phase|Protocol Violation|0|||
130658639|NCT03901352|470373068|FG001|Double-blind Phase|Protocol Violation|1|||
130658640|NCT03901352|470373067|FG000|Double-blind Phase|Withdrawal by Subject|10|||
130658641|NCT03901352|470373068|FG001|Double-blind Phase|Withdrawal by Subject|8|||
130658642|NCT03901352|470373067|FG000|Open-label Extension Phase|Adverse Event|24|||
130658643|NCT03901352|470373068|FG001|Open-label Extension Phase|Adverse Event|0|||
130658644|NCT03901352|470373067|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
130658645|NCT03901352|470373068|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130658646|NCT03901352|470373067|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
130658647|NCT03901352|470373068|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130658648|NCT03901352|470373067|FG000|Open-label Extension Phase|Other|1|||
130658649|NCT03901352|470373068|FG001|Open-label Extension Phase|Other|0|||
130658650|NCT04635631|470373069|FG000|Overall Study|Adverse Event|1|||
130658651|NCT04635631|470373069|FG000|Overall Study|Progressive disease|13|||
130658652|NCT04635631|470373069|FG000|Overall Study|Withdrawal by Subject|1|||
130658653|NCT02050373|470373070|FG000|Overall Study|Adverse Event|4|||
130658654|NCT02050373|470373071|FG001|Overall Study|Adverse Event|7|||
130658655|NCT02050373|470373070|FG000|Overall Study|Death|3|||
130658656|NCT02050373|470373071|FG001|Overall Study|Death|3|||
130658657|NCT03901339|470373073|FG000|Overall Study|Death|220|||
130658658|NCT03901339|470373074|FG001|Overall Study|Death|192|||
130658659|NCT03901339|470373073|FG000|Overall Study|Informed consent withdrawn|13|||
130658660|NCT03901339|470373074|FG001|Overall Study|Informed consent withdrawn|40|||
130658661|NCT03901339|470373073|FG000|Overall Study|Sponsor request|30|||
130658662|NCT03901339|470373074|FG001|Overall Study|Sponsor request|23|||
130658663|NCT03901339|470373073|FG000|Overall Study|Reason not specified|5|||
130658664|NCT03901339|470373074|FG001|Overall Study|Reason not specified|7|||
130658665|NCT03901339|470373073|FG000|Overall Study|Lost to Follow-up|4|||
130658666|NCT03901339|470373074|FG001|Overall Study|Lost to Follow-up|7|||
130658667|NCT03901339|470373073|FG000|Overall Study|Covid19|0|||
130658668|NCT03901339|470373074|FG001|Overall Study|Covid19|2|||
130658669|NCT00572910|470373075|FG000|Overall Study|Adverse Event|1|||
130658670|NCT00572910|470373076|FG001|Overall Study|Adverse Event|2|||
130658671|NCT00572910|470373077|FG002|Overall Study|Adverse Event|0|||
130658672|NCT00572910|470373078|FG003|Overall Study|Adverse Event|2|||
130658673|NCT00572910|470373079|FG004|Overall Study|Adverse Event|0|||
130658674|NCT00572910|470373080|FG005|Overall Study|Adverse Event|0|||
130658675|NCT00572910|470373081|FG006|Overall Study|Adverse Event|4|||
130658676|NCT00572910|470373082|FG007|Overall Study|Adverse Event|2|||
130658677|NCT00572910|470373083|FG008|Overall Study|Adverse Event|1|||
130658678|NCT00572910|470373084|FG009|Overall Study|Adverse Event|3|||
130658679|NCT00572910|470373085|FG010|Overall Study|Adverse Event|2|||
130658680|NCT00572910|470373075|FG000|Overall Study|Lost to Follow-up|0|||
130658681|NCT00572910|470373076|FG001|Overall Study|Lost to Follow-up|1|||
130658682|NCT00572910|470373077|FG002|Overall Study|Lost to Follow-up|1|||
130658683|NCT00572910|470373078|FG003|Overall Study|Lost to Follow-up|2|||
130658684|NCT00572910|470373079|FG004|Overall Study|Lost to Follow-up|1|||
130658685|NCT00572910|470373080|FG005|Overall Study|Lost to Follow-up|0|||
130658686|NCT00572910|470373081|FG006|Overall Study|Lost to Follow-up|0|||
130658687|NCT00572910|470373082|FG007|Overall Study|Lost to Follow-up|0|||
130658688|NCT00572910|470373083|FG008|Overall Study|Lost to Follow-up|0|||
130658689|NCT00572910|470373084|FG009|Overall Study|Lost to Follow-up|1|||
130658690|NCT00572910|470373085|FG010|Overall Study|Lost to Follow-up|0|||
130658691|NCT00572910|470373075|FG000|Overall Study|Withdrawal by Subject|3|||
130658692|NCT00572910|470373076|FG001|Overall Study|Withdrawal by Subject|0|||
130658693|NCT00572910|470373077|FG002|Overall Study|Withdrawal by Subject|1|||
130658694|NCT00572910|470373078|FG003|Overall Study|Withdrawal by Subject|0|||
130658695|NCT00572910|470373079|FG004|Overall Study|Withdrawal by Subject|1|||
130658696|NCT00572910|470373080|FG005|Overall Study|Withdrawal by Subject|3|||
130658697|NCT00572910|470373081|FG006|Overall Study|Withdrawal by Subject|0|||
130658698|NCT00572910|470373082|FG007|Overall Study|Withdrawal by Subject|2|||
130658699|NCT00572910|470373083|FG008|Overall Study|Withdrawal by Subject|2|||
130658700|NCT00572910|470373084|FG009|Overall Study|Withdrawal by Subject|2|||
130658701|NCT00572910|470373085|FG010|Overall Study|Withdrawal by Subject|1|||
130658702|NCT00592007|470373090|FG000|Overall Study|Withdrawal by Subject|1|||
130658703|NCT00592007|470373090|FG000|Overall Study|patient ineligible (out of lab range)|1|||
130658704|NCT00457418|470373091|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
130658705|NCT00457418|470373091|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
130658706|NCT00457418|470373091|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
130658707|NCT00457418|470373091|FG000|Post PK Maintenance|Adverse Event|10|||
130658708|NCT00457418|470373091|FG000|Post PK Maintenance|Progression of Disease|6|||
130658709|NCT00457418|470373091|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
130658710|NCT00457418|470373091|FG000|Post PK Maintenance|Lost to Follow-up|1|||
130658711|NCT01785472|470373092|FG000|Overall Study|Adverse Event|5|||
130328653|NCT00719472|469173354|FG000|Enrolled in Study|Subject decision to withdraw|8|||
130328654|NCT00719472|469173354|FG000|Enrolled in Study|Various Reasons|17|||
130328655|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
130328656|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Death|5|||
130328657|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
130658712|NCT01785472|470373093|FG001|Overall Study|Adverse Event|4|||
130658713|NCT01785472|470373094|FG002|Overall Study|Adverse Event|6|||
130658714|NCT01785472|470373092|FG000|Overall Study|Lack of Efficacy|2|||
130658715|NCT01785472|470373093|FG001|Overall Study|Lack of Efficacy|0|||
130658716|NCT01785472|470373094|FG002|Overall Study|Lack of Efficacy|1|||
130658717|NCT01785472|470373092|FG000|Overall Study|Lost to Follow-up|1|||
130658718|NCT01785472|470373093|FG001|Overall Study|Lost to Follow-up|2|||
130658719|NCT01785472|470373094|FG002|Overall Study|Lost to Follow-up|0|||
130658720|NCT01785472|470373092|FG000|Overall Study|Physician Decision|1|||
130658721|NCT01785472|470373093|FG001|Overall Study|Physician Decision|1|||
130658722|NCT01785472|470373094|FG002|Overall Study|Physician Decision|1|||
130658723|NCT01785472|470373092|FG000|Overall Study|Protocol deviation|0|||
130658724|NCT01785472|470373093|FG001|Overall Study|Protocol deviation|2|||
130658725|NCT01785472|470373094|FG002|Overall Study|Protocol deviation|2|||
130658726|NCT01785472|470373092|FG000|Overall Study|Subject/guardian decision|15|||
130658727|NCT01785472|470373093|FG001|Overall Study|Subject/guardian decision|10|||
130658728|NCT01785472|470373094|FG002|Overall Study|Subject/guardian decision|11|||
130658729|NCT01785472|470373092|FG000|Overall Study|Technical problems|0|||
130658730|NCT01785472|470373093|FG001|Overall Study|Technical problems|0|||
130658731|NCT01785472|470373094|FG002|Overall Study|Technical problems|1|||
130658732|NCT00595127|470373095|FG000|Overall Study|Death|6|||
130658733|NCT00595127|470373095|FG000|Overall Study|Relapsed|3|||
130658734|NCT00595127|470373095|FG000|Overall Study|joined another trial|1|||
130658735|NCT02086968|470373097|FG000|Overall Study|Adverse Event|1|||
130658736|NCT02086968|470373098|FG001|Overall Study|Adverse Event|5|||
130658737|NCT02086968|470373097|FG000|Overall Study|Lost to Follow-up|2|||
130658738|NCT02086968|470373098|FG001|Overall Study|Lost to Follow-up|3|||
130658739|NCT02086968|470373097|FG000|Overall Study|Study drug received outside protocol|0|||
130658740|NCT02086968|470373098|FG001|Overall Study|Study drug received outside protocol|1|||
130658741|NCT02086968|470373097|FG000|Overall Study|Physician Decision|4|||
130658742|NCT02086968|470373098|FG001|Overall Study|Physician Decision|0|||
130658743|NCT02086968|470373097|FG000|Overall Study|Withdrawal by Subject|1|||
130215619|NCT00262002|468751781|FG004|Overall Study|Lost to Follow-up|0|||
130658744|NCT02086968|470373098|FG001|Overall Study|Withdrawal by Subject|4|||
130328658|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
130658745|NCT01569074|470373102|FG000|Overall Study|Study stopped|6|||
130658746|NCT01569074|470373103|FG001|Overall Study|Study stopped|6|||
130658747|NCT01569074|470373104|FG002|Overall Study|Study stopped|8|||
130215620|NCT00262002|468751782|FG005|Overall Study|Lost to Follow-up|1|||
130658748|NCT01569074|470373105|FG003|Overall Study|Study stopped|7|||
130658749|NCT01569074|470373106|FG004|Overall Study|Study stopped|7|||
130658750|NCT01569074|470373102|FG000|Overall Study|Study-specific discontinuation criteria|0|||
130658751|NCT01569074|470373103|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130215621|NCT00262002|468751783|FG006|Overall Study|Lost to Follow-up|0|||
130215622|NCT00262002|468751777|FG000|Overall Study|Inapropriate enrollment|0|||
130215623|NCT00262002|468751778|FG001|Overall Study|Inapropriate enrollment|1|||
130215624|NCT00262002|468751779|FG002|Overall Study|Inapropriate enrollment|0|||
130215625|NCT00262002|468751780|FG003|Overall Study|Inapropriate enrollment|0|||
130215626|NCT00262002|468751781|FG004|Overall Study|Inapropriate enrollment|0|||
130215627|NCT00262002|468751782|FG005|Overall Study|Inapropriate enrollment|0|||
130215628|NCT00262002|468751783|FG006|Overall Study|Inapropriate enrollment|0|||
130215629|NCT00262002|468751777|FG000|Overall Study|Protocol Violation|3|||
130215630|NCT00262002|468751778|FG001|Overall Study|Protocol Violation|2|||
130215631|NCT00262002|468751779|FG002|Overall Study|Protocol Violation|0|||
130215632|NCT00262002|468751780|FG003|Overall Study|Protocol Violation|2|||
130215633|NCT00262002|468751781|FG004|Overall Study|Protocol Violation|5|||
130215634|NCT00262002|468751782|FG005|Overall Study|Protocol Violation|3|||
130215635|NCT00262002|468751783|FG006|Overall Study|Protocol Violation|2|||
130215636|NCT00262002|468751777|FG000|Overall Study|Unable to classify|0|||
130215637|NCT00262002|468751778|FG001|Overall Study|Unable to classify|0|||
130215638|NCT00262002|468751779|FG002|Overall Study|Unable to classify|0|||
130215639|NCT00262002|468751780|FG003|Overall Study|Unable to classify|0|||
130215640|NCT00262002|468751781|FG004|Overall Study|Unable to classify|0|||
130215641|NCT00262002|468751782|FG005|Overall Study|Unable to classify|0|||
130215642|NCT00262002|468751783|FG006|Overall Study|Unable to classify|2|||
130215643|NCT01790516|468751784|FG000|Overall Study|Physician Decision|1|||
130215644|NCT01790516|468751785|FG001|Overall Study|Physician Decision|0|||
130215645|NCT01554163|468751786|FG000|Overall Study|Adverse Event|3|||
130215646|NCT01554163|468751787|FG001|Overall Study|Adverse Event|0|||
130215647|NCT01554163|468751786|FG000|Overall Study|Lack of Efficacy|1|||
130215648|NCT01554163|468751787|FG001|Overall Study|Lack of Efficacy|0|||
130215649|NCT01554163|468751786|FG000|Overall Study|Lost to Follow-up|1|||
130215650|NCT01554163|468751787|FG001|Overall Study|Lost to Follow-up|0|||
130215651|NCT01554163|468751786|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130215652|NCT01554163|468751787|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130215653|NCT01554163|468751786|FG000|Overall Study|Protocol Violation|0|||
130215654|NCT01554163|468751787|FG001|Overall Study|Protocol Violation|4|||
130215655|NCT01554163|468751786|FG000|Overall Study|Withdrawal by Subject|1|||
130215656|NCT01554163|468751787|FG001|Overall Study|Withdrawal by Subject|5|||
130215657|NCT01554163|468751786|FG000|Overall Study|Not Treated|1|||
130215658|NCT01554163|468751787|FG001|Overall Study|Not Treated|0|||
130215659|NCT02226120|468751788|FG000|Overall Study|Adverse Event|60|||
130215660|NCT02226120|468751788|FG000|Overall Study|Death|172|||
130215661|NCT02226120|468751788|FG000|Overall Study|Study terminated by sponsor|1|||
130215662|NCT02226120|468751788|FG000|Overall Study|Technical problems|4|||
130215663|NCT02226120|468751788|FG000|Overall Study|Lost to Follow-up|13|||
130215664|NCT02226120|468751788|FG000|Overall Study|Physician Decision|21|||
130215665|NCT02226120|468751788|FG000|Overall Study|Withdrawal by parent/guardian|36|||
130215666|NCT02226120|468751788|FG000|Overall Study|Non-compliance with study drug|10|||
130215667|NCT02226120|468751788|FG000|Overall Study|Protocol deviation|1|||
130215668|NCT02226120|468751788|FG000|Overall Study|missing treatment disposition pages|2|||
130215669|NCT03034135|468751789|FG000|Overall Study|Withdrawal by Subject|2|||
130215670|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
130215671|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
130215672|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
130215673|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
130215674|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
130215675|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
130215676|NCT01972464|468751793|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130215677|NCT01972464|468751794|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130215678|NCT02526160|468753819|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
130215679|NCT02526160|468753820|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
130215680|NCT02526160|468753819|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
130215681|NCT02526160|468753820|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
130215682|NCT02526160|468753819|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130215683|NCT02526160|468753820|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130215684|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Death|0|||
130215685|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Death|1|||
130215686|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
130215687|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
130215688|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
130215689|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
130215690|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
130658752|NCT01569074|470373104|FG002|Overall Study|Study-specific discontinuation criteria|0|||
130658753|NCT01569074|470373105|FG003|Overall Study|Study-specific discontinuation criteria|0|||
130658754|NCT01569074|470373106|FG004|Overall Study|Study-specific discontinuation criteria|0|||
130658755|NCT01569074|470373102|FG000|Overall Study|Severe non-compliance to protocol|0|||
130658756|NCT01569074|470373103|FG001|Overall Study|Severe non-compliance to protocol|0|||
130328659|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
130328660|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
130328661|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
130328662|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Death|6|||
130328663|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Disease progression|3|||
130328664|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
130328665|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
130328666|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
130328667|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
130328668|NCT01244893|469173355|FG000|Baseline|Protocol Violation|0|||
130328669|NCT01244893|469173356|FG001|Baseline|Protocol Violation|1|||
130328670|NCT01244893|469173355|FG000|1-Week Follow Up|Lost to Follow-up|1|||
130328671|NCT01244893|469173356|FG001|1-Week Follow Up|Lost to Follow-up|0|||
130328672|NCT00357552|469173357|FG000|Screening|Did not meet eligibility criteria|84|||
130328673|NCT00357552|469173357|FG000|Weeks 0 to 24|Death|1|||
130328674|NCT00357552|469173357|FG000|Weeks 24 to 104|Death|3|||
130328675|NCT00357552|469173357|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
130328676|NCT00882557|469173360|FG000|Overall Study|Withdrawal by Subject|1|||
130328677|NCT00882557|469173361|FG001|Overall Study|Withdrawal by Subject|0|||
130328678|NCT00882557|469173360|FG000|Overall Study|Trouble with Vein Access|1|||
130328679|NCT00882557|469173361|FG001|Overall Study|Trouble with Vein Access|0|||
130328680|NCT00882557|469173360|FG000|Overall Study|Randomized Not Treated|0|||
130328681|NCT00882557|469173361|FG001|Overall Study|Randomized Not Treated|1|||
130328682|NCT02803580|469173366|FG000|Overall Study|Death|13|||
130328683|NCT02803580|469173366|FG000|Overall Study|Lost to Follow-up|19|||
130328684|NCT02803580|469173366|FG000|Overall Study|Withdrawal by Subject|3|||
130328685|NCT02803580|469173366|FG000|Overall Study|Inclusion in clinical trial|1|||
130328686|NCT02054104|469173371|FG000|Overall Study|Did not want to continue due to college classes|1|||
130328687|NCT02054104|469173372|FG001|Overall Study|Did not want to continue due to college classes|0|||
130328688|NCT02054104|469173371|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
130328689|NCT02054104|469173372|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
130328690|NCT02054104|469173371|FG000|Overall Study|No evidence of immunologic response|2|||
130328691|NCT02054104|469173372|FG001|Overall Study|No evidence of immunologic response|2|||
130328692|NCT02054104|469173371|FG000|Overall Study|Disease Progression On Study|4|||
130328693|NCT02054104|469173372|FG001|Overall Study|Disease Progression On Study|5|||
130328694|NCT02054104|469173371|FG000|Overall Study|Diagnosis of lymphoma|0|||
130328695|NCT02054104|469173372|FG001|Overall Study|Diagnosis of lymphoma|1|||
130328696|NCT02054104|469173371|FG000|Overall Study|Inconclusive response|0|||
130328697|NCT02054104|469173372|FG001|Overall Study|Inconclusive response|1|||
130328698|NCT00084136|469173373|FG000|PI Comparison|Death|10|||
130328699|NCT00084136|469173374|FG001|PI Comparison|Death|9|||
130328700|NCT00084136|469173375|FG002|PI Comparison|Death|0|||
130328701|NCT00084136|469173373|FG000|PI Comparison|Lost to Follow-up|11|||
130328702|NCT00084136|469173374|FG001|PI Comparison|Lost to Follow-up|8|||
130328703|NCT00084136|469173375|FG002|PI Comparison|Lost to Follow-up|0|||
130328704|NCT00084136|469173373|FG000|PI Comparison|Withdrawal by Subject|33|||
130328705|NCT00084136|469173374|FG001|PI Comparison|Withdrawal by Subject|30|||
130328706|NCT00084136|469173375|FG002|PI Comparison|Withdrawal by Subject|0|||
130328707|NCT00084136|469173373|FG000|PI Comparison|Clinic site closed|1|||
130328708|NCT00084136|469173374|FG001|PI Comparison|Clinic site closed|0|||
130328709|NCT00084136|469173375|FG002|PI Comparison|Clinic site closed|0|||
130328710|NCT00084136|469173373|FG000|NRTI Comparison|Death|20|||
130328711|NCT00084136|469173374|FG001|NRTI Comparison|Death|0|||
130328712|NCT00084136|469173375|FG002|NRTI Comparison|Death|18|||
130328713|NCT00084136|469173373|FG000|NRTI Comparison|Lost to Follow-up|14|||
130328714|NCT00084136|469173374|FG001|NRTI Comparison|Lost to Follow-up|0|||
130658757|NCT01569074|470373104|FG002|Overall Study|Severe non-compliance to protocol|1|||
130328715|NCT00084136|469173375|FG002|NRTI Comparison|Lost to Follow-up|12|||
130328716|NCT00084136|469173373|FG000|NRTI Comparison|Withdrawal by Subject|54|||
130328717|NCT00084136|469173374|FG001|NRTI Comparison|Withdrawal by Subject|0|||
130328718|NCT00084136|469173375|FG002|NRTI Comparison|Withdrawal by Subject|38|||
130328719|NCT00084136|469173373|FG000|NRTI Comparison|Clinic site closed|12|||
130328720|NCT00084136|469173374|FG001|NRTI Comparison|Clinic site closed|0|||
130328721|NCT00084136|469173375|FG002|NRTI Comparison|Clinic site closed|14|||
130328722|NCT00084136|469173373|FG000|NRTI Comparison|Not reason above|1|||
130658758|NCT01569074|470373105|FG003|Overall Study|Severe non-compliance to protocol|0|||
130328723|NCT00084136|469173374|FG001|NRTI Comparison|Not reason above|0|||
130328724|NCT00084136|469173375|FG002|NRTI Comparison|Not reason above|0|||
130328725|NCT00836693|469173378|FG000|Overall Study|Adverse Event|4|||
130328726|NCT00836693|469173379|FG001|Overall Study|Adverse Event|1|||
130328727|NCT00836693|469173378|FG000|Overall Study|Sponsor Decision|0|||
130328728|NCT00836693|469173379|FG001|Overall Study|Sponsor Decision|1|||
130328729|NCT00836693|469173378|FG000|Overall Study|Physician Decision|2|||
130328730|NCT00836693|469173379|FG001|Overall Study|Physician Decision|0|||
130328731|NCT00836693|469173378|FG000|Overall Study|Withdrawal by Subject|9|||
130328732|NCT00836693|469173379|FG001|Overall Study|Withdrawal by Subject|4|||
130328733|NCT00836693|469173378|FG000|Overall Study|Protocol Violation|1|||
130328734|NCT00836693|469173379|FG001|Overall Study|Protocol Violation|0|||
130328735|NCT00836693|469173378|FG000|Overall Study|Lost to Follow-up|1|||
130328736|NCT00836693|469173379|FG001|Overall Study|Lost to Follow-up|0|||
130328737|NCT02612779|469173380|FG000|Overall Study|Administrative reason by sponsor|4|||
130328738|NCT02612779|469173381|FG001|Overall Study|Administrative reason by sponsor|1|||
130328739|NCT02612779|469173380|FG000|Overall Study|No longer meet study criteria|0|||
130328740|NCT02612779|469173381|FG001|Overall Study|No longer meet study criteria|1|||
130328741|NCT02612779|469173380|FG000|Overall Study|Disease progression|29|||
130328742|NCT02612779|469173381|FG001|Overall Study|Disease progression|2|||
130328743|NCT02612779|469173380|FG000|Overall Study|Study drug toxicity|10|||
130658759|NCT01569074|470373106|FG004|Overall Study|Severe non-compliance to protocol|0|||
130658760|NCT01569074|470373102|FG000|Overall Study|eg change in circumstances|0|||
130658761|NCT01569074|470373103|FG001|Overall Study|eg change in circumstances|2|||
130658762|NCT01569074|470373104|FG002|Overall Study|eg change in circumstances|0|||
130658763|NCT01569074|470373105|FG003|Overall Study|eg change in circumstances|1|||
130658764|NCT01569074|470373106|FG004|Overall Study|eg change in circumstances|1|||
130658765|NCT01569074|470373102|FG000|Overall Study|Adverse Event|1|||
130658766|NCT01569074|470373103|FG001|Overall Study|Adverse Event|0|||
130658767|NCT01569074|470373104|FG002|Overall Study|Adverse Event|3|||
130658768|NCT01569074|470373105|FG003|Overall Study|Adverse Event|0|||
130658769|NCT01569074|470373106|FG004|Overall Study|Adverse Event|0|||
130658770|NCT03099161|470373107|FG000|Overall Study|Adverse Event|0|||
130658771|NCT03099161|470373108|FG001|Overall Study|Adverse Event|0|||
130658772|NCT03099161|470373109|FG002|Overall Study|Adverse Event|2|||
130658773|NCT03099161|470373107|FG000|Overall Study|Physician Decision|2|||
130658774|NCT03099161|470373108|FG001|Overall Study|Physician Decision|0|||
130658775|NCT03099161|470373109|FG002|Overall Study|Physician Decision|0|||
130658776|NCT03099161|470373107|FG000|Overall Study|Progressive Disease|1|||
130658777|NCT03099161|470373108|FG001|Overall Study|Progressive Disease|4|||
130658778|NCT03099161|470373109|FG002|Overall Study|Progressive Disease|1|||
130658779|NCT02723786|470373111|FG000|Overall Study|Lost to Follow-up|1|||
130658780|NCT00556166|470373123|FG000|Overall Study|Withdrawal by Subject|1|||
130658781|NCT02985515|470373126|FG000|Olfaction Testing|Lost to Follow-up|0|||
130658782|NCT02985515|470373127|FG001|Olfaction Testing|Lost to Follow-up|5|||
130658783|NCT02985515|470373126|FG000|Olfaction Testing|Protocol Violation|0|||
130658784|NCT02985515|470373127|FG001|Olfaction Testing|Protocol Violation|3|||
130658785|NCT00742859|470373132|FG000|Overall Study|Adverse Event|5|||
130658786|NCT00742859|470373133|FG001|Overall Study|Adverse Event|6|||
130658787|NCT00742859|470373134|FG002|Overall Study|Adverse Event|3|||
130658788|NCT00742859|470373135|FG003|Overall Study|Adverse Event|1|||
130658789|NCT00742859|470373132|FG000|Overall Study|Death|1|||
130658790|NCT00742859|470373133|FG001|Overall Study|Death|0|||
130658791|NCT00742859|470373134|FG002|Overall Study|Death|0|||
130658792|NCT00742859|470373135|FG003|Overall Study|Death|1|||
130658793|NCT00742859|470373132|FG000|Overall Study|Physician Decision|1|||
130658794|NCT00742859|470373133|FG001|Overall Study|Physician Decision|2|||
130658795|NCT00742859|470373134|FG002|Overall Study|Physician Decision|0|||
130658796|NCT00742859|470373135|FG003|Overall Study|Physician Decision|0|||
130658797|NCT00742859|470373132|FG000|Overall Study|Withdrawal by Subject|4|||
130658798|NCT00742859|470373133|FG001|Overall Study|Withdrawal by Subject|2|||
130658799|NCT00742859|470373134|FG002|Overall Study|Withdrawal by Subject|4|||
130328744|NCT02612779|469173381|FG001|Overall Study|Study drug toxicity|1|||
130328745|NCT02612779|469173380|FG000|Overall Study|Death|1|||
130328746|NCT02612779|469173381|FG001|Overall Study|Death|0|||
130328747|NCT02612779|469173380|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130328748|NCT02612779|469173381|FG001|Overall Study|Adverse event unrelated to study drug|0|||
130658800|NCT00742859|470373135|FG003|Overall Study|Withdrawal by Subject|1|||
130658801|NCT00742859|470373132|FG000|Overall Study|Endpoint|0|||
130328749|NCT02612779|469173380|FG000|Overall Study|Participant withdrew consent|4|||
130328750|NCT02612779|469173381|FG001|Overall Study|Participant withdrew consent|0|||
130328751|NCT02612779|469173380|FG000|Overall Study|Lost to Follow-up|1|||
130658802|NCT00742859|470373133|FG001|Overall Study|Endpoint|1|||
130658803|NCT00742859|470373134|FG002|Overall Study|Endpoint|1|||
130658804|NCT00742859|470373135|FG003|Overall Study|Endpoint|2|||
130658805|NCT00742859|470373132|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
130328752|NCT02612779|469173381|FG001|Overall Study|Lost to Follow-up|0|||
130328753|NCT02612779|469173380|FG000|Overall Study|Maximum clinical benefit|10|||
130328754|NCT02612779|469173381|FG001|Overall Study|Maximum clinical benefit|1|||
130658806|NCT00742859|470373133|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
130215691|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
130328755|NCT02612779|469173380|FG000|Overall Study|Other reasons|4|||
130328756|NCT02612779|469173381|FG001|Overall Study|Other reasons|0|||
130328757|NCT01657019|469173382|FG000|Overall Study|Withdrawal by Subject|65|||
130328758|NCT01657019|469173382|FG000|Overall Study|Adverse Event|55|||
130328759|NCT01657019|469173382|FG000|Overall Study|Lost to Follow-up|48|||
130328760|NCT01657019|469173382|FG000|Overall Study|Protocol Violation|6|||
130328761|NCT01657019|469173382|FG000|Overall Study|Lack of Efficacy|3|||
130328762|NCT01657019|469173382|FG000|Overall Study|Other|58|||
130328763|NCT01750229|469173385|FG000|Randomized Crossover Phase|Adverse Event|1|||
130328764|NCT01750229|469173385|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
130328765|NCT01750229|469173385|FG000|Long-term Follow-up Phase|Adverse Event|2|||
130328766|NCT01750229|469173385|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
130328767|NCT02346721|469173386|FG000|Overall Study|Withdrew Consent|3|||
130328768|NCT02346721|469173386|FG000|Overall Study|Lack of Efficacy|1|||
130328769|NCT03809104|469173387|FG000|Overall Study|Withdrawal by Subject|3|||
130328770|NCT02968004|469173388|FG000|Main Study Phase|Adverse Event|1|||
130328771|NCT02968004|469173389|FG001|Main Study Phase|Adverse Event|0|||
130658807|NCT00742859|470373134|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
130658808|NCT00742859|470373135|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
130658809|NCT00742859|470373132|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
130658810|NCT00742859|470373133|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
130658811|NCT00742859|470373134|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
130658812|NCT00742859|470373135|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
130658813|NCT00742859|470373132|FG000|Overall Study|Sponsor request patient out of town|0|||
130658814|NCT00742859|470373133|FG001|Overall Study|Sponsor request patient out of town|0|||
130658815|NCT00742859|470373134|FG002|Overall Study|Sponsor request patient out of town|1|||
130658816|NCT00742859|470373135|FG003|Overall Study|Sponsor request patient out of town|1|||
130658817|NCT00742859|470373132|FG000|Overall Study|Site error|0|||
130658818|NCT00742859|470373133|FG001|Overall Study|Site error|0|||
130658819|NCT00742859|470373134|FG002|Overall Study|Site error|1|||
130658820|NCT00742859|470373135|FG003|Overall Study|Site error|1|||
130658821|NCT00962013|470373140|FG000|Overall Study|Did not have surgery|1|||
130658822|NCT00962013|470373140|FG000|Overall Study|Death|8|||
130658823|NCT00962013|470373140|FG000|Overall Study|Lost to Follow-up|12|||
130658824|NCT00962013|470373140|FG000|Overall Study|Unable/Unwilling to return|6|||
130658825|NCT00962013|470373140|FG000|Overall Study|Withdrawal by Subject|8|||
130658826|NCT00962013|470373140|FG000|Overall Study|Removal of study device|3|||
130658827|NCT00962013|470373140|FG000|Overall Study|Site Termination|24|||
130658828|NCT00962013|470373140|FG000|Overall Study|No 5 year evaluation|6|||
130658829|NCT01984229|470373149|FG000|Safety Follow-up Period|Adverse Event|1|||
130658830|NCT01984229|470373150|FG001|Safety Follow-up Period|Adverse Event|1|||
130658831|NCT01984229|470373149|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
130658832|NCT01984229|470373150|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130658833|NCT03186794|470373152|FG000|Overall Study|Physician Decision|2|||
130658834|NCT03186794|470373152|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
130658835|NCT00834366|470373153|FG000|Treatment Period 1|Adverse Event|1|||
130658836|NCT00834366|470373154|FG001|Treatment Period 1|Adverse Event|1|||
130658837|NCT02380248|470373156|FG000|Overall Study|Lost to Follow-up|11|||
130658838|NCT02380248|470373156|FG000|Overall Study|Withdrawal by Subject|3|||
130658839|NCT01275170|470373157|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
130658840|NCT01275170|470373158|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658841|NCT01275170|470373159|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658842|NCT01275170|470373160|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658843|NCT01275170|470373161|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658844|NCT01275170|470373162|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658845|NCT01275170|470373163|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658846|NCT01275170|470373164|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
130658847|NCT00314262|470373170|FG000|Overall Study|Adverse Event|2|||
130658848|NCT00314262|470373170|FG000|Overall Study|Withdrawal by Subject|2|||
130658849|NCT00314262|470373170|FG000|Overall Study|Physician Decision|1|||
130658850|NCT00083226|470373171|FG000|Overall Study|Lack of Efficacy|19|||
130658851|NCT00083226|470373171|FG000|Overall Study|Adverse Event|9|||
130658852|NCT00083226|470373171|FG000|Overall Study|Death|4|||
130328772|NCT02968004|469173388|FG000|Main Study Phase|Withdrawal by Subject|0|||
130328773|NCT02968004|469173389|FG001|Main Study Phase|Withdrawal by Subject|1|||
130328774|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
130658853|NCT00083226|470373171|FG000|Overall Study|Withdrawal by Subject|4|||
130658854|NCT00083226|470373171|FG000|Overall Study|Other|2|||
130658855|NCT00083226|470373171|FG000|Overall Study|ineligible or not receiving treatment|4|||
130658856|NCT00604175|470373178|FG000|Entry Through Week 28|Death|2|||
130658857|NCT00604175|470373179|FG001|Entry Through Week 28|Death|0|||
130658858|NCT00604175|470373180|FG002|Entry Through Week 28|Death|0|||
130658859|NCT00604175|470373178|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
130328775|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
130658860|NCT00604175|470373179|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
130658861|NCT00604175|470373180|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
130658862|NCT00604175|470373178|FG000|Entry Through Week 28|Lost to Follow-up|4|||
130658863|NCT00604175|470373179|FG001|Entry Through Week 28|Lost to Follow-up|3|||
130658864|NCT00604175|470373180|FG002|Entry Through Week 28|Lost to Follow-up|0|||
130658865|NCT00604175|470373178|FG000|Entry Through Week 28|Ineligible|1|||
130658866|NCT00604175|470373179|FG001|Entry Through Week 28|Ineligible|0|||
130658867|NCT00604175|470373180|FG002|Entry Through Week 28|Ineligible|0|||
130658868|NCT00604175|470373178|FG000|Entry Through Week 28|Did not start intervention|2|||
130328776|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130328777|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130328778|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
130328779|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
130328780|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130328781|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130328782|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130328783|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130328784|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
130328785|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
130328786|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
130328787|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
130328788|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
130328789|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
130328790|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
130328791|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
130328792|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
130328793|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
130328794|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
130328795|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
130328796|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
130328797|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
130328798|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
130328799|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
130328800|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
130328801|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
130328802|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
130328803|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
130328804|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
130328805|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
130328806|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
130328807|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
130328808|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
130328809|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
130328810|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
130328811|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
130328812|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
130328813|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
130328814|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
130328815|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
130328816|NCT00885170|469173400|FG000|Overall Study|Adverse Event|12|||
130328817|NCT00885170|469173401|FG001|Overall Study|Adverse Event|4|||
130328818|NCT00885170|469173400|FG000|Overall Study|Excessive bone loss|6|||
130328819|NCT00885170|469173401|FG001|Overall Study|Excessive bone loss|3|||
130328820|NCT00885170|469173400|FG000|Overall Study|Lost to Follow-up|2|||
130328821|NCT00885170|469173401|FG001|Overall Study|Lost to Follow-up|1|||
130328822|NCT00885170|469173400|FG000|Overall Study|Physician Decision|2|||
130328823|NCT00885170|469173401|FG001|Overall Study|Physician Decision|1|||
130328824|NCT00885170|469173400|FG000|Overall Study|Protocol Violation|3|||
130328825|NCT00885170|469173401|FG001|Overall Study|Protocol Violation|1|||
130328826|NCT00885170|469173400|FG000|Overall Study|Withdrawal by Subject|13|||
130328827|NCT00885170|469173401|FG001|Overall Study|Withdrawal by Subject|13|||
130328828|NCT03771664|469173402|FG000|Overall Study|Adverse Event|1|||
130328829|NCT03771664|469173403|FG001|Overall Study|Adverse Event|0|||
130658869|NCT00604175|470373179|FG001|Entry Through Week 28|Did not start intervention|0|||
130658870|NCT00604175|470373180|FG002|Entry Through Week 28|Did not start intervention|1|||
130658871|NCT00604175|470373178|FG000|Week 29 Through Week 72|Death|0|||
130658872|NCT00604175|470373179|FG001|Week 29 Through Week 72|Death|0|||
130658873|NCT00604175|470373180|FG002|Week 29 Through Week 72|Death|1|||
130328830|NCT03771664|469173402|FG000|Overall Study|Lost to Follow-up|1|||
130328831|NCT03771664|469173403|FG001|Overall Study|Lost to Follow-up|0|||
130658874|NCT00604175|470373178|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
130658875|NCT00604175|470373179|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
130658876|NCT00604175|470373180|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
130658877|NCT00604175|470373178|FG000|Week 29 Through Week 72|Site closure|0|||
130658878|NCT00604175|470373179|FG001|Week 29 Through Week 72|Site closure|1|||
130658879|NCT00604175|470373180|FG002|Week 29 Through Week 72|Site closure|0|||
130658880|NCT00604175|470373178|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
130658881|NCT00604175|470373179|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
130658882|NCT00604175|470373180|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
130658883|NCT02044094|470373181|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
130658884|NCT02044094|470373181|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
130658885|NCT02044094|470373181|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
130658886|NCT02044094|470373181|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
130658887|NCT02044094|470373181|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
130658888|NCT02044094|470373181|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
130658889|NCT02044094|470373181|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
130658890|NCT02044094|470373181|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
130658891|NCT03993288|470374643|FG000|Overall Study|Lost to Follow-up|2|||
130658892|NCT03993288|470374644|FG001|Overall Study|Lost to Follow-up|1|||
130658893|NCT03993288|470374643|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
130658894|NCT03993288|470374644|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
130658895|NCT03993288|470374643|FG000|Overall Study|wrong randomization|0|||
130658896|NCT03993288|470374644|FG001|Overall Study|wrong randomization|1|||
130658897|NCT03993288|470374643|FG000|Overall Study|improper enrollment|0|||
130658898|NCT03993288|470374644|FG001|Overall Study|improper enrollment|1|||
130658899|NCT03993288|470374643|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
130658900|NCT03993288|470374644|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
130658901|NCT03993288|470374643|FG000|Overall Study|developed SAE|2|||
130658902|NCT03993288|470374644|FG001|Overall Study|developed SAE|0|||
130658903|NCT03993288|470374643|FG000|Overall Study|consent withdrawal|1|||
130658904|NCT03993288|470374644|FG001|Overall Study|consent withdrawal|0|||
130658905|NCT03993288|470374643|FG000|Overall Study|did not follow the treatment schedule|1|||
130658906|NCT03993288|470374644|FG001|Overall Study|did not follow the treatment schedule|0|||
130658907|NCT03993288|470374643|FG000|Overall Study|did not follow the treatment regimen|1|||
130658908|NCT03993288|470374644|FG001|Overall Study|did not follow the treatment regimen|0|||
130658909|NCT03993288|470374643|FG000|Overall Study|Adverse Event|1|||
130658910|NCT03993288|470374644|FG001|Overall Study|Adverse Event|0|||
130658911|NCT03993288|470374643|FG000|Overall Study|Withdrawal by Subject|1|||
130658912|NCT03993288|470374644|FG001|Overall Study|Withdrawal by Subject|1|||
130658913|NCT00915473|470374645|FG000|Screening|Withdrawal by Subject|1|||
130658914|NCT00915473|470374646|FG001|Screening|Withdrawal by Subject|0|||
130658915|NCT00915473|470374645|FG000|4-week Follow Up|Lost to Follow-up|1|||
130658916|NCT00915473|470374646|FG001|4-week Follow Up|Lost to Follow-up|5|||
130658917|NCT03526679|470374647|FG000|Overall Study|still under treatment|2|||
130658918|NCT03443973|470374648|FG000|Double-blind Treatment Period|Adverse Event|5|||
130658919|NCT03443973|470374649|FG001|Double-blind Treatment Period|Adverse Event|19|||
130658920|NCT03443973|470374650|FG002|Double-blind Treatment Period|Adverse Event|0|||
130658921|NCT03443973|470374651|FG003|Double-blind Treatment Period|Adverse Event|0|||
130658922|NCT03443973|470374648|FG000|Double-blind Treatment Period|Death|5|||
130658923|NCT03443973|470374649|FG001|Double-blind Treatment Period|Death|7|||
130658924|NCT03443973|470374650|FG002|Double-blind Treatment Period|Death|0|||
130658925|NCT03443973|470374651|FG003|Double-blind Treatment Period|Death|0|||
130658926|NCT03443973|470374648|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
130658927|NCT03443973|470374649|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130658928|NCT03443973|470374650|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130658929|NCT03443973|470374651|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
130658930|NCT03443973|470374648|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130658931|NCT03443973|470374649|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130658932|NCT03443973|470374650|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130658933|NCT03443973|470374651|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130658934|NCT03443973|470374648|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
130215692|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
130215693|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
130215694|NCT01048944|468753823|FG000|Overall Study|Protocol Violation|8|||
130215695|NCT01048944|468753824|FG001|Overall Study|Protocol Violation|10|||
130215696|NCT01048944|468753825|FG002|Overall Study|Protocol Violation|10|||
130658935|NCT03443973|470374649|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
130658936|NCT03443973|470374650|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
130658937|NCT03443973|470374651|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
130658938|NCT03443973|470374648|FG000|Double-blind Treatment Period|Physician Decision|5|||
130658939|NCT03443973|470374649|FG001|Double-blind Treatment Period|Physician Decision|6|||
130215697|NCT01048944|468753826|FG003|Overall Study|Protocol Violation|2|||
130215698|NCT01844817|468753827|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
130215699|NCT01844817|468753828|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
130328832|NCT03771664|469173402|FG000|Overall Study|Withdrawal by Participant|1|||
130328833|NCT03771664|469173403|FG001|Overall Study|Withdrawal by Participant|4|||
130328834|NCT03771664|469173402|FG000|Overall Study|Randomized but not Treated|0|||
130328835|NCT03771664|469173403|FG001|Overall Study|Randomized but not Treated|1|||
130328836|NCT00561925|469173404|FG000|14 Day Lead-In Period|Adverse Event|38|||
130328837|NCT00561925|469173405|FG001|14 Day Lead-In Period|Adverse Event|0|||
130328838|NCT00561925|469173406|FG002|14 Day Lead-In Period|Adverse Event|0|||
130328839|NCT00561925|469173407|FG003|14 Day Lead-In Period|Adverse Event|0|||
130328840|NCT00561925|469173408|FG004|14 Day Lead-In Period|Adverse Event|0|||
130328841|NCT00561925|469173404|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
130328842|NCT00561925|469173405|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328843|NCT00561925|469173406|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328844|NCT00561925|469173407|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328845|NCT00561925|469173408|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328846|NCT00561925|469173404|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
130328847|NCT00561925|469173405|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
130328848|NCT00561925|469173406|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
130328849|NCT00561925|469173407|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
130328850|NCT00561925|469173408|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
130328851|NCT00561925|469173404|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
130328852|NCT00561925|469173405|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328853|NCT00561925|469173406|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328854|NCT00561925|469173407|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328855|NCT00561925|469173408|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328856|NCT00561925|469173404|FG000|14 Day Lead-In Period|Other|5|||
130328857|NCT00561925|469173405|FG001|14 Day Lead-In Period|Other|0|||
130328858|NCT00561925|469173406|FG002|14 Day Lead-In Period|Other|0|||
130328859|NCT00561925|469173407|FG003|14 Day Lead-In Period|Other|0|||
130328860|NCT00561925|469173408|FG004|14 Day Lead-In Period|Other|0|||
130328861|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328862|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
130328863|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
130328864|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328865|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328866|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328867|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
130328868|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
130328869|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328870|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328871|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328872|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
130328873|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
130328874|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328875|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328876|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328877|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
130328878|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
130328879|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328880|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328881|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328882|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
130328883|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
130328884|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328885|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328886|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328887|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
130328888|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
130328889|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328890|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328891|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Death|0|||
130328892|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Death|6|||
130328893|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Death|3|||
130328894|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Death|0|||
130328895|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Death|0|||
130328896|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328897|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
130328898|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328899|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328900|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328901|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Other|0|||
130658940|NCT03443973|470374650|FG002|Double-blind Treatment Period|Physician Decision|0|||
130658941|NCT03443973|470374651|FG003|Double-blind Treatment Period|Physician Decision|0|||
130658942|NCT03443973|470374648|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
130328902|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Other|8|||
130328903|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Other|11|||
130328904|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Other|0|||
130328905|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Other|0|||
130328906|NCT00561925|469173404|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
130328907|NCT00561925|469173405|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
130328908|NCT00561925|469173406|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
130328909|NCT00561925|469173407|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
130328910|NCT00561925|469173408|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
130328911|NCT00891904|469173409|FG000|Overall Study|Death|1|||
130328912|NCT00891904|469173409|FG000|Overall Study|Adverse Event|1|||
130328913|NCT05021978|469173410|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
130328914|NCT05021978|469173411|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328915|NCT05021978|469173412|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328916|NCT05021978|469173413|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328917|NCT05021978|469173410|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328918|NCT05021978|469173411|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
130328919|NCT05021978|469173412|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328920|NCT05021978|469173413|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328921|NCT03096288|469173415|FG000|Overall Study|Withdrawal by Subject|0|||
130328922|NCT03096288|469173416|FG001|Overall Study|Withdrawal by Subject|1|||
130328923|NCT03096288|469173417|FG002|Overall Study|Withdrawal by Subject|0|||
130328924|NCT03096288|469173418|FG003|Overall Study|Withdrawal by Subject|1|||
130328925|NCT04639258|469173423|FG000|Overall Study|Screen failure|5|||
130328926|NCT04639258|469173423|FG000|Overall Study|Physician Decision|2|||
130328927|NCT04639258|469173423|FG000|Overall Study|Early study termination|3|||
130328928|NCT04639258|469173423|FG000|Overall Study|Withdrawal by Subject|1|||
130328929|NCT02819804|469173425|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
130328930|NCT01782378|469173426|FG000|First Series|Lost to Follow-up|7|||
130328931|NCT01782378|469173427|FG001|First Series|Lost to Follow-up|8|||
130328932|NCT01782378|469173426|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
130328933|NCT01782378|469173427|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
130328934|NCT01782378|469173426|FG000|Second Series|Lost to Follow-up|8|||
130328935|NCT01782378|469173427|FG001|Second Series|Lost to Follow-up|7|||
130328936|NCT01782378|469173426|FG000|Second Series|Did not choose to complete S2 Optional|18|||
130328937|NCT01782378|469173427|FG001|Second Series|Did not choose to complete S2 Optional|0|||
130328938|NCT03815929|469173430|FG000|Overall Study|Lost to Follow-up|2|||
130328939|NCT03815929|469173431|FG001|Overall Study|Lost to Follow-up|1|||
130328940|NCT03815929|469173432|FG002|Overall Study|Lost to Follow-up|0|||
130328941|NCT03815929|469173430|FG000|Overall Study|Physician Decision|2|||
130328942|NCT03815929|469173431|FG001|Overall Study|Physician Decision|2|||
130328943|NCT03815929|469173432|FG002|Overall Study|Physician Decision|0|||
130328944|NCT03815929|469173430|FG000|Overall Study|Withdrawal by Subject|0|||
130328945|NCT03815929|469173431|FG001|Overall Study|Withdrawal by Subject|0|||
130328946|NCT03815929|469173432|FG002|Overall Study|Withdrawal by Subject|1|||
130328947|NCT02205736|469173433|FG000|Overall Study|Lost to Follow-up|106|||
130328948|NCT05615922|469173439|FG000|Overall Study|Lost to Follow-up|1|||
130328949|NCT03173248|469173443|FG000|Overall Study|Death|28|||
130328950|NCT03173248|469173444|FG001|Overall Study|Death|46|||
130328951|NCT03173248|469173443|FG000|Overall Study|Lost to Follow-up|0|||
130328952|NCT03173248|469173444|FG001|Overall Study|Lost to Follow-up|1|||
130328953|NCT03173248|469173443|FG000|Overall Study|Withdrawal by Subject|6|||
130328954|NCT03173248|469173444|FG001|Overall Study|Withdrawal by Subject|4|||
130328955|NCT03173248|469173443|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
130328956|NCT03173248|469173444|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
130328957|NCT02991768|469173446|FG000|Overall Study|Physician Decision|4|||
130328958|NCT04500158|469173449|FG000|Overall Study|Physician Decision|17|||
130328959|NCT04500158|469173450|FG001|Overall Study|Physician Decision|11|||
130328960|NCT02807402|469173453|FG000|Overall Study|Failure to Return|1|||
130658943|NCT03443973|470374649|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
130328961|NCT02807402|469173453|FG000|Overall Study|Death|3|||
130328962|NCT02807402|469173453|FG000|Overall Study|Other|2|||
130328963|NCT04801420|469173455|FG000|Overall Study|Other|1|||
130328964|NCT04801420|469173456|FG001|Overall Study|Other|2|||
130328965|NCT04801420|469173457|FG002|Overall Study|Other|1|||
130328966|NCT04801420|469173455|FG000|Overall Study|Lost to Follow-up|7|||
130328967|NCT04801420|469173456|FG001|Overall Study|Lost to Follow-up|9|||
130328968|NCT04801420|469173457|FG002|Overall Study|Lost to Follow-up|10|||
130328969|NCT04801420|469173455|FG000|Overall Study|Moved from study area|0|||
130328970|NCT04801420|469173456|FG001|Overall Study|Moved from study area|1|||
130328971|NCT04801420|469173457|FG002|Overall Study|Moved from study area|1|||
130328972|NCT04801420|469173455|FG000|Overall Study|Withdrawal by Subject|5|||
130328973|NCT04801420|469173456|FG001|Overall Study|Withdrawal by Subject|1|||
130328974|NCT04801420|469173457|FG002|Overall Study|Withdrawal by Subject|4|||
130328975|NCT04801420|469173455|FG000|Overall Study|Individual stopping criteria reached|0|||
130328976|NCT04801420|469173456|FG001|Overall Study|Individual stopping criteria reached|1|||
130328977|NCT04801420|469173457|FG002|Overall Study|Individual stopping criteria reached|0|||
130328978|NCT04801420|469173455|FG000|Overall Study|Ongoing in the study|195|||
130328979|NCT04801420|469173456|FG001|Overall Study|Ongoing in the study|195|||
130328980|NCT04801420|469173457|FG002|Overall Study|Ongoing in the study|192|||
130328981|NCT04774094|469173458|FG000|Overall Study|Other|2|||
130328982|NCT04774094|469173458|FG000|Overall Study|Withdrawal by Subject|9|||
130328983|NCT04774094|469173458|FG000|Overall Study|Lost to Follow-up|7|||
130328984|NCT04774094|469173458|FG000|Overall Study|Lack of Efficacy|5|||
130328985|NCT04774094|469173458|FG000|Overall Study|Death|17|||
130328986|NCT04774094|469173458|FG000|Overall Study|Adverse Event|4|||
130328987|NCT01376804|469175312|FG000|Treatment Period|Withdrawal by Subject|1|||
130328988|NCT01376804|469175312|FG000|Treatment Period|Adverse Event|6|||
130328989|NCT01376804|469175312|FG000|Treatment Period|Patient did not receive study drug|1|||
130658944|NCT03443973|470374650|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
130658945|NCT03443973|470374651|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
130658946|NCT03443973|470374648|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
130658947|NCT03443973|470374649|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
130658948|NCT03443973|470374650|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130658949|NCT03443973|470374651|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
130658950|NCT03443973|470374648|FG000|Open-label Extension Period|Reason Not Specified|0|||
130658951|NCT03443973|470374649|FG001|Open-label Extension Period|Reason Not Specified|0|||
130328990|NCT01357850|469175313|FG000|Overall Study|Lost to Follow-up|1|||
130328991|NCT01357850|469175314|FG001|Overall Study|Lost to Follow-up|0|||
130328992|NCT01357850|469175315|FG002|Overall Study|Lost to Follow-up|0|||
130328993|NCT01357850|469175316|FG003|Overall Study|Lost to Follow-up|0|||
130658952|NCT03443973|470374650|FG002|Open-label Extension Period|Reason Not Specified|3|||
130658953|NCT03443973|470374651|FG003|Open-label Extension Period|Reason Not Specified|0|||
130658954|NCT03443973|470374648|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130658955|NCT03443973|470374649|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130658956|NCT03443973|470374650|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
130658957|NCT03443973|470374651|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
130658958|NCT01956123|470374652|FG000|COS Cycle 2|Protocol Violation|8|||
130658959|NCT01956123|470374653|FG001|COS Cycle 2|Protocol Violation|3|||
130658960|NCT01956123|470374654|FG002|COS Cycle 2|Protocol Violation|0|||
130658961|NCT01956123|470374655|FG003|COS Cycle 2|Protocol Violation|0|||
130658962|NCT01956123|470374652|FG000|COS Cycle 2|Adverse Event|3|||
130658963|NCT01956123|470374653|FG001|COS Cycle 2|Adverse Event|4|||
130658964|NCT01956123|470374654|FG002|COS Cycle 2|Adverse Event|0|||
130658965|NCT01956123|470374655|FG003|COS Cycle 2|Adverse Event|0|||
130658966|NCT01956123|470374652|FG000|COS Cycle 2|Personal Reasons|2|||
130658967|NCT01956123|470374653|FG001|COS Cycle 2|Personal Reasons|0|||
130658968|NCT01956123|470374654|FG002|COS Cycle 2|Personal Reasons|0|||
130658969|NCT01956123|470374655|FG003|COS Cycle 2|Personal Reasons|0|||
130658970|NCT01956123|470374652|FG000|COS Cycle 2|Withdrawal by Subject|1|||
130658971|NCT01956123|470374653|FG001|COS Cycle 2|Withdrawal by Subject|0|||
130658972|NCT01956123|470374654|FG002|COS Cycle 2|Withdrawal by Subject|0|||
130658973|NCT01956123|470374655|FG003|COS Cycle 2|Withdrawal by Subject|0|||
130658974|NCT01956123|470374652|FG000|COS Cycle 3|Protocol Violation|0|||
130658975|NCT01956123|470374653|FG001|COS Cycle 3|Protocol Violation|0|||
130658976|NCT01956123|470374654|FG002|COS Cycle 3|Protocol Violation|2|||
130658977|NCT01956123|470374655|FG003|COS Cycle 3|Protocol Violation|1|||
130658978|NCT01956123|470374652|FG000|COS Cycle 3|Adverse Event|0|||
130658979|NCT01956123|470374653|FG001|COS Cycle 3|Adverse Event|0|||
130658980|NCT01956123|470374654|FG002|COS Cycle 3|Adverse Event|3|||
130658981|NCT01956123|470374655|FG003|COS Cycle 3|Adverse Event|0|||
130328994|NCT00753506|469175319|FG000|Overall Study|Withdrawal by Subject|4|||
130328995|NCT00753506|469175320|FG001|Overall Study|Withdrawal by Subject|1|||
130328996|NCT00753506|469175319|FG000|Overall Study|Lost to Follow-up|2|||
130328997|NCT00753506|469175320|FG001|Overall Study|Lost to Follow-up|0|||
130328998|NCT00753506|469175319|FG000|Overall Study|Other reason|1|||
130658982|NCT01956123|470374652|FG000|COS Cycle 3|Personal Reasons|0|||
130658983|NCT01956123|470374653|FG001|COS Cycle 3|Personal Reasons|0|||
130658984|NCT01956123|470374654|FG002|COS Cycle 3|Personal Reasons|1|||
130658985|NCT01956123|470374655|FG003|COS Cycle 3|Personal Reasons|0|||
130658986|NCT01956123|470374652|FG000|COS Cycle 3|Withdrawal by Subject|0|||
130658987|NCT01956123|470374653|FG001|COS Cycle 3|Withdrawal by Subject|0|||
130658988|NCT01956123|470374654|FG002|COS Cycle 3|Withdrawal by Subject|0|||
130658989|NCT01956123|470374655|FG003|COS Cycle 3|Withdrawal by Subject|1|||
130328999|NCT00753506|469175320|FG001|Overall Study|Other reason|1|||
130329000|NCT01600716|469175321|FG000|Overall Study|Other Reasons|3|||
130329001|NCT01600716|469175322|FG001|Overall Study|Other Reasons|1|||
130329002|NCT01600716|469175321|FG000|Overall Study|Personal Reasons|0|||
130329003|NCT01600716|469175322|FG001|Overall Study|Personal Reasons|2|||
130329004|NCT01600716|469175321|FG000|Overall Study|Lost to Follow-up|0|||
130329005|NCT01600716|469175322|FG001|Overall Study|Lost to Follow-up|2|||
130329006|NCT01600716|469175321|FG000|Overall Study|Pregnancy|1|||
130329007|NCT01600716|469175322|FG001|Overall Study|Pregnancy|0|||
130329008|NCT01600716|469175321|FG000|Overall Study|Lack of Efficacy|2|||
130329009|NCT01600716|469175322|FG001|Overall Study|Lack of Efficacy|1|||
130329010|NCT01600716|469175321|FG000|Overall Study|Adverse Event|1|||
130329011|NCT01600716|469175322|FG001|Overall Study|Adverse Event|1|||
130329012|NCT03926611|469175326|FG000|Overall Study|Adverse Event|0|||
130329013|NCT03926611|469175327|FG001|Overall Study|Adverse Event|0|||
130329014|NCT03926611|469175328|FG002|Overall Study|Adverse Event|0|||
130329015|NCT03926611|469175329|FG003|Overall Study|Adverse Event|3|||
130329016|NCT03926611|469175330|FG004|Overall Study|Adverse Event|1|||
130329017|NCT03926611|469175331|FG005|Overall Study|Adverse Event|3|||
130329018|NCT03926611|469175332|FG006|Overall Study|Adverse Event|0|||
130329019|NCT03926611|469175326|FG000|Overall Study|Lack of Efficacy|1|||
130329020|NCT03926611|469175327|FG001|Overall Study|Lack of Efficacy|2|||
130329021|NCT03926611|469175328|FG002|Overall Study|Lack of Efficacy|0|||
130329022|NCT03926611|469175329|FG003|Overall Study|Lack of Efficacy|0|||
130329023|NCT03926611|469175330|FG004|Overall Study|Lack of Efficacy|1|||
130329024|NCT03926611|469175331|FG005|Overall Study|Lack of Efficacy|0|||
130329025|NCT03926611|469175332|FG006|Overall Study|Lack of Efficacy|1|||
130329026|NCT03926611|469175326|FG000|Overall Study|Physician Decision|0|||
130329027|NCT03926611|469175327|FG001|Overall Study|Physician Decision|0|||
130329028|NCT03926611|469175328|FG002|Overall Study|Physician Decision|0|||
130329029|NCT03926611|469175329|FG003|Overall Study|Physician Decision|0|||
130329030|NCT03926611|469175330|FG004|Overall Study|Physician Decision|0|||
130329031|NCT03926611|469175331|FG005|Overall Study|Physician Decision|1|||
130329032|NCT03926611|469175332|FG006|Overall Study|Physician Decision|0|||
130329033|NCT03926611|469175326|FG000|Overall Study|Protocol Violation|1|||
130329034|NCT03926611|469175327|FG001|Overall Study|Protocol Violation|0|||
130329035|NCT03926611|469175328|FG002|Overall Study|Protocol Violation|0|||
130329036|NCT03926611|469175329|FG003|Overall Study|Protocol Violation|1|||
130329037|NCT03926611|469175330|FG004|Overall Study|Protocol Violation|1|||
130329038|NCT03926611|469175331|FG005|Overall Study|Protocol Violation|1|||
130329039|NCT03926611|469175332|FG006|Overall Study|Protocol Violation|1|||
130329040|NCT03926611|469175326|FG000|Overall Study|Technical problems|0|||
130329041|NCT03926611|469175327|FG001|Overall Study|Technical problems|0|||
130329042|NCT03926611|469175328|FG002|Overall Study|Technical problems|0|||
130329043|NCT03926611|469175329|FG003|Overall Study|Technical problems|0|||
130329044|NCT03926611|469175330|FG004|Overall Study|Technical problems|0|||
130329045|NCT03926611|469175331|FG005|Overall Study|Technical problems|1|||
130329046|NCT03926611|469175332|FG006|Overall Study|Technical problems|0|||
130329047|NCT03926611|469175326|FG000|Overall Study|Withdrawal by Subject|1|||
130329048|NCT03926611|469175327|FG001|Overall Study|Withdrawal by Subject|1|||
130329049|NCT03926611|469175328|FG002|Overall Study|Withdrawal by Subject|1|||
130329050|NCT03926611|469175329|FG003|Overall Study|Withdrawal by Subject|0|||
130329051|NCT03926611|469175330|FG004|Overall Study|Withdrawal by Subject|0|||
130329052|NCT03926611|469175331|FG005|Overall Study|Withdrawal by Subject|1|||
130329053|NCT03926611|469175332|FG006|Overall Study|Withdrawal by Subject|3|||
130329054|NCT03926611|469175326|FG000|Overall Study|Covid-19 pandemic|0|||
130329055|NCT03926611|469175327|FG001|Overall Study|Covid-19 pandemic|0|||
130329056|NCT03926611|469175328|FG002|Overall Study|Covid-19 pandemic|1|||
130329057|NCT03926611|469175329|FG003|Overall Study|Covid-19 pandemic|0|||
130329058|NCT03926611|469175330|FG004|Overall Study|Covid-19 pandemic|1|||
130329059|NCT03926611|469175331|FG005|Overall Study|Covid-19 pandemic|2|||
130329060|NCT03926611|469175332|FG006|Overall Study|Covid-19 pandemic|0|||
130329061|NCT02230670|469175335|FG000|Overall Study|Adverse Event|1|||
130329062|NCT02230670|469175336|FG001|Overall Study|Adverse Event|2|||
130329063|NCT02230670|469175335|FG000|Overall Study|Withdrawal by Subject|2|||
130329064|NCT02230670|469175336|FG001|Overall Study|Withdrawal by Subject|2|||
130329065|NCT02230670|469175335|FG000|Overall Study|Physician Decision|0|||
130329066|NCT02230670|469175336|FG001|Overall Study|Physician Decision|1|||
130329067|NCT02230670|469175335|FG000|Overall Study|Protocol Violation|0|||
130329068|NCT02230670|469175336|FG001|Overall Study|Protocol Violation|1|||
130329069|NCT02230670|469175335|FG000|Overall Study|Progression to Child-Pugh C|1|||
130329070|NCT02230670|469175336|FG001|Overall Study|Progression to Child-Pugh C|2|||
130329071|NCT03722238|469175337|FG000|Overall Study|Protocol Violation|1|||
130329072|NCT03722238|469175338|FG001|Overall Study|Protocol Violation|0|||
130329073|NCT03722238|469175337|FG000|Overall Study|Physician Decision|1|||
130329074|NCT03722238|469175338|FG001|Overall Study|Physician Decision|0|||
130329075|NCT03722238|469175337|FG000|Overall Study|Death|1|||
130329076|NCT03722238|469175338|FG001|Overall Study|Death|0|||
130552129|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
130552130|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
130552131|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
130552132|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
130329077|NCT03722238|469175337|FG000|Overall Study|Lost to Follow-up|6|||
130329078|NCT03722238|469175338|FG001|Overall Study|Lost to Follow-up|0|||
130329079|NCT03722238|469175337|FG000|Overall Study|Partial missing data|44|||
130658990|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
130658991|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
130658992|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
130658993|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
130658994|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
130658995|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
130658996|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
130658997|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
130658998|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
130658999|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
130659000|NCT01777191|470374658|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
130659001|NCT01777191|470374659|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
130659002|NCT01777191|470374658|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
130659003|NCT01777191|470374659|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
130659004|NCT01777191|470374658|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
130659005|NCT01777191|470374659|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
130659006|NCT01777191|470374658|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
130659007|NCT01777191|470374659|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
130659008|NCT01777191|470374658|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
130659009|NCT01777191|470374659|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
130659010|NCT01777191|470374658|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
130659011|NCT01777191|470374659|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
130659012|NCT03576131|470374669|FG000|Overall Study|Investigator decision|0|||
130659013|NCT03576131|470374670|FG001|Overall Study|Investigator decision|0|||
130659014|NCT03576131|470374671|FG002|Overall Study|Investigator decision|0|||
130659015|NCT03576131|470374672|FG003|Overall Study|Investigator decision|1|||
130659016|NCT03576131|470374673|FG004|Overall Study|Investigator decision|0|||
130659017|NCT03576131|470374674|FG005|Overall Study|Investigator decision|1|||
130659018|NCT03576131|470374675|FG006|Overall Study|Investigator decision|0|||
130659019|NCT03576131|470374676|FG007|Overall Study|Investigator decision|0|||
130659020|NCT03576131|470374669|FG000|Overall Study|Withdrawal by Subject|1|||
130659021|NCT03576131|470374670|FG001|Overall Study|Withdrawal by Subject|1|||
130659022|NCT03576131|470374671|FG002|Overall Study|Withdrawal by Subject|0|||
130659023|NCT03576131|470374672|FG003|Overall Study|Withdrawal by Subject|1|||
130659024|NCT03576131|470374673|FG004|Overall Study|Withdrawal by Subject|2|||
130659025|NCT03576131|470374674|FG005|Overall Study|Withdrawal by Subject|3|||
130659026|NCT03576131|470374675|FG006|Overall Study|Withdrawal by Subject|1|||
130659027|NCT03576131|470374676|FG007|Overall Study|Withdrawal by Subject|0|||
130659028|NCT03576131|470374669|FG000|Overall Study|Death|3|||
130659029|NCT03576131|470374670|FG001|Overall Study|Death|3|||
130659030|NCT03576131|470374671|FG002|Overall Study|Death|1|||
130659031|NCT03576131|470374672|FG003|Overall Study|Death|5|||
130659032|NCT03576131|470374673|FG004|Overall Study|Death|4|||
130659033|NCT03576131|470374674|FG005|Overall Study|Death|1|||
130659034|NCT03576131|470374675|FG006|Overall Study|Death|0|||
130659035|NCT03576131|470374676|FG007|Overall Study|Death|1|||
130659036|NCT03576131|470374669|FG000|Overall Study|New anti-cancer treatment|5|||
130659037|NCT03576131|470374670|FG001|Overall Study|New anti-cancer treatment|1|||
130659038|NCT03576131|470374671|FG002|Overall Study|New anti-cancer treatment|2|||
130659039|NCT03576131|470374672|FG003|Overall Study|New anti-cancer treatment|3|||
130659040|NCT03576131|470374673|FG004|Overall Study|New anti-cancer treatment|0|||
130659041|NCT03576131|470374674|FG005|Overall Study|New anti-cancer treatment|0|||
130659042|NCT03576131|470374675|FG006|Overall Study|New anti-cancer treatment|0|||
130659043|NCT03576131|470374676|FG007|Overall Study|New anti-cancer treatment|0|||
130329080|NCT03722238|469175338|FG001|Overall Study|Partial missing data|1|||
130329081|NCT03722238|469175337|FG000|Overall Study|Withdrawal by Subject|2|||
130329082|NCT03722238|469175338|FG001|Overall Study|Withdrawal by Subject|0|||
130329083|NCT03722238|469175337|FG000|Overall Study|Other|4|||
130329084|NCT03722238|469175338|FG001|Overall Study|Other|0|||
130329085|NCT03722238|469175337|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
130329086|NCT03722238|469175338|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
130329087|NCT03722238|469175337|FG000|Overall Study|Did not meet risk classification group criteria|90|||
130329088|NCT03722238|469175338|FG001|Overall Study|Did not meet risk classification group criteria|0|||
130329089|NCT03722238|469175337|FG000|Overall Study|Did not sign consent|17|||
130329090|NCT03722238|469175338|FG001|Overall Study|Did not sign consent|0|||
130329091|NCT03722238|469175337|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
130329092|NCT03722238|469175338|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
130329093|NCT03722238|469175337|FG000|Overall Study|Not willing to purchase study medication|142|||
130659044|NCT03576131|470374669|FG000|Overall Study|Unspecified reason|0|||
130329094|NCT03722238|469175338|FG001|Overall Study|Not willing to purchase study medication|0|||
130215700|NCT01844817|468753827|FG000|Treatment|Progressive Disease|27|||
130215701|NCT01844817|468753828|FG001|Treatment|Progressive Disease|36|||
130215702|NCT01844817|468753827|FG000|Treatment|Adverse Event|17|||
130215703|NCT01844817|468753828|FG001|Treatment|Adverse Event|9|||
130215704|NCT01844817|468753827|FG000|Treatment|Withdrawal by Subject|10|||
130215705|NCT01844817|468753828|FG001|Treatment|Withdrawal by Subject|6|||
130215706|NCT01844817|468753827|FG000|Treatment|Death|10|||
130215707|NCT01844817|468753828|FG001|Treatment|Death|8|||
130215708|NCT01844817|468753827|FG000|Treatment|Lost to Follow-up|0|||
130215709|NCT01844817|468753828|FG001|Treatment|Lost to Follow-up|1|||
130215710|NCT01844817|468753827|FG000|Treatment|Other|0|||
130215711|NCT01844817|468753828|FG001|Treatment|Other|3|||
130215712|NCT01133704|468753829|FG000|Overall Study|Death|44|||
130215713|NCT01133704|468753830|FG001|Overall Study|Death|26|||
130215714|NCT01133704|468753829|FG000|Overall Study|Patient refused to continue|4|||
130215715|NCT01133704|468753830|FG001|Overall Study|Patient refused to continue|0|||
130215716|NCT01133704|468753829|FG000|Overall Study|Study Closure|1|||
130215717|NCT01133704|468753830|FG001|Overall Study|Study Closure|0|||
130215718|NCT03396822|468753833|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
130215719|NCT03396822|468753833|FG000|Overall Study|Physician Decision|1|||
130215720|NCT04985942|468753834|FG000|Overall Study|Adverse Event|14|||
130215721|NCT04985942|468753835|FG001|Overall Study|Adverse Event|2|||
130215722|NCT04985942|468753834|FG000|Overall Study|Lack of Efficacy|0|||
130215723|NCT04985942|468753835|FG001|Overall Study|Lack of Efficacy|3|||
130215724|NCT04985942|468753834|FG000|Overall Study|Lost to Follow-up|1|||
130215725|NCT04985942|468753835|FG001|Overall Study|Lost to Follow-up|1|||
130215726|NCT04985942|468753834|FG000|Overall Study|Protocol Violation|1|||
130215727|NCT04985942|468753835|FG001|Overall Study|Protocol Violation|1|||
130215728|NCT04985942|468753834|FG000|Overall Study|Withdrawal by Subject|5|||
130215729|NCT04985942|468753835|FG001|Overall Study|Withdrawal by Subject|4|||
130215730|NCT03630705|468753836|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
130215731|NCT03630705|468753837|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
130215732|NCT03630705|468753838|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130215733|NCT03630705|468753839|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130215734|NCT03630705|468753836|FG000|Overall Study|Lost to Follow-up|1|||
130215735|NCT03630705|468753837|FG001|Overall Study|Lost to Follow-up|2|||
130215736|NCT03630705|468753838|FG002|Overall Study|Lost to Follow-up|0|||
130215737|NCT03630705|468753839|FG003|Overall Study|Lost to Follow-up|0|||
130215738|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
130215739|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
130215740|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
130215741|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
130215742|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
130215743|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
130215744|NCT03638466|468753845|FG000|Overall Study|Early Termination|0|||
130215745|NCT03638466|468753846|FG001|Overall Study|Early Termination|1|||
130215746|NCT02576977|468753847|FG000|Overall Study|Adverse Event|13|||
130215747|NCT02576977|468753848|FG001|Overall Study|Adverse Event|2|||
130215748|NCT02576977|468753847|FG000|Overall Study|Death|73|||
130215749|NCT02576977|468753848|FG001|Overall Study|Death|60|||
130215750|NCT02576977|468753847|FG000|Overall Study|Screen failure|1|||
130215751|NCT02576977|468753848|FG001|Overall Study|Screen failure|0|||
130215752|NCT02576977|468753847|FG000|Overall Study|Study Terminated at Selected Sites|27|||
130215753|NCT02576977|468753848|FG001|Overall Study|Study Terminated at Selected Sites|50|||
130215754|NCT02576977|468753847|FG000|Overall Study|Withdrawal by Subject|11|||
130215755|NCT02576977|468753848|FG001|Overall Study|Withdrawal by Subject|11|||
130215756|NCT02576977|468753847|FG000|Overall Study|Final Disposition Unknown|0|||
130215757|NCT02576977|468753848|FG001|Overall Study|Final Disposition Unknown|1|||
130215758|NCT02576977|468753847|FG000|Overall Study|Lost to Follow-up|1|||
130215759|NCT02576977|468753848|FG001|Overall Study|Lost to Follow-up|0|||
130215760|NCT02576977|468753847|FG000|Overall Study|Progressive Disease|0|||
130215761|NCT02576977|468753848|FG001|Overall Study|Progressive Disease|1|||
130215762|NCT03251482|468753849|FG000|Overall Study|Withdrawal by Subject|0|||
130215763|NCT03251482|468753850|FG001|Overall Study|Withdrawal by Subject|1|||
130215764|NCT03251482|468753851|FG002|Overall Study|Withdrawal by Subject|0|||
130215765|NCT03251482|468753852|FG003|Overall Study|Withdrawal by Subject|0|||
130215766|NCT03251482|468753853|FG004|Overall Study|Withdrawal by Subject|0|||
130215767|NCT02447328|468753856|FG000|Overall Study|Withdrawal by Subject|1|||
130215768|NCT01128400|468753857|FG000|Overall Study|Lost to Follow-up|1|||
130215769|NCT01128400|468753858|FG001|Overall Study|Lost to Follow-up|0|||
130215770|NCT01128400|468753859|FG002|Overall Study|Lost to Follow-up|1|||
130215771|NCT01128400|468753857|FG000|Overall Study|Screening failure|1|||
130215772|NCT01128400|468753858|FG001|Overall Study|Screening failure|0|||
130215773|NCT01128400|468753859|FG002|Overall Study|Screening failure|0|||
130215774|NCT01128400|468753857|FG000|Overall Study|were not invited to participate on taste|0|||
130215775|NCT01128400|468753858|FG001|Overall Study|were not invited to participate on taste|0|||
130215776|NCT01128400|468753859|FG002|Overall Study|were not invited to participate on taste|15|||
130215777|NCT01128400|468753857|FG000|Overall Study|Excluded due to sinus problems|0|||
130215778|NCT01128400|468753858|FG001|Overall Study|Excluded due to sinus problems|1|||
130215779|NCT01128400|468753859|FG002|Overall Study|Excluded due to sinus problems|0|||
130215780|NCT00314808|468753865|FG000|Overall Study|Disease Progression without AE|4|||
130215781|NCT00314808|468753865|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
130215782|NCT04304508|468753866|FG000|Overall Study|Subject Decision|29|||
130215783|NCT04304508|468753867|FG001|Overall Study|Subject Decision|39|||
130215784|NCT04304508|468753868|FG002|Overall Study|Subject Decision|37|||
130215785|NCT04304508|468753869|FG003|Overall Study|Subject Decision|48|||
130215786|NCT04304508|468753866|FG000|Overall Study|Death|6|||
130215787|NCT04304508|468753867|FG001|Overall Study|Death|1|||
130215788|NCT04304508|468753868|FG002|Overall Study|Death|8|||
130215789|NCT04304508|468753869|FG003|Overall Study|Death|5|||
130215790|NCT04304508|468753866|FG000|Overall Study|Non-compliance With Study Drug|3|||
130215791|NCT04304508|468753867|FG001|Overall Study|Non-compliance With Study Drug|1|||
130215792|NCT04304508|468753868|FG002|Overall Study|Non-compliance With Study Drug|2|||
130215793|NCT04304508|468753869|FG003|Overall Study|Non-compliance With Study Drug|0|||
130215794|NCT04304508|468753866|FG000|Overall Study|Switching To Other Therapy|1|||
130215795|NCT04304508|468753867|FG001|Overall Study|Switching To Other Therapy|1|||
130215796|NCT04304508|468753868|FG002|Overall Study|Switching To Other Therapy|1|||
130215797|NCT04304508|468753869|FG003|Overall Study|Switching To Other Therapy|2|||
130215798|NCT04304508|468753866|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130215799|NCT04304508|468753867|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
130215800|NCT04304508|468753868|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130215801|NCT04304508|468753869|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
130215802|NCT04304508|468753866|FG000|Overall Study|Withdrawal by Subject|7|||
130215803|NCT04304508|468753867|FG001|Overall Study|Withdrawal by Subject|5|||
130215804|NCT04304508|468753868|FG002|Overall Study|Withdrawal by Subject|11|||
130215805|NCT04304508|468753869|FG003|Overall Study|Withdrawal by Subject|6|||
130215806|NCT04304508|468753866|FG000|Overall Study|Logistical Difficulties|2|||
130215807|NCT04304508|468753867|FG001|Overall Study|Logistical Difficulties|2|||
130215808|NCT04304508|468753868|FG002|Overall Study|Logistical Difficulties|3|||
130215809|NCT04304508|468753869|FG003|Overall Study|Logistical Difficulties|2|||
130215810|NCT04304508|468753866|FG000|Overall Study|Missing Information|1|||
130215811|NCT04304508|468753867|FG001|Overall Study|Missing Information|2|||
130215812|NCT04304508|468753868|FG002|Overall Study|Missing Information|1|||
130215813|NCT04304508|468753869|FG003|Overall Study|Missing Information|3|||
130215814|NCT04304508|468753866|FG000|Overall Study|Other|7|||
130215815|NCT04304508|468753867|FG001|Overall Study|Other|6|||
130215816|NCT04304508|468753868|FG002|Overall Study|Other|5|||
130215817|NCT04304508|468753869|FG003|Overall Study|Other|4|||
130215818|NCT04304508|468753866|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
130215819|NCT04304508|468753867|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215820|NCT04304508|468753868|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215821|NCT04304508|468753869|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215822|NCT04304508|468753866|FG000|Overall Study|Physician Decision|3|||
130215823|NCT04304508|468753867|FG001|Overall Study|Physician Decision|4|||
130215824|NCT04304508|468753868|FG002|Overall Study|Physician Decision|9|||
130215825|NCT04304508|468753869|FG003|Overall Study|Physician Decision|7|||
130215826|NCT04304508|468753866|FG000|Overall Study|Study drug never administered|10|||
130215827|NCT04304508|468753867|FG001|Overall Study|Study drug never administered|4|||
130215828|NCT04304508|468753868|FG002|Overall Study|Study drug never administered|4|||
130215829|NCT04304508|468753869|FG003|Overall Study|Study drug never administered|4|||
130215830|NCT04304508|468753866|FG000|Overall Study|Adverse Event|49|||
130215831|NCT04304508|468753867|FG001|Overall Study|Adverse Event|50|||
130215832|NCT04304508|468753868|FG002|Overall Study|Adverse Event|51|||
130215833|NCT04304508|468753869|FG003|Overall Study|Adverse Event|56|||
130215834|NCT04304508|468753866|FG000|Overall Study|Lost to Follow-up|1|||
130215835|NCT04304508|468753867|FG001|Overall Study|Lost to Follow-up|5|||
130215836|NCT04304508|468753868|FG002|Overall Study|Lost to Follow-up|2|||
130215837|NCT04304508|468753869|FG003|Overall Study|Lost to Follow-up|3|||
130215838|NCT02688764|468753870|FG000|Overall Study|Adverse Event|3|||
130215839|NCT02688764|468753871|FG001|Overall Study|Adverse Event|3|||
130215840|NCT02688764|468753870|FG000|Overall Study|AE/Kidney transplant|1|||
130215841|NCT02688764|468753871|FG001|Overall Study|AE/Kidney transplant|0|||
130215842|NCT02688764|468753870|FG000|Overall Study|AE/Lack of efficacy|1|||
130215843|NCT02688764|468753871|FG001|Overall Study|AE/Lack of efficacy|0|||
130215844|NCT02688764|468753870|FG000|Overall Study|AE/Non-compl.|1|||
130215845|NCT02688764|468753871|FG001|Overall Study|AE/Non-compl.|0|||
130215846|NCT02688764|468753870|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
130215847|NCT02688764|468753871|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
130215848|NCT02688764|468753870|FG000|Overall Study|AE/Other|0|||
130215849|NCT02688764|468753871|FG001|Overall Study|AE/Other|1|||
130215850|NCT02688764|468753870|FG000|Overall Study|AE/Physician decision|1|||
130215851|NCT02688764|468753871|FG001|Overall Study|AE/Physician decision|0|||
130215852|NCT02688764|468753870|FG000|Overall Study|AE/Withd. parent|3|||
130659045|NCT03576131|470374670|FG001|Overall Study|Unspecified reason|0|||
130659046|NCT03576131|470374671|FG002|Overall Study|Unspecified reason|1|||
130659047|NCT03576131|470374672|FG003|Overall Study|Unspecified reason|1|||
130659048|NCT03576131|470374673|FG004|Overall Study|Unspecified reason|1|||
130659049|NCT03576131|470374674|FG005|Overall Study|Unspecified reason|1|||
130659050|NCT03576131|470374675|FG006|Overall Study|Unspecified reason|0|||
130659051|NCT03576131|470374676|FG007|Overall Study|Unspecified reason|0|||
130659052|NCT03576131|470374669|FG000|Overall Study|Subject non-compliance|0|||
130659053|NCT03576131|470374670|FG001|Overall Study|Subject non-compliance|0|||
130329095|NCT03722238|469175337|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
130329096|NCT03722238|469175338|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
130329097|NCT02004093|469175339|FG000|Overall Study|Death|2|||
130329098|NCT02004093|469175340|FG001|Overall Study|Death|1|||
130329099|NCT02004093|469175339|FG000|Overall Study|Lack of Efficacy|66|||
130329100|NCT02004093|469175340|FG001|Overall Study|Lack of Efficacy|62|||
130329101|NCT02004093|469175339|FG000|Overall Study|Protocol Violation|0|||
130329102|NCT02004093|469175340|FG001|Overall Study|Protocol Violation|1|||
130329103|NCT02004093|469175339|FG000|Overall Study|Lost to Follow-up|0|||
130329104|NCT02004093|469175340|FG001|Overall Study|Lost to Follow-up|1|||
130329105|NCT02004093|469175339|FG000|Overall Study|Withdrawal by Subject|3|||
130329106|NCT02004093|469175340|FG001|Overall Study|Withdrawal by Subject|7|||
130329107|NCT02004093|469175339|FG000|Overall Study|Other|3|||
130329108|NCT02004093|469175340|FG001|Overall Study|Other|1|||
130329109|NCT01411891|469175341|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
130329110|NCT01411891|469175342|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
130329111|NCT00414596|469175343|FG000|Overall Study|Protocol Violation|2|||
130329112|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Adverse Event|9|||
130329113|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Adverse Event|3|||
130329114|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Death|7|||
130329115|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Death|7|||
130329116|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
130329117|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
130329118|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Physician Decision|1|||
130329119|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Physician Decision|0|||
130329120|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
130329121|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
130329122|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
130329123|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
130329124|NCT02558296|469175344|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
130329125|NCT02558296|469175345|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
130329126|NCT02558296|469175344|FG000|Completed the Study|Adverse Event|14|||
130329127|NCT02558296|469175345|FG001|Completed the Study|Adverse Event|5|||
130329128|NCT02558296|469175344|FG000|Completed the Study|Death|39|||
130329129|NCT02558296|469175345|FG001|Completed the Study|Death|25|||
130329130|NCT02558296|469175344|FG000|Completed the Study|Lost to Follow-up|31|||
130329131|NCT02558296|469175345|FG001|Completed the Study|Lost to Follow-up|23|||
130329132|NCT02558296|469175344|FG000|Completed the Study|Physician Decision|6|||
130329133|NCT02558296|469175345|FG001|Completed the Study|Physician Decision|0|||
130329134|NCT02558296|469175344|FG000|Completed the Study|Protocol Violation|2|||
130329135|NCT02558296|469175345|FG001|Completed the Study|Protocol Violation|1|||
130329136|NCT02558296|469175344|FG000|Completed the Study|Withdrawal by Subject|53|||
130329137|NCT02558296|469175345|FG001|Completed the Study|Withdrawal by Subject|31|||
130329138|NCT02558296|469175344|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
130329139|NCT02558296|469175345|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
130329140|NCT00297258|469175346|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
130329141|NCT00297258|469175346|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
130329142|NCT00297258|469175346|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
130329143|NCT00297258|469175346|FG000|Overall Study|Intercurrent Illness|3|||
130329144|NCT00297258|469175346|FG000|Overall Study|Intercurrent Death|2|||
130329145|NCT00297258|469175346|FG000|Overall Study|Deteriorization of General Condition|1|||
130329146|NCT00297258|469175346|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
130329147|NCT00297258|469175346|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
130329148|NCT00297258|469175346|FG000|Overall Study|Switch to Commercial Treatment|1|||
130329149|NCT00297258|469175346|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
130329150|NCT00346697|469175349|FG000|Overall Study|Lost to Follow-up|0|||
130329151|NCT00346697|469175350|FG001|Overall Study|Lost to Follow-up|1|||
130329152|NCT00734539|469175351|FG000|Main Study|Death|33|||
130329153|NCT00734539|469175352|FG001|Main Study|Death|32|||
130329154|NCT00734539|469175351|FG000|Main Study|Physician Decision|2|||
130659054|NCT03576131|470374671|FG002|Overall Study|Subject non-compliance|0|||
130659055|NCT03576131|470374672|FG003|Overall Study|Subject non-compliance|0|||
130659056|NCT03576131|470374673|FG004|Overall Study|Subject non-compliance|0|||
130659057|NCT03576131|470374674|FG005|Overall Study|Subject non-compliance|1|||
130329155|NCT00734539|469175352|FG001|Main Study|Physician Decision|0|||
130659058|NCT03576131|470374675|FG006|Overall Study|Subject non-compliance|0|||
130659059|NCT03576131|470374676|FG007|Overall Study|Subject non-compliance|0|||
130329156|NCT00734539|469175351|FG000|Main Study|Withdrawal by Subject|1|||
130329157|NCT00734539|469175352|FG001|Main Study|Withdrawal by Subject|3|||
130329158|NCT00734539|469175351|FG000|Main Study|Enrolled in error; ineligible|1|||
130329159|NCT00734539|469175352|FG001|Main Study|Enrolled in error; ineligible|0|||
130329160|NCT02504151|469175357|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
130329161|NCT02504151|469175358|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
130329162|NCT02504151|469175357|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
130329163|NCT02504151|469175358|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
130329164|NCT02504151|469175357|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130329165|NCT02504151|469175358|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130329166|NCT02504151|469175357|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
130329167|NCT02504151|469175358|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130329168|NCT05038982|469175359|FG000|Overall Study|Withdrawal by Subject|0|||
130329169|NCT05038982|469175360|FG001|Overall Study|Withdrawal by Subject|2|||
130329170|NCT02557139|469175366|FG000|Overall Study|Significant liver elevation|1|||
130329171|NCT02557139|469175367|FG001|Overall Study|Significant liver elevation|0|||
130329172|NCT02557139|469175368|FG002|Overall Study|Significant liver elevation|1|||
130329173|NCT02557139|469175366|FG000|Overall Study|Withdrawal by Subject|1|||
130329174|NCT02557139|469175367|FG001|Overall Study|Withdrawal by Subject|0|||
130329175|NCT02557139|469175368|FG002|Overall Study|Withdrawal by Subject|0|||
130329176|NCT02557139|469175366|FG000|Overall Study|Illness of prohibited medication|0|||
130329177|NCT02557139|469175367|FG001|Overall Study|Illness of prohibited medication|0|||
130329178|NCT02557139|469175368|FG002|Overall Study|Illness of prohibited medication|1|||
130329179|NCT01454102|469175369|FG000|Overall Study|Continuing in the treatment period|0|||
130329180|NCT01454102|469175370|FG001|Overall Study|Continuing in the treatment period|0|||
130329181|NCT01454102|469175371|FG002|Overall Study|Continuing in the treatment period|0|||
130329182|NCT01454102|469175372|FG003|Overall Study|Continuing in the treatment period|0|||
130329183|NCT01454102|469175373|FG004|Overall Study|Continuing in the treatment period|3|||
130329184|NCT01454102|469175374|FG005|Overall Study|Continuing in the treatment period|3|||
130329185|NCT01454102|469175375|FG006|Overall Study|Continuing in the treatment period|2|||
130329186|NCT01454102|469175376|FG007|Overall Study|Continuing in the treatment period|0|||
130329187|NCT01454102|469175377|FG008|Overall Study|Continuing in the treatment period|1|||
130329188|NCT01454102|469175378|FG009|Overall Study|Continuing in the treatment period|0|||
130329189|NCT01454102|469175379|FG010|Overall Study|Continuing in the treatment period|0|||
130329190|NCT01454102|469175380|FG011|Overall Study|Continuing in the treatment period|4|||
130659060|NCT03069365|470374685|FG000|Overall Study|Adverse Event|1|||
130659061|NCT02886494|470374686|FG000|Overall Study|Adverse Event|1|||
130659062|NCT02886494|470374687|FG001|Overall Study|Adverse Event|0|||
130659063|NCT02886494|470374686|FG000|Overall Study|Withdrawal by Subject|12|||
130659064|NCT02886494|470374687|FG001|Overall Study|Withdrawal by Subject|3|||
130659065|NCT02886494|470374686|FG000|Overall Study|Protocol Violation|4|||
130659066|NCT02886494|470374687|FG001|Overall Study|Protocol Violation|1|||
130659067|NCT02780115|470374688|FG000|Overall Study|Withdrawal by Subject|0|||
130659068|NCT02780115|470374689|FG001|Overall Study|Withdrawal by Subject|1|||
130659069|NCT02780115|470374690|FG002|Overall Study|Withdrawal by Subject|1|||
130659070|NCT02780115|470374691|FG003|Overall Study|Withdrawal by Subject|0|||
130659071|NCT02780115|470374692|FG004|Overall Study|Withdrawal by Subject|0|||
130659072|NCT02780115|470374688|FG000|Overall Study|Adverse Event|0|||
130659073|NCT02780115|470374689|FG001|Overall Study|Adverse Event|0|||
130659074|NCT02780115|470374690|FG002|Overall Study|Adverse Event|0|||
130659075|NCT02780115|470374691|FG003|Overall Study|Adverse Event|1|||
130659076|NCT02780115|470374692|FG004|Overall Study|Adverse Event|1|||
130659077|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
130659078|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
130659079|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
130659080|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
130659081|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
130659082|NCT01179191|470374693|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
130659083|NCT01179191|470374693|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
130659084|NCT01179191|470374693|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
130659085|NCT01179191|470374693|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
130329191|NCT01454102|469175381|FG012|Overall Study|Continuing in the treatment period|7|||
130329192|NCT01454102|469175382|FG013|Overall Study|Continuing in the treatment period|4|||
130329193|NCT01454102|469175383|FG014|Overall Study|Continuing in the treatment period|3|||
130659086|NCT01179191|470374693|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
130659087|NCT01179191|470374693|FG000|Maintenance Phase (8 Weeks)|Other|66|||
130659088|NCT02742818|470374697|FG000|Overall Study|Adverse Event|0|||
130659089|NCT02742818|470374698|FG001|Overall Study|Adverse Event|1|||
130659090|NCT02742818|470374697|FG000|Overall Study|Protocol Violation|0|||
130659091|NCT02742818|470374698|FG001|Overall Study|Protocol Violation|1|||
130215853|NCT02688764|468753871|FG001|Overall Study|AE/Withd. parent|0|||
130659092|NCT03972709|470374703|FG000|Overall Study|Withdrawal by Subject|18|||
130659093|NCT03972709|470374704|FG001|Overall Study|Withdrawal by Subject|7|||
130659094|NCT03972709|470374705|FG002|Overall Study|Withdrawal by Subject|14|||
130659095|NCT03972709|470374703|FG000|Overall Study|Study Terminated by Sponsor|48|||
130659096|NCT03972709|470374704|FG001|Overall Study|Study Terminated by Sponsor|25|||
130659097|NCT03972709|470374705|FG002|Overall Study|Study Terminated by Sponsor|50|||
130659098|NCT03972709|470374703|FG000|Overall Study|Physician Decision|1|||
130659099|NCT03972709|470374704|FG001|Overall Study|Physician Decision|0|||
130659100|NCT03972709|470374705|FG002|Overall Study|Physician Decision|0|||
130659101|NCT03972709|470374703|FG000|Overall Study|COVID-19|0|||
130659102|NCT03972709|470374704|FG001|Overall Study|COVID-19|1|||
130659103|NCT03972709|470374705|FG002|Overall Study|COVID-19|1|||
130659104|NCT03972709|470374703|FG000|Overall Study|Lost to Follow-up|6|||
130659105|NCT03972709|470374704|FG001|Overall Study|Lost to Follow-up|1|||
130659106|NCT03972709|470374705|FG002|Overall Study|Lost to Follow-up|2|||
130659107|NCT03972709|470374703|FG000|Overall Study|Death|5|||
130659108|NCT03972709|470374704|FG001|Overall Study|Death|1|||
130659109|NCT03972709|470374705|FG002|Overall Study|Death|4|||
130659110|NCT03972709|470374703|FG000|Overall Study|Adverse Event|3|||
130659111|NCT03972709|470374704|FG001|Overall Study|Adverse Event|1|||
130659112|NCT03972709|470374705|FG002|Overall Study|Adverse Event|4|||
130659113|NCT03972709|470374703|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
130659114|NCT03972709|470374704|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
130659115|NCT03972709|470374705|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
130659116|NCT03972709|470374703|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
130659117|NCT03972709|470374704|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
130659118|NCT03972709|470374705|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
130659119|NCT03972709|470374703|FG000|Overall Study|Subject Unable to be Contacted|0|||
130659120|NCT03972709|470374704|FG001|Overall Study|Subject Unable to be Contacted|1|||
130659121|NCT03972709|470374705|FG002|Overall Study|Subject Unable to be Contacted|0|||
130659122|NCT03972709|470374703|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
130659123|NCT03972709|470374704|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
130659124|NCT03972709|470374705|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
130659125|NCT03972709|470374703|FG000|Overall Study|Subject Moved|0|||
130659126|NCT03972709|470374704|FG001|Overall Study|Subject Moved|1|||
130659127|NCT03972709|470374705|FG002|Overall Study|Subject Moved|0|||
130659128|NCT03972709|470374703|FG000|Overall Study|Missed Study Visits|1|||
130659129|NCT03972709|470374704|FG001|Overall Study|Missed Study Visits|0|||
130659130|NCT03972709|470374705|FG002|Overall Study|Missed Study Visits|0|||
130659131|NCT05013749|470374715|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
130659132|NCT05013749|470374716|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
130659133|NCT05013749|470374715|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
130659134|NCT05013749|470374716|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
130659135|NCT02017535|470374717|FG000|Overall Study|Withdrawal by Subject|1|||
130659136|NCT02017535|470374718|FG001|Overall Study|Withdrawal by Subject|0|||
130659137|NCT02017535|470374719|FG002|Overall Study|Withdrawal by Subject|0|||
130329194|NCT01454102|469175384|FG015|Overall Study|Continuing in the treatment period|1|||
130329195|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
130329196|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
130329197|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
130329198|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
130329199|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
130329200|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
130329201|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
130329202|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
130329203|NCT02592798|469175390|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
130329204|NCT02592798|469175391|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
130329205|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
130329206|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
130329207|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
130329208|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
130329209|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
130659138|NCT02017535|470374720|FG003|Overall Study|Withdrawal by Subject|0|||
130329210|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
130659139|NCT01393626|470374721|FG000|Overall Study|Adverse Event|2|||
130659140|NCT01393626|470374722|FG001|Overall Study|Adverse Event|1|||
130329211|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
130659141|NCT01393626|470374723|FG002|Overall Study|Adverse Event|5|||
130659142|NCT01393626|470374724|FG003|Overall Study|Adverse Event|0|||
130659143|NCT01393626|470374721|FG000|Overall Study|Did not meet entrance criteria|1|||
130659144|NCT01393626|470374722|FG001|Overall Study|Did not meet entrance criteria|0|||
130659145|NCT01393626|470374723|FG002|Overall Study|Did not meet entrance criteria|0|||
130659146|NCT01393626|470374724|FG003|Overall Study|Did not meet entrance criteria|0|||
130659147|NCT01393626|470374721|FG000|Overall Study|Lack of Efficacy|6|||
130659148|NCT01393626|470374722|FG001|Overall Study|Lack of Efficacy|6|||
130659149|NCT01393626|470374723|FG002|Overall Study|Lack of Efficacy|4|||
130659150|NCT01393626|470374724|FG003|Overall Study|Lack of Efficacy|1|||
130659151|NCT01393626|470374721|FG000|Overall Study|Lost to Follow-up|1|||
130659152|NCT01393626|470374722|FG001|Overall Study|Lost to Follow-up|1|||
130659153|NCT01393626|470374723|FG002|Overall Study|Lost to Follow-up|1|||
130659154|NCT01393626|470374724|FG003|Overall Study|Lost to Follow-up|0|||
130659155|NCT01393626|470374721|FG000|Overall Study|Withdrawal by Subject|6|||
130659156|NCT01393626|470374722|FG001|Overall Study|Withdrawal by Subject|4|||
130659157|NCT01393626|470374723|FG002|Overall Study|Withdrawal by Subject|0|||
130659158|NCT01393626|470374724|FG003|Overall Study|Withdrawal by Subject|0|||
130659159|NCT01393626|470374721|FG000|Overall Study|Other|1|||
130659160|NCT01393626|470374722|FG001|Overall Study|Other|0|||
130659161|NCT01393626|470374723|FG002|Overall Study|Other|0|||
130659162|NCT01393626|470374724|FG003|Overall Study|Other|0|||
130659163|NCT01393626|470374721|FG000|Overall Study|Protocol Violation|1|||
130659164|NCT01393626|470374722|FG001|Overall Study|Protocol Violation|0|||
130659165|NCT01393626|470374723|FG002|Overall Study|Protocol Violation|2|||
130659166|NCT01393626|470374724|FG003|Overall Study|Protocol Violation|0|||
130659167|NCT02426125|470374725|FG000|Overall Study|Lost to Follow-up|14|||
130659168|NCT02426125|470374726|FG001|Overall Study|Lost to Follow-up|12|||
130659169|NCT02426125|470374725|FG000|Overall Study|Withdrawal by Subject|13|||
130659170|NCT02426125|470374726|FG001|Overall Study|Withdrawal by Subject|14|||
130659171|NCT02426125|470374725|FG000|Overall Study|Death|185|||
130329212|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
130329213|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
130329214|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
130329215|NCT02592798|469175390|FG000|Transition From DB2 to OLE|Other reasons|1|||
130329216|NCT02592798|469175391|FG001|Transition From DB2 to OLE|Other reasons|0|||
130329217|NCT02592798|469175390|FG000|Open Label Period (OLE)|Other reasons|0|||
130329218|NCT02592798|469175391|FG001|Open Label Period (OLE)|Other reasons|2|||
130329219|NCT02592798|469175390|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
130329220|NCT02592798|469175391|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
130329221|NCT02592798|469175390|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
130329222|NCT02592798|469175391|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
130329223|NCT02592798|469175390|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
130329224|NCT02592798|469175391|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
130329225|NCT02592798|469175390|FG000|Open Label Period (OLE)|Adverse Event|0|||
130329226|NCT02592798|469175391|FG001|Open Label Period (OLE)|Adverse Event|1|||
130329227|NCT00705016|469175392|FG000|Overall Study|Adverse Event|6|||
130329228|NCT00705016|469175393|FG001|Overall Study|Adverse Event|11|||
130329229|NCT00705016|469175394|FG002|Overall Study|Adverse Event|10|||
130329230|NCT00705016|469175392|FG000|Overall Study|Death|5|||
130329231|NCT00705016|469175393|FG001|Overall Study|Death|7|||
130329232|NCT00705016|469175394|FG002|Overall Study|Death|5|||
130329233|NCT00705016|469175392|FG000|Overall Study|Protocol Violation|0|||
130329234|NCT00705016|469175393|FG001|Overall Study|Protocol Violation|1|||
130329235|NCT00705016|469175394|FG002|Overall Study|Protocol Violation|1|||
130329236|NCT00705016|469175392|FG000|Overall Study|Withdrawal by Subject|4|||
130329237|NCT00705016|469175393|FG001|Overall Study|Withdrawal by Subject|3|||
130329238|NCT00705016|469175394|FG002|Overall Study|Withdrawal by Subject|2|||
130329239|NCT00705016|469175392|FG000|Overall Study|Progressive Disease|33|||
130329240|NCT00705016|469175393|FG001|Overall Study|Progressive Disease|29|||
130329241|NCT00705016|469175394|FG002|Overall Study|Progressive Disease|33|||
130329242|NCT00705016|469175392|FG000|Overall Study|Symptomatic Deterioration|3|||
130329243|NCT00705016|469175393|FG001|Overall Study|Symptomatic Deterioration|1|||
130329244|NCT00705016|469175394|FG002|Overall Study|Symptomatic Deterioration|1|||
130329245|NCT00705016|469175392|FG000|Overall Study|Other|9|||
130329246|NCT00705016|469175393|FG001|Overall Study|Other|6|||
130329247|NCT00705016|469175394|FG002|Overall Study|Other|6|||
130329248|NCT03853109|469175397|FG000|Overall Study|Withdrawal by Subject|0|||
130659172|NCT02426125|470374726|FG001|Overall Study|Death|200|||
130659173|NCT02426125|470374725|FG000|Overall Study|Randomized, But Never Treated|5|||
130659174|NCT02426125|470374726|FG001|Overall Study|Randomized, But Never Treated|2|||
130659175|NCT02858076|470374727|FG000|Overall Study|Death|6|||
130659176|NCT02858076|470374728|FG001|Overall Study|Death|3|||
130659177|NCT02858076|470374727|FG000|Overall Study|Withdrawal by Subject|1|||
130659178|NCT02858076|470374728|FG001|Overall Study|Withdrawal by Subject|5|||
130659179|NCT02858076|470374727|FG000|Overall Study|Lost to Follow-up|2|||
130329249|NCT03853109|469175398|FG001|Overall Study|Withdrawal by Subject|0|||
130329250|NCT03853109|469175399|FG002|Overall Study|Withdrawal by Subject|1|||
130329251|NCT03853109|469175400|FG003|Overall Study|Withdrawal by Subject|2|||
130329252|NCT03853109|469175401|FG004|Overall Study|Withdrawal by Subject|1|||
130329253|NCT03853109|469175402|FG005|Overall Study|Withdrawal by Subject|4|||
130659180|NCT02858076|470374728|FG001|Overall Study|Lost to Follow-up|7|||
130659181|NCT02858076|470374727|FG000|Overall Study|Completed Out of Window|1|||
130659182|NCT02858076|470374728|FG001|Overall Study|Completed Out of Window|3|||
130659183|NCT03506425|470374729|FG000|Overall Study|Adverse Event|1|||
130659184|NCT03506425|470374730|FG001|Overall Study|Adverse Event|3|||
130659185|NCT03506425|470374731|FG002|Overall Study|Adverse Event|0|||
130329254|NCT03853109|469175403|FG006|Overall Study|Withdrawal by Subject|5|||
130329255|NCT03853109|469175404|FG007|Overall Study|Withdrawal by Subject|3|||
130329256|NCT03853109|469175397|FG000|Overall Study|Decision by Sponsor|0|||
130329257|NCT03853109|469175398|FG001|Overall Study|Decision by Sponsor|0|||
130329258|NCT03853109|469175399|FG002|Overall Study|Decision by Sponsor|1|||
130329259|NCT03853109|469175400|FG003|Overall Study|Decision by Sponsor|0|||
130329260|NCT03853109|469175401|FG004|Overall Study|Decision by Sponsor|1|||
130329261|NCT03853109|469175402|FG005|Overall Study|Decision by Sponsor|1|||
130329262|NCT03853109|469175403|FG006|Overall Study|Decision by Sponsor|10|||
130329263|NCT03853109|469175404|FG007|Overall Study|Decision by Sponsor|2|||
130329264|NCT03853109|469175397|FG000|Overall Study|Lost to Follow-up|0|||
130329265|NCT03853109|469175398|FG001|Overall Study|Lost to Follow-up|0|||
130329266|NCT03853109|469175399|FG002|Overall Study|Lost to Follow-up|0|||
130329267|NCT03853109|469175400|FG003|Overall Study|Lost to Follow-up|0|||
130329268|NCT03853109|469175401|FG004|Overall Study|Lost to Follow-up|1|||
130329269|NCT03853109|469175402|FG005|Overall Study|Lost to Follow-up|3|||
130329270|NCT03853109|469175403|FG006|Overall Study|Lost to Follow-up|0|||
130329271|NCT03853109|469175404|FG007|Overall Study|Lost to Follow-up|0|||
130329272|NCT03853109|469175397|FG000|Overall Study|Death|2|||
130329273|NCT03853109|469175398|FG001|Overall Study|Death|5|||
130329274|NCT03853109|469175399|FG002|Overall Study|Death|8|||
130329275|NCT03853109|469175400|FG003|Overall Study|Death|10|||
130329276|NCT03853109|469175401|FG004|Overall Study|Death|3|||
130329277|NCT03853109|469175402|FG005|Overall Study|Death|20|||
130329278|NCT03853109|469175403|FG006|Overall Study|Death|10|||
130659186|NCT03506425|470374729|FG000|Overall Study|Death|1|||
130659187|NCT03506425|470374730|FG001|Overall Study|Death|0|||
130659188|NCT03506425|470374731|FG002|Overall Study|Death|0|||
130659189|NCT03506425|470374729|FG000|Overall Study|Withdrawal by Subject|0|||
130659190|NCT03506425|470374730|FG001|Overall Study|Withdrawal by Subject|0|||
130659191|NCT03506425|470374731|FG002|Overall Study|Withdrawal by Subject|1|||
130659192|NCT04088734|470374734|FG000|Overall Study|Other, Not Specified|5|||
130659193|NCT00096200|470374735|FG000|Overall Study|Adverse Event|0|||
130659194|NCT00096200|470374736|FG001|Overall Study|Adverse Event|4|||
130659195|NCT00096200|470374737|FG002|Overall Study|Adverse Event|0|||
130659196|NCT00096200|470374735|FG000|Overall Study|Withdrawal by Subject|1|||
130659197|NCT00096200|470374736|FG001|Overall Study|Withdrawal by Subject|2|||
130659198|NCT00096200|470374737|FG002|Overall Study|Withdrawal by Subject|0|||
130659199|NCT00096200|470374735|FG000|Overall Study|Ineligible pathology|0|||
130659200|NCT00096200|470374736|FG001|Overall Study|Ineligible pathology|1|||
130659201|NCT00096200|470374737|FG002|Overall Study|Ineligible pathology|0|||
130659202|NCT00938015|470374741|FG000|Overall Study|Death|2|||
130659203|NCT00938015|470374741|FG000|Overall Study|Lost to Follow-up|32|||
130659204|NCT00938015|470374741|FG000|Overall Study|Adverse Event|32|||
130659205|NCT00938015|470374741|FG000|Overall Study|Non-responder|52|||
130659206|NCT00938015|470374741|FG000|Overall Study|Reason not related to Etanercept|29|||
130659207|NCT02341482|470374742|FG000|Overall Study|Adverse Event|1|||
130659208|NCT00090259|470374748|FG000|Overall Study|Lost to Follow-up|30|||
130659209|NCT00090259|470374749|FG001|Overall Study|Lost to Follow-up|26|||
130659210|NCT00090259|470374748|FG000|Overall Study|Withdrawal by Subject|21|||
130659211|NCT00090259|470374749|FG001|Overall Study|Withdrawal by Subject|15|||
130659212|NCT00090259|470374748|FG000|Overall Study|Investigator site closed|11|||
130659213|NCT00090259|470374749|FG001|Overall Study|Investigator site closed|7|||
130659214|NCT00358670|470374752|FG000|Overall Study|Adverse Event|26|||
130659215|NCT00358670|470374753|FG001|Overall Study|Adverse Event|29|||
130659216|NCT00358670|470374752|FG000|Overall Study|Lack of Efficacy|20|||
130329279|NCT03853109|469175404|FG007|Overall Study|Death|5|||
130659217|NCT00358670|470374753|FG001|Overall Study|Lack of Efficacy|23|||
130659218|NCT00358670|470374752|FG000|Overall Study|Protocol Violation|6|||
130659219|NCT00358670|470374753|FG001|Overall Study|Protocol Violation|9|||
130329280|NCT01721044|469175409|FG000|Treatment Period|Adverse Event|7|||
130329281|NCT01721044|469175410|FG001|Treatment Period|Adverse Event|7|||
130329282|NCT01721044|469175411|FG002|Treatment Period|Adverse Event|10|||
130659220|NCT00358670|470374752|FG000|Overall Study|Lost to Follow-up|4|||
130659221|NCT00358670|470374753|FG001|Overall Study|Lost to Follow-up|5|||
130659222|NCT00358670|470374752|FG000|Overall Study|Withdrawal by Subject|13|||
130659223|NCT00358670|470374753|FG001|Overall Study|Withdrawal by Subject|24|||
130329283|NCT01721044|469175409|FG000|Treatment Period|Death|0|||
130329284|NCT01721044|469175410|FG001|Treatment Period|Death|0|||
130329285|NCT01721044|469175411|FG002|Treatment Period|Death|1|||
130329286|NCT01721044|469175409|FG000|Treatment Period|Lack of Efficacy|16|||
130659224|NCT00358670|470374752|FG000|Overall Study|Protocol Defined Clinical Event|0|||
130659225|NCT00358670|470374753|FG001|Overall Study|Protocol Defined Clinical Event|1|||
130659226|NCT00358670|470374752|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130659227|NCT00358670|470374753|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
130659228|NCT00358670|470374752|FG000|Overall Study|Administrative|153|||
130659229|NCT00358670|470374753|FG001|Overall Study|Administrative|125|||
130659230|NCT00981019|470374754|FG000|Overall Study|Did not respond|65|||
130659231|NCT00981019|470374754|FG000|Overall Study|Did not match target population|94|||
130659232|NCT00981019|470374754|FG000|Overall Study|Inadvertent exclusion|239|||
130659233|NCT00981019|470374754|FG000|Overall Study|Hit the survey after closure|79|||
130659234|NCT00960687|470374755|FG000|Washout Period of 7 Days|Adverse Event|3|||
130659235|NCT00960687|470374756|FG001|Washout Period of 7 Days|Adverse Event|2|||
130659236|NCT00960687|470374755|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130659237|NCT00960687|470374756|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130659238|NCT02704130|470374757|FG000|Overall Study|Physician Decision|5|||
130659239|NCT02704130|470374758|FG001|Overall Study|Physician Decision|3|||
130659240|NCT02666768|470374759|FG000|Overall Study|Withdrawal by Subject|4|||
130659241|NCT00285012|470374762|FG000|Assigned to Study Treatment (Tx)|Other|2|||
130659242|NCT00285012|470374763|FG001|Assigned to Study Treatment (Tx)|Other|3|||
130659243|NCT00285012|470374762|FG000|Received Study Tx|Death|2|||
130659244|NCT00285012|470374763|FG001|Received Study Tx|Death|1|||
130659245|NCT00285012|470374762|FG000|Received Study Tx|Adverse Event|5|||
130659246|NCT00285012|470374763|FG001|Received Study Tx|Adverse Event|11|||
130659247|NCT00285012|470374762|FG000|Received Study Tx|Lack of Efficacy|0|||
130659248|NCT00285012|470374763|FG001|Received Study Tx|Lack of Efficacy|3|||
130659249|NCT00285012|470374762|FG000|Received Study Tx|Lost to Follow-up|29|||
130659250|NCT00285012|470374763|FG001|Received Study Tx|Lost to Follow-up|31|||
130659251|NCT00285012|470374762|FG000|Received Study Tx|Withdrawal by Subject|31|||
130659252|NCT00285012|470374763|FG001|Received Study Tx|Withdrawal by Subject|43|||
130659253|NCT00285012|470374762|FG000|Received Study Tx|Other|5|||
130659254|NCT00285012|470374763|FG001|Received Study Tx|Other|5|||
130659255|NCT02873195|470374766|FG000|Overall Study|Ineligible|5|||
130659256|NCT02873195|470374767|FG001|Overall Study|Ineligible|0|||
130659257|NCT05004181|470374768|FG000|Overall Study|Withdrawal of consent|0|||
130659258|NCT05004181|470374769|FG001|Overall Study|Withdrawal of consent|0|||
130659259|NCT05004181|470374770|FG002|Overall Study|Withdrawal of consent|1|||
130659260|NCT05004181|470374771|FG003|Overall Study|Withdrawal of consent|3|||
130659261|NCT05004181|470374772|FG004|Overall Study|Withdrawal of consent|3|||
130659262|NCT05004181|470374773|FG005|Overall Study|Withdrawal of consent|0|||
130659263|NCT05004181|470374774|FG006|Overall Study|Withdrawal of consent|30|||
130659264|NCT05004181|470374775|FG007|Overall Study|Withdrawal of consent|9|||
130659265|NCT05004181|470374776|FG008|Overall Study|Withdrawal of consent|3|||
130659266|NCT05004181|470374777|FG009|Overall Study|Withdrawal of consent|2|||
130659267|NCT05004181|470374778|FG010|Overall Study|Withdrawal of consent|5|||
130659268|NCT05004181|470374779|FG011|Overall Study|Withdrawal of consent|1|||
130659269|NCT05004181|470374768|FG000|Overall Study|Lost to Follow-up|2|||
130659270|NCT05004181|470374769|FG001|Overall Study|Lost to Follow-up|4|||
130659271|NCT05004181|470374770|FG002|Overall Study|Lost to Follow-up|2|||
130659272|NCT05004181|470374771|FG003|Overall Study|Lost to Follow-up|3|||
130659273|NCT05004181|470374772|FG004|Overall Study|Lost to Follow-up|5|||
130659274|NCT05004181|470374773|FG005|Overall Study|Lost to Follow-up|2|||
130659275|NCT05004181|470374774|FG006|Overall Study|Lost to Follow-up|15|||
130659276|NCT05004181|470374775|FG007|Overall Study|Lost to Follow-up|12|||
130659277|NCT05004181|470374776|FG008|Overall Study|Lost to Follow-up|38|||
130659278|NCT05004181|470374777|FG009|Overall Study|Lost to Follow-up|6|||
130659279|NCT05004181|470374778|FG010|Overall Study|Lost to Follow-up|6|||
130659280|NCT05004181|470374779|FG011|Overall Study|Lost to Follow-up|0|||
130659281|NCT05004181|470374768|FG000|Overall Study|Death|0|||
130659282|NCT05004181|470374769|FG001|Overall Study|Death|0|||
130215854|NCT02688764|468753870|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
130215855|NCT02688764|468753871|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
130215856|NCT02688764|468753870|FG000|Overall Study|AE/Withd. subject|1|||
130215857|NCT02688764|468753871|FG001|Overall Study|AE/Withd. subject|0|||
130215858|NCT02688764|468753870|FG000|Overall Study|Kidney transplant|10|||
130215859|NCT02688764|468753871|FG001|Overall Study|Kidney transplant|4|||
130215860|NCT02688764|468753870|FG000|Overall Study|Lack of Efficacy|3|||
130215861|NCT02688764|468753871|FG001|Overall Study|Lack of Efficacy|2|||
130215862|NCT02688764|468753870|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
130215863|NCT02688764|468753871|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
130215864|NCT02688764|468753870|FG000|Overall Study|Non-compliance with study drug|4|||
130215865|NCT02688764|468753871|FG001|Overall Study|Non-compliance with study drug|0|||
130215866|NCT02688764|468753870|FG000|Overall Study|Non-compl./Physician decision|2|||
130215867|NCT02688764|468753871|FG001|Overall Study|Non-compl./Physician decision|0|||
130215868|NCT02688764|468753870|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
130659283|NCT05004181|470374770|FG002|Overall Study|Death|0|||
130659284|NCT05004181|470374771|FG003|Overall Study|Death|0|||
130659285|NCT05004181|470374772|FG004|Overall Study|Death|0|||
130659286|NCT05004181|470374773|FG005|Overall Study|Death|0|||
130659287|NCT05004181|470374774|FG006|Overall Study|Death|1|||
130659288|NCT05004181|470374775|FG007|Overall Study|Death|0|||
130659289|NCT05004181|470374776|FG008|Overall Study|Death|2|||
130659290|NCT05004181|470374777|FG009|Overall Study|Death|0|||
130659291|NCT05004181|470374778|FG010|Overall Study|Death|0|||
130659292|NCT05004181|470374779|FG011|Overall Study|Death|0|||
130659293|NCT05004181|470374768|FG000|Overall Study|Physician Decision|0|||
130329287|NCT01721044|469175410|FG001|Treatment Period|Lack of Efficacy|4|||
130329288|NCT01721044|469175411|FG002|Treatment Period|Lack of Efficacy|4|||
130329289|NCT01721044|469175409|FG000|Treatment Period|Lost to Follow-up|0|||
130329290|NCT01721044|469175410|FG001|Treatment Period|Lost to Follow-up|0|||
130329291|NCT01721044|469175411|FG002|Treatment Period|Lost to Follow-up|1|||
130329292|NCT01721044|469175409|FG000|Treatment Period|Physician Decision|1|||
130329293|NCT01721044|469175410|FG001|Treatment Period|Physician Decision|0|||
130329294|NCT01721044|469175411|FG002|Treatment Period|Physician Decision|2|||
130329295|NCT01721044|469175409|FG000|Treatment Period|Protocol Violation|1|||
130329296|NCT01721044|469175410|FG001|Treatment Period|Protocol Violation|0|||
130329297|NCT01721044|469175411|FG002|Treatment Period|Protocol Violation|0|||
130659294|NCT05004181|470374769|FG001|Overall Study|Physician Decision|0|||
130659295|NCT05004181|470374770|FG002|Overall Study|Physician Decision|0|||
130659296|NCT05004181|470374771|FG003|Overall Study|Physician Decision|0|||
130659297|NCT05004181|470374772|FG004|Overall Study|Physician Decision|0|||
130659298|NCT05004181|470374773|FG005|Overall Study|Physician Decision|0|||
130659299|NCT05004181|470374774|FG006|Overall Study|Physician Decision|2|||
130659300|NCT05004181|470374775|FG007|Overall Study|Physician Decision|0|||
130659301|NCT05004181|470374776|FG008|Overall Study|Physician Decision|7|||
130659302|NCT05004181|470374777|FG009|Overall Study|Physician Decision|0|||
130659303|NCT05004181|470374778|FG010|Overall Study|Physician Decision|0|||
130659304|NCT05004181|470374779|FG011|Overall Study|Physician Decision|0|||
130659305|NCT05004181|470374768|FG000|Overall Study|Withdrawal by Subject|2|||
130659306|NCT05004181|470374769|FG001|Overall Study|Withdrawal by Subject|3|||
130659307|NCT05004181|470374770|FG002|Overall Study|Withdrawal by Subject|2|||
130659308|NCT05004181|470374771|FG003|Overall Study|Withdrawal by Subject|2|||
130659309|NCT05004181|470374772|FG004|Overall Study|Withdrawal by Subject|4|||
130659310|NCT05004181|470374773|FG005|Overall Study|Withdrawal by Subject|2|||
130659311|NCT05004181|470374774|FG006|Overall Study|Withdrawal by Subject|4|||
130659312|NCT05004181|470374775|FG007|Overall Study|Withdrawal by Subject|22|||
130329298|NCT01721044|469175409|FG000|Treatment Period|Withdrawal by Subject|7|||
130329299|NCT01721044|469175410|FG001|Treatment Period|Withdrawal by Subject|6|||
130329300|NCT01721044|469175411|FG002|Treatment Period|Withdrawal by Subject|1|||
130329301|NCT04032093|469175414|FG000|Overall Study|Lost to Follow-up|7|||
130329302|NCT04032093|469175415|FG001|Overall Study|Lost to Follow-up|7|||
130329303|NCT04032093|469175416|FG002|Overall Study|Lost to Follow-up|6|||
130329304|NCT04032093|469175417|FG003|Overall Study|Lost to Follow-up|10|||
130329305|NCT04032093|469175418|FG004|Overall Study|Lost to Follow-up|13|||
130329306|NCT04032093|469175419|FG005|Overall Study|Lost to Follow-up|7|||
130329307|NCT04032093|469175420|FG006|Overall Study|Lost to Follow-up|7|||
130329308|NCT04032093|469175421|FG007|Overall Study|Lost to Follow-up|5|||
130329309|NCT04032093|469175422|FG008|Overall Study|Lost to Follow-up|9|||
130329310|NCT04032093|469175423|FG009|Overall Study|Lost to Follow-up|12|||
130329311|NCT04032093|469175414|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329312|NCT04032093|469175415|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329313|NCT04032093|469175416|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329314|NCT04032093|469175417|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
130329315|NCT04032093|469175418|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329316|NCT04032093|469175419|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329317|NCT04032093|469175420|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329318|NCT04032093|469175421|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329319|NCT04032093|469175422|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329320|NCT04032093|469175423|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329321|NCT04032093|469175414|FG000|Overall Study|Other|1|||
130329322|NCT04032093|469175415|FG001|Overall Study|Other|0|||
130329323|NCT04032093|469175416|FG002|Overall Study|Other|0|||
130329324|NCT04032093|469175417|FG003|Overall Study|Other|1|||
130329325|NCT04032093|469175418|FG004|Overall Study|Other|1|||
130329326|NCT04032093|469175419|FG005|Overall Study|Other|0|||
130329327|NCT04032093|469175420|FG006|Overall Study|Other|0|||
130329328|NCT04032093|469175421|FG007|Overall Study|Other|0|||
130329329|NCT04032093|469175422|FG008|Overall Study|Other|0|||
130329330|NCT04032093|469175423|FG009|Overall Study|Other|1|||
130329331|NCT04032093|469175414|FG000|Overall Study|Withdrawal by Subject|1|||
130329332|NCT04032093|469175415|FG001|Overall Study|Withdrawal by Subject|3|||
130329333|NCT04032093|469175416|FG002|Overall Study|Withdrawal by Subject|2|||
130329334|NCT04032093|469175417|FG003|Overall Study|Withdrawal by Subject|2|||
130329335|NCT04032093|469175418|FG004|Overall Study|Withdrawal by Subject|3|||
130659313|NCT05004181|470374776|FG008|Overall Study|Withdrawal by Subject|8|||
130659314|NCT05004181|470374777|FG009|Overall Study|Withdrawal by Subject|1|||
130659315|NCT05004181|470374778|FG010|Overall Study|Withdrawal by Subject|3|||
130659316|NCT05004181|470374779|FG011|Overall Study|Withdrawal by Subject|2|||
130659317|NCT05004181|470374768|FG000|Overall Study|Protocol Violation|2|||
130659318|NCT05004181|470374769|FG001|Overall Study|Protocol Violation|3|||
130659319|NCT05004181|470374770|FG002|Overall Study|Protocol Violation|0|||
130659320|NCT05004181|470374771|FG003|Overall Study|Protocol Violation|0|||
130659321|NCT05004181|470374772|FG004|Overall Study|Protocol Violation|1|||
130659322|NCT05004181|470374773|FG005|Overall Study|Protocol Violation|0|||
130659323|NCT05004181|470374774|FG006|Overall Study|Protocol Violation|16|||
130659324|NCT05004181|470374775|FG007|Overall Study|Protocol Violation|18|||
130659325|NCT05004181|470374776|FG008|Overall Study|Protocol Violation|2|||
130659326|NCT05004181|470374777|FG009|Overall Study|Protocol Violation|2|||
130659327|NCT05004181|470374778|FG010|Overall Study|Protocol Violation|2|||
130659328|NCT05004181|470374779|FG011|Overall Study|Protocol Violation|1|||
130659329|NCT05004181|470374768|FG000|Overall Study|Not further specified|1|||
130659330|NCT05004181|470374769|FG001|Overall Study|Not further specified|0|||
130659331|NCT05004181|470374770|FG002|Overall Study|Not further specified|0|||
130659332|NCT05004181|470374771|FG003|Overall Study|Not further specified|0|||
130659333|NCT05004181|470374772|FG004|Overall Study|Not further specified|0|||
130659334|NCT05004181|470374773|FG005|Overall Study|Not further specified|0|||
130659335|NCT05004181|470374774|FG006|Overall Study|Not further specified|1|||
130659336|NCT05004181|470374775|FG007|Overall Study|Not further specified|0|||
130659337|NCT05004181|470374776|FG008|Overall Study|Not further specified|2|||
130659338|NCT05004181|470374777|FG009|Overall Study|Not further specified|1|||
130659339|NCT05004181|470374778|FG010|Overall Study|Not further specified|0|||
130659340|NCT05004181|470374779|FG011|Overall Study|Not further specified|1|||
130659341|NCT04278872|470374780|FG000|Overall Study|Adverse Event|1|||
130659342|NCT04278872|470374781|FG001|Overall Study|Adverse Event|0|||
130659343|NCT04278872|470374780|FG000|Overall Study|Protocol Violation|0|||
130659344|NCT04278872|470374781|FG001|Overall Study|Protocol Violation|1|||
130659345|NCT04278872|470374780|FG000|Overall Study|Study Termination|2|||
130659346|NCT04278872|470374781|FG001|Overall Study|Study Termination|0|||
130659347|NCT00752895|470374782|FG000|Overall Study|Withdrawal by Subject|8|||
130659348|NCT00752895|470374783|FG001|Overall Study|Withdrawal by Subject|3|||
130659349|NCT00096031|470374784|FG000|Overall Study|Adverse Event|3|||
130659350|NCT00096031|470374784|FG000|Overall Study|Lack of Efficacy|42|||
130659351|NCT00096031|470374784|FG000|Overall Study|Death|4|||
130659352|NCT00096031|470374784|FG000|Overall Study|Withdrawal by Subject|1|||
130659353|NCT00096031|470374784|FG000|Overall Study|Ineligible|8|||
130659354|NCT00096031|470374784|FG000|Overall Study|Not protocol specified|5|||
130659355|NCT03353415|470374787|FG000|Masked CGM Wear|Lost to Follow-up|2|||
130329336|NCT04032093|469175419|FG005|Overall Study|Withdrawal by Subject|0|||
130329337|NCT04032093|469175420|FG006|Overall Study|Withdrawal by Subject|0|||
130329338|NCT04032093|469175421|FG007|Overall Study|Withdrawal by Subject|0|||
130329339|NCT04032093|469175422|FG008|Overall Study|Withdrawal by Subject|0|||
130329340|NCT04032093|469175423|FG009|Overall Study|Withdrawal by Subject|0|||
130329341|NCT04032093|469175414|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130329342|NCT04032093|469175415|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130329343|NCT04032093|469175416|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130329344|NCT04032093|469175417|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130329345|NCT04032093|469175418|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130329346|NCT04032093|469175419|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130329347|NCT04032093|469175420|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
130329348|NCT04032093|469175421|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130329349|NCT04032093|469175422|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
130329350|NCT04032093|469175423|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
130329351|NCT04032093|469175414|FG000|Overall Study|Adverse Event|0|||
130329352|NCT04032093|469175415|FG001|Overall Study|Adverse Event|0|||
130329353|NCT04032093|469175416|FG002|Overall Study|Adverse Event|0|||
130329354|NCT04032093|469175417|FG003|Overall Study|Adverse Event|0|||
130329355|NCT04032093|469175418|FG004|Overall Study|Adverse Event|0|||
130329356|NCT04032093|469175419|FG005|Overall Study|Adverse Event|0|||
130329357|NCT04032093|469175420|FG006|Overall Study|Adverse Event|0|||
130329358|NCT04032093|469175421|FG007|Overall Study|Adverse Event|0|||
130659356|NCT03353415|470374787|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
130329359|NCT04032093|469175422|FG008|Overall Study|Adverse Event|0|||
130329360|NCT04032093|469175423|FG009|Overall Study|Adverse Event|1|||
130659357|NCT05257109|470374788|FG000|Overall Study|Withdrawal by Subject|1|||
130659358|NCT05257109|470374789|FG001|Overall Study|Withdrawal by Subject|0|||
130659359|NCT05257109|470374790|FG002|Overall Study|Withdrawal by Subject|0|||
130659360|NCT05257109|470374791|FG003|Overall Study|Withdrawal by Subject|0|||
130659361|NCT00359073|470376735|FG000|Overall Study|Withdrawal by Subject|1|||
130329361|NCT04032093|469175414|FG000|Overall Study|Physician Decision|0|||
130329362|NCT04032093|469175415|FG001|Overall Study|Physician Decision|0|||
130659362|NCT00359073|470376736|FG001|Overall Study|Withdrawal by Subject|1|||
130659363|NCT00359073|470376735|FG000|Overall Study|Eligibility criteria no longer met|3|||
130659364|NCT00359073|470376736|FG001|Overall Study|Eligibility criteria no longer met|0|||
130659365|NCT00359073|470376735|FG000|Overall Study|developed RV16 antibody|0|||
130659366|NCT00359073|470376736|FG001|Overall Study|developed RV16 antibody|1|||
130329363|NCT04032093|469175416|FG002|Overall Study|Physician Decision|0|||
130659367|NCT03387423|470376737|FG000|Overall Study|Lost to Follow-up|16|||
130329364|NCT04032093|469175417|FG003|Overall Study|Physician Decision|0|||
130329365|NCT04032093|469175418|FG004|Overall Study|Physician Decision|0|||
130329366|NCT04032093|469175419|FG005|Overall Study|Physician Decision|1|||
130329367|NCT04032093|469175420|FG006|Overall Study|Physician Decision|0|||
130329368|NCT04032093|469175421|FG007|Overall Study|Physician Decision|0|||
130329369|NCT04032093|469175422|FG008|Overall Study|Physician Decision|0|||
130329370|NCT04032093|469175423|FG009|Overall Study|Physician Decision|0|||
130659368|NCT03387423|470376738|FG001|Overall Study|Lost to Follow-up|12|||
130659369|NCT03387423|470376739|FG002|Overall Study|Lost to Follow-up|1|||
130659370|NCT03387423|470376740|FG003|Overall Study|Lost to Follow-up|0|||
130659371|NCT03387423|470376737|FG000|Overall Study|Other|0|||
130659372|NCT03387423|470376738|FG001|Overall Study|Other|3|||
130659373|NCT03387423|470376739|FG002|Overall Study|Other|0|||
130659374|NCT03387423|470376740|FG003|Overall Study|Other|0|||
130659375|NCT03387423|470376737|FG000|Overall Study|Administrative Reason|166|||
130659376|NCT03387423|470376738|FG001|Overall Study|Administrative Reason|89|||
130659377|NCT03387423|470376739|FG002|Overall Study|Administrative Reason|17|||
130659378|NCT03387423|470376740|FG003|Overall Study|Administrative Reason|19|||
130659379|NCT03387423|470376737|FG000|Overall Study|Revocation Consent|76|||
130659380|NCT03387423|470376738|FG001|Overall Study|Revocation Consent|32|||
130659381|NCT03387423|470376739|FG002|Overall Study|Revocation Consent|3|||
130659382|NCT03387423|470376740|FG003|Overall Study|Revocation Consent|5|||
130659383|NCT01371006|470376741|FG000|Overall Study|Adverse Event|1|||
130659384|NCT01371006|470376742|FG001|Overall Study|Adverse Event|0|||
130659385|NCT03515837|470376744|FG000|Overall Study|Death|219|||
130659386|NCT03515837|470376745|FG001|Overall Study|Death|227|||
130659387|NCT03515837|470376744|FG000|Overall Study|Lost to Follow-up|0|||
130659388|NCT03515837|470376745|FG001|Overall Study|Lost to Follow-up|1|||
130659389|NCT03515837|470376744|FG000|Overall Study|Withdrawal by Subject|0|||
130659390|NCT03515837|470376745|FG001|Overall Study|Withdrawal by Subject|4|||
130659391|NCT03515837|470376744|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
130659392|NCT03515837|470376745|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
130659393|NCT01964898|470376746|FG000|Overall Study|ineligible post-randomization|1|||
130659394|NCT01964898|470376747|FG001|Overall Study|ineligible post-randomization|1|||
130659395|NCT01964898|470376746|FG000|Overall Study|did not receive the allocated interventi|2|||
130659396|NCT01964898|470376747|FG001|Overall Study|did not receive the allocated interventi|1|||
130659397|NCT01964898|470376746|FG000|Overall Study|Lost to Follow-up|3|||
130659398|NCT01964898|470376747|FG001|Overall Study|Lost to Follow-up|5|||
130659399|NCT01964898|470376746|FG000|Overall Study|Withdrawal by Subject|1|||
130659400|NCT01964898|470376747|FG001|Overall Study|Withdrawal by Subject|0|||
130659401|NCT02325401|470376750|FG000|Overall Study|Withdrawal by Subject|0|||
130659402|NCT02325401|470376751|FG001|Overall Study|Withdrawal by Subject|1|||
130659403|NCT02325401|470376752|FG002|Overall Study|Withdrawal by Subject|1|||
130659404|NCT02209454|470376756|FG000|Second Period|Adverse Event|1|||
130659405|NCT02209454|470376757|FG001|Second Period|Adverse Event|0|||
130659406|NCT01652573|470376758|FG000|Overall Study|Adverse Event|0|||
130659407|NCT01652573|470376759|FG001|Overall Study|Adverse Event|1|||
130659408|NCT00740480|470376760|FG000|Overall Study|Adverse Event|1|||
130659409|NCT00740480|470376760|FG000|Overall Study|Physician Decision|1|||
130659410|NCT00934622|470376761|FG000|Overall Study|Lost to Follow-up|7|||
130659411|NCT00934622|470376761|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
130659412|NCT01856686|470376765|FG000|Overall Study|Lost to Follow-up|5|||
130659413|NCT01856686|470376766|FG001|Overall Study|Lost to Follow-up|11|||
130659414|NCT00602979|470376769|FG000|Overall Study|Lost to Follow-up|3|||
130659415|NCT00602979|470376770|FG001|Overall Study|Lost to Follow-up|2|||
130659416|NCT00602979|470376771|FG002|Overall Study|Lost to Follow-up|3|||
130659417|NCT00602979|470376772|FG003|Overall Study|Lost to Follow-up|2|||
130659418|NCT00602979|470376773|FG004|Overall Study|Lost to Follow-up|3|||
130659419|NCT00602979|470376769|FG000|Overall Study|Failed Intubation|0|||
130659420|NCT00602979|470376770|FG001|Overall Study|Failed Intubation|1|||
130659421|NCT00602979|470376771|FG002|Overall Study|Failed Intubation|0|||
130329371|NCT01654302|469175430|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
130329372|NCT01654302|469175431|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
130329373|NCT03133793|469175435|FG000|Overall Study|Withdrawal by Subject|0|||
130659422|NCT00602979|470376772|FG003|Overall Study|Failed Intubation|1|||
130659423|NCT00602979|470376773|FG004|Overall Study|Failed Intubation|0|||
130329374|NCT03133793|469175436|FG001|Overall Study|Withdrawal by Subject|4|||
130659424|NCT00468312|470376774|FG000|Overall Study|Adverse Event|2|||
130659425|NCT00468312|470376775|FG001|Overall Study|Adverse Event|1|||
130659426|NCT00468312|470376774|FG000|Overall Study|Lack of Efficacy|0|||
130329375|NCT03133793|469175437|FG002|Overall Study|Withdrawal by Subject|2|||
130329376|NCT03133793|469175438|FG003|Overall Study|Withdrawal by Subject|4|||
130659427|NCT00468312|470376775|FG001|Overall Study|Lack of Efficacy|1|||
130329377|NCT03133793|469175435|FG000|Overall Study|Lost to Follow-up|1|||
130329378|NCT03133793|469175436|FG001|Overall Study|Lost to Follow-up|0|||
130659428|NCT00468312|470376774|FG000|Overall Study|Withdrawal by Subject|0|||
130659429|NCT00468312|470376775|FG001|Overall Study|Withdrawal by Subject|1|||
130659430|NCT00468312|470376774|FG000|Overall Study|Protocol Violation|2|||
130329379|NCT03133793|469175437|FG002|Overall Study|Lost to Follow-up|2|||
130329380|NCT03133793|469175438|FG003|Overall Study|Lost to Follow-up|0|||
130329381|NCT03133793|469175435|FG000|Overall Study|Death|0|||
130329382|NCT03133793|469175436|FG001|Overall Study|Death|0|||
130329383|NCT03133793|469175437|FG002|Overall Study|Death|0|||
130329384|NCT03133793|469175438|FG003|Overall Study|Death|1|||
130329385|NCT02839200|469175439|FG000|Overall Study|Withdrawal by Subject|2|||
130329386|NCT02839200|469175440|FG001|Overall Study|Withdrawal by Subject|0|||
130329387|NCT02839200|469175441|FG002|Overall Study|Withdrawal by Subject|1|||
130329388|NCT02839200|469175442|FG003|Overall Study|Withdrawal by Subject|0|||
130329389|NCT02839200|469175443|FG004|Overall Study|Withdrawal by Subject|0|||
130329390|NCT02839200|469175444|FG005|Overall Study|Withdrawal by Subject|1|||
130329391|NCT02839200|469175439|FG000|Overall Study|Lost to Follow-up|2|||
130329392|NCT02839200|469175440|FG001|Overall Study|Lost to Follow-up|0|||
130329393|NCT02839200|469175441|FG002|Overall Study|Lost to Follow-up|0|||
130329394|NCT02839200|469175442|FG003|Overall Study|Lost to Follow-up|0|||
130329395|NCT02839200|469175443|FG004|Overall Study|Lost to Follow-up|1|||
130329396|NCT02839200|469175444|FG005|Overall Study|Lost to Follow-up|0|||
130329397|NCT02839200|469175439|FG000|Overall Study|Adverse Event|0|||
130329398|NCT02839200|469175440|FG001|Overall Study|Adverse Event|0|||
130329399|NCT02839200|469175441|FG002|Overall Study|Adverse Event|0|||
130329400|NCT02839200|469175442|FG003|Overall Study|Adverse Event|0|||
130329401|NCT02839200|469175443|FG004|Overall Study|Adverse Event|1|||
130329402|NCT02839200|469175444|FG005|Overall Study|Adverse Event|0|||
130329403|NCT02839200|469175439|FG000|Overall Study|Randomized in error|0|||
130329404|NCT02839200|469175440|FG001|Overall Study|Randomized in error|1|||
130329405|NCT02839200|469175441|FG002|Overall Study|Randomized in error|0|||
130329406|NCT02839200|469175442|FG003|Overall Study|Randomized in error|0|||
130659431|NCT00468312|470376775|FG001|Overall Study|Protocol Violation|1|||
130659432|NCT00468312|470376774|FG000|Overall Study|Did not meet protocol eligibility|0|||
130659433|NCT00468312|470376775|FG001|Overall Study|Did not meet protocol eligibility|1|||
130659434|NCT01052038|470376776|FG000|Overall Study|Lost to Follow-up|2|||
130659435|NCT01052038|470376777|FG001|Overall Study|Lost to Follow-up|3|||
130659436|NCT01052038|470376778|FG002|Overall Study|Lost to Follow-up|1|||
130659437|NCT01052038|470376776|FG000|Overall Study|Protocol Violation|2|||
130659438|NCT01052038|470376777|FG001|Overall Study|Protocol Violation|3|||
130659439|NCT01052038|470376778|FG002|Overall Study|Protocol Violation|3|||
130659440|NCT03349437|470376781|FG000|Screening|Screen Fail|4|||
130659441|NCT03349437|470376782|FG001|Screening|Screen Fail|0|||
130659442|NCT03349437|470376783|FG002|Screening|Screen Fail|0|||
130659443|NCT03349437|470376781|FG000|Screening|Withdrawn|1|||
130659444|NCT03349437|470376782|FG001|Screening|Withdrawn|0|||
130659445|NCT03349437|470376783|FG002|Screening|Withdrawn|0|||
130659446|NCT01461369|470376784|FG000|Overall Study|Lack of Efficacy|2|||
130659447|NCT01461369|470376785|FG001|Overall Study|Lack of Efficacy|0|||
130659448|NCT01461369|470376786|FG002|Overall Study|Lack of Efficacy|6|||
130659449|NCT01461369|470376784|FG000|Overall Study|Lost to Follow-up|0|||
130659450|NCT01461369|470376785|FG001|Overall Study|Lost to Follow-up|0|||
130659451|NCT01461369|470376786|FG002|Overall Study|Lost to Follow-up|3|||
130659452|NCT01461369|470376784|FG000|Overall Study|Adverse Event|9|||
130659453|NCT01461369|470376785|FG001|Overall Study|Adverse Event|12|||
130659454|NCT01461369|470376786|FG002|Overall Study|Adverse Event|4|||
130659455|NCT01461369|470376784|FG000|Overall Study|Protocol Violation|1|||
130659456|NCT01461369|470376785|FG001|Overall Study|Protocol Violation|2|||
130659457|NCT01461369|470376786|FG002|Overall Study|Protocol Violation|2|||
130659458|NCT01461369|470376784|FG000|Overall Study|Withdrawal by Subject|1|||
130659459|NCT01461369|470376785|FG001|Overall Study|Withdrawal by Subject|3|||
130329407|NCT02839200|469175443|FG004|Overall Study|Randomized in error|0|||
130329408|NCT02839200|469175444|FG005|Overall Study|Randomized in error|0|||
130329409|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
130329410|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
130329411|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
130659460|NCT01461369|470376786|FG002|Overall Study|Withdrawal by Subject|2|||
130329412|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
130329413|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
130659461|NCT02962739|470376789|FG000|Overall Study|Withdrawal by Subject|0|||
130329414|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
130659462|NCT02962739|470376790|FG001|Overall Study|Withdrawal by Subject|1|||
130329415|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
130329416|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
130329417|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
130329418|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
130329419|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
130329420|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
130329421|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
130329422|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
130329423|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
130329424|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
130329425|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
130329426|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
130329427|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329428|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329429|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329430|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
130329431|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
130329432|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
130329433|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
130329434|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
130329435|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
130329436|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
130329437|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
130329438|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
130329439|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
130329440|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
130329441|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
130329442|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
130329443|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
130329444|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
130329445|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
130329446|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
130329447|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
130329448|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Not treated|0|||
130329449|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Not treated|0|||
130329450|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Not treated|1|||
130329451|NCT04139018|469175448|FG000|Overall Study|Screen fail|1|||
130329452|NCT04139018|469175449|FG001|Overall Study|Screen fail|0|||
130329453|NCT04139018|469175448|FG000|Overall Study|Withdrawal by Subject|2|||
130329454|NCT04139018|469175449|FG001|Overall Study|Withdrawal by Subject|0|||
130329455|NCT04139018|469175448|FG000|Overall Study|Lost to Follow-up|0|||
130329456|NCT04139018|469175449|FG001|Overall Study|Lost to Follow-up|1|||
130329457|NCT03486834|469175451|FG000|Overall Study|Withdrawal by Subject|46|||
130329458|NCT03486834|469175452|FG001|Overall Study|Withdrawal by Subject|46|||
130329459|NCT03486834|469175453|FG002|Overall Study|Withdrawal by Subject|52|||
130329460|NCT03486834|469175451|FG000|Overall Study|Adverse Event|8|||
130329461|NCT03486834|469175452|FG001|Overall Study|Adverse Event|7|||
130329462|NCT03486834|469175453|FG002|Overall Study|Adverse Event|0|||
130329463|NCT03486834|469175451|FG000|Overall Study|Lost to Follow-up|41|||
130329464|NCT03486834|469175452|FG001|Overall Study|Lost to Follow-up|24|||
130329465|NCT03486834|469175453|FG002|Overall Study|Lost to Follow-up|39|||
130329466|NCT03486834|469175451|FG000|Overall Study|Non-compliance with Study Drug|2|||
130329467|NCT03486834|469175452|FG001|Overall Study|Non-compliance with Study Drug|2|||
130329468|NCT03486834|469175453|FG002|Overall Study|Non-compliance with Study Drug|0|||
130329469|NCT03486834|469175451|FG000|Overall Study|Physician Decision|5|||
130329470|NCT03486834|469175452|FG001|Overall Study|Physician Decision|2|||
130329471|NCT03486834|469175453|FG002|Overall Study|Physician Decision|3|||
130329472|NCT03486834|469175451|FG000|Overall Study|Pregnancy|10|||
130329473|NCT03486834|469175452|FG001|Overall Study|Pregnancy|12|||
130329474|NCT03486834|469175453|FG002|Overall Study|Pregnancy|12|||
130329475|NCT03486834|469175451|FG000|Overall Study|Protocol Deviation|2|||
130329476|NCT03486834|469175452|FG001|Overall Study|Protocol Deviation|3|||
130329477|NCT03486834|469175453|FG002|Overall Study|Protocol Deviation|3|||
130329478|NCT03486834|469175451|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130329479|NCT03486834|469175452|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130329480|NCT03486834|469175453|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130329481|NCT03486834|469175451|FG000|Overall Study|Randomized but not treated|4|||
130329482|NCT03486834|469175452|FG001|Overall Study|Randomized but not treated|4|||
130329483|NCT03486834|469175453|FG002|Overall Study|Randomized but not treated|1|||
130329484|NCT04476797|469175454|FG000|Overall Study|Withdrawal by Subject|1|||
130329485|NCT04476797|469175455|FG001|Overall Study|Withdrawal by Subject|0|||
130659463|NCT02962739|470376791|FG002|Overall Study|Withdrawal by Subject|0|||
130659464|NCT02962739|470376792|FG003|Overall Study|Withdrawal by Subject|0|||
130659465|NCT02962739|470376793|FG004|Overall Study|Withdrawal by Subject|0|||
130659466|NCT02962739|470376794|FG005|Overall Study|Withdrawal by Subject|0|||
130659467|NCT02962739|470376789|FG000|Overall Study|Protocol Violation|0|||
130659468|NCT02962739|470376790|FG001|Overall Study|Protocol Violation|0|||
130659469|NCT02962739|470376791|FG002|Overall Study|Protocol Violation|1|||
130659470|NCT02962739|470376792|FG003|Overall Study|Protocol Violation|0|||
130659471|NCT02962739|470376793|FG004|Overall Study|Protocol Violation|1|||
130659472|NCT02962739|470376794|FG005|Overall Study|Protocol Violation|0|||
130659473|NCT00734617|470376795|FG000|Overall Study|Adverse Event|4|||
130659474|NCT00734617|470376796|FG001|Overall Study|Adverse Event|7|||
130659475|NCT00734617|470376795|FG000|Overall Study|Withdrawal by Subject|103|||
130659476|NCT00734617|470376796|FG001|Overall Study|Withdrawal by Subject|95|||
130659477|NCT02406742|470376797|FG000|Overall Study|Progression of Disease|5|||
130659478|NCT02406742|470376798|FG001|Overall Study|Progression of Disease|1|||
130659479|NCT02406742|470376799|FG002|Overall Study|Progression of Disease|6|||
130659480|NCT02406742|470376797|FG000|Overall Study|Adverse Event|3|||
130659481|NCT02406742|470376798|FG001|Overall Study|Adverse Event|0|||
130659482|NCT02406742|470376799|FG002|Overall Study|Adverse Event|2|||
130659483|NCT02406742|470376797|FG000|Overall Study|Death|1|||
130659484|NCT02406742|470376798|FG001|Overall Study|Death|0|||
130659485|NCT02406742|470376799|FG002|Overall Study|Death|0|||
130659486|NCT02406742|470376797|FG000|Overall Study|Lack of Efficacy|0|||
130659487|NCT02406742|470376798|FG001|Overall Study|Lack of Efficacy|0|||
130659488|NCT02406742|470376799|FG002|Overall Study|Lack of Efficacy|1|||
130659489|NCT02406742|470376797|FG000|Overall Study|Withdrawal by Participant|1|||
130659490|NCT02406742|470376798|FG001|Overall Study|Withdrawal by Participant|2|||
130659491|NCT02406742|470376799|FG002|Overall Study|Withdrawal by Participant|0|||
130659492|NCT02406742|470376797|FG000|Overall Study|Physician Decision|1|||
130659493|NCT02406742|470376798|FG001|Overall Study|Physician Decision|2|||
130659494|NCT02406742|470376799|FG002|Overall Study|Physician Decision|1|||
130659495|NCT02406742|470376797|FG000|Overall Study|Transition to other treatment|2|||
130659496|NCT02406742|470376798|FG001|Overall Study|Transition to other treatment|0|||
130659497|NCT02406742|470376799|FG002|Overall Study|Transition to other treatment|1|||
130659498|NCT02406742|470376797|FG000|Overall Study|Other Reasons|1|||
130659499|NCT02406742|470376798|FG001|Overall Study|Other Reasons|11|||
130659500|NCT02406742|470376799|FG002|Overall Study|Other Reasons|5|||
130659501|NCT02367729|470376800|FG000|Overall Study|Organic disorder diagnosed|2|||
130659502|NCT02367729|470376801|FG001|Overall Study|Organic disorder diagnosed|1|||
130659503|NCT02367729|470376800|FG000|Overall Study|Adverse Event|1|||
130659504|NCT02367729|470376801|FG001|Overall Study|Adverse Event|2|||
130659505|NCT02367729|470376800|FG000|Overall Study|Withdrawal by Subject|0|||
130659506|NCT02367729|470376801|FG001|Overall Study|Withdrawal by Subject|5|||
130659507|NCT00759174|470376806|FG000|Overall Study|Other|0|||
130659508|NCT00759174|470376807|FG001|Overall Study|Other|2|||
130659509|NCT01890109|470376808|FG000|Overall Study|Withdrawal by Subject|0|||
130659510|NCT01890109|470376809|FG001|Overall Study|Withdrawal by Subject|3|||
130659511|NCT01890109|470376808|FG000|Overall Study|Lost to Follow-up|1|||
130659512|NCT01890109|470376809|FG001|Overall Study|Lost to Follow-up|2|||
130659513|NCT01643928|470376810|FG000|Overall Study|Lost to Follow-up|1|||
130659514|NCT01643928|470376811|FG001|Overall Study|Lost to Follow-up|0|||
130659515|NCT01643928|470376812|FG002|Overall Study|Lost to Follow-up|2|||
130659516|NCT01643928|470376813|FG003|Overall Study|Lost to Follow-up|0|||
130659517|NCT01643928|470376814|FG004|Overall Study|Lost to Follow-up|0|||
130659518|NCT01643928|470376810|FG000|Overall Study|Withdrawal by Subject|2|||
130659519|NCT01643928|470376811|FG001|Overall Study|Withdrawal by Subject|0|||
130659520|NCT01643928|470376812|FG002|Overall Study|Withdrawal by Subject|0|||
130659521|NCT01643928|470376813|FG003|Overall Study|Withdrawal by Subject|1|||
130659522|NCT01643928|470376814|FG004|Overall Study|Withdrawal by Subject|0|||
130659523|NCT01643928|470376810|FG000|Overall Study|Pregnancy|0|||
130659524|NCT01643928|470376811|FG001|Overall Study|Pregnancy|0|||
130659525|NCT01643928|470376812|FG002|Overall Study|Pregnancy|0|||
130659526|NCT01643928|470376813|FG003|Overall Study|Pregnancy|1|||
130659527|NCT01643928|470376814|FG004|Overall Study|Pregnancy|0|||
130659528|NCT01643928|470376810|FG000|Overall Study|Other|5|||
130659529|NCT01643928|470376811|FG001|Overall Study|Other|1|||
130659530|NCT01643928|470376812|FG002|Overall Study|Other|1|||
130659531|NCT01643928|470376813|FG003|Overall Study|Other|0|||
130659532|NCT01643928|470376814|FG004|Overall Study|Other|0|||
130659533|NCT01643928|470376810|FG000|Overall Study|Adverse Event|2|||
130659534|NCT01643928|470376811|FG001|Overall Study|Adverse Event|1|||
130659535|NCT01643928|470376812|FG002|Overall Study|Adverse Event|0|||
130659536|NCT01643928|470376813|FG003|Overall Study|Adverse Event|1|||
130659537|NCT01643928|470376814|FG004|Overall Study|Adverse Event|2|||
130659538|NCT03692078|470376815|FG000|Overall Study|Adverse Event|0|||
130659539|NCT03692078|470376816|FG001|Overall Study|Adverse Event|0|||
130659540|NCT03692078|470376817|FG002|Overall Study|Adverse Event|0|||
130659541|NCT03692078|470376818|FG003|Overall Study|Adverse Event|0|||
130659542|NCT03692078|470376819|FG004|Overall Study|Adverse Event|0|||
130659543|NCT03692078|470376820|FG005|Overall Study|Adverse Event|1|||
130659544|NCT03692078|470376821|FG006|Overall Study|Adverse Event|0|||
130329486|NCT04476797|469175456|FG002|Overall Study|Withdrawal by Subject|0|||
130329487|NCT04476797|469175454|FG000|Overall Study|Death|0|||
130329488|NCT04476797|469175455|FG001|Overall Study|Death|1|||
130659545|NCT03692078|470376815|FG000|Overall Study|Enrollment Closed|5|||
130659546|NCT03692078|470376816|FG001|Overall Study|Enrollment Closed|0|||
130329489|NCT04476797|469175456|FG002|Overall Study|Death|2|||
130329490|NCT04476797|469175454|FG000|Overall Study|Sponsor Terminated Study|0|||
130329491|NCT04476797|469175455|FG001|Overall Study|Sponsor Terminated Study|18|||
130329492|NCT04476797|469175456|FG002|Overall Study|Sponsor Terminated Study|17|||
130329493|NCT03614156|469175473|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
130329494|NCT03614156|469175474|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329495|NCT03614156|469175475|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329496|NCT03614156|469175476|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329497|NCT03614156|469175473|FG000|Open-Label Treatment Period|Adverse Event|7|||
130329498|NCT03614156|469175474|FG001|Open-Label Treatment Period|Adverse Event|0|||
130329499|NCT03614156|469175475|FG002|Open-Label Treatment Period|Adverse Event|0|||
130329500|NCT03614156|469175476|FG003|Open-Label Treatment Period|Adverse Event|0|||
130329501|NCT03614156|469175473|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
130329502|NCT03614156|469175474|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130329503|NCT03614156|469175475|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130329504|NCT03614156|469175476|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130329505|NCT03614156|469175473|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
130329506|NCT03614156|469175474|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329507|NCT03614156|469175475|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329508|NCT03614156|469175476|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329509|NCT03614156|469175473|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
130329510|NCT03614156|469175474|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130329511|NCT03614156|469175475|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130329512|NCT03614156|469175476|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130329513|NCT03614156|469175473|FG000|Open-Label Treatment Period|Protocol Violation|2|||
130329514|NCT03614156|469175474|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130329515|NCT03614156|469175475|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130329516|NCT03614156|469175476|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130329517|NCT03614156|469175473|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
130329518|NCT03614156|469175474|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329519|NCT03614156|469175475|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329520|NCT03614156|469175476|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329521|NCT03614156|469175473|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
130329522|NCT03614156|469175474|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329523|NCT03614156|469175475|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329524|NCT03614156|469175476|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329525|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130329526|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
130329527|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130329528|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
130329529|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130329530|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
130329531|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130329532|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130329533|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130329534|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130329535|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
130329536|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
130329537|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
130329538|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329539|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329540|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329541|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
130329542|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
130659547|NCT03692078|470376817|FG002|Overall Study|Enrollment Closed|0|||
130329543|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
130329544|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
130659548|NCT03692078|470376818|FG003|Overall Study|Enrollment Closed|0|||
130659549|NCT03692078|470376819|FG004|Overall Study|Enrollment Closed|0|||
130659550|NCT03692078|470376820|FG005|Overall Study|Enrollment Closed|0|||
130659551|NCT03692078|470376821|FG006|Overall Study|Enrollment Closed|0|||
130659552|NCT03692078|470376815|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
130329545|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130659553|NCT03692078|470376816|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
130659554|NCT03692078|470376817|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
130659555|NCT03692078|470376818|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
130659556|NCT03692078|470376819|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
130659557|NCT03692078|470376820|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
130659558|NCT03692078|470376821|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
130659559|NCT03692078|470376815|FG000|Overall Study|Withdrawal by Subject|0|||
130659560|NCT03692078|470376816|FG001|Overall Study|Withdrawal by Subject|2|||
130659561|NCT03692078|470376817|FG002|Overall Study|Withdrawal by Subject|0|||
130329546|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
130329547|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130329548|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130329549|NCT03614156|469175473|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
130329550|NCT03614156|469175474|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329551|NCT03614156|469175475|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329552|NCT03614156|469175476|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329553|NCT03614156|469175473|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329554|NCT03614156|469175474|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329555|NCT03614156|469175475|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
130329556|NCT03614156|469175476|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329557|NCT03614156|469175473|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
130329558|NCT03614156|469175474|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
130329559|NCT03614156|469175475|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
130329560|NCT03614156|469175476|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
130329561|NCT04287517|469175481|FG000|Overall Study|Withdrawal by Subject|1|||
130329562|NCT04287517|469175482|FG001|Overall Study|Withdrawal by Subject|1|||
130329563|NCT03070964|469175483|FG000|Overall Study|Progressive disease|8|||
130329564|NCT03070964|469175483|FG000|Overall Study|Treatment-unrelated adverse event|2|||
130329565|NCT03070964|469175483|FG000|Overall Study|Never treated|1|||
130329566|NCT03070964|469175483|FG000|Overall Study|Physician Decision|1|||
130329567|NCT03070964|469175483|FG000|Overall Study|Withdrawal by Subject|1|||
130329568|NCT03070964|469175483|FG000|Overall Study|Adverse Event|1|||
130329569|NCT01094119|469175484|FG000|Overall Study|Lack of Efficacy|2|||
130329570|NCT01094119|469175485|FG001|Overall Study|Lack of Efficacy|4|||
130329571|NCT00834093|469175488|FG000|Overall Study|Progressive Disease|3|||
130329572|NCT00834093|469175488|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
130329573|NCT02745119|469175489|FG000|Overall Study|Adverse Event|1|||
130329574|NCT02745119|469175490|FG001|Overall Study|Adverse Event|0|||
130329575|NCT02745119|469175491|FG002|Overall Study|Adverse Event|1|||
130329576|NCT02745119|469175492|FG003|Overall Study|Adverse Event|3|||
130329577|NCT02745119|469175489|FG000|Overall Study|Death|3|||
130329578|NCT02745119|469175490|FG001|Overall Study|Death|3|||
130329579|NCT02745119|469175491|FG002|Overall Study|Death|0|||
130329580|NCT02745119|469175492|FG003|Overall Study|Death|4|||
130329581|NCT02745119|469175489|FG000|Overall Study|Lost to Follow-up|0|||
130329582|NCT02745119|469175490|FG001|Overall Study|Lost to Follow-up|0|||
130329583|NCT02745119|469175491|FG002|Overall Study|Lost to Follow-up|0|||
130329584|NCT02745119|469175492|FG003|Overall Study|Lost to Follow-up|1|||
130329585|NCT02745119|469175489|FG000|Overall Study|Protocol Deviation|0|||
130329586|NCT02745119|469175490|FG001|Overall Study|Protocol Deviation|0|||
130329587|NCT02745119|469175491|FG002|Overall Study|Protocol Deviation|0|||
130329588|NCT02745119|469175492|FG003|Overall Study|Protocol Deviation|1|||
130329589|NCT02745119|469175489|FG000|Overall Study|Withdrawal by Subject|7|||
130329590|NCT02745119|469175490|FG001|Overall Study|Withdrawal by Subject|15|||
130329591|NCT02745119|469175491|FG002|Overall Study|Withdrawal by Subject|8|||
130329592|NCT02745119|469175492|FG003|Overall Study|Withdrawal by Subject|14|||
130329593|NCT02745119|469175489|FG000|Overall Study|Study Terminated by Sponsor|134|||
130329594|NCT02745119|469175490|FG001|Overall Study|Study Terminated by Sponsor|252|||
130329595|NCT02745119|469175491|FG002|Overall Study|Study Terminated by Sponsor|135|||
130329596|NCT02745119|469175492|FG003|Overall Study|Study Terminated by Sponsor|251|||
130659562|NCT03692078|470376818|FG003|Overall Study|Withdrawal by Subject|1|||
130659563|NCT03692078|470376819|FG004|Overall Study|Withdrawal by Subject|5|||
130329597|NCT02745119|469175489|FG000|Overall Study|Physician Decision|0|||
130329598|NCT02745119|469175490|FG001|Overall Study|Physician Decision|2|||
130329599|NCT02745119|469175491|FG002|Overall Study|Physician Decision|2|||
130659564|NCT03692078|470376820|FG005|Overall Study|Withdrawal by Subject|3|||
130329600|NCT02745119|469175492|FG003|Overall Study|Physician Decision|2|||
130329601|NCT02745119|469175489|FG000|Overall Study|Reason Not Specified|0|||
130329602|NCT02745119|469175490|FG001|Overall Study|Reason Not Specified|2|||
130329603|NCT02745119|469175491|FG002|Overall Study|Reason Not Specified|0|||
130329604|NCT02745119|469175492|FG003|Overall Study|Reason Not Specified|1|||
130329605|NCT01587924|469175493|FG000|Overall Study|Adverse Event|0|||
130329606|NCT01587924|469175494|FG001|Overall Study|Adverse Event|2|||
130329607|NCT01587924|469175495|FG002|Overall Study|Adverse Event|0|||
130659565|NCT03692078|470376821|FG006|Overall Study|Withdrawal by Subject|3|||
130659566|NCT01563029|470376822|FG000|Overall Study|Adverse Event|1|||
130659567|NCT01563029|470376823|FG001|Overall Study|Adverse Event|0|||
130659568|NCT01563029|470376824|FG002|Overall Study|Adverse Event|1|||
130659569|NCT01563029|470376825|FG003|Overall Study|Adverse Event|2|||
130659570|NCT01563029|470376826|FG004|Overall Study|Adverse Event|1|||
130659571|NCT01563029|470376822|FG000|Overall Study|Lack of Efficacy|42|||
130659572|NCT01563029|470376823|FG001|Overall Study|Lack of Efficacy|16|||
130659573|NCT01563029|470376824|FG002|Overall Study|Lack of Efficacy|23|||
130659574|NCT01563029|470376825|FG003|Overall Study|Lack of Efficacy|21|||
130659575|NCT01563029|470376826|FG004|Overall Study|Lack of Efficacy|19|||
130659576|NCT01563029|470376822|FG000|Overall Study|Protocol Violation|1|||
130659577|NCT01563029|470376823|FG001|Overall Study|Protocol Violation|2|||
130659578|NCT01563029|470376824|FG002|Overall Study|Protocol Violation|3|||
130659579|NCT01563029|470376825|FG003|Overall Study|Protocol Violation|1|||
130659580|NCT01563029|470376826|FG004|Overall Study|Protocol Violation|3|||
130329608|NCT01587924|469175496|FG003|Overall Study|Adverse Event|0|||
130329609|NCT01587924|469175493|FG000|Overall Study|Protocol Violation|2|||
130329610|NCT01587924|469175494|FG001|Overall Study|Protocol Violation|1|||
130329611|NCT01587924|469175495|FG002|Overall Study|Protocol Violation|2|||
130329612|NCT01587924|469175496|FG003|Overall Study|Protocol Violation|1|||
130329613|NCT01587924|469175493|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
130329614|NCT01587924|469175494|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
130329615|NCT01587924|469175495|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
130329616|NCT01587924|469175496|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
130329617|NCT01587924|469175493|FG000|Overall Study|Withdrawal by Subject|0|||
130329618|NCT01587924|469175494|FG001|Overall Study|Withdrawal by Subject|1|||
130329619|NCT01587924|469175495|FG002|Overall Study|Withdrawal by Subject|1|||
130329620|NCT01587924|469175496|FG003|Overall Study|Withdrawal by Subject|0|||
130329621|NCT00432172|469175497|FG000|Overall Study|Physician Decision|0|||
130329622|NCT00432172|469175498|FG001|Overall Study|Physician Decision|0|||
130329623|NCT00432172|469175499|FG002|Overall Study|Physician Decision|2|||
130329624|NCT00432172|469175500|FG003|Overall Study|Physician Decision|0|||
130329625|NCT00432172|469175497|FG000|Overall Study|Adverse Event|4|||
130329626|NCT00432172|469175498|FG001|Overall Study|Adverse Event|2|||
130329627|NCT00432172|469175499|FG002|Overall Study|Adverse Event|4|||
130329628|NCT00432172|469175500|FG003|Overall Study|Adverse Event|3|||
130329629|NCT00432172|469175497|FG000|Overall Study|Disease progression|0|||
130329630|NCT00432172|469175498|FG001|Overall Study|Disease progression|2|||
130329631|NCT00432172|469175499|FG002|Overall Study|Disease progression|5|||
130329632|NCT00432172|469175500|FG003|Overall Study|Disease progression|1|||
130329633|NCT00432172|469175497|FG000|Overall Study|Withdrawal by Subject|0|||
130329634|NCT00432172|469175498|FG001|Overall Study|Withdrawal by Subject|1|||
130329635|NCT00432172|469175499|FG002|Overall Study|Withdrawal by Subject|0|||
130329636|NCT00432172|469175500|FG003|Overall Study|Withdrawal by Subject|2|||
130329637|NCT00432172|469175497|FG000|Overall Study|No treatment received|2|||
130329638|NCT00432172|469175498|FG001|Overall Study|No treatment received|2|||
130329639|NCT00432172|469175499|FG002|Overall Study|No treatment received|0|||
130329640|NCT00432172|469175500|FG003|Overall Study|No treatment received|1|||
130329641|NCT02425943|469175501|FG000|Overall Study|Adverse Event|3|||
130329642|NCT02425943|469175502|FG001|Overall Study|Adverse Event|1|||
130329643|NCT02425943|469175501|FG000|Overall Study|Lost to Follow-up|59|||
130329644|NCT02425943|469175502|FG001|Overall Study|Lost to Follow-up|37|||
130329645|NCT02425943|469175501|FG000|Overall Study|Protocol Violation|4|||
130329646|NCT02425943|469175502|FG001|Overall Study|Protocol Violation|1|||
130329647|NCT02425943|469175501|FG000|Overall Study|Withdrawal by Subject|64|||
130329648|NCT02425943|469175502|FG001|Overall Study|Withdrawal by Subject|31|||
130329649|NCT02425943|469175501|FG000|Overall Study|Other|6|||
130329650|NCT02425943|469175502|FG001|Overall Study|Other|0|||
130329651|NCT03313037|469175509|FG000|Overall Study|Protocol Violation|4|||
130329652|NCT03313037|469175510|FG001|Overall Study|Protocol Violation|1|||
130329653|NCT03313037|469175509|FG000|Overall Study|Other|1|||
130659581|NCT01563029|470376822|FG000|Overall Study|Protocol defined stopping criteria|1|||
130659582|NCT01563029|470376823|FG001|Overall Study|Protocol defined stopping criteria|0|||
130659583|NCT01563029|470376824|FG002|Overall Study|Protocol defined stopping criteria|0|||
130659584|NCT01563029|470376825|FG003|Overall Study|Protocol defined stopping criteria|0|||
130659585|NCT01563029|470376826|FG004|Overall Study|Protocol defined stopping criteria|0|||
130659586|NCT01563029|470376822|FG000|Overall Study|Lost to Follow-up|1|||
130659587|NCT01563029|470376823|FG001|Overall Study|Lost to Follow-up|0|||
130329654|NCT03313037|469175510|FG001|Overall Study|Other|1|||
130329655|NCT03313037|469175509|FG000|Overall Study|Withdrawal by Subject|4|||
130329656|NCT03313037|469175510|FG001|Overall Study|Withdrawal by Subject|3|||
130329657|NCT03313037|469175509|FG000|Overall Study|No longer meets eligibility criteria|1|||
130329658|NCT03313037|469175510|FG001|Overall Study|No longer meets eligibility criteria|7|||
130329659|NCT03313037|469175509|FG000|Overall Study|Lost to Follow-up|9|||
130659588|NCT01563029|470376824|FG002|Overall Study|Lost to Follow-up|1|||
130659589|NCT01563029|470376825|FG003|Overall Study|Lost to Follow-up|1|||
130659590|NCT01563029|470376826|FG004|Overall Study|Lost to Follow-up|1|||
130659591|NCT01563029|470376822|FG000|Overall Study|Physician Decision|3|||
130659592|NCT01563029|470376823|FG001|Overall Study|Physician Decision|5|||
130659593|NCT01563029|470376824|FG002|Overall Study|Physician Decision|2|||
130659594|NCT01563029|470376825|FG003|Overall Study|Physician Decision|4|||
130659595|NCT01563029|470376826|FG004|Overall Study|Physician Decision|2|||
130659596|NCT01563029|470376822|FG000|Overall Study|Withdrawal by Subject|4|||
130329660|NCT03313037|469175510|FG001|Overall Study|Lost to Follow-up|8|||
130329661|NCT03313037|469175509|FG000|Overall Study|Randomized but not treated|1|||
130329662|NCT03313037|469175510|FG001|Overall Study|Randomized but not treated|0|||
130329663|NCT02379091|469175511|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130329664|NCT02379091|469175512|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130329665|NCT02379091|469175513|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130329666|NCT02379091|469175514|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130659597|NCT01563029|470376823|FG001|Overall Study|Withdrawal by Subject|1|||
130329667|NCT02379091|469175511|FG000|Overall Study|Principal Investigator Discretion|0|||
130329668|NCT02379091|469175512|FG001|Overall Study|Principal Investigator Discretion|1|||
130329669|NCT02379091|469175513|FG002|Overall Study|Principal Investigator Discretion|0|||
130329670|NCT02379091|469175514|FG003|Overall Study|Principal Investigator Discretion|0|||
130329671|NCT02379091|469175511|FG000|Overall Study|Lost to Follow-up|0|||
130329672|NCT02379091|469175512|FG001|Overall Study|Lost to Follow-up|0|||
130329673|NCT02379091|469175513|FG002|Overall Study|Lost to Follow-up|0|||
130329674|NCT02379091|469175514|FG003|Overall Study|Lost to Follow-up|1|||
130329675|NCT02379091|469175511|FG000|Overall Study|Voluntary Withdrawal|2|||
130329676|NCT02379091|469175512|FG001|Overall Study|Voluntary Withdrawal|5|||
130329677|NCT02379091|469175513|FG002|Overall Study|Voluntary Withdrawal|2|||
130329678|NCT02379091|469175514|FG003|Overall Study|Voluntary Withdrawal|4|||
130659598|NCT01563029|470376824|FG002|Overall Study|Withdrawal by Subject|3|||
130329679|NCT02379091|469175511|FG000|Overall Study|Study Termination|7|||
130329680|NCT02379091|469175512|FG001|Overall Study|Study Termination|2|||
130329681|NCT02379091|469175513|FG002|Overall Study|Study Termination|5|||
130329682|NCT02379091|469175514|FG003|Overall Study|Study Termination|8|||
130329683|NCT02379091|469175511|FG000|Overall Study|Lack of Efficacy|3|||
130329684|NCT02379091|469175512|FG001|Overall Study|Lack of Efficacy|0|||
130329685|NCT02379091|469175513|FG002|Overall Study|Lack of Efficacy|0|||
130329686|NCT02379091|469175514|FG003|Overall Study|Lack of Efficacy|0|||
130329687|NCT04161157|469175518|FG000|Overall Study|Lost to Follow-up|4|||
130329688|NCT04161157|469175518|FG000|Overall Study|Death|3|||
130329689|NCT04161157|469175518|FG000|Overall Study|Ineligible|2|||
130329690|NCT04161157|469175518|FG000|Overall Study|Withdrawal by Subject|4|||
130329691|NCT03278249|469175523|FG000|Overall Study|Withdrawal by Subject|2|||
130329692|NCT03278249|469175523|FG000|Overall Study|Lost to Follow-up|1|||
130329693|NCT04988477|469175524|FG000|Overall Study|Death|1|||
130329694|NCT04988477|469175525|FG001|Overall Study|Death|0|||
130329695|NCT04988477|469175526|FG002|Overall Study|Death|0|||
130329696|NCT04988477|469175524|FG000|Overall Study|Lost to Follow-up|5|||
130329697|NCT04988477|469175525|FG001|Overall Study|Lost to Follow-up|2|||
130329698|NCT04988477|469175526|FG002|Overall Study|Lost to Follow-up|0|||
130329699|NCT04988477|469175524|FG000|Overall Study|Withdrawal by Subject|2|||
130329700|NCT04988477|469175525|FG001|Overall Study|Withdrawal by Subject|0|||
130329701|NCT04988477|469175526|FG002|Overall Study|Withdrawal by Subject|0|||
130329702|NCT01354899|469176885|FG000|Overall Study|discharge from the hospital|2|||
130329703|NCT01354899|469176885|FG000|Overall Study|Protocol Violation|1|||
130329704|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
130329705|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
130659599|NCT01563029|470376825|FG003|Overall Study|Withdrawal by Subject|4|||
130659600|NCT01563029|470376826|FG004|Overall Study|Withdrawal by Subject|3|||
130659601|NCT01569594|470376827|FG000|Overall Study|Physician Decision|4|||
130659602|NCT01569594|470376827|FG000|Overall Study|Death|13|||
130659603|NCT01569594|470376827|FG000|Overall Study|Lost to Follow-up|22|||
130659604|NCT01569594|470376827|FG000|Overall Study|Adverse Event|2|||
130659605|NCT01569594|470376827|FG000|Overall Study|Withdrawal by Subject|13|||
130659606|NCT01569594|470376827|FG000|Overall Study|Other|4|||
130659607|NCT01569594|470376827|FG000|Overall Study|No ECM used|9|||
130659608|NCT01826201|470376830|FG000|Overall Study|Non compliance with protocol|4|||
130329706|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Patient requirement|20|||
130329707|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Death|5|||
130329708|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Change of therapy|6|||
130329709|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
130329710|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
130329711|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
130329712|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
130329713|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
130329714|NCT00641667|469176887|FG000|Overall Study|Withdrawal by Subject|1|||
130659609|NCT01615822|470376831|FG000|Period 1|Withdrawal by Subject|0|||
130329715|NCT00641667|469176887|FG000|Overall Study|Adverse Event|1|||
130659610|NCT01615822|470376832|FG001|Period 1|Withdrawal by Subject|1|||
130659611|NCT01615822|470376833|FG002|Period 1|Withdrawal by Subject|0|||
130659612|NCT01615822|470376831|FG000|Period 1|Adverse Event|1|||
130329716|NCT00641667|469176887|FG000|Overall Study|Physician Decision|1|||
130329717|NCT00641667|469176887|FG000|Overall Study|Worsening of underlying disease|3|||
130329718|NCT03349034|469176888|FG000|Overall Study|catheters dislodged during transport|2|||
130329719|NCT03349034|469176889|FG001|Overall Study|catheters dislodged during transport|0|||
130329720|NCT03349034|469176888|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
130329721|NCT03349034|469176889|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
130329722|NCT03349034|469176888|FG000|Overall Study|soft tissue flap used|1|||
130329723|NCT03349034|469176889|FG001|Overall Study|soft tissue flap used|0|||
130329724|NCT03349034|469176888|FG000|Overall Study|Other|0|||
130329725|NCT03349034|469176889|FG001|Overall Study|Other|1|||
130329726|NCT00865566|469176890|FG000|Overall Study|Death|1|||
130329727|NCT00865566|469176891|FG001|Overall Study|Death|11|||
130329728|NCT00865566|469176890|FG000|Overall Study|Lost to Follow-up|314|||
130329729|NCT00865566|469176891|FG001|Overall Study|Lost to Follow-up|315|||
130329730|NCT00865566|469176890|FG000|Overall Study|Withdrawal by Subject|45|||
130329731|NCT00865566|469176891|FG001|Overall Study|Withdrawal by Subject|65|||
130329732|NCT00865566|469176890|FG000|Overall Study|Physician Decision|0|||
130329733|NCT00865566|469176891|FG001|Overall Study|Physician Decision|1|||
130329734|NCT00865566|469176890|FG000|Overall Study|Participant relocated|78|||
130329735|NCT00865566|469176891|FG001|Overall Study|Participant relocated|107|||
130329736|NCT00865566|469176890|FG000|Overall Study|Participant unable to adhere|27|||
130329737|NCT00865566|469176891|FG001|Overall Study|Participant unable to adhere|42|||
130329738|NCT00865566|469176890|FG000|Overall Study|Other; N=245 due to early study closure|154|||
130329739|NCT00865566|469176891|FG001|Overall Study|Other; N=245 due to early study closure|139|||
130329740|NCT00865566|469176890|FG000|Overall Study|HIV infection|5|||
130329741|NCT00865566|469176891|FG001|Overall Study|HIV infection|7|||
130329742|NCT00815659|469176892|FG000|Overall Study|Adverse Event|9|||
130329743|NCT00815659|469176892|FG000|Overall Study|Withdrawal by Subject|9|||
130329744|NCT00815659|469176892|FG000|Overall Study|Lost to Follow-up|4|||
130329745|NCT00815659|469176892|FG000|Overall Study|Protocol Violation|1|||
130329746|NCT03847896|469176893|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329747|NCT03847896|469176894|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329748|NCT03847896|469176895|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
130329749|NCT03847896|469176896|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329750|NCT03847896|469176897|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329751|NCT03847896|469176893|FG000|Overall Study|Withdrawal by Subject|2|||
130329752|NCT03847896|469176894|FG001|Overall Study|Withdrawal by Subject|10|||
130329753|NCT03847896|469176895|FG002|Overall Study|Withdrawal by Subject|5|||
130329754|NCT03847896|469176896|FG003|Overall Study|Withdrawal by Subject|9|||
130659613|NCT01615822|470376832|FG001|Period 1|Adverse Event|1|||
130659614|NCT01615822|470376833|FG002|Period 1|Adverse Event|0|||
130659615|NCT01615822|470376831|FG000|Period 2|Lost to Follow-up|0|||
130659616|NCT01615822|470376832|FG001|Period 2|Lost to Follow-up|1|||
130329755|NCT03847896|469176897|FG004|Overall Study|Withdrawal by Subject|8|||
130329756|NCT03847896|469176893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130329757|NCT03847896|469176894|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130329758|NCT03847896|469176895|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130329759|NCT03847896|469176896|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130329760|NCT03847896|469176897|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130329761|NCT03847896|469176893|FG000|Overall Study|Adverse Event|2|||
130329762|NCT03847896|469176894|FG001|Overall Study|Adverse Event|1|||
130329763|NCT03847896|469176895|FG002|Overall Study|Adverse Event|3|||
130659617|NCT01615822|470376833|FG002|Period 2|Lost to Follow-up|2|||
130659618|NCT02861534|470376834|FG000|Overall Study|Death|541|||
130659619|NCT02861534|470376835|FG001|Overall Study|Death|552|||
130659620|NCT02861534|470376834|FG000|Overall Study|Lost to Follow-up|14|||
130659621|NCT02861534|470376835|FG001|Overall Study|Lost to Follow-up|14|||
130659622|NCT02861534|470376834|FG000|Overall Study|Site Terminated by Sponsor|4|||
130659623|NCT02861534|470376835|FG001|Overall Study|Site Terminated by Sponsor|3|||
130659624|NCT02861534|470376834|FG000|Overall Study|Withdrawal by Subject|15|||
130659625|NCT02861534|470376835|FG001|Overall Study|Withdrawal by Subject|18|||
130329764|NCT03847896|469176896|FG003|Overall Study|Adverse Event|2|||
130329765|NCT03847896|469176897|FG004|Overall Study|Adverse Event|4|||
130329766|NCT03847896|469176893|FG000|Overall Study|A severe exacerbation event|0|||
130329767|NCT03847896|469176894|FG001|Overall Study|A severe exacerbation event|0|||
130329768|NCT03847896|469176895|FG002|Overall Study|A severe exacerbation event|0|||
130329769|NCT03847896|469176896|FG003|Overall Study|A severe exacerbation event|0|||
130329770|NCT03847896|469176897|FG004|Overall Study|A severe exacerbation event|3|||
130329771|NCT03847896|469176893|FG000|Overall Study|Protocol Violation|0|||
130329772|NCT03847896|469176894|FG001|Overall Study|Protocol Violation|2|||
130329773|NCT03847896|469176895|FG002|Overall Study|Protocol Violation|1|||
130659626|NCT00916617|470376838|FG000|Overall Study|Adverse Event|3|||
130659627|NCT00916617|470376839|FG001|Overall Study|Adverse Event|2|||
130659628|NCT00916617|470376840|FG002|Overall Study|Adverse Event|6|||
130329774|NCT03847896|469176896|FG003|Overall Study|Protocol Violation|0|||
130329775|NCT03847896|469176897|FG004|Overall Study|Protocol Violation|2|||
130329776|NCT03847896|469176893|FG000|Overall Study|Lost to Follow-up|0|||
130329777|NCT03847896|469176894|FG001|Overall Study|Lost to Follow-up|0|||
130329778|NCT03847896|469176895|FG002|Overall Study|Lost to Follow-up|0|||
130329779|NCT03847896|469176896|FG003|Overall Study|Lost to Follow-up|1|||
130329780|NCT03847896|469176897|FG004|Overall Study|Lost to Follow-up|0|||
130329781|NCT03847896|469176893|FG000|Overall Study|Condition under investigation worsened|0|||
130329782|NCT03847896|469176894|FG001|Overall Study|Condition under investigation worsened|0|||
130329783|NCT03847896|469176895|FG002|Overall Study|Condition under investigation worsened|0|||
130329784|NCT03847896|469176896|FG003|Overall Study|Condition under investigation worsened|1|||
130329785|NCT03847896|469176897|FG004|Overall Study|Condition under investigation worsened|1|||
130329786|NCT03847896|469176893|FG000|Overall Study|Lack of Efficacy|0|||
130329787|NCT03847896|469176894|FG001|Overall Study|Lack of Efficacy|0|||
130329788|NCT03847896|469176895|FG002|Overall Study|Lack of Efficacy|0|||
130329789|NCT03847896|469176896|FG003|Overall Study|Lack of Efficacy|2|||
130329790|NCT03847896|469176897|FG004|Overall Study|Lack of Efficacy|2|||
130329791|NCT03847896|469176893|FG000|Overall Study|Other reasons|3|||
130329792|NCT03847896|469176894|FG001|Overall Study|Other reasons|3|||
130329793|NCT03847896|469176895|FG002|Overall Study|Other reasons|1|||
130329794|NCT03847896|469176896|FG003|Overall Study|Other reasons|2|||
130329795|NCT03847896|469176897|FG004|Overall Study|Other reasons|1|||
130329796|NCT02395471|469176898|FG000|Overall Study|Lost to Follow-up|2|||
130659629|NCT00916617|470376841|FG003|Overall Study|Adverse Event|3|||
130659630|NCT00916617|470376838|FG000|Overall Study|Withdrawal by Subject|3|||
130659631|NCT00916617|470376839|FG001|Overall Study|Withdrawal by Subject|2|||
130659632|NCT00916617|470376840|FG002|Overall Study|Withdrawal by Subject|0|||
130659633|NCT00916617|470376841|FG003|Overall Study|Withdrawal by Subject|1|||
130659634|NCT00916617|470376838|FG000|Overall Study|Caregiver Request|3|||
130329797|NCT02395471|469176899|FG001|Overall Study|Lost to Follow-up|0|||
130329798|NCT02395471|469176898|FG000|Overall Study|Withdrawal by Subject|2|||
130659635|NCT00916617|470376839|FG001|Overall Study|Caregiver Request|2|||
130659636|NCT00916617|470376840|FG002|Overall Study|Caregiver Request|1|||
130659637|NCT00916617|470376841|FG003|Overall Study|Caregiver Request|0|||
130659638|NCT00916617|470376838|FG000|Overall Study|Physician Decision|1|||
130659639|NCT00916617|470376839|FG001|Overall Study|Physician Decision|1|||
130659640|NCT00916617|470376840|FG002|Overall Study|Physician Decision|0|||
130659641|NCT00916617|470376841|FG003|Overall Study|Physician Decision|0|||
130659642|NCT00916617|470376838|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
130659643|NCT00916617|470376839|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
130659644|NCT00916617|470376840|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
130659645|NCT00916617|470376841|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
130659646|NCT00916617|470376838|FG000|Overall Study|Lost to Follow-up|2|||
130659647|NCT00916617|470376839|FG001|Overall Study|Lost to Follow-up|1|||
130659648|NCT00916617|470376840|FG002|Overall Study|Lost to Follow-up|0|||
130659649|NCT00916617|470376841|FG003|Overall Study|Lost to Follow-up|0|||
130659650|NCT00916617|470376838|FG000|Overall Study|Lack of Efficacy|1|||
130659651|NCT00916617|470376839|FG001|Overall Study|Lack of Efficacy|0|||
130659652|NCT00916617|470376840|FG002|Overall Study|Lack of Efficacy|0|||
130659653|NCT00916617|470376841|FG003|Overall Study|Lack of Efficacy|0|||
130659654|NCT00916617|470376838|FG000|Overall Study|Other|2|||
130659655|NCT00916617|470376839|FG001|Overall Study|Other|0|||
130659656|NCT00916617|470376840|FG002|Overall Study|Other|0|||
130659657|NCT00916617|470376841|FG003|Overall Study|Other|2|||
130659658|NCT01988337|470376844|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
130659659|NCT01260194|470376845|FG000|Overall Study|Withdrawal of Consent|1|||
130659660|NCT04854707|470376848|FG000|Overall Study|Lack of Efficacy|78|||
130659661|NCT04854707|470376849|FG001|Overall Study|Lack of Efficacy|59|||
130659662|NCT04854707|470376850|FG002|Overall Study|Lack of Efficacy|30|||
130659663|NCT01612780|470376856|FG000|Overall Study|Treatment not completed|1|||
130659664|NCT01612780|470376856|FG000|Overall Study|Withdrawal by Subject|5|||
130659665|NCT03466060|470376857|FG000|Period 1|Test Lens Damage|0|||
130329799|NCT02395471|469176899|FG001|Overall Study|Withdrawal by Subject|1|||
130659666|NCT03466060|470376858|FG001|Period 1|Test Lens Damage|2|||
130659667|NCT03466060|470376859|FG002|Period 1|Test Lens Damage|0|||
130659668|NCT03466060|470376860|FG003|Period 1|Test Lens Damage|0|||
130659669|NCT03466060|470376861|FG004|Period 1|Test Lens Damage|0|||
130659670|NCT03466060|470376862|FG005|Period 1|Test Lens Damage|0|||
130659671|NCT03466060|470376857|FG000|Period 1|Withdrawal by Subject|0|||
130659672|NCT03466060|470376858|FG001|Period 1|Withdrawal by Subject|0|||
130659673|NCT03466060|470376859|FG002|Period 1|Withdrawal by Subject|2|||
130659674|NCT03466060|470376860|FG003|Period 1|Withdrawal by Subject|0|||
130329800|NCT02395471|469176898|FG000|Overall Study|Physician Decision|1|||
130329801|NCT02395471|469176899|FG001|Overall Study|Physician Decision|0|||
130329802|NCT02395471|469176898|FG000|Overall Study|Protocol Violation|0|||
130329803|NCT02395471|469176899|FG001|Overall Study|Protocol Violation|1|||
130659675|NCT03466060|470376861|FG004|Period 1|Withdrawal by Subject|0|||
130659676|NCT03466060|470376862|FG005|Period 1|Withdrawal by Subject|0|||
130659677|NCT03466060|470376857|FG000|Period 1|Lost to Follow-up|0|||
130659678|NCT03466060|470376858|FG001|Period 1|Lost to Follow-up|0|||
130659679|NCT03466060|470376859|FG002|Period 1|Lost to Follow-up|0|||
130659680|NCT03466060|470376860|FG003|Period 1|Lost to Follow-up|1|||
130659681|NCT03466060|470376861|FG004|Period 1|Lost to Follow-up|0|||
130659682|NCT03466060|470376862|FG005|Period 1|Lost to Follow-up|0|||
130659683|NCT03466060|470376857|FG000|Period 1|Grade 2 Conjunctivitis|0|||
130659684|NCT03466060|470376858|FG001|Period 1|Grade 2 Conjunctivitis|0|||
130659685|NCT03466060|470376859|FG002|Period 1|Grade 2 Conjunctivitis|1|||
130659686|NCT03466060|470376860|FG003|Period 1|Grade 2 Conjunctivitis|0|||
130659687|NCT03466060|470376861|FG004|Period 1|Grade 2 Conjunctivitis|0|||
130659688|NCT03466060|470376862|FG005|Period 1|Grade 2 Conjunctivitis|0|||
130659689|NCT03466060|470376857|FG000|Period 2|Lens Handling Difficulties|0|||
130659690|NCT03466060|470376858|FG001|Period 2|Lens Handling Difficulties|0|||
130659691|NCT03466060|470376859|FG002|Period 2|Lens Handling Difficulties|1|||
130329804|NCT02395471|469176898|FG000|Overall Study|Failure to swollow sponge twice|1|||
130329805|NCT02395471|469176899|FG001|Overall Study|Failure to swollow sponge twice|0|||
130329806|NCT02395471|469176898|FG000|Overall Study|Patient did not return for procedure|0|||
130329807|NCT02395471|469176899|FG001|Overall Study|Patient did not return for procedure|1|||
130329808|NCT02395471|469176898|FG000|Overall Study|Subject not eligible|1|||
130659692|NCT03466060|470376860|FG003|Period 2|Lens Handling Difficulties|0|||
130659693|NCT03466060|470376861|FG004|Period 2|Lens Handling Difficulties|0|||
130659694|NCT03466060|470376862|FG005|Period 2|Lens Handling Difficulties|0|||
130659695|NCT04732728|470376866|FG000|Overall Study|Death|12|||
130659696|NCT04732728|470376866|FG000|Overall Study|Withdrawn|136|||
130329809|NCT02395471|469176899|FG001|Overall Study|Subject not eligible|0|||
130329810|NCT02978781|469176900|FG000|Part A|Adverse Event|1|||
130329811|NCT02978781|469176901|FG001|Part A|Adverse Event|1|||
130329812|NCT02978781|469176902|FG002|Part A|Adverse Event|0|||
130329813|NCT02978781|469176903|FG003|Part A|Adverse Event|0|||
130329814|NCT02978781|469176904|FG004|Part A|Adverse Event|0|||
130329815|NCT02978781|469176900|FG000|Part A|Withdrawal by Subject|0|||
130329816|NCT02978781|469176901|FG001|Part A|Withdrawal by Subject|1|||
130329817|NCT02978781|469176902|FG002|Part A|Withdrawal by Subject|0|||
130329818|NCT02978781|469176903|FG003|Part A|Withdrawal by Subject|0|||
130329819|NCT02978781|469176904|FG004|Part A|Withdrawal by Subject|0|||
130329820|NCT02978781|469176900|FG000|Part B|Withdrawal by Subject|0|||
130329821|NCT02978781|469176901|FG001|Part B|Withdrawal by Subject|0|||
130329822|NCT02978781|469176902|FG002|Part B|Withdrawal by Subject|0|||
130329823|NCT02978781|469176903|FG003|Part B|Withdrawal by Subject|1|||
130329824|NCT02978781|469176904|FG004|Part B|Withdrawal by Subject|0|||
130329825|NCT02978781|469176900|FG000|Part C|Adverse Event|0|||
130329826|NCT02978781|469176901|FG001|Part C|Adverse Event|0|||
130329827|NCT02978781|469176902|FG002|Part C|Adverse Event|0|||
130329828|NCT02978781|469176903|FG003|Part C|Adverse Event|0|||
130329829|NCT02978781|469176904|FG004|Part C|Adverse Event|2|||
130329830|NCT02978781|469176900|FG000|Part C|Withdrawal by Subject|0|||
130329831|NCT02978781|469176901|FG001|Part C|Withdrawal by Subject|0|||
130329832|NCT02978781|469176902|FG002|Part C|Withdrawal by Subject|0|||
130329833|NCT02978781|469176903|FG003|Part C|Withdrawal by Subject|0|||
130329834|NCT02978781|469176904|FG004|Part C|Withdrawal by Subject|1|||
130329835|NCT02978781|469176900|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329836|NCT02978781|469176901|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329837|NCT02978781|469176902|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329838|NCT02978781|469176903|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329839|NCT02978781|469176904|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
130329840|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
130329841|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
130329842|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Adverse Event|31|||
130329843|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Adverse Event|21|||
130329844|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
130329845|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
130329846|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130329847|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130329848|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
130329849|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
130329850|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
130329851|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
130329852|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Administrative problems|3|||
130329853|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Administrative problems|3|||
130329854|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Death|5|||
130659697|NCT01339000|470376869|FG000|Overall Study|study closed due to lack of drug supply|1|||
130659698|NCT01339000|470376870|FG001|Overall Study|study closed due to lack of drug supply|0|||
130659699|NCT02072174|470376871|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
130659700|NCT02072174|470376872|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
130659701|NCT02072174|470376871|FG000|Overall Study|Protocol Violation|16|||
130329855|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Death|8|||
130659702|NCT02072174|470376872|FG001|Overall Study|Protocol Violation|23|||
130659703|NCT02072174|470376871|FG000|Overall Study|Physician Decision|0|||
130659704|NCT02072174|470376872|FG001|Overall Study|Physician Decision|1|||
130659705|NCT02072174|470376871|FG000|Overall Study|Non-compliance with protocol requirement|2|||
130659706|NCT02072174|470376872|FG001|Overall Study|Non-compliance with protocol requirement|0|||
130659707|NCT05674721|470376874|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
130659708|NCT05674721|470376875|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
130329856|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Disease progression|139|||
130329857|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Disease progression|119|||
130329858|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
130329859|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
130329860|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
130329861|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
130329862|NCT00785785|469176905|FG000|Optional Extension Phase|Adverse Event|4|||
130329863|NCT00785785|469176906|FG001|Optional Extension Phase|Adverse Event|5|||
130329864|NCT00785785|469176905|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
130329865|NCT00785785|469176906|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
130329866|NCT00785785|469176905|FG000|Optional Extension Phase|Lost to Follow-up|1|||
130329867|NCT00785785|469176906|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130329868|NCT00785785|469176905|FG000|Optional Extension Phase|Administrative problems|2|||
130329869|NCT00785785|469176906|FG001|Optional Extension Phase|Administrative problems|0|||
130329870|NCT00785785|469176905|FG000|Optional Extension Phase|Death|1|||
130329871|NCT00785785|469176906|FG001|Optional Extension Phase|Death|5|||
130329872|NCT00785785|469176905|FG000|Optional Extension Phase|Disease progression|22|||
130329873|NCT00785785|469176906|FG001|Optional Extension Phase|Disease progression|70|||
130329874|NCT00785785|469176905|FG000|Optional Extension Phase|Protocol deviation|0|||
130329875|NCT00785785|469176906|FG001|Optional Extension Phase|Protocol deviation|2|||
130329876|NCT00785785|469176905|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
130329877|NCT00785785|469176906|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
130329878|NCT02453321|469176907|FG000|Overall Study|Weakness|1|||
130329879|NCT02453321|469176908|FG001|Overall Study|Weakness|1|||
130329880|NCT02453321|469176909|FG002|Overall Study|Weakness|2|||
130329881|NCT02453321|469176907|FG000|Overall Study|Deep Venous Thrombosis|0|||
130329882|NCT02453321|469176908|FG001|Overall Study|Deep Venous Thrombosis|1|||
130329883|NCT02453321|469176909|FG002|Overall Study|Deep Venous Thrombosis|0|||
130329884|NCT00521404|469176910|FG000|Overall Study|Adverse Event|13|||
130329885|NCT00521404|469176910|FG000|Overall Study|Disease Progression|33|||
130329886|NCT00521404|469176910|FG000|Overall Study|Investigator decision|5|||
130329887|NCT00521404|469176910|FG000|Overall Study|Withdrawal of consent|3|||
130329888|NCT00521404|469176910|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
130329889|NCT00521404|469176910|FG000|Overall Study|Other|7|||
130659709|NCT05674721|470376874|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
130659710|NCT05674721|470376875|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
130659711|NCT02643394|470376882|FG000|Overall Study|Protocol Violation|4|||
130659712|NCT02643394|470376883|FG001|Overall Study|Protocol Violation|5|||
130329890|NCT02282605|469176913|FG000|Overall Study|negative SA result on Day -1|3|||
130329891|NCT02282605|469176914|FG001|Overall Study|negative SA result on Day -1|0|||
130329892|NCT02282605|469176915|FG002|Overall Study|negative SA result on Day -1|0|||
130329893|NCT03584789|469176918|FG000|Overall Study|refused EHR permission|19|||
130329894|NCT03584789|469176919|FG001|Overall Study|refused EHR permission|28|||
130329895|NCT03584789|469176920|FG002|Overall Study|refused EHR permission|23|||
130329896|NCT03584789|469176918|FG000|Overall Study|patients tied to a provider who retired|0|||
130329897|NCT03584789|469176919|FG001|Overall Study|patients tied to a provider who retired|0|||
130329898|NCT03584789|469176920|FG002|Overall Study|patients tied to a provider who retired|3|||
130329899|NCT02035267|469176921|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
130329900|NCT02035267|469176922|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
130329901|NCT02035267|469176923|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
130329902|NCT02035267|469176924|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
130329903|NCT02035267|469176921|FG000|Overall Study|Adverse Event|0|||
130329904|NCT02035267|469176922|FG001|Overall Study|Adverse Event|0|||
130329905|NCT02035267|469176923|FG002|Overall Study|Adverse Event|1|||
130329906|NCT02035267|469176924|FG003|Overall Study|Adverse Event|0|||
130659713|NCT00664066|470376884|FG000|Overall Study|Study terminated|3|||
130659714|NCT03701516|470376885|FG000|Period 1|Lost to Follow-up|0|||
130659715|NCT03701516|470376886|FG001|Period 1|Lost to Follow-up|1|||
130329907|NCT02035267|469176921|FG000|Overall Study|Lost to Follow-up|0|||
130329908|NCT02035267|469176922|FG001|Overall Study|Lost to Follow-up|0|||
130329909|NCT02035267|469176923|FG002|Overall Study|Lost to Follow-up|0|||
130329910|NCT02035267|469176924|FG003|Overall Study|Lost to Follow-up|1|||
130329911|NCT02035267|469176921|FG000|Overall Study|Other unspecified|0|||
130659716|NCT03701516|470376885|FG000|Period 1|Adverse Event|0|||
130659717|NCT03701516|470376886|FG001|Period 1|Adverse Event|2|||
130659718|NCT03701516|470376885|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
130659719|NCT03701516|470376886|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130329912|NCT02035267|469176922|FG001|Overall Study|Other unspecified|1|||
130329913|NCT02035267|469176923|FG002|Overall Study|Other unspecified|0|||
130329914|NCT02035267|469176924|FG003|Overall Study|Other unspecified|0|||
130329915|NCT00823615|469176933|FG000|Period 2|Lost to Follow-up|2|||
130329916|NCT00823615|469176934|FG001|Period 2|Lost to Follow-up|0|||
130329917|NCT00823615|469176933|FG000|Period 2|Time/Job Conflict|1|||
130329918|NCT00823615|469176934|FG001|Period 2|Time/Job Conflict|2|||
130329919|NCT00098813|469176935|FG000|Overall Study|Death|8|||
130329920|NCT00098813|469176935|FG000|Overall Study|Protocol Violation|1|||
130329921|NCT00098813|469176935|FG000|Overall Study|Withdrawal by Subject|7|||
130329922|NCT00098813|469176935|FG000|Overall Study|Progression of Disease|1|||
130329923|NCT00098813|469176935|FG000|Overall Study|Other complicating disease|1|||
130329924|NCT00098813|469176935|FG000|Overall Study|Reversal of RAI resistance|1|||
130329925|NCT00892099|469176937|FG000|Overall Study|Death|1|||
130329926|NCT00892099|469176938|FG001|Overall Study|Death|0|||
130329927|NCT00892099|469176939|FG002|Overall Study|Death|1|||
130329928|NCT00892099|469176937|FG000|Overall Study|Adverse Event|1|||
130329929|NCT00892099|469176938|FG001|Overall Study|Adverse Event|0|||
130329930|NCT00892099|469176939|FG002|Overall Study|Adverse Event|0|||
130329931|NCT00892099|469176937|FG000|Overall Study|replocated|1|||
130329932|NCT00892099|469176938|FG001|Overall Study|replocated|0|||
130329933|NCT00892099|469176939|FG002|Overall Study|replocated|2|||
130329934|NCT00892099|469176937|FG000|Overall Study|Prolonged hospitalization|1|||
130329935|NCT00892099|469176938|FG001|Overall Study|Prolonged hospitalization|0|||
130329936|NCT00892099|469176939|FG002|Overall Study|Prolonged hospitalization|1|||
130329937|NCT00892099|469176937|FG000|Overall Study|no further details|1|||
130329938|NCT00892099|469176938|FG001|Overall Study|no further details|0|||
130329939|NCT00892099|469176939|FG002|Overall Study|no further details|1|||
130329940|NCT00892099|469176937|FG000|Overall Study|kidney function recovered|0|||
130329941|NCT00892099|469176938|FG001|Overall Study|kidney function recovered|1|||
130329942|NCT00892099|469176939|FG002|Overall Study|kidney function recovered|0|||
130329943|NCT00892099|469176937|FG000|Overall Study|investigator decision|0|||
130329944|NCT00892099|469176938|FG001|Overall Study|investigator decision|0|||
130329945|NCT00892099|469176939|FG002|Overall Study|investigator decision|1|||
130329946|NCT00892099|469176937|FG000|Overall Study|Lost to Follow-up|0|||
130329947|NCT00892099|469176938|FG001|Overall Study|Lost to Follow-up|0|||
130329948|NCT00892099|469176939|FG002|Overall Study|Lost to Follow-up|1|||
130329949|NCT04396639|469176940|FG000|Overall Study|Withdrawal by Subject|1|||
130329950|NCT04396639|469176940|FG000|Overall Study|Other|1|||
130329951|NCT01532986|469176941|FG000|Overall Study|Death|9|||
130329952|NCT01532986|469176942|FG001|Overall Study|Death|9|||
130329953|NCT01532986|469176941|FG000|Overall Study|Withdrawal by Subject|7|||
130329954|NCT01532986|469176942|FG001|Overall Study|Withdrawal by Subject|10|||
130329955|NCT01532986|469176941|FG000|Overall Study|Physician Decision|7|||
130329956|NCT01532986|469176942|FG001|Overall Study|Physician Decision|5|||
130329957|NCT00043979|469176943|FG000|Period 1|recipient with progressive disease|7|||
130329958|NCT00043979|469176944|FG001|Period 1|recipient with progressive disease|4|||
130329959|NCT00043979|469176945|FG002|Period 1|recipient with progressive disease|3|||
130329960|NCT00658359|469176948|FG000|Overall Study|Death|3|||
130329961|NCT00658359|469176949|FG001|Overall Study|Death|1|||
130329962|NCT00658359|469176950|FG002|Overall Study|Death|2|||
130329963|NCT00658359|469176948|FG000|Overall Study|Adverse Event|13|||
130329964|NCT00658359|469176949|FG001|Overall Study|Adverse Event|6|||
130329965|NCT00658359|469176950|FG002|Overall Study|Adverse Event|9|||
130329966|NCT00658359|469176948|FG000|Overall Study|Protocol Violation|1|||
130329967|NCT00658359|469176949|FG001|Overall Study|Protocol Violation|0|||
130329968|NCT00658359|469176950|FG002|Overall Study|Protocol Violation|0|||
130329969|NCT00658359|469176948|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
130329970|NCT00658359|469176949|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
130329971|NCT00658359|469176950|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
130329972|NCT00658359|469176948|FG000|Overall Study|Withdrawal by Subject|7|||
130329973|NCT00658359|469176949|FG001|Overall Study|Withdrawal by Subject|4|||
130329974|NCT00658359|469176950|FG002|Overall Study|Withdrawal by Subject|2|||
130329975|NCT00658359|469176948|FG000|Overall Study|Lost to Follow-up|2|||
130329976|NCT00658359|469176949|FG001|Overall Study|Lost to Follow-up|2|||
130659720|NCT03701516|470376885|FG000|Period 1|Non Compliance to Protocol|2|||
130659721|NCT03701516|470376886|FG001|Period 1|Non Compliance to Protocol|1|||
130329977|NCT00658359|469176950|FG002|Overall Study|Lost to Follow-up|4|||
130329978|NCT00658359|469176948|FG000|Overall Study|Lack of Efficacy|0|||
130329979|NCT00658359|469176949|FG001|Overall Study|Lack of Efficacy|1|||
130329980|NCT00658359|469176950|FG002|Overall Study|Lack of Efficacy|0|||
130329981|NCT02754440|469176951|FG000|Overall Study|Protocol Violation|3|||
130329982|NCT02754440|469176952|FG001|Overall Study|Protocol Violation|2|||
130329983|NCT02754440|469176953|FG002|Overall Study|Protocol Violation|2|||
130329984|NCT02754440|469176954|FG003|Overall Study|Protocol Violation|6|||
130329985|NCT02754440|469176951|FG000|Overall Study|Adverse Event|3|||
130329986|NCT02754440|469176952|FG001|Overall Study|Adverse Event|1|||
130329987|NCT02754440|469176953|FG002|Overall Study|Adverse Event|0|||
130329988|NCT02754440|469176954|FG003|Overall Study|Adverse Event|9|||
130659722|NCT03701516|470376885|FG000|Period 1|Withdrawal by Subject|0|||
130659723|NCT03701516|470376886|FG001|Period 1|Withdrawal by Subject|1|||
130659724|NCT03701516|470376885|FG000|Period 2|failed to meet all eligibility creiteria|1|||
130659725|NCT03701516|470376886|FG001|Period 2|failed to meet all eligibility creiteria|0|||
130659726|NCT03701516|470376885|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
130659727|NCT03701516|470376886|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
130659728|NCT03083639|470376887|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
130659729|NCT03083639|470376888|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
130329989|NCT02754440|469176951|FG000|Overall Study|Withdrawal by Subject|0|||
130329990|NCT02754440|469176952|FG001|Overall Study|Withdrawal by Subject|0|||
130329991|NCT02754440|469176953|FG002|Overall Study|Withdrawal by Subject|0|||
130329992|NCT02754440|469176954|FG003|Overall Study|Withdrawal by Subject|1|||
130329993|NCT02754440|469176951|FG000|Overall Study|Equipment failure|0|||
130329994|NCT02754440|469176952|FG001|Overall Study|Equipment failure|5|||
130329995|NCT02754440|469176953|FG002|Overall Study|Equipment failure|5|||
130329996|NCT02754440|469176954|FG003|Overall Study|Equipment failure|7|||
130329997|NCT02754440|469176951|FG000|Overall Study|Subject issues not resulting in AE|0|||
130659730|NCT03083639|470376887|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
130659731|NCT03083639|470376888|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
130659732|NCT01591499|470376889|FG000|Baseline Visit|Withdrawal by Subject|0|||
130659733|NCT01591499|470376890|FG001|Baseline Visit|Withdrawal by Subject|2|||
130659734|NCT01591499|470376891|FG002|Baseline Visit|Withdrawal by Subject|0|||
130659735|NCT01591499|470376892|FG003|Baseline Visit|Withdrawal by Subject|2|||
130659736|NCT01591499|470376889|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
130659737|NCT01591499|470376890|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
130659738|NCT01591499|470376891|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
130659739|NCT01591499|470376892|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
130659740|NCT01591499|470376889|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
130329998|NCT02754440|469176952|FG001|Overall Study|Subject issues not resulting in AE|0|||
130329999|NCT02754440|469176953|FG002|Overall Study|Subject issues not resulting in AE|0|||
130330000|NCT02754440|469176954|FG003|Overall Study|Subject issues not resulting in AE|12|||
130330001|NCT01189032|469176957|FG000|Overall Study|Adverse Event|1|||
130330002|NCT01189032|469176958|FG001|Overall Study|Adverse Event|3|||
130330003|NCT01189032|469176959|FG002|Overall Study|Adverse Event|4|||
130330004|NCT01189032|469176957|FG000|Overall Study|Lack of Efficacy|2|||
130330005|NCT01189032|469176958|FG001|Overall Study|Lack of Efficacy|3|||
130330006|NCT01189032|469176959|FG002|Overall Study|Lack of Efficacy|0|||
130330007|NCT01189032|469176957|FG000|Overall Study|Withdrawal by Subject|1|||
130330008|NCT01189032|469176958|FG001|Overall Study|Withdrawal by Subject|0|||
130330009|NCT01189032|469176959|FG002|Overall Study|Withdrawal by Subject|1|||
130330010|NCT01189032|469176957|FG000|Overall Study|Protocol Violation|1|||
130330011|NCT01189032|469176958|FG001|Overall Study|Protocol Violation|1|||
130330012|NCT01189032|469176959|FG002|Overall Study|Protocol Violation|1|||
130330013|NCT03388164|469176964|FG000|Overall Study|Withdrawal by Subject|3|||
130330014|NCT03388164|469176965|FG001|Overall Study|Withdrawal by Subject|1|||
130330015|NCT05375760|469176968|FG000|Overall Study|Adverse Event|1|||
130330016|NCT05375760|469176969|FG001|Overall Study|Adverse Event|0|||
130330017|NCT05375760|469176968|FG000|Overall Study|Death|0|||
130330018|NCT05375760|469176969|FG001|Overall Study|Death|1|||
130330019|NCT05375760|469176968|FG000|Overall Study|Lost to Follow-up|6|||
130330020|NCT05375760|469176969|FG001|Overall Study|Lost to Follow-up|6|||
130330021|NCT05375760|469176968|FG000|Overall Study|Withdrawal by Subject|17|||
130330022|NCT05375760|469176969|FG001|Overall Study|Withdrawal by Subject|19|||
130330023|NCT05375760|469176968|FG000|Overall Study|Dosing halted by FDA|96|||
130330024|NCT05375760|469176969|FG001|Overall Study|Dosing halted by FDA|100|||
130330025|NCT05375760|469176968|FG000|Overall Study|Not compliant with study visit|2|||
130330026|NCT05375760|469176969|FG001|Overall Study|Not compliant with study visit|0|||
130330027|NCT05375760|469176968|FG000|Overall Study|Physician Decision|1|||
130330028|NCT05375760|469176969|FG001|Overall Study|Physician Decision|0|||
130330029|NCT05375760|469176968|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
130330030|NCT05375760|469176969|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
130330031|NCT05375760|469176968|FG000|Overall Study|Participant moved|1|||
130659741|NCT01591499|470376890|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
130659742|NCT01591499|470376891|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
130659743|NCT01591499|470376892|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
130330032|NCT05375760|469176969|FG001|Overall Study|Participant moved|0|||
130659744|NCT05083559|470376893|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
130330033|NCT00363480|469176970|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
130330034|NCT00363480|469176970|FG000|Overall Study|Adverse Event|4|||
130330035|NCT00363480|469176970|FG000|Overall Study|Lost to Follow-up|5|||
130330036|NCT00363480|469176970|FG000|Overall Study|Withdrawal by Subject|5|||
130330037|NCT00363480|469176970|FG000|Overall Study|Non-compliance of subject|1|||
130330038|NCT00363480|469176970|FG000|Overall Study|Participant discontinued on its own|1|||
130330039|NCT01457703|469176971|FG000|Overall Study|Screen Failure|5|||
130330040|NCT01457703|469176972|FG001|Overall Study|Screen Failure|7|||
130330041|NCT01457703|469176971|FG000|Overall Study|Withdrawal by Subject|1|||
130330042|NCT01457703|469176972|FG001|Overall Study|Withdrawal by Subject|4|||
130330043|NCT00949702|469176973|FG000|Overall Study|Death|40|||
130330044|NCT00949702|469176973|FG000|Overall Study|Disease progression|7|||
130330045|NCT00949702|469176973|FG000|Overall Study|Withdrawal of consent|1|||
130330046|NCT06042855|469176976|FG000|Overall Study|No Receipt of Study Drug|48|||
130330047|NCT06042855|469176977|FG001|Overall Study|No Receipt of Study Drug|57|||
130330048|NCT06042855|469176976|FG000|Overall Study|Administratively Withdrawn|59|||
130330049|NCT06042855|469176977|FG001|Overall Study|Administratively Withdrawn|59|||
130330050|NCT02129699|469176982|FG000|Overall Study|Did not start treatment|3|||
130330051|NCT02129699|469176983|FG001|Overall Study|Did not start treatment|2|||
130330052|NCT00525161|469176986|FG000|Overall Study|Adverse Event|1|||
130330053|NCT01076361|469176990|FG000|Overall Study|22 leads were excluded from analysis|21|||
130330054|NCT02447003|469176991|FG000|Overall Study|Other|0|||
130330055|NCT02447003|469176992|FG001|Overall Study|Other|4|||
130330056|NCT02447003|469176991|FG000|Overall Study|Site discontinued|0|||
130330057|NCT02447003|469176992|FG001|Overall Study|Site discontinued|2|||
130330058|NCT02447003|469176991|FG000|Overall Study|Physician Decision|0|||
130330059|NCT02447003|469176992|FG001|Overall Study|Physician Decision|1|||
130330060|NCT02447003|469176991|FG000|Overall Study|Withdrawal by Subject|4|||
130330061|NCT02447003|469176992|FG001|Overall Study|Withdrawal by Subject|3|||
130330062|NCT02447003|469176991|FG000|Overall Study|Sponsor Decision|6|||
130330063|NCT02447003|469176992|FG001|Overall Study|Sponsor Decision|11|||
130330064|NCT02447003|469176991|FG000|Overall Study|Progressive Disease|1|||
130330065|NCT02447003|469176992|FG001|Overall Study|Progressive Disease|0|||
130330066|NCT02447003|469176991|FG000|Overall Study|Lost to Follow-up|5|||
130330067|NCT02447003|469176992|FG001|Overall Study|Lost to Follow-up|0|||
130330068|NCT02447003|469176991|FG000|Overall Study|Death|154|||
130330069|NCT02447003|469176992|FG001|Overall Study|Death|63|||
130330070|NCT03848728|469176993|FG000|Overall Study|Death|16|||
130330071|NCT03848728|469176994|FG001|Overall Study|Death|13|||
130330072|NCT03848728|469176993|FG000|Overall Study|Outmigrated to non-study community|98|||
130330073|NCT03848728|469176994|FG001|Overall Study|Outmigrated to non-study community|106|||
130330074|NCT03848728|469176993|FG000|Overall Study|Transfered to non-study clinic|32|||
130330075|NCT03848728|469176994|FG001|Overall Study|Transfered to non-study clinic|48|||
130330076|NCT03848728|469176993|FG000|Overall Study|Withdrawal by Subject|1|||
130330077|NCT03848728|469176994|FG001|Overall Study|Withdrawal by Subject|0|||
130330078|NCT00630838|469176997|FG000|Overall Study|Death|0|||
130330079|NCT00630838|469176998|FG001|Overall Study|Death|1|||
130330080|NCT00630838|469176997|FG000|Overall Study|Lost to Follow-up|0|||
130330081|NCT00630838|469176998|FG001|Overall Study|Lost to Follow-up|1|||
130330082|NCT01108185|469176999|FG000|Overall Study|Non-compliance|15|||
130330083|NCT01108185|469176999|FG000|Overall Study|Lost to Follow-up|12|||
130330084|NCT02581410|469177000|FG000|Vaccination Phase|Adverse Event|2|||
130330085|NCT02581410|469177001|FG001|Vaccination Phase|Adverse Event|1|||
130330086|NCT02581410|469177000|FG000|Vaccination Phase|Withdrawal by Subject|0|||
130659745|NCT05083559|470376894|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
130659746|NCT05083559|470376893|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
130659747|NCT05083559|470376894|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
130659748|NCT05083559|470376893|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
130659749|NCT05083559|470376894|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
130659750|NCT03940742|470376896|FG000|Overall Study|Lost to Follow-up|0|||
130659751|NCT03940742|470376897|FG001|Overall Study|Lost to Follow-up|0|||
130659752|NCT03940742|470376898|FG002|Overall Study|Lost to Follow-up|0|||
130659753|NCT03940742|470376899|FG003|Overall Study|Lost to Follow-up|1|||
130659754|NCT02032823|470376900|FG000|Overall Study|Death|75|||
130659755|NCT02032823|470376901|FG001|Overall Study|Death|109|||
130659756|NCT02032823|470376900|FG000|Overall Study|Lost to Follow-up|18|||
130659757|NCT02032823|470376901|FG001|Overall Study|Lost to Follow-up|17|||
130330087|NCT02581410|469177001|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130330088|NCT02581410|469177000|FG000|Vaccination Phase|Migrated/moved from study area|0|||
130330089|NCT02581410|469177001|FG001|Vaccination Phase|Migrated/moved from study area|1|||
130330090|NCT02581410|469177000|FG000|End of Study Phase|Adverse Event|4|||
130659758|NCT02032823|470376900|FG000|Overall Study|Withdrawal by Subject|70|||
130659759|NCT02032823|470376901|FG001|Overall Study|Withdrawal by Subject|53|||
130659760|NCT02032823|470376900|FG000|Overall Study|Ongoing study at data cut-off|755|||
130659761|NCT02032823|470376901|FG001|Overall Study|Ongoing study at data cut-off|731|||
130330091|NCT02581410|469177001|FG001|End of Study Phase|Adverse Event|3|||
130659762|NCT02032823|470376900|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
130330092|NCT02581410|469177000|FG000|End of Study Phase|Withdrawal by Subject|1|||
130330093|NCT02581410|469177001|FG001|End of Study Phase|Withdrawal by Subject|2|||
130330094|NCT02581410|469177000|FG000|End of Study Phase|Migrated/moved from study area|0|||
130330095|NCT02581410|469177001|FG001|End of Study Phase|Migrated/moved from study area|3|||
130330096|NCT02581410|469177000|FG000|End of Study Phase|Lost to Follow-up|0|||
130330097|NCT02581410|469177001|FG001|End of Study Phase|Lost to Follow-up|2|||
130330098|NCT02581410|469177000|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
130330099|NCT02581410|469177001|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
130330100|NCT00670748|469177004|FG000|Overall Study|Death during treatment|1|||
130330101|NCT00670748|469177005|FG001|Overall Study|Death during treatment|1|||
130330102|NCT00670748|469177006|FG002|Overall Study|Death during treatment|1|||
130330103|NCT00670748|469177007|FG003|Overall Study|Death during treatment|0|||
130330104|NCT00670748|469177004|FG000|Overall Study|Not off study|2|||
130330105|NCT00670748|469177005|FG001|Overall Study|Not off study|1|||
130330106|NCT00670748|469177006|FG002|Overall Study|Not off study|1|||
130330107|NCT00670748|469177007|FG003|Overall Study|Not off study|1|||
130330108|NCT06083506|469177012|FG000|Overall Study|Physician Decision|2|||
130330109|NCT06083506|469177012|FG000|Overall Study|Lack of Efficacy|1|||
130330110|NCT03529422|469177013|FG000|Overall Study|Withdrawal by Subject|1|||
130330111|NCT03529422|469177013|FG000|Overall Study|Protocol Violation|1|||
130330112|NCT03529422|469177013|FG000|Overall Study|Disease progression|2|||
130330113|NCT02000115|469177014|FG000|Overall Study|Death|56|||
130330114|NCT02000115|469177015|FG001|Overall Study|Death|45|||
130330115|NCT02000115|469177016|FG002|Overall Study|Death|0|||
130330116|NCT02000115|469177017|FG003|Overall Study|Death|0|||
130330117|NCT02000115|469177014|FG000|Overall Study|Missed Visit|6|||
130330118|NCT02000115|469177015|FG001|Overall Study|Missed Visit|8|||
130330119|NCT02000115|469177016|FG002|Overall Study|Missed Visit|1|||
130330120|NCT02000115|469177017|FG003|Overall Study|Missed Visit|0|||
130330121|NCT02000115|469177014|FG000|Overall Study|Protocol Violation|2|||
130330122|NCT02000115|469177015|FG001|Overall Study|Protocol Violation|1|||
130330123|NCT02000115|469177016|FG002|Overall Study|Protocol Violation|0|||
130330124|NCT02000115|469177017|FG003|Overall Study|Protocol Violation|0|||
130330125|NCT02000115|469177014|FG000|Overall Study|Physician Decision|2|||
130330126|NCT02000115|469177015|FG001|Overall Study|Physician Decision|0|||
130330127|NCT02000115|469177016|FG002|Overall Study|Physician Decision|0|||
130330128|NCT02000115|469177017|FG003|Overall Study|Physician Decision|0|||
130330129|NCT02000115|469177014|FG000|Overall Study|Withdrawal by Subject|11|||
130330130|NCT02000115|469177015|FG001|Overall Study|Withdrawal by Subject|11|||
130330131|NCT02000115|469177016|FG002|Overall Study|Withdrawal by Subject|0|||
130330132|NCT02000115|469177017|FG003|Overall Study|Withdrawal by Subject|0|||
130659763|NCT02032823|470376901|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
130659764|NCT03428217|470376902|FG000|Overall Study|Death|89|||
130330133|NCT02000115|469177014|FG000|Overall Study|Lost to Follow-up|0|||
130330134|NCT02000115|469177015|FG001|Overall Study|Lost to Follow-up|1|||
130330135|NCT02000115|469177016|FG002|Overall Study|Lost to Follow-up|0|||
130659765|NCT03428217|470376903|FG001|Overall Study|Death|93|||
130659766|NCT03428217|470376902|FG000|Overall Study|Withdrawal by Subject|8|||
130659767|NCT03428217|470376903|FG001|Overall Study|Withdrawal by Subject|7|||
130659768|NCT03428217|470376902|FG000|Overall Study|Lost to Follow-up|1|||
130659769|NCT03428217|470376903|FG001|Overall Study|Lost to Follow-up|3|||
130659770|NCT03428217|470376902|FG000|Overall Study|Study terminated by sponsor|124|||
130659771|NCT03428217|470376903|FG001|Overall Study|Study terminated by sponsor|118|||
130659772|NCT03428217|470376902|FG000|Overall Study|Other, Not Specified|1|||
130659773|NCT03428217|470376903|FG001|Overall Study|Other, Not Specified|0|||
130659774|NCT03889197|470376904|FG000|Overall Study|Withdrawal by Subject|1|||
130659775|NCT03889197|470376905|FG001|Overall Study|Withdrawal by Subject|0|||
130659776|NCT03889197|470376904|FG000|Overall Study|Physician Decision|0|||
130659777|NCT03889197|470376905|FG001|Overall Study|Physician Decision|1|||
130659778|NCT03889197|470376904|FG000|Overall Study|met exclusion criteria|0|||
130659779|NCT03889197|470376905|FG001|Overall Study|met exclusion criteria|1|||
130659780|NCT03889197|470376904|FG000|Overall Study|Protocol Violation|1|||
130659781|NCT03889197|470376905|FG001|Overall Study|Protocol Violation|0|||
130659782|NCT05899218|470376906|FG000|Overall Study|Lost to Follow-up|2|||
130659783|NCT05899218|470376907|FG001|Overall Study|Lost to Follow-up|2|||
130659784|NCT05899218|470376906|FG000|Overall Study|deemed ineligible out of country|1|||
130659785|NCT05899218|470376907|FG001|Overall Study|deemed ineligible out of country|0|||
130659786|NCT05246111|470376908|FG000|Period 01|NOT ELIGIBLE IC5|1|||
130659787|NCT05246111|470376909|FG001|Period 01|NOT ELIGIBLE IC5|0|||
130659788|NCT03151226|470376910|FG000|Overall Study|Withdrawal by Subject|2|||
130659789|NCT03151226|470376910|FG000|Overall Study|not wear device correctly|1|||
130659790|NCT02038959|470378876|FG000|Overall Study|Withdrawal by Subject|6|||
130330136|NCT02000115|469177017|FG003|Overall Study|Lost to Follow-up|0|||
130330137|NCT02000115|469177014|FG000|Overall Study|Non-compliance|2|||
130330138|NCT02000115|469177015|FG001|Overall Study|Non-compliance|1|||
130330139|NCT02000115|469177016|FG002|Overall Study|Non-compliance|0|||
130659791|NCT02038959|470378877|FG001|Overall Study|Withdrawal by Subject|8|||
130659792|NCT00819091|470378884|FG000|Overall Study|Adverse Event|3|||
130659793|NCT00819091|470378885|FG001|Overall Study|Adverse Event|5|||
130330140|NCT02000115|469177017|FG003|Overall Study|Non-compliance|0|||
130330141|NCT02000115|469177014|FG000|Overall Study|Withdrawn on day of randomization|0|||
130330142|NCT02000115|469177015|FG001|Overall Study|Withdrawn on day of randomization|1|||
130330143|NCT02000115|469177016|FG002|Overall Study|Withdrawn on day of randomization|0|||
130659794|NCT00819091|470378884|FG000|Overall Study|Protocol Violation|0|||
130659795|NCT00819091|470378885|FG001|Overall Study|Protocol Violation|1|||
130659796|NCT00819091|470378884|FG000|Overall Study|Lost to Follow-up|2|||
130659797|NCT00819091|470378885|FG001|Overall Study|Lost to Follow-up|0|||
130659798|NCT00819091|470378884|FG000|Overall Study|Withdrawal by Subject|1|||
130659799|NCT00819091|470378885|FG001|Overall Study|Withdrawal by Subject|2|||
130659800|NCT00819091|470378884|FG000|Overall Study|Other|1|||
130659801|NCT00819091|470378885|FG001|Overall Study|Other|2|||
130659802|NCT02237118|470378889|FG000|Overall Study|Protocol Violation|0|||
130659803|NCT02237118|470378890|FG001|Overall Study|Protocol Violation|1|||
130659804|NCT02237118|470378889|FG000|Overall Study|consent withdrawn|1|||
130659805|NCT02237118|470378890|FG001|Overall Study|consent withdrawn|0|||
130659806|NCT03284424|470378891|FG000|Overall Study|Death|70|||
130330144|NCT02000115|469177017|FG003|Overall Study|Withdrawn on day of randomization|0|||
130330145|NCT02000115|469177014|FG000|Overall Study|Still on Study|0|||
130330146|NCT02000115|469177015|FG001|Overall Study|Still on Study|0|||
130659807|NCT03284424|470378892|FG001|Overall Study|Death|24|||
130659808|NCT03284424|470378891|FG000|Overall Study|Lost to Follow-up|3|||
130659809|NCT03284424|470378892|FG001|Overall Study|Lost to Follow-up|1|||
130659810|NCT03284424|470378891|FG000|Overall Study|Physician Decision|1|||
130659811|NCT03284424|470378892|FG001|Overall Study|Physician Decision|2|||
130659812|NCT03284424|470378891|FG000|Overall Study|Withdrawal by Subject|4|||
130659813|NCT03284424|470378892|FG001|Overall Study|Withdrawal by Subject|5|||
130659814|NCT03284424|470378891|FG000|Overall Study|Sponsor's decision|27|||
130659815|NCT03284424|470378892|FG001|Overall Study|Sponsor's decision|22|||
130659816|NCT01787188|470378894|FG000|Overall Study|Adverse Event|2|||
130659817|NCT01787188|470378895|FG001|Overall Study|Adverse Event|4|||
130659818|NCT01787188|470378896|FG002|Overall Study|Adverse Event|6|||
130659819|NCT01787188|470378894|FG000|Overall Study|Lack of Efficacy|7|||
130659820|NCT01787188|470378895|FG001|Overall Study|Lack of Efficacy|3|||
130659821|NCT01787188|470378896|FG002|Overall Study|Lack of Efficacy|5|||
130659822|NCT01787188|470378894|FG000|Overall Study|Non-compliance with Study Drug|0|||
130659823|NCT01787188|470378895|FG001|Overall Study|Non-compliance with Study Drug|1|||
130659824|NCT01787188|470378896|FG002|Overall Study|Non-compliance with Study Drug|0|||
130659825|NCT01787188|470378894|FG000|Overall Study|Withdrawal by Subject|4|||
130659826|NCT01787188|470378895|FG001|Overall Study|Withdrawal by Subject|3|||
130659827|NCT01787188|470378896|FG002|Overall Study|Withdrawal by Subject|2|||
130659828|NCT01787188|470378894|FG000|Overall Study|Protocol Violation|3|||
130659829|NCT01787188|470378895|FG001|Overall Study|Protocol Violation|2|||
130659830|NCT01787188|470378896|FG002|Overall Study|Protocol Violation|3|||
130659831|NCT01787188|470378894|FG000|Overall Study|Lost to Follow-up|1|||
130659832|NCT01787188|470378895|FG001|Overall Study|Lost to Follow-up|2|||
130659833|NCT01787188|470378896|FG002|Overall Study|Lost to Follow-up|2|||
130659834|NCT01787188|470378894|FG000|Overall Study|Other, including patient moved|0|||
130659835|NCT01787188|470378895|FG001|Overall Study|Other, including patient moved|3|||
130659836|NCT01787188|470378896|FG002|Overall Study|Other, including patient moved|0|||
130659837|NCT05349188|470378899|FG000|Overall Study|Withdrawal by Subject|1|||
130659838|NCT05349188|470378900|FG001|Overall Study|Withdrawal by Subject|0|||
130659839|NCT02756078|470378901|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
130659840|NCT02756078|470378902|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
130659841|NCT02756078|470378901|FG000|Period 1|Lost to Follow-up|0|||
130659842|NCT02756078|470378902|FG001|Period 1|Lost to Follow-up|2|||
130659843|NCT02756078|470378901|FG000|Period 1|Protocol Violation|0|||
130659844|NCT02756078|470378902|FG001|Period 1|Protocol Violation|1|||
130659845|NCT02756078|470378901|FG000|Period 1|Adverse Event|1|||
130659846|NCT02756078|470378902|FG001|Period 1|Adverse Event|10|||
130659847|NCT02756078|470378901|FG000|Period 1|Withdrawal by Subject|6|||
130330147|NCT02000115|469177016|FG002|Overall Study|Still on Study|0|||
130330148|NCT02000115|469177017|FG003|Overall Study|Still on Study|53|||
130659848|NCT02756078|470378902|FG001|Period 1|Withdrawal by Subject|6|||
130659849|NCT02756078|470378901|FG000|Period 1|Lens Discomfort|2|||
130659850|NCT02756078|470378902|FG001|Period 1|Lens Discomfort|2|||
130659851|NCT02756078|470378901|FG000|Period 2|Adverse Event|3|||
130659852|NCT02756078|470378902|FG001|Period 2|Adverse Event|5|||
130330149|NCT05006573|469177018|FG000|Double-blind Treatment Period|Physician Decision|2|||
130330150|NCT05006573|469177019|FG001|Double-blind Treatment Period|Physician Decision|0|||
130330151|NCT05006573|469177018|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
130659853|NCT02756078|470378901|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
130330152|NCT05006573|469177019|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
130330153|NCT05006573|469177018|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130659854|NCT02756078|470378902|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
130659855|NCT02756078|470378901|FG000|Period 2|Withdrawal by Subject|3|||
130659856|NCT02756078|470378902|FG001|Period 2|Withdrawal by Subject|1|||
130659857|NCT00835068|470378905|FG000|Overall Study|Death|1|||
130659858|NCT00835068|470378906|FG001|Overall Study|Death|0|||
130659859|NCT00835068|470378905|FG000|Overall Study|Adverse Event|0|||
130659860|NCT00835068|470378906|FG001|Overall Study|Adverse Event|1|||
130659861|NCT00835068|470378905|FG000|Overall Study|Other|8|||
130659862|NCT00835068|470378906|FG001|Overall Study|Other|0|||
130659863|NCT00835068|470378905|FG000|Overall Study|Withdrawal by Subject|1|||
130659864|NCT00835068|470378906|FG001|Overall Study|Withdrawal by Subject|0|||
130659865|NCT02575807|470378907|FG000|Overall Study|Death|8|||
130659866|NCT02575807|470378908|FG001|Overall Study|Death|3|||
130659867|NCT02575807|470378909|FG002|Overall Study|Death|7|||
130659868|NCT02575807|470378910|FG003|Overall Study|Death|0|||
130659869|NCT02575807|470378911|FG004|Overall Study|Death|1|||
130659870|NCT02575807|470378907|FG000|Overall Study|Study terminated by Sponsor|0|||
130659871|NCT02575807|470378908|FG001|Overall Study|Study terminated by Sponsor|1|||
130659872|NCT02575807|470378909|FG002|Overall Study|Study terminated by Sponsor|7|||
130659873|NCT02575807|470378910|FG003|Overall Study|Study terminated by Sponsor|0|||
130659874|NCT02575807|470378911|FG004|Overall Study|Study terminated by Sponsor|1|||
130659875|NCT02575807|470378907|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
130659876|NCT02575807|470378908|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
130659877|NCT02575807|470378909|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
130659878|NCT02575807|470378910|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
130659879|NCT02575807|470378911|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
130659880|NCT02575807|470378907|FG000|Overall Study|Terminated due to physician decision|0|||
130659881|NCT02575807|470378908|FG001|Overall Study|Terminated due to physician decision|0|||
130659882|NCT02575807|470378909|FG002|Overall Study|Terminated due to physician decision|1|||
130659883|NCT02575807|470378910|FG003|Overall Study|Terminated due to physician decision|0|||
130659884|NCT02575807|470378911|FG004|Overall Study|Terminated due to physician decision|0|||
130659885|NCT02575807|470378907|FG000|Overall Study|Subject ineligible - medical implant|0|||
130659886|NCT02575807|470378908|FG001|Overall Study|Subject ineligible - medical implant|0|||
130659887|NCT02575807|470378909|FG002|Overall Study|Subject ineligible - medical implant|0|||
130659888|NCT02575807|470378910|FG003|Overall Study|Subject ineligible - medical implant|1|||
130330154|NCT05006573|469177019|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130330155|NCT05006573|469177018|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130330156|NCT05006573|469177019|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130330157|NCT05006573|469177018|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
130330158|NCT05006573|469177019|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
130330159|NCT05006573|469177018|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
130330160|NCT05006573|469177019|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
130330161|NCT03493464|469177024|FG000|Overall Study|Surgery not performed|1|||
130330162|NCT05462756|469178379|FG000|Treatment Period|Adverse Event|3|||
130330163|NCT05462756|469178380|FG001|Treatment Period|Adverse Event|0|||
130330164|NCT05462756|469178379|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
130330165|NCT05462756|469178380|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
130330166|NCT05462756|469178379|FG000|Treatment Period|Death|0|||
130330167|NCT05462756|469178380|FG001|Treatment Period|Death|1|||
130330168|NCT05462756|469178379|FG000|Treatment Period|Lost to Follow-up|2|||
130330169|NCT05462756|469178380|FG001|Treatment Period|Lost to Follow-up|1|||
130330170|NCT05462756|469178379|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
130330171|NCT05462756|469178380|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
130330172|NCT05462756|469178379|FG000|Treatment Period|Physician Decision|2|||
130330173|NCT05462756|469178380|FG001|Treatment Period|Physician Decision|0|||
130330174|NCT05462756|469178379|FG000|Treatment Period|Protocol Violation|0|||
130330175|NCT05462756|469178380|FG001|Treatment Period|Protocol Violation|1|||
130330176|NCT05462756|469178379|FG000|Treatment Period|Withdrawal by Subject|5|||
130330177|NCT05462756|469178380|FG001|Treatment Period|Withdrawal by Subject|12|||
130330178|NCT05462756|469178379|FG000|Follow-Up Period|Adverse Event|1|||
130330179|NCT05462756|469178380|FG001|Follow-Up Period|Adverse Event|0|||
130330180|NCT05462756|469178379|FG000|Follow-Up Period|Death|1|||
130330181|NCT05462756|469178380|FG001|Follow-Up Period|Death|0|||
130330182|NCT05462756|469178379|FG000|Follow-Up Period|Lost to Follow-up|3|||
130330183|NCT05462756|469178380|FG001|Follow-Up Period|Lost to Follow-up|1|||
130330184|NCT05462756|469178379|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130330185|NCT05462756|469178380|FG001|Follow-Up Period|Withdrawal by Subject|4|||
130330186|NCT00990704|469178381|FG000|Overall Study|Adverse Event|1|||
130330187|NCT00990704|469178382|FG001|Overall Study|Adverse Event|1|||
130330188|NCT00990704|469178381|FG000|Overall Study|Physician Decision|0|||
130330189|NCT00990704|469178382|FG001|Overall Study|Physician Decision|1|||
130330190|NCT04040933|469178383|FG000|Overall Study|Protocol Violation|1|||
130330191|NCT04040933|469178383|FG000|Overall Study|Withdrawal by Subject|2|||
130330192|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
130330193|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130330194|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130330195|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
130330196|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
130659889|NCT02575807|470378911|FG004|Overall Study|Subject ineligible - medical implant|0|||
130659890|NCT02575807|470378907|FG000|Overall Study|Withdrawal by Subject|0|||
130659891|NCT02575807|470378908|FG001|Overall Study|Withdrawal by Subject|0|||
130659892|NCT02575807|470378909|FG002|Overall Study|Withdrawal by Subject|1|||
130330197|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
130330198|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
130330199|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130330200|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130330201|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
130330202|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130330203|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130330204|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
130330205|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130330206|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130330207|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
130330208|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130330209|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130330210|NCT01235741|469178387|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
130330211|NCT01235741|469178388|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
130330212|NCT01235741|469178389|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
130330213|NCT01235741|469178387|FG000|Randomized to Treatment|Adverse Event|0|||
130330214|NCT01235741|469178388|FG001|Randomized to Treatment|Adverse Event|1|||
130330215|NCT01235741|469178389|FG002|Randomized to Treatment|Adverse Event|1|||
130330216|NCT01235741|469178387|FG000|Randomized to Treatment|Sponsor terminated study|0|||
130330217|NCT01235741|469178388|FG001|Randomized to Treatment|Sponsor terminated study|35|||
130330218|NCT01235741|469178389|FG002|Randomized to Treatment|Sponsor terminated study|34|||
130330219|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
130330220|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
130330221|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
130330222|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
130330223|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
130330224|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
130330225|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
130330226|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
130330227|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
130330228|NCT00904033|469178394|FG000|Overall Study|Withdrawal by Subject|1|||
130330229|NCT00904033|469178395|FG001|Overall Study|Withdrawal by Subject|1|||
130330230|NCT00904033|469178396|FG002|Overall Study|Withdrawal by Subject|0|||
130330231|NCT00904033|469178397|FG003|Overall Study|Withdrawal by Subject|0|||
130330232|NCT00904033|469178394|FG000|Overall Study|Physician Decision|0|||
130330233|NCT00904033|469178395|FG001|Overall Study|Physician Decision|0|||
130330234|NCT00904033|469178396|FG002|Overall Study|Physician Decision|1|||
130330235|NCT00904033|469178397|FG003|Overall Study|Physician Decision|0|||
130330236|NCT00904033|469178394|FG000|Overall Study|Unable to obtain final blood draw|0|||
130330237|NCT00904033|469178395|FG001|Overall Study|Unable to obtain final blood draw|0|||
130330238|NCT00904033|469178396|FG002|Overall Study|Unable to obtain final blood draw|0|||
130330239|NCT00904033|469178397|FG003|Overall Study|Unable to obtain final blood draw|2|||
130330240|NCT01177397|469178398|FG000|Overall Study|Protocol Violation|0|||
130330241|NCT01177397|469178399|FG001|Overall Study|Protocol Violation|0|||
130330242|NCT01177397|469178400|FG002|Overall Study|Protocol Violation|0|||
130330243|NCT01177397|469178401|FG003|Overall Study|Protocol Violation|0|||
130330244|NCT01177397|469178402|FG004|Overall Study|Protocol Violation|0|||
130659893|NCT02575807|470378910|FG003|Overall Study|Withdrawal by Subject|1|||
130659894|NCT02575807|470378911|FG004|Overall Study|Withdrawal by Subject|2|||
130659895|NCT02180659|470378912|FG000|Overall Study|Adverse Event|1|||
130659896|NCT02180659|470378913|FG001|Overall Study|Adverse Event|0|||
130659897|NCT02180659|470378912|FG000|Overall Study|Lost to Follow-up|4|||
130659898|NCT02180659|470378913|FG001|Overall Study|Lost to Follow-up|2|||
130659899|NCT02180659|470378912|FG000|Overall Study|Subject incarcerated during conduct|1|||
130659900|NCT02180659|470378913|FG001|Overall Study|Subject incarcerated during conduct|0|||
130659901|NCT02180659|470378912|FG000|Overall Study|Withdrawal by Subject|0|||
130659902|NCT02180659|470378913|FG001|Overall Study|Withdrawal by Subject|2|||
130659903|NCT02180659|470378912|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
130659904|NCT02180659|470378913|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
130659905|NCT01495793|470378914|FG000|Overall Study|Lost to Follow-up|1|||
130330245|NCT01177397|469178403|FG005|Overall Study|Protocol Violation|1|||
130330246|NCT01177397|469178404|FG006|Overall Study|Protocol Violation|0|||
130330247|NCT01177397|469178405|FG007|Overall Study|Protocol Violation|0|||
130330248|NCT01177397|469178406|FG008|Overall Study|Protocol Violation|0|||
130330249|NCT01177397|469178407|FG009|Overall Study|Protocol Violation|0|||
130330250|NCT01177397|469178408|FG010|Overall Study|Protocol Violation|0|||
130330251|NCT01177397|469178409|FG011|Overall Study|Protocol Violation|0|||
130659906|NCT01495793|470378914|FG000|Overall Study|Violation of inclusion criteria|1|||
130659907|NCT03014570|470378917|FG000|Overall Study|COVID-19 Restrictions|38|||
130659908|NCT03014570|470378918|FG001|Overall Study|COVID-19 Restrictions|24|||
130330252|NCT01177397|469178398|FG000|Overall Study|Lost to Follow-up|0|||
130330253|NCT01177397|469178399|FG001|Overall Study|Lost to Follow-up|0|||
130330254|NCT01177397|469178400|FG002|Overall Study|Lost to Follow-up|0|||
130330255|NCT01177397|469178401|FG003|Overall Study|Lost to Follow-up|0|||
130330256|NCT01177397|469178402|FG004|Overall Study|Lost to Follow-up|1|||
130330257|NCT01177397|469178403|FG005|Overall Study|Lost to Follow-up|0|||
130330258|NCT01177397|469178404|FG006|Overall Study|Lost to Follow-up|0|||
130330259|NCT01177397|469178405|FG007|Overall Study|Lost to Follow-up|2|||
130330260|NCT01177397|469178406|FG008|Overall Study|Lost to Follow-up|0|||
130330261|NCT01177397|469178407|FG009|Overall Study|Lost to Follow-up|0|||
130330262|NCT01177397|469178408|FG010|Overall Study|Lost to Follow-up|0|||
130330263|NCT01177397|469178409|FG011|Overall Study|Lost to Follow-up|0|||
130330264|NCT01177397|469178398|FG000|Overall Study|Death|0|||
130330265|NCT01177397|469178399|FG001|Overall Study|Death|0|||
130330266|NCT01177397|469178400|FG002|Overall Study|Death|1|||
130330267|NCT01177397|469178401|FG003|Overall Study|Death|1|||
130330268|NCT01177397|469178402|FG004|Overall Study|Death|0|||
130330269|NCT01177397|469178403|FG005|Overall Study|Death|0|||
130330270|NCT01177397|469178404|FG006|Overall Study|Death|0|||
130330271|NCT01177397|469178405|FG007|Overall Study|Death|5|||
130330272|NCT01177397|469178406|FG008|Overall Study|Death|2|||
130330273|NCT01177397|469178407|FG009|Overall Study|Death|1|||
130330274|NCT01177397|469178408|FG010|Overall Study|Death|0|||
130330275|NCT01177397|469178409|FG011|Overall Study|Death|0|||
130330276|NCT01177397|469178398|FG000|Overall Study|Withdrawal by Subject|0|||
130330277|NCT01177397|469178399|FG001|Overall Study|Withdrawal by Subject|0|||
130330278|NCT01177397|469178400|FG002|Overall Study|Withdrawal by Subject|1|||
130330279|NCT01177397|469178401|FG003|Overall Study|Withdrawal by Subject|1|||
130330280|NCT01177397|469178402|FG004|Overall Study|Withdrawal by Subject|1|||
130330281|NCT01177397|469178403|FG005|Overall Study|Withdrawal by Subject|2|||
130330282|NCT01177397|469178404|FG006|Overall Study|Withdrawal by Subject|0|||
130330283|NCT01177397|469178405|FG007|Overall Study|Withdrawal by Subject|5|||
130330284|NCT01177397|469178406|FG008|Overall Study|Withdrawal by Subject|9|||
130330285|NCT01177397|469178407|FG009|Overall Study|Withdrawal by Subject|1|||
130330286|NCT01177397|469178408|FG010|Overall Study|Withdrawal by Subject|1|||
130330287|NCT01177397|469178409|FG011|Overall Study|Withdrawal by Subject|0|||
130330288|NCT01177397|469178398|FG000|Overall Study|Adverse Event|0|||
130330289|NCT01177397|469178399|FG001|Overall Study|Adverse Event|0|||
130330290|NCT01177397|469178400|FG002|Overall Study|Adverse Event|1|||
130659909|NCT03014570|470378917|FG000|Overall Study|Death|70|||
130659910|NCT03014570|470378918|FG001|Overall Study|Death|79|||
130659911|NCT03014570|470378917|FG000|Overall Study|Transfer from facility|11|||
130659912|NCT03014570|470378918|FG001|Overall Study|Transfer from facility|14|||
130659913|NCT03014570|470378917|FG000|Overall Study|Hospitalized|5|||
130659914|NCT03014570|470378918|FG001|Overall Study|Hospitalized|3|||
130330291|NCT01177397|469178401|FG003|Overall Study|Adverse Event|2|||
130330292|NCT01177397|469178402|FG004|Overall Study|Adverse Event|0|||
130330293|NCT01177397|469178403|FG005|Overall Study|Adverse Event|12|||
130330294|NCT01177397|469178404|FG006|Overall Study|Adverse Event|1|||
130330295|NCT01177397|469178405|FG007|Overall Study|Adverse Event|14|||
130330296|NCT01177397|469178406|FG008|Overall Study|Adverse Event|8|||
130330297|NCT01177397|469178407|FG009|Overall Study|Adverse Event|6|||
130330298|NCT01177397|469178408|FG010|Overall Study|Adverse Event|3|||
130330299|NCT01177397|469178409|FG011|Overall Study|Adverse Event|7|||
130330300|NCT01177397|469178398|FG000|Overall Study|Disease progression|1|||
130330301|NCT01177397|469178399|FG001|Overall Study|Disease progression|2|||
130330302|NCT01177397|469178400|FG002|Overall Study|Disease progression|5|||
130330303|NCT01177397|469178401|FG003|Overall Study|Disease progression|5|||
130330304|NCT01177397|469178402|FG004|Overall Study|Disease progression|4|||
130330305|NCT01177397|469178403|FG005|Overall Study|Disease progression|10|||
130330306|NCT01177397|469178404|FG006|Overall Study|Disease progression|10|||
130330307|NCT01177397|469178405|FG007|Overall Study|Disease progression|21|||
130330308|NCT01177397|469178406|FG008|Overall Study|Disease progression|18|||
130330309|NCT01177397|469178407|FG009|Overall Study|Disease progression|12|||
130330310|NCT01177397|469178408|FG010|Overall Study|Disease progression|10|||
130330311|NCT01177397|469178409|FG011|Overall Study|Disease progression|8|||
130330312|NCT01177397|469178398|FG000|Overall Study|Other reasons|0|||
130330313|NCT01177397|469178399|FG001|Overall Study|Other reasons|0|||
130330314|NCT01177397|469178400|FG002|Overall Study|Other reasons|1|||
130330315|NCT01177397|469178401|FG003|Overall Study|Other reasons|0|||
130659915|NCT03014570|470378917|FG000|Overall Study|Transfer within facility|1|||
130659916|NCT03014570|470378918|FG001|Overall Study|Transfer within facility|0|||
130330316|NCT01177397|469178402|FG004|Overall Study|Other reasons|1|||
130330317|NCT01177397|469178403|FG005|Overall Study|Other reasons|1|||
130330318|NCT01177397|469178404|FG006|Overall Study|Other reasons|2|||
130330319|NCT01177397|469178405|FG007|Overall Study|Other reasons|6|||
130659917|NCT03014570|470378917|FG000|Overall Study|Site refusal|0|||
130330320|NCT01177397|469178406|FG008|Overall Study|Other reasons|10|||
130330321|NCT01177397|469178407|FG009|Overall Study|Other reasons|8|||
130330322|NCT01177397|469178408|FG010|Overall Study|Other reasons|0|||
130659918|NCT03014570|470378918|FG001|Overall Study|Site refusal|11|||
130330323|NCT01177397|469178409|FG011|Overall Study|Other reasons|2|||
130330324|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
130330325|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
130659919|NCT00478673|470378919|FG000|30-Days Post-Procedure|Death|2|||
130659920|NCT00478673|470378919|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
130659921|NCT00478673|470378919|FG000|30-Days Post-Procedure|Missed Visit|7|||
130659922|NCT00478673|470378919|FG000|12-Months Post-Procedure|Death|23|||
130659923|NCT00478673|470378919|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
130659924|NCT00478673|470378919|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
130659925|NCT00478673|470378919|FG000|12-Months Post-Procedure|Missed Visit|25|||
130659926|NCT00478673|470378919|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
130659927|NCT03332212|470378920|FG000|Overall Study|Not treated|0|||
130659928|NCT03332212|470378921|FG001|Overall Study|Not treated|1|||
130659929|NCT03332212|470378922|FG002|Overall Study|Not treated|0|||
130659930|NCT03332212|470378923|FG003|Overall Study|Not treated|0|||
130659931|NCT03332212|470378920|FG000|Overall Study|Adverse Event|0|||
130659932|NCT03332212|470378921|FG001|Overall Study|Adverse Event|0|||
130659933|NCT03332212|470378922|FG002|Overall Study|Adverse Event|0|||
130659934|NCT03332212|470378923|FG003|Overall Study|Adverse Event|1|||
130659935|NCT03332212|470378920|FG000|Overall Study|worsening of disease under study|1|||
130659936|NCT03332212|470378921|FG001|Overall Study|worsening of disease under study|1|||
130659937|NCT03332212|470378922|FG002|Overall Study|worsening of disease under study|0|||
130659938|NCT03332212|470378923|FG003|Overall Study|worsening of disease under study|0|||
130659939|NCT02125734|470378927|FG000|Period 2|Adverse Event|0|||
130659940|NCT02125734|470378928|FG001|Period 2|Adverse Event|1|||
130659941|NCT01308762|470378929|FG000|Overall Study|Protocol Violation|0|||
130659942|NCT01308762|470378930|FG001|Overall Study|Protocol Violation|1|||
130659943|NCT01308762|470378931|FG002|Overall Study|Protocol Violation|0|||
130659944|NCT01216319|470378937|FG000|Overall Study|Lost to Follow-up|2|||
130659945|NCT01216319|470378937|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
130659946|NCT00929864|470378941|FG000|Overall Study|Death|1|||
130659947|NCT00929864|470378942|FG001|Overall Study|Death|1|||
130659948|NCT00929864|470378941|FG000|Overall Study|Adverse Event|11|||
130659949|NCT00929864|470378942|FG001|Overall Study|Adverse Event|30|||
130659950|NCT00929864|470378941|FG000|Overall Study|Lack of Efficacy|19|||
130659951|NCT00929864|470378942|FG001|Overall Study|Lack of Efficacy|16|||
130659952|NCT00929864|470378941|FG000|Overall Study|Lost to Follow-up|7|||
130659953|NCT00929864|470378942|FG001|Overall Study|Lost to Follow-up|12|||
130659954|NCT00929864|470378941|FG000|Overall Study|Withdrawal by Subject|20|||
130659955|NCT00929864|470378942|FG001|Overall Study|Withdrawal by Subject|9|||
130659956|NCT00929864|470378941|FG000|Overall Study|No longer met criteria|2|||
130659957|NCT00929864|470378942|FG001|Overall Study|No longer met criteria|1|||
130659958|NCT00929864|470378941|FG000|Overall Study|Poor or non-compliance|3|||
130659959|NCT00929864|470378942|FG001|Overall Study|Poor or non-compliance|3|||
130659960|NCT00929864|470378941|FG000|Overall Study|Pregnancy|0|||
130659961|NCT00929864|470378942|FG001|Overall Study|Pregnancy|3|||
130659962|NCT00929864|470378941|FG000|Overall Study|Administrative reason by Sponsor|1|||
130659963|NCT00929864|470378942|FG001|Overall Study|Administrative reason by Sponsor|1|||
130659964|NCT00929864|470378941|FG000|Overall Study|Non-specified|2|||
130659965|NCT00929864|470378942|FG001|Overall Study|Non-specified|7|||
130659966|NCT02304302|470378945|FG000|Overall Study|Adverse Event|2|||
130659967|NCT02304302|470378946|FG001|Overall Study|Adverse Event|3|||
130659968|NCT02304302|470378945|FG000|Overall Study|Lost to Follow-up|1|||
130659969|NCT02304302|470378946|FG001|Overall Study|Lost to Follow-up|4|||
130659970|NCT02304302|470378945|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
130659971|NCT02304302|470378946|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
130330326|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
130330327|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
130330328|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
130330329|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
130330330|NCT00118417|469178410|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130330331|NCT00118417|469178411|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130330332|NCT00118417|469178410|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
130659972|NCT00391118|470378947|FG000|Overall Study|Adverse Event|3|||
130659973|NCT00391118|470378948|FG001|Overall Study|Adverse Event|10|||
130659974|NCT00391118|470378949|FG002|Overall Study|Adverse Event|7|||
130659975|NCT00391118|470378947|FG000|Overall Study|Lost to Follow-up|0|||
130659976|NCT00391118|470378948|FG001|Overall Study|Lost to Follow-up|2|||
130659977|NCT00391118|470378949|FG002|Overall Study|Lost to Follow-up|3|||
130659978|NCT00391118|470378947|FG000|Overall Study|Withdrawal by Subject|0|||
130659979|NCT00391118|470378948|FG001|Overall Study|Withdrawal by Subject|9|||
130659980|NCT00391118|470378949|FG002|Overall Study|Withdrawal by Subject|1|||
130659981|NCT00391118|470378947|FG000|Overall Study|Death|0|||
130659982|NCT00391118|470378948|FG001|Overall Study|Death|1|||
130330333|NCT00118417|469178411|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
130659983|NCT00391118|470378949|FG002|Overall Study|Death|0|||
130659984|NCT00391118|470378947|FG000|Overall Study|Physician Decision|0|||
130659985|NCT00391118|470378948|FG001|Overall Study|Physician Decision|3|||
130330334|NCT01383356|469178412|FG000|Period 1|Adverse Event|5|||
130330335|NCT01383356|469178413|FG001|Period 1|Adverse Event|3|||
130330336|NCT01383356|469178412|FG000|Period 1|Non-compliance|3|||
130330337|NCT01383356|469178413|FG001|Period 1|Non-compliance|0|||
130330338|NCT01383356|469178412|FG000|Period 1|Out of Range Mid-study-Test|0|||
130330339|NCT01383356|469178413|FG001|Period 1|Out of Range Mid-study-Test|1|||
130330340|NCT01383356|469178412|FG000|Period 1|Personal|0|||
130330341|NCT01383356|469178413|FG001|Period 1|Personal|2|||
130330342|NCT00998296|469178414|FG000|Overall Study|Progressive disease|0|||
130330343|NCT00998296|469178415|FG001|Overall Study|Progressive disease|1|||
130330344|NCT00998296|469178416|FG002|Overall Study|Progressive disease|0|||
130330345|NCT00998296|469178417|FG003|Overall Study|Progressive disease|0|||
130330346|NCT00998296|469178418|FG004|Overall Study|Progressive disease|0|||
130330347|NCT00998296|469178419|FG005|Overall Study|Progressive disease|0|||
130330348|NCT00998296|469178420|FG006|Overall Study|Progressive disease|1|||
130330349|NCT00998296|469178421|FG007|Overall Study|Progressive disease|0|||
130330350|NCT00998296|469178422|FG008|Overall Study|Progressive disease|0|||
130330351|NCT00998296|469178423|FG009|Overall Study|Progressive disease|14|||
130330352|NCT00998296|469178424|FG010|Overall Study|Progressive disease|5|||
130330353|NCT00998296|469178414|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330354|NCT00998296|469178415|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330355|NCT00998296|469178416|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330356|NCT00998296|469178417|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330357|NCT00998296|469178418|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
130330358|NCT00998296|469178419|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330359|NCT00998296|469178420|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330360|NCT00998296|469178421|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
130330361|NCT00998296|469178422|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
130330362|NCT00998296|469178423|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330363|NCT00998296|469178424|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330364|NCT00998296|469178414|FG000|Overall Study|Other adverse event|0|||
130330365|NCT00998296|469178415|FG001|Overall Study|Other adverse event|0|||
130330366|NCT00998296|469178416|FG002|Overall Study|Other adverse event|0|||
130330367|NCT00998296|469178417|FG003|Overall Study|Other adverse event|0|||
130330368|NCT00998296|469178418|FG004|Overall Study|Other adverse event|1|||
130330369|NCT00998296|469178419|FG005|Overall Study|Other adverse event|0|||
130330370|NCT00998296|469178420|FG006|Overall Study|Other adverse event|0|||
130330371|NCT00998296|469178421|FG007|Overall Study|Other adverse event|0|||
130330372|NCT00998296|469178422|FG008|Overall Study|Other adverse event|0|||
130330373|NCT00998296|469178423|FG009|Overall Study|Other adverse event|1|||
130330374|NCT00998296|469178424|FG010|Overall Study|Other adverse event|2|||
130330375|NCT00998296|469178414|FG000|Overall Study|Refused to continue taking trial med.|0|||
130330376|NCT00998296|469178415|FG001|Overall Study|Refused to continue taking trial med.|0|||
130330377|NCT00998296|469178416|FG002|Overall Study|Refused to continue taking trial med.|0|||
130330378|NCT00998296|469178417|FG003|Overall Study|Refused to continue taking trial med.|0|||
130330379|NCT00998296|469178418|FG004|Overall Study|Refused to continue taking trial med.|0|||
130330380|NCT00998296|469178419|FG005|Overall Study|Refused to continue taking trial med.|0|||
130330381|NCT00998296|469178420|FG006|Overall Study|Refused to continue taking trial med.|0|||
130330382|NCT00998296|469178421|FG007|Overall Study|Refused to continue taking trial med.|0|||
130330383|NCT00998296|469178422|FG008|Overall Study|Refused to continue taking trial med.|0|||
130330384|NCT00998296|469178423|FG009|Overall Study|Refused to continue taking trial med.|2|||
130330385|NCT00998296|469178424|FG010|Overall Study|Refused to continue taking trial med.|0|||
130330386|NCT00998296|469178414|FG000|Overall Study|Reason other than those specified above|0|||
130330387|NCT00998296|469178415|FG001|Overall Study|Reason other than those specified above|0|||
130330388|NCT00998296|469178416|FG002|Overall Study|Reason other than those specified above|0|||
130330389|NCT00998296|469178417|FG003|Overall Study|Reason other than those specified above|0|||
130330390|NCT00998296|469178418|FG004|Overall Study|Reason other than those specified above|0|||
130330391|NCT00998296|469178419|FG005|Overall Study|Reason other than those specified above|0|||
130330392|NCT00998296|469178420|FG006|Overall Study|Reason other than those specified above|0|||
130330393|NCT00998296|469178421|FG007|Overall Study|Reason other than those specified above|0|||
130330394|NCT00998296|469178422|FG008|Overall Study|Reason other than those specified above|0|||
130330395|NCT00998296|469178423|FG009|Overall Study|Reason other than those specified above|1|||
130330396|NCT00998296|469178424|FG010|Overall Study|Reason other than those specified above|0|||
130330397|NCT01544335|469178427|FG000|Overall Study|Lost to Follow-up|27|||
130330398|NCT01544335|469178427|FG000|Overall Study|Death|4|||
130330399|NCT01544335|469178427|FG000|Overall Study|Disease progression|3|||
130330400|NCT01544335|469178427|FG000|Overall Study|Baseline Measurements not Available|19|||
130552133|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
130552134|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
130552135|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
130552136|NCT03548987|469990124|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
130552137|NCT03548987|469990125|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
130552138|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
130330401|NCT03219528|469178428|FG000|Overall Study|Lost to Follow-up|5|||
130330402|NCT03219528|469178429|FG001|Overall Study|Lost to Follow-up|4|||
130330403|NCT03219528|469178428|FG000|Overall Study|Withdrawal by Subject|4|||
130330404|NCT03219528|469178429|FG001|Overall Study|Withdrawal by Subject|4|||
130330405|NCT02120898|469178432|FG000|Overall Study|Withdrawal by Subject|4|||
130330406|NCT02120898|469178433|FG001|Overall Study|Withdrawal by Subject|2|||
130330407|NCT02120898|469178434|FG002|Overall Study|Withdrawal by Subject|2|||
130330408|NCT02120898|469178432|FG000|Overall Study|Non-compliance with study drug|3|||
130330409|NCT02120898|469178433|FG001|Overall Study|Non-compliance with study drug|0|||
130330410|NCT02120898|469178434|FG002|Overall Study|Non-compliance with study drug|0|||
130330411|NCT02120898|469178432|FG000|Overall Study|Adverse Event|1|||
130330412|NCT02120898|469178433|FG001|Overall Study|Adverse Event|2|||
130330413|NCT02120898|469178434|FG002|Overall Study|Adverse Event|1|||
130330414|NCT02120898|469178432|FG000|Overall Study|Protocol Violation|1|||
130330415|NCT02120898|469178433|FG001|Overall Study|Protocol Violation|2|||
130330416|NCT02120898|469178434|FG002|Overall Study|Protocol Violation|0|||
130330417|NCT02120898|469178432|FG000|Overall Study|Lost to Follow-up|0|||
130330418|NCT02120898|469178433|FG001|Overall Study|Lost to Follow-up|0|||
130330419|NCT02120898|469178434|FG002|Overall Study|Lost to Follow-up|1|||
130330420|NCT04085289|469178435|FG000|Overall Study|Withdrawal by Subject|0|||
130330421|NCT04085289|469178436|FG001|Overall Study|Withdrawal by Subject|0|||
130330422|NCT04085289|469178437|FG002|Overall Study|Withdrawal by Subject|1|||
130330423|NCT02919995|469178440|FG000|Overall Study|Adverse Event|0|||
130330424|NCT02919995|469178441|FG001|Overall Study|Adverse Event|0|||
130330425|NCT02919995|469178442|FG002|Overall Study|Adverse Event|0|||
130330426|NCT02919995|469178443|FG003|Overall Study|Adverse Event|0|||
130330427|NCT02919995|469178444|FG004|Overall Study|Adverse Event|0|||
130330428|NCT02919995|469178445|FG005|Overall Study|Adverse Event|1|||
130330429|NCT02560558|469178447|FG000|Overall Study|Adverse Event|1|||
130330430|NCT02560558|469178448|FG001|Overall Study|Adverse Event|0|||
130330431|NCT02560558|469178447|FG000|Overall Study|Death|0|||
130330432|NCT02560558|469178448|FG001|Overall Study|Death|2|||
130330433|NCT02560558|469178447|FG000|Overall Study|Lost to Follow-up|0|||
130330434|NCT02560558|469178448|FG001|Overall Study|Lost to Follow-up|4|||
130330435|NCT02560558|469178447|FG000|Overall Study|Protocol Violation|3|||
130330436|NCT02560558|469178448|FG001|Overall Study|Protocol Violation|0|||
130330437|NCT02560558|469178447|FG000|Overall Study|Withdrawal by Subject|3|||
130330438|NCT02560558|469178448|FG001|Overall Study|Withdrawal by Subject|0|||
130330439|NCT02454517|469178455|FG000|Overall Study|Withdrawal by Subject|3|||
130659986|NCT00391118|470378949|FG002|Overall Study|Physician Decision|0|||
130659987|NCT00391118|470378947|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
130659988|NCT00391118|470378948|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
130659989|NCT00391118|470378949|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
130659990|NCT00391118|470378947|FG000|Overall Study|Progressive Disease|7|||
130659991|NCT00391118|470378948|FG001|Overall Study|Progressive Disease|26|||
130659992|NCT00391118|470378949|FG002|Overall Study|Progressive Disease|43|||
130659993|NCT00391118|470378947|FG000|Overall Study|Sponsor Decision|0|||
130659994|NCT00391118|470378948|FG001|Overall Study|Sponsor Decision|1|||
130659995|NCT00391118|470378949|FG002|Overall Study|Sponsor Decision|3|||
130659996|NCT00391118|470378947|FG000|Overall Study|Protocol Violation|1|||
130330440|NCT02454517|469178456|FG001|Overall Study|Withdrawal by Subject|0|||
130330441|NCT02454517|469178455|FG000|Overall Study|Lost to Follow-up|4|||
130330442|NCT02454517|469178456|FG001|Overall Study|Lost to Follow-up|7|||
130330443|NCT02454517|469178455|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
130330444|NCT02454517|469178456|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
130330445|NCT00473382|469178457|FG000|Core Study|Adverse Event|3|||
130330446|NCT00473382|469178458|FG001|Core Study|Adverse Event|1|||
130330447|NCT00473382|469178459|FG002|Core Study|Adverse Event|1|||
130659997|NCT00391118|470378948|FG001|Overall Study|Protocol Violation|0|||
130659998|NCT00391118|470378949|FG002|Overall Study|Protocol Violation|0|||
130659999|NCT05473247|470378950|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
130660000|NCT02392559|470378951|FG000|Overall Study|Withdrawal by Subject|0|||
130660001|NCT02392559|470378952|FG001|Overall Study|Withdrawal by Subject|1|||
130330448|NCT00473382|469178457|FG000|Core Study|Death|3|||
130330449|NCT00473382|469178458|FG001|Core Study|Death|5|||
130330450|NCT00473382|469178459|FG002|Core Study|Death|10|||
130330451|NCT00473382|469178457|FG000|Core Study|Lost to Follow-up|3|||
130330452|NCT00473382|469178458|FG001|Core Study|Lost to Follow-up|3|||
130330453|NCT00473382|469178459|FG002|Core Study|Lost to Follow-up|3|||
130330454|NCT00473382|469178457|FG000|Core Study|Physician Decision|1|||
130330455|NCT00473382|469178458|FG001|Core Study|Physician Decision|2|||
130330456|NCT00473382|469178459|FG002|Core Study|Physician Decision|2|||
130330457|NCT00473382|469178457|FG000|Core Study|Subject non-compliance|5|||
130330458|NCT00473382|469178458|FG001|Core Study|Subject non-compliance|2|||
130330459|NCT00473382|469178459|FG002|Core Study|Subject non-compliance|1|||
130330460|NCT00473382|469178457|FG000|Core Study|Subject needed other treatment|1|||
130330461|NCT00473382|469178458|FG001|Core Study|Subject needed other treatment|3|||
130330462|NCT00473382|469178459|FG002|Core Study|Subject needed other treatment|2|||
130330463|NCT00473382|469178457|FG000|Core Study|Subject's decision|12|||
130330464|NCT00473382|469178458|FG001|Core Study|Subject's decision|11|||
130330465|NCT00473382|469178459|FG002|Core Study|Subject's decision|10|||
130330466|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130330467|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130330468|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
130330469|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Death|1|||
130330470|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Death|3|||
130330471|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Death|3|||
130330472|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130330473|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130330474|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130330475|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
130330476|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
130330477|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
130330478|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
130330479|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
130330480|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
130330481|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
130330482|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
130330483|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
130330484|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130330485|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130330486|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130330487|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Death|1|||
130330488|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Death|7|||
130330489|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Death|4|||
130330490|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130330491|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130330492|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130330493|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
130330494|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
130330495|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
130330496|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
130330497|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
130330498|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
130330499|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
130330500|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
130330501|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
130330502|NCT01134055|469178460|FG000|Overall Study|Adverse Event|5|||
130330503|NCT01134055|469178461|FG001|Overall Study|Adverse Event|2|||
130330504|NCT01134055|469178462|FG002|Overall Study|Adverse Event|2|||
130330505|NCT01134055|469178463|FG003|Overall Study|Adverse Event|2|||
130330506|NCT01134055|469178464|FG004|Overall Study|Adverse Event|5|||
130330507|NCT01134055|469178465|FG005|Overall Study|Adverse Event|7|||
130330508|NCT01134055|469178466|FG006|Overall Study|Adverse Event|2|||
130330509|NCT01134055|469178460|FG000|Overall Study|Lost to Follow-up|0|||
130330510|NCT01134055|469178461|FG001|Overall Study|Lost to Follow-up|1|||
130330511|NCT01134055|469178462|FG002|Overall Study|Lost to Follow-up|0|||
130330512|NCT01134055|469178463|FG003|Overall Study|Lost to Follow-up|1|||
130330513|NCT01134055|469178464|FG004|Overall Study|Lost to Follow-up|0|||
130330514|NCT01134055|469178465|FG005|Overall Study|Lost to Follow-up|0|||
130330515|NCT01134055|469178466|FG006|Overall Study|Lost to Follow-up|0|||
130330516|NCT01134055|469178460|FG000|Overall Study|Withdrawal by Subject|3|||
130330517|NCT01134055|469178461|FG001|Overall Study|Withdrawal by Subject|3|||
130330518|NCT01134055|469178462|FG002|Overall Study|Withdrawal by Subject|1|||
130330519|NCT01134055|469178463|FG003|Overall Study|Withdrawal by Subject|2|||
130330520|NCT01134055|469178464|FG004|Overall Study|Withdrawal by Subject|0|||
130330521|NCT01134055|469178465|FG005|Overall Study|Withdrawal by Subject|0|||
130330522|NCT01134055|469178466|FG006|Overall Study|Withdrawal by Subject|8|||
130330523|NCT01134055|469178460|FG000|Overall Study|Protocol Violation|0|||
130330524|NCT01134055|469178461|FG001|Overall Study|Protocol Violation|0|||
130330525|NCT01134055|469178462|FG002|Overall Study|Protocol Violation|0|||
130330526|NCT01134055|469178463|FG003|Overall Study|Protocol Violation|1|||
130330527|NCT01134055|469178464|FG004|Overall Study|Protocol Violation|1|||
130330528|NCT01134055|469178465|FG005|Overall Study|Protocol Violation|0|||
130330529|NCT01134055|469178466|FG006|Overall Study|Protocol Violation|0|||
130330530|NCT01134055|469178460|FG000|Overall Study|Physician Decision|0|||
130330531|NCT01134055|469178461|FG001|Overall Study|Physician Decision|0|||
130330532|NCT01134055|469178462|FG002|Overall Study|Physician Decision|0|||
130660002|NCT03078192|470378954|FG000|Overall Study|Withdrawal by Subject|2|||
130660003|NCT03078192|470378955|FG001|Overall Study|Withdrawal by Subject|1|||
130660004|NCT03078192|470378954|FG000|Overall Study|screen failure|0|||
130660005|NCT03078192|470378955|FG001|Overall Study|screen failure|3|||
130660006|NCT02508649|470378958|FG000|Overall Study|Withdrawal by Subject|4|||
130660007|NCT02508649|470378959|FG001|Overall Study|Withdrawal by Subject|6|||
130660008|NCT02508649|470378960|FG002|Overall Study|Withdrawal by Subject|5|||
130660009|NCT02508649|470378961|FG003|Overall Study|Withdrawal by Subject|6|||
130660010|NCT02508649|470378958|FG000|Overall Study|Investigator withdrew the subject|1|||
130660011|NCT02508649|470378959|FG001|Overall Study|Investigator withdrew the subject|2|||
130660012|NCT02508649|470378960|FG002|Overall Study|Investigator withdrew the subject|1|||
130660013|NCT02508649|470378961|FG003|Overall Study|Investigator withdrew the subject|0|||
130660014|NCT02508649|470378958|FG000|Overall Study|Post randomization screening failure|12|||
130660015|NCT02508649|470378959|FG001|Overall Study|Post randomization screening failure|4|||
130660016|NCT02508649|470378960|FG002|Overall Study|Post randomization screening failure|9|||
130660017|NCT02508649|470378961|FG003|Overall Study|Post randomization screening failure|3|||
130660018|NCT02508649|470378958|FG000|Overall Study|Lost to Follow-up|1|||
130660019|NCT02508649|470378959|FG001|Overall Study|Lost to Follow-up|1|||
130660020|NCT02508649|470378960|FG002|Overall Study|Lost to Follow-up|0|||
130660021|NCT02508649|470378961|FG003|Overall Study|Lost to Follow-up|1|||
130660022|NCT03107715|470378962|FG000|Overall Study|did not deliver at the home hospital|4|||
130660023|NCT03107715|470378963|FG001|Overall Study|did not deliver at the home hospital|6|||
130330533|NCT01134055|469178463|FG003|Overall Study|Physician Decision|0|||
130330534|NCT01134055|469178464|FG004|Overall Study|Physician Decision|0|||
130330535|NCT01134055|469178465|FG005|Overall Study|Physician Decision|0|||
130330536|NCT01134055|469178466|FG006|Overall Study|Physician Decision|1|||
130330537|NCT00275509|469178467|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
130330538|NCT00275509|469178468|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
130330539|NCT00594815|469178469|FG000|Overall Study|Never Treated|3|||
130330540|NCT00594815|469178469|FG000|Overall Study|Withdrawal by Subject|2|||
130330541|NCT00594815|469178469|FG000|Overall Study|Toxicity|4|||
130330542|NCT00131248|469178470|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
130330543|NCT00131248|469178471|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
130330544|NCT03023397|469178472|FG000|Run-In|Failed screening allergen challenge|1|||
130330545|NCT03023397|469178473|FG001|Run-In|Failed screening allergen challenge|0|||
130330546|NCT03023397|469178474|FG002|Run-In|Failed screening allergen challenge|0|||
130330547|NCT03023397|469178472|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
130330548|NCT03023397|469178473|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130330549|NCT03023397|469178474|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130330550|NCT01146795|469178478|FG000|Overall Study|Withdrawal by Subject|4|||
130330551|NCT01146795|469178478|FG000|Overall Study|Adverse Event|6|||
130330552|NCT01146795|469178478|FG000|Overall Study|Still in treatment at study closure|10|||
130330553|NCT01599637|469178486|FG000|Overall Study|administrative problems|0|||
130330554|NCT01599637|469178487|FG001|Overall Study|administrative problems|2|||
130330555|NCT01599637|469178488|FG002|Overall Study|administrative problems|0|||
130330556|NCT01599637|469178486|FG000|Overall Study|Adverse Event|1|||
130330557|NCT01599637|469178487|FG001|Overall Study|Adverse Event|0|||
130330558|NCT01599637|469178488|FG002|Overall Study|Adverse Event|0|||
130330559|NCT02721966|469178489|FG000|Overall Study|Protocol Violation|1|||
130330560|NCT02721966|469178490|FG001|Overall Study|Protocol Violation|0|||
130215869|NCT02688764|468753871|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
130215870|NCT02688764|468753870|FG000|Overall Study|Non-compl./Withd. subject|0|||
130215871|NCT02688764|468753871|FG001|Overall Study|Non-compl./Withd. subject|2|||
130215872|NCT02688764|468753870|FG000|Overall Study|Phosphorus level outside safe range|0|||
130215873|NCT02688764|468753871|FG001|Overall Study|Phosphorus level outside safe range|1|||
130215874|NCT02688764|468753870|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
130215875|NCT02688764|468753871|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
130330561|NCT02721966|469178491|FG002|Overall Study|Protocol Violation|0|||
130330562|NCT02721966|469178492|FG003|Overall Study|Protocol Violation|0|||
130330563|NCT02721966|469178493|FG004|Overall Study|Protocol Violation|0|||
130330564|NCT02721966|469178489|FG000|Overall Study|Withdrawal by Subject|9|||
130330565|NCT02721966|469178490|FG001|Overall Study|Withdrawal by Subject|2|||
130330566|NCT02721966|469178491|FG002|Overall Study|Withdrawal by Subject|3|||
130330567|NCT02721966|469178492|FG003|Overall Study|Withdrawal by Subject|7|||
130330568|NCT02721966|469178493|FG004|Overall Study|Withdrawal by Subject|0|||
130660024|NCT03107715|470378962|FG000|Overall Study|infant stillborn|0|||
130215876|NCT02688764|468753870|FG000|Overall Study|Study drug taste/Withd. parent|1|||
130660025|NCT03107715|470378963|FG001|Overall Study|infant stillborn|1|||
130660026|NCT03594175|470378971|FG000|Overall Study|Not treated|8|||
130660027|NCT03594175|470378972|FG001|Overall Study|Not treated|1|||
130660028|NCT03594175|470378973|FG002|Overall Study|Not treated|5|||
130330569|NCT02721966|469178489|FG000|Overall Study|Adverse Event|4|||
130330570|NCT02721966|469178490|FG001|Overall Study|Adverse Event|4|||
130660029|NCT03594175|470378971|FG000|Overall Study|Adverse Event|3|||
130660030|NCT03594175|470378972|FG001|Overall Study|Adverse Event|0|||
130330571|NCT02721966|469178491|FG002|Overall Study|Adverse Event|3|||
130330572|NCT02721966|469178492|FG003|Overall Study|Adverse Event|0|||
130660031|NCT03594175|470378973|FG002|Overall Study|Adverse Event|0|||
130660032|NCT03594175|470378971|FG000|Overall Study|Withdrawal by Subject|3|||
130660033|NCT03594175|470378972|FG001|Overall Study|Withdrawal by Subject|0|||
130330573|NCT02721966|469178493|FG004|Overall Study|Adverse Event|0|||
130330574|NCT02721966|469178489|FG000|Overall Study|Death|1|||
130330575|NCT02721966|469178490|FG001|Overall Study|Death|0|||
130330576|NCT02721966|469178491|FG002|Overall Study|Death|0|||
130660034|NCT03594175|470378973|FG002|Overall Study|Withdrawal by Subject|0|||
130660035|NCT03594175|470378971|FG000|Overall Study|Protocol Violation|2|||
130660036|NCT03594175|470378972|FG001|Overall Study|Protocol Violation|2|||
130660037|NCT03594175|470378973|FG002|Overall Study|Protocol Violation|2|||
130660038|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660039|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660040|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130330577|NCT02721966|469178492|FG003|Overall Study|Death|0|||
130330578|NCT02721966|469178493|FG004|Overall Study|Death|0|||
130330579|NCT02721966|469178489|FG000|Overall Study|Lack of Efficacy|7|||
130330580|NCT02721966|469178490|FG001|Overall Study|Lack of Efficacy|4|||
130330581|NCT02721966|469178491|FG002|Overall Study|Lack of Efficacy|0|||
130330582|NCT02721966|469178492|FG003|Overall Study|Lack of Efficacy|0|||
130330583|NCT02721966|469178493|FG004|Overall Study|Lack of Efficacy|0|||
130330584|NCT02721966|469178489|FG000|Overall Study|Lost to Follow-up|0|||
130660041|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130660042|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130660043|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660044|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660045|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660046|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130330585|NCT02721966|469178490|FG001|Overall Study|Lost to Follow-up|0|||
130330586|NCT02721966|469178491|FG002|Overall Study|Lost to Follow-up|3|||
130330587|NCT02721966|469178492|FG003|Overall Study|Lost to Follow-up|0|||
130330588|NCT02721966|469178493|FG004|Overall Study|Lost to Follow-up|0|||
130330589|NCT02721966|469178489|FG000|Overall Study|Physician Decision|1|||
130330590|NCT02721966|469178490|FG001|Overall Study|Physician Decision|1|||
130330591|NCT02721966|469178491|FG002|Overall Study|Physician Decision|0|||
130330592|NCT02721966|469178492|FG003|Overall Study|Physician Decision|0|||
130330593|NCT02721966|469178493|FG004|Overall Study|Physician Decision|0|||
130330594|NCT02721966|469178489|FG000|Overall Study|Pregnancy|1|||
130330595|NCT02721966|469178490|FG001|Overall Study|Pregnancy|0|||
130330596|NCT02721966|469178491|FG002|Overall Study|Pregnancy|0|||
130330597|NCT02721966|469178492|FG003|Overall Study|Pregnancy|0|||
130330598|NCT02721966|469178493|FG004|Overall Study|Pregnancy|0|||
130330599|NCT02721966|469178489|FG000|Overall Study|Did not continue to period 2|5|||
130330600|NCT02721966|469178490|FG001|Overall Study|Did not continue to period 2|12|||
130330601|NCT02721966|469178491|FG002|Overall Study|Did not continue to period 2|0|||
130330602|NCT02721966|469178492|FG003|Overall Study|Did not continue to period 2|0|||
130330603|NCT02721966|469178493|FG004|Overall Study|Did not continue to period 2|5|||
130330604|NCT03857867|469178494|FG000|Overall Study|Physician Decision|1|||
130330605|NCT02157883|469178495|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
130330606|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
130330607|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
130330608|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
130330609|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
130330610|NCT01106248|469178497|FG000|Overall Study|Adverse Event|1|||
130330611|NCT01106248|469178497|FG000|Overall Study|Administrative|2|||
130660047|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130660048|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660049|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660050|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130660051|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
130660052|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130330612|NCT00357903|469178498|FG000|Overall Study|Adverse Event|87|||
130330613|NCT00357903|469178499|FG001|Overall Study|Adverse Event|4|||
130330614|NCT00357903|469178498|FG000|Overall Study|Death|33|||
130330615|NCT00357903|469178499|FG001|Overall Study|Death|0|||
130330616|NCT00357903|469178498|FG000|Overall Study|Lost to Follow-up|23|||
130330617|NCT00357903|469178499|FG001|Overall Study|Lost to Follow-up|4|||
130330618|NCT00357903|469178498|FG000|Overall Study|Physician Decision|39|||
130330619|NCT00357903|469178499|FG001|Overall Study|Physician Decision|5|||
130330620|NCT00357903|469178498|FG000|Overall Study|Withdrawal by Subject|57|||
130330621|NCT00357903|469178499|FG001|Overall Study|Withdrawal by Subject|7|||
130330622|NCT00357903|469178498|FG000|Overall Study|Completed month 12 only|0|||
130330623|NCT00357903|469178499|FG001|Overall Study|Completed month 12 only|1|||
130330624|NCT00357903|469178498|FG000|Overall Study|Protocol issues|14|||
130330625|NCT00357903|469178499|FG001|Overall Study|Protocol issues|3|||
130330626|NCT00357903|469178498|FG000|Overall Study|Response status|61|||
130330627|NCT00357903|469178499|FG001|Overall Study|Response status|9|||
130330628|NCT00357903|469178498|FG000|Overall Study|Other|49|||
130330629|NCT00357903|469178499|FG001|Overall Study|Other|10|||
130330630|NCT00606593|469178500|FG000|Overall Study|Adverse Event|0|||
130330631|NCT00606593|469178501|FG001|Overall Study|Adverse Event|0|||
130330632|NCT00606593|469178502|FG002|Overall Study|Adverse Event|0|||
130330633|NCT00606593|469178503|FG003|Overall Study|Adverse Event|1|||
130330634|NCT00606593|469178504|FG004|Overall Study|Adverse Event|1|||
130330635|NCT00606593|469178505|FG005|Overall Study|Adverse Event|0|||
130330636|NCT00606593|469178506|FG006|Overall Study|Adverse Event|1|||
130330637|NCT00606593|469178507|FG007|Overall Study|Adverse Event|2|||
130330638|NCT00606593|469178508|FG008|Overall Study|Adverse Event|1|||
130330639|NCT00606593|469178509|FG009|Overall Study|Adverse Event|0|||
130330640|NCT00606593|469178500|FG000|Overall Study|Withdrawal of consent|1|||
130330641|NCT00606593|469178501|FG001|Overall Study|Withdrawal of consent|0|||
130330642|NCT00606593|469178502|FG002|Overall Study|Withdrawal of consent|1|||
130330643|NCT00606593|469178503|FG003|Overall Study|Withdrawal of consent|0|||
130330644|NCT00606593|469178504|FG004|Overall Study|Withdrawal of consent|0|||
130330645|NCT00606593|469178505|FG005|Overall Study|Withdrawal of consent|0|||
130330646|NCT00606593|469178506|FG006|Overall Study|Withdrawal of consent|0|||
130330647|NCT00606593|469178507|FG007|Overall Study|Withdrawal of consent|0|||
130330648|NCT00606593|469178508|FG008|Overall Study|Withdrawal of consent|0|||
130330649|NCT00606593|469178509|FG009|Overall Study|Withdrawal of consent|0|||
130330650|NCT00606593|469178500|FG000|Overall Study|Administrative/Other|0|||
130330651|NCT00606593|469178501|FG001|Overall Study|Administrative/Other|0|||
130330652|NCT00606593|469178502|FG002|Overall Study|Administrative/Other|1|||
130330653|NCT00606593|469178503|FG003|Overall Study|Administrative/Other|0|||
130330654|NCT00606593|469178504|FG004|Overall Study|Administrative/Other|0|||
130330655|NCT00606593|469178505|FG005|Overall Study|Administrative/Other|0|||
130330656|NCT00606593|469178506|FG006|Overall Study|Administrative/Other|0|||
130330657|NCT00606593|469178507|FG007|Overall Study|Administrative/Other|0|||
130330658|NCT00606593|469178508|FG008|Overall Study|Administrative/Other|0|||
130330659|NCT00606593|469178509|FG009|Overall Study|Administrative/Other|0|||
130330660|NCT03181529|469178510|FG000|Overall Study|Withdrawal by Subject|1|||
130330661|NCT03181529|469178511|FG001|Overall Study|Withdrawal by Subject|1|||
130330662|NCT03181529|469178510|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
130330663|NCT03181529|469178511|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
130330664|NCT02374450|469178512|FG000|Overall Study|Protocol Violation|0|||
130330665|NCT02374450|469178513|FG001|Overall Study|Protocol Violation|1|||
130330666|NCT02374450|469178514|FG002|Overall Study|Protocol Violation|0|||
130330667|NCT02374450|469178512|FG000|Overall Study|Withdrawal by Subject|91|||
130330668|NCT02374450|469178513|FG001|Overall Study|Withdrawal by Subject|110|||
130330669|NCT02374450|469178514|FG002|Overall Study|Withdrawal by Subject|4|||
130330670|NCT02374450|469178512|FG000|Overall Study|Lost to Follow-up|168|||
130330671|NCT02374450|469178513|FG001|Overall Study|Lost to Follow-up|194|||
130330672|NCT02374450|469178514|FG002|Overall Study|Lost to Follow-up|138|||
130330673|NCT02374450|469178512|FG000|Overall Study|Death|173|||
130330674|NCT02374450|469178513|FG001|Overall Study|Death|185|||
130330675|NCT02374450|469178514|FG002|Overall Study|Death|81|||
130330676|NCT02374450|469178512|FG000|Overall Study|Migrated from the study area|538|||
130330677|NCT02374450|469178513|FG001|Overall Study|Migrated from the study area|648|||
130330678|NCT02374450|469178514|FG002|Overall Study|Migrated from the study area|181|||
130330679|NCT02374450|469178512|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
130330680|NCT02374450|469178513|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
130330681|NCT02374450|469178514|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
130330682|NCT02374450|469178512|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
130330683|NCT02374450|469178513|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130330684|NCT02374450|469178514|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130330685|NCT02374450|469178512|FG000|Overall Study|Other|0|||
130330686|NCT02374450|469178513|FG001|Overall Study|Other|21|||
130330687|NCT02374450|469178514|FG002|Overall Study|Other|79|||
130330688|NCT01442103|469180122|FG000|Overall Study|Lost to Follow-up|2|||
130330689|NCT02202759|469180123|FG000|Overall Study|Study Terminated by Sponsor|3|||
130330690|NCT02202759|469180124|FG001|Overall Study|Study Terminated by Sponsor|3|||
130330691|NCT02202759|469180125|FG002|Overall Study|Study Terminated by Sponsor|3|||
130330692|NCT02202759|469180123|FG000|Overall Study|Withdrawal by Subject|2|||
130330693|NCT02202759|469180124|FG001|Overall Study|Withdrawal by Subject|1|||
130330694|NCT02202759|469180125|FG002|Overall Study|Withdrawal by Subject|1|||
130330695|NCT02202759|469180123|FG000|Overall Study|Reason not Specified|4|||
130330696|NCT02202759|469180124|FG001|Overall Study|Reason not Specified|11|||
130330697|NCT02202759|469180125|FG002|Overall Study|Reason not Specified|10|||
130330698|NCT01987453|469180126|FG000|Overall Study|Death|0|||
130330699|NCT01987453|469180127|FG001|Overall Study|Death|0|||
130330700|NCT01987453|469180128|FG002|Overall Study|Death|1|||
130330701|NCT01987453|469180126|FG000|Overall Study|Lack of Efficacy|1|||
130330702|NCT01987453|469180127|FG001|Overall Study|Lack of Efficacy|12|||
130330703|NCT01987453|469180128|FG002|Overall Study|Lack of Efficacy|0|||
130330704|NCT01590888|469180130|FG000|Overall Study|Adverse Event|3|||
130330705|NCT01590888|469180131|FG001|Overall Study|Adverse Event|0|||
130330706|NCT01590888|469180132|FG002|Overall Study|Adverse Event|1|||
130330707|NCT01590888|469180130|FG000|Overall Study|Lost to Follow-up|1|||
130330708|NCT01590888|469180131|FG001|Overall Study|Lost to Follow-up|0|||
130330709|NCT01590888|469180132|FG002|Overall Study|Lost to Follow-up|0|||
130330710|NCT04953728|469180133|FG000|Overall Study|Withdrawal by Subject|3|||
130330711|NCT04953728|469180133|FG000|Overall Study|Physician Decision|1|||
130330712|NCT02105662|469180134|FG000|Overall Study|Lost to Follow-up|5|||
130330713|NCT02105662|469180134|FG000|Overall Study|Withdrawal by Subject|1|||
130330714|NCT02331277|469180137|FG000|Overall Study|Withdrawal by Subject|1|||
130330715|NCT02331277|469180138|FG001|Overall Study|Withdrawal by Subject|0|||
130330716|NCT03978117|469180139|FG000|Overall Study|Non-Compliance|26|||
130330717|NCT03978117|469180140|FG001|Overall Study|Non-Compliance|26|||
130330718|NCT03978117|469180139|FG000|Overall Study|Lost to Follow-up|4|||
130330719|NCT03978117|469180140|FG001|Overall Study|Lost to Follow-up|4|||
130330720|NCT01528969|469180147|FG000|Overall Study|absent from the school at baseline|2|||
130330721|NCT01528969|469180148|FG001|Overall Study|absent from the school at baseline|0|||
130330722|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
130330723|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
130330724|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
130330725|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130330726|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130330727|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130330728|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130330729|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130330730|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130330731|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130330732|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130330733|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
130330734|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
130330735|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130330736|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130330737|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130330738|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130330739|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130330740|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130330741|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130330742|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130330743|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130330744|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130660053|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
130660054|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
130660055|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
130660056|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130660057|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660058|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660059|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660060|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660061|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660062|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130660063|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660064|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660065|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660066|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130330745|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130330746|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Other|10|||
130330747|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Other|2|||
130330748|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Other|6|||
130330749|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130215877|NCT02688764|468753871|FG001|Overall Study|Study drug taste/Withd. parent|0|||
130330750|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130330751|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130660067|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660068|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660069|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660070|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130660071|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130660072|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130660073|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130660074|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130660075|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130660076|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130660077|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660078|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660079|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660080|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660081|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130660082|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660083|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660084|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660085|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660086|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660087|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660088|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660089|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660090|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130660091|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660092|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660093|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
130660094|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130660095|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660096|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660097|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660098|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660099|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660100|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660101|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660102|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660103|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660104|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660105|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130660106|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660107|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660108|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130660109|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660110|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660111|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130660112|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130660113|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130660114|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130660115|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130660116|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660117|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130660118|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660119|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660120|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130660121|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660122|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660123|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130330752|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130330753|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130330754|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130660124|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130660125|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660126|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130660127|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
130660128|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
130660129|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130660130|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130660131|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
130660132|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130660133|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660134|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660135|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
130330755|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130330756|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130330757|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130330758|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130330759|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130330760|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
130660136|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660137|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660138|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660139|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660140|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660141|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660142|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130330761|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130330762|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130330763|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130330764|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Other|8|||
130330765|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Other|3|||
130330766|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130330767|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130330768|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130330769|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130330770|NCT04614974|469180157|FG000|Overall Study|Lost to Follow-up|14|||
130330771|NCT04614974|469180158|FG001|Overall Study|Lost to Follow-up|11|||
130330772|NCT01635153|469180159|FG000|Overall Study|Lost to Follow-up|40|||
130330773|NCT01635153|469180160|FG001|Overall Study|Lost to Follow-up|43|||
130330774|NCT01263197|469180172|FG000|First Intervention (Period 1)|Adverse Event|0|||
130330775|NCT01263197|469180173|FG001|First Intervention (Period 1)|Adverse Event|0|||
130330776|NCT01263197|469180174|FG002|First Intervention (Period 1)|Adverse Event|0|||
130330777|NCT01263197|469180175|FG003|First Intervention (Period 1)|Adverse Event|0|||
130330778|NCT01263197|469180176|FG004|First Intervention (Period 1)|Adverse Event|0|||
130330779|NCT01263197|469180177|FG005|First Intervention (Period 1)|Adverse Event|1|||
130330780|NCT01263197|469180172|FG000|Washout Period 1|Protocol Violation|0|||
130330781|NCT01263197|469180173|FG001|Washout Period 1|Protocol Violation|0|||
130330782|NCT01263197|469180174|FG002|Washout Period 1|Protocol Violation|0|||
130330783|NCT01263197|469180175|FG003|Washout Period 1|Protocol Violation|0|||
130330784|NCT01263197|469180176|FG004|Washout Period 1|Protocol Violation|1|||
130330785|NCT01263197|469180177|FG005|Washout Period 1|Protocol Violation|0|||
130330786|NCT01263197|469180172|FG000|Washout Period 2|Physician Decision|0|||
130330787|NCT01263197|469180173|FG001|Washout Period 2|Physician Decision|0|||
130330788|NCT01263197|469180174|FG002|Washout Period 2|Physician Decision|0|||
130330789|NCT01263197|469180175|FG003|Washout Period 2|Physician Decision|0|||
130330790|NCT01263197|469180176|FG004|Washout Period 2|Physician Decision|0|||
130330791|NCT01263197|469180177|FG005|Washout Period 2|Physician Decision|1|||
130330792|NCT01263197|469180172|FG000|Washout Period 2|Protocol Violation|0|||
130330793|NCT01263197|469180173|FG001|Washout Period 2|Protocol Violation|0|||
130330794|NCT01263197|469180174|FG002|Washout Period 2|Protocol Violation|0|||
130330795|NCT01263197|469180175|FG003|Washout Period 2|Protocol Violation|1|||
130330796|NCT01263197|469180176|FG004|Washout Period 2|Protocol Violation|0|||
130330797|NCT01263197|469180177|FG005|Washout Period 2|Protocol Violation|0|||
130330798|NCT01263197|469180172|FG000|Third Intervention (Period 3)|Adverse Event|0|||
130330799|NCT01263197|469180173|FG001|Third Intervention (Period 3)|Adverse Event|1|||
130215878|NCT02688764|468753870|FG000|Overall Study|Subject moving out|2|||
130330800|NCT01263197|469180174|FG002|Third Intervention (Period 3)|Adverse Event|0|||
130330801|NCT01263197|469180175|FG003|Third Intervention (Period 3)|Adverse Event|0|||
130660143|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660144|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660145|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660146|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660147|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660148|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130660149|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
130660150|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
130660151|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130660152|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660153|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660154|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660155|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660156|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
130660157|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660158|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660159|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130330802|NCT01263197|469180176|FG004|Third Intervention (Period 3)|Adverse Event|0|||
130330803|NCT01263197|469180177|FG005|Third Intervention (Period 3)|Adverse Event|0|||
130330804|NCT02892448|469180178|FG000|Overall Study|Screening failure|2|||
130330805|NCT02892448|469180179|FG001|Overall Study|Screening failure|2|||
130330806|NCT02892448|469180180|FG002|Overall Study|Screening failure|1|||
130660160|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660161|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
130660162|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660163|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660164|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660165|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660166|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660167|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660168|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660169|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660170|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130660171|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130660172|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660173|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660174|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660175|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660176|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130660177|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660178|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660179|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660180|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660181|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130660182|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660183|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660184|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
130660185|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130660186|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
130660187|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
130660188|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
130660189|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130660190|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660191|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660192|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660193|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660194|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660195|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660196|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660197|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660198|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660199|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130330807|NCT00499083|469180181|FG000|Overall Study|Not evaluable|3|||
130330808|NCT00686686|469180182|FG000|Overall Study|Non-compliance|1|||
130330809|NCT00686686|469180182|FG000|Overall Study|Adverse Event|2|||
130660200|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
130660201|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130215879|NCT02688764|468753871|FG001|Overall Study|Subject moving out|0|||
130660202|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660203|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660204|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660205|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660206|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660207|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660208|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130660209|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130660210|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130660211|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660212|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660213|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130660214|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130660215|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660216|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130660217|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660218|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130660219|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660220|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660221|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130660222|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130660223|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130660224|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130660225|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130660226|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
130660227|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130660228|NCT01915498|470378974|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
130660229|NCT01915498|470378975|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130660230|NCT01915498|470378976|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130660231|NCT01915498|470378977|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
130660232|NCT01915498|470378978|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
130660233|NCT01915498|470378979|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
130660234|NCT01915498|470378980|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
130660235|NCT01915498|470378981|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
130660236|NCT01915498|470378982|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
130660237|NCT01915498|470378983|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
130660238|NCT01915498|470378984|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130660239|NCT01915498|470378985|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
130660240|NCT01915498|470378986|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130660241|NCT01915498|470378987|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
130660242|NCT01915498|470378988|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
130660243|NCT01915498|470378989|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
130660244|NCT01915498|470378990|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
130660245|NCT01915498|470378991|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
130215880|NCT02688764|468753870|FG000|Overall Study|Subject taken off dialysis|1|||
130215881|NCT02688764|468753871|FG001|Overall Study|Subject taken off dialysis|0|||
130215882|NCT02688764|468753870|FG000|Overall Study|Withdrawal by parent|3|||
130215883|NCT02688764|468753871|FG001|Overall Study|Withdrawal by parent|0|||
130215884|NCT02113007|468753872|FG000|Overall Study|Progressive disease|2|||
130215885|NCT00885378|468753873|FG000|Overall Study|Lack of Efficacy|2|||
130660246|NCT01915498|470378992|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
130660247|NCT01915498|470378974|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660248|NCT01915498|470378975|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660249|NCT01915498|470378976|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660250|NCT01915498|470378977|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660251|NCT01915498|470378978|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660252|NCT01915498|470378979|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660253|NCT01915498|470378980|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660254|NCT01915498|470378981|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660255|NCT01915498|470378982|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660256|NCT01915498|470378983|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130215886|NCT00885378|468753874|FG001|Overall Study|Lack of Efficacy|2|||
130215887|NCT00885378|468753873|FG000|Overall Study|Withdrawal by Subject|1|||
130215888|NCT00885378|468753874|FG001|Overall Study|Withdrawal by Subject|2|||
130215889|NCT00885378|468753873|FG000|Overall Study|Lost to Follow-up|1|||
130215890|NCT00885378|468753874|FG001|Overall Study|Lost to Follow-up|2|||
130660257|NCT01915498|470378984|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660258|NCT01915498|470378985|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660259|NCT01915498|470378986|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660260|NCT01915498|470378987|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660261|NCT01915498|470378988|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660262|NCT01915498|470378989|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660263|NCT01915498|470378990|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660264|NCT01915498|470378991|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130660265|NCT01915498|470378992|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
130660266|NCT01915498|470378974|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660267|NCT01915498|470378975|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660268|NCT01915498|470378976|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660269|NCT01915498|470378977|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660270|NCT01915498|470378978|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660271|NCT01915498|470378979|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660272|NCT01915498|470378980|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660273|NCT01915498|470378981|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660274|NCT01915498|470378982|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660275|NCT01915498|470378983|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660276|NCT01915498|470378984|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660277|NCT01915498|470378985|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660278|NCT01915498|470378986|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660279|NCT01915498|470378987|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660280|NCT01915498|470378988|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660281|NCT01915498|470378989|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660282|NCT01915498|470378990|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660283|NCT01915498|470378991|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130660284|NCT01915498|470378992|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
130660285|NCT01915498|470378974|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660286|NCT01915498|470378975|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660287|NCT01915498|470378976|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660288|NCT01915498|470378977|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660289|NCT01915498|470378978|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660290|NCT01915498|470378979|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660291|NCT01915498|470378980|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660292|NCT01915498|470378981|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660293|NCT01915498|470378982|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660294|NCT01915498|470378983|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660295|NCT01915498|470378984|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660296|NCT01915498|470378985|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660297|NCT01915498|470378986|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660298|NCT01915498|470378987|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660299|NCT01915498|470378988|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660300|NCT01915498|470378989|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660301|NCT01915498|470378990|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660302|NCT01915498|470378991|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130660303|NCT01915498|470378992|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
130660304|NCT01907516|470378993|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
130660305|NCT01907516|470378994|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
130660306|NCT01907516|470378993|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
130660307|NCT01907516|470378994|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
130660308|NCT01907516|470378993|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
130660309|NCT01907516|470378994|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
130660310|NCT01907516|470378993|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
130660311|NCT01907516|470378994|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
130660312|NCT00633217|470378997|FG000|Overall Study|Adverse Event|5|||
130660313|NCT00633217|470378998|FG001|Overall Study|Adverse Event|9|||
130660314|NCT00633217|470378997|FG000|Overall Study|Lack of Efficacy|0|||
130660315|NCT00633217|470378998|FG001|Overall Study|Lack of Efficacy|2|||
130660316|NCT00633217|470378997|FG000|Overall Study|Protocol Violation|3|||
130660317|NCT00633217|470378998|FG001|Overall Study|Protocol Violation|7|||
130660318|NCT00633217|470378997|FG000|Overall Study|Lost to Follow-up|2|||
130660319|NCT00633217|470378998|FG001|Overall Study|Lost to Follow-up|2|||
130660320|NCT00633217|470378997|FG000|Overall Study|Investigator Discretion|2|||
130660321|NCT00633217|470378998|FG001|Overall Study|Investigator Discretion|0|||
130660322|NCT00633217|470378997|FG000|Overall Study|Withdrew Consent|3|||
130660323|NCT00633217|470378998|FG001|Overall Study|Withdrew Consent|3|||
130660324|NCT04881448|470378999|FG000|Overall Study|Study cancelled by sponsor|220|||
130660325|NCT04881448|470378999|FG000|Overall Study|Withdrawal by Subject|2|||
130660326|NCT04881448|470378999|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
130660327|NCT00005879|470379004|FG000|Overall Study|Withdrawal by Subject|8|||
130660328|NCT00005879|470379005|FG001|Overall Study|Withdrawal by Subject|10|||
130660329|NCT00689273|470379006|FG000|Overall Study|Adverse Event|3|||
130660330|NCT00689273|470379007|FG001|Overall Study|Adverse Event|1|||
130660331|NCT00689273|470379006|FG000|Overall Study|Lack of Efficacy|3|||
130660332|NCT00689273|470379007|FG001|Overall Study|Lack of Efficacy|0|||
130660333|NCT00689273|470379006|FG000|Overall Study|Lost to Follow-up|0|||
130660334|NCT00689273|470379007|FG001|Overall Study|Lost to Follow-up|2|||
130660335|NCT00689273|470379006|FG000|Overall Study|Other|6|||
130660336|NCT00689273|470379007|FG001|Overall Study|Other|2|||
130660337|NCT00689273|470379006|FG000|Overall Study|Randomized but not Treated|1|||
130660338|NCT00689273|470379007|FG001|Overall Study|Randomized but not Treated|0|||
130660339|NCT01238172|470379009|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
130660340|NCT01238172|470379010|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
130660341|NCT01238172|470379009|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
130660342|NCT01238172|470379010|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
130660343|NCT05022121|470379013|FG000|Overall Study|Lack of Efficacy|1|||
130660344|NCT05022121|470379014|FG001|Overall Study|Lack of Efficacy|0|||
130660345|NCT05022121|470379013|FG000|Overall Study|Lost to Follow-up|0|||
130660346|NCT05022121|470379014|FG001|Overall Study|Lost to Follow-up|2|||
130660347|NCT02531698|470379016|FG000|Overall Study|Adverse Event|2|||
130660348|NCT02531698|470379017|FG001|Overall Study|Adverse Event|1|||
130660349|NCT02531698|470379016|FG000|Overall Study|Withdrawal by Subject|6|||
130660350|NCT02531698|470379017|FG001|Overall Study|Withdrawal by Subject|1|||
130660351|NCT02531698|470379016|FG000|Overall Study|Protocol Violation|2|||
130660352|NCT02531698|470379017|FG001|Overall Study|Protocol Violation|0|||
130660353|NCT02531698|470379016|FG000|Overall Study|Lost to Follow-up|1|||
130660354|NCT02531698|470379017|FG001|Overall Study|Lost to Follow-up|0|||
130660355|NCT02395536|470379021|FG000|Overall Study|Lost to Follow-up|4|||
130660356|NCT02395536|470379022|FG001|Overall Study|Lost to Follow-up|4|||
130660357|NCT02395536|470379021|FG000|Overall Study|Death|2|||
130660358|NCT02395536|470379022|FG001|Overall Study|Death|0|||
130660359|NCT02395536|470379021|FG000|Overall Study|Physician Decision|4|||
130660360|NCT02395536|470379022|FG001|Overall Study|Physician Decision|6|||
130660361|NCT02395536|470379021|FG000|Overall Study|Withdrawal by Subject|9|||
130433165|NCT02914314|469550368|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
130433166|NCT02914314|469550365|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130433167|NCT02914314|469550366|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130433168|NCT02914314|469550367|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
130433169|NCT02914314|469550368|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130433170|NCT02914314|469550365|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130433171|NCT02914314|469550366|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130660362|NCT02395536|470379022|FG001|Overall Study|Withdrawal by Subject|17|||
130660363|NCT02395536|470379021|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
130660364|NCT02395536|470379022|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
130660365|NCT02395536|470379021|FG000|Overall Study|Insurance issue|0|||
130660366|NCT02395536|470379022|FG001|Overall Study|Insurance issue|1|||
130660367|NCT00891527|470381399|FG000|Overall Study|Withdrawal by Subject|2|||
130660368|NCT01186744|470381400|FG000|Overall Study|Lack of Efficacy|156|||
130660369|NCT01186744|470381401|FG001|Overall Study|Lack of Efficacy|99|||
130660370|NCT01186744|470381402|FG002|Overall Study|Lack of Efficacy|0|||
130660371|NCT01186744|470381403|FG003|Overall Study|Lack of Efficacy|2|||
130660372|NCT01186744|470381404|FG004|Overall Study|Lack of Efficacy|2|||
130660373|NCT01186744|470381405|FG005|Overall Study|Lack of Efficacy|5|||
130660374|NCT01186744|470381400|FG000|Overall Study|Protocol Violation|1|||
130660375|NCT01186744|470381401|FG001|Overall Study|Protocol Violation|2|||
130660376|NCT01186744|470381402|FG002|Overall Study|Protocol Violation|0|||
130660377|NCT01186744|470381403|FG003|Overall Study|Protocol Violation|1|||
130660378|NCT01186744|470381404|FG004|Overall Study|Protocol Violation|1|||
130660379|NCT01186744|470381405|FG005|Overall Study|Protocol Violation|2|||
130660380|NCT01186744|470381400|FG000|Overall Study|Lost to Follow-up|15|||
130660381|NCT01186744|470381401|FG001|Overall Study|Lost to Follow-up|16|||
130660382|NCT01186744|470381402|FG002|Overall Study|Lost to Follow-up|2|||
130660383|NCT01186744|470381403|FG003|Overall Study|Lost to Follow-up|1|||
130660384|NCT01186744|470381404|FG004|Overall Study|Lost to Follow-up|1|||
130330810|NCT00686686|469180182|FG000|Overall Study|Lost to Follow-up|3|||
130660385|NCT01186744|470381405|FG005|Overall Study|Lost to Follow-up|4|||
130660386|NCT01186744|470381400|FG000|Overall Study|Screen failure|1|||
130660387|NCT01186744|470381401|FG001|Overall Study|Screen failure|1|||
130330811|NCT01012440|469180183|FG000|Overall Study|Withdrawal by Subject|2|||
130660388|NCT01186744|470381402|FG002|Overall Study|Screen failure|0|||
130660389|NCT01186744|470381403|FG003|Overall Study|Screen failure|1|||
130660390|NCT01186744|470381404|FG004|Overall Study|Screen failure|0|||
130660391|NCT01186744|470381405|FG005|Overall Study|Screen failure|0|||
130660392|NCT01186744|470381400|FG000|Overall Study|Withdrawal by Subject|14|||
130660393|NCT01186744|470381401|FG001|Overall Study|Withdrawal by Subject|10|||
130660394|NCT01186744|470381402|FG002|Overall Study|Withdrawal by Subject|2|||
130660395|NCT01186744|470381403|FG003|Overall Study|Withdrawal by Subject|5|||
130660396|NCT01186744|470381404|FG004|Overall Study|Withdrawal by Subject|0|||
130660397|NCT01186744|470381405|FG005|Overall Study|Withdrawal by Subject|6|||
130660398|NCT01186744|470381400|FG000|Overall Study|Study terminated by Sponsor|1|||
130660399|NCT01186744|470381401|FG001|Overall Study|Study terminated by Sponsor|0|||
130660400|NCT01186744|470381402|FG002|Overall Study|Study terminated by Sponsor|0|||
130660401|NCT01186744|470381403|FG003|Overall Study|Study terminated by Sponsor|0|||
130660402|NCT01186744|470381404|FG004|Overall Study|Study terminated by Sponsor|0|||
130660403|NCT01186744|470381405|FG005|Overall Study|Study terminated by Sponsor|0|||
130660404|NCT01186744|470381400|FG000|Overall Study|Other|9|||
130660405|NCT01186744|470381401|FG001|Overall Study|Other|10|||
130660406|NCT01186744|470381402|FG002|Overall Study|Other|1|||
130660407|NCT01186744|470381403|FG003|Overall Study|Other|2|||
130660408|NCT01186744|470381404|FG004|Overall Study|Other|1|||
130660409|NCT01186744|470381405|FG005|Overall Study|Other|5|||
130660410|NCT01186744|470381400|FG000|Overall Study|Adverse Event|10|||
130660411|NCT01186744|470381401|FG001|Overall Study|Adverse Event|14|||
130660412|NCT01186744|470381402|FG002|Overall Study|Adverse Event|1|||
130660413|NCT01186744|470381403|FG003|Overall Study|Adverse Event|0|||
130660414|NCT01186744|470381404|FG004|Overall Study|Adverse Event|1|||
130660415|NCT01186744|470381405|FG005|Overall Study|Adverse Event|4|||
130660416|NCT01186744|470381400|FG000|Overall Study|Death|1|||
130660417|NCT01186744|470381401|FG001|Overall Study|Death|0|||
130660418|NCT01186744|470381402|FG002|Overall Study|Death|0|||
130660419|NCT01186744|470381403|FG003|Overall Study|Death|0|||
130660420|NCT01186744|470381404|FG004|Overall Study|Death|0|||
130660421|NCT01186744|470381405|FG005|Overall Study|Death|0|||
130660422|NCT01020773|470381408|FG000|Overall Study|Withdrawal by Subject|4|||
130660423|NCT01020773|470381409|FG001|Overall Study|Withdrawal by Subject|3|||
130660424|NCT01389024|470381410|FG000|Overall Study|Withdrawal by Subject|0|||
130660425|NCT01389024|470381411|FG001|Overall Study|Withdrawal by Subject|1|||
130660426|NCT01389024|470381410|FG000|Overall Study|Lost to Follow-up|1|||
130660427|NCT01389024|470381411|FG001|Overall Study|Lost to Follow-up|0|||
130660428|NCT00545441|470381414|FG000|Overall Study|Fistula draining at 6 months|2|||
130660429|NCT00545441|470381415|FG001|Overall Study|Fistula draining at 6 months|4|||
130660430|NCT00545441|470381414|FG000|Overall Study|Lost to Follow-up|9|||
130660431|NCT00545441|470381415|FG001|Overall Study|Lost to Follow-up|5|||
130660432|NCT00545441|470381414|FG000|Overall Study|Technical failure|0|||
130660433|NCT00545441|470381415|FG001|Overall Study|Technical failure|1|||
130660434|NCT00545441|470381414|FG000|Overall Study|Withdrawal by Subject|1|||
130660435|NCT00545441|470381415|FG001|Overall Study|Withdrawal by Subject|1|||
130660436|NCT00545441|470381414|FG000|Overall Study|Persistence or recurrence of fistula|5|||
130660437|NCT00545441|470381415|FG001|Overall Study|Persistence or recurrence of fistula|2|||
130660438|NCT00545441|470381414|FG000|Overall Study|Patients were not treated|1|||
130660439|NCT00545441|470381415|FG001|Overall Study|Patients were not treated|3|||
130660440|NCT02803138|470381416|FG000|Overall Study|Failure to return|38|||
130660441|NCT02803138|470381416|FG000|Overall Study|Insufficient virological response|2|||
130660442|NCT02803138|470381416|FG000|Overall Study|Withdrawn consent|1|||
130660443|NCT02803138|470381416|FG000|Overall Study|Death|1|||
130660444|NCT02803138|470381416|FG000|Overall Study|Other, not specified|28|||
130660445|NCT04071366|470381417|FG000|Part 1: Open-label (29 Days)|Death|4|||
130660446|NCT04071366|470381418|FG001|Part 1: Open-label (29 Days)|Death|2|||
130660447|NCT04071366|470381419|FG002|Part 1: Open-label (29 Days)|Death|8|||
130660448|NCT04071366|470381420|FG003|Part 1: Open-label (29 Days)|Death|0|||
130660449|NCT04071366|470381421|FG004|Part 1: Open-label (29 Days)|Death|0|||
130660450|NCT04071366|470381417|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130660451|NCT04071366|470381418|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130330812|NCT01254422|469180187|FG000|Overall Study|Protocol Violation|1|||
130330813|NCT01254422|469180188|FG001|Overall Study|Protocol Violation|0|||
130660452|NCT04071366|470381419|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
130660453|NCT04071366|470381420|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130660454|NCT04071366|470381421|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130660455|NCT04071366|470381417|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
130660456|NCT04071366|470381418|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130330814|NCT01254422|469180187|FG000|Overall Study|Adverse Event|1|||
130660457|NCT04071366|470381419|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
130660458|NCT04071366|470381420|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130660459|NCT04071366|470381421|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130660460|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Death|0|||
130660461|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Death|0|||
130660462|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Death|0|||
130330815|NCT01254422|469180188|FG001|Overall Study|Adverse Event|0|||
130660463|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Death|2|||
130660464|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Death|2|||
130660465|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130660466|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130660467|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130660468|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130660469|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
130660470|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
130660471|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
130660472|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
130660473|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
130660474|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
130660475|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130660476|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130660477|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130660478|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
130660479|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
130660480|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130660481|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130660482|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130660483|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130660484|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
130660485|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130660486|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130660487|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130660488|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
130660489|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130660490|NCT04071366|470381417|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130660491|NCT04071366|470381418|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130660492|NCT04071366|470381419|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130660493|NCT04071366|470381420|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
130660494|NCT04071366|470381421|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130660495|NCT00858234|470381422|FG000|Overall Study|Adverse Event|6|||
130660496|NCT00858234|470381422|FG000|Overall Study|Progressive disease|2|||
130660497|NCT00858234|470381422|FG000|Overall Study|Status unknown|1|||
130660498|NCT00640614|470381424|FG000|Overall Study|Lost to Follow-up|1|||
130660499|NCT00640614|470381425|FG001|Overall Study|Lost to Follow-up|0|||
130660500|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
130660501|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
130660502|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
130660503|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Death|1|||
130660504|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
130660505|NCT00529802|470381426|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
130660506|NCT00529802|470381426|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
130660507|NCT02675426|470381427|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
130660508|NCT02675426|470381428|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
130660509|NCT02675426|470381429|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
130433172|NCT02914314|469550367|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
130433173|NCT02914314|469550368|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130433174|NCT02914314|469550365|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130433175|NCT02914314|469550366|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130433176|NCT02914314|469550367|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
130433177|NCT02914314|469550368|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130433178|NCT01859793|469550372|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
130660510|NCT02675426|470381430|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
130660511|NCT02675426|470381427|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
130660512|NCT02675426|470381428|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
130660513|NCT02675426|470381429|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
130660514|NCT02675426|470381430|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
130660515|NCT02675426|470381427|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
130660516|NCT02675426|470381428|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
130330816|NCT01254422|469180187|FG000|Overall Study|Serious adverse event|0|||
130330817|NCT01254422|469180188|FG001|Overall Study|Serious adverse event|1|||
130660517|NCT02675426|470381429|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
130660518|NCT02675426|470381430|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
130660519|NCT02675426|470381427|FG000|Period 1: Week 1 to Week 12|Other|2|||
130660520|NCT02675426|470381428|FG001|Period 1: Week 1 to Week 12|Other|1|||
130660521|NCT02675426|470381429|FG002|Period 1: Week 1 to Week 12|Other|0|||
130660522|NCT02675426|470381430|FG003|Period 1: Week 1 to Week 12|Other|2|||
130660523|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
130330818|NCT01254422|469180187|FG000|Overall Study|Lost to Follow-up|1|||
130660524|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
130660525|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
130660526|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
130660527|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
130433179|NCT01859793|469550373|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
130433180|NCT01859793|469550372|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
130433181|NCT01859793|469550373|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
130433182|NCT01859793|469550372|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130433183|NCT01859793|469550373|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130433184|NCT01859793|469550372|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
130433185|NCT01859793|469550373|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
130433186|NCT01735396|469550377|FG000|Overall Study|not evaluable|1|||
130433187|NCT02002182|469550378|FG000|Overall Study|Withdraw from study|3|||
130433188|NCT02002182|469550379|FG001|Overall Study|Withdraw from study|1|||
130433189|NCT02002182|469550378|FG000|Overall Study|Health Reasons|1|||
130433190|NCT02002182|469550379|FG001|Overall Study|Health Reasons|0|||
130660528|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
130660529|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
130660530|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
130660531|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
130660532|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
130660533|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
130660534|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
130660535|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
130660536|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
130660537|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
130660538|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
130660539|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
130660540|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
130660541|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
130660542|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
130660543|NCT02675426|470381427|FG000|Period 2: Week 12 to Week 260|Other|8|||
130660544|NCT02675426|470381428|FG001|Period 2: Week 12 to Week 260|Other|12|||
130660545|NCT02675426|470381429|FG002|Period 2: Week 12 to Week 260|Other|23|||
130660546|NCT02675426|470381430|FG003|Period 2: Week 12 to Week 260|Other|15|||
130660547|NCT02156466|470381433|FG000|Overall Study|Adverse Event|0|||
130660548|NCT02156466|470381434|FG001|Overall Study|Adverse Event|0|||
130660549|NCT02156466|470381435|FG002|Overall Study|Adverse Event|1|||
130660550|NCT02156466|470381436|FG003|Overall Study|Adverse Event|1|||
130660551|NCT02156466|470381437|FG004|Overall Study|Adverse Event|0|||
130660552|NCT02156466|470381433|FG000|Overall Study|Quantiferon Positivity|0|||
130660553|NCT02156466|470381434|FG001|Overall Study|Quantiferon Positivity|0|||
130660554|NCT02156466|470381435|FG002|Overall Study|Quantiferon Positivity|0|||
130660555|NCT02156466|470381436|FG003|Overall Study|Quantiferon Positivity|1|||
130660556|NCT02156466|470381437|FG004|Overall Study|Quantiferon Positivity|0|||
130660557|NCT00080288|470381438|FG000|Overall Study|Adverse Event|7|||
130660558|NCT00080288|470381439|FG001|Overall Study|Adverse Event|4|||
130660559|NCT00080288|470381438|FG000|Overall Study|Lost to Follow-up|3|||
130660560|NCT00080288|470381439|FG001|Overall Study|Lost to Follow-up|5|||
130660561|NCT00080288|470381438|FG000|Overall Study|Physician Decision|6|||
130660562|NCT00080288|470381439|FG001|Overall Study|Physician Decision|2|||
130660563|NCT00080288|470381438|FG000|Overall Study|Withdrawal by Subject|3|||
130660564|NCT00080288|470381439|FG001|Overall Study|Withdrawal by Subject|16|||
130660565|NCT00080288|470381438|FG000|Overall Study|Miscellaneous|11|||
130660566|NCT00080288|470381439|FG001|Overall Study|Miscellaneous|11|||
130660567|NCT04470622|470381440|FG000|Overall Study|Withdrawal by Subject|0|||
130660568|NCT04470622|470381441|FG001|Overall Study|Withdrawal by Subject|1|||
130660569|NCT04470622|470381440|FG000|Overall Study|Screen Failure|0|||
130660570|NCT04470622|470381441|FG001|Overall Study|Screen Failure|1|||
130660571|NCT04470622|470381440|FG000|Overall Study|Death|0|||
130660572|NCT04470622|470381441|FG001|Overall Study|Death|1|||
130660573|NCT02953262|470381442|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
130660574|NCT02953262|470381443|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
130660575|NCT02953262|470381444|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
130660576|NCT02953262|470381445|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
130660577|NCT00765999|470381453|FG000|Overall Study|Adverse Event|203|||
130660578|NCT00765999|470381453|FG000|Overall Study|Insufficient Therapeutic Response|100|||
130660579|NCT00765999|470381453|FG000|Overall Study|Protocol Violation|95|||
130660580|NCT00765999|470381453|FG000|Overall Study|Consent Withdrawn|202|||
130660581|NCT00765999|470381453|FG000|Overall Study|Lost to Follow-up|131|||
130660582|NCT00765999|470381453|FG000|Overall Study|Study Terminated by Sponsor|2|||
130660583|NCT00765999|470381453|FG000|Overall Study|Other Miscellaneous Reasons|51|||
130330819|NCT01254422|469180188|FG001|Overall Study|Lost to Follow-up|0|||
130330820|NCT00643162|469180189|FG000|Overall Study|Withdrawal by Subject|1|||
130330821|NCT00643162|469180190|FG001|Overall Study|Withdrawal by Subject|1|||
130330822|NCT02691507|469180191|FG000|Overall Study|Missed Visit 3|0|||
130330823|NCT02691507|469180192|FG001|Overall Study|Missed Visit 3|1|||
130660584|NCT03981614|470381458|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
130660585|NCT03981614|470381459|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
130660586|NCT03981614|470381460|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
130660587|NCT00499252|470381461|FG000|Overall Study|Adverse Event|3|||
130660588|NCT00499252|470381461|FG000|Overall Study|Refused further treatment|2|||
130660589|NCT00499252|470381461|FG000|Overall Study|Ineligible|4|||
130660590|NCT00499252|470381461|FG000|Overall Study|<no further label>|3|||
130660591|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
130660592|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
130660593|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
130660594|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
130660595|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
130660596|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
130660597|NCT00566631|470381462|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
130660598|NCT00566631|470381462|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
130660599|NCT00566631|470381462|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
130660600|NCT00566631|470381462|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
130660601|NCT00566631|470381462|FG000|Part 2: Extension Phase|Adverse Event|11|||
130660602|NCT00566631|470381462|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
130660603|NCT00566631|470381462|FG000|Part 2: Extension Phase|Death|1|||
130660604|NCT00566631|470381462|FG000|Part 2: Extension Phase|Other|5|||
130660605|NCT03387735|470381463|FG000|Overall Study|Lost to Follow-up|4|||
130660606|NCT03387735|470381464|FG001|Overall Study|Lost to Follow-up|8|||
130660607|NCT03387735|470381463|FG000|Overall Study|Death|4|||
130660608|NCT03387735|470381464|FG001|Overall Study|Death|8|||
130660609|NCT00110084|470381465|FG000|Overall Study|Adverse Event|9|||
130433191|NCT02002182|469550378|FG000|Overall Study|Death|1|||
130433192|NCT02002182|469550379|FG001|Overall Study|Death|0|||
130433193|NCT04146896|469550380|FG000|Overall Study|Adverse Event|5|||
130433194|NCT04146896|469550381|FG001|Overall Study|Adverse Event|8|||
130433195|NCT04146896|469550380|FG000|Overall Study|Lack of Efficacy|3|||
130433196|NCT04146896|469550381|FG001|Overall Study|Lack of Efficacy|2|||
130433197|NCT04146896|469550380|FG000|Overall Study|Lost to Follow-up|0|||
130660610|NCT00110084|470381465|FG000|Overall Study|Death|1|||
130660611|NCT00110084|470381465|FG000|Overall Study|Patient Refusal|10|||
130660612|NCT00110084|470381465|FG000|Overall Study|Alternate Therapy|5|||
130660613|NCT00110084|470381465|FG000|Overall Study|Intercurrent Illness|1|||
130660614|NCT00110084|470381465|FG000|Overall Study|Other|2|||
130660615|NCT00537056|470381466|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
130660616|NCT03020966|470381470|FG000|Overall Study|Withdrawal by Subject|2|||
130660617|NCT03020966|470381471|FG001|Overall Study|Withdrawal by Subject|0|||
130660618|NCT01346501|470381476|FG000|Overall Study|Initiated Other Biological Agents|3|||
130660619|NCT01346501|470381477|FG001|Overall Study|Initiated Other Biological Agents|1|||
130660620|NCT01346501|470381476|FG000|Overall Study|Other|8|||
130660621|NCT01346501|470381477|FG001|Overall Study|Other|12|||
130433198|NCT04146896|469550381|FG001|Overall Study|Lost to Follow-up|1|||
130433199|NCT04146896|469550380|FG000|Overall Study|Non-compliance|5|||
130433200|NCT04146896|469550381|FG001|Overall Study|Non-compliance|4|||
130433201|NCT04146896|469550380|FG000|Overall Study|Withdrawal by Subject|3|||
130433202|NCT04146896|469550381|FG001|Overall Study|Withdrawal by Subject|5|||
130433203|NCT04146896|469550380|FG000|Overall Study|Randomized in error|1|||
130433204|NCT04146896|469550381|FG001|Overall Study|Randomized in error|2|||
130433205|NCT04296890|469550382|FG000|Overall Study|Withdrawal by Subject|1|||
130433206|NCT04296890|469550382|FG000|Overall Study|Death|62|||
130433207|NCT04296890|469550382|FG000|Overall Study|Lost to Follow-up|3|||
130433208|NCT04296890|469550382|FG000|Overall Study|Other than specified|2|||
130433209|NCT05400746|469550383|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
130660622|NCT02628418|470381478|FG000|Overall Study|Lost to Follow-up|1|||
130660623|NCT02628418|470381479|FG001|Overall Study|Lost to Follow-up|2|||
130660624|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130660625|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
130660626|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130660627|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130660628|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
130660629|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
130660630|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130330824|NCT00541385|469180193|FG000|Overall Study|Adverse Event|6|||
130330825|NCT00541385|469180194|FG001|Overall Study|Adverse Event|3|||
130330826|NCT00541385|469180193|FG000|Overall Study|Withdrawal by Subject|2|||
130660631|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130660632|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130660633|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
130660634|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130660635|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130660636|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
130660637|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
130660638|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
130660639|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
130660640|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
130660641|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
130660642|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
130660643|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
130660644|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130660645|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
130660646|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130660647|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130660648|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
130660649|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130660650|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130660651|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130660652|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
130660653|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
130660654|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
130660655|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
130660656|NCT03747939|470381480|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130660657|NCT03747939|470381481|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
130660658|NCT03747939|470381482|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130660659|NCT03747939|470381483|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130660660|NCT03747939|470381480|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
130660661|NCT03747939|470381481|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
130660662|NCT03747939|470381482|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
130660663|NCT03747939|470381483|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
130660664|NCT03747939|470381480|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
130433210|NCT05400746|469550384|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
130433211|NCT05400746|469550385|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
130433212|NCT02277743|469550390|FG000|Overall Study|Protocol Violation|1|||
130433213|NCT02277743|469550391|FG001|Overall Study|Protocol Violation|1|||
130433214|NCT02277743|469550392|FG002|Overall Study|Protocol Violation|1|||
130660665|NCT03747939|470381481|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
130660666|NCT03747939|470381482|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
130660667|NCT03747939|470381483|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
130660668|NCT03747939|470381480|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
130660669|NCT03747939|470381481|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
130660670|NCT03747939|470381482|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
130660671|NCT03747939|470381483|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
130660672|NCT03747939|470381480|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
130660673|NCT03747939|470381481|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
130330827|NCT00541385|469180194|FG001|Overall Study|Withdrawal by Subject|2|||
130660674|NCT03747939|470381482|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
130660675|NCT03747939|470381483|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
130660676|NCT03747939|470381480|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130660677|NCT03747939|470381481|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130660678|NCT03747939|470381482|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130660679|NCT03747939|470381483|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
130660680|NCT01215955|470381484|FG000|Overall Study|Adverse Event|1|||
130660681|NCT01215955|470381485|FG001|Overall Study|Adverse Event|4|||
130660682|NCT01215955|470381486|FG002|Overall Study|Adverse Event|2|||
130660683|NCT01215955|470381487|FG003|Overall Study|Adverse Event|3|||
130660684|NCT01215955|470381484|FG000|Overall Study|Death|2|||
130660685|NCT01215955|470381485|FG001|Overall Study|Death|0|||
130660686|NCT01215955|470381486|FG002|Overall Study|Death|1|||
130660687|NCT01215955|470381487|FG003|Overall Study|Death|3|||
130660688|NCT01215955|470381484|FG000|Overall Study|Entry Criteria Not Met|1|||
130660689|NCT01215955|470381485|FG001|Overall Study|Entry Criteria Not Met|3|||
130660690|NCT01215955|470381486|FG002|Overall Study|Entry Criteria Not Met|4|||
130660691|NCT01215955|470381487|FG003|Overall Study|Entry Criteria Not Met|7|||
130660692|NCT01215955|470381484|FG000|Overall Study|Lack of Efficacy|1|||
130660693|NCT01215955|470381485|FG001|Overall Study|Lack of Efficacy|2|||
130660694|NCT01215955|470381486|FG002|Overall Study|Lack of Efficacy|1|||
130660695|NCT01215955|470381487|FG003|Overall Study|Lack of Efficacy|0|||
130660696|NCT01215955|470381484|FG000|Overall Study|Lost to Follow-up|4|||
130660697|NCT01215955|470381485|FG001|Overall Study|Lost to Follow-up|4|||
130660698|NCT01215955|470381486|FG002|Overall Study|Lost to Follow-up|8|||
130660699|NCT01215955|470381487|FG003|Overall Study|Lost to Follow-up|9|||
130660700|NCT01215955|470381484|FG000|Overall Study|Physician Decision|4|||
130660701|NCT01215955|470381485|FG001|Overall Study|Physician Decision|10|||
130660702|NCT01215955|470381486|FG002|Overall Study|Physician Decision|8|||
130660703|NCT01215955|470381487|FG003|Overall Study|Physician Decision|11|||
130660704|NCT01215955|470381484|FG000|Overall Study|Protocol Violation|17|||
130660705|NCT01215955|470381485|FG001|Overall Study|Protocol Violation|13|||
130660706|NCT01215955|470381486|FG002|Overall Study|Protocol Violation|8|||
130660707|NCT01215955|470381487|FG003|Overall Study|Protocol Violation|8|||
130660708|NCT01215955|470381484|FG000|Overall Study|Sponsor Decision|1|||
130660709|NCT01215955|470381485|FG001|Overall Study|Sponsor Decision|2|||
130660710|NCT01215955|470381486|FG002|Overall Study|Sponsor Decision|0|||
130660711|NCT01215955|470381487|FG003|Overall Study|Sponsor Decision|1|||
130660712|NCT01215955|470381484|FG000|Overall Study|Withdrawal by Subject|14|||
130660713|NCT01215955|470381485|FG001|Overall Study|Withdrawal by Subject|15|||
130660714|NCT01215955|470381486|FG002|Overall Study|Withdrawal by Subject|13|||
130660715|NCT01215955|470381487|FG003|Overall Study|Withdrawal by Subject|9|||
130660716|NCT01215955|470381484|FG000|Overall Study|Quality Issues|0|||
130660717|NCT01215955|470381485|FG001|Overall Study|Quality Issues|0|||
130660718|NCT01215955|470381486|FG002|Overall Study|Quality Issues|3|||
130660719|NCT01215955|470381487|FG003|Overall Study|Quality Issues|2|||
130660720|NCT01523301|470381488|FG000|Overall Study|Adverse Event|25|||
130660721|NCT01523301|470381489|FG001|Overall Study|Adverse Event|16|||
130660722|NCT01523301|470381488|FG000|Overall Study|Lack of Efficacy|0|||
130660723|NCT01523301|470381489|FG001|Overall Study|Lack of Efficacy|2|||
130660724|NCT01523301|470381488|FG000|Overall Study|Protocol Violation|3|||
130660725|NCT01523301|470381489|FG001|Overall Study|Protocol Violation|4|||
130215891|NCT00885378|468753873|FG000|Overall Study|Poor/Noncompliance|2|||
130215892|NCT00885378|468753874|FG001|Overall Study|Poor/Noncompliance|2|||
130330828|NCT00541385|469180193|FG000|Overall Study|Lost to Follow-up|6|||
130330829|NCT00541385|469180194|FG001|Overall Study|Lost to Follow-up|1|||
130330830|NCT00541385|469180193|FG000|Overall Study|Parasite reappearance/malaria|67|||
130330831|NCT00541385|469180194|FG001|Overall Study|Parasite reappearance/malaria|32|||
130330832|NCT04139798|469180196|FG000|Overall Study|Withdrawal by Subject|6|||
130330833|NCT04139798|469180197|FG001|Overall Study|Withdrawal by Subject|5|||
130330834|NCT04139798|469180196|FG000|Overall Study|Lost to Follow-up|2|||
130330835|NCT04139798|469180197|FG001|Overall Study|Lost to Follow-up|5|||
130330836|NCT04139798|469180196|FG000|Overall Study|Discontinued|4|||
130330837|NCT04139798|469180197|FG001|Overall Study|Discontinued|2|||
130330838|NCT04139798|469180196|FG000|Overall Study|Adverse Event|1|||
130330839|NCT04139798|469180197|FG001|Overall Study|Adverse Event|3|||
130330840|NCT04139798|469180196|FG000|Overall Study|Protocol Violation|1|||
130330841|NCT04139798|469180197|FG001|Overall Study|Protocol Violation|0|||
130330842|NCT03155841|469180198|FG000|Overall Study|Protocol Violation|3|||
130330843|NCT03155841|469180199|FG001|Overall Study|Protocol Violation|4|||
130330844|NCT02699749|469180202|FG000|Overall Study|Other|0|||
130330845|NCT02699749|469180203|FG001|Overall Study|Other|0|||
130330846|NCT02699749|469180204|FG002|Overall Study|Other|2|||
130330847|NCT02699749|469180205|FG003|Overall Study|Other|0|||
130330848|NCT02699749|469180206|FG004|Overall Study|Other|0|||
130330849|NCT02699749|469180207|FG005|Overall Study|Other|1|||
130330850|NCT02699749|469180208|FG006|Overall Study|Other|1|||
130330851|NCT02699749|469180209|FG007|Overall Study|Other|0|||
130330852|NCT02699749|469180210|FG008|Overall Study|Other|0|||
130330853|NCT02699749|469180211|FG009|Overall Study|Other|0|||
130660726|NCT01523301|470381488|FG000|Overall Study|Lost to Follow-up|1|||
130660727|NCT01523301|470381489|FG001|Overall Study|Lost to Follow-up|0|||
130660728|NCT01523301|470381488|FG000|Overall Study|Withdrawal by Subject|6|||
130660729|NCT01523301|470381489|FG001|Overall Study|Withdrawal by Subject|8|||
130660730|NCT01523301|470381488|FG000|Overall Study|Other Reason|0|||
130660731|NCT01523301|470381489|FG001|Overall Study|Other Reason|2|||
130660732|NCT01447628|470381490|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130660733|NCT01447628|470381491|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130660734|NCT01447628|470381492|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130660735|NCT01447628|470381493|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
130330854|NCT02699749|469180212|FG010|Overall Study|Other|1|||
130330855|NCT02699749|469180213|FG011|Overall Study|Other|0|||
130330856|NCT02699749|469180214|FG012|Overall Study|Other|0|||
130330857|NCT02699749|469180215|FG013|Overall Study|Other|0|||
130330858|NCT02699749|469180202|FG000|Overall Study|Progressive Disease|3|||
130330859|NCT02699749|469180203|FG001|Overall Study|Progressive Disease|3|||
130330860|NCT02699749|469180204|FG002|Overall Study|Progressive Disease|14|||
130330861|NCT02699749|469180205|FG003|Overall Study|Progressive Disease|3|||
130330862|NCT02699749|469180206|FG004|Overall Study|Progressive Disease|3|||
130330863|NCT02699749|469180207|FG005|Overall Study|Progressive Disease|7|||
130330864|NCT02699749|469180208|FG006|Overall Study|Progressive Disease|5|||
130330865|NCT02699749|469180209|FG007|Overall Study|Progressive Disease|5|||
130330866|NCT02699749|469180210|FG008|Overall Study|Progressive Disease|6|||
130330867|NCT02699749|469180211|FG009|Overall Study|Progressive Disease|6|||
130330868|NCT02699749|469180212|FG010|Overall Study|Progressive Disease|5|||
130330869|NCT02699749|469180213|FG011|Overall Study|Progressive Disease|4|||
130330870|NCT02699749|469180214|FG012|Overall Study|Progressive Disease|3|||
130330871|NCT02699749|469180215|FG013|Overall Study|Progressive Disease|5|||
130330872|NCT02699749|469180202|FG000|Overall Study|Death|0|||
130330873|NCT02699749|469180203|FG001|Overall Study|Death|0|||
130330874|NCT02699749|469180204|FG002|Overall Study|Death|0|||
130330875|NCT02699749|469180205|FG003|Overall Study|Death|0|||
130330876|NCT02699749|469180206|FG004|Overall Study|Death|0|||
130330877|NCT02699749|469180207|FG005|Overall Study|Death|0|||
130330878|NCT02699749|469180208|FG006|Overall Study|Death|0|||
130330879|NCT02699749|469180209|FG007|Overall Study|Death|0|||
130330880|NCT02699749|469180210|FG008|Overall Study|Death|0|||
130330881|NCT02699749|469180211|FG009|Overall Study|Death|0|||
130330882|NCT02699749|469180212|FG010|Overall Study|Death|0|||
130330883|NCT02699749|469180213|FG011|Overall Study|Death|0|||
130330884|NCT02699749|469180214|FG012|Overall Study|Death|0|||
130330885|NCT02699749|469180215|FG013|Overall Study|Death|1|||
130330886|NCT02699749|469180202|FG000|Overall Study|Lost to Follow-up|0|||
130330887|NCT02699749|469180203|FG001|Overall Study|Lost to Follow-up|0|||
130330888|NCT02699749|469180204|FG002|Overall Study|Lost to Follow-up|0|||
130330889|NCT02699749|469180205|FG003|Overall Study|Lost to Follow-up|0|||
130330890|NCT02699749|469180206|FG004|Overall Study|Lost to Follow-up|0|||
130330891|NCT02699749|469180207|FG005|Overall Study|Lost to Follow-up|1|||
130330892|NCT02699749|469180208|FG006|Overall Study|Lost to Follow-up|0|||
130330893|NCT02699749|469180209|FG007|Overall Study|Lost to Follow-up|1|||
130330894|NCT02699749|469180210|FG008|Overall Study|Lost to Follow-up|0|||
130330895|NCT02699749|469180211|FG009|Overall Study|Lost to Follow-up|0|||
130330896|NCT02699749|469180212|FG010|Overall Study|Lost to Follow-up|0|||
130330897|NCT02699749|469180213|FG011|Overall Study|Lost to Follow-up|0|||
130330898|NCT02699749|469180214|FG012|Overall Study|Lost to Follow-up|0|||
130330899|NCT02699749|469180215|FG013|Overall Study|Lost to Follow-up|0|||
130330900|NCT00888940|469180217|FG000|Overall Study|Adverse Event|12|||
130330901|NCT00888940|469180218|FG001|Overall Study|Adverse Event|3|||
130330902|NCT00888940|469180217|FG000|Overall Study|Lost to Follow-up|5|||
130330903|NCT00888940|469180218|FG001|Overall Study|Lost to Follow-up|5|||
130330904|NCT00888940|469180217|FG000|Overall Study|Randomized Not Treated|11|||
130330905|NCT00888940|469180218|FG001|Overall Study|Randomized Not Treated|13|||
130330906|NCT01578486|469180219|FG000|Overall Study|Physician Decision|3|||
130330907|NCT01578486|469180219|FG000|Overall Study|Withdrawal by Subject|2|||
130330908|NCT02536963|469180220|FG000|Overall Study|Withdrawal by Subject|18|||
130330909|NCT02668393|469180222|FG000|Overall Study|Progressive disease|6|||
130330910|NCT02668393|469180223|FG001|Overall Study|Progressive disease|3|||
130330911|NCT02668393|469180222|FG000|Overall Study|Adverse Event|0|||
130330912|NCT02668393|469180223|FG001|Overall Study|Adverse Event|2|||
130330913|NCT02668393|469180222|FG000|Overall Study|Withdrawal from the trial|0|||
130330914|NCT02668393|469180223|FG001|Overall Study|Withdrawal from the trial|1|||
130330915|NCT02668393|469180222|FG000|Overall Study|Lack of benefit and side effects|1|||
130330916|NCT02668393|469180223|FG001|Overall Study|Lack of benefit and side effects|0|||
130215893|NCT00885378|468753873|FG000|Overall Study|Protocol Violation|2|||
130215894|NCT00885378|468753874|FG001|Overall Study|Protocol Violation|0|||
130330917|NCT02141204|469180224|FG000|Overall Study|Lost to Follow-up|2|||
130330918|NCT02141204|469180225|FG001|Overall Study|Lost to Follow-up|1|||
130330919|NCT02141204|469180224|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
130330920|NCT02141204|469180225|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
130330921|NCT02141204|469180224|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130330922|NCT02141204|469180225|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
130330923|NCT02141204|469180224|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
130330924|NCT02141204|469180225|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
130330925|NCT00607373|469180226|FG000|Treatment Period|Adverse Event|0|||
130330926|NCT00607373|469180227|FG001|Treatment Period|Adverse Event|4|||
130330927|NCT00607373|469180226|FG000|Treatment Period|Physician Decision|0|||
130330928|NCT00607373|469180227|FG001|Treatment Period|Physician Decision|1|||
130330929|NCT00607373|469180226|FG000|Treatment Period|Withdrawal by Subject|0|||
130330930|NCT00607373|469180227|FG001|Treatment Period|Withdrawal by Subject|1|||
130330931|NCT00607373|469180226|FG000|Follow-up Period|Other|0|||
130330932|NCT00607373|469180227|FG001|Follow-up Period|Other|1|||
130330933|NCT00607373|469180226|FG000|Follow-up Period|Protocol Violation|0|||
130330934|NCT00607373|469180227|FG001|Follow-up Period|Protocol Violation|1|||
130330935|NCT00607373|469180226|FG000|Follow-up Period|Withdrawal by Subject|1|||
130330936|NCT00607373|469180227|FG001|Follow-up Period|Withdrawal by Subject|3|||
130330937|NCT02170077|469180228|FG000|Overall Study|Withdrawal by Subject|3|||
130330938|NCT02170077|469180229|FG001|Overall Study|Withdrawal by Subject|4|||
130330939|NCT02170077|469180230|FG002|Overall Study|Withdrawal by Subject|2|||
130330940|NCT02170077|469180228|FG000|Overall Study|Adverse Event|4|||
130330941|NCT02170077|469180229|FG001|Overall Study|Adverse Event|4|||
130330942|NCT02170077|469180230|FG002|Overall Study|Adverse Event|4|||
130330943|NCT02170077|469180228|FG000|Overall Study|Lost to Follow-up|0|||
130330944|NCT02170077|469180229|FG001|Overall Study|Lost to Follow-up|1|||
130330945|NCT02170077|469180230|FG002|Overall Study|Lost to Follow-up|0|||
130330946|NCT02170077|469180228|FG000|Overall Study|Exclusion criteria|2|||
130330947|NCT02170077|469180229|FG001|Overall Study|Exclusion criteria|2|||
130330948|NCT02170077|469180230|FG002|Overall Study|Exclusion criteria|5|||
130330949|NCT02170077|469180228|FG000|Overall Study|Exacerbation of seizures|0|||
130330950|NCT02170077|469180229|FG001|Overall Study|Exacerbation of seizures|2|||
130330951|NCT02170077|469180230|FG002|Overall Study|Exacerbation of seizures|1|||
130330952|NCT01780974|469180233|FG000|Overall Study|Death|1|||
130330953|NCT01780974|469180234|FG001|Overall Study|Death|0|||
130330954|NCT01780974|469180233|FG000|Overall Study|Adverse Event|1|||
130330955|NCT01780974|469180234|FG001|Overall Study|Adverse Event|3|||
130330956|NCT01724346|469180235|FG000|Overall Study|Death|42|||
130330957|NCT01724346|469180236|FG001|Overall Study|Death|42|||
130330958|NCT01724346|469180235|FG000|Overall Study|Lost to Follow-up|5|||
130330959|NCT01724346|469180236|FG001|Overall Study|Lost to Follow-up|1|||
130330960|NCT01724346|469180235|FG000|Overall Study|Withdrawal by Subject|27|||
130330961|NCT01724346|469180236|FG001|Overall Study|Withdrawal by Subject|19|||
130330962|NCT01724346|469180235|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
130330963|NCT01724346|469180236|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
130330964|NCT00787644|469180237|FG000|Overall Study|Lost to Follow-up|1|||
130330965|NCT00787644|469180238|FG001|Overall Study|Lost to Follow-up|1|||
130330966|NCT00787644|469180237|FG000|Overall Study|Withdrawal by Subject|1|||
130330967|NCT00787644|469180238|FG001|Overall Study|Withdrawal by Subject|1|||
130330968|NCT01642589|469180242|FG000|Overall Study|Withdrawal by Subject|1|||
130330969|NCT01642589|469180243|FG001|Overall Study|Withdrawal by Subject|1|||
130330970|NCT02876601|469180248|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330971|NCT02876601|469180249|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330972|NCT02876601|469180250|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
130330973|NCT02876601|469180251|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330974|NCT00256997|469180254|FG000|Overall Study|Protocol Violation|1|||
130330975|NCT00256997|469180255|FG001|Overall Study|Protocol Violation|4|||
130330976|NCT00256997|469180254|FG000|Overall Study|Lack of Efficacy|1|||
130330977|NCT00256997|469180255|FG001|Overall Study|Lack of Efficacy|4|||
130330978|NCT00256997|469180254|FG000|Overall Study|Death|2|||
130330979|NCT00256997|469180255|FG001|Overall Study|Death|0|||
130330980|NCT00256997|469180254|FG000|Overall Study|Adverse Event|4|||
130330981|NCT00256997|469180255|FG001|Overall Study|Adverse Event|0|||
130330982|NCT00256997|469180254|FG000|Overall Study|Lost to Follow-up|3|||
130330983|NCT00256997|469180255|FG001|Overall Study|Lost to Follow-up|5|||
130330984|NCT00256997|469180254|FG000|Overall Study|Withdrawal by Subject|13|||
130330985|NCT00256997|469180255|FG001|Overall Study|Withdrawal by Subject|3|||
130330986|NCT00256997|469180254|FG000|Overall Study|Started but not treated|2|||
130330987|NCT00256997|469180255|FG001|Overall Study|Started but not treated|0|||
130330988|NCT00256997|469180254|FG000|Overall Study|Other|5|||
130330989|NCT00256997|469180255|FG001|Overall Study|Other|8|||
130330990|NCT00256997|469180254|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
130330991|NCT00256997|469180255|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
130330992|NCT00256997|469180254|FG000|Overall Study|Participant Non-compliant|3|||
130215895|NCT04750278|468753875|FG000|Overall Study|Death|9|||
130330993|NCT00256997|469180255|FG001|Overall Study|Participant Non-compliant|6|||
130330994|NCT00256997|469180254|FG000|Overall Study|Investigator Withdrew Participant|2|||
130330995|NCT00256997|469180255|FG001|Overall Study|Investigator Withdrew Participant|1|||
130330996|NCT00354432|469180256|FG000|Overall Study|Adverse Event|3|||
130330997|NCT00354432|469180257|FG001|Overall Study|Adverse Event|1|||
130330998|NCT00354432|469180258|FG002|Overall Study|Adverse Event|5|||
130330999|NCT00354432|469180259|FG003|Overall Study|Adverse Event|5|||
130331000|NCT00354432|469180256|FG000|Overall Study|Off/Toxicity|3|||
130331001|NCT00354432|469180257|FG001|Overall Study|Off/Toxicity|7|||
130331002|NCT00354432|469180258|FG002|Overall Study|Off/Toxicity|5|||
130331003|NCT00354432|469180259|FG003|Overall Study|Off/Toxicity|5|||
130331004|NCT02736578|469180260|FG000|Overall Study|Adverse Event|1|||
130331005|NCT02736578|469180261|FG001|Overall Study|Adverse Event|0|||
130331006|NCT04163016|469180264|FG000|Enrollment|Adverse Event|1|||
130331007|NCT04163016|469180265|FG001|Enrollment|Adverse Event|0|||
130331008|NCT04163016|469180266|FG002|Enrollment|Adverse Event|0|||
130331009|NCT04163016|469180267|FG003|Enrollment|Adverse Event|0|||
130331010|NCT04163016|469180264|FG000|Treatment|Adverse Event|0|||
130331011|NCT04163016|469180265|FG001|Treatment|Adverse Event|1|||
130331012|NCT04163016|469180266|FG002|Treatment|Adverse Event|0|||
130331013|NCT04163016|469180267|FG003|Treatment|Adverse Event|0|||
130331014|NCT04163016|469180264|FG000|Treatment|Withdrawal by Subject|0|||
130331015|NCT04163016|469180265|FG001|Treatment|Withdrawal by Subject|2|||
130331016|NCT04163016|469180266|FG002|Treatment|Withdrawal by Subject|0|||
130331017|NCT04163016|469180267|FG003|Treatment|Withdrawal by Subject|0|||
130331018|NCT04163016|469180264|FG000|Treatment|Indeterminate TB-test|0|||
130331019|NCT04163016|469180265|FG001|Treatment|Indeterminate TB-test|0|||
130331020|NCT04163016|469180266|FG002|Treatment|Indeterminate TB-test|0|||
130331021|NCT04163016|469180267|FG003|Treatment|Indeterminate TB-test|1|||
130331022|NCT04163016|469180264|FG000|Treatment|Participant did not want to continue in study|0|||
130331023|NCT04163016|469180265|FG001|Treatment|Participant did not want to continue in study|0|||
130331024|NCT04163016|469180266|FG002|Treatment|Participant did not want to continue in study|0|||
130331025|NCT04163016|469180267|FG003|Treatment|Participant did not want to continue in study|1|||
130331026|NCT01967238|469180268|FG000|Overall Study|Adverse Event|1|||
130331027|NCT01967238|469180269|FG001|Overall Study|Adverse Event|1|||
130331028|NCT01967238|469180270|FG002|Overall Study|Adverse Event|0|||
130331029|NCT01967238|469180268|FG000|Overall Study|Lost to Follow-up|1|||
130331030|NCT01967238|469180269|FG001|Overall Study|Lost to Follow-up|0|||
130331031|NCT01967238|469180270|FG002|Overall Study|Lost to Follow-up|1|||
130331032|NCT01967238|469180268|FG000|Overall Study|Withdrawal by Subject|0|||
130331033|NCT01967238|469180269|FG001|Overall Study|Withdrawal by Subject|0|||
130331034|NCT01967238|469180270|FG002|Overall Study|Withdrawal by Subject|1|||
130331035|NCT05232682|469180271|FG000|Overall Study|Lost to Follow-up|2|||
130331036|NCT03387085|469180272|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
130331037|NCT02015637|469181454|FG000|Overall Study|Lost to Follow-up|3|||
130331038|NCT02015637|469181455|FG001|Overall Study|Lost to Follow-up|5|||
130331039|NCT02015637|469181454|FG000|Overall Study|Adverse Event|3|||
130660736|NCT03087773|470381494|FG000|Overall Study|Withdrawal by Subject|8|||
130331040|NCT02015637|469181455|FG001|Overall Study|Adverse Event|0|||
130331041|NCT02015637|469181454|FG000|Overall Study|Did not take study drug|2|||
130331042|NCT02015637|469181455|FG001|Overall Study|Did not take study drug|0|||
130331043|NCT02223858|469181458|FG000|Overall Study|Death|1|||
130331044|NCT02223858|469181459|FG001|Overall Study|Death|1|||
130331045|NCT02223858|469181458|FG000|Overall Study|Lost to Follow-up|6|||
130331046|NCT02223858|469181459|FG001|Overall Study|Lost to Follow-up|11|||
130331047|NCT02223858|469181458|FG000|Overall Study|Withdrawal by Subject|8|||
130331048|NCT02223858|469181459|FG001|Overall Study|Withdrawal by Subject|5|||
130331049|NCT02223858|469181458|FG000|Overall Study|Refused|9|||
130331050|NCT02223858|469181459|FG001|Overall Study|Refused|9|||
130331051|NCT04455815|469181460|FG000|Randomisation Phase|Adverse Event|1|||
130331052|NCT04455815|469181461|FG001|Randomisation Phase|Adverse Event|0|||
130331053|NCT04455815|469181460|FG000|Treatment Phase|Adverse Event|0|||
130331054|NCT04455815|469181461|FG001|Treatment Phase|Adverse Event|1|||
130331055|NCT04455815|469181460|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
130331056|NCT04455815|469181461|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
130331057|NCT04455815|469181460|FG000|Treatment Phase|Withdrawal by Subject|1|||
130331058|NCT04455815|469181461|FG001|Treatment Phase|Withdrawal by Subject|1|||
130331059|NCT02106390|469181462|FG000|Overall Study|Withdrawal by Subject|15|||
130331060|NCT02106390|469181463|FG001|Overall Study|Withdrawal by Subject|16|||
130331061|NCT02106390|469181464|FG002|Overall Study|Withdrawal by Subject|15|||
130331062|NCT02106390|469181462|FG000|Overall Study|Lost to Follow-up|25|||
130331063|NCT02106390|469181463|FG001|Overall Study|Lost to Follow-up|20|||
130331064|NCT02106390|469181464|FG002|Overall Study|Lost to Follow-up|13|||
130331065|NCT02106390|469181462|FG000|Overall Study|Other: Administrative Reason|8|||
130331066|NCT02106390|469181463|FG001|Overall Study|Other: Administrative Reason|5|||
130331067|NCT02106390|469181464|FG002|Overall Study|Other: Administrative Reason|12|||
130331068|NCT02106390|469181462|FG000|Overall Study|Other: Unspecified|1|||
130331069|NCT02106390|469181463|FG001|Overall Study|Other: Unspecified|4|||
130331070|NCT02106390|469181464|FG002|Overall Study|Other: Unspecified|2|||
130331071|NCT02106390|469181462|FG000|Overall Study|Adverse Event|0|||
130331072|NCT02106390|469181463|FG001|Overall Study|Adverse Event|2|||
130331073|NCT02106390|469181464|FG002|Overall Study|Adverse Event|1|||
130331074|NCT02106390|469181462|FG000|Overall Study|Protocol Violation|0|||
130331075|NCT02106390|469181463|FG001|Overall Study|Protocol Violation|1|||
130331076|NCT02106390|469181464|FG002|Overall Study|Protocol Violation|0|||
130331077|NCT03198507|469181465|FG000|Overall Study|Withdrawal by Subject|1|||
130331078|NCT03198507|469181466|FG001|Overall Study|Withdrawal by Subject|0|||
130331079|NCT00241839|469181469|FG000|Overall Study|Withdrawal by Subject|18|||
130331080|NCT00241839|469181470|FG001|Overall Study|Withdrawal by Subject|17|||
130331081|NCT00241839|469181469|FG000|Overall Study|Adverse Event|1|||
130331082|NCT00241839|469181470|FG001|Overall Study|Adverse Event|1|||
130331083|NCT00831181|469181471|FG000|Overall Study|Adverse Event|12|||
130331084|NCT02863419|469181472|FG000|Overall Study|Lost to Follow-up|0|||
130331085|NCT02863419|469181473|FG001|Overall Study|Lost to Follow-up|1|||
130331086|NCT02863419|469181474|FG002|Overall Study|Lost to Follow-up|4|||
130331087|NCT02863419|469181472|FG000|Overall Study|Withdrawal by Subject|5|||
130331088|NCT02863419|469181473|FG001|Overall Study|Withdrawal by Subject|5|||
130331089|NCT02863419|469181474|FG002|Overall Study|Withdrawal by Subject|3|||
130331090|NCT02863419|469181472|FG000|Overall Study|Died|3|||
130331091|NCT02863419|469181473|FG001|Overall Study|Died|4|||
130331092|NCT02863419|469181474|FG002|Overall Study|Died|1|||
130331093|NCT00196313|469181477|FG000|Overall Study|Protocol Violation|2|||
130331094|NCT00196313|469181478|FG001|Overall Study|Protocol Violation|3|||
130331095|NCT00196313|469181477|FG000|Overall Study|Withdrawal by Subject|3|||
130331096|NCT00196313|469181478|FG001|Overall Study|Withdrawal by Subject|1|||
130331097|NCT00196313|469181477|FG000|Overall Study|Adverse Event|3|||
130331098|NCT00196313|469181478|FG001|Overall Study|Adverse Event|1|||
130331099|NCT00196313|469181477|FG000|Overall Study|Subject Pregnant|1|||
130331100|NCT00196313|469181478|FG001|Overall Study|Subject Pregnant|1|||
130331101|NCT00196313|469181477|FG000|Overall Study|Lost to Follow-up|2|||
130331102|NCT00196313|469181478|FG001|Overall Study|Lost to Follow-up|2|||
130331103|NCT02577718|469181479|FG000|Overall Study|Death|6|||
130331104|NCT02577718|469181479|FG000|Overall Study|Withdrawal by Subject|2|||
130331105|NCT01967576|469181480|FG000|Overall Study|Withdrawal by Subject|3|||
130331106|NCT01967576|469181480|FG000|Overall Study|Progressed/Removed from treatment|1|||
130331107|NCT01967576|469181480|FG000|Overall Study|Study closing at site|1|||
130331108|NCT01967576|469181480|FG000|Overall Study|Adverse Event|1|||
130331109|NCT01967576|469181480|FG000|Overall Study|Refused further treatment|1|||
130331110|NCT03196349|469181481|FG000|Overall Study|Did not receive study drug|0|||
130331111|NCT03196349|469181482|FG001|Overall Study|Did not receive study drug|1|||
130331112|NCT03196349|469181483|FG002|Overall Study|Did not receive study drug|2|||
130331113|NCT03196349|469181481|FG000|Overall Study|No data entered|2|||
130331114|NCT03196349|469181482|FG001|Overall Study|No data entered|4|||
130331115|NCT03196349|469181483|FG002|Overall Study|No data entered|0|||
130331116|NCT03196349|469181481|FG000|Overall Study|Study Terminated early|15|||
130331117|NCT03196349|469181482|FG001|Overall Study|Study Terminated early|9|||
130331118|NCT03196349|469181483|FG002|Overall Study|Study Terminated early|11|||
130331119|NCT03967444|469181484|FG000|Overall Study|Lost to Follow-up|1|||
130331120|NCT03967444|469181485|FG001|Overall Study|Lost to Follow-up|2|||
130331121|NCT01821118|469181492|FG000|Overall Study|Death|0|||
130331122|NCT01821118|469181493|FG001|Overall Study|Death|1|||
130331123|NCT01605799|469181494|FG000|Overall Study|Withdrawal by Subject|2|||
130331124|NCT01605799|469181495|FG001|Overall Study|Withdrawal by Subject|1|||
130331125|NCT00345358|469181496|FG000|Primary Vaccination Phase|Other|0|||
130331126|NCT00345358|469181497|FG001|Primary Vaccination Phase|Other|1|||
130331127|NCT00345358|469181498|FG002|Primary Vaccination Phase|Other|1|||
130331128|NCT00345358|469181499|FG003|Primary Vaccination Phase|Other|0|||
130331129|NCT00345358|469181496|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
130331130|NCT00345358|469181497|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130331131|NCT00345358|469181498|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130331132|NCT00345358|469181499|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
130331133|NCT00345358|469181496|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
130331134|NCT00345358|469181497|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
130331135|NCT00345358|469181498|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
130331136|NCT00345358|469181499|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
130331137|NCT00345358|469181496|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
130331138|NCT00345358|469181497|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
130331139|NCT00345358|469181498|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
130331140|NCT00345358|469181499|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
130331141|NCT00345358|469181496|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130331142|NCT00345358|469181497|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331143|NCT00345358|469181498|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331144|NCT00345358|469181499|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331145|NCT00345358|469181496|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
130331146|NCT00345358|469181497|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
130331147|NCT00345358|469181498|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
130331148|NCT00345358|469181499|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
130331149|NCT00477386|469181500|FG000|Overall Study|Adverse Event|4|||
130331150|NCT00477386|469181501|FG001|Overall Study|Adverse Event|8|||
130215896|NCT04750278|468753876|FG001|Overall Study|Death|10|||
130331151|NCT00477386|469181500|FG000|Overall Study|Disease progression, relapse|3|||
130331152|NCT00477386|469181501|FG001|Overall Study|Disease progression, relapse|4|||
130331153|NCT00477386|469181500|FG000|Overall Study|Disease progression, refractory|1|||
130331154|NCT00477386|469181501|FG001|Overall Study|Disease progression, refractory|3|||
130331155|NCT00477386|469181500|FG000|Overall Study|Other|1|||
130215897|NCT04750278|468753877|FG002|Overall Study|Death|10|||
130331156|NCT00477386|469181501|FG001|Overall Study|Other|2|||
130331157|NCT00477386|469181500|FG000|Overall Study|Physician Decision|1|||
130331158|NCT00477386|469181501|FG001|Overall Study|Physician Decision|0|||
130331159|NCT00477386|469181500|FG000|Overall Study|Withdrawal by Subject|1|||
130331160|NCT00477386|469181501|FG001|Overall Study|Withdrawal by Subject|0|||
130331161|NCT02207088|469181502|FG000|Overall Study|Adverse Event|2|||
130331162|NCT01812252|469181503|FG000|Overall Study|Persistent Disease|1|||
130331163|NCT01812252|469181504|FG001|Overall Study|Persistent Disease|0|||
130331164|NCT01812252|469181503|FG000|Overall Study|Not transplanted|11|||
130331165|NCT01812252|469181504|FG001|Overall Study|Not transplanted|11|||
130331166|NCT01812252|469181503|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
130331167|NCT01812252|469181504|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
130331168|NCT01812252|469181503|FG000|Overall Study|Withdrawal by Subject|1|||
130331169|NCT01812252|469181504|FG001|Overall Study|Withdrawal by Subject|1|||
130331170|NCT01812252|469181503|FG000|Overall Study|Screen Failure|1|||
130331171|NCT01812252|469181504|FG001|Overall Study|Screen Failure|0|||
130331172|NCT02284243|469181505|FG000|Overall Study|Lack of Efficacy|3|||
130331173|NCT02284243|469181506|FG001|Overall Study|Lack of Efficacy|3|||
130331174|NCT02284243|469181505|FG000|Overall Study|Adverse Event|1|||
130331175|NCT02284243|469181506|FG001|Overall Study|Adverse Event|0|||
130331176|NCT04269889|469181508|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
130331177|NCT04634253|469181509|FG000|Overall Study|Adverse Event|1|||
130331178|NCT04634253|469181510|FG001|Overall Study|Adverse Event|1|||
130331179|NCT04634253|469181511|FG002|Overall Study|Adverse Event|0|||
130331180|NCT04634253|469181509|FG000|Overall Study|Physician Decision|0|||
130331181|NCT04634253|469181510|FG001|Overall Study|Physician Decision|1|||
130331182|NCT04634253|469181511|FG002|Overall Study|Physician Decision|0|||
130331183|NCT04634253|469181509|FG000|Overall Study|Withdrawal by Subject|1|||
130331184|NCT04634253|469181510|FG001|Overall Study|Withdrawal by Subject|0|||
130331185|NCT04634253|469181511|FG002|Overall Study|Withdrawal by Subject|3|||
130331186|NCT01499355|469181512|FG000|Run-In Period|Study Termination|15|||
130331187|NCT01499355|469181513|FG001|Run-In Period|Study Termination|0|||
130331188|NCT01499355|469181514|FG002|Run-In Period|Study Termination|0|||
130331189|NCT01499355|469181515|FG003|Run-In Period|Study Termination|0|||
130331190|NCT01499355|469181512|FG000|Run-In Period|Other|3|||
130331191|NCT01499355|469181513|FG001|Run-In Period|Other|0|||
130331192|NCT01499355|469181514|FG002|Run-In Period|Other|0|||
130331193|NCT01499355|469181515|FG003|Run-In Period|Other|0|||
130331194|NCT01499355|469181512|FG000|Run-In Period|Death|2|||
130331195|NCT01499355|469181513|FG001|Run-In Period|Death|0|||
130331196|NCT01499355|469181514|FG002|Run-In Period|Death|0|||
130331197|NCT01499355|469181515|FG003|Run-In Period|Death|0|||
130331198|NCT01499355|469181512|FG000|Run-In Period|Investigator Decision|2|||
130331199|NCT01499355|469181513|FG001|Run-In Period|Investigator Decision|0|||
130331200|NCT01499355|469181514|FG002|Run-In Period|Investigator Decision|0|||
130331201|NCT01499355|469181515|FG003|Run-In Period|Investigator Decision|0|||
130331202|NCT01499355|469181512|FG000|Run-In Period|Consent Withdrawn|1|||
130331203|NCT01499355|469181513|FG001|Run-In Period|Consent Withdrawn|0|||
130331204|NCT01499355|469181514|FG002|Run-In Period|Consent Withdrawn|0|||
130331205|NCT01499355|469181515|FG003|Run-In Period|Consent Withdrawn|0|||
130331206|NCT01499355|469181512|FG000|Run-In Period|Adverse Event|8|||
130331207|NCT01499355|469181513|FG001|Run-In Period|Adverse Event|0|||
130331208|NCT01499355|469181514|FG002|Run-In Period|Adverse Event|0|||
130331209|NCT01499355|469181515|FG003|Run-In Period|Adverse Event|0|||
130331210|NCT01499355|469181512|FG000|Double-Blind Period|Adverse Event|0|||
130331211|NCT01499355|469181513|FG001|Double-Blind Period|Adverse Event|2|||
130331212|NCT01499355|469181514|FG002|Double-Blind Period|Adverse Event|3|||
130331213|NCT01499355|469181515|FG003|Double-Blind Period|Adverse Event|2|||
130331214|NCT01499355|469181512|FG000|Double-Blind Period|Study Termination|0|||
130331215|NCT01499355|469181513|FG001|Double-Blind Period|Study Termination|18|||
130331216|NCT01499355|469181514|FG002|Double-Blind Period|Study Termination|16|||
130331217|NCT01499355|469181515|FG003|Double-Blind Period|Study Termination|14|||
130331218|NCT01499355|469181512|FG000|Double-Blind Period|Other|0|||
130331219|NCT01499355|469181513|FG001|Double-Blind Period|Other|1|||
130331220|NCT01499355|469181514|FG002|Double-Blind Period|Other|2|||
130331221|NCT01499355|469181515|FG003|Double-Blind Period|Other|2|||
130331222|NCT01499355|469181512|FG000|Double-Blind Period|Death|0|||
130331223|NCT01499355|469181513|FG001|Double-Blind Period|Death|1|||
130331224|NCT01499355|469181514|FG002|Double-Blind Period|Death|0|||
130331225|NCT01499355|469181515|FG003|Double-Blind Period|Death|0|||
130331226|NCT01499355|469181512|FG000|Double-Blind Period|Investigator Decision|0|||
130331227|NCT01499355|469181513|FG001|Double-Blind Period|Investigator Decision|0|||
130331228|NCT01499355|469181514|FG002|Double-Blind Period|Investigator Decision|3|||
130331229|NCT01499355|469181515|FG003|Double-Blind Period|Investigator Decision|3|||
130331230|NCT01499355|469181512|FG000|Double-Blind Period|Consent Withdrawn|0|||
130331231|NCT01499355|469181513|FG001|Double-Blind Period|Consent Withdrawn|0|||
130331232|NCT01499355|469181514|FG002|Double-Blind Period|Consent Withdrawn|1|||
130331233|NCT01499355|469181515|FG003|Double-Blind Period|Consent Withdrawn|2|||
130331234|NCT01499355|469181512|FG000|Double-Blind Period|Lost to Follow-up|0|||
130331235|NCT01499355|469181513|FG001|Double-Blind Period|Lost to Follow-up|1|||
130331236|NCT01499355|469181514|FG002|Double-Blind Period|Lost to Follow-up|0|||
130331237|NCT01499355|469181515|FG003|Double-Blind Period|Lost to Follow-up|0|||
130331238|NCT01526733|469181516|FG000|Phase 1|Protocol Violation|1|||
130331239|NCT01526733|469181517|FG001|Phase 1|Protocol Violation|0|||
130331240|NCT01526733|469181516|FG000|Phase 1|Withdrawal by Subject|1|||
130331241|NCT01526733|469181517|FG001|Phase 1|Withdrawal by Subject|1|||
130331242|NCT01310075|469181518|FG000|Overall Study|Lost to Follow-up|1|||
130331243|NCT01310075|469181519|FG001|Overall Study|Lost to Follow-up|0|||
130331244|NCT01310075|469181518|FG000|Overall Study|Physician Decision|10|||
130331245|NCT01310075|469181519|FG001|Overall Study|Physician Decision|7|||
130331246|NCT01310075|469181518|FG000|Overall Study|Protocol Violation|2|||
130331247|NCT01310075|469181519|FG001|Overall Study|Protocol Violation|2|||
130331248|NCT01310075|469181518|FG000|Overall Study|Withdrawal by Subject|1|||
130331249|NCT01310075|469181519|FG001|Overall Study|Withdrawal by Subject|1|||
130331250|NCT02395081|469181520|FG000|Overall Study|Withdrawal by Subject|1|||
130331251|NCT02395081|469181521|FG001|Overall Study|Withdrawal by Subject|1|||
130331252|NCT02395081|469181522|FG002|Overall Study|Withdrawal by Subject|0|||
130331253|NCT02395081|469181520|FG000|Overall Study|Moved where blood couldn't be collected|4|||
130331254|NCT02395081|469181521|FG001|Overall Study|Moved where blood couldn't be collected|1|||
130331255|NCT02395081|469181522|FG002|Overall Study|Moved where blood couldn't be collected|3|||
130331256|NCT02395081|469181520|FG000|Overall Study|Fetal Loss|2|||
130331257|NCT02395081|469181521|FG001|Overall Study|Fetal Loss|3|||
130331258|NCT02395081|469181522|FG002|Overall Study|Fetal Loss|1|||
130331259|NCT02991040|469181523|FG000|Overall Study|Withdrawal by Subject|2|||
130331260|NCT02991040|469181523|FG000|Overall Study|Lost to Follow-up|2|||
130331261|NCT01869764|469181524|FG000|Overall Study|Withdrawal by Subject|0|||
130331262|NCT01869764|469181525|FG001|Overall Study|Withdrawal by Subject|2|||
130331263|NCT01286480|469181526|FG000|Overall Study|Withdrawal by Subject|5|||
130331264|NCT01286480|469181527|FG001|Overall Study|Withdrawal by Subject|3|||
130331265|NCT01626872|469181528|FG000|Overall Study|Physician Decision|13|||
130331266|NCT01626872|469181529|FG001|Overall Study|Physician Decision|9|||
130331267|NCT01626872|469181530|FG002|Overall Study|Physician Decision|6|||
130331268|NCT01626872|469181528|FG000|Overall Study|Withdrawal by Subject|19|||
130331269|NCT01626872|469181529|FG001|Overall Study|Withdrawal by Subject|27|||
130331270|NCT01626872|469181530|FG002|Overall Study|Withdrawal by Subject|8|||
130331271|NCT01626872|469181528|FG000|Overall Study|Adverse Event (including Death)|20|||
130331272|NCT01626872|469181529|FG001|Overall Study|Adverse Event (including Death)|28|||
130331273|NCT01626872|469181530|FG002|Overall Study|Adverse Event (including Death)|8|||
130331274|NCT01626872|469181528|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
130331275|NCT01626872|469181529|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
130331276|NCT01626872|469181530|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
130331277|NCT00960999|469181531|FG000|Overall Study|Withdrawal by Subject|1|||
130331278|NCT00960999|469181532|FG001|Overall Study|Withdrawal by Subject|0|||
130331279|NCT00960999|469181531|FG000|Overall Study|Protocol Violation|5|||
130331280|NCT00960999|469181532|FG001|Overall Study|Protocol Violation|2|||
130331281|NCT00960999|469181531|FG000|Overall Study|RT dose constraints not met|2|||
130331282|NCT00960999|469181532|FG001|Overall Study|RT dose constraints not met|0|||
130331283|NCT01696188|469181533|FG000|Overall Study|Protocol Violation|1|||
130331284|NCT01696188|469181534|FG001|Overall Study|Protocol Violation|1|||
130331285|NCT01918306|469181535|FG000|Overall Study|progresive disease|4|||
130331286|NCT01918306|469181536|FG001|Overall Study|progresive disease|0|||
130331287|NCT01918306|469181537|FG002|Overall Study|progresive disease|1|||
130331288|NCT01918306|469181538|FG003|Overall Study|progresive disease|1|||
130331289|NCT01918306|469181535|FG000|Overall Study|Withdrawal by Subject|0|||
130331290|NCT01918306|469181536|FG001|Overall Study|Withdrawal by Subject|0|||
130331291|NCT01918306|469181537|FG002|Overall Study|Withdrawal by Subject|0|||
130331292|NCT01918306|469181538|FG003|Overall Study|Withdrawal by Subject|2|||
130331293|NCT01918306|469181535|FG000|Overall Study|neutropenia|1|||
130331294|NCT01918306|469181536|FG001|Overall Study|neutropenia|0|||
130331295|NCT01918306|469181537|FG002|Overall Study|neutropenia|0|||
130331296|NCT01918306|469181538|FG003|Overall Study|neutropenia|0|||
130331297|NCT01918306|469181535|FG000|Overall Study|Lack of Efficacy|1|||
130331298|NCT01918306|469181536|FG001|Overall Study|Lack of Efficacy|0|||
130215898|NCT04750278|468753875|FG000|Overall Study|Withdrawal by Subject|4|||
130215899|NCT04750278|468753876|FG001|Overall Study|Withdrawal by Subject|1|||
130215900|NCT04750278|468753877|FG002|Overall Study|Withdrawal by Subject|2|||
130215901|NCT04750278|468753875|FG000|Overall Study|Lost to Follow-up|1|||
130331299|NCT01918306|469181537|FG002|Overall Study|Lack of Efficacy|0|||
130331300|NCT01918306|469181538|FG003|Overall Study|Lack of Efficacy|0|||
130331301|NCT01918306|469181535|FG000|Overall Study|progress disease, crossover|0|||
130331302|NCT01918306|469181536|FG001|Overall Study|progress disease, crossover|0|||
130331303|NCT01918306|469181537|FG002|Overall Study|progress disease, crossover|1|||
130331304|NCT01918306|469181538|FG003|Overall Study|progress disease, crossover|0|||
130331305|NCT01958164|469181540|FG000|Overall Study|Adverse Event|0|||
130331306|NCT01958164|469181541|FG001|Overall Study|Adverse Event|2|||
130215902|NCT04750278|468753876|FG001|Overall Study|Lost to Follow-up|1|||
130331307|NCT01958164|469181540|FG000|Overall Study|Lost to Follow-up|2|||
130331308|NCT01958164|469181541|FG001|Overall Study|Lost to Follow-up|3|||
130331309|NCT02963506|469181542|FG000|Double-Blind Period|Adverse Event|0|||
130331310|NCT02963506|469181543|FG001|Double-Blind Period|Adverse Event|0|||
130331311|NCT02963506|469181544|FG002|Double-Blind Period|Adverse Event|1|||
130215903|NCT04750278|468753877|FG002|Overall Study|Lost to Follow-up|1|||
130331312|NCT02963506|469181545|FG003|Double-Blind Period|Adverse Event|0|||
130331313|NCT02963506|469181546|FG004|Double-Blind Period|Adverse Event|0|||
130331314|NCT02963506|469181547|FG005|Double-Blind Period|Adverse Event|0|||
130331315|NCT02963506|469181548|FG006|Double-Blind Period|Adverse Event|0|||
130331316|NCT02963506|469181549|FG007|Double-Blind Period|Adverse Event|0|||
130331317|NCT02963506|469181550|FG008|Double-Blind Period|Adverse Event|0|||
130331318|NCT02963506|469181551|FG009|Double-Blind Period|Adverse Event|0|||
130331319|NCT02963506|469181552|FG010|Double-Blind Period|Adverse Event|0|||
130331320|NCT02963506|469181553|FG011|Double-Blind Period|Adverse Event|0|||
130331321|NCT02963506|469181554|FG012|Double-Blind Period|Adverse Event|0|||
130331322|NCT02963506|469181542|FG000|Double-Blind Period|Death|0|||
130331323|NCT02963506|469181543|FG001|Double-Blind Period|Death|0|||
130331324|NCT02963506|469181544|FG002|Double-Blind Period|Death|0|||
130331325|NCT02963506|469181545|FG003|Double-Blind Period|Death|1|||
130331326|NCT02963506|469181546|FG004|Double-Blind Period|Death|0|||
130331327|NCT02963506|469181547|FG005|Double-Blind Period|Death|0|||
130331328|NCT02963506|469181548|FG006|Double-Blind Period|Death|0|||
130331329|NCT02963506|469181549|FG007|Double-Blind Period|Death|0|||
130331330|NCT02963506|469181550|FG008|Double-Blind Period|Death|0|||
130331331|NCT02963506|469181551|FG009|Double-Blind Period|Death|0|||
130331332|NCT02963506|469181552|FG010|Double-Blind Period|Death|0|||
130331333|NCT02963506|469181553|FG011|Double-Blind Period|Death|0|||
130331334|NCT02963506|469181554|FG012|Double-Blind Period|Death|0|||
130331335|NCT02963506|469181542|FG000|Double-Blind Period|Lost to Follow-up|0|||
130331336|NCT02963506|469181543|FG001|Double-Blind Period|Lost to Follow-up|1|||
130331337|NCT02963506|469181544|FG002|Double-Blind Period|Lost to Follow-up|0|||
130331338|NCT02963506|469181545|FG003|Double-Blind Period|Lost to Follow-up|0|||
130331339|NCT02963506|469181546|FG004|Double-Blind Period|Lost to Follow-up|0|||
130331340|NCT02963506|469181547|FG005|Double-Blind Period|Lost to Follow-up|0|||
130331341|NCT02963506|469181548|FG006|Double-Blind Period|Lost to Follow-up|0|||
130331342|NCT02963506|469181549|FG007|Double-Blind Period|Lost to Follow-up|0|||
130331343|NCT02963506|469181550|FG008|Double-Blind Period|Lost to Follow-up|0|||
130331344|NCT02963506|469181551|FG009|Double-Blind Period|Lost to Follow-up|0|||
130331345|NCT02963506|469181552|FG010|Double-Blind Period|Lost to Follow-up|0|||
130331346|NCT02963506|469181553|FG011|Double-Blind Period|Lost to Follow-up|0|||
130331347|NCT02963506|469181554|FG012|Double-Blind Period|Lost to Follow-up|0|||
130331348|NCT02963506|469181542|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130331349|NCT02963506|469181543|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130331350|NCT02963506|469181544|FG002|Double-Blind Period|Withdrawal by Subject|1|||
130331351|NCT02963506|469181545|FG003|Double-Blind Period|Withdrawal by Subject|1|||
130331352|NCT02963506|469181546|FG004|Double-Blind Period|Withdrawal by Subject|0|||
130331353|NCT02963506|469181547|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130331354|NCT02963506|469181548|FG006|Double-Blind Period|Withdrawal by Subject|0|||
130331355|NCT02963506|469181549|FG007|Double-Blind Period|Withdrawal by Subject|0|||
130331356|NCT02963506|469181550|FG008|Double-Blind Period|Withdrawal by Subject|0|||
130331357|NCT02963506|469181551|FG009|Double-Blind Period|Withdrawal by Subject|0|||
130331358|NCT02963506|469181552|FG010|Double-Blind Period|Withdrawal by Subject|0|||
130331359|NCT02963506|469181553|FG011|Double-Blind Period|Withdrawal by Subject|0|||
130331360|NCT02963506|469181554|FG012|Double-Blind Period|Withdrawal by Subject|0|||
130331361|NCT02963506|469181542|FG000|Double-Blind Period|No compliance|0|||
130331362|NCT02963506|469181543|FG001|Double-Blind Period|No compliance|1|||
130331363|NCT02963506|469181544|FG002|Double-Blind Period|No compliance|0|||
130331364|NCT02963506|469181545|FG003|Double-Blind Period|No compliance|0|||
130331365|NCT02963506|469181546|FG004|Double-Blind Period|No compliance|0|||
130331366|NCT02963506|469181547|FG005|Double-Blind Period|No compliance|0|||
130331367|NCT02963506|469181548|FG006|Double-Blind Period|No compliance|0|||
130331368|NCT02963506|469181549|FG007|Double-Blind Period|No compliance|0|||
130331369|NCT02963506|469181550|FG008|Double-Blind Period|No compliance|0|||
130331370|NCT02963506|469181551|FG009|Double-Blind Period|No compliance|0|||
130331371|NCT02963506|469181552|FG010|Double-Blind Period|No compliance|0|||
130331372|NCT02963506|469181553|FG011|Double-Blind Period|No compliance|0|||
130331373|NCT02963506|469181554|FG012|Double-Blind Period|No compliance|0|||
130331374|NCT02963506|469181542|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331375|NCT02963506|469181543|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
130331376|NCT02963506|469181544|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331377|NCT02963506|469181545|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331378|NCT02963506|469181546|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331379|NCT02963506|469181547|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331380|NCT02963506|469181548|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331381|NCT02963506|469181549|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331382|NCT02963506|469181550|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331383|NCT02963506|469181551|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331384|NCT02963506|469181552|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331385|NCT02963506|469181553|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331386|NCT02963506|469181554|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331387|NCT02963506|469181542|FG000|Dose-Blind Period|Adverse Event|0|||
130331388|NCT02963506|469181543|FG001|Dose-Blind Period|Adverse Event|0|||
130331389|NCT02963506|469181544|FG002|Dose-Blind Period|Adverse Event|0|||
130331390|NCT02963506|469181545|FG003|Dose-Blind Period|Adverse Event|0|||
130331391|NCT02963506|469181546|FG004|Dose-Blind Period|Adverse Event|0|||
130331392|NCT02963506|469181547|FG005|Dose-Blind Period|Adverse Event|1|||
130331393|NCT02963506|469181548|FG006|Dose-Blind Period|Adverse Event|3|||
130331394|NCT02963506|469181549|FG007|Dose-Blind Period|Adverse Event|2|||
130331395|NCT02963506|469181550|FG008|Dose-Blind Period|Adverse Event|2|||
130331396|NCT02963506|469181551|FG009|Dose-Blind Period|Adverse Event|2|||
130331397|NCT02963506|469181552|FG010|Dose-Blind Period|Adverse Event|1|||
130331398|NCT02963506|469181553|FG011|Dose-Blind Period|Adverse Event|1|||
130331399|NCT02963506|469181554|FG012|Dose-Blind Period|Adverse Event|6|||
130331400|NCT02963506|469181542|FG000|Dose-Blind Period|Lack of Efficacy|0|||
130331401|NCT02963506|469181543|FG001|Dose-Blind Period|Lack of Efficacy|0|||
130331402|NCT02963506|469181544|FG002|Dose-Blind Period|Lack of Efficacy|0|||
130331403|NCT02963506|469181545|FG003|Dose-Blind Period|Lack of Efficacy|0|||
130331404|NCT02963506|469181546|FG004|Dose-Blind Period|Lack of Efficacy|0|||
130331405|NCT02963506|469181547|FG005|Dose-Blind Period|Lack of Efficacy|0|||
130331406|NCT02963506|469181548|FG006|Dose-Blind Period|Lack of Efficacy|0|||
130331407|NCT02963506|469181549|FG007|Dose-Blind Period|Lack of Efficacy|1|||
130660737|NCT03087773|470381495|FG001|Overall Study|Withdrawal by Subject|4|||
130660738|NCT03087773|470381494|FG000|Overall Study|Lost to Follow-up|12|||
130331408|NCT02963506|469181550|FG008|Dose-Blind Period|Lack of Efficacy|0|||
130331409|NCT02963506|469181551|FG009|Dose-Blind Period|Lack of Efficacy|1|||
130331410|NCT02963506|469181552|FG010|Dose-Blind Period|Lack of Efficacy|0|||
130331411|NCT02963506|469181553|FG011|Dose-Blind Period|Lack of Efficacy|0|||
130331412|NCT02963506|469181554|FG012|Dose-Blind Period|Lack of Efficacy|0|||
130331413|NCT02963506|469181542|FG000|Dose-Blind Period|Lost to Follow-up|0|||
130331414|NCT02963506|469181543|FG001|Dose-Blind Period|Lost to Follow-up|0|||
130331415|NCT02963506|469181544|FG002|Dose-Blind Period|Lost to Follow-up|0|||
130331416|NCT02963506|469181545|FG003|Dose-Blind Period|Lost to Follow-up|0|||
130660739|NCT03087773|470381495|FG001|Overall Study|Lost to Follow-up|8|||
130660740|NCT00185731|470381496|FG000|Overall Study|Withdrawal by Subject|1|||
130660741|NCT00185731|470381496|FG000|Overall Study|Not Eligible|1|||
130660742|NCT03891875|470381503|FG000|Overall Study|Withdrawal by Subject|20|||
130660743|NCT03891875|470381504|FG001|Overall Study|Withdrawal by Subject|3|||
130660744|NCT03891875|470381503|FG000|Overall Study|Adverse Event|10|||
130660745|NCT03891875|470381504|FG001|Overall Study|Adverse Event|4|||
130660746|NCT03891875|470381503|FG000|Overall Study|Physician Decision|1|||
130660747|NCT03891875|470381504|FG001|Overall Study|Physician Decision|1|||
130660748|NCT03891875|470381503|FG000|Overall Study|Protocol Violation|1|||
130660749|NCT03891875|470381504|FG001|Overall Study|Protocol Violation|0|||
130660750|NCT03891875|470381503|FG000|Overall Study|Lost to Follow-up|1|||
130660751|NCT03891875|470381504|FG001|Overall Study|Lost to Follow-up|0|||
130660752|NCT03891875|470381503|FG000|Overall Study|COVID-19 infection|1|||
130660753|NCT03891875|470381504|FG001|Overall Study|COVID-19 infection|0|||
130660754|NCT00943384|470381505|FG000|Overall Study|Dispositioned prior to treatment|23|||
130660755|NCT00943384|470381505|FG000|Overall Study|Treated off protocol-protocol violation|5|||
130660756|NCT00943384|470381505|FG000|Overall Study|Lost to Follow-up|16|||
130660757|NCT00943384|470381505|FG000|Overall Study|Withdrawal by Subject|5|||
130660758|NCT00481871|470381511|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
130660759|NCT00481871|470381512|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
130660760|NCT00481871|470381513|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
130660761|NCT00481871|470381514|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
130660762|NCT00481871|470381515|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
130660763|NCT03454672|470381518|FG000|Overall Study|Adverse Event|1|||
130660764|NCT03454672|470381519|FG001|Overall Study|Adverse Event|1|||
130660765|NCT03454672|470381518|FG000|Overall Study|Lost to Follow-up|1|||
130660766|NCT03454672|470381519|FG001|Overall Study|Lost to Follow-up|3|||
130660767|NCT03454672|470381518|FG000|Overall Study|painful|1|||
130660768|NCT03454672|470381519|FG001|Overall Study|painful|2|||
130660769|NCT03454672|470381518|FG000|Overall Study|Non-compliance|2|||
130660770|NCT03454672|470381519|FG001|Overall Study|Non-compliance|4|||
130660771|NCT03454672|470381518|FG000|Overall Study|personal reasons|3|||
130660772|NCT03454672|470381519|FG001|Overall Study|personal reasons|2|||
130331417|NCT02963506|469181546|FG004|Dose-Blind Period|Lost to Follow-up|0|||
130331418|NCT02963506|469181547|FG005|Dose-Blind Period|Lost to Follow-up|1|||
130331419|NCT02963506|469181548|FG006|Dose-Blind Period|Lost to Follow-up|0|||
130331420|NCT02963506|469181549|FG007|Dose-Blind Period|Lost to Follow-up|0|||
130331421|NCT02963506|469181550|FG008|Dose-Blind Period|Lost to Follow-up|1|||
130331422|NCT02963506|469181551|FG009|Dose-Blind Period|Lost to Follow-up|0|||
130660773|NCT03454672|470381518|FG000|Overall Study|Withdrawal by Subject|1|||
130660774|NCT03454672|470381519|FG001|Overall Study|Withdrawal by Subject|0|||
130660775|NCT00402779|470381520|FG000|Overall Study|Screen Failure|77|||
130660776|NCT00402779|470381521|FG001|Overall Study|Screen Failure|76|||
130660777|NCT02149199|470381523|FG000|Overall Study|Study specific withdrawal criteria|4|||
130660778|NCT02149199|470381524|FG001|Overall Study|Study specific withdrawal criteria|21|||
130660779|NCT02149199|470381525|FG002|Overall Study|Study specific withdrawal criteria|6|||
130331423|NCT02963506|469181552|FG010|Dose-Blind Period|Lost to Follow-up|0|||
130331424|NCT02963506|469181553|FG011|Dose-Blind Period|Lost to Follow-up|1|||
130660780|NCT02149199|470381523|FG000|Overall Study|Other|20|||
130660781|NCT02149199|470381524|FG001|Overall Study|Other|25|||
130660782|NCT02149199|470381525|FG002|Overall Study|Other|20|||
130660783|NCT02149199|470381523|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
130660784|NCT02149199|470381524|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
130660785|NCT02149199|470381525|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
130660786|NCT02149199|470381523|FG000|Overall Study|Withdrawal by Subject|75|||
130331425|NCT02963506|469181554|FG012|Dose-Blind Period|Lost to Follow-up|0|||
130331426|NCT02963506|469181542|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
130331427|NCT02963506|469181543|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
130331428|NCT02963506|469181544|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
130331429|NCT02963506|469181545|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
130433215|NCT02277743|469550390|FG000|Overall Study|Adverse Event|10|||
130433216|NCT02277743|469550391|FG001|Overall Study|Adverse Event|6|||
130433217|NCT02277743|469550392|FG002|Overall Study|Adverse Event|6|||
130433218|NCT02277743|469550390|FG000|Overall Study|Lack of Efficacy|11|||
130433219|NCT02277743|469550391|FG001|Overall Study|Lack of Efficacy|4|||
130433220|NCT02277743|469550392|FG002|Overall Study|Lack of Efficacy|3|||
130433221|NCT02277743|469550390|FG000|Overall Study|Other than specified above|18|||
130433222|NCT02277743|469550391|FG001|Overall Study|Other than specified above|5|||
130331430|NCT02963506|469181546|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
130331431|NCT02963506|469181547|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
130331432|NCT02963506|469181548|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
130331433|NCT02963506|469181549|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
130433223|NCT02277743|469550392|FG002|Overall Study|Other than specified above|16|||
130433224|NCT01224158|469550393|FG000|Overall Study|Withdrawal by Subject|1|||
130433225|NCT01224158|469550394|FG001|Overall Study|Withdrawal by Subject|0|||
130433226|NCT02055157|469550395|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130331434|NCT02963506|469181550|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
130331435|NCT02963506|469181551|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
130331436|NCT02963506|469181552|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
130331437|NCT02963506|469181553|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
130331438|NCT02963506|469181554|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
130433227|NCT02055157|469550396|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
130433228|NCT02055157|469550397|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130331439|NCT02963506|469181542|FG000|Dose-Blind Period|Sponsor decision|0|||
130331440|NCT02963506|469181543|FG001|Dose-Blind Period|Sponsor decision|0|||
130331441|NCT02963506|469181544|FG002|Dose-Blind Period|Sponsor decision|0|||
130331442|NCT02963506|469181545|FG003|Dose-Blind Period|Sponsor decision|0|||
130331443|NCT02963506|469181546|FG004|Dose-Blind Period|Sponsor decision|0|||
130331444|NCT02963506|469181547|FG005|Dose-Blind Period|Sponsor decision|1|||
130331445|NCT02963506|469181548|FG006|Dose-Blind Period|Sponsor decision|0|||
130331446|NCT02963506|469181549|FG007|Dose-Blind Period|Sponsor decision|0|||
130331447|NCT02963506|469181550|FG008|Dose-Blind Period|Sponsor decision|0|||
130331448|NCT02963506|469181551|FG009|Dose-Blind Period|Sponsor decision|0|||
130331449|NCT02963506|469181552|FG010|Dose-Blind Period|Sponsor decision|0|||
130331450|NCT02963506|469181553|FG011|Dose-Blind Period|Sponsor decision|0|||
130331451|NCT02963506|469181554|FG012|Dose-Blind Period|Sponsor decision|0|||
130331452|NCT02963506|469181542|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331453|NCT02963506|469181543|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331454|NCT02963506|469181544|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331455|NCT02963506|469181545|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331456|NCT02963506|469181546|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331457|NCT02963506|469181547|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331458|NCT02963506|469181548|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331459|NCT02963506|469181549|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331460|NCT02963506|469181550|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331461|NCT02963506|469181551|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331462|NCT02963506|469181552|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331463|NCT02963506|469181553|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331464|NCT02963506|469181554|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
130331465|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
130331466|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
130331467|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
130331468|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
130331469|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
130331470|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
130331471|NCT00828204|469181557|FG000|Main Study: After Study Restart|Adverse Event|0|||
130433229|NCT02055157|469550398|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130433230|NCT02055157|469550395|FG000|Initial 6 Months|Adverse Event|0|||
130433231|NCT02055157|469550396|FG001|Initial 6 Months|Adverse Event|0|||
130331472|NCT00828204|469181558|FG001|Main Study: After Study Restart|Adverse Event|2|||
130331473|NCT00828204|469181557|FG000|Main Study: After Study Restart|Noncompliance|0|||
130331474|NCT00828204|469181558|FG001|Main Study: After Study Restart|Noncompliance|1|||
130331475|NCT00828204|469181557|FG000|Extension Study|Lost to Follow-up|0|||
130331476|NCT00828204|469181558|FG001|Extension Study|Lost to Follow-up|1|||
130331477|NCT00828204|469181557|FG000|Extension Study|Physician Decision|0|||
130331478|NCT00828204|469181558|FG001|Extension Study|Physician Decision|2|||
130331479|NCT00750438|469181561|FG000|Overall Study|Protocol Violation|4|||
130331480|NCT00750438|469181562|FG001|Overall Study|Protocol Violation|1|||
130331481|NCT00750438|469181561|FG000|Overall Study|Physician Decision|2|||
130331482|NCT00750438|469181562|FG001|Overall Study|Physician Decision|2|||
130331483|NCT00750438|469181561|FG000|Overall Study|Withdrawal by Subject|1|||
130331484|NCT00750438|469181562|FG001|Overall Study|Withdrawal by Subject|1|||
130331485|NCT00928408|469181567|FG000|Overall Study|Other|2|||
130331486|NCT00928408|469181567|FG000|Overall Study|Withdrawal by Subject|4|||
130331487|NCT00928408|469181567|FG000|Overall Study|Death|5|||
130331488|NCT00928408|469181567|FG000|Overall Study|Lost to Follow-up|12|||
130331489|NCT00536744|469181568|FG000|Overall Study|Adverse Event|13|||
130331490|NCT00536744|469181569|FG001|Overall Study|Adverse Event|10|||
130331491|NCT00536744|469181568|FG000|Overall Study|Death|2|||
130331492|NCT00536744|469181569|FG001|Overall Study|Death|1|||
130331493|NCT00536744|469181568|FG000|Overall Study|Physician Decision|3|||
130331494|NCT00536744|469181569|FG001|Overall Study|Physician Decision|1|||
130331495|NCT00536744|469181568|FG000|Overall Study|Lost to Follow-up|3|||
130331496|NCT00536744|469181569|FG001|Overall Study|Lost to Follow-up|5|||
130331497|NCT00536744|469181568|FG000|Overall Study|Withdrawal by Subject|7|||
130331498|NCT00536744|469181569|FG001|Overall Study|Withdrawal by Subject|8|||
130331499|NCT00536744|469181568|FG000|Overall Study|PI tried alternative treatment|1|||
130331500|NCT00536744|469181569|FG001|Overall Study|PI tried alternative treatment|3|||
130331501|NCT02827877|469181570|FG000|Overall Study|Withdrawal by Subject|1|||
130331502|NCT00145158|469183369|FG000|Overall Study|premature withdrawal|2|||
130331503|NCT00145158|469183370|FG001|Overall Study|premature withdrawal|3|||
130331504|NCT03252925|469183371|FG000|Overall Study|Withdrawal by Subject|1|||
130331505|NCT03252925|469183372|FG001|Overall Study|Withdrawal by Subject|0|||
130331506|NCT03252925|469183371|FG000|Overall Study|Protocol Violation|6|||
130331507|NCT03252925|469183372|FG001|Overall Study|Protocol Violation|0|||
130331508|NCT03252925|469183371|FG000|Overall Study|Adverse Event|1|||
130331509|NCT03252925|469183372|FG001|Overall Study|Adverse Event|0|||
130331510|NCT03252925|469183371|FG000|Overall Study|Lost to Follow-up|6|||
130331511|NCT03252925|469183372|FG001|Overall Study|Lost to Follow-up|6|||
130331512|NCT00499616|469183373|FG000|Overall Study|Death|1|||
130331513|NCT00499616|469183374|FG001|Overall Study|Death|5|||
130331514|NCT00499616|469183375|FG002|Overall Study|Death|3|||
130331515|NCT00499616|469183376|FG003|Overall Study|Death|1|||
130331516|NCT00499616|469183373|FG000|Overall Study|Lack of Efficacy|5|||
130331517|NCT00499616|469183374|FG001|Overall Study|Lack of Efficacy|0|||
130331518|NCT00499616|469183375|FG002|Overall Study|Lack of Efficacy|19|||
130331519|NCT00499616|469183376|FG003|Overall Study|Lack of Efficacy|0|||
130331520|NCT00499616|469183373|FG000|Overall Study|Lost to Follow-up|0|||
130331521|NCT00499616|469183374|FG001|Overall Study|Lost to Follow-up|0|||
130331522|NCT00499616|469183375|FG002|Overall Study|Lost to Follow-up|1|||
130331523|NCT00499616|469183376|FG003|Overall Study|Lost to Follow-up|0|||
130331524|NCT00499616|469183373|FG000|Overall Study|Physician Decision|6|||
130331525|NCT00499616|469183374|FG001|Overall Study|Physician Decision|16|||
130331526|NCT00499616|469183375|FG002|Overall Study|Physician Decision|9|||
130331527|NCT00499616|469183376|FG003|Overall Study|Physician Decision|0|||
130331528|NCT00499616|469183373|FG000|Overall Study|Withdrawal by Subject|1|||
130331529|NCT00499616|469183374|FG001|Overall Study|Withdrawal by Subject|0|||
130331530|NCT00499616|469183375|FG002|Overall Study|Withdrawal by Subject|1|||
130331531|NCT00499616|469183376|FG003|Overall Study|Withdrawal by Subject|0|||
130331532|NCT00499616|469183373|FG000|Overall Study|Ineligible|1|||
130331533|NCT00499616|469183374|FG001|Overall Study|Ineligible|2|||
130331534|NCT00499616|469183375|FG002|Overall Study|Ineligible|0|||
130331535|NCT00499616|469183376|FG003|Overall Study|Ineligible|15|||
130331536|NCT00499616|469183373|FG000|Overall Study|Not evaluable|0|||
130331537|NCT00499616|469183374|FG001|Overall Study|Not evaluable|0|||
130331538|NCT00499616|469183375|FG002|Overall Study|Not evaluable|0|||
130331539|NCT00499616|469183376|FG003|Overall Study|Not evaluable|41|||
130331540|NCT00499616|469183373|FG000|Overall Study|Patient/Parent Refusal|1|||
130331541|NCT00499616|469183374|FG001|Overall Study|Patient/Parent Refusal|5|||
130331542|NCT00499616|469183375|FG002|Overall Study|Patient/Parent Refusal|3|||
130331543|NCT00499616|469183376|FG003|Overall Study|Patient/Parent Refusal|0|||
130331544|NCT00123422|469183377|FG000|Overall Study|Physician Decision|2|||
130331545|NCT00123422|469183378|FG001|Overall Study|Physician Decision|2|||
130331546|NCT00123422|469183379|FG002|Overall Study|Physician Decision|6|||
130331547|NCT00123422|469183377|FG000|Overall Study|Withdrawal by Subject|1|||
130331548|NCT00123422|469183378|FG001|Overall Study|Withdrawal by Subject|2|||
130331549|NCT00123422|469183379|FG002|Overall Study|Withdrawal by Subject|2|||
130331550|NCT00123422|469183377|FG000|Overall Study|Lost to Follow-up|1|||
130331551|NCT00123422|469183378|FG001|Overall Study|Lost to Follow-up|2|||
130331552|NCT00123422|469183379|FG002|Overall Study|Lost to Follow-up|2|||
130331553|NCT04555616|469183380|FG000|Overall Study|Death|1|||
130331554|NCT04555616|469183381|FG001|Overall Study|Death|0|||
130331555|NCT04555616|469183382|FG002|Overall Study|Death|1|||
130331556|NCT04555616|469183380|FG000|Overall Study|Withdrawal by Subject|2|||
130331557|NCT04555616|469183381|FG001|Overall Study|Withdrawal by Subject|1|||
130331558|NCT04555616|469183382|FG002|Overall Study|Withdrawal by Subject|0|||
130331559|NCT01938716|469183385|FG000|Overall Study|Physician Decision|2|||
130331560|NCT01938716|469183385|FG000|Overall Study|Withdrawal by Subject|2|||
130331561|NCT01358721|469183386|FG000|Overall Study|Withdrawal by Subject|0|||
130331562|NCT01358721|469183387|FG001|Overall Study|Withdrawal by Subject|0|||
130331563|NCT01358721|469183388|FG002|Overall Study|Withdrawal by Subject|0|||
130331564|NCT01358721|469183389|FG003|Overall Study|Withdrawal by Subject|1|||
130331565|NCT01358721|469183386|FG000|Overall Study|Death|0|||
130331566|NCT01358721|469183387|FG001|Overall Study|Death|2|||
130331567|NCT01358721|469183388|FG002|Overall Study|Death|0|||
130331568|NCT01358721|469183389|FG003|Overall Study|Death|0|||
130331569|NCT01358721|469183386|FG000|Overall Study|Study Drug Toxicity|1|||
130331570|NCT01358721|469183387|FG001|Overall Study|Study Drug Toxicity|3|||
130331571|NCT01358721|469183388|FG002|Overall Study|Study Drug Toxicity|4|||
130331572|NCT01358721|469183389|FG003|Overall Study|Study Drug Toxicity|5|||
130331573|NCT01358721|469183386|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
130215904|NCT04750278|468753875|FG000|Overall Study|Pregnancy|1|||
130215905|NCT04750278|468753876|FG001|Overall Study|Pregnancy|0|||
130215906|NCT04750278|468753877|FG002|Overall Study|Pregnancy|0|||
130215907|NCT04750278|468753875|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130215908|NCT04750278|468753876|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
130215909|NCT04750278|468753877|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130215910|NCT04750278|468753875|FG000|Overall Study|Non-compliance|0|||
130215911|NCT04750278|468753876|FG001|Overall Study|Non-compliance|0|||
130215912|NCT04750278|468753877|FG002|Overall Study|Non-compliance|1|||
130215913|NCT04750278|468753875|FG000|Overall Study|Transfer to Outside Facility|0|||
130215914|NCT04750278|468753876|FG001|Overall Study|Transfer to Outside Facility|2|||
130215915|NCT04750278|468753877|FG002|Overall Study|Transfer to Outside Facility|1|||
130215916|NCT04750278|468753875|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130215917|NCT04750278|468753876|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
130215918|NCT04750278|468753877|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130215919|NCT04750278|468753875|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130215920|NCT04750278|468753876|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130215921|NCT04750278|468753877|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
130215922|NCT02579382|468753880|FG000|Main Study Phase|Lost to Follow-up|0|||
130215923|NCT02579382|468753881|FG001|Main Study Phase|Lost to Follow-up|0|||
130215924|NCT02579382|468753882|FG002|Main Study Phase|Lost to Follow-up|2|||
130215925|NCT02579382|468753883|FG003|Main Study Phase|Lost to Follow-up|0|||
130215926|NCT02579382|468753880|FG000|Main Study Phase|Withdrew Consent|0|||
130215927|NCT02579382|468753881|FG001|Main Study Phase|Withdrew Consent|0|||
130215928|NCT02579382|468753882|FG002|Main Study Phase|Withdrew Consent|0|||
130215929|NCT02579382|468753883|FG003|Main Study Phase|Withdrew Consent|2|||
130215930|NCT02579382|468753880|FG000|Main Study Phase|Lack of Efficacy|0|||
130215931|NCT02579382|468753881|FG001|Main Study Phase|Lack of Efficacy|0|||
130215932|NCT02579382|468753882|FG002|Main Study Phase|Lack of Efficacy|0|||
130215933|NCT02579382|468753883|FG003|Main Study Phase|Lack of Efficacy|1|||
130215934|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
130215935|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
130215936|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
130215937|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
130215938|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
130215939|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130215940|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
130215941|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130215942|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
130215943|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215944|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215945|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215946|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130331574|NCT01358721|469183387|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
130331575|NCT01358721|469183388|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
130331576|NCT01358721|469183389|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
130215947|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
130331577|NCT01358721|469183386|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130331578|NCT01358721|469183387|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130331579|NCT01358721|469183388|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130331580|NCT01358721|469183389|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
130331581|NCT01358721|469183386|FG000|Overall Study|Adverse Event related to study drug|1|||
130331582|NCT01358721|469183387|FG001|Overall Study|Adverse Event related to study drug|0|||
130331583|NCT01358721|469183388|FG002|Overall Study|Adverse Event related to study drug|0|||
130331584|NCT01358721|469183389|FG003|Overall Study|Adverse Event related to study drug|1|||
130331585|NCT01358721|469183386|FG000|Overall Study|Disease Progression|19|||
130331586|NCT01358721|469183387|FG001|Overall Study|Disease Progression|15|||
130331587|NCT01358721|469183388|FG002|Overall Study|Disease Progression|17|||
130331588|NCT01358721|469183389|FG003|Overall Study|Disease Progression|15|||
130331589|NCT01358721|469183386|FG000|Overall Study|Out of State/Unmet Criteria|0|||
130331590|NCT01358721|469183387|FG001|Overall Study|Out of State/Unmet Criteria|0|||
130331591|NCT01358721|469183388|FG002|Overall Study|Out of State/Unmet Criteria|1|||
130331592|NCT01358721|469183389|FG003|Overall Study|Out of State/Unmet Criteria|0|||
130331593|NCT01908803|469183390|FG000|Overall Study|Adverse Event|1|||
130331594|NCT01908803|469183391|FG001|Overall Study|Adverse Event|0|||
130331595|NCT01908803|469183390|FG000|Overall Study|Physician Decision|0|||
130331596|NCT01908803|469183391|FG001|Overall Study|Physician Decision|1|||
130331597|NCT01908803|469183390|FG000|Overall Study|Withdrawal by Subject|1|||
130215948|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130215949|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130215950|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215951|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
130215952|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215953|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215954|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215955|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
130215956|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215957|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215958|NCT01775787|468753884|FG000|First 7-10 Days|Adverse Event|0|||
130215959|NCT01775787|468753885|FG001|First 7-10 Days|Adverse Event|1|||
130215960|NCT01775787|468753884|FG000|First 7-10 Days|family emergency|0|||
130215961|NCT01775787|468753885|FG001|First 7-10 Days|family emergency|1|||
130215962|NCT01775787|468753884|FG000|First 7-10 Days|time commitment|0|||
130215963|NCT01775787|468753885|FG001|First 7-10 Days|time commitment|2|||
130215964|NCT01775787|468753884|FG000|First 7-10 Days|concerns with using IV|1|||
130215965|NCT01775787|468753885|FG001|First 7-10 Days|concerns with using IV|2|||
130215966|NCT01775787|468753884|FG000|Second 7-10 Days|time commitment|0|||
130215967|NCT01775787|468753885|FG001|Second 7-10 Days|time commitment|1|||
130215968|NCT01775787|468753884|FG000|Second 7-10 Days|concerns with using IV|0|||
130215969|NCT01775787|468753885|FG001|Second 7-10 Days|concerns with using IV|1|||
130215970|NCT04076319|468753895|FG000|Overall Study|Withdrawal by Subject|2|||
130215971|NCT04076319|468753896|FG001|Overall Study|Withdrawal by Subject|0|||
130215972|NCT04076319|468753895|FG000|Overall Study|Death|1|||
130215973|NCT04076319|468753896|FG001|Overall Study|Death|0|||
130215974|NCT01054222|468753897|FG000|Overall Study|Lack of Efficacy|1|||
130215975|NCT01054222|468753897|FG000|Overall Study|Lost to Follow-up|4|||
130215976|NCT01054222|468753897|FG000|Overall Study|Withdrawal by Subject|6|||
130215977|NCT00824655|468753898|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
130215978|NCT00824655|468753899|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
130215979|NCT00824655|468753898|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
130215980|NCT00824655|468753899|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
130215981|NCT03252145|468753900|FG000|Overall Study|Withdrawal by Subject|1|||
130215982|NCT03252145|468753901|FG001|Overall Study|Withdrawal by Subject|0|||
130215983|NCT03252145|468753900|FG000|Overall Study|Complicating Disease|1|||
130215984|NCT03252145|468753901|FG001|Overall Study|Complicating Disease|2|||
130215985|NCT03504189|468753902|FG000|Overall Study|Withdrawal by Subject|1|||
130215986|NCT03504189|468753902|FG000|Overall Study|Screening Failure|1|||
130215987|NCT03504189|468753902|FG000|Overall Study|Device Failure|2|||
130215988|NCT03091738|468753903|FG000|Overall Study|Adverse Event|1|||
130215989|NCT03091738|468753903|FG000|Overall Study|Lost to Follow-up|1|||
130215990|NCT04336475|468753904|FG000|Overall Study|pain|1|||
130215991|NCT04336475|468753905|FG001|Overall Study|pain|0|||
130215992|NCT04336475|468753904|FG000|Overall Study|upper respiratory infection|1|||
130215993|NCT04336475|468753905|FG001|Overall Study|upper respiratory infection|0|||
130215994|NCT04336475|468753904|FG000|Overall Study|Lost to Follow-up|0|||
130215995|NCT04336475|468753905|FG001|Overall Study|Lost to Follow-up|2|||
130215996|NCT00199849|468753918|FG000|Overall Study|Unrelated illness or complication|0|||
130215997|NCT00199849|468753919|FG001|Overall Study|Unrelated illness or complication|1|||
130215998|NCT00199849|468753920|FG002|Overall Study|Unrelated illness or complication|0|||
130331598|NCT01908803|469183391|FG001|Overall Study|Withdrawal by Subject|0|||
130331599|NCT01908803|469183390|FG000|Overall Study|Randomization Error|1|||
130215999|NCT00199849|468753918|FG000|Overall Study|Progressive disease requiring intervention|0|||
130216000|NCT00199849|468753919|FG001|Overall Study|Progressive disease requiring intervention|0|||
130331600|NCT01908803|469183391|FG001|Overall Study|Randomization Error|0|||
130331601|NCT01908803|469183390|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
130331602|NCT01908803|469183391|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
130331603|NCT00867815|469183392|FG000|Overall Study|Lost to Follow-up|1|||
130331604|NCT00001213|469183393|FG000|Overall Study|Death|18|||
130331605|NCT01554241|469183394|FG000|Overall Study|Death|3|||
130331606|NCT01554241|469183395|FG001|Overall Study|Death|1|||
130331607|NCT01554241|469183396|FG002|Overall Study|Death|1|||
130331608|NCT01554241|469183397|FG003|Overall Study|Death|0|||
130331609|NCT01554241|469183394|FG000|Overall Study|protocol specified renal stone|0|||
130331610|NCT01554241|469183395|FG001|Overall Study|protocol specified renal stone|0|||
130331611|NCT01554241|469183396|FG002|Overall Study|protocol specified renal stone|0|||
130331612|NCT01554241|469183397|FG003|Overall Study|protocol specified renal stone|1|||
130331613|NCT01554241|469183394|FG000|Overall Study|protocol specified change in eGFR|0|||
130331614|NCT01554241|469183395|FG001|Overall Study|protocol specified change in eGFR|0|||
130331615|NCT01554241|469183396|FG002|Overall Study|protocol specified change in eGFR|1|||
130331616|NCT01554241|469183397|FG003|Overall Study|protocol specified change in eGFR|0|||
130331617|NCT01554241|469183394|FG000|Overall Study|Withdrawal by Subject|0|||
130331618|NCT01554241|469183395|FG001|Overall Study|Withdrawal by Subject|0|||
130331619|NCT01554241|469183396|FG002|Overall Study|Withdrawal by Subject|2|||
130331620|NCT01554241|469183397|FG003|Overall Study|Withdrawal by Subject|0|||
130331621|NCT00372593|469183404|FG000|Overall Study|Adverse Event|43|||
130331622|NCT00372593|469183405|FG001|Overall Study|Adverse Event|45|||
130331623|NCT00372593|469183406|FG002|Overall Study|Adverse Event|0|||
130331624|NCT00372593|469183404|FG000|Overall Study|Death|16|||
130331625|NCT00372593|469183405|FG001|Overall Study|Death|20|||
130331626|NCT00372593|469183406|FG002|Overall Study|Death|1|||
130331627|NCT00372593|469183404|FG000|Overall Study|Lack of Efficacy|82|||
130331628|NCT00372593|469183405|FG001|Overall Study|Lack of Efficacy|71|||
130331629|NCT00372593|469183406|FG002|Overall Study|Lack of Efficacy|2|||
130331630|NCT00372593|469183404|FG000|Overall Study|Lost to Follow-up|1|||
130331631|NCT00372593|469183405|FG001|Overall Study|Lost to Follow-up|0|||
130331632|NCT00372593|469183406|FG002|Overall Study|Lost to Follow-up|0|||
130331633|NCT00372593|469183404|FG000|Overall Study|Physician Decision|42|||
130331634|NCT00372593|469183405|FG001|Overall Study|Physician Decision|41|||
130331635|NCT00372593|469183406|FG002|Overall Study|Physician Decision|0|||
130331636|NCT00372593|469183404|FG000|Overall Study|Ineligible|20|||
130331637|NCT00372593|469183405|FG001|Overall Study|Ineligible|21|||
130331638|NCT00372593|469183406|FG002|Overall Study|Ineligible|1|||
130331639|NCT00433004|469183407|FG000|Overall Study|Lost to Follow-up|5|||
130331640|NCT00433004|469183408|FG001|Overall Study|Lost to Follow-up|7|||
130331641|NCT03534180|469183409|FG000|Overall Study|Withdrawal by Subject|1|||
130331642|NCT00220636|469183410|FG000|Overall Study|Withdrawal by Subject|4|||
130331643|NCT00330967|469183411|FG000|Overall Study|Withdrawal by Subject|0|||
130331644|NCT00330967|469183412|FG001|Overall Study|Withdrawal by Subject|5|||
130331645|NCT00330967|469183411|FG000|Overall Study|Physician Decision|0|||
130331646|NCT00330967|469183412|FG001|Overall Study|Physician Decision|9|||
130331647|NCT00790088|469183415|FG000|Overall Study|Protocol Violation|11|||
130331648|NCT00790088|469183415|FG000|Overall Study|Withdrawal by Subject|17|||
130331649|NCT00790088|469183415|FG000|Overall Study|Lost to Follow-up|7|||
130331650|NCT00790088|469183415|FG000|Overall Study|Physician Decision|4|||
130331651|NCT05661409|469183416|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
130331652|NCT05661409|469183417|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
130331653|NCT05661409|469183418|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
130331654|NCT05661409|469183419|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
130331655|NCT05661409|469183420|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
130331656|NCT05661409|469183421|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
130331657|NCT05661409|469183416|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
130331658|NCT05661409|469183417|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
130331659|NCT05661409|469183418|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
130331660|NCT05661409|469183419|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
130331661|NCT05661409|469183420|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
130331662|NCT05661409|469183421|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
130331663|NCT05661409|469183416|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331664|NCT05661409|469183417|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331665|NCT05661409|469183418|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331666|NCT05661409|469183419|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
130331667|NCT05661409|469183420|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130331668|NCT05661409|469183421|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130331669|NCT05661409|469183416|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331670|NCT05661409|469183417|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331671|NCT05661409|469183418|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331672|NCT05661409|469183419|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331673|NCT05661409|469183420|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331674|NCT05661409|469183421|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
130331675|NCT05661409|469183416|FG000|Overall Study|Miscommu-nication about administration|0|||
130331676|NCT05661409|469183417|FG001|Overall Study|Miscommu-nication about administration|0|||
130331677|NCT05661409|469183418|FG002|Overall Study|Miscommu-nication about administration|0|||
130331678|NCT05661409|469183419|FG003|Overall Study|Miscommu-nication about administration|0|||
130331679|NCT05661409|469183420|FG004|Overall Study|Miscommu-nication about administration|0|||
130331680|NCT05661409|469183421|FG005|Overall Study|Miscommu-nication about administration|1|||
130331681|NCT04439136|469183422|FG000|Overall Study|Ineligible|1|||
130331682|NCT04439136|469183422|FG000|Overall Study|Never Started Treatment|2|||
130331683|NCT04439136|469183422|FG000|Overall Study|Adverse Event|4|||
130331684|NCT04439136|469183422|FG000|Overall Study|Death|3|||
130331685|NCT04439136|469183422|FG000|Overall Study|Disease Progression|27|||
130331686|NCT04439136|469183422|FG000|Overall Study|Alternative Therapy|1|||
130331687|NCT04439136|469183422|FG000|Overall Study|Increased Tumor Burden|1|||
130331688|NCT04439136|469183422|FG000|Overall Study|Symptomatic Detrioration|1|||
130331689|NCT02578706|469183425|FG000|Overall Study|Withdrawal by Subject|1|||
130331690|NCT02578706|469183426|FG001|Overall Study|Withdrawal by Subject|0|||
130331691|NCT02578706|469183427|FG002|Overall Study|Withdrawal by Subject|0|||
130331692|NCT02578706|469183425|FG000|Overall Study|Lost to Follow-up|0|||
130331693|NCT02578706|469183426|FG001|Overall Study|Lost to Follow-up|4|||
130331694|NCT02578706|469183427|FG002|Overall Study|Lost to Follow-up|0|||
130331695|NCT02578706|469183425|FG000|Overall Study|Physician Decision|0|||
130331696|NCT02578706|469183426|FG001|Overall Study|Physician Decision|1|||
130331697|NCT02578706|469183427|FG002|Overall Study|Physician Decision|0|||
130331698|NCT01662102|469183432|FG000|Overall Study|Sponsor's decision|1|||
130331699|NCT01662102|469183433|FG001|Overall Study|Sponsor's decision|0|||
130331700|NCT01995838|469183436|FG000|Overall Study|Lost to Follow-up|0|||
130331701|NCT01995838|469183437|FG001|Overall Study|Lost to Follow-up|1|||
130331702|NCT01995838|469183438|FG002|Overall Study|Lost to Follow-up|0|||
130331703|NCT01995838|469183439|FG003|Overall Study|Lost to Follow-up|0|||
130331704|NCT01995838|469183440|FG004|Overall Study|Lost to Follow-up|0|||
130331705|NCT01995838|469183441|FG005|Overall Study|Lost to Follow-up|0|||
130331706|NCT01995838|469183442|FG006|Overall Study|Lost to Follow-up|1|||
130331707|NCT01995838|469183436|FG000|Overall Study|Participant choice|2|||
130331708|NCT01995838|469183437|FG001|Overall Study|Participant choice|0|||
130331709|NCT01995838|469183438|FG002|Overall Study|Participant choice|0|||
130331710|NCT01995838|469183439|FG003|Overall Study|Participant choice|0|||
130331711|NCT01995838|469183440|FG004|Overall Study|Participant choice|0|||
130331712|NCT01995838|469183441|FG005|Overall Study|Participant choice|1|||
130331713|NCT01995838|469183442|FG006|Overall Study|Participant choice|1|||
130331714|NCT01995838|469183436|FG000|Overall Study|Adverse Event|0|||
130331715|NCT01995838|469183437|FG001|Overall Study|Adverse Event|0|||
130331716|NCT01995838|469183438|FG002|Overall Study|Adverse Event|0|||
130331717|NCT01995838|469183439|FG003|Overall Study|Adverse Event|0|||
130331718|NCT01995838|469183440|FG004|Overall Study|Adverse Event|0|||
130331719|NCT01995838|469183441|FG005|Overall Study|Adverse Event|0|||
130331720|NCT01995838|469183442|FG006|Overall Study|Adverse Event|1|||
130331721|NCT01995838|469183436|FG000|Overall Study|Withdrawal by Subject|0|||
130331722|NCT01995838|469183437|FG001|Overall Study|Withdrawal by Subject|0|||
130331723|NCT01995838|469183438|FG002|Overall Study|Withdrawal by Subject|0|||
130331724|NCT01995838|469183439|FG003|Overall Study|Withdrawal by Subject|0|||
130331725|NCT01995838|469183440|FG004|Overall Study|Withdrawal by Subject|1|||
130331726|NCT01995838|469183441|FG005|Overall Study|Withdrawal by Subject|0|||
130331727|NCT01995838|469183442|FG006|Overall Study|Withdrawal by Subject|0|||
130331728|NCT01995838|469183436|FG000|Overall Study|Other|3|||
130331729|NCT01995838|469183437|FG001|Overall Study|Other|1|||
130331730|NCT01995838|469183438|FG002|Overall Study|Other|0|||
130331731|NCT01995838|469183439|FG003|Overall Study|Other|2|||
130331732|NCT01995838|469183440|FG004|Overall Study|Other|1|||
130331733|NCT01995838|469183441|FG005|Overall Study|Other|1|||
130331734|NCT01995838|469183442|FG006|Overall Study|Other|2|||
130331735|NCT00380367|469183445|FG000|Overall Study|Lost to Follow-up|1|||
130331736|NCT00380367|469183445|FG000|Overall Study|Withdrawal by Subject|1|||
130331737|NCT00439517|469183453|FG000|Overall Study|Subject on treatment|1|||
130331738|NCT00439517|469183454|FG001|Overall Study|Subject on treatment|0|||
130331739|NCT00439517|469183453|FG000|Overall Study|Subject in survival follow-up|1|||
130331740|NCT00439517|469183454|FG001|Overall Study|Subject in survival follow-up|0|||
130331741|NCT01519921|469183464|FG000|Overall Study|Adverse Event|10|||
130331742|NCT01519921|469183465|FG001|Overall Study|Adverse Event|9|||
130331743|NCT01519921|469183464|FG000|Overall Study|Lack of Efficacy|4|||
130331744|NCT01519921|469183465|FG001|Overall Study|Lack of Efficacy|3|||
130331745|NCT01519921|469183464|FG000|Overall Study|Withdrawal by Subject|3|||
130331746|NCT01519921|469183465|FG001|Overall Study|Withdrawal by Subject|0|||
130331747|NCT01519921|469183464|FG000|Overall Study|Lost to Follow-up|2|||
130331748|NCT01519921|469183465|FG001|Overall Study|Lost to Follow-up|1|||
130331749|NCT01519921|469183464|FG000|Overall Study|Treatment refusal|2|||
130331750|NCT01519921|469183465|FG001|Overall Study|Treatment refusal|1|||
130331751|NCT01519921|469183464|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
130331752|NCT01519921|469183465|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
130331753|NCT00060840|469183468|FG000|Overall Study|Change in surgical plan|2|||
130331754|NCT00060840|469183469|FG001|Overall Study|Change in surgical plan|6|||
130331755|NCT00060840|469183468|FG000|Overall Study|Death|0|||
130331756|NCT00060840|469183469|FG001|Overall Study|Death|1|||
130331757|NCT00060840|469183468|FG000|Overall Study|Withdrawal by Subject|0|||
130331758|NCT00060840|469183469|FG001|Overall Study|Withdrawal by Subject|1|||
130331759|NCT00060840|469183468|FG000|Overall Study|Subinvestigator unavailable|0|||
130331760|NCT00060840|469183469|FG001|Overall Study|Subinvestigator unavailable|1|||
130331761|NCT00060840|469183468|FG000|Overall Study|Physician Decision|1|||
130331762|NCT00060840|469183469|FG001|Overall Study|Physician Decision|0|||
130331763|NCT00060840|469183468|FG000|Overall Study|Other|1|||
130331764|NCT00060840|469183469|FG001|Overall Study|Other|0|||
130331765|NCT01216189|469183474|FG000|Overall Study|Lost to Follow-up|21|||
130331766|NCT01216189|469183475|FG001|Overall Study|Lost to Follow-up|3|||
130331767|NCT01216189|469183474|FG000|Overall Study|Death|4|||
130331768|NCT01216189|469183475|FG001|Overall Study|Death|2|||
130331769|NCT00125164|469183476|FG000|Overall Study|Adverse Event|0|||
130331770|NCT00125164|469183477|FG001|Overall Study|Adverse Event|0|||
130331771|NCT00125164|469183478|FG002|Overall Study|Adverse Event|2|||
130331772|NCT00125164|469183479|FG003|Overall Study|Adverse Event|4|||
130331773|NCT00125164|469183476|FG000|Overall Study|Lost to Follow-up|0|||
130331774|NCT00125164|469183477|FG001|Overall Study|Lost to Follow-up|0|||
130331775|NCT00125164|469183478|FG002|Overall Study|Lost to Follow-up|1|||
130331776|NCT00125164|469183479|FG003|Overall Study|Lost to Follow-up|1|||
130331777|NCT00125164|469183476|FG000|Overall Study|Withdrawal by Subject|2|||
130331778|NCT00125164|469183477|FG001|Overall Study|Withdrawal by Subject|0|||
130331779|NCT00125164|469183478|FG002|Overall Study|Withdrawal by Subject|1|||
130331780|NCT00125164|469183479|FG003|Overall Study|Withdrawal by Subject|1|||
130331781|NCT01339052|469183480|FG000|Overall Study|Disease progression|13|||
130331782|NCT01339052|469183481|FG001|Overall Study|Disease progression|46|||
130331783|NCT01339052|469183480|FG000|Overall Study|Adverse Event|1|||
130331784|NCT01339052|469183481|FG001|Overall Study|Adverse Event|1|||
130331785|NCT01339052|469183480|FG000|Overall Study|Withdrawal by Subject|0|||
130331786|NCT01339052|469183481|FG001|Overall Study|Withdrawal by Subject|3|||
130331787|NCT01339052|469183480|FG000|Overall Study|Physician Decision|1|||
130331788|NCT01339052|469183481|FG001|Overall Study|Physician Decision|0|||
130331789|NCT02637037|469183482|FG000|Overall Study|Positive drug screen at admission|1|||
130331790|NCT02637037|469183483|FG001|Overall Study|Positive drug screen at admission|0|||
130331791|NCT02637037|469183482|FG000|Overall Study|Withdrawal by Subject|2|||
130331792|NCT02637037|469183483|FG001|Overall Study|Withdrawal by Subject|1|||
130331793|NCT02637037|469183482|FG000|Overall Study|Adverse Event|1|||
130331794|NCT02637037|469183483|FG001|Overall Study|Adverse Event|0|||
130331795|NCT01469377|469183486|FG000|Overall Study|Protocol Deviation|7|||
130331796|NCT01469377|469183487|FG001|Overall Study|Protocol Deviation|10|||
130331797|NCT01469377|469183488|FG002|Overall Study|Protocol Deviation|10|||
130331798|NCT01469377|469183486|FG000|Overall Study|Lost to Follow-up|3|||
130331799|NCT01469377|469183487|FG001|Overall Study|Lost to Follow-up|2|||
130331800|NCT01469377|469183488|FG002|Overall Study|Lost to Follow-up|5|||
130331801|NCT01469377|469183486|FG000|Overall Study|Withdrawal of Consent|12|||
130331802|NCT01469377|469183487|FG001|Overall Study|Withdrawal of Consent|14|||
130331803|NCT01469377|469183488|FG002|Overall Study|Withdrawal of Consent|15|||
130331804|NCT01469377|469183486|FG000|Overall Study|Adverse Event|8|||
130331805|NCT01469377|469183487|FG001|Overall Study|Adverse Event|18|||
130331806|NCT01469377|469183488|FG002|Overall Study|Adverse Event|36|||
130331807|NCT01469377|469183486|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130331808|NCT01469377|469183487|FG001|Overall Study|Insufficient Therapeutic Response|4|||
130331809|NCT01469377|469183488|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130331810|NCT01469377|469183486|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130331811|NCT01469377|469183487|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130331812|NCT01469377|469183488|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130331813|NCT01733680|469183489|FG000|Overall Study|Withdrawal by Subject|0|||
130331814|NCT01733680|469183490|FG001|Overall Study|Withdrawal by Subject|1|||
130331815|NCT04308291|469183497|FG000|Run-In Phase|Withdrawal by Subject|4|||
130331816|NCT04308291|469183497|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
130331817|NCT04308291|469183497|FG000|Study Phase 6-M|Physician Decision|2|||
130331818|NCT04308291|469183497|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
130331819|NCT04308291|469183497|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
130331820|NCT04308291|469183497|FG000|Study Phase 12-M|Physician Decision|2|||
130331821|NCT04308291|469183497|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
130331822|NCT02565108|469183498|FG000|Overall Study|Adverse Event|1|||
130331823|NCT02565108|469183499|FG001|Overall Study|Adverse Event|0|||
130331824|NCT02565108|469183498|FG000|Overall Study|Withdrew Consent|1|||
130331825|NCT02565108|469183499|FG001|Overall Study|Withdrew Consent|0|||
130331826|NCT02453711|469183500|FG000|Overall Study|Withdrawal by Subject|5|||
130331827|NCT02453711|469183501|FG001|Overall Study|Withdrawal by Subject|4|||
130331828|NCT02453711|469183502|FG002|Overall Study|Withdrawal by Subject|6|||
130331829|NCT02453711|469183503|FG003|Overall Study|Withdrawal by Subject|4|||
130331830|NCT02453711|469183504|FG004|Overall Study|Withdrawal by Subject|1|||
130331831|NCT02453711|469183505|FG005|Overall Study|Withdrawal by Subject|1|||
130331832|NCT02453711|469183506|FG006|Overall Study|Withdrawal by Subject|0|||
130331833|NCT02453711|469183507|FG007|Overall Study|Withdrawal by Subject|1|||
130331834|NCT02453711|469183508|FG008|Overall Study|Withdrawal by Subject|7|||
130331835|NCT02453711|469183500|FG000|Overall Study|Lost to Follow-up|5|||
130331836|NCT02453711|469183501|FG001|Overall Study|Lost to Follow-up|3|||
130331837|NCT02453711|469183502|FG002|Overall Study|Lost to Follow-up|2|||
130331838|NCT02453711|469183503|FG003|Overall Study|Lost to Follow-up|3|||
130331839|NCT02453711|469183504|FG004|Overall Study|Lost to Follow-up|1|||
130331840|NCT02453711|469183505|FG005|Overall Study|Lost to Follow-up|5|||
130331841|NCT02453711|469183506|FG006|Overall Study|Lost to Follow-up|2|||
130331842|NCT02453711|469183507|FG007|Overall Study|Lost to Follow-up|6|||
130331843|NCT02453711|469183508|FG008|Overall Study|Lost to Follow-up|6|||
130331844|NCT02453711|469183500|FG000|Overall Study|Death|0|||
130331845|NCT02453711|469183501|FG001|Overall Study|Death|0|||
130331846|NCT02453711|469183502|FG002|Overall Study|Death|0|||
130331847|NCT02453711|469183503|FG003|Overall Study|Death|0|||
130331848|NCT02453711|469183504|FG004|Overall Study|Death|0|||
130331849|NCT02453711|469183505|FG005|Overall Study|Death|0|||
130331850|NCT02453711|469183506|FG006|Overall Study|Death|1|||
130331851|NCT02453711|469183507|FG007|Overall Study|Death|0|||
130331852|NCT02453711|469183508|FG008|Overall Study|Death|0|||
130331853|NCT02453711|469183500|FG000|Overall Study|Unclassified|1|||
130331854|NCT02453711|469183501|FG001|Overall Study|Unclassified|0|||
130331855|NCT02453711|469183502|FG002|Overall Study|Unclassified|1|||
130331856|NCT02453711|469183503|FG003|Overall Study|Unclassified|0|||
130331857|NCT02453711|469183504|FG004|Overall Study|Unclassified|0|||
130331858|NCT02453711|469183505|FG005|Overall Study|Unclassified|0|||
130331859|NCT02453711|469183506|FG006|Overall Study|Unclassified|0|||
130331860|NCT02453711|469183507|FG007|Overall Study|Unclassified|0|||
130331861|NCT02453711|469183508|FG008|Overall Study|Unclassified|0|||
130331862|NCT01273519|469183509|FG000|Overall Study|Adverse Event|3|||
130331863|NCT01273519|469183510|FG001|Overall Study|Adverse Event|0|||
130331864|NCT01273519|469183511|FG002|Overall Study|Adverse Event|0|||
130331865|NCT01273519|469183509|FG000|Overall Study|Lost to Follow-up|2|||
130331866|NCT01273519|469183510|FG001|Overall Study|Lost to Follow-up|1|||
130331867|NCT01273519|469183511|FG002|Overall Study|Lost to Follow-up|3|||
130331868|NCT01273519|469183509|FG000|Overall Study|Lack of Efficacy|8|||
130331869|NCT01273519|469183510|FG001|Overall Study|Lack of Efficacy|3|||
130331870|NCT01273519|469183511|FG002|Overall Study|Lack of Efficacy|4|||
130331871|NCT01273519|469183509|FG000|Overall Study|Other|6|||
130331872|NCT01273519|469183510|FG001|Overall Study|Other|1|||
130331873|NCT01273519|469183511|FG002|Overall Study|Other|1|||
130331874|NCT02302339|469183512|FG000|Overall Study|Lost to Follow-up|1|||
130331875|NCT02302339|469183513|FG001|Overall Study|Lost to Follow-up|0|||
130331876|NCT02302339|469183514|FG002|Overall Study|Lost to Follow-up|0|||
130331877|NCT02302339|469183515|FG003|Overall Study|Lost to Follow-up|0|||
130331878|NCT02302339|469183512|FG000|Overall Study|Withdrawal by Subject|0|||
130331879|NCT02302339|469183513|FG001|Overall Study|Withdrawal by Subject|2|||
130331880|NCT02302339|469183514|FG002|Overall Study|Withdrawal by Subject|1|||
130331881|NCT02302339|469183515|FG003|Overall Study|Withdrawal by Subject|0|||
130331882|NCT02908672|469183516|FG000|Run-in Period|Death|12|||
130331883|NCT02908672|469183517|FG001|Run-in Period|Death|10|||
130331884|NCT02908672|469183518|FG002|Run-in Period|Death|0|||
130331885|NCT02908672|469183519|FG003|Run-in Period|Death|0|||
130331886|NCT02908672|469183516|FG000|Run-in Period|Lost to Follow-up|1|||
130331887|NCT02908672|469183517|FG001|Run-in Period|Lost to Follow-up|1|||
130331888|NCT02908672|469183518|FG002|Run-in Period|Lost to Follow-up|0|||
130331889|NCT02908672|469183519|FG003|Run-in Period|Lost to Follow-up|0|||
130216001|NCT00199849|468753920|FG002|Overall Study|Progressive disease requiring intervention|1|||
130331890|NCT02908672|469183516|FG000|Run-in Period|Reason Not Specified|2|||
130331891|NCT02908672|469183517|FG001|Run-in Period|Reason Not Specified|0|||
130331892|NCT02908672|469183518|FG002|Run-in Period|Reason Not Specified|0|||
130331893|NCT02908672|469183519|FG003|Run-in Period|Reason Not Specified|0|||
130331894|NCT02908672|469183516|FG000|Run-in Period|Protocol Violation|1|||
130331895|NCT02908672|469183517|FG001|Run-in Period|Protocol Violation|1|||
130331896|NCT02908672|469183518|FG002|Run-in Period|Protocol Violation|0|||
130331897|NCT02908672|469183519|FG003|Run-in Period|Protocol Violation|0|||
130331898|NCT02908672|469183516|FG000|Run-in Period|Study Ended by Sponsor|5|||
130331899|NCT02908672|469183517|FG001|Run-in Period|Study Ended by Sponsor|1|||
130331900|NCT02908672|469183518|FG002|Run-in Period|Study Ended by Sponsor|0|||
130331901|NCT02908672|469183519|FG003|Run-in Period|Study Ended by Sponsor|0|||
130331902|NCT02908672|469183516|FG000|Run-in Period|Withdrawal by Subject|3|||
130331903|NCT02908672|469183517|FG001|Run-in Period|Withdrawal by Subject|9|||
130331904|NCT02908672|469183518|FG002|Run-in Period|Withdrawal by Subject|0|||
130331905|NCT02908672|469183519|FG003|Run-in Period|Withdrawal by Subject|0|||
130331906|NCT02908672|469183516|FG000|Triple Combination Period|Death|0|||
130331907|NCT02908672|469183517|FG001|Triple Combination Period|Death|0|||
130331908|NCT02908672|469183518|FG002|Triple Combination Period|Death|150|||
130331909|NCT02908672|469183519|FG003|Triple Combination Period|Death|127|||
130331910|NCT02908672|469183516|FG000|Triple Combination Period|Lost to Follow-up|0|||
130331911|NCT02908672|469183517|FG001|Triple Combination Period|Lost to Follow-up|0|||
130331912|NCT02908672|469183518|FG002|Triple Combination Period|Lost to Follow-up|6|||
130331913|NCT02908672|469183519|FG003|Triple Combination Period|Lost to Follow-up|8|||
130331914|NCT02908672|469183516|FG000|Triple Combination Period|Reason Not Specified|0|||
130331915|NCT02908672|469183517|FG001|Triple Combination Period|Reason Not Specified|0|||
130331916|NCT02908672|469183518|FG002|Triple Combination Period|Reason Not Specified|0|||
130331917|NCT02908672|469183519|FG003|Triple Combination Period|Reason Not Specified|1|||
130331918|NCT02908672|469183516|FG000|Triple Combination Period|Physician Decision|0|||
130331919|NCT02908672|469183517|FG001|Triple Combination Period|Physician Decision|0|||
130331920|NCT02908672|469183518|FG002|Triple Combination Period|Physician Decision|1|||
130331921|NCT02908672|469183519|FG003|Triple Combination Period|Physician Decision|1|||
130331922|NCT02908672|469183516|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
130331923|NCT02908672|469183517|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
130331924|NCT02908672|469183518|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
130331925|NCT02908672|469183519|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
130331926|NCT02908672|469183516|FG000|Triple Combination Period|Withdrawal by Subject|0|||
130331927|NCT02908672|469183517|FG001|Triple Combination Period|Withdrawal by Subject|0|||
130331928|NCT02908672|469183518|FG002|Triple Combination Period|Withdrawal by Subject|13|||
130331929|NCT02908672|469183519|FG003|Triple Combination Period|Withdrawal by Subject|16|||
130331930|NCT01185080|469183520|FG000|Overall Study|Adverse Event|1|||
130331931|NCT01185080|469183521|FG001|Overall Study|Adverse Event|1|||
130331932|NCT01185080|469183522|FG002|Overall Study|Adverse Event|0|||
130331933|NCT01185080|469183520|FG000|Overall Study|Personal reasons|0|||
130331934|NCT01185080|469183521|FG001|Overall Study|Personal reasons|0|||
130331935|NCT01185080|469183522|FG002|Overall Study|Personal reasons|1|||
130331936|NCT01104311|469183523|FG000|Overall Study|Withdrawal by Subject|6|||
130331937|NCT01104311|469183524|FG001|Overall Study|Withdrawal by Subject|6|||
130331938|NCT01104311|469183523|FG000|Overall Study|Protocol Violation|0|||
130331939|NCT01104311|469183524|FG001|Overall Study|Protocol Violation|1|||
130331940|NCT01104311|469183523|FG000|Overall Study|Physician Decision|2|||
130331941|NCT01104311|469183524|FG001|Overall Study|Physician Decision|2|||
130331942|NCT01104311|469183523|FG000|Overall Study|low compliance|1|||
130331943|NCT01104311|469183524|FG001|Overall Study|low compliance|1|||
130331944|NCT01104311|469183523|FG000|Overall Study|Adverse Event|1|||
130331945|NCT01104311|469183524|FG001|Overall Study|Adverse Event|2|||
130331946|NCT01705509|469184941|FG000|Inclusion CPET|Screen Failure|5|||
130331947|NCT01705509|469184941|FG000|Inclusion CPET|Withdrawal by Subject|2|||
130331948|NCT01705509|469184941|FG000|CPET w/ Ranexa|Screen Failure|2|||
130331949|NCT01227018|469184942|FG000|Overall Study|Disease progression|9|||
130331950|NCT01227018|469184942|FG000|Overall Study|Toxicity|2|||
130331951|NCT01227018|469184942|FG000|Overall Study|Withdrew after beginning treatment|4|||
130331952|NCT01413204|469184945|FG000|Overall Study|Adverse Event|1|||
130331953|NCT01413204|469184946|FG001|Overall Study|Adverse Event|2|||
130331954|NCT01413204|469184947|FG002|Overall Study|Adverse Event|2|||
130331955|NCT01413204|469184945|FG000|Overall Study|Physician Decision|3|||
130331956|NCT01413204|469184946|FG001|Overall Study|Physician Decision|0|||
130331957|NCT01413204|469184947|FG002|Overall Study|Physician Decision|2|||
130331958|NCT01413204|469184945|FG000|Overall Study|Withdrawal by Subject|1|||
130331959|NCT01413204|469184946|FG001|Overall Study|Withdrawal by Subject|4|||
130331960|NCT01413204|469184947|FG002|Overall Study|Withdrawal by Subject|4|||
130331961|NCT01413204|469184945|FG000|Overall Study|Clearly not eligible for the study|0|||
130331962|NCT01413204|469184946|FG001|Overall Study|Clearly not eligible for the study|0|||
130331963|NCT01413204|469184947|FG002|Overall Study|Clearly not eligible for the study|1|||
130331964|NCT01413204|469184945|FG000|Overall Study|Fasting plasma glucose level increased|1|||
130331965|NCT01413204|469184946|FG001|Overall Study|Fasting plasma glucose level increased|0|||
130331966|NCT01413204|469184947|FG002|Overall Study|Fasting plasma glucose level increased|10|||
130331967|NCT01039376|469184948|FG000|Overall Study|Lost to Follow-up|5|||
130331968|NCT01039376|469184949|FG001|Overall Study|Lost to Follow-up|12|||
130331969|NCT01039376|469184948|FG000|Overall Study|Physician Decision|15|||
130331970|NCT01039376|469184949|FG001|Overall Study|Physician Decision|10|||
130331971|NCT01039376|469184948|FG000|Overall Study|Withdrawal by Subject|20|||
130331972|NCT01039376|469184949|FG001|Overall Study|Withdrawal by Subject|32|||
130331973|NCT01039376|469184948|FG000|Overall Study|Study terminated by Sponsor|90|||
130331974|NCT01039376|469184949|FG001|Overall Study|Study terminated by Sponsor|72|||
130331975|NCT00753649|469184950|FG000|Overall Study|Migrated/moved from study area|1|||
130331976|NCT00753649|469184951|FG001|Overall Study|Migrated/moved from study area|0|||
130331977|NCT00753649|469184950|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
130331978|NCT00753649|469184951|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
130331979|NCT00753649|469184950|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
130331980|NCT00753649|469184951|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
130331981|NCT00753649|469184950|FG000|Overall Study|Protocol Violation|2|||
130331982|NCT00753649|469184951|FG001|Overall Study|Protocol Violation|0|||
130331983|NCT01255436|469184954|FG000|Overall Study|Lost to Follow-up|178|||
130331984|NCT01255436|469184955|FG001|Overall Study|Lost to Follow-up|191|||
130331985|NCT01255436|469184954|FG000|Overall Study|Death, stroke, or MI|4|||
130331986|NCT01255436|469184955|FG001|Overall Study|Death, stroke, or MI|3|||
130331987|NCT04816669|469184956|FG000|Part 1|Adverse Event|1|||
130331988|NCT04816669|469184957|FG001|Part 1|Adverse Event|1|||
130331989|NCT04816669|469184958|FG002|Part 1|Adverse Event|0|||
130331990|NCT04816669|469184959|FG003|Part 1|Adverse Event|0|||
130331991|NCT04816669|469184956|FG000|Part 1|Lost to Follow-up|2|||
130331992|NCT04816669|469184957|FG001|Part 1|Lost to Follow-up|2|||
130331993|NCT04816669|469184958|FG002|Part 1|Lost to Follow-up|0|||
130331994|NCT04816669|469184959|FG003|Part 1|Lost to Follow-up|0|||
130331995|NCT04816669|469184956|FG000|Part 1|Protocol Violation|0|||
130331996|NCT04816669|469184957|FG001|Part 1|Protocol Violation|1|||
130331997|NCT04816669|469184958|FG002|Part 1|Protocol Violation|0|||
130331998|NCT04816669|469184959|FG003|Part 1|Protocol Violation|0|||
130331999|NCT04816669|469184956|FG000|Part 1|Withdrawal by Subject|1|||
130332000|NCT04816669|469184957|FG001|Part 1|Withdrawal by Subject|2|||
130332001|NCT04816669|469184958|FG002|Part 1|Withdrawal by Subject|0|||
130332002|NCT04816669|469184959|FG003|Part 1|Withdrawal by Subject|0|||
130332003|NCT04816669|469184956|FG000|Part 2|Other|0|||
130332004|NCT04816669|469184957|FG001|Part 2|Other|0|||
130332005|NCT04816669|469184958|FG002|Part 2|Other|1|||
130332006|NCT04816669|469184959|FG003|Part 2|Other|0|||
130332007|NCT04816669|469184956|FG000|Part 2|Withdrawal by Subject|0|||
130332008|NCT04816669|469184957|FG001|Part 2|Withdrawal by Subject|0|||
130332009|NCT04816669|469184958|FG002|Part 2|Withdrawal by Subject|0|||
130332010|NCT04816669|469184959|FG003|Part 2|Withdrawal by Subject|1|||
130332011|NCT04816669|469184956|FG000|Part 2|Lost to Follow-up|0|||
130332012|NCT04816669|469184957|FG001|Part 2|Lost to Follow-up|0|||
130332013|NCT04816669|469184958|FG002|Part 2|Lost to Follow-up|1|||
130332014|NCT04816669|469184959|FG003|Part 2|Lost to Follow-up|0|||
130332015|NCT01229267|469184960|FG000|Overall Study|Adverse Event|4|||
130332016|NCT01229267|469184961|FG001|Overall Study|Adverse Event|6|||
130332017|NCT01229267|469184962|FG002|Overall Study|Adverse Event|3|||
130332018|NCT01229267|469184963|FG003|Overall Study|Adverse Event|2|||
130332019|NCT01229267|469184964|FG004|Overall Study|Adverse Event|10|||
130332020|NCT01229267|469184960|FG000|Overall Study|Death|40|||
130332021|NCT01229267|469184961|FG001|Overall Study|Death|37|||
130332022|NCT01229267|469184962|FG002|Overall Study|Death|35|||
130332023|NCT01229267|469184963|FG003|Overall Study|Death|13|||
130332024|NCT01229267|469184964|FG004|Overall Study|Death|103|||
130332025|NCT01229267|469184960|FG000|Overall Study|Withdrawal by Subject|23|||
130332026|NCT01229267|469184961|FG001|Overall Study|Withdrawal by Subject|22|||
130332027|NCT01229267|469184962|FG002|Overall Study|Withdrawal by Subject|32|||
130332028|NCT01229267|469184963|FG003|Overall Study|Withdrawal by Subject|14|||
130332029|NCT01229267|469184964|FG004|Overall Study|Withdrawal by Subject|59|||
130332030|NCT01229267|469184960|FG000|Overall Study|Protocol Violation|0|||
130332031|NCT01229267|469184961|FG001|Overall Study|Protocol Violation|1|||
130332032|NCT01229267|469184962|FG002|Overall Study|Protocol Violation|0|||
130332033|NCT01229267|469184963|FG003|Overall Study|Protocol Violation|0|||
130332034|NCT01229267|469184964|FG004|Overall Study|Protocol Violation|0|||
130332035|NCT01229267|469184960|FG000|Overall Study|Progressive disease|0|||
130332036|NCT01229267|469184961|FG001|Overall Study|Progressive disease|0|||
130332037|NCT01229267|469184962|FG002|Overall Study|Progressive disease|0|||
130332038|NCT01229267|469184963|FG003|Overall Study|Progressive disease|0|||
130332039|NCT01229267|469184964|FG004|Overall Study|Progressive disease|1|||
130332040|NCT01229267|469184960|FG000|Overall Study|Physician Decision|8|||
130332041|NCT01229267|469184961|FG001|Overall Study|Physician Decision|11|||
130332042|NCT01229267|469184962|FG002|Overall Study|Physician Decision|8|||
130332043|NCT01229267|469184963|FG003|Overall Study|Physician Decision|3|||
130332044|NCT01229267|469184964|FG004|Overall Study|Physician Decision|25|||
130332045|NCT01229267|469184960|FG000|Overall Study|Lost to Follow-up|6|||
130332046|NCT01229267|469184961|FG001|Overall Study|Lost to Follow-up|5|||
130332047|NCT01229267|469184962|FG002|Overall Study|Lost to Follow-up|8|||
130332048|NCT01229267|469184963|FG003|Overall Study|Lost to Follow-up|3|||
130332049|NCT01229267|469184964|FG004|Overall Study|Lost to Follow-up|22|||
130332050|NCT01864603|469184976|FG000|Stage 2|DSMB design modification|86056|||
130332051|NCT01864603|469184977|FG001|Stage 2|DSMB design modification|92558|||
130332052|NCT02446899|469184978|FG000|Overall Study|Adverse Event|4|||
130332053|NCT02446899|469184979|FG001|Overall Study|Adverse Event|7|||
130332054|NCT02446899|469184978|FG000|Overall Study|Condition Under Investigation Worsened|1|||
130332055|NCT02446899|469184979|FG001|Overall Study|Condition Under Investigation Worsened|4|||
130332056|NCT02446899|469184978|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
130332057|NCT02446899|469184979|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
130332058|NCT02446899|469184978|FG000|Overall Study|Lack of Efficacy|2|||
130332059|NCT02446899|469184979|FG001|Overall Study|Lack of Efficacy|8|||
130332060|NCT02446899|469184978|FG000|Overall Study|Lost to Follow-up|1|||
130332061|NCT02446899|469184979|FG001|Overall Study|Lost to Follow-up|3|||
130332062|NCT02446899|469184978|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130332063|NCT02446899|469184979|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
130332064|NCT02446899|469184978|FG000|Overall Study|Withdrawal by Subject|11|||
130332065|NCT02446899|469184979|FG001|Overall Study|Withdrawal by Subject|19|||
130332066|NCT02446899|469184978|FG000|Overall Study|Miscellaneous|5|||
130332067|NCT02446899|469184979|FG001|Overall Study|Miscellaneous|4|||
130332068|NCT02446899|469184978|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130332069|NCT02446899|469184979|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130332070|NCT04050202|469184980|FG000|Overall Study|Lost to Follow-up|2|||
130332071|NCT01499277|469184985|FG000|Overall Study|Adverse Event|3|||
130332072|NCT01499277|469184986|FG001|Overall Study|Adverse Event|6|||
130332073|NCT01499277|469184985|FG000|Overall Study|Death|3|||
130332074|NCT01499277|469184986|FG001|Overall Study|Death|2|||
130332075|NCT01499277|469184985|FG000|Overall Study|Lost to Follow-up|15|||
130332076|NCT01499277|469184986|FG001|Overall Study|Lost to Follow-up|8|||
130332077|NCT01499277|469184985|FG000|Overall Study|Protocol Violation|2|||
130332078|NCT01499277|469184986|FG001|Overall Study|Protocol Violation|3|||
130332079|NCT01499277|469184985|FG000|Overall Study|Withdrawal by Subject|16|||
130332080|NCT01499277|469184986|FG001|Overall Study|Withdrawal by Subject|6|||
130332081|NCT01499277|469184985|FG000|Overall Study|Lack of therapeutic response and other|8|||
130332082|NCT01499277|469184986|FG001|Overall Study|Lack of therapeutic response and other|7|||
130332083|NCT02974543|469184987|FG000|Overall Study|Withdrawal by Subject|1|||
130332084|NCT02974543|469184988|FG001|Overall Study|Withdrawal by Subject|0|||
130332085|NCT00742235|469184989|FG000|Overall Study|Lost to Follow-up|0|||
130332086|NCT00742235|469184990|FG001|Overall Study|Lost to Follow-up|31|||
130332087|NCT01237899|469184991|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
130332088|NCT01237899|469184992|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
130332089|NCT01237899|469184993|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
130332090|NCT01237899|469184994|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
130332091|NCT01237899|469184995|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
130332092|NCT01237899|469184996|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
130332093|NCT01237899|469184997|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
130332094|NCT01237899|469184998|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
130332095|NCT01237899|469184999|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
130332096|NCT01237899|469185000|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
130332097|NCT01237899|469185001|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
130332098|NCT02141438|469185003|FG000|Overall Study|Death|1308|||
130332099|NCT02141438|469185003|FG000|Overall Study|Lost to Follow-up|84|||
130332100|NCT02141438|469185003|FG000|Overall Study|Withdrawal by Subject|52|||
130332101|NCT02141438|469185003|FG000|Overall Study|Physician Decision|1|||
130332102|NCT02141438|469185003|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
130332103|NCT04329806|469185004|FG000|Overall Study|Physician Decision|3|||
130216002|NCT00199849|468753918|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130216003|NCT00199849|468753919|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130216004|NCT00199849|468753920|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
130216005|NCT04727528|468753921|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
130216006|NCT04727528|468753922|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
130216007|NCT04727528|468753921|FG000|Open-label Period|Randomized who did not receive treatment|1|||
130216008|NCT04727528|468753922|FG001|Open-label Period|Randomized who did not receive treatment|0|||
130216009|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130216010|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Adverse Event|1|||
130216011|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Death|0|||
130216012|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Death|1|||
130216013|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
130216014|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
130216015|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
130216016|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
130216017|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Physician Decision|0|||
130216018|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Physician Decision|1|||
130216019|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
130216020|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130216021|NCT01763827|468753929|FG000|Overall Study|Withdrawal by Subject|1|||
130216022|NCT01763827|468753930|FG001|Overall Study|Withdrawal by Subject|0|||
130216023|NCT01763827|468753931|FG002|Overall Study|Withdrawal by Subject|0|||
130216024|NCT01763827|468753932|FG003|Overall Study|Withdrawal by Subject|0|||
130216025|NCT01763827|468753933|FG004|Overall Study|Withdrawal by Subject|2|||
130216026|NCT01763827|468753934|FG005|Overall Study|Withdrawal by Subject|0|||
130216027|NCT01763827|468753929|FG000|Overall Study|Decision by sponsor|2|||
130332104|NCT04329806|469185005|FG001|Overall Study|Physician Decision|4|||
130332105|NCT02636595|469185008|FG000|Overall Study|Lost to Follow-up|1|||
130332106|NCT02636595|469185008|FG000|Overall Study|Other|1|||
130332107|NCT04730271|469185009|FG000|Overall Study|Adverse Event|0|||
130332108|NCT04730271|469185010|FG001|Overall Study|Adverse Event|2|||
130332109|NCT04730271|469185009|FG000|Overall Study|Withdrawal by Subject|1|||
130332110|NCT04730271|469185010|FG001|Overall Study|Withdrawal by Subject|1|||
130332111|NCT04730271|469185009|FG000|Overall Study|Protocol Violation|7|||
130332112|NCT04730271|469185010|FG001|Overall Study|Protocol Violation|13|||
130332113|NCT04730271|469185009|FG000|Overall Study|Lost to Follow-up|3|||
130332114|NCT04730271|469185010|FG001|Overall Study|Lost to Follow-up|3|||
130332115|NCT04730271|469185009|FG000|Overall Study|Death|1|||
130332116|NCT04730271|469185010|FG001|Overall Study|Death|0|||
130332117|NCT05782179|469185013|FG000|Overall Study|Adverse Event|0|||
130332118|NCT05782179|469185014|FG001|Overall Study|Adverse Event|0|||
130332119|NCT05782179|469185015|FG002|Overall Study|Adverse Event|2|||
130332120|NCT05782179|469185016|FG003|Overall Study|Adverse Event|0|||
130332121|NCT05782179|469185017|FG004|Overall Study|Adverse Event|0|||
130332122|NCT05782179|469185018|FG005|Overall Study|Adverse Event|0|||
130332123|NCT03682770|469185021|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332124|NCT03682770|469185022|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
130332125|NCT03682770|469185023|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332126|NCT03682770|469185024|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332127|NCT03682770|469185025|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332128|NCT03682770|469185026|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332129|NCT03682770|469185027|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332130|NCT03682770|469185021|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130332131|NCT03682770|469185022|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130332132|NCT03682770|469185023|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332133|NCT03682770|469185024|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332134|NCT03682770|469185025|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332135|NCT03682770|469185026|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332136|NCT03682770|469185027|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332137|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332138|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332139|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
130332140|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
130332141|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332142|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332143|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332144|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332145|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332146|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332147|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
130332148|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332149|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332150|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332151|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332152|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332153|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
130332154|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
130332155|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332156|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332157|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332158|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332159|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332160|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
130332161|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332162|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332163|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332164|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332165|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332166|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332167|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
130332168|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332169|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332170|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332171|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332172|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332173|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332174|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332175|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
130332176|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332177|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332178|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332179|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332180|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332181|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332182|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332183|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
130332184|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130332185|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130332186|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332187|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332188|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332189|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332190|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
130332191|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332192|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332193|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332194|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332195|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332196|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332197|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332198|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
130332199|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332200|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332201|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332202|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332203|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332204|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332205|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
130332206|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
130332207|NCT02362282|469185028|FG000|Overall Study|Withdrawal by Subject|1|||
130332208|NCT02362282|469185029|FG001|Overall Study|Withdrawal by Subject|0|||
130332209|NCT01470326|469185030|FG000|Overall Study|Protocol Violation|32|||
130332210|NCT01470326|469185030|FG000|Overall Study|No Drug Administration Information|2|||
130332211|NCT01470326|469185030|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
130332212|NCT01166282|469185031|FG000|Open-label Period|Adverse Event|0|||
130332213|NCT01166282|469185032|FG001|Open-label Period|Adverse Event|0|||
130332214|NCT01166282|469185033|FG002|Open-label Period|Adverse Event|6|||
130332215|NCT01166282|469185031|FG000|Open-label Period|Withdrawal by Subject|0|||
130332216|NCT01166282|469185032|FG001|Open-label Period|Withdrawal by Subject|0|||
130332217|NCT01166282|469185033|FG002|Open-label Period|Withdrawal by Subject|4|||
130332218|NCT01166282|469185031|FG000|Open-label Period|Lack of Efficacy|0|||
130332219|NCT01166282|469185032|FG001|Open-label Period|Lack of Efficacy|0|||
130332220|NCT01166282|469185033|FG002|Open-label Period|Lack of Efficacy|2|||
130332221|NCT01166282|469185031|FG000|Open-label Period|Remission|0|||
130332222|NCT01166282|469185032|FG001|Open-label Period|Remission|0|||
130332223|NCT01166282|469185033|FG002|Open-label Period|Remission|4|||
130332224|NCT01166282|469185031|FG000|Open-label Period|Irregular Compliance|0|||
130332225|NCT01166282|469185032|FG001|Open-label Period|Irregular Compliance|0|||
130332226|NCT01166282|469185033|FG002|Open-label Period|Irregular Compliance|1|||
130332227|NCT02194985|469185038|FG000|Overall Study|Adverse Event|1|||
130332228|NCT02194985|469185038|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
130332229|NCT02194985|469185038|FG000|Overall Study|Physician Decision|4|||
130332230|NCT02194985|469185038|FG000|Overall Study|Lost to Follow-up|1|||
130332231|NCT02194985|469185038|FG000|Overall Study|Withdrawal by Subject|2|||
130332232|NCT00392769|469185041|FG000|Overall Study|Clinical Deterioration|9|||
130332233|NCT00392769|469185041|FG000|Overall Study|Adverse Event|1|||
130332234|NCT02561832|469185042|FG000|Overall Study|Withdrawal by Subject|1|||
130332235|NCT02561832|469185043|FG001|Overall Study|Withdrawal by Subject|1|||
130332236|NCT02561832|469185042|FG000|Overall Study|Adverse Event|3|||
130332237|NCT02561832|469185043|FG001|Overall Study|Adverse Event|0|||
130332238|NCT02561832|469185042|FG000|Overall Study|Disease progression|3|||
130332239|NCT02561832|469185043|FG001|Overall Study|Disease progression|3|||
130332240|NCT02304367|469185044|FG000|Overall Study|Lack of Response to Bruosumab|1|||
130332241|NCT02304367|469185044|FG000|Overall Study|Sponsor Decision|3|||
130332242|NCT02304367|469185044|FG000|Overall Study|Death|2|||
130332243|NCT02304367|469185044|FG000|Overall Study|Physician Decision|1|||
130332244|NCT02304367|469185044|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
130332245|NCT00318643|469185045|FG000|Overall Study|Adverse Event|0|||
130332246|NCT00318643|469185046|FG001|Overall Study|Adverse Event|0|||
130332247|NCT00318643|469185047|FG002|Overall Study|Adverse Event|0|||
130332248|NCT00318643|469185048|FG003|Overall Study|Adverse Event|0|||
130332249|NCT00318643|469185049|FG004|Overall Study|Adverse Event|1|||
130332250|NCT00318643|469185045|FG000|Overall Study|Participant's Decision|0|||
130332251|NCT00318643|469185046|FG001|Overall Study|Participant's Decision|0|||
130332252|NCT00318643|469185047|FG002|Overall Study|Participant's Decision|0|||
130332253|NCT00318643|469185048|FG003|Overall Study|Participant's Decision|0|||
130332254|NCT00318643|469185049|FG004|Overall Study|Participant's Decision|1|||
130332255|NCT00318643|469185045|FG000|Overall Study|Investigator's Decision|0|||
130332256|NCT00318643|469185046|FG001|Overall Study|Investigator's Decision|0|||
130332257|NCT00318643|469185047|FG002|Overall Study|Investigator's Decision|0|||
130332258|NCT00318643|469185048|FG003|Overall Study|Investigator's Decision|0|||
130332259|NCT00318643|469185049|FG004|Overall Study|Investigator's Decision|1|||
130332260|NCT04411667|469185052|FG000|Overall Study|Physician Decision|1|||
130332261|NCT04411667|469185053|FG001|Overall Study|Physician Decision|0|||
130332262|NCT00067002|469185054|FG000|Overall Study|Early Death|1|||
130332263|NCT00067002|469185055|FG001|Overall Study|Early Death|2|||
130332264|NCT00067002|469185054|FG000|Overall Study|Delayed|1|||
130332265|NCT00067002|469185055|FG001|Overall Study|Delayed|1|||
130332266|NCT00067002|469185054|FG000|Overall Study|Graft Failure|5|||
130332267|NCT00067002|469185055|FG001|Overall Study|Graft Failure|6|||
130332268|NCT01354314|469185060|FG000|Overall Study|Lost to Follow-up|1|||
130332269|NCT01354314|469185061|FG001|Overall Study|Lost to Follow-up|0|||
130332270|NCT01354314|469185062|FG002|Overall Study|Lost to Follow-up|1|||
130332271|NCT01354314|469185063|FG003|Overall Study|Lost to Follow-up|1|||
130332272|NCT01354314|469185060|FG000|Overall Study|Withdrawal by Subject|0|||
130332273|NCT01354314|469185061|FG001|Overall Study|Withdrawal by Subject|0|||
130332274|NCT01354314|469185062|FG002|Overall Study|Withdrawal by Subject|1|||
130332275|NCT01354314|469185063|FG003|Overall Study|Withdrawal by Subject|0|||
130332276|NCT01354314|469185060|FG000|Overall Study|Adverse Event|0|||
130332277|NCT01354314|469185061|FG001|Overall Study|Adverse Event|0|||
130332278|NCT01354314|469185062|FG002|Overall Study|Adverse Event|0|||
130332279|NCT01354314|469185063|FG003|Overall Study|Adverse Event|1|||
130332280|NCT01354314|469185060|FG000|Overall Study|Protocol Violation|1|||
130332281|NCT01354314|469185061|FG001|Overall Study|Protocol Violation|1|||
130332282|NCT01354314|469185062|FG002|Overall Study|Protocol Violation|0|||
130332283|NCT01354314|469185063|FG003|Overall Study|Protocol Violation|0|||
130332284|NCT01354314|469185060|FG000|Overall Study|Less than 90% Adherence|4|||
130332285|NCT01354314|469185061|FG001|Overall Study|Less than 90% Adherence|2|||
130332286|NCT01354314|469185062|FG002|Overall Study|Less than 90% Adherence|6|||
130332287|NCT01354314|469185063|FG003|Overall Study|Less than 90% Adherence|4|||
130332288|NCT00714870|469185065|FG000|Overall Study|Lost to Follow-up|22|||
130332289|NCT00714870|469185066|FG001|Overall Study|Lost to Follow-up|5|||
130332290|NCT00714870|469185065|FG000|Overall Study|patient unable to come b/c back pain|1|||
130332291|NCT00714870|469185066|FG001|Overall Study|patient unable to come b/c back pain|0|||
130332292|NCT00714870|469185065|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
130332293|NCT00714870|469185066|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
130332294|NCT03399552|469185067|FG000|Overall Study|No evidence of disease|1|||
130332295|NCT03399552|469185067|FG000|Overall Study|Unevaluable|1|||
130332296|NCT02357368|469185068|FG000|Overall Study|Lost to Follow-up|0|||
130332297|NCT02357368|469185069|FG001|Overall Study|Lost to Follow-up|0|||
130332298|NCT02357368|469185070|FG002|Overall Study|Lost to Follow-up|0|||
130332299|NCT02357368|469185071|FG003|Overall Study|Lost to Follow-up|1|||
130332300|NCT02357368|469185068|FG000|Overall Study|Pregnancy|3|||
130332301|NCT02357368|469185069|FG001|Overall Study|Pregnancy|2|||
130332302|NCT02357368|469185070|FG002|Overall Study|Pregnancy|0|||
130332303|NCT02357368|469185071|FG003|Overall Study|Pregnancy|0|||
130332304|NCT02357368|469185068|FG000|Overall Study|Withdrawal by Subject|3|||
130332305|NCT02357368|469185069|FG001|Overall Study|Withdrawal by Subject|1|||
130332306|NCT02357368|469185070|FG002|Overall Study|Withdrawal by Subject|1|||
130332307|NCT02357368|469185071|FG003|Overall Study|Withdrawal by Subject|2|||
130332308|NCT02377817|469185072|FG000|Overall Study|Transportation/childcare barriers.|2|||
130332309|NCT02377817|469185073|FG001|Overall Study|Transportation/childcare barriers.|0|||
130332310|NCT02377817|469185072|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
130332311|NCT02377817|469185073|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
130332312|NCT03895840|469185074|FG000|Overall Study|Withdrawal by Subject|21|||
130332313|NCT01931566|469185075|FG000|Overall Study|Randomized But Not Treated|6|||
130332314|NCT01931566|469185076|FG001|Overall Study|Randomized But Not Treated|9|||
130332315|NCT01931566|469185077|FG002|Overall Study|Randomized But Not Treated|14|||
130332316|NCT01931566|469185075|FG000|Overall Study|Adverse Event|37|||
130332317|NCT01931566|469185076|FG001|Overall Study|Adverse Event|167|||
130332318|NCT01931566|469185077|FG002|Overall Study|Adverse Event|132|||
130332319|NCT01931566|469185075|FG000|Overall Study|Major Protocol Deviation|5|||
130332320|NCT01931566|469185076|FG001|Overall Study|Major Protocol Deviation|14|||
130332321|NCT01931566|469185077|FG002|Overall Study|Major Protocol Deviation|21|||
130332322|NCT01931566|469185075|FG000|Overall Study|Lost to Follow-up|3|||
130332323|NCT01931566|469185076|FG001|Overall Study|Lost to Follow-up|26|||
130332324|NCT01931566|469185077|FG002|Overall Study|Lost to Follow-up|23|||
130332325|NCT01931566|469185075|FG000|Overall Study|Voluntary Withdrawal|78|||
130332326|NCT01931566|469185076|FG001|Overall Study|Voluntary Withdrawal|245|||
130332327|NCT01931566|469185077|FG002|Overall Study|Voluntary Withdrawal|225|||
130332328|NCT01931566|469185075|FG000|Overall Study|Study Termination|289|||
130332329|NCT01931566|469185076|FG001|Overall Study|Study Termination|968|||
130332330|NCT01931566|469185077|FG002|Overall Study|Study Termination|1037|||
130332331|NCT01931566|469185075|FG000|Overall Study|Reason Not Specified|11|||
130332332|NCT01931566|469185076|FG001|Overall Study|Reason Not Specified|47|||
130332333|NCT01931566|469185077|FG002|Overall Study|Reason Not Specified|53|||
130332334|NCT01931566|469185075|FG000|Overall Study|Missing|0|||
130332335|NCT01931566|469185076|FG001|Overall Study|Missing|0|||
130332336|NCT01931566|469185077|FG002|Overall Study|Missing|1|||
130332337|NCT00760617|469185081|FG000|Overall Study|Adverse Event|5|||
130332338|NCT00760617|469185082|FG001|Overall Study|Adverse Event|2|||
130332339|NCT00760617|469185083|FG002|Overall Study|Adverse Event|0|||
130332340|NCT00760617|469185081|FG000|Overall Study|Lost to Follow-up|0|||
130332341|NCT00760617|469185082|FG001|Overall Study|Lost to Follow-up|0|||
130332342|NCT00760617|469185083|FG002|Overall Study|Lost to Follow-up|5|||
130332343|NCT04625101|469185084|FG000|Overall Study|Withdrawal by Subject|0|||
130332344|NCT04625101|469185085|FG001|Overall Study|Withdrawal by Subject|1|||
130332345|NCT04625101|469185084|FG000|Overall Study|Protocol Deviation|1|||
130332346|NCT04625101|469185085|FG001|Overall Study|Protocol Deviation|0|||
130332347|NCT02817464|469185086|FG000|Overall Study|Lost to Follow-up|1|||
130332348|NCT02817464|469185087|FG001|Overall Study|Lost to Follow-up|0|||
130332349|NCT02817464|469185086|FG000|Overall Study|Discontinued early due to personal decision|1|||
130332350|NCT02817464|469185087|FG001|Overall Study|Discontinued early due to personal decision|1|||
130332351|NCT03207763|469186613|FG000|Overall Study|Lost to Follow-up|1|||
130332352|NCT03207763|469186614|FG001|Overall Study|Lost to Follow-up|0|||
130332353|NCT02605122|469186615|FG000|Overall Study|Withdrawal by Subject|4|||
130332354|NCT02605122|469186616|FG001|Overall Study|Withdrawal by Subject|1|||
130332355|NCT02605122|469186615|FG000|Overall Study|Lost to Follow-up|1|||
130332356|NCT02605122|469186616|FG001|Overall Study|Lost to Follow-up|1|||
130332357|NCT00684060|469186617|FG000|Overall Study|Lost to Follow-up|1|||
130332358|NCT00684060|469186618|FG001|Overall Study|Lost to Follow-up|0|||
130332359|NCT00684060|469186617|FG000|Overall Study|New stenosis identified|1|||
130332360|NCT00684060|469186618|FG001|Overall Study|New stenosis identified|0|||
130332361|NCT00684060|469186617|FG000|Overall Study|Unable to collect MRI|1|||
130332362|NCT00684060|469186618|FG001|Overall Study|Unable to collect MRI|2|||
130332363|NCT00684060|469186617|FG000|Overall Study|Death|0|||
130332364|NCT00684060|469186618|FG001|Overall Study|Death|1|||
130332365|NCT00702715|469186623|FG000|Overall Study|Lost to Follow-up|1|||
130332366|NCT00702715|469186624|FG001|Overall Study|Lost to Follow-up|0|||
130332367|NCT03751657|469186625|FG000|Overall Study|Physician Decision|0|||
130332368|NCT03751657|469186626|FG001|Overall Study|Physician Decision|1|||
130332369|NCT03751657|469186625|FG000|Overall Study|Withdrawal by Subject|1|||
130332370|NCT03751657|469186626|FG001|Overall Study|Withdrawal by Subject|1|||
130332371|NCT03751657|469186625|FG000|Overall Study|Lost to Follow-up|2|||
130332372|NCT03751657|469186626|FG001|Overall Study|Lost to Follow-up|1|||
130332373|NCT00807001|469186634|FG000|Overall Study|Non-compliance|0|||
130332374|NCT00807001|469186635|FG001|Overall Study|Non-compliance|1|||
130332375|NCT00807001|469186636|FG002|Overall Study|Non-compliance|0|||
130332376|NCT00807001|469186637|FG003|Overall Study|Non-compliance|0|||
130332377|NCT00807001|469186638|FG004|Overall Study|Non-compliance|0|||
130332378|NCT00854113|469186640|FG000|Overall Study|Adverse Event|0|||
130332379|NCT00854113|469186641|FG001|Overall Study|Adverse Event|0|||
130332380|NCT00854113|469186642|FG002|Overall Study|Adverse Event|0|||
130332381|NCT00854113|469186643|FG003|Overall Study|Adverse Event|0|||
130332382|NCT00854113|469186644|FG004|Overall Study|Adverse Event|0|||
130332383|NCT00854113|469186645|FG005|Overall Study|Adverse Event|0|||
130332384|NCT00854113|469186646|FG006|Overall Study|Adverse Event|0|||
130332385|NCT00854113|469186647|FG007|Overall Study|Adverse Event|2|||
130332386|NCT00854113|469186648|FG008|Overall Study|Adverse Event|0|||
130332387|NCT00854113|469186649|FG009|Overall Study|Adverse Event|0|||
130332388|NCT00854113|469186650|FG010|Overall Study|Adverse Event|0|||
130332389|NCT00854113|469186640|FG000|Overall Study|Withdrawal by Subject|0|||
130332390|NCT00854113|469186641|FG001|Overall Study|Withdrawal by Subject|0|||
130332391|NCT00854113|469186642|FG002|Overall Study|Withdrawal by Subject|0|||
130332392|NCT00854113|469186643|FG003|Overall Study|Withdrawal by Subject|0|||
130332393|NCT00854113|469186644|FG004|Overall Study|Withdrawal by Subject|0|||
130332394|NCT00854113|469186645|FG005|Overall Study|Withdrawal by Subject|0|||
130332395|NCT00854113|469186646|FG006|Overall Study|Withdrawal by Subject|0|||
130332396|NCT00854113|469186647|FG007|Overall Study|Withdrawal by Subject|1|||
130332397|NCT00854113|469186648|FG008|Overall Study|Withdrawal by Subject|1|||
130332398|NCT00854113|469186649|FG009|Overall Study|Withdrawal by Subject|0|||
130332399|NCT00854113|469186650|FG010|Overall Study|Withdrawal by Subject|0|||
130332400|NCT02273596|469186654|FG000|24-Week Treatment Period|Adverse Event|3|||
130332401|NCT02273596|469186654|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
130332402|NCT02273596|469186654|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
130332403|NCT02273596|469186654|FG000|24-Week Treatment Period|Physician Decision|1|||
130332404|NCT02273596|469186654|FG000|24-Week Treatment Period|Protocol Deviation|1|||
130332405|NCT02273596|469186654|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
130332406|NCT02273596|469186654|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
130332407|NCT02273596|469186654|FG000|Extension Period|Lost to Follow-up|1|||
130332408|NCT02273596|469186654|FG000|Extension Period|Protocol Deviation|1|||
130332409|NCT02604160|469186655|FG000|Overall Study|Protocol Violation|0|||
130332410|NCT02604160|469186656|FG001|Overall Study|Protocol Violation|1|||
130332411|NCT02604160|469186655|FG000|Overall Study|Physician Decision|0|||
130332412|NCT02604160|469186656|FG001|Overall Study|Physician Decision|1|||
130332413|NCT01596062|469186657|FG000|Overall Study|Adverse Event|1|||
130332414|NCT01596062|469186658|FG001|Overall Study|Adverse Event|0|||
130332415|NCT01596062|469186659|FG002|Overall Study|Adverse Event|2|||
130332416|NCT01596062|469186657|FG000|Overall Study|Lack of Efficacy|0|||
130332417|NCT01596062|469186658|FG001|Overall Study|Lack of Efficacy|0|||
130332418|NCT01596062|469186659|FG002|Overall Study|Lack of Efficacy|1|||
130332419|NCT02139592|469186660|FG000|Overall Study|Case Report Forms Uncollected|8|||
130332420|NCT02687191|469186661|FG000|Overall Study|Death|0|||
130332421|NCT02687191|469186662|FG001|Overall Study|Death|1|||
130332422|NCT02687191|469186663|FG002|Overall Study|Death|1|||
130332423|NCT02687191|469186664|FG003|Overall Study|Death|0|||
130332424|NCT02687191|469186665|FG004|Overall Study|Death|1|||
130332425|NCT02687191|469186666|FG005|Overall Study|Death|1|||
130332426|NCT02687191|469186661|FG000|Overall Study|Withdrawal by Subject|0|||
130332427|NCT02687191|469186662|FG001|Overall Study|Withdrawal by Subject|0|||
130332428|NCT02687191|469186663|FG002|Overall Study|Withdrawal by Subject|0|||
130332429|NCT02687191|469186664|FG003|Overall Study|Withdrawal by Subject|1|||
130332430|NCT02687191|469186665|FG004|Overall Study|Withdrawal by Subject|0|||
130332431|NCT02687191|469186666|FG005|Overall Study|Withdrawal by Subject|0|||
130332432|NCT03180840|469186667|FG000|Overall Study|Withdrawal by Subject|1|||
130332433|NCT01788358|469186668|FG000|Overall Study|Other|11|||
130332434|NCT01788358|469186668|FG000|Overall Study|Logistical difficulties|1|||
130332435|NCT01788358|469186668|FG000|Overall Study|Lost to Follow-up|5|||
130332436|NCT01788358|469186668|FG000|Overall Study|Protocol Violation|3|||
130332437|NCT01788358|469186668|FG000|Overall Study|Withdrawal by Subject|26|||
130332438|NCT01788358|469186668|FG000|Overall Study|Lack of Efficacy|1|||
130332439|NCT01788358|469186668|FG000|Overall Study|Adverse Event|51|||
130332440|NCT02736890|469186671|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
130332441|NCT02736890|469186672|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
130332442|NCT02736890|469186671|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
130332443|NCT02736890|469186672|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
130332444|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130332445|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130332446|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
130332447|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
130332448|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
130332449|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
130332450|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Recurrence|2|||
130332451|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Recurrence|0|||
130332452|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Adverse Event|2|||
130332453|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Adverse Event|6|||
130332454|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Participant wishes|12|||
130332455|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Participant wishes|7|||
130332456|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Physician Decision|2|||
130332457|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Physician Decision|1|||
130332458|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
130332459|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
130332460|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Death|0|||
130332461|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Death|1|||
130332462|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
130332463|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
130332464|NCT05097963|469186675|FG000|Overall Study|Protocol Violation|13|||
130332465|NCT05097963|469186675|FG000|Overall Study|Withdrawal by Subject|21|||
130332466|NCT02873702|469186678|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
130332467|NCT02873702|469186679|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
130332468|NCT02873702|469186680|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
130332469|NCT02873702|469186681|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
130332470|NCT02873702|469186678|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332471|NCT02873702|469186679|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
130332472|NCT02873702|469186680|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332473|NCT02873702|469186681|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332474|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332475|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332476|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
130332477|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332478|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130332479|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130332480|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
130332481|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
130332482|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130332483|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130332484|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
130332485|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
130332486|NCT02948634|469186685|FG000|Overall Study|Lack of efficacy and study suspended|10|||
130216028|NCT01763827|468753930|FG001|Overall Study|Decision by sponsor|0|||
130216029|NCT01763827|468753931|FG002|Overall Study|Decision by sponsor|3|||
130216030|NCT01763827|468753932|FG003|Overall Study|Decision by sponsor|0|||
130216031|NCT01763827|468753933|FG004|Overall Study|Decision by sponsor|2|||
130216032|NCT01763827|468753934|FG005|Overall Study|Decision by sponsor|1|||
130216033|NCT01763827|468753929|FG000|Overall Study|Lost to Follow-up|0|||
130216034|NCT01763827|468753930|FG001|Overall Study|Lost to Follow-up|1|||
130216035|NCT01763827|468753931|FG002|Overall Study|Lost to Follow-up|1|||
130216036|NCT01763827|468753932|FG003|Overall Study|Lost to Follow-up|1|||
130216037|NCT01763827|468753933|FG004|Overall Study|Lost to Follow-up|2|||
130216038|NCT01763827|468753934|FG005|Overall Study|Lost to Follow-up|1|||
130216039|NCT02906579|468753939|FG000|Overall Study|Adverse Event|1|||
130216040|NCT02906579|468753939|FG000|Overall Study|Physician Decision|1|||
130216041|NCT01826981|468753940|FG000|Overall Study|Lack of Efficacy|0|||
130216042|NCT01826981|468753941|FG001|Overall Study|Lack of Efficacy|1|||
130216043|NCT01826981|468753942|FG002|Overall Study|Lack of Efficacy|0|||
130216044|NCT01826981|468753943|FG003|Overall Study|Lack of Efficacy|0|||
130216045|NCT01826981|468753944|FG004|Overall Study|Lack of Efficacy|5|||
130216046|NCT01826981|468753945|FG005|Overall Study|Lack of Efficacy|0|||
130216047|NCT01826981|468753946|FG006|Overall Study|Lack of Efficacy|0|||
130216048|NCT01826981|468753947|FG007|Overall Study|Lack of Efficacy|8|||
130216049|NCT01826981|468753948|FG008|Overall Study|Lack of Efficacy|7|||
130216050|NCT01826981|468753949|FG009|Overall Study|Lack of Efficacy|0|||
130216051|NCT01826981|468753950|FG010|Overall Study|Lack of Efficacy|1|||
130216052|NCT01826981|468753951|FG011|Overall Study|Lack of Efficacy|0|||
130216053|NCT01826981|468753952|FG012|Overall Study|Lack of Efficacy|0|||
130216054|NCT01826981|468753953|FG013|Overall Study|Lack of Efficacy|3|||
130216055|NCT01826981|468753954|FG014|Overall Study|Lack of Efficacy|0|||
130216056|NCT01826981|468753940|FG000|Overall Study|Lost to Follow-up|0|||
130216057|NCT01826981|468753941|FG001|Overall Study|Lost to Follow-up|0|||
130216058|NCT01826981|468753942|FG002|Overall Study|Lost to Follow-up|0|||
130216059|NCT01826981|468753943|FG003|Overall Study|Lost to Follow-up|0|||
130216060|NCT01826981|468753944|FG004|Overall Study|Lost to Follow-up|1|||
130216061|NCT01826981|468753945|FG005|Overall Study|Lost to Follow-up|1|||
130216062|NCT01826981|468753946|FG006|Overall Study|Lost to Follow-up|0|||
130216063|NCT01826981|468753947|FG007|Overall Study|Lost to Follow-up|1|||
130216064|NCT01826981|468753948|FG008|Overall Study|Lost to Follow-up|0|||
130216065|NCT01826981|468753949|FG009|Overall Study|Lost to Follow-up|1|||
130216066|NCT01826981|468753950|FG010|Overall Study|Lost to Follow-up|1|||
130216067|NCT01826981|468753951|FG011|Overall Study|Lost to Follow-up|1|||
130216068|NCT01826981|468753952|FG012|Overall Study|Lost to Follow-up|1|||
130216069|NCT01826981|468753953|FG013|Overall Study|Lost to Follow-up|0|||
130216070|NCT01826981|468753954|FG014|Overall Study|Lost to Follow-up|0|||
130216071|NCT01826981|468753940|FG000|Overall Study|Withdrew Consent|0|||
130216072|NCT01826981|468753941|FG001|Overall Study|Withdrew Consent|0|||
130216073|NCT01826981|468753942|FG002|Overall Study|Withdrew Consent|0|||
130216074|NCT01826981|468753943|FG003|Overall Study|Withdrew Consent|0|||
130216075|NCT01826981|468753944|FG004|Overall Study|Withdrew Consent|0|||
130216076|NCT01826981|468753945|FG005|Overall Study|Withdrew Consent|0|||
130216077|NCT01826981|468753946|FG006|Overall Study|Withdrew Consent|1|||
130216078|NCT01826981|468753947|FG007|Overall Study|Withdrew Consent|1|||
130216079|NCT01826981|468753948|FG008|Overall Study|Withdrew Consent|0|||
130332487|NCT02948634|469186686|FG001|Overall Study|Lack of efficacy and study suspended|2|||
130552139|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
130216080|NCT01826981|468753949|FG009|Overall Study|Withdrew Consent|0|||
130216081|NCT01826981|468753950|FG010|Overall Study|Withdrew Consent|0|||
130216082|NCT01826981|468753951|FG011|Overall Study|Withdrew Consent|1|||
130216083|NCT01826981|468753952|FG012|Overall Study|Withdrew Consent|0|||
130216084|NCT01826981|468753953|FG013|Overall Study|Withdrew Consent|1|||
130216085|NCT01826981|468753954|FG014|Overall Study|Withdrew Consent|0|||
130216086|NCT01826981|468753940|FG000|Overall Study|Adverse Event|0|||
130216087|NCT01826981|468753941|FG001|Overall Study|Adverse Event|0|||
130216088|NCT01826981|468753942|FG002|Overall Study|Adverse Event|0|||
130216089|NCT01826981|468753943|FG003|Overall Study|Adverse Event|0|||
130216090|NCT01826981|468753944|FG004|Overall Study|Adverse Event|1|||
130216091|NCT01826981|468753945|FG005|Overall Study|Adverse Event|0|||
130216092|NCT01826981|468753946|FG006|Overall Study|Adverse Event|0|||
130216093|NCT01826981|468753947|FG007|Overall Study|Adverse Event|0|||
130216094|NCT01826981|468753948|FG008|Overall Study|Adverse Event|0|||
130332488|NCT03830892|469186691|FG000|Overall Study|Physician Decision|2|||
130332489|NCT03830892|469186692|FG001|Overall Study|Physician Decision|3|||
130332490|NCT03830892|469186691|FG000|Overall Study|Study terminated due to COVID|4|||
130332491|NCT03830892|469186692|FG001|Overall Study|Study terminated due to COVID|0|||
130332492|NCT03830892|469186691|FG000|Overall Study|Protocol Violation|0|||
130332493|NCT03830892|469186692|FG001|Overall Study|Protocol Violation|1|||
130332494|NCT03830892|469186691|FG000|Overall Study|Withdrawal by Subject|0|||
130332495|NCT03830892|469186692|FG001|Overall Study|Withdrawal by Subject|2|||
130332496|NCT01262989|469186695|FG000|Period 1|Lost to Follow-up|1|||
130332497|NCT01262989|469186696|FG001|Period 1|Lost to Follow-up|1|||
130332498|NCT01262989|469186695|FG000|Period 1|Intercurrent disease|0|||
130332499|NCT01262989|469186696|FG001|Period 1|Intercurrent disease|1|||
130332500|NCT01262989|469186695|FG000|Period 1|Positive answer for exclusion criteria|0|||
130332501|NCT01262989|469186696|FG001|Period 1|Positive answer for exclusion criteria|1|||
130332502|NCT01262989|469186695|FG000|Period 2|Intercurrent disease|0|||
130332503|NCT01262989|469186696|FG001|Period 2|Intercurrent disease|1|||
130332504|NCT03599089|469186697|FG000|Overall Study|Lost to Follow-up|1|||
130332505|NCT03599089|469186698|FG001|Overall Study|Lost to Follow-up|0|||
130332506|NCT03599089|469186699|FG002|Overall Study|Lost to Follow-up|0|||
130332507|NCT03599089|469186700|FG003|Overall Study|Lost to Follow-up|0|||
130332508|NCT03599089|469186697|FG000|Overall Study|Withdrawal by Subject|2|||
130332509|NCT03599089|469186698|FG001|Overall Study|Withdrawal by Subject|1|||
130332510|NCT03599089|469186699|FG002|Overall Study|Withdrawal by Subject|0|||
130332511|NCT03599089|469186700|FG003|Overall Study|Withdrawal by Subject|0|||
130332512|NCT03599089|469186697|FG000|Overall Study|Lack of Efficacy|0|||
130332513|NCT03599089|469186698|FG001|Overall Study|Lack of Efficacy|0|||
130332514|NCT03599089|469186699|FG002|Overall Study|Lack of Efficacy|1|||
130332515|NCT03599089|469186700|FG003|Overall Study|Lack of Efficacy|2|||
130332516|NCT03214666|469186701|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332517|NCT03214666|469186702|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332518|NCT03214666|469186703|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332519|NCT03214666|469186704|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332520|NCT03214666|469186705|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
130332521|NCT03214666|469186706|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332522|NCT00470275|469186707|FG000|Overall Study|Death|1|||
130332523|NCT00470275|469186707|FG000|Overall Study|Lack of Efficacy|7|||
130332524|NCT00470275|469186707|FG000|Overall Study|Withdrawal by Subject|2|||
130332525|NCT03048578|469186708|FG000|Overall Study|Withdrawal by Subject|5|||
130332526|NCT03048578|469186709|FG001|Overall Study|Withdrawal by Subject|6|||
130332527|NCT03048578|469186708|FG000|Overall Study|Lost to Follow-up|22|||
130332528|NCT03048578|469186709|FG001|Overall Study|Lost to Follow-up|10|||
130332529|NCT03048578|469186708|FG000|Overall Study|Adverse Event|1|||
130332530|NCT03048578|469186709|FG001|Overall Study|Adverse Event|2|||
130332531|NCT03048578|469186708|FG000|Overall Study|Terminated|3|||
130332532|NCT03048578|469186709|FG001|Overall Study|Terminated|2|||
130332533|NCT00526071|469186710|FG000|Overall Study|Adverse Event|1|||
130332534|NCT00526071|469186710|FG000|Overall Study|Withdrawal by Subject|1|||
130332535|NCT00526071|469186710|FG000|Overall Study|Lack of Response to Study Drug|4|||
130332536|NCT02500797|469186715|FG000|Overall Study|Cancel (rapid disease progression)|0|||
130332537|NCT02500797|469186716|FG001|Overall Study|Cancel (rapid disease progression)|0|||
130332538|NCT02500797|469186717|FG002|Overall Study|Cancel (rapid disease progression)|0|||
130332539|NCT02500797|469186718|FG003|Overall Study|Cancel (rapid disease progression)|0|||
130332540|NCT02500797|469186719|FG004|Overall Study|Cancel (rapid disease progression)|1|||
130332541|NCT02500797|469186720|FG005|Overall Study|Cancel (rapid disease progression)|1|||
130332542|NCT02500797|469186721|FG006|Overall Study|Cancel (rapid disease progression)|0|||
130332543|NCT02500797|469186722|FG007|Overall Study|Cancel (rapid disease progression)|0|||
130332544|NCT02500797|469186715|FG000|Overall Study|Withdrawal by Subject|1|||
130332545|NCT02500797|469186716|FG001|Overall Study|Withdrawal by Subject|0|||
130332546|NCT02500797|469186717|FG002|Overall Study|Withdrawal by Subject|0|||
130332547|NCT02500797|469186718|FG003|Overall Study|Withdrawal by Subject|0|||
130332548|NCT02500797|469186719|FG004|Overall Study|Withdrawal by Subject|0|||
130332549|NCT02500797|469186720|FG005|Overall Study|Withdrawal by Subject|0|||
130332550|NCT02500797|469186721|FG006|Overall Study|Withdrawal by Subject|0|||
130332551|NCT02500797|469186722|FG007|Overall Study|Withdrawal by Subject|0|||
130332552|NCT01415882|469186725|FG000|Overall Study|Ineligible|1|||
130332553|NCT01415882|469186726|FG001|Overall Study|Ineligible|0|||
130332554|NCT01415882|469186727|FG002|Overall Study|Ineligible|0|||
130332555|NCT01415882|469186728|FG003|Overall Study|Ineligible|3|||
130332556|NCT01415882|469186729|FG004|Overall Study|Ineligible|0|||
130332557|NCT01415882|469186725|FG000|Overall Study|Withdrawal by Subject|0|||
130332558|NCT01415882|469186726|FG001|Overall Study|Withdrawal by Subject|1|||
130332559|NCT01415882|469186727|FG002|Overall Study|Withdrawal by Subject|0|||
130332560|NCT01415882|469186728|FG003|Overall Study|Withdrawal by Subject|1|||
130332561|NCT01415882|469186729|FG004|Overall Study|Withdrawal by Subject|0|||
130332562|NCT00357006|469186730|FG000|Overall Study|Lost to Follow-up|1|||
130332563|NCT00357006|469186731|FG001|Overall Study|Lost to Follow-up|2|||
130332564|NCT00357006|469186732|FG002|Overall Study|Lost to Follow-up|1|||
130332565|NCT00357006|469186730|FG000|Overall Study|Withdrawal by Subject|1|||
130332566|NCT00357006|469186731|FG001|Overall Study|Withdrawal by Subject|3|||
130332567|NCT00357006|469186732|FG002|Overall Study|Withdrawal by Subject|2|||
130332568|NCT00976560|469186733|FG000|Overall Study|Adverse Event|5|||
130332569|NCT00976560|469186734|FG001|Overall Study|Adverse Event|5|||
130332570|NCT00976560|469186733|FG000|Overall Study|Lack of Efficacy|3|||
130332571|NCT00976560|469186734|FG001|Overall Study|Lack of Efficacy|5|||
130332572|NCT00976560|469186733|FG000|Overall Study|Protocol Violation|1|||
130332573|NCT00976560|469186734|FG001|Overall Study|Protocol Violation|0|||
130332574|NCT00976560|469186733|FG000|Overall Study|Lost to Follow-up|1|||
130332575|NCT00976560|469186734|FG001|Overall Study|Lost to Follow-up|0|||
130332576|NCT00976560|469186733|FG000|Overall Study|Physician Decision|2|||
130332577|NCT00976560|469186734|FG001|Overall Study|Physician Decision|0|||
130332578|NCT00976560|469186733|FG000|Overall Study|Withdrawal by Subject|2|||
130332579|NCT00976560|469186734|FG001|Overall Study|Withdrawal by Subject|3|||
130332580|NCT03710161|469186735|FG000|Overall Study|Study halted due to COVID pandemic|3|||
130332581|NCT03710161|469186736|FG001|Overall Study|Study halted due to COVID pandemic|2|||
130332582|NCT03339219|469186744|FG000|Overall Study|Death|12|||
130332583|NCT03339219|469186744|FG000|Overall Study|Site Terminated by Sponsor|22|||
130332584|NCT03339219|469186744|FG000|Overall Study|Withdrawal by Subject|1|||
130332585|NCT01932437|469186746|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332586|NCT01932437|469186747|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332587|NCT01932437|469186748|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332588|NCT01932437|469186749|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332589|NCT01932437|469186750|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332590|NCT01932437|469186751|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
130332591|NCT00074490|469186752|FG000|Overall Study|Progressive malignancy|0|||
130332592|NCT00074490|469186753|FG001|Overall Study|Progressive malignancy|7|||
130332593|NCT00074490|469186754|FG002|Overall Study|Progressive malignancy|0|||
130332594|NCT00074490|469186755|FG003|Overall Study|Progressive malignancy|0|||
130332595|NCT00074490|469186756|FG004|Overall Study|Progressive malignancy|3|||
130332596|NCT00074490|469186757|FG005|Overall Study|Progressive malignancy|0|||
130332597|NCT00467753|469186763|FG000|Overall Study|Lost to Follow-up|1|||
130332598|NCT00467753|469186764|FG001|Overall Study|Lost to Follow-up|2|||
130332599|NCT00467753|469186763|FG000|Overall Study|Adverse Event|2|||
130332600|NCT00467753|469186764|FG001|Overall Study|Adverse Event|0|||
130332601|NCT02175030|469186765|FG000|Overall Study|Failed screen after consent|7|||
130332602|NCT02175030|469186766|FG001|Overall Study|Failed screen after consent|6|||
130332603|NCT02175030|469186765|FG000|Overall Study|Failed IUD Insertion|20|||
130332604|NCT02175030|469186766|FG001|Overall Study|Failed IUD Insertion|21|||
130332605|NCT02175030|469186765|FG000|Overall Study|Physician Decision|1|||
130332606|NCT02175030|469186766|FG001|Overall Study|Physician Decision|1|||
130332607|NCT02175030|469186765|FG000|Overall Study|Lost to Follow-up|6|||
130332608|NCT02175030|469186766|FG001|Overall Study|Lost to Follow-up|6|||
130332609|NCT02175030|469186765|FG000|Overall Study|Withdrawal by Subject|1|||
130332610|NCT02175030|469186766|FG001|Overall Study|Withdrawal by Subject|4|||
130332611|NCT03695367|469186769|FG000|Overall Study|Missed the Day 28 visit.|1|||
130332612|NCT03695367|469186770|FG001|Overall Study|Missed the Day 28 visit.|0|||
130332613|NCT03695367|469186769|FG000|Overall Study|Lost to Follow-up|0|||
130332614|NCT03695367|469186770|FG001|Overall Study|Lost to Follow-up|1|||
130332615|NCT03695367|469186769|FG000|Overall Study|Withdrawal by Subject|0|||
130332616|NCT03695367|469186770|FG001|Overall Study|Withdrawal by Subject|1|||
130332617|NCT03695367|469186769|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
130332618|NCT03695367|469186770|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
130332619|NCT01077050|469188497|FG000|Overall Study|Subjects signed ICF could not be located|1|||
130332620|NCT01077050|469188497|FG000|Overall Study|Screen failure|8|||
130332621|NCT03894813|469188498|FG000|Overall Study|Adverse Event|1|||
130332622|NCT03894813|469188499|FG001|Overall Study|Adverse Event|1|||
130332623|NCT03894813|469188498|FG000|Overall Study|Lack of Efficacy|3|||
130332624|NCT03894813|469188499|FG001|Overall Study|Lack of Efficacy|3|||
130332625|NCT03894813|469188498|FG000|Overall Study|Lost to Follow-up|1|||
130332626|NCT03894813|469188499|FG001|Overall Study|Lost to Follow-up|0|||
130332627|NCT03894813|469188498|FG000|Overall Study|Pregnancy|2|||
130332628|NCT03894813|469188499|FG001|Overall Study|Pregnancy|1|||
130332629|NCT03894813|469188498|FG000|Overall Study|Protocol Violation|3|||
130332630|NCT03894813|469188499|FG001|Overall Study|Protocol Violation|7|||
130332631|NCT03894813|469188498|FG000|Overall Study|Withdrawal by Subject|1|||
130332632|NCT03894813|469188499|FG001|Overall Study|Withdrawal by Subject|3|||
130332633|NCT03894813|469188498|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
130332634|NCT03894813|469188499|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
130332635|NCT03773796|469188500|FG000|Overall Study|Adverse Event|1|||
130332636|NCT03773796|469188500|FG000|Overall Study|Withdrawal by Subject|1|||
130332637|NCT03773796|469188500|FG000|Overall Study|Lack of Efficacy|1|||
130332638|NCT03805659|469188501|FG000|Overall Study|Withdrawal by Subject|0|||
130332639|NCT03805659|469188502|FG001|Overall Study|Withdrawal by Subject|1|||
130332640|NCT01250145|469188504|FG000|Overall Study|Adverse Event|2|||
130332641|NCT01250145|469188505|FG001|Overall Study|Adverse Event|1|||
130332642|NCT01250145|469188504|FG000|Overall Study|Withdrawal by Subject|0|||
130332643|NCT01250145|469188505|FG001|Overall Study|Withdrawal by Subject|4|||
130332644|NCT01069900|469188508|FG000|Overall Study|Technical problems|0|||
130332645|NCT01069900|469188509|FG001|Overall Study|Technical problems|1|||
130332646|NCT01069900|469188508|FG000|Overall Study|Lost to Follow-up|7|||
130332647|NCT01069900|469188509|FG001|Overall Study|Lost to Follow-up|1|||
130332648|NCT01069900|469188508|FG000|Overall Study|Withdrawal by Subject|6|||
130332649|NCT01069900|469188509|FG001|Overall Study|Withdrawal by Subject|1|||
130332650|NCT01069900|469188508|FG000|Overall Study|Protocol Violation|4|||
130332651|NCT01069900|469188509|FG001|Overall Study|Protocol Violation|1|||
130332652|NCT01069900|469188508|FG000|Overall Study|Insufficient Therapeutic effect|1|||
130332653|NCT01069900|469188509|FG001|Overall Study|Insufficient Therapeutic effect|0|||
130332654|NCT01675544|469188510|FG000|Overall Study|Withdrawal by Subject|2|||
130332655|NCT03675321|469188512|FG000|Overall Study|Lack of Efficacy|2|||
130332656|NCT03675321|469188513|FG001|Overall Study|Lack of Efficacy|2|||
130332657|NCT03675321|469188512|FG000|Overall Study|Withdrawal by Subject|1|||
130332658|NCT03675321|469188513|FG001|Overall Study|Withdrawal by Subject|3|||
130332659|NCT01491607|469188517|FG000|Overall Study|Lost to Follow-up|7|||
130332660|NCT01491607|469188517|FG000|Overall Study|Withdrawal by Subject|3|||
130332661|NCT01317277|469188518|FG000|Overall Study|Lost to Follow-up|3|||
130332662|NCT01317277|469188519|FG001|Overall Study|Lost to Follow-up|1|||
130332663|NCT01317277|469188518|FG000|Overall Study|Lost MEMS|1|||
130332664|NCT01317277|469188519|FG001|Overall Study|Lost MEMS|1|||
130332665|NCT01317277|469188518|FG000|Overall Study|Unable to comply with intervention|1|||
130332666|NCT01317277|469188519|FG001|Overall Study|Unable to comply with intervention|0|||
130332667|NCT01317277|469188518|FG000|Overall Study|Withdrawal by Subject|1|||
130332668|NCT01317277|469188519|FG001|Overall Study|Withdrawal by Subject|0|||
130332669|NCT01317277|469188518|FG000|Overall Study|Adverse Event|1|||
130332670|NCT01317277|469188519|FG001|Overall Study|Adverse Event|0|||
130332671|NCT00774566|469188520|FG000|Overall Study|Protocol Violation|18|||
130332672|NCT00774566|469188521|FG001|Overall Study|Protocol Violation|15|||
130332673|NCT02999672|469188528|FG000|Overall Study|Death|0|||
130332674|NCT02999672|469188529|FG001|Overall Study|Death|1|||
130332675|NCT02999672|469188528|FG000|Overall Study|Study Terminated by Sponsor|0|||
130332676|NCT02999672|469188529|FG001|Overall Study|Study Terminated by Sponsor|1|||
130332677|NCT02999672|469188528|FG000|Overall Study|Progressive Disease|9|||
130332678|NCT02999672|469188529|FG001|Overall Study|Progressive Disease|5|||
130332679|NCT02999672|469188528|FG000|Overall Study|Adverse Event|4|||
130332680|NCT02999672|469188529|FG001|Overall Study|Adverse Event|0|||
130332681|NCT03565497|469188530|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
130332682|NCT03565497|469188531|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
130332683|NCT03565497|469188532|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
130332684|NCT03565497|469188530|FG000|Overall Study|Lost to Follow-up|1|||
130332685|NCT03565497|469188531|FG001|Overall Study|Lost to Follow-up|1|||
130332686|NCT03565497|469188532|FG002|Overall Study|Lost to Follow-up|2|||
130332687|NCT03565497|469188530|FG000|Overall Study|Withdrawal by Subject|1|||
130332688|NCT03565497|469188531|FG001|Overall Study|Withdrawal by Subject|1|||
130332689|NCT03565497|469188532|FG002|Overall Study|Withdrawal by Subject|1|||
130332690|NCT01075685|469188533|FG000|Overall Study|Protocol Violation|9|||
130332691|NCT01075685|469188534|FG001|Overall Study|Protocol Violation|1|||
130332692|NCT01075685|469188533|FG000|Overall Study|Withdrawal by Subject|20|||
130332693|NCT01075685|469188534|FG001|Overall Study|Withdrawal by Subject|5|||
130332694|NCT01075685|469188533|FG000|Overall Study|Lost to Follow-up|563|||
130332695|NCT01075685|469188534|FG001|Overall Study|Lost to Follow-up|220|||
130332696|NCT02858362|469188537|FG000|Overall Study|Protocol Violation|0|||
130332697|NCT02858362|469188538|FG001|Overall Study|Protocol Violation|1|||
130332698|NCT02858362|469188539|FG002|Overall Study|Protocol Violation|0|||
130332699|NCT02858362|469188537|FG000|Overall Study|Withdrawal by Subject|1|||
130332700|NCT02858362|469188538|FG001|Overall Study|Withdrawal by Subject|0|||
130332701|NCT02858362|469188539|FG002|Overall Study|Withdrawal by Subject|0|||
130332702|NCT02858362|469188537|FG000|Overall Study|Early Study Termination|0|||
130332703|NCT02858362|469188538|FG001|Overall Study|Early Study Termination|0|||
130332704|NCT02858362|469188539|FG002|Overall Study|Early Study Termination|3|||
130332705|NCT02858362|469188537|FG000|Overall Study|Lost to Follow-up|1|||
130332706|NCT02858362|469188538|FG001|Overall Study|Lost to Follow-up|0|||
130332707|NCT02858362|469188539|FG002|Overall Study|Lost to Follow-up|0|||
130332708|NCT02813577|469188541|FG000|Overall Study|Study terminated|4|||
130332709|NCT01301027|469188542|FG000|Overall Study|Physician Decision|2|||
130332710|NCT01301027|469188543|FG001|Overall Study|Physician Decision|0|||
130332711|NCT01301027|469188542|FG000|Overall Study|Withdrawal by Subject|2|||
130332712|NCT01301027|469188543|FG001|Overall Study|Withdrawal by Subject|3|||
130332713|NCT01301027|469188542|FG000|Overall Study|Adverse Event|0|||
130332714|NCT01301027|469188543|FG001|Overall Study|Adverse Event|2|||
130332715|NCT01301027|469188542|FG000|Overall Study|Fracture|1|||
130332716|NCT01301027|469188543|FG001|Overall Study|Fracture|3|||
130332717|NCT01301027|469188542|FG000|Overall Study|Transplant|0|||
130332718|NCT01301027|469188543|FG001|Overall Study|Transplant|2|||
130332719|NCT01301027|469188542|FG000|Overall Study|Volume Overload|3|||
130332720|NCT01301027|469188543|FG001|Overall Study|Volume Overload|0|||
130332721|NCT02023697|469188544|FG000|Treatment Period|Radiological progression|13|||
130332722|NCT02023697|469188545|FG001|Treatment Period|Radiological progression|17|||
130332723|NCT02023697|469188546|FG002|Treatment Period|Radiological progression|26|||
130332724|NCT02023697|469188544|FG000|Treatment Period|Never Treated|5|||
130332725|NCT02023697|469188545|FG001|Treatment Period|Never Treated|6|||
130332726|NCT02023697|469188546|FG002|Treatment Period|Never Treated|10|||
130332727|NCT02023697|469188544|FG000|Treatment Period|Adverse Event|13|||
130332728|NCT02023697|469188545|FG001|Treatment Period|Adverse Event|25|||
130332729|NCT02023697|469188546|FG002|Treatment Period|Adverse Event|23|||
130332730|NCT02023697|469188544|FG000|Treatment Period|Logistical difficulties|1|||
130332731|NCT02023697|469188545|FG001|Treatment Period|Logistical difficulties|1|||
130332732|NCT02023697|469188546|FG002|Treatment Period|Logistical difficulties|1|||
130332733|NCT02023697|469188544|FG000|Treatment Period|Clinical progression|10|||
130332734|NCT02023697|469188545|FG001|Treatment Period|Clinical progression|8|||
130332735|NCT02023697|469188546|FG002|Treatment Period|Clinical progression|28|||
130332736|NCT02023697|469188544|FG000|Treatment Period|Withdrawal by Subject|4|||
130332737|NCT02023697|469188545|FG001|Treatment Period|Withdrawal by Subject|5|||
130332738|NCT02023697|469188546|FG002|Treatment Period|Withdrawal by Subject|13|||
130332739|NCT02023697|469188544|FG000|Treatment Period|Safety outcome reached|0|||
130332740|NCT02023697|469188545|FG001|Treatment Period|Safety outcome reached|1|||
130332741|NCT02023697|469188546|FG002|Treatment Period|Safety outcome reached|0|||
130332742|NCT02023697|469188544|FG000|Treatment Period|Physician Decision|0|||
130332743|NCT02023697|469188545|FG001|Treatment Period|Physician Decision|0|||
130332744|NCT02023697|469188546|FG002|Treatment Period|Physician Decision|1|||
130332745|NCT02023697|469188544|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
130332746|NCT02023697|469188545|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
130332747|NCT02023697|469188546|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
130332748|NCT02023697|469188544|FG000|Active Follow-up Period|Lost to Follow-up|1|||
130332749|NCT02023697|469188545|FG001|Active Follow-up Period|Lost to Follow-up|1|||
130332750|NCT02023697|469188546|FG002|Active Follow-up Period|Lost to Follow-up|1|||
130332751|NCT02023697|469188544|FG000|Active Follow-up Period|Deterioration of general condition|1|||
130332752|NCT02023697|469188545|FG001|Active Follow-up Period|Deterioration of general condition|1|||
130332753|NCT02023697|469188546|FG002|Active Follow-up Period|Deterioration of general condition|1|||
130332754|NCT02023697|469188544|FG000|Active Follow-up Period|Other unspecified|2|||
130332755|NCT02023697|469188545|FG001|Active Follow-up Period|Other unspecified|0|||
130332756|NCT02023697|469188546|FG002|Active Follow-up Period|Other unspecified|1|||
130332757|NCT02023697|469188544|FG000|Active Follow-up Period|Clinical progression|0|||
130332758|NCT02023697|469188545|FG001|Active Follow-up Period|Clinical progression|2|||
130332759|NCT02023697|469188546|FG002|Active Follow-up Period|Clinical progression|1|||
130332760|NCT02023697|469188544|FG000|Active Follow-up Period|Radiological progression|0|||
130332761|NCT02023697|469188545|FG001|Active Follow-up Period|Radiological progression|0|||
130332762|NCT02023697|469188546|FG002|Active Follow-up Period|Radiological progression|1|||
130332763|NCT02023697|469188544|FG000|Active Follow-up Period|Death|83|||
130332764|NCT02023697|469188545|FG001|Active Follow-up Period|Death|82|||
130332765|NCT02023697|469188546|FG002|Active Follow-up Period|Death|87|||
130332766|NCT02023697|469188544|FG000|Long-term Follow-up Period|Death|9|||
130332767|NCT02023697|469188545|FG001|Long-term Follow-up Period|Death|6|||
130332768|NCT02023697|469188546|FG002|Long-term Follow-up Period|Death|4|||
130332769|NCT02023697|469188544|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
130332770|NCT02023697|469188545|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
130332771|NCT02023697|469188546|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
130332772|NCT02023697|469188544|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
130332773|NCT02023697|469188545|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
130332774|NCT02023697|469188546|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
130332775|NCT02023697|469188544|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130332776|NCT02023697|469188545|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
130332777|NCT02023697|469188546|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130332778|NCT02023697|469188544|FG000|Long-term Follow-up Period|Technical problems|0|||
130332779|NCT02023697|469188545|FG001|Long-term Follow-up Period|Technical problems|0|||
130332780|NCT02023697|469188546|FG002|Long-term Follow-up Period|Technical problems|1|||
130332781|NCT02023697|469188544|FG000|Long-term Follow-up Period|Other unspecified|6|||
130332782|NCT02023697|469188545|FG001|Long-term Follow-up Period|Other unspecified|3|||
130332783|NCT02023697|469188546|FG002|Long-term Follow-up Period|Other unspecified|5|||
130332784|NCT00845897|469188547|FG000|Overall Study|Lost to Follow-up|1|||
130332785|NCT00845897|469188548|FG001|Overall Study|Lost to Follow-up|1|||
130332786|NCT00845897|469188549|FG002|Overall Study|Lost to Follow-up|0|||
130332787|NCT00845897|469188547|FG000|Overall Study|Withdrawal by Subject|0|||
130332788|NCT00845897|469188548|FG001|Overall Study|Withdrawal by Subject|3|||
130332789|NCT00845897|469188549|FG002|Overall Study|Withdrawal by Subject|2|||
130332790|NCT00845897|469188547|FG000|Overall Study|Ulcer did not heal|1|||
130332791|NCT00845897|469188548|FG001|Overall Study|Ulcer did not heal|0|||
130332792|NCT00845897|469188549|FG002|Overall Study|Ulcer did not heal|1|||
130332793|NCT00845897|469188547|FG000|Overall Study|Too ill to participate|0|||
130332794|NCT00845897|469188548|FG001|Overall Study|Too ill to participate|1|||
130332795|NCT00845897|469188549|FG002|Overall Study|Too ill to participate|0|||
130332796|NCT02722499|469188550|FG000|Overall Study|Lost to Follow-up|2|||
130332797|NCT02722499|469188551|FG001|Overall Study|Lost to Follow-up|0|||
130332798|NCT02722499|469188552|FG002|Overall Study|Lost to Follow-up|1|||
130332799|NCT03566485|469188562|FG000|Overall Study|Disease progression|5|||
130332800|NCT03566485|469188563|FG001|Overall Study|Disease progression|4|||
130332801|NCT03566485|469188562|FG000|Overall Study|Clinical progression|0|||
130332802|NCT03566485|469188563|FG001|Overall Study|Clinical progression|1|||
130332803|NCT03566485|469188562|FG000|Overall Study|Toxicity|0|||
130332804|NCT03566485|469188563|FG001|Overall Study|Toxicity|2|||
130332805|NCT04999852|469188564|FG000|Overall Study|Withdrawal by Subject|11|||
130332806|NCT04999852|469188565|FG001|Overall Study|Withdrawal by Subject|1|||
130332807|NCT04999852|469188564|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
130332808|NCT04999852|469188565|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
130433232|NCT02055157|469550397|FG002|Initial 6 Months|Adverse Event|0|||
130433233|NCT02055157|469550398|FG003|Initial 6 Months|Adverse Event|1|||
130433234|NCT02055157|469550395|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
130433235|NCT02055157|469550396|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
130332813|NCT03610269|469188569|FG000|Overall Study|Physician Decision|10|||
130332814|NCT03610269|469188569|FG000|Overall Study|Protocol Violation|1|||
130332815|NCT03610269|469188569|FG000|Overall Study|Unable to draw blood|1|||
130332816|NCT03610269|469188569|FG000|Overall Study|Screen fail|4|||
130332817|NCT00478023|469188570|FG000|Overall Study|Adverse Event|11|||
130332818|NCT00478023|469188571|FG001|Overall Study|Adverse Event|7|||
130332819|NCT00478023|469188572|FG002|Overall Study|Adverse Event|8|||
130332820|NCT00478023|469188573|FG003|Overall Study|Adverse Event|14|||
130332821|NCT00478023|469188574|FG004|Overall Study|Adverse Event|6|||
130332822|NCT00478023|469188570|FG000|Overall Study|Death|1|||
130332823|NCT00478023|469188571|FG001|Overall Study|Death|0|||
130332824|NCT00478023|469188572|FG002|Overall Study|Death|0|||
130332825|NCT00478023|469188573|FG003|Overall Study|Death|0|||
130332826|NCT00478023|469188574|FG004|Overall Study|Death|0|||
130332827|NCT00478023|469188570|FG000|Overall Study|Lack of Efficacy|11|||
130332828|NCT00478023|469188571|FG001|Overall Study|Lack of Efficacy|10|||
130332829|NCT00478023|469188572|FG002|Overall Study|Lack of Efficacy|4|||
130332830|NCT00478023|469188573|FG003|Overall Study|Lack of Efficacy|5|||
130332831|NCT00478023|469188574|FG004|Overall Study|Lack of Efficacy|41|||
130332832|NCT00478023|469188570|FG000|Overall Study|Lost to Follow-up|3|||
130332833|NCT00478023|469188571|FG001|Overall Study|Lost to Follow-up|1|||
130332834|NCT00478023|469188572|FG002|Overall Study|Lost to Follow-up|1|||
130332835|NCT00478023|469188573|FG003|Overall Study|Lost to Follow-up|1|||
130332836|NCT00478023|469188574|FG004|Overall Study|Lost to Follow-up|0|||
130332837|NCT00478023|469188570|FG000|Overall Study|Withdrawal by Subject|2|||
130332838|NCT00478023|469188571|FG001|Overall Study|Withdrawal by Subject|3|||
130332839|NCT00478023|469188572|FG002|Overall Study|Withdrawal by Subject|2|||
130332840|NCT00478023|469188573|FG003|Overall Study|Withdrawal by Subject|4|||
130332841|NCT00478023|469188574|FG004|Overall Study|Withdrawal by Subject|5|||
130332842|NCT00478023|469188570|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
130332843|NCT00478023|469188571|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
130332844|NCT00478023|469188572|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
130332845|NCT00478023|469188573|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
130332846|NCT00478023|469188574|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
130332847|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
130332848|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
130332849|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
130332850|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
130332851|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332852|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332853|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332854|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332855|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332856|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332857|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130332858|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332859|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332860|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332861|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
130332862|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
130332863|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
130332864|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
130332865|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332866|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332867|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332868|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130332869|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332870|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130332871|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332872|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332873|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332874|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332875|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
130332876|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
130332877|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
130332878|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
130332879|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
130332880|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
130332881|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
130332882|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130332883|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332884|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332885|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332886|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332887|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332888|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332889|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332890|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332891|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332892|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
130332893|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332894|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332895|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332896|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130332897|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130332898|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130332899|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332900|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332901|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332902|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130332903|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332904|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130332905|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332906|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332907|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332908|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332909|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332910|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
130332911|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332912|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332913|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332914|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
130332915|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130332916|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130332917|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332918|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
130332919|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
130332920|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332921|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332922|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332923|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332924|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332925|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332926|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332927|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332928|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332929|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332930|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332931|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332932|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332933|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332934|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332935|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332936|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130332937|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332938|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332939|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130332940|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332941|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332942|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332943|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130332944|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332945|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
130332946|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
130332947|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
130332948|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
130332949|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
130332950|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
130332951|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
130332952|NCT00611026|469188583|FG000|Randomized to Double-blind Treatment|Not treated|2|||
130332953|NCT00611026|469188584|FG001|Randomized to Double-blind Treatment|Not treated|1|||
130332954|NCT00611026|469188585|FG002|Randomized to Double-blind Treatment|Not treated|3|||
130332955|NCT00611026|469188583|FG000|Double-blind Treatment Period|Death|1|||
130332956|NCT00611026|469188584|FG001|Double-blind Treatment Period|Death|0|||
130332957|NCT00611026|469188585|FG002|Double-blind Treatment Period|Death|0|||
130332958|NCT00611026|469188583|FG000|Double-blind Treatment Period|Adverse Event|9|||
130332959|NCT00611026|469188584|FG001|Double-blind Treatment Period|Adverse Event|28|||
130332960|NCT00611026|469188585|FG002|Double-blind Treatment Period|Adverse Event|46|||
130332961|NCT00611026|469188583|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
130332962|NCT00611026|469188584|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
130332963|NCT00611026|469188585|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
130332964|NCT00611026|469188583|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130332965|NCT00611026|469188584|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
130332966|NCT00611026|469188585|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
130332967|NCT00611026|469188583|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130332968|NCT00611026|469188584|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
130332969|NCT00611026|469188585|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
130332970|NCT00611026|469188583|FG000|Double-blind Treatment Period|Other|13|||
130332971|NCT00611026|469188584|FG001|Double-blind Treatment Period|Other|20|||
130332972|NCT00611026|469188585|FG002|Double-blind Treatment Period|Other|18|||
130332973|NCT01147874|469188587|FG000|Overall Study|Adverse Event|5|||
130332974|NCT01147874|469188587|FG000|Overall Study|Investigator's Request|1|||
130332975|NCT01147874|469188587|FG000|Overall Study|Lost to Follow-up|25|||
130332976|NCT01147874|469188587|FG000|Overall Study|Other|5|||
130332977|NCT01147874|469188587|FG000|Overall Study|Protocol Violation|5|||
130332978|NCT01147874|469188587|FG000|Overall Study|Sponsor's Decision|2|||
130332979|NCT01147874|469188587|FG000|Overall Study|Withdrawal by Subject|24|||
130332980|NCT02533453|469188595|FG000|Overall Study|Adverse Event|6|||
130332981|NCT02533453|469188595|FG000|Overall Study|Protocol Violation|1|||
130332982|NCT02533453|469188595|FG000|Overall Study|Withdrawal by Subject|2|||
130332983|NCT00885534|469188596|FG000|Overall Study|Patient deemed ineligible|1|||
130332984|NCT04292899|469188598|FG000|Overall Study|Death|21|||
130332985|NCT04292899|469188599|FG001|Overall Study|Death|28|||
130332986|NCT04292899|469188600|FG002|Overall Study|Death|188|||
130332987|NCT04292899|469188601|FG003|Overall Study|Death|371|||
130332988|NCT04292899|469188598|FG000|Overall Study|Lost to Follow-up|8|||
130332989|NCT04292899|469188599|FG001|Overall Study|Lost to Follow-up|4|||
130332990|NCT04292899|469188600|FG002|Overall Study|Lost to Follow-up|22|||
130332991|NCT04292899|469188601|FG003|Overall Study|Lost to Follow-up|235|||
130332992|NCT04292899|469188598|FG000|Overall Study|Withdrew consent|1|||
130332993|NCT04292899|469188599|FG001|Overall Study|Withdrew consent|0|||
130332994|NCT04292899|469188600|FG002|Overall Study|Withdrew consent|11|||
130332995|NCT04292899|469188601|FG003|Overall Study|Withdrew consent|32|||
130332996|NCT04292899|469188598|FG000|Overall Study|Adverse Event|2|||
130332997|NCT04292899|469188599|FG001|Overall Study|Adverse Event|1|||
130332998|NCT04292899|469188600|FG002|Overall Study|Adverse Event|2|||
130332999|NCT04292899|469188601|FG003|Overall Study|Adverse Event|2|||
130333000|NCT04292899|469188598|FG000|Overall Study|Investigator's Discretion|0|||
130333001|NCT04292899|469188599|FG001|Overall Study|Investigator's Discretion|0|||
130333002|NCT04292899|469188600|FG002|Overall Study|Investigator's Discretion|0|||
130333003|NCT04292899|469188601|FG003|Overall Study|Investigator's Discretion|3|||
130333004|NCT04292899|469188598|FG000|Overall Study|Non-compliance With Study Drug|0|||
130333005|NCT04292899|469188599|FG001|Overall Study|Non-compliance With Study Drug|0|||
130333006|NCT04292899|469188600|FG002|Overall Study|Non-compliance With Study Drug|0|||
130333007|NCT04292899|469188601|FG003|Overall Study|Non-compliance With Study Drug|1|||
130333008|NCT04292899|469188598|FG000|Overall Study|Protocol Violation|0|||
130333009|NCT04292899|469188599|FG001|Overall Study|Protocol Violation|0|||
130333010|NCT04292899|469188600|FG002|Overall Study|Protocol Violation|0|||
130333011|NCT04292899|469188601|FG003|Overall Study|Protocol Violation|1|||
130333012|NCT01209325|469188607|FG000|Overall Study|Lost to Follow-up|24|||
130333013|NCT01209325|469188607|FG000|Overall Study|Adverse Event|1|||
130333014|NCT01209325|469188607|FG000|Overall Study|Relocated|3|||
130333015|NCT01209325|469188607|FG000|Overall Study|Refusal after starting therapy|8|||
130333016|NCT01209325|469188607|FG000|Overall Study|Protocol Violation|4|||
130333017|NCT01209325|469188607|FG000|Overall Study|Refusal prior to therapy|1|||
130333018|NCT01209325|469188607|FG000|Overall Study|Incarceration|2|||
130333019|NCT00396253|469188608|FG000|Overall Study|Protocol Violation|1|||
130333020|NCT00396253|469188608|FG000|Overall Study|Withdrawal by Subject|7|||
130333021|NCT00396253|469188608|FG000|Overall Study|Death|3|||
130333022|NCT00396253|469188608|FG000|Overall Study|Physician Decision|1|||
130333023|NCT00396253|469188608|FG000|Overall Study|Change in eligibility status|1|||
130333024|NCT05340478|469188612|FG000|Overall Study|Scheduling Issues|10|||
130333025|NCT05340478|469188613|FG001|Overall Study|Scheduling Issues|4|||
130333026|NCT05340478|469188612|FG000|Overall Study|Neither member of dyad started treatment|2|||
130333027|NCT05340478|469188613|FG001|Overall Study|Neither member of dyad started treatment|2|||
130333028|NCT05340478|469188612|FG000|Overall Study|Withdrawn from study|2|||
130333029|NCT05340478|469188613|FG001|Overall Study|Withdrawn from study|2|||
130333030|NCT05340478|469188612|FG000|Overall Study|Lost to Follow-up|1|||
130333031|NCT05340478|469188613|FG001|Overall Study|Lost to Follow-up|4|||
130333032|NCT02506244|469188614|FG000|Overall Study|Did not undergo active monitoring|458|||
130333033|NCT02506244|469188615|FG001|Overall Study|Did not undergo active monitoring|459|||
130333034|NCT02506244|469188616|FG002|Overall Study|Did not undergo active monitoring|0|||
130333035|NCT00314795|469188617|FG000|Overall Study|Adverse Event|8|||
130333036|NCT00314795|469188617|FG000|Overall Study|Death|4|||
130333037|NCT00314795|469188617|FG000|Overall Study|Reason not Specified|3|||
130333038|NCT00314795|469188617|FG000|Overall Study|Renal Transplant|3|||
130333039|NCT00314795|469188617|FG000|Overall Study|Participants Withdrew Consent|2|||
130333040|NCT02116205|469188621|FG000|Overall Study|Withdrawal by Subject|2|||
130333041|NCT02116205|469188622|FG001|Overall Study|Withdrawal by Subject|4|||
130333042|NCT02116205|469188623|FG002|Overall Study|Withdrawal by Subject|1|||
130333043|NCT02116205|469188624|FG003|Overall Study|Withdrawal by Subject|3|||
130333044|NCT02116205|469188621|FG000|Overall Study|Lost to Follow-up|0|||
130333045|NCT02116205|469188622|FG001|Overall Study|Lost to Follow-up|2|||
130333046|NCT02116205|469188623|FG002|Overall Study|Lost to Follow-up|1|||
130333047|NCT02116205|469188624|FG003|Overall Study|Lost to Follow-up|2|||
130333048|NCT02116205|469188621|FG000|Overall Study|Physician Decision|0|||
130333049|NCT02116205|469188622|FG001|Overall Study|Physician Decision|1|||
130333050|NCT02116205|469188623|FG002|Overall Study|Physician Decision|1|||
130333051|NCT02116205|469188624|FG003|Overall Study|Physician Decision|1|||
130333052|NCT02116205|469188621|FG000|Overall Study|Exclusion criteria|0|||
130333053|NCT02116205|469188622|FG001|Overall Study|Exclusion criteria|0|||
130333054|NCT02116205|469188623|FG002|Overall Study|Exclusion criteria|1|||
130333055|NCT02116205|469188624|FG003|Overall Study|Exclusion criteria|0|||
130333056|NCT02541604|469188625|FG000|Overall Study|Death|6|||
130333057|NCT02541604|469188626|FG001|Overall Study|Death|5|||
130333058|NCT02541604|469188627|FG002|Overall Study|Death|7|||
130333059|NCT02541604|469188628|FG003|Overall Study|Death|2|||
130333060|NCT02541604|469188629|FG004|Overall Study|Death|9|||
130333061|NCT02541604|469188630|FG005|Overall Study|Death|8|||
130333062|NCT02541604|469188631|FG006|Overall Study|Death|9|||
130333063|NCT02541604|469188632|FG007|Overall Study|Death|9|||
130333064|NCT02541604|469188633|FG008|Overall Study|Death|3|||
130333065|NCT02541604|469188634|FG009|Overall Study|Death|4|||
130333066|NCT02541604|469188635|FG010|Overall Study|Death|2|||
130333067|NCT02541604|469188636|FG011|Overall Study|Death|3|||
130333068|NCT02541604|469188625|FG000|Overall Study|Lost to Follow-up|2|||
130333069|NCT02541604|469188626|FG001|Overall Study|Lost to Follow-up|0|||
130433236|NCT02055157|469550397|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
130333070|NCT02541604|469188627|FG002|Overall Study|Lost to Follow-up|1|||
130333071|NCT02541604|469188628|FG003|Overall Study|Lost to Follow-up|0|||
130333072|NCT02541604|469188629|FG004|Overall Study|Lost to Follow-up|0|||
130333073|NCT02541604|469188630|FG005|Overall Study|Lost to Follow-up|1|||
130333074|NCT02541604|469188631|FG006|Overall Study|Lost to Follow-up|1|||
130333075|NCT02541604|469188632|FG007|Overall Study|Lost to Follow-up|0|||
130333076|NCT02541604|469188633|FG008|Overall Study|Lost to Follow-up|0|||
130333077|NCT02541604|469188634|FG009|Overall Study|Lost to Follow-up|0|||
130333078|NCT02541604|469188635|FG010|Overall Study|Lost to Follow-up|0|||
130333079|NCT02541604|469188636|FG011|Overall Study|Lost to Follow-up|0|||
130333080|NCT02541604|469188625|FG000|Overall Study|Withdrawal by Subject|2|||
130333081|NCT02541604|469188626|FG001|Overall Study|Withdrawal by Subject|0|||
130333082|NCT02541604|469188627|FG002|Overall Study|Withdrawal by Subject|1|||
130333083|NCT02541604|469188628|FG003|Overall Study|Withdrawal by Subject|0|||
130333084|NCT02541604|469188629|FG004|Overall Study|Withdrawal by Subject|1|||
130333085|NCT02541604|469188630|FG005|Overall Study|Withdrawal by Subject|1|||
130333086|NCT02541604|469188631|FG006|Overall Study|Withdrawal by Subject|0|||
130333087|NCT02541604|469188632|FG007|Overall Study|Withdrawal by Subject|0|||
130333088|NCT02541604|469188633|FG008|Overall Study|Withdrawal by Subject|1|||
130333089|NCT02541604|469188634|FG009|Overall Study|Withdrawal by Subject|0|||
130333090|NCT02541604|469188635|FG010|Overall Study|Withdrawal by Subject|0|||
130333091|NCT02541604|469188636|FG011|Overall Study|Withdrawal by Subject|0|||
130333092|NCT02541604|469188625|FG000|Overall Study|Study Terminated by Sponsor|1|||
130333093|NCT02541604|469188626|FG001|Overall Study|Study Terminated by Sponsor|4|||
130333094|NCT02541604|469188627|FG002|Overall Study|Study Terminated by Sponsor|2|||
130333095|NCT02541604|469188628|FG003|Overall Study|Study Terminated by Sponsor|1|||
130333096|NCT02541604|469188629|FG004|Overall Study|Study Terminated by Sponsor|0|||
130333097|NCT02541604|469188630|FG005|Overall Study|Study Terminated by Sponsor|0|||
130333098|NCT02541604|469188631|FG006|Overall Study|Study Terminated by Sponsor|0|||
130333099|NCT02541604|469188632|FG007|Overall Study|Study Terminated by Sponsor|0|||
130433237|NCT02055157|469550398|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
130433238|NCT02055157|469550395|FG000|18-month Extension|Investigator decision|0|||
130433239|NCT02055157|469550396|FG001|18-month Extension|Investigator decision|1|||
130660787|NCT02149199|470381524|FG001|Overall Study|Withdrawal by Subject|93|||
130333100|NCT02541604|469188633|FG008|Overall Study|Study Terminated by Sponsor|0|||
130333101|NCT02541604|469188634|FG009|Overall Study|Study Terminated by Sponsor|0|||
130333102|NCT02541604|469188635|FG010|Overall Study|Study Terminated by Sponsor|0|||
130333103|NCT02541604|469188636|FG011|Overall Study|Study Terminated by Sponsor|0|||
130333104|NCT02541604|469188625|FG000|Overall Study|Medical condition may jeopardize safety|0|||
130333105|NCT02541604|469188626|FG001|Overall Study|Medical condition may jeopardize safety|0|||
130333106|NCT02541604|469188627|FG002|Overall Study|Medical condition may jeopardize safety|0|||
130333107|NCT02541604|469188628|FG003|Overall Study|Medical condition may jeopardize safety|0|||
130333108|NCT02541604|469188629|FG004|Overall Study|Medical condition may jeopardize safety|0|||
130333109|NCT02541604|469188630|FG005|Overall Study|Medical condition may jeopardize safety|0|||
130333110|NCT02541604|469188631|FG006|Overall Study|Medical condition may jeopardize safety|0|||
130333111|NCT02541604|469188632|FG007|Overall Study|Medical condition may jeopardize safety|1|||
130333112|NCT02541604|469188633|FG008|Overall Study|Medical condition may jeopardize safety|0|||
130333113|NCT02541604|469188634|FG009|Overall Study|Medical condition may jeopardize safety|0|||
130333114|NCT02541604|469188635|FG010|Overall Study|Medical condition may jeopardize safety|0|||
130333115|NCT02541604|469188636|FG011|Overall Study|Medical condition may jeopardize safety|0|||
130333116|NCT02752165|469188643|FG000|Overall Study|Withdrawal by Subject|6|||
130333117|NCT02752165|469188644|FG001|Overall Study|Withdrawal by Subject|6|||
130333118|NCT02752165|469188643|FG000|Overall Study|Protocol Violation|6|||
130333119|NCT02752165|469188644|FG001|Overall Study|Protocol Violation|5|||
130333120|NCT02752165|469188643|FG000|Overall Study|Lost to Follow-up|33|||
130333121|NCT02752165|469188644|FG001|Overall Study|Lost to Follow-up|38|||
130333122|NCT01704599|469188646|FG000|Overall Study|Adverse Event|1|||
130333123|NCT02840461|469188647|FG000|Overall Study|Adverse Event|1|||
130333124|NCT02840461|469188648|FG001|Overall Study|Adverse Event|5|||
130333125|NCT02840461|469188649|FG002|Overall Study|Adverse Event|3|||
130333126|NCT02840461|469188647|FG000|Overall Study|Lost to Follow-up|10|||
130333127|NCT02840461|469188648|FG001|Overall Study|Lost to Follow-up|7|||
130333128|NCT02840461|469188649|FG002|Overall Study|Lost to Follow-up|6|||
130333129|NCT02840461|469188647|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
130333130|NCT02840461|469188648|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
130333131|NCT02840461|469188649|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
130333132|NCT02840461|469188647|FG000|Overall Study|Protocol Violation|2|||
130333133|NCT02840461|469188648|FG001|Overall Study|Protocol Violation|3|||
130660788|NCT02149199|470381525|FG002|Overall Study|Withdrawal by Subject|77|||
130660789|NCT02149199|470381523|FG000|Overall Study|Protocol Violation|16|||
130333134|NCT02840461|469188649|FG002|Overall Study|Protocol Violation|1|||
130333135|NCT02840461|469188647|FG000|Overall Study|Withdrawal by Subject|10|||
130333136|NCT02840461|469188648|FG001|Overall Study|Withdrawal by Subject|6|||
130333137|NCT02840461|469188649|FG002|Overall Study|Withdrawal by Subject|2|||
130333138|NCT02840461|469188647|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
130333139|NCT02840461|469188648|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
130333140|NCT02840461|469188649|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
130333141|NCT01737502|469188652|FG000|Phase I|Disease progression|2|||
130660790|NCT02149199|470381524|FG001|Overall Study|Protocol Violation|13|||
130333142|NCT01737502|469188653|FG001|Phase I|Disease progression|3|||
130333143|NCT01737502|469188652|FG000|Phase I|Complicating disease|1|||
130333144|NCT01737502|469188653|FG001|Phase I|Complicating disease|0|||
130333145|NCT01737502|469188652|FG000|Phase II|Adverse Event|0|||
130333146|NCT01737502|469188653|FG001|Phase II|Adverse Event|3|||
130333147|NCT01737502|469188652|FG000|Phase II|Disease progression|0|||
130333148|NCT01737502|469188653|FG001|Phase II|Disease progression|18|||
130333149|NCT01737502|469188652|FG000|Phase II|Death|0|||
130333150|NCT01737502|469188653|FG001|Phase II|Death|1|||
130333151|NCT01737502|469188652|FG000|Phase II|Transition to hospice care|0|||
130333152|NCT01737502|469188653|FG001|Phase II|Transition to hospice care|1|||
130333153|NCT04672655|469188654|FG000|Overall Study|Lost to Follow-up|12|||
130333154|NCT04672655|469188655|FG001|Overall Study|Lost to Follow-up|17|||
130333155|NCT04672655|469188654|FG000|Overall Study|Withdrawal by Subject|1|||
130333156|NCT04672655|469188655|FG001|Overall Study|Withdrawal by Subject|0|||
130333157|NCT04672655|469188654|FG000|Overall Study|Withdrawal by Study|1|||
130333158|NCT04672655|469188655|FG001|Overall Study|Withdrawal by Study|0|||
130333159|NCT00494676|469188656|FG000|Allocation|Withdrawal by Subject|2|||
130333160|NCT00494676|469188657|FG001|Allocation|Withdrawal by Subject|4|||
130333161|NCT00494676|469188656|FG000|First Intervention|Withdrawal by Subject|1|||
130333162|NCT00494676|469188657|FG001|First Intervention|Withdrawal by Subject|3|||
130333163|NCT00494676|469188656|FG000|Second Intervention|Withdrawal by Subject|1|||
130333164|NCT00494676|469188657|FG001|Second Intervention|Withdrawal by Subject|1|||
130333165|NCT05767749|469188661|FG000|Overall Study|Withdrawal by Subject|0|||
130333166|NCT05767749|469188662|FG001|Overall Study|Withdrawal by Subject|0|||
130333167|NCT05767749|469188663|FG002|Overall Study|Withdrawal by Subject|2|||
130333168|NCT05767749|469188664|FG003|Overall Study|Withdrawal by Subject|2|||
130333169|NCT05767749|469188665|FG004|Overall Study|Withdrawal by Subject|2|||
130333170|NCT05767749|469188666|FG005|Overall Study|Withdrawal by Subject|2|||
130333171|NCT02067676|469189680|FG000|Overall Study|Withdrawal by Subject|1|||
130333172|NCT02067676|469189681|FG001|Overall Study|Withdrawal by Subject|0|||
130333173|NCT02067676|469189682|FG002|Overall Study|Withdrawal by Subject|0|||
130333174|NCT02067676|469189683|FG003|Overall Study|Withdrawal by Subject|0|||
130333175|NCT02067676|469189684|FG004|Overall Study|Withdrawal by Subject|0|||
130333176|NCT02067676|469189685|FG005|Overall Study|Withdrawal by Subject|0|||
130333177|NCT00996333|469189686|FG000|Overall Study|Screen failure|1|||
130333178|NCT00996333|469189686|FG000|Overall Study|Withdrawal by Subject|1|||
130333179|NCT00996333|469189686|FG000|Overall Study|Death|4|||
130333180|NCT00996333|469189686|FG000|Overall Study|Adverse Event|1|||
130660791|NCT02149199|470381525|FG002|Overall Study|Protocol Violation|15|||
130660792|NCT02149199|470381523|FG000|Overall Study|Lost to Follow-up|3|||
130660793|NCT02149199|470381524|FG001|Overall Study|Lost to Follow-up|12|||
130660794|NCT02149199|470381525|FG002|Overall Study|Lost to Follow-up|11|||
130660795|NCT02149199|470381523|FG000|Overall Study|Death|0|||
130660796|NCT02149199|470381524|FG001|Overall Study|Death|0|||
130433240|NCT02055157|469550397|FG002|18-month Extension|Investigator decision|0|||
130433241|NCT02055157|469550398|FG003|18-month Extension|Investigator decision|0|||
130433242|NCT02055157|469550395|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
130433243|NCT02055157|469550396|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130433244|NCT02055157|469550397|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130333181|NCT00996333|469189686|FG000|Overall Study|Physician Decision|1|||
130333182|NCT00996333|469189686|FG000|Overall Study|Other|5|||
130333183|NCT04939415|469189694|FG000|Overall Study|Withdrawal by Subject|1|||
130333184|NCT04939415|469189695|FG001|Overall Study|Withdrawal by Subject|3|||
130333185|NCT04939415|469189694|FG000|Overall Study|Lost to Follow-up|0|||
130333186|NCT04939415|469189695|FG001|Overall Study|Lost to Follow-up|2|||
130333187|NCT00369265|469189696|FG000|Overall Study|Study terminated|4|||
130333188|NCT00369265|469189697|FG001|Overall Study|Study terminated|7|||
130333189|NCT00068419|469189700|FG000|Overall Study|Adverse Event|3|||
130333190|NCT00068419|469189700|FG000|Overall Study|Lack of Efficacy|24|||
130333191|NCT00068419|469189700|FG000|Overall Study|Lost to Follow-up|1|||
130333192|NCT00068419|469189700|FG000|Overall Study|Physician Decision|7|||
130333193|NCT00068419|469189700|FG000|Overall Study|Withdrawal by Subject|14|||
130333194|NCT00068419|469189700|FG000|Overall Study|Ineligible|11|||
130333195|NCT00092443|469189701|FG000|Overall Study|Adverse Event|9|||
130333196|NCT00092443|469189702|FG001|Overall Study|Adverse Event|13|||
130333197|NCT00092443|469189701|FG000|Overall Study|Lost to Follow-up|7|||
130433245|NCT02055157|469550398|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130333198|NCT00092443|469189702|FG001|Overall Study|Lost to Follow-up|3|||
130333199|NCT00092443|469189701|FG000|Overall Study|Protocol Violation|11|||
130333200|NCT00092443|469189702|FG001|Overall Study|Protocol Violation|9|||
130660797|NCT02149199|470381525|FG002|Overall Study|Death|1|||
130333201|NCT00092443|469189701|FG000|Overall Study|Withdrawal by Subject|9|||
130333202|NCT00092443|469189702|FG001|Overall Study|Withdrawal by Subject|11|||
130333203|NCT00092443|469189701|FG000|Overall Study|Moved|5|||
130333204|NCT00092443|469189702|FG001|Overall Study|Moved|5|||
130333205|NCT00092443|469189701|FG000|Overall Study|Other|17|||
130333206|NCT00092443|469189702|FG001|Overall Study|Other|13|||
130333207|NCT01160822|469189703|FG000|Overall Study|Adverse Event|0|||
130333208|NCT01160822|469189704|FG001|Overall Study|Adverse Event|0|||
130333209|NCT01160822|469189705|FG002|Overall Study|Adverse Event|0|||
130333210|NCT01160822|469189706|FG003|Overall Study|Adverse Event|0|||
130333211|NCT01160822|469189707|FG004|Overall Study|Adverse Event|1|||
130333212|NCT01160822|469189708|FG005|Overall Study|Adverse Event|2|||
130333213|NCT01160822|469189709|FG006|Overall Study|Adverse Event|5|||
130333214|NCT01160822|469189703|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130333215|NCT01160822|469189704|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130333216|NCT01160822|469189705|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130333217|NCT01160822|469189706|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130333218|NCT01160822|469189707|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
130333219|NCT01160822|469189708|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
130333220|NCT01160822|469189709|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
130333221|NCT01160822|469189703|FG000|Overall Study|Withdrawal by Subject|0|||
130333222|NCT01160822|469189704|FG001|Overall Study|Withdrawal by Subject|0|||
130333223|NCT01160822|469189705|FG002|Overall Study|Withdrawal by Subject|0|||
130333224|NCT01160822|469189706|FG003|Overall Study|Withdrawal by Subject|0|||
130333225|NCT01160822|469189707|FG004|Overall Study|Withdrawal by Subject|0|||
130333226|NCT01160822|469189708|FG005|Overall Study|Withdrawal by Subject|0|||
130333227|NCT01160822|469189709|FG006|Overall Study|Withdrawal by Subject|1|||
130333228|NCT01160822|469189703|FG000|Overall Study|Lost to Follow-up|0|||
130333229|NCT01160822|469189704|FG001|Overall Study|Lost to Follow-up|0|||
130333230|NCT01160822|469189705|FG002|Overall Study|Lost to Follow-up|0|||
130333231|NCT01160822|469189706|FG003|Overall Study|Lost to Follow-up|0|||
130333232|NCT01160822|469189707|FG004|Overall Study|Lost to Follow-up|1|||
130333233|NCT01160822|469189708|FG005|Overall Study|Lost to Follow-up|0|||
130333234|NCT01160822|469189709|FG006|Overall Study|Lost to Follow-up|0|||
130333235|NCT01160822|469189703|FG000|Overall Study|Administrative problems|0|||
130333236|NCT01160822|469189704|FG001|Overall Study|Administrative problems|0|||
130333237|NCT01160822|469189705|FG002|Overall Study|Administrative problems|0|||
130333238|NCT01160822|469189706|FG003|Overall Study|Administrative problems|0|||
130333239|NCT01160822|469189707|FG004|Overall Study|Administrative problems|1|||
130333240|NCT01160822|469189708|FG005|Overall Study|Administrative problems|0|||
130333241|NCT01160822|469189709|FG006|Overall Study|Administrative problems|0|||
130333242|NCT01160822|469189703|FG000|Overall Study|Protocol deviation|0|||
130333243|NCT01160822|469189704|FG001|Overall Study|Protocol deviation|0|||
130333244|NCT01160822|469189705|FG002|Overall Study|Protocol deviation|0|||
130333245|NCT01160822|469189706|FG003|Overall Study|Protocol deviation|0|||
130333246|NCT01160822|469189707|FG004|Overall Study|Protocol deviation|2|||
130333247|NCT01160822|469189708|FG005|Overall Study|Protocol deviation|0|||
130333248|NCT01160822|469189709|FG006|Overall Study|Protocol deviation|0|||
130333249|NCT04717336|469189714|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130333250|NCT04717336|469189715|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130333251|NCT04717336|469189714|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130333252|NCT04717336|469189715|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130333253|NCT01500720|469189722|FG000|Overall Study|Randomized But Not Treated|1|||
130333254|NCT01500720|469189723|FG001|Overall Study|Randomized But Not Treated|1|||
130333255|NCT01500720|469189722|FG000|Overall Study|Other|4|||
130333256|NCT01500720|469189723|FG001|Overall Study|Other|8|||
130333257|NCT02527421|469189724|FG000|Overall Study|Withdrawal by Subject|1|||
130333258|NCT02527421|469189725|FG001|Overall Study|Withdrawal by Subject|0|||
130333259|NCT00806819|469189726|FG000|Overall Study|progressive disease (modified RECIST )|217|||
130333260|NCT00806819|469189727|FG001|Overall Study|progressive disease (modified RECIST )|216|||
130333261|NCT00806819|469189726|FG000|Overall Study|Worsening or AE of underlying disease|18|||
130333262|NCT00806819|469189727|FG001|Overall Study|Worsening or AE of underlying disease|25|||
130333263|NCT00806819|469189726|FG000|Overall Study|Other AE|38|||
130333264|NCT00806819|469189727|FG001|Overall Study|Other AE|40|||
130333265|NCT00806819|469189726|FG000|Overall Study|Protocol Violation|9|||
130333266|NCT00806819|469189727|FG001|Overall Study|Protocol Violation|4|||
130333267|NCT00806819|469189726|FG000|Overall Study|Lost to Follow-up|1|||
130333268|NCT00806819|469189727|FG001|Overall Study|Lost to Follow-up|0|||
130333269|NCT00806819|469189726|FG000|Overall Study|Withdrawal by Subject|32|||
130333270|NCT00806819|469189727|FG001|Overall Study|Withdrawal by Subject|29|||
130333271|NCT00806819|469189726|FG000|Overall Study|Not treated|6|||
130333272|NCT00806819|469189727|FG001|Overall Study|Not treated|3|||
130333273|NCT00806819|469189726|FG000|Overall Study|Reasons other than stated above|25|||
130333274|NCT00806819|469189727|FG001|Overall Study|Reasons other than stated above|41|||
130333275|NCT01615029|469189733|FG000|Overall Study|Adverse Event|0|||
130333276|NCT01615029|469189734|FG001|Overall Study|Adverse Event|0|||
130333277|NCT01615029|469189735|FG002|Overall Study|Adverse Event|0|||
130333278|NCT01615029|469189736|FG003|Overall Study|Adverse Event|0|||
130333279|NCT01615029|469189737|FG004|Overall Study|Adverse Event|1|||
130333280|NCT01615029|469189733|FG000|Overall Study|Death|0|||
130333281|NCT01615029|469189734|FG001|Overall Study|Death|0|||
130333282|NCT01615029|469189735|FG002|Overall Study|Death|0|||
130333283|NCT01615029|469189736|FG003|Overall Study|Death|0|||
130333284|NCT01615029|469189737|FG004|Overall Study|Death|1|||
130333285|NCT01615029|469189733|FG000|Overall Study|Lost to Follow-up|0|||
130333286|NCT01615029|469189734|FG001|Overall Study|Lost to Follow-up|0|||
130333287|NCT01615029|469189735|FG002|Overall Study|Lost to Follow-up|0|||
130333288|NCT01615029|469189736|FG003|Overall Study|Lost to Follow-up|0|||
130333289|NCT01615029|469189737|FG004|Overall Study|Lost to Follow-up|1|||
130333290|NCT01615029|469189733|FG000|Overall Study|Progressive disease|2|||
130333291|NCT01615029|469189734|FG001|Overall Study|Progressive disease|1|||
130333292|NCT01615029|469189735|FG002|Overall Study|Progressive disease|1|||
130333293|NCT01615029|469189736|FG003|Overall Study|Progressive disease|1|||
130333294|NCT01615029|469189737|FG004|Overall Study|Progressive disease|5|||
130333295|NCT01615029|469189733|FG000|Overall Study|Physician Decision|0|||
130333296|NCT01615029|469189734|FG001|Overall Study|Physician Decision|0|||
130333297|NCT01615029|469189735|FG002|Overall Study|Physician Decision|0|||
130333298|NCT01615029|469189736|FG003|Overall Study|Physician Decision|0|||
130333299|NCT01615029|469189737|FG004|Overall Study|Physician Decision|1|||
130333300|NCT01615029|469189733|FG000|Overall Study|Ongoing|1|||
130333301|NCT01615029|469189734|FG001|Overall Study|Ongoing|2|||
130333302|NCT01615029|469189735|FG002|Overall Study|Ongoing|3|||
130333303|NCT01615029|469189736|FG003|Overall Study|Ongoing|2|||
130333304|NCT01615029|469189737|FG004|Overall Study|Ongoing|23|||
130333305|NCT00802945|469189743|FG000|Overall Study|Death|27|||
130333306|NCT00802945|469189744|FG001|Overall Study|Death|23|||
130333307|NCT00802945|469189743|FG000|Overall Study|Terminated by sponsor|8|||
130333308|NCT00802945|469189744|FG001|Overall Study|Terminated by sponsor|12|||
130333309|NCT03843541|469189745|FG000|Overall Study|Adverse Event|4|||
130333310|NCT03843541|469189746|FG001|Overall Study|Adverse Event|2|||
130333311|NCT03843541|469189747|FG002|Overall Study|Adverse Event|3|||
130333312|NCT03843541|469189745|FG000|Overall Study|Death|1|||
130333313|NCT03843541|469189746|FG001|Overall Study|Death|0|||
130333314|NCT03843541|469189747|FG002|Overall Study|Death|0|||
130333315|NCT03843541|469189745|FG000|Overall Study|Lack of adherence to study medication|0|||
130333316|NCT03843541|469189746|FG001|Overall Study|Lack of adherence to study medication|0|||
130333317|NCT03843541|469189747|FG002|Overall Study|Lack of adherence to study medication|1|||
130333318|NCT03843541|469189745|FG000|Overall Study|Physician Decision|1|||
130333319|NCT03843541|469189746|FG001|Overall Study|Physician Decision|2|||
130333320|NCT03843541|469189747|FG002|Overall Study|Physician Decision|2|||
130333321|NCT03843541|469189745|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
130333322|NCT03843541|469189746|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
130333323|NCT03843541|469189747|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
130333324|NCT03843541|469189745|FG000|Overall Study|Withdrawal by Subject|6|||
130333325|NCT03843541|469189746|FG001|Overall Study|Withdrawal by Subject|9|||
130333326|NCT03843541|469189747|FG002|Overall Study|Withdrawal by Subject|7|||
130333327|NCT03843541|469189745|FG000|Overall Study|Administration of rescue mucolytic|0|||
130333328|NCT03843541|469189746|FG001|Overall Study|Administration of rescue mucolytic|0|||
130333329|NCT03843541|469189747|FG002|Overall Study|Administration of rescue mucolytic|1|||
130333330|NCT03843541|469189745|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
130333331|NCT03843541|469189746|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
130333332|NCT03843541|469189747|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
130333333|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333334|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
130333335|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333336|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333337|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333338|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
130333339|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333340|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333341|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130333342|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130333343|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130333344|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130333345|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
130333346|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
130333347|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
130333348|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
130333349|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333350|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
130333351|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333352|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333353|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
130333354|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
130333355|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130333356|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130333357|NCT05307692|469189751|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333358|NCT05307692|469189752|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333359|NCT05307692|469189753|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333360|NCT05307692|469189754|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
130333361|NCT05307692|469189751|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333362|NCT05307692|469189752|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333363|NCT05307692|469189753|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333364|NCT05307692|469189754|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
130333365|NCT02003924|469189757|FG000|Double-blind Phase|Lost to Follow-up|2|||
130333366|NCT02003924|469189758|FG001|Double-blind Phase|Lost to Follow-up|1|||
130333367|NCT02003924|469189759|FG002|Double-blind Phase|Lost to Follow-up|0|||
130333368|NCT02003924|469189757|FG000|Double-blind Phase|Protocol Violation|1|||
130333369|NCT02003924|469189758|FG001|Double-blind Phase|Protocol Violation|2|||
130333370|NCT02003924|469189759|FG002|Double-blind Phase|Protocol Violation|0|||
130333371|NCT02003924|469189757|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
130333372|NCT02003924|469189758|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
130333373|NCT02003924|469189759|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
130333374|NCT02003924|469189757|FG000|Double-blind Phase|Disease Progression|229|||
130333375|NCT02003924|469189758|FG001|Double-blind Phase|Disease Progression|247|||
130333376|NCT02003924|469189759|FG002|Double-blind Phase|Disease Progression|0|||
130333377|NCT02003924|469189757|FG000|Double-blind Phase|Adverse Event|120|||
130333378|NCT02003924|469189758|FG001|Double-blind Phase|Adverse Event|31|||
130333379|NCT02003924|469189759|FG002|Double-blind Phase|Adverse Event|0|||
130333380|NCT02003924|469189757|FG000|Double-blind Phase|Randomized But not Treated|3|||
130333381|NCT02003924|469189758|FG001|Double-blind Phase|Randomized But not Treated|3|||
130433246|NCT03976466|469550399|FG000|Overall Study|Lost to Follow-up|1|||
130433247|NCT03976466|469550400|FG001|Overall Study|Lost to Follow-up|3|||
130433248|NCT00733499|469550405|FG000|Pre-operative|Protocol Violation|0|||
130433249|NCT00733499|469550406|FG001|Pre-operative|Protocol Violation|1|||
130433250|NCT00733499|469550405|FG000|3 Months Follow-up|Death|1|||
130433251|NCT00733499|469550406|FG001|3 Months Follow-up|Death|2|||
130433252|NCT00733499|469550405|FG000|6 Months Follow-up|Death|0|||
130433253|NCT00733499|469550406|FG001|6 Months Follow-up|Death|2|||
130433254|NCT00733499|469550405|FG000|6 Months Follow-up|Adverse Event|0|||
130433255|NCT00733499|469550406|FG001|6 Months Follow-up|Adverse Event|1|||
130433256|NCT00733499|469550405|FG000|12 Months Follow-up|Death|2|||
130333382|NCT02003924|469189759|FG002|Double-blind Phase|Randomized But not Treated|0|||
130333383|NCT02003924|469189757|FG000|Double-blind Phase|Other|29|||
130333384|NCT02003924|469189758|FG001|Double-blind Phase|Other|50|||
130333385|NCT02003924|469189759|FG002|Double-blind Phase|Other|0|||
130333386|NCT02003924|469189757|FG000|Open-label Phase|Lost to Follow-up|0|||
130333387|NCT02003924|469189758|FG001|Open-label Phase|Lost to Follow-up|0|||
130333388|NCT02003924|469189759|FG002|Open-label Phase|Lost to Follow-up|1|||
130333389|NCT02003924|469189757|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
130333390|NCT02003924|469189758|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
130333391|NCT02003924|469189759|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
130333392|NCT02003924|469189757|FG000|Open-label Phase|Disease Progression|59|||
130333393|NCT02003924|469189758|FG001|Open-label Phase|Disease Progression|0|||
130333394|NCT02003924|469189759|FG002|Open-label Phase|Disease Progression|5|||
130333395|NCT02003924|469189757|FG000|Open-label Phase|Adverse Event|25|||
130333396|NCT02003924|469189758|FG001|Open-label Phase|Adverse Event|0|||
130333397|NCT02003924|469189759|FG002|Open-label Phase|Adverse Event|10|||
130333398|NCT02003924|469189757|FG000|Open-label Phase|Other|7|||
130333399|NCT02003924|469189758|FG001|Open-label Phase|Other|0|||
130433257|NCT00733499|469550406|FG001|12 Months Follow-up|Death|1|||
130433258|NCT00733499|469550405|FG000|24 Months Follow-up|Death|0|||
130433259|NCT00733499|469550406|FG001|24 Months Follow-up|Death|1|||
130333400|NCT02003924|469189759|FG002|Open-label Phase|Other|0|||
130433260|NCT00733499|469550405|FG000|5 Year Followup|Adverse Event|2|||
130433261|NCT00733499|469550406|FG001|5 Year Followup|Adverse Event|2|||
130333401|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Death|288|||
130333402|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Death|174|||
130333403|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Death|4|||
130333404|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
130333405|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
130333406|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
130333407|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
130333408|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
130333409|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
130433262|NCT00733499|469550405|FG000|5 Year Followup|Non device related AE|0|||
130433263|NCT00733499|469550406|FG001|5 Year Followup|Non device related AE|1|||
130433264|NCT00733499|469550405|FG000|5 Year Followup|Revision of Study Implant|0|||
130433265|NCT00733499|469550406|FG001|5 Year Followup|Revision of Study Implant|1|||
130333410|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Other|5|||
130433266|NCT00733499|469550405|FG000|5 Year Followup|Lost to Follow-up|2|||
130433267|NCT00733499|469550406|FG001|5 Year Followup|Lost to Follow-up|0|||
130433268|NCT00733499|469550405|FG000|5 Year Followup|Death|13|||
130433269|NCT00733499|469550406|FG001|5 Year Followup|Death|19|||
130433270|NCT00733499|469550405|FG000|5 Year Followup|missing, unable to locate|0|||
130433271|NCT00733499|469550406|FG001|5 Year Followup|missing, unable to locate|1|||
130433272|NCT00733499|469550405|FG000|5 Year Followup|Withdrawal by Subject|4|||
130433273|NCT00733499|469550406|FG001|5 Year Followup|Withdrawal by Subject|1|||
130433274|NCT00733499|469550405|FG000|10 Year Followup|Death|9|||
130333411|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Other|2|||
130333412|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Other|1|||
130333413|NCT00560352|469189764|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130333414|NCT00560352|469189765|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130333415|NCT00560352|469189766|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130333416|NCT00560352|469189764|FG000|Overall Study|Study drug toxicity|3|||
130333417|NCT00560352|469189765|FG001|Overall Study|Study drug toxicity|0|||
130333418|NCT00560352|469189766|FG002|Overall Study|Study drug toxicity|1|||
130333419|NCT00560352|469189764|FG000|Overall Study|Disease progression|0|||
130333420|NCT00560352|469189765|FG001|Overall Study|Disease progression|1|||
130333421|NCT00560352|469189766|FG002|Overall Study|Disease progression|1|||
130333422|NCT00560352|469189764|FG000|Overall Study|Withdrawal by Subject|1|||
130333423|NCT00560352|469189765|FG001|Overall Study|Withdrawal by Subject|1|||
130333424|NCT00560352|469189766|FG002|Overall Study|Withdrawal by Subject|1|||
130333425|NCT00560352|469189764|FG000|Overall Study|Maximum clinical benefit|1|||
130333426|NCT00560352|469189765|FG001|Overall Study|Maximum clinical benefit|0|||
130333427|NCT00560352|469189766|FG002|Overall Study|Maximum clinical benefit|0|||
130333428|NCT04434937|469189767|FG000|Overall Study|Death|4|||
130333429|NCT04434937|469189767|FG000|Overall Study|Withdrawal by Subject|1|||
130333430|NCT04434937|469189767|FG000|Overall Study|Transitioned to Rollover Study|19|||
130333431|NCT04434937|469189767|FG000|Overall Study|Progressive Disease|18|||
130333432|NCT04695977|469189772|FG000|Overall Study|Sponsor Decision|9|||
130333433|NCT04695977|469189773|FG001|Overall Study|Sponsor Decision|4|||
130333434|NCT04695977|469189772|FG000|Overall Study|Death|2|||
130333435|NCT04695977|469189773|FG001|Overall Study|Death|5|||
130333436|NCT03083873|469191815|FG000|Overall Study|Death|6|||
130333437|NCT03083873|469191816|FG001|Overall Study|Death|15|||
130333438|NCT03083873|469191817|FG002|Overall Study|Death|13|||
130333439|NCT03083873|469191818|FG003|Overall Study|Death|9|||
130333440|NCT03083873|469191819|FG004|Overall Study|Death|0|||
130333441|NCT03083873|469191815|FG000|Overall Study|Sponsor Terminated Study|0|||
130333442|NCT03083873|469191816|FG001|Overall Study|Sponsor Terminated Study|1|||
130333443|NCT03083873|469191817|FG002|Overall Study|Sponsor Terminated Study|2|||
130333444|NCT03083873|469191818|FG003|Overall Study|Sponsor Terminated Study|3|||
130333445|NCT03083873|469191819|FG004|Overall Study|Sponsor Terminated Study|0|||
130333446|NCT03083873|469191815|FG000|Overall Study|Lost to Follow-up|0|||
130333447|NCT03083873|469191816|FG001|Overall Study|Lost to Follow-up|1|||
130333448|NCT03083873|469191817|FG002|Overall Study|Lost to Follow-up|1|||
130333449|NCT03083873|469191818|FG003|Overall Study|Lost to Follow-up|0|||
130333450|NCT03083873|469191819|FG004|Overall Study|Lost to Follow-up|0|||
130333451|NCT03083873|469191815|FG000|Overall Study|Withdrawal by Subject|2|||
130333452|NCT03083873|469191816|FG001|Overall Study|Withdrawal by Subject|0|||
130333453|NCT03083873|469191817|FG002|Overall Study|Withdrawal by Subject|0|||
130333454|NCT03083873|469191818|FG003|Overall Study|Withdrawal by Subject|0|||
130333455|NCT03083873|469191819|FG004|Overall Study|Withdrawal by Subject|0|||
130333456|NCT03083873|469191815|FG000|Overall Study|Did Not Receive TIL|2|||
130333457|NCT03083873|469191816|FG001|Overall Study|Did Not Receive TIL|5|||
130333458|NCT03083873|469191817|FG002|Overall Study|Did Not Receive TIL|3|||
130333459|NCT03083873|469191818|FG003|Overall Study|Did Not Receive TIL|1|||
130333460|NCT03083873|469191819|FG004|Overall Study|Did Not Receive TIL|0|||
130333461|NCT01677377|469191820|FG000|Overall Study|Protocol Violation|1|||
130433275|NCT00733499|469550406|FG001|10 Year Followup|Death|7|||
130433276|NCT00733499|469550405|FG000|10 Year Followup|Adverse Event|3|||
130333462|NCT01677377|469191821|FG001|Overall Study|Protocol Violation|0|||
130333463|NCT01677377|469191822|FG002|Overall Study|Protocol Violation|0|||
130333464|NCT01677377|469191820|FG000|Overall Study|Lost to Follow-up|0|||
130333465|NCT01677377|469191821|FG001|Overall Study|Lost to Follow-up|1|||
130333466|NCT01677377|469191822|FG002|Overall Study|Lost to Follow-up|1|||
130333467|NCT01677377|469191820|FG000|Overall Study|Withdrawal by Subject|0|||
130333468|NCT01677377|469191821|FG001|Overall Study|Withdrawal by Subject|0|||
130333469|NCT01677377|469191822|FG002|Overall Study|Withdrawal by Subject|3|||
130333470|NCT01677377|469191820|FG000|Overall Study|Lack of Efficacy|0|||
130333471|NCT01677377|469191821|FG001|Overall Study|Lack of Efficacy|0|||
130333472|NCT01677377|469191822|FG002|Overall Study|Lack of Efficacy|1|||
130333473|NCT01677377|469191820|FG000|Overall Study|Pregnancy|0|||
130333474|NCT01677377|469191821|FG001|Overall Study|Pregnancy|0|||
130433277|NCT00733499|469550406|FG001|10 Year Followup|Adverse Event|3|||
130333475|NCT01677377|469191822|FG002|Overall Study|Pregnancy|1|||
130333476|NCT02656693|469191836|FG000|Overall Study|Pregnancy|1|||
130433278|NCT00733499|469550405|FG000|10 Year Followup|Lost to Follow-up|3|||
130333477|NCT02656693|469191837|FG001|Overall Study|Pregnancy|1|||
130333478|NCT02656693|469191838|FG002|Overall Study|Pregnancy|1|||
130333479|NCT02656693|469191836|FG000|Overall Study|Bariatric surgery|0|||
130333480|NCT02656693|469191837|FG001|Overall Study|Bariatric surgery|1|||
130333481|NCT02656693|469191838|FG002|Overall Study|Bariatric surgery|2|||
130333482|NCT02269267|469191840|FG000|Overall Study|Death|5|||
130333483|NCT00796419|469191842|FG000|Overall Study|Death|0|||
130333484|NCT00796419|469191843|FG001|Overall Study|Death|1|||
130433279|NCT00733499|469550406|FG001|10 Year Followup|Lost to Follow-up|2|||
130433280|NCT00733499|469550405|FG000|10 Year Followup|Withdrawal by Subject|5|||
130433281|NCT00733499|469550406|FG001|10 Year Followup|Withdrawal by Subject|5|||
130433282|NCT00733499|469550405|FG000|10 Year Followup|missing, unable to locate|0|||
130433283|NCT00733499|469550406|FG001|10 Year Followup|missing, unable to locate|2|||
130433284|NCT02739347|469550407|FG000|Overall Study|Adverse Event|3|||
130433285|NCT02739347|469550408|FG001|Overall Study|Adverse Event|0|||
130433286|NCT02739347|469550407|FG000|Overall Study|Protocol Violation|0|||
130433287|NCT02739347|469550408|FG001|Overall Study|Protocol Violation|1|||
130433288|NCT02739347|469550407|FG000|Overall Study|Lost to Follow-up|0|||
130433289|NCT02739347|469550408|FG001|Overall Study|Lost to Follow-up|2|||
130433290|NCT03929562|469550409|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
130433291|NCT03929562|469550410|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
130433292|NCT03929562|469550409|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
130433293|NCT03929562|469550410|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
130433294|NCT03929562|469550409|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
130433295|NCT03929562|469550410|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
130433296|NCT01778556|469550411|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
130433297|NCT01778556|469550412|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
130433298|NCT01778556|469550411|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130433299|NCT01778556|469550412|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
130433300|NCT01778556|469550411|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
130433301|NCT01778556|469550412|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
130433302|NCT01778556|469550411|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
130433303|NCT01778556|469550412|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
130433304|NCT01235403|469550416|FG000|Overall Study|Adverse Event|14|||
130333515|NCT01193257|469191852|FG000|Overall Study|Death|202|||
130333516|NCT01193257|469191853|FG001|Overall Study|Death|391|||
130333517|NCT01193257|469191852|FG000|Overall Study|Study termination by sponsor|0|||
130333518|NCT01193257|469191853|FG001|Overall Study|Study termination by sponsor|3|||
130333519|NCT01193257|469191852|FG000|Overall Study|Withdrawal by Subject|26|||
130333520|NCT01193257|469191853|FG001|Overall Study|Withdrawal by Subject|86|||
130333521|NCT01193257|469191852|FG000|Overall Study|Lost to Follow-up|2|||
130333522|NCT01193257|469191853|FG001|Overall Study|Lost to Follow-up|3|||
130333523|NCT01193257|469191852|FG000|Overall Study|Unblinded due to futility|135|||
130333524|NCT01193257|469191853|FG001|Overall Study|Unblinded due to futility|251|||
130333525|NCT01027273|469191856|FG000|Overall Study|Lost to Follow-up|57|||
130333526|NCT01027273|469191857|FG001|Overall Study|Lost to Follow-up|31|||
130333527|NCT01027273|469191856|FG000|Overall Study|Death|2|||
130333528|NCT01027273|469191857|FG001|Overall Study|Death|2|||
130333529|NCT00337675|469191859|FG000|Overall Study|Adverse Event|10|||
130333530|NCT00337675|469191860|FG001|Overall Study|Adverse Event|9|||
130333531|NCT00337675|469191861|FG002|Overall Study|Adverse Event|19|||
130333532|NCT00337675|469191859|FG000|Overall Study|Lack of Efficacy|10|||
130333533|NCT00337675|469191860|FG001|Overall Study|Lack of Efficacy|7|||
130333534|NCT00337675|469191861|FG002|Overall Study|Lack of Efficacy|9|||
130333535|NCT00337675|469191859|FG000|Overall Study|Lost to Follow-up|22|||
130333536|NCT00337675|469191860|FG001|Overall Study|Lost to Follow-up|19|||
130333537|NCT00337675|469191861|FG002|Overall Study|Lost to Follow-up|17|||
130333538|NCT00337675|469191859|FG000|Overall Study|Physician Decision|9|||
130333539|NCT00337675|469191860|FG001|Overall Study|Physician Decision|17|||
130333540|NCT00337675|469191861|FG002|Overall Study|Physician Decision|14|||
130333541|NCT00337675|469191859|FG000|Overall Study|Protocol Violation|21|||
130333542|NCT00337675|469191860|FG001|Overall Study|Protocol Violation|24|||
130333543|NCT00337675|469191861|FG002|Overall Study|Protocol Violation|19|||
130333544|NCT00337675|469191859|FG000|Overall Study|Withdrawal by Subject|25|||
130333545|NCT00337675|469191860|FG001|Overall Study|Withdrawal by Subject|25|||
130333546|NCT00337675|469191861|FG002|Overall Study|Withdrawal by Subject|19|||
130333547|NCT00337675|469191859|FG000|Overall Study|Progressive Disease|0|||
130333548|NCT00337675|469191860|FG001|Overall Study|Progressive Disease|2|||
130333549|NCT00337675|469191861|FG002|Overall Study|Progressive Disease|0|||
130333550|NCT00337675|469191859|FG000|Overall Study|Trial Terminated|0|||
130333551|NCT00337675|469191860|FG001|Overall Study|Trial Terminated|0|||
130333552|NCT00337675|469191861|FG002|Overall Study|Trial Terminated|2|||
130333553|NCT06170242|469191862|FG000|Overall Study|Lost to Follow-up|0|||
130333554|NCT06170242|469191863|FG001|Overall Study|Lost to Follow-up|0|||
130333555|NCT06170242|469191864|FG002|Overall Study|Lost to Follow-up|1|||
130333556|NCT06170242|469191865|FG003|Overall Study|Lost to Follow-up|1|||
130333557|NCT02586207|469191873|FG000|Overall Study|Physician Decision|1|||
130333558|NCT02586207|469191873|FG000|Overall Study|Withdrawal by Subject|1|||
130333559|NCT00441064|469191874|FG000|Overall Study|Adverse Event|1|||
130333560|NCT00441064|469191875|FG001|Overall Study|Adverse Event|0|||
130333561|NCT00441064|469191874|FG000|Overall Study|Abnormal laboratory values|0|||
130333562|NCT00441064|469191875|FG001|Overall Study|Abnormal laboratory values|2|||
130333563|NCT00441064|469191874|FG000|Overall Study|Abnormal test procedure results|0|||
130333564|NCT00441064|469191875|FG001|Overall Study|Abnormal test procedure results|1|||
130333565|NCT00441064|469191874|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130333566|NCT00441064|469191875|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130333567|NCT00441064|469191874|FG000|Overall Study|Protocol Deviation|3|||
130333568|NCT00441064|469191875|FG001|Overall Study|Protocol Deviation|2|||
130333569|NCT00441064|469191874|FG000|Overall Study|Patient withdrew consent|5|||
130333570|NCT00441064|469191875|FG001|Overall Study|Patient withdrew consent|2|||
130333571|NCT03962504|469191876|FG000|Overall Study|Other|11|||
130333572|NCT03962504|469191877|FG001|Overall Study|Other|32|||
130333573|NCT03776812|469191878|FG000|Overall Study|Death|53|||
130333574|NCT03776812|469191879|FG001|Overall Study|Death|49|||
130333575|NCT03776812|469191880|FG002|Overall Study|Death|56|||
130333576|NCT03776812|469191878|FG000|Overall Study|Withdrawal by Subject|1|||
130333577|NCT03776812|469191879|FG001|Overall Study|Withdrawal by Subject|7|||
130333578|NCT03776812|469191880|FG002|Overall Study|Withdrawal by Subject|2|||
130333579|NCT03776812|469191878|FG000|Overall Study|Lost to Follow-up|1|||
130333580|NCT03776812|469191879|FG001|Overall Study|Lost to Follow-up|1|||
130333581|NCT03776812|469191880|FG002|Overall Study|Lost to Follow-up|0|||
130333582|NCT03776812|469191878|FG000|Overall Study|Did not enter long-term follow-up|3|||
130333583|NCT03776812|469191879|FG001|Overall Study|Did not enter long-term follow-up|3|||
130333584|NCT03776812|469191880|FG002|Overall Study|Did not enter long-term follow-up|2|||
130333585|NCT00048074|469191883|FG000|Overall Study|Adverse Event|46|||
130333586|NCT00048074|469191884|FG001|Overall Study|Adverse Event|41|||
130333587|NCT00048074|469191885|FG002|Overall Study|Adverse Event|53|||
130333588|NCT00048074|469191883|FG000|Overall Study|Death|3|||
130333589|NCT00048074|469191884|FG001|Overall Study|Death|3|||
130333590|NCT00048074|469191885|FG002|Overall Study|Death|2|||
130333591|NCT00048074|469191883|FG000|Overall Study|Lost to Follow-up|2|||
130333592|NCT00048074|469191884|FG001|Overall Study|Lost to Follow-up|6|||
130333593|NCT00048074|469191885|FG002|Overall Study|Lost to Follow-up|6|||
130333594|NCT00048074|469191883|FG000|Overall Study|Withdrawal by Subject|28|||
130333595|NCT00048074|469191884|FG001|Overall Study|Withdrawal by Subject|30|||
130333596|NCT00048074|469191885|FG002|Overall Study|Withdrawal by Subject|35|||
130333597|NCT00048074|469191883|FG000|Overall Study|Protocol Violation|1|||
130333598|NCT00048074|469191884|FG001|Overall Study|Protocol Violation|3|||
130333599|NCT00048074|469191885|FG002|Overall Study|Protocol Violation|0|||
130333600|NCT00048074|469191883|FG000|Overall Study|Study participation was terminated|0|||
130333601|NCT00048074|469191884|FG001|Overall Study|Study participation was terminated|1|||
130333602|NCT00048074|469191885|FG002|Overall Study|Study participation was terminated|0|||
130333603|NCT00048074|469191883|FG000|Overall Study|Husband ill|0|||
130333604|NCT00048074|469191884|FG001|Overall Study|Husband ill|1|||
130333605|NCT00048074|469191885|FG002|Overall Study|Husband ill|0|||
130333606|NCT00048074|469191883|FG000|Overall Study|Poor compliance|0|||
130333607|NCT00048074|469191884|FG001|Overall Study|Poor compliance|1|||
130333608|NCT00048074|469191885|FG002|Overall Study|Poor compliance|0|||
130333609|NCT00048074|469191883|FG000|Overall Study|Out of station|0|||
130333610|NCT00048074|469191884|FG001|Overall Study|Out of station|1|||
130333611|NCT00048074|469191885|FG002|Overall Study|Out of station|1|||
130433305|NCT01235403|469550416|FG000|Overall Study|Lost to Follow-up|2|||
130433306|NCT01235403|469550416|FG000|Overall Study|Withdrawal by Subject|4|||
130433307|NCT01235403|469550416|FG000|Overall Study|Lack of Efficacy|2|||
130333612|NCT00048074|469191883|FG000|Overall Study|Social reasons|1|||
130333613|NCT00048074|469191884|FG001|Overall Study|Social reasons|0|||
130333614|NCT00048074|469191885|FG002|Overall Study|Social reasons|0|||
130333615|NCT02873377|469191886|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130333616|NCT02873377|469191887|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130333617|NCT02873377|469191886|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
130333618|NCT02873377|469191887|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
130433308|NCT01235403|469550416|FG000|Overall Study|Other reasons for premature termination|4|||
130333619|NCT01032889|469191897|FG000|Overall Study|Adverse Event|2|||
130333620|NCT01032889|469191898|FG001|Overall Study|Adverse Event|2|||
130333621|NCT01032889|469191899|FG002|Overall Study|Adverse Event|0|||
130333622|NCT01032889|469191897|FG000|Overall Study|Withdrawal of Consent|1|||
130333623|NCT01032889|469191898|FG001|Overall Study|Withdrawal of Consent|2|||
130333624|NCT01032889|469191899|FG002|Overall Study|Withdrawal of Consent|1|||
130333625|NCT01032889|469191897|FG000|Overall Study|Patient Request|0|||
130333626|NCT01032889|469191898|FG001|Overall Study|Patient Request|1|||
130333627|NCT01032889|469191899|FG002|Overall Study|Patient Request|0|||
130333628|NCT01032889|469191897|FG000|Overall Study|Lost to Follow-up|1|||
130333629|NCT01032889|469191898|FG001|Overall Study|Lost to Follow-up|1|||
130333630|NCT01032889|469191899|FG002|Overall Study|Lost to Follow-up|0|||
130433309|NCT02296190|469550417|FG000|Overall Study|Lost to Follow-up|0|||
130333631|NCT01032889|469191897|FG000|Overall Study|Lack of Submental Fat|2|||
130333632|NCT01032889|469191898|FG001|Overall Study|Lack of Submental Fat|8|||
130333633|NCT01032889|469191899|FG002|Overall Study|Lack of Submental Fat|1|||
130333634|NCT01032889|469191897|FG000|Overall Study|Miscellaneous Reasons|2|||
130333635|NCT01032889|469191898|FG001|Overall Study|Miscellaneous Reasons|1|||
130333636|NCT01032889|469191899|FG002|Overall Study|Miscellaneous Reasons|1|||
130333637|NCT02039843|469191900|FG000|Randomization and Observation Period|Adverse Event|2|||
130333638|NCT02039843|469191901|FG001|Randomization and Observation Period|Adverse Event|0|||
130333639|NCT02039843|469191900|FG000|Randomization and Observation Period|Death|1|||
130333640|NCT02039843|469191901|FG001|Randomization and Observation Period|Death|0|||
130333641|NCT02039843|469191900|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
130333642|NCT02039843|469191901|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
130333643|NCT02039843|469191900|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
130333644|NCT02039843|469191901|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
130333645|NCT02039843|469191900|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
130333646|NCT02039843|469191901|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
130333647|NCT02039843|469191900|FG000|Pairing With a Study Dog|Death|1|||
130333648|NCT02039843|469191901|FG001|Pairing With a Study Dog|Death|0|||
130333649|NCT02039843|469191900|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
130333650|NCT02039843|469191901|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
130333651|NCT02039843|469191900|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
130333652|NCT02039843|469191901|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
130333653|NCT02039843|469191900|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
130333654|NCT02039843|469191901|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
130333655|NCT02624986|469191905|FG000|Overall Study|Death|0|||
130333656|NCT02624986|469191906|FG001|Overall Study|Death|1|||
130333657|NCT02624986|469191907|FG002|Overall Study|Death|2|||
130333658|NCT02624986|469191908|FG003|Overall Study|Death|2|||
130333659|NCT02624986|469191909|FG004|Overall Study|Death|2|||
130333660|NCT02624986|469191910|FG005|Overall Study|Death|0|||
130333661|NCT02624986|469191911|FG006|Overall Study|Death|0|||
130333662|NCT02624986|469191912|FG007|Overall Study|Death|1|||
130333663|NCT02624986|469191905|FG000|Overall Study|Study Terminated by Sponsor|1|||
130333664|NCT02624986|469191906|FG001|Overall Study|Study Terminated by Sponsor|1|||
130333665|NCT02624986|469191907|FG002|Overall Study|Study Terminated by Sponsor|0|||
130333666|NCT02624986|469191908|FG003|Overall Study|Study Terminated by Sponsor|1|||
130333667|NCT02624986|469191909|FG004|Overall Study|Study Terminated by Sponsor|2|||
130333668|NCT02624986|469191910|FG005|Overall Study|Study Terminated by Sponsor|2|||
130333669|NCT02624986|469191911|FG006|Overall Study|Study Terminated by Sponsor|4|||
130333670|NCT02624986|469191912|FG007|Overall Study|Study Terminated by Sponsor|3|||
130333671|NCT02624986|469191905|FG000|Overall Study|Progressive Disease|0|||
130333672|NCT02624986|469191906|FG001|Overall Study|Progressive Disease|1|||
130333673|NCT02624986|469191907|FG002|Overall Study|Progressive Disease|0|||
130333674|NCT02624986|469191908|FG003|Overall Study|Progressive Disease|0|||
130333675|NCT02624986|469191909|FG004|Overall Study|Progressive Disease|0|||
130333676|NCT02624986|469191910|FG005|Overall Study|Progressive Disease|0|||
130333677|NCT02624986|469191911|FG006|Overall Study|Progressive Disease|0|||
130333678|NCT02624986|469191912|FG007|Overall Study|Progressive Disease|0|||
130333679|NCT02624986|469191905|FG000|Overall Study|Protocol Violation|1|||
130333680|NCT02624986|469191906|FG001|Overall Study|Protocol Violation|0|||
130333681|NCT02624986|469191907|FG002|Overall Study|Protocol Violation|0|||
130333682|NCT02624986|469191908|FG003|Overall Study|Protocol Violation|0|||
130333683|NCT02624986|469191909|FG004|Overall Study|Protocol Violation|0|||
130333684|NCT02624986|469191910|FG005|Overall Study|Protocol Violation|0|||
130333685|NCT02624986|469191911|FG006|Overall Study|Protocol Violation|0|||
130333686|NCT02624986|469191912|FG007|Overall Study|Protocol Violation|0|||
130333687|NCT02624986|469191905|FG000|Overall Study|Withdrawal by Subject|0|||
130333688|NCT02624986|469191906|FG001|Overall Study|Withdrawal by Subject|0|||
130333689|NCT02624986|469191907|FG002|Overall Study|Withdrawal by Subject|0|||
130333690|NCT02624986|469191908|FG003|Overall Study|Withdrawal by Subject|0|||
130333691|NCT02624986|469191909|FG004|Overall Study|Withdrawal by Subject|0|||
130333692|NCT02624986|469191910|FG005|Overall Study|Withdrawal by Subject|0|||
130333693|NCT02624986|469191911|FG006|Overall Study|Withdrawal by Subject|0|||
130333694|NCT02624986|469191912|FG007|Overall Study|Withdrawal by Subject|1|||
130333695|NCT00740857|469191914|FG000|Overall Study|Withdrawal by Subject|1|||
130333696|NCT00740857|469191915|FG001|Overall Study|Withdrawal by Subject|0|||
130333697|NCT00740857|469191916|FG002|Overall Study|Withdrawal by Subject|0|||
130333698|NCT03532451|469191920|FG000|Overall Study|Withdrawal by Subject|0|||
130333699|NCT03532451|469191921|FG001|Overall Study|Withdrawal by Subject|1|||
130333700|NCT03532451|469191920|FG000|Overall Study|Did not undergo surgery|1|||
130333701|NCT03532451|469191921|FG001|Overall Study|Did not undergo surgery|1|||
130333702|NCT00912197|469191922|FG000|Overall Study|Withdrawal by Subject|3|||
130333703|NCT00912197|469191923|FG001|Overall Study|Withdrawal by Subject|3|||
130333704|NCT01326104|469191929|FG000|Overall Study|progressed prior to vaccine|0|||
130333705|NCT01326104|469191930|FG001|Overall Study|progressed prior to vaccine|2|||
130333706|NCT01326104|469191929|FG000|Overall Study|unable to make vaccine|0|||
130333707|NCT01326104|469191930|FG001|Overall Study|unable to make vaccine|2|||
130333708|NCT01287741|469191931|FG000|Overall Study|Withdrawal by Subject|35|||
130333709|NCT01287741|469191932|FG001|Overall Study|Withdrawal by Subject|38|||
130333710|NCT01287741|469191931|FG000|Overall Study|Protocol Violation|2|||
130333711|NCT01287741|469191932|FG001|Overall Study|Protocol Violation|0|||
130333712|NCT01287741|469191931|FG000|Overall Study|Physician Decision|15|||
130333713|NCT01287741|469191932|FG001|Overall Study|Physician Decision|23|||
130333714|NCT01287741|469191931|FG000|Overall Study|Non-compliance|8|||
130333715|NCT01287741|469191932|FG001|Overall Study|Non-compliance|6|||
130333716|NCT01287741|469191931|FG000|Overall Study|Lost to Follow-up|10|||
130433310|NCT02296190|469550418|FG001|Overall Study|Lost to Follow-up|0|||
130433311|NCT02296190|469550419|FG002|Overall Study|Lost to Follow-up|0|||
130433312|NCT02296190|469550420|FG003|Overall Study|Lost to Follow-up|0|||
130433313|NCT02296190|469550421|FG004|Overall Study|Lost to Follow-up|1|||
130433314|NCT02296190|469550422|FG005|Overall Study|Lost to Follow-up|0|||
130433315|NCT02296190|469550417|FG000|Overall Study|Failure to induce PSVT|6|||
130660798|NCT02149199|470381523|FG000|Overall Study|Adverse Event|6|||
130660799|NCT02149199|470381524|FG001|Overall Study|Adverse Event|15|||
130660800|NCT02149199|470381525|FG002|Overall Study|Adverse Event|9|||
130660801|NCT03252756|470381526|FG000|Overall Study|Protocol Violation|2|||
130660802|NCT03252756|470381527|FG001|Overall Study|Protocol Violation|4|||
130660803|NCT03252756|470381526|FG000|Overall Study|COVID-19 Pandemic|1|||
130660804|NCT03252756|470381527|FG001|Overall Study|COVID-19 Pandemic|1|||
130660805|NCT03252756|470381526|FG000|Overall Study|Study Drug Expiration|0|||
130660806|NCT03252756|470381527|FG001|Overall Study|Study Drug Expiration|1|||
130660807|NCT01500434|470381530|FG000|Overall Study|Death|1|||
130333717|NCT01287741|469191932|FG001|Overall Study|Lost to Follow-up|8|||
130333718|NCT01287741|469191931|FG000|Overall Study|Death|32|||
130333719|NCT01287741|469191932|FG001|Overall Study|Death|44|||
130333720|NCT01287741|469191931|FG000|Overall Study|Adverse Event|4|||
130333721|NCT01287741|469191932|FG001|Overall Study|Adverse Event|6|||
130333722|NCT01287741|469191931|FG000|Overall Study|Study terminated by Sponsor|307|||
130333723|NCT01287741|469191932|FG001|Overall Study|Study terminated by Sponsor|315|||
130333724|NCT01287741|469191931|FG000|Overall Study|Progressive disease|190|||
130333725|NCT01287741|469191932|FG001|Overall Study|Progressive disease|166|||
130333726|NCT01287741|469191931|FG000|Overall Study|Reason not specified|23|||
130333727|NCT01287741|469191932|FG001|Overall Study|Reason not specified|9|||
130333728|NCT04421027|469191933|FG000|Treatment Period|Adverse Event|5|||
130333729|NCT04421027|469191934|FG001|Treatment Period|Adverse Event|3|||
130333730|NCT04421027|469191935|FG002|Treatment Period|Adverse Event|0|||
130333731|NCT04421027|469191936|FG003|Treatment Period|Adverse Event|0|||
130333732|NCT04421027|469191933|FG000|Treatment Period|Death|98|||
130333733|NCT04421027|469191934|FG001|Treatment Period|Death|61|||
130333734|NCT04421027|469191935|FG002|Treatment Period|Death|0|||
130333735|NCT04421027|469191936|FG003|Treatment Period|Death|0|||
130333736|NCT04421027|469191933|FG000|Treatment Period|Lost to Follow-up|22|||
130333737|NCT04421027|469191934|FG001|Treatment Period|Lost to Follow-up|20|||
130333738|NCT04421027|469191935|FG002|Treatment Period|Lost to Follow-up|0|||
130333739|NCT04421027|469191936|FG003|Treatment Period|Lost to Follow-up|0|||
130333740|NCT04421027|469191933|FG000|Treatment Period|Other-Unknown|15|||
130333741|NCT04421027|469191934|FG001|Treatment Period|Other-Unknown|9|||
130333742|NCT04421027|469191935|FG002|Treatment Period|Other-Unknown|0|||
130333743|NCT04421027|469191936|FG003|Treatment Period|Other-Unknown|0|||
130333744|NCT04421027|469191933|FG000|Treatment Period|Physician Decision|1|||
130333745|NCT04421027|469191934|FG001|Treatment Period|Physician Decision|1|||
130333746|NCT04421027|469191935|FG002|Treatment Period|Physician Decision|0|||
130333747|NCT04421027|469191936|FG003|Treatment Period|Physician Decision|0|||
130333748|NCT04421027|469191933|FG000|Treatment Period|Withdrawal by Subject|7|||
130333749|NCT04421027|469191934|FG001|Treatment Period|Withdrawal by Subject|12|||
130333750|NCT04421027|469191935|FG002|Treatment Period|Withdrawal by Subject|0|||
130333751|NCT04421027|469191936|FG003|Treatment Period|Withdrawal by Subject|0|||
130333752|NCT04421027|469191933|FG000|Treatment Period|Randomized Not Dosed|9|||
130333753|NCT04421027|469191934|FG001|Treatment Period|Randomized Not Dosed|14|||
130333754|NCT04421027|469191935|FG002|Treatment Period|Randomized Not Dosed|0|||
130333755|NCT04421027|469191936|FG003|Treatment Period|Randomized Not Dosed|0|||
130333756|NCT04421027|469191933|FG000|Follow-Up Period|Adverse Event|0|||
130333757|NCT04421027|469191934|FG001|Follow-Up Period|Adverse Event|0|||
130333758|NCT04421027|469191935|FG002|Follow-Up Period|Adverse Event|0|||
130333759|NCT04421027|469191936|FG003|Follow-Up Period|Adverse Event|3|||
130333760|NCT04421027|469191933|FG000|Follow-Up Period|Death|0|||
130333761|NCT04421027|469191934|FG001|Follow-Up Period|Death|0|||
130333762|NCT04421027|469191935|FG002|Follow-Up Period|Death|16|||
130333763|NCT04421027|469191936|FG003|Follow-Up Period|Death|17|||
130333764|NCT04421027|469191933|FG000|Follow-Up Period|Lost to Follow-up|0|||
130333765|NCT04421027|469191934|FG001|Follow-Up Period|Lost to Follow-up|0|||
130333766|NCT04421027|469191935|FG002|Follow-Up Period|Lost to Follow-up|7|||
130333767|NCT04421027|469191936|FG003|Follow-Up Period|Lost to Follow-up|7|||
130660808|NCT01500434|470381530|FG000|Overall Study|Withdrawal by Subject|1|||
130333768|NCT04421027|469191933|FG000|Follow-Up Period|Protocol Deviation|0|||
130333769|NCT04421027|469191934|FG001|Follow-Up Period|Protocol Deviation|0|||
130333770|NCT04421027|469191935|FG002|Follow-Up Period|Protocol Deviation|1|||
130333771|NCT04421027|469191936|FG003|Follow-Up Period|Protocol Deviation|0|||
130333772|NCT04421027|469191933|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333773|NCT04421027|469191934|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333774|NCT04421027|469191935|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
130333775|NCT04421027|469191936|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333776|NCT04421027|469191933|FG000|Follow-Up Period|Left message, participant did not call back|0|||
130333777|NCT04421027|469191934|FG001|Follow-Up Period|Left message, participant did not call back|0|||
130333778|NCT04421027|469191935|FG002|Follow-Up Period|Left message, participant did not call back|0|||
130333779|NCT04421027|469191936|FG003|Follow-Up Period|Left message, participant did not call back|1|||
130333780|NCT04421027|469191933|FG000|Follow-Up Period|Participant died|0|||
130333781|NCT04421027|469191934|FG001|Follow-Up Period|Participant died|0|||
130333782|NCT04421027|469191935|FG002|Follow-Up Period|Participant died|0|||
130333783|NCT04421027|469191936|FG003|Follow-Up Period|Participant died|1|||
130333784|NCT04421027|469191933|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333785|NCT04421027|469191934|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333786|NCT04421027|469191935|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333787|NCT04421027|469191936|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
130333788|NCT02930018|469191946|FG000|Overall Study|Lost to Follow-up|1|||
130333789|NCT02930018|469191947|FG001|Overall Study|Lost to Follow-up|1|||
130333790|NCT02930018|469191946|FG000|Overall Study|Withdrawal by Subject|5|||
130333791|NCT02930018|469191947|FG001|Overall Study|Withdrawal by Subject|2|||
130333792|NCT03892967|469191948|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
130333793|NCT03892967|469191949|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
130333794|NCT03892967|469191950|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
130333795|NCT03892967|469191951|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
130333796|NCT03892967|469191952|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
130333797|NCT03892967|469191948|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
130333798|NCT03892967|469191949|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
130333799|NCT03892967|469191950|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
130333800|NCT03892967|469191951|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
130333801|NCT03892967|469191952|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
130333802|NCT03892967|469191948|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
130333803|NCT03892967|469191949|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
130333804|NCT03892967|469191950|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
130333805|NCT03892967|469191951|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
130333806|NCT03892967|469191952|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
130333807|NCT03892967|469191948|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
130333808|NCT03892967|469191949|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
130333809|NCT03892967|469191950|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
130333810|NCT03892967|469191951|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
130333811|NCT03892967|469191952|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
130333812|NCT03892967|469191948|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
130333813|NCT03892967|469191949|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
130333814|NCT03892967|469191950|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
130333815|NCT03892967|469191951|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
130333816|NCT03892967|469191952|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
130333817|NCT03892967|469191948|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
130333818|NCT03892967|469191949|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
130660809|NCT01500434|470381530|FG000|Overall Study|Missed 12-month follow-up|5|||
130660810|NCT01966107|470381534|FG000|Overall Study|excluded from FAS|21|||
130660811|NCT01966107|470381535|FG001|Overall Study|excluded from FAS|20|||
130660812|NCT01966107|470381534|FG000|Overall Study|discontinued treatment|345|||
130660813|NCT01966107|470381535|FG001|Overall Study|discontinued treatment|372|||
130660814|NCT01966107|470381534|FG000|Overall Study|due to study closure|164|||
130660815|NCT01966107|470381535|FG001|Overall Study|due to study closure|186|||
130660816|NCT01966107|470381534|FG000|Overall Study|withdrew from the study|272|||
130333819|NCT03892967|469191950|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
130333820|NCT03892967|469191951|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
130333821|NCT03892967|469191952|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
130333822|NCT00114517|469191956|FG000|Overall Study|Adverse Event|6|||
130333823|NCT00114517|469191957|FG001|Overall Study|Adverse Event|1|||
130333824|NCT00114517|469191958|FG002|Overall Study|Adverse Event|6|||
130333825|NCT00114517|469191959|FG003|Overall Study|Adverse Event|3|||
130333826|NCT00114517|469191956|FG000|Overall Study|Lost to Follow-up|2|||
130333827|NCT00114517|469191957|FG001|Overall Study|Lost to Follow-up|2|||
130660817|NCT01966107|470381535|FG001|Overall Study|withdrew from the study|303|||
130660818|NCT00532779|470381536|FG000|Overall Study|Adverse Event|122|||
130660819|NCT00532779|470381537|FG001|Overall Study|Adverse Event|112|||
130660820|NCT00532779|470381538|FG002|Overall Study|Adverse Event|56|||
130333828|NCT00114517|469191958|FG002|Overall Study|Lost to Follow-up|2|||
130333829|NCT00114517|469191959|FG003|Overall Study|Lost to Follow-up|1|||
130333830|NCT00114517|469191956|FG000|Overall Study|Too busy|3|||
130333831|NCT00114517|469191957|FG001|Overall Study|Too busy|1|||
130333832|NCT00114517|469191958|FG002|Overall Study|Too busy|1|||
130333833|NCT00114517|469191959|FG003|Overall Study|Too busy|2|||
130333834|NCT00114517|469191956|FG000|Overall Study|Moved from area|0|||
130333835|NCT00114517|469191957|FG001|Overall Study|Moved from area|3|||
130333836|NCT00114517|469191958|FG002|Overall Study|Moved from area|2|||
130333837|NCT00114517|469191959|FG003|Overall Study|Moved from area|1|||
130333838|NCT00114517|469191956|FG000|Overall Study|Did not want estradiol|1|||
130333839|NCT00114517|469191957|FG001|Overall Study|Did not want estradiol|1|||
130333840|NCT00114517|469191958|FG002|Overall Study|Did not want estradiol|0|||
130333841|NCT00114517|469191959|FG003|Overall Study|Did not want estradiol|0|||
130333842|NCT00114517|469191956|FG000|Overall Study|Armed-services duty|0|||
130333843|NCT00114517|469191957|FG001|Overall Study|Armed-services duty|1|||
130333844|NCT00114517|469191958|FG002|Overall Study|Armed-services duty|0|||
130333845|NCT00114517|469191959|FG003|Overall Study|Armed-services duty|1|||
130333846|NCT00114517|469191956|FG000|Overall Study|Competing family issue|0|||
130333847|NCT00114517|469191957|FG001|Overall Study|Competing family issue|1|||
130333848|NCT00114517|469191958|FG002|Overall Study|Competing family issue|0|||
130333849|NCT00114517|469191959|FG003|Overall Study|Competing family issue|1|||
130333850|NCT00114517|469191956|FG000|Overall Study|Physician Decision|0|||
130333851|NCT00114517|469191957|FG001|Overall Study|Physician Decision|1|||
130660821|NCT00532779|470381536|FG000|Overall Study|Lost to Follow-up|76|||
130660822|NCT00532779|470381537|FG001|Overall Study|Lost to Follow-up|65|||
130660823|NCT00532779|470381538|FG002|Overall Study|Lost to Follow-up|66|||
130333852|NCT00114517|469191958|FG002|Overall Study|Physician Decision|0|||
130333853|NCT00114517|469191959|FG003|Overall Study|Physician Decision|0|||
130333854|NCT00114517|469191956|FG000|Overall Study|Lost interest|0|||
130333855|NCT00114517|469191957|FG001|Overall Study|Lost interest|0|||
130333856|NCT00114517|469191958|FG002|Overall Study|Lost interest|1|||
130333857|NCT00114517|469191959|FG003|Overall Study|Lost interest|0|||
130333858|NCT00114517|469191956|FG000|Overall Study|Weight increase|0|||
130333859|NCT00114517|469191957|FG001|Overall Study|Weight increase|0|||
130333860|NCT00114517|469191958|FG002|Overall Study|Weight increase|1|||
130660824|NCT00532779|470381536|FG000|Overall Study|Withdrawal by Subject|63|||
130660825|NCT00532779|470381537|FG001|Overall Study|Withdrawal by Subject|60|||
130660826|NCT00532779|470381538|FG002|Overall Study|Withdrawal by Subject|90|||
130660827|NCT00532779|470381536|FG000|Overall Study|Lack of Efficacy|12|||
130660828|NCT00532779|470381537|FG001|Overall Study|Lack of Efficacy|12|||
130660829|NCT00532779|470381538|FG002|Overall Study|Lack of Efficacy|40|||
130660830|NCT00532779|470381536|FG000|Overall Study|Protocol Violation|5|||
130660831|NCT00532779|470381537|FG001|Overall Study|Protocol Violation|9|||
130660832|NCT00532779|470381538|FG002|Overall Study|Protocol Violation|7|||
130660833|NCT00532779|470381536|FG000|Overall Study|Pregnancy|2|||
130333861|NCT00114517|469191959|FG003|Overall Study|Weight increase|0|||
130333862|NCT00114517|469191956|FG000|Overall Study|Concern about blood clots|0|||
130333863|NCT00114517|469191957|FG001|Overall Study|Concern about blood clots|0|||
130660834|NCT00532779|470381537|FG001|Overall Study|Pregnancy|5|||
130333864|NCT00114517|469191958|FG002|Overall Study|Concern about blood clots|1|||
130333865|NCT00114517|469191959|FG003|Overall Study|Concern about blood clots|0|||
130333866|NCT00114517|469191956|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130333867|NCT00114517|469191957|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130333868|NCT00114517|469191958|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130660835|NCT00532779|470381538|FG002|Overall Study|Pregnancy|3|||
130660836|NCT00532779|470381536|FG000|Overall Study|Death|0|||
130660837|NCT00532779|470381537|FG001|Overall Study|Death|1|||
130660838|NCT00532779|470381538|FG002|Overall Study|Death|0|||
130660839|NCT00532779|470381536|FG000|Overall Study|Drug noncompliance, moved, other|14|||
130660840|NCT00532779|470381537|FG001|Overall Study|Drug noncompliance, moved, other|23|||
130333869|NCT00114517|469191959|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
130333870|NCT03474965|469191960|FG000|Overall Study|Pregnancy|1|||
130333871|NCT03474965|469191961|FG001|Overall Study|Pregnancy|0|||
130333872|NCT03474965|469191962|FG002|Overall Study|Pregnancy|0|||
130333873|NCT03474965|469191963|FG003|Overall Study|Pregnancy|0|||
130333874|NCT03474965|469191960|FG000|Overall Study|Lost to Follow-up|0|||
130333875|NCT03474965|469191961|FG001|Overall Study|Lost to Follow-up|0|||
130333876|NCT03474965|469191962|FG002|Overall Study|Lost to Follow-up|1|||
130333877|NCT03474965|469191963|FG003|Overall Study|Lost to Follow-up|0|||
130333878|NCT03474965|469191960|FG000|Overall Study|Death|1|||
130333879|NCT03474965|469191961|FG001|Overall Study|Death|0|||
130333880|NCT03474965|469191962|FG002|Overall Study|Death|0|||
130333881|NCT03474965|469191963|FG003|Overall Study|Death|0|||
130333882|NCT03474965|469191960|FG000|Overall Study|Adverse Event|1|||
130333883|NCT03474965|469191961|FG001|Overall Study|Adverse Event|0|||
130333884|NCT03474965|469191962|FG002|Overall Study|Adverse Event|0|||
130333885|NCT03474965|469191963|FG003|Overall Study|Adverse Event|1|||
130333886|NCT03474965|469191960|FG000|Overall Study|Physician Decision|3|||
130333887|NCT03474965|469191961|FG001|Overall Study|Physician Decision|1|||
130333888|NCT03474965|469191962|FG002|Overall Study|Physician Decision|2|||
130333889|NCT03474965|469191963|FG003|Overall Study|Physician Decision|0|||
130333890|NCT03474965|469191960|FG000|Overall Study|Participant Decision|7|||
130333891|NCT03474965|469191961|FG001|Overall Study|Participant Decision|0|||
130333892|NCT03474965|469191962|FG002|Overall Study|Participant Decision|1|||
130333893|NCT03474965|469191963|FG003|Overall Study|Participant Decision|0|||
130333894|NCT03474965|469191960|FG000|Overall Study|Guardian Decision|4|||
130333895|NCT03474965|469191961|FG001|Overall Study|Guardian Decision|2|||
130333896|NCT03474965|469191962|FG002|Overall Study|Guardian Decision|7|||
130333897|NCT03474965|469191963|FG003|Overall Study|Guardian Decision|2|||
130333898|NCT02255435|469193024|FG000|Overall Study|Patient's Limited Time Availability|0|||
130333899|NCT02255435|469193025|FG001|Overall Study|Patient's Limited Time Availability|0|||
130333900|NCT02255435|469193026|FG002|Overall Study|Patient's Limited Time Availability|0|||
130333901|NCT02255435|469193027|FG003|Overall Study|Patient's Limited Time Availability|0|||
130333902|NCT02255435|469193028|FG004|Overall Study|Patient's Limited Time Availability|0|||
130333903|NCT02255435|469193029|FG005|Overall Study|Patient's Limited Time Availability|0|||
130333904|NCT02255435|469193030|FG006|Overall Study|Patient's Limited Time Availability|0|||
130333905|NCT02255435|469193031|FG007|Overall Study|Patient's Limited Time Availability|1|||
130333906|NCT02255435|469193032|FG008|Overall Study|Patient's Limited Time Availability|0|||
130333907|NCT02255435|469193033|FG009|Overall Study|Patient's Limited Time Availability|0|||
130333908|NCT02255435|469193024|FG000|Overall Study|Withdrawal by Subject|0|||
130333909|NCT02255435|469193025|FG001|Overall Study|Withdrawal by Subject|0|||
130333910|NCT02255435|469193026|FG002|Overall Study|Withdrawal by Subject|0|||
130333911|NCT02255435|469193027|FG003|Overall Study|Withdrawal by Subject|0|||
130333912|NCT02255435|469193028|FG004|Overall Study|Withdrawal by Subject|0|||
130333913|NCT02255435|469193029|FG005|Overall Study|Withdrawal by Subject|0|||
130333914|NCT02255435|469193030|FG006|Overall Study|Withdrawal by Subject|0|||
130333915|NCT02255435|469193031|FG007|Overall Study|Withdrawal by Subject|0|||
130333916|NCT02255435|469193032|FG008|Overall Study|Withdrawal by Subject|1|||
130333917|NCT02255435|469193033|FG009|Overall Study|Withdrawal by Subject|4|||
130333918|NCT02255435|469193024|FG000|Overall Study|Administrative reasons|0|||
130333919|NCT02255435|469193025|FG001|Overall Study|Administrative reasons|0|||
130333920|NCT02255435|469193026|FG002|Overall Study|Administrative reasons|0|||
130333921|NCT02255435|469193027|FG003|Overall Study|Administrative reasons|0|||
130333922|NCT02255435|469193028|FG004|Overall Study|Administrative reasons|0|||
130333923|NCT02255435|469193029|FG005|Overall Study|Administrative reasons|0|||
130333924|NCT02255435|469193030|FG006|Overall Study|Administrative reasons|0|||
130333925|NCT02255435|469193031|FG007|Overall Study|Administrative reasons|0|||
130333926|NCT02255435|469193032|FG008|Overall Study|Administrative reasons|0|||
130333927|NCT02255435|469193033|FG009|Overall Study|Administrative reasons|2|||
130333928|NCT03656562|469193034|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
130376462|NCT00887978|469343697|FG000|Overall Study|Withdrawal by Subject|1|||
130376463|NCT00887978|469343698|FG001|Overall Study|Withdrawal by Subject|2|||
130376464|NCT00887978|469343697|FG000|Overall Study|Lost to Follow-up|0|||
130376465|NCT00887978|469343698|FG001|Overall Study|Lost to Follow-up|1|||
130376466|NCT05353985|469343705|FG000|Overall Study|Adverse Event|5|||
130376467|NCT05353985|469343706|FG001|Overall Study|Adverse Event|7|||
130376468|NCT05353985|469343705|FG000|Overall Study|Lost to Follow-up|1|||
130376469|NCT05353985|469343706|FG001|Overall Study|Lost to Follow-up|1|||
130376470|NCT05353985|469343705|FG000|Overall Study|Protocol Violation|1|||
130376471|NCT05353985|469343706|FG001|Overall Study|Protocol Violation|0|||
130376472|NCT05353985|469343705|FG000|Overall Study|Withdrawal by Subject|13|||
130376473|NCT05353985|469343706|FG001|Overall Study|Withdrawal by Subject|17|||
130376474|NCT05353985|469343705|FG000|Overall Study|Reason Not Specified|1|||
130333929|NCT03656562|469193035|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
130333930|NCT03656562|469193036|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
130333931|NCT03656562|469193037|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
130333932|NCT03656562|469193034|FG000|Overall Study|Physician Decision|1|||
130333933|NCT03656562|469193035|FG001|Overall Study|Physician Decision|2|||
130333934|NCT03656562|469193036|FG002|Overall Study|Physician Decision|0|||
130333935|NCT03656562|469193037|FG003|Overall Study|Physician Decision|0|||
130333936|NCT03656562|469193034|FG000|Overall Study|Subject Decision|3|||
130333937|NCT03656562|469193035|FG001|Overall Study|Subject Decision|5|||
130333938|NCT03656562|469193036|FG002|Overall Study|Subject Decision|0|||
130333939|NCT03656562|469193037|FG003|Overall Study|Subject Decision|2|||
130333940|NCT04269265|469193038|FG000|Overall Study|Physician Decision|1|||
130333941|NCT04269265|469193038|FG000|Overall Study|Withdrawal by Subject|1|||
130333942|NCT04269265|469193038|FG000|Overall Study|Overenrolled (sample size reached)|4|||
130333943|NCT04838626|469193039|FG000|Overall Study|Adverse Event|2|||
130333944|NCT04838626|469193039|FG000|Overall Study|Physician Decision|6|||
130333945|NCT04838626|469193039|FG000|Overall Study|Protocol Violation|3|||
130333946|NCT04838626|469193039|FG000|Overall Study|Withdrawal by Subject|9|||
130333947|NCT04838626|469193039|FG000|Overall Study|Technical Problems|2|||
130333948|NCT02867384|469193040|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
130333949|NCT02867384|469193041|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
130333950|NCT02867384|469193042|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
130333951|NCT02867384|469193040|FG000|Overall Study|Progression/ Relapse|15|||
130333952|NCT02867384|469193041|FG001|Overall Study|Progression/ Relapse|19|||
130333953|NCT02867384|469193042|FG002|Overall Study|Progression/ Relapse|0|||
130333954|NCT02867384|469193040|FG000|Overall Study|Adverse Event|13|||
130333955|NCT02867384|469193041|FG001|Overall Study|Adverse Event|1|||
130333956|NCT02867384|469193042|FG002|Overall Study|Adverse Event|0|||
130333957|NCT02867384|469193040|FG000|Overall Study|Withdrawal by Subject|6|||
130333958|NCT02867384|469193041|FG001|Overall Study|Withdrawal by Subject|5|||
130333959|NCT02867384|469193042|FG002|Overall Study|Withdrawal by Subject|0|||
130333960|NCT02867384|469193040|FG000|Overall Study|Physician Decision|1|||
130333961|NCT02867384|469193041|FG001|Overall Study|Physician Decision|2|||
130333962|NCT02867384|469193042|FG002|Overall Study|Physician Decision|0|||
130333963|NCT02867384|469193040|FG000|Overall Study|Patient compliance|1|||
130333964|NCT02867384|469193041|FG001|Overall Study|Patient compliance|0|||
130333965|NCT02867384|469193042|FG002|Overall Study|Patient compliance|0|||
130333966|NCT02867384|469193040|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130333967|NCT02867384|469193041|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130333968|NCT02867384|469193042|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
130333969|NCT02867384|469193040|FG000|Overall Study|Never start treatment|3|||
130333970|NCT02867384|469193041|FG001|Overall Study|Never start treatment|0|||
130333971|NCT02867384|469193042|FG002|Overall Study|Never start treatment|0|||
130333972|NCT03901469|469193046|FG000|Overall Study|Radiographic Progression|4|||
130333973|NCT03901469|469193047|FG001|Overall Study|Radiographic Progression|6|||
130333974|NCT03901469|469193048|FG002|Overall Study|Radiographic Progression|3|||
130333975|NCT03901469|469193049|FG003|Overall Study|Radiographic Progression|30|||
130333976|NCT03901469|469193050|FG004|Overall Study|Radiographic Progression|7|||
130333977|NCT03901469|469193051|FG005|Overall Study|Radiographic Progression|2|||
130333978|NCT03901469|469193052|FG006|Overall Study|Radiographic Progression|11|||
130333979|NCT03901469|469193046|FG000|Overall Study|Clinical Progression|0|||
130333980|NCT03901469|469193047|FG001|Overall Study|Clinical Progression|2|||
130333981|NCT03901469|469193048|FG002|Overall Study|Clinical Progression|0|||
130333982|NCT03901469|469193049|FG003|Overall Study|Clinical Progression|7|||
130333983|NCT03901469|469193050|FG004|Overall Study|Clinical Progression|6|||
130333984|NCT03901469|469193051|FG005|Overall Study|Clinical Progression|0|||
130333985|NCT03901469|469193052|FG006|Overall Study|Clinical Progression|2|||
130333986|NCT03901469|469193046|FG000|Overall Study|Adverse Event|1|||
130333987|NCT03901469|469193047|FG001|Overall Study|Adverse Event|0|||
130333988|NCT03901469|469193048|FG002|Overall Study|Adverse Event|0|||
130333989|NCT03901469|469193049|FG003|Overall Study|Adverse Event|0|||
130333990|NCT03901469|469193050|FG004|Overall Study|Adverse Event|0|||
130333991|NCT03901469|469193051|FG005|Overall Study|Adverse Event|0|||
130333992|NCT03901469|469193052|FG006|Overall Study|Adverse Event|9|||
130333993|NCT03901469|469193046|FG000|Overall Study|Physician Decision|0|||
130333994|NCT03901469|469193047|FG001|Overall Study|Physician Decision|0|||
130333995|NCT03901469|469193048|FG002|Overall Study|Physician Decision|0|||
130333996|NCT03901469|469193049|FG003|Overall Study|Physician Decision|1|||
130333997|NCT03901469|469193050|FG004|Overall Study|Physician Decision|0|||
130333998|NCT03901469|469193051|FG005|Overall Study|Physician Decision|0|||
130333999|NCT03901469|469193052|FG006|Overall Study|Physician Decision|0|||
130334000|NCT03901469|469193046|FG000|Overall Study|Withdrawal by Subject|0|||
130334001|NCT03901469|469193047|FG001|Overall Study|Withdrawal by Subject|0|||
130334002|NCT03901469|469193048|FG002|Overall Study|Withdrawal by Subject|0|||
130334003|NCT03901469|469193049|FG003|Overall Study|Withdrawal by Subject|0|||
130334004|NCT03901469|469193050|FG004|Overall Study|Withdrawal by Subject|2|||
130334005|NCT03901469|469193051|FG005|Overall Study|Withdrawal by Subject|0|||
130334006|NCT03901469|469193052|FG006|Overall Study|Withdrawal by Subject|8|||
130334007|NCT03901469|469193046|FG000|Overall Study|Death|0|||
130334008|NCT03901469|469193047|FG001|Overall Study|Death|0|||
130334009|NCT03901469|469193048|FG002|Overall Study|Death|0|||
130334010|NCT03901469|469193049|FG003|Overall Study|Death|3|||
130334011|NCT03901469|469193050|FG004|Overall Study|Death|5|||
130334012|NCT03901469|469193051|FG005|Overall Study|Death|0|||
130334013|NCT03901469|469193052|FG006|Overall Study|Death|1|||
130334014|NCT03901469|469193046|FG000|Overall Study|Termination of study by sponsor|0|||
130334015|NCT03901469|469193047|FG001|Overall Study|Termination of study by sponsor|0|||
130334016|NCT03901469|469193048|FG002|Overall Study|Termination of study by sponsor|0|||
130334017|NCT03901469|469193049|FG003|Overall Study|Termination of study by sponsor|0|||
130334018|NCT03901469|469193050|FG004|Overall Study|Termination of study by sponsor|1|||
130334019|NCT03901469|469193051|FG005|Overall Study|Termination of study by sponsor|1|||
130334020|NCT03901469|469193052|FG006|Overall Study|Termination of study by sponsor|0|||
130334021|NCT03901469|469193046|FG000|Overall Study|Not Reported|1|||
130334022|NCT03901469|469193047|FG001|Overall Study|Not Reported|0|||
130334023|NCT03901469|469193048|FG002|Overall Study|Not Reported|0|||
130660841|NCT00532779|470381538|FG002|Overall Study|Drug noncompliance, moved, other|29|||
130660842|NCT02662556|470381539|FG000|Overall Study|Adverse Event|4|||
130660843|NCT02662556|470381539|FG000|Overall Study|Lack of Efficacy|4|||
130660844|NCT01556165|470381540|FG000|Overall Study|Adverse Event|5|||
130660845|NCT01556165|470381541|FG001|Overall Study|Adverse Event|3|||
130660846|NCT01556165|470381540|FG000|Overall Study|Protocol Violation|0|||
130334024|NCT03901469|469193049|FG003|Overall Study|Not Reported|1|||
130334025|NCT03901469|469193050|FG004|Overall Study|Not Reported|0|||
130334026|NCT03901469|469193051|FG005|Overall Study|Not Reported|0|||
130334027|NCT03901469|469193052|FG006|Overall Study|Not Reported|1|||
130660847|NCT01556165|470381541|FG001|Overall Study|Protocol Violation|3|||
130660848|NCT01556165|470381540|FG000|Overall Study|Withdrawal of Consent|7|||
130660849|NCT01556165|470381541|FG001|Overall Study|Withdrawal of Consent|1|||
130334028|NCT03738228|469193056|FG000|Overall Study|Never received study treatment|2|||
130334029|NCT03738228|469193057|FG001|Overall Study|Never received study treatment|2|||
130334030|NCT04896073|469193058|FG000|Overall Study|Screen failure|0|||
130660850|NCT00701558|470381542|FG000|Overall Study|Death|7|||
130660851|NCT00701558|470381542|FG000|Overall Study|Lost to Follow-up|8|||
130660852|NCT00131937|470381543|FG000|Overall Study|Adverse Event|3|||
130660853|NCT00131937|470381543|FG000|Overall Study|Withdrawal by Subject|2|||
130660854|NCT00131937|470381543|FG000|Overall Study|Physician Decision|1|||
130660855|NCT00131937|470381543|FG000|Overall Study|Disease Progression|7|||
130660856|NCT00131937|470381543|FG000|Overall Study|Alternative therapy|1|||
130660857|NCT01640964|470381544|FG000|Overall Study|Lost to Follow-up|0|||
130334031|NCT04896073|469193059|FG001|Overall Study|Screen failure|2|||
130334032|NCT04896073|469193058|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130334033|NCT04896073|469193059|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
130334034|NCT01385176|469193060|FG000|Randomization Phase|Death|1|||
130334035|NCT01385176|469193061|FG001|Randomization Phase|Death|2|||
130334036|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Death|1|||
130334037|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Death|2|||
130334038|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Physician Decision|0|||
130334039|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Physician Decision|1|||
130334040|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
130334041|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
130334042|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
130334043|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
130334044|NCT02306161|469193062|FG000|Overall Study|Death|1|||
130334045|NCT02306161|469193063|FG001|Overall Study|Death|3|||
130334046|NCT02306161|469193062|FG000|Overall Study|Lack of Efficacy|20|||
130334047|NCT02306161|469193063|FG001|Overall Study|Lack of Efficacy|43|||
130334048|NCT02306161|469193062|FG000|Overall Study|Physician Decision|30|||
130334049|NCT02306161|469193063|FG001|Overall Study|Physician Decision|18|||
130334050|NCT02306161|469193062|FG000|Overall Study|Withdrawal by Subject|4|||
130334051|NCT02306161|469193063|FG001|Overall Study|Withdrawal by Subject|0|||
130334052|NCT02306161|469193062|FG000|Overall Study|Ineligible|9|||
130660858|NCT01640964|470381545|FG001|Overall Study|Lost to Follow-up|0|||
130334053|NCT02306161|469193063|FG001|Overall Study|Ineligible|5|||
130334054|NCT04995419|469193064|FG000|Overall Study|Withdrawal by Subject|3|||
130334055|NCT04995419|469193064|FG000|Overall Study|Progressive Disease|19|||
130334056|NCT04995419|469193064|FG000|Overall Study|Adverse Event|2|||
130334057|NCT04995419|469193064|FG000|Overall Study|Ongoing|16|||
130334058|NCT03306173|469193065|FG000|Overall Study|Lost to Follow-up|16|||
130334059|NCT03306173|469193066|FG001|Overall Study|Lost to Follow-up|23|||
130334060|NCT03306173|469193065|FG000|Overall Study|Withdrawal by Subject|4|||
130660859|NCT01640964|470381546|FG002|Overall Study|Lost to Follow-up|1|||
130660860|NCT01640964|470381544|FG000|Overall Study|Protocol Deviation|1|||
130334061|NCT03306173|469193066|FG001|Overall Study|Withdrawal by Subject|3|||
130334062|NCT03306173|469193065|FG000|Overall Study|Discontinued|4|||
130660861|NCT01640964|470381545|FG001|Overall Study|Protocol Deviation|1|||
130660862|NCT01640964|470381546|FG002|Overall Study|Protocol Deviation|2|||
130660863|NCT02787746|470381547|FG000|Overall Study|Adverse Event|42|||
130660864|NCT02787746|470381547|FG000|Overall Study|Withdrawal by Subject|65|||
130660865|NCT02787746|470381547|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
130660866|NCT01788163|470382981|FG000|Overall Study|Other|53|||
130334063|NCT03306173|469193066|FG001|Overall Study|Discontinued|4|||
130334064|NCT04758637|469193067|FG000|Overall Study|Lost to Follow-up|0|||
130660867|NCT01788163|470382982|FG001|Overall Study|Other|0|||
130660868|NCT01788163|470382983|FG002|Overall Study|Other|0|||
130334065|NCT04758637|469193068|FG001|Overall Study|Lost to Follow-up|1|||
130334066|NCT04758637|469193069|FG002|Overall Study|Lost to Follow-up|0|||
130334067|NCT04758637|469193070|FG003|Overall Study|Lost to Follow-up|0|||
130334068|NCT05064358|469193076|FG000|Overall Study|Death|23|||
130334069|NCT05064358|469193077|FG001|Overall Study|Death|23|||
130334070|NCT05064358|469193078|FG002|Overall Study|Death|25|||
130334071|NCT05064358|469193079|FG003|Overall Study|Death|21|||
130334072|NCT05064358|469193080|FG004|Overall Study|Death|5|||
130334073|NCT05064358|469193076|FG000|Overall Study|Lost to Follow-up|1|||
130334074|NCT05064358|469193077|FG001|Overall Study|Lost to Follow-up|2|||
130334075|NCT05064358|469193078|FG002|Overall Study|Lost to Follow-up|0|||
130334076|NCT05064358|469193079|FG003|Overall Study|Lost to Follow-up|2|||
130334077|NCT05064358|469193080|FG004|Overall Study|Lost to Follow-up|0|||
130334078|NCT05064358|469193076|FG000|Overall Study|Physician Decision|1|||
130334079|NCT05064358|469193077|FG001|Overall Study|Physician Decision|1|||
130334080|NCT05064358|469193078|FG002|Overall Study|Physician Decision|2|||
130334081|NCT05064358|469193079|FG003|Overall Study|Physician Decision|0|||
130334082|NCT05064358|469193080|FG004|Overall Study|Physician Decision|0|||
130334083|NCT05064358|469193076|FG000|Overall Study|Withdrawal by Subject|4|||
130334084|NCT05064358|469193077|FG001|Overall Study|Withdrawal by Subject|5|||
130334085|NCT05064358|469193078|FG002|Overall Study|Withdrawal by Subject|3|||
130334086|NCT05064358|469193079|FG003|Overall Study|Withdrawal by Subject|6|||
130334087|NCT05064358|469193080|FG004|Overall Study|Withdrawal by Subject|3|||
130334088|NCT05064358|469193076|FG000|Overall Study|Ongoing at the time of analysis|1|||
130334089|NCT05064358|469193077|FG001|Overall Study|Ongoing at the time of analysis|2|||
130334090|NCT05064358|469193078|FG002|Overall Study|Ongoing at the time of analysis|2|||
130334091|NCT05064358|469193079|FG003|Overall Study|Ongoing at the time of analysis|2|||
130334092|NCT05064358|469193080|FG004|Overall Study|Ongoing at the time of analysis|2|||
130334093|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334094|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
130334095|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334096|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334097|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334098|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334099|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334100|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334101|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334102|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334103|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
130334104|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130334105|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
130334106|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130334107|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334108|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334109|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334110|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334111|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334112|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334113|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130334114|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334115|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130334116|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334117|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334118|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334119|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334120|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130660869|NCT01788163|470382984|FG003|Overall Study|Other|0|||
130660870|NCT01788163|470382985|FG004|Overall Study|Other|0|||
130334121|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334122|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334123|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334124|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334125|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334126|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334127|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
130334128|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130334129|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130334130|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130334131|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130334132|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130334133|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334134|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334135|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334136|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334137|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
130334138|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130660871|NCT01788163|470382986|FG005|Overall Study|Other|7|||
130334139|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334140|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130660872|NCT01788163|470382987|FG006|Overall Study|Other|1|||
130334141|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334142|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334143|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334144|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334145|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334146|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334147|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334148|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130334149|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334150|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334151|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334152|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130660873|NCT01788163|470382988|FG007|Overall Study|Other|48|||
130660874|NCT01788163|470382989|FG008|Overall Study|Other|15|||
130334153|NCT02621151|469193091|FG000|Overall Study|Not eligible for trial|6|||
130334154|NCT04073225|469193092|FG000|Overall Study|Lost to Follow-up|4|||
130334155|NCT04073225|469193093|FG001|Overall Study|Lost to Follow-up|3|||
130334156|NCT02253316|469193103|FG000|Consolidation|Progression|4|||
130334157|NCT02253316|469193104|FG001|Consolidation|Progression|0|||
130334158|NCT02253316|469193105|FG002|Consolidation|Progression|0|||
130334159|NCT02253316|469193103|FG000|Consolidation|Non-Compliance|1|||
130334160|NCT02253316|469193104|FG001|Consolidation|Non-Compliance|0|||
130334161|NCT02253316|469193105|FG002|Consolidation|Non-Compliance|0|||
130433316|NCT02296190|469550418|FG001|Overall Study|Failure to induce PSVT|10|||
130433317|NCT02296190|469550419|FG002|Overall Study|Failure to induce PSVT|5|||
130433318|NCT02296190|469550420|FG003|Overall Study|Failure to induce PSVT|13|||
130433319|NCT02296190|469550421|FG004|Overall Study|Failure to induce PSVT|8|||
130433320|NCT02296190|469550422|FG005|Overall Study|Failure to induce PSVT|0|||
130433321|NCT02296190|469550417|FG000|Overall Study|Physician Decision|1|||
130433322|NCT02296190|469550418|FG001|Overall Study|Physician Decision|1|||
130433323|NCT02296190|469550419|FG002|Overall Study|Physician Decision|0|||
130433324|NCT02296190|469550420|FG003|Overall Study|Physician Decision|1|||
130433325|NCT02296190|469550421|FG004|Overall Study|Physician Decision|2|||
130433326|NCT02296190|469550422|FG005|Overall Study|Physician Decision|0|||
130433327|NCT02296190|469550417|FG000|Overall Study|Withdrawal by Subject|0|||
130334162|NCT02253316|469193103|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
130334163|NCT02253316|469193104|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
130334164|NCT02253316|469193105|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
130334165|NCT02253316|469193103|FG000|Consolidation|Secondary Malignancy|2|||
130334166|NCT02253316|469193104|FG001|Consolidation|Secondary Malignancy|0|||
130334167|NCT02253316|469193105|FG002|Consolidation|Secondary Malignancy|0|||
130334168|NCT02253316|469193103|FG000|Consolidation|Adverse Event|7|||
130334169|NCT02253316|469193104|FG001|Consolidation|Adverse Event|0|||
130433328|NCT02296190|469550418|FG001|Overall Study|Withdrawal by Subject|1|||
130334170|NCT02253316|469193105|FG002|Consolidation|Adverse Event|0|||
130433329|NCT02296190|469550419|FG002|Overall Study|Withdrawal by Subject|0|||
130433330|NCT02296190|469550420|FG003|Overall Study|Withdrawal by Subject|0|||
130433331|NCT02296190|469550421|FG004|Overall Study|Withdrawal by Subject|0|||
130433332|NCT02296190|469550422|FG005|Overall Study|Withdrawal by Subject|0|||
130334171|NCT02253316|469193103|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
130334172|NCT02253316|469193104|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
130334173|NCT02253316|469193105|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
130334174|NCT02253316|469193103|FG000|Maintenance|Physician Decision|0|||
130334175|NCT02253316|469193104|FG001|Maintenance|Physician Decision|7|||
130334176|NCT02253316|469193105|FG002|Maintenance|Physician Decision|16|||
130433333|NCT02296190|469550417|FG000|Overall Study|PSVT < 5 minutes|5|||
130433334|NCT02296190|469550418|FG001|Overall Study|PSVT < 5 minutes|6|||
130433335|NCT02296190|469550419|FG002|Overall Study|PSVT < 5 minutes|6|||
130433336|NCT02296190|469550420|FG003|Overall Study|PSVT < 5 minutes|6|||
130433337|NCT02296190|469550421|FG004|Overall Study|PSVT < 5 minutes|5|||
130660875|NCT01788163|470382981|FG000|Overall Study|Withdrawal by Subject|2|||
130660876|NCT01788163|470382982|FG001|Overall Study|Withdrawal by Subject|0|||
130660877|NCT01788163|470382983|FG002|Overall Study|Withdrawal by Subject|0|||
130660878|NCT01788163|470382984|FG003|Overall Study|Withdrawal by Subject|0|||
130660879|NCT01788163|470382985|FG004|Overall Study|Withdrawal by Subject|0|||
130660880|NCT01788163|470382986|FG005|Overall Study|Withdrawal by Subject|0|||
130660881|NCT01788163|470382987|FG006|Overall Study|Withdrawal by Subject|0|||
130660882|NCT01788163|470382988|FG007|Overall Study|Withdrawal by Subject|0|||
130660883|NCT01788163|470382989|FG008|Overall Study|Withdrawal by Subject|1|||
130660884|NCT00265239|470382990|FG000|Overall Study|Adverse Event|2|||
130660885|NCT00265239|470382991|FG001|Overall Study|Adverse Event|1|||
130660886|NCT00424515|470382994|FG000|Overall Study|Progressive Disease|10|||
130660887|NCT00424515|470382995|FG001|Overall Study|Progressive Disease|11|||
130660888|NCT00424515|470382994|FG000|Overall Study|Adverse Event|0|||
130334177|NCT02253316|469193103|FG000|Maintenance|Non-Compliance|0|||
130334178|NCT02253316|469193104|FG001|Maintenance|Non-Compliance|1|||
130660889|NCT00424515|470382995|FG001|Overall Study|Adverse Event|1|||
130660890|NCT00424515|470382994|FG000|Overall Study|Intercurrent Illness|0|||
130660891|NCT00424515|470382995|FG001|Overall Study|Intercurrent Illness|1|||
130660892|NCT00424515|470382994|FG000|Overall Study|Withdrawal by Subject|1|||
130660893|NCT00424515|470382995|FG001|Overall Study|Withdrawal by Subject|0|||
130660894|NCT00267020|470382996|FG000|Overall Study|Adverse Event|22|||
130660895|NCT00267020|470382997|FG001|Overall Study|Adverse Event|5|||
130660896|NCT00267020|470382996|FG000|Overall Study|Death|2|||
130433338|NCT02296190|469550422|FG005|Overall Study|PSVT < 5 minutes|0|||
130433339|NCT02296190|469550417|FG000|Overall Study|Patient was given Propofol|0|||
130433340|NCT02296190|469550418|FG001|Overall Study|Patient was given Propofol|1|||
130433341|NCT02296190|469550419|FG002|Overall Study|Patient was given Propofol|0|||
130433342|NCT02296190|469550420|FG003|Overall Study|Patient was given Propofol|1|||
130433343|NCT02296190|469550421|FG004|Overall Study|Patient was given Propofol|0|||
130433344|NCT02296190|469550422|FG005|Overall Study|Patient was given Propofol|0|||
130433345|NCT02296190|469550417|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
130433346|NCT02296190|469550418|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
130433347|NCT02296190|469550419|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
130433348|NCT02296190|469550420|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
130433349|NCT02296190|469550421|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
130660897|NCT00267020|470382997|FG001|Overall Study|Death|1|||
130660898|NCT00267020|470382996|FG000|Overall Study|Withdrawal by Subject|17|||
130660899|NCT00267020|470382997|FG001|Overall Study|Withdrawal by Subject|7|||
130660900|NCT00267020|470382996|FG000|Overall Study|Physician Decision|3|||
130660901|NCT00267020|470382997|FG001|Overall Study|Physician Decision|2|||
130660902|NCT00267020|470382996|FG000|Overall Study|Disease Progression|39|||
130660903|NCT00267020|470382997|FG001|Overall Study|Disease Progression|25|||
130660904|NCT00267020|470382996|FG000|Overall Study|Unrelated Complication|1|||
130660905|NCT00267020|470382997|FG001|Overall Study|Unrelated Complication|1|||
130660906|NCT00267020|470382996|FG000|Overall Study|Sponsor Request|1|||
130433350|NCT02296190|469550422|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
130334179|NCT02253316|469193105|FG002|Maintenance|Non-Compliance|1|||
130334180|NCT02253316|469193103|FG000|Maintenance|Secondary Malignancy|0|||
130334181|NCT02253316|469193104|FG001|Maintenance|Secondary Malignancy|2|||
130334182|NCT02253316|469193105|FG002|Maintenance|Secondary Malignancy|6|||
130334183|NCT02253316|469193103|FG000|Maintenance|Adverse Event|0|||
130433351|NCT02296190|469550417|FG000|Overall Study|Blood pressure <100 after sedation|0|||
130433352|NCT02296190|469550418|FG001|Overall Study|Blood pressure <100 after sedation|0|||
130433353|NCT02296190|469550419|FG002|Overall Study|Blood pressure <100 after sedation|0|||
130433354|NCT02296190|469550420|FG003|Overall Study|Blood pressure <100 after sedation|1|||
130433355|NCT02296190|469550421|FG004|Overall Study|Blood pressure <100 after sedation|0|||
130433356|NCT02296190|469550422|FG005|Overall Study|Blood pressure <100 after sedation|0|||
130433357|NCT02296190|469550417|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130660907|NCT00267020|470382997|FG001|Overall Study|Sponsor Request|0|||
130660908|NCT00267020|470382996|FG000|Overall Study|Other|1|||
130660909|NCT00267020|470382997|FG001|Overall Study|Other|2|||
130433358|NCT02296190|469550418|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
130334184|NCT02253316|469193104|FG001|Maintenance|Adverse Event|8|||
130433359|NCT02296190|469550419|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
130433360|NCT02296190|469550420|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130433361|NCT02296190|469550421|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130660910|NCT01678924|470382998|FG000|Overall Study|Adverse Event|1|||
130660911|NCT01678924|470382999|FG001|Overall Study|Adverse Event|1|||
130334185|NCT02253316|469193105|FG002|Maintenance|Adverse Event|12|||
130334186|NCT02253316|469193103|FG000|Maintenance|Still receiving active treatment|0|||
130334187|NCT02253316|469193104|FG001|Maintenance|Still receiving active treatment|4|||
130334188|NCT02253316|469193105|FG002|Maintenance|Still receiving active treatment|0|||
130334189|NCT00124306|469193109|FG000|Overall Study|Adverse Event|7|||
130334190|NCT00124306|469193110|FG001|Overall Study|Adverse Event|2|||
130334191|NCT00124306|469193109|FG000|Overall Study|Lost to Follow-up|10|||
130334192|NCT00124306|469193110|FG001|Overall Study|Lost to Follow-up|6|||
130334193|NCT00124306|469193109|FG000|Overall Study|Lack of Efficacy|3|||
130334194|NCT00124306|469193110|FG001|Overall Study|Lack of Efficacy|6|||
130334195|NCT00124306|469193109|FG000|Overall Study|Personal constraints|0|||
130334196|NCT00124306|469193110|FG001|Overall Study|Personal constraints|2|||
130334197|NCT00124306|469193109|FG000|Overall Study|Use of unacceptable medication|1|||
130334198|NCT00124306|469193110|FG001|Overall Study|Use of unacceptable medication|0|||
130433362|NCT02296190|469550422|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130433363|NCT02296190|469550417|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
130433364|NCT02296190|469550418|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
130433365|NCT02296190|469550419|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
130433366|NCT02296190|469550420|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
130433367|NCT02296190|469550421|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
130660912|NCT01678924|470383000|FG002|Overall Study|Adverse Event|0|||
130660913|NCT01678924|470383001|FG003|Overall Study|Adverse Event|1|||
130660914|NCT01678924|470382998|FG000|Overall Study|Lack of Efficacy|7|||
130660915|NCT01678924|470382999|FG001|Overall Study|Lack of Efficacy|2|||
130660916|NCT01678924|470383000|FG002|Overall Study|Lack of Efficacy|0|||
130660917|NCT01678924|470383001|FG003|Overall Study|Lack of Efficacy|5|||
130660918|NCT01678924|470382998|FG000|Overall Study|Lost to Follow-up|0|||
130660919|NCT01678924|470382999|FG001|Overall Study|Lost to Follow-up|4|||
130660920|NCT01678924|470383000|FG002|Overall Study|Lost to Follow-up|0|||
130660921|NCT01678924|470383001|FG003|Overall Study|Lost to Follow-up|2|||
130660922|NCT01678924|470382998|FG000|Overall Study|Personal Reasons|2|||
130660923|NCT01678924|470382999|FG001|Overall Study|Personal Reasons|2|||
130660924|NCT01678924|470383000|FG002|Overall Study|Personal Reasons|2|||
130660925|NCT01678924|470383001|FG003|Overall Study|Personal Reasons|7|||
130660926|NCT01678924|470382998|FG000|Overall Study|Withdrawal by Subject|0|||
130660927|NCT01678924|470382999|FG001|Overall Study|Withdrawal by Subject|3|||
130660928|NCT01678924|470383000|FG002|Overall Study|Withdrawal by Subject|0|||
130660929|NCT01678924|470383001|FG003|Overall Study|Withdrawal by Subject|2|||
130433368|NCT02296190|469550422|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
130433369|NCT02296190|469550417|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130433370|NCT02296190|469550418|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
130433371|NCT02296190|469550419|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130433372|NCT02296190|469550420|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130433373|NCT02296190|469550421|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130660930|NCT01678924|470382998|FG000|Overall Study|Unable to attend scheduled visits|0|||
130660931|NCT01678924|470382999|FG001|Overall Study|Unable to attend scheduled visits|0|||
130660932|NCT01678924|470383000|FG002|Overall Study|Unable to attend scheduled visits|0|||
130660933|NCT01678924|470383001|FG003|Overall Study|Unable to attend scheduled visits|1|||
130660934|NCT00021229|470383004|FG000|Overall Study|Adverse Event|10|||
130660935|NCT00021229|470383005|FG001|Overall Study|Adverse Event|5|||
130660936|NCT00021229|470383006|FG002|Overall Study|Adverse Event|2|||
130660937|NCT00021229|470383004|FG000|Overall Study|Death|0|||
130660938|NCT00021229|470383005|FG001|Overall Study|Death|1|||
130660939|NCT00021229|470383006|FG002|Overall Study|Death|0|||
130660940|NCT00021229|470383004|FG000|Overall Study|Withdrawal by Subject|7|||
130660941|NCT00021229|470383005|FG001|Overall Study|Withdrawal by Subject|7|||
130660942|NCT00021229|470383006|FG002|Overall Study|Withdrawal by Subject|1|||
130660943|NCT00021229|470383004|FG000|Overall Study|Progressive Disease|15|||
130660944|NCT00021229|470383005|FG001|Overall Study|Progressive Disease|19|||
130660945|NCT00021229|470383006|FG002|Overall Study|Progressive Disease|12|||
130660946|NCT00021229|470383004|FG000|Overall Study|Protocol Violation|1|||
130660947|NCT00021229|470383005|FG001|Overall Study|Protocol Violation|1|||
130660948|NCT00021229|470383006|FG002|Overall Study|Protocol Violation|0|||
130660949|NCT00021229|470383004|FG000|Overall Study|Physician Decision|0|||
130660950|NCT00021229|470383005|FG001|Overall Study|Physician Decision|0|||
130660951|NCT00021229|470383006|FG002|Overall Study|Physician Decision|1|||
130433374|NCT02296190|469550422|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130433375|NCT02296190|469550417|FG000|Overall Study|Lab result not available in time|1|||
130433376|NCT02296190|469550418|FG001|Overall Study|Lab result not available in time|0|||
130433377|NCT02296190|469550419|FG002|Overall Study|Lab result not available in time|0|||
130433378|NCT02296190|469550420|FG003|Overall Study|Lab result not available in time|0|||
130660952|NCT00021229|470383004|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
130660953|NCT00021229|470383005|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
130334199|NCT00124306|469193109|FG000|Overall Study|Abnormal lab result|0|||
130334200|NCT00124306|469193110|FG001|Overall Study|Abnormal lab result|1|||
130334201|NCT00124306|469193109|FG000|Overall Study|Other|2|||
130660954|NCT00021229|470383006|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
130660955|NCT02428231|470383012|FG000|Overall Study|Other|10|||
130433379|NCT02296190|469550421|FG004|Overall Study|Lab result not available in time|0|||
130433380|NCT02296190|469550422|FG005|Overall Study|Lab result not available in time|0|||
130433381|NCT00717314|469550423|FG000|Overall Study|Adverse Event|3|||
130433382|NCT00717314|469550424|FG001|Overall Study|Adverse Event|2|||
130433383|NCT00717314|469550423|FG000|Overall Study|Protocol Violation|1|||
130433384|NCT00717314|469550424|FG001|Overall Study|Protocol Violation|0|||
130433385|NCT00717314|469550423|FG000|Overall Study|Lost to Follow-up|1|||
130433386|NCT00717314|469550424|FG001|Overall Study|Lost to Follow-up|5|||
130433387|NCT00717314|469550423|FG000|Overall Study|Withdrawal by Subject|1|||
130433388|NCT00717314|469550424|FG001|Overall Study|Withdrawal by Subject|3|||
130433389|NCT03682705|469550426|FG000|Overall Study|Adverse Event|1|||
130433390|NCT03682705|469550427|FG001|Overall Study|Adverse Event|1|||
130433391|NCT03682705|469550428|FG002|Overall Study|Adverse Event|1|||
130433392|NCT03682705|469550429|FG003|Overall Study|Adverse Event|0|||
130433393|NCT03682705|469550430|FG004|Overall Study|Adverse Event|1|||
130433394|NCT03682705|469550431|FG005|Overall Study|Adverse Event|1|||
130433395|NCT03682705|469550426|FG000|Overall Study|Withdrawal by Subject|1|||
130433396|NCT03682705|469550427|FG001|Overall Study|Withdrawal by Subject|3|||
130433397|NCT03682705|469550428|FG002|Overall Study|Withdrawal by Subject|2|||
130433398|NCT03682705|469550429|FG003|Overall Study|Withdrawal by Subject|4|||
130433399|NCT03682705|469550430|FG004|Overall Study|Withdrawal by Subject|0|||
130660956|NCT02428231|470383013|FG001|Overall Study|Other|16|||
130660957|NCT02428231|470383012|FG000|Overall Study|Required Symptomatic Therapy|0|||
130660958|NCT02428231|470383013|FG001|Overall Study|Required Symptomatic Therapy|1|||
130660959|NCT02428231|470383012|FG000|Overall Study|Adverse Event|3|||
130660960|NCT02428231|470383013|FG001|Overall Study|Adverse Event|0|||
130660961|NCT01784419|470383014|FG000|Overall Study|Adverse Event|3|||
130660962|NCT01336608|470383015|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
130660963|NCT01336608|470383016|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130660964|NCT01336608|470383017|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130334202|NCT00124306|469193110|FG001|Overall Study|Other|0|||
130334203|NCT02112916|469193111|FG000|Overall Study|Adverse Event|6|||
130334204|NCT02112916|469193112|FG001|Overall Study|Adverse Event|9|||
130334205|NCT02112916|469193113|FG002|Overall Study|Adverse Event|3|||
130334206|NCT02112916|469193114|FG003|Overall Study|Adverse Event|2|||
130334207|NCT02112916|469193111|FG000|Overall Study|Death|9|||
130334208|NCT02112916|469193112|FG001|Overall Study|Death|9|||
130334209|NCT02112916|469193113|FG002|Overall Study|Death|3|||
130334210|NCT02112916|469193114|FG003|Overall Study|Death|4|||
130334211|NCT02112916|469193111|FG000|Overall Study|Lost to Follow-up|1|||
130334212|NCT02112916|469193112|FG001|Overall Study|Lost to Follow-up|0|||
130334213|NCT02112916|469193113|FG002|Overall Study|Lost to Follow-up|0|||
130334214|NCT02112916|469193114|FG003|Overall Study|Lost to Follow-up|0|||
130334215|NCT02112916|469193111|FG000|Overall Study|Physician Decision|94|||
130334216|NCT02112916|469193112|FG001|Overall Study|Physician Decision|72|||
130334217|NCT02112916|469193113|FG002|Overall Study|Physician Decision|24|||
130334218|NCT02112916|469193114|FG003|Overall Study|Physician Decision|15|||
130334219|NCT02112916|469193111|FG000|Overall Study|Withdrawal by Subject|5|||
130334220|NCT02112916|469193112|FG001|Overall Study|Withdrawal by Subject|3|||
130334221|NCT02112916|469193113|FG002|Overall Study|Withdrawal by Subject|1|||
130334222|NCT02112916|469193114|FG003|Overall Study|Withdrawal by Subject|1|||
130334223|NCT02112916|469193111|FG000|Overall Study|Ineligible|4|||
130334224|NCT02112916|469193112|FG001|Overall Study|Ineligible|8|||
130334225|NCT02112916|469193113|FG002|Overall Study|Ineligible|3|||
130334226|NCT02112916|469193114|FG003|Overall Study|Ineligible|8|||
130334227|NCT02112916|469193111|FG000|Overall Study|Inevaluable|6|||
130334228|NCT02112916|469193112|FG001|Overall Study|Inevaluable|4|||
130334229|NCT02112916|469193113|FG002|Overall Study|Inevaluable|5|||
130334230|NCT02112916|469193114|FG003|Overall Study|Inevaluable|5|||
130334231|NCT02112916|469193111|FG000|Overall Study|Refusal of further protocol therapy|19|||
130334232|NCT02112916|469193112|FG001|Overall Study|Refusal of further protocol therapy|16|||
130334233|NCT02112916|469193113|FG002|Overall Study|Refusal of further protocol therapy|1|||
130334234|NCT02112916|469193114|FG003|Overall Study|Refusal of further protocol therapy|7|||
130334235|NCT02112916|469193111|FG000|Overall Study|Development of SMN|1|||
130334236|NCT02112916|469193112|FG001|Overall Study|Development of SMN|0|||
130334237|NCT02112916|469193113|FG002|Overall Study|Development of SMN|0|||
130660965|NCT01336608|470383018|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130660966|NCT01336608|470383015|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
130660967|NCT01336608|470383016|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130334238|NCT02112916|469193114|FG003|Overall Study|Development of SMN|1|||
130334239|NCT02112916|469193111|FG000|Overall Study|Relapse/Progression|10|||
130334240|NCT02112916|469193112|FG001|Overall Study|Relapse/Progression|18|||
130334241|NCT02112916|469193113|FG002|Overall Study|Relapse/Progression|15|||
130334242|NCT02112916|469193114|FG003|Overall Study|Relapse/Progression|2|||
130334243|NCT02112916|469193111|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
130334244|NCT02112916|469193112|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
130660968|NCT01336608|470383017|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130660969|NCT01336608|470383018|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130660970|NCT01336608|470383015|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
130660971|NCT01336608|470383016|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130660972|NCT01336608|470383017|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130660973|NCT01336608|470383018|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130660974|NCT01336608|470383015|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
130660975|NCT01336608|470383016|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130660976|NCT01336608|470383017|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130660977|NCT01336608|470383018|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130660978|NCT01336608|470383015|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
130660979|NCT01336608|470383016|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130660980|NCT01336608|470383017|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130660981|NCT01336608|470383018|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130660982|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130660983|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
130660984|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
130660985|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
130660986|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130660987|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130660988|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130660989|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130660990|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130660991|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130660992|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130660993|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
130660994|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130660995|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130660996|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130660997|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130660998|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
130660999|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
130661000|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
130661001|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
130661002|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130661003|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130661004|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130661005|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130661006|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130661007|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
130661008|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130661009|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
130661010|NCT01336608|470383015|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130661011|NCT01336608|470383016|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130661012|NCT01336608|470383017|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
130661013|NCT01336608|470383018|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
130661014|NCT02253654|470383019|FG000|Overall Study|Withdrawal by Subject|12|||
130661015|NCT02253654|470383020|FG001|Overall Study|Withdrawal by Subject|4|||
130661016|NCT02253654|470383019|FG000|Overall Study|Decision by Sponsor|1|||
130661017|NCT02253654|470383020|FG001|Overall Study|Decision by Sponsor|1|||
130661018|NCT02253654|470383019|FG000|Overall Study|Lost to Follow-up|2|||
130661019|NCT02253654|470383020|FG001|Overall Study|Lost to Follow-up|5|||
130661020|NCT02253654|470383019|FG000|Overall Study|Death|4|||
130661021|NCT02253654|470383020|FG001|Overall Study|Death|7|||
130661022|NCT02253654|470383019|FG000|Overall Study|Did Not Receive Study Treatment|4|||
130661023|NCT02253654|470383020|FG001|Overall Study|Did Not Receive Study Treatment|1|||
130661024|NCT03044431|470383023|FG000|Overall Study|Lost to Follow-up|59|||
130661025|NCT03456726|470383024|FG000|Overall Study|Disease Progression|6|||
130661026|NCT03456726|470383025|FG001|Overall Study|Disease Progression|1|||
130661027|NCT03456726|470383024|FG000|Overall Study|Adverse Event|4|||
130661028|NCT03456726|470383025|FG001|Overall Study|Adverse Event|2|||
130661029|NCT03456726|470383024|FG000|Overall Study|Withdrawal by Subject|1|||
130661030|NCT03456726|470383025|FG001|Overall Study|Withdrawal by Subject|0|||
130661031|NCT03456726|470383024|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
130661032|NCT03456726|470383025|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
130661033|NCT00399490|470383026|FG000|Overall Study|Adverse Event|19|||
130334245|NCT02112916|469193113|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
130334246|NCT02112916|469193114|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
130334247|NCT02112916|469193111|FG000|Overall Study|Still on Therapy|44|||
130334248|NCT02112916|469193112|FG001|Overall Study|Still on Therapy|47|||
130334249|NCT02112916|469193113|FG002|Overall Study|Still on Therapy|3|||
130334250|NCT02112916|469193114|FG003|Overall Study|Still on Therapy|2|||
130334251|NCT02112916|469193111|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
130334252|NCT02112916|469193112|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
130334253|NCT02112916|469193113|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
130334254|NCT02112916|469193114|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
130334255|NCT02112916|469193111|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
130334256|NCT02112916|469193112|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
130334257|NCT02112916|469193113|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
130334258|NCT02112916|469193114|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
130334259|NCT04238819|469193115|FG000|Overall Study|Ongoing Treatment|0|||
130334260|NCT04238819|469193116|FG001|Overall Study|Ongoing Treatment|0|||
130334261|NCT04238819|469193117|FG002|Overall Study|Ongoing Treatment|0|||
130334262|NCT04238819|469193118|FG003|Overall Study|Ongoing Treatment|0|||
130334263|NCT04238819|469193119|FG004|Overall Study|Ongoing Treatment|1|||
130334264|NCT04238819|469193120|FG005|Overall Study|Ongoing Treatment|4|||
130334265|NCT04238819|469193121|FG006|Overall Study|Ongoing Treatment|0|||
130334266|NCT04238819|469193115|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
130334267|NCT04238819|469193116|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
130334268|NCT04238819|469193117|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
130334269|NCT04238819|469193118|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
130334270|NCT04238819|469193119|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
130334271|NCT04238819|469193120|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
130334272|NCT04238819|469193121|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
130334273|NCT03568461|469193122|FG000|Overall Study|Death|7|||
130334274|NCT03568461|469193122|FG000|Overall Study|Physician Decision|5|||
130334275|NCT03568461|469193122|FG000|Overall Study|Subject decision|5|||
130334276|NCT03568461|469193122|FG000|Overall Study|Lost to Follow-up|1|||
130334277|NCT05109234|469193123|FG000|Overall Study|Adverse Event|2|||
130661034|NCT00399490|470383026|FG000|Overall Study|Lack of Efficacy|31|||
130661035|NCT00399490|470383026|FG000|Overall Study|Lost to Follow-up|5|||
130334278|NCT05109234|469193124|FG001|Overall Study|Adverse Event|2|||
130334279|NCT05109234|469193123|FG000|Overall Study|Lack of Efficacy|5|||
130334280|NCT05109234|469193124|FG001|Overall Study|Lack of Efficacy|0|||
130334281|NCT05109234|469193123|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
130334282|NCT05109234|469193124|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
130334283|NCT05109234|469193123|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
130334284|NCT05109234|469193124|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
130334285|NCT05109234|469193123|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
130334286|NCT05109234|469193124|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
130334287|NCT05109234|469193123|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
130334288|NCT05109234|469193124|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
130334289|NCT02355184|469193125|FG000|Overall Study|Lost to Follow-up|2|||
130334290|NCT02355184|469193125|FG000|Overall Study|Study Terminated|10|||
130334291|NCT00539864|469193760|FG000|Overall Study|Lost to Follow-up|0|||
130334292|NCT00539864|469193761|FG001|Overall Study|Lost to Follow-up|1|||
130334293|NCT00539864|469193760|FG000|Overall Study|Withdrawal by Subject|1|||
130334294|NCT00539864|469193761|FG001|Overall Study|Withdrawal by Subject|1|||
130334295|NCT00943072|469193764|FG000|Overall Study|Adverse Event|0|||
130334296|NCT00943072|469193765|FG001|Overall Study|Adverse Event|3|||
130334297|NCT00943072|469193764|FG000|Overall Study|Death|0|||
130334298|NCT00943072|469193765|FG001|Overall Study|Death|2|||
130216095|NCT01826981|468753949|FG009|Overall Study|Adverse Event|0|||
130216096|NCT01826981|468753950|FG010|Overall Study|Adverse Event|0|||
130216097|NCT01826981|468753951|FG011|Overall Study|Adverse Event|0|||
130216098|NCT01826981|468753952|FG012|Overall Study|Adverse Event|0|||
130216099|NCT01826981|468753953|FG013|Overall Study|Adverse Event|0|||
130334299|NCT00943072|469193764|FG000|Overall Study|Withdrawal by Subject|3|||
130334300|NCT00943072|469193765|FG001|Overall Study|Withdrawal by Subject|1|||
130334301|NCT00943072|469193764|FG000|Overall Study|Protocol Violation|0|||
130216100|NCT01826981|468753954|FG014|Overall Study|Adverse Event|0|||
130216101|NCT01826981|468753940|FG000|Overall Study|Upper G-I Haemorrhage|0|||
130216102|NCT01826981|468753941|FG001|Overall Study|Upper G-I Haemorrhage|0|||
130334302|NCT00943072|469193765|FG001|Overall Study|Protocol Violation|1|||
130334303|NCT00943072|469193764|FG000|Overall Study|Lost to Follow-up|1|||
130334304|NCT00943072|469193765|FG001|Overall Study|Lost to Follow-up|2|||
130334305|NCT00943072|469193764|FG000|Overall Study|Lack of Efficacy|0|||
130334306|NCT00943072|469193765|FG001|Overall Study|Lack of Efficacy|4|||
130334307|NCT00943072|469193764|FG000|Overall Study|Other|1|||
130334308|NCT00943072|469193765|FG001|Overall Study|Other|1|||
130661036|NCT00399490|470383026|FG000|Overall Study|Withdrawal by Subject|18|||
130216103|NCT01826981|468753942|FG002|Overall Study|Upper G-I Haemorrhage|0|||
130216104|NCT01826981|468753943|FG003|Overall Study|Upper G-I Haemorrhage|0|||
130216105|NCT01826981|468753944|FG004|Overall Study|Upper G-I Haemorrhage|0|||
130216106|NCT01826981|468753945|FG005|Overall Study|Upper G-I Haemorrhage|0|||
130216107|NCT01826981|468753946|FG006|Overall Study|Upper G-I Haemorrhage|0|||
130216108|NCT01826981|468753947|FG007|Overall Study|Upper G-I Haemorrhage|0|||
130216109|NCT01826981|468753948|FG008|Overall Study|Upper G-I Haemorrhage|0|||
130216110|NCT01826981|468753949|FG009|Overall Study|Upper G-I Haemorrhage|0|||
130216111|NCT01826981|468753950|FG010|Overall Study|Upper G-I Haemorrhage|0|||
130216112|NCT01826981|468753951|FG011|Overall Study|Upper G-I Haemorrhage|0|||
130216113|NCT01826981|468753952|FG012|Overall Study|Upper G-I Haemorrhage|0|||
130216114|NCT01826981|468753953|FG013|Overall Study|Upper G-I Haemorrhage|1|||
130216115|NCT01826981|468753954|FG014|Overall Study|Upper G-I Haemorrhage|0|||
130216116|NCT01826981|468753940|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
130661037|NCT00399490|470383026|FG000|Overall Study|Other|25|||
130661038|NCT02328547|470383027|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
130661039|NCT02328547|470383028|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
130661040|NCT02328547|470383027|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130661041|NCT02328547|470383028|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
130661042|NCT02576054|470383032|FG000|Overall Study|Withdrawal by Subject|1|||
130661043|NCT00344305|470383033|FG000|Overall Study|Lost to Follow-up|2|||
130661044|NCT00344305|470383034|FG001|Overall Study|Lost to Follow-up|0|||
130661045|NCT00344305|470383033|FG000|Overall Study|Participant was not contacted in window|0|||
130661046|NCT00344305|470383034|FG001|Overall Study|Participant was not contacted in window|1|||
130661047|NCT01190098|470383035|FG000|Overall Study|Adverse Event|2|||
130661048|NCT01190098|470383036|FG001|Overall Study|Adverse Event|0|||
130661049|NCT01190098|470383035|FG000|Overall Study|Patient coomorbidity|0|||
130661050|NCT01190098|470383036|FG001|Overall Study|Patient coomorbidity|1|||
130661051|NCT01190098|470383035|FG000|Overall Study|Lack of transportation|1|||
130661052|NCT01190098|470383036|FG001|Overall Study|Lack of transportation|0|||
130661053|NCT01190098|470383035|FG000|Overall Study|Other|0|||
130661054|NCT01190098|470383036|FG001|Overall Study|Other|1|||
130661055|NCT02957682|470383037|FG000|Overall Study|Adverse Event|64|||
130661056|NCT02957682|470383038|FG001|Overall Study|Adverse Event|67|||
130661057|NCT02957682|470383037|FG000|Overall Study|Poor Compliance to Protocol|30|||
130661058|NCT02957682|470383038|FG001|Overall Study|Poor Compliance to Protocol|26|||
130661059|NCT02957682|470383037|FG000|Overall Study|Physician Decision|4|||
130661060|NCT02957682|470383038|FG001|Overall Study|Physician Decision|4|||
130661061|NCT02957682|470383037|FG000|Overall Study|Study Terminated by Sponsor|4|||
130661062|NCT02957682|470383038|FG001|Overall Study|Study Terminated by Sponsor|3|||
130661063|NCT02957682|470383037|FG000|Overall Study|Subject Moved|10|||
130661064|NCT02957682|470383038|FG001|Overall Study|Subject Moved|16|||
130661065|NCT02957682|470383037|FG000|Overall Study|Withdrawal by Subject|64|||
130661066|NCT02957682|470383038|FG001|Overall Study|Withdrawal by Subject|33|||
130661067|NCT02957682|470383037|FG000|Overall Study|Related to IMP Administration|3|||
130661068|NCT02957682|470383038|FG001|Overall Study|Related to IMP Administration|6|||
130661069|NCT02957682|470383037|FG000|Overall Study|Non-disclosed|16|||
130661070|NCT02957682|470383038|FG001|Overall Study|Non-disclosed|12|||
130661071|NCT02957682|470383037|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
130661072|NCT02957682|470383038|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
130661073|NCT00791154|470383047|FG000|Overall Study|Noncompliance|0|||
130661074|NCT00791154|470383048|FG001|Overall Study|Noncompliance|1|||
130661075|NCT00791154|470383049|FG002|Overall Study|Noncompliance|0|||
130661076|NCT00791154|470383050|FG003|Overall Study|Noncompliance|0|||
130661077|NCT00791154|470383051|FG004|Overall Study|Noncompliance|1|||
130661078|NCT00791154|470383052|FG005|Overall Study|Noncompliance|1|||
130661079|NCT00791154|470383053|FG006|Overall Study|Noncompliance|1|||
130661080|NCT00791154|470383047|FG000|Overall Study|Adverse Event|0|||
130661081|NCT00791154|470383048|FG001|Overall Study|Adverse Event|0|||
130661082|NCT00791154|470383049|FG002|Overall Study|Adverse Event|0|||
130661083|NCT00791154|470383050|FG003|Overall Study|Adverse Event|0|||
130661084|NCT00791154|470383051|FG004|Overall Study|Adverse Event|2|||
130661085|NCT00791154|470383052|FG005|Overall Study|Adverse Event|0|||
130216117|NCT01826981|468753941|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216118|NCT01826981|468753942|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
130661086|NCT00791154|470383053|FG006|Overall Study|Adverse Event|1|||
130661087|NCT00791154|470383047|FG000|Overall Study|Full Consent withdrawn|1|||
130661088|NCT00791154|470383048|FG001|Overall Study|Full Consent withdrawn|3|||
130661089|NCT00791154|470383049|FG002|Overall Study|Full Consent withdrawn|0|||
130661090|NCT00791154|470383050|FG003|Overall Study|Full Consent withdrawn|0|||
130661091|NCT00791154|470383051|FG004|Overall Study|Full Consent withdrawn|1|||
130661092|NCT00791154|470383052|FG005|Overall Study|Full Consent withdrawn|3|||
130661093|NCT00791154|470383053|FG006|Overall Study|Full Consent withdrawn|1|||
130661094|NCT00791154|470383047|FG000|Overall Study|Lost to Follow-up|0|||
130661095|NCT00791154|470383048|FG001|Overall Study|Lost to Follow-up|0|||
130661096|NCT00791154|470383049|FG002|Overall Study|Lost to Follow-up|0|||
130661097|NCT00791154|470383050|FG003|Overall Study|Lost to Follow-up|1|||
130661098|NCT00791154|470383051|FG004|Overall Study|Lost to Follow-up|2|||
130661099|NCT00791154|470383052|FG005|Overall Study|Lost to Follow-up|0|||
130661100|NCT00791154|470383053|FG006|Overall Study|Lost to Follow-up|4|||
130661101|NCT00791154|470383047|FG000|Overall Study|Death|5|||
130661102|NCT00791154|470383048|FG001|Overall Study|Death|4|||
130661103|NCT00791154|470383049|FG002|Overall Study|Death|4|||
130661104|NCT00791154|470383050|FG003|Overall Study|Death|7|||
130661105|NCT00791154|470383051|FG004|Overall Study|Death|54|||
130661106|NCT00791154|470383052|FG005|Overall Study|Death|54|||
130661107|NCT00791154|470383053|FG006|Overall Study|Death|52|||
130661108|NCT00791154|470383047|FG000|Overall Study|Other event|0|||
130661109|NCT00791154|470383048|FG001|Overall Study|Other event|0|||
130661110|NCT00791154|470383049|FG002|Overall Study|Other event|2|||
130661111|NCT00791154|470383050|FG003|Overall Study|Other event|0|||
130661112|NCT00791154|470383051|FG004|Overall Study|Other event|2|||
130661113|NCT00791154|470383052|FG005|Overall Study|Other event|4|||
130661114|NCT00791154|470383053|FG006|Overall Study|Other event|2|||
130661115|NCT00953927|470383054|FG000|Overall Study|Lost to Follow-up|61|||
130661116|NCT00953927|470383055|FG001|Overall Study|Lost to Follow-up|65|||
130661117|NCT00953927|470383054|FG000|Overall Study|Withdrawal by Subject|36|||
130661118|NCT00953927|470383055|FG001|Overall Study|Withdrawal by Subject|25|||
130661119|NCT00953927|470383054|FG000|Overall Study|Death|7|||
130661120|NCT00953927|470383055|FG001|Overall Study|Death|4|||
130661121|NCT00953927|470383054|FG000|Overall Study|Other study discontinuation|1|||
130661122|NCT00953927|470383055|FG001|Overall Study|Other study discontinuation|1|||
130661123|NCT03578276|470383058|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
130661124|NCT03578276|470383059|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
130661125|NCT00981409|470383060|FG000|Overall Study|Adverse Event|4|||
130661126|NCT00981409|470383061|FG001|Overall Study|Adverse Event|0|||
130661127|NCT00981409|470383060|FG000|Overall Study|Protocol Violation|0|||
130661128|NCT00981409|470383061|FG001|Overall Study|Protocol Violation|1|||
130661129|NCT00981409|470383060|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
130661130|NCT00981409|470383061|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
130661131|NCT00078312|470383072|FG000|Overall Study|Adverse Event|43|||
130661132|NCT00078312|470383072|FG000|Overall Study|Lack of Efficacy|15|||
130661133|NCT00078312|470383072|FG000|Overall Study|Lost to Follow-up|41|||
130661134|NCT00078312|470383072|FG000|Overall Study|Physician Decision|9|||
130661135|NCT00078312|470383072|FG000|Overall Study|Protocol Violation|3|||
130661136|NCT00078312|470383072|FG000|Overall Study|Withdrawal by Subject|33|||
130661137|NCT00078312|470383072|FG000|Overall Study|Miscellaneous|33|||
130661138|NCT04840901|470383073|FG000|Overall Study|Lost to Follow-up|3|||
130661139|NCT04840901|470383074|FG001|Overall Study|Lost to Follow-up|1|||
130661140|NCT04840901|470383073|FG000|Overall Study|Moved|1|||
130661141|NCT04840901|470383074|FG001|Overall Study|Moved|0|||
130661142|NCT04840901|470383073|FG000|Overall Study|Unable to comply with study schedule|0|||
130661143|NCT04840901|470383074|FG001|Overall Study|Unable to comply with study schedule|1|||
130661144|NCT04840901|470383073|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
130661145|NCT04840901|470383074|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
130334309|NCT03887702|469193768|FG000|Overall Study|Study terminated|0|||
130334310|NCT03887702|469193769|FG001|Overall Study|Study terminated|0|||
130661146|NCT01268683|470383075|FG000|Overall Study|Lost to Follow-up|1|||
130661147|NCT01268683|470383075|FG000|Overall Study|Death|1|||
130661148|NCT02216214|470383076|FG000|Overall Study|Randomized Never Received Study Drug|1|||
130661149|NCT02216214|470383077|FG001|Overall Study|Randomized Never Received Study Drug|0|||
130661150|NCT02216214|470383076|FG000|Overall Study|Adverse Event|10|||
130661151|NCT02216214|470383077|FG001|Overall Study|Adverse Event|8|||
130661152|NCT02216214|470383076|FG000|Overall Study|Lack of Efficacy|2|||
130661153|NCT02216214|470383077|FG001|Overall Study|Lack of Efficacy|2|||
130661154|NCT02216214|470383076|FG000|Overall Study|Lost to Follow-up|3|||
130661155|NCT02216214|470383077|FG001|Overall Study|Lost to Follow-up|2|||
130661156|NCT02216214|470383076|FG000|Overall Study|Protocol Violation|4|||
130661157|NCT02216214|470383077|FG001|Overall Study|Protocol Violation|2|||
130334311|NCT03887702|469193770|FG002|Overall Study|Study terminated|2|||
130334312|NCT03887702|469193771|FG003|Overall Study|Study terminated|2|||
130661158|NCT02216214|470383076|FG000|Overall Study|Withdrawal by Subject|22|||
130661159|NCT02216214|470383077|FG001|Overall Study|Withdrawal by Subject|20|||
130334313|NCT01088048|469193777|FG000|Overall Study|Adverse Event|7|||
130334314|NCT01088048|469193778|FG001|Overall Study|Adverse Event|9|||
130661160|NCT02216214|470383076|FG000|Overall Study|Study Terminated By Sponsor|0|||
130661161|NCT02216214|470383077|FG001|Overall Study|Study Terminated By Sponsor|1|||
130661162|NCT02216214|470383076|FG000|Overall Study|Miscellaneous|1|||
130661163|NCT02216214|470383077|FG001|Overall Study|Miscellaneous|1|||
130661164|NCT05354206|470383078|FG000|Overall Study|Withdrawal by Subject|1|||
130661165|NCT05354206|470383079|FG001|Overall Study|Withdrawal by Subject|0|||
130661166|NCT00713830|470383080|FG000|Overall Study|Adverse Event|23|||
130661167|NCT00713830|470383081|FG001|Overall Study|Adverse Event|71|||
130661168|NCT00713830|470383080|FG000|Overall Study|Lack of Efficacy|24|||
130661169|NCT00713830|470383081|FG001|Overall Study|Lack of Efficacy|16|||
130661170|NCT00713830|470383080|FG000|Overall Study|Lost to Follow-up|2|||
130661171|NCT00713830|470383081|FG001|Overall Study|Lost to Follow-up|9|||
130661172|NCT00713830|470383080|FG000|Overall Study|Withdrawal by Subject|13|||
130661173|NCT00713830|470383081|FG001|Overall Study|Withdrawal by Subject|23|||
130661174|NCT00713830|470383080|FG000|Overall Study|Poor Compliance to Protocol|7|||
130661175|NCT00713830|470383081|FG001|Overall Study|Poor Compliance to Protocol|14|||
130661176|NCT00713830|470383080|FG000|Overall Study|Familial and Personal Reasons|9|||
130661177|NCT00713830|470383081|FG001|Overall Study|Familial and Personal Reasons|34|||
130661178|NCT00713830|470383080|FG000|Overall Study|Sponsor Decision|4|||
130661179|NCT00713830|470383081|FG001|Overall Study|Sponsor Decision|10|||
130661180|NCT00902265|470383082|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
130661181|NCT00902265|470383082|FG000|Overall Study|Adverse Event|2|||
130661182|NCT00902265|470383082|FG000|Overall Study|Lack of Efficacy|2|||
130661183|NCT00902265|470383082|FG000|Overall Study|Protocol Violation|1|||
130661184|NCT04701658|470383083|FG000|Overall Study|Lost to Follow-up|6|||
130661185|NCT05016765|470383084|FG000|Overall Study|Lost to Follow-up|4|||
130661186|NCT04101721|470383087|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
130661187|NCT04101721|470383088|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130661188|NCT04101721|470383087|FG000|Overall Study|Death|0|||
130661189|NCT04101721|470383088|FG001|Overall Study|Death|1|||
130661190|NCT04101721|470383087|FG000|Overall Study|Lost to Follow-up|0|||
130661191|NCT04101721|470383088|FG001|Overall Study|Lost to Follow-up|3|||
130661192|NCT02494583|470383091|FG000|Overall Study|Death|224|||
130661193|NCT02494583|470383092|FG001|Overall Study|Death|214|||
130661194|NCT02494583|470383093|FG002|Overall Study|Death|225|||
130661195|NCT02494583|470383091|FG000|Overall Study|Lost to Follow-up|1|||
130661196|NCT02494583|470383092|FG001|Overall Study|Lost to Follow-up|0|||
130661197|NCT02494583|470383093|FG002|Overall Study|Lost to Follow-up|0|||
130661198|NCT02494583|470383091|FG000|Overall Study|Protocol Violation|1|||
130661199|NCT02494583|470383092|FG001|Overall Study|Protocol Violation|2|||
130661200|NCT02494583|470383093|FG002|Overall Study|Protocol Violation|0|||
130661201|NCT02494583|470383091|FG000|Overall Study|Screen Failure|0|||
130661202|NCT02494583|470383092|FG001|Overall Study|Screen Failure|1|||
130661203|NCT02494583|470383093|FG002|Overall Study|Screen Failure|0|||
130661204|NCT02494583|470383091|FG000|Overall Study|Transferred to Extension Study|15|||
130661205|NCT02494583|470383092|FG001|Overall Study|Transferred to Extension Study|15|||
130661206|NCT02494583|470383093|FG002|Overall Study|Transferred to Extension Study|6|||
130661207|NCT02494583|470383091|FG000|Overall Study|Did Not Continue on Extension Study|8|||
130661208|NCT02494583|470383092|FG001|Overall Study|Did Not Continue on Extension Study|10|||
130661209|NCT02494583|470383093|FG002|Overall Study|Did Not Continue on Extension Study|4|||
130661210|NCT02494583|470383091|FG000|Overall Study|Withdrawal by Subject|7|||
130661211|NCT02494583|470383092|FG001|Overall Study|Withdrawal by Subject|15|||
130661212|NCT02494583|470383093|FG002|Overall Study|Withdrawal by Subject|15|||
130661213|NCT03151707|470383096|FG000|Overall Study|Lost to Follow-up|6|||
130661214|NCT02362646|470383100|FG000|Overall Study|Death|15|||
130661215|NCT02362646|470383101|FG001|Overall Study|Death|8|||
130661216|NCT02362646|470383100|FG000|Overall Study|Withdrawal by Subject|2|||
130661217|NCT02362646|470383101|FG001|Overall Study|Withdrawal by Subject|2|||
130661218|NCT02362646|470383100|FG000|Overall Study|received transplant|21|||
130661219|NCT02362646|470383101|FG001|Overall Study|received transplant|14|||
130661220|NCT00865306|470383102|FG000|Controlled Trial|Lost to Follow-up|1|||
130661221|NCT00865306|470383103|FG001|Controlled Trial|Lost to Follow-up|1|||
130661222|NCT00865306|470383102|FG000|Controlled Trial|Difficulty commuting|2|||
130661223|NCT00865306|470383103|FG001|Controlled Trial|Difficulty commuting|0|||
130661224|NCT00865306|470383102|FG000|Controlled Trial|Improved btw baseline and first session|1|||
130661225|NCT00865306|470383103|FG001|Controlled Trial|Improved btw baseline and first session|0|||
130661226|NCT00865306|470383102|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
130661227|NCT00865306|470383103|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
130661228|NCT00865306|470383102|FG000|Controlled Trial|Withdrawal by Subject|0|||
130661229|NCT00865306|470383103|FG001|Controlled Trial|Withdrawal by Subject|1|||
130661230|NCT02058368|470383105|FG000|Overall Study|Adverse Event|15|||
130661231|NCT02058368|470383106|FG001|Overall Study|Adverse Event|20|||
130661232|NCT02058368|470383105|FG000|Overall Study|Lack of Efficacy|0|||
130661233|NCT02058368|470383106|FG001|Overall Study|Lack of Efficacy|1|||
130661234|NCT02058368|470383105|FG000|Overall Study|Protocol Violation|0|||
130661235|NCT02058368|470383106|FG001|Overall Study|Protocol Violation|4|||
130661236|NCT02058368|470383105|FG000|Overall Study|Lost to Follow-up|2|||
130661237|NCT02058368|470383106|FG001|Overall Study|Lost to Follow-up|0|||
130661238|NCT02058368|470383105|FG000|Overall Study|Physician Decision|2|||
130661239|NCT02058368|470383106|FG001|Overall Study|Physician Decision|3|||
130661240|NCT02058368|470383105|FG000|Overall Study|Withdrawal by Subject|22|||
130334315|NCT01088048|469193779|FG002|Overall Study|Adverse Event|7|||
130334316|NCT01088048|469193780|FG003|Overall Study|Adverse Event|5|||
130334317|NCT01088048|469193781|FG004|Overall Study|Adverse Event|6|||
130334318|NCT01088048|469193782|FG005|Overall Study|Adverse Event|3|||
130661241|NCT02058368|470383106|FG001|Overall Study|Withdrawal by Subject|26|||
130661242|NCT02181842|470383107|FG000|Overall Study|Case Report Forms Uncollected|2|||
130334319|NCT01088048|469193783|FG006|Overall Study|Adverse Event|3|||
130334320|NCT01088048|469193784|FG007|Overall Study|Adverse Event|0|||
130334321|NCT01088048|469193785|FG008|Overall Study|Adverse Event|2|||
130334322|NCT01088048|469193786|FG009|Overall Study|Adverse Event|2|||
130334323|NCT01088048|469193777|FG000|Overall Study|Withdrew Consent|1|||
130334324|NCT01088048|469193778|FG001|Overall Study|Withdrew Consent|1|||
130334325|NCT01088048|469193779|FG002|Overall Study|Withdrew Consent|1|||
130334326|NCT01088048|469193780|FG003|Overall Study|Withdrew Consent|1|||
130334327|NCT01088048|469193781|FG004|Overall Study|Withdrew Consent|2|||
130334328|NCT01088048|469193782|FG005|Overall Study|Withdrew Consent|1|||
130334329|NCT01088048|469193783|FG006|Overall Study|Withdrew Consent|0|||
130334330|NCT01088048|469193784|FG007|Overall Study|Withdrew Consent|2|||
130334331|NCT01088048|469193785|FG008|Overall Study|Withdrew Consent|2|||
130334332|NCT01088048|469193786|FG009|Overall Study|Withdrew Consent|1|||
130334333|NCT01088048|469193777|FG000|Overall Study|Concomitant Medication Prohibited|1|||
130334334|NCT01088048|469193778|FG001|Overall Study|Concomitant Medication Prohibited|0|||
130334335|NCT01088048|469193779|FG002|Overall Study|Concomitant Medication Prohibited|0|||
130334336|NCT01088048|469193780|FG003|Overall Study|Concomitant Medication Prohibited|0|||
130334337|NCT01088048|469193781|FG004|Overall Study|Concomitant Medication Prohibited|0|||
130334338|NCT01088048|469193782|FG005|Overall Study|Concomitant Medication Prohibited|0|||
130334339|NCT01088048|469193783|FG006|Overall Study|Concomitant Medication Prohibited|0|||
130661243|NCT01652872|470383108|FG000|Overall Study|Death|36|||
130334340|NCT01088048|469193784|FG007|Overall Study|Concomitant Medication Prohibited|0|||
130334341|NCT01088048|469193785|FG008|Overall Study|Concomitant Medication Prohibited|0|||
130334342|NCT01088048|469193786|FG009|Overall Study|Concomitant Medication Prohibited|0|||
130334343|NCT01088048|469193777|FG000|Overall Study|Investigator Request|2|||
130661244|NCT01652872|470383109|FG001|Overall Study|Death|39|||
130661245|NCT01652872|470383108|FG000|Overall Study|Lost to Follow-up|28|||
130661246|NCT01652872|470383109|FG001|Overall Study|Lost to Follow-up|23|||
130661247|NCT01652872|470383108|FG000|Overall Study|Decision by sponsor|5|||
130661248|NCT01652872|470383109|FG001|Overall Study|Decision by sponsor|7|||
130661249|NCT01652872|470383108|FG000|Overall Study|Withdrawal by Subject|76|||
130661250|NCT01652872|470383109|FG001|Overall Study|Withdrawal by Subject|84|||
130661251|NCT02703454|470384543|FG000|Overall Study|Not treated|1|||
130661252|NCT02703454|470384544|FG001|Overall Study|Not treated|3|||
130661253|NCT02703454|470384543|FG000|Overall Study|Withdrawal by Subject|4|||
130661254|NCT02703454|470384544|FG001|Overall Study|Withdrawal by Subject|3|||
130661255|NCT02703454|470384543|FG000|Overall Study|Lost to Follow-up|1|||
130661256|NCT02703454|470384544|FG001|Overall Study|Lost to Follow-up|2|||
130661257|NCT02703454|470384543|FG000|Overall Study|Study discontinuation|5|||
130661258|NCT02703454|470384544|FG001|Overall Study|Study discontinuation|8|||
130661259|NCT02284373|470384545|FG000|Overall Study|Withdrawal by Subject|0|||
130661260|NCT02284373|470384546|FG001|Overall Study|Withdrawal by Subject|1|||
130661261|NCT02284373|470384547|FG002|Overall Study|Withdrawal by Subject|0|||
130661262|NCT02284373|470384545|FG000|Overall Study|Other|0|||
130661263|NCT02284373|470384546|FG001|Overall Study|Other|1|||
130661264|NCT02284373|470384547|FG002|Overall Study|Other|0|||
130661265|NCT02284373|470384545|FG000|Overall Study|Lost to Follow-up|0|||
130661266|NCT02284373|470384546|FG001|Overall Study|Lost to Follow-up|1|||
130661267|NCT02284373|470384547|FG002|Overall Study|Lost to Follow-up|0|||
130661268|NCT02499406|470384548|FG000|Overall Study|missed 3 treatment sessions|4|||
130661269|NCT01396161|470384549|FG000|Overall Study|Withdrawal by Subject|0|||
130661270|NCT01396161|470384550|FG001|Overall Study|Withdrawal by Subject|0|||
130661271|NCT01396161|470384551|FG002|Overall Study|Withdrawal by Subject|0|||
130661272|NCT01396161|470384552|FG003|Overall Study|Withdrawal by Subject|0|||
130661273|NCT01396161|470384553|FG004|Overall Study|Withdrawal by Subject|1|||
130661274|NCT01396161|470384554|FG005|Overall Study|Withdrawal by Subject|0|||
130661275|NCT01396161|470384555|FG006|Overall Study|Withdrawal by Subject|0|||
130661276|NCT01396161|470384549|FG000|Overall Study|Other|0|||
130661277|NCT01396161|470384550|FG001|Overall Study|Other|0|||
130661278|NCT01396161|470384551|FG002|Overall Study|Other|0|||
130661279|NCT01396161|470384552|FG003|Overall Study|Other|0|||
130216119|NCT01826981|468753943|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
130334344|NCT01088048|469193778|FG001|Overall Study|Investigator Request|2|||
130334345|NCT01088048|469193779|FG002|Overall Study|Investigator Request|0|||
130334346|NCT01088048|469193780|FG003|Overall Study|Investigator Request|0|||
130334347|NCT01088048|469193781|FG004|Overall Study|Investigator Request|3|||
130334348|NCT01088048|469193782|FG005|Overall Study|Investigator Request|1|||
130334349|NCT01088048|469193783|FG006|Overall Study|Investigator Request|1|||
130334350|NCT01088048|469193784|FG007|Overall Study|Investigator Request|0|||
130334351|NCT01088048|469193785|FG008|Overall Study|Investigator Request|0|||
130661280|NCT01396161|470384553|FG004|Overall Study|Other|0|||
130661281|NCT01396161|470384554|FG005|Overall Study|Other|0|||
130661282|NCT01396161|470384555|FG006|Overall Study|Other|1|||
130661283|NCT04651218|470384556|FG000|Overall Study|Withdrawal by Subject|0|||
130661284|NCT04651218|470384557|FG001|Overall Study|Withdrawal by Subject|2|||
130661285|NCT01399125|470384558|FG000|Overall Study|Adverse Event|32|||
130661286|NCT01399125|470384559|FG001|Overall Study|Adverse Event|30|||
130661287|NCT01399125|470384558|FG000|Overall Study|Abnormal Lab values|0|||
130661288|NCT01399125|470384559|FG001|Overall Study|Abnormal Lab values|1|||
130661289|NCT01399125|470384558|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130661290|NCT01399125|470384559|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130661291|NCT01399125|470384558|FG000|Overall Study|Withdrawal by Subject|5|||
130661292|NCT01399125|470384559|FG001|Overall Study|Withdrawal by Subject|8|||
130661293|NCT01399125|470384558|FG000|Overall Study|Lost to Follow-up|2|||
130661294|NCT01399125|470384559|FG001|Overall Study|Lost to Follow-up|3|||
130661295|NCT01399125|470384558|FG000|Overall Study|Administrative Problems|7|||
130661296|NCT01399125|470384559|FG001|Overall Study|Administrative Problems|11|||
130661297|NCT01399125|470384558|FG000|Overall Study|Death|0|||
130661298|NCT01399125|470384559|FG001|Overall Study|Death|1|||
130661299|NCT01399125|470384558|FG000|Overall Study|Protocol Deviation|5|||
130661300|NCT01399125|470384559|FG001|Overall Study|Protocol Deviation|2|||
130661301|NCT00647426|470384560|FG000|Overall Study|Withdrawal by Subject|2|||
130661302|NCT03543046|470384563|FG000|Overall Study|Adverse Event|1|||
130661303|NCT03543046|470384564|FG001|Overall Study|Adverse Event|1|||
130661304|NCT03543046|470384563|FG000|Overall Study|Physician Decision|1|||
130661305|NCT03543046|470384564|FG001|Overall Study|Physician Decision|1|||
130661306|NCT03543046|470384563|FG000|Overall Study|Protocol Violation|1|||
130661307|NCT03543046|470384564|FG001|Overall Study|Protocol Violation|0|||
130661308|NCT01227954|470384565|FG000|Overall Study|Protocol Violation|6|||
130661309|NCT01227954|470384565|FG000|Overall Study|No protocol treatment|7|||
130661310|NCT01296152|470384566|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130661311|NCT02787785|470384573|FG000|Overall Study|Death|3|||
130661312|NCT02787785|470384574|FG001|Overall Study|Death|4|||
130661313|NCT02787785|470384573|FG000|Overall Study|Lost to Follow-up|1|||
130661314|NCT02787785|470384574|FG001|Overall Study|Lost to Follow-up|1|||
130661315|NCT02787785|470384573|FG000|Overall Study|Withdrawal by Subject|0|||
130661316|NCT02787785|470384574|FG001|Overall Study|Withdrawal by Subject|5|||
130661317|NCT00103259|470384578|FG000|Overall Study|Death|3|||
130661318|NCT00103259|470384579|FG001|Overall Study|Death|2|||
130661319|NCT00103259|470384578|FG000|Overall Study|Withdrawal by Subject|2|||
130661320|NCT00103259|470384579|FG001|Overall Study|Withdrawal by Subject|3|||
130661321|NCT00103259|470384578|FG000|Overall Study|alternative therapy|1|||
130661322|NCT00103259|470384579|FG001|Overall Study|alternative therapy|0|||
130661323|NCT00103259|470384578|FG000|Overall Study|other (reasons were not specified)|2|||
130661324|NCT00103259|470384579|FG001|Overall Study|other (reasons were not specified)|1|||
130661325|NCT00103259|470384578|FG000|Overall Study|ineligible/no protocol therapy|4|||
130661326|NCT00103259|470384579|FG001|Overall Study|ineligible/no protocol therapy|6|||
130661327|NCT02866695|470384584|FG000|Overall Study|Adverse Event|1|||
130661328|NCT02866695|470384584|FG000|Overall Study|Lost to Follow-up|1|||
130661329|NCT03224234|470384585|FG000|Main Study|Lost to Follow-up|5|||
130661330|NCT03224234|470384586|FG001|Main Study|Lost to Follow-up|5|||
130661331|NCT02610842|470384587|FG000|Overall Study|Lost to Follow-up|5|||
130661332|NCT00756652|470384588|FG000|Original Phase|Withdrawal by Subject|864|||
130661333|NCT00756652|470384589|FG001|Original Phase|Withdrawal by Subject|23|||
130661334|NCT00756652|470384588|FG000|Original Phase|Lost to Follow-up|601|||
130661335|NCT00756652|470384589|FG001|Original Phase|Lost to Follow-up|0|||
130661336|NCT00756652|470384588|FG000|Original Phase|Other Discontinuation|797|||
130661337|NCT00756652|470384589|FG001|Original Phase|Other Discontinuation|5|||
130661338|NCT00756652|470384588|FG000|Original Phase|Participant Noncompliance|18622|||
130661339|NCT00756652|470384589|FG001|Original Phase|Participant Noncompliance|424|||
130661340|NCT00756652|470384588|FG000|Original Phase|Unknown Discontinuation Reason|2|||
130661341|NCT00756652|470384589|FG001|Original Phase|Unknown Discontinuation Reason|0|||
130661342|NCT00756652|470384588|FG000|Original Phase|Participants without data|3259|||
130661343|NCT00756652|470384589|FG001|Original Phase|Participants without data|466|||
130661344|NCT00756652|470384588|FG000|Original Phase|Death|168|||
130661345|NCT00756652|470384589|FG001|Original Phase|Death|1|||
130661346|NCT00756652|470384588|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
130661347|NCT00756652|470384589|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
130661348|NCT00756652|470384588|FG000|Re-Op Phase|Withdrawal by Subject|62|||
130661349|NCT00756652|470384589|FG001|Re-Op Phase|Withdrawal by Subject|0|||
130661350|NCT00756652|470384588|FG000|Re-Op Phase|Death|6|||
130661351|NCT00756652|470384589|FG001|Re-Op Phase|Death|0|||
130661352|NCT00756652|470384588|FG000|Re-Op Phase|Lost to Follow-up|340|||
130661353|NCT00756652|470384589|FG001|Re-Op Phase|Lost to Follow-up|0|||
130661354|NCT00756652|470384588|FG000|Re-Op Phase|Site Closed|2454|||
130661355|NCT00756652|470384589|FG001|Re-Op Phase|Site Closed|0|||
130661356|NCT00756652|470384588|FG000|Re-Op Phase|Withdrawn after explant|14|||
130661357|NCT00756652|470384589|FG001|Re-Op Phase|Withdrawn after explant|0|||
130661358|NCT02564952|470384590|FG000|Overall Study|Adverse Event|6|||
130661359|NCT02564952|470384590|FG000|Overall Study|Lost to Follow-up|1|||
130661360|NCT02564952|470384590|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
130661361|NCT02564952|470384590|FG000|Overall Study|Withdrawal by Subject|1|||
130661362|NCT02564952|470384590|FG000|Overall Study|Low Efficacy|1|||
130661363|NCT02564952|470384590|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130661364|NCT00038467|470384591|FG000|Overall Study|Adverse Event|170|||
130661365|NCT00038467|470384592|FG001|Overall Study|Adverse Event|145|||
130661366|NCT00038467|470384591|FG000|Overall Study|Withdrawal by Subject|150|||
130661367|NCT00038467|470384592|FG001|Overall Study|Withdrawal by Subject|107|||
130661368|NCT00038467|470384591|FG000|Overall Study|Protocol Violation|19|||
130661369|NCT00038467|470384592|FG001|Overall Study|Protocol Violation|22|||
130661370|NCT00038467|470384591|FG000|Overall Study|Death|22|||
130661371|NCT00038467|470384592|FG001|Overall Study|Death|16|||
130661372|NCT00038467|470384591|FG000|Overall Study|Lost to Follow-up|15|||
130661373|NCT00038467|470384592|FG001|Overall Study|Lost to Follow-up|10|||
130661374|NCT00038467|470384591|FG000|Overall Study|Recurrence|109|||
130661375|NCT00038467|470384592|FG001|Overall Study|Recurrence|179|||
130661376|NCT00038467|470384591|FG000|Overall Study|Randomized, but not treated|31|||
130661377|NCT00038467|470384592|FG001|Overall Study|Randomized, but not treated|35|||
130661378|NCT00038467|470384591|FG000|Overall Study|Other|26|||
130661379|NCT00038467|470384592|FG001|Overall Study|Other|28|||
130661380|NCT01988493|470384593|FG000|Overall Study|Randomized but not treated|0|||
130661381|NCT01988493|470384594|FG001|Overall Study|Randomized but not treated|0|||
130661382|NCT01988493|470384595|FG002|Overall Study|Randomized but not treated|0|||
130661383|NCT01988493|470384596|FG003|Overall Study|Randomized but not treated|0|||
130661384|NCT01988493|470384597|FG004|Overall Study|Randomized but not treated|1|||
130661385|NCT00627458|470384598|FG000|Overall Study|Migrated from study area|1|||
130661386|NCT00627458|470384599|FG001|Overall Study|Migrated from study area|0|||
130661387|NCT00627458|470384600|FG002|Overall Study|Migrated from study area|1|||
130661388|NCT00627458|470384598|FG000|Overall Study|Withdrawal by Subject|2|||
130661389|NCT00627458|470384599|FG001|Overall Study|Withdrawal by Subject|6|||
130661390|NCT00627458|470384600|FG002|Overall Study|Withdrawal by Subject|5|||
130661391|NCT00627458|470384598|FG000|Overall Study|Lost to Follow-up|1|||
130661392|NCT00627458|470384599|FG001|Overall Study|Lost to Follow-up|1|||
130661393|NCT00627458|470384600|FG002|Overall Study|Lost to Follow-up|0|||
130661394|NCT02268045|470384602|FG000|Overall Study|Death|4|||
130661395|NCT02268045|470384603|FG001|Overall Study|Death|4|||
130661396|NCT02268045|470384602|FG000|Overall Study|Disease Progression|2|||
130661397|NCT02268045|470384603|FG001|Overall Study|Disease Progression|1|||
130661398|NCT02268045|470384602|FG000|Overall Study|Adverse Event|7|||
130661399|NCT02268045|470384603|FG001|Overall Study|Adverse Event|7|||
130661400|NCT02268045|470384602|FG000|Overall Study|Withdrawal by Subject|2|||
130661401|NCT02268045|470384603|FG001|Overall Study|Withdrawal by Subject|6|||
130661402|NCT02268045|470384602|FG000|Overall Study|Physician Decision|0|||
130661403|NCT02268045|470384603|FG001|Overall Study|Physician Decision|1|||
130661404|NCT02268045|470384602|FG000|Overall Study|Protocol Violation|1|||
130661405|NCT02268045|470384603|FG001|Overall Study|Protocol Violation|1|||
130661406|NCT01766310|470384604|FG000|Overall Study|Lost to Follow-up|1|||
130661407|NCT01766310|470384605|FG001|Overall Study|Lost to Follow-up|3|||
130661408|NCT01154673|470384606|FG000|Overall Study|Lost to Follow-up|1|||
130661409|NCT01154673|470384607|FG001|Overall Study|Lost to Follow-up|0|||
130661410|NCT01154673|470384606|FG000|Overall Study|moved out of province|1|||
130661411|NCT01154673|470384607|FG001|Overall Study|moved out of province|0|||
130661412|NCT00646282|470384610|FG000|Overall Study|Protocol terminated|4|||
130661413|NCT00646282|470384611|FG001|Overall Study|Protocol terminated|4|||
130661414|NCT02617446|470384612|FG000|Overall Study|Withdrawal by Subject|0|||
130661415|NCT02617446|470384613|FG001|Overall Study|Withdrawal by Subject|2|||
130661416|NCT02617446|470384614|FG002|Overall Study|Withdrawal by Subject|0|||
130661417|NCT02617446|470384612|FG000|Overall Study|Adverse Event|1|||
130661418|NCT02617446|470384613|FG001|Overall Study|Adverse Event|0|||
130661419|NCT02617446|470384614|FG002|Overall Study|Adverse Event|5|||
130661420|NCT02617446|470384612|FG000|Overall Study|Lost to Follow-up|3|||
130216120|NCT01826981|468753944|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
130661421|NCT02617446|470384613|FG001|Overall Study|Lost to Follow-up|0|||
130661422|NCT02617446|470384614|FG002|Overall Study|Lost to Follow-up|0|||
130661423|NCT02617446|470384612|FG000|Overall Study|Death|0|||
130661424|NCT02617446|470384613|FG001|Overall Study|Death|0|||
130661425|NCT02617446|470384614|FG002|Overall Study|Death|2|||
130661426|NCT01556490|470384623|FG000|Randomized Patients Summary|Protocol Violation|22|||
130661427|NCT01556490|470384624|FG001|Randomized Patients Summary|Protocol Violation|23|||
130661428|NCT01556490|470384623|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
130661429|NCT01556490|470384624|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
130661430|NCT00530088|470384625|FG000|Overall Study|Disease Progression|4|||
130661431|NCT00530088|470384625|FG000|Overall Study|Physician Decision|4|||
130661432|NCT00530088|470384625|FG000|Overall Study|Other Not Specified|2|||
130661433|NCT00902278|470384626|FG000|Overall Study|Physician Decision|1|||
130661434|NCT00902278|470384627|FG001|Overall Study|Physician Decision|0|||
130216121|NCT01826981|468753945|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
130661435|NCT00902278|470384628|FG002|Overall Study|Physician Decision|2|||
130661436|NCT00902278|470384629|FG003|Overall Study|Physician Decision|0|||
130661437|NCT00902278|470384630|FG004|Overall Study|Physician Decision|1|||
130661438|NCT00902278|470384626|FG000|Overall Study|Lost to Follow-up|3|||
130661439|NCT00902278|470384627|FG001|Overall Study|Lost to Follow-up|2|||
130661440|NCT00902278|470384628|FG002|Overall Study|Lost to Follow-up|3|||
130661441|NCT00902278|470384629|FG003|Overall Study|Lost to Follow-up|0|||
130661442|NCT00902278|470384630|FG004|Overall Study|Lost to Follow-up|1|||
130661443|NCT04529096|470384631|FG000|Overall Study|Adverse Event|6|||
130661444|NCT04529096|470384632|FG001|Overall Study|Adverse Event|1|||
130661445|NCT04529096|470384631|FG000|Overall Study|Lack of Efficacy|1|||
130661446|NCT04529096|470384632|FG001|Overall Study|Lack of Efficacy|0|||
130661447|NCT04529096|470384631|FG000|Overall Study|Lost to Follow-up|1|||
130661448|NCT04529096|470384632|FG001|Overall Study|Lost to Follow-up|1|||
130661449|NCT04529096|470384631|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130661450|NCT04529096|470384632|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130661451|NCT04529096|470384631|FG000|Overall Study|Physician Decision|1|||
130661452|NCT04529096|470384632|FG001|Overall Study|Physician Decision|3|||
130661453|NCT04529096|470384631|FG000|Overall Study|Withdrawal by Subject|5|||
130661454|NCT04529096|470384632|FG001|Overall Study|Withdrawal by Subject|0|||
130661455|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
130661456|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
130661457|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
130661458|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
130661459|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
130661460|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
130661461|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
130661462|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130661463|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
130661464|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130661465|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130661466|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
130661467|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130661468|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130661469|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130661470|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130661471|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130661472|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130661473|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
130661474|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
130661475|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
130661476|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
130661477|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
130661478|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
130661479|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
130661480|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
130661481|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130661482|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130661483|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130661484|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
130661485|NCT03985293|470384643|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
130661486|NCT03985293|470384644|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
130661487|NCT03985293|470384645|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
130661488|NCT03985293|470384646|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
130661489|NCT03985293|470384647|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
130661490|NCT03985293|470384648|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
130661491|NCT03985293|470384643|FG000|FOLLOW-UP|Lost to Follow-up|0|||
130661492|NCT03985293|470384644|FG001|FOLLOW-UP|Lost to Follow-up|0|||
130661493|NCT03985293|470384645|FG002|FOLLOW-UP|Lost to Follow-up|1|||
130661494|NCT03985293|470384646|FG003|FOLLOW-UP|Lost to Follow-up|0|||
130661495|NCT03985293|470384647|FG004|FOLLOW-UP|Lost to Follow-up|0|||
130661496|NCT03985293|470384648|FG005|FOLLOW-UP|Lost to Follow-up|0|||
130661497|NCT00390572|470384649|FG000|Overall Study|Lost to Follow-up|8|||
130661498|NCT00390572|470384650|FG001|Overall Study|Lost to Follow-up|4|||
130661499|NCT00390572|470384649|FG000|Overall Study|health condition|0|||
130661500|NCT00390572|470384650|FG001|Overall Study|health condition|1|||
130661501|NCT01345058|470384657|FG000|Overall Study|Withdrawal by Subject|1|||
130661502|NCT01345058|470384658|FG001|Overall Study|Withdrawal by Subject|0|||
130661503|NCT01345058|470384657|FG000|Overall Study|Participant Reported Increase in Events|1|||
130661504|NCT01345058|470384658|FG001|Overall Study|Participant Reported Increase in Events|0|||
130661505|NCT01345058|470384657|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
130661506|NCT01345058|470384658|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
130661507|NCT01345058|470384657|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
130661508|NCT01345058|470384658|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
130661509|NCT01345058|470384657|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
130661510|NCT01345058|470384658|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
130661511|NCT01892020|470384665|FG000|Period 1|Adverse Event|1|||
130661512|NCT01892020|470384666|FG001|Period 1|Adverse Event|1|||
130661513|NCT01892020|470384665|FG000|Period 1|Protocol Violation|2|||
130661514|NCT01892020|470384666|FG001|Period 1|Protocol Violation|4|||
130661515|NCT01892020|470384665|FG000|Period 1|Unclassified|0|||
130661516|NCT01892020|470384666|FG001|Period 1|Unclassified|1|||
130661517|NCT01892020|470384665|FG000|Period 2|Protocol Violation|1|||
130661518|NCT01892020|470384666|FG001|Period 2|Protocol Violation|0|||
130661519|NCT04822701|470384678|FG000|Overall Study|Not treated|2|||
130661520|NCT04822701|470384679|FG001|Overall Study|Not treated|0|||
130661521|NCT04822701|470384678|FG000|Overall Study|Lost to Follow-up|1|||
130661522|NCT04822701|470384679|FG001|Overall Study|Lost to Follow-up|0|||
130661523|NCT04822701|470384678|FG000|Overall Study|Withdrawal by Subject|1|||
130661524|NCT04822701|470384679|FG001|Overall Study|Withdrawal by Subject|0|||
130661525|NCT00391092|470386432|FG000|Overall Study|Death|78|||
130661526|NCT00391092|470386433|FG001|Overall Study|Death|81|||
130661527|NCT00391092|470386432|FG000|Overall Study|Lost to Follow-up|13|||
130661528|NCT00391092|470386433|FG001|Overall Study|Lost to Follow-up|18|||
130661529|NCT00391092|470386432|FG000|Overall Study|Alive on treatment|29|||
130661530|NCT00391092|470386433|FG001|Overall Study|Alive on treatment|33|||
130661531|NCT00391092|470386432|FG000|Overall Study|Alive in follow-up|88|||
130661532|NCT00391092|470386433|FG001|Overall Study|Alive in follow-up|84|||
130661533|NCT00303316|470386438|FG000|Overall Study|Protocol Violation|1|||
130661534|NCT00303316|470386439|FG001|Overall Study|Protocol Violation|0|||
130661535|NCT00303316|470386438|FG000|Overall Study|Lost to Follow-up|0|||
130661536|NCT00303316|470386439|FG001|Overall Study|Lost to Follow-up|1|||
130661537|NCT00303316|470386438|FG000|Overall Study|Withdrawal by Subject|1|||
130661538|NCT00303316|470386439|FG001|Overall Study|Withdrawal by Subject|2|||
130661539|NCT01726335|470386440|FG000|Overall Study|Lost to Follow-up|2|||
130661540|NCT01726335|470386440|FG000|Overall Study|Withdrawal by Subject|15|||
130661541|NCT01726335|470386440|FG000|Overall Study|Adverse Event|4|||
130661542|NCT01726335|470386440|FG000|Overall Study|Lost to Follow-up|2|||
130661543|NCT01726335|470386440|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
130661544|NCT01586624|470386441|FG000|Overall Study|Adverse Event|3|||
130661545|NCT01586624|470386442|FG001|Overall Study|Adverse Event|0|||
130661546|NCT01586624|470386443|FG002|Overall Study|Adverse Event|2|||
130661547|NCT01586624|470386444|FG003|Overall Study|Adverse Event|1|||
130661548|NCT01586624|470386445|FG004|Overall Study|Adverse Event|3|||
130661549|NCT01586624|470386446|FG005|Overall Study|Adverse Event|3|||
130661550|NCT01586624|470386447|FG006|Overall Study|Adverse Event|2|||
130661551|NCT01586624|470386448|FG007|Overall Study|Adverse Event|3|||
130661552|NCT01586624|470386441|FG000|Overall Study|Physician Decision|0|||
130661553|NCT01586624|470386442|FG001|Overall Study|Physician Decision|1|||
130661554|NCT01586624|470386443|FG002|Overall Study|Physician Decision|1|||
130661555|NCT01586624|470386444|FG003|Overall Study|Physician Decision|0|||
130661556|NCT01586624|470386445|FG004|Overall Study|Physician Decision|2|||
130661557|NCT01586624|470386446|FG005|Overall Study|Physician Decision|0|||
130661558|NCT01586624|470386447|FG006|Overall Study|Physician Decision|1|||
130661559|NCT01586624|470386448|FG007|Overall Study|Physician Decision|1|||
130661560|NCT01586624|470386441|FG000|Overall Study|Withdrawal by Subject|0|||
130661561|NCT01586624|470386442|FG001|Overall Study|Withdrawal by Subject|0|||
130661562|NCT01586624|470386443|FG002|Overall Study|Withdrawal by Subject|0|||
130661563|NCT01586624|470386444|FG003|Overall Study|Withdrawal by Subject|1|||
130661564|NCT01586624|470386445|FG004|Overall Study|Withdrawal by Subject|0|||
130661565|NCT01586624|470386446|FG005|Overall Study|Withdrawal by Subject|0|||
130661566|NCT01586624|470386447|FG006|Overall Study|Withdrawal by Subject|0|||
130661567|NCT01586624|470386448|FG007|Overall Study|Withdrawal by Subject|0|||
130661568|NCT01586624|470386441|FG000|Overall Study|Evidence of disease progression|1|||
130661569|NCT01586624|470386442|FG001|Overall Study|Evidence of disease progression|3|||
130661570|NCT01586624|470386443|FG002|Overall Study|Evidence of disease progression|2|||
130661571|NCT01586624|470386444|FG003|Overall Study|Evidence of disease progression|5|||
130661572|NCT01586624|470386445|FG004|Overall Study|Evidence of disease progression|3|||
130661573|NCT01586624|470386446|FG005|Overall Study|Evidence of disease progression|5|||
130661574|NCT01586624|470386447|FG006|Overall Study|Evidence of disease progression|4|||
130661575|NCT01586624|470386448|FG007|Overall Study|Evidence of disease progression|6|||
130661576|NCT01586624|470386441|FG000|Overall Study|Screen failure (no treatment received)|0|||
130661577|NCT01586624|470386442|FG001|Overall Study|Screen failure (no treatment received)|0|||
130661578|NCT01586624|470386443|FG002|Overall Study|Screen failure (no treatment received)|0|||
130661579|NCT01586624|470386444|FG003|Overall Study|Screen failure (no treatment received)|0|||
130661580|NCT01586624|470386445|FG004|Overall Study|Screen failure (no treatment received)|0|||
130661581|NCT01586624|470386446|FG005|Overall Study|Screen failure (no treatment received)|0|||
130661582|NCT01586624|470386447|FG006|Overall Study|Screen failure (no treatment received)|1|||
130661583|NCT01586624|470386448|FG007|Overall Study|Screen failure (no treatment received)|0|||
130661584|NCT01796860|470386455|FG000|Overall Study|Withdrawal by Subject|3|||
130661585|NCT02016755|470386459|FG000|Overall Study|Major amputation of index limb|2|||
130661586|NCT02016755|470386459|FG000|Overall Study|Adverse Event|2|||
130334352|NCT01088048|469193786|FG009|Overall Study|Investigator Request|0|||
130334353|NCT01088048|469193777|FG000|Overall Study|Patient Non-compliance|0|||
130334354|NCT01088048|469193778|FG001|Overall Study|Patient Non-compliance|1|||
130334355|NCT01088048|469193779|FG002|Overall Study|Patient Non-compliance|0|||
130334356|NCT01088048|469193780|FG003|Overall Study|Patient Non-compliance|0|||
130334357|NCT01088048|469193781|FG004|Overall Study|Patient Non-compliance|0|||
130334358|NCT01088048|469193782|FG005|Overall Study|Patient Non-compliance|0|||
130334359|NCT01088048|469193783|FG006|Overall Study|Patient Non-compliance|0|||
130334360|NCT01088048|469193784|FG007|Overall Study|Patient Non-compliance|0|||
130334361|NCT01088048|469193785|FG008|Overall Study|Patient Non-compliance|0|||
130334362|NCT01088048|469193786|FG009|Overall Study|Patient Non-compliance|0|||
130334363|NCT01088048|469193777|FG000|Overall Study|Disease Progression|7|||
130334364|NCT01088048|469193778|FG001|Overall Study|Disease Progression|4|||
130334365|NCT01088048|469193779|FG002|Overall Study|Disease Progression|3|||
130334366|NCT01088048|469193780|FG003|Overall Study|Disease Progression|5|||
130334367|NCT01088048|469193781|FG004|Overall Study|Disease Progression|3|||
130334368|NCT01088048|469193782|FG005|Overall Study|Disease Progression|3|||
130334369|NCT01088048|469193783|FG006|Overall Study|Disease Progression|2|||
130334370|NCT01088048|469193784|FG007|Overall Study|Disease Progression|1|||
130334371|NCT01088048|469193785|FG008|Overall Study|Disease Progression|0|||
130661587|NCT02016755|470386459|FG000|Overall Study|Physician Decision|1|||
130661588|NCT02016755|470386459|FG000|Overall Study|Death|2|||
130661589|NCT00414011|470386463|FG000|Overall Study|Physician Decision|3|||
130661590|NCT00414011|470386463|FG000|Overall Study|Withdrawal by Subject|2|||
130661591|NCT02476851|470386464|FG000|Overall Study|Protocol Violation|1|||
130661592|NCT02476851|470386465|FG001|Overall Study|Protocol Violation|1|||
130661593|NCT00306852|470386472|FG000|Overall Study|Death|14|||
130661594|NCT00306852|470386473|FG001|Overall Study|Death|14|||
130661595|NCT00306852|470386472|FG000|Overall Study|Lost to Follow-up|15|||
130661596|NCT00306852|470386473|FG001|Overall Study|Lost to Follow-up|24|||
130661597|NCT00883740|470386474|FG000|First Intervention|Lost to Follow-up|1|||
130661598|NCT00883740|470386475|FG001|First Intervention|Lost to Follow-up|0|||
130661599|NCT00883740|470386474|FG000|First Intervention|No longer willing to participate|2|||
130661600|NCT00883740|470386475|FG001|First Intervention|No longer willing to participate|0|||
130661601|NCT00883740|470386474|FG000|First Intervention|Protocol Violation|3|||
130661602|NCT00883740|470386475|FG001|First Intervention|Protocol Violation|6|||
130661603|NCT00883740|470386474|FG000|First Intervention|Adverse Event|1|||
130661604|NCT00883740|470386475|FG001|First Intervention|Adverse Event|2|||
130661605|NCT00883740|470386474|FG000|Second Intervention|Protocol Violation|1|||
130661606|NCT00883740|470386475|FG001|Second Intervention|Protocol Violation|0|||
130661607|NCT00883740|470386474|FG000|Second Intervention|No longer willing to participate|0|||
130661608|NCT00883740|470386475|FG001|Second Intervention|No longer willing to participate|1|||
130661609|NCT03869684|470386478|FG000|Overall Study|Adverse Event|0|||
130661610|NCT03869684|470386479|FG001|Overall Study|Adverse Event|3|||
130661611|NCT03869684|470386480|FG002|Overall Study|Adverse Event|1|||
130661612|NCT03869684|470386478|FG000|Overall Study|Withdrawal by Subject|1|||
130661613|NCT03869684|470386479|FG001|Overall Study|Withdrawal by Subject|0|||
130661614|NCT03869684|470386480|FG002|Overall Study|Withdrawal by Subject|0|||
130661615|NCT03869684|470386478|FG000|Overall Study|Lost to Follow-up|1|||
130661616|NCT03869684|470386479|FG001|Overall Study|Lost to Follow-up|0|||
130661617|NCT03869684|470386480|FG002|Overall Study|Lost to Follow-up|0|||
130661618|NCT03869684|470386478|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
130661619|NCT03869684|470386479|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
130661620|NCT03869684|470386480|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
130661621|NCT04056299|470386481|FG000|Overall Study|Sponsor discontinued study|3|||
130661622|NCT04056299|470386482|FG001|Overall Study|Sponsor discontinued study|3|||
130661623|NCT01414062|470386487|FG000|Overall Study|Lost to Follow-up|3|||
130661624|NCT01414062|470386488|FG001|Overall Study|Lost to Follow-up|2|||
130661625|NCT01414062|470386487|FG000|Overall Study|Left Country|1|||
130661626|NCT01414062|470386488|FG001|Overall Study|Left Country|1|||
130661627|NCT01414062|470386487|FG000|Overall Study|Family Disapproval|1|||
130661628|NCT01414062|470386488|FG001|Overall Study|Family Disapproval|0|||
130661629|NCT01414062|470386487|FG000|Overall Study|Withdrawal by Subject|0|||
130661630|NCT01414062|470386488|FG001|Overall Study|Withdrawal by Subject|1|||
130661631|NCT04285983|470386489|FG000|Overall Study|Protocol Violation|6|||
130661632|NCT04936334|470386490|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
130661633|NCT00422058|470386491|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
130661634|NCT00422058|470386492|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
130216122|NCT01826981|468753946|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
130661635|NCT00422058|470386493|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
130216123|NCT01826981|468753947|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
130334372|NCT01088048|469193786|FG009|Overall Study|Disease Progression|0|||
130334373|NCT01088048|469193777|FG000|Overall Study|Death|1|||
130334374|NCT01088048|469193778|FG001|Overall Study|Death|5|||
130334375|NCT01088048|469193779|FG002|Overall Study|Death|3|||
130334376|NCT01088048|469193780|FG003|Overall Study|Death|3|||
130334377|NCT01088048|469193781|FG004|Overall Study|Death|1|||
130661636|NCT00422058|470386494|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
130661637|NCT00422058|470386495|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
130661638|NCT00422058|470386496|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
130661639|NCT00422058|470386491|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
130661640|NCT00422058|470386492|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
130661641|NCT00422058|470386493|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
130661642|NCT00422058|470386494|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
130661643|NCT00422058|470386495|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
130661644|NCT00422058|470386496|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
130661645|NCT00422058|470386491|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
130661646|NCT00422058|470386492|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130661647|NCT00422058|470386493|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130661648|NCT00422058|470386494|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
130661649|NCT00422058|470386495|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
130661650|NCT00422058|470386496|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130661651|NCT00422058|470386491|FG000|Double-Blind, Week 0-20|Other|11|||
130661652|NCT00422058|470386492|FG001|Double-Blind, Week 0-20|Other|3|||
130661653|NCT00422058|470386493|FG002|Double-Blind, Week 0-20|Other|8|||
130661654|NCT00422058|470386494|FG003|Double-Blind, Week 0-20|Other|8|||
130661655|NCT00422058|470386495|FG004|Double-Blind, Week 0-20|Other|4|||
130661656|NCT00422058|470386496|FG005|Double-Blind, Week 0-20|Other|10|||
130661657|NCT00422058|470386491|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
130661658|NCT00422058|470386492|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
130661659|NCT00422058|470386493|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
130661660|NCT00422058|470386494|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
130661661|NCT00422058|470386495|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
130661662|NCT00422058|470386496|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
130661663|NCT00422058|470386491|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
130661664|NCT00422058|470386492|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
130661665|NCT00422058|470386493|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
130661666|NCT00422058|470386494|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
130661667|NCT00422058|470386495|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
130661668|NCT00422058|470386496|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
130661669|NCT00422058|470386491|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
130661670|NCT00422058|470386492|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
130661671|NCT00422058|470386493|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
130661672|NCT00422058|470386494|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
130661673|NCT00422058|470386495|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
130661674|NCT00422058|470386496|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
130661675|NCT00422058|470386491|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
130661676|NCT00422058|470386492|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
130661677|NCT00422058|470386493|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
130661678|NCT00422058|470386494|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
130661679|NCT00422058|470386495|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
130661680|NCT00422058|470386496|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
130661681|NCT00422058|470386491|FG000|Open-Label Extension, Week 20-104|Other|13|||
130661682|NCT00422058|470386492|FG001|Open-Label Extension, Week 20-104|Other|14|||
130661683|NCT00422058|470386493|FG002|Open-Label Extension, Week 20-104|Other|6|||
130661684|NCT00422058|470386494|FG003|Open-Label Extension, Week 20-104|Other|13|||
130661685|NCT00422058|470386495|FG004|Open-Label Extension, Week 20-104|Other|16|||
130661686|NCT00422058|470386496|FG005|Open-Label Extension, Week 20-104|Other|18|||
130661687|NCT01850108|470386501|FG000|Overall Study|Lost to Follow-up|4|||
130661688|NCT01850108|470386501|FG000|Overall Study|Not eligible|1|||
130661689|NCT01850108|470386501|FG000|Overall Study|Failed engraftment|2|||
130661690|NCT01850108|470386501|FG000|Overall Study|Physician Decision|1|||
130661691|NCT04330482|470386506|FG000|Overall Study|Lost to Follow-up|2|||
130661692|NCT04330482|470386507|FG001|Overall Study|Lost to Follow-up|1|||
130661693|NCT04330482|470386506|FG000|Overall Study|Withdrawal by Subject|0|||
130661694|NCT04330482|470386507|FG001|Overall Study|Withdrawal by Subject|3|||
130661695|NCT05144477|470386509|FG000|Overall Study|Withdrawal by Subject|1|||
130661696|NCT05144477|470386510|FG001|Overall Study|Withdrawal by Subject|1|||
130334378|NCT01088048|469193782|FG005|Overall Study|Death|3|||
130334379|NCT01088048|469193783|FG006|Overall Study|Death|0|||
130661697|NCT04333199|470386511|FG000|Evaluated Patients|Lost to Follow-up|0|||
130661698|NCT04333199|470386512|FG001|Evaluated Patients|Lost to Follow-up|1|||
130661699|NCT04333199|470386513|FG002|Evaluated Patients|Lost to Follow-up|2|||
130661700|NCT01155284|470386524|FG000|Overall Study|Withdrawal by Subject|4|||
130661701|NCT01155284|470386525|FG001|Overall Study|Withdrawal by Subject|3|||
130661702|NCT01155284|470386524|FG000|Overall Study|Lost to Follow-up|1|||
130661703|NCT01155284|470386525|FG001|Overall Study|Lost to Follow-up|2|||
130661704|NCT01155284|470386524|FG000|Overall Study|Physician Decision|1|||
130661705|NCT01155284|470386525|FG001|Overall Study|Physician Decision|0|||
130661706|NCT01155284|470386524|FG000|Overall Study|Adverse Event|1|||
130661707|NCT01155284|470386525|FG001|Overall Study|Adverse Event|0|||
130661708|NCT01289990|470386531|FG000|Overall Study|Death|0|||
130661709|NCT01289990|470386532|FG001|Overall Study|Death|0|||
130661710|NCT01289990|470386533|FG002|Overall Study|Death|0|||
130661711|NCT01289990|470386534|FG003|Overall Study|Death|1|||
130661712|NCT01289990|470386535|FG004|Overall Study|Death|2|||
130661713|NCT01289990|470386536|FG005|Overall Study|Death|1|||
130661714|NCT01289990|470386537|FG006|Overall Study|Death|0|||
130661715|NCT01289990|470386538|FG007|Overall Study|Death|0|||
130661716|NCT01289990|470386539|FG008|Overall Study|Death|0|||
130661717|NCT01289990|470386540|FG009|Overall Study|Death|0|||
130661718|NCT01289990|470386541|FG010|Overall Study|Death|0|||
130661719|NCT01289990|470386542|FG011|Overall Study|Death|1|||
130661720|NCT01289990|470386543|FG012|Overall Study|Death|0|||
130661721|NCT01289990|470386531|FG000|Overall Study|Lost to Follow-up|3|||
130661722|NCT01289990|470386532|FG001|Overall Study|Lost to Follow-up|2|||
130661723|NCT01289990|470386533|FG002|Overall Study|Lost to Follow-up|5|||
130661724|NCT01289990|470386534|FG003|Overall Study|Lost to Follow-up|5|||
130661725|NCT01289990|470386535|FG004|Overall Study|Lost to Follow-up|3|||
130661726|NCT01289990|470386536|FG005|Overall Study|Lost to Follow-up|4|||
130661727|NCT01289990|470386537|FG006|Overall Study|Lost to Follow-up|2|||
130661728|NCT01289990|470386538|FG007|Overall Study|Lost to Follow-up|2|||
130661729|NCT01289990|470386539|FG008|Overall Study|Lost to Follow-up|1|||
130661730|NCT01289990|470386540|FG009|Overall Study|Lost to Follow-up|4|||
130661731|NCT01289990|470386541|FG010|Overall Study|Lost to Follow-up|2|||
130661732|NCT01289990|470386542|FG011|Overall Study|Lost to Follow-up|1|||
130661733|NCT01289990|470386543|FG012|Overall Study|Lost to Follow-up|2|||
130661734|NCT01289990|470386531|FG000|Overall Study|Withdrawal by Subject|15|||
130661735|NCT01289990|470386532|FG001|Overall Study|Withdrawal by Subject|14|||
130661736|NCT01289990|470386533|FG002|Overall Study|Withdrawal by Subject|12|||
130661737|NCT01289990|470386534|FG003|Overall Study|Withdrawal by Subject|13|||
130661738|NCT01289990|470386535|FG004|Overall Study|Withdrawal by Subject|8|||
130661739|NCT01289990|470386536|FG005|Overall Study|Withdrawal by Subject|7|||
130661740|NCT01289990|470386537|FG006|Overall Study|Withdrawal by Subject|13|||
130661741|NCT01289990|470386538|FG007|Overall Study|Withdrawal by Subject|9|||
130661742|NCT01289990|470386539|FG008|Overall Study|Withdrawal by Subject|12|||
130661743|NCT01289990|470386540|FG009|Overall Study|Withdrawal by Subject|13|||
130661744|NCT01289990|470386541|FG010|Overall Study|Withdrawal by Subject|11|||
130661745|NCT01289990|470386542|FG011|Overall Study|Withdrawal by Subject|13|||
130661746|NCT01289990|470386543|FG012|Overall Study|Withdrawal by Subject|16|||
130661747|NCT01289990|470386531|FG000|Overall Study|discontinued in preceding trial|18|||
130661748|NCT01289990|470386532|FG001|Overall Study|discontinued in preceding trial|20|||
130661749|NCT01289990|470386533|FG002|Overall Study|discontinued in preceding trial|41|||
130661750|NCT01289990|470386534|FG003|Overall Study|discontinued in preceding trial|17|||
130661751|NCT01289990|470386535|FG004|Overall Study|discontinued in preceding trial|11|||
130661752|NCT01289990|470386536|FG005|Overall Study|discontinued in preceding trial|12|||
130661753|NCT01289990|470386537|FG006|Overall Study|discontinued in preceding trial|18|||
130661754|NCT01289990|470386538|FG007|Overall Study|discontinued in preceding trial|8|||
130661755|NCT01289990|470386539|FG008|Overall Study|discontinued in preceding trial|17|||
130661756|NCT01289990|470386540|FG009|Overall Study|discontinued in preceding trial|21|||
130661757|NCT01289990|470386541|FG010|Overall Study|discontinued in preceding trial|17|||
130661758|NCT01289990|470386542|FG011|Overall Study|discontinued in preceding trial|17|||
130661759|NCT01289990|470386543|FG012|Overall Study|discontinued in preceding trial|24|||
130661760|NCT01289990|470386531|FG000|Overall Study|did not continue in extension|41|||
130661761|NCT01289990|470386532|FG001|Overall Study|did not continue in extension|45|||
130661762|NCT01289990|470386533|FG002|Overall Study|did not continue in extension|51|||
130661763|NCT01289990|470386534|FG003|Overall Study|did not continue in extension|51|||
130334380|NCT01088048|469193784|FG007|Overall Study|Death|0|||
130334381|NCT01088048|469193785|FG008|Overall Study|Death|3|||
130334382|NCT01088048|469193786|FG009|Overall Study|Death|1|||
130334383|NCT01088048|469193777|FG000|Overall Study|Other|3|||
130334384|NCT01088048|469193778|FG001|Overall Study|Other|5|||
130334385|NCT01088048|469193779|FG002|Overall Study|Other|0|||
130334386|NCT01088048|469193780|FG003|Overall Study|Other|0|||
130334387|NCT01088048|469193781|FG004|Overall Study|Other|2|||
130334388|NCT01088048|469193782|FG005|Overall Study|Other|0|||
130661764|NCT01289990|470386535|FG004|Overall Study|did not continue in extension|48|||
130661765|NCT01289990|470386536|FG005|Overall Study|did not continue in extension|50|||
130661766|NCT01289990|470386537|FG006|Overall Study|did not continue in extension|54|||
130661767|NCT01289990|470386538|FG007|Overall Study|did not continue in extension|36|||
130334389|NCT01088048|469193783|FG006|Overall Study|Other|0|||
130334390|NCT01088048|469193784|FG007|Overall Study|Other|2|||
130334391|NCT01088048|469193785|FG008|Overall Study|Other|0|||
130661768|NCT01289990|470386539|FG008|Overall Study|did not continue in extension|44|||
130661769|NCT01289990|470386540|FG009|Overall Study|did not continue in extension|48|||
130334392|NCT01088048|469193786|FG009|Overall Study|Other|0|||
130334393|NCT02563067|469193788|FG000|Overall Study|Subject/guardian decision|14|||
130334394|NCT02563067|469193789|FG001|Overall Study|Subject/guardian decision|20|||
130334395|NCT02563067|469193790|FG002|Overall Study|Subject/guardian decision|16|||
130334396|NCT02563067|469193788|FG000|Overall Study|Physician Decision|0|||
130334397|NCT02563067|469193789|FG001|Overall Study|Physician Decision|1|||
130334398|NCT02563067|469193790|FG002|Overall Study|Physician Decision|3|||
130334399|NCT02563067|469193788|FG000|Overall Study|Lost to Follow-up|1|||
130334400|NCT02563067|469193789|FG001|Overall Study|Lost to Follow-up|2|||
130334401|NCT02563067|469193790|FG002|Overall Study|Lost to Follow-up|0|||
130552140|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
130552141|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
130552142|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
130552143|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
130552144|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
130552145|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
130552146|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
130552147|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
130552148|NCT03548987|469990124|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
130552149|NCT03548987|469990125|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
130552150|NCT00756470|469990127|FG000|Overall Study|Withdrawal by Subject|1|||
130552151|NCT00756470|469990127|FG000|Overall Study|Adverse Event|4|||
130552152|NCT00820027|469990128|FG000|Overall Study|Adverse Event|15|||
130552153|NCT00820027|469990129|FG001|Overall Study|Adverse Event|8|||
130552154|NCT00820027|469990130|FG002|Overall Study|Adverse Event|10|||
130552155|NCT00820027|469990131|FG003|Overall Study|Adverse Event|5|||
130552156|NCT00820027|469990128|FG000|Overall Study|Lack of Efficacy|2|||
130552157|NCT00820027|469990129|FG001|Overall Study|Lack of Efficacy|1|||
130552158|NCT00820027|469990130|FG002|Overall Study|Lack of Efficacy|2|||
130552159|NCT00820027|469990131|FG003|Overall Study|Lack of Efficacy|2|||
130552160|NCT00820027|469990128|FG000|Overall Study|Physician Decision|0|||
130552161|NCT00820027|469990129|FG001|Overall Study|Physician Decision|1|||
130552162|NCT00820027|469990130|FG002|Overall Study|Physician Decision|1|||
130552163|NCT00820027|469990131|FG003|Overall Study|Physician Decision|0|||
130552164|NCT00820027|469990128|FG000|Overall Study|Protocol Violation|3|||
130552165|NCT00820027|469990129|FG001|Overall Study|Protocol Violation|0|||
130552166|NCT00820027|469990130|FG002|Overall Study|Protocol Violation|4|||
130552167|NCT00820027|469990131|FG003|Overall Study|Protocol Violation|0|||
130552168|NCT00820027|469990128|FG000|Overall Study|Withdrawal by Subject|6|||
130552169|NCT00820027|469990129|FG001|Overall Study|Withdrawal by Subject|4|||
130552170|NCT00820027|469990130|FG002|Overall Study|Withdrawal by Subject|4|||
130552171|NCT00820027|469990131|FG003|Overall Study|Withdrawal by Subject|6|||
130552172|NCT03285178|469990132|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
130552173|NCT03285178|469990133|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552174|NCT03285178|469990134|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552175|NCT03285178|469990135|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552176|NCT03285178|469990136|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552177|NCT03285178|469990137|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552178|NCT03285178|469990138|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
130552179|NCT03285178|469990132|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
130552180|NCT03285178|469990133|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552181|NCT03285178|469990134|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552182|NCT03285178|469990135|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552183|NCT03285178|469990136|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552184|NCT03285178|469990137|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552185|NCT03285178|469990138|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
130552186|NCT03285178|469990132|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
130552187|NCT03285178|469990133|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
130552188|NCT03285178|469990134|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
130552189|NCT03285178|469990135|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
130552190|NCT03285178|469990136|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
130552191|NCT03285178|469990137|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
130552192|NCT03285178|469990138|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
130552193|NCT03285178|469990132|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
130552194|NCT03285178|469990133|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130552195|NCT03285178|469990134|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130552196|NCT03285178|469990135|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130334402|NCT02563067|469193788|FG000|Overall Study|Technical problems|0|||
130334403|NCT02563067|469193789|FG001|Overall Study|Technical problems|1|||
130661770|NCT01289990|470386541|FG010|Overall Study|did not continue in extension|45|||
130661771|NCT01289990|470386542|FG011|Overall Study|did not continue in extension|34|||
130661772|NCT01289990|470386543|FG012|Overall Study|did not continue in extension|56|||
130661773|NCT01289990|470386531|FG000|Overall Study|Not treated|0|||
130661774|NCT01289990|470386532|FG001|Overall Study|Not treated|0|||
130661775|NCT01289990|470386533|FG002|Overall Study|Not treated|0|||
130661776|NCT01289990|470386534|FG003|Overall Study|Not treated|0|||
130661777|NCT01289990|470386535|FG004|Overall Study|Not treated|0|||
130661778|NCT01289990|470386536|FG005|Overall Study|Not treated|0|||
130661779|NCT01289990|470386537|FG006|Overall Study|Not treated|1|||
130661780|NCT01289990|470386538|FG007|Overall Study|Not treated|0|||
130661781|NCT01289990|470386539|FG008|Overall Study|Not treated|1|||
130661782|NCT01289990|470386540|FG009|Overall Study|Not treated|0|||
130661783|NCT01289990|470386541|FG010|Overall Study|Not treated|1|||
130661784|NCT01289990|470386542|FG011|Overall Study|Not treated|2|||
130661785|NCT01289990|470386543|FG012|Overall Study|Not treated|0|||
130661786|NCT04529499|470386544|FG000|Overall Study|Withdrawal by Subject|9|||
130661787|NCT04529499|470386545|FG001|Overall Study|Withdrawal by Subject|11|||
130661788|NCT04529499|470386544|FG000|Overall Study|Physician Decision|1|||
130661789|NCT04529499|470386545|FG001|Overall Study|Physician Decision|2|||
130661790|NCT04529499|470386544|FG000|Overall Study|Adverse Event|4|||
130661791|NCT04529499|470386545|FG001|Overall Study|Adverse Event|4|||
130661792|NCT04529499|470386544|FG000|Overall Study|Death|14|||
130661793|NCT04529499|470386545|FG001|Overall Study|Death|11|||
130661794|NCT04529499|470386544|FG000|Overall Study|Lost to Follow-up|1|||
130661795|NCT04529499|470386545|FG001|Overall Study|Lost to Follow-up|1|||
130661796|NCT04529499|470386544|FG000|Overall Study|Others|7|||
130661797|NCT04529499|470386545|FG001|Overall Study|Others|11|||
130661798|NCT00683904|470386546|FG000|Dose Level 1|Disease progression|2|||
130661799|NCT00683904|470386547|FG001|Dose Level 1|Disease progression|0|||
130661800|NCT00683904|470386546|FG000|Dose Level 1|Adverse Event|1|||
130661801|NCT00683904|470386547|FG001|Dose Level 1|Adverse Event|0|||
130661802|NCT00683904|470386546|FG000|Dose Level 2|Adverse Event|0|||
130661803|NCT00683904|470386547|FG001|Dose Level 2|Adverse Event|2|||
130661804|NCT00758706|470386548|FG000|Overall Study|Adverse Event|4|||
130661805|NCT00758706|470386549|FG001|Overall Study|Adverse Event|4|||
130661806|NCT03611751|470386550|FG000|Pre-treatment|Randomized but not treated|1|||
130661807|NCT03611751|470386551|FG001|Pre-treatment|Randomized but not treated|1|||
130661808|NCT03611751|470386552|FG002|Pre-treatment|Randomized but not treated|0|||
130661809|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
130661810|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
130661811|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
130661812|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
130661813|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
130661814|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
130661815|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
130661816|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
130661817|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
130661818|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
130661819|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
130661820|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
130661821|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
130661822|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
130661823|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
130661824|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
130661825|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
130661826|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
130661827|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
130661828|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
130661829|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
130661830|NCT03611751|470386550|FG000|Treatment Week 0 - Week 16|Death|0|||
130661831|NCT03611751|470386551|FG001|Treatment Week 0 - Week 16|Death|0|||
130661832|NCT03611751|470386552|FG002|Treatment Week 0 - Week 16|Death|1|||
130661833|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
130661834|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
130661835|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
130661836|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
130661837|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130661838|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
130661839|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
130661840|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130661841|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130661842|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
130661843|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
130661844|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
130661845|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
130661846|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
130661847|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
130661848|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
130661849|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
130661850|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
130661851|NCT03611751|470386550|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
130661852|NCT03611751|470386551|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
130661853|NCT03611751|470386552|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
130661854|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
130661855|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
130661856|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
130661857|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
130661858|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
130661859|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130661860|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
130661861|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
130661862|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
130661863|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
130661864|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
130661865|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
130661866|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
130661867|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
130661868|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130661869|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
130661870|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
130661871|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
130661872|NCT03611751|470386550|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
130661873|NCT03611751|470386551|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
130661874|NCT03611751|470386552|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
130661875|NCT03467971|470386553|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130661876|NCT03467971|470386554|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130661877|NCT01488071|470386559|FG000|Overall Study|Adverse Event|15|||
130661878|NCT01488071|470386560|FG001|Overall Study|Adverse Event|23|||
130661879|NCT01488071|470386559|FG000|Overall Study|Lack of Efficacy|11|||
130661880|NCT01488071|470386560|FG001|Overall Study|Lack of Efficacy|17|||
130661881|NCT01488071|470386559|FG000|Overall Study|Non-compliance with study drug|2|||
130661882|NCT01488071|470386560|FG001|Overall Study|Non-compliance with study drug|0|||
130661883|NCT01488071|470386559|FG000|Overall Study|Protocol Violation|5|||
130661884|NCT01488071|470386560|FG001|Overall Study|Protocol Violation|7|||
130661885|NCT01488071|470386559|FG000|Overall Study|Withdrawal of Consent|14|||
130661886|NCT01488071|470386560|FG001|Overall Study|Withdrawal of Consent|12|||
130661887|NCT01488071|470386559|FG000|Overall Study|Lost to Follow-up|1|||
130661888|NCT01488071|470386560|FG001|Overall Study|Lost to Follow-up|0|||
130661889|NCT01488071|470386559|FG000|Overall Study|Administrative or Other Reason(s)|5|||
130661890|NCT01488071|470386560|FG001|Overall Study|Administrative or Other Reason(s)|4|||
130661891|NCT05789420|470386561|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
130661892|NCT05789420|470386561|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
130661893|NCT02587325|470386562|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
130661894|NCT02587325|470386563|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
130661895|NCT02587325|470386564|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
130661896|NCT02587325|470386565|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
130661897|NCT02587325|470386566|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
130661898|NCT02587325|470386562|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130661899|NCT02587325|470386563|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130661900|NCT02587325|470386564|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130661901|NCT02587325|470386565|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
130661902|NCT02587325|470386566|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130661903|NCT02587325|470386562|FG000|32-Week Optional Extension Part|Adverse Event|0|||
130661904|NCT02587325|470386563|FG001|32-Week Optional Extension Part|Adverse Event|0|||
130661905|NCT02587325|470386564|FG002|32-Week Optional Extension Part|Adverse Event|1|||
130661906|NCT02587325|470386565|FG003|32-Week Optional Extension Part|Adverse Event|0|||
130661907|NCT02587325|470386566|FG004|32-Week Optional Extension Part|Adverse Event|0|||
130661908|NCT02587325|470386562|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
130661909|NCT02587325|470386563|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
130661910|NCT02587325|470386564|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
130661911|NCT02587325|470386565|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
130661912|NCT02587325|470386566|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
130661913|NCT01220128|470386567|FG000|Overall Study|Progressive disease|0|||
130661914|NCT01220128|470386568|FG001|Overall Study|Progressive disease|0|||
130661915|NCT01220128|470386569|FG002|Overall Study|Progressive disease|2|||
130661916|NCT01220128|470386570|FG003|Overall Study|Progressive disease|0|||
130661917|NCT01220128|470386571|FG004|Overall Study|Progressive disease|0|||
130661918|NCT01220128|470386572|FG005|Overall Study|Progressive disease|0|||
130661919|NCT01220128|470386573|FG006|Overall Study|Progressive disease|0|||
130552197|NCT03285178|469990136|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130552198|NCT03285178|469990137|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130552199|NCT03285178|469990138|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
130552200|NCT03285178|469990132|FG000|Single-Blind Run-In Period|Physician Decision|2|||
130552201|NCT03285178|469990133|FG001|Single-Blind Run-In Period|Physician Decision|0|||
130552202|NCT03285178|469990134|FG002|Single-Blind Run-In Period|Physician Decision|0|||
130552203|NCT03285178|469990135|FG003|Single-Blind Run-In Period|Physician Decision|0|||
130552204|NCT03285178|469990136|FG004|Single-Blind Run-In Period|Physician Decision|0|||
130661920|NCT01220128|470386567|FG000|Overall Study|Sponsor study termination|0|||
130661921|NCT01220128|470386568|FG001|Overall Study|Sponsor study termination|1|||
130661922|NCT01220128|470386569|FG002|Overall Study|Sponsor study termination|0|||
130661923|NCT01220128|470386570|FG003|Overall Study|Sponsor study termination|0|||
130334404|NCT02563067|469193790|FG002|Overall Study|Technical problems|0|||
130334405|NCT02563067|469193788|FG000|Overall Study|Lack of Efficacy|1|||
130334406|NCT02563067|469193789|FG001|Overall Study|Lack of Efficacy|0|||
130334407|NCT02563067|469193790|FG002|Overall Study|Lack of Efficacy|0|||
130334408|NCT02563067|469193788|FG000|Overall Study|Death|0|||
130334409|NCT02563067|469193789|FG001|Overall Study|Death|1|||
130334410|NCT02563067|469193790|FG002|Overall Study|Death|1|||
130334411|NCT02563067|469193788|FG000|Overall Study|Adverse Event|2|||
130334412|NCT02563067|469193789|FG001|Overall Study|Adverse Event|1|||
130334413|NCT02563067|469193790|FG002|Overall Study|Adverse Event|0|||
130334414|NCT02563067|469193788|FG000|Overall Study|Death post Treatment/safety period|1|||
130334415|NCT02563067|469193789|FG001|Overall Study|Death post Treatment/safety period|0|||
130334416|NCT02563067|469193790|FG002|Overall Study|Death post Treatment/safety period|0|||
130334417|NCT03544333|469193800|FG000|Overall Study|Withdrawal by Subject|1|||
130334418|NCT03544333|469193801|FG001|Overall Study|Withdrawal by Subject|0|||
130334419|NCT01039519|469193805|FG000|Treatment|Progressive disease|20|||
130334420|NCT01039519|469193805|FG000|Treatment|Treatment failure|2|||
130334421|NCT01039519|469193805|FG000|Treatment|Adverse Event|3|||
130334422|NCT01039519|469193805|FG000|Treatment|Physician Decision|2|||
130334423|NCT01039519|469193805|FG000|Survival Follow-up|Death|23|||
130334424|NCT01039519|469193805|FG000|Survival Follow-up|Sponsor decision|4|||
130661924|NCT01220128|470386571|FG004|Overall Study|Sponsor study termination|0|||
130661925|NCT01220128|470386572|FG005|Overall Study|Sponsor study termination|0|||
130661926|NCT01220128|470386573|FG006|Overall Study|Sponsor study termination|1|||
130661927|NCT01220128|470386567|FG000|Overall Study|Adverse event, serious fatal|2|||
130661928|NCT01220128|470386568|FG001|Overall Study|Adverse event, serious fatal|0|||
130661929|NCT01220128|470386569|FG002|Overall Study|Adverse event, serious fatal|0|||
130661930|NCT01220128|470386570|FG003|Overall Study|Adverse event, serious fatal|0|||
130661931|NCT01220128|470386571|FG004|Overall Study|Adverse event, serious fatal|0|||
130661932|NCT01220128|470386572|FG005|Overall Study|Adverse event, serious fatal|0|||
130661933|NCT01220128|470386573|FG006|Overall Study|Adverse event, serious fatal|1|||
130661934|NCT01220128|470386567|FG000|Overall Study|Adverse event, non-fatal|1|||
130661935|NCT01220128|470386568|FG001|Overall Study|Adverse event, non-fatal|0|||
130661936|NCT01220128|470386569|FG002|Overall Study|Adverse event, non-fatal|0|||
130661937|NCT01220128|470386570|FG003|Overall Study|Adverse event, non-fatal|0|||
130661938|NCT01220128|470386571|FG004|Overall Study|Adverse event, non-fatal|0|||
130661939|NCT01220128|470386572|FG005|Overall Study|Adverse event, non-fatal|0|||
130661940|NCT01220128|470386573|FG006|Overall Study|Adverse event, non-fatal|3|||
130661941|NCT01220128|470386567|FG000|Overall Study|Other|0|||
130661942|NCT01220128|470386568|FG001|Overall Study|Other|0|||
130661943|NCT01220128|470386569|FG002|Overall Study|Other|1|||
130661944|NCT01220128|470386570|FG003|Overall Study|Other|0|||
130661945|NCT01220128|470386571|FG004|Overall Study|Other|0|||
130661946|NCT01220128|470386572|FG005|Overall Study|Other|0|||
130661947|NCT01220128|470386573|FG006|Overall Study|Other|0|||
130661948|NCT01220128|470386567|FG000|Overall Study|Consent withdrawn by subject|1|||
130661949|NCT01220128|470386568|FG001|Overall Study|Consent withdrawn by subject|0|||
130661950|NCT01220128|470386569|FG002|Overall Study|Consent withdrawn by subject|0|||
130661951|NCT01220128|470386570|FG003|Overall Study|Consent withdrawn by subject|0|||
130661952|NCT01220128|470386571|FG004|Overall Study|Consent withdrawn by subject|0|||
130334425|NCT01330108|469193808|FG000|Overall Study|Withdrawal by Subject|4|||
130334426|NCT00485134|469193809|FG000|Overall Study|Lost to Follow-up|1|||
130334427|NCT00485134|469193810|FG001|Overall Study|Lost to Follow-up|0|||
130334428|NCT00485134|469193811|FG002|Overall Study|Lost to Follow-up|0|||
130334429|NCT00485134|469193812|FG003|Overall Study|Lost to Follow-up|0|||
130661953|NCT01220128|470386572|FG005|Overall Study|Consent withdrawn by subject|0|||
130661954|NCT01220128|470386573|FG006|Overall Study|Consent withdrawn by subject|0|||
130661955|NCT03302299|470388461|FG000|Overall Study|Protocol Violation|1|||
130661956|NCT02239692|470388462|FG000|Overall Study|Incomplete colonoscopy|1|||
130661957|NCT02239692|470388463|FG001|Overall Study|Incomplete colonoscopy|2|||
130552205|NCT03285178|469990137|FG005|Single-Blind Run-In Period|Physician Decision|0|||
130334430|NCT00485134|469193813|FG004|Overall Study|Lost to Follow-up|0|||
130334431|NCT00485134|469193814|FG005|Overall Study|Lost to Follow-up|0|||
130334432|NCT00485134|469193815|FG006|Overall Study|Lost to Follow-up|0|||
130661958|NCT02239692|470388462|FG000|Overall Study|Adverse Event|0|||
130661959|NCT02239692|470388463|FG001|Overall Study|Adverse Event|1|||
130661960|NCT02239692|470388462|FG000|Overall Study|Physician Decision|0|||
130661961|NCT02239692|470388463|FG001|Overall Study|Physician Decision|1|||
130661962|NCT02239692|470388462|FG000|Overall Study|Lost to Follow-up|1|||
130661963|NCT02239692|470388463|FG001|Overall Study|Lost to Follow-up|4|||
130661964|NCT02239692|470388462|FG000|Overall Study|Withdrawal by Subject|3|||
130661965|NCT02239692|470388463|FG001|Overall Study|Withdrawal by Subject|5|||
130661966|NCT02239692|470388462|FG000|Overall Study|Other reason|1|||
130661967|NCT02239692|470388463|FG001|Overall Study|Other reason|0|||
130661968|NCT04318535|470388464|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
130661969|NCT04318535|470388465|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
130661970|NCT04318535|470388466|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
130661971|NCT01901146|470388468|FG000|Neoadjuvant Phase|Death|1|||
130661972|NCT01901146|470388469|FG001|Neoadjuvant Phase|Death|2|||
130661973|NCT01901146|470388470|FG002|Neoadjuvant Phase|Death|0|||
130661974|NCT01901146|470388471|FG003|Neoadjuvant Phase|Death|0|||
130661975|NCT01901146|470388472|FG004|Neoadjuvant Phase|Death|0|||
130661976|NCT01901146|470388468|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
130661977|NCT01901146|470388469|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
130661978|NCT01901146|470388470|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130661979|NCT01901146|470388471|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130661980|NCT01901146|470388472|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130661981|NCT01901146|470388468|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
130661982|NCT01901146|470388469|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
130661983|NCT01901146|470388470|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
130661984|NCT01901146|470388471|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
130661985|NCT01901146|470388472|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
130661986|NCT01901146|470388468|FG000|Neoadjuvant Phase|Physician Decision|1|||
130661987|NCT01901146|470388469|FG001|Neoadjuvant Phase|Physician Decision|2|||
130661988|NCT01901146|470388470|FG002|Neoadjuvant Phase|Physician Decision|0|||
130661989|NCT01901146|470388471|FG003|Neoadjuvant Phase|Physician Decision|0|||
130661990|NCT01901146|470388472|FG004|Neoadjuvant Phase|Physician Decision|0|||
130661991|NCT01901146|470388468|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
130661992|NCT01901146|470388469|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
130661993|NCT01901146|470388470|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
130661994|NCT01901146|470388471|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
130661995|NCT01901146|470388472|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
130661996|NCT01901146|470388468|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130661997|NCT01901146|470388469|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
130661998|NCT01901146|470388470|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130661999|NCT01901146|470388471|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130662000|NCT01901146|470388472|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130662001|NCT01901146|470388468|FG000|Adjuvant Phase|Other|0|||
130662002|NCT01901146|470388469|FG001|Adjuvant Phase|Other|0|||
130662003|NCT01901146|470388470|FG002|Adjuvant Phase|Other|1|||
130662004|NCT01901146|470388471|FG003|Adjuvant Phase|Other|0|||
130662005|NCT01901146|470388472|FG004|Adjuvant Phase|Other|0|||
130662006|NCT01901146|470388468|FG000|Adjuvant Phase|Death|0|||
130662007|NCT01901146|470388469|FG001|Adjuvant Phase|Death|0|||
130662008|NCT01901146|470388470|FG002|Adjuvant Phase|Death|0|||
130662009|NCT01901146|470388471|FG003|Adjuvant Phase|Death|0|||
130662010|NCT01901146|470388472|FG004|Adjuvant Phase|Death|3|||
130662011|NCT01901146|470388468|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
130662012|NCT01901146|470388469|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
130662013|NCT01901146|470388470|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
130662014|NCT01901146|470388471|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
130662015|NCT01901146|470388472|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
130662016|NCT01901146|470388468|FG000|Adjuvant Phase|Physician Decision|0|||
130662017|NCT01901146|470388469|FG001|Adjuvant Phase|Physician Decision|0|||
130662018|NCT01901146|470388470|FG002|Adjuvant Phase|Physician Decision|9|||
130662019|NCT01901146|470388471|FG003|Adjuvant Phase|Physician Decision|2|||
130662020|NCT01901146|470388472|FG004|Adjuvant Phase|Physician Decision|4|||
130662021|NCT01901146|470388468|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
130662022|NCT01901146|470388469|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
130662023|NCT01901146|470388470|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
130662024|NCT01901146|470388471|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
130662025|NCT01901146|470388472|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
130662026|NCT01614925|470388473|FG000|Overall Study|Withdrawal by Subject|1|||
130662027|NCT01614925|470388474|FG001|Overall Study|Withdrawal by Subject|0|||
130662028|NCT01614925|470388473|FG000|Overall Study|Protocol Violation|3|||
130662029|NCT01614925|470388474|FG001|Overall Study|Protocol Violation|2|||
130662030|NCT02996448|470388475|FG000|Overall Study|Study terminated due to adverse effects|3|||
130662031|NCT01160198|470388476|FG000|Overall Study|Withdrawal by Subject|2|||
130662032|NCT01160198|470388477|FG001|Overall Study|Withdrawal by Subject|1|||
130334433|NCT00485134|469193816|FG007|Overall Study|Lost to Follow-up|0|||
130662033|NCT01160198|470388478|FG002|Overall Study|Withdrawal by Subject|0|||
130662034|NCT01160198|470388476|FG000|Overall Study|Adverse Event|0|||
130662035|NCT01160198|470388477|FG001|Overall Study|Adverse Event|1|||
130662036|NCT01160198|470388478|FG002|Overall Study|Adverse Event|0|||
130662037|NCT01160198|470388476|FG000|Overall Study|Lost to Follow-up|0|||
130662038|NCT01160198|470388477|FG001|Overall Study|Lost to Follow-up|1|||
130662039|NCT01160198|470388478|FG002|Overall Study|Lost to Follow-up|0|||
130662040|NCT01160198|470388476|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
130662041|NCT01160198|470388477|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
130662042|NCT01160198|470388478|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
130662043|NCT03343054|470388480|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
130662044|NCT03343054|470388481|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
130662045|NCT03343054|470388482|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
130662046|NCT03343054|470388480|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
130662047|NCT03343054|470388481|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
130662048|NCT03343054|470388482|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
130662049|NCT03343054|470388480|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
130662050|NCT03343054|470388481|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
130662051|NCT03343054|470388482|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
130662052|NCT03343054|470388480|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
130662053|NCT03343054|470388481|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
130662054|NCT03343054|470388482|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
130662055|NCT01467570|470388483|FG000|Overall Study|Lost to Follow-up|8|||
130662056|NCT01467570|470388484|FG001|Overall Study|Lost to Follow-up|9|||
130662057|NCT02626182|470388485|FG000|Overall Study|Adverse Event|2|||
130662058|NCT02626182|470388486|FG001|Overall Study|Adverse Event|0|||
130662059|NCT03555890|470388491|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130662060|NCT03555890|470388492|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130662061|NCT03555890|470388493|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130662062|NCT03555890|470388494|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130662063|NCT03372369|470388495|FG000|Qualification Period|Withdrawal by Subject|16|||
130662064|NCT03372369|470388496|FG001|Qualification Period|Withdrawal by Subject|13|||
130662065|NCT03372369|470388495|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
130662066|NCT03372369|470388496|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
130662067|NCT03372369|470388495|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
130662068|NCT03372369|470388496|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
130662069|NCT01392170|470388497|FG000|Overall Study|Withdrawal by Subject|1|||
130662070|NCT01392170|470388497|FG000|Overall Study|Ineligible|1|||
130662071|NCT03174925|470388508|FG000|Overall Study|Elastographic images not retrievable|2|||
130662072|NCT03174925|470388508|FG000|Overall Study|Elastography image not interpretable|1|||
130662073|NCT01791127|470388509|FG000|Overall Study|Death|356|||
130662074|NCT01791127|470388509|FG000|Overall Study|Patient has withdrawn from study|293|||
130662075|NCT01791127|470388509|FG000|Overall Study|Lost to Follow-up|42|||
130662076|NCT01791127|470388509|FG000|Overall Study|All Siello leads are explanted|31|||
130662077|NCT01791127|470388509|FG000|Overall Study|Completion of 30 day safety registry|1|||
130662078|NCT01791127|470388509|FG000|Overall Study|Study terminated for EP Passion|749|||
130662079|NCT04247594|470388512|FG000|Overall Study|Withdrawal by Subject|4|||
130662080|NCT02748616|470388518|FG000|Overall Study|Lost to Follow-up|1|||
130662081|NCT02748616|470388518|FG000|Overall Study|Withdrawal by Subject|2|||
130662082|NCT02748616|470388518|FG000|Overall Study|Physician Decision|2|||
130662083|NCT02748616|470388518|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
130662084|NCT00589693|470388520|FG000|Overall Study|randomized in error|12|||
130662085|NCT00589693|470388521|FG001|Overall Study|randomized in error|6|||
130662086|NCT00589693|470388520|FG000|Overall Study|Adverse Event|4|||
130662087|NCT00589693|470388521|FG001|Overall Study|Adverse Event|4|||
130662088|NCT00589693|470388520|FG000|Overall Study|Death|26|||
130662089|NCT00589693|470388521|FG001|Overall Study|Death|16|||
130662090|NCT00589693|470388520|FG000|Overall Study|Lack of Efficacy|0|||
130662091|NCT00589693|470388521|FG001|Overall Study|Lack of Efficacy|1|||
130662092|NCT00589693|470388520|FG000|Overall Study|Lost to Follow-up|1|||
130662093|NCT00589693|470388521|FG001|Overall Study|Lost to Follow-up|0|||
130662094|NCT00589693|470388520|FG000|Overall Study|Physician Decision|0|||
130662095|NCT00589693|470388521|FG001|Overall Study|Physician Decision|1|||
130662096|NCT00589693|470388520|FG000|Overall Study|Protocol Violation|1|||
130662097|NCT00589693|470388521|FG001|Overall Study|Protocol Violation|1|||
130662098|NCT03231709|470388522|FG000|Treatment Period 1|Reason not Specified|0|||
130662099|NCT03231709|470388523|FG001|Treatment Period 1|Reason not Specified|1|||
130334434|NCT00485134|469193809|FG000|Overall Study|Withdrawal by Subject|0|||
130662100|NCT03231709|470388522|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
130662101|NCT03231709|470388523|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
130662102|NCT04057118|470388524|FG000|Overall Study|Adverse Event|1|||
130334435|NCT00485134|469193810|FG001|Overall Study|Withdrawal by Subject|1|||
130662103|NCT04057118|470388525|FG001|Overall Study|Adverse Event|0|||
130662104|NCT04057118|470388526|FG002|Overall Study|Adverse Event|1|||
130662105|NCT04057118|470388527|FG003|Overall Study|Adverse Event|1|||
130662106|NCT04057118|470388524|FG000|Overall Study|Physician Decision|0|||
130662107|NCT04057118|470388525|FG001|Overall Study|Physician Decision|0|||
130662108|NCT04057118|470388526|FG002|Overall Study|Physician Decision|1|||
130662109|NCT04057118|470388527|FG003|Overall Study|Physician Decision|1|||
130662110|NCT04057118|470388524|FG000|Overall Study|Withdrawal by Subject|2|||
130662111|NCT04057118|470388525|FG001|Overall Study|Withdrawal by Subject|2|||
130662112|NCT04057118|470388526|FG002|Overall Study|Withdrawal by Subject|0|||
130662113|NCT04057118|470388527|FG003|Overall Study|Withdrawal by Subject|2|||
130662114|NCT04057118|470388524|FG000|Overall Study|Not Specific|0|||
130662115|NCT04057118|470388525|FG001|Overall Study|Not Specific|0|||
130662116|NCT04057118|470388526|FG002|Overall Study|Not Specific|1|||
130662117|NCT04057118|470388527|FG003|Overall Study|Not Specific|1|||
130662118|NCT03273712|470388528|FG000|Overall Study|Death|5|||
130662119|NCT03273712|470388528|FG000|Overall Study|Adverse Event|1|||
130662120|NCT03273712|470388528|FG000|Overall Study|Disease Progression|1|||
130662121|NCT03959137|470388531|FG000|Overall Study|Protocol Violation|6|||
130662122|NCT00190684|470388532|FG000|Overall Study|Adverse Event|86|||
130662123|NCT00190684|470388532|FG000|Overall Study|Satisfactory response|80|||
130662124|NCT00190684|470388532|FG000|Overall Study|Lack of efficacy|204|||
130662125|NCT00190684|470388532|FG000|Overall Study|Lost to Follow-up|232|||
130662126|NCT00190684|470388532|FG000|Overall Study|Patient moved|60|||
130662127|NCT00190684|470388532|FG000|Overall Study|Patient Decision|432|||
130662128|NCT00190684|470388532|FG000|Overall Study|Clinical relapse|67|||
130662129|NCT00190684|470388532|FG000|Overall Study|Sponsor's decision|17|||
130662130|NCT00190684|470388532|FG000|Overall Study|Physician Decision|84|||
130662131|NCT00190684|470388532|FG000|Overall Study|Protocol Violation|123|||
130662132|NCT00190684|470388532|FG000|Overall Study|Study Period III Completed|103|||
130662133|NCT00190684|470388532|FG000|Overall Study|Study Period V Completed|1|||
130662134|NCT00995488|470388538|FG000|Overall Study|Withdrawal by Subject|1|||
130662135|NCT02702271|470388539|FG000|Overall Study|Death|36|||
130662136|NCT02702271|470388540|FG001|Overall Study|Death|7|||
130662137|NCT02702271|470388539|FG000|Overall Study|Lost to Follow-up|12|||
130662138|NCT02702271|470388540|FG001|Overall Study|Lost to Follow-up|0|||
130662139|NCT02702271|470388539|FG000|Overall Study|Withdrawal by Subject|8|||
130662140|NCT02702271|470388540|FG001|Overall Study|Withdrawal by Subject|1|||
130662141|NCT02702271|470388539|FG000|Overall Study|Physician Decision|2|||
130662142|NCT02702271|470388540|FG001|Overall Study|Physician Decision|0|||
130662143|NCT02702271|470388539|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
130662144|NCT02702271|470388540|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
130662145|NCT01494649|470388541|FG000|Overall Study|Lost to Follow-up|0|||
130662146|NCT01494649|470388542|FG001|Overall Study|Lost to Follow-up|1|||
130662147|NCT01174368|470388543|FG000|Overall Study|Withdrawal by Subject|1|||
130662148|NCT05166512|470388546|FG000|Randomized|Lost to Follow-up|2|||
130662149|NCT05166512|470388547|FG001|Randomized|Lost to Follow-up|0|||
130662150|NCT05166512|470388546|FG000|Randomized|Withdrawal by Subject|1|||
130662151|NCT05166512|470388547|FG001|Randomized|Withdrawal by Subject|0|||
130662152|NCT05166512|470388546|FG000|Baseline Data Collection|Lost to Follow-up|0|||
130662153|NCT05166512|470388547|FG001|Baseline Data Collection|Lost to Follow-up|3|||
130662154|NCT05166512|470388546|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
130662155|NCT05166512|470388547|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
130662156|NCT05166512|470388546|FG000|Baseline Data Collection|Protocol Violation|2|||
130662157|NCT05166512|470388547|FG001|Baseline Data Collection|Protocol Violation|0|||
130662158|NCT05166512|470388546|FG000|4 Month Data Collection|Lost to Follow-up|1|||
130662159|NCT05166512|470388547|FG001|4 Month Data Collection|Lost to Follow-up|0|||
130662160|NCT05166512|470388546|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
130662161|NCT05166512|470388547|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
130662162|NCT05166512|470388546|FG000|12 Month Data Collection|Lost to Follow-up|3|||
130662163|NCT05166512|470388547|FG001|12 Month Data Collection|Lost to Follow-up|1|||
130662164|NCT05166512|470388546|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
130662165|NCT05166512|470388547|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
130662166|NCT02139306|470388548|FG000|Overall Study|Withdrawal by Subject|4|||
130662167|NCT02139306|470388549|FG001|Overall Study|Withdrawal by Subject|6|||
130662168|NCT02139306|470388548|FG000|Overall Study|Adverse Event|3|||
130662169|NCT02139306|470388549|FG001|Overall Study|Adverse Event|4|||
130662170|NCT02139306|470388548|FG000|Overall Study|Physician Decision|0|||
130662171|NCT02139306|470388549|FG001|Overall Study|Physician Decision|1|||
130662172|NCT02139306|470388548|FG000|Overall Study|Other Unspecified|2|||
130662173|NCT02139306|470388549|FG001|Overall Study|Other Unspecified|3|||
130662174|NCT02139306|470388548|FG000|Overall Study|Protocol Violation|4|||
130662175|NCT02139306|470388549|FG001|Overall Study|Protocol Violation|0|||
130662176|NCT04449354|470388550|FG000|Overall Study|Withdrawal by Subject|1|||
130662177|NCT02913261|470388551|FG000|Overall Study|Technical problems|0|||
130662178|NCT02913261|470388552|FG001|Overall Study|Technical problems|1|||
130662179|NCT02913261|470388551|FG000|Overall Study|Lack of Efficacy|32|||
130662180|NCT02913261|470388552|FG001|Overall Study|Lack of Efficacy|69|||
130662181|NCT02913261|470388551|FG000|Overall Study|Adverse Event|27|||
130662182|NCT02913261|470388552|FG001|Overall Study|Adverse Event|5|||
130662183|NCT02913261|470388551|FG000|Overall Study|Death|25|||
130662184|NCT02913261|470388552|FG001|Overall Study|Death|22|||
130662185|NCT02913261|470388551|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
130662186|NCT02913261|470388552|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
130662187|NCT02913261|470388551|FG000|Overall Study|Disease relapse|8|||
130662188|NCT02913261|470388552|FG001|Overall Study|Disease relapse|13|||
130662189|NCT02913261|470388551|FG000|Overall Study|Physician Decision|8|||
130662190|NCT02913261|470388552|FG001|Overall Study|Physician Decision|9|||
130662191|NCT02913261|470388551|FG000|Overall Study|Subject/guardian decision|4|||
130662192|NCT02913261|470388552|FG001|Overall Study|Subject/guardian decision|6|||
130662193|NCT02913261|470388551|FG000|Overall Study|Graft loss|2|||
130662194|NCT02913261|470388552|FG001|Overall Study|Graft loss|0|||
130662195|NCT00000135|470388575|FG000|Overall Study|Death|27|||
130662196|NCT00000135|470388576|FG001|Overall Study|Death|14|||
130662197|NCT02340078|470388577|FG000|Overall Study|Protocol Violation|1|||
130662198|NCT01831596|470388578|FG000|Overall Study|Other|8|||
130662199|NCT01311505|470388579|FG000|First Intervention Period|Protocol Violation|0|||
130662200|NCT01311505|470388580|FG001|First Intervention Period|Protocol Violation|1|||
130662201|NCT00567996|470388584|FG000|Overall Study|Adverse Event|18|||
130662202|NCT00567996|470388585|FG001|Overall Study|Adverse Event|16|||
130662203|NCT00567996|470388586|FG002|Overall Study|Adverse Event|13|||
130662204|NCT00567996|470388584|FG000|Overall Study|Protocol Deviation|9|||
130662205|NCT00567996|470388585|FG001|Overall Study|Protocol Deviation|11|||
130662206|NCT00567996|470388586|FG002|Overall Study|Protocol Deviation|13|||
130662207|NCT00567996|470388584|FG000|Overall Study|Withdrawal by Subject|8|||
130662208|NCT00567996|470388585|FG001|Overall Study|Withdrawal by Subject|12|||
130662209|NCT00567996|470388586|FG002|Overall Study|Withdrawal by Subject|22|||
130662210|NCT00567996|470388584|FG000|Overall Study|Abnormal Lab value(s)|2|||
130662211|NCT00567996|470388585|FG001|Overall Study|Abnormal Lab value(s)|1|||
130662212|NCT00567996|470388586|FG002|Overall Study|Abnormal Lab value(s)|2|||
130662213|NCT00567996|470388584|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130662214|NCT00567996|470388585|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130662215|NCT00567996|470388586|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130662216|NCT00567996|470388584|FG000|Overall Study|Lost to Follow-up|2|||
130662217|NCT00567996|470388585|FG001|Overall Study|Lost to Follow-up|5|||
130662218|NCT00567996|470388586|FG002|Overall Study|Lost to Follow-up|2|||
130662219|NCT00567996|470388584|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130662220|NCT00567996|470388585|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130662221|NCT00567996|470388586|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
130662222|NCT00567996|470388584|FG000|Overall Study|Administrative problems|1|||
130662223|NCT00567996|470388585|FG001|Overall Study|Administrative problems|1|||
130662224|NCT00567996|470388586|FG002|Overall Study|Administrative problems|0|||
130662225|NCT00567996|470388584|FG000|Overall Study|Death|1|||
130662226|NCT00567996|470388585|FG001|Overall Study|Death|0|||
130662227|NCT00567996|470388586|FG002|Overall Study|Death|2|||
130662228|NCT00567996|470388584|FG000|Overall Study|Patient's inability to use the device|0|||
130662229|NCT00567996|470388585|FG001|Overall Study|Patient's inability to use the device|1|||
130662230|NCT00567996|470388586|FG002|Overall Study|Patient's inability to use the device|0|||
130662231|NCT02956005|470388587|FG000|Overall Study|Not eligible|1|||
130662232|NCT02956005|470388587|FG000|Overall Study|Withdrawal by Subject|3|||
130662233|NCT02956005|470388587|FG000|Overall Study|Physician Decision|12|||
130662234|NCT02524665|470388590|FG000|Overall Study|Lost to Follow-up|1|||
130662235|NCT02602080|470388591|FG000|Overall Study|Protocol Violation|6|||
130662236|NCT02602080|470388592|FG001|Overall Study|Protocol Violation|1|||
130662237|NCT02602080|470388593|FG002|Overall Study|Protocol Violation|3|||
130662238|NCT03022799|470388596|FG000|Overall Study|Adverse Event|0|||
130662239|NCT03022799|470388597|FG001|Overall Study|Adverse Event|0|||
130662240|NCT03022799|470388598|FG002|Overall Study|Adverse Event|0|||
130662241|NCT03022799|470388599|FG003|Overall Study|Adverse Event|0|||
130662242|NCT03022799|470388600|FG004|Overall Study|Adverse Event|0|||
130662243|NCT03022799|470388601|FG005|Overall Study|Adverse Event|0|||
130662244|NCT03022799|470388602|FG006|Overall Study|Adverse Event|0|||
130662245|NCT03022799|470388603|FG007|Overall Study|Adverse Event|0|||
130662246|NCT03022799|470388604|FG008|Overall Study|Adverse Event|0|||
130662247|NCT03022799|470388605|FG009|Overall Study|Adverse Event|1|||
130662248|NCT03022799|470388606|FG010|Overall Study|Adverse Event|1|||
130662249|NCT03022799|470388607|FG011|Overall Study|Adverse Event|0|||
130662250|NCT03022799|470388608|FG012|Overall Study|Adverse Event|0|||
130662251|NCT00883129|470388612|FG000|Overall Study|Adverse Event|7|||
130662252|NCT00883129|470388613|FG001|Overall Study|Adverse Event|15|||
130662253|NCT00883129|470388612|FG000|Overall Study|Withdrawal by Subject|8|||
130662254|NCT00883129|470388613|FG001|Overall Study|Withdrawal by Subject|9|||
130662255|NCT00883129|470388612|FG000|Overall Study|Non-compliance|3|||
130662256|NCT00883129|470388613|FG001|Overall Study|Non-compliance|6|||
130662257|NCT00883129|470388612|FG000|Overall Study|Lost to Follow-up|1|||
130662258|NCT00883129|470388613|FG001|Overall Study|Lost to Follow-up|2|||
130662259|NCT00883129|470388612|FG000|Overall Study|Death|1|||
130662260|NCT00883129|470388613|FG001|Overall Study|Death|2|||
130662261|NCT00883129|470388612|FG000|Overall Study|Defined Treatment Failure|0|||
130662262|NCT00883129|470388613|FG001|Overall Study|Defined Treatment Failure|2|||
130662263|NCT03273257|470388614|FG000|Overall Study|Death|0|||
130662264|NCT03273257|470388615|FG001|Overall Study|Death|1|||
130662265|NCT03273257|470388614|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
130662266|NCT03273257|470388615|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
130662267|NCT03273257|470388614|FG000|Overall Study|Study terminated|3|||
130662268|NCT03273257|470388615|FG001|Overall Study|Study terminated|2|||
130662269|NCT04355767|470388617|FG000|Overall Study|Withdrawal by Subject|2|||
130662270|NCT04355767|470388618|FG001|Overall Study|Withdrawal by Subject|2|||
130662271|NCT04355767|470388617|FG000|Overall Study|Death|5|||
130662272|NCT04355767|470388618|FG001|Overall Study|Death|1|||
130662273|NCT01185639|470388619|FG000|Overall Study|Progressed and didn't receive therapy|2|||
130662274|NCT01999322|470388620|FG000|Overall Study|Adverse Event|1|||
130662275|NCT01999322|470388621|FG001|Overall Study|Adverse Event|0|||
130662276|NCT02200614|470388622|FG000|Double Blind Treatment|Adverse Event|86|||
130662277|NCT02200614|470388623|FG001|Double Blind Treatment|Adverse Event|48|||
130662278|NCT02200614|470388622|FG000|Double Blind Treatment|Confirmed metastasis|120|||
130662279|NCT02200614|470388623|FG001|Double Blind Treatment|Confirmed metastasis|140|||
130662280|NCT02200614|470388622|FG000|Double Blind Treatment|Judgment of the investigator|59|||
130662281|NCT02200614|470388623|FG001|Double Blind Treatment|Judgment of the investigator|99|||
130662282|NCT02200614|470388622|FG000|Double Blind Treatment|Metastasis by local reading|1|||
130662283|NCT02200614|470388623|FG001|Double Blind Treatment|Metastasis by local reading|3|||
130662284|NCT02200614|470388622|FG000|Double Blind Treatment|Other reason|6|||
130662285|NCT02200614|470388623|FG001|Double Blind Treatment|Other reason|2|||
130662286|NCT02200614|470388622|FG000|Double Blind Treatment|Personal reason|77|||
130662287|NCT02200614|470388623|FG001|Double Blind Treatment|Personal reason|85|||
130662288|NCT02200614|470388622|FG000|Double Blind Treatment|Protocol deviation|14|||
130662289|NCT02200614|470388623|FG001|Double Blind Treatment|Protocol deviation|7|||
130662290|NCT02200614|470388622|FG000|Double Blind Treatment|Not treated|1|||
130662291|NCT02200614|470388623|FG001|Double Blind Treatment|Not treated|0|||
130662292|NCT02200614|470388622|FG000|Open Label|Adverse Event|41|||
130662293|NCT02200614|470388623|FG001|Open Label|Adverse Event|11|||
130662294|NCT02200614|470388622|FG000|Open Label|Confirmed metastasis|1|||
130662295|NCT02200614|470388623|FG001|Open Label|Confirmed metastasis|0|||
130662296|NCT02200614|470388622|FG000|Open Label|Judgment of the investigator|29|||
130662297|NCT02200614|470388623|FG001|Open Label|Judgment of the investigator|2|||
130662298|NCT02200614|470388622|FG000|Open Label|Metastasis by local reading|138|||
130662299|NCT02200614|470388623|FG001|Open Label|Metastasis by local reading|27|||
130662300|NCT02200614|470388622|FG000|Open Label|Other reason|22|||
130662301|NCT02200614|470388623|FG001|Open Label|Other reason|4|||
130662302|NCT02200614|470388622|FG000|Open Label|Personal reason|60|||
130662303|NCT02200614|470388623|FG001|Open Label|Personal reason|8|||
130662304|NCT02200614|470388622|FG000|Open Label|Protocol deviation|3|||
130662305|NCT02200614|470388623|FG001|Open Label|Protocol deviation|2|||
130662306|NCT02200614|470388622|FG000|Open Label|Missing|2|||
130662307|NCT02200614|470388623|FG001|Open Label|Missing|2|||
130662308|NCT01898884|470388624|FG000|Multiple Dose Period|Adverse Event|0|||
130662309|NCT01898884|470388625|FG001|Multiple Dose Period|Adverse Event|0|||
130662310|NCT01898884|470388626|FG002|Multiple Dose Period|Adverse Event|0|||
130662311|NCT01898884|470388627|FG003|Multiple Dose Period|Adverse Event|0|||
130662312|NCT01898884|470388628|FG004|Multiple Dose Period|Adverse Event|0|||
130662313|NCT01898884|470388629|FG005|Multiple Dose Period|Adverse Event|0|||
130662314|NCT01898884|470388630|FG006|Multiple Dose Period|Adverse Event|1|||
130662315|NCT01898884|470388631|FG007|Multiple Dose Period|Adverse Event|0|||
130662316|NCT01898884|470388632|FG008|Multiple Dose Period|Adverse Event|0|||
130662317|NCT01898884|470388624|FG000|Multiple Dose Period|Randomized Not Treated|0|||
130662318|NCT01898884|470388625|FG001|Multiple Dose Period|Randomized Not Treated|0|||
130662319|NCT01898884|470388626|FG002|Multiple Dose Period|Randomized Not Treated|0|||
130662320|NCT01898884|470388627|FG003|Multiple Dose Period|Randomized Not Treated|0|||
130662321|NCT01898884|470388628|FG004|Multiple Dose Period|Randomized Not Treated|0|||
130662322|NCT01898884|470388629|FG005|Multiple Dose Period|Randomized Not Treated|0|||
130662323|NCT01898884|470388630|FG006|Multiple Dose Period|Randomized Not Treated|0|||
130662324|NCT01898884|470388631|FG007|Multiple Dose Period|Randomized Not Treated|0|||
130662325|NCT01898884|470388632|FG008|Multiple Dose Period|Randomized Not Treated|1|||
130662326|NCT00759759|470388633|FG000|Overall Study|didn't return for period 2|1|||
130662327|NCT00759759|470388634|FG001|Overall Study|didn't return for period 2|0|||
130662328|NCT00759759|470388633|FG000|Overall Study|Didn't receive drug in period 2|1|||
130662329|NCT00759759|470388634|FG001|Overall Study|Didn't receive drug in period 2|0|||
130662330|NCT00759759|470388633|FG000|Overall Study|Withdrawal by Subject|2|||
130662331|NCT00759759|470388634|FG001|Overall Study|Withdrawal by Subject|1|||
130662332|NCT01211613|470390200|FG000|Overall Study|Lost to Follow-up|2|||
130662333|NCT01211613|470390201|FG001|Overall Study|Lost to Follow-up|2|||
130662334|NCT01211613|470390202|FG002|Overall Study|Lost to Follow-up|2|||
130662335|NCT01211613|470390200|FG000|Overall Study|Withdrawal by Subject|1|||
130662336|NCT01211613|470390201|FG001|Overall Study|Withdrawal by Subject|0|||
130662337|NCT01211613|470390202|FG002|Overall Study|Withdrawal by Subject|0|||
130662338|NCT03853213|470390203|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
130662339|NCT03853213|470390204|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
130662340|NCT03853213|470390203|FG000|Overall Study|Other (e.g., too busy)|0|||
130662341|NCT03853213|470390204|FG001|Overall Study|Other (e.g., too busy)|2|||
130662342|NCT01458132|470390205|FG000|Overall Study|Other|15|||
130662343|NCT01458132|470390206|FG001|Overall Study|Other|3|||
130662344|NCT00833976|470390211|FG000|Overall Study|Withdrawal by Subject|5|||
130662345|NCT00833976|470390211|FG000|Overall Study|Lost to Follow-up|4|||
130662346|NCT00833976|470390211|FG000|Overall Study|Did not meet eligibility criteria|41|||
130662347|NCT00833976|470390211|FG000|Overall Study|Physician Decision|1|||
130662348|NCT03911960|470390212|FG000|Overall Study|Lost to Follow-up|5|||
130662349|NCT03911960|470390213|FG001|Overall Study|Lost to Follow-up|3|||
130662350|NCT00297492|470390214|FG000|Set Quit Date|Lost to Follow-up|7|||
130662351|NCT00297492|470390215|FG001|Set Quit Date|Lost to Follow-up|13|||
130662352|NCT00297492|470390216|FG002|Set Quit Date|Lost to Follow-up|5|||
130662353|NCT00297492|470390214|FG000|6 Month Follow-up|Lost to Follow-up|63|||
130662354|NCT00297492|470390215|FG001|6 Month Follow-up|Lost to Follow-up|49|||
130662355|NCT00297492|470390216|FG002|6 Month Follow-up|Lost to Follow-up|27|||
130662356|NCT02437890|470390221|FG000|Overall Study|Non-compliance to study drug|0|||
130662357|NCT02437890|470390222|FG001|Overall Study|Non-compliance to study drug|1|||
130662358|NCT02437890|470390223|FG002|Overall Study|Non-compliance to study drug|0|||
130662359|NCT02437890|470390224|FG003|Overall Study|Non-compliance to study drug|0|||
130662360|NCT02437890|470390225|FG004|Overall Study|Non-compliance to study drug|1|||
130662361|NCT02437890|470390221|FG000|Overall Study|Sponsor's decision|1|||
130662362|NCT02437890|470390222|FG001|Overall Study|Sponsor's decision|1|||
130662363|NCT02437890|470390223|FG002|Overall Study|Sponsor's decision|4|||
130662364|NCT02437890|470390224|FG003|Overall Study|Sponsor's decision|0|||
130662365|NCT02437890|470390225|FG004|Overall Study|Sponsor's decision|2|||
130662366|NCT02437890|470390221|FG000|Overall Study|Physician Decision|0|||
130662367|NCT02437890|470390222|FG001|Overall Study|Physician Decision|0|||
130662368|NCT02437890|470390223|FG002|Overall Study|Physician Decision|0|||
130662369|NCT02437890|470390224|FG003|Overall Study|Physician Decision|1|||
130662370|NCT02437890|470390225|FG004|Overall Study|Physician Decision|0|||
130662371|NCT02437890|470390221|FG000|Overall Study|Unable to attend visit(s)|1|||
130662372|NCT02437890|470390222|FG001|Overall Study|Unable to attend visit(s)|0|||
130662373|NCT02437890|470390223|FG002|Overall Study|Unable to attend visit(s)|0|||
130662374|NCT02437890|470390224|FG003|Overall Study|Unable to attend visit(s)|0|||
130662375|NCT02437890|470390225|FG004|Overall Study|Unable to attend visit(s)|0|||
130662376|NCT02437890|470390221|FG000|Overall Study|Lack of Efficacy|1|||
130662377|NCT02437890|470390222|FG001|Overall Study|Lack of Efficacy|3|||
130662378|NCT02437890|470390223|FG002|Overall Study|Lack of Efficacy|0|||
130662379|NCT02437890|470390224|FG003|Overall Study|Lack of Efficacy|3|||
130662380|NCT02437890|470390225|FG004|Overall Study|Lack of Efficacy|1|||
130662381|NCT02437890|470390221|FG000|Overall Study|Adverse Event|4|||
130662382|NCT02437890|470390222|FG001|Overall Study|Adverse Event|9|||
130662383|NCT02437890|470390223|FG002|Overall Study|Adverse Event|5|||
130662384|NCT02437890|470390224|FG003|Overall Study|Adverse Event|11|||
130662385|NCT02437890|470390225|FG004|Overall Study|Adverse Event|7|||
130662386|NCT02437890|470390221|FG000|Overall Study|Withdrawal by Subject|1|||
130662387|NCT02437890|470390222|FG001|Overall Study|Withdrawal by Subject|2|||
130662388|NCT02437890|470390223|FG002|Overall Study|Withdrawal by Subject|6|||
130662389|NCT02437890|470390224|FG003|Overall Study|Withdrawal by Subject|5|||
130662390|NCT02437890|470390225|FG004|Overall Study|Withdrawal by Subject|5|||
130662391|NCT02437890|470390221|FG000|Overall Study|Death|0|||
130662392|NCT02437890|470390222|FG001|Overall Study|Death|0|||
130662393|NCT02437890|470390223|FG002|Overall Study|Death|0|||
130662394|NCT02437890|470390224|FG003|Overall Study|Death|2|||
130662395|NCT02437890|470390225|FG004|Overall Study|Death|0|||
130662396|NCT02414854|470390226|FG000|Overall Study|Adverse Event|9|||
130662397|NCT02414854|470390227|FG001|Overall Study|Adverse Event|7|||
130662398|NCT02414854|470390228|FG002|Overall Study|Adverse Event|1|||
130662399|NCT02414854|470390229|FG003|Overall Study|Adverse Event|12|||
130662400|NCT02414854|470390226|FG000|Overall Study|Poor compliance to protocol|1|||
130662401|NCT02414854|470390227|FG001|Overall Study|Poor compliance to protocol|1|||
130662402|NCT02414854|470390228|FG002|Overall Study|Poor compliance to protocol|2|||
130662403|NCT02414854|470390229|FG003|Overall Study|Poor compliance to protocol|2|||
130662404|NCT02414854|470390226|FG000|Overall Study|Other than specified above|12|||
130662405|NCT02414854|470390227|FG001|Overall Study|Other than specified above|37|||
130662406|NCT02414854|470390228|FG002|Overall Study|Other than specified above|17|||
130662407|NCT02414854|470390229|FG003|Overall Study|Other than specified above|37|||
130662408|NCT04723173|470390230|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
130662409|NCT01422720|470390231|FG000|Overall Study|Adverse Event|16|||
130662410|NCT01422720|470390231|FG000|Overall Study|Lack of Efficacy|1|||
130662411|NCT01422720|470390231|FG000|Overall Study|Withdrawal by Subject|4|||
130662412|NCT01422720|470390231|FG000|Overall Study|Ineligibility|1|||
130662413|NCT00606801|470390232|FG000|Intervention|Protocol Violation|3|||
130662414|NCT00606801|470390233|FG001|Intervention|Protocol Violation|3|||
130662415|NCT02082262|470390234|FG000|Overall Study|Withdrawal by Subject|3|||
130662416|NCT02082262|470390234|FG000|Overall Study|Adverse Event|48|||
130662417|NCT01074307|470390238|FG000|Overall Study|No primary endpoint evaluation|14|||
130662418|NCT01074307|470390239|FG001|Overall Study|No primary endpoint evaluation|6|||
130662419|NCT01074307|470390238|FG000|Overall Study|Exclusion criterion|0|||
130662420|NCT01074307|470390239|FG001|Overall Study|Exclusion criterion|1|||
130662421|NCT01074307|470390238|FG000|Overall Study|Protocol Violation|8|||
130662422|NCT01074307|470390239|FG001|Overall Study|Protocol Violation|5|||
130662423|NCT02162511|470390244|FG000|Overall Study|Lack of Efficacy|0|||
130662424|NCT02162511|470390245|FG001|Overall Study|Lack of Efficacy|0|||
130662425|NCT02162511|470390246|FG002|Overall Study|Lack of Efficacy|2|||
130662426|NCT01408576|470390247|FG000|Overall Study|Lack of Efficacy|17|||
130662427|NCT01408576|470390248|FG001|Overall Study|Lack of Efficacy|30|||
130662428|NCT01408576|470390249|FG002|Overall Study|Lack of Efficacy|48|||
130662429|NCT01408576|470390247|FG000|Overall Study|Protocol Violation|1|||
130662430|NCT01408576|470390248|FG001|Overall Study|Protocol Violation|2|||
130662431|NCT01408576|470390249|FG002|Overall Study|Protocol Violation|2|||
130662432|NCT01408576|470390247|FG000|Overall Study|Lost to Follow-up|10|||
130662433|NCT01408576|470390248|FG001|Overall Study|Lost to Follow-up|9|||
130662434|NCT01408576|470390249|FG002|Overall Study|Lost to Follow-up|17|||
130662435|NCT01408576|470390247|FG000|Overall Study|Withdrawal by Subject|34|||
130662436|NCT01408576|470390248|FG001|Overall Study|Withdrawal by Subject|60|||
130662437|NCT01408576|470390249|FG002|Overall Study|Withdrawal by Subject|66|||
130662438|NCT01408576|470390247|FG000|Overall Study|Sponsor terminated study|89|||
130662439|NCT01408576|470390248|FG001|Overall Study|Sponsor terminated study|333|||
130662440|NCT01408576|470390249|FG002|Overall Study|Sponsor terminated study|330|||
130662441|NCT01408576|470390247|FG000|Overall Study|AE, serious fatal|4|||
130662442|NCT01408576|470390248|FG001|Overall Study|AE, serious fatal|4|||
130662443|NCT01408576|470390249|FG002|Overall Study|AE, serious fatal|1|||
130662444|NCT01408576|470390247|FG000|Overall Study|SAE, non-fatal|11|||
130662445|NCT01408576|470390248|FG001|Overall Study|SAE, non-fatal|23|||
130662446|NCT01408576|470390249|FG002|Overall Study|SAE, non-fatal|14|||
130662447|NCT01408576|470390247|FG000|Overall Study|AE, non-serious non-fatal|12|||
130662448|NCT01408576|470390248|FG001|Overall Study|AE, non-serious non-fatal|19|||
130662449|NCT01408576|470390249|FG002|Overall Study|AE, non-serious non-fatal|11|||
130662450|NCT01408576|470390247|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130662451|NCT01408576|470390248|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130662452|NCT01408576|470390249|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130662453|NCT01408576|470390247|FG000|Overall Study|AE, unknown type|0|||
130662454|NCT01408576|470390248|FG001|Overall Study|AE, unknown type|1|||
130662455|NCT01408576|470390249|FG002|Overall Study|AE, unknown type|0|||
130662456|NCT01408576|470390247|FG000|Overall Study|Other|10|||
130662457|NCT01408576|470390248|FG001|Overall Study|Other|16|||
130662458|NCT01408576|470390249|FG002|Overall Study|Other|18|||
130662459|NCT00802529|470390250|FG000|Overall Study|Lost to Follow-up|0|||
130662460|NCT00802529|470390251|FG001|Overall Study|Lost to Follow-up|1|||
130662461|NCT00552617|470390253|FG000|Overall Study|Not Treated|0|||
130662462|NCT00552617|470390254|FG001|Overall Study|Not Treated|0|||
130662463|NCT00552617|470390255|FG002|Overall Study|Not Treated|1|||
130662464|NCT00552617|470390256|FG003|Overall Study|Not Treated|0|||
130662465|NCT00552617|470390257|FG004|Overall Study|Not Treated|0|||
130662466|NCT00552617|470390258|FG005|Overall Study|Not Treated|0|||
130662467|NCT00552617|470390259|FG006|Overall Study|Not Treated|0|||
130662468|NCT00552617|470390260|FG007|Overall Study|Not Treated|0|||
130662469|NCT00552617|470390261|FG008|Overall Study|Not Treated|0|||
130662470|NCT00552617|470390262|FG009|Overall Study|Not Treated|1|||
130662471|NCT00552617|470390253|FG000|Overall Study|Lost to Follow-up|0|||
130662472|NCT00552617|470390254|FG001|Overall Study|Lost to Follow-up|0|||
130662473|NCT00552617|470390255|FG002|Overall Study|Lost to Follow-up|0|||
130662474|NCT00552617|470390256|FG003|Overall Study|Lost to Follow-up|1|||
130662475|NCT00552617|470390257|FG004|Overall Study|Lost to Follow-up|0|||
130662476|NCT00552617|470390258|FG005|Overall Study|Lost to Follow-up|2|||
130662477|NCT00552617|470390259|FG006|Overall Study|Lost to Follow-up|0|||
130662478|NCT00552617|470390260|FG007|Overall Study|Lost to Follow-up|0|||
130662479|NCT00552617|470390261|FG008|Overall Study|Lost to Follow-up|2|||
130662480|NCT00552617|470390262|FG009|Overall Study|Lost to Follow-up|0|||
130662481|NCT00337129|470390270|FG000|Overall Study|Adverse Event|4|||
130662482|NCT00337129|470390270|FG000|Overall Study|Withdrawal by Subject|1|||
130662483|NCT00337129|470390270|FG000|Overall Study|Lack of Efficacy|32|||
130662484|NCT00337129|470390270|FG000|Overall Study|Death|2|||
130662485|NCT00337129|470390270|FG000|Overall Study|not protocol specified|1|||
130662486|NCT00563524|470390273|FG000|Overall Study|Adverse Event|0|||
130662487|NCT00563524|470390274|FG001|Overall Study|Adverse Event|1|||
130662488|NCT00563524|470390275|FG002|Overall Study|Adverse Event|0|||
130662489|NCT00563524|470390276|FG003|Overall Study|Adverse Event|0|||
130662490|NCT00563524|470390277|FG004|Overall Study|Adverse Event|2|||
130662491|NCT00563524|470390278|FG005|Overall Study|Adverse Event|0|||
130662492|NCT00563524|470390273|FG000|Overall Study|Lost to Follow-up|1|||
130662493|NCT00563524|470390274|FG001|Overall Study|Lost to Follow-up|0|||
130662494|NCT00563524|470390275|FG002|Overall Study|Lost to Follow-up|0|||
130662495|NCT00563524|470390276|FG003|Overall Study|Lost to Follow-up|0|||
130662496|NCT00563524|470390277|FG004|Overall Study|Lost to Follow-up|0|||
130662497|NCT00563524|470390278|FG005|Overall Study|Lost to Follow-up|0|||
130662498|NCT00563524|470390273|FG000|Overall Study|Protocol Violation|0|||
130662499|NCT00563524|470390274|FG001|Overall Study|Protocol Violation|1|||
130662500|NCT00563524|470390275|FG002|Overall Study|Protocol Violation|0|||
130662501|NCT00563524|470390276|FG003|Overall Study|Protocol Violation|0|||
130662502|NCT00563524|470390277|FG004|Overall Study|Protocol Violation|0|||
130662503|NCT00563524|470390278|FG005|Overall Study|Protocol Violation|0|||
130662504|NCT00563524|470390273|FG000|Overall Study|Withdrawal by Subject|1|||
130662505|NCT00563524|470390274|FG001|Overall Study|Withdrawal by Subject|1|||
130662506|NCT00563524|470390275|FG002|Overall Study|Withdrawal by Subject|3|||
130662507|NCT00563524|470390276|FG003|Overall Study|Withdrawal by Subject|0|||
130662508|NCT00563524|470390277|FG004|Overall Study|Withdrawal by Subject|0|||
130662509|NCT00563524|470390278|FG005|Overall Study|Withdrawal by Subject|1|||
130662510|NCT02766088|470390283|FG000|Overall Study|Sponsor study termination|498|||
130662511|NCT02766088|470390283|FG000|Overall Study|Migrated/moved from the study area|1|||
130662512|NCT02766088|470390283|FG000|Overall Study|Lost to Follow-up|5|||
130662513|NCT02766088|470390283|FG000|Overall Study|Other|1|||
130662514|NCT02766088|470390283|FG000|Overall Study|Death|1|||
130662515|NCT01222715|470390284|FG000|Overall Study|Adverse Event|0|||
130662516|NCT01222715|470390285|FG001|Overall Study|Adverse Event|4|||
130662517|NCT01222715|470390284|FG000|Overall Study|Death|0|||
130662518|NCT01222715|470390285|FG001|Overall Study|Death|1|||
130662519|NCT01222715|470390284|FG000|Overall Study|Lack of Efficacy|22|||
130662520|NCT01222715|470390285|FG001|Overall Study|Lack of Efficacy|14|||
130662521|NCT01222715|470390284|FG000|Overall Study|Physician Decision|12|||
130662522|NCT01222715|470390285|FG001|Overall Study|Physician Decision|2|||
130662523|NCT01222715|470390284|FG000|Overall Study|Refusal of further protocol therapy|0|||
130662524|NCT01222715|470390285|FG001|Overall Study|Refusal of further protocol therapy|4|||
130662525|NCT01222715|470390284|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
130662526|NCT01222715|470390285|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
130662527|NCT01222715|470390284|FG000|Overall Study|Ineligible|0|||
130662528|NCT01222715|470390285|FG001|Overall Study|Ineligible|1|||
130662529|NCT01222715|470390284|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
130662530|NCT01222715|470390285|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
130662531|NCT02360397|470390286|FG000|Overall Study|Incomplete screening|3|||
130662532|NCT02360397|470390286|FG000|Overall Study|Adverse Event|1|||
130662533|NCT01537549|470390287|FG000|Overall Study|Lost to Follow-up|1|||
130662534|NCT01537549|470390287|FG000|Overall Study|Withdrawal by Subject|2|||
130662535|NCT02239601|470390296|FG000|Overall Study|Withdrawal by Subject|3|||
130662536|NCT02239601|470390297|FG001|Overall Study|Withdrawal by Subject|4|||
130662537|NCT02239601|470390296|FG000|Overall Study|Protocol Violation|4|||
130662538|NCT02239601|470390297|FG001|Overall Study|Protocol Violation|2|||
130662539|NCT01508325|470390298|FG000|Overall Study|Withdrawal by Subject|8|||
130662540|NCT01508325|470390299|FG001|Overall Study|Withdrawal by Subject|9|||
130662541|NCT01508325|470390298|FG000|Overall Study|Protocol Violation|0|||
130662542|NCT01508325|470390299|FG001|Overall Study|Protocol Violation|3|||
130662543|NCT01508325|470390298|FG000|Overall Study|Physician Decision|2|||
130662544|NCT01508325|470390299|FG001|Overall Study|Physician Decision|1|||
130662545|NCT01508325|470390298|FG000|Overall Study|Adverse Event|1|||
130662546|NCT01508325|470390299|FG001|Overall Study|Adverse Event|0|||
130662547|NCT01508325|470390298|FG000|Overall Study|Lost to Follow-up|5|||
130662548|NCT01508325|470390299|FG001|Overall Study|Lost to Follow-up|6|||
130662549|NCT01508325|470390298|FG000|Overall Study|Other|2|||
130662550|NCT01508325|470390299|FG001|Overall Study|Other|2|||
130662551|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
130662552|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130662553|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
130662554|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130662555|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130662556|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130662557|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130662558|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130662559|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130662560|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130662561|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
130662562|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130662563|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130662564|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130662565|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130662566|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130662567|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
130662568|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130662569|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130662570|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130662571|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
130662572|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130662573|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130662574|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130662575|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130662576|NCT04682639|470390300|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130662577|NCT04682639|470390301|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130662578|NCT04682639|470390302|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130662579|NCT04682639|470390303|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130662580|NCT04682639|470390304|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130662581|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
130662582|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
130662583|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
130662584|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
130662585|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
130662586|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Other|1|||
130662587|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Other|2|||
130662588|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Other|0|||
130662589|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Other|0|||
130662590|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Other|1|||
130662591|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
130662592|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
130662593|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130662594|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130662595|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130662596|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
130662597|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
130662598|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130662599|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130662600|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130662601|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130662602|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
130662603|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130662604|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130662605|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130662606|NCT04682639|470390300|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
130662607|NCT04682639|470390301|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
130662608|NCT04682639|470390302|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
130662609|NCT04682639|470390303|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
130662610|NCT04682639|470390304|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
130662611|NCT01286207|470390305|FG000|Overall Study|Adverse Event|27|||
130662612|NCT01286207|470390306|FG001|Overall Study|Adverse Event|41|||
130662613|NCT01286207|470390307|FG002|Overall Study|Adverse Event|8|||
130662614|NCT01286207|470390305|FG000|Overall Study|Lost to Follow-up|49|||
130662615|NCT01286207|470390306|FG001|Overall Study|Lost to Follow-up|43|||
130662616|NCT01286207|470390307|FG002|Overall Study|Lost to Follow-up|20|||
130662617|NCT01286207|470390305|FG000|Overall Study|Withdrawal by Subject|93|||
130662618|NCT01286207|470390306|FG001|Overall Study|Withdrawal by Subject|79|||
130662619|NCT01286207|470390307|FG002|Overall Study|Withdrawal by Subject|41|||
130662620|NCT01286207|470390305|FG000|Overall Study|Lack of Response|92|||
130662621|NCT01286207|470390306|FG001|Overall Study|Lack of Response|38|||
130662622|NCT01286207|470390307|FG002|Overall Study|Lack of Response|8|||
130662623|NCT01286207|470390305|FG000|Overall Study|Other|37|||
130662624|NCT01286207|470390306|FG001|Overall Study|Other|47|||
130662625|NCT01286207|470390307|FG002|Overall Study|Other|13|||
130662626|NCT01383954|470390308|FG000|Overall Study|Lack of Efficacy|2|||
130662627|NCT01383954|470390308|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
130662628|NCT01383954|470390308|FG000|Overall Study|Adverse Event|1|||
130662629|NCT01383954|470390308|FG000|Overall Study|Reason Not Specified|9|||
130662630|NCT00450177|470390309|FG000|Overall Study|Adverse Event|7|||
130216124|NCT01826981|468753948|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
130662631|NCT00450177|470390310|FG001|Overall Study|Adverse Event|4|||
130662632|NCT00450177|470390309|FG000|Overall Study|Withdrawal by Subject|1|||
130662633|NCT00450177|470390310|FG001|Overall Study|Withdrawal by Subject|6|||
130662634|NCT00450177|470390309|FG000|Overall Study|Withdrawal by Primary Team|1|||
130662635|NCT00450177|470390310|FG001|Overall Study|Withdrawal by Primary Team|1|||
130662636|NCT00763269|470390314|FG000|Overall Study|Lost to Follow-up|12|||
130662637|NCT00763269|470390315|FG001|Overall Study|Lost to Follow-up|13|||
130662638|NCT02609178|470390317|FG000|First Crown|Withdrawal by Subject|0|||
130662639|NCT02609178|470390318|FG001|First Crown|Withdrawal by Subject|0|||
130662640|NCT02609178|470390319|FG002|First Crown|Withdrawal by Subject|1|||
130662641|NCT02609178|470390320|FG003|First Crown|Withdrawal by Subject|1|||
130662642|NCT02609178|470390321|FG004|First Crown|Withdrawal by Subject|0|||
130662643|NCT02609178|470390322|FG005|First Crown|Withdrawal by Subject|0|||
130662644|NCT01128153|470390323|FG000|Overall Study|Adverse Event|1|||
130662645|NCT01128153|470390324|FG001|Overall Study|Adverse Event|3|||
130662646|NCT01128153|470390323|FG000|Overall Study|Condition under investigation worsened|8|||
130662647|NCT01128153|470390324|FG001|Overall Study|Condition under investigation worsened|7|||
130662648|NCT01128153|470390323|FG000|Overall Study|Withdrawal by Subject|2|||
130662649|NCT01128153|470390324|FG001|Overall Study|Withdrawal by Subject|3|||
130662650|NCT01128153|470390323|FG000|Overall Study|Incorrect enrolment to study|2|||
130662651|NCT01128153|470390324|FG001|Overall Study|Incorrect enrolment to study|1|||
130662652|NCT01128153|470390323|FG000|Overall Study|Protocol Violation|2|||
130662653|NCT01128153|470390324|FG001|Overall Study|Protocol Violation|0|||
130662654|NCT01128153|470390323|FG000|Overall Study|Developed discontinuation criteria|1|||
130662655|NCT01128153|470390324|FG001|Overall Study|Developed discontinuation criteria|1|||
130662656|NCT02419469|470390325|FG000|Overall Study|Withdrawal by Subject|1|||
130662657|NCT01682512|470390326|FG000|Overall Study|Adverse Event|6|||
130662658|NCT01682512|470390327|FG001|Overall Study|Adverse Event|5|||
130662659|NCT01682512|470390328|FG002|Overall Study|Adverse Event|2|||
130662660|NCT01682512|470390326|FG000|Overall Study|Withdrawal by Subject|2|||
130662661|NCT01682512|470390327|FG001|Overall Study|Withdrawal by Subject|6|||
130662662|NCT01682512|470390328|FG002|Overall Study|Withdrawal by Subject|3|||
130662663|NCT01682512|470390326|FG000|Overall Study|Physician Decision|0|||
130662664|NCT01682512|470390327|FG001|Overall Study|Physician Decision|2|||
130662665|NCT01682512|470390328|FG002|Overall Study|Physician Decision|0|||
130662666|NCT01682512|470390326|FG000|Overall Study|Study terminated by sponsor|46|||
130662667|NCT01682512|470390327|FG001|Overall Study|Study terminated by sponsor|43|||
130662668|NCT01682512|470390328|FG002|Overall Study|Study terminated by sponsor|0|||
130662669|NCT01682512|470390326|FG000|Overall Study|Lost to Follow-up|3|||
130662670|NCT01682512|470390327|FG001|Overall Study|Lost to Follow-up|0|||
130662671|NCT01682512|470390328|FG002|Overall Study|Lost to Follow-up|2|||
130662672|NCT01682512|470390326|FG000|Overall Study|Protocol Violation|2|||
130662673|NCT01682512|470390327|FG001|Overall Study|Protocol Violation|3|||
130662674|NCT01682512|470390328|FG002|Overall Study|Protocol Violation|2|||
130662675|NCT01682512|470390326|FG000|Overall Study|Primary lack of efficacy|10|||
130662676|NCT01682512|470390327|FG001|Overall Study|Primary lack of efficacy|7|||
130662677|NCT01682512|470390328|FG002|Overall Study|Primary lack of efficacy|7|||
130662678|NCT01682512|470390326|FG000|Overall Study|Secondary lack of efficacy|1|||
130662679|NCT01682512|470390327|FG001|Overall Study|Secondary lack of efficacy|1|||
130662680|NCT01682512|470390328|FG002|Overall Study|Secondary lack of efficacy|0|||
130662681|NCT01682512|470390326|FG000|Overall Study|Other than stated above|2|||
130662682|NCT01682512|470390327|FG001|Overall Study|Other than stated above|4|||
130662683|NCT01682512|470390328|FG002|Overall Study|Other than stated above|2|||
130662684|NCT04736576|470390331|FG000|Overall Study|Progressive disease|3|||
130662685|NCT04736576|470390332|FG001|Overall Study|Progressive disease|1|||
130662686|NCT04736576|470390331|FG000|Overall Study|Death|1|||
130662687|NCT04736576|470390332|FG001|Overall Study|Death|0|||
130662688|NCT00829439|470390333|FG000|Overall Study|Adverse Event|0|||
130662689|NCT00829439|470390334|FG001|Overall Study|Adverse Event|0|||
130662690|NCT00829439|470390335|FG002|Overall Study|Adverse Event|1|||
130662691|NCT00829439|470390336|FG003|Overall Study|Adverse Event|0|||
130662692|NCT00817778|470391890|FG000|Overall Study|Adverse Event|1|||
130662693|NCT00817778|470391891|FG001|Overall Study|Adverse Event|0|||
130662694|NCT00817778|470391890|FG000|Overall Study|Withdrawal by Subject|1|||
130662695|NCT00817778|470391891|FG001|Overall Study|Withdrawal by Subject|1|||
130662696|NCT00817778|470391890|FG000|Overall Study|Protocol Violation|0|||
130662697|NCT00817778|470391891|FG001|Overall Study|Protocol Violation|1|||
130662698|NCT00817778|470391890|FG000|Overall Study|Study-specific discontinuation criteria|0|||
130662699|NCT00817778|470391891|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130662700|NCT00817778|470391890|FG000|Overall Study|Poor venous access|1|||
130662701|NCT00817778|470391891|FG001|Overall Study|Poor venous access|0|||
130662702|NCT02923115|470391896|FG000|Overall Study|Lost to Follow-up|0|||
130334436|NCT00485134|469193811|FG002|Overall Study|Withdrawal by Subject|0|||
130662703|NCT02923115|470391897|FG001|Overall Study|Lost to Follow-up|0|||
130662704|NCT02923115|470391898|FG002|Overall Study|Lost to Follow-up|0|||
130662705|NCT02923115|470391899|FG003|Overall Study|Lost to Follow-up|1|||
130662706|NCT02923115|470391900|FG004|Overall Study|Lost to Follow-up|0|||
130662707|NCT02923115|470391901|FG005|Overall Study|Lost to Follow-up|0|||
130662708|NCT02923115|470391896|FG000|Overall Study|Withdrawal by Subject|0|||
130662709|NCT02923115|470391897|FG001|Overall Study|Withdrawal by Subject|1|||
130662710|NCT02923115|470391898|FG002|Overall Study|Withdrawal by Subject|0|||
130662711|NCT02923115|470391899|FG003|Overall Study|Withdrawal by Subject|0|||
130662712|NCT02923115|470391900|FG004|Overall Study|Withdrawal by Subject|0|||
130662713|NCT02923115|470391901|FG005|Overall Study|Withdrawal by Subject|0|||
130662714|NCT02923115|470391896|FG000|Overall Study|Randomized, but not dosed|0|||
130662715|NCT02923115|470391897|FG001|Overall Study|Randomized, but not dosed|0|||
130662716|NCT02923115|470391898|FG002|Overall Study|Randomized, but not dosed|3|||
130662717|NCT02923115|470391899|FG003|Overall Study|Randomized, but not dosed|1|||
130662718|NCT02923115|470391900|FG004|Overall Study|Randomized, but not dosed|5|||
130662719|NCT02923115|470391901|FG005|Overall Study|Randomized, but not dosed|0|||
130662720|NCT00520494|470391902|FG000|Overall Study|Withdrawal by Subject|1|||
130662721|NCT03471182|470391905|FG000|Overall Study|Withdrawal by Subject|1|||
130662722|NCT03471182|470391906|FG001|Overall Study|Withdrawal by Subject|1|||
130662723|NCT03471182|470391907|FG002|Overall Study|Withdrawal by Subject|0|||
130662724|NCT03471182|470391905|FG000|Overall Study|Technical failure|2|||
130662725|NCT03471182|470391906|FG001|Overall Study|Technical failure|0|||
130662726|NCT03471182|470391907|FG002|Overall Study|Technical failure|0|||
130662727|NCT00068406|470391908|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
130662728|NCT00068406|470391908|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
130662729|NCT03451331|470391909|FG000|Overall Study|Withdrawal by Subject|1|||
130662730|NCT03451331|470391910|FG001|Overall Study|Withdrawal by Subject|0|||
130662731|NCT03451331|470391909|FG000|Overall Study|Unable to start treatment.|1|||
130662732|NCT03451331|470391910|FG001|Overall Study|Unable to start treatment.|1|||
130662733|NCT01875991|470391911|FG000|Overall Study|Withdrawal by Subject|6|||
130662734|NCT01875991|470391912|FG001|Overall Study|Withdrawal by Subject|6|||
130662735|NCT01875991|470391911|FG000|Overall Study|Sponsor Decision|1|||
130662736|NCT01875991|470391912|FG001|Overall Study|Sponsor Decision|0|||
130662737|NCT01785875|470391915|FG000|Overall Study|Withdrawal by Subject|41|||
130662738|NCT01785875|470391916|FG001|Overall Study|Withdrawal by Subject|34|||
130662739|NCT01785875|470391917|FG002|Overall Study|Withdrawal by Subject|36|||
130662740|NCT01785875|470391915|FG000|Overall Study|Lost to Follow-up|19|||
130662741|NCT01785875|470391916|FG001|Overall Study|Lost to Follow-up|22|||
130662742|NCT01785875|470391917|FG002|Overall Study|Lost to Follow-up|6|||
130662743|NCT01785875|470391915|FG000|Overall Study|Death|27|||
130662744|NCT01785875|470391916|FG001|Overall Study|Death|16|||
130662745|NCT01785875|470391917|FG002|Overall Study|Death|7|||
130662746|NCT01785875|470391915|FG000|Overall Study|Sponsor Decision|0|||
130662747|NCT01785875|470391916|FG001|Overall Study|Sponsor Decision|2|||
130662748|NCT01785875|470391917|FG002|Overall Study|Sponsor Decision|0|||
130662749|NCT01785875|470391915|FG000|Overall Study|Protocol Specified Criteria|207|||
130662750|NCT01785875|470391916|FG001|Overall Study|Protocol Specified Criteria|214|||
130662751|NCT01785875|470391917|FG002|Overall Study|Protocol Specified Criteria|55|||
130662752|NCT01785875|470391915|FG000|Overall Study|Missing|0|||
130662753|NCT01785875|470391916|FG001|Overall Study|Missing|1|||
130662754|NCT01785875|470391917|FG002|Overall Study|Missing|3|||
130662755|NCT00417027|470391920|FG000|Overall Study|Protocol Violation|0|||
130662756|NCT00417027|470391921|FG001|Overall Study|Protocol Violation|5|||
130662757|NCT00417027|470391922|FG002|Overall Study|Protocol Violation|5|||
130662758|NCT00707174|470391923|FG000|Overall Study|Adverse Event|1|||
130662759|NCT00707174|470391924|FG001|Overall Study|Adverse Event|6|||
130662760|NCT00707174|470391923|FG000|Overall Study|Withdrawal by Subject|4|||
130662761|NCT00707174|470391924|FG001|Overall Study|Withdrawal by Subject|1|||
130662762|NCT04991311|470391925|FG000|Overall Study|Adverse Event|1|||
130662763|NCT00054275|470391926|FG000|Overall Study|Withdrawal by Subject|4|||
130662764|NCT00054275|470391926|FG000|Overall Study|Adverse Event|5|||
130662765|NCT00054275|470391926|FG000|Overall Study|Progressive disease in cycle 1|1|||
130662766|NCT00054275|470391926|FG000|Overall Study|Physician Decision|1|||
130662767|NCT02030834|470391936|FG000|Overall Study|Death|4|||
130662768|NCT02030834|470391937|FG001|Overall Study|Death|0|||
130662769|NCT02030834|470391938|FG002|Overall Study|Death|0|||
130662770|NCT02030834|470391936|FG000|Overall Study|Manufacturing failure|2|||
130662771|NCT02030834|470391937|FG001|Overall Study|Manufacturing failure|0|||
130662772|NCT02030834|470391938|FG002|Overall Study|Manufacturing failure|1|||
130662773|NCT02030834|470391936|FG000|Overall Study|Disease progression|2|||
130662774|NCT02030834|470391937|FG001|Overall Study|Disease progression|0|||
130662775|NCT02030834|470391938|FG002|Overall Study|Disease progression|2|||
130662776|NCT02030834|470391936|FG000|Overall Study|Lost to Follow-up|1|||
130662777|NCT02030834|470391937|FG001|Overall Study|Lost to Follow-up|0|||
130662778|NCT02030834|470391938|FG002|Overall Study|Lost to Follow-up|0|||
130662779|NCT02030834|470391936|FG000|Overall Study|Withdrawal by Subject|1|||
130662780|NCT02030834|470391937|FG001|Overall Study|Withdrawal by Subject|0|||
130662781|NCT02030834|470391938|FG002|Overall Study|Withdrawal by Subject|0|||
130662782|NCT02030834|470391936|FG000|Overall Study|Lack of funding|1|||
130662783|NCT02030834|470391937|FG001|Overall Study|Lack of funding|0|||
130662784|NCT02030834|470391938|FG002|Overall Study|Lack of funding|0|||
130662785|NCT01440595|470391939|FG000|Overall Study|Lost to Follow-up|0|||
130662786|NCT01440595|470391940|FG001|Overall Study|Lost to Follow-up|1|||
130662787|NCT01440595|470391941|FG002|Overall Study|Lost to Follow-up|0|||
130662788|NCT01440595|470391939|FG000|Overall Study|Study terminated by sponsor.|1|||
130662789|NCT01440595|470391940|FG001|Overall Study|Study terminated by sponsor.|2|||
130662790|NCT01440595|470391941|FG002|Overall Study|Study terminated by sponsor.|1|||
130662791|NCT01347879|470391942|FG000|Overall Study|Adverse Event|0|||
130662792|NCT01347879|470391943|FG001|Overall Study|Adverse Event|12|||
130662793|NCT01347879|470391942|FG000|Overall Study|Lost to Follow-up|2|||
130662794|NCT01347879|470391943|FG001|Overall Study|Lost to Follow-up|0|||
130662795|NCT01347879|470391942|FG000|Overall Study|Withdrawal by Subject|3|||
130662796|NCT01347879|470391943|FG001|Overall Study|Withdrawal by Subject|2|||
130662797|NCT01347879|470391942|FG000|Overall Study|Other|2|||
130662798|NCT01347879|470391943|FG001|Overall Study|Other|3|||
130662799|NCT01238822|470391948|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
130662800|NCT00996918|470391954|FG000|Overall Study|Lack of Efficacy|1|||
130662801|NCT00996918|470391955|FG001|Overall Study|Lack of Efficacy|1|||
130662802|NCT00996918|470391956|FG002|Overall Study|Lack of Efficacy|2|||
130662803|NCT00996918|470391957|FG003|Overall Study|Lack of Efficacy|2|||
130662804|NCT00996918|470391958|FG004|Overall Study|Lack of Efficacy|0|||
130662805|NCT00996918|470391954|FG000|Overall Study|Adverse Event|2|||
130662806|NCT00996918|470391955|FG001|Overall Study|Adverse Event|5|||
130662807|NCT00996918|470391956|FG002|Overall Study|Adverse Event|2|||
130662808|NCT00996918|470391957|FG003|Overall Study|Adverse Event|6|||
130662809|NCT00996918|470391958|FG004|Overall Study|Adverse Event|0|||
130662810|NCT00996918|470391954|FG000|Overall Study|Withdrawal by Subject|1|||
130662811|NCT00996918|470391955|FG001|Overall Study|Withdrawal by Subject|4|||
130662812|NCT00996918|470391956|FG002|Overall Study|Withdrawal by Subject|3|||
130662813|NCT00996918|470391957|FG003|Overall Study|Withdrawal by Subject|3|||
130662814|NCT00996918|470391958|FG004|Overall Study|Withdrawal by Subject|2|||
130662815|NCT00996918|470391954|FG000|Overall Study|Physician Decision|1|||
130662816|NCT00996918|470391955|FG001|Overall Study|Physician Decision|0|||
130662817|NCT00996918|470391956|FG002|Overall Study|Physician Decision|0|||
130662818|NCT00996918|470391957|FG003|Overall Study|Physician Decision|0|||
130662819|NCT00996918|470391958|FG004|Overall Study|Physician Decision|0|||
130662820|NCT00996918|470391954|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
130662821|NCT00996918|470391955|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
130662822|NCT00996918|470391956|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
130662823|NCT00996918|470391957|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
130662824|NCT00996918|470391958|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
130662825|NCT00996918|470391954|FG000|Overall Study|Loss of Caregiver|0|||
130662826|NCT00996918|470391955|FG001|Overall Study|Loss of Caregiver|1|||
130662827|NCT00996918|470391956|FG002|Overall Study|Loss of Caregiver|0|||
130662828|NCT00996918|470391957|FG003|Overall Study|Loss of Caregiver|0|||
130662829|NCT00996918|470391958|FG004|Overall Study|Loss of Caregiver|0|||
130662830|NCT00996918|470391954|FG000|Overall Study|Other|3|||
130662831|NCT00996918|470391955|FG001|Overall Study|Other|1|||
130662832|NCT00996918|470391956|FG002|Overall Study|Other|0|||
130662833|NCT00996918|470391957|FG003|Overall Study|Other|0|||
130662834|NCT00996918|470391958|FG004|Overall Study|Other|0|||
130662835|NCT04440007|470391966|FG000|Overall Study|Adverse Event|0|||
130662836|NCT04440007|470391967|FG001|Overall Study|Adverse Event|1|||
130662837|NCT04440007|470391966|FG000|Overall Study|Lost to Follow-up|1|||
130662838|NCT04440007|470391967|FG001|Overall Study|Lost to Follow-up|3|||
130662839|NCT04440007|470391966|FG000|Overall Study|Death|7|||
130334437|NCT00485134|469193812|FG003|Overall Study|Withdrawal by Subject|0|||
130334438|NCT00485134|469193813|FG004|Overall Study|Withdrawal by Subject|0|||
130334439|NCT00485134|469193814|FG005|Overall Study|Withdrawal by Subject|0|||
130334440|NCT00485134|469193815|FG006|Overall Study|Withdrawal by Subject|0|||
130334441|NCT00485134|469193816|FG007|Overall Study|Withdrawal by Subject|0|||
130552206|NCT03285178|469990138|FG006|Single-Blind Run-In Period|Physician Decision|0|||
130552207|NCT03285178|469990132|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130552208|NCT03285178|469990133|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
130552209|NCT03285178|469990134|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
130552210|NCT03285178|469990135|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130552211|NCT03285178|469990136|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130552212|NCT03285178|469990137|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130552213|NCT03285178|469990138|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130552214|NCT03285178|469990132|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130552215|NCT03285178|469990133|FG001|Double-Blind Treatment Period|Adverse Event|0|||
130552216|NCT03285178|469990134|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130552217|NCT03285178|469990135|FG003|Double-Blind Treatment Period|Adverse Event|0|||
130552218|NCT03285178|469990136|FG004|Double-Blind Treatment Period|Adverse Event|0|||
130552219|NCT03285178|469990137|FG005|Double-Blind Treatment Period|Adverse Event|0|||
130552220|NCT03285178|469990138|FG006|Double-Blind Treatment Period|Adverse Event|2|||
130552221|NCT03285178|469990132|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130552222|NCT03285178|469990133|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130552223|NCT03285178|469990134|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130552224|NCT03285178|469990135|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
130552225|NCT03285178|469990136|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
130552226|NCT03285178|469990137|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
130662840|NCT04440007|470391967|FG001|Overall Study|Death|2|||
130662841|NCT04440007|470391966|FG000|Overall Study|Physician Decision|1|||
130662842|NCT04440007|470391967|FG001|Overall Study|Physician Decision|1|||
130662843|NCT04440007|470391966|FG000|Overall Study|Withdrawal by Subject|2|||
130662844|NCT04440007|470391967|FG001|Overall Study|Withdrawal by Subject|1|||
130662845|NCT04440007|470391966|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
130662846|NCT04440007|470391967|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
130662847|NCT04440007|470391966|FG000|Overall Study|Discontinued prior to dosing|0|||
130662848|NCT04440007|470391967|FG001|Overall Study|Discontinued prior to dosing|2|||
130662849|NCT01466673|470391968|FG000|Overall Study|Non-compliance with study treatment|2|||
130662850|NCT01466673|470391969|FG001|Overall Study|Non-compliance with study treatment|0|||
130662851|NCT01466673|470391968|FG000|Overall Study|Lost to Follow-up|3|||
130662852|NCT01466673|470391969|FG001|Overall Study|Lost to Follow-up|5|||
130662853|NCT01466673|470391968|FG000|Overall Study|Adverse Event|2|||
130662854|NCT01466673|470391969|FG001|Overall Study|Adverse Event|1|||
130662855|NCT00854607|470391970|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
130662856|NCT00965263|470391978|FG000|Overall Study|Physician Decision|2|||
130662857|NCT00965263|470391979|FG001|Overall Study|Physician Decision|0|||
130662858|NCT00965263|470391978|FG000|Overall Study|Family emergency|0|||
130662859|NCT00965263|470391979|FG001|Overall Study|Family emergency|1|||
130662860|NCT00965263|470391978|FG000|Overall Study|Protocol Violation|0|||
130662861|NCT00965263|470391979|FG001|Overall Study|Protocol Violation|2|||
130662862|NCT02567266|470391980|FG000|Overall Study|Withdrawal by Subject|10|||
130662863|NCT02567266|470391981|FG001|Overall Study|Withdrawal by Subject|7|||
130662864|NCT02567266|470391982|FG002|Overall Study|Withdrawal by Subject|6|||
130662865|NCT02567266|470391980|FG000|Overall Study|Lost to Follow-up|13|||
130662866|NCT02567266|470391981|FG001|Overall Study|Lost to Follow-up|8|||
130662867|NCT02567266|470391982|FG002|Overall Study|Lost to Follow-up|10|||
130662868|NCT00123487|470391983|FG000|Randomized|Death prior to starting treatment|0|||
130662869|NCT00123487|470391984|FG001|Randomized|Death prior to starting treatment|1|||
130662870|NCT00123487|470391983|FG000|Randomized|SAE prior to starting treatment|1|||
130662871|NCT00123487|470391984|FG001|Randomized|SAE prior to starting treatment|0|||
130662872|NCT00123487|470391983|FG000|Treated With Study Drug|Adverse Event|23|||
130662873|NCT00123487|470391984|FG001|Treated With Study Drug|Adverse Event|22|||
130662874|NCT00123487|470391983|FG000|Treated With Study Drug|Disease Progression|141|||
130662875|NCT00123487|470391984|FG001|Treated With Study Drug|Disease Progression|122|||
130662876|NCT00123487|470391983|FG000|Treated With Study Drug|Physician Decision|8|||
130662877|NCT00123487|470391984|FG001|Treated With Study Drug|Physician Decision|9|||
130662878|NCT00123487|470391983|FG000|Treated With Study Drug|Other|59|||
130662879|NCT00123487|470391984|FG001|Treated With Study Drug|Other|58|||
130662880|NCT00123487|470391983|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
130662881|NCT00123487|470391984|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
130662882|NCT00123487|470391983|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
130662883|NCT00123487|470391984|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
130662884|NCT00123487|470391983|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
130662885|NCT00123487|470391984|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
130662886|NCT03835975|470391985|FG000|Overall Study|Lost to Follow-up|1|||
130662887|NCT03835975|470391986|FG001|Overall Study|Lost to Follow-up|1|||
130662888|NCT03835975|470391987|FG002|Overall Study|Lost to Follow-up|0|||
130662889|NCT03835975|470391988|FG003|Overall Study|Lost to Follow-up|0|||
130662890|NCT03835975|470391989|FG004|Overall Study|Lost to Follow-up|0|||
130662891|NCT03835975|470391985|FG000|Overall Study|No longer met eligibility criteria|0|||
130662892|NCT03835975|470391986|FG001|Overall Study|No longer met eligibility criteria|1|||
130662893|NCT03835975|470391987|FG002|Overall Study|No longer met eligibility criteria|0|||
130662894|NCT03835975|470391988|FG003|Overall Study|No longer met eligibility criteria|0|||
130662895|NCT03835975|470391989|FG004|Overall Study|No longer met eligibility criteria|0|||
130662896|NCT03835975|470391985|FG000|Overall Study|Protocol Violation|1|||
130662897|NCT03835975|470391986|FG001|Overall Study|Protocol Violation|1|||
130662898|NCT03835975|470391987|FG002|Overall Study|Protocol Violation|2|||
130662899|NCT03835975|470391988|FG003|Overall Study|Protocol Violation|0|||
130662900|NCT03835975|470391989|FG004|Overall Study|Protocol Violation|0|||
130552227|NCT03285178|469990138|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
130552228|NCT03285178|469990132|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130552229|NCT03285178|469990133|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130552230|NCT03285178|469990134|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130552231|NCT03285178|469990135|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130552232|NCT03285178|469990136|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130552233|NCT03285178|469990137|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130552234|NCT03285178|469990138|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130552235|NCT03285178|469990132|FG000|Double-Blind Treatment Period|COVID-19|0|||
130552236|NCT03285178|469990133|FG001|Double-Blind Treatment Period|COVID-19|0|||
130552237|NCT03285178|469990134|FG002|Double-Blind Treatment Period|COVID-19|1|||
130552238|NCT03285178|469990135|FG003|Double-Blind Treatment Period|COVID-19|0|||
130552239|NCT03285178|469990136|FG004|Double-Blind Treatment Period|COVID-19|0|||
130552240|NCT03285178|469990137|FG005|Double-Blind Treatment Period|COVID-19|0|||
130552241|NCT03285178|469990138|FG006|Double-Blind Treatment Period|COVID-19|0|||
130552242|NCT01388790|469990139|FG000|Overall Study|Ongoing at data cut-off date|8|||
130552243|NCT01128894|469990140|FG000|Overall Study|Adverse Event|31|||
130552244|NCT01128894|469990141|FG001|Overall Study|Adverse Event|41|||
130552245|NCT01128894|469990140|FG000|Overall Study|Protocol Violation|2|||
130552246|NCT01128894|469990141|FG001|Overall Study|Protocol Violation|1|||
130552247|NCT01128894|469990140|FG000|Overall Study|Noncompliance|4|||
130552248|NCT01128894|469990141|FG001|Overall Study|Noncompliance|5|||
130552249|NCT01128894|469990140|FG000|Overall Study|Lost to Follow-up|8|||
130552250|NCT01128894|469990141|FG001|Overall Study|Lost to Follow-up|8|||
130552251|NCT01128894|469990140|FG000|Overall Study|Withdrawal by Subject|10|||
130552252|NCT01128894|469990141|FG001|Overall Study|Withdrawal by Subject|12|||
130552253|NCT01128894|469990140|FG000|Overall Study|Physician Decision|2|||
130552254|NCT01128894|469990141|FG001|Overall Study|Physician Decision|1|||
130552255|NCT01128894|469990140|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
130552256|NCT01128894|469990141|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
130552257|NCT00195507|469990142|FG000|Overall Study|Adverse Event|24|||
130552258|NCT00195507|469990143|FG001|Overall Study|Adverse Event|13|||
130552259|NCT00195507|469990142|FG000|Overall Study|Death|0|||
130552260|NCT00195507|469990143|FG001|Overall Study|Death|1|||
130552261|NCT00195507|469990142|FG000|Overall Study|Failed to Return|4|||
130552262|NCT00195507|469990143|FG001|Overall Study|Failed to Return|3|||
130552263|NCT00195507|469990142|FG000|Overall Study|Physician Decision|1|||
130552264|NCT00195507|469990143|FG001|Overall Study|Physician Decision|2|||
130552265|NCT00195507|469990142|FG000|Overall Study|Lost to Follow-up|3|||
130552266|NCT00195507|469990143|FG001|Overall Study|Lost to Follow-up|2|||
130552267|NCT00195507|469990142|FG000|Overall Study|Protocol Violation|5|||
130552268|NCT00195507|469990143|FG001|Overall Study|Protocol Violation|4|||
130552269|NCT00195507|469990142|FG000|Overall Study|Lack of Efficacy|40|||
130552270|NCT00195507|469990143|FG001|Overall Study|Lack of Efficacy|67|||
130552271|NCT00195507|469990142|FG000|Overall Study|Withdrawal by Subject|16|||
130552272|NCT00195507|469990143|FG001|Overall Study|Withdrawal by Subject|23|||
130552273|NCT00195507|469990142|FG000|Overall Study|Protocol Deviation|6|||
130552274|NCT00195507|469990143|FG001|Overall Study|Protocol Deviation|3|||
130552275|NCT00973362|469990144|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
130552276|NCT00973362|469990145|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
130552277|NCT00973362|469990144|FG000|Baseline Evaluation|No colposcopy visit|62|||
130552278|NCT00973362|469990145|FG001|Baseline Evaluation|No colposcopy visit|0|||
130552279|NCT00973362|469990144|FG000|Baseline Evaluation|Inevaluable|686|||
130552280|NCT00973362|469990145|FG001|Baseline Evaluation|Inevaluable|223|||
130552281|NCT00973362|469990144|FG000|3-Year Follow-up|Lost to Follow-up|17|||
130552282|NCT00973362|469990145|FG001|3-Year Follow-up|Lost to Follow-up|0|||
130552283|NCT01630434|469990152|FG000|Overall Study|Donor lungs turned down|1|||
130552284|NCT01630434|469990153|FG001|Overall Study|Donor lungs turned down|0|||
130552285|NCT01630434|469990152|FG000|Overall Study|Protocol Violation|9|||
130552286|NCT01630434|469990153|FG001|Overall Study|Protocol Violation|4|||
130552287|NCT01630434|469990152|FG000|Overall Study|Death|20|||
130552288|NCT01630434|469990153|FG001|Overall Study|Death|26|||
130552289|NCT02804178|469990156|FG000|Overall Study|Adverse Event|1|||
130552290|NCT01106404|469990157|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
130552291|NCT01106404|469990158|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
130552292|NCT01106404|469990157|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
130552293|NCT01106404|469990158|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
130552294|NCT01106404|469990157|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
130552295|NCT01106404|469990158|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
130552296|NCT01106404|469990157|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
130552297|NCT01106404|469990158|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
130552298|NCT00775450|469990159|FG000|Overall Study|Serious Adverse Event|2|||
130552299|NCT00775450|469990160|FG001|Overall Study|Serious Adverse Event|0|||
130552300|NCT00775450|469990161|FG002|Overall Study|Serious Adverse Event|0|||
130552301|NCT00775450|469990162|FG003|Overall Study|Serious Adverse Event|0|||
130552302|NCT00775450|469990163|FG004|Overall Study|Serious Adverse Event|0|||
130552303|NCT00775450|469990159|FG000|Overall Study|Protocol Violation|0|||
130552304|NCT00775450|469990160|FG001|Overall Study|Protocol Violation|0|||
130552305|NCT00775450|469990161|FG002|Overall Study|Protocol Violation|0|||
130552306|NCT00775450|469990162|FG003|Overall Study|Protocol Violation|0|||
130552307|NCT00775450|469990163|FG004|Overall Study|Protocol Violation|1|||
130552308|NCT00775450|469990159|FG000|Overall Study|Withdrawal by Subject|1|||
130552309|NCT00775450|469990160|FG001|Overall Study|Withdrawal by Subject|0|||
130552310|NCT00775450|469990161|FG002|Overall Study|Withdrawal by Subject|0|||
130552311|NCT00775450|469990162|FG003|Overall Study|Withdrawal by Subject|0|||
130552312|NCT00775450|469990163|FG004|Overall Study|Withdrawal by Subject|1|||
130552313|NCT01749540|469990166|FG000|Overall Study|Protocol Violation|0|||
130552314|NCT01749540|469990167|FG001|Overall Study|Protocol Violation|0|||
130552315|NCT01749540|469990168|FG002|Overall Study|Protocol Violation|0|||
130662901|NCT03835975|470391985|FG000|Overall Study|Withdrawal by Subject|1|||
130662902|NCT03835975|470391986|FG001|Overall Study|Withdrawal by Subject|0|||
130662903|NCT03835975|470391987|FG002|Overall Study|Withdrawal by Subject|1|||
130662904|NCT03835975|470391988|FG003|Overall Study|Withdrawal by Subject|1|||
130662905|NCT03835975|470391989|FG004|Overall Study|Withdrawal by Subject|0|||
130662906|NCT00061945|470391990|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
130662907|NCT00061945|470391991|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
130662908|NCT00061945|470391990|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
130662909|NCT00061945|470391991|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
130662910|NCT00061945|470391990|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
130662911|NCT00061945|470391991|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
130662912|NCT00061945|470391990|FG000|Course IV: Alemtuzumab|Early exits|6|||
130662913|NCT00061945|470391991|FG001|Course IV: Alemtuzumab|Early exits|15|||
130662914|NCT01039584|470391992|FG000|Overall Study|Withdrawal by Subject|4|||
130662915|NCT01039584|470391993|FG001|Overall Study|Withdrawal by Subject|2|||
130662916|NCT01039584|470391994|FG002|Overall Study|Withdrawal by Subject|1|||
130662917|NCT01039584|470391992|FG000|Overall Study|Protocol Violation|10|||
130662918|NCT01039584|470391993|FG001|Overall Study|Protocol Violation|4|||
130662919|NCT01039584|470391994|FG002|Overall Study|Protocol Violation|6|||
130662920|NCT01039584|470391992|FG000|Overall Study|Lost to Follow-up|5|||
130662921|NCT01039584|470391993|FG001|Overall Study|Lost to Follow-up|3|||
130662922|NCT01039584|470391994|FG002|Overall Study|Lost to Follow-up|4|||
130662923|NCT01039584|470391992|FG000|Overall Study|Negative Baseline culture for Candida|59|||
130662924|NCT01039584|470391993|FG001|Overall Study|Negative Baseline culture for Candida|59|||
130662925|NCT01039584|470391994|FG002|Overall Study|Negative Baseline culture for Candida|24|||
130662926|NCT01039584|470391992|FG000|Overall Study|Lack of Efficacy|7|||
130662927|NCT01039584|470391993|FG001|Overall Study|Lack of Efficacy|6|||
130662928|NCT01039584|470391994|FG002|Overall Study|Lack of Efficacy|10|||
130662929|NCT01039584|470391992|FG000|Overall Study|other|1|||
130662930|NCT01039584|470391993|FG001|Overall Study|other|3|||
130662931|NCT01039584|470391994|FG002|Overall Study|other|1|||
130662932|NCT01039584|470391992|FG000|Overall Study|Pap smear with significant pathology|10|||
130662933|NCT01039584|470391993|FG001|Overall Study|Pap smear with significant pathology|10|||
130662934|NCT01039584|470391994|FG002|Overall Study|Pap smear with significant pathology|3|||
130662935|NCT01039584|470391992|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
130662936|NCT01039584|470391993|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
130662937|NCT01039584|470391994|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
130662938|NCT03672396|470391995|FG000|Overall Study|Withdrawal by Subject|4|||
130662939|NCT03672396|470391995|FG000|Overall Study|Physician Decision|1|||
130662940|NCT03672396|470391995|FG000|Overall Study|Adverse Event|1|||
130662941|NCT00975884|470391997|FG000|Overall Study|Adverse Event|1|||
130662942|NCT00975884|470391998|FG001|Overall Study|Adverse Event|0|||
130662943|NCT00975884|470391997|FG000|Overall Study|Lost to Follow-up|5|||
130662944|NCT00975884|470391998|FG001|Overall Study|Lost to Follow-up|3|||
130662945|NCT00975884|470391997|FG000|Overall Study|Withdrawal by Subject|9|||
130662946|NCT00975884|470391998|FG001|Overall Study|Withdrawal by Subject|9|||
130662947|NCT00975884|470391997|FG000|Overall Study|Other|1|||
130662948|NCT00975884|470391998|FG001|Overall Study|Other|3|||
130662949|NCT01656967|470391999|FG000|Overall Study|faulty monitor|1|||
130662950|NCT01656967|470392000|FG001|Overall Study|faulty monitor|0|||
130662951|NCT01656967|470391999|FG000|Overall Study|unsuccessful ETT insertion|3|||
130662952|NCT01656967|470392000|FG001|Overall Study|unsuccessful ETT insertion|2|||
130662953|NCT00479765|470392001|FG000|Overall Study|study terminated|4|||
130662954|NCT00420849|470392002|FG000|Overall Study|Lack of Efficacy|154|||
130662955|NCT00420849|470392002|FG000|Overall Study|Adverse Event|107|||
130662956|NCT00420849|470392002|FG000|Overall Study|Withdrawal by Subject|28|||
130662957|NCT00420849|470392002|FG000|Overall Study|Death|18|||
130662958|NCT00420849|470392002|FG000|Overall Study|Other|14|||
130662959|NCT00420849|470392002|FG000|Overall Study|Transplant|8|||
130662960|NCT00420849|470392002|FG000|Overall Study|Protocol Violation|1|||
130662961|NCT00420849|470392002|FG000|Overall Study|Lost to Follow-up|1|||
130662962|NCT00944125|470392003|FG000|3 to 6 Months|Withdrawal by Subject|0|||
130662963|NCT00944125|470392004|FG001|3 to 6 Months|Withdrawal by Subject|2|||
130662964|NCT00944125|470392003|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
130662965|NCT00944125|470392004|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
130662966|NCT00446134|470392005|FG000|Overall Study|Adverse Event|7|||
130334442|NCT00485134|469193809|FG000|Overall Study|Change in health status|0|||
130334443|NCT00485134|469193810|FG001|Overall Study|Change in health status|1|||
130662967|NCT00446134|470392006|FG001|Overall Study|Adverse Event|17|||
130662968|NCT00446134|470392007|FG002|Overall Study|Adverse Event|13|||
130662969|NCT00446134|470392008|FG003|Overall Study|Adverse Event|18|||
130662970|NCT00446134|470392005|FG000|Overall Study|Lack of Efficacy|19|||
130662971|NCT00446134|470392006|FG001|Overall Study|Lack of Efficacy|19|||
130662972|NCT00446134|470392007|FG002|Overall Study|Lack of Efficacy|24|||
130662973|NCT00446134|470392008|FG003|Overall Study|Lack of Efficacy|19|||
130662974|NCT00446134|470392005|FG000|Overall Study|Protocol Violation|0|||
130552316|NCT01749540|469990169|FG003|Overall Study|Protocol Violation|0|||
130552317|NCT01749540|469990170|FG004|Overall Study|Protocol Violation|0|||
130552318|NCT01749540|469990171|FG005|Overall Study|Protocol Violation|1|||
130552319|NCT01749540|469990172|FG006|Overall Study|Protocol Violation|1|||
130552320|NCT01749540|469990166|FG000|Overall Study|Withdrawal by Subject|0|||
130552321|NCT01749540|469990167|FG001|Overall Study|Withdrawal by Subject|0|||
130552322|NCT01749540|469990168|FG002|Overall Study|Withdrawal by Subject|0|||
130552323|NCT01749540|469990169|FG003|Overall Study|Withdrawal by Subject|1|||
130552324|NCT01749540|469990170|FG004|Overall Study|Withdrawal by Subject|0|||
130552325|NCT01749540|469990171|FG005|Overall Study|Withdrawal by Subject|0|||
130552326|NCT01749540|469990172|FG006|Overall Study|Withdrawal by Subject|0|||
130552327|NCT01749540|469990166|FG000|Overall Study|Initiated into extension study A536-06|0|||
130552328|NCT01749540|469990167|FG001|Overall Study|Initiated into extension study A536-06|0|||
130552329|NCT01749540|469990168|FG002|Overall Study|Initiated into extension study A536-06|0|||
130552330|NCT01749540|469990169|FG003|Overall Study|Initiated into extension study A536-06|0|||
130552331|NCT01749540|469990170|FG004|Overall Study|Initiated into extension study A536-06|0|||
130552332|NCT01749540|469990171|FG005|Overall Study|Initiated into extension study A536-06|2|||
130552333|NCT01749540|469990172|FG006|Overall Study|Initiated into extension study A536-06|24|||
130552334|NCT00576836|469990173|FG000|Overall Study|Death|0|||
130552335|NCT00576836|469990174|FG001|Overall Study|Death|1|||
130552336|NCT00576836|469990173|FG000|Overall Study|Physician Decision|0|||
130552337|NCT00576836|469990174|FG001|Overall Study|Physician Decision|1|||
130552338|NCT01296347|469990175|FG000|Allocation|Withdrawal by Subject|1|||
130552339|NCT01296347|469990176|FG001|Allocation|Withdrawal by Subject|2|||
130552340|NCT01296347|469990175|FG000|Allocation|Lack of Efficacy|1|||
130552341|NCT01296347|469990176|FG001|Allocation|Lack of Efficacy|2|||
130552342|NCT01296347|469990175|FG000|Allocation|not received infusion|1|||
130552343|NCT01296347|469990176|FG001|Allocation|not received infusion|0|||
130552344|NCT01296347|469990175|FG000|6 Week Follow up|Death|0|||
130552345|NCT01296347|469990176|FG001|6 Week Follow up|Death|1|||
130552346|NCT01296347|469990175|FG000|3 Month Follow up|Death|1|||
130552347|NCT01296347|469990176|FG001|3 Month Follow up|Death|0|||
130552348|NCT01296347|469990175|FG000|3 Month Follow up|Lost to Follow-up|0|||
130552349|NCT01296347|469990176|FG001|3 Month Follow up|Lost to Follow-up|1|||
130552350|NCT01296347|469990175|FG000|6 Month Follow up|Death|2|||
130552351|NCT01296347|469990176|FG001|6 Month Follow up|Death|1|||
130552352|NCT01296347|469990175|FG000|6 Month Follow up|Lost to Follow-up|0|||
130552353|NCT01296347|469990176|FG001|6 Month Follow up|Lost to Follow-up|1|||
130552354|NCT01296347|469990175|FG000|12 Month Follow up|Lost to Follow-up|3|||
130552355|NCT01296347|469990176|FG001|12 Month Follow up|Lost to Follow-up|1|||
130552356|NCT01296347|469990175|FG000|12 Month Follow up|Death|1|||
130552357|NCT01296347|469990176|FG001|12 Month Follow up|Death|1|||
130552358|NCT01296347|469990175|FG000|12 Month Follow up|Withdrawal by Subject|0|||
130552359|NCT01296347|469990176|FG001|12 Month Follow up|Withdrawal by Subject|1|||
130552360|NCT02240693|469990177|FG000|Overall Study|Adverse Event|0|||
130552361|NCT02240693|469990178|FG001|Overall Study|Adverse Event|0|||
130552362|NCT02240693|469990179|FG002|Overall Study|Adverse Event|0|||
130552363|NCT02240693|469990180|FG003|Overall Study|Adverse Event|0|||
130552364|NCT02240693|469990181|FG004|Overall Study|Adverse Event|1|||
130552365|NCT02240693|469990177|FG000|Overall Study|Withdrawal by Subject|0|||
130552366|NCT02240693|469990178|FG001|Overall Study|Withdrawal by Subject|0|||
130552367|NCT02240693|469990179|FG002|Overall Study|Withdrawal by Subject|2|||
130552368|NCT02240693|469990180|FG003|Overall Study|Withdrawal by Subject|1|||
130552369|NCT02240693|469990181|FG004|Overall Study|Withdrawal by Subject|0|||
130552370|NCT02240693|469990177|FG000|Overall Study|Other than specified|0|||
130552371|NCT02240693|469990178|FG001|Overall Study|Other than specified|0|||
130552372|NCT02240693|469990179|FG002|Overall Study|Other than specified|2|||
130552373|NCT02240693|469990180|FG003|Overall Study|Other than specified|0|||
130552374|NCT02240693|469990181|FG004|Overall Study|Other than specified|0|||
130552375|NCT01116882|469990182|FG000|30-day|Lost to Follow-up|50|||
130552376|NCT01116882|469990183|FG001|30-day|Lost to Follow-up|21|||
130552377|NCT01116882|469990182|FG000|30-day|Withdrawal by Subject|2|||
130552378|NCT01116882|469990183|FG001|30-day|Withdrawal by Subject|4|||
130552379|NCT01116882|469990182|FG000|30-day|Other Reasons|16|||
130552380|NCT01116882|469990183|FG001|30-day|Other Reasons|6|||
130552381|NCT01116882|469990182|FG000|12-month|Lost to Follow-up|111|||
130552382|NCT01116882|469990183|FG001|12-month|Lost to Follow-up|42|||
130552383|NCT01116882|469990182|FG000|12-month|Other Reasons|151|||
130552384|NCT01116882|469990183|FG001|12-month|Other Reasons|49|||
130552385|NCT01116882|469990182|FG000|12-month|Withdrawal by Subject|5|||
130552386|NCT01116882|469990183|FG001|12-month|Withdrawal by Subject|8|||
130552387|NCT00971243|469990186|FG000|Double Blind Period|Adverse Event|2|||
130552388|NCT00971243|469990187|FG001|Double Blind Period|Adverse Event|3|||
130552389|NCT00971243|469990188|FG002|Double Blind Period|Adverse Event|2|||
130552390|NCT00971243|469990189|FG003|Double Blind Period|Adverse Event|2|||
130552391|NCT00971243|469990190|FG004|Double Blind Period|Adverse Event|3|||
130662975|NCT00446134|470392006|FG001|Overall Study|Protocol Violation|2|||
130662976|NCT00446134|470392007|FG002|Overall Study|Protocol Violation|1|||
130662977|NCT00446134|470392008|FG003|Overall Study|Protocol Violation|0|||
130662978|NCT00446134|470392005|FG000|Overall Study|Lost to Follow-up|1|||
130662979|NCT00446134|470392006|FG001|Overall Study|Lost to Follow-up|3|||
130662980|NCT00446134|470392007|FG002|Overall Study|Lost to Follow-up|1|||
130662981|NCT00446134|470392008|FG003|Overall Study|Lost to Follow-up|1|||
130662982|NCT00446134|470392005|FG000|Overall Study|Withdrawal by Subject|3|||
130662983|NCT00446134|470392006|FG001|Overall Study|Withdrawal by Subject|3|||
130662984|NCT00446134|470392007|FG002|Overall Study|Withdrawal by Subject|1|||
130662985|NCT00446134|470392008|FG003|Overall Study|Withdrawal by Subject|3|||
130662986|NCT00446134|470392005|FG000|Overall Study|Physician Decision|0|||
130662987|NCT00446134|470392006|FG001|Overall Study|Physician Decision|0|||
130662988|NCT00446134|470392007|FG002|Overall Study|Physician Decision|0|||
130662989|NCT00446134|470392008|FG003|Overall Study|Physician Decision|2|||
130662990|NCT00446134|470392005|FG000|Overall Study|Adverse Event-Diarrhea|1|||
130662991|NCT00446134|470392006|FG001|Overall Study|Adverse Event-Diarrhea|1|||
130662992|NCT00446134|470392007|FG002|Overall Study|Adverse Event-Diarrhea|2|||
130662993|NCT00446134|470392008|FG003|Overall Study|Adverse Event-Diarrhea|0|||
130662994|NCT00446134|470392005|FG000|Overall Study|Reason Not Completed|3|||
130662995|NCT00446134|470392006|FG001|Overall Study|Reason Not Completed|0|||
130662996|NCT00446134|470392007|FG002|Overall Study|Reason Not Completed|1|||
130662997|NCT00446134|470392008|FG003|Overall Study|Reason Not Completed|2|||
130662998|NCT04816877|470392009|FG000|Overall Study|Withdrawal by Subject|1|||
130662999|NCT04816877|470392010|FG001|Overall Study|Withdrawal by Subject|0|||
130663000|NCT00928135|470392011|FG000|Overall Study|Withdrawal by Subject|1|||
130663001|NCT00928135|470392012|FG001|Overall Study|Withdrawal by Subject|0|||
130663002|NCT03338673|470392015|FG000|Overall Study|Lost to Follow-up|1|||
130663003|NCT03338673|470392016|FG001|Overall Study|Lost to Follow-up|1|||
130663004|NCT00434148|470392019|FG000|Overall Study|Adverse Event|18|||
130663005|NCT00434148|470392020|FG001|Overall Study|Adverse Event|18|||
130663006|NCT00434148|470392019|FG000|Overall Study|Lack of Efficacy|25|||
130663007|NCT00434148|470392020|FG001|Overall Study|Lack of Efficacy|28|||
130663008|NCT00434148|470392019|FG000|Overall Study|Withdrawal by Subject|15|||
130663009|NCT00434148|470392020|FG001|Overall Study|Withdrawal by Subject|15|||
130663010|NCT00434148|470392019|FG000|Overall Study|Protocol Violation|4|||
130663011|NCT00434148|470392020|FG001|Overall Study|Protocol Violation|0|||
130663012|NCT00434148|470392019|FG000|Overall Study|Administrative problems|6|||
130663013|NCT00434148|470392020|FG001|Overall Study|Administrative problems|10|||
130663014|NCT00434148|470392019|FG000|Overall Study|Lost to Follow-up|0|||
130663015|NCT00434148|470392020|FG001|Overall Study|Lost to Follow-up|1|||
130663016|NCT00434148|470392019|FG000|Overall Study|Condition no longer requires study drug|1|||
130663017|NCT00434148|470392020|FG001|Overall Study|Condition no longer requires study drug|0|||
130663018|NCT00434148|470392019|FG000|Overall Study|Abnormal test procedure result|0|||
130663019|NCT00434148|470392020|FG001|Overall Study|Abnormal test procedure result|1|||
130663020|NCT01861717|470392028|FG000|Overall Study|Lost to Follow-up|1|||
130663021|NCT01861717|470392028|FG000|Overall Study|Withdrawal by Subject|1|||
130663022|NCT03033069|470392029|FG000|Overall Study|Adverse Event|6|||
130663023|NCT03033069|470392030|FG001|Overall Study|Adverse Event|7|||
130663024|NCT03033069|470392031|FG002|Overall Study|Adverse Event|4|||
130663025|NCT03033069|470392032|FG003|Overall Study|Adverse Event|6|||
130663026|NCT03033069|470392029|FG000|Overall Study|Lack of Efficacy|0|||
130663027|NCT03033069|470392030|FG001|Overall Study|Lack of Efficacy|0|||
130663028|NCT03033069|470392031|FG002|Overall Study|Lack of Efficacy|1|||
130663029|NCT03033069|470392032|FG003|Overall Study|Lack of Efficacy|0|||
130663030|NCT03033069|470392029|FG000|Overall Study|Lost to Follow-up|6|||
130663031|NCT03033069|470392030|FG001|Overall Study|Lost to Follow-up|5|||
130334444|NCT00485134|469193811|FG002|Overall Study|Change in health status|2|||
130334445|NCT00485134|469193812|FG003|Overall Study|Change in health status|1|||
130334446|NCT00485134|469193813|FG004|Overall Study|Change in health status|0|||
130334447|NCT00485134|469193814|FG005|Overall Study|Change in health status|1|||
130334448|NCT00485134|469193815|FG006|Overall Study|Change in health status|0|||
130334449|NCT00485134|469193816|FG007|Overall Study|Change in health status|0|||
130334450|NCT00485134|469193809|FG000|Overall Study|Withdrew for adverse event|0|||
130334451|NCT00485134|469193810|FG001|Overall Study|Withdrew for adverse event|0|||
130334452|NCT00485134|469193811|FG002|Overall Study|Withdrew for adverse event|1|||
130663032|NCT03033069|470392031|FG002|Overall Study|Lost to Follow-up|5|||
130663033|NCT03033069|470392032|FG003|Overall Study|Lost to Follow-up|6|||
130663034|NCT03033069|470392029|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130663035|NCT03033069|470392030|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130663036|NCT03033069|470392031|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130663037|NCT03033069|470392032|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130663038|NCT03033069|470392029|FG000|Overall Study|Protocol Deviation|0|||
130663039|NCT03033069|470392030|FG001|Overall Study|Protocol Deviation|1|||
130663040|NCT03033069|470392031|FG002|Overall Study|Protocol Deviation|0|||
130663041|NCT03033069|470392032|FG003|Overall Study|Protocol Deviation|0|||
130334453|NCT00485134|469193812|FG003|Overall Study|Withdrew for adverse event|0|||
130663042|NCT03033069|470392029|FG000|Overall Study|Withdrawal by Subject|10|||
130663043|NCT03033069|470392030|FG001|Overall Study|Withdrawal by Subject|10|||
130663044|NCT03033069|470392031|FG002|Overall Study|Withdrawal by Subject|11|||
130663045|NCT03033069|470392032|FG003|Overall Study|Withdrawal by Subject|6|||
130663046|NCT03033069|470392029|FG000|Overall Study|Withdrawal By Caregiver|1|||
130663047|NCT03033069|470392030|FG001|Overall Study|Withdrawal By Caregiver|0|||
130663048|NCT03033069|470392031|FG002|Overall Study|Withdrawal By Caregiver|0|||
130663049|NCT03033069|470392032|FG003|Overall Study|Withdrawal By Caregiver|0|||
130663050|NCT03033069|470392029|FG000|Overall Study|Reason not Specified|0|||
130663051|NCT03033069|470392030|FG001|Overall Study|Reason not Specified|1|||
130663052|NCT03033069|470392031|FG002|Overall Study|Reason not Specified|0|||
130663053|NCT03033069|470392032|FG003|Overall Study|Reason not Specified|1|||
130663054|NCT02623426|470392035|FG000|Overall Study|Lost to Follow-up|0|||
130663055|NCT02623426|470392036|FG001|Overall Study|Lost to Follow-up|0|||
130663056|NCT02623426|470392037|FG002|Overall Study|Lost to Follow-up|1|||
130663057|NCT02623426|470392035|FG000|Overall Study|Withdrawal by Subject|1|||
130663058|NCT02623426|470392036|FG001|Overall Study|Withdrawal by Subject|2|||
130663059|NCT02623426|470392037|FG002|Overall Study|Withdrawal by Subject|2|||
130663060|NCT05458895|470392042|FG000|Overall Study|Withdrawal by Subject|8|||
130663061|NCT05458895|470392042|FG000|Overall Study|Lost to Follow-up|17|||
130663062|NCT05458895|470392042|FG000|Overall Study|Pregnancy|2|||
130663063|NCT05458895|470392042|FG000|Overall Study|Withdrawal by Study Team|1|||
130663064|NCT04639310|470392043|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
130663065|NCT04639310|470392044|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
130663066|NCT01858558|470393762|FG000|Overall Study|Death|1|||
130663067|NCT01858558|470393763|FG001|Overall Study|Death|1|||
130663068|NCT01858558|470393762|FG000|Overall Study|Lost to Follow-up|1|||
130663069|NCT01858558|470393763|FG001|Overall Study|Lost to Follow-up|0|||
130663070|NCT01858558|470393762|FG000|Overall Study|Disease progression|3|||
130663071|NCT01858558|470393763|FG001|Overall Study|Disease progression|1|||
130663072|NCT01858558|470393762|FG000|Overall Study|Product contamination|2|||
130663073|NCT01858558|470393763|FG001|Overall Study|Product contamination|0|||
130663074|NCT01858558|470393762|FG000|Overall Study|Failed expansion of cell product|2|||
130663075|NCT01858558|470393763|FG001|Overall Study|Failed expansion of cell product|0|||
130663076|NCT01142466|470393764|FG000|Overall Study|Adverse Event|2|||
130663077|NCT01142466|470393765|FG001|Overall Study|Adverse Event|1|||
130663078|NCT01142466|470393764|FG000|Overall Study|Withdrawal by Subject|1|||
130663079|NCT01142466|470393765|FG001|Overall Study|Withdrawal by Subject|1|||
130663080|NCT00569231|470393766|FG000|Overall Study|Study unrelated surgery|1|||
130663081|NCT00569231|470393766|FG000|Overall Study|Airfare expense|2|||
130663082|NCT00569231|470393766|FG000|Overall Study|Withdrawal by Subject|1|||
130663083|NCT00569231|470393766|FG000|Overall Study|Car accident injury|1|||
130663084|NCT00569231|470393766|FG000|Overall Study|Non-compliance|2|||
130663085|NCT00700310|470393769|FG000|Overall Study|Adverse Event|6|||
130663086|NCT00700310|470393770|FG001|Overall Study|Adverse Event|10|||
130663087|NCT00700310|470393771|FG002|Overall Study|Adverse Event|5|||
130663088|NCT00700310|470393772|FG003|Overall Study|Adverse Event|11|||
130663089|NCT00700310|470393769|FG000|Overall Study|Lost to Follow-up|4|||
130663090|NCT00700310|470393770|FG001|Overall Study|Lost to Follow-up|1|||
130663091|NCT00700310|470393771|FG002|Overall Study|Lost to Follow-up|0|||
130663092|NCT00700310|470393772|FG003|Overall Study|Lost to Follow-up|1|||
130663093|NCT00700310|470393769|FG000|Overall Study|Withdrawal by Subject|8|||
130663094|NCT00700310|470393770|FG001|Overall Study|Withdrawal by Subject|9|||
130663095|NCT00700310|470393771|FG002|Overall Study|Withdrawal by Subject|8|||
130663096|NCT00700310|470393772|FG003|Overall Study|Withdrawal by Subject|8|||
130663097|NCT00700310|470393769|FG000|Overall Study|Lack of Efficacy|0|||
130663098|NCT00700310|470393770|FG001|Overall Study|Lack of Efficacy|3|||
130663099|NCT00700310|470393771|FG002|Overall Study|Lack of Efficacy|0|||
130663100|NCT00700310|470393772|FG003|Overall Study|Lack of Efficacy|1|||
130663101|NCT00700310|470393769|FG000|Overall Study|Administrative/Other|1|||
130663102|NCT00700310|470393770|FG001|Overall Study|Administrative/Other|3|||
130663103|NCT00700310|470393771|FG002|Overall Study|Administrative/Other|1|||
130663104|NCT00700310|470393772|FG003|Overall Study|Administrative/Other|3|||
130663105|NCT00700310|470393769|FG000|Overall Study|Randomized, Not Treated|2|||
130663106|NCT00700310|470393770|FG001|Overall Study|Randomized, Not Treated|0|||
130663107|NCT00700310|470393771|FG002|Overall Study|Randomized, Not Treated|2|||
130663108|NCT00700310|470393772|FG003|Overall Study|Randomized, Not Treated|2|||
130663109|NCT00681824|470393777|FG000|Overall Study|withdrawn by investigator|0|||
130663110|NCT00681824|470393778|FG001|Overall Study|withdrawn by investigator|0|||
130663111|NCT00681824|470393779|FG002|Overall Study|withdrawn by investigator|1|||
130663112|NCT00681824|470393777|FG000|Overall Study|scheduling conflict|1|||
130663113|NCT00681824|470393778|FG001|Overall Study|scheduling conflict|0|||
130663114|NCT00681824|470393779|FG002|Overall Study|scheduling conflict|0|||
130663115|NCT00681824|470393777|FG000|Overall Study|Death|0|||
130663116|NCT00681824|470393778|FG001|Overall Study|Death|1|||
130663117|NCT00681824|470393779|FG002|Overall Study|Death|0|||
130663118|NCT03724916|470393780|FG000|Overall Study|Withdrawal by Subject|0|||
130334454|NCT00485134|469193813|FG004|Overall Study|Withdrew for adverse event|0|||
130334455|NCT00485134|469193814|FG005|Overall Study|Withdrew for adverse event|0|||
130334456|NCT00485134|469193815|FG006|Overall Study|Withdrew for adverse event|0|||
130334457|NCT00485134|469193816|FG007|Overall Study|Withdrew for adverse event|0|||
130334458|NCT00485134|469193809|FG000|Overall Study|Positive drug test|0|||
130334459|NCT00485134|469193810|FG001|Overall Study|Positive drug test|0|||
130334460|NCT00485134|469193811|FG002|Overall Study|Positive drug test|0|||
130334461|NCT00485134|469193812|FG003|Overall Study|Positive drug test|0|||
130334462|NCT00485134|469193813|FG004|Overall Study|Positive drug test|2|||
130334463|NCT00485134|469193814|FG005|Overall Study|Positive drug test|1|||
130334464|NCT00485134|469193815|FG006|Overall Study|Positive drug test|0|||
130334465|NCT00485134|469193816|FG007|Overall Study|Positive drug test|0|||
130334466|NCT00485134|469193809|FG000|Overall Study|Non-compliance|0|||
130552392|NCT00971243|469990186|FG000|Double Blind Period|Lost to Follow-up|0|||
130552393|NCT00971243|469990187|FG001|Double Blind Period|Lost to Follow-up|1|||
130552394|NCT00971243|469990188|FG002|Double Blind Period|Lost to Follow-up|1|||
130552395|NCT00971243|469990189|FG003|Double Blind Period|Lost to Follow-up|0|||
130552396|NCT00971243|469990190|FG004|Double Blind Period|Lost to Follow-up|1|||
130552397|NCT00971243|469990186|FG000|Double Blind Period|Physician Decision|10|||
130552398|NCT00971243|469990187|FG001|Double Blind Period|Physician Decision|6|||
130552399|NCT00971243|469990188|FG002|Double Blind Period|Physician Decision|7|||
130552400|NCT00971243|469990189|FG003|Double Blind Period|Physician Decision|6|||
130552401|NCT00971243|469990190|FG004|Double Blind Period|Physician Decision|7|||
130552402|NCT00971243|469990186|FG000|Double Blind Period|Protocol Violation|2|||
130552403|NCT00971243|469990187|FG001|Double Blind Period|Protocol Violation|0|||
130552404|NCT00971243|469990188|FG002|Double Blind Period|Protocol Violation|3|||
130552405|NCT00971243|469990189|FG003|Double Blind Period|Protocol Violation|2|||
130552406|NCT00971243|469990190|FG004|Double Blind Period|Protocol Violation|2|||
130552407|NCT00971243|469990186|FG000|Double Blind Period|Withdrawal by Subject|4|||
130552408|NCT00971243|469990187|FG001|Double Blind Period|Withdrawal by Subject|1|||
130552409|NCT00971243|469990188|FG002|Double Blind Period|Withdrawal by Subject|4|||
130552410|NCT00971243|469990189|FG003|Double Blind Period|Withdrawal by Subject|4|||
130552411|NCT00971243|469990190|FG004|Double Blind Period|Withdrawal by Subject|4|||
130552412|NCT00971243|469990186|FG000|Double Blind Period|Other reasons|1|||
130552413|NCT00971243|469990187|FG001|Double Blind Period|Other reasons|0|||
130552414|NCT00971243|469990188|FG002|Double Blind Period|Other reasons|2|||
130552415|NCT00971243|469990189|FG003|Double Blind Period|Other reasons|0|||
130552416|NCT00971243|469990190|FG004|Double Blind Period|Other reasons|1|||
130552417|NCT00971243|469990186|FG000|Open-label Period|Adverse Event|1|||
130552418|NCT00971243|469990187|FG001|Open-label Period|Adverse Event|0|||
130552419|NCT00971243|469990188|FG002|Open-label Period|Adverse Event|1|||
130552420|NCT00971243|469990189|FG003|Open-label Period|Adverse Event|1|||
130552421|NCT00971243|469990190|FG004|Open-label Period|Adverse Event|0|||
130552422|NCT00971243|469990186|FG000|Open-label Period|Physician Decision|5|||
130552423|NCT00971243|469990187|FG001|Open-label Period|Physician Decision|9|||
130552424|NCT00971243|469990188|FG002|Open-label Period|Physician Decision|3|||
130552425|NCT00971243|469990189|FG003|Open-label Period|Physician Decision|7|||
130552426|NCT00971243|469990190|FG004|Open-label Period|Physician Decision|2|||
130552427|NCT00971243|469990186|FG000|Open-label Period|Protocol Violation|1|||
130552428|NCT00971243|469990187|FG001|Open-label Period|Protocol Violation|1|||
130552429|NCT00971243|469990188|FG002|Open-label Period|Protocol Violation|1|||
130552430|NCT00971243|469990189|FG003|Open-label Period|Protocol Violation|0|||
130552431|NCT00971243|469990190|FG004|Open-label Period|Protocol Violation|1|||
130552432|NCT00971243|469990186|FG000|Open-label Period|Withdrawal by Subject|1|||
130552433|NCT00971243|469990187|FG001|Open-label Period|Withdrawal by Subject|0|||
130552434|NCT00971243|469990188|FG002|Open-label Period|Withdrawal by Subject|0|||
130552435|NCT00971243|469990189|FG003|Open-label Period|Withdrawal by Subject|2|||
130552436|NCT00971243|469990190|FG004|Open-label Period|Withdrawal by Subject|1|||
130552437|NCT00971243|469990186|FG000|Open-label Period|Other reason|0|||
130552438|NCT00971243|469990187|FG001|Open-label Period|Other reason|0|||
130552439|NCT00971243|469990188|FG002|Open-label Period|Other reason|0|||
130552440|NCT00971243|469990189|FG003|Open-label Period|Other reason|0|||
130552441|NCT00971243|469990190|FG004|Open-label Period|Other reason|2|||
130552442|NCT02092220|469990192|FG000|Period 1|Unrelated Illness|0|||
130552443|NCT02092220|469990193|FG001|Period 1|Unrelated Illness|2|||
130552444|NCT02092220|469990192|FG000|Period 2|Severe Hypoglycaemia|1|||
130552445|NCT02092220|469990193|FG001|Period 2|Severe Hypoglycaemia|0|||
130552446|NCT02092220|469990192|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
130552447|NCT02092220|469990193|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
130552448|NCT02739360|469990194|FG000|Overall Study|Adverse Event|1|||
130552449|NCT02739360|469990194|FG000|Overall Study|Study terminated by Sponsor|2|||
130334467|NCT00485134|469193810|FG001|Overall Study|Non-compliance|0|||
130334468|NCT00485134|469193811|FG002|Overall Study|Non-compliance|0|||
130334469|NCT00485134|469193812|FG003|Overall Study|Non-compliance|0|||
130552450|NCT01193920|469990195|FG000|Overall Study|Withdrawal by Subject|1|||
130552451|NCT01193920|469990196|FG001|Overall Study|Withdrawal by Subject|0|||
130552452|NCT01193920|469990197|FG002|Overall Study|Withdrawal by Subject|5|||
130552453|NCT01193920|469990198|FG003|Overall Study|Withdrawal by Subject|1|||
130663119|NCT03724916|470393781|FG001|Overall Study|Withdrawal by Subject|1|||
130663120|NCT03724916|470393782|FG002|Overall Study|Withdrawal by Subject|1|||
130663121|NCT03724916|470393783|FG003|Overall Study|Withdrawal by Subject|2|||
130663122|NCT03724916|470393780|FG000|Overall Study|Randomized but not Treated|1|||
130663123|NCT03724916|470393781|FG001|Overall Study|Randomized but not Treated|0|||
130663124|NCT03724916|470393782|FG002|Overall Study|Randomized but not Treated|0|||
130663125|NCT03724916|470393783|FG003|Overall Study|Randomized but not Treated|0|||
130663126|NCT04575038|470393784|FG000|Overall Study|Withdrawal by Subject|1|||
130663127|NCT04575038|470393785|FG001|Overall Study|Withdrawal by Subject|1|||
130663128|NCT04388527|470393790|FG000|Overall Study|Death|14|||
130663129|NCT04388527|470393790|FG000|Overall Study|Withdrawal by Subject|2|||
130663130|NCT04388527|470393790|FG000|Overall Study|Lost to Follow-up|1|||
130663131|NCT02018042|470393793|FG000|Overall Study|Withdrawal by Subject|1|||
130663132|NCT01954082|470393794|FG000|Overall Study|Study Suspension|42|||
130663133|NCT01954082|470393795|FG001|Overall Study|Study Suspension|36|||
130663134|NCT01954082|470393794|FG000|Overall Study|Adverse Event|10|||
130663135|NCT01954082|470393795|FG001|Overall Study|Adverse Event|4|||
130663136|NCT01954082|470393794|FG000|Overall Study|Intolerance|0|||
130663137|NCT01954082|470393795|FG001|Overall Study|Intolerance|1|||
130663138|NCT01954082|470393794|FG000|Overall Study|Non-compliance|6|||
130663139|NCT01954082|470393795|FG001|Overall Study|Non-compliance|4|||
130663140|NCT01954082|470393794|FG000|Overall Study|Physician Decision|2|||
130663141|NCT01954082|470393795|FG001|Overall Study|Physician Decision|0|||
130663142|NCT01954082|470393794|FG000|Overall Study|Parent Decision|1|||
130663143|NCT01954082|470393795|FG001|Overall Study|Parent Decision|0|||
130663144|NCT01954082|470393794|FG000|Overall Study|Withdrawal by Subject|0|||
130663145|NCT01954082|470393795|FG001|Overall Study|Withdrawal by Subject|1|||
130663146|NCT01954082|470393794|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
130663147|NCT01954082|470393795|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
130663148|NCT01954082|470393794|FG000|Overall Study|Redirection of Care|0|||
130663149|NCT01954082|470393795|FG001|Overall Study|Redirection of Care|2|||
130663150|NCT01954082|470393794|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
130663151|NCT01954082|470393795|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
130663152|NCT01954082|470393794|FG000|Overall Study|Comfort Care|0|||
130663153|NCT01954082|470393795|FG001|Overall Study|Comfort Care|1|||
130663154|NCT01954082|470393794|FG000|Overall Study|Infant Moved|0|||
130663155|NCT01954082|470393795|FG001|Overall Study|Infant Moved|1|||
130663156|NCT01954082|470393794|FG000|Overall Study|Randomized not Treated|4|||
130663157|NCT01954082|470393795|FG001|Overall Study|Randomized not Treated|2|||
130663158|NCT02454972|470393796|FG000|Overall Study|Progressive disease|17|||
130663159|NCT02454972|470393797|FG001|Overall Study|Progressive disease|16|||
130663160|NCT02454972|470393798|FG002|Overall Study|Progressive disease|59|||
130663161|NCT02454972|470393799|FG003|Overall Study|Progressive disease|23|||
130663162|NCT02454972|470393800|FG004|Overall Study|Progressive disease|16|||
130663163|NCT02454972|470393801|FG005|Overall Study|Progressive disease|12|||
130663164|NCT02454972|470393802|FG006|Overall Study|Progressive disease|19|||
130663165|NCT02454972|470393803|FG007|Overall Study|Progressive disease|27|||
130663166|NCT02454972|470393804|FG008|Overall Study|Progressive disease|0|||
130663167|NCT02454972|470393796|FG000|Overall Study|Death|0|||
130663168|NCT02454972|470393797|FG001|Overall Study|Death|0|||
130663169|NCT02454972|470393798|FG002|Overall Study|Death|5|||
130663170|NCT02454972|470393799|FG003|Overall Study|Death|1|||
130663171|NCT02454972|470393800|FG004|Overall Study|Death|0|||
130663172|NCT02454972|470393801|FG005|Overall Study|Death|0|||
130663173|NCT02454972|470393802|FG006|Overall Study|Death|0|||
130663174|NCT02454972|470393803|FG007|Overall Study|Death|0|||
130663175|NCT02454972|470393804|FG008|Overall Study|Death|95|||
130663176|NCT02454972|470393796|FG000|Overall Study|Physician Decision|0|||
130663177|NCT02454972|470393797|FG001|Overall Study|Physician Decision|1|||
130663178|NCT02454972|470393798|FG002|Overall Study|Physician Decision|2|||
130663179|NCT02454972|470393799|FG003|Overall Study|Physician Decision|1|||
130663180|NCT02454972|470393800|FG004|Overall Study|Physician Decision|2|||
130663181|NCT02454972|470393801|FG005|Overall Study|Physician Decision|0|||
130663182|NCT02454972|470393802|FG006|Overall Study|Physician Decision|0|||
130663183|NCT02454972|470393803|FG007|Overall Study|Physician Decision|1|||
130663184|NCT02454972|470393804|FG008|Overall Study|Physician Decision|0|||
130663185|NCT02454972|470393796|FG000|Overall Study|Non treatment-related adverse event|2|||
130663186|NCT02454972|470393797|FG001|Overall Study|Non treatment-related adverse event|0|||
130663187|NCT02454972|470393798|FG002|Overall Study|Non treatment-related adverse event|1|||
130663188|NCT02454972|470393799|FG003|Overall Study|Non treatment-related adverse event|0|||
130663189|NCT02454972|470393800|FG004|Overall Study|Non treatment-related adverse event|0|||
130663190|NCT02454972|470393801|FG005|Overall Study|Non treatment-related adverse event|1|||
130663191|NCT02454972|470393802|FG006|Overall Study|Non treatment-related adverse event|0|||
130663192|NCT02454972|470393803|FG007|Overall Study|Non treatment-related adverse event|1|||
130663193|NCT02454972|470393804|FG008|Overall Study|Non treatment-related adverse event|0|||
130663194|NCT02454972|470393796|FG000|Overall Study|Treatment-related adverse events|0|||
130663195|NCT02454972|470393797|FG001|Overall Study|Treatment-related adverse events|1|||
130663196|NCT02454972|470393798|FG002|Overall Study|Treatment-related adverse events|1|||
130663197|NCT02454972|470393799|FG003|Overall Study|Treatment-related adverse events|0|||
130663198|NCT02454972|470393800|FG004|Overall Study|Treatment-related adverse events|2|||
130663199|NCT02454972|470393801|FG005|Overall Study|Treatment-related adverse events|0|||
130663200|NCT02454972|470393802|FG006|Overall Study|Treatment-related adverse events|0|||
130663201|NCT02454972|470393803|FG007|Overall Study|Treatment-related adverse events|2|||
130663202|NCT02454972|470393804|FG008|Overall Study|Treatment-related adverse events|0|||
130663203|NCT02454972|470393796|FG000|Overall Study|Patient moves to compassionate use|0|||
130663204|NCT02454972|470393797|FG001|Overall Study|Patient moves to compassionate use|0|||
130663205|NCT02454972|470393798|FG002|Overall Study|Patient moves to compassionate use|0|||
130663206|NCT02454972|470393799|FG003|Overall Study|Patient moves to compassionate use|0|||
130663207|NCT02454972|470393800|FG004|Overall Study|Patient moves to compassionate use|0|||
130663208|NCT02454972|470393801|FG005|Overall Study|Patient moves to compassionate use|0|||
130663209|NCT02454972|470393802|FG006|Overall Study|Patient moves to compassionate use|2|||
130663210|NCT02454972|470393803|FG007|Overall Study|Patient moves to compassionate use|0|||
130663211|NCT02454972|470393804|FG008|Overall Study|Patient moves to compassionate use|0|||
130663212|NCT02454972|470393796|FG000|Overall Study|Withdrawal by Subject|0|||
130663213|NCT02454972|470393797|FG001|Overall Study|Withdrawal by Subject|1|||
130663214|NCT02454972|470393798|FG002|Overall Study|Withdrawal by Subject|5|||
130663215|NCT02454972|470393799|FG003|Overall Study|Withdrawal by Subject|2|||
130663216|NCT02454972|470393800|FG004|Overall Study|Withdrawal by Subject|3|||
130663217|NCT02454972|470393801|FG005|Overall Study|Withdrawal by Subject|2|||
130663218|NCT02454972|470393802|FG006|Overall Study|Withdrawal by Subject|0|||
130663219|NCT02454972|470393803|FG007|Overall Study|Withdrawal by Subject|1|||
130663220|NCT02454972|470393804|FG008|Overall Study|Withdrawal by Subject|2|||
130663221|NCT02454972|470393796|FG000|Overall Study|Multiple delay/holds on treatment|0|||
130663222|NCT02454972|470393797|FG001|Overall Study|Multiple delay/holds on treatment|0|||
130663223|NCT02454972|470393798|FG002|Overall Study|Multiple delay/holds on treatment|0|||
130663224|NCT02454972|470393799|FG003|Overall Study|Multiple delay/holds on treatment|1|||
130663225|NCT02454972|470393800|FG004|Overall Study|Multiple delay/holds on treatment|0|||
130663226|NCT02454972|470393801|FG005|Overall Study|Multiple delay/holds on treatment|0|||
130663227|NCT02454972|470393802|FG006|Overall Study|Multiple delay/holds on treatment|0|||
130663228|NCT02454972|470393803|FG007|Overall Study|Multiple delay/holds on treatment|0|||
130663229|NCT02454972|470393804|FG008|Overall Study|Multiple delay/holds on treatment|0|||
130663230|NCT02454972|470393796|FG000|Overall Study|Never treated|0|||
130663231|NCT02454972|470393797|FG001|Overall Study|Never treated|0|||
130663232|NCT02454972|470393798|FG002|Overall Study|Never treated|3|||
130663233|NCT02454972|470393799|FG003|Overall Study|Never treated|1|||
130663234|NCT02454972|470393800|FG004|Overall Study|Never treated|1|||
130663235|NCT02454972|470393801|FG005|Overall Study|Never treated|0|||
130663236|NCT02454972|470393802|FG006|Overall Study|Never treated|0|||
130663237|NCT02454972|470393803|FG007|Overall Study|Never treated|0|||
130663238|NCT02454972|470393804|FG008|Overall Study|Never treated|5|||
130663239|NCT02454972|470393796|FG000|Overall Study|Lost to Follow-up|0|||
130663240|NCT02454972|470393797|FG001|Overall Study|Lost to Follow-up|0|||
130663241|NCT02454972|470393798|FG002|Overall Study|Lost to Follow-up|0|||
130663242|NCT02454972|470393799|FG003|Overall Study|Lost to Follow-up|0|||
130663243|NCT02454972|470393800|FG004|Overall Study|Lost to Follow-up|0|||
130663244|NCT02454972|470393801|FG005|Overall Study|Lost to Follow-up|0|||
130663245|NCT02454972|470393802|FG006|Overall Study|Lost to Follow-up|0|||
130663246|NCT02454972|470393803|FG007|Overall Study|Lost to Follow-up|0|||
130663247|NCT02454972|470393804|FG008|Overall Study|Lost to Follow-up|2|||
130663248|NCT02454972|470393796|FG000|Overall Study|Study termination|0|||
130663249|NCT02454972|470393797|FG001|Overall Study|Study termination|0|||
130663250|NCT02454972|470393798|FG002|Overall Study|Study termination|0|||
130663251|NCT02454972|470393799|FG003|Overall Study|Study termination|0|||
130663252|NCT02454972|470393800|FG004|Overall Study|Study termination|0|||
130663253|NCT02454972|470393801|FG005|Overall Study|Study termination|0|||
130663254|NCT02454972|470393802|FG006|Overall Study|Study termination|0|||
130663255|NCT02454972|470393803|FG007|Overall Study|Study termination|0|||
130663256|NCT02454972|470393804|FG008|Overall Study|Study termination|6|||
130663257|NCT01377233|470393805|FG000|Open-label|Adverse Event|1|||
130663258|NCT01377233|470393806|FG001|Open-label|Adverse Event|0|||
130663259|NCT01377233|470393807|FG002|Open-label|Adverse Event|0|||
130663260|NCT01377233|470393808|FG003|Open-label|Adverse Event|0|||
130663261|NCT01377233|470393809|FG004|Open-label|Adverse Event|0|||
130663262|NCT01377233|470393805|FG000|Open-label|Withdrawal by Subject|3|||
130663263|NCT01377233|470393806|FG001|Open-label|Withdrawal by Subject|0|||
130663264|NCT01377233|470393807|FG002|Open-label|Withdrawal by Subject|0|||
130663265|NCT01377233|470393808|FG003|Open-label|Withdrawal by Subject|0|||
130663266|NCT01377233|470393809|FG004|Open-label|Withdrawal by Subject|0|||
130216125|NCT01826981|468753949|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
130663267|NCT01377233|470393805|FG000|Double-blind|Adverse Event|0|||
130663268|NCT01377233|470393806|FG001|Double-blind|Adverse Event|1|||
130663269|NCT01377233|470393807|FG002|Double-blind|Adverse Event|2|||
130663270|NCT01377233|470393808|FG003|Double-blind|Adverse Event|2|||
130663271|NCT01377233|470393809|FG004|Double-blind|Adverse Event|0|||
130663272|NCT01377233|470393805|FG000|Double-blind|Protocol Violation|0|||
130663273|NCT01377233|470393806|FG001|Double-blind|Protocol Violation|0|||
130663274|NCT01377233|470393807|FG002|Double-blind|Protocol Violation|0|||
130663275|NCT01377233|470393808|FG003|Double-blind|Protocol Violation|0|||
130663276|NCT01377233|470393809|FG004|Double-blind|Protocol Violation|1|||
130663277|NCT01377233|470393805|FG000|Double-blind|Withdrawal by Subject|0|||
130663278|NCT01377233|470393806|FG001|Double-blind|Withdrawal by Subject|0|||
130663279|NCT01377233|470393807|FG002|Double-blind|Withdrawal by Subject|0|||
130663280|NCT01377233|470393808|FG003|Double-blind|Withdrawal by Subject|1|||
130663281|NCT01377233|470393809|FG004|Double-blind|Withdrawal by Subject|0|||
130663282|NCT01377233|470393805|FG000|Double-blind|Administrative or other|0|||
130663283|NCT01377233|470393806|FG001|Double-blind|Administrative or other|0|||
130663284|NCT01377233|470393807|FG002|Double-blind|Administrative or other|0|||
130663285|NCT01377233|470393808|FG003|Double-blind|Administrative or other|1|||
130663286|NCT01377233|470393809|FG004|Double-blind|Administrative or other|1|||
130663287|NCT00618774|470393812|FG000|Overall Study|Adverse Event|5|||
130663288|NCT00618774|470393813|FG001|Overall Study|Adverse Event|3|||
130663289|NCT00618774|470393812|FG000|Overall Study|Withdrawal by Subject|1|||
130663290|NCT00618774|470393813|FG001|Overall Study|Withdrawal by Subject|0|||
130663291|NCT00755937|470393814|FG000|Recruitment|Unknown if infliximab received|164|||
130663292|NCT00755937|470393814|FG000|Observational Follow-up|Lost to Follow-up|148|||
130663293|NCT00572156|470393815|FG000|Overall Study|Adverse Event|3|||
130663294|NCT00572156|470393816|FG001|Overall Study|Adverse Event|1|||
130663295|NCT00572156|470393817|FG002|Overall Study|Adverse Event|5|||
130663296|NCT00572156|470393818|FG003|Overall Study|Adverse Event|1|||
130663297|NCT00572156|470393815|FG000|Overall Study|Lost to Follow-up|1|||
130663298|NCT00572156|470393816|FG001|Overall Study|Lost to Follow-up|1|||
130663299|NCT00572156|470393817|FG002|Overall Study|Lost to Follow-up|1|||
130663300|NCT00572156|470393818|FG003|Overall Study|Lost to Follow-up|0|||
130663301|NCT00572156|470393815|FG000|Overall Study|Protocol Violation|1|||
130663302|NCT00572156|470393816|FG001|Overall Study|Protocol Violation|2|||
130663303|NCT00572156|470393817|FG002|Overall Study|Protocol Violation|0|||
130663304|NCT00572156|470393818|FG003|Overall Study|Protocol Violation|2|||
130663305|NCT00572156|470393815|FG000|Overall Study|Patient/Parent Decision|1|||
130663306|NCT00572156|470393816|FG001|Overall Study|Patient/Parent Decision|6|||
130663307|NCT00572156|470393817|FG002|Overall Study|Patient/Parent Decision|4|||
130663308|NCT00572156|470393818|FG003|Overall Study|Patient/Parent Decision|3|||
130663309|NCT00572156|470393815|FG000|Overall Study|Sponsor Decision|20|||
130663310|NCT00572156|470393816|FG001|Overall Study|Sponsor Decision|16|||
130663311|NCT00572156|470393817|FG002|Overall Study|Sponsor Decision|17|||
130663312|NCT00572156|470393818|FG003|Overall Study|Sponsor Decision|19|||
130663313|NCT02261974|470393819|FG000|Overall Study|Withdrawal by Subject|3|||
130663314|NCT02261974|470393820|FG001|Overall Study|Withdrawal by Subject|2|||
130663315|NCT02261974|470393819|FG000|Overall Study|Pregnancy|0|||
130663316|NCT02261974|470393820|FG001|Overall Study|Pregnancy|1|||
130663317|NCT02261974|470393819|FG000|Overall Study|Missed treatment cut-off date|6|||
130663318|NCT02261974|470393820|FG001|Overall Study|Missed treatment cut-off date|3|||
130663319|NCT02261974|470393819|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
130663320|NCT02261974|470393820|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
130663321|NCT02261974|470393819|FG000|Overall Study|Lost to Follow-up|2|||
130663322|NCT02261974|470393820|FG001|Overall Study|Lost to Follow-up|0|||
130663323|NCT02261974|470393819|FG000|Overall Study|Adverse Event|1|||
130663324|NCT02261974|470393820|FG001|Overall Study|Adverse Event|0|||
130663325|NCT01223196|470393821|FG000|Overall Study|Lost to Follow-up|2|||
130663326|NCT01223196|470393822|FG001|Overall Study|Lost to Follow-up|0|||
130663327|NCT01223196|470393821|FG000|Overall Study|Physician Decision|1|||
130663328|NCT01223196|470393822|FG001|Overall Study|Physician Decision|0|||
130663329|NCT01223196|470393821|FG000|Overall Study|Withdrawal by Subject|1|||
130663330|NCT01223196|470393822|FG001|Overall Study|Withdrawal by Subject|0|||
130334470|NCT00485134|469193813|FG004|Overall Study|Non-compliance|1|||
130334471|NCT00485134|469193814|FG005|Overall Study|Non-compliance|2|||
130334472|NCT00485134|469193815|FG006|Overall Study|Non-compliance|2|||
130334473|NCT00485134|469193816|FG007|Overall Study|Non-compliance|0|||
130663331|NCT05180630|470393823|FG000|First Intervention|Physician Decision|0|||
130663332|NCT05180630|470393824|FG001|First Intervention|Physician Decision|0|||
130663333|NCT05180630|470393825|FG002|First Intervention|Physician Decision|3|||
130663334|NCT00709735|470393828|FG000|Overall Study|Lost to Follow-up|1|||
130663335|NCT00709735|470393829|FG001|Overall Study|Lost to Follow-up|1|||
130663336|NCT00709735|470393828|FG000|Overall Study|Relapse into Opioid Abuse|0|||
130663337|NCT00709735|470393829|FG001|Overall Study|Relapse into Opioid Abuse|1|||
130663338|NCT00709735|470393828|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
130663339|NCT00709735|470393829|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
130663340|NCT02725671|470393830|FG000|Overall Study|Lost to Follow-up|1|||
130663341|NCT00666718|470393831|FG000|Overall Study|Adverse Event|0|||
130663342|NCT00666718|470393832|FG001|Overall Study|Adverse Event|1|||
130663343|NCT00666718|470393831|FG000|Overall Study|Death|1|||
130663344|NCT00666718|470393832|FG001|Overall Study|Death|0|||
130663345|NCT00666718|470393831|FG000|Overall Study|Lost to Follow-up|1|||
130663346|NCT00666718|470393832|FG001|Overall Study|Lost to Follow-up|0|||
130334474|NCT00485134|469193809|FG000|Overall Study|Unable to comply with study schedule|0|||
130334475|NCT00485134|469193810|FG001|Overall Study|Unable to comply with study schedule|0|||
130334476|NCT00485134|469193811|FG002|Overall Study|Unable to comply with study schedule|0|||
130334477|NCT00485134|469193812|FG003|Overall Study|Unable to comply with study schedule|0|||
130334478|NCT00485134|469193813|FG004|Overall Study|Unable to comply with study schedule|0|||
130334479|NCT00485134|469193814|FG005|Overall Study|Unable to comply with study schedule|0|||
130334480|NCT00485134|469193815|FG006|Overall Study|Unable to comply with study schedule|0|||
130334481|NCT00485134|469193816|FG007|Overall Study|Unable to comply with study schedule|1|||
130552454|NCT01193920|469990199|FG004|Overall Study|Withdrawal by Subject|3|||
130552455|NCT01193920|469990200|FG005|Overall Study|Withdrawal by Subject|1|||
130552456|NCT01193920|469990201|FG006|Overall Study|Withdrawal by Subject|3|||
130552457|NCT01193920|469990202|FG007|Overall Study|Withdrawal by Subject|0|||
130552458|NCT01193920|469990203|FG008|Overall Study|Withdrawal by Subject|1|||
130552459|NCT01193920|469990204|FG009|Overall Study|Withdrawal by Subject|0|||
130552460|NCT01193920|469990195|FG000|Overall Study|Lost to Follow-up|1|||
130552461|NCT01193920|469990196|FG001|Overall Study|Lost to Follow-up|0|||
130552462|NCT01193920|469990197|FG002|Overall Study|Lost to Follow-up|1|||
130552463|NCT01193920|469990198|FG003|Overall Study|Lost to Follow-up|1|||
130552464|NCT01193920|469990199|FG004|Overall Study|Lost to Follow-up|3|||
130552465|NCT01193920|469990200|FG005|Overall Study|Lost to Follow-up|3|||
130552466|NCT01193920|469990201|FG006|Overall Study|Lost to Follow-up|1|||
130552467|NCT01193920|469990202|FG007|Overall Study|Lost to Follow-up|0|||
130552468|NCT01193920|469990203|FG008|Overall Study|Lost to Follow-up|2|||
130552469|NCT01193920|469990204|FG009|Overall Study|Lost to Follow-up|3|||
130552470|NCT01193920|469990195|FG000|Overall Study|Protocol Violation|1|||
130552471|NCT01193920|469990196|FG001|Overall Study|Protocol Violation|0|||
130552472|NCT01193920|469990197|FG002|Overall Study|Protocol Violation|0|||
130552473|NCT01193920|469990198|FG003|Overall Study|Protocol Violation|0|||
130552474|NCT01193920|469990199|FG004|Overall Study|Protocol Violation|0|||
130552475|NCT01193920|469990200|FG005|Overall Study|Protocol Violation|0|||
130552476|NCT01193920|469990201|FG006|Overall Study|Protocol Violation|0|||
130552477|NCT01193920|469990202|FG007|Overall Study|Protocol Violation|0|||
130552478|NCT01193920|469990203|FG008|Overall Study|Protocol Violation|0|||
130552479|NCT01193920|469990204|FG009|Overall Study|Protocol Violation|0|||
130552480|NCT01193920|469990195|FG000|Overall Study|Death|0|||
130552481|NCT01193920|469990196|FG001|Overall Study|Death|0|||
130552482|NCT01193920|469990197|FG002|Overall Study|Death|0|||
130552483|NCT01193920|469990198|FG003|Overall Study|Death|1|||
130552484|NCT01193920|469990199|FG004|Overall Study|Death|0|||
130552485|NCT01193920|469990200|FG005|Overall Study|Death|0|||
130552486|NCT01193920|469990201|FG006|Overall Study|Death|2|||
130552487|NCT01193920|469990202|FG007|Overall Study|Death|3|||
130552488|NCT01193920|469990203|FG008|Overall Study|Death|2|||
130552489|NCT01193920|469990204|FG009|Overall Study|Death|4|||
130552490|NCT01193920|469990195|FG000|Overall Study|Unable to classify|0|||
130552491|NCT01193920|469990196|FG001|Overall Study|Unable to classify|0|||
130552492|NCT01193920|469990197|FG002|Overall Study|Unable to classify|0|||
130552493|NCT01193920|469990198|FG003|Overall Study|Unable to classify|1|||
130552494|NCT01193920|469990199|FG004|Overall Study|Unable to classify|0|||
130552495|NCT01193920|469990200|FG005|Overall Study|Unable to classify|0|||
130552496|NCT01193920|469990201|FG006|Overall Study|Unable to classify|0|||
130552497|NCT01193920|469990202|FG007|Overall Study|Unable to classify|1|||
130552498|NCT01193920|469990203|FG008|Overall Study|Unable to classify|0|||
130552499|NCT01193920|469990204|FG009|Overall Study|Unable to classify|0|||
130552500|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
130552501|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
130552502|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
130552503|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
130552504|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
130552505|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
130552506|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
130552507|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
130552508|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
130552509|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
130552510|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
130552511|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
130552512|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
130552513|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
130552514|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
130552515|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
130552516|NCT01231516|469990207|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
130552517|NCT01231516|469990208|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
130552518|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
130334482|NCT00485134|469193809|FG000|Overall Study|Pregnancy|0|||
130334483|NCT00485134|469193810|FG001|Overall Study|Pregnancy|0|||
130334484|NCT00485134|469193811|FG002|Overall Study|Pregnancy|0|||
130334485|NCT00485134|469193812|FG003|Overall Study|Pregnancy|0|||
130334486|NCT00485134|469193813|FG004|Overall Study|Pregnancy|0|||
130334487|NCT00485134|469193814|FG005|Overall Study|Pregnancy|0|||
130334488|NCT00485134|469193815|FG006|Overall Study|Pregnancy|1|||
130334489|NCT00485134|469193816|FG007|Overall Study|Pregnancy|0|||
130334490|NCT04294680|469193817|FG000|Overall Study|Withdrawal by Subject|2|||
130334491|NCT04294680|469193818|FG001|Overall Study|Withdrawal by Subject|1|||
130334492|NCT04294680|469193817|FG000|Overall Study|Follow-up visits completed outside of window|1|||
130334493|NCT04294680|469193818|FG001|Overall Study|Follow-up visits completed outside of window|0|||
130334494|NCT04027608|469193819|FG000|Overall Study|Withdrawal by Subject|13|||
130334495|NCT04027608|469193820|FG001|Overall Study|Withdrawal by Subject|2|||
130334496|NCT04027608|469193819|FG000|Overall Study|Protocol Violation|2|||
130334497|NCT04027608|469193820|FG001|Overall Study|Protocol Violation|1|||
130334498|NCT04027608|469193819|FG000|Overall Study|Physician Decision|1|||
130334499|NCT04027608|469193820|FG001|Overall Study|Physician Decision|0|||
130334500|NCT04027608|469193819|FG000|Overall Study|Lost to Follow-up|20|||
130334501|NCT04027608|469193820|FG001|Overall Study|Lost to Follow-up|4|||
130334502|NCT00993148|469193823|FG000|Overall Study|Lost to Follow-up|2|||
130334503|NCT00993148|469193823|FG000|Overall Study|never initiated treatment|1|||
130334504|NCT05564052|469193824|FG000|Overall Study|Withdrawal by Subject|0|||
130334505|NCT05564052|469193825|FG001|Overall Study|Withdrawal by Subject|0|||
130334506|NCT05564052|469193826|FG002|Overall Study|Withdrawal by Subject|0|||
130334507|NCT05564052|469193827|FG003|Overall Study|Withdrawal by Subject|1|||
130334510|NCT00924027|469193832|FG000|Overall Study|Lost to Further Follow-Up|4|||
130334511|NCT00924027|469193833|FG001|Overall Study|Lost to Further Follow-Up|0|||
130334512|NCT00924027|469193834|FG002|Overall Study|Lost to Further Follow-Up|0|||
130334513|NCT00924027|469193835|FG003|Overall Study|Lost to Further Follow-Up|0|||
130334514|NCT00924027|469193832|FG000|Overall Study|Physician Decision|1|||
130334515|NCT00924027|469193833|FG001|Overall Study|Physician Decision|0|||
130334516|NCT00924027|469193834|FG002|Overall Study|Physician Decision|0|||
130334517|NCT00924027|469193835|FG003|Overall Study|Physician Decision|1|||
130334518|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
130334519|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
130334520|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
130334521|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
130334522|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
130334523|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
130334524|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
130334525|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
130334526|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
130334527|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
130334528|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
130334529|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
130334530|NCT04193189|469193836|FG000|Overall Study|Lost to Follow-up|9|||
130334531|NCT04193189|469193837|FG001|Overall Study|Lost to Follow-up|7|||
130334532|NCT04193189|469193838|FG002|Overall Study|Lost to Follow-up|9|||
130334533|NCT04193189|469193839|FG003|Overall Study|Lost to Follow-up|0|||
130334534|NCT04193189|469193836|FG000|Overall Study|Withdrawal by Subject|1|||
130334535|NCT04193189|469193837|FG001|Overall Study|Withdrawal by Subject|2|||
130334536|NCT04193189|469193838|FG002|Overall Study|Withdrawal by Subject|2|||
130334537|NCT04193189|469193839|FG003|Overall Study|Withdrawal by Subject|0|||
130334538|NCT04193189|469193836|FG000|Overall Study|Death|1|||
130334539|NCT04193189|469193837|FG001|Overall Study|Death|1|||
130334540|NCT04193189|469193838|FG002|Overall Study|Death|0|||
130334541|NCT04193189|469193839|FG003|Overall Study|Death|0|||
130334542|NCT04193189|469193836|FG000|Overall Study|Protocol Violation|0|||
130334543|NCT04193189|469193837|FG001|Overall Study|Protocol Violation|0|||
130334544|NCT04193189|469193838|FG002|Overall Study|Protocol Violation|0|||
130334545|NCT04193189|469193839|FG003|Overall Study|Protocol Violation|1|||
130334546|NCT02840799|469195474|FG000|Phase 1|Physician Decision|1|||
130334547|NCT02840799|469195475|FG001|Phase 1|Physician Decision|3|||
130334548|NCT02840799|469195474|FG000|Phase 1|Withdrawal by Subject|4|||
130334549|NCT02840799|469195475|FG001|Phase 1|Withdrawal by Subject|0|||
130334550|NCT02840799|469195474|FG000|Phase 2 (Crossover)|Adverse Event|0|||
130334551|NCT02840799|469195475|FG001|Phase 2 (Crossover)|Adverse Event|1|||
130334552|NCT02840799|469195474|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
130334553|NCT02840799|469195475|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
130334554|NCT02565784|469195476|FG000|First Treatment|Adverse Event|1|||
130334555|NCT02565784|469195476|FG000|First Treatment|Withdrawal by Subject|1|||
130334556|NCT02565784|469195476|FG000|Second Treatment|Withdrawal by Subject|2|||
130334557|NCT00552188|469195482|FG000|Overall Study|Adverse Event|0|||
130334558|NCT00552188|469195483|FG001|Overall Study|Adverse Event|2|||
130663347|NCT00666718|470393831|FG000|Overall Study|Entry Criteria Not Met|2|||
130663348|NCT00666718|470393832|FG001|Overall Study|Entry Criteria Not Met|0|||
130663349|NCT00666718|470393831|FG000|Overall Study|Protocol Violation|1|||
130663350|NCT00666718|470393832|FG001|Overall Study|Protocol Violation|3|||
130663351|NCT00666718|470393831|FG000|Overall Study|Withdrawal by Subject|7|||
130663352|NCT00666718|470393832|FG001|Overall Study|Withdrawal by Subject|12|||
130663353|NCT00666718|470393831|FG000|Overall Study|Physician Decision|0|||
130663354|NCT00666718|470393832|FG001|Overall Study|Physician Decision|2|||
130663355|NCT00963599|470393833|FG000|Overall Study|Adverse Event|2|||
130663356|NCT00963599|470393834|FG001|Overall Study|Adverse Event|0|||
130663357|NCT00963599|470393835|FG002|Overall Study|Adverse Event|1|||
130663358|NCT00963599|470393836|FG003|Overall Study|Adverse Event|2|||
130663359|NCT00963599|470393833|FG000|Overall Study|Lack of Efficacy|0|||
130663360|NCT00963599|470393834|FG001|Overall Study|Lack of Efficacy|2|||
130663361|NCT00963599|470393835|FG002|Overall Study|Lack of Efficacy|1|||
130663362|NCT00963599|470393836|FG003|Overall Study|Lack of Efficacy|4|||
130663363|NCT00963599|470393833|FG000|Overall Study|Lost to Follow-up|0|||
130663364|NCT00963599|470393834|FG001|Overall Study|Lost to Follow-up|1|||
130663365|NCT00963599|470393835|FG002|Overall Study|Lost to Follow-up|1|||
130663366|NCT00963599|470393836|FG003|Overall Study|Lost to Follow-up|1|||
130663367|NCT00963599|470393833|FG000|Overall Study|Protocol Violation|2|||
130663368|NCT00963599|470393834|FG001|Overall Study|Protocol Violation|2|||
130663369|NCT00963599|470393835|FG002|Overall Study|Protocol Violation|3|||
130663370|NCT00963599|470393836|FG003|Overall Study|Protocol Violation|4|||
130663371|NCT00963599|470393833|FG000|Overall Study|Withdrawal by Subject|2|||
130663372|NCT00963599|470393834|FG001|Overall Study|Withdrawal by Subject|1|||
130663373|NCT00963599|470393835|FG002|Overall Study|Withdrawal by Subject|3|||
130663374|NCT00963599|470393836|FG003|Overall Study|Withdrawal by Subject|3|||
130663375|NCT03496207|470393839|FG000|Base Study|Adverse Event|0|||
130663376|NCT03496207|470393840|FG001|Base Study|Adverse Event|0|||
130663377|NCT03496207|470393841|FG002|Base Study|Adverse Event|1|||
130663378|NCT03496207|470393842|FG003|Base Study|Adverse Event|1|||
130663379|NCT03496207|470393843|FG004|Base Study|Adverse Event|4|||
130663380|NCT03496207|470393839|FG000|Base Study|Death|0|||
130663381|NCT03496207|470393840|FG001|Base Study|Death|0|||
130663382|NCT03496207|470393841|FG002|Base Study|Death|0|||
130663383|NCT03496207|470393842|FG003|Base Study|Death|0|||
130663384|NCT03496207|470393843|FG004|Base Study|Death|1|||
130663385|NCT03496207|470393839|FG000|Base Study|Withdrawal by Subject|0|||
130663386|NCT03496207|470393840|FG001|Base Study|Withdrawal by Subject|0|||
130663387|NCT03496207|470393841|FG002|Base Study|Withdrawal by Subject|1|||
130663388|NCT03496207|470393842|FG003|Base Study|Withdrawal by Subject|0|||
130663389|NCT03496207|470393843|FG004|Base Study|Withdrawal by Subject|1|||
130663390|NCT03496207|470393839|FG000|Extension Period|Adverse Event|0|||
130663391|NCT03496207|470393840|FG001|Extension Period|Adverse Event|0|||
130663392|NCT03496207|470393841|FG002|Extension Period|Adverse Event|0|||
130663393|NCT03496207|470393842|FG003|Extension Period|Adverse Event|1|||
130663394|NCT03496207|470393843|FG004|Extension Period|Adverse Event|1|||
130663395|NCT03496207|470393839|FG000|Extension Period|Death|1|||
130663396|NCT03496207|470393840|FG001|Extension Period|Death|0|||
130663397|NCT03496207|470393841|FG002|Extension Period|Death|0|||
130663398|NCT03496207|470393842|FG003|Extension Period|Death|1|||
130663399|NCT03496207|470393843|FG004|Extension Period|Death|2|||
130663400|NCT03496207|470393839|FG000|Extension Period|Withdrawal by Subject|1|||
130663401|NCT03496207|470393840|FG001|Extension Period|Withdrawal by Subject|0|||
130663402|NCT03496207|470393841|FG002|Extension Period|Withdrawal by Subject|0|||
130663403|NCT03496207|470393842|FG003|Extension Period|Withdrawal by Subject|1|||
130663404|NCT03496207|470393843|FG004|Extension Period|Withdrawal by Subject|1|||
130663405|NCT03496207|470393839|FG000|Extension Period|Elevated hemoglobin levels|0|||
130663406|NCT03496207|470393840|FG001|Extension Period|Elevated hemoglobin levels|0|||
130663407|NCT03496207|470393841|FG002|Extension Period|Elevated hemoglobin levels|0|||
130663408|NCT03496207|470393842|FG003|Extension Period|Elevated hemoglobin levels|0|||
130663409|NCT03496207|470393843|FG004|Extension Period|Elevated hemoglobin levels|1|||
130663410|NCT00810615|470393846|FG000|Overall Study|Withdrawal by Subject|1|||
130663411|NCT00810615|470393847|FG001|Overall Study|Withdrawal by Subject|1|||
130334559|NCT00552188|469195482|FG000|Overall Study|Lost to Follow-up|2|||
130334560|NCT00552188|469195483|FG001|Overall Study|Lost to Follow-up|1|||
130663412|NCT02525562|470393848|FG000|Overall Study|Death|9|||
130663413|NCT02525562|470393849|FG001|Overall Study|Death|0|||
130663414|NCT02525562|470393850|FG002|Overall Study|Death|0|||
130663415|NCT02525562|470393848|FG000|Overall Study|Lost to Follow-up|19|||
130663416|NCT02525562|470393849|FG001|Overall Study|Lost to Follow-up|0|||
130663417|NCT02525562|470393850|FG002|Overall Study|Lost to Follow-up|0|||
130663418|NCT02525562|470393848|FG000|Overall Study|Withdrawal by Subject|37|||
130663419|NCT02525562|470393849|FG001|Overall Study|Withdrawal by Subject|0|||
130663420|NCT02525562|470393850|FG002|Overall Study|Withdrawal by Subject|0|||
130663421|NCT02525562|470393848|FG000|Overall Study|Revision/Removal of Study Device|4|||
130663422|NCT02525562|470393849|FG001|Overall Study|Revision/Removal of Study Device|0|||
130663423|NCT02525562|470393850|FG002|Overall Study|Revision/Removal of Study Device|0|||
130663424|NCT02525562|470393848|FG000|Overall Study|Study Closed by Sponsor|154|||
130334561|NCT00552188|469195482|FG000|Overall Study|Withdrawal of consent|0|||
130334562|NCT00552188|469195483|FG001|Overall Study|Withdrawal of consent|1|||
130334563|NCT00552188|469195482|FG000|Overall Study|Subject returned to home country|0|||
130334564|NCT00552188|469195483|FG001|Overall Study|Subject returned to home country|1|||
130334565|NCT00476008|469195493|FG000|Overall Study|Adverse Event|4|||
130334566|NCT00476008|469195494|FG001|Overall Study|Adverse Event|4|||
130334567|NCT00476008|469195493|FG000|Overall Study|Placebo concerns|2|||
130334568|NCT00476008|469195494|FG001|Overall Study|Placebo concerns|2|||
130334569|NCT00476008|469195493|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
130334570|NCT00476008|469195494|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
130334571|NCT00476008|469195493|FG000|Overall Study|Withdrawal by Subject|0|||
130334572|NCT00476008|469195494|FG001|Overall Study|Withdrawal by Subject|1|||
130663425|NCT02525562|470393849|FG001|Overall Study|Study Closed by Sponsor|0|||
130663426|NCT02525562|470393850|FG002|Overall Study|Study Closed by Sponsor|0|||
130663427|NCT01255722|470393851|FG000|Overall Study|Adverse Event|0|||
130663428|NCT01255722|470393852|FG001|Overall Study|Adverse Event|1|||
130663429|NCT01255722|470393853|FG002|Overall Study|Adverse Event|1|||
130663430|NCT01255722|470393851|FG000|Overall Study|asymptomatic patient|1|||
130663431|NCT01255722|470393852|FG001|Overall Study|asymptomatic patient|0|||
130663432|NCT01255722|470393853|FG002|Overall Study|asymptomatic patient|0|||
130663433|NCT01255722|470393851|FG000|Overall Study|beta-blocker contraindicated|2|||
130663434|NCT01255722|470393852|FG001|Overall Study|beta-blocker contraindicated|0|||
130663435|NCT01255722|470393853|FG002|Overall Study|beta-blocker contraindicated|0|||
130663436|NCT02164539|470393854|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
130663437|NCT02164539|470393855|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
130663438|NCT02164539|470393856|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
130663439|NCT02164539|470393857|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
130663440|NCT02164539|470393858|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
130663441|NCT02164539|470393859|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
130663442|NCT02164539|470393860|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
130663443|NCT02164539|470393854|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
130663444|NCT02164539|470393855|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
130663445|NCT02164539|470393856|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
130663446|NCT02164539|470393857|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
130663447|NCT02164539|470393858|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
130663448|NCT02164539|470393859|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
130663449|NCT02164539|470393860|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
130663450|NCT02164539|470393854|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
130663451|NCT02164539|470393855|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
130663452|NCT02164539|470393856|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
130663453|NCT02164539|470393857|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
130663454|NCT02164539|470393858|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
130663455|NCT02164539|470393859|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
130663456|NCT02164539|470393860|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
130663457|NCT02164539|470393854|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
130663458|NCT02164539|470393855|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663459|NCT02164539|470393856|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663460|NCT02164539|470393857|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663461|NCT02164539|470393858|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663462|NCT02164539|470393859|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663463|NCT02164539|470393860|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130663464|NCT02164539|470393854|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
130663465|NCT02164539|470393855|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
130663466|NCT02164539|470393856|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
130663467|NCT02164539|470393857|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
130663468|NCT02164539|470393858|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
130663469|NCT02164539|470393859|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
130663470|NCT02164539|470393860|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
130663471|NCT02164539|470393854|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
130334573|NCT00476008|469195493|FG000|Overall Study|Death|1|||
130334574|NCT00476008|469195494|FG001|Overall Study|Death|0|||
130334575|NCT01168219|469195498|FG000|Overall Study|off study before starting treatment|2|||
130334576|NCT01168219|469195498|FG000|Overall Study|withdrew before transplant|1|||
130334577|NCT01168219|469195498|FG000|Overall Study|ineligible due to CML|2|||
130334578|NCT00792571|469195499|FG000|Overall Study|Death|1|||
130334579|NCT00792571|469195499|FG000|Overall Study|Adverse Event|4|||
130663472|NCT02164539|470393855|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
130663473|NCT02164539|470393856|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
130663474|NCT02164539|470393857|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
130334580|NCT00792571|469195499|FG000|Overall Study|Withdrawal by Subject|1|||
130663475|NCT02164539|470393858|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
130663476|NCT02164539|470393859|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
130663477|NCT02164539|470393860|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
130663478|NCT02643966|470393861|FG000|First Screening Round|ineligible|1|||
130663479|NCT02643966|470393861|FG000|First Screening Round|excluded from analysis|2|||
130334581|NCT00792571|469195499|FG000|Overall Study|Other|4|||
130334582|NCT02600819|469195500|FG000|GEN Phase|Adverse Event|2|||
130334583|NCT02600819|469195501|FG001|GEN Phase|Adverse Event|0|||
130334584|NCT02600819|469195500|FG000|GEN Phase|Death|2|||
130334585|NCT02600819|469195501|FG001|GEN Phase|Death|0|||
130334586|NCT02600819|469195500|FG000|GEN Phase|Investigator's Discretion|4|||
130334587|NCT02600819|469195501|FG001|GEN Phase|Investigator's Discretion|0|||
130334588|NCT02600819|469195500|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
130334589|NCT02600819|469195501|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
130334590|NCT02600819|469195500|FG000|GEN Phase|Withdrew Consent|5|||
130334591|NCT02600819|469195501|FG001|GEN Phase|Withdrew Consent|0|||
130334592|NCT02600819|469195500|FG000|GEN Phase|Lost to Follow-up|2|||
130334593|NCT02600819|469195501|FG001|GEN Phase|Lost to Follow-up|0|||
130334594|NCT01621802|469195503|FG000|Overall Study|Protocol Violation|0|||
130663480|NCT02643966|470393861|FG000|First Screening Round|Lost to Follow-up|56|||
130663481|NCT02643966|470393861|FG000|First Screening Round|Withdrawal by Subject|28|||
130663482|NCT02643966|470393861|FG000|First Screening Round|Death|1|||
130663483|NCT02643966|470393861|FG000|Between First and Second Screening|Lost to Follow-up|65|||
130663484|NCT02643966|470393861|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
130663485|NCT02643966|470393861|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
130663486|NCT02643966|470393861|FG000|Second Screening Round|Withdrawal by Subject|20|||
130663487|NCT02643966|470393861|FG000|Second Screening Round|Lost to Follow-up|57|||
130663488|NCT02643966|470393861|FG000|Second Screening Round|Physician Decision|2|||
130663489|NCT02643966|470393861|FG000|Second Screening Round|Death|4|||
130663490|NCT02643966|470393861|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
130663491|NCT02643966|470393861|FG000|Between Second and Third Screening|Death|1|||
130663492|NCT02643966|470393861|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
130663493|NCT02643966|470393861|FG000|Third Screening Round|PI excluded|2|||
130663494|NCT02643966|470393861|FG000|Third Screening Round|Lost to Follow-up|241|||
130663495|NCT01612702|470393864|FG000|Overall Study|Protocol Violation|11|||
130663496|NCT01612702|470393865|FG001|Overall Study|Protocol Violation|11|||
130663497|NCT01542736|470393866|FG000|Overall Study|Death|1|||
130663498|NCT02400905|470393867|FG000|Overall Study|Death|24|||
130663499|NCT02400905|470393867|FG000|Overall Study|Lost to Follow-up|18|||
130663500|NCT02400905|470393867|FG000|Overall Study|Withdrawal by Subject|16|||
130663501|NCT02400905|470393867|FG000|Overall Study|Physician Decision|4|||
130663502|NCT02400905|470393867|FG000|Overall Study|Other|1|||
130663503|NCT02441179|470393874|FG000|Overall Study|Withdrawal by Subject|1|||
130663504|NCT02441179|470393875|FG001|Overall Study|Withdrawal by Subject|1|||
130663505|NCT03091400|470393876|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
130663506|NCT03091400|470393877|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
130663507|NCT00051636|470393878|FG000|Period 1 - Core|Adverse Event|2|||
130663508|NCT00051636|470393879|FG001|Period 1 - Core|Adverse Event|2|||
130663509|NCT00051636|470393878|FG000|Period 1 - Core|Protocol Violation|1|||
130663510|NCT00051636|470393879|FG001|Period 1 - Core|Protocol Violation|0|||
130663511|NCT00051636|470393878|FG000|Period 1 - Core|Withdrawal by Subject|1|||
130663512|NCT00051636|470393879|FG001|Period 1 - Core|Withdrawal by Subject|2|||
130663513|NCT00051636|470393878|FG000|Period 1 - Core|Lost to Follow-up|0|||
130663514|NCT00051636|470393879|FG001|Period 1 - Core|Lost to Follow-up|2|||
130663515|NCT00051636|470393878|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
130663516|NCT00051636|470393879|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
130663517|NCT00051636|470393878|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
130663518|NCT00051636|470393879|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
130663519|NCT00051636|470393878|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
130663520|NCT00051636|470393879|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
130663521|NCT00051636|470393878|FG000|Period 2- Extended Observation Period|Death|4|||
130663522|NCT00051636|470393879|FG001|Period 2- Extended Observation Period|Death|5|||
130663523|NCT00051636|470393878|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
130663524|NCT00051636|470393879|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
130663525|NCT00743119|470393884|FG000|Overall Study|unreliable|3|||
130663526|NCT00743119|470393884|FG000|Overall Study|Withdrawal by Subject|1|||
130663527|NCT02176642|470393885|FG000|Overall Study|Withdrawal by Subject|0|||
130663528|NCT02176642|470393886|FG001|Overall Study|Withdrawal by Subject|1|||
130663529|NCT00295620|470393888|FG000|Overall Study|Lost to Follow-up|9|||
130663530|NCT00295620|470393889|FG001|Overall Study|Lost to Follow-up|5|||
130663531|NCT00295620|470393888|FG000|Overall Study|Withdrawal by Subject|37|||
130663532|NCT00295620|470393889|FG001|Overall Study|Withdrawal by Subject|50|||
130663533|NCT00295620|470393888|FG000|Overall Study|Death|206|||
130663534|NCT00295620|470393889|FG001|Overall Study|Death|207|||
130663535|NCT00295620|470393888|FG000|Overall Study|Other reasons|10|||
130334595|NCT01621802|469195504|FG001|Overall Study|Protocol Violation|0|||
130334596|NCT01621802|469195505|FG002|Overall Study|Protocol Violation|0|||
130334597|NCT01621802|469195506|FG003|Overall Study|Protocol Violation|0|||
130663536|NCT00295620|470393889|FG001|Overall Study|Other reasons|9|||
130663537|NCT00295620|470393888|FG000|Overall Study|Discontinuation by sponsor|580|||
130663538|NCT00295620|470393889|FG001|Overall Study|Discontinuation by sponsor|593|||
130663539|NCT00295620|470393888|FG000|Overall Study|Protocol Violation|30|||
130663540|NCT00295620|470393889|FG001|Overall Study|Protocol Violation|32|||
130663541|NCT01309828|470393890|FG000|Overall Study|Adverse Event|10|||
130663542|NCT01309828|470393891|FG001|Overall Study|Adverse Event|11|||
130663543|NCT01309828|470393890|FG000|Overall Study|Voluntary Withdrawal|5|||
130663544|NCT01309828|470393891|FG001|Overall Study|Voluntary Withdrawal|4|||
130663545|NCT01309828|470393890|FG000|Overall Study|Major Protocol Deviation|0|||
130663546|NCT01309828|470393891|FG001|Overall Study|Major Protocol Deviation|1|||
130663547|NCT01309828|470393890|FG000|Overall Study|Other|1|||
130663548|NCT01309828|470393891|FG001|Overall Study|Other|0|||
130663549|NCT00217971|470393892|FG000|Overall Study|Adverse Event|1|||
130663550|NCT00217971|470393893|FG001|Overall Study|Adverse Event|1|||
130663551|NCT00217971|470393892|FG000|Overall Study|Lost to Follow-up|15|||
130663552|NCT00217971|470393893|FG001|Overall Study|Lost to Follow-up|19|||
130663553|NCT00217971|470393892|FG000|Overall Study|Physician Decision|0|||
130663554|NCT00217971|470393893|FG001|Overall Study|Physician Decision|1|||
130663555|NCT00217971|470393892|FG000|Overall Study|Withdrawal by Subject|7|||
130663556|NCT00217971|470393893|FG001|Overall Study|Withdrawal by Subject|12|||
130663557|NCT00217971|470393892|FG000|Overall Study|non compliant|1|||
130663558|NCT00217971|470393893|FG001|Overall Study|non compliant|0|||
130663559|NCT02989610|470393894|FG000|Overall Study|Withdrawal by Subject|20|||
130663560|NCT02989610|470393894|FG000|Overall Study|Departure of PI from Site|8|||
130663561|NCT02989610|470393894|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
130663562|NCT02989610|470393894|FG000|Overall Study|Lost to Follow-up|3|||
130663563|NCT02989610|470393894|FG000|Overall Study|Death|3|||
130663564|NCT02989610|470393894|FG000|Overall Study|System Explant|3|||
130663565|NCT02989610|470393894|FG000|Overall Study|Subject Non-Compliance|2|||
130663566|NCT02989610|470393894|FG000|Overall Study|System Revision|2|||
130663567|NCT02989610|470393894|FG000|Overall Study|PI Left, Study Closing|1|||
130663568|NCT02989610|470393894|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
130663569|NCT02989610|470393894|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
130663570|NCT02556632|470393899|FG000|Overall Study|Lost to Follow-up|1|||
130663571|NCT02556632|470393900|FG001|Overall Study|Lost to Follow-up|0|||
130663572|NCT02556632|470393901|FG002|Overall Study|Lost to Follow-up|0|||
130663573|NCT02556632|470393899|FG000|Overall Study|Disliked Intervention|1|||
130663574|NCT02556632|470393900|FG001|Overall Study|Disliked Intervention|1|||
130663575|NCT02556632|470393901|FG002|Overall Study|Disliked Intervention|1|||
130663576|NCT02556632|470393899|FG000|Overall Study|No Reason|1|||
130663577|NCT02556632|470393900|FG001|Overall Study|No Reason|0|||
130663578|NCT02556632|470393901|FG002|Overall Study|No Reason|1|||
130663579|NCT02556632|470393899|FG000|Overall Study|Personal Issues|0|||
130663580|NCT02556632|470393900|FG001|Overall Study|Personal Issues|1|||
130663581|NCT02556632|470393901|FG002|Overall Study|Personal Issues|1|||
130663582|NCT02556632|470393899|FG000|Overall Study|Changed Mind|0|||
130663583|NCT02556632|470393900|FG001|Overall Study|Changed Mind|1|||
130663584|NCT02556632|470393901|FG002|Overall Study|Changed Mind|0|||
130663585|NCT02556632|470393899|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
130663586|NCT02556632|470393900|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
130663587|NCT02556632|470393901|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
130663588|NCT02556632|470393899|FG000|Overall Study|Unrelated Adverse Event|1|||
130663589|NCT02556632|470393900|FG001|Overall Study|Unrelated Adverse Event|0|||
130663590|NCT02556632|470393901|FG002|Overall Study|Unrelated Adverse Event|3|||
130334598|NCT01621802|469195507|FG004|Overall Study|Protocol Violation|0|||
130334599|NCT01621802|469195508|FG005|Overall Study|Protocol Violation|1|||
130334600|NCT01621802|469195503|FG000|Overall Study|Withdrawal by Subject|8|||
130334601|NCT01621802|469195504|FG001|Overall Study|Withdrawal by Subject|4|||
130334602|NCT01621802|469195505|FG002|Overall Study|Withdrawal by Subject|4|||
130334603|NCT01621802|469195506|FG003|Overall Study|Withdrawal by Subject|2|||
130334604|NCT01621802|469195507|FG004|Overall Study|Withdrawal by Subject|2|||
130334605|NCT01621802|469195508|FG005|Overall Study|Withdrawal by Subject|0|||
130663591|NCT02556632|470393899|FG000|Overall Study|Related Adverse Event|0|||
130663592|NCT02556632|470393900|FG001|Overall Study|Related Adverse Event|1|||
130663593|NCT02556632|470393901|FG002|Overall Study|Related Adverse Event|0|||
130663594|NCT02556632|470393899|FG000|Overall Study|Possibly Related Adverse Event|0|||
130334606|NCT01621802|469195503|FG000|Overall Study|Migrated/moved from study area|0|||
130334607|NCT01621802|469195504|FG001|Overall Study|Migrated/moved from study area|0|||
130663595|NCT02556632|470393900|FG001|Overall Study|Possibly Related Adverse Event|0|||
130663596|NCT02556632|470393901|FG002|Overall Study|Possibly Related Adverse Event|1|||
130663597|NCT02556632|470393899|FG000|Overall Study|Did Not Start RT|0|||
130663598|NCT02556632|470393900|FG001|Overall Study|Did Not Start RT|1|||
130663599|NCT02556632|470393901|FG002|Overall Study|Did Not Start RT|0|||
130663600|NCT02556632|470393899|FG000|Overall Study|Ineligible|0|||
130663601|NCT02556632|470393900|FG001|Overall Study|Ineligible|1|||
130663602|NCT02556632|470393901|FG002|Overall Study|Ineligible|0|||
130663603|NCT02556632|470393899|FG000|Overall Study|Disliked Study Procedures|0|||
130663604|NCT02556632|470393900|FG001|Overall Study|Disliked Study Procedures|0|||
130663605|NCT02556632|470393901|FG002|Overall Study|Disliked Study Procedures|1|||
130663606|NCT02556632|470393899|FG000|Overall Study|Treatment or Change Delay|0|||
130663607|NCT02556632|470393900|FG001|Overall Study|Treatment or Change Delay|0|||
130663608|NCT02556632|470393901|FG002|Overall Study|Treatment or Change Delay|1|||
130663609|NCT04508621|470393904|FG000|Overall Study|Adverse Event|39|||
130663610|NCT04508621|470393905|FG001|Overall Study|Adverse Event|16|||
130663611|NCT04508621|470393904|FG000|Overall Study|Lack of Efficacy|2|||
130663612|NCT04508621|470393905|FG001|Overall Study|Lack of Efficacy|8|||
130663613|NCT04508621|470393904|FG000|Overall Study|Physician Decision|0|||
130663614|NCT04508621|470393905|FG001|Overall Study|Physician Decision|1|||
130663615|NCT04508621|470393904|FG000|Overall Study|Withdrawal by Subject|10|||
130663616|NCT04508621|470393905|FG001|Overall Study|Withdrawal by Subject|14|||
130663617|NCT04508621|470393904|FG000|Overall Study|Lost to Follow-up|12|||
130663618|NCT04508621|470393905|FG001|Overall Study|Lost to Follow-up|9|||
130663619|NCT04508621|470393904|FG000|Overall Study|COVID-19 related crisis|3|||
130663620|NCT04508621|470393905|FG001|Overall Study|COVID-19 related crisis|0|||
130663621|NCT04508621|470393904|FG000|Overall Study|Subject non-compliance|1|||
130663622|NCT04508621|470393905|FG001|Overall Study|Subject non-compliance|0|||
130663623|NCT00808015|470393906|FG000|Overall Study|Death|1|||
130663624|NCT00808015|470393906|FG000|Overall Study|Lack of Efficacy|58|||
130663625|NCT00808015|470393906|FG000|Overall Study|Lost to Follow-up|76|||
130663626|NCT00808015|470393906|FG000|Overall Study|Participants not willing to participate|158|||
130663627|NCT00808015|470393906|FG000|Overall Study|Adverse Event|22|||
130663628|NCT00808015|470393906|FG000|Overall Study|Other|25|||
130663629|NCT00808015|470393906|FG000|Overall Study|Enrolled but not treated|4|||
130663630|NCT01066039|470393907|FG000|Overall Study|Adverse Event|6|||
130663631|NCT01066039|470393907|FG000|Overall Study|Withdrawal by Subject|17|||
130663632|NCT01066039|470393907|FG000|Overall Study|Protocol Violation|2|||
130663633|NCT01066039|470393907|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
130663634|NCT01066039|470393907|FG000|Overall Study|Investigator's Request|1|||
130663635|NCT01066039|470393907|FG000|Overall Study|Dropout due to Insulin Administration|1|||
130663636|NCT01066039|470393907|FG000|Overall Study|Additional Antihypertensive Required|4|||
130663637|NCT01066039|470393907|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
130663638|NCT01066039|470393907|FG000|Overall Study|Failure to Control Blood Pressure|1|||
130663639|NCT01066039|470393907|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
130663640|NCT02574260|470393909|FG000|Overall Study|Disease Progression|1|||
130663641|NCT00084617|470393924|FG000|Overall Study|Withdrawal by Subject|7|||
130663642|NCT00084617|470393924|FG000|Overall Study|Lack of Efficacy|1|||
130663643|NCT00084617|470393924|FG000|Overall Study|Protocol Violation|1|||
130663644|NCT01625286|470393925|FG000|Overall Study|Adverse Event|0|||
130663645|NCT01625286|470393926|FG001|Overall Study|Adverse Event|0|||
130663646|NCT01625286|470393927|FG002|Overall Study|Adverse Event|0|||
130663647|NCT01625286|470393928|FG003|Overall Study|Adverse Event|0|||
130663648|NCT01625286|470393929|FG004|Overall Study|Adverse Event|1|||
130663649|NCT01625286|470393930|FG005|Overall Study|Adverse Event|2|||
130663650|NCT01625286|470393931|FG006|Overall Study|Adverse Event|1|||
130663651|NCT01625286|470393925|FG000|Overall Study|Death|0|||
130334608|NCT01621802|469195505|FG002|Overall Study|Migrated/moved from study area|2|||
130663652|NCT01625286|470393926|FG001|Overall Study|Death|0|||
130663653|NCT01625286|470393927|FG002|Overall Study|Death|1|||
130663654|NCT01625286|470393928|FG003|Overall Study|Death|1|||
130663655|NCT01625286|470393929|FG004|Overall Study|Death|0|||
130663656|NCT01625286|470393930|FG005|Overall Study|Death|11|||
130663657|NCT01625286|470393931|FG006|Overall Study|Death|16|||
130663658|NCT01625286|470393925|FG000|Overall Study|Withdrawal by Subject|0|||
130663659|NCT01625286|470393926|FG001|Overall Study|Withdrawal by Subject|1|||
130663660|NCT01625286|470393927|FG002|Overall Study|Withdrawal by Subject|0|||
130663661|NCT01625286|470393928|FG003|Overall Study|Withdrawal by Subject|1|||
130663662|NCT01625286|470393929|FG004|Overall Study|Withdrawal by Subject|0|||
130663663|NCT01625286|470393930|FG005|Overall Study|Withdrawal by Subject|0|||
130663664|NCT01625286|470393931|FG006|Overall Study|Withdrawal by Subject|1|||
130663665|NCT01625286|470393925|FG000|Overall Study|Any reason not specifically recorded|0|||
130663666|NCT01625286|470393926|FG001|Overall Study|Any reason not specifically recorded|0|||
130663667|NCT01625286|470393927|FG002|Overall Study|Any reason not specifically recorded|0|||
130663668|NCT01625286|470393928|FG003|Overall Study|Any reason not specifically recorded|0|||
130334609|NCT01621802|469195506|FG003|Overall Study|Migrated/moved from study area|0|||
130663669|NCT01625286|470393929|FG004|Overall Study|Any reason not specifically recorded|0|||
130663670|NCT01625286|470393930|FG005|Overall Study|Any reason not specifically recorded|1|||
130663671|NCT01625286|470393931|FG006|Overall Study|Any reason not specifically recorded|0|||
130334610|NCT01621802|469195507|FG004|Overall Study|Migrated/moved from study area|1|||
130334611|NCT01621802|469195508|FG005|Overall Study|Migrated/moved from study area|0|||
130663672|NCT01625286|470393925|FG000|Overall Study|Progressive disease|6|||
130334612|NCT01621802|469195503|FG000|Overall Study|Others|3|||
130663673|NCT01625286|470393926|FG001|Overall Study|Progressive disease|3|||
130334613|NCT01621802|469195504|FG001|Overall Study|Others|3|||
130334614|NCT01621802|469195505|FG002|Overall Study|Others|3|||
130663674|NCT01625286|470393927|FG002|Overall Study|Progressive disease|4|||
130663675|NCT01625286|470393928|FG003|Overall Study|Progressive disease|5|||
130663676|NCT01625286|470393929|FG004|Overall Study|Progressive disease|5|||
130663677|NCT01625286|470393930|FG005|Overall Study|Progressive disease|0|||
130663678|NCT01625286|470393931|FG006|Overall Study|Progressive disease|0|||
130663679|NCT01625286|470393925|FG000|Overall Study|Lost to Follow-up|0|||
130663680|NCT01625286|470393926|FG001|Overall Study|Lost to Follow-up|0|||
130663681|NCT01625286|470393927|FG002|Overall Study|Lost to Follow-up|0|||
130663682|NCT01625286|470393928|FG003|Overall Study|Lost to Follow-up|0|||
130663683|NCT01625286|470393929|FG004|Overall Study|Lost to Follow-up|0|||
130663684|NCT01625286|470393930|FG005|Overall Study|Lost to Follow-up|0|||
130663685|NCT01625286|470393931|FG006|Overall Study|Lost to Follow-up|1|||
130663686|NCT00828516|470393932|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
130663687|NCT03724968|470395648|FG000|Overall Study|Insurance issues|0|||
130663688|NCT03724968|470395649|FG001|Overall Study|Insurance issues|1|||
130663689|NCT03724968|470395648|FG000|Overall Study|Study closed|0|||
130663690|NCT03724968|470395649|FG001|Overall Study|Study closed|1|||
130663691|NCT03591107|470395654|FG000|Overall Study|Same patient in both arms|1|||
130663692|NCT03591107|470395655|FG001|Overall Study|Same patient in both arms|1|||
130663693|NCT03591107|470395654|FG000|Overall Study|Sought care at other clinics|0|||
130663694|NCT03591107|470395655|FG001|Overall Study|Sought care at other clinics|2|||
130663695|NCT03591107|470395654|FG000|Overall Study|Discharged from clinic|0|||
130663696|NCT03591107|470395655|FG001|Overall Study|Discharged from clinic|1|||
130663697|NCT03591107|470395654|FG000|Overall Study|Withdrawal by Subject|0|||
130663698|NCT03591107|470395655|FG001|Overall Study|Withdrawal by Subject|1|||
130663699|NCT01902134|470395656|FG000|Overall Study|Adverse Event|3|||
130663700|NCT01902134|470395657|FG001|Overall Study|Adverse Event|1|||
130663701|NCT01902134|470395658|FG002|Overall Study|Adverse Event|2|||
130663702|NCT01902134|470395659|FG003|Overall Study|Adverse Event|1|||
130663703|NCT01902134|470395660|FG004|Overall Study|Adverse Event|1|||
130663704|NCT01902134|470395661|FG005|Overall Study|Adverse Event|3|||
130663705|NCT01902134|470395656|FG000|Overall Study|Lack of Efficacy|0|||
130663706|NCT01902134|470395657|FG001|Overall Study|Lack of Efficacy|0|||
130663707|NCT01902134|470395658|FG002|Overall Study|Lack of Efficacy|2|||
130663708|NCT01902134|470395659|FG003|Overall Study|Lack of Efficacy|0|||
130663709|NCT01902134|470395660|FG004|Overall Study|Lack of Efficacy|0|||
130334615|NCT01621802|469195506|FG003|Overall Study|Others|2|||
130334616|NCT01621802|469195507|FG004|Overall Study|Others|1|||
130334617|NCT01621802|469195508|FG005|Overall Study|Others|0|||
130334618|NCT01621802|469195503|FG000|Overall Study|Lost to Follow-up|36|||
130334619|NCT01621802|469195504|FG001|Overall Study|Lost to Follow-up|16|||
130334620|NCT01621802|469195505|FG002|Overall Study|Lost to Follow-up|24|||
130334621|NCT01621802|469195506|FG003|Overall Study|Lost to Follow-up|7|||
130334622|NCT01621802|469195507|FG004|Overall Study|Lost to Follow-up|31|||
130334623|NCT01621802|469195508|FG005|Overall Study|Lost to Follow-up|11|||
130334624|NCT03790696|469195509|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
130334625|NCT03790696|469195510|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
130334626|NCT01149148|469195511|FG000|Overall Study|Lost to Follow-up|1|||
130334627|NCT01149148|469195512|FG001|Overall Study|Lost to Follow-up|2|||
130334628|NCT01149148|469195511|FG000|Overall Study|Death|1|||
130334629|NCT01149148|469195512|FG001|Overall Study|Death|0|||
130334630|NCT03436082|469195513|FG000|Overall Study|Did not undergo procedure|1|||
130334631|NCT03436082|469195514|FG001|Overall Study|Did not undergo procedure|0|||
130334632|NCT00950859|469195517|FG000|Overall Study|Adverse Event|3|||
130334633|NCT00950859|469195518|FG001|Overall Study|Adverse Event|3|||
130334634|NCT00950859|469195517|FG000|Overall Study|Insufficient Viral Load Response|12|||
130334635|NCT00950859|469195518|FG001|Overall Study|Insufficient Viral Load Response|3|||
130334636|NCT00950859|469195517|FG000|Overall Study|Protocol Violation|1|||
130334637|NCT00950859|469195518|FG001|Overall Study|Protocol Violation|1|||
130334638|NCT00950859|469195517|FG000|Overall Study|Lost to Follow-up|0|||
130334639|NCT00950859|469195518|FG001|Overall Study|Lost to Follow-up|3|||
130334640|NCT04896086|469195519|FG000|Overall Study|Lost to Follow-up|0|||
130334641|NCT04896086|469195520|FG001|Overall Study|Lost to Follow-up|2|||
130334642|NCT04896086|469195521|FG002|Overall Study|Lost to Follow-up|1|||
130334643|NCT04896086|469195522|FG003|Overall Study|Lost to Follow-up|0|||
130334644|NCT04896086|469195523|FG004|Overall Study|Lost to Follow-up|0|||
130334645|NCT04896086|469195519|FG000|Overall Study|Physician Decision|0|||
130334646|NCT04896086|469195520|FG001|Overall Study|Physician Decision|1|||
130334647|NCT04896086|469195521|FG002|Overall Study|Physician Decision|0|||
130334648|NCT04896086|469195522|FG003|Overall Study|Physician Decision|0|||
130663710|NCT01902134|470395661|FG005|Overall Study|Lack of Efficacy|1|||
130663711|NCT01902134|470395656|FG000|Overall Study|Physician Decision|0|||
130663712|NCT01902134|470395657|FG001|Overall Study|Physician Decision|1|||
130663713|NCT01902134|470395658|FG002|Overall Study|Physician Decision|0|||
130663714|NCT01902134|470395659|FG003|Overall Study|Physician Decision|0|||
130663715|NCT01902134|470395660|FG004|Overall Study|Physician Decision|0|||
130663716|NCT01902134|470395661|FG005|Overall Study|Physician Decision|0|||
130663717|NCT01902134|470395656|FG000|Overall Study|Protocol Violation|0|||
130663718|NCT01902134|470395657|FG001|Overall Study|Protocol Violation|0|||
130663719|NCT01902134|470395658|FG002|Overall Study|Protocol Violation|0|||
130663720|NCT01902134|470395659|FG003|Overall Study|Protocol Violation|0|||
130663721|NCT01902134|470395660|FG004|Overall Study|Protocol Violation|0|||
130663722|NCT01902134|470395661|FG005|Overall Study|Protocol Violation|1|||
130663723|NCT01902134|470395656|FG000|Overall Study|Withdrawal by Subject|4|||
130663724|NCT01902134|470395657|FG001|Overall Study|Withdrawal by Subject|8|||
130663725|NCT01902134|470395658|FG002|Overall Study|Withdrawal by Subject|9|||
130334649|NCT04896086|469195523|FG004|Overall Study|Physician Decision|0|||
130334650|NCT04896086|469195519|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334651|NCT04896086|469195520|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334652|NCT04896086|469195521|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334653|NCT04896086|469195522|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
130334654|NCT04896086|469195523|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334655|NCT04896086|469195519|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334656|NCT04896086|469195520|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334657|NCT04896086|469195521|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334658|NCT04896086|469195522|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
130334659|NCT04896086|469195523|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334660|NCT02249832|469195526|FG000|Overall Study|Withdrawal by Subject|3|||
130334661|NCT02249832|469195526|FG000|Overall Study|Lost to Follow-up|10|||
130334662|NCT00243269|469195535|FG000|Overall Study|Protocol Violation|2|||
130334663|NCT00243269|469195536|FG001|Overall Study|Protocol Violation|1|||
130334664|NCT00243269|469195537|FG002|Overall Study|Protocol Violation|0|||
130334665|NCT00243269|469195538|FG003|Overall Study|Protocol Violation|1|||
130334666|NCT00243269|469195535|FG000|Overall Study|Lost to Follow-up|1|||
130334667|NCT00243269|469195536|FG001|Overall Study|Lost to Follow-up|0|||
130334668|NCT00243269|469195537|FG002|Overall Study|Lost to Follow-up|1|||
130334669|NCT00243269|469195538|FG003|Overall Study|Lost to Follow-up|3|||
130334670|NCT00970684|469195540|FG000|Overall Study|Lack of Efficacy|5|||
130334671|NCT00970684|469195540|FG000|Overall Study|Adverse Event|4|||
130334672|NCT00970684|469195540|FG000|Overall Study|Withdrawal by Subject|1|||
130334673|NCT00481091|469195541|FG000|Overall Study|Withdrawal by Subject|0|||
130334674|NCT00481091|469195542|FG001|Overall Study|Withdrawal by Subject|1|||
130334675|NCT00481091|469195543|FG002|Overall Study|Withdrawal by Subject|1|||
130334676|NCT00481091|469195544|FG003|Overall Study|Withdrawal by Subject|0|||
130334677|NCT00481091|469195545|FG004|Overall Study|Withdrawal by Subject|0|||
130334678|NCT00481091|469195546|FG005|Overall Study|Withdrawal by Subject|0|||
130334679|NCT00481091|469195547|FG006|Overall Study|Withdrawal by Subject|0|||
130334680|NCT00481091|469195548|FG007|Overall Study|Withdrawal by Subject|0|||
130334681|NCT00481091|469195549|FG008|Overall Study|Withdrawal by Subject|1|||
130334682|NCT00481091|469195550|FG009|Overall Study|Withdrawal by Subject|6|||
130334683|NCT00481091|469195541|FG000|Overall Study|Other, Not Specified|0|||
130334684|NCT00481091|469195542|FG001|Overall Study|Other, Not Specified|1|||
130334685|NCT00481091|469195543|FG002|Overall Study|Other, Not Specified|1|||
130334686|NCT00481091|469195544|FG003|Overall Study|Other, Not Specified|0|||
130334687|NCT00481091|469195545|FG004|Overall Study|Other, Not Specified|0|||
130334688|NCT00481091|469195546|FG005|Overall Study|Other, Not Specified|1|||
130334689|NCT00481091|469195547|FG006|Overall Study|Other, Not Specified|0|||
130334690|NCT00481091|469195548|FG007|Overall Study|Other, Not Specified|0|||
130334691|NCT00481091|469195549|FG008|Overall Study|Other, Not Specified|0|||
130334692|NCT00481091|469195550|FG009|Overall Study|Other, Not Specified|4|||
130334693|NCT00481091|469195541|FG000|Overall Study|Adverse Event|1|||
130334694|NCT00481091|469195542|FG001|Overall Study|Adverse Event|2|||
130334695|NCT00481091|469195543|FG002|Overall Study|Adverse Event|0|||
130334696|NCT00481091|469195544|FG003|Overall Study|Adverse Event|1|||
130334697|NCT00481091|469195545|FG004|Overall Study|Adverse Event|1|||
130334698|NCT00481091|469195546|FG005|Overall Study|Adverse Event|1|||
130334699|NCT00481091|469195547|FG006|Overall Study|Adverse Event|2|||
130334700|NCT00481091|469195548|FG007|Overall Study|Adverse Event|1|||
130334701|NCT00481091|469195549|FG008|Overall Study|Adverse Event|1|||
130334702|NCT00481091|469195550|FG009|Overall Study|Adverse Event|6|||
130334703|NCT00481091|469195541|FG000|Overall Study|Progressive disease clinical|0|||
130334704|NCT00481091|469195542|FG001|Overall Study|Progressive disease clinical|0|||
130334705|NCT00481091|469195543|FG002|Overall Study|Progressive disease clinical|0|||
130334706|NCT00481091|469195544|FG003|Overall Study|Progressive disease clinical|0|||
130334707|NCT00481091|469195545|FG004|Overall Study|Progressive disease clinical|0|||
130334708|NCT00481091|469195546|FG005|Overall Study|Progressive disease clinical|0|||
130334709|NCT00481091|469195547|FG006|Overall Study|Progressive disease clinical|0|||
130334710|NCT00481091|469195548|FG007|Overall Study|Progressive disease clinical|0|||
130663726|NCT01902134|470395659|FG003|Overall Study|Withdrawal by Subject|1|||
130663727|NCT01902134|470395660|FG004|Overall Study|Withdrawal by Subject|5|||
130334711|NCT00481091|469195549|FG008|Overall Study|Progressive disease clinical|1|||
130334712|NCT00481091|469195550|FG009|Overall Study|Progressive disease clinical|7|||
130334713|NCT00481091|469195541|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130334714|NCT00481091|469195542|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130334715|NCT00481091|469195543|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334716|NCT00481091|469195544|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334717|NCT00481091|469195545|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334718|NCT00481091|469195546|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130663728|NCT01902134|470395661|FG005|Overall Study|Withdrawal by Subject|4|||
130663729|NCT01902134|470395656|FG000|Overall Study|no compliance|1|||
130663730|NCT01902134|470395657|FG001|Overall Study|no compliance|0|||
130663731|NCT01902134|470395658|FG002|Overall Study|no compliance|0|||
130663732|NCT01902134|470395659|FG003|Overall Study|no compliance|0|||
130334719|NCT00481091|469195547|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334720|NCT00481091|469195548|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334721|NCT00481091|469195549|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334722|NCT00481091|469195550|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334723|NCT00481091|469195541|FG000|Overall Study|Progressive disease other|1|||
130334724|NCT00481091|469195542|FG001|Overall Study|Progressive disease other|1|||
130334725|NCT00481091|469195543|FG002|Overall Study|Progressive disease other|0|||
130334726|NCT00481091|469195544|FG003|Overall Study|Progressive disease other|1|||
130334727|NCT00481091|469195545|FG004|Overall Study|Progressive disease other|1|||
130334728|NCT00481091|469195546|FG005|Overall Study|Progressive disease other|1|||
130663733|NCT01902134|470395660|FG004|Overall Study|no compliance|0|||
130663734|NCT01902134|470395661|FG005|Overall Study|no compliance|0|||
130663735|NCT01902134|470395656|FG000|Overall Study|Other|0|||
130334729|NCT00481091|469195547|FG006|Overall Study|Progressive disease other|0|||
130334730|NCT00481091|469195548|FG007|Overall Study|Progressive disease other|2|||
130334731|NCT00481091|469195549|FG008|Overall Study|Progressive disease other|0|||
130663736|NCT01902134|470395657|FG001|Overall Study|Other|1|||
130663737|NCT01902134|470395658|FG002|Overall Study|Other|2|||
130663738|NCT01902134|470395659|FG003|Overall Study|Other|0|||
130663739|NCT01902134|470395660|FG004|Overall Study|Other|1|||
130663740|NCT01902134|470395661|FG005|Overall Study|Other|0|||
130663741|NCT00305110|470395662|FG000|Overall Study|Missing data|29|||
130663742|NCT00678379|470395663|FG000|Overall Study|Injection performed after tonsillectomy|2|||
130663743|NCT00678379|470395664|FG001|Overall Study|Injection performed after tonsillectomy|0|||
130663744|NCT00678379|470395665|FG002|Overall Study|Injection performed after tonsillectomy|1|||
130663745|NCT00678379|470395663|FG000|Overall Study|Incomplete Data|4|||
130663746|NCT00678379|470395664|FG001|Overall Study|Incomplete Data|3|||
130663747|NCT00678379|470395665|FG002|Overall Study|Incomplete Data|3|||
130663748|NCT01084603|470395670|FG000|Baseline|Withdrawal by Subject|2|||
130663749|NCT01084603|470395670|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
130663750|NCT01084603|470395670|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
130663751|NCT01084603|470395670|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
130663752|NCT01084603|470395670|FG000|Washout Period 4|Adverse Event|1|||
130663753|NCT01270841|470395672|FG000|Overall Study|Adverse Event|0|||
130663754|NCT01270841|470395673|FG001|Overall Study|Adverse Event|1|||
130663755|NCT01270841|470395674|FG002|Overall Study|Adverse Event|0|||
130663756|NCT01270841|470395675|FG003|Overall Study|Adverse Event|3|||
130663757|NCT01270841|470395672|FG000|Overall Study|Withdrawal by Subject|3|||
130663758|NCT01270841|470395673|FG001|Overall Study|Withdrawal by Subject|2|||
130663759|NCT01270841|470395674|FG002|Overall Study|Withdrawal by Subject|3|||
130663760|NCT01270841|470395675|FG003|Overall Study|Withdrawal by Subject|3|||
130663761|NCT01270841|470395672|FG000|Overall Study|Lost to Follow-up|3|||
130663762|NCT01270841|470395673|FG001|Overall Study|Lost to Follow-up|1|||
130663763|NCT01270841|470395674|FG002|Overall Study|Lost to Follow-up|4|||
130663764|NCT01270841|470395675|FG003|Overall Study|Lost to Follow-up|2|||
130663765|NCT01270841|470395672|FG000|Overall Study|Physician Decision|0|||
130663766|NCT01270841|470395673|FG001|Overall Study|Physician Decision|1|||
130663767|NCT01270841|470395674|FG002|Overall Study|Physician Decision|0|||
130663768|NCT01270841|470395675|FG003|Overall Study|Physician Decision|0|||
130663769|NCT01270841|470395672|FG000|Overall Study|Did not qualify|6|||
130334732|NCT00481091|469195550|FG009|Overall Study|Progressive disease other|0|||
130334733|NCT00481091|469195541|FG000|Overall Study|No reason given|0|||
130334734|NCT00481091|469195542|FG001|Overall Study|No reason given|0|||
130334735|NCT00481091|469195543|FG002|Overall Study|No reason given|1|||
130663770|NCT01270841|470395673|FG001|Overall Study|Did not qualify|3|||
130663771|NCT01270841|470395674|FG002|Overall Study|Did not qualify|4|||
130663772|NCT01270841|470395675|FG003|Overall Study|Did not qualify|5|||
130663773|NCT01270841|470395672|FG000|Overall Study|Protocol Violation|1|||
130663774|NCT01270841|470395673|FG001|Overall Study|Protocol Violation|5|||
130663775|NCT01270841|470395674|FG002|Overall Study|Protocol Violation|0|||
130663776|NCT01270841|470395675|FG003|Overall Study|Protocol Violation|0|||
130663777|NCT01270841|470395672|FG000|Overall Study|Enrolled in error|0|||
130663778|NCT01270841|470395673|FG001|Overall Study|Enrolled in error|1|||
130663779|NCT01270841|470395674|FG002|Overall Study|Enrolled in error|0|||
130663780|NCT01270841|470395675|FG003|Overall Study|Enrolled in error|0|||
130663781|NCT02082912|470395676|FG000|Overall Study|Physician Decision|0|||
130663782|NCT02082912|470395677|FG001|Overall Study|Physician Decision|1|||
130663783|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
130663784|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
130663785|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
130663786|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
130663787|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
130663788|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
130663789|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
130663790|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
130663791|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663792|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663793|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663794|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
130663795|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
130663796|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663797|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663798|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130663799|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
130663800|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
130663801|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
130663802|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
130663803|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
130663804|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
130663805|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
130663806|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
130663807|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
130663808|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130663809|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
130663810|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130663811|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
130663812|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130663813|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130663814|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130663815|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
130663816|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130663817|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
130663818|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
130663819|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130663820|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130663821|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
130663822|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130663823|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
130663824|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
130663825|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
130663826|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
130663827|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
130663828|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
130663829|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
130663830|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
130663831|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
130663832|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
130663833|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130663834|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
130663835|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130663836|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130663837|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130663838|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130663839|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
130663840|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
130663841|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
130663842|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
130663843|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
130663844|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
130663845|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
130663846|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
130663847|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
130663848|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
130663849|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
130663850|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
130663851|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
130663852|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
130663853|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
130663854|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
130663855|NCT04440163|470395683|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
130663856|NCT04440163|470395684|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
130663857|NCT04440163|470395685|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
130663858|NCT04440163|470395686|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
130334736|NCT00481091|469195544|FG003|Overall Study|No reason given|1|||
130334737|NCT00481091|469195545|FG004|Overall Study|No reason given|1|||
130334738|NCT00481091|469195546|FG005|Overall Study|No reason given|0|||
130334739|NCT00481091|469195547|FG006|Overall Study|No reason given|1|||
130334740|NCT00481091|469195548|FG007|Overall Study|No reason given|1|||
130334741|NCT00481091|469195549|FG008|Overall Study|No reason given|1|||
130334742|NCT00481091|469195550|FG009|Overall Study|No reason given|4|||
130663859|NCT04440163|470395687|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
130663860|NCT04440163|470395688|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
130663861|NCT04440163|470395689|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
130663862|NCT04440163|470395690|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
130663863|NCT04440163|470395683|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
130663864|NCT04440163|470395684|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
130663865|NCT04440163|470395685|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
130663866|NCT04440163|470395686|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
130663867|NCT04440163|470395687|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
130663868|NCT04440163|470395688|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
130663869|NCT04440163|470395689|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
130663870|NCT04440163|470395690|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
130663871|NCT04440163|470395683|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663872|NCT04440163|470395684|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663873|NCT04440163|470395685|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663874|NCT04440163|470395686|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
130663875|NCT04440163|470395687|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663876|NCT04440163|470395688|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663877|NCT04440163|470395689|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663878|NCT04440163|470395690|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130663879|NCT03137082|470395693|FG000|Overall Study|Withdrawal by Subject|1|||
130663880|NCT03137082|470395694|FG001|Overall Study|Withdrawal by Subject|1|||
130663881|NCT03137082|470395693|FG000|Overall Study|Lost to Follow-up|1|||
130663882|NCT03137082|470395694|FG001|Overall Study|Lost to Follow-up|0|||
130663883|NCT00544557|470395695|FG000|Overall Study|Adverse Event|140|||
130663884|NCT00544557|470395695|FG000|Overall Study|Lack of Efficacy|196|||
130663885|NCT00544557|470395695|FG000|Overall Study|Other|98|||
130663886|NCT01020305|470395701|FG000|Overall Study|Adverse Event|2|||
130663887|NCT00467818|470395702|FG000|Overall Study|Adverse Event|1|||
130663888|NCT00467818|470395703|FG001|Overall Study|Adverse Event|0|||
130663889|NCT00467818|470395702|FG000|Overall Study|Lost to Follow-up|2|||
130663890|NCT00467818|470395703|FG001|Overall Study|Lost to Follow-up|2|||
130663891|NCT01017029|470395707|FG000|Overall Study|Lost to Follow-up|1|||
130663892|NCT01017029|470395708|FG001|Overall Study|Lost to Follow-up|0|||
130663893|NCT01017029|470395707|FG000|Overall Study|Administrative problem|0|||
130663894|NCT01017029|470395708|FG001|Overall Study|Administrative problem|1|||
130663895|NCT01017029|470395707|FG000|Overall Study|Death|3|||
130663896|NCT01017029|470395708|FG001|Overall Study|Death|1|||
130663897|NCT02753400|470395710|FG000|Overall Study|Adverse Event|3|||
130663898|NCT02753400|470395711|FG001|Overall Study|Adverse Event|0|||
130663899|NCT02753400|470395710|FG000|Overall Study|Withdrawal by Subject|2|||
130663900|NCT02753400|470395711|FG001|Overall Study|Withdrawal by Subject|1|||
130334743|NCT01296672|469195551|FG000|Overall Study|Lost to Follow-up|73|||
130334744|NCT01296672|469195552|FG001|Overall Study|Lost to Follow-up|18|||
130334745|NCT04661579|469195553|FG000|Overall Study|Lost to Follow-up|19|||
130663901|NCT01415921|470395712|FG000|Overall Study|Adverse Event|0|||
130663902|NCT01415921|470395713|FG001|Overall Study|Adverse Event|1|||
130663903|NCT01415921|470395712|FG000|Overall Study|Physician Decision|1|||
130663904|NCT01415921|470395713|FG001|Overall Study|Physician Decision|1|||
130663905|NCT01415921|470395712|FG000|Overall Study|Withdrawal by Subject|0|||
130663906|NCT01415921|470395713|FG001|Overall Study|Withdrawal by Subject|1|||
130663907|NCT01415921|470395712|FG000|Overall Study|Other|2|||
130663908|NCT01415921|470395713|FG001|Overall Study|Other|0|||
130663909|NCT01830920|470395718|FG000|Overall Study|Adverse Event|1|||
130663910|NCT01830920|470395719|FG001|Overall Study|Adverse Event|0|||
130663911|NCT01830920|470395720|FG002|Overall Study|Adverse Event|1|||
130663912|NCT01830920|470395721|FG003|Overall Study|Adverse Event|0|||
130663913|NCT01830920|470395722|FG004|Overall Study|Adverse Event|0|||
130663914|NCT01830920|470395718|FG000|Overall Study|Withdrawal by Subject|2|||
130663915|NCT01830920|470395719|FG001|Overall Study|Withdrawal by Subject|2|||
130663916|NCT01830920|470395720|FG002|Overall Study|Withdrawal by Subject|1|||
130663917|NCT01830920|470395721|FG003|Overall Study|Withdrawal by Subject|7|||
130334746|NCT04661579|469195554|FG001|Overall Study|Lost to Follow-up|10|||
130334747|NCT04661579|469195555|FG002|Overall Study|Lost to Follow-up|2|||
130334748|NCT04661579|469195556|FG003|Overall Study|Lost to Follow-up|7|||
130334749|NCT04661579|469195557|FG004|Overall Study|Lost to Follow-up|11|||
130334750|NCT04661579|469195553|FG000|Overall Study|Physician Decision|2|||
130334751|NCT04661579|469195554|FG001|Overall Study|Physician Decision|0|||
130334752|NCT04661579|469195555|FG002|Overall Study|Physician Decision|0|||
130334753|NCT04661579|469195556|FG003|Overall Study|Physician Decision|1|||
130334754|NCT04661579|469195557|FG004|Overall Study|Physician Decision|0|||
130334755|NCT04661579|469195553|FG000|Overall Study|Withdrawal by Subject|1|||
130334756|NCT04661579|469195554|FG001|Overall Study|Withdrawal by Subject|4|||
130334757|NCT04661579|469195555|FG002|Overall Study|Withdrawal by Subject|0|||
130334758|NCT04661579|469195556|FG003|Overall Study|Withdrawal by Subject|2|||
130334759|NCT04661579|469195557|FG004|Overall Study|Withdrawal by Subject|0|||
130334760|NCT04661579|469195553|FG000|Overall Study|Death|1|||
130334761|NCT04661579|469195554|FG001|Overall Study|Death|0|||
130334762|NCT04661579|469195555|FG002|Overall Study|Death|0|||
130334763|NCT04661579|469195556|FG003|Overall Study|Death|0|||
130334764|NCT04661579|469195557|FG004|Overall Study|Death|0|||
130334765|NCT04661579|469195553|FG000|Overall Study|Other|1|||
130334766|NCT04661579|469195554|FG001|Overall Study|Other|2|||
130334767|NCT04661579|469195555|FG002|Overall Study|Other|1|||
130334768|NCT04661579|469195556|FG003|Overall Study|Other|1|||
130334769|NCT04661579|469195557|FG004|Overall Study|Other|1|||
130334770|NCT04661579|469195553|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
130334771|NCT04661579|469195554|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
130334772|NCT04661579|469195555|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
130334773|NCT04661579|469195556|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
130334774|NCT04661579|469195557|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
130334775|NCT00796978|469195559|FG000|Overall Study|Cardiac adverse event|5|||
130334776|NCT00796978|469195559|FG000|Overall Study|Adverse Event|4|||
130334777|NCT00796978|469195559|FG000|Overall Study|Withdrawal by Subject|3|||
130334778|NCT00859456|469195560|FG000|Overall Study|Adverse Event|3|||
130334779|NCT00859456|469195560|FG000|Overall Study|Progressive disease|2|||
130334780|NCT00859456|469195560|FG000|Overall Study|Non-compliance|3|||
130334781|NCT00578292|469195561|FG000|Overall Study|Death|1|||
130334782|NCT00578292|469195561|FG000|Overall Study|Graft failure|2|||
130334783|NCT04849559|469195562|FG000|Overall Study|Withdrawal by Subject|2|||
130334784|NCT04849559|469195563|FG001|Overall Study|Withdrawal by Subject|1|||
130334785|NCT02910986|469195564|FG000|Overall Study|non-Latina|14|||
130334786|NCT02910986|469195565|FG001|Overall Study|non-Latina|13|||
130334787|NCT02910986|469195566|FG002|Overall Study|non-Latina|12|||
130334788|NCT02910986|469195564|FG000|Overall Study|Failure to return T! survey|72|||
130334789|NCT02910986|469195565|FG001|Overall Study|Failure to return T! survey|84|||
130334790|NCT02910986|469195566|FG002|Overall Study|Failure to return T! survey|72|||
130334791|NCT02910986|469195564|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
130334792|NCT02910986|469195565|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
130663918|NCT01830920|470395722|FG004|Overall Study|Withdrawal by Subject|1|||
130663919|NCT01830920|470395718|FG000|Overall Study|Death|3|||
130663920|NCT01830920|470395719|FG001|Overall Study|Death|3|||
130663921|NCT01830920|470395720|FG002|Overall Study|Death|5|||
130663922|NCT01830920|470395721|FG003|Overall Study|Death|4|||
130663923|NCT01830920|470395722|FG004|Overall Study|Death|4|||
130334793|NCT02910986|469195566|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
130334794|NCT02910986|469195564|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130334795|NCT02910986|469195565|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130334796|NCT02910986|469195566|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
130334797|NCT03527732|469195569|FG000|Overall Study|Lost to Follow-up|21|||
130334798|NCT03527732|469195570|FG001|Overall Study|Lost to Follow-up|23|||
130334799|NCT03527732|469195571|FG002|Overall Study|Lost to Follow-up|80|||
130334800|NCT03527732|469195572|FG003|Overall Study|Lost to Follow-up|62|||
130334801|NCT03527732|469195573|FG004|Overall Study|Lost to Follow-up|12|||
130334802|NCT03527732|469195574|FG005|Overall Study|Lost to Follow-up|20|||
130552519|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
130552520|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
130552521|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
130552522|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
130552523|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
130552524|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
130552525|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
130552526|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
130552527|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
130552528|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
130552529|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
130552530|NCT01231516|469990207|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
130552531|NCT01231516|469990208|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
130552532|NCT03170154|469990209|FG000|Overall Study|Lost to Follow-up|4|||
130552533|NCT03170154|469990209|FG000|Overall Study|Death|2|||
130552534|NCT03170154|469990209|FG000|Overall Study|Withdrawal by Subject|2|||
130552535|NCT05266586|469990210|FG000|Overall Study|Adverse Event|2|||
130552536|NCT05266586|469990211|FG001|Overall Study|Adverse Event|2|||
130552537|NCT05266586|469990212|FG002|Overall Study|Adverse Event|1|||
130552538|NCT05266586|469990210|FG000|Overall Study|Withdrawal by Subject|1|||
130552539|NCT05266586|469990211|FG001|Overall Study|Withdrawal by Subject|0|||
130552540|NCT05266586|469990212|FG002|Overall Study|Withdrawal by Subject|1|||
130552541|NCT05266586|469990210|FG000|Overall Study|Non-compliance with study drug|0|||
130552542|NCT05266586|469990211|FG001|Overall Study|Non-compliance with study drug|1|||
130552543|NCT05266586|469990212|FG002|Overall Study|Non-compliance with study drug|0|||
130552544|NCT05266586|469990210|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
130552545|NCT05266586|469990211|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
130552546|NCT05266586|469990212|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
130552547|NCT01117857|469990213|FG000|Overall Study|Lost to Follow-up|4|||
130552548|NCT01117857|469990213|FG000|Overall Study|Withdrawal by Subject|4|||
130552549|NCT01117857|469990213|FG000|Overall Study|Physician Decision|1|||
130552550|NCT00633061|469990214|FG000|Overall Study|Study closed|86|||
130552551|NCT00633061|469990215|FG001|Overall Study|Study closed|0|||
130552552|NCT05245097|469990216|FG000|Overall Study|Adverse Event|13|||
130552553|NCT05245097|469990217|FG001|Overall Study|Adverse Event|2|||
130552554|NCT05245097|469990216|FG000|Overall Study|Protocol Violation|8|||
130552555|NCT05245097|469990217|FG001|Overall Study|Protocol Violation|6|||
130552556|NCT05245097|469990216|FG000|Overall Study|Withdrawal by Subject|18|||
130552557|NCT05245097|469990217|FG001|Overall Study|Withdrawal by Subject|0|||
130552558|NCT05245097|469990216|FG000|Overall Study|Death|6|||
130552559|NCT05245097|469990217|FG001|Overall Study|Death|7|||
130552560|NCT05245097|469990216|FG000|Overall Study|Physician Decision|6|||
130552561|NCT05245097|469990217|FG001|Overall Study|Physician Decision|0|||
130552562|NCT05245097|469990216|FG000|Overall Study|Relocation|4|||
130552563|NCT05245097|469990217|FG001|Overall Study|Relocation|3|||
130552564|NCT00607022|469990225|FG000|Overall Study|Withdrawal by Subject|1|||
130552565|NCT00607022|469990226|FG001|Overall Study|Withdrawal by Subject|0|||
130552566|NCT00607022|469990227|FG002|Overall Study|Withdrawal by Subject|0|||
130552567|NCT02730598|469990230|FG000|Overall Study|Withdrawal by Subject|3|||
130552568|NCT02730598|469990231|FG001|Overall Study|Withdrawal by Subject|3|||
130552569|NCT02730598|469990230|FG000|Overall Study|Protocol Violation|0|||
130552570|NCT02730598|469990231|FG001|Overall Study|Protocol Violation|1|||
130552571|NCT02730598|469990230|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
130552572|NCT02730598|469990231|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
130552573|NCT03282240|469990232|FG000|Overall Study|Adverse Event|2|||
130552574|NCT03282240|469990233|FG001|Overall Study|Adverse Event|2|||
130552575|NCT03282240|469990234|FG002|Overall Study|Adverse Event|0|||
130552576|NCT03282240|469990232|FG000|Overall Study|Lost to Follow-up|3|||
130552577|NCT03282240|469990233|FG001|Overall Study|Lost to Follow-up|0|||
130552578|NCT03282240|469990234|FG002|Overall Study|Lost to Follow-up|0|||
130552579|NCT03282240|469990232|FG000|Overall Study|Protocol Deviation|4|||
130552580|NCT03282240|469990233|FG001|Overall Study|Protocol Deviation|1|||
130552581|NCT03282240|469990234|FG002|Overall Study|Protocol Deviation|2|||
130552582|NCT03282240|469990232|FG000|Overall Study|Withdrawal by Subject|1|||
130552583|NCT03282240|469990233|FG001|Overall Study|Withdrawal by Subject|0|||
130552584|NCT03282240|469990234|FG002|Overall Study|Withdrawal by Subject|1|||
130552585|NCT01675479|469990235|FG000|Overall Study|Lost to Follow-up|11|||
130552586|NCT03254485|469990236|FG000|Overall Study|Adverse Event|3|||
130552587|NCT03254485|469990237|FG001|Overall Study|Adverse Event|0|||
130552588|NCT03254485|469990238|FG002|Overall Study|Adverse Event|0|||
130552589|NCT03254485|469990239|FG003|Overall Study|Adverse Event|6|||
130552590|NCT03254485|469990236|FG000|Overall Study|Protocol Violation|6|||
130663924|NCT01830920|470395718|FG000|Overall Study|Other|15|||
130663925|NCT01830920|470395719|FG001|Overall Study|Other|1|||
130663926|NCT01830920|470395720|FG002|Overall Study|Other|1|||
130663927|NCT01830920|470395721|FG003|Overall Study|Other|5|||
130663928|NCT01830920|470395722|FG004|Overall Study|Other|3|||
130663929|NCT01313728|470395723|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
130663930|NCT03876873|470395726|FG000|Overall Study|Physician Decision|0|||
130663931|NCT03876873|470395727|FG001|Overall Study|Physician Decision|1|||
130663932|NCT03547531|470395728|FG000|Overall Study|not coming in data collection : sick|2|||
130663933|NCT03547531|470395729|FG001|Overall Study|not coming in data collection : sick|2|||
130663934|NCT03547531|470395728|FG000|Overall Study|having family occasion|0|||
130663935|NCT03547531|470395729|FG001|Overall Study|having family occasion|2|||
130663936|NCT03402126|470395731|FG000|Overall Study|Lost to Follow-up|6|||
130663937|NCT03402126|470395731|FG000|Overall Study|Protocol Violation|10|||
130663938|NCT03402126|470395731|FG000|Overall Study|Sponsor request/Study termination|29|||
130663939|NCT03402126|470395731|FG000|Overall Study|Study product no longer in use|1|||
130663940|NCT03402126|470395731|FG000|Overall Study|Technical problems|1|||
130663941|NCT03402126|470395731|FG000|Overall Study|Withdrawal by Subject|6|||
130663942|NCT03402126|470395731|FG000|Overall Study|Physician Decision|2|||
130663943|NCT03402126|470395731|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
130663944|NCT03402126|470395731|FG000|Overall Study|Death|4|||
130663945|NCT02117479|470395732|FG000|Overall Study|Death|13|||
130663946|NCT02117479|470395733|FG001|Overall Study|Death|8|||
130663947|NCT02117479|470395732|FG000|Overall Study|Adverse Event|8|||
130663948|NCT02117479|470395733|FG001|Overall Study|Adverse Event|16|||
130663949|NCT02117479|470395732|FG000|Overall Study|Subject decision|8|||
130663950|NCT02117479|470395733|FG001|Overall Study|Subject decision|9|||
130663951|NCT02117479|470395732|FG000|Overall Study|Disease progression|104|||
130663952|NCT02117479|470395733|FG001|Overall Study|Disease progression|108|||
130663953|NCT02117479|470395732|FG000|Overall Study|Noncompliance with study treatment|1|||
130663954|NCT02117479|470395733|FG001|Overall Study|Noncompliance with study treatment|0|||
130663955|NCT02117479|470395732|FG000|Overall Study|Study terminated by the sponsor|4|||
130663956|NCT02117479|470395733|FG001|Overall Study|Study terminated by the sponsor|6|||
130663957|NCT02117479|470395732|FG000|Overall Study|Physician Decision|7|||
130663958|NCT02117479|470395733|FG001|Overall Study|Physician Decision|2|||
130663959|NCT02117479|470395732|FG000|Overall Study|Other unspecified|11|||
130663960|NCT02117479|470395733|FG001|Overall Study|Other unspecified|7|||
130663961|NCT01959230|470395734|FG000|Overall Study|Failure to follow study procedures|0|||
130663962|NCT01959230|470395735|FG001|Overall Study|Failure to follow study procedures|1|||
130663963|NCT01959230|470395734|FG000|Overall Study|Administrative reasons|2|||
130663964|NCT01959230|470395735|FG001|Overall Study|Administrative reasons|0|||
130663965|NCT01959230|470395734|FG000|Overall Study|Withdrawal by Subject|2|||
130663966|NCT01959230|470395735|FG001|Overall Study|Withdrawal by Subject|0|||
130663967|NCT01453374|470395736|FG000|Overall Study|Adverse Event|7|||
130663968|NCT01453374|470395736|FG000|Overall Study|Lack of Efficacy|1|||
130663969|NCT01453374|470395736|FG000|Overall Study|Lost to Follow-up|3|||
130663970|NCT01453374|470395736|FG000|Overall Study|Withdrawal by Subject|5|||
130663971|NCT01453374|470395736|FG000|Overall Study|Incarcerated|2|||
130663972|NCT00720304|470395737|FG000|Overall Study|Withdrawal by Subject|14|||
130663973|NCT00720304|470395738|FG001|Overall Study|Withdrawal by Subject|1|||
130663974|NCT00720304|470395737|FG000|Overall Study|Death|1|||
130663975|NCT00720304|470395738|FG001|Overall Study|Death|0|||
130663976|NCT00720304|470395737|FG000|Overall Study|Physician Decision|5|||
130663977|NCT00720304|470395738|FG001|Overall Study|Physician Decision|2|||
130663978|NCT00720304|470395737|FG000|Overall Study|Adverse Event|3|||
130663979|NCT00720304|470395738|FG001|Overall Study|Adverse Event|1|||
130663980|NCT00720304|470395737|FG000|Overall Study|Disease progression|6|||
130663981|NCT00720304|470395738|FG001|Overall Study|Disease progression|1|||
130663982|NCT01333475|470395739|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
130663983|NCT01333475|470395740|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
130663984|NCT01333475|470395739|FG000|Overall Study|Toxicity|1|||
130663985|NCT01333475|470395740|FG001|Overall Study|Toxicity|3|||
130663986|NCT02981602|470395741|FG000|Overall Study|Adverse Event|0|||
130663987|NCT02981602|470395742|FG001|Overall Study|Adverse Event|0|||
130663988|NCT02981602|470395743|FG002|Overall Study|Adverse Event|0|||
130663989|NCT02981602|470395744|FG003|Overall Study|Adverse Event|1|||
130663990|NCT02981602|470395745|FG004|Overall Study|Adverse Event|0|||
130663991|NCT00386100|470395746|FG000|Overall Study|Did not receive study medication|6|||
130663992|NCT00386100|470395747|FG001|Overall Study|Did not receive study medication|4|||
130663993|NCT00386100|470395746|FG000|Overall Study|Adverse Event|15|||
130663994|NCT00386100|470395747|FG001|Overall Study|Adverse Event|25|||
130663995|NCT00386100|470395746|FG000|Overall Study|Death|0|||
130663996|NCT00386100|470395747|FG001|Overall Study|Death|1|||
130663997|NCT00386100|470395746|FG000|Overall Study|Insufficient therapeutic effect|30|||
130663998|NCT00386100|470395747|FG001|Overall Study|Insufficient therapeutic effect|6|||
130663999|NCT00386100|470395746|FG000|Overall Study|Lost to Follow-up|29|||
130664000|NCT00386100|470395747|FG001|Overall Study|Lost to Follow-up|29|||
130664001|NCT00386100|470395746|FG000|Overall Study|Non-compliance|18|||
130664002|NCT00386100|470395747|FG001|Overall Study|Non-compliance|19|||
130664003|NCT00386100|470395746|FG000|Overall Study|Protocol Violation|5|||
130664004|NCT00386100|470395747|FG001|Overall Study|Protocol Violation|3|||
130664005|NCT00386100|470395746|FG000|Overall Study|Withdrawal by Subject|32|||
130664006|NCT00386100|470395747|FG001|Overall Study|Withdrawal by Subject|31|||
130664007|NCT00386100|470395746|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
130664008|NCT00386100|470395747|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
130664009|NCT00386100|470395746|FG000|Overall Study|BMD <2.5|1|||
130664010|NCT00386100|470395747|FG001|Overall Study|BMD <2.5|0|||
130664011|NCT00386100|470395746|FG000|Overall Study|Consecutive elevated Hba1C|1|||
130664012|NCT00386100|470395747|FG001|Overall Study|Consecutive elevated Hba1C|0|||
130664013|NCT00386100|470395746|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
130664014|NCT00386100|470395747|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
130664015|NCT00386100|470395746|FG000|Overall Study|Laboratory findings|1|||
130664016|NCT00386100|470395747|FG001|Overall Study|Laboratory findings|0|||
130664017|NCT00386100|470395746|FG000|Overall Study|Participant's concern due to CPK levels|1|||
130664018|NCT00386100|470395747|FG001|Overall Study|Participant's concern due to CPK levels|0|||
130664019|NCT00386100|470395746|FG000|Overall Study|Participant moving out of state|2|||
130664020|NCT00386100|470395747|FG001|Overall Study|Participant moving out of state|0|||
130664021|NCT00386100|470395746|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
130334803|NCT02280408|469195575|FG000|Overall Study|Lost to Follow-up|0|||
130334804|NCT02280408|469195576|FG001|Overall Study|Lost to Follow-up|2|||
130334805|NCT02280408|469195577|FG002|Overall Study|Lost to Follow-up|0|||
130334806|NCT02280408|469195578|FG003|Overall Study|Lost to Follow-up|0|||
130334807|NCT02474069|469195579|FG000|Selection Phase (SP)|Adverse Event|8|||
130334808|NCT02474069|469195580|FG001|Selection Phase (SP)|Adverse Event|0|||
130334809|NCT02474069|469195581|FG002|Selection Phase (SP)|Adverse Event|0|||
130334810|NCT02474069|469195579|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
130334811|NCT02474069|469195580|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
130334812|NCT02474069|469195581|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
130334813|NCT02474069|469195579|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
130334814|NCT02474069|469195580|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
130334815|NCT02474069|469195581|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
130334816|NCT02474069|469195579|FG000|Selection Phase (SP)|Physician Decision|1|||
130334817|NCT02474069|469195580|FG001|Selection Phase (SP)|Physician Decision|0|||
130334818|NCT02474069|469195581|FG002|Selection Phase (SP)|Physician Decision|0|||
130334819|NCT02474069|469195579|FG000|Selection Phase (SP)|Protocol Violation|1|||
130334820|NCT02474069|469195580|FG001|Selection Phase (SP)|Protocol Violation|0|||
130334821|NCT02474069|469195581|FG002|Selection Phase (SP)|Protocol Violation|0|||
130334822|NCT02474069|469195579|FG000|Selection Phase (SP)|No longer requires treatment|1|||
130334823|NCT02474069|469195580|FG001|Selection Phase (SP)|No longer requires treatment|0|||
130334824|NCT02474069|469195581|FG002|Selection Phase (SP)|No longer requires treatment|0|||
130334825|NCT02474069|469195579|FG000|Selection Phase (SP)|Technical Problem|1|||
130334826|NCT02474069|469195580|FG001|Selection Phase (SP)|Technical Problem|0|||
130334827|NCT02474069|469195581|FG002|Selection Phase (SP)|Technical Problem|0|||
130334828|NCT02474069|469195579|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
130552591|NCT03254485|469990237|FG001|Overall Study|Protocol Violation|0|||
130552592|NCT03254485|469990238|FG002|Overall Study|Protocol Violation|0|||
130552593|NCT03254485|469990239|FG003|Overall Study|Protocol Violation|2|||
130552594|NCT03254485|469990236|FG000|Overall Study|Withdrawal by Subject|1|||
130552595|NCT03254485|469990237|FG001|Overall Study|Withdrawal by Subject|0|||
130552596|NCT03254485|469990238|FG002|Overall Study|Withdrawal by Subject|0|||
130552597|NCT03254485|469990239|FG003|Overall Study|Withdrawal by Subject|4|||
130552598|NCT03254485|469990236|FG000|Overall Study|Death|0|||
130552599|NCT03254485|469990237|FG001|Overall Study|Death|0|||
130552600|NCT03254485|469990238|FG002|Overall Study|Death|0|||
130552601|NCT03254485|469990239|FG003|Overall Study|Death|1|||
130552602|NCT03254485|469990236|FG000|Overall Study|Lost to Follow-up|1|||
130552603|NCT03254485|469990237|FG001|Overall Study|Lost to Follow-up|0|||
130552604|NCT03254485|469990238|FG002|Overall Study|Lost to Follow-up|0|||
130552605|NCT03254485|469990239|FG003|Overall Study|Lost to Follow-up|0|||
130552606|NCT03254485|469990236|FG000|Overall Study|Other|1|||
130552607|NCT03254485|469990237|FG001|Overall Study|Other|0|||
130552608|NCT03254485|469990238|FG002|Overall Study|Other|0|||
130552609|NCT03254485|469990239|FG003|Overall Study|Other|2|||
130552610|NCT02910739|469990240|FG000|Overall Study|Adverse Event|1|||
130552611|NCT02910739|469990241|FG001|Overall Study|Adverse Event|0|||
130552612|NCT02910739|469990242|FG002|Overall Study|Adverse Event|0|||
130552613|NCT02910739|469990243|FG003|Overall Study|Adverse Event|0|||
130552614|NCT02146326|469990244|FG000|Overall Study|Lost to Follow-up|3|||
130552615|NCT02146326|469990245|FG001|Overall Study|Lost to Follow-up|3|||
130552616|NCT02146326|469990246|FG002|Overall Study|Lost to Follow-up|11|||
130552617|NCT02146326|469990247|FG003|Overall Study|Lost to Follow-up|19|||
130552618|NCT02146326|469990244|FG000|Overall Study|Withdrawal by Subject|2|||
130552619|NCT02146326|469990245|FG001|Overall Study|Withdrawal by Subject|1|||
130552620|NCT02146326|469990246|FG002|Overall Study|Withdrawal by Subject|15|||
130664022|NCT00386100|470395747|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
130664023|NCT00386100|470395746|FG000|Overall Study|Didn't meet entry criteria|1|||
130664024|NCT00386100|470395747|FG001|Overall Study|Didn't meet entry criteria|1|||
130664025|NCT00386100|470395746|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
130664026|NCT00386100|470395747|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
130664027|NCT00386100|470395746|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
130664028|NCT00386100|470395747|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
130664029|NCT00386100|470395746|FG000|Overall Study|Bad metabolic control & patient security|1|||
130664030|NCT00386100|470395747|FG001|Overall Study|Bad metabolic control & patient security|0|||
130664031|NCT00386100|470395746|FG000|Overall Study|Bone loss by DXA bone scan|1|||
130664032|NCT00386100|470395747|FG001|Overall Study|Bone loss by DXA bone scan|0|||
130664033|NCT00386100|470395746|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
130664034|NCT00386100|470395747|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
130664035|NCT00386100|470395746|FG000|Overall Study|7.6% bone loss|1|||
130664036|NCT00386100|470395747|FG001|Overall Study|7.6% bone loss|0|||
130664037|NCT00386100|470395746|FG000|Overall Study|Osteoporosis|0|||
130664038|NCT00386100|470395747|FG001|Overall Study|Osteoporosis|1|||
130664039|NCT00386100|470395746|FG000|Overall Study|Positive pregnancy test|1|||
130664040|NCT00386100|470395747|FG001|Overall Study|Positive pregnancy test|3|||
130664041|NCT00386100|470395746|FG000|Overall Study|Out of country for 5 months|1|||
130664042|NCT00386100|470395747|FG001|Overall Study|Out of country for 5 months|0|||
130664043|NCT00386100|470395746|FG000|Overall Study|Hb1Ac >8%|0|||
130664044|NCT00386100|470395747|FG001|Overall Study|Hb1Ac >8%|1|||
130664045|NCT00386100|470395746|FG000|Overall Study|Participant randomized in error|1|||
130664046|NCT00386100|470395747|FG001|Overall Study|Participant randomized in error|0|||
130664047|NCT01706770|470395748|FG000|Overall Study|Lost to Follow-up|1|||
130664048|NCT01706770|470395749|FG001|Overall Study|Lost to Follow-up|0|||
130664049|NCT01706770|470395748|FG000|Overall Study|Physician Decision|1|||
130664050|NCT01706770|470395749|FG001|Overall Study|Physician Decision|0|||
130664051|NCT03636542|470395752|FG000|Overall Study|Lost to Follow-up|1|||
130664052|NCT03636542|470395753|FG001|Overall Study|Lost to Follow-up|1|||
130664053|NCT03636542|470395752|FG000|Overall Study|Physician Decision|0|||
130664054|NCT03636542|470395753|FG001|Overall Study|Physician Decision|1|||
130664055|NCT03636542|470395752|FG000|Overall Study|Withdrawal by Subject|1|||
130664056|NCT03636542|470395753|FG001|Overall Study|Withdrawal by Subject|0|||
130664057|NCT03674827|470395756|FG000|Treatment Phase|Adverse Event|0|||
130664058|NCT03674827|470395757|FG001|Treatment Phase|Adverse Event|0|||
130664059|NCT03674827|470395758|FG002|Treatment Phase|Adverse Event|0|||
130664060|NCT03674827|470395759|FG003|Treatment Phase|Adverse Event|0|||
130664061|NCT03674827|470395760|FG004|Treatment Phase|Adverse Event|0|||
130664062|NCT03674827|470395761|FG005|Treatment Phase|Adverse Event|2|||
130664063|NCT03674827|470395756|FG000|Treatment Phase|Death|2|||
130664064|NCT03674827|470395757|FG001|Treatment Phase|Death|0|||
130664065|NCT03674827|470395758|FG002|Treatment Phase|Death|0|||
130664066|NCT03674827|470395759|FG003|Treatment Phase|Death|0|||
130664067|NCT03674827|470395760|FG004|Treatment Phase|Death|1|||
130664068|NCT03674827|470395761|FG005|Treatment Phase|Death|0|||
130664069|NCT03674827|470395756|FG000|Treatment Phase|Progressive Disease|0|||
130664070|NCT03674827|470395757|FG001|Treatment Phase|Progressive Disease|4|||
130664071|NCT03674827|470395758|FG002|Treatment Phase|Progressive Disease|3|||
130664072|NCT03674827|470395759|FG003|Treatment Phase|Progressive Disease|4|||
130664073|NCT03674827|470395760|FG004|Treatment Phase|Progressive Disease|4|||
130664074|NCT03674827|470395761|FG005|Treatment Phase|Progressive Disease|9|||
130664075|NCT03674827|470395756|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
130664076|NCT03674827|470395757|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
130664077|NCT03674827|470395758|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
130664078|NCT03674827|470395759|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
130664079|NCT03674827|470395760|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
130664080|NCT03674827|470395761|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
130664081|NCT03674827|470395756|FG000|Treatment Phase|Withdrawal by Subject|0|||
130216126|NCT01826981|468753950|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216127|NCT01826981|468753951|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
130664082|NCT03674827|470395757|FG001|Treatment Phase|Withdrawal by Subject|0|||
130664083|NCT03674827|470395758|FG002|Treatment Phase|Withdrawal by Subject|0|||
130664084|NCT03674827|470395759|FG003|Treatment Phase|Withdrawal by Subject|0|||
130664085|NCT03674827|470395760|FG004|Treatment Phase|Withdrawal by Subject|0|||
130664086|NCT03674827|470395761|FG005|Treatment Phase|Withdrawal by Subject|1|||
130664087|NCT03674827|470395756|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
130664088|NCT03674827|470395757|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
130664089|NCT03674827|470395758|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
130664090|NCT03674827|470395759|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
130664091|NCT03674827|470395760|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
130216128|NCT01826981|468753952|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216129|NCT01826981|468753953|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
130664092|NCT03674827|470395761|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
130664093|NCT03674827|470395756|FG000|Treatment Phase|Other|0|||
130664094|NCT03674827|470395757|FG001|Treatment Phase|Other|1|||
130664095|NCT03674827|470395758|FG002|Treatment Phase|Other|0|||
130664096|NCT03674827|470395759|FG003|Treatment Phase|Other|0|||
130664097|NCT03674827|470395760|FG004|Treatment Phase|Other|0|||
130664098|NCT03674827|470395761|FG005|Treatment Phase|Other|1|||
130664099|NCT03674827|470395756|FG000|Long-Term Follow-up Phase|Death|2|||
130664100|NCT03674827|470395757|FG001|Long-Term Follow-up Phase|Death|4|||
130664101|NCT03674827|470395758|FG002|Long-Term Follow-up Phase|Death|2|||
130664102|NCT03674827|470395759|FG003|Long-Term Follow-up Phase|Death|3|||
130664103|NCT03674827|470395760|FG004|Long-Term Follow-up Phase|Death|2|||
130664104|NCT03674827|470395761|FG005|Long-Term Follow-up Phase|Death|6|||
130664105|NCT03674827|470395756|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
130664106|NCT03674827|470395757|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
130664107|NCT03674827|470395758|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
130664108|NCT03674827|470395759|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
130664109|NCT03674827|470395760|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
130664110|NCT03674827|470395761|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
130664111|NCT03674827|470395756|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130664112|NCT03674827|470395757|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130664113|NCT03674827|470395758|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
130664114|NCT03674827|470395759|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
130664115|NCT03674827|470395760|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130664116|NCT03674827|470395761|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
130664117|NCT00527397|470395762|FG000|Overall Study|Adverse Event|3|||
130664118|NCT00527397|470395762|FG000|Overall Study|Lack of Efficacy|1|||
130664119|NCT00527397|470395762|FG000|Overall Study|Protocol Violation|1|||
130664120|NCT00527397|470395762|FG000|Overall Study|Withdrawal by Subject|6|||
130664121|NCT00527397|470395762|FG000|Overall Study|Study terminated by sponsor|13|||
130664122|NCT01783483|470395763|FG000|Overall Study|Death|3|||
130664123|NCT01783483|470395764|FG001|Overall Study|Death|3|||
130664124|NCT01783483|470395763|FG000|Overall Study|Lost to Follow-up|14|||
130664125|NCT01783483|470395764|FG001|Overall Study|Lost to Follow-up|10|||
130664126|NCT01783483|470395763|FG000|Overall Study|Withdrawal by Subject|2|||
130664127|NCT01783483|470395764|FG001|Overall Study|Withdrawal by Subject|1|||
130664128|NCT01783483|470395763|FG000|Overall Study|Physician Decision|1|||
130664129|NCT01783483|470395764|FG001|Overall Study|Physician Decision|1|||
130664130|NCT04130919|470395770|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
130664131|NCT04130919|470395771|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
130664132|NCT04130919|470395772|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
130664133|NCT04130919|470395773|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
130664134|NCT04130919|470395774|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
130664135|NCT04130919|470395775|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
130664136|NCT04130919|470395770|FG000|Blinded Treatment Phase|Adverse Event|0|||
130664137|NCT04130919|470395771|FG001|Blinded Treatment Phase|Adverse Event|0|||
130664138|NCT04130919|470395772|FG002|Blinded Treatment Phase|Adverse Event|1|||
130664139|NCT04130919|470395773|FG003|Blinded Treatment Phase|Adverse Event|0|||
130664140|NCT04130919|470395774|FG004|Blinded Treatment Phase|Adverse Event|0|||
130664141|NCT04130919|470395775|FG005|Blinded Treatment Phase|Adverse Event|0|||
130664142|NCT04130919|470395770|FG000|Blinded Treatment Phase|Disease worsening|0|||
130664143|NCT04130919|470395771|FG001|Blinded Treatment Phase|Disease worsening|0|||
130664144|NCT04130919|470395772|FG002|Blinded Treatment Phase|Disease worsening|1|||
130664145|NCT04130919|470395773|FG003|Blinded Treatment Phase|Disease worsening|0|||
130664146|NCT04130919|470395774|FG004|Blinded Treatment Phase|Disease worsening|0|||
130664147|NCT04130919|470395775|FG005|Blinded Treatment Phase|Disease worsening|0|||
130664148|NCT04130919|470395770|FG000|Blinded Treatment Phase|Investigator's decision|0|||
130664149|NCT04130919|470395771|FG001|Blinded Treatment Phase|Investigator's decision|1|||
130664150|NCT04130919|470395772|FG002|Blinded Treatment Phase|Investigator's decision|0|||
130664151|NCT04130919|470395773|FG003|Blinded Treatment Phase|Investigator's decision|0|||
130664152|NCT04130919|470395774|FG004|Blinded Treatment Phase|Investigator's decision|0|||
130664153|NCT04130919|470395775|FG005|Blinded Treatment Phase|Investigator's decision|0|||
130664154|NCT04130919|470395770|FG000|Blinded Treatment Phase|Withdrew consent|1|||
130664155|NCT04130919|470395771|FG001|Blinded Treatment Phase|Withdrew consent|0|||
130664156|NCT04130919|470395772|FG002|Blinded Treatment Phase|Withdrew consent|0|||
130664157|NCT04130919|470395773|FG003|Blinded Treatment Phase|Withdrew consent|0|||
130664158|NCT04130919|470395774|FG004|Blinded Treatment Phase|Withdrew consent|0|||
130664159|NCT04130919|470395775|FG005|Blinded Treatment Phase|Withdrew consent|0|||
130664160|NCT04130919|470395770|FG000|Open-label Treatment Phase|Withdrew consent|0|||
130664161|NCT04130919|470395771|FG001|Open-label Treatment Phase|Withdrew consent|0|||
130664162|NCT04130919|470395772|FG002|Open-label Treatment Phase|Withdrew consent|0|||
130334829|NCT02474069|469195580|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
130433400|NCT03682705|469550431|FG005|Overall Study|Withdrawal by Subject|1|||
130433401|NCT03682705|469550426|FG000|Overall Study|Other, not specified|0|||
130433402|NCT03682705|469550427|FG001|Overall Study|Other, not specified|0|||
130433403|NCT03682705|469550428|FG002|Overall Study|Other, not specified|0|||
130433404|NCT03682705|469550429|FG003|Overall Study|Other, not specified|1|||
130433405|NCT03682705|469550430|FG004|Overall Study|Other, not specified|2|||
130433406|NCT03682705|469550431|FG005|Overall Study|Other, not specified|0|||
130433407|NCT03682705|469550426|FG000|Overall Study|Lost to Follow-up|0|||
130433408|NCT03682705|469550427|FG001|Overall Study|Lost to Follow-up|0|||
130433409|NCT03682705|469550428|FG002|Overall Study|Lost to Follow-up|0|||
130433410|NCT03682705|469550429|FG003|Overall Study|Lost to Follow-up|0|||
130433411|NCT03682705|469550430|FG004|Overall Study|Lost to Follow-up|3|||
130433412|NCT03682705|469550431|FG005|Overall Study|Lost to Follow-up|0|||
130433413|NCT00117156|469550432|FG000|Overall Study|Adverse Event|9|||
130433414|NCT00117156|469550432|FG000|Overall Study|Physician Decision|1|||
130433415|NCT00117156|469550432|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
130433416|NCT01919970|469550433|FG000|Overall Study|Withdrawal by Subject|3|||
130433417|NCT01919970|469550434|FG001|Overall Study|Withdrawal by Subject|0|||
130433418|NCT04043962|469550435|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
130664163|NCT04130919|470395773|FG003|Open-label Treatment Phase|Withdrew consent|1|||
130664164|NCT04130919|470395774|FG004|Open-label Treatment Phase|Withdrew consent|1|||
130664165|NCT04130919|470395775|FG005|Open-label Treatment Phase|Withdrew consent|1|||
130664166|NCT04130919|470395770|FG000|Open-label Treatment Phase|Disease worsening|0|||
130664167|NCT04130919|470395771|FG001|Open-label Treatment Phase|Disease worsening|0|||
130664168|NCT04130919|470395772|FG002|Open-label Treatment Phase|Disease worsening|0|||
130664169|NCT04130919|470395773|FG003|Open-label Treatment Phase|Disease worsening|1|||
130664170|NCT04130919|470395774|FG004|Open-label Treatment Phase|Disease worsening|0|||
130664171|NCT04130919|470395775|FG005|Open-label Treatment Phase|Disease worsening|1|||
130664172|NCT04130919|470395770|FG000|Open-label Treatment Phase|Investigator's decision|0|||
130664173|NCT04130919|470395771|FG001|Open-label Treatment Phase|Investigator's decision|0|||
130664174|NCT04130919|470395772|FG002|Open-label Treatment Phase|Investigator's decision|0|||
130664175|NCT04130919|470395773|FG003|Open-label Treatment Phase|Investigator's decision|1|||
130664176|NCT04130919|470395774|FG004|Open-label Treatment Phase|Investigator's decision|0|||
130664177|NCT04130919|470395775|FG005|Open-label Treatment Phase|Investigator's decision|0|||
130664178|NCT04130919|470395770|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130664179|NCT04130919|470395771|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130664180|NCT04130919|470395772|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
130664181|NCT04130919|470395773|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
130664182|NCT04130919|470395774|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
130664183|NCT04130919|470395775|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
130664184|NCT04130919|470395770|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130664185|NCT04130919|470395771|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130664186|NCT04130919|470395772|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130664187|NCT04130919|470395773|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130664188|NCT04130919|470395774|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
130664189|NCT04130919|470395775|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130664190|NCT02624518|470395776|FG000|Overall Study|Physician Decision|1|||
130664191|NCT00370396|470395779|FG000|Overall Study|Withdrawal by Subject|0|||
130664192|NCT00370396|470395780|FG001|Overall Study|Withdrawal by Subject|0|||
130664193|NCT00370396|470395781|FG002|Overall Study|Withdrawal by Subject|1|||
130664194|NCT00370396|470395779|FG000|Overall Study|Lost to Follow-up|11|||
130664195|NCT00370396|470395780|FG001|Overall Study|Lost to Follow-up|1|||
130664196|NCT00370396|470395781|FG002|Overall Study|Lost to Follow-up|0|||
130664197|NCT01462695|470395782|FG000|Overall Study|Adverse Event|1|||
130664198|NCT01462695|470395783|FG001|Overall Study|Adverse Event|1|||
130664199|NCT01462695|470395782|FG000|Overall Study|Death|2|||
130664200|NCT01462695|470395783|FG001|Overall Study|Death|0|||
130664201|NCT01462695|470395782|FG000|Overall Study|Lack of Efficacy|6|||
130664202|NCT01462695|470395783|FG001|Overall Study|Lack of Efficacy|12|||
130664203|NCT01462695|470395782|FG000|Overall Study|Physician Decision|5|||
130664204|NCT01462695|470395783|FG001|Overall Study|Physician Decision|0|||
130664205|NCT01462695|470395782|FG000|Overall Study|Withdrawal by Subject|2|||
130664206|NCT01462695|470395783|FG001|Overall Study|Withdrawal by Subject|0|||
130664207|NCT01462695|470395782|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
130664208|NCT01462695|470395783|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
130664209|NCT01364298|470395785|FG000|Overall Study|Adverse Event|3|||
130664210|NCT01364298|470395786|FG001|Overall Study|Adverse Event|4|||
130664211|NCT01364298|470395785|FG000|Overall Study|Lack of adherence to treatment|1|||
130664212|NCT01364298|470395786|FG001|Overall Study|Lack of adherence to treatment|3|||
130664213|NCT01364298|470395785|FG000|Overall Study|Lack of Efficacy|1|||
130664214|NCT01364298|470395786|FG001|Overall Study|Lack of Efficacy|0|||
130664215|NCT01364298|470395785|FG000|Overall Study|Lost to Follow-up|5|||
130664216|NCT01364298|470395786|FG001|Overall Study|Lost to Follow-up|10|||
130664217|NCT01364298|470395785|FG000|Overall Study|Withdrawal by Subject|3|||
130433419|NCT04043962|469550435|FG000|Post-Treatment|Withdrawal by Subject|5|||
130664218|NCT01364298|470395786|FG001|Overall Study|Withdrawal by Subject|3|||
130664219|NCT01364298|470395785|FG000|Overall Study|Other|1|||
130664220|NCT01364298|470395786|FG001|Overall Study|Other|3|||
130664221|NCT03797222|470395789|FG000|Overall Study|Withdrawal by Subject|1|||
130664222|NCT00659581|470395792|FG000|Overall Study|Adverse Event|1006|||
130664223|NCT00659581|470395792|FG000|Overall Study|Lack of Efficacy|1183|||
130664224|NCT00659581|470395792|FG000|Overall Study|Other|6393|||
130664225|NCT00725725|470395796|FG000|Overall Study|Adverse Event|1|||
130664226|NCT00725725|470395797|FG001|Overall Study|Adverse Event|3|||
130664227|NCT00725725|470395798|FG002|Overall Study|Adverse Event|2|||
130664228|NCT00725725|470395796|FG000|Overall Study|Lost to Follow-up|2|||
130664229|NCT00725725|470395797|FG001|Overall Study|Lost to Follow-up|0|||
130664230|NCT00725725|470395798|FG002|Overall Study|Lost to Follow-up|2|||
130664231|NCT00725725|470395796|FG000|Overall Study|Withdrawal by Subject|1|||
130664232|NCT00725725|470395797|FG001|Overall Study|Withdrawal by Subject|0|||
130664233|NCT00725725|470395798|FG002|Overall Study|Withdrawal by Subject|1|||
130664234|NCT00725725|470395796|FG000|Overall Study|Protocol Violation|0|||
130664235|NCT00725725|470395797|FG001|Overall Study|Protocol Violation|1|||
130664236|NCT00725725|470395798|FG002|Overall Study|Protocol Violation|0|||
130664237|NCT01619085|470395799|FG000|Overall Study|Adverse Event|231|||
130664238|NCT01619085|470395799|FG000|Overall Study|Protocol Violation|4|||
130664239|NCT01619085|470395799|FG000|Overall Study|Lost to Follow-up|3|||
130664240|NCT01619085|470395799|FG000|Overall Study|Withdrawal by Subject|45|||
130664241|NCT01619085|470395799|FG000|Overall Study|Other than specified|96|||
130664242|NCT01619085|470395799|FG000|Overall Study|Not treated|1|||
130664243|NCT01619085|470395799|FG000|Overall Study|Death|145|||
130664244|NCT03125629|470395800|FG000|Overall Study|Withdrawal by Subject|2|||
130664245|NCT03125629|470395800|FG000|Overall Study|Equipment malfunction|1|||
130664246|NCT03909971|470395801|FG000|Overall Study|Other Reasons Not Specified|0|||
130664247|NCT03909971|470395802|FG001|Overall Study|Other Reasons Not Specified|1|||
130664248|NCT03909971|470395801|FG000|Overall Study|Global Deterioration of Health Status|2|||
130664249|NCT03909971|470395802|FG001|Overall Study|Global Deterioration of Health Status|1|||
130664250|NCT03909971|470395801|FG000|Overall Study|Progressive Disease|6|||
130664251|NCT03909971|470395802|FG001|Overall Study|Progressive Disease|14|||
130664252|NCT03909971|470395801|FG000|Overall Study|Death|2|||
130664253|NCT03909971|470395802|FG001|Overall Study|Death|6|||
130664254|NCT03053622|470397377|FG000|Overall Study|Lost to Follow-up|0|||
130664255|NCT03053622|470397378|FG001|Overall Study|Lost to Follow-up|0|||
130664256|NCT03053622|470397379|FG002|Overall Study|Lost to Follow-up|0|||
130664257|NCT03053622|470397380|FG003|Overall Study|Lost to Follow-up|1|||
130664258|NCT02598622|470397381|FG000|Overall Study|Withdrawal by Subject|3|||
130664259|NCT02598622|470397382|FG001|Overall Study|Withdrawal by Subject|0|||
130664260|NCT02598622|470397381|FG000|Overall Study|Physician Decision|3|||
130664261|NCT02598622|470397382|FG001|Overall Study|Physician Decision|0|||
130664262|NCT01355523|470397386|FG000|Overall Study|Withdrawal by Subject|1|||
130664263|NCT01355523|470397387|FG001|Overall Study|Withdrawal by Subject|4|||
130664264|NCT01355523|470397386|FG000|Overall Study|Lost to Follow-up|0|||
130664265|NCT01355523|470397387|FG001|Overall Study|Lost to Follow-up|2|||
130664266|NCT01355523|470397386|FG000|Overall Study|Protocol Violation|0|||
130664267|NCT01355523|470397387|FG001|Overall Study|Protocol Violation|2|||
130664268|NCT01355523|470397386|FG000|Overall Study|Adverse Event|0|||
130664269|NCT01355523|470397387|FG001|Overall Study|Adverse Event|2|||
130664270|NCT01835470|470397388|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
130664271|NCT01835470|470397388|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
130664272|NCT01272193|470397389|FG000|Overall Study|Adverse Event|1|||
130664273|NCT01272193|470397390|FG001|Overall Study|Adverse Event|1|||
130664274|NCT01272193|470397389|FG000|Overall Study|Lack of Efficacy|0|||
130664275|NCT01272193|470397390|FG001|Overall Study|Lack of Efficacy|3|||
130664276|NCT01272193|470397389|FG000|Overall Study|Withdrawal Criteria|1|||
130664277|NCT01272193|470397390|FG001|Overall Study|Withdrawal Criteria|1|||
130664278|NCT01272193|470397389|FG000|Overall Study|Unclassified|8|||
130664279|NCT01272193|470397390|FG001|Overall Study|Unclassified|7|||
130664280|NCT01440647|470397393|FG000|Overall Study|Death|2|||
130664281|NCT01440647|470397394|FG001|Overall Study|Death|3|||
130664282|NCT04335110|470397417|FG000|Overall Study|Withdrawal by Subject|1|||
130664283|NCT04335110|470397418|FG001|Overall Study|Withdrawal by Subject|1|||
130664284|NCT04335110|470397417|FG000|Overall Study|Death|0|||
130216130|NCT01826981|468753954|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216131|NCT02030119|468753955|FG000|Overall Study|Withdrawal by Subject|3|||
130216132|NCT02030119|468753956|FG001|Overall Study|Withdrawal by Subject|1|||
130664285|NCT04335110|470397418|FG001|Overall Study|Death|1|||
130664286|NCT00350519|470397419|FG000|Overall Study|Death|0|||
130664287|NCT00350519|470397420|FG001|Overall Study|Death|1|||
130664288|NCT00350519|470397419|FG000|Overall Study|Physician Decision|0|||
130664289|NCT00350519|470397420|FG001|Overall Study|Physician Decision|1|||
130664290|NCT00350519|470397419|FG000|Overall Study|Protocol Violation|1|||
130664291|NCT00350519|470397420|FG001|Overall Study|Protocol Violation|2|||
130664292|NCT00350519|470397419|FG000|Overall Study|Withdrawal by Subject|3|||
130664293|NCT00350519|470397420|FG001|Overall Study|Withdrawal by Subject|2|||
130664294|NCT02595528|470397421|FG000|Overall Study|Withdrawal by Subject|1|||
130664295|NCT02595528|470397422|FG001|Overall Study|Withdrawal by Subject|2|||
130664296|NCT02595528|470397423|FG002|Overall Study|Withdrawal by Subject|1|||
130664297|NCT02595528|470397424|FG003|Overall Study|Withdrawal by Subject|3|||
130664298|NCT02595528|470397421|FG000|Overall Study|Lost to Follow-up|1|||
130664299|NCT02595528|470397422|FG001|Overall Study|Lost to Follow-up|1|||
130664300|NCT02595528|470397423|FG002|Overall Study|Lost to Follow-up|0|||
130664301|NCT02595528|470397424|FG003|Overall Study|Lost to Follow-up|1|||
130664302|NCT00096382|470397425|FG000|Overall Study|Not treated|1|||
130664303|NCT00096382|470397426|FG001|Overall Study|Not treated|0|||
130664304|NCT00096382|470397425|FG000|Overall Study|Death during treatment|1|||
130664305|NCT00096382|470397426|FG001|Overall Study|Death during treatment|0|||
130664306|NCT03836729|470397427|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
130664307|NCT00948025|470397429|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
130664308|NCT00948025|470397430|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
130664309|NCT00948025|470397429|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
130664310|NCT00948025|470397430|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
130664311|NCT00948025|470397429|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
130664312|NCT00948025|470397430|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
130664313|NCT01637961|470397431|FG000|Overall Study|Ineligible: wrong primary|1|||
130664314|NCT01637961|470397431|FG000|Overall Study|Ineligible: inadequate pathology|1|||
130664315|NCT03101293|470397435|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
130664316|NCT03101293|470397436|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
130664317|NCT03862625|470397443|FG000|Overall Study|Lost to Follow-up|0|||
130664318|NCT03862625|470397444|FG001|Overall Study|Lost to Follow-up|1|||
130664319|NCT01326702|470397445|FG000|Overall Study|Other|1|||
130664320|NCT01326702|470397446|FG001|Overall Study|Other|0|||
130664321|NCT01326702|470397447|FG002|Overall Study|Other|0|||
130664322|NCT01326702|470397448|FG003|Overall Study|Other|0|||
130664323|NCT01326702|470397449|FG004|Overall Study|Other|0|||
130664324|NCT01326702|470397450|FG005|Overall Study|Other|1|||
130664325|NCT01326702|470397451|FG006|Overall Study|Other|0|||
130664326|NCT01326702|470397445|FG000|Overall Study|progressive disease|1|||
130664327|NCT01326702|470397446|FG001|Overall Study|progressive disease|1|||
130664328|NCT01326702|470397447|FG002|Overall Study|progressive disease|3|||
130664329|NCT01326702|470397448|FG003|Overall Study|progressive disease|1|||
130664330|NCT01326702|470397449|FG004|Overall Study|progressive disease|3|||
130664331|NCT01326702|470397450|FG005|Overall Study|progressive disease|2|||
130664332|NCT01326702|470397451|FG006|Overall Study|progressive disease|3|||
130664333|NCT01326702|470397445|FG000|Overall Study|Death|0|||
130664334|NCT01326702|470397446|FG001|Overall Study|Death|1|||
130664335|NCT01326702|470397447|FG002|Overall Study|Death|0|||
130664336|NCT01326702|470397448|FG003|Overall Study|Death|0|||
130664337|NCT01326702|470397449|FG004|Overall Study|Death|0|||
130664338|NCT01326702|470397450|FG005|Overall Study|Death|0|||
130664339|NCT01326702|470397451|FG006|Overall Study|Death|0|||
130664340|NCT01326702|470397445|FG000|Overall Study|Adverse Event|0|||
130664341|NCT01326702|470397446|FG001|Overall Study|Adverse Event|0|||
130664342|NCT01326702|470397447|FG002|Overall Study|Adverse Event|1|||
130664343|NCT01326702|470397448|FG003|Overall Study|Adverse Event|1|||
130664344|NCT01326702|470397449|FG004|Overall Study|Adverse Event|0|||
130664345|NCT01326702|470397450|FG005|Overall Study|Adverse Event|3|||
130664346|NCT01326702|470397451|FG006|Overall Study|Adverse Event|1|||
130664347|NCT01326702|470397445|FG000|Overall Study|Withdrawal by Subject|0|||
130664348|NCT01326702|470397446|FG001|Overall Study|Withdrawal by Subject|0|||
130664349|NCT01326702|470397447|FG002|Overall Study|Withdrawal by Subject|1|||
130664350|NCT01326702|470397448|FG003|Overall Study|Withdrawal by Subject|0|||
130664351|NCT01326702|470397449|FG004|Overall Study|Withdrawal by Subject|1|||
130664352|NCT01326702|470397450|FG005|Overall Study|Withdrawal by Subject|1|||
130664353|NCT01326702|470397451|FG006|Overall Study|Withdrawal by Subject|3|||
130664354|NCT01326702|470397445|FG000|Overall Study|Not Treated|0|||
130664355|NCT01326702|470397446|FG001|Overall Study|Not Treated|0|||
130664356|NCT01326702|470397447|FG002|Overall Study|Not Treated|0|||
130664357|NCT01326702|470397448|FG003|Overall Study|Not Treated|1|||
130664358|NCT01326702|470397449|FG004|Overall Study|Not Treated|0|||
130664359|NCT01326702|470397450|FG005|Overall Study|Not Treated|1|||
130664360|NCT01326702|470397451|FG006|Overall Study|Not Treated|0|||
130664361|NCT03333382|470397462|FG000|Overall Study|Lost to Follow-up|1|||
130664362|NCT03333382|470397463|FG001|Overall Study|Lost to Follow-up|0|||
130664363|NCT00550420|470397464|FG000|Overall Study|Adverse Event|28|||
130664364|NCT00550420|470397464|FG000|Overall Study|Lost to Follow-up|8|||
130664365|NCT00550420|470397464|FG000|Overall Study|Protocol Violation|11|||
130664366|NCT00550420|470397464|FG000|Overall Study|Withdrawal by Subject|30|||
130664367|NCT00550420|470397464|FG000|Overall Study|Still in study at termination|206|||
130664368|NCT00550420|470397464|FG000|Overall Study|Missing|2|||
130664369|NCT00550420|470397464|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
130664370|NCT00550420|470397464|FG000|Overall Study|Investigators opinion|1|||
130664371|NCT00550420|470397464|FG000|Overall Study|Lack of curative effect|1|||
130664372|NCT00550420|470397464|FG000|Overall Study|Unethical stop of enrollment|2|||
130664373|NCT00550420|470397464|FG000|Overall Study|Caregiver's decision to withdraw|1|||
130664374|NCT00550420|470397464|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
130664375|NCT00550420|470397464|FG000|Overall Study|Exclusion criteria|1|||
130664376|NCT00550420|470397464|FG000|Overall Study|Prohibited medicine|1|||
130664377|NCT02773446|470397470|FG000|First Admission|Withdrawal by Subject|0|||
130664378|NCT02773446|470397471|FG001|First Admission|Withdrawal by Subject|0|||
130664379|NCT02773446|470397472|FG002|First Admission|Withdrawal by Subject|0|||
130664380|NCT02773446|470397473|FG003|First Admission|Withdrawal by Subject|1|||
130664381|NCT02773446|470397474|FG004|First Admission|Withdrawal by Subject|0|||
130664382|NCT02773446|470397475|FG005|First Admission|Withdrawal by Subject|0|||
130664383|NCT02773446|470397470|FG000|First Admission|Lost to Follow-up|1|||
130664384|NCT02773446|470397471|FG001|First Admission|Lost to Follow-up|0|||
130664385|NCT02773446|470397472|FG002|First Admission|Lost to Follow-up|0|||
130664386|NCT02773446|470397473|FG003|First Admission|Lost to Follow-up|0|||
130664387|NCT02773446|470397474|FG004|First Admission|Lost to Follow-up|0|||
130664388|NCT02773446|470397475|FG005|First Admission|Lost to Follow-up|0|||
130664389|NCT04378010|470397476|FG000|Overall Study|Adverse Event|8|||
130664390|NCT04378010|470397477|FG001|Overall Study|Adverse Event|14|||
130664391|NCT04378010|470397478|FG002|Overall Study|Adverse Event|4|||
130664392|NCT04378010|470397476|FG000|Overall Study|Withdrawal by Subject|0|||
130664393|NCT04378010|470397477|FG001|Overall Study|Withdrawal by Subject|2|||
130664394|NCT04378010|470397478|FG002|Overall Study|Withdrawal by Subject|1|||
130664395|NCT04378010|470397476|FG000|Overall Study|Protocol Violation|2|||
130664396|NCT04378010|470397477|FG001|Overall Study|Protocol Violation|1|||
130664397|NCT04378010|470397478|FG002|Overall Study|Protocol Violation|4|||
130664398|NCT04378010|470397476|FG000|Overall Study|Study terminated by Sponsor|22|||
130664399|NCT04378010|470397477|FG001|Overall Study|Study terminated by Sponsor|16|||
130664400|NCT04378010|470397478|FG002|Overall Study|Study terminated by Sponsor|22|||
130664401|NCT04378010|470397476|FG000|Overall Study|Subject inability to complete study visit|0|||
130664402|NCT04378010|470397477|FG001|Overall Study|Subject inability to complete study visit|0|||
130664403|NCT04378010|470397478|FG002|Overall Study|Subject inability to complete study visit|1|||
130664404|NCT04378010|470397476|FG000|Overall Study|Subject never dosed|0|||
130664405|NCT04378010|470397477|FG001|Overall Study|Subject never dosed|1|||
130664406|NCT04378010|470397478|FG002|Overall Study|Subject never dosed|0|||
130664407|NCT02513459|470397479|FG000|Overall Study|Adverse Event|7|||
130664408|NCT02513459|470397479|FG000|Overall Study|Withdrew consent|5|||
130664409|NCT02513459|470397479|FG000|Overall Study|Loss of efficacy|2|||
130664410|NCT02513459|470397479|FG000|Overall Study|Pregnancy|2|||
130664411|NCT02513459|470397479|FG000|Overall Study|Subject decision|2|||
130664412|NCT02513459|470397479|FG000|Overall Study|Lack of response|1|||
130664413|NCT02513459|470397479|FG000|Overall Study|Reproductive plans|1|||
130664414|NCT02513459|470397479|FG000|Overall Study|Surgery planned-- not done|1|||
130664415|NCT03237611|470397480|FG000|Overall Study|Withdrawal by Subject|1|||
130664416|NCT03237611|470397480|FG000|Overall Study|Ineligible|1|||
130664417|NCT04023994|470397481|FG000|Overall Study|Lost to Follow-up|0|||
130664418|NCT04023994|470397482|FG001|Overall Study|Lost to Follow-up|1|||
130664419|NCT04023994|470397483|FG002|Overall Study|Lost to Follow-up|2|||
130664420|NCT04023994|470397484|FG003|Overall Study|Lost to Follow-up|0|||
130664421|NCT04023994|470397485|FG004|Overall Study|Lost to Follow-up|0|||
130664422|NCT04023994|470397486|FG005|Overall Study|Lost to Follow-up|0|||
130664423|NCT04023994|470397481|FG000|Overall Study|Withdrawal by Subject|0|||
130664424|NCT04023994|470397482|FG001|Overall Study|Withdrawal by Subject|0|||
130664425|NCT04023994|470397483|FG002|Overall Study|Withdrawal by Subject|0|||
130664426|NCT04023994|470397484|FG003|Overall Study|Withdrawal by Subject|1|||
130664427|NCT04023994|470397485|FG004|Overall Study|Withdrawal by Subject|0|||
130664428|NCT04023994|470397486|FG005|Overall Study|Withdrawal by Subject|0|||
130664429|NCT00923195|470397487|FG000|Overall Study|Death|0|||
130664430|NCT00923195|470397488|FG001|Overall Study|Death|1|||
130664431|NCT01613131|470397491|FG000|Overall Study|Withdrawal by Subject|3|||
130664432|NCT01613131|470397492|FG001|Overall Study|Withdrawal by Subject|5|||
130664433|NCT00787566|470397493|FG000|Overall Study|AE related to chemotherapy|0|||
130664434|NCT00787566|470397494|FG001|Overall Study|AE related to chemotherapy|1|||
130664435|NCT00787566|470397495|FG002|Overall Study|AE related to chemotherapy|0|||
130664436|NCT01814761|470397496|FG000|Overall Study|Other Reasons|1|||
130664437|NCT01814761|470397497|FG001|Overall Study|Other Reasons|10|||
130664438|NCT01814761|470397496|FG000|Overall Study|Ocular Adverse Event|6|||
130664439|NCT01814761|470397497|FG001|Overall Study|Ocular Adverse Event|15|||
130664440|NCT01814761|470397496|FG000|Overall Study|Lost to Follow-up|1|||
130664441|NCT01814761|470397497|FG001|Overall Study|Lost to Follow-up|5|||
130664442|NCT01169987|470397500|FG000|Overall Study|Withdrawal by Subject|3|||
130664443|NCT01169987|470397500|FG000|Overall Study|Lost to Follow-up|24|||
130664444|NCT01169987|470397500|FG000|Overall Study|Other|4|||
130664445|NCT00423488|470397503|FG000|Overall Study|No evidence of study drug intake|2|||
130664446|NCT00423488|470397504|FG001|Overall Study|No evidence of study drug intake|1|||
130664447|NCT00423488|470397503|FG000|Overall Study|No post baseline data|3|||
130664448|NCT00423488|470397504|FG001|Overall Study|No post baseline data|0|||
130664449|NCT00363129|470397506|FG000|Overall Study|Withdrawal by Subject|11|||
130664450|NCT00363129|470397507|FG001|Overall Study|Withdrawal by Subject|18|||
130664451|NCT00363129|470397506|FG000|Overall Study|Adverse Event|8|||
130664452|NCT00363129|470397507|FG001|Overall Study|Adverse Event|3|||
130664453|NCT00363129|470397506|FG000|Overall Study|Alternate Treatment|2|||
130664454|NCT00363129|470397507|FG001|Overall Study|Alternate Treatment|4|||
130664455|NCT00363129|470397506|FG000|Overall Study|Other Medical Problems|2|||
130664456|NCT00363129|470397507|FG001|Overall Study|Other Medical Problems|4|||
130664457|NCT00363129|470397506|FG000|Overall Study|Death|0|||
130664458|NCT00363129|470397507|FG001|Overall Study|Death|1|||
130664459|NCT00363129|470397506|FG000|Overall Study|Other Reasons|6|||
130664460|NCT00363129|470397507|FG001|Overall Study|Other Reasons|3|||
130664461|NCT03125915|470397508|FG000|1 Month Follow up|Lost to Follow-up|3|||
130664462|NCT03125915|470397509|FG001|1 Month Follow up|Lost to Follow-up|3|||
130664463|NCT03125915|470397510|FG002|1 Month Follow up|Lost to Follow-up|2|||
130664464|NCT03125915|470397511|FG003|1 Month Follow up|Lost to Follow-up|3|||
130664465|NCT03125915|470397508|FG000|3 Month Follow-up|Lost to Follow-up|6|||
130664466|NCT03125915|470397509|FG001|3 Month Follow-up|Lost to Follow-up|4|||
130664467|NCT03125915|470397510|FG002|3 Month Follow-up|Lost to Follow-up|4|||
130664468|NCT03125915|470397511|FG003|3 Month Follow-up|Lost to Follow-up|2|||
130664469|NCT03125915|470397508|FG000|6 Month Follow-up|Lost to Follow-up|7|||
130664470|NCT03125915|470397509|FG001|6 Month Follow-up|Lost to Follow-up|3|||
130664471|NCT03125915|470397510|FG002|6 Month Follow-up|Lost to Follow-up|6|||
130664472|NCT03125915|470397511|FG003|6 Month Follow-up|Lost to Follow-up|3|||
130664473|NCT04523831|470397517|FG000|Overall Study|Lost to Follow-up|15|||
130664474|NCT04523831|470397518|FG001|Overall Study|Lost to Follow-up|17|||
130664475|NCT04523831|470397517|FG000|Overall Study|Death|0|||
130664476|NCT04523831|470397518|FG001|Overall Study|Death|3|||
130664477|NCT04523831|470397517|FG000|Overall Study|Adverse Event|2|||
130664478|NCT04523831|470397518|FG001|Overall Study|Adverse Event|0|||
130664479|NCT04556838|470397519|FG000|Overall Study|Withdrawal by Subject|3|||
130664480|NCT04556838|470397520|FG001|Overall Study|Withdrawal by Subject|1|||
130664481|NCT04556838|470397521|FG002|Overall Study|Withdrawal by Subject|2|||
130664482|NCT04556838|470397519|FG000|Overall Study|Adverse Event|0|||
130664483|NCT04556838|470397520|FG001|Overall Study|Adverse Event|1|||
130664484|NCT04556838|470397521|FG002|Overall Study|Adverse Event|1|||
130664485|NCT04556838|470397519|FG000|Overall Study|Lost to Follow-up|0|||
130664486|NCT04556838|470397520|FG001|Overall Study|Lost to Follow-up|0|||
130664487|NCT04556838|470397521|FG002|Overall Study|Lost to Follow-up|2|||
130664488|NCT04556838|470397519|FG000|Overall Study|Subject travel|0|||
130664489|NCT04556838|470397520|FG001|Overall Study|Subject travel|1|||
130664490|NCT04556838|470397521|FG002|Overall Study|Subject travel|0|||
130664491|NCT04556838|470397519|FG000|Overall Study|Physician Decision|1|||
130664492|NCT04556838|470397520|FG001|Overall Study|Physician Decision|0|||
130664493|NCT04556838|470397521|FG002|Overall Study|Physician Decision|0|||
130664494|NCT00430638|470397524|FG000|Overall Study|Adverse Event|15|||
130664495|NCT00430638|470397525|FG001|Overall Study|Adverse Event|15|||
130664496|NCT00430638|470397524|FG000|Overall Study|Uncontrolled blood pressure|48|||
130664497|NCT00430638|470397525|FG001|Overall Study|Uncontrolled blood pressure|13|||
130664498|NCT00430638|470397524|FG000|Overall Study|Lost to Follow-up|1|||
130664499|NCT00430638|470397525|FG001|Overall Study|Lost to Follow-up|7|||
130664500|NCT00430638|470397524|FG000|Overall Study|Protocol Violation|6|||
130664501|NCT00430638|470397525|FG001|Overall Study|Protocol Violation|4|||
130664502|NCT00430638|470397524|FG000|Overall Study|Withdrawal by Subject|4|||
130664503|NCT00430638|470397525|FG001|Overall Study|Withdrawal by Subject|6|||
130664504|NCT00430638|470397524|FG000|Overall Study|Non-compliant|2|||
130664505|NCT00430638|470397525|FG001|Overall Study|Non-compliant|1|||
130664506|NCT00430638|470397524|FG000|Overall Study|Other|2|||
130664507|NCT00430638|470397525|FG001|Overall Study|Other|2|||
130664508|NCT03185949|470397526|FG000|ITT Analysis|Withdrawal by Subject|4|||
130664509|NCT03185949|470397527|FG001|ITT Analysis|Withdrawal by Subject|3|||
130664510|NCT03185949|470397526|FG000|PP Analysis|Protocol Violation|2|||
130664511|NCT03185949|470397527|FG001|PP Analysis|Protocol Violation|2|||
130664512|NCT03185949|470397526|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
130664513|NCT03185949|470397527|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
130334830|NCT02474069|469195581|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
130334831|NCT02474069|469195579|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
130334832|NCT02474069|469195580|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
130664514|NCT05166421|470397536|FG000|Overall Study|Other|3|||
130664515|NCT05166421|470397537|FG001|Overall Study|Other|1|||
130664516|NCT05166421|470397538|FG002|Overall Study|Other|1|||
130664517|NCT05166421|470397536|FG000|Overall Study|Withdrawal by Subject|5|||
130664518|NCT05166421|470397537|FG001|Overall Study|Withdrawal by Subject|3|||
130664519|NCT05166421|470397538|FG002|Overall Study|Withdrawal by Subject|6|||
130664520|NCT05166421|470397536|FG000|Overall Study|Lost to Follow-up|4|||
130664521|NCT05166421|470397537|FG001|Overall Study|Lost to Follow-up|1|||
130664522|NCT05166421|470397538|FG002|Overall Study|Lost to Follow-up|7|||
130664523|NCT03627195|470399430|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
130664524|NCT03627195|470399431|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130664525|NCT03627195|470399432|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130664526|NCT03627195|470399433|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130664527|NCT03627195|470399434|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130664528|NCT03627195|470399435|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130664529|NCT01835132|470399442|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
130664530|NCT00856778|470399443|FG000|Overall Study|Adverse Event|7|||
130664531|NCT00856778|470399443|FG000|Overall Study|Withdrawal by Subject|10|||
130664532|NCT00856778|470399443|FG000|Overall Study|Study deviation|2|||
130664533|NCT00856778|470399443|FG000|Overall Study|Lost to Follow-up|5|||
130664534|NCT00782275|470399447|FG000|Overall Study|Adverse Event|11|||
130664535|NCT00782275|470399447|FG000|Overall Study|Withdrawal by Subject|1|||
130664536|NCT00782275|470399447|FG000|Overall Study|Progressive Disease|21|||
130664537|NCT00782275|470399447|FG000|Overall Study|Physician Decision|4|||
130664538|NCT00782275|470399447|FG000|Overall Study|Not started treatment|1|||
130664539|NCT00782275|470399447|FG000|Overall Study|Other|3|||
130664540|NCT00331773|470399450|FG000|Overall Study|Withdrawal by Subject|6|||
130664541|NCT00331773|470399451|FG001|Overall Study|Withdrawal by Subject|4|||
130664542|NCT00331773|470399450|FG000|Overall Study|Protocol Violation|10|||
130664543|NCT00331773|470399451|FG001|Overall Study|Protocol Violation|3|||
130664544|NCT00289731|470399452|FG000|Overall Study|Adverse Event|1|||
130664545|NCT00289731|470399453|FG001|Overall Study|Adverse Event|2|||
130664546|NCT00289731|470399454|FG002|Overall Study|Adverse Event|2|||
130664547|NCT00289731|470399452|FG000|Overall Study|Other|1|||
130664548|NCT00289731|470399453|FG001|Overall Study|Other|0|||
130664549|NCT00289731|470399454|FG002|Overall Study|Other|0|||
130664550|NCT02019979|470399455|FG000|Overall Study|study terminated|14|||
130664551|NCT00525031|470399463|FG000|Overall Study|Disease Progression|1|||
130664552|NCT00525031|470399464|FG001|Overall Study|Disease Progression|1|||
130664553|NCT02140164|470399465|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
130664554|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130664555|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
130664556|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130664557|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130664558|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
130664559|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
130664560|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
130664561|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
130664562|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
130664563|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
130664564|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
130664565|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
130664566|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
130664567|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
130664568|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
130664569|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
130664570|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
130664571|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
130664572|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
130664573|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
130664574|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
130664575|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
130664576|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
130664577|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
130664578|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
130664579|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
130664580|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
130664581|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
130664582|NCT01872689|470399470|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
130664583|NCT01872689|470399471|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
130664584|NCT01872689|470399472|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
130664585|NCT01872689|470399473|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
130664586|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
130664587|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
130664588|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
130664589|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
130664590|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
130664591|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
130664592|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
130664593|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
130664594|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130664595|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
130664596|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130664597|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130664598|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
130664599|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
130664600|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
130664601|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
130664602|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
130664603|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
130664604|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
130664605|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
130664606|NCT01872689|470399470|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
130664607|NCT01872689|470399471|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
130664608|NCT01872689|470399472|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
130664609|NCT01872689|470399473|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
130664610|NCT00686374|470399477|FG000|Overall Study|Lack of Efficacy|10|||
130664611|NCT00686374|470399477|FG000|Overall Study|Adverse Event|8|||
130664612|NCT00686374|470399477|FG000|Overall Study|Withdrew consent|5|||
130664613|NCT00686374|470399477|FG000|Overall Study|Lost to Follow-up|1|||
130664614|NCT00686374|470399477|FG000|Overall Study|Missing reason|33|||
130664615|NCT00686374|470399477|FG000|Overall Study|Other, not specified|4|||
130664616|NCT02143947|470399479|FG000|Overall Study|Lost to Follow-up|4|||
130664617|NCT02143947|470399480|FG001|Overall Study|Lost to Follow-up|2|||
130664618|NCT01244815|470399481|FG000|Overall Study|Not Treated|0|||
130664619|NCT01244815|470399482|FG001|Overall Study|Not Treated|1|||
130664620|NCT01244815|470399483|FG002|Overall Study|Not Treated|0|||
130664621|NCT01244815|470399484|FG003|Overall Study|Not Treated|0|||
130664622|NCT01244815|470399481|FG000|Overall Study|Adverse Event|4|||
130664623|NCT01244815|470399482|FG001|Overall Study|Adverse Event|7|||
130664624|NCT01244815|470399483|FG002|Overall Study|Adverse Event|5|||
130664625|NCT01244815|470399484|FG003|Overall Study|Adverse Event|5|||
130664626|NCT01244815|470399481|FG000|Overall Study|Treatment Failure|0|||
130664627|NCT01244815|470399482|FG001|Overall Study|Treatment Failure|0|||
130664628|NCT01244815|470399483|FG002|Overall Study|Treatment Failure|0|||
130664629|NCT01244815|470399484|FG003|Overall Study|Treatment Failure|1|||
130664630|NCT01244815|470399481|FG000|Overall Study|Lost to Follow-up|3|||
130664631|NCT01244815|470399482|FG001|Overall Study|Lost to Follow-up|2|||
130664632|NCT01244815|470399483|FG002|Overall Study|Lost to Follow-up|3|||
130664633|NCT01244815|470399484|FG003|Overall Study|Lost to Follow-up|2|||
130664634|NCT01244815|470399481|FG000|Overall Study|Withdrawal by Subject|0|||
130664635|NCT01244815|470399482|FG001|Overall Study|Withdrawal by Subject|2|||
130664636|NCT01244815|470399483|FG002|Overall Study|Withdrawal by Subject|0|||
130664637|NCT01244815|470399484|FG003|Overall Study|Withdrawal by Subject|3|||
130664638|NCT01244815|470399481|FG000|Overall Study|Protocol Violation|7|||
130664639|NCT01244815|470399482|FG001|Overall Study|Protocol Violation|4|||
130664640|NCT01244815|470399483|FG002|Overall Study|Protocol Violation|3|||
130664641|NCT01244815|470399484|FG003|Overall Study|Protocol Violation|1|||
130664642|NCT01244815|470399481|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130664643|NCT01244815|470399482|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130664644|NCT01244815|470399483|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
130664645|NCT01244815|470399484|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
130664646|NCT00697112|470399486|FG000|Overall Study|Adverse Event|8|||
130664647|NCT00697112|470399486|FG000|Overall Study|Lost to Follow-up|1|||
130664648|NCT00697112|470399486|FG000|Overall Study|Did not meet inclusion criteria|1|||
130664649|NCT03066440|470399489|FG000|Overall Study|Physician Decision|1|||
130664650|NCT03066440|470399490|FG001|Overall Study|Physician Decision|1|||
130664651|NCT03066440|470399489|FG000|Overall Study|Protocol Violation|0|||
130664652|NCT03066440|470399490|FG001|Overall Study|Protocol Violation|2|||
130664653|NCT00736333|470399491|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
130664654|NCT00736333|470399491|FG000|Overall Study|Data Missing|2|||
130664655|NCT00736333|470399491|FG000|Overall Study|Tumor Progression|75|||
130664656|NCT00736333|470399491|FG000|Overall Study|Toxicity|6|||
130664657|NCT00736333|470399491|FG000|Overall Study|Withdrawal by Subject|10|||
130664658|NCT00736333|470399491|FG000|Overall Study|Death|7|||
130664659|NCT00736333|470399491|FG000|Overall Study|Other|4|||
130664660|NCT01106352|470399494|FG000|Overall Study|Subjects untreated|0|||
130664661|NCT01106352|470399495|FG001|Overall Study|Subjects untreated|0|||
130664662|NCT01106352|470399496|FG002|Overall Study|Subjects untreated|0|||
130664663|NCT01106352|470399497|FG003|Overall Study|Subjects untreated|3|||
130664664|NCT01106352|470399498|FG004|Overall Study|Subjects untreated|4|||
130664665|NCT01106352|470399494|FG000|Overall Study|Sponsor Decision|1|||
130664666|NCT01106352|470399495|FG001|Overall Study|Sponsor Decision|0|||
130664667|NCT01106352|470399496|FG002|Overall Study|Sponsor Decision|0|||
130664668|NCT01106352|470399497|FG003|Overall Study|Sponsor Decision|0|||
130664669|NCT01106352|470399498|FG004|Overall Study|Sponsor Decision|0|||
130664670|NCT01106352|470399494|FG000|Overall Study|Too ill to come in for the visit|0|||
130664671|NCT01106352|470399495|FG001|Overall Study|Too ill to come in for the visit|0|||
130664672|NCT01106352|470399496|FG002|Overall Study|Too ill to come in for the visit|1|||
130664673|NCT01106352|470399497|FG003|Overall Study|Too ill to come in for the visit|0|||
130664674|NCT01106352|470399498|FG004|Overall Study|Too ill to come in for the visit|0|||
130664675|NCT01106352|470399494|FG000|Overall Study|Lost to Follow-up|0|||
130664676|NCT01106352|470399495|FG001|Overall Study|Lost to Follow-up|0|||
130664677|NCT01106352|470399496|FG002|Overall Study|Lost to Follow-up|0|||
130664678|NCT01106352|470399497|FG003|Overall Study|Lost to Follow-up|0|||
130664679|NCT01106352|470399498|FG004|Overall Study|Lost to Follow-up|1|||
130664680|NCT01106352|470399494|FG000|Overall Study|Death|0|||
130664681|NCT01106352|470399495|FG001|Overall Study|Death|0|||
130664682|NCT01106352|470399496|FG002|Overall Study|Death|1|||
130664683|NCT01106352|470399497|FG003|Overall Study|Death|3|||
130664684|NCT01106352|470399498|FG004|Overall Study|Death|1|||
130664685|NCT01106352|470399494|FG000|Overall Study|Disease progression|0|||
130664686|NCT01106352|470399495|FG001|Overall Study|Disease progression|0|||
130664687|NCT01106352|470399496|FG002|Overall Study|Disease progression|0|||
130664688|NCT01106352|470399497|FG003|Overall Study|Disease progression|1|||
130664689|NCT01106352|470399498|FG004|Overall Study|Disease progression|0|||
130664690|NCT01106352|470399494|FG000|Overall Study|Withdrawal by Subject|0|||
130664691|NCT01106352|470399495|FG001|Overall Study|Withdrawal by Subject|0|||
130664692|NCT01106352|470399496|FG002|Overall Study|Withdrawal by Subject|0|||
130664693|NCT01106352|470399497|FG003|Overall Study|Withdrawal by Subject|3|||
130664694|NCT01106352|470399498|FG004|Overall Study|Withdrawal by Subject|2|||
130664695|NCT01106352|470399494|FG000|Overall Study|Went on hospice|0|||
130664696|NCT01106352|470399495|FG001|Overall Study|Went on hospice|0|||
130664697|NCT01106352|470399496|FG002|Overall Study|Went on hospice|0|||
130664698|NCT01106352|470399497|FG003|Overall Study|Went on hospice|1|||
130664699|NCT01106352|470399498|FG004|Overall Study|Went on hospice|0|||
130664700|NCT01106352|470399494|FG000|Overall Study|Subject entered hospice|0|||
130664701|NCT01106352|470399495|FG001|Overall Study|Subject entered hospice|0|||
130664702|NCT01106352|470399496|FG002|Overall Study|Subject entered hospice|0|||
130664703|NCT01106352|470399497|FG003|Overall Study|Subject entered hospice|1|||
130664704|NCT01106352|470399498|FG004|Overall Study|Subject entered hospice|0|||
130664705|NCT01106352|470399494|FG000|Overall Study|Home hospice since July 2013|0|||
130664706|NCT01106352|470399495|FG001|Overall Study|Home hospice since July 2013|0|||
130664707|NCT01106352|470399496|FG002|Overall Study|Home hospice since July 2013|0|||
130664708|NCT01106352|470399497|FG003|Overall Study|Home hospice since July 2013|1|||
130664709|NCT01106352|470399498|FG004|Overall Study|Home hospice since July 2013|0|||
130664710|NCT03944707|470399506|FG000|Overall Study|Adverse Event|0|||
130664711|NCT03944707|470399507|FG001|Overall Study|Adverse Event|2|||
130664712|NCT03944707|470399506|FG000|Overall Study|Study terminated by sponsor|12|||
130664713|NCT03944707|470399507|FG001|Overall Study|Study terminated by sponsor|7|||
130664714|NCT03944707|470399506|FG000|Overall Study|Subject decision|0|||
130664715|NCT03944707|470399507|FG001|Overall Study|Subject decision|1|||
130664716|NCT02444182|470399508|FG000|Overall Study|non-compliance|2|||
130664717|NCT02444182|470399509|FG001|Overall Study|non-compliance|1|||
130664718|NCT02444182|470399508|FG000|Overall Study|Lost to Follow-up|0|||
130664719|NCT02444182|470399509|FG001|Overall Study|Lost to Follow-up|4|||
130664720|NCT04126733|470399512|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
130664721|NCT04126733|470399512|FG000|Treatment Period|Adverse Event|8|||
130664722|NCT04126733|470399512|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
130664723|NCT04126733|470399512|FG000|Treatment Period|Physician Decision|5|||
130664724|NCT04126733|470399512|FG000|Treatment Period|Death|1|||
130664725|NCT04126733|470399512|FG000|Treatment Period|Other Reasons|2|||
130664726|NCT04126733|470399512|FG000|Active Follow-up Period|Death|13|||
130664727|NCT04126733|470399512|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
130664728|NCT04126733|470399512|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
130664729|NCT04126733|470399512|FG000|Active Follow-up Period|Other Reasons|1|||
130664730|NCT04126733|470399512|FG000|Long-term Follow-up Period|Death|22|||
130664731|NCT04126733|470399512|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
130664732|NCT04126733|470399512|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
130664733|NCT02598193|470399514|FG000|Overall Study|Adverse Event|13|||
130664734|NCT02598193|470399514|FG000|Overall Study|Withdrawal by Subject|1|||
130664735|NCT02598193|470399514|FG000|Overall Study|Listed in active lung transplant list|1|||
130664736|NCT02598193|470399514|FG000|Overall Study|Does not want to take Nintedanib|1|||
130664737|NCT02487979|470399517|FG000|Overall Study|Physician Decision|2|||
130664738|NCT02487979|470399517|FG000|Overall Study|Withdrawal by Subject|2|||
130664739|NCT02487979|470399517|FG000|Overall Study|Progressive Disease|17|||
130664740|NCT00447694|470399518|FG000|Overall Study|Adverse Event|2|||
130664741|NCT00447694|470399518|FG000|Overall Study|Abnormal laboratory value|1|||
130664742|NCT00447694|470399518|FG000|Overall Study|Abnormal test procedure result|1|||
130664743|NCT00447694|470399518|FG000|Overall Study|Withdrawal by Subject|2|||
130664744|NCT02354976|470399525|FG000|Overall Study|Other - reason not specified|1|||
130664745|NCT02354976|470399526|FG001|Overall Study|Other - reason not specified|0|||
130664746|NCT02354976|470399527|FG002|Overall Study|Other - reason not specified|1|||
130664747|NCT02354976|470399525|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
130664748|NCT02354976|470399526|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
130664749|NCT02354976|470399527|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
130664750|NCT02354976|470399525|FG000|Overall Study|Adverse Event|1|||
130664751|NCT02354976|470399526|FG001|Overall Study|Adverse Event|0|||
130664752|NCT02354976|470399527|FG002|Overall Study|Adverse Event|2|||
130664753|NCT00986154|470399528|FG000|Overall Study|Death|136|||
130664754|NCT00986154|470399529|FG001|Overall Study|Death|127|||
130664755|NCT00986154|470399528|FG000|Overall Study|Lost to Follow-up|7|||
130664756|NCT00986154|470399529|FG001|Overall Study|Lost to Follow-up|4|||
130664757|NCT00986154|470399528|FG000|Overall Study|Withdrawal by Subject|32|||
130664758|NCT00986154|470399529|FG001|Overall Study|Withdrawal by Subject|33|||
130664759|NCT00986154|470399528|FG000|Overall Study|investigator/subject decide not continue|6|||
130664760|NCT00986154|470399529|FG001|Overall Study|investigator/subject decide not continue|3|||
130664761|NCT00986154|470399528|FG000|Overall Study|never received study drug|25|||
130664762|NCT00986154|470399529|FG001|Overall Study|never received study drug|27|||
130664763|NCT03726437|470399530|FG000|Overall Study|Lost to Follow-up|85|||
130664764|NCT03726437|470399531|FG001|Overall Study|Lost to Follow-up|76|||
130664765|NCT00068445|470399533|FG000|Randomization|Cancel|1|||
130664766|NCT00068445|470399534|FG001|Randomization|Cancel|3|||
130664767|NCT00068445|470399533|FG000|Randomization|Ineligible|1|||
130664768|NCT00068445|470399534|FG001|Randomization|Ineligible|1|||
130664769|NCT00068445|470399533|FG000|Treatment|Refused Further Treatment|13|||
130664770|NCT00068445|470399534|FG001|Treatment|Refused Further Treatment|10|||
130664771|NCT00068445|470399533|FG000|Treatment|Adverse Event|7|||
130664772|NCT00068445|470399534|FG001|Treatment|Adverse Event|1|||
130664773|NCT00068445|470399533|FG000|Treatment|Other (Specifics not available)|9|||
130664774|NCT00068445|470399534|FG001|Treatment|Other (Specifics not available)|5|||
130664775|NCT01896700|470399535|FG000|Overall Study|Adverse Event|4|||
130664776|NCT01896700|470399536|FG001|Overall Study|Adverse Event|5|||
130664777|NCT01896700|470399535|FG000|Overall Study|Withdrawal by Subject|0|||
130664778|NCT01896700|470399536|FG001|Overall Study|Withdrawal by Subject|1|||
130664779|NCT00886782|470399538|FG000|Overall Study|Disease progression|3|||
130664780|NCT00886782|470399539|FG001|Overall Study|Disease progression|3|||
130664781|NCT00886782|470399540|FG002|Overall Study|Disease progression|3|||
130664782|NCT00886782|470399538|FG000|Overall Study|Study drug toxicity|0|||
130664783|NCT00886782|470399539|FG001|Overall Study|Study drug toxicity|0|||
130664784|NCT00886782|470399540|FG002|Overall Study|Study drug toxicity|1|||
130664785|NCT00886782|470399538|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
130664786|NCT00886782|470399539|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
130664787|NCT00886782|470399540|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
130664788|NCT03118765|470399541|FG000|Overall Study|Withdrawal by Subject|0|||
130334833|NCT02474069|469195581|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
130334834|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
130334835|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
130334836|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
130334837|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
130334838|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
130334839|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
130334840|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130334841|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130334842|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
130334843|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
130334844|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130334845|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130334846|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
130334847|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
130334848|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
130334849|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
130334850|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
130334851|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
130334852|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
130334853|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
130334854|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
130334855|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
130334856|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
130334857|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
130334858|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
130664789|NCT03118765|470399542|FG001|Overall Study|Withdrawal by Subject|0|||
130664790|NCT03118765|470399543|FG002|Overall Study|Withdrawal by Subject|1|||
130664791|NCT03118765|470399544|FG003|Overall Study|Withdrawal by Subject|0|||
130664792|NCT03118765|470399545|FG004|Overall Study|Withdrawal by Subject|0|||
130664793|NCT03118765|470399541|FG000|Overall Study|Adverse Event|1|||
130664794|NCT03118765|470399542|FG001|Overall Study|Adverse Event|1|||
130664795|NCT03118765|470399543|FG002|Overall Study|Adverse Event|1|||
130664796|NCT03118765|470399544|FG003|Overall Study|Adverse Event|1|||
130664797|NCT03118765|470399545|FG004|Overall Study|Adverse Event|1|||
130664798|NCT03118765|470399541|FG000|Overall Study|Non compliance with Study Procedures|0|||
130664799|NCT03118765|470399542|FG001|Overall Study|Non compliance with Study Procedures|0|||
130664800|NCT03118765|470399543|FG002|Overall Study|Non compliance with Study Procedures|0|||
130664801|NCT03118765|470399544|FG003|Overall Study|Non compliance with Study Procedures|1|||
130664802|NCT03118765|470399545|FG004|Overall Study|Non compliance with Study Procedures|0|||
130664803|NCT03118765|470399541|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130664804|NCT03118765|470399542|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
130664805|NCT03118765|470399543|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
130664806|NCT03118765|470399544|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130664807|NCT03118765|470399545|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130664808|NCT03118765|470399541|FG000|Overall Study|COPD Exacerbation|1|||
130664809|NCT03118765|470399542|FG001|Overall Study|COPD Exacerbation|0|||
130664810|NCT03118765|470399543|FG002|Overall Study|COPD Exacerbation|0|||
130664811|NCT03118765|470399544|FG003|Overall Study|COPD Exacerbation|1|||
130664812|NCT03118765|470399545|FG004|Overall Study|COPD Exacerbation|0|||
130664813|NCT03118765|470399541|FG000|Overall Study|Lost to Follow-up|1|||
130664814|NCT03118765|470399542|FG001|Overall Study|Lost to Follow-up|0|||
130664815|NCT03118765|470399543|FG002|Overall Study|Lost to Follow-up|1|||
130664816|NCT03118765|470399544|FG003|Overall Study|Lost to Follow-up|0|||
130664817|NCT03118765|470399545|FG004|Overall Study|Lost to Follow-up|0|||
130664818|NCT03118765|470399541|FG000|Overall Study|Sponsor Decision|1|||
130664819|NCT03118765|470399542|FG001|Overall Study|Sponsor Decision|0|||
130664820|NCT03118765|470399543|FG002|Overall Study|Sponsor Decision|1|||
130664821|NCT03118765|470399544|FG003|Overall Study|Sponsor Decision|0|||
130664822|NCT03118765|470399545|FG004|Overall Study|Sponsor Decision|1|||
130664823|NCT00849524|470399546|FG000|Overall Study|Lack of Efficacy|3|||
130664824|NCT00879970|470399549|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
130664825|NCT00879970|470399550|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
130664826|NCT00879970|470399551|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
130664827|NCT00879970|470399552|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
130664828|NCT00879970|470399553|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
130664829|NCT00879970|470399549|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
130664830|NCT00879970|470399550|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
130664831|NCT00879970|470399551|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
130664832|NCT00879970|470399552|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
130664833|NCT00879970|470399553|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
130664834|NCT00879970|470399549|FG000|Period 1 TZD Randomization|Death|2|||
130664835|NCT00879970|470399550|FG001|Period 1 TZD Randomization|Death|1|||
130664836|NCT00879970|470399551|FG002|Period 1 TZD Randomization|Death|0|||
130664837|NCT00879970|470399552|FG003|Period 1 TZD Randomization|Death|0|||
130664838|NCT00879970|470399553|FG004|Period 1 TZD Randomization|Death|0|||
130664839|NCT00879970|470399549|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
130664840|NCT00879970|470399550|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130664841|NCT00879970|470399551|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
130664842|NCT00879970|470399552|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130664843|NCT00879970|470399553|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130664844|NCT00879970|470399549|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130664845|NCT00879970|470399550|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130664846|NCT00879970|470399551|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130664847|NCT00879970|470399552|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
130664848|NCT00879970|470399553|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
130664849|NCT00879970|470399549|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130664850|NCT00879970|470399550|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130664851|NCT00879970|470399551|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130664852|NCT00879970|470399552|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130664853|NCT00879970|470399553|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
130664854|NCT00879970|470399549|FG000|Period 2 Vitamin D Randomization|Death|0|||
130664855|NCT00879970|470399550|FG001|Period 2 Vitamin D Randomization|Death|0|||
130664856|NCT00879970|470399551|FG002|Period 2 Vitamin D Randomization|Death|0|||
130664857|NCT00879970|470399552|FG003|Period 2 Vitamin D Randomization|Death|2|||
130664858|NCT00879970|470399553|FG004|Period 2 Vitamin D Randomization|Death|0|||
130664859|NCT01749033|470399555|FG000|Overall Study|Did not receive allocated intervention|3|||
130664860|NCT01749033|470399556|FG001|Overall Study|Did not receive allocated intervention|3|||
130664861|NCT01749033|470399557|FG002|Overall Study|Did not receive allocated intervention|0|||
130664862|NCT01749033|470399555|FG000|Overall Study|Lost to Follow-up|0|||
130664863|NCT01749033|470399556|FG001|Overall Study|Lost to Follow-up|2|||
130664864|NCT01749033|470399557|FG002|Overall Study|Lost to Follow-up|1|||
130664865|NCT00068237|470399558|FG000|Overall Study|Ineligible|3|||
130664866|NCT00068237|470399558|FG000|Overall Study|No protocol treatment received|2|||
130664867|NCT01358708|470399559|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130664868|NCT01358708|470399560|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130664869|NCT01358708|470399559|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130664870|NCT01358708|470399560|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
130664871|NCT03056001|470399561|FG000|Overall Study|Death|24|||
130664872|NCT04380701|470399562|FG000|Overall Study|Pregnancy|0|||
130664873|NCT04380701|470399563|FG001|Overall Study|Pregnancy|0|||
130664874|NCT04380701|470399564|FG002|Overall Study|Pregnancy|0|||
130664875|NCT04380701|470399565|FG003|Overall Study|Pregnancy|0|||
130664876|NCT04380701|470399566|FG004|Overall Study|Pregnancy|0|||
130664877|NCT04380701|470399567|FG005|Overall Study|Pregnancy|0|||
130664878|NCT04380701|470399568|FG006|Overall Study|Pregnancy|0|||
130664879|NCT04380701|470399569|FG007|Overall Study|Pregnancy|0|||
130664880|NCT04380701|470399570|FG008|Overall Study|Pregnancy|0|||
130664881|NCT04380701|470399571|FG009|Overall Study|Pregnancy|0|||
130664882|NCT04380701|470399572|FG010|Overall Study|Pregnancy|0|||
130664883|NCT04380701|470399573|FG011|Overall Study|Pregnancy|0|||
130664884|NCT04380701|470399574|FG012|Overall Study|Pregnancy|0|||
130664885|NCT04380701|470399575|FG013|Overall Study|Pregnancy|0|||
130664886|NCT04380701|470399576|FG014|Overall Study|Pregnancy|0|||
130664887|NCT04380701|470399577|FG015|Overall Study|Pregnancy|0|||
130664888|NCT04380701|470399578|FG016|Overall Study|Pregnancy|0|||
130664889|NCT04380701|470399579|FG017|Overall Study|Pregnancy|0|||
130664890|NCT04380701|470399580|FG018|Overall Study|Pregnancy|0|||
130664891|NCT04380701|470399581|FG019|Overall Study|Pregnancy|0|||
130664892|NCT04380701|470399582|FG020|Overall Study|Pregnancy|0|||
130664893|NCT04380701|470399583|FG021|Overall Study|Pregnancy|0|||
130664894|NCT04380701|470399584|FG022|Overall Study|Pregnancy|0|||
130664895|NCT04380701|470399585|FG023|Overall Study|Pregnancy|0|||
130664896|NCT04380701|470399586|FG024|Overall Study|Pregnancy|0|||
130664897|NCT04380701|470399587|FG025|Overall Study|Pregnancy|0|||
130664898|NCT04380701|470399588|FG026|Overall Study|Pregnancy|0|||
130664899|NCT04380701|470399589|FG027|Overall Study|Pregnancy|0|||
130664900|NCT04380701|470399590|FG028|Overall Study|Pregnancy|0|||
130664901|NCT04380701|470399591|FG029|Overall Study|Pregnancy|0|||
130664902|NCT04380701|470399592|FG030|Overall Study|Pregnancy|0|||
130664903|NCT04380701|470399593|FG031|Overall Study|Pregnancy|0|||
130664904|NCT04380701|470399594|FG032|Overall Study|Pregnancy|1|||
130664905|NCT04380701|470399595|FG033|Overall Study|Pregnancy|0|||
130664906|NCT04380701|470399562|FG000|Overall Study|Lost to Follow-up|0|||
130664907|NCT04380701|470399563|FG001|Overall Study|Lost to Follow-up|0|||
130664908|NCT04380701|470399564|FG002|Overall Study|Lost to Follow-up|0|||
130664909|NCT04380701|470399565|FG003|Overall Study|Lost to Follow-up|0|||
130664910|NCT04380701|470399566|FG004|Overall Study|Lost to Follow-up|0|||
130664911|NCT04380701|470399567|FG005|Overall Study|Lost to Follow-up|0|||
130664912|NCT04380701|470399568|FG006|Overall Study|Lost to Follow-up|0|||
130664913|NCT04380701|470399569|FG007|Overall Study|Lost to Follow-up|0|||
130664914|NCT04380701|470399570|FG008|Overall Study|Lost to Follow-up|0|||
130664915|NCT04380701|470399571|FG009|Overall Study|Lost to Follow-up|0|||
130664916|NCT04380701|470399572|FG010|Overall Study|Lost to Follow-up|0|||
130664917|NCT04380701|470399573|FG011|Overall Study|Lost to Follow-up|0|||
130664918|NCT04380701|470399574|FG012|Overall Study|Lost to Follow-up|0|||
130664919|NCT04380701|470399575|FG013|Overall Study|Lost to Follow-up|0|||
130664920|NCT04380701|470399576|FG014|Overall Study|Lost to Follow-up|0|||
130664921|NCT04380701|470399577|FG015|Overall Study|Lost to Follow-up|0|||
130664922|NCT04380701|470399578|FG016|Overall Study|Lost to Follow-up|0|||
130664923|NCT04380701|470399579|FG017|Overall Study|Lost to Follow-up|0|||
130664924|NCT04380701|470399580|FG018|Overall Study|Lost to Follow-up|0|||
130664925|NCT04380701|470399581|FG019|Overall Study|Lost to Follow-up|0|||
130664926|NCT04380701|470399582|FG020|Overall Study|Lost to Follow-up|1|||
130664927|NCT04380701|470399583|FG021|Overall Study|Lost to Follow-up|0|||
130664928|NCT04380701|470399584|FG022|Overall Study|Lost to Follow-up|0|||
130664929|NCT04380701|470399585|FG023|Overall Study|Lost to Follow-up|1|||
130664930|NCT04380701|470399586|FG024|Overall Study|Lost to Follow-up|0|||
130664931|NCT04380701|470399587|FG025|Overall Study|Lost to Follow-up|0|||
130664932|NCT04380701|470399588|FG026|Overall Study|Lost to Follow-up|0|||
130664933|NCT04380701|470399589|FG027|Overall Study|Lost to Follow-up|0|||
130664934|NCT04380701|470399590|FG028|Overall Study|Lost to Follow-up|0|||
130664935|NCT04380701|470399591|FG029|Overall Study|Lost to Follow-up|1|||
130664936|NCT04380701|470399592|FG030|Overall Study|Lost to Follow-up|0|||
130664937|NCT04380701|470399593|FG031|Overall Study|Lost to Follow-up|0|||
130664938|NCT04380701|470399594|FG032|Overall Study|Lost to Follow-up|0|||
130664939|NCT04380701|470399595|FG033|Overall Study|Lost to Follow-up|1|||
130664940|NCT04380701|470399562|FG000|Overall Study|Private reason(s)|0|||
130664941|NCT04380701|470399563|FG001|Overall Study|Private reason(s)|0|||
130664942|NCT04380701|470399564|FG002|Overall Study|Private reason(s)|0|||
130664943|NCT04380701|470399565|FG003|Overall Study|Private reason(s)|0|||
130664944|NCT04380701|470399566|FG004|Overall Study|Private reason(s)|0|||
130664945|NCT04380701|470399567|FG005|Overall Study|Private reason(s)|0|||
130664946|NCT04380701|470399568|FG006|Overall Study|Private reason(s)|1|||
130664947|NCT04380701|470399569|FG007|Overall Study|Private reason(s)|0|||
130664948|NCT04380701|470399570|FG008|Overall Study|Private reason(s)|1|||
130664949|NCT04380701|470399571|FG009|Overall Study|Private reason(s)|1|||
130664950|NCT04380701|470399572|FG010|Overall Study|Private reason(s)|0|||
130664951|NCT04380701|470399573|FG011|Overall Study|Private reason(s)|0|||
130664952|NCT04380701|470399574|FG012|Overall Study|Private reason(s)|0|||
130664953|NCT04380701|470399575|FG013|Overall Study|Private reason(s)|0|||
130664954|NCT04380701|470399576|FG014|Overall Study|Private reason(s)|0|||
130664955|NCT04380701|470399577|FG015|Overall Study|Private reason(s)|0|||
130664956|NCT04380701|470399578|FG016|Overall Study|Private reason(s)|0|||
130664957|NCT04380701|470399579|FG017|Overall Study|Private reason(s)|0|||
130664958|NCT04380701|470399580|FG018|Overall Study|Private reason(s)|0|||
130664959|NCT04380701|470399581|FG019|Overall Study|Private reason(s)|0|||
130664960|NCT04380701|470399582|FG020|Overall Study|Private reason(s)|0|||
130664961|NCT04380701|470399583|FG021|Overall Study|Private reason(s)|0|||
130664962|NCT04380701|470399584|FG022|Overall Study|Private reason(s)|0|||
130664963|NCT04380701|470399585|FG023|Overall Study|Private reason(s)|1|||
130664964|NCT04380701|470399586|FG024|Overall Study|Private reason(s)|0|||
130664965|NCT04380701|470399587|FG025|Overall Study|Private reason(s)|0|||
130664966|NCT04380701|470399588|FG026|Overall Study|Private reason(s)|0|||
130664967|NCT04380701|470399589|FG027|Overall Study|Private reason(s)|0|||
130664968|NCT04380701|470399590|FG028|Overall Study|Private reason(s)|0|||
130664969|NCT04380701|470399591|FG029|Overall Study|Private reason(s)|1|||
130664970|NCT04380701|470399592|FG030|Overall Study|Private reason(s)|0|||
130664971|NCT04380701|470399593|FG031|Overall Study|Private reason(s)|0|||
130664972|NCT04380701|470399594|FG032|Overall Study|Private reason(s)|0|||
130664973|NCT04380701|470399595|FG033|Overall Study|Private reason(s)|0|||
130664974|NCT04380701|470399562|FG000|Overall Study|Withdrawal by Subject|0|||
130664975|NCT04380701|470399563|FG001|Overall Study|Withdrawal by Subject|0|||
130664976|NCT04380701|470399564|FG002|Overall Study|Withdrawal by Subject|0|||
130664977|NCT04380701|470399565|FG003|Overall Study|Withdrawal by Subject|0|||
130664978|NCT04380701|470399566|FG004|Overall Study|Withdrawal by Subject|0|||
130664979|NCT04380701|470399567|FG005|Overall Study|Withdrawal by Subject|0|||
130664980|NCT04380701|470399568|FG006|Overall Study|Withdrawal by Subject|1|||
130664981|NCT04380701|470399569|FG007|Overall Study|Withdrawal by Subject|1|||
130664982|NCT04380701|470399570|FG008|Overall Study|Withdrawal by Subject|0|||
130664983|NCT04380701|470399571|FG009|Overall Study|Withdrawal by Subject|0|||
130664984|NCT04380701|470399572|FG010|Overall Study|Withdrawal by Subject|0|||
130664985|NCT04380701|470399573|FG011|Overall Study|Withdrawal by Subject|1|||
130664986|NCT04380701|470399574|FG012|Overall Study|Withdrawal by Subject|0|||
130664987|NCT04380701|470399575|FG013|Overall Study|Withdrawal by Subject|1|||
130664988|NCT04380701|470399576|FG014|Overall Study|Withdrawal by Subject|0|||
130664989|NCT04380701|470399577|FG015|Overall Study|Withdrawal by Subject|0|||
130664990|NCT04380701|470399578|FG016|Overall Study|Withdrawal by Subject|1|||
130664991|NCT04380701|470399579|FG017|Overall Study|Withdrawal by Subject|0|||
130664992|NCT04380701|470399580|FG018|Overall Study|Withdrawal by Subject|0|||
130664993|NCT04380701|470399581|FG019|Overall Study|Withdrawal by Subject|0|||
130664994|NCT04380701|470399582|FG020|Overall Study|Withdrawal by Subject|0|||
130664995|NCT04380701|470399583|FG021|Overall Study|Withdrawal by Subject|0|||
130664996|NCT04380701|470399584|FG022|Overall Study|Withdrawal by Subject|2|||
130664997|NCT04380701|470399585|FG023|Overall Study|Withdrawal by Subject|2|||
130664998|NCT04380701|470399586|FG024|Overall Study|Withdrawal by Subject|1|||
130664999|NCT04380701|470399587|FG025|Overall Study|Withdrawal by Subject|1|||
130665000|NCT04380701|470399588|FG026|Overall Study|Withdrawal by Subject|0|||
130665001|NCT04380701|470399589|FG027|Overall Study|Withdrawal by Subject|0|||
130665002|NCT04380701|470399590|FG028|Overall Study|Withdrawal by Subject|0|||
130665003|NCT04380701|470399591|FG029|Overall Study|Withdrawal by Subject|0|||
130665004|NCT04380701|470399592|FG030|Overall Study|Withdrawal by Subject|0|||
130665005|NCT04380701|470399593|FG031|Overall Study|Withdrawal by Subject|0|||
130665006|NCT04380701|470399594|FG032|Overall Study|Withdrawal by Subject|0|||
130665007|NCT04380701|470399595|FG033|Overall Study|Withdrawal by Subject|0|||
130665008|NCT04380701|470399562|FG000|Overall Study|Adverse Event|0|||
130665009|NCT04380701|470399563|FG001|Overall Study|Adverse Event|0|||
130665010|NCT04380701|470399564|FG002|Overall Study|Adverse Event|0|||
130665011|NCT04380701|470399565|FG003|Overall Study|Adverse Event|0|||
130665012|NCT04380701|470399566|FG004|Overall Study|Adverse Event|0|||
130665013|NCT04380701|470399567|FG005|Overall Study|Adverse Event|1|||
130665014|NCT04380701|470399568|FG006|Overall Study|Adverse Event|0|||
130665015|NCT04380701|470399569|FG007|Overall Study|Adverse Event|0|||
130665016|NCT04380701|470399570|FG008|Overall Study|Adverse Event|0|||
130665017|NCT04380701|470399571|FG009|Overall Study|Adverse Event|0|||
130665018|NCT04380701|470399572|FG010|Overall Study|Adverse Event|0|||
130665019|NCT04380701|470399573|FG011|Overall Study|Adverse Event|0|||
130665020|NCT04380701|470399574|FG012|Overall Study|Adverse Event|0|||
130665021|NCT04380701|470399575|FG013|Overall Study|Adverse Event|0|||
130665022|NCT04380701|470399576|FG014|Overall Study|Adverse Event|0|||
130665023|NCT04380701|470399577|FG015|Overall Study|Adverse Event|1|||
130665024|NCT04380701|470399578|FG016|Overall Study|Adverse Event|0|||
130665025|NCT04380701|470399579|FG017|Overall Study|Adverse Event|0|||
130665026|NCT04380701|470399580|FG018|Overall Study|Adverse Event|0|||
130665027|NCT04380701|470399581|FG019|Overall Study|Adverse Event|1|||
130665028|NCT04380701|470399582|FG020|Overall Study|Adverse Event|0|||
130665029|NCT04380701|470399583|FG021|Overall Study|Adverse Event|0|||
130665030|NCT04380701|470399584|FG022|Overall Study|Adverse Event|0|||
130665031|NCT04380701|470399585|FG023|Overall Study|Adverse Event|0|||
130665032|NCT04380701|470399586|FG024|Overall Study|Adverse Event|0|||
130665033|NCT04380701|470399587|FG025|Overall Study|Adverse Event|0|||
130665034|NCT04380701|470399588|FG026|Overall Study|Adverse Event|0|||
130665035|NCT04380701|470399589|FG027|Overall Study|Adverse Event|0|||
130665036|NCT04380701|470399590|FG028|Overall Study|Adverse Event|0|||
130665037|NCT04380701|470399591|FG029|Overall Study|Adverse Event|0|||
130665038|NCT04380701|470399592|FG030|Overall Study|Adverse Event|0|||
130665039|NCT04380701|470399593|FG031|Overall Study|Adverse Event|0|||
130665040|NCT04380701|470399594|FG032|Overall Study|Adverse Event|0|||
130665041|NCT04380701|470399595|FG033|Overall Study|Adverse Event|0|||
130665042|NCT04380701|470399562|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
130665043|NCT04380701|470399563|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
130665044|NCT04380701|470399564|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
130665045|NCT04380701|470399565|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
130665046|NCT04380701|470399566|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
130665047|NCT04380701|470399567|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
130665048|NCT04380701|470399568|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
130665049|NCT04380701|470399569|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
130665050|NCT04380701|470399570|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
130665051|NCT04380701|470399571|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
130665052|NCT04380701|470399572|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
130665053|NCT04380701|470399573|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
130665054|NCT04380701|470399574|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
130665055|NCT04380701|470399575|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
130665056|NCT04380701|470399576|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
130665057|NCT04380701|470399577|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
130665058|NCT04380701|470399578|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
130665059|NCT04380701|470399579|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
130665060|NCT04380701|470399580|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
130665061|NCT04380701|470399581|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
130665062|NCT04380701|470399582|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
130665063|NCT04380701|470399583|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
130665064|NCT04380701|470399584|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
130665065|NCT04380701|470399585|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
130665066|NCT04380701|470399586|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
130665067|NCT04380701|470399587|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
130665068|NCT04380701|470399588|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
130665069|NCT04380701|470399589|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
130665070|NCT04380701|470399590|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
130665071|NCT04380701|470399591|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
130665072|NCT04380701|470399592|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
130665073|NCT04380701|470399593|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
130665074|NCT04380701|470399594|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
130665075|NCT04380701|470399595|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
130665076|NCT04380701|470399562|FG000|Overall Study|Physician Decision|0|||
130665077|NCT04380701|470399563|FG001|Overall Study|Physician Decision|0|||
130665078|NCT04380701|470399564|FG002|Overall Study|Physician Decision|0|||
130665079|NCT04380701|470399565|FG003|Overall Study|Physician Decision|0|||
130665080|NCT04380701|470399566|FG004|Overall Study|Physician Decision|0|||
130665081|NCT04380701|470399567|FG005|Overall Study|Physician Decision|0|||
130665082|NCT04380701|470399568|FG006|Overall Study|Physician Decision|0|||
130665083|NCT04380701|470399569|FG007|Overall Study|Physician Decision|0|||
130665084|NCT04380701|470399570|FG008|Overall Study|Physician Decision|0|||
130665085|NCT04380701|470399571|FG009|Overall Study|Physician Decision|0|||
130665086|NCT04380701|470399572|FG010|Overall Study|Physician Decision|0|||
130665087|NCT04380701|470399573|FG011|Overall Study|Physician Decision|0|||
130665088|NCT04380701|470399574|FG012|Overall Study|Physician Decision|0|||
130665089|NCT04380701|470399575|FG013|Overall Study|Physician Decision|0|||
130665090|NCT04380701|470399576|FG014|Overall Study|Physician Decision|0|||
130665091|NCT04380701|470399577|FG015|Overall Study|Physician Decision|0|||
130665092|NCT04380701|470399578|FG016|Overall Study|Physician Decision|0|||
130665093|NCT04380701|470399579|FG017|Overall Study|Physician Decision|0|||
130665094|NCT04380701|470399580|FG018|Overall Study|Physician Decision|0|||
130665095|NCT04380701|470399581|FG019|Overall Study|Physician Decision|0|||
130665096|NCT04380701|470399582|FG020|Overall Study|Physician Decision|0|||
130665097|NCT04380701|470399583|FG021|Overall Study|Physician Decision|0|||
130334859|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
130665098|NCT04380701|470399584|FG022|Overall Study|Physician Decision|0|||
130665099|NCT04380701|470399585|FG023|Overall Study|Physician Decision|0|||
130665100|NCT04380701|470399586|FG024|Overall Study|Physician Decision|2|||
130334860|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
130665101|NCT04380701|470399587|FG025|Overall Study|Physician Decision|0|||
130665102|NCT04380701|470399588|FG026|Overall Study|Physician Decision|0|||
130665103|NCT04380701|470399589|FG027|Overall Study|Physician Decision|0|||
130665104|NCT04380701|470399590|FG028|Overall Study|Physician Decision|0|||
130665105|NCT04380701|470399591|FG029|Overall Study|Physician Decision|0|||
130665106|NCT04380701|470399592|FG030|Overall Study|Physician Decision|0|||
130665107|NCT04380701|470399593|FG031|Overall Study|Physician Decision|0|||
130665108|NCT04380701|470399594|FG032|Overall Study|Physician Decision|0|||
130665109|NCT04380701|470399595|FG033|Overall Study|Physician Decision|0|||
130665110|NCT04380701|470399562|FG000|Overall Study|Death|0|||
130665111|NCT04380701|470399563|FG001|Overall Study|Death|0|||
130665112|NCT04380701|470399564|FG002|Overall Study|Death|0|||
130665113|NCT04380701|470399565|FG003|Overall Study|Death|0|||
130665114|NCT04380701|470399566|FG004|Overall Study|Death|0|||
130665115|NCT04380701|470399567|FG005|Overall Study|Death|0|||
130665116|NCT04380701|470399568|FG006|Overall Study|Death|0|||
130665117|NCT04380701|470399569|FG007|Overall Study|Death|0|||
130665118|NCT04380701|470399570|FG008|Overall Study|Death|0|||
130665119|NCT04380701|470399571|FG009|Overall Study|Death|0|||
130665120|NCT04380701|470399572|FG010|Overall Study|Death|0|||
130665121|NCT04380701|470399573|FG011|Overall Study|Death|0|||
130665122|NCT04380701|470399574|FG012|Overall Study|Death|0|||
130665123|NCT04380701|470399575|FG013|Overall Study|Death|0|||
130665124|NCT04380701|470399576|FG014|Overall Study|Death|0|||
130665125|NCT04380701|470399577|FG015|Overall Study|Death|0|||
130665126|NCT04380701|470399578|FG016|Overall Study|Death|0|||
130665127|NCT04380701|470399579|FG017|Overall Study|Death|0|||
130665128|NCT04380701|470399580|FG018|Overall Study|Death|0|||
130665129|NCT04380701|470399581|FG019|Overall Study|Death|0|||
130665130|NCT04380701|470399582|FG020|Overall Study|Death|0|||
130665131|NCT04380701|470399583|FG021|Overall Study|Death|0|||
130665132|NCT04380701|470399584|FG022|Overall Study|Death|0|||
130665133|NCT04380701|470399585|FG023|Overall Study|Death|0|||
130665134|NCT04380701|470399586|FG024|Overall Study|Death|1|||
130665135|NCT04380701|470399587|FG025|Overall Study|Death|0|||
130665136|NCT04380701|470399588|FG026|Overall Study|Death|0|||
130665137|NCT04380701|470399589|FG027|Overall Study|Death|0|||
130665138|NCT04380701|470399590|FG028|Overall Study|Death|0|||
130665139|NCT04380701|470399591|FG029|Overall Study|Death|0|||
130665140|NCT04380701|470399592|FG030|Overall Study|Death|0|||
130665141|NCT04380701|470399593|FG031|Overall Study|Death|0|||
130665142|NCT04380701|470399594|FG032|Overall Study|Death|0|||
130665143|NCT04380701|470399595|FG033|Overall Study|Death|0|||
130665144|NCT04380701|470399562|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665145|NCT04380701|470399563|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665146|NCT04380701|470399564|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665147|NCT04380701|470399565|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665148|NCT04380701|470399566|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665149|NCT04380701|470399567|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665150|NCT04380701|470399568|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665151|NCT04380701|470399569|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665152|NCT04380701|470399570|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665153|NCT04380701|470399571|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665154|NCT04380701|470399572|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665155|NCT04380701|470399573|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665156|NCT04380701|470399574|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665157|NCT04380701|470399575|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665158|NCT04380701|470399576|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665159|NCT04380701|470399577|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665160|NCT04380701|470399578|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665161|NCT04380701|470399579|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665162|NCT04380701|470399580|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665163|NCT04380701|470399581|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665164|NCT04380701|470399582|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665165|NCT04380701|470399583|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
130665166|NCT04380701|470399584|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
130665167|NCT04380701|470399585|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
130665168|NCT04380701|470399586|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
130665169|NCT04380701|470399587|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665170|NCT04380701|470399588|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665171|NCT04380701|470399589|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665172|NCT04380701|470399590|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665173|NCT04380701|470399591|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665174|NCT04380701|470399592|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665175|NCT04380701|470399593|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665176|NCT04380701|470399594|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665177|NCT04380701|470399595|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130665178|NCT03707522|470399596|FG000|Overall Study|Lost to Follow-up|24|||
130665179|NCT03707522|470399597|FG001|Overall Study|Lost to Follow-up|27|||
130665180|NCT03707522|470399598|FG002|Overall Study|Lost to Follow-up|41|||
130665181|NCT03707522|470399599|FG003|Overall Study|Lost to Follow-up|36|||
130665182|NCT04363736|470399600|FG000|Overall Study|Withdrawal by Subject|1|||
130665183|NCT04363736|470399601|FG001|Overall Study|Withdrawal by Subject|0|||
130665184|NCT04363736|470399600|FG000|Overall Study|Lost to Follow-up|10|||
130665185|NCT04363736|470399601|FG001|Overall Study|Lost to Follow-up|7|||
130665186|NCT04363736|470399600|FG000|Overall Study|Death|8|||
130665187|NCT04363736|470399601|FG001|Overall Study|Death|6|||
130665188|NCT00383019|470399602|FG000|Overall Study|Adverse Event|5|||
130665189|NCT00383019|470399603|FG001|Overall Study|Adverse Event|1|||
130665190|NCT00383019|470399602|FG000|Overall Study|Withdrawal by Subject|0|||
130665191|NCT00383019|470399603|FG001|Overall Study|Withdrawal by Subject|1|||
130665192|NCT00990093|470399604|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
130665193|NCT00990093|470399605|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
130665194|NCT00990093|470399604|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
130665195|NCT00990093|470399605|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
130665196|NCT00990093|470399604|FG000|Test Period 1 (1-14 Days)|Other|1|||
130665197|NCT00990093|470399605|FG001|Test Period 1 (1-14 Days)|Other|0|||
130665198|NCT00990093|470399604|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
130665199|NCT00990093|470399605|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
130665200|NCT00990093|470399604|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
130665201|NCT00990093|470399605|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
130665202|NCT00990093|470399604|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
130665203|NCT00990093|470399605|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
130665204|NCT00990093|470399604|FG000|Test Period 2 (15-28 Days)|Other|0|||
130665205|NCT00990093|470399605|FG001|Test Period 2 (15-28 Days)|Other|1|||
130665206|NCT00995930|470399606|FG000|Overall Study|Protocol deviation|2|||
130665207|NCT00995930|470399607|FG001|Overall Study|Protocol deviation|5|||
130665208|NCT00995930|470399606|FG000|Overall Study|Death|0|||
130665209|NCT00995930|470399607|FG001|Overall Study|Death|1|||
130665210|NCT00995930|470399606|FG000|Overall Study|Administrative problems|4|||
130665211|NCT00995930|470399607|FG001|Overall Study|Administrative problems|2|||
130665212|NCT00995930|470399606|FG000|Overall Study|Lost to Follow-up|1|||
130665213|NCT00995930|470399607|FG001|Overall Study|Lost to Follow-up|2|||
130665214|NCT00995930|470399606|FG000|Overall Study|Withdrawal by Subject|3|||
130665215|NCT00995930|470399607|FG001|Overall Study|Withdrawal by Subject|4|||
130665216|NCT00995930|470399606|FG000|Overall Study|Adverse Event|11|||
130665217|NCT00995930|470399607|FG001|Overall Study|Adverse Event|14|||
130665218|NCT01458119|470399608|FG000|Overall Study|Physician Decision|4|||
130665219|NCT01458119|470399608|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
130665220|NCT01458119|470399608|FG000|Overall Study|Pregnancy|1|||
130665221|NCT01458119|470399608|FG000|Overall Study|Death|2|||
130665222|NCT01458119|470399608|FG000|Overall Study|Adverse Event|1|||
130665223|NCT01458119|470399608|FG000|Overall Study|Consent Withdrawn by Participant|8|||
130665224|NCT01458119|470399608|FG000|Overall Study|Non-compliance With Study Drug|3|||
130665225|NCT05003167|470399609|FG000|Overall Study|Withdrawal by Subject|1|||
130665226|NCT02367781|470399610|FG000|Overall Study|Withdrawal by Subject|20|||
130665227|NCT02367781|470399611|FG001|Overall Study|Withdrawal by Subject|13|||
130665228|NCT02367781|470399610|FG000|Overall Study|Protocol Violation|0|||
130665229|NCT02367781|470399611|FG001|Overall Study|Protocol Violation|1|||
130665230|NCT02367781|470399610|FG000|Overall Study|Physician Decision|7|||
130665231|NCT02367781|470399611|FG001|Overall Study|Physician Decision|0|||
130665232|NCT02367781|470399610|FG000|Overall Study|Randomized in Error|5|||
130665233|NCT02367781|470399611|FG001|Overall Study|Randomized in Error|4|||
130665234|NCT02367781|470399610|FG000|Overall Study|Non-Compliance|1|||
130665235|NCT02367781|470399611|FG001|Overall Study|Non-Compliance|0|||
130665236|NCT02367781|470399610|FG000|Overall Study|Lost to Follow-up|1|||
130665237|NCT02367781|470399611|FG001|Overall Study|Lost to Follow-up|2|||
130665238|NCT02367781|470399610|FG000|Overall Study|Death|330|||
130665239|NCT02367781|470399611|FG001|Overall Study|Death|176|||
130665240|NCT02367781|470399610|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
130665241|NCT02367781|470399611|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
130665242|NCT02367781|470399610|FG000|Overall Study|Prolonged Hospitalization|1|||
130665243|NCT02367781|470399611|FG001|Overall Study|Prolonged Hospitalization|0|||
130665244|NCT02367781|470399610|FG000|Overall Study|Death Prior First Dose|1|||
130665245|NCT02367781|470399611|FG001|Overall Study|Death Prior First Dose|0|||
130665246|NCT02367781|470399610|FG000|Overall Study|Administrative-Change Facility|1|||
130665247|NCT02367781|470399611|FG001|Overall Study|Administrative-Change Facility|0|||
130665248|NCT02367781|470399610|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
130665249|NCT02367781|470399611|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
130665250|NCT02367781|470399610|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
130665251|NCT02367781|470399611|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
130665252|NCT02367781|470399610|FG000|Overall Study|Study Terminated by Sponsor|3|||
130665253|NCT02367781|470399611|FG001|Overall Study|Study Terminated by Sponsor|1|||
130665254|NCT02367781|470399610|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
130665255|NCT02367781|470399611|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
130665256|NCT02367781|470399610|FG000|Overall Study|Sponsor Decision|2|||
130665257|NCT02367781|470399611|FG001|Overall Study|Sponsor Decision|0|||
130665258|NCT02367781|470399610|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
130665259|NCT02367781|470399611|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
130665260|NCT01123980|470399614|FG000|Overall Study|Adverse Event|1|||
130665261|NCT01123980|470399615|FG001|Overall Study|Adverse Event|1|||
130665262|NCT01123980|470399614|FG000|Overall Study|Lack of Efficacy|1|||
130665263|NCT01123980|470399615|FG001|Overall Study|Lack of Efficacy|0|||
130665264|NCT01123980|470399614|FG000|Overall Study|Physician Decision|0|||
130665265|NCT01123980|470399615|FG001|Overall Study|Physician Decision|1|||
130665266|NCT01123980|470399614|FG000|Overall Study|Lost to Follow-up|0|||
130665267|NCT01123980|470399615|FG001|Overall Study|Lost to Follow-up|6|||
130665268|NCT01123980|470399614|FG000|Overall Study|Protocol Violation|6|||
130665269|NCT01123980|470399615|FG001|Overall Study|Protocol Violation|6|||
130665270|NCT01123980|470399614|FG000|Overall Study|Withdrawal by Subject|5|||
130665271|NCT01123980|470399615|FG001|Overall Study|Withdrawal by Subject|3|||
130665272|NCT01123980|470399614|FG000|Overall Study|Unclassified|6|||
130665273|NCT01123980|470399615|FG001|Overall Study|Unclassified|7|||
130665274|NCT01225991|470399616|FG000|Overall Study|Withdrawal by Subject|6|||
130665275|NCT02094937|470399617|FG000|8 Weeks in Period 1|Adverse Event|9|||
130665276|NCT02094937|470399618|FG001|8 Weeks in Period 1|Adverse Event|0|||
130665277|NCT02094937|470399619|FG002|8 Weeks in Period 1|Adverse Event|0|||
130665278|NCT02094937|470399620|FG003|8 Weeks in Period 1|Adverse Event|0|||
130665279|NCT02094937|470399617|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
130665280|NCT02094937|470399618|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
130665281|NCT02094937|470399619|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
130665282|NCT02094937|470399620|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
130665283|NCT02094937|470399617|FG000|8 Weeks in Period 1|Protocol Violation|2|||
130665284|NCT02094937|470399618|FG001|8 Weeks in Period 1|Protocol Violation|0|||
130665285|NCT02094937|470399619|FG002|8 Weeks in Period 1|Protocol Violation|0|||
130665286|NCT02094937|470399620|FG003|8 Weeks in Period 1|Protocol Violation|0|||
130665287|NCT02094937|470399617|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
130665288|NCT02094937|470399618|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130665289|NCT02094937|470399619|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130665290|NCT02094937|470399620|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130665291|NCT02094937|470399617|FG000|8 Weeks in Period 1|Physician Decision|1|||
130665292|NCT02094937|470399618|FG001|8 Weeks in Period 1|Physician Decision|0|||
130665293|NCT02094937|470399619|FG002|8 Weeks in Period 1|Physician Decision|0|||
130665294|NCT02094937|470399620|FG003|8 Weeks in Period 1|Physician Decision|0|||
130665295|NCT02094937|470399617|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
130665296|NCT02094937|470399618|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
130665297|NCT02094937|470399619|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
130665298|NCT02094937|470399620|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
130665299|NCT02094937|470399617|FG000|12 Weeks in Period 2|Adverse Event|0|||
130665300|NCT02094937|470399618|FG001|12 Weeks in Period 2|Adverse Event|2|||
130665301|NCT02094937|470399619|FG002|12 Weeks in Period 2|Adverse Event|4|||
130665302|NCT02094937|470399620|FG003|12 Weeks in Period 2|Adverse Event|1|||
130665303|NCT02094937|470399617|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
130665304|NCT02094937|470399618|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
130334861|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
130334862|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
130334863|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
130334864|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
130334865|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
130334866|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
130334867|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
130334868|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
130334869|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
130334870|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
130334871|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
130665305|NCT02094937|470399619|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
130665306|NCT02094937|470399620|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
130665307|NCT02094937|470399617|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
130665308|NCT02094937|470399618|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
130665309|NCT02094937|470399619|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
130665310|NCT02094937|470399620|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
130665311|NCT02094937|470399617|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
130665312|NCT02094937|470399618|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
130665313|NCT02094937|470399619|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
130665314|NCT02094937|470399620|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
130665315|NCT02094937|470399617|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
130665316|NCT02094937|470399618|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
130665317|NCT02094937|470399619|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
130665318|NCT02094937|470399620|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
130665319|NCT01133392|470399621|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
130665320|NCT01133392|470399622|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
130665321|NCT01133392|470399621|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
130665322|NCT01133392|470399622|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
130665323|NCT00343642|470401030|FG000|Overall Study|Lost to Follow-up|0|||
130665324|NCT00343642|470401031|FG001|Overall Study|Lost to Follow-up|1|||
130665325|NCT00343642|470401032|FG002|Overall Study|Lost to Follow-up|0|||
130665326|NCT00343642|470401030|FG000|Overall Study|Pregnancy|1|||
130665327|NCT00343642|470401031|FG001|Overall Study|Pregnancy|0|||
130665328|NCT00343642|470401032|FG002|Overall Study|Pregnancy|2|||
130665329|NCT00343642|470401030|FG000|Overall Study|Withdrawal by Subject|2|||
130665330|NCT00343642|470401031|FG001|Overall Study|Withdrawal by Subject|3|||
130665331|NCT00343642|470401032|FG002|Overall Study|Withdrawal by Subject|4|||
130665332|NCT00343642|470401030|FG000|Overall Study|Adverse Event|0|||
130665333|NCT00343642|470401031|FG001|Overall Study|Adverse Event|0|||
130665334|NCT00343642|470401032|FG002|Overall Study|Adverse Event|1|||
130665335|NCT00343642|470401030|FG000|Overall Study|Flare up|6|||
130665336|NCT00343642|470401031|FG001|Overall Study|Flare up|4|||
130665337|NCT00343642|470401032|FG002|Overall Study|Flare up|0|||
130665338|NCT00860574|470401033|FG000|Overall Study|Death|2|||
130665339|NCT00860574|470401033|FG000|Overall Study|Relapse|1|||
130665340|NCT01246986|470401034|FG000|Overall Study|Lost to Follow-up|0|||
130665341|NCT01246986|470401035|FG001|Overall Study|Lost to Follow-up|1|||
130665342|NCT01246986|470401036|FG002|Overall Study|Lost to Follow-up|3|||
130665343|NCT01246986|470401037|FG003|Overall Study|Lost to Follow-up|0|||
130665344|NCT01246986|470401038|FG004|Overall Study|Lost to Follow-up|0|||
130665345|NCT01246986|470401039|FG005|Overall Study|Lost to Follow-up|1|||
130665346|NCT01246986|470401040|FG006|Overall Study|Lost to Follow-up|0|||
130665347|NCT01246986|470401034|FG000|Overall Study|Withdrawal by Subject|3|||
130665348|NCT01246986|470401035|FG001|Overall Study|Withdrawal by Subject|4|||
130665349|NCT01246986|470401036|FG002|Overall Study|Withdrawal by Subject|3|||
130665350|NCT01246986|470401037|FG003|Overall Study|Withdrawal by Subject|0|||
130665351|NCT01246986|470401038|FG004|Overall Study|Withdrawal by Subject|4|||
130665352|NCT01246986|470401039|FG005|Overall Study|Withdrawal by Subject|0|||
130665353|NCT01246986|470401040|FG006|Overall Study|Withdrawal by Subject|0|||
130665354|NCT01335399|470401044|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
130665355|NCT01335399|470401045|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
130665356|NCT01335399|470401044|FG000|Pre-treatment Period|Participant request to discontinue|0|||
130665357|NCT01335399|470401045|FG001|Pre-treatment Period|Participant request to discontinue|1|||
130665358|NCT01335399|470401044|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
130665359|NCT01335399|470401045|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
130665360|NCT01335399|470401044|FG000|Pre-treatment Period|Consent withdrawal|3|||
130665361|NCT01335399|470401045|FG001|Pre-treatment Period|Consent withdrawal|0|||
130665362|NCT01335399|470401044|FG000|Treatment Period|Disease progression|117|||
130665363|NCT01335399|470401045|FG001|Treatment Period|Disease progression|145|||
130665364|NCT01335399|470401044|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
130665365|NCT01335399|470401045|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
130665366|NCT01335399|470401044|FG000|Treatment Period|Study drug toxicity|52|||
130665367|NCT01335399|470401045|FG001|Treatment Period|Study drug toxicity|64|||
130665368|NCT01335399|470401044|FG000|Treatment Period|Participant request to discontinue|30|||
130665369|NCT01335399|470401045|FG001|Treatment Period|Participant request to discontinue|22|||
130665370|NCT01335399|470401044|FG000|Treatment Period|Other reasons|30|||
130665371|NCT01335399|470401045|FG001|Treatment Period|Other reasons|30|||
130665372|NCT01335399|470401044|FG000|Treatment Period|Consent withdrawal|10|||
130665373|NCT01335399|470401045|FG001|Treatment Period|Consent withdrawal|7|||
130665374|NCT01335399|470401044|FG000|Treatment Period|Death|7|||
130665375|NCT01335399|470401045|FG001|Treatment Period|Death|6|||
130665376|NCT01335399|470401044|FG000|Treatment Period|Poor/Non-compliance|3|||
130665377|NCT01335399|470401045|FG001|Treatment Period|Poor/Non-compliance|4|||
130665378|NCT01335399|470401044|FG000|Treatment Period|Lost to Follow-up|2|||
130665379|NCT01335399|470401045|FG001|Treatment Period|Lost to Follow-up|2|||
130665380|NCT01335399|470401044|FG000|Treatment Period|Maximum clinical benefit|1|||
130665381|NCT01335399|470401045|FG001|Treatment Period|Maximum clinical benefit|1|||
130665382|NCT01335399|470401044|FG000|Treatment Period|No longer meet study criteria|1|||
130665383|NCT01335399|470401045|FG001|Treatment Period|No longer meet study criteria|1|||
130665384|NCT01335399|470401044|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
130665385|NCT01335399|470401045|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
130665386|NCT01416142|470401046|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
130665387|NCT01416142|470401047|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
130665388|NCT01416142|470401048|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
130665389|NCT02464059|470401049|FG000|Overall Study|Lost to Follow-up|6|||
130665390|NCT01011907|470401052|FG000|Overall Study|Withdrawal by Subject|13|||
130665391|NCT01011907|470401053|FG001|Overall Study|Withdrawal by Subject|11|||
130665392|NCT01011907|470401052|FG000|Overall Study|Adverse Event|1|||
130665393|NCT01011907|470401053|FG001|Overall Study|Adverse Event|4|||
130665394|NCT00304954|470401054|FG000|Overall Study|Withdrawal by Subject|0|||
130665395|NCT00304954|470401055|FG001|Overall Study|Withdrawal by Subject|0|||
130665396|NCT00304954|470401056|FG002|Overall Study|Withdrawal by Subject|1|||
130665397|NCT00304954|470401057|FG003|Overall Study|Withdrawal by Subject|0|||
130665398|NCT00304954|470401054|FG000|Overall Study|Adverse Event|1|||
130665399|NCT00304954|470401055|FG001|Overall Study|Adverse Event|0|||
130665400|NCT00304954|470401056|FG002|Overall Study|Adverse Event|0|||
130665401|NCT00304954|470401057|FG003|Overall Study|Adverse Event|0|||
130665402|NCT01406873|470401062|FG000|Overall Study|Withdrawal by Subject|1|||
130665403|NCT01406873|470401063|FG001|Overall Study|Withdrawal by Subject|1|||
130665404|NCT03990389|470401064|FG000|Overall Study|Lost to Follow-up|3|||
130665405|NCT03990389|470401065|FG001|Overall Study|Lost to Follow-up|0|||
130665406|NCT00207714|470401066|FG000|Overall Study|Adverse Event|6|||
130665407|NCT00207714|470401067|FG001|Overall Study|Adverse Event|2|||
130665408|NCT00207714|470401068|FG002|Overall Study|Adverse Event|4|||
130665409|NCT00207714|470401069|FG003|Overall Study|Adverse Event|3|||
130665410|NCT00207714|470401070|FG004|Overall Study|Adverse Event|1|||
130334872|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
130334873|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
130334874|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130334875|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130334876|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
130334877|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
130334878|NCT01623050|469195586|FG000|Overall Study|Lost to Follow-up|9|||
130334879|NCT01191762|469195587|FG000|Overall Study|Adverse Event|1|||
130334880|NCT01191762|469195588|FG001|Overall Study|Adverse Event|0|||
130334881|NCT00459186|469195589|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
130334882|NCT00459186|469195589|FG000|PET Imaging and Assessment|Adverse Event|3|||
130334883|NCT03710083|469195590|FG000|Overall Study|Withdrawal by Subject|2|||
130665411|NCT00207714|470401066|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130665412|NCT00207714|470401067|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130665413|NCT00207714|470401068|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130665414|NCT00207714|470401069|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
130665415|NCT00207714|470401070|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
130665416|NCT00207714|470401066|FG000|Overall Study|Other|3|||
130334884|NCT03710083|469195590|FG000|Overall Study|Unsuccessful Procedure|1|||
130665417|NCT00207714|470401067|FG001|Overall Study|Other|2|||
130665418|NCT00207714|470401068|FG002|Overall Study|Other|5|||
130665419|NCT00207714|470401069|FG003|Overall Study|Other|1|||
130665420|NCT00207714|470401070|FG004|Overall Study|Other|0|||
130665421|NCT00736099|470401072|FG000|Overall Study|Adverse Event|61|||
130665422|NCT00736099|470401073|FG001|Overall Study|Adverse Event|18|||
130334885|NCT00838513|469195591|FG000|Screening Period|Screen Failure|3|||
130334886|NCT00838513|469195591|FG000|Extension Treatment Period|Death|1|||
130552621|NCT02146326|469990247|FG003|Overall Study|Withdrawal by Subject|11|||
130552622|NCT02146326|469990244|FG000|Overall Study|Separated from mental health center|23|||
130552623|NCT02146326|469990245|FG001|Overall Study|Separated from mental health center|33|||
130552624|NCT02146326|469990246|FG002|Overall Study|Separated from mental health center|0|||
130552625|NCT02146326|469990247|FG003|Overall Study|Separated from mental health center|0|||
130552626|NCT02146326|469990244|FG000|Overall Study|Incarcerated|0|||
130552627|NCT02146326|469990245|FG001|Overall Study|Incarcerated|0|||
130552628|NCT02146326|469990246|FG002|Overall Study|Incarcerated|3|||
130552629|NCT02146326|469990247|FG003|Overall Study|Incarcerated|8|||
130552630|NCT02146326|469990244|FG000|Overall Study|Death|0|||
130552631|NCT02146326|469990245|FG001|Overall Study|Death|0|||
130552632|NCT02146326|469990246|FG002|Overall Study|Death|4|||
130552633|NCT02146326|469990247|FG003|Overall Study|Death|4|||
130552634|NCT02146326|469990244|FG000|Overall Study|Unable to complete interview|0|||
130552635|NCT02146326|469990245|FG001|Overall Study|Unable to complete interview|0|||
130552636|NCT02146326|469990246|FG002|Overall Study|Unable to complete interview|10|||
130552637|NCT02146326|469990247|FG003|Overall Study|Unable to complete interview|6|||
130552638|NCT01340651|469990249|FG000|Overall Study|Adverse Event|3|||
130552639|NCT01340651|469990249|FG000|Overall Study|Consent Withdrawn|2|||
130552640|NCT01340651|469990249|FG000|Overall Study|Commercial Supply per Sponsor|12|||
130552641|NCT01696942|469990254|FG000|Overall Study|Withdrawal by Subject|1|||
130552642|NCT01696942|469990255|FG001|Overall Study|Withdrawal by Subject|0|||
130552643|NCT01696942|469990254|FG000|Overall Study|Protocol Violation|1|||
130552644|NCT01696942|469990255|FG001|Overall Study|Protocol Violation|2|||
130665423|NCT00736099|470401072|FG000|Overall Study|Protocol Violation|10|||
130665424|NCT00736099|470401073|FG001|Overall Study|Protocol Violation|4|||
130665425|NCT00736099|470401072|FG000|Overall Study|Lost to Follow-up|12|||
130665426|NCT00736099|470401073|FG001|Overall Study|Lost to Follow-up|5|||
130665427|NCT00736099|470401072|FG000|Overall Study|Withdrawal by Subject|42|||
130665428|NCT00736099|470401073|FG001|Overall Study|Withdrawal by Subject|13|||
130665429|NCT00736099|470401072|FG000|Overall Study|Lack of Efficacy|15|||
130665430|NCT00736099|470401073|FG001|Overall Study|Lack of Efficacy|8|||
130334887|NCT00838513|469195591|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
130665431|NCT00736099|470401072|FG000|Overall Study|Other reason|43|||
130665432|NCT00736099|470401073|FG001|Overall Study|Other reason|10|||
130665433|NCT02290028|470401076|FG000|Overall Study|Death|217|||
130665434|NCT02290028|470401076|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
130665435|NCT02290028|470401076|FG000|Overall Study|No longer under care of study physician|76|||
130665436|NCT02290028|470401076|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
130665437|NCT02290028|470401076|FG000|Overall Study|Withdrawal by Subject|52|||
130665438|NCT02290028|470401076|FG000|Overall Study|Study site closure|44|||
130665439|NCT02290028|470401076|FG000|Overall Study|Lost to Follow-up|34|||
130665440|NCT02290028|470401076|FG000|Overall Study|Miscellaneous|10|||
130665441|NCT02290028|470401076|FG000|Overall Study|Transition to EP PASSION|1295|||
130665442|NCT02290028|470401076|FG000|Overall Study|Planned study completion at 12 months|257|||
130665443|NCT03202511|470401077|FG000|Overall Study|Withdrawal by Subject|1|||
130665444|NCT03202511|470401078|FG001|Overall Study|Withdrawal by Subject|0|||
130665445|NCT00833547|470401079|FG000|Overall Study|Withdrawal by Subject|2|||
130665446|NCT00833547|470401080|FG001|Overall Study|Withdrawal by Subject|2|||
130665447|NCT00686790|470401081|FG000|Overall Study|Adverse Event|2|||
130665448|NCT00686790|470401081|FG000|Overall Study|Withdrawal by Subject|1|||
130665449|NCT00686790|470401081|FG000|Overall Study|Death|1|||
130665450|NCT00686790|470401081|FG000|Overall Study|Lost to Follow-up|12|||
130665451|NCT00265083|470401082|FG000|Overall Study|Adverse Event|5|||
130665452|NCT00265083|470401083|FG001|Overall Study|Adverse Event|13|||
130665453|NCT00265083|470401084|FG002|Overall Study|Adverse Event|15|||
130665454|NCT00265083|470401082|FG000|Overall Study|Lost to Follow-up|3|||
130665455|NCT00265083|470401083|FG001|Overall Study|Lost to Follow-up|4|||
130665456|NCT00265083|470401084|FG002|Overall Study|Lost to Follow-up|4|||
130665457|NCT00265083|470401082|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
130665458|NCT00265083|470401083|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130665459|NCT00265083|470401084|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
130665460|NCT00265083|470401082|FG000|Overall Study|Other|1|||
130665461|NCT00265083|470401083|FG001|Overall Study|Other|12|||
130665462|NCT00265083|470401084|FG002|Overall Study|Other|9|||
130665463|NCT03208933|470401085|FG000|Overall Study|Death|3|||
130665464|NCT03208933|470401085|FG000|Overall Study|Withdrawal by Subject|3|||
130665465|NCT03208933|470401085|FG000|Overall Study|Adverse Event|1|||
130665466|NCT03208933|470401085|FG000|Overall Study|Lost to Follow-up|2|||
130665467|NCT03208933|470401085|FG000|Overall Study|Physician Decision|3|||
130665468|NCT03208933|470401085|FG000|Overall Study|Protocol Violation|1|||
130665469|NCT04242186|470401086|FG000|Overall Study|Death|5|||
130665470|NCT00379587|470401087|FG000|Overall Study|Lost to Follow-up|2|||
130665471|NCT01070966|470401098|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
130665472|NCT01070966|470401098|FG000|Participants for Safety Evaluation|Off-label use|9|||
130334888|NCT01388335|469195596|FG000|Period 1|Progressive Disease|1|||
130334889|NCT01388335|469195596|FG000|Period 2|Progressive Disease|2|||
130334890|NCT01388335|469195596|FG000|Period 2|Sponsor Decision|1|||
130334891|NCT01388335|469195596|FG000|Safety Extension|Progressive Disease|7|||
130334892|NCT00889720|469195597|FG000|Overall Study|Withdrawal by Subject|4|||
130334893|NCT00889720|469195597|FG000|Overall Study|Other|4|||
130334894|NCT00670306|469195598|FG000|Overall Study|Adverse Event|8|||
130334895|NCT00670306|469195598|FG000|Overall Study|Lack of Efficacy|10|||
130334896|NCT00670306|469195598|FG000|Overall Study|Withdrawal by Subject|9|||
130334897|NCT00670306|469195598|FG000|Overall Study|Physician Decision|1|||
130334898|NCT00670306|469195598|FG000|Overall Study|Lost to Follow-up|8|||
130665473|NCT01070966|470401098|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
130665474|NCT01070966|470401098|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
130665475|NCT01070966|470401098|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
130665476|NCT01070966|470401098|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
130334899|NCT00670306|469195598|FG000|Overall Study|incl/excl criterias did not meet|19|||
130334900|NCT00775593|469195599|FG000|Overall Study|Unmet eligibility criteria|6|||
130665477|NCT01070966|470401098|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
130334901|NCT00775593|469195599|FG000|Overall Study|Death|1|||
130334902|NCT03904693|469195600|FG000|Overall Study|Death|0|||
130334903|NCT03904693|469195601|FG001|Overall Study|Death|0|||
130334904|NCT03904693|469195602|FG002|Overall Study|Death|3|||
130665478|NCT01070966|470401098|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
130665479|NCT02770716|470401099|FG000|Overall Study|Death|101|||
130665480|NCT02770716|470401100|FG001|Overall Study|Death|45|||
130665481|NCT02770716|470401099|FG000|Overall Study|Withdrawal by Subject|4|||
130665482|NCT02770716|470401100|FG001|Overall Study|Withdrawal by Subject|2|||
130665483|NCT02770716|470401099|FG000|Overall Study|Lost to Follow-up|1|||
130665484|NCT02770716|470401100|FG001|Overall Study|Lost to Follow-up|0|||
130665485|NCT02770716|470401099|FG000|Overall Study|Various reasons|6|||
130665486|NCT02770716|470401100|FG001|Overall Study|Various reasons|2|||
130665487|NCT01725113|470401101|FG000|Overall Study|Kidney Transplant|1|||
130665488|NCT01725113|470401102|FG001|Overall Study|Kidney Transplant|1|||
130665489|NCT01725113|470401101|FG000|Overall Study|Withdrawal by Subject|0|||
130665490|NCT01725113|470401102|FG001|Overall Study|Withdrawal by Subject|1|||
130665491|NCT03989115|470401103|FG000|Overall Study|Withdrawal by Subject|2|||
130665492|NCT03989115|470401104|FG001|Overall Study|Withdrawal by Subject|1|||
130665493|NCT03989115|470401105|FG002|Overall Study|Withdrawal by Subject|3|||
130665494|NCT03989115|470401106|FG003|Overall Study|Withdrawal by Subject|0|||
130665495|NCT03989115|470401107|FG004|Overall Study|Withdrawal by Subject|17|||
130665496|NCT03989115|470401108|FG005|Overall Study|Withdrawal by Subject|1|||
130665497|NCT03989115|470401109|FG006|Overall Study|Withdrawal by Subject|0|||
130665498|NCT03989115|470401110|FG007|Overall Study|Withdrawal by Subject|0|||
130665499|NCT03989115|470401103|FG000|Overall Study|Sponsor decision to terminate the study|1|||
130665500|NCT03989115|470401104|FG001|Overall Study|Sponsor decision to terminate the study|1|||
130665501|NCT03989115|470401105|FG002|Overall Study|Sponsor decision to terminate the study|0|||
130665502|NCT03989115|470401106|FG003|Overall Study|Sponsor decision to terminate the study|1|||
130665503|NCT03989115|470401107|FG004|Overall Study|Sponsor decision to terminate the study|11|||
130665504|NCT03989115|470401108|FG005|Overall Study|Sponsor decision to terminate the study|0|||
130665505|NCT03989115|470401109|FG006|Overall Study|Sponsor decision to terminate the study|2|||
130665506|NCT03989115|470401110|FG007|Overall Study|Sponsor decision to terminate the study|1|||
130665507|NCT03989115|470401103|FG000|Overall Study|Lost to Follow-up|2|||
130665508|NCT03989115|470401104|FG001|Overall Study|Lost to Follow-up|0|||
130665509|NCT03989115|470401105|FG002|Overall Study|Lost to Follow-up|0|||
130665510|NCT03989115|470401106|FG003|Overall Study|Lost to Follow-up|0|||
130665511|NCT03989115|470401107|FG004|Overall Study|Lost to Follow-up|1|||
130665512|NCT03989115|470401108|FG005|Overall Study|Lost to Follow-up|0|||
130665513|NCT03989115|470401109|FG006|Overall Study|Lost to Follow-up|0|||
130665514|NCT03989115|470401110|FG007|Overall Study|Lost to Follow-up|0|||
130665515|NCT03989115|470401103|FG000|Overall Study|Death|2|||
130665516|NCT03989115|470401104|FG001|Overall Study|Death|2|||
130665517|NCT03989115|470401105|FG002|Overall Study|Death|9|||
130665518|NCT03989115|470401106|FG003|Overall Study|Death|6|||
130665519|NCT03989115|470401107|FG004|Overall Study|Death|31|||
130665520|NCT03989115|470401108|FG005|Overall Study|Death|6|||
130665521|NCT03989115|470401109|FG006|Overall Study|Death|2|||
130665522|NCT03989115|470401110|FG007|Overall Study|Death|3|||
130665523|NCT03989115|470401103|FG000|Overall Study|Other|1|||
130665524|NCT03989115|470401104|FG001|Overall Study|Other|2|||
130665525|NCT03989115|470401105|FG002|Overall Study|Other|0|||
130665526|NCT03989115|470401106|FG003|Overall Study|Other|0|||
130665527|NCT03989115|470401107|FG004|Overall Study|Other|5|||
130665528|NCT03989115|470401108|FG005|Overall Study|Other|0|||
130665529|NCT03989115|470401109|FG006|Overall Study|Other|0|||
130665530|NCT03989115|470401110|FG007|Overall Study|Other|0|||
130665531|NCT01808209|470401111|FG000|Overall Study|Lost to Follow-up|0|||
130665532|NCT01808209|470401112|FG001|Overall Study|Lost to Follow-up|1|||
130665533|NCT02629133|470401116|FG000|Overall Study|Lost to Follow-up|3|||
130665534|NCT02629133|470401117|FG001|Overall Study|Lost to Follow-up|1|||
130665535|NCT02629133|470401116|FG000|Overall Study|Withdrawal by Subject|1|||
130665536|NCT02629133|470401117|FG001|Overall Study|Withdrawal by Subject|1|||
130665537|NCT01507831|470401118|FG000|Overall Study|Randomized but not treated|0|||
130665538|NCT01507831|470401119|FG001|Overall Study|Randomized but not treated|3|||
130665539|NCT01507831|470401118|FG000|Overall Study|Adverse Event|48|||
130665540|NCT01507831|470401119|FG001|Overall Study|Adverse Event|113|||
130665541|NCT01507831|470401118|FG000|Overall Study|Death|6|||
130665542|NCT01507831|470401119|FG001|Overall Study|Death|2|||
130665543|NCT01507831|470401118|FG000|Overall Study|Poor compliance to protocol|38|||
130665544|NCT01507831|470401119|FG001|Overall Study|Poor compliance to protocol|60|||
130665545|NCT01507831|470401118|FG000|Overall Study|Physician Decision|0|||
130665546|NCT01507831|470401119|FG001|Overall Study|Physician Decision|4|||
130665547|NCT01507831|470401118|FG000|Overall Study|Participant moved|5|||
130665548|NCT01507831|470401119|FG001|Overall Study|Participant moved|19|||
130665549|NCT01507831|470401118|FG000|Overall Study|Consent withdrawn by participant|34|||
130665550|NCT01507831|470401119|FG001|Overall Study|Consent withdrawn by participant|72|||
130665551|NCT01507831|470401118|FG000|Overall Study|Related to study drug administration|5|||
130665552|NCT01507831|470401119|FG001|Overall Study|Related to study drug administration|14|||
130665553|NCT01507831|470401118|FG000|Overall Study|Last visit outside protocol visit window|51|||
130665554|NCT01507831|470401119|FG001|Overall Study|Last visit outside protocol visit window|143|||
130665555|NCT01507831|470401118|FG000|Overall Study|Selection criteria finally not met|0|||
130665556|NCT01507831|470401119|FG001|Overall Study|Selection criteria finally not met|1|||
130665557|NCT01507831|470401118|FG000|Overall Study|Site closure|0|||
130665558|NCT01507831|470401119|FG001|Overall Study|Site closure|3|||
130665559|NCT01507831|470401118|FG000|Overall Study|Potential lost to follow-up|3|||
130665560|NCT01507831|470401119|FG001|Overall Study|Potential lost to follow-up|0|||
130665561|NCT01507831|470401118|FG000|Overall Study|Other|3|||
130665562|NCT01507831|470401119|FG001|Overall Study|Other|6|||
130665563|NCT03296553|470401121|FG000|Overall Study|Withdrawal by Subject|1|||
130665564|NCT03296553|470401122|FG001|Overall Study|Withdrawal by Subject|1|||
130665565|NCT03296553|470401121|FG000|Overall Study|Death|1|||
130665566|NCT03296553|470401122|FG001|Overall Study|Death|0|||
130665567|NCT02295280|470401123|FG000|Overall Study|Adverse Event|0|||
130665568|NCT02295280|470401124|FG001|Overall Study|Adverse Event|1|||
130665569|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
130665570|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
130665571|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
130665572|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
130665573|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
130665574|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
130665575|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
130665576|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
130665577|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
130665578|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
130665579|NCT00124449|470401125|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
130665580|NCT00124449|470401126|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
130665581|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
130665582|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
130665583|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
130665584|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
130665585|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
130665586|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
130665587|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
130665588|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
130665589|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
130665590|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
130665591|NCT00124449|470401125|FG000|18-Month Untreated Observation Period|Relocated|1|||
130665592|NCT00124449|470401126|FG001|18-Month Untreated Observation Period|Relocated|0|||
130665593|NCT02971605|470401127|FG000|Overall Study|Withdrawal by Subject|1|||
130665594|NCT01021137|470401128|FG000|Overall Study|Lost to Follow-up|9|||
130665595|NCT01021137|470401129|FG001|Overall Study|Lost to Follow-up|4|||
130665596|NCT01021137|470401130|FG002|Overall Study|Lost to Follow-up|2|||
130665597|NCT01021137|470401131|FG003|Overall Study|Lost to Follow-up|6|||
130665598|NCT01021137|470401128|FG000|Overall Study|Withdrawal by Subject|1|||
130665599|NCT01021137|470401129|FG001|Overall Study|Withdrawal by Subject|0|||
130665600|NCT01021137|470401130|FG002|Overall Study|Withdrawal by Subject|0|||
130665601|NCT01021137|470401131|FG003|Overall Study|Withdrawal by Subject|3|||
130665602|NCT03439293|470401132|FG000|Overall Study|Death|22|||
130665603|NCT03439293|470401132|FG000|Overall Study|Withdrawal by Subject|8|||
130665604|NCT03439293|470401132|FG000|Overall Study|Lost to Follow-up|2|||
130665605|NCT03439293|470401132|FG000|Overall Study|Reason Not Specified|28|||
130665606|NCT03439293|470401132|FG000|Overall Study|Missing|1|||
130665607|NCT02766400|470401137|FG000|Overall Study|Death|1|||
130665608|NCT02766400|470401138|FG001|Overall Study|Death|2|||
130665609|NCT02766400|470401137|FG000|Overall Study|Withdrawal by Subject|1|||
130665610|NCT02766400|470401138|FG001|Overall Study|Withdrawal by Subject|0|||
130665611|NCT03499249|470401145|FG000|Overall Study|Physician Decision|1|||
130665612|NCT01374906|470401148|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130665613|NCT01374906|470401149|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130665614|NCT01374906|470401148|FG000|Overall Study|Administrative problems|2|||
130665615|NCT01374906|470401149|FG001|Overall Study|Administrative problems|2|||
130665616|NCT01374906|470401148|FG000|Overall Study|Adverse Event|10|||
130665617|NCT01374906|470401149|FG001|Overall Study|Adverse Event|11|||
130665618|NCT01374906|470401148|FG000|Overall Study|Death|0|||
130665619|NCT01374906|470401149|FG001|Overall Study|Death|2|||
130665620|NCT01374906|470401148|FG000|Overall Study|Protocol Violation|2|||
130665621|NCT01374906|470401149|FG001|Overall Study|Protocol Violation|2|||
130665622|NCT01374906|470401148|FG000|Overall Study|Withdrawal by Subject|15|||
130665623|NCT01374906|470401149|FG001|Overall Study|Withdrawal by Subject|9|||
130665624|NCT01374906|470401148|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
130665625|NCT01374906|470401149|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
130665626|NCT02475980|470401150|FG000|Overall Study|Lost to Follow-up|4|||
130665627|NCT02475980|470401150|FG000|Overall Study|Withdrawal by Subject|1|||
130665628|NCT00789828|470401151|FG000|Core Period (48 Weeks)|Administrative problems|0|||
130665629|NCT00789828|470401152|FG001|Core Period (48 Weeks)|Administrative problems|1|||
130665630|NCT00789828|470401151|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
130665631|NCT00789828|470401152|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
130665632|NCT00789828|470401151|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
130665633|NCT00789828|470401152|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
130665634|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
130665635|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
130665636|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
130665637|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
130665638|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
130665639|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
130665640|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
130665641|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
130665642|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Death|1|||
130665643|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Death|0|||
130665644|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
130665645|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
130665646|NCT00789828|470401151|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
130665647|NCT00789828|470401152|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
130665648|NCT05788237|470401153|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130665649|NCT05788237|470401154|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
130665650|NCT05788237|470401155|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130665651|NCT05788237|470401156|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130665652|NCT05788237|470401153|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130665653|NCT05788237|470401154|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
130665654|NCT05788237|470401155|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130665655|NCT05788237|470401156|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130665656|NCT05788237|470401153|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
130665657|NCT05788237|470401154|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
130665658|NCT05788237|470401155|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
130665659|NCT05788237|470401156|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
130665660|NCT05788237|470401153|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
130665661|NCT05788237|470401154|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
130665662|NCT05788237|470401155|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
130665663|NCT05788237|470401156|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
130665664|NCT05788237|470401153|FG000|SSA (Approximately 2 Months)|Death|0|||
130665665|NCT05788237|470401154|FG001|SSA (Approximately 2 Months)|Death|1|||
130665666|NCT05788237|470401155|FG002|SSA (Approximately 2 Months)|Death|0|||
130665667|NCT05788237|470401156|FG003|SSA (Approximately 2 Months)|Death|0|||
130665668|NCT05788237|470401153|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130665669|NCT05788237|470401154|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130665670|NCT05788237|470401155|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
130665671|NCT05788237|470401156|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130665672|NCT05788237|470401153|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130665673|NCT05788237|470401154|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130665674|NCT05788237|470401155|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130665675|NCT05788237|470401156|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
130665676|NCT05788237|470401153|FG000|SSB (Approximately 1 Month)|Other|0|||
130665677|NCT05788237|470401154|FG001|SSB (Approximately 1 Month)|Other|0|||
130665678|NCT05788237|470401155|FG002|SSB (Approximately 1 Month)|Other|0|||
130665679|NCT05788237|470401156|FG003|SSB (Approximately 1 Month)|Other|1|||
130665680|NCT02842086|470401157|FG000|Overall Study|Randomized but Never Treated|6|||
130665681|NCT02842086|470401158|FG001|Overall Study|Randomized but Never Treated|6|||
130665682|NCT02842086|470401157|FG000|Overall Study|Still in Double-Blind Phase|7|||
130665683|NCT02842086|470401158|FG001|Overall Study|Still in Double-Blind Phase|3|||
130665684|NCT02842086|470401157|FG000|Overall Study|Adverse Event|18|||
130665685|NCT02842086|470401158|FG001|Overall Study|Adverse Event|20|||
130665686|NCT02842086|470401157|FG000|Overall Study|Death|3|||
130665687|NCT02842086|470401158|FG001|Overall Study|Death|3|||
130665688|NCT02842086|470401157|FG000|Overall Study|Investigator's Discretion|9|||
130665689|NCT02842086|470401158|FG001|Overall Study|Investigator's Discretion|13|||
130665690|NCT02842086|470401157|FG000|Overall Study|Non-Compliance with Study Drug|9|||
130665691|NCT02842086|470401158|FG001|Overall Study|Non-Compliance with Study Drug|8|||
130665692|NCT02842086|470401157|FG000|Overall Study|Protocol Violation|8|||
130665693|NCT02842086|470401158|FG001|Overall Study|Protocol Violation|4|||
130665694|NCT02842086|470401157|FG000|Overall Study|Withdrew Consent|205|||
130665695|NCT02842086|470401158|FG001|Overall Study|Withdrew Consent|194|||
130665696|NCT02842086|470401157|FG000|Overall Study|Lost to Follow-up|274|||
130334905|NCT03904693|469195600|FG000|Overall Study|Physician Decision|0|||
130334906|NCT03904693|469195601|FG001|Overall Study|Physician Decision|0|||
130665697|NCT02842086|470401158|FG001|Overall Study|Lost to Follow-up|236|||
130665698|NCT02842086|470401157|FG000|Overall Study|HIV-1 Infection|5|||
130665699|NCT02842086|470401158|FG001|Overall Study|HIV-1 Infection|6|||
130665700|NCT03751124|470401159|FG000|Overall Study|Adverse Event|4|||
130665701|NCT03751124|470401160|FG001|Overall Study|Adverse Event|3|||
130665702|NCT03751124|470401159|FG000|Overall Study|Protocol Deviation|0|||
130665703|NCT03751124|470401160|FG001|Overall Study|Protocol Deviation|1|||
130665704|NCT03751124|470401159|FG000|Overall Study|Lost to Follow-up|6|||
130665705|NCT03751124|470401160|FG001|Overall Study|Lost to Follow-up|4|||
130665706|NCT03751124|470401159|FG000|Overall Study|Withdrawal by Subject|6|||
130665707|NCT03751124|470401160|FG001|Overall Study|Withdrawal by Subject|8|||
130665708|NCT03751124|470401159|FG000|Overall Study|Lack of Efficacy|1|||
130665709|NCT03751124|470401160|FG001|Overall Study|Lack of Efficacy|1|||
130665710|NCT03751124|470401159|FG000|Overall Study|Pregnancy|0|||
130665711|NCT03751124|470401160|FG001|Overall Study|Pregnancy|1|||
130665712|NCT03751124|470401159|FG000|Overall Study|Other|9|||
130665713|NCT03751124|470401160|FG001|Overall Study|Other|9|||
130665714|NCT03751124|470401159|FG000|Overall Study|Participants who did not receive any study drug|0|||
130665715|NCT03751124|470401160|FG001|Overall Study|Participants who did not receive any study drug|1|||
130665716|NCT00555399|470401163|FG000|Overall Study|Withdrawal by Subject|0|||
130665717|NCT00555399|470401164|FG001|Overall Study|Withdrawal by Subject|0|||
130665718|NCT00555399|470401165|FG002|Overall Study|Withdrawal by Subject|1|||
130665719|NCT00555399|470401166|FG003|Overall Study|Withdrawal by Subject|0|||
130665720|NCT00555399|470401167|FG004|Overall Study|Withdrawal by Subject|0|||
130665721|NCT00555399|470401168|FG005|Overall Study|Withdrawal by Subject|0|||
130665722|NCT00555399|470401169|FG006|Overall Study|Withdrawal by Subject|0|||
130665723|NCT00555399|470401170|FG007|Overall Study|Withdrawal by Subject|0|||
130665724|NCT00555399|470401171|FG008|Overall Study|Withdrawal by Subject|0|||
130665725|NCT00555399|470401172|FG009|Overall Study|Withdrawal by Subject|0|||
130665726|NCT00555399|470401173|FG010|Overall Study|Withdrawal by Subject|0|||
130665727|NCT00555399|470401174|FG011|Overall Study|Withdrawal by Subject|1|||
130665728|NCT00555399|470401163|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
130665729|NCT00555399|470401164|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
130665730|NCT00555399|470401165|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
130665731|NCT00555399|470401166|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
130665732|NCT00555399|470401167|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
130665733|NCT00555399|470401168|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
130665734|NCT00555399|470401169|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
130665735|NCT00555399|470401170|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
130665736|NCT00555399|470401171|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
130665737|NCT00555399|470401172|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
130665738|NCT00555399|470401173|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
130665739|NCT00555399|470401174|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
130665740|NCT00534092|470402854|FG000|Overall Study|Lost to Follow-up|1|||
130665741|NCT00534092|470402855|FG001|Overall Study|Lost to Follow-up|0|||
130665742|NCT00534092|470402854|FG000|Overall Study|personal reasons/family concerns|1|||
130665743|NCT00534092|470402855|FG001|Overall Study|personal reasons/family concerns|0|||
130665744|NCT02323295|470402862|FG000|Overall Study|Adverse Event|0|||
130665745|NCT02323295|470402863|FG001|Overall Study|Adverse Event|1|||
130665746|NCT02323295|470402862|FG000|Overall Study|Withdrawal by Subject|0|||
130665747|NCT02323295|470402863|FG001|Overall Study|Withdrawal by Subject|1|||
130665748|NCT02323295|470402862|FG000|Overall Study|Patient did not have surgery as planned.|0|||
130665749|NCT02323295|470402863|FG001|Overall Study|Patient did not have surgery as planned.|1|||
130665750|NCT00830063|470402864|FG000|Overall Study|Adverse Event|7|||
130665751|NCT00830063|470402865|FG001|Overall Study|Adverse Event|13|||
130665752|NCT00830063|470402866|FG002|Overall Study|Adverse Event|16|||
130665753|NCT00830063|470402867|FG003|Overall Study|Adverse Event|13|||
130665754|NCT00830063|470402864|FG000|Overall Study|Death|1|||
130665755|NCT00830063|470402865|FG001|Overall Study|Death|0|||
130665756|NCT00830063|470402866|FG002|Overall Study|Death|0|||
130665757|NCT00830063|470402867|FG003|Overall Study|Death|0|||
130665758|NCT00830063|470402864|FG000|Overall Study|Lost to Follow-up|0|||
130665759|NCT00830063|470402865|FG001|Overall Study|Lost to Follow-up|0|||
130665760|NCT00830063|470402866|FG002|Overall Study|Lost to Follow-up|3|||
130665761|NCT00830063|470402867|FG003|Overall Study|Lost to Follow-up|1|||
130665762|NCT00830063|470402864|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
130665763|NCT00830063|470402865|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
130665764|NCT00830063|470402866|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
130665765|NCT00830063|470402867|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
130665766|NCT00830063|470402864|FG000|Overall Study|Lack of Efficacy|51|||
130665767|NCT00830063|470402865|FG001|Overall Study|Lack of Efficacy|23|||
130665768|NCT00830063|470402866|FG002|Overall Study|Lack of Efficacy|25|||
130665769|NCT00830063|470402867|FG003|Overall Study|Lack of Efficacy|32|||
130665770|NCT00830063|470402864|FG000|Overall Study|Other|5|||
130665771|NCT00830063|470402865|FG001|Overall Study|Other|5|||
130665772|NCT00830063|470402866|FG002|Overall Study|Other|8|||
130665773|NCT00830063|470402867|FG003|Overall Study|Other|6|||
130665774|NCT00830063|470402864|FG000|Overall Study|Withdrawal by Subject|16|||
130665775|NCT00830063|470402865|FG001|Overall Study|Withdrawal by Subject|10|||
130665776|NCT00830063|470402866|FG002|Overall Study|Withdrawal by Subject|16|||
130665777|NCT00830063|470402867|FG003|Overall Study|Withdrawal by Subject|13|||
130665778|NCT00830063|470402864|FG000|Overall Study|Protocol Violation|1|||
130665779|NCT00830063|470402865|FG001|Overall Study|Protocol Violation|0|||
130665780|NCT00830063|470402866|FG002|Overall Study|Protocol Violation|3|||
130665781|NCT00830063|470402867|FG003|Overall Study|Protocol Violation|2|||
130665782|NCT00830063|470402864|FG000|Overall Study|Randomized But Not Treated|0|||
130665783|NCT00830063|470402865|FG001|Overall Study|Randomized But Not Treated|2|||
130665784|NCT00830063|470402866|FG002|Overall Study|Randomized But Not Treated|0|||
130665785|NCT00830063|470402867|FG003|Overall Study|Randomized But Not Treated|2|||
130665786|NCT00775983|470402868|FG000|Overall Study|Protocol Violation|1|||
130665787|NCT00775983|470402869|FG001|Overall Study|Protocol Violation|2|||
130665788|NCT01155063|470402870|FG000|Overall Study|Adverse Event|1|||
130665789|NCT01155063|470402870|FG000|Overall Study|Withdrawal by Subject|1|||
130665790|NCT01155063|470402870|FG000|Overall Study|Study terminated by sponsor|87|||
130665791|NCT01314703|470402871|FG000|Overall Study|screen failure and closed enrollment|8|||
130665792|NCT00881959|470402874|FG000|Overall Study|Lost to Follow-up|2|||
130665793|NCT00881959|470402875|FG001|Overall Study|Lost to Follow-up|4|||
130665794|NCT01427920|470402883|FG000|Overall Study|Adverse Event|1|||
130665795|NCT01427920|470402884|FG001|Overall Study|Adverse Event|2|||
130665796|NCT01427920|470402883|FG000|Overall Study|Lack of Efficacy|1|||
130665797|NCT01427920|470402884|FG001|Overall Study|Lack of Efficacy|0|||
130665798|NCT01427920|470402883|FG000|Overall Study|Protocol Violation|1|||
130665799|NCT01427920|470402884|FG001|Overall Study|Protocol Violation|3|||
130665800|NCT01427920|470402883|FG000|Overall Study|Withdrawal Criteria|4|||
130665801|NCT01427920|470402884|FG001|Overall Study|Withdrawal Criteria|4|||
130665802|NCT01427920|470402883|FG000|Overall Study|Unclassified|2|||
130665803|NCT01427920|470402884|FG001|Overall Study|Unclassified|8|||
130665804|NCT04228302|470402885|FG000|Overall Study|Adverse Event|0|||
130665805|NCT04228302|470402886|FG001|Overall Study|Adverse Event|0|||
130665806|NCT04228302|470402887|FG002|Overall Study|Adverse Event|0|||
130665807|NCT04228302|470402888|FG003|Overall Study|Adverse Event|0|||
130665808|NCT04228302|470402889|FG004|Overall Study|Adverse Event|1|||
130665809|NCT04228302|470402890|FG005|Overall Study|Adverse Event|0|||
130665810|NCT00751998|470402906|FG000|Overall Study|Lost to Follow-up|7|||
130665811|NCT00751998|470402906|FG000|Overall Study|Death|11|||
130665812|NCT00751998|470402906|FG000|Overall Study|Withdrawal by Subject|2|||
130665813|NCT03216954|470402907|FG000|Overall Study|Adverse Event|0|||
130665814|NCT03216954|470402908|FG001|Overall Study|Adverse Event|0|||
130665815|NCT03216954|470402909|FG002|Overall Study|Adverse Event|1|||
130665816|NCT03216954|470402910|FG003|Overall Study|Adverse Event|0|||
130665817|NCT03216954|470402911|FG004|Overall Study|Adverse Event|1|||
130665818|NCT03216954|470402907|FG000|Overall Study|Withdrawal by Subject|2|||
130665819|NCT03216954|470402908|FG001|Overall Study|Withdrawal by Subject|0|||
130665820|NCT03216954|470402909|FG002|Overall Study|Withdrawal by Subject|0|||
130665821|NCT03216954|470402910|FG003|Overall Study|Withdrawal by Subject|0|||
130665822|NCT03216954|470402911|FG004|Overall Study|Withdrawal by Subject|0|||
130665823|NCT03216954|470402907|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130665824|NCT03216954|470402908|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
130665825|NCT03216954|470402909|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130665826|NCT03216954|470402910|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130665827|NCT03216954|470402911|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130665828|NCT01965535|470402912|FG000|Overall Study|Lack of Efficacy|2|||
130665829|NCT01965535|470402913|FG001|Overall Study|Lack of Efficacy|1|||
130665830|NCT02983227|470402914|FG000|Overall Study|Adverse Event|21|||
130665831|NCT02983227|470402915|FG001|Overall Study|Adverse Event|3|||
130665832|NCT02983227|470402914|FG000|Overall Study|Death|3|||
130665833|NCT02983227|470402915|FG001|Overall Study|Death|0|||
130665834|NCT02983227|470402914|FG000|Overall Study|Lack of Efficacy|8|||
130665835|NCT02983227|470402915|FG001|Overall Study|Lack of Efficacy|1|||
130665836|NCT02983227|470402914|FG000|Overall Study|Lost to Follow-up|3|||
130665837|NCT02983227|470402915|FG001|Overall Study|Lost to Follow-up|0|||
130665838|NCT02983227|470402914|FG000|Overall Study|Multiple Reasons|2|||
130665839|NCT02983227|470402915|FG001|Overall Study|Multiple Reasons|1|||
130665840|NCT02983227|470402914|FG000|Overall Study|Physician Decision|3|||
130665841|NCT02983227|470402915|FG001|Overall Study|Physician Decision|1|||
130665842|NCT02983227|470402914|FG000|Overall Study|Withdrawal by Subject|19|||
130665843|NCT02983227|470402915|FG001|Overall Study|Withdrawal by Subject|8|||
130552645|NCT01696942|469990254|FG000|Overall Study|screen failure|0|||
130665844|NCT01946282|470402920|FG000|Year 1|Did not return FIT kit|4186|||
130665845|NCT01946282|470402921|FG001|Year 1|Did not return FIT kit|608|||
130665846|NCT01946282|470402922|FG002|Year 1|Did not return FIT kit|654|||
130665847|NCT01946282|470402920|FG000|Year 2|Did not return FIT kit|803|||
130665848|NCT01946282|470402921|FG001|Year 2|Did not return FIT kit|131|||
130665849|NCT01946282|470402922|FG002|Year 2|Did not return FIT kit|115|||
130552646|NCT01696942|469990255|FG001|Overall Study|screen failure|1|||
130665850|NCT01946282|470402920|FG000|Year 3|Did not return FIT kit|288|||
130665851|NCT01946282|470402921|FG001|Year 3|Did not return FIT kit|43|||
130665852|NCT01946282|470402922|FG002|Year 3|Did not return FIT kit|30|||
130665853|NCT01493531|470402923|FG000|Overall Study|Adverse Event|4|||
130665854|NCT01493531|470402924|FG001|Overall Study|Adverse Event|12|||
130665855|NCT01493531|470402925|FG002|Overall Study|Adverse Event|9|||
130665856|NCT01493531|470402923|FG000|Overall Study|Gout flare|3|||
130665857|NCT01493531|470402924|FG001|Overall Study|Gout flare|0|||
130665858|NCT01493531|470402925|FG002|Overall Study|Gout flare|2|||
130665859|NCT01493531|470402923|FG000|Overall Study|Protocol Violation|8|||
130665860|NCT01493531|470402924|FG001|Overall Study|Protocol Violation|15|||
130665861|NCT01493531|470402925|FG002|Overall Study|Protocol Violation|12|||
130665862|NCT01493531|470402923|FG000|Overall Study|Sponsor terminated study|5|||
130665863|NCT01493531|470402924|FG001|Overall Study|Sponsor terminated study|2|||
130665864|NCT01493531|470402925|FG002|Overall Study|Sponsor terminated study|3|||
130665865|NCT01493531|470402923|FG000|Overall Study|Lost to Follow-up|5|||
130665866|NCT01493531|470402924|FG001|Overall Study|Lost to Follow-up|7|||
130665867|NCT01493531|470402925|FG002|Overall Study|Lost to Follow-up|11|||
130665868|NCT01493531|470402923|FG000|Overall Study|Withdrawal by Subject|16|||
130665869|NCT01493531|470402924|FG001|Overall Study|Withdrawal by Subject|13|||
130665870|NCT01493531|470402925|FG002|Overall Study|Withdrawal by Subject|11|||
130665871|NCT01493531|470402923|FG000|Overall Study|Death|0|||
130665872|NCT01493531|470402924|FG001|Overall Study|Death|1|||
130665873|NCT01493531|470402925|FG002|Overall Study|Death|0|||
130665874|NCT01027884|470402931|FG000|Overall Study|Adverse Event|2|||
130665875|NCT01027884|470402932|FG001|Overall Study|Adverse Event|1|||
130665876|NCT01027884|470402931|FG000|Overall Study|Protocol Violation|1|||
130665877|NCT01027884|470402932|FG001|Overall Study|Protocol Violation|0|||
130665878|NCT01027884|470402931|FG000|Overall Study|Non-compliance|1|||
130665879|NCT01027884|470402932|FG001|Overall Study|Non-compliance|1|||
130665880|NCT01027884|470402931|FG000|Overall Study|Withdrawal by Subject|0|||
130665881|NCT01027884|470402932|FG001|Overall Study|Withdrawal by Subject|1|||
130665882|NCT01027884|470402931|FG000|Overall Study|Lost to Follow-up|0|||
130665883|NCT01027884|470402932|FG001|Overall Study|Lost to Follow-up|1|||
130665884|NCT01027884|470402931|FG000|Overall Study|Spinal fixation surgery|0|||
130665885|NCT01027884|470402932|FG001|Overall Study|Spinal fixation surgery|3|||
130665886|NCT03670537|470402934|FG000|Overall Study|Protocol Violation|1|||
130665887|NCT02059187|470402935|FG000|Overall Study|Adverse Event|0|||
130665888|NCT02059187|470402936|FG001|Overall Study|Adverse Event|3|||
130665889|NCT02059187|470402935|FG000|Overall Study|Death|1|||
130665890|NCT02059187|470402936|FG001|Overall Study|Death|1|||
130665891|NCT02059187|470402935|FG000|Overall Study|Lost to Follow-up|9|||
130665892|NCT02059187|470402936|FG001|Overall Study|Lost to Follow-up|8|||
130665893|NCT02059187|470402935|FG000|Overall Study|Non-compliance with study drug|1|||
130665894|NCT02059187|470402936|FG001|Overall Study|Non-compliance with study drug|0|||
130665895|NCT02059187|470402935|FG000|Overall Study|Physician Decision|1|||
130665896|NCT02059187|470402936|FG001|Overall Study|Physician Decision|2|||
130665897|NCT02059187|470402935|FG000|Overall Study|Protocol Violation|1|||
130665898|NCT02059187|470402936|FG001|Overall Study|Protocol Violation|0|||
130665899|NCT02059187|470402935|FG000|Overall Study|Withdrawal by Subject|12|||
130665900|NCT02059187|470402936|FG001|Overall Study|Withdrawal by Subject|8|||
130665901|NCT03070431|470402937|FG000|Overall Study|Withdrawal by Subject|2|||
130665902|NCT03070431|470402937|FG000|Overall Study|Lost to Follow-up|2|||
130665903|NCT01889862|470402938|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
130665904|NCT01889862|470402939|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130665905|NCT01889862|470402940|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130665906|NCT01889862|470402941|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130334907|NCT03904693|469195602|FG002|Overall Study|Physician Decision|2|||
130334908|NCT03904693|469195600|FG000|Overall Study|Withdrawal by Subject|0|||
130334909|NCT03904693|469195601|FG001|Overall Study|Withdrawal by Subject|1|||
130334910|NCT03904693|469195602|FG002|Overall Study|Withdrawal by Subject|4|||
130334911|NCT02100696|469195603|FG000|Induction Phase|Adverse Event|0|||
130334912|NCT02100696|469195604|FG001|Induction Phase|Adverse Event|0|||
130334913|NCT02100696|469195605|FG002|Induction Phase|Adverse Event|1|||
130334914|NCT02100696|469195606|FG003|Induction Phase|Adverse Event|0|||
130334915|NCT02100696|469195607|FG004|Induction Phase|Adverse Event|0|||
130334916|NCT02100696|469195608|FG005|Induction Phase|Adverse Event|0|||
130665907|NCT01889862|470402942|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130665908|NCT01889862|470402938|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
130665909|NCT01889862|470402939|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130665910|NCT01889862|470402940|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130665911|NCT01889862|470402941|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130665912|NCT01889862|470402942|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130665913|NCT01889862|470402938|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
130665914|NCT01889862|470402939|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130665915|NCT01889862|470402940|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130665916|NCT01889862|470402941|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130665917|NCT01889862|470402942|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130334917|NCT02100696|469195603|FG000|Induction Phase|Lost to Follow-up|1|||
130665918|NCT01889862|470402938|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
130665919|NCT01889862|470402939|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130665920|NCT01889862|470402940|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130665921|NCT01889862|470402941|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130665922|NCT01889862|470402942|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130665923|NCT01889862|470402938|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130665924|NCT01889862|470402939|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130665925|NCT01889862|470402940|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
130665926|NCT01889862|470402941|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130665927|NCT01889862|470402942|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130665928|NCT01889862|470402938|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130665929|NCT01889862|470402939|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130665930|NCT01889862|470402940|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130665931|NCT01889862|470402941|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130665932|NCT01889862|470402942|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
130665933|NCT01889862|470402938|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130665934|NCT01889862|470402939|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130665935|NCT01889862|470402940|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130665936|NCT01889862|470402941|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130665937|NCT01889862|470402942|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
130665938|NCT01889862|470402938|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130665939|NCT01889862|470402939|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130665940|NCT01889862|470402940|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130665941|NCT01889862|470402941|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130665942|NCT01889862|470402942|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
130665943|NCT01889862|470402938|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130665944|NCT01889862|470402939|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130665945|NCT01889862|470402940|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130665946|NCT01889862|470402941|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130665947|NCT01889862|470402942|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
130665948|NCT01889862|470402938|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130665949|NCT01889862|470402939|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130665950|NCT01889862|470402940|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130665951|NCT01889862|470402941|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130665952|NCT01889862|470402942|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
130665953|NCT00845026|470402943|FG000|Study Period III|Adverse Event|23|||
130665954|NCT00845026|470402944|FG001|Study Period III|Adverse Event|19|||
130665955|NCT00845026|470402943|FG000|Study Period III|Perceived lack of efficacy|27|||
130665956|NCT00845026|470402944|FG001|Study Period III|Perceived lack of efficacy|15|||
130665957|NCT00845026|470402943|FG000|Study Period III|Withdrawal by Subject|19|||
130665958|NCT00845026|470402944|FG001|Study Period III|Withdrawal by Subject|15|||
130665959|NCT00845026|470402943|FG000|Study Period III|Entry Criteria not met|8|||
130665960|NCT00845026|470402944|FG001|Study Period III|Entry Criteria not met|11|||
130665961|NCT00845026|470402943|FG000|Study Period III|Lost to Follow-up|4|||
130665962|NCT00845026|470402944|FG001|Study Period III|Lost to Follow-up|5|||
130665963|NCT00845026|470402943|FG000|Study Period III|Protocol Violation|8|||
130665964|NCT00845026|470402944|FG001|Study Period III|Protocol Violation|1|||
130665965|NCT00845026|470402943|FG000|Study Period III|Scheduled conflict|3|||
130665966|NCT00845026|470402944|FG001|Study Period III|Scheduled conflict|1|||
130665967|NCT00845026|470402943|FG000|Study Period III|Subject is moving or has moved|2|||
130665968|NCT00845026|470402944|FG001|Study Period III|Subject is moving or has moved|4|||
130665969|NCT00845026|470402943|FG000|Study Period III|Transportation issues|1|||
130665970|NCT00845026|470402944|FG001|Study Period III|Transportation issues|1|||
130665971|NCT00845026|470402943|FG000|Study Period IV|Adverse Event|4|||
130665972|NCT00845026|470402944|FG001|Study Period IV|Adverse Event|0|||
130665973|NCT00845026|470402943|FG000|Study Period IV|Perceived lack of efficacy|2|||
130665974|NCT00845026|470402944|FG001|Study Period IV|Perceived lack of efficacy|1|||
130665975|NCT00845026|470402943|FG000|Study Period IV|Protocol Violation|3|||
130665976|NCT00845026|470402944|FG001|Study Period IV|Protocol Violation|1|||
130665977|NCT00845026|470402943|FG000|Study Period IV|Lost to Follow-up|1|||
130665978|NCT00845026|470402944|FG001|Study Period IV|Lost to Follow-up|0|||
130665979|NCT00845026|470402943|FG000|Study Period IV|Withdrawal by Subject|4|||
130665980|NCT00845026|470402944|FG001|Study Period IV|Withdrawal by Subject|1|||
130334918|NCT02100696|469195604|FG001|Induction Phase|Lost to Follow-up|0|||
130334919|NCT02100696|469195605|FG002|Induction Phase|Lost to Follow-up|1|||
130334920|NCT02100696|469195606|FG003|Induction Phase|Lost to Follow-up|0|||
130334921|NCT02100696|469195607|FG004|Induction Phase|Lost to Follow-up|0|||
130665981|NCT00845026|470402943|FG000|Study Period IV|Entry Criteria Not Met|1|||
130665982|NCT00845026|470402944|FG001|Study Period IV|Entry Criteria Not Met|0|||
130665983|NCT00845026|470402943|FG000|Study Period IV|Subject is moving or has moved|0|||
130665984|NCT00845026|470402944|FG001|Study Period IV|Subject is moving or has moved|1|||
130665985|NCT00845026|470402943|FG000|Study Period IV|Scheduling conflict|1|||
130665986|NCT00845026|470402944|FG001|Study Period IV|Scheduling conflict|0|||
130334922|NCT02100696|469195608|FG005|Induction Phase|Lost to Follow-up|0|||
130552647|NCT01598311|469990260|FG000|Overall Study|Physician Decision|4|||
130665987|NCT01325532|470402945|FG000|Overall Study|Withdrawal by Subject|2|||
130665988|NCT01325532|470402946|FG001|Overall Study|Withdrawal by Subject|0|||
130665989|NCT03012815|470402947|FG000|Overall Study|Lost to Follow-up|1|||
130665990|NCT03012815|470402948|FG001|Overall Study|Lost to Follow-up|0|||
130665991|NCT03012815|470402947|FG000|Overall Study|Physician Decision|3|||
130665992|NCT03012815|470402948|FG001|Overall Study|Physician Decision|2|||
130665993|NCT03012815|470402947|FG000|Overall Study|Adverse Event|1|||
130665994|NCT03012815|470402948|FG001|Overall Study|Adverse Event|0|||
130665995|NCT01252238|470402949|FG000|Overall Study|Sponsor terminated study|4|||
130665996|NCT01252238|470402950|FG001|Overall Study|Sponsor terminated study|4|||
130665997|NCT01252238|470402951|FG002|Overall Study|Sponsor terminated study|4|||
130665998|NCT02065791|470402952|FG000|Overall Study|Closed Site|1|||
130665999|NCT02065791|470402953|FG001|Overall Study|Closed Site|1|||
130666000|NCT02065791|470402952|FG000|Overall Study|Withdrawal by Subject|11|||
130666001|NCT02065791|470402953|FG001|Overall Study|Withdrawal by Subject|5|||
130666002|NCT02065791|470402952|FG000|Overall Study|Lost to Follow-up|13|||
130666003|NCT02065791|470402953|FG001|Overall Study|Lost to Follow-up|9|||
130666004|NCT00272961|470402954|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
130666005|NCT00272961|470402955|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130666006|NCT00272961|470402956|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130666007|NCT00272961|470402957|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130666008|NCT00272961|470402958|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130666009|NCT00272961|470402954|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
130666010|NCT00272961|470402955|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130666011|NCT00272961|470402956|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130666012|NCT00272961|470402957|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130666013|NCT00272961|470402958|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130666014|NCT00272961|470402954|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
130666015|NCT00272961|470402955|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130666016|NCT00272961|470402956|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130666017|NCT00272961|470402957|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130666018|NCT00272961|470402958|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130666019|NCT00272961|470402954|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
130666020|NCT00272961|470402955|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130666021|NCT00272961|470402956|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130666022|NCT00272961|470402957|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130666023|NCT00272961|470402958|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130666024|NCT00272961|470402954|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
130666025|NCT00272961|470402955|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
130666026|NCT00272961|470402956|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
130666027|NCT00272961|470402957|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
130666028|NCT00272961|470402958|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
130666029|NCT00272961|470402954|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
130666030|NCT00272961|470402955|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
130666031|NCT00272961|470402956|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
130666032|NCT00272961|470402957|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
130666033|NCT00272961|470402958|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
130666034|NCT00272961|470402954|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
130666035|NCT00272961|470402955|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130666036|NCT00272961|470402956|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
130666037|NCT00272961|470402957|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130666038|NCT00272961|470402958|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130666039|NCT00272961|470402954|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
130666040|NCT00272961|470402955|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
130666041|NCT00272961|470402956|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
130666042|NCT00272961|470402957|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
130666043|NCT00272961|470402958|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
130666044|NCT01610167|470402964|FG000|Overall Study|Scheduling conflict.|0|||
130666045|NCT01610167|470402965|FG001|Overall Study|Scheduling conflict.|0|||
130666046|NCT01610167|470402966|FG002|Overall Study|Scheduling conflict.|2|||
130666047|NCT00411762|470402968|FG000|Overall Study|Withdrawal by Subject|5|||
130666048|NCT01238211|470402969|FG000|Overall Study|Continues active treatment|31|||
130666049|NCT01238211|470402969|FG000|Overall Study|Adverse Event|7|||
130666050|NCT01238211|470402969|FG000|Overall Study|Death|4|||
130666051|NCT01238211|470402969|FG000|Overall Study|Relapse/Progression|2|||
130666052|NCT01238211|470402969|FG000|Overall Study|Withdrawal by Subject|7|||
130666053|NCT01238211|470402969|FG000|Overall Study|Non-protocol treatment|4|||
130666054|NCT01238211|470402969|FG000|Overall Study|Investigator/Patient Decision|3|||
130666055|NCT04428502|470402970|FG000|Overall Study|Did not meet entrance criteria|14|||
130666056|NCT00449930|470402973|FG000|Overall Study|Adverse Event|9|||
130334923|NCT02100696|469195603|FG000|Induction Phase|Protocol Violation|0|||
130666057|NCT00449930|470402974|FG001|Overall Study|Adverse Event|19|||
130666058|NCT00449930|470402973|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
130666059|NCT00449930|470402974|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
130666060|NCT00449930|470402973|FG000|Overall Study|Lack of Efficacy|10|||
130666061|NCT00449930|470402974|FG001|Overall Study|Lack of Efficacy|1|||
130666062|NCT00449930|470402973|FG000|Overall Study|Lost to Follow-up|9|||
130666063|NCT00449930|470402974|FG001|Overall Study|Lost to Follow-up|14|||
130666064|NCT00449930|470402973|FG000|Overall Study|Physician Decision|1|||
130666065|NCT00449930|470402974|FG001|Overall Study|Physician Decision|2|||
130666066|NCT00449930|470402973|FG000|Overall Study|Protocol Violation|14|||
130666067|NCT00449930|470402974|FG001|Overall Study|Protocol Violation|15|||
130666068|NCT00449930|470402973|FG000|Overall Study|Withdrawal by Subject|16|||
130666069|NCT00449930|470402974|FG001|Overall Study|Withdrawal by Subject|23|||
130666070|NCT00449930|470402973|FG000|Overall Study|Glycemic discontinuation criteria|1|||
130334924|NCT02100696|469195604|FG001|Induction Phase|Protocol Violation|1|||
130666071|NCT00449930|470402974|FG001|Overall Study|Glycemic discontinuation criteria|1|||
130666072|NCT01864525|470402975|FG000|Overall Study|Adverse Event|1|||
130666073|NCT01864525|470402976|FG001|Overall Study|Adverse Event|0|||
130666074|NCT01890785|470402977|FG000|Third Intervention|Withdrawal by Subject|0|||
130666075|NCT01890785|470402978|FG001|Third Intervention|Withdrawal by Subject|1|||
130666076|NCT01890785|470402979|FG002|Third Intervention|Withdrawal by Subject|0|||
130334925|NCT02100696|469195605|FG002|Induction Phase|Protocol Violation|1|||
130334926|NCT02100696|469195606|FG003|Induction Phase|Protocol Violation|0|||
130334927|NCT02100696|469195607|FG004|Induction Phase|Protocol Violation|0|||
130334928|NCT02100696|469195608|FG005|Induction Phase|Protocol Violation|0|||
130334929|NCT02100696|469195603|FG000|Induction Phase|Withdrawal by Subject|8|||
130334930|NCT02100696|469195604|FG001|Induction Phase|Withdrawal by Subject|2|||
130334931|NCT02100696|469195605|FG002|Induction Phase|Withdrawal by Subject|13|||
130334932|NCT02100696|469195606|FG003|Induction Phase|Withdrawal by Subject|0|||
130334933|NCT02100696|469195607|FG004|Induction Phase|Withdrawal by Subject|0|||
130334934|NCT02100696|469195608|FG005|Induction Phase|Withdrawal by Subject|0|||
130334935|NCT02100696|469195603|FG000|Induction Phase|Physician Decision|1|||
130334936|NCT02100696|469195604|FG001|Induction Phase|Physician Decision|0|||
130334937|NCT02100696|469195605|FG002|Induction Phase|Physician Decision|2|||
130334938|NCT02100696|469195606|FG003|Induction Phase|Physician Decision|0|||
130334939|NCT02100696|469195607|FG004|Induction Phase|Physician Decision|0|||
130334940|NCT02100696|469195608|FG005|Induction Phase|Physician Decision|0|||
130334941|NCT02100696|469195603|FG000|Induction Phase|Multiple Reasons|5|||
130334942|NCT02100696|469195604|FG001|Induction Phase|Multiple Reasons|2|||
130334943|NCT02100696|469195605|FG002|Induction Phase|Multiple Reasons|8|||
130334944|NCT02100696|469195606|FG003|Induction Phase|Multiple Reasons|0|||
130334945|NCT02100696|469195607|FG004|Induction Phase|Multiple Reasons|0|||
130334946|NCT02100696|469195608|FG005|Induction Phase|Multiple Reasons|0|||
130334947|NCT02100696|469195603|FG000|Maintenance Phase|Adverse Event|0|||
130334948|NCT02100696|469195604|FG001|Maintenance Phase|Adverse Event|0|||
130334949|NCT02100696|469195605|FG002|Maintenance Phase|Adverse Event|0|||
130334950|NCT02100696|469195606|FG003|Maintenance Phase|Adverse Event|0|||
130334951|NCT02100696|469195607|FG004|Maintenance Phase|Adverse Event|0|||
130334952|NCT02100696|469195608|FG005|Maintenance Phase|Adverse Event|2|||
130334953|NCT02100696|469195603|FG000|Maintenance Phase|Lost to Follow-up|0|||
130334954|NCT02100696|469195604|FG001|Maintenance Phase|Lost to Follow-up|0|||
130334955|NCT02100696|469195605|FG002|Maintenance Phase|Lost to Follow-up|0|||
130334956|NCT02100696|469195606|FG003|Maintenance Phase|Lost to Follow-up|0|||
130334957|NCT02100696|469195607|FG004|Maintenance Phase|Lost to Follow-up|1|||
130334958|NCT02100696|469195608|FG005|Maintenance Phase|Lost to Follow-up|0|||
130334959|NCT02100696|469195603|FG000|Maintenance Phase|Protocol Violation|0|||
130334960|NCT02100696|469195604|FG001|Maintenance Phase|Protocol Violation|0|||
130334961|NCT02100696|469195605|FG002|Maintenance Phase|Protocol Violation|0|||
130334962|NCT02100696|469195606|FG003|Maintenance Phase|Protocol Violation|0|||
130334963|NCT02100696|469195607|FG004|Maintenance Phase|Protocol Violation|1|||
130334964|NCT02100696|469195608|FG005|Maintenance Phase|Protocol Violation|0|||
130334965|NCT02100696|469195603|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130334966|NCT02100696|469195604|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130334967|NCT02100696|469195605|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130334968|NCT02100696|469195606|FG003|Maintenance Phase|Withdrawal by Subject|1|||
130334969|NCT02100696|469195607|FG004|Maintenance Phase|Withdrawal by Subject|4|||
130334970|NCT02100696|469195608|FG005|Maintenance Phase|Withdrawal by Subject|2|||
130334971|NCT02100696|469195603|FG000|Maintenance Phase|Physician Decision|0|||
130334972|NCT02100696|469195604|FG001|Maintenance Phase|Physician Decision|0|||
130666077|NCT01890785|470402980|FG003|Third Intervention|Withdrawal by Subject|0|||
130334973|NCT02100696|469195605|FG002|Maintenance Phase|Physician Decision|0|||
130334974|NCT02100696|469195606|FG003|Maintenance Phase|Physician Decision|0|||
130334975|NCT02100696|469195607|FG004|Maintenance Phase|Physician Decision|1|||
130334976|NCT02100696|469195608|FG005|Maintenance Phase|Physician Decision|0|||
130666078|NCT01890785|470402981|FG004|Third Intervention|Withdrawal by Subject|0|||
130666079|NCT01890785|470402982|FG005|Third Intervention|Withdrawal by Subject|0|||
130334977|NCT02100696|469195603|FG000|Maintenance Phase|Multiple Reasons|0|||
130334978|NCT02100696|469195604|FG001|Maintenance Phase|Multiple Reasons|0|||
130334979|NCT02100696|469195605|FG002|Maintenance Phase|Multiple Reasons|0|||
130334980|NCT02100696|469195606|FG003|Maintenance Phase|Multiple Reasons|0|||
130334981|NCT02100696|469195607|FG004|Maintenance Phase|Multiple Reasons|2|||
130334982|NCT02100696|469195608|FG005|Maintenance Phase|Multiple Reasons|1|||
130334983|NCT03865381|469195611|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
130334984|NCT03865381|469195611|FG000|Overall Study|Withdrawal by Subject|2|||
130334985|NCT05626322|469195612|FG000|Overall Study|Death|2|||
130334986|NCT05626322|469195613|FG001|Overall Study|Death|0|||
130334987|NCT05626322|469195614|FG002|Overall Study|Death|0|||
130334988|NCT05626322|469195612|FG000|Overall Study|Physician Decision|1|||
130334989|NCT05626322|469195613|FG001|Overall Study|Physician Decision|0|||
130666080|NCT03712228|470402983|FG000|Treatment Period 1|Lack of Efficacy|0|||
130666081|NCT03712228|470402984|FG001|Treatment Period 1|Lack of Efficacy|0|||
130666082|NCT03712228|470402985|FG002|Treatment Period 1|Lack of Efficacy|0|||
130666083|NCT03712228|470402986|FG003|Treatment Period 1|Lack of Efficacy|0|||
130666084|NCT03712228|470402987|FG004|Treatment Period 1|Lack of Efficacy|0|||
130666085|NCT03712228|470402988|FG005|Treatment Period 1|Lack of Efficacy|1|||
130666086|NCT03712228|470402983|FG000|Treatment Period 2|Pregnancy|0|||
130666087|NCT03712228|470402984|FG001|Treatment Period 2|Pregnancy|0|||
130666088|NCT03712228|470402985|FG002|Treatment Period 2|Pregnancy|0|||
130666089|NCT03712228|470402986|FG003|Treatment Period 2|Pregnancy|1|||
130666090|NCT03712228|470402987|FG004|Treatment Period 2|Pregnancy|0|||
130666091|NCT03712228|470402988|FG005|Treatment Period 2|Pregnancy|0|||
130666092|NCT03712228|470402983|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130666093|NCT03712228|470402984|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130666094|NCT03712228|470402985|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130666095|NCT03712228|470402986|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130666096|NCT03712228|470402987|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130666097|NCT03712228|470402988|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130666098|NCT01964105|470402989|FG000|Overall Study|Lost to Follow-up|2|||
130666099|NCT01964105|470402990|FG001|Overall Study|Lost to Follow-up|13|||
130666100|NCT01964105|470402991|FG002|Overall Study|Lost to Follow-up|0|||
130666101|NCT00558519|470402992|FG000|Overall Study|Ph+|20|||
130666102|NCT00558519|470402992|FG000|Overall Study|Ineligible|1|||
130666103|NCT00558519|470402992|FG000|Overall Study|Insufficient data|1|||
130666104|NCT00558519|470402992|FG000|Overall Study|Never received treatment|1|||
130666105|NCT03001011|470402993|FG000|Overall Study|Adverse Event|9|||
130666106|NCT03001011|470402994|FG001|Overall Study|Adverse Event|3|||
130666107|NCT03001011|470402993|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
130666108|NCT03001011|470402994|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
130666109|NCT03001011|470402993|FG000|Overall Study|Other than specified above|3|||
130666110|NCT03001011|470402994|FG001|Overall Study|Other than specified above|8|||
130666111|NCT02875067|470402995|FG000|Overall Study|Withdrawal by Subject|1|||
130666112|NCT02875067|470402995|FG000|Overall Study|Withdrawal by Termination of Study|5|||
130666113|NCT00065065|470402996|FG000|Overall Study|Adverse Event|3|||
130666114|NCT00065065|470402997|FG001|Overall Study|Adverse Event|2|||
130666115|NCT00065065|470402996|FG000|Overall Study|Withdrawal by Subject|1|||
130666116|NCT00065065|470402997|FG001|Overall Study|Withdrawal by Subject|5|||
130666117|NCT00065065|470402996|FG000|Overall Study|Lack of Efficacy|4|||
130666118|NCT00065065|470402997|FG001|Overall Study|Lack of Efficacy|11|||
130666119|NCT00065065|470402996|FG000|Overall Study|Other|2|||
130666120|NCT00065065|470402997|FG001|Overall Study|Other|2|||
130666121|NCT02713243|470403001|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
130666122|NCT02713243|470403002|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
130666123|NCT02713243|470403001|FG000|Overall Study|Administrative problems|0|||
130666124|NCT02713243|470403002|FG001|Overall Study|Administrative problems|1|||
130666125|NCT02713243|470403001|FG000|Overall Study|Protocol deviation|0|||
130666126|NCT02713243|470403002|FG001|Overall Study|Protocol deviation|1|||
130334990|NCT05626322|469195614|FG002|Overall Study|Physician Decision|0|||
130334991|NCT05626322|469195612|FG000|Overall Study|Progressive Disease|0|||
130334992|NCT05626322|469195613|FG001|Overall Study|Progressive Disease|1|||
130334993|NCT05626322|469195614|FG002|Overall Study|Progressive Disease|1|||
130334994|NCT05626322|469195612|FG000|Overall Study|Study terminated by sponsor|0|||
130334995|NCT05626322|469195613|FG001|Overall Study|Study terminated by sponsor|1|||
130334996|NCT05626322|469195614|FG002|Overall Study|Study terminated by sponsor|0|||
130334997|NCT01668589|469195619|FG000|Overall Study|Lost to Follow-up|29|||
130334998|NCT01668589|469195620|FG001|Overall Study|Lost to Follow-up|37|||
130334999|NCT01668589|469195621|FG002|Overall Study|Lost to Follow-up|15|||
130666127|NCT01050673|470403003|FG000|Overall Study|Physician Decision|4|||
130666128|NCT01050673|470403004|FG001|Overall Study|Physician Decision|5|||
130666129|NCT05288673|470403005|FG000|Overall Study|Consent withdrawn by subject|0|||
130666130|NCT05288673|470403006|FG001|Overall Study|Consent withdrawn by subject|0|||
130666131|NCT05288673|470403007|FG002|Overall Study|Consent withdrawn by subject|1|||
130666132|NCT01254045|470403008|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
130666133|NCT01254045|470403009|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130666134|NCT01254045|470403010|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130666135|NCT01254045|470403011|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130666136|NCT01254045|470403012|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130666137|NCT01254045|470403013|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130666138|NCT00665626|470403016|FG000|Overall Study|Lack of Efficacy|8|||
130666139|NCT00665626|470403017|FG001|Overall Study|Lack of Efficacy|5|||
130666140|NCT00665626|470403016|FG000|Overall Study|Lost to Follow-up|0|||
130666141|NCT00665626|470403017|FG001|Overall Study|Lost to Follow-up|2|||
130666142|NCT00665626|470403016|FG000|Overall Study|Withdrawal by Subject|0|||
130666143|NCT00665626|470403017|FG001|Overall Study|Withdrawal by Subject|1|||
130666144|NCT00665626|470403016|FG000|Overall Study|Protocol Violation|0|||
130666145|NCT00665626|470403017|FG001|Overall Study|Protocol Violation|2|||
130666146|NCT00665626|470403016|FG000|Overall Study|Adverse Event|1|||
130666147|NCT00665626|470403017|FG001|Overall Study|Adverse Event|9|||
130666148|NCT00665626|470403016|FG000|Overall Study|Due to exclusion criteria|0|||
130666149|NCT00665626|470403017|FG001|Overall Study|Due to exclusion criteria|1|||
130666150|NCT00665626|470403016|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
130666151|NCT00665626|470403017|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
130666152|NCT00665626|470403016|FG000|Overall Study|Unably to comply with dosing regimen|0|||
130666153|NCT00665626|470403017|FG001|Overall Study|Unably to comply with dosing regimen|1|||
130666154|NCT00665626|470403016|FG000|Overall Study|Death|1|||
130666155|NCT00665626|470403017|FG001|Overall Study|Death|0|||
130666156|NCT04147611|470403018|FG000|Overall Study|Physician Decision|0|||
130666157|NCT04147611|470403019|FG001|Overall Study|Physician Decision|1|||
130666158|NCT00435825|470403020|FG000|Overall Study|Abnormality of Laboratory Test|0|||
130666159|NCT00435825|470403021|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130666160|NCT00435825|470403022|FG002|Overall Study|Abnormality of Laboratory Test|0|||
130666161|NCT00435825|470403023|FG003|Overall Study|Abnormality of Laboratory Test|0|||
130666162|NCT00435825|470403020|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130666163|NCT00435825|470403021|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130666164|NCT00435825|470403022|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130666165|NCT00435825|470403023|FG003|Overall Study|Insufficient Therapeutic Response|3|||
130666166|NCT00435825|470403020|FG000|Overall Study|Other Protocol Violation|1|||
130666167|NCT00435825|470403021|FG001|Overall Study|Other Protocol Violation|0|||
130666168|NCT00435825|470403022|FG002|Overall Study|Other Protocol Violation|0|||
130666169|NCT00435825|470403023|FG003|Overall Study|Other Protocol Violation|0|||
130666170|NCT00435825|470403020|FG000|Overall Study|Refused treatment|2|||
130666171|NCT00435825|470403021|FG001|Overall Study|Refused treatment|0|||
130666172|NCT00435825|470403022|FG002|Overall Study|Refused treatment|0|||
130666173|NCT00435825|470403023|FG003|Overall Study|Refused treatment|5|||
130666174|NCT00435825|470403020|FG000|Overall Study|Failure to return|5|||
130666175|NCT00435825|470403021|FG001|Overall Study|Failure to return|0|||
130666176|NCT00435825|470403022|FG002|Overall Study|Failure to return|4|||
130666177|NCT00435825|470403023|FG003|Overall Study|Failure to return|0|||
130666178|NCT00435825|470403020|FG000|Overall Study|Did not receive study drug|1|||
130666179|NCT00435825|470403021|FG001|Overall Study|Did not receive study drug|0|||
130666180|NCT00435825|470403022|FG002|Overall Study|Did not receive study drug|2|||
130666181|NCT00435825|470403023|FG003|Overall Study|Did not receive study drug|0|||
130666182|NCT00435825|470403020|FG000|Overall Study|Did not enter follow-up|0|||
130666183|NCT00435825|470403021|FG001|Overall Study|Did not enter follow-up|4|||
130666184|NCT00435825|470403022|FG002|Overall Study|Did not enter follow-up|1|||
130666185|NCT00435825|470403023|FG003|Overall Study|Did not enter follow-up|3|||
130666186|NCT00435825|470403020|FG000|Overall Study|Did not complete full follow-up period|6|||
130666187|NCT00435825|470403021|FG001|Overall Study|Did not complete full follow-up period|6|||
130666188|NCT00435825|470403022|FG002|Overall Study|Did not complete full follow-up period|4|||
130666189|NCT00435825|470403023|FG003|Overall Study|Did not complete full follow-up period|5|||
130666190|NCT00530439|470403024|FG000|Overall Study|GDM|9|||
130666191|NCT00530439|470403025|FG001|Overall Study|GDM|3|||
130666192|NCT00530439|470403024|FG000|Overall Study|Withdraw|18|||
130666193|NCT00530439|470403025|FG001|Overall Study|Withdraw|14|||
130666194|NCT00530439|470403024|FG000|Overall Study|Missed abortion|1|||
130666195|NCT00530439|470403025|FG001|Overall Study|Missed abortion|4|||
130666196|NCT00530439|470403024|FG000|Overall Study|Misclassification|2|||
130666197|NCT00530439|470403025|FG001|Overall Study|Misclassification|0|||
130666198|NCT00530439|470403024|FG000|Overall Study|Twin pregnancy|0|||
130666199|NCT00530439|470403025|FG001|Overall Study|Twin pregnancy|2|||
130666200|NCT00530439|470403024|FG000|Overall Study|Severe malformation/abortion|0|||
130666201|NCT00530439|470403025|FG001|Overall Study|Severe malformation/abortion|3|||
130666202|NCT01529749|470403026|FG000|Overall Study|Lost to Follow-up|0|||
130666203|NCT01529749|470403027|FG001|Overall Study|Lost to Follow-up|1|||
130666204|NCT01529749|470403028|FG002|Overall Study|Lost to Follow-up|1|||
130666205|NCT01529749|470403029|FG003|Overall Study|Lost to Follow-up|0|||
130666206|NCT01529749|470403026|FG000|Overall Study|Physician Decision|0|||
130666207|NCT01529749|470403027|FG001|Overall Study|Physician Decision|0|||
130666208|NCT01529749|470403028|FG002|Overall Study|Physician Decision|0|||
130666209|NCT01529749|470403029|FG003|Overall Study|Physician Decision|1|||
130335000|NCT01668589|469195622|FG003|Overall Study|Lost to Follow-up|5|||
130335001|NCT01668589|469195619|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
130335002|NCT01668589|469195620|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
130335003|NCT01668589|469195621|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
130335004|NCT01668589|469195622|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
130335005|NCT01668589|469195619|FG000|Overall Study|Death|12|||
130666210|NCT01529749|470403026|FG000|Overall Study|Withdrawal by Subject|0|||
130666211|NCT01529749|470403027|FG001|Overall Study|Withdrawal by Subject|1|||
130666212|NCT01529749|470403028|FG002|Overall Study|Withdrawal by Subject|1|||
130666213|NCT01529749|470403029|FG003|Overall Study|Withdrawal by Subject|0|||
130666214|NCT01529749|470403026|FG000|Overall Study|Protocol Violation|0|||
130666215|NCT01529749|470403027|FG001|Overall Study|Protocol Violation|0|||
130666216|NCT01529749|470403028|FG002|Overall Study|Protocol Violation|0|||
130666217|NCT01529749|470403029|FG003|Overall Study|Protocol Violation|1|||
130666218|NCT00378482|470403030|FG000|Overall Study|Lost to Follow-up|1|||
130666219|NCT00378482|470403030|FG000|Overall Study|Lack of Efficacy|8|||
130666220|NCT00378482|470403030|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
130666221|NCT00378482|470403030|FG000|Overall Study|Withdrawal by Subject|4|||
130666222|NCT00378482|470403030|FG000|Overall Study|Adverse Event|9|||
130335006|NCT01668589|469195620|FG001|Overall Study|Death|3|||
130335007|NCT01668589|469195621|FG002|Overall Study|Death|2|||
130335008|NCT01668589|469195622|FG003|Overall Study|Death|11|||
130335009|NCT01668589|469195619|FG000|Overall Study|Other|44|||
130335010|NCT01668589|469195620|FG001|Overall Study|Other|10|||
130666223|NCT01375010|470404232|FG000|Overall Study|Lost to Follow-up|8|||
130666224|NCT01375010|470404233|FG001|Overall Study|Lost to Follow-up|2|||
130666225|NCT01375010|470404232|FG000|Overall Study|Withdrawal by Subject|4|||
130666226|NCT01375010|470404233|FG001|Overall Study|Withdrawal by Subject|2|||
130666227|NCT02614703|470404234|FG000|Overall Study|Withdrawal by Subject|7|||
130666228|NCT02614703|470404235|FG001|Overall Study|Withdrawal by Subject|1|||
130666229|NCT02402933|470404236|FG000|Overall Study|Withdrawal by Subject|4|||
130666230|NCT02402933|470404236|FG000|Overall Study|Discontinued; Site Termination|10|||
130666231|NCT01681771|470404239|FG000|Overall Study|Lost to Follow-up|4|||
130666232|NCT01681771|470404240|FG001|Overall Study|Lost to Follow-up|2|||
130666233|NCT01792284|470404245|FG000|Lead-in Period|Adverse Event|15|||
130666234|NCT01792284|470404246|FG001|Lead-in Period|Adverse Event|0|||
130666235|NCT01792284|470404247|FG002|Lead-in Period|Adverse Event|0|||
130666236|NCT01792284|470404245|FG000|Lead-in Period|Lost to Follow-up|2|||
130666237|NCT01792284|470404246|FG001|Lead-in Period|Lost to Follow-up|0|||
130666238|NCT01792284|470404247|FG002|Lead-in Period|Lost to Follow-up|0|||
130666239|NCT01792284|470404245|FG000|Lead-in Period|Protocol Violation|1|||
130666240|NCT01792284|470404246|FG001|Lead-in Period|Protocol Violation|0|||
130666241|NCT01792284|470404247|FG002|Lead-in Period|Protocol Violation|0|||
130666242|NCT01792284|470404245|FG000|Lead-in Period|Withdrawal by Subject|10|||
130666243|NCT01792284|470404246|FG001|Lead-in Period|Withdrawal by Subject|0|||
130666244|NCT01792284|470404247|FG002|Lead-in Period|Withdrawal by Subject|0|||
130666245|NCT01792284|470404245|FG000|Lead-in Period|Physician Decision|1|||
130666246|NCT01792284|470404246|FG001|Lead-in Period|Physician Decision|0|||
130666247|NCT01792284|470404247|FG002|Lead-in Period|Physician Decision|0|||
130666248|NCT01792284|470404245|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
130666249|NCT01792284|470404246|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
130666250|NCT01792284|470404247|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
130666251|NCT01792284|470404245|FG000|Randomization Period 1|Withdrawal by Subject|0|||
130666252|NCT01792284|470404246|FG001|Randomization Period 1|Withdrawal by Subject|1|||
130666253|NCT01792284|470404247|FG002|Randomization Period 1|Withdrawal by Subject|1|||
130666254|NCT01792284|470404245|FG000|Randomization Period 1|Physician Decision|0|||
130666255|NCT01792284|470404246|FG001|Randomization Period 1|Physician Decision|1|||
130666256|NCT01792284|470404247|FG002|Randomization Period 1|Physician Decision|1|||
130666257|NCT01792284|470404245|FG000|Randomization Period 1|Adverse Event|0|||
130666258|NCT01792284|470404246|FG001|Randomization Period 1|Adverse Event|0|||
130666259|NCT01792284|470404247|FG002|Randomization Period 1|Adverse Event|2|||
130666260|NCT01792284|470404245|FG000|Randomization Period 1|Lost to Follow-up|0|||
130666261|NCT01792284|470404246|FG001|Randomization Period 1|Lost to Follow-up|0|||
130666262|NCT01792284|470404247|FG002|Randomization Period 1|Lost to Follow-up|1|||
130335011|NCT01668589|469195621|FG002|Overall Study|Other|7|||
130666263|NCT01792284|470404245|FG000|Randomization Period 2|Protocol Violation|0|||
130666264|NCT01792284|470404246|FG001|Randomization Period 2|Protocol Violation|1|||
130335012|NCT01668589|469195622|FG003|Overall Study|Other|15|||
130666265|NCT01792284|470404247|FG002|Randomization Period 2|Protocol Violation|0|||
130666266|NCT01792284|470404245|FG000|Randomization Period 2|Withdrawal by Subject|0|||
130666267|NCT01792284|470404246|FG001|Randomization Period 2|Withdrawal by Subject|2|||
130666268|NCT01792284|470404247|FG002|Randomization Period 2|Withdrawal by Subject|0|||
130666269|NCT02919475|470404249|FG000|Overall Study|Adverse Event|3|||
130666270|NCT02919475|470404250|FG001|Overall Study|Adverse Event|3|||
130666271|NCT02919475|470404251|FG002|Overall Study|Adverse Event|3|||
130666272|NCT02919475|470404252|FG003|Overall Study|Adverse Event|9|||
130666273|NCT02919475|470404253|FG004|Overall Study|Adverse Event|2|||
130666274|NCT02919475|470404249|FG000|Overall Study|Death|0|||
130666275|NCT02919475|470404250|FG001|Overall Study|Death|1|||
130666276|NCT02919475|470404251|FG002|Overall Study|Death|0|||
130666277|NCT02919475|470404252|FG003|Overall Study|Death|0|||
130666278|NCT02919475|470404253|FG004|Overall Study|Death|0|||
130666279|NCT02919475|470404249|FG000|Overall Study|Lost to Follow-up|0|||
130666280|NCT02919475|470404250|FG001|Overall Study|Lost to Follow-up|0|||
130666281|NCT02919475|470404251|FG002|Overall Study|Lost to Follow-up|0|||
130666282|NCT02919475|470404252|FG003|Overall Study|Lost to Follow-up|1|||
130666283|NCT02919475|470404253|FG004|Overall Study|Lost to Follow-up|0|||
130666284|NCT02919475|470404249|FG000|Overall Study|Withdrawal by Subject|2|||
130666285|NCT02919475|470404250|FG001|Overall Study|Withdrawal by Subject|3|||
130666286|NCT02919475|470404251|FG002|Overall Study|Withdrawal by Subject|1|||
130666287|NCT02919475|470404252|FG003|Overall Study|Withdrawal by Subject|2|||
130666288|NCT02919475|470404253|FG004|Overall Study|Withdrawal by Subject|2|||
130666289|NCT02919475|470404249|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130666290|NCT02919475|470404250|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130666291|NCT02919475|470404251|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130666292|NCT02919475|470404252|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130666293|NCT02919475|470404253|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130666294|NCT02962882|470404256|FG000|Overall Study|Adverse Event|2|||
130666295|NCT02962882|470404256|FG000|Overall Study|Withdrawal by Subject|2|||
130666296|NCT02962882|470404256|FG000|Overall Study|Transfer from ICU|32|||
130666297|NCT01663714|470404257|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
130666298|NCT01663714|470404257|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
130335013|NCT01519167|469195623|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
130335014|NCT01519167|469195624|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
130335015|NCT01519167|469195623|FG000|Overall Study|Adverse Event|0|||
130666299|NCT01663714|470404257|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
130666300|NCT01663714|470404257|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
130666301|NCT01663714|470404257|FG000|Long-Term Follow-Up|Death|4|||
130666302|NCT01663714|470404257|FG000|Long-Term Follow-Up|Non-compliance|1|||
130666303|NCT00597584|470404258|FG000|Overall Study|Adverse Event|4|||
130666304|NCT00597584|470404259|FG001|Overall Study|Adverse Event|2|||
130666305|NCT00597584|470404258|FG000|Overall Study|Death|53|||
130666306|NCT00597584|470404259|FG001|Overall Study|Death|30|||
130666307|NCT00597584|470404258|FG000|Overall Study|Lack of Efficacy|1|||
130666308|NCT00597584|470404259|FG001|Overall Study|Lack of Efficacy|0|||
130666309|NCT00597584|470404258|FG000|Overall Study|Lost to Follow-up|2|||
130666310|NCT00597584|470404259|FG001|Overall Study|Lost to Follow-up|4|||
130666311|NCT00597584|470404258|FG000|Overall Study|Physician Decision|3|||
130666312|NCT00597584|470404259|FG001|Overall Study|Physician Decision|0|||
130666313|NCT00597584|470404258|FG000|Overall Study|Pregnancy|2|||
130666314|NCT00597584|470404259|FG001|Overall Study|Pregnancy|0|||
130666315|NCT00597584|470404258|FG000|Overall Study|Withdrawal by Subject|44|||
130666316|NCT00597584|470404259|FG001|Overall Study|Withdrawal by Subject|12|||
130666317|NCT00597584|470404258|FG000|Overall Study|Discontinued Dialysis|0|||
130666318|NCT00597584|470404259|FG001|Overall Study|Discontinued Dialysis|1|||
130666319|NCT00597584|470404258|FG000|Overall Study|Lost ability to consent|1|||
130666320|NCT00597584|470404259|FG001|Overall Study|Lost ability to consent|1|||
130666321|NCT00597584|470404258|FG000|Overall Study|Never dosed|1|||
130666322|NCT00597584|470404259|FG001|Overall Study|Never dosed|0|||
130666323|NCT00597584|470404258|FG000|Overall Study|Relocation|8|||
130666324|NCT00597584|470404259|FG001|Overall Study|Relocation|6|||
130666325|NCT00597584|470404258|FG000|Overall Study|Renal transplant|9|||
130666326|NCT00597584|470404259|FG001|Overall Study|Renal transplant|7|||
130666327|NCT00515073|470404260|FG000|Overall Study|Withdrawal by Subject|1|||
130666328|NCT00515073|470404260|FG000|Overall Study|Physician Decision|1|||
130666329|NCT02791659|470404261|FG000|Overall Study|Protocol Violation|0|||
130666330|NCT02791659|470404262|FG001|Overall Study|Protocol Violation|1|||
130666331|NCT01456052|470404263|FG000|Overall Study|Adverse Event|1|||
130666332|NCT01456052|470404264|FG001|Overall Study|Adverse Event|1|||
130335016|NCT01519167|469195624|FG001|Overall Study|Adverse Event|1|||
130335017|NCT01519167|469195623|FG000|Overall Study|Lack of Efficacy|0|||
130335018|NCT01519167|469195624|FG001|Overall Study|Lack of Efficacy|1|||
130335019|NCT01519167|469195623|FG000|Overall Study|Medical condition changes&deep sedation|0|||
130335020|NCT01519167|469195624|FG001|Overall Study|Medical condition changes&deep sedation|2|||
130666333|NCT01456052|470404265|FG002|Overall Study|Adverse Event|2|||
130666334|NCT01456052|470404263|FG000|Overall Study|Consent withdrawn|0|||
130666335|NCT01456052|470404264|FG001|Overall Study|Consent withdrawn|2|||
130552648|NCT01598311|469990261|FG001|Overall Study|Physician Decision|5|||
130552649|NCT01598311|469990260|FG000|Overall Study|Adverse Event|9|||
130666336|NCT01456052|470404265|FG002|Overall Study|Consent withdrawn|1|||
130666337|NCT01456052|470404263|FG000|Overall Study|Protocol Violation|0|||
130666338|NCT01456052|470404264|FG001|Overall Study|Protocol Violation|1|||
130666339|NCT01456052|470404265|FG002|Overall Study|Protocol Violation|0|||
130666340|NCT01456052|470404263|FG000|Overall Study|Physician Decision|1|||
130666341|NCT01456052|470404264|FG001|Overall Study|Physician Decision|0|||
130666342|NCT01456052|470404265|FG002|Overall Study|Physician Decision|1|||
130666343|NCT01456052|470404263|FG000|Overall Study|Treatment Failure|0|||
130666344|NCT01456052|470404264|FG001|Overall Study|Treatment Failure|1|||
130666345|NCT01456052|470404265|FG002|Overall Study|Treatment Failure|1|||
130666346|NCT01904383|470404268|FG000|Overall Study|CRF not collected|117|||
130666347|NCT01904383|470404268|FG000|Overall Study|Reason not listed|147|||
130666348|NCT01904383|470404268|FG000|Overall Study|Lost to Follow-up|674|||
130666349|NCT01904383|470404268|FG000|Overall Study|Lack of Efficacy|370|||
130666350|NCT01904383|470404268|FG000|Overall Study|Improvement|141|||
130666351|NCT01904383|470404268|FG000|Overall Study|Adverse Event|271|||
130666352|NCT01904383|470404268|FG000|Overall Study|No patient visit after entry|54|||
130666353|NCT01294592|470404269|FG000|Overall Study|Adverse Event|28|||
130666354|NCT01294592|470404270|FG001|Overall Study|Adverse Event|13|||
130666355|NCT01294592|470404269|FG000|Overall Study|Lack of Efficacy|7|||
130666356|NCT01294592|470404270|FG001|Overall Study|Lack of Efficacy|5|||
130666357|NCT01294592|470404269|FG000|Overall Study|Protocol Violation|1|||
130666358|NCT01294592|470404270|FG001|Overall Study|Protocol Violation|7|||
130666359|NCT01294592|470404269|FG000|Overall Study|Lost to Follow-up|7|||
130666360|NCT01294592|470404270|FG001|Overall Study|Lost to Follow-up|9|||
130666361|NCT01294592|470404269|FG000|Overall Study|Physician Decision|6|||
130666362|NCT01294592|470404270|FG001|Overall Study|Physician Decision|11|||
130666363|NCT01294592|470404269|FG000|Overall Study|Withdrawal by Subject|28|||
130666364|NCT01294592|470404270|FG001|Overall Study|Withdrawal by Subject|28|||
130666365|NCT02762565|470404271|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
130666366|NCT01113710|470404272|FG000|Overall Study|Adverse Event|64|||
130666367|NCT01113710|470404272|FG000|Overall Study|Lack of Efficacy|41|||
130666368|NCT01113710|470404272|FG000|Overall Study|No Information Available|40|||
130666369|NCT01113710|470404272|FG000|Overall Study|Withdrawal by Subject|28|||
130666370|NCT01113710|470404272|FG000|Overall Study|Lost to Follow-up|20|||
130666371|NCT01113710|470404272|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
130666372|NCT01113710|470404272|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
130666373|NCT01113710|470404272|FG000|Overall Study|Lack of Patient's Compliance|8|||
130666374|NCT01113710|470404272|FG000|Overall Study|Other|7|||
130666375|NCT01113710|470404272|FG000|Overall Study|Adverse Event/Other|5|||
130666376|NCT01113710|470404272|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
130666377|NCT01113710|470404272|FG000|Overall Study|Lack of Efficacy/Other|4|||
130666378|NCT01113710|470404272|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
130666379|NCT01113710|470404272|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
130666380|NCT01113710|470404272|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
130666381|NCT01113710|470404272|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
130666382|NCT01113710|470404272|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
130666383|NCT01113710|470404272|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
130666384|NCT01113710|470404272|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
130666385|NCT01113710|470404272|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
130666386|NCT01113710|470404272|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
130666387|NCT01113710|470404272|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
130666388|NCT01113710|470404272|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
130666389|NCT01113710|470404272|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
130666390|NCT01113710|470404272|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
130666391|NCT00623623|470404273|FG000|Overall Study|Previous enrolment into this study|1|||
130666392|NCT00623623|470404274|FG001|Overall Study|Previous enrolment into this study|1|||
130666393|NCT02265952|470404276|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
130666394|NCT02265952|470404277|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
130666395|NCT02265952|470404276|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
130666396|NCT02265952|470404277|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
130666397|NCT01042977|470404278|FG000|Overall Study|Adverse Event|4|||
130666398|NCT01042977|470404279|FG001|Overall Study|Adverse Event|12|||
130666399|NCT01042977|470404278|FG000|Overall Study|Death|2|||
130666400|NCT01042977|470404279|FG001|Overall Study|Death|1|||
130666401|NCT01042977|470404278|FG000|Overall Study|Withdrawal by Subject|8|||
130666402|NCT01042977|470404279|FG001|Overall Study|Withdrawal by Subject|16|||
130666403|NCT01042977|470404278|FG000|Overall Study|Lost to Follow-up|0|||
130666404|NCT01042977|470404279|FG001|Overall Study|Lost to Follow-up|2|||
130666405|NCT01042977|470404278|FG000|Overall Study|Poor/non-compliance|3|||
130666406|NCT01042977|470404279|FG001|Overall Study|Poor/non-compliance|4|||
130666407|NCT01042977|470404278|FG000|Overall Study|Subject no longer meets study criteria|15|||
130666408|NCT01042977|470404279|FG001|Overall Study|Subject no longer meets study criteria|13|||
130666409|NCT01042977|470404278|FG000|Overall Study|Incorrect enrollment|6|||
130666410|NCT01042977|470404279|FG001|Overall Study|Incorrect enrollment|4|||
130666411|NCT01042977|470404278|FG000|Overall Study|Safety|0|||
130666412|NCT01042977|470404279|FG001|Overall Study|Safety|2|||
130666413|NCT01042977|470404278|FG000|Overall Study|Administrative reason by sponsor|0|||
130216133|NCT02030119|468753957|FG002|Overall Study|Withdrawal by Subject|5|||
130666414|NCT01042977|470404279|FG001|Overall Study|Administrative reason by sponsor|1|||
130666415|NCT01042977|470404278|FG000|Overall Study|Various|3|||
130335021|NCT01519167|469195623|FG000|Overall Study|Physician Decision|0|||
130335022|NCT01519167|469195624|FG001|Overall Study|Physician Decision|1|||
130335023|NCT04200352|469195632|FG000|Overall Study|Death|1|||
130335024|NCT04200352|469195632|FG000|Overall Study|Adverse Event|6|||
130335025|NCT04200352|469195632|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130335026|NCT04200352|469195632|FG000|Overall Study|Lack of Efficacy|1|||
130335027|NCT04200352|469195632|FG000|Overall Study|Other than specified|6|||
130335028|NCT00233064|469195633|FG000|Overall Study|Lost to Follow-up|7|||
130335029|NCT00233064|469195634|FG001|Overall Study|Lost to Follow-up|7|||
130335030|NCT00233064|469195633|FG000|Overall Study|Withdrawal by Subject|5|||
130335031|NCT00233064|469195634|FG001|Overall Study|Withdrawal by Subject|3|||
130666416|NCT01042977|470404279|FG001|Overall Study|Various|0|||
130666417|NCT02499354|470404280|FG000|Overall Study|Withdrawal by Subject|1|||
130666418|NCT02499354|470404281|FG001|Overall Study|Withdrawal by Subject|0|||
130666419|NCT02424565|470404284|FG000|Period 1 (D0)|Protocol Violation|0|||
130666420|NCT02424565|470404285|FG001|Period 1 (D0)|Protocol Violation|1|||
130666421|NCT03650400|470404286|FG000|Overall Study|Study terminated by sponsor|0|||
130666422|NCT03650400|470404287|FG001|Overall Study|Study terminated by sponsor|5|||
130666423|NCT01759381|470404288|FG000|Overall Study|Death|1|||
130666424|NCT01759381|470404289|FG001|Overall Study|Death|0|||
130666425|NCT00447603|470404291|FG000|Screening|Withdrawal by Subject|1|||
130666426|NCT00447603|470404292|FG001|Screening|Withdrawal by Subject|0|||
130666427|NCT00447603|470404293|FG002|Screening|Withdrawal by Subject|0|||
130666428|NCT00447603|470404291|FG000|Screening|Protocol Violation|1|||
130666429|NCT00447603|470404292|FG001|Screening|Protocol Violation|0|||
130666430|NCT00447603|470404293|FG002|Screening|Protocol Violation|0|||
130666431|NCT00447603|470404291|FG000|Screening|Screen Failure|4|||
130666432|NCT00447603|470404292|FG001|Screening|Screen Failure|0|||
130666433|NCT00447603|470404293|FG002|Screening|Screen Failure|0|||
130666434|NCT00447603|470404291|FG000|Screening|Study Terminated by Sponsor|15|||
130666435|NCT00447603|470404292|FG001|Screening|Study Terminated by Sponsor|0|||
130666436|NCT00447603|470404293|FG002|Screening|Study Terminated by Sponsor|0|||
130666437|NCT00447603|470404291|FG000|Filter Period|Adverse Event|0|||
130666438|NCT00447603|470404292|FG001|Filter Period|Adverse Event|0|||
130666439|NCT00447603|470404293|FG002|Filter Period|Adverse Event|1|||
130666440|NCT00447603|470404291|FG000|Filter Period|Screen Failure|0|||
130666441|NCT00447603|470404292|FG001|Filter Period|Screen Failure|3|||
130666442|NCT00447603|470404293|FG002|Filter Period|Screen Failure|4|||
130335032|NCT00233064|469195633|FG000|Overall Study|Death|0|||
130335033|NCT00233064|469195634|FG001|Overall Study|Death|1|||
130335034|NCT00233064|469195633|FG000|Overall Study|Relocation|0|||
130335035|NCT00233064|469195634|FG001|Overall Study|Relocation|1|||
130335036|NCT00233064|469195633|FG000|Overall Study|Protocol Violation|1|||
130335037|NCT00233064|469195634|FG001|Overall Study|Protocol Violation|0|||
130335038|NCT00233064|469195633|FG000|Overall Study|Moved to Dom. Republic|1|||
130335039|NCT00233064|469195634|FG001|Overall Study|Moved to Dom. Republic|0|||
130335040|NCT01120964|469195641|FG000|Overall Study|Did not receive full treatment|1|||
130335041|NCT01120964|469195642|FG001|Overall Study|Did not receive full treatment|0|||
130335042|NCT04237116|469195646|FG000|Overall Study|Adverse Event|0|||
130335043|NCT04237116|469195647|FG001|Overall Study|Adverse Event|1|||
130335044|NCT04237116|469195646|FG000|Overall Study|Study terminated by Sponsor|4|||
130335045|NCT04237116|469195647|FG001|Overall Study|Study terminated by Sponsor|1|||
130335046|NCT00829504|469195648|FG000|First Intervention|Adverse Event|1|||
130335047|NCT00829504|469195649|FG001|First Intervention|Adverse Event|0|||
130335048|NCT00829504|469195648|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130335049|NCT00829504|469195649|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130335050|NCT00829504|469195648|FG000|Second Intervention|Physician Decision|1|||
130335051|NCT00829504|469195649|FG001|Second Intervention|Physician Decision|0|||
130335052|NCT03212144|469195650|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
130335053|NCT03212144|469195651|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
130335054|NCT03212144|469195650|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
130335055|NCT03212144|469195651|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
130666443|NCT00447603|470404291|FG000|Filter Period|Study terminated by Sponsor|0|||
130666444|NCT00447603|470404292|FG001|Filter Period|Study terminated by Sponsor|1|||
130335056|NCT00599339|469195652|FG000|Overall Study|Adverse Event|79|||
130335057|NCT00599339|469195652|FG000|Overall Study|Withdrawal by Subject|137|||
130335058|NCT00599339|469195652|FG000|Overall Study|Other Reason|179|||
130335059|NCT00599339|469195652|FG000|Overall Study|Lost to Follow-up|221|||
130335060|NCT00599339|469195652|FG000|Overall Study|No valid data consent|36|||
130335061|NCT00599339|469195652|FG000|Overall Study|Study Termination Status Unknown|12|||
130335062|NCT02102204|469197327|FG000|Overall Study|Withdrawal by Subject|137|||
130335063|NCT02102204|469197327|FG000|Overall Study|Death|92|||
130335064|NCT02102204|469197327|FG000|Overall Study|Lost to Follow-up|65|||
130666445|NCT00447603|470404293|FG002|Filter Period|Study terminated by Sponsor|10|||
130335065|NCT02102204|469197327|FG000|Overall Study|Sponsor Decision|5|||
130335066|NCT02102204|469197327|FG000|Overall Study|Ongoing|5|||
130666446|NCT02732561|470404298|FG000|Overall Study|Lost to Follow-up|1|||
130666447|NCT02732561|470404299|FG001|Overall Study|Lost to Follow-up|1|||
130666448|NCT02732561|470404298|FG000|Overall Study|Withdrawal by Subject|1|||
130666449|NCT02732561|470404299|FG001|Overall Study|Withdrawal by Subject|0|||
130666450|NCT02410837|470404301|FG000|Overall Study|Death|387|||
130666451|NCT02410837|470404301|FG000|Overall Study|Lost to Follow-up|50|||
130666452|NCT02410837|470404301|FG000|Overall Study|Withdrawal by Subject|44|||
130666453|NCT02410837|470404301|FG000|Overall Study|Physician Decision|6|||
130666454|NCT02410837|470404301|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
130666455|NCT00837577|470404302|FG000|Double-blind Period|Clinical Adverse Event|1|||
130666456|NCT00837577|470404303|FG001|Double-blind Period|Clinical Adverse Event|0|||
130666457|NCT00837577|470404302|FG000|Double-blind Period|Withdrawal by Subject|1|||
130666458|NCT00837577|470404303|FG001|Double-blind Period|Withdrawal by Subject|0|||
130666459|NCT00837577|470404302|FG000|Open-label Period|Clinical Adverse Event|2|||
130666460|NCT00837577|470404303|FG001|Open-label Period|Clinical Adverse Event|2|||
130666461|NCT00837577|470404302|FG000|Open-label Period|Laboratory Adverse Event|0|||
130666462|NCT00837577|470404303|FG001|Open-label Period|Laboratory Adverse Event|1|||
130666463|NCT00837577|470404302|FG000|Open-label Period|Lack of Efficacy|4|||
130666464|NCT00837577|470404303|FG001|Open-label Period|Lack of Efficacy|3|||
130666465|NCT00837577|470404302|FG000|Open-label Period|Withdrawal by Subject|1|||
130666466|NCT00837577|470404303|FG001|Open-label Period|Withdrawal by Subject|2|||
130666467|NCT00837577|470404302|FG000|Open-label Period|Other Reason|1|||
130666468|NCT00837577|470404303|FG001|Open-label Period|Other Reason|1|||
130666469|NCT03031431|470404306|FG000|Overall Study|Infant removed by maternal request|1|||
130666470|NCT01205529|470404307|FG000|Overall Study|Procedure Cancelled|4|||
130666471|NCT01205529|470404307|FG000|Overall Study|Withdrawal by Subject|2|||
130666472|NCT01205529|470404307|FG000|Overall Study|Physician Decision|4|||
130666473|NCT01205529|470404307|FG000|Overall Study|Unstable post op|15|||
130666474|NCT01205529|470404307|FG000|Overall Study|No longer met criteria|30|||
130666475|NCT00106028|470404312|FG000|Overall Study|Adverse Event|3|||
130666476|NCT00106028|470404313|FG001|Overall Study|Adverse Event|2|||
130666477|NCT00106028|470404312|FG000|Overall Study|Protocol Violation|1|||
130666478|NCT00106028|470404313|FG001|Overall Study|Protocol Violation|1|||
130666479|NCT00106028|470404312|FG000|Overall Study|Withdrawal by Subject|2|||
130666480|NCT00106028|470404313|FG001|Overall Study|Withdrawal by Subject|8|||
130666481|NCT00106028|470404312|FG000|Overall Study|Lost to Follow-up|0|||
130666482|NCT00106028|470404313|FG001|Overall Study|Lost to Follow-up|1|||
130666483|NCT01280981|470404314|FG000|Overall Study|Withdrawal by Subject|11|||
130666484|NCT01280981|470404314|FG000|Overall Study|Protocol Violation|2|||
130666485|NCT01280981|470404314|FG000|Overall Study|Lack of Efficacy|13|||
130666486|NCT01280981|470404314|FG000|Overall Study|Lost to Follow-up|3|||
130666487|NCT01280981|470404314|FG000|Overall Study|Adverse Event|6|||
130666488|NCT01280981|470404314|FG000|Overall Study|Irregular or discontinued menses|3|||
130666489|NCT01280981|470404314|FG000|Overall Study|Failed to return|45|||
130666490|NCT01280981|470404314|FG000|Overall Study|Non-compliance with protocol|3|||
130666491|NCT01280981|470404314|FG000|Overall Study|Withdrawal of consent|3|||
130666492|NCT01280981|470404314|FG000|Overall Study|Elective surgery|2|||
130666493|NCT01280981|470404314|FG000|Overall Study|Study site closure|1|||
130666494|NCT06371079|470404316|FG000|Overall Study|Missing data|88|||
130666495|NCT06371079|470404317|FG001|Overall Study|Missing data|247|||
130666496|NCT01256398|470404318|FG000|Overall Study|Withdrawal by Subject|1|||
130666497|NCT03276962|470404319|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
130666498|NCT03276962|470404320|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
130666499|NCT03276962|470404321|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
130666500|NCT03276962|470404322|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
130666501|NCT03276962|470404323|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
130666502|NCT03276962|470404319|FG000|Overall Study|Protocol Deviation|2|||
130666503|NCT03276962|470404320|FG001|Overall Study|Protocol Deviation|0|||
130666504|NCT03276962|470404321|FG002|Overall Study|Protocol Deviation|1|||
130666505|NCT03276962|470404322|FG003|Overall Study|Protocol Deviation|2|||
130666506|NCT03276962|470404323|FG004|Overall Study|Protocol Deviation|1|||
130666507|NCT03276962|470404319|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
130666508|NCT03276962|470404320|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130666509|NCT03276962|470404321|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
130666510|NCT03276962|470404322|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130666511|NCT03276962|470404323|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
130666512|NCT03276962|470404319|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
130666513|NCT03276962|470404320|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
130666514|NCT03276962|470404321|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
130666515|NCT03276962|470404322|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
130666516|NCT03276962|470404323|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
130666517|NCT03276962|470404319|FG000|Overall Study|Lost to Follow-up|10|||
130666518|NCT03276962|470404320|FG001|Overall Study|Lost to Follow-up|10|||
130666519|NCT03276962|470404321|FG002|Overall Study|Lost to Follow-up|4|||
130666520|NCT03276962|470404322|FG003|Overall Study|Lost to Follow-up|6|||
130666521|NCT03276962|470404323|FG004|Overall Study|Lost to Follow-up|10|||
130666522|NCT03276962|470404319|FG000|Overall Study|Other|0|||
130666523|NCT03276962|470404320|FG001|Overall Study|Other|2|||
130666524|NCT03276962|470404321|FG002|Overall Study|Other|0|||
130666525|NCT03276962|470404322|FG003|Overall Study|Other|2|||
130666526|NCT03276962|470404323|FG004|Overall Study|Other|1|||
130666527|NCT03550794|470404332|FG000|Overall Study|No longer met inclusion criteria|1|||
130666528|NCT03550794|470404333|FG001|Overall Study|No longer met inclusion criteria|2|||
130666529|NCT03550794|470404332|FG000|Overall Study|Goals of care changed|1|||
130666530|NCT03550794|470404333|FG001|Overall Study|Goals of care changed|0|||
130666531|NCT03550794|470404332|FG000|Overall Study|Withdrawal by Subject|2|||
130666532|NCT03550794|470404333|FG001|Overall Study|Withdrawal by Subject|0|||
130666533|NCT03550794|470404332|FG000|Overall Study|Death|0|||
130666534|NCT03550794|470404333|FG001|Overall Study|Death|1|||
130666535|NCT03056352|470404334|FG000|Overall Study|Lost to Follow-up|1|||
130666536|NCT00597207|470404339|FG000|Overall Study|Lost to Follow-up|5|||
130666537|NCT00597207|470404340|FG001|Overall Study|Lost to Follow-up|7|||
130666538|NCT00520351|470404341|FG000|First Intervention|Withdrawal by Subject|1|||
130666539|NCT00520351|470404342|FG001|First Intervention|Withdrawal by Subject|1|||
130666540|NCT02278952|470404343|FG000|Overall Study|Insufficient Sample|6|||
130666541|NCT00729365|470404350|FG000|Overall Study|Physician Decision|33|||
130666542|NCT00729365|470404351|FG001|Overall Study|Physician Decision|6|||
130666543|NCT00729365|470404352|FG002|Overall Study|Physician Decision|7|||
130666544|NCT00869089|470404353|FG000|Overall Study|Lost to Follow-up|1|||
130666545|NCT00869089|470404353|FG000|Overall Study|Withdrawal by Subject|1|||
130666546|NCT00869089|470404353|FG000|Overall Study|Screen Fail|1|||
130666547|NCT01559818|470404360|FG000|Overall Study|Physician Decision|1|||
130666548|NCT01559818|470404360|FG000|Overall Study|Pregnancy|1|||
130666549|NCT01559818|470404360|FG000|Overall Study|Study terminated by Sponsor|4|||
130666550|NCT01559818|470404360|FG000|Overall Study|Withdrawal by Subject|1|||
130666551|NCT04071626|470404361|FG000|Overall Study|Withdrawal by Subject|1|||
130666552|NCT04071626|470404362|FG001|Overall Study|Withdrawal by Subject|1|||
130666553|NCT04071626|470404361|FG000|Overall Study|Protocol Violation|0|||
130666554|NCT04071626|470404362|FG001|Overall Study|Protocol Violation|1|||
130666555|NCT01963676|470406079|FG000|Overall Study|Withdrawal by Subject|1|||
130666556|NCT01963676|470406080|FG001|Overall Study|Withdrawal by Subject|0|||
130666557|NCT01246973|470406081|FG000|Overall Study|Other|38|||
130666558|NCT01246973|470406082|FG001|Overall Study|Other|25|||
130666559|NCT01246973|470406081|FG000|Overall Study|Adverse Event|16|||
130666560|NCT01246973|470406082|FG001|Overall Study|Adverse Event|9|||
130666561|NCT01246973|470406081|FG000|Overall Study|Withdrawal by Subject|7|||
130666562|NCT01246973|470406082|FG001|Overall Study|Withdrawal by Subject|13|||
130666563|NCT00766506|470406083|FG000|Overall Study|Use rescue medication after 3 hours|3|||
130666564|NCT00766506|470406084|FG001|Overall Study|Use rescue medication after 3 hours|0|||
130666565|NCT00766506|470406083|FG000|Overall Study|Other|2|||
130666566|NCT00766506|470406084|FG001|Overall Study|Other|2|||
130666567|NCT02496221|470406085|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
130666568|NCT02496221|470406086|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
130666569|NCT02496221|470406085|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
130666570|NCT02496221|470406086|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
130666571|NCT02496221|470406085|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
130666572|NCT02496221|470406086|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
130666573|NCT03262233|470406087|FG000|Overall Study|Withdrawal by Subject|12|||
130666574|NCT03262233|470406088|FG001|Overall Study|Withdrawal by Subject|8|||
130666575|NCT03262233|470406089|FG002|Overall Study|Withdrawal by Subject|21|||
130666576|NCT03262233|470406090|FG003|Overall Study|Withdrawal by Subject|13|||
130666577|NCT03262233|470406087|FG000|Overall Study|Declined due to shock|1|||
130666578|NCT03262233|470406088|FG001|Overall Study|Declined due to shock|2|||
130666579|NCT03262233|470406089|FG002|Overall Study|Declined due to shock|2|||
130666580|NCT03262233|470406090|FG003|Overall Study|Declined due to shock|3|||
130666581|NCT03262233|470406087|FG000|Overall Study|Protocol Violation|5|||
130666582|NCT03262233|470406088|FG001|Overall Study|Protocol Violation|10|||
130666583|NCT03262233|470406089|FG002|Overall Study|Protocol Violation|2|||
130666584|NCT03262233|470406090|FG003|Overall Study|Protocol Violation|13|||
130666585|NCT03262233|470406087|FG000|Overall Study|data collection artifact|0|||
130666586|NCT03262233|470406088|FG001|Overall Study|data collection artifact|1|||
130666587|NCT03262233|470406089|FG002|Overall Study|data collection artifact|0|||
130666588|NCT03262233|470406090|FG003|Overall Study|data collection artifact|0|||
130666589|NCT01120600|470406093|FG000|Overall Study|Adverse Event|7|||
130666590|NCT01120600|470406094|FG001|Overall Study|Adverse Event|7|||
130666591|NCT01120600|470406093|FG000|Overall Study|Excessive Bone Loss|0|||
130666592|NCT01120600|470406094|FG001|Overall Study|Excessive Bone Loss|4|||
130666593|NCT01120600|470406093|FG000|Overall Study|Lost to Follow-up|1|||
130666594|NCT01120600|470406094|FG001|Overall Study|Lost to Follow-up|3|||
130666595|NCT01120600|470406093|FG000|Overall Study|Physician Decision|1|||
130666596|NCT01120600|470406094|FG001|Overall Study|Physician Decision|3|||
130666597|NCT01120600|470406093|FG000|Overall Study|Protocol Violation|0|||
130666598|NCT01120600|470406094|FG001|Overall Study|Protocol Violation|4|||
130666599|NCT01120600|470406093|FG000|Overall Study|Withdrawal by Subject|10|||
130666600|NCT01120600|470406094|FG001|Overall Study|Withdrawal by Subject|11|||
130666601|NCT01165242|470406095|FG000|Overall Study|Unreachable Subjects|1|||
130666602|NCT01165242|470406096|FG001|Overall Study|Unreachable Subjects|0|||
130666603|NCT01165242|470406097|FG002|Overall Study|Unreachable Subjects|0|||
130666604|NCT01165242|470406095|FG000|Overall Study|Incarcerated Subjects|0|||
130666605|NCT01165242|470406096|FG001|Overall Study|Incarcerated Subjects|1|||
130666606|NCT01165242|470406097|FG002|Overall Study|Incarcerated Subjects|0|||
130666607|NCT01165242|470406095|FG000|Overall Study|Visit 2 Declined by Subject|0|||
130666608|NCT01165242|470406096|FG001|Overall Study|Visit 2 Declined by Subject|0|||
130666609|NCT01165242|470406097|FG002|Overall Study|Visit 2 Declined by Subject|1|||
130666610|NCT01165242|470406095|FG000|Overall Study|Withdrawal by Subject|0|||
130666611|NCT01165242|470406096|FG001|Overall Study|Withdrawal by Subject|2|||
130666612|NCT01165242|470406097|FG002|Overall Study|Withdrawal by Subject|2|||
130666613|NCT01165242|470406095|FG000|Overall Study|Extended Holiday|0|||
130666614|NCT01165242|470406096|FG001|Overall Study|Extended Holiday|0|||
130666615|NCT01165242|470406097|FG002|Overall Study|Extended Holiday|1|||
130666616|NCT01165242|470406095|FG000|Overall Study|Lost to Follow-up|9|||
130666617|NCT01165242|470406096|FG001|Overall Study|Lost to Follow-up|7|||
130666618|NCT01165242|470406097|FG002|Overall Study|Lost to Follow-up|10|||
130666619|NCT03770000|470406098|FG000|Overall Study|Premature discontinuation due to PD|0|||
130666620|NCT03770000|470406099|FG001|Overall Study|Premature discontinuation due to PD|0|||
130666621|NCT03770000|470406100|FG002|Overall Study|Premature discontinuation due to PD|1|||
130666622|NCT03770000|470406101|FG003|Overall Study|Premature discontinuation due to PD|3|||
130666623|NCT03770000|470406102|FG004|Overall Study|Premature discontinuation due to PD|2|||
130666624|NCT01690520|470406105|FG000|Overall Study|Death|25|||
130666625|NCT01690520|470406106|FG001|Overall Study|Death|21|||
130666626|NCT01690520|470406105|FG000|Overall Study|Lost to Follow-up|2|||
130666627|NCT01690520|470406106|FG001|Overall Study|Lost to Follow-up|3|||
130666628|NCT01690520|470406105|FG000|Overall Study|Withdrawal by Subject|2|||
130666629|NCT01690520|470406106|FG001|Overall Study|Withdrawal by Subject|0|||
130666630|NCT01690520|470406105|FG000|Overall Study|Relapse|0|||
130666631|NCT01690520|470406106|FG001|Overall Study|Relapse|1|||
130666632|NCT01690520|470406105|FG000|Overall Study|Other|0|||
130666633|NCT01690520|470406106|FG001|Overall Study|Other|1|||
130666634|NCT01690520|470406105|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
130666635|NCT01690520|470406106|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
130666636|NCT01169649|470406110|FG000|Overall Study|Patient Not Treated|3|||
130666637|NCT00660790|470406111|FG000|Baseline to 3 Months|Death|1|||
130666638|NCT00660790|470406111|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
130666639|NCT00660790|470406111|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
130666640|NCT03840811|470406112|FG000|Overall Study|Lost to Follow-up|0|||
130666641|NCT03840811|470406113|FG001|Overall Study|Lost to Follow-up|0|||
130666642|NCT03840811|470406114|FG002|Overall Study|Lost to Follow-up|1|||
130666643|NCT01625845|470406115|FG000|Overall Study|Adverse Event|1|||
130666644|NCT01625845|470406116|FG001|Overall Study|Adverse Event|2|||
130666645|NCT01625845|470406115|FG000|Overall Study|Lost to Follow-up|2|||
130666646|NCT01625845|470406116|FG001|Overall Study|Lost to Follow-up|1|||
130666647|NCT01625845|470406115|FG000|Overall Study|Withdrawal by Subject|2|||
130666648|NCT01625845|470406116|FG001|Overall Study|Withdrawal by Subject|0|||
130666649|NCT01078623|470406117|FG000|Treatment Period 1|Adverse Event|1|||
130666650|NCT01078623|470406118|FG001|Treatment Period 1|Adverse Event|1|||
130666651|NCT01078623|470406119|FG002|Treatment Period 1|Adverse Event|1|||
130666652|NCT01078623|470406120|FG003|Treatment Period 1|Adverse Event|0|||
130666653|NCT01078623|470406121|FG004|Treatment Period 1|Adverse Event|0|||
130666654|NCT01078623|470406122|FG005|Treatment Period 1|Adverse Event|0|||
130666655|NCT01078623|470406123|FG006|Treatment Period 1|Adverse Event|1|||
130666656|NCT01078623|470406124|FG007|Treatment Period 1|Adverse Event|0|||
130666657|NCT01078623|470406125|FG008|Treatment Period 1|Adverse Event|1|||
130666658|NCT01078623|470406126|FG009|Treatment Period 1|Adverse Event|1|||
130666659|NCT01078623|470406127|FG010|Treatment Period 1|Adverse Event|0|||
130666660|NCT01078623|470406128|FG011|Treatment Period 1|Adverse Event|0|||
130666661|NCT01078623|470406129|FG012|Treatment Period 1|Adverse Event|0|||
130335067|NCT02260180|469197328|FG000|Overall Study|Adverse Event|2|||
130335068|NCT02260180|469197329|FG001|Overall Study|Adverse Event|0|||
130335069|NCT02260180|469197330|FG002|Overall Study|Adverse Event|1|||
130335070|NCT03860818|469197333|FG000|Overall Study|Death|144|||
130666662|NCT01078623|470406130|FG013|Treatment Period 1|Adverse Event|0|||
130666663|NCT01078623|470406131|FG014|Treatment Period 1|Adverse Event|0|||
130666664|NCT01078623|470406132|FG015|Treatment Period 1|Adverse Event|0|||
130666665|NCT01078623|470406133|FG016|Treatment Period 1|Adverse Event|0|||
130666666|NCT01078623|470406134|FG017|Treatment Period 1|Adverse Event|0|||
130666667|NCT01078623|470406135|FG018|Treatment Period 1|Adverse Event|0|||
130666668|NCT01078623|470406136|FG019|Treatment Period 1|Adverse Event|0|||
130666669|NCT01078623|470406117|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130335071|NCT03860818|469197334|FG001|Overall Study|Death|195|||
130552650|NCT01598311|469990261|FG001|Overall Study|Adverse Event|13|||
130666670|NCT01078623|470406118|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130666671|NCT01078623|470406119|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130666672|NCT01078623|470406120|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130666673|NCT01078623|470406121|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130666674|NCT01078623|470406122|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130666675|NCT01078623|470406123|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130666676|NCT01078623|470406124|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130666677|NCT01078623|470406125|FG008|Treatment Period 1|Withdrawal by Subject|0|||
130666678|NCT01078623|470406126|FG009|Treatment Period 1|Withdrawal by Subject|0|||
130666679|NCT01078623|470406127|FG010|Treatment Period 1|Withdrawal by Subject|1|||
130666680|NCT01078623|470406128|FG011|Treatment Period 1|Withdrawal by Subject|0|||
130666681|NCT01078623|470406129|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130666682|NCT01078623|470406130|FG013|Treatment Period 1|Withdrawal by Subject|0|||
130666683|NCT01078623|470406131|FG014|Treatment Period 1|Withdrawal by Subject|0|||
130666684|NCT01078623|470406132|FG015|Treatment Period 1|Withdrawal by Subject|0|||
130666685|NCT01078623|470406133|FG016|Treatment Period 1|Withdrawal by Subject|0|||
130666686|NCT01078623|470406134|FG017|Treatment Period 1|Withdrawal by Subject|0|||
130666687|NCT01078623|470406135|FG018|Treatment Period 1|Withdrawal by Subject|0|||
130666688|NCT01078623|470406136|FG019|Treatment Period 1|Withdrawal by Subject|0|||
130335072|NCT03860818|469197333|FG000|Overall Study|Graft Loss|32|||
130335073|NCT03860818|469197334|FG001|Overall Study|Graft Loss|45|||
130335074|NCT03126344|469197335|FG000|Overall Study|Lost to Follow-up|0|||
130335075|NCT03126344|469197336|FG001|Overall Study|Lost to Follow-up|0|||
130335076|NCT03126344|469197337|FG002|Overall Study|Lost to Follow-up|5|||
130335077|NCT03052400|469197338|FG000|Overall Study|Lost to Follow-up|1|||
130335078|NCT03052400|469197339|FG001|Overall Study|Lost to Follow-up|0|||
130335079|NCT03052400|469197338|FG000|Overall Study|Withdrawal by Subject|0|||
130335080|NCT03052400|469197339|FG001|Overall Study|Withdrawal by Subject|1|||
130335081|NCT00555061|469197340|FG000|Overall Study|Adverse Event|3|||
130335082|NCT00555061|469197340|FG000|Overall Study|Protocol Violation|1|||
130335083|NCT00555061|469197340|FG000|Overall Study|Lost to Follow-up|2|||
130335084|NCT00555061|469197340|FG000|Overall Study|Withdrawal by Subject|2|||
130335085|NCT00555061|469197340|FG000|Overall Study|Participant enrolled, but never treated|1|||
130335086|NCT01396447|469197341|FG000|Overall Study|Did Not Receive Treatment|3|||
130335087|NCT01396447|469197342|FG001|Overall Study|Did Not Receive Treatment|2|||
130335088|NCT01396447|469197343|FG002|Overall Study|Did Not Receive Treatment|1|||
130335089|NCT01396447|469197344|FG003|Overall Study|Did Not Receive Treatment|0|||
130335090|NCT01396447|469197341|FG000|Overall Study|Adverse Event|15|||
130335091|NCT01396447|469197342|FG001|Overall Study|Adverse Event|12|||
130335092|NCT01396447|469197343|FG002|Overall Study|Adverse Event|12|||
130335093|NCT01396447|469197344|FG003|Overall Study|Adverse Event|17|||
130335094|NCT01396447|469197341|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130335095|NCT01396447|469197342|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130335096|NCT01396447|469197343|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130335097|NCT01396447|469197344|FG003|Overall Study|Insufficient Therapeutic Response|4|||
130335098|NCT01396447|469197341|FG000|Overall Study|Protocol Violation|5|||
130335099|NCT01396447|469197342|FG001|Overall Study|Protocol Violation|2|||
130335100|NCT01396447|469197343|FG002|Overall Study|Protocol Violation|3|||
130335101|NCT01396447|469197344|FG003|Overall Study|Protocol Violation|7|||
130335102|NCT01396447|469197341|FG000|Overall Study|Withdrawal of Consent|11|||
130335103|NCT01396447|469197342|FG001|Overall Study|Withdrawal of Consent|9|||
130335104|NCT01396447|469197343|FG002|Overall Study|Withdrawal of Consent|4|||
130335105|NCT01396447|469197344|FG003|Overall Study|Withdrawal of Consent|15|||
130335106|NCT01396447|469197341|FG000|Overall Study|Lost to Follow-up|4|||
130335107|NCT01396447|469197342|FG001|Overall Study|Lost to Follow-up|8|||
130335108|NCT01396447|469197343|FG002|Overall Study|Lost to Follow-up|7|||
130335109|NCT01396447|469197344|FG003|Overall Study|Lost to Follow-up|9|||
130335110|NCT01396447|469197341|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130335111|NCT01396447|469197342|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130335112|NCT01396447|469197343|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130335113|NCT01396447|469197344|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130335114|NCT04881942|469197345|FG000|Overall Study|Adverse Event|0|||
130335115|NCT04881942|469197346|FG001|Overall Study|Adverse Event|0|||
130335116|NCT04881942|469197347|FG002|Overall Study|Adverse Event|0|||
130335117|NCT04881942|469197348|FG003|Overall Study|Adverse Event|0|||
130335118|NCT04881942|469197349|FG004|Overall Study|Adverse Event|1|||
130335119|NCT04881942|469197345|FG000|Overall Study|Alternates|0|||
130666689|NCT01078623|470406117|FG000|Treatment Period 1|Protocol Violation|0|||
130666690|NCT01078623|470406118|FG001|Treatment Period 1|Protocol Violation|0|||
130666691|NCT01078623|470406119|FG002|Treatment Period 1|Protocol Violation|0|||
130335120|NCT04881942|469197346|FG001|Overall Study|Alternates|0|||
130335121|NCT04881942|469197347|FG002|Overall Study|Alternates|0|||
130335122|NCT04881942|469197348|FG003|Overall Study|Alternates|0|||
130335123|NCT04881942|469197349|FG004|Overall Study|Alternates|2|||
130335124|NCT01349959|469197350|FG000|Overall Study|Adverse Event|7|||
130335125|NCT02675634|469197351|FG000|Test Period 1|Adverse Event|0|||
130335126|NCT02675634|469197352|FG001|Test Period 1|Adverse Event|1|||
130335127|NCT02675634|469197353|FG002|Test Period 1|Adverse Event|0|||
130335128|NCT02675634|469197354|FG003|Test Period 1|Adverse Event|1|||
130335129|NCT02675634|469197355|FG004|Test Period 1|Adverse Event|0|||
130335130|NCT02675634|469197356|FG005|Test Period 1|Adverse Event|0|||
130552651|NCT01598311|469990260|FG000|Overall Study|Lost to Follow-up|7|||
130666692|NCT01078623|470406120|FG003|Treatment Period 1|Protocol Violation|0|||
130666693|NCT01078623|470406121|FG004|Treatment Period 1|Protocol Violation|0|||
130666694|NCT01078623|470406122|FG005|Treatment Period 1|Protocol Violation|1|||
130666695|NCT01078623|470406123|FG006|Treatment Period 1|Protocol Violation|0|||
130666696|NCT01078623|470406124|FG007|Treatment Period 1|Protocol Violation|0|||
130666697|NCT01078623|470406125|FG008|Treatment Period 1|Protocol Violation|0|||
130666698|NCT01078623|470406126|FG009|Treatment Period 1|Protocol Violation|0|||
130666699|NCT01078623|470406127|FG010|Treatment Period 1|Protocol Violation|0|||
130666700|NCT01078623|470406128|FG011|Treatment Period 1|Protocol Violation|0|||
130666701|NCT01078623|470406129|FG012|Treatment Period 1|Protocol Violation|0|||
130666702|NCT01078623|470406130|FG013|Treatment Period 1|Protocol Violation|0|||
130666703|NCT01078623|470406131|FG014|Treatment Period 1|Protocol Violation|0|||
130666704|NCT01078623|470406132|FG015|Treatment Period 1|Protocol Violation|0|||
130666705|NCT01078623|470406133|FG016|Treatment Period 1|Protocol Violation|0|||
130666706|NCT01078623|470406134|FG017|Treatment Period 1|Protocol Violation|0|||
130666707|NCT01078623|470406135|FG018|Treatment Period 1|Protocol Violation|0|||
130666708|NCT01078623|470406136|FG019|Treatment Period 1|Protocol Violation|0|||
130666709|NCT01078623|470406117|FG000|Treatment Period 2|Adverse Event|0|||
130666710|NCT01078623|470406118|FG001|Treatment Period 2|Adverse Event|0|||
130666711|NCT01078623|470406119|FG002|Treatment Period 2|Adverse Event|0|||
130666712|NCT01078623|470406120|FG003|Treatment Period 2|Adverse Event|0|||
130666713|NCT01078623|470406121|FG004|Treatment Period 2|Adverse Event|0|||
130666714|NCT01078623|470406122|FG005|Treatment Period 2|Adverse Event|0|||
130666715|NCT01078623|470406123|FG006|Treatment Period 2|Adverse Event|1|||
130666716|NCT01078623|470406124|FG007|Treatment Period 2|Adverse Event|0|||
130666717|NCT01078623|470406125|FG008|Treatment Period 2|Adverse Event|0|||
130666718|NCT01078623|470406126|FG009|Treatment Period 2|Adverse Event|0|||
130666719|NCT01078623|470406127|FG010|Treatment Period 2|Adverse Event|0|||
130666720|NCT01078623|470406128|FG011|Treatment Period 2|Adverse Event|0|||
130666721|NCT01078623|470406129|FG012|Treatment Period 2|Adverse Event|0|||
130666722|NCT01078623|470406130|FG013|Treatment Period 2|Adverse Event|0|||
130666723|NCT01078623|470406131|FG014|Treatment Period 2|Adverse Event|0|||
130666724|NCT01078623|470406132|FG015|Treatment Period 2|Adverse Event|0|||
130666725|NCT01078623|470406133|FG016|Treatment Period 2|Adverse Event|0|||
130666726|NCT01078623|470406134|FG017|Treatment Period 2|Adverse Event|0|||
130666727|NCT01078623|470406135|FG018|Treatment Period 2|Adverse Event|1|||
130666728|NCT01078623|470406136|FG019|Treatment Period 2|Adverse Event|0|||
130666729|NCT01078623|470406117|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130666730|NCT01078623|470406118|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130666731|NCT01078623|470406119|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130666732|NCT01078623|470406120|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130666733|NCT01078623|470406121|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130666734|NCT01078623|470406122|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130666735|NCT01078623|470406123|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130666736|NCT01078623|470406124|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130666737|NCT01078623|470406125|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130666738|NCT01078623|470406126|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130666739|NCT01078623|470406127|FG010|Treatment Period 2|Withdrawal by Subject|0|||
130666740|NCT01078623|470406128|FG011|Treatment Period 2|Withdrawal by Subject|0|||
130666741|NCT01078623|470406129|FG012|Treatment Period 2|Withdrawal by Subject|0|||
130666742|NCT01078623|470406130|FG013|Treatment Period 2|Withdrawal by Subject|0|||
130666743|NCT01078623|470406131|FG014|Treatment Period 2|Withdrawal by Subject|0|||
130666744|NCT01078623|470406132|FG015|Treatment Period 2|Withdrawal by Subject|0|||
130666745|NCT01078623|470406133|FG016|Treatment Period 2|Withdrawal by Subject|0|||
130666746|NCT01078623|470406134|FG017|Treatment Period 2|Withdrawal by Subject|0|||
130666747|NCT01078623|470406135|FG018|Treatment Period 2|Withdrawal by Subject|0|||
130666748|NCT01078623|470406136|FG019|Treatment Period 2|Withdrawal by Subject|0|||
130666749|NCT01078623|470406117|FG000|Treatment Period 3|Adverse Event|0|||
130666750|NCT01078623|470406118|FG001|Treatment Period 3|Adverse Event|0|||
130666751|NCT01078623|470406119|FG002|Treatment Period 3|Adverse Event|0|||
130666752|NCT01078623|470406120|FG003|Treatment Period 3|Adverse Event|0|||
130666753|NCT01078623|470406121|FG004|Treatment Period 3|Adverse Event|1|||
130666754|NCT01078623|470406122|FG005|Treatment Period 3|Adverse Event|0|||
130666755|NCT01078623|470406123|FG006|Treatment Period 3|Adverse Event|0|||
130666756|NCT01078623|470406124|FG007|Treatment Period 3|Adverse Event|0|||
130666757|NCT01078623|470406125|FG008|Treatment Period 3|Adverse Event|0|||
130666758|NCT01078623|470406126|FG009|Treatment Period 3|Adverse Event|0|||
130666759|NCT01078623|470406127|FG010|Treatment Period 3|Adverse Event|0|||
130666760|NCT01078623|470406128|FG011|Treatment Period 3|Adverse Event|0|||
130666761|NCT01078623|470406129|FG012|Treatment Period 3|Adverse Event|0|||
130666762|NCT01078623|470406130|FG013|Treatment Period 3|Adverse Event|1|||
130666763|NCT01078623|470406131|FG014|Treatment Period 3|Adverse Event|0|||
130666764|NCT01078623|470406132|FG015|Treatment Period 3|Adverse Event|0|||
130666765|NCT01078623|470406133|FG016|Treatment Period 3|Adverse Event|0|||
130666766|NCT01078623|470406134|FG017|Treatment Period 3|Adverse Event|0|||
130666767|NCT01078623|470406135|FG018|Treatment Period 3|Adverse Event|0|||
130666768|NCT01078623|470406136|FG019|Treatment Period 3|Adverse Event|0|||
130666769|NCT01078623|470406117|FG000|Treatment Period 4|Adverse Event|0|||
130666770|NCT01078623|470406118|FG001|Treatment Period 4|Adverse Event|0|||
130666771|NCT01078623|470406119|FG002|Treatment Period 4|Adverse Event|1|||
130666772|NCT01078623|470406120|FG003|Treatment Period 4|Adverse Event|0|||
130666773|NCT01078623|470406121|FG004|Treatment Period 4|Adverse Event|0|||
130666774|NCT01078623|470406122|FG005|Treatment Period 4|Adverse Event|0|||
130666775|NCT01078623|470406123|FG006|Treatment Period 4|Adverse Event|0|||
130666776|NCT01078623|470406124|FG007|Treatment Period 4|Adverse Event|0|||
130666777|NCT01078623|470406125|FG008|Treatment Period 4|Adverse Event|0|||
130335131|NCT02675634|469197351|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
130335132|NCT02675634|469197352|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
130666778|NCT01078623|470406126|FG009|Treatment Period 4|Adverse Event|0|||
130666779|NCT01078623|470406127|FG010|Treatment Period 4|Adverse Event|0|||
130666780|NCT01078623|470406128|FG011|Treatment Period 4|Adverse Event|0|||
130666781|NCT01078623|470406129|FG012|Treatment Period 4|Adverse Event|0|||
130666782|NCT01078623|470406130|FG013|Treatment Period 4|Adverse Event|0|||
130666783|NCT01078623|470406131|FG014|Treatment Period 4|Adverse Event|0|||
130666784|NCT01078623|470406132|FG015|Treatment Period 4|Adverse Event|0|||
130666785|NCT01078623|470406133|FG016|Treatment Period 4|Adverse Event|0|||
130666786|NCT01078623|470406134|FG017|Treatment Period 4|Adverse Event|0|||
130666787|NCT01078623|470406135|FG018|Treatment Period 4|Adverse Event|0|||
130666788|NCT01078623|470406136|FG019|Treatment Period 4|Adverse Event|0|||
130666789|NCT01078623|470406117|FG000|Treatment Period 4|Withdrawal by Subject|0|||
130666790|NCT01078623|470406118|FG001|Treatment Period 4|Withdrawal by Subject|0|||
130666791|NCT01078623|470406119|FG002|Treatment Period 4|Withdrawal by Subject|0|||
130666792|NCT01078623|470406120|FG003|Treatment Period 4|Withdrawal by Subject|0|||
130666793|NCT01078623|470406121|FG004|Treatment Period 4|Withdrawal by Subject|0|||
130666794|NCT01078623|470406122|FG005|Treatment Period 4|Withdrawal by Subject|0|||
130666795|NCT01078623|470406123|FG006|Treatment Period 4|Withdrawal by Subject|0|||
130666796|NCT01078623|470406124|FG007|Treatment Period 4|Withdrawal by Subject|0|||
130666797|NCT01078623|470406125|FG008|Treatment Period 4|Withdrawal by Subject|0|||
130666798|NCT01078623|470406126|FG009|Treatment Period 4|Withdrawal by Subject|0|||
130666799|NCT01078623|470406127|FG010|Treatment Period 4|Withdrawal by Subject|0|||
130666800|NCT01078623|470406128|FG011|Treatment Period 4|Withdrawal by Subject|0|||
130666801|NCT01078623|470406129|FG012|Treatment Period 4|Withdrawal by Subject|0|||
130666802|NCT01078623|470406130|FG013|Treatment Period 4|Withdrawal by Subject|0|||
130666803|NCT01078623|470406131|FG014|Treatment Period 4|Withdrawal by Subject|0|||
130666804|NCT01078623|470406132|FG015|Treatment Period 4|Withdrawal by Subject|1|||
130666805|NCT01078623|470406133|FG016|Treatment Period 4|Withdrawal by Subject|0|||
130666806|NCT01078623|470406134|FG017|Treatment Period 4|Withdrawal by Subject|0|||
130666807|NCT01078623|470406135|FG018|Treatment Period 4|Withdrawal by Subject|0|||
130666808|NCT01078623|470406136|FG019|Treatment Period 4|Withdrawal by Subject|0|||
130666809|NCT04356573|470406137|FG000|Overall Study|Didn't Qualify|1|||
130666810|NCT04356573|470406138|FG001|Overall Study|Didn't Qualify|0|||
130666811|NCT03568500|470406139|FG000|Overall Study|Lost to Follow-up|1|||
130666812|NCT03568500|470406140|FG001|Overall Study|Lost to Follow-up|1|||
130666813|NCT03568500|470406141|FG002|Overall Study|Lost to Follow-up|2|||
130666814|NCT03568500|470406139|FG000|Overall Study|Adverse Event|1|||
130666815|NCT03568500|470406140|FG001|Overall Study|Adverse Event|1|||
130666816|NCT03568500|470406141|FG002|Overall Study|Adverse Event|2|||
130666817|NCT03568500|470406139|FG000|Overall Study|Physician Decision|1|||
130666818|NCT03568500|470406140|FG001|Overall Study|Physician Decision|0|||
130666819|NCT03568500|470406141|FG002|Overall Study|Physician Decision|0|||
130666820|NCT03568500|470406139|FG000|Overall Study|Withdrawal by Subject|4|||
130666821|NCT03568500|470406140|FG001|Overall Study|Withdrawal by Subject|2|||
130335133|NCT02675634|469197353|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
130335134|NCT02675634|469197354|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
130335135|NCT02675634|469197355|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
130335136|NCT02675634|469197356|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
130335137|NCT02675634|469197351|FG000|Test Period 2|Lack of Efficacy|1|||
130335138|NCT02675634|469197352|FG001|Test Period 2|Lack of Efficacy|0|||
130335139|NCT02675634|469197353|FG002|Test Period 2|Lack of Efficacy|0|||
130335140|NCT02675634|469197354|FG003|Test Period 2|Lack of Efficacy|0|||
130335141|NCT02675634|469197355|FG004|Test Period 2|Lack of Efficacy|0|||
130335142|NCT02675634|469197356|FG005|Test Period 2|Lack of Efficacy|0|||
130335143|NCT02675634|469197351|FG000|Test Period 2|Adverse Event|0|||
130335144|NCT02675634|469197352|FG001|Test Period 2|Adverse Event|0|||
130335145|NCT02675634|469197353|FG002|Test Period 2|Adverse Event|0|||
130335146|NCT02675634|469197354|FG003|Test Period 2|Adverse Event|0|||
130335147|NCT02675634|469197355|FG004|Test Period 2|Adverse Event|0|||
130666822|NCT03568500|470406141|FG002|Overall Study|Withdrawal by Subject|0|||
130666823|NCT03568500|470406139|FG000|Overall Study|Technical Problems|2|||
130666824|NCT03568500|470406140|FG001|Overall Study|Technical Problems|1|||
130666825|NCT03568500|470406141|FG002|Overall Study|Technical Problems|0|||
130666826|NCT03568500|470406139|FG000|Overall Study|Participant Noncompliance|1|||
130666827|NCT03568500|470406140|FG001|Overall Study|Participant Noncompliance|1|||
130666828|NCT03568500|470406141|FG002|Overall Study|Participant Noncompliance|0|||
130666829|NCT04132232|470406150|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
130666830|NCT04132232|470406151|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
130666831|NCT04132232|470406150|FG000|Overall Study|Lost to Follow-up|6|||
130666832|NCT04132232|470406151|FG001|Overall Study|Lost to Follow-up|7|||
130666833|NCT00368537|470406153|FG000|Randomization|No study drug dosed|13|||
130666834|NCT00368537|470406154|FG001|Randomization|No study drug dosed|6|||
130666835|NCT00368537|470406153|FG000|Baseline Participants|Lost to Follow-up|16|||
130666836|NCT00368537|470406154|FG001|Baseline Participants|Lost to Follow-up|17|||
130666837|NCT00368537|470406153|FG000|Baseline Participants|Withdrawal by Subject|6|||
130666838|NCT00368537|470406154|FG001|Baseline Participants|Withdrawal by Subject|4|||
130666839|NCT00368537|470406153|FG000|Baseline Participants|Death|1|||
130666840|NCT00368537|470406154|FG001|Baseline Participants|Death|2|||
130666841|NCT00368537|470406153|FG000|Baseline Participants|No susceptibility|1|||
130666842|NCT00368537|470406154|FG001|Baseline Participants|No susceptibility|0|||
130666843|NCT00368537|470406153|FG000|Baseline Participants|Patient uncompliant|0|||
130666844|NCT00368537|470406154|FG001|Baseline Participants|Patient uncompliant|1|||
130666845|NCT01368276|470406166|FG000|Overall Study|Death|1|||
130666846|NCT01368276|470406167|FG001|Overall Study|Death|10|||
130666847|NCT00685919|470406168|FG000|Overall Study|Withdrawal by Subject|0|||
130666848|NCT00685919|470406169|FG001|Overall Study|Withdrawal by Subject|0|||
130666849|NCT00685919|470406170|FG002|Overall Study|Withdrawal by Subject|1|||
130666850|NCT00685919|470406171|FG003|Overall Study|Withdrawal by Subject|0|||
130666851|NCT00685919|470406168|FG000|Overall Study|Physician Decision|1|||
130666852|NCT00685919|470406169|FG001|Overall Study|Physician Decision|0|||
130666853|NCT00685919|470406170|FG002|Overall Study|Physician Decision|0|||
130666854|NCT00685919|470406171|FG003|Overall Study|Physician Decision|0|||
130666855|NCT01886300|470406178|FG000|Overall Study|Trial terminated by sponsor|16|||
130666856|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
130666857|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130666858|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
130666859|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130666860|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130666861|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130666862|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
130666863|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130335148|NCT02675634|469197356|FG005|Test Period 2|Adverse Event|1|||
130335149|NCT01652534|469197357|FG000|Overall Study|Lack of Efficacy|1|||
130335150|NCT01652534|469197358|FG001|Overall Study|Lack of Efficacy|0|||
130335151|NCT02105961|469197359|FG000|Overall Study|Adverse Event|18|||
130335152|NCT02105961|469197360|FG001|Overall Study|Adverse Event|7|||
130335153|NCT02105961|469197361|FG002|Overall Study|Adverse Event|13|||
130335154|NCT02105961|469197359|FG000|Overall Study|Lack of Efficacy|3|||
130335155|NCT02105961|469197360|FG001|Overall Study|Lack of Efficacy|0|||
130335156|NCT02105961|469197361|FG002|Overall Study|Lack of Efficacy|3|||
130335157|NCT02105961|469197359|FG000|Overall Study|Lost to Follow-up|2|||
130335158|NCT02105961|469197360|FG001|Overall Study|Lost to Follow-up|0|||
130335159|NCT02105961|469197361|FG002|Overall Study|Lost to Follow-up|1|||
130335160|NCT02105961|469197359|FG000|Overall Study|Physician Decision|3|||
130335161|NCT02105961|469197360|FG001|Overall Study|Physician Decision|3|||
130335162|NCT02105961|469197361|FG002|Overall Study|Physician Decision|2|||
130335163|NCT02105961|469197359|FG000|Overall Study|Withdrawal by Subject|15|||
130335164|NCT02105961|469197360|FG001|Overall Study|Withdrawal by Subject|7|||
130335165|NCT02105961|469197361|FG002|Overall Study|Withdrawal by Subject|11|||
130335166|NCT03860259|469197362|FG000|Overall Study|Lost to Follow-up|5|||
130335167|NCT03860259|469197363|FG001|Overall Study|Lost to Follow-up|5|||
130335168|NCT03860259|469197362|FG000|Overall Study|Protocol Violation|1|||
130335169|NCT03860259|469197363|FG001|Overall Study|Protocol Violation|0|||
130335170|NCT00811018|469197364|FG000|Overall Study|Additional Chronic Treatment|31|||
130335171|NCT00811018|469197364|FG000|Overall Study|Adverse Event|79|||
130335172|NCT00811018|469197364|FG000|Overall Study|Death|147|||
130335173|NCT00811018|469197364|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
130335174|NCT00811018|469197364|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
130335175|NCT00811018|469197364|FG000|Overall Study|Investigator Decision|57|||
130335176|NCT00811018|469197364|FG000|Overall Study|Lost to Follow-up|19|||
130335177|NCT00811018|469197364|FG000|Overall Study|Pregnancy|6|||
130335178|NCT00811018|469197364|FG000|Overall Study|Sponsor Decision|450|||
130335179|NCT00811018|469197364|FG000|Overall Study|Withdrawal by Subject|70|||
130335180|NCT00811018|469197364|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
130335181|NCT00811018|469197364|FG000|Overall Study|Other|26|||
130335182|NCT00934362|469197368|FG000|Overall Study|Adverse Event|1|||
130335183|NCT00934362|469197369|FG001|Overall Study|Adverse Event|0|||
130666864|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
130666865|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
130666866|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
130666867|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
130666868|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
130335184|NCT01092117|469197370|FG000|Index Procedure to 1 Month|Death|1|||
130335185|NCT01092117|469197370|FG000|1 Month|Death|1|||
130335186|NCT01092117|469197370|FG000|1 Month|Withdrawal by Subject|1|||
130335187|NCT01092117|469197370|FG000|1 Month|Lost to Follow-up|1|||
130666869|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130666870|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130666871|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
130666872|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130666873|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130666874|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
130666875|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130666876|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
130666877|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
130666878|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
130666879|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
130666880|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130666881|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130666882|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
130666883|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130666884|NCT00528879|470406181|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
130666885|NCT00528879|470406182|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
130666886|NCT00528879|470406183|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
130666887|NCT00528879|470406184|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
130666888|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
130666889|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
130666890|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
130666891|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
130666892|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
130666893|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
130666894|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
130666895|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
130666896|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
130666897|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
130666898|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
130666899|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
130666900|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
130666901|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
130666902|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
130666903|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
130666904|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
130666905|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
130666906|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
130666907|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
130666908|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
130666909|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
130666910|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
130666911|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
130666912|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
130666913|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
130666914|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
130666915|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
130666916|NCT00528879|470406181|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130666917|NCT00528879|470406182|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130666918|NCT00528879|470406183|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130666919|NCT00528879|470406184|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
130666920|NCT04133519|470406185|FG000|Overall Study|Withdrawal by Subject|5|||
130335188|NCT01092117|469197370|FG000|6 Months|Death|2|||
130335189|NCT01092117|469197370|FG000|6 Months|Withdrawal by Subject|3|||
130335190|NCT01092117|469197370|FG000|12 Month|Death|11|||
130335191|NCT01092117|469197370|FG000|12 Month|Withdrawal by Subject|2|||
130335192|NCT01092117|469197370|FG000|12 Month|Lost to Follow-up|1|||
130335193|NCT01092117|469197370|FG000|Year 2|Death|5|||
130335194|NCT01092117|469197370|FG000|Year 2|Withdrawal by Subject|4|||
130552652|NCT01598311|469990261|FG001|Overall Study|Lost to Follow-up|12|||
130335195|NCT01092117|469197370|FG000|Year 2|Lost to Follow-up|1|||
130335196|NCT01092117|469197370|FG000|Year 3|Death|7|||
130335197|NCT01092117|469197370|FG000|Year 3|Withdrawal by Subject|9|||
130335198|NCT01092117|469197370|FG000|Year 3|Lost to Follow-up|3|||
130335199|NCT01092117|469197370|FG000|Year 4|Death|8|||
130666921|NCT04133519|470406186|FG001|Overall Study|Withdrawal by Subject|4|||
130666922|NCT04133519|470406185|FG000|Overall Study|Protocol Violation|0|||
130666923|NCT04133519|470406186|FG001|Overall Study|Protocol Violation|1|||
130666924|NCT04133519|470406185|FG000|Overall Study|Never started treatment|1|||
130666925|NCT04133519|470406186|FG001|Overall Study|Never started treatment|1|||
130666926|NCT02217345|470406187|FG000|Overall Study|Lost to Follow-up|2|||
130666927|NCT02217345|470406188|FG001|Overall Study|Lost to Follow-up|1|||
130666928|NCT02217345|470406187|FG000|Overall Study|Withdrawal by Subject|3|||
130666929|NCT02217345|470406188|FG001|Overall Study|Withdrawal by Subject|2|||
130666930|NCT02217345|470406187|FG000|Overall Study|Adverse Event|2|||
130666931|NCT02217345|470406188|FG001|Overall Study|Adverse Event|1|||
130666932|NCT02217345|470406187|FG000|Overall Study|Physician Decision|0|||
130666933|NCT02217345|470406188|FG001|Overall Study|Physician Decision|1|||
130666934|NCT03196791|470406189|FG000|Overall Study|Protocol Violation|7|||
130666935|NCT03196791|470406190|FG001|Overall Study|Protocol Violation|3|||
130666936|NCT03196791|470406189|FG000|Overall Study|Withdrawal by Subject|3|||
130666937|NCT03196791|470406190|FG001|Overall Study|Withdrawal by Subject|2|||
130666938|NCT00575328|470406191|FG000|Overall Study|Adverse Event|1|||
130666939|NCT00575328|470406192|FG001|Overall Study|Adverse Event|1|||
130666940|NCT00575328|470406191|FG000|Overall Study|Lost to Follow-up|2|||
130666941|NCT00575328|470406192|FG001|Overall Study|Lost to Follow-up|1|||
130666942|NCT02191579|470406203|FG000|Treatment 1|Multiple Reasons Specified|27|||
130666943|NCT02191579|470406204|FG001|Treatment 1|Multiple Reasons Specified|58|||
130666944|NCT02191579|470406203|FG000|Treatment 2|Multiple Reasons Specified|0|||
130666945|NCT02191579|470406204|FG001|Treatment 2|Multiple Reasons Specified|25|||
130666946|NCT03940586|470406211|FG000|Overall Study|Death|3|||
130666947|NCT03940586|470406212|FG001|Overall Study|Death|2|||
130666948|NCT03940586|470406213|FG002|Overall Study|Death|0|||
130666949|NCT03940586|470406211|FG000|Overall Study|Physician Decision|1|||
130666950|NCT03940586|470406212|FG001|Overall Study|Physician Decision|0|||
130666951|NCT03940586|470406213|FG002|Overall Study|Physician Decision|1|||
130666952|NCT03940586|470406211|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
130666953|NCT03940586|470406212|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
130666954|NCT03940586|470406213|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130666955|NCT03940586|470406211|FG000|Overall Study|Not Treated|0|||
130666956|NCT03940586|470406212|FG001|Overall Study|Not Treated|2|||
130666957|NCT03940586|470406213|FG002|Overall Study|Not Treated|0|||
130666958|NCT00964223|470406214|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
130666959|NCT03077828|470406215|FG000|Treatment Cycles|Death|1|||
130666960|NCT03077828|470406215|FG000|Treatment Cycles|Withdrawal by Subject|1|||
130666961|NCT03077828|470406215|FG000|Treatment Cycles|Screen Fail|2|||
130666962|NCT03077828|470406215|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
130666963|NCT03077828|470406215|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
130335200|NCT01092117|469197370|FG000|Year 4|Withdrawal by Subject|4|||
130335201|NCT01092117|469197370|FG000|Year 4|Lost to Follow-up|4|||
130335202|NCT04380519|469197371|FG000|Overall Study|Withdrawal by Subject|4|||
130335203|NCT04380519|469197372|FG001|Overall Study|Withdrawal by Subject|0|||
130335204|NCT04380519|469197373|FG002|Overall Study|Withdrawal by Subject|1|||
130335205|NCT04380519|469197371|FG000|Overall Study|Death|14|||
130335206|NCT04380519|469197372|FG001|Overall Study|Death|9|||
130335207|NCT04380519|469197373|FG002|Overall Study|Death|6|||
130335208|NCT04380519|469197371|FG000|Overall Study|Adverse Event|0|||
130335209|NCT04380519|469197372|FG001|Overall Study|Adverse Event|1|||
130335210|NCT04380519|469197373|FG002|Overall Study|Adverse Event|0|||
130335211|NCT04380519|469197371|FG000|Overall Study|relatives' decision|0|||
130335212|NCT04380519|469197372|FG001|Overall Study|relatives' decision|1|||
130335213|NCT04380519|469197373|FG002|Overall Study|relatives' decision|0|||
130335214|NCT02147561|469197376|FG000|Overall Study|Lost to Follow-up|3|||
130335215|NCT02147561|469197376|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
130335216|NCT00393861|469197379|FG000|Overall Study|Adverse Event|2|||
130335217|NCT00393861|469197379|FG000|Overall Study|Disease Progression|24|||
130335218|NCT05300763|469197380|FG000|Overall Study|Adverse Event|0|||
130335219|NCT05300763|469197381|FG001|Overall Study|Adverse Event|1|||
130335220|NCT05300763|469197380|FG000|Overall Study|Major Protocol Deviation|1|||
130666964|NCT03077828|470406215|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
130666965|NCT03077828|470406215|FG000|Follow-up|Patients still in follow-up|15|||
130666966|NCT00345683|470406219|FG000|Overall Study|Lost to Follow-up|19|||
130666967|NCT00345683|470406220|FG001|Overall Study|Lost to Follow-up|7|||
130666968|NCT00345683|470406219|FG000|Overall Study|Other|6|||
130666969|NCT00345683|470406220|FG001|Overall Study|Other|2|||
130666970|NCT04288115|470406221|FG000|Overall Study|Withdrawal by Subject|0|||
130666971|NCT04288115|470406222|FG001|Overall Study|Withdrawal by Subject|1|||
130666972|NCT04288115|470406221|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
130720914|NCT01140503|470601560|FG000|Overall Study|Withdrawal by Subject|1|||
130335221|NCT05300763|469197381|FG001|Overall Study|Major Protocol Deviation|0|||
130335222|NCT05300763|469197380|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130335223|NCT05300763|469197381|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130335224|NCT01727024|469197382|FG000|Period 1|Lost to Follow-up|1|||
130666973|NCT04288115|470406222|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
130666974|NCT05037409|470406225|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
130666975|NCT05037409|470406226|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
130666976|NCT05037409|470406227|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
130666977|NCT00931385|470406228|FG000|Overall Study|Adverse Event|2|||
130666978|NCT00931385|470406229|FG001|Overall Study|Adverse Event|1|||
130666979|NCT00931385|470406230|FG002|Overall Study|Adverse Event|0|||
130666980|NCT00931385|470406231|FG003|Overall Study|Adverse Event|3|||
130666981|NCT00931385|470406228|FG000|Overall Study|Protocol Violation|0|||
130666982|NCT00931385|470406229|FG001|Overall Study|Protocol Violation|0|||
130666983|NCT00931385|470406230|FG002|Overall Study|Protocol Violation|1|||
130666984|NCT00931385|470406231|FG003|Overall Study|Protocol Violation|0|||
130666985|NCT00931385|470406228|FG000|Overall Study|Withdrawal by Subject|0|||
130666986|NCT00931385|470406229|FG001|Overall Study|Withdrawal by Subject|1|||
130666987|NCT00931385|470406230|FG002|Overall Study|Withdrawal by Subject|0|||
130666988|NCT00931385|470406231|FG003|Overall Study|Withdrawal by Subject|1|||
130666989|NCT00931385|470406228|FG000|Overall Study|Lost to Follow-up|0|||
130335225|NCT01727024|469197383|FG001|Period 1|Lost to Follow-up|1|||
130335226|NCT01727024|469197382|FG000|Period 1|Withdrawal by Subject|2|||
130335227|NCT01727024|469197383|FG001|Period 1|Withdrawal by Subject|3|||
130335228|NCT01485172|469197384|FG000|Overall Study|Adverse Event|2|||
130335229|NCT01485172|469197385|FG001|Overall Study|Adverse Event|1|||
130335230|NCT01485172|469197386|FG002|Overall Study|Adverse Event|2|||
130335231|NCT01485172|469197387|FG003|Overall Study|Adverse Event|2|||
130335232|NCT01485172|469197388|FG004|Overall Study|Adverse Event|1|||
130335233|NCT01485172|469197389|FG005|Overall Study|Adverse Event|2|||
130335234|NCT01485172|469197384|FG000|Overall Study|Lack of Efficacy|2|||
130335235|NCT01485172|469197385|FG001|Overall Study|Lack of Efficacy|0|||
130666990|NCT00931385|470406229|FG001|Overall Study|Lost to Follow-up|0|||
130666991|NCT00931385|470406230|FG002|Overall Study|Lost to Follow-up|0|||
130666992|NCT00931385|470406231|FG003|Overall Study|Lost to Follow-up|1|||
130666993|NCT01298596|470406234|FG000|Overall Study|Withdrawal by Subject|1|||
130666994|NCT01298596|470406235|FG001|Overall Study|Withdrawal by Subject|1|||
130666995|NCT01298596|470406234|FG000|Overall Study|Death|5|||
130666996|NCT01298596|470406235|FG001|Overall Study|Death|3|||
130666997|NCT01298596|470406234|FG000|Overall Study|Lost to Follow-up|6|||
130666998|NCT01298596|470406235|FG001|Overall Study|Lost to Follow-up|14|||
130666999|NCT01298596|470406234|FG000|Overall Study|Referred for further management|16|||
130667000|NCT01298596|470406235|FG001|Overall Study|Referred for further management|15|||
130667001|NCT04128696|470406242|FG000|Overall Study|Lost to Follow-up|3|||
130667002|NCT04128696|470406243|FG001|Overall Study|Lost to Follow-up|7|||
130667003|NCT04128696|470406242|FG000|Overall Study|Withdrawal by Subject|12|||
130667004|NCT04128696|470406243|FG001|Overall Study|Withdrawal by Subject|11|||
130667005|NCT04128696|470406242|FG000|Overall Study|Study Closed/Terminated|26|||
130667006|NCT04128696|470406243|FG001|Overall Study|Study Closed/Terminated|38|||
130667007|NCT04128696|470406242|FG000|Overall Study|Physician Decision|2|||
130667008|NCT04128696|470406243|FG001|Overall Study|Physician Decision|3|||
130667009|NCT00585039|470406244|FG000|Overall Study|medication spilled|2|||
130667010|NCT00585039|470406245|FG001|Overall Study|medication spilled|0|||
130667011|NCT01010230|470406246|FG000|Overall Study|Withdrawal by Subject|6|||
130667012|NCT01010230|470406247|FG001|Overall Study|Withdrawal by Subject|5|||
130667013|NCT01010230|470406246|FG000|Overall Study|Lost to Follow-up|4|||
130667014|NCT01010230|470406247|FG001|Overall Study|Lost to Follow-up|2|||
130667015|NCT01629693|470406250|FG000|Overall Study|Lost to Follow-up|2|||
130667016|NCT01629693|470406251|FG001|Overall Study|Lost to Follow-up|4|||
130667017|NCT01629693|470406250|FG000|Overall Study|Withdrawal by Subject|2|||
130667018|NCT01629693|470406251|FG001|Overall Study|Withdrawal by Subject|2|||
130667019|NCT01629693|470406250|FG000|Overall Study|Adverse Event|1|||
130667020|NCT01629693|470406251|FG001|Overall Study|Adverse Event|0|||
130667021|NCT01629693|470406250|FG000|Overall Study|Investigator decision|0|||
130667022|NCT01629693|470406251|FG001|Overall Study|Investigator decision|1|||
130335236|NCT01485172|469197386|FG002|Overall Study|Lack of Efficacy|0|||
130335237|NCT01485172|469197387|FG003|Overall Study|Lack of Efficacy|0|||
130667023|NCT01629693|470406250|FG000|Overall Study|Poor comfort of study lenses|0|||
130667024|NCT01629693|470406251|FG001|Overall Study|Poor comfort of study lenses|2|||
130667025|NCT01629693|470406250|FG000|Overall Study|Subject decision unrelated to AE|0|||
130667026|NCT01629693|470406251|FG001|Overall Study|Subject decision unrelated to AE|1|||
130335238|NCT01485172|469197388|FG004|Overall Study|Lack of Efficacy|0|||
130667027|NCT01585831|470406258|FG000|Overall Study|Physician Decision|0|||
130667028|NCT01585831|470406259|FG001|Overall Study|Physician Decision|1|||
130667029|NCT01585831|470406258|FG000|Overall Study|Withdrawal by Subject|2|||
130667030|NCT01585831|470406259|FG001|Overall Study|Withdrawal by Subject|1|||
130667031|NCT02046369|470406260|FG000|Overall Study|Adverse Event|3|||
130667032|NCT02046369|470406261|FG001|Overall Study|Adverse Event|3|||
130335239|NCT01485172|469197389|FG005|Overall Study|Lack of Efficacy|0|||
130335240|NCT01485172|469197384|FG000|Overall Study|Protocol Violation|0|||
130335241|NCT01485172|469197385|FG001|Overall Study|Protocol Violation|0|||
130667033|NCT02046369|470406260|FG000|Overall Study|Lack of Efficacy|3|||
130667034|NCT02046369|470406261|FG001|Overall Study|Lack of Efficacy|3|||
130667035|NCT02046369|470406260|FG000|Overall Study|Lost to Follow-up|3|||
130667036|NCT02046369|470406261|FG001|Overall Study|Lost to Follow-up|3|||
130667037|NCT02046369|470406260|FG000|Overall Study|Protocol Violation|1|||
130667038|NCT02046369|470406261|FG001|Overall Study|Protocol Violation|2|||
130667039|NCT02046369|470406260|FG000|Overall Study|Withdrawal by Subject|3|||
130667040|NCT02046369|470406261|FG001|Overall Study|Withdrawal by Subject|6|||
130667041|NCT02046369|470406260|FG000|Overall Study|never received study drug|0|||
130667042|NCT02046369|470406261|FG001|Overall Study|never received study drug|1|||
130667043|NCT02046369|470406260|FG000|Overall Study|non compliance|1|||
130667044|NCT02046369|470406261|FG001|Overall Study|non compliance|0|||
130667045|NCT03120520|470406262|FG000|Overall Study|Lost to Follow-up|1|||
130667046|NCT03120520|470406263|FG001|Overall Study|Lost to Follow-up|1|||
130667047|NCT03120520|470406264|FG002|Overall Study|Lost to Follow-up|1|||
130667048|NCT03120520|470406265|FG003|Overall Study|Lost to Follow-up|1|||
130667049|NCT03120520|470406262|FG000|Overall Study|Withdrawal by Subject|3|||
130667050|NCT03120520|470406263|FG001|Overall Study|Withdrawal by Subject|2|||
130667051|NCT03120520|470406264|FG002|Overall Study|Withdrawal by Subject|3|||
130667052|NCT03120520|470406265|FG003|Overall Study|Withdrawal by Subject|2|||
130667053|NCT03120520|470406262|FG000|Overall Study|Other|0|||
130667054|NCT03120520|470406263|FG001|Overall Study|Other|1|||
130667055|NCT03120520|470406264|FG002|Overall Study|Other|0|||
130667056|NCT03120520|470406265|FG003|Overall Study|Other|0|||
130667057|NCT04385199|470406266|FG000|Overall Study|Withdrawal by Subject|1|||
130667058|NCT04385199|470406267|FG001|Overall Study|Withdrawal by Subject|0|||
130667059|NCT02133352|470406271|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
130667060|NCT04444752|470406272|FG000|Overall Study|Adverse Event|1|||
130667061|NCT04444752|470406273|FG001|Overall Study|Adverse Event|0|||
130667062|NCT04444752|470406274|FG002|Overall Study|Adverse Event|0|||
130667063|NCT04444752|470406275|FG003|Overall Study|Adverse Event|2|||
130667064|NCT04444752|470406272|FG000|Overall Study|Lost to Follow-up|2|||
130667065|NCT04444752|470406273|FG001|Overall Study|Lost to Follow-up|6|||
130667066|NCT04444752|470406274|FG002|Overall Study|Lost to Follow-up|2|||
130667067|NCT04444752|470406275|FG003|Overall Study|Lost to Follow-up|5|||
130667068|NCT04444752|470406272|FG000|Overall Study|Physician Decision|0|||
130667069|NCT04444752|470406273|FG001|Overall Study|Physician Decision|0|||
130667070|NCT04444752|470406274|FG002|Overall Study|Physician Decision|0|||
130667071|NCT04444752|470406275|FG003|Overall Study|Physician Decision|2|||
130667072|NCT04444752|470406272|FG000|Overall Study|Pregnancy|0|||
130667073|NCT04444752|470406273|FG001|Overall Study|Pregnancy|0|||
130667074|NCT04444752|470406274|FG002|Overall Study|Pregnancy|0|||
130667075|NCT04444752|470406275|FG003|Overall Study|Pregnancy|1|||
130667076|NCT04444752|470406272|FG000|Overall Study|Withdrawal by Subject|6|||
130667077|NCT04444752|470406273|FG001|Overall Study|Withdrawal by Subject|5|||
130667078|NCT04444752|470406274|FG002|Overall Study|Withdrawal by Subject|3|||
130667079|NCT04444752|470406275|FG003|Overall Study|Withdrawal by Subject|4|||
130667080|NCT04444752|470406272|FG000|Overall Study|Protocol Violation|1|||
130667081|NCT04444752|470406273|FG001|Overall Study|Protocol Violation|1|||
130667082|NCT04444752|470406274|FG002|Overall Study|Protocol Violation|0|||
130667083|NCT04444752|470406275|FG003|Overall Study|Protocol Violation|0|||
130667084|NCT04444752|470406272|FG000|Overall Study|Patient moving out of town|1|||
130667085|NCT04444752|470406273|FG001|Overall Study|Patient moving out of town|0|||
130667086|NCT04444752|470406274|FG002|Overall Study|Patient moving out of town|0|||
130667087|NCT04444752|470406275|FG003|Overall Study|Patient moving out of town|1|||
130667088|NCT04444752|470406272|FG000|Overall Study|Lack of Efficacy|0|||
130667089|NCT04444752|470406273|FG001|Overall Study|Lack of Efficacy|0|||
130667090|NCT04444752|470406274|FG002|Overall Study|Lack of Efficacy|0|||
130667091|NCT04444752|470406275|FG003|Overall Study|Lack of Efficacy|1|||
130667092|NCT04444752|470406272|FG000|Overall Study|Death|0|||
130667093|NCT04444752|470406273|FG001|Overall Study|Death|0|||
130667094|NCT04444752|470406274|FG002|Overall Study|Death|1|||
130667095|NCT04444752|470406275|FG003|Overall Study|Death|0|||
130667096|NCT00579254|470406276|FG000|Overall Study|Lost to Follow-up|39|||
130667097|NCT00579254|470406276|FG000|Overall Study|Discontinued when study terminated|73|||
130667098|NCT02557672|470406277|FG000|Overall Study|Withdrawal by Subject|4|||
130667099|NCT02557672|470406278|FG001|Overall Study|Withdrawal by Subject|2|||
130667100|NCT03705169|470406279|FG000|Overall Study|Lost to Follow-up|0|||
130667101|NCT03705169|470406280|FG001|Overall Study|Lost to Follow-up|0|||
130667102|NCT03705169|470406281|FG002|Overall Study|Lost to Follow-up|0|||
130667103|NCT03705169|470406282|FG003|Overall Study|Lost to Follow-up|2|||
130667104|NCT03705169|470406283|FG004|Overall Study|Lost to Follow-up|0|||
130667105|NCT03705169|470406284|FG005|Overall Study|Lost to Follow-up|2|||
130667106|NCT03705169|470406285|FG006|Overall Study|Lost to Follow-up|1|||
130667107|NCT03705169|470406286|FG007|Overall Study|Lost to Follow-up|0|||
130667108|NCT03705169|470406287|FG008|Overall Study|Lost to Follow-up|0|||
130667109|NCT03705169|470406288|FG009|Overall Study|Lost to Follow-up|1|||
130667110|NCT03705169|470406279|FG000|Overall Study|Adverse Event|0|||
130667111|NCT03705169|470406280|FG001|Overall Study|Adverse Event|0|||
130667112|NCT03705169|470406281|FG002|Overall Study|Adverse Event|0|||
130667113|NCT03705169|470406282|FG003|Overall Study|Adverse Event|1|||
130667114|NCT03705169|470406283|FG004|Overall Study|Adverse Event|0|||
130667115|NCT03705169|470406284|FG005|Overall Study|Adverse Event|0|||
130667116|NCT03705169|470406285|FG006|Overall Study|Adverse Event|0|||
130667117|NCT03705169|470406286|FG007|Overall Study|Adverse Event|0|||
130667118|NCT03705169|470406287|FG008|Overall Study|Adverse Event|0|||
130667119|NCT03705169|470406288|FG009|Overall Study|Adverse Event|0|||
130667120|NCT03705169|470406279|FG000|Overall Study|Site Closure|0|||
130667121|NCT03705169|470406280|FG001|Overall Study|Site Closure|0|||
130667122|NCT03705169|470406281|FG002|Overall Study|Site Closure|0|||
130667123|NCT03705169|470406282|FG003|Overall Study|Site Closure|1|||
130667124|NCT03705169|470406283|FG004|Overall Study|Site Closure|0|||
130667125|NCT03705169|470406284|FG005|Overall Study|Site Closure|0|||
130667126|NCT03705169|470406285|FG006|Overall Study|Site Closure|0|||
130667127|NCT03705169|470406286|FG007|Overall Study|Site Closure|0|||
130667128|NCT03705169|470406287|FG008|Overall Study|Site Closure|0|||
130667129|NCT03705169|470406288|FG009|Overall Study|Site Closure|0|||
130667130|NCT03705169|470406279|FG000|Overall Study|Did not receive study treatment|0|||
130667131|NCT03705169|470406280|FG001|Overall Study|Did not receive study treatment|0|||
130667132|NCT03705169|470406281|FG002|Overall Study|Did not receive study treatment|0|||
130667133|NCT03705169|470406282|FG003|Overall Study|Did not receive study treatment|1|||
130667134|NCT03705169|470406283|FG004|Overall Study|Did not receive study treatment|0|||
130667135|NCT03705169|470406284|FG005|Overall Study|Did not receive study treatment|0|||
130667136|NCT03705169|470406285|FG006|Overall Study|Did not receive study treatment|0|||
130667137|NCT03705169|470406286|FG007|Overall Study|Did not receive study treatment|0|||
130667138|NCT03705169|470406287|FG008|Overall Study|Did not receive study treatment|0|||
130667139|NCT03705169|470406288|FG009|Overall Study|Did not receive study treatment|0|||
130667140|NCT03705169|470406279|FG000|Overall Study|Concerns about study visit compliance|0|||
130667141|NCT03705169|470406280|FG001|Overall Study|Concerns about study visit compliance|0|||
130667142|NCT03705169|470406281|FG002|Overall Study|Concerns about study visit compliance|0|||
130667143|NCT03705169|470406282|FG003|Overall Study|Concerns about study visit compliance|1|||
130667144|NCT03705169|470406283|FG004|Overall Study|Concerns about study visit compliance|0|||
130667145|NCT03705169|470406284|FG005|Overall Study|Concerns about study visit compliance|0|||
130667146|NCT03705169|470406285|FG006|Overall Study|Concerns about study visit compliance|0|||
130667147|NCT03705169|470406286|FG007|Overall Study|Concerns about study visit compliance|0|||
130667148|NCT03705169|470406287|FG008|Overall Study|Concerns about study visit compliance|0|||
130667149|NCT03705169|470406288|FG009|Overall Study|Concerns about study visit compliance|0|||
130667150|NCT01759537|470406289|FG000|Overall Study|Death|1|||
130667151|NCT01759537|470406290|FG001|Overall Study|Death|1|||
130667152|NCT01759537|470406289|FG000|Overall Study|Pregnancy|1|||
130667153|NCT01759537|470406290|FG001|Overall Study|Pregnancy|1|||
130667154|NCT01759537|470406289|FG000|Overall Study|Lost to Follow-up|9|||
130667155|NCT01759537|470406290|FG001|Overall Study|Lost to Follow-up|9|||
130667156|NCT01759537|470406289|FG000|Overall Study|Accident involving jaw fracture|1|||
130667157|NCT01759537|470406290|FG001|Overall Study|Accident involving jaw fracture|1|||
130667158|NCT01759537|470406289|FG000|Overall Study|Subcrestal implant too coronal|1|||
130667159|NCT01759537|470406290|FG001|Overall Study|Subcrestal implant too coronal|1|||
130667160|NCT00420290|470406291|FG000|Overall Study|Adverse Event|3|||
130667161|NCT00420290|470406292|FG001|Overall Study|Adverse Event|1|||
130667162|NCT00420290|470406291|FG000|Overall Study|Withdrawal by Subject|0|||
130667163|NCT00420290|470406292|FG001|Overall Study|Withdrawal by Subject|2|||
130667164|NCT00420290|470406291|FG000|Overall Study|did not meet inclusion/exclusion|1|||
130667165|NCT00420290|470406292|FG001|Overall Study|did not meet inclusion/exclusion|1|||
130667166|NCT03877237|470408094|FG000|Overall Study|Adverse Event|1|||
130667167|NCT03877237|470408095|FG001|Overall Study|Adverse Event|2|||
130667168|NCT03877237|470408094|FG000|Overall Study|Death|3|||
130667169|NCT03877237|470408095|FG001|Overall Study|Death|2|||
130667170|NCT03877237|470408094|FG000|Overall Study|Physician Decision|1|||
130667171|NCT03877237|470408095|FG001|Overall Study|Physician Decision|0|||
130667172|NCT03877237|470408094|FG000|Overall Study|Withdrawal by Subject|0|||
130667173|NCT03877237|470408095|FG001|Overall Study|Withdrawal by Subject|2|||
130667174|NCT00566098|470408098|FG000|Collection of MILs|Withdrawal by Subject|1|||
130667175|NCT00566098|470408098|FG000|Collection of MILs|Relapsed|1|||
130667176|NCT00566098|470408098|FG000|Generation of MILs Product|Relapsed|1|||
130667177|NCT00566098|470408098|FG000|Administration of ASCT+MILs|Death|10|||
130667178|NCT00566098|470408098|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
130667179|NCT02236754|470408099|FG000|Overall Study|Withdrawal by Subject|1|||
130667180|NCT02236754|470408100|FG001|Overall Study|Withdrawal by Subject|0|||
130667181|NCT04006847|470408101|FG000|Overall Study|Product issue|1|||
130667182|NCT00382291|470408102|FG000|Overall Study|Adverse Event|1|||
130667183|NCT00382291|470408103|FG001|Overall Study|Adverse Event|2|||
130667184|NCT00382291|470408104|FG002|Overall Study|Adverse Event|2|||
130667185|NCT00382291|470408102|FG000|Overall Study|Protocol Violation|1|||
130667186|NCT00382291|470408103|FG001|Overall Study|Protocol Violation|0|||
130667187|NCT00382291|470408104|FG002|Overall Study|Protocol Violation|0|||
130667188|NCT00382291|470408102|FG000|Overall Study|Temporary study suspension|2|||
130335242|NCT01485172|469197386|FG002|Overall Study|Protocol Violation|4|||
130335243|NCT01485172|469197387|FG003|Overall Study|Protocol Violation|5|||
130335244|NCT01485172|469197388|FG004|Overall Study|Protocol Violation|1|||
130335245|NCT01485172|469197389|FG005|Overall Study|Protocol Violation|0|||
130335246|NCT01485172|469197384|FG000|Overall Study|Protocol defined stopping criteria|1|||
130335247|NCT01485172|469197385|FG001|Overall Study|Protocol defined stopping criteria|0|||
130335248|NCT01485172|469197386|FG002|Overall Study|Protocol defined stopping criteria|0|||
130667189|NCT00382291|470408103|FG001|Overall Study|Temporary study suspension|2|||
130667190|NCT00382291|470408104|FG002|Overall Study|Temporary study suspension|5|||
130667191|NCT00382291|470408102|FG000|Overall Study|Withdrawal by Subject|0|||
130667192|NCT00382291|470408103|FG001|Overall Study|Withdrawal by Subject|2|||
130335249|NCT01485172|469197387|FG003|Overall Study|Protocol defined stopping criteria|0|||
130335250|NCT01485172|469197388|FG004|Overall Study|Protocol defined stopping criteria|1|||
130335251|NCT01485172|469197389|FG005|Overall Study|Protocol defined stopping criteria|0|||
130335252|NCT01485172|469197384|FG000|Overall Study|Lost to Follow-up|0|||
130335253|NCT01485172|469197385|FG001|Overall Study|Lost to Follow-up|0|||
130335254|NCT01485172|469197386|FG002|Overall Study|Lost to Follow-up|1|||
130335255|NCT01485172|469197387|FG003|Overall Study|Lost to Follow-up|0|||
130335256|NCT01485172|469197388|FG004|Overall Study|Lost to Follow-up|0|||
130335257|NCT01485172|469197389|FG005|Overall Study|Lost to Follow-up|1|||
130335258|NCT01485172|469197384|FG000|Overall Study|Physician Decision|0|||
130335259|NCT01485172|469197385|FG001|Overall Study|Physician Decision|0|||
130335260|NCT01485172|469197386|FG002|Overall Study|Physician Decision|0|||
130335261|NCT01485172|469197387|FG003|Overall Study|Physician Decision|0|||
130335262|NCT01485172|469197388|FG004|Overall Study|Physician Decision|1|||
130335263|NCT01485172|469197389|FG005|Overall Study|Physician Decision|0|||
130335264|NCT01485172|469197384|FG000|Overall Study|Withdrawal by Subject|2|||
130335265|NCT01485172|469197385|FG001|Overall Study|Withdrawal by Subject|0|||
130335266|NCT01485172|469197386|FG002|Overall Study|Withdrawal by Subject|0|||
130335267|NCT01485172|469197387|FG003|Overall Study|Withdrawal by Subject|1|||
130335268|NCT01485172|469197388|FG004|Overall Study|Withdrawal by Subject|1|||
130335269|NCT01485172|469197389|FG005|Overall Study|Withdrawal by Subject|1|||
130335270|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
130335271|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
130335272|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
130335273|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
130335274|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
130335275|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
130335276|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
130335277|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
130335278|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
130335279|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
130667193|NCT00382291|470408104|FG002|Overall Study|Withdrawal by Subject|0|||
130667194|NCT00382291|470408102|FG000|Overall Study|Physician Decision|0|||
130667195|NCT00382291|470408103|FG001|Overall Study|Physician Decision|1|||
130667196|NCT00382291|470408104|FG002|Overall Study|Physician Decision|0|||
130667197|NCT00382291|470408102|FG000|Overall Study|Lack of Efficacy|0|||
130667198|NCT00382291|470408103|FG001|Overall Study|Lack of Efficacy|0|||
130667199|NCT00382291|470408104|FG002|Overall Study|Lack of Efficacy|1|||
130667200|NCT02092961|470408107|FG000|Overall Study|Not reported|1|||
130667201|NCT02092961|470408108|FG001|Overall Study|Not reported|0|||
130667202|NCT02092961|470408109|FG002|Overall Study|Not reported|1|||
130667203|NCT02092961|470408107|FG000|Overall Study|Study stopped|13|||
130667204|NCT02092961|470408108|FG001|Overall Study|Study stopped|9|||
130667205|NCT02092961|470408109|FG002|Overall Study|Study stopped|12|||
130667206|NCT02092961|470408107|FG000|Overall Study|Lack of therapeutic response|2|||
130667207|NCT02092961|470408108|FG001|Overall Study|Lack of therapeutic response|1|||
130667208|NCT02092961|470408109|FG002|Overall Study|Lack of therapeutic response|3|||
130667209|NCT02092961|470408107|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
130667210|NCT02092961|470408108|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130335280|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
130335281|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
130667211|NCT02092961|470408109|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
130335282|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130335283|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130335284|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
130335285|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
130335286|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
130335287|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
130335288|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
130335289|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
130667212|NCT02092961|470408107|FG000|Overall Study|Adverse Event|2|||
130667213|NCT02092961|470408108|FG001|Overall Study|Adverse Event|4|||
130667214|NCT02092961|470408109|FG002|Overall Study|Adverse Event|0|||
130667215|NCT01623830|470408113|FG000|Overall Study|Withdrawal by Subject|6|||
130667216|NCT01623830|470408114|FG001|Overall Study|Withdrawal by Subject|7|||
130667217|NCT01623830|470408113|FG000|Overall Study|Exclusion from Study|1|||
130667218|NCT01623830|470408114|FG001|Overall Study|Exclusion from Study|2|||
130667219|NCT01847313|470408115|FG000|Overall Study|Death|0|||
130667220|NCT01847313|470408116|FG001|Overall Study|Death|1|||
130667221|NCT01847313|470408115|FG000|Overall Study|Withdrawal by Subject|0|||
130667222|NCT01847313|470408116|FG001|Overall Study|Withdrawal by Subject|1|||
130667223|NCT02853929|470408117|FG000|Overall Study|Lost to Follow-up|3|||
130667224|NCT02853929|470408118|FG001|Overall Study|Lost to Follow-up|0|||
130667225|NCT02853929|470408117|FG000|Overall Study|Withdrawal by Subject|1|||
130667226|NCT02853929|470408118|FG001|Overall Study|Withdrawal by Subject|0|||
130667227|NCT02853929|470408117|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
130667228|NCT02853929|470408118|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
130667229|NCT03549130|470408119|FG000|Overall Study|Adverse Event|0|||
130667230|NCT03549130|470408120|FG001|Overall Study|Adverse Event|1|||
130667231|NCT03549130|470408119|FG000|Overall Study|Lost to Follow-up|0|||
130667232|NCT03549130|470408120|FG001|Overall Study|Lost to Follow-up|1|||
130667233|NCT00463866|470408121|FG000|Overall Study|Adverse Event|70|||
130667234|NCT00463866|470408122|FG001|Overall Study|Adverse Event|93|||
130667235|NCT00463866|470408121|FG000|Overall Study|Withdrawal by Subject|81|||
130667236|NCT00463866|470408122|FG001|Overall Study|Withdrawal by Subject|79|||
130667237|NCT00463866|470408121|FG000|Overall Study|Lost to Follow-up|46|||
130667238|NCT00463866|470408122|FG001|Overall Study|Lost to Follow-up|55|||
130667239|NCT00463866|470408121|FG000|Overall Study|Incorrect Enrolment|64|||
130667240|NCT00463866|470408122|FG001|Overall Study|Incorrect Enrolment|66|||
130667241|NCT00463866|470408121|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
130667242|NCT00463866|470408122|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
130667243|NCT00463866|470408121|FG000|Overall Study|Safety Reason|1|||
130667244|NCT00463866|470408122|FG001|Overall Study|Safety Reason|3|||
130667245|NCT00463866|470408121|FG000|Overall Study|Mis-Randomization of subject|0|||
130667246|NCT00463866|470408122|FG001|Overall Study|Mis-Randomization of subject|1|||
130667247|NCT00463866|470408121|FG000|Overall Study|Other|22|||
130667248|NCT00463866|470408122|FG001|Overall Study|Other|22|||
130667249|NCT01677910|470408123|FG000|Double-Blind Treatment Period|Adverse Event|6|||
130667250|NCT01677910|470408124|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130667251|NCT01677910|470408125|FG002|Double-Blind Treatment Period|Adverse Event|3|||
130667252|NCT01677910|470408126|FG003|Double-Blind Treatment Period|Adverse Event|0|||
130667253|NCT01677910|470408123|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130667254|NCT01677910|470408124|FG001|Double-Blind Treatment Period|Physician Decision|0|||
130667255|NCT01677910|470408125|FG002|Double-Blind Treatment Period|Physician Decision|1|||
130667256|NCT01677910|470408126|FG003|Double-Blind Treatment Period|Physician Decision|0|||
130667257|NCT01677910|470408123|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
130667258|NCT01677910|470408124|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
130667259|NCT01677910|470408125|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
130667260|NCT01677910|470408126|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
130667261|NCT01677910|470408123|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
130667262|NCT01677910|470408124|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
130667263|NCT01677910|470408125|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
130667264|NCT01677910|470408126|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
130667265|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
130667266|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
130667267|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
130667268|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
130667269|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130667270|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130667271|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130667272|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
130667273|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130667274|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130667275|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130667276|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
130667277|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130667278|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130335290|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
130667279|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130335291|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
130667280|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
130667281|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
130335292|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
130667282|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
130667283|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
130720915|NCT00724048|470601561|FG000|Overall Study|Adverse Event|1|||
130667284|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
130667285|NCT01677910|470408123|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130667286|NCT01677910|470408124|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130667287|NCT01677910|470408125|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130667288|NCT01677910|470408126|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
130667289|NCT03341273|470408131|FG000|Overall Study|Lost to Follow-up|7|||
130667290|NCT03341273|470408132|FG001|Overall Study|Lost to Follow-up|7|||
130667291|NCT03341273|470408131|FG000|Overall Study|Withdrawal by Subject|4|||
130667292|NCT03341273|470408132|FG001|Overall Study|Withdrawal by Subject|2|||
130667293|NCT03341273|470408131|FG000|Overall Study|Physician Decision|1|||
130667294|NCT03341273|470408132|FG001|Overall Study|Physician Decision|0|||
130667295|NCT03341273|470408131|FG000|Overall Study|Protocol Violation|0|||
130667296|NCT03341273|470408132|FG001|Overall Study|Protocol Violation|1|||
130667297|NCT03341273|470408131|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
130667298|NCT03341273|470408132|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
130667299|NCT03341273|470408131|FG000|Overall Study|Became ineligible after enrollment|1|||
130667300|NCT03341273|470408132|FG001|Overall Study|Became ineligible after enrollment|0|||
130667301|NCT03341273|470408131|FG000|Overall Study|Not Eligible at Enrollment|0|||
130667302|NCT03341273|470408132|FG001|Overall Study|Not Eligible at Enrollment|1|||
130667303|NCT03341273|470408131|FG000|Overall Study|Participant incarcerated|1|||
130667304|NCT03341273|470408132|FG001|Overall Study|Participant incarcerated|0|||
130667305|NCT01717456|470408133|FG000|End of Treatment|Physician Decision|0|||
130667306|NCT01717456|470408134|FG001|End of Treatment|Physician Decision|1|||
130667307|NCT01717456|470408133|FG000|End of Treatment|Lost to Follow-up|0|||
130667308|NCT01717456|470408134|FG001|End of Treatment|Lost to Follow-up|1|||
130667309|NCT01717456|470408133|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
130667310|NCT01717456|470408134|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
130667311|NCT02008721|470408135|FG000|Overall Study|Withdrawal by Subject|5|||
130667312|NCT02008721|470408136|FG001|Overall Study|Withdrawal by Subject|1|||
130667313|NCT02008721|470408135|FG000|Overall Study|Death|4|||
130667314|NCT02008721|470408136|FG001|Overall Study|Death|2|||
130667315|NCT02008721|470408135|FG000|Overall Study|Adverse Event|3|||
130667316|NCT02008721|470408136|FG001|Overall Study|Adverse Event|5|||
130667317|NCT02008721|470408135|FG000|Overall Study|Protocol Violation|3|||
130667318|NCT02008721|470408136|FG001|Overall Study|Protocol Violation|2|||
130667319|NCT03870997|470408139|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
130667320|NCT03870997|470408140|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
130667321|NCT03870997|470408141|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
130667322|NCT03870997|470408142|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
130667323|NCT03870997|470408143|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
130667324|NCT03870997|470408144|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
130667325|NCT00267007|470408145|FG000|Overall Study|Withdrawal by Subject|6|||
130667326|NCT00267007|470408146|FG001|Overall Study|Withdrawal by Subject|0|||
130667327|NCT00267007|470408145|FG000|Overall Study|Lost to Follow-up|1|||
130667328|NCT00267007|470408146|FG001|Overall Study|Lost to Follow-up|0|||
130667329|NCT00267007|470408145|FG000|Overall Study|Non-compliance|0|||
130667330|NCT00267007|470408146|FG001|Overall Study|Non-compliance|1|||
130667331|NCT00267007|470408145|FG000|Overall Study|Adverse Event|1|||
130667332|NCT00267007|470408146|FG001|Overall Study|Adverse Event|0|||
130667333|NCT01825876|470408150|FG000|Period 2|Withdrawal by Subject|0|||
130667334|NCT01825876|470408151|FG001|Period 2|Withdrawal by Subject|1|||
130667335|NCT03751020|470408154|FG000|Overall Study|Withdrawal by Subject|2|||
130667336|NCT03751020|470408155|FG001|Overall Study|Withdrawal by Subject|0|||
130667337|NCT03751020|470408156|FG002|Overall Study|Withdrawal by Subject|0|||
130667338|NCT03751020|470408154|FG000|Overall Study|Lost to Follow-up|7|||
130667339|NCT03751020|470408155|FG001|Overall Study|Lost to Follow-up|4|||
130667340|NCT03751020|470408156|FG002|Overall Study|Lost to Follow-up|10|||
130667341|NCT00667719|470408159|FG000|Overall Study|Adverse Event|39|||
130667342|NCT00667719|470408159|FG000|Overall Study|Abnormal Test Procedure|1|||
130667343|NCT00667719|470408159|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130667344|NCT00667719|470408159|FG000|Overall Study|Protocol Violation|3|||
130667345|NCT00667719|470408159|FG000|Overall Study|Withdrawal by Subject|17|||
130667346|NCT00667719|470408159|FG000|Overall Study|Lost to Follow-up|8|||
130667347|NCT00078819|470408160|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130667348|NCT00078819|470408161|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
130667349|NCT00078819|470408162|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130667350|NCT00078819|470408163|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130667351|NCT00078819|470408160|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
130667352|NCT00078819|470408161|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130667353|NCT00078819|470408162|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130667354|NCT00078819|470408163|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130667355|NCT00078819|470408160|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
130667356|NCT00078819|470408161|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
130667357|NCT00078819|470408162|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
130667358|NCT00078819|470408163|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
130667359|NCT00078819|470408160|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
130667360|NCT00078819|470408161|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
130667361|NCT00078819|470408162|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
130667362|NCT00078819|470408163|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
130667363|NCT00078819|470408160|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
130667364|NCT00078819|470408161|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
130667365|NCT00078819|470408162|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
130335293|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
130335294|NCT00202878|469197395|FG000|Overall Study|Death|964|||
130335295|NCT00202878|469197396|FG001|Overall Study|Death|968|||
130335296|NCT00202878|469197395|FG000|Overall Study|Only Vital Status Known|357|||
130335297|NCT00202878|469197396|FG001|Overall Study|Only Vital Status Known|356|||
130335298|NCT00202878|469197395|FG000|Overall Study|Lost to Follow-up|44|||
130335299|NCT00202878|469197396|FG001|Overall Study|Lost to Follow-up|49|||
130335300|NCT00202878|469197395|FG000|Overall Study|Site Closure|39|||
130335301|NCT00202878|469197396|FG001|Overall Study|Site Closure|36|||
130335302|NCT00202878|469197395|FG000|Overall Study|Withdrawal by Subject|795|||
130335303|NCT00202878|469197396|FG001|Overall Study|Withdrawal by Subject|808|||
130335304|NCT02920242|469197397|FG000|Overall Study|Withdrawal by Subject|1|||
130335305|NCT02920242|469197398|FG001|Overall Study|Withdrawal by Subject|0|||
130335306|NCT02920242|469197399|FG002|Overall Study|Withdrawal by Subject|1|||
130335307|NCT02920242|469197397|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
130335308|NCT02920242|469197398|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
130335309|NCT02920242|469197399|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
130335310|NCT01587014|469197400|FG000|Overall Study|Death|2|||
130335311|NCT03801031|469197405|FG000|Overall Study|Lost to Follow-up|1|||
130335312|NCT03801031|469197406|FG001|Overall Study|Lost to Follow-up|0|||
130335313|NCT03801031|469197405|FG000|Overall Study|Unable to comply|1|||
130335314|NCT03801031|469197406|FG001|Overall Study|Unable to comply|0|||
130335315|NCT03801031|469197405|FG000|Overall Study|Withdrawal by Subject|0|||
130335316|NCT03801031|469197406|FG001|Overall Study|Withdrawal by Subject|1|||
130335317|NCT02948088|469197407|FG000|Overall Study|Lost to Follow-up|8|||
130335318|NCT02948088|469197407|FG000|Overall Study|Death|1|||
130335319|NCT02948088|469197407|FG000|Overall Study|Withdrawal by Subject|4|||
130335320|NCT02948088|469197407|FG000|Overall Study|Other|2|||
130335321|NCT01942733|469197408|FG000|Overall Study|Lost to Follow-up|1|||
130335322|NCT01942733|469197408|FG000|Overall Study|Non-compliance with IMP|1|||
130335323|NCT01942733|469197408|FG000|Overall Study|Administrative|1|||
130335324|NCT01409811|469197409|FG000|Overall Study|Insurance denial|1|||
130335325|NCT00634101|469197410|FG000|Overall Study|Study Terminated|3|||
130335326|NCT00634101|469197411|FG001|Overall Study|Study Terminated|3|||
130335327|NCT00634101|469197410|FG000|Overall Study|Lost to Follow-up|2|||
130335328|NCT00634101|469197411|FG001|Overall Study|Lost to Follow-up|0|||
130335329|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
130335330|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
130335331|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
130335332|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
130335333|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130335334|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130335335|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
130335336|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
130335337|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
130335338|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
130335339|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
130335340|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
130335341|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
130335342|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
130667366|NCT00078819|470408163|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
130667367|NCT00078819|470408160|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
130335343|NCT00573144|469197419|FG000|Overall Study|Withdrawal by Subject|2|||
130335344|NCT00573144|469197420|FG001|Overall Study|Withdrawal by Subject|3|||
130335345|NCT02625909|469197421|FG000|Overall Study|Death|2|||
130335346|NCT02625909|469197422|FG001|Overall Study|Death|0|||
130335347|NCT02625909|469197421|FG000|Overall Study|Lost to Follow-up|3|||
130335348|NCT02625909|469197422|FG001|Overall Study|Lost to Follow-up|5|||
130335349|NCT02625909|469197421|FG000|Overall Study|Lack of Efficacy|9|||
130335350|NCT02625909|469197422|FG001|Overall Study|Lack of Efficacy|2|||
130335351|NCT02625909|469197421|FG000|Overall Study|Reinfection|3|||
130335352|NCT02625909|469197422|FG001|Overall Study|Reinfection|2|||
130335353|NCT00953056|469197423|FG000|Overall Study|Withdrew Consent|0|||
130335354|NCT00953056|469197424|FG001|Overall Study|Withdrew Consent|0|||
130667368|NCT00078819|470408161|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
130667369|NCT00078819|470408162|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
130667370|NCT00078819|470408163|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
130667371|NCT00078819|470408160|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
130667372|NCT00078819|470408161|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
130667373|NCT00078819|470408162|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
130667374|NCT00078819|470408163|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
130667375|NCT00078819|470408160|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130667376|NCT00078819|470408161|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130667377|NCT00078819|470408162|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130667378|NCT00078819|470408163|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
130667379|NCT00323609|470408164|FG000|Overall Study|Death|16|||
130667380|NCT00323609|470408165|FG001|Overall Study|Death|21|||
130667381|NCT00323609|470408166|FG002|Overall Study|Death|0|||
130667382|NCT00323609|470408167|FG003|Overall Study|Death|0|||
130667383|NCT00323609|470408164|FG000|Overall Study|Lost to Follow-up|9|||
130667384|NCT00323609|470408165|FG001|Overall Study|Lost to Follow-up|10|||
130667385|NCT00323609|470408166|FG002|Overall Study|Lost to Follow-up|0|||
130667386|NCT00323609|470408167|FG003|Overall Study|Lost to Follow-up|0|||
130667387|NCT00323609|470408164|FG000|Overall Study|Physician Decision|2|||
130667388|NCT00323609|470408165|FG001|Overall Study|Physician Decision|0|||
130667389|NCT00323609|470408166|FG002|Overall Study|Physician Decision|0|||
130667390|NCT00323609|470408167|FG003|Overall Study|Physician Decision|1|||
130667391|NCT00323609|470408164|FG000|Overall Study|Withdrawal by Subject|11|||
130667392|NCT00323609|470408165|FG001|Overall Study|Withdrawal by Subject|23|||
130667393|NCT00323609|470408166|FG002|Overall Study|Withdrawal by Subject|4|||
130667394|NCT00323609|470408167|FG003|Overall Study|Withdrawal by Subject|4|||
130667395|NCT00323609|470408164|FG000|Overall Study|Other non-VCF-related medical condition|3|||
130667396|NCT00323609|470408165|FG001|Overall Study|Other non-VCF-related medical condition|2|||
130667397|NCT00323609|470408166|FG002|Overall Study|Other non-VCF-related medical condition|0|||
130667398|NCT00323609|470408167|FG003|Overall Study|Other non-VCF-related medical condition|0|||
130667399|NCT00323609|470408164|FG000|Overall Study|Sponsor discontinued trial|29|||
130667400|NCT00323609|470408165|FG001|Overall Study|Sponsor discontinued trial|29|||
130667401|NCT00323609|470408166|FG002|Overall Study|Sponsor discontinued trial|0|||
130667402|NCT00323609|470408167|FG003|Overall Study|Sponsor discontinued trial|0|||
130667403|NCT00323609|470408164|FG000|Overall Study|Unrelenting or severe back pain|1|||
130667404|NCT00323609|470408165|FG001|Overall Study|Unrelenting or severe back pain|1|||
130667405|NCT00323609|470408166|FG002|Overall Study|Unrelenting or severe back pain|0|||
130667406|NCT00323609|470408167|FG003|Overall Study|Unrelenting or severe back pain|0|||
130667407|NCT00323609|470408164|FG000|Overall Study|Logistical withdrawal|9|||
130667408|NCT00323609|470408165|FG001|Overall Study|Logistical withdrawal|5|||
130667409|NCT00323609|470408166|FG002|Overall Study|Logistical withdrawal|0|||
130667410|NCT00323609|470408167|FG003|Overall Study|Logistical withdrawal|1|||
130667411|NCT00323609|470408164|FG000|Overall Study|Other reason|11|||
130667412|NCT00323609|470408165|FG001|Overall Study|Other reason|8|||
130667413|NCT00323609|470408166|FG002|Overall Study|Other reason|4|||
130667414|NCT00323609|470408167|FG003|Overall Study|Other reason|9|||
130667415|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667416|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667417|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667418|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
130667419|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667420|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667421|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667422|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667423|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667424|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130667425|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130667426|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130667427|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Adverse Event|1|||
130667428|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Adverse Event|1|||
130667429|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Adverse Event|1|||
130667430|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Adverse Event|1|||
130335355|NCT00953056|469197425|FG002|Overall Study|Withdrew Consent|0|||
130667431|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Adverse Event|0|||
130667432|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Adverse Event|0|||
130667433|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Adverse Event|0|||
130667434|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Adverse Event|0|||
130667435|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
130667436|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
130335356|NCT00953056|469197426|FG003|Overall Study|Withdrew Consent|0|||
130667437|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
130667438|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
130667439|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
130667440|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
130667441|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
130667442|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
130667443|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
130667444|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
130667445|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667446|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667447|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667448|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130667449|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
130667450|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
130667451|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667452|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
130667453|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667454|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
130667455|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130667456|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130667457|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667458|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667459|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667460|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667461|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667462|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130667463|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667464|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130667465|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667466|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667467|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667468|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667469|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
130667470|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
130667471|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667472|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667473|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667474|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130667475|NCT00950599|470408171|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
130667476|NCT00950599|470408172|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130667477|NCT00950599|470408173|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130667478|NCT00950599|470408174|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
130667479|NCT00950599|470408175|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
130667480|NCT00950599|470408176|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
130667481|NCT00950599|470408177|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130667482|NCT00950599|470408178|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130667483|NCT00950599|470408179|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130667484|NCT00950599|470408180|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130667485|NCT00950599|470408171|FG000|Follow-Up Period|Adverse Event|0|||
130667486|NCT00950599|470408172|FG001|Follow-Up Period|Adverse Event|0|||
130667487|NCT00950599|470408173|FG002|Follow-Up Period|Adverse Event|0|||
130667488|NCT00950599|470408174|FG003|Follow-Up Period|Adverse Event|0|||
130667489|NCT00950599|470408175|FG004|Follow-Up Period|Adverse Event|0|||
130667490|NCT00950599|470408176|FG005|Follow-Up Period|Adverse Event|0|||
130667491|NCT00950599|470408177|FG006|Follow-Up Period|Adverse Event|0|||
130667492|NCT00950599|470408178|FG007|Follow-Up Period|Adverse Event|0|||
130667493|NCT00950599|470408179|FG008|Follow-Up Period|Adverse Event|1|||
130667494|NCT00950599|470408180|FG009|Follow-Up Period|Adverse Event|0|||
130667495|NCT00950599|470408171|FG000|Follow-Up Period|Lack of Efficacy|0|||
130667496|NCT00950599|470408172|FG001|Follow-Up Period|Lack of Efficacy|0|||
130667497|NCT00950599|470408173|FG002|Follow-Up Period|Lack of Efficacy|0|||
130667498|NCT00950599|470408174|FG003|Follow-Up Period|Lack of Efficacy|0|||
130667499|NCT00950599|470408175|FG004|Follow-Up Period|Lack of Efficacy|0|||
130667500|NCT00950599|470408176|FG005|Follow-Up Period|Lack of Efficacy|0|||
130667501|NCT00950599|470408177|FG006|Follow-Up Period|Lack of Efficacy|0|||
130667502|NCT00950599|470408178|FG007|Follow-Up Period|Lack of Efficacy|0|||
130667503|NCT00950599|470408179|FG008|Follow-Up Period|Lack of Efficacy|3|||
130667504|NCT00950599|470408180|FG009|Follow-Up Period|Lack of Efficacy|0|||
130667505|NCT00950599|470408171|FG000|Follow-Up Period|Lost to Follow-up|0|||
130667506|NCT00950599|470408172|FG001|Follow-Up Period|Lost to Follow-up|0|||
130667507|NCT00950599|470408173|FG002|Follow-Up Period|Lost to Follow-up|0|||
130667508|NCT00950599|470408174|FG003|Follow-Up Period|Lost to Follow-up|0|||
130667509|NCT00950599|470408175|FG004|Follow-Up Period|Lost to Follow-up|0|||
130667510|NCT00950599|470408176|FG005|Follow-Up Period|Lost to Follow-up|0|||
130667511|NCT00950599|470408177|FG006|Follow-Up Period|Lost to Follow-up|0|||
130667512|NCT00950599|470408178|FG007|Follow-Up Period|Lost to Follow-up|0|||
130667513|NCT00950599|470408179|FG008|Follow-Up Period|Lost to Follow-up|5|||
130667514|NCT00950599|470408180|FG009|Follow-Up Period|Lost to Follow-up|1|||
130667515|NCT00950599|470408171|FG000|Follow-Up Period|Physician Decision|0|||
130667516|NCT00950599|470408172|FG001|Follow-Up Period|Physician Decision|0|||
130667517|NCT00950599|470408173|FG002|Follow-Up Period|Physician Decision|0|||
130667518|NCT00950599|470408174|FG003|Follow-Up Period|Physician Decision|0|||
130667519|NCT00950599|470408175|FG004|Follow-Up Period|Physician Decision|0|||
130667520|NCT00950599|470408176|FG005|Follow-Up Period|Physician Decision|0|||
130667521|NCT00950599|470408177|FG006|Follow-Up Period|Physician Decision|0|||
130667522|NCT00950599|470408178|FG007|Follow-Up Period|Physician Decision|0|||
130667523|NCT00950599|470408179|FG008|Follow-Up Period|Physician Decision|1|||
130667524|NCT00950599|470408180|FG009|Follow-Up Period|Physician Decision|0|||
130667525|NCT00950599|470408171|FG000|Follow-Up Period|Poor/Noncompliance|0|||
130667526|NCT00950599|470408172|FG001|Follow-Up Period|Poor/Noncompliance|0|||
130667527|NCT00950599|470408173|FG002|Follow-Up Period|Poor/Noncompliance|0|||
130667528|NCT00950599|470408174|FG003|Follow-Up Period|Poor/Noncompliance|0|||
130667529|NCT00950599|470408175|FG004|Follow-Up Period|Poor/Noncompliance|0|||
130667530|NCT00950599|470408176|FG005|Follow-Up Period|Poor/Noncompliance|0|||
130667531|NCT00950599|470408177|FG006|Follow-Up Period|Poor/Noncompliance|0|||
130667532|NCT00950599|470408178|FG007|Follow-Up Period|Poor/Noncompliance|0|||
130667533|NCT00950599|470408179|FG008|Follow-Up Period|Poor/Noncompliance|1|||
130667534|NCT00950599|470408180|FG009|Follow-Up Period|Poor/Noncompliance|0|||
130667535|NCT00950599|470408171|FG000|Follow-Up Period|Subject withdrew Consent|0|||
130667536|NCT00950599|470408172|FG001|Follow-Up Period|Subject withdrew Consent|0|||
130667537|NCT00950599|470408173|FG002|Follow-Up Period|Subject withdrew Consent|0|||
130667538|NCT00950599|470408174|FG003|Follow-Up Period|Subject withdrew Consent|0|||
130667539|NCT00950599|470408175|FG004|Follow-Up Period|Subject withdrew Consent|0|||
130667540|NCT00950599|470408176|FG005|Follow-Up Period|Subject withdrew Consent|0|||
130667541|NCT00950599|470408177|FG006|Follow-Up Period|Subject withdrew Consent|0|||
130667542|NCT00950599|470408178|FG007|Follow-Up Period|Subject withdrew Consent|0|||
130667543|NCT00950599|470408179|FG008|Follow-Up Period|Subject withdrew Consent|2|||
130667544|NCT00950599|470408180|FG009|Follow-Up Period|Subject withdrew Consent|1|||
130667545|NCT00971204|470408181|FG000|Overall Study|Did not meet all criteria-not treated|14|||
130667546|NCT00971204|470408181|FG000|Overall Study|Lost to Follow-up|10|||
130667547|NCT02436135|470408182|FG000|Overall Study|Progressive Disease|3|||
130667548|NCT02436135|470408183|FG001|Overall Study|Progressive Disease|1|||
130667549|NCT02436135|470408182|FG000|Overall Study|Investigator Discretion|1|||
130667550|NCT02436135|470408183|FG001|Overall Study|Investigator Discretion|2|||
130667551|NCT02436135|470408182|FG000|Overall Study|Adverse Event|1|||
130667552|NCT02436135|470408183|FG001|Overall Study|Adverse Event|0|||
130667553|NCT02436135|470408182|FG000|Overall Study|Withdrawal by Participant|1|||
130667554|NCT02436135|470408183|FG001|Overall Study|Withdrawal by Participant|0|||
130667555|NCT02436135|470408182|FG000|Overall Study|Study Terminated By Sponsor|0|||
130667556|NCT02436135|470408183|FG001|Overall Study|Study Terminated By Sponsor|1|||
130667557|NCT02729194|470408184|FG000|Overall Study|Withdrawal by Subject|3|||
130667558|NCT00475852|470408185|FG000|Overall Study|Death|444|||
130667559|NCT00475852|470408186|FG001|Overall Study|Death|456|||
130667560|NCT00475852|470408185|FG000|Overall Study|Withdrawal by Subject|19|||
130667561|NCT00475852|470408186|FG001|Overall Study|Withdrawal by Subject|24|||
130667562|NCT00475852|470408185|FG000|Overall Study|Lost to Follow-up|54|||
130667563|NCT00475852|470408186|FG001|Overall Study|Lost to Follow-up|68|||
130667564|NCT01361607|470408188|FG000|Overall Study|Adverse Event|38|||
130667565|NCT01361607|470408189|FG001|Overall Study|Adverse Event|29|||
130667566|NCT01361607|470408188|FG000|Overall Study|Withdrawal by Subject|19|||
130667567|NCT01361607|470408189|FG001|Overall Study|Withdrawal by Subject|8|||
130667568|NCT01361607|470408188|FG000|Overall Study|Withdrawal by Investigator|5|||
130667569|NCT01361607|470408189|FG001|Overall Study|Withdrawal by Investigator|3|||
130667570|NCT01361607|470408188|FG000|Overall Study|Lost to Follow-up|1|||
130667571|NCT01361607|470408189|FG001|Overall Study|Lost to Follow-up|0|||
130667572|NCT01361607|470408188|FG000|Overall Study|Met Withdrawal Criteria|1|||
130667573|NCT01361607|470408189|FG001|Overall Study|Met Withdrawal Criteria|1|||
130667574|NCT00297479|470408190|FG000|Overall Study|Lost to Follow-up|37|||
130667575|NCT00297479|470408191|FG001|Overall Study|Lost to Follow-up|54|||
130667576|NCT00297479|470408192|FG002|Overall Study|Lost to Follow-up|51|||
130667577|NCT01664494|470408195|FG000|Overall Study|Withdrawal by Subject|27|||
130667578|NCT01664494|470408195|FG000|Overall Study|Death|18|||
130667579|NCT01664494|470408195|FG000|Overall Study|Other|49|||
130667580|NCT01664494|470408195|FG000|Overall Study|Lost to Follow-up|99|||
130667581|NCT03412019|470408196|FG000|Overall Study|Withdrawal by Subject|1|||
130667582|NCT03412019|470408197|FG001|Overall Study|Withdrawal by Subject|1|||
130335357|NCT00953056|469197427|FG004|Overall Study|Withdrew Consent|2|||
130667583|NCT03063632|470408203|FG000|Overall Study|Death|4|||
130667584|NCT03063632|470408204|FG001|Overall Study|Death|6|||
130667585|NCT03063632|470408203|FG000|Overall Study|Lost to Follow-up|0|||
130667586|NCT03063632|470408204|FG001|Overall Study|Lost to Follow-up|1|||
130667587|NCT03063632|470408203|FG000|Overall Study|Withdrawal by Subject|0|||
130667588|NCT03063632|470408204|FG001|Overall Study|Withdrawal by Subject|2|||
130667589|NCT03063632|470408203|FG000|Overall Study|Physician Decision|2|||
130667590|NCT03063632|470408204|FG001|Overall Study|Physician Decision|0|||
130667591|NCT03063632|470408203|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
130667592|NCT03063632|470408204|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
130667593|NCT00373685|470408207|FG000|Overall Study|Death|2|||
130667594|NCT00373685|470408208|FG001|Overall Study|Death|1|||
130667595|NCT00373685|470408207|FG000|Overall Study|Adverse Event|278|||
130667596|NCT00373685|470408208|FG001|Overall Study|Adverse Event|253|||
130667597|NCT00373685|470408207|FG000|Overall Study|Insufficient clinical response|169|||
130667598|NCT00373685|470408208|FG001|Overall Study|Insufficient clinical response|119|||
130667599|NCT00373685|470408207|FG000|Overall Study|Did not meet entrance criteria|167|||
130667600|NCT00373685|470408208|FG001|Overall Study|Did not meet entrance criteria|184|||
130667601|NCT00373685|470408207|FG000|Overall Study|Lost to follow up|83|||
130667602|NCT00373685|470408208|FG001|Overall Study|Lost to follow up|103|||
130667603|NCT00373685|470408207|FG000|Overall Study|No longer willing to participate|337|||
130667604|NCT00373685|470408208|FG001|Overall Study|No longer willing to participate|352|||
130667605|NCT00373685|470408207|FG000|Overall Study|Other|149|||
130667606|NCT00373685|470408208|FG001|Overall Study|Other|146|||
130667607|NCT00373685|470408207|FG000|Overall Study|Protocol Violation|191|||
130667608|NCT00373685|470408208|FG001|Overall Study|Protocol Violation|182|||
130667609|NCT00373685|470408207|FG000|Overall Study|Final Status Unknown|12|||
130667610|NCT00373685|470408208|FG001|Overall Study|Final Status Unknown|4|||
130667611|NCT00373685|470408207|FG000|Overall Study|Randomized, not treated|51|||
130667612|NCT00373685|470408208|FG001|Overall Study|Randomized, not treated|77|||
130667613|NCT02570165|470408209|FG000|Overall Study|Adverse Event|1|||
130667614|NCT02570165|470408210|FG001|Overall Study|Adverse Event|0|||
130667615|NCT02570165|470408211|FG002|Overall Study|Adverse Event|2|||
130667616|NCT02570165|470408212|FG003|Overall Study|Adverse Event|0|||
130667617|NCT02570165|470408213|FG004|Overall Study|Adverse Event|0|||
130667618|NCT02570165|470408214|FG005|Overall Study|Adverse Event|0|||
130667619|NCT02570165|470408215|FG006|Overall Study|Adverse Event|0|||
130667620|NCT02570165|470408209|FG000|Overall Study|Lack of Efficacy|0|||
130667621|NCT02570165|470408210|FG001|Overall Study|Lack of Efficacy|1|||
130667622|NCT02570165|470408211|FG002|Overall Study|Lack of Efficacy|0|||
130667623|NCT02570165|470408212|FG003|Overall Study|Lack of Efficacy|0|||
130667624|NCT02570165|470408213|FG004|Overall Study|Lack of Efficacy|4|||
130667625|NCT02570165|470408214|FG005|Overall Study|Lack of Efficacy|0|||
130667626|NCT02570165|470408215|FG006|Overall Study|Lack of Efficacy|0|||
130335358|NCT00953056|469197428|FG005|Overall Study|Withdrew Consent|3|||
130335359|NCT00953056|469197423|FG000|Overall Study|Serious Adverse Event|0|||
130335360|NCT00953056|469197424|FG001|Overall Study|Serious Adverse Event|0|||
130335361|NCT00953056|469197425|FG002|Overall Study|Serious Adverse Event|0|||
130335362|NCT00953056|469197426|FG003|Overall Study|Serious Adverse Event|0|||
130335363|NCT00953056|469197427|FG004|Overall Study|Serious Adverse Event|0|||
130335364|NCT00953056|469197428|FG005|Overall Study|Serious Adverse Event|1|||
130335365|NCT02367833|469197429|FG000|Overall Study|Withdrawal by Subject|1|||
130335366|NCT02367833|469197430|FG001|Overall Study|Withdrawal by Subject|1|||
130335367|NCT02367833|469197431|FG002|Overall Study|Withdrawal by Subject|0|||
130335368|NCT01077076|469197432|FG000|First Intervention|Withdrawal by Subject|1|||
130335369|NCT01077076|469197433|FG001|First Intervention|Withdrawal by Subject|0|||
130335370|NCT01077076|469197434|FG002|First Intervention|Withdrawal by Subject|0|||
130335371|NCT01077076|469197435|FG003|First Intervention|Withdrawal by Subject|0|||
130335372|NCT01077076|469197436|FG004|First Intervention|Withdrawal by Subject|0|||
130667627|NCT02570165|470408209|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
130667628|NCT02570165|470408210|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
130667629|NCT02570165|470408211|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
130667630|NCT02570165|470408212|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
130667631|NCT02570165|470408213|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
130667632|NCT02570165|470408214|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
130667633|NCT02570165|470408215|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
130667634|NCT02570165|470408209|FG000|Overall Study|Lost to Follow-up|0|||
130667635|NCT02570165|470408210|FG001|Overall Study|Lost to Follow-up|0|||
130667636|NCT02570165|470408211|FG002|Overall Study|Lost to Follow-up|1|||
130667637|NCT02570165|470408212|FG003|Overall Study|Lost to Follow-up|1|||
130667638|NCT02570165|470408213|FG004|Overall Study|Lost to Follow-up|0|||
130667639|NCT02570165|470408214|FG005|Overall Study|Lost to Follow-up|0|||
130667640|NCT02570165|470408215|FG006|Overall Study|Lost to Follow-up|0|||
130335373|NCT01077076|469197437|FG005|First Intervention|Withdrawal by Subject|0|||
130335374|NCT01077076|469197432|FG000|Third Intervention|Death in the participant's family|0|||
130335375|NCT01077076|469197433|FG001|Third Intervention|Death in the participant's family|0|||
130667641|NCT02570165|470408209|FG000|Overall Study|Physician Decision|0|||
130667642|NCT02570165|470408210|FG001|Overall Study|Physician Decision|1|||
130667643|NCT02570165|470408211|FG002|Overall Study|Physician Decision|0|||
130667644|NCT02570165|470408212|FG003|Overall Study|Physician Decision|0|||
130667645|NCT02570165|470408213|FG004|Overall Study|Physician Decision|0|||
130667646|NCT02570165|470408214|FG005|Overall Study|Physician Decision|0|||
130667647|NCT02570165|470408215|FG006|Overall Study|Physician Decision|0|||
130667648|NCT02570165|470408209|FG000|Overall Study|Withdrawal by Subject|0|||
130667649|NCT02570165|470408210|FG001|Overall Study|Withdrawal by Subject|0|||
130667650|NCT02570165|470408211|FG002|Overall Study|Withdrawal by Subject|0|||
130667651|NCT02570165|470408212|FG003|Overall Study|Withdrawal by Subject|2|||
130667652|NCT02570165|470408213|FG004|Overall Study|Withdrawal by Subject|1|||
130667653|NCT02570165|470408214|FG005|Overall Study|Withdrawal by Subject|0|||
130667654|NCT02570165|470408215|FG006|Overall Study|Withdrawal by Subject|0|||
130667655|NCT02570165|470408209|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667656|NCT02570165|470408210|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667657|NCT02570165|470408211|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667658|NCT02570165|470408212|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667659|NCT02570165|470408213|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667660|NCT02570165|470408214|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
130667661|NCT02570165|470408215|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
130667662|NCT02570165|470408209|FG000|Overall Study|Withdrawal Request by GSK|0|||
130667663|NCT02570165|470408210|FG001|Overall Study|Withdrawal Request by GSK|0|||
130667664|NCT02570165|470408211|FG002|Overall Study|Withdrawal Request by GSK|2|||
130667665|NCT02570165|470408212|FG003|Overall Study|Withdrawal Request by GSK|0|||
130667666|NCT02570165|470408213|FG004|Overall Study|Withdrawal Request by GSK|0|||
130667667|NCT02570165|470408214|FG005|Overall Study|Withdrawal Request by GSK|0|||
130667668|NCT02570165|470408215|FG006|Overall Study|Withdrawal Request by GSK|0|||
130667669|NCT01789281|470408216|FG000|Overall Study|Disease progression|15|||
130667670|NCT01789281|470408217|FG001|Overall Study|Disease progression|4|||
130667671|NCT01789281|470408216|FG000|Overall Study|Adverse Event|5|||
130667672|NCT01789281|470408217|FG001|Overall Study|Adverse Event|5|||
130667673|NCT01789281|470408216|FG000|Overall Study|Withdrawal by Subject|1|||
130667674|NCT01789281|470408217|FG001|Overall Study|Withdrawal by Subject|0|||
130335376|NCT01077076|469197434|FG002|Third Intervention|Death in the participant's family|0|||
130335377|NCT01077076|469197435|FG003|Third Intervention|Death in the participant's family|0|||
130335378|NCT01077076|469197436|FG004|Third Intervention|Death in the participant's family|0|||
130335379|NCT01077076|469197437|FG005|Third Intervention|Death in the participant's family|1|||
130335380|NCT00035932|469197438|FG000|Overall Study|Adverse Event|10|||
130335381|NCT00035932|469197439|FG001|Overall Study|Adverse Event|9|||
130335382|NCT00035932|469197440|FG002|Overall Study|Adverse Event|9|||
130335383|NCT00035932|469197438|FG000|Overall Study|Death|0|||
130335384|NCT00035932|469197439|FG001|Overall Study|Death|0|||
130335385|NCT00035932|469197440|FG002|Overall Study|Death|1|||
130335386|NCT00035932|469197438|FG000|Overall Study|Disease Progression / Relapse|1|||
130335387|NCT00035932|469197439|FG001|Overall Study|Disease Progression / Relapse|1|||
130335388|NCT00035932|469197440|FG002|Overall Study|Disease Progression / Relapse|0|||
130335389|NCT00035932|469197438|FG000|Overall Study|Lost to Follow-up|4|||
130335390|NCT00035932|469197439|FG001|Overall Study|Lost to Follow-up|4|||
130335391|NCT00035932|469197440|FG002|Overall Study|Lost to Follow-up|3|||
130335392|NCT00035932|469197438|FG000|Overall Study|Noncompliance|6|||
130335393|NCT00035932|469197439|FG001|Overall Study|Noncompliance|7|||
130335394|NCT00035932|469197440|FG002|Overall Study|Noncompliance|6|||
130335395|NCT00035932|469197438|FG000|Overall Study|Protocol Violation While on Study|0|||
130335396|NCT00035932|469197439|FG001|Overall Study|Protocol Violation While on Study|1|||
130335397|NCT00035932|469197440|FG002|Overall Study|Protocol Violation While on Study|2|||
130335398|NCT00035932|469197438|FG000|Overall Study|Withdrawal by Subject|1|||
130335399|NCT00035932|469197439|FG001|Overall Study|Withdrawal by Subject|5|||
130335400|NCT00035932|469197440|FG002|Overall Study|Withdrawal by Subject|0|||
130335401|NCT00035932|469197438|FG000|Overall Study|Study Termination by Sponsor|1|||
130335402|NCT00035932|469197439|FG001|Overall Study|Study Termination by Sponsor|0|||
130667675|NCT01789281|470408216|FG000|Overall Study|Lost to Follow-up|1|||
130667676|NCT01789281|470408217|FG001|Overall Study|Lost to Follow-up|0|||
130335403|NCT00035932|469197440|FG002|Overall Study|Study Termination by Sponsor|0|||
130335404|NCT00035932|469197438|FG000|Overall Study|Lack of Efficacy|33|||
130335405|NCT00035932|469197439|FG001|Overall Study|Lack of Efficacy|33|||
130667677|NCT01789281|470408216|FG000|Overall Study|Administrative problems|0|||
130667678|NCT01789281|470408217|FG001|Overall Study|Administrative problems|1|||
130667679|NCT02746705|470408222|FG000|Overall Study|Physician Decision|1|||
130667680|NCT02746705|470408223|FG001|Overall Study|Physician Decision|1|||
130667681|NCT02746705|470408222|FG000|Overall Study|Lost to Follow-up|1|||
130335406|NCT00035932|469197440|FG002|Overall Study|Lack of Efficacy|28|||
130335407|NCT04413617|469197443|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335408|NCT04413617|469197444|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130667682|NCT02746705|470408223|FG001|Overall Study|Lost to Follow-up|0|||
130667683|NCT02746705|470408222|FG000|Overall Study|outlier scores deemed not valid|0|||
130667684|NCT02746705|470408223|FG001|Overall Study|outlier scores deemed not valid|1|||
130667685|NCT00479401|470408224|FG000|Overall Study|Adverse Event|24|||
130667686|NCT00479401|470408225|FG001|Overall Study|Adverse Event|20|||
130667687|NCT00479401|470408226|FG002|Overall Study|Adverse Event|4|||
130667688|NCT00479401|470408224|FG000|Overall Study|Lack of Efficacy|2|||
130667689|NCT00479401|470408225|FG001|Overall Study|Lack of Efficacy|2|||
130667690|NCT00479401|470408226|FG002|Overall Study|Lack of Efficacy|4|||
130667691|NCT00479401|470408224|FG000|Overall Study|Protocol Violation|2|||
130667692|NCT00479401|470408225|FG001|Overall Study|Protocol Violation|1|||
130667693|NCT00479401|470408226|FG002|Overall Study|Protocol Violation|1|||
130667694|NCT00479401|470408224|FG000|Overall Study|Lost to Follow-up|1|||
130667695|NCT00479401|470408225|FG001|Overall Study|Lost to Follow-up|1|||
130667696|NCT00479401|470408226|FG002|Overall Study|Lost to Follow-up|1|||
130667697|NCT00479401|470408224|FG000|Overall Study|Withdrawal by Subject|16|||
130667698|NCT00479401|470408225|FG001|Overall Study|Withdrawal by Subject|10|||
130667699|NCT00479401|470408226|FG002|Overall Study|Withdrawal by Subject|2|||
130667700|NCT00479401|470408224|FG000|Overall Study|Exclusion criteria, relocation|4|||
130667701|NCT00479401|470408225|FG001|Overall Study|Exclusion criteria, relocation|3|||
130667702|NCT00479401|470408226|FG002|Overall Study|Exclusion criteria, relocation|0|||
130667703|NCT01430104|470408229|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
130667704|NCT02124746|470408230|FG000|Overall Study|Adverse Event|2|||
130335409|NCT04413617|469197445|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335410|NCT04413617|469197446|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
130335411|NCT04413617|469197447|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335412|NCT04413617|469197443|FG000|Overall Study|Protocol Violation|0|||
130335413|NCT04413617|469197444|FG001|Overall Study|Protocol Violation|1|||
130335414|NCT04413617|469197445|FG002|Overall Study|Protocol Violation|0|||
130335415|NCT04413617|469197446|FG003|Overall Study|Protocol Violation|0|||
130335416|NCT04413617|469197447|FG004|Overall Study|Protocol Violation|1|||
130335417|NCT04413617|469197443|FG000|Overall Study|Lack of Efficacy|2|||
130335418|NCT04413617|469197444|FG001|Overall Study|Lack of Efficacy|0|||
130335419|NCT04413617|469197445|FG002|Overall Study|Lack of Efficacy|2|||
130335420|NCT04413617|469197446|FG003|Overall Study|Lack of Efficacy|1|||
130335421|NCT04413617|469197447|FG004|Overall Study|Lack of Efficacy|0|||
130335422|NCT04413617|469197443|FG000|Overall Study|Withdrawal by Subject|3|||
130335423|NCT04413617|469197444|FG001|Overall Study|Withdrawal by Subject|4|||
130335424|NCT04413617|469197445|FG002|Overall Study|Withdrawal by Subject|2|||
130335425|NCT04413617|469197446|FG003|Overall Study|Withdrawal by Subject|5|||
130335426|NCT04413617|469197447|FG004|Overall Study|Withdrawal by Subject|3|||
130335427|NCT04413617|469197443|FG000|Overall Study|Death|1|||
130335428|NCT04413617|469197444|FG001|Overall Study|Death|0|||
130335429|NCT04413617|469197445|FG002|Overall Study|Death|0|||
130335430|NCT04413617|469197446|FG003|Overall Study|Death|0|||
130335431|NCT04413617|469197447|FG004|Overall Study|Death|0|||
130335432|NCT04413617|469197443|FG000|Overall Study|Adverse Event|1|||
130335433|NCT04413617|469197444|FG001|Overall Study|Adverse Event|0|||
130335434|NCT04413617|469197445|FG002|Overall Study|Adverse Event|0|||
130335435|NCT04413617|469197446|FG003|Overall Study|Adverse Event|1|||
130335436|NCT04413617|469197447|FG004|Overall Study|Adverse Event|1|||
130335437|NCT04413617|469197443|FG000|Overall Study|COVID-19|0|||
130335438|NCT04413617|469197444|FG001|Overall Study|COVID-19|1|||
130335439|NCT04413617|469197445|FG002|Overall Study|COVID-19|0|||
130335440|NCT04413617|469197446|FG003|Overall Study|COVID-19|0|||
130335441|NCT04413617|469197447|FG004|Overall Study|COVID-19|0|||
130335442|NCT01327482|469197448|FG000|Overall Study|Adverse Event|1|||
130335443|NCT00476229|469197449|FG000|Overall Study|Progressive shortness of breath|1|||
130335444|NCT02164461|469197450|FG000|Overall Study|Adverse Event|0|||
130335445|NCT02164461|469197451|FG001|Overall Study|Adverse Event|0|||
130335446|NCT02164461|469197452|FG002|Overall Study|Adverse Event|1|||
130335447|NCT02164461|469197450|FG000|Overall Study|Disease Progression|1|||
130335448|NCT02164461|469197451|FG001|Overall Study|Disease Progression|3|||
130335449|NCT02164461|469197452|FG002|Overall Study|Disease Progression|4|||
130335450|NCT02164461|469197450|FG000|Overall Study|Withdrawal by Subject|0|||
130335451|NCT02164461|469197451|FG001|Overall Study|Withdrawal by Subject|3|||
130335452|NCT02164461|469197452|FG002|Overall Study|Withdrawal by Subject|0|||
130335453|NCT01192191|469197454|FG000|Overall Study|Adverse Event|7|||
130335454|NCT01192191|469197455|FG001|Overall Study|Adverse Event|12|||
130335455|NCT01192191|469197454|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
130335456|NCT01192191|469197455|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
130335457|NCT01192191|469197454|FG000|Overall Study|Lost to Follow-up|0|||
130335458|NCT01192191|469197455|FG001|Overall Study|Lost to Follow-up|1|||
130335459|NCT01192191|469197454|FG000|Overall Study|Withdrawal by Subject|1|||
130335460|NCT01192191|469197455|FG001|Overall Study|Withdrawal by Subject|6|||
130335461|NCT01583296|469197458|FG000|Overall Study|Withdrawal by Subject|11|||
130667705|NCT02124746|470408231|FG001|Overall Study|Adverse Event|1|||
130667706|NCT02124746|470408232|FG002|Overall Study|Adverse Event|2|||
130667707|NCT02124746|470408230|FG000|Overall Study|Death|2|||
130667708|NCT02124746|470408231|FG001|Overall Study|Death|1|||
130335462|NCT01583296|469197459|FG001|Overall Study|Withdrawal by Subject|10|||
130335463|NCT01047553|469197460|FG000|Overall Study|Adverse Event|10|||
130335464|NCT01047553|469197461|FG001|Overall Study|Adverse Event|5|||
130667709|NCT02124746|470408232|FG002|Overall Study|Death|3|||
130667710|NCT02124746|470408230|FG000|Overall Study|Lack of Efficacy|3|||
130667711|NCT02124746|470408231|FG001|Overall Study|Lack of Efficacy|2|||
130667712|NCT02124746|470408232|FG002|Overall Study|Lack of Efficacy|2|||
130667713|NCT02124746|470408230|FG000|Overall Study|Physician Decision|6|||
130667714|NCT02124746|470408231|FG001|Overall Study|Physician Decision|4|||
130667715|NCT02124746|470408232|FG002|Overall Study|Physician Decision|5|||
130667716|NCT02124746|470408230|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130667717|NCT02124746|470408231|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130667718|NCT02124746|470408232|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130667719|NCT02124746|470408230|FG000|Overall Study|Withdrawal by Subject|3|||
130667720|NCT02124746|470408231|FG001|Overall Study|Withdrawal by Subject|3|||
130335465|NCT01047553|469197460|FG000|Overall Study|Withdrawal by Subject|4|||
130335466|NCT01047553|469197461|FG001|Overall Study|Withdrawal by Subject|2|||
130335467|NCT01047553|469197460|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
130335468|NCT01047553|469197461|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
130335469|NCT01047553|469197460|FG000|Overall Study|Lost to Follow-up|1|||
130335470|NCT01047553|469197461|FG001|Overall Study|Lost to Follow-up|0|||
130335471|NCT01047553|469197460|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
130335472|NCT01047553|469197461|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
130335473|NCT01047553|469197460|FG000|Overall Study|PI's decision|0|||
130335474|NCT01047553|469197461|FG001|Overall Study|PI's decision|1|||
130335475|NCT01063283|469197462|FG000|Cycle 1|Adverse Event|2|||
130335476|NCT01063283|469197463|FG001|Cycle 1|Adverse Event|0|||
130335477|NCT01063283|469197464|FG002|Cycle 1|Adverse Event|0|||
130335478|NCT01063283|469197462|FG000|Cycle 1|Technical failure in data collection|1|||
130335479|NCT01063283|469197463|FG001|Cycle 1|Technical failure in data collection|0|||
130335480|NCT01063283|469197464|FG002|Cycle 1|Technical failure in data collection|0|||
130335481|NCT03179319|469197465|FG000|Overall Study|Lost to Follow-up|6|||
130335482|NCT03179319|469197466|FG001|Overall Study|Lost to Follow-up|0|||
130335483|NCT01120717|469197467|FG000|Overall Study|Withdrawal by Subject|11|||
130335484|NCT01120717|469197468|FG001|Overall Study|Withdrawal by Subject|6|||
130335485|NCT01120717|469197467|FG000|Overall Study|Adverse Event|10|||
130335486|NCT01120717|469197468|FG001|Overall Study|Adverse Event|6|||
130335487|NCT01120717|469197467|FG000|Overall Study|Protocol Deviation|2|||
130335488|NCT01120717|469197468|FG001|Overall Study|Protocol Deviation|5|||
130335489|NCT01120717|469197467|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130335490|NCT01120717|469197468|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130335491|NCT01120717|469197467|FG000|Overall Study|Lost to Follow-up|2|||
130335492|NCT01120717|469197468|FG001|Overall Study|Lost to Follow-up|3|||
130335493|NCT01120717|469197467|FG000|Overall Study|Death|3|||
130335494|NCT01120717|469197468|FG001|Overall Study|Death|1|||
130335495|NCT01120717|469197467|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130335496|NCT01120717|469197468|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130335497|NCT00948441|469197475|FG000|Overall Study|no longer meet inclusion criteria|1|||
130335498|NCT00948441|469197476|FG001|Overall Study|no longer meet inclusion criteria|4|||
130335499|NCT00472030|469197480|FG000|Overall Study|Physician Decision|1|||
130335500|NCT00472030|469197481|FG001|Overall Study|Physician Decision|0|||
130335501|NCT04198714|469197482|FG000|Overall Study|Physician Decision|0|||
130335502|NCT04198714|469197483|FG001|Overall Study|Physician Decision|1|||
130335503|NCT02923921|469199644|FG000|Overall Study|Sponsor Decision|39|||
130335504|NCT02923921|469199645|FG001|Overall Study|Sponsor Decision|38|||
130335505|NCT02923921|469199644|FG000|Overall Study|Lost to Follow-up|1|||
130335506|NCT02923921|469199645|FG001|Overall Study|Lost to Follow-up|0|||
130335507|NCT02923921|469199644|FG000|Overall Study|Withdrawal by Subject|6|||
130335508|NCT02923921|469199645|FG001|Overall Study|Withdrawal by Subject|13|||
130335509|NCT02923921|469199644|FG000|Overall Study|Unknown, Not Collected|7|||
130335510|NCT02923921|469199645|FG001|Overall Study|Unknown, Not Collected|6|||
130335511|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
130667721|NCT02124746|470408232|FG002|Overall Study|Withdrawal by Subject|0|||
130667722|NCT02124746|470408230|FG000|Overall Study|Study Terminated by Sponsor|0|||
130335512|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
130335513|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
130335514|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130335515|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
130335516|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130335517|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
130335518|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
130335519|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
130335520|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
130667723|NCT02124746|470408231|FG001|Overall Study|Study Terminated by Sponsor|0|||
130667724|NCT02124746|470408232|FG002|Overall Study|Study Terminated by Sponsor|6|||
130667725|NCT02124746|470408230|FG000|Overall Study|Disease Progression|3|||
130667726|NCT02124746|470408231|FG001|Overall Study|Disease Progression|6|||
130667727|NCT02124746|470408232|FG002|Overall Study|Disease Progression|4|||
130667728|NCT00571922|470408238|FG000|Overall Study|Completion unknown|36|||
130667729|NCT00571922|470408239|FG001|Overall Study|Completion unknown|36|||
130667730|NCT02544633|470409716|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
130667731|NCT02544633|470409717|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
130667732|NCT02544633|470409718|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
130667733|NCT02544633|470409719|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
130667734|NCT02544633|470409716|FG000|Treatment Period|Adverse Event|7|||
130667735|NCT02544633|470409717|FG001|Treatment Period|Adverse Event|4|||
130667736|NCT02544633|470409718|FG002|Treatment Period|Adverse Event|0|||
130667737|NCT02544633|470409719|FG003|Treatment Period|Adverse Event|5|||
130667738|NCT02544633|470409716|FG000|Treatment Period|Lack of Efficacy|17|||
130667739|NCT02544633|470409717|FG001|Treatment Period|Lack of Efficacy|11|||
130667740|NCT02544633|470409718|FG002|Treatment Period|Lack of Efficacy|5|||
130667741|NCT02544633|470409719|FG003|Treatment Period|Lack of Efficacy|5|||
130667742|NCT02544633|470409716|FG000|Treatment Period|Global Deterioration of Health|3|||
130667743|NCT02544633|470409717|FG001|Treatment Period|Global Deterioration of Health|3|||
130667744|NCT02544633|470409718|FG002|Treatment Period|Global Deterioration of Health|0|||
130667745|NCT02544633|470409719|FG003|Treatment Period|Global Deterioration of Health|1|||
130667746|NCT02544633|470409716|FG000|Treatment Period|Withdrawal by Subject|1|||
130667747|NCT02544633|470409717|FG001|Treatment Period|Withdrawal by Subject|0|||
130667748|NCT02544633|470409718|FG002|Treatment Period|Withdrawal by Subject|0|||
130667749|NCT02544633|470409719|FG003|Treatment Period|Withdrawal by Subject|0|||
130667750|NCT02544633|470409716|FG000|Treatment Period|Lost to Follow-up|0|||
130667751|NCT02544633|470409717|FG001|Treatment Period|Lost to Follow-up|1|||
130667752|NCT02544633|470409718|FG002|Treatment Period|Lost to Follow-up|0|||
130667753|NCT02544633|470409719|FG003|Treatment Period|Lost to Follow-up|0|||
130667754|NCT02544633|470409716|FG000|Treatment Period|Death|0|||
130667755|NCT02544633|470409717|FG001|Treatment Period|Death|0|||
130667756|NCT02544633|470409718|FG002|Treatment Period|Death|1|||
130667757|NCT02544633|470409719|FG003|Treatment Period|Death|0|||
130667758|NCT02544633|470409716|FG000|Treatment Period|Non-compliance|0|||
130667759|NCT02544633|470409717|FG001|Treatment Period|Non-compliance|0|||
130667760|NCT02544633|470409718|FG002|Treatment Period|Non-compliance|1|||
130667761|NCT02544633|470409719|FG003|Treatment Period|Non-compliance|0|||
130667762|NCT02544633|470409716|FG000|Treatment Period|Clinical Disease Progression|0|||
130667763|NCT02544633|470409717|FG001|Treatment Period|Clinical Disease Progression|0|||
130667764|NCT02544633|470409718|FG002|Treatment Period|Clinical Disease Progression|0|||
130667765|NCT02544633|470409719|FG003|Treatment Period|Clinical Disease Progression|1|||
130667766|NCT02544633|470409716|FG000|Survival Follow-up Period|Death|12|||
130667767|NCT02544633|470409717|FG001|Survival Follow-up Period|Death|14|||
130667768|NCT02544633|470409718|FG002|Survival Follow-up Period|Death|3|||
130667769|NCT02544633|470409719|FG003|Survival Follow-up Period|Death|9|||
130667770|NCT02544633|470409716|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
130667771|NCT02544633|470409717|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
130667772|NCT02544633|470409718|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
130667773|NCT02544633|470409719|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
130667774|NCT02544633|470409716|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
130667775|NCT02544633|470409717|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
130667776|NCT02544633|470409718|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
130667777|NCT02544633|470409719|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
130667778|NCT02544633|470409716|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
130667779|NCT02544633|470409717|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
130667780|NCT02544633|470409718|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
130667781|NCT02544633|470409719|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
130552653|NCT01598311|469990260|FG000|Overall Study|Withdrawal by Subject|9|||
130552654|NCT01598311|469990261|FG001|Overall Study|Withdrawal by Subject|13|||
130552655|NCT01598311|469990260|FG000|Overall Study|No reason provided.|0|||
130552656|NCT01598311|469990261|FG001|Overall Study|No reason provided.|5|||
130552657|NCT01598311|469990260|FG000|Overall Study|Randomized but never treated|8|||
130552658|NCT01598311|469990261|FG001|Overall Study|Randomized but never treated|5|||
130552659|NCT01598311|469990260|FG000|Overall Study|Treated but no confirmed CDAD|9|||
130552660|NCT01598311|469990261|FG001|Overall Study|Treated but no confirmed CDAD|8|||
130552661|NCT01598311|469990260|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
130667782|NCT01977352|470409720|FG000|Overall Study|Lost to Follow-up|1|||
130667783|NCT01977352|470409721|FG001|Overall Study|Lost to Follow-up|2|||
130667784|NCT02270983|470409722|FG000|Overall Study|Adverse Event|3|||
130667785|NCT02270983|470409723|FG001|Overall Study|Adverse Event|2|||
130667786|NCT02270983|470409724|FG002|Overall Study|Adverse Event|6|||
130667787|NCT02270983|470409722|FG000|Overall Study|Lack of Efficacy|2|||
130667788|NCT02270983|470409723|FG001|Overall Study|Lack of Efficacy|1|||
130667789|NCT02270983|470409724|FG002|Overall Study|Lack of Efficacy|1|||
130667790|NCT02270983|470409722|FG000|Overall Study|Withdrawal by Subject|1|||
130667791|NCT02270983|470409723|FG001|Overall Study|Withdrawal by Subject|0|||
130720916|NCT00724048|470601562|FG001|Overall Study|Adverse Event|1|||
130667792|NCT02270983|470409724|FG002|Overall Study|Withdrawal by Subject|2|||
130667793|NCT02270983|470409722|FG000|Overall Study|Lost to Follow-up|1|||
130667794|NCT02270983|470409723|FG001|Overall Study|Lost to Follow-up|1|||
130667795|NCT02270983|470409724|FG002|Overall Study|Lost to Follow-up|2|||
130667796|NCT02270983|470409722|FG000|Overall Study|Protocol Violation|1|||
130667797|NCT02270983|470409723|FG001|Overall Study|Protocol Violation|1|||
130667798|NCT02270983|470409724|FG002|Overall Study|Protocol Violation|1|||
130667799|NCT02270983|470409722|FG000|Overall Study|family emergency|0|||
130667800|NCT02270983|470409723|FG001|Overall Study|family emergency|1|||
130667801|NCT02270983|470409724|FG002|Overall Study|family emergency|0|||
130667802|NCT02270983|470409722|FG000|Overall Study|study procedure non-compliance|1|||
130667803|NCT02270983|470409723|FG001|Overall Study|study procedure non-compliance|0|||
130667804|NCT02270983|470409724|FG002|Overall Study|study procedure non-compliance|0|||
130667805|NCT02270983|470409722|FG000|Overall Study|moved away from study site|0|||
130667806|NCT02270983|470409723|FG001|Overall Study|moved away from study site|1|||
130667807|NCT02270983|470409724|FG002|Overall Study|moved away from study site|0|||
130667808|NCT00854620|470409727|FG000|Overall Study|Adverse Event|1|||
130667809|NCT00928252|470409728|FG000|Overall Study|Physician Decision|3|||
130667810|NCT01605461|470409730|FG000|Overall Study|Lost to Follow-up|3|||
130667811|NCT01605461|470409730|FG000|Overall Study|Withdrawal by Subject|1|||
130667812|NCT02024698|470409731|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
130667813|NCT02024698|470409732|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
130667814|NCT00275028|470409733|FG000|Overall Study|Withdrew consent before treatment began|1|||
130667815|NCT00275028|470409733|FG000|Overall Study|Withdrawal by Subject|5|||
130667816|NCT00275028|470409733|FG000|Overall Study|Adverse Event|9|||
130667817|NCT00275028|470409733|FG000|Overall Study|Progressive Disease|30|||
130667818|NCT00275028|470409733|FG000|Overall Study|Physician Decision|2|||
130667819|NCT02370784|470409737|FG000|Overall Study|Patient started prohibited medication|0|||
130667820|NCT02370784|470409738|FG001|Overall Study|Patient started prohibited medication|1|||
130667821|NCT00331630|470409739|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
130667822|NCT00331630|470409739|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
130667823|NCT00331630|470409739|FG000|Follow up for 5 Years|Death|5|||
130667824|NCT00331630|470409739|FG000|Follow up for 5 Years|Data collection was stopped|24|||
130667825|NCT03763331|470409742|FG000|Overall Study|Lost to Follow-up|1|||
130667826|NCT03763331|470409743|FG001|Overall Study|Lost to Follow-up|0|||
130667827|NCT03763331|470409742|FG000|Overall Study|Withdrawal by Subject|1|||
130667828|NCT03763331|470409743|FG001|Overall Study|Withdrawal by Subject|0|||
130667829|NCT03763331|470409742|FG000|Overall Study|Non-compliance|0|||
130667830|NCT03763331|470409743|FG001|Overall Study|Non-compliance|3|||
130667831|NCT01312779|470409744|FG000|Overall Study|Withdrawal by Subject|2|||
130667832|NCT01312779|470409744|FG000|Overall Study|Death|3|||
130667833|NCT01312779|470409744|FG000|Overall Study|Not Implanted with Device|27|||
130667834|NCT04741503|470409745|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
130667835|NCT04741503|470409746|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
130667836|NCT04741503|470409747|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
130667837|NCT04741503|470409745|FG000|Initial Enrollment|Overquotas removed|0|||
130667838|NCT04741503|470409746|FG001|Initial Enrollment|Overquotas removed|0|||
130667839|NCT04741503|470409747|FG002|Initial Enrollment|Overquotas removed|186|||
130667840|NCT04741503|470409745|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
130667841|NCT04741503|470409746|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
130667842|NCT04741503|470409747|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
130667843|NCT02280421|470409750|FG000|Washout (2 Weeks)|Adverse Event|0|||
130667844|NCT02280421|470409751|FG001|Washout (2 Weeks)|Adverse Event|1|||
130667845|NCT02280421|470409750|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130667846|NCT02280421|470409751|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
130667847|NCT02764489|470409761|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
130667848|NCT02764489|470409762|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
130667849|NCT02764489|470409761|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
130667850|NCT02764489|470409762|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
130667851|NCT02764489|470409761|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
130667852|NCT02764489|470409762|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
130667853|NCT02764489|470409761|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
130667854|NCT02764489|470409762|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
130667855|NCT00693784|470409763|FG000|Overall Study|Lost to Follow-up|2|||
130667856|NCT00693784|470409763|FG000|Overall Study|Withdrawal by Subject|2|||
130667857|NCT00326885|470409767|FG000|Overall Study|Adverse Event|1|||
130667858|NCT00326885|470409767|FG000|Overall Study|Withdrawal by Subject|3|||
130667859|NCT00326885|470409767|FG000|Overall Study|Physician Decision|1|||
130667860|NCT00326885|470409767|FG000|Overall Study|Hospice withdrew consent|2|||
130667861|NCT01706198|470409768|FG000|Overall Study|Adverse Event|12|||
130667862|NCT01706198|470409769|FG001|Overall Study|Adverse Event|15|||
130667863|NCT01706198|470409768|FG000|Overall Study|Protocol Violation|7|||
130667864|NCT01706198|470409769|FG001|Overall Study|Protocol Violation|5|||
130667865|NCT01706198|470409768|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
130667866|NCT01706198|470409769|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
130667867|NCT01706198|470409768|FG000|Overall Study|Lost to Follow-up|97|||
130667868|NCT01706198|470409769|FG001|Overall Study|Lost to Follow-up|93|||
130667869|NCT01706198|470409768|FG000|Overall Study|Physician Decision|23|||
130667870|NCT01706198|470409769|FG001|Overall Study|Physician Decision|37|||
130667871|NCT01706198|470409768|FG000|Overall Study|Withdrawal by Subject|23|||
130667872|NCT01706198|470409769|FG001|Overall Study|Withdrawal by Subject|31|||
130667873|NCT04313283|470409771|FG000|Overall Study|did not complete intervention|4|||
130667874|NCT01473758|470409772|FG000|Cycle 1|Adverse Event|10|||
130667875|NCT01473758|470409773|FG001|Cycle 1|Adverse Event|2|||
130667876|NCT01473758|470409774|FG002|Cycle 1|Adverse Event|0|||
130667877|NCT01473758|470409775|FG003|Cycle 1|Adverse Event|0|||
130667878|NCT01473758|470409772|FG000|Cycle 1|Withdrawal by Subject|1|||
130667879|NCT01473758|470409773|FG001|Cycle 1|Withdrawal by Subject|1|||
130667880|NCT01473758|470409774|FG002|Cycle 1|Withdrawal by Subject|0|||
130667881|NCT01473758|470409775|FG003|Cycle 1|Withdrawal by Subject|0|||
130667882|NCT01473758|470409772|FG000|Cycle 2|Adverse Event|0|||
130667883|NCT01473758|470409773|FG001|Cycle 2|Adverse Event|0|||
130667884|NCT01473758|470409774|FG002|Cycle 2|Adverse Event|5|||
130667885|NCT01473758|470409775|FG003|Cycle 2|Adverse Event|0|||
130667886|NCT02763579|470409776|FG000|Global Period|Death|167|||
130667887|NCT02763579|470409777|FG001|Global Period|Death|151|||
130667888|NCT02763579|470409778|FG002|Global Period|Death|0|||
130667889|NCT02763579|470409779|FG003|Global Period|Death|0|||
130667890|NCT02763579|470409776|FG000|Global Period|Lost to Follow-up|2|||
130667891|NCT02763579|470409777|FG001|Global Period|Lost to Follow-up|4|||
130667892|NCT02763579|470409778|FG002|Global Period|Lost to Follow-up|0|||
130667893|NCT02763579|470409779|FG003|Global Period|Lost to Follow-up|0|||
130667894|NCT02763579|470409776|FG000|Global Period|Physician Decision|0|||
130667895|NCT02763579|470409777|FG001|Global Period|Physician Decision|2|||
130667896|NCT02763579|470409778|FG002|Global Period|Physician Decision|0|||
130667897|NCT02763579|470409779|FG003|Global Period|Physician Decision|0|||
130667898|NCT02763579|470409776|FG000|Global Period|Study Terminated By Sponsor|21|||
130667899|NCT02763579|470409777|FG001|Global Period|Study Terminated By Sponsor|26|||
130667900|NCT02763579|470409778|FG002|Global Period|Study Terminated By Sponsor|0|||
130667901|NCT02763579|470409779|FG003|Global Period|Study Terminated By Sponsor|0|||
130667902|NCT02763579|470409776|FG000|Global Period|Withdrawal by Subject|12|||
130667903|NCT02763579|470409777|FG001|Global Period|Withdrawal by Subject|18|||
130667904|NCT02763579|470409778|FG002|Global Period|Withdrawal by Subject|0|||
130667905|NCT02763579|470409779|FG003|Global Period|Withdrawal by Subject|0|||
130667906|NCT02763579|470409776|FG000|China Period|Death|0|||
130667907|NCT02763579|470409777|FG001|China Period|Death|0|||
130667908|NCT02763579|470409778|FG002|China Period|Death|46|||
130667909|NCT02763579|470409779|FG003|China Period|Death|48|||
130667910|NCT02763579|470409776|FG000|China Period|Lost to Follow-up|0|||
130667911|NCT02763579|470409777|FG001|China Period|Lost to Follow-up|0|||
130667912|NCT02763579|470409778|FG002|China Period|Lost to Follow-up|1|||
130667913|NCT02763579|470409779|FG003|China Period|Lost to Follow-up|1|||
130667914|NCT02763579|470409776|FG000|China Period|Physician Decision|0|||
130667915|NCT02763579|470409777|FG001|China Period|Physician Decision|0|||
130667916|NCT02763579|470409778|FG002|China Period|Physician Decision|0|||
130667917|NCT02763579|470409779|FG003|China Period|Physician Decision|1|||
130335521|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130335522|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130335523|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
130335524|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
130335525|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
130335526|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130335527|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130335528|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
130335529|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
130667918|NCT02763579|470409776|FG000|China Period|Study Terminated By Sponsor|0|||
130667919|NCT02763579|470409777|FG001|China Period|Study Terminated By Sponsor|0|||
130667920|NCT02763579|470409778|FG002|China Period|Study Terminated By Sponsor|3|||
130667921|NCT02763579|470409779|FG003|China Period|Study Terminated By Sponsor|4|||
130667922|NCT02763579|470409776|FG000|China Period|Withdrawal by Subject|0|||
130667923|NCT02763579|470409777|FG001|China Period|Withdrawal by Subject|0|||
130667924|NCT02763579|470409778|FG002|China Period|Withdrawal by Subject|3|||
130667925|NCT02763579|470409779|FG003|China Period|Withdrawal by Subject|3|||
130335530|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
130667926|NCT02965820|470409780|FG000|Period 2, Second 30 Days|Adverse Event|1|||
130667927|NCT02965820|470409781|FG001|Period 2, Second 30 Days|Adverse Event|1|||
130667928|NCT01967888|470409782|FG000|Overall Study|Lost to Follow-up|6|||
130667929|NCT01967888|470409783|FG001|Overall Study|Lost to Follow-up|4|||
130667930|NCT01967888|470409782|FG000|Overall Study|Withdrawal by Subject|1|||
130667931|NCT01967888|470409783|FG001|Overall Study|Withdrawal by Subject|1|||
130667932|NCT01967888|470409782|FG000|Overall Study|Did Not Have Transplant|1|||
130667933|NCT01967888|470409783|FG001|Overall Study|Did Not Have Transplant|0|||
130667934|NCT01967888|470409782|FG000|Overall Study|Research visit not done, data recorded|1|||
130667935|NCT01967888|470409783|FG001|Overall Study|Research visit not done, data recorded|0|||
130335531|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
130335532|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130335533|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130335534|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
130335535|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
130667936|NCT01967888|470409782|FG000|Overall Study|Subject excluded after randomization|1|||
130667937|NCT01967888|470409783|FG001|Overall Study|Subject excluded after randomization|0|||
130667938|NCT01967888|470409782|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
130667939|NCT01967888|470409783|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
130335536|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
130335537|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
130335538|NCT00295880|469199649|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
130667940|NCT01967888|470409782|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
130667941|NCT01967888|470409783|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
130667942|NCT00553540|470409784|FG000|Overall Study|discharged after first visit|2|||
130667943|NCT00553540|470409785|FG001|Overall Study|discharged after first visit|5|||
130667944|NCT02622074|470409786|FG000|Overall Study|Death|4|||
130667945|NCT02622074|470409787|FG001|Overall Study|Death|0|||
130667946|NCT02622074|470409788|FG002|Overall Study|Death|0|||
130667947|NCT02622074|470409789|FG003|Overall Study|Death|1|||
130667948|NCT02622074|470409790|FG004|Overall Study|Death|1|||
130667949|NCT02622074|470409791|FG005|Overall Study|Death|0|||
130667950|NCT02622074|470409786|FG000|Overall Study|Withdrawal by Subject|0|||
130667951|NCT02622074|470409787|FG001|Overall Study|Withdrawal by Subject|1|||
130667952|NCT02622074|470409788|FG002|Overall Study|Withdrawal by Subject|0|||
130667953|NCT02622074|470409789|FG003|Overall Study|Withdrawal by Subject|0|||
130667954|NCT02622074|470409790|FG004|Overall Study|Withdrawal by Subject|0|||
130667955|NCT02622074|470409791|FG005|Overall Study|Withdrawal by Subject|0|||
130667956|NCT02114931|470409792|FG000|Overall Study|Withdrawal by Subject|15|||
130667957|NCT02114931|470409793|FG001|Overall Study|Withdrawal by Subject|18|||
130667958|NCT02114931|470409792|FG000|Overall Study|Adverse Event|4|||
130667959|NCT02114931|470409793|FG001|Overall Study|Adverse Event|6|||
130667960|NCT02114931|470409792|FG000|Overall Study|Lost to Follow-up|3|||
130667961|NCT02114931|470409793|FG001|Overall Study|Lost to Follow-up|3|||
130667962|NCT02114931|470409792|FG000|Overall Study|Physician Decision|1|||
130667963|NCT02114931|470409793|FG001|Overall Study|Physician Decision|2|||
130667964|NCT02114931|470409792|FG000|Overall Study|Other|2|||
130667965|NCT02114931|470409793|FG001|Overall Study|Other|1|||
130667966|NCT03565211|470409795|FG000|Overall Study|Withdrawal by Subject|2|||
130667967|NCT03565211|470409795|FG000|Overall Study|Lost to Follow-up|1|||
130667968|NCT03565211|470409795|FG000|Overall Study|Adverse Event|44|||
130667969|NCT03565211|470409795|FG000|Overall Study|Personal issues|1|||
130667970|NCT01894984|470409799|FG000|Overall Study|Other|314|||
130667971|NCT01894984|470409800|FG001|Overall Study|Other|175|||
130667972|NCT00033631|470409801|FG000|Overall Study|Protocol Violation|14|||
130667973|NCT00033631|470409802|FG001|Overall Study|Protocol Violation|11|||
130667974|NCT00033631|470409801|FG000|Overall Study|Withdrawal by Subject|4|||
130667975|NCT00033631|470409802|FG001|Overall Study|Withdrawal by Subject|4|||
130667976|NCT01827371|470409804|FG000|Overall Study|Adverse Event|0|||
130667977|NCT01827371|470409805|FG001|Overall Study|Adverse Event|0|||
130667978|NCT01827371|470409806|FG002|Overall Study|Adverse Event|4|||
130667979|NCT01827371|470409807|FG003|Overall Study|Adverse Event|2|||
130667980|NCT01827371|470409804|FG000|Overall Study|Lost to Follow-up|0|||
130667981|NCT01827371|470409805|FG001|Overall Study|Lost to Follow-up|2|||
130667982|NCT01827371|470409806|FG002|Overall Study|Lost to Follow-up|0|||
130667983|NCT01827371|470409807|FG003|Overall Study|Lost to Follow-up|4|||
130667984|NCT01827371|470409804|FG000|Overall Study|Protocol Violation|1|||
130667985|NCT01827371|470409805|FG001|Overall Study|Protocol Violation|0|||
130667986|NCT01827371|470409806|FG002|Overall Study|Protocol Violation|0|||
130667987|NCT01827371|470409807|FG003|Overall Study|Protocol Violation|0|||
130667988|NCT01827371|470409804|FG000|Overall Study|Withdrawal by Subject|1|||
130667989|NCT01827371|470409805|FG001|Overall Study|Withdrawal by Subject|2|||
130667990|NCT01827371|470409806|FG002|Overall Study|Withdrawal by Subject|2|||
130667991|NCT01827371|470409807|FG003|Overall Study|Withdrawal by Subject|3|||
130667992|NCT01827371|470409804|FG000|Overall Study|Physician Decision|0|||
130667993|NCT01827371|470409805|FG001|Overall Study|Physician Decision|1|||
130667994|NCT01827371|470409806|FG002|Overall Study|Physician Decision|0|||
130667995|NCT01827371|470409807|FG003|Overall Study|Physician Decision|1|||
130667996|NCT01827371|470409804|FG000|Overall Study|Temporary study halt to vaccinations|11|||
130667997|NCT01827371|470409805|FG001|Overall Study|Temporary study halt to vaccinations|2|||
130667998|NCT01827371|470409806|FG002|Overall Study|Temporary study halt to vaccinations|5|||
130667999|NCT01827371|470409807|FG003|Overall Study|Temporary study halt to vaccinations|13|||
130668000|NCT01427803|470409812|FG000|Overall Study|Lost to Follow-up|32|||
130668001|NCT01427803|470409813|FG001|Overall Study|Lost to Follow-up|26|||
130668002|NCT01427803|470409812|FG000|Overall Study|Withdrawal by Subject|20|||
130668003|NCT01427803|470409813|FG001|Overall Study|Withdrawal by Subject|0|||
130668004|NCT01427803|470409812|FG000|Overall Study|Unable to complete full treatment period|6|||
130668005|NCT01427803|470409813|FG001|Overall Study|Unable to complete full treatment period|0|||
130668006|NCT01427803|470409812|FG000|Overall Study|Protocol Violation|1|||
130668007|NCT01427803|470409813|FG001|Overall Study|Protocol Violation|0|||
130668008|NCT01427803|470409812|FG000|Overall Study|Physician Decision|3|||
130668009|NCT01427803|470409813|FG001|Overall Study|Physician Decision|0|||
130668010|NCT01427803|470409812|FG000|Overall Study|did not take product|1|||
130668011|NCT01427803|470409813|FG001|Overall Study|did not take product|0|||
130668012|NCT01571635|470409814|FG000|Overall Study|Adverse Event|3|||
130668013|NCT01571635|470409815|FG001|Overall Study|Adverse Event|0|||
130668014|NCT01571635|470409816|FG002|Overall Study|Adverse Event|2|||
130668015|NCT01571635|470409817|FG003|Overall Study|Adverse Event|3|||
130668016|NCT01571635|470409818|FG004|Overall Study|Adverse Event|5|||
130668017|NCT01571635|470409814|FG000|Overall Study|Other reasons|2|||
130668018|NCT01571635|470409815|FG001|Overall Study|Other reasons|1|||
130668019|NCT01571635|470409816|FG002|Overall Study|Other reasons|2|||
130668020|NCT01571635|470409817|FG003|Overall Study|Other reasons|2|||
130668021|NCT01571635|470409818|FG004|Overall Study|Other reasons|1|||
130668022|NCT01571635|470409814|FG000|Overall Study|Study terminated by sponsor|0|||
130668023|NCT01571635|470409815|FG001|Overall Study|Study terminated by sponsor|4|||
130668024|NCT01571635|470409816|FG002|Overall Study|Study terminated by sponsor|1|||
130668025|NCT01571635|470409817|FG003|Overall Study|Study terminated by sponsor|3|||
130668026|NCT01571635|470409818|FG004|Overall Study|Study terminated by sponsor|1|||
130668027|NCT01571635|470409814|FG000|Overall Study|Withdrew consent|1|||
130668028|NCT01571635|470409815|FG001|Overall Study|Withdrew consent|1|||
130668029|NCT01571635|470409816|FG002|Overall Study|Withdrew consent|2|||
130668030|NCT01571635|470409817|FG003|Overall Study|Withdrew consent|3|||
130668031|NCT01571635|470409818|FG004|Overall Study|Withdrew consent|0|||
130668032|NCT01571635|470409814|FG000|Overall Study|Lack of Efficacy|0|||
130668033|NCT01571635|470409815|FG001|Overall Study|Lack of Efficacy|2|||
130668034|NCT01571635|470409816|FG002|Overall Study|Lack of Efficacy|0|||
130668035|NCT01571635|470409817|FG003|Overall Study|Lack of Efficacy|1|||
130668036|NCT01571635|470409818|FG004|Overall Study|Lack of Efficacy|2|||
130668037|NCT04304950|470409823|FG000|Overall Study|Lost to Follow-up|1|||
130668038|NCT04304950|470409824|FG001|Overall Study|Lost to Follow-up|1|||
130668039|NCT02418910|470409825|FG000|Overall Study|Lost to Follow-up|3|||
130668040|NCT02418910|470409825|FG000|Overall Study|Withdrawal by Subject|4|||
130668041|NCT03634488|470409827|FG000|Overall Study|Death|1|||
130668042|NCT03634488|470409828|FG001|Overall Study|Death|0|||
130668043|NCT03634488|470409829|FG002|Overall Study|Death|0|||
130668044|NCT03634488|470409827|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
130668045|NCT03634488|470409828|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
130668046|NCT03634488|470409829|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
130668047|NCT03182686|470409830|FG000|Overall Study|Lost to Follow-up|2|||
130668048|NCT03182686|470409831|FG001|Overall Study|Lost to Follow-up|0|||
130668049|NCT03182686|470409830|FG000|Overall Study|Adverse Event|2|||
130668050|NCT03182686|470409831|FG001|Overall Study|Adverse Event|0|||
130668051|NCT03182686|470409830|FG000|Overall Study|Withdrawal by Subject|3|||
130668052|NCT03182686|470409831|FG001|Overall Study|Withdrawal by Subject|0|||
130668053|NCT01154127|470409832|FG000|Period 1 (21 Days)|Adverse Event|3|||
130668054|NCT01154127|470409833|FG001|Period 1 (21 Days)|Adverse Event|4|||
130668055|NCT01154127|470409832|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
130335539|NCT00295880|469199649|FG000|Overall Study|Unit randomization did not occur|1|||
130335540|NCT01474239|469199650|FG000|Overall Study|Disease Progression|37|||
130335541|NCT01474239|469199651|FG001|Overall Study|Disease Progression|25|||
130335542|NCT01474239|469199650|FG000|Overall Study|Adverse Event|12|||
130335543|NCT01474239|469199651|FG001|Overall Study|Adverse Event|3|||
130335544|NCT01474239|469199650|FG000|Overall Study|Withdrawal by Subject|1|||
130552662|NCT01598311|469990261|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
130552663|NCT00688103|469990262|FG000|Overall Study|Adverse Event|4|||
130552664|NCT00688103|469990263|FG001|Overall Study|Adverse Event|1|||
130552665|NCT00688103|469990262|FG000|Overall Study|Lack of Efficacy|11|||
130552666|NCT00688103|469990263|FG001|Overall Study|Lack of Efficacy|1|||
130552667|NCT00688103|469990262|FG000|Overall Study|Withdrawal by Subject|4|||
130552668|NCT00688103|469990263|FG001|Overall Study|Withdrawal by Subject|2|||
130552669|NCT00688103|469990262|FG000|Overall Study|complex reasons|11|||
130552670|NCT00688103|469990263|FG001|Overall Study|complex reasons|9|||
130552671|NCT01313117|469990264|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
130668056|NCT01154127|470409833|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
130335545|NCT01474239|469199651|FG001|Overall Study|Withdrawal by Subject|2|||
130552672|NCT01313117|469990264|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
130552673|NCT03602261|469990267|FG000|Overall Study|Adverse Event|5|||
130668057|NCT01154127|470409832|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
130668058|NCT01154127|470409833|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
130668059|NCT01154127|470409832|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
130668060|NCT01154127|470409833|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
130668061|NCT01154127|470409832|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
130668062|NCT01154127|470409833|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
130668063|NCT01697449|470409840|FG000|Overall Study|Disease progression|47|||
130668064|NCT01697449|470409840|FG000|Overall Study|Adverse Event|7|||
130668065|NCT01697449|470409840|FG000|Overall Study|Lost to Follow-up|5|||
130668066|NCT01697449|470409840|FG000|Overall Study|Withdrawal by Subject|2|||
130668067|NCT01697449|470409840|FG000|Overall Study|Physician Decision|1|||
130668068|NCT01697449|470409840|FG000|Overall Study|Death|2|||
130668069|NCT01697449|470409840|FG000|Overall Study|Other|1|||
130668070|NCT01697449|470409840|FG000|Overall Study|Missing|25|||
130668071|NCT02390219|470409841|FG000|Overall Study|Death|1|||
130668072|NCT02390219|470409841|FG000|Overall Study|Physician Decision|1|||
130668073|NCT02390219|470409841|FG000|Overall Study|Adverse Event|6|||
130668074|NCT02390219|470409841|FG000|Overall Study|Withdrawal by Subject|1|||
130668075|NCT02390219|470409841|FG000|Overall Study|Lost to Follow-up|2|||
130668076|NCT02390219|470409841|FG000|Overall Study|Other|2|||
130668077|NCT01169844|470409842|FG000|Overall Study|Adverse Event|0|||
130668078|NCT01169844|470409843|FG001|Overall Study|Adverse Event|1|||
130668079|NCT01169844|470409842|FG000|Overall Study|Patient withdrew consent|4|||
130668080|NCT01169844|470409843|FG001|Overall Study|Patient withdrew consent|0|||
130668081|NCT01169844|470409842|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130668082|NCT01169844|470409843|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130668083|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
130668084|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
130668085|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
130668086|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
130668087|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
130668088|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
130668089|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
130668090|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
130668091|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
130668092|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
130668093|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
130668094|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
130668095|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
130668096|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
130668097|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
130668098|NCT00529568|470409844|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
130668099|NCT00529568|470409845|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
130668100|NCT00529568|470409846|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
130668101|NCT00529568|470409844|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
130668102|NCT00529568|470409845|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
130668103|NCT00529568|470409846|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
130668104|NCT00529568|470409844|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
130668105|NCT00529568|470409845|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
130668106|NCT00529568|470409846|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
130668107|NCT00529568|470409844|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
130668108|NCT00529568|470409845|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
130668109|NCT00529568|470409846|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
130668110|NCT00529568|470409844|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
130668111|NCT00529568|470409845|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
130668112|NCT00529568|470409846|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
130668113|NCT00529568|470409844|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
130668114|NCT00529568|470409845|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
130668115|NCT00529568|470409846|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
130668116|NCT01201356|470409847|FG000|Overall Study|Adverse Event|170|||
130668117|NCT01201356|470409847|FG000|Overall Study|Abnormal laboratory value(s)|51|||
130668118|NCT01201356|470409847|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130668119|NCT01201356|470409847|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
130668120|NCT01201356|470409847|FG000|Overall Study|Condition no longer requires study drug|12|||
130668121|NCT01201356|470409847|FG000|Overall Study|Withdrawal by Subject|144|||
130668122|NCT01201356|470409847|FG000|Overall Study|Lost to Follow-up|50|||
130668123|NCT01201356|470409847|FG000|Overall Study|administrative problems|74|||
130668124|NCT01201356|470409847|FG000|Overall Study|Death|16|||
130668125|NCT01201356|470409847|FG000|Overall Study|Protocol Violation|12|||
130668126|NCT00811070|470409848|FG000|Overall Study|Death|0|||
130668127|NCT00811070|470409849|FG001|Overall Study|Death|0|||
130335546|NCT01474239|469199650|FG000|Overall Study|Death|1|||
130335547|NCT01474239|469199651|FG001|Overall Study|Death|1|||
130335548|NCT01474239|469199650|FG000|Overall Study|Clinical Disease Progression|7|||
130335549|NCT01474239|469199651|FG001|Overall Study|Clinical Disease Progression|1|||
130668128|NCT00811070|470409850|FG002|Overall Study|Death|0|||
130668129|NCT00811070|470409851|FG003|Overall Study|Death|2|||
130668130|NCT00811070|470409852|FG004|Overall Study|Death|5|||
130668131|NCT00811070|470409853|FG005|Overall Study|Death|0|||
130668132|NCT00811070|470409848|FG000|Overall Study|Other|1|||
130668133|NCT00811070|470409849|FG001|Overall Study|Other|0|||
130668134|NCT00811070|470409850|FG002|Overall Study|Other|0|||
130668135|NCT00811070|470409851|FG003|Overall Study|Other|0|||
130668136|NCT00811070|470409852|FG004|Overall Study|Other|0|||
130668137|NCT00811070|470409853|FG005|Overall Study|Other|0|||
130668138|NCT00811070|470409848|FG000|Overall Study|Withdrawal by Subject|0|||
130668139|NCT00811070|470409849|FG001|Overall Study|Withdrawal by Subject|1|||
130668140|NCT00811070|470409850|FG002|Overall Study|Withdrawal by Subject|0|||
130668141|NCT00811070|470409851|FG003|Overall Study|Withdrawal by Subject|0|||
130668142|NCT00811070|470409852|FG004|Overall Study|Withdrawal by Subject|0|||
130668143|NCT00811070|470409853|FG005|Overall Study|Withdrawal by Subject|0|||
130668144|NCT00811070|470409848|FG000|Overall Study|Physician Decision|0|||
130668145|NCT00811070|470409849|FG001|Overall Study|Physician Decision|0|||
130668146|NCT00811070|470409850|FG002|Overall Study|Physician Decision|0|||
130668147|NCT00811070|470409851|FG003|Overall Study|Physician Decision|0|||
130668148|NCT00811070|470409852|FG004|Overall Study|Physician Decision|0|||
130668149|NCT00811070|470409853|FG005|Overall Study|Physician Decision|1|||
130668150|NCT04079842|470409854|FG000|Overall Study|Request of subject|2|||
130668151|NCT04079842|470409854|FG000|Overall Study|Unable to draw Arterial samples|1|||
130668152|NCT01025193|470409855|FG000|Overall Study|Protocol Violation|1|||
130668153|NCT01025193|470409855|FG000|Overall Study|Adverse Event|3|||
130668154|NCT02904200|470409856|FG000|Overall Study|Withdrawal by Subject|1|||
130668155|NCT02904200|470409857|FG001|Overall Study|Withdrawal by Subject|0|||
130668156|NCT00185211|470409858|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
130668157|NCT00185211|470409859|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
130668158|NCT00185211|470409858|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
130668159|NCT00185211|470409859|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
130668160|NCT00185211|470409858|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
130668161|NCT00185211|470409859|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
130668162|NCT00185211|470409858|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
130668163|NCT00185211|470409859|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
130668164|NCT00185211|470409858|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
130668165|NCT00185211|470409859|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
130668166|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
130668167|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
130668168|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
130668169|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
130668170|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
130668171|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
130668172|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
130668173|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
130668174|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
130668175|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
130668176|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
130668177|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
130668178|NCT00185211|470409858|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
130668179|NCT00185211|470409859|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
130668180|NCT03372083|470411816|FG000|Overall Study|Adverse Event|3|||
130668181|NCT03372083|470411816|FG000|Overall Study|Physician Decision|1|||
130668182|NCT03372083|470411816|FG000|Overall Study|Withdrawal by Subject|1|||
130335550|NCT01474239|469199650|FG000|Overall Study|Withdrawal for Economic Reason|1|||
130668183|NCT02266706|470411817|FG000|Overall Study|Withdrawal by Subject|0|||
130668184|NCT02266706|470411818|FG001|Overall Study|Withdrawal by Subject|1|||
130668185|NCT02266706|470411819|FG002|Overall Study|Withdrawal by Subject|1|||
130335551|NCT01474239|469199651|FG001|Overall Study|Withdrawal for Economic Reason|0|||
130668186|NCT02266706|470411820|FG003|Overall Study|Withdrawal by Subject|0|||
130668187|NCT02266706|470411821|FG004|Overall Study|Withdrawal by Subject|0|||
130668188|NCT02266706|470411822|FG005|Overall Study|Withdrawal by Subject|1|||
130668189|NCT02266706|470411823|FG006|Overall Study|Withdrawal by Subject|0|||
130668190|NCT02266706|470411824|FG007|Overall Study|Withdrawal by Subject|0|||
130335552|NCT01139008|469199652|FG000|Overall Study|Withdrawal by Subject|5|||
130668191|NCT02266706|470411825|FG008|Overall Study|Withdrawal by Subject|0|||
130335553|NCT01139008|469199652|FG000|Overall Study|Non-compliant, lost product|1|||
130335554|NCT01715857|469199653|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
130668192|NCT02266706|470411817|FG000|Overall Study|Screen failure|0|||
130668193|NCT02266706|470411818|FG001|Overall Study|Screen failure|0|||
130668194|NCT02266706|470411819|FG002|Overall Study|Screen failure|0|||
130668195|NCT02266706|470411820|FG003|Overall Study|Screen failure|0|||
130668196|NCT02266706|470411821|FG004|Overall Study|Screen failure|0|||
130668197|NCT02266706|470411822|FG005|Overall Study|Screen failure|1|||
130668198|NCT02266706|470411823|FG006|Overall Study|Screen failure|1|||
130668199|NCT02266706|470411824|FG007|Overall Study|Screen failure|0|||
130668200|NCT02266706|470411825|FG008|Overall Study|Screen failure|0|||
130668201|NCT02266706|470411817|FG000|Overall Study|Enrollment in another study|0|||
130668202|NCT02266706|470411818|FG001|Overall Study|Enrollment in another study|0|||
130668203|NCT02266706|470411819|FG002|Overall Study|Enrollment in another study|0|||
130668204|NCT02266706|470411820|FG003|Overall Study|Enrollment in another study|1|||
130668205|NCT02266706|470411821|FG004|Overall Study|Enrollment in another study|0|||
130668206|NCT02266706|470411822|FG005|Overall Study|Enrollment in another study|0|||
130668207|NCT02266706|470411823|FG006|Overall Study|Enrollment in another study|0|||
130668208|NCT02266706|470411824|FG007|Overall Study|Enrollment in another study|0|||
130668209|NCT02266706|470411825|FG008|Overall Study|Enrollment in another study|0|||
130668210|NCT00409188|470411826|FG000|Overall Study|Ongoing at data cut-off|383|||
130668211|NCT00409188|470411827|FG001|Overall Study|Ongoing at data cut-off|175|||
130668212|NCT02257632|470411833|FG000|Overall Study|Withdrawal by Subject|0|||
130668213|NCT02257632|470411834|FG001|Overall Study|Withdrawal by Subject|1|||
130668214|NCT02257632|470411833|FG000|Overall Study|Adverse Event|1|||
130668215|NCT02257632|470411834|FG001|Overall Study|Adverse Event|2|||
130668216|NCT01393990|470411835|FG000|Overall Study|Adverse Event|0|||
130668217|NCT01393990|470411836|FG001|Overall Study|Adverse Event|0|||
130668218|NCT01393990|470411837|FG002|Overall Study|Adverse Event|0|||
130668219|NCT01393990|470411838|FG003|Overall Study|Adverse Event|0|||
130668220|NCT01393990|470411839|FG004|Overall Study|Adverse Event|0|||
130668221|NCT01393990|470411840|FG005|Overall Study|Adverse Event|0|||
130668222|NCT01393990|470411841|FG006|Overall Study|Adverse Event|0|||
130668223|NCT01393990|470411842|FG007|Overall Study|Adverse Event|0|||
130668224|NCT01393990|470411843|FG008|Overall Study|Adverse Event|0|||
130668225|NCT01393990|470411844|FG009|Overall Study|Adverse Event|0|||
130668226|NCT01393990|470411845|FG010|Overall Study|Adverse Event|0|||
130668227|NCT01393990|470411846|FG011|Overall Study|Adverse Event|0|||
130668228|NCT01393990|470411847|FG012|Overall Study|Adverse Event|0|||
130668229|NCT01393990|470411848|FG013|Overall Study|Adverse Event|0|||
130668230|NCT01393990|470411849|FG014|Overall Study|Adverse Event|1|||
130668231|NCT01393990|470411850|FG015|Overall Study|Adverse Event|1|||
130668232|NCT01393990|470411851|FG016|Overall Study|Adverse Event|0|||
130668233|NCT01393990|470411852|FG017|Overall Study|Adverse Event|0|||
130668234|NCT01393990|470411835|FG000|Overall Study|Progressive Disease|1|||
130668235|NCT01393990|470411836|FG001|Overall Study|Progressive Disease|0|||
130668236|NCT01393990|470411837|FG002|Overall Study|Progressive Disease|0|||
130668237|NCT01393990|470411838|FG003|Overall Study|Progressive Disease|1|||
130668238|NCT01393990|470411839|FG004|Overall Study|Progressive Disease|1|||
130668239|NCT01393990|470411840|FG005|Overall Study|Progressive Disease|1|||
130668240|NCT01393990|470411841|FG006|Overall Study|Progressive Disease|1|||
130668241|NCT01393990|470411842|FG007|Overall Study|Progressive Disease|1|||
130668242|NCT01393990|470411843|FG008|Overall Study|Progressive Disease|3|||
130668243|NCT01393990|470411844|FG009|Overall Study|Progressive Disease|1|||
130668244|NCT01393990|470411845|FG010|Overall Study|Progressive Disease|0|||
130668245|NCT01393990|470411846|FG011|Overall Study|Progressive Disease|0|||
130668246|NCT01393990|470411847|FG012|Overall Study|Progressive Disease|0|||
130668247|NCT01393990|470411848|FG013|Overall Study|Progressive Disease|1|||
130668248|NCT01393990|470411849|FG014|Overall Study|Progressive Disease|6|||
130668249|NCT01393990|470411850|FG015|Overall Study|Progressive Disease|1|||
130668250|NCT01393990|470411851|FG016|Overall Study|Progressive Disease|0|||
130668251|NCT01393990|470411852|FG017|Overall Study|Progressive Disease|0|||
130668252|NCT01393990|470411835|FG000|Overall Study|Death|0|||
130668253|NCT01393990|470411836|FG001|Overall Study|Death|0|||
130668254|NCT01393990|470411837|FG002|Overall Study|Death|0|||
130668255|NCT01393990|470411838|FG003|Overall Study|Death|0|||
130335555|NCT00505778|469199654|FG000|Overall Study|Adverse Event|2|||
130668256|NCT01393990|470411839|FG004|Overall Study|Death|1|||
130668257|NCT01393990|470411840|FG005|Overall Study|Death|0|||
130668258|NCT01393990|470411841|FG006|Overall Study|Death|0|||
130668259|NCT01393990|470411842|FG007|Overall Study|Death|0|||
130668260|NCT01393990|470411843|FG008|Overall Study|Death|0|||
130668261|NCT01393990|470411844|FG009|Overall Study|Death|0|||
130668262|NCT01393990|470411845|FG010|Overall Study|Death|0|||
130668263|NCT01393990|470411846|FG011|Overall Study|Death|0|||
130668264|NCT01393990|470411847|FG012|Overall Study|Death|0|||
130668265|NCT01393990|470411848|FG013|Overall Study|Death|1|||
130668266|NCT01393990|470411849|FG014|Overall Study|Death|1|||
130668267|NCT01393990|470411850|FG015|Overall Study|Death|0|||
130668268|NCT01393990|470411851|FG016|Overall Study|Death|0|||
130668269|NCT01393990|470411852|FG017|Overall Study|Death|0|||
130668270|NCT01393990|470411835|FG000|Overall Study|Withdrawal by Subject|0|||
130668271|NCT01393990|470411836|FG001|Overall Study|Withdrawal by Subject|0|||
130668272|NCT01393990|470411837|FG002|Overall Study|Withdrawal by Subject|0|||
130668273|NCT01393990|470411838|FG003|Overall Study|Withdrawal by Subject|0|||
130668274|NCT01393990|470411839|FG004|Overall Study|Withdrawal by Subject|0|||
130668275|NCT01393990|470411840|FG005|Overall Study|Withdrawal by Subject|0|||
130668276|NCT01393990|470411841|FG006|Overall Study|Withdrawal by Subject|0|||
130668277|NCT01393990|470411842|FG007|Overall Study|Withdrawal by Subject|0|||
130668278|NCT01393990|470411843|FG008|Overall Study|Withdrawal by Subject|0|||
130668279|NCT01393990|470411844|FG009|Overall Study|Withdrawal by Subject|0|||
130668280|NCT01393990|470411845|FG010|Overall Study|Withdrawal by Subject|0|||
130668281|NCT01393990|470411846|FG011|Overall Study|Withdrawal by Subject|0|||
130668282|NCT01393990|470411847|FG012|Overall Study|Withdrawal by Subject|0|||
130668283|NCT01393990|470411848|FG013|Overall Study|Withdrawal by Subject|0|||
130668284|NCT01393990|470411849|FG014|Overall Study|Withdrawal by Subject|1|||
130668285|NCT01393990|470411850|FG015|Overall Study|Withdrawal by Subject|1|||
130668286|NCT01393990|470411851|FG016|Overall Study|Withdrawal by Subject|0|||
130668287|NCT01393990|470411852|FG017|Overall Study|Withdrawal by Subject|0|||
130668288|NCT01859390|470411853|FG000|Overall Study|Insufficient Sputum Collected|1|||
130668289|NCT01859390|470411854|FG001|Overall Study|Insufficient Sputum Collected|3|||
130668290|NCT01859390|470411853|FG000|Overall Study|Sample Missing Collection Date|0|||
130668291|NCT01859390|470411854|FG001|Overall Study|Sample Missing Collection Date|1|||
130668292|NCT01859390|470411853|FG000|Overall Study|Tube Cracked|0|||
130668293|NCT01859390|470411854|FG001|Overall Study|Tube Cracked|2|||
130668294|NCT01859390|470411853|FG000|Overall Study|Shipment Error|0|||
130668295|NCT01859390|470411854|FG001|Overall Study|Shipment Error|1|||
130668296|NCT02038634|470411856|FG000|Overall Study|Lost to Follow-up|0|||
130668297|NCT02038634|470411857|FG001|Overall Study|Lost to Follow-up|1|||
130668298|NCT01664052|470411858|FG000|Phase 1|No device placement|6|||
130668299|NCT01664052|470411859|FG001|Phase 1|No device placement|0|||
130668300|NCT01664052|470411858|FG000|Phase 1|No HSG 1 hr post placement|1|||
130668301|NCT01664052|470411859|FG001|Phase 1|No HSG 1 hr post placement|0|||
130668302|NCT01664052|470411858|FG000|Phase 2|No device placement|0|||
130668303|NCT01664052|470411859|FG001|Phase 2|No device placement|4|||
130668304|NCT01084005|470411860|FG000|Overall Study|Adverse Event|1|||
130668305|NCT01084005|470411861|FG001|Overall Study|Adverse Event|8|||
130668306|NCT01084005|470411860|FG000|Overall Study|Protocol Violation|3|||
130668307|NCT01084005|470411861|FG001|Overall Study|Protocol Violation|7|||
130668308|NCT01084005|470411860|FG000|Overall Study|Withdrawal by Subject|1|||
130668309|NCT01084005|470411861|FG001|Overall Study|Withdrawal by Subject|1|||
130668310|NCT00549198|470411862|FG000|Overall Study|Adverse Event|28|||
130668311|NCT00549198|470411863|FG001|Overall Study|Adverse Event|26|||
130668312|NCT00549198|470411862|FG000|Overall Study|Insufficient Viral Load Response|4|||
130668313|NCT00549198|470411863|FG001|Overall Study|Insufficient Viral Load Response|2|||
130668314|NCT00549198|470411862|FG000|Overall Study|Protocol-defined Virological Failure|7|||
130668315|NCT00549198|470411863|FG001|Overall Study|Protocol-defined Virological Failure|0|||
130668316|NCT00549198|470411862|FG000|Overall Study|Non-compliance|2|||
130668317|NCT00549198|470411863|FG001|Overall Study|Non-compliance|4|||
130668318|NCT00549198|470411862|FG000|Overall Study|Lost to Follow-up|7|||
130668319|NCT00549198|470411863|FG001|Overall Study|Lost to Follow-up|8|||
130668320|NCT00549198|470411862|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
130668321|NCT00549198|470411863|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130668322|NCT00549198|470411862|FG000|Overall Study|Protocol Violation|7|||
130668323|NCT00549198|470411863|FG001|Overall Study|Protocol Violation|2|||
130668324|NCT00549198|470411862|FG000|Overall Study|Investigator Decision|4|||
130668325|NCT00549198|470411863|FG001|Overall Study|Investigator Decision|3|||
130668326|NCT00549198|470411862|FG000|Overall Study|Withdrawal by Subject|7|||
130668327|NCT00549198|470411863|FG001|Overall Study|Withdrawal by Subject|7|||
130335556|NCT00505778|469199655|FG001|Overall Study|Adverse Event|7|||
130335557|NCT00505778|469199654|FG000|Overall Study|Physician Decision|8|||
130335558|NCT00505778|469199655|FG001|Overall Study|Physician Decision|14|||
130335559|NCT00505778|469199654|FG000|Overall Study|Lost to Follow-up|17|||
130335560|NCT00505778|469199655|FG001|Overall Study|Lost to Follow-up|23|||
130335561|NCT00505778|469199654|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
130668328|NCT00549198|470411862|FG000|Overall Study|Disease Progression|1|||
130668329|NCT00549198|470411863|FG001|Overall Study|Disease Progression|0|||
130668330|NCT00549198|470411862|FG000|Overall Study|Participant Moved|2|||
130668331|NCT00549198|470411863|FG001|Overall Study|Participant Moved|0|||
130668332|NCT00549198|470411862|FG000|Overall Study|Participant not able to perform Week 96|1|||
130668333|NCT00549198|470411863|FG001|Overall Study|Participant not able to perform Week 96|0|||
130668334|NCT00549198|470411862|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
130668335|NCT00549198|470411863|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
130668336|NCT00549198|470411862|FG000|Overall Study|Prohibited Medication|1|||
130668337|NCT00549198|470411863|FG001|Overall Study|Prohibited Medication|2|||
130335562|NCT00505778|469199655|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
130668338|NCT00549198|470411862|FG000|Overall Study|Participant planning pregnancy|1|||
130668339|NCT00549198|470411863|FG001|Overall Study|Participant planning pregnancy|0|||
130720917|NCT00724048|470601563|FG002|Overall Study|Adverse Event|1|||
130668340|NCT00549198|470411862|FG000|Overall Study|Participant overweight, no scan possible|1|||
130668341|NCT00549198|470411863|FG001|Overall Study|Participant overweight, no scan possible|0|||
130668342|NCT00549198|470411862|FG000|Overall Study|No scan facilities|0|||
130668343|NCT00549198|470411863|FG001|Overall Study|No scan facilities|2|||
130668344|NCT00549198|470411862|FG000|Overall Study|Pregnancy|0|||
130668345|NCT00549198|470411863|FG001|Overall Study|Pregnancy|3|||
130668346|NCT00549198|470411862|FG000|Overall Study|Not Exposed to Study Drug|3|||
130668347|NCT00549198|470411863|FG001|Overall Study|Not Exposed to Study Drug|4|||
130668348|NCT02480010|470411868|FG000|Overall Study|Adverse Event|3|||
130668349|NCT02480010|470411869|FG001|Overall Study|Adverse Event|1|||
130668350|NCT02480010|470411868|FG000|Overall Study|Death|1|||
130668351|NCT02480010|470411869|FG001|Overall Study|Death|0|||
130668352|NCT02480010|470411868|FG000|Overall Study|Insufficient therapeutic response|31|||
130668353|NCT02480010|470411869|FG001|Overall Study|Insufficient therapeutic response|29|||
130668354|NCT02480010|470411868|FG000|Overall Study|Refused Treatment|0|||
130668355|NCT02480010|470411869|FG001|Overall Study|Refused Treatment|3|||
130668356|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
130668357|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668358|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668359|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668360|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668361|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668362|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130668363|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
130668364|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668365|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668366|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668367|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668368|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668369|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130668370|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
130668371|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668372|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668373|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668374|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668375|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668376|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
130668377|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
130668378|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668379|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668380|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668381|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668382|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668383|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130668384|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
130668385|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668386|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668387|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668388|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668389|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668390|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130668391|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
130668392|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668393|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668394|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668395|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668396|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668397|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
130668398|NCT00606684|470411879|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
130668399|NCT00606684|470411880|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668400|NCT00606684|470411881|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668401|NCT00606684|470411882|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668402|NCT00606684|470411883|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668403|NCT00606684|470411884|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668404|NCT00606684|470411885|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130668405|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130668406|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Adverse Event|3|||
130668407|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Adverse Event|2|||
130335563|NCT00505778|469199654|FG000|Overall Study|Protocol Violation|7|||
130335564|NCT00505778|469199655|FG001|Overall Study|Protocol Violation|9|||
130335565|NCT00505778|469199654|FG000|Overall Study|Withdrawal by Subject|29|||
130335566|NCT00505778|469199655|FG001|Overall Study|Withdrawal by Subject|14|||
130335567|NCT00505778|469199654|FG000|Overall Study|Relapse|65|||
130335568|NCT00505778|469199655|FG001|Overall Study|Relapse|65|||
130335569|NCT00505778|469199654|FG000|Overall Study|Took No Study Drug|2|||
130335570|NCT00505778|469199655|FG001|Overall Study|Took No Study Drug|2|||
130335571|NCT05367492|469199657|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130335572|NCT05367492|469199658|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
130335573|NCT05367492|469199659|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130335574|NCT05367492|469199657|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
130335575|NCT05367492|469199658|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
130335576|NCT05367492|469199659|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
130335577|NCT05367492|469199657|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
130335578|NCT05367492|469199658|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
130335579|NCT05367492|469199659|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
130335580|NCT05367492|469199657|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130335581|NCT05367492|469199658|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
130335582|NCT05367492|469199659|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130335583|NCT00808080|469199661|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
130335584|NCT00423917|469199664|FG000|Overall Study|Cancel|2|||
130335585|NCT00423917|469199664|FG000|Overall Study|Ineligible|1|||
130335586|NCT03085797|469199665|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
130335587|NCT03085797|469199666|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
130335588|NCT03085797|469199665|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
130335589|NCT03085797|469199666|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
130335590|NCT03085797|469199665|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
130335591|NCT03085797|469199666|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
130335592|NCT01837823|469199667|FG000|Overall Study|Lost to Follow-up|6|||
130335593|NCT00436345|469199672|FG000|Overall Study|ICU resident beyond follow-up period|3|||
130335594|NCT00436345|469199673|FG001|Overall Study|ICU resident beyond follow-up period|0|||
130335595|NCT01175083|469199674|FG000|Primary Epoch|Withdrawal by Subject|0|||
130335596|NCT01175083|469199675|FG001|Primary Epoch|Withdrawal by Subject|0|||
130335597|NCT01175083|469199676|FG002|Primary Epoch|Withdrawal by Subject|0|||
130335598|NCT01175083|469199677|FG003|Primary Epoch|Withdrawal by Subject|0|||
130335599|NCT01175083|469199678|FG004|Primary Epoch|Withdrawal by Subject|0|||
130335600|NCT01175083|469199679|FG005|Primary Epoch|Withdrawal by Subject|2|||
130335601|NCT01175083|469199674|FG000|Primary Epoch|Lost to Follow-up|0|||
130335602|NCT01175083|469199675|FG001|Primary Epoch|Lost to Follow-up|0|||
130335603|NCT01175083|469199676|FG002|Primary Epoch|Lost to Follow-up|0|||
130335604|NCT01175083|469199677|FG003|Primary Epoch|Lost to Follow-up|0|||
130335605|NCT01175083|469199678|FG004|Primary Epoch|Lost to Follow-up|0|||
130335606|NCT01175083|469199679|FG005|Primary Epoch|Lost to Follow-up|1|||
130335607|NCT01175083|469199674|FG000|Booster Epoch|Death|0|||
130335608|NCT01175083|469199675|FG001|Booster Epoch|Death|0|||
130335609|NCT01175083|469199676|FG002|Booster Epoch|Death|1|||
130335610|NCT01175083|469199677|FG003|Booster Epoch|Death|0|||
130335611|NCT01175083|469199678|FG004|Booster Epoch|Death|0|||
130335612|NCT01175083|469199679|FG005|Booster Epoch|Death|0|||
130335613|NCT01175083|469199674|FG000|Booster Epoch|Withdrawal by Subject|0|||
130335614|NCT01175083|469199675|FG001|Booster Epoch|Withdrawal by Subject|0|||
130335615|NCT01175083|469199676|FG002|Booster Epoch|Withdrawal by Subject|0|||
130335616|NCT01175083|469199677|FG003|Booster Epoch|Withdrawal by Subject|1|||
130335617|NCT01175083|469199678|FG004|Booster Epoch|Withdrawal by Subject|0|||
130335618|NCT01175083|469199679|FG005|Booster Epoch|Withdrawal by Subject|0|||
130335619|NCT00475306|469199680|FG000|Overall Study|Protocol Violation|1|||
130335620|NCT00475306|469199681|FG001|Overall Study|Protocol Violation|1|||
130335621|NCT00475306|469199682|FG002|Overall Study|Protocol Violation|0|||
130335622|NCT00475306|469199683|FG003|Overall Study|Protocol Violation|1|||
130335623|NCT01716052|469199684|FG000|Overall Study|Withdrawal of funding|1|||
130335624|NCT01716052|469199685|FG001|Overall Study|Withdrawal of funding|1|||
130335625|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
130335626|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
130335627|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
130335628|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
130335629|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130335630|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
130335631|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
130668408|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Adverse Event|4|||
130335632|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130335633|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
130335634|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
130668409|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Adverse Event|2|||
130668410|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Adverse Event|0|||
130668411|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Adverse Event|1|||
130668412|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130668413|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130668414|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130668415|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
130668416|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
130668417|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
130668418|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
130668419|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130668420|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
130668421|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
130668422|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
130335635|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
130335636|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
130668423|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
130668424|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
130668425|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
130668426|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
130668427|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130668428|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
130668429|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130335637|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335638|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
130668430|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
130668431|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
130668432|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130335639|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335640|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335641|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
130335642|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130335643|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130335644|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
130335645|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
130335646|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130335647|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130335648|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
130335649|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130335650|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
130335651|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
130335652|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130335653|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
130335654|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
130335655|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
130335656|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
130335657|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335658|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
130335659|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335660|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335661|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335662|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
130335663|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335664|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335665|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335666|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
130335667|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335668|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335669|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335670|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
130668433|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130668434|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Physician Decision|5|||
130668435|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Physician Decision|1|||
130668436|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Physician Decision|0|||
130216134|NCT02030119|468753958|FG003|Overall Study|Withdrawal by Subject|3|||
130668437|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Physician Decision|3|||
130668438|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Physician Decision|1|||
130668439|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Physician Decision|2|||
130668440|NCT00606684|470411879|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130668441|NCT00606684|470411880|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130668442|NCT00606684|470411881|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130668443|NCT00606684|470411882|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130668444|NCT00606684|470411883|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130668445|NCT00606684|470411884|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130668446|NCT00606684|470411885|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130668447|NCT00910858|470411891|FG000|Pharmacokinetic Phase|Adverse Event|1|||
130668448|NCT00910858|470411892|FG001|Pharmacokinetic Phase|Adverse Event|0|||
130668449|NCT00910858|470411893|FG002|Pharmacokinetic Phase|Adverse Event|0|||
130668450|NCT00910858|470411891|FG000|Monotherapy Phase|Adverse Event|3|||
130668451|NCT00910858|470411892|FG001|Monotherapy Phase|Adverse Event|2|||
130668452|NCT00910858|470411893|FG002|Monotherapy Phase|Adverse Event|0|||
130668453|NCT00910858|470411891|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
130668454|NCT00910858|470411892|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
130668455|NCT00910858|470411893|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
130668456|NCT00910858|470411891|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
130668457|NCT00910858|470411892|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
130668458|NCT00910858|470411893|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
130668459|NCT00910858|470411891|FG000|Monotherapy Phase|Protocol Violation|1|||
130668460|NCT00910858|470411892|FG001|Monotherapy Phase|Protocol Violation|0|||
130668461|NCT00910858|470411893|FG002|Monotherapy Phase|Protocol Violation|0|||
130668462|NCT00910858|470411891|FG000|Monotherapy Phase|Other|3|||
130668463|NCT00910858|470411892|FG001|Monotherapy Phase|Other|4|||
130668464|NCT00910858|470411893|FG002|Monotherapy Phase|Other|2|||
130668465|NCT00910858|470411891|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
130668466|NCT00910858|470411892|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
130668467|NCT00910858|470411893|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
130668468|NCT00910858|470411891|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
130668469|NCT00910858|470411892|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
130668470|NCT00910858|470411893|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
130668471|NCT00910858|470411891|FG000|Combined Treatment Phase|Protocol Violation|1|||
130668472|NCT00910858|470411892|FG001|Combined Treatment Phase|Protocol Violation|0|||
130668473|NCT00910858|470411893|FG002|Combined Treatment Phase|Protocol Violation|0|||
130668474|NCT00910858|470411891|FG000|Combined Treatment Phase|Other|0|||
130668475|NCT00910858|470411892|FG001|Combined Treatment Phase|Other|2|||
130668476|NCT00910858|470411893|FG002|Combined Treatment Phase|Other|1|||
130668477|NCT01703741|470411900|FG000|Overall Study|Withdrawal by Subject|6|||
130668478|NCT01703741|470411900|FG000|Overall Study|Adverse Event|2|||
130668479|NCT01703741|470411900|FG000|Overall Study|Physician Decision|2|||
130668480|NCT01703741|470411900|FG000|Overall Study|Protocol Violation|1|||
130668481|NCT01703741|470411900|FG000|Overall Study|Lost to Follow-up|3|||
130668482|NCT01703741|470411900|FG000|Overall Study|Subject did not want to continue|2|||
130668483|NCT01703741|470411900|FG000|Overall Study|Subject cannot comply with study visits|1|||
130668484|NCT01703741|470411900|FG000|Overall Study|Subject started testosterone injections|1|||
130668485|NCT01170364|470411901|FG000|Overall Study|Protocol Violation|4|||
130668486|NCT01170364|470411902|FG001|Overall Study|Protocol Violation|1|||
130668487|NCT01381900|470411903|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
130668488|NCT01381900|470411904|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
130668489|NCT01381900|470411905|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
130668490|NCT01381900|470411903|FG000|Overall Study|Adverse Event|4|||
130668491|NCT01381900|470411904|FG001|Overall Study|Adverse Event|6|||
130668492|NCT01381900|470411905|FG002|Overall Study|Adverse Event|7|||
130668493|NCT01381900|470411903|FG000|Overall Study|Noncompliance with study drug|0|||
130668494|NCT01381900|470411904|FG001|Overall Study|Noncompliance with study drug|0|||
130668495|NCT01381900|470411905|FG002|Overall Study|Noncompliance with study drug|1|||
130668496|NCT01381900|470411903|FG000|Overall Study|Physician Decision|0|||
130668497|NCT01381900|470411904|FG001|Overall Study|Physician Decision|1|||
130668498|NCT01381900|470411905|FG002|Overall Study|Physician Decision|1|||
130668499|NCT01381900|470411903|FG000|Overall Study|Protocol Violation|0|||
130668500|NCT01381900|470411904|FG001|Overall Study|Protocol Violation|1|||
130668501|NCT01381900|470411905|FG002|Overall Study|Protocol Violation|1|||
130668502|NCT01381900|470411903|FG000|Overall Study|Withdrawal by Subject|0|||
130668503|NCT01381900|470411904|FG001|Overall Study|Withdrawal by Subject|0|||
130668504|NCT01381900|470411905|FG002|Overall Study|Withdrawal by Subject|1|||
130668505|NCT01381900|470411903|FG000|Overall Study|Early withdraw|3|||
130668506|NCT01381900|470411904|FG001|Overall Study|Early withdraw|1|||
130668507|NCT01381900|470411905|FG002|Overall Study|Early withdraw|1|||
130668508|NCT02041494|470411906|FG000|Overall Study|Death|1|||
130668509|NCT02041494|470411907|FG001|Overall Study|Death|3|||
130668510|NCT02041494|470411906|FG000|Overall Study|Lost to Follow-up|2|||
130668511|NCT02041494|470411907|FG001|Overall Study|Lost to Follow-up|6|||
130668512|NCT02041494|470411906|FG000|Overall Study|study terminated|16|||
130668513|NCT02041494|470411907|FG001|Overall Study|study terminated|11|||
130668514|NCT00608205|470411908|FG000|Overall Study|Adverse Event|3|||
130668515|NCT00608205|470411909|FG001|Overall Study|Adverse Event|2|||
130668516|NCT00608205|470411908|FG000|Overall Study|Patient non-compliant|0|||
130668517|NCT00608205|470411909|FG001|Overall Study|Patient non-compliant|1|||
130668518|NCT01797120|470411912|FG000|Overall Study|Disesae progression|37|||
130668519|NCT01797120|470411913|FG001|Overall Study|Disesae progression|49|||
130668520|NCT01797120|470411912|FG000|Overall Study|Adverse Event|13|||
130668521|NCT01797120|470411913|FG001|Overall Study|Adverse Event|5|||
130668522|NCT01797120|470411912|FG000|Overall Study|Withdrawal by Subject|6|||
130668523|NCT01797120|470411913|FG001|Overall Study|Withdrawal by Subject|6|||
130668524|NCT01797120|470411912|FG000|Overall Study|Symptomatic progression|2|||
130668525|NCT01797120|470411913|FG001|Overall Study|Symptomatic progression|1|||
130668526|NCT01797120|470411912|FG000|Overall Study|Non-compliance|1|||
130668527|NCT01797120|470411913|FG001|Overall Study|Non-compliance|0|||
130668528|NCT01797120|470411912|FG000|Overall Study|Physician Decision|3|||
130668529|NCT01797120|470411913|FG001|Overall Study|Physician Decision|0|||
130668530|NCT01797120|470411912|FG000|Overall Study|still on treatment|2|||
130668531|NCT01797120|470411913|FG001|Overall Study|still on treatment|4|||
130668532|NCT01797120|470411912|FG000|Overall Study|never start protocol therapy|2|||
130668533|NCT01797120|470411913|FG001|Overall Study|never start protocol therapy|0|||
130668534|NCT00827359|470411919|FG000|Overall Study|Progressive Diseas|19|||
130668535|NCT00827359|470411919|FG000|Overall Study|Unacceptable Toxicity|5|||
130668536|NCT00827359|470411919|FG000|Overall Study|Ineligible|1|||
130668537|NCT03840135|470411920|FG000|Overall Study|Protocol Violation|6|||
130668538|NCT03840135|470411921|FG001|Overall Study|Protocol Violation|1|||
130668539|NCT03840135|470411920|FG000|Overall Study|Withdrawal by Subject|1|||
130668540|NCT03840135|470411921|FG001|Overall Study|Withdrawal by Subject|0|||
130668541|NCT01401478|470411926|FG000|Overall Study|Study drug not available|6|||
130668542|NCT01401478|470411926|FG000|Overall Study|Adverse Event|5|||
130668543|NCT01401478|470411926|FG000|Overall Study|Hyperphosphatemia|5|||
130668544|NCT01401478|470411926|FG000|Overall Study|Lost to Follow-up|5|||
130668545|NCT01401478|470411926|FG000|Overall Study|Kidney transplantation|3|||
130668546|NCT01401478|470411926|FG000|Overall Study|Withdrawal by Subject|3|||
130668547|NCT01401478|470411926|FG000|Overall Study|Blood samples not available|1|||
130668548|NCT01401478|470411926|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
130668549|NCT01401478|470411926|FG000|Overall Study|Low intact parathyroid hormone|1|||
130335671|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335672|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335673|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335674|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
130335675|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335676|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335677|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
130335678|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335679|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335680|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335681|NCT02078960|469199690|FG000|Treatment Period|Other|0|||
130335682|NCT02078960|469199691|FG001|Treatment Period|Other|0|||
130335683|NCT02078960|469199692|FG002|Treatment Period|Other|1|||
130335684|NCT02078960|469199690|FG000|Treatment Period|Lack of Efficacy|0|||
130335685|NCT02078960|469199691|FG001|Treatment Period|Lack of Efficacy|1|||
130335686|NCT02078960|469199692|FG002|Treatment Period|Lack of Efficacy|0|||
130335687|NCT02078960|469199690|FG000|Treatment Period|Disease progression - accelerated phase|0|||
130335688|NCT02078960|469199691|FG001|Treatment Period|Disease progression - accelerated phase|1|||
130335689|NCT02078960|469199692|FG002|Treatment Period|Disease progression - accelerated phase|0|||
130335690|NCT02078960|469199690|FG000|Treatment Period|Disease progression - blast phase|1|||
130335691|NCT02078960|469199691|FG001|Treatment Period|Disease progression - blast phase|0|||
130335692|NCT02078960|469199692|FG002|Treatment Period|Disease progression - blast phase|0|||
130335693|NCT02078960|469199690|FG000|Treatment Period|Withdrawal by Subject|0|||
130335694|NCT02078960|469199691|FG001|Treatment Period|Withdrawal by Subject|1|||
130335695|NCT02078960|469199692|FG002|Treatment Period|Withdrawal by Subject|1|||
130335696|NCT02078960|469199690|FG000|Treatment Period|Adverse Event|1|||
130335697|NCT02078960|469199691|FG001|Treatment Period|Adverse Event|0|||
130335698|NCT02078960|469199692|FG002|Treatment Period|Adverse Event|0|||
130668550|NCT01401478|470411926|FG000|Overall Study|Serious adverse event|1|||
130668551|NCT01809314|470411927|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
130668552|NCT01809314|470411927|FG000|Overall Study|Adverse Event|6|||
130335699|NCT02078960|469199690|FG000|Treatment Period|Death|0|||
130335700|NCT02078960|469199691|FG001|Treatment Period|Death|0|||
130668553|NCT01809314|470411927|FG000|Overall Study|Insufficient Therapeutic Response|14|||
130668554|NCT01809314|470411927|FG000|Overall Study|Lost to Follow-up|724|||
130335701|NCT02078960|469199692|FG002|Treatment Period|Death|1|||
130335702|NCT02078960|469199690|FG000|Follow-up Period|Death|2|||
130335703|NCT02078960|469199691|FG001|Follow-up Period|Death|0|||
130335704|NCT02078960|469199692|FG002|Follow-up Period|Death|0|||
130335705|NCT02078960|469199690|FG000|Follow-up Period|Lost to Follow-up|0|||
130335706|NCT02078960|469199691|FG001|Follow-up Period|Lost to Follow-up|1|||
130335707|NCT02078960|469199692|FG002|Follow-up Period|Lost to Follow-up|0|||
130335708|NCT03275350|469199694|FG000|Overall Study|Lost to Follow-up|4|||
130335709|NCT03275350|469199695|FG001|Overall Study|Lost to Follow-up|6|||
130335710|NCT03275350|469199694|FG000|Overall Study|Death|2|||
130335711|NCT03275350|469199695|FG001|Overall Study|Death|1|||
130335712|NCT03275350|469199694|FG000|Overall Study|Physician Decision|1|||
130335713|NCT03275350|469199695|FG001|Overall Study|Physician Decision|0|||
130335714|NCT03275350|469199694|FG000|Overall Study|Incarcerated|1|||
130335715|NCT03275350|469199695|FG001|Overall Study|Incarcerated|1|||
130335716|NCT00975689|469199698|FG000|Overall Study|Adverse Event|0|||
130552674|NCT03602261|469990268|FG001|Overall Study|Adverse Event|1|||
130552675|NCT03602261|469990267|FG000|Overall Study|Physician Decision|1|||
130552676|NCT03602261|469990268|FG001|Overall Study|Physician Decision|0|||
130552677|NCT03602261|469990267|FG000|Overall Study|Withdrawal by Subject|1|||
130552678|NCT03602261|469990268|FG001|Overall Study|Withdrawal by Subject|1|||
130552679|NCT03602261|469990267|FG000|Overall Study|Lack of Efficacy|0|||
130552680|NCT03602261|469990268|FG001|Overall Study|Lack of Efficacy|1|||
130552681|NCT03602261|469990267|FG000|Overall Study|Subject moving out of state|1|||
130552682|NCT03602261|469990268|FG001|Overall Study|Subject moving out of state|0|||
130552683|NCT05677893|469991483|FG000|Overall Study|Withdrawal by Subject|0|||
130552684|NCT05677893|469991484|FG001|Overall Study|Withdrawal by Subject|0|||
130552685|NCT05677893|469991485|FG002|Overall Study|Withdrawal by Subject|0|||
130552686|NCT05677893|469991486|FG003|Overall Study|Withdrawal by Subject|0|||
130552687|NCT05677893|469991487|FG004|Overall Study|Withdrawal by Subject|1|||
130552688|NCT05677893|469991488|FG005|Overall Study|Withdrawal by Subject|1|||
130552689|NCT05677893|469991489|FG006|Overall Study|Withdrawal by Subject|0|||
130552690|NCT05677893|469991483|FG000|Overall Study|Others|1|||
130552691|NCT05677893|469991484|FG001|Overall Study|Others|0|||
130552692|NCT05677893|469991485|FG002|Overall Study|Others|0|||
130552693|NCT05677893|469991486|FG003|Overall Study|Others|0|||
130552694|NCT05677893|469991487|FG004|Overall Study|Others|0|||
130552695|NCT05677893|469991488|FG005|Overall Study|Others|0|||
130552696|NCT05677893|469991489|FG006|Overall Study|Others|0|||
130552697|NCT01485354|469991492|FG000|Overall Study|Withdrawal by Subject|5|||
130552698|NCT02101034|469991493|FG000|Overall Study|Enrolled but did not start treatment|0|||
130552699|NCT02101034|469991494|FG001|Overall Study|Enrolled but did not start treatment|0|||
130552700|NCT02101034|469991495|FG002|Overall Study|Enrolled but did not start treatment|1|||
130552701|NCT02101034|469991496|FG003|Overall Study|Enrolled but did not start treatment|0|||
130552702|NCT02101034|469991497|FG004|Overall Study|Enrolled but did not start treatment|0|||
130552703|NCT01103245|469991502|FG000|Overall Study|Withdrawal by Subject|1|||
130552704|NCT01103245|469991503|FG001|Overall Study|Withdrawal by Subject|0|||
130552705|NCT01103245|469991504|FG002|Overall Study|Withdrawal by Subject|3|||
130552706|NCT01103245|469991505|FG003|Overall Study|Withdrawal by Subject|0|||
130552707|NCT01103245|469991502|FG000|Overall Study|Inadequate IV access|1|||
130552708|NCT01103245|469991503|FG001|Overall Study|Inadequate IV access|0|||
130552709|NCT01103245|469991504|FG002|Overall Study|Inadequate IV access|0|||
130552710|NCT01103245|469991505|FG003|Overall Study|Inadequate IV access|0|||
130552711|NCT01103245|469991502|FG000|Overall Study|Adverse Event|0|||
130552712|NCT01103245|469991503|FG001|Overall Study|Adverse Event|2|||
130552713|NCT01103245|469991504|FG002|Overall Study|Adverse Event|1|||
130552714|NCT01103245|469991505|FG003|Overall Study|Adverse Event|0|||
130552715|NCT01103245|469991502|FG000|Overall Study|Physician Decision|1|||
130552716|NCT01103245|469991503|FG001|Overall Study|Physician Decision|0|||
130552717|NCT01103245|469991504|FG002|Overall Study|Physician Decision|0|||
130552718|NCT01103245|469991505|FG003|Overall Study|Physician Decision|0|||
130552719|NCT01101477|469991507|FG000|Overall Study|Protocol Violation|5|||
130552720|NCT01101477|469991508|FG001|Overall Study|Protocol Violation|3|||
130552721|NCT01101477|469991509|FG002|Overall Study|Protocol Violation|1|||
130552722|NCT00720941|469991510|FG000|Overall Study|Protocol Violation|1|||
130668555|NCT01684722|470411928|FG000|Overall Study|Lost to Follow-up|78|||
130552723|NCT00720941|469991511|FG001|Overall Study|Protocol Violation|2|||
130552724|NCT00720941|469991510|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
130552725|NCT00720941|469991511|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
130552726|NCT00720941|469991510|FG000|Overall Study|Lost to Follow-up|20|||
130552727|NCT00720941|469991511|FG001|Overall Study|Lost to Follow-up|15|||
130552728|NCT00720941|469991510|FG000|Overall Study|Physician Decision|14|||
130552729|NCT00720941|469991511|FG001|Overall Study|Physician Decision|12|||
130552730|NCT00720941|469991510|FG000|Overall Study|Withdrawal by Subject|29|||
130552731|NCT00720941|469991511|FG001|Overall Study|Withdrawal by Subject|36|||
130552732|NCT00604279|469991512|FG000|Overall Study|Lack of Efficacy|22|||
130335717|NCT00975689|469199699|FG001|Overall Study|Adverse Event|3|||
130668556|NCT01684722|470411929|FG001|Overall Study|Lost to Follow-up|56|||
130668557|NCT01684722|470411930|FG002|Overall Study|Lost to Follow-up|75|||
130668558|NCT01684722|470411931|FG003|Overall Study|Lost to Follow-up|89|||
130668559|NCT01684722|470411928|FG000|Overall Study|Death|19|||
130668560|NCT01684722|470411929|FG001|Overall Study|Death|21|||
130668561|NCT01684722|470411930|FG002|Overall Study|Death|19|||
130668562|NCT01684722|470411931|FG003|Overall Study|Death|21|||
130668563|NCT01814137|470411932|FG000|Overall Study|Adverse Event|0|||
130668564|NCT01814137|470411933|FG001|Overall Study|Adverse Event|1|||
130668565|NCT01814137|470411932|FG000|Overall Study|Withdrawal by Subject|2|||
130668566|NCT01814137|470411933|FG001|Overall Study|Withdrawal by Subject|2|||
130668567|NCT01814137|470411932|FG000|Overall Study|Physician Decision|1|||
130668568|NCT01814137|470411933|FG001|Overall Study|Physician Decision|1|||
130668569|NCT01814137|470411932|FG000|Overall Study|Unclassified|2|||
130668570|NCT01814137|470411933|FG001|Overall Study|Unclassified|1|||
130668571|NCT00219557|470411934|FG000|Phase 1|Lack of Efficacy|3|||
130668572|NCT00219557|470411935|FG001|Phase 1|Lack of Efficacy|0|||
130668573|NCT00219557|470411936|FG002|Phase 1|Lack of Efficacy|0|||
130668574|NCT00219557|470411934|FG000|Phase 1|Adverse Event|2|||
130668575|NCT00219557|470411935|FG001|Phase 1|Adverse Event|0|||
130668576|NCT00219557|470411936|FG002|Phase 1|Adverse Event|0|||
130668577|NCT00219557|470411934|FG000|Phase 1|Withdrawal by Subject|1|||
130668578|NCT00219557|470411935|FG001|Phase 1|Withdrawal by Subject|0|||
130668579|NCT00219557|470411936|FG002|Phase 1|Withdrawal by Subject|0|||
130668580|NCT00219557|470411934|FG000|Phase 1|Started chemotherapy at other institute|1|||
130668581|NCT00219557|470411935|FG001|Phase 1|Started chemotherapy at other institute|0|||
130668582|NCT00219557|470411936|FG002|Phase 1|Started chemotherapy at other institute|0|||
130668583|NCT00219557|470411934|FG000|Phase 2|Lack of Efficacy|0|||
130668584|NCT00219557|470411935|FG001|Phase 2|Lack of Efficacy|21|||
130335718|NCT00975689|469199698|FG000|Overall Study|Withdrawal by Subject|1|||
130335719|NCT00975689|469199699|FG001|Overall Study|Withdrawal by Subject|0|||
130335720|NCT00975689|469199698|FG000|Overall Study|Physician Decision|1|||
130335721|NCT00975689|469199699|FG001|Overall Study|Physician Decision|0|||
130335722|NCT02597478|469199704|FG000|Overall Study|Withdrawal by Subject|2|||
130668585|NCT00219557|470411936|FG002|Phase 2|Lack of Efficacy|15|||
130668586|NCT00219557|470411934|FG000|Phase 2|Adverse Event|0|||
130335723|NCT02597478|469199705|FG001|Overall Study|Withdrawal by Subject|0|||
130335724|NCT02597478|469199704|FG000|Overall Study|Change of opioid dose|1|||
130335725|NCT02597478|469199705|FG001|Overall Study|Change of opioid dose|0|||
130335726|NCT02597478|469199704|FG000|Overall Study|Insufficient exertional dyspnea|0|||
130335727|NCT02597478|469199705|FG001|Overall Study|Insufficient exertional dyspnea|1|||
130335728|NCT01652469|469199706|FG000|Overall Study|Withdrawal by Subject|1|||
130335729|NCT01652469|469199707|FG001|Overall Study|Withdrawal by Subject|4|||
130335730|NCT01652469|469199706|FG000|Overall Study|Lost to Follow-up|0|||
130335731|NCT01652469|469199707|FG001|Overall Study|Lost to Follow-up|2|||
130335732|NCT01402102|469199708|FG000|Overall Study|Protocol Violation|1|||
130335733|NCT01402102|469199709|FG001|Overall Study|Protocol Violation|0|||
130335734|NCT01402102|469199708|FG000|Overall Study|Insufficiency of compliance|1|||
130335735|NCT01402102|469199709|FG001|Overall Study|Insufficiency of compliance|1|||
130335736|NCT01402102|469199708|FG000|Overall Study|Withdrawal by Subject|0|||
130335737|NCT01402102|469199709|FG001|Overall Study|Withdrawal by Subject|2|||
130335738|NCT01305577|469199711|FG000|Overall Study|Adverse Event|2|||
130335739|NCT01305577|469199712|FG001|Overall Study|Adverse Event|2|||
130335740|NCT01305577|469199713|FG002|Overall Study|Adverse Event|1|||
130335741|NCT01305577|469199711|FG000|Overall Study|Withdrawal by Subject|7|||
130335742|NCT01305577|469199712|FG001|Overall Study|Withdrawal by Subject|5|||
130335743|NCT01305577|469199713|FG002|Overall Study|Withdrawal by Subject|6|||
130335744|NCT01305577|469199711|FG000|Overall Study|Lost to Follow-up|4|||
130335745|NCT01305577|469199712|FG001|Overall Study|Lost to Follow-up|3|||
130335746|NCT01305577|469199713|FG002|Overall Study|Lost to Follow-up|2|||
130335747|NCT01305577|469199711|FG000|Overall Study|Protocol Deviation|0|||
130335748|NCT01305577|469199712|FG001|Overall Study|Protocol Deviation|1|||
130335749|NCT01305577|469199713|FG002|Overall Study|Protocol Deviation|1|||
130335750|NCT00905645|469199714|FG000|Overall Study|Death (not device related)|10|||
130335751|NCT00905645|469199715|FG001|Overall Study|Death (not device related)|4|||
130335752|NCT00905645|469199716|FG002|Overall Study|Death (not device related)|15|||
130668587|NCT00219557|470411935|FG001|Phase 2|Adverse Event|22|||
130668588|NCT00219557|470411936|FG002|Phase 2|Adverse Event|2|||
130668589|NCT00219557|470411934|FG000|Phase 2|Death|0|||
130668590|NCT00219557|470411935|FG001|Phase 2|Death|8|||
130668591|NCT00219557|470411936|FG002|Phase 2|Death|2|||
130335753|NCT00905645|469199717|FG003|Overall Study|Death (not device related)|8|||
130335754|NCT00905645|469199714|FG000|Overall Study|Explantation of study device(s)|78|||
130335755|NCT00905645|469199715|FG001|Overall Study|Explantation of study device(s)|47|||
130335756|NCT00905645|469199716|FG002|Overall Study|Explantation of study device(s)|28|||
130668592|NCT00219557|470411934|FG000|Phase 2|Other|0|||
130668593|NCT00219557|470411935|FG001|Phase 2|Other|8|||
130668594|NCT00219557|470411936|FG002|Phase 2|Other|6|||
130668595|NCT00219557|470411934|FG000|Phase 2|Withdrawal by Subject|0|||
130668596|NCT00219557|470411935|FG001|Phase 2|Withdrawal by Subject|9|||
130668597|NCT00219557|470411936|FG002|Phase 2|Withdrawal by Subject|5|||
130668598|NCT00219557|470411934|FG000|Phase 2|Treatment not received|0|||
130668599|NCT00219557|470411935|FG001|Phase 2|Treatment not received|1|||
130668600|NCT00219557|470411936|FG002|Phase 2|Treatment not received|3|||
130668601|NCT00863057|470411939|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130668602|NCT00863057|470411940|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130668603|NCT00863057|470411941|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
130668604|NCT00863057|470411942|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130668605|NCT00863057|470411939|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
130668606|NCT00863057|470411940|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
130668607|NCT00863057|470411941|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
130668608|NCT00863057|470411942|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
130668609|NCT00863057|470411939|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
130668610|NCT00863057|470411940|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
130668611|NCT00863057|470411941|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
130668612|NCT00863057|470411942|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
130668613|NCT00863057|470411939|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
130668614|NCT00863057|470411940|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
130668615|NCT00863057|470411941|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
130668616|NCT00863057|470411942|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
130668617|NCT02741271|470411949|FG000|Overall Study|Lost to Follow-up|2|||
130668618|NCT02741271|470411950|FG001|Overall Study|Lost to Follow-up|0|||
130668619|NCT02741271|470411949|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130668620|NCT02741271|470411950|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130668621|NCT03652961|470411951|FG000|Overall Study|Lost to Follow-up|3|||
130668622|NCT03652961|470411951|FG000|Overall Study|Screen Failure|1|||
130668623|NCT01612156|470411952|FG000|Overall Study|Protocol Violation|2|||
130668624|NCT01612156|470411953|FG001|Overall Study|Protocol Violation|0|||
130668625|NCT00410410|470411954|FG000|Induction Period (IP)|Death|1|||
130668626|NCT00410410|470411955|FG001|Induction Period (IP)|Death|0|||
130668627|NCT00410410|470411956|FG002|Induction Period (IP)|Death|0|||
130668628|NCT00410410|470411957|FG003|Induction Period (IP)|Death|0|||
130668629|NCT00410410|470411958|FG004|Induction Period (IP)|Death|0|||
130668630|NCT00410410|470411959|FG005|Induction Period (IP)|Death|0|||
130668631|NCT00410410|470411960|FG006|Induction Period (IP)|Death|0|||
130668632|NCT00410410|470411961|FG007|Induction Period (IP)|Death|0|||
130668633|NCT00410410|470411962|FG008|Induction Period (IP)|Death|0|||
130668634|NCT00410410|470411954|FG000|Induction Period (IP)|Adverse Event|3|||
130668635|NCT00410410|470411955|FG001|Induction Period (IP)|Adverse Event|4|||
130668636|NCT00410410|470411956|FG002|Induction Period (IP)|Adverse Event|2|||
130668637|NCT00410410|470411957|FG003|Induction Period (IP)|Adverse Event|4|||
130668638|NCT00410410|470411958|FG004|Induction Period (IP)|Adverse Event|1|||
130668639|NCT00410410|470411959|FG005|Induction Period (IP)|Adverse Event|0|||
130668640|NCT00410410|470411960|FG006|Induction Period (IP)|Adverse Event|0|||
130668641|NCT00410410|470411961|FG007|Induction Period (IP)|Adverse Event|0|||
130668642|NCT00410410|470411962|FG008|Induction Period (IP)|Adverse Event|0|||
130668643|NCT00410410|470411954|FG000|Induction Period (IP)|Lack of Efficacy|26|||
130668644|NCT00410410|470411955|FG001|Induction Period (IP)|Lack of Efficacy|24|||
130668645|NCT00410410|470411956|FG002|Induction Period (IP)|Lack of Efficacy|8|||
130668646|NCT00410410|470411957|FG003|Induction Period (IP)|Lack of Efficacy|8|||
130668647|NCT00410410|470411958|FG004|Induction Period (IP)|Lack of Efficacy|7|||
130668648|NCT00410410|470411959|FG005|Induction Period (IP)|Lack of Efficacy|7|||
130668649|NCT00410410|470411960|FG006|Induction Period (IP)|Lack of Efficacy|0|||
130668650|NCT00410410|470411961|FG007|Induction Period (IP)|Lack of Efficacy|0|||
130668651|NCT00410410|470411962|FG008|Induction Period (IP)|Lack of Efficacy|0|||
130668652|NCT00410410|470411954|FG000|Induction Period (IP)|Lost to Follow-up|2|||
130668653|NCT00410410|470411955|FG001|Induction Period (IP)|Lost to Follow-up|2|||
130668654|NCT00410410|470411956|FG002|Induction Period (IP)|Lost to Follow-up|2|||
130668655|NCT00410410|470411957|FG003|Induction Period (IP)|Lost to Follow-up|3|||
130668656|NCT00410410|470411958|FG004|Induction Period (IP)|Lost to Follow-up|0|||
130668657|NCT00410410|470411959|FG005|Induction Period (IP)|Lost to Follow-up|1|||
130668658|NCT00410410|470411960|FG006|Induction Period (IP)|Lost to Follow-up|0|||
130668659|NCT00410410|470411961|FG007|Induction Period (IP)|Lost to Follow-up|0|||
130668660|NCT00410410|470411962|FG008|Induction Period (IP)|Lost to Follow-up|0|||
130668661|NCT00410410|470411954|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
130668662|NCT00410410|470411955|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
130668663|NCT00410410|470411956|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
130668664|NCT00410410|470411957|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
130668665|NCT00410410|470411958|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
130668666|NCT00410410|470411959|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
130668667|NCT00410410|470411960|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
130668668|NCT00410410|470411961|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
130668669|NCT00410410|470411962|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
130668670|NCT00410410|470411954|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130720918|NCT00724048|470601564|FG003|Overall Study|Adverse Event|0|||
130668671|NCT00410410|470411955|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668672|NCT00410410|470411956|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
130668673|NCT00410410|470411957|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668674|NCT00410410|470411958|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668675|NCT00410410|470411959|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668676|NCT00410410|470411960|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668677|NCT00410410|470411961|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668678|NCT00410410|470411962|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130668679|NCT00410410|470411954|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668680|NCT00410410|470411955|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668681|NCT00410410|470411956|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668682|NCT00410410|470411957|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668683|NCT00410410|470411958|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
130668684|NCT00410410|470411959|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
130668685|NCT00410410|470411960|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668686|NCT00410410|470411961|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668687|NCT00410410|470411962|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130668688|NCT00410410|470411954|FG000|Induction Period (IP)|Other|0|||
130668689|NCT00410410|470411955|FG001|Induction Period (IP)|Other|0|||
130668690|NCT00410410|470411956|FG002|Induction Period (IP)|Other|1|||
130668691|NCT00410410|470411957|FG003|Induction Period (IP)|Other|0|||
130668692|NCT00410410|470411958|FG004|Induction Period (IP)|Other|0|||
130668693|NCT00410410|470411959|FG005|Induction Period (IP)|Other|0|||
130668694|NCT00410410|470411960|FG006|Induction Period (IP)|Other|0|||
130668695|NCT00410410|470411961|FG007|Induction Period (IP)|Other|0|||
130668696|NCT00410410|470411962|FG008|Induction Period (IP)|Other|0|||
130668697|NCT00410410|470411954|FG000|Maintenance Period (MP)|Death|0|||
130668698|NCT00410410|470411955|FG001|Maintenance Period (MP)|Death|0|||
130668699|NCT00410410|470411956|FG002|Maintenance Period (MP)|Death|0|||
130668700|NCT00410410|470411957|FG003|Maintenance Period (MP)|Death|0|||
130668701|NCT00410410|470411958|FG004|Maintenance Period (MP)|Death|0|||
130668702|NCT00410410|470411959|FG005|Maintenance Period (MP)|Death|0|||
130668703|NCT00410410|470411960|FG006|Maintenance Period (MP)|Death|1|||
130668704|NCT00410410|470411961|FG007|Maintenance Period (MP)|Death|0|||
130668705|NCT00410410|470411962|FG008|Maintenance Period (MP)|Death|0|||
130668706|NCT00410410|470411954|FG000|Maintenance Period (MP)|Adverse Event|0|||
130668707|NCT00410410|470411955|FG001|Maintenance Period (MP)|Adverse Event|0|||
130668708|NCT00410410|470411956|FG002|Maintenance Period (MP)|Adverse Event|0|||
130668709|NCT00410410|470411957|FG003|Maintenance Period (MP)|Adverse Event|0|||
130668710|NCT00410410|470411958|FG004|Maintenance Period (MP)|Adverse Event|0|||
130668711|NCT00410410|470411959|FG005|Maintenance Period (MP)|Adverse Event|0|||
130668712|NCT00410410|470411960|FG006|Maintenance Period (MP)|Adverse Event|1|||
130668713|NCT00410410|470411961|FG007|Maintenance Period (MP)|Adverse Event|3|||
130668714|NCT00410410|470411962|FG008|Maintenance Period (MP)|Adverse Event|0|||
130668715|NCT00410410|470411954|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
130668716|NCT00410410|470411955|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
130668717|NCT00410410|470411956|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
130668718|NCT00410410|470411957|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130668719|NCT00410410|470411958|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
130668720|NCT00410410|470411959|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130668721|NCT00410410|470411960|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
130668722|NCT00410410|470411961|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
130668723|NCT00410410|470411962|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
130668724|NCT00410410|470411954|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
130668725|NCT00410410|470411955|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
130668726|NCT00410410|470411956|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
130668727|NCT00410410|470411957|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
130668728|NCT00410410|470411958|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
130668729|NCT00410410|470411959|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
130668730|NCT00410410|470411960|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
130668731|NCT00410410|470411961|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
130668732|NCT00410410|470411962|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
130668733|NCT00410410|470411954|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668734|NCT00410410|470411955|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668735|NCT00410410|470411956|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668736|NCT00410410|470411957|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668737|NCT00410410|470411958|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668738|NCT00410410|470411959|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668739|NCT00410410|470411960|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
130668740|NCT00410410|470411961|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
130668741|NCT00410410|470411962|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
130668742|NCT00410410|470411954|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130720919|NCT00724048|470601561|FG000|Overall Study|Lost to Follow-up|0|||
130668743|NCT00410410|470411955|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668744|NCT00410410|470411956|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668745|NCT00410410|470411957|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668746|NCT00410410|470411958|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668747|NCT00410410|470411959|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668748|NCT00410410|470411960|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
130668749|NCT00410410|470411961|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
130668750|NCT00410410|470411962|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130668751|NCT00410410|470411954|FG000|Open-Label Period (OL)|Death|0|||
130668752|NCT00410410|470411955|FG001|Open-Label Period (OL)|Death|0|||
130668753|NCT00410410|470411956|FG002|Open-Label Period (OL)|Death|0|||
130668754|NCT00410410|470411957|FG003|Open-Label Period (OL)|Death|0|||
130668755|NCT00410410|470411958|FG004|Open-Label Period (OL)|Death|0|||
130668756|NCT00410410|470411959|FG005|Open-Label Period (OL)|Death|0|||
130668757|NCT00410410|470411960|FG006|Open-Label Period (OL)|Death|0|||
130668758|NCT00410410|470411961|FG007|Open-Label Period (OL)|Death|0|||
130668759|NCT00410410|470411962|FG008|Open-Label Period (OL)|Death|1|||
130668760|NCT00410410|470411954|FG000|Open-Label Period (OL)|Adverse Event|0|||
130668761|NCT00410410|470411955|FG001|Open-Label Period (OL)|Adverse Event|0|||
130668762|NCT00410410|470411956|FG002|Open-Label Period (OL)|Adverse Event|0|||
130668763|NCT00410410|470411957|FG003|Open-Label Period (OL)|Adverse Event|0|||
130668764|NCT00410410|470411958|FG004|Open-Label Period (OL)|Adverse Event|0|||
130668765|NCT00410410|470411959|FG005|Open-Label Period (OL)|Adverse Event|0|||
130668766|NCT00410410|470411960|FG006|Open-Label Period (OL)|Adverse Event|0|||
130668767|NCT00410410|470411961|FG007|Open-Label Period (OL)|Adverse Event|0|||
130668768|NCT00410410|470411962|FG008|Open-Label Period (OL)|Adverse Event|10|||
130668769|NCT00410410|470411954|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
130668770|NCT00410410|470411955|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
130668771|NCT00410410|470411956|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
130668772|NCT00410410|470411957|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
130668773|NCT00410410|470411958|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
130668774|NCT00410410|470411959|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
130668775|NCT00410410|470411960|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
130668776|NCT00410410|470411961|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
130668777|NCT00410410|470411962|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
130668778|NCT00410410|470411954|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
130668779|NCT00410410|470411955|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
130668780|NCT00410410|470411956|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
130668781|NCT00410410|470411957|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
130668782|NCT00410410|470411958|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
130668783|NCT00410410|470411959|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
130668784|NCT00410410|470411960|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
130668785|NCT00410410|470411961|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
130668786|NCT00410410|470411962|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
130668787|NCT00410410|470411954|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668788|NCT00410410|470411955|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668789|NCT00410410|470411956|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668790|NCT00410410|470411957|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668791|NCT00410410|470411958|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668792|NCT00410410|470411959|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668793|NCT00410410|470411960|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
130335757|NCT00905645|469199717|FG003|Overall Study|Explantation of study device(s)|21|||
130335758|NCT00905645|469199714|FG000|Overall Study|Subject Request|41|||
130335759|NCT00905645|469199715|FG001|Overall Study|Subject Request|17|||
130335760|NCT00905645|469199716|FG002|Overall Study|Subject Request|13|||
130335761|NCT00905645|469199717|FG003|Overall Study|Subject Request|11|||
130552733|NCT00604279|469991513|FG001|Overall Study|Lack of Efficacy|9|||
130668794|NCT00410410|470411961|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
130668795|NCT00410410|470411962|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
130668796|NCT00410410|470411954|FG000|Open-Label Period (OL)|Pregnancy|0|||
130668797|NCT00410410|470411955|FG001|Open-Label Period (OL)|Pregnancy|0|||
130668798|NCT00410410|470411956|FG002|Open-Label Period (OL)|Pregnancy|0|||
130668799|NCT00410410|470411957|FG003|Open-Label Period (OL)|Pregnancy|0|||
130668800|NCT00410410|470411958|FG004|Open-Label Period (OL)|Pregnancy|0|||
130668801|NCT00410410|470411959|FG005|Open-Label Period (OL)|Pregnancy|0|||
130668802|NCT00410410|470411960|FG006|Open-Label Period (OL)|Pregnancy|0|||
130668803|NCT00410410|470411961|FG007|Open-Label Period (OL)|Pregnancy|0|||
130668804|NCT00410410|470411962|FG008|Open-Label Period (OL)|Pregnancy|1|||
130335762|NCT00905645|469199714|FG000|Overall Study|Lost to Follow-up|299|||
130335763|NCT00905645|469199715|FG001|Overall Study|Lost to Follow-up|103|||
130335764|NCT00905645|469199716|FG002|Overall Study|Lost to Follow-up|51|||
130668805|NCT00410410|470411954|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668806|NCT00410410|470411955|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668807|NCT00410410|470411956|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668808|NCT00410410|470411957|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668809|NCT00410410|470411958|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668810|NCT00410410|470411959|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668811|NCT00410410|470411960|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668812|NCT00410410|470411961|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130668813|NCT00410410|470411962|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
130668814|NCT00410410|470411954|FG000|Open-Label Period (OL)|Other|0|||
130668815|NCT00410410|470411955|FG001|Open-Label Period (OL)|Other|0|||
130668816|NCT00410410|470411956|FG002|Open-Label Period (OL)|Other|0|||
130668817|NCT00410410|470411957|FG003|Open-Label Period (OL)|Other|0|||
130668818|NCT00410410|470411958|FG004|Open-Label Period (OL)|Other|0|||
130668819|NCT00410410|470411959|FG005|Open-Label Period (OL)|Other|0|||
130668820|NCT00410410|470411960|FG006|Open-Label Period (OL)|Other|0|||
130668821|NCT00410410|470411961|FG007|Open-Label Period (OL)|Other|0|||
130668822|NCT00410410|470411962|FG008|Open-Label Period (OL)|Other|7|||
130668823|NCT01783496|470411963|FG000|Overall Study|Lost to Follow-up|0|||
130668824|NCT01783496|470411964|FG001|Overall Study|Lost to Follow-up|0|||
130668825|NCT01783496|470411965|FG002|Overall Study|Lost to Follow-up|0|||
130668826|NCT01783496|470411966|FG003|Overall Study|Lost to Follow-up|2|||
130668827|NCT01783496|470411967|FG004|Overall Study|Lost to Follow-up|0|||
130668828|NCT01783496|470411968|FG005|Overall Study|Lost to Follow-up|1|||
130668829|NCT01783496|470411963|FG000|Overall Study|Withdrawal by Subject|1|||
130668830|NCT01783496|470411964|FG001|Overall Study|Withdrawal by Subject|0|||
130668831|NCT01783496|470411965|FG002|Overall Study|Withdrawal by Subject|0|||
130668832|NCT01783496|470411966|FG003|Overall Study|Withdrawal by Subject|0|||
130668833|NCT01783496|470411967|FG004|Overall Study|Withdrawal by Subject|0|||
130668834|NCT01783496|470411968|FG005|Overall Study|Withdrawal by Subject|0|||
130668835|NCT01023269|470411969|FG000|Overall Study|early termination of the study|2|||
130668836|NCT01023269|470411970|FG001|Overall Study|early termination of the study|0|||
130668837|NCT00947011|470411973|FG000|Overall Study|Study was terminated,PI left institution|12|||
130668838|NCT00814658|470411974|FG000|Overall Study|Lost to Follow-up|0|||
130668839|NCT00814658|470411975|FG001|Overall Study|Lost to Follow-up|1|||
130668840|NCT00814658|470411974|FG000|Overall Study|Physician Decision|1|||
130668841|NCT00814658|470411975|FG001|Overall Study|Physician Decision|0|||
130668842|NCT00814658|470411974|FG000|Overall Study|Adverse Event|3|||
130668843|NCT00814658|470411975|FG001|Overall Study|Adverse Event|3|||
130668844|NCT05266456|470411976|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
130668845|NCT05266456|470411977|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
130668846|NCT05266456|470411978|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
130668847|NCT05266456|470411979|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
130668848|NCT05266456|470411976|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130668849|NCT05266456|470411977|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130668850|NCT05266456|470411978|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130668851|NCT05266456|470411979|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
130668852|NCT05266456|470411976|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
130668853|NCT05266456|470411977|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
130668854|NCT05266456|470411978|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
130668855|NCT05266456|470411979|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
130668856|NCT05266456|470411976|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130668857|NCT05266456|470411977|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130668858|NCT05266456|470411978|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
130668859|NCT05266456|470411979|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130668860|NCT05266456|470411976|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
130668861|NCT05266456|470411977|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
130668862|NCT05266456|470411978|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
130668863|NCT05266456|470411979|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
130668864|NCT01141283|470411980|FG000|Overall Study|Adverse Event|56|||
130668865|NCT01141283|470411980|FG000|Overall Study|Lost to Follow-up|4|||
130668866|NCT01141283|470411980|FG000|Overall Study|Withdrawal by Subject|14|||
130668867|NCT01141283|470411980|FG000|Overall Study|Administrative|4|||
130668868|NCT01141283|470411980|FG000|Overall Study|Lack of Efficacy|10|||
130668869|NCT02868281|470411982|FG000|Overall Study|Adverse Event|2|||
130668870|NCT02868281|470411983|FG001|Overall Study|Adverse Event|2|||
130668871|NCT02868281|470411982|FG000|Overall Study|Protocol Violation|13|||
130668872|NCT02868281|470411983|FG001|Overall Study|Protocol Violation|10|||
130668873|NCT02868281|470411982|FG000|Overall Study|Lost to Follow-up|3|||
130668874|NCT02868281|470411983|FG001|Overall Study|Lost to Follow-up|6|||
130668875|NCT02868281|470411982|FG000|Overall Study|Withdrawal by Subject|11|||
130668876|NCT02868281|470411983|FG001|Overall Study|Withdrawal by Subject|15|||
130668877|NCT02868281|470411982|FG000|Overall Study|Physician Decision|2|||
130668878|NCT02868281|470411983|FG001|Overall Study|Physician Decision|0|||
130668879|NCT02868281|470411982|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
130668880|NCT02868281|470411983|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
130668881|NCT02868281|470411982|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
130335765|NCT00905645|469199717|FG003|Overall Study|Lost to Follow-up|12|||
130668882|NCT02868281|470411983|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
130668883|NCT02868281|470411982|FG000|Overall Study|Long journey/moving away|1|||
130668884|NCT02868281|470411983|FG001|Overall Study|Long journey/moving away|1|||
130668885|NCT01722266|470411984|FG000|Overall Study|Withdrawal by Subject|1|||
130668886|NCT01722266|470411985|FG001|Overall Study|Withdrawal by Subject|2|||
130668887|NCT01722266|470411986|FG002|Overall Study|Withdrawal by Subject|0|||
130668888|NCT01722266|470411987|FG003|Overall Study|Withdrawal by Subject|0|||
130668889|NCT01722266|470411984|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
130668890|NCT01722266|470411985|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
130668891|NCT01722266|470411986|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
130668892|NCT01722266|470411987|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
130668893|NCT01722266|470411984|FG000|Overall Study|Dropped out due to Nausea|0|||
130668894|NCT01722266|470411985|FG001|Overall Study|Dropped out due to Nausea|0|||
130668895|NCT01722266|470411986|FG002|Overall Study|Dropped out due to Nausea|2|||
130668896|NCT01722266|470411987|FG003|Overall Study|Dropped out due to Nausea|0|||
130668897|NCT02862535|470411991|FG000|Overall Study|Death|7|||
130668898|NCT02862535|470411992|FG001|Overall Study|Death|3|||
130668899|NCT02862535|470411993|FG002|Overall Study|Death|2|||
130668900|NCT02862535|470411994|FG003|Overall Study|Death|5|||
130668901|NCT02862535|470411991|FG000|Overall Study|Study Terminated by Sponsor|1|||
130668902|NCT02862535|470411992|FG001|Overall Study|Study Terminated by Sponsor|3|||
130668903|NCT02862535|470411993|FG002|Overall Study|Study Terminated by Sponsor|8|||
130668904|NCT02862535|470411994|FG003|Overall Study|Study Terminated by Sponsor|5|||
130668905|NCT02862535|470411991|FG000|Overall Study|Enrolled, not Treated|1|||
130668906|NCT02862535|470411992|FG001|Overall Study|Enrolled, not Treated|0|||
130668907|NCT02862535|470411993|FG002|Overall Study|Enrolled, not Treated|0|||
130668908|NCT02862535|470411994|FG003|Overall Study|Enrolled, not Treated|1|||
130668909|NCT02472977|470412000|FG000|Overall Study|Disease progression|4|||
130668910|NCT02472977|470412001|FG001|Overall Study|Disease progression|25|||
130668911|NCT02472977|470412002|FG002|Overall Study|Disease progression|6|||
130668912|NCT02472977|470412000|FG000|Overall Study|Withdrawal by Subject|0|||
130668913|NCT02472977|470412001|FG001|Overall Study|Withdrawal by Subject|1|||
130668914|NCT02472977|470412002|FG002|Overall Study|Withdrawal by Subject|0|||
130668915|NCT02472977|470412000|FG000|Overall Study|Study drug toxicity|2|||
130668916|NCT02472977|470412001|FG001|Overall Study|Study drug toxicity|0|||
130668917|NCT02472977|470412002|FG002|Overall Study|Study drug toxicity|2|||
130668918|NCT02472977|470412000|FG000|Overall Study|Subject request to discontinue treatment|0|||
130668919|NCT02472977|470412001|FG001|Overall Study|Subject request to discontinue treatment|1|||
130668920|NCT02472977|470412002|FG002|Overall Study|Subject request to discontinue treatment|0|||
130668921|NCT00738920|470412003|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
130668922|NCT00738920|470412004|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
130668923|NCT00738920|470412005|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
130668924|NCT00738920|470412003|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
130668925|NCT00738920|470412004|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
130668926|NCT00738920|470412005|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
130668927|NCT00738920|470412003|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
130668928|NCT00738920|470412004|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
130668929|NCT00738920|470412005|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
130668930|NCT00738920|470412003|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
130668931|NCT00738920|470412004|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
130668932|NCT00738920|470412005|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
130668933|NCT00738920|470412003|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
130668934|NCT00738920|470412004|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
130668935|NCT00738920|470412005|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
130668936|NCT00738920|470412003|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
130668937|NCT00738920|470412004|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
130668938|NCT00738920|470412005|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
130668939|NCT00738920|470412003|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
130668940|NCT00738920|470412004|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
130668941|NCT00738920|470412005|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
130668942|NCT00738920|470412003|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
130668943|NCT00738920|470412004|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
130668944|NCT00738920|470412005|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
130668945|NCT00738920|470412003|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
130668946|NCT00738920|470412004|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
130668947|NCT00738920|470412005|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
130668948|NCT00738920|470412003|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
130668949|NCT00738920|470412004|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
130668950|NCT00738920|470412005|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
130668951|NCT00720798|470413742|FG000|Overall Study|Adverse Event|304|||
130668952|NCT00720798|470413742|FG000|Overall Study|Death|39|||
130668953|NCT00720798|470413742|FG000|Overall Study|Insufficient Therapeutic Response|129|||
130668954|NCT00720798|470413742|FG000|Overall Study|Protocol Violation|4|||
130668955|NCT00720798|470413742|FG000|Overall Study|Refused Treatment|151|||
130668956|NCT00720798|470413742|FG000|Overall Study|Failure to Return|46|||
130668957|NCT00720798|470413742|FG000|Overall Study|Reason not Specified|83|||
130668958|NCT00433381|470413743|FG000|Overall Study|Ineligible / no protocol treatment|3|||
130668959|NCT00433381|470413744|FG001|Overall Study|Ineligible / no protocol treatment|3|||
130668960|NCT00598559|470413746|FG000|Overall Study|Adverse Event|11|||
130668961|NCT00598559|470413747|FG001|Overall Study|Adverse Event|7|||
130668962|NCT00598559|470413748|FG002|Overall Study|Adverse Event|0|||
130668963|NCT00598559|470413746|FG000|Overall Study|Withdrawal by Subject|2|||
130668964|NCT00598559|470413747|FG001|Overall Study|Withdrawal by Subject|2|||
130668965|NCT00598559|470413748|FG002|Overall Study|Withdrawal by Subject|0|||
130668966|NCT00598559|470413746|FG000|Overall Study|Protocol Non-compliance|1|||
130668967|NCT00598559|470413747|FG001|Overall Study|Protocol Non-compliance|0|||
130668968|NCT00598559|470413748|FG002|Overall Study|Protocol Non-compliance|0|||
130668969|NCT00598559|470413746|FG000|Overall Study|Early discharge from hospital|9|||
130668970|NCT00598559|470413747|FG001|Overall Study|Early discharge from hospital|12|||
130668971|NCT00598559|470413748|FG002|Overall Study|Early discharge from hospital|3|||
130668972|NCT00598559|470413746|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
130668973|NCT00598559|470413747|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
130668974|NCT00598559|470413748|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
130668975|NCT01059071|470413749|FG000|Overall Study|Lack of Efficacy|1|||
130668976|NCT01059071|470413750|FG001|Overall Study|Lack of Efficacy|4|||
130668977|NCT01059071|470413751|FG002|Overall Study|Lack of Efficacy|2|||
130668978|NCT01059071|470413752|FG003|Overall Study|Lack of Efficacy|3|||
130668979|NCT01059071|470413749|FG000|Overall Study|Withdrawal by Subject|1|||
130668980|NCT01059071|470413750|FG001|Overall Study|Withdrawal by Subject|0|||
130668981|NCT01059071|470413751|FG002|Overall Study|Withdrawal by Subject|0|||
130668982|NCT01059071|470413752|FG003|Overall Study|Withdrawal by Subject|2|||
130668983|NCT01059071|470413749|FG000|Overall Study|Physician Decision|0|||
130668984|NCT01059071|470413750|FG001|Overall Study|Physician Decision|0|||
130668985|NCT01059071|470413751|FG002|Overall Study|Physician Decision|0|||
130668986|NCT01059071|470413752|FG003|Overall Study|Physician Decision|1|||
130668987|NCT00936884|470413757|FG000|Double-blind|Withdrawal by Subject|6|||
130668988|NCT00936884|470413758|FG001|Double-blind|Withdrawal by Subject|4|||
130668989|NCT00936884|470413759|FG002|Double-blind|Withdrawal by Subject|0|||
130668990|NCT00936884|470413757|FG000|Double-blind|Death|2|||
130668991|NCT00936884|470413758|FG001|Double-blind|Death|1|||
130668992|NCT00936884|470413759|FG002|Double-blind|Death|0|||
130668993|NCT00936884|470413757|FG000|Double-blind|Lack of Efficacy|1|||
130668994|NCT00936884|470413758|FG001|Double-blind|Lack of Efficacy|1|||
130668995|NCT00936884|470413759|FG002|Double-blind|Lack of Efficacy|0|||
130668996|NCT00936884|470413757|FG000|Double-blind|Adverse Event|1|||
130668997|NCT00936884|470413758|FG001|Double-blind|Adverse Event|0|||
130668998|NCT00936884|470413759|FG002|Double-blind|Adverse Event|0|||
130668999|NCT00936884|470413757|FG000|Double-blind|Physician Decision|1|||
130669000|NCT00936884|470413758|FG001|Double-blind|Physician Decision|0|||
130669001|NCT00936884|470413759|FG002|Double-blind|Physician Decision|0|||
130669002|NCT00936884|470413757|FG000|Double-blind|No post baseline diary entry|1|||
130669003|NCT00936884|470413758|FG001|Double-blind|No post baseline diary entry|0|||
130669004|NCT00936884|470413759|FG002|Double-blind|No post baseline diary entry|0|||
130669005|NCT00936884|470413757|FG000|Double-blind|Did not receive study drug|0|||
130669006|NCT00936884|470413758|FG001|Double-blind|Did not receive study drug|1|||
130669007|NCT00936884|470413759|FG002|Double-blind|Did not receive study drug|0|||
130669008|NCT01034137|470413764|FG000|Overall Study|Adverse Event|9|||
130669009|NCT01034137|470413765|FG001|Overall Study|Adverse Event|10|||
130669010|NCT01034137|470413766|FG002|Overall Study|Adverse Event|8|||
130669011|NCT01034137|470413764|FG000|Overall Study|Withdrawal by Subject|4|||
130669012|NCT01034137|470413765|FG001|Overall Study|Withdrawal by Subject|3|||
130669013|NCT01034137|470413766|FG002|Overall Study|Withdrawal by Subject|3|||
130669014|NCT01034137|470413764|FG000|Overall Study|Lack of Efficacy|9|||
130669015|NCT01034137|470413765|FG001|Overall Study|Lack of Efficacy|4|||
130669016|NCT01034137|470413766|FG002|Overall Study|Lack of Efficacy|13|||
130669017|NCT01034137|470413764|FG000|Overall Study|Protocol Violation|2|||
130669018|NCT01034137|470413765|FG001|Overall Study|Protocol Violation|2|||
130669019|NCT01034137|470413766|FG002|Overall Study|Protocol Violation|1|||
130669020|NCT01034137|470413764|FG000|Overall Study|Refused treatment or did not cooperate|2|||
130669021|NCT01034137|470413765|FG001|Overall Study|Refused treatment or did not cooperate|0|||
130669022|NCT01034137|470413766|FG002|Overall Study|Refused treatment or did not cooperate|1|||
130669023|NCT01034137|470413764|FG000|Overall Study|Administrative or other|2|||
130669024|NCT01034137|470413765|FG001|Overall Study|Administrative or other|3|||
130669025|NCT01034137|470413766|FG002|Overall Study|Administrative or other|4|||
130669026|NCT01764854|470413767|FG000|Overall Study|Adverse Event|0|||
130669027|NCT01764854|470413768|FG001|Overall Study|Adverse Event|0|||
130669028|NCT01764854|470413769|FG002|Overall Study|Adverse Event|2|||
130669029|NCT01764854|470413770|FG003|Overall Study|Adverse Event|0|||
130669030|NCT01764854|470413767|FG000|Overall Study|Withdrawal by Subject|0|||
130669031|NCT01764854|470413768|FG001|Overall Study|Withdrawal by Subject|0|||
130669032|NCT01764854|470413769|FG002|Overall Study|Withdrawal by Subject|1|||
130669033|NCT01764854|470413770|FG003|Overall Study|Withdrawal by Subject|0|||
130669034|NCT01764854|470413767|FG000|Overall Study|relocation|0|||
130669035|NCT01764854|470413768|FG001|Overall Study|relocation|0|||
130669036|NCT01764854|470413769|FG002|Overall Study|relocation|2|||
130669037|NCT01764854|470413770|FG003|Overall Study|relocation|0|||
130669038|NCT01764854|470413767|FG000|Overall Study|Protocol Violation|0|||
130669039|NCT01764854|470413768|FG001|Overall Study|Protocol Violation|0|||
130669040|NCT01764854|470413769|FG002|Overall Study|Protocol Violation|1|||
130669041|NCT01764854|470413770|FG003|Overall Study|Protocol Violation|2|||
130669042|NCT03377556|470413782|FG000|Overall Study|Adverse Event|5|||
130669043|NCT03377556|470413782|FG000|Overall Study|Refusal unrelated to adverse events|1|||
130669044|NCT03377556|470413782|FG000|Overall Study|Progression/relapse|38|||
130669045|NCT03377556|470413782|FG000|Overall Study|Death|3|||
130669046|NCT00472446|470413783|FG000|Overall Study|Protocol Violation|0|||
130669047|NCT00472446|470413784|FG001|Overall Study|Protocol Violation|0|||
130669048|NCT00472446|470413785|FG002|Overall Study|Protocol Violation|0|||
130669049|NCT00472446|470413786|FG003|Overall Study|Protocol Violation|1|||
130669050|NCT00472446|470413783|FG000|Overall Study|Reintervention|0|||
130669051|NCT00472446|470413784|FG001|Overall Study|Reintervention|0|||
130669052|NCT00472446|470413785|FG002|Overall Study|Reintervention|1|||
130669053|NCT00472446|470413786|FG003|Overall Study|Reintervention|1|||
130669054|NCT00472446|470413783|FG000|Overall Study|Questionnaires not returned|5|||
130669055|NCT00472446|470413784|FG001|Overall Study|Questionnaires not returned|6|||
130669056|NCT00472446|470413785|FG002|Overall Study|Questionnaires not returned|6|||
130669057|NCT00472446|470413786|FG003|Overall Study|Questionnaires not returned|4|||
130669058|NCT00827827|470413787|FG000|Overall Study|Lost to Follow-up|3|||
130669059|NCT00827827|470413788|FG001|Overall Study|Lost to Follow-up|0|||
130669060|NCT00827827|470413787|FG000|Overall Study|Fall at home- hospitalization|1|||
130669061|NCT00827827|470413788|FG001|Overall Study|Fall at home- hospitalization|0|||
130669062|NCT00827827|470413787|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
130669063|NCT00827827|470413788|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
130669064|NCT00827827|470413787|FG000|Overall Study|Gout|1|||
130669065|NCT00827827|470413788|FG001|Overall Study|Gout|0|||
130669066|NCT00827827|470413787|FG000|Overall Study|Transportation issues|1|||
130669067|NCT00827827|470413788|FG001|Overall Study|Transportation issues|0|||
130669068|NCT00827827|470413787|FG000|Overall Study|Burned with water at home|1|||
130669069|NCT00827827|470413788|FG001|Overall Study|Burned with water at home|0|||
130669070|NCT01165684|470413791|FG000|Overall Study|Adverse Event|1|||
130669071|NCT01165684|470413792|FG001|Overall Study|Adverse Event|1|||
130669072|NCT01165684|470413791|FG000|Overall Study|Lack of Efficacy|2|||
130669073|NCT01165684|470413792|FG001|Overall Study|Lack of Efficacy|1|||
130669074|NCT01165684|470413791|FG000|Overall Study|Protocol Violation|7|||
130669075|NCT01165684|470413792|FG001|Overall Study|Protocol Violation|15|||
130669076|NCT01165684|470413791|FG000|Overall Study|Withdrawal Criteria|2|||
130669077|NCT01165684|470413792|FG001|Overall Study|Withdrawal Criteria|13|||
130669078|NCT01165684|470413791|FG000|Overall Study|Unclassified|16|||
130669079|NCT01165684|470413792|FG001|Overall Study|Unclassified|22|||
130669080|NCT00671879|470413795|FG000|Overall Study|Withdrawal by Subject|0|||
130669081|NCT00671879|470413796|FG001|Overall Study|Withdrawal by Subject|4|||
130669082|NCT00671879|470413797|FG002|Overall Study|Withdrawal by Subject|6|||
130669083|NCT04633837|470413798|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
130669084|NCT04633837|470413799|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
130669085|NCT00901628|470413800|FG000|Overall Study|disconnection of catheter|4|||
130669086|NCT00901628|470413801|FG001|Overall Study|disconnection of catheter|8|||
130669087|NCT00901628|470413800|FG000|Overall Study|disconnection of drain|0|||
130669088|NCT00901628|470413801|FG001|Overall Study|disconnection of drain|1|||
130669089|NCT00901628|470413800|FG000|Overall Study|peroneal nerve palsy|0|||
130669090|NCT00901628|470413801|FG001|Overall Study|peroneal nerve palsy|1|||
130669091|NCT01909466|470413809|FG000|Overall Study|Lost to Follow-up|5|||
130669092|NCT01909466|470413810|FG001|Overall Study|Lost to Follow-up|7|||
130669093|NCT01909466|470413809|FG000|Overall Study|Adverse Event|3|||
130669094|NCT01909466|470413810|FG001|Overall Study|Adverse Event|4|||
130669095|NCT01909466|470413809|FG000|Overall Study|Met Withdrawal Criteria|0|||
130669096|NCT01909466|470413810|FG001|Overall Study|Met Withdrawal Criteria|3|||
130669097|NCT01909466|470413809|FG000|Overall Study|Physician Decision|2|||
130669098|NCT01909466|470413810|FG001|Overall Study|Physician Decision|0|||
130669099|NCT01909466|470413809|FG000|Overall Study|Withdrawal by Subject|11|||
130669100|NCT01909466|470413810|FG001|Overall Study|Withdrawal by Subject|9|||
130669101|NCT01909466|470413809|FG000|Overall Study|Lack of Efficacy|1|||
130669102|NCT01909466|470413810|FG001|Overall Study|Lack of Efficacy|0|||
130335766|NCT01386970|469199718|FG000|Overall Study|Withdrawal by Subject|0|||
130669103|NCT01339910|470413811|FG000|Overall Study|Withdrawal by Subject|1|||
130669104|NCT01339910|470413812|FG001|Overall Study|Withdrawal by Subject|0|||
130669105|NCT01339910|470413811|FG000|Overall Study|Physician Decision|1|||
130669106|NCT01339910|470413812|FG001|Overall Study|Physician Decision|0|||
130669107|NCT01339910|470413811|FG000|Overall Study|Disease relapse|1|||
130669108|NCT01339910|470413812|FG001|Overall Study|Disease relapse|4|||
130669109|NCT01567306|470413814|FG000|Overall Study|Protocol Violation|2|||
130669110|NCT01567306|470413815|FG001|Overall Study|Protocol Violation|2|||
130669111|NCT01567306|470413816|FG002|Overall Study|Protocol Violation|0|||
130669112|NCT01567306|470413817|FG003|Overall Study|Protocol Violation|3|||
130669113|NCT01567306|470413818|FG004|Overall Study|Protocol Violation|1|||
130669114|NCT01567306|470413819|FG005|Overall Study|Protocol Violation|1|||
130669115|NCT01567306|470413814|FG000|Overall Study|Change site living|1|||
130669116|NCT01567306|470413815|FG001|Overall Study|Change site living|0|||
130669117|NCT01567306|470413816|FG002|Overall Study|Change site living|0|||
130669118|NCT01567306|470413817|FG003|Overall Study|Change site living|0|||
130669119|NCT01567306|470413818|FG004|Overall Study|Change site living|0|||
130669120|NCT01567306|470413819|FG005|Overall Study|Change site living|0|||
130669121|NCT01567306|470413814|FG000|Overall Study|Adverse Event|0|||
130669122|NCT01567306|470413815|FG001|Overall Study|Adverse Event|0|||
130669123|NCT01567306|470413816|FG002|Overall Study|Adverse Event|0|||
130669124|NCT01567306|470413817|FG003|Overall Study|Adverse Event|2|||
130669125|NCT01567306|470413818|FG004|Overall Study|Adverse Event|4|||
130669126|NCT01567306|470413819|FG005|Overall Study|Adverse Event|1|||
130669127|NCT01567306|470413814|FG000|Overall Study|Lost to Follow-up|0|||
130669128|NCT01567306|470413815|FG001|Overall Study|Lost to Follow-up|0|||
130669129|NCT01567306|470413816|FG002|Overall Study|Lost to Follow-up|0|||
130669130|NCT01567306|470413817|FG003|Overall Study|Lost to Follow-up|0|||
130669131|NCT01567306|470413818|FG004|Overall Study|Lost to Follow-up|2|||
130669132|NCT01567306|470413819|FG005|Overall Study|Lost to Follow-up|0|||
130669133|NCT01567306|470413814|FG000|Overall Study|Withdrawal by Subject|0|||
130669134|NCT01567306|470413815|FG001|Overall Study|Withdrawal by Subject|0|||
130669135|NCT01567306|470413816|FG002|Overall Study|Withdrawal by Subject|0|||
130669136|NCT01567306|470413817|FG003|Overall Study|Withdrawal by Subject|0|||
130669137|NCT01567306|470413818|FG004|Overall Study|Withdrawal by Subject|0|||
130669138|NCT01567306|470413819|FG005|Overall Study|Withdrawal by Subject|1|||
130669139|NCT00738673|470413824|FG000|Overall Study|Adverse Event|1|||
130669140|NCT00738673|470413825|FG001|Overall Study|Adverse Event|0|||
130669141|NCT00738673|470413824|FG000|Overall Study|Lack of Efficacy|19|||
130669142|NCT00738673|470413825|FG001|Overall Study|Lack of Efficacy|8|||
130669143|NCT00738673|470413824|FG000|Overall Study|Protocol Violation|1|||
130669144|NCT00738673|470413825|FG001|Overall Study|Protocol Violation|2|||
130669145|NCT00738673|470413824|FG000|Overall Study|Withdrawal by Subject|3|||
130335767|NCT01386970|469199719|FG001|Overall Study|Withdrawal by Subject|1|||
130335768|NCT01386970|469199718|FG000|Overall Study|Adverse Event|4|||
130335769|NCT01386970|469199719|FG001|Overall Study|Adverse Event|1|||
130335770|NCT04931888|469199720|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
130335771|NCT04931888|469199721|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
130335772|NCT04931888|469199722|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
130335773|NCT04931888|469199723|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
130335774|NCT01976741|469199735|FG000|Overall Study|Withdrawal by Subject|1|||
130669146|NCT00738673|470413825|FG001|Overall Study|Withdrawal by Subject|1|||
130669147|NCT02736227|470413828|FG000|Overall Study|Withdrawal by Subject|0|||
130669148|NCT02736227|470413829|FG001|Overall Study|Withdrawal by Subject|0|||
130669149|NCT02736227|470413830|FG002|Overall Study|Withdrawal by Subject|1|||
130669150|NCT02736227|470413828|FG000|Overall Study|Physician Decision|0|||
130669151|NCT02736227|470413829|FG001|Overall Study|Physician Decision|0|||
130669152|NCT02736227|470413830|FG002|Overall Study|Physician Decision|5|||
130669153|NCT02736227|470413828|FG000|Overall Study|Non Compliant|0|||
130669154|NCT02736227|470413829|FG001|Overall Study|Non Compliant|0|||
130669155|NCT02736227|470413830|FG002|Overall Study|Non Compliant|2|||
130669156|NCT04120194|470413831|FG000|Overall Study|Lost to Follow-up|11|||
130669157|NCT04120194|470413832|FG001|Overall Study|Lost to Follow-up|8|||
130669158|NCT04120194|470413831|FG000|Overall Study|Adverse Event|4|||
130669159|NCT04120194|470413832|FG001|Overall Study|Adverse Event|5|||
130335775|NCT01976741|469199736|FG001|Overall Study|Withdrawal by Subject|0|||
130669160|NCT04120194|470413831|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
130669161|NCT04120194|470413832|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
130669162|NCT04120194|470413831|FG000|Overall Study|Miscellaneous|4|||
130669163|NCT04120194|470413832|FG001|Overall Study|Miscellaneous|5|||
130669164|NCT01159769|470413833|FG000|Overall Study|Adverse Event|1|||
130669165|NCT02555618|470413834|FG000|Overall Study|Sponsor's Circumstances|1|||
130669166|NCT02555618|470413835|FG001|Overall Study|Sponsor's Circumstances|0|||
130669167|NCT02063698|470413836|FG000|Overall Study|did not complete booklet for days 2-8|1|||
130669168|NCT02063698|470413837|FG001|Overall Study|did not complete booklet for days 2-8|2|||
130669169|NCT01953783|470413838|FG000|Overall Study|Progressive disease|2|||
130669170|NCT00686920|470413839|FG000|Overall Study|Death|45|||
130669171|NCT00686920|470413840|FG001|Overall Study|Death|14|||
130669172|NCT00686920|470413839|FG000|Overall Study|Liver Transplant|23|||
130669173|NCT00686920|470413840|FG001|Overall Study|Liver Transplant|8|||
130669174|NCT00686920|470413839|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
130669175|NCT00686920|470413840|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
130669176|NCT00686920|470413839|FG000|Overall Study|Withdrawal by Subject|23|||
130669177|NCT00686920|470413840|FG001|Overall Study|Withdrawal by Subject|5|||
130669178|NCT00686920|470413839|FG000|Overall Study|Protocol Violation|2|||
130669179|NCT00686920|470413840|FG001|Overall Study|Protocol Violation|1|||
130669180|NCT00686920|470413839|FG000|Overall Study|Adverse Event|10|||
130669181|NCT00686920|470413840|FG001|Overall Study|Adverse Event|2|||
130669182|NCT00686920|470413839|FG000|Overall Study|Personal Reason|0|||
130669183|NCT00686920|470413840|FG001|Overall Study|Personal Reason|1|||
130669184|NCT00686920|470413839|FG000|Overall Study|Lost to Follow-up|15|||
130669185|NCT00686920|470413840|FG001|Overall Study|Lost to Follow-up|3|||
130669186|NCT00686920|470413839|FG000|Overall Study|Moved to Another State|1|||
130669187|NCT00686920|470413840|FG001|Overall Study|Moved to Another State|0|||
130669188|NCT00686920|470413839|FG000|Overall Study|Transferred to Nursing Home|1|||
130669189|NCT00686920|470413840|FG001|Overall Study|Transferred to Nursing Home|0|||
130669190|NCT00686920|470413839|FG000|Overall Study|Noncompliance|9|||
130669191|NCT00686920|470413840|FG001|Overall Study|Noncompliance|0|||
130669192|NCT00686920|470413839|FG000|Overall Study|Principal Investigator Decision|2|||
130669193|NCT00686920|470413840|FG001|Overall Study|Principal Investigator Decision|0|||
130669194|NCT00591253|470413843|FG000|Overall Study|Adverse Event|3|||
130669195|NCT00591253|470413844|FG001|Overall Study|Adverse Event|3|||
130669196|NCT00591253|470413845|FG002|Overall Study|Adverse Event|1|||
130669197|NCT00591253|470413843|FG000|Overall Study|Protocol Violation|2|||
130669198|NCT00591253|470413844|FG001|Overall Study|Protocol Violation|2|||
130669199|NCT00591253|470413845|FG002|Overall Study|Protocol Violation|2|||
130669200|NCT00591253|470413843|FG000|Overall Study|Lost to Follow-up|2|||
130669201|NCT00591253|470413844|FG001|Overall Study|Lost to Follow-up|4|||
130669202|NCT00591253|470413845|FG002|Overall Study|Lost to Follow-up|0|||
130669203|NCT00591253|470413843|FG000|Overall Study|Withdrawal by Subject|1|||
130669204|NCT00591253|470413844|FG001|Overall Study|Withdrawal by Subject|7|||
130669205|NCT00591253|470413845|FG002|Overall Study|Withdrawal by Subject|6|||
130669206|NCT00591253|470413843|FG000|Overall Study|Lack of Efficacy|1|||
130669207|NCT00591253|470413844|FG001|Overall Study|Lack of Efficacy|0|||
130669208|NCT00591253|470413845|FG002|Overall Study|Lack of Efficacy|3|||
130669209|NCT00591253|470413843|FG000|Overall Study|Other|5|||
130669210|NCT00591253|470413844|FG001|Overall Study|Other|5|||
130669211|NCT00591253|470413845|FG002|Overall Study|Other|3|||
130669212|NCT03811249|470413846|FG000|Overall Study|Withdrawal by Subject|44|||
130669213|NCT03811249|470413846|FG000|Overall Study|Missed Visit|24|||
130669214|NCT03124381|470413847|FG000|Overall Study|Lost to Follow-up|1|||
130669215|NCT03124381|470413848|FG001|Overall Study|Lost to Follow-up|1|||
130669216|NCT03124381|470413847|FG000|Overall Study|Withdrawal by Subject|6|||
130669217|NCT03124381|470413848|FG001|Overall Study|Withdrawal by Subject|3|||
130669218|NCT03124381|470413847|FG000|Overall Study|Protocol Violation|0|||
130669219|NCT03124381|470413848|FG001|Overall Study|Protocol Violation|1|||
130669220|NCT03124381|470413847|FG000|Overall Study|Adverse Event|1|||
130669221|NCT03124381|470413848|FG001|Overall Study|Adverse Event|1|||
130669222|NCT03124381|470413847|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
130669223|NCT03124381|470413848|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
130669224|NCT01783730|470413849|FG000|Overall Study|Failed to meet inclusion criteria|6|||
130669225|NCT01841359|470413850|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
130669226|NCT01841359|470413850|FG000|Overall Study|Concommitant medical issues|2|||
130669227|NCT01841359|470413850|FG000|Overall Study|Adverse Event|3|||
130669228|NCT01841359|470413850|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
130669229|NCT02151461|470413851|FG000|Overall Study|Adverse Event|5|||
130669230|NCT02151461|470413852|FG001|Overall Study|Adverse Event|1|||
130669231|NCT02151461|470413853|FG002|Overall Study|Adverse Event|0|||
130669232|NCT02151461|470413854|FG003|Overall Study|Adverse Event|2|||
130669233|NCT02151461|470413851|FG000|Overall Study|Lost to Follow-up|0|||
130669234|NCT02151461|470413852|FG001|Overall Study|Lost to Follow-up|0|||
130669235|NCT02151461|470413853|FG002|Overall Study|Lost to Follow-up|1|||
130669236|NCT02151461|470413854|FG003|Overall Study|Lost to Follow-up|1|||
130669237|NCT02151461|470413851|FG000|Overall Study|Withdrawal by Subject|1|||
130669238|NCT02151461|470413852|FG001|Overall Study|Withdrawal by Subject|0|||
130669239|NCT02151461|470413853|FG002|Overall Study|Withdrawal by Subject|1|||
130669240|NCT02151461|470413854|FG003|Overall Study|Withdrawal by Subject|1|||
130669241|NCT02151461|470413851|FG000|Overall Study|Treatment discontinuation|0|||
130669242|NCT02151461|470413852|FG001|Overall Study|Treatment discontinuation|0|||
130669243|NCT02151461|470413853|FG002|Overall Study|Treatment discontinuation|1|||
130669244|NCT02151461|470413854|FG003|Overall Study|Treatment discontinuation|0|||
130216135|NCT02030119|468753955|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130552734|NCT00604279|469991512|FG000|Overall Study|Lost to Follow-up|9|||
130669245|NCT02168270|470413855|FG000|Overall Study|Lack of Efficacy|4|||
130669246|NCT02533999|470413856|FG000|Overall Study|Lost to Follow-up|3|||
130669247|NCT02533999|470413857|FG001|Overall Study|Lost to Follow-up|5|||
130669248|NCT02533999|470413856|FG000|Overall Study|Protocol Violation|3|||
130669249|NCT02533999|470413857|FG001|Overall Study|Protocol Violation|0|||
130669250|NCT02533999|470413856|FG000|Overall Study|Adverse Event|0|||
130669251|NCT02533999|470413857|FG001|Overall Study|Adverse Event|1|||
130669252|NCT02533999|470413856|FG000|Overall Study|Randomized but intervention not received|0|||
130669253|NCT02533999|470413857|FG001|Overall Study|Randomized but intervention not received|1|||
130669254|NCT01102777|470413858|FG000|Overall Study|Death|2|||
130669255|NCT01102777|470413859|FG001|Overall Study|Death|6|||
130669256|NCT01102777|470413858|FG000|Overall Study|Lost to Follow-up|7|||
130669257|NCT01102777|470413859|FG001|Overall Study|Lost to Follow-up|10|||
130669258|NCT01875445|470413860|FG000|Overall Study|Lost to Follow-up|5|||
130669259|NCT01875445|470413861|FG001|Overall Study|Lost to Follow-up|0|||
130669260|NCT01875445|470413860|FG000|Overall Study|Withdrawal by Subject|2|||
130669261|NCT01875445|470413861|FG001|Overall Study|Withdrawal by Subject|0|||
130669262|NCT00706706|470413862|FG000|Overall Study|Death|53|||
130669263|NCT00706706|470413862|FG000|Overall Study|Lost to Follow-up|7|||
130669264|NCT00706706|470413862|FG000|Overall Study|Study endpoint had reached|45|||
130669265|NCT05017493|470413863|FG000|Overall Study|Withdrawal by Subject|26|||
130669266|NCT05017493|470413864|FG001|Overall Study|Withdrawal by Subject|0|||
130669267|NCT05017493|470413863|FG000|Overall Study|Physician Decision|15|||
130669268|NCT05017493|470413864|FG001|Overall Study|Physician Decision|0|||
130669269|NCT05017493|470413863|FG000|Overall Study|Protocol Violation|81|||
130669270|NCT05017493|470413864|FG001|Overall Study|Protocol Violation|0|||
130669271|NCT01154153|470413869|FG000|Overall Study|Poor compliance to protocol|2|||
130669272|NCT01154153|470413870|FG001|Overall Study|Poor compliance to protocol|0|||
130669273|NCT01154153|470413869|FG000|Overall Study|Unable to use labs|2|||
130669274|NCT01154153|470413870|FG001|Overall Study|Unable to use labs|3|||
130669275|NCT01154153|470413869|FG000|Overall Study|Withdrew consent|1|||
130669276|NCT01154153|470413870|FG001|Overall Study|Withdrew consent|0|||
130669277|NCT00771901|470413873|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
130669278|NCT00771901|470413874|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
130669279|NCT00771901|470413875|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
130669280|NCT01086215|470413876|FG000|Overall Study|Death|14|||
130669281|NCT01086215|470413877|FG001|Overall Study|Death|8|||
130669282|NCT01086215|470413878|FG002|Overall Study|Death|8|||
130669283|NCT01086215|470413879|FG003|Overall Study|Death|1|||
130669284|NCT01086215|470413876|FG000|Overall Study|Lost to Follow-up|22|||
130669285|NCT01086215|470413877|FG001|Overall Study|Lost to Follow-up|39|||
130669286|NCT01086215|470413878|FG002|Overall Study|Lost to Follow-up|18|||
130669287|NCT01086215|470413879|FG003|Overall Study|Lost to Follow-up|2|||
130669288|NCT01965652|470413880|FG000|Overall Study|Adverse Event|40|||
130669289|NCT01965652|470413881|FG001|Overall Study|Adverse Event|37|||
130669290|NCT01965652|470413880|FG000|Overall Study|Withdrawal by Subject|62|||
130669291|NCT01965652|470413881|FG001|Overall Study|Withdrawal by Subject|69|||
130669292|NCT01965652|470413880|FG000|Overall Study|Lost to Follow-up|53|||
130669293|NCT01965652|470413881|FG001|Overall Study|Lost to Follow-up|40|||
130669294|NCT01965652|470413880|FG000|Overall Study|Protocol Violation|34|||
130669295|NCT01965652|470413881|FG001|Overall Study|Protocol Violation|38|||
130669296|NCT01965652|470413880|FG000|Overall Study|Death|3|||
130669297|NCT01965652|470413881|FG001|Overall Study|Death|4|||
130669298|NCT01965652|470413880|FG000|Overall Study|Other - Miscellaneous|18|||
130669299|NCT01965652|470413881|FG001|Overall Study|Other - Miscellaneous|21|||
130669300|NCT01965652|470413880|FG000|Overall Study|Pregnancy|0|||
130669301|NCT01965652|470413881|FG001|Overall Study|Pregnancy|1|||
130669302|NCT01121900|470413884|FG000|First Intervention Period|Adverse Event|1|||
130669303|NCT01121900|470413885|FG001|First Intervention Period|Adverse Event|1|||
130669304|NCT01121900|470413884|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130669305|NCT01121900|470413885|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130669306|NCT01328054|470413886|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
130669307|NCT01328054|470413887|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
130335776|NCT01976741|469199737|FG002|Overall Study|Withdrawal by Subject|1|||
130335777|NCT01976741|469199738|FG003|Overall Study|Withdrawal by Subject|1|||
130335778|NCT01976741|469199739|FG004|Overall Study|Withdrawal by Subject|0|||
130669308|NCT01328054|470413886|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
130669309|NCT01328054|470413887|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
130669310|NCT01328054|470413886|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
130669311|NCT01328054|470413887|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
130669312|NCT03760510|470413888|FG000|Overall Study|Not ventilated for 24 hours|105|||
130669313|NCT03760510|470413889|FG001|Overall Study|Not ventilated for 24 hours|97|||
130669314|NCT05478603|470413890|FG000|Overall Study|Withdrawal by Subject|0|||
130669315|NCT05478603|470413891|FG001|Overall Study|Withdrawal by Subject|1|||
130669316|NCT05478603|470413892|FG002|Overall Study|Withdrawal by Subject|0|||
130669317|NCT05478603|470413893|FG003|Overall Study|Withdrawal by Subject|0|||
130669318|NCT00291330|470413896|FG000|Overall Study|Adverse Event|47|||
130669319|NCT00291330|470413897|FG001|Overall Study|Adverse Event|40|||
130669320|NCT00291330|470413896|FG000|Overall Study|Protocol Violation|13|||
130669321|NCT00291330|470413897|FG001|Overall Study|Protocol Violation|20|||
130669322|NCT00291330|470413896|FG000|Overall Study|Lost to Follow-up|16|||
130669323|NCT00291330|470413897|FG001|Overall Study|Lost to Follow-up|11|||
130335779|NCT01976741|469199740|FG005|Overall Study|Withdrawal by Subject|0|||
130335780|NCT01976741|469199741|FG006|Overall Study|Withdrawal by Subject|1|||
130335781|NCT01976741|469199742|FG007|Overall Study|Withdrawal by Subject|4|||
130335782|NCT01976741|469199743|FG008|Overall Study|Withdrawal by Subject|0|||
130335783|NCT01976741|469199744|FG009|Overall Study|Withdrawal by Subject|0|||
130335784|NCT01976741|469199735|FG000|Overall Study|Adverse Event|0|||
130335785|NCT01976741|469199736|FG001|Overall Study|Adverse Event|0|||
130335786|NCT01976741|469199737|FG002|Overall Study|Adverse Event|2|||
130335787|NCT01976741|469199738|FG003|Overall Study|Adverse Event|0|||
130335788|NCT01976741|469199739|FG004|Overall Study|Adverse Event|0|||
130335789|NCT01976741|469199740|FG005|Overall Study|Adverse Event|0|||
130335790|NCT01976741|469199741|FG006|Overall Study|Adverse Event|3|||
130335791|NCT01976741|469199742|FG007|Overall Study|Adverse Event|8|||
130335792|NCT01976741|469199743|FG008|Overall Study|Adverse Event|1|||
130335793|NCT01976741|469199744|FG009|Overall Study|Adverse Event|4|||
130335794|NCT02167139|469199745|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
130552735|NCT00604279|469991513|FG001|Overall Study|Lost to Follow-up|14|||
130669324|NCT00291330|470413896|FG000|Overall Study|Withdrawal by Subject|22|||
130669325|NCT00291330|470413897|FG001|Overall Study|Withdrawal by Subject|25|||
130669326|NCT00291330|470413896|FG000|Overall Study|Other|3|||
130669327|NCT00291330|470413897|FG001|Overall Study|Other|1|||
130669328|NCT00566709|470413900|FG000|Overall Study|Protocol Violation|5|||
130669329|NCT00566709|470413901|FG001|Overall Study|Protocol Violation|0|||
130669330|NCT03443869|470413904|FG000|Overall Study|Death|3|||
130669331|NCT03443869|470413905|FG001|Overall Study|Death|3|||
130669332|NCT03443869|470413904|FG000|Overall Study|Withdrawal by Subject|34|||
130669333|NCT03443869|470413905|FG001|Overall Study|Withdrawal by Subject|22|||
130669334|NCT03443869|470413904|FG000|Overall Study|Lost to Follow-up|1|||
130669335|NCT03443869|470413905|FG001|Overall Study|Lost to Follow-up|2|||
130669336|NCT03443869|470413904|FG000|Overall Study|Physician Decision|3|||
130669337|NCT03443869|470413905|FG001|Overall Study|Physician Decision|3|||
130669338|NCT03443869|470413904|FG000|Overall Study|Other|4|||
130669339|NCT03443869|470413905|FG001|Overall Study|Other|4|||
130669340|NCT00299728|470413906|FG000|Overall Study|Lost to Follow-up|0|||
130669341|NCT00299728|470413907|FG001|Overall Study|Lost to Follow-up|1|||
130669342|NCT00299728|470413906|FG000|Overall Study|Withdrawal by Subject|0|||
130669343|NCT00299728|470413907|FG001|Overall Study|Withdrawal by Subject|1|||
130669344|NCT00299728|470413906|FG000|Overall Study|Progressive disease|0|||
130669345|NCT00299728|470413907|FG001|Overall Study|Progressive disease|1|||
130669346|NCT02378506|470413908|FG000|Overall Study|Lack of Efficacy|3|||
130669347|NCT02378506|470413908|FG000|Overall Study|Withdrawal by Subject|4|||
130669348|NCT02378506|470413908|FG000|Overall Study|Protocol Violation|2|||
130669349|NCT02378506|470413908|FG000|Overall Study|Death|1|||
130669350|NCT02378506|470413908|FG000|Overall Study|Adverse Event|14|||
130669351|NCT02378506|470413908|FG000|Overall Study|Randomized But Not Treated|1|||
130669352|NCT01606137|470413909|FG000|Overall Study|Adverse Event|85|||
130669353|NCT01606137|470413909|FG000|Overall Study|Withdrawal by Subject|74|||
130669354|NCT01606137|470413909|FG000|Overall Study|Lack of Efficacy|56|||
130669355|NCT01606137|470413909|FG000|Overall Study|Lost to Follow-up|15|||
130669356|NCT01606137|470413909|FG000|Overall Study|Protocol Violation|1|||
130669357|NCT01606137|470413909|FG000|Overall Study|Patient non-compliance|9|||
130669358|NCT01606137|470413909|FG000|Overall Study|Death|1|||
130669359|NCT01606137|470413909|FG000|Overall Study|Decreased/no pain|4|||
130669360|NCT01606137|470413909|FG000|Overall Study|Issues with driving|4|||
130669361|NCT01606137|470413909|FG000|Overall Study|multiple sclerosis less stable|1|||
130669362|NCT01606137|470413909|FG000|Overall Study|Increased bilirubin|1|||
130669363|NCT01606137|470413909|FG000|Overall Study|Spray causes nausea|1|||
130669364|NCT01606137|470413909|FG000|Overall Study|Not enough improvement|4|||
130669365|NCT01606137|470413909|FG000|Overall Study|Wanted to try another treatment|1|||
130669366|NCT01606137|470413909|FG000|Overall Study|Patient leaving country|1|||
130669367|NCT01606137|470413909|FG000|Overall Study|Personal reasons|1|||
130669368|NCT01606137|470413909|FG000|Overall Study|Unable to tolerate study med. taste|1|||
130669369|NCT01606137|470413909|FG000|Overall Study|Patient moving|1|||
130669370|NCT01606137|470413909|FG000|Overall Study|Unable to collect consistent data|1|||
130669371|NCT03572933|470415504|FG000|Overall Study|Adverse Event|4|||
130669372|NCT03572933|470415505|FG001|Overall Study|Adverse Event|1|||
130669373|NCT03572933|470415504|FG000|Overall Study|Withdrawal by Subject|0|||
130669374|NCT03572933|470415505|FG001|Overall Study|Withdrawal by Subject|1|||
130669375|NCT01907737|470415506|FG000|Overall Study|Withdrawal by Subject|1|||
130669376|NCT00678392|470415508|FG000|Overall Study|Adverse Event|0|||
130669377|NCT00678392|470415509|FG001|Overall Study|Adverse Event|6|||
130669378|NCT00678392|470415508|FG000|Overall Study|Death|280|||
130669379|NCT00678392|470415509|FG001|Overall Study|Death|269|||
130669380|NCT00678392|470415508|FG000|Overall Study|Lost to Follow-up|15|||
130335795|NCT02167139|469199746|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
130335796|NCT02167139|469199747|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130335797|NCT02167139|469199748|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130669381|NCT00678392|470415509|FG001|Overall Study|Lost to Follow-up|13|||
130669382|NCT00678392|470415508|FG000|Overall Study|Objective Progression or Relapse|3|||
130669383|NCT00678392|470415509|FG001|Overall Study|Objective Progression or Relapse|8|||
130669384|NCT00678392|470415508|FG000|Overall Study|Sponsor's Decision|1|||
130669385|NCT00678392|470415509|FG001|Overall Study|Sponsor's Decision|2|||
130669386|NCT00678392|470415508|FG000|Overall Study|Withdrawal by Subject|4|||
130669387|NCT00678392|470415509|FG001|Overall Study|Withdrawal by Subject|4|||
130669388|NCT00678392|470415508|FG000|Overall Study|Randomized But Not Treated|2|||
130669389|NCT00678392|470415509|FG001|Overall Study|Randomized But Not Treated|7|||
130669390|NCT00678392|470415508|FG000|Overall Study|Other|56|||
130669391|NCT00678392|470415509|FG001|Overall Study|Other|53|||
130669392|NCT01405820|470415512|FG000|Randomized Treatment Period|Adverse Event|3|||
130669393|NCT01405820|470415513|FG001|Randomized Treatment Period|Adverse Event|3|||
130669394|NCT01405820|470415514|FG002|Randomized Treatment Period|Adverse Event|3|||
130669395|NCT01405820|470415515|FG003|Randomized Treatment Period|Adverse Event|0|||
130669396|NCT01405820|470415516|FG004|Randomized Treatment Period|Adverse Event|2|||
130669397|NCT01405820|470415517|FG005|Randomized Treatment Period|Adverse Event|1|||
130669398|NCT01405820|470415512|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
130669399|NCT01405820|470415513|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
130669400|NCT01405820|470415514|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
130669401|NCT01405820|470415515|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
130669402|NCT01405820|470415516|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
130669403|NCT01405820|470415517|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
130669404|NCT01405820|470415512|FG000|Randomized Treatment Period|Other|2|||
130669405|NCT01405820|470415513|FG001|Randomized Treatment Period|Other|2|||
130669406|NCT01405820|470415514|FG002|Randomized Treatment Period|Other|1|||
130669407|NCT01405820|470415515|FG003|Randomized Treatment Period|Other|1|||
130669408|NCT01405820|470415516|FG004|Randomized Treatment Period|Other|0|||
130669409|NCT01405820|470415517|FG005|Randomized Treatment Period|Other|0|||
130669410|NCT01405820|470415512|FG000|Randomized Treatment Period|Physician Decision|0|||
130669411|NCT01405820|470415513|FG001|Randomized Treatment Period|Physician Decision|2|||
130669412|NCT01405820|470415514|FG002|Randomized Treatment Period|Physician Decision|1|||
130669413|NCT01405820|470415515|FG003|Randomized Treatment Period|Physician Decision|0|||
130669414|NCT01405820|470415516|FG004|Randomized Treatment Period|Physician Decision|0|||
130669415|NCT01405820|470415517|FG005|Randomized Treatment Period|Physician Decision|0|||
130669416|NCT01405820|470415512|FG000|Randomized Treatment Period|Rescue|0|||
130669417|NCT01405820|470415513|FG001|Randomized Treatment Period|Rescue|1|||
130669418|NCT01405820|470415514|FG002|Randomized Treatment Period|Rescue|13|||
130669419|NCT01405820|470415515|FG003|Randomized Treatment Period|Rescue|10|||
130669420|NCT01405820|470415516|FG004|Randomized Treatment Period|Rescue|8|||
130669421|NCT01405820|470415517|FG005|Randomized Treatment Period|Rescue|8|||
130669422|NCT01405820|470415512|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
130669423|NCT01405820|470415513|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
130669424|NCT01405820|470415514|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
130669425|NCT01405820|470415515|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
130669426|NCT01405820|470415516|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
130669427|NCT01405820|470415517|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
130669428|NCT01405820|470415512|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
130669429|NCT01405820|470415513|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
130669430|NCT01405820|470415514|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
130669431|NCT01405820|470415515|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
130669432|NCT01405820|470415516|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
130669433|NCT01405820|470415517|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
130669434|NCT01405820|470415512|FG000|Randomized Treatment Period|Death|0|||
130669435|NCT01405820|470415513|FG001|Randomized Treatment Period|Death|0|||
130669436|NCT01405820|470415514|FG002|Randomized Treatment Period|Death|0|||
130669437|NCT01405820|470415515|FG003|Randomized Treatment Period|Death|1|||
130669438|NCT01405820|470415516|FG004|Randomized Treatment Period|Death|0|||
130669439|NCT01405820|470415517|FG005|Randomized Treatment Period|Death|0|||
130669440|NCT01405820|470415512|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130552736|NCT00604279|469991512|FG000|Overall Study|Pregnancy|2|||
130669441|NCT01405820|470415513|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130669442|NCT01405820|470415514|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130669443|NCT01405820|470415515|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
130669444|NCT01405820|470415516|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130669445|NCT01405820|470415517|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130669446|NCT01405820|470415512|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
130669447|NCT01405820|470415513|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
130669448|NCT01405820|470415514|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
130669449|NCT01405820|470415515|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
130669450|NCT01405820|470415516|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
130669451|NCT01405820|470415517|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
130669452|NCT01405820|470415512|FG000|Open-Label Treatment Period|Other|1|||
130669453|NCT01405820|470415513|FG001|Open-Label Treatment Period|Other|1|||
130669454|NCT01405820|470415514|FG002|Open-Label Treatment Period|Other|1|||
130669455|NCT01405820|470415515|FG003|Open-Label Treatment Period|Other|1|||
130669456|NCT01405820|470415516|FG004|Open-Label Treatment Period|Other|1|||
130669457|NCT01405820|470415517|FG005|Open-Label Treatment Period|Other|1|||
130669458|NCT01405820|470415512|FG000|Open-Label Treatment Period|Physician Decision|0|||
130669459|NCT01405820|470415513|FG001|Open-Label Treatment Period|Physician Decision|0|||
130669460|NCT01405820|470415514|FG002|Open-Label Treatment Period|Physician Decision|1|||
130669461|NCT01405820|470415515|FG003|Open-Label Treatment Period|Physician Decision|2|||
130669462|NCT01405820|470415516|FG004|Open-Label Treatment Period|Physician Decision|1|||
130669463|NCT01405820|470415517|FG005|Open-Label Treatment Period|Physician Decision|0|||
130669464|NCT01405820|470415512|FG000|Open-Label Treatment Period|Adverse Event|0|||
130669465|NCT01405820|470415513|FG001|Open-Label Treatment Period|Adverse Event|0|||
130669466|NCT01405820|470415514|FG002|Open-Label Treatment Period|Adverse Event|0|||
130669467|NCT01405820|470415515|FG003|Open-Label Treatment Period|Adverse Event|1|||
130669468|NCT01405820|470415516|FG004|Open-Label Treatment Period|Adverse Event|0|||
130669469|NCT01405820|470415517|FG005|Open-Label Treatment Period|Adverse Event|0|||
130669470|NCT01418352|470415524|FG000|Overall Study|Lost to Follow-up|2|||
130669471|NCT01418352|470415525|FG001|Overall Study|Lost to Follow-up|0|||
130669472|NCT01418352|470415526|FG002|Overall Study|Lost to Follow-up|0|||
130669473|NCT01418352|470415527|FG003|Overall Study|Lost to Follow-up|0|||
130669474|NCT01418352|470415524|FG000|Overall Study|Adverse Event|0|||
130335798|NCT02167139|469199745|FG000|Randomised, Double-blind|Adverse Event|2|||
130335799|NCT02167139|469199746|FG001|Randomised, Double-blind|Adverse Event|9|||
130335800|NCT02167139|469199747|FG002|Randomised, Double-blind|Adverse Event|0|||
130335801|NCT02167139|469199748|FG003|Randomised, Double-blind|Adverse Event|0|||
130335802|NCT02167139|469199745|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
130335803|NCT02167139|469199746|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
130335804|NCT02167139|469199747|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130335805|NCT02167139|469199748|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130335806|NCT02167139|469199745|FG000|Randomised, Double-blind|Other|3|||
130335807|NCT02167139|469199746|FG001|Randomised, Double-blind|Other|0|||
130335808|NCT02167139|469199747|FG002|Randomised, Double-blind|Other|0|||
130335809|NCT02167139|469199748|FG003|Randomised, Double-blind|Other|0|||
130335810|NCT02167139|469199745|FG000|Transition-extension|Adverse Event|2|||
130335811|NCT02167139|469199746|FG001|Transition-extension|Adverse Event|0|||
130335812|NCT02167139|469199747|FG002|Transition-extension|Adverse Event|2|||
130335813|NCT02167139|469199748|FG003|Transition-extension|Adverse Event|3|||
130335814|NCT02167139|469199745|FG000|Transition-extension|Withdrawal by Subject|2|||
130335815|NCT02167139|469199746|FG001|Transition-extension|Withdrawal by Subject|0|||
130335816|NCT02167139|469199747|FG002|Transition-extension|Withdrawal by Subject|4|||
130335817|NCT02167139|469199748|FG003|Transition-extension|Withdrawal by Subject|1|||
130335818|NCT02167139|469199745|FG000|Transition-extension|Lack of Efficacy|0|||
130335819|NCT02167139|469199746|FG001|Transition-extension|Lack of Efficacy|0|||
130335820|NCT02167139|469199747|FG002|Transition-extension|Lack of Efficacy|1|||
130335821|NCT02167139|469199748|FG003|Transition-extension|Lack of Efficacy|1|||
130335822|NCT02167139|469199745|FG000|Transition-extension|Other|1|||
130335823|NCT02167139|469199746|FG001|Transition-extension|Other|0|||
130335824|NCT02167139|469199747|FG002|Transition-extension|Other|1|||
130335825|NCT02167139|469199748|FG003|Transition-extension|Other|0|||
130335826|NCT02167139|469199745|FG000|Transition-extension|Lost to Follow-up|1|||
130335827|NCT02167139|469199746|FG001|Transition-extension|Lost to Follow-up|0|||
130335828|NCT02167139|469199747|FG002|Transition-extension|Lost to Follow-up|0|||
130335829|NCT02167139|469199748|FG003|Transition-extension|Lost to Follow-up|0|||
130335830|NCT03350672|469199751|FG000|Overall Study|Withdrawal by Subject|7|||
130335831|NCT03350672|469199752|FG001|Overall Study|Withdrawal by Subject|0|||
130335832|NCT03350672|469199753|FG002|Overall Study|Withdrawal by Subject|0|||
130335833|NCT02504216|469199754|FG000|Overall Study|Lost to Follow-up|3|||
130335834|NCT02504216|469199755|FG001|Overall Study|Lost to Follow-up|3|||
130335835|NCT02504216|469199754|FG000|Overall Study|Withdrawal by Subject|8|||
130335836|NCT02504216|469199755|FG001|Overall Study|Withdrawal by Subject|12|||
130335837|NCT00223080|469199756|FG000|Overall Study|Withdrawal by Subject|253|||
130669475|NCT01418352|470415525|FG001|Overall Study|Adverse Event|1|||
130669476|NCT01418352|470415526|FG002|Overall Study|Adverse Event|0|||
130335838|NCT00223080|469199757|FG001|Overall Study|Withdrawal by Subject|232|||
130335839|NCT00223080|469199756|FG000|Overall Study|Required contraindicated med|0|||
130335840|NCT00223080|469199757|FG001|Overall Study|Required contraindicated med|1|||
130335841|NCT00223080|469199756|FG000|Overall Study|Non-compliant|7|||
130335842|NCT00223080|469199757|FG001|Overall Study|Non-compliant|7|||
130335843|NCT00223080|469199756|FG000|Overall Study|Moved from study area|37|||
130335844|NCT00223080|469199757|FG001|Overall Study|Moved from study area|47|||
130669477|NCT01418352|470415527|FG003|Overall Study|Adverse Event|0|||
130669478|NCT01418352|470415524|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
130669479|NCT01418352|470415525|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
130669480|NCT01418352|470415526|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
130669481|NCT01418352|470415527|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
130335845|NCT00223080|469199756|FG000|Overall Study|Lost to Follow-up|259|||
130335846|NCT00223080|469199757|FG001|Overall Study|Lost to Follow-up|284|||
130335847|NCT00223080|469199756|FG000|Overall Study|Death|85|||
130335848|NCT00223080|469199757|FG001|Overall Study|Death|74|||
130335849|NCT00223080|469199756|FG000|Overall Study|Other|14|||
130335850|NCT00223080|469199757|FG001|Overall Study|Other|11|||
130335851|NCT00223080|469199756|FG000|Overall Study|Reason not provided|141|||
130335852|NCT00223080|469199757|FG001|Overall Study|Reason not provided|140|||
130669482|NCT01418352|470415524|FG000|Overall Study|Subject Withdrew Consent|0|||
130669483|NCT01418352|470415525|FG001|Overall Study|Subject Withdrew Consent|1|||
130335853|NCT00223080|469199756|FG000|Overall Study|Adverse Event|0|||
130335854|NCT00223080|469199757|FG001|Overall Study|Adverse Event|1|||
130335855|NCT02598583|469199758|FG000|Extension Period|Withdrawal by Subject|1|||
130335856|NCT02598583|469199759|FG001|Extension Period|Withdrawal by Subject|0|||
130335857|NCT03237286|469199760|FG000|Overall Study|Withdrawal by Subject|1|||
130335858|NCT03237286|469199761|FG001|Overall Study|Withdrawal by Subject|0|||
130335859|NCT03237286|469199762|FG002|Overall Study|Withdrawal by Subject|2|||
130669484|NCT01418352|470415526|FG002|Overall Study|Subject Withdrew Consent|2|||
130669485|NCT01418352|470415527|FG003|Overall Study|Subject Withdrew Consent|1|||
130669486|NCT01418352|470415524|FG000|Overall Study|Protocol Deviation|0|||
130669487|NCT01418352|470415525|FG001|Overall Study|Protocol Deviation|0|||
130669488|NCT01418352|470415526|FG002|Overall Study|Protocol Deviation|1|||
130669489|NCT01418352|470415527|FG003|Overall Study|Protocol Deviation|0|||
130669490|NCT01418352|470415524|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
130669491|NCT01418352|470415525|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130669492|NCT01418352|470415526|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130669493|NCT01418352|470415527|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130669494|NCT00619619|470415528|FG000|Overall Study|Physician Decision|0|||
130669495|NCT00619619|470415529|FG001|Overall Study|Physician Decision|0|||
130669496|NCT00619619|470415530|FG002|Overall Study|Physician Decision|1|||
130669497|NCT00619619|470415531|FG003|Overall Study|Physician Decision|0|||
130669498|NCT00619619|470415532|FG004|Overall Study|Physician Decision|0|||
130669499|NCT00619619|470415533|FG005|Overall Study|Physician Decision|0|||
130669500|NCT00619619|470415534|FG006|Overall Study|Physician Decision|0|||
130669501|NCT00619619|470415535|FG007|Overall Study|Physician Decision|0|||
130669502|NCT00619619|470415528|FG000|Overall Study|Protocol Violation|0|||
130669503|NCT00619619|470415529|FG001|Overall Study|Protocol Violation|0|||
130669504|NCT00619619|470415530|FG002|Overall Study|Protocol Violation|0|||
130669505|NCT00619619|470415531|FG003|Overall Study|Protocol Violation|1|||
130669506|NCT00619619|470415532|FG004|Overall Study|Protocol Violation|0|||
130669507|NCT00619619|470415533|FG005|Overall Study|Protocol Violation|0|||
130669508|NCT00619619|470415534|FG006|Overall Study|Protocol Violation|1|||
130669509|NCT00619619|470415535|FG007|Overall Study|Protocol Violation|1|||
130669510|NCT00619619|470415528|FG000|Overall Study|Adverse Event|0|||
130669511|NCT00619619|470415529|FG001|Overall Study|Adverse Event|0|||
130669512|NCT00619619|470415530|FG002|Overall Study|Adverse Event|0|||
130669513|NCT00619619|470415531|FG003|Overall Study|Adverse Event|0|||
130669514|NCT00619619|470415532|FG004|Overall Study|Adverse Event|2|||
130669515|NCT00619619|470415533|FG005|Overall Study|Adverse Event|0|||
130669516|NCT00619619|470415534|FG006|Overall Study|Adverse Event|0|||
130669517|NCT00619619|470415535|FG007|Overall Study|Adverse Event|2|||
130669518|NCT01092702|470415536|FG000|Overall Study|Withdrawal by Subject|7|||
130669519|NCT01092702|470415536|FG000|Overall Study|Lost to Follow-up|2|||
130669520|NCT03263819|470415537|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
130669521|NCT03263819|470415538|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
130669522|NCT01271933|470415547|FG000|Single-Blind Phase|Lack of Efficacy|37|||
130669523|NCT01271933|470415548|FG001|Single-Blind Phase|Lack of Efficacy|0|||
130669524|NCT01271933|470415549|FG002|Single-Blind Phase|Lack of Efficacy|0|||
130669525|NCT01271933|470415547|FG000|Single-Blind Phase|Lost to Follow-up|10|||
130669526|NCT01271933|470415548|FG001|Single-Blind Phase|Lost to Follow-up|0|||
130669527|NCT01271933|470415549|FG002|Single-Blind Phase|Lost to Follow-up|0|||
130669528|NCT01271933|470415547|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
130669529|NCT01271933|470415548|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
130669530|NCT01271933|470415549|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
130335860|NCT03237286|469199760|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130335861|NCT03237286|469199761|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130669531|NCT01271933|470415547|FG000|Single-Blind Phase|Protocol Violation|3|||
130669532|NCT01271933|470415548|FG001|Single-Blind Phase|Protocol Violation|0|||
130669533|NCT01271933|470415549|FG002|Single-Blind Phase|Protocol Violation|0|||
130335862|NCT03237286|469199762|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
130669534|NCT01271933|470415547|FG000|Single-Blind Phase|Adverse Event|52|||
130669535|NCT01271933|470415548|FG001|Single-Blind Phase|Adverse Event|0|||
130669536|NCT01271933|470415549|FG002|Single-Blind Phase|Adverse Event|0|||
130335863|NCT00947882|469199772|FG000|Overall Study|Adverse Event|0|||
130669537|NCT01271933|470415547|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
130720920|NCT00724048|470601562|FG001|Overall Study|Lost to Follow-up|1|||
130669538|NCT01271933|470415548|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
130669539|NCT01271933|470415549|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
130669540|NCT01271933|470415547|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
130669541|NCT01271933|470415548|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
130669542|NCT01271933|470415549|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
130669543|NCT01271933|470415547|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
130669544|NCT01271933|470415548|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
130669545|NCT01271933|470415549|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
130669546|NCT01271933|470415547|FG000|Double-Blind Phase|Randomized but not treated|0|||
130669547|NCT01271933|470415548|FG001|Double-Blind Phase|Randomized but not treated|0|||
130669548|NCT01271933|470415549|FG002|Double-Blind Phase|Randomized but not treated|1|||
130669549|NCT01271933|470415547|FG000|Double-Blind Phase|Lack of Efficacy|0|||
130669550|NCT01271933|470415548|FG001|Double-Blind Phase|Lack of Efficacy|6|||
130669551|NCT01271933|470415549|FG002|Double-Blind Phase|Lack of Efficacy|9|||
130669552|NCT01271933|470415547|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130669553|NCT01271933|470415548|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130669554|NCT01271933|470415549|FG002|Double-Blind Phase|Lost to Follow-up|1|||
130669555|NCT01271933|470415547|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130669556|NCT01271933|470415548|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130669557|NCT01271933|470415549|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
130669558|NCT01271933|470415547|FG000|Double-Blind Phase|Adverse Event|0|||
130669559|NCT01271933|470415548|FG001|Double-Blind Phase|Adverse Event|3|||
130669560|NCT01271933|470415549|FG002|Double-Blind Phase|Adverse Event|0|||
130669561|NCT01271933|470415547|FG000|Double-Blind Phase|Participant request-personal reason|0|||
130669562|NCT01271933|470415548|FG001|Double-Blind Phase|Participant request-personal reason|1|||
130669563|NCT01271933|470415549|FG002|Double-Blind Phase|Participant request-personal reason|0|||
130669564|NCT01138150|470415550|FG000|Overall Study|blood unable to be processed|0|||
130669565|NCT01138150|470415551|FG001|Overall Study|blood unable to be processed|1|||
130669566|NCT01138150|470415550|FG000|Overall Study|Physician Decision|1|||
130669567|NCT01138150|470415551|FG001|Overall Study|Physician Decision|0|||
130669568|NCT01620983|470415552|FG000|Overall Study|Lost to Follow-up|8|||
130669569|NCT01620983|470415553|FG001|Overall Study|Lost to Follow-up|4|||
130669570|NCT01620983|470415554|FG002|Overall Study|Lost to Follow-up|9|||
130669571|NCT01620983|470415552|FG000|Overall Study|Withdrawal by Subject|6|||
130669572|NCT01620983|470415553|FG001|Overall Study|Withdrawal by Subject|8|||
130669573|NCT01620983|470415554|FG002|Overall Study|Withdrawal by Subject|1|||
130669574|NCT01620983|470415552|FG000|Overall Study|Death|2|||
130669575|NCT01620983|470415553|FG001|Overall Study|Death|0|||
130669576|NCT01620983|470415554|FG002|Overall Study|Death|0|||
130669577|NCT01620983|470415552|FG000|Overall Study|Physician Decision|3|||
130669578|NCT01620983|470415553|FG001|Overall Study|Physician Decision|10|||
130669579|NCT01620983|470415554|FG002|Overall Study|Physician Decision|5|||
130669580|NCT05085964|470415556|FG000|Overall Study|Premature termination of study|21|||
130669581|NCT05085964|470415557|FG001|Overall Study|Premature termination of study|0|||
130669582|NCT00545233|470415558|FG000|Overall Study|Adverse Event|10|||
130669583|NCT00545233|470415559|FG001|Overall Study|Adverse Event|5|||
130669584|NCT00545233|470415558|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
130669585|NCT00545233|470415559|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130669586|NCT00545233|470415558|FG000|Overall Study|Protocol Violation|2|||
130669587|NCT00545233|470415559|FG001|Overall Study|Protocol Violation|0|||
130669588|NCT00545233|470415558|FG000|Overall Study|Refused Treatment|9|||
130669589|NCT00545233|470415559|FG001|Overall Study|Refused Treatment|7|||
130669590|NCT00545233|470415558|FG000|Overall Study|Failure to Return|4|||
130669591|NCT00545233|470415559|FG001|Overall Study|Failure to Return|6|||
130669592|NCT00545233|470415558|FG000|Overall Study|Insufficient response|14|||
130669593|NCT00545233|470415559|FG001|Overall Study|Insufficient response|15|||
130669594|NCT00545233|470415558|FG000|Overall Study|Physician Decision|2|||
130669595|NCT00545233|470415559|FG001|Overall Study|Physician Decision|1|||
130669596|NCT01208402|470415562|FG000|Overall Study|Withdrawal by Subject|1|||
130669597|NCT01208402|470415563|FG001|Overall Study|Withdrawal by Subject|0|||
130669598|NCT01335464|470415566|FG000|Overall Study|Adverse Event|15|||
130669599|NCT01335464|470415567|FG001|Overall Study|Adverse Event|25|||
130669600|NCT01335464|470415566|FG000|Overall Study|Non compliant with protocol|2|||
130669601|NCT01335464|470415567|FG001|Overall Study|Non compliant with protocol|0|||
130669602|NCT01335464|470415566|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
130669603|NCT01335464|470415567|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
130669604|NCT01335464|470415566|FG000|Overall Study|Not treated|2|||
130669605|NCT01335464|470415567|FG001|Overall Study|Not treated|0|||
130669606|NCT01335464|470415566|FG000|Overall Study|Reason other than those stated above|1|||
130669607|NCT01335464|470415567|FG001|Overall Study|Reason other than those stated above|1|||
130669608|NCT03156270|470415568|FG000|Overall Study|Failed pre-treatment screening|1|||
130669609|NCT03156270|470415568|FG000|Overall Study|Lost to Follow-up|1|||
130669610|NCT00446654|470415569|FG000|Overall Study|Withdrawal by Subject|1|||
130669611|NCT00446654|470415570|FG001|Overall Study|Withdrawal by Subject|0|||
130335864|NCT00947882|469199773|FG001|Overall Study|Adverse Event|1|||
130669612|NCT00446654|470415569|FG000|Overall Study|Adverse Event|1|||
130669613|NCT00446654|470415570|FG001|Overall Study|Adverse Event|0|||
130669614|NCT01504867|470415574|FG000|Overall Study|Inclusion criteria not met|2|||
130669615|NCT01504867|470415575|FG001|Overall Study|Inclusion criteria not met|2|||
130669616|NCT01504867|470415574|FG000|Overall Study|Consent revoked|5|||
130669617|NCT01504867|470415575|FG001|Overall Study|Consent revoked|1|||
130669618|NCT00871169|470415576|FG000|Overall Study|Protocol Violation|1|||
130669619|NCT00871169|470415576|FG000|Overall Study|Patient did not receive study treatment|2|||
130669620|NCT02110706|470415580|FG000|Overall Study|Adverse Event|2|||
130669621|NCT02110706|470415581|FG001|Overall Study|Adverse Event|3|||
130669622|NCT02110706|470415580|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
130669623|NCT02110706|470415581|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
130669624|NCT03210259|470415582|FG000|12-Week Run-in Period|Adverse Event|1|||
130669625|NCT03210259|470415583|FG001|12-Week Run-in Period|Adverse Event|0|||
130669626|NCT03210259|470415584|FG002|12-Week Run-in Period|Adverse Event|0|||
130669627|NCT03210259|470415582|FG000|12-Week Run-in Period|Death|1|||
130669628|NCT03210259|470415583|FG001|12-Week Run-in Period|Death|0|||
130669629|NCT03210259|470415584|FG002|12-Week Run-in Period|Death|0|||
130669630|NCT03210259|470415582|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
130669631|NCT03210259|470415583|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
130669632|NCT03210259|470415584|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
130669633|NCT03210259|470415582|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
130669634|NCT03210259|470415583|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
130669635|NCT03210259|470415584|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
130669636|NCT03210259|470415582|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
130669637|NCT03210259|470415583|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
130669638|NCT03210259|470415584|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
130669639|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
130669640|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
130669641|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
130669642|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
130669643|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
130669644|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
130669645|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
130669646|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
130669647|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
130669648|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
130669649|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
130669650|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
130669651|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
130669652|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
130669653|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
130669654|NCT03210259|470415582|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
130669655|NCT03210259|470415583|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
130669656|NCT03210259|470415584|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
130669657|NCT02087059|470415585|FG000|Overall Study|Disease Progression|1|||
130669658|NCT02087059|470415585|FG000|Overall Study|Adverse Event|5|||
130669659|NCT02087059|470415585|FG000|Overall Study|Lost to Follow-up|1|||
130669660|NCT00252187|470415586|FG000|Overall Study|Adverse Event|3|||
130669661|NCT00252187|470415587|FG001|Overall Study|Adverse Event|1|||
130669662|NCT00252187|470415586|FG000|Overall Study|Withdrawal by Subject|1|||
130669663|NCT00252187|470415587|FG001|Overall Study|Withdrawal by Subject|0|||
130669664|NCT02175966|470415590|FG000|Follow-up Period|Lack of Efficacy|10|||
130669665|NCT02175966|470415591|FG001|Follow-up Period|Lack of Efficacy|6|||
130669666|NCT00210626|470415596|FG000|Overall Study|Adverse Event|1|||
130669667|NCT00210626|470415597|FG001|Overall Study|Adverse Event|2|||
130669668|NCT00210626|470415596|FG000|Overall Study|Protocol Violation|1|||
130669669|NCT00210626|470415597|FG001|Overall Study|Protocol Violation|5|||
130669670|NCT00210626|470415596|FG000|Overall Study|Lost to Follow-up|11|||
130669671|NCT00210626|470415597|FG001|Overall Study|Lost to Follow-up|11|||
130669672|NCT00210626|470415596|FG000|Overall Study|Death|1|||
130669673|NCT00210626|470415597|FG001|Overall Study|Death|0|||
130669674|NCT00210626|470415596|FG000|Overall Study|Withdrawal by Subject|29|||
130669675|NCT00210626|470415597|FG001|Overall Study|Withdrawal by Subject|20|||
130669676|NCT00210626|470415596|FG000|Overall Study|Physician Decision|0|||
130669677|NCT00210626|470415597|FG001|Overall Study|Physician Decision|2|||
130669678|NCT00210626|470415596|FG000|Overall Study|Sponser Request|1|||
130669679|NCT00210626|470415597|FG001|Overall Study|Sponser Request|0|||
130669680|NCT00210626|470415596|FG000|Overall Study|Other|4|||
130669681|NCT00210626|470415597|FG001|Overall Study|Other|5|||
130669682|NCT02473510|470415598|FG000|Overall Study|Lost to Follow-up|1|||
130669683|NCT02473510|470415599|FG001|Overall Study|Lost to Follow-up|2|||
130669684|NCT01306253|470415600|FG000|Overall Study|Lost to Follow-up|1|||
130669685|NCT01306253|470415601|FG001|Overall Study|Lost to Follow-up|1|||
130669686|NCT01261325|470415602|FG000|Overall Study|Lack of Efficacy|1|||
130335865|NCT00947882|469199774|FG002|Overall Study|Adverse Event|4|||
130335866|NCT00947882|469199775|FG003|Overall Study|Adverse Event|4|||
130335867|NCT00947882|469199772|FG000|Overall Study|Withdrawal by Subject|2|||
130335868|NCT00947882|469199773|FG001|Overall Study|Withdrawal by Subject|0|||
130335869|NCT00947882|469199774|FG002|Overall Study|Withdrawal by Subject|8|||
130335870|NCT00947882|469199775|FG003|Overall Study|Withdrawal by Subject|2|||
130335871|NCT00947882|469199772|FG000|Overall Study|Protocol Violation|0|||
130335872|NCT00947882|469199773|FG001|Overall Study|Protocol Violation|0|||
130335873|NCT00947882|469199774|FG002|Overall Study|Protocol Violation|1|||
130335874|NCT00947882|469199775|FG003|Overall Study|Protocol Violation|0|||
130335875|NCT00947882|469199772|FG000|Overall Study|Lost to Follow-up|0|||
130335876|NCT00947882|469199773|FG001|Overall Study|Lost to Follow-up|2|||
130335877|NCT00947882|469199774|FG002|Overall Study|Lost to Follow-up|1|||
130335878|NCT00947882|469199775|FG003|Overall Study|Lost to Follow-up|0|||
130669687|NCT01261325|470415603|FG001|Overall Study|Lack of Efficacy|1|||
130669688|NCT01261325|470415604|FG002|Overall Study|Lack of Efficacy|0|||
130669689|NCT01261325|470415602|FG000|Overall Study|Withdrawal by Subject|2|||
130669690|NCT01261325|470415603|FG001|Overall Study|Withdrawal by Subject|2|||
130669691|NCT01261325|470415604|FG002|Overall Study|Withdrawal by Subject|4|||
130669692|NCT01261325|470415602|FG000|Overall Study|SAE, non-fatal|1|||
130669693|NCT01261325|470415603|FG001|Overall Study|SAE, non-fatal|5|||
130669694|NCT01261325|470415604|FG002|Overall Study|SAE, non-fatal|1|||
130335879|NCT00947882|469199772|FG000|Overall Study|Other/Unknown|10|||
130335880|NCT00947882|469199773|FG001|Overall Study|Other/Unknown|13|||
130335881|NCT00947882|469199774|FG002|Overall Study|Other/Unknown|3|||
130335882|NCT00947882|469199775|FG003|Overall Study|Other/Unknown|6|||
130335883|NCT00947882|469199772|FG000|Overall Study|Trial Terminated by Sponsor|62|||
130335884|NCT00947882|469199773|FG001|Overall Study|Trial Terminated by Sponsor|61|||
130335885|NCT00947882|469199774|FG002|Overall Study|Trial Terminated by Sponsor|62|||
130335886|NCT00947882|469199775|FG003|Overall Study|Trial Terminated by Sponsor|70|||
130669695|NCT01261325|470415602|FG000|Overall Study|AE, non-serious non-fatal|9|||
130669696|NCT01261325|470415603|FG001|Overall Study|AE, non-serious non-fatal|15|||
130669697|NCT01261325|470415604|FG002|Overall Study|AE, non-serious non-fatal|13|||
130669698|NCT01261325|470415602|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130669699|NCT01261325|470415603|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130669700|NCT01261325|470415604|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130669701|NCT01261325|470415602|FG000|Overall Study|Non Compliance|2|||
130669702|NCT01261325|470415603|FG001|Overall Study|Non Compliance|0|||
130669703|NCT01261325|470415604|FG002|Overall Study|Non Compliance|0|||
130669704|NCT01261325|470415602|FG000|Overall Study|Patient Randomized by Mistake|0|||
130669705|NCT01261325|470415603|FG001|Overall Study|Patient Randomized by Mistake|1|||
130669706|NCT01261325|470415604|FG002|Overall Study|Patient Randomized by Mistake|0|||
130669707|NCT01261325|470415602|FG000|Overall Study|Erroneously Randomized|1|||
130669708|NCT01261325|470415603|FG001|Overall Study|Erroneously Randomized|0|||
130669709|NCT01261325|470415604|FG002|Overall Study|Erroneously Randomized|0|||
130669710|NCT01261325|470415602|FG000|Overall Study|Screen Failure|1|||
130669711|NCT01261325|470415603|FG001|Overall Study|Screen Failure|0|||
130669712|NCT01261325|470415604|FG002|Overall Study|Screen Failure|0|||
130669713|NCT01261325|470415602|FG000|Overall Study|Randomized in Error|0|||
130669714|NCT01261325|470415603|FG001|Overall Study|Randomized in Error|0|||
130669715|NCT01261325|470415604|FG002|Overall Study|Randomized in Error|1|||
130669716|NCT01261325|470415602|FG000|Overall Study|Protocol Violation|0|||
130669717|NCT01261325|470415603|FG001|Overall Study|Protocol Violation|3|||
130669718|NCT01261325|470415604|FG002|Overall Study|Protocol Violation|1|||
130669719|NCT01261325|470415602|FG000|Overall Study|Lost to Follow-up|0|||
130669720|NCT01261325|470415603|FG001|Overall Study|Lost to Follow-up|1|||
130669721|NCT01261325|470415604|FG002|Overall Study|Lost to Follow-up|3|||
130669722|NCT01261325|470415602|FG000|Overall Study|AE, serious fatal|0|||
130669723|NCT01261325|470415603|FG001|Overall Study|AE, serious fatal|0|||
130669724|NCT01261325|470415604|FG002|Overall Study|AE, serious fatal|2|||
130669725|NCT02280356|470415605|FG000|Overall Study|Not Treated|2|||
130669726|NCT02280356|470415605|FG000|Overall Study|Withdrawal by Subject|1|||
130669727|NCT02280356|470415605|FG000|Overall Study|Not evaluable|2|||
130335887|NCT01262820|469199776|FG000|Overall Study|Adverse Event|5|||
130552737|NCT00604279|469991513|FG001|Overall Study|Pregnancy|0|||
130669728|NCT03469271|470415611|FG000|Overall Study|Withdrawal by Subject|2|||
130669729|NCT03469271|470415612|FG001|Overall Study|Withdrawal by Subject|0|||
130669730|NCT03469271|470415613|FG002|Overall Study|Withdrawal by Subject|0|||
130669731|NCT03469271|470415614|FG003|Overall Study|Withdrawal by Subject|1|||
130669732|NCT03493698|470415615|FG000|Treatment Period C|Adverse Event|1|||
130669733|NCT03493698|470415615|FG000|Treatment Period C|Withdrawal by Subject|1|||
130669734|NCT00408876|470415620|FG000|Overall Study|Adverse Event|9|||
130669735|NCT00408876|470415621|FG001|Overall Study|Adverse Event|17|||
130335888|NCT01262820|469199776|FG000|Overall Study|Lack of Efficacy|9|||
130335889|NCT01262820|469199776|FG000|Overall Study|Drug held for 21+ days|1|||
130335890|NCT00104520|469199777|FG000|Overall Study|Unrelated adverse event|34|||
130335891|NCT00104520|469199778|FG001|Overall Study|Unrelated adverse event|47|||
130335892|NCT00104520|469199777|FG000|Overall Study|Study drug intolerance|0|||
130669736|NCT00408876|470415622|FG002|Overall Study|Adverse Event|27|||
130669737|NCT00408876|470415623|FG003|Overall Study|Adverse Event|10|||
130669738|NCT00408876|470415620|FG000|Overall Study|Withdrawal by Subject|3|||
130669739|NCT00408876|470415621|FG001|Overall Study|Withdrawal by Subject|6|||
130669740|NCT00408876|470415622|FG002|Overall Study|Withdrawal by Subject|6|||
130669741|NCT00408876|470415623|FG003|Overall Study|Withdrawal by Subject|14|||
130669742|NCT00408876|470415620|FG000|Overall Study|Lack of Efficacy|2|||
130669743|NCT00408876|470415621|FG001|Overall Study|Lack of Efficacy|4|||
130669744|NCT00408876|470415622|FG002|Overall Study|Lack of Efficacy|5|||
130669745|NCT00408876|470415623|FG003|Overall Study|Lack of Efficacy|6|||
130669746|NCT00408876|470415620|FG000|Overall Study|Lost to Follow-up|1|||
130669747|NCT00408876|470415621|FG001|Overall Study|Lost to Follow-up|6|||
130669748|NCT00408876|470415622|FG002|Overall Study|Lost to Follow-up|5|||
130669749|NCT00408876|470415623|FG003|Overall Study|Lost to Follow-up|2|||
130669750|NCT00408876|470415620|FG000|Overall Study|Protocol Violation|0|||
130669751|NCT00408876|470415621|FG001|Overall Study|Protocol Violation|3|||
130669752|NCT00408876|470415622|FG002|Overall Study|Protocol Violation|4|||
130669753|NCT00408876|470415623|FG003|Overall Study|Protocol Violation|3|||
130669754|NCT00408876|470415620|FG000|Overall Study|Physician Decision|1|||
130669755|NCT00408876|470415621|FG001|Overall Study|Physician Decision|0|||
130669756|NCT00408876|470415622|FG002|Overall Study|Physician Decision|3|||
130669757|NCT00408876|470415623|FG003|Overall Study|Physician Decision|0|||
130669758|NCT02006147|470415624|FG000|Overall Study|Protocol Violation|1|||
130669759|NCT02006147|470415625|FG001|Overall Study|Protocol Violation|1|||
130669760|NCT02006147|470415626|FG002|Overall Study|Protocol Violation|0|||
130669761|NCT02006147|470415627|FG003|Overall Study|Protocol Violation|0|||
130669762|NCT02006147|470415624|FG000|Overall Study|Withdrawal by Subject|0|||
130669763|NCT02006147|470415625|FG001|Overall Study|Withdrawal by Subject|1|||
130669764|NCT02006147|470415626|FG002|Overall Study|Withdrawal by Subject|0|||
130669765|NCT02006147|470415627|FG003|Overall Study|Withdrawal by Subject|0|||
130669766|NCT02006147|470415624|FG000|Overall Study|Withdrawal by Sponsor|1|||
130669767|NCT02006147|470415625|FG001|Overall Study|Withdrawal by Sponsor|0|||
130669768|NCT02006147|470415626|FG002|Overall Study|Withdrawal by Sponsor|0|||
130669769|NCT02006147|470415627|FG003|Overall Study|Withdrawal by Sponsor|0|||
130669770|NCT03361956|470415628|FG000|Overall Study|Adverse Event|1|||
130669771|NCT03361956|470415629|FG001|Overall Study|Adverse Event|0|||
130669772|NCT03361956|470415630|FG002|Overall Study|Adverse Event|1|||
130669773|NCT03361956|470415631|FG003|Overall Study|Adverse Event|1|||
130669774|NCT03361956|470415632|FG004|Overall Study|Adverse Event|0|||
130669775|NCT03361956|470415628|FG000|Overall Study|Other|0|||
130669776|NCT03361956|470415629|FG001|Overall Study|Other|0|||
130669777|NCT03361956|470415630|FG002|Overall Study|Other|0|||
130669778|NCT03361956|470415631|FG003|Overall Study|Other|1|||
130669779|NCT03361956|470415632|FG004|Overall Study|Other|0|||
130669780|NCT03361956|470415628|FG000|Overall Study|Withdrawal by Subject|2|||
130669781|NCT03361956|470415629|FG001|Overall Study|Withdrawal by Subject|2|||
130669782|NCT03361956|470415630|FG002|Overall Study|Withdrawal by Subject|2|||
130669783|NCT03361956|470415631|FG003|Overall Study|Withdrawal by Subject|0|||
130669784|NCT03361956|470415632|FG004|Overall Study|Withdrawal by Subject|3|||
130669785|NCT03361956|470415628|FG000|Overall Study|Disease Relapse|0|||
130669786|NCT03361956|470415629|FG001|Overall Study|Disease Relapse|0|||
130669787|NCT03361956|470415630|FG002|Overall Study|Disease Relapse|1|||
130669788|NCT03361956|470415631|FG003|Overall Study|Disease Relapse|0|||
130669789|NCT03361956|470415632|FG004|Overall Study|Disease Relapse|0|||
130669790|NCT03361956|470415628|FG000|Overall Study|Physician Decision|0|||
130669791|NCT03361956|470415629|FG001|Overall Study|Physician Decision|2|||
130669792|NCT03361956|470415630|FG002|Overall Study|Physician Decision|0|||
130669793|NCT03361956|470415631|FG003|Overall Study|Physician Decision|1|||
130669794|NCT03361956|470415632|FG004|Overall Study|Physician Decision|0|||
130669795|NCT03361956|470415628|FG000|Overall Study|Lost to Follow-up|0|||
130669796|NCT03361956|470415629|FG001|Overall Study|Lost to Follow-up|0|||
130669797|NCT03361956|470415630|FG002|Overall Study|Lost to Follow-up|1|||
130669798|NCT03361956|470415631|FG003|Overall Study|Lost to Follow-up|1|||
130669799|NCT03361956|470415632|FG004|Overall Study|Lost to Follow-up|2|||
130669800|NCT03558997|470415634|FG000|Overall Study|Adverse Event|0|||
130669801|NCT03558997|470415635|FG001|Overall Study|Adverse Event|2|||
130669802|NCT03558997|470415636|FG002|Overall Study|Adverse Event|5|||
130669803|NCT03558997|470415637|FG003|Overall Study|Adverse Event|1|||
130669804|NCT03558997|470415634|FG000|Overall Study|Physician Decision|0|||
130669805|NCT03558997|470415635|FG001|Overall Study|Physician Decision|0|||
130669806|NCT03558997|470415636|FG002|Overall Study|Physician Decision|1|||
130669807|NCT03558997|470415637|FG003|Overall Study|Physician Decision|0|||
130669808|NCT03558997|470415634|FG000|Overall Study|Withdrawal by Subject|1|||
130669809|NCT03558997|470415635|FG001|Overall Study|Withdrawal by Subject|0|||
130669810|NCT03558997|470415636|FG002|Overall Study|Withdrawal by Subject|1|||
130669811|NCT03558997|470415637|FG003|Overall Study|Withdrawal by Subject|1|||
130669812|NCT03558997|470415634|FG000|Overall Study|Lost to Follow-up|0|||
130669813|NCT03558997|470415635|FG001|Overall Study|Lost to Follow-up|0|||
130669814|NCT03558997|470415636|FG002|Overall Study|Lost to Follow-up|1|||
130669815|NCT03558997|470415637|FG003|Overall Study|Lost to Follow-up|0|||
130669816|NCT02230085|470415640|FG000|Overall Study|Physician Decision|1|||
130669817|NCT02230085|470415640|FG000|Overall Study|Withdrawal by Subject|3|||
130669818|NCT01405950|470418081|FG000|Overall Study|Withdrawal by Subject|1|||
130669819|NCT01405950|470418082|FG001|Overall Study|Withdrawal by Subject|0|||
130669820|NCT01405950|470418083|FG002|Overall Study|Withdrawal by Subject|0|||
130669821|NCT01405950|470418084|FG003|Overall Study|Withdrawal by Subject|0|||
130669822|NCT02410252|470418085|FG000|Overall Study|Withdrawal by Subject|4|||
130669823|NCT02410252|470418085|FG000|Overall Study|Physician Decision|2|||
130669824|NCT00387712|470418088|FG000|Overall Study|Physician Decision|6|||
130669825|NCT00387712|470418089|FG001|Overall Study|Physician Decision|4|||
130669826|NCT00387712|470418088|FG000|Overall Study|Lost to Follow-up|17|||
130669827|NCT00387712|470418089|FG001|Overall Study|Lost to Follow-up|20|||
130669828|NCT00387712|470418088|FG000|Overall Study|Withdrawal by Subject|6|||
130669829|NCT00387712|470418089|FG001|Overall Study|Withdrawal by Subject|12|||
130669830|NCT01772368|470418096|FG000|Overall Study|Adverse Event|1|||
130669831|NCT01772368|470418096|FG000|Overall Study|Withdrawal by Subject|3|||
130669832|NCT01772368|470418096|FG000|Overall Study|Protocol Violation|2|||
130669833|NCT01772368|470418096|FG000|Overall Study|Other|1|||
130669834|NCT01452529|470418097|FG000|Run-in Period|Adverse Event|96|||
130669835|NCT01452529|470418098|FG001|Run-in Period|Adverse Event|0|||
130669836|NCT01452529|470418099|FG002|Run-in Period|Adverse Event|0|||
130669837|NCT01452529|470418097|FG000|Run-in Period|Withdrawal by Subject|49|||
130669838|NCT01452529|470418098|FG001|Run-in Period|Withdrawal by Subject|0|||
130669839|NCT01452529|470418099|FG002|Run-in Period|Withdrawal by Subject|0|||
130669840|NCT01452529|470418097|FG000|Run-in Period|Lost to Follow-up|19|||
130669841|NCT01452529|470418098|FG001|Run-in Period|Lost to Follow-up|0|||
130669842|NCT01452529|470418099|FG002|Run-in Period|Lost to Follow-up|0|||
130669843|NCT01452529|470418097|FG000|Run-in Period|Lack of Efficacy|46|||
130669844|NCT01452529|470418098|FG001|Run-in Period|Lack of Efficacy|0|||
130669845|NCT01452529|470418099|FG002|Run-in Period|Lack of Efficacy|0|||
130669846|NCT01452529|470418097|FG000|Run-in Period|Confirmed or suspected diversion|23|||
130669847|NCT01452529|470418098|FG001|Run-in Period|Confirmed or suspected diversion|0|||
130669848|NCT01452529|470418099|FG002|Run-in Period|Confirmed or suspected diversion|0|||
130669849|NCT01452529|470418097|FG000|Run-in Period|Administrative|21|||
130669850|NCT01452529|470418098|FG001|Run-in Period|Administrative|0|||
130669851|NCT01452529|470418099|FG002|Run-in Period|Administrative|0|||
130669852|NCT01452529|470418097|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
130669853|NCT01452529|470418098|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
130669854|NCT01452529|470418099|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
130669855|NCT01452529|470418097|FG000|Double-blind (DB) Period|Adverse Event|0|||
130669856|NCT01452529|470418098|FG001|Double-blind (DB) Period|Adverse Event|18|||
130669857|NCT01452529|470418099|FG002|Double-blind (DB) Period|Adverse Event|11|||
130669858|NCT01452529|470418097|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
130669859|NCT01452529|470418098|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
130669860|NCT01452529|470418099|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
130669861|NCT01452529|470418097|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
130669862|NCT01452529|470418098|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
130669863|NCT01452529|470418099|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
130669864|NCT01452529|470418097|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
130669865|NCT01452529|470418098|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
130669866|NCT01452529|470418099|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
130669867|NCT01452529|470418097|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
130669868|NCT01452529|470418098|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
130669869|NCT01452529|470418099|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
130669870|NCT01452529|470418097|FG000|Double-blind (DB) Period|Administrative|0|||
130669871|NCT01452529|470418098|FG001|Double-blind (DB) Period|Administrative|11|||
130669872|NCT01452529|470418099|FG002|Double-blind (DB) Period|Administrative|7|||
130669873|NCT03347695|470418106|FG000|Overall Study|Death|0|||
130669874|NCT03347695|470418107|FG001|Overall Study|Death|4|||
130669875|NCT03347695|470418106|FG000|Overall Study|Lost to Follow-up|0|||
130669876|NCT03347695|470418107|FG001|Overall Study|Lost to Follow-up|1|||
130669877|NCT00909727|470418128|FG000|Overall Study|Adverse Event|1|||
130669878|NCT00909727|470418129|FG001|Overall Study|Adverse Event|0|||
130669879|NCT00909727|470418128|FG000|Overall Study|Wrong Genotype|1|||
130669880|NCT00909727|470418129|FG001|Overall Study|Wrong Genotype|0|||
130669881|NCT00909727|470418128|FG000|Overall Study|Withdrawal of Consent|1|||
130669882|NCT00909727|470418129|FG001|Overall Study|Withdrawal of Consent|0|||
130669883|NCT00909727|470418128|FG000|Overall Study|Prohibited Medication|1|||
130669884|NCT00909727|470418129|FG001|Overall Study|Prohibited Medication|0|||
130669885|NCT00295854|470418134|FG000|Overall Study|Adverse Event|7|||
130669886|NCT00295854|470418135|FG001|Overall Study|Adverse Event|7|||
130669887|NCT00295854|470418136|FG002|Overall Study|Adverse Event|6|||
130669888|NCT00295854|470418134|FG000|Overall Study|Protocol Violation|1|||
130669889|NCT00295854|470418135|FG001|Overall Study|Protocol Violation|1|||
130669890|NCT00295854|470418136|FG002|Overall Study|Protocol Violation|1|||
130669891|NCT00295854|470418134|FG000|Overall Study|Lost to Follow-up|2|||
130669892|NCT00295854|470418135|FG001|Overall Study|Lost to Follow-up|0|||
130335893|NCT00104520|469199778|FG001|Overall Study|Study drug intolerance|1|||
130335894|NCT00104520|469199777|FG000|Overall Study|Related adverse event|13|||
130335895|NCT00104520|469199778|FG001|Overall Study|Related adverse event|15|||
130335896|NCT00104520|469199777|FG000|Overall Study|Lost to Follow-up|1|||
130335897|NCT00104520|469199778|FG001|Overall Study|Lost to Follow-up|0|||
130335898|NCT00104520|469199777|FG000|Overall Study|Noncompliance|0|||
130335899|NCT00104520|469199778|FG001|Overall Study|Noncompliance|2|||
130335900|NCT00104520|469199777|FG000|Overall Study|Personal/administrative|1|||
130335901|NCT00104520|469199778|FG001|Overall Study|Personal/administrative|1|||
130335902|NCT00104520|469199777|FG000|Overall Study|Other|1|||
130335903|NCT00104520|469199778|FG001|Overall Study|Other|5|||
130335904|NCT01026324|469199780|FG000|Follow up/Survival|Withdrawal by Subject|1|||
130335905|NCT01026324|469199781|FG001|Follow up/Survival|Withdrawal by Subject|0|||
130335906|NCT01026324|469199782|FG002|Follow up/Survival|Withdrawal by Subject|0|||
130335907|NCT05188053|469199783|FG000|Overall Study|Lost to Follow-up|23|||
130335908|NCT05188053|469199784|FG001|Overall Study|Lost to Follow-up|30|||
130335909|NCT05188053|469199783|FG000|Overall Study|Protocol Violation|16|||
130335910|NCT05188053|469199784|FG001|Overall Study|Protocol Violation|16|||
130669893|NCT00295854|470418136|FG002|Overall Study|Lost to Follow-up|1|||
130335911|NCT05188053|469199783|FG000|Overall Study|Physician Decision|3|||
130335912|NCT05188053|469199784|FG001|Overall Study|Physician Decision|0|||
130335913|NCT05188053|469199783|FG000|Overall Study|Withdrawal by Subject|0|||
130335914|NCT05188053|469199784|FG001|Overall Study|Withdrawal by Subject|1|||
130335915|NCT05334212|469199785|FG000|Overall Study|Study terminated prematurely|7|||
130335916|NCT01561313|469199786|FG000|Overall Study|Withdrawal by Subject|1|||
130335917|NCT01561313|469199787|FG001|Overall Study|Withdrawal by Subject|0|||
130335918|NCT01561313|469199786|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
130335919|NCT01561313|469199787|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
130335920|NCT04393454|469199788|FG000|Overall Study|Death|1|||
130335921|NCT04393454|469199788|FG000|Overall Study|Lost to Follow-up|1|||
130335922|NCT03304249|469199790|FG000|Overall Study|Lost to Follow-up|8|||
130335923|NCT03304249|469199791|FG001|Overall Study|Lost to Follow-up|10|||
130335924|NCT03304249|469199790|FG000|Overall Study|Withdrawal by Subject|12|||
130335925|NCT03304249|469199791|FG001|Overall Study|Withdrawal by Subject|2|||
130335926|NCT03304249|469199790|FG000|Overall Study|Moved Out of District|4|||
130335927|NCT03304249|469199791|FG001|Overall Study|Moved Out of District|2|||
130335928|NCT04189224|469199792|FG000|Period 2|Adverse Event|0|||
130335929|NCT04189224|469199793|FG001|Period 2|Adverse Event|1|||
130335930|NCT02970942|469199794|FG000|Overall Study|Death|0|||
130335931|NCT02970942|469199795|FG001|Overall Study|Death|1|||
130335932|NCT02970942|469199796|FG002|Overall Study|Death|0|||
130335933|NCT02970942|469199797|FG003|Overall Study|Death|0|||
130335934|NCT02970942|469199794|FG000|Overall Study|Lost to Follow-up|1|||
130335935|NCT02970942|469199795|FG001|Overall Study|Lost to Follow-up|0|||
130335936|NCT02970942|469199796|FG002|Overall Study|Lost to Follow-up|2|||
130335937|NCT02970942|469199797|FG003|Overall Study|Lost to Follow-up|1|||
130669894|NCT00295854|470418134|FG000|Overall Study|Withdrawal by Subject|3|||
130669895|NCT00295854|470418135|FG001|Overall Study|Withdrawal by Subject|7|||
130669896|NCT00295854|470418136|FG002|Overall Study|Withdrawal by Subject|4|||
130669897|NCT00295854|470418134|FG000|Overall Study|did not continue to meet criteria|1|||
130669898|NCT00295854|470418135|FG001|Overall Study|did not continue to meet criteria|1|||
130669899|NCT00295854|470418136|FG002|Overall Study|did not continue to meet criteria|2|||
130669900|NCT00295854|470418134|FG000|Overall Study|required a prohibited medication|1|||
130669901|NCT00295854|470418135|FG001|Overall Study|required a prohibited medication|0|||
130669902|NCT00295854|470418136|FG002|Overall Study|required a prohibited medication|0|||
130669903|NCT00295854|470418134|FG000|Overall Study|Other|3|||
130669904|NCT00295854|470418135|FG001|Overall Study|Other|5|||
130669905|NCT00295854|470418136|FG002|Overall Study|Other|1|||
130669906|NCT00772577|470418137|FG000|Overall Study|Adverse Event|6|||
130669907|NCT00772577|470418138|FG001|Overall Study|Adverse Event|3|||
130669908|NCT00772577|470418137|FG000|Overall Study|Abnormal laboratory values|0|||
130669909|NCT00772577|470418138|FG001|Overall Study|Abnormal laboratory values|1|||
130669910|NCT00772577|470418137|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130669911|NCT00772577|470418138|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130669912|NCT00772577|470418137|FG000|Overall Study|Patient withdrew consent|8|||
130669913|NCT00772577|470418138|FG001|Overall Study|Patient withdrew consent|5|||
130335938|NCT02970942|469199794|FG000|Overall Study|Withdrawal by Subject|3|||
130335939|NCT02970942|469199795|FG001|Overall Study|Withdrawal by Subject|5|||
130335940|NCT02970942|469199796|FG002|Overall Study|Withdrawal by Subject|3|||
130335941|NCT02970942|469199797|FG003|Overall Study|Withdrawal by Subject|2|||
130669914|NCT00772577|470418137|FG000|Overall Study|Lost to Follow-up|4|||
130335942|NCT02529553|469199798|FG000|Overall Study|Progressive Disease|1|||
130335943|NCT02529553|469199799|FG001|Overall Study|Progressive Disease|0|||
130335944|NCT02529553|469199800|FG002|Overall Study|Progressive Disease|1|||
130335945|NCT02529553|469199801|FG003|Overall Study|Progressive Disease|3|||
130335946|NCT02529553|469199802|FG004|Overall Study|Progressive Disease|2|||
130335947|NCT02529553|469199803|FG005|Overall Study|Progressive Disease|3|||
130552738|NCT00604279|469991512|FG000|Overall Study|Protocol Violation|3|||
130669915|NCT00772577|470418138|FG001|Overall Study|Lost to Follow-up|3|||
130669916|NCT00772577|470418137|FG000|Overall Study|Administrative problems|2|||
130669917|NCT00772577|470418138|FG001|Overall Study|Administrative problems|1|||
130669918|NCT00772577|470418137|FG000|Overall Study|Protocol Deviation|3|||
130669919|NCT00772577|470418138|FG001|Overall Study|Protocol Deviation|2|||
130669920|NCT00672620|470418139|FG000|Overall Study|Adverse Event|7|||
130669921|NCT00672620|470418140|FG001|Overall Study|Adverse Event|7|||
130335948|NCT02529553|469199804|FG006|Overall Study|Progressive Disease|3|||
130669922|NCT00672620|470418141|FG002|Overall Study|Adverse Event|12|||
130669923|NCT00672620|470418142|FG003|Overall Study|Adverse Event|17|||
130669924|NCT00672620|470418139|FG000|Overall Study|Lack of Efficacy|1|||
130669925|NCT00672620|470418140|FG001|Overall Study|Lack of Efficacy|2|||
130669926|NCT00672620|470418141|FG002|Overall Study|Lack of Efficacy|2|||
130669927|NCT00672620|470418142|FG003|Overall Study|Lack of Efficacy|0|||
130669928|NCT00672620|470418139|FG000|Overall Study|Noncompliance with Study Drug|3|||
130669929|NCT00672620|470418140|FG001|Overall Study|Noncompliance with Study Drug|4|||
130669930|NCT00672620|470418141|FG002|Overall Study|Noncompliance with Study Drug|0|||
130669931|NCT00672620|470418142|FG003|Overall Study|Noncompliance with Study Drug|2|||
130669932|NCT00672620|470418139|FG000|Overall Study|Protocol Deviations|5|||
130669933|NCT00672620|470418140|FG001|Overall Study|Protocol Deviations|7|||
130669934|NCT00672620|470418141|FG002|Overall Study|Protocol Deviations|2|||
130669935|NCT00672620|470418142|FG003|Overall Study|Protocol Deviations|5|||
130669936|NCT00672620|470418139|FG000|Overall Study|Withdrawal of Consent|6|||
130669937|NCT00672620|470418140|FG001|Overall Study|Withdrawal of Consent|12|||
130669938|NCT00672620|470418141|FG002|Overall Study|Withdrawal of Consent|5|||
130669939|NCT00672620|470418142|FG003|Overall Study|Withdrawal of Consent|6|||
130669940|NCT00672620|470418139|FG000|Overall Study|Lost to Follow-up|8|||
130669941|NCT00672620|470418140|FG001|Overall Study|Lost to Follow-up|19|||
130669942|NCT00672620|470418141|FG002|Overall Study|Lost to Follow-up|8|||
130669943|NCT00672620|470418142|FG003|Overall Study|Lost to Follow-up|11|||
130669944|NCT00672620|470418139|FG000|Overall Study|Reason not Specified|3|||
130669945|NCT00672620|470418140|FG001|Overall Study|Reason not Specified|3|||
130669946|NCT00672620|470418141|FG002|Overall Study|Reason not Specified|2|||
130669947|NCT00672620|470418142|FG003|Overall Study|Reason not Specified|1|||
130669948|NCT03211156|470418143|FG000|Overall Study|Withdrawal by Subject|0|||
130669949|NCT03211156|470418144|FG001|Overall Study|Withdrawal by Subject|2|||
130669950|NCT03211156|470418143|FG000|Overall Study|Lost to Follow-up|1|||
130335949|NCT02529553|469199805|FG007|Overall Study|Progressive Disease|5|||
130335950|NCT02529553|469199806|FG008|Overall Study|Progressive Disease|3|||
130335951|NCT02529553|469199798|FG000|Overall Study|Physician Decision|0|||
130335952|NCT02529553|469199799|FG001|Overall Study|Physician Decision|1|||
130335953|NCT02529553|469199800|FG002|Overall Study|Physician Decision|0|||
130335954|NCT02529553|469199801|FG003|Overall Study|Physician Decision|0|||
130335955|NCT02529553|469199802|FG004|Overall Study|Physician Decision|1|||
130335956|NCT02529553|469199803|FG005|Overall Study|Physician Decision|0|||
130335957|NCT02529553|469199804|FG006|Overall Study|Physician Decision|0|||
130335958|NCT02529553|469199805|FG007|Overall Study|Physician Decision|0|||
130335959|NCT02529553|469199806|FG008|Overall Study|Physician Decision|0|||
130335960|NCT02529553|469199798|FG000|Overall Study|Withdrawal by Subject|0|||
130335961|NCT02529553|469199799|FG001|Overall Study|Withdrawal by Subject|0|||
130335962|NCT02529553|469199800|FG002|Overall Study|Withdrawal by Subject|0|||
130335963|NCT02529553|469199801|FG003|Overall Study|Withdrawal by Subject|0|||
130335964|NCT02529553|469199802|FG004|Overall Study|Withdrawal by Subject|0|||
130335965|NCT02529553|469199803|FG005|Overall Study|Withdrawal by Subject|1|||
130335966|NCT02529553|469199804|FG006|Overall Study|Withdrawal by Subject|0|||
130335967|NCT02529553|469199805|FG007|Overall Study|Withdrawal by Subject|1|||
130335968|NCT02529553|469199806|FG008|Overall Study|Withdrawal by Subject|0|||
130335969|NCT00488683|469199807|FG000|Overall Study|Withdrawal by Subject|1|||
130335970|NCT00488683|469199808|FG001|Overall Study|Withdrawal by Subject|2|||
130335971|NCT00488683|469199809|FG002|Overall Study|Withdrawal by Subject|2|||
130335972|NCT00488683|469199807|FG000|Overall Study|Lost to Follow-up|5|||
130335973|NCT00488683|469199808|FG001|Overall Study|Lost to Follow-up|3|||
130335974|NCT00488683|469199809|FG002|Overall Study|Lost to Follow-up|0|||
130335975|NCT00488683|469199807|FG000|Overall Study|Protocol Violation|5|||
130335976|NCT00488683|469199808|FG001|Overall Study|Protocol Violation|1|||
130335977|NCT00488683|469199809|FG002|Overall Study|Protocol Violation|0|||
130335978|NCT00488683|469199807|FG000|Overall Study|Unable to Classify|1|||
130669951|NCT03211156|470418144|FG001|Overall Study|Lost to Follow-up|1|||
130669952|NCT03211156|470418143|FG000|Overall Study|Adverse Event|1|||
130669953|NCT03211156|470418144|FG001|Overall Study|Adverse Event|0|||
130669954|NCT03487796|470418148|FG000|Overall Study|Lost to Follow-up|18|||
130669955|NCT03487796|470418149|FG001|Overall Study|Lost to Follow-up|6|||
130669956|NCT04272775|470418150|FG000|Overall Study|Study Terminated by Sponsor|1|||
130335979|NCT00488683|469199808|FG001|Overall Study|Unable to Classify|0|||
130335980|NCT00488683|469199809|FG002|Overall Study|Unable to Classify|0|||
130335981|NCT01865552|469201305|FG000|Period 1|Adverse Event|1|||
130335982|NCT01865552|469201306|FG001|Period 1|Adverse Event|0|||
130335983|NCT01865552|469201307|FG002|Period 1|Adverse Event|0|||
130335984|NCT01865552|469201308|FG003|Period 1|Adverse Event|1|||
130669957|NCT04272775|470418151|FG001|Overall Study|Study Terminated by Sponsor|0|||
130669958|NCT04272775|470418150|FG000|Overall Study|Protocol Violation|0|||
130669959|NCT04272775|470418151|FG001|Overall Study|Protocol Violation|1|||
130669960|NCT04272775|470418150|FG000|Overall Study|Symptomatic Deterioration|1|||
130669961|NCT04272775|470418151|FG001|Overall Study|Symptomatic Deterioration|1|||
130669962|NCT04272775|470418150|FG000|Overall Study|Withdrawal by Subject|1|||
130669963|NCT04272775|470418151|FG001|Overall Study|Withdrawal by Subject|2|||
130669964|NCT04272775|470418150|FG000|Overall Study|Adverse Event|1|||
130669965|NCT04272775|470418151|FG001|Overall Study|Adverse Event|2|||
130669966|NCT04272775|470418150|FG000|Overall Study|Progressive Disease|3|||
130669967|NCT04272775|470418151|FG001|Overall Study|Progressive Disease|1|||
130669968|NCT00124020|470418152|FG000|Overall Study|Death|67|||
130669969|NCT00124020|470418153|FG001|Overall Study|Death|71|||
130669970|NCT00124020|470418152|FG000|Overall Study|Withdrawal by Subject|13|||
130669971|NCT00124020|470418153|FG001|Overall Study|Withdrawal by Subject|11|||
130669972|NCT00124020|470418152|FG000|Overall Study|Lost to Follow-up|5|||
130669973|NCT00124020|470418153|FG001|Overall Study|Lost to Follow-up|8|||
130669974|NCT00124020|470418152|FG000|Overall Study|Other|1|||
130669975|NCT00124020|470418153|FG001|Overall Study|Other|1|||
130669976|NCT00124020|470418152|FG000|Overall Study|Transfer to another hospital|2|||
130669977|NCT00124020|470418153|FG001|Overall Study|Transfer to another hospital|0|||
130669978|NCT02043366|470418154|FG000|Overall Study|Lost to Follow-up|2|||
130669979|NCT02043366|470418155|FG001|Overall Study|Lost to Follow-up|2|||
130669980|NCT02043366|470418156|FG002|Overall Study|Lost to Follow-up|2|||
130669981|NCT02043366|470418157|FG003|Overall Study|Lost to Follow-up|2|||
130669982|NCT02043366|470418158|FG004|Overall Study|Lost to Follow-up|2|||
130669983|NCT02043366|470418159|FG005|Overall Study|Lost to Follow-up|2|||
130669984|NCT00891774|470418162|FG000|Overall Study|Lost to Follow-up|5|||
130669985|NCT00891774|470418162|FG000|Overall Study|Illness (Self/Mother)|3|||
130669986|NCT00891774|470418162|FG000|Overall Study|Withdrawal by Subject|2|||
130669987|NCT00891774|470418162|FG000|Overall Study|Protocol Violation|4|||
130669988|NCT03175120|470418164|FG000|Overall Study|Adverse Event|2|||
130669989|NCT03175120|470418165|FG001|Overall Study|Adverse Event|2|||
130669990|NCT03175120|470418164|FG000|Overall Study|Protocol Violation|5|||
130669991|NCT03175120|470418165|FG001|Overall Study|Protocol Violation|2|||
130669992|NCT03175120|470418164|FG000|Overall Study|Lost to Follow-up|1|||
130669993|NCT03175120|470418165|FG001|Overall Study|Lost to Follow-up|0|||
130669994|NCT03175120|470418164|FG000|Overall Study|Withdrawal by Subject|2|||
130669995|NCT03175120|470418165|FG001|Overall Study|Withdrawal by Subject|5|||
130669996|NCT03175120|470418164|FG000|Overall Study|Other|2|||
130669997|NCT03175120|470418165|FG001|Overall Study|Other|3|||
130669998|NCT01977092|470418166|FG000|Overall Study|Death|3|||
130669999|NCT01977092|470418167|FG001|Overall Study|Death|4|||
130670000|NCT01977092|470418166|FG000|Overall Study|Lost to Follow-up|23|||
130670001|NCT01977092|470418167|FG001|Overall Study|Lost to Follow-up|14|||
130670002|NCT01977092|470418166|FG000|Overall Study|Withdrawal by Subject|2|||
130670003|NCT01977092|470418167|FG001|Overall Study|Withdrawal by Subject|1|||
130670004|NCT01977092|470418166|FG000|Overall Study|In prison|3|||
130670005|NCT01977092|470418167|FG001|Overall Study|In prison|11|||
130670006|NCT03038113|470418168|FG000|Overall Study|Withdrawal by Subject|0|||
130670007|NCT03038113|470418169|FG001|Overall Study|Withdrawal by Subject|0|||
130670008|NCT03038113|470418170|FG002|Overall Study|Withdrawal by Subject|1|||
130670009|NCT03038113|470418171|FG003|Overall Study|Withdrawal by Subject|0|||
130670010|NCT03038113|470418172|FG004|Overall Study|Withdrawal by Subject|0|||
130670011|NCT03038113|470418173|FG005|Overall Study|Withdrawal by Subject|0|||
130670012|NCT03038113|470418174|FG006|Overall Study|Withdrawal by Subject|0|||
130670013|NCT03038113|470418175|FG007|Overall Study|Withdrawal by Subject|0|||
130670014|NCT03038113|470418176|FG008|Overall Study|Withdrawal by Subject|0|||
130670015|NCT03038113|470418177|FG009|Overall Study|Withdrawal by Subject|0|||
130670016|NCT03038113|470418178|FG010|Overall Study|Withdrawal by Subject|0|||
130670017|NCT03038113|470418179|FG011|Overall Study|Withdrawal by Subject|0|||
130670018|NCT03038113|470418180|FG012|Overall Study|Withdrawal by Subject|0|||
130670019|NCT03038113|470418181|FG013|Overall Study|Withdrawal by Subject|1|||
130670020|NCT03038113|470418168|FG000|Overall Study|Lost to Follow-up|0|||
130670021|NCT03038113|470418169|FG001|Overall Study|Lost to Follow-up|0|||
130670022|NCT03038113|470418170|FG002|Overall Study|Lost to Follow-up|0|||
130670023|NCT03038113|470418171|FG003|Overall Study|Lost to Follow-up|0|||
130670024|NCT03038113|470418172|FG004|Overall Study|Lost to Follow-up|0|||
130670025|NCT03038113|470418173|FG005|Overall Study|Lost to Follow-up|0|||
130670026|NCT03038113|470418174|FG006|Overall Study|Lost to Follow-up|1|||
130670027|NCT03038113|470418175|FG007|Overall Study|Lost to Follow-up|0|||
130670028|NCT03038113|470418176|FG008|Overall Study|Lost to Follow-up|0|||
130670029|NCT03038113|470418177|FG009|Overall Study|Lost to Follow-up|0|||
130670030|NCT03038113|470418178|FG010|Overall Study|Lost to Follow-up|0|||
130670031|NCT03038113|470418179|FG011|Overall Study|Lost to Follow-up|0|||
130670032|NCT03038113|470418180|FG012|Overall Study|Lost to Follow-up|0|||
130670033|NCT03038113|470418181|FG013|Overall Study|Lost to Follow-up|0|||
130670034|NCT01698320|470418183|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
130670035|NCT01698320|470418184|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
130670036|NCT01698320|470418185|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
130670037|NCT01698320|470418183|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
130670038|NCT01698320|470418184|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
130670039|NCT01698320|470418185|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
130670040|NCT01698320|470418183|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
130670041|NCT01698320|470418184|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
130670042|NCT01698320|470418185|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
130670043|NCT01698320|470418183|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
130670044|NCT01698320|470418184|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
130670045|NCT01698320|470418185|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
130670046|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Adverse Event|0|||
130670047|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Adverse Event|1|||
130670048|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Adverse Event|1|||
130670049|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
130670050|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
130670051|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
130670052|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
130670053|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
130670054|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
130670055|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Pregnancy|0|||
130670056|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Pregnancy|1|||
130670057|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Pregnancy|1|||
130670058|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
130670059|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
130670060|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
130670061|NCT01698320|470418183|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
130670062|NCT01698320|470418184|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
130670063|NCT01698320|470418185|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
130670064|NCT01698320|470418183|FG000|40-Week Open-Label Period|Adverse Event|0|||
130670065|NCT01698320|470418184|FG001|40-Week Open-Label Period|Adverse Event|3|||
130670066|NCT01698320|470418185|FG002|40-Week Open-Label Period|Adverse Event|2|||
130670067|NCT01698320|470418183|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
130670068|NCT01698320|470418184|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
130670069|NCT01698320|470418185|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
130670070|NCT01698320|470418183|FG000|40-Week Open-Label Period|Pregnancy|0|||
130670071|NCT01698320|470418184|FG001|40-Week Open-Label Period|Pregnancy|2|||
130670072|NCT01698320|470418185|FG002|40-Week Open-Label Period|Pregnancy|1|||
130670073|NCT01698320|470418183|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
130670074|NCT01698320|470418184|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
130670075|NCT01698320|470418185|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
130670076|NCT01698320|470418183|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
130670077|NCT01698320|470418184|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
130670078|NCT01698320|470418185|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
130670079|NCT01952574|470418186|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
130670080|NCT01952574|470418187|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
130670081|NCT01952574|470418188|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
130670082|NCT01952574|470418189|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
130670083|NCT01952574|470418190|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130670084|NCT01952574|470418191|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130670085|NCT01952574|470418192|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130670086|NCT01952574|470418186|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
130670087|NCT01952574|470418187|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
130670088|NCT01952574|470418188|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
130670089|NCT01952574|470418189|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
130670090|NCT01952574|470418190|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
130670091|NCT01952574|470418191|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
130670092|NCT01952574|470418192|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
130335985|NCT01865552|469201309|FG004|Period 1|Adverse Event|1|||
130335986|NCT01865552|469201310|FG005|Period 1|Adverse Event|1|||
130335987|NCT01865552|469201305|FG000|Period 1|Pathological lab|0|||
130335988|NCT01865552|469201306|FG001|Period 1|Pathological lab|0|||
130335989|NCT01865552|469201307|FG002|Period 1|Pathological lab|0|||
130335990|NCT01865552|469201308|FG003|Period 1|Pathological lab|0|||
130335991|NCT01865552|469201309|FG004|Period 1|Pathological lab|1|||
130335992|NCT01865552|469201310|FG005|Period 1|Pathological lab|0|||
130335993|NCT01865552|469201305|FG000|Period 1|Other|0|||
130335994|NCT01865552|469201306|FG001|Period 1|Other|0|||
130552739|NCT00604279|469991513|FG001|Overall Study|Protocol Violation|1|||
130335995|NCT01865552|469201307|FG002|Period 1|Other|0|||
130552740|NCT00604279|469991512|FG000|Overall Study|Withdrawal by Subject|16|||
130335996|NCT01865552|469201308|FG003|Period 1|Other|0|||
130335997|NCT01865552|469201309|FG004|Period 1|Other|1|||
130335998|NCT01865552|469201310|FG005|Period 1|Other|0|||
130335999|NCT02175199|469201313|FG000|Overall Study|Withdrawal by Subject|1|||
130670093|NCT01952574|470418186|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
130670094|NCT01952574|470418187|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130670095|NCT01952574|470418188|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
130670096|NCT01952574|470418189|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
130670097|NCT01952574|470418190|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
130670098|NCT01952574|470418191|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
130670099|NCT01952574|470418192|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
130670100|NCT01952574|470418186|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670101|NCT01952574|470418187|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670102|NCT01952574|470418188|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670103|NCT01952574|470418189|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670104|NCT01952574|470418190|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
130670105|NCT01952574|470418191|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670106|NCT01952574|470418192|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
130670107|NCT01952574|470418186|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
130670108|NCT01952574|470418187|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
130670109|NCT01952574|470418188|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
130670110|NCT01952574|470418189|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
130670111|NCT01952574|470418190|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
130670112|NCT01952574|470418191|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
130670113|NCT01952574|470418192|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
130670114|NCT01952574|470418186|FG000|Open-label Treatment Phase|Missing|0|||
130670115|NCT01952574|470418187|FG001|Open-label Treatment Phase|Missing|0|||
130670116|NCT01952574|470418188|FG002|Open-label Treatment Phase|Missing|0|||
130336000|NCT02175199|469201314|FG001|Overall Study|Withdrawal by Subject|5|||
130336001|NCT02175199|469201313|FG000|Overall Study|Randomized in Error|1|||
130336002|NCT02175199|469201314|FG001|Overall Study|Randomized in Error|0|||
130336003|NCT02175199|469201313|FG000|Overall Study|Sponsor Decision|1|||
130336004|NCT02175199|469201314|FG001|Overall Study|Sponsor Decision|0|||
130336005|NCT03983317|469201321|FG000|Overall Study|Physician Decision|5|||
130336006|NCT01761162|469201322|FG000|Overall Study|Withdrawal by Subject|3|||
130336007|NCT02741518|469201323|FG000|Overall Study|Withdrawal by Subject|1|||
130336008|NCT02741518|469201324|FG001|Overall Study|Withdrawal by Subject|1|||
130336009|NCT01349049|469201325|FG000|Overall Study|Disease progression|3|||
130336010|NCT01349049|469201326|FG001|Overall Study|Disease progression|5|||
130336011|NCT01349049|469201327|FG002|Overall Study|Disease progression|3|||
130336012|NCT01349049|469201328|FG003|Overall Study|Disease progression|2|||
130336013|NCT01349049|469201329|FG004|Overall Study|Disease progression|2|||
130336014|NCT01349049|469201330|FG005|Overall Study|Disease progression|2|||
130336015|NCT01349049|469201331|FG006|Overall Study|Disease progression|3|||
130336016|NCT01349049|469201332|FG007|Overall Study|Disease progression|2|||
130336017|NCT01349049|469201333|FG008|Overall Study|Disease progression|33|||
130336018|NCT01349049|469201325|FG000|Overall Study|Adverse Event|0|||
130336019|NCT01349049|469201326|FG001|Overall Study|Adverse Event|1|||
130336020|NCT01349049|469201327|FG002|Overall Study|Adverse Event|0|||
130336021|NCT01349049|469201328|FG003|Overall Study|Adverse Event|0|||
130336022|NCT01349049|469201329|FG004|Overall Study|Adverse Event|0|||
130336023|NCT01349049|469201330|FG005|Overall Study|Adverse Event|3|||
130336024|NCT01349049|469201331|FG006|Overall Study|Adverse Event|1|||
130336025|NCT01349049|469201332|FG007|Overall Study|Adverse Event|0|||
130336026|NCT01349049|469201333|FG008|Overall Study|Adverse Event|4|||
130336027|NCT01349049|469201325|FG000|Overall Study|Physician Decision|0|||
130336028|NCT01349049|469201326|FG001|Overall Study|Physician Decision|1|||
130336029|NCT01349049|469201327|FG002|Overall Study|Physician Decision|0|||
130336030|NCT01349049|469201328|FG003|Overall Study|Physician Decision|0|||
130336031|NCT01349049|469201329|FG004|Overall Study|Physician Decision|0|||
130336032|NCT01349049|469201330|FG005|Overall Study|Physician Decision|0|||
130336033|NCT01349049|469201331|FG006|Overall Study|Physician Decision|0|||
130670117|NCT01952574|470418189|FG003|Open-label Treatment Phase|Missing|0|||
130670118|NCT01952574|470418190|FG004|Open-label Treatment Phase|Missing|4|||
130336034|NCT01349049|469201332|FG007|Overall Study|Physician Decision|0|||
130336035|NCT01349049|469201333|FG008|Overall Study|Physician Decision|2|||
130336036|NCT01349049|469201325|FG000|Overall Study|Protocol Violation|0|||
130336037|NCT01349049|469201326|FG001|Overall Study|Protocol Violation|0|||
130336038|NCT01349049|469201327|FG002|Overall Study|Protocol Violation|0|||
130336039|NCT01349049|469201328|FG003|Overall Study|Protocol Violation|0|||
130670119|NCT01952574|470418191|FG005|Open-label Treatment Phase|Missing|0|||
130670120|NCT01952574|470418192|FG006|Open-label Treatment Phase|Missing|0|||
130670121|NCT01952574|470418186|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130336040|NCT01349049|469201329|FG004|Overall Study|Protocol Violation|0|||
130336041|NCT01349049|469201330|FG005|Overall Study|Protocol Violation|0|||
130336042|NCT01349049|469201331|FG006|Overall Study|Protocol Violation|0|||
130336043|NCT01349049|469201332|FG007|Overall Study|Protocol Violation|0|||
130336044|NCT01349049|469201333|FG008|Overall Study|Protocol Violation|1|||
130336045|NCT01349049|469201325|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
130336046|NCT01349049|469201326|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
130336047|NCT01349049|469201327|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
130336048|NCT01349049|469201328|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
130336049|NCT01349049|469201329|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
130336050|NCT01349049|469201330|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
130670122|NCT01952574|470418187|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130670123|NCT01952574|470418188|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
130670124|NCT01952574|470418189|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
130670125|NCT01952574|470418190|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
130670126|NCT01952574|470418191|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
130670127|NCT01952574|470418192|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
130670128|NCT01952574|470418186|FG000|Open-label Treatment Phase|Death|0|||
130670129|NCT01952574|470418187|FG001|Open-label Treatment Phase|Death|0|||
130670130|NCT01952574|470418188|FG002|Open-label Treatment Phase|Death|0|||
130670131|NCT01952574|470418189|FG003|Open-label Treatment Phase|Death|0|||
130670132|NCT01952574|470418190|FG004|Open-label Treatment Phase|Death|1|||
130670133|NCT01952574|470418191|FG005|Open-label Treatment Phase|Death|0|||
130670134|NCT01952574|470418192|FG006|Open-label Treatment Phase|Death|0|||
130670135|NCT01952574|470418186|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670136|NCT01952574|470418187|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670137|NCT01952574|470418188|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670138|NCT01952574|470418189|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670139|NCT01952574|470418190|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670140|NCT01952574|470418191|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
130670141|NCT01952574|470418192|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130670142|NCT01952574|470418186|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
130670143|NCT01952574|470418187|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
130670144|NCT01952574|470418188|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
130670145|NCT01952574|470418189|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
130670146|NCT01952574|470418190|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
130670147|NCT01952574|470418191|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
130670148|NCT01952574|470418192|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
130670149|NCT00770991|470418199|FG000|Overall Study|Physician Decision|2|||
130670150|NCT00770991|470418200|FG001|Overall Study|Physician Decision|0|||
130670151|NCT00770991|470418199|FG000|Overall Study|Withdrawal by Subject|1|||
130670152|NCT00770991|470418200|FG001|Overall Study|Withdrawal by Subject|0|||
130670153|NCT00770991|470418199|FG000|Overall Study|Adverse Event|1|||
130670154|NCT00770991|470418200|FG001|Overall Study|Adverse Event|5|||
130670155|NCT00770991|470418199|FG000|Overall Study|Pregnancy|1|||
130670156|NCT00770991|470418200|FG001|Overall Study|Pregnancy|0|||
130670157|NCT00871728|470418211|FG000|Overall Study|Adverse Event|1|||
130670158|NCT00871728|470418211|FG000|Overall Study|Protocol Violation|7|||
130670159|NCT00871728|470418211|FG000|Overall Study|Lost to Follow-up|2|||
130670160|NCT00871728|470418211|FG000|Overall Study|Failed to Visit Hospital|4|||
130670161|NCT00871728|470418211|FG000|Overall Study|Participant Non-compliance|1|||
130670162|NCT00871728|470418211|FG000|Overall Study|Withdrawal of Informed Consent|5|||
130670163|NCT04147715|470418214|FG000|Overall Study|Adverse Event|0|||
130670164|NCT04147715|470418215|FG001|Overall Study|Adverse Event|0|||
130670165|NCT04147715|470418216|FG002|Overall Study|Adverse Event|0|||
130670166|NCT04147715|470418217|FG003|Overall Study|Adverse Event|0|||
130670167|NCT04147715|470418218|FG004|Overall Study|Adverse Event|0|||
130670168|NCT04147715|470418219|FG005|Overall Study|Adverse Event|0|||
130670169|NCT04147715|470418220|FG006|Overall Study|Adverse Event|0|||
130670170|NCT04147715|470418221|FG007|Overall Study|Adverse Event|2|||
130670171|NCT04147715|470418222|FG008|Overall Study|Adverse Event|1|||
130670172|NCT04147715|470418223|FG009|Overall Study|Adverse Event|0|||
130670173|NCT04147715|470418224|FG010|Overall Study|Adverse Event|0|||
130670174|NCT04147715|470418225|FG011|Overall Study|Adverse Event|0|||
130670175|NCT03404206|470418226|FG000|Overall Study|Withdrawal by Subject|1|||
130670176|NCT03404206|470418227|FG001|Overall Study|Withdrawal by Subject|1|||
130670177|NCT03404206|470418228|FG002|Overall Study|Withdrawal by Subject|0|||
130670178|NCT03404206|470418226|FG000|Overall Study|Lost to Follow-up|3|||
130670179|NCT03404206|470418227|FG001|Overall Study|Lost to Follow-up|1|||
130670180|NCT03404206|470418228|FG002|Overall Study|Lost to Follow-up|0|||
130670181|NCT01829295|470418237|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
130670182|NCT01829295|470418238|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
130670183|NCT01829295|470418239|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
130670184|NCT01829295|470418240|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
130670185|NCT01829295|470418237|FG000|6-12 Months|Adverse Event|0|||
130670186|NCT01829295|470418238|FG001|6-12 Months|Adverse Event|0|||
130670187|NCT01829295|470418239|FG002|6-12 Months|Adverse Event|3|||
130670188|NCT01829295|470418240|FG003|6-12 Months|Adverse Event|2|||
130670189|NCT01829295|470418237|FG000|6-12 Months|Lost to Follow-up|2|||
130670190|NCT01829295|470418238|FG001|6-12 Months|Lost to Follow-up|0|||
130670191|NCT01829295|470418239|FG002|6-12 Months|Lost to Follow-up|0|||
130670192|NCT01829295|470418240|FG003|6-12 Months|Lost to Follow-up|0|||
130336051|NCT01349049|469201331|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
130336052|NCT01349049|469201332|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
130336053|NCT01349049|469201333|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
130336054|NCT01349049|469201325|FG000|Overall Study|Other|0|||
130336055|NCT01349049|469201326|FG001|Overall Study|Other|0|||
130336056|NCT01349049|469201327|FG002|Overall Study|Other|0|||
130336057|NCT01349049|469201328|FG003|Overall Study|Other|0|||
130336058|NCT01349049|469201329|FG004|Overall Study|Other|0|||
130336059|NCT01349049|469201330|FG005|Overall Study|Other|1|||
130336060|NCT01349049|469201331|FG006|Overall Study|Other|0|||
130336061|NCT01349049|469201332|FG007|Overall Study|Other|0|||
130336062|NCT01349049|469201333|FG008|Overall Study|Other|4|||
130336063|NCT01349049|469201325|FG000|Overall Study|Death|0|||
130336064|NCT01349049|469201326|FG001|Overall Study|Death|0|||
130336065|NCT01349049|469201327|FG002|Overall Study|Death|0|||
130336066|NCT01349049|469201328|FG003|Overall Study|Death|0|||
130336067|NCT01349049|469201329|FG004|Overall Study|Death|0|||
130336068|NCT01349049|469201330|FG005|Overall Study|Death|0|||
130336069|NCT01349049|469201331|FG006|Overall Study|Death|0|||
130336070|NCT01349049|469201332|FG007|Overall Study|Death|1|||
130336071|NCT01349049|469201333|FG008|Overall Study|Death|5|||
130336072|NCT01349049|469201325|FG000|Overall Study|Non-compliance|0|||
130670193|NCT01829295|470418237|FG000|6-12 Months|Withdrawal by Subject|2|||
130670194|NCT01829295|470418238|FG001|6-12 Months|Withdrawal by Subject|2|||
130670195|NCT01829295|470418239|FG002|6-12 Months|Withdrawal by Subject|0|||
130670196|NCT01829295|470418240|FG003|6-12 Months|Withdrawal by Subject|0|||
130336073|NCT01349049|469201326|FG001|Overall Study|Non-compliance|0|||
130336074|NCT01349049|469201327|FG002|Overall Study|Non-compliance|0|||
130336075|NCT01349049|469201328|FG003|Overall Study|Non-compliance|1|||
130336076|NCT01349049|469201329|FG004|Overall Study|Non-compliance|0|||
130336077|NCT01349049|469201330|FG005|Overall Study|Non-compliance|0|||
130336078|NCT01349049|469201331|FG006|Overall Study|Non-compliance|0|||
130336079|NCT01349049|469201332|FG007|Overall Study|Non-compliance|0|||
130336080|NCT01349049|469201333|FG008|Overall Study|Non-compliance|0|||
130336081|NCT01349049|469201325|FG000|Overall Study|Withdrawal by Subject|0|||
130336082|NCT01349049|469201326|FG001|Overall Study|Withdrawal by Subject|0|||
130336083|NCT01349049|469201327|FG002|Overall Study|Withdrawal by Subject|0|||
130336084|NCT01349049|469201328|FG003|Overall Study|Withdrawal by Subject|0|||
130336085|NCT01349049|469201329|FG004|Overall Study|Withdrawal by Subject|0|||
130336086|NCT01349049|469201330|FG005|Overall Study|Withdrawal by Subject|0|||
130336087|NCT01349049|469201331|FG006|Overall Study|Withdrawal by Subject|0|||
130336088|NCT01349049|469201332|FG007|Overall Study|Withdrawal by Subject|0|||
130336089|NCT01349049|469201333|FG008|Overall Study|Withdrawal by Subject|6|||
130336090|NCT04681352|469201340|FG000|Overall Study|Lost to Follow-up|2|||
130336091|NCT04681352|469201340|FG000|Overall Study|Withdrawal by Subject|22|||
130336092|NCT01643772|469201341|FG000|Overall Study|Protocol Violation|0|||
130336093|NCT01643772|469201342|FG001|Overall Study|Protocol Violation|0|||
130336094|NCT01643772|469201343|FG002|Overall Study|Protocol Violation|0|||
130336095|NCT01643772|469201344|FG003|Overall Study|Protocol Violation|1|||
130336096|NCT01643772|469201341|FG000|Overall Study|Adverse Event|0|||
130336097|NCT01643772|469201342|FG001|Overall Study|Adverse Event|0|||
130336098|NCT01643772|469201343|FG002|Overall Study|Adverse Event|0|||
130336099|NCT01643772|469201344|FG003|Overall Study|Adverse Event|1|||
130336100|NCT02881567|469201351|FG000|Overall Study|Adverse Event|1|||
130336101|NCT02881567|469201351|FG000|Overall Study|Lost to Follow-up|3|||
130336102|NCT02881567|469201351|FG000|Overall Study|Consent withdrawn|1|||
130336103|NCT02881567|469201351|FG000|Overall Study|Investigator decision|1|||
130336104|NCT02881567|469201351|FG000|Overall Study|Study terminated by sponsor|9|||
130336105|NCT02881567|469201351|FG000|Overall Study|Reason not Specified|3|||
130336106|NCT00373113|469201352|FG000|Overall Study|Death|1|||
130336107|NCT00373113|469201353|FG001|Overall Study|Death|7|||
130336108|NCT00373113|469201352|FG000|Overall Study|Adverse Event|38|||
130670197|NCT01626859|470418241|FG000|Overall Study|Adverse Event|1|||
130336109|NCT00373113|469201353|FG001|Overall Study|Adverse Event|24|||
130336110|NCT00373113|469201352|FG000|Overall Study|Study terminated by sponsor|9|||
130336111|NCT00373113|469201353|FG001|Overall Study|Study terminated by sponsor|1|||
130336112|NCT00373113|469201352|FG000|Overall Study|Global deterioration of health status|10|||
130336113|NCT00373113|469201353|FG001|Overall Study|Global deterioration of health status|7|||
130336114|NCT00373113|469201352|FG000|Overall Study|Lost to Follow-up|1|||
130336115|NCT00373113|469201353|FG001|Overall Study|Lost to Follow-up|3|||
130336116|NCT00373113|469201352|FG000|Overall Study|Objective progression or relapse|150|||
130336117|NCT00373113|469201353|FG001|Overall Study|Objective progression or relapse|169|||
130336118|NCT00373113|469201352|FG000|Overall Study|Other|14|||
130336119|NCT00373113|469201353|FG001|Overall Study|Other|17|||
130336120|NCT00373113|469201352|FG000|Overall Study|Protocol Violation|5|||
130670198|NCT01626859|470418242|FG001|Overall Study|Adverse Event|3|||
130336121|NCT00373113|469201353|FG001|Overall Study|Protocol Violation|1|||
130336122|NCT00373113|469201352|FG000|Overall Study|Withdrawal by Subject|10|||
130336123|NCT00373113|469201353|FG001|Overall Study|Withdrawal by Subject|15|||
130336124|NCT04248491|469201354|FG000|Overall Study|Lost to Follow-up|1|||
130670199|NCT01626859|470418243|FG002|Overall Study|Adverse Event|2|||
130670200|NCT01626859|470418241|FG000|Overall Study|Physician Decision|0|||
130670201|NCT01626859|470418242|FG001|Overall Study|Physician Decision|1|||
130670202|NCT01626859|470418243|FG002|Overall Study|Physician Decision|0|||
130670203|NCT01626859|470418241|FG000|Overall Study|Withdrawal by Subject|1|||
130670204|NCT01626859|470418242|FG001|Overall Study|Withdrawal by Subject|4|||
130670205|NCT01626859|470418243|FG002|Overall Study|Withdrawal by Subject|2|||
130670206|NCT02629965|470418244|FG000|Period 1|Adverse Event|1|||
130336125|NCT04248491|469201355|FG001|Overall Study|Lost to Follow-up|0|||
130336126|NCT02364336|469201359|FG000|Overall Study|Adverse Event|0|||
130336127|NCT02364336|469201360|FG001|Overall Study|Adverse Event|1|||
130670207|NCT02629965|470418245|FG001|Period 1|Adverse Event|0|||
130670208|NCT02629965|470418244|FG000|Period 1|Unexpected worsening of disease|2|||
130670209|NCT02629965|470418245|FG001|Period 1|Unexpected worsening of disease|0|||
130670210|NCT02629965|470418244|FG000|Period 1|Other than listed above|1|||
130670211|NCT02629965|470418245|FG001|Period 1|Other than listed above|2|||
130670212|NCT02629965|470418244|FG000|Period 2|Adverse Event|1|||
130670213|NCT02629965|470418245|FG001|Period 2|Adverse Event|0|||
130670214|NCT02330081|470418246|FG000|Overall Study|Adverse Event|1|||
130670215|NCT02330081|470418246|FG000|Overall Study|Donation did not meet criteria|1|||
130670216|NCT02330081|470418246|FG000|Overall Study|Protocol Violation|6|||
130670217|NCT02826603|470418247|FG000|Overall Study|Adverse Event|17|||
130670218|NCT02826603|470418248|FG001|Overall Study|Adverse Event|9|||
130670219|NCT02826603|470418247|FG000|Overall Study|Lack of Efficacy|4|||
130670220|NCT02826603|470418248|FG001|Overall Study|Lack of Efficacy|9|||
130670221|NCT02826603|470418247|FG000|Overall Study|Lost to Follow-up|13|||
130670222|NCT02826603|470418248|FG001|Overall Study|Lost to Follow-up|12|||
130670223|NCT02826603|470418247|FG000|Overall Study|Noncompliance with treatment|0|||
130336128|NCT01731938|469201361|FG000|Preliminary Part I|Withdrawal by Subject|2|||
130336129|NCT01731938|469201362|FG001|Preliminary Part I|Withdrawal by Subject|2|||
130336130|NCT01731938|469201361|FG000|Preliminary Part I|Physician Decision|1|||
130336131|NCT01731938|469201362|FG001|Preliminary Part I|Physician Decision|0|||
130336132|NCT01731938|469201361|FG000|Preliminary Part I|Lost to Follow-up|0|||
130336133|NCT01731938|469201362|FG001|Preliminary Part I|Lost to Follow-up|3|||
130336134|NCT01731938|469201361|FG000|Preliminary Part I|Missed Week 6 visit|0|||
130336135|NCT01731938|469201362|FG001|Preliminary Part I|Missed Week 6 visit|3|||
130336136|NCT01731938|469201361|FG000|Primary Part II|Withdrawal by Subject|5|||
130336137|NCT01731938|469201362|FG001|Primary Part II|Withdrawal by Subject|4|||
130336138|NCT01731938|469201361|FG000|Primary Part II|Lost to Follow-up|4|||
130336139|NCT01731938|469201362|FG001|Primary Part II|Lost to Follow-up|5|||
130336140|NCT01731938|469201361|FG000|Primary Part II|Death|2|||
130336141|NCT01731938|469201362|FG001|Primary Part II|Death|1|||
130336142|NCT01731938|469201361|FG000|Primary Part II|Missed Week 6 visit|2|||
130336143|NCT01731938|469201362|FG001|Primary Part II|Missed Week 6 visit|3|||
130336144|NCT00771953|469201363|FG000|Overall Study|Adverse Event|5|||
130336145|NCT00771953|469201364|FG001|Overall Study|Adverse Event|3|||
130336146|NCT00771953|469201363|FG000|Overall Study|Death|2|||
130336147|NCT00771953|469201364|FG001|Overall Study|Death|2|||
130336148|NCT00771953|469201363|FG000|Overall Study|Progression before active Tx|1|||
130336149|NCT00771953|469201364|FG001|Overall Study|Progression before active Tx|2|||
130336150|NCT00771953|469201363|FG000|Overall Study|Sponsor decision|1|||
130336151|NCT00771953|469201364|FG001|Overall Study|Sponsor decision|0|||
130336152|NCT00771953|469201363|FG000|Overall Study|Other complicating disease|1|||
130336153|NCT00771953|469201364|FG001|Overall Study|Other complicating disease|0|||
130336154|NCT00771953|469201363|FG000|Overall Study|Withdrawal by Subject|0|||
130336155|NCT00771953|469201364|FG001|Overall Study|Withdrawal by Subject|3|||
130336156|NCT00856518|469201368|FG000|Overall Study|Lost to Follow-up|4|||
130336157|NCT00856518|469201369|FG001|Overall Study|Lost to Follow-up|2|||
130336158|NCT00947193|469201370|FG000|Overall Study|Lost to Follow-up|1|||
130336159|NCT00947193|469201371|FG001|Overall Study|Lost to Follow-up|0|||
130336160|NCT00947193|469201370|FG000|Overall Study|Withdrawal by Subject|1|||
130336161|NCT00947193|469201371|FG001|Overall Study|Withdrawal by Subject|0|||
130336162|NCT00947193|469201370|FG000|Overall Study|Factor VIII >1%|1|||
130670224|NCT02826603|470418248|FG001|Overall Study|Noncompliance with treatment|2|||
130670225|NCT02826603|470418247|FG000|Overall Study|Physician Decision|1|||
130670226|NCT02826603|470418248|FG001|Overall Study|Physician Decision|7|||
130670227|NCT02826603|470418247|FG000|Overall Study|Pregnancy|1|||
130670228|NCT02826603|470418248|FG001|Overall Study|Pregnancy|2|||
130336163|NCT00947193|469201371|FG001|Overall Study|Factor VIII >1%|0|||
130336164|NCT00926029|469201373|FG000|Overall Study|Lost to Follow-up|2|||
130336165|NCT00926029|469201374|FG001|Overall Study|Lost to Follow-up|1|||
130336166|NCT00926029|469201375|FG002|Overall Study|Lost to Follow-up|1|||
130336167|NCT05246514|469201376|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
130336168|NCT05246514|469201376|FG000|Overall Study|Withdrawal by Subject|1|||
130336169|NCT05246514|469201376|FG000|Overall Study|Death|13|||
130336170|NCT04154189|469201377|FG000|Overall Study|Withdrawal by Subject|4|||
130336171|NCT04154189|469201378|FG001|Overall Study|Withdrawal by Subject|6|||
130670229|NCT02826603|470418247|FG000|Overall Study|Protocol Violation|3|||
130670230|NCT02826603|470418248|FG001|Overall Study|Protocol Violation|3|||
130336172|NCT04154189|469201377|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
130336173|NCT04154189|469201378|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
130336174|NCT04154189|469201377|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
130336175|NCT04154189|469201378|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
130336176|NCT04154189|469201377|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
130336177|NCT04154189|469201378|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
130336178|NCT04154189|469201377|FG000|Overall Study|Death|25|||
130336179|NCT04154189|469201378|FG001|Overall Study|Death|25|||
130336180|NCT00486291|469201379|FG000|Overall Study|Adverse Event|3|||
130336181|NCT00486291|469201380|FG001|Overall Study|Adverse Event|4|||
130336182|NCT00486291|469201379|FG000|Overall Study|Lost to Follow-up|3|||
130336183|NCT00486291|469201380|FG001|Overall Study|Lost to Follow-up|7|||
130336184|NCT00486291|469201379|FG000|Overall Study|protocol non-compliance|10|||
130336185|NCT00486291|469201380|FG001|Overall Study|protocol non-compliance|15|||
130336186|NCT00486291|469201379|FG000|Overall Study|requirement for restricted medication|0|||
130336187|NCT00486291|469201380|FG001|Overall Study|requirement for restricted medication|3|||
130336188|NCT00126490|469201381|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
130336189|NCT00975780|469201382|FG000|Follow Up|Death|88|||
130336190|NCT00975780|469201383|FG001|Follow Up|Death|122|||
130336191|NCT00975780|469201382|FG000|Follow Up|Facility Withdrawal|7|||
130336192|NCT00975780|469201383|FG001|Follow Up|Facility Withdrawal|23|||
130336193|NCT00975780|469201382|FG000|Follow Up|Discharged from Facility|7|||
130336194|NCT00975780|469201383|FG001|Follow Up|Discharged from Facility|12|||
130336195|NCT03051178|469201386|FG000|Overall Study|Withdrawal by Subject|5|||
130336196|NCT01598506|469201387|FG000|Overall Study|Withdrawal by Subject|2|||
130336197|NCT04080167|469201390|FG000|Overall Study|Lost to Follow-up-Patients|7|||
130336198|NCT04080167|469201391|FG001|Overall Study|Lost to Follow-up-Patients|14|||
130336199|NCT04080167|469201392|FG002|Overall Study|Lost to Follow-up-Patients|0|||
130336200|NCT04080167|469201390|FG000|Overall Study|Lost to Follow-up-Providers|2|||
130336201|NCT04080167|469201391|FG001|Overall Study|Lost to Follow-up-Providers|2|||
130336202|NCT04080167|469201392|FG002|Overall Study|Lost to Follow-up-Providers|0|||
130336203|NCT04080167|469201390|FG000|Overall Study|Withdrawal by Subject|1|||
130336204|NCT04080167|469201391|FG001|Overall Study|Withdrawal by Subject|2|||
130336205|NCT04080167|469201392|FG002|Overall Study|Withdrawal by Subject|0|||
130336206|NCT04080167|469201390|FG000|Overall Study|Withdrawal by Provider|0|||
130336207|NCT04080167|469201391|FG001|Overall Study|Withdrawal by Provider|0|||
130336208|NCT04080167|469201392|FG002|Overall Study|Withdrawal by Provider|4|||
130336209|NCT04080167|469201390|FG000|Overall Study|Death-Patient|2|||
130336210|NCT04080167|469201391|FG001|Overall Study|Death-Patient|1|||
130336211|NCT04080167|469201392|FG002|Overall Study|Death-Patient|0|||
130336212|NCT04080167|469201390|FG000|Overall Study|Hydroxyurea New Starts|0|||
130336213|NCT04080167|469201391|FG001|Overall Study|Hydroxyurea New Starts|0|||
130336214|NCT04080167|469201392|FG002|Overall Study|Hydroxyurea New Starts|1|||
130336215|NCT04080167|469201390|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
130336216|NCT04080167|469201391|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
130336217|NCT04080167|469201392|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
130336218|NCT00312195|469201393|FG000|Overall Study|Adverse Event|4|||
130336219|NCT00312195|469201394|FG001|Overall Study|Adverse Event|6|||
130336220|NCT00312195|469201393|FG000|Overall Study|Lost to Follow-up|1|||
130336221|NCT00312195|469201394|FG001|Overall Study|Lost to Follow-up|0|||
130336222|NCT00312195|469201393|FG000|Overall Study|Protocol Violation|1|||
130336223|NCT00312195|469201394|FG001|Overall Study|Protocol Violation|0|||
130336224|NCT02511106|469201395|FG000|Overall Study|Lost to Follow-up|6|||
130336225|NCT02511106|469201396|FG001|Overall Study|Lost to Follow-up|4|||
130336226|NCT02511106|469201395|FG000|Overall Study|Withdrawal by Subject|24|||
130336227|NCT02511106|469201396|FG001|Overall Study|Withdrawal by Subject|21|||
130670231|NCT02826603|470418247|FG000|Overall Study|Withdrawal by Subject|20|||
130670232|NCT02826603|470418248|FG001|Overall Study|Withdrawal by Subject|19|||
130670233|NCT02826603|470418247|FG000|Overall Study|Death|2|||
130670234|NCT02826603|470418248|FG001|Overall Study|Death|0|||
130670235|NCT02826603|470418247|FG000|Overall Study|New therapy for study indication|0|||
130670236|NCT02826603|470418248|FG001|Overall Study|New therapy for study indication|1|||
130336228|NCT02511106|469201395|FG000|Overall Study|Death|42|||
130336229|NCT02511106|469201396|FG001|Overall Study|Death|82|||
130336230|NCT02511106|469201395|FG000|Overall Study|Ongoing study at data cut-off|3|||
130670237|NCT01337050|470418254|FG000|Overall Study|Death|0|||
130670238|NCT01337050|470418255|FG001|Overall Study|Death|0|||
130336231|NCT02511106|469201396|FG001|Overall Study|Ongoing study at data cut-off|2|||
130336232|NCT02511106|469201395|FG000|Overall Study|Without specified reason|3|||
130336233|NCT02511106|469201396|FG001|Overall Study|Without specified reason|0|||
130336234|NCT02657408|469201397|FG000|Overall Study|Adverse Event|3|||
130336235|NCT02657408|469201398|FG001|Overall Study|Adverse Event|7|||
130336236|NCT00324961|469201401|FG000|Overall Study|Adverse Event|5|||
130336237|NCT00324961|469201401|FG000|Overall Study|Consent Withdrawn|11|||
130670239|NCT01337050|470418256|FG002|Overall Study|Death|4|||
130670240|NCT01337050|470418254|FG000|Overall Study|Other|4|||
130670241|NCT01337050|470418255|FG001|Overall Study|Other|6|||
130670242|NCT01337050|470418256|FG002|Overall Study|Other|8|||
130670243|NCT01337050|470418254|FG000|Overall Study|Participants refused further follow-up|0|||
130670244|NCT01337050|470418255|FG001|Overall Study|Participants refused further follow-up|7|||
130670245|NCT01337050|470418256|FG002|Overall Study|Participants refused further follow-up|7|||
130670246|NCT00003102|470418257|FG000|Overall Study|Physician Decision|1|||
130670247|NCT00003102|470418258|FG001|Overall Study|Physician Decision|1|||
130670248|NCT00003102|470418259|FG002|Overall Study|Physician Decision|0|||
130670249|NCT00003102|470418257|FG000|Overall Study|Progressive Disease|0|||
130670250|NCT00003102|470418258|FG001|Overall Study|Progressive Disease|1|||
130670251|NCT00003102|470418259|FG002|Overall Study|Progressive Disease|0|||
130670252|NCT00003102|470418257|FG000|Overall Study|Adverse Event|0|||
130670253|NCT00003102|470418258|FG001|Overall Study|Adverse Event|1|||
130670254|NCT00003102|470418259|FG002|Overall Study|Adverse Event|1|||
130670255|NCT00003102|470418257|FG000|Overall Study|Death|0|||
130670256|NCT00003102|470418258|FG001|Overall Study|Death|0|||
130670257|NCT00003102|470418259|FG002|Overall Study|Death|1|||
130670258|NCT00583596|470418260|FG000|Overall Study|Lost to Follow-up|110|||
130670259|NCT00583596|470418260|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
130670260|NCT00583596|470418260|FG000|Overall Study|Death|2|||
130670261|NCT00583596|470418260|FG000|Overall Study|Withdrawal by Subject|6|||
130670262|NCT00583596|470418260|FG000|Overall Study|Lost to Follow-up|94|||
130670263|NCT00583596|470418260|FG000|Overall Study|Data not complete|1|||
130670264|NCT00583596|470418260|FG000|Overall Study|Not consented|15|||
130670265|NCT00583596|470418260|FG000|Overall Study|Outside f-up window|26|||
130670266|NCT00656019|470418261|FG000|Overall Study|Not Eligible|10|||
130670267|NCT00656019|470418262|FG001|Overall Study|Not Eligible|0|||
130670268|NCT00656019|470418263|FG002|Overall Study|Not Eligible|0|||
130670269|NCT00656019|470418264|FG003|Overall Study|Not Eligible|0|||
130670270|NCT00656019|470418261|FG000|Overall Study|Withdrawal by Subject|2|||
130670271|NCT00656019|470418262|FG001|Overall Study|Withdrawal by Subject|0|||
130670272|NCT00656019|470418263|FG002|Overall Study|Withdrawal by Subject|0|||
130670273|NCT00656019|470418264|FG003|Overall Study|Withdrawal by Subject|0|||
130670274|NCT00656019|470418261|FG000|Overall Study|Lost to Follow-up|2|||
130670275|NCT00656019|470418262|FG001|Overall Study|Lost to Follow-up|1|||
130670276|NCT00656019|470418263|FG002|Overall Study|Lost to Follow-up|0|||
130670277|NCT00656019|470418264|FG003|Overall Study|Lost to Follow-up|0|||
130670278|NCT00096486|470418269|FG000|Overall Study|Withdrawal by Subject|0|||
130670279|NCT00096486|470418270|FG001|Overall Study|Withdrawal by Subject|0|||
130670280|NCT00096486|470418271|FG002|Overall Study|Withdrawal by Subject|1|||
130670281|NCT00096486|470418272|FG003|Overall Study|Withdrawal by Subject|1|||
130670282|NCT00096486|470418269|FG000|Overall Study|Not Treated|0|||
130670283|NCT00096486|470418270|FG001|Overall Study|Not Treated|0|||
130670284|NCT00096486|470418271|FG002|Overall Study|Not Treated|1|||
130670285|NCT00096486|470418272|FG003|Overall Study|Not Treated|1|||
130670286|NCT00895583|470418273|FG000|Overall Study|Adverse Event|28|||
130670287|NCT00895583|470418274|FG001|Overall Study|Adverse Event|4|||
130670288|NCT00895583|470418273|FG000|Overall Study|Death|2|||
130670289|NCT00895583|470418274|FG001|Overall Study|Death|1|||
130670290|NCT00895583|470418273|FG000|Overall Study|Physician Decision|3|||
130670291|NCT00895583|470418274|FG001|Overall Study|Physician Decision|1|||
130670292|NCT00895583|470418273|FG000|Overall Study|Lost to Follow-up|1|||
130670293|NCT00895583|470418274|FG001|Overall Study|Lost to Follow-up|3|||
130670294|NCT00895583|470418273|FG000|Overall Study|Protocol Violation|1|||
130670295|NCT00895583|470418274|FG001|Overall Study|Protocol Violation|0|||
130670296|NCT00895583|470418273|FG000|Overall Study|Withdrawal by Subject|4|||
130670297|NCT00895583|470418274|FG001|Overall Study|Withdrawal by Subject|2|||
130670298|NCT00895583|470418273|FG000|Overall Study|Lack of Efficacy|5|||
130670299|NCT00895583|470418274|FG001|Overall Study|Lack of Efficacy|0|||
130670300|NCT00895583|470418273|FG000|Overall Study|Other|0|||
130670301|NCT00895583|470418274|FG001|Overall Study|Other|1|||
130670302|NCT04535583|470418275|FG000|Overall Study|Lost to Follow-up|1|||
130670303|NCT04535583|470418275|FG000|Overall Study|Physician Decision|1|||
130670304|NCT04535583|470418275|FG000|Overall Study|Withdrawal by Subject|1|||
130670305|NCT01078090|470418276|FG000|Overall Study|Lost to Follow-up|2363|||
130670306|NCT01078090|470418276|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
130670307|NCT01078090|470418276|FG000|Overall Study|Lack of Efficacy|1193|||
130670308|NCT01078090|470418276|FG000|Overall Study|ADR and lack of efficacy|61|||
130670309|NCT01078090|470418276|FG000|Overall Study|Other|523|||
130670310|NCT04049552|470418278|FG000|Overall Study|Lost to Follow-up|1|||
130670311|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
130670312|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
130670313|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
130670314|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
130670315|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
130670316|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Adverse Event|60|||
130670317|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Adverse Event|0|||
130670318|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Adverse Event|0|||
130670319|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Adverse Event|0|||
130670320|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Adverse Event|0|||
130336238|NCT00324961|469201401|FG000|Overall Study|Lost to Follow-up|22|||
130336239|NCT00324961|469201401|FG000|Overall Study|Protocol Violation|3|||
130336240|NCT00324961|469201401|FG000|Overall Study|Other|2|||
130336241|NCT00344487|469201402|FG000|Overall Study|immunologic failure|1|||
130670321|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
130670322|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130670323|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130670324|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130670325|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130670326|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Physician Decision|10|||
130670327|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Physician Decision|0|||
130670328|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Physician Decision|0|||
130670329|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Physician Decision|0|||
130670330|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Physician Decision|0|||
130670331|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
130670332|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130670333|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130670334|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130670335|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130670336|NCT01360632|470418284|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
130670337|NCT01360632|470418285|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
130670338|NCT01360632|470418286|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
130670339|NCT01360632|470418287|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
130670340|NCT01360632|470418288|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
130670341|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
130670342|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
130670343|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
130670344|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
130670345|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
130670346|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Adverse Event|0|||
130670347|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Adverse Event|3|||
130670348|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Adverse Event|9|||
130670349|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Adverse Event|3|||
130670350|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Adverse Event|0|||
130670351|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130670352|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130670353|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
130670354|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
130670355|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130670356|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Physician Decision|0|||
130670357|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Physician Decision|0|||
130670358|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Physician Decision|0|||
130670359|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Physician Decision|1|||
130670360|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Physician Decision|0|||
130670361|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130670362|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
130670363|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
130670364|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
130670365|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130670366|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
130670367|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
130670368|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
130670369|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
130670370|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
130670371|NCT01360632|470418284|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
130670372|NCT01360632|470418285|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
130670373|NCT01360632|470418286|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
130670374|NCT01360632|470418287|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
130670375|NCT01360632|470418288|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
130670376|NCT01360632|470418284|FG000|Phase A+|Lost to Follow-up|0|||
130670377|NCT01360632|470418285|FG001|Phase A+|Lost to Follow-up|0|||
130670378|NCT01360632|470418286|FG002|Phase A+|Lost to Follow-up|0|||
130670379|NCT01360632|470418287|FG003|Phase A+|Lost to Follow-up|0|||
130670380|NCT01360632|470418288|FG004|Phase A+|Lost to Follow-up|2|||
130670381|NCT01360632|470418284|FG000|Phase A+|Adverse Event|0|||
130670382|NCT01360632|470418285|FG001|Phase A+|Adverse Event|0|||
130670383|NCT01360632|470418286|FG002|Phase A+|Adverse Event|0|||
130670384|NCT01360632|470418287|FG003|Phase A+|Adverse Event|0|||
130670385|NCT01360632|470418288|FG004|Phase A+|Adverse Event|2|||
130336242|NCT01459497|469201406|FG000|Overall Study|Inability to meet trial constraints.|1|||
130670386|NCT01360632|470418284|FG000|Phase A+|Met Withdrawal Criteria|0|||
130670387|NCT01360632|470418285|FG001|Phase A+|Met Withdrawal Criteria|0|||
130670388|NCT01360632|470418286|FG002|Phase A+|Met Withdrawal Criteria|0|||
130670389|NCT01360632|470418287|FG003|Phase A+|Met Withdrawal Criteria|0|||
130670390|NCT01360632|470418288|FG004|Phase A+|Met Withdrawal Criteria|7|||
130670391|NCT01360632|470418284|FG000|Phase A+|Physician Decision|0|||
130336243|NCT01459497|469201407|FG001|Overall Study|Inability to meet trial constraints.|0|||
130670392|NCT01360632|470418285|FG001|Phase A+|Physician Decision|0|||
130670393|NCT01360632|470418286|FG002|Phase A+|Physician Decision|0|||
130670394|NCT01360632|470418287|FG003|Phase A+|Physician Decision|0|||
130670395|NCT01360632|470418288|FG004|Phase A+|Physician Decision|3|||
130670396|NCT01360632|470418284|FG000|Phase A+|Withdrawal by Subject|0|||
130670397|NCT01360632|470418285|FG001|Phase A+|Withdrawal by Subject|0|||
130670398|NCT01360632|470418286|FG002|Phase A+|Withdrawal by Subject|0|||
130670399|NCT01360632|470418287|FG003|Phase A+|Withdrawal by Subject|0|||
130670400|NCT01360632|470418288|FG004|Phase A+|Withdrawal by Subject|8|||
130670401|NCT01360632|470418284|FG000|Phase A+|Protocol Deviation|0|||
130670402|NCT01360632|470418285|FG001|Phase A+|Protocol Deviation|0|||
130670403|NCT01360632|470418286|FG002|Phase A+|Protocol Deviation|0|||
130670404|NCT01360632|470418287|FG003|Phase A+|Protocol Deviation|0|||
130670405|NCT01360632|470418288|FG004|Phase A+|Protocol Deviation|3|||
130670406|NCT02173301|470418289|FG000|Overall Study|Adverse Event|7|||
130670407|NCT02173301|470418290|FG001|Overall Study|Adverse Event|8|||
130670408|NCT02173301|470418291|FG002|Overall Study|Adverse Event|13|||
130670409|NCT02173301|470418292|FG003|Overall Study|Adverse Event|5|||
130670410|NCT02173301|470418289|FG000|Overall Study|Withdrawal by Subject|8|||
130670411|NCT02173301|470418290|FG001|Overall Study|Withdrawal by Subject|10|||
130670412|NCT02173301|470418291|FG002|Overall Study|Withdrawal by Subject|4|||
130670413|NCT02173301|470418292|FG003|Overall Study|Withdrawal by Subject|8|||
130670414|NCT02173301|470418289|FG000|Overall Study|Lost to Follow-up|4|||
130670415|NCT02173301|470418290|FG001|Overall Study|Lost to Follow-up|4|||
130670416|NCT02173301|470418291|FG002|Overall Study|Lost to Follow-up|2|||
130670417|NCT02173301|470418292|FG003|Overall Study|Lost to Follow-up|2|||
130670418|NCT02173301|470418289|FG000|Overall Study|Protocol Violation|0|||
130670419|NCT02173301|470418290|FG001|Overall Study|Protocol Violation|1|||
130670420|NCT02173301|470418291|FG002|Overall Study|Protocol Violation|0|||
130670421|NCT02173301|470418292|FG003|Overall Study|Protocol Violation|0|||
130670422|NCT02173301|470418289|FG000|Overall Study|Physician Decision|0|||
130670423|NCT02173301|470418290|FG001|Overall Study|Physician Decision|0|||
130670424|NCT02173301|470418291|FG002|Overall Study|Physician Decision|1|||
130670425|NCT02173301|470418292|FG003|Overall Study|Physician Decision|0|||
130670426|NCT02173301|470418289|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
130670427|NCT02173301|470418290|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130670428|NCT02173301|470418291|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130670429|NCT02173301|470418292|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130670430|NCT03016078|470418293|FG000|Overall Study|Protocol Violation|1|||
130670431|NCT03016078|470418293|FG000|Overall Study|Protocol Violation|1|||
130670432|NCT02123459|470418296|FG000|Washout Period (1 Day)|Adverse Event|1|||
130670433|NCT02123459|470418297|FG001|Washout Period (1 Day)|Adverse Event|0|||
130670434|NCT02196506|470418302|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
130670435|NCT02196506|470418303|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
130670436|NCT02196506|470418304|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
130670437|NCT02196506|470418305|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
130670438|NCT02196506|470418302|FG000|Phase A|Withdrawal by Subject|34|||
130670439|NCT02196506|470418303|FG001|Phase A|Withdrawal by Subject|0|||
130670440|NCT02196506|470418304|FG002|Phase A|Withdrawal by Subject|0|||
130670441|NCT02196506|470418305|FG003|Phase A|Withdrawal by Subject|0|||
130670442|NCT02196506|470418302|FG000|Phase A|Adverse Event|22|||
130670443|NCT02196506|470418303|FG001|Phase A|Adverse Event|0|||
130670444|NCT02196506|470418304|FG002|Phase A|Adverse Event|0|||
130670445|NCT02196506|470418305|FG003|Phase A|Adverse Event|0|||
130670446|NCT02196506|470418302|FG000|Phase A|Lost to Follow-up|9|||
130670447|NCT02196506|470418303|FG001|Phase A|Lost to Follow-up|0|||
130670448|NCT02196506|470418304|FG002|Phase A|Lost to Follow-up|0|||
130670449|NCT02196506|470418305|FG003|Phase A|Lost to Follow-up|0|||
130670450|NCT02196506|470418302|FG000|Phase A|Protocol deviation|12|||
130670451|NCT02196506|470418303|FG001|Phase A|Protocol deviation|0|||
130336244|NCT01459497|469201406|FG000|Overall Study|Physician Decision|1|||
130336245|NCT01459497|469201407|FG001|Overall Study|Physician Decision|1|||
130336246|NCT01459497|469201406|FG000|Overall Study|Hospitalization.|0|||
130336247|NCT01459497|469201407|FG001|Overall Study|Hospitalization.|3|||
130670452|NCT02196506|470418304|FG002|Phase A|Protocol deviation|0|||
130670453|NCT02196506|470418305|FG003|Phase A|Protocol deviation|0|||
130670454|NCT02196506|470418302|FG000|Phase A|Participant withdrawn by investigator|10|||
130670455|NCT02196506|470418303|FG001|Phase A|Participant withdrawn by investigator|0|||
130670456|NCT02196506|470418304|FG002|Phase A|Participant withdrawn by investigator|0|||
130336248|NCT01459497|469201406|FG000|Overall Study|Disease progression.|0|||
130670457|NCT02196506|470418305|FG003|Phase A|Participant withdrawn by investigator|0|||
130670458|NCT02196506|470418302|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
130670459|NCT02196506|470418303|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
130670460|NCT02196506|470418304|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
130670461|NCT02196506|470418305|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
130670462|NCT02196506|470418302|FG000|Phase B|Lack of Efficacy|0|||
130336249|NCT01459497|469201407|FG001|Overall Study|Disease progression.|1|||
130336250|NCT03530124|469201410|FG000|Overall Study|Withdrawal by Subject|0|||
130336251|NCT03530124|469201411|FG001|Overall Study|Withdrawal by Subject|1|||
130336252|NCT03530124|469201410|FG000|Overall Study|Protocol Violation|1|||
130336253|NCT03530124|469201411|FG001|Overall Study|Protocol Violation|0|||
130336254|NCT03530124|469201410|FG000|Overall Study|Discharged prior to study completion|1|||
130336255|NCT03530124|469201411|FG001|Overall Study|Discharged prior to study completion|0|||
130336256|NCT05343624|469201412|FG000|Overall Study|Chart review not completed|1|||
130336257|NCT00862082|469201413|FG000|Overall Study|Sponsor decision to terminate the study|5|||
130336258|NCT00862082|469201414|FG001|Overall Study|Sponsor decision to terminate the study|0|||
130336259|NCT00862082|469201413|FG000|Overall Study|Withdrawal by Subject|0|||
130336260|NCT00862082|469201414|FG001|Overall Study|Withdrawal by Subject|1|||
130336261|NCT02447302|469201426|FG000|Overall Study|Physician Decision|1|||
130336262|NCT02447302|469201427|FG001|Overall Study|Physician Decision|0|||
130336263|NCT02447302|469201428|FG002|Overall Study|Physician Decision|0|||
130336264|NCT02447302|469201426|FG000|Overall Study|Adverse Event|4|||
130336265|NCT02447302|469201427|FG001|Overall Study|Adverse Event|3|||
130336266|NCT02447302|469201428|FG002|Overall Study|Adverse Event|0|||
130336267|NCT02447302|469201426|FG000|Overall Study|Withdrawal by Subject|0|||
130336268|NCT02447302|469201427|FG001|Overall Study|Withdrawal by Subject|1|||
130336269|NCT02447302|469201428|FG002|Overall Study|Withdrawal by Subject|5|||
130336270|NCT02447302|469201426|FG000|Overall Study|Sponsor Decision|0|||
130336271|NCT02447302|469201427|FG001|Overall Study|Sponsor Decision|0|||
130336272|NCT02447302|469201428|FG002|Overall Study|Sponsor Decision|1|||
130336273|NCT01456897|469201431|FG000|Overall Study|Adverse Event|19|||
130336274|NCT01456897|469201432|FG001|Overall Study|Adverse Event|22|||
130336275|NCT01456897|469201431|FG000|Overall Study|Protocol Violation|3|||
130336276|NCT01456897|469201432|FG001|Overall Study|Protocol Violation|4|||
130336277|NCT01456897|469201431|FG000|Overall Study|Physician Decision|5|||
130336278|NCT01456897|469201432|FG001|Overall Study|Physician Decision|3|||
130336279|NCT01456897|469201431|FG000|Overall Study|Withdrawal by Subject|44|||
130336280|NCT01456897|469201432|FG001|Overall Study|Withdrawal by Subject|17|||
130336281|NCT01456897|469201431|FG000|Overall Study|Lack of Efficacy|4|||
130336282|NCT01456897|469201432|FG001|Overall Study|Lack of Efficacy|11|||
130336283|NCT01396070|469201438|FG000|Overall Study|Withdrawal by Subject|2|||
130336284|NCT01396070|469201438|FG000|Overall Study|Death|2|||
130336285|NCT01396070|469201438|FG000|Overall Study|Adverse Event|8|||
130336286|NCT01396070|469201438|FG000|Overall Study|Physician Decision|3|||
130336287|NCT01396070|469201438|FG000|Overall Study|Lack of Efficacy|4|||
130336288|NCT02152956|469201440|FG000|Overall Study|Adverse Event|0|||
130336289|NCT02152956|469201441|FG001|Overall Study|Adverse Event|0|||
130336290|NCT02152956|469201442|FG002|Overall Study|Adverse Event|0|||
130336291|NCT02152956|469201443|FG003|Overall Study|Adverse Event|0|||
130336292|NCT02152956|469201444|FG004|Overall Study|Adverse Event|0|||
130336293|NCT02152956|469201445|FG005|Overall Study|Adverse Event|0|||
130336294|NCT02152956|469201446|FG006|Overall Study|Adverse Event|0|||
130670463|NCT02196506|470418303|FG001|Phase B|Lack of Efficacy|1|||
130670464|NCT02196506|470418304|FG002|Phase B|Lack of Efficacy|2|||
130670465|NCT02196506|470418305|FG003|Phase B|Lack of Efficacy|0|||
130670466|NCT02196506|470418302|FG000|Phase B|Withdrawal by Participant|0|||
130670467|NCT02196506|470418303|FG001|Phase B|Withdrawal by Participant|8|||
130670468|NCT02196506|470418304|FG002|Phase B|Withdrawal by Participant|1|||
130670469|NCT02196506|470418305|FG003|Phase B|Withdrawal by Participant|0|||
130670470|NCT02196506|470418302|FG000|Phase B|Adverse Event|0|||
130670471|NCT02196506|470418303|FG001|Phase B|Adverse Event|4|||
130670472|NCT02196506|470418304|FG002|Phase B|Adverse Event|1|||
130670473|NCT02196506|470418305|FG003|Phase B|Adverse Event|0|||
130670474|NCT02196506|470418302|FG000|Phase B|Lost to Follow-up|0|||
130670475|NCT02196506|470418303|FG001|Phase B|Lost to Follow-up|2|||
130670476|NCT02196506|470418304|FG002|Phase B|Lost to Follow-up|1|||
130670477|NCT02196506|470418305|FG003|Phase B|Lost to Follow-up|0|||
130670478|NCT02196506|470418302|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
130336295|NCT02152956|469201447|FG007|Overall Study|Adverse Event|0|||
130336296|NCT02152956|469201448|FG008|Overall Study|Adverse Event|0|||
130336297|NCT02152956|469201449|FG009|Overall Study|Adverse Event|0|||
130336298|NCT02152956|469201450|FG010|Overall Study|Adverse Event|0|||
130336299|NCT02152956|469201451|FG011|Overall Study|Adverse Event|4|||
130336300|NCT02152956|469201452|FG012|Overall Study|Adverse Event|0|||
130336301|NCT02152956|469201440|FG000|Overall Study|Death|0|||
130336302|NCT02152956|469201441|FG001|Overall Study|Death|3|||
130670479|NCT02196506|470418303|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
130336303|NCT02152956|469201442|FG002|Overall Study|Death|3|||
130336304|NCT02152956|469201443|FG003|Overall Study|Death|4|||
130336305|NCT02152956|469201444|FG004|Overall Study|Death|1|||
130336306|NCT02152956|469201445|FG005|Overall Study|Death|2|||
130336307|NCT02152956|469201446|FG006|Overall Study|Death|6|||
130670480|NCT02196506|470418304|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
130670481|NCT02196506|470418305|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
130670482|NCT02196506|470418302|FG000|Phase A+|Withdrawal by Participant|0|||
130670483|NCT02196506|470418303|FG001|Phase A+|Withdrawal by Participant|0|||
130670484|NCT02196506|470418304|FG002|Phase A+|Withdrawal by Participant|0|||
130670485|NCT02196506|470418305|FG003|Phase A+|Withdrawal by Participant|5|||
130670486|NCT02196506|470418302|FG000|Phase A+|Adverse Event|0|||
130670487|NCT02196506|470418303|FG001|Phase A+|Adverse Event|0|||
130670488|NCT02196506|470418304|FG002|Phase A+|Adverse Event|0|||
130670489|NCT02196506|470418305|FG003|Phase A+|Adverse Event|1|||
130670490|NCT02196506|470418302|FG000|Phase A+|Lost to Follow-up|0|||
130670491|NCT02196506|470418303|FG001|Phase A+|Lost to Follow-up|0|||
130670492|NCT02196506|470418304|FG002|Phase A+|Lost to Follow-up|0|||
130670493|NCT02196506|470418305|FG003|Phase A+|Lost to Follow-up|6|||
130670494|NCT02196506|470418302|FG000|Phase A+|Participant withdrawn by investigator|0|||
130670495|NCT02196506|470418303|FG001|Phase A+|Participant withdrawn by investigator|0|||
130670496|NCT02196506|470418304|FG002|Phase A+|Participant withdrawn by investigator|0|||
130670497|NCT02196506|470418305|FG003|Phase A+|Participant withdrawn by investigator|1|||
130670498|NCT00254397|470418306|FG000|Overall Study|Disease Progression|4|||
130670499|NCT00254397|470418307|FG001|Overall Study|Disease Progression|1|||
130670500|NCT00254397|470418308|FG002|Overall Study|Disease Progression|16|||
130670501|NCT00254397|470418309|FG003|Overall Study|Disease Progression|23|||
130670502|NCT00254397|470418306|FG000|Overall Study|Non-Compliant|0|||
130670503|NCT00254397|470418307|FG001|Overall Study|Non-Compliant|0|||
130670504|NCT00254397|470418308|FG002|Overall Study|Non-Compliant|0|||
130670505|NCT00254397|470418309|FG003|Overall Study|Non-Compliant|1|||
130670506|NCT00254397|470418306|FG000|Overall Study|Adverse Event|2|||
130670507|NCT00254397|470418307|FG001|Overall Study|Adverse Event|0|||
130670508|NCT00254397|470418308|FG002|Overall Study|Adverse Event|3|||
130670509|NCT00254397|470418309|FG003|Overall Study|Adverse Event|1|||
130670510|NCT01715415|470418321|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
130670511|NCT01715415|470418322|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
130670512|NCT01715415|470418321|FG000|Double-blind Treatment|Adverse Event|3|||
130670513|NCT01715415|470418322|FG001|Double-blind Treatment|Adverse Event|0|||
130670514|NCT01715415|470418321|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
130670515|NCT01715415|470418322|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
130670516|NCT01715415|470418321|FG000|Double-blind Treatment|Other|1|||
130670517|NCT01715415|470418322|FG001|Double-blind Treatment|Other|0|||
130670518|NCT01715415|470418321|FG000|Open-label Treatment|Adverse Event|0|||
130336308|NCT02152956|469201447|FG007|Overall Study|Death|6|||
130336309|NCT02152956|469201448|FG008|Overall Study|Death|4|||
130336310|NCT02152956|469201449|FG009|Overall Study|Death|5|||
130336311|NCT02152956|469201450|FG010|Overall Study|Death|3|||
130336312|NCT02152956|469201451|FG011|Overall Study|Death|143|||
130336313|NCT02152956|469201452|FG012|Overall Study|Death|12|||
130336314|NCT02152956|469201440|FG000|Overall Study|Lost to Follow-up|0|||
130336315|NCT02152956|469201441|FG001|Overall Study|Lost to Follow-up|1|||
130336316|NCT02152956|469201442|FG002|Overall Study|Lost to Follow-up|0|||
130336317|NCT02152956|469201443|FG003|Overall Study|Lost to Follow-up|0|||
130336318|NCT02152956|469201444|FG004|Overall Study|Lost to Follow-up|0|||
130336319|NCT02152956|469201445|FG005|Overall Study|Lost to Follow-up|0|||
130336320|NCT02152956|469201446|FG006|Overall Study|Lost to Follow-up|0|||
130336321|NCT02152956|469201447|FG007|Overall Study|Lost to Follow-up|0|||
130336322|NCT02152956|469201448|FG008|Overall Study|Lost to Follow-up|0|||
130336323|NCT02152956|469201449|FG009|Overall Study|Lost to Follow-up|0|||
130336324|NCT02152956|469201450|FG010|Overall Study|Lost to Follow-up|0|||
130336325|NCT02152956|469201451|FG011|Overall Study|Lost to Follow-up|3|||
130336326|NCT02152956|469201452|FG012|Overall Study|Lost to Follow-up|0|||
130336327|NCT02152956|469201440|FG000|Overall Study|Withdrawal by Subject|1|||
130336328|NCT02152956|469201441|FG001|Overall Study|Withdrawal by Subject|0|||
130336329|NCT02152956|469201442|FG002|Overall Study|Withdrawal by Subject|1|||
130336330|NCT02152956|469201443|FG003|Overall Study|Withdrawal by Subject|0|||
130336331|NCT02152956|469201444|FG004|Overall Study|Withdrawal by Subject|2|||
130336332|NCT02152956|469201445|FG005|Overall Study|Withdrawal by Subject|2|||
130336333|NCT02152956|469201446|FG006|Overall Study|Withdrawal by Subject|0|||
130336334|NCT02152956|469201447|FG007|Overall Study|Withdrawal by Subject|0|||
130336335|NCT02152956|469201448|FG008|Overall Study|Withdrawal by Subject|1|||
130336336|NCT02152956|469201449|FG009|Overall Study|Withdrawal by Subject|0|||
130336337|NCT02152956|469201450|FG010|Overall Study|Withdrawal by Subject|0|||
130336338|NCT02152956|469201451|FG011|Overall Study|Withdrawal by Subject|4|||
130336339|NCT02152956|469201452|FG012|Overall Study|Withdrawal by Subject|0|||
130336340|NCT02152956|469201440|FG000|Overall Study|Physician Decision|0|||
130336341|NCT02152956|469201441|FG001|Overall Study|Physician Decision|0|||
130336342|NCT02152956|469201442|FG002|Overall Study|Physician Decision|0|||
130336343|NCT02152956|469201443|FG003|Overall Study|Physician Decision|0|||
130336344|NCT02152956|469201444|FG004|Overall Study|Physician Decision|0|||
130670519|NCT01715415|470418322|FG001|Open-label Treatment|Adverse Event|1|||
130670520|NCT01715415|470418321|FG000|Open-label Treatment|Subject Noncompliant|0|||
130670521|NCT01715415|470418322|FG001|Open-label Treatment|Subject Noncompliant|1|||
130670522|NCT01015612|470418323|FG000|Overall Study|Death|113|||
130670523|NCT01015612|470418323|FG000|Overall Study|Withdrawal by Subject|40|||
130670524|NCT00066807|470418324|FG000|Overall Study|Study was terminated early|14|||
130670525|NCT00066807|470418325|FG001|Overall Study|Study was terminated early|15|||
130336345|NCT02152956|469201445|FG005|Overall Study|Physician Decision|0|||
130670526|NCT05028751|470418326|FG000|Overall Study|Study Terminated by Sponsor|3|||
130670527|NCT05028751|470418327|FG001|Overall Study|Study Terminated by Sponsor|0|||
130670528|NCT05028751|470418328|FG002|Overall Study|Study Terminated by Sponsor|0|||
130670529|NCT05028751|470418329|FG003|Overall Study|Study Terminated by Sponsor|0|||
130336346|NCT02152956|469201446|FG006|Overall Study|Physician Decision|0|||
130336347|NCT02152956|469201447|FG007|Overall Study|Physician Decision|0|||
130336348|NCT02152956|469201448|FG008|Overall Study|Physician Decision|0|||
130336349|NCT02152956|469201449|FG009|Overall Study|Physician Decision|0|||
130336350|NCT02152956|469201450|FG010|Overall Study|Physician Decision|0|||
130336351|NCT02152956|469201451|FG011|Overall Study|Physician Decision|1|||
130336352|NCT02152956|469201452|FG012|Overall Study|Physician Decision|0|||
130336353|NCT02152956|469201440|FG000|Overall Study|Study terminated by sponsor|0|||
130336354|NCT02152956|469201441|FG001|Overall Study|Study terminated by sponsor|0|||
130336355|NCT02152956|469201442|FG002|Overall Study|Study terminated by sponsor|0|||
130336356|NCT02152956|469201443|FG003|Overall Study|Study terminated by sponsor|0|||
130336357|NCT02152956|469201444|FG004|Overall Study|Study terminated by sponsor|0|||
130336358|NCT02152956|469201445|FG005|Overall Study|Study terminated by sponsor|0|||
130336359|NCT02152956|469201446|FG006|Overall Study|Study terminated by sponsor|0|||
130336360|NCT02152956|469201447|FG007|Overall Study|Study terminated by sponsor|0|||
130336361|NCT02152956|469201448|FG008|Overall Study|Study terminated by sponsor|0|||
130336362|NCT02152956|469201449|FG009|Overall Study|Study terminated by sponsor|0|||
130336363|NCT02152956|469201450|FG010|Overall Study|Study terminated by sponsor|0|||
130336364|NCT02152956|469201451|FG011|Overall Study|Study terminated by sponsor|29|||
130336365|NCT02152956|469201452|FG012|Overall Study|Study terminated by sponsor|0|||
130336366|NCT02152956|469201440|FG000|Overall Study|progressive disease|0|||
130336367|NCT02152956|469201441|FG001|Overall Study|progressive disease|0|||
130336368|NCT02152956|469201442|FG002|Overall Study|progressive disease|0|||
130336369|NCT02152956|469201443|FG003|Overall Study|progressive disease|0|||
130336370|NCT02152956|469201444|FG004|Overall Study|progressive disease|0|||
130336371|NCT02152956|469201445|FG005|Overall Study|progressive disease|0|||
130670530|NCT05028751|470418326|FG000|Overall Study|Death|9|||
130670531|NCT05028751|470418327|FG001|Overall Study|Death|3|||
130670532|NCT05028751|470418328|FG002|Overall Study|Death|2|||
130670533|NCT05028751|470418329|FG003|Overall Study|Death|4|||
130670534|NCT05028751|470418326|FG000|Overall Study|Withdrawal by Subject|0|||
130670535|NCT05028751|470418327|FG001|Overall Study|Withdrawal by Subject|0|||
130670536|NCT05028751|470418328|FG002|Overall Study|Withdrawal by Subject|1|||
130670537|NCT05028751|470418329|FG003|Overall Study|Withdrawal by Subject|0|||
130670538|NCT05028751|470418326|FG000|Overall Study|Miscellaneous|2|||
130670539|NCT05028751|470418327|FG001|Overall Study|Miscellaneous|0|||
130670540|NCT05028751|470418328|FG002|Overall Study|Miscellaneous|0|||
130670541|NCT05028751|470418329|FG003|Overall Study|Miscellaneous|0|||
130670542|NCT03586830|470418331|FG000|Overall Study|Site terminated by Sponsor|1|||
130670543|NCT03586830|470418332|FG001|Overall Study|Site terminated by Sponsor|4|||
130670544|NCT03586830|470418333|FG002|Overall Study|Site terminated by Sponsor|3|||
130670545|NCT03586830|470418334|FG003|Overall Study|Site terminated by Sponsor|3|||
130670546|NCT03586830|470418331|FG000|Overall Study|Lost to Follow-up|0|||
130670547|NCT03586830|470418332|FG001|Overall Study|Lost to Follow-up|2|||
130670548|NCT03586830|470418333|FG002|Overall Study|Lost to Follow-up|2|||
130670549|NCT03586830|470418334|FG003|Overall Study|Lost to Follow-up|1|||
130670550|NCT03586830|470418331|FG000|Overall Study|Withdrawal by Subject|1|||
130670551|NCT03586830|470418332|FG001|Overall Study|Withdrawal by Subject|0|||
130670552|NCT03586830|470418333|FG002|Overall Study|Withdrawal by Subject|3|||
130670553|NCT03586830|470418334|FG003|Overall Study|Withdrawal by Subject|1|||
130670554|NCT04578548|470418335|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130670555|NCT04578548|470418336|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130670556|NCT04578548|470418335|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
130670557|NCT04578548|470418336|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
130670558|NCT04578548|470418335|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
130670559|NCT04578548|470418336|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
130670560|NCT04578548|470418335|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
130336372|NCT02152956|469201446|FG006|Overall Study|progressive disease|0|||
130336373|NCT02152956|469201447|FG007|Overall Study|progressive disease|0|||
130336374|NCT02152956|469201448|FG008|Overall Study|progressive disease|1|||
130336375|NCT02152956|469201449|FG009|Overall Study|progressive disease|0|||
130336376|NCT02152956|469201450|FG010|Overall Study|progressive disease|0|||
130336377|NCT02152956|469201451|FG011|Overall Study|progressive disease|1|||
130336378|NCT02152956|469201452|FG012|Overall Study|progressive disease|0|||
130336379|NCT02445794|469201453|FG000|Overall Study|Adverse Event|0|||
130336380|NCT02445794|469201454|FG001|Overall Study|Adverse Event|0|||
130336381|NCT02445794|469201455|FG002|Overall Study|Adverse Event|2|||
130670561|NCT04578548|470418336|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
130670562|NCT04578548|470418335|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
130670563|NCT04578548|470418336|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
130670564|NCT04578548|470418335|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
130670565|NCT04578548|470418336|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
130670566|NCT00395083|470418339|FG000|Overall Study|Withdrawal by Subject|6|||
130670567|NCT00395083|470418340|FG001|Overall Study|Withdrawal by Subject|5|||
130670568|NCT00395083|470418339|FG000|Overall Study|Developed another disease|4|||
130670569|NCT00395083|470418340|FG001|Overall Study|Developed another disease|3|||
130670570|NCT00972153|470418341|FG000|Overall Study|Equipment malfunction during case|0|||
130670571|NCT00972153|470418342|FG001|Overall Study|Equipment malfunction during case|1|||
130670572|NCT00972153|470418343|FG002|Overall Study|Equipment malfunction during case|0|||
130670573|NCT04136626|470418344|FG000|Treatment Phase|Withdrawal by Subject|1|||
130670574|NCT04136626|470418345|FG001|Treatment Phase|Withdrawal by Subject|9|||
130670575|NCT04136626|470418344|FG000|Treatment Phase|Adverse Event|1|||
130336382|NCT02445794|469201456|FG003|Overall Study|Adverse Event|0|||
130336383|NCT01064947|469201458|FG000|Overall Study|negative culture|41|||
130336384|NCT04549545|469203413|FG000|Initial Period|Withdrawal by Subject|4|||
130336385|NCT04549545|469203414|FG001|Initial Period|Withdrawal by Subject|0|||
130336386|NCT04549545|469203413|FG000|Initial Period|Additional ENT Procedure|3|||
130336387|NCT04549545|469203414|FG001|Initial Period|Additional ENT Procedure|0|||
130336388|NCT04549545|469203413|FG000|Initial Period|Lost to Follow-up|3|||
130336389|NCT04549545|469203414|FG001|Initial Period|Lost to Follow-up|1|||
130336390|NCT04549545|469203413|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
130336391|NCT04549545|469203414|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
130336392|NCT04549545|469203413|FG000|Crossover Period|Additional ENT Procedure|0|||
130336393|NCT04549545|469203414|FG001|Crossover Period|Additional ENT Procedure|6|||
130336394|NCT04549545|469203413|FG000|Crossover Period|Lost to Follow-up|0|||
130336395|NCT04549545|469203414|FG001|Crossover Period|Lost to Follow-up|1|||
130336396|NCT04549545|469203413|FG000|Crossover Period|Withdrawal by Subject|0|||
130336397|NCT04549545|469203414|FG001|Crossover Period|Withdrawal by Subject|4|||
130336398|NCT01006291|469203415|FG000|Overall Study|Adverse Event|2|||
130336399|NCT01006291|469203416|FG001|Overall Study|Adverse Event|1|||
130336400|NCT01006291|469203417|FG002|Overall Study|Adverse Event|2|||
130670576|NCT04136626|470418345|FG001|Treatment Phase|Adverse Event|0|||
130670577|NCT04136626|470418344|FG000|Treatment Phase|Lost to Follow-up|1|||
130670578|NCT04136626|470418345|FG001|Treatment Phase|Lost to Follow-up|5|||
130670579|NCT04136626|470418344|FG000|12-month Follow-up|Lost to Follow-up|8|||
130670580|NCT04136626|470418345|FG001|12-month Follow-up|Lost to Follow-up|7|||
130670581|NCT00628745|470418346|FG000|Overall Study|Withdrawal by Subject|63|||
130670582|NCT00628745|470418347|FG001|Overall Study|Withdrawal by Subject|3|||
130670583|NCT00628745|470418348|FG002|Overall Study|Withdrawal by Subject|9|||
130670584|NCT00628745|470418349|FG003|Overall Study|Withdrawal by Subject|2|||
130670585|NCT00628745|470418350|FG004|Overall Study|Withdrawal by Subject|69|||
130670586|NCT00628745|470418346|FG000|Overall Study|Does not meet inclusion criteria|0|||
130670587|NCT00628745|470418347|FG001|Overall Study|Does not meet inclusion criteria|12|||
130670588|NCT00628745|470418348|FG002|Overall Study|Does not meet inclusion criteria|0|||
130670589|NCT00628745|470418349|FG003|Overall Study|Does not meet inclusion criteria|0|||
130670590|NCT00628745|470418350|FG004|Overall Study|Does not meet inclusion criteria|18|||
130670591|NCT00628745|470418346|FG000|Overall Study|Participation in an interventional clinical trial|81|||
130670592|NCT00628745|470418347|FG001|Overall Study|Participation in an interventional clinical trial|4|||
130670593|NCT00628745|470418348|FG002|Overall Study|Participation in an interventional clinical trial|7|||
130670594|NCT00628745|470418349|FG003|Overall Study|Participation in an interventional clinical trial|0|||
130670595|NCT00628745|470418350|FG004|Overall Study|Participation in an interventional clinical trial|63|||
130670596|NCT00628745|470418346|FG000|Overall Study|Physician Decision|8|||
130670597|NCT00628745|470418347|FG001|Overall Study|Physician Decision|4|||
130670598|NCT00628745|470418348|FG002|Overall Study|Physician Decision|3|||
130670599|NCT00628745|470418349|FG003|Overall Study|Physician Decision|0|||
130670600|NCT00628745|470418350|FG004|Overall Study|Physician Decision|30|||
130670601|NCT00628745|470418346|FG000|Overall Study|Lost to Follow-up|109|||
130670602|NCT00628745|470418347|FG001|Overall Study|Lost to Follow-up|7|||
130670603|NCT00628745|470418348|FG002|Overall Study|Lost to Follow-up|7|||
130670604|NCT00628745|470418349|FG003|Overall Study|Lost to Follow-up|0|||
130336401|NCT01006291|469203415|FG000|Overall Study|Lack of Efficacy|2|||
130336402|NCT01006291|469203416|FG001|Overall Study|Lack of Efficacy|2|||
130336403|NCT01006291|469203417|FG002|Overall Study|Lack of Efficacy|1|||
130336404|NCT01006291|469203415|FG000|Overall Study|Protocol Violation|3|||
130336405|NCT01006291|469203416|FG001|Overall Study|Protocol Violation|3|||
130336406|NCT01006291|469203417|FG002|Overall Study|Protocol Violation|3|||
130336407|NCT01006291|469203415|FG000|Overall Study|Withdrawal criteria|5|||
130336408|NCT01006291|469203416|FG001|Overall Study|Withdrawal criteria|4|||
130336409|NCT01006291|469203417|FG002|Overall Study|Withdrawal criteria|4|||
130336410|NCT01006291|469203415|FG000|Overall Study|Other|14|||
130670605|NCT00628745|470418350|FG004|Overall Study|Lost to Follow-up|498|||
130670606|NCT00628745|470418346|FG000|Overall Study|Death|197|||
130670607|NCT00628745|470418347|FG001|Overall Study|Death|81|||
130670608|NCT00628745|470418348|FG002|Overall Study|Death|12|||
130670609|NCT00628745|470418349|FG003|Overall Study|Death|4|||
130670610|NCT00628745|470418350|FG004|Overall Study|Death|939|||
130720921|NCT00724048|470601563|FG002|Overall Study|Lost to Follow-up|0|||
130336411|NCT01006291|469203416|FG001|Overall Study|Other|14|||
130336412|NCT01006291|469203417|FG002|Overall Study|Other|17|||
130336413|NCT03079102|469203418|FG000|Overall Study|Physician Decision|0|||
130336414|NCT03079102|469203419|FG001|Overall Study|Physician Decision|1|||
130336415|NCT02810444|469203420|FG000|Overall Study|Screen Failures|14|||
130336416|NCT02810444|469203420|FG000|Overall Study|Withdrawal by Subject|4|||
130670611|NCT00628745|470418346|FG000|Overall Study|Participant transferred to another THAOS site|6|||
130670612|NCT00628745|470418347|FG001|Overall Study|Participant transferred to another THAOS site|0|||
130336417|NCT02810444|469203420|FG000|Overall Study|Adverse Event|3|||
130336418|NCT02785770|469203421|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
130336419|NCT02785770|469203422|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
130336420|NCT02785770|469203423|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
130336421|NCT02785770|469203424|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
130670613|NCT00628745|470418348|FG002|Overall Study|Participant transferred to another THAOS site|0|||
130670614|NCT00628745|470418349|FG003|Overall Study|Participant transferred to another THAOS site|0|||
130670615|NCT00628745|470418350|FG004|Overall Study|Participant transferred to another THAOS site|7|||
130670616|NCT00628745|470418346|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
130670617|NCT00628745|470418347|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
130670618|NCT00628745|470418348|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
130670619|NCT00628745|470418349|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
130670620|NCT00628745|470418350|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
130670621|NCT00628745|470418346|FG000|Overall Study|Site closure|152|||
130670622|NCT00628745|470418347|FG001|Overall Study|Site closure|146|||
130670623|NCT00628745|470418348|FG002|Overall Study|Site closure|6|||
130670624|NCT00628745|470418349|FG003|Overall Study|Site closure|8|||
130670625|NCT00628745|470418350|FG004|Overall Study|Site closure|691|||
130670626|NCT00628745|470418346|FG000|Overall Study|Duplicate participant|0|||
130670627|NCT00628745|470418347|FG001|Overall Study|Duplicate participant|0|||
130670628|NCT00628745|470418348|FG002|Overall Study|Duplicate participant|0|||
130670629|NCT00628745|470418349|FG003|Overall Study|Duplicate participant|0|||
130670630|NCT00628745|470418350|FG004|Overall Study|Duplicate participant|1|||
130670631|NCT00628745|470418346|FG000|Overall Study|Missing|4|||
130670632|NCT00628745|470418347|FG001|Overall Study|Missing|3|||
130670633|NCT00628745|470418348|FG002|Overall Study|Missing|0|||
130670634|NCT00628745|470418349|FG003|Overall Study|Missing|0|||
130670635|NCT00628745|470418350|FG004|Overall Study|Missing|10|||
130670636|NCT00628745|470418346|FG000|Overall Study|Othe reasons|987|||
130670637|NCT00628745|470418347|FG001|Overall Study|Othe reasons|373|||
130670638|NCT00628745|470418348|FG002|Overall Study|Othe reasons|105|||
130670639|NCT00628745|470418349|FG003|Overall Study|Othe reasons|1|||
130670640|NCT00628745|470418350|FG004|Overall Study|Othe reasons|1772|||
130670641|NCT00982410|470420010|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
130670642|NCT00982410|470420011|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
130670643|NCT00982410|470420010|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
130670644|NCT00982410|470420011|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
130670645|NCT00982410|470420010|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
130670646|NCT00982410|470420011|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
130670647|NCT00982410|470420010|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
130670648|NCT00982410|470420011|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
130670649|NCT00982410|470420010|FG000|6-month Follow-up Assessment|participant no transportation|1|||
130336422|NCT02785770|469203421|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336423|NCT02785770|469203422|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336424|NCT02785770|469203423|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
130336425|NCT02785770|469203424|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336426|NCT02785770|469203421|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336427|NCT02785770|469203422|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336428|NCT02785770|469203423|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336429|NCT02785770|469203424|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
130336430|NCT04518995|469203425|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
130336431|NCT04518995|469203426|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
130336432|NCT04518995|469203427|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
130336433|NCT04518995|469203425|FG000|Overall Study|Lack of Efficacy|2|||
130336434|NCT04518995|469203426|FG001|Overall Study|Lack of Efficacy|1|||
130670650|NCT00982410|470420011|FG001|6-month Follow-up Assessment|participant no transportation|0|||
130670651|NCT00982410|470420010|FG000|6-month Follow-up Assessment|incarceration|0|||
130670652|NCT00982410|470420011|FG001|6-month Follow-up Assessment|incarceration|2|||
130670653|NCT00982410|470420010|FG000|6-month Follow-up Assessment|patent surgery|0|||
130670654|NCT00982410|470420011|FG001|6-month Follow-up Assessment|patent surgery|1|||
130336435|NCT04518995|469203427|FG002|Overall Study|Lack of Efficacy|0|||
130336436|NCT04518995|469203425|FG000|Overall Study|Non-compliance With Study Drug|0|||
130670655|NCT00982410|470420010|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
130670656|NCT00982410|470420011|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
130670657|NCT00982410|470420010|FG000|12-month Follow-up Assessment|Death|0|||
130670658|NCT00982410|470420011|FG001|12-month Follow-up Assessment|Death|2|||
130670659|NCT00982410|470420010|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
130670660|NCT00982410|470420011|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
130670661|NCT00982410|470420010|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
130670662|NCT00982410|470420011|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
130670663|NCT00982410|470420010|FG000|12-month Follow-up Assessment|incarceration|2|||
130670664|NCT00982410|470420011|FG001|12-month Follow-up Assessment|incarceration|1|||
130670665|NCT00982410|470420010|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
130670666|NCT00982410|470420011|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
130670667|NCT03322462|470420012|FG000|Overall Study|Technical difficulties|2|||
130670668|NCT03322462|470420012|FG000|Overall Study|Other|1|||
130670669|NCT02004847|470420013|FG000|Overall Study|Protocol Violation|1|||
130670670|NCT02004847|470420014|FG001|Overall Study|Protocol Violation|1|||
130670671|NCT02034799|470420015|FG000|Overall Study|Withdrawal by Subject|0|||
130670672|NCT02034799|470420016|FG001|Overall Study|Withdrawal by Subject|2|||
130670673|NCT02034799|470420015|FG000|Overall Study|Lost to Follow-up|0|||
130670674|NCT02034799|470420016|FG001|Overall Study|Lost to Follow-up|1|||
130670675|NCT02034799|470420015|FG000|Overall Study|Death|2|||
130670676|NCT02034799|470420016|FG001|Overall Study|Death|1|||
130670677|NCT00434161|470420025|FG000|Overall Study|Adverse Event|5|||
130670678|NCT00434161|470420026|FG001|Overall Study|Adverse Event|1|||
130670679|NCT00434161|470420027|FG002|Overall Study|Adverse Event|4|||
130670680|NCT00434161|470420025|FG000|Overall Study|Lost to Follow-up|0|||
130670681|NCT00434161|470420026|FG001|Overall Study|Lost to Follow-up|1|||
130670682|NCT00434161|470420027|FG002|Overall Study|Lost to Follow-up|0|||
130670683|NCT00434161|470420025|FG000|Overall Study|Death|1|||
130670684|NCT00434161|470420026|FG001|Overall Study|Death|0|||
130670685|NCT00434161|470420027|FG002|Overall Study|Death|1|||
130670686|NCT00434161|470420025|FG000|Overall Study|Non-Compliance|1|||
130670687|NCT00434161|470420026|FG001|Overall Study|Non-Compliance|1|||
130670688|NCT00434161|470420027|FG002|Overall Study|Non-Compliance|0|||
130670689|NCT00434161|470420025|FG000|Overall Study|Withdrawal by Subject|2|||
130670690|NCT00434161|470420026|FG001|Overall Study|Withdrawal by Subject|0|||
130670691|NCT00434161|470420027|FG002|Overall Study|Withdrawal by Subject|3|||
130670692|NCT00434161|470420025|FG000|Overall Study|Logistical error study assessments|1|||
130670693|NCT00434161|470420026|FG001|Overall Study|Logistical error study assessments|0|||
130670694|NCT00434161|470420027|FG002|Overall Study|Logistical error study assessments|3|||
130670695|NCT03342898|470420028|FG000|Overall Study|Adverse Event|3|||
130670696|NCT03342898|470420029|FG001|Overall Study|Adverse Event|1|||
130670697|NCT03342898|470420030|FG002|Overall Study|Adverse Event|0|||
130670698|NCT03342898|470420028|FG000|Overall Study|Lost to Follow-up|44|||
130670699|NCT03342898|470420029|FG001|Overall Study|Lost to Follow-up|40|||
130670700|NCT03342898|470420030|FG002|Overall Study|Lost to Follow-up|42|||
130670701|NCT03342898|470420028|FG000|Overall Study|Withdrawal of Consent|5|||
130670702|NCT03342898|470420029|FG001|Overall Study|Withdrawal of Consent|9|||
130670703|NCT03342898|470420030|FG002|Overall Study|Withdrawal of Consent|11|||
130670704|NCT03342898|470420028|FG000|Overall Study|Death|0|||
130670705|NCT03342898|470420029|FG001|Overall Study|Death|1|||
130670706|NCT03342898|470420030|FG002|Overall Study|Death|1|||
130670707|NCT03342898|470420028|FG000|Overall Study|Reason not Specified|2|||
130670708|NCT03342898|470420029|FG001|Overall Study|Reason not Specified|2|||
130670709|NCT03342898|470420030|FG002|Overall Study|Reason not Specified|0|||
130670710|NCT01267266|470420031|FG000|Enrollment Phase|Withdrawal by Subject|2|||
130670711|NCT01267266|470420032|FG001|Enrollment Phase|Withdrawal by Subject|0|||
130670712|NCT01267266|470420031|FG000|Lead-in Phase|Lack of Efficacy|20|||
130670713|NCT01267266|470420032|FG001|Lead-in Phase|Lack of Efficacy|0|||
130670714|NCT01267266|470420031|FG000|Lead-in Phase|Adverse Event|2|||
130670715|NCT01267266|470420032|FG001|Lead-in Phase|Adverse Event|0|||
130670716|NCT01267266|470420031|FG000|Lead-in Phase|Withdrawal by Subject|1|||
130670717|NCT01267266|470420032|FG001|Lead-in Phase|Withdrawal by Subject|0|||
130670718|NCT01466686|470420042|FG000|Overall Study|Withdrawal by Subject|1|||
130670719|NCT01907087|470420046|FG000|Overall Study|Withdrawal by Subject|1|||
130670720|NCT05216978|470420047|FG000|Overall Study|Withdrawal by Subject|3|||
130670721|NCT05216978|470420047|FG000|Overall Study|Lost to Follow-up|5|||
130670722|NCT00658320|470420049|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
130670723|NCT00658320|470420050|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
130670724|NCT00658320|470420049|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
130670725|NCT00658320|470420050|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
130670726|NCT00658320|470420049|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
130670727|NCT00658320|470420050|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
130670728|NCT00658320|470420049|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
130670729|NCT00658320|470420050|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
130670730|NCT02668783|470420053|FG000|Overall Study|Pregnancy|0|||
130336437|NCT04518995|469203426|FG001|Overall Study|Non-compliance With Study Drug|3|||
130336438|NCT04518995|469203427|FG002|Overall Study|Non-compliance With Study Drug|2|||
130336439|NCT04518995|469203425|FG000|Overall Study|Pregnancy|0|||
130336440|NCT04518995|469203426|FG001|Overall Study|Pregnancy|0|||
130670731|NCT02668783|470420054|FG001|Overall Study|Pregnancy|1|||
130670732|NCT02668783|470420053|FG000|Overall Study|Protocol Violation|2|||
130670733|NCT02668783|470420054|FG001|Overall Study|Protocol Violation|1|||
130670734|NCT02668783|470420053|FG000|Overall Study|Study terminated by sponsor|9|||
130670735|NCT02668783|470420054|FG001|Overall Study|Study terminated by sponsor|10|||
130670736|NCT02668783|470420053|FG000|Overall Study|Subject moved|1|||
130670737|NCT02668783|470420054|FG001|Overall Study|Subject moved|0|||
130670738|NCT02668783|470420053|FG000|Overall Study|Withdrawal by Subject|1|||
130670739|NCT02668783|470420054|FG001|Overall Study|Withdrawal by Subject|0|||
130670740|NCT02884206|470420055|FG000|Valsartan Run-in Period|Death|1|||
130670741|NCT02884206|470420056|FG001|Valsartan Run-in Period|Death|0|||
130670742|NCT02884206|470420057|FG002|Valsartan Run-in Period|Death|0|||
130670743|NCT02884206|470420055|FG000|Valsartan Run-in Period|Adverse Event|31|||
130670744|NCT02884206|470420056|FG001|Valsartan Run-in Period|Adverse Event|0|||
130670745|NCT02884206|470420057|FG002|Valsartan Run-in Period|Adverse Event|0|||
130670746|NCT02884206|470420055|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
130670747|NCT02884206|470420056|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
130670748|NCT02884206|470420057|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
130670749|NCT02884206|470420055|FG000|Valsartan Run-in Period|Protocol deviation|4|||
130670750|NCT02884206|470420056|FG001|Valsartan Run-in Period|Protocol deviation|0|||
130670751|NCT02884206|470420057|FG002|Valsartan Run-in Period|Protocol deviation|0|||
130670752|NCT02884206|470420055|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
130670753|NCT02884206|470420056|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
130670754|NCT02884206|470420057|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
130670755|NCT02884206|470420055|FG000|Valsartan Run-in Period|Physician Decision|1|||
130670756|NCT02884206|470420056|FG001|Valsartan Run-in Period|Physician Decision|0|||
130670757|NCT02884206|470420057|FG002|Valsartan Run-in Period|Physician Decision|0|||
130670758|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Adverse Event|38|||
130670759|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Adverse Event|0|||
130670760|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Adverse Event|0|||
130670761|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Death|2|||
130670762|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Death|0|||
130670763|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Death|0|||
130670764|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
130670765|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
130670766|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
130670767|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
130670768|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
130670769|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
130670770|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
130670771|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
130670772|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
130670773|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Physician Decision|1|||
130670774|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Physician Decision|0|||
130670775|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Physician Decision|0|||
130670776|NCT02884206|470420055|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
130670777|NCT02884206|470420056|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
130670778|NCT02884206|470420057|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
130670779|NCT02884206|470420055|FG000|Double-Blind Period|Death|0|||
130670780|NCT02884206|470420056|FG001|Double-Blind Period|Death|28|||
130670781|NCT02884206|470420057|FG002|Double-Blind Period|Death|39|||
130670782|NCT02884206|470420055|FG000|Double-Blind Period|Patient/guardian decision|0|||
130670783|NCT02884206|470420056|FG001|Double-Blind Period|Patient/guardian decision|10|||
130670784|NCT02884206|470420057|FG002|Double-Blind Period|Patient/guardian decision|13|||
130670785|NCT02884206|470420055|FG000|Double-Blind Period|Lost to Follow-up|0|||
130670786|NCT02884206|470420056|FG001|Double-Blind Period|Lost to Follow-up|4|||
130670787|NCT02884206|470420057|FG002|Double-Blind Period|Lost to Follow-up|4|||
130670788|NCT02884206|470420055|FG000|Double-Blind Period|Physician Decision|0|||
130670789|NCT02884206|470420056|FG001|Double-Blind Period|Physician Decision|2|||
130670790|NCT02884206|470420057|FG002|Double-Blind Period|Physician Decision|0|||
130670791|NCT02884206|470420055|FG000|Double-Blind Period|Adverse Event|0|||
130670792|NCT02884206|470420056|FG001|Double-Blind Period|Adverse Event|0|||
130670793|NCT02884206|470420057|FG002|Double-Blind Period|Adverse Event|3|||
130670794|NCT02884206|470420055|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
130670795|NCT02884206|470420056|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
130670796|NCT02884206|470420057|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
130670797|NCT00112489|470420060|FG000|Overall Study|Refused further treatment|8|||
130670798|NCT00112489|470420060|FG000|Overall Study|Adverse Event|12|||
130670799|NCT00112489|470420060|FG000|Overall Study|Death|2|||
130336441|NCT04518995|469203427|FG002|Overall Study|Pregnancy|1|||
130336442|NCT04518995|469203425|FG000|Overall Study|Protocol Violation|2|||
130670800|NCT00112489|470420060|FG000|Overall Study|Other, Not Specified|9|||
130670801|NCT00112489|470420060|FG000|Overall Study|Patient never treated|2|||
130670802|NCT00112489|470420060|FG000|Overall Study|Ineligible|7|||
130670803|NCT01003886|470420061|FG000|Overall Study|Lack of Efficacy|5|||
130670804|NCT01003886|470420061|FG000|Overall Study|Lost to Follow-up|169|||
130670805|NCT01003886|470420061|FG000|Overall Study|Withdrawal by Subject|39|||
130670806|NCT01003886|470420061|FG000|Overall Study|Other|14|||
130670807|NCT01003886|470420061|FG000|Overall Study|Adverse Event|3|||
130670808|NCT04467697|470420062|FG000|Overall Study|Adverse Event|2|||
130670809|NCT04467697|470420062|FG000|Overall Study|Lost to Follow-up|6|||
130670810|NCT04467697|470420062|FG000|Overall Study|Withdrawal by Subject|9|||
130670811|NCT04467697|470420062|FG000|Overall Study|Protocol Violation|3|||
130670812|NCT05751629|470420065|FG000|Overall Study|Withdrawal by Subject|6|||
130670813|NCT05751629|470420065|FG000|Overall Study|Death|25|||
130670814|NCT05751629|470420065|FG000|Overall Study|Study Site Closed|9|||
130670815|NCT05751629|470420065|FG000|Overall Study|Physician Decision|1|||
130670816|NCT02231710|470420066|FG000|Overall Study|Physician Decision|1|||
130670817|NCT04081337|470420067|FG000|Overall Study|Adverse Event|0|||
130670818|NCT04081337|470420068|FG001|Overall Study|Adverse Event|1|||
130670819|NCT04081337|470420067|FG000|Overall Study|Withdrawal by Subject|2|||
130670820|NCT04081337|470420068|FG001|Overall Study|Withdrawal by Subject|0|||
130670821|NCT04081337|470420067|FG000|Overall Study|Physician Decision|1|||
130670822|NCT04081337|470420068|FG001|Overall Study|Physician Decision|2|||
130670823|NCT04081337|470420067|FG000|Overall Study|Lost to Follow-up|1|||
130670824|NCT04081337|470420068|FG001|Overall Study|Lost to Follow-up|0|||
130670825|NCT00829413|470420069|FG000|Overall Study|No study drug admimnistered|13|||
130670826|NCT00829413|470420069|FG000|Overall Study|Training Patients|67|||
130670827|NCT00829413|470420069|FG000|Overall Study|No truth standard procedure available|9|||
130670828|NCT00829413|470420069|FG000|Overall Study|Technically inadequate truth standard|2|||
130670829|NCT00829413|470420069|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
130670830|NCT01799590|470420072|FG000|Overall Study|Adverse Event|13|||
130670831|NCT01799590|470420073|FG001|Overall Study|Adverse Event|7|||
130670832|NCT01799590|470420074|FG002|Overall Study|Adverse Event|5|||
130670833|NCT01799590|470420072|FG000|Overall Study|Pregnancy|2|||
130670834|NCT01799590|470420073|FG001|Overall Study|Pregnancy|0|||
130670835|NCT01799590|470420074|FG002|Overall Study|Pregnancy|0|||
130670836|NCT01799590|470420072|FG000|Overall Study|Lack of Efficacy|3|||
130670837|NCT01799590|470420073|FG001|Overall Study|Lack of Efficacy|1|||
130670838|NCT01799590|470420074|FG002|Overall Study|Lack of Efficacy|3|||
130670839|NCT01799590|470420072|FG000|Overall Study|Participants convenience|4|||
130670840|NCT01799590|470420073|FG001|Overall Study|Participants convenience|4|||
130670841|NCT01799590|470420074|FG002|Overall Study|Participants convenience|2|||
130670842|NCT01799590|470420072|FG000|Overall Study|Aggravation of complications|0|||
130670843|NCT01799590|470420073|FG001|Overall Study|Aggravation of complications|1|||
130670844|NCT01799590|470420074|FG002|Overall Study|Aggravation of complications|1|||
130670845|NCT01799590|470420072|FG000|Overall Study|Using drugs with restricted days of use|0|||
130670846|NCT01799590|470420073|FG001|Overall Study|Using drugs with restricted days of use|3|||
130670847|NCT01799590|470420074|FG002|Overall Study|Using drugs with restricted days of use|2|||
130670848|NCT01799590|470420072|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
130670849|NCT01799590|470420073|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
130670850|NCT01799590|470420074|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
130670851|NCT01799590|470420072|FG000|Overall Study|Other|3|||
130670852|NCT01799590|470420073|FG001|Overall Study|Other|0|||
130670853|NCT01799590|470420074|FG002|Overall Study|Other|1|||
130670854|NCT01489956|470420075|FG000|Overall Study|Lost to Follow-up|1|||
130670855|NCT01489956|470420076|FG001|Overall Study|Lost to Follow-up|0|||
130670856|NCT01489956|470420077|FG002|Overall Study|Lost to Follow-up|0|||
130670857|NCT01489956|470420075|FG000|Overall Study|Withdrawal by Subject|0|||
130670858|NCT01489956|470420076|FG001|Overall Study|Withdrawal by Subject|0|||
130670859|NCT01489956|470420077|FG002|Overall Study|Withdrawal by Subject|1|||
130670860|NCT03341507|470420080|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
130670861|NCT02927847|470420081|FG000|Overall Study|Lost to Follow-up|1|||
130670862|NCT02927847|470420082|FG001|Overall Study|Lost to Follow-up|0|||
130670863|NCT02927847|470420081|FG000|Overall Study|Withdrawal by Subject|4|||
130670864|NCT02927847|470420082|FG001|Overall Study|Withdrawal by Subject|2|||
130670865|NCT02927847|470420081|FG000|Overall Study|PI withdrawn due to missed visits|1|||
130670866|NCT02927847|470420082|FG001|Overall Study|PI withdrawn due to missed visits|1|||
130670867|NCT00723554|470420083|FG000|Overall Study|Adverse Event|12|||
130670868|NCT00723554|470420083|FG000|Overall Study|Investigator's judgement|5|||
130670869|NCT00723554|470420083|FG000|Overall Study|Inhaled medication other than iloprost|4|||
130670870|NCT00723554|470420083|FG000|Overall Study|Withdrawal of consent|3|||
130670871|NCT00723554|470420083|FG000|Overall Study|Other|3|||
130670872|NCT00723554|470420083|FG000|Overall Study|Lost to Follow-up|1|||
130670873|NCT00723554|470420083|FG000|Overall Study|Non-compliance|1|||
130670874|NCT03255031|470420084|FG000|Overall Study|Adverse Event|5|||
130670875|NCT03255031|470420085|FG001|Overall Study|Adverse Event|3|||
130670876|NCT03255031|470420084|FG000|Overall Study|Physician Decision|2|||
130336443|NCT04518995|469203426|FG001|Overall Study|Protocol Violation|0|||
130336444|NCT04518995|469203427|FG002|Overall Study|Protocol Violation|1|||
130336445|NCT04518995|469203425|FG000|Overall Study|Reason not Specified|4|||
130336446|NCT04518995|469203426|FG001|Overall Study|Reason not Specified|11|||
130336447|NCT04518995|469203427|FG002|Overall Study|Reason not Specified|2|||
130336448|NCT04518995|469203425|FG000|Overall Study|Lost to Follow-up|1|||
130336449|NCT04518995|469203426|FG001|Overall Study|Lost to Follow-up|10|||
130336450|NCT04518995|469203427|FG002|Overall Study|Lost to Follow-up|6|||
130336451|NCT02891070|469203432|FG000|Overall Study|Adverse Event|1|||
130336452|NCT02891070|469203433|FG001|Overall Study|Adverse Event|0|||
130670877|NCT03255031|470420085|FG001|Overall Study|Physician Decision|1|||
130670878|NCT03255031|470420084|FG000|Overall Study|Withdrawal by Subject|9|||
130670879|NCT03255031|470420085|FG001|Overall Study|Withdrawal by Subject|3|||
130670880|NCT01689974|470420087|FG000|Overall Study|Termination of Study|5|||
130670881|NCT01689974|470420088|FG001|Overall Study|Termination of Study|5|||
130670882|NCT00415532|470420092|FG000|Treatment Period|Adverse Event|2|||
130670883|NCT00415532|470420093|FG001|Treatment Period|Adverse Event|3|||
130670884|NCT00415532|470420092|FG000|Treatment Period|Death|2|||
130670885|NCT00415532|470420093|FG001|Treatment Period|Death|1|||
130670886|NCT00415532|470420092|FG000|Treatment Period|Lost to Follow-up|1|||
130670887|NCT00415532|470420093|FG001|Treatment Period|Lost to Follow-up|1|||
130670888|NCT00415532|470420092|FG000|Treatment Period|Protocol Violation|1|||
130670889|NCT00415532|470420093|FG001|Treatment Period|Protocol Violation|0|||
130670890|NCT00415532|470420092|FG000|Treatment Period|Withdrawal by Subject|6|||
130670891|NCT00415532|470420093|FG001|Treatment Period|Withdrawal by Subject|6|||
130670892|NCT00415532|470420092|FG000|Treatment Period|Other|2|||
130670893|NCT00415532|470420093|FG001|Treatment Period|Other|2|||
130670894|NCT00415532|470420092|FG000|Treatment Period|Ineligibility determined|1|||
130670895|NCT00415532|470420093|FG001|Treatment Period|Ineligibility determined|1|||
130670896|NCT00415532|470420092|FG000|Treatment Period|Noncompliance|1|||
130670897|NCT00415532|470420093|FG001|Treatment Period|Noncompliance|1|||
130670898|NCT00415532|470420092|FG000|Treatment Period|Requirement for alternative therapy|1|||
130670899|NCT00415532|470420093|FG001|Treatment Period|Requirement for alternative therapy|0|||
130670900|NCT00415532|470420092|FG000|Safety Follow Up Period|Adverse Event|1|||
130670901|NCT00415532|470420093|FG001|Safety Follow Up Period|Adverse Event|3|||
130670902|NCT00415532|470420092|FG000|Safety Follow Up Period|Death|3|||
130670903|NCT00415532|470420093|FG001|Safety Follow Up Period|Death|0|||
130670904|NCT00415532|470420092|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
130670905|NCT00415532|470420093|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
130670906|NCT00415532|470420092|FG000|Safety Follow Up Period|Other|1|||
130670907|NCT00415532|470420093|FG001|Safety Follow Up Period|Other|4|||
130670908|NCT00415532|470420092|FG000|Safety Follow Up Period|Ineligibility determined|1|||
130670909|NCT00415532|470420093|FG001|Safety Follow Up Period|Ineligibility determined|1|||
130670910|NCT00415532|470420092|FG000|Safety Follow Up Period|Noncompliance|1|||
130670911|NCT00415532|470420093|FG001|Safety Follow Up Period|Noncompliance|0|||
130670912|NCT00415532|470420092|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
130670913|NCT00415532|470420093|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
130670914|NCT02040766|470420097|FG000|Overall Study|Adverse Event|1|||
130670915|NCT02040766|470420098|FG001|Overall Study|Adverse Event|1|||
130670916|NCT02040766|470420099|FG002|Overall Study|Adverse Event|1|||
130670917|NCT02040766|470420100|FG003|Overall Study|Adverse Event|0|||
130670918|NCT02040766|470420101|FG004|Overall Study|Adverse Event|2|||
130670919|NCT02040766|470420097|FG000|Overall Study|Withdrawal by Subject|4|||
130670920|NCT02040766|470420098|FG001|Overall Study|Withdrawal by Subject|3|||
130670921|NCT02040766|470420099|FG002|Overall Study|Withdrawal by Subject|2|||
130670922|NCT02040766|470420100|FG003|Overall Study|Withdrawal by Subject|3|||
130670923|NCT02040766|470420101|FG004|Overall Study|Withdrawal by Subject|2|||
130670924|NCT02040766|470420097|FG000|Overall Study|Non-compliance|0|||
130670925|NCT02040766|470420098|FG001|Overall Study|Non-compliance|1|||
130670926|NCT02040766|470420099|FG002|Overall Study|Non-compliance|0|||
130670927|NCT02040766|470420100|FG003|Overall Study|Non-compliance|0|||
130670928|NCT02040766|470420101|FG004|Overall Study|Non-compliance|0|||
130670929|NCT02040766|470420097|FG000|Overall Study|Protocol Violation|2|||
130670930|NCT02040766|470420098|FG001|Overall Study|Protocol Violation|1|||
130670931|NCT02040766|470420099|FG002|Overall Study|Protocol Violation|2|||
130670932|NCT02040766|470420100|FG003|Overall Study|Protocol Violation|3|||
130670933|NCT02040766|470420101|FG004|Overall Study|Protocol Violation|0|||
130670934|NCT02040766|470420097|FG000|Overall Study|Lost to Follow-up|4|||
130670935|NCT02040766|470420098|FG001|Overall Study|Lost to Follow-up|1|||
130670936|NCT02040766|470420099|FG002|Overall Study|Lost to Follow-up|3|||
130670937|NCT02040766|470420100|FG003|Overall Study|Lost to Follow-up|1|||
130670938|NCT02040766|470420101|FG004|Overall Study|Lost to Follow-up|4|||
130670939|NCT02040766|470420097|FG000|Overall Study|Not reported|1|||
130336453|NCT02891070|469203432|FG000|Overall Study|Physician Decision|0|||
130336454|NCT02891070|469203433|FG001|Overall Study|Physician Decision|1|||
130670940|NCT02040766|470420098|FG001|Overall Study|Not reported|0|||
130336455|NCT02891070|469203432|FG000|Overall Study|Lost to Follow-up|4|||
130670941|NCT02040766|470420099|FG002|Overall Study|Not reported|0|||
130336456|NCT02891070|469203433|FG001|Overall Study|Lost to Follow-up|4|||
130336457|NCT02891070|469203432|FG000|Overall Study|Other|1|||
130336458|NCT02891070|469203433|FG001|Overall Study|Other|0|||
130336459|NCT02891070|469203432|FG000|Overall Study|Protocol Violation|0|||
130336460|NCT02891070|469203433|FG001|Overall Study|Protocol Violation|1|||
130336461|NCT02891070|469203432|FG000|Overall Study|Withdrawal by Subject|1|||
130336462|NCT02891070|469203433|FG001|Overall Study|Withdrawal by Subject|2|||
130336463|NCT02891070|469203432|FG000|Overall Study|Death|3|||
130336464|NCT02891070|469203433|FG001|Overall Study|Death|0|||
130336465|NCT04491604|469203436|FG000|Overall Study|Withdrawal by Subject|3|||
130336466|NCT00545272|469203437|FG000|Overall Study|Protocol deviation|0|||
130336467|NCT00545272|469203438|FG001|Overall Study|Protocol deviation|1|||
130336468|NCT00545272|469203439|FG002|Overall Study|Protocol deviation|0|||
130336469|NCT00545272|469203440|FG003|Overall Study|Protocol deviation|1|||
130336470|NCT00545272|469203441|FG004|Overall Study|Protocol deviation|0|||
130336471|NCT00545272|469203442|FG005|Overall Study|Protocol deviation|1|||
130336472|NCT00545272|469203437|FG000|Overall Study|Adverse Event|0|||
130336473|NCT00545272|469203438|FG001|Overall Study|Adverse Event|0|||
130336474|NCT00545272|469203439|FG002|Overall Study|Adverse Event|1|||
130336475|NCT00545272|469203440|FG003|Overall Study|Adverse Event|0|||
130336476|NCT00545272|469203441|FG004|Overall Study|Adverse Event|0|||
130336477|NCT00545272|469203442|FG005|Overall Study|Adverse Event|1|||
130336478|NCT00545272|469203437|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130336479|NCT00545272|469203438|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130336480|NCT00545272|469203439|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130336481|NCT00545272|469203440|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130336482|NCT00545272|469203441|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130336483|NCT00545272|469203442|FG005|Overall Study|Abnormal laboratory value(s)|1|||
130336484|NCT00545272|469203437|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130336485|NCT00545272|469203438|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130336486|NCT00545272|469203439|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130336487|NCT00545272|469203440|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130336488|NCT00545272|469203441|FG004|Overall Study|Abnormal test procedure result(s)|1|||
130336489|NCT00545272|469203442|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130336490|NCT00545272|469203437|FG000|Overall Study|Lost to Follow-up|0|||
130336491|NCT00545272|469203438|FG001|Overall Study|Lost to Follow-up|0|||
130336492|NCT00545272|469203439|FG002|Overall Study|Lost to Follow-up|0|||
130336493|NCT00545272|469203440|FG003|Overall Study|Lost to Follow-up|0|||
130336494|NCT00545272|469203441|FG004|Overall Study|Lost to Follow-up|1|||
130336495|NCT00545272|469203442|FG005|Overall Study|Lost to Follow-up|0|||
130336496|NCT02934503|469203443|FG000|Overall Study|progression of disease|3|||
130336497|NCT02934503|469203443|FG000|Overall Study|Withdrawal by Subject|1|||
130336498|NCT00724867|469203444|FG000|Overall Study|Adverse Event|25|||
130336499|NCT00724867|469203444|FG000|Overall Study|Lack of Efficacy|14|||
130336500|NCT00724867|469203444|FG000|Overall Study|Lost to Follow-up|12|||
130336501|NCT00724867|469203444|FG000|Overall Study|Non-compliance with study drug|6|||
130670942|NCT02040766|470420100|FG003|Overall Study|Not reported|0|||
130670943|NCT02040766|470420101|FG004|Overall Study|Not reported|0|||
130336502|NCT00724867|469203444|FG000|Overall Study|Physician Decision|17|||
130336503|NCT00724867|469203444|FG000|Overall Study|Protocol Violation|1|||
130336504|NCT00724867|469203444|FG000|Overall Study|Withdrawal by Subject|31|||
130336505|NCT00724867|469203444|FG000|Overall Study|Sponsor decision to end study|14|||
130336506|NCT00724867|469203444|FG000|Overall Study|Subject incarcerated|1|||
130670944|NCT02040766|470420097|FG000|Overall Study|Lack of Efficacy|6|||
130670945|NCT02040766|470420098|FG001|Overall Study|Lack of Efficacy|3|||
130670946|NCT02040766|470420099|FG002|Overall Study|Lack of Efficacy|4|||
130670947|NCT02040766|470420100|FG003|Overall Study|Lack of Efficacy|6|||
130670948|NCT02040766|470420101|FG004|Overall Study|Lack of Efficacy|5|||
130670949|NCT02974114|470420102|FG000|Overall Study|Other (Not specified)|0|||
130670950|NCT02974114|470420103|FG001|Overall Study|Other (Not specified)|1|||
130670951|NCT02974114|470420104|FG002|Overall Study|Other (Not specified)|2|||
130670952|NCT01580020|470420105|FG000|Overall Study|Lack of Efficacy|0|||
130670953|NCT01580020|470420106|FG001|Overall Study|Lack of Efficacy|5|||
130670954|NCT01580020|470420107|FG002|Overall Study|Lack of Efficacy|0|||
130670955|NCT01580020|470420108|FG003|Overall Study|Lack of Efficacy|1|||
130336507|NCT00724867|469203444|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
130336508|NCT00724867|469203444|FG000|Overall Study|Subject moved out of state|1|||
130336509|NCT00724867|469203444|FG000|Overall Study|Elected to exit due to site closure|2|||
130336510|NCT04335136|469203446|FG000|Overall Study|Death|8|||
130336511|NCT04335136|469203447|FG001|Overall Study|Death|4|||
130336512|NCT04335136|469203446|FG000|Overall Study|Lost to Follow-up|2|||
130336513|NCT04335136|469203447|FG001|Overall Study|Lost to Follow-up|0|||
130336514|NCT04335136|469203446|FG000|Overall Study|Protocol Violation|1|||
130336515|NCT04335136|469203447|FG001|Overall Study|Protocol Violation|0|||
130670956|NCT01580020|470420105|FG000|Overall Study|Withdrawal by Subject|0|||
130670957|NCT01580020|470420106|FG001|Overall Study|Withdrawal by Subject|1|||
130670958|NCT01580020|470420107|FG002|Overall Study|Withdrawal by Subject|1|||
130670959|NCT01580020|470420108|FG003|Overall Study|Withdrawal by Subject|0|||
130670960|NCT01580020|470420105|FG000|Overall Study|Adverse Event|1|||
130670961|NCT01580020|470420106|FG001|Overall Study|Adverse Event|1|||
130670962|NCT01580020|470420107|FG002|Overall Study|Adverse Event|1|||
130670963|NCT01580020|470420108|FG003|Overall Study|Adverse Event|1|||
130670964|NCT01580020|470420105|FG000|Overall Study|Administrative Problems|0|||
130670965|NCT01580020|470420106|FG001|Overall Study|Administrative Problems|0|||
130670966|NCT01580020|470420107|FG002|Overall Study|Administrative Problems|1|||
130670967|NCT01580020|470420108|FG003|Overall Study|Administrative Problems|0|||
130670968|NCT01580020|470420105|FG000|Overall Study|Lost to Follow-up|0|||
130670969|NCT01580020|470420106|FG001|Overall Study|Lost to Follow-up|0|||
130670970|NCT01580020|470420107|FG002|Overall Study|Lost to Follow-up|1|||
130670971|NCT01580020|470420108|FG003|Overall Study|Lost to Follow-up|0|||
130670972|NCT01724359|470420109|FG000|Overall Study|Adverse Event|10|||
130670973|NCT01724359|470420109|FG000|Overall Study|Death|1|||
130670974|NCT01724359|470420109|FG000|Overall Study|Other|20|||
130670975|NCT00593333|470420111|FG000|Overall Study|Lost to Follow-up|10|||
130670976|NCT00593333|470420112|FG001|Overall Study|Lost to Follow-up|11|||
130670977|NCT01752920|470420113|FG000|Overall Study|Adverse Event|1|||
130670978|NCT01752920|470420114|FG001|Overall Study|Adverse Event|0|||
130670979|NCT01752920|470420115|FG002|Overall Study|Adverse Event|5|||
130670980|NCT01752920|470420116|FG003|Overall Study|Adverse Event|10|||
130670981|NCT01752920|470420113|FG000|Overall Study|Clinical Disease Progression|6|||
130670982|NCT01752920|470420114|FG001|Overall Study|Clinical Disease Progression|4|||
130670983|NCT01752920|470420115|FG002|Overall Study|Clinical Disease Progression|1|||
130670984|NCT01752920|470420116|FG003|Overall Study|Clinical Disease Progression|13|||
130670985|NCT01752920|470420113|FG000|Overall Study|Physician Decision|1|||
130670986|NCT01752920|470420114|FG001|Overall Study|Physician Decision|0|||
130670987|NCT01752920|470420115|FG002|Overall Study|Physician Decision|0|||
130670988|NCT01752920|470420116|FG003|Overall Study|Physician Decision|3|||
130670989|NCT01752920|470420113|FG000|Overall Study|Radiographic Disease Progression|20|||
130670990|NCT01752920|470420114|FG001|Overall Study|Radiographic Disease Progression|7|||
130670991|NCT01752920|470420115|FG002|Overall Study|Radiographic Disease Progression|12|||
130670992|NCT01752920|470420116|FG003|Overall Study|Radiographic Disease Progression|29|||
130670993|NCT01752920|470420113|FG000|Overall Study|Study Terminated by Sponsor|0|||
130670994|NCT01752920|470420114|FG001|Overall Study|Study Terminated by Sponsor|0|||
130670995|NCT01752920|470420115|FG002|Overall Study|Study Terminated by Sponsor|0|||
130670996|NCT01752920|470420116|FG003|Overall Study|Study Terminated by Sponsor|1|||
130670997|NCT01752920|470420113|FG000|Overall Study|Withdrawal by Subject|0|||
130670998|NCT01752920|470420114|FG001|Overall Study|Withdrawal by Subject|1|||
130670999|NCT01752920|470420115|FG002|Overall Study|Withdrawal by Subject|0|||
130671000|NCT01752920|470420116|FG003|Overall Study|Withdrawal by Subject|1|||
130671001|NCT01752920|470420113|FG000|Overall Study|Lack of clinical benefit|1|||
130671002|NCT01752920|470420114|FG001|Overall Study|Lack of clinical benefit|1|||
130671003|NCT01752920|470420115|FG002|Overall Study|Lack of clinical benefit|1|||
130671004|NCT01752920|470420116|FG003|Overall Study|Lack of clinical benefit|1|||
130671005|NCT01186978|470420117|FG000|Overall Study|Withdrawal by Subject|1|||
130671006|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
130671007|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
130671008|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
130671009|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
130671010|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
130671011|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
130671012|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
130671013|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
130671014|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
130671015|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
130671016|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
130671017|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
130671018|NCT01227668|470420118|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
130671019|NCT01227668|470420119|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
130671020|NCT01227668|470420118|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
130671021|NCT01227668|470420119|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
130671022|NCT01227668|470420118|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
130671023|NCT01227668|470420119|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
130671024|NCT01227668|470420118|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
130671025|NCT01227668|470420119|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
130671026|NCT01227668|470420118|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
130671027|NCT01227668|470420119|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
130671028|NCT01227668|470420118|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
130671029|NCT01227668|470420119|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
130671030|NCT01709383|470420125|FG000|Overall Study|Lost to Follow-up|1|||
130671031|NCT01709383|470420126|FG001|Overall Study|Lost to Follow-up|0|||
130671032|NCT03264066|470420127|FG000|Overall Study|Adverse Event|1|||
130336516|NCT04335136|469203446|FG000|Overall Study|Withdrawal by Subject|1|||
130336517|NCT04335136|469203447|FG001|Overall Study|Withdrawal by Subject|1|||
130336518|NCT04335136|469203446|FG000|Overall Study|Health-threatening condition|0|||
130336519|NCT04335136|469203447|FG001|Overall Study|Health-threatening condition|1|||
130336520|NCT04335136|469203446|FG000|Overall Study|Adverse Event|0|||
130336521|NCT04335136|469203447|FG001|Overall Study|Adverse Event|1|||
130336522|NCT04335136|469203446|FG000|Overall Study|Erroneously randomized|2|||
130336523|NCT04335136|469203447|FG001|Overall Study|Erroneously randomized|0|||
130336524|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
130336525|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
130336526|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130336527|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130336528|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
130336529|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336530|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336531|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336532|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
130336533|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336534|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336535|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336536|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336537|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
130336538|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336539|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336540|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336541|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
130336542|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336543|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336544|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336545|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336546|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
130336547|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336548|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336549|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336550|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
130336551|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336552|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336553|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336554|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
130336555|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336556|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336557|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336558|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
130336559|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336560|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
130336561|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
130336562|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
130336563|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
130336564|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336565|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336566|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336567|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
130336568|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336569|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336570|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336571|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
130336572|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336573|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336574|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336575|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
130336576|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
130336577|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
130336578|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
130336579|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
130336580|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336581|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336582|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336583|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
130336584|NCT01049009|469203452|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130671033|NCT03264066|470420128|FG001|Overall Study|Adverse Event|1|||
130671034|NCT03264066|470420129|FG002|Overall Study|Adverse Event|0|||
130671035|NCT03264066|470420130|FG003|Overall Study|Adverse Event|0|||
130671036|NCT03264066|470420131|FG004|Overall Study|Adverse Event|0|||
130671037|NCT03264066|470420132|FG005|Overall Study|Adverse Event|0|||
130671038|NCT03264066|470420127|FG000|Overall Study|Death|12|||
130671039|NCT03264066|470420128|FG001|Overall Study|Death|12|||
130671040|NCT03264066|470420129|FG002|Overall Study|Death|8|||
130671041|NCT03264066|470420130|FG003|Overall Study|Death|10|||
130671042|NCT03264066|470420131|FG004|Overall Study|Death|6|||
130671043|NCT03264066|470420132|FG005|Overall Study|Death|1|||
130336585|NCT01049009|469203453|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130336586|NCT01049009|469203452|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130336587|NCT01049009|469203453|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130336588|NCT01049009|469203452|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130336589|NCT01049009|469203453|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
130336590|NCT01049009|469203452|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
130336591|NCT01049009|469203453|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
130336592|NCT02423902|469203454|FG000|Overall Study|Disease progression|1|||
130336593|NCT02423902|469203455|FG001|Overall Study|Disease progression|4|||
130336594|NCT02136069|469203456|FG000|Overall Study|UC flare-up|1|||
130336595|NCT02136069|469203457|FG001|Overall Study|UC flare-up|0|||
130336596|NCT02136069|469203456|FG000|Overall Study|Adverse Event|6|||
130336597|NCT02136069|469203457|FG001|Overall Study|Adverse Event|8|||
130336598|NCT02136069|469203456|FG000|Overall Study|Death|0|||
130336599|NCT02136069|469203457|FG001|Overall Study|Death|1|||
130336600|NCT02136069|469203456|FG000|Overall Study|Lack of Efficacy|10|||
130336601|NCT02136069|469203457|FG001|Overall Study|Lack of Efficacy|4|||
130336602|NCT02136069|469203456|FG000|Overall Study|Lost to Follow-up|1|||
130336603|NCT02136069|469203457|FG001|Overall Study|Lost to Follow-up|0|||
130336604|NCT02136069|469203456|FG000|Overall Study|Non-Compliance|1|||
130336605|NCT02136069|469203457|FG001|Overall Study|Non-Compliance|0|||
130336606|NCT02136069|469203456|FG000|Overall Study|Physician Decision|5|||
130336607|NCT02136069|469203457|FG001|Overall Study|Physician Decision|4|||
130336608|NCT02136069|469203456|FG000|Overall Study|Withdrawal by Subject|10|||
130336609|NCT02136069|469203457|FG001|Overall Study|Withdrawal by Subject|11|||
130336610|NCT04538144|469203458|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130336611|NCT04538144|469203459|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
130336612|NCT04538144|469203460|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
130336613|NCT04538144|469203461|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
130336614|NCT01092546|469203462|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
130336615|NCT00622440|469203463|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
130336616|NCT00622440|469203464|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
130336617|NCT00622440|469203463|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
130336618|NCT00622440|469203464|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
130336619|NCT00622440|469203463|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
130336620|NCT00622440|469203464|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
130336621|NCT00622440|469203463|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
130336622|NCT00622440|469203464|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
130336623|NCT01667419|469203469|FG000|Overall Study|Reason Not Specified|1|||
130336624|NCT01667419|469203470|FG001|Overall Study|Reason Not Specified|0|||
130336625|NCT01667419|469203471|FG002|Overall Study|Reason Not Specified|0|||
130336626|NCT01667419|469203472|FG003|Overall Study|Reason Not Specified|0|||
130336627|NCT01667419|469203469|FG000|Overall Study|Withdrawal by Subject|16|||
130336628|NCT01667419|469203470|FG001|Overall Study|Withdrawal by Subject|8|||
130336629|NCT01667419|469203471|FG002|Overall Study|Withdrawal by Subject|9|||
130336630|NCT01667419|469203472|FG003|Overall Study|Withdrawal by Subject|8|||
130336631|NCT01667419|469203469|FG000|Overall Study|Non-compliance|0|||
130336632|NCT01667419|469203470|FG001|Overall Study|Non-compliance|0|||
130336633|NCT01667419|469203471|FG002|Overall Study|Non-compliance|0|||
130336634|NCT01667419|469203472|FG003|Overall Study|Non-compliance|1|||
130336635|NCT01667419|469203469|FG000|Overall Study|Protocol Violation|1|||
130336636|NCT01667419|469203470|FG001|Overall Study|Protocol Violation|0|||
130336637|NCT01667419|469203471|FG002|Overall Study|Protocol Violation|0|||
130336638|NCT01667419|469203472|FG003|Overall Study|Protocol Violation|0|||
130336639|NCT01667419|469203469|FG000|Overall Study|Lost to Follow-up|7|||
130336640|NCT01667419|469203470|FG001|Overall Study|Lost to Follow-up|6|||
130336641|NCT01667419|469203471|FG002|Overall Study|Lost to Follow-up|2|||
130336642|NCT01667419|469203472|FG003|Overall Study|Lost to Follow-up|4|||
130336643|NCT01667419|469203469|FG000|Overall Study|Death|18|||
130336644|NCT01667419|469203470|FG001|Overall Study|Death|33|||
130336645|NCT01667419|469203471|FG002|Overall Study|Death|25|||
130336646|NCT01667419|469203472|FG003|Overall Study|Death|26|||
130336647|NCT04364984|469203473|FG000|Overall Study|Death|2|||
130336648|NCT04364984|469203474|FG001|Overall Study|Death|2|||
130671044|NCT03264066|470420127|FG000|Overall Study|Lost to Follow-up|1|||
130671045|NCT03264066|470420128|FG001|Overall Study|Lost to Follow-up|0|||
130671046|NCT03264066|470420129|FG002|Overall Study|Lost to Follow-up|0|||
130336649|NCT04364984|469203475|FG002|Overall Study|Death|0|||
130336650|NCT01941186|469203476|FG000|Follow-up|Lost to Follow-up|1|||
130336651|NCT01941186|469203477|FG001|Follow-up|Lost to Follow-up|0|||
130336652|NCT02722304|469203478|FG000|Overall Study|Study Terminated by Sponsor|1|||
130336653|NCT02722304|469203479|FG001|Overall Study|Study Terminated by Sponsor|0|||
130336654|NCT02722304|469203480|FG002|Overall Study|Study Terminated by Sponsor|2|||
130336655|NCT02722304|469203481|FG003|Overall Study|Study Terminated by Sponsor|1|||
130336656|NCT02722304|469203482|FG004|Overall Study|Study Terminated by Sponsor|1|||
130336657|NCT02722304|469203478|FG000|Overall Study|Other|0|||
130336658|NCT02722304|469203479|FG001|Overall Study|Other|0|||
130336659|NCT02722304|469203480|FG002|Overall Study|Other|0|||
130336660|NCT02722304|469203481|FG003|Overall Study|Other|1|||
130336661|NCT02722304|469203482|FG004|Overall Study|Other|1|||
130336662|NCT01068600|469203483|FG000|Overall Study|Withdrawal by Subject|5|||
130336663|NCT01068600|469203484|FG001|Overall Study|Withdrawal by Subject|6|||
130336664|NCT01068600|469203483|FG000|Overall Study|Adverse Event|3|||
130336665|NCT01068600|469203484|FG001|Overall Study|Adverse Event|3|||
130336666|NCT01068600|469203483|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130336667|NCT01068600|469203484|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130336668|NCT01068600|469203483|FG000|Overall Study|Lost to Follow-up|1|||
130336669|NCT01068600|469203484|FG001|Overall Study|Lost to Follow-up|2|||
130336670|NCT01068600|469203483|FG000|Overall Study|Protocol deviation|1|||
130336671|NCT01068600|469203484|FG001|Overall Study|Protocol deviation|1|||
130336672|NCT01068600|469203483|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130336673|NCT01068600|469203484|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130336674|NCT01068600|469203483|FG000|Overall Study|Administrative problems|0|||
130336675|NCT01068600|469203484|FG001|Overall Study|Administrative problems|1|||
130336676|NCT02644109|469203485|FG000|Overall Study|Adverse Event|0|||
130336677|NCT02644109|469203486|FG001|Overall Study|Adverse Event|4|||
130336678|NCT01519869|469203489|FG000|Overall Study|Lost to Follow-up|1|||
130336679|NCT03023813|469203490|FG000|Overall Study|Lost to Follow-up|1|||
130336680|NCT03023813|469203491|FG001|Overall Study|Lost to Follow-up|2|||
130336681|NCT03023813|469203492|FG002|Overall Study|Lost to Follow-up|0|||
130336682|NCT00329797|469203499|FG000|Overall Study|Protocol Violation|1|||
130336683|NCT00329797|469203500|FG001|Overall Study|Protocol Violation|0|||
130336684|NCT00329797|469203499|FG000|Overall Study|Withdrawal by Subject|6|||
130336685|NCT00329797|469203500|FG001|Overall Study|Withdrawal by Subject|6|||
130336686|NCT04254913|469203503|FG000|Overall Study|Adverse Event|1|||
130336687|NCT01396057|469203504|FG000|Overall Study|Adverse Event|2|||
130336688|NCT01396057|469203505|FG001|Overall Study|Adverse Event|6|||
130336689|NCT01396057|469203504|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130336690|NCT01396057|469203505|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130336691|NCT01396057|469203504|FG000|Overall Study|Protocol deviation|4|||
130336692|NCT01396057|469203505|FG001|Overall Study|Protocol deviation|4|||
130336693|NCT01396057|469203504|FG000|Overall Study|Consent withdrawn|3|||
130336694|NCT01396057|469203505|FG001|Overall Study|Consent withdrawn|2|||
130336695|NCT04535453|469203506|FG000|Overall Study|Death|0|||
130336696|NCT04535453|469203507|FG001|Overall Study|Death|1|||
130336697|NCT04535453|469203508|FG002|Overall Study|Death|0|||
130336698|NCT04535453|469203509|FG003|Overall Study|Death|0|||
130336699|NCT04535453|469203510|FG004|Overall Study|Death|0|||
130336700|NCT04535453|469203511|FG005|Overall Study|Death|0|||
130336701|NCT04535453|469203512|FG006|Overall Study|Death|0|||
130336702|NCT04535453|469203513|FG007|Overall Study|Death|0|||
130336703|NCT04535453|469203514|FG008|Overall Study|Death|0|||
130336704|NCT04535453|469203515|FG009|Overall Study|Death|0|||
130336705|NCT04535453|469203516|FG010|Overall Study|Death|0|||
130336706|NCT04535453|469203517|FG011|Overall Study|Death|0|||
130336707|NCT04535453|469203506|FG000|Overall Study|Lost to Follow-up|1|||
130336708|NCT04535453|469203507|FG001|Overall Study|Lost to Follow-up|1|||
130336709|NCT04535453|469203508|FG002|Overall Study|Lost to Follow-up|1|||
130336710|NCT04535453|469203509|FG003|Overall Study|Lost to Follow-up|0|||
130336711|NCT04535453|469203510|FG004|Overall Study|Lost to Follow-up|3|||
130336712|NCT04535453|469203511|FG005|Overall Study|Lost to Follow-up|1|||
130336713|NCT04535453|469203512|FG006|Overall Study|Lost to Follow-up|0|||
130336714|NCT04535453|469203513|FG007|Overall Study|Lost to Follow-up|0|||
130336715|NCT04535453|469203514|FG008|Overall Study|Lost to Follow-up|1|||
130336716|NCT04535453|469203515|FG009|Overall Study|Lost to Follow-up|1|||
130336717|NCT04535453|469203516|FG010|Overall Study|Lost to Follow-up|0|||
130336718|NCT04535453|469203517|FG011|Overall Study|Lost to Follow-up|0|||
130336719|NCT04535453|469203506|FG000|Overall Study|Physician Decision|0|||
130336720|NCT04535453|469203507|FG001|Overall Study|Physician Decision|0|||
130336721|NCT04535453|469203508|FG002|Overall Study|Physician Decision|0|||
130336722|NCT04535453|469203509|FG003|Overall Study|Physician Decision|1|||
130336723|NCT04535453|469203510|FG004|Overall Study|Physician Decision|0|||
130336724|NCT04535453|469203511|FG005|Overall Study|Physician Decision|0|||
130336725|NCT04535453|469203512|FG006|Overall Study|Physician Decision|0|||
130336726|NCT04535453|469203513|FG007|Overall Study|Physician Decision|0|||
130336727|NCT04535453|469203514|FG008|Overall Study|Physician Decision|0|||
130336728|NCT04535453|469203515|FG009|Overall Study|Physician Decision|0|||
130336729|NCT04535453|469203516|FG010|Overall Study|Physician Decision|0|||
130336730|NCT04535453|469203517|FG011|Overall Study|Physician Decision|0|||
130336731|NCT04535453|469203506|FG000|Overall Study|Withdrawal by Subject|3|||
130336732|NCT04535453|469203507|FG001|Overall Study|Withdrawal by Subject|6|||
130336733|NCT04535453|469203508|FG002|Overall Study|Withdrawal by Subject|3|||
130336734|NCT04535453|469203509|FG003|Overall Study|Withdrawal by Subject|3|||
130336735|NCT04535453|469203510|FG004|Overall Study|Withdrawal by Subject|2|||
130336736|NCT04535453|469203511|FG005|Overall Study|Withdrawal by Subject|1|||
130336737|NCT04535453|469203512|FG006|Overall Study|Withdrawal by Subject|1|||
130336738|NCT04535453|469203513|FG007|Overall Study|Withdrawal by Subject|1|||
130336739|NCT04535453|469203514|FG008|Overall Study|Withdrawal by Subject|1|||
130336740|NCT04535453|469203515|FG009|Overall Study|Withdrawal by Subject|1|||
130336741|NCT04535453|469203516|FG010|Overall Study|Withdrawal by Subject|0|||
130336742|NCT04535453|469203517|FG011|Overall Study|Withdrawal by Subject|1|||
130336743|NCT04535453|469203506|FG000|Overall Study|Other|0|||
130336744|NCT04535453|469203507|FG001|Overall Study|Other|0|||
130336745|NCT04535453|469203508|FG002|Overall Study|Other|1|||
130336746|NCT04535453|469203509|FG003|Overall Study|Other|0|||
130336747|NCT04535453|469203510|FG004|Overall Study|Other|1|||
130336748|NCT04535453|469203511|FG005|Overall Study|Other|0|||
130336749|NCT04535453|469203512|FG006|Overall Study|Other|1|||
130336750|NCT04535453|469203513|FG007|Overall Study|Other|1|||
130336751|NCT04535453|469203514|FG008|Overall Study|Other|1|||
130336752|NCT04535453|469203515|FG009|Overall Study|Other|0|||
130336753|NCT04535453|469203516|FG010|Overall Study|Other|0|||
130336754|NCT04535453|469203517|FG011|Overall Study|Other|0|||
130336755|NCT02695420|469203518|FG000|Overall Study|Death|0|||
130336756|NCT02695420|469203519|FG001|Overall Study|Death|1|||
130336757|NCT02695420|469203520|FG002|Overall Study|Death|0|||
130336758|NCT02695420|469203521|FG003|Overall Study|Death|0|||
130336759|NCT00916929|469203524|FG000|Overall Study|Lost to Follow-up|1|||
130336760|NCT00916929|469203525|FG001|Overall Study|Lost to Follow-up|3|||
130336761|NCT00916929|469203524|FG000|Overall Study|Death|5|||
130336762|NCT00916929|469203525|FG001|Overall Study|Death|10|||
130336763|NCT00916929|469203524|FG000|Overall Study|Withdrawal by Subject|1|||
130336764|NCT00916929|469203525|FG001|Overall Study|Withdrawal by Subject|5|||
130336765|NCT00916929|469203524|FG000|Overall Study|Left ventricular epicardial lead|1|||
130336766|NCT00916929|469203525|FG001|Overall Study|Left ventricular epicardial lead|2|||
130336767|NCT00916929|469203524|FG000|Overall Study|Transferred to hospice care|1|||
130336768|NCT00916929|469203525|FG001|Overall Study|Transferred to hospice care|1|||
130336769|NCT00916929|469203524|FG000|Overall Study|System explant|1|||
130336770|NCT00916929|469203525|FG001|Overall Study|System explant|0|||
130336771|NCT00916929|469203524|FG000|Overall Study|Moved to another state|0|||
130336772|NCT00916929|469203525|FG001|Overall Study|Moved to another state|1|||
130336773|NCT00916929|469203524|FG000|Overall Study|Device unable to process impedance data|0|||
130336774|NCT00916929|469203525|FG001|Overall Study|Device unable to process impedance data|7|||
130336775|NCT01742286|469203527|FG000|Escalation Phase|Administrative problems|1|||
130336776|NCT01742286|469203528|FG001|Escalation Phase|Administrative problems|1|||
130336777|NCT01742286|469203529|FG002|Escalation Phase|Administrative problems|0|||
130336778|NCT01742286|469203530|FG003|Escalation Phase|Administrative problems|0|||
130336779|NCT01742286|469203531|FG004|Escalation Phase|Administrative problems|0|||
130336780|NCT01742286|469203532|FG005|Escalation Phase|Administrative problems|0|||
130336781|NCT01742286|469203533|FG006|Escalation Phase|Administrative problems|2|||
130336782|NCT01742286|469203527|FG000|Escalation Phase|Adverse Event|0|||
130336783|NCT01742286|469203528|FG001|Escalation Phase|Adverse Event|1|||
130336784|NCT01742286|469203529|FG002|Escalation Phase|Adverse Event|2|||
130336785|NCT01742286|469203530|FG003|Escalation Phase|Adverse Event|0|||
130336786|NCT01742286|469203531|FG004|Escalation Phase|Adverse Event|0|||
130336787|NCT01742286|469203532|FG005|Escalation Phase|Adverse Event|1|||
130336788|NCT01742286|469203533|FG006|Escalation Phase|Adverse Event|0|||
130336789|NCT01742286|469203527|FG000|Escalation Phase|Disease progression|3|||
130336790|NCT01742286|469203528|FG001|Escalation Phase|Disease progression|7|||
130336791|NCT01742286|469203529|FG002|Escalation Phase|Disease progression|4|||
130336792|NCT01742286|469203530|FG003|Escalation Phase|Disease progression|1|||
130336793|NCT01742286|469203531|FG004|Escalation Phase|Disease progression|4|||
130336794|NCT01742286|469203532|FG005|Escalation Phase|Disease progression|3|||
130336795|NCT01742286|469203533|FG006|Escalation Phase|Disease progression|2|||
130336796|NCT01742286|469203527|FG000|Escalation Phase|Death|0|||
130336797|NCT01742286|469203528|FG001|Escalation Phase|Death|0|||
130336798|NCT01742286|469203529|FG002|Escalation Phase|Death|0|||
130336799|NCT01742286|469203530|FG003|Escalation Phase|Death|0|||
130336800|NCT01742286|469203531|FG004|Escalation Phase|Death|0|||
130336801|NCT01742286|469203532|FG005|Escalation Phase|Death|1|||
130336802|NCT01742286|469203533|FG006|Escalation Phase|Death|0|||
130336803|NCT01742286|469203527|FG000|Escalation Phase|Physician Decision|0|||
130336804|NCT01742286|469203528|FG001|Escalation Phase|Physician Decision|3|||
130336805|NCT01742286|469203529|FG002|Escalation Phase|Physician Decision|0|||
130336806|NCT01742286|469203530|FG003|Escalation Phase|Physician Decision|1|||
130336807|NCT01742286|469203531|FG004|Escalation Phase|Physician Decision|0|||
130336808|NCT01742286|469203532|FG005|Escalation Phase|Physician Decision|0|||
130336809|NCT01742286|469203533|FG006|Escalation Phase|Physician Decision|2|||
130336810|NCT01742286|469203527|FG000|Escalation Phase|Subject/guardian decision|1|||
130336811|NCT01742286|469203528|FG001|Escalation Phase|Subject/guardian decision|0|||
130336812|NCT01742286|469203529|FG002|Escalation Phase|Subject/guardian decision|0|||
130336813|NCT01742286|469203530|FG003|Escalation Phase|Subject/guardian decision|0|||
130336814|NCT01742286|469203531|FG004|Escalation Phase|Subject/guardian decision|0|||
130336815|NCT01742286|469203532|FG005|Escalation Phase|Subject/guardian decision|0|||
130336816|NCT01742286|469203533|FG006|Escalation Phase|Subject/guardian decision|0|||
130336817|NCT01742286|469203527|FG000|Expansion Phase|Administrative problems|0|||
130336818|NCT01742286|469203528|FG001|Expansion Phase|Administrative problems|0|||
130336819|NCT01742286|469203529|FG002|Expansion Phase|Administrative problems|0|||
130336820|NCT01742286|469203530|FG003|Expansion Phase|Administrative problems|0|||
130336821|NCT01742286|469203531|FG004|Expansion Phase|Administrative problems|0|||
130336822|NCT01742286|469203532|FG005|Expansion Phase|Administrative problems|0|||
130336823|NCT01742286|469203533|FG006|Expansion Phase|Administrative problems|5|||
130336824|NCT01742286|469203527|FG000|Expansion Phase|Physician Decision|0|||
130336825|NCT01742286|469203528|FG001|Expansion Phase|Physician Decision|0|||
130336826|NCT01742286|469203529|FG002|Expansion Phase|Physician Decision|4|||
130336827|NCT01742286|469203530|FG003|Expansion Phase|Physician Decision|0|||
130336828|NCT01742286|469203531|FG004|Expansion Phase|Physician Decision|0|||
130336829|NCT01742286|469203532|FG005|Expansion Phase|Physician Decision|0|||
130336830|NCT01742286|469203533|FG006|Expansion Phase|Physician Decision|9|||
130336831|NCT01742286|469203527|FG000|Expansion Phase|Adverse Event|0|||
130336832|NCT01742286|469203528|FG001|Expansion Phase|Adverse Event|0|||
130336833|NCT01742286|469203529|FG002|Expansion Phase|Adverse Event|0|||
130336834|NCT01742286|469203530|FG003|Expansion Phase|Adverse Event|0|||
130336835|NCT01742286|469203531|FG004|Expansion Phase|Adverse Event|0|||
130336836|NCT01742286|469203532|FG005|Expansion Phase|Adverse Event|0|||
130336837|NCT01742286|469203533|FG006|Expansion Phase|Adverse Event|6|||
130336838|NCT01742286|469203527|FG000|Expansion Phase|Disease progression|0|||
130336839|NCT01742286|469203528|FG001|Expansion Phase|Disease progression|0|||
130336840|NCT01742286|469203529|FG002|Expansion Phase|Disease progression|3|||
130336841|NCT01742286|469203530|FG003|Expansion Phase|Disease progression|0|||
130336842|NCT01742286|469203531|FG004|Expansion Phase|Disease progression|0|||
130336843|NCT01742286|469203532|FG005|Expansion Phase|Disease progression|0|||
130336844|NCT01742286|469203533|FG006|Expansion Phase|Disease progression|15|||
130336845|NCT01742286|469203527|FG000|Expansion Phase|Withdrawal by Subject|0|||
130336846|NCT01742286|469203528|FG001|Expansion Phase|Withdrawal by Subject|0|||
130336847|NCT01742286|469203529|FG002|Expansion Phase|Withdrawal by Subject|0|||
130336848|NCT01742286|469203530|FG003|Expansion Phase|Withdrawal by Subject|0|||
130336849|NCT01742286|469203531|FG004|Expansion Phase|Withdrawal by Subject|0|||
130336850|NCT01742286|469203532|FG005|Expansion Phase|Withdrawal by Subject|0|||
130336851|NCT01742286|469203533|FG006|Expansion Phase|Withdrawal by Subject|1|||
130336852|NCT04530136|469203534|FG000|Overall Study|Lost to Follow-up|2|||
130336853|NCT04530136|469203535|FG001|Overall Study|Lost to Follow-up|3|||
130336854|NCT04530136|469203534|FG000|Overall Study|Withdrawal by Subject|1|||
130336855|NCT04530136|469203535|FG001|Overall Study|Withdrawal by Subject|0|||
130336856|NCT04530136|469203534|FG000|Overall Study|Death|0|||
130336857|NCT04530136|469203535|FG001|Overall Study|Death|1|||
130336858|NCT02087423|469203536|FG000|Overall Study|Withdrawal by Subject|20|||
130336859|NCT02087423|469203537|FG001|Overall Study|Withdrawal by Subject|20|||
130336860|NCT02087423|469203538|FG002|Overall Study|Withdrawal by Subject|3|||
130336861|NCT02087423|469203536|FG000|Overall Study|Death|68|||
130336862|NCT02087423|469203537|FG001|Overall Study|Death|207|||
130336863|NCT02087423|469203538|FG002|Overall Study|Death|40|||
130336864|NCT02087423|469203536|FG000|Overall Study|Lost to Follow-up|0|||
130336865|NCT02087423|469203537|FG001|Overall Study|Lost to Follow-up|2|||
130336866|NCT02087423|469203538|FG002|Overall Study|Lost to Follow-up|0|||
130336867|NCT02087423|469203536|FG000|Overall Study|Terminated from study at final DCO|23|||
130336868|NCT02087423|469203537|FG001|Overall Study|Terminated from study at final DCO|36|||
130336869|NCT02087423|469203538|FG002|Overall Study|Terminated from study at final DCO|25|||
130336870|NCT01387542|469203539|FG000|Overall Study|Adverse Event|3|||
130336871|NCT01387542|469203539|FG000|Overall Study|Withdrawal by Subject|1|||
130336872|NCT01387542|469203539|FG000|Overall Study|Changed diagnosis|1|||
130336873|NCT01387542|469203539|FG000|Overall Study|Insufficient response|1|||
130336874|NCT01387542|469203539|FG000|Overall Study|Non-compliant|1|||
130336875|NCT01387542|469203539|FG000|Overall Study|Lost to Follow-up|1|||
130336876|NCT01010867|469203540|FG000|Overall Study|< 50% adherence to probiotic|1|||
130336877|NCT01233232|469203543|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
130336878|NCT01233232|469203544|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
130336879|NCT01233232|469203545|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
130336880|NCT02762370|469203546|FG000|Overall Study|Protocol Violation|1|||
130336881|NCT02762370|469203547|FG001|Overall Study|Protocol Violation|0|||
130336882|NCT03500224|469203548|FG000|Overall Study|Withdrawal by Subject|2|||
130336883|NCT01324401|469203551|FG000|Overall Study|Withdrawn before any treatment|0|||
130336884|NCT01324401|469203552|FG001|Overall Study|Withdrawn before any treatment|3|||
130671047|NCT03264066|470420130|FG003|Overall Study|Lost to Follow-up|0|||
130671048|NCT03264066|470420131|FG004|Overall Study|Lost to Follow-up|0|||
130671049|NCT03264066|470420132|FG005|Overall Study|Lost to Follow-up|0|||
130336885|NCT01324401|469203551|FG000|Overall Study|Adverse Event|1|||
130336886|NCT01324401|469203552|FG001|Overall Study|Adverse Event|3|||
130336887|NCT01708902|469203554|FG000|Overall Study|Adverse Event|3|||
130336888|NCT01708902|469203555|FG001|Overall Study|Adverse Event|4|||
130336889|NCT01708902|469203556|FG002|Overall Study|Adverse Event|9|||
130336890|NCT01708902|469203557|FG003|Overall Study|Adverse Event|2|||
130336891|NCT01708902|469203558|FG004|Overall Study|Adverse Event|7|||
130336892|NCT01708902|469203559|FG005|Overall Study|Adverse Event|3|||
130336893|NCT01708902|469203560|FG006|Overall Study|Adverse Event|5|||
130336894|NCT01708902|469203554|FG000|Overall Study|Lack of Efficacy|3|||
130336895|NCT01708902|469203555|FG001|Overall Study|Lack of Efficacy|1|||
130336896|NCT01708902|469203556|FG002|Overall Study|Lack of Efficacy|0|||
130336897|NCT01708902|469203557|FG003|Overall Study|Lack of Efficacy|0|||
130336898|NCT01708902|469203558|FG004|Overall Study|Lack of Efficacy|0|||
130336899|NCT01708902|469203559|FG005|Overall Study|Lack of Efficacy|1|||
130336900|NCT01708902|469203560|FG006|Overall Study|Lack of Efficacy|0|||
130336901|NCT01708902|469203554|FG000|Overall Study|Non compliance with protocol|0|||
130336902|NCT01708902|469203555|FG001|Overall Study|Non compliance with protocol|2|||
130336903|NCT01708902|469203556|FG002|Overall Study|Non compliance with protocol|1|||
130336904|NCT01708902|469203557|FG003|Overall Study|Non compliance with protocol|3|||
130336905|NCT01708902|469203558|FG004|Overall Study|Non compliance with protocol|0|||
130336906|NCT01708902|469203559|FG005|Overall Study|Non compliance with protocol|0|||
130336907|NCT01708902|469203560|FG006|Overall Study|Non compliance with protocol|0|||
130336908|NCT01708902|469203554|FG000|Overall Study|Lost to Follow-up|2|||
130336909|NCT01708902|469203555|FG001|Overall Study|Lost to Follow-up|1|||
130336910|NCT01708902|469203556|FG002|Overall Study|Lost to Follow-up|2|||
130336911|NCT01708902|469203557|FG003|Overall Study|Lost to Follow-up|2|||
130336912|NCT01708902|469203558|FG004|Overall Study|Lost to Follow-up|0|||
130336913|NCT01708902|469203559|FG005|Overall Study|Lost to Follow-up|0|||
130336914|NCT01708902|469203560|FG006|Overall Study|Lost to Follow-up|1|||
130336915|NCT01708902|469203554|FG000|Overall Study|Refused to continue trial medication|8|||
130336916|NCT01708902|469203555|FG001|Overall Study|Refused to continue trial medication|0|||
130336917|NCT01708902|469203556|FG002|Overall Study|Refused to continue trial medication|4|||
130336918|NCT01708902|469203557|FG003|Overall Study|Refused to continue trial medication|2|||
130336919|NCT01708902|469203558|FG004|Overall Study|Refused to continue trial medication|8|||
130336920|NCT01708902|469203559|FG005|Overall Study|Refused to continue trial medication|1|||
130336921|NCT01708902|469203560|FG006|Overall Study|Refused to continue trial medication|1|||
130336922|NCT01708902|469203554|FG000|Overall Study|Other Reason|1|||
130336923|NCT01708902|469203555|FG001|Overall Study|Other Reason|0|||
130336924|NCT01708902|469203556|FG002|Overall Study|Other Reason|1|||
130336925|NCT01708902|469203557|FG003|Overall Study|Other Reason|1|||
130336926|NCT01708902|469203558|FG004|Overall Study|Other Reason|1|||
130336927|NCT01708902|469203559|FG005|Overall Study|Other Reason|2|||
130336928|NCT01708902|469203560|FG006|Overall Study|Other Reason|0|||
130336929|NCT02633020|469203562|FG000|Overall Study|Adverse Event|1|||
130336930|NCT02633020|469203563|FG001|Overall Study|Adverse Event|0|||
130336931|NCT00530816|469203564|FG000|Overall Study|Progressive Disease|16|||
130336932|NCT00530816|469203565|FG001|Overall Study|Progressive Disease|24|||
130336933|NCT00530816|469203566|FG002|Overall Study|Progressive Disease|24|||
130336934|NCT00530816|469203564|FG000|Overall Study|Adverse Event|6|||
130336935|NCT00530816|469203565|FG001|Overall Study|Adverse Event|13|||
130336936|NCT00530816|469203566|FG002|Overall Study|Adverse Event|7|||
130336937|NCT00530816|469203564|FG000|Overall Study|Other|3|||
130336938|NCT00530816|469203565|FG001|Overall Study|Other|3|||
130336939|NCT00530816|469203566|FG002|Overall Study|Other|4|||
130336940|NCT00530816|469203564|FG000|Overall Study|Withdrawal by Subject|1|||
130336941|NCT00530816|469203565|FG001|Overall Study|Withdrawal by Subject|2|||
130336942|NCT00530816|469203566|FG002|Overall Study|Withdrawal by Subject|6|||
130336943|NCT01136785|469203567|FG000|Overall Study|Protocol Violation|2|||
130336944|NCT01136785|469203568|FG001|Overall Study|Protocol Violation|1|||
130336945|NCT01388985|469203571|FG000|Overall Study|Death|0|||
130336946|NCT01388985|469203572|FG001|Overall Study|Death|1|||
130336947|NCT01388985|469203571|FG000|Overall Study|Lost to Follow-up|30|||
130336948|NCT01388985|469203572|FG001|Overall Study|Lost to Follow-up|30|||
130336949|NCT01388985|469203571|FG000|Overall Study|Withdrawal by Subject|13|||
130336950|NCT01388985|469203572|FG001|Overall Study|Withdrawal by Subject|4|||
130336951|NCT01388985|469203571|FG000|Overall Study|Subject unavailable|1|||
130336952|NCT01388985|469203572|FG001|Overall Study|Subject unavailable|1|||
130671050|NCT03264066|470420127|FG000|Overall Study|Progressive Disease|0|||
130336953|NCT01388985|469203571|FG000|Overall Study|Other (no reason)|0|||
130336954|NCT01388985|469203572|FG001|Overall Study|Other (no reason)|1|||
130671051|NCT03264066|470420128|FG001|Overall Study|Progressive Disease|2|||
130336955|NCT01388985|469203571|FG000|Overall Study|Error of nurse|5|||
130336956|NCT01388985|469203572|FG001|Overall Study|Error of nurse|1|||
130671052|NCT03264066|470420129|FG002|Overall Study|Progressive Disease|1|||
130336957|NCT01057589|469203573|FG000|Overall Study|Disease Progression|35|||
130336958|NCT01057589|469203573|FG000|Overall Study|Adverse Event|10|||
130336959|NCT01057589|469203573|FG000|Overall Study|Physician Decision|8|||
130336960|NCT01057589|469203573|FG000|Overall Study|Withdrawal by Subject|3|||
130336961|NCT01057589|469203573|FG000|Overall Study|Sponsor Decision|1|||
130336962|NCT01057589|469203573|FG000|Overall Study|Death|8|||
130336963|NCT01057589|469203573|FG000|Overall Study|Lost to Follow-up|1|||
130336964|NCT02954172|469203578|FG000|Overall Study|Protocol Violation|3|||
130336965|NCT02954172|469203579|FG001|Overall Study|Protocol Violation|0|||
130336966|NCT02954172|469203578|FG000|Overall Study|allergic reaction|2|||
130336967|NCT02954172|469203579|FG001|Overall Study|allergic reaction|1|||
130336968|NCT02954172|469203578|FG000|Overall Study|non-measurable lesions at baseline|1|||
130336969|NCT02954172|469203579|FG001|Overall Study|non-measurable lesions at baseline|2|||
130336970|NCT00853567|469203580|FG000|Overall Study|Study prematurely terminated|71|||
130336971|NCT01497366|469203584|FG000|Overall Study|Virologic failure|2|||
130336972|NCT01497366|469203585|FG001|Overall Study|Virologic failure|50|||
130336973|NCT01497366|469203584|FG000|Overall Study|Lost to Follow-up|11|||
130336974|NCT01497366|469203585|FG001|Overall Study|Lost to Follow-up|10|||
130336975|NCT01497366|469203584|FG000|Overall Study|Withdrawal by Subject|6|||
130336976|NCT01497366|469203585|FG001|Overall Study|Withdrawal by Subject|6|||
130336977|NCT01497366|469203584|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
130336978|NCT01497366|469203585|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
130336979|NCT01497366|469203584|FG000|Overall Study|Other|5|||
130336980|NCT01497366|469203585|FG001|Overall Study|Other|0|||
130336981|NCT01497366|469203584|FG000|Overall Study|Death|1|||
130336982|NCT01497366|469203585|FG001|Overall Study|Death|1|||
130336983|NCT01497366|469203584|FG000|Overall Study|Randomized but not treated|7|||
130336984|NCT01497366|469203585|FG001|Overall Study|Randomized but not treated|21|||
130336985|NCT02745080|469203599|FG000|Overall Study|Adverse Event|13|||
130671053|NCT03264066|470420130|FG003|Overall Study|Progressive Disease|0|||
130336986|NCT02745080|469203600|FG001|Overall Study|Adverse Event|21|||
130671054|NCT03264066|470420131|FG004|Overall Study|Progressive Disease|0|||
130671055|NCT03264066|470420132|FG005|Overall Study|Progressive Disease|0|||
130671056|NCT03264066|470420127|FG000|Overall Study|Study Terminated by Sponsor|5|||
130671057|NCT03264066|470420128|FG001|Overall Study|Study Terminated by Sponsor|5|||
130671058|NCT03264066|470420129|FG002|Overall Study|Study Terminated by Sponsor|8|||
130671059|NCT03264066|470420130|FG003|Overall Study|Study Terminated by Sponsor|5|||
130671060|NCT03264066|470420131|FG004|Overall Study|Study Terminated by Sponsor|1|||
130671061|NCT03264066|470420132|FG005|Overall Study|Study Terminated by Sponsor|2|||
130336987|NCT02745080|469203599|FG000|Overall Study|Lack of Efficacy|11|||
130336988|NCT02745080|469203600|FG001|Overall Study|Lack of Efficacy|23|||
130336989|NCT02745080|469203599|FG000|Overall Study|Lost to Follow-up|3|||
130336990|NCT02745080|469203600|FG001|Overall Study|Lost to Follow-up|3|||
130336991|NCT02745080|469203599|FG000|Overall Study|Physician Decision|3|||
130336992|NCT02745080|469203600|FG001|Overall Study|Physician Decision|0|||
130336993|NCT02745080|469203599|FG000|Overall Study|Protocol Violation|3|||
130336994|NCT02745080|469203600|FG001|Overall Study|Protocol Violation|1|||
130336995|NCT02745080|469203599|FG000|Overall Study|Withdrawal by Subject|22|||
130336996|NCT02745080|469203600|FG001|Overall Study|Withdrawal by Subject|41|||
130336997|NCT00531427|469203603|FG000|Overall Study|Withdrawal by Subject|7|||
130336998|NCT00531427|469203604|FG001|Overall Study|Withdrawal by Subject|13|||
130336999|NCT00531427|469203603|FG000|Overall Study|Adverse Event|44|||
130337000|NCT00531427|469203604|FG001|Overall Study|Adverse Event|30|||
130337001|NCT00531427|469203603|FG000|Overall Study|Lost to Follow-up|4|||
130337002|NCT00531427|469203604|FG001|Overall Study|Lost to Follow-up|3|||
130337003|NCT00531427|469203603|FG000|Overall Study|Lack of Efficacy|14|||
130337004|NCT00531427|469203604|FG001|Overall Study|Lack of Efficacy|39|||
130337005|NCT00531427|469203603|FG000|Overall Study|Administrative|4|||
130337006|NCT00531427|469203604|FG001|Overall Study|Administrative|9|||
130337007|NCT00843284|469205417|FG000|Overall Study|Adverse Event|39|||
130337008|NCT00843284|469205417|FG000|Overall Study|Lack of Efficacy|5|||
130337009|NCT00843284|469205417|FG000|Overall Study|Lost to Follow-up|11|||
130337010|NCT00843284|469205417|FG000|Overall Study|Other|10|||
130337011|NCT00843284|469205417|FG000|Overall Study|Withdrawal by Subject|4|||
130337012|NCT00843284|469205417|FG000|Overall Study|Death|3|||
130337013|NCT00798759|469205421|FG000|Overall Study|Adverse Event|3|||
130337014|NCT00798759|469205422|FG001|Overall Study|Adverse Event|3|||
130337015|NCT00798759|469205421|FG000|Overall Study|Lost to Follow-up|1|||
130671062|NCT03264066|470420127|FG000|Overall Study|Withdrawal by Subject|1|||
130337016|NCT00798759|469205422|FG001|Overall Study|Lost to Follow-up|1|||
130337017|NCT00798759|469205421|FG000|Overall Study|Protocol Violation|4|||
130337018|NCT00798759|469205422|FG001|Overall Study|Protocol Violation|8|||
130337019|NCT00798759|469205421|FG000|Overall Study|Other|0|||
130337020|NCT00798759|469205422|FG001|Overall Study|Other|1|||
130337021|NCT00724711|469205423|FG000|Overall Study|Adverse Event|7|||
130337022|NCT00724711|469205424|FG001|Overall Study|Adverse Event|3|||
130337023|NCT00724711|469205423|FG000|Overall Study|Pregnancy|0|||
130671063|NCT03264066|470420128|FG001|Overall Study|Withdrawal by Subject|0|||
130671064|NCT03264066|470420129|FG002|Overall Study|Withdrawal by Subject|0|||
130720922|NCT00724048|470601564|FG003|Overall Study|Lost to Follow-up|0|||
130337024|NCT00724711|469205424|FG001|Overall Study|Pregnancy|1|||
130337025|NCT00724711|469205423|FG000|Overall Study|Lack of Efficacy|0|||
130337026|NCT00724711|469205424|FG001|Overall Study|Lack of Efficacy|1|||
130337027|NCT00724711|469205423|FG000|Overall Study|Physician Decision|0|||
130337028|NCT00724711|469205424|FG001|Overall Study|Physician Decision|3|||
130337029|NCT00724711|469205423|FG000|Overall Study|Withdrawal by Subject|5|||
130337030|NCT00724711|469205424|FG001|Overall Study|Withdrawal by Subject|4|||
130337031|NCT00724711|469205423|FG000|Overall Study|Lost to Follow-up|4|||
130337032|NCT00724711|469205424|FG001|Overall Study|Lost to Follow-up|5|||
130337033|NCT00724711|469205423|FG000|Overall Study|Protocol Violation|1|||
130337034|NCT00724711|469205424|FG001|Overall Study|Protocol Violation|0|||
130337035|NCT01945710|469205425|FG000|Overall Study|Progressive Disease|5|||
130337036|NCT01945710|469205426|FG001|Overall Study|Progressive Disease|4|||
130337037|NCT01945710|469205427|FG002|Overall Study|Progressive Disease|3|||
130337038|NCT01945710|469205428|FG003|Overall Study|Progressive Disease|2|||
130337039|NCT01945710|469205429|FG004|Overall Study|Progressive Disease|7|||
130337040|NCT01945710|469205430|FG005|Overall Study|Progressive Disease|3|||
130337041|NCT01945710|469205431|FG006|Overall Study|Progressive Disease|19|||
130337042|NCT01945710|469205425|FG000|Overall Study|Adverse Event|0|||
130337043|NCT01945710|469205426|FG001|Overall Study|Adverse Event|1|||
130337044|NCT01945710|469205427|FG002|Overall Study|Adverse Event|0|||
130337045|NCT01945710|469205428|FG003|Overall Study|Adverse Event|0|||
130337046|NCT01945710|469205429|FG004|Overall Study|Adverse Event|0|||
130337047|NCT01945710|469205430|FG005|Overall Study|Adverse Event|0|||
130337048|NCT01945710|469205431|FG006|Overall Study|Adverse Event|0|||
130337049|NCT01945710|469205425|FG000|Overall Study|Other|2|||
130337050|NCT01945710|469205426|FG001|Overall Study|Other|0|||
130337051|NCT01945710|469205427|FG002|Overall Study|Other|3|||
130337052|NCT01945710|469205428|FG003|Overall Study|Other|1|||
130337053|NCT01945710|469205429|FG004|Overall Study|Other|1|||
130337054|NCT01945710|469205430|FG005|Overall Study|Other|0|||
130337055|NCT01945710|469205431|FG006|Overall Study|Other|4|||
130337056|NCT01945710|469205425|FG000|Overall Study|Withdrawal by Subject|0|||
130337057|NCT01945710|469205426|FG001|Overall Study|Withdrawal by Subject|1|||
130337058|NCT01945710|469205427|FG002|Overall Study|Withdrawal by Subject|1|||
130337059|NCT01945710|469205428|FG003|Overall Study|Withdrawal by Subject|0|||
130337060|NCT01945710|469205429|FG004|Overall Study|Withdrawal by Subject|1|||
130337061|NCT01945710|469205430|FG005|Overall Study|Withdrawal by Subject|0|||
130337062|NCT01945710|469205431|FG006|Overall Study|Withdrawal by Subject|0|||
130337063|NCT00375609|469205432|FG000|Overall Study|Did not receive treatment|1|||
130337064|NCT00375609|469205433|FG001|Overall Study|Did not receive treatment|0|||
130337065|NCT00375609|469205434|FG002|Overall Study|Did not receive treatment|0|||
130337066|NCT00375609|469205432|FG000|Overall Study|Adverse Event|0|||
130337067|NCT00375609|469205433|FG001|Overall Study|Adverse Event|3|||
130337068|NCT00375609|469205434|FG002|Overall Study|Adverse Event|0|||
130337069|NCT00375609|469205432|FG000|Overall Study|Lost to Follow-up|1|||
130337070|NCT00375609|469205433|FG001|Overall Study|Lost to Follow-up|0|||
130337071|NCT00375609|469205434|FG002|Overall Study|Lost to Follow-up|0|||
130671065|NCT03264066|470420130|FG003|Overall Study|Withdrawal by Subject|5|||
130671066|NCT03264066|470420131|FG004|Overall Study|Withdrawal by Subject|0|||
130671067|NCT03264066|470420132|FG005|Overall Study|Withdrawal by Subject|0|||
130671068|NCT01193517|470420138|FG000|Overall Study|Early Progression|1|||
130671069|NCT01193517|470420139|FG001|Overall Study|Early Progression|0|||
130671070|NCT01193517|470420140|FG002|Overall Study|Early Progression|0|||
130671071|NCT02115256|470420141|FG000|Overall Study|Withdrawal by Subject|0|||
130671072|NCT02115256|470420142|FG001|Overall Study|Withdrawal by Subject|1|||
130671073|NCT00905489|470420145|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
130671074|NCT00905489|470420145|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
130671075|NCT00905489|470420145|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
130671076|NCT02668302|470420149|FG000|Overall Study|Withdrawal by Subject|1|||
130671077|NCT02668302|470420150|FG001|Overall Study|Withdrawal by Subject|0|||
130671078|NCT03775681|470420151|FG000|Overall Study|Physician Decision|3|||
130671079|NCT00616928|470420152|FG000|Overall Study|Adverse Event|6|||
130671080|NCT00616928|470420153|FG001|Overall Study|Adverse Event|3|||
130671081|NCT00616928|470420154|FG002|Overall Study|Adverse Event|2|||
130337072|NCT00375609|469205432|FG000|Overall Study|Physician Decision|0|||
130337073|NCT00375609|469205433|FG001|Overall Study|Physician Decision|0|||
130337074|NCT00375609|469205434|FG002|Overall Study|Physician Decision|1|||
130337075|NCT00375609|469205432|FG000|Overall Study|Withdrawal by Subject|1|||
130337076|NCT00375609|469205433|FG001|Overall Study|Withdrawal by Subject|4|||
130337077|NCT00375609|469205434|FG002|Overall Study|Withdrawal by Subject|0|||
130337078|NCT00375609|469205432|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
130337079|NCT00375609|469205433|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130671082|NCT00616928|470420155|FG003|Overall Study|Adverse Event|2|||
130671083|NCT00616928|470420152|FG000|Overall Study|Other|51|||
130671084|NCT00616928|470420153|FG001|Overall Study|Other|8|||
130671085|NCT00616928|470420154|FG002|Overall Study|Other|15|||
130671086|NCT00616928|470420155|FG003|Overall Study|Other|5|||
130671087|NCT00616928|470420152|FG000|Overall Study|Lost to Follow-up|5|||
130671088|NCT00616928|470420153|FG001|Overall Study|Lost to Follow-up|7|||
130671089|NCT00616928|470420154|FG002|Overall Study|Lost to Follow-up|0|||
130671090|NCT00616928|470420155|FG003|Overall Study|Lost to Follow-up|0|||
130671091|NCT01512979|470420160|FG000|Overall Study|Adverse Event|2|||
130671092|NCT01512979|470420161|FG001|Overall Study|Adverse Event|2|||
130671093|NCT01512979|470420160|FG000|Overall Study|Protocol Violation|1|||
130671094|NCT01512979|470420161|FG001|Overall Study|Protocol Violation|4|||
130671095|NCT01512979|470420160|FG000|Overall Study|Lost to Follow-up|2|||
130671096|NCT01512979|470420161|FG001|Overall Study|Lost to Follow-up|5|||
130671097|NCT01512979|470420160|FG000|Overall Study|Withdrawal by Subject|1|||
130671098|NCT01512979|470420161|FG001|Overall Study|Withdrawal by Subject|2|||
130671099|NCT01512979|470420160|FG000|Overall Study|Reason other than stated above|13|||
130671100|NCT01512979|470420161|FG001|Overall Study|Reason other than stated above|9|||
130671101|NCT00526890|470420165|FG000|Overall Study|Adverse Event|2|||
130671102|NCT03529955|470420166|FG000|Overall Study|Adverse Event|1|||
130337080|NCT00375609|469205434|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130337081|NCT02338882|469205439|FG000|Overall Study|Death|1|||
130337082|NCT02338882|469205440|FG001|Overall Study|Death|0|||
130337083|NCT02338882|469205439|FG000|Overall Study|Lost to Follow-up|6|||
130337084|NCT02338882|469205440|FG001|Overall Study|Lost to Follow-up|3|||
130337085|NCT04838977|469205443|FG000|Overall Study|Lost to Follow-up|2|||
130337086|NCT04838977|469205444|FG001|Overall Study|Lost to Follow-up|3|||
130337087|NCT04838977|469205443|FG000|Overall Study|Withdrawal by Subject|1|||
130337088|NCT04838977|469205444|FG001|Overall Study|Withdrawal by Subject|1|||
130337089|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337090|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337091|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
130337092|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
130337093|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
130337094|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
130337095|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
130337096|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337097|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
130337098|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337099|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337100|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337101|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337102|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337103|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337104|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337105|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337106|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337107|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337108|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337109|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337110|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337111|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337112|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337113|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337114|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
130337115|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337116|NCT01536067|469205458|FG000|Overall Study|Disease Progression|1|||
130337117|NCT03120351|469205459|FG000|Overall Study|Physician Decision|1|||
130337118|NCT03120351|469205460|FG001|Overall Study|Physician Decision|1|||
130671103|NCT03529955|470420166|FG000|Overall Study|Lack of Efficacy|1|||
130671104|NCT00580983|470420167|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
130671105|NCT02468557|470421674|FG000|Overall Study|Adverse Event|1|||
130671106|NCT02468557|470421674|FG000|Overall Study|Death|1|||
130671107|NCT02468557|470421674|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
130671108|NCT02468557|470421674|FG000|Overall Study|All Enrolled but Never Dosed|4|||
130337119|NCT01256190|469205461|FG000|Overall Study|Lost to Follow-up|2|||
130337120|NCT01256190|469205462|FG001|Overall Study|Lost to Follow-up|0|||
130337121|NCT02350478|469205463|FG000|Overall Study|Lost to Follow-up|5|||
130337122|NCT02350478|469205464|FG001|Overall Study|Lost to Follow-up|1|||
130337123|NCT03646123|469205477|FG000|Overall Study|Withdrawal by Subject|2|||
130337124|NCT03646123|469205478|FG001|Overall Study|Withdrawal by Subject|2|||
130337125|NCT03646123|469205479|FG002|Overall Study|Withdrawal by Subject|3|||
130337126|NCT03646123|469205477|FG000|Overall Study|Study termination by sponsor|0|||
130671109|NCT00759148|470421678|FG000|Overall Study|Adverse Event|1|||
130671110|NCT00759148|470421679|FG001|Overall Study|Adverse Event|6|||
130671111|NCT00759148|470421678|FG000|Overall Study|Withdrawal by Subject|3|||
130671112|NCT00759148|470421679|FG001|Overall Study|Withdrawal by Subject|7|||
130671113|NCT00759148|470421678|FG000|Overall Study|Lost to Follow-up|3|||
130337127|NCT03646123|469205478|FG001|Overall Study|Study termination by sponsor|45|||
130337128|NCT03646123|469205479|FG002|Overall Study|Study termination by sponsor|139|||
130337129|NCT03646123|469205477|FG000|Overall Study|Lost to Follow-up|4|||
130337130|NCT03646123|469205478|FG001|Overall Study|Lost to Follow-up|10|||
130337131|NCT03646123|469205479|FG002|Overall Study|Lost to Follow-up|10|||
130337132|NCT03646123|469205477|FG000|Overall Study|Death|2|||
130337133|NCT03646123|469205478|FG001|Overall Study|Death|1|||
130337134|NCT03646123|469205479|FG002|Overall Study|Death|1|||
130337135|NCT03646123|469205477|FG000|Overall Study|Other|2|||
130337136|NCT03646123|469205478|FG001|Overall Study|Other|0|||
130337137|NCT03646123|469205479|FG002|Overall Study|Other|2|||
130337138|NCT04195893|469205486|FG000|Second Intervention|Withdrawal by Subject|1|||
130337139|NCT04195893|469205487|FG001|Second Intervention|Withdrawal by Subject|0|||
130337140|NCT03679754|469205490|FG000|Overall Study|Investigator request|1|||
130337141|NCT00964171|469205491|FG000|Overall Study|Death|5|||
130337142|NCT03037580|469205495|FG000|Overall Study|Withdrawal by Subject|3|||
130337143|NCT03037580|469205496|FG001|Overall Study|Withdrawal by Subject|0|||
130337144|NCT03037580|469205495|FG000|Overall Study|Adverse Event|1|||
130337145|NCT03037580|469205496|FG001|Overall Study|Adverse Event|0|||
130337146|NCT03037580|469205495|FG000|Overall Study|Study Terminated by Sponsor|12|||
130337147|NCT03037580|469205496|FG001|Overall Study|Study Terminated by Sponsor|15|||
130337148|NCT03037580|469205495|FG000|Overall Study|Death|0|||
130337149|NCT03037580|469205496|FG001|Overall Study|Death|1|||
130337150|NCT02442804|469205497|FG000|Overall Study|Withdrawal by Subject|0|||
130337151|NCT02442804|469205498|FG001|Overall Study|Withdrawal by Subject|1|||
130337152|NCT02442804|469205497|FG000|Overall Study|Adverse Event|1|||
130337153|NCT02442804|469205498|FG001|Overall Study|Adverse Event|0|||
130337154|NCT02036853|469205499|FG000|Overall Study|Adverse Event|0|||
130337155|NCT02036853|469205500|FG001|Overall Study|Adverse Event|2|||
130337156|NCT02036853|469205499|FG000|Overall Study|Lack of Efficacy|0|||
130337157|NCT02036853|469205500|FG001|Overall Study|Lack of Efficacy|2|||
130337158|NCT02036853|469205499|FG000|Overall Study|Physician Decision|0|||
130337159|NCT02036853|469205500|FG001|Overall Study|Physician Decision|1|||
130337160|NCT02036853|469205499|FG000|Overall Study|Withdrawal by Subject|0|||
130337161|NCT02036853|469205500|FG001|Overall Study|Withdrawal by Subject|1|||
130337162|NCT01309282|469205504|FG000|Overall Study|Lost to Follow-up|1|||
130337163|NCT00499590|469205507|FG000|Overall Study|Study Terminated|112|||
130337164|NCT00499590|469205508|FG001|Overall Study|Study Terminated|112|||
130337165|NCT00499590|469205509|FG002|Overall Study|Study Terminated|112|||
130337166|NCT00499590|469205507|FG000|Overall Study|Not treated|1|||
130337167|NCT00499590|469205508|FG001|Overall Study|Not treated|0|||
130337168|NCT00499590|469205509|FG002|Overall Study|Not treated|1|||
130337169|NCT05661851|469205511|FG000|Overall Study|Protocol Violation|1|||
130337170|NCT05661851|469205512|FG001|Overall Study|Protocol Violation|1|||
130337171|NCT05661851|469205511|FG000|Overall Study|Covid-19 Related|3|||
130337172|NCT05661851|469205512|FG001|Overall Study|Covid-19 Related|4|||
130337173|NCT05661851|469205511|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
130337174|NCT05661851|469205512|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
130337175|NCT05661851|469205511|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
130337176|NCT05661851|469205512|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
130337177|NCT00612807|469205513|FG000|Overall Study|Withdrawal by Subject|2|||
130337178|NCT00612807|469205514|FG001|Overall Study|Withdrawal by Subject|0|||
130337179|NCT02055118|469205521|FG000|Overall Study|Withdrawal by Subject|0|||
130337180|NCT02055118|469205522|FG001|Overall Study|Withdrawal by Subject|2|||
130337181|NCT02055118|469205523|FG002|Overall Study|Withdrawal by Subject|0|||
130337182|NCT02281383|469205524|FG000|Overall Study|Progressive Disease|1|||
130337183|NCT02281383|469205524|FG000|Overall Study|Withdrawal by Subject|6|||
130337184|NCT02281383|469205524|FG000|Overall Study|Protocol Violation|2|||
130337185|NCT02281383|469205524|FG000|Overall Study|Death|1|||
130337186|NCT02281383|469205524|FG000|Overall Study|Adverse Event|2|||
130337187|NCT02259088|469205525|FG000|Overall Study|Adverse Event|6|||
130671114|NCT00759148|470421679|FG001|Overall Study|Lost to Follow-up|9|||
130671115|NCT00759148|470421678|FG000|Overall Study|Treatment Failure|6|||
130671116|NCT00759148|470421679|FG001|Overall Study|Treatment Failure|10|||
130337188|NCT02259088|469205526|FG001|Overall Study|Adverse Event|4|||
130671117|NCT00759148|470421678|FG000|Overall Study|Reason not given|1|||
130337189|NCT02259088|469205525|FG000|Overall Study|Lost to Follow-up|2|||
130337190|NCT02259088|469205526|FG001|Overall Study|Lost to Follow-up|0|||
130337191|NCT02259088|469205525|FG000|Overall Study|Death|2|||
130337192|NCT02259088|469205526|FG001|Overall Study|Death|0|||
130337193|NCT02259088|469205525|FG000|Overall Study|Physician Decision|5|||
130337194|NCT02259088|469205526|FG001|Overall Study|Physician Decision|2|||
130337195|NCT02259088|469205525|FG000|Overall Study|Protocol deviation|5|||
130337196|NCT02259088|469205526|FG001|Overall Study|Protocol deviation|0|||
130337197|NCT02259088|469205525|FG000|Overall Study|Subject/guardian decision|8|||
130337198|NCT02259088|469205526|FG001|Overall Study|Subject/guardian decision|8|||
130337199|NCT01001325|469205529|FG000|Overall Study|Lost to Follow-up|16|||
130671118|NCT00759148|470421679|FG001|Overall Study|Reason not given|0|||
130671119|NCT03381248|470421680|FG000|0-6 Months|Withdrawal by Subject|4|||
130671120|NCT03381248|470421681|FG001|0-6 Months|Withdrawal by Subject|1|||
130671121|NCT03381248|470421680|FG000|0-6 Months|Lost to Follow-up|3|||
130671122|NCT03381248|470421681|FG001|0-6 Months|Lost to Follow-up|2|||
130671123|NCT03381248|470421680|FG000|0-6 Months|Lack of Efficacy|1|||
130671124|NCT03381248|470421681|FG001|0-6 Months|Lack of Efficacy|0|||
130671125|NCT03381248|470421680|FG000|0-6 Months|Adverse Event|1|||
130671126|NCT03381248|470421681|FG001|0-6 Months|Adverse Event|0|||
130671127|NCT03381248|470421680|FG000|0-6 Months|Protocol Violation|2|||
130671128|NCT03381248|470421681|FG001|0-6 Months|Protocol Violation|1|||
130671129|NCT03381248|470421680|FG000|0-6 Months|Physician Decision|1|||
130671130|NCT03381248|470421681|FG001|0-6 Months|Physician Decision|0|||
130671131|NCT03381248|470421680|FG000|0-6 Months|Planning another procedure|1|||
130671132|NCT03381248|470421681|FG001|0-6 Months|Planning another procedure|2|||
130671133|NCT03381248|470421680|FG000|6-12 Months|Withdrawal by Subject|1|||
130671134|NCT03381248|470421681|FG001|6-12 Months|Withdrawal by Subject|3|||
130671135|NCT03381248|470421680|FG000|6-12 Months|Lost to Follow-up|0|||
130671136|NCT03381248|470421681|FG001|6-12 Months|Lost to Follow-up|2|||
130671137|NCT03381248|470421680|FG000|6-12 Months|Protocol Violation|3|||
130671138|NCT03381248|470421681|FG001|6-12 Months|Protocol Violation|2|||
130671139|NCT03381248|470421680|FG000|6-12 Months|Planning another procedure|6|||
130671140|NCT03381248|470421681|FG001|6-12 Months|Planning another procedure|2|||
130671141|NCT03381248|470421680|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
130671142|NCT03381248|470421681|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
130671143|NCT03381248|470421680|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
130671144|NCT03381248|470421681|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
130671145|NCT03381248|470421680|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
130671146|NCT03381248|470421681|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
130671147|NCT01133821|470421682|FG000|Overall Study|Lost to Follow-up|8|||
130671148|NCT01133821|470421683|FG001|Overall Study|Lost to Follow-up|11|||
130671149|NCT01133821|470421682|FG000|Overall Study|Withdrawal by Subject|8|||
130671150|NCT01133821|470421683|FG001|Overall Study|Withdrawal by Subject|3|||
130671151|NCT01133821|470421682|FG000|Overall Study|preferred other treatment|1|||
130671152|NCT01133821|470421683|FG001|Overall Study|preferred other treatment|1|||
130671153|NCT01133821|470421682|FG000|Overall Study|Protocol Violation|0|||
130671154|NCT01133821|470421683|FG001|Overall Study|Protocol Violation|1|||
130671155|NCT01133821|470421682|FG000|Overall Study|Refused participation|1|||
130671156|NCT01133821|470421683|FG001|Overall Study|Refused participation|3|||
130671157|NCT01387282|470421684|FG000|Overall Study|Death|47|||
130671158|NCT01387282|470421685|FG001|Overall Study|Death|16|||
130671159|NCT01387282|470421684|FG000|Overall Study|Other|5|||
130671160|NCT01387282|470421685|FG001|Overall Study|Other|1|||
130671161|NCT01387282|470421684|FG000|Overall Study|Unrelated AE|6|||
130671162|NCT01387282|470421685|FG001|Overall Study|Unrelated AE|4|||
130671163|NCT01387282|470421684|FG000|Overall Study|Withdrawal by patient|33|||
130671164|NCT01387282|470421685|FG001|Overall Study|Withdrawal by patient|23|||
130671165|NCT01387282|470421684|FG000|Overall Study|Study drug-related AE|2|||
130671166|NCT01387282|470421685|FG001|Overall Study|Study drug-related AE|2|||
130671167|NCT01387282|470421684|FG000|Overall Study|Lost to Follow-up|4|||
130671168|NCT01387282|470421685|FG001|Overall Study|Lost to Follow-up|1|||
130671169|NCT03273387|470421686|FG000|Overall Study|Death|2|||
130337200|NCT01001325|469205530|FG001|Overall Study|Lost to Follow-up|10|||
130337201|NCT01001325|469205529|FG000|Overall Study|Protocol Violation|2|||
130337202|NCT01001325|469205530|FG001|Overall Study|Protocol Violation|0|||
130337203|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
130337204|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337205|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337206|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337207|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337208|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
130337209|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
130671170|NCT03273387|470421687|FG001|Overall Study|Death|2|||
130671171|NCT03273387|470421686|FG000|Overall Study|Withdrawal by Subject|1|||
130671172|NCT03273387|470421687|FG001|Overall Study|Withdrawal by Subject|1|||
130671173|NCT02049359|470421688|FG000|Overall Study|Lost to Follow-up|26|||
130671174|NCT02049359|470421689|FG001|Overall Study|Lost to Follow-up|19|||
130671175|NCT03551730|470421697|FG000|Overall Study|Adverse Event|1|||
130671176|NCT03551730|470421698|FG001|Overall Study|Adverse Event|0|||
130671177|NCT03551730|470421699|FG002|Overall Study|Adverse Event|0|||
130671178|NCT03551730|470421700|FG003|Overall Study|Adverse Event|0|||
130671179|NCT03907280|470421701|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
130337210|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
130337211|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
130671180|NCT03907280|470421702|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
130671181|NCT03907280|470421703|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
130337212|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
130337213|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
130337214|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337215|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337216|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337217|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337218|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
130337219|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
130337220|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337221|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337222|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337223|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
130337224|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337225|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337226|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337227|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337228|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337229|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
130337230|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337231|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337232|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337233|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337234|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337235|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
130337236|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
130337237|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337238|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
130337239|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
130337240|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
130337241|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
130337242|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
130337243|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337244|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337245|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
130337246|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337247|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337248|NCT00899431|469205536|FG000|Overall Study|Physician Decision|1|||
130337249|NCT00899431|469205537|FG001|Overall Study|Physician Decision|0|||
130337250|NCT00899431|469205538|FG002|Overall Study|Physician Decision|0|||
130337251|NCT00661427|469205539|FG000|Overall Study|Adverse Event|5|||
130337252|NCT00661427|469205540|FG001|Overall Study|Adverse Event|5|||
130337253|NCT00661427|469205539|FG000|Overall Study|Patient not treated|0|||
130337254|NCT00661427|469205540|FG001|Overall Study|Patient not treated|2|||
130337255|NCT01821560|469205541|FG000|Overall Study|Lost to Follow-up|5|||
130337256|NCT01821560|469205542|FG001|Overall Study|Lost to Follow-up|5|||
130337257|NCT01821560|469205541|FG000|Overall Study|Withdrawal by Subject|1|||
130337258|NCT01821560|469205542|FG001|Overall Study|Withdrawal by Subject|1|||
130337259|NCT01821560|469205541|FG000|Overall Study|Protocol Violation|0|||
130337260|NCT01821560|469205542|FG001|Overall Study|Protocol Violation|1|||
130337261|NCT01338298|469205543|FG000|Overall Study|Withdrawal by Subject|1|||
130337262|NCT01338298|469205544|FG001|Overall Study|Withdrawal by Subject|1|||
130337263|NCT01338298|469205543|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
130337264|NCT01338298|469205544|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
130337265|NCT01338298|469205543|FG000|Overall Study|Administrative error|0|||
130337266|NCT01338298|469205544|FG001|Overall Study|Administrative error|1|||
130337267|NCT01338298|469205543|FG000|Overall Study|Positive symptom worsening|1|||
130337268|NCT01338298|469205544|FG001|Overall Study|Positive symptom worsening|0|||
130337269|NCT01338298|469205543|FG000|Overall Study|Depressive symptoms and nausea|1|||
130337270|NCT01338298|469205544|FG001|Overall Study|Depressive symptoms and nausea|0|||
130337271|NCT01338298|469205543|FG000|Overall Study|Non-adherence|1|||
130337272|NCT01338298|469205544|FG001|Overall Study|Non-adherence|0|||
130337273|NCT02872285|469205545|FG000|Overall Study|Withdrawal by Subject|2|||
130337274|NCT02872285|469205546|FG001|Overall Study|Withdrawal by Subject|0|||
130337275|NCT02872285|469205545|FG000|Overall Study|Lost to Follow-up|2|||
130337276|NCT02872285|469205546|FG001|Overall Study|Lost to Follow-up|2|||
130671182|NCT00673361|470421706|FG000|Overall Study|Screen Failure|2|||
130337277|NCT02872285|469205545|FG000|Overall Study|Discontinued due to back surgery|1|||
130337278|NCT02872285|469205546|FG001|Overall Study|Discontinued due to back surgery|0|||
130337279|NCT01253577|469205549|FG000|Overall Study|Lost to Follow-up|3|||
130337280|NCT00334113|469205550|FG000|Overall Study|Lost to Follow-up|2|||
130337281|NCT00334113|469205551|FG001|Overall Study|Lost to Follow-up|2|||
130337282|NCT00334113|469205550|FG000|Overall Study|Withdrawal by Subject|0|||
130337283|NCT00334113|469205551|FG001|Overall Study|Withdrawal by Subject|1|||
130337284|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
130337285|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
130337286|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
130337287|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
130337288|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Other|2|||
130337289|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
130337290|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
130337291|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
130337292|NCT02509026|469205552|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
130337293|NCT02509026|469205552|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
130337294|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
130337295|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
130337296|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
130337297|NCT00721968|469205553|FG000|Overall Study|Lost to Follow-up|2|||
130337298|NCT00721968|469205554|FG001|Overall Study|Lost to Follow-up|0|||
130337299|NCT05601544|469205555|FG000|Phase 2 Period 1|Adverse Event|0|||
130337300|NCT05601544|469205556|FG001|Phase 2 Period 1|Adverse Event|1|||
130337301|NCT05601544|469205557|FG002|Phase 2 Period 1|Adverse Event|0|||
130337302|NCT05601544|469205558|FG003|Phase 2 Period 1|Adverse Event|0|||
130337303|NCT05601544|469205559|FG004|Phase 2 Period 1|Adverse Event|0|||
130337304|NCT05601544|469205560|FG005|Phase 2 Period 1|Adverse Event|0|||
130337305|NCT02626624|469205572|FG000|Overall Study|Adverse Event|1|||
130337306|NCT02626624|469205572|FG000|Overall Study|Lost to Follow-up|3|||
130337307|NCT02626624|469205572|FG000|Overall Study|Protocol Violation|4|||
130337308|NCT02626624|469205572|FG000|Overall Study|Death|2|||
130337309|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
130337310|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
130337311|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
130337312|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
130337313|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
130337314|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337315|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337316|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337317|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
130337318|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337319|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337320|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337321|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
130337322|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337323|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337324|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337325|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
130337326|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337327|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337328|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337329|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
130337330|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130337331|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130671183|NCT01464827|470421707|FG000|Overall Study|Adverse Event|0|||
130671184|NCT01464827|470421708|FG001|Overall Study|Adverse Event|0|||
130671185|NCT01464827|470421709|FG002|Overall Study|Adverse Event|0|||
130671186|NCT01464827|470421710|FG003|Overall Study|Adverse Event|0|||
130671187|NCT01464827|470421711|FG004|Overall Study|Adverse Event|0|||
130671188|NCT01464827|470421712|FG005|Overall Study|Adverse Event|0|||
130671189|NCT01464827|470421713|FG006|Overall Study|Adverse Event|0|||
130671190|NCT01464827|470421714|FG007|Overall Study|Adverse Event|0|||
130671191|NCT01464827|470421715|FG008|Overall Study|Adverse Event|0|||
130671192|NCT01464827|470421716|FG009|Overall Study|Adverse Event|0|||
130671193|NCT01464827|470421717|FG010|Overall Study|Adverse Event|0|||
130671194|NCT01464827|470421718|FG011|Overall Study|Adverse Event|0|||
130671195|NCT01464827|470421719|FG012|Overall Study|Adverse Event|1|||
130671196|NCT01464827|470421720|FG013|Overall Study|Adverse Event|0|||
130671197|NCT01464827|470421707|FG000|Overall Study|Withdrawal by Subject|1|||
130671198|NCT01464827|470421708|FG001|Overall Study|Withdrawal by Subject|0|||
130671199|NCT01464827|470421709|FG002|Overall Study|Withdrawal by Subject|0|||
130671200|NCT01464827|470421710|FG003|Overall Study|Withdrawal by Subject|0|||
130337332|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130337333|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
130337334|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130671201|NCT01464827|470421711|FG004|Overall Study|Withdrawal by Subject|1|||
130671202|NCT01464827|470421712|FG005|Overall Study|Withdrawal by Subject|0|||
130671203|NCT01464827|470421713|FG006|Overall Study|Withdrawal by Subject|0|||
130337335|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130337336|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130337337|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
130337338|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337339|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337340|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337341|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
130337342|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
130337343|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
130337344|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
130337345|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337346|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337347|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337348|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
130337349|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
130337350|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
130337351|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
130337352|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
130337353|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337354|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337355|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337356|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
130337357|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
130337358|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
130337359|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
130337360|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
130337361|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130337362|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
130337363|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
130337364|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130337365|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
130337366|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
130337367|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
130337368|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
130337369|NCT03374202|469205581|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
130337370|NCT03374202|469205582|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
130337371|NCT03374202|469205583|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
130337372|NCT03374202|469205581|FG000|Five Year Long Term Follow Up|Death|0|||
130337373|NCT03374202|469205582|FG001|Five Year Long Term Follow Up|Death|1|||
130337374|NCT03374202|469205583|FG002|Five Year Long Term Follow Up|Death|0|||
130671204|NCT01464827|470421714|FG007|Overall Study|Withdrawal by Subject|1|||
130671205|NCT01464827|470421715|FG008|Overall Study|Withdrawal by Subject|0|||
130671206|NCT01464827|470421716|FG009|Overall Study|Withdrawal by Subject|0|||
130671207|NCT01464827|470421717|FG010|Overall Study|Withdrawal by Subject|0|||
130671208|NCT01464827|470421718|FG011|Overall Study|Withdrawal by Subject|0|||
130671209|NCT01464827|470421719|FG012|Overall Study|Withdrawal by Subject|0|||
130671210|NCT01464827|470421720|FG013|Overall Study|Withdrawal by Subject|0|||
130671211|NCT01464827|470421707|FG000|Overall Study|Lost to Follow-up|0|||
130671212|NCT01464827|470421708|FG001|Overall Study|Lost to Follow-up|2|||
130671213|NCT01464827|470421709|FG002|Overall Study|Lost to Follow-up|0|||
130671214|NCT01464827|470421710|FG003|Overall Study|Lost to Follow-up|2|||
130671215|NCT01464827|470421711|FG004|Overall Study|Lost to Follow-up|3|||
130671216|NCT01464827|470421712|FG005|Overall Study|Lost to Follow-up|1|||
130671217|NCT01464827|470421713|FG006|Overall Study|Lost to Follow-up|2|||
130671218|NCT01464827|470421714|FG007|Overall Study|Lost to Follow-up|2|||
130671219|NCT01464827|470421715|FG008|Overall Study|Lost to Follow-up|0|||
130671220|NCT01464827|470421716|FG009|Overall Study|Lost to Follow-up|0|||
130671221|NCT01464827|470421717|FG010|Overall Study|Lost to Follow-up|0|||
130671222|NCT01464827|470421718|FG011|Overall Study|Lost to Follow-up|1|||
130671223|NCT01464827|470421719|FG012|Overall Study|Lost to Follow-up|0|||
130671224|NCT01464827|470421720|FG013|Overall Study|Lost to Follow-up|1|||
130671225|NCT01464827|470421707|FG000|Overall Study|Other|2|||
130671226|NCT01464827|470421708|FG001|Overall Study|Other|3|||
130671227|NCT01464827|470421709|FG002|Overall Study|Other|0|||
130671228|NCT01464827|470421710|FG003|Overall Study|Other|2|||
130671229|NCT01464827|470421711|FG004|Overall Study|Other|3|||
130671230|NCT01464827|470421712|FG005|Overall Study|Other|0|||
130337375|NCT01868542|469207292|FG000|Overall Study|Protocol Violation|0|||
130337376|NCT01868542|469207293|FG001|Overall Study|Protocol Violation|1|||
130337377|NCT01868542|469207292|FG000|Overall Study|Unclassified|0|||
130337378|NCT01868542|469207293|FG001|Overall Study|Unclassified|1|||
130337379|NCT00122980|469207300|FG000|Overall Study|Death|0|||
130671231|NCT01464827|470421713|FG006|Overall Study|Other|1|||
130337380|NCT00122980|469207301|FG001|Overall Study|Death|1|||
130337381|NCT00122980|469207300|FG000|Overall Study|Physician Decision|2|||
130671232|NCT01464827|470421714|FG007|Overall Study|Other|0|||
130671233|NCT01464827|470421715|FG008|Overall Study|Other|3|||
130671234|NCT01464827|470421716|FG009|Overall Study|Other|1|||
130671235|NCT01464827|470421717|FG010|Overall Study|Other|2|||
130671236|NCT01464827|470421718|FG011|Overall Study|Other|0|||
130337382|NCT00122980|469207301|FG001|Overall Study|Physician Decision|0|||
130337383|NCT00122980|469207300|FG000|Overall Study|Protocol Violation|5|||
130337384|NCT00122980|469207301|FG001|Overall Study|Protocol Violation|1|||
130337385|NCT00122980|469207300|FG000|Overall Study|Withdrawal by Subject|2|||
130337386|NCT00122980|469207301|FG001|Overall Study|Withdrawal by Subject|3|||
130337387|NCT00122980|469207300|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
130337388|NCT00122980|469207301|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
130337389|NCT00122980|469207300|FG000|Overall Study|Study termination|27|||
130337390|NCT00122980|469207301|FG001|Overall Study|Study termination|35|||
130337391|NCT01124864|469207302|FG000|Overall Study|Follow up phase competed as per protocol|18|||
130337392|NCT01124864|469207303|FG001|Overall Study|Follow up phase competed as per protocol|22|||
130337393|NCT01124864|469207304|FG002|Overall Study|Follow up phase competed as per protocol|24|||
130337394|NCT01124864|469207305|FG003|Overall Study|Follow up phase competed as per protocol|18|||
130337395|NCT01124864|469207306|FG004|Overall Study|Follow up phase competed as per protocol|26|||
130337396|NCT01124864|469207307|FG005|Overall Study|Follow up phase competed as per protocol|2|||
130337397|NCT01124864|469207302|FG000|Overall Study|Death|6|||
130337398|NCT01124864|469207303|FG001|Overall Study|Death|9|||
130337399|NCT01124864|469207304|FG002|Overall Study|Death|6|||
130337400|NCT01124864|469207305|FG003|Overall Study|Death|2|||
130337401|NCT01124864|469207306|FG004|Overall Study|Death|1|||
130337402|NCT01124864|469207307|FG005|Overall Study|Death|0|||
130337403|NCT01124864|469207302|FG000|Overall Study|Withdrawal by Subject|2|||
130337404|NCT01124864|469207303|FG001|Overall Study|Withdrawal by Subject|3|||
130337405|NCT01124864|469207304|FG002|Overall Study|Withdrawal by Subject|4|||
130337406|NCT01124864|469207305|FG003|Overall Study|Withdrawal by Subject|0|||
130337407|NCT01124864|469207306|FG004|Overall Study|Withdrawal by Subject|2|||
130671237|NCT01464827|470421719|FG012|Overall Study|Other|1|||
130671238|NCT01464827|470421720|FG013|Overall Study|Other|0|||
130671239|NCT01464827|470421707|FG000|Overall Study|Not Treated|0|||
130671240|NCT01464827|470421708|FG001|Overall Study|Not Treated|2|||
130671241|NCT01464827|470421709|FG002|Overall Study|Not Treated|0|||
130671242|NCT01464827|470421710|FG003|Overall Study|Not Treated|0|||
130671243|NCT01464827|470421711|FG004|Overall Study|Not Treated|1|||
130671244|NCT01464827|470421712|FG005|Overall Study|Not Treated|0|||
130671245|NCT01464827|470421713|FG006|Overall Study|Not Treated|1|||
130671246|NCT01464827|470421714|FG007|Overall Study|Not Treated|0|||
130671247|NCT01464827|470421715|FG008|Overall Study|Not Treated|0|||
130337408|NCT01124864|469207307|FG005|Overall Study|Withdrawal by Subject|1|||
130337409|NCT01124864|469207302|FG000|Overall Study|Lost to Follow-up|1|||
130337410|NCT01124864|469207303|FG001|Overall Study|Lost to Follow-up|1|||
130671248|NCT01464827|470421716|FG009|Overall Study|Not Treated|2|||
130337411|NCT01124864|469207304|FG002|Overall Study|Lost to Follow-up|0|||
130671249|NCT01464827|470421717|FG010|Overall Study|Not Treated|0|||
130671250|NCT01464827|470421718|FG011|Overall Study|Not Treated|1|||
130671251|NCT01464827|470421719|FG012|Overall Study|Not Treated|0|||
130671252|NCT01464827|470421720|FG013|Overall Study|Not Treated|2|||
130671253|NCT05487456|470421721|FG000|Overall Study|Withdrawal by Subject|0|||
130671254|NCT05487456|470421722|FG001|Overall Study|Withdrawal by Subject|0|||
130671255|NCT05487456|470421723|FG002|Overall Study|Withdrawal by Subject|1|||
130671256|NCT05487456|470421724|FG003|Overall Study|Withdrawal by Subject|0|||
130671257|NCT03882047|470421727|FG000|Overall Study|Adverse Event|0|||
130671258|NCT03882047|470421728|FG001|Overall Study|Adverse Event|2|||
130671259|NCT03882047|470421729|FG002|Overall Study|Adverse Event|2|||
130671260|NCT03882047|470421727|FG000|Overall Study|Treatment Failure|3|||
130671261|NCT03882047|470421728|FG001|Overall Study|Treatment Failure|3|||
130671262|NCT03882047|470421729|FG002|Overall Study|Treatment Failure|12|||
130671263|NCT03882047|470421727|FG000|Overall Study|Lost to Follow-up|0|||
130671264|NCT03882047|470421728|FG001|Overall Study|Lost to Follow-up|1|||
130671265|NCT03882047|470421729|FG002|Overall Study|Lost to Follow-up|0|||
130671266|NCT03882047|470421727|FG000|Overall Study|Did Not Wish to Continue|1|||
130337412|NCT01124864|469207305|FG003|Overall Study|Lost to Follow-up|1|||
130337413|NCT01124864|469207306|FG004|Overall Study|Lost to Follow-up|0|||
130337414|NCT01124864|469207307|FG005|Overall Study|Lost to Follow-up|0|||
130671267|NCT03882047|470421728|FG001|Overall Study|Did Not Wish to Continue|4|||
130671268|NCT03882047|470421729|FG002|Overall Study|Did Not Wish to Continue|1|||
130671269|NCT03882047|470421727|FG000|Overall Study|Noncompliance With Protocol|2|||
130671270|NCT03882047|470421728|FG001|Overall Study|Noncompliance With Protocol|0|||
130671271|NCT03882047|470421729|FG002|Overall Study|Noncompliance With Protocol|0|||
130337415|NCT01124864|469207302|FG000|Overall Study|Protocol Violation|1|||
130337416|NCT01124864|469207303|FG001|Overall Study|Protocol Violation|0|||
130337417|NCT01124864|469207304|FG002|Overall Study|Protocol Violation|0|||
130337418|NCT01124864|469207305|FG003|Overall Study|Protocol Violation|0|||
130671272|NCT03882047|470421727|FG000|Overall Study|Did Not Meet Eligibility|0|||
130671273|NCT03882047|470421728|FG001|Overall Study|Did Not Meet Eligibility|0|||
130337419|NCT01124864|469207306|FG004|Overall Study|Protocol Violation|1|||
130337420|NCT01124864|469207307|FG005|Overall Study|Protocol Violation|0|||
130671274|NCT03882047|470421729|FG002|Overall Study|Did Not Meet Eligibility|1|||
130671275|NCT00441584|470421730|FG000|Overall Study|Lack of Efficacy|79|||
130671276|NCT00441584|470421730|FG000|Overall Study|Withdrawal by Subject|8|||
130671277|NCT00441584|470421730|FG000|Overall Study|Adverse Event|6|||
130337421|NCT01243242|469207308|FG000|Overall Study|Adverse Event|1|||
130337422|NCT01243242|469207309|FG001|Overall Study|Adverse Event|1|||
130337423|NCT01243242|469207308|FG000|Overall Study|Withdrawal by Subject|1|||
130337424|NCT01243242|469207309|FG001|Overall Study|Withdrawal by Subject|1|||
130337425|NCT01243242|469207308|FG000|Overall Study|Physician Decision|0|||
130337426|NCT01243242|469207309|FG001|Overall Study|Physician Decision|1|||
130337427|NCT01243242|469207308|FG000|Overall Study|sponsor decision|0|||
130337428|NCT01243242|469207309|FG001|Overall Study|sponsor decision|1|||
130337429|NCT01243242|469207308|FG000|Overall Study|non compliance|1|||
130337430|NCT01243242|469207309|FG001|Overall Study|non compliance|0|||
130337431|NCT01256294|469207319|FG000|Overall Study|Adverse Event|1|||
130337432|NCT01256294|469207320|FG001|Overall Study|Adverse Event|0|||
130337433|NCT01256294|469207319|FG000|Overall Study|Withdrawal by Subject|1|||
130337434|NCT01256294|469207320|FG001|Overall Study|Withdrawal by Subject|1|||
130337435|NCT01256294|469207319|FG000|Overall Study|Protocol deviation|2|||
130337436|NCT01256294|469207320|FG001|Overall Study|Protocol deviation|1|||
130337437|NCT02160899|469207321|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337438|NCT02160899|469207322|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130337439|NCT02160899|469207323|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337440|NCT02160899|469207324|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
130337441|NCT02160899|469207325|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
130337442|NCT02160899|469207326|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337443|NCT01368562|469207327|FG000|Overall Study|Adverse Event|1|||
130337444|NCT01368562|469207327|FG000|Overall Study|Disease progression|1|||
130337445|NCT01368562|469207327|FG000|Overall Study|Lost to Follow-up|1|||
130337446|NCT01368562|469207327|FG000|Overall Study|Death|6|||
130337447|NCT01368562|469207327|FG000|Overall Study|Unresponsive to treatment|5|||
130337448|NCT01368562|469207327|FG000|Overall Study|Other|3|||
130337449|NCT01368562|469207327|FG000|Overall Study|Other than specified|2|||
130337450|NCT01754727|469207328|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130337451|NCT00669409|469207331|FG000|Part 2|Withdrawal by Subject|0|||
130337452|NCT00669409|469207332|FG001|Part 2|Withdrawal by Subject|0|||
130337453|NCT00669409|469207333|FG002|Part 2|Withdrawal by Subject|0|||
130337454|NCT00669409|469207334|FG003|Part 2|Withdrawal by Subject|0|||
130337455|NCT00669409|469207335|FG004|Part 2|Withdrawal by Subject|0|||
130337456|NCT00669409|469207336|FG005|Part 2|Withdrawal by Subject|0|||
130337457|NCT00669409|469207337|FG006|Part 2|Withdrawal by Subject|0|||
130337458|NCT00669409|469207338|FG007|Part 2|Withdrawal by Subject|0|||
130337459|NCT00669409|469207339|FG008|Part 2|Withdrawal by Subject|0|||
130337460|NCT00669409|469207340|FG009|Part 2|Withdrawal by Subject|1|||
130337461|NCT00669409|469207341|FG010|Part 2|Withdrawal by Subject|0|||
130337462|NCT02314637|469207342|FG000|Overall Study|Adverse Event|4|||
130337463|NCT02314637|469207343|FG001|Overall Study|Adverse Event|8|||
130337464|NCT02314637|469207342|FG000|Overall Study|Lack of Efficacy|1|||
130337465|NCT02314637|469207343|FG001|Overall Study|Lack of Efficacy|0|||
130337466|NCT02314637|469207342|FG000|Overall Study|Physician Decision|5|||
130671278|NCT00441584|470421730|FG000|Overall Study|Protocol Violation|5|||
130671279|NCT00441584|470421730|FG000|Overall Study|Lost to Follow-up|4|||
130671280|NCT00441584|470421730|FG000|Overall Study|Failure to meet eligibility criteria|3|||
130671281|NCT01333033|470421733|FG000|Overall Study|Ineligible|0|||
130671282|NCT01333033|470421734|FG001|Overall Study|Ineligible|0|||
130671283|NCT01333033|470421735|FG002|Overall Study|Ineligible|0|||
130671284|NCT01333033|470421736|FG003|Overall Study|Ineligible|0|||
130671285|NCT01333033|470421737|FG004|Overall Study|Ineligible|6|||
130671286|NCT01333033|470421738|FG005|Overall Study|Ineligible|8|||
130671287|NCT01333033|470421733|FG000|Overall Study|Withdrawal by Subject|0|||
130671288|NCT01333033|470421734|FG001|Overall Study|Withdrawal by Subject|0|||
130671289|NCT01333033|470421735|FG002|Overall Study|Withdrawal by Subject|0|||
130337467|NCT02314637|469207343|FG001|Overall Study|Physician Decision|2|||
130337468|NCT02314637|469207342|FG000|Overall Study|Withdrawal by Subject|5|||
130337469|NCT02314637|469207343|FG001|Overall Study|Withdrawal by Subject|4|||
130337470|NCT02314637|469207342|FG000|Overall Study|Other Reason|1|||
130337471|NCT02314637|469207343|FG001|Overall Study|Other Reason|0|||
130337472|NCT03539549|469207344|FG000|Overall Study|Adverse Event|12|||
130337473|NCT03539549|469207344|FG000|Overall Study|Lost to Follow-up|1|||
130337474|NCT03539549|469207344|FG000|Overall Study|Death|2|||
130337475|NCT03539549|469207344|FG000|Overall Study|Progressive Disease|1|||
130337476|NCT03539549|469207344|FG000|Overall Study|Reason not Specified|1|||
130337477|NCT02864862|469207345|FG000|Overall Study|Lost to Follow-up|1|||
130337478|NCT02864862|469207346|FG001|Overall Study|Lost to Follow-up|0|||
130337479|NCT02864862|469207347|FG002|Overall Study|Lost to Follow-up|1|||
130671290|NCT01333033|470421736|FG003|Overall Study|Withdrawal by Subject|0|||
130671291|NCT01333033|470421737|FG004|Overall Study|Withdrawal by Subject|4|||
130671292|NCT01333033|470421738|FG005|Overall Study|Withdrawal by Subject|2|||
130671293|NCT01333033|470421733|FG000|Overall Study|PET inevaluable|0|||
130337480|NCT02864862|469207345|FG000|Overall Study|Protocol Violation|0|||
130337481|NCT02864862|469207346|FG001|Overall Study|Protocol Violation|0|||
130671294|NCT01333033|470421734|FG001|Overall Study|PET inevaluable|0|||
130337482|NCT02864862|469207347|FG002|Overall Study|Protocol Violation|1|||
130337483|NCT04693234|469207351|FG000|Overall Study|Death|79|||
130337484|NCT04693234|469207352|FG001|Overall Study|Death|19|||
130337485|NCT04693234|469207351|FG000|Overall Study|Sponsor Ended Study|47|||
130337486|NCT04693234|469207352|FG001|Overall Study|Sponsor Ended Study|18|||
130337487|NCT04693234|469207351|FG000|Overall Study|Withdrawal by Subject|10|||
130337488|NCT04693234|469207352|FG001|Overall Study|Withdrawal by Subject|2|||
130337489|NCT04693234|469207351|FG000|Overall Study|Lost to Follow-up|2|||
130337490|NCT04693234|469207352|FG001|Overall Study|Lost to Follow-up|1|||
130337491|NCT04643158|469207353|FG000|Overall Study|Study terminated by sponsor|0|||
130337492|NCT04643158|469207354|FG001|Overall Study|Study terminated by sponsor|0|||
130337493|NCT04643158|469207355|FG002|Overall Study|Study terminated by sponsor|1|||
130337494|NCT04643158|469207356|FG003|Overall Study|Study terminated by sponsor|0|||
130337495|NCT04643158|469207357|FG004|Overall Study|Study terminated by sponsor|0|||
130337496|NCT04643158|469207358|FG005|Overall Study|Study terminated by sponsor|1|||
130337497|NCT04643158|469207359|FG006|Overall Study|Study terminated by sponsor|0|||
130337498|NCT04643158|469207353|FG000|Overall Study|Global/country situation|0|||
130337499|NCT04643158|469207354|FG001|Overall Study|Global/country situation|0|||
130337500|NCT04643158|469207355|FG002|Overall Study|Global/country situation|1|||
130337501|NCT04643158|469207356|FG003|Overall Study|Global/country situation|0|||
130337502|NCT04643158|469207357|FG004|Overall Study|Global/country situation|0|||
130337503|NCT04643158|469207358|FG005|Overall Study|Global/country situation|0|||
130337504|NCT04643158|469207359|FG006|Overall Study|Global/country situation|0|||
130337505|NCT04643158|469207353|FG000|Overall Study|Withdrawal by Subject|0|||
130337506|NCT04643158|469207354|FG001|Overall Study|Withdrawal by Subject|0|||
130337507|NCT04643158|469207355|FG002|Overall Study|Withdrawal by Subject|0|||
130337508|NCT04643158|469207356|FG003|Overall Study|Withdrawal by Subject|0|||
130337509|NCT04643158|469207357|FG004|Overall Study|Withdrawal by Subject|0|||
130337510|NCT04643158|469207358|FG005|Overall Study|Withdrawal by Subject|1|||
130337511|NCT04643158|469207359|FG006|Overall Study|Withdrawal by Subject|0|||
130337512|NCT04540198|469207360|FG000|Overall Study|Lost to Follow-up|25|||
130337513|NCT04540198|469207361|FG001|Overall Study|Lost to Follow-up|23|||
130337514|NCT04540198|469207360|FG000|Overall Study|Withdrawal by Subject|15|||
130337515|NCT04540198|469207361|FG001|Overall Study|Withdrawal by Subject|9|||
130337516|NCT04540198|469207360|FG000|Overall Study|Discontinued|1|||
130337517|NCT04540198|469207361|FG001|Overall Study|Discontinued|0|||
130337518|NCT02888119|469207362|FG000|Overall Study|Lost to Follow-up|5|||
130337519|NCT02888119|469207363|FG001|Overall Study|Lost to Follow-up|4|||
130337520|NCT02888119|469207364|FG002|Overall Study|Lost to Follow-up|0|||
130337521|NCT02123472|469207366|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
130337522|NCT02123472|469207367|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130337523|NCT01474018|469207368|FG000|Overall Study|Lost to Follow-up|0|||
130337524|NCT01474018|469207369|FG001|Overall Study|Lost to Follow-up|1|||
130337525|NCT01474018|469207368|FG000|Overall Study|Withdrawal by Subject|0|||
130337526|NCT01474018|469207369|FG001|Overall Study|Withdrawal by Subject|2|||
130337527|NCT02433080|469207370|FG000|Overall Study|Lost to Follow-up|1|||
130337528|NCT02433080|469207371|FG001|Overall Study|Lost to Follow-up|2|||
130337529|NCT02433080|469207370|FG000|Overall Study|Withdrawal by Subject|0|||
130337530|NCT02433080|469207371|FG001|Overall Study|Withdrawal by Subject|2|||
130337531|NCT01015638|469207374|FG000|Overall Study|Withdrawal by Subject|1|||
130337532|NCT01015638|469207375|FG001|Overall Study|Withdrawal by Subject|0|||
130337533|NCT00910299|469207381|FG000|Overall Study|Withdrawal by Subject|16|||
130337534|NCT00910299|469207382|FG001|Overall Study|Withdrawal by Subject|13|||
130337535|NCT00910299|469207381|FG000|Overall Study|Sponsor Decision|58|||
130337536|NCT00910299|469207382|FG001|Overall Study|Sponsor Decision|60|||
130337537|NCT00910299|469207381|FG000|Overall Study|Didn't receive any study drug|2|||
130337538|NCT00910299|469207382|FG001|Overall Study|Didn't receive any study drug|1|||
130337539|NCT00711477|469207383|FG000|Overall Study|Adverse Event|3|||
130337540|NCT00711477|469207384|FG001|Overall Study|Adverse Event|1|||
130337541|NCT00711477|469207383|FG000|Overall Study|Lost to Follow-up|0|||
130337542|NCT00711477|469207384|FG001|Overall Study|Lost to Follow-up|1|||
130337543|NCT00711477|469207383|FG000|Overall Study|Noncompliance|0|||
130337544|NCT00711477|469207384|FG001|Overall Study|Noncompliance|1|||
130337545|NCT02929407|469207389|FG000|Overall Study|Adverse Event|1|||
130337546|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
130337547|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337548|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337549|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337550|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Death|3|||
130337551|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Death|0|||
130337552|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Death|0|||
130337553|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Death|0|||
130337554|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
130337555|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337556|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337557|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337558|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
130671295|NCT01333033|470421735|FG002|Overall Study|PET inevaluable|0|||
130337559|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337560|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337561|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337562|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
130337563|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337564|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337565|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337566|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
130337567|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337568|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337569|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337570|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337571|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
130337572|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337573|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337574|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
130337575|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
130337576|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
130671296|NCT01333033|470421736|FG003|Overall Study|PET inevaluable|0|||
130671297|NCT01333033|470421737|FG004|Overall Study|PET inevaluable|2|||
130671298|NCT01333033|470421738|FG005|Overall Study|PET inevaluable|4|||
130337577|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
130337578|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337579|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
130337580|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337581|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337582|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337583|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
130337584|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337585|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337586|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337587|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
130337588|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337589|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337590|NCT00884741|469207390|FG000|Randomization|Protocol Violation|0|||
130337591|NCT00884741|469207391|FG001|Randomization|Protocol Violation|0|||
130337592|NCT00884741|469207392|FG002|Randomization|Protocol Violation|8|||
130337593|NCT00884741|469207393|FG003|Randomization|Protocol Violation|8|||
130337594|NCT01014910|469207394|FG000|Overall Study|Withdrawal by Subject|0|||
130337595|NCT01014910|469207395|FG001|Overall Study|Withdrawal by Subject|2|||
130337596|NCT00145977|469207396|FG000|Overall Study|Lack of Efficacy|0|||
130337597|NCT00145977|469207397|FG001|Overall Study|Lack of Efficacy|4|||
130337598|NCT00145977|469207396|FG000|Overall Study|Lost to Follow-up|1|||
130337599|NCT00145977|469207397|FG001|Overall Study|Lost to Follow-up|0|||
130337600|NCT00145977|469207396|FG000|Overall Study|Withdrawal by Subject|1|||
130337601|NCT00145977|469207397|FG001|Overall Study|Withdrawal by Subject|0|||
130337602|NCT00782834|469207398|FG000|Treatment Phase|fibrous tumor not GIST|1|||
130337603|NCT01215097|469207400|FG000|Overall Study|Adverse Event|1|||
130337604|NCT01215097|469207401|FG001|Overall Study|Adverse Event|3|||
130337605|NCT01215097|469207400|FG000|Overall Study|Protocol Violation|0|||
130337606|NCT01215097|469207401|FG001|Overall Study|Protocol Violation|2|||
130337607|NCT01215097|469207400|FG000|Overall Study|Lost to Follow-up|2|||
130337608|NCT01215097|469207401|FG001|Overall Study|Lost to Follow-up|0|||
130337609|NCT01215097|469207400|FG000|Overall Study|Withdrawal by Subject|6|||
130337610|NCT01215097|469207401|FG001|Overall Study|Withdrawal by Subject|3|||
130337611|NCT01215097|469207400|FG000|Overall Study|Lack of Efficacy|0|||
130337612|NCT01215097|469207401|FG001|Overall Study|Lack of Efficacy|3|||
130337613|NCT01215097|469207400|FG000|Overall Study|patient's refusal to come|2|||
130337614|NCT01215097|469207401|FG001|Overall Study|patient's refusal to come|2|||
130337615|NCT01215097|469207400|FG000|Overall Study|patient's private reason|1|||
130337616|NCT01215097|469207401|FG001|Overall Study|patient's private reason|1|||
130337617|NCT02252939|469207403|FG000|Overall Study|Lost to Follow-up|3|||
130337618|NCT01033448|469207404|FG000|Overall Study|Withdrawal by Subject|4|||
130671299|NCT01333033|470421733|FG000|Overall Study|Adverse Event|0|||
130337619|NCT01033448|469207404|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
130337620|NCT01033448|469207404|FG000|Overall Study|Lost to Follow-up|3|||
130337621|NCT01033448|469207404|FG000|Overall Study|Withdrew due to other reasons|3|||
130337622|NCT01033448|469207404|FG000|Overall Study|Unknown disposition|1|||
130671300|NCT01333033|470421734|FG001|Overall Study|Adverse Event|0|||
130671301|NCT01333033|470421735|FG002|Overall Study|Adverse Event|0|||
130671302|NCT01333033|470421736|FG003|Overall Study|Adverse Event|0|||
130671303|NCT01333033|470421737|FG004|Overall Study|Adverse Event|2|||
130671304|NCT01333033|470421738|FG005|Overall Study|Adverse Event|1|||
130671305|NCT01333033|470421733|FG000|Overall Study|Progression|0|||
130671306|NCT01333033|470421734|FG001|Overall Study|Progression|0|||
130671307|NCT01333033|470421735|FG002|Overall Study|Progression|0|||
130671308|NCT01333033|470421736|FG003|Overall Study|Progression|0|||
130671309|NCT01333033|470421737|FG004|Overall Study|Progression|0|||
130671310|NCT01333033|470421738|FG005|Overall Study|Progression|1|||
130671311|NCT01333033|470421733|FG000|Overall Study|MD Decision|0|||
130671312|NCT01333033|470421734|FG001|Overall Study|MD Decision|0|||
130671313|NCT01333033|470421735|FG002|Overall Study|MD Decision|0|||
130671314|NCT01333033|470421736|FG003|Overall Study|MD Decision|0|||
130671315|NCT01333033|470421737|FG004|Overall Study|MD Decision|0|||
130671316|NCT01333033|470421738|FG005|Overall Study|MD Decision|2|||
130671317|NCT03687125|470421739|FG000|Overall Study|Progressive Disease|2|||
130671318|NCT03687125|470421740|FG001|Overall Study|Progressive Disease|1|||
130671319|NCT03687125|470421739|FG000|Overall Study|Protocol Violation|1|||
130671320|NCT03687125|470421740|FG001|Overall Study|Protocol Violation|0|||
130671321|NCT01992107|470421741|FG000|Overall Study|Administrative reasons|2|||
130671322|NCT01992107|470421742|FG001|Overall Study|Administrative reasons|0|||
130671323|NCT01992107|470421743|FG002|Overall Study|Administrative reasons|0|||
130671324|NCT01992107|470421741|FG000|Overall Study|Adverse Event|0|||
130671325|NCT01992107|470421742|FG001|Overall Study|Adverse Event|1|||
130671326|NCT01992107|470421743|FG002|Overall Study|Adverse Event|0|||
130671327|NCT01992107|470421741|FG000|Overall Study|Lost to Follow-up|46|||
130671328|NCT01992107|470421742|FG001|Overall Study|Lost to Follow-up|22|||
130671329|NCT01992107|470421743|FG002|Overall Study|Lost to Follow-up|26|||
130671330|NCT01992107|470421741|FG000|Overall Study|noncompliance and were unavailable|7|||
130671331|NCT01992107|470421742|FG001|Overall Study|noncompliance and were unavailable|3|||
130671332|NCT01992107|470421743|FG002|Overall Study|noncompliance and were unavailable|2|||
130337623|NCT01818752|469207405|FG000|Overall Study|Adverse Event|64|||
130337624|NCT01818752|469207406|FG001|Overall Study|Adverse Event|74|||
130337625|NCT01818752|469207405|FG000|Overall Study|Death|14|||
130337626|NCT01818752|469207406|FG001|Overall Study|Death|18|||
130337627|NCT01818752|469207405|FG000|Overall Study|Non-compliance|16|||
130337628|NCT01818752|469207406|FG001|Overall Study|Non-compliance|20|||
130337629|NCT01818752|469207405|FG000|Overall Study|Withdrawal by Subject|15|||
130337630|NCT01818752|469207406|FG001|Overall Study|Withdrawal by Subject|14|||
130337631|NCT01818752|469207405|FG000|Overall Study|Physician Decision|9|||
130337632|NCT01818752|469207406|FG001|Overall Study|Physician Decision|8|||
130337633|NCT01818752|469207405|FG000|Overall Study|Disease Progression|54|||
130337634|NCT01818752|469207406|FG001|Overall Study|Disease Progression|48|||
130337635|NCT01818752|469207405|FG000|Overall Study|Other|7|||
130337636|NCT01818752|469207406|FG001|Overall Study|Other|8|||
130337637|NCT01818752|469207405|FG000|Overall Study|Continuing Treatment|1|||
130337638|NCT01818752|469207406|FG001|Overall Study|Continuing Treatment|4|||
130337639|NCT01818752|469207405|FG000|Overall Study|Randomized but not Dosed|7|||
130337640|NCT01818752|469207406|FG001|Overall Study|Randomized but not Dosed|4|||
130337641|NCT04270370|469207407|FG000|Overall Study|Lost to Follow-up|1|||
130337642|NCT04270370|469207408|FG001|Overall Study|Lost to Follow-up|0|||
130337643|NCT04270370|469207409|FG002|Overall Study|Lost to Follow-up|0|||
130337644|NCT04270370|469207410|FG003|Overall Study|Lost to Follow-up|0|||
130337645|NCT04270370|469207411|FG004|Overall Study|Lost to Follow-up|0|||
130337646|NCT04270370|469207412|FG005|Overall Study|Lost to Follow-up|0|||
130337647|NCT04270370|469207413|FG006|Overall Study|Lost to Follow-up|0|||
130337648|NCT04270370|469207414|FG007|Overall Study|Lost to Follow-up|0|||
130337649|NCT04270370|469207415|FG008|Overall Study|Lost to Follow-up|1|||
130337650|NCT04270370|469207416|FG009|Overall Study|Lost to Follow-up|0|||
130337651|NCT04270370|469207417|FG010|Overall Study|Lost to Follow-up|0|||
130337652|NCT04270370|469207418|FG011|Overall Study|Lost to Follow-up|0|||
130337653|NCT01324141|469207419|FG000|Overall Study|Declined to participate before treatment started|1|||
130337654|NCT01324141|469207419|FG000|Overall Study|Disease progression on study|1|||
130337655|NCT00870584|469207422|FG000|Overall Study|Adverse Event|3|||
130671333|NCT01992107|470421741|FG000|Overall Study|Withdrawal by Subject|13|||
130337656|NCT00870584|469207423|FG001|Overall Study|Adverse Event|3|||
130337657|NCT00870584|469207422|FG000|Overall Study|Withdrawal by Subject|6|||
130337658|NCT00870584|469207423|FG001|Overall Study|Withdrawal by Subject|7|||
130337659|NCT00870584|469207422|FG000|Overall Study|Lost to Follow-up|5|||
130337660|NCT00870584|469207423|FG001|Overall Study|Lost to Follow-up|1|||
130671334|NCT01992107|470421742|FG001|Overall Study|Withdrawal by Subject|7|||
130671335|NCT01992107|470421743|FG002|Overall Study|Withdrawal by Subject|8|||
130671336|NCT02022007|470421746|FG000|Overall Study|Withdrawal by Subject|1|||
130671337|NCT02022007|470421747|FG001|Overall Study|Withdrawal by Subject|1|||
130671338|NCT02022007|470421748|FG002|Overall Study|Withdrawal by Subject|1|||
130671339|NCT02022007|470421746|FG000|Overall Study|Noncompliant|0|||
130337661|NCT00870584|469207422|FG000|Overall Study|Protocol Deviation|2|||
130337662|NCT00870584|469207423|FG001|Overall Study|Protocol Deviation|2|||
130671340|NCT02022007|470421747|FG001|Overall Study|Noncompliant|0|||
130671341|NCT02022007|470421748|FG002|Overall Study|Noncompliant|1|||
130671342|NCT02087046|470421749|FG000|Overall Study|Adverse Event|4|||
130671343|NCT02087046|470421749|FG000|Overall Study|Death|1|||
130671344|NCT02087046|470421749|FG000|Overall Study|Lost to Follow-up|3|||
130671345|NCT02087046|470421749|FG000|Overall Study|Withdrawal by Subject|2|||
130671346|NCT02087046|470421749|FG000|Overall Study|Physician Decision|1|||
130671347|NCT01107535|470421750|FG000|Overall Study|Death|5|||
130671348|NCT01214603|470421751|FG000|Overall Study|Adverse Event|0|||
130671349|NCT01214603|470421752|FG001|Overall Study|Adverse Event|0|||
130671350|NCT01214603|470421753|FG002|Overall Study|Adverse Event|1|||
130671351|NCT01214603|470421751|FG000|Overall Study|Death|1|||
130671352|NCT01214603|470421752|FG001|Overall Study|Death|0|||
130337663|NCT02560025|469207424|FG000|Overall Study|Ineligible after consent/ registration|3|||
130337664|NCT02703337|469207425|FG000|Period One (Part A)|Withdrawal by Subject|0|||
130337665|NCT02703337|469207426|FG001|Period One (Part A)|Withdrawal by Subject|0|||
130337666|NCT02703337|469207427|FG002|Period One (Part A)|Withdrawal by Subject|0|||
130337667|NCT02703337|469207428|FG003|Period One (Part A)|Withdrawal by Subject|0|||
130337668|NCT02703337|469207429|FG004|Period One (Part A)|Withdrawal by Subject|1|||
130671353|NCT01214603|470421753|FG002|Overall Study|Death|0|||
130671354|NCT01214603|470421751|FG000|Overall Study|Progressive Disease|4|||
130671355|NCT01214603|470421752|FG001|Overall Study|Progressive Disease|1|||
130671356|NCT01214603|470421753|FG002|Overall Study|Progressive Disease|3|||
130671357|NCT01388647|470421754|FG000|Overall Study|Adverse Event|1|||
130671358|NCT01388647|470421755|FG001|Overall Study|Adverse Event|2|||
130671359|NCT02444533|470421756|FG000|Overall Study|Not able to complete forms|0|||
130671360|NCT02444533|470421757|FG001|Overall Study|Not able to complete forms|2|||
130671361|NCT02444533|470421756|FG000|Overall Study|Only gave post-procedure complications|2|||
130671362|NCT02444533|470421757|FG001|Overall Study|Only gave post-procedure complications|2|||
130671363|NCT03567057|470421758|FG000|Overall Study|Adverse Event|56|||
130671364|NCT03567057|470421759|FG001|Overall Study|Adverse Event|53|||
130671365|NCT03567057|470421760|FG002|Overall Study|Adverse Event|28|||
130671366|NCT03567057|470421758|FG000|Overall Study|Withdrawal by Subject|22|||
130671367|NCT03567057|470421759|FG001|Overall Study|Withdrawal by Subject|24|||
130671368|NCT03567057|470421760|FG002|Overall Study|Withdrawal by Subject|13|||
130671369|NCT03567057|470421758|FG000|Overall Study|Lost to Follow-up|3|||
130671370|NCT03567057|470421759|FG001|Overall Study|Lost to Follow-up|5|||
130671371|NCT03567057|470421760|FG002|Overall Study|Lost to Follow-up|2|||
130671372|NCT03567057|470421758|FG000|Overall Study|COVID-19 pandemic|4|||
130671373|NCT03567057|470421759|FG001|Overall Study|COVID-19 pandemic|3|||
130671374|NCT03567057|470421760|FG002|Overall Study|COVID-19 pandemic|0|||
130671375|NCT03567057|470421758|FG000|Overall Study|Non-compliance with study drug|4|||
130671376|NCT03567057|470421759|FG001|Overall Study|Non-compliance with study drug|2|||
130671377|NCT03567057|470421760|FG002|Overall Study|Non-compliance with study drug|0|||
130671378|NCT03567057|470421758|FG000|Overall Study|Lack of Efficacy|3|||
130671379|NCT03567057|470421759|FG001|Overall Study|Lack of Efficacy|0|||
130671380|NCT03567057|470421760|FG002|Overall Study|Lack of Efficacy|1|||
130671381|NCT03567057|470421758|FG000|Overall Study|Death|1|||
130671382|NCT03567057|470421759|FG001|Overall Study|Death|0|||
130671383|NCT03567057|470421760|FG002|Overall Study|Death|0|||
130671384|NCT03567057|470421758|FG000|Overall Study|Physician Decision|1|||
130671385|NCT03567057|470421759|FG001|Overall Study|Physician Decision|0|||
130671386|NCT03567057|470421760|FG002|Overall Study|Physician Decision|0|||
130671387|NCT03567057|470421758|FG000|Overall Study|Unstable medical condition|1|||
130671388|NCT03567057|470421759|FG001|Overall Study|Unstable medical condition|0|||
130671389|NCT03567057|470421760|FG002|Overall Study|Unstable medical condition|0|||
130671390|NCT03567057|470421758|FG000|Overall Study|Medical history event|0|||
130671391|NCT03567057|470421759|FG001|Overall Study|Medical history event|0|||
130671392|NCT03567057|470421760|FG002|Overall Study|Medical history event|1|||
130671393|NCT03567057|470421758|FG000|Overall Study|Other|0|||
130671394|NCT03567057|470421759|FG001|Overall Study|Other|0|||
130671395|NCT03567057|470421760|FG002|Overall Study|Other|1|||
130671396|NCT00490061|470421761|FG000|Overall Study|Physician Decision|1|||
130671397|NCT01155583|470421762|FG000|Phase I|Screen failure - did not start treatment|0|||
130671398|NCT01155583|470421763|FG001|Phase I|Screen failure - did not start treatment|0|||
130671399|NCT01155583|470421764|FG002|Phase I|Screen failure - did not start treatment|0|||
130671400|NCT01155583|470421765|FG003|Phase I|Screen failure - did not start treatment|0|||
130671401|NCT01155583|470421766|FG004|Phase I|Screen failure - did not start treatment|1|||
130671402|NCT01155583|470421767|FG005|Phase I|Screen failure - did not start treatment|0|||
130671403|NCT01155583|470421768|FG006|Phase I|Screen failure - did not start treatment|0|||
130337669|NCT02703337|469207430|FG005|Period One (Part A)|Withdrawal by Subject|0|||
130337670|NCT02703337|469207431|FG006|Period One (Part A)|Withdrawal by Subject|0|||
130671404|NCT01155583|470421769|FG007|Phase I|Screen failure - did not start treatment|2|||
130671405|NCT01155583|470421770|FG008|Phase I|Screen failure - did not start treatment|0|||
130671406|NCT01155583|470421762|FG000|Phase I|Withdrawal by Subject|0|||
130671407|NCT01155583|470421763|FG001|Phase I|Withdrawal by Subject|0|||
130671408|NCT01155583|470421764|FG002|Phase I|Withdrawal by Subject|0|||
130671409|NCT01155583|470421765|FG003|Phase I|Withdrawal by Subject|0|||
130671410|NCT01155583|470421766|FG004|Phase I|Withdrawal by Subject|0|||
130671411|NCT01155583|470421767|FG005|Phase I|Withdrawal by Subject|0|||
130671412|NCT01155583|470421768|FG006|Phase I|Withdrawal by Subject|0|||
130337671|NCT02703337|469207432|FG007|Period One (Part A)|Withdrawal by Subject|0|||
130337672|NCT00282308|469207433|FG000|Treatment Period|Lost to Follow-up|1|||
130337673|NCT00282308|469207434|FG001|Treatment Period|Lost to Follow-up|0|||
130337674|NCT00282308|469207435|FG002|Treatment Period|Lost to Follow-up|0|||
130337675|NCT00282308|469207433|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
130337676|NCT00282308|469207434|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
130337677|NCT00282308|469207435|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337678|NCT00282308|469207433|FG000|Treatment Period|Adverse Event|0|||
130337679|NCT00282308|469207434|FG001|Treatment Period|Adverse Event|2|||
130337680|NCT00282308|469207435|FG002|Treatment Period|Adverse Event|0|||
130337681|NCT00282308|469207433|FG000|Treatment Period|Not Treated with Study Drug|1|||
130337682|NCT00282308|469207434|FG001|Treatment Period|Not Treated with Study Drug|0|||
130337683|NCT00282308|469207435|FG002|Treatment Period|Not Treated with Study Drug|0|||
130337684|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
130337685|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
130337686|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
130337687|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130337688|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130671413|NCT01155583|470421769|FG007|Phase I|Withdrawal by Subject|1|||
130671414|NCT01155583|470421770|FG008|Phase I|Withdrawal by Subject|0|||
130671415|NCT00952484|470421775|FG000|Overall Study|Withdrawal by Subject|0|||
130337689|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
130337690|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337691|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337692|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
130337693|NCT00282308|469207433|FG000|Safety Follow-up Period|Adverse Event|0|||
130337694|NCT00282308|469207434|FG001|Safety Follow-up Period|Adverse Event|0|||
130337695|NCT00282308|469207435|FG002|Safety Follow-up Period|Adverse Event|1|||
130337696|NCT00282308|469207433|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
130337697|NCT00282308|469207434|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130337698|NCT00282308|469207435|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
130337699|NCT00282308|469207433|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
130337700|NCT00282308|469207434|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
130337701|NCT00282308|469207435|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
130337702|NCT00282308|469207433|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130337703|NCT00282308|469207434|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130337704|NCT00282308|469207435|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
130337705|NCT04303195|469207436|FG000|Overall Study|Adverse Event|1|||
130337706|NCT04303195|469207437|FG001|Overall Study|Adverse Event|3|||
130337707|NCT04303195|469207438|FG002|Overall Study|Adverse Event|7|||
130337708|NCT04303195|469207439|FG003|Overall Study|Adverse Event|0|||
130337709|NCT04303195|469207436|FG000|Overall Study|Lost to Follow-up|1|||
130337710|NCT04303195|469207437|FG001|Overall Study|Lost to Follow-up|0|||
130337711|NCT04303195|469207438|FG002|Overall Study|Lost to Follow-up|1|||
130337712|NCT04303195|469207439|FG003|Overall Study|Lost to Follow-up|4|||
130337713|NCT04303195|469207436|FG000|Overall Study|Withdrawal by Subject|3|||
130337714|NCT04303195|469207437|FG001|Overall Study|Withdrawal by Subject|1|||
130337715|NCT04303195|469207438|FG002|Overall Study|Withdrawal by Subject|1|||
130337716|NCT04303195|469207439|FG003|Overall Study|Withdrawal by Subject|1|||
130337717|NCT04303195|469207436|FG000|Overall Study|No study drug administered or protocol deviation|0|||
130337718|NCT04303195|469207437|FG001|Overall Study|No study drug administered or protocol deviation|2|||
130337719|NCT04303195|469207438|FG002|Overall Study|No study drug administered or protocol deviation|0|||
130337720|NCT04303195|469207439|FG003|Overall Study|No study drug administered or protocol deviation|2|||
130337721|NCT06457204|469207440|FG000|Washout|Adverse Event|0|||
130337722|NCT06457204|469207441|FG001|Washout|Adverse Event|2|||
130337723|NCT01065454|469207442|FG000|Treatment|Adverse Event|7|||
130337724|NCT01065454|469207443|FG001|Treatment|Adverse Event|4|||
130337725|NCT01065454|469207444|FG002|Treatment|Adverse Event|3|||
130337726|NCT01065454|469207445|FG003|Treatment|Adverse Event|6|||
130337727|NCT01065454|469207442|FG000|Treatment|Death|1|||
130337728|NCT01065454|469207443|FG001|Treatment|Death|0|||
130337729|NCT01065454|469207444|FG002|Treatment|Death|0|||
130337730|NCT01065454|469207445|FG003|Treatment|Death|0|||
130337731|NCT01065454|469207442|FG000|Treatment|Non-compliance|1|||
130337732|NCT01065454|469207443|FG001|Treatment|Non-compliance|0|||
130671416|NCT00952484|470421776|FG001|Overall Study|Withdrawal by Subject|1|||
130337733|NCT01065454|469207444|FG002|Treatment|Non-compliance|0|||
130337734|NCT01065454|469207445|FG003|Treatment|Non-compliance|1|||
130337735|NCT01065454|469207442|FG000|Treatment|Protocol Decision|0|||
130337736|NCT01065454|469207443|FG001|Treatment|Protocol Decision|0|||
130337737|NCT01065454|469207444|FG002|Treatment|Protocol Decision|3|||
130337738|NCT01065454|469207445|FG003|Treatment|Protocol Decision|2|||
130337739|NCT01065454|469207442|FG000|Treatment|Protocol Violation|1|||
130671417|NCT00952484|470421777|FG002|Overall Study|Withdrawal by Subject|0|||
130671418|NCT00886483|470421784|FG000|Overall Study|Lost to Follow-up|0|||
130671419|NCT00886483|470421785|FG001|Overall Study|Lost to Follow-up|1|||
130671420|NCT00886483|470421784|FG000|Overall Study|Pursue medications|1|||
130671421|NCT00886483|470421785|FG001|Overall Study|Pursue medications|2|||
130671422|NCT00886483|470421784|FG000|Overall Study|Distance to center, poor grades|1|||
130671423|NCT00886483|470421785|FG001|Overall Study|Distance to center, poor grades|0|||
130671424|NCT00192296|470421788|FG000|Overall Study|Withdrawal by Subject|0|||
130671425|NCT00192296|470421789|FG001|Overall Study|Withdrawal by Subject|1|||
130216136|NCT02030119|468753956|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130216137|NCT02030119|468753957|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130216138|NCT02030119|468753958|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130216139|NCT00759655|468753959|FG000|Overall Study|Termination of the study by sponsor|1|||
130216140|NCT02213380|468753962|FG000|Underwent Randomization|Withdrawal by Subject|2|||
130216141|NCT02213380|468753963|FG001|Underwent Randomization|Withdrawal by Subject|0|||
130216142|NCT02213380|468753962|FG000|Underwent Randomization|Not treated|3|||
130216143|NCT02213380|468753963|FG001|Underwent Randomization|Not treated|3|||
130216144|NCT02213380|468753962|FG000|Per-protocol Analysis|Protocol Violation|32|||
130216145|NCT02213380|468753963|FG001|Per-protocol Analysis|Protocol Violation|36|||
130216146|NCT01310127|468753964|FG000|Overall Study|Protocol Violation|1|||
130216147|NCT01310127|468753965|FG001|Overall Study|Protocol Violation|1|||
130216148|NCT01310127|468753964|FG000|Overall Study|advanced psc cataract outlier|1|||
130216149|NCT01310127|468753965|FG001|Overall Study|advanced psc cataract outlier|0|||
130216150|NCT03498313|468753966|FG000|Experimental Period 1|Adverse Event|1|||
130216151|NCT03498313|468753967|FG001|Experimental Period 1|Adverse Event|0|||
130216152|NCT03498313|468753968|FG002|Experimental Period 1|Adverse Event|0|||
130216153|NCT03498313|468753969|FG003|Experimental Period 1|Adverse Event|1|||
130216154|NCT03498313|468753970|FG004|Experimental Period 1|Adverse Event|0|||
130216155|NCT03498313|468753971|FG005|Experimental Period 1|Adverse Event|0|||
130216156|NCT03498313|468753966|FG000|Experimental Period 1|Withdrawal by Subject|0|||
130216157|NCT03498313|468753967|FG001|Experimental Period 1|Withdrawal by Subject|1|||
130216158|NCT03498313|468753968|FG002|Experimental Period 1|Withdrawal by Subject|0|||
130216159|NCT03498313|468753969|FG003|Experimental Period 1|Withdrawal by Subject|0|||
130216160|NCT03498313|468753970|FG004|Experimental Period 1|Withdrawal by Subject|0|||
130216161|NCT03498313|468753971|FG005|Experimental Period 1|Withdrawal by Subject|0|||
130216162|NCT03498313|468753966|FG000|Washout Period 1|Anovulation|1|||
130216163|NCT03498313|468753967|FG001|Washout Period 1|Anovulation|0|||
130216164|NCT03498313|468753968|FG002|Washout Period 1|Anovulation|0|||
130216165|NCT03498313|468753969|FG003|Washout Period 1|Anovulation|0|||
130216166|NCT03498313|468753970|FG004|Washout Period 1|Anovulation|0|||
130216167|NCT03498313|468753971|FG005|Washout Period 1|Anovulation|0|||
130216168|NCT03498313|468753966|FG000|Washout Period 1|Withdrawal by Subject|0|||
130216169|NCT03498313|468753967|FG001|Washout Period 1|Withdrawal by Subject|3|||
130216170|NCT03498313|468753968|FG002|Washout Period 1|Withdrawal by Subject|0|||
130216171|NCT03498313|468753969|FG003|Washout Period 1|Withdrawal by Subject|1|||
130216172|NCT03498313|468753970|FG004|Washout Period 1|Withdrawal by Subject|0|||
130216173|NCT03498313|468753971|FG005|Washout Period 1|Withdrawal by Subject|1|||
130216174|NCT03498313|468753966|FG000|Experimental Period 2|Adverse Event|0|||
130216175|NCT03498313|468753967|FG001|Experimental Period 2|Adverse Event|0|||
130216176|NCT03498313|468753968|FG002|Experimental Period 2|Adverse Event|0|||
130216177|NCT03498313|468753969|FG003|Experimental Period 2|Adverse Event|0|||
130216178|NCT03498313|468753970|FG004|Experimental Period 2|Adverse Event|1|||
130216179|NCT03498313|468753971|FG005|Experimental Period 2|Adverse Event|2|||
130216180|NCT03498313|468753966|FG000|Washout Period 2|Physician Decision|1|||
130216181|NCT03498313|468753967|FG001|Washout Period 2|Physician Decision|0|||
130216182|NCT03498313|468753968|FG002|Washout Period 2|Physician Decision|0|||
130216183|NCT03498313|468753969|FG003|Washout Period 2|Physician Decision|1|||
130216184|NCT03498313|468753970|FG004|Washout Period 2|Physician Decision|0|||
130216185|NCT03498313|468753971|FG005|Washout Period 2|Physician Decision|1|||
130216186|NCT03498313|468753966|FG000|Washout Period 2|Withdrawal by Subject|3|||
130216187|NCT03498313|468753967|FG001|Washout Period 2|Withdrawal by Subject|2|||
130216188|NCT03498313|468753968|FG002|Washout Period 2|Withdrawal by Subject|0|||
130216189|NCT03498313|468753969|FG003|Washout Period 2|Withdrawal by Subject|0|||
130216190|NCT03498313|468753970|FG004|Washout Period 2|Withdrawal by Subject|2|||
130216191|NCT03498313|468753971|FG005|Washout Period 2|Withdrawal by Subject|0|||
130216192|NCT03498313|468753966|FG000|Washout Period 2|Anovulation|0|||
130216193|NCT03498313|468753967|FG001|Washout Period 2|Anovulation|0|||
130216194|NCT03498313|468753968|FG002|Washout Period 2|Anovulation|0|||
130337740|NCT01065454|469207443|FG001|Treatment|Protocol Violation|0|||
130671426|NCT00192296|470421790|FG002|Overall Study|Withdrawal by Subject|0|||
130216195|NCT03498313|468753969|FG003|Washout Period 2|Anovulation|0|||
130216196|NCT03498313|468753970|FG004|Washout Period 2|Anovulation|0|||
130216197|NCT03498313|468753971|FG005|Washout Period 2|Anovulation|1|||
130216198|NCT00184002|468753972|FG000|Overall Study|Adverse Event|9|||
130216199|NCT00184002|468753972|FG000|Overall Study|Death|3|||
130216200|NCT00184002|468753972|FG000|Overall Study|Physician Decision|1|||
130671427|NCT00192296|470421791|FG003|Overall Study|Withdrawal by Subject|0|||
130671428|NCT03465891|470421792|FG000|Overall Study|Withdrawal by Subject|0|||
130671429|NCT03465891|470421793|FG001|Overall Study|Withdrawal by Subject|1|||
130671430|NCT03465891|470421792|FG000|Overall Study|Disease progression|1|||
130671431|NCT03465891|470421793|FG001|Overall Study|Disease progression|0|||
130671432|NCT01001169|470421794|FG000|Overall Study|Withdrawal by Subject|2|||
130671433|NCT01001169|470421795|FG001|Overall Study|Withdrawal by Subject|1|||
130671434|NCT02536378|470421800|FG000|Overall Study|Physician Decision|0|||
130671435|NCT02536378|470421801|FG001|Overall Study|Physician Decision|2|||
130671436|NCT02536378|470421800|FG000|Overall Study|Withdrawal by Subject|0|||
130671437|NCT02536378|470421801|FG001|Overall Study|Withdrawal by Subject|1|||
130671438|NCT02536378|470421800|FG000|Overall Study|Death|1|||
130671439|NCT02536378|470421801|FG001|Overall Study|Death|2|||
130671440|NCT02536378|470421800|FG000|Overall Study|Patient refused further follow up|6|||
130671441|NCT02536378|470421801|FG001|Overall Study|Patient refused further follow up|2|||
130671442|NCT00798889|470421802|FG000|Overall Study|Adverse Event|53|||
130671443|NCT00798889|470421802|FG000|Overall Study|Protocol Violation|2|||
130671444|NCT00798889|470421802|FG000|Overall Study|Withdrawal by Subject|31|||
130671445|NCT00798889|470421802|FG000|Overall Study|Lost to Follow-up|1|||
130671446|NCT00798889|470421802|FG000|Overall Study|Lack of Efficacy|213|||
130671447|NCT00798889|470421802|FG000|Overall Study|Decision of Sponsor|11|||
130671448|NCT00798889|470421802|FG000|Overall Study|Enrolled, Not treated|3|||
130671449|NCT00617461|470421803|FG000|First Treatment Intervention Period|Adverse Event|2|||
130671450|NCT00617461|470421804|FG001|First Treatment Intervention Period|Adverse Event|0|||
130671451|NCT00617461|470421803|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
130671452|NCT00617461|470421804|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
130337741|NCT01065454|469207444|FG002|Treatment|Protocol Violation|1|||
130337742|NCT01065454|469207445|FG003|Treatment|Protocol Violation|0|||
130337743|NCT01065454|469207442|FG000|Treatment|Withdrawal by Subject|3|||
130337744|NCT01065454|469207443|FG001|Treatment|Withdrawal by Subject|1|||
130337745|NCT01065454|469207444|FG002|Treatment|Withdrawal by Subject|2|||
130337746|NCT01065454|469207445|FG003|Treatment|Withdrawal by Subject|3|||
130337747|NCT01065454|469207442|FG000|Follow up|Adverse Event|1|||
130337748|NCT01065454|469207443|FG001|Follow up|Adverse Event|0|||
130337749|NCT01065454|469207444|FG002|Follow up|Adverse Event|0|||
130337750|NCT01065454|469207445|FG003|Follow up|Adverse Event|1|||
130337751|NCT01065454|469207442|FG000|Follow up|Death|0|||
130337752|NCT01065454|469207443|FG001|Follow up|Death|1|||
130337753|NCT01065454|469207444|FG002|Follow up|Death|1|||
130337754|NCT01065454|469207445|FG003|Follow up|Death|0|||
130337755|NCT01065454|469207442|FG000|Follow up|Lost to Follow-up|0|||
130337756|NCT01065454|469207443|FG001|Follow up|Lost to Follow-up|0|||
130337757|NCT01065454|469207444|FG002|Follow up|Lost to Follow-up|0|||
130337758|NCT01065454|469207445|FG003|Follow up|Lost to Follow-up|1|||
130337759|NCT01065454|469207442|FG000|Follow up|Progressive disease|0|||
130337760|NCT01065454|469207443|FG001|Follow up|Progressive disease|0|||
130337761|NCT01065454|469207444|FG002|Follow up|Progressive disease|0|||
130337762|NCT01065454|469207445|FG003|Follow up|Progressive disease|1|||
130337763|NCT01065454|469207442|FG000|Follow up|Withdrawal by Subject|1|||
130337764|NCT01065454|469207443|FG001|Follow up|Withdrawal by Subject|1|||
130337765|NCT01065454|469207444|FG002|Follow up|Withdrawal by Subject|1|||
130337766|NCT01065454|469207445|FG003|Follow up|Withdrawal by Subject|0|||
130337767|NCT01065454|469207442|FG000|Follow up|study ongoing|37|||
130337768|NCT01065454|469207443|FG001|Follow up|study ongoing|22|||
130337769|NCT01065454|469207444|FG002|Follow up|study ongoing|15|||
130337770|NCT01065454|469207445|FG003|Follow up|study ongoing|41|||
130337771|NCT01601652|469207446|FG000|Overall Study|Death|1|||
130337772|NCT01097005|469207456|FG000|Overall Study|Case Report Form not collected|18|||
130337773|NCT01097005|469207456|FG000|Overall Study|Subjects cannot visit the hospital|1|||
130337774|NCT01097005|469207456|FG000|Overall Study|Poor medication compliance|1|||
130337775|NCT01097005|469207456|FG000|Overall Study|No examination data available|244|||
130337776|NCT01097005|469207456|FG000|Overall Study|Deviation from exclusion criteria|37|||
130337777|NCT01097005|469207456|FG000|Overall Study|Adverse Event|14|||
130337778|NCT01097005|469207456|FG000|Overall Study|Discontinuance by complication|50|||
130337779|NCT01395524|469208723|FG000|Overall Study|Non-compliance with study schedule|1|||
130337780|NCT01395524|469208724|FG001|Overall Study|Non-compliance with study schedule|0|||
130337781|NCT01395524|469208725|FG002|Overall Study|Non-compliance with study schedule|1|||
130671453|NCT00617461|470421803|FG000|First Treatment Intervention Period|Protocol Violation|2|||
130671454|NCT00617461|470421804|FG001|First Treatment Intervention Period|Protocol Violation|1|||
130671455|NCT00617461|470421803|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
130337782|NCT01395524|469208723|FG000|Overall Study|Lost to Follow-up|3|||
130337783|NCT01395524|469208724|FG001|Overall Study|Lost to Follow-up|1|||
130337784|NCT01395524|469208725|FG002|Overall Study|Lost to Follow-up|1|||
130671456|NCT00617461|470421804|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
130671457|NCT00617461|470421803|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
130337785|NCT01395524|469208723|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130337786|NCT01395524|469208724|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
130337787|NCT01395524|469208725|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130337788|NCT01395524|469208723|FG000|Overall Study|Severe noncompliance with protocol|1|||
130337789|NCT01395524|469208724|FG001|Overall Study|Severe noncompliance with protocol|0|||
130337790|NCT01395524|469208725|FG002|Overall Study|Severe noncompliance with protocol|0|||
130337791|NCT01395524|469208723|FG000|Overall Study|Adverse Event|4|||
130337792|NCT01395524|469208724|FG001|Overall Study|Adverse Event|4|||
130337793|NCT01395524|469208725|FG002|Overall Study|Adverse Event|3|||
130337794|NCT01395524|469208723|FG000|Overall Study|Death|1|||
130337795|NCT01395524|469208724|FG001|Overall Study|Death|0|||
130337796|NCT01395524|469208725|FG002|Overall Study|Death|0|||
130337797|NCT01395524|469208723|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130337798|NCT01395524|469208724|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130337799|NCT01395524|469208725|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130337800|NCT01395524|469208723|FG000|Overall Study|Withdrawal by Subject|4|||
130337801|NCT01395524|469208724|FG001|Overall Study|Withdrawal by Subject|8|||
130337802|NCT01395524|469208725|FG002|Overall Study|Withdrawal by Subject|8|||
130337803|NCT01395524|469208723|FG000|Overall Study|Did not receive treatment|1|||
130337804|NCT01395524|469208724|FG001|Overall Study|Did not receive treatment|1|||
130337805|NCT01395524|469208725|FG002|Overall Study|Did not receive treatment|3|||
130337806|NCT01395524|469208723|FG000|Overall Study|Subject had spinal surgery|0|||
130337807|NCT01395524|469208724|FG001|Overall Study|Subject had spinal surgery|0|||
130337808|NCT01395524|469208725|FG002|Overall Study|Subject had spinal surgery|1|||
130337809|NCT01657461|469208726|FG000|Overall Study|Death|9|||
130337810|NCT01657461|469208727|FG001|Overall Study|Death|12|||
130337811|NCT01657461|469208726|FG000|Overall Study|Lost to Follow-up|0|||
130337812|NCT01657461|469208727|FG001|Overall Study|Lost to Follow-up|3|||
130337813|NCT01657461|469208726|FG000|Overall Study|Physician Decision|0|||
130337814|NCT01657461|469208727|FG001|Overall Study|Physician Decision|2|||
130337815|NCT01657461|469208726|FG000|Overall Study|Withdrawal by Subject|1|||
130337816|NCT01657461|469208727|FG001|Overall Study|Withdrawal by Subject|3|||
130337817|NCT00942994|469208731|FG000|Overall Study|Adverse Event|7|||
130337818|NCT00942994|469208732|FG001|Overall Study|Adverse Event|4|||
130337819|NCT00942994|469208731|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130337820|NCT00942994|469208732|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130337821|NCT00942994|469208731|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130337822|NCT00942994|469208732|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130337823|NCT00942994|469208731|FG000|Overall Study|Patient withdrew consent|5|||
130337824|NCT00942994|469208732|FG001|Overall Study|Patient withdrew consent|8|||
130337825|NCT00942994|469208731|FG000|Overall Study|Lost to Follow-up|1|||
130337826|NCT00942994|469208732|FG001|Overall Study|Lost to Follow-up|4|||
130337827|NCT00942994|469208731|FG000|Overall Study|Protocol deviation|1|||
130337828|NCT00942994|469208732|FG001|Overall Study|Protocol deviation|2|||
130337829|NCT03583385|469208733|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130337830|NCT03583385|469208734|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130337831|NCT03583385|469208733|FG000|Treatment Period 2|Adverse Event|1|||
130337832|NCT03583385|469208734|FG001|Treatment Period 2|Adverse Event|0|||
130337833|NCT01311024|469208746|FG000|Overall Study|Protocol Violation|35|||
130337834|NCT01311024|469208747|FG001|Overall Study|Protocol Violation|22|||
130337835|NCT01523275|469208748|FG000|Overall Study|Lost to Follow-up|1|||
130671458|NCT00617461|470421804|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
130671459|NCT00617461|470421803|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
130671460|NCT00617461|470421804|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
130671461|NCT00617461|470421803|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
130671462|NCT00617461|470421804|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
130337836|NCT01523275|469208749|FG001|Overall Study|Lost to Follow-up|2|||
130337837|NCT01523275|469208748|FG000|Overall Study|Withdrawal by Subject|1|||
130337838|NCT01523275|469208749|FG001|Overall Study|Withdrawal by Subject|0|||
130337839|NCT05573386|469208750|FG000|Overall Study|Withdrawal by Subject|3|||
130337840|NCT05573386|469208751|FG001|Overall Study|Withdrawal by Subject|2|||
130337841|NCT01802073|469208752|FG000|Overall Study|Lost to Follow-up|0|||
130337842|NCT01802073|469208753|FG001|Overall Study|Lost to Follow-up|1|||
130337843|NCT01802073|469208752|FG000|Overall Study|Non-compliant|4|||
130337844|NCT01802073|469208753|FG001|Overall Study|Non-compliant|2|||
130337845|NCT01802073|469208752|FG000|Overall Study|Withdrawal by Subject|1|||
130337846|NCT01802073|469208753|FG001|Overall Study|Withdrawal by Subject|1|||
130337847|NCT01802073|469208752|FG000|Overall Study|Physician Decision|0|||
130337848|NCT01802073|469208753|FG001|Overall Study|Physician Decision|7|||
130337849|NCT00918736|469208756|FG000|Overall Study|Withdrawal by Subject|4|||
130337850|NCT01137604|469208757|FG000|Overall Study|Adverse Event|3|||
130671463|NCT00617461|470421803|FG000|Second Treatment Intervention Period|Adverse Event|0|||
130337851|NCT01137604|469208758|FG001|Overall Study|Adverse Event|6|||
130337852|NCT01137604|469208759|FG002|Overall Study|Adverse Event|9|||
130337853|NCT01137604|469208760|FG003|Overall Study|Adverse Event|9|||
130337854|NCT01137604|469208757|FG000|Overall Study|Participant Choice|0|||
130337855|NCT01137604|469208758|FG001|Overall Study|Participant Choice|2|||
130337856|NCT01137604|469208759|FG002|Overall Study|Participant Choice|2|||
130337857|NCT01137604|469208760|FG003|Overall Study|Participant Choice|0|||
130337858|NCT01137604|469208757|FG000|Overall Study|Withdrawal of consent|0|||
130337859|NCT01137604|469208758|FG001|Overall Study|Withdrawal of consent|0|||
130337860|NCT01137604|469208759|FG002|Overall Study|Withdrawal of consent|0|||
130337861|NCT01137604|469208760|FG003|Overall Study|Withdrawal of consent|2|||
130337862|NCT01137604|469208757|FG000|Overall Study|Clinical progression/deterioration|1|||
130337863|NCT01137604|469208758|FG001|Overall Study|Clinical progression/deterioration|2|||
130337864|NCT01137604|469208759|FG002|Overall Study|Clinical progression/deterioration|2|||
130337865|NCT01137604|469208760|FG003|Overall Study|Clinical progression/deterioration|0|||
130337866|NCT03462511|469208764|FG000|Overall Study|Withdrawal by Subject|2|||
130337867|NCT03462511|469208765|FG001|Overall Study|Withdrawal by Subject|3|||
130337868|NCT02925416|469208766|FG000|Overall Study|Adverse Event|2|||
130337869|NCT02925416|469208767|FG001|Overall Study|Adverse Event|0|||
130337870|NCT00200356|469208768|FG000|Overall Study|Lack of Efficacy|3|||
130337871|NCT00200356|469208769|FG001|Overall Study|Lack of Efficacy|3|||
130337872|NCT00200356|469208768|FG000|Overall Study|Protocol Violation|4|||
130337873|NCT00200356|469208769|FG001|Overall Study|Protocol Violation|4|||
130337874|NCT00200356|469208768|FG000|Overall Study|Nontreatment|1|||
130337875|NCT00200356|469208769|FG001|Overall Study|Nontreatment|0|||
130337876|NCT01297491|469208770|FG000|Overall Study|Adverse Event|11|||
130337877|NCT01297491|469208771|FG001|Overall Study|Adverse Event|6|||
130337878|NCT01297491|469208770|FG000|Overall Study|Physician Decision|3|||
130337879|NCT01297491|469208771|FG001|Overall Study|Physician Decision|2|||
130337880|NCT01297491|469208770|FG000|Overall Study|Progressive disease|11|||
130337881|NCT01297491|469208771|FG001|Overall Study|Progressive disease|20|||
130337882|NCT01297491|469208770|FG000|Overall Study|Patient/Guardian decision|3|||
130337883|NCT01297491|469208771|FG001|Overall Study|Patient/Guardian decision|4|||
130337884|NCT01297491|469208770|FG000|Overall Study|Death|2|||
130337885|NCT01297491|469208771|FG001|Overall Study|Death|1|||
130337886|NCT02424578|469208775|FG000|Overall Study|Withdrawal by Subject|0|||
130337887|NCT02424578|469208776|FG001|Overall Study|Withdrawal by Subject|1|||
130337888|NCT01703754|469208781|FG000|Overall Study|Clinically significant disease progression|2|||
130337889|NCT01703754|469208782|FG001|Overall Study|Clinically significant disease progression|2|||
130337890|NCT01703754|469208783|FG002|Overall Study|Clinically significant disease progression|1|||
130337891|NCT01703754|469208781|FG000|Overall Study|Adverse Event|1|||
130337892|NCT01703754|469208782|FG001|Overall Study|Adverse Event|1|||
130337893|NCT01703754|469208783|FG002|Overall Study|Adverse Event|0|||
130337894|NCT01703754|469208781|FG000|Overall Study|Withdrawal by Subject|2|||
130337895|NCT01703754|469208782|FG001|Overall Study|Withdrawal by Subject|0|||
130337896|NCT01703754|469208783|FG002|Overall Study|Withdrawal by Subject|0|||
130337897|NCT01989208|469208784|FG000|200 mg (7 Days)|Protocol Violation|0|||
130337898|NCT01989208|469208785|FG001|200 mg (7 Days)|Protocol Violation|1|||
130337899|NCT04973436|469208786|FG000|Overall Study|Lost to Follow-up|3|||
130337900|NCT04973436|469208786|FG000|Overall Study|Withdrawal by Subject|1|||
130337901|NCT04973436|469208786|FG000|Overall Study|Death|2|||
130337902|NCT00566696|469208787|FG000|Overall Study|Met Exclusion Criteria|2|||
130337903|NCT00566696|469208787|FG000|Overall Study|Muromonab not available|1|||
130337904|NCT00566696|469208787|FG000|Overall Study|Health Status Change|1|||
130337905|NCT00566696|469208787|FG000|Overall Study|Physician Decision|1|||
130337906|NCT00566696|469208787|FG000|Overall Study|Non-Patient Donors|37|||
130337907|NCT02872935|469208788|FG000|Overall Study|Other|0|||
130337908|NCT02872935|469208789|FG001|Overall Study|Other|1|||
130337909|NCT01276054|469208793|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
130337910|NCT01276054|469208794|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
130337911|NCT02640508|469208795|FG000|Overall Study|Death|19|||
130337912|NCT02640508|469208795|FG000|Overall Study|Withdrawal by Subject|8|||
130671464|NCT00617461|470421804|FG001|Second Treatment Intervention Period|Adverse Event|1|||
130671465|NCT00617461|470421803|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
130671466|NCT00617461|470421804|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
130671467|NCT00617461|470421803|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
130671468|NCT00617461|470421804|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
130671469|NCT00617461|470421803|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
130671470|NCT00617461|470421804|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
130671471|NCT00358826|470421808|FG000|Core Study|Adverse Event|1|||
130337913|NCT02640508|469208795|FG000|Overall Study|Physician Decision|1|||
130337914|NCT02640508|469208795|FG000|Overall Study|Lost to Follow-up|1|||
130337915|NCT02792829|469208796|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337916|NCT02792829|469208797|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
130671472|NCT00358826|470421809|FG001|Core Study|Adverse Event|3|||
130671473|NCT00358826|470421810|FG002|Core Study|Adverse Event|1|||
130337917|NCT02792829|469208798|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130671474|NCT00358826|470421811|FG003|Core Study|Adverse Event|1|||
130337918|NCT02792829|469208799|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337919|NCT02792829|469208800|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337920|NCT02792829|469208801|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337921|NCT02792829|469208802|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337922|NCT02792829|469208803|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337923|NCT02792829|469208796|FG000|Treatment Period 2|Adverse Event|0|||
130337924|NCT02792829|469208797|FG001|Treatment Period 2|Adverse Event|0|||
130337925|NCT02792829|469208798|FG002|Treatment Period 2|Adverse Event|0|||
130337926|NCT02792829|469208799|FG003|Treatment Period 2|Adverse Event|0|||
130337927|NCT02792829|469208800|FG004|Treatment Period 2|Adverse Event|1|||
130337928|NCT02792829|469208801|FG005|Treatment Period 2|Adverse Event|0|||
130337929|NCT02792829|469208802|FG006|Treatment Period 2|Adverse Event|1|||
130337930|NCT02792829|469208803|FG007|Treatment Period 2|Adverse Event|1|||
130337931|NCT02792829|469208796|FG000|Treatment Period 2|Use of proscribed medications|0|||
130337932|NCT02792829|469208797|FG001|Treatment Period 2|Use of proscribed medications|0|||
130337933|NCT02792829|469208798|FG002|Treatment Period 2|Use of proscribed medications|0|||
130337934|NCT02792829|469208799|FG003|Treatment Period 2|Use of proscribed medications|0|||
130671475|NCT00358826|470421812|FG004|Core Study|Adverse Event|0|||
130671476|NCT00358826|470421813|FG005|Core Study|Adverse Event|0|||
130671477|NCT00358826|470421814|FG006|Core Study|Adverse Event|0|||
130337935|NCT02792829|469208800|FG004|Treatment Period 2|Use of proscribed medications|0|||
130337936|NCT02792829|469208801|FG005|Treatment Period 2|Use of proscribed medications|0|||
130337937|NCT02792829|469208802|FG006|Treatment Period 2|Use of proscribed medications|0|||
130337938|NCT02792829|469208803|FG007|Treatment Period 2|Use of proscribed medications|1|||
130337939|NCT05405257|469208804|FG000|Overall Study|Withdrawal by Subject|1|||
130337940|NCT00452361|469208805|FG000|Overall Study|Adverse Event|8|||
130337941|NCT00452361|469208806|FG001|Overall Study|Adverse Event|0|||
130337942|NCT00452361|469208805|FG000|Overall Study|Withdrawal by Subject|0|||
130337943|NCT00452361|469208806|FG001|Overall Study|Withdrawal by Subject|1|||
130337944|NCT00452361|469208805|FG000|Overall Study|Premature termination|13|||
130337945|NCT00452361|469208806|FG001|Overall Study|Premature termination|9|||
130337946|NCT00776919|469208807|FG000|Overall Study|Withdrawal by Subject|16|||
130671478|NCT00358826|470421815|FG007|Core Study|Adverse Event|0|||
130671479|NCT00358826|470421808|FG000|Core Study|Withdrawal by Subject|2|||
130671480|NCT00358826|470421809|FG001|Core Study|Withdrawal by Subject|2|||
130671481|NCT00358826|470421810|FG002|Core Study|Withdrawal by Subject|0|||
130671482|NCT00358826|470421811|FG003|Core Study|Withdrawal by Subject|0|||
130671483|NCT00358826|470421812|FG004|Core Study|Withdrawal by Subject|0|||
130671484|NCT00358826|470421813|FG005|Core Study|Withdrawal by Subject|0|||
130671485|NCT00358826|470421814|FG006|Core Study|Withdrawal by Subject|0|||
130671486|NCT00358826|470421815|FG007|Core Study|Withdrawal by Subject|0|||
130671487|NCT00358826|470421808|FG000|Core Study|Lost to Follow-up|0|||
130671488|NCT00358826|470421809|FG001|Core Study|Lost to Follow-up|0|||
130671489|NCT00358826|470421810|FG002|Core Study|Lost to Follow-up|0|||
130671490|NCT00358826|470421811|FG003|Core Study|Lost to Follow-up|1|||
130671491|NCT00358826|470421812|FG004|Core Study|Lost to Follow-up|0|||
130671492|NCT00358826|470421813|FG005|Core Study|Lost to Follow-up|0|||
130671493|NCT00358826|470421814|FG006|Core Study|Lost to Follow-up|0|||
130671494|NCT00358826|470421815|FG007|Core Study|Lost to Follow-up|0|||
130671495|NCT00358826|470421808|FG000|Core Study|Physician Decision|0|||
130671496|NCT00358826|470421809|FG001|Core Study|Physician Decision|0|||
130671497|NCT00358826|470421810|FG002|Core Study|Physician Decision|1|||
130671498|NCT00358826|470421811|FG003|Core Study|Physician Decision|0|||
130671499|NCT00358826|470421812|FG004|Core Study|Physician Decision|0|||
130671500|NCT00358826|470421813|FG005|Core Study|Physician Decision|0|||
130671501|NCT00358826|470421814|FG006|Core Study|Physician Decision|0|||
130671502|NCT00358826|470421815|FG007|Core Study|Physician Decision|0|||
130671503|NCT00358826|470421808|FG000|MDCT Substudy|Adverse Event|0|||
130337947|NCT00776919|469208808|FG001|Overall Study|Withdrawal by Subject|14|||
130337948|NCT00776919|469208809|FG002|Overall Study|Withdrawal by Subject|15|||
130337949|NCT00776919|469208810|FG003|Overall Study|Withdrawal by Subject|26|||
130337950|NCT00776919|469208807|FG000|Overall Study|Lost to Follow-up|8|||
130337951|NCT00776919|469208808|FG001|Overall Study|Lost to Follow-up|12|||
130337952|NCT00776919|469208809|FG002|Overall Study|Lost to Follow-up|11|||
130337953|NCT00776919|469208810|FG003|Overall Study|Lost to Follow-up|8|||
130337954|NCT00776919|469208807|FG000|Overall Study|Adverse Event|1|||
130671504|NCT00358826|470421809|FG001|MDCT Substudy|Adverse Event|0|||
130671505|NCT00358826|470421810|FG002|MDCT Substudy|Adverse Event|0|||
130671506|NCT00358826|470421811|FG003|MDCT Substudy|Adverse Event|0|||
130671507|NCT00358826|470421812|FG004|MDCT Substudy|Adverse Event|1|||
130671508|NCT00358826|470421813|FG005|MDCT Substudy|Adverse Event|0|||
130671509|NCT00358826|470421814|FG006|MDCT Substudy|Adverse Event|0|||
130671510|NCT00358826|470421815|FG007|MDCT Substudy|Adverse Event|0|||
130671511|NCT00358826|470421808|FG000|MDCT Substudy|Lost to Follow-up|0|||
130671512|NCT00358826|470421809|FG001|MDCT Substudy|Lost to Follow-up|0|||
130216201|NCT00184002|468753972|FG000|Overall Study|Withdrawal by Subject|4|||
130337955|NCT00776919|469208808|FG001|Overall Study|Adverse Event|0|||
130337956|NCT00776919|469208809|FG002|Overall Study|Adverse Event|2|||
130337957|NCT00776919|469208810|FG003|Overall Study|Adverse Event|2|||
130671513|NCT00358826|470421810|FG002|MDCT Substudy|Lost to Follow-up|0|||
130671514|NCT00358826|470421811|FG003|MDCT Substudy|Lost to Follow-up|0|||
130671515|NCT00358826|470421812|FG004|MDCT Substudy|Lost to Follow-up|0|||
130671516|NCT00358826|470421813|FG005|MDCT Substudy|Lost to Follow-up|1|||
130671517|NCT00358826|470421814|FG006|MDCT Substudy|Lost to Follow-up|0|||
130671518|NCT00358826|470421815|FG007|MDCT Substudy|Lost to Follow-up|0|||
130671519|NCT00358826|470421808|FG000|MDCT Substudy|Withdrawal by Subject|0|||
130671520|NCT00358826|470421809|FG001|MDCT Substudy|Withdrawal by Subject|0|||
130671521|NCT00358826|470421810|FG002|MDCT Substudy|Withdrawal by Subject|0|||
130671522|NCT00358826|470421811|FG003|MDCT Substudy|Withdrawal by Subject|0|||
130671523|NCT00358826|470421812|FG004|MDCT Substudy|Withdrawal by Subject|0|||
130671524|NCT00358826|470421813|FG005|MDCT Substudy|Withdrawal by Subject|1|||
130671525|NCT00358826|470421814|FG006|MDCT Substudy|Withdrawal by Subject|0|||
130671526|NCT00358826|470421815|FG007|MDCT Substudy|Withdrawal by Subject|0|||
130671527|NCT00903383|470421816|FG000|Overall Study|Adverse Event|1|||
130671528|NCT00903383|470421817|FG001|Overall Study|Adverse Event|2|||
130671529|NCT00903383|470421818|FG002|Overall Study|Adverse Event|3|||
130671530|NCT00903383|470421819|FG003|Overall Study|Adverse Event|1|||
130671531|NCT00903383|470421816|FG000|Overall Study|Physician Decision|1|||
130671532|NCT00903383|470421817|FG001|Overall Study|Physician Decision|2|||
130671533|NCT00903383|470421818|FG002|Overall Study|Physician Decision|0|||
130671534|NCT00903383|470421819|FG003|Overall Study|Physician Decision|0|||
130671535|NCT00903383|470421816|FG000|Overall Study|Lost to Follow-up|0|||
130337958|NCT00776919|469208807|FG000|Overall Study|Protocol Violation|1|||
130337959|NCT00776919|469208808|FG001|Overall Study|Protocol Violation|2|||
130337960|NCT00776919|469208809|FG002|Overall Study|Protocol Violation|0|||
130337961|NCT00776919|469208810|FG003|Overall Study|Protocol Violation|1|||
130337962|NCT00776919|469208807|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
130337963|NCT00776919|469208808|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
130337964|NCT00776919|469208809|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
130337965|NCT00776919|469208810|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
130337966|NCT03116152|469208813|FG000|Overall Study|Disease Progression|49|||
130337967|NCT03116152|469208814|FG001|Overall Study|Disease Progression|47|||
130337968|NCT03116152|469208813|FG000|Overall Study|Death|5|||
130337969|NCT03116152|469208814|FG001|Overall Study|Death|2|||
130337970|NCT03116152|469208813|FG000|Overall Study|Adverse Event|21|||
130337971|NCT03116152|469208814|FG001|Overall Study|Adverse Event|7|||
130337972|NCT03116152|469208813|FG000|Overall Study|Protocol Violation|2|||
130337973|NCT03116152|469208814|FG001|Overall Study|Protocol Violation|2|||
130337974|NCT03116152|469208813|FG000|Overall Study|Withdrawal by Subject|0|||
130337975|NCT03116152|469208814|FG001|Overall Study|Withdrawal by Subject|1|||
130337976|NCT03116152|469208813|FG000|Overall Study|Physician Decision|3|||
130337977|NCT03116152|469208814|FG001|Overall Study|Physician Decision|2|||
130337978|NCT03116152|469208813|FG000|Overall Study|other|11|||
130337979|NCT03116152|469208814|FG001|Overall Study|other|34|||
130337980|NCT02379637|469208818|FG000|Overall Study|Protocol Violation|0|||
130337981|NCT02379637|469208819|FG001|Overall Study|Protocol Violation|1|||
130337982|NCT02379637|469208818|FG000|Overall Study|Adverse Event|1|||
130337983|NCT02379637|469208819|FG001|Overall Study|Adverse Event|0|||
130337984|NCT02379637|469208818|FG000|Overall Study|Withdrawal by Subject|1|||
130337985|NCT02379637|469208819|FG001|Overall Study|Withdrawal by Subject|0|||
130337986|NCT02791763|469208820|FG000|Overall Study|Protocol Violation|0|||
130337987|NCT02791763|469208821|FG001|Overall Study|Protocol Violation|0|||
130337988|NCT02791763|469208822|FG002|Overall Study|Protocol Violation|1|||
130337989|NCT02791763|469208820|FG000|Overall Study|Withdrawal by Subject|5|||
130337990|NCT02791763|469208821|FG001|Overall Study|Withdrawal by Subject|1|||
130337991|NCT02791763|469208822|FG002|Overall Study|Withdrawal by Subject|0|||
130337992|NCT02791763|469208820|FG000|Overall Study|Physician Decision|0|||
130337993|NCT02791763|469208821|FG001|Overall Study|Physician Decision|1|||
130337994|NCT02791763|469208822|FG002|Overall Study|Physician Decision|0|||
130337995|NCT02791763|469208820|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
130337996|NCT02791763|469208821|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
130337997|NCT02791763|469208822|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
130337998|NCT02791763|469208820|FG000|Overall Study|Cancer event|1|||
130337999|NCT02791763|469208821|FG001|Overall Study|Cancer event|3|||
130338000|NCT02791763|469208822|FG002|Overall Study|Cancer event|0|||
130338001|NCT02791763|469208820|FG000|Overall Study|Participant had renal transplant|3|||
130338002|NCT02791763|469208821|FG001|Overall Study|Participant had renal transplant|0|||
130338003|NCT02791763|469208822|FG002|Overall Study|Participant had renal transplant|0|||
130338004|NCT02791763|469208820|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
130338005|NCT02791763|469208821|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
130338006|NCT02791763|469208822|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
130338007|NCT02791763|469208820|FG000|Overall Study|Adverse Event|12|||
130671536|NCT00903383|470421817|FG001|Overall Study|Lost to Follow-up|0|||
130671537|NCT00903383|470421818|FG002|Overall Study|Lost to Follow-up|0|||
130671538|NCT00903383|470421819|FG003|Overall Study|Lost to Follow-up|1|||
130671539|NCT00903383|470421816|FG000|Overall Study|Decision of Sponsor|1|||
130338008|NCT02791763|469208821|FG001|Overall Study|Adverse Event|13|||
130338009|NCT02791763|469208822|FG002|Overall Study|Adverse Event|7|||
130338010|NCT03179605|469208823|FG000|Overall Study|Withdrawal by Subject|1|||
130671540|NCT00903383|470421817|FG001|Overall Study|Decision of Sponsor|0|||
130671541|NCT00903383|470421818|FG002|Overall Study|Decision of Sponsor|0|||
130671542|NCT00903383|470421819|FG003|Overall Study|Decision of Sponsor|0|||
130671543|NCT00903383|470421816|FG000|Overall Study|Withdrawal by Subject|4|||
130216202|NCT02171429|468753973|FG000|Overall Study|Other|0|||
130216203|NCT02171429|468753974|FG001|Overall Study|Other|1|||
130216204|NCT02171429|468753975|FG002|Overall Study|Other|1|||
130216205|NCT02171429|468753973|FG000|Overall Study|Non-Compliance|0|||
130216206|NCT02171429|468753974|FG001|Overall Study|Non-Compliance|0|||
130216207|NCT02171429|468753975|FG002|Overall Study|Non-Compliance|1|||
130216208|NCT02171429|468753973|FG000|Overall Study|Physician Decision|0|||
130216209|NCT02171429|468753974|FG001|Overall Study|Physician Decision|0|||
130216210|NCT02171429|468753975|FG002|Overall Study|Physician Decision|1|||
130216211|NCT02171429|468753973|FG000|Overall Study|Withdrawal by Subject|1|||
130216212|NCT02171429|468753974|FG001|Overall Study|Withdrawal by Subject|1|||
130216213|NCT02171429|468753975|FG002|Overall Study|Withdrawal by Subject|1|||
130216214|NCT02171429|468753973|FG000|Overall Study|Lost to Follow-up|0|||
130216215|NCT02171429|468753974|FG001|Overall Study|Lost to Follow-up|1|||
130216216|NCT02171429|468753975|FG002|Overall Study|Lost to Follow-up|0|||
130216217|NCT02171429|468753973|FG000|Overall Study|Death|0|||
130216218|NCT02171429|468753974|FG001|Overall Study|Death|0|||
130216219|NCT02171429|468753975|FG002|Overall Study|Death|1|||
130216220|NCT02020889|468753977|FG000|Overall Study|Adverse Event|0|||
130216221|NCT02020889|468753978|FG001|Overall Study|Adverse Event|1|||
130216222|NCT02020889|468753977|FG000|Overall Study|Lack of Efficacy|1|||
130216223|NCT02020889|468753978|FG001|Overall Study|Lack of Efficacy|0|||
130216224|NCT02020889|468753977|FG000|Overall Study|Lost to Follow-up|1|||
130216225|NCT02020889|468753978|FG001|Overall Study|Lost to Follow-up|0|||
130216226|NCT02020889|468753977|FG000|Overall Study|Physician Decision|2|||
130216227|NCT02020889|468753978|FG001|Overall Study|Physician Decision|0|||
130216228|NCT02020889|468753977|FG000|Overall Study|Withdrawal by Subject|3|||
130216229|NCT02020889|468753978|FG001|Overall Study|Withdrawal by Subject|2|||
130216230|NCT02768792|468753979|FG000|Overall Study|Adverse Event|1|||
130216231|NCT05980013|468753980|FG000|Overall Study|Withdrawal by Subject|0|||
130216232|NCT05980013|468753981|FG001|Overall Study|Withdrawal by Subject|1|||
130216233|NCT05980013|468753980|FG000|Overall Study|Device Error|0|||
130216234|NCT05980013|468753981|FG001|Overall Study|Device Error|1|||
130216235|NCT01768559|468753982|FG000|Overall Study|Randomized but not treated|0|||
130216236|NCT01768559|468753983|FG001|Overall Study|Randomized but not treated|0|||
130216237|NCT01768559|468753984|FG002|Overall Study|Randomized but not treated|1|||
130216238|NCT01768559|468753982|FG000|Overall Study|Adverse Event|15|||
130216239|NCT01768559|468753983|FG001|Overall Study|Adverse Event|2|||
130216240|NCT01768559|468753984|FG002|Overall Study|Adverse Event|5|||
130216241|NCT01768559|468753982|FG000|Overall Study|Lack of Efficacy|6|||
130216242|NCT01768559|468753983|FG001|Overall Study|Lack of Efficacy|4|||
130216243|NCT01768559|468753984|FG002|Overall Study|Lack of Efficacy|0|||
130216244|NCT01768559|468753982|FG000|Overall Study|Poor compliance to protocol|0|||
130216245|NCT01768559|468753983|FG001|Overall Study|Poor compliance to protocol|3|||
130216246|NCT01768559|468753984|FG002|Overall Study|Poor compliance to protocol|2|||
130216247|NCT01768559|468753982|FG000|Overall Study|Other than specified|9|||
130216248|NCT01768559|468753983|FG001|Overall Study|Other than specified|8|||
130216249|NCT01768559|468753984|FG002|Overall Study|Other than specified|5|||
130216250|NCT00398047|468753989|FG000|Overall Study|all patient progressed before completion|3|||
130216251|NCT00902746|468753990|FG000|Overall Study|Protocol Violation|7|||
130216252|NCT00902746|468753990|FG000|Overall Study|Withdrawal by Subject|16|||
130216253|NCT00902746|468753990|FG000|Overall Study|Adverse Event|8|||
130216254|NCT00902746|468753990|FG000|Overall Study|Lost to Follow-up|3|||
130216255|NCT00902746|468753990|FG000|Overall Study|Physician Decision|2|||
130216256|NCT02347072|468753992|FG000|Overall Study|Adverse Event|2|||
130216257|NCT02347072|468753992|FG000|Overall Study|Withdrawal by Subject|6|||
130216258|NCT02347072|468753992|FG000|Overall Study|Physician Decision|1|||
130216259|NCT02347072|468753992|FG000|Overall Study|Lost to Follow-up|2|||
130216260|NCT02347072|468753992|FG000|Overall Study|Protocol Violation|1|||
130216261|NCT02347072|468753992|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
130216262|NCT02793947|468755479|FG000|Overall Study|Death|1|||
130216263|NCT02793947|468755480|FG001|Overall Study|Death|0|||
130216264|NCT02793947|468755479|FG000|Overall Study|Physician Decision|1|||
130216265|NCT02793947|468755480|FG001|Overall Study|Physician Decision|5|||
130216266|NCT03746405|468755488|FG000|Overall Study|Withdrawal by Subject|3|||
130216267|NCT03746405|468755489|FG001|Overall Study|Withdrawal by Subject|0|||
130216268|NCT03746405|468755488|FG000|Overall Study|technical difficulties|0|||
130216269|NCT03746405|468755489|FG001|Overall Study|technical difficulties|2|||
130216270|NCT03479008|468755490|FG000|Overall Study|Withdrawal by Subject|3|||
130216271|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
130216272|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
130671544|NCT00903383|470421817|FG001|Overall Study|Withdrawal by Subject|1|||
130216273|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
130216274|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
130216275|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Other|1|||
130216276|NCT00412932|468755491|FG000|Olmesartan 40 mg|Adverse Event|4|||
130338011|NCT00635999|469208824|FG000|Overall Study|Withdrawal by Subject|4|||
130338012|NCT00635999|469208825|FG001|Overall Study|Withdrawal by Subject|2|||
130216277|NCT00412932|468755491|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
130338013|NCT00635999|469208826|FG002|Overall Study|Withdrawal by Subject|1|||
130338014|NCT02410343|469208827|FG000|Core Period (24 Weeks)|Adverse Event|1|||
130338015|NCT02410343|469208828|FG001|Core Period (24 Weeks)|Adverse Event|0|||
130338016|NCT02410343|469208827|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
130338017|NCT02410343|469208828|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
130338018|NCT02410343|469208827|FG000|Extension Period (12 Months)|Adverse Event|1|||
130338019|NCT02410343|469208828|FG001|Extension Period (12 Months)|Adverse Event|0|||
130338020|NCT02410343|469208827|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
130338021|NCT02410343|469208828|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
130338022|NCT00228553|469208829|FG000|Overall Study|Adverse Event|112|||
130338023|NCT00228553|469208829|FG000|Overall Study|Lack of Efficacy|34|||
130338024|NCT00228553|469208829|FG000|Overall Study|Lost to Follow-up|67|||
130338025|NCT00228553|469208829|FG000|Overall Study|Physician Decision|48|||
130338026|NCT00228553|469208829|FG000|Overall Study|Protocol Violation|6|||
130338027|NCT00228553|469208829|FG000|Overall Study|Withdrawal by Subject|115|||
130338028|NCT00228553|469208829|FG000|Overall Study|Pregnancy|2|||
130338029|NCT00228553|469208829|FG000|Overall Study|Miscellaneous|46|||
130338030|NCT02878798|469208830|FG000|Overall Study|Withdrawal by Subject|5|||
130338031|NCT02878798|469208831|FG001|Overall Study|Withdrawal by Subject|4|||
130338032|NCT02878798|469208830|FG000|Overall Study|Lost to Follow-up|2|||
130338033|NCT02878798|469208831|FG001|Overall Study|Lost to Follow-up|2|||
130338034|NCT02878798|469208830|FG000|Overall Study|Protocol Violation|0|||
130338035|NCT02878798|469208831|FG001|Overall Study|Protocol Violation|1|||
130338036|NCT02720042|469208832|FG000|Overall Study|Death|3|||
130338037|NCT02720042|469208832|FG000|Overall Study|Lost to Follow-up|4|||
130338038|NCT02720042|469208832|FG000|Overall Study|Withdrawal by Subject|1|||
130338039|NCT02720042|469208832|FG000|Overall Study|Physician Decision|3|||
130338040|NCT02720042|469208832|FG000|Overall Study|Phasix Mesh explanted|1|||
130338041|NCT02720042|469208832|FG000|Overall Study|unable due to non-study-related illness|3|||
130338042|NCT00101452|469208835|FG000|Overall Study|Adverse Event|2|||
130338043|NCT00101452|469208836|FG001|Overall Study|Adverse Event|0|||
130338044|NCT00101452|469208837|FG002|Overall Study|Adverse Event|1|||
130338045|NCT00101452|469208835|FG000|Overall Study|Lost to Follow-up|13|||
130338046|NCT00101452|469208836|FG001|Overall Study|Lost to Follow-up|8|||
130338047|NCT00101452|469208837|FG002|Overall Study|Lost to Follow-up|14|||
130338048|NCT00101452|469208835|FG000|Overall Study|Withdrawal by Subject|10|||
130338049|NCT00101452|469208836|FG001|Overall Study|Withdrawal by Subject|14|||
130338050|NCT00101452|469208837|FG002|Overall Study|Withdrawal by Subject|9|||
130338051|NCT00101452|469208835|FG000|Overall Study|Baseline Fail|2|||
130338052|NCT00101452|469208836|FG001|Overall Study|Baseline Fail|1|||
130338053|NCT00101452|469208837|FG002|Overall Study|Baseline Fail|2|||
130338054|NCT00101452|469208835|FG000|Overall Study|Physician Decision|0|||
130338055|NCT00101452|469208836|FG001|Overall Study|Physician Decision|3|||
130338056|NCT00101452|469208837|FG002|Overall Study|Physician Decision|2|||
130338057|NCT00101452|469208835|FG000|Overall Study|Protocol Violation|2|||
130338058|NCT00101452|469208836|FG001|Overall Study|Protocol Violation|1|||
130338059|NCT00101452|469208837|FG002|Overall Study|Protocol Violation|3|||
130338060|NCT00101452|469208835|FG000|Overall Study|Other|15|||
130338061|NCT00101452|469208836|FG001|Overall Study|Other|16|||
130338062|NCT00101452|469208837|FG002|Overall Study|Other|12|||
130338063|NCT01516034|469208840|FG000|Overall Study|Physician Decision|1|||
130338064|NCT01516034|469208840|FG000|Overall Study|Lack of Efficacy|7|||
130338065|NCT05477108|469208845|FG000|Overall Study|Participants randomized, not treated|1|||
130338066|NCT05477108|469208846|FG001|Overall Study|Participants randomized, not treated|1|||
130338067|NCT05477108|469208847|FG002|Overall Study|Participants randomized, not treated|1|||
130338068|NCT05477108|469208845|FG000|Overall Study|Physician Decision|0|||
130338069|NCT05477108|469208846|FG001|Overall Study|Physician Decision|0|||
130338070|NCT05477108|469208847|FG002|Overall Study|Physician Decision|1|||
130338071|NCT05477108|469208845|FG000|Overall Study|withdrawn from study|0|||
130338072|NCT05477108|469208846|FG001|Overall Study|withdrawn from study|0|||
130338073|NCT05477108|469208847|FG002|Overall Study|withdrawn from study|1|||
130338074|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
130338075|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
130338076|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
130338077|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
130338078|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
130338079|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
130338080|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130338081|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130338082|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
130338083|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
130338084|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
130338085|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
130338086|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
130338087|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
130338088|NCT01165216|469208857|FG000|Overall Study|Adverse Event|6|||
130338089|NCT01165216|469208858|FG001|Overall Study|Adverse Event|3|||
130338090|NCT01165216|469208857|FG000|Overall Study|Withdrawal by Subject|1|||
130338091|NCT01165216|469208858|FG001|Overall Study|Withdrawal by Subject|1|||
130338092|NCT01165216|469208857|FG000|Overall Study|Disease progression|1|||
130338093|NCT01165216|469208858|FG001|Overall Study|Disease progression|3|||
130338094|NCT05688670|469208860|FG000|Overall Study|Change in surgery plan|1|||
130338095|NCT05688670|469208861|FG001|Overall Study|Change in surgery plan|4|||
130338096|NCT05688670|469208860|FG000|Overall Study|Inability to extubate|1|||
130338097|NCT05688670|469208861|FG001|Overall Study|Inability to extubate|2|||
130338098|NCT05688670|469208860|FG000|Overall Study|Day of surgery cancellation|0|||
130338099|NCT05688670|469208861|FG001|Overall Study|Day of surgery cancellation|1|||
130338100|NCT05688670|469208860|FG000|Overall Study|Reintubated on PCICU arrival|0|||
130338101|NCT05688670|469208861|FG001|Overall Study|Reintubated on PCICU arrival|1|||
130338102|NCT03425253|469208862|FG000|Overall Study|Adverse Event|2|||
130338103|NCT03425253|469208862|FG000|Overall Study|Lost to Follow-up|3|||
130338104|NCT03425253|469208862|FG000|Overall Study|Withdrew Consent|6|||
130338105|NCT03425253|469208862|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
130338106|NCT01217307|469210758|FG000|Overall Study|Withdrawal by Subject|0|||
130338107|NCT01217307|469210759|FG001|Overall Study|Withdrawal by Subject|1|||
130338108|NCT04129151|469210762|FG000|Overall Study|Adverse Event|1|||
130338109|NCT04129151|469210762|FG000|Overall Study|Disease Progression|7|||
130338110|NCT04129151|469210762|FG000|Overall Study|Study closure|1|||
130338111|NCT02730195|469210763|FG000|Overall Study|Withdrawal by Subject|1|||
130338112|NCT01463007|469210764|FG000|Overall Study|Physician Decision|1|||
130338113|NCT00689117|469210765|FG000|Overall Study|Adverse Event|6|||
130338114|NCT00689117|469210766|FG001|Overall Study|Adverse Event|0|||
130338115|NCT00689117|469210767|FG002|Overall Study|Adverse Event|5|||
130338116|NCT00689117|469210768|FG003|Overall Study|Adverse Event|0|||
130338117|NCT00689117|469210765|FG000|Overall Study|Lost to Follow-up|26|||
130338118|NCT00689117|469210766|FG001|Overall Study|Lost to Follow-up|19|||
130338119|NCT00689117|469210767|FG002|Overall Study|Lost to Follow-up|17|||
130338120|NCT00689117|469210768|FG003|Overall Study|Lost to Follow-up|11|||
130338121|NCT00689117|469210765|FG000|Overall Study|Lack of Efficacy|1|||
130338122|NCT00689117|469210766|FG001|Overall Study|Lack of Efficacy|2|||
130338123|NCT00689117|469210767|FG002|Overall Study|Lack of Efficacy|2|||
130338124|NCT00689117|469210768|FG003|Overall Study|Lack of Efficacy|2|||
130338125|NCT00689117|469210765|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
130338126|NCT00689117|469210766|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
130338127|NCT00689117|469210767|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
130338128|NCT00689117|469210768|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
130338129|NCT00689117|469210765|FG000|Overall Study|Withdrawal by Subject|19|||
130338130|NCT00689117|469210766|FG001|Overall Study|Withdrawal by Subject|18|||
130338131|NCT00689117|469210767|FG002|Overall Study|Withdrawal by Subject|26|||
130338132|NCT00689117|469210768|FG003|Overall Study|Withdrawal by Subject|13|||
130338133|NCT00689117|469210765|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
130338134|NCT00689117|469210766|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
130338135|NCT00689117|469210767|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
130338136|NCT00689117|469210768|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
130338137|NCT00689117|469210765|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130338138|NCT00689117|469210766|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130338139|NCT00689117|469210767|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130338140|NCT00689117|469210768|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130338141|NCT00689117|469210765|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
130338142|NCT00689117|469210766|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
130338143|NCT00689117|469210767|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
130671545|NCT00903383|470421818|FG002|Overall Study|Withdrawal by Subject|0|||
130671546|NCT00903383|470421819|FG003|Overall Study|Withdrawal by Subject|2|||
130671547|NCT00903383|470421816|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
130338144|NCT00689117|469210768|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
130338145|NCT00689117|469210765|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
130338146|NCT00689117|469210766|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
130338147|NCT00689117|469210767|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
130671548|NCT00903383|470421817|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
130338148|NCT00689117|469210768|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
130338149|NCT00689117|469210765|FG000|Overall Study|Use of Prohibitive Medication|2|||
130338150|NCT00689117|469210766|FG001|Overall Study|Use of Prohibitive Medication|1|||
130338151|NCT00689117|469210767|FG002|Overall Study|Use of Prohibitive Medication|3|||
130338152|NCT00689117|469210768|FG003|Overall Study|Use of Prohibitive Medication|0|||
130338153|NCT00689117|469210765|FG000|Overall Study|Pregnancy|0|||
130671549|NCT00903383|470421818|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
130671550|NCT00903383|470421819|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
130671551|NCT00903383|470421816|FG000|Overall Study|Patient Decision|0|||
130671552|NCT00903383|470421817|FG001|Overall Study|Patient Decision|0|||
130671553|NCT00903383|470421818|FG002|Overall Study|Patient Decision|0|||
130671554|NCT00903383|470421819|FG003|Overall Study|Patient Decision|1|||
130671555|NCT01821625|470421822|FG000|Overall Study|Withdrawal by Subject|2|||
130671556|NCT01821625|470421822|FG000|Overall Study|Lack of Efficacy|2|||
130671557|NCT01821625|470421822|FG000|Overall Study|Adverse Event|1|||
130671558|NCT01821625|470421822|FG000|Overall Study|Medical contraindication|1|||
130338154|NCT00689117|469210766|FG001|Overall Study|Pregnancy|2|||
130338155|NCT00689117|469210767|FG002|Overall Study|Pregnancy|0|||
130338156|NCT00689117|469210768|FG003|Overall Study|Pregnancy|2|||
130338157|NCT00689117|469210765|FG000|Overall Study|Incarceration|2|||
130338158|NCT00689117|469210766|FG001|Overall Study|Incarceration|0|||
130338159|NCT00689117|469210767|FG002|Overall Study|Incarceration|0|||
130338160|NCT00689117|469210768|FG003|Overall Study|Incarceration|0|||
130338161|NCT00689117|469210765|FG000|Overall Study|Fear of Birth Defects|0|||
130338162|NCT00689117|469210766|FG001|Overall Study|Fear of Birth Defects|0|||
130338163|NCT00689117|469210767|FG002|Overall Study|Fear of Birth Defects|1|||
130338164|NCT00689117|469210768|FG003|Overall Study|Fear of Birth Defects|0|||
130338165|NCT00689117|469210765|FG000|Overall Study|Transportation|1|||
130338166|NCT00689117|469210766|FG001|Overall Study|Transportation|0|||
130338167|NCT00689117|469210767|FG002|Overall Study|Transportation|0|||
130338168|NCT00689117|469210768|FG003|Overall Study|Transportation|0|||
130338169|NCT00689117|469210765|FG000|Overall Study|Patient Withdrew from Study|0|||
130338170|NCT00689117|469210766|FG001|Overall Study|Patient Withdrew from Study|0|||
130338171|NCT00689117|469210767|FG002|Overall Study|Patient Withdrew from Study|0|||
130338172|NCT00689117|469210768|FG003|Overall Study|Patient Withdrew from Study|1|||
130338173|NCT00689117|469210765|FG000|Overall Study|Personal Reason|0|||
130338174|NCT00689117|469210766|FG001|Overall Study|Personal Reason|1|||
130338175|NCT00689117|469210767|FG002|Overall Study|Personal Reason|0|||
130338176|NCT00689117|469210768|FG003|Overall Study|Personal Reason|0|||
130338177|NCT00689117|469210765|FG000|Overall Study|Dispensing Error|0|||
130338178|NCT00689117|469210766|FG001|Overall Study|Dispensing Error|1|||
130338179|NCT00689117|469210767|FG002|Overall Study|Dispensing Error|0|||
130338180|NCT00689117|469210768|FG003|Overall Study|Dispensing Error|0|||
130338181|NCT01206322|469210769|FG000|Overall Study|Adverse Event|0|||
130338182|NCT01206322|469210770|FG001|Overall Study|Adverse Event|0|||
130338183|NCT01206322|469210771|FG002|Overall Study|Adverse Event|0|||
130338184|NCT01206322|469210772|FG003|Overall Study|Adverse Event|1|||
130338185|NCT00859638|469210775|FG000|Overall Study|Lost to Follow-up|6|||
130338186|NCT00859638|469210776|FG001|Overall Study|Lost to Follow-up|1|||
130338187|NCT00859638|469210775|FG000|Overall Study|Withdrawal by Subject|3|||
130338188|NCT00859638|469210776|FG001|Overall Study|Withdrawal by Subject|2|||
130338189|NCT00859638|469210775|FG000|Overall Study|Ill health|1|||
130338190|NCT00859638|469210776|FG001|Overall Study|Ill health|1|||
130338191|NCT02969408|469210777|FG000|Overall Study|Adverse Event|2|||
130338192|NCT02969408|469210777|FG000|Overall Study|Withdrawal by Subject|8|||
130338193|NCT02969408|469210777|FG000|Overall Study|Lost to Follow-up|4|||
130338194|NCT02969408|469210777|FG000|Overall Study|Protocol Violation|1|||
130338195|NCT02969408|469210777|FG000|Overall Study|Other than specified|1|||
130338196|NCT02779556|469210778|FG000|Baseline|Partial baseline interview completed|1|||
130338197|NCT02779556|469210779|FG001|Baseline|Partial baseline interview completed|0|||
130338198|NCT02779556|469210778|FG000|3 Months|Lost to Follow-up|40|||
130338199|NCT02779556|469210779|FG001|3 Months|Lost to Follow-up|29|||
130338200|NCT02779556|469210778|FG000|3 Months|Missed 3 month clinic visit|27|||
130338201|NCT02779556|469210779|FG001|3 Months|Missed 3 month clinic visit|19|||
130338202|NCT02779556|469210778|FG000|6 Month|Lost to Follow-up|33|||
130338203|NCT02779556|469210779|FG001|6 Month|Lost to Follow-up|39|||
130338204|NCT02779556|469210778|FG000|6 Month HbA1c|No value collected during window|69|||
130338205|NCT02779556|469210779|FG001|6 Month HbA1c|No value collected during window|50|||
130338206|NCT02779556|469210778|FG000|12 Month HbA1c|No value collected during window|138|||
130338207|NCT02779556|469210779|FG001|12 Month HbA1c|No value collected during window|102|||
130338208|NCT03110770|469210783|FG000|Overall Study|Death|1|||
130338209|NCT03110770|469210784|FG001|Overall Study|Death|0|||
130338210|NCT03110770|469210785|FG002|Overall Study|Death|0|||
130338211|NCT03110770|469210786|FG003|Overall Study|Death|1|||
130671559|NCT00320593|470421823|FG000|Overall Study|Lost to Follow-up|3|||
130338212|NCT03110770|469210787|FG004|Overall Study|Death|0|||
130338213|NCT03110770|469210783|FG000|Overall Study|Enrolled but did not receive product|0|||
130338214|NCT03110770|469210784|FG001|Overall Study|Enrolled but did not receive product|0|||
130338215|NCT03110770|469210785|FG002|Overall Study|Enrolled but did not receive product|0|||
130338216|NCT03110770|469210786|FG003|Overall Study|Enrolled but did not receive product|8|||
130338217|NCT03110770|469210787|FG004|Overall Study|Enrolled but did not receive product|7|||
130338218|NCT03110770|469210783|FG000|Overall Study|Lost to Follow-up|0|||
130338219|NCT03110770|469210784|FG001|Overall Study|Lost to Follow-up|0|||
130338220|NCT03110770|469210785|FG002|Overall Study|Lost to Follow-up|0|||
130338221|NCT03110770|469210786|FG003|Overall Study|Lost to Follow-up|53|||
130338222|NCT03110770|469210787|FG004|Overall Study|Lost to Follow-up|45|||
130338223|NCT03110770|469210783|FG000|Overall Study|Investigator Decision|0|||
130338224|NCT03110770|469210784|FG001|Overall Study|Investigator Decision|0|||
130338225|NCT03110770|469210785|FG002|Overall Study|Investigator Decision|0|||
130338226|NCT03110770|469210786|FG003|Overall Study|Investigator Decision|5|||
130338227|NCT03110770|469210787|FG004|Overall Study|Investigator Decision|3|||
130671560|NCT00320593|470421824|FG001|Overall Study|Lost to Follow-up|0|||
130671561|NCT00320593|470421823|FG000|Overall Study|Moved to another state|1|||
130671562|NCT00320593|470421824|FG001|Overall Study|Moved to another state|0|||
130671563|NCT00320593|470421823|FG000|Overall Study|Withdrawal by Subject|2|||
130671564|NCT00320593|470421824|FG001|Overall Study|Withdrawal by Subject|1|||
130671565|NCT00320593|470421823|FG000|Overall Study|Withdrawal by clinical center|1|||
130671566|NCT00320593|470421824|FG001|Overall Study|Withdrawal by clinical center|0|||
130671567|NCT00457665|470421827|FG000|12 Months|Drug allergy|1|||
130671568|NCT00457665|470421828|FG001|12 Months|Drug allergy|1|||
130671569|NCT00457665|470421827|FG000|12 Months|High HIV viral load|5|||
130671570|NCT00457665|470421828|FG001|12 Months|High HIV viral load|1|||
130671571|NCT00457665|470421827|FG000|12 Months|Lipodystrophy|2|||
130671572|NCT00457665|470421828|FG001|12 Months|Lipodystrophy|0|||
130671573|NCT00457665|470421827|FG000|12 Months|Withdrawal by Subject|0|||
130671574|NCT00457665|470421828|FG001|12 Months|Withdrawal by Subject|2|||
130671575|NCT00457665|470421827|FG000|12 Months|Abnormal Liver function tests|0|||
130671576|NCT00457665|470421828|FG001|12 Months|Abnormal Liver function tests|5|||
130671577|NCT00457665|470421827|FG000|24 Months|Withdrawal by Subject|3|||
130671578|NCT00457665|470421828|FG001|24 Months|Withdrawal by Subject|2|||
130671579|NCT00457665|470421827|FG000|24 Months|Lipodystrophy|1|||
130671580|NCT00457665|470421828|FG001|24 Months|Lipodystrophy|1|||
130671581|NCT00457665|470421827|FG000|24 Months|Abnormal liver function tests|1|||
130671582|NCT00457665|470421828|FG001|24 Months|Abnormal liver function tests|5|||
130671583|NCT01716754|470421831|FG000|Overall Study|Death|0|||
130671584|NCT01716754|470421832|FG001|Overall Study|Death|0|||
130671585|NCT01716754|470421833|FG002|Overall Study|Death|0|||
130671586|NCT01716754|470421834|FG003|Overall Study|Death|1|||
130671587|NCT01716754|470421831|FG000|Overall Study|Protocol deviation|0|||
130671588|NCT01716754|470421832|FG001|Overall Study|Protocol deviation|2|||
130671589|NCT01716754|470421833|FG002|Overall Study|Protocol deviation|7|||
130671590|NCT01716754|470421834|FG003|Overall Study|Protocol deviation|2|||
130671591|NCT01716754|470421831|FG000|Overall Study|Non-compliance with study treatment|0|||
130671592|NCT01716754|470421832|FG001|Overall Study|Non-compliance with study treatment|0|||
130671593|NCT01716754|470421833|FG002|Overall Study|Non-compliance with study treatment|1|||
130671594|NCT01716754|470421834|FG003|Overall Study|Non-compliance with study treatment|0|||
130671595|NCT01716754|470421831|FG000|Overall Study|Physician Decision|1|||
130671596|NCT01716754|470421832|FG001|Overall Study|Physician Decision|0|||
130671597|NCT01716754|470421833|FG002|Overall Study|Physician Decision|0|||
130671598|NCT01716754|470421834|FG003|Overall Study|Physician Decision|0|||
130671599|NCT01716754|470421831|FG000|Overall Study|Lost to Follow-up|1|||
130671600|NCT01716754|470421832|FG001|Overall Study|Lost to Follow-up|0|||
130671601|NCT01716754|470421833|FG002|Overall Study|Lost to Follow-up|0|||
130671602|NCT01716754|470421834|FG003|Overall Study|Lost to Follow-up|1|||
130671603|NCT01716754|470421831|FG000|Overall Study|Adverse Event|4|||
130671604|NCT01716754|470421832|FG001|Overall Study|Adverse Event|2|||
130671605|NCT01716754|470421833|FG002|Overall Study|Adverse Event|2|||
130671606|NCT01716754|470421834|FG003|Overall Study|Adverse Event|1|||
130671607|NCT01716754|470421831|FG000|Overall Study|Withdrawal by Subject|5|||
130671608|NCT01716754|470421832|FG001|Overall Study|Withdrawal by Subject|0|||
130671609|NCT01716754|470421833|FG002|Overall Study|Withdrawal by Subject|4|||
130671610|NCT01716754|470421834|FG003|Overall Study|Withdrawal by Subject|3|||
130671611|NCT00481247|470421835|FG000|Overall Study|Death|0|||
130671612|NCT00481247|470421836|FG001|Overall Study|Death|1|||
130671613|NCT00481247|470421835|FG000|Overall Study|Disease progression|18|||
130671614|NCT00481247|470421836|FG001|Overall Study|Disease progression|22|||
130671615|NCT00481247|470421835|FG000|Overall Study|Intolerance|42|||
130671616|NCT00481247|470421836|FG001|Overall Study|Intolerance|17|||
130671617|NCT00481247|470421835|FG000|Overall Study|Treatment failure|10|||
130671618|NCT00481247|470421836|FG001|Overall Study|Treatment failure|14|||
130671619|NCT00481247|470421835|FG000|Overall Study|AE unrelated to study drug|13|||
130671620|NCT00481247|470421836|FG001|Overall Study|AE unrelated to study drug|4|||
130671621|NCT00481247|470421835|FG000|Overall Study|Withdrawal by Subject|8|||
130671622|NCT00481247|470421836|FG001|Overall Study|Withdrawal by Subject|13|||
130671623|NCT00481247|470421835|FG000|Overall Study|Pregnancy|2|||
130671624|NCT00481247|470421836|FG001|Overall Study|Pregnancy|1|||
130671625|NCT00481247|470421835|FG000|Overall Study|Lost to Follow-up|1|||
130671626|NCT00481247|470421836|FG001|Overall Study|Lost to Follow-up|2|||
130671627|NCT00481247|470421835|FG000|Overall Study|Poor compliance/noncompliance|1|||
130671628|NCT00481247|470421836|FG001|Overall Study|Poor compliance/noncompliance|7|||
130671629|NCT00481247|470421835|FG000|Overall Study|Administrative reason by sponsor|157|||
130338228|NCT03110770|469210783|FG000|Overall Study|Withdrawal by Subject|0|||
130671630|NCT00481247|470421836|FG001|Overall Study|Administrative reason by sponsor|162|||
130671631|NCT00481247|470421835|FG000|Overall Study|Varied|6|||
130671632|NCT00481247|470421836|FG001|Overall Study|Varied|15|||
130671633|NCT00481247|470421835|FG000|Overall Study|Did not receive treatment|1|||
130671634|NCT00481247|470421836|FG001|Overall Study|Did not receive treatment|2|||
130671635|NCT02535000|470421837|FG000|Overall Study|Cancellation of surgery.|1|||
130671636|NCT02535000|470421838|FG001|Overall Study|Cancellation of surgery.|2|||
130671637|NCT04317781|470421840|FG000|Overall Study|Adverse Event|1|||
130671638|NCT04317781|470421840|FG000|Overall Study|Disease relapse|1|||
130671639|NCT04317781|470421840|FG000|Overall Study|Withdrawal by Subject|1|||
130671640|NCT01620489|470421841|FG000|Overall Study|Adverse Event|17|||
130671641|NCT01620489|470421842|FG001|Overall Study|Adverse Event|4|||
130671642|NCT01620489|470421841|FG000|Overall Study|Protocol Violation|0|||
130671643|NCT01620489|470421842|FG001|Overall Study|Protocol Violation|3|||
130671644|NCT01620489|470421841|FG000|Overall Study|Withdrawal Criteria|17|||
130671645|NCT01620489|470421842|FG001|Overall Study|Withdrawal Criteria|25|||
130671646|NCT01620489|470421841|FG000|Overall Study|Unclassified|1|||
130671647|NCT01620489|470421842|FG001|Overall Study|Unclassified|2|||
130671648|NCT02649231|470421843|FG000|Overall Study|Adverse Event|0|||
130671649|NCT02649231|470421844|FG001|Overall Study|Adverse Event|0|||
130671650|NCT02649231|470421845|FG002|Overall Study|Adverse Event|0|||
130671651|NCT02649231|470421846|FG003|Overall Study|Adverse Event|1|||
130671652|NCT02649231|470421843|FG000|Overall Study|Lost to Follow-up|2|||
130671653|NCT02649231|470421844|FG001|Overall Study|Lost to Follow-up|1|||
130671654|NCT02649231|470421845|FG002|Overall Study|Lost to Follow-up|1|||
130671655|NCT02649231|470421846|FG003|Overall Study|Lost to Follow-up|0|||
130671656|NCT02649231|470421843|FG000|Overall Study|Withdrawal by Subject|0|||
130671657|NCT02649231|470421844|FG001|Overall Study|Withdrawal by Subject|1|||
130338229|NCT03110770|469210784|FG001|Overall Study|Withdrawal by Subject|0|||
130671658|NCT02649231|470421845|FG002|Overall Study|Withdrawal by Subject|0|||
130671659|NCT02649231|470421846|FG003|Overall Study|Withdrawal by Subject|1|||
130671660|NCT02649231|470421843|FG000|Overall Study|Protocol Violation|2|||
130671661|NCT02649231|470421844|FG001|Overall Study|Protocol Violation|1|||
130671662|NCT02649231|470421845|FG002|Overall Study|Protocol Violation|1|||
130671663|NCT02649231|470421846|FG003|Overall Study|Protocol Violation|0|||
130671664|NCT01738581|470421847|FG000|Overall Study|Lost to Follow-up|1|||
130671665|NCT01738581|470421848|FG001|Overall Study|Lost to Follow-up|0|||
130671666|NCT00696709|470421849|FG000|Overall Study|Withdrawal by Subject|1|||
130671667|NCT00696709|470421850|FG001|Overall Study|Withdrawal by Subject|2|||
130671668|NCT00696709|470421851|FG002|Overall Study|Withdrawal by Subject|1|||
130671669|NCT00696709|470421852|FG003|Overall Study|Withdrawal by Subject|4|||
130671670|NCT00696709|470421853|FG004|Overall Study|Withdrawal by Subject|3|||
130671671|NCT00696709|470421849|FG000|Overall Study|Protocol Violation|1|||
130338230|NCT03110770|469210785|FG002|Overall Study|Withdrawal by Subject|0|||
130338231|NCT03110770|469210786|FG003|Overall Study|Withdrawal by Subject|24|||
130338232|NCT03110770|469210787|FG004|Overall Study|Withdrawal by Subject|24|||
130338233|NCT03110770|469210783|FG000|Overall Study|Moved from area|5|||
130338234|NCT03110770|469210784|FG001|Overall Study|Moved from area|0|||
130338235|NCT03110770|469210785|FG002|Overall Study|Moved from area|2|||
130338236|NCT03110770|469210786|FG003|Overall Study|Moved from area|42|||
130338237|NCT03110770|469210787|FG004|Overall Study|Moved from area|43|||
130338238|NCT03110770|469210783|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130338239|NCT03110770|469210784|FG001|Overall Study|Illness/Injury unrelated to product|0|||
130338240|NCT03110770|469210785|FG002|Overall Study|Illness/Injury unrelated to product|0|||
130338241|NCT03110770|469210786|FG003|Overall Study|Illness/Injury unrelated to product|0|||
130338242|NCT03110770|469210787|FG004|Overall Study|Illness/Injury unrelated to product|1|||
130338243|NCT01086358|469210790|FG000|First Intervention|Lost to Follow-up|9|||
130338244|NCT01086358|469210791|FG001|First Intervention|Lost to Follow-up|4|||
130338245|NCT01086358|469210790|FG000|First Intervention|Withdrawal by Subject|0|||
130338246|NCT01086358|469210791|FG001|First Intervention|Withdrawal by Subject|1|||
130338247|NCT01086358|469210790|FG000|Second Intervention|Lost to Follow-up|4|||
130338248|NCT01086358|469210791|FG001|Second Intervention|Lost to Follow-up|4|||
130338249|NCT01767142|469210792|FG000|Overall Study|Lost to Follow-up|3|||
130338250|NCT03206788|469210795|FG000|Overall Study|Withdrawal by Subject|0|||
130338251|NCT03206788|469210796|FG001|Overall Study|Withdrawal by Subject|1|||
130338252|NCT03206788|469210795|FG000|Overall Study|Adverse Event|0|||
130671672|NCT00696709|470421850|FG001|Overall Study|Protocol Violation|0|||
130671673|NCT00696709|470421851|FG002|Overall Study|Protocol Violation|0|||
130671674|NCT00696709|470421852|FG003|Overall Study|Protocol Violation|0|||
130671675|NCT00696709|470421853|FG004|Overall Study|Protocol Violation|0|||
130671676|NCT00696709|470421849|FG000|Overall Study|Lost to Follow-up|1|||
130671677|NCT00696709|470421850|FG001|Overall Study|Lost to Follow-up|1|||
130671678|NCT00696709|470421851|FG002|Overall Study|Lost to Follow-up|0|||
130671679|NCT00696709|470421852|FG003|Overall Study|Lost to Follow-up|0|||
130671680|NCT00696709|470421853|FG004|Overall Study|Lost to Follow-up|0|||
130671681|NCT00696709|470421849|FG000|Overall Study|Adverse Event|0|||
130338253|NCT03206788|469210796|FG001|Overall Study|Adverse Event|1|||
130671682|NCT00696709|470421850|FG001|Overall Study|Adverse Event|0|||
130671683|NCT00696709|470421851|FG002|Overall Study|Adverse Event|0|||
130671684|NCT00696709|470421852|FG003|Overall Study|Adverse Event|1|||
130671685|NCT00696709|470421853|FG004|Overall Study|Adverse Event|0|||
130216278|NCT00412932|468755491|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
130216279|NCT00412932|468755491|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
130216280|NCT00412932|468755491|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
130216281|NCT00412932|468755491|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
130216282|NCT00412932|468755491|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130216283|NCT01490840|468755492|FG000|Phase 1|Lost to Follow-up|1|||
130216284|NCT01490840|468755493|FG001|Phase 1|Lost to Follow-up|0|||
130216285|NCT01490840|468755492|FG000|Phase 1|Adverse Event|2|||
130216286|NCT01490840|468755493|FG001|Phase 1|Adverse Event|1|||
130216287|NCT01490840|468755492|FG000|Phase 1|Withdrawal by Subject|6|||
130216288|NCT01490840|468755493|FG001|Phase 1|Withdrawal by Subject|5|||
130216289|NCT01490840|468755492|FG000|Phase 1|Visit 6a omitted|1|||
130216290|NCT01490840|468755493|FG001|Phase 1|Visit 6a omitted|0|||
130216291|NCT01490840|468755492|FG000|Phase 2|Withdrawal by Subject|4|||
130216292|NCT01490840|468755493|FG001|Phase 2|Withdrawal by Subject|3|||
130216293|NCT01490840|468755492|FG000|Phase 2|Permanent interruption of fingolimod|0|||
130216294|NCT01490840|468755493|FG001|Phase 2|Permanent interruption of fingolimod|1|||
130216295|NCT01490840|468755492|FG000|Phase 2|Lost to Follow-up|1|||
130216296|NCT01490840|468755493|FG001|Phase 2|Lost to Follow-up|1|||
130216297|NCT01490840|468755492|FG000|Phase 2|Adverse Event|1|||
130216298|NCT01490840|468755493|FG001|Phase 2|Adverse Event|1|||
130216299|NCT01704755|468755497|FG000|Overall Study|Adverse Event|4|||
130216300|NCT01704755|468755498|FG001|Overall Study|Adverse Event|1|||
130216301|NCT01704755|468755497|FG000|Overall Study|Lost to Follow-up|3|||
130216302|NCT01704755|468755498|FG001|Overall Study|Lost to Follow-up|4|||
130216303|NCT01704755|468755497|FG000|Overall Study|Withdrew consent|1|||
130216304|NCT01704755|468755498|FG001|Overall Study|Withdrew consent|1|||
130216305|NCT01704755|468755497|FG000|Overall Study|Other (not specified)|3|||
130216306|NCT01704755|468755498|FG001|Overall Study|Other (not specified)|1|||
130216307|NCT01704755|468755497|FG000|Overall Study|Withdrew consent and personal issues|1|||
130216308|NCT01704755|468755498|FG001|Overall Study|Withdrew consent and personal issues|0|||
130216309|NCT04105842|468755499|FG000|Overall Study|Withdrawal by Subject|2|||
130216310|NCT01639703|468755500|FG000|Overall Study|Withdrawal by Subject|5|||
130216311|NCT01639703|468755500|FG000|Overall Study|Other reason|7|||
130216312|NCT02087670|468755501|FG000|Overall Study|Withdrawal by Subject|3|||
130216313|NCT02087670|468755502|FG001|Overall Study|Withdrawal by Subject|2|||
130216314|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
130216315|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130216316|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
130216317|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130216318|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
130216319|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216320|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216321|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216322|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
130216323|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
130216324|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
130216325|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
130216326|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216327|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216328|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
130216329|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216330|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
130216331|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216332|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216333|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216334|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216335|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216336|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
130216337|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216338|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
130216339|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216340|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216341|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216342|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130216343|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130338254|NCT03206788|469210795|FG000|Overall Study|Physician Decision|0|||
130671686|NCT00321711|470421854|FG000|Part A|Adverse Event|3|||
130338255|NCT03206788|469210796|FG001|Overall Study|Physician Decision|1|||
130338256|NCT02471612|469210797|FG000|Overall Study|Lost to Follow-up|2|||
130338257|NCT02082340|469210798|FG000|Overall Study|Lost to Follow-up|1|||
130338258|NCT02082340|469210799|FG001|Overall Study|Lost to Follow-up|1|||
130338259|NCT05194579|469210806|FG000|Overall Study|Lost to Follow-up|2|||
130338260|NCT05194579|469210807|FG001|Overall Study|Lost to Follow-up|3|||
130338261|NCT05194579|469210806|FG000|Overall Study|Withdrawal by Subject|3|||
130338262|NCT05194579|469210807|FG001|Overall Study|Withdrawal by Subject|4|||
130338263|NCT05194579|469210806|FG000|Overall Study|Refused further study procedures|0|||
130338264|NCT05194579|469210807|FG001|Overall Study|Refused further study procedures|1|||
130338265|NCT05194579|469210806|FG000|Overall Study|Protocol deviation|1|||
130338266|NCT05194579|469210807|FG001|Overall Study|Protocol deviation|0|||
130338267|NCT03595228|469210808|FG000|Overall Study|Death|2|||
130338268|NCT03595228|469210808|FG000|Overall Study|Lack of Efficacy|13|||
130338269|NCT03595228|469210808|FG000|Overall Study|Withdrawal by Subject|3|||
130338270|NCT03595228|469210808|FG000|Overall Study|Withdrawal by Sponsor|1|||
130338271|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130338272|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130338273|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130338274|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130338275|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
130338276|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
130338277|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
130338278|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
130338279|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
130338280|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
130338281|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
130338282|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
130338283|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130338284|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130338285|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
130338286|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
130338287|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
130338288|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
130338289|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
130338290|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
130338291|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
130338292|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
130338293|NCT00567255|469210815|FG000|Overall Study|Adverse Event|241|||
130338294|NCT00567255|469210816|FG001|Overall Study|Adverse Event|68|||
130338295|NCT00567255|469210815|FG000|Overall Study|Lost to Follow-up|77|||
130338296|NCT00567255|469210816|FG001|Overall Study|Lost to Follow-up|48|||
130338297|NCT00567255|469210815|FG000|Overall Study|Withdrawal by Subject|75|||
130338298|NCT00567255|469210816|FG001|Overall Study|Withdrawal by Subject|56|||
130338299|NCT00567255|469210815|FG000|Overall Study|Lack of Efficacy|19|||
130338300|NCT00567255|469210816|FG001|Overall Study|Lack of Efficacy|33|||
130338301|NCT00567255|469210815|FG000|Overall Study|Protocol Violation|20|||
130338302|NCT00567255|469210816|FG001|Overall Study|Protocol Violation|8|||
130338303|NCT00567255|469210815|FG000|Overall Study|Pregnancy|6|||
130338304|NCT00567255|469210816|FG001|Overall Study|Pregnancy|0|||
130338305|NCT00567255|469210815|FG000|Overall Study|Drug noncompliance,moved,other|25|||
130338306|NCT00567255|469210816|FG001|Overall Study|Drug noncompliance,moved,other|15|||
130338307|NCT03083990|469210819|FG000|Overall Study|Adverse Event|1|||
130338308|NCT03083990|469210820|FG001|Overall Study|Adverse Event|0|||
130338309|NCT00984620|469210821|FG000|Overall Study|Adverse Event|5|||
130338310|NCT00984620|469210822|FG001|Overall Study|Adverse Event|5|||
130338311|NCT00984620|469210821|FG000|Overall Study|Lost to Follow-up|1|||
130671687|NCT00321711|470421855|FG001|Part A|Adverse Event|3|||
130671688|NCT00321711|470421856|FG002|Part A|Adverse Event|2|||
130671689|NCT00321711|470421857|FG003|Part A|Adverse Event|0|||
130338312|NCT00984620|469210822|FG001|Overall Study|Lost to Follow-up|1|||
130338313|NCT00984620|469210821|FG000|Overall Study|Withdrawal by Subject|0|||
130338314|NCT00984620|469210822|FG001|Overall Study|Withdrawal by Subject|2|||
130338315|NCT00984620|469210821|FG000|Overall Study|reason other than listed above|0|||
130338316|NCT00984620|469210822|FG001|Overall Study|reason other than listed above|4|||
130338317|NCT01018810|469210823|FG000|Overall Study|Withdrawal by Subject|0|||
130338318|NCT01018810|469210824|FG001|Overall Study|Withdrawal by Subject|1|||
130338319|NCT01018810|469210825|FG002|Overall Study|Withdrawal by Subject|0|||
130338320|NCT01018810|469210826|FG003|Overall Study|Withdrawal by Subject|0|||
130338321|NCT01018810|469210827|FG004|Overall Study|Withdrawal by Subject|0|||
130338322|NCT01018810|469210823|FG000|Overall Study|Sponsor Decision|2|||
130338323|NCT01018810|469210824|FG001|Overall Study|Sponsor Decision|0|||
130338324|NCT01018810|469210825|FG002|Overall Study|Sponsor Decision|1|||
130338325|NCT01018810|469210826|FG003|Overall Study|Sponsor Decision|1|||
130671690|NCT00321711|470421858|FG004|Part A|Adverse Event|0|||
130338326|NCT01018810|469210827|FG004|Overall Study|Sponsor Decision|1|||
130338327|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
130338328|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
130338329|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Adverse Event|7|||
130338330|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Adverse Event|6|||
130338331|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
130338332|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
130338333|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Physician Decision|4|||
130338334|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Physician Decision|4|||
130338335|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
130338336|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
130338337|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130338338|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130338339|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
130338340|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
130338341|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Non-compliance|1|||
130338342|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Non-compliance|0|||
130338343|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
130338344|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
130338345|NCT00470834|469210828|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
130338346|NCT00470834|469210829|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
130338347|NCT00470834|469210828|FG000|Extension Period (24 Months)|Adverse Event|3|||
130338348|NCT00470834|469210829|FG001|Extension Period (24 Months)|Adverse Event|4|||
130338349|NCT00470834|469210828|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
130338350|NCT00470834|469210829|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
130338351|NCT00470834|469210828|FG000|Extension Period (24 Months)|Physician Decision|4|||
130338352|NCT00470834|469210829|FG001|Extension Period (24 Months)|Physician Decision|3|||
130338353|NCT00470834|469210828|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
130338354|NCT00470834|469210829|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
130338355|NCT00470834|469210828|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
130338356|NCT00470834|469210829|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
130338357|NCT00470834|469210828|FG000|Extension Period (24 Months)|Non-compliance|0|||
130338358|NCT00470834|469210829|FG001|Extension Period (24 Months)|Non-compliance|1|||
130338359|NCT00470834|469210828|FG000|Extension Period (24 Months)|Disease Progression|0|||
130338360|NCT00470834|469210829|FG001|Extension Period (24 Months)|Disease Progression|1|||
130338361|NCT00862641|469210832|FG000|Overall Study|Randomized, but drug not received|1|||
130338362|NCT00862641|469210833|FG001|Overall Study|Randomized, but drug not received|4|||
130338363|NCT00862641|469210834|FG002|Overall Study|Randomized, but drug not received|1|||
130338364|NCT00862641|469210835|FG003|Overall Study|Randomized, but drug not received|4|||
130338365|NCT02365480|469210836|FG000|Overall Study|Withdrawal by Subject|2|||
130338366|NCT02365480|469210837|FG001|Overall Study|Withdrawal by Subject|0|||
130338367|NCT04534686|469210838|FG000|Baseline Measurement|Lost to Follow-up|4|||
130338368|NCT04534686|469210839|FG001|Baseline Measurement|Lost to Follow-up|6|||
130338369|NCT04534686|469210838|FG000|Baseline Measurement|Withdrawal by Subject|3|||
130338370|NCT04534686|469210839|FG001|Baseline Measurement|Withdrawal by Subject|1|||
130338371|NCT04534686|469210838|FG000|Intervention|Withdrawal by Subject|2|||
130338372|NCT04534686|469210839|FG001|Intervention|Withdrawal by Subject|2|||
130338373|NCT01781299|469210843|FG000|Overall Study|Withdrawal by Subject|0|||
130338374|NCT01781299|469210844|FG001|Overall Study|Withdrawal by Subject|1|||
130338375|NCT01798849|469210848|FG000|Overall Study|Physician Decision|0|||
130338376|NCT01798849|469210849|FG001|Overall Study|Physician Decision|0|||
130338377|NCT01798849|469210850|FG002|Overall Study|Physician Decision|1|||
130338378|NCT02636361|469210851|FG000|Period 4|Physician Decision|0|||
130338379|NCT02636361|469210852|FG001|Period 4|Physician Decision|0|||
130671691|NCT00321711|470421854|FG000|Part A|Withdrawal by Subject|1|||
130671692|NCT00321711|470421855|FG001|Part A|Withdrawal by Subject|1|||
130671693|NCT00321711|470421856|FG002|Part A|Withdrawal by Subject|1|||
130671694|NCT00321711|470421857|FG003|Part A|Withdrawal by Subject|0|||
130671695|NCT00321711|470421858|FG004|Part A|Withdrawal by Subject|0|||
130671696|NCT00321711|470421854|FG000|Part A|Disease progression|0|||
130338380|NCT02636361|469210853|FG002|Period 4|Physician Decision|0|||
130338381|NCT02636361|469210854|FG003|Period 4|Physician Decision|1|||
130338382|NCT02636361|469210855|FG004|Period 4|Physician Decision|0|||
130338383|NCT02032238|469210856|FG000|Overall Study|Lost to Follow-up|2|||
130338384|NCT02032238|469210857|FG001|Overall Study|Lost to Follow-up|0|||
130671697|NCT00321711|470421855|FG001|Part A|Disease progression|1|||
130338385|NCT00246740|469210866|FG000|Initial Enrollment|Death|1|||
130338386|NCT00246740|469210867|FG001|Initial Enrollment|Death|0|||
130338387|NCT00246740|469210866|FG000|Initial Enrollment|Additional surgery scheduled|0|||
130338388|NCT00246740|469210867|FG001|Initial Enrollment|Additional surgery scheduled|2|||
130338389|NCT00246740|469210866|FG000|Initial Enrollment|Surgery schedule change|4|||
130338390|NCT00246740|469210867|FG001|Initial Enrollment|Surgery schedule change|4|||
130671698|NCT00321711|470421856|FG002|Part A|Disease progression|0|||
130671699|NCT00321711|470421857|FG003|Part A|Disease progression|0|||
130671700|NCT00321711|470421858|FG004|Part A|Disease progression|0|||
130671701|NCT00321711|470421854|FG000|Part A|Requirement for alternative therapy|0|||
130671702|NCT00321711|470421855|FG001|Part A|Requirement for alternative therapy|2|||
130671703|NCT00321711|470421856|FG002|Part A|Requirement for alternative therapy|1|||
130671704|NCT00321711|470421857|FG003|Part A|Requirement for alternative therapy|0|||
130671705|NCT00321711|470421858|FG004|Part A|Requirement for alternative therapy|0|||
130671706|NCT00321711|470421854|FG000|Part A|Physician Decision|0|||
130671707|NCT00321711|470421855|FG001|Part A|Physician Decision|1|||
130671708|NCT00321711|470421856|FG002|Part A|Physician Decision|3|||
130671709|NCT00321711|470421857|FG003|Part A|Physician Decision|0|||
130338391|NCT00246740|469210866|FG000|Initial Enrollment|Other|1|||
130338392|NCT00246740|469210867|FG001|Initial Enrollment|Other|2|||
130671710|NCT00321711|470421858|FG004|Part A|Physician Decision|0|||
130671711|NCT00321711|470421854|FG000|Part A|Other|1|||
130671712|NCT00321711|470421855|FG001|Part A|Other|2|||
130671713|NCT00321711|470421856|FG002|Part A|Other|3|||
130671714|NCT00321711|470421857|FG003|Part A|Other|0|||
130671715|NCT00321711|470421858|FG004|Part A|Other|0|||
130671716|NCT00321711|470421854|FG000|Part A|Protocol deviation|0|||
130671717|NCT00321711|470421855|FG001|Part A|Protocol deviation|0|||
130671718|NCT00321711|470421856|FG002|Part A|Protocol deviation|1|||
130671719|NCT00321711|470421857|FG003|Part A|Protocol deviation|0|||
130671720|NCT00321711|470421858|FG004|Part A|Protocol deviation|0|||
130671721|NCT00321711|470421854|FG000|Part B|Noncompliance|0|||
130671722|NCT00321711|470421855|FG001|Part B|Noncompliance|0|||
130671723|NCT00321711|470421856|FG002|Part B|Noncompliance|0|||
130671724|NCT00321711|470421857|FG003|Part B|Noncompliance|0|||
130671725|NCT00321711|470421858|FG004|Part B|Noncompliance|1|||
130671726|NCT00321711|470421854|FG000|Part B|Adverse Event|0|||
130671727|NCT00321711|470421855|FG001|Part B|Adverse Event|0|||
130671728|NCT00321711|470421856|FG002|Part B|Adverse Event|0|||
130671729|NCT00321711|470421857|FG003|Part B|Adverse Event|2|||
130671730|NCT00321711|470421858|FG004|Part B|Adverse Event|1|||
130671731|NCT00321711|470421854|FG000|Part B|Disease progression|0|||
130671732|NCT00321711|470421855|FG001|Part B|Disease progression|0|||
130671733|NCT00321711|470421856|FG002|Part B|Disease progression|0|||
130671734|NCT00321711|470421857|FG003|Part B|Disease progression|1|||
130671735|NCT00321711|470421858|FG004|Part B|Disease progression|0|||
130671736|NCT00321711|470421854|FG000|Part B|Physician Decision|0|||
130671737|NCT00321711|470421855|FG001|Part B|Physician Decision|0|||
130671738|NCT00321711|470421856|FG002|Part B|Physician Decision|0|||
130671739|NCT00321711|470421857|FG003|Part B|Physician Decision|1|||
130671740|NCT00321711|470421858|FG004|Part B|Physician Decision|2|||
130671741|NCT00321711|470421854|FG000|Part B|Death|0|||
130671742|NCT00321711|470421855|FG001|Part B|Death|0|||
130671743|NCT00321711|470421856|FG002|Part B|Death|0|||
130671744|NCT00321711|470421857|FG003|Part B|Death|2|||
130671745|NCT00321711|470421858|FG004|Part B|Death|1|||
130338393|NCT02969655|469210869|FG000|Overall Study|Withdrawal by Subject|3|||
130338394|NCT02969655|469210870|FG001|Overall Study|Withdrawal by Subject|2|||
130338395|NCT02969655|469210869|FG000|Overall Study|Physician Decision|4|||
130338396|NCT02969655|469210870|FG001|Overall Study|Physician Decision|3|||
130338397|NCT02969655|469210869|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
130338398|NCT02969655|469210870|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
130671746|NCT01484028|470421863|FG000|Period 1|Lost to Follow-up|0|||
130671747|NCT01484028|470421864|FG001|Period 1|Lost to Follow-up|1|||
130671748|NCT01484028|470421865|FG002|Period 1|Lost to Follow-up|0|||
130671749|NCT01484028|470421866|FG003|Period 1|Lost to Follow-up|0|||
130671750|NCT01484028|470421863|FG000|Period 1|Non-Compliance to Protocol|0|||
130671751|NCT01484028|470421864|FG001|Period 1|Non-Compliance to Protocol|1|||
130338399|NCT02969655|469210869|FG000|Overall Study|Adverse Event|10|||
130671752|NCT01484028|470421865|FG002|Period 1|Non-Compliance to Protocol|0|||
130671753|NCT01484028|470421866|FG003|Period 1|Non-Compliance to Protocol|1|||
130671754|NCT01484028|470421863|FG000|Period 1|Lens Discomfort|0|||
130671755|NCT01484028|470421864|FG001|Period 1|Lens Discomfort|1|||
130671756|NCT01484028|470421865|FG002|Period 1|Lens Discomfort|0|||
130671757|NCT01484028|470421866|FG003|Period 1|Lens Discomfort|0|||
130671758|NCT04014959|470423459|FG000|Baseline MRI and Assessments|Physician Decision|2|||
130671759|NCT04014959|470423459|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
130671760|NCT04014959|470423459|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
130671761|NCT03997448|470423464|FG000|Study Treatment|Disease Progression|1|||
130671762|NCT03997448|470423464|FG000|Study Treatment|Symptomatic Deterioration|1|||
130671763|NCT03997448|470423464|FG000|Follow up|Death|2|||
130552741|NCT00604279|469991513|FG001|Overall Study|Withdrawal by Subject|5|||
130671764|NCT03997448|470423464|FG000|Follow up|study terminated|1|||
130671765|NCT02482805|470423467|FG000|Overall Study|Lost to Follow-up|4|||
130671766|NCT02482805|470423468|FG001|Overall Study|Lost to Follow-up|4|||
130671767|NCT02482805|470423469|FG002|Overall Study|Lost to Follow-up|0|||
130671768|NCT01144663|470423472|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
130671769|NCT01144663|470423473|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
130338400|NCT02969655|469210870|FG001|Overall Study|Adverse Event|8|||
130338401|NCT01510769|469210871|FG000|Overall Study|Adverse Event|7|||
130338402|NCT01510769|469210872|FG001|Overall Study|Adverse Event|6|||
130338403|NCT01510769|469210873|FG002|Overall Study|Adverse Event|4|||
130338404|NCT01510769|469210871|FG000|Overall Study|Gout Flare|0|||
130338405|NCT01510769|469210872|FG001|Overall Study|Gout Flare|3|||
130338406|NCT01510769|469210873|FG002|Overall Study|Gout Flare|1|||
130338407|NCT01510769|469210871|FG000|Overall Study|Protocol Violation|11|||
130338408|NCT01510769|469210872|FG001|Overall Study|Protocol Violation|10|||
130338409|NCT01510769|469210873|FG002|Overall Study|Protocol Violation|9|||
130338410|NCT01510769|469210871|FG000|Overall Study|Lost to Follow-up|5|||
130338411|NCT01510769|469210872|FG001|Overall Study|Lost to Follow-up|1|||
130338412|NCT01510769|469210873|FG002|Overall Study|Lost to Follow-up|5|||
130338413|NCT01510769|469210871|FG000|Overall Study|Withdrawal by Subject|3|||
130338414|NCT01510769|469210872|FG001|Overall Study|Withdrawal by Subject|4|||
130338415|NCT01510769|469210873|FG002|Overall Study|Withdrawal by Subject|3|||
130338416|NCT01510769|469210871|FG000|Overall Study|Death|1|||
130338417|NCT01510769|469210872|FG001|Overall Study|Death|1|||
130338418|NCT01510769|469210873|FG002|Overall Study|Death|0|||
130338419|NCT00335764|469210876|FG000|Overall Study|wrong histology|1|||
130338420|NCT00335764|469210877|FG001|Overall Study|wrong histology|0|||
130338421|NCT00335764|469210878|FG002|Overall Study|wrong histology|0|||
130338422|NCT00335764|469210879|FG003|Overall Study|wrong histology|0|||
130338423|NCT00335764|469210880|FG004|Overall Study|wrong histology|1|||
130338424|NCT02466659|469210881|FG000|Overall Study|Lost to Follow-up|5|||
130338425|NCT02466659|469210882|FG001|Overall Study|Lost to Follow-up|2|||
130338426|NCT01536392|469210885|FG000|Overall Study|Adverse Event|2|||
130338427|NCT01536392|469210886|FG001|Overall Study|Adverse Event|2|||
130338428|NCT01536392|469210885|FG000|Overall Study|Physician Decision|2|||
130338429|NCT01536392|469210886|FG001|Overall Study|Physician Decision|3|||
130338430|NCT01536392|469210885|FG000|Overall Study|Withdrawal by Subject|3|||
130338431|NCT01536392|469210886|FG001|Overall Study|Withdrawal by Subject|6|||
130338432|NCT01536392|469210885|FG000|Overall Study|Non Compliance|3|||
130338433|NCT01536392|469210886|FG001|Overall Study|Non Compliance|4|||
130338434|NCT01536392|469210885|FG000|Overall Study|Completed therapy early|3|||
130338435|NCT01536392|469210886|FG001|Overall Study|Completed therapy early|0|||
130338436|NCT00934440|469210887|FG000|Overall Study|Lost to Follow-up|1|||
130338437|NCT03060551|469210888|FG000|Overall Study|Withdrawal by Subject|1|||
130338438|NCT03060551|469210888|FG000|Overall Study|Adverse Event|1|||
130338439|NCT04614324|469210893|FG000|Overall Study|Lost to Follow-up|3|||
130338440|NCT04614324|469210893|FG000|Overall Study|Physician Decision|1|||
130338441|NCT04614324|469210893|FG000|Overall Study|Withdrawal by Subject|2|||
130338442|NCT04614324|469210893|FG000|Overall Study|Remaining in Follow up|123|||
130338443|NCT05289037|469210894|FG000|Overall Study|Withdrawal by Subject|7|||
130338444|NCT05289037|469210895|FG001|Overall Study|Withdrawal by Subject|0|||
130338445|NCT05289037|469210896|FG002|Overall Study|Withdrawal by Subject|3|||
130338446|NCT05289037|469210897|FG003|Overall Study|Withdrawal by Subject|3|||
130338447|NCT05289037|469210898|FG004|Overall Study|Withdrawal by Subject|1|||
130338448|NCT05289037|469210899|FG005|Overall Study|Withdrawal by Subject|5|||
130338449|NCT05289037|469210900|FG006|Overall Study|Withdrawal by Subject|2|||
130338450|NCT05289037|469210901|FG007|Overall Study|Withdrawal by Subject|1|||
130338451|NCT05289037|469210902|FG008|Overall Study|Withdrawal by Subject|2|||
130338452|NCT05289037|469210903|FG009|Overall Study|Withdrawal by Subject|2|||
130338453|NCT05289037|469210904|FG010|Overall Study|Withdrawal by Subject|1|||
130338454|NCT05289037|469210905|FG011|Overall Study|Withdrawal by Subject|0|||
130338455|NCT05289037|469210906|FG012|Overall Study|Withdrawal by Subject|1|||
130338456|NCT05289037|469210907|FG013|Overall Study|Withdrawal by Subject|2|||
130338457|NCT05289037|469210908|FG014|Overall Study|Withdrawal by Subject|0|||
130338458|NCT05289037|469210909|FG015|Overall Study|Withdrawal by Subject|3|||
130338459|NCT05289037|469210910|FG016|Overall Study|Withdrawal by Subject|3|||
130338460|NCT05289037|469210894|FG000|Overall Study|Lost to Follow-up|1|||
130338461|NCT05289037|469210895|FG001|Overall Study|Lost to Follow-up|4|||
130338462|NCT05289037|469210896|FG002|Overall Study|Lost to Follow-up|3|||
130338463|NCT05289037|469210897|FG003|Overall Study|Lost to Follow-up|3|||
130338464|NCT05289037|469210898|FG004|Overall Study|Lost to Follow-up|3|||
130338465|NCT05289037|469210899|FG005|Overall Study|Lost to Follow-up|2|||
130338466|NCT05289037|469210900|FG006|Overall Study|Lost to Follow-up|3|||
130338467|NCT05289037|469210901|FG007|Overall Study|Lost to Follow-up|2|||
130338468|NCT05289037|469210902|FG008|Overall Study|Lost to Follow-up|2|||
130338469|NCT05289037|469210903|FG009|Overall Study|Lost to Follow-up|1|||
130338470|NCT05289037|469210904|FG010|Overall Study|Lost to Follow-up|3|||
130338471|NCT05289037|469210905|FG011|Overall Study|Lost to Follow-up|4|||
130338472|NCT05289037|469210906|FG012|Overall Study|Lost to Follow-up|2|||
130338473|NCT05289037|469210907|FG013|Overall Study|Lost to Follow-up|7|||
130338474|NCT05289037|469210908|FG014|Overall Study|Lost to Follow-up|4|||
130338475|NCT05289037|469210909|FG015|Overall Study|Lost to Follow-up|6|||
130338476|NCT05289037|469210910|FG016|Overall Study|Lost to Follow-up|4|||
130338477|NCT05289037|469210894|FG000|Overall Study|Death|0|||
130338478|NCT05289037|469210895|FG001|Overall Study|Death|0|||
130338479|NCT05289037|469210896|FG002|Overall Study|Death|0|||
130338480|NCT05289037|469210897|FG003|Overall Study|Death|0|||
130338481|NCT05289037|469210898|FG004|Overall Study|Death|0|||
130338482|NCT05289037|469210899|FG005|Overall Study|Death|1|||
130338483|NCT05289037|469210900|FG006|Overall Study|Death|0|||
130338484|NCT05289037|469210901|FG007|Overall Study|Death|0|||
130338485|NCT05289037|469210902|FG008|Overall Study|Death|0|||
130671770|NCT01144663|470423474|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
130671771|NCT01144663|470423475|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
130671772|NCT01144663|470423472|FG000|Primary Vaccination Phase|Adverse Event|1|||
130671773|NCT01144663|470423473|FG001|Primary Vaccination Phase|Adverse Event|0|||
130671774|NCT01144663|470423474|FG002|Primary Vaccination Phase|Adverse Event|0|||
130671775|NCT01144663|470423475|FG003|Primary Vaccination Phase|Adverse Event|1|||
130671776|NCT01144663|470423472|FG000|Primary Vaccination Phase|Protocol Violation|2|||
130671777|NCT01144663|470423473|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130671778|NCT01144663|470423474|FG002|Primary Vaccination Phase|Protocol Violation|1|||
130671779|NCT01144663|470423475|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130671780|NCT01144663|470423472|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
130671781|NCT01144663|470423473|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
130671782|NCT01144663|470423474|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
130671783|NCT01144663|470423475|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
130671784|NCT01144663|470423472|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
130671785|NCT01144663|470423473|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
130671786|NCT01144663|470423474|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
130671787|NCT01144663|470423475|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
130671788|NCT01144663|470423472|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
130671789|NCT01144663|470423473|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
130671790|NCT01144663|470423474|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
130671791|NCT01144663|470423475|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
130671792|NCT01144663|470423472|FG000|Primary Vaccination Phase|Other|0|||
130671793|NCT01144663|470423473|FG001|Primary Vaccination Phase|Other|1|||
130671794|NCT01144663|470423474|FG002|Primary Vaccination Phase|Other|0|||
130671795|NCT01144663|470423475|FG003|Primary Vaccination Phase|Other|2|||
130671796|NCT01144663|470423472|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
130671797|NCT01144663|470423473|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130671798|NCT01144663|470423474|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
130671799|NCT01144663|470423475|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
130671800|NCT01144663|470423472|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
130671801|NCT01144663|470423473|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
130671802|NCT01144663|470423474|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
130671803|NCT01144663|470423475|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
130671804|NCT01144663|470423472|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
130671805|NCT01144663|470423473|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
130338486|NCT05289037|469210903|FG009|Overall Study|Death|0|||
130671806|NCT01144663|470423474|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
130671807|NCT01144663|470423475|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
130671808|NCT01144663|470423472|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
130671809|NCT01144663|470423473|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
130671810|NCT01144663|470423474|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
130671811|NCT01144663|470423475|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
130671812|NCT01144663|470423472|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
130671813|NCT01144663|470423473|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
130671814|NCT01144663|470423474|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
130671815|NCT01144663|470423475|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
130671816|NCT01144663|470423472|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
130671817|NCT01144663|470423473|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
130671818|NCT01144663|470423474|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
130671819|NCT01144663|470423475|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
130671820|NCT02497391|470423477|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
130671821|NCT02497391|470423478|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
130338487|NCT05289037|469210904|FG010|Overall Study|Death|0|||
130671822|NCT02497391|470423479|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
130671823|NCT02497391|470423480|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
130671824|NCT02497391|470423481|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
130671825|NCT02497391|470423482|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
130671826|NCT02497391|470423477|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
130671827|NCT02497391|470423478|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
130671828|NCT02497391|470423479|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
130671829|NCT02497391|470423480|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
130671830|NCT02497391|470423481|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
130338488|NCT05289037|469210905|FG011|Overall Study|Death|0|||
130338489|NCT05289037|469210906|FG012|Overall Study|Death|0|||
130338490|NCT05289037|469210907|FG013|Overall Study|Death|0|||
130671831|NCT02497391|470423482|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
130671832|NCT02497391|470423477|FG000|Period 3 (14 Days)|Adverse Event|0|||
130671833|NCT02497391|470423478|FG001|Period 3 (14 Days)|Adverse Event|1|||
130671834|NCT02497391|470423479|FG002|Period 3 (14 Days)|Adverse Event|0|||
130671835|NCT02497391|470423480|FG003|Period 3 (14 Days)|Adverse Event|0|||
130671836|NCT02497391|470423481|FG004|Period 3 (14 Days)|Adverse Event|0|||
130671837|NCT02497391|470423482|FG005|Period 3 (14 Days)|Adverse Event|0|||
130338491|NCT05289037|469210908|FG014|Overall Study|Death|1|||
130338492|NCT05289037|469210909|FG015|Overall Study|Death|0|||
130338493|NCT05289037|469210910|FG016|Overall Study|Death|0|||
130338494|NCT05289037|469210894|FG000|Overall Study|Did not receive vaccine|0|||
130338495|NCT05289037|469210895|FG001|Overall Study|Did not receive vaccine|3|||
130338496|NCT05289037|469210896|FG002|Overall Study|Did not receive vaccine|0|||
130338497|NCT05289037|469210897|FG003|Overall Study|Did not receive vaccine|0|||
130338498|NCT05289037|469210898|FG004|Overall Study|Did not receive vaccine|1|||
130338499|NCT05289037|469210899|FG005|Overall Study|Did not receive vaccine|1|||
130338500|NCT05289037|469210900|FG006|Overall Study|Did not receive vaccine|1|||
130338501|NCT05289037|469210901|FG007|Overall Study|Did not receive vaccine|0|||
130338502|NCT05289037|469210902|FG008|Overall Study|Did not receive vaccine|0|||
130338503|NCT05289037|469210903|FG009|Overall Study|Did not receive vaccine|0|||
130338504|NCT05289037|469210904|FG010|Overall Study|Did not receive vaccine|0|||
130338505|NCT05289037|469210905|FG011|Overall Study|Did not receive vaccine|0|||
130338506|NCT05289037|469210906|FG012|Overall Study|Did not receive vaccine|0|||
130338507|NCT05289037|469210907|FG013|Overall Study|Did not receive vaccine|0|||
130338508|NCT05289037|469210908|FG014|Overall Study|Did not receive vaccine|1|||
130338509|NCT05289037|469210909|FG015|Overall Study|Did not receive vaccine|0|||
130338510|NCT05289037|469210910|FG016|Overall Study|Did not receive vaccine|0|||
130338511|NCT05289037|469210894|FG000|Overall Study|Unable to make last visit|0|||
130338512|NCT05289037|469210895|FG001|Overall Study|Unable to make last visit|0|||
130338513|NCT05289037|469210896|FG002|Overall Study|Unable to make last visit|1|||
130338514|NCT05289037|469210897|FG003|Overall Study|Unable to make last visit|0|||
130338515|NCT05289037|469210898|FG004|Overall Study|Unable to make last visit|0|||
130338516|NCT05289037|469210899|FG005|Overall Study|Unable to make last visit|0|||
130338517|NCT05289037|469210900|FG006|Overall Study|Unable to make last visit|0|||
130338518|NCT05289037|469210901|FG007|Overall Study|Unable to make last visit|0|||
130338519|NCT05289037|469210902|FG008|Overall Study|Unable to make last visit|0|||
130338520|NCT05289037|469210903|FG009|Overall Study|Unable to make last visit|0|||
130338521|NCT05289037|469210904|FG010|Overall Study|Unable to make last visit|0|||
130338522|NCT05289037|469210905|FG011|Overall Study|Unable to make last visit|0|||
130338523|NCT05289037|469210906|FG012|Overall Study|Unable to make last visit|0|||
130338524|NCT05289037|469210907|FG013|Overall Study|Unable to make last visit|0|||
130338525|NCT05289037|469210908|FG014|Overall Study|Unable to make last visit|0|||
130338526|NCT05289037|469210909|FG015|Overall Study|Unable to make last visit|0|||
130338527|NCT05289037|469210910|FG016|Overall Study|Unable to make last visit|0|||
130338528|NCT05289037|469210894|FG000|Overall Study|Protocol deviation|0|||
130338529|NCT05289037|469210895|FG001|Overall Study|Protocol deviation|0|||
130338530|NCT05289037|469210896|FG002|Overall Study|Protocol deviation|0|||
130338531|NCT05289037|469210897|FG003|Overall Study|Protocol deviation|0|||
130338532|NCT05289037|469210898|FG004|Overall Study|Protocol deviation|0|||
130338533|NCT05289037|469210899|FG005|Overall Study|Protocol deviation|0|||
130338534|NCT05289037|469210900|FG006|Overall Study|Protocol deviation|0|||
130338535|NCT05289037|469210901|FG007|Overall Study|Protocol deviation|0|||
130338536|NCT05289037|469210902|FG008|Overall Study|Protocol deviation|0|||
130338537|NCT05289037|469210903|FG009|Overall Study|Protocol deviation|0|||
130338538|NCT05289037|469210904|FG010|Overall Study|Protocol deviation|0|||
130338539|NCT05289037|469210905|FG011|Overall Study|Protocol deviation|0|||
130338540|NCT05289037|469210906|FG012|Overall Study|Protocol deviation|0|||
130671838|NCT02497391|470423477|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
130338541|NCT05289037|469210907|FG013|Overall Study|Protocol deviation|0|||
130338542|NCT05289037|469210908|FG014|Overall Study|Protocol deviation|0|||
130338543|NCT05289037|469210909|FG015|Overall Study|Protocol deviation|1|||
130338544|NCT05289037|469210910|FG016|Overall Study|Protocol deviation|0|||
130338545|NCT05141448|469210911|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338546|NCT05141448|469210912|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130338547|NCT05141448|469210913|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338548|NCT05141448|469210914|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338549|NCT05141448|469210915|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338550|NCT05141448|469210916|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338551|NCT05141448|469210911|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338552|NCT05141448|469210912|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338553|NCT05141448|469210913|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338554|NCT05141448|469210914|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130671839|NCT02497391|470423478|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
130552742|NCT00604279|469991512|FG000|Overall Study|Adverse Event|4|||
130338555|NCT05141448|469210915|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130338556|NCT05141448|469210916|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338557|NCT05141448|469210911|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338558|NCT05141448|469210912|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130338559|NCT05141448|469210913|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338560|NCT05141448|469210914|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338561|NCT05141448|469210915|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338562|NCT05141448|469210916|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338563|NCT05141448|469210911|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338564|NCT05141448|469210912|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338565|NCT05141448|469210913|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338566|NCT05141448|469210914|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338567|NCT05141448|469210915|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338568|NCT05141448|469210916|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130338569|NCT05141448|469210911|FG000|Period 2|COVID-19 Related|0|||
130338570|NCT05141448|469210912|FG001|Period 2|COVID-19 Related|0|||
130338571|NCT05141448|469210913|FG002|Period 2|COVID-19 Related|0|||
130338572|NCT05141448|469210914|FG003|Period 2|COVID-19 Related|1|||
130338573|NCT05141448|469210915|FG004|Period 2|COVID-19 Related|0|||
130338574|NCT05141448|469210916|FG005|Period 2|COVID-19 Related|1|||
130338575|NCT05141448|469210911|FG000|3|Covid-19 related|2|||
130338576|NCT05141448|469210912|FG001|3|Covid-19 related|0|||
130338577|NCT05141448|469210913|FG002|3|Covid-19 related|0|||
130338578|NCT05141448|469210914|FG003|3|Covid-19 related|0|||
130338579|NCT05141448|469210915|FG004|3|Covid-19 related|0|||
130338580|NCT05141448|469210916|FG005|3|Covid-19 related|1|||
130338581|NCT05141448|469210911|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
130338582|NCT05141448|469210912|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
130338583|NCT05141448|469210913|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
130338584|NCT05141448|469210914|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
130338585|NCT05141448|469210915|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
130338586|NCT05141448|469210916|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
130338587|NCT04627285|469210917|FG000|Overall Study|Adverse Event|0|||
130338588|NCT04627285|469210918|FG001|Overall Study|Adverse Event|2|||
130338589|NCT04627285|469210917|FG000|Overall Study|Lost to Follow-up|1|||
130338590|NCT04627285|469210918|FG001|Overall Study|Lost to Follow-up|0|||
130338591|NCT04627285|469210917|FG000|Overall Study|Withdrawal by Subject|1|||
130338592|NCT04627285|469210918|FG001|Overall Study|Withdrawal by Subject|1|||
130338593|NCT04627285|469210917|FG000|Overall Study|Sponsor decision|5|||
130338594|NCT04627285|469210918|FG001|Overall Study|Sponsor decision|0|||
130338595|NCT04627285|469210917|FG000|Overall Study|Participant left country; aunt informed the site|0|||
130338596|NCT04627285|469210918|FG001|Overall Study|Participant left country; aunt informed the site|1|||
130338597|NCT02051933|469213097|FG000|Overall Study|Physician Decision|0|||
130338598|NCT02051933|469213098|FG001|Overall Study|Physician Decision|1|||
130338599|NCT01221285|469213099|FG000|Overall Study|Withdrawal by Subject|1|||
130338600|NCT02123251|469213100|FG000|Overall Study|Death|1|||
130338601|NCT02123251|469213101|FG001|Overall Study|Death|1|||
130338602|NCT02123251|469213100|FG000|Overall Study|Withdrawal by Subject|0|||
130338603|NCT02123251|469213101|FG001|Overall Study|Withdrawal by Subject|3|||
130338604|NCT02123251|469213100|FG000|Overall Study|Lost Medicaid eligibility|29|||
130338605|NCT02123251|469213101|FG001|Overall Study|Lost Medicaid eligibility|22|||
130338606|NCT02123251|469213100|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
130338607|NCT02123251|469213101|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
130338608|NCT01904773|469213102|FG000|Screen|Screen failure|3|||
130338609|NCT01904773|469213103|FG001|Screen|Screen failure|0|||
130338610|NCT01904773|469213104|FG002|Screen|Screen failure|0|||
130338611|NCT01904773|469213105|FG003|Screen|Screen failure|0|||
130338612|NCT01904773|469213106|FG004|Screen|Screen failure|0|||
130338613|NCT01904773|469213107|FG005|Screen|Screen failure|0|||
130338614|NCT01904773|469213108|FG006|Screen|Screen failure|0|||
130338615|NCT01904773|469213109|FG007|Screen|Screen failure|0|||
130338616|NCT01904773|469213110|FG008|Screen|Screen failure|0|||
130338617|NCT01904773|469213102|FG000|Screen|Withdrawal by Subject|1|||
130338618|NCT01904773|469213103|FG001|Screen|Withdrawal by Subject|0|||
130338619|NCT01904773|469213104|FG002|Screen|Withdrawal by Subject|0|||
130338620|NCT01904773|469213105|FG003|Screen|Withdrawal by Subject|0|||
130338621|NCT01904773|469213106|FG004|Screen|Withdrawal by Subject|0|||
130338622|NCT01904773|469213107|FG005|Screen|Withdrawal by Subject|0|||
130338623|NCT01904773|469213108|FG006|Screen|Withdrawal by Subject|0|||
130338624|NCT01904773|469213109|FG007|Screen|Withdrawal by Subject|0|||
130338625|NCT01904773|469213110|FG008|Screen|Withdrawal by Subject|0|||
130338626|NCT01904773|469213102|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
130338627|NCT01904773|469213103|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338628|NCT01904773|469213104|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130671840|NCT02497391|470423479|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
130671841|NCT02497391|470423480|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
130671842|NCT02497391|470423481|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
130671843|NCT02497391|470423482|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
130671844|NCT02497391|470423477|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
130671845|NCT02497391|470423478|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
130671846|NCT02497391|470423479|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
130671847|NCT02497391|470423480|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
130671848|NCT02497391|470423481|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
130671849|NCT02497391|470423482|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
130671850|NCT00633152|470423493|FG000|Overall Study|Adverse Event|1|||
130671851|NCT00633152|470423494|FG001|Overall Study|Adverse Event|0|||
130671852|NCT00633152|470423493|FG000|Overall Study|Randomized, did not receive study drug|5|||
130671853|NCT00633152|470423494|FG001|Overall Study|Randomized, did not receive study drug|2|||
130671854|NCT00633152|470423493|FG000|Overall Study|Withdrawal by Subject|1|||
130671855|NCT00633152|470423494|FG001|Overall Study|Withdrawal by Subject|1|||
130671856|NCT00633152|470423493|FG000|Overall Study|Lost to Follow-up|4|||
130671857|NCT00633152|470423494|FG001|Overall Study|Lost to Follow-up|1|||
130671858|NCT00633152|470423493|FG000|Overall Study|Miscellaneous Other|3|||
130671859|NCT00633152|470423494|FG001|Overall Study|Miscellaneous Other|2|||
130671860|NCT02180061|470423495|FG000|Overall Study|Adverse Event|4|||
130671861|NCT02180061|470423496|FG001|Overall Study|Adverse Event|2|||
130671862|NCT02180061|470423495|FG000|Overall Study|Clinical Progression|5|||
130671863|NCT02180061|470423496|FG001|Overall Study|Clinical Progression|1|||
130671864|NCT02180061|470423495|FG000|Overall Study|Progressive Disease|15|||
130671865|NCT02180061|470423496|FG001|Overall Study|Progressive Disease|5|||
130671866|NCT02180061|470423495|FG000|Overall Study|Physician Decision|1|||
130671867|NCT02180061|470423496|FG001|Overall Study|Physician Decision|0|||
130671868|NCT01469364|470423497|FG000|Overall Study|Adverse Event|1|||
130671869|NCT01469364|470423497|FG000|Overall Study|Withdrawal by Subject|1|||
130671870|NCT03433001|470423516|FG000|Overall Study|Lack of Efficacy|109|||
130671871|NCT03433001|470423516|FG000|Overall Study|Adverse Event|69|||
130671872|NCT03433001|470423516|FG000|Overall Study|Withdrawal by Subject|10|||
130671873|NCT03433001|470423516|FG000|Overall Study|Death|12|||
130671874|NCT03433001|470423516|FG000|Overall Study|Lost to Follow-up|4|||
130671875|NCT03433001|470423516|FG000|Overall Study|Other|25|||
130671876|NCT01007916|470423517|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
130671877|NCT01007916|470423518|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
130671878|NCT01007916|470423517|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
130671879|NCT01007916|470423518|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
130671880|NCT02040428|470423522|FG000|Overall Study|Death|4|||
130671881|NCT02040428|470423523|FG001|Overall Study|Death|3|||
130671882|NCT02040428|470423522|FG000|Overall Study|Withdrawal by Subject|1|||
130671883|NCT02040428|470423523|FG001|Overall Study|Withdrawal by Subject|1|||
130671884|NCT01165996|470423537|FG000|Overall Study|Death|1|||
130671885|NCT01165996|470423537|FG000|Overall Study|Physician Decision|1|||
130671886|NCT01927757|470423554|FG000|Overall Study|Withdrawal by Subject|14|||
130671887|NCT01927757|470423554|FG000|Overall Study|Lost to Follow-up|2|||
130671888|NCT01927757|470423554|FG000|Overall Study|Decision by Sponsor|2|||
130671889|NCT01927757|470423554|FG000|Overall Study|Other|1|||
130671890|NCT01927757|470423554|FG000|Overall Study|Ethical Reasons|4|||
130671891|NCT01399723|470423555|FG000|Overall Study|Lost to Follow-up|0|||
130671892|NCT01399723|470423556|FG001|Overall Study|Lost to Follow-up|1|||
130671893|NCT00268346|470423560|FG000|Overall Study|Adverse Event|0|||
130671894|NCT00268346|470423561|FG001|Overall Study|Adverse Event|1|||
130671895|NCT00268346|470423560|FG000|Overall Study|Death|0|||
130671896|NCT00268346|470423561|FG001|Overall Study|Death|1|||
130671897|NCT00268346|470423560|FG000|Overall Study|Withdrawal by Subject|0|||
130671898|NCT00268346|470423561|FG001|Overall Study|Withdrawal by Subject|1|||
130671899|NCT00294723|470423562|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
130671900|NCT00294723|470423563|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
130671901|NCT00294723|470423564|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
130671902|NCT00294723|470423562|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
130671903|NCT00294723|470423563|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
130671904|NCT00294723|470423564|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
130671905|NCT00294723|470423562|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
130671906|NCT00294723|470423563|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
130671907|NCT00294723|470423564|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
130671908|NCT00294723|470423562|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
130671909|NCT00294723|470423563|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
130552743|NCT00604279|469991513|FG001|Overall Study|Adverse Event|5|||
130671910|NCT00294723|470423564|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
130671911|NCT00294723|470423562|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
130671912|NCT00294723|470423563|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
130671913|NCT00294723|470423564|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
130671914|NCT00294723|470423562|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
130338629|NCT01904773|469213105|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338630|NCT01904773|469213106|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338631|NCT01904773|469213107|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338632|NCT01904773|469213108|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338633|NCT01904773|469213109|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338634|NCT01904773|469213110|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338635|NCT01904773|469213102|FG000|First Intervention|Adverse Event|0|||
130338636|NCT01904773|469213103|FG001|First Intervention|Adverse Event|0|||
130338637|NCT01904773|469213104|FG002|First Intervention|Adverse Event|0|||
130338638|NCT01904773|469213105|FG003|First Intervention|Adverse Event|0|||
130338639|NCT01904773|469213106|FG004|First Intervention|Adverse Event|0|||
130338640|NCT01904773|469213107|FG005|First Intervention|Adverse Event|0|||
130338641|NCT01904773|469213108|FG006|First Intervention|Adverse Event|1|||
130338642|NCT01904773|469213109|FG007|First Intervention|Adverse Event|0|||
130338643|NCT01904773|469213110|FG008|First Intervention|Adverse Event|0|||
130338644|NCT01904773|469213102|FG000|Placebo Washout First Intervention|Condition worsened|0|||
130338645|NCT01904773|469213103|FG001|Placebo Washout First Intervention|Condition worsened|1|||
130338646|NCT01904773|469213104|FG002|Placebo Washout First Intervention|Condition worsened|0|||
130338647|NCT01904773|469213105|FG003|Placebo Washout First Intervention|Condition worsened|0|||
130338648|NCT01904773|469213106|FG004|Placebo Washout First Intervention|Condition worsened|0|||
130338649|NCT01904773|469213107|FG005|Placebo Washout First Intervention|Condition worsened|0|||
130338650|NCT01904773|469213108|FG006|Placebo Washout First Intervention|Condition worsened|0|||
130338651|NCT01904773|469213109|FG007|Placebo Washout First Intervention|Condition worsened|0|||
130338652|NCT01904773|469213110|FG008|Placebo Washout First Intervention|Condition worsened|0|||
130338653|NCT01904773|469213102|FG000|Fifth Intervention|Adverse Event|0|||
130338654|NCT01904773|469213103|FG001|Fifth Intervention|Adverse Event|0|||
130338655|NCT01904773|469213104|FG002|Fifth Intervention|Adverse Event|0|||
130338656|NCT01904773|469213105|FG003|Fifth Intervention|Adverse Event|0|||
130338657|NCT01904773|469213106|FG004|Fifth Intervention|Adverse Event|0|||
130338658|NCT01904773|469213107|FG005|Fifth Intervention|Adverse Event|0|||
130338659|NCT01904773|469213108|FG006|Fifth Intervention|Adverse Event|0|||
130338660|NCT01904773|469213109|FG007|Fifth Intervention|Adverse Event|1|||
130338661|NCT01904773|469213110|FG008|Fifth Intervention|Adverse Event|0|||
130338662|NCT01904773|469213102|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338663|NCT01904773|469213103|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
130338664|NCT01904773|469213104|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338665|NCT01904773|469213105|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338666|NCT01904773|469213106|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338667|NCT01904773|469213107|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338668|NCT01904773|469213108|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338669|NCT01904773|469213109|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338670|NCT01904773|469213110|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338671|NCT00220779|469213114|FG000|Overall Study|Adverse Event|1|||
130338672|NCT00220779|469213115|FG001|Overall Study|Adverse Event|0|||
130338673|NCT00220779|469213116|FG002|Overall Study|Adverse Event|0|||
130338674|NCT00220779|469213114|FG000|Overall Study|Withdrawal by Subject|1|||
130338675|NCT00220779|469213115|FG001|Overall Study|Withdrawal by Subject|4|||
130338676|NCT00220779|469213116|FG002|Overall Study|Withdrawal by Subject|1|||
130338677|NCT00220779|469213114|FG000|Overall Study|Non-compliance|1|||
130338678|NCT00220779|469213115|FG001|Overall Study|Non-compliance|0|||
130338679|NCT00220779|469213116|FG002|Overall Study|Non-compliance|0|||
130338680|NCT00220779|469213114|FG000|Overall Study|Too time consuming|1|||
130338681|NCT00220779|469213115|FG001|Overall Study|Too time consuming|0|||
130338682|NCT00220779|469213116|FG002|Overall Study|Too time consuming|0|||
130338683|NCT00220779|469213114|FG000|Overall Study|Pregnancy|0|||
130338684|NCT00220779|469213115|FG001|Overall Study|Pregnancy|0|||
130338685|NCT00220779|469213116|FG002|Overall Study|Pregnancy|2|||
130338686|NCT00220779|469213114|FG000|Overall Study|Lack of Efficacy|3|||
130671915|NCT00294723|470423563|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
130671916|NCT00294723|470423564|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
130216344|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
130338687|NCT00220779|469213115|FG001|Overall Study|Lack of Efficacy|0|||
130338688|NCT00220779|469213116|FG002|Overall Study|Lack of Efficacy|1|||
130338689|NCT02248675|469213117|FG000|Overall Study|Lost to Follow-up|3|||
130338690|NCT02248675|469213118|FG001|Overall Study|Lost to Follow-up|1|||
130338691|NCT03390101|469213121|FG000|Weeks 0-12|Withdrawal by Subject|0|||
130338692|NCT03390101|469213122|FG001|Weeks 0-12|Withdrawal by Subject|1|||
130338693|NCT03390101|469213123|FG002|Weeks 0-12|Withdrawal by Subject|1|||
130338694|NCT03390101|469213121|FG000|Weeks 0-12|Lost to Follow-up|0|||
130338695|NCT03390101|469213122|FG001|Weeks 0-12|Lost to Follow-up|1|||
130338696|NCT03390101|469213123|FG002|Weeks 0-12|Lost to Follow-up|0|||
130338697|NCT03390101|469213121|FG000|Weeks 12-54|Withdrawal by Subject|0|||
130338698|NCT03390101|469213122|FG001|Weeks 12-54|Withdrawal by Subject|3|||
130671917|NCT00294723|470423562|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
130671918|NCT00294723|470423563|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
130671919|NCT00294723|470423564|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
130671920|NCT00294723|470423562|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
130671921|NCT00294723|470423563|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
130671922|NCT00294723|470423564|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
130671923|NCT00294723|470423562|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
130671924|NCT00294723|470423563|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
130671925|NCT00294723|470423564|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
130671926|NCT00294723|470423562|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
130671927|NCT00294723|470423563|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
130671928|NCT00294723|470423564|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
130671929|NCT00294723|470423562|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130671930|NCT00294723|470423563|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130671931|NCT00294723|470423564|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130671932|NCT00294723|470423562|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
130671933|NCT00294723|470423563|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
130671934|NCT00294723|470423564|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
130671935|NCT00752791|470423565|FG000|Overall Study|Adverse Event|7|||
130671936|NCT00752791|470423565|FG000|Overall Study|Withdrawal by Subject|1|||
130671937|NCT00752791|470423565|FG000|Overall Study|Physician Decision|1|||
130671938|NCT00752791|470423565|FG000|Overall Study|Death|1|||
130671939|NCT00752791|470423565|FG000|Overall Study|Renal transplant|3|||
130671940|NCT00752791|470423565|FG000|Overall Study|Switched to hemodialysis|2|||
130671941|NCT00752791|470423565|FG000|Overall Study|Protocol deviation|1|||
130671942|NCT01958281|470423566|FG000|Overall Study|Lack of Efficacy|5|||
130671943|NCT01958281|470423567|FG001|Overall Study|Lack of Efficacy|2|||
130671944|NCT01958281|470423568|FG002|Overall Study|Lack of Efficacy|0|||
130671945|NCT01958281|470423566|FG000|Overall Study|Adverse Event|0|||
130671946|NCT01958281|470423567|FG001|Overall Study|Adverse Event|2|||
130671947|NCT01958281|470423568|FG002|Overall Study|Adverse Event|0|||
130671948|NCT01958281|470423566|FG000|Overall Study|Withdrew Consent|1|||
130671949|NCT01958281|470423567|FG001|Overall Study|Withdrew Consent|0|||
130671950|NCT01958281|470423568|FG002|Overall Study|Withdrew Consent|0|||
130671951|NCT02784106|470423569|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
130671952|NCT02784106|470423570|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
130671953|NCT02784106|470423571|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130671954|NCT02784106|470423572|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130671955|NCT02784106|470423569|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130671956|NCT02784106|470423570|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130671957|NCT02784106|470423571|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130671958|NCT02784106|470423572|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130671959|NCT02784106|470423569|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
130671960|NCT02784106|470423570|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130671961|NCT02784106|470423571|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130671962|NCT02784106|470423572|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130671963|NCT02784106|470423569|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130671964|NCT02784106|470423570|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130671965|NCT02784106|470423571|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130671966|NCT02784106|470423572|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130671967|NCT02784106|470423569|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
130671968|NCT02784106|470423570|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
130671969|NCT02784106|470423571|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
130671970|NCT02784106|470423572|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
130671971|NCT02784106|470423569|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
130671972|NCT02784106|470423570|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
130671973|NCT02784106|470423571|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
130671974|NCT02784106|470423572|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
130671975|NCT03222141|470423575|FG000|Overall Study|Death|15|||
130671976|NCT03222141|470423575|FG000|Overall Study|Lost to Follow-up|3|||
130671977|NCT01851590|470423588|FG000|Overall Study|Withdrawal by Subject|0|||
130671978|NCT01851590|470423589|FG001|Overall Study|Withdrawal by Subject|0|||
130671979|NCT01851590|470423590|FG002|Overall Study|Withdrawal by Subject|1|||
130671980|NCT01851590|470423588|FG000|Overall Study|Adverse Event|0|||
130671981|NCT01851590|470423589|FG001|Overall Study|Adverse Event|0|||
130671982|NCT01851590|470423590|FG002|Overall Study|Adverse Event|2|||
130671983|NCT01851590|470423588|FG000|Overall Study|Lack of Efficacy|0|||
130671984|NCT01851590|470423589|FG001|Overall Study|Lack of Efficacy|1|||
130671985|NCT01851590|470423590|FG002|Overall Study|Lack of Efficacy|0|||
130338699|NCT03390101|469213123|FG002|Weeks 12-54|Withdrawal by Subject|1|||
130671986|NCT02611752|470423593|FG000|Overall Study|Adverse Event|0|||
130671987|NCT02611752|470423594|FG001|Overall Study|Adverse Event|1|||
130671988|NCT00310856|470423595|FG000|Overall Study|Withdrawal by Subject|2|||
130671989|NCT00310856|470423596|FG001|Overall Study|Withdrawal by Subject|2|||
130671990|NCT00310856|470423597|FG002|Overall Study|Withdrawal by Subject|2|||
130671991|NCT00310856|470423595|FG000|Overall Study|Lost to Follow-up|1|||
130671992|NCT00310856|470423596|FG001|Overall Study|Lost to Follow-up|2|||
130671993|NCT00310856|470423597|FG002|Overall Study|Lost to Follow-up|6|||
130671994|NCT00310856|470423595|FG000|Overall Study|Inappropriate enrollment|1|||
130671995|NCT00310856|470423596|FG001|Overall Study|Inappropriate enrollment|1|||
130671996|NCT00310856|470423597|FG002|Overall Study|Inappropriate enrollment|0|||
130671997|NCT00310856|470423595|FG000|Overall Study|Unable to classify|1|||
130216345|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130216346|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
130216347|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216348|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216349|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216350|NCT00587795|468755507|FG000|Overall Study|Withdrawal by Subject|1|||
130216351|NCT00587795|468755508|FG001|Overall Study|Withdrawal by Subject|0|||
130216352|NCT02869893|468755513|FG000|Overall Study|participant aversion to IV|5|||
130216353|NCT02869893|468755513|FG000|Overall Study|participant fear of MRI scanner|2|||
130216354|NCT03146741|468755514|FG000|Overall Study|Txp with non-HCV+ heart|4|||
130216355|NCT03146741|468755514|FG000|Overall Study|Listeted for MOT|2|||
130216356|NCT03146741|468755514|FG000|Overall Study|Physician Decision|2|||
130216357|NCT03146741|468755514|FG000|Overall Study|Awaiting txp|2|||
130216358|NCT00837967|468755515|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
130216359|NCT00837967|468755516|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
130216360|NCT00551525|468755517|FG000|Overall Study|Protocol Violation|5|||
130216361|NCT04676724|468755518|FG000|Overall Study|Adverse Event|2|||
130216362|NCT04676724|468755519|FG001|Overall Study|Adverse Event|0|||
130216363|NCT04676724|468755518|FG000|Overall Study|Lost to Follow-up|1|||
130216364|NCT04676724|468755519|FG001|Overall Study|Lost to Follow-up|0|||
130216365|NCT04676724|468755518|FG000|Overall Study|Physician Decision|0|||
130216366|NCT04676724|468755519|FG001|Overall Study|Physician Decision|1|||
130216367|NCT04676724|468755518|FG000|Overall Study|Withdrawal by Subject|3|||
130216368|NCT04676724|468755519|FG001|Overall Study|Withdrawal by Subject|2|||
130216369|NCT02081001|468755525|FG000|Overall Study|Adverse Event|0|||
130216370|NCT02081001|468755526|FG001|Overall Study|Adverse Event|0|||
130216371|NCT02081001|468755527|FG002|Overall Study|Adverse Event|0|||
130216372|NCT02081001|468755528|FG003|Overall Study|Adverse Event|0|||
130216373|NCT02081001|468755529|FG004|Overall Study|Adverse Event|1|||
130216374|NCT02081001|468755530|FG005|Overall Study|Adverse Event|0|||
130216375|NCT02081001|468755531|FG006|Overall Study|Adverse Event|0|||
130216376|NCT02081001|468755532|FG007|Overall Study|Adverse Event|0|||
130216377|NCT02081001|468755533|FG008|Overall Study|Adverse Event|0|||
130216378|NCT02081001|468755534|FG009|Overall Study|Adverse Event|0|||
130216379|NCT02081001|468755535|FG010|Overall Study|Adverse Event|0|||
130216380|NCT02081001|468755536|FG011|Overall Study|Adverse Event|0|||
130216381|NCT02588092|468755557|FG000|Overall Study|Death|4|||
130216382|NCT02588092|468755558|FG001|Overall Study|Death|3|||
130216383|NCT02588092|468755559|FG002|Overall Study|Death|3|||
130216384|NCT02588092|468755560|FG003|Overall Study|Death|3|||
130216385|NCT02588092|468755561|FG004|Overall Study|Death|2|||
130216386|NCT02588092|468755562|FG005|Overall Study|Death|2|||
130216387|NCT02588092|468755563|FG006|Overall Study|Death|2|||
130216388|NCT02588092|468755564|FG007|Overall Study|Death|1|||
130216389|NCT02588092|468755565|FG008|Overall Study|Death|5|||
130216390|NCT02588092|468755566|FG009|Overall Study|Death|2|||
130216391|NCT02588092|468755557|FG000|Overall Study|Withdrawal by Subject|0|||
130216392|NCT02588092|468755558|FG001|Overall Study|Withdrawal by Subject|0|||
130216393|NCT02588092|468755559|FG002|Overall Study|Withdrawal by Subject|0|||
130216394|NCT02588092|468755560|FG003|Overall Study|Withdrawal by Subject|0|||
130216395|NCT02588092|468755561|FG004|Overall Study|Withdrawal by Subject|0|||
130216396|NCT02588092|468755562|FG005|Overall Study|Withdrawal by Subject|1|||
130216397|NCT02588092|468755563|FG006|Overall Study|Withdrawal by Subject|1|||
130216398|NCT02588092|468755564|FG007|Overall Study|Withdrawal by Subject|2|||
130216399|NCT02588092|468755565|FG008|Overall Study|Withdrawal by Subject|0|||
130216400|NCT02588092|468755566|FG009|Overall Study|Withdrawal by Subject|0|||
130216401|NCT02588092|468755557|FG000|Overall Study|Started Another Treatment|0|||
130216402|NCT02588092|468755558|FG001|Overall Study|Started Another Treatment|0|||
130216403|NCT02588092|468755559|FG002|Overall Study|Started Another Treatment|0|||
130216404|NCT02588092|468755560|FG003|Overall Study|Started Another Treatment|0|||
130216405|NCT02588092|468755561|FG004|Overall Study|Started Another Treatment|1|||
130216406|NCT02588092|468755562|FG005|Overall Study|Started Another Treatment|0|||
130216407|NCT02588092|468755563|FG006|Overall Study|Started Another Treatment|0|||
130216408|NCT02588092|468755564|FG007|Overall Study|Started Another Treatment|1|||
130671998|NCT00310856|470423596|FG001|Overall Study|Unable to classify|0|||
130671999|NCT00310856|470423597|FG002|Overall Study|Unable to classify|0|||
130672000|NCT01855126|470423601|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
130672001|NCT01855126|470423602|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
130672002|NCT01855126|470423601|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130672003|NCT01855126|470423602|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130672004|NCT01748890|470423613|FG000|Overall Study|Insufficient recruitment for analysis|4|||
130672005|NCT03740100|470423614|FG000|Overall Study|Adverse Event|1|||
130672006|NCT03740100|470423614|FG000|Overall Study|Death|1|||
130672007|NCT03387059|470423616|FG000|Overall Study|Study termination|5|||
130672008|NCT03387059|470423617|FG001|Overall Study|Study termination|4|||
130672009|NCT02995837|470423619|FG000|Overall Study|Lost to Follow-up|9|||
130672010|NCT02995837|470423620|FG001|Overall Study|Lost to Follow-up|8|||
130672011|NCT01859702|470423621|FG000|Overall Study|Protocol deviation|3|||
130672012|NCT01859702|470423621|FG000|Overall Study|Adverse Event|2|||
130338700|NCT03390101|469213121|FG000|Weeks 12-54|Pregnancy|1|||
130338701|NCT03390101|469213122|FG001|Weeks 12-54|Pregnancy|0|||
130338702|NCT03390101|469213123|FG002|Weeks 12-54|Pregnancy|0|||
130338703|NCT03390101|469213121|FG000|Weeks 12-54|Adverse Event|2|||
130338704|NCT03390101|469213122|FG001|Weeks 12-54|Adverse Event|1|||
130338705|NCT03390101|469213123|FG002|Weeks 12-54|Adverse Event|1|||
130338706|NCT00281658|469213128|FG000|Randomized Phase|Adverse Event|0|||
130338707|NCT00281658|469213129|FG001|Randomized Phase|Adverse Event|2|||
130338708|NCT00281658|469213130|FG002|Randomized Phase|Adverse Event|0|||
130338709|NCT00281658|469213131|FG003|Randomized Phase|Adverse Event|0|||
130672013|NCT01077713|470423626|FG000|Overall Study|Withdrawal by Subject|1|||
130672014|NCT01077713|470423627|FG001|Overall Study|Withdrawal by Subject|2|||
130672015|NCT01077713|470423626|FG000|Overall Study|Progressive Disease (PD)|0|||
130672016|NCT01077713|470423627|FG001|Overall Study|Progressive Disease (PD)|1|||
130672017|NCT01077713|470423626|FG000|Overall Study|Death|28|||
130672018|NCT01077713|470423627|FG001|Overall Study|Death|29|||
130672019|NCT01077713|470423626|FG000|Overall Study|Lost to Follow-up|1|||
130672020|NCT01077713|470423627|FG001|Overall Study|Lost to Follow-up|1|||
130672021|NCT01077713|470423626|FG000|Overall Study|Adverse Event|2|||
130672022|NCT01077713|470423627|FG001|Overall Study|Adverse Event|1|||
130672023|NCT01077713|470423626|FG000|Overall Study|Other|4|||
130672024|NCT01077713|470423627|FG001|Overall Study|Other|2|||
130672025|NCT00289458|470423628|FG000|Overall Study|Death|1|||
130672026|NCT00289458|470423629|FG001|Overall Study|Death|0|||
130672027|NCT00289458|470423630|FG002|Overall Study|Death|0|||
130672028|NCT00289458|470423628|FG000|Overall Study|Physician Decision|3|||
130672029|NCT00289458|470423629|FG001|Overall Study|Physician Decision|4|||
130672030|NCT00289458|470423630|FG002|Overall Study|Physician Decision|2|||
130672031|NCT00289458|470423628|FG000|Overall Study|Withdrawal by Subject|2|||
130672032|NCT00289458|470423629|FG001|Overall Study|Withdrawal by Subject|2|||
130672033|NCT00289458|470423630|FG002|Overall Study|Withdrawal by Subject|4|||
130672034|NCT00874757|470423631|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
130672035|NCT02806232|470425502|FG000|Overall Study|Lost to Follow-up|1|||
130672036|NCT02806232|470425503|FG001|Overall Study|Lost to Follow-up|2|||
130672037|NCT02806232|470425504|FG002|Overall Study|Lost to Follow-up|1|||
130672038|NCT02806232|470425505|FG003|Overall Study|Lost to Follow-up|0|||
130672039|NCT02806232|470425506|FG004|Overall Study|Lost to Follow-up|0|||
130672040|NCT02806232|470425507|FG005|Overall Study|Lost to Follow-up|1|||
130672041|NCT02806232|470425508|FG006|Overall Study|Lost to Follow-up|0|||
130672042|NCT02806232|470425509|FG007|Overall Study|Lost to Follow-up|0|||
130672043|NCT02806232|470425510|FG008|Overall Study|Lost to Follow-up|0|||
130672044|NCT02806232|470425502|FG000|Overall Study|Withdrawal by Subject|0|||
130672045|NCT02806232|470425503|FG001|Overall Study|Withdrawal by Subject|2|||
130672046|NCT02806232|470425504|FG002|Overall Study|Withdrawal by Subject|0|||
130672047|NCT02806232|470425505|FG003|Overall Study|Withdrawal by Subject|0|||
130672048|NCT02806232|470425506|FG004|Overall Study|Withdrawal by Subject|2|||
130672049|NCT02806232|470425507|FG005|Overall Study|Withdrawal by Subject|1|||
130672050|NCT02806232|470425508|FG006|Overall Study|Withdrawal by Subject|0|||
130672051|NCT02806232|470425509|FG007|Overall Study|Withdrawal by Subject|0|||
130672052|NCT02806232|470425510|FG008|Overall Study|Withdrawal by Subject|0|||
130672053|NCT01621490|470425515|FG000|Overall Study|Subject no longer meets study criteria|0|||
130672054|NCT01621490|470425516|FG001|Overall Study|Subject no longer meets study criteria|0|||
130672055|NCT01621490|470425517|FG002|Overall Study|Subject no longer meets study criteria|0|||
130672056|NCT01621490|470425518|FG003|Overall Study|Subject no longer meets study criteria|0|||
130672057|NCT01621490|470425519|FG004|Overall Study|Subject no longer meets study criteria|1|||
130672058|NCT01621490|470425520|FG005|Overall Study|Subject no longer meets study criteria|0|||
130672059|NCT01621490|470425521|FG006|Overall Study|Subject no longer meets study criteria|0|||
130338710|NCT00281658|469213128|FG000|Randomized Phase|Lost to Follow-up|34|||
130338711|NCT00281658|469213129|FG001|Randomized Phase|Lost to Follow-up|27|||
130338712|NCT00281658|469213130|FG002|Randomized Phase|Lost to Follow-up|0|||
130672060|NCT01621490|470425522|FG007|Overall Study|Subject no longer meets study criteria|0|||
130672061|NCT01621490|470425523|FG008|Overall Study|Subject no longer meets study criteria|0|||
130338713|NCT00281658|469213131|FG003|Randomized Phase|Lost to Follow-up|0|||
130338714|NCT00281658|469213128|FG000|Randomized Phase|Withdrawal by Subject|8|||
130338715|NCT00281658|469213129|FG001|Randomized Phase|Withdrawal by Subject|7|||
130338716|NCT00281658|469213130|FG002|Randomized Phase|Withdrawal by Subject|0|||
130672062|NCT01621490|470425524|FG009|Overall Study|Subject no longer meets study criteria|0|||
130338717|NCT00281658|469213131|FG003|Randomized Phase|Withdrawal by Subject|0|||
130338718|NCT00281658|469213128|FG000|Randomized Phase|Study closed/terminated|1|||
130338719|NCT00281658|469213129|FG001|Randomized Phase|Study closed/terminated|1|||
130338720|NCT00281658|469213130|FG002|Randomized Phase|Study closed/terminated|0|||
130338721|NCT00281658|469213131|FG003|Randomized Phase|Study closed/terminated|0|||
130338722|NCT00281658|469213128|FG000|Randomized Phase|Disease progression|36|||
130338723|NCT00281658|469213129|FG001|Randomized Phase|Disease progression|27|||
130338724|NCT00281658|469213130|FG002|Randomized Phase|Disease progression|0|||
130338725|NCT00281658|469213131|FG003|Randomized Phase|Disease progression|0|||
130338726|NCT00281658|469213128|FG000|Randomized Phase|Physician Decision|1|||
130338727|NCT00281658|469213129|FG001|Randomized Phase|Physician Decision|1|||
130338728|NCT00281658|469213130|FG002|Randomized Phase|Physician Decision|0|||
130338729|NCT00281658|469213131|FG003|Randomized Phase|Physician Decision|0|||
130338730|NCT00281658|469213128|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
130338731|NCT00281658|469213129|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
130338732|NCT00281658|469213130|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
130338733|NCT00281658|469213131|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
130338734|NCT00281658|469213128|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
130338735|NCT00281658|469213129|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
130338736|NCT00281658|469213130|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
130338737|NCT00281658|469213131|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
130338738|NCT00281658|469213128|FG000|Randomized Phase|Treatment ongoing|1|||
130338739|NCT00281658|469213129|FG001|Randomized Phase|Treatment ongoing|0|||
130338740|NCT00281658|469213130|FG002|Randomized Phase|Treatment ongoing|0|||
130338741|NCT00281658|469213131|FG003|Randomized Phase|Treatment ongoing|0|||
130338742|NCT00281658|469213128|FG000|Open Label Phase|Adverse Event|0|||
130338743|NCT00281658|469213129|FG001|Open Label Phase|Adverse Event|0|||
130338744|NCT00281658|469213130|FG002|Open Label Phase|Adverse Event|1|||
130338745|NCT00281658|469213131|FG003|Open Label Phase|Adverse Event|0|||
130338746|NCT00281658|469213128|FG000|Open Label Phase|Lost to Follow-up|0|||
130338747|NCT00281658|469213129|FG001|Open Label Phase|Lost to Follow-up|0|||
130338748|NCT00281658|469213130|FG002|Open Label Phase|Lost to Follow-up|16|||
130338749|NCT00281658|469213131|FG003|Open Label Phase|Lost to Follow-up|2|||
130338750|NCT00281658|469213128|FG000|Open Label Phase|Withdrawal by Subject|0|||
130338751|NCT00281658|469213129|FG001|Open Label Phase|Withdrawal by Subject|0|||
130338752|NCT00281658|469213130|FG002|Open Label Phase|Withdrawal by Subject|3|||
130338753|NCT00281658|469213131|FG003|Open Label Phase|Withdrawal by Subject|2|||
130338754|NCT00281658|469213128|FG000|Open Label Phase|Disease progression|0|||
130338755|NCT00281658|469213129|FG001|Open Label Phase|Disease progression|0|||
130338756|NCT00281658|469213130|FG002|Open Label Phase|Disease progression|18|||
130338757|NCT00281658|469213131|FG003|Open Label Phase|Disease progression|0|||
130338758|NCT00281658|469213128|FG000|Open Label Phase|Physician Decision|0|||
130338759|NCT00281658|469213129|FG001|Open Label Phase|Physician Decision|0|||
130338760|NCT00281658|469213130|FG002|Open Label Phase|Physician Decision|1|||
130338761|NCT00281658|469213131|FG003|Open Label Phase|Physician Decision|0|||
130338762|NCT00281658|469213128|FG000|Open Label Phase|Relocation of patient|0|||
130338763|NCT00281658|469213129|FG001|Open Label Phase|Relocation of patient|0|||
130338764|NCT00281658|469213130|FG002|Open Label Phase|Relocation of patient|1|||
130338765|NCT00281658|469213131|FG003|Open Label Phase|Relocation of patient|0|||
130338766|NCT00281658|469213128|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
130338767|NCT00281658|469213129|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
130338768|NCT00281658|469213130|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
130338769|NCT00281658|469213131|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
130338770|NCT00813943|469213135|FG000|Overall Study|Ongoing at cut-off date|5|||
130338771|NCT00813943|469213136|FG001|Overall Study|Ongoing at cut-off date|5|||
130672063|NCT01621490|470425525|FG010|Overall Study|Subject no longer meets study criteria|0|||
130672064|NCT01621490|470425515|FG000|Overall Study|Maximum clinical benefit|3|||
130672065|NCT01621490|470425516|FG001|Overall Study|Maximum clinical benefit|2|||
130338772|NCT00813943|469213137|FG002|Overall Study|Ongoing at cut-off date|3|||
130338773|NCT01343693|469213138|FG000|Overall Study|Lost to Follow-up|9|||
130338774|NCT01235598|469213139|FG000|Overall Study|Adverse Event|0|||
130338775|NCT01235598|469213140|FG001|Overall Study|Adverse Event|3|||
130338776|NCT01235598|469213139|FG000|Overall Study|Lack of Efficacy|0|||
130338777|NCT01235598|469213140|FG001|Overall Study|Lack of Efficacy|1|||
130338778|NCT01235598|469213139|FG000|Overall Study|Withdrawal by Subject|1|||
130338779|NCT01235598|469213140|FG001|Overall Study|Withdrawal by Subject|0|||
130338780|NCT02551991|469213141|FG000|Overall Study|Death|5|||
130338781|NCT02551991|469213142|FG001|Overall Study|Death|7|||
130672066|NCT01621490|470425517|FG002|Overall Study|Maximum clinical benefit|0|||
130672067|NCT01621490|470425518|FG003|Overall Study|Maximum clinical benefit|0|||
130672068|NCT01621490|470425519|FG004|Overall Study|Maximum clinical benefit|0|||
130672069|NCT01621490|470425520|FG005|Overall Study|Maximum clinical benefit|0|||
130672070|NCT01621490|470425521|FG006|Overall Study|Maximum clinical benefit|1|||
130672071|NCT01621490|470425522|FG007|Overall Study|Maximum clinical benefit|2|||
130672072|NCT01621490|470425523|FG008|Overall Study|Maximum clinical benefit|2|||
130672073|NCT01621490|470425524|FG009|Overall Study|Maximum clinical benefit|0|||
130672074|NCT01621490|470425525|FG010|Overall Study|Maximum clinical benefit|0|||
130672075|NCT01621490|470425515|FG000|Overall Study|Withdrawal by Subject|1|||
130672076|NCT01621490|470425516|FG001|Overall Study|Withdrawal by Subject|0|||
130672077|NCT01621490|470425517|FG002|Overall Study|Withdrawal by Subject|0|||
130672078|NCT01621490|470425518|FG003|Overall Study|Withdrawal by Subject|0|||
130672079|NCT01621490|470425519|FG004|Overall Study|Withdrawal by Subject|0|||
130672080|NCT01621490|470425520|FG005|Overall Study|Withdrawal by Subject|1|||
130672081|NCT01621490|470425521|FG006|Overall Study|Withdrawal by Subject|0|||
130672082|NCT01621490|470425522|FG007|Overall Study|Withdrawal by Subject|0|||
130672083|NCT01621490|470425523|FG008|Overall Study|Withdrawal by Subject|0|||
130672084|NCT01621490|470425524|FG009|Overall Study|Withdrawal by Subject|0|||
130338782|NCT02551991|469213143|FG002|Overall Study|Death|8|||
130672085|NCT01621490|470425525|FG010|Overall Study|Withdrawal by Subject|0|||
130672086|NCT01621490|470425515|FG000|Overall Study|Subject request to discontinue study|1|||
130672087|NCT01621490|470425516|FG001|Overall Study|Subject request to discontinue study|3|||
130672088|NCT01621490|470425517|FG002|Overall Study|Subject request to discontinue study|1|||
130672089|NCT01621490|470425518|FG003|Overall Study|Subject request to discontinue study|1|||
130672090|NCT01621490|470425519|FG004|Overall Study|Subject request to discontinue study|0|||
130672091|NCT01621490|470425520|FG005|Overall Study|Subject request to discontinue study|2|||
130672092|NCT01621490|470425521|FG006|Overall Study|Subject request to discontinue study|1|||
130672093|NCT01621490|470425522|FG007|Overall Study|Subject request to discontinue study|0|||
130672094|NCT01621490|470425523|FG008|Overall Study|Subject request to discontinue study|1|||
130672095|NCT01621490|470425524|FG009|Overall Study|Subject request to discontinue study|0|||
130672096|NCT01621490|470425525|FG010|Overall Study|Subject request to discontinue study|0|||
130672097|NCT01621490|470425515|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130338783|NCT02551991|469213144|FG003|Overall Study|Death|7|||
130338784|NCT02551991|469213145|FG004|Overall Study|Death|17|||
130338785|NCT02551991|469213141|FG000|Overall Study|Withdrawal by Subject|1|||
130672098|NCT01621490|470425516|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130672099|NCT01621490|470425517|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130338786|NCT02551991|469213142|FG001|Overall Study|Withdrawal by Subject|0|||
130338787|NCT02551991|469213143|FG002|Overall Study|Withdrawal by Subject|0|||
130338788|NCT02551991|469213144|FG003|Overall Study|Withdrawal by Subject|0|||
130338789|NCT02551991|469213145|FG004|Overall Study|Withdrawal by Subject|2|||
130338790|NCT02551991|469213141|FG000|Overall Study|Lost to Follow-up|0|||
130338791|NCT02551991|469213142|FG001|Overall Study|Lost to Follow-up|0|||
130338792|NCT02551991|469213143|FG002|Overall Study|Lost to Follow-up|1|||
130338793|NCT02551991|469213144|FG003|Overall Study|Lost to Follow-up|0|||
130338794|NCT02551991|469213145|FG004|Overall Study|Lost to Follow-up|0|||
130338795|NCT02551991|469213141|FG000|Overall Study|Sponsor Decision|1|||
130338796|NCT02551991|469213142|FG001|Overall Study|Sponsor Decision|0|||
130338797|NCT02551991|469213143|FG002|Overall Study|Sponsor Decision|1|||
130338798|NCT02551991|469213144|FG003|Overall Study|Sponsor Decision|0|||
130338799|NCT02551991|469213145|FG004|Overall Study|Sponsor Decision|5|||
130338800|NCT02551991|469213141|FG000|Overall Study|Other|0|||
130338801|NCT02551991|469213142|FG001|Overall Study|Other|0|||
130338802|NCT02551991|469213143|FG002|Overall Study|Other|0|||
130338803|NCT02551991|469213144|FG003|Overall Study|Other|0|||
130338804|NCT02551991|469213145|FG004|Overall Study|Other|1|||
130338805|NCT00265148|469213146|FG000|Overall Study|Adverse Event|2|||
130338806|NCT00265148|469213147|FG001|Overall Study|Adverse Event|2|||
130338807|NCT00265148|469213146|FG000|Overall Study|Lack of Efficacy|0|||
130338808|NCT00265148|469213147|FG001|Overall Study|Lack of Efficacy|2|||
130672100|NCT01621490|470425518|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130672101|NCT01621490|470425519|FG004|Overall Study|Adverse event unrelated to study drug|0|||
130672102|NCT01621490|470425520|FG005|Overall Study|Adverse event unrelated to study drug|0|||
130672103|NCT01621490|470425521|FG006|Overall Study|Adverse event unrelated to study drug|0|||
130672104|NCT01621490|470425522|FG007|Overall Study|Adverse event unrelated to study drug|2|||
130672105|NCT01621490|470425523|FG008|Overall Study|Adverse event unrelated to study drug|0|||
130672106|NCT01621490|470425524|FG009|Overall Study|Adverse event unrelated to study drug|0|||
130338809|NCT00265148|469213146|FG000|Overall Study|Protocol Violation|3|||
130338810|NCT00265148|469213147|FG001|Overall Study|Protocol Violation|2|||
130338811|NCT00265148|469213146|FG000|Overall Study|Lost to Follow-up|0|||
130338812|NCT00265148|469213147|FG001|Overall Study|Lost to Follow-up|1|||
130338813|NCT00265148|469213146|FG000|Overall Study|Withdrawal by Subject|2|||
130338814|NCT00265148|469213147|FG001|Overall Study|Withdrawal by Subject|1|||
130338815|NCT00265148|469213146|FG000|Overall Study|Physician Decision|1|||
130216409|NCT02588092|468755565|FG008|Overall Study|Started Another Treatment|0|||
130216410|NCT02588092|468755566|FG009|Overall Study|Started Another Treatment|0|||
130216411|NCT02588092|468755557|FG000|Overall Study|Sponsor Decision|0|||
130216412|NCT02588092|468755558|FG001|Overall Study|Sponsor Decision|0|||
130216413|NCT02588092|468755559|FG002|Overall Study|Sponsor Decision|0|||
130216414|NCT02588092|468755560|FG003|Overall Study|Sponsor Decision|0|||
130216415|NCT02588092|468755561|FG004|Overall Study|Sponsor Decision|0|||
130216416|NCT02588092|468755562|FG005|Overall Study|Sponsor Decision|0|||
130216417|NCT02588092|468755563|FG006|Overall Study|Sponsor Decision|0|||
130216418|NCT02588092|468755564|FG007|Overall Study|Sponsor Decision|0|||
130216419|NCT02588092|468755565|FG008|Overall Study|Sponsor Decision|1|||
130216420|NCT02588092|468755566|FG009|Overall Study|Sponsor Decision|1|||
130216421|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130216422|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130216423|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
130216424|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
130216425|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
130216426|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
130216427|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Death|0|||
130216428|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Death|1|||
130216429|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Death|0|||
130216430|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
130216431|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
130216432|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
130216433|NCT01030718|468755567|FG000|Study CA180-036 Only|insufficient effect|1|||
130216434|NCT01030718|468755568|FG001|Study CA180-036 Only|insufficient effect|1|||
130216435|NCT01030718|468755569|FG002|Study CA180-036 Only|insufficient effect|5|||
130216436|NCT01030718|468755567|FG000|Study CA180-036 Only|Adverse Event|2|||
130216437|NCT01030718|468755568|FG001|Study CA180-036 Only|Adverse Event|3|||
130216438|NCT01030718|468755569|FG002|Study CA180-036 Only|Adverse Event|0|||
130216439|NCT01030718|468755567|FG000|Study CA180-036 Only|Death|0|||
130216440|NCT01030718|468755568|FG001|Study CA180-036 Only|Death|1|||
130216441|NCT01030718|468755569|FG002|Study CA180-036 Only|Death|0|||
130216442|NCT01030718|468755567|FG000|Study CA180-036 Only|Other Reasons|0|||
130216443|NCT01030718|468755568|FG001|Study CA180-036 Only|Other Reasons|2|||
130216444|NCT01030718|468755569|FG002|Study CA180-036 Only|Other Reasons|0|||
130216445|NCT00099632|468755572|FG000|Overall Study|Lost to Follow-up|1|||
130216446|NCT00099632|468755573|FG001|Overall Study|Lost to Follow-up|0|||
130216447|NCT00099632|468755574|FG002|Overall Study|Lost to Follow-up|3|||
130216448|NCT00099632|468755575|FG003|Overall Study|Lost to Follow-up|1|||
130216449|NCT00099632|468755576|FG004|Overall Study|Lost to Follow-up|1|||
130216450|NCT00099632|468755577|FG005|Overall Study|Lost to Follow-up|0|||
130216451|NCT00099632|468755572|FG000|Overall Study|Withdrawal by Subject|0|||
130216452|NCT00099632|468755573|FG001|Overall Study|Withdrawal by Subject|1|||
130216453|NCT00099632|468755574|FG002|Overall Study|Withdrawal by Subject|0|||
130216454|NCT00099632|468755575|FG003|Overall Study|Withdrawal by Subject|0|||
130216455|NCT00099632|468755576|FG004|Overall Study|Withdrawal by Subject|0|||
130216456|NCT00099632|468755577|FG005|Overall Study|Withdrawal by Subject|1|||
130216457|NCT00099632|468755572|FG000|Overall Study|Protocol Violation|0|||
130216458|NCT00099632|468755573|FG001|Overall Study|Protocol Violation|0|||
130216459|NCT00099632|468755574|FG002|Overall Study|Protocol Violation|0|||
130216460|NCT00099632|468755575|FG003|Overall Study|Protocol Violation|0|||
130216461|NCT00099632|468755576|FG004|Overall Study|Protocol Violation|0|||
130216462|NCT00099632|468755577|FG005|Overall Study|Protocol Violation|1|||
130216463|NCT00423813|468755578|FG000|Overall Study|Adverse Event|11|||
130216464|NCT00423813|468755579|FG001|Overall Study|Adverse Event|30|||
130216465|NCT00423813|468755580|FG002|Overall Study|Adverse Event|40|||
130216466|NCT00423813|468755578|FG000|Overall Study|Withdrawal by Subject|6|||
130216467|NCT00423813|468755579|FG001|Overall Study|Withdrawal by Subject|8|||
130216468|NCT00423813|468755580|FG002|Overall Study|Withdrawal by Subject|5|||
130216469|NCT00423813|468755578|FG000|Overall Study|Lost to Follow-up|5|||
130216470|NCT00423813|468755579|FG001|Overall Study|Lost to Follow-up|4|||
130216471|NCT00423813|468755580|FG002|Overall Study|Lost to Follow-up|4|||
130216472|NCT00423813|468755578|FG000|Overall Study|Lack of Efficacy|23|||
130216473|NCT00423813|468755579|FG001|Overall Study|Lack of Efficacy|18|||
130216474|NCT00423813|468755580|FG002|Overall Study|Lack of Efficacy|19|||
130216475|NCT00423813|468755578|FG000|Overall Study|Physician Decision|2|||
130216476|NCT00423813|468755579|FG001|Overall Study|Physician Decision|0|||
130216477|NCT00423813|468755580|FG002|Overall Study|Physician Decision|0|||
130216478|NCT00423813|468755578|FG000|Overall Study|Sponsor Decision|0|||
130216479|NCT00423813|468755579|FG001|Overall Study|Sponsor Decision|1|||
130216480|NCT00423813|468755580|FG002|Overall Study|Sponsor Decision|0|||
130216481|NCT00423813|468755578|FG000|Overall Study|Protocol Violation|9|||
130216482|NCT00423813|468755579|FG001|Overall Study|Protocol Violation|4|||
130216483|NCT00423813|468755580|FG002|Overall Study|Protocol Violation|4|||
130216484|NCT00423813|468755578|FG000|Overall Study|Pregnancy|0|||
130216485|NCT00423813|468755579|FG001|Overall Study|Pregnancy|0|||
130216486|NCT00423813|468755580|FG002|Overall Study|Pregnancy|1|||
130338816|NCT00265148|469213147|FG001|Overall Study|Physician Decision|0|||
130672107|NCT01621490|470425525|FG010|Overall Study|Adverse event unrelated to study drug|0|||
130338817|NCT00265148|469213146|FG000|Overall Study|Increasing frailty|0|||
130672108|NCT01621490|470425515|FG000|Overall Study|Disease progression|27|||
130672109|NCT01621490|470425516|FG001|Overall Study|Disease progression|28|||
130672110|NCT01621490|470425517|FG002|Overall Study|Disease progression|1|||
130672111|NCT01621490|470425518|FG003|Overall Study|Disease progression|5|||
130672112|NCT01621490|470425519|FG004|Overall Study|Disease progression|3|||
130338818|NCT00265148|469213147|FG001|Overall Study|Increasing frailty|1|||
130338819|NCT00265148|469213146|FG000|Overall Study|Subject chose to change of the dose|1|||
130338820|NCT00265148|469213147|FG001|Overall Study|Subject chose to change of the dose|0|||
130672113|NCT01621490|470425520|FG005|Overall Study|Disease progression|8|||
130672114|NCT01621490|470425521|FG006|Overall Study|Disease progression|7|||
130672115|NCT01621490|470425522|FG007|Overall Study|Disease progression|1|||
130672116|NCT01621490|470425523|FG008|Overall Study|Disease progression|4|||
130338821|NCT00387790|469213152|FG000|Overall Study|Adverse Event|5|||
130338822|NCT00387790|469213152|FG000|Overall Study|Lack of Efficacy|2|||
130338823|NCT00387790|469213152|FG000|Overall Study|Physician Decision|2|||
130338824|NCT00387790|469213152|FG000|Overall Study|Withdrawal by Subject|3|||
130338825|NCT00387790|469213152|FG000|Overall Study|Ineligible for study|2|||
130338826|NCT01874340|469213155|FG000|Overall Study|Study terminated by Sponsor|6|||
130338827|NCT01874340|469213156|FG001|Overall Study|Study terminated by Sponsor|8|||
130338828|NCT01874340|469213157|FG002|Overall Study|Study terminated by Sponsor|8|||
130338829|NCT01874340|469213158|FG003|Overall Study|Study terminated by Sponsor|4|||
130338830|NCT01874340|469213155|FG000|Overall Study|Withdrawal by Subject|0|||
130338831|NCT01874340|469213156|FG001|Overall Study|Withdrawal by Subject|0|||
130338832|NCT01874340|469213157|FG002|Overall Study|Withdrawal by Subject|0|||
130338833|NCT01874340|469213158|FG003|Overall Study|Withdrawal by Subject|1|||
130338834|NCT00444678|469213167|FG000|Overall Study|Toxicity|11|||
130338835|NCT00444678|469213167|FG000|Overall Study|Disease Progression|12|||
130338836|NCT00444678|469213167|FG000|Overall Study|Death|3|||
130338837|NCT00444678|469213167|FG000|Overall Study|Physician Decision|3|||
130338838|NCT00444678|469213167|FG000|Overall Study|Withdrawal by Subject|2|||
130338839|NCT00606905|469213170|FG000|Overall Study|No Pregnancy|9|||
130338840|NCT00606905|469213171|FG001|Overall Study|No Pregnancy|6|||
130338841|NCT00606905|469213170|FG000|Overall Study|Non-Index Pregnancy|1|||
130338842|NCT00606905|469213171|FG001|Overall Study|Non-Index Pregnancy|4|||
130338843|NCT00606905|469213170|FG000|Overall Study|Withdrew|5|||
130338844|NCT00606905|469213171|FG001|Overall Study|Withdrew|5|||
130338845|NCT03179202|469213172|FG000|Overall Study|Screen Failure|67|||
130338846|NCT03179202|469213172|FG000|Overall Study|Subject Lost to Follow Up|12|||
130338847|NCT03179202|469213172|FG000|Overall Study|Withdrawal by Subject|7|||
130338848|NCT03179202|469213172|FG000|Overall Study|Adverse Event|3|||
130338849|NCT03179202|469213172|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
130338850|NCT03179202|469213172|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
130338851|NCT03255629|469213173|FG000|Overall Study|Adverse Event|1|||
130338852|NCT03255629|469213174|FG001|Overall Study|Adverse Event|0|||
130338853|NCT03255629|469213173|FG000|Overall Study|did not experience hypoglycemia|2|||
130338854|NCT03255629|469213174|FG001|Overall Study|did not experience hypoglycemia|1|||
130338855|NCT01625260|469213182|FG000|Overall Study|Adverse Event|3|||
130338856|NCT01625260|469213183|FG001|Overall Study|Adverse Event|0|||
130338857|NCT01625260|469213182|FG000|Overall Study|Study Terminated by Investigator|2|||
130338858|NCT01625260|469213183|FG001|Overall Study|Study Terminated by Investigator|0|||
130338859|NCT01625260|469213182|FG000|Overall Study|Disease Progression|2|||
130338860|NCT01625260|469213183|FG001|Overall Study|Disease Progression|0|||
130338861|NCT01625260|469213182|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
130338862|NCT01625260|469213183|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
130338863|NCT03899805|469213184|FG000|Overall Study|Physician Decision|3|||
130338864|NCT03899805|469213185|FG001|Overall Study|Physician Decision|0|||
130338865|NCT03899805|469213186|FG002|Overall Study|Physician Decision|2|||
130338866|NCT03899805|469213184|FG000|Overall Study|Withdrawal by Subject|1|||
130338867|NCT03899805|469213185|FG001|Overall Study|Withdrawal by Subject|0|||
130338868|NCT03899805|469213186|FG002|Overall Study|Withdrawal by Subject|2|||
130338869|NCT03899805|469213184|FG000|Overall Study|Progressive Disease|10|||
130338870|NCT03899805|469213185|FG001|Overall Study|Progressive Disease|18|||
130338871|NCT03899805|469213186|FG002|Overall Study|Progressive Disease|12|||
130672117|NCT01621490|470425524|FG009|Overall Study|Disease progression|1|||
130672118|NCT01621490|470425525|FG010|Overall Study|Disease progression|1|||
130672119|NCT01621490|470425515|FG000|Overall Study|Study drug toxicity|1|||
130672120|NCT01621490|470425516|FG001|Overall Study|Study drug toxicity|4|||
130338872|NCT03899805|469213184|FG000|Overall Study|Adverse Event|3|||
130338873|NCT03899805|469213185|FG001|Overall Study|Adverse Event|1|||
130338874|NCT03899805|469213186|FG002|Overall Study|Adverse Event|0|||
130338875|NCT03899805|469213184|FG000|Overall Study|Death|2|||
130338876|NCT03899805|469213185|FG001|Overall Study|Death|0|||
130338877|NCT03899805|469213186|FG002|Overall Study|Death|0|||
130672121|NCT01621490|470425517|FG002|Overall Study|Study drug toxicity|5|||
130672122|NCT01621490|470425518|FG003|Overall Study|Study drug toxicity|3|||
130338878|NCT03899805|469213184|FG000|Overall Study|Came off for surgery|0|||
130338879|NCT03899805|469213185|FG001|Overall Study|Came off for surgery|0|||
130338880|NCT03899805|469213186|FG002|Overall Study|Came off for surgery|1|||
130338881|NCT03317405|469213187|FG000|Overall Study|Withdrawal by Subject|1|||
130338882|NCT03317405|469213188|FG001|Overall Study|Withdrawal by Subject|0|||
130338883|NCT03317405|469213189|FG002|Overall Study|Withdrawal by Subject|0|||
130338884|NCT03317405|469213187|FG000|Overall Study|Physician Decision|0|||
130338885|NCT03317405|469213188|FG001|Overall Study|Physician Decision|0|||
130338886|NCT03317405|469213189|FG002|Overall Study|Physician Decision|1|||
130338887|NCT03317405|469213187|FG000|Overall Study|Surgery Rescheduled|0|||
130338888|NCT03317405|469213188|FG001|Overall Study|Surgery Rescheduled|1|||
130338889|NCT03317405|469213189|FG002|Overall Study|Surgery Rescheduled|0|||
130338890|NCT01024309|469213190|FG000|Overall Study|Physician Decision|4|||
130338891|NCT01024309|469213191|FG001|Overall Study|Physician Decision|0|||
130338892|NCT01024309|469213190|FG000|Overall Study|Withdrawal by Subject|4|||
130338893|NCT01024309|469213191|FG001|Overall Study|Withdrawal by Subject|4|||
130338894|NCT01639729|469213194|FG000|Overall Study|Withdrawal by Subject|1|||
130338895|NCT01639729|469213195|FG001|Overall Study|Withdrawal by Subject|0|||
130338896|NCT01639729|469213196|FG002|Overall Study|Withdrawal by Subject|1|||
130338897|NCT01639729|469213197|FG003|Overall Study|Withdrawal by Subject|1|||
130338898|NCT01639729|469213198|FG004|Overall Study|Withdrawal by Subject|0|||
130338899|NCT01639729|469213199|FG005|Overall Study|Withdrawal by Subject|0|||
130338900|NCT01640314|469213202|FG000|Overall Study|Protocol Violation|0|||
130338901|NCT01640314|469213203|FG001|Overall Study|Protocol Violation|1|||
130338902|NCT03672097|469213204|FG000|Period 1|Withdrawal by Subject|2|||
130338903|NCT03672097|469213204|FG000|Period 1|Adverse Event|1|||
130338904|NCT03672097|469213204|FG000|Period 1|Did not receive treatment|1|||
130338905|NCT03672097|469213204|FG000|Period 2|Withdrawal by Subject|3|||
130338906|NCT03672097|469213204|FG000|Period 2|Other|1|||
130338907|NCT01290796|469213205|FG000|Overall Study|Lost to Follow-up|21|||
130338908|NCT01290796|469213205|FG000|Overall Study|Withdrawal by Subject|4|||
130338909|NCT01290796|469213205|FG000|Overall Study|Physician Decision|2|||
130338910|NCT01290796|469213205|FG000|Overall Study|Secondary Surgical Intervention|2|||
130338911|NCT01290796|469213205|FG000|Overall Study|Withdrawal by Sponsor|1|||
130338912|NCT03087617|469213206|FG000|Overall Study|Lost to Follow-up|32|||
130338913|NCT03087617|469213207|FG001|Overall Study|Lost to Follow-up|30|||
130338914|NCT03087617|469213208|FG002|Overall Study|Lost to Follow-up|30|||
130338915|NCT03087617|469213209|FG003|Overall Study|Lost to Follow-up|39|||
130338916|NCT04450381|469213211|FG000|Overall Study|Protocol Violation|4|||
130338917|NCT04450381|469213211|FG000|Overall Study|Wrong device setting|2|||
130338918|NCT04556383|469213219|FG000|PCP|Lack of Efficacy|28|||
130338919|NCT04556383|469213220|FG001|PCP|Lack of Efficacy|23|||
130338920|NCT04556383|469213221|FG002|PCP|Lack of Efficacy|23|||
130338921|NCT04556383|469213222|FG003|PCP|Lack of Efficacy|0|||
130338922|NCT04556383|469213219|FG000|PCP|Study terminated by sponsor|15|||
130338923|NCT04556383|469213220|FG001|PCP|Study terminated by sponsor|13|||
130338924|NCT04556383|469213221|FG002|PCP|Study terminated by sponsor|16|||
130338925|NCT04556383|469213222|FG003|PCP|Study terminated by sponsor|0|||
130338926|NCT04556383|469213219|FG000|PCP|Withdrawal by Subject|8|||
130338927|NCT04556383|469213220|FG001|PCP|Withdrawal by Subject|6|||
130338928|NCT04556383|469213221|FG002|PCP|Withdrawal by Subject|6|||
130338929|NCT04556383|469213222|FG003|PCP|Withdrawal by Subject|0|||
130338930|NCT04556383|469213219|FG000|PCP|Adverse Event|1|||
130338931|NCT04556383|469213220|FG001|PCP|Adverse Event|7|||
130338932|NCT04556383|469213221|FG002|PCP|Adverse Event|7|||
130338933|NCT04556383|469213222|FG003|PCP|Adverse Event|0|||
130338934|NCT04556383|469213219|FG000|PCP|Other, Not Specified|1|||
130338935|NCT04556383|469213220|FG001|PCP|Other, Not Specified|2|||
130338936|NCT04556383|469213221|FG002|PCP|Other, Not Specified|1|||
130338937|NCT04556383|469213222|FG003|PCP|Other, Not Specified|0|||
130338938|NCT04556383|469213219|FG000|PCP|Protocol Violation|1|||
130338939|NCT04556383|469213220|FG001|PCP|Protocol Violation|0|||
130338940|NCT04556383|469213221|FG002|PCP|Protocol Violation|1|||
130338941|NCT04556383|469213222|FG003|PCP|Protocol Violation|0|||
130338942|NCT04556383|469213219|FG000|PCP|Lost to Follow-up|1|||
130338943|NCT04556383|469213220|FG001|PCP|Lost to Follow-up|0|||
130338944|NCT04556383|469213221|FG002|PCP|Lost to Follow-up|0|||
130338945|NCT04556383|469213222|FG003|PCP|Lost to Follow-up|0|||
130338946|NCT04556383|469213219|FG000|PCP|Physician Decision|0|||
130338947|NCT04556383|469213220|FG001|PCP|Physician Decision|1|||
130338948|NCT04556383|469213221|FG002|PCP|Physician Decision|0|||
130338949|NCT04556383|469213222|FG003|PCP|Physician Decision|0|||
130338950|NCT04556383|469213219|FG000|PCP|Site terminated by sponsor|0|||
130338951|NCT04556383|469213220|FG001|PCP|Site terminated by sponsor|1|||
130338952|NCT04556383|469213221|FG002|PCP|Site terminated by sponsor|0|||
130338953|NCT04556383|469213222|FG003|PCP|Site terminated by sponsor|0|||
130338954|NCT04556383|469213219|FG000|OLE|Study terminated by sponsor|0|||
130338955|NCT04556383|469213220|FG001|OLE|Study terminated by sponsor|0|||
130338956|NCT04556383|469213221|FG002|OLE|Study terminated by sponsor|0|||
130338957|NCT04556383|469213222|FG003|OLE|Study terminated by sponsor|68|||
130338958|NCT04556383|469213219|FG000|OLE|Withdrawal by Subject|0|||
130338959|NCT04556383|469213220|FG001|OLE|Withdrawal by Subject|0|||
130338960|NCT04556383|469213221|FG002|OLE|Withdrawal by Subject|0|||
130338961|NCT04556383|469213222|FG003|OLE|Withdrawal by Subject|10|||
130338962|NCT04556383|469213219|FG000|OLE|Lack of Efficacy|0|||
130338963|NCT04556383|469213220|FG001|OLE|Lack of Efficacy|0|||
130338964|NCT04556383|469213221|FG002|OLE|Lack of Efficacy|0|||
130338965|NCT04556383|469213222|FG003|OLE|Lack of Efficacy|7|||
130338966|NCT04556383|469213219|FG000|OLE|Adverse Event|0|||
130672123|NCT01621490|470425519|FG004|Overall Study|Study drug toxicity|1|||
130672124|NCT01621490|470425520|FG005|Overall Study|Study drug toxicity|10|||
130672125|NCT01621490|470425521|FG006|Overall Study|Study drug toxicity|1|||
130672126|NCT01621490|470425522|FG007|Overall Study|Study drug toxicity|4|||
130672127|NCT01621490|470425523|FG008|Overall Study|Study drug toxicity|1|||
130672128|NCT01621490|470425524|FG009|Overall Study|Study drug toxicity|0|||
130672129|NCT01621490|470425525|FG010|Overall Study|Study drug toxicity|0|||
130672130|NCT01621490|470425515|FG000|Overall Study|Death|0|||
130672131|NCT01621490|470425516|FG001|Overall Study|Death|0|||
130672132|NCT01621490|470425517|FG002|Overall Study|Death|0|||
130672133|NCT01621490|470425518|FG003|Overall Study|Death|0|||
130672134|NCT01621490|470425519|FG004|Overall Study|Death|0|||
130672135|NCT01621490|470425520|FG005|Overall Study|Death|0|||
130672136|NCT01621490|470425521|FG006|Overall Study|Death|0|||
130672137|NCT01621490|470425522|FG007|Overall Study|Death|0|||
130672138|NCT01621490|470425523|FG008|Overall Study|Death|1|||
130672139|NCT01621490|470425524|FG009|Overall Study|Death|0|||
130672140|NCT01621490|470425525|FG010|Overall Study|Death|0|||
130672141|NCT01621490|470425515|FG000|Overall Study|Other reasons|7|||
130672142|NCT01621490|470425516|FG001|Overall Study|Other reasons|6|||
130672143|NCT01621490|470425517|FG002|Overall Study|Other reasons|4|||
130672144|NCT01621490|470425518|FG003|Overall Study|Other reasons|1|||
130672145|NCT01621490|470425519|FG004|Overall Study|Other reasons|1|||
130672146|NCT01621490|470425520|FG005|Overall Study|Other reasons|3|||
130672147|NCT01621490|470425521|FG006|Overall Study|Other reasons|1|||
130672148|NCT01621490|470425522|FG007|Overall Study|Other reasons|1|||
130672149|NCT01621490|470425523|FG008|Overall Study|Other reasons|1|||
130672150|NCT01621490|470425524|FG009|Overall Study|Other reasons|0|||
130672151|NCT01621490|470425525|FG010|Overall Study|Other reasons|0|||
130672152|NCT00506753|470425526|FG000|Overall Study|Lost to Follow-up|21|||
130672153|NCT00506753|470425527|FG001|Overall Study|Lost to Follow-up|15|||
130672154|NCT00125359|470425528|FG000|Overall Study|Death|4|||
130672155|NCT00125359|470425528|FG000|Overall Study|Adverse Event|5|||
130672156|NCT00125359|470425528|FG000|Overall Study|Physician Decision|14|||
130672157|NCT02451670|470425529|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
130672158|NCT02451670|470425530|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
130672159|NCT00461500|470425531|FG000|Overall Study|Adverse Event|1|||
130672160|NCT00461500|470425532|FG001|Overall Study|Adverse Event|0|||
130672161|NCT00461500|470425531|FG000|Overall Study|Lack of Efficacy|0|||
130672162|NCT00461500|470425532|FG001|Overall Study|Lack of Efficacy|1|||
130672163|NCT00461500|470425531|FG000|Overall Study|Expired Drug Treatment|1|||
130672164|NCT00461500|470425532|FG001|Overall Study|Expired Drug Treatment|1|||
130672165|NCT00461500|470425531|FG000|Overall Study|Study Stopped|1|||
130672166|NCT00461500|470425532|FG001|Overall Study|Study Stopped|2|||
130672167|NCT00461500|470425531|FG000|Overall Study|Drug Treatment Misuse|1|||
130672168|NCT00461500|470425532|FG001|Overall Study|Drug Treatment Misuse|0|||
130672169|NCT00461500|470425531|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
130672170|NCT00461500|470425532|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
130672171|NCT00461500|470425531|FG000|Overall Study|Lost to Follow-up|2|||
130672172|NCT00461500|470425532|FG001|Overall Study|Lost to Follow-up|2|||
130672173|NCT01513551|470425537|FG000|Overall Study|Death|0|||
130672174|NCT01513551|470425538|FG001|Overall Study|Death|1|||
130672175|NCT01513551|470425539|FG002|Overall Study|Death|0|||
130672176|NCT01513551|470425537|FG000|Overall Study|Lost to Follow-up|3|||
130672177|NCT01513551|470425538|FG001|Overall Study|Lost to Follow-up|5|||
130672178|NCT01513551|470425539|FG002|Overall Study|Lost to Follow-up|2|||
130672179|NCT01513551|470425537|FG000|Overall Study|Withdrawal by Subject|1|||
130672180|NCT01513551|470425538|FG001|Overall Study|Withdrawal by Subject|0|||
130672181|NCT01513551|470425539|FG002|Overall Study|Withdrawal by Subject|2|||
130338967|NCT04556383|469213220|FG001|OLE|Adverse Event|0|||
130672182|NCT01513551|470425537|FG000|Overall Study|Randomized but not vaccinated|0|||
130672183|NCT01513551|470425538|FG001|Overall Study|Randomized but not vaccinated|0|||
130216487|NCT00423813|468755578|FG000|Overall Study|Subject started night shift work|1|||
130672184|NCT01513551|470425539|FG002|Overall Study|Randomized but not vaccinated|1|||
130672185|NCT01806597|470425540|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
130672186|NCT01806597|470425541|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
130672187|NCT01806597|470425542|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130672188|NCT01806597|470425543|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130672189|NCT01806597|470425544|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
130672190|NCT01806597|470425545|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130672191|NCT01806597|470425540|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
130672192|NCT01806597|470425541|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130216488|NCT00423813|468755579|FG001|Overall Study|Subject started night shift work|0|||
130338968|NCT04556383|469213221|FG002|OLE|Adverse Event|0|||
130672193|NCT01806597|470425542|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130672194|NCT01806597|470425543|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130338969|NCT04556383|469213222|FG003|OLE|Adverse Event|2|||
130338970|NCT04556383|469213219|FG000|OLE|Other, Not Specified|0|||
130338971|NCT04556383|469213220|FG001|OLE|Other, Not Specified|0|||
130338972|NCT04556383|469213221|FG002|OLE|Other, Not Specified|0|||
130338973|NCT04556383|469213222|FG003|OLE|Other, Not Specified|2|||
130338974|NCT04556383|469213219|FG000|OLE|Death|0|||
130338975|NCT04556383|469213220|FG001|OLE|Death|0|||
130338976|NCT04556383|469213221|FG002|OLE|Death|0|||
130338977|NCT04556383|469213222|FG003|OLE|Death|1|||
130338978|NCT04556383|469213219|FG000|OLE|Lost to Follow-up|0|||
130338979|NCT04556383|469213220|FG001|OLE|Lost to Follow-up|0|||
130338980|NCT04556383|469213221|FG002|OLE|Lost to Follow-up|0|||
130338981|NCT04556383|469213222|FG003|OLE|Lost to Follow-up|1|||
130338982|NCT01994889|469213228|FG000|Overall Study|Adverse Event|5|||
130338983|NCT01994889|469213229|FG001|Overall Study|Adverse Event|12|||
130338984|NCT01994889|469213230|FG002|Overall Study|Adverse Event|11|||
130338985|NCT01994889|469213228|FG000|Overall Study|Cardiac Device Implantation|0|||
130338986|NCT01994889|469213229|FG001|Overall Study|Cardiac Device Implantation|2|||
130338987|NCT01994889|469213230|FG002|Overall Study|Cardiac Device Implantation|0|||
130338988|NCT01994889|469213228|FG000|Overall Study|Organ Transplantation|1|||
130338989|NCT01994889|469213229|FG001|Overall Study|Organ Transplantation|5|||
130338990|NCT01994889|469213230|FG002|Overall Study|Organ Transplantation|5|||
130338991|NCT01994889|469213228|FG000|Overall Study|No longer willing to participate|8|||
130338992|NCT01994889|469213229|FG001|Overall Study|No longer willing to participate|17|||
130338993|NCT01994889|469213230|FG002|Overall Study|No longer willing to participate|37|||
130338994|NCT01994889|469213228|FG000|Overall Study|Lost to Follow-up|0|||
130338995|NCT01994889|469213229|FG001|Overall Study|Lost to Follow-up|1|||
130338996|NCT01994889|469213230|FG002|Overall Study|Lost to Follow-up|0|||
130338997|NCT01994889|469213228|FG000|Overall Study|Protocol Violation|0|||
130338998|NCT01994889|469213229|FG001|Overall Study|Protocol Violation|1|||
130338999|NCT01994889|469213230|FG002|Overall Study|Protocol Violation|1|||
130339000|NCT01994889|469213228|FG000|Overall Study|Death|14|||
130339001|NCT01994889|469213229|FG001|Overall Study|Death|25|||
130339002|NCT01994889|469213230|FG002|Overall Study|Death|38|||
130339003|NCT00929643|469213231|FG000|Overall Study|Protocol Violation|2|||
130339004|NCT02873429|469213234|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
130339005|NCT02873429|469213235|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
130339006|NCT02873429|469213234|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130339007|NCT02873429|469213235|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130339008|NCT02873429|469213234|FG000|16 Weeks|Lost to Follow-up|3|||
130339009|NCT02873429|469213235|FG001|16 Weeks|Lost to Follow-up|0|||
130339010|NCT00744042|469213236|FG000|Overall Study|Withdrawal by Subject|1|||
130339011|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
130339012|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
130339013|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
130339014|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130339015|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130339016|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130339017|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130339018|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130339019|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130339020|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130339021|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130339022|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130339023|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
130339024|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
130339025|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
130339026|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130339027|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130339028|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
130672195|NCT01806597|470425544|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
130339029|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
130339030|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130339031|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130339032|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130339033|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130339034|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130672196|NCT01806597|470425545|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130672197|NCT01806597|470425540|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130339035|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130339036|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130339037|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
130672198|NCT01806597|470425541|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
130672199|NCT01806597|470425542|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130672200|NCT01806597|470425543|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130672201|NCT01806597|470425544|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130339038|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
130339039|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
130339040|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
130339041|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
130339042|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
130339043|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
130339044|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130339045|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130339046|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
130339047|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
130339048|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
130339049|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
130339050|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
130339051|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
130339052|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
130339053|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Death|1|||
130339054|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Death|0|||
130339055|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Death|0|||
130339056|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Other|4|||
130339057|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Other|1|||
130339058|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Other|0|||
130339059|NCT02228980|469213243|FG000|Overall Study|Adverse Event|14|||
130339060|NCT02228980|469213244|FG001|Overall Study|Adverse Event|0|||
130339061|NCT02228980|469213245|FG002|Overall Study|Adverse Event|0|||
130339062|NCT02228980|469213246|FG003|Overall Study|Adverse Event|0|||
130339063|NCT02228980|469213243|FG000|Overall Study|Protocol Violation|7|||
130339064|NCT02228980|469213244|FG001|Overall Study|Protocol Violation|0|||
130339065|NCT02228980|469213245|FG002|Overall Study|Protocol Violation|0|||
130339066|NCT02228980|469213246|FG003|Overall Study|Protocol Violation|0|||
130339067|NCT02228980|469213243|FG000|Overall Study|Withdrawal by Subject|3|||
130339068|NCT02228980|469213244|FG001|Overall Study|Withdrawal by Subject|3|||
130339069|NCT02228980|469213245|FG002|Overall Study|Withdrawal by Subject|2|||
130339070|NCT02228980|469213246|FG003|Overall Study|Withdrawal by Subject|3|||
130339071|NCT04629066|469213247|FG000|Overall Study|Lost to Follow-up|3|||
130339072|NCT04629066|469213248|FG001|Overall Study|Lost to Follow-up|2|||
130339073|NCT00530504|469213251|FG000|Overall Study|Death|54|||
130339074|NCT00530504|469213251|FG000|Overall Study|Lost to Follow-up|26|||
130339075|NCT00530504|469213251|FG000|Overall Study|Withdrawal by Subject|39|||
130339076|NCT00530504|469213251|FG000|Overall Study|Exited study due to other reasons|33|||
130339077|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339078|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130339079|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339080|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
130339081|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339082|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
130339083|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130339084|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339085|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
130339086|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130339087|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339088|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130339089|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339090|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339091|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339092|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130672202|NCT01806597|470425545|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130672203|NCT01806597|470425540|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
130672204|NCT01806597|470425541|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
130339093|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339094|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339095|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339096|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
130672205|NCT01806597|470425542|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130672206|NCT01806597|470425543|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130339097|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339098|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339099|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339100|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
130339101|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339102|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
130339103|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
130339104|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Other|0|||
130339105|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Other|0|||
130339106|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Other|1|||
130339107|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Other|1|||
130339108|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Other|0|||
130339109|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Other|0|||
130339110|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Other|0|||
130339111|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Other|1|||
130339112|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Other|0|||
130339113|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Death|0|||
130339114|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Death|0|||
130339115|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Death|0|||
130339116|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Death|0|||
130672207|NCT01806597|470425544|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
130339117|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Death|0|||
130339118|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Death|1|||
130339119|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Death|0|||
130339120|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Death|0|||
130339121|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Death|0|||
130339122|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339123|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339124|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339125|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339126|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339127|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
130339128|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
130339129|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339130|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339131|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
130339132|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339133|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339134|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339135|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339136|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339137|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339138|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339139|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339140|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339141|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339142|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339143|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339144|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339145|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339146|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339147|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339148|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
130339149|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339150|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339151|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339152|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339153|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130672208|NCT01806597|470425545|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130672209|NCT01806597|470425540|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130672210|NCT01806597|470425541|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
130672211|NCT01806597|470425542|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130672212|NCT01806597|470425543|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130672213|NCT01806597|470425544|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130339154|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339155|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339156|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130216489|NCT00423813|468755580|FG002|Overall Study|Subject started night shift work|0|||
130672214|NCT01806597|470425545|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130672215|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
130672216|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
130672217|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
130672218|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
130672219|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
130672220|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
130672221|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
130339157|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
130339158|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
130339159|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
130339160|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
130339161|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
130339162|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
130339163|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
130339164|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
130339165|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
130339166|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
130339167|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Other|0|||
130339168|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Other|0|||
130339169|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Other|0|||
130339170|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Other|0|||
130339171|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Other|0|||
130339172|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Other|0|||
130339173|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Other|0|||
130339174|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Other|0|||
130339175|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Other|1|||
130339176|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Death|0|||
130339177|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Death|0|||
130339178|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Death|0|||
130339179|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Death|0|||
130339180|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Death|0|||
130339181|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Death|0|||
130339182|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Death|0|||
130339183|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Death|0|||
130339184|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Death|2|||
130339185|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339186|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339187|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339188|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339189|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339190|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339191|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339192|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339193|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
130339194|NCT02537015|469213269|FG000|Overall Study|Adverse Event|3|||
130339195|NCT02537015|469213269|FG000|Overall Study|Withdrawal by Subject|2|||
130339196|NCT02537015|469213269|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130339197|NCT01808092|469213270|FG000|Overall Study|Death|39|||
130339198|NCT01808092|469213271|FG001|Overall Study|Death|29|||
130339199|NCT01808092|469213270|FG000|Overall Study|Lost to Follow-up|3|||
130339200|NCT01808092|469213271|FG001|Overall Study|Lost to Follow-up|7|||
130339201|NCT01808092|469213270|FG000|Overall Study|Withdrawal by Subject|9|||
130339202|NCT01808092|469213271|FG001|Overall Study|Withdrawal by Subject|4|||
130339203|NCT01808092|469213270|FG000|Overall Study|Other Eligibility criteria|3|||
130339204|NCT01808092|469213271|FG001|Overall Study|Other Eligibility criteria|5|||
130339205|NCT03952039|469213272|FG000|Overall Study|Adverse Event|22|||
130339206|NCT03952039|469213273|FG001|Overall Study|Adverse Event|8|||
130339207|NCT03952039|469213272|FG000|Overall Study|Withdrawal by Participant|17|||
130339208|NCT03952039|469213273|FG001|Overall Study|Withdrawal by Participant|12|||
130339209|NCT03952039|469213272|FG000|Overall Study|Death|13|||
130339210|NCT03952039|469213273|FG001|Overall Study|Death|6|||
130339211|NCT03952039|469213272|FG000|Overall Study|Lack of Efficacy|12|||
130339212|NCT03952039|469213273|FG001|Overall Study|Lack of Efficacy|2|||
130339213|NCT03952039|469213272|FG000|Overall Study|Physician Decision|9|||
130339214|NCT03952039|469213273|FG001|Overall Study|Physician Decision|3|||
130339215|NCT03952039|469213272|FG000|Overall Study|Progressive Disease|6|||
130339216|NCT03952039|469213273|FG001|Overall Study|Progressive Disease|4|||
130339217|NCT03952039|469213272|FG000|Overall Study|Other Reasons|12|||
130339218|NCT03952039|469213273|FG001|Overall Study|Other Reasons|4|||
130339219|NCT05009979|469213274|FG000|Overall Study|Withdrawal by Subject|1|||
130339220|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
130672222|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
130339221|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
130339222|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Physician Decision|1|||
130339223|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Physician Decision|1|||
130339224|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
130339225|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
130339226|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Death|4|||
130339227|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Death|3|||
130339228|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Graft loss|0|||
130339229|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Graft loss|1|||
130339230|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
130339231|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
130339232|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Physician Decision|2|||
130339233|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Physician Decision|4|||
130339234|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
130339235|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
130339236|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Death|8|||
130339237|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Death|4|||
130339238|NCT01888432|469214900|FG000|36-month Analysis (Extension)|Death|1|||
130339239|NCT01888432|469214901|FG001|36-month Analysis (Extension)|Death|0|||
130339240|NCT00130247|469214904|FG000|Overall Study|Pregnancy|1|||
130339241|NCT00130247|469214905|FG001|Overall Study|Pregnancy|0|||
130339242|NCT00130247|469214904|FG000|Overall Study|Post-randomization exclusion|1|||
130339243|NCT00130247|469214905|FG001|Overall Study|Post-randomization exclusion|2|||
130339244|NCT00130247|469214904|FG000|Overall Study|Not compliant with DOT|0|||
130339245|NCT00130247|469214905|FG001|Overall Study|Not compliant with DOT|2|||
130339246|NCT03844945|469214906|FG000|Overall Study|Adverse Event|1|||
130339247|NCT03844945|469214907|FG001|Overall Study|Adverse Event|1|||
130339248|NCT03844945|469214908|FG002|Overall Study|Adverse Event|4|||
130339249|NCT03844945|469214909|FG003|Overall Study|Adverse Event|0|||
130339250|NCT03844945|469214906|FG000|Overall Study|Withdrawal by Subject|0|||
130339251|NCT03844945|469214907|FG001|Overall Study|Withdrawal by Subject|0|||
130339252|NCT03844945|469214908|FG002|Overall Study|Withdrawal by Subject|1|||
130339253|NCT03844945|469214909|FG003|Overall Study|Withdrawal by Subject|0|||
130672223|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
130672224|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
130672225|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
130672226|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
130672227|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
130672228|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130672229|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130672230|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130672231|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130672232|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130672233|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
130672234|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
130672235|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130672236|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130672237|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130672238|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130672239|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
130672240|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130672241|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130672242|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130672243|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130672244|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130672245|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130672246|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
130672247|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130672248|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
130672249|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130672250|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130672251|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
130672252|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
130672253|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
130672254|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
130672255|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
130339254|NCT03844945|469214906|FG000|Overall Study|Lack of Efficacy|0|||
130339255|NCT03844945|469214907|FG001|Overall Study|Lack of Efficacy|0|||
130339256|NCT03844945|469214908|FG002|Overall Study|Lack of Efficacy|0|||
130672256|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
130339257|NCT03844945|469214909|FG003|Overall Study|Lack of Efficacy|1|||
130339258|NCT04473235|469214910|FG000|Overall Study|Lost to Follow-up|6|||
130339259|NCT04473235|469214911|FG001|Overall Study|Lost to Follow-up|5|||
130339260|NCT04473235|469214910|FG000|Overall Study|Declined continuation|2|||
130339261|NCT04473235|469214911|FG001|Overall Study|Declined continuation|0|||
130339262|NCT04473235|469214910|FG000|Overall Study|Physician Decision|1|||
130339263|NCT04473235|469214911|FG001|Overall Study|Physician Decision|1|||
130339264|NCT04473235|469214910|FG000|Overall Study|Protocol Violation|10|||
130339265|NCT04473235|469214911|FG001|Overall Study|Protocol Violation|6|||
130339266|NCT01754402|469214912|FG000|Overall Study|Death|0|||
130339267|NCT01754402|469214913|FG001|Overall Study|Death|0|||
130339268|NCT01754402|469214914|FG002|Overall Study|Death|1|||
130339269|NCT01754402|469214912|FG000|Overall Study|Adverse Event|2|||
130339270|NCT01754402|469214913|FG001|Overall Study|Adverse Event|2|||
130339271|NCT01754402|469214914|FG002|Overall Study|Adverse Event|1|||
130339272|NCT01754402|469214912|FG000|Overall Study|Withdrawal by Subject|0|||
130339273|NCT01754402|469214913|FG001|Overall Study|Withdrawal by Subject|0|||
130339274|NCT01754402|469214914|FG002|Overall Study|Withdrawal by Subject|1|||
130339275|NCT01754402|469214912|FG000|Overall Study|Lack of Efficacy|0|||
130339276|NCT01754402|469214913|FG001|Overall Study|Lack of Efficacy|0|||
130339277|NCT01754402|469214914|FG002|Overall Study|Lack of Efficacy|1|||
130339278|NCT01282463|469214915|FG000|Overall Study|Lost to Follow-up|1|||
130339279|NCT01282463|469214916|FG001|Overall Study|Lost to Follow-up|0|||
130672257|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
130672258|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
130672259|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
130672260|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
130672261|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
130672262|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
130672263|NCT01806597|470425540|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
130672264|NCT01806597|470425541|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130672265|NCT01806597|470425542|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130672266|NCT01806597|470425543|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130672267|NCT01806597|470425544|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130672268|NCT01806597|470425545|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130672269|NCT01806597|470425540|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130672270|NCT01806597|470425541|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130672271|NCT01806597|470425542|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130672272|NCT01806597|470425543|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130672273|NCT01806597|470425544|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130672274|NCT01806597|470425545|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
130672275|NCT01806597|470425540|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130672276|NCT01806597|470425541|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130672277|NCT01806597|470425542|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130672278|NCT01806597|470425543|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130672279|NCT01806597|470425544|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130672280|NCT01806597|470425545|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
130672281|NCT01806597|470425540|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130672282|NCT01806597|470425541|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130672283|NCT01806597|470425542|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130672284|NCT01806597|470425543|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130672285|NCT01806597|470425544|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130672286|NCT01806597|470425545|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
130672287|NCT01806597|470425540|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130672288|NCT01806597|470425541|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130672289|NCT01806597|470425542|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130672290|NCT01806597|470425543|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130672291|NCT01806597|470425544|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130672292|NCT01806597|470425545|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
130672293|NCT01806597|470425540|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130339280|NCT01282463|469214917|FG002|Overall Study|Lost to Follow-up|0|||
130339281|NCT01282463|469214915|FG000|Overall Study|Withdrawal by Subject|6|||
130339282|NCT01282463|469214916|FG001|Overall Study|Withdrawal by Subject|2|||
130339283|NCT01282463|469214917|FG002|Overall Study|Withdrawal by Subject|3|||
130339284|NCT01282463|469214915|FG000|Overall Study|"Never Treated Death"|0|||
130339285|NCT01282463|469214916|FG001|Overall Study|"Never Treated Death"|1|||
130339286|NCT01282463|469214917|FG002|Overall Study|"Never Treated Death"|0|||
130339287|NCT01282463|469214915|FG000|Overall Study|"Never Treated PD"|0|||
130339288|NCT01282463|469214916|FG001|Overall Study|"Never Treated PD"|1|||
130339289|NCT01282463|469214917|FG002|Overall Study|"Never Treated PD"|0|||
130339290|NCT01282463|469214915|FG000|Overall Study|Protocol Violation|0|||
130339291|NCT01282463|469214916|FG001|Overall Study|Protocol Violation|0|||
130339292|NCT01282463|469214917|FG002|Overall Study|Protocol Violation|1|||
130339293|NCT01282463|469214915|FG000|Overall Study|Physician Decision|1|||
130339294|NCT01282463|469214916|FG001|Overall Study|Physician Decision|0|||
130339295|NCT01282463|469214917|FG002|Overall Study|Physician Decision|0|||
130339296|NCT00588861|469214923|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
130339297|NCT00588861|469214924|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
130339298|NCT00588861|469214923|FG000|6 Months|Patients did not return for follow-up|98|||
130339299|NCT00588861|469214924|FG001|6 Months|Patients did not return for follow-up|73|||
130339300|NCT00588861|469214923|FG000|1 Year|Patients did not return for follow-up|89|||
130339301|NCT00588861|469214924|FG001|1 Year|Patients did not return for follow-up|82|||
130339302|NCT00588861|469214923|FG000|2 Years|Patients did not return for follow-up|92|||
130339303|NCT00588861|469214924|FG001|2 Years|Patients did not return for follow-up|87|||
130339304|NCT00588861|469214923|FG000|4 Years|Patients did not return for follow-up|91|||
130339305|NCT00588861|469214924|FG001|4 Years|Patients did not return for follow-up|103|||
130339306|NCT00588861|469214923|FG000|6 Years|Patients did not return for follow-up|104|||
130339307|NCT00588861|469214924|FG001|6 Years|Patients did not return for follow-up|109|||
130339308|NCT00588861|469214923|FG000|8 Years|Patients did not return for follow-up|105|||
130339309|NCT00588861|469214924|FG001|8 Years|Patients did not return for follow-up|114|||
130339310|NCT00588861|469214923|FG000|10 Years|Incomplete due to study termination|107|||
130339311|NCT00588861|469214924|FG001|10 Years|Incomplete due to study termination|114|||
130339312|NCT01239992|469214925|FG000|Overall Study|Withdrawal by Subject|2|||
130339313|NCT02848729|469214928|FG000|Overall Study|Withdrawal by Subject|1|||
130339314|NCT02848729|469214929|FG001|Overall Study|Withdrawal by Subject|0|||
130339315|NCT02848729|469214928|FG000|Overall Study|Emesis|15|||
130339316|NCT02848729|469214929|FG001|Overall Study|Emesis|11|||
130339317|NCT00791076|469214930|FG000|Overall Study|Study was terminated,PI left institution|8|||
130339318|NCT02052414|469214933|FG000|Overall Study|Adverse Event|12|||
130339319|NCT02052414|469214933|FG000|Overall Study|Lack of Efficacy|2|||
130339320|NCT02052414|469214933|FG000|Overall Study|Withdrawal by Subject|3|||
130339321|NCT02704143|469214936|FG000|Overall Study|disease progression|10|||
130339322|NCT02151773|469214937|FG000|Overall Study|Protocol Deviation|64|||
130339323|NCT00395343|469214938|FG000|Overall Study|Adverse Event|13|||
130339324|NCT00395343|469214939|FG001|Overall Study|Adverse Event|5|||
130339325|NCT00395343|469214938|FG000|Overall Study|Lack of Efficacy|0|||
130339326|NCT00395343|469214939|FG001|Overall Study|Lack of Efficacy|1|||
130339327|NCT00395343|469214938|FG000|Overall Study|Lost to Follow-up|4|||
130339328|NCT00395343|469214939|FG001|Overall Study|Lost to Follow-up|4|||
130339329|NCT00395343|469214938|FG000|Overall Study|Physician Decision|2|||
130339330|NCT00395343|469214939|FG001|Overall Study|Physician Decision|4|||
130339331|NCT00395343|469214938|FG000|Overall Study|Protocol Violation|6|||
130339332|NCT00395343|469214939|FG001|Overall Study|Protocol Violation|8|||
130339333|NCT00395343|469214938|FG000|Overall Study|Withdrawal by Subject|11|||
130339334|NCT00395343|469214939|FG001|Overall Study|Withdrawal by Subject|12|||
130339335|NCT00395343|469214938|FG000|Overall Study|Other|5|||
130339336|NCT00395343|469214939|FG001|Overall Study|Other|2|||
130339337|NCT04605991|469214942|FG000|Overall Study|Adverse Event|5|||
130339338|NCT04605991|469214942|FG000|Overall Study|Lack of Efficacy|1|||
130339339|NCT04605991|469214942|FG000|Overall Study|Lost to Follow-up|8|||
130339340|NCT04605991|469214942|FG000|Overall Study|Physician Decision|4|||
130339341|NCT04605991|469214942|FG000|Overall Study|Withdrawal by Subject|14|||
130339342|NCT04605991|469214942|FG000|Overall Study|Non-compliance with study|1|||
130339343|NCT03263702|469214943|FG000|Overall Study|Lost to Follow-up|2|||
130339344|NCT03263702|469214944|FG001|Overall Study|Lost to Follow-up|2|||
130339345|NCT03263702|469214943|FG000|Overall Study|Withdrawal by Subject|1|||
130339346|NCT03263702|469214944|FG001|Overall Study|Withdrawal by Subject|2|||
130339347|NCT00966875|469214946|FG000|Part A|Adverse Event|2|||
130339348|NCT00966875|469214947|FG001|Part A|Adverse Event|1|||
130339349|NCT00966875|469214948|FG002|Part A|Adverse Event|0|||
130339350|NCT00966875|469214949|FG003|Part A|Adverse Event|1|||
130672294|NCT01806597|470425541|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130672295|NCT01806597|470425542|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130339351|NCT00966875|469214950|FG004|Part A|Adverse Event|0|||
130339352|NCT00966875|469214951|FG005|Part A|Adverse Event|1|||
130339353|NCT00966875|469214952|FG006|Part A|Adverse Event|0|||
130339354|NCT00966875|469214953|FG007|Part A|Adverse Event|3|||
130339355|NCT00966875|469214954|FG008|Part A|Adverse Event|3|||
130339356|NCT00966875|469214946|FG000|Part A|Entry Criteria|0|||
130339357|NCT00966875|469214947|FG001|Part A|Entry Criteria|0|||
130339358|NCT00966875|469214948|FG002|Part A|Entry Criteria|0|||
130339359|NCT00966875|469214949|FG003|Part A|Entry Criteria|0|||
130339360|NCT00966875|469214950|FG004|Part A|Entry Criteria|0|||
130339361|NCT00966875|469214951|FG005|Part A|Entry Criteria|2|||
130339362|NCT00966875|469214952|FG006|Part A|Entry Criteria|0|||
130552744|NCT00604279|469991512|FG000|Overall Study|Other|8|||
130552745|NCT00604279|469991513|FG001|Overall Study|Other|4|||
130339363|NCT00966875|469214953|FG007|Part A|Entry Criteria|0|||
130339364|NCT00966875|469214954|FG008|Part A|Entry Criteria|0|||
130339365|NCT00966875|469214946|FG000|Part A|Lack of Efficacy|0|||
130339366|NCT00966875|469214947|FG001|Part A|Lack of Efficacy|1|||
130339367|NCT00966875|469214948|FG002|Part A|Lack of Efficacy|0|||
130339368|NCT00966875|469214949|FG003|Part A|Lack of Efficacy|0|||
130339369|NCT00966875|469214950|FG004|Part A|Lack of Efficacy|0|||
130339370|NCT00966875|469214951|FG005|Part A|Lack of Efficacy|0|||
130339371|NCT00966875|469214952|FG006|Part A|Lack of Efficacy|4|||
130339372|NCT00966875|469214953|FG007|Part A|Lack of Efficacy|0|||
130339373|NCT00966875|469214954|FG008|Part A|Lack of Efficacy|0|||
130339374|NCT00966875|469214946|FG000|Part A|Lost to Follow-up|2|||
130339375|NCT00966875|469214947|FG001|Part A|Lost to Follow-up|0|||
130339376|NCT00966875|469214948|FG002|Part A|Lost to Follow-up|0|||
130339377|NCT00966875|469214949|FG003|Part A|Lost to Follow-up|0|||
130339378|NCT00966875|469214950|FG004|Part A|Lost to Follow-up|0|||
130339379|NCT00966875|469214951|FG005|Part A|Lost to Follow-up|1|||
130339380|NCT00966875|469214952|FG006|Part A|Lost to Follow-up|0|||
130339381|NCT00966875|469214953|FG007|Part A|Lost to Follow-up|0|||
130339382|NCT00966875|469214954|FG008|Part A|Lost to Follow-up|0|||
130339383|NCT00966875|469214946|FG000|Part A|Parent/Caregiver Decision|0|||
130339384|NCT00966875|469214947|FG001|Part A|Parent/Caregiver Decision|0|||
130339385|NCT00966875|469214948|FG002|Part A|Parent/Caregiver Decision|0|||
130339386|NCT00966875|469214949|FG003|Part A|Parent/Caregiver Decision|1|||
130339387|NCT00966875|469214950|FG004|Part A|Parent/Caregiver Decision|0|||
130339388|NCT00966875|469214951|FG005|Part A|Parent/Caregiver Decision|0|||
130339389|NCT00966875|469214952|FG006|Part A|Parent/Caregiver Decision|0|||
130339390|NCT00966875|469214953|FG007|Part A|Parent/Caregiver Decision|0|||
130339391|NCT00966875|469214954|FG008|Part A|Parent/Caregiver Decision|0|||
130339392|NCT00966875|469214946|FG000|Part A|Physician Decision|0|||
130339393|NCT00966875|469214947|FG001|Part A|Physician Decision|0|||
130339394|NCT00966875|469214948|FG002|Part A|Physician Decision|0|||
130339395|NCT00966875|469214949|FG003|Part A|Physician Decision|0|||
130339396|NCT00966875|469214950|FG004|Part A|Physician Decision|1|||
130339397|NCT00966875|469214951|FG005|Part A|Physician Decision|0|||
130339398|NCT00966875|469214952|FG006|Part A|Physician Decision|1|||
130339399|NCT00966875|469214953|FG007|Part A|Physician Decision|0|||
130339400|NCT00966875|469214954|FG008|Part A|Physician Decision|2|||
130339401|NCT00966875|469214946|FG000|Part A|Sponsor Decision|0|||
130339402|NCT00966875|469214947|FG001|Part A|Sponsor Decision|0|||
130339403|NCT00966875|469214948|FG002|Part A|Sponsor Decision|1|||
130339404|NCT00966875|469214949|FG003|Part A|Sponsor Decision|0|||
130339405|NCT00966875|469214950|FG004|Part A|Sponsor Decision|1|||
130339406|NCT00966875|469214951|FG005|Part A|Sponsor Decision|0|||
130339407|NCT00966875|469214952|FG006|Part A|Sponsor Decision|0|||
130339408|NCT00966875|469214953|FG007|Part A|Sponsor Decision|2|||
130339409|NCT00966875|469214954|FG008|Part A|Sponsor Decision|1|||
130339410|NCT00966875|469214946|FG000|Part A|Withdrawal by Subject|2|||
130339411|NCT00966875|469214947|FG001|Part A|Withdrawal by Subject|2|||
130339412|NCT00966875|469214948|FG002|Part A|Withdrawal by Subject|1|||
130339413|NCT00966875|469214949|FG003|Part A|Withdrawal by Subject|1|||
130339414|NCT00966875|469214950|FG004|Part A|Withdrawal by Subject|3|||
130339415|NCT00966875|469214951|FG005|Part A|Withdrawal by Subject|0|||
130339416|NCT00966875|469214952|FG006|Part A|Withdrawal by Subject|5|||
130339417|NCT00966875|469214953|FG007|Part A|Withdrawal by Subject|1|||
130339418|NCT00966875|469214954|FG008|Part A|Withdrawal by Subject|1|||
130672296|NCT01806597|470425543|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130672297|NCT01806597|470425544|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130672298|NCT01806597|470425545|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
130339419|NCT00966875|469214946|FG000|Part A|Protocol Violation|0|||
130339420|NCT00966875|469214947|FG001|Part A|Protocol Violation|0|||
130339421|NCT00966875|469214948|FG002|Part A|Protocol Violation|0|||
130339422|NCT00966875|469214949|FG003|Part A|Protocol Violation|0|||
130339423|NCT00966875|469214950|FG004|Part A|Protocol Violation|0|||
130339424|NCT00966875|469214951|FG005|Part A|Protocol Violation|0|||
130339425|NCT00966875|469214952|FG006|Part A|Protocol Violation|2|||
130339426|NCT00966875|469214953|FG007|Part A|Protocol Violation|1|||
130339427|NCT00966875|469214954|FG008|Part A|Protocol Violation|1|||
130339428|NCT00966875|469214946|FG000|Part B|Adverse Event|0|||
130339429|NCT00966875|469214947|FG001|Part B|Adverse Event|1|||
130339430|NCT00966875|469214948|FG002|Part B|Adverse Event|1|||
130339431|NCT00966875|469214949|FG003|Part B|Adverse Event|0|||
130339432|NCT00966875|469214950|FG004|Part B|Adverse Event|1|||
130339433|NCT00966875|469214951|FG005|Part B|Adverse Event|0|||
130339434|NCT00966875|469214952|FG006|Part B|Adverse Event|5|||
130339435|NCT00966875|469214953|FG007|Part B|Adverse Event|2|||
130339436|NCT00966875|469214954|FG008|Part B|Adverse Event|2|||
130339437|NCT00966875|469214946|FG000|Part B|Death|0|||
130339438|NCT00966875|469214947|FG001|Part B|Death|0|||
130339439|NCT00966875|469214948|FG002|Part B|Death|1|||
130339440|NCT00966875|469214949|FG003|Part B|Death|0|||
130339441|NCT00966875|469214950|FG004|Part B|Death|0|||
130339442|NCT00966875|469214951|FG005|Part B|Death|0|||
130339443|NCT00966875|469214952|FG006|Part B|Death|0|||
130339444|NCT00966875|469214953|FG007|Part B|Death|1|||
130339445|NCT00966875|469214954|FG008|Part B|Death|0|||
130339446|NCT00966875|469214946|FG000|Part B|Lack of Efficacy|2|||
130339447|NCT00966875|469214947|FG001|Part B|Lack of Efficacy|1|||
130339448|NCT00966875|469214948|FG002|Part B|Lack of Efficacy|1|||
130339449|NCT00966875|469214949|FG003|Part B|Lack of Efficacy|1|||
130339450|NCT00966875|469214950|FG004|Part B|Lack of Efficacy|2|||
130339451|NCT00966875|469214951|FG005|Part B|Lack of Efficacy|3|||
130339452|NCT00966875|469214952|FG006|Part B|Lack of Efficacy|12|||
130339453|NCT00966875|469214953|FG007|Part B|Lack of Efficacy|9|||
130339454|NCT00966875|469214954|FG008|Part B|Lack of Efficacy|6|||
130339455|NCT00966875|469214946|FG000|Part B|Lost to Follow-up|0|||
130339456|NCT00966875|469214947|FG001|Part B|Lost to Follow-up|0|||
130339457|NCT00966875|469214948|FG002|Part B|Lost to Follow-up|0|||
130339458|NCT00966875|469214949|FG003|Part B|Lost to Follow-up|1|||
130339459|NCT00966875|469214950|FG004|Part B|Lost to Follow-up|0|||
130339460|NCT00966875|469214951|FG005|Part B|Lost to Follow-up|0|||
130672299|NCT02247479|470425549|FG000|Overall Study|Adverse Event|8|||
130672300|NCT02247479|470425550|FG001|Overall Study|Adverse Event|9|||
130672301|NCT02247479|470425551|FG002|Overall Study|Adverse Event|8|||
130672302|NCT02247479|470425549|FG000|Overall Study|Death|5|||
130672303|NCT02247479|470425550|FG001|Overall Study|Death|4|||
130672304|NCT02247479|470425551|FG002|Overall Study|Death|6|||
130672305|NCT02247479|470425549|FG000|Overall Study|Lost to Follow-up|3|||
130672306|NCT02247479|470425550|FG001|Overall Study|Lost to Follow-up|3|||
130672307|NCT02247479|470425551|FG002|Overall Study|Lost to Follow-up|1|||
130672308|NCT02247479|470425549|FG000|Overall Study|Non-compliance|0|||
130672309|NCT02247479|470425550|FG001|Overall Study|Non-compliance|0|||
130672310|NCT02247479|470425551|FG002|Overall Study|Non-compliance|1|||
130672311|NCT02247479|470425549|FG000|Overall Study|Withdrawal by Subject|25|||
130672312|NCT02247479|470425550|FG001|Overall Study|Withdrawal by Subject|29|||
130672313|NCT02247479|470425551|FG002|Overall Study|Withdrawal by Subject|24|||
130672314|NCT02247479|470425549|FG000|Overall Study|Study Terminated by Sponsor|98|||
130672315|NCT02247479|470425550|FG001|Overall Study|Study Terminated by Sponsor|88|||
130339461|NCT00966875|469214952|FG006|Part B|Lost to Follow-up|0|||
130672316|NCT02247479|470425551|FG002|Overall Study|Study Terminated by Sponsor|94|||
130672317|NCT02247479|470425549|FG000|Overall Study|Physician Decision|1|||
130672318|NCT02247479|470425550|FG001|Overall Study|Physician Decision|0|||
130672319|NCT02247479|470425551|FG002|Overall Study|Physician Decision|2|||
130672320|NCT02247479|470425549|FG000|Overall Study|Unspecified Reason|2|||
130672321|NCT02247479|470425550|FG001|Overall Study|Unspecified Reason|5|||
130672322|NCT02247479|470425551|FG002|Overall Study|Unspecified Reason|2|||
130672323|NCT01073020|470425552|FG000|Overall Study|Withdrawal by Subject|6|||
130672324|NCT01073020|470425553|FG001|Overall Study|Withdrawal by Subject|4|||
130672325|NCT01073020|470425554|FG002|Overall Study|Withdrawal by Subject|1|||
130672326|NCT01073020|470425555|FG003|Overall Study|Withdrawal by Subject|2|||
130672327|NCT01073020|470425552|FG000|Overall Study|Physician Decision|1|||
130672328|NCT01073020|470425553|FG001|Overall Study|Physician Decision|0|||
130339462|NCT00966875|469214953|FG007|Part B|Lost to Follow-up|0|||
130339463|NCT00966875|469214954|FG008|Part B|Lost to Follow-up|1|||
130339464|NCT00966875|469214946|FG000|Part B|Physician Decision|0|||
130339465|NCT00966875|469214947|FG001|Part B|Physician Decision|0|||
130339466|NCT00966875|469214948|FG002|Part B|Physician Decision|1|||
130339467|NCT00966875|469214949|FG003|Part B|Physician Decision|0|||
130339468|NCT00966875|469214950|FG004|Part B|Physician Decision|2|||
130339469|NCT00966875|469214951|FG005|Part B|Physician Decision|1|||
130339470|NCT00966875|469214952|FG006|Part B|Physician Decision|0|||
130339471|NCT00966875|469214953|FG007|Part B|Physician Decision|0|||
130339472|NCT00966875|469214954|FG008|Part B|Physician Decision|2|||
130339473|NCT00966875|469214946|FG000|Part B|Sponsor Decision|1|||
130339474|NCT00966875|469214947|FG001|Part B|Sponsor Decision|0|||
130339475|NCT00966875|469214948|FG002|Part B|Sponsor Decision|0|||
130339476|NCT00966875|469214949|FG003|Part B|Sponsor Decision|0|||
130672329|NCT01073020|470425554|FG002|Overall Study|Physician Decision|2|||
130672330|NCT01073020|470425555|FG003|Overall Study|Physician Decision|0|||
130339477|NCT00966875|469214950|FG004|Part B|Sponsor Decision|0|||
130339478|NCT00966875|469214951|FG005|Part B|Sponsor Decision|1|||
130672331|NCT01073020|470425552|FG000|Overall Study|Death|0|||
130339479|NCT00966875|469214952|FG006|Part B|Sponsor Decision|0|||
130339480|NCT00966875|469214953|FG007|Part B|Sponsor Decision|2|||
130339481|NCT00966875|469214954|FG008|Part B|Sponsor Decision|1|||
130339482|NCT00966875|469214946|FG000|Part B|Withdrawal by Subject|2|||
130339483|NCT00966875|469214947|FG001|Part B|Withdrawal by Subject|1|||
130339484|NCT00966875|469214948|FG002|Part B|Withdrawal by Subject|2|||
130672332|NCT01073020|470425553|FG001|Overall Study|Death|1|||
130672333|NCT01073020|470425554|FG002|Overall Study|Death|0|||
130672334|NCT01073020|470425555|FG003|Overall Study|Death|0|||
130672335|NCT01335477|470425556|FG000|Overall Study|Adverse Event|30|||
130339485|NCT00966875|469214949|FG003|Part B|Withdrawal by Subject|1|||
130672336|NCT01335477|470425557|FG001|Overall Study|Adverse Event|42|||
130339486|NCT00966875|469214950|FG004|Part B|Withdrawal by Subject|2|||
130339487|NCT00966875|469214951|FG005|Part B|Withdrawal by Subject|1|||
130339488|NCT00966875|469214952|FG006|Part B|Withdrawal by Subject|4|||
130339489|NCT00966875|469214953|FG007|Part B|Withdrawal by Subject|5|||
130672337|NCT01335477|470425556|FG000|Overall Study|Non compliant with protocol|0|||
130672338|NCT01335477|470425557|FG001|Overall Study|Non compliant with protocol|2|||
130672339|NCT01335477|470425556|FG000|Overall Study|Lost to Follow-up|1|||
130672340|NCT01335477|470425557|FG001|Overall Study|Lost to Follow-up|2|||
130672341|NCT01335477|470425556|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
130672342|NCT01335477|470425557|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
130672343|NCT01335477|470425556|FG000|Overall Study|Not treated|1|||
130672344|NCT01335477|470425557|FG001|Overall Study|Not treated|2|||
130672345|NCT01335477|470425556|FG000|Overall Study|Reason other than those stated above|2|||
130672346|NCT01335477|470425557|FG001|Overall Study|Reason other than those stated above|2|||
130672347|NCT03031899|470425563|FG000|Overall Study|Protocol Violation|1|||
130672348|NCT03031899|470425563|FG000|Overall Study|lesion disappeared after stopping habit|1|||
130672349|NCT03740698|470425564|FG000|Overall Study|Physician Decision|0|||
130672350|NCT03740698|470425565|FG001|Overall Study|Physician Decision|1|||
130672351|NCT03740698|470425566|FG002|Overall Study|Physician Decision|1|||
130672352|NCT00094302|470425567|FG000|Overall Study|Lost to Follow-up|43|||
130672353|NCT00094302|470425568|FG001|Overall Study|Lost to Follow-up|41|||
130672354|NCT00094302|470425567|FG000|Overall Study|Physician Decision|5|||
130672355|NCT00094302|470425568|FG001|Overall Study|Physician Decision|8|||
130672356|NCT00094302|470425567|FG000|Overall Study|Withdrawal by Subject|103|||
130672357|NCT00094302|470425568|FG001|Overall Study|Withdrawal by Subject|111|||
130672358|NCT00094302|470425567|FG000|Overall Study|Death|266|||
130672359|NCT00094302|470425568|FG001|Overall Study|Death|246|||
130672360|NCT01162499|470425574|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
130672361|NCT01162499|470425575|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
130672362|NCT01590433|470425576|FG000|Overall Study|Lost to Follow-up|20|||
130672363|NCT01590433|470425577|FG001|Overall Study|Lost to Follow-up|8|||
130672364|NCT01590433|470425576|FG000|Overall Study|Withdrawal by Subject|21|||
130672365|NCT01590433|470425577|FG001|Overall Study|Withdrawal by Subject|11|||
130672366|NCT01590433|470425576|FG000|Overall Study|Adverse Event|11|||
130672367|NCT01590433|470425577|FG001|Overall Study|Adverse Event|3|||
130672368|NCT00555009|470425578|FG000|Overall Study|Withdrawal by Subject|0|||
130672369|NCT00555009|470425579|FG001|Overall Study|Withdrawal by Subject|1|||
130672370|NCT00555009|470425578|FG000|Overall Study|Terminated by Sponsor|2|||
130672371|NCT00555009|470425579|FG001|Overall Study|Terminated by Sponsor|5|||
130672372|NCT02058628|470425580|FG000|Overall Study|Adverse Event|1|||
130672373|NCT02058628|470425581|FG001|Overall Study|Adverse Event|0|||
130672374|NCT02058628|470425580|FG000|Overall Study|Withdrawal by Subject|2|||
130672375|NCT02058628|470425581|FG001|Overall Study|Withdrawal by Subject|2|||
130672376|NCT02058628|470425580|FG000|Overall Study|Lost to Follow-up|2|||
130672377|NCT02058628|470425581|FG001|Overall Study|Lost to Follow-up|4|||
130672378|NCT02058628|470425580|FG000|Overall Study|Not in time schedule|0|||
130672379|NCT02058628|470425581|FG001|Overall Study|Not in time schedule|1|||
130672380|NCT02058628|470425580|FG000|Overall Study|The visit date was not in timeline|0|||
130672381|NCT02058628|470425581|FG001|Overall Study|The visit date was not in timeline|1|||
130672382|NCT02058628|470425580|FG000|Overall Study|A lot of time for study for participant|1|||
130672383|NCT02058628|470425581|FG001|Overall Study|A lot of time for study for participant|0|||
130672384|NCT02058628|470425580|FG000|Overall Study|Non compliance|1|||
130672385|NCT02058628|470425581|FG001|Overall Study|Non compliance|0|||
130672386|NCT03355742|470425582|FG000|Overall Study|Lost to Follow-up|4|||
130672387|NCT03355742|470425582|FG000|Overall Study|Withdrawal by Subject|29|||
130672388|NCT03355742|470425582|FG000|Overall Study|Physician Decision|6|||
130672389|NCT03355742|470425582|FG000|Overall Study|Death|55|||
130672390|NCT03355742|470425582|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
130672391|NCT01787825|470425584|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
130672392|NCT01787825|470425585|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
130672393|NCT01787825|470425584|FG000|Overall Study|Data Not Analyzable|5|||
130339490|NCT00966875|469214954|FG008|Part B|Withdrawal by Subject|5|||
130339491|NCT00966875|469214946|FG000|Part B|Entry Criteria|0|||
130339492|NCT00966875|469214947|FG001|Part B|Entry Criteria|0|||
130339493|NCT00966875|469214948|FG002|Part B|Entry Criteria|0|||
130339494|NCT00966875|469214949|FG003|Part B|Entry Criteria|0|||
130339495|NCT00966875|469214950|FG004|Part B|Entry Criteria|0|||
130339496|NCT00966875|469214951|FG005|Part B|Entry Criteria|0|||
130339497|NCT00966875|469214952|FG006|Part B|Entry Criteria|1|||
130339498|NCT00966875|469214953|FG007|Part B|Entry Criteria|0|||
130339499|NCT00966875|469214954|FG008|Part B|Entry Criteria|1|||
130672394|NCT01787825|470425585|FG001|Overall Study|Data Not Analyzable|1|||
130339500|NCT01589653|469214955|FG000|Overall Study|Protocol Violation|3|||
130672395|NCT00989261|470425590|FG000|Overall Study|Still in follow up|12|||
130672396|NCT00989261|470425591|FG001|Overall Study|Still in follow up|21|||
130672397|NCT00989261|470425590|FG000|Overall Study|Withdrawal by Subject|0|||
130339501|NCT01589653|469214956|FG001|Overall Study|Protocol Violation|1|||
130339502|NCT01589653|469214955|FG000|Overall Study|Withdrawal criteria|4|||
130672398|NCT00989261|470425591|FG001|Overall Study|Withdrawal by Subject|1|||
130672399|NCT00989261|470425590|FG000|Overall Study|Lost to Follow-up|3|||
130672400|NCT00989261|470425591|FG001|Overall Study|Lost to Follow-up|0|||
130672401|NCT01507896|470425594|FG000|Overall Study|Withdrawal by Subject|1|||
130339503|NCT01589653|469214956|FG001|Overall Study|Withdrawal criteria|7|||
130672402|NCT01507896|470425594|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
130672403|NCT00585351|470425596|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
130672404|NCT00585351|470425597|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
130672405|NCT00585351|470425598|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
130672406|NCT00585351|470425599|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
130672407|NCT00585351|470425600|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
130672408|NCT00585351|470425601|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
130672409|NCT00585351|470425602|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
130672410|NCT00585351|470425603|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
130672411|NCT00585351|470425596|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
130672412|NCT00585351|470425597|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
130672413|NCT00585351|470425598|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
130672414|NCT00585351|470425599|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
130672415|NCT00585351|470425600|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
130672416|NCT00585351|470425601|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
130672417|NCT00585351|470425602|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
130672418|NCT00585351|470425603|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
130672419|NCT00585351|470425596|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
130672420|NCT00585351|470425597|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
130339504|NCT01589653|469214955|FG000|Overall Study|Unclassified|0|||
130339505|NCT01589653|469214956|FG001|Overall Study|Unclassified|3|||
130339506|NCT04657666|469214957|FG000|Period 1|Withdrawal of participant consent|2|||
130339507|NCT04657666|469214958|FG001|Period 1|Withdrawal of participant consent|1|||
130339508|NCT04657666|469214957|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
130339509|NCT04657666|469214958|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
130339510|NCT04657666|469214957|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
130339511|NCT04657666|469214958|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
130339512|NCT04657666|469214957|FG000|Period 2|Other|2|||
130339513|NCT04657666|469214958|FG001|Period 2|Other|0|||
130339514|NCT04657666|469214957|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
130339515|NCT04657666|469214958|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
130339516|NCT02386189|469214959|FG000|Overall Study|Lost to Follow-up|2|||
130339517|NCT02386189|469214960|FG001|Overall Study|Lost to Follow-up|3|||
130339518|NCT02386189|469214959|FG000|Overall Study|Withdrawal by Subject|1|||
130339519|NCT02386189|469214960|FG001|Overall Study|Withdrawal by Subject|0|||
130339520|NCT02386189|469214959|FG000|Overall Study|Death|1|||
130339521|NCT02386189|469214960|FG001|Overall Study|Death|0|||
130339522|NCT03700684|469214969|FG000|Overall Study|COVID-19|0|||
130339523|NCT03700684|469214970|FG001|Overall Study|COVID-19|0|||
130339524|NCT03700684|469214971|FG002|Overall Study|COVID-19|2|||
130339525|NCT03319745|469214973|FG000|Overall Study|Death|1|||
130339526|NCT03319745|469214973|FG000|Overall Study|Toxicity Precluding Surgery|1|||
130339527|NCT01317550|469214974|FG000|Overall Study|Withdrawal by Subject|1|||
130339528|NCT01317550|469214975|FG001|Overall Study|Withdrawal by Subject|0|||
130339529|NCT01317550|469214976|FG002|Overall Study|Withdrawal by Subject|0|||
130339530|NCT01317550|469214977|FG003|Overall Study|Withdrawal by Subject|0|||
130339531|NCT01317550|469214974|FG000|Overall Study|Lack of compliance study med|1|||
130339532|NCT01317550|469214975|FG001|Overall Study|Lack of compliance study med|0|||
130339533|NCT01317550|469214976|FG002|Overall Study|Lack of compliance study med|0|||
130339534|NCT01317550|469214977|FG003|Overall Study|Lack of compliance study med|0|||
130339535|NCT00870103|469214978|FG000|Overall Study|Physician Decision|2|||
130339536|NCT00870103|469214978|FG000|Overall Study|Lost to Follow-up|2|||
130339537|NCT01120782|469214979|FG000|Overall Study|Test article shipping error|11|||
130339538|NCT04975438|469214980|FG000|Overall Study|Lost to Follow-up|1|||
130339539|NCT04975438|469214981|FG001|Overall Study|Lost to Follow-up|0|||
130339540|NCT04975438|469214982|FG002|Overall Study|Lost to Follow-up|1|||
130339541|NCT04975438|469214983|FG003|Overall Study|Lost to Follow-up|0|||
130339542|NCT04975438|469214980|FG000|Overall Study|Withdrawal by Subject|1|||
130339543|NCT04975438|469214981|FG001|Overall Study|Withdrawal by Subject|0|||
130339544|NCT04975438|469214982|FG002|Overall Study|Withdrawal by Subject|0|||
130339545|NCT04975438|469214983|FG003|Overall Study|Withdrawal by Subject|0|||
130339546|NCT00787267|469214985|FG000|Overall Study|Screen failure/Ineligible|10|||
130339547|NCT00787267|469214985|FG000|Overall Study|No Reason Provided|1|||
130339548|NCT00787267|469214985|FG000|Overall Study|Withdrawal by Subject|1|||
130339549|NCT00865280|469214986|FG000|Overall Study|Withdrawal by Subject|4|||
130339550|NCT00865280|469214987|FG001|Overall Study|Withdrawal by Subject|1|||
130339551|NCT00865280|469214986|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
130339552|NCT00865280|469214987|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
130339553|NCT00865280|469214986|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
130339554|NCT00865280|469214987|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
130339555|NCT00865280|469214986|FG000|Overall Study|Exclusion Condition|1|||
130339556|NCT00865280|469214987|FG001|Overall Study|Exclusion Condition|0|||
130339557|NCT00865280|469214986|FG000|Overall Study|Adverse Event|0|||
130672421|NCT00585351|470425598|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
130672422|NCT00585351|470425599|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
130672423|NCT00585351|470425600|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
130672424|NCT00585351|470425601|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
130672425|NCT00585351|470425602|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
130672426|NCT00585351|470425603|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
130672427|NCT00585351|470425596|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
130672428|NCT00585351|470425597|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
130339558|NCT00865280|469214987|FG001|Overall Study|Adverse Event|1|||
130339559|NCT01950013|469214994|FG000|Overall Study|Withdrawal by Subject|0|||
130339560|NCT01950013|469214995|FG001|Overall Study|Withdrawal by Subject|2|||
130339561|NCT01950013|469214996|FG002|Overall Study|Withdrawal by Subject|0|||
130339562|NCT03091348|469214999|FG000|Overall Study|Lost to Follow-up|2|||
130339563|NCT03091348|469215000|FG001|Overall Study|Lost to Follow-up|1|||
130339564|NCT00706342|469215001|FG000|Overall Study|Adverse Event|3|||
130339565|NCT00706342|469215001|FG000|Overall Study|Not responding to treatment|2|||
130339566|NCT00706342|469215001|FG000|Overall Study|Withdrawn due to failure to respond|1|||
130339567|NCT00706342|469215001|FG000|Overall Study|Death|1|||
130339568|NCT00706342|469215001|FG000|Overall Study|Withdrew from the study on his own.|1|||
130339569|NCT00706342|469215001|FG000|Overall Study|Investigator discretion|2|||
130339570|NCT00706342|469215001|FG000|Overall Study|Non-responder Week 12|1|||
130339571|NCT00706342|469215001|FG000|Overall Study|Ongoing|6|||
130339572|NCT00706342|469215001|FG000|Overall Study|WIthdrawal of consent|1|||
130339573|NCT01419197|469215003|FG000|Overall Study|Death|247|||
130339574|NCT01419197|469215004|FG001|Overall Study|Death|122|||
130339575|NCT01419197|469215003|FG000|Overall Study|Physician Decision|4|||
130339576|NCT01419197|469215004|FG001|Overall Study|Physician Decision|4|||
130339577|NCT01419197|469215003|FG000|Overall Study|Non-compliance|3|||
130339578|NCT01419197|469215004|FG001|Overall Study|Non-compliance|1|||
130339579|NCT01419197|469215003|FG000|Overall Study|Withdrawal by Subject|33|||
130339580|NCT01419197|469215004|FG001|Overall Study|Withdrawal by Subject|32|||
130339581|NCT01419197|469215003|FG000|Overall Study|Study Completed by Sponsor|103|||
130339582|NCT01419197|469215004|FG001|Overall Study|Study Completed by Sponsor|34|||
130339583|NCT01419197|469215003|FG000|Overall Study|Reason Not Specified|0|||
130339584|NCT01419197|469215004|FG001|Overall Study|Reason Not Specified|1|||
130339585|NCT01419197|469215003|FG000|Overall Study|Lost to Follow-up|14|||
130339586|NCT01419197|469215004|FG001|Overall Study|Lost to Follow-up|4|||
130339587|NCT00146848|469215005|FG000|Pre-randomization|Death|19|||
130339588|NCT00146848|469215006|FG001|Pre-randomization|Death|0|||
130339589|NCT00146848|469215007|FG002|Pre-randomization|Death|0|||
130339590|NCT00146848|469215005|FG000|Pre-randomization|Lost to Follow-up|70|||
130339591|NCT00146848|469215006|FG001|Pre-randomization|Lost to Follow-up|0|||
130339592|NCT00146848|469215007|FG002|Pre-randomization|Lost to Follow-up|0|||
130339593|NCT00146848|469215005|FG000|Pre-randomization|Physician Decision|8|||
130339594|NCT00146848|469215006|FG001|Pre-randomization|Physician Decision|0|||
130339595|NCT00146848|469215007|FG002|Pre-randomization|Physician Decision|0|||
130339596|NCT00146848|469215005|FG000|Pre-randomization|Protocol Violation|172|||
130339597|NCT00146848|469215006|FG001|Pre-randomization|Protocol Violation|0|||
130339598|NCT00146848|469215007|FG002|Pre-randomization|Protocol Violation|0|||
130339599|NCT00146848|469215005|FG000|Pre-randomization|Withdrawal by Subject|40|||
130339600|NCT00146848|469215006|FG001|Pre-randomization|Withdrawal by Subject|0|||
130339601|NCT00146848|469215007|FG002|Pre-randomization|Withdrawal by Subject|0|||
130339602|NCT00146848|469215005|FG000|Post-randomization|Lost to Follow-up|12|||
130339603|NCT00146848|469215006|FG001|Post-randomization|Lost to Follow-up|15|||
130339604|NCT00146848|469215007|FG002|Post-randomization|Lost to Follow-up|12|||
130339605|NCT00146848|469215005|FG000|Post-randomization|Withdrawn|26|||
130339606|NCT00146848|469215006|FG001|Post-randomization|Withdrawn|32|||
130339607|NCT00146848|469215007|FG002|Post-randomization|Withdrawn|27|||
130339608|NCT00119678|469215008|FG000|Double-blind Treatment Period|Death|1|||
130339609|NCT00119678|469215009|FG001|Double-blind Treatment Period|Death|0|||
130339610|NCT00119678|469215008|FG000|Double-blind Treatment Period|Adverse Event|7|||
130339611|NCT00119678|469215009|FG001|Double-blind Treatment Period|Adverse Event|1|||
130339612|NCT00119678|469215008|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
130339613|NCT00119678|469215009|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
130339614|NCT00119678|469215008|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130339615|NCT00119678|469215009|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
130339616|NCT00119678|469215008|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
130339617|NCT00119678|469215009|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
130339618|NCT00119678|469215008|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
130339619|NCT00119678|469215009|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
130339620|NCT00119678|469215008|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
130339621|NCT00119678|469215009|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
130339622|NCT00119678|469215008|FG000|Double-blind Treatment Period|Pregnancy|0|||
130339623|NCT00119678|469215009|FG001|Double-blind Treatment Period|Pregnancy|2|||
130339624|NCT00119678|469215008|FG000|Double-blind Treatment Period|Not treated|1|||
130339625|NCT00119678|469215009|FG001|Double-blind Treatment Period|Not treated|2|||
130339626|NCT00119678|469215008|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
130339627|NCT00119678|469215009|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
130339628|NCT00119678|469215008|FG000|Open-label Treatment Period|Death|1|||
130672429|NCT00585351|470425598|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672430|NCT00585351|470425599|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672431|NCT00585351|470425600|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672432|NCT00585351|470425601|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672433|NCT00585351|470425602|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672434|NCT00585351|470425603|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130672435|NCT00585351|470425596|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672436|NCT00585351|470425597|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672437|NCT00585351|470425598|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672438|NCT00585351|470425599|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672439|NCT00585351|470425600|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672440|NCT00585351|470425601|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130672441|NCT00585351|470425602|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
130672442|NCT00585351|470425603|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
130672443|NCT00585351|470425596|FG000|Enrollment Period (Intervention)|Death|0|||
130672444|NCT00585351|470425597|FG001|Enrollment Period (Intervention)|Death|0|||
130672445|NCT00585351|470425598|FG002|Enrollment Period (Intervention)|Death|0|||
130672446|NCT00585351|470425599|FG003|Enrollment Period (Intervention)|Death|0|||
130672447|NCT00585351|470425600|FG004|Enrollment Period (Intervention)|Death|1|||
130672448|NCT00585351|470425601|FG005|Enrollment Period (Intervention)|Death|0|||
130672449|NCT00585351|470425602|FG006|Enrollment Period (Intervention)|Death|1|||
130672450|NCT00585351|470425603|FG007|Enrollment Period (Intervention)|Death|0|||
130672451|NCT00585351|470425596|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672452|NCT00585351|470425597|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672453|NCT00585351|470425598|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672454|NCT00585351|470425599|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672455|NCT00585351|470425600|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
130672456|NCT00585351|470425601|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
130672457|NCT00585351|470425602|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672458|NCT00585351|470425603|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130672459|NCT01842958|470425605|FG000|Overall Study|Lost to Follow-up|1|||
130672460|NCT01842958|470425606|FG001|Overall Study|Lost to Follow-up|1|||
130672461|NCT01829477|470425607|FG000|Overall Study|Study Terminated by Sponsor|15|||
130672462|NCT01829477|470425608|FG001|Overall Study|Study Terminated by Sponsor|15|||
130672463|NCT01829477|470425607|FG000|Overall Study|Withdrawal by Subject|1|||
130672464|NCT01829477|470425608|FG001|Overall Study|Withdrawal by Subject|0|||
130672465|NCT00818623|470425613|FG000|Overall Study|Adverse Event|1|||
130672466|NCT00818623|470425614|FG001|Overall Study|Adverse Event|0|||
130672467|NCT00818623|470425615|FG002|Overall Study|Adverse Event|1|||
130672468|NCT00818623|470425616|FG003|Overall Study|Adverse Event|0|||
130672469|NCT00818623|470425617|FG004|Overall Study|Adverse Event|0|||
130672470|NCT00818623|470425618|FG005|Overall Study|Adverse Event|1|||
130672471|NCT00818623|470425619|FG006|Overall Study|Adverse Event|0|||
130672472|NCT00818623|470425620|FG007|Overall Study|Adverse Event|0|||
130672473|NCT00818623|470425613|FG000|Overall Study|Bad prostate specific antigen response|0|||
130672474|NCT00818623|470425614|FG001|Overall Study|Bad prostate specific antigen response|3|||
130672475|NCT00818623|470425615|FG002|Overall Study|Bad prostate specific antigen response|2|||
130339629|NCT00119678|469215009|FG001|Open-label Treatment Period|Death|0|||
130339630|NCT00119678|469215008|FG000|Open-label Treatment Period|Adverse Event|3|||
130339631|NCT00119678|469215009|FG001|Open-label Treatment Period|Adverse Event|0|||
130339632|NCT00119678|469215008|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
130339633|NCT00119678|469215009|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
130339634|NCT00119678|469215008|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
130339635|NCT00119678|469215009|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130339636|NCT00119678|469215008|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
130339637|NCT00119678|469215009|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
130339638|NCT00119678|469215008|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
130339639|NCT00119678|469215009|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
130339640|NCT00119678|469215008|FG000|Open-label Treatment Period|Pregnancy|1|||
130339641|NCT00119678|469215009|FG001|Open-label Treatment Period|Pregnancy|0|||
130552746|NCT00355056|469991514|FG000|Randomization Period|Early Termination|4|||
130672476|NCT00818623|470425616|FG003|Overall Study|Bad prostate specific antigen response|5|||
130672477|NCT00818623|470425617|FG004|Overall Study|Bad prostate specific antigen response|0|||
130672478|NCT00818623|470425618|FG005|Overall Study|Bad prostate specific antigen response|1|||
130672479|NCT00818623|470425619|FG006|Overall Study|Bad prostate specific antigen response|0|||
130672480|NCT00818623|470425620|FG007|Overall Study|Bad prostate specific antigen response|0|||
130672481|NCT00818623|470425613|FG000|Overall Study|Withdrawal by Subject|0|||
130672482|NCT00818623|470425614|FG001|Overall Study|Withdrawal by Subject|1|||
130672483|NCT00818623|470425615|FG002|Overall Study|Withdrawal by Subject|1|||
130672484|NCT00818623|470425616|FG003|Overall Study|Withdrawal by Subject|0|||
130672485|NCT00818623|470425617|FG004|Overall Study|Withdrawal by Subject|0|||
130672486|NCT00818623|470425618|FG005|Overall Study|Withdrawal by Subject|1|||
130672487|NCT00818623|470425619|FG006|Overall Study|Withdrawal by Subject|1|||
130672488|NCT00818623|470425620|FG007|Overall Study|Withdrawal by Subject|1|||
130672489|NCT00818623|470425613|FG000|Overall Study|Protocol Violation|1|||
130672490|NCT00818623|470425614|FG001|Overall Study|Protocol Violation|0|||
130672491|NCT00818623|470425615|FG002|Overall Study|Protocol Violation|0|||
130672492|NCT00818623|470425616|FG003|Overall Study|Protocol Violation|0|||
130672493|NCT00818623|470425617|FG004|Overall Study|Protocol Violation|1|||
130672494|NCT00818623|470425618|FG005|Overall Study|Protocol Violation|0|||
130672495|NCT00818623|470425619|FG006|Overall Study|Protocol Violation|1|||
130672496|NCT00818623|470425620|FG007|Overall Study|Protocol Violation|0|||
130672497|NCT00818623|470425613|FG000|Overall Study|Need of additional treatment|0|||
130672498|NCT00818623|470425614|FG001|Overall Study|Need of additional treatment|0|||
130672499|NCT00818623|470425615|FG002|Overall Study|Need of additional treatment|0|||
130672500|NCT00818623|470425616|FG003|Overall Study|Need of additional treatment|0|||
130672501|NCT00818623|470425617|FG004|Overall Study|Need of additional treatment|1|||
130672502|NCT00818623|470425618|FG005|Overall Study|Need of additional treatment|0|||
130672503|NCT00818623|470425619|FG006|Overall Study|Need of additional treatment|0|||
130672504|NCT00818623|470425620|FG007|Overall Study|Need of additional treatment|0|||
130672505|NCT00818623|470425613|FG000|Overall Study|Lack of trial drug at site|0|||
130672506|NCT00818623|470425614|FG001|Overall Study|Lack of trial drug at site|0|||
130672507|NCT00818623|470425615|FG002|Overall Study|Lack of trial drug at site|0|||
130672508|NCT00818623|470425616|FG003|Overall Study|Lack of trial drug at site|0|||
130672509|NCT00818623|470425617|FG004|Overall Study|Lack of trial drug at site|2|||
130672510|NCT00818623|470425618|FG005|Overall Study|Lack of trial drug at site|0|||
130672511|NCT00818623|470425619|FG006|Overall Study|Lack of trial drug at site|1|||
130672512|NCT00818623|470425620|FG007|Overall Study|Lack of trial drug at site|0|||
130672513|NCT00818623|470425613|FG000|Overall Study|Disease progression|0|||
130672514|NCT00818623|470425614|FG001|Overall Study|Disease progression|0|||
130672515|NCT00818623|470425615|FG002|Overall Study|Disease progression|0|||
130672516|NCT00818623|470425616|FG003|Overall Study|Disease progression|0|||
130672517|NCT00818623|470425617|FG004|Overall Study|Disease progression|0|||
130672518|NCT00818623|470425618|FG005|Overall Study|Disease progression|0|||
130672519|NCT00818623|470425619|FG006|Overall Study|Disease progression|1|||
130672520|NCT00818623|470425620|FG007|Overall Study|Disease progression|0|||
130672521|NCT00602030|470425621|FG000|Lead-in Phase|Disease Progression|2|||
130672522|NCT00602030|470425622|FG001|Lead-in Phase|Disease Progression|3|||
130672523|NCT00602030|470425623|FG002|Lead-in Phase|Disease Progression|0|||
130672524|NCT00602030|470425624|FG003|Lead-in Phase|Disease Progression|0|||
130672525|NCT00602030|470425625|FG004|Lead-in Phase|Disease Progression|0|||
130672526|NCT00602030|470425621|FG000|Lead-in Phase|Adverse Event|0|||
130672527|NCT00602030|470425622|FG001|Lead-in Phase|Adverse Event|2|||
130672528|NCT00602030|470425623|FG002|Lead-in Phase|Adverse Event|0|||
130672529|NCT00602030|470425624|FG003|Lead-in Phase|Adverse Event|0|||
130672530|NCT00602030|470425625|FG004|Lead-in Phase|Adverse Event|0|||
130672531|NCT00602030|470425621|FG000|Double-blind Phase|Disease progression|0|||
130672532|NCT00602030|470425622|FG001|Double-blind Phase|Disease progression|0|||
130672533|NCT00602030|470425623|FG002|Double-blind Phase|Disease progression|33|||
130672534|NCT00602030|470425624|FG003|Double-blind Phase|Disease progression|30|||
130672535|NCT00602030|470425625|FG004|Double-blind Phase|Disease progression|0|||
130672536|NCT00602030|470425621|FG000|Double-blind Phase|Adverse Event|0|||
130672537|NCT00602030|470425622|FG001|Double-blind Phase|Adverse Event|0|||
130672538|NCT00602030|470425623|FG002|Double-blind Phase|Adverse Event|9|||
130672539|NCT00602030|470425624|FG003|Double-blind Phase|Adverse Event|18|||
130672540|NCT00602030|470425625|FG004|Double-blind Phase|Adverse Event|0|||
130672541|NCT00602030|470425621|FG000|Double-blind Phase|Consent withdrawal|0|||
130672542|NCT00602030|470425622|FG001|Double-blind Phase|Consent withdrawal|0|||
130672543|NCT00602030|470425623|FG002|Double-blind Phase|Consent withdrawal|4|||
130672544|NCT00602030|470425624|FG003|Double-blind Phase|Consent withdrawal|3|||
130672545|NCT00602030|470425625|FG004|Double-blind Phase|Consent withdrawal|0|||
130672546|NCT00602030|470425621|FG000|Double-blind Phase|Death|0|||
130672547|NCT00602030|470425622|FG001|Double-blind Phase|Death|0|||
130672548|NCT00602030|470425623|FG002|Double-blind Phase|Death|3|||
130672549|NCT00602030|470425624|FG003|Double-blind Phase|Death|3|||
130672550|NCT00602030|470425625|FG004|Double-blind Phase|Death|0|||
130672551|NCT00602030|470425621|FG000|Double-blind Phase|Administrative decision|0|||
130672552|NCT00602030|470425622|FG001|Double-blind Phase|Administrative decision|0|||
130339642|NCT00119678|469215008|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
130339643|NCT00119678|469215009|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
130339644|NCT01761240|469215010|FG000|Overall Study|Progressive disease:radiology assessment|3|||
130339645|NCT01761240|469215011|FG001|Overall Study|Progressive disease:radiology assessment|3|||
130339646|NCT01761240|469215012|FG002|Overall Study|Progressive disease:radiology assessment|0|||
130339647|NCT01761240|469215013|FG003|Overall Study|Progressive disease:radiology assessment|0|||
130339648|NCT01761240|469215014|FG004|Overall Study|Progressive disease:radiology assessment|0|||
130339649|NCT01761240|469215010|FG000|Overall Study|Progressive disease:clinical assessment|0|||
130339650|NCT01761240|469215011|FG001|Overall Study|Progressive disease:clinical assessment|0|||
130339651|NCT01761240|469215012|FG002|Overall Study|Progressive disease:clinical assessment|3|||
130339652|NCT01761240|469215013|FG003|Overall Study|Progressive disease:clinical assessment|1|||
130339653|NCT01761240|469215014|FG004|Overall Study|Progressive disease:clinical assessment|0|||
130339654|NCT01761240|469215010|FG000|Overall Study|Withdrawal by Subject|0|||
130339655|NCT01761240|469215011|FG001|Overall Study|Withdrawal by Subject|0|||
130339656|NCT01761240|469215012|FG002|Overall Study|Withdrawal by Subject|0|||
130339657|NCT01761240|469215013|FG003|Overall Study|Withdrawal by Subject|3|||
130339658|NCT01761240|469215014|FG004|Overall Study|Withdrawal by Subject|1|||
130339659|NCT01761240|469215010|FG000|Overall Study|Adverse Event|0|||
130339660|NCT01761240|469215011|FG001|Overall Study|Adverse Event|0|||
130339661|NCT01761240|469215012|FG002|Overall Study|Adverse Event|0|||
130339662|NCT01761240|469215013|FG003|Overall Study|Adverse Event|1|||
130339663|NCT01761240|469215014|FG004|Overall Study|Adverse Event|6|||
130339664|NCT01761240|469215010|FG000|Overall Study|Death|0|||
130339665|NCT01761240|469215011|FG001|Overall Study|Death|1|||
130339666|NCT01761240|469215012|FG002|Overall Study|Death|1|||
130339667|NCT01761240|469215013|FG003|Overall Study|Death|2|||
130339668|NCT01761240|469215014|FG004|Overall Study|Death|1|||
130339669|NCT01761240|469215010|FG000|Overall Study|Non-compliance|0|||
130339670|NCT01761240|469215011|FG001|Overall Study|Non-compliance|0|||
130339671|NCT01761240|469215012|FG002|Overall Study|Non-compliance|1|||
130339672|NCT01761240|469215013|FG003|Overall Study|Non-compliance|0|||
130339673|NCT01761240|469215014|FG004|Overall Study|Non-compliance|0|||
130339674|NCT00509145|469215015|FG000|Overall Study|Death|0|||
130339675|NCT00509145|469215016|FG001|Overall Study|Death|2|||
130339676|NCT00509145|469215015|FG000|Overall Study|Adverse Event|42|||
130339677|NCT00509145|469215016|FG001|Overall Study|Adverse Event|28|||
130339678|NCT00509145|469215015|FG000|Overall Study|Withdrawal by Subject|32|||
130339679|NCT00509145|469215016|FG001|Overall Study|Withdrawal by Subject|38|||
130339680|NCT00509145|469215015|FG000|Overall Study|Physician Decision|11|||
130339681|NCT00509145|469215016|FG001|Overall Study|Physician Decision|14|||
130339682|NCT00509145|469215015|FG000|Overall Study|Protocol Violation|1|||
130339683|NCT00509145|469215016|FG001|Overall Study|Protocol Violation|6|||
130339684|NCT00509145|469215015|FG000|Overall Study|Pregnancy|3|||
130339685|NCT00509145|469215016|FG001|Overall Study|Pregnancy|8|||
130339686|NCT00509145|469215015|FG000|Overall Study|Lost to Follow-up|6|||
130339687|NCT00509145|469215016|FG001|Overall Study|Lost to Follow-up|5|||
130339688|NCT00509145|469215015|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
130339689|NCT00509145|469215016|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
130339690|NCT00509145|469215015|FG000|Overall Study|Other|6|||
130339691|NCT00509145|469215016|FG001|Overall Study|Other|6|||
130339692|NCT00750152|469215017|FG000|Overall Study|Adverse Event|2|||
130339693|NCT00750152|469215018|FG001|Overall Study|Adverse Event|1|||
130339694|NCT00750152|469215017|FG000|Overall Study|Lost to Follow-up|8|||
130339695|NCT00750152|469215018|FG001|Overall Study|Lost to Follow-up|13|||
130339696|NCT00750152|469215017|FG000|Overall Study|Withdrawal by Subject|3|||
130339697|NCT00750152|469215018|FG001|Overall Study|Withdrawal by Subject|3|||
130339698|NCT00750152|469215017|FG000|Overall Study|Physician Decision|1|||
130339699|NCT00750152|469215018|FG001|Overall Study|Physician Decision|1|||
130339700|NCT00750152|469215017|FG000|Overall Study|Non-compliance|0|||
130339701|NCT00750152|469215018|FG001|Overall Study|Non-compliance|1|||
130339702|NCT00750152|469215017|FG000|Overall Study|Termination by sponsor|1|||
130339703|NCT00750152|469215018|FG001|Overall Study|Termination by sponsor|0|||
130339704|NCT00750152|469215017|FG000|Overall Study|Other|7|||
130339705|NCT00750152|469215018|FG001|Overall Study|Other|8|||
130339706|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130339707|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339708|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339709|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
130339710|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130339711|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130339712|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
130339713|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
130339714|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
130552747|NCT00355056|469991515|FG001|Randomization Period|Early Termination|6|||
130339715|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
130339716|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130339717|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130339718|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
130339719|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
130339720|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
130339721|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
130339722|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
130339723|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
130339724|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
130339725|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
130339726|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
130339727|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339728|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130339729|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339730|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130339731|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130339732|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
130339733|NCT01028300|469215024|FG000|Overall Study|Study Terminated|4|||
130339734|NCT01214395|469215027|FG000|Overall Study|All patients had infection|5|||
130339735|NCT00715910|469215031|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
130339736|NCT00715910|469215032|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
130339737|NCT00715910|469215033|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
130339738|NCT00715910|469215034|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
130339739|NCT00715910|469215035|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
130339740|NCT00715910|469215036|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
130339741|NCT00715910|469215031|FG000|Booster and ESFU Phase|Other|0|||
130339742|NCT00715910|469215032|FG001|Booster and ESFU Phase|Other|0|||
130339743|NCT00715910|469215033|FG002|Booster and ESFU Phase|Other|0|||
130339744|NCT00715910|469215034|FG003|Booster and ESFU Phase|Other|5|||
130339745|NCT00715910|469215035|FG004|Booster and ESFU Phase|Other|1|||
130339746|NCT00715910|469215036|FG005|Booster and ESFU Phase|Other|0|||
130339747|NCT02034409|469215037|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
130339748|NCT02034409|469215038|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
130339749|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
130339750|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
130339751|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
130339752|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
130339753|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130339754|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130339755|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
130339756|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
130339757|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
130339758|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
130339759|NCT01030666|469215039|FG000|Overall Study|Lost to Follow-up|3|||
130339760|NCT01030666|469215040|FG001|Overall Study|Lost to Follow-up|2|||
130339761|NCT01699867|469215041|FG000|Overall Study|Screening Failure|3|||
130339762|NCT00006289|469215042|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
130339763|NCT00006289|469215043|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
130339764|NCT00006289|469215042|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
130339765|NCT00006289|469215043|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
130339766|NCT03703297|469215050|FG000|Overall Study|Death|115|||
130339767|NCT03703297|469215051|FG001|Overall Study|Death|0|||
130339768|NCT03703297|469215052|FG002|Overall Study|Death|144|||
130339769|NCT03703297|469215050|FG000|Overall Study|Withdrawal by Subject|9|||
130339770|NCT03703297|469215051|FG001|Overall Study|Withdrawal by Subject|0|||
130339771|NCT03703297|469215052|FG002|Overall Study|Withdrawal by Subject|11|||
130339772|NCT03703297|469215050|FG000|Overall Study|Ongoing at the time of DCO|140|||
130339773|NCT03703297|469215051|FG001|Overall Study|Ongoing at the time of DCO|200|||
130339774|NCT03703297|469215052|FG002|Overall Study|Ongoing at the time of DCO|111|||
130339775|NCT02156271|469217967|FG000|Overall Study|Physician Decision|4|||
130339776|NCT02156271|469217968|FG001|Overall Study|Physician Decision|3|||
130339777|NCT03320824|469217969|FG000|Overall Study|Withdrawal by Subject|8|||
130339778|NCT03320824|469217970|FG001|Overall Study|Withdrawal by Subject|1|||
130339779|NCT03320824|469217969|FG000|Overall Study|Lost to Follow-up|10|||
130339780|NCT03320824|469217970|FG001|Overall Study|Lost to Follow-up|1|||
130339781|NCT03320824|469217969|FG000|Overall Study|moved out of state|0|||
130339782|NCT03320824|469217970|FG001|Overall Study|moved out of state|1|||
130339783|NCT03320824|469217969|FG000|Overall Study|could not complete final visit|0|||
130339784|NCT03320824|469217970|FG001|Overall Study|could not complete final visit|1|||
130339785|NCT03387111|469217971|FG000|Overall Study|Progressive Disease|3|||
130672553|NCT00602030|470425623|FG002|Double-blind Phase|Administrative decision|0|||
130672554|NCT00602030|470425624|FG003|Double-blind Phase|Administrative decision|2|||
130672555|NCT00602030|470425625|FG004|Double-blind Phase|Administrative decision|0|||
130672556|NCT00602030|470425621|FG000|Double-blind Phase|Ineligibility|0|||
130672557|NCT00602030|470425622|FG001|Double-blind Phase|Ineligibility|0|||
130672558|NCT00602030|470425623|FG002|Double-blind Phase|Ineligibility|0|||
130672559|NCT00602030|470425624|FG003|Double-blind Phase|Ineligibility|1|||
130672560|NCT00602030|470425625|FG004|Double-blind Phase|Ineligibility|0|||
130672561|NCT00602030|470425621|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
130672562|NCT00602030|470425622|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
130672563|NCT00602030|470425623|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
130672564|NCT00602030|470425624|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
130672565|NCT00602030|470425625|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
130672566|NCT00602030|470425621|FG000|Double-blind Phase|Reason not specified|0|||
130672567|NCT00602030|470425622|FG001|Double-blind Phase|Reason not specified|0|||
130672568|NCT00602030|470425623|FG002|Double-blind Phase|Reason not specified|4|||
130339786|NCT03387111|469217971|FG000|Overall Study|Other|1|||
130339787|NCT02617485|469217978|FG000|Treatment and Observation Period|Adverse Event|9|||
130339788|NCT02617485|469217979|FG001|Treatment and Observation Period|Adverse Event|1|||
130339789|NCT02617485|469217978|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
130339790|NCT02617485|469217979|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
130339791|NCT02617485|469217978|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
130339792|NCT02617485|469217979|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
130672569|NCT00602030|470425624|FG003|Double-blind Phase|Reason not specified|2|||
130672570|NCT00602030|470425625|FG004|Double-blind Phase|Reason not specified|0|||
130672571|NCT00602030|470425621|FG000|Crossover Phase|Disease Progression|0|||
130339793|NCT02617485|469217978|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
130339794|NCT02617485|469217979|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
130339795|NCT02617485|469217978|FG000|Treatment and Observation Period|Physician Decision|0|||
130339796|NCT02617485|469217979|FG001|Treatment and Observation Period|Physician Decision|1|||
130339797|NCT02617485|469217978|FG000|Follow-up Period|Adverse Event|1|||
130339798|NCT02617485|469217979|FG001|Follow-up Period|Adverse Event|0|||
130339799|NCT02617485|469217978|FG000|Follow-up Period|Withdrawal by Subject|1|||
130339800|NCT02617485|469217979|FG001|Follow-up Period|Withdrawal by Subject|0|||
130339801|NCT02617485|469217978|FG000|Follow-up Period|Disease progression|2|||
130339802|NCT02617485|469217979|FG001|Follow-up Period|Disease progression|1|||
130339803|NCT02617485|469217978|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
130339804|NCT02617485|469217979|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
130339805|NCT02617485|469217978|FG000|Follow-up Period|Patient needed radiotherapy|9|||
130339806|NCT02617485|469217979|FG001|Follow-up Period|Patient needed radiotherapy|5|||
130339807|NCT02617485|469217978|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
130339808|NCT02617485|469217979|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
130339809|NCT04590248|469217981|FG000|Overall Study|Lost to Follow-up|1|||
130339810|NCT04590248|469217981|FG000|Overall Study|Withdrawal by Subject|16|||
130339811|NCT04590248|469217981|FG000|Overall Study|Other|2|||
130339812|NCT00615901|469217982|FG000|Overall Study|Withdrawal by Subject|2|||
130339813|NCT00615901|469217982|FG000|Overall Study|Adverse Event|7|||
130339814|NCT03598114|469217983|FG000|Overall Study|Staff turnover/left the program|3|||
130339815|NCT03598114|469217984|FG001|Overall Study|Staff turnover/left the program|39|||
130339816|NCT02527200|469217985|FG000|Overall Study|Withdrawal by Subject|3|||
130339817|NCT02527200|469217986|FG001|Overall Study|Withdrawal by Subject|2|||
130339818|NCT02527200|469217987|FG002|Overall Study|Withdrawal by Subject|1|||
130339819|NCT02527200|469217988|FG003|Overall Study|Withdrawal by Subject|0|||
130339820|NCT02527200|469217985|FG000|Overall Study|Unclassified|0|||
130339821|NCT02527200|469217986|FG001|Overall Study|Unclassified|1|||
130339822|NCT02527200|469217987|FG002|Overall Study|Unclassified|0|||
130339823|NCT02527200|469217988|FG003|Overall Study|Unclassified|0|||
130339824|NCT02527200|469217985|FG000|Overall Study|Lost to Follow-up|0|||
130339825|NCT02527200|469217986|FG001|Overall Study|Lost to Follow-up|0|||
130339826|NCT02527200|469217987|FG002|Overall Study|Lost to Follow-up|1|||
130339827|NCT02527200|469217988|FG003|Overall Study|Lost to Follow-up|0|||
130339828|NCT04250077|469217992|FG000|Overall Study|Withdrawal by Subject|0|||
130339829|NCT04250077|469217993|FG001|Overall Study|Withdrawal by Subject|1|||
130339830|NCT04250077|469217994|FG002|Overall Study|Withdrawal by Subject|0|||
130339831|NCT04250077|469217992|FG000|Overall Study|Lost to Follow-up|2|||
130339832|NCT04250077|469217993|FG001|Overall Study|Lost to Follow-up|3|||
130672572|NCT00602030|470425622|FG001|Crossover Phase|Disease Progression|0|||
130339833|NCT04250077|469217994|FG002|Overall Study|Lost to Follow-up|0|||
130339834|NCT01022398|469217995|FG000|Overall Study|Study terminated|2|||
130672573|NCT00602030|470425623|FG002|Crossover Phase|Disease Progression|0|||
130339835|NCT01022398|469217996|FG001|Overall Study|Study terminated|2|||
130339836|NCT00640224|469217997|FG000|Overall Study|Lost to Follow-up|5|||
130339837|NCT00640224|469217998|FG001|Overall Study|Lost to Follow-up|2|||
130672574|NCT00602030|470425624|FG003|Crossover Phase|Disease Progression|0|||
130339838|NCT00640224|469217999|FG002|Overall Study|Lost to Follow-up|0|||
130339839|NCT00640224|469218000|FG003|Overall Study|Lost to Follow-up|0|||
130339840|NCT00640224|469217997|FG000|Overall Study|Withdrawal by Subject|1|||
130339841|NCT00640224|469217998|FG001|Overall Study|Withdrawal by Subject|0|||
130339842|NCT00640224|469217999|FG002|Overall Study|Withdrawal by Subject|0|||
130339843|NCT00640224|469218000|FG003|Overall Study|Withdrawal by Subject|0|||
130339844|NCT00640224|469217997|FG000|Overall Study|Headaches|0|||
130339845|NCT00640224|469217998|FG001|Overall Study|Headaches|1|||
130339846|NCT00640224|469217999|FG002|Overall Study|Headaches|0|||
130339847|NCT00640224|469218000|FG003|Overall Study|Headaches|0|||
130339848|NCT02937584|469218005|FG000|Period 1|Adverse Event|1|||
130339849|NCT02937584|469218006|FG001|Period 1|Adverse Event|2|||
130339850|NCT02937584|469218005|FG000|Washout|Adverse Event|0|||
130339851|NCT02937584|469218006|FG001|Washout|Adverse Event|1|||
130339852|NCT04075734|469218015|FG000|Overall Study|Lost to Follow-up|1|||
130339853|NCT04075734|469218016|FG001|Overall Study|Lost to Follow-up|1|||
130339854|NCT04075734|469218017|FG002|Overall Study|Lost to Follow-up|0|||
130339855|NCT04075734|469218015|FG000|Overall Study|Withdrawal by Subject|3|||
130339856|NCT04075734|469218016|FG001|Overall Study|Withdrawal by Subject|0|||
130339857|NCT04075734|469218017|FG002|Overall Study|Withdrawal by Subject|0|||
130672575|NCT00602030|470425625|FG004|Crossover Phase|Disease Progression|11|||
130672576|NCT00602030|470425621|FG000|Crossover Phase|Adverse Event|0|||
130672577|NCT00602030|470425622|FG001|Crossover Phase|Adverse Event|0|||
130672578|NCT00602030|470425623|FG002|Crossover Phase|Adverse Event|0|||
130672579|NCT00602030|470425624|FG003|Crossover Phase|Adverse Event|0|||
130672580|NCT00602030|470425625|FG004|Crossover Phase|Adverse Event|3|||
130672581|NCT00602030|470425621|FG000|Crossover Phase|Consent withdrawal|0|||
130672582|NCT00602030|470425622|FG001|Crossover Phase|Consent withdrawal|0|||
130672583|NCT00602030|470425623|FG002|Crossover Phase|Consent withdrawal|0|||
130672584|NCT00602030|470425624|FG003|Crossover Phase|Consent withdrawal|0|||
130672585|NCT00602030|470425625|FG004|Crossover Phase|Consent withdrawal|2|||
130672586|NCT00947856|470425633|FG000|Treatment Period|Progressive Disease|33|||
130672587|NCT00947856|470425634|FG001|Treatment Period|Progressive Disease|12|||
130672588|NCT00947856|470425633|FG000|Treatment Period|Adverse Event|15|||
130672589|NCT00947856|470425634|FG001|Treatment Period|Adverse Event|9|||
130672590|NCT00947856|470425633|FG000|Treatment Period|Physician Decision|14|||
130672591|NCT00947856|470425634|FG001|Treatment Period|Physician Decision|6|||
130672592|NCT00947856|470425633|FG000|Treatment Period|Study Stopped by Sponsor|4|||
130672593|NCT00947856|470425634|FG001|Treatment Period|Study Stopped by Sponsor|4|||
130672594|NCT00947856|470425633|FG000|Treatment Period|Withdrawal by Subject|12|||
130672595|NCT00947856|470425634|FG001|Treatment Period|Withdrawal by Subject|1|||
130672596|NCT00947856|470425633|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
130672597|NCT00947856|470425634|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
130672598|NCT00947856|470425633|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
130672599|NCT00947856|470425634|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
130672600|NCT00947856|470425633|FG000|Follow-up Period|Lost to Follow-up|7|||
130672601|NCT00947856|470425634|FG001|Follow-up Period|Lost to Follow-up|0|||
130672602|NCT00947856|470425633|FG000|Follow-up Period|Patient unavailable for site visits|1|||
130672603|NCT00947856|470425634|FG001|Follow-up Period|Patient unavailable for site visits|0|||
130672604|NCT00947856|470425633|FG000|Follow-up Period|Withdrawal by Subject|1|||
130672605|NCT00947856|470425634|FG001|Follow-up Period|Withdrawal by Subject|0|||
130672606|NCT00543439|470425635|FG000|Period 1|Adverse Event|0|||
130672607|NCT00543439|470425636|FG001|Period 1|Adverse Event|2|||
130672608|NCT00543439|470425637|FG002|Period 1|Adverse Event|1|||
130672609|NCT00543439|470425635|FG000|Period 1|Withdrawal by Subject|1|||
130672610|NCT00543439|470425636|FG001|Period 1|Withdrawal by Subject|1|||
130672611|NCT00543439|470425637|FG002|Period 1|Withdrawal by Subject|0|||
130672612|NCT00543439|470425635|FG000|Period 1|Physician Decision|0|||
130672613|NCT00543439|470425636|FG001|Period 1|Physician Decision|0|||
130672614|NCT00543439|470425637|FG002|Period 1|Physician Decision|1|||
130672615|NCT00543439|470425635|FG000|Period 2|Protocol Violation|1|||
130339858|NCT03615040|469218018|FG000|Overall Study|Withdrawal by Subject|2|||
130339859|NCT03615040|469218019|FG001|Overall Study|Withdrawal by Subject|1|||
130339860|NCT03615040|469218018|FG000|Overall Study|Physician Decision|2|||
130672616|NCT00543439|470425636|FG001|Period 2|Protocol Violation|0|||
130672617|NCT00543439|470425637|FG002|Period 2|Protocol Violation|1|||
130672618|NCT00543439|470425635|FG000|Period 2|Adverse Event|0|||
130339861|NCT03615040|469218019|FG001|Overall Study|Physician Decision|2|||
130339862|NCT03615040|469218018|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
130339863|NCT03615040|469218019|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
130339864|NCT03615040|469218018|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
130339865|NCT03615040|469218019|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
130339866|NCT03615040|469218018|FG000|Overall Study|Death|0|||
130339867|NCT03615040|469218019|FG001|Overall Study|Death|2|||
130672619|NCT00543439|470425636|FG001|Period 2|Adverse Event|1|||
130672620|NCT00543439|470425637|FG002|Period 2|Adverse Event|1|||
130672621|NCT01211769|470425638|FG000|Overall Study|Lost to Follow-up|7|||
130672622|NCT01211769|470425639|FG001|Overall Study|Lost to Follow-up|9|||
130672623|NCT01211769|470425640|FG002|Overall Study|Lost to Follow-up|5|||
130339868|NCT01776307|469218020|FG000|Overall Study|Not dosed|0|||
130339869|NCT01776307|469218021|FG001|Overall Study|Not dosed|0|||
130339870|NCT01776307|469218022|FG002|Overall Study|Not dosed|1|||
130339871|NCT04074161|469218030|FG000|Overall Study|Withdrawal by Subject|2|||
130339872|NCT04074161|469218031|FG001|Overall Study|Withdrawal by Subject|4|||
130339873|NCT04074161|469218032|FG002|Overall Study|Withdrawal by Subject|1|||
130339874|NCT04074161|469218030|FG000|Overall Study|Lost to Follow-up|4|||
130339875|NCT04074161|469218031|FG001|Overall Study|Lost to Follow-up|5|||
130339876|NCT04074161|469218032|FG002|Overall Study|Lost to Follow-up|3|||
130339877|NCT03890666|469218039|FG000|Overall Study|Withdrawal by Subject|0|||
130339878|NCT03890666|469218040|FG001|Overall Study|Withdrawal by Subject|1|||
130339879|NCT03890666|469218039|FG000|Overall Study|Protocol deviation|1|||
130339880|NCT03890666|469218040|FG001|Overall Study|Protocol deviation|4|||
130339881|NCT03890666|469218039|FG000|Overall Study|Lost to Follow-up|2|||
130339882|NCT03890666|469218040|FG001|Overall Study|Lost to Follow-up|5|||
130339883|NCT03890666|469218039|FG000|Overall Study|Other than specified|1|||
130339884|NCT03890666|469218040|FG001|Overall Study|Other than specified|8|||
130339885|NCT03232333|469218041|FG000|Overall Study|Infection or Osteomyelitis|9|||
130339886|NCT03232333|469218041|FG000|Overall Study|Lost to Follow-up|4|||
130339887|NCT03232333|469218041|FG000|Overall Study|Withdrawal by Subject|2|||
130339888|NCT03052426|469218042|FG000|Overall Study|Withdrawal by Subject|0|||
130339889|NCT03052426|469218043|FG001|Overall Study|Withdrawal by Subject|1|||
130339890|NCT03052426|469218044|FG002|Overall Study|Withdrawal by Subject|0|||
130339891|NCT03052426|469218042|FG000|Overall Study|Lost to Follow-up|2|||
130339892|NCT03052426|469218043|FG001|Overall Study|Lost to Follow-up|0|||
130339893|NCT03052426|469218044|FG002|Overall Study|Lost to Follow-up|1|||
130339894|NCT01853839|469218046|FG000|Overall Study|Violated inclusion criteria|2|||
130339895|NCT01853839|469218046|FG000|Overall Study|Not meet ITT population definition|58|||
130339896|NCT01853839|469218046|FG000|Overall Study|End of treatment visit too early|33|||
130339897|NCT01853839|469218046|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
130339898|NCT04145219|469218047|FG000|Overall Study|Adverse Event|18|||
130339899|NCT04145219|469218048|FG001|Overall Study|Adverse Event|6|||
130339900|NCT04145219|469218047|FG000|Overall Study|Lost to Follow-up|2|||
130339901|NCT04145219|469218048|FG001|Overall Study|Lost to Follow-up|3|||
130339902|NCT04145219|469218047|FG000|Overall Study|Physician Decision|0|||
130339903|NCT04145219|469218048|FG001|Overall Study|Physician Decision|2|||
130339904|NCT04145219|469218047|FG000|Overall Study|Withdrawal by Subject|12|||
130339905|NCT04145219|469218048|FG001|Overall Study|Withdrawal by Subject|8|||
130339906|NCT04145219|469218047|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130339907|NCT04145219|469218048|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130339908|NCT02709538|469218049|FG000|Overall Study|Adverse Event|13|||
130339909|NCT02709538|469218050|FG001|Overall Study|Adverse Event|2|||
130339910|NCT02709538|469218051|FG002|Overall Study|Adverse Event|3|||
130339911|NCT02709538|469218049|FG000|Overall Study|Lack of Efficacy|1|||
130339912|NCT02709538|469218050|FG001|Overall Study|Lack of Efficacy|0|||
130339913|NCT02709538|469218051|FG002|Overall Study|Lack of Efficacy|0|||
130339914|NCT02709538|469218049|FG000|Overall Study|Lost to Follow-up|24|||
130672624|NCT01211769|470425641|FG003|Overall Study|Lost to Follow-up|9|||
130672625|NCT01211769|470425638|FG000|Overall Study|Physician Decision|2|||
130672626|NCT01211769|470425639|FG001|Overall Study|Physician Decision|0|||
130672627|NCT01211769|470425640|FG002|Overall Study|Physician Decision|2|||
130672628|NCT01211769|470425641|FG003|Overall Study|Physician Decision|1|||
130672629|NCT01211769|470425638|FG000|Overall Study|Adverse Event|0|||
130672630|NCT01211769|470425639|FG001|Overall Study|Adverse Event|1|||
130672631|NCT01211769|470425640|FG002|Overall Study|Adverse Event|1|||
130672632|NCT01211769|470425641|FG003|Overall Study|Adverse Event|1|||
130672633|NCT01214330|470425642|FG000|Overall Study|Withdrawal by Subject|2|||
130672634|NCT01214330|470425642|FG000|Overall Study|Withdrawal by Subject|2|||
130672635|NCT01348542|470425644|FG000|Overall Study|Withdrawal by Subject|3|||
130672636|NCT01348542|470425645|FG001|Overall Study|Withdrawal by Subject|0|||
130672637|NCT03402893|470425646|FG000|Overall Study|Withdrawal by Subject|1|||
130672638|NCT00686036|470425647|FG000|Overall Study|Adverse Event|3|||
130672639|NCT00686036|470425648|FG001|Overall Study|Adverse Event|0|||
130672640|NCT00686036|470425647|FG000|Overall Study|Withdrawal by Subject|3|||
130672641|NCT00686036|470425648|FG001|Overall Study|Withdrawal by Subject|1|||
130339915|NCT02709538|469218050|FG001|Overall Study|Lost to Follow-up|8|||
130339916|NCT02709538|469218051|FG002|Overall Study|Lost to Follow-up|4|||
130339917|NCT02709538|469218049|FG000|Overall Study|Physician Decision|1|||
130339918|NCT02709538|469218050|FG001|Overall Study|Physician Decision|0|||
130672642|NCT00686036|470425647|FG000|Overall Study|Study terminated by AstraZeneca|2|||
130339919|NCT02709538|469218051|FG002|Overall Study|Physician Decision|0|||
130672643|NCT00686036|470425648|FG001|Overall Study|Study terminated by AstraZeneca|1|||
130339920|NCT02709538|469218049|FG000|Overall Study|Withdrawal by Subject|40|||
130339921|NCT02709538|469218050|FG001|Overall Study|Withdrawal by Subject|7|||
130339922|NCT02709538|469218051|FG002|Overall Study|Withdrawal by Subject|4|||
130339923|NCT02709538|469218049|FG000|Overall Study|Non-compliance with study procedures|5|||
130339924|NCT02709538|469218050|FG001|Overall Study|Non-compliance with study procedures|0|||
130339925|NCT02709538|469218051|FG002|Overall Study|Non-compliance with study procedures|0|||
130339926|NCT02709538|469218049|FG000|Overall Study|Non-compliance with study drug|2|||
130339927|NCT02709538|469218050|FG001|Overall Study|Non-compliance with study drug|0|||
130339928|NCT02709538|469218051|FG002|Overall Study|Non-compliance with study drug|0|||
130339929|NCT02709538|469218049|FG000|Overall Study|Protocol deviation|10|||
130339930|NCT02709538|469218050|FG001|Overall Study|Protocol deviation|4|||
130339931|NCT02709538|469218051|FG002|Overall Study|Protocol deviation|4|||
130339932|NCT02709538|469218049|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
130339933|NCT02709538|469218050|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130339934|NCT02709538|469218051|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130339935|NCT02709538|469218049|FG000|Overall Study|Other|16|||
130339936|NCT02709538|469218050|FG001|Overall Study|Other|7|||
130339937|NCT02709538|469218051|FG002|Overall Study|Other|5|||
130339938|NCT02059291|469218052|FG000|Epoch 2|Lack of Efficacy|0|||
130339939|NCT02059291|469218053|FG001|Epoch 2|Lack of Efficacy|0|||
130339940|NCT02059291|469218054|FG002|Epoch 2|Lack of Efficacy|0|||
130339941|NCT02059291|469218055|FG003|Epoch 2|Lack of Efficacy|1|||
130339942|NCT02059291|469218056|FG004|Epoch 2|Lack of Efficacy|0|||
130339943|NCT02059291|469218057|FG005|Epoch 2|Lack of Efficacy|1|||
130339944|NCT02059291|469218058|FG006|Epoch 2|Lack of Efficacy|0|||
130672644|NCT00686036|470425647|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
130672645|NCT00686036|470425648|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
130672646|NCT00686036|470425647|FG000|Overall Study|Other reasons not identified|0|||
130672647|NCT00686036|470425648|FG001|Overall Study|Other reasons not identified|4|||
130672648|NCT00926289|470425649|FG000|Overall Study|Adverse Event|9|||
130672649|NCT00926289|470425650|FG001|Overall Study|Adverse Event|11|||
130672650|NCT00926289|470425649|FG000|Overall Study|Protocol Violation|8|||
130672651|NCT00926289|470425650|FG001|Overall Study|Protocol Violation|12|||
130672652|NCT00926289|470425649|FG000|Overall Study|Lost to Follow-up|3|||
130672653|NCT00926289|470425650|FG001|Overall Study|Lost to Follow-up|6|||
130672654|NCT00926289|470425649|FG000|Overall Study|Withdrawal by Subject|4|||
130672655|NCT00926289|470425650|FG001|Overall Study|Withdrawal by Subject|4|||
130672656|NCT00926289|470425649|FG000|Overall Study|Other|1|||
130672657|NCT00926289|470425650|FG001|Overall Study|Other|3|||
130672658|NCT00146770|470425651|FG000|Overall Study|Adverse Event|2|||
130672659|NCT00146770|470425652|FG001|Overall Study|Adverse Event|0|||
130672660|NCT00146770|470425651|FG000|Overall Study|Pregnancy|1|||
130339945|NCT02059291|469218059|FG007|Epoch 2|Lack of Efficacy|0|||
130339946|NCT02059291|469218060|FG008|Epoch 2|Lack of Efficacy|0|||
130339947|NCT02059291|469218061|FG009|Epoch 2|Lack of Efficacy|0|||
130339948|NCT02059291|469218062|FG010|Epoch 2|Lack of Efficacy|0|||
130339949|NCT02059291|469218063|FG011|Epoch 2|Lack of Efficacy|0|||
130339950|NCT02059291|469218064|FG012|Epoch 2|Lack of Efficacy|0|||
130339951|NCT02059291|469218065|FG013|Epoch 2|Lack of Efficacy|0|||
130339952|NCT02059291|469218066|FG014|Epoch 2|Lack of Efficacy|0|||
130339953|NCT02059291|469218067|FG015|Epoch 2|Lack of Efficacy|0|||
130339954|NCT02059291|469218068|FG016|Epoch 2|Lack of Efficacy|0|||
130339955|NCT02059291|469218069|FG017|Epoch 2|Lack of Efficacy|0|||
130339956|NCT02059291|469218070|FG018|Epoch 2|Lack of Efficacy|0|||
130339957|NCT02059291|469218071|FG019|Epoch 2|Lack of Efficacy|0|||
130339958|NCT02059291|469218072|FG020|Epoch 2|Lack of Efficacy|0|||
130339959|NCT02059291|469218073|FG021|Epoch 2|Lack of Efficacy|0|||
130339960|NCT02059291|469218074|FG022|Epoch 2|Lack of Efficacy|0|||
130339961|NCT02059291|469218075|FG023|Epoch 2|Lack of Efficacy|0|||
130339962|NCT02059291|469218076|FG024|Epoch 2|Lack of Efficacy|0|||
130339963|NCT02059291|469218052|FG000|Epoch 2|Adverse Event|0|||
130339964|NCT02059291|469218053|FG001|Epoch 2|Adverse Event|0|||
130339965|NCT02059291|469218054|FG002|Epoch 2|Adverse Event|1|||
130339966|NCT02059291|469218055|FG003|Epoch 2|Adverse Event|1|||
130339967|NCT02059291|469218056|FG004|Epoch 2|Adverse Event|0|||
130339968|NCT02059291|469218057|FG005|Epoch 2|Adverse Event|0|||
130339969|NCT02059291|469218058|FG006|Epoch 2|Adverse Event|0|||
130339970|NCT02059291|469218059|FG007|Epoch 2|Adverse Event|1|||
130339971|NCT02059291|469218060|FG008|Epoch 2|Adverse Event|1|||
130672661|NCT00146770|470425652|FG001|Overall Study|Pregnancy|0|||
130339972|NCT02059291|469218061|FG009|Epoch 2|Adverse Event|0|||
130339973|NCT02059291|469218062|FG010|Epoch 2|Adverse Event|0|||
130339974|NCT02059291|469218063|FG011|Epoch 2|Adverse Event|0|||
130339975|NCT02059291|469218064|FG012|Epoch 2|Adverse Event|0|||
130339976|NCT02059291|469218065|FG013|Epoch 2|Adverse Event|0|||
130339977|NCT02059291|469218066|FG014|Epoch 2|Adverse Event|0|||
130339978|NCT02059291|469218067|FG015|Epoch 2|Adverse Event|0|||
130339979|NCT02059291|469218068|FG016|Epoch 2|Adverse Event|0|||
130339980|NCT02059291|469218069|FG017|Epoch 2|Adverse Event|0|||
130339981|NCT02059291|469218070|FG018|Epoch 2|Adverse Event|0|||
130339982|NCT02059291|469218071|FG019|Epoch 2|Adverse Event|0|||
130339983|NCT02059291|469218072|FG020|Epoch 2|Adverse Event|0|||
130339984|NCT02059291|469218073|FG021|Epoch 2|Adverse Event|0|||
130339985|NCT02059291|469218074|FG022|Epoch 2|Adverse Event|0|||
130339986|NCT02059291|469218075|FG023|Epoch 2|Adverse Event|0|||
130339987|NCT02059291|469218076|FG024|Epoch 2|Adverse Event|0|||
130339988|NCT02059291|469218052|FG000|Epoch 2|Withdrawal by Subject|0|||
130339989|NCT02059291|469218053|FG001|Epoch 2|Withdrawal by Subject|1|||
130672662|NCT00146770|470425651|FG000|Overall Study|Withdrawal by Subject|2|||
130339990|NCT02059291|469218054|FG002|Epoch 2|Withdrawal by Subject|0|||
130339991|NCT02059291|469218055|FG003|Epoch 2|Withdrawal by Subject|0|||
130339992|NCT02059291|469218056|FG004|Epoch 2|Withdrawal by Subject|0|||
130339993|NCT02059291|469218057|FG005|Epoch 2|Withdrawal by Subject|1|||
130339994|NCT02059291|469218058|FG006|Epoch 2|Withdrawal by Subject|0|||
130339995|NCT02059291|469218059|FG007|Epoch 2|Withdrawal by Subject|0|||
130339996|NCT02059291|469218060|FG008|Epoch 2|Withdrawal by Subject|1|||
130339997|NCT02059291|469218061|FG009|Epoch 2|Withdrawal by Subject|0|||
130339998|NCT02059291|469218062|FG010|Epoch 2|Withdrawal by Subject|0|||
130339999|NCT02059291|469218063|FG011|Epoch 2|Withdrawal by Subject|0|||
130340000|NCT02059291|469218064|FG012|Epoch 2|Withdrawal by Subject|0|||
130340001|NCT02059291|469218065|FG013|Epoch 2|Withdrawal by Subject|0|||
130340002|NCT02059291|469218066|FG014|Epoch 2|Withdrawal by Subject|0|||
130340003|NCT02059291|469218067|FG015|Epoch 2|Withdrawal by Subject|0|||
130340004|NCT02059291|469218068|FG016|Epoch 2|Withdrawal by Subject|0|||
130340005|NCT02059291|469218069|FG017|Epoch 2|Withdrawal by Subject|0|||
130340006|NCT02059291|469218070|FG018|Epoch 2|Withdrawal by Subject|0|||
130340007|NCT02059291|469218071|FG019|Epoch 2|Withdrawal by Subject|0|||
130340008|NCT02059291|469218072|FG020|Epoch 2|Withdrawal by Subject|0|||
130340009|NCT02059291|469218073|FG021|Epoch 2|Withdrawal by Subject|0|||
130340010|NCT02059291|469218074|FG022|Epoch 2|Withdrawal by Subject|0|||
130340011|NCT02059291|469218075|FG023|Epoch 2|Withdrawal by Subject|0|||
130340012|NCT02059291|469218076|FG024|Epoch 2|Withdrawal by Subject|0|||
130340013|NCT02059291|469218052|FG000|Epoch 3|Physician Decision|0|||
130340014|NCT02059291|469218053|FG001|Epoch 3|Physician Decision|0|||
130340015|NCT02059291|469218054|FG002|Epoch 3|Physician Decision|0|||
130340016|NCT02059291|469218055|FG003|Epoch 3|Physician Decision|0|||
130340017|NCT02059291|469218056|FG004|Epoch 3|Physician Decision|0|||
130340018|NCT02059291|469218057|FG005|Epoch 3|Physician Decision|0|||
130340019|NCT02059291|469218058|FG006|Epoch 3|Physician Decision|0|||
130340020|NCT02059291|469218059|FG007|Epoch 3|Physician Decision|0|||
130340021|NCT02059291|469218060|FG008|Epoch 3|Physician Decision|0|||
130340022|NCT02059291|469218061|FG009|Epoch 3|Physician Decision|0|||
130340023|NCT02059291|469218062|FG010|Epoch 3|Physician Decision|0|||
130340024|NCT02059291|469218063|FG011|Epoch 3|Physician Decision|0|||
130340025|NCT02059291|469218064|FG012|Epoch 3|Physician Decision|0|||
130340026|NCT02059291|469218065|FG013|Epoch 3|Physician Decision|1|||
130340027|NCT02059291|469218066|FG014|Epoch 3|Physician Decision|0|||
130340028|NCT02059291|469218067|FG015|Epoch 3|Physician Decision|1|||
130340029|NCT02059291|469218068|FG016|Epoch 3|Physician Decision|0|||
130340030|NCT02059291|469218069|FG017|Epoch 3|Physician Decision|0|||
130340031|NCT02059291|469218070|FG018|Epoch 3|Physician Decision|0|||
130672663|NCT00146770|470425652|FG001|Overall Study|Withdrawal by Subject|0|||
130672664|NCT01070394|470425654|FG000|Overall Study|Adverse Event|6|||
130672665|NCT01070394|470425654|FG000|Overall Study|Withdrawal by Subject|1|||
130672666|NCT01098240|470425655|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
130672667|NCT01098240|470425656|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
130672668|NCT01098240|470425657|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
130672669|NCT01098240|470425655|FG000|Open-Label Phase|Protocol Violation|4|||
130672670|NCT01098240|470425656|FG001|Open-Label Phase|Protocol Violation|0|||
130672671|NCT01098240|470425657|FG002|Open-Label Phase|Protocol Violation|0|||
130672672|NCT01098240|470425655|FG000|Open-Label Phase|Lost to Follow-up|13|||
130672673|NCT01098240|470425656|FG001|Open-Label Phase|Lost to Follow-up|0|||
130672674|NCT01098240|470425657|FG002|Open-Label Phase|Lost to Follow-up|0|||
130672675|NCT01098240|470425655|FG000|Open-Label Phase|Other|19|||
130672676|NCT01098240|470425656|FG001|Open-Label Phase|Other|0|||
130672677|NCT01098240|470425657|FG002|Open-Label Phase|Other|0|||
130672678|NCT01098240|470425655|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
130672679|NCT01098240|470425656|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130672680|NCT01098240|470425657|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130672681|NCT01098240|470425655|FG000|Open-Label Phase|Pregnancy|1|||
130672682|NCT01098240|470425656|FG001|Open-Label Phase|Pregnancy|0|||
130672683|NCT01098240|470425657|FG002|Open-Label Phase|Pregnancy|0|||
130672684|NCT01098240|470425655|FG000|Open-Label Phase|Withdrawal by Subject|9|||
130340032|NCT02059291|469218071|FG019|Epoch 3|Physician Decision|0|||
130340033|NCT02059291|469218072|FG020|Epoch 3|Physician Decision|0|||
130340034|NCT02059291|469218073|FG021|Epoch 3|Physician Decision|0|||
130340035|NCT02059291|469218074|FG022|Epoch 3|Physician Decision|0|||
130340036|NCT02059291|469218075|FG023|Epoch 3|Physician Decision|0|||
130340037|NCT02059291|469218076|FG024|Epoch 3|Physician Decision|0|||
130340038|NCT02059291|469218052|FG000|Epoch 3|Adverse Event|0|||
130340039|NCT02059291|469218053|FG001|Epoch 3|Adverse Event|0|||
130340040|NCT02059291|469218054|FG002|Epoch 3|Adverse Event|0|||
130340041|NCT02059291|469218055|FG003|Epoch 3|Adverse Event|0|||
130340042|NCT02059291|469218056|FG004|Epoch 3|Adverse Event|0|||
130340043|NCT02059291|469218057|FG005|Epoch 3|Adverse Event|0|||
130340044|NCT02059291|469218058|FG006|Epoch 3|Adverse Event|0|||
130340045|NCT02059291|469218059|FG007|Epoch 3|Adverse Event|0|||
130340046|NCT02059291|469218060|FG008|Epoch 3|Adverse Event|0|||
130340047|NCT02059291|469218061|FG009|Epoch 3|Adverse Event|0|||
130672685|NCT01098240|470425656|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130672686|NCT01098240|470425657|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130672687|NCT01098240|470425655|FG000|Open-Label Phase|Adverse Event|12|||
130340048|NCT02059291|469218062|FG010|Epoch 3|Adverse Event|0|||
130340049|NCT02059291|469218063|FG011|Epoch 3|Adverse Event|0|||
130340050|NCT02059291|469218064|FG012|Epoch 3|Adverse Event|0|||
130340051|NCT02059291|469218065|FG013|Epoch 3|Adverse Event|0|||
130672688|NCT01098240|470425656|FG001|Open-Label Phase|Adverse Event|0|||
130672689|NCT01098240|470425657|FG002|Open-Label Phase|Adverse Event|0|||
130672690|NCT01098240|470425655|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
130672691|NCT01098240|470425656|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
130672692|NCT01098240|470425657|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
130672693|NCT01098240|470425655|FG000|Double-Blind Phase|Protocol Violation|0|||
130672694|NCT01098240|470425656|FG001|Double-Blind Phase|Protocol Violation|2|||
130672695|NCT01098240|470425657|FG002|Double-Blind Phase|Protocol Violation|4|||
130672696|NCT01098240|470425655|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130672697|NCT01098240|470425656|FG001|Double-Blind Phase|Lost to Follow-up|2|||
130672698|NCT01098240|470425657|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130672699|NCT01098240|470425655|FG000|Double-Blind Phase|Other|0|||
130672700|NCT01098240|470425656|FG001|Double-Blind Phase|Other|2|||
130672701|NCT01098240|470425657|FG002|Double-Blind Phase|Other|2|||
130672702|NCT01098240|470425655|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
130672703|NCT01098240|470425656|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
130672704|NCT01098240|470425657|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
130672705|NCT01098240|470425655|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
130672706|NCT01098240|470425656|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
130672707|NCT01098240|470425657|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
130672708|NCT01098240|470425655|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130672709|NCT01098240|470425656|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130672710|NCT01098240|470425657|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
130672711|NCT01098240|470425655|FG000|Double-Blind Phase|Adverse Event|0|||
130672712|NCT01098240|470425656|FG001|Double-Blind Phase|Adverse Event|3|||
130672713|NCT01098240|470425657|FG002|Double-Blind Phase|Adverse Event|3|||
130672714|NCT03280537|470425658|FG000|Overall Study|Withdrawal by Subject|2|||
130672715|NCT03280537|470425659|FG001|Overall Study|Withdrawal by Subject|4|||
130672716|NCT03083132|470425660|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
130672717|NCT03083132|470425661|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
130672718|NCT03083132|470425660|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
130672719|NCT03083132|470425661|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
130672720|NCT03083132|470425660|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
130672721|NCT03083132|470425661|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
130672722|NCT01588106|470425662|FG000|Overall Study|Withdrawal by Subject|5|||
130672723|NCT01588106|470425663|FG001|Overall Study|Withdrawal by Subject|4|||
130672724|NCT03118739|470425664|FG000|Overall Study|Physician Decision|0|||
130672725|NCT03118739|470425665|FG001|Overall Study|Physician Decision|1|||
130672726|NCT03118739|470425664|FG000|Overall Study|Withdrawal by Subject|5|||
130672727|NCT03118739|470425665|FG001|Overall Study|Withdrawal by Subject|3|||
130672728|NCT03118739|470425664|FG000|Overall Study|Lost to Follow-up|2|||
130672729|NCT03118739|470425665|FG001|Overall Study|Lost to Follow-up|0|||
130672730|NCT00669955|470425666|FG000|Overall Study|Adverse Event|3|||
130672731|NCT00669955|470425667|FG001|Overall Study|Adverse Event|5|||
130216490|NCT00423813|468755578|FG000|Overall Study|Will start exclusionary medications|0|||
130216491|NCT00423813|468755579|FG001|Overall Study|Will start exclusionary medications|1|||
130216492|NCT00423813|468755580|FG002|Overall Study|Will start exclusionary medications|0|||
130216493|NCT00423813|468755578|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130216494|NCT00423813|468755579|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130216495|NCT00423813|468755580|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
130216496|NCT01386944|468755582|FG000|Overall Study|Adverse Event|26|||
130216497|NCT01386944|468755582|FG000|Overall Study|Lack of Efficacy|14|||
130216498|NCT01386944|468755582|FG000|Overall Study|Lost to Follow-up|8|||
130216499|NCT01386944|468755582|FG000|Overall Study|Unspecified reason|8|||
130216500|NCT03853291|468755583|FG000|Overall Study|Lost to Follow-up|1|||
130216501|NCT03853291|468755584|FG001|Overall Study|Lost to Follow-up|2|||
130216502|NCT03853291|468755585|FG002|Overall Study|Lost to Follow-up|0|||
130216503|NCT03853291|468755586|FG003|Overall Study|Lost to Follow-up|0|||
130216504|NCT03853291|468755587|FG004|Overall Study|Lost to Follow-up|0|||
130216505|NCT03853291|468755588|FG005|Overall Study|Lost to Follow-up|0|||
130216506|NCT03853291|468755583|FG000|Overall Study|Determined to be ineligible|1|||
130216507|NCT03853291|468755584|FG001|Overall Study|Determined to be ineligible|1|||
130216508|NCT03853291|468755585|FG002|Overall Study|Determined to be ineligible|0|||
130216509|NCT03853291|468755586|FG003|Overall Study|Determined to be ineligible|0|||
130216510|NCT03853291|468755587|FG004|Overall Study|Determined to be ineligible|0|||
130216511|NCT03853291|468755588|FG005|Overall Study|Determined to be ineligible|0|||
130216512|NCT03883477|468755589|FG000|Overall Study|Death|1|||
130216513|NCT03883477|468755590|FG001|Overall Study|Death|0|||
130340052|NCT02059291|469218066|FG014|Epoch 3|Adverse Event|0|||
130672732|NCT00669955|470425666|FG000|Overall Study|Death|0|||
130672733|NCT00669955|470425667|FG001|Overall Study|Death|1|||
130672734|NCT00669955|470425666|FG000|Overall Study|Withdrawal by Subject|2|||
130672735|NCT00669955|470425667|FG001|Overall Study|Withdrawal by Subject|3|||
130672736|NCT00669955|470425666|FG000|Overall Study|Lost to Follow-up|5|||
130672737|NCT00669955|470425667|FG001|Overall Study|Lost to Follow-up|7|||
130672738|NCT00669955|470425666|FG000|Overall Study|Protocol Violation|2|||
130672739|NCT00669955|470425667|FG001|Overall Study|Protocol Violation|7|||
130672740|NCT00669955|470425666|FG000|Overall Study|Investigator Sponsor Judgement|0|||
130672741|NCT00669955|470425667|FG001|Overall Study|Investigator Sponsor Judgement|1|||
130672742|NCT00669955|470425666|FG000|Overall Study|not compliant with study drug/visit|2|||
130672743|NCT00669955|470425667|FG001|Overall Study|not compliant with study drug/visit|3|||
130672744|NCT03507439|470425671|FG000|Overall Study|Other|2|||
130672745|NCT03507439|470425672|FG001|Overall Study|Other|1|||
130672746|NCT03507439|470425671|FG000|Overall Study|Withdrawal by Subject|1|||
130672747|NCT03507439|470425672|FG001|Overall Study|Withdrawal by Subject|0|||
130672748|NCT03507439|470425671|FG000|Overall Study|Death|1|||
130672749|NCT03507439|470425672|FG001|Overall Study|Death|1|||
130672750|NCT04274192|470425673|FG000|Overall Study|Protocol Violation|1|||
130340053|NCT02059291|469218067|FG015|Epoch 3|Adverse Event|1|||
130340054|NCT02059291|469218068|FG016|Epoch 3|Adverse Event|0|||
130340055|NCT02059291|469218069|FG017|Epoch 3|Adverse Event|0|||
130340056|NCT02059291|469218070|FG018|Epoch 3|Adverse Event|0|||
130340057|NCT02059291|469218071|FG019|Epoch 3|Adverse Event|0|||
130340058|NCT02059291|469218072|FG020|Epoch 3|Adverse Event|0|||
130340059|NCT02059291|469218073|FG021|Epoch 3|Adverse Event|0|||
130340060|NCT02059291|469218074|FG022|Epoch 3|Adverse Event|0|||
130340061|NCT02059291|469218075|FG023|Epoch 3|Adverse Event|0|||
130340062|NCT02059291|469218076|FG024|Epoch 3|Adverse Event|0|||
130340063|NCT02059291|469218052|FG000|Epoch 3|Lack of Efficacy|0|||
130340064|NCT02059291|469218053|FG001|Epoch 3|Lack of Efficacy|0|||
130340065|NCT02059291|469218054|FG002|Epoch 3|Lack of Efficacy|0|||
130340066|NCT02059291|469218055|FG003|Epoch 3|Lack of Efficacy|0|||
130340067|NCT02059291|469218056|FG004|Epoch 3|Lack of Efficacy|0|||
130340068|NCT02059291|469218057|FG005|Epoch 3|Lack of Efficacy|0|||
130340069|NCT02059291|469218058|FG006|Epoch 3|Lack of Efficacy|0|||
130340070|NCT02059291|469218059|FG007|Epoch 3|Lack of Efficacy|0|||
130340071|NCT02059291|469218060|FG008|Epoch 3|Lack of Efficacy|0|||
130340072|NCT02059291|469218061|FG009|Epoch 3|Lack of Efficacy|0|||
130340073|NCT02059291|469218062|FG010|Epoch 3|Lack of Efficacy|0|||
130340074|NCT02059291|469218063|FG011|Epoch 3|Lack of Efficacy|0|||
130340075|NCT02059291|469218064|FG012|Epoch 3|Lack of Efficacy|0|||
130340076|NCT02059291|469218065|FG013|Epoch 3|Lack of Efficacy|0|||
130340077|NCT02059291|469218066|FG014|Epoch 3|Lack of Efficacy|0|||
130340078|NCT02059291|469218067|FG015|Epoch 3|Lack of Efficacy|3|||
130340079|NCT02059291|469218068|FG016|Epoch 3|Lack of Efficacy|0|||
130340080|NCT02059291|469218069|FG017|Epoch 3|Lack of Efficacy|0|||
130340081|NCT02059291|469218070|FG018|Epoch 3|Lack of Efficacy|0|||
130340082|NCT02059291|469218071|FG019|Epoch 3|Lack of Efficacy|0|||
130340083|NCT02059291|469218072|FG020|Epoch 3|Lack of Efficacy|0|||
130340084|NCT02059291|469218073|FG021|Epoch 3|Lack of Efficacy|0|||
130340085|NCT02059291|469218074|FG022|Epoch 3|Lack of Efficacy|0|||
130340086|NCT02059291|469218075|FG023|Epoch 3|Lack of Efficacy|0|||
130340087|NCT02059291|469218076|FG024|Epoch 3|Lack of Efficacy|0|||
130340088|NCT02059291|469218052|FG000|Epoch 3|Withdrawal by Subject|0|||
130340089|NCT02059291|469218053|FG001|Epoch 3|Withdrawal by Subject|0|||
130340090|NCT02059291|469218054|FG002|Epoch 3|Withdrawal by Subject|0|||
130340091|NCT02059291|469218055|FG003|Epoch 3|Withdrawal by Subject|0|||
130340092|NCT02059291|469218056|FG004|Epoch 3|Withdrawal by Subject|0|||
130340093|NCT02059291|469218057|FG005|Epoch 3|Withdrawal by Subject|0|||
130340094|NCT02059291|469218058|FG006|Epoch 3|Withdrawal by Subject|0|||
130340095|NCT02059291|469218059|FG007|Epoch 3|Withdrawal by Subject|0|||
130340096|NCT02059291|469218060|FG008|Epoch 3|Withdrawal by Subject|0|||
130340097|NCT02059291|469218061|FG009|Epoch 3|Withdrawal by Subject|0|||
130340098|NCT02059291|469218062|FG010|Epoch 3|Withdrawal by Subject|0|||
130340099|NCT02059291|469218063|FG011|Epoch 3|Withdrawal by Subject|0|||
130340100|NCT02059291|469218064|FG012|Epoch 3|Withdrawal by Subject|0|||
130340101|NCT02059291|469218065|FG013|Epoch 3|Withdrawal by Subject|0|||
130340102|NCT02059291|469218066|FG014|Epoch 3|Withdrawal by Subject|0|||
130672751|NCT04274192|470425674|FG001|Overall Study|Protocol Violation|0|||
130340103|NCT02059291|469218067|FG015|Epoch 3|Withdrawal by Subject|1|||
130340104|NCT02059291|469218068|FG016|Epoch 3|Withdrawal by Subject|0|||
130340105|NCT02059291|469218069|FG017|Epoch 3|Withdrawal by Subject|0|||
130340106|NCT02059291|469218070|FG018|Epoch 3|Withdrawal by Subject|0|||
130340107|NCT02059291|469218071|FG019|Epoch 3|Withdrawal by Subject|0|||
130340108|NCT02059291|469218072|FG020|Epoch 3|Withdrawal by Subject|0|||
130340109|NCT02059291|469218073|FG021|Epoch 3|Withdrawal by Subject|0|||
130340110|NCT02059291|469218074|FG022|Epoch 3|Withdrawal by Subject|0|||
130340111|NCT02059291|469218075|FG023|Epoch 3|Withdrawal by Subject|0|||
130340112|NCT02059291|469218076|FG024|Epoch 3|Withdrawal by Subject|0|||
130340113|NCT02059291|469218052|FG000|Epoch 4|Adverse Event|0|||
130340114|NCT02059291|469218053|FG001|Epoch 4|Adverse Event|0|||
130672752|NCT04527471|470427338|FG000|Overall Study|Adverse Event|1|||
130672753|NCT04527471|470427339|FG001|Overall Study|Adverse Event|0|||
130340115|NCT02059291|469218054|FG002|Epoch 4|Adverse Event|0|||
130340116|NCT02059291|469218055|FG003|Epoch 4|Adverse Event|0|||
130340117|NCT02059291|469218056|FG004|Epoch 4|Adverse Event|0|||
130340118|NCT02059291|469218057|FG005|Epoch 4|Adverse Event|0|||
130340119|NCT02059291|469218058|FG006|Epoch 4|Adverse Event|0|||
130340120|NCT02059291|469218059|FG007|Epoch 4|Adverse Event|0|||
130340121|NCT02059291|469218060|FG008|Epoch 4|Adverse Event|0|||
130340122|NCT02059291|469218061|FG009|Epoch 4|Adverse Event|0|||
130340123|NCT02059291|469218062|FG010|Epoch 4|Adverse Event|0|||
130340124|NCT02059291|469218063|FG011|Epoch 4|Adverse Event|0|||
130340125|NCT02059291|469218064|FG012|Epoch 4|Adverse Event|0|||
130340126|NCT02059291|469218065|FG013|Epoch 4|Adverse Event|0|||
130340127|NCT02059291|469218066|FG014|Epoch 4|Adverse Event|0|||
130340128|NCT02059291|469218067|FG015|Epoch 4|Adverse Event|0|||
130340129|NCT02059291|469218068|FG016|Epoch 4|Adverse Event|1|||
130340130|NCT02059291|469218069|FG017|Epoch 4|Adverse Event|0|||
130340131|NCT02059291|469218070|FG018|Epoch 4|Adverse Event|0|||
130340132|NCT02059291|469218071|FG019|Epoch 4|Adverse Event|0|||
130340133|NCT02059291|469218072|FG020|Epoch 4|Adverse Event|0|||
130340134|NCT02059291|469218073|FG021|Epoch 4|Adverse Event|0|||
130340135|NCT02059291|469218074|FG022|Epoch 4|Adverse Event|1|||
130340136|NCT02059291|469218075|FG023|Epoch 4|Adverse Event|0|||
130340137|NCT02059291|469218076|FG024|Epoch 4|Adverse Event|0|||
130340138|NCT02059291|469218052|FG000|Epoch 4|Pregnancy|0|||
130340139|NCT02059291|469218053|FG001|Epoch 4|Pregnancy|0|||
130340140|NCT02059291|469218054|FG002|Epoch 4|Pregnancy|0|||
130672754|NCT04527471|470427338|FG000|Overall Study|Lost to Follow-up|1|||
130672755|NCT04527471|470427339|FG001|Overall Study|Lost to Follow-up|0|||
130672756|NCT00096265|470427347|FG000|Overall Study|Ineligible|1|||
130672757|NCT00096265|470427348|FG001|Overall Study|Ineligible|0|||
130672758|NCT00096265|470427349|FG002|Overall Study|Ineligible|0|||
130672759|NCT01506323|470427350|FG000|Overall Study|Lost to Follow-up|5|||
130672760|NCT01506323|470427351|FG001|Overall Study|Lost to Follow-up|4|||
130672761|NCT01506323|470427350|FG000|Overall Study|Withdrawal by Subject|4|||
130672762|NCT01506323|470427351|FG001|Overall Study|Withdrawal by Subject|4|||
130672763|NCT01506323|470427350|FG000|Overall Study|Lack of Efficacy|1|||
130672764|NCT01506323|470427351|FG001|Overall Study|Lack of Efficacy|3|||
130672765|NCT01506323|470427350|FG000|Overall Study|Moved out of area|5|||
130672766|NCT01506323|470427351|FG001|Overall Study|Moved out of area|2|||
130672767|NCT01506323|470427350|FG000|Overall Study|Schedule or Transportation conflict|8|||
130672768|NCT01506323|470427351|FG001|Overall Study|Schedule or Transportation conflict|0|||
130672769|NCT01506323|470427350|FG000|Overall Study|Started another treatment|1|||
130672770|NCT01506323|470427351|FG001|Overall Study|Started another treatment|0|||
130672771|NCT02891200|470427352|FG000|Overall Study|Lost to Follow-up|31|||
130672772|NCT02891200|470427353|FG001|Overall Study|Lost to Follow-up|36|||
130672773|NCT02891200|470427352|FG000|Overall Study|Death|10|||
130672774|NCT02891200|470427353|FG001|Overall Study|Death|9|||
130672775|NCT02891200|470427352|FG000|Overall Study|Withdrawal by Subject|1|||
130672776|NCT02891200|470427353|FG001|Overall Study|Withdrawal by Subject|4|||
130672777|NCT00444795|470427355|FG000|Overall Study|Not Treated|1|||
130672778|NCT00444795|470427355|FG000|Overall Study|Treated Prior to the Contract Date|2|||
130672779|NCT00988169|470427356|FG000|Overall Study|Withdrawal by Subject|1|||
130672780|NCT03083483|470427367|FG000|Overall Study|Adverse Event|1|||
130672781|NCT03083483|470427368|FG001|Overall Study|Adverse Event|1|||
130672782|NCT03083483|470427369|FG002|Overall Study|Adverse Event|1|||
130672783|NCT03083483|470427367|FG000|Overall Study|Lost to Follow-up|2|||
130672784|NCT03083483|470427368|FG001|Overall Study|Lost to Follow-up|1|||
130672785|NCT03083483|470427369|FG002|Overall Study|Lost to Follow-up|1|||
130672786|NCT03083483|470427367|FG000|Overall Study|technological issues|1|||
130672787|NCT03083483|470427368|FG001|Overall Study|technological issues|0|||
130672788|NCT03083483|470427369|FG002|Overall Study|technological issues|1|||
130672789|NCT02710071|470427370|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
130672790|NCT02710071|470427371|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
130672791|NCT02710071|470427370|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
130672792|NCT02710071|470427371|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
130340141|NCT02059291|469218055|FG003|Epoch 4|Pregnancy|0|||
130672793|NCT02637557|470427378|FG000|Overall Study|Adverse Event|3|||
130672794|NCT02637557|470427379|FG001|Overall Study|Adverse Event|1|||
130340142|NCT02059291|469218056|FG004|Epoch 4|Pregnancy|0|||
130340143|NCT02059291|469218057|FG005|Epoch 4|Pregnancy|0|||
130340144|NCT02059291|469218058|FG006|Epoch 4|Pregnancy|0|||
130672795|NCT02637557|470427380|FG002|Overall Study|Adverse Event|3|||
130672796|NCT02637557|470427381|FG003|Overall Study|Adverse Event|3|||
130340145|NCT02059291|469218059|FG007|Epoch 4|Pregnancy|0|||
130340146|NCT02059291|469218060|FG008|Epoch 4|Pregnancy|0|||
130340147|NCT02059291|469218061|FG009|Epoch 4|Pregnancy|0|||
130340148|NCT02059291|469218062|FG010|Epoch 4|Pregnancy|0|||
130340149|NCT02059291|469218063|FG011|Epoch 4|Pregnancy|0|||
130340150|NCT02059291|469218064|FG012|Epoch 4|Pregnancy|0|||
130672797|NCT02637557|470427378|FG000|Overall Study|Lost to Follow-up|1|||
130672798|NCT02637557|470427379|FG001|Overall Study|Lost to Follow-up|1|||
130672799|NCT02637557|470427380|FG002|Overall Study|Lost to Follow-up|0|||
130672800|NCT02637557|470427381|FG003|Overall Study|Lost to Follow-up|1|||
130340151|NCT02059291|469218065|FG013|Epoch 4|Pregnancy|0|||
130340152|NCT02059291|469218066|FG014|Epoch 4|Pregnancy|0|||
130340153|NCT02059291|469218067|FG015|Epoch 4|Pregnancy|0|||
130340154|NCT02059291|469218068|FG016|Epoch 4|Pregnancy|1|||
130340155|NCT02059291|469218069|FG017|Epoch 4|Pregnancy|0|||
130340156|NCT02059291|469218070|FG018|Epoch 4|Pregnancy|0|||
130340157|NCT02059291|469218071|FG019|Epoch 4|Pregnancy|0|||
130340158|NCT02059291|469218072|FG020|Epoch 4|Pregnancy|0|||
130340159|NCT02059291|469218073|FG021|Epoch 4|Pregnancy|0|||
130340160|NCT02059291|469218074|FG022|Epoch 4|Pregnancy|0|||
130340161|NCT02059291|469218075|FG023|Epoch 4|Pregnancy|0|||
130340162|NCT02059291|469218076|FG024|Epoch 4|Pregnancy|0|||
130340163|NCT02059291|469218052|FG000|Epoch 4|Withdrawal by Subject|0|||
130340164|NCT02059291|469218053|FG001|Epoch 4|Withdrawal by Subject|0|||
130340165|NCT02059291|469218054|FG002|Epoch 4|Withdrawal by Subject|0|||
130340166|NCT02059291|469218055|FG003|Epoch 4|Withdrawal by Subject|0|||
130340167|NCT02059291|469218056|FG004|Epoch 4|Withdrawal by Subject|0|||
130340168|NCT02059291|469218057|FG005|Epoch 4|Withdrawal by Subject|0|||
130340169|NCT02059291|469218058|FG006|Epoch 4|Withdrawal by Subject|0|||
130340170|NCT02059291|469218059|FG007|Epoch 4|Withdrawal by Subject|0|||
130340171|NCT02059291|469218060|FG008|Epoch 4|Withdrawal by Subject|0|||
130340172|NCT02059291|469218061|FG009|Epoch 4|Withdrawal by Subject|0|||
130340173|NCT02059291|469218062|FG010|Epoch 4|Withdrawal by Subject|0|||
130340174|NCT02059291|469218063|FG011|Epoch 4|Withdrawal by Subject|0|||
130340175|NCT02059291|469218064|FG012|Epoch 4|Withdrawal by Subject|0|||
130340176|NCT02059291|469218065|FG013|Epoch 4|Withdrawal by Subject|0|||
130340177|NCT02059291|469218066|FG014|Epoch 4|Withdrawal by Subject|0|||
130340178|NCT02059291|469218067|FG015|Epoch 4|Withdrawal by Subject|0|||
130340179|NCT02059291|469218068|FG016|Epoch 4|Withdrawal by Subject|0|||
130340180|NCT02059291|469218069|FG017|Epoch 4|Withdrawal by Subject|0|||
130340181|NCT02059291|469218070|FG018|Epoch 4|Withdrawal by Subject|0|||
130340182|NCT02059291|469218071|FG019|Epoch 4|Withdrawal by Subject|0|||
130340183|NCT02059291|469218072|FG020|Epoch 4|Withdrawal by Subject|1|||
130340184|NCT02059291|469218073|FG021|Epoch 4|Withdrawal by Subject|0|||
130340185|NCT02059291|469218074|FG022|Epoch 4|Withdrawal by Subject|0|||
130340186|NCT02059291|469218075|FG023|Epoch 4|Withdrawal by Subject|0|||
130340187|NCT02059291|469218076|FG024|Epoch 4|Withdrawal by Subject|0|||
130340188|NCT02059291|469218052|FG000|Epoch 4|Lack of Efficacy|0|||
130340189|NCT02059291|469218053|FG001|Epoch 4|Lack of Efficacy|0|||
130340190|NCT02059291|469218054|FG002|Epoch 4|Lack of Efficacy|0|||
130340191|NCT02059291|469218055|FG003|Epoch 4|Lack of Efficacy|0|||
130340192|NCT02059291|469218056|FG004|Epoch 4|Lack of Efficacy|0|||
130340193|NCT02059291|469218057|FG005|Epoch 4|Lack of Efficacy|0|||
130340194|NCT02059291|469218058|FG006|Epoch 4|Lack of Efficacy|0|||
130340195|NCT02059291|469218059|FG007|Epoch 4|Lack of Efficacy|0|||
130340196|NCT02059291|469218060|FG008|Epoch 4|Lack of Efficacy|0|||
130340197|NCT02059291|469218061|FG009|Epoch 4|Lack of Efficacy|0|||
130340198|NCT02059291|469218062|FG010|Epoch 4|Lack of Efficacy|0|||
130340199|NCT02059291|469218063|FG011|Epoch 4|Lack of Efficacy|0|||
130340200|NCT02059291|469218064|FG012|Epoch 4|Lack of Efficacy|0|||
130340201|NCT02059291|469218065|FG013|Epoch 4|Lack of Efficacy|0|||
130340202|NCT02059291|469218066|FG014|Epoch 4|Lack of Efficacy|0|||
130340203|NCT02059291|469218067|FG015|Epoch 4|Lack of Efficacy|0|||
130340204|NCT02059291|469218068|FG016|Epoch 4|Lack of Efficacy|0|||
130340205|NCT02059291|469218069|FG017|Epoch 4|Lack of Efficacy|0|||
130340206|NCT02059291|469218070|FG018|Epoch 4|Lack of Efficacy|0|||
130340207|NCT02059291|469218071|FG019|Epoch 4|Lack of Efficacy|0|||
130340208|NCT02059291|469218072|FG020|Epoch 4|Lack of Efficacy|0|||
130340209|NCT02059291|469218073|FG021|Epoch 4|Lack of Efficacy|0|||
130340210|NCT02059291|469218074|FG022|Epoch 4|Lack of Efficacy|0|||
130340211|NCT02059291|469218075|FG023|Epoch 4|Lack of Efficacy|1|||
130340212|NCT02059291|469218076|FG024|Epoch 4|Lack of Efficacy|0|||
130340213|NCT01433289|469218077|FG000|Overall Study|Pregnancy|0|||
130340214|NCT01433289|469218078|FG001|Overall Study|Pregnancy|1|||
130340215|NCT01433289|469218079|FG002|Overall Study|Pregnancy|0|||
130340216|NCT01433289|469218080|FG003|Overall Study|Pregnancy|0|||
130340217|NCT04343235|469218081|FG000|Overall Study|Lost to Follow-up|3|||
130340218|NCT04343235|469218082|FG001|Overall Study|Lost to Follow-up|2|||
130340219|NCT01763996|469218083|FG000|Treatment Period 2|Adverse Event|0|||
130340220|NCT01763996|469218084|FG001|Treatment Period 2|Adverse Event|1|||
130340221|NCT01788215|469218087|FG000|Overall Study|Withdrawal by Subject|0|||
130340222|NCT01788215|469218088|FG001|Overall Study|Withdrawal by Subject|1|||
130340223|NCT01788215|469218087|FG000|Overall Study|Lost to Follow-up|2|||
130340224|NCT01788215|469218088|FG001|Overall Study|Lost to Follow-up|0|||
130340225|NCT00275340|469218089|FG000|Overall Study|Lost to Follow-up|2|||
130340226|NCT00275340|469218090|FG001|Overall Study|Lost to Follow-up|4|||
130340227|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
130340228|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
130340229|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
130340230|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
130340231|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
130340232|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
130340233|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130340234|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130340235|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
130340236|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
130340237|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
130340238|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
130340239|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
130340240|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
130340241|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
130340242|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
130340243|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
130340244|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
130340245|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130340246|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130340247|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
130672801|NCT02637557|470427378|FG000|Overall Study|Physician Decision|1|||
130672802|NCT02637557|470427379|FG001|Overall Study|Physician Decision|0|||
130340248|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
130340249|NCT00612105|469218094|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
130340250|NCT00612105|469218095|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
130340251|NCT01105767|469218096|FG000|Overall Study|Lost to Follow-up|1160|||
130340252|NCT01105767|469218097|FG001|Overall Study|Lost to Follow-up|1614|||
130340253|NCT01105767|469218098|FG002|Overall Study|Lost to Follow-up|1184|||
130340254|NCT00743106|469218099|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
130340255|NCT00743106|469218100|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
130340256|NCT02674204|469218102|FG000|Overall Study|Adverse Event|1|||
130340257|NCT02674204|469218103|FG001|Overall Study|Adverse Event|0|||
130340258|NCT02874144|469218106|FG000|Overall Study|Lost to Follow-up|3|||
130340259|NCT02874144|469218107|FG001|Overall Study|Lost to Follow-up|5|||
130340260|NCT00486811|469218108|FG000|Overall Study|Adverse Event|28|||
130340261|NCT00486811|469218109|FG001|Overall Study|Adverse Event|60|||
130340262|NCT00486811|469218110|FG002|Overall Study|Adverse Event|135|||
130340263|NCT00486811|469218108|FG000|Overall Study|Lack of Efficacy|34|||
130340264|NCT00486811|469218109|FG001|Overall Study|Lack of Efficacy|14|||
130340265|NCT00486811|469218110|FG002|Overall Study|Lack of Efficacy|7|||
130340266|NCT00486811|469218108|FG000|Overall Study|Lost to Follow-up|4|||
130340267|NCT00486811|469218109|FG001|Overall Study|Lost to Follow-up|6|||
130340268|NCT00486811|469218110|FG002|Overall Study|Lost to Follow-up|4|||
130340269|NCT00486811|469218108|FG000|Overall Study|Withdrawal by Subject|33|||
130340270|NCT00486811|469218109|FG001|Overall Study|Withdrawal by Subject|44|||
130340271|NCT00486811|469218110|FG002|Overall Study|Withdrawal by Subject|58|||
130672803|NCT02637557|470427380|FG002|Overall Study|Physician Decision|0|||
130672804|NCT02637557|470427381|FG003|Overall Study|Physician Decision|0|||
130672805|NCT02637557|470427378|FG000|Overall Study|Protocol Violation|2|||
130672806|NCT02637557|470427379|FG001|Overall Study|Protocol Violation|0|||
130672807|NCT02637557|470427380|FG002|Overall Study|Protocol Violation|2|||
130672808|NCT02637557|470427381|FG003|Overall Study|Protocol Violation|1|||
130672809|NCT02637557|470427378|FG000|Overall Study|Withdrawal by Subject|1|||
130672810|NCT02637557|470427379|FG001|Overall Study|Withdrawal by Subject|3|||
130672811|NCT02637557|470427380|FG002|Overall Study|Withdrawal by Subject|4|||
130672812|NCT02637557|470427381|FG003|Overall Study|Withdrawal by Subject|2|||
130672813|NCT00613574|470427382|FG000|Overall Study|Adverse Event|3|||
130672814|NCT00613574|470427382|FG000|Overall Study|Lost to Follow-up|2|||
130672815|NCT00613574|470427382|FG000|Overall Study|Other|1|||
130672816|NCT04604184|470427389|FG000|Overall Study|Adverse Event|5|||
130672817|NCT04604184|470427390|FG001|Overall Study|Adverse Event|5|||
130672818|NCT04604184|470427389|FG000|Overall Study|Death|2|||
130672819|NCT04604184|470427390|FG001|Overall Study|Death|1|||
130672820|NCT04604184|470427389|FG000|Overall Study|Withdrawal by Subject|1|||
130672821|NCT04604184|470427390|FG001|Overall Study|Withdrawal by Subject|3|||
130672822|NCT04604184|470427389|FG000|Overall Study|Not treated|2|||
130672823|NCT04604184|470427390|FG001|Overall Study|Not treated|2|||
130672824|NCT04604184|470427389|FG000|Overall Study|Due to sponsor decision|9|||
130672825|NCT04604184|470427390|FG001|Overall Study|Due to sponsor decision|7|||
130340272|NCT00486811|469218108|FG000|Overall Study|Study drug non-compliant|5|||
130340273|NCT00486811|469218109|FG001|Overall Study|Study drug non-compliant|6|||
130340274|NCT00486811|469218110|FG002|Overall Study|Study drug non-compliant|3|||
130340275|NCT00486811|469218108|FG000|Overall Study|All other|18|||
130340276|NCT00486811|469218109|FG001|Overall Study|All other|11|||
130552748|NCT01072877|469991521|FG000|Overall Study|Lost to Follow-up|1|||
130672826|NCT04604184|470427389|FG000|Overall Study|Physician Decision|0|||
130672827|NCT04604184|470427390|FG001|Overall Study|Physician Decision|1|||
130672828|NCT04604184|470427389|FG000|Overall Study|Transfer to healthcare|1|||
130672829|NCT04604184|470427390|FG001|Overall Study|Transfer to healthcare|0|||
130672830|NCT01751412|470427391|FG000|Overall Study|Disease Progression Before Treatment|1|||
130216514|NCT03883477|468755589|FG000|Overall Study|Protocol Violation|0|||
130340277|NCT00486811|469218110|FG002|Overall Study|All other|7|||
130340278|NCT03753789|469218111|FG000|Overall Study|Withdrawal by Subject|2|||
130340279|NCT01578850|469218116|FG000|Period 1|Insufficient Clinical Response|1|||
130340280|NCT01578850|469218117|FG001|Period 1|Insufficient Clinical Response|0|||
130340281|NCT01578850|469218118|FG002|Period 1|Insufficient Clinical Response|0|||
130340282|NCT01578850|469218116|FG000|Period 1|Adverse Event|11|||
130340283|NCT01578850|469218117|FG001|Period 1|Adverse Event|0|||
130340284|NCT01578850|469218118|FG002|Period 1|Adverse Event|0|||
130340285|NCT01578850|469218116|FG000|Period 1|Death|1|||
130340286|NCT01578850|469218117|FG001|Period 1|Death|0|||
130340287|NCT01578850|469218118|FG002|Period 1|Death|0|||
130340288|NCT01578850|469218116|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
130340289|NCT01578850|469218117|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
130340290|NCT01578850|469218118|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
130340291|NCT01578850|469218116|FG000|Period 1|Withdrawal by Subject|9|||
130340292|NCT01578850|469218117|FG001|Period 1|Withdrawal by Subject|0|||
130340293|NCT01578850|469218118|FG002|Period 1|Withdrawal by Subject|0|||
130340294|NCT01578850|469218116|FG000|Period 1|Study Terminated by Sponsor|3|||
130340295|NCT01578850|469218117|FG001|Period 1|Study Terminated by Sponsor|0|||
130340296|NCT01578850|469218118|FG002|Period 1|Study Terminated by Sponsor|0|||
130340297|NCT01578850|469218116|FG000|Period 2|Insufficient Clinical Response|0|||
130340298|NCT01578850|469218117|FG001|Period 2|Insufficient Clinical Response|1|||
130340299|NCT01578850|469218118|FG002|Period 2|Insufficient Clinical Response|0|||
130340300|NCT01578850|469218116|FG000|Period 2|Adverse Event|0|||
130340301|NCT01578850|469218117|FG001|Period 2|Adverse Event|3|||
130340302|NCT01578850|469218118|FG002|Period 2|Adverse Event|6|||
130340303|NCT01578850|469218116|FG000|Period 2|Lost to Follow-up|0|||
130340304|NCT01578850|469218117|FG001|Period 2|Lost to Follow-up|1|||
130340305|NCT01578850|469218118|FG002|Period 2|Lost to Follow-up|2|||
130340306|NCT01578850|469218116|FG000|Period 2|Withdrawal by Subject|0|||
130340307|NCT01578850|469218117|FG001|Period 2|Withdrawal by Subject|2|||
130340308|NCT01578850|469218118|FG002|Period 2|Withdrawal by Subject|2|||
130340309|NCT01578850|469218116|FG000|Period 2|Study Terminated by Sponsor|0|||
130340310|NCT01578850|469218117|FG001|Period 2|Study Terminated by Sponsor|5|||
130340311|NCT01578850|469218118|FG002|Period 2|Study Terminated by Sponsor|4|||
130340312|NCT01578850|469218116|FG000|Period 2|Unspecified Reasons|0|||
130340313|NCT01578850|469218117|FG001|Period 2|Unspecified Reasons|1|||
130340314|NCT01578850|469218118|FG002|Period 2|Unspecified Reasons|0|||
130340315|NCT01711216|469218121|FG000|Overall Study|Adverse Event|4|||
130340316|NCT01711216|469218121|FG000|Overall Study|Pregnancy|56|||
130340317|NCT01711216|469218121|FG000|Overall Study|Withdrawal by Subject|6|||
130340318|NCT01711216|469218121|FG000|Overall Study|Lost to Follow-up|46|||
130340319|NCT01711216|469218121|FG000|Overall Study|variety of other minor reasons|83|||
130340320|NCT01711216|469218121|FG000|Overall Study|no reason specified|22|||
130340321|NCT02929498|469218122|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
130340322|NCT02929498|469218123|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130340323|NCT02929498|469218124|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130340324|NCT02929498|469218122|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
130340325|NCT02929498|469218123|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130340326|NCT02929498|469218124|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130340327|NCT02744040|469218125|FG000|Overall Study|Withdrawal by Subject|3|||
130340328|NCT02744040|469218126|FG001|Overall Study|Withdrawal by Subject|2|||
130340329|NCT02744040|469218127|FG002|Overall Study|Withdrawal by Subject|2|||
130340330|NCT02744040|469218125|FG000|Overall Study|Physician Decision|0|||
130340331|NCT02744040|469218126|FG001|Overall Study|Physician Decision|8|||
130340332|NCT02744040|469218127|FG002|Overall Study|Physician Decision|13|||
130340333|NCT02744040|469218125|FG000|Overall Study|Lost to Follow-up|3|||
130340334|NCT02744040|469218126|FG001|Overall Study|Lost to Follow-up|1|||
130340335|NCT02744040|469218127|FG002|Overall Study|Lost to Follow-up|7|||
130340336|NCT00096356|469218128|FG000|Overall Study|Adverse Event|11|||
130340337|NCT00096356|469218129|FG001|Overall Study|Adverse Event|9|||
130340338|NCT00096356|469218128|FG000|Overall Study|Physician Decision|5|||
130340339|NCT00096356|469218129|FG001|Overall Study|Physician Decision|3|||
130340340|NCT00096356|469218128|FG000|Overall Study|Withdrawal by Subject|17|||
130340341|NCT00096356|469218129|FG001|Overall Study|Withdrawal by Subject|23|||
130340342|NCT00096356|469218128|FG000|Overall Study|Lack of Efficacy|1|||
130340343|NCT00096356|469218129|FG001|Overall Study|Lack of Efficacy|0|||
130340344|NCT00096356|469218128|FG000|Overall Study|multiple reasons|10|||
130340345|NCT00096356|469218129|FG001|Overall Study|multiple reasons|18|||
130340346|NCT04002908|469218133|FG000|Overall Study|Death|41|||
130340347|NCT04002908|469218134|FG001|Overall Study|Death|0|||
130216515|NCT03883477|468755590|FG001|Overall Study|Protocol Violation|1|||
130340348|NCT04002908|469218135|FG002|Overall Study|Death|0|||
130340349|NCT04002908|469218136|FG003|Overall Study|Death|0|||
130340350|NCT04002908|469218133|FG000|Overall Study|Withdrawal by Subject|112|||
130340351|NCT04002908|469218134|FG001|Overall Study|Withdrawal by Subject|0|||
130340352|NCT04002908|469218135|FG002|Overall Study|Withdrawal by Subject|0|||
130340353|NCT04002908|469218136|FG003|Overall Study|Withdrawal by Subject|0|||
130340354|NCT04002908|469218133|FG000|Overall Study|Lost to Follow-up|72|||
130340355|NCT04002908|469218134|FG001|Overall Study|Lost to Follow-up|0|||
130340356|NCT04002908|469218135|FG002|Overall Study|Lost to Follow-up|0|||
130340357|NCT04002908|469218136|FG003|Overall Study|Lost to Follow-up|0|||
130340358|NCT04002908|469218133|FG000|Overall Study|Infant died, so mother withdrawn|34|||
130340359|NCT04002908|469218134|FG001|Overall Study|Infant died, so mother withdrawn|0|||
130340360|NCT04002908|469218135|FG002|Overall Study|Infant died, so mother withdrawn|0|||
130340361|NCT04002908|469218136|FG003|Overall Study|Infant died, so mother withdrawn|0|||
130340362|NCT04359901|469218141|FG000|Overall Study|Withdrawal by Subject|0|||
130340363|NCT04359901|469218142|FG001|Overall Study|Withdrawal by Subject|1|||
130340364|NCT04359901|469218141|FG000|Overall Study|Death|6|||
130340365|NCT04359901|469218142|FG001|Overall Study|Death|2|||
130340366|NCT05092360|469218143|FG000|Overall Study|Withdrawal by Subject|21|||
130340367|NCT05092360|469218144|FG001|Overall Study|Withdrawal by Subject|4|||
130340368|NCT05092360|469218145|FG002|Overall Study|Withdrawal by Subject|9|||
130340369|NCT05092360|469218146|FG003|Overall Study|Withdrawal by Subject|26|||
130340370|NCT05092360|469218143|FG000|Overall Study|Death|97|||
130340371|NCT05092360|469218144|FG001|Overall Study|Death|14|||
130340372|NCT05092360|469218145|FG002|Overall Study|Death|31|||
130340373|NCT05092360|469218146|FG003|Overall Study|Death|101|||
130340374|NCT05092360|469218143|FG000|Overall Study|Lost to Follow-up|1|||
130672831|NCT03734237|470427394|FG000|Overall Study|Lost to Follow-up|1|||
130672832|NCT03734237|470427395|FG001|Overall Study|Lost to Follow-up|3|||
130340375|NCT05092360|469218144|FG001|Overall Study|Lost to Follow-up|2|||
130340376|NCT05092360|469218145|FG002|Overall Study|Lost to Follow-up|2|||
130340377|NCT05092360|469218146|FG003|Overall Study|Lost to Follow-up|2|||
130340378|NCT05092360|469218143|FG000|Overall Study|Study terminated by sponsor|65|||
130340379|NCT05092360|469218144|FG001|Overall Study|Study terminated by sponsor|7|||
130340380|NCT05092360|469218145|FG002|Overall Study|Study terminated by sponsor|13|||
130340381|NCT05092360|469218146|FG003|Overall Study|Study terminated by sponsor|61|||
130340382|NCT01525225|469218149|FG000|Enrollment|No longer met study criteria|1|||
130340383|NCT01525225|469218149|FG000|Enrollment|Other|1|||
130340384|NCT00243841|469218150|FG000|Overall Study|Physician Decision|0|||
130340385|NCT00243841|469218151|FG001|Overall Study|Physician Decision|0|||
130340386|NCT00243841|469218152|FG002|Overall Study|Physician Decision|1|||
130340387|NCT00243841|469218153|FG003|Overall Study|Physician Decision|0|||
130340388|NCT00243841|469218154|FG004|Overall Study|Physician Decision|0|||
130340389|NCT00243841|469218155|FG005|Overall Study|Physician Decision|2|||
130340390|NCT00363545|469218156|FG000|Overall Study|Serious Adverse Event|0|||
130340391|NCT00363545|469218157|FG001|Overall Study|Serious Adverse Event|1|||
130672833|NCT03734237|470427396|FG002|Overall Study|Lost to Follow-up|0|||
130672834|NCT03734237|470427394|FG000|Overall Study|Withdrawal by Subject|7|||
130672835|NCT03734237|470427395|FG001|Overall Study|Withdrawal by Subject|9|||
130672836|NCT03734237|470427396|FG002|Overall Study|Withdrawal by Subject|10|||
130672837|NCT02711956|470427397|FG000|Overall Study|Adverse Event|0|||
130672838|NCT02711956|470427398|FG001|Overall Study|Adverse Event|0|||
130672839|NCT02711956|470427399|FG002|Overall Study|Adverse Event|0|||
130672840|NCT02711956|470427400|FG003|Overall Study|Adverse Event|1|||
130672841|NCT02711956|470427401|FG004|Overall Study|Adverse Event|2|||
130672842|NCT02711956|470427402|FG005|Overall Study|Adverse Event|0|||
130672843|NCT02711956|470427403|FG006|Overall Study|Adverse Event|0|||
130672844|NCT02711956|470427404|FG007|Overall Study|Adverse Event|1|||
130672845|NCT02711956|470427405|FG008|Overall Study|Adverse Event|1|||
130672846|NCT02711956|470427406|FG009|Overall Study|Adverse Event|1|||
130672847|NCT02711956|470427407|FG010|Overall Study|Adverse Event|1|||
130672848|NCT02711956|470427408|FG011|Overall Study|Adverse Event|0|||
130340392|NCT00363545|469218156|FG000|Overall Study|Withdrawal by Subject|12|||
130340393|NCT00363545|469218157|FG001|Overall Study|Withdrawal by Subject|15|||
130340394|NCT00363545|469218156|FG000|Overall Study|Migrated/moved from study area|3|||
130340395|NCT00363545|469218157|FG001|Overall Study|Migrated/moved from study area|6|||
130340396|NCT00363545|469218156|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
130340397|NCT00363545|469218157|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
130340398|NCT00363545|469218156|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
130340399|NCT00363545|469218157|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
130340400|NCT00363545|469218156|FG000|Overall Study|Others|1|||
130340401|NCT00363545|469218157|FG001|Overall Study|Others|0|||
130340402|NCT01379508|469218158|FG000|Treatment to Week 104|Adverse Event|2|||
130340403|NCT01379508|469218159|FG001|Treatment to Week 104|Adverse Event|0|||
130340404|NCT01379508|469218160|FG002|Treatment to Week 104|Adverse Event|5|||
130340405|NCT01379508|469218161|FG003|Treatment to Week 104|Adverse Event|0|||
130672849|NCT02711956|470427409|FG012|Overall Study|Adverse Event|0|||
130672850|NCT02711956|470427410|FG013|Overall Study|Adverse Event|0|||
130672851|NCT02711956|470427411|FG014|Overall Study|Adverse Event|2|||
130340406|NCT01379508|469218158|FG000|Treatment to Week 104|Abnormal lab value|1|||
130340407|NCT01379508|469218159|FG001|Treatment to Week 104|Abnormal lab value|0|||
130672852|NCT02711956|470427397|FG000|Overall Study|Physician Decision|0|||
130672853|NCT02711956|470427398|FG001|Overall Study|Physician Decision|0|||
130672854|NCT02711956|470427399|FG002|Overall Study|Physician Decision|0|||
130672855|NCT02711956|470427400|FG003|Overall Study|Physician Decision|2|||
130672856|NCT02711956|470427401|FG004|Overall Study|Physician Decision|0|||
130672857|NCT02711956|470427402|FG005|Overall Study|Physician Decision|0|||
130672858|NCT02711956|470427403|FG006|Overall Study|Physician Decision|0|||
130672859|NCT02711956|470427404|FG007|Overall Study|Physician Decision|0|||
130672860|NCT02711956|470427405|FG008|Overall Study|Physician Decision|0|||
130672861|NCT02711956|470427406|FG009|Overall Study|Physician Decision|0|||
130672862|NCT02711956|470427407|FG010|Overall Study|Physician Decision|0|||
130672863|NCT02711956|470427408|FG011|Overall Study|Physician Decision|0|||
130672864|NCT02711956|470427409|FG012|Overall Study|Physician Decision|0|||
130672865|NCT02711956|470427410|FG013|Overall Study|Physician Decision|0|||
130672866|NCT02711956|470427411|FG014|Overall Study|Physician Decision|0|||
130672867|NCT02711956|470427397|FG000|Overall Study|Withdrawal by Subject|0|||
130672868|NCT02711956|470427398|FG001|Overall Study|Withdrawal by Subject|0|||
130672869|NCT02711956|470427399|FG002|Overall Study|Withdrawal by Subject|0|||
130672870|NCT02711956|470427400|FG003|Overall Study|Withdrawal by Subject|0|||
130672871|NCT02711956|470427401|FG004|Overall Study|Withdrawal by Subject|0|||
130672872|NCT02711956|470427402|FG005|Overall Study|Withdrawal by Subject|0|||
130672873|NCT02711956|470427403|FG006|Overall Study|Withdrawal by Subject|1|||
130672874|NCT02711956|470427404|FG007|Overall Study|Withdrawal by Subject|0|||
130672875|NCT02711956|470427405|FG008|Overall Study|Withdrawal by Subject|0|||
130672876|NCT02711956|470427406|FG009|Overall Study|Withdrawal by Subject|0|||
130672877|NCT02711956|470427407|FG010|Overall Study|Withdrawal by Subject|0|||
130672878|NCT02711956|470427408|FG011|Overall Study|Withdrawal by Subject|1|||
130672879|NCT02711956|470427409|FG012|Overall Study|Withdrawal by Subject|6|||
130672880|NCT02711956|470427410|FG013|Overall Study|Withdrawal by Subject|0|||
130672881|NCT02711956|470427411|FG014|Overall Study|Withdrawal by Subject|1|||
130672882|NCT02711956|470427397|FG000|Overall Study|Clinical progression|1|||
130672883|NCT02711956|470427398|FG001|Overall Study|Clinical progression|0|||
130672884|NCT02711956|470427399|FG002|Overall Study|Clinical progression|0|||
130672885|NCT02711956|470427400|FG003|Overall Study|Clinical progression|0|||
130672886|NCT02711956|470427401|FG004|Overall Study|Clinical progression|0|||
130672887|NCT02711956|470427402|FG005|Overall Study|Clinical progression|0|||
130672888|NCT02711956|470427403|FG006|Overall Study|Clinical progression|1|||
130672889|NCT02711956|470427404|FG007|Overall Study|Clinical progression|0|||
130672890|NCT02711956|470427405|FG008|Overall Study|Clinical progression|1|||
130672891|NCT02711956|470427406|FG009|Overall Study|Clinical progression|0|||
130672892|NCT02711956|470427407|FG010|Overall Study|Clinical progression|0|||
130340408|NCT01379508|469218160|FG002|Treatment to Week 104|Abnormal lab value|0|||
130340409|NCT01379508|469218161|FG003|Treatment to Week 104|Abnormal lab value|0|||
130340410|NCT01379508|469218158|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
130340411|NCT01379508|469218159|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340412|NCT01379508|469218160|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340413|NCT01379508|469218161|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340414|NCT01379508|469218158|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
130340415|NCT01379508|469218159|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
130340416|NCT01379508|469218160|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
130340417|NCT01379508|469218161|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
130340418|NCT01379508|469218158|FG000|Treatment to Week 104|Lost to Follow-up|5|||
130340419|NCT01379508|469218159|FG001|Treatment to Week 104|Lost to Follow-up|0|||
130340420|NCT01379508|469218160|FG002|Treatment to Week 104|Lost to Follow-up|3|||
130340421|NCT01379508|469218161|FG003|Treatment to Week 104|Lost to Follow-up|0|||
130340422|NCT01379508|469218158|FG000|Treatment to Week 104|Administrative problems|3|||
130340423|NCT01379508|469218159|FG001|Treatment to Week 104|Administrative problems|1|||
130340424|NCT01379508|469218160|FG002|Treatment to Week 104|Administrative problems|0|||
130340425|NCT01379508|469218161|FG003|Treatment to Week 104|Administrative problems|0|||
130340426|NCT01379508|469218158|FG000|Treatment to Week 104|Protocol Violation|1|||
130340427|NCT01379508|469218159|FG001|Treatment to Week 104|Protocol Violation|1|||
130340428|NCT01379508|469218160|FG002|Treatment to Week 104|Protocol Violation|1|||
130340429|NCT01379508|469218161|FG003|Treatment to Week 104|Protocol Violation|0|||
130340430|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
130340431|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
130340432|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
130340433|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
130340434|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
130340435|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
130340436|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
130552749|NCT01072877|469991522|FG001|Overall Study|Lost to Follow-up|1|||
130672893|NCT02711956|470427408|FG011|Overall Study|Clinical progression|2|||
130672894|NCT02711956|470427409|FG012|Overall Study|Clinical progression|4|||
130672895|NCT02711956|470427410|FG013|Overall Study|Clinical progression|1|||
130672896|NCT02711956|470427411|FG014|Overall Study|Clinical progression|1|||
130672897|NCT02711956|470427397|FG000|Overall Study|Radiographic progression|1|||
130672898|NCT02711956|470427398|FG001|Overall Study|Radiographic progression|1|||
130672899|NCT02711956|470427399|FG002|Overall Study|Radiographic progression|2|||
130340437|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
130340438|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
130340439|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
130340440|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
130340441|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
130340442|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
130340443|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
130340444|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
130340445|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
130340446|NCT04236141|469219434|FG000|Overall Study|Death|18|||
130340447|NCT04236141|469219435|FG001|Overall Study|Death|10|||
130672900|NCT02711956|470427400|FG003|Overall Study|Radiographic progression|0|||
130672901|NCT02711956|470427401|FG004|Overall Study|Radiographic progression|1|||
130672902|NCT02711956|470427402|FG005|Overall Study|Radiographic progression|0|||
130672903|NCT02711956|470427403|FG006|Overall Study|Radiographic progression|0|||
130672904|NCT02711956|470427404|FG007|Overall Study|Radiographic progression|0|||
130340448|NCT04236141|469219434|FG000|Overall Study|Withdrawal by Participant|1|||
130340449|NCT04236141|469219435|FG001|Overall Study|Withdrawal by Participant|0|||
130340450|NCT04236141|469219434|FG000|Overall Study|Reason not Specified|1|||
130340451|NCT04236141|469219435|FG001|Overall Study|Reason not Specified|0|||
130340452|NCT04236141|469219434|FG000|Overall Study|Study terminated by Sponsor|8|||
130340453|NCT04236141|469219435|FG001|Overall Study|Study terminated by Sponsor|4|||
130340454|NCT01925131|469219436|FG000|Overall Study|Death|0|||
130340455|NCT01925131|469219437|FG001|Overall Study|Death|0|||
130340456|NCT01925131|469219438|FG002|Overall Study|Death|1|||
130340457|NCT01925131|469219439|FG003|Overall Study|Death|0|||
130340458|NCT01925131|469219440|FG004|Overall Study|Death|0|||
130340459|NCT01925131|469219441|FG005|Overall Study|Death|0|||
130340460|NCT01925131|469219436|FG000|Overall Study|Progression/Relapse|1|||
130340461|NCT01925131|469219437|FG001|Overall Study|Progression/Relapse|1|||
130340462|NCT01925131|469219438|FG002|Overall Study|Progression/Relapse|4|||
130340463|NCT01925131|469219439|FG003|Overall Study|Progression/Relapse|0|||
130340464|NCT01925131|469219440|FG004|Overall Study|Progression/Relapse|0|||
130340465|NCT01925131|469219441|FG005|Overall Study|Progression/Relapse|1|||
130672905|NCT02711956|470427405|FG008|Overall Study|Radiographic progression|2|||
130672906|NCT02711956|470427406|FG009|Overall Study|Radiographic progression|1|||
130672907|NCT02711956|470427407|FG010|Overall Study|Radiographic progression|0|||
130672908|NCT02711956|470427408|FG011|Overall Study|Radiographic progression|5|||
130672909|NCT02711956|470427409|FG012|Overall Study|Radiographic progression|3|||
130672910|NCT02711956|470427410|FG013|Overall Study|Radiographic progression|0|||
130672911|NCT02711956|470427411|FG014|Overall Study|Radiographic progression|1|||
130672912|NCT02711956|470427397|FG000|Overall Study|PSA progression with clinical progression|0|||
130672913|NCT02711956|470427398|FG001|Overall Study|PSA progression with clinical progression|0|||
130672914|NCT02711956|470427399|FG002|Overall Study|PSA progression with clinical progression|0|||
130672915|NCT02711956|470427400|FG003|Overall Study|PSA progression with clinical progression|0|||
130672916|NCT02711956|470427401|FG004|Overall Study|PSA progression with clinical progression|1|||
130672917|NCT02711956|470427402|FG005|Overall Study|PSA progression with clinical progression|0|||
130672918|NCT02711956|470427403|FG006|Overall Study|PSA progression with clinical progression|0|||
130672919|NCT02711956|470427404|FG007|Overall Study|PSA progression with clinical progression|0|||
130672920|NCT02711956|470427405|FG008|Overall Study|PSA progression with clinical progression|0|||
130672921|NCT02711956|470427406|FG009|Overall Study|PSA progression with clinical progression|0|||
130672922|NCT02711956|470427407|FG010|Overall Study|PSA progression with clinical progression|0|||
130672923|NCT02711956|470427408|FG011|Overall Study|PSA progression with clinical progression|0|||
130672924|NCT02711956|470427409|FG012|Overall Study|PSA progression with clinical progression|1|||
130672925|NCT02711956|470427410|FG013|Overall Study|PSA progression with clinical progression|1|||
130340466|NCT01925131|469219436|FG000|Overall Study|Patient Refusal|1|||
130340467|NCT01925131|469219437|FG001|Overall Study|Patient Refusal|0|||
130340468|NCT01925131|469219438|FG002|Overall Study|Patient Refusal|0|||
130340469|NCT01925131|469219439|FG003|Overall Study|Patient Refusal|0|||
130340470|NCT01925131|469219440|FG004|Overall Study|Patient Refusal|0|||
130340471|NCT01925131|469219441|FG005|Overall Study|Patient Refusal|0|||
130340472|NCT01925131|469219436|FG000|Overall Study|Adverse Event|0|||
130340473|NCT01925131|469219437|FG001|Overall Study|Adverse Event|0|||
130340474|NCT01925131|469219438|FG002|Overall Study|Adverse Event|2|||
130340475|NCT01925131|469219439|FG003|Overall Study|Adverse Event|0|||
130340476|NCT01925131|469219440|FG004|Overall Study|Adverse Event|1|||
130340477|NCT01925131|469219441|FG005|Overall Study|Adverse Event|3|||
130340478|NCT01925131|469219436|FG000|Overall Study|Other - Not Protocol Specified|3|||
130340479|NCT01925131|469219437|FG001|Overall Study|Other - Not Protocol Specified|1|||
130340480|NCT01925131|469219438|FG002|Overall Study|Other - Not Protocol Specified|2|||
130340481|NCT01925131|469219439|FG003|Overall Study|Other - Not Protocol Specified|5|||
130340482|NCT01925131|469219440|FG004|Overall Study|Other - Not Protocol Specified|10|||
130672926|NCT02711956|470427411|FG014|Overall Study|PSA progression with clinical progression|0|||
130672927|NCT02711956|470427397|FG000|Overall Study|PSA progression with radiographic progression|0|||
130340483|NCT01925131|469219441|FG005|Overall Study|Other - Not Protocol Specified|6|||
130340484|NCT01696929|469219442|FG000|Overall Study|Physician Decision|1|||
130340485|NCT01794338|469219443|FG000|Overall Study|Death|2|||
130340486|NCT01794338|469219444|FG001|Overall Study|Death|0|||
130340487|NCT01794338|469219443|FG000|Overall Study|Lost to Follow-up|6|||
130340488|NCT01794338|469219444|FG001|Overall Study|Lost to Follow-up|9|||
130340489|NCT01954927|469219445|FG000|Overall Study|Withdrawal by Subject|3|||
130340490|NCT01954927|469219446|FG001|Overall Study|Withdrawal by Subject|1|||
130340491|NCT00955305|469219447|FG000|Overall Study|Disease progression|39|||
130340492|NCT00955305|469219448|FG001|Overall Study|Disease progression|41|||
130340493|NCT00955305|469219447|FG000|Overall Study|Adverse Event|22|||
130340494|NCT00955305|469219448|FG001|Overall Study|Adverse Event|22|||
130340495|NCT00955305|469219447|FG000|Overall Study|Death|2|||
130340496|NCT00955305|469219448|FG001|Overall Study|Death|1|||
130340497|NCT00955305|469219447|FG000|Overall Study|Withdrawal by Subject|5|||
130340498|NCT00955305|469219448|FG001|Overall Study|Withdrawal by Subject|4|||
130340499|NCT00955305|469219447|FG000|Overall Study|Alternative therapy|4|||
130340500|NCT00955305|469219448|FG001|Overall Study|Alternative therapy|0|||
130340501|NCT00955305|469219447|FG000|Overall Study|Other complicating disease|2|||
130340502|NCT00955305|469219448|FG001|Overall Study|Other complicating disease|4|||
130340503|NCT00955305|469219447|FG000|Overall Study|Physician Decision|1|||
130340504|NCT00955305|469219448|FG001|Overall Study|Physician Decision|0|||
130340505|NCT00955305|469219447|FG000|Overall Study|Continued presence of residual disease|0|||
130340506|NCT00955305|469219448|FG001|Overall Study|Continued presence of residual disease|1|||
130340507|NCT00955305|469219447|FG000|Overall Study|Functional decline|2|||
130340508|NCT00955305|469219448|FG001|Overall Study|Functional decline|0|||
130340509|NCT00955305|469219447|FG000|Overall Study|Maximum response achieved|0|||
130340510|NCT00955305|469219448|FG001|Overall Study|Maximum response achieved|1|||
130340511|NCT00955305|469219447|FG000|Overall Study|Lost to Follow-up|0|||
130340512|NCT00955305|469219448|FG001|Overall Study|Lost to Follow-up|1|||
130340513|NCT00955305|469219447|FG000|Overall Study|No off-treatment reason submitted|1|||
130340514|NCT00955305|469219448|FG001|Overall Study|No off-treatment reason submitted|0|||
130340515|NCT00955305|469219447|FG000|Overall Study|Never started protocol treatment|5|||
130340516|NCT00955305|469219448|FG001|Overall Study|Never started protocol treatment|5|||
130340517|NCT00955305|469219447|FG000|Overall Study|Ineligible|5|||
130340518|NCT00955305|469219448|FG001|Overall Study|Ineligible|7|||
130340519|NCT00109590|469219449|FG000|Overall Study|Lost to Follow-up|1|||
130340520|NCT00109590|469219450|FG001|Overall Study|Lost to Follow-up|0|||
130340521|NCT00109590|469219451|FG002|Overall Study|Lost to Follow-up|1|||
130340522|NCT00109590|469219449|FG000|Overall Study|Never Started Treatment|1|||
130340523|NCT00109590|469219450|FG001|Overall Study|Never Started Treatment|2|||
130340524|NCT00109590|469219451|FG002|Overall Study|Never Started Treatment|3|||
130340525|NCT03254108|469219455|FG000|Overall Study|Adverse Event|0|||
130340526|NCT03254108|469219456|FG001|Overall Study|Adverse Event|2|||
130340527|NCT03254108|469219457|FG002|Overall Study|Adverse Event|0|||
130340528|NCT03254108|469219458|FG003|Overall Study|Adverse Event|1|||
130340529|NCT03254108|469219459|FG004|Overall Study|Adverse Event|1|||
130340530|NCT03254108|469219455|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340531|NCT03254108|469219456|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340532|NCT03254108|469219457|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340533|NCT03254108|469219458|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340534|NCT03254108|469219459|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
130340535|NCT00745849|469219460|FG000|First Intervention|Withdrawal by Subject|0|||
130340536|NCT00745849|469219461|FG001|First Intervention|Withdrawal by Subject|1|||
130340537|NCT00745849|469219460|FG000|First Intervention|Lost to Follow-up|1|||
130340538|NCT00745849|469219461|FG001|First Intervention|Lost to Follow-up|1|||
130672928|NCT02711956|470427398|FG001|Overall Study|PSA progression with radiographic progression|1|||
130672929|NCT02711956|470427399|FG002|Overall Study|PSA progression with radiographic progression|0|||
130672930|NCT02711956|470427400|FG003|Overall Study|PSA progression with radiographic progression|0|||
130672931|NCT02711956|470427401|FG004|Overall Study|PSA progression with radiographic progression|0|||
130672932|NCT02711956|470427402|FG005|Overall Study|PSA progression with radiographic progression|2|||
130672933|NCT02711956|470427403|FG006|Overall Study|PSA progression with radiographic progression|2|||
130672934|NCT02711956|470427404|FG007|Overall Study|PSA progression with radiographic progression|1|||
130672935|NCT02711956|470427405|FG008|Overall Study|PSA progression with radiographic progression|0|||
130672936|NCT02711956|470427406|FG009|Overall Study|PSA progression with radiographic progression|1|||
130672937|NCT02711956|470427407|FG010|Overall Study|PSA progression with radiographic progression|0|||
130672938|NCT02711956|470427408|FG011|Overall Study|PSA progression with radiographic progression|1|||
130340539|NCT00745849|469219460|FG000|Second Intervention|Lost to Follow-up|2|||
130340540|NCT00745849|469219461|FG001|Second Intervention|Lost to Follow-up|1|||
130340541|NCT00409331|469219468|FG000|Overall Study|Physician Decision|1|||
130340542|NCT01511055|469219473|FG000|Overall Study|Withdrawal by Subject|6|||
130340543|NCT00830869|469219474|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
130672939|NCT02711956|470427409|FG012|Overall Study|PSA progression with radiographic progression|2|||
130672940|NCT02711956|470427410|FG013|Overall Study|PSA progression with radiographic progression|3|||
130672941|NCT02711956|470427411|FG014|Overall Study|PSA progression with radiographic progression|3|||
130672942|NCT01844583|470427412|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
130672943|NCT01844583|470427413|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
130672944|NCT01625377|470427414|FG000|Overall Study|Death|1|||
130672945|NCT01625377|470427415|FG001|Overall Study|Death|1|||
130672946|NCT01625377|470427414|FG000|Overall Study|Administrative Problem|1|||
130672947|NCT01625377|470427415|FG001|Overall Study|Administrative Problem|1|||
130672948|NCT01625377|470427414|FG000|Overall Study|Protocol Violation|0|||
130672949|NCT01625377|470427415|FG001|Overall Study|Protocol Violation|3|||
130672950|NCT01625377|470427414|FG000|Overall Study|Adverse Event|3|||
130672951|NCT01625377|470427415|FG001|Overall Study|Adverse Event|16|||
130672952|NCT01625377|470427414|FG000|Overall Study|Graft loss|1|||
130672953|NCT01625377|470427415|FG001|Overall Study|Graft loss|0|||
130672954|NCT01625377|470427414|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130672955|NCT01625377|470427415|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130672956|NCT01625377|470427414|FG000|Overall Study|Abnormal laboratory values|1|||
130672957|NCT01625377|470427415|FG001|Overall Study|Abnormal laboratory values|0|||
130672958|NCT03294538|470427420|FG000|Overall Study|Adverse Event|0|||
130672959|NCT03294538|470427421|FG001|Overall Study|Adverse Event|1|||
130340544|NCT00830869|469219475|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
130340545|NCT00830869|469219476|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
130340546|NCT00830869|469219477|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
130340547|NCT00830869|469219478|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
130340548|NCT00830869|469219479|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
130340549|NCT00830869|469219480|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
130340550|NCT00830869|469219481|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
130340551|NCT00830869|469219482|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
130340552|NCT00830869|469219483|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
130340553|NCT00830869|469219484|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
130340554|NCT00830869|469219485|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
130340555|NCT00830869|469219474|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
130340556|NCT00830869|469219475|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
130340557|NCT00830869|469219476|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
130340558|NCT00830869|469219477|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
130340559|NCT00830869|469219478|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
130340560|NCT00830869|469219479|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
130340561|NCT00830869|469219480|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
130340562|NCT00830869|469219481|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
130340563|NCT00830869|469219482|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
130340564|NCT00830869|469219483|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
130340565|NCT00830869|469219484|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
130340566|NCT00830869|469219485|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
130340567|NCT00830869|469219474|FG000|Period 1: Part 1|Adverse Event|0|||
130340568|NCT00830869|469219475|FG001|Period 1: Part 1|Adverse Event|0|||
130340569|NCT00830869|469219476|FG002|Period 1: Part 1|Adverse Event|0|||
130340570|NCT00830869|469219477|FG003|Period 1: Part 1|Adverse Event|0|||
130340571|NCT00830869|469219478|FG004|Period 1: Part 1|Adverse Event|0|||
130340572|NCT00830869|469219479|FG005|Period 1: Part 1|Adverse Event|1|||
130340573|NCT00830869|469219480|FG006|Period 1: Part 1|Adverse Event|1|||
130340574|NCT00830869|469219481|FG007|Period 1: Part 1|Adverse Event|0|||
130340575|NCT00830869|469219482|FG008|Period 1: Part 1|Adverse Event|0|||
130340576|NCT00830869|469219483|FG009|Period 1: Part 1|Adverse Event|0|||
130340577|NCT00830869|469219484|FG010|Period 1: Part 1|Adverse Event|0|||
130340578|NCT00830869|469219485|FG011|Period 1: Part 1|Adverse Event|0|||
130340579|NCT00830869|469219474|FG000|Period 1: Part 1|Progressive disease|1|||
130340580|NCT00830869|469219475|FG001|Period 1: Part 1|Progressive disease|0|||
130340581|NCT00830869|469219476|FG002|Period 1: Part 1|Progressive disease|1|||
130340582|NCT00830869|469219477|FG003|Period 1: Part 1|Progressive disease|6|||
130340583|NCT00830869|469219478|FG004|Period 1: Part 1|Progressive disease|4|||
130340584|NCT00830869|469219479|FG005|Period 1: Part 1|Progressive disease|4|||
130340585|NCT00830869|469219480|FG006|Period 1: Part 1|Progressive disease|1|||
130672960|NCT03294538|470427422|FG002|Overall Study|Adverse Event|1|||
130672961|NCT03294538|470427420|FG000|Overall Study|Lost to Follow-up|1|||
130340586|NCT00830869|469219481|FG007|Period 1: Part 1|Progressive disease|0|||
130340587|NCT00830869|469219482|FG008|Period 1: Part 1|Progressive disease|0|||
130340588|NCT00830869|469219483|FG009|Period 1: Part 1|Progressive disease|0|||
130340589|NCT00830869|469219484|FG010|Period 1: Part 1|Progressive disease|0|||
130340590|NCT00830869|469219485|FG011|Period 1: Part 1|Progressive disease|0|||
130672962|NCT03294538|470427421|FG001|Overall Study|Lost to Follow-up|0|||
130672963|NCT03294538|470427422|FG002|Overall Study|Lost to Follow-up|0|||
130672964|NCT03294538|470427420|FG000|Overall Study|Outside of Visit Window|4|||
130672965|NCT03294538|470427421|FG001|Overall Study|Outside of Visit Window|4|||
130672966|NCT03294538|470427422|FG002|Overall Study|Outside of Visit Window|1|||
130672967|NCT00449072|470427429|FG000|Overall Study|Adverse Event|3|||
130340591|NCT00830869|469219474|FG000|Period 2: Part 2|Protocol Violation|0|||
130340592|NCT00830869|469219475|FG001|Period 2: Part 2|Protocol Violation|0|||
130340593|NCT00830869|469219476|FG002|Period 2: Part 2|Protocol Violation|0|||
130340594|NCT00830869|469219477|FG003|Period 2: Part 2|Protocol Violation|0|||
130340595|NCT00830869|469219478|FG004|Period 2: Part 2|Protocol Violation|0|||
130340596|NCT00830869|469219479|FG005|Period 2: Part 2|Protocol Violation|0|||
130340597|NCT00830869|469219480|FG006|Period 2: Part 2|Protocol Violation|0|||
130340598|NCT00830869|469219481|FG007|Period 2: Part 2|Protocol Violation|1|||
130340599|NCT00830869|469219482|FG008|Period 2: Part 2|Protocol Violation|0|||
130340600|NCT00830869|469219483|FG009|Period 2: Part 2|Protocol Violation|1|||
130340601|NCT00830869|469219484|FG010|Period 2: Part 2|Protocol Violation|0|||
130340602|NCT00830869|469219485|FG011|Period 2: Part 2|Protocol Violation|0|||
130340603|NCT00830869|469219474|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
130340604|NCT00830869|469219475|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
130340605|NCT00830869|469219476|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
130340606|NCT00830869|469219477|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
130340607|NCT00830869|469219478|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
130340608|NCT00830869|469219479|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
130340609|NCT00830869|469219480|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
130340610|NCT00830869|469219481|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
130340611|NCT00830869|469219482|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
130340612|NCT00830869|469219483|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
130340613|NCT00830869|469219484|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
130340614|NCT00830869|469219485|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
130340615|NCT00830869|469219474|FG000|Period 2: Part 2|Adverse Event|0|||
130340616|NCT00830869|469219475|FG001|Period 2: Part 2|Adverse Event|0|||
130340617|NCT00830869|469219476|FG002|Period 2: Part 2|Adverse Event|0|||
130340618|NCT00830869|469219477|FG003|Period 2: Part 2|Adverse Event|0|||
130340619|NCT00830869|469219478|FG004|Period 2: Part 2|Adverse Event|0|||
130340620|NCT00830869|469219479|FG005|Period 2: Part 2|Adverse Event|0|||
130340621|NCT00830869|469219480|FG006|Period 2: Part 2|Adverse Event|0|||
130340622|NCT00830869|469219481|FG007|Period 2: Part 2|Adverse Event|4|||
130340623|NCT00830869|469219482|FG008|Period 2: Part 2|Adverse Event|3|||
130340624|NCT00830869|469219483|FG009|Period 2: Part 2|Adverse Event|2|||
130340625|NCT00830869|469219484|FG010|Period 2: Part 2|Adverse Event|2|||
130340626|NCT00830869|469219485|FG011|Period 2: Part 2|Adverse Event|0|||
130340627|NCT00830869|469219474|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
130340628|NCT00830869|469219475|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
130340629|NCT00830869|469219476|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
130340630|NCT00830869|469219477|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
130340631|NCT00830869|469219478|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
130340632|NCT00830869|469219479|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
130340633|NCT00830869|469219480|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
130340634|NCT00830869|469219481|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
130340635|NCT00830869|469219482|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
130340636|NCT00830869|469219483|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
130340637|NCT00830869|469219484|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
130340638|NCT00830869|469219485|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
130340639|NCT00830869|469219474|FG000|Period 2: Part 2|Progressive disease|0|||
130340640|NCT00830869|469219475|FG001|Period 2: Part 2|Progressive disease|0|||
130340641|NCT00830869|469219476|FG002|Period 2: Part 2|Progressive disease|0|||
130340642|NCT00830869|469219477|FG003|Period 2: Part 2|Progressive disease|0|||
130340643|NCT00830869|469219478|FG004|Period 2: Part 2|Progressive disease|0|||
130340644|NCT00830869|469219479|FG005|Period 2: Part 2|Progressive disease|0|||
130340645|NCT00830869|469219480|FG006|Period 2: Part 2|Progressive disease|0|||
130340646|NCT00830869|469219481|FG007|Period 2: Part 2|Progressive disease|14|||
130340647|NCT00830869|469219482|FG008|Period 2: Part 2|Progressive disease|11|||
130340648|NCT00830869|469219483|FG009|Period 2: Part 2|Progressive disease|12|||
130340649|NCT00830869|469219484|FG010|Period 2: Part 2|Progressive disease|8|||
130340650|NCT00830869|469219485|FG011|Period 2: Part 2|Progressive disease|15|||
130340651|NCT00830869|469219474|FG000|Period 2: Part 2|Other|0|||
130340652|NCT00830869|469219475|FG001|Period 2: Part 2|Other|0|||
130340653|NCT00830869|469219476|FG002|Period 2: Part 2|Other|0|||
130340654|NCT00830869|469219477|FG003|Period 2: Part 2|Other|0|||
130340655|NCT00830869|469219478|FG004|Period 2: Part 2|Other|0|||
130340656|NCT00830869|469219479|FG005|Period 2: Part 2|Other|0|||
130340657|NCT00830869|469219480|FG006|Period 2: Part 2|Other|0|||
130340658|NCT00830869|469219481|FG007|Period 2: Part 2|Other|0|||
130340659|NCT00830869|469219482|FG008|Period 2: Part 2|Other|0|||
130340660|NCT00830869|469219483|FG009|Period 2: Part 2|Other|1|||
130340661|NCT00830869|469219484|FG010|Period 2: Part 2|Other|0|||
130340662|NCT00830869|469219485|FG011|Period 2: Part 2|Other|0|||
130340663|NCT00617669|469219486|FG000|Overall Study|Withdrawal by Subject|71|||
130340664|NCT00617669|469219487|FG001|Overall Study|Withdrawal by Subject|77|||
130340665|NCT00617669|469219486|FG000|Overall Study|Lost to Follow-up|3|||
130340666|NCT00617669|469219487|FG001|Overall Study|Lost to Follow-up|2|||
130552750|NCT01072877|469991523|FG002|Overall Study|Lost to Follow-up|0|||
130672968|NCT00449072|470427430|FG001|Overall Study|Adverse Event|1|||
130672969|NCT00449072|470427429|FG000|Overall Study|Protocol Violation|14|||
130672970|NCT00449072|470427430|FG001|Overall Study|Protocol Violation|12|||
130672971|NCT00449072|470427429|FG000|Overall Study|Lost to Follow-up|5|||
130672972|NCT00449072|470427430|FG001|Overall Study|Lost to Follow-up|7|||
130672973|NCT00449072|470427429|FG000|Overall Study|Withdrawal by Subject|11|||
130340667|NCT00617669|469219486|FG000|Overall Study|Adverse Event|87|||
130340668|NCT00617669|469219487|FG001|Overall Study|Adverse Event|76|||
130340669|NCT00617669|469219486|FG000|Overall Study|Protocol Violation|2|||
130340670|NCT00617669|469219487|FG001|Overall Study|Protocol Violation|3|||
130340671|NCT00617669|469219486|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
130340672|NCT00617669|469219487|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
130340673|NCT00617669|469219486|FG000|Overall Study|Patients randomized but not treated|2|||
130340674|NCT00617669|469219487|FG001|Overall Study|Patients randomized but not treated|3|||
130340675|NCT03745820|469219488|FG000|Overall Study|Adverse Event|0|||
130340676|NCT03745820|469219489|FG001|Overall Study|Adverse Event|3|||
130340677|NCT03745820|469219490|FG002|Overall Study|Adverse Event|2|||
130340678|NCT03745820|469219488|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130340679|NCT03745820|469219489|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130340680|NCT03745820|469219490|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130340681|NCT03745820|469219488|FG000|Overall Study|Withdrawal by Subject|4|||
130340682|NCT03745820|469219489|FG001|Overall Study|Withdrawal by Subject|4|||
130340683|NCT03745820|469219490|FG002|Overall Study|Withdrawal by Subject|4|||
130340684|NCT03745820|469219488|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
130340685|NCT03745820|469219489|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
130340686|NCT03745820|469219490|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
130340687|NCT03745820|469219488|FG000|Overall Study|Lost to Follow-up|2|||
130340688|NCT03745820|469219489|FG001|Overall Study|Lost to Follow-up|0|||
130340689|NCT03745820|469219490|FG002|Overall Study|Lost to Follow-up|3|||
130340690|NCT03745820|469219488|FG000|Overall Study|Reason not Specified|2|||
130340691|NCT03745820|469219489|FG001|Overall Study|Reason not Specified|4|||
130340692|NCT03745820|469219490|FG002|Overall Study|Reason not Specified|1|||
130340693|NCT00507728|469219491|FG000|Randomization to Month 3|Lost to Follow-up|15|||
130340694|NCT00507728|469219492|FG001|Randomization to Month 3|Lost to Follow-up|14|||
130340695|NCT00507728|469219493|FG002|Randomization to Month 3|Lost to Follow-up|20|||
130340696|NCT00507728|469219491|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
130340697|NCT00507728|469219492|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
130340698|NCT00507728|469219493|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
130340699|NCT03680742|469219494|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
130340700|NCT01410357|469219495|FG000|Overall Study|Death|2|||
130340701|NCT01410357|469219496|FG001|Overall Study|Death|1|||
130340702|NCT01410357|469219495|FG000|Overall Study|Withdrawal by Subject|1|||
130340703|NCT01410357|469219496|FG001|Overall Study|Withdrawal by Subject|2|||
130340704|NCT01410357|469219495|FG000|Overall Study|Lost to Follow-up|23|||
130340705|NCT01410357|469219496|FG001|Overall Study|Lost to Follow-up|21|||
130340706|NCT00668733|469219497|FG000|Overall Study|Lost to Follow-up|2|||
130340707|NCT00668733|469219498|FG001|Overall Study|Lost to Follow-up|3|||
130340708|NCT00668733|469219497|FG000|Overall Study|Withdrawal by Subject|0|||
130340709|NCT00668733|469219498|FG001|Overall Study|Withdrawal by Subject|4|||
130340710|NCT01909791|469219499|FG000|Overall Study|Death|9|||
130340711|NCT01909791|469219500|FG001|Overall Study|Death|8|||
130340712|NCT01909791|469219501|FG002|Overall Study|Death|4|||
130340713|NCT01909791|469219499|FG000|Overall Study|Withdrawal by Subject|5|||
130340714|NCT01909791|469219500|FG001|Overall Study|Withdrawal by Subject|9|||
130340715|NCT01909791|469219501|FG002|Overall Study|Withdrawal by Subject|13|||
130340716|NCT01909791|469219499|FG000|Overall Study|Lost to Follow-up|5|||
130340717|NCT01909791|469219500|FG001|Overall Study|Lost to Follow-up|11|||
130340718|NCT01909791|469219501|FG002|Overall Study|Lost to Follow-up|10|||
130340719|NCT01909791|469219499|FG000|Overall Study|Missed Visit|2|||
130340720|NCT01909791|469219500|FG001|Overall Study|Missed Visit|0|||
130340721|NCT01909791|469219501|FG002|Overall Study|Missed Visit|1|||
130340722|NCT01659554|469219502|FG000|Overall Study|Study Termination|4|||
130340723|NCT00945906|469219505|FG000|Overall Study|Withdrawal by Subject|1|||
130340724|NCT00945906|469219505|FG000|Overall Study|Did not want to return for last visit|2|||
130340725|NCT00945906|469219505|FG000|Overall Study|Unable to return for last visit|2|||
130340726|NCT00945906|469219505|FG000|Overall Study|Moved to another country|2|||
130340727|NCT03330002|469219508|FG000|Overall Study|Lost to Follow-up|15|||
130340728|NCT03330002|469219508|FG000|Overall Study|Death|7|||
130340729|NCT00635219|469219509|FG000|Overall Study|Adverse Event|12|||
130340730|NCT00635219|469219510|FG001|Overall Study|Adverse Event|10|||
130340731|NCT00635219|469219511|FG002|Overall Study|Adverse Event|18|||
130340732|NCT00635219|469219512|FG003|Overall Study|Adverse Event|15|||
130672974|NCT00449072|470427430|FG001|Overall Study|Withdrawal by Subject|8|||
130340733|NCT00635219|469219513|FG004|Overall Study|Adverse Event|19|||
130340734|NCT00635219|469219509|FG000|Overall Study|Lack of Efficacy|5|||
130340735|NCT00635219|469219510|FG001|Overall Study|Lack of Efficacy|6|||
130672975|NCT00449072|470427429|FG000|Overall Study|Lack of Efficacy|1|||
130340736|NCT00635219|469219511|FG002|Overall Study|Lack of Efficacy|3|||
130340737|NCT00635219|469219512|FG003|Overall Study|Lack of Efficacy|4|||
130340738|NCT00635219|469219513|FG004|Overall Study|Lack of Efficacy|6|||
130340739|NCT00635219|469219509|FG000|Overall Study|Non-compliance With Study Product|0|||
130340740|NCT00635219|469219510|FG001|Overall Study|Non-compliance With Study Product|0|||
130340741|NCT00635219|469219511|FG002|Overall Study|Non-compliance With Study Product|0|||
130340742|NCT00635219|469219512|FG003|Overall Study|Non-compliance With Study Product|2|||
130340743|NCT00635219|469219513|FG004|Overall Study|Non-compliance With Study Product|1|||
130340744|NCT00635219|469219509|FG000|Overall Study|Protocol Violation|0|||
130340745|NCT00635219|469219510|FG001|Overall Study|Protocol Violation|2|||
130340746|NCT00635219|469219511|FG002|Overall Study|Protocol Violation|3|||
130340747|NCT00635219|469219512|FG003|Overall Study|Protocol Violation|2|||
130340748|NCT00635219|469219513|FG004|Overall Study|Protocol Violation|4|||
130340749|NCT00635219|469219509|FG000|Overall Study|Withdrawal of Consent|8|||
130340750|NCT00635219|469219510|FG001|Overall Study|Withdrawal of Consent|6|||
130340751|NCT00635219|469219511|FG002|Overall Study|Withdrawal of Consent|8|||
130340752|NCT00635219|469219512|FG003|Overall Study|Withdrawal of Consent|11|||
130340753|NCT00635219|469219513|FG004|Overall Study|Withdrawal of Consent|8|||
130340754|NCT00635219|469219509|FG000|Overall Study|Lost to Follow-up|0|||
130340755|NCT00635219|469219510|FG001|Overall Study|Lost to Follow-up|0|||
130340756|NCT00635219|469219511|FG002|Overall Study|Lost to Follow-up|2|||
130340757|NCT00635219|469219512|FG003|Overall Study|Lost to Follow-up|0|||
130340758|NCT00635219|469219513|FG004|Overall Study|Lost to Follow-up|3|||
130340759|NCT00635219|469219509|FG000|Overall Study|Administrative or Other Reasons|0|||
130340760|NCT00635219|469219510|FG001|Overall Study|Administrative or Other Reasons|1|||
130340761|NCT00635219|469219511|FG002|Overall Study|Administrative or Other Reasons|1|||
130340762|NCT00635219|469219512|FG003|Overall Study|Administrative or Other Reasons|0|||
130340763|NCT00635219|469219513|FG004|Overall Study|Administrative or Other Reasons|1|||
130340764|NCT01598129|469219514|FG000|Overall Study|Disease progression|6|||
130340765|NCT01598129|469219514|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
130340766|NCT01598129|469219514|FG000|Overall Study|Withdrawal by Subject|1|||
130340767|NCT00505076|469219515|FG000|Overall Study|Adverse Event|1|||
130340768|NCT00505076|469219516|FG001|Overall Study|Adverse Event|0|||
130340769|NCT00505076|469219517|FG002|Overall Study|Adverse Event|1|||
130340770|NCT00505076|469219515|FG000|Overall Study|Protocol Violation|2|||
130340771|NCT00505076|469219516|FG001|Overall Study|Protocol Violation|1|||
130340772|NCT00505076|469219517|FG002|Overall Study|Protocol Violation|2|||
130340773|NCT00505076|469219515|FG000|Overall Study|Withdrawal by Subject|0|||
130340774|NCT00505076|469219516|FG001|Overall Study|Withdrawal by Subject|1|||
130340775|NCT00505076|469219517|FG002|Overall Study|Withdrawal by Subject|2|||
130340776|NCT00591318|469219520|FG000|Overall Study|Lack of Efficacy|2|||
130340777|NCT00591318|469219521|FG001|Overall Study|Lack of Efficacy|0|||
130340778|NCT00591318|469219520|FG000|Overall Study|Adverse Event|2|||
130340779|NCT00591318|469219521|FG001|Overall Study|Adverse Event|0|||
130340780|NCT00233454|469219524|FG000|Overall Study|Death|6|||
130340781|NCT04224688|469219528|FG000|Overall Study|Withdrawal by Subject|1|||
130340782|NCT04224688|469219529|FG001|Overall Study|Withdrawal by Subject|3|||
130340783|NCT04224688|469219528|FG000|Overall Study|Lack of Efficacy|1|||
130340784|NCT04224688|469219529|FG001|Overall Study|Lack of Efficacy|1|||
130340785|NCT04224688|469219528|FG000|Overall Study|Adverse event, not fatal|0|||
130340786|NCT04224688|469219529|FG001|Overall Study|Adverse event, not fatal|2|||
130672976|NCT00449072|470427430|FG001|Overall Study|Lack of Efficacy|1|||
130672977|NCT00449072|470427429|FG000|Overall Study|Physician Decision|1|||
130340787|NCT04224688|469219528|FG000|Overall Study|COVID-19|0|||
130340788|NCT04224688|469219529|FG001|Overall Study|COVID-19|1|||
130340789|NCT02745145|469219532|FG000|Overall Study|Adverse Event|1|||
130672978|NCT00449072|470427430|FG001|Overall Study|Physician Decision|0|||
130672979|NCT00449072|470427429|FG000|Overall Study|Not treated|0|||
130672980|NCT00449072|470427430|FG001|Overall Study|Not treated|1|||
130672981|NCT00449072|470427429|FG000|Overall Study|Excluded medication|0|||
130672982|NCT00449072|470427430|FG001|Overall Study|Excluded medication|2|||
130340790|NCT02745145|469219533|FG001|Overall Study|Adverse Event|0|||
130340791|NCT02745145|469219534|FG002|Overall Study|Adverse Event|0|||
130340792|NCT02745145|469219532|FG000|Overall Study|Death|0|||
130340793|NCT02745145|469219533|FG001|Overall Study|Death|1|||
130340794|NCT02745145|469219534|FG002|Overall Study|Death|0|||
130340795|NCT02745145|469219532|FG000|Overall Study|Progressive disease|0|||
130340796|NCT02745145|469219533|FG001|Overall Study|Progressive disease|0|||
130340797|NCT02745145|469219534|FG002|Overall Study|Progressive disease|1|||
130340798|NCT02745145|469219532|FG000|Overall Study|Withdrew consent|1|||
130340799|NCT02745145|469219533|FG001|Overall Study|Withdrew consent|1|||
130340800|NCT02745145|469219534|FG002|Overall Study|Withdrew consent|1|||
130340801|NCT02745145|469219532|FG000|Overall Study|Study Termination|8|||
130340802|NCT02745145|469219533|FG001|Overall Study|Study Termination|3|||
130340803|NCT02745145|469219534|FG002|Overall Study|Study Termination|7|||
130340804|NCT00388583|469219535|FG000|Overall Study|Protocol Violation|1|||
130340805|NCT00388583|469219536|FG001|Overall Study|Protocol Violation|0|||
130340806|NCT00388583|469219535|FG000|Overall Study|Withdrawal by Subject|3|||
130672983|NCT00449072|470427429|FG000|Overall Study|Non-compliance|2|||
130340807|NCT00388583|469219536|FG001|Overall Study|Withdrawal by Subject|3|||
130340808|NCT00388583|469219535|FG000|Overall Study|Serious Adverse Event|2|||
130340809|NCT00388583|469219536|FG001|Overall Study|Serious Adverse Event|0|||
130340810|NCT00388583|469219535|FG000|Overall Study|Did not receive vaccine|0|||
130340811|NCT00388583|469219536|FG001|Overall Study|Did not receive vaccine|1|||
130340812|NCT01155011|469219538|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
130340813|NCT01155011|469219539|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
130340814|NCT01155011|469219538|FG000|Baseline to 6 Months|investigator decision, moved|4|||
130340815|NCT01155011|469219539|FG001|Baseline to 6 Months|investigator decision, moved|5|||
130340816|NCT01155011|469219538|FG000|Baseline to 6 Months|Death|0|||
130340817|NCT01155011|469219539|FG001|Baseline to 6 Months|Death|1|||
130340818|NCT01155011|469219538|FG000|6 to 12 Months|Withdrawal by Subject|8|||
130340819|NCT01155011|469219539|FG001|6 to 12 Months|Withdrawal by Subject|5|||
130340820|NCT01155011|469219538|FG000|6 to 12 Months|Death|1|||
130340821|NCT01155011|469219539|FG001|6 to 12 Months|Death|5|||
130340822|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
130340823|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
130340824|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
130340825|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
130340826|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
130340827|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
130340828|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
130340829|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130340830|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130340831|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
130340832|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
130340833|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
130340834|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
130340835|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
130340836|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
130340837|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
130340838|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
130340839|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
130340840|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
130340841|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
130340842|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
130340843|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
130340844|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
130340845|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
130340846|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
130340847|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
130340848|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
130340849|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
130340850|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
130340851|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
130340852|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
130340853|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130340854|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130340855|NCT01743001|469219543|FG000|Overall Study|Physician Decision|1|||
130340856|NCT01743001|469219544|FG001|Overall Study|Physician Decision|0|||
130340857|NCT01743001|469219543|FG000|Overall Study|Pregnancy|1|||
130340858|NCT01743001|469219544|FG001|Overall Study|Pregnancy|0|||
130340859|NCT01743001|469219543|FG000|Overall Study|Death|1|||
130340860|NCT01743001|469219544|FG001|Overall Study|Death|0|||
130340861|NCT01565343|469219547|FG000|Overall Study|Administrative decision/technical issues|1|||
130340862|NCT01565343|469219548|FG001|Overall Study|Administrative decision/technical issues|0|||
130340863|NCT01565343|469219549|FG002|Overall Study|Administrative decision/technical issues|0|||
130340864|NCT00271505|469219562|FG000|Overall Study|Screen Failure|3|||
130340865|NCT00271505|469219562|FG000|Overall Study|Adverse Event|1|||
130340866|NCT00271505|469219562|FG000|Overall Study|Death|1|||
130340867|NCT03288142|469219568|FG000|Overall Study|Lost to Follow-up|22|||
130340868|NCT03288142|469219569|FG001|Overall Study|Lost to Follow-up|15|||
130340869|NCT00946153|469219570|FG000|Phase 2|Adverse Event|0|||
130340870|NCT00946153|469219571|FG001|Phase 2|Adverse Event|0|||
130340871|NCT00946153|469219572|FG002|Phase 2|Adverse Event|0|||
130340872|NCT00946153|469219573|FG003|Phase 2|Adverse Event|0|||
130340873|NCT00946153|469219574|FG004|Phase 2|Adverse Event|6|||
130340874|NCT00946153|469219570|FG000|Phase 2|Need more reduction of dose|0|||
130340875|NCT00946153|469219571|FG001|Phase 2|Need more reduction of dose|0|||
130340876|NCT00946153|469219572|FG002|Phase 2|Need more reduction of dose|0|||
130340877|NCT00946153|469219573|FG003|Phase 2|Need more reduction of dose|0|||
130340878|NCT00946153|469219574|FG004|Phase 2|Need more reduction of dose|2|||
130672984|NCT00449072|470427430|FG001|Overall Study|Non-compliance|5|||
130672985|NCT00449072|470427429|FG000|Overall Study|Sponsor decision|1|||
130672986|NCT00449072|470427430|FG001|Overall Study|Sponsor decision|3|||
130672987|NCT00449072|470427429|FG000|Overall Study|Relocation|3|||
130672988|NCT00449072|470427430|FG001|Overall Study|Relocation|2|||
130672989|NCT01769378|470427431|FG000|Overall Study|Adverse Event|10|||
130672990|NCT01769378|470427432|FG001|Overall Study|Adverse Event|0|||
130672991|NCT01769378|470427431|FG000|Overall Study|Entry criteria not met|1|||
130672992|NCT01769378|470427432|FG001|Overall Study|Entry criteria not met|0|||
130672993|NCT01769378|470427431|FG000|Overall Study|Protocol Violation|1|||
130672994|NCT01769378|470427432|FG001|Overall Study|Protocol Violation|1|||
130672995|NCT01769378|470427431|FG000|Overall Study|Withdrawal by Subject|10|||
130672996|NCT01769378|470427432|FG001|Overall Study|Withdrawal by Subject|3|||
130672997|NCT01769378|470427431|FG000|Overall Study|Sponsor Decision|1|||
130672998|NCT01769378|470427432|FG001|Overall Study|Sponsor Decision|0|||
130672999|NCT01769378|470427431|FG000|Overall Study|Lost to Follow-up|2|||
130673000|NCT01769378|470427432|FG001|Overall Study|Lost to Follow-up|0|||
130673001|NCT00718159|470427433|FG000|Overall Study|Progressive Disease|3|||
130340879|NCT00946153|469219570|FG000|Phase 2|Physician Decision|0|||
130340880|NCT00946153|469219571|FG001|Phase 2|Physician Decision|0|||
130340881|NCT00946153|469219572|FG002|Phase 2|Physician Decision|0|||
130340882|NCT00946153|469219573|FG003|Phase 2|Physician Decision|0|||
130340883|NCT00946153|469219574|FG004|Phase 2|Physician Decision|1|||
130340884|NCT00946153|469219570|FG000|Phase 2|14 days washout for recovery due to AE|0|||
130340885|NCT00946153|469219571|FG001|Phase 2|14 days washout for recovery due to AE|0|||
130340886|NCT00946153|469219572|FG002|Phase 2|14 days washout for recovery due to AE|0|||
130340887|NCT00946153|469219573|FG003|Phase 2|14 days washout for recovery due to AE|0|||
130340888|NCT00946153|469219574|FG004|Phase 2|14 days washout for recovery due to AE|4|||
130340889|NCT01948193|469220964|FG000|Overall Study|Serious event|2|||
130340890|NCT01948193|469220964|FG000|Overall Study|Lost to Follow-up|7|||
130340891|NCT02522624|469220965|FG000|Overall Study|Technical failure|1|||
130340892|NCT02522624|469220966|FG001|Overall Study|Technical failure|0|||
130340893|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
130340894|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
130340895|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
130340896|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
130340897|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
130340898|NCT00490529|469220968|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
130340899|NCT03254459|469220969|FG000|Overall Study|Adverse Event|7|||
130340900|NCT03254459|469220970|FG001|Overall Study|Adverse Event|20|||
130340901|NCT03254459|469220969|FG000|Overall Study|Withdrawal by Subject Consent|3|||
130340902|NCT03254459|469220970|FG001|Overall Study|Withdrawal by Subject Consent|1|||
130340903|NCT03254459|469220969|FG000|Overall Study|Lost to Follow-up|0|||
130340904|NCT03254459|469220970|FG001|Overall Study|Lost to Follow-up|1|||
130340905|NCT03254459|469220969|FG000|Overall Study|Miscellaneous|0|||
130340906|NCT03254459|469220970|FG001|Overall Study|Miscellaneous|1|||
130340907|NCT00727441|469220971|FG000|Overall Study|Disease Progression|11|||
130340908|NCT00727441|469220972|FG001|Overall Study|Disease Progression|14|||
130340909|NCT00727441|469220973|FG002|Overall Study|Disease Progression|17|||
130340910|NCT00727441|469220971|FG000|Overall Study|Eligibility|7|||
130340911|NCT00727441|469220972|FG001|Overall Study|Eligibility|5|||
130340912|NCT00727441|469220973|FG002|Overall Study|Eligibility|7|||
130340913|NCT00727441|469220971|FG000|Overall Study|Death|0|||
130340914|NCT00727441|469220972|FG001|Overall Study|Death|1|||
130340915|NCT00727441|469220973|FG002|Overall Study|Death|1|||
130340916|NCT00727441|469220971|FG000|Overall Study|Physician Decision|0|||
130340917|NCT00727441|469220972|FG001|Overall Study|Physician Decision|1|||
130340918|NCT00727441|469220973|FG002|Overall Study|Physician Decision|0|||
130340919|NCT00727441|469220971|FG000|Overall Study|Withdrawal by Subject|0|||
130340920|NCT00727441|469220972|FG001|Overall Study|Withdrawal by Subject|1|||
130340921|NCT00727441|469220973|FG002|Overall Study|Withdrawal by Subject|0|||
130340922|NCT00535288|469220974|FG000|Overall Study|Adverse Event|20|||
130340923|NCT00535288|469220975|FG001|Overall Study|Adverse Event|19|||
130340924|NCT00535288|469220976|FG002|Overall Study|Adverse Event|25|||
130340925|NCT00535288|469220977|FG003|Overall Study|Adverse Event|20|||
130340926|NCT00535288|469220978|FG004|Overall Study|Adverse Event|30|||
130340927|NCT00535288|469220974|FG000|Overall Study|Lost to Follow-up|0|||
130340928|NCT00535288|469220975|FG001|Overall Study|Lost to Follow-up|3|||
130340929|NCT00535288|469220976|FG002|Overall Study|Lost to Follow-up|0|||
130340930|NCT00535288|469220977|FG003|Overall Study|Lost to Follow-up|0|||
130340931|NCT00535288|469220978|FG004|Overall Study|Lost to Follow-up|0|||
130340932|NCT00535288|469220974|FG000|Overall Study|Lack of Efficacy|26|||
130673002|NCT00718159|470427434|FG001|Overall Study|Progressive Disease|3|||
130340933|NCT00535288|469220975|FG001|Overall Study|Lack of Efficacy|3|||
130340934|NCT00535288|469220976|FG002|Overall Study|Lack of Efficacy|4|||
130673003|NCT00718159|470427435|FG002|Overall Study|Progressive Disease|2|||
130673004|NCT00718159|470427436|FG003|Overall Study|Progressive Disease|0|||
130673005|NCT00718159|470427437|FG004|Overall Study|Progressive Disease|6|||
130340935|NCT00535288|469220977|FG003|Overall Study|Lack of Efficacy|4|||
130340936|NCT00535288|469220978|FG004|Overall Study|Lack of Efficacy|7|||
130340937|NCT00535288|469220974|FG000|Overall Study|Unwilling to cooperate|6|||
130340938|NCT00535288|469220975|FG001|Overall Study|Unwilling to cooperate|6|||
130340939|NCT00535288|469220976|FG002|Overall Study|Unwilling to cooperate|3|||
130340940|NCT00535288|469220977|FG003|Overall Study|Unwilling to cooperate|3|||
130340941|NCT00535288|469220978|FG004|Overall Study|Unwilling to cooperate|4|||
130340942|NCT00535288|469220974|FG000|Overall Study|Other|2|||
130340943|NCT00535288|469220975|FG001|Overall Study|Other|1|||
130340944|NCT00535288|469220976|FG002|Overall Study|Other|1|||
130340945|NCT00535288|469220977|FG003|Overall Study|Other|2|||
130340946|NCT00535288|469220978|FG004|Overall Study|Other|1|||
130340947|NCT01129583|469220984|FG000|Overall Study|Death|1|||
130340948|NCT01129583|469220985|FG001|Overall Study|Death|0|||
130340949|NCT01129583|469220984|FG000|Overall Study|Lost to Follow-up|1|||
130340950|NCT01129583|469220985|FG001|Overall Study|Lost to Follow-up|1|||
130340951|NCT01129583|469220984|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130340952|NCT01129583|469220985|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130340953|NCT02600871|469220986|FG000|Overall Study|Lost to Follow-up|13|||
130340954|NCT02600871|469220987|FG001|Overall Study|Lost to Follow-up|10|||
130340955|NCT03135119|469221003|FG000|Overall Study|Lost to Follow-up|2|||
130340956|NCT03135119|469221004|FG001|Overall Study|Lost to Follow-up|0|||
130340957|NCT03135119|469221003|FG000|Overall Study|Physician Decision|1|||
130340958|NCT03135119|469221004|FG001|Overall Study|Physician Decision|1|||
130340959|NCT03135119|469221003|FG000|Overall Study|COVID-19 Shutdown|2|||
130340960|NCT03135119|469221004|FG001|Overall Study|COVID-19 Shutdown|2|||
130340961|NCT00361634|469221009|FG000|Overall Study|Lost to Follow-up|1|||
130340962|NCT00361634|469221009|FG000|Overall Study|Withdrawal by Subject|1|||
130340963|NCT00833417|469221010|FG000|Overall Study|Adverse Event|5|||
130340964|NCT00833417|469221011|FG001|Overall Study|Adverse Event|16|||
130340965|NCT00833417|469221010|FG000|Overall Study|Death|1|||
130340966|NCT00833417|469221011|FG001|Overall Study|Death|3|||
130340967|NCT00833417|469221010|FG000|Overall Study|Lost to Follow-up|1|||
130340968|NCT00833417|469221011|FG001|Overall Study|Lost to Follow-up|2|||
130340969|NCT00833417|469221010|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
130340970|NCT00833417|469221011|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
130340971|NCT00833417|469221010|FG000|Overall Study|Patient Decision to Withdraw|4|||
130340972|NCT00833417|469221011|FG001|Overall Study|Patient Decision to Withdraw|23|||
130340973|NCT00833417|469221010|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
130340974|NCT00833417|469221011|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
130340975|NCT00833417|469221010|FG000|Overall Study|Disease Progression|18|||
130673006|NCT00718159|470427438|FG005|Overall Study|Progressive Disease|0|||
130673007|NCT00718159|470427439|FG006|Overall Study|Progressive Disease|0|||
130673008|NCT00718159|470427433|FG000|Overall Study|Death due to Adverse Event|0|||
130673009|NCT00718159|470427434|FG001|Overall Study|Death due to Adverse Event|0|||
130673010|NCT00718159|470427435|FG002|Overall Study|Death due to Adverse Event|0|||
130673011|NCT00718159|470427436|FG003|Overall Study|Death due to Adverse Event|2|||
130673012|NCT00718159|470427437|FG004|Overall Study|Death due to Adverse Event|2|||
130673013|NCT00718159|470427438|FG005|Overall Study|Death due to Adverse Event|0|||
130673014|NCT00718159|470427439|FG006|Overall Study|Death due to Adverse Event|0|||
130673015|NCT00718159|470427433|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
130673016|NCT00718159|470427434|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
130673017|NCT00718159|470427435|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
130673018|NCT00718159|470427436|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
130673019|NCT00718159|470427437|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
130673020|NCT00718159|470427438|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
130673021|NCT00718159|470427439|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
130673022|NCT00718159|470427433|FG000|Overall Study|Investigator Decision|0|||
130673023|NCT00718159|470427434|FG001|Overall Study|Investigator Decision|0|||
130673024|NCT00718159|470427435|FG002|Overall Study|Investigator Decision|0|||
130673025|NCT00718159|470427436|FG003|Overall Study|Investigator Decision|0|||
130673026|NCT00718159|470427437|FG004|Overall Study|Investigator Decision|0|||
130340976|NCT00833417|469221011|FG001|Overall Study|Disease Progression|17|||
130340977|NCT00833417|469221010|FG000|Overall Study|Reason Not Specified|0|||
130340978|NCT00833417|469221011|FG001|Overall Study|Reason Not Specified|1|||
130340979|NCT05315908|469221012|FG000|Overall Study|Lost to Follow-up|4477|||
130340980|NCT05315908|469221013|FG001|Overall Study|Lost to Follow-up|4606|||
130340981|NCT01561898|469221014|FG000|Overall Study|Withdrawal by Subject|0|||
130340982|NCT01561898|469221015|FG001|Overall Study|Withdrawal by Subject|8|||
130340983|NCT01561898|469221016|FG002|Overall Study|Withdrawal by Subject|12|||
130340984|NCT01561898|469221017|FG003|Overall Study|Withdrawal by Subject|5|||
130340985|NCT01561898|469221014|FG000|Overall Study|Lack of Efficacy|0|||
130340986|NCT01561898|469221015|FG001|Overall Study|Lack of Efficacy|8|||
130340987|NCT01561898|469221016|FG002|Overall Study|Lack of Efficacy|10|||
130340988|NCT01561898|469221017|FG003|Overall Study|Lack of Efficacy|5|||
130673027|NCT00718159|470427438|FG005|Overall Study|Investigator Decision|1|||
130673028|NCT00718159|470427439|FG006|Overall Study|Investigator Decision|1|||
130340989|NCT01561898|469221014|FG000|Overall Study|Worsening of complications|0|||
130340990|NCT01561898|469221015|FG001|Overall Study|Worsening of complications|1|||
130340991|NCT01561898|469221016|FG002|Overall Study|Worsening of complications|0|||
130340992|NCT01561898|469221017|FG003|Overall Study|Worsening of complications|0|||
130340993|NCT01561898|469221014|FG000|Overall Study|Lost to Follow-up|0|||
130340994|NCT01561898|469221015|FG001|Overall Study|Lost to Follow-up|0|||
130340995|NCT01561898|469221016|FG002|Overall Study|Lost to Follow-up|1|||
130340996|NCT01561898|469221017|FG003|Overall Study|Lost to Follow-up|0|||
130340997|NCT01561898|469221014|FG000|Overall Study|Adverse Event|1|||
130340998|NCT01561898|469221015|FG001|Overall Study|Adverse Event|19|||
130340999|NCT01561898|469221016|FG002|Overall Study|Adverse Event|14|||
130341000|NCT01561898|469221017|FG003|Overall Study|Adverse Event|9|||
130341001|NCT01561898|469221014|FG000|Overall Study|Physician Decision|1|||
130341002|NCT01561898|469221015|FG001|Overall Study|Physician Decision|5|||
130341003|NCT01561898|469221016|FG002|Overall Study|Physician Decision|7|||
130341004|NCT01561898|469221017|FG003|Overall Study|Physician Decision|1|||
130341005|NCT00294762|469221018|FG000|Overall Study|Did not receive study treatment|3|||
130341006|NCT00294762|469221019|FG001|Overall Study|Did not receive study treatment|3|||
130341007|NCT02238080|469221020|FG000|Overall Study|Death|13|||
130341008|NCT02238080|469221020|FG000|Overall Study|Treatment interrupted|6|||
130341009|NCT02238080|469221020|FG000|Overall Study|Withdrawal by Subject|2|||
130341010|NCT02238080|469221020|FG000|Overall Study|Other|4|||
130341011|NCT01738646|469221021|FG000|Overall Study|Still Receiving Treatment|2|||
130341012|NCT04093024|469221022|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130341013|NCT04093024|469221023|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130341014|NCT04093024|469221022|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
130341015|NCT04093024|469221023|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
130341016|NCT04093024|469221022|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
130341017|NCT04093024|469221023|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
130341018|NCT04093024|469221022|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
130341019|NCT04093024|469221023|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
130341020|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
130341021|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130341022|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130341023|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
130341024|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130341025|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130341026|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
130341027|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
130341028|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
130341029|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
130341030|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
130341031|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
130341032|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
130341033|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130341034|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130341035|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130341036|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130341037|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
130341038|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
130341039|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
130341040|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
130341041|NCT04493892|469221033|FG000|Overall Study|Withdrawal by Subject|15|||
130341042|NCT02366091|469221038|FG000|Overall Study|Withdrawal by Subject|3|||
130341043|NCT02366091|469221039|FG001|Overall Study|Withdrawal by Subject|7|||
130341044|NCT02366091|469221040|FG002|Overall Study|Withdrawal by Subject|3|||
130341045|NCT02366091|469221041|FG003|Overall Study|Withdrawal by Subject|1|||
130341046|NCT02160041|469221042|FG000|Overall Study|Adverse Event|11|||
130341047|NCT02160041|469221042|FG000|Overall Study|Death|2|||
130341048|NCT02160041|469221042|FG000|Overall Study|disease progression|57|||
130341049|NCT02160041|469221042|FG000|Overall Study|Protocol Violation|1|||
130341050|NCT02160041|469221042|FG000|Overall Study|non-compliance with study|1|||
130341051|NCT02160041|469221042|FG000|Overall Study|Physician Decision|3|||
130341052|NCT02160041|469221042|FG000|Overall Study|Withdrawal by Subject|8|||
130341053|NCT02160041|469221042|FG000|Overall Study|study terminated by by sponsor|1|||
130341054|NCT01403948|469221043|FG000|Overall Study|Progressive disease|0|||
130341055|NCT01403948|469221044|FG001|Overall Study|Progressive disease|2|||
130341056|NCT01403948|469221045|FG002|Overall Study|Progressive disease|2|||
130341057|NCT01403948|469221046|FG003|Overall Study|Progressive disease|4|||
130341058|NCT01403948|469221047|FG004|Overall Study|Progressive disease|2|||
130341059|NCT01403948|469221048|FG005|Overall Study|Progressive disease|6|||
130673029|NCT01798485|470427448|FG000|Overall Study|Adverse Event|32|||
130673030|NCT01798485|470427449|FG001|Overall Study|Adverse Event|40|||
130673031|NCT01798485|470427448|FG000|Overall Study|Withdrawal by Subject|27|||
130673032|NCT01798485|470427449|FG001|Overall Study|Withdrawal by Subject|31|||
130673033|NCT01798485|470427448|FG000|Overall Study|Lost to Follow-up|0|||
130673034|NCT01798485|470427449|FG001|Overall Study|Lost to Follow-up|3|||
130673035|NCT01798485|470427448|FG000|Overall Study|Physician Decision|14|||
130673036|NCT01798485|470427449|FG001|Overall Study|Physician Decision|10|||
130673037|NCT01798485|470427448|FG000|Overall Study|Objective Disease Progression|152|||
130673038|NCT01798485|470427449|FG001|Overall Study|Objective Disease Progression|106|||
130673039|NCT01798485|470427448|FG000|Overall Study|Death|25|||
130673040|NCT01798485|470427449|FG001|Overall Study|Death|22|||
130673041|NCT01798485|470427448|FG000|Overall Study|Sponsor Decision|61|||
130673042|NCT01798485|470427449|FG001|Overall Study|Sponsor Decision|54|||
130673043|NCT01798485|470427448|FG000|Overall Study|Clinical Progression|35|||
130673044|NCT01798485|470427449|FG001|Overall Study|Clinical Progression|24|||
130673045|NCT00681863|470427450|FG000|Overall Study|Adverse Event|1|||
130673046|NCT00681863|470427450|FG000|Overall Study|Lost to Follow-up|2|||
130673047|NCT00681863|470427450|FG000|Overall Study|Lack of Efficacy|2|||
130673048|NCT00681863|470427450|FG000|Overall Study|Other|18|||
130673049|NCT01076166|470427451|FG000|Overall Study|Adverse Event|3|||
130673050|NCT01076166|470427451|FG000|Overall Study|Symptoms improved/resolved|6|||
130673051|NCT00638157|470427471|FG000|Overall Study|Adverse Event|0|||
130341060|NCT01403948|469221049|FG006|Overall Study|Progressive disease|2|||
130341061|NCT01403948|469221050|FG007|Overall Study|Progressive disease|4|||
130341062|NCT01403948|469221051|FG008|Overall Study|Progressive disease|5|||
130341063|NCT01403948|469221052|FG009|Overall Study|Progressive disease|5|||
130341064|NCT01403948|469221043|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341065|NCT01403948|469221044|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341066|NCT01403948|469221045|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341067|NCT01403948|469221046|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341068|NCT01403948|469221047|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
130341069|NCT01403948|469221048|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341070|NCT01403948|469221049|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
130341071|NCT01403948|469221050|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341072|NCT01403948|469221051|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
130341073|NCT01403948|469221052|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341074|NCT01403948|469221043|FG000|Overall Study|Lost to Follow-up|0|||
130341075|NCT01403948|469221044|FG001|Overall Study|Lost to Follow-up|0|||
130673052|NCT00638157|470427472|FG001|Overall Study|Adverse Event|1|||
130673053|NCT00638157|470427471|FG000|Overall Study|Clinical (symptomatic) failure|1|||
130673054|NCT00638157|470427472|FG001|Overall Study|Clinical (symptomatic) failure|1|||
130673055|NCT00638157|470427471|FG000|Overall Study|Microbiological failure|1|||
130673056|NCT00638157|470427472|FG001|Overall Study|Microbiological failure|0|||
130673057|NCT00638157|470427471|FG000|Overall Study|Lost to Follow-up|1|||
130673058|NCT00638157|470427472|FG001|Overall Study|Lost to Follow-up|0|||
130673059|NCT00638157|470427471|FG000|Overall Study|Physician Decision|1|||
130673060|NCT00638157|470427472|FG001|Overall Study|Physician Decision|0|||
130673061|NCT00638157|470427471|FG000|Overall Study|Other|1|||
130673062|NCT00638157|470427472|FG001|Overall Study|Other|2|||
130673063|NCT00638157|470427471|FG000|Overall Study|Randomized, not treated|2|||
130673064|NCT00638157|470427472|FG001|Overall Study|Randomized, not treated|0|||
130673065|NCT00876733|470427477|FG000|Overall Study|Adverse Event|34|||
130673066|NCT00876733|470427478|FG001|Overall Study|Adverse Event|20|||
130673067|NCT00876733|470427479|FG002|Overall Study|Adverse Event|10|||
130673068|NCT00876733|470427480|FG003|Overall Study|Adverse Event|3|||
130673069|NCT00876733|470427477|FG000|Overall Study|Lack of Efficacy|17|||
130673070|NCT00876733|470427478|FG001|Overall Study|Lack of Efficacy|9|||
130673071|NCT00876733|470427479|FG002|Overall Study|Lack of Efficacy|10|||
130673072|NCT00876733|470427480|FG003|Overall Study|Lack of Efficacy|1|||
130341076|NCT01403948|469221045|FG002|Overall Study|Lost to Follow-up|0|||
130341077|NCT01403948|469221046|FG003|Overall Study|Lost to Follow-up|0|||
130673073|NCT00876733|470427477|FG000|Overall Study|Lost to Follow-up|26|||
130673074|NCT00876733|470427478|FG001|Overall Study|Lost to Follow-up|10|||
130673075|NCT00876733|470427479|FG002|Overall Study|Lost to Follow-up|3|||
130673076|NCT00876733|470427480|FG003|Overall Study|Lost to Follow-up|2|||
130673077|NCT00876733|470427477|FG000|Overall Study|Data not available|14|||
130673078|NCT00876733|470427478|FG001|Overall Study|Data not available|3|||
130341078|NCT01403948|469221047|FG004|Overall Study|Lost to Follow-up|0|||
130341079|NCT01403948|469221048|FG005|Overall Study|Lost to Follow-up|0|||
130341080|NCT01403948|469221049|FG006|Overall Study|Lost to Follow-up|0|||
130673079|NCT00876733|470427479|FG002|Overall Study|Data not available|7|||
130673080|NCT00876733|470427480|FG003|Overall Study|Data not available|1|||
130673081|NCT02843074|470427481|FG000|Overall Study|Withdrawal by Subject|5|||
130673082|NCT02843074|470427481|FG000|Overall Study|Progressive disease|1|||
130673083|NCT02843074|470427481|FG000|Overall Study|Physician Decision|1|||
130673084|NCT02843074|470427481|FG000|Overall Study|Lost to Follow-up|1|||
130673085|NCT02843074|470427481|FG000|Overall Study|Death|9|||
130673086|NCT05476679|470427482|FG000|Overall Study|Withdrawal by Subject|0|||
130673087|NCT05476679|470427483|FG001|Overall Study|Withdrawal by Subject|0|||
130673088|NCT05476679|470427484|FG002|Overall Study|Withdrawal by Subject|0|||
130673089|NCT05476679|470427485|FG003|Overall Study|Withdrawal by Subject|1|||
130673090|NCT05476679|470427486|FG004|Overall Study|Withdrawal by Subject|0|||
130673091|NCT05476679|470427482|FG000|Overall Study|Lost to Follow-up|0|||
130673092|NCT05476679|470427483|FG001|Overall Study|Lost to Follow-up|0|||
130673093|NCT05476679|470427484|FG002|Overall Study|Lost to Follow-up|0|||
130673094|NCT05476679|470427485|FG003|Overall Study|Lost to Follow-up|1|||
130673095|NCT05476679|470427486|FG004|Overall Study|Lost to Follow-up|0|||
130673096|NCT01199601|470427492|FG000|Overall Study|Lost to Follow-up|47|||
130673097|NCT01199601|470427493|FG001|Overall Study|Lost to Follow-up|66|||
130673098|NCT01199601|470427492|FG000|Overall Study|Withdrawal by Subject|15|||
130673099|NCT01199601|470427493|FG001|Overall Study|Withdrawal by Subject|3|||
130673100|NCT01199601|470427492|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
130673101|NCT01199601|470427493|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
130673102|NCT02669264|470427494|FG000|Overall Study|Death|5|||
130673103|NCT02669264|470427495|FG001|Overall Study|Death|5|||
130673104|NCT02669264|470427496|FG002|Overall Study|Death|3|||
130673105|NCT02669264|470427497|FG003|Overall Study|Death|3|||
130673106|NCT02669264|470427498|FG004|Overall Study|Death|3|||
130673107|NCT02669264|470427499|FG005|Overall Study|Death|6|||
130673108|NCT02669264|470427500|FG006|Overall Study|Death|3|||
130673109|NCT02669264|470427494|FG000|Overall Study|Withdrawal by Subject|0|||
130673110|NCT02669264|470427495|FG001|Overall Study|Withdrawal by Subject|1|||
130673111|NCT02669264|470427496|FG002|Overall Study|Withdrawal by Subject|0|||
130673112|NCT02669264|470427497|FG003|Overall Study|Withdrawal by Subject|0|||
130673113|NCT02669264|470427498|FG004|Overall Study|Withdrawal by Subject|1|||
130673114|NCT02669264|470427499|FG005|Overall Study|Withdrawal by Subject|0|||
130673115|NCT02669264|470427500|FG006|Overall Study|Withdrawal by Subject|0|||
130673116|NCT02669264|470427494|FG000|Overall Study|Lost to Follow-up|0|||
130673117|NCT02669264|470427495|FG001|Overall Study|Lost to Follow-up|0|||
130673118|NCT02669264|470427496|FG002|Overall Study|Lost to Follow-up|0|||
130673119|NCT02669264|470427497|FG003|Overall Study|Lost to Follow-up|0|||
130673120|NCT02669264|470427498|FG004|Overall Study|Lost to Follow-up|1|||
130673121|NCT02669264|470427499|FG005|Overall Study|Lost to Follow-up|0|||
130673122|NCT02669264|470427500|FG006|Overall Study|Lost to Follow-up|0|||
130673123|NCT02669264|470427494|FG000|Overall Study|Miscellaneous|0|||
130673124|NCT02669264|470427495|FG001|Overall Study|Miscellaneous|0|||
130673125|NCT02669264|470427496|FG002|Overall Study|Miscellaneous|0|||
130673126|NCT02669264|470427497|FG003|Overall Study|Miscellaneous|0|||
130673127|NCT02669264|470427498|FG004|Overall Study|Miscellaneous|0|||
130673128|NCT02669264|470427499|FG005|Overall Study|Miscellaneous|0|||
130673129|NCT02669264|470427500|FG006|Overall Study|Miscellaneous|2|||
130673130|NCT01688037|470427501|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
130673131|NCT01688037|470427502|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
130673132|NCT01688037|470427503|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
130673133|NCT01688037|470427501|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
130673134|NCT01688037|470427502|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
130673135|NCT01688037|470427503|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
130673136|NCT01688037|470427501|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
130673137|NCT01688037|470427502|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
130673138|NCT01688037|470427503|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
130673139|NCT01688037|470427501|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130673140|NCT01688037|470427502|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
130673141|NCT01688037|470427503|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130673142|NCT01688037|470427501|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
130673143|NCT01688037|470427502|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
130673144|NCT01688037|470427503|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
130673145|NCT01688037|470427501|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
130673146|NCT01688037|470427502|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
130673147|NCT01688037|470427503|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
130673148|NCT01688037|470427501|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
130673149|NCT01688037|470427502|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
130673150|NCT01688037|470427503|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
130673151|NCT01688037|470427501|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
130341081|NCT01403948|469221050|FG007|Overall Study|Lost to Follow-up|0|||
130673152|NCT01688037|470427502|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
130673153|NCT01688037|470427503|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
130673154|NCT01688037|470427501|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
130673155|NCT01688037|470427502|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
130673156|NCT01688037|470427503|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
130673157|NCT01688037|470427501|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
130673158|NCT01688037|470427502|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
130673159|NCT01688037|470427503|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
130673160|NCT02100956|470427504|FG000|At Least One Week Between Injections|Adverse Event|0|||
130673161|NCT02100956|470427505|FG001|At Least One Week Between Injections|Adverse Event|1|||
130673162|NCT03035227|470427506|FG000|Overall Study|study stopped due to PI leaving institut|1|||
130673163|NCT03035227|470427507|FG001|Overall Study|study stopped due to PI leaving institut|1|||
130673164|NCT00859469|470427509|FG000|Overall Study|Adverse Event|2|||
130673165|NCT00859469|470427509|FG000|Overall Study|Lack of Efficacy|9|||
130673166|NCT00859469|470427509|FG000|Overall Study|Withdrawal by Subject|1|||
130673167|NCT00859469|470427509|FG000|Overall Study|Death|16|||
130673168|NCT02220907|470427510|FG000|Overall Study|Adverse Event|7|||
130673169|NCT02220907|470427510|FG000|Overall Study|Physician Decision|1|||
130673170|NCT02220907|470427510|FG000|Overall Study|Withdrawal by Subject|2|||
130673171|NCT02220907|470427510|FG000|Overall Study|Conflict with the stopping criteria|1|||
130673172|NCT03111147|470427511|FG000|Overall Study|Lost to Follow-up|2|||
130673173|NCT03111147|470427512|FG001|Overall Study|Lost to Follow-up|5|||
130673174|NCT03111147|470427511|FG000|Overall Study|Withdrawal by Subject|4|||
130673175|NCT03111147|470427512|FG001|Overall Study|Withdrawal by Subject|3|||
130673176|NCT03111147|470427511|FG000|Overall Study|Protocol Violation|2|||
130673177|NCT03111147|470427512|FG001|Overall Study|Protocol Violation|1|||
130673178|NCT03111147|470427511|FG000|Overall Study|Death|1|||
130673179|NCT03111147|470427512|FG001|Overall Study|Death|1|||
130673180|NCT00095199|470427515|FG000|Overall Study|Adverse Event|40|||
130673181|NCT00095199|470427516|FG001|Overall Study|Adverse Event|22|||
130673182|NCT00095199|470427517|FG002|Overall Study|Adverse Event|26|||
130673183|NCT00095199|470427518|FG003|Overall Study|Adverse Event|11|||
130673184|NCT00095199|470427515|FG000|Overall Study|Progressive disease|213|||
130673185|NCT00095199|470427516|FG001|Overall Study|Progressive disease|179|||
130673186|NCT00095199|470427517|FG002|Overall Study|Progressive disease|105|||
130673187|NCT00095199|470427518|FG003|Overall Study|Progressive disease|98|||
130673188|NCT00095199|470427515|FG000|Overall Study|Death|10|||
130673189|NCT00095199|470427516|FG001|Overall Study|Death|6|||
130673190|NCT00095199|470427517|FG002|Overall Study|Death|11|||
130673191|NCT00095199|470427518|FG003|Overall Study|Death|9|||
130673192|NCT00095199|470427515|FG000|Overall Study|Withdrawal by Subject|21|||
130673193|NCT00095199|470427516|FG001|Overall Study|Withdrawal by Subject|16|||
130673194|NCT00095199|470427517|FG002|Overall Study|Withdrawal by Subject|13|||
130673195|NCT00095199|470427518|FG003|Overall Study|Withdrawal by Subject|22|||
130673196|NCT00095199|470427515|FG000|Overall Study|Protocol Violation|4|||
130673197|NCT00095199|470427516|FG001|Overall Study|Protocol Violation|4|||
130673198|NCT00095199|470427517|FG002|Overall Study|Protocol Violation|2|||
130673199|NCT00095199|470427518|FG003|Overall Study|Protocol Violation|0|||
130673200|NCT00095199|470427515|FG000|Overall Study|Liver function test results elevated|0|||
130673201|NCT00095199|470427516|FG001|Overall Study|Liver function test results elevated|0|||
130673202|NCT00095199|470427517|FG002|Overall Study|Liver function test results elevated|1|||
130673203|NCT00095199|470427518|FG003|Overall Study|Liver function test results elevated|1|||
130673204|NCT00095199|470427515|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
130673205|NCT00095199|470427516|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
130673206|NCT00095199|470427517|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
130673207|NCT00095199|470427518|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
130673208|NCT00095199|470427515|FG000|Overall Study|Physician Decision|5|||
130673209|NCT00095199|470427516|FG001|Overall Study|Physician Decision|6|||
130673210|NCT00095199|470427517|FG002|Overall Study|Physician Decision|1|||
130673211|NCT00095199|470427518|FG003|Overall Study|Physician Decision|1|||
130673212|NCT00095199|470427515|FG000|Overall Study|Not eligible|1|||
130673213|NCT00095199|470427516|FG001|Overall Study|Not eligible|7|||
130673214|NCT00095199|470427517|FG002|Overall Study|Not eligible|0|||
130673215|NCT00095199|470427518|FG003|Overall Study|Not eligible|1|||
130673216|NCT00095199|470427515|FG000|Overall Study|Started Palliative Radiotherapy|1|||
130341082|NCT01403948|469221051|FG008|Overall Study|Lost to Follow-up|0|||
130341083|NCT01403948|469221052|FG009|Overall Study|Lost to Follow-up|1|||
130341084|NCT01403948|469221043|FG000|Overall Study|Refused cont. medication|0|||
130673217|NCT00095199|470427516|FG001|Overall Study|Started Palliative Radiotherapy|0|||
130673218|NCT00095199|470427517|FG002|Overall Study|Started Palliative Radiotherapy|0|||
130673219|NCT00095199|470427518|FG003|Overall Study|Started Palliative Radiotherapy|0|||
130673220|NCT00095199|470427515|FG000|Overall Study|Started radiotherapy regimen|0|||
130673221|NCT00095199|470427516|FG001|Overall Study|Started radiotherapy regimen|1|||
130673222|NCT00095199|470427517|FG002|Overall Study|Started radiotherapy regimen|0|||
130673223|NCT00095199|470427518|FG003|Overall Study|Started radiotherapy regimen|0|||
130673224|NCT00095199|470427515|FG000|Overall Study|Primary tumor removed in other surgery|0|||
130673225|NCT00095199|470427516|FG001|Overall Study|Primary tumor removed in other surgery|1|||
130673226|NCT00095199|470427517|FG002|Overall Study|Primary tumor removed in other surgery|0|||
130673227|NCT00095199|470427518|FG003|Overall Study|Primary tumor removed in other surgery|0|||
130673228|NCT00095199|470427515|FG000|Overall Study|Data inadvertently lost by site|1|||
130673229|NCT00095199|470427516|FG001|Overall Study|Data inadvertently lost by site|0|||
130673230|NCT00095199|470427517|FG002|Overall Study|Data inadvertently lost by site|0|||
130673231|NCT00095199|470427518|FG003|Overall Study|Data inadvertently lost by site|0|||
130673232|NCT01896297|470427521|FG000|Overall Study|Died in post treatment phase|1|||
130673233|NCT00832078|470429019|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
130673234|NCT00832078|470429020|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
130673235|NCT00832078|470429019|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
130673236|NCT00832078|470429020|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
130673237|NCT01767597|470429021|FG000|Overall Study|Incomplete intervention|3|||
130341085|NCT01403948|469221044|FG001|Overall Study|Refused cont. medication|0|||
130341086|NCT01403948|469221045|FG002|Overall Study|Refused cont. medication|0|||
130341087|NCT01403948|469221046|FG003|Overall Study|Refused cont. medication|0|||
130341088|NCT01403948|469221047|FG004|Overall Study|Refused cont. medication|1|||
130341089|NCT01403948|469221048|FG005|Overall Study|Refused cont. medication|0|||
130341090|NCT01403948|469221049|FG006|Overall Study|Refused cont. medication|0|||
130341091|NCT01403948|469221050|FG007|Overall Study|Refused cont. medication|0|||
130673238|NCT01767597|470429022|FG001|Overall Study|Incomplete intervention|1|||
130673239|NCT01767597|470429021|FG000|Overall Study|Withdrawal by Subject|1|||
130673240|NCT01767597|470429022|FG001|Overall Study|Withdrawal by Subject|0|||
130673241|NCT02961920|470429023|FG000|Overall Study|did not achive stydy protocol schedule|1|||
130673242|NCT02961920|470429024|FG001|Overall Study|did not achive stydy protocol schedule|1|||
130673243|NCT02232074|470429025|FG000|Overall Study|Withdrawal by Subject|5|||
130673244|NCT02232074|470429026|FG001|Overall Study|Withdrawal by Subject|3|||
130673245|NCT02232074|470429025|FG000|Overall Study|No legal concerns at baseline|36|||
130673246|NCT02232074|470429026|FG001|Overall Study|No legal concerns at baseline|41|||
130673247|NCT02232074|470429025|FG000|Overall Study|deemed ineligible|0|||
130673248|NCT02232074|470429026|FG001|Overall Study|deemed ineligible|1|||
130673249|NCT04480463|470429029|FG000|Overall Study|Death|0|||
130673250|NCT04480463|470429030|FG001|Overall Study|Death|1|||
130673251|NCT04480463|470429029|FG000|Overall Study|Adverse Event|6|||
130673252|NCT04480463|470429030|FG001|Overall Study|Adverse Event|8|||
130673253|NCT04480463|470429029|FG000|Overall Study|Lost to Follow-up|3|||
130673254|NCT04480463|470429030|FG001|Overall Study|Lost to Follow-up|2|||
130673255|NCT04480463|470429029|FG000|Overall Study|Physician Decision|2|||
130673256|NCT04480463|470429030|FG001|Overall Study|Physician Decision|5|||
130673257|NCT04480463|470429029|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
130673258|NCT04480463|470429030|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
130673259|NCT04480463|470429029|FG000|Overall Study|Protocol Violation|2|||
130673260|NCT04480463|470429030|FG001|Overall Study|Protocol Violation|1|||
130673261|NCT04480463|470429029|FG000|Overall Study|Withdrawal by Subject|6|||
130673262|NCT04480463|470429030|FG001|Overall Study|Withdrawal by Subject|7|||
130673263|NCT04480463|470429029|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
130673264|NCT04480463|470429030|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
130673265|NCT04480463|470429029|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
130673266|NCT04480463|470429030|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
130673267|NCT04480463|470429029|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
130673268|NCT04480463|470429030|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
130673269|NCT04480463|470429029|FG000|Overall Study|Other|6|||
130673270|NCT04480463|470429030|FG001|Overall Study|Other|4|||
130673271|NCT01579474|470429032|FG000|Overall Study|Adverse Event|1|||
130341092|NCT01403948|469221051|FG008|Overall Study|Refused cont. medication|0|||
130341093|NCT01403948|469221052|FG009|Overall Study|Refused cont. medication|1|||
130341094|NCT01403948|469221043|FG000|Overall Study|other than above|1|||
130341095|NCT01403948|469221044|FG001|Overall Study|other than above|2|||
130341096|NCT01403948|469221045|FG002|Overall Study|other than above|1|||
130341097|NCT01403948|469221046|FG003|Overall Study|other than above|0|||
130341098|NCT01403948|469221047|FG004|Overall Study|other than above|1|||
130341099|NCT01403948|469221048|FG005|Overall Study|other than above|1|||
130341100|NCT01403948|469221049|FG006|Overall Study|other than above|2|||
130341101|NCT01403948|469221050|FG007|Overall Study|other than above|0|||
130673272|NCT01579474|470429033|FG001|Overall Study|Adverse Event|13|||
130673273|NCT01579474|470429034|FG002|Overall Study|Adverse Event|2|||
130673274|NCT01579474|470429035|FG003|Overall Study|Adverse Event|0|||
130673275|NCT01579474|470429036|FG004|Overall Study|Adverse Event|0|||
130673276|NCT01579474|470429037|FG005|Overall Study|Adverse Event|1|||
130673277|NCT01579474|470429032|FG000|Overall Study|Lack of Efficacy|1|||
130673278|NCT01579474|470429033|FG001|Overall Study|Lack of Efficacy|0|||
130341102|NCT01403948|469221051|FG008|Overall Study|other than above|0|||
130341103|NCT01403948|469221052|FG009|Overall Study|other than above|0|||
130341104|NCT00763698|469221053|FG000|Overall Study|Unsuccessful Implant|5|||
130341105|NCT00763698|469221053|FG000|Overall Study|Death|4|||
130341106|NCT00763698|469221053|FG000|Overall Study|Withdrawal by Subject|1|||
130341107|NCT01960907|469221056|FG000|Overall Study|Death|4|||
130341108|NCT01960907|469221057|FG001|Overall Study|Death|3|||
130341109|NCT01960907|469221056|FG000|Overall Study|Withdrawal by Subject|32|||
130673279|NCT01579474|470429034|FG002|Overall Study|Lack of Efficacy|0|||
130673280|NCT01579474|470429035|FG003|Overall Study|Lack of Efficacy|0|||
130673281|NCT01579474|470429036|FG004|Overall Study|Lack of Efficacy|1|||
130673282|NCT01579474|470429037|FG005|Overall Study|Lack of Efficacy|0|||
130341110|NCT01960907|469221057|FG001|Overall Study|Withdrawal by Subject|42|||
130341111|NCT00080899|469221058|FG000|Overall Study|Adverse Event|1|||
130673283|NCT01579474|470429032|FG000|Overall Study|Withdrawal by Subject|1|||
130673284|NCT01579474|470429033|FG001|Overall Study|Withdrawal by Subject|0|||
130673285|NCT01579474|470429034|FG002|Overall Study|Withdrawal by Subject|0|||
130673286|NCT01579474|470429035|FG003|Overall Study|Withdrawal by Subject|0|||
130341112|NCT00717236|469221059|FG000|Double-Blind Period|Adverse Event|33|||
130341113|NCT00717236|469221060|FG001|Double-Blind Period|Adverse Event|6|||
130341114|NCT00717236|469221059|FG000|Double-Blind Period|Lack of Efficacy|6|||
130673287|NCT01579474|470429036|FG004|Overall Study|Withdrawal by Subject|0|||
130673288|NCT01579474|470429037|FG005|Overall Study|Withdrawal by Subject|0|||
130673289|NCT02637076|470429038|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
130673290|NCT02637076|470429039|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
130673291|NCT02637076|470429038|FG000|Overall Study|Withdrawal by Subject|0|||
130673292|NCT02637076|470429039|FG001|Overall Study|Withdrawal by Subject|4|||
130673293|NCT00130520|470429040|FG000|Overall Study|Adverse Event|11|||
130673294|NCT00130520|470429040|FG000|Overall Study|Death|1|||
130673295|NCT00130520|470429040|FG000|Overall Study|Physician Decision|1|||
130673296|NCT00130520|470429040|FG000|Overall Study|Withdrawal by Subject|1|||
130673297|NCT00130520|470429040|FG000|Overall Study|Disease Progression|23|||
130673298|NCT00130520|470429040|FG000|Overall Study|Protocol non-compliance|1|||
130673299|NCT00130520|470429040|FG000|Overall Study|Did not meet re-treatment criteria|1|||
130673300|NCT01238848|470429042|FG000|Overall Study|Physician Decision|13|||
130673301|NCT01238848|470429043|FG001|Overall Study|Physician Decision|5|||
130673302|NCT00576901|470429045|FG000|Overall Study|Withdrawal by Subject|1|||
130673303|NCT00576901|470429045|FG000|Overall Study|Disease course|1|||
130673304|NCT00576901|470429045|FG000|Overall Study|Protocol Violation|1|||
130673305|NCT01755858|470429048|FG000|Overall Study|Adverse Event|1|||
130673306|NCT01755858|470429049|FG001|Overall Study|Adverse Event|1|||
130673307|NCT02398188|470429050|FG000|Overall Study|Adverse Event|2|||
130673308|NCT02398188|470429051|FG001|Overall Study|Adverse Event|3|||
130673309|NCT02398188|470429050|FG000|Overall Study|Lost to Follow-up|5|||
130673310|NCT02398188|470429051|FG001|Overall Study|Lost to Follow-up|0|||
130673311|NCT02398188|470429050|FG000|Overall Study|Non-compliance|4|||
130673312|NCT02398188|470429051|FG001|Overall Study|Non-compliance|4|||
130673313|NCT02398188|470429050|FG000|Overall Study|Protocol Violation|6|||
130673314|NCT02398188|470429051|FG001|Overall Study|Protocol Violation|10|||
130673315|NCT02398188|470429050|FG000|Overall Study|Sponsor Decision|2|||
130673316|NCT02398188|470429051|FG001|Overall Study|Sponsor Decision|1|||
130673317|NCT02398188|470429050|FG000|Overall Study|Pregnancy|1|||
130673318|NCT02398188|470429051|FG001|Overall Study|Pregnancy|0|||
130673319|NCT02398188|470429050|FG000|Overall Study|Withdrawal by Subject|7|||
130673320|NCT02398188|470429051|FG001|Overall Study|Withdrawal by Subject|16|||
130673321|NCT00782509|470429052|FG000|Overall Study|Adverse Event|20|||
130673322|NCT00782509|470429053|FG001|Overall Study|Adverse Event|10|||
130673323|NCT00782509|470429054|FG002|Overall Study|Adverse Event|20|||
130673324|NCT00782509|470429052|FG000|Overall Study|Lost to Follow-up|1|||
130673325|NCT00782509|470429053|FG001|Overall Study|Lost to Follow-up|2|||
130673326|NCT00782509|470429054|FG002|Overall Study|Lost to Follow-up|3|||
130673327|NCT00782509|470429052|FG000|Overall Study|Withdrawal by Subject|3|||
130673328|NCT00782509|470429053|FG001|Overall Study|Withdrawal by Subject|5|||
130673329|NCT00782509|470429054|FG002|Overall Study|Withdrawal by Subject|8|||
130673330|NCT00782509|470429052|FG000|Overall Study|Non compliance with protocol|2|||
130673331|NCT00782509|470429053|FG001|Overall Study|Non compliance with protocol|0|||
130673332|NCT00782509|470429054|FG002|Overall Study|Non compliance with protocol|0|||
130673333|NCT00782509|470429052|FG000|Overall Study|Other reasons not stated above|5|||
130673334|NCT00782509|470429053|FG001|Overall Study|Other reasons not stated above|2|||
130673335|NCT00782509|470429054|FG002|Overall Study|Other reasons not stated above|3|||
130673336|NCT00782509|470429052|FG000|Overall Study|Lack of Efficacy|10|||
130341115|NCT00717236|469221060|FG001|Double-Blind Period|Lack of Efficacy|6|||
130673337|NCT00782509|470429053|FG001|Overall Study|Lack of Efficacy|5|||
130673338|NCT00782509|470429054|FG002|Overall Study|Lack of Efficacy|2|||
130673339|NCT01259869|470429055|FG000|Overall Study|Duplicated registration|1|||
130673340|NCT00175019|470429056|FG000|Overall Study|Adverse Event|54|||
130673341|NCT00175019|470429057|FG001|Overall Study|Adverse Event|22|||
130673342|NCT00175019|470429058|FG002|Overall Study|Adverse Event|2|||
130673343|NCT00175019|470429056|FG000|Overall Study|Protocol Violation|6|||
130673344|NCT00175019|470429057|FG001|Overall Study|Protocol Violation|3|||
130673345|NCT00175019|470429058|FG002|Overall Study|Protocol Violation|3|||
130673346|NCT00175019|470429056|FG000|Overall Study|Lost to Follow-up|42|||
130673347|NCT00175019|470429057|FG001|Overall Study|Lost to Follow-up|39|||
130341116|NCT00717236|469221059|FG000|Double-Blind Period|Lost to Follow-up|3|||
130341117|NCT00717236|469221060|FG001|Double-Blind Period|Lost to Follow-up|5|||
130673348|NCT00175019|470429058|FG002|Overall Study|Lost to Follow-up|9|||
130673349|NCT00175019|470429056|FG000|Overall Study|Did not continue under Amendment 4|1|||
130673350|NCT00175019|470429057|FG001|Overall Study|Did not continue under Amendment 4|1|||
130673351|NCT00175019|470429058|FG002|Overall Study|Did not continue under Amendment 4|2|||
130673352|NCT00175019|470429056|FG000|Overall Study|Personal Reason(s)|39|||
130673353|NCT00175019|470429057|FG001|Overall Study|Personal Reason(s)|31|||
130673354|NCT00175019|470429058|FG002|Overall Study|Personal Reason(s)|8|||
130673355|NCT00175019|470429056|FG000|Overall Study|Therapeutic Failure|10|||
130673356|NCT00175019|470429057|FG001|Overall Study|Therapeutic Failure|38|||
130673357|NCT00175019|470429058|FG002|Overall Study|Therapeutic Failure|22|||
130673358|NCT00175019|470429056|FG000|Overall Study|Gout Flare|2|||
130673359|NCT00175019|470429057|FG001|Overall Study|Gout Flare|3|||
130673360|NCT00175019|470429058|FG002|Overall Study|Gout Flare|0|||
130673361|NCT00175019|470429056|FG000|Overall Study|Reason Not Specified|40|||
130673362|NCT00175019|470429057|FG001|Overall Study|Reason Not Specified|34|||
130673363|NCT00175019|470429058|FG002|Overall Study|Reason Not Specified|11|||
130673364|NCT03209570|470429059|FG000|Overall Study|Death|1|||
130673365|NCT03209570|470429060|FG001|Overall Study|Death|0|||
130673366|NCT03209570|470429059|FG000|Overall Study|Incomplete Data|8|||
130673367|NCT03209570|470429060|FG001|Overall Study|Incomplete Data|10|||
130673368|NCT03209570|470429059|FG000|Overall Study|Protocol Violation|1|||
130673369|NCT03209570|470429060|FG001|Overall Study|Protocol Violation|0|||
130673370|NCT03209570|470429059|FG000|Overall Study|Withdrawal by Subject|0|||
130673371|NCT03209570|470429060|FG001|Overall Study|Withdrawal by Subject|3|||
130673372|NCT00220701|470429071|FG000|Overall Study|Lost to Follow-up|5|||
130673373|NCT00220701|470429072|FG001|Overall Study|Lost to Follow-up|4|||
130673374|NCT00755326|470429074|FG000|Overall Study|Lost to Follow-up|2|||
130673375|NCT00755326|470429075|FG001|Overall Study|Lost to Follow-up|3|||
130673376|NCT04041570|470429081|FG000|Overall Study|Moved from Area|0|||
130673377|NCT04041570|470429082|FG001|Overall Study|Moved from Area|2|||
130673378|NCT01338636|470429083|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
130673379|NCT02385526|470429084|FG000|Overall Study|Withdrawal by Subject|0|||
130673380|NCT02385526|470429085|FG001|Overall Study|Withdrawal by Subject|2|||
130673381|NCT02385526|470429086|FG002|Overall Study|Withdrawal by Subject|0|||
130673382|NCT02385526|470429084|FG000|Overall Study|Lost to Follow-up|0|||
130673383|NCT02385526|470429085|FG001|Overall Study|Lost to Follow-up|1|||
130673384|NCT02385526|470429086|FG002|Overall Study|Lost to Follow-up|0|||
130673385|NCT02385526|470429084|FG000|Overall Study|Physician Decision|1|||
130673386|NCT02385526|470429085|FG001|Overall Study|Physician Decision|0|||
130673387|NCT02385526|470429086|FG002|Overall Study|Physician Decision|0|||
130673388|NCT02385526|470429084|FG000|Overall Study|Protocol Violation|1|||
130673389|NCT02385526|470429085|FG001|Overall Study|Protocol Violation|0|||
130673390|NCT02385526|470429086|FG002|Overall Study|Protocol Violation|0|||
130673391|NCT03532009|470429087|FG000|Overall Study|Other|1|||
130673392|NCT03532009|470429088|FG001|Overall Study|Other|1|||
130673393|NCT03532009|470429087|FG000|Overall Study|Death|1|||
130673394|NCT03532009|470429088|FG001|Overall Study|Death|1|||
130673395|NCT03532009|470429087|FG000|Overall Study|Withdrawal by Patient|0|||
130673396|NCT03532009|470429088|FG001|Overall Study|Withdrawal by Patient|2|||
130673397|NCT02035137|470429090|FG000|Overall Study|Physician Decision|0|||
130673398|NCT02035137|470429091|FG001|Overall Study|Physician Decision|0|||
130673399|NCT02035137|470429092|FG002|Overall Study|Physician Decision|1|||
130673400|NCT02035137|470429090|FG000|Overall Study|Withdrawal by Subject|0|||
130673401|NCT02035137|470429091|FG001|Overall Study|Withdrawal by Subject|1|||
130673402|NCT02035137|470429092|FG002|Overall Study|Withdrawal by Subject|2|||
130673403|NCT02035137|470429090|FG000|Overall Study|Ineligible|0|||
130673404|NCT02035137|470429091|FG001|Overall Study|Ineligible|1|||
130673405|NCT02035137|470429092|FG002|Overall Study|Ineligible|2|||
130673406|NCT02035137|470429090|FG000|Overall Study|Disease progression prior to treatment start|2|||
130673407|NCT02035137|470429091|FG001|Overall Study|Disease progression prior to treatment start|0|||
130673408|NCT02035137|470429092|FG002|Overall Study|Disease progression prior to treatment start|0|||
130673409|NCT01006707|470429108|FG000|Study Session 1|Lost to Follow-up|2|||
130673410|NCT01006707|470429109|FG001|Study Session 1|Lost to Follow-up|0|||
130673411|NCT01006707|470429110|FG002|Study Session 1|Lost to Follow-up|0|||
130673412|NCT01006707|470429108|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
130341118|NCT00717236|469221059|FG000|Double-Blind Period|Withdrawal by Subject|10|||
130673413|NCT01006707|470429109|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
130673414|NCT01006707|470429110|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
130673415|NCT02750306|470429111|FG000|Overall Study|Withdrawal by Subject|5|||
130673416|NCT02750306|470429112|FG001|Overall Study|Withdrawal by Subject|2|||
130673417|NCT02750306|470429111|FG000|Overall Study|Protocol Violation|1|||
130673418|NCT02750306|470429112|FG001|Overall Study|Protocol Violation|0|||
130673419|NCT02737306|470429113|FG000|Overall Study|Adverse Event|3|||
130673420|NCT02737306|470429114|FG001|Overall Study|Adverse Event|0|||
130673421|NCT02737306|470429113|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
130673422|NCT02737306|470429114|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
130673423|NCT05034731|470429115|FG000|Overall Study|Screen fail|1|||
130673424|NCT05034731|470429116|FG001|Overall Study|Screen fail|1|||
130673425|NCT00283686|470429118|FG000|Overall Study|Death|1|||
130673426|NCT00283686|470429119|FG001|Overall Study|Death|1|||
130673427|NCT00283686|470429120|FG002|Overall Study|Death|1|||
130673428|NCT00283686|470429121|FG003|Overall Study|Death|0|||
130673429|NCT00283686|470429118|FG000|Overall Study|Lost to Follow-up|21|||
130673430|NCT00283686|470429119|FG001|Overall Study|Lost to Follow-up|31|||
130673431|NCT00283686|470429120|FG002|Overall Study|Lost to Follow-up|26|||
130673432|NCT00283686|470429121|FG003|Overall Study|Lost to Follow-up|20|||
130673433|NCT00283686|470429118|FG000|Overall Study|Less than full participation|7|||
130673434|NCT00283686|470429119|FG001|Overall Study|Less than full participation|9|||
130673435|NCT00283686|470429120|FG002|Overall Study|Less than full participation|6|||
130673436|NCT00283686|470429121|FG003|Overall Study|Less than full participation|12|||
130673437|NCT02970669|470429122|FG000|Double-blind Period|Adverse Event|4|||
130673438|NCT02970669|470429123|FG001|Double-blind Period|Adverse Event|0|||
130673439|NCT02970669|470429122|FG000|Double-blind Period|Death|1|||
130673440|NCT02970669|470429123|FG001|Double-blind Period|Death|0|||
130673441|NCT02970669|470429122|FG000|Double-blind Period|Study terminated by sponsor|1|||
130673442|NCT02970669|470429123|FG001|Double-blind Period|Study terminated by sponsor|2|||
130673443|NCT02970669|470429122|FG000|Double-blind Period|Physician Decision|0|||
130673444|NCT02970669|470429123|FG001|Double-blind Period|Physician Decision|2|||
130673445|NCT02970669|470429122|FG000|Double-blind Period|Withdrawal by Subject|2|||
130673446|NCT02970669|470429123|FG001|Double-blind Period|Withdrawal by Subject|2|||
130673447|NCT02970669|470429122|FG000|Open-label Period|Withdrawal by Subject|2|||
130673448|NCT02970669|470429123|FG001|Open-label Period|Withdrawal by Subject|2|||
130673449|NCT02970669|470429122|FG000|Open-label Period|Adverse Event|1|||
130673450|NCT02970669|470429123|FG001|Open-label Period|Adverse Event|0|||
130673451|NCT02970669|470429122|FG000|Open-label Period|Physician Decision|1|||
130673452|NCT02970669|470429123|FG001|Open-label Period|Physician Decision|0|||
130673453|NCT03521999|470429124|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
130673454|NCT03521999|470429125|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
130673455|NCT03521999|470429124|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
130673456|NCT03521999|470429125|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
130673457|NCT03521999|470429124|FG000|Completed 3 Month Follow up|Death|0|||
130673458|NCT03521999|470429125|FG001|Completed 3 Month Follow up|Death|1|||
130673459|NCT03521999|470429124|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
130673460|NCT03521999|470429125|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
130673461|NCT00467584|470429130|FG000|Overall Study|Withdrawal by Subject|4|||
130673462|NCT00467584|470429131|FG001|Overall Study|Withdrawal by Subject|5|||
130673463|NCT00467584|470429132|FG002|Overall Study|Withdrawal by Subject|1|||
130673464|NCT01498484|470429136|FG000|Overall Study|Death|6|||
130341119|NCT00717236|469221060|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130341120|NCT00717236|469221059|FG000|Double-Blind Period|Loss of efficacy|3|||
130341121|NCT00717236|469221060|FG001|Double-Blind Period|Loss of efficacy|0|||
130341122|NCT00717236|469221059|FG000|Double-Blind Period|Other: Death|1|||
130341123|NCT00717236|469221060|FG001|Double-Blind Period|Other: Death|0|||
130341124|NCT00717236|469221059|FG000|Double-Blind Period|Other: Pregnancy|1|||
130341125|NCT00717236|469221060|FG001|Double-Blind Period|Other: Pregnancy|0|||
130341126|NCT00717236|469221059|FG000|Double-Blind Period|Other: Protocol Violation|2|||
130341127|NCT00717236|469221060|FG001|Double-Blind Period|Other: Protocol Violation|0|||
130341128|NCT00717236|469221059|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
130341129|NCT00717236|469221060|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
130341130|NCT00717236|469221059|FG000|Double-Blind Period|Other: Site withdrew|2|||
130341131|NCT00717236|469221060|FG001|Double-Blind Period|Other: Site withdrew|0|||
130341132|NCT00717236|469221059|FG000|Double-Blind Period|Other: Screening failure|1|||
130341133|NCT00717236|469221060|FG001|Double-Blind Period|Other: Screening failure|0|||
130341134|NCT00717236|469221059|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
130341135|NCT00717236|469221060|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
130341136|NCT00717236|469221059|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
130341137|NCT00717236|469221060|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
130341138|NCT00717236|469221059|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
130673465|NCT01498484|470429137|FG001|Overall Study|Death|3|||
130673466|NCT01498484|470429138|FG002|Overall Study|Death|1|||
130673467|NCT01498484|470429139|FG003|Overall Study|Death|1|||
130673468|NCT01498484|470429140|FG004|Overall Study|Death|0|||
130673469|NCT01498484|470429141|FG005|Overall Study|Death|0|||
130673470|NCT01498484|470429142|FG006|Overall Study|Death|10|||
130673471|NCT01498484|470429143|FG007|Overall Study|Death|1|||
130673472|NCT01498484|470429144|FG008|Overall Study|Death|0|||
130673473|NCT01498484|470429136|FG000|Overall Study|Physician Decision|3|||
130673474|NCT01498484|470429137|FG001|Overall Study|Physician Decision|2|||
130673475|NCT01498484|470429138|FG002|Overall Study|Physician Decision|1|||
130673476|NCT01498484|470429139|FG003|Overall Study|Physician Decision|1|||
130673477|NCT01498484|470429140|FG004|Overall Study|Physician Decision|0|||
130673478|NCT01498484|470429141|FG005|Overall Study|Physician Decision|0|||
130341139|NCT00717236|469221060|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
130341140|NCT00717236|469221059|FG000|Double-Blind Period|Other: History of cancer|1|||
130673479|NCT01498484|470429142|FG006|Overall Study|Physician Decision|8|||
130673480|NCT01498484|470429143|FG007|Overall Study|Physician Decision|13|||
130673481|NCT01498484|470429144|FG008|Overall Study|Physician Decision|1|||
130673482|NCT01498484|470429136|FG000|Overall Study|Adverse Event|0|||
130673483|NCT01498484|470429137|FG001|Overall Study|Adverse Event|0|||
130673484|NCT01498484|470429138|FG002|Overall Study|Adverse Event|0|||
130673485|NCT01498484|470429139|FG003|Overall Study|Adverse Event|0|||
130673486|NCT01498484|470429140|FG004|Overall Study|Adverse Event|0|||
130673487|NCT01498484|470429141|FG005|Overall Study|Adverse Event|1|||
130673488|NCT01498484|470429142|FG006|Overall Study|Adverse Event|0|||
130341141|NCT00717236|469221060|FG001|Double-Blind Period|Other: History of cancer|0|||
130341142|NCT00717236|469221059|FG000|Double-Blind Period|Other: Sponsor request|1|||
130673489|NCT01498484|470429143|FG007|Overall Study|Adverse Event|0|||
130673490|NCT01498484|470429144|FG008|Overall Study|Adverse Event|0|||
130673491|NCT01498484|470429136|FG000|Overall Study|Withdrawal by Subject|0|||
130673492|NCT01498484|470429137|FG001|Overall Study|Withdrawal by Subject|0|||
130673493|NCT01498484|470429138|FG002|Overall Study|Withdrawal by Subject|0|||
130673494|NCT01498484|470429139|FG003|Overall Study|Withdrawal by Subject|1|||
130673495|NCT01498484|470429140|FG004|Overall Study|Withdrawal by Subject|0|||
130673496|NCT01498484|470429141|FG005|Overall Study|Withdrawal by Subject|0|||
130673497|NCT01498484|470429142|FG006|Overall Study|Withdrawal by Subject|1|||
130673498|NCT01498484|470429143|FG007|Overall Study|Withdrawal by Subject|0|||
130673499|NCT01498484|470429144|FG008|Overall Study|Withdrawal by Subject|0|||
130673500|NCT01498484|470429136|FG000|Overall Study|Other|5|||
130673501|NCT01498484|470429137|FG001|Overall Study|Other|2|||
130673502|NCT01498484|470429138|FG002|Overall Study|Other|0|||
130673503|NCT01498484|470429139|FG003|Overall Study|Other|0|||
130673504|NCT01498484|470429140|FG004|Overall Study|Other|1|||
130673505|NCT01498484|470429141|FG005|Overall Study|Other|0|||
130673506|NCT01498484|470429142|FG006|Overall Study|Other|3|||
130673507|NCT01498484|470429143|FG007|Overall Study|Other|0|||
130673508|NCT01498484|470429144|FG008|Overall Study|Other|1|||
130341143|NCT00717236|469221060|FG001|Double-Blind Period|Other: Sponsor request|0|||
130341144|NCT00717236|469221059|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
130341145|NCT00717236|469221060|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
130341146|NCT00717236|469221059|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
130341147|NCT00717236|469221060|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
130341148|NCT00717236|469221059|FG000|Double-Blind Period|Other: Subject moved|1|||
130341149|NCT00717236|469221060|FG001|Double-Blind Period|Other: Subject moved|1|||
130341150|NCT00717236|469221059|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
130341151|NCT00717236|469221060|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
130341152|NCT00717236|469221059|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
130341153|NCT00717236|469221060|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
130341154|NCT00717236|469221059|FG000|Double-Blind Period|Other: Transportation problems|0|||
130341155|NCT00717236|469221060|FG001|Double-Blind Period|Other: Transportation problems|1|||
130341156|NCT00717236|469221059|FG000|Double-Blind Period|Other: Investigator Decision|0|||
130341157|NCT00717236|469221060|FG001|Double-Blind Period|Other: Investigator Decision|1|||
130341158|NCT00717236|469221059|FG000|Open-Label Period|Adverse Event|29|||
130341159|NCT00717236|469221060|FG001|Open-Label Period|Adverse Event|4|||
130341160|NCT00717236|469221059|FG000|Open-Label Period|Lack of Efficacy|30|||
130341161|NCT00717236|469221060|FG001|Open-Label Period|Lack of Efficacy|8|||
130341162|NCT00717236|469221059|FG000|Open-Label Period|Lost to Follow-up|28|||
130341163|NCT00717236|469221060|FG001|Open-Label Period|Lost to Follow-up|4|||
130341164|NCT00717236|469221059|FG000|Open-Label Period|Withdrawal by Subject|20|||
130341165|NCT00717236|469221060|FG001|Open-Label Period|Withdrawal by Subject|2|||
130341166|NCT00717236|469221059|FG000|Open-Label Period|Loss of Efficacy|6|||
130341167|NCT00717236|469221060|FG001|Open-Label Period|Loss of Efficacy|1|||
130341168|NCT00717236|469221059|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
130341169|NCT00717236|469221060|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
130341170|NCT00717236|469221059|FG000|Open-Label Period|Other: Lack of Compliance|1|||
130341171|NCT00717236|469221060|FG001|Open-Label Period|Other: Lack of Compliance|1|||
130341172|NCT00717236|469221059|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
130341173|NCT00717236|469221060|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
130341174|NCT00717236|469221059|FG000|Open-Label Period|Other: Moved|1|||
130673509|NCT00319956|470429145|FG000|Overall Study|Death|20|||
130673510|NCT00319956|470429146|FG001|Overall Study|Death|24|||
130673511|NCT02607800|470429148|FG000|Overall Study|Lost to Follow-up|7|||
130673512|NCT02607800|470429149|FG001|Overall Study|Lost to Follow-up|10|||
130673513|NCT02607800|470429148|FG000|Overall Study|Withdrew Consent|2|||
130673514|NCT02607800|470429149|FG001|Overall Study|Withdrew Consent|0|||
130673515|NCT02607800|470429148|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
130341175|NCT00717236|469221060|FG001|Open-Label Period|Other: Moved|0|||
130341176|NCT00717236|469221059|FG000|Open-Label Period|Other: Investigator Decision|1|||
130341177|NCT00717236|469221060|FG001|Open-Label Period|Other: Investigator Decision|0|||
130341178|NCT00717236|469221059|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
130673516|NCT02607800|470429149|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
130673517|NCT00753714|470429150|FG000|Overall Study|Lack of Efficacy|21|||
130341179|NCT00717236|469221060|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
130341180|NCT00717236|469221059|FG000|Open-Label Period|Other: Sponsor Request|3|||
130341181|NCT00717236|469221060|FG001|Open-Label Period|Other: Sponsor Request|0|||
130341182|NCT00717236|469221059|FG000|Open-Label Period|Other: Cataract Surgery|1|||
130341183|NCT00717236|469221060|FG001|Open-Label Period|Other: Cataract Surgery|0|||
130341184|NCT00717236|469221059|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
130341185|NCT00717236|469221060|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
130341186|NCT00717236|469221059|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
130341187|NCT00717236|469221060|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
130341188|NCT00717236|469221059|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
130341189|NCT00717236|469221060|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
130341190|NCT00475982|469221061|FG000|Overall Study|surgery rescheduled|7|||
130341191|NCT00475982|469221062|FG001|Overall Study|surgery rescheduled|3|||
130341192|NCT00783198|469221067|FG000|Overall Study|Adverse Event|15|||
130341193|NCT00783198|469221068|FG001|Overall Study|Adverse Event|19|||
130341194|NCT00783198|469221069|FG002|Overall Study|Adverse Event|3|||
130341195|NCT00783198|469221067|FG000|Overall Study|Lost to Follow-up|11|||
130341196|NCT00783198|469221068|FG001|Overall Study|Lost to Follow-up|1|||
130341197|NCT00783198|469221069|FG002|Overall Study|Lost to Follow-up|7|||
130673518|NCT00753714|470429151|FG001|Overall Study|Lack of Efficacy|34|||
130341198|NCT00783198|469221067|FG000|Overall Study|Withdrawal by Subject|22|||
130341199|NCT00783198|469221068|FG001|Overall Study|Withdrawal by Subject|14|||
130341200|NCT00783198|469221069|FG002|Overall Study|Withdrawal by Subject|20|||
130341201|NCT00783198|469221067|FG000|Overall Study|Noncompliance with protocol|7|||
130341202|NCT00783198|469221068|FG001|Overall Study|Noncompliance with protocol|7|||
130341203|NCT00783198|469221069|FG002|Overall Study|Noncompliance with protocol|10|||
130341204|NCT00783198|469221067|FG000|Overall Study|Did not meet protocol eligibility|0|||
130341205|NCT00783198|469221068|FG001|Overall Study|Did not meet protocol eligibility|1|||
130341206|NCT00783198|469221069|FG002|Overall Study|Did not meet protocol eligibility|0|||
130341207|NCT00783198|469221067|FG000|Overall Study|Administrative|2|||
130341208|NCT00783198|469221068|FG001|Overall Study|Administrative|1|||
130341209|NCT00783198|469221069|FG002|Overall Study|Administrative|2|||
130341210|NCT03704636|469221070|FG000|Overall Study|Inadequate Venous Flow|3|||
130341211|NCT00539188|469221073|FG000|Overall Study|Withdrawal by Subject|1|||
130341212|NCT00539188|469221074|FG001|Overall Study|Withdrawal by Subject|0|||
130341213|NCT00539188|469221073|FG000|Overall Study|Lost to Follow-up|2|||
130341214|NCT00539188|469221074|FG001|Overall Study|Lost to Follow-up|1|||
130341215|NCT04784442|469221075|FG000|Overall Study|Adverse Event|1|||
130341216|NCT04784442|469221076|FG001|Overall Study|Adverse Event|0|||
130341217|NCT04784442|469221077|FG002|Overall Study|Adverse Event|2|||
130341218|NCT04784442|469221078|FG003|Overall Study|Adverse Event|1|||
130341219|NCT04784442|469221075|FG000|Overall Study|Protocol Violation|1|||
130341220|NCT04784442|469221076|FG001|Overall Study|Protocol Violation|0|||
130341221|NCT04784442|469221077|FG002|Overall Study|Protocol Violation|0|||
130341222|NCT04784442|469221078|FG003|Overall Study|Protocol Violation|0|||
130341223|NCT04784442|469221075|FG000|Overall Study|Non-compliance with study drug|1|||
130341224|NCT04784442|469221076|FG001|Overall Study|Non-compliance with study drug|0|||
130341225|NCT04784442|469221077|FG002|Overall Study|Non-compliance with study drug|0|||
130341226|NCT04784442|469221078|FG003|Overall Study|Non-compliance with study drug|0|||
130341227|NCT00852371|469221081|FG000|Overall Study|Lost to Follow-up|2|||
130341228|NCT00852371|469221082|FG001|Overall Study|Lost to Follow-up|3|||
130341229|NCT00852371|469221083|FG002|Overall Study|Lost to Follow-up|4|||
130341230|NCT00852371|469221084|FG003|Overall Study|Lost to Follow-up|2|||
130673519|NCT00753714|470429150|FG000|Overall Study|Adverse Event|26|||
130673520|NCT00753714|470429151|FG001|Overall Study|Adverse Event|18|||
130673521|NCT00753714|470429150|FG000|Overall Study|Protocol Violation|1|||
130673522|NCT00753714|470429151|FG001|Overall Study|Protocol Violation|0|||
130673523|NCT00753714|470429150|FG000|Overall Study|Lost to Follow-up|0|||
130673524|NCT00753714|470429151|FG001|Overall Study|Lost to Follow-up|1|||
130673525|NCT00753714|470429150|FG000|Overall Study|Withdrawal by Subject|2|||
130673526|NCT00753714|470429151|FG001|Overall Study|Withdrawal by Subject|1|||
130673527|NCT00753714|470429150|FG000|Overall Study|Death|3|||
130673528|NCT00753714|470429151|FG001|Overall Study|Death|3|||
130341231|NCT01590758|469221085|FG000|Overall Study|Withdrawal by Subject|0|||
130341232|NCT01590758|469221086|FG001|Overall Study|Withdrawal by Subject|3|||
130341233|NCT01590758|469221085|FG000|Overall Study|Physician Decision|1|||
130341234|NCT01590758|469221086|FG001|Overall Study|Physician Decision|2|||
130673529|NCT00753714|470429150|FG000|Overall Study|Other|7|||
130673530|NCT00753714|470429151|FG001|Overall Study|Other|5|||
130341235|NCT01590758|469221085|FG000|Overall Study|Lost to Follow-up|4|||
130341236|NCT01590758|469221086|FG001|Overall Study|Lost to Follow-up|2|||
130341237|NCT04525885|469221087|FG000|Overall Study|Screen Failure|1|||
130341238|NCT04525885|469221088|FG001|Overall Study|Screen Failure|0|||
130341239|NCT04525885|469221089|FG002|Overall Study|Screen Failure|0|||
130341240|NCT04525885|469221087|FG000|Overall Study|Withdrawal by Subject|14|||
130341241|NCT04525885|469221088|FG001|Overall Study|Withdrawal by Subject|6|||
130341242|NCT04525885|469221089|FG002|Overall Study|Withdrawal by Subject|20|||
130673531|NCT02486796|470429152|FG000|Overall Study|Withdrawal by Subject|1|||
130673532|NCT02486796|470429153|FG001|Overall Study|Withdrawal by Subject|1|||
130673533|NCT02486796|470429152|FG000|Overall Study|Physician Decision|1|||
130673534|NCT02486796|470429153|FG001|Overall Study|Physician Decision|0|||
130673535|NCT01185288|470429154|FG000|Overall Study|Adverse Event|7|||
130673536|NCT01185288|470429155|FG001|Overall Study|Adverse Event|6|||
130341243|NCT04525885|469221087|FG000|Overall Study|Physician Decision|1|||
130341244|NCT04525885|469221088|FG001|Overall Study|Physician Decision|0|||
130341245|NCT04525885|469221089|FG002|Overall Study|Physician Decision|1|||
130341246|NCT02756806|469221090|FG000|Overall Study|Study terminated early|5|||
130341247|NCT02717832|469221091|FG000|Overall Study|Inability to place IV|3|||
130341248|NCT01008423|469221092|FG000|Overall Study|Adverse Event|13|||
130341249|NCT01008423|469221093|FG001|Overall Study|Adverse Event|6|||
130341250|NCT01008423|469221092|FG000|Overall Study|Withdrawal by Subject|4|||
130341251|NCT01008423|469221093|FG001|Overall Study|Withdrawal by Subject|7|||
130341252|NCT01008423|469221092|FG000|Overall Study|Lost to Follow-up|0|||
130341253|NCT01008423|469221093|FG001|Overall Study|Lost to Follow-up|2|||
130341254|NCT01008423|469221092|FG000|Overall Study|Low Cortisol|0|||
130341255|NCT01008423|469221093|FG001|Overall Study|Low Cortisol|1|||
130341256|NCT01008423|469221092|FG000|Overall Study|Lack of Efficacy|0|||
130341257|NCT01008423|469221093|FG001|Overall Study|Lack of Efficacy|5|||
130341258|NCT01008423|469221092|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
130341259|NCT01008423|469221093|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
130341260|NCT01008423|469221092|FG000|Overall Study|Personal Conflict|1|||
130341261|NCT01008423|469221093|FG001|Overall Study|Personal Conflict|0|||
130341262|NCT01008423|469221092|FG000|Overall Study|Other|0|||
130341263|NCT01008423|469221093|FG001|Overall Study|Other|1|||
130341264|NCT00934843|469221095|FG000|Overall Study|Protocol Violation|0|||
130341265|NCT00934843|469221096|FG001|Overall Study|Protocol Violation|1|||
130341266|NCT01144299|469221097|FG000|Overall Study|Lost to Follow-up|1|||
130341267|NCT01144299|469221098|FG001|Overall Study|Lost to Follow-up|0|||
130341268|NCT01144299|469221097|FG000|Overall Study|Withdrawal by Subject|1|||
130341269|NCT01144299|469221098|FG001|Overall Study|Withdrawal by Subject|0|||
130341270|NCT03698591|469221101|FG000|Overall Study|Withdrawal by Subject|2|||
130341271|NCT03698591|469221102|FG001|Overall Study|Withdrawal by Subject|2|||
130341272|NCT03698591|469221101|FG000|Overall Study|Failed drug screen|1|||
130341273|NCT03698591|469221102|FG001|Overall Study|Failed drug screen|1|||
130341274|NCT03698591|469221101|FG000|Overall Study|Failed health screen|0|||
130341275|NCT03698591|469221102|FG001|Overall Study|Failed health screen|1|||
130341276|NCT03698591|469221101|FG000|Overall Study|Ineligible for financial compensation|1|||
130341277|NCT03698591|469221102|FG001|Overall Study|Ineligible for financial compensation|0|||
130341278|NCT03698591|469221101|FG000|Overall Study|Equipment Error|1|||
130341279|NCT03698591|469221102|FG001|Overall Study|Equipment Error|0|||
130341280|NCT03698591|469221101|FG000|Overall Study|Could not establish TMS dosage|0|||
130341281|NCT03698591|469221102|FG001|Overall Study|Could not establish TMS dosage|1|||
130341282|NCT01675167|469221104|FG000|Open-label Titration Phase|Adverse Event|81|||
130341283|NCT01675167|469221105|FG001|Open-label Titration Phase|Adverse Event|0|||
130341284|NCT01675167|469221106|FG002|Open-label Titration Phase|Adverse Event|0|||
130341285|NCT01675167|469221104|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
130341286|NCT01675167|469221105|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
130341287|NCT01675167|469221106|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
130341288|NCT01675167|469221104|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
130341289|NCT01675167|469221105|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
130341290|NCT01675167|469221106|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
130341291|NCT01675167|469221104|FG000|Open-label Titration Phase|Protocol Violation|43|||
130341292|NCT01675167|469221105|FG001|Open-label Titration Phase|Protocol Violation|0|||
130341293|NCT01675167|469221106|FG002|Open-label Titration Phase|Protocol Violation|0|||
130341294|NCT01675167|469221104|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
130341295|NCT01675167|469221105|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
130341296|NCT01675167|469221106|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
130673537|NCT01185288|470429154|FG000|Overall Study|Withdrawal by Subject|6|||
130673538|NCT01185288|470429155|FG001|Overall Study|Withdrawal by Subject|4|||
130341297|NCT01675167|469221104|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
130341298|NCT01675167|469221105|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
130341299|NCT01675167|469221106|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
130341300|NCT01675167|469221104|FG000|Open-label Titration Phase|Other|55|||
130341301|NCT01675167|469221105|FG001|Open-label Titration Phase|Other|0|||
130341302|NCT01675167|469221106|FG002|Open-label Titration Phase|Other|0|||
130341303|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130341304|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
130341305|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
130341306|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130673539|NCT01185288|470429154|FG000|Overall Study|Lost to Follow-up|2|||
130673540|NCT01185288|470429155|FG001|Overall Study|Lost to Follow-up|5|||
130673541|NCT01185288|470429154|FG000|Overall Study|Lack of Efficacy|2|||
130673542|NCT01185288|470429155|FG001|Overall Study|Lack of Efficacy|0|||
130673543|NCT01185288|470429154|FG000|Overall Study|Investigator discretion|1|||
130673544|NCT01185288|470429155|FG001|Overall Study|Investigator discretion|0|||
130673545|NCT01185288|470429154|FG000|Overall Study|Did not meet inclusion criteria|1|||
130673546|NCT01185288|470429155|FG001|Overall Study|Did not meet inclusion criteria|0|||
130673547|NCT01185288|470429154|FG000|Overall Study|Noncompliance|0|||
130673548|NCT01185288|470429155|FG001|Overall Study|Noncompliance|1|||
130673549|NCT00278512|470429156|FG000|Overall Study|Death|1|||
130673550|NCT00278512|470429157|FG001|Overall Study|Death|0|||
130673551|NCT01202747|470429158|FG000|Overall Study|Withdrawal by Subject|1|||
130673552|NCT01620177|470429159|FG000|Overall Study|Failure at Screening Visit|43|||
130673553|NCT01620177|470429159|FG000|Overall Study|Withdrawal by Subject|26|||
130673554|NCT01620177|470429159|FG000|Overall Study|Lost to Follow-up|7|||
130673555|NCT01620177|470429159|FG000|Overall Study|Physician Decision|2|||
130673556|NCT01620177|470429159|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
130673557|NCT02292238|470429163|FG000|Overall Study|Protocol Violation|1|||
130673558|NCT02292238|470429164|FG001|Overall Study|Protocol Violation|2|||
130673559|NCT02292238|470429163|FG000|Overall Study|Withdrawal by Subject|2|||
130673560|NCT02292238|470429164|FG001|Overall Study|Withdrawal by Subject|1|||
130673561|NCT02292238|470429163|FG000|Overall Study|Lost to Follow-up|1|||
130673562|NCT02292238|470429164|FG001|Overall Study|Lost to Follow-up|0|||
130673563|NCT02292238|470429163|FG000|Overall Study|Physician Decision|0|||
130673564|NCT02292238|470429164|FG001|Overall Study|Physician Decision|1|||
130673565|NCT01789320|470429165|FG000|Overall Study|Re-enrolled into study|1|||
130673566|NCT01789320|470429165|FG000|Overall Study|Lost to Follow-up|1|||
130673567|NCT01626885|470429172|FG000|Overall Study|Adverse Event|8|||
130673568|NCT01626885|470429172|FG000|Overall Study|Withdrawal by Subject|4|||
130673569|NCT01533428|470429175|FG000|Overall Study|Adverse Event|0|||
130341307|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130341308|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130341309|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130341310|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Adverse Event|5|||
130341311|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Adverse Event|13|||
130341312|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130341313|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
130341314|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
130341315|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130341316|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130341317|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
130341318|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
130341319|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
130341320|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
130341321|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Other|0|||
130341322|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Other|7|||
130341323|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Other|5|||
130341324|NCT00881868|469221107|FG000|Overall Study|Adverse Event|0|||
130341325|NCT00881868|469221108|FG001|Overall Study|Adverse Event|1|||
130341326|NCT00881868|469221107|FG000|Overall Study|Lost to Follow-up|2|||
130341327|NCT00881868|469221108|FG001|Overall Study|Lost to Follow-up|1|||
130341328|NCT00881868|469221107|FG000|Overall Study|Physician Decision|4|||
130341329|NCT00881868|469221108|FG001|Overall Study|Physician Decision|0|||
130341330|NCT00881868|469221107|FG000|Overall Study|Protocol Violation|2|||
130341331|NCT00881868|469221108|FG001|Overall Study|Protocol Violation|0|||
130341332|NCT03255083|469221109|FG000|Overall Study|Clinical progression|1|||
130341333|NCT03255083|469221110|FG001|Overall Study|Clinical progression|0|||
130341334|NCT03255083|469221111|FG002|Overall Study|Clinical progression|0|||
130341335|NCT03255083|469221112|FG003|Overall Study|Clinical progression|0|||
130341336|NCT03255083|469221109|FG000|Overall Study|Adverse Event|0|||
130341337|NCT03255083|469221110|FG001|Overall Study|Adverse Event|1|||
130341338|NCT03255083|469221111|FG002|Overall Study|Adverse Event|0|||
130341339|NCT03255083|469221112|FG003|Overall Study|Adverse Event|0|||
130341340|NCT03255083|469221109|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
130673570|NCT01533428|470429176|FG001|Overall Study|Adverse Event|1|||
130673571|NCT01533428|470429175|FG000|Overall Study|Lost to Follow-up|2|||
130341341|NCT03255083|469221110|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
130341342|NCT03255083|469221111|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
130341343|NCT03255083|469221112|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
130341344|NCT03255083|469221109|FG000|Overall Study|Withdrawal by Subject|1|||
130673572|NCT01533428|470429176|FG001|Overall Study|Lost to Follow-up|1|||
130673573|NCT01533428|470429175|FG000|Overall Study|Withdrawal by Subject|7|||
130673574|NCT01533428|470429176|FG001|Overall Study|Withdrawal by Subject|6|||
130673575|NCT01364870|470429177|FG000|Overall Study|Withdrawal by Subject|13|||
130673576|NCT01364870|470429178|FG001|Overall Study|Withdrawal by Subject|24|||
130341345|NCT03255083|469221110|FG001|Overall Study|Withdrawal by Subject|1|||
130341346|NCT03255083|469221111|FG002|Overall Study|Withdrawal by Subject|1|||
130341347|NCT03255083|469221112|FG003|Overall Study|Withdrawal by Subject|0|||
130341348|NCT01182844|469221113|FG000|Overall Study|Withdrawal by Subject|0|||
130341349|NCT01182844|469221114|FG001|Overall Study|Withdrawal by Subject|2|||
130341350|NCT01457352|469221115|FG000|Period 1|Adverse Event|2|||
130341351|NCT01457352|469221116|FG001|Period 1|Adverse Event|0|||
130341352|NCT01457352|469221115|FG000|Period 1|Withdrawal by Subject|2|||
130341353|NCT01457352|469221116|FG001|Period 1|Withdrawal by Subject|0|||
130673577|NCT01364870|470429179|FG002|Overall Study|Withdrawal by Subject|10|||
130673578|NCT01364870|470429177|FG000|Overall Study|Adverse Event|8|||
130673579|NCT01364870|470429178|FG001|Overall Study|Adverse Event|6|||
130673580|NCT01364870|470429179|FG002|Overall Study|Adverse Event|4|||
130673581|NCT01364870|470429177|FG000|Overall Study|Protocol Violation|1|||
130673582|NCT01364870|470429178|FG001|Overall Study|Protocol Violation|0|||
130673583|NCT01364870|470429179|FG002|Overall Study|Protocol Violation|0|||
130673584|NCT02666430|470429180|FG000|Period 1|Lost to Follow-up|1|||
130673585|NCT02666430|470429181|FG001|Period 1|Lost to Follow-up|0|||
130673586|NCT02666430|470429180|FG000|Period 1|Adverse Event|0|||
130673587|NCT02666430|470429181|FG001|Period 1|Adverse Event|1|||
130673588|NCT02666430|470429180|FG000|Period 2|Withdrawal by Subject|1|||
130673589|NCT02666430|470429181|FG001|Period 2|Withdrawal by Subject|4|||
130673590|NCT02666430|470429180|FG000|Period 3|Lost to Follow-up|1|||
130673591|NCT02666430|470429181|FG001|Period 3|Lost to Follow-up|0|||
130673592|NCT03828461|470429182|FG000|Overall Study|Lost to Follow-up|1|||
130673593|NCT03828461|470429182|FG000|Overall Study|Withdrawal by Subject|3|||
130673594|NCT00576199|470429183|FG000|Overall Study|Adverse Event|12|||
130216516|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
130216517|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
130216518|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
130216519|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
130216520|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
130216521|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
130216522|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
130216523|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216524|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216525|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216526|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
130216527|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
130216528|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
130216529|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
130216530|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
130216531|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
130216532|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
130673595|NCT00576199|470429183|FG000|Overall Study|Insufficient Therapeutic Response|14|||
130673596|NCT00576199|470429183|FG000|Overall Study|Refused Treatment|2|||
130673597|NCT00576199|470429183|FG000|Overall Study|Reason Unspecified|2|||
130673598|NCT04317053|470429185|FG000|Overall Study|Withdrawn (screen failure)|4|||
130673599|NCT04317053|470429186|FG001|Overall Study|Withdrawn (screen failure)|2|||
130673600|NCT05188521|470430823|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
130673601|NCT05188521|470430824|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
130673602|NCT01341639|470430825|FG000|Infant Series|Protocol Violation|1|||
130673603|NCT01341639|470430826|FG001|Infant Series|Protocol Violation|0|||
130673604|NCT01341639|470430825|FG000|Infant Series|Not Vaccinated|0|||
130673605|NCT01341639|470430826|FG001|Infant Series|Not Vaccinated|1|||
130673606|NCT01341639|470430825|FG000|Infant Series|Adverse Event|0|||
130673607|NCT01341639|470430826|FG001|Infant Series|Adverse Event|5|||
130673608|NCT01341639|470430825|FG000|Infant Series|Withdrawal by Subject|11|||
130673609|NCT01341639|470430826|FG001|Infant Series|Withdrawal by Subject|8|||
130673610|NCT01341639|470430825|FG000|Infant Series|Lost to Follow-up|0|||
130673611|NCT01341639|470430826|FG001|Infant Series|Lost to Follow-up|2|||
130673612|NCT01341639|470430825|FG000|Infant Series|Site 0048 Participants|17|||
130673613|NCT01341639|470430826|FG001|Infant Series|Site 0048 Participants|16|||
130673614|NCT01341639|470430825|FG000|Interim Period|Withdrawal by Subject|6|||
130673615|NCT01341639|470430826|FG001|Interim Period|Withdrawal by Subject|7|||
130673616|NCT01341639|470430825|FG000|Interim Period|Lost to Follow-up|2|||
130673617|NCT01341639|470430826|FG001|Interim Period|Lost to Follow-up|0|||
130673618|NCT01341639|470430825|FG000|Interim Period|Physician Decision|0|||
130216533|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130216534|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130341354|NCT01457352|469221115|FG000|Period 1|Physician Decision|2|||
130341355|NCT01457352|469221116|FG001|Period 1|Physician Decision|0|||
130673619|NCT01341639|470430826|FG001|Interim Period|Physician Decision|1|||
130673620|NCT01341639|470430825|FG000|Interim Period|Protocol Violation|0|||
130673621|NCT01341639|470430826|FG001|Interim Period|Protocol Violation|1|||
130673622|NCT01341639|470430825|FG000|Post-Treatment|Withdrawal by Subject|0|||
130341356|NCT01457352|469221115|FG000|Period 1|MS related disease progression|1|||
130341357|NCT01457352|469221116|FG001|Period 1|MS related disease progression|0|||
130341358|NCT01457352|469221115|FG000|Period 1|Withdrawn|1|||
130341359|NCT01457352|469221116|FG001|Period 1|Withdrawn|0|||
130341360|NCT01457352|469221115|FG000|Period 1|withdrew per sponsor|1|||
130341361|NCT01457352|469221116|FG001|Period 1|withdrew per sponsor|0|||
130341362|NCT01457352|469221115|FG000|Period 1|Protocol Violation|4|||
130341363|NCT01457352|469221116|FG001|Period 1|Protocol Violation|0|||
130341364|NCT01457352|469221115|FG000|Period 1|Did not meet eligibility criteria|3|||
130341365|NCT01457352|469221116|FG001|Period 1|Did not meet eligibility criteria|0|||
130341366|NCT01457352|469221115|FG000|Period 2|Withdrawal by Subject|23|||
130341367|NCT01457352|469221116|FG001|Period 2|Withdrawal by Subject|0|||
130341368|NCT01457352|469221115|FG000|Period 2|Adverse Event|22|||
130341369|NCT01457352|469221116|FG001|Period 2|Adverse Event|0|||
130341370|NCT01457352|469221115|FG000|Period 2|no analysis|10|||
130341371|NCT01457352|469221116|FG001|Period 2|no analysis|0|||
130341372|NCT01457352|469221115|FG000|Period 2|Lack of Efficacy|8|||
130341373|NCT01457352|469221116|FG001|Period 2|Lack of Efficacy|0|||
130341374|NCT01457352|469221115|FG000|Period 2|Protocol Violation|4|||
130341375|NCT01457352|469221116|FG001|Period 2|Protocol Violation|0|||
130341376|NCT01457352|469221115|FG000|Period 2|Sponsor's withdrawal|7|||
130341377|NCT01457352|469221116|FG001|Period 2|Sponsor's withdrawal|0|||
130341378|NCT01457352|469221115|FG000|Period 2|Lost to Follow-up|1|||
130341379|NCT01457352|469221116|FG001|Period 2|Lost to Follow-up|0|||
130341380|NCT01457352|469221115|FG000|Period 2|dose change|1|||
130341381|NCT01457352|469221116|FG001|Period 2|dose change|0|||
130341382|NCT01457352|469221115|FG000|Period 2|Physician Decision|1|||
130341383|NCT01457352|469221116|FG001|Period 2|Physician Decision|0|||
130341384|NCT01457352|469221115|FG000|Period 2|Did not meet eligibility criteria|3|||
130341385|NCT01457352|469221116|FG001|Period 2|Did not meet eligibility criteria|0|||
130341386|NCT01457352|469221115|FG000|Period 3|Adverse Event|1|||
130341387|NCT01457352|469221116|FG001|Period 3|Adverse Event|1|||
130673623|NCT01341639|470430826|FG001|Post-Treatment|Withdrawal by Subject|1|||
130673624|NCT01341639|470430825|FG000|Post-Treatment|Adverse Event|0|||
130673625|NCT01341639|470430826|FG001|Post-Treatment|Adverse Event|2|||
130341388|NCT01457352|469221115|FG000|Period 3|Withdrawal by Subject|0|||
130341389|NCT01457352|469221116|FG001|Period 3|Withdrawal by Subject|2|||
130673626|NCT04582266|470430827|FG000|Overall Study|Lost to Follow-up|7|||
130673627|NCT04582266|470430828|FG001|Overall Study|Lost to Follow-up|5|||
130673628|NCT04582266|470430827|FG000|Overall Study|Withdrawal by Subject|1|||
130673629|NCT04582266|470430828|FG001|Overall Study|Withdrawal by Subject|0|||
130673630|NCT04582266|470430827|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
130673631|NCT04582266|470430828|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
130673632|NCT01241461|470430829|FG000|Overall Study|Progressive Disease|3|||
130673633|NCT01241461|470430830|FG001|Overall Study|Progressive Disease|6|||
130673634|NCT01132118|470430831|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
130673635|NCT01132118|470430832|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
130673636|NCT01132118|470430831|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130673637|NCT01132118|470430832|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
130673638|NCT01132118|470430831|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
130673639|NCT01132118|470430832|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
130673640|NCT03705351|470430835|FG000|Overall Study|Study termination|3|||
130673641|NCT03705351|470430835|FG000|Overall Study|Death|1|||
130673642|NCT03705351|470430835|FG000|Overall Study|Lack of Efficacy|2|||
130673643|NCT03705351|470430835|FG000|Overall Study|Withdrawal by Subject|1|||
130673644|NCT01299038|470430843|FG000|Overall Study|Withdrawal by Subject|1|||
130673645|NCT01299038|470430844|FG001|Overall Study|Withdrawal by Subject|0|||
130673646|NCT00322556|470430845|FG000|Overall Study|Adverse Event|1|||
130673647|NCT00322556|470430845|FG000|Overall Study|Withdrawal by Subject|1|||
130673648|NCT00322556|470430845|FG000|Overall Study|Lost to Follow-up|3|||
130673649|NCT00322556|470430845|FG000|Overall Study|Other Reason|7|||
130673650|NCT00704418|470430846|FG000|Overall Study|Withdrawal by Subject|2|||
130673651|NCT00704418|470430847|FG001|Overall Study|Withdrawal by Subject|0|||
130673652|NCT00704418|470430846|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
130673653|NCT00704418|470430847|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
130673654|NCT02322879|470430848|FG000|First Intervention|Physician Decision|1|||
130216535|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130341390|NCT01457352|469221115|FG000|Period 3|incorrect treatment|0|||
130341391|NCT01457352|469221116|FG001|Period 3|incorrect treatment|1|||
130341392|NCT01457352|469221115|FG000|Period 3|Sponsor's withdrawal|0|||
130341393|NCT01457352|469221116|FG001|Period 3|Sponsor's withdrawal|1|||
130341394|NCT04174365|469221117|FG000|Overall Study|Lost to Follow-up|1|||
130341395|NCT04174365|469221118|FG001|Overall Study|Lost to Follow-up|2|||
130341396|NCT04174365|469221117|FG000|Overall Study|Adverse Event|2|||
130341397|NCT04174365|469221118|FG001|Overall Study|Adverse Event|1|||
130341398|NCT04174365|469221117|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
130341399|NCT04174365|469221118|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
130552751|NCT01072877|469991524|FG003|Overall Study|Lost to Follow-up|2|||
130673655|NCT02322879|470430849|FG001|First Intervention|Physician Decision|0|||
130673656|NCT02295774|470430850|FG000|Overall Study|Physician Decision|1|||
130673657|NCT02295774|470430850|FG000|Overall Study|Withdrawal by Subject|2|||
130673658|NCT01673009|470430852|FG000|Overall Study|Physician Decision|5|||
130673659|NCT01673009|470430852|FG000|Overall Study|Withdrawal by Subject|8|||
130673660|NCT02623959|470430855|FG000|Overall Study|Progression|0|||
130341400|NCT04174365|469221117|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
130341401|NCT04174365|469221118|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
130341402|NCT04174365|469221117|FG000|Overall Study|Protocol Deviation|1|||
130341403|NCT04174365|469221118|FG001|Overall Study|Protocol Deviation|0|||
130341404|NCT04174365|469221117|FG000|Overall Study|Lack of Efficacy|0|||
130341405|NCT04174365|469221118|FG001|Overall Study|Lack of Efficacy|2|||
130341406|NCT04174365|469221117|FG000|Overall Study|Disease Relapse|1|||
130341407|NCT04174365|469221118|FG001|Overall Study|Disease Relapse|0|||
130341408|NCT04174365|469221117|FG000|Overall Study|Reason Not Specified|0|||
130341409|NCT04174365|469221118|FG001|Overall Study|Reason Not Specified|1|||
130341410|NCT01031836|469223034|FG000|Stage I|Adverse Event|1|||
130341411|NCT01031836|469223035|FG001|Stage I|Adverse Event|1|||
130341412|NCT01031836|469223036|FG002|Stage I|Adverse Event|0|||
130341413|NCT01031836|469223037|FG003|Stage I|Adverse Event|0|||
130341414|NCT01031836|469223038|FG004|Stage I|Adverse Event|0|||
130341415|NCT01031836|469223039|FG005|Stage I|Adverse Event|0|||
130341416|NCT01031836|469223034|FG000|Stage I|Other|0|||
130341417|NCT01031836|469223035|FG001|Stage I|Other|1|||
130341418|NCT01031836|469223036|FG002|Stage I|Other|0|||
130341419|NCT01031836|469223037|FG003|Stage I|Other|0|||
130341420|NCT01031836|469223038|FG004|Stage I|Other|0|||
130341421|NCT01031836|469223039|FG005|Stage I|Other|1|||
130341422|NCT01031836|469223034|FG000|Stage II|Adverse Event|0|||
130341423|NCT01031836|469223035|FG001|Stage II|Adverse Event|0|||
130341424|NCT01031836|469223036|FG002|Stage II|Adverse Event|2|||
130341425|NCT01031836|469223037|FG003|Stage II|Adverse Event|2|||
130341426|NCT01031836|469223038|FG004|Stage II|Adverse Event|1|||
130341427|NCT01031836|469223039|FG005|Stage II|Adverse Event|1|||
130341428|NCT01031836|469223034|FG000|Stage II|Other|2|||
130341429|NCT01031836|469223035|FG001|Stage II|Other|0|||
130341430|NCT01031836|469223036|FG002|Stage II|Other|0|||
130341431|NCT01031836|469223037|FG003|Stage II|Other|1|||
130341432|NCT01031836|469223038|FG004|Stage II|Other|1|||
130341433|NCT01031836|469223039|FG005|Stage II|Other|0|||
130341434|NCT03859973|469223047|FG000|Overall Study|Other reason than listed|3|||
130341435|NCT03859973|469223048|FG001|Overall Study|Other reason than listed|2|||
130341436|NCT03859973|469223047|FG000|Overall Study|COVID-19 related, not due to AE|3|||
130341437|NCT03859973|469223048|FG001|Overall Study|COVID-19 related, not due to AE|4|||
130341438|NCT03859973|469223047|FG000|Overall Study|Withdrawal by Subject|8|||
130341439|NCT03859973|469223048|FG001|Overall Study|Withdrawal by Subject|9|||
130341440|NCT03859973|469223047|FG000|Overall Study|Lost to Follow-up|2|||
130341441|NCT03859973|469223048|FG001|Overall Study|Lost to Follow-up|3|||
130341442|NCT03859973|469223047|FG000|Overall Study|Protocol Violation|1|||
130341443|NCT03859973|469223048|FG001|Overall Study|Protocol Violation|3|||
130341444|NCT03859973|469223047|FG000|Overall Study|Adverse Event|3|||
130341445|NCT03859973|469223048|FG001|Overall Study|Adverse Event|5|||
130341446|NCT02855541|469223049|FG000|Overall Study|Change in health status|2|||
130341447|NCT02855541|469223049|FG000|Overall Study|Withdrawal by Subject|2|||
130341448|NCT00422513|469223050|FG000|Overall Study|Lack of Efficacy|4|||
130341449|NCT00422513|469223051|FG001|Overall Study|Lack of Efficacy|5|||
130341450|NCT00422513|469223050|FG000|Overall Study|Protocol Violation|23|||
130341451|NCT00422513|469223051|FG001|Overall Study|Protocol Violation|7|||
130341452|NCT00422513|469223050|FG000|Overall Study|Refused Treatment|4|||
130341453|NCT00422513|469223051|FG001|Overall Study|Refused Treatment|2|||
130341454|NCT00422513|469223050|FG000|Overall Study|Withdrawal by Subject|2|||
130341455|NCT00422513|469223051|FG001|Overall Study|Withdrawal by Subject|1|||
130341456|NCT00422513|469223050|FG000|Overall Study|early termination of the study|67|||
130341457|NCT00422513|469223051|FG001|Overall Study|early termination of the study|80|||
130341458|NCT00422513|469223050|FG000|Overall Study|Adverse Event|4|||
130673661|NCT02623959|470430856|FG001|Overall Study|Progression|1|||
130673662|NCT00384033|470430863|FG000|Overall Study|Adverse Event|10|||
130341459|NCT00422513|469223051|FG001|Overall Study|Adverse Event|4|||
130341460|NCT00422513|469223050|FG000|Overall Study|Death|3|||
130673663|NCT00384033|470430864|FG001|Overall Study|Adverse Event|8|||
130341461|NCT00422513|469223051|FG001|Overall Study|Death|7|||
130341462|NCT03032380|469223052|FG000|Overall Study|Adverse Event|0|||
130341463|NCT03032380|469223053|FG001|Overall Study|Adverse Event|1|||
130341464|NCT03032380|469223052|FG000|Overall Study|Lack of Efficacy|1|||
130341465|NCT03032380|469223053|FG001|Overall Study|Lack of Efficacy|0|||
130341466|NCT03032380|469223052|FG000|Overall Study|Withdrawal by Subject|2|||
130341467|NCT03032380|469223053|FG001|Overall Study|Withdrawal by Subject|3|||
130341468|NCT03032380|469223052|FG000|Overall Study|Recovery|0|||
130341469|NCT03032380|469223053|FG001|Overall Study|Recovery|1|||
130341470|NCT03032380|469223052|FG000|Overall Study|Death|39|||
130341471|NCT03032380|469223053|FG001|Overall Study|Death|34|||
130341472|NCT03032380|469223052|FG000|Overall Study|Other - Miscellaneous|0|||
130673664|NCT00384033|470430865|FG002|Overall Study|Adverse Event|11|||
130673665|NCT00384033|470430866|FG003|Overall Study|Adverse Event|20|||
130341473|NCT03032380|469223053|FG001|Overall Study|Other - Miscellaneous|1|||
130673666|NCT00384033|470430863|FG000|Overall Study|Failed to return|1|||
130673667|NCT00384033|470430864|FG001|Overall Study|Failed to return|3|||
130673668|NCT00384033|470430865|FG002|Overall Study|Failed to return|2|||
130673669|NCT00384033|470430866|FG003|Overall Study|Failed to return|2|||
130673670|NCT00384033|470430863|FG000|Overall Study|Physician Decision|1|||
130673671|NCT00384033|470430864|FG001|Overall Study|Physician Decision|0|||
130673672|NCT00384033|470430865|FG002|Overall Study|Physician Decision|0|||
130673673|NCT00384033|470430866|FG003|Overall Study|Physician Decision|0|||
130673674|NCT00384033|470430863|FG000|Overall Study|Lost to Follow-up|6|||
130673675|NCT00384033|470430864|FG001|Overall Study|Lost to Follow-up|12|||
130673676|NCT00384033|470430865|FG002|Overall Study|Lost to Follow-up|7|||
130673677|NCT00384033|470430866|FG003|Overall Study|Lost to Follow-up|7|||
130673678|NCT00384033|470430863|FG000|Overall Study|Other|2|||
130673679|NCT00384033|470430864|FG001|Overall Study|Other|0|||
130673680|NCT00384033|470430865|FG002|Overall Study|Other|0|||
130673681|NCT00384033|470430866|FG003|Overall Study|Other|0|||
130673682|NCT00384033|470430863|FG000|Overall Study|Protocol Violation|5|||
130673683|NCT00384033|470430864|FG001|Overall Study|Protocol Violation|0|||
130673684|NCT00384033|470430865|FG002|Overall Study|Protocol Violation|5|||
130673685|NCT00384033|470430866|FG003|Overall Study|Protocol Violation|6|||
130673686|NCT00384033|470430863|FG000|Overall Study|Withdrawal by Subject|6|||
130673687|NCT00384033|470430864|FG001|Overall Study|Withdrawal by Subject|2|||
130673688|NCT00384033|470430865|FG002|Overall Study|Withdrawal by Subject|5|||
130673689|NCT00384033|470430866|FG003|Overall Study|Withdrawal by Subject|2|||
130673690|NCT00384033|470430863|FG000|Overall Study|Lack of Efficacy|7|||
130673691|NCT00384033|470430864|FG001|Overall Study|Lack of Efficacy|3|||
130673692|NCT00384033|470430865|FG002|Overall Study|Lack of Efficacy|3|||
130673693|NCT00384033|470430866|FG003|Overall Study|Lack of Efficacy|1|||
130673694|NCT00384033|470430863|FG000|Overall Study|Randomized but not treated|3|||
130673695|NCT00384033|470430864|FG001|Overall Study|Randomized but not treated|7|||
130673696|NCT00384033|470430865|FG002|Overall Study|Randomized but not treated|10|||
130673697|NCT00384033|470430866|FG003|Overall Study|Randomized but not treated|2|||
130673698|NCT00290745|470430867|FG000|Overall Study|Withdrawal by Subject|4|||
130673699|NCT00290745|470430867|FG000|Overall Study|Physician Decision|2|||
130673700|NCT00290745|470430867|FG000|Overall Study|Surgery after 3 months for progression|3|||
130673701|NCT00290745|470430867|FG000|Overall Study|Baseline MRI not available|3|||
130673702|NCT03361423|470430868|FG000|Overall Study|Withdrawal by Subject|4|||
130673703|NCT03361423|470430869|FG001|Overall Study|Withdrawal by Subject|3|||
130673704|NCT03361423|470430868|FG000|Overall Study|Did not treat|19|||
130673705|NCT03361423|470430869|FG001|Overall Study|Did not treat|18|||
130673706|NCT03361423|470430868|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
130673707|NCT03361423|470430869|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
130673708|NCT03361423|470430868|FG000|Overall Study|Missing data|4|||
130673709|NCT03361423|470430869|FG001|Overall Study|Missing data|1|||
130673710|NCT01336894|470430870|FG000|Follow-up|Study terminated prematurely|2|||
130673711|NCT01336894|470430871|FG001|Follow-up|Study terminated prematurely|7|||
130673712|NCT00622908|470430872|FG000|Overall Study|Protocol Violation|1|||
130673713|NCT00622908|470430873|FG001|Overall Study|Protocol Violation|0|||
130673714|NCT00622908|470430872|FG000|Overall Study|Adverse Event|0|||
130673715|NCT00622908|470430873|FG001|Overall Study|Adverse Event|1|||
130673716|NCT00622908|470430872|FG000|Overall Study|Lack of Efficacy|1|||
130341474|NCT01128621|469223058|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
130341475|NCT01128621|469223059|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
130341476|NCT02267317|469223060|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
130341477|NCT02267317|469223061|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341478|NCT02267317|469223062|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341479|NCT02267317|469223063|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130673717|NCT00622908|470430873|FG001|Overall Study|Lack of Efficacy|7|||
130673718|NCT00622908|470430872|FG000|Overall Study|Lost to Follow-up|1|||
130673719|NCT00622908|470430873|FG001|Overall Study|Lost to Follow-up|0|||
130673720|NCT00622908|470430872|FG000|Overall Study|Refusal|0|||
130673721|NCT00622908|470430873|FG001|Overall Study|Refusal|1|||
130673722|NCT00622908|470430872|FG000|Overall Study|Termination by study sponser|0|||
130673723|NCT00622908|470430873|FG001|Overall Study|Termination by study sponser|1|||
130673724|NCT03937466|470430874|FG000|Overall Study|not eligbile after the 2-week diary|9|||
130673725|NCT03937466|470430874|FG000|Overall Study|never returned their diary|6|||
130673726|NCT03937466|470430874|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
130673727|NCT03937466|470430874|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
130673728|NCT00113490|470430875|FG000|Overall Study|Withdrawal by Subject|1|||
130673729|NCT00113490|470430876|FG001|Overall Study|Withdrawal by Subject|3|||
130673730|NCT00113490|470430875|FG000|Overall Study|Lost to Follow-up|1|||
130673731|NCT00113490|470430876|FG001|Overall Study|Lost to Follow-up|0|||
130552752|NCT01072877|469991525|FG004|Overall Study|Lost to Follow-up|0|||
130673732|NCT02162758|470430877|FG000|Overall Study|Study termination|0|||
130673733|NCT02162758|470430878|FG001|Overall Study|Study termination|1|||
130673734|NCT04471935|470430879|FG000|Overall Study|Withdrawal by Subject|1|||
130673735|NCT04471935|470430879|FG000|Overall Study|Deemed ineligible to participate|1|||
130673736|NCT01659567|470430882|FG000|Overall Study|Lack of Efficacy|22|||
130673737|NCT01659567|470430882|FG000|Overall Study|Switched to Pegferon|6|||
130673738|NCT01659567|470430882|FG000|Overall Study|Adverse Event|12|||
130673739|NCT01659567|470430882|FG000|Overall Study|Good result at early stage of treatment|5|||
130673740|NCT01659567|470430882|FG000|Overall Study|Withdrawal by Subject|64|||
130673741|NCT01659567|470430882|FG000|Overall Study|Progression of the main disease|1|||
130673742|NCT01659567|470430882|FG000|Overall Study|Other|13|||
130673743|NCT03019965|470430883|FG000|Overall Study|Withdrawal by Subject|1|||
130673744|NCT03019965|470430884|FG001|Overall Study|Withdrawal by Subject|0|||
130673745|NCT03019965|470430883|FG000|Overall Study|Protocol Violation|1|||
130673746|NCT03019965|470430884|FG001|Overall Study|Protocol Violation|3|||
130673747|NCT03019965|470430883|FG000|Overall Study|viral or fungal infection|3|||
130673748|NCT03019965|470430884|FG001|Overall Study|viral or fungal infection|4|||
130673749|NCT03019965|470430883|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
130673750|NCT03019965|470430884|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
130673751|NCT03019965|470430883|FG000|Overall Study|Physician Decision|1|||
130673752|NCT03019965|470430884|FG001|Overall Study|Physician Decision|1|||
130673753|NCT03213210|470430885|FG000|Overall Study|Lost to Follow-up|2|||
130673754|NCT03213210|470430885|FG000|Overall Study|Study termination|3|||
130673755|NCT01325207|470430893|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130673756|NCT01325207|470430894|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130673757|NCT01325207|470430895|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130673758|NCT01325207|470430896|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130673759|NCT01325207|470430897|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
130341480|NCT02267317|469223064|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341481|NCT02267317|469223065|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130673760|NCT01325207|470430898|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130673761|NCT01325207|470430893|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
130673762|NCT01325207|470430894|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
130673763|NCT01325207|470430895|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
130673764|NCT01325207|470430896|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
130673765|NCT01325207|470430897|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
130673766|NCT01325207|470430898|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
130673767|NCT01325207|470430893|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130673768|NCT01325207|470430894|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130673769|NCT01325207|470430895|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130673770|NCT01325207|470430896|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130673771|NCT01325207|470430897|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
130673772|NCT01325207|470430898|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
130673773|NCT01325207|470430893|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130673774|NCT01325207|470430894|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
130673775|NCT01325207|470430895|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130673776|NCT01325207|470430896|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130673777|NCT01325207|470430897|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130673778|NCT01325207|470430898|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130673779|NCT01325207|470430893|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130673780|NCT01325207|470430894|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130673781|NCT01325207|470430895|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130673782|NCT01325207|470430896|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130673783|NCT01325207|470430897|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130673784|NCT01325207|470430898|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
130673785|NCT01325207|470430893|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130673786|NCT01325207|470430894|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130673787|NCT01325207|470430895|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130673788|NCT01325207|470430896|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130673789|NCT01325207|470430897|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130673790|NCT01325207|470430898|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
130341482|NCT02267317|469223060|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
130341483|NCT02267317|469223061|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130341484|NCT02267317|469223062|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130673791|NCT01325207|470430893|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130341485|NCT02267317|469223063|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130341486|NCT02267317|469223064|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130673792|NCT01325207|470430894|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130673793|NCT01325207|470430895|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130673794|NCT01325207|470430896|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130673795|NCT01325207|470430897|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
130673796|NCT01325207|470430898|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130673797|NCT00708422|470430899|FG000|Overall Study|Adverse Event|3|||
130673798|NCT00708422|470430900|FG001|Overall Study|Adverse Event|1|||
130673799|NCT00708422|470430899|FG000|Overall Study|Withdrawal by Subject|1|||
130673800|NCT00708422|470430900|FG001|Overall Study|Withdrawal by Subject|0|||
130673801|NCT01254409|470430901|FG000|Overall Study|Adverse Event|0|||
130673802|NCT01254409|470430902|FG001|Overall Study|Adverse Event|1|||
130673803|NCT01254409|470430903|FG002|Overall Study|Adverse Event|0|||
130673804|NCT01254409|470430904|FG003|Overall Study|Adverse Event|0|||
130673805|NCT00299156|470430907|FG000|Period 2 (Randomized)|Screen Failure|0|||
130673806|NCT00299156|470430908|FG001|Period 2 (Randomized)|Screen Failure|1|||
130673807|NCT00299156|470430909|FG002|Period 2 (Randomized)|Screen Failure|0|||
130673808|NCT01166568|470430919|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
130673809|NCT01166568|470430920|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
130673810|NCT01166568|470430921|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
130673811|NCT01166568|470430919|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
130673812|NCT01166568|470430920|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
130673813|NCT01166568|470430921|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
130216536|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
130216537|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216538|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216539|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216540|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216541|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
130216542|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
130216543|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
130216544|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
130216545|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
130216546|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
130216547|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
130216548|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
130216549|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
130216550|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
130216551|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130216552|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130216553|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
130216554|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
130216555|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
130216556|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
130216557|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
130216558|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
130216559|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
130216560|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
130216561|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216562|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216563|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
130216564|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216565|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216566|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216567|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216568|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
130216569|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216570|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216571|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
130216572|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
130216573|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
130216574|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
130216575|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
130216576|NCT03762681|468755603|FG000|Part 1|Withdrawal by Subject|0|||
130216577|NCT03762681|468755604|FG001|Part 1|Withdrawal by Subject|0|||
130216578|NCT03762681|468755605|FG002|Part 1|Withdrawal by Subject|0|||
130216579|NCT03762681|468755606|FG003|Part 1|Withdrawal by Subject|1|||
130216580|NCT03762681|468755607|FG004|Part 1|Withdrawal by Subject|0|||
130216581|NCT03762681|468755608|FG005|Part 1|Withdrawal by Subject|0|||
130216582|NCT03762681|468755609|FG006|Part 1|Withdrawal by Subject|0|||
130216583|NCT03762681|468755610|FG007|Part 1|Withdrawal by Subject|0|||
130673814|NCT01166568|470430919|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
130673815|NCT01166568|470430920|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
130673816|NCT01166568|470430921|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
130673817|NCT00684671|470430922|FG000|Overall Study|Adverse Event|1|||
130673818|NCT00684671|470430923|FG001|Overall Study|Adverse Event|0|||
130673819|NCT00684671|470430924|FG002|Overall Study|Adverse Event|0|||
130673820|NCT00684671|470430922|FG000|Overall Study|Lost to Follow-up|1|||
130673821|NCT00684671|470430923|FG001|Overall Study|Lost to Follow-up|0|||
130673822|NCT00684671|470430924|FG002|Overall Study|Lost to Follow-up|0|||
130673823|NCT00684671|470430922|FG000|Overall Study|Alcoholic dependance|1|||
130673824|NCT00684671|470430923|FG001|Overall Study|Alcoholic dependance|0|||
130673825|NCT00684671|470430924|FG002|Overall Study|Alcoholic dependance|0|||
130673826|NCT03335371|470430925|FG000|Overall Study|Lost to Follow-up|0|||
130673827|NCT03335371|470430926|FG001|Overall Study|Lost to Follow-up|0|||
130673828|NCT03335371|470430927|FG002|Overall Study|Lost to Follow-up|0|||
130673829|NCT03335371|470430928|FG003|Overall Study|Lost to Follow-up|0|||
130673830|NCT03335371|470430929|FG004|Overall Study|Lost to Follow-up|1|||
130673831|NCT03335371|470430925|FG000|Overall Study|Withdrawal by Subject|0|||
130673832|NCT03335371|470430926|FG001|Overall Study|Withdrawal by Subject|0|||
130673833|NCT03335371|470430927|FG002|Overall Study|Withdrawal by Subject|0|||
130673834|NCT03335371|470430928|FG003|Overall Study|Withdrawal by Subject|0|||
130673835|NCT03335371|470430929|FG004|Overall Study|Withdrawal by Subject|1|||
130673836|NCT03335371|470430925|FG000|Overall Study|Randomization Error|0|||
130341487|NCT02267317|469223065|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130341488|NCT00796445|469223068|FG000|Overall Study|Protocol Violation|5|||
130341489|NCT00796445|469223069|FG001|Overall Study|Protocol Violation|3|||
130341490|NCT00796445|469223068|FG000|Overall Study|Adverse event, serious fatal|10|||
130341491|NCT00796445|469223069|FG001|Overall Study|Adverse event, serious fatal|5|||
130341492|NCT00796445|469223068|FG000|Overall Study|Adverse event, non-fatal|4|||
130341493|NCT00796445|469223069|FG001|Overall Study|Adverse event, non-fatal|0|||
130341494|NCT00796445|469223068|FG000|Overall Study|Disease progression/recurrence|537|||
130341495|NCT00796445|469223069|FG001|Overall Study|Disease progression/recurrence|268|||
130341496|NCT00796445|469223068|FG000|Overall Study|Other|10|||
130341497|NCT00796445|469223069|FG001|Overall Study|Other|7|||
130341498|NCT00796445|469223068|FG000|Overall Study|Withdrawal by Subject|18|||
130341499|NCT00796445|469223069|FG001|Overall Study|Withdrawal by Subject|9|||
130341500|NCT00796445|469223068|FG000|Overall Study|Invalid Informed Consent Form|1|||
130341501|NCT00796445|469223069|FG001|Overall Study|Invalid Informed Consent Form|0|||
130341502|NCT02208063|469223070|FG000|Overall Study|Death|3|||
130341503|NCT02208063|469223071|FG001|Overall Study|Death|5|||
130341504|NCT02208063|469223070|FG000|Overall Study|Not Specified in report|3|||
130341505|NCT02208063|469223071|FG001|Overall Study|Not Specified in report|4|||
130341506|NCT02208063|469223070|FG000|Overall Study|Withdrawal by Subject|5|||
130341507|NCT02208063|469223071|FG001|Overall Study|Withdrawal by Subject|2|||
130341508|NCT02208063|469223070|FG000|Overall Study|Lost to Follow-up|1|||
130341509|NCT02208063|469223071|FG001|Overall Study|Lost to Follow-up|0|||
130341510|NCT00917644|469223072|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
130341511|NCT00917644|469223073|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
130341512|NCT00917644|469223072|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
130341513|NCT00917644|469223073|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
130341514|NCT00917644|469223072|FG000|Period 2: Second Intervention|family emergency|1|||
130341515|NCT00917644|469223073|FG001|Period 2: Second Intervention|family emergency|0|||
130341516|NCT00422084|469223078|FG000|Overall Study|Adverse Event|21|||
130341517|NCT00422084|469223079|FG001|Overall Study|Adverse Event|7|||
130341518|NCT00422084|469223078|FG000|Overall Study|Withdrawal by Subject|12|||
130341519|NCT00422084|469223079|FG001|Overall Study|Withdrawal by Subject|9|||
130341520|NCT00422084|469223078|FG000|Overall Study|Lost to Follow-up|14|||
130341521|NCT00422084|469223079|FG001|Overall Study|Lost to Follow-up|9|||
130341522|NCT00422084|469223078|FG000|Overall Study|Protocol Violation|4|||
130673837|NCT03335371|470430926|FG001|Overall Study|Randomization Error|0|||
130673838|NCT03335371|470430927|FG002|Overall Study|Randomization Error|1|||
130673839|NCT03335371|470430928|FG003|Overall Study|Randomization Error|0|||
130673840|NCT03335371|470430929|FG004|Overall Study|Randomization Error|0|||
130341523|NCT00422084|469223079|FG001|Overall Study|Protocol Violation|1|||
130341524|NCT00422084|469223078|FG000|Overall Study|Lack of Efficacy|40|||
130341525|NCT00422084|469223079|FG001|Overall Study|Lack of Efficacy|42|||
130341526|NCT00422084|469223078|FG000|Overall Study|P. vivax infection|3|||
130341527|NCT00422084|469223079|FG001|Overall Study|P. vivax infection|6|||
130341528|NCT00422084|469223078|FG000|Overall Study|Cyesis|1|||
130341529|NCT00422084|469223079|FG001|Overall Study|Cyesis|0|||
130341530|NCT00422084|469223078|FG000|Overall Study|Withdrawn from study accidentally|1|||
130341531|NCT00422084|469223079|FG001|Overall Study|Withdrawn from study accidentally|0|||
130341532|NCT00422084|469223078|FG000|Overall Study|Non-compliance|1|||
130673841|NCT01725451|470430930|FG000|Period 1|Withdrawal by Subject|1|||
130673842|NCT01725451|470430931|FG001|Period 1|Withdrawal by Subject|0|||
130673843|NCT01725451|470430932|FG002|Period 1|Withdrawal by Subject|0|||
130673844|NCT01725451|470430933|FG003|Period 1|Withdrawal by Subject|0|||
130673845|NCT01725451|470430930|FG000|Washout From Period 3|Protocol Violation|0|||
130673846|NCT01725451|470430931|FG001|Washout From Period 3|Protocol Violation|0|||
130673847|NCT01725451|470430932|FG002|Washout From Period 3|Protocol Violation|1|||
130673848|NCT01725451|470430933|FG003|Washout From Period 3|Protocol Violation|0|||
130673849|NCT01725451|470430930|FG000|Washout From Period 3|Adverse Event|0|||
130673850|NCT01725451|470430931|FG001|Washout From Period 3|Adverse Event|1|||
130673851|NCT01725451|470430932|FG002|Washout From Period 3|Adverse Event|0|||
130673852|NCT01725451|470430933|FG003|Washout From Period 3|Adverse Event|0|||
130673853|NCT01725451|470430930|FG000|Period 4|Adverse Event|0|||
130673854|NCT01725451|470430931|FG001|Period 4|Adverse Event|0|||
130673855|NCT01725451|470430932|FG002|Period 4|Adverse Event|1|||
130673856|NCT01725451|470430933|FG003|Period 4|Adverse Event|0|||
130673857|NCT01564758|470430934|FG000|Overall Study|Death|8|||
130673858|NCT01564758|470430934|FG000|Overall Study|Adverse Event|3|||
130673859|NCT01564758|470430934|FG000|Overall Study|Other|3|||
130673860|NCT00249821|470430935|FG000|Overall Study|Technical problem|0|||
130673861|NCT00249821|470430936|FG001|Overall Study|Technical problem|1|||
130673862|NCT02482571|470430937|FG000|Overall Study|Adverse Event|1|||
130673863|NCT02482571|470430937|FG000|Overall Study|Scanner or Respiract failure|3|||
130673864|NCT02482571|470430937|FG000|Overall Study|Withdrawal by Subject|4|||
130673865|NCT01446913|470430938|FG000|Overall Study|Significant illness|1|||
130673866|NCT01446913|470430939|FG001|Overall Study|Significant illness|1|||
130673867|NCT01446913|470430940|FG002|Overall Study|Significant illness|1|||
130673868|NCT01446913|470430938|FG000|Overall Study|Withdrawal by Subject|5|||
130673869|NCT01446913|470430939|FG001|Overall Study|Withdrawal by Subject|3|||
130673870|NCT01446913|470430940|FG002|Overall Study|Withdrawal by Subject|5|||
130673871|NCT01446913|470430938|FG000|Overall Study|Physician Decision|0|||
130673872|NCT01446913|470430939|FG001|Overall Study|Physician Decision|0|||
130673873|NCT01446913|470430940|FG002|Overall Study|Physician Decision|2|||
130673874|NCT01446913|470430938|FG000|Overall Study|Lost to Follow-up|3|||
130673875|NCT01446913|470430939|FG001|Overall Study|Lost to Follow-up|5|||
130673876|NCT01446913|470430940|FG002|Overall Study|Lost to Follow-up|3|||
130673877|NCT02789111|470430943|FG000|Overall Study|Withdrawal by Subject|1|||
130673878|NCT02789111|470430944|FG001|Overall Study|Withdrawal by Subject|4|||
130673879|NCT00717756|470430948|FG000|Overall Study|Withdrawal by Subject|1|||
130673880|NCT00673790|470430949|FG000|Overall Study|Adverse Event|23|||
130673881|NCT00673790|470430950|FG001|Overall Study|Adverse Event|14|||
130673882|NCT00673790|470430951|FG002|Overall Study|Adverse Event|2|||
130673883|NCT00673790|470430949|FG000|Overall Study|Lack of Efficacy|2|||
130673884|NCT00673790|470430950|FG001|Overall Study|Lack of Efficacy|2|||
130673885|NCT00673790|470430951|FG002|Overall Study|Lack of Efficacy|2|||
130673886|NCT00673790|470430949|FG000|Overall Study|Protocol Violation|6|||
130673887|NCT00673790|470430950|FG001|Overall Study|Protocol Violation|9|||
130673888|NCT00673790|470430951|FG002|Overall Study|Protocol Violation|1|||
130673889|NCT00673790|470430949|FG000|Overall Study|Withdrawal by Subject|7|||
130673890|NCT00673790|470430950|FG001|Overall Study|Withdrawal by Subject|4|||
130673891|NCT00673790|470430951|FG002|Overall Study|Withdrawal by Subject|1|||
130673892|NCT00673790|470430949|FG000|Overall Study|Lost to Follow-up|6|||
130673893|NCT00673790|470430950|FG001|Overall Study|Lost to Follow-up|6|||
130673894|NCT00673790|470430951|FG002|Overall Study|Lost to Follow-up|5|||
130673895|NCT00673790|470430949|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
130673896|NCT00673790|470430950|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
130673897|NCT00673790|470430951|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
130673898|NCT00673790|470430949|FG000|Overall Study|Poor compliance|1|||
130673899|NCT00673790|470430950|FG001|Overall Study|Poor compliance|0|||
130673900|NCT00673790|470430951|FG002|Overall Study|Poor compliance|0|||
130673901|NCT00673790|470430949|FG000|Overall Study|Participated in two Nebivolol studies|0|||
130673902|NCT00673790|470430950|FG001|Overall Study|Participated in two Nebivolol studies|0|||
130673903|NCT00673790|470430951|FG002|Overall Study|Participated in two Nebivolol studies|1|||
130673904|NCT00673790|470430949|FG000|Overall Study|Unconfirmed pregnancy|0|||
130673905|NCT00673790|470430950|FG001|Overall Study|Unconfirmed pregnancy|1|||
130673906|NCT00673790|470430951|FG002|Overall Study|Unconfirmed pregnancy|0|||
130673907|NCT00673790|470430949|FG000|Overall Study|Randomization criteria not met|0|||
130673908|NCT00673790|470430950|FG001|Overall Study|Randomization criteria not met|1|||
130673909|NCT00673790|470430951|FG002|Overall Study|Randomization criteria not met|0|||
130673910|NCT00601484|470430955|FG000|Overall Study|Adverse Event|0|||
130673911|NCT00601484|470430956|FG001|Overall Study|Adverse Event|1|||
130673912|NCT00601484|470430955|FG000|Overall Study|Lost to Follow-up|4|||
130673913|NCT00601484|470430956|FG001|Overall Study|Lost to Follow-up|3|||
130673914|NCT00601484|470430955|FG000|Overall Study|Lack of Efficacy|0|||
130673915|NCT00601484|470430956|FG001|Overall Study|Lack of Efficacy|2|||
130673916|NCT00601484|470430955|FG000|Overall Study|Withdrawal by Subject|1|||
130673917|NCT00601484|470430956|FG001|Overall Study|Withdrawal by Subject|1|||
130673918|NCT00601484|470430955|FG000|Overall Study|Randomized, but not treated|0|||
130673919|NCT00601484|470430956|FG001|Overall Study|Randomized, but not treated|1|||
130673920|NCT00745251|470430957|FG000|Overall Study|Adverse Event|1|||
130673921|NCT00745251|470430958|FG001|Overall Study|Adverse Event|2|||
130673922|NCT00745251|470430957|FG000|Overall Study|Withdrawal by Subject|1|||
130673923|NCT00745251|470430958|FG001|Overall Study|Withdrawal by Subject|1|||
130673924|NCT02928848|470430959|FG000|Arm 2|Withdrawal by Subject|1|||
130673925|NCT02928848|470430960|FG001|Arm 2|Withdrawal by Subject|0|||
130673926|NCT01200394|470430961|FG000|Overall Study|Adverse Event|0|||
130673927|NCT01200394|470430962|FG001|Overall Study|Adverse Event|14|||
130673928|NCT01200394|470430961|FG000|Overall Study|Death|1|||
130673929|NCT01200394|470430962|FG001|Overall Study|Death|0|||
130673930|NCT01200394|470430961|FG000|Overall Study|Lost to Follow-up|0|||
130673931|NCT01200394|470430962|FG001|Overall Study|Lost to Follow-up|1|||
130673932|NCT01200394|470430961|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130673933|NCT01200394|470430962|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
130673934|NCT01200394|470430961|FG000|Overall Study|Protocol Violation|0|||
130673935|NCT01200394|470430962|FG001|Overall Study|Protocol Violation|3|||
130673936|NCT01200394|470430961|FG000|Overall Study|Withdrawal by Subject|0|||
130673937|NCT01200394|470430962|FG001|Overall Study|Withdrawal by Subject|5|||
130673938|NCT01200394|470430961|FG000|Overall Study|Other|0|||
130673939|NCT01200394|470430962|FG001|Overall Study|Other|1|||
130673940|NCT02729896|470430963|FG000|Overall Study|Death|0|||
130673941|NCT02729896|470430964|FG001|Overall Study|Death|2|||
130673942|NCT02729896|470430965|FG002|Overall Study|Death|13|||
130673943|NCT02729896|470430963|FG000|Overall Study|Lost to Follow-up|0|||
130673944|NCT02729896|470430964|FG001|Overall Study|Lost to Follow-up|2|||
130673945|NCT02729896|470430965|FG002|Overall Study|Lost to Follow-up|3|||
130673946|NCT02729896|470430963|FG000|Overall Study|Other|0|||
130673947|NCT02729896|470430964|FG001|Overall Study|Other|2|||
130673948|NCT02729896|470430965|FG002|Overall Study|Other|0|||
130673949|NCT02729896|470430963|FG000|Overall Study|Physician Decision|1|||
130673950|NCT02729896|470430964|FG001|Overall Study|Physician Decision|2|||
130673951|NCT02729896|470430965|FG002|Overall Study|Physician Decision|3|||
130673952|NCT02729896|470430963|FG000|Overall Study|Progressive Disease|0|||
130673953|NCT02729896|470430964|FG001|Overall Study|Progressive Disease|1|||
130673954|NCT02729896|470430965|FG002|Overall Study|Progressive Disease|0|||
130673955|NCT02729896|470430963|FG000|Overall Study|Withdrawal by Subject|1|||
130673956|NCT02729896|470430964|FG001|Overall Study|Withdrawal by Subject|0|||
130673957|NCT02729896|470430965|FG002|Overall Study|Withdrawal by Subject|3|||
130673958|NCT00582309|470430966|FG000|Overall Study|Protocol Violation|0|||
130673959|NCT00582309|470430967|FG001|Overall Study|Protocol Violation|0|||
130673960|NCT00582309|470430968|FG002|Overall Study|Protocol Violation|2|||
130673961|NCT01463683|470430972|FG000|Overall Study|Adverse Event|2|||
130673962|NCT01463683|470430973|FG001|Overall Study|Adverse Event|0|||
130673963|NCT01463683|470430974|FG002|Overall Study|Adverse Event|0|||
130673964|NCT01463683|470430972|FG000|Overall Study|Lost to Follow-up|10|||
130673965|NCT01463683|470430973|FG001|Overall Study|Lost to Follow-up|9|||
130673966|NCT01463683|470430974|FG002|Overall Study|Lost to Follow-up|7|||
130673967|NCT01463683|470430972|FG000|Overall Study|Physician Decision|0|||
130673968|NCT01463683|470430973|FG001|Overall Study|Physician Decision|3|||
130673969|NCT01463683|470430974|FG002|Overall Study|Physician Decision|1|||
130673970|NCT01463683|470430972|FG000|Overall Study|Pregnancy|2|||
130673971|NCT01463683|470430973|FG001|Overall Study|Pregnancy|2|||
130673972|NCT01463683|470430974|FG002|Overall Study|Pregnancy|1|||
130673973|NCT01463683|470430972|FG000|Overall Study|Withdrawal by Subject|5|||
130673974|NCT01463683|470430973|FG001|Overall Study|Withdrawal by Subject|17|||
130673975|NCT01463683|470430974|FG002|Overall Study|Withdrawal by Subject|2|||
130673976|NCT01618305|470430975|FG000|Overall Study|Death|0|||
130673977|NCT01618305|470430976|FG001|Overall Study|Death|1|||
130673978|NCT01618305|470430975|FG000|Overall Study|Lost to Follow-up|11|||
130673979|NCT01618305|470430976|FG001|Overall Study|Lost to Follow-up|7|||
130673980|NCT01618305|470430975|FG000|Overall Study|Protocol Violation|1|||
130673981|NCT01618305|470430976|FG001|Overall Study|Protocol Violation|0|||
130673982|NCT01618305|470430975|FG000|Overall Study|Withdrawal by Subject|3|||
130673983|NCT01618305|470430976|FG001|Overall Study|Withdrawal by Subject|2|||
130673984|NCT04345471|470430981|FG000|Overall Study|Adverse Event|8|||
130673985|NCT04345471|470430982|FG001|Overall Study|Adverse Event|5|||
130673986|NCT04345471|470430983|FG002|Overall Study|Adverse Event|6|||
130673987|NCT04345471|470430981|FG000|Overall Study|Lack of Efficacy|1|||
130673988|NCT04345471|470430982|FG001|Overall Study|Lack of Efficacy|1|||
130673989|NCT04345471|470430983|FG002|Overall Study|Lack of Efficacy|0|||
130673990|NCT04345471|470430981|FG000|Overall Study|Protocol Violation|0|||
130673991|NCT04345471|470430982|FG001|Overall Study|Protocol Violation|1|||
130673992|NCT04345471|470430983|FG002|Overall Study|Protocol Violation|2|||
130673993|NCT04345471|470430981|FG000|Overall Study|Withdrawal by Subject|10|||
130673994|NCT04345471|470430982|FG001|Overall Study|Withdrawal by Subject|5|||
130216584|NCT03762681|468755603|FG000|Part 2a|Pandemic Travel Restrictions|0|||
130216585|NCT03762681|468755604|FG001|Part 2a|Pandemic Travel Restrictions|0|||
130673995|NCT04345471|470430983|FG002|Overall Study|Withdrawal by Subject|10|||
130673996|NCT03896490|470431018|FG000|Overall Study|Withdrawal by Subject|1|||
130673997|NCT03896490|470431019|FG001|Overall Study|Withdrawal by Subject|1|||
130673998|NCT00003782|470431020|FG000|Overall Study|No follow up data|30|||
130673999|NCT00003782|470431021|FG001|Overall Study|No follow up data|31|||
130674000|NCT00003782|470431022|FG002|Overall Study|No follow up data|26|||
130674001|NCT01890707|470431023|FG000|Overall Study|Lost to Follow-up|1|||
130674002|NCT01890707|470431024|FG001|Overall Study|Lost to Follow-up|1|||
130674003|NCT01326026|470431026|FG000|Overall Study|Adverse Event|4|||
130674004|NCT01326026|470431027|FG001|Overall Study|Adverse Event|3|||
130674005|NCT01326026|470431026|FG000|Overall Study|Withdrawal Criteria|5|||
130674006|NCT01326026|470431027|FG001|Overall Study|Withdrawal Criteria|7|||
130674007|NCT01326026|470431026|FG000|Overall Study|Other|3|||
130674008|NCT01326026|470431027|FG001|Overall Study|Other|3|||
130674009|NCT01628120|470432583|FG000|Overall Study|Withdrawal by Subject|7|||
130674010|NCT01628120|470432583|FG000|Overall Study|Adverse Event|12|||
130674011|NCT01628120|470432583|FG000|Overall Study|Lost to Follow-up|1|||
130674012|NCT01628120|470432583|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
130674013|NCT01628120|470432583|FG000|Overall Study|Non-compliant with Study Procedures|1|||
130674014|NCT01628120|470432583|FG000|Overall Study|Not Treated|3|||
130674015|NCT01628120|470432583|FG000|Overall Study|Sponsor Decision|5|||
130674016|NCT01628120|470432583|FG000|Overall Study|Switched Dialysis Method|2|||
130674017|NCT01628120|470432583|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
130674018|NCT01628120|470432583|FG000|Overall Study|Moved or Relocated|5|||
130674019|NCT01628120|470432583|FG000|Overall Study|Kidney Transplant|2|||
130674020|NCT01628120|470432583|FG000|Overall Study|Use of Standard of Care|1|||
130674021|NCT01075763|470432588|FG000|Overall Study|Lost to Follow-up|2|||
130674022|NCT01075763|470432589|FG001|Overall Study|Lost to Follow-up|1|||
130674023|NCT01075763|470432588|FG000|Overall Study|Lack of Efficacy|0|||
130674024|NCT01075763|470432589|FG001|Overall Study|Lack of Efficacy|1|||
130674025|NCT01075763|470432588|FG000|Overall Study|Withdrawal by Subject|2|||
130674026|NCT01075763|470432589|FG001|Overall Study|Withdrawal by Subject|2|||
130674027|NCT00586521|470432590|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
130674028|NCT03731182|470432597|FG000|Overall Study|Lost to Follow-up|2|||
130674029|NCT03731182|470432598|FG001|Overall Study|Lost to Follow-up|0|||
130674030|NCT03731182|470432597|FG000|Overall Study|Physician Decision|1|||
130674031|NCT03731182|470432598|FG001|Overall Study|Physician Decision|0|||
130674032|NCT03731182|470432597|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
130674033|NCT03731182|470432598|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130674034|NCT00582036|470432599|FG000|Overall Study|Withdrawal by Subject|0|||
130674035|NCT00582036|470432600|FG001|Overall Study|Withdrawal by Subject|1|||
130674036|NCT04161144|470432602|FG000|Overall Study|Withdrawal by Subject|0|||
130674037|NCT04161144|470432603|FG001|Overall Study|Withdrawal by Subject|1|||
130674038|NCT04161144|470432602|FG000|Overall Study|Protocol Violation|1|||
130674039|NCT04161144|470432603|FG001|Overall Study|Protocol Violation|0|||
130674040|NCT02207621|470432605|FG000|Overall Study|Adverse Event|71|||
130674041|NCT02207621|470432606|FG001|Overall Study|Adverse Event|15|||
130674042|NCT02207621|470432607|FG002|Overall Study|Adverse Event|132|||
130674043|NCT02207621|470432605|FG000|Overall Study|Withdrawal by Subject|9|||
130341533|NCT00422084|469223079|FG001|Overall Study|Non-compliance|0|||
130341534|NCT00422084|469223078|FG000|Overall Study|Re-location|0|||
130341535|NCT00422084|469223079|FG001|Overall Study|Re-location|1|||
130341536|NCT00422084|469223078|FG000|Overall Study|Not defined|1|||
130341537|NCT00422084|469223079|FG001|Overall Study|Not defined|1|||
130341538|NCT03774823|469223082|FG000|Overall Study|Withdrawal by Subject|1|||
130341539|NCT03774823|469223083|FG001|Overall Study|Withdrawal by Subject|1|||
130341540|NCT01253811|469223084|FG000|Overall Study|Withdrawal criteria|1|||
130341541|NCT01087736|469223085|FG000|Overall Study|Lost to Follow-up|1|||
130341542|NCT01087736|469223086|FG001|Overall Study|Lost to Follow-up|0|||
130341543|NCT01087736|469223085|FG000|Overall Study|Death|0|||
130341544|NCT01087736|469223086|FG001|Overall Study|Death|1|||
130341545|NCT01087736|469223085|FG000|Overall Study|Withdrawal by Subject|0|||
130341546|NCT01087736|469223086|FG001|Overall Study|Withdrawal by Subject|1|||
130341547|NCT00958438|469223090|FG000|Overall Study|Protocol Violation|3|||
130341548|NCT00958438|469223091|FG001|Overall Study|Protocol Violation|2|||
130341549|NCT00958438|469223092|FG002|Overall Study|Protocol Violation|2|||
130341550|NCT00958438|469223090|FG000|Overall Study|Withdrawal by Subject|4|||
130341551|NCT00958438|469223091|FG001|Overall Study|Withdrawal by Subject|2|||
130341552|NCT00958438|469223092|FG002|Overall Study|Withdrawal by Subject|1|||
130341553|NCT00958438|469223090|FG000|Overall Study|Adverse Event|0|||
130674044|NCT02207621|470432606|FG001|Overall Study|Withdrawal by Subject|9|||
130674045|NCT02207621|470432607|FG002|Overall Study|Withdrawal by Subject|13|||
130674046|NCT02207621|470432605|FG000|Overall Study|Non-Compliant|3|||
130341554|NCT00958438|469223091|FG001|Overall Study|Adverse Event|3|||
130341555|NCT00958438|469223092|FG002|Overall Study|Adverse Event|0|||
130341556|NCT00958438|469223090|FG000|Overall Study|Physician Decision|1|||
130341557|NCT00958438|469223091|FG001|Overall Study|Physician Decision|0|||
130341558|NCT00958438|469223092|FG002|Overall Study|Physician Decision|1|||
130341559|NCT00958438|469223090|FG000|Overall Study|Other than specified above|2|||
130674047|NCT02207621|470432606|FG001|Overall Study|Non-Compliant|3|||
130341560|NCT00958438|469223091|FG001|Overall Study|Other than specified above|3|||
130341561|NCT00958438|469223092|FG002|Overall Study|Other than specified above|2|||
130341562|NCT00759564|469223093|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
130674048|NCT02207621|470432607|FG002|Overall Study|Non-Compliant|1|||
130674049|NCT02207621|470432605|FG000|Overall Study|Lost to Follow-up|1|||
130674050|NCT02207621|470432606|FG001|Overall Study|Lost to Follow-up|0|||
130674051|NCT02207621|470432607|FG002|Overall Study|Lost to Follow-up|3|||
130674052|NCT02207621|470432605|FG000|Overall Study|Lack of Efficacy|10|||
130674053|NCT02207621|470432606|FG001|Overall Study|Lack of Efficacy|2|||
130674054|NCT02207621|470432607|FG002|Overall Study|Lack of Efficacy|4|||
130674055|NCT02207621|470432605|FG000|Overall Study|Disallowed Concurrent Medication|2|||
130674056|NCT02207621|470432606|FG001|Overall Study|Disallowed Concurrent Medication|5|||
130674057|NCT02207621|470432607|FG002|Overall Study|Disallowed Concurrent Medication|2|||
130674058|NCT02207621|470432605|FG000|Overall Study|Physician Decision|1|||
130674059|NCT02207621|470432606|FG001|Overall Study|Physician Decision|2|||
130674060|NCT02207621|470432607|FG002|Overall Study|Physician Decision|2|||
130674061|NCT02207621|470432605|FG000|Overall Study|Protocol Violation|4|||
130674062|NCT02207621|470432606|FG001|Overall Study|Protocol Violation|10|||
130674063|NCT02207621|470432607|FG002|Overall Study|Protocol Violation|6|||
130674064|NCT02207621|470432605|FG000|Overall Study|Death|2|||
130674065|NCT02207621|470432606|FG001|Overall Study|Death|0|||
130674066|NCT02207621|470432607|FG002|Overall Study|Death|0|||
130674067|NCT02207621|470432605|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
130674068|NCT02207621|470432606|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
130674069|NCT02207621|470432607|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
130674070|NCT01090765|470432610|FG000|Overall Study|Patient withdrew consent|0|||
130674071|NCT01090765|470432611|FG001|Overall Study|Patient withdrew consent|0|||
130674072|NCT01090765|470432612|FG002|Overall Study|Patient withdrew consent|0|||
130674073|NCT01090765|470432613|FG003|Overall Study|Patient withdrew consent|0|||
130674074|NCT01090765|470432614|FG004|Overall Study|Patient withdrew consent|1|||
130674075|NCT01090765|470432615|FG005|Overall Study|Patient withdrew consent|1|||
130674076|NCT01090765|470432610|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
130674077|NCT01090765|470432611|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
130674078|NCT01090765|470432612|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
130674079|NCT01090765|470432613|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
130674080|NCT01090765|470432614|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
130674081|NCT01090765|470432615|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
130674082|NCT01090765|470432610|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
130674083|NCT01090765|470432611|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
130674084|NCT01090765|470432612|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
130674085|NCT01090765|470432613|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
130674086|NCT01090765|470432614|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
130674087|NCT01090765|470432615|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
130674088|NCT00421174|470432616|FG000|Overall Study|Withdrawal by Subject|0|||
130674089|NCT00421174|470432617|FG001|Overall Study|Withdrawal by Subject|1|||
130674090|NCT00421174|470432616|FG000|Overall Study|Ineligible due to infection|2|||
130674091|NCT00421174|470432617|FG001|Overall Study|Ineligible due to infection|0|||
130674092|NCT02396381|470432618|FG000|Overall Study|Adverse Event|3|||
130674093|NCT02396381|470432619|FG001|Overall Study|Adverse Event|2|||
130674094|NCT02396381|470432618|FG000|Overall Study|Withdrawal by Subject|33|||
130674095|NCT02396381|470432619|FG001|Overall Study|Withdrawal by Subject|24|||
130674096|NCT02396381|470432618|FG000|Overall Study|Lost to Follow-up|49|||
130674097|NCT02396381|470432619|FG001|Overall Study|Lost to Follow-up|31|||
130674098|NCT02396381|470432618|FG000|Overall Study|Protocol Violation|1|||
130341563|NCT00759564|469223094|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341564|NCT00759564|469223095|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341565|NCT00759564|469223096|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341566|NCT00759564|469223097|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
130341567|NCT02788279|469223098|FG000|Overall Study|Death|62|||
130341568|NCT02788279|469223099|FG001|Overall Study|Death|136|||
130341569|NCT02788279|469223100|FG002|Overall Study|Death|72|||
130341570|NCT02788279|469223098|FG000|Overall Study|Withdrawal by Subject|10|||
130341571|NCT02788279|469223099|FG001|Overall Study|Withdrawal by Subject|15|||
130341572|NCT02788279|469223100|FG002|Overall Study|Withdrawal by Subject|5|||
130341573|NCT02788279|469223098|FG000|Overall Study|Lost to Follow-up|0|||
130341574|NCT02788279|469223099|FG001|Overall Study|Lost to Follow-up|3|||
130341575|NCT02788279|469223100|FG002|Overall Study|Lost to Follow-up|2|||
130341576|NCT02788279|469223098|FG000|Overall Study|Sponsor decision|18|||
130341577|NCT02788279|469223099|FG001|Overall Study|Sponsor decision|29|||
130341578|NCT02788279|469223100|FG002|Overall Study|Sponsor decision|11|||
130341579|NCT00329849|469223101|FG000|Overall Study|Withdrawal by Subject|6|||
130674099|NCT02396381|470432619|FG001|Overall Study|Protocol Violation|0|||
130341580|NCT00329849|469223102|FG001|Overall Study|Withdrawal by Subject|4|||
130341581|NCT00653432|469223103|FG000|Overall Study|Adverse Event|4|||
130341582|NCT00653432|469223104|FG001|Overall Study|Adverse Event|1|||
130674100|NCT02396381|470432618|FG000|Overall Study|Site terminated by sponsor|7|||
130341583|NCT00653432|469223103|FG000|Overall Study|Withdrawal by Subject|4|||
130341584|NCT00653432|469223104|FG001|Overall Study|Withdrawal by Subject|5|||
130341585|NCT00653432|469223103|FG000|Overall Study|Lost to Follow-up|7|||
130341586|NCT00653432|469223104|FG001|Overall Study|Lost to Follow-up|6|||
130341587|NCT00653432|469223103|FG000|Overall Study|Use/Need of Con Therapy|2|||
130341588|NCT00653432|469223104|FG001|Overall Study|Use/Need of Con Therapy|1|||
130341589|NCT00653432|469223103|FG000|Overall Study|Other - Reason Not Provided|5|||
130341590|NCT00653432|469223104|FG001|Overall Study|Other - Reason Not Provided|3|||
130341591|NCT01782469|469223105|FG000|Overall Study|Lost to Follow-up|1|||
130341592|NCT00835211|469223109|FG000|First Intervention|Withdrawal by Subject|0|||
130341593|NCT00835211|469223110|FG001|First Intervention|Withdrawal by Subject|1|||
130341594|NCT00835211|469223109|FG000|Washout: 7 Days|Adverse Event|2|||
130341595|NCT00835211|469223110|FG001|Washout: 7 Days|Adverse Event|1|||
130341596|NCT00835211|469223109|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130341597|NCT00835211|469223110|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130341598|NCT02343549|469223111|FG000|Overall Study|Death|11|||
130341599|NCT02343549|469223111|FG000|Overall Study|Withdrawal by Subject|2|||
130341600|NCT01090323|469223112|FG000|Overall Study|Adverse Event|12|||
130341601|NCT01090323|469223113|FG001|Overall Study|Adverse Event|2|||
130341602|NCT01090323|469223112|FG000|Overall Study|Abnormal Lab Values|3|||
130341603|NCT01090323|469223113|FG001|Overall Study|Abnormal Lab Values|1|||
130341604|NCT01090323|469223112|FG000|Overall Study|Abnormal Test Procedure Results|2|||
130341605|NCT01090323|469223113|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130341606|NCT01090323|469223112|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130341607|NCT01090323|469223113|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130341608|NCT01090323|469223112|FG000|Overall Study|Condition no longer requires drug|5|||
130341609|NCT01090323|469223113|FG001|Overall Study|Condition no longer requires drug|4|||
130341610|NCT01090323|469223112|FG000|Overall Study|Protocol Violation|2|||
130341611|NCT01090323|469223113|FG001|Overall Study|Protocol Violation|1|||
130341612|NCT01090323|469223112|FG000|Overall Study|Withdrew consent|33|||
130341613|NCT01090323|469223113|FG001|Overall Study|Withdrew consent|11|||
130341614|NCT01090323|469223112|FG000|Overall Study|Lost to Follow-up|11|||
130341615|NCT01090323|469223113|FG001|Overall Study|Lost to Follow-up|6|||
130341616|NCT01090323|469223112|FG000|Overall Study|Administrative problems|6|||
130674101|NCT02396381|470432619|FG001|Overall Study|Site terminated by sponsor|8|||
130674102|NCT02396381|470432618|FG000|Overall Study|Physician Decision|5|||
130674103|NCT02396381|470432619|FG001|Overall Study|Physician Decision|5|||
130674104|NCT02396381|470432618|FG000|Overall Study|Pregnancy|2|||
130674105|NCT02396381|470432619|FG001|Overall Study|Pregnancy|0|||
130674106|NCT02396381|470432618|FG000|Overall Study|Non-compliance with study procedures|1|||
130674107|NCT02396381|470432619|FG001|Overall Study|Non-compliance with study procedures|0|||
130674108|NCT02396381|470432618|FG000|Overall Study|Moved out of town/state|1|||
130674109|NCT02396381|470432619|FG001|Overall Study|Moved out of town/state|3|||
130674110|NCT02396381|470432618|FG000|Overall Study|Could not complete visit|1|||
130674111|NCT02396381|470432619|FG001|Overall Study|Could not complete visit|0|||
130674112|NCT02396381|470432618|FG000|Overall Study|Possible conflict of interest|1|||
130674113|NCT02396381|470432619|FG001|Overall Study|Possible conflict of interest|0|||
130674114|NCT02396381|470432618|FG000|Overall Study|Randomization/Screening Error|3|||
130674115|NCT02396381|470432619|FG001|Overall Study|Randomization/Screening Error|1|||
130674116|NCT00356200|470432621|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
130341617|NCT01090323|469223113|FG001|Overall Study|Administrative problems|4|||
130341618|NCT01090323|469223112|FG000|Overall Study|Death|1|||
130341619|NCT01090323|469223113|FG001|Overall Study|Death|2|||
130341620|NCT01090323|469223112|FG000|Overall Study|Stopped end of core|7|||
130341621|NCT01090323|469223113|FG001|Overall Study|Stopped end of core|0|||
130341622|NCT01090323|469223112|FG000|Overall Study|Stopped end of extension 1#|3|||
130341623|NCT01090323|469223113|FG001|Overall Study|Stopped end of extension 1#|1|||
130341624|NCT05498701|469223114|FG000|Period 3|Adverse Event|1|||
130341625|NCT05498701|469223115|FG001|Period 3|Adverse Event|0|||
130341626|NCT01864005|469223116|FG000|Overall Study|Protocol Violation|0|||
130341627|NCT01864005|469223117|FG001|Overall Study|Protocol Violation|1|||
130341628|NCT01864005|469223116|FG000|Overall Study|Withdrawal by Subject|0|||
130341629|NCT01864005|469223117|FG001|Overall Study|Withdrawal by Subject|1|||
130341630|NCT01864005|469223116|FG000|Overall Study|Incorrect enrolment|1|||
130341631|NCT01864005|469223117|FG001|Overall Study|Incorrect enrolment|0|||
130341632|NCT01864005|469223116|FG000|Overall Study|Disease need|1|||
130674117|NCT00356200|470432622|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
130216586|NCT03762681|468755605|FG002|Part 2a|Pandemic Travel Restrictions|0|||
130341633|NCT01864005|469223117|FG001|Overall Study|Disease need|1|||
130341634|NCT01864005|469223116|FG000|Overall Study|Need GP IIb/IIIa|1|||
130341635|NCT01864005|469223117|FG001|Overall Study|Need GP IIb/IIIa|3|||
130216587|NCT03762681|468755606|FG003|Part 2a|Pandemic Travel Restrictions|0|||
130341636|NCT02184572|469223121|FG000|Overall Study|Lost to Follow-up|29|||
130341637|NCT02184572|469223122|FG001|Overall Study|Lost to Follow-up|21|||
130341638|NCT02184572|469223121|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
130341639|NCT02184572|469223122|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
130341640|NCT02184572|469223121|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
130341641|NCT02184572|469223122|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
130552753|NCT00995020|469991526|FG000|Overall Study|margin analysis not performed|2|||
130341642|NCT02184572|469223121|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
130674118|NCT00356200|470432621|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
130674119|NCT00356200|470432622|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
130674120|NCT01000337|470432626|FG000|Overall Study|Lost to Follow-up|4|||
130674121|NCT01000337|470432627|FG001|Overall Study|Lost to Follow-up|3|||
130674122|NCT02173704|470432628|FG000|Overall Study|Adverse Event|1|||
130674123|NCT02173704|470432629|FG001|Overall Study|Adverse Event|0|||
130674124|NCT02173704|470432628|FG000|Overall Study|Lost to Follow-up|1|||
130674125|NCT02173704|470432629|FG001|Overall Study|Lost to Follow-up|0|||
130674126|NCT02173704|470432628|FG000|Overall Study|Other|1|||
130674127|NCT02173704|470432629|FG001|Overall Study|Other|0|||
130674128|NCT02173704|470432628|FG000|Overall Study|Protocol Violation|1|||
130674129|NCT02173704|470432629|FG001|Overall Study|Protocol Violation|0|||
130674130|NCT02173704|470432628|FG000|Overall Study|Withdrawal by Subject|9|||
130674131|NCT02173704|470432629|FG001|Overall Study|Withdrawal by Subject|4|||
130674132|NCT00419926|470432630|FG000|Overall Study|Withdrawal by Subject|7|||
130674133|NCT00419926|470432631|FG001|Overall Study|Withdrawal by Subject|3|||
130341643|NCT02184572|469223122|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
130341644|NCT02184572|469223121|FG000|Overall Study|Traveling Outside The Country|1|||
130341645|NCT02184572|469223122|FG001|Overall Study|Traveling Outside The Country|0|||
130341646|NCT02184572|469223121|FG000|Overall Study|Withdrawal by Subject|14|||
130341647|NCT02184572|469223122|FG001|Overall Study|Withdrawal by Subject|9|||
130341648|NCT00638183|469223126|FG000|Overall Study|Adverse Event|23|||
130341649|NCT00638183|469223126|FG000|Overall Study|Lack of Efficacy|14|||
130341650|NCT00638183|469223126|FG000|Overall Study|Physician Decision|9|||
130341651|NCT00638183|469223126|FG000|Overall Study|Lost to Follow-up|46|||
130341652|NCT00638183|469223126|FG000|Overall Study|Other reason not defined above|27|||
130341653|NCT00006409|469223127|FG000|Baseline|Protocol Violation|48|||
130341654|NCT00006409|469223128|FG001|Baseline|Protocol Violation|70|||
130341655|NCT00006409|469223129|FG002|Baseline|Protocol Violation|0|||
130341656|NCT00006409|469223130|FG003|Baseline|Protocol Violation|0|||
130341657|NCT00006409|469223131|FG004|Baseline|Protocol Violation|0|||
130341658|NCT00006409|469223132|FG005|Baseline|Protocol Violation|0|||
130341659|NCT00006409|469223127|FG000|Post-2 Year Intervention|Protocol Violation|0|||
130341660|NCT00006409|469223128|FG001|Post-2 Year Intervention|Protocol Violation|0|||
130341661|NCT00006409|469223129|FG002|Post-2 Year Intervention|Protocol Violation|251|||
130341662|NCT00006409|469223130|FG003|Post-2 Year Intervention|Protocol Violation|168|||
130341663|NCT00006409|469223131|FG004|Post-2 Year Intervention|Protocol Violation|0|||
130341664|NCT00006409|469223132|FG005|Post-2 Year Intervention|Protocol Violation|0|||
130341665|NCT00006409|469223127|FG000|Post-3 Year Intervention|Protocol Violation|0|||
130341666|NCT00006409|469223128|FG001|Post-3 Year Intervention|Protocol Violation|0|||
130341667|NCT00006409|469223129|FG002|Post-3 Year Intervention|Protocol Violation|0|||
130341668|NCT00006409|469223130|FG003|Post-3 Year Intervention|Protocol Violation|0|||
130341669|NCT00006409|469223131|FG004|Post-3 Year Intervention|Protocol Violation|62|||
130341670|NCT00006409|469223132|FG005|Post-3 Year Intervention|Protocol Violation|62|||
130341671|NCT02350764|469223133|FG000|Overall Study|Adverse Event|4|||
130341672|NCT02350764|469223133|FG000|Overall Study|Death|3|||
130341673|NCT02350764|469223133|FG000|Overall Study|Physician Decision|2|||
130341674|NCT02350764|469223133|FG000|Overall Study|Withdrawal by Subject|2|||
130341675|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130341676|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130341677|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130341678|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130341679|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
130341680|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130341681|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130341682|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341683|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341684|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341685|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130341686|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
130341687|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341688|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341689|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341690|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130341691|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341692|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130341693|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130341694|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
130341695|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130674134|NCT00419926|470432630|FG000|Overall Study|Administrative Problem|4|||
130674135|NCT00419926|470432631|FG001|Overall Study|Administrative Problem|4|||
130674136|NCT00419926|470432630|FG000|Overall Study|Lost to Follow-up|1|||
130674137|NCT00419926|470432631|FG001|Overall Study|Lost to Follow-up|2|||
130674138|NCT00419926|470432630|FG000|Overall Study|Death|2|||
130674139|NCT00419926|470432631|FG001|Overall Study|Death|1|||
130674140|NCT02374918|470432632|FG000|Overall Study|Protocol Violation|2|||
130674141|NCT02374918|470432633|FG001|Overall Study|Protocol Violation|0|||
130674142|NCT02374918|470432634|FG002|Overall Study|Protocol Violation|2|||
130674143|NCT02374918|470432635|FG003|Overall Study|Protocol Violation|1|||
130674144|NCT02374918|470432632|FG000|Overall Study|Withdrawal by Subject|1|||
130674145|NCT02374918|470432633|FG001|Overall Study|Withdrawal by Subject|1|||
130341696|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130341697|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
130341698|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130674146|NCT02374918|470432634|FG002|Overall Study|Withdrawal by Subject|1|||
130674147|NCT02374918|470432635|FG003|Overall Study|Withdrawal by Subject|0|||
130674148|NCT02374918|470432632|FG000|Overall Study|Lack of Efficacy|0|||
130674149|NCT02374918|470432633|FG001|Overall Study|Lack of Efficacy|0|||
130674150|NCT02374918|470432634|FG002|Overall Study|Lack of Efficacy|1|||
130674151|NCT02374918|470432635|FG003|Overall Study|Lack of Efficacy|1|||
130674152|NCT01180244|470432636|FG000|Overall Study|Lack of Efficacy|0|||
130674153|NCT01180244|470432637|FG001|Overall Study|Lack of Efficacy|7|||
130674154|NCT01180244|470432636|FG000|Overall Study|Physician Decision|3|||
130674155|NCT01180244|470432637|FG001|Overall Study|Physician Decision|0|||
130674156|NCT01180244|470432636|FG000|Overall Study|Adverse Event|1|||
130674157|NCT01180244|470432637|FG001|Overall Study|Adverse Event|0|||
130674158|NCT01180244|470432636|FG000|Overall Study|Withdrawal by Subject|0|||
130674159|NCT01180244|470432637|FG001|Overall Study|Withdrawal by Subject|1|||
130674160|NCT01180244|470432636|FG000|Overall Study|Protocol Violation|1|||
130674161|NCT01180244|470432637|FG001|Overall Study|Protocol Violation|0|||
130674162|NCT01180244|470432636|FG000|Overall Study|Lost to Follow-up|1|||
130674163|NCT01180244|470432637|FG001|Overall Study|Lost to Follow-up|0|||
130674164|NCT00729859|470432638|FG000|Overall Study|Adverse Event|0|||
130674165|NCT00729859|470432639|FG001|Overall Study|Adverse Event|1|||
130674166|NCT00729859|470432640|FG002|Overall Study|Adverse Event|0|||
130674167|NCT00729859|470432638|FG000|Overall Study|Withdrawal by Subject|0|||
130674168|NCT00729859|470432639|FG001|Overall Study|Withdrawal by Subject|1|||
130674169|NCT00729859|470432640|FG002|Overall Study|Withdrawal by Subject|0|||
130674170|NCT02623829|470432643|FG000|Overall Study|Lost to Follow-up|1|||
130674171|NCT02623829|470432644|FG001|Overall Study|Lost to Follow-up|1|||
130674172|NCT03349333|470432645|FG000|Overall Study|Progression of Disease|36|||
130674173|NCT03349333|470432645|FG000|Overall Study|Adverse Event|11|||
130674174|NCT03349333|470432645|FG000|Overall Study|Other|6|||
130674175|NCT03349333|470432645|FG000|Overall Study|Withdrawal by Subject|5|||
130674176|NCT03349333|470432645|FG000|Overall Study|Conditions interfere with participation|2|||
130674177|NCT03349333|470432645|FG000|Overall Study|Physician Decision|2|||
130674178|NCT03349333|470432645|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
130674179|NCT03349333|470432645|FG000|Overall Study|Patients in treatment less than 24 month|8|||
130674180|NCT00783796|470432646|FG000|Overall Study|Did not receive any stent|4|||
130674181|NCT00783796|470432646|FG000|Overall Study|Received non-XIENCE V stent|1|||
130674182|NCT00783796|470432646|FG000|Overall Study|Received commercial XIENCE V stent|1|||
130674183|NCT03267264|470432648|FG000|Overall Study|Withdrawal by Subject|1|||
130674184|NCT03267264|470432649|FG001|Overall Study|Withdrawal by Subject|0|||
130674185|NCT03267264|470432650|FG002|Overall Study|Withdrawal by Subject|2|||
130674186|NCT03267264|470432651|FG003|Overall Study|Withdrawal by Subject|4|||
130674187|NCT01766921|470432652|FG000|Overall Study|Administrative Reason|5|||
130674188|NCT01766921|470432653|FG001|Overall Study|Administrative Reason|5|||
130674189|NCT01766921|470432652|FG000|Overall Study|Death|1|||
130674190|NCT01766921|470432653|FG001|Overall Study|Death|1|||
130674191|NCT01766921|470432652|FG000|Overall Study|Lost to Follow-up|1|||
130674192|NCT01766921|470432653|FG001|Overall Study|Lost to Follow-up|3|||
130674193|NCT01766921|470432652|FG000|Overall Study|Unclassified|2|||
130674194|NCT01766921|470432653|FG001|Overall Study|Unclassified|2|||
130341699|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
130341700|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341701|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341702|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130674195|NCT01766921|470432652|FG000|Overall Study|Protocol Violation|1|||
130674196|NCT01766921|470432653|FG001|Overall Study|Protocol Violation|1|||
130341703|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341704|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130674197|NCT01766921|470432652|FG000|Overall Study|Withdrawal by Subject|14|||
130674198|NCT01766921|470432653|FG001|Overall Study|Withdrawal by Subject|5|||
130674199|NCT01915732|470432654|FG000|Overall Study|Withdrawal by Subject|18|||
130674200|NCT01915732|470432655|FG001|Overall Study|Withdrawal by Subject|18|||
130674201|NCT01915732|470432654|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130674202|NCT01915732|470432655|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130674203|NCT01915732|470432654|FG000|Overall Study|Adverse Event|12|||
130674204|NCT01915732|470432655|FG001|Overall Study|Adverse Event|4|||
130674205|NCT01915732|470432654|FG000|Overall Study|Protocol Violation|5|||
130674206|NCT01915732|470432655|FG001|Overall Study|Protocol Violation|5|||
130674207|NCT01915732|470432654|FG000|Overall Study|Lack of Efficacy|6|||
130674208|NCT01915732|470432655|FG001|Overall Study|Lack of Efficacy|11|||
130674209|NCT01915732|470432654|FG000|Overall Study|Lost to Follow-up|22|||
130674210|NCT01915732|470432655|FG001|Overall Study|Lost to Follow-up|26|||
130674211|NCT01915732|470432654|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
130674212|NCT01915732|470432655|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
130674213|NCT01915732|470432654|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
130674214|NCT01915732|470432655|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
130674215|NCT01915732|470432654|FG000|Overall Study|Drug Release Error|1|||
130674216|NCT01915732|470432655|FG001|Overall Study|Drug Release Error|0|||
130674217|NCT01915732|470432654|FG000|Overall Study|Recovered|1|||
130674218|NCT01915732|470432655|FG001|Overall Study|Recovered|0|||
130674219|NCT01915732|470432654|FG000|Overall Study|Pregnancy|1|||
130674220|NCT01915732|470432655|FG001|Overall Study|Pregnancy|0|||
130674221|NCT01915732|470432654|FG000|Overall Study|Poor Perceived Efficacy|1|||
130674222|NCT01915732|470432655|FG001|Overall Study|Poor Perceived Efficacy|0|||
130674223|NCT01915732|470432654|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
130674224|NCT01915732|470432655|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
130674225|NCT01915732|470432654|FG000|Overall Study|Got Well|0|||
130674226|NCT01915732|470432655|FG001|Overall Study|Got Well|1|||
130674227|NCT01915732|470432654|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
130674228|NCT01915732|470432655|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
130674229|NCT01915732|470432654|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
130674230|NCT01915732|470432655|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
130674231|NCT01915732|470432654|FG000|Overall Study|Job Transfer|0|||
130674232|NCT01915732|470432655|FG001|Overall Study|Job Transfer|1|||
130674233|NCT01915732|470432654|FG000|Overall Study|Improper Facial Procedure|0|||
130674234|NCT01915732|470432655|FG001|Overall Study|Improper Facial Procedure|1|||
130674235|NCT01915732|470432654|FG000|Overall Study|Poor Conscious Effect|0|||
130674236|NCT01915732|470432655|FG001|Overall Study|Poor Conscious Effect|1|||
130674237|NCT01654380|470432664|FG000|Part B, Period 1|Physician Decision|0|||
130674238|NCT01654380|470432665|FG001|Part B, Period 1|Physician Decision|0|||
130674239|NCT01654380|470432666|FG002|Part B, Period 1|Physician Decision|1|||
130674240|NCT01654380|470432667|FG003|Part B, Period 1|Physician Decision|0|||
130674241|NCT02015793|470432672|FG000|Overall Study|Adverse Event|3|||
130674242|NCT02015793|470432673|FG001|Overall Study|Adverse Event|3|||
130674243|NCT02015793|470432672|FG000|Overall Study|Withdrawal by Subject|1|||
130674244|NCT02015793|470432673|FG001|Overall Study|Withdrawal by Subject|1|||
130674245|NCT00601354|470432674|FG000|Overall Study|Lost to Follow-up|4|||
130674246|NCT00601354|470432675|FG001|Overall Study|Lost to Follow-up|5|||
130674247|NCT01862328|470432676|FG000|Overall Study|Progressive Disease|3|||
130674248|NCT01862328|470432677|FG001|Overall Study|Progressive Disease|11|||
130674249|NCT01862328|470432678|FG002|Overall Study|Progressive Disease|5|||
130674250|NCT01862328|470432679|FG003|Overall Study|Progressive Disease|6|||
130674251|NCT01862328|470432680|FG004|Overall Study|Progressive Disease|7|||
130674252|NCT01862328|470432681|FG005|Overall Study|Progressive Disease|4|||
130674253|NCT01862328|470432682|FG006|Overall Study|Progressive Disease|3|||
130674254|NCT01862328|470432676|FG000|Overall Study|Adverse Event|0|||
130674255|NCT01862328|470432677|FG001|Overall Study|Adverse Event|4|||
130674256|NCT01862328|470432678|FG002|Overall Study|Adverse Event|0|||
130674257|NCT01862328|470432679|FG003|Overall Study|Adverse Event|1|||
130674258|NCT01862328|470432680|FG004|Overall Study|Adverse Event|0|||
130674259|NCT01862328|470432681|FG005|Overall Study|Adverse Event|2|||
130674260|NCT01862328|470432682|FG006|Overall Study|Adverse Event|4|||
130674261|NCT01862328|470432676|FG000|Overall Study|Other|0|||
130674262|NCT01862328|470432677|FG001|Overall Study|Other|2|||
130674263|NCT01862328|470432678|FG002|Overall Study|Other|1|||
130674264|NCT01862328|470432679|FG003|Overall Study|Other|0|||
130341705|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130341706|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130341707|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130341708|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130341709|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130341710|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130341711|NCT01328444|469223134|FG000|Washout Period (14 Days)|Adverse Event|1|||
130674265|NCT01862328|470432680|FG004|Overall Study|Other|4|||
130674266|NCT01862328|470432681|FG005|Overall Study|Other|0|||
130674267|NCT01862328|470432682|FG006|Overall Study|Other|1|||
130674268|NCT01862328|470432676|FG000|Overall Study|Withdrawal by Subject|1|||
130674269|NCT01862328|470432677|FG001|Overall Study|Withdrawal by Subject|1|||
130674270|NCT01862328|470432678|FG002|Overall Study|Withdrawal by Subject|0|||
130674271|NCT01862328|470432679|FG003|Overall Study|Withdrawal by Subject|0|||
130674272|NCT01862328|470432680|FG004|Overall Study|Withdrawal by Subject|1|||
130674273|NCT01862328|470432681|FG005|Overall Study|Withdrawal by Subject|1|||
130674274|NCT01862328|470432682|FG006|Overall Study|Withdrawal by Subject|1|||
130674275|NCT01862328|470432676|FG000|Overall Study|Symptomatic Deterioration|0|||
130674276|NCT01862328|470432677|FG001|Overall Study|Symptomatic Deterioration|0|||
130674277|NCT01862328|470432678|FG002|Overall Study|Symptomatic Deterioration|0|||
130674278|NCT01862328|470432679|FG003|Overall Study|Symptomatic Deterioration|0|||
130674279|NCT01862328|470432680|FG004|Overall Study|Symptomatic Deterioration|0|||
130674280|NCT01862328|470432681|FG005|Overall Study|Symptomatic Deterioration|0|||
130674281|NCT01862328|470432682|FG006|Overall Study|Symptomatic Deterioration|1|||
130674282|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
130674283|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
130674284|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Death|0|||
130674285|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Death|1|||
130674286|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
130674287|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
130674288|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
130674289|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
130341712|NCT01328444|469223135|FG001|Washout Period (14 Days)|Adverse Event|1|||
130674290|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
130674291|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
130674292|NCT01656889|470432683|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
130674293|NCT01656889|470432684|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
130674294|NCT01656889|470432683|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
130674295|NCT01656889|470432684|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
130674296|NCT01656889|470432683|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
130674297|NCT01656889|470432684|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
130674298|NCT01656889|470432683|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
130674299|NCT01656889|470432684|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
130674300|NCT01656889|470432683|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
130674301|NCT01656889|470432684|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
130674302|NCT02521948|470432685|FG000|Overall Study|Adverse Event|2|||
130674303|NCT02521948|470432685|FG000|Overall Study|Death|4|||
130674304|NCT02521948|470432685|FG000|Overall Study|Lost to Follow-up|1|||
130674305|NCT02521948|470432685|FG000|Overall Study|Did not attend one or both follow-ups|6|||
130674306|NCT02427607|470432686|FG000|Overall Study|Withdrawal by Subject|1|||
130674307|NCT00423800|470432687|FG000|Overall Study|Protocol Violation|0|||
130674308|NCT00423800|470432688|FG001|Overall Study|Protocol Violation|1|||
130674309|NCT04000009|470432689|FG000|Overall Study|Adverse Event|13|||
130674310|NCT04000009|470432689|FG000|Overall Study|Lack of Efficacy|7|||
130674311|NCT04000009|470432689|FG000|Overall Study|Lost to Follow-up|8|||
130674312|NCT04000009|470432689|FG000|Overall Study|Noncompliance with study drug|4|||
130674313|NCT04000009|470432689|FG000|Overall Study|Physician Decision|1|||
130674314|NCT04000009|470432689|FG000|Overall Study|Use of prohibited medication|3|||
130674315|NCT04000009|470432689|FG000|Overall Study|Pregnancy|1|||
130674316|NCT04000009|470432689|FG000|Overall Study|Withdrawal by Subject|22|||
130674317|NCT04000009|470432689|FG000|Overall Study|Study terminated by sponsor|98|||
130674318|NCT04000009|470432689|FG000|Overall Study|Not further specified|8|||
130674319|NCT00679783|470432691|FG000|Overall Study|Adverse Event|0|||
130674320|NCT00679783|470432692|FG001|Overall Study|Adverse Event|0|||
130674321|NCT00679783|470432693|FG002|Overall Study|Adverse Event|0|||
130674322|NCT00679783|470432694|FG003|Overall Study|Adverse Event|3|||
130674323|NCT00679783|470432695|FG004|Overall Study|Adverse Event|0|||
130674324|NCT00679783|470432696|FG005|Overall Study|Adverse Event|0|||
130674325|NCT00679783|470432697|FG006|Overall Study|Adverse Event|1|||
130341713|NCT01328444|469223136|FG002|Washout Period (14 Days)|Adverse Event|0|||
130674326|NCT00679783|470432691|FG000|Overall Study|Lack of Efficacy|0|||
130674327|NCT00679783|470432692|FG001|Overall Study|Lack of Efficacy|1|||
130674328|NCT00679783|470432693|FG002|Overall Study|Lack of Efficacy|0|||
130674329|NCT00679783|470432694|FG003|Overall Study|Lack of Efficacy|2|||
130674330|NCT00679783|470432695|FG004|Overall Study|Lack of Efficacy|0|||
130674331|NCT00679783|470432696|FG005|Overall Study|Lack of Efficacy|0|||
130674332|NCT00679783|470432697|FG006|Overall Study|Lack of Efficacy|0|||
130674333|NCT00679783|470432691|FG000|Overall Study|Withdrawal by Subject|0|||
130674334|NCT00679783|470432692|FG001|Overall Study|Withdrawal by Subject|0|||
130674335|NCT00679783|470432693|FG002|Overall Study|Withdrawal by Subject|1|||
130341714|NCT01328444|469223137|FG003|Washout Period (14 Days)|Adverse Event|1|||
130341715|NCT01328444|469223138|FG004|Washout Period (14 Days)|Adverse Event|1|||
130674336|NCT00679783|470432694|FG003|Overall Study|Withdrawal by Subject|1|||
130674337|NCT00679783|470432695|FG004|Overall Study|Withdrawal by Subject|0|||
130674338|NCT00679783|470432696|FG005|Overall Study|Withdrawal by Subject|0|||
130674339|NCT00679783|470432697|FG006|Overall Study|Withdrawal by Subject|0|||
130674340|NCT00679783|470432691|FG000|Overall Study|Not Captured|0|||
130341716|NCT01328444|469223139|FG005|Washout Period (14 Days)|Adverse Event|2|||
130341717|NCT01328444|469223134|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
130674341|NCT00679783|470432692|FG001|Overall Study|Not Captured|0|||
130674342|NCT00679783|470432693|FG002|Overall Study|Not Captured|0|||
130674343|NCT00679783|470432694|FG003|Overall Study|Not Captured|5|||
130674344|NCT00679783|470432695|FG004|Overall Study|Not Captured|0|||
130674345|NCT00679783|470432696|FG005|Overall Study|Not Captured|0|||
130674346|NCT00679783|470432697|FG006|Overall Study|Not Captured|0|||
130674347|NCT00679783|470432691|FG000|Overall Study|Ongoing at data cut-off|2|||
130674348|NCT00679783|470432692|FG001|Overall Study|Ongoing at data cut-off|2|||
130674349|NCT00679783|470432693|FG002|Overall Study|Ongoing at data cut-off|0|||
130674350|NCT00679783|470432694|FG003|Overall Study|Ongoing at data cut-off|9|||
130674351|NCT00679783|470432695|FG004|Overall Study|Ongoing at data cut-off|1|||
130674352|NCT00679783|470432696|FG005|Overall Study|Ongoing at data cut-off|0|||
130674353|NCT00679783|470432697|FG006|Overall Study|Ongoing at data cut-off|0|||
130674354|NCT01754259|470432700|FG000|Overall Study|Withdrawal by Subject|2|||
130674355|NCT01754259|470432701|FG001|Overall Study|Withdrawal by Subject|4|||
130674356|NCT01754259|470432700|FG000|Overall Study|Adverse Event|3|||
130674357|NCT01754259|470432701|FG001|Overall Study|Adverse Event|1|||
130674358|NCT01754259|470432700|FG000|Overall Study|Lost to Follow-up|0|||
130674359|NCT01754259|470432701|FG001|Overall Study|Lost to Follow-up|1|||
130674360|NCT00814320|470432702|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
130674361|NCT00814320|470432703|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
130674362|NCT00814320|470432702|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
130674363|NCT00814320|470432703|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
130674364|NCT00814320|470432702|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
130674365|NCT00814320|470432703|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
130674366|NCT00814320|470432702|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
130674367|NCT00814320|470432703|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
130674368|NCT00814320|470432702|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
130674369|NCT00814320|470432703|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
130674370|NCT00814320|470432702|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
130674371|NCT00814320|470432703|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
130674372|NCT00814320|470432702|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
130674373|NCT00814320|470432703|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
130674374|NCT00814320|470432702|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
130674375|NCT00814320|470432703|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
130674376|NCT00814320|470432702|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
130674377|NCT00814320|470432703|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
130674378|NCT00814320|470432702|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
130674379|NCT00814320|470432703|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
130674380|NCT00491504|470432704|FG000|Overall Study|Adverse Event|0|||
130674381|NCT00491504|470432705|FG001|Overall Study|Adverse Event|1|||
130674382|NCT00491504|470432706|FG002|Overall Study|Adverse Event|0|||
130674383|NCT00491504|470432707|FG003|Overall Study|Adverse Event|0|||
130674384|NCT00491504|470432704|FG000|Overall Study|Withdrawal by Subject|0|||
130674385|NCT00491504|470432705|FG001|Overall Study|Withdrawal by Subject|0|||
130674386|NCT00491504|470432706|FG002|Overall Study|Withdrawal by Subject|1|||
130674387|NCT00491504|470432707|FG003|Overall Study|Withdrawal by Subject|2|||
130674388|NCT00491504|470432704|FG000|Overall Study|Protocol Violation|0|||
130674389|NCT00491504|470432705|FG001|Overall Study|Protocol Violation|0|||
130674390|NCT00491504|470432706|FG002|Overall Study|Protocol Violation|3|||
130674391|NCT00491504|470432707|FG003|Overall Study|Protocol Violation|2|||
130674392|NCT00619385|470432708|FG000|Overall Study|Adverse Event|0|||
130674393|NCT00619385|470432709|FG001|Overall Study|Adverse Event|0|||
130674394|NCT00619385|470432710|FG002|Overall Study|Adverse Event|3|||
130674395|NCT00619385|470432708|FG000|Overall Study|Other|1|||
130674396|NCT00619385|470432709|FG001|Overall Study|Other|2|||
130674397|NCT00619385|470432710|FG002|Overall Study|Other|1|||
130674398|NCT02041702|470432713|FG000|Overall Study|Lost to Follow-up|1|||
130674399|NCT02041702|470432714|FG001|Overall Study|Lost to Follow-up|6|||
130674400|NCT02041702|470432713|FG000|Overall Study|Death|4|||
130674401|NCT02041702|470432714|FG001|Overall Study|Death|0|||
130674402|NCT02041702|470432713|FG000|Overall Study|Withdrawal by Subject|4|||
130674403|NCT02041702|470432714|FG001|Overall Study|Withdrawal by Subject|3|||
130674404|NCT02041702|470432713|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
130674405|NCT02041702|470432714|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
130674406|NCT02041702|470432713|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
130341718|NCT01328444|469223135|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
130674407|NCT02041702|470432714|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
130674408|NCT00306384|470432715|FG000|Overall Study|Adverse Event|103|||
130674409|NCT00306384|470432716|FG001|Overall Study|Adverse Event|87|||
130674410|NCT00306384|470432717|FG002|Overall Study|Adverse Event|40|||
130674411|NCT00306384|470432715|FG000|Overall Study|Major protocol deviation|43|||
130674412|NCT00306384|470432716|FG001|Overall Study|Major protocol deviation|51|||
130674413|NCT00306384|470432717|FG002|Overall Study|Major protocol deviation|18|||
130674414|NCT00306384|470432715|FG000|Overall Study|Lost to Follow-up|57|||
130674415|NCT00306384|470432716|FG001|Overall Study|Lost to Follow-up|41|||
130674416|NCT00306384|470432717|FG002|Overall Study|Lost to Follow-up|35|||
130674417|NCT00306384|470432715|FG000|Overall Study|Voluntary withdrawal|199|||
130674418|NCT00306384|470432716|FG001|Overall Study|Voluntary withdrawal|187|||
130674419|NCT00306384|470432717|FG002|Overall Study|Voluntary withdrawal|91|||
130341719|NCT01328444|469223136|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
130341720|NCT01328444|469223137|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
130341721|NCT01328444|469223138|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
130341722|NCT01328444|469223139|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
130341723|NCT01328444|469223134|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341724|NCT01328444|469223135|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341725|NCT01328444|469223136|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341726|NCT01328444|469223137|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341727|NCT01328444|469223138|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341728|NCT01328444|469223139|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
130341729|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
130674420|NCT00306384|470432715|FG000|Overall Study|Study termination|1|||
130674421|NCT00306384|470432716|FG001|Overall Study|Study termination|0|||
130674422|NCT00306384|470432717|FG002|Overall Study|Study termination|1|||
130674423|NCT00306384|470432715|FG000|Overall Study|Pregnancy|3|||
130674424|NCT00306384|470432716|FG001|Overall Study|Pregnancy|1|||
130674425|NCT00306384|470432717|FG002|Overall Study|Pregnancy|1|||
130674426|NCT00306384|470432715|FG000|Overall Study|Lack of Efficacy|26|||
130674427|NCT00306384|470432716|FG001|Overall Study|Lack of Efficacy|40|||
130674428|NCT00306384|470432717|FG002|Overall Study|Lack of Efficacy|38|||
130674429|NCT00306384|470432715|FG000|Overall Study|Investigator discretion|28|||
130674430|NCT00306384|470432716|FG001|Overall Study|Investigator discretion|31|||
130674431|NCT00306384|470432717|FG002|Overall Study|Investigator discretion|21|||
130674432|NCT00306384|470432715|FG000|Overall Study|Other|80|||
130674433|NCT00306384|470432716|FG001|Overall Study|Other|70|||
130674434|NCT00306384|470432717|FG002|Overall Study|Other|32|||
130674435|NCT00306384|470432715|FG000|Overall Study|Site closure|2|||
130674436|NCT00306384|470432716|FG001|Overall Study|Site closure|0|||
130674437|NCT00306384|470432717|FG002|Overall Study|Site closure|0|||
130674438|NCT03850509|470432718|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
130674439|NCT03850509|470432719|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
130674440|NCT00969332|470432720|FG000|Overall Study|Physician Decision|8|||
130674441|NCT00969332|470432720|FG000|Overall Study|Withdrawal by Subject|3|||
130674442|NCT01565083|470432724|FG000|Overall Study|Withdrawal by Subject|6|||
130674443|NCT01565083|470432725|FG001|Overall Study|Withdrawal by Subject|4|||
130674444|NCT01565083|470432724|FG000|Overall Study|Lost to Follow-up|2|||
130674445|NCT01565083|470432725|FG001|Overall Study|Lost to Follow-up|7|||
130674446|NCT01565083|470432724|FG000|Overall Study|Death|22|||
130674447|NCT01565083|470432725|FG001|Overall Study|Death|23|||
130341730|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130341731|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130341732|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130674448|NCT01565083|470432724|FG000|Overall Study|Other|3|||
130674449|NCT01565083|470432725|FG001|Overall Study|Other|5|||
130674450|NCT02708277|470432726|FG000|Overall Study|Lost to Follow-up|7|||
130674451|NCT02708277|470432727|FG001|Overall Study|Lost to Follow-up|4|||
130674452|NCT01058421|470432728|FG000|1 Month Outcomes|Death|10|||
130674453|NCT01058421|470432729|FG001|1 Month Outcomes|Death|6|||
130674454|NCT01058421|470432728|FG000|1 Month Outcomes|Lost to Follow-up|8|||
130674455|NCT01058421|470432729|FG001|1 Month Outcomes|Lost to Follow-up|7|||
130674456|NCT01058421|470432728|FG000|1 Month Outcomes|Remained in Hospital|5|||
130674457|NCT01058421|470432729|FG001|1 Month Outcomes|Remained in Hospital|12|||
130674458|NCT01058421|470432728|FG000|1 Month Outcomes|Remained in Other Facility|16|||
130674459|NCT01058421|470432729|FG001|1 Month Outcomes|Remained in Other Facility|17|||
130341733|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130341734|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130341735|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
130674460|NCT01058421|470432728|FG000|3 Month Outcomes|Death|3|||
130674461|NCT01058421|470432729|FG001|3 Month Outcomes|Death|5|||
130674462|NCT01058421|470432728|FG000|3 Month Outcomes|Lost to Follow-up|12|||
130674463|NCT01058421|470432729|FG001|3 Month Outcomes|Lost to Follow-up|11|||
130674464|NCT01058421|470432728|FG000|3 Month Outcomes|Remained in Hospital|0|||
130341736|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130674465|NCT01058421|470432729|FG001|3 Month Outcomes|Remained in Hospital|2|||
130674466|NCT01058421|470432728|FG000|3 Month Outcomes|Remained in Other Facility|5|||
130674467|NCT01058421|470432729|FG001|3 Month Outcomes|Remained in Other Facility|8|||
130341737|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130674468|NCT01058421|470432728|FG000|6 Month Outcomes|Death|2|||
130674469|NCT01058421|470432729|FG001|6 Month Outcomes|Death|2|||
130341738|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
130341739|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
130341740|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
130674470|NCT01058421|470432728|FG000|6 Month Outcomes|Lost to Follow-up|16|||
130674471|NCT01058421|470432729|FG001|6 Month Outcomes|Lost to Follow-up|21|||
130674472|NCT01058421|470432728|FG000|6 Month Outcomes|Remained in Other Facility|1|||
130674473|NCT01058421|470432729|FG001|6 Month Outcomes|Remained in Other Facility|3|||
130674474|NCT01960816|470432730|FG000|Overall Study|Lost to Follow-up|1|||
130674475|NCT01118728|470432731|FG000|Overall Study|Adverse Event|17|||
130674476|NCT01118728|470432731|FG000|Overall Study|Lack of Efficacy|27|||
130674477|NCT01118728|470432731|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
130674478|NCT01118728|470432731|FG000|Overall Study|Withdrawal by Subject|3|||
130674479|NCT01118728|470432731|FG000|Overall Study|Lost to Follow-up|4|||
130674480|NCT00385541|470432732|FG000|Overall Study|severe pain, clinician requested unblind|0|||
130674481|NCT00385541|470432733|FG001|Overall Study|severe pain, clinician requested unblind|1|||
130674482|NCT00929708|470432734|FG000|Overall Study|Protocol Violation|2|||
130674483|NCT00929708|470432735|FG001|Overall Study|Protocol Violation|1|||
130674484|NCT00929708|470432736|FG002|Overall Study|Protocol Violation|1|||
130674485|NCT00929708|470432737|FG003|Overall Study|Protocol Violation|1|||
130674486|NCT00929708|470432738|FG004|Overall Study|Protocol Violation|1|||
130674487|NCT00929708|470432734|FG000|Overall Study|Withdrawal by Subject|2|||
130674488|NCT00929708|470432735|FG001|Overall Study|Withdrawal by Subject|0|||
130674489|NCT00929708|470432736|FG002|Overall Study|Withdrawal by Subject|0|||
130674490|NCT00929708|470432737|FG003|Overall Study|Withdrawal by Subject|2|||
130674491|NCT00929708|470432738|FG004|Overall Study|Withdrawal by Subject|1|||
130674492|NCT00929708|470432734|FG000|Overall Study|Adverse Event|0|||
130674493|NCT00929708|470432735|FG001|Overall Study|Adverse Event|0|||
130674494|NCT00929708|470432736|FG002|Overall Study|Adverse Event|0|||
130674495|NCT00929708|470432737|FG003|Overall Study|Adverse Event|0|||
130674496|NCT00929708|470432738|FG004|Overall Study|Adverse Event|3|||
130674497|NCT00929708|470432734|FG000|Overall Study|Physician Decision|0|||
130674498|NCT00929708|470432735|FG001|Overall Study|Physician Decision|2|||
130674499|NCT00929708|470432736|FG002|Overall Study|Physician Decision|2|||
130674500|NCT00929708|470432737|FG003|Overall Study|Physician Decision|2|||
130674501|NCT00929708|470432738|FG004|Overall Study|Physician Decision|1|||
130674502|NCT00929708|470432734|FG000|Overall Study|Lost to Follow-up|0|||
130674503|NCT00929708|470432735|FG001|Overall Study|Lost to Follow-up|0|||
130674504|NCT00929708|470432736|FG002|Overall Study|Lost to Follow-up|0|||
130674505|NCT00929708|470432737|FG003|Overall Study|Lost to Follow-up|1|||
130674506|NCT00929708|470432738|FG004|Overall Study|Lost to Follow-up|0|||
130674507|NCT01893138|470432739|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130674508|NCT01893138|470432740|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130674509|NCT01893138|470432739|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
130674510|NCT01893138|470432740|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
130674511|NCT01893138|470432739|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
130674512|NCT01893138|470432740|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
130674513|NCT01893138|470432739|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
130674514|NCT01893138|470432740|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
130674515|NCT01893138|470432739|FG000|Open Label - Unblinded Period|Adverse Event|1|||
130674516|NCT01893138|470432740|FG001|Open Label - Unblinded Period|Adverse Event|0|||
130674517|NCT03329027|470434692|FG000|Overall Study|Lost to Follow-up|1|||
130674518|NCT03329027|470434693|FG001|Overall Study|Lost to Follow-up|0|||
130674519|NCT03329027|470434694|FG002|Overall Study|Lost to Follow-up|1|||
130674520|NCT03329027|470434692|FG000|Overall Study|Protocol Violation|9|||
130674521|NCT03329027|470434693|FG001|Overall Study|Protocol Violation|5|||
130674522|NCT03329027|470434694|FG002|Overall Study|Protocol Violation|7|||
130674523|NCT02761980|470434700|FG000|Overall Study|Adverse Event|4|||
130674524|NCT02761980|470434701|FG001|Overall Study|Adverse Event|6|||
130674525|NCT02761980|470434702|FG002|Overall Study|Adverse Event|5|||
130674526|NCT02761980|470434703|FG003|Overall Study|Adverse Event|6|||
130674527|NCT02761980|470434700|FG000|Overall Study|Withdrawal by Subject|0|||
130674528|NCT02761980|470434701|FG001|Overall Study|Withdrawal by Subject|1|||
130674529|NCT02761980|470434702|FG002|Overall Study|Withdrawal by Subject|0|||
130674530|NCT02761980|470434703|FG003|Overall Study|Withdrawal by Subject|0|||
130674531|NCT02761980|470434700|FG000|Overall Study|Other|0|||
130674532|NCT02761980|470434701|FG001|Overall Study|Other|0|||
130674533|NCT02761980|470434702|FG002|Overall Study|Other|1|||
130674534|NCT02761980|470434703|FG003|Overall Study|Other|0|||
130674535|NCT01052116|470434704|FG000|Overall Study|Lost to Follow-up|11|||
130674536|NCT01052116|470434705|FG001|Overall Study|Lost to Follow-up|17|||
130674537|NCT01052116|470434704|FG000|Overall Study|Withdrawal by Subject|3|||
130674538|NCT01052116|470434705|FG001|Overall Study|Withdrawal by Subject|6|||
130674539|NCT01052116|470434704|FG000|Overall Study|Spirometry not performed|0|||
130674540|NCT01052116|470434705|FG001|Overall Study|Spirometry not performed|4|||
130674541|NCT01768858|470434706|FG000|Overall Study|Lost to Follow-up|9|||
130674542|NCT01768858|470434706|FG000|Overall Study|Lack of Efficacy|8|||
130674543|NCT01768858|470434706|FG000|Overall Study|Serious Adverse Event|1|||
130674544|NCT01768858|470434706|FG000|Overall Study|Participant moved to Germany|1|||
130674545|NCT01768858|470434706|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
130674546|NCT01768858|470434706|FG000|Overall Study|Exanthema|1|||
130674547|NCT01768858|470434706|FG000|Overall Study|Withdrawal by Subject|1|||
130674548|NCT02742090|470434707|FG000|Overall Study|Adverse Event|10|||
130674549|NCT02742090|470434707|FG000|Overall Study|Death|3|||
130674550|NCT02742090|470434707|FG000|Overall Study|Disease Progression|25|||
130674551|NCT02742090|470434707|FG000|Overall Study|Investigator's Decision|1|||
130674552|NCT02742090|470434707|FG000|Overall Study|Lost to Follow-up|1|||
130674553|NCT02742090|470434707|FG000|Overall Study|Non-compliance with Study|1|||
130674554|NCT02742090|470434707|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
130674555|NCT02742090|470434707|FG000|Overall Study|Withdrawal by Subject|4|||
130674556|NCT02742090|470434707|FG000|Overall Study|Reason Not Specified|1|||
130674557|NCT00836927|470434710|FG000|Overall Study|Progressive disease|2|||
130674558|NCT00836927|470434711|FG001|Overall Study|Progressive disease|0|||
130674559|NCT00836927|470434712|FG002|Overall Study|Progressive disease|0|||
130674560|NCT00836927|470434713|FG003|Overall Study|Progressive disease|1|||
130674561|NCT00836927|470434714|FG004|Overall Study|Progressive disease|1|||
130674562|NCT00836927|470434710|FG000|Overall Study|Withdrawal by Subject|1|||
130674563|NCT00836927|470434711|FG001|Overall Study|Withdrawal by Subject|0|||
130674564|NCT00836927|470434712|FG002|Overall Study|Withdrawal by Subject|0|||
130674565|NCT00836927|470434713|FG003|Overall Study|Withdrawal by Subject|0|||
130674566|NCT00836927|470434714|FG004|Overall Study|Withdrawal by Subject|0|||
130674567|NCT02192905|470434720|FG000|Overall Study|Lost to Follow-up|1|||
130674568|NCT04820842|470434722|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130674569|NCT04820842|470434723|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
130674570|NCT04820842|470434724|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
130674571|NCT04820842|470434725|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130674572|NCT04820842|470434726|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130674573|NCT04820842|470434727|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130674574|NCT04820842|470434728|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130674575|NCT04820842|470434722|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
130674576|NCT04820842|470434723|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
130674577|NCT04820842|470434724|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
130674578|NCT04820842|470434725|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674579|NCT04820842|470434726|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674580|NCT04820842|470434727|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674581|NCT04820842|470434728|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674582|NCT04820842|470434722|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130674583|NCT04820842|470434723|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
130674584|NCT04820842|470434724|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130674585|NCT04820842|470434725|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130674586|NCT04820842|470434726|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130674587|NCT04820842|470434727|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130674588|NCT04820842|470434728|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130341741|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130341742|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341743|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341744|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341745|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130341746|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341747|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341748|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341749|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341750|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130341751|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130341752|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341753|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130341754|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130341755|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341756|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341757|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341758|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130341759|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341760|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341761|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130674589|NCT04820842|470434722|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674590|NCT04820842|470434723|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674591|NCT04820842|470434724|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130341762|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341763|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130341764|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130341765|NCT03531632|469223140|FG000|Overall Study|Adverse Event|0|||
130341766|NCT03531632|469223141|FG001|Overall Study|Adverse Event|0|||
130341767|NCT03531632|469223142|FG002|Overall Study|Adverse Event|1|||
130341768|NCT03531632|469223140|FG000|Overall Study|Death|4|||
130341769|NCT03531632|469223141|FG001|Overall Study|Death|0|||
130341770|NCT03531632|469223142|FG002|Overall Study|Death|14|||
130341771|NCT03531632|469223140|FG000|Overall Study|Study Terminated|1|||
130341772|NCT03531632|469223141|FG001|Overall Study|Study Terminated|3|||
130341773|NCT03531632|469223142|FG002|Overall Study|Study Terminated|11|||
130341774|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341775|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341776|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341777|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341778|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341779|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341780|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130674592|NCT04820842|470434725|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
130674593|NCT04820842|470434726|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674594|NCT04820842|470434727|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130674595|NCT04820842|470434728|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
130674596|NCT02688400|470434733|FG000|Overall Study|Protocol Violation|2|||
130674597|NCT02688400|470434734|FG001|Overall Study|Protocol Violation|5|||
130674598|NCT02688400|470434733|FG000|Overall Study|Lack of Efficacy|7|||
130674599|NCT02688400|470434734|FG001|Overall Study|Lack of Efficacy|7|||
130674600|NCT02688400|470434733|FG000|Overall Study|Adverse Event|21|||
130674601|NCT02688400|470434734|FG001|Overall Study|Adverse Event|12|||
130674602|NCT02688400|470434733|FG000|Overall Study|Withdrawal by Subject|15|||
130674603|NCT02688400|470434734|FG001|Overall Study|Withdrawal by Subject|13|||
130674604|NCT02688400|470434733|FG000|Overall Study|No study medication intake|1|||
130674605|NCT02688400|470434734|FG001|Overall Study|No study medication intake|4|||
130674606|NCT02688400|470434733|FG000|Overall Study|Lost to Follow-up|0|||
130674607|NCT02688400|470434734|FG001|Overall Study|Lost to Follow-up|3|||
130674608|NCT02006706|470434736|FG000|Overall Study|Lost to Follow-up|1|||
130674609|NCT00958256|470434737|FG000|Overall Study|Adverse Event|3|||
130674610|NCT03036579|470434739|FG000|2 Years|Lost to Follow-up|1|||
130674611|NCT03036579|470434740|FG001|2 Years|Lost to Follow-up|0|||
130674612|NCT03036579|470434739|FG000|3 Years|Lost to Follow-up|0|||
130674613|NCT03036579|470434740|FG001|3 Years|Lost to Follow-up|1|||
130674614|NCT02848599|470434741|FG000|Overall Study|Protocol Violation|7|||
130674615|NCT02848599|470434742|FG001|Overall Study|Protocol Violation|9|||
130674616|NCT00992407|470434746|FG000|Overall Study|Protocol Violation|2|||
130674617|NCT00992407|470434747|FG001|Overall Study|Protocol Violation|1|||
130674618|NCT00992407|470434746|FG000|Overall Study|Lost to Follow-up|3|||
130674619|NCT00992407|470434747|FG001|Overall Study|Lost to Follow-up|3|||
130674620|NCT00992407|470434746|FG000|Overall Study|Adverse Event|3|||
130674621|NCT00992407|470434747|FG001|Overall Study|Adverse Event|2|||
130674622|NCT00992407|470434746|FG000|Overall Study|protocol Violation & Adverse events|2|||
130674623|NCT00992407|470434747|FG001|Overall Study|protocol Violation & Adverse events|4|||
130674624|NCT00992407|470434746|FG000|Overall Study|Other|2|||
130674625|NCT00992407|470434747|FG001|Overall Study|Other|0|||
130674626|NCT00992407|470434746|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
130674627|NCT00992407|470434747|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
130674628|NCT00992407|470434746|FG000|Overall Study|Study medication not administered|17|||
130674629|NCT00992407|470434747|FG001|Overall Study|Study medication not administered|13|||
130674630|NCT00635778|470434750|FG000|Overall Study|Adverse Event|1|||
130341781|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130341782|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130341783|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130674631|NCT00635778|470434751|FG001|Overall Study|Adverse Event|0|||
130674632|NCT00635778|470434752|FG002|Overall Study|Adverse Event|0|||
130674633|NCT00635778|470434753|FG003|Overall Study|Adverse Event|3|||
130674634|NCT00635778|470434754|FG004|Overall Study|Adverse Event|3|||
130674635|NCT00635778|470434755|FG005|Overall Study|Adverse Event|6|||
130674636|NCT00635778|470434756|FG006|Overall Study|Adverse Event|1|||
130674637|NCT00635778|470434750|FG000|Overall Study|Withdrawal by Subject|0|||
130674638|NCT00635778|470434751|FG001|Overall Study|Withdrawal by Subject|0|||
130674639|NCT00635778|470434752|FG002|Overall Study|Withdrawal by Subject|0|||
130674640|NCT00635778|470434753|FG003|Overall Study|Withdrawal by Subject|1|||
130674641|NCT00635778|470434754|FG004|Overall Study|Withdrawal by Subject|0|||
130674642|NCT00635778|470434755|FG005|Overall Study|Withdrawal by Subject|1|||
130674643|NCT00635778|470434756|FG006|Overall Study|Withdrawal by Subject|1|||
130674644|NCT00635778|470434750|FG000|Overall Study|Progressive disease|0|||
130674645|NCT00635778|470434751|FG001|Overall Study|Progressive disease|3|||
130674646|NCT00635778|470434752|FG002|Overall Study|Progressive disease|3|||
130674647|NCT00635778|470434753|FG003|Overall Study|Progressive disease|4|||
130674648|NCT00635778|470434754|FG004|Overall Study|Progressive disease|5|||
130674649|NCT00635778|470434755|FG005|Overall Study|Progressive disease|14|||
130674650|NCT00635778|470434756|FG006|Overall Study|Progressive disease|4|||
130674651|NCT00812253|470434757|FG000|Overall Study|Withdrawal by Subject|3|||
130674652|NCT00812253|470434758|FG001|Overall Study|Withdrawal by Subject|2|||
130674653|NCT00812253|470434757|FG000|Overall Study|Protocol Violation|1|||
130674654|NCT00812253|470434758|FG001|Overall Study|Protocol Violation|1|||
130674655|NCT00812253|470434757|FG000|Overall Study|Lost to Follow-up|2|||
130674656|NCT00812253|470434758|FG001|Overall Study|Lost to Follow-up|0|||
130674657|NCT01884025|470434759|FG000|Overall Study|Lost to Follow-up|3|||
130674658|NCT01884025|470434760|FG001|Overall Study|Lost to Follow-up|4|||
130674659|NCT02918162|470434761|FG000|Overall Study|Withdrawal by Subject|1|||
130674660|NCT02918162|470434761|FG000|Overall Study|Omental Disease|1|||
130674661|NCT00395226|470434762|FG000|Overall Study|Adverse Event|4|||
130674662|NCT00395226|470434763|FG001|Overall Study|Adverse Event|3|||
130674663|NCT00395226|470434762|FG000|Overall Study|Withdrawal by Subject|0|||
130674664|NCT00395226|470434763|FG001|Overall Study|Withdrawal by Subject|1|||
130674665|NCT00395226|470434762|FG000|Overall Study|Lost to Follow-up|0|||
130674666|NCT00395226|470434763|FG001|Overall Study|Lost to Follow-up|1|||
130674667|NCT02540356|470434768|FG000|Overall Study|Terminated due to disease progression|1|||
130674668|NCT02540356|470434769|FG001|Overall Study|Terminated due to disease progression|0|||
130674669|NCT01513148|470434770|FG000|Overall Study|Protocol Violation|2|||
130674670|NCT01513148|470434771|FG001|Overall Study|Protocol Violation|2|||
130674671|NCT00437281|470434776|FG000|Overall Study|Adverse Event|0|||
130674672|NCT00437281|470434777|FG001|Overall Study|Adverse Event|0|||
130674673|NCT00437281|470434778|FG002|Overall Study|Adverse Event|0|||
130674674|NCT00437281|470434779|FG003|Overall Study|Adverse Event|1|||
130674675|NCT00437281|470434780|FG004|Overall Study|Adverse Event|0|||
130674676|NCT00437281|470434781|FG005|Overall Study|Adverse Event|1|||
130674677|NCT00437281|470434782|FG006|Overall Study|Adverse Event|0|||
130674678|NCT00437281|470434783|FG007|Overall Study|Adverse Event|0|||
130674679|NCT00437281|470434784|FG008|Overall Study|Adverse Event|0|||
130674680|NCT00437281|470434785|FG009|Overall Study|Adverse Event|1|||
130674681|NCT00437281|470434786|FG010|Overall Study|Adverse Event|0|||
130674682|NCT00437281|470434787|FG011|Overall Study|Adverse Event|0|||
130674683|NCT00437281|470434788|FG012|Overall Study|Adverse Event|0|||
130674684|NCT00437281|470434789|FG013|Overall Study|Adverse Event|1|||
130674685|NCT00437281|470434790|FG014|Overall Study|Adverse Event|1|||
130674686|NCT00437281|470434791|FG015|Overall Study|Adverse Event|0|||
130674687|NCT00437281|470434792|FG016|Overall Study|Adverse Event|0|||
130674688|NCT00437281|470434793|FG017|Overall Study|Adverse Event|0|||
130674689|NCT00437281|470434794|FG018|Overall Study|Adverse Event|1|||
130674690|NCT00437281|470434795|FG019|Overall Study|Adverse Event|0|||
130674691|NCT00437281|470434776|FG000|Overall Study|Lost to Follow-up|0|||
130674692|NCT00437281|470434777|FG001|Overall Study|Lost to Follow-up|0|||
130674693|NCT00437281|470434778|FG002|Overall Study|Lost to Follow-up|0|||
130674694|NCT00437281|470434779|FG003|Overall Study|Lost to Follow-up|0|||
130674695|NCT00437281|470434780|FG004|Overall Study|Lost to Follow-up|0|||
130674696|NCT00437281|470434781|FG005|Overall Study|Lost to Follow-up|0|||
130674697|NCT00437281|470434782|FG006|Overall Study|Lost to Follow-up|0|||
130674698|NCT00437281|470434783|FG007|Overall Study|Lost to Follow-up|0|||
130674699|NCT00437281|470434784|FG008|Overall Study|Lost to Follow-up|0|||
130674700|NCT00437281|470434785|FG009|Overall Study|Lost to Follow-up|0|||
130674701|NCT00437281|470434786|FG010|Overall Study|Lost to Follow-up|0|||
130674702|NCT00437281|470434787|FG011|Overall Study|Lost to Follow-up|0|||
130341784|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130341785|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130341786|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341787|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341788|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130341789|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130674703|NCT00437281|470434788|FG012|Overall Study|Lost to Follow-up|0|||
130674704|NCT00437281|470434789|FG013|Overall Study|Lost to Follow-up|0|||
130674705|NCT00437281|470434790|FG014|Overall Study|Lost to Follow-up|0|||
130674706|NCT00437281|470434791|FG015|Overall Study|Lost to Follow-up|0|||
130674707|NCT00437281|470434792|FG016|Overall Study|Lost to Follow-up|0|||
130674708|NCT00437281|470434793|FG017|Overall Study|Lost to Follow-up|0|||
130674709|NCT00437281|470434794|FG018|Overall Study|Lost to Follow-up|0|||
130674710|NCT00437281|470434795|FG019|Overall Study|Lost to Follow-up|1|||
130674711|NCT00947427|470434796|FG000|Overall Study|Withdrawal by Subject|1|||
130674712|NCT00947427|470434797|FG001|Overall Study|Withdrawal by Subject|3|||
130674713|NCT00947427|470434796|FG000|Overall Study|Protocol Violation|0|||
130674714|NCT00947427|470434797|FG001|Overall Study|Protocol Violation|1|||
130674715|NCT01411995|470434800|FG000|Overall Study|Failed IUD insertion|0|||
130674716|NCT01411995|470434801|FG001|Overall Study|Failed IUD insertion|1|||
130674717|NCT00936975|470434802|FG000|Overall Study|Withdrawal by Subject|1|||
130674718|NCT00936975|470434802|FG000|Overall Study|Disease progression|3|||
130674719|NCT00936975|470434802|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
130674720|NCT04104646|470434804|FG000|Overall Study|Withdrawal by Subject|1|||
130674721|NCT04104646|470434805|FG001|Overall Study|Withdrawal by Subject|1|||
130674722|NCT04104646|470434804|FG000|Overall Study|Lost to Follow-up|1|||
130674723|NCT04104646|470434805|FG001|Overall Study|Lost to Follow-up|0|||
130674724|NCT04104646|470434804|FG000|Overall Study|Physician Decision|2|||
130674725|NCT04104646|470434805|FG001|Overall Study|Physician Decision|0|||
130674726|NCT02974153|470434806|FG000|Overall Study|Adverse Event|6|||
130674727|NCT02974153|470434807|FG001|Overall Study|Adverse Event|0|||
130674728|NCT02974153|470434808|FG002|Overall Study|Adverse Event|1|||
130674729|NCT02974153|470434806|FG000|Overall Study|Lack of Efficacy|6|||
130674730|NCT02974153|470434807|FG001|Overall Study|Lack of Efficacy|5|||
130674731|NCT02974153|470434808|FG002|Overall Study|Lack of Efficacy|10|||
130674732|NCT02974153|470434806|FG000|Overall Study|Lost to Follow-up|9|||
130674733|NCT02974153|470434807|FG001|Overall Study|Lost to Follow-up|10|||
130674734|NCT02974153|470434808|FG002|Overall Study|Lost to Follow-up|17|||
130674735|NCT02974153|470434806|FG000|Overall Study|Physician Decision|0|||
130674736|NCT02974153|470434807|FG001|Overall Study|Physician Decision|2|||
130674737|NCT02974153|470434808|FG002|Overall Study|Physician Decision|1|||
130674738|NCT02974153|470434806|FG000|Overall Study|Withdrawal by Subject|9|||
130674739|NCT02974153|470434807|FG001|Overall Study|Withdrawal by Subject|16|||
130674740|NCT02974153|470434808|FG002|Overall Study|Withdrawal by Subject|11|||
130674741|NCT02974153|470434806|FG000|Overall Study|Study Burden|8|||
130674742|NCT02974153|470434807|FG001|Overall Study|Study Burden|7|||
130674743|NCT02974153|470434808|FG002|Overall Study|Study Burden|3|||
130674744|NCT02974153|470434806|FG000|Overall Study|Other|14|||
130674745|NCT02974153|470434807|FG001|Overall Study|Other|8|||
130674746|NCT02974153|470434808|FG002|Overall Study|Other|7|||
130674747|NCT02277769|470434809|FG000|Overall Study|Protocol Violation|3|||
130674748|NCT02277769|470434810|FG001|Overall Study|Protocol Violation|3|||
130674749|NCT02277769|470434811|FG002|Overall Study|Protocol Violation|5|||
130674750|NCT02277769|470434809|FG000|Overall Study|Lack of Efficacy|17|||
130674751|NCT02277769|470434810|FG001|Overall Study|Lack of Efficacy|0|||
130674752|NCT02277769|470434811|FG002|Overall Study|Lack of Efficacy|4|||
130674753|NCT02277769|470434809|FG000|Overall Study|Adverse Event|14|||
130674754|NCT02277769|470434810|FG001|Overall Study|Adverse Event|2|||
130674755|NCT02277769|470434811|FG002|Overall Study|Adverse Event|4|||
130674756|NCT02277769|470434809|FG000|Overall Study|Other than specified above|12|||
130674757|NCT02277769|470434810|FG001|Overall Study|Other than specified above|8|||
130674758|NCT02277769|470434811|FG002|Overall Study|Other than specified above|5|||
130674759|NCT03730103|470434812|FG000|Overall Study|Did not meet inclusion criteria|0|||
130674760|NCT03730103|470434813|FG001|Overall Study|Did not meet inclusion criteria|5|||
130674761|NCT01488578|470434814|FG000|Overall Study|Protocol Violation|1836|||
130674762|NCT02308111|470434815|FG000|Overall Study|Adverse Event|31|||
130674763|NCT02308111|470434816|FG001|Overall Study|Adverse Event|19|||
130674764|NCT02308111|470434815|FG000|Overall Study|Death|9|||
130674765|NCT02308111|470434816|FG001|Overall Study|Death|6|||
130674766|NCT02308111|470434815|FG000|Overall Study|Lost to Follow-up|2|||
130674767|NCT02308111|470434816|FG001|Overall Study|Lost to Follow-up|7|||
130674768|NCT02308111|470434815|FG000|Overall Study|Physician Decision|6|||
130674769|NCT02308111|470434816|FG001|Overall Study|Physician Decision|17|||
130674770|NCT02308111|470434815|FG000|Overall Study|Protocol Violation|0|||
130674771|NCT02308111|470434816|FG001|Overall Study|Protocol Violation|1|||
130674772|NCT02308111|470434815|FG000|Overall Study|Withdrawal by Subject|28|||
130674773|NCT02308111|470434816|FG001|Overall Study|Withdrawal by Subject|38|||
130674774|NCT02308111|470434815|FG000|Overall Study|Study Terminated by Sponsor|72|||
130674775|NCT02308111|470434816|FG001|Overall Study|Study Terminated by Sponsor|61|||
130674776|NCT02308111|470434815|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
130674777|NCT02308111|470434816|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
130674778|NCT02308111|470434815|FG000|Overall Study|Site Closure|3|||
130674779|NCT02308111|470434816|FG001|Overall Study|Site Closure|3|||
130674780|NCT02308111|470434815|FG000|Overall Study|Non-compliance with Study Drug|3|||
130674781|NCT02308111|470434816|FG001|Overall Study|Non-compliance with Study Drug|1|||
130674782|NCT02308111|470434815|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
130674783|NCT02308111|470434816|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
130674784|NCT02308111|470434815|FG000|Overall Study|Liver Transplant|3|||
130674785|NCT02308111|470434816|FG001|Overall Study|Liver Transplant|3|||
130674786|NCT02308111|470434815|FG000|Overall Study|Liver Transplant Waitlist|2|||
130674787|NCT02308111|470434816|FG001|Overall Study|Liver Transplant Waitlist|2|||
130674788|NCT02308111|470434815|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
130674789|NCT02308111|470434816|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
130674790|NCT03271528|470434819|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
130674791|NCT03271528|470434820|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
130674792|NCT03271528|470434819|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
130674793|NCT03271528|470434820|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
130674794|NCT03271528|470434819|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
130674795|NCT03271528|470434820|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
130674796|NCT03271528|470434819|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
130674797|NCT03271528|470434820|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
130674798|NCT03271528|470434819|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
130674799|NCT03271528|470434820|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
130674800|NCT03271528|470434819|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
130674801|NCT03271528|470434820|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
130674802|NCT03271528|470434819|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
130341790|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130341791|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341792|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
130341793|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341794|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341795|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130674803|NCT03271528|470434820|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
130674804|NCT01873859|470434823|FG000|Overall Study|Withdrawal by Subject|0|||
130674805|NCT01873859|470434824|FG001|Overall Study|Withdrawal by Subject|4|||
130674806|NCT03977584|470434825|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
130674807|NCT03977584|470434826|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
130674808|NCT03977584|470434827|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
130674809|NCT03504852|470434831|FG000|Overall Study|Withdrawal of informed consent|2|||
130674810|NCT03504852|470434832|FG001|Overall Study|Withdrawal of informed consent|1|||
130674811|NCT03504852|470434833|FG002|Overall Study|Withdrawal of informed consent|0|||
130674812|NCT03504852|470434831|FG000|Overall Study|Withdrawal by Subject|5|||
130674813|NCT03504852|470434832|FG001|Overall Study|Withdrawal by Subject|5|||
130674814|NCT03504852|470434833|FG002|Overall Study|Withdrawal by Subject|1|||
130674815|NCT03504852|470434831|FG000|Overall Study|Lost to Follow-up|4|||
130674816|NCT03504852|470434832|FG001|Overall Study|Lost to Follow-up|1|||
130674817|NCT03504852|470434833|FG002|Overall Study|Lost to Follow-up|0|||
130674818|NCT03504852|470434831|FG000|Overall Study|New therapy for study indication|1|||
130674819|NCT03504852|470434832|FG001|Overall Study|New therapy for study indication|0|||
130674820|NCT03504852|470434833|FG002|Overall Study|New therapy for study indication|0|||
130674821|NCT03504852|470434831|FG000|Overall Study|Lack of Efficacy|1|||
130674822|NCT03504852|470434832|FG001|Overall Study|Lack of Efficacy|2|||
130674823|NCT03504852|470434833|FG002|Overall Study|Lack of Efficacy|0|||
130674824|NCT03504852|470434831|FG000|Overall Study|Death|0|||
130674825|NCT03504852|470434832|FG001|Overall Study|Death|1|||
130674826|NCT03504852|470434833|FG002|Overall Study|Death|0|||
130341796|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341797|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341798|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
130341799|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
130341800|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
130341801|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
130341802|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
130341803|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
130341804|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
130341805|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
130341806|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341807|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341808|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341809|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341810|NCT00600119|469223143|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130341811|NCT00600119|469223144|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341812|NCT00600119|469223145|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341813|NCT00600119|469223146|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130341814|NCT00600119|469223147|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341815|NCT00600119|469223148|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
130341816|NCT00600119|469223143|FG000|Double-blind Treatment Period|Other|0|||
130341817|NCT00600119|469223144|FG001|Double-blind Treatment Period|Other|0|||
130341818|NCT00600119|469223145|FG002|Double-blind Treatment Period|Other|0|||
130341819|NCT00600119|469223146|FG003|Double-blind Treatment Period|Other|0|||
130341820|NCT00600119|469223147|FG004|Double-blind Treatment Period|Other|2|||
130341821|NCT00600119|469223148|FG005|Double-blind Treatment Period|Other|1|||
130674827|NCT03504852|470434831|FG000|Overall Study|Adverse Event|4|||
130674828|NCT03504852|470434832|FG001|Overall Study|Adverse Event|8|||
130674829|NCT03504852|470434833|FG002|Overall Study|Adverse Event|2|||
130674830|NCT01066052|470434834|FG000|Overall Study|Enrolled But Not Treated|3|||
130674831|NCT01066052|470434835|FG001|Overall Study|Enrolled But Not Treated|0|||
130674832|NCT01835145|470434836|FG000|Overall Study|Ineligible prior to treatment|1|||
130674833|NCT01835145|470434837|FG001|Overall Study|Ineligible prior to treatment|0|||
130674834|NCT01309919|470434858|FG000|Overall Study|Did not receive a postpartum IUD|17|||
130674835|NCT01309919|470434859|FG001|Overall Study|Did not receive a postpartum IUD|48|||
130674836|NCT00319449|470434860|FG000|Overall Study|Subject did not wish to continue|1|||
130674837|NCT00319449|470434861|FG001|Overall Study|Subject did not wish to continue|0|||
130674838|NCT00319449|470434860|FG000|Overall Study|Noncompliance with the protocol|1|||
130674839|NCT00319449|470434861|FG001|Overall Study|Noncompliance with the protocol|0|||
130674840|NCT02102490|470434862|FG000|Overall Study|Death|6|||
130674841|NCT02102490|470434862|FG000|Overall Study|Lost to Follow-up|1|||
130674842|NCT01346410|470434863|FG000|Overall Study|Death|1|||
130674843|NCT00979628|470434864|FG000|Overall Study|received regimen < 24 hours|7|||
130674844|NCT00979628|470434865|FG001|Overall Study|received regimen < 24 hours|6|||
130674845|NCT00979628|470434866|FG002|Overall Study|received regimen < 24 hours|5|||
130674846|NCT00979628|470434864|FG000|Overall Study|received steroids|1|||
130674847|NCT00979628|470434865|FG001|Overall Study|received steroids|1|||
130674848|NCT00979628|470434866|FG002|Overall Study|received steroids|0|||
130674849|NCT00979628|470434864|FG000|Overall Study|transferred to ICU|1|||
130674850|NCT00979628|470434865|FG001|Overall Study|transferred to ICU|2|||
130674851|NCT00979628|470434866|FG002|Overall Study|transferred to ICU|1|||
130674852|NCT01736553|470434871|FG000|Overall Study|Death|12|||
130674853|NCT01736553|470434872|FG001|Overall Study|Death|0|||
130674854|NCT01736553|470434871|FG000|Overall Study|Withdrawal by Subject|5|||
130674855|NCT01736553|470434872|FG001|Overall Study|Withdrawal by Subject|2|||
130674856|NCT01736553|470434871|FG000|Overall Study|Lost to Follow-up|2|||
130674857|NCT01736553|470434872|FG001|Overall Study|Lost to Follow-up|2|||
130674858|NCT02154529|470434873|FG000|Overall Study|Death|1|||
130674859|NCT02154529|470434874|FG001|Overall Study|Death|1|||
130674860|NCT02154529|470434875|FG002|Overall Study|Death|5|||
130674861|NCT02154529|470434876|FG003|Overall Study|Death|1|||
130674862|NCT02154529|470434873|FG000|Overall Study|Termination of study by sponsor|2|||
130674863|NCT02154529|470434874|FG001|Overall Study|Termination of study by sponsor|2|||
130674864|NCT02154529|470434875|FG002|Overall Study|Termination of study by sponsor|3|||
130674865|NCT02154529|470434876|FG003|Overall Study|Termination of study by sponsor|1|||
130674866|NCT02154529|470434873|FG000|Overall Study|Lost to Follow-up|1|||
130674867|NCT02154529|470434874|FG001|Overall Study|Lost to Follow-up|0|||
130674868|NCT02154529|470434875|FG002|Overall Study|Lost to Follow-up|0|||
130674869|NCT02154529|470434876|FG003|Overall Study|Lost to Follow-up|0|||
130674870|NCT00458302|470436779|FG000|Overall Study|Adverse Event|4|||
130674871|NCT00458302|470436780|FG001|Overall Study|Adverse Event|14|||
130674872|NCT00458302|470436779|FG000|Overall Study|Pregnancy|2|||
130674873|NCT00458302|470436780|FG001|Overall Study|Pregnancy|1|||
130674874|NCT00458302|470436779|FG000|Overall Study|Protocol Violation|0|||
130674875|NCT00458302|470436780|FG001|Overall Study|Protocol Violation|2|||
130674876|NCT00458302|470436779|FG000|Overall Study|Withdrawal by Subject|6|||
130674877|NCT00458302|470436780|FG001|Overall Study|Withdrawal by Subject|4|||
130674878|NCT00458302|470436779|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
130674879|NCT00458302|470436780|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
130341822|NCT00600119|469223143|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341823|NCT00600119|469223144|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130341824|NCT00600119|469223145|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341825|NCT00600119|469223146|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341826|NCT00600119|469223147|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130341827|NCT00600119|469223148|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341828|NCT00600119|469223143|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341829|NCT00600119|469223144|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
130341830|NCT00600119|469223145|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341831|NCT00600119|469223146|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130552754|NCT00995020|469991527|FG001|Overall Study|margin analysis not performed|5|||
130674880|NCT00458302|470436779|FG000|Overall Study|Study Termination By Sponsor|1|||
130674881|NCT00458302|470436780|FG001|Overall Study|Study Termination By Sponsor|0|||
130674882|NCT00458302|470436779|FG000|Overall Study|Lost to Follow-up|2|||
130674883|NCT00458302|470436780|FG001|Overall Study|Lost to Follow-up|0|||
130674884|NCT00458302|470436779|FG000|Overall Study|Other|4|||
130674885|NCT00458302|470436780|FG001|Overall Study|Other|2|||
130674886|NCT02178709|470436782|FG000|Overall Study|Adverse Event|5|||
130674887|NCT02178709|470436782|FG000|Overall Study|Death|2|||
130674888|NCT02178709|470436782|FG000|Overall Study|Withdrawal by Subject|2|||
130674889|NCT02178709|470436782|FG000|Overall Study|Physician Decision|2|||
130674890|NCT02178709|470436782|FG000|Overall Study|Disease Progression|5|||
130674891|NCT02224456|470436783|FG000|Overall Study|Lack of Efficacy|1|||
130674892|NCT02224456|470436783|FG000|Overall Study|Lost to Follow-up|15|||
130674893|NCT02224456|470436783|FG000|Overall Study|Withdrawal by Subject|9|||
130674894|NCT02224456|470436783|FG000|Overall Study|Physician Decision|3|||
130674895|NCT02224456|470436783|FG000|Overall Study|Death|2|||
130674896|NCT02224456|470436783|FG000|Overall Study|Pregnancy|4|||
130674897|NCT02224456|470436783|FG000|Overall Study|Protocol Violation|1|||
130674898|NCT02224456|470436783|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
130674899|NCT02946385|470436784|FG000|Overall Study|Lost to Follow-up|0|||
130674900|NCT02946385|470436785|FG001|Overall Study|Lost to Follow-up|0|||
130674901|NCT02946385|470436786|FG002|Overall Study|Lost to Follow-up|3|||
130674902|NCT02946385|470436787|FG003|Overall Study|Lost to Follow-up|0|||
130674903|NCT02946385|470436788|FG004|Overall Study|Lost to Follow-up|2|||
130674904|NCT02946385|470436789|FG005|Overall Study|Lost to Follow-up|1|||
130341832|NCT00600119|469223147|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341833|NCT00600119|469223148|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341834|NCT00600119|469223143|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
130341835|NCT00600119|469223144|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
130341836|NCT00600119|469223145|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
130341837|NCT00600119|469223146|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
130341838|NCT00600119|469223147|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
130341839|NCT00600119|469223148|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
130341840|NCT00600119|469223143|FG000|Double-blind Treatment Period|Physician Decision|2|||
130341841|NCT00600119|469223144|FG001|Double-blind Treatment Period|Physician Decision|0|||
130341842|NCT00600119|469223145|FG002|Double-blind Treatment Period|Physician Decision|0|||
130341843|NCT00600119|469223146|FG003|Double-blind Treatment Period|Physician Decision|0|||
130341844|NCT00600119|469223147|FG004|Double-blind Treatment Period|Physician Decision|0|||
130674905|NCT01379781|470436790|FG000|Overall Study|Lost to Follow-up|11|||
130674906|NCT01379781|470436791|FG001|Overall Study|Lost to Follow-up|8|||
130674907|NCT01644890|470436792|FG000|Overall Study|Adverse Event|7|||
130674908|NCT01644890|470436793|FG001|Overall Study|Adverse Event|20|||
130674909|NCT01644890|470436792|FG000|Overall Study|Death|1|||
130674910|NCT01644890|470436793|FG001|Overall Study|Death|3|||
130674911|NCT01644890|470436792|FG000|Overall Study|Physician Decision|3|||
130674912|NCT01644890|470436793|FG001|Overall Study|Physician Decision|9|||
130674913|NCT01644890|470436792|FG000|Overall Study|Protocol Violation|6|||
130674914|NCT01644890|470436793|FG001|Overall Study|Protocol Violation|7|||
130674915|NCT01644890|470436792|FG000|Overall Study|Withdrawal by Subject|19|||
130674916|NCT01644890|470436793|FG001|Overall Study|Withdrawal by Subject|27|||
130674917|NCT01644890|470436792|FG000|Overall Study|Progression Disease|160|||
130674918|NCT01644890|470436793|FG001|Overall Study|Progression Disease|131|||
130674919|NCT01644890|470436792|FG000|Overall Study|Clinical Progression|6|||
130674920|NCT01644890|470436793|FG001|Overall Study|Clinical Progression|6|||
130674921|NCT01644890|470436792|FG000|Overall Study|> 28 days since last dose of study drug|6|||
130674922|NCT01644890|470436793|FG001|Overall Study|> 28 days since last dose of study drug|3|||
130674923|NCT01644890|470436792|FG000|Overall Study|Other|8|||
130674924|NCT01644890|470436793|FG001|Overall Study|Other|9|||
130674925|NCT01060670|470436796|FG000|Run In|screen failure|0|||
130674926|NCT01060670|470436797|FG001|Run In|screen failure|238|||
130674927|NCT04849988|470436800|FG000|Overall Study|Lack of Efficacy|3|||
130674928|NCT04849988|470436801|FG001|Overall Study|Lack of Efficacy|4|||
130674929|NCT04849988|470436802|FG002|Overall Study|Lack of Efficacy|1|||
130674930|NCT04849988|470436803|FG003|Overall Study|Lack of Efficacy|4|||
130674931|NCT04849988|470436800|FG000|Overall Study|Other reasons|1|||
130674932|NCT04849988|470436801|FG001|Overall Study|Other reasons|2|||
130674933|NCT04849988|470436802|FG002|Overall Study|Other reasons|2|||
130674934|NCT04849988|470436803|FG003|Overall Study|Other reasons|1|||
130674935|NCT02146430|470436808|FG000|Overall Study|Protocol Violation|5|||
130674936|NCT02146430|470436809|FG001|Overall Study|Protocol Violation|4|||
130674937|NCT02146430|470436810|FG002|Overall Study|Protocol Violation|8|||
130674938|NCT02146430|470436811|FG003|Overall Study|Protocol Violation|6|||
130674939|NCT02146430|470436808|FG000|Overall Study|Lack of Efficacy|13|||
130341845|NCT00600119|469223148|FG005|Double-blind Treatment Period|Physician Decision|0|||
130341846|NCT00600119|469223143|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130674940|NCT02146430|470436809|FG001|Overall Study|Lack of Efficacy|11|||
130674941|NCT02146430|470436810|FG002|Overall Study|Lack of Efficacy|8|||
130674942|NCT02146430|470436811|FG003|Overall Study|Lack of Efficacy|5|||
130674943|NCT02146430|470436808|FG000|Overall Study|Adverse Event|20|||
130674944|NCT02146430|470436809|FG001|Overall Study|Adverse Event|40|||
130674945|NCT02146430|470436810|FG002|Overall Study|Adverse Event|32|||
130674946|NCT02146430|470436811|FG003|Overall Study|Adverse Event|49|||
130674947|NCT02146430|470436808|FG000|Overall Study|Reason missing or not reported|2|||
130674948|NCT02146430|470436809|FG001|Overall Study|Reason missing or not reported|3|||
130674949|NCT02146430|470436810|FG002|Overall Study|Reason missing or not reported|4|||
130341847|NCT00600119|469223144|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130674950|NCT02146430|470436811|FG003|Overall Study|Reason missing or not reported|5|||
130674951|NCT02146430|470436808|FG000|Overall Study|Withdrawal by Subject|27|||
130674952|NCT02146430|470436809|FG001|Overall Study|Withdrawal by Subject|29|||
130674953|NCT02146430|470436810|FG002|Overall Study|Withdrawal by Subject|30|||
130341848|NCT00600119|469223145|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130341849|NCT00600119|469223146|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130341850|NCT00600119|469223147|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
130674954|NCT02146430|470436811|FG003|Overall Study|Withdrawal by Subject|34|||
130674955|NCT01893905|470436812|FG000|Overall Study|Withdrawal by Subject|1|||
130674956|NCT01893905|470436813|FG001|Overall Study|Withdrawal by Subject|0|||
130674957|NCT01893905|470436812|FG000|Overall Study|Adverse Event|9|||
130674958|NCT01893905|470436813|FG001|Overall Study|Adverse Event|3|||
130674959|NCT01893905|470436812|FG000|Overall Study|Lack of Efficacy|5|||
130674960|NCT01893905|470436813|FG001|Overall Study|Lack of Efficacy|7|||
130674961|NCT01893905|470436812|FG000|Overall Study|Lost to Follow-up|1|||
130674962|NCT01893905|470436813|FG001|Overall Study|Lost to Follow-up|0|||
130674963|NCT01893905|470436812|FG000|Overall Study|Protocol Violation|6|||
130674964|NCT01893905|470436813|FG001|Overall Study|Protocol Violation|1|||
130674965|NCT01893905|470436812|FG000|Overall Study|Lack of adherence to treatment|2|||
130674966|NCT01893905|470436813|FG001|Overall Study|Lack of adherence to treatment|0|||
130674967|NCT01893905|470436812|FG000|Overall Study|Other reason|1|||
130674968|NCT01893905|470436813|FG001|Overall Study|Other reason|3|||
130674969|NCT03093324|470436814|FG000|Overall Study|Adverse Event|4|||
130674970|NCT03093324|470436815|FG001|Overall Study|Adverse Event|15|||
130674971|NCT03093324|470436814|FG000|Overall Study|Lost to Follow-up|1|||
130674972|NCT03093324|470436815|FG001|Overall Study|Lost to Follow-up|0|||
130674973|NCT03093324|470436814|FG000|Overall Study|Protocol Deviation|2|||
130674974|NCT03093324|470436815|FG001|Overall Study|Protocol Deviation|2|||
130674975|NCT03093324|470436814|FG000|Overall Study|Withdrawal by Subject|2|||
130674976|NCT03093324|470436815|FG001|Overall Study|Withdrawal by Subject|2|||
130674977|NCT00614055|470436819|FG000|Overall Study|Adverse Event|1|||
130674978|NCT00614055|470436820|FG001|Overall Study|Adverse Event|0|||
130674979|NCT00614055|470436821|FG002|Overall Study|Adverse Event|0|||
130674980|NCT00614055|470436819|FG000|Overall Study|Protocol Violation|2|||
130674981|NCT00614055|470436820|FG001|Overall Study|Protocol Violation|2|||
130674982|NCT00614055|470436821|FG002|Overall Study|Protocol Violation|1|||
130674983|NCT00614055|470436819|FG000|Overall Study|Lack of Efficacy|0|||
130674984|NCT00614055|470436820|FG001|Overall Study|Lack of Efficacy|0|||
130674985|NCT00614055|470436821|FG002|Overall Study|Lack of Efficacy|2|||
130674986|NCT00614055|470436819|FG000|Overall Study|Unclassified|1|||
130674987|NCT00614055|470436820|FG001|Overall Study|Unclassified|4|||
130674988|NCT00614055|470436821|FG002|Overall Study|Unclassified|2|||
130674989|NCT01691859|470436823|FG000|Overall Study|Adverse Event|19|||
130674990|NCT01691859|470436823|FG000|Overall Study|Lack of Efficacy|11|||
130674991|NCT01691859|470436823|FG000|Overall Study|Protocol Violation|4|||
130674992|NCT01691859|470436823|FG000|Overall Study|Product commercially available|221|||
130674993|NCT01691859|470436823|FG000|Overall Study|Study closed/terminated|50|||
130674994|NCT01691859|470436823|FG000|Overall Study|Lost to Follow-up|5|||
130674995|NCT01691859|470436823|FG000|Overall Study|Physician Decision|6|||
130674996|NCT01691859|470436823|FG000|Overall Study|Withdrawal by Subject|31|||
130674997|NCT01296932|470436824|FG000|Overall Study|Dose limiting toxicity|0|||
130674998|NCT01296932|470436825|FG001|Overall Study|Dose limiting toxicity|0|||
130674999|NCT01296932|470436826|FG002|Overall Study|Dose limiting toxicity|0|||
130675000|NCT01296932|470436827|FG003|Overall Study|Dose limiting toxicity|0|||
130675001|NCT01296932|470436828|FG004|Overall Study|Dose limiting toxicity|0|||
130675002|NCT01296932|470436829|FG005|Overall Study|Dose limiting toxicity|0|||
130675003|NCT01296932|470436830|FG006|Overall Study|Dose limiting toxicity|1|||
130675004|NCT01296932|470436831|FG007|Overall Study|Dose limiting toxicity|0|||
130675005|NCT01296932|470436832|FG008|Overall Study|Dose limiting toxicity|1|||
130675006|NCT01296932|470436824|FG000|Overall Study|Progressive disease|2|||
130675007|NCT01296932|470436825|FG001|Overall Study|Progressive disease|0|||
130675008|NCT01296932|470436826|FG002|Overall Study|Progressive disease|1|||
130675009|NCT01296932|470436827|FG003|Overall Study|Progressive disease|1|||
130675010|NCT01296932|470436828|FG004|Overall Study|Progressive disease|2|||
130675011|NCT01296932|470436829|FG005|Overall Study|Progressive disease|3|||
130675012|NCT01296932|470436830|FG006|Overall Study|Progressive disease|1|||
130675013|NCT01296932|470436831|FG007|Overall Study|Progressive disease|0|||
130675014|NCT01296932|470436832|FG008|Overall Study|Progressive disease|0|||
130675015|NCT01296932|470436824|FG000|Overall Study|Withdrawal by Subject|0|||
130675016|NCT01296932|470436825|FG001|Overall Study|Withdrawal by Subject|0|||
130675017|NCT01296932|470436826|FG002|Overall Study|Withdrawal by Subject|1|||
130675018|NCT01296932|470436827|FG003|Overall Study|Withdrawal by Subject|1|||
130341851|NCT00600119|469223148|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130341852|NCT00600119|469223143|FG000|Double-blind Treatment Period|Adverse Event|1|||
130675019|NCT01296932|470436828|FG004|Overall Study|Withdrawal by Subject|0|||
130675020|NCT01296932|470436829|FG005|Overall Study|Withdrawal by Subject|0|||
130675021|NCT01296932|470436830|FG006|Overall Study|Withdrawal by Subject|3|||
130675022|NCT01296932|470436831|FG007|Overall Study|Withdrawal by Subject|0|||
130675023|NCT01296932|470436832|FG008|Overall Study|Withdrawal by Subject|0|||
130675024|NCT01296932|470436824|FG000|Overall Study|Adverse Event|1|||
130675025|NCT01296932|470436825|FG001|Overall Study|Adverse Event|1|||
130675026|NCT01296932|470436826|FG002|Overall Study|Adverse Event|1|||
130675027|NCT01296932|470436827|FG003|Overall Study|Adverse Event|2|||
130675028|NCT01296932|470436828|FG004|Overall Study|Adverse Event|1|||
130675029|NCT01296932|470436829|FG005|Overall Study|Adverse Event|0|||
130675030|NCT01296932|470436830|FG006|Overall Study|Adverse Event|0|||
130675031|NCT01296932|470436831|FG007|Overall Study|Adverse Event|0|||
130675032|NCT01296932|470436832|FG008|Overall Study|Adverse Event|1|||
130675033|NCT01296932|470436824|FG000|Overall Study|Investigator decision|0|||
130675034|NCT01296932|470436825|FG001|Overall Study|Investigator decision|1|||
130675035|NCT01296932|470436826|FG002|Overall Study|Investigator decision|0|||
130675036|NCT01296932|470436827|FG003|Overall Study|Investigator decision|1|||
130675037|NCT01296932|470436828|FG004|Overall Study|Investigator decision|0|||
130675038|NCT01296932|470436829|FG005|Overall Study|Investigator decision|0|||
130675039|NCT01296932|470436830|FG006|Overall Study|Investigator decision|1|||
130675040|NCT01296932|470436831|FG007|Overall Study|Investigator decision|0|||
130675041|NCT01296932|470436832|FG008|Overall Study|Investigator decision|1|||
130675042|NCT01296932|470436824|FG000|Overall Study|No clinical benefit anymore|0|||
130675043|NCT01296932|470436825|FG001|Overall Study|No clinical benefit anymore|1|||
130675044|NCT01296932|470436826|FG002|Overall Study|No clinical benefit anymore|0|||
130675045|NCT01296932|470436827|FG003|Overall Study|No clinical benefit anymore|0|||
130675046|NCT01296932|470436828|FG004|Overall Study|No clinical benefit anymore|0|||
130675047|NCT01296932|470436829|FG005|Overall Study|No clinical benefit anymore|0|||
130675048|NCT01296932|470436830|FG006|Overall Study|No clinical benefit anymore|0|||
130675049|NCT01296932|470436831|FG007|Overall Study|No clinical benefit anymore|0|||
130675050|NCT01296932|470436832|FG008|Overall Study|No clinical benefit anymore|0|||
130675051|NCT01296932|470436824|FG000|Overall Study|Physician Decision|0|||
130675052|NCT01296932|470436825|FG001|Overall Study|Physician Decision|0|||
130675053|NCT01296932|470436826|FG002|Overall Study|Physician Decision|1|||
130675054|NCT01296932|470436827|FG003|Overall Study|Physician Decision|0|||
130675055|NCT01296932|470436828|FG004|Overall Study|Physician Decision|0|||
130675056|NCT01296932|470436829|FG005|Overall Study|Physician Decision|0|||
130675057|NCT01296932|470436830|FG006|Overall Study|Physician Decision|0|||
130675058|NCT01296932|470436831|FG007|Overall Study|Physician Decision|0|||
130675059|NCT01296932|470436832|FG008|Overall Study|Physician Decision|0|||
130675060|NCT01296932|470436824|FG000|Overall Study|IV problems, administration not possible|0|||
130675061|NCT01296932|470436825|FG001|Overall Study|IV problems, administration not possible|0|||
130675062|NCT01296932|470436826|FG002|Overall Study|IV problems, administration not possible|1|||
130675063|NCT01296932|470436827|FG003|Overall Study|IV problems, administration not possible|0|||
130675064|NCT01296932|470436828|FG004|Overall Study|IV problems, administration not possible|0|||
130675065|NCT01296932|470436829|FG005|Overall Study|IV problems, administration not possible|0|||
130675066|NCT01296932|470436830|FG006|Overall Study|IV problems, administration not possible|0|||
130675067|NCT01296932|470436831|FG007|Overall Study|IV problems, administration not possible|0|||
130675068|NCT01296932|470436832|FG008|Overall Study|IV problems, administration not possible|0|||
130675069|NCT01296932|470436824|FG000|Overall Study|per protocol|0|||
130675070|NCT01296932|470436825|FG001|Overall Study|per protocol|0|||
130675071|NCT01296932|470436826|FG002|Overall Study|per protocol|1|||
130675072|NCT01296932|470436827|FG003|Overall Study|per protocol|1|||
130675073|NCT01296932|470436828|FG004|Overall Study|per protocol|0|||
130675074|NCT01296932|470436829|FG005|Overall Study|per protocol|0|||
130675075|NCT01296932|470436830|FG006|Overall Study|per protocol|0|||
130675076|NCT01296932|470436831|FG007|Overall Study|per protocol|0|||
130675077|NCT01296932|470436832|FG008|Overall Study|per protocol|0|||
130675078|NCT01296932|470436824|FG000|Overall Study|Low benefit and too many side effects|0|||
130675079|NCT01296932|470436825|FG001|Overall Study|Low benefit and too many side effects|0|||
130675080|NCT01296932|470436826|FG002|Overall Study|Low benefit and too many side effects|0|||
130675081|NCT01296932|470436827|FG003|Overall Study|Low benefit and too many side effects|0|||
130675082|NCT01296932|470436828|FG004|Overall Study|Low benefit and too many side effects|0|||
130675083|NCT01296932|470436829|FG005|Overall Study|Low benefit and too many side effects|0|||
130675084|NCT01296932|470436830|FG006|Overall Study|Low benefit and too many side effects|0|||
130675085|NCT01296932|470436831|FG007|Overall Study|Low benefit and too many side effects|1|||
130675086|NCT01296932|470436832|FG008|Overall Study|Low benefit and too many side effects|0|||
130675087|NCT01296932|470436824|FG000|Overall Study|No adequate treatment response|0|||
130675088|NCT01296932|470436825|FG001|Overall Study|No adequate treatment response|0|||
130675089|NCT01296932|470436826|FG002|Overall Study|No adequate treatment response|0|||
130675090|NCT01296932|470436827|FG003|Overall Study|No adequate treatment response|0|||
130341853|NCT00600119|469223144|FG001|Double-blind Treatment Period|Adverse Event|1|||
130341854|NCT00600119|469223145|FG002|Double-blind Treatment Period|Adverse Event|0|||
130341855|NCT00600119|469223146|FG003|Double-blind Treatment Period|Adverse Event|1|||
130675091|NCT01296932|470436828|FG004|Overall Study|No adequate treatment response|0|||
130341856|NCT00600119|469223147|FG004|Double-blind Treatment Period|Adverse Event|2|||
130216588|NCT03762681|468755607|FG004|Part 2a|Pandemic Travel Restrictions|0|||
130675092|NCT01296932|470436829|FG005|Overall Study|No adequate treatment response|0|||
130675093|NCT01296932|470436830|FG006|Overall Study|No adequate treatment response|0|||
130675094|NCT01296932|470436831|FG007|Overall Study|No adequate treatment response|1|||
130675095|NCT01296932|470436832|FG008|Overall Study|No adequate treatment response|0|||
130675096|NCT01296932|470436824|FG000|Overall Study|Dosage already reduced, AE still present|0|||
130675097|NCT01296932|470436825|FG001|Overall Study|Dosage already reduced, AE still present|0|||
130675098|NCT01296932|470436826|FG002|Overall Study|Dosage already reduced, AE still present|0|||
130675099|NCT01296932|470436827|FG003|Overall Study|Dosage already reduced, AE still present|0|||
130675100|NCT01296932|470436828|FG004|Overall Study|Dosage already reduced, AE still present|0|||
130675101|NCT01296932|470436829|FG005|Overall Study|Dosage already reduced, AE still present|0|||
130675102|NCT01296932|470436830|FG006|Overall Study|Dosage already reduced, AE still present|0|||
130675103|NCT01296932|470436831|FG007|Overall Study|Dosage already reduced, AE still present|0|||
130675104|NCT01296932|470436832|FG008|Overall Study|Dosage already reduced, AE still present|1|||
130675105|NCT02352337|470436833|FG000|Overall Study|Patients never treated|4|||
130675106|NCT02352337|470436834|FG001|Overall Study|Patients never treated|1|||
130675107|NCT02352337|470436835|FG002|Overall Study|Patients never treated|2|||
130675108|NCT02458638|470436836|FG000|Overall Study|Death|309|||
130675109|NCT02458638|470436836|FG000|Overall Study|End of Cohort/End of Study|67|||
130675110|NCT02458638|470436836|FG000|Overall Study|Lost to Follow-up|31|||
130675111|NCT02458638|470436836|FG000|Overall Study|Other Reasons|4|||
130675112|NCT02458638|470436836|FG000|Overall Study|Physician Decision|1|||
130675113|NCT02458638|470436836|FG000|Overall Study|Withdrawal by Subject|47|||
130675114|NCT01829464|470436839|FG000|Overall Study|Adverse Event|1|||
130675115|NCT01829464|470436840|FG001|Overall Study|Adverse Event|0|||
130675116|NCT01829464|470436841|FG002|Overall Study|Adverse Event|0|||
130675117|NCT01829464|470436839|FG000|Overall Study|Lost to Follow-up|0|||
130675118|NCT01829464|470436840|FG001|Overall Study|Lost to Follow-up|0|||
130675119|NCT01829464|470436841|FG002|Overall Study|Lost to Follow-up|1|||
130675120|NCT01829464|470436839|FG000|Overall Study|Withdrawal by Subject|2|||
130675121|NCT01829464|470436840|FG001|Overall Study|Withdrawal by Subject|0|||
130675122|NCT01829464|470436841|FG002|Overall Study|Withdrawal by Subject|0|||
130675123|NCT01829464|470436839|FG000|Overall Study|Study terminated by sponsor|25|||
130675124|NCT01829464|470436840|FG001|Overall Study|Study terminated by sponsor|28|||
130675125|NCT01829464|470436841|FG002|Overall Study|Study terminated by sponsor|25|||
130675126|NCT01829464|470436839|FG000|Overall Study|Lack of Efficacy|0|||
130675127|NCT01829464|470436840|FG001|Overall Study|Lack of Efficacy|1|||
130675128|NCT01829464|470436841|FG002|Overall Study|Lack of Efficacy|0|||
130675129|NCT01290263|470436846|FG000|Overall Study|Adverse Event|0|||
130675130|NCT01290263|470436847|FG001|Overall Study|Adverse Event|0|||
130675131|NCT01290263|470436848|FG002|Overall Study|Adverse Event|0|||
130675132|NCT01290263|470436849|FG003|Overall Study|Adverse Event|1|||
130675133|NCT01290263|470436850|FG004|Overall Study|Adverse Event|1|||
130675134|NCT01290263|470436846|FG000|Overall Study|Lack of Efficacy|8|||
130675135|NCT01290263|470436847|FG001|Overall Study|Lack of Efficacy|2|||
130675136|NCT01290263|470436848|FG002|Overall Study|Lack of Efficacy|7|||
130675137|NCT01290263|470436849|FG003|Overall Study|Lack of Efficacy|24|||
130675138|NCT01290263|470436850|FG004|Overall Study|Lack of Efficacy|33|||
130675139|NCT01290263|470436846|FG000|Overall Study|Withdrawal by Subject|3|||
130675140|NCT01290263|470436847|FG001|Overall Study|Withdrawal by Subject|1|||
130675141|NCT01290263|470436848|FG002|Overall Study|Withdrawal by Subject|0|||
130675142|NCT01290263|470436849|FG003|Overall Study|Withdrawal by Subject|1|||
130675143|NCT01290263|470436850|FG004|Overall Study|Withdrawal by Subject|2|||
130675144|NCT01290263|470436846|FG000|Overall Study|Participant Non-Compliance|0|||
130675145|NCT01290263|470436847|FG001|Overall Study|Participant Non-Compliance|0|||
130675146|NCT01290263|470436848|FG002|Overall Study|Participant Non-Compliance|0|||
130675147|NCT01290263|470436849|FG003|Overall Study|Participant Non-Compliance|1|||
130675148|NCT01290263|470436850|FG004|Overall Study|Participant Non-Compliance|1|||
130675149|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
130675150|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
130675151|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
130675152|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
130675153|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
130675154|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
130675155|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
130675156|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
130675157|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130675158|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130675159|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130675160|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
130675161|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
130675162|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
130675163|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
130675164|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
130675165|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
130675166|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
130675167|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
130675168|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
130675169|NCT04700449|470436851|FG000|Stage 1: Double-Blind Period|Other|0|||
130675170|NCT04700449|470436852|FG001|Stage 1: Double-Blind Period|Other|0|||
130675171|NCT04700449|470436853|FG002|Stage 1: Double-Blind Period|Other|1|||
130675172|NCT04700449|470436854|FG003|Stage 1: Double-Blind Period|Other|0|||
130675173|NCT04700449|470436851|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
130675174|NCT04700449|470436852|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
130675175|NCT04700449|470436853|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
130675176|NCT04700449|470436854|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
130675177|NCT04700449|470436851|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130675178|NCT04700449|470436852|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130675179|NCT04700449|470436853|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130675180|NCT04700449|470436854|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
130675181|NCT04700449|470436851|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130675182|NCT04700449|470436852|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130675183|NCT04700449|470436853|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
130675184|NCT04700449|470436854|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130675185|NCT04700449|470436851|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130675186|NCT04700449|470436852|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130675187|NCT04700449|470436853|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
130675188|NCT04700449|470436854|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130675189|NCT04700449|470436851|FG000|Stage 2 Sub-study 1|Other|1|||
130675190|NCT04700449|470436852|FG001|Stage 2 Sub-study 1|Other|2|||
130675191|NCT04700449|470436853|FG002|Stage 2 Sub-study 1|Other|0|||
130675192|NCT04700449|470436854|FG003|Stage 2 Sub-study 1|Other|0|||
130675193|NCT04700449|470436851|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
130675194|NCT04700449|470436852|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
130675195|NCT04700449|470436853|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
130675196|NCT04700449|470436854|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
130675197|NCT04700449|470436851|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130675198|NCT04700449|470436852|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130675199|NCT04700449|470436853|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130675200|NCT04700449|470436854|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
130675201|NCT04700449|470436851|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130675202|NCT04700449|470436852|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130675203|NCT04700449|470436853|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130675204|NCT04700449|470436854|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
130675205|NCT04700449|470436851|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
130675206|NCT04700449|470436852|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
130675207|NCT04700449|470436853|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
130675208|NCT04700449|470436854|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
130675209|NCT04700449|470436851|FG000|Stage 2 Sub-study 2|Other|0|||
130675210|NCT04700449|470436852|FG001|Stage 2 Sub-study 2|Other|0|||
130675211|NCT04700449|470436853|FG002|Stage 2 Sub-study 2|Other|0|||
130675212|NCT04700449|470436854|FG003|Stage 2 Sub-study 2|Other|5|||
130675213|NCT03738332|470436855|FG000|Overall Study|Withdrawal by Subject|1|||
130675214|NCT02336737|470436856|FG000|Overall Study|Withdrawal by Subject|5|||
130675215|NCT02336737|470436856|FG000|Overall Study|Physician Decision|8|||
130675216|NCT02228382|470436857|FG000|Overall Study|Death|5|||
130675217|NCT02228382|470436858|FG001|Overall Study|Death|7|||
130675218|NCT02228382|470436859|FG002|Overall Study|Death|5|||
130675219|NCT02228382|470436860|FG003|Overall Study|Death|0|||
130675220|NCT02228382|470436861|FG004|Overall Study|Death|2|||
130675221|NCT02228382|470436857|FG000|Overall Study|Participant refused further follow-up|0|||
130675222|NCT02228382|470436858|FG001|Overall Study|Participant refused further follow-up|0|||
130675223|NCT02228382|470436859|FG002|Overall Study|Participant refused further follow-up|1|||
130675224|NCT02228382|470436860|FG003|Overall Study|Participant refused further follow-up|0|||
130675225|NCT02228382|470436861|FG004|Overall Study|Participant refused further follow-up|0|||
130675226|NCT02228382|470436857|FG000|Overall Study|Study terminated by sponsor|3|||
130675227|NCT02228382|470436858|FG001|Overall Study|Study terminated by sponsor|5|||
130675228|NCT02228382|470436859|FG002|Overall Study|Study terminated by sponsor|7|||
130675229|NCT02228382|470436860|FG003|Overall Study|Study terminated by sponsor|0|||
130675230|NCT02228382|470436861|FG004|Overall Study|Study terminated by sponsor|0|||
130675231|NCT02228382|470436857|FG000|Overall Study|Lost to Follow-up|0|||
130675232|NCT02228382|470436858|FG001|Overall Study|Lost to Follow-up|0|||
130675233|NCT02228382|470436859|FG002|Overall Study|Lost to Follow-up|3|||
130675234|NCT02228382|470436860|FG003|Overall Study|Lost to Follow-up|1|||
130341857|NCT00600119|469223148|FG005|Double-blind Treatment Period|Adverse Event|10|||
130341858|NCT00600119|469223143|FG000|Follow-up Period|Adverse Event|0|||
130341859|NCT00600119|469223144|FG001|Follow-up Period|Adverse Event|0|||
130675235|NCT02228382|470436861|FG004|Overall Study|Lost to Follow-up|0|||
130675236|NCT02228382|470436857|FG000|Overall Study|Withdrawal by Subject|0|||
130675237|NCT02228382|470436858|FG001|Overall Study|Withdrawal by Subject|3|||
130675238|NCT02228382|470436859|FG002|Overall Study|Withdrawal by Subject|2|||
130675239|NCT02228382|470436860|FG003|Overall Study|Withdrawal by Subject|1|||
130675240|NCT02228382|470436861|FG004|Overall Study|Withdrawal by Subject|0|||
130675241|NCT02228382|470436857|FG000|Overall Study|Other|2|||
130675242|NCT02228382|470436858|FG001|Overall Study|Other|3|||
130341860|NCT00600119|469223145|FG002|Follow-up Period|Adverse Event|0|||
130675243|NCT02228382|470436859|FG002|Overall Study|Other|3|||
130675244|NCT02228382|470436860|FG003|Overall Study|Other|0|||
130675245|NCT02228382|470436861|FG004|Overall Study|Other|0|||
130675246|NCT02324465|470436862|FG000|Overall Study|device failure|0|||
130675247|NCT02324465|470436863|FG001|Overall Study|device failure|1|||
130675248|NCT02655237|470436866|FG000|Overall Study|Adverse Event|10|||
130675249|NCT02655237|470436867|FG001|Overall Study|Adverse Event|7|||
130675250|NCT02655237|470436866|FG000|Overall Study|Protocol Deviation|2|||
130675251|NCT02655237|470436867|FG001|Overall Study|Protocol Deviation|0|||
130675252|NCT02655237|470436866|FG000|Overall Study|Withdrawal by Participant|1|||
130675253|NCT02655237|470436867|FG001|Overall Study|Withdrawal by Participant|2|||
130675254|NCT02655237|470436866|FG000|Overall Study|Lack of Efficacy|0|||
130675255|NCT02655237|470436867|FG001|Overall Study|Lack of Efficacy|1|||
130675256|NCT02655237|470436866|FG000|Overall Study|Recovery Leading to Surgery|2|||
130675257|NCT02655237|470436867|FG001|Overall Study|Recovery Leading to Surgery|1|||
130341861|NCT00600119|469223146|FG003|Follow-up Period|Adverse Event|0|||
130341862|NCT00600119|469223147|FG004|Follow-up Period|Adverse Event|0|||
130341863|NCT00600119|469223148|FG005|Follow-up Period|Adverse Event|1|||
130341864|NCT00600119|469223143|FG000|Follow-up Period|Other|1|||
130675258|NCT02655237|470436866|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
130675259|NCT02655237|470436867|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
130675260|NCT02655237|470436866|FG000|Overall Study|Randomized but Not Treated|1|||
130675261|NCT02655237|470436867|FG001|Overall Study|Randomized but Not Treated|0|||
130675262|NCT02132247|470436868|FG000|Overall Study|Protocol Violation|1|||
130675263|NCT02132247|470436869|FG001|Overall Study|Protocol Violation|0|||
130675264|NCT00520741|470436872|FG000|Overall Study|Adverse Event|16|||
130675265|NCT00520741|470436873|FG001|Overall Study|Adverse Event|56|||
130675266|NCT00520741|470436872|FG000|Overall Study|Lack of Efficacy|11|||
130675267|NCT00520741|470436873|FG001|Overall Study|Lack of Efficacy|30|||
130675268|NCT00520741|470436872|FG000|Overall Study|Withdrawal by Subject|0|||
130675269|NCT00520741|470436873|FG001|Overall Study|Withdrawal by Subject|11|||
130675270|NCT00520741|470436872|FG000|Overall Study|Protocol Violation|2|||
130675271|NCT00520741|470436873|FG001|Overall Study|Protocol Violation|15|||
130675272|NCT00520741|470436872|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
130675273|NCT00520741|470436873|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
130675274|NCT00520741|470436872|FG000|Overall Study|Lost to Follow-up|4|||
130675275|NCT00520741|470436873|FG001|Overall Study|Lost to Follow-up|4|||
130675276|NCT00520741|470436872|FG000|Overall Study|Other reasons for premature termination|0|||
130675277|NCT00520741|470436873|FG001|Overall Study|Other reasons for premature termination|6|||
130675278|NCT03679741|470436874|FG000|Period 1|No longer meet eligibility criteria|1|||
130675279|NCT03679741|470436875|FG001|Period 1|No longer meet eligibility criteria|0|||
130675280|NCT03679741|470436874|FG000|Period 1|Lost to Follow-up|0|||
130675281|NCT03679741|470436875|FG001|Period 1|Lost to Follow-up|1|||
130675282|NCT03679741|470436874|FG000|Period 1|Adverse Event|1|||
130675283|NCT03679741|470436875|FG001|Period 1|Adverse Event|1|||
130675284|NCT03679741|470436874|FG000|Period 1|Withdrawal by Subject|0|||
130675285|NCT03679741|470436875|FG001|Period 1|Withdrawal by Subject|1|||
130675286|NCT03679741|470436874|FG000|Period 2|Adverse Event|2|||
130675287|NCT03679741|470436875|FG001|Period 2|Adverse Event|1|||
130675288|NCT03679741|470436874|FG000|Period 2|Withdrawal by Subject|1|||
130675289|NCT03679741|470436875|FG001|Period 2|Withdrawal by Subject|1|||
130675290|NCT02750761|470436877|FG000|Overall Study|Lost to Follow-up|0|||
130675291|NCT02750761|470436878|FG001|Overall Study|Lost to Follow-up|0|||
130675292|NCT02750761|470436879|FG002|Overall Study|Lost to Follow-up|1|||
130675293|NCT02750761|470436880|FG003|Overall Study|Lost to Follow-up|0|||
130675294|NCT02750761|470436881|FG004|Overall Study|Lost to Follow-up|0|||
130675295|NCT02750761|470436882|FG005|Overall Study|Lost to Follow-up|0|||
130341865|NCT00600119|469223144|FG001|Follow-up Period|Other|0|||
130341866|NCT00600119|469223145|FG002|Follow-up Period|Other|0|||
130341867|NCT00600119|469223146|FG003|Follow-up Period|Other|0|||
130341868|NCT00600119|469223147|FG004|Follow-up Period|Other|0|||
130341869|NCT00600119|469223148|FG005|Follow-up Period|Other|0|||
130341870|NCT03241368|469223149|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
130341871|NCT03241368|469223149|FG000|Overall Study|Lost to Follow-up|1|||
130675296|NCT01860976|470436883|FG000|Blinded Treatment|Adverse Event|1|||
130675297|NCT01860976|470436884|FG001|Blinded Treatment|Adverse Event|3|||
130675298|NCT01860976|470436883|FG000|Blinded Treatment|Lack of Efficacy|5|||
130675299|NCT01860976|470436884|FG001|Blinded Treatment|Lack of Efficacy|12|||
130675300|NCT01860976|470436883|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
130675301|NCT01860976|470436884|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
130675302|NCT01860976|470436883|FG000|Blinded Treatment|Withdrawal by Subject|3|||
130675303|NCT01860976|470436884|FG001|Blinded Treatment|Withdrawal by Subject|5|||
130675304|NCT01860976|470436883|FG000|Blinded Treatment|Subject no longer met criteria|1|||
130341872|NCT03241368|469223149|FG000|Overall Study|Physician Decision|6|||
130341873|NCT03241368|469223149|FG000|Overall Study|Withdrawal by Subject|6|||
130341874|NCT03241368|469223149|FG000|Overall Study|Protocol Violation|1|||
130341875|NCT00729469|469223150|FG000|Overall Study|Adverse Event|14|||
130341876|NCT00729469|469223151|FG001|Overall Study|Adverse Event|25|||
130675305|NCT01860976|470436884|FG001|Blinded Treatment|Subject no longer met criteria|0|||
130675306|NCT01860976|470436883|FG000|Blinded Treatment|Entered Open-Label in error|0|||
130675307|NCT01860976|470436884|FG001|Blinded Treatment|Entered Open-Label in error|1|||
130675308|NCT01860976|470436883|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
130675309|NCT01860976|470436884|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
130675310|NCT01860976|470436883|FG000|Open-Label|Adverse Event|2|||
130675311|NCT01860976|470436884|FG001|Open-Label|Adverse Event|4|||
130675312|NCT01860976|470436883|FG000|Open-Label|Lack of Efficacy|16|||
130675313|NCT01860976|470436884|FG001|Open-Label|Lack of Efficacy|8|||
130675314|NCT01860976|470436883|FG000|Open-Label|Lost to Follow-up|1|||
130675315|NCT01860976|470436884|FG001|Open-Label|Lost to Follow-up|2|||
130675316|NCT01860976|470436883|FG000|Open-Label|Subject request discontinue treatment|4|||
130675317|NCT01860976|470436884|FG001|Open-Label|Subject request discontinue treatment|3|||
130675318|NCT01860976|470436883|FG000|Open-Label|Withdrawal by Subject|4|||
130675319|NCT01860976|470436884|FG001|Open-Label|Withdrawal by Subject|1|||
130675320|NCT01860976|470436883|FG000|Open-Label|Other Reasons|1|||
130675321|NCT01860976|470436884|FG001|Open-Label|Other Reasons|1|||
130675322|NCT01860976|470436883|FG000|Long Term Extension|Adverse Event|4|||
130675323|NCT01860976|470436884|FG001|Long Term Extension|Adverse Event|0|||
130675324|NCT01860976|470436883|FG000|Long Term Extension|Lack of Efficacy|2|||
130675325|NCT01860976|470436884|FG001|Long Term Extension|Lack of Efficacy|0|||
130675326|NCT01860976|470436883|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
130675327|NCT01860976|470436884|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
130675328|NCT01860976|470436883|FG000|Long Term Extension|Lost to Follow-up|2|||
130675329|NCT01860976|470436884|FG001|Long Term Extension|Lost to Follow-up|0|||
130675330|NCT01860976|470436883|FG000|Long Term Extension|subject withdrew consent|7|||
130675331|NCT01860976|470436884|FG001|Long Term Extension|subject withdrew consent|0|||
130675332|NCT02227862|470436885|FG000|Overall Study|Protocol Violation|7|||
130675333|NCT02227862|470436886|FG001|Overall Study|Protocol Violation|9|||
130675334|NCT02227862|470436885|FG000|Overall Study|Other|0|||
130675335|NCT02227862|470436886|FG001|Overall Study|Other|2|||
130675336|NCT02227862|470436885|FG000|Overall Study|Adverse Event|4|||
130675337|NCT02227862|470436886|FG001|Overall Study|Adverse Event|3|||
130675338|NCT02227862|470436885|FG000|Overall Study|Withdrawal by Subject|7|||
130675339|NCT02227862|470436886|FG001|Overall Study|Withdrawal by Subject|6|||
130675340|NCT02227862|470436885|FG000|Overall Study|Lost to Follow-up|1|||
130675341|NCT02227862|470436886|FG001|Overall Study|Lost to Follow-up|2|||
130675342|NCT01612000|470436888|FG000|Overall Study|Lost to Follow-up|6|||
130675343|NCT01612000|470436889|FG001|Overall Study|Lost to Follow-up|4|||
130675344|NCT01612000|470436890|FG002|Overall Study|Lost to Follow-up|4|||
130675345|NCT01612000|470436891|FG003|Overall Study|Lost to Follow-up|8|||
130675346|NCT01612000|470436888|FG000|Overall Study|Physician Decision|0|||
130675347|NCT01612000|470436889|FG001|Overall Study|Physician Decision|0|||
130675348|NCT01612000|470436890|FG002|Overall Study|Physician Decision|1|||
130675349|NCT01612000|470436891|FG003|Overall Study|Physician Decision|0|||
130675350|NCT01612000|470436888|FG000|Overall Study|Withdrawal by Subject|3|||
130675351|NCT01612000|470436889|FG001|Overall Study|Withdrawal by Subject|1|||
130675352|NCT01612000|470436890|FG002|Overall Study|Withdrawal by Subject|2|||
130675353|NCT01612000|470436891|FG003|Overall Study|Withdrawal by Subject|2|||
130675354|NCT02354586|470436895|FG000|Overall Study|Death|230|||
130675355|NCT02354586|470436895|FG000|Overall Study|Withdrawal by Subject|59|||
130675356|NCT02354586|470436895|FG000|Overall Study|Lost to Follow-up|11|||
130675357|NCT02354586|470436895|FG000|Overall Study|Sponsor decision|51|||
130675358|NCT02354586|470436895|FG000|Overall Study|Site closure|2|||
130675359|NCT02354586|470436895|FG000|Overall Study|Intercurrent illness|1|||
130675360|NCT02354586|470436895|FG000|Overall Study|Protocol Violation|3|||
130675361|NCT02354586|470436895|FG000|Overall Study|Physician Decision|13|||
130675362|NCT02354586|470436895|FG000|Overall Study|Lack of Efficacy|86|||
130675363|NCT02354586|470436895|FG000|Overall Study|Adverse Event|7|||
130675364|NCT00634907|470436897|FG000|Overall Study|Withdrawal by Subject|3|||
130675365|NCT00634907|470436898|FG001|Overall Study|Withdrawal by Subject|0|||
130675366|NCT00634907|470436897|FG000|Overall Study|Physician Decision|3|||
130675367|NCT00634907|470436898|FG001|Overall Study|Physician Decision|9|||
130341877|NCT00729469|469223150|FG000|Overall Study|Lost to Follow-up|9|||
130341878|NCT00729469|469223151|FG001|Overall Study|Lost to Follow-up|9|||
130341879|NCT00729469|469223150|FG000|Overall Study|Protocol Violation|2|||
130675368|NCT00634907|470436897|FG000|Overall Study|Withdrawal by Subject|11|||
130675369|NCT00634907|470436898|FG001|Overall Study|Withdrawal by Subject|8|||
130675370|NCT02204371|470436904|FG000|Overall Study|Adverse Event|1|||
130675371|NCT02419313|470436905|FG000|First Intervention|Lost to Follow-up|2|||
130675372|NCT02419313|470436906|FG001|First Intervention|Lost to Follow-up|0|||
130341880|NCT00729469|469223151|FG001|Overall Study|Protocol Violation|1|||
130341881|NCT00729469|469223150|FG000|Overall Study|Withdrawal by Subject|19|||
130675373|NCT02419313|470436905|FG000|Second Intervention|Lost to Follow-up|1|||
130341882|NCT00729469|469223151|FG001|Overall Study|Withdrawal by Subject|8|||
130675374|NCT02419313|470436906|FG001|Second Intervention|Lost to Follow-up|0|||
130675375|NCT00620763|470436909|FG000|Period: First Intervention|Withdrawal by Subject|0|||
130675376|NCT00620763|470436910|FG001|Period: First Intervention|Withdrawal by Subject|2|||
130675377|NCT00620763|470436909|FG000|Period: First Intervention|Protocol Violation|0|||
130675378|NCT00620763|470436910|FG001|Period: First Intervention|Protocol Violation|3|||
130675379|NCT00620763|470436909|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
130675380|NCT00620763|470436910|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
130675381|NCT00368966|470436914|FG000|Infant Series|Withdrawal by Subject|11|||
130675382|NCT00368966|470436915|FG001|Infant Series|Withdrawal by Subject|6|||
130675383|NCT00368966|470436914|FG000|Infant Series|Protocol Violation|2|||
130675384|NCT00368966|470436915|FG001|Infant Series|Protocol Violation|1|||
130675385|NCT00368966|470436914|FG000|Infant Series|Lost to Follow-up|2|||
130675386|NCT00368966|470436915|FG001|Infant Series|Lost to Follow-up|0|||
130675387|NCT00368966|470436914|FG000|Infant Series|Randomization error|0|||
130675388|NCT00368966|470436915|FG001|Infant Series|Randomization error|1|||
130675389|NCT00368966|470436914|FG000|Infant Series|Failed to meet eligibility criteria|0|||
130675390|NCT00368966|470436915|FG001|Infant Series|Failed to meet eligibility criteria|1|||
130675391|NCT00368966|470436914|FG000|Infant Series|Adverse Event|0|||
130675392|NCT00368966|470436915|FG001|Infant Series|Adverse Event|1|||
130675393|NCT00368966|470436914|FG000|Infant Series|Failed to return|1|||
130675394|NCT00368966|470436915|FG001|Infant Series|Failed to return|0|||
130675395|NCT00368966|470436914|FG000|After Infant|Failed to return|3|||
130675396|NCT00368966|470436915|FG001|After Infant|Failed to return|1|||
130675397|NCT00368966|470436914|FG000|After Infant|Adverse Event|1|||
130675398|NCT00368966|470436915|FG001|After Infant|Adverse Event|2|||
130675399|NCT00368966|470436914|FG000|After Infant|Withdrawal by Subject|1|||
130675400|NCT00368966|470436915|FG001|After Infant|Withdrawal by Subject|1|||
130675401|NCT00368966|470436914|FG000|After Infant|Death|1|||
130675402|NCT00368966|470436915|FG001|After Infant|Death|0|||
130675403|NCT00368966|470436914|FG000|After Infant|Lost to Follow-up|0|||
130675404|NCT00368966|470436915|FG001|After Infant|Lost to Follow-up|1|||
130675405|NCT00368966|470436914|FG000|Toddler Dose|Withdrawal by Subject|1|||
130675406|NCT00368966|470436915|FG001|Toddler Dose|Withdrawal by Subject|1|||
130675407|NCT00368966|470436914|FG000|Toddler Dose|Lost to Follow-up|0|||
130675408|NCT00368966|470436915|FG001|Toddler Dose|Lost to Follow-up|2|||
130675409|NCT02866175|470436916|FG000|Overall Study|Adverse Event|56|||
130675410|NCT02866175|470436917|FG001|Overall Study|Adverse Event|54|||
130675411|NCT02866175|470436916|FG000|Overall Study|Withdrawal by Subject|31|||
130675412|NCT02866175|470436917|FG001|Overall Study|Withdrawal by Subject|52|||
130675413|NCT02866175|470436916|FG000|Overall Study|Death|30|||
130675414|NCT02866175|470436917|FG001|Overall Study|Death|23|||
130675415|NCT02866175|470436916|FG000|Overall Study|Other|7|||
130675416|NCT02866175|470436917|FG001|Overall Study|Other|14|||
130675417|NCT02866175|470436916|FG000|Overall Study|Progressive disease|1|||
130675418|NCT02866175|470436917|FG001|Overall Study|Progressive disease|1|||
130675419|NCT02866175|470436916|FG000|Overall Study|Lost to Follow-up|2|||
130675420|NCT02866175|470436917|FG001|Overall Study|Lost to Follow-up|0|||
130675421|NCT02866175|470436916|FG000|Overall Study|Lack of Efficacy|0|||
130675422|NCT02866175|470436917|FG001|Overall Study|Lack of Efficacy|1|||
130675423|NCT02866175|470436916|FG000|Overall Study|Physician Decision|3|||
130675424|NCT02866175|470436917|FG001|Overall Study|Physician Decision|15|||
130675425|NCT02866175|470436916|FG000|Overall Study|Did not receive treatment|5|||
130675426|NCT02866175|470436917|FG001|Overall Study|Did not receive treatment|15|||
130675427|NCT01694485|470436918|FG000|Overall Study|Withdrawal by Subject|20|||
130675428|NCT01694485|470436919|FG001|Overall Study|Withdrawal by Subject|6|||
130675429|NCT01694485|470436920|FG002|Overall Study|Withdrawal by Subject|7|||
130675430|NCT01694485|470436921|FG003|Overall Study|Withdrawal by Subject|25|||
130675431|NCT01694485|470436922|FG004|Overall Study|Withdrawal by Subject|18|||
130675432|NCT01694485|470436918|FG000|Overall Study|Sponsor Decision|3|||
130675433|NCT01694485|470436919|FG001|Overall Study|Sponsor Decision|0|||
130675434|NCT01694485|470436920|FG002|Overall Study|Sponsor Decision|0|||
130675435|NCT01694485|470436921|FG003|Overall Study|Sponsor Decision|2|||
130675436|NCT01694485|470436922|FG004|Overall Study|Sponsor Decision|0|||
130675437|NCT01694485|470436918|FG000|Overall Study|Lost to Follow-up|9|||
130675438|NCT01694485|470436919|FG001|Overall Study|Lost to Follow-up|1|||
130675439|NCT01694485|470436920|FG002|Overall Study|Lost to Follow-up|6|||
130341883|NCT00729469|469223150|FG000|Overall Study|Other-Not mentioned|9|||
130341884|NCT00729469|469223151|FG001|Overall Study|Other-Not mentioned|4|||
130341885|NCT01270802|469223154|FG000|Overall Study|Withdrawal by Subject|1|||
130341886|NCT01270802|469223155|FG001|Overall Study|Withdrawal by Subject|0|||
130341887|NCT01270802|469223154|FG000|Overall Study|Adverse Event|1|||
130675440|NCT01694485|470436921|FG003|Overall Study|Lost to Follow-up|10|||
130675441|NCT01694485|470436922|FG004|Overall Study|Lost to Follow-up|7|||
130675442|NCT01694485|470436918|FG000|Overall Study|Death|1|||
130675443|NCT01694485|470436919|FG001|Overall Study|Death|0|||
130675444|NCT01694485|470436920|FG002|Overall Study|Death|0|||
130675445|NCT01694485|470436921|FG003|Overall Study|Death|1|||
130675446|NCT01694485|470436922|FG004|Overall Study|Death|0|||
130675447|NCT01595009|470436923|FG000|Core|Patients completed per protocol|85|||
130341888|NCT01270802|469223155|FG001|Overall Study|Adverse Event|0|||
130675448|NCT01595009|470436924|FG001|Core|Patients completed per protocol|44|||
130675449|NCT01595009|470436925|FG002|Core|Patients completed per protocol|0|||
130675450|NCT01595009|470436926|FG003|Core|Patients completed per protocol|0|||
130675451|NCT01595009|470436923|FG000|Core|Adverse Event|19|||
130675452|NCT01595009|470436924|FG001|Core|Adverse Event|23|||
130675453|NCT01595009|470436925|FG002|Core|Adverse Event|0|||
130675454|NCT01595009|470436926|FG003|Core|Adverse Event|0|||
130675455|NCT01595009|470436923|FG000|Core|Disease progression|14|||
130675456|NCT01595009|470436924|FG001|Core|Disease progression|26|||
130675457|NCT01595009|470436925|FG002|Core|Disease progression|0|||
130675458|NCT01595009|470436926|FG003|Core|Disease progression|0|||
130675459|NCT01595009|470436923|FG000|Core|Withdrawal by Subject|4|||
130675460|NCT01595009|470436924|FG001|Core|Withdrawal by Subject|17|||
130675461|NCT01595009|470436925|FG002|Core|Withdrawal by Subject|0|||
130675462|NCT01595009|470436926|FG003|Core|Withdrawal by Subject|0|||
130675463|NCT01595009|470436923|FG000|Core|Death|3|||
130675464|NCT01595009|470436924|FG001|Core|Death|6|||
130675465|NCT01595009|470436925|FG002|Core|Death|0|||
130675466|NCT01595009|470436926|FG003|Core|Death|0|||
130675467|NCT01595009|470436923|FG000|Core|Lost to Follow-up|1|||
130675468|NCT01595009|470436924|FG001|Core|Lost to Follow-up|2|||
130675469|NCT01595009|470436925|FG002|Core|Lost to Follow-up|0|||
130675470|NCT01595009|470436926|FG003|Core|Lost to Follow-up|0|||
130675471|NCT01595009|470436923|FG000|Core|Protocol deviation|0|||
130675472|NCT01595009|470436924|FG001|Core|Protocol deviation|1|||
130675473|NCT01595009|470436925|FG002|Core|Protocol deviation|0|||
130675474|NCT01595009|470436926|FG003|Core|Protocol deviation|0|||
130675475|NCT01595009|470436923|FG000|Core|Administrative problems|0|||
130675476|NCT01595009|470436924|FG001|Core|Administrative problems|1|||
130675477|NCT01595009|470436925|FG002|Core|Administrative problems|0|||
130675478|NCT01595009|470436926|FG003|Core|Administrative problems|0|||
130675479|NCT01595009|470436923|FG000|Extension|Administrative problems|0|||
130675480|NCT01595009|470436924|FG001|Extension|Administrative problems|0|||
130675481|NCT01595009|470436925|FG002|Extension|Administrative problems|0|||
130675482|NCT01595009|470436926|FG003|Extension|Administrative problems|1|||
130341889|NCT01270802|469223154|FG000|Overall Study|Lost to Follow-up|0|||
130675483|NCT01595009|470436923|FG000|Extension|Patients completed per protocol|0|||
130675484|NCT01595009|470436924|FG001|Extension|Patients completed per protocol|0|||
130675485|NCT01595009|470436925|FG002|Extension|Patients completed per protocol|0|||
130675486|NCT01595009|470436926|FG003|Extension|Patients completed per protocol|2|||
130675487|NCT01595009|470436923|FG000|Extension|Disease progression|0|||
130675488|NCT01595009|470436924|FG001|Extension|Disease progression|0|||
130675489|NCT01595009|470436925|FG002|Extension|Disease progression|4|||
130675490|NCT01595009|470436926|FG003|Extension|Disease progression|7|||
130675491|NCT01595009|470436923|FG000|Extension|Adverse Event|0|||
130675492|NCT01595009|470436924|FG001|Extension|Adverse Event|0|||
130675493|NCT01595009|470436925|FG002|Extension|Adverse Event|0|||
130675494|NCT01595009|470436926|FG003|Extension|Adverse Event|1|||
130675495|NCT02907203|470436928|FG000|Overall Study|Death|1|||
130341890|NCT01270802|469223155|FG001|Overall Study|Lost to Follow-up|1|||
130341891|NCT01566214|469223156|FG000|Overall Study|Lost to Follow-up|3|||
130341892|NCT01566214|469223157|FG001|Overall Study|Lost to Follow-up|0|||
130341893|NCT00561977|469223158|FG000|Overall Study|Withdrawal by Subject|0|||
130341894|NCT00561977|469223159|FG001|Overall Study|Withdrawal by Subject|2|||
130341895|NCT00561977|469223160|FG002|Overall Study|Withdrawal by Subject|1|||
130341896|NCT00561977|469223158|FG000|Overall Study|Pregnancy|0|||
130341897|NCT00561977|469223159|FG001|Overall Study|Pregnancy|1|||
130341898|NCT00561977|469223160|FG002|Overall Study|Pregnancy|1|||
130341899|NCT04620798|469223163|FG000|Overall Study|Lost to Follow-up|126|||
130341900|NCT04620798|469223164|FG001|Overall Study|Lost to Follow-up|138|||
130341901|NCT01616693|469223168|FG000|Evaluated for Safety|Physician Decision|1|||
130341902|NCT01616693|469223169|FG001|Evaluated for Safety|Physician Decision|0|||
130341903|NCT01616693|469223170|FG002|Evaluated for Safety|Physician Decision|1|||
130341904|NCT01616693|469223171|FG003|Evaluated for Safety|Physician Decision|0|||
130341905|NCT01616693|469223168|FG000|Received Both Vaccines|Adverse Event|2|||
130552755|NCT00995020|469991526|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
130675496|NCT02907203|470436928|FG000|Overall Study|Lost to Follow-up|3|||
130675497|NCT02907203|470436928|FG000|Overall Study|Withdrawal by Subject|3|||
130675498|NCT02907203|470436928|FG000|Overall Study|Surgical bypass|1|||
130675499|NCT04956666|470436929|FG000|Overall Study|Adverse Event|18|||
130675500|NCT04956666|470436929|FG000|Overall Study|Physician Decision|5|||
130675501|NCT00662025|470436933|FG000|Overall Study|Objective progression or relapse|51|||
130675502|NCT00662025|470436933|FG000|Overall Study|Adverse Event|7|||
130675503|NCT00662025|470436933|FG000|Overall Study|Withdrawal by Subject|1|||
130675504|NCT00662025|470436933|FG000|Overall Study|Results of other clinical study|2|||
130341906|NCT01616693|469223169|FG001|Received Both Vaccines|Adverse Event|0|||
130341907|NCT01616693|469223170|FG002|Received Both Vaccines|Adverse Event|0|||
130341908|NCT01616693|469223171|FG003|Received Both Vaccines|Adverse Event|0|||
130341909|NCT01616693|469223168|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
130675505|NCT00662025|470436933|FG000|Overall Study|Target lesion cannot be evaluated|1|||
130675506|NCT00662025|470436933|FG000|Overall Study|Domestic circumstances|1|||
130675507|NCT00760383|470436934|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
130675508|NCT00760383|470436935|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
130675509|NCT00626925|470436936|FG000|Overall Study|Lost to Follow-up|1|||
130675510|NCT00626925|470436937|FG001|Overall Study|Lost to Follow-up|2|||
130675511|NCT00626925|470436936|FG000|Overall Study|relapse|1|||
130675512|NCT00626925|470436937|FG001|Overall Study|relapse|0|||
130675513|NCT00626925|470436936|FG000|Overall Study|Adverse effect|6|||
130675514|NCT00626925|470436937|FG001|Overall Study|Adverse effect|2|||
130675515|NCT00626925|470436936|FG000|Overall Study|Lack of Efficacy|1|||
130675516|NCT00626925|470436937|FG001|Overall Study|Lack of Efficacy|4|||
130675517|NCT00626925|470436936|FG000|Overall Study|Time constraints|3|||
130675518|NCT00626925|470436937|FG001|Overall Study|Time constraints|1|||
130675519|NCT01215942|470436942|FG000|Treatment Period|Adverse Event|15|||
130675520|NCT01215942|470436943|FG001|Treatment Period|Adverse Event|26|||
130341910|NCT01616693|469223169|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
130341911|NCT01616693|469223170|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
130341912|NCT01616693|469223171|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
130341913|NCT01616693|469223168|FG000|Received Both Vaccines|Lost to Follow-up|4|||
130341914|NCT01616693|469223169|FG001|Received Both Vaccines|Lost to Follow-up|3|||
130341915|NCT01616693|469223170|FG002|Received Both Vaccines|Lost to Follow-up|4|||
130341916|NCT01616693|469223171|FG003|Received Both Vaccines|Lost to Follow-up|4|||
130341917|NCT01616693|469223168|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
130341918|NCT01616693|469223169|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
130341919|NCT01616693|469223170|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
130341920|NCT01616693|469223171|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
130341921|NCT00832624|469223175|FG000|Overall Study|Study Terminated|10|||
130341922|NCT02395172|469223176|FG000|Overall Study|Participants randomized but not treated|3|||
130341923|NCT02395172|469223177|FG001|Overall Study|Participants randomized but not treated|31|||
130341924|NCT00653939|469223178|FG000|Overall Study|Adverse Event|1|||
130341925|NCT00653939|469223179|FG001|Overall Study|Adverse Event|3|||
130341926|NCT00653939|469223178|FG000|Overall Study|Withdrawal by Subject|3|||
130341927|NCT00653939|469223179|FG001|Overall Study|Withdrawal by Subject|3|||
130341928|NCT00653939|469223178|FG000|Overall Study|Physician Decision|4|||
130341929|NCT00653939|469223179|FG001|Overall Study|Physician Decision|0|||
130341930|NCT00653939|469223178|FG000|Overall Study|Disease Progression|2|||
130341931|NCT00653939|469223179|FG001|Overall Study|Disease Progression|3|||
130341932|NCT00653939|469223178|FG000|Overall Study|Other|2|||
130341933|NCT00653939|469223179|FG001|Overall Study|Other|6|||
130341934|NCT01546623|469223180|FG000|Overall Study|Adverse Event|2|||
130341935|NCT01546623|469223181|FG001|Overall Study|Adverse Event|3|||
130341936|NCT01546623|469223180|FG000|Overall Study|Major Protocol Deviation|1|||
130341937|NCT01546623|469223181|FG001|Overall Study|Major Protocol Deviation|1|||
130341938|NCT01546623|469223180|FG000|Overall Study|High Prostate specific antigen|2|||
130341939|NCT01546623|469223181|FG001|Overall Study|High Prostate specific antigen|1|||
130341940|NCT01546623|469223180|FG000|Overall Study|Did Not Receive Study Drug|1|||
130341941|NCT01546623|469223181|FG001|Overall Study|Did Not Receive Study Drug|1|||
130341942|NCT01134705|469223182|FG000|Overall Study|Adverse Event|1|||
130341943|NCT01134705|469223183|FG001|Overall Study|Adverse Event|7|||
130341944|NCT01134705|469223182|FG000|Overall Study|Withdrawal by Subject|6|||
130341945|NCT01134705|469223183|FG001|Overall Study|Withdrawal by Subject|6|||
130341946|NCT01134705|469223182|FG000|Overall Study|Pregnancy|1|||
130341947|NCT01134705|469223183|FG001|Overall Study|Pregnancy|0|||
130341948|NCT01134705|469223182|FG000|Overall Study|Lost to Follow-up|5|||
130341949|NCT01134705|469223183|FG001|Overall Study|Lost to Follow-up|2|||
130341950|NCT01134705|469223182|FG000|Overall Study|Protocol Violation|1|||
130341951|NCT01134705|469223183|FG001|Overall Study|Protocol Violation|1|||
130341952|NCT01134705|469223182|FG000|Overall Study|Other|1|||
130341953|NCT01134705|469223183|FG001|Overall Study|Other|6|||
130341954|NCT01375075|469223193|FG000|Overall Study|Adverse Event|0|||
130341955|NCT01375075|469223194|FG001|Overall Study|Adverse Event|0|||
130341956|NCT01375075|469223195|FG002|Overall Study|Adverse Event|3|||
130341957|NCT01375075|469223196|FG003|Overall Study|Adverse Event|1|||
130341958|NCT01375075|469223197|FG004|Overall Study|Adverse Event|0|||
130341959|NCT01375075|469223198|FG005|Overall Study|Adverse Event|1|||
130341960|NCT01375075|469223193|FG000|Overall Study|Entry Criterion Not Met|1|||
130341961|NCT01375075|469223194|FG001|Overall Study|Entry Criterion Not Met|0|||
130341962|NCT01375075|469223195|FG002|Overall Study|Entry Criterion Not Met|0|||
130341963|NCT01375075|469223196|FG003|Overall Study|Entry Criterion Not Met|0|||
130341964|NCT01375075|469223197|FG004|Overall Study|Entry Criterion Not Met|0|||
130341965|NCT01375075|469223198|FG005|Overall Study|Entry Criterion Not Met|1|||
130675521|NCT01215942|470436942|FG000|Treatment Period|Death|2|||
130675522|NCT01215942|470436943|FG001|Treatment Period|Death|4|||
130341966|NCT01375075|469223193|FG000|Overall Study|Withdrawal by Subject|0|||
130341967|NCT01375075|469223194|FG001|Overall Study|Withdrawal by Subject|1|||
130341968|NCT01375075|469223195|FG002|Overall Study|Withdrawal by Subject|0|||
130341969|NCT01375075|469223196|FG003|Overall Study|Withdrawal by Subject|0|||
130341970|NCT01375075|469223197|FG004|Overall Study|Withdrawal by Subject|0|||
130675523|NCT01215942|470436942|FG000|Treatment Period|Lack of Efficacy|23|||
130675524|NCT01215942|470436943|FG001|Treatment Period|Lack of Efficacy|62|||
130675525|NCT01215942|470436942|FG000|Treatment Period|Lost to Follow-up|3|||
130675526|NCT01215942|470436943|FG001|Treatment Period|Lost to Follow-up|4|||
130675527|NCT01215942|470436942|FG000|Treatment Period|Withdrawal by Subject|17|||
130675528|NCT01215942|470436943|FG001|Treatment Period|Withdrawal by Subject|40|||
130675529|NCT01215942|470436942|FG000|Treatment Period|Physician Decision|5|||
130675530|NCT01215942|470436943|FG001|Treatment Period|Physician Decision|5|||
130675531|NCT01215942|470436942|FG000|Treatment Period|Protocol Violation|0|||
130675532|NCT01215942|470436943|FG001|Treatment Period|Protocol Violation|1|||
130675533|NCT01215942|470436942|FG000|Treatment Period|Sponsor Decision|349|||
130675534|NCT01215942|470436943|FG001|Treatment Period|Sponsor Decision|530|||
130675535|NCT01215942|470436942|FG000|Post-Treatment Follow-Up Period|Death|0|||
130675536|NCT01215942|470436943|FG001|Post-Treatment Follow-Up Period|Death|1|||
130675537|NCT01215942|470436942|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130675538|NCT01215942|470436943|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130675539|NCT01215942|470436942|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
130675540|NCT01215942|470436943|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
130675541|NCT01215942|470436942|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
130675542|NCT01215942|470436943|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
130675543|NCT01215942|470436942|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
130675544|NCT01215942|470436943|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
130341971|NCT01375075|469223198|FG005|Overall Study|Withdrawal by Subject|1|||
130341972|NCT01011309|469223200|FG000|Overall Study|Adverse Event|2|||
130341973|NCT01011309|469223201|FG001|Overall Study|Adverse Event|1|||
130341974|NCT01011309|469223202|FG002|Overall Study|Adverse Event|2|||
130341975|NCT01011309|469223200|FG000|Overall Study|Lack of Efficacy|0|||
130675545|NCT03305055|470436944|FG000|Overall Study|Withdrawal by Subject|0|||
130675546|NCT03305055|470436945|FG001|Overall Study|Withdrawal by Subject|1|||
130675547|NCT03305055|470436944|FG000|Overall Study|Adverse Event|1|||
130675548|NCT03305055|470436945|FG001|Overall Study|Adverse Event|1|||
130675549|NCT04652453|470436949|FG000|Overall Study|Death|8|||
130675550|NCT04652453|470436950|FG001|Overall Study|Death|2|||
130675551|NCT04652453|470436951|FG002|Overall Study|Death|0|||
130675552|NCT04652453|470436949|FG000|Overall Study|Hospice|5|||
130675553|NCT04652453|470436950|FG001|Overall Study|Hospice|5|||
130675554|NCT04652453|470436951|FG002|Overall Study|Hospice|0|||
130675555|NCT04652453|470436949|FG000|Overall Study|Withdrawal by Subject|2|||
130675556|NCT04652453|470436950|FG001|Overall Study|Withdrawal by Subject|0|||
130675557|NCT04652453|470436951|FG002|Overall Study|Withdrawal by Subject|0|||
130675558|NCT02978326|470436953|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
130675559|NCT02978326|470436954|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
130675560|NCT02978326|470436955|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
130675561|NCT02978326|470436953|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
130675562|NCT02978326|470436954|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
130675563|NCT02978326|470436955|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
130675564|NCT02978326|470436953|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
130341976|NCT01011309|469223201|FG001|Overall Study|Lack of Efficacy|1|||
130341977|NCT01011309|469223202|FG002|Overall Study|Lack of Efficacy|0|||
130341978|NCT01011309|469223200|FG000|Overall Study|Protocol Violation|0|||
130675565|NCT02978326|470436954|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
130675566|NCT02978326|470436955|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
130341979|NCT01011309|469223201|FG001|Overall Study|Protocol Violation|1|||
130341980|NCT01011309|469223202|FG002|Overall Study|Protocol Violation|3|||
130341981|NCT00831493|469223203|FG000|Overall Study|Intractable nausea and vomiting|1|||
130341982|NCT03976648|469223212|FG000|Overall Study|Adverse Event|0|||
130341983|NCT03976648|469223213|FG001|Overall Study|Adverse Event|2|||
130341984|NCT03976648|469223212|FG000|Overall Study|Study terminated by sponsor|21|||
130341985|NCT03976648|469223213|FG001|Overall Study|Study terminated by sponsor|8|||
130341986|NCT01981551|469223214|FG000|Overall Study|Refused further treatment|8|||
130341987|NCT01981551|469223214|FG000|Overall Study|Adverse Event|1|||
130341988|NCT00960570|469223215|FG000|21 Day Washout Period|Adverse Event|1|||
130341989|NCT00960570|469223215|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
130341990|NCT00960570|469223215|FG000|1 Day Period Between Dosing|Adverse Event|2|||
130341991|NCT00960570|469223215|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
130341992|NCT01451437|469223216|FG000|Overall Study|Adverse Event|0|||
130341993|NCT01451437|469223217|FG001|Overall Study|Adverse Event|0|||
130341994|NCT01451437|469223218|FG002|Overall Study|Adverse Event|0|||
130675567|NCT02978326|470436953|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
130675568|NCT02978326|470436954|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
130675569|NCT02978326|470436955|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
130675570|NCT01937364|470436958|FG000|Overall Study|Adverse Event|2|||
130675571|NCT01937364|470436959|FG001|Overall Study|Adverse Event|1|||
130216589|NCT03762681|468755608|FG005|Part 2a|Pandemic Travel Restrictions|0|||
130341995|NCT01451437|469223219|FG003|Overall Study|Adverse Event|0|||
130341996|NCT01451437|469223220|FG004|Overall Study|Adverse Event|0|||
130341997|NCT01451437|469223221|FG005|Overall Study|Adverse Event|1|||
130675572|NCT00203307|470436960|FG000|First Intervention|Adverse Event|2|||
130675573|NCT00203307|470436961|FG001|First Intervention|Adverse Event|0|||
130675574|NCT00313703|470438648|FG000|Overall Study|Lost to Follow-up|11|||
130675575|NCT00313703|470438649|FG001|Overall Study|Lost to Follow-up|2|||
130675576|NCT00313703|470438650|FG002|Overall Study|Lost to Follow-up|5|||
130675577|NCT00313703|470438651|FG003|Overall Study|Lost to Follow-up|12|||
130675578|NCT00101582|470438654|FG000|Overall Study|Ineligibility determined|0|||
130675579|NCT00101582|470438655|FG001|Overall Study|Ineligibility determined|1|||
130675580|NCT00101582|470438654|FG000|Overall Study|Adverse Event|1|||
130675581|NCT00101582|470438655|FG001|Overall Study|Adverse Event|4|||
130675582|NCT00101582|470438654|FG000|Overall Study|Withdrawal by Subject|6|||
130675583|NCT00101582|470438655|FG001|Overall Study|Withdrawal by Subject|4|||
130675584|NCT00101582|470438654|FG000|Overall Study|Physician Decision|1|||
130675585|NCT00101582|470438655|FG001|Overall Study|Physician Decision|0|||
130675586|NCT00101582|470438654|FG000|Overall Study|Death|3|||
130675587|NCT00101582|470438655|FG001|Overall Study|Death|5|||
130675588|NCT00101582|470438654|FG000|Overall Study|Other|0|||
130675589|NCT00101582|470438655|FG001|Overall Study|Other|1|||
130675590|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
130675591|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
130675592|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
130675593|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
130675594|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
130675595|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
130675596|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
130675597|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
130675598|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
130675599|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
130675600|NCT00056160|470438656|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
130675601|NCT00056160|470438657|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
130675602|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
130675603|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
130675604|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
130675605|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
130675606|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
130675607|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
130675608|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
130675609|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
130675610|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
130675611|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
130675612|NCT00056160|470438656|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
130675613|NCT00056160|470438657|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
130675614|NCT00056160|470438656|FG000|Final Follow-up|Transferred into expanded access study.|3|||
130675615|NCT00056160|470438657|FG001|Final Follow-up|Transferred into expanded access study.|0|||
130675616|NCT00056160|470438656|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
130675617|NCT00056160|470438657|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
130675618|NCT00056160|470438656|FG000|Final Follow-up|Adverse Event|1|||
130675619|NCT00056160|470438657|FG001|Final Follow-up|Adverse Event|0|||
130675620|NCT03312530|470438659|FG000|Overall Study|Death|5|||
130675621|NCT03312530|470438660|FG001|Overall Study|Death|5|||
130675622|NCT03312530|470438661|FG002|Overall Study|Death|4|||
130675623|NCT03312530|470438662|FG003|Overall Study|Death|10|||
130675624|NCT03312530|470438663|FG004|Overall Study|Death|8|||
130675625|NCT03312530|470438659|FG000|Overall Study|Lost to Follow-up|0|||
130675626|NCT03312530|470438660|FG001|Overall Study|Lost to Follow-up|0|||
130675627|NCT03312530|470438661|FG002|Overall Study|Lost to Follow-up|0|||
130675628|NCT03312530|470438662|FG003|Overall Study|Lost to Follow-up|1|||
130675629|NCT03312530|470438663|FG004|Overall Study|Lost to Follow-up|0|||
130675630|NCT03312530|470438659|FG000|Overall Study|Participant in another sponsor study.|0|||
130675631|NCT03312530|470438660|FG001|Overall Study|Participant in another sponsor study.|0|||
130675632|NCT03312530|470438661|FG002|Overall Study|Participant in another sponsor study.|0|||
130675633|NCT03312530|470438662|FG003|Overall Study|Participant in another sponsor study.|1|||
130675634|NCT03312530|470438663|FG004|Overall Study|Participant in another sponsor study.|0|||
130675635|NCT03312530|470438659|FG000|Overall Study|Study terminated by sponsor|1|||
130675636|NCT03312530|470438660|FG001|Overall Study|Study terminated by sponsor|0|||
130675637|NCT03312530|470438661|FG002|Overall Study|Study terminated by sponsor|2|||
130675638|NCT03312530|470438662|FG003|Overall Study|Study terminated by sponsor|3|||
130675639|NCT03312530|470438663|FG004|Overall Study|Study terminated by sponsor|7|||
130675640|NCT03312530|470438659|FG000|Overall Study|Withdrawal by Subject|0|||
130675641|NCT03312530|470438660|FG001|Overall Study|Withdrawal by Subject|1|||
130675642|NCT03312530|470438661|FG002|Overall Study|Withdrawal by Subject|0|||
130675643|NCT03312530|470438662|FG003|Overall Study|Withdrawal by Subject|0|||
130675644|NCT03312530|470438663|FG004|Overall Study|Withdrawal by Subject|0|||
130675645|NCT03312530|470438659|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130720923|NCT00724048|470601561|FG000|Overall Study|Withdrawal by Subject|1|||
130675646|NCT03312530|470438660|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130675647|NCT03312530|470438661|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130675648|NCT03312530|470438662|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
130675649|NCT03312530|470438663|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130675650|NCT04583579|470438664|FG000|Overall Study|Lost to Follow-up|4|||
130675651|NCT00278200|470438665|FG000|Overall Study|Death|1|||
130675652|NCT00278200|470438666|FG001|Overall Study|Death|3|||
130675653|NCT00278200|470438665|FG000|Overall Study|Physician Decision|0|||
130675654|NCT00278200|470438666|FG001|Overall Study|Physician Decision|1|||
130675655|NCT03519256|470438674|FG000|Overall Study|Disease recurrence|4|||
130675656|NCT03519256|470438675|FG001|Overall Study|Disease recurrence|4|||
130675657|NCT03519256|470438676|FG002|Overall Study|Disease recurrence|5|||
130675658|NCT03519256|470438677|FG003|Overall Study|Disease recurrence|2|||
130675659|NCT03519256|470438674|FG000|Overall Study|Study drug toxicity|0|||
130675660|NCT03519256|470438675|FG001|Overall Study|Study drug toxicity|2|||
130675661|NCT03519256|470438676|FG002|Overall Study|Study drug toxicity|5|||
130675662|NCT03519256|470438677|FG003|Overall Study|Study drug toxicity|2|||
130675663|NCT03519256|470438674|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130341998|NCT01451437|469223222|FG006|Overall Study|Adverse Event|1|||
130341999|NCT01451437|469223223|FG007|Overall Study|Adverse Event|2|||
130342000|NCT01451437|469223224|FG008|Overall Study|Adverse Event|1|||
130675664|NCT03519256|470438675|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130675665|NCT03519256|470438676|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130675666|NCT03519256|470438677|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130675667|NCT03519256|470438674|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130675668|NCT03519256|470438675|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130675669|NCT03519256|470438676|FG002|Overall Study|Participant request to discontinue study treatment|0|||
130675670|NCT03519256|470438677|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130675671|NCT03519256|470438674|FG000|Overall Study|Other reasons|0|||
130675672|NCT03519256|470438675|FG001|Overall Study|Other reasons|0|||
130675673|NCT03519256|470438676|FG002|Overall Study|Other reasons|2|||
130675674|NCT03519256|470438677|FG003|Overall Study|Other reasons|0|||
130675675|NCT03519256|470438674|FG000|Overall Study|Disease progression|6|||
130675676|NCT03519256|470438675|FG001|Overall Study|Disease progression|3|||
130675677|NCT03519256|470438676|FG002|Overall Study|Disease progression|2|||
130675678|NCT03519256|470438677|FG003|Overall Study|Disease progression|1|||
130675679|NCT03519256|470438674|FG000|Overall Study|Lost to Follow-up|0|||
130675680|NCT03519256|470438675|FG001|Overall Study|Lost to Follow-up|1|||
130675681|NCT03519256|470438676|FG002|Overall Study|Lost to Follow-up|0|||
130675682|NCT03519256|470438677|FG003|Overall Study|Lost to Follow-up|0|||
130675683|NCT05431153|470438678|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130675684|NCT05431153|470438679|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130675685|NCT05431153|470438680|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130675686|NCT05431153|470438681|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130675687|NCT05431153|470438682|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
130675688|NCT05431153|470438683|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130675689|NCT04828161|470438684|FG000|Overall Study|Withdrawal by Subject|0|||
130675690|NCT04828161|470438685|FG001|Overall Study|Withdrawal by Subject|3|||
130675691|NCT04828161|470438686|FG002|Overall Study|Withdrawal by Subject|3|||
130675692|NCT04828161|470438687|FG003|Overall Study|Withdrawal by Subject|4|||
130675693|NCT04828161|470438684|FG000|Overall Study|Lost to Follow-up|1|||
130675694|NCT04828161|470438685|FG001|Overall Study|Lost to Follow-up|4|||
130675695|NCT04828161|470438686|FG002|Overall Study|Lost to Follow-up|2|||
130675696|NCT04828161|470438687|FG003|Overall Study|Lost to Follow-up|2|||
130675697|NCT04828161|470438684|FG000|Overall Study|Other|2|||
130675698|NCT04828161|470438685|FG001|Overall Study|Other|0|||
130675699|NCT04828161|470438686|FG002|Overall Study|Other|2|||
130675700|NCT04828161|470438687|FG003|Overall Study|Other|0|||
130675701|NCT04828161|470438684|FG000|Overall Study|Death|0|||
130675702|NCT04828161|470438685|FG001|Overall Study|Death|0|||
130342001|NCT01451437|469223216|FG000|Overall Study|Physician Decision|1|||
130342002|NCT01451437|469223217|FG001|Overall Study|Physician Decision|1|||
130342003|NCT01451437|469223218|FG002|Overall Study|Physician Decision|2|||
130675703|NCT04828161|470438686|FG002|Overall Study|Death|0|||
130675704|NCT04828161|470438687|FG003|Overall Study|Death|2|||
130675705|NCT00135707|470438696|FG000|Overall Study|Lost to Follow-up|94|||
130675706|NCT00135707|470438697|FG001|Overall Study|Lost to Follow-up|89|||
130675707|NCT00135707|470438696|FG000|Overall Study|Withdrawal by Subject|0|||
130675708|NCT00135707|470438697|FG001|Overall Study|Withdrawal by Subject|1|||
130675709|NCT00135707|470438696|FG000|Overall Study|Institutional review board request|1|||
130216590|NCT03762681|468755609|FG006|Part 2a|Pandemic Travel Restrictions|0|||
130342004|NCT01451437|469223219|FG003|Overall Study|Physician Decision|0|||
130342005|NCT01451437|469223220|FG004|Overall Study|Physician Decision|0|||
130342006|NCT01451437|469223221|FG005|Overall Study|Physician Decision|0|||
130342007|NCT01451437|469223222|FG006|Overall Study|Physician Decision|0|||
130342008|NCT01451437|469223223|FG007|Overall Study|Physician Decision|0|||
130342009|NCT01451437|469223224|FG008|Overall Study|Physician Decision|0|||
130342010|NCT01451437|469223216|FG000|Overall Study|Disease Progression|0|||
130342011|NCT01451437|469223217|FG001|Overall Study|Disease Progression|0|||
130342012|NCT01451437|469223218|FG002|Overall Study|Disease Progression|1|||
130342013|NCT01451437|469223219|FG003|Overall Study|Disease Progression|1|||
130342014|NCT01451437|469223220|FG004|Overall Study|Disease Progression|3|||
130342015|NCT01451437|469223221|FG005|Overall Study|Disease Progression|2|||
130342016|NCT01451437|469223222|FG006|Overall Study|Disease Progression|3|||
130342017|NCT01451437|469223223|FG007|Overall Study|Disease Progression|1|||
130342018|NCT01451437|469223224|FG008|Overall Study|Disease Progression|3|||
130342019|NCT01451437|469223216|FG000|Overall Study|Protocol Violation|0|||
130342020|NCT01451437|469223217|FG001|Overall Study|Protocol Violation|0|||
130342021|NCT01451437|469223218|FG002|Overall Study|Protocol Violation|0|||
130552756|NCT00995020|469991527|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
130675710|NCT00135707|470438697|FG001|Overall Study|Institutional review board request|0|||
130675711|NCT03093454|470438698|FG000|Overall Study|Withdrawal by Subject|1|||
130675712|NCT03093454|470438699|FG001|Overall Study|Withdrawal by Subject|1|||
130675713|NCT03093454|470438698|FG000|Overall Study|Scheduling conflict|3|||
130675714|NCT03093454|470438699|FG001|Overall Study|Scheduling conflict|1|||
130675715|NCT03093454|470438698|FG000|Overall Study|Physician Decision|2|||
130675716|NCT03093454|470438699|FG001|Overall Study|Physician Decision|1|||
130675717|NCT04540497|470438703|FG000|Overall Study|Adverse Event|0|||
130675718|NCT04540497|470438704|FG001|Overall Study|Adverse Event|2|||
130675719|NCT04540497|470438703|FG000|Overall Study|Lost to Follow-up|1|||
130675720|NCT04540497|470438704|FG001|Overall Study|Lost to Follow-up|0|||
130675721|NCT04540497|470438703|FG000|Overall Study|Withdrawal by Subject|1|||
130675722|NCT04540497|470438704|FG001|Overall Study|Withdrawal by Subject|1|||
130675723|NCT04540497|470438703|FG000|Overall Study|Miscellaneous|2|||
130675724|NCT04540497|470438704|FG001|Overall Study|Miscellaneous|1|||
130675725|NCT02524379|470438709|FG000|Overall Study|Death|1|||
130675726|NCT01521559|470438712|FG000|Overall Study|Adverse Event|0|||
130675727|NCT01521559|470438713|FG001|Overall Study|Adverse Event|4|||
130675728|NCT01521559|470438712|FG000|Overall Study|Death|1|||
130675729|NCT01521559|470438713|FG001|Overall Study|Death|0|||
130675730|NCT01521559|470438712|FG000|Overall Study|Withdrawal by Subject|9|||
130675731|NCT01521559|470438713|FG001|Overall Study|Withdrawal by Subject|11|||
130675732|NCT01521559|470438712|FG000|Overall Study|Lost to Follow-up|3|||
130675733|NCT01521559|470438713|FG001|Overall Study|Lost to Follow-up|1|||
130675734|NCT01521559|470438712|FG000|Overall Study|Protocol Violation|1|||
130675735|NCT01521559|470438713|FG001|Overall Study|Protocol Violation|0|||
130675736|NCT01521559|470438712|FG000|Overall Study|Other|1|||
130675737|NCT01521559|470438713|FG001|Overall Study|Other|2|||
130675738|NCT00275002|470438715|FG000|Overall Study|Death|1|||
130675739|NCT00275002|470438716|FG001|Overall Study|Death|0|||
130675740|NCT00275002|470438715|FG000|Overall Study|Disease progression|21|||
130675741|NCT00275002|470438716|FG001|Overall Study|Disease progression|15|||
130675742|NCT00275002|470438715|FG000|Overall Study|Adverse Event|0|||
130675743|NCT00275002|470438716|FG001|Overall Study|Adverse Event|1|||
130675744|NCT00576381|470438723|FG000|Overall Study|Reoperation|3|||
130675745|NCT00576381|470438723|FG000|Overall Study|Adverse Event|4|||
130675746|NCT01031537|470438727|FG000|Overall Study|medical reasons not related to study|3|||
130675747|NCT01031537|470438727|FG000|Overall Study|Lack of Efficacy|1|||
130675748|NCT01031537|470438727|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
130675749|NCT01031537|470438727|FG000|Overall Study|moved, met exclusion criteria|10|||
130675750|NCT01031537|470438727|FG000|Overall Study|Withdrawal by Subject|5|||
130675751|NCT01031537|470438727|FG000|Overall Study|PI removal, no longer met eligibility|12|||
130675752|NCT01506947|470438731|FG000|Overall Study|Lost to Follow-up|7|||
130675753|NCT01506947|470438731|FG000|Overall Study|Adverse Event|5|||
130675754|NCT01506947|470438731|FG000|Overall Study|Death|1|||
130675755|NCT01506947|470438731|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
130675756|NCT01700621|470438732|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
130675757|NCT01700621|470438733|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
130675758|NCT01700621|470438732|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
130675759|NCT01700621|470438733|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
130675760|NCT01700621|470438732|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
130342022|NCT01451437|469223219|FG003|Overall Study|Protocol Violation|0|||
130342023|NCT01451437|469223220|FG004|Overall Study|Protocol Violation|0|||
130342024|NCT01451437|469223221|FG005|Overall Study|Protocol Violation|0|||
130342025|NCT01451437|469223222|FG006|Overall Study|Protocol Violation|1|||
130342026|NCT01451437|469223223|FG007|Overall Study|Protocol Violation|0|||
130342027|NCT01451437|469223224|FG008|Overall Study|Protocol Violation|0|||
130342028|NCT01451437|469223216|FG000|Overall Study|Withdrawal by Subject|0|||
130342029|NCT01451437|469223217|FG001|Overall Study|Withdrawal by Subject|0|||
130342030|NCT01451437|469223218|FG002|Overall Study|Withdrawal by Subject|0|||
130675761|NCT01700621|470438733|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
130675762|NCT02166697|470438734|FG000|Overall Study|Protocol Violation|347|||
130675763|NCT02720510|470438738|FG000|Overall Study|Study Terminated by the sponsor|2|||
130675764|NCT02720510|470438739|FG001|Overall Study|Study Terminated by the sponsor|0|||
130675765|NCT02720510|470438738|FG000|Overall Study|Adverse Event|0|||
130675766|NCT02720510|470438739|FG001|Overall Study|Adverse Event|1|||
130675767|NCT02720510|470438738|FG000|Overall Study|Physician Decision|1|||
130675768|NCT02720510|470438739|FG001|Overall Study|Physician Decision|2|||
130675769|NCT01618266|470438749|FG000|Overall Study|Lost to Follow-up|9|||
130675770|NCT01618266|470438749|FG000|Overall Study|Treatment satisfaction|10|||
130675771|NCT01618266|470438749|FG000|Overall Study|Other reasons|11|||
130675772|NCT01618266|470438749|FG000|Overall Study|Lack of Efficacy|23|||
130675773|NCT01618266|470438749|FG000|Overall Study|Protocol Violation|43|||
130675774|NCT02985151|470438750|FG000|Original Randomization|Withdrawal by Subject|0|||
130675775|NCT02985151|470438751|FG001|Original Randomization|Withdrawal by Subject|1|||
130675776|NCT03522948|470438760|FG000|Overall Study|Lost to Follow-up|1|||
130675777|NCT00084084|470438761|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
130675778|NCT00084084|470438761|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
130675779|NCT01802879|470438762|FG000|Overall Study|Administrative problems|2|||
130675780|NCT01802879|470438762|FG000|Overall Study|Disease progression|6|||
130675781|NCT01816477|470438767|FG000|Overall Study|Withdrawal by Subject|13|||
130675782|NCT01816477|470438768|FG001|Overall Study|Withdrawal by Subject|1|||
130675783|NCT01816477|470438767|FG000|Overall Study|Unable to tolerate catheter placement|3|||
130675784|NCT01816477|470438768|FG001|Overall Study|Unable to tolerate catheter placement|0|||
130675785|NCT01047345|470438771|FG000|Base Study|Adverse Event|3|||
130675786|NCT01047345|470438772|FG001|Base Study|Adverse Event|0|||
130675787|NCT01047345|470438773|FG002|Base Study|Adverse Event|0|||
130675788|NCT01047345|470438771|FG000|Base Study|Lost to Follow-up|4|||
130675789|NCT01047345|470438772|FG001|Base Study|Lost to Follow-up|1|||
130675790|NCT01047345|470438773|FG002|Base Study|Lost to Follow-up|0|||
130675791|NCT01047345|470438771|FG000|Base Study|Protocol Violation|3|||
130675792|NCT01047345|470438772|FG001|Base Study|Protocol Violation|1|||
130675793|NCT01047345|470438773|FG002|Base Study|Protocol Violation|0|||
130675794|NCT01047345|470438771|FG000|Base Study|Withdrawal by Subject|12|||
130675795|NCT01047345|470438772|FG001|Base Study|Withdrawal by Subject|4|||
130675796|NCT01047345|470438773|FG002|Base Study|Withdrawal by Subject|0|||
130675797|NCT01047345|470438771|FG000|Extension|Withdrawal by Subject|0|||
130675798|NCT01047345|470438772|FG001|Extension|Withdrawal by Subject|0|||
130675799|NCT01047345|470438773|FG002|Extension|Withdrawal by Subject|1|||
130675800|NCT01047345|470438771|FG000|Extension|Lost to Follow-up|0|||
130675801|NCT01047345|470438772|FG001|Extension|Lost to Follow-up|0|||
130675802|NCT01047345|470438773|FG002|Extension|Lost to Follow-up|5|||
130675803|NCT00819247|470438774|FG000|Overall Study|Adverse Event|0|||
130675804|NCT00819247|470438775|FG001|Overall Study|Adverse Event|5|||
130675805|NCT00819247|470438776|FG002|Overall Study|Adverse Event|3|||
130675806|NCT00819247|470438774|FG000|Overall Study|Insufficient testosterone response|5|||
130675807|NCT00819247|470438775|FG001|Overall Study|Insufficient testosterone response|8|||
130675808|NCT00819247|470438776|FG002|Overall Study|Insufficient testosterone response|10|||
130675809|NCT00819247|470438774|FG000|Overall Study|Withdrawal by Subject|1|||
130675810|NCT00819247|470438775|FG001|Overall Study|Withdrawal by Subject|0|||
130675811|NCT00819247|470438776|FG002|Overall Study|Withdrawal by Subject|0|||
130675812|NCT00819247|470438774|FG000|Overall Study|Protocol Violation|1|||
130675813|NCT00819247|470438775|FG001|Overall Study|Protocol Violation|0|||
130675814|NCT00819247|470438776|FG002|Overall Study|Protocol Violation|1|||
130675815|NCT00819247|470438774|FG000|Overall Study|Mistakenly withdrawn|0|||
130675816|NCT00819247|470438775|FG001|Overall Study|Mistakenly withdrawn|1|||
130675817|NCT00819247|470438776|FG002|Overall Study|Mistakenly withdrawn|0|||
130675818|NCT00819247|470438774|FG000|Overall Study|Bad prostate-specific antigen response|3|||
130675819|NCT00819247|470438775|FG001|Overall Study|Bad prostate-specific antigen response|2|||
130675820|NCT00819247|470438776|FG002|Overall Study|Bad prostate-specific antigen response|0|||
130675821|NCT00819247|470438774|FG000|Overall Study|Other|1|||
130675822|NCT00819247|470438775|FG001|Overall Study|Other|0|||
130675823|NCT00819247|470438776|FG002|Overall Study|Other|0|||
130675824|NCT02187042|470438777|FG000|Overall Study|Death|1|||
130675825|NCT02187042|470438778|FG001|Overall Study|Death|1|||
130675826|NCT02187042|470438777|FG000|Overall Study|Toxicity|6|||
130675827|NCT02187042|470438778|FG001|Overall Study|Toxicity|5|||
130675828|NCT02187042|470438777|FG000|Overall Study|Participant choice|1|||
130675829|NCT02187042|470438778|FG001|Overall Study|Participant choice|0|||
130675830|NCT02187042|470438777|FG000|Overall Study|Doctor choice|1|||
130675831|NCT02187042|470438778|FG001|Overall Study|Doctor choice|0|||
130675832|NCT02187042|470438777|FG000|Overall Study|Progressive disease|4|||
130675833|NCT02187042|470438778|FG001|Overall Study|Progressive disease|8|||
130552757|NCT02720536|469991528|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
130675834|NCT00108732|470438779|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
130675835|NCT00108732|470438779|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
130675836|NCT00108732|470438779|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
130675837|NCT00108732|470438779|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
130675838|NCT00108732|470438779|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
130675839|NCT00108732|470438779|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
130675840|NCT00108732|470438779|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
130675841|NCT02116803|470438781|FG000|Overall Study|Adverse Event|2|||
130675842|NCT02116803|470438782|FG001|Overall Study|Adverse Event|1|||
130675843|NCT02116803|470438781|FG000|Overall Study|Physician Decision|1|||
130675844|NCT02116803|470438782|FG001|Overall Study|Physician Decision|0|||
130675845|NCT02116803|470438781|FG000|Overall Study|Progressive disease|4|||
130675846|NCT02116803|470438782|FG001|Overall Study|Progressive disease|0|||
130675847|NCT02116803|470438781|FG000|Overall Study|Study terminated by sponsor|2|||
130675848|NCT02116803|470438782|FG001|Overall Study|Study terminated by sponsor|1|||
130675849|NCT02116803|470438781|FG000|Overall Study|Death|1|||
130675850|NCT02116803|470438782|FG001|Overall Study|Death|0|||
130675851|NCT00698685|470438785|FG000|Overall Study|Sister withdrew as donor|1|||
130675852|NCT00698685|470438785|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
130675853|NCT00282256|470438786|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
130675854|NCT00282256|470438786|FG000|Extension Treatment Period|Adverse Event|2|||
130675855|NCT01457053|470438789|FG000|Overall Study|Unable to undergo selected treatment|1|||
130675856|NCT01457053|470438790|FG001|Overall Study|Unable to undergo selected treatment|1|||
130675857|NCT02626949|470438794|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
130675858|NCT02626949|470438795|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
130675859|NCT02626949|470438794|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
130675860|NCT02626949|470438795|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
130675861|NCT02626949|470438794|FG000|Enrolled|Lost to Follow-up|7|||
130675862|NCT02626949|470438795|FG001|Enrolled|Lost to Follow-up|6|||
130675863|NCT02626949|470438794|FG000|Enrolled|Withdrawal by Subject|3|||
130675864|NCT02626949|470438795|FG001|Enrolled|Withdrawal by Subject|2|||
130675865|NCT00329602|470438797|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
130675866|NCT00329602|470438798|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
130675867|NCT00329602|470438799|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
130675868|NCT00329602|470438797|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
130675869|NCT00329602|470438798|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
130675870|NCT00329602|470438799|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
130675871|NCT00329602|470438797|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
130675872|NCT00329602|470438798|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
130675873|NCT00329602|470438799|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
130675874|NCT00329602|470438797|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
130675875|NCT00329602|470438798|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
130675876|NCT00329602|470438799|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
130675877|NCT00329602|470438797|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
130675878|NCT00329602|470438798|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
130675879|NCT00329602|470438799|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
130675880|NCT00329602|470438797|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
130675881|NCT00329602|470438798|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
130675882|NCT00329602|470438799|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
130675883|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
130675884|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
130675885|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
130675886|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
130675887|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
130675888|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
130675889|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
130675890|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
130675891|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
130675892|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
130675893|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
130675894|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
130675895|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
130675896|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
130675897|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
130675898|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
130675899|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
130675900|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
130675901|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
130675902|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
130675903|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
130675904|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
130720924|NCT00724048|470601562|FG001|Overall Study|Withdrawal by Subject|2|||
130675905|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
130675906|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
130675907|NCT00455533|470438800|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
130675908|NCT00455533|470438801|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
130675909|NCT00455533|470438802|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
130675910|NCT00455533|470438800|FG000|Period Two: Randomized Period|Death|0|||
130675911|NCT00455533|470438801|FG001|Period Two: Randomized Period|Death|0|||
130675912|NCT00455533|470438802|FG002|Period Two: Randomized Period|Death|3|||
130675913|NCT00455533|470438800|FG000|Period Two: Randomized Period|Disease Progression|0|||
130675914|NCT00455533|470438801|FG001|Period Two: Randomized Period|Disease Progression|1|||
130675915|NCT00455533|470438802|FG002|Period Two: Randomized Period|Disease Progression|1|||
130675916|NCT00455533|470438800|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
130675917|NCT00455533|470438801|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
130675918|NCT00455533|470438802|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
130675919|NCT00455533|470438800|FG000|Period Two: Randomized Period|Other - need reasons|0|||
130675920|NCT00455533|470438801|FG001|Period Two: Randomized Period|Other - need reasons|1|||
130675921|NCT00455533|470438802|FG002|Period Two: Randomized Period|Other - need reasons|0|||
130675922|NCT00455533|470438800|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
130675923|NCT00455533|470438801|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
130675924|NCT00455533|470438802|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
130675925|NCT00455533|470438800|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
130675926|NCT00455533|470438801|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
130675927|NCT00455533|470438802|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
130675928|NCT02576990|470438807|FG000|Overall Study|Death|29|||
130675929|NCT02576990|470438808|FG001|Overall Study|Death|18|||
130675930|NCT02576990|470438807|FG000|Overall Study|Physician Decision|1|||
130675931|NCT02576990|470438808|FG001|Overall Study|Physician Decision|0|||
130675932|NCT02576990|470438807|FG000|Overall Study|Screen failure|2|||
130675933|NCT02576990|470438808|FG001|Overall Study|Screen failure|0|||
130675934|NCT02576990|470438807|FG000|Overall Study|Sponsor's decision|24|||
130675935|NCT02576990|470438808|FG001|Overall Study|Sponsor's decision|4|||
130675936|NCT02576990|470438807|FG000|Overall Study|Withdrawal by Subject|0|||
130675937|NCT02576990|470438808|FG001|Overall Study|Withdrawal by Subject|2|||
130675938|NCT02415959|470438809|FG000|Overall Study|Adverse Event|0|||
130675939|NCT02415959|470438810|FG001|Overall Study|Adverse Event|1|||
130675940|NCT02415959|470438811|FG002|Overall Study|Adverse Event|0|||
130675941|NCT02415959|470438812|FG003|Overall Study|Adverse Event|0|||
130675942|NCT02415959|470438813|FG004|Overall Study|Adverse Event|0|||
130675943|NCT02415959|470438809|FG000|Overall Study|Protocol Violation|0|||
130675944|NCT02415959|470438810|FG001|Overall Study|Protocol Violation|0|||
130675945|NCT02415959|470438811|FG002|Overall Study|Protocol Violation|0|||
130675946|NCT02415959|470438812|FG003|Overall Study|Protocol Violation|1|||
130675947|NCT02415959|470438813|FG004|Overall Study|Protocol Violation|0|||
130675948|NCT00911859|470438814|FG000|Treatment Period|Adverse Event|3|||
130675949|NCT00911859|470438815|FG001|Treatment Period|Adverse Event|3|||
130675950|NCT00911859|470438816|FG002|Treatment Period|Adverse Event|7|||
130675951|NCT00911859|470438814|FG000|Treatment Period|Death|1|||
130675952|NCT00911859|470438815|FG001|Treatment Period|Death|3|||
130675953|NCT00911859|470438816|FG002|Treatment Period|Death|5|||
130675954|NCT00911859|470438814|FG000|Treatment Period|Lack of Efficacy|1|||
130675955|NCT00911859|470438815|FG001|Treatment Period|Lack of Efficacy|7|||
130675956|NCT00911859|470438816|FG002|Treatment Period|Lack of Efficacy|5|||
130675957|NCT00911859|470438814|FG000|Treatment Period|Physician Decision|3|||
130675958|NCT00911859|470438815|FG001|Treatment Period|Physician Decision|3|||
130675959|NCT00911859|470438816|FG002|Treatment Period|Physician Decision|3|||
130675960|NCT00911859|470438814|FG000|Treatment Period|Withdrawal by Subject|0|||
130675961|NCT00911859|470438815|FG001|Treatment Period|Withdrawal by Subject|4|||
130675962|NCT00911859|470438816|FG002|Treatment Period|Withdrawal by Subject|5|||
130675963|NCT00911859|470438814|FG000|Treatment Period|Did not receive study treatment|0|||
130675964|NCT00911859|470438815|FG001|Treatment Period|Did not receive study treatment|1|||
130675965|NCT00911859|470438816|FG002|Treatment Period|Did not receive study treatment|0|||
130675966|NCT00911859|470438814|FG000|Maintainance Period|Lack of Efficacy|0|||
130675967|NCT00911859|470438815|FG001|Maintainance Period|Lack of Efficacy|0|||
130675968|NCT00911859|470438816|FG002|Maintainance Period|Lack of Efficacy|9|||
130675969|NCT00911859|470438814|FG000|Maintainance Period|Physician Decision|0|||
130675970|NCT00911859|470438815|FG001|Maintainance Period|Physician Decision|0|||
130675971|NCT00911859|470438816|FG002|Maintainance Period|Physician Decision|9|||
130675972|NCT00911859|470438814|FG000|Maintainance Period|Withdrawal by Subject|0|||
130675973|NCT00911859|470438815|FG001|Maintainance Period|Withdrawal by Subject|0|||
130675974|NCT00911859|470438816|FG002|Maintainance Period|Withdrawal by Subject|3|||
130675975|NCT00911859|470438814|FG000|Follow-up Period|Death|5|||
130675976|NCT00911859|470438815|FG001|Follow-up Period|Death|8|||
130675977|NCT00911859|470438816|FG002|Follow-up Period|Death|10|||
130675978|NCT00911859|470438814|FG000|Follow-up Period|Lost to Follow-up|1|||
130552758|NCT02720536|469991528|FG000|Overall Study|PR - pregnancy|2|||
130675979|NCT00911859|470438815|FG001|Follow-up Period|Lost to Follow-up|1|||
130675980|NCT00911859|470438816|FG002|Follow-up Period|Lost to Follow-up|0|||
130675981|NCT00911859|470438814|FG000|Follow-up Period|Withdrawal by Subject|0|||
130675982|NCT00911859|470438815|FG001|Follow-up Period|Withdrawal by Subject|4|||
130675983|NCT00911859|470438816|FG002|Follow-up Period|Withdrawal by Subject|4|||
130675984|NCT00911859|470438814|FG000|Follow-up Period|Study terminated by sponsor|5|||
130675985|NCT00911859|470438815|FG001|Follow-up Period|Study terminated by sponsor|33|||
130675986|NCT00911859|470438816|FG002|Follow-up Period|Study terminated by sponsor|27|||
130675987|NCT01048333|470438817|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130675988|NCT01048333|470438818|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
130675989|NCT01048333|470438819|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130675990|NCT01048333|470438820|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130675991|NCT01048333|470438821|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130675992|NCT01048333|470438822|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130675993|NCT02456909|470438825|FG000|Overall Study|Did not receive allocated intervention|24|||
130675994|NCT02456909|470438826|FG001|Overall Study|Did not receive allocated intervention|26|||
130675995|NCT02456909|470438825|FG000|Overall Study|Did not complete the primary outcome|0|||
130675996|NCT02456909|470438826|FG001|Overall Study|Did not complete the primary outcome|1|||
130675997|NCT01497938|470438829|FG000|Overall Study|Adverse Event|0|||
130675998|NCT01497938|470438830|FG001|Overall Study|Adverse Event|1|||
130675999|NCT01497938|470438829|FG000|Overall Study|Physician Decision|0|||
130676000|NCT01497938|470438830|FG001|Overall Study|Physician Decision|1|||
130676001|NCT01497938|470438829|FG000|Overall Study|Withdrawal by Subject|4|||
130676002|NCT01497938|470438830|FG001|Overall Study|Withdrawal by Subject|0|||
130676003|NCT01497938|470438829|FG000|Overall Study|Device Violation|1|||
130676004|NCT01497938|470438830|FG001|Overall Study|Device Violation|0|||
130676005|NCT05200858|470438831|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
130676006|NCT05200858|470438832|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
130676007|NCT05200858|470438833|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
130676008|NCT05200858|470438834|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
130676009|NCT01691508|470441055|FG000|Overall Study|Adverse Event|3|||
130676010|NCT01691508|470441056|FG001|Overall Study|Adverse Event|3|||
130676011|NCT01691508|470441055|FG000|Overall Study|Withdrawal by Subject|1|||
130676012|NCT01691508|470441056|FG001|Overall Study|Withdrawal by Subject|0|||
130676013|NCT00623103|470441065|FG000|Overall Study|Adverse Event|70|||
130676014|NCT00623103|470441066|FG001|Overall Study|Adverse Event|60|||
130676015|NCT00623103|470441065|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130676016|NCT00623103|470441066|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
130676017|NCT00623103|470441065|FG000|Overall Study|Withdrawal by Subject|18|||
130676018|NCT00623103|470441066|FG001|Overall Study|Withdrawal by Subject|24|||
130676019|NCT00623103|470441065|FG000|Overall Study|Lost to Follow-up|4|||
130676020|NCT00623103|470441066|FG001|Overall Study|Lost to Follow-up|1|||
130676021|NCT00623103|470441065|FG000|Overall Study|Administrative problems|2|||
130676022|NCT00623103|470441066|FG001|Overall Study|Administrative problems|4|||
130676023|NCT00623103|470441065|FG000|Overall Study|Death|11|||
130676024|NCT00623103|470441066|FG001|Overall Study|Death|11|||
130676025|NCT00623103|470441065|FG000|Overall Study|Protocol deviation|2|||
130676026|NCT00623103|470441066|FG001|Overall Study|Protocol deviation|1|||
130676027|NCT00625807|470441069|FG000|Overall Study|schedule conflict|2|||
130676028|NCT00625807|470441070|FG001|Overall Study|schedule conflict|8|||
130676029|NCT02224391|470441071|FG000|Overall Study|Lost to Follow-up|26|||
130676030|NCT02224391|470441072|FG001|Overall Study|Lost to Follow-up|19|||
130676031|NCT02224391|470441071|FG000|Overall Study|Withdrawal by Subject|6|||
130676032|NCT02224391|470441072|FG001|Overall Study|Withdrawal by Subject|5|||
130676033|NCT01974895|470441073|FG000|Overall Study|Protocol Violation|1|||
130676034|NCT01974895|470441074|FG001|Overall Study|Protocol Violation|0|||
130676035|NCT01974895|470441073|FG000|Overall Study|Lost to Follow-up|4|||
130676036|NCT01974895|470441074|FG001|Overall Study|Lost to Follow-up|6|||
130676037|NCT01974895|470441073|FG000|Overall Study|Withdrawal by Subject|0|||
130676038|NCT01974895|470441074|FG001|Overall Study|Withdrawal by Subject|1|||
130676039|NCT01974895|470441073|FG000|Overall Study|Other (Missed Visit)|1|||
130676040|NCT01974895|470441074|FG001|Overall Study|Other (Missed Visit)|0|||
130676041|NCT01974895|470441073|FG000|Overall Study|Other (Reason unknown)|9|||
130676042|NCT01974895|470441074|FG001|Overall Study|Other (Reason unknown)|8|||
130676043|NCT01984242|470441075|FG000|Overall Study|Death|52|||
130676044|NCT01984242|470441076|FG001|Overall Study|Death|50|||
130676045|NCT01984242|470441077|FG002|Overall Study|Death|52|||
130676046|NCT01984242|470441075|FG000|Overall Study|Withdrawal by Subject|5|||
130676047|NCT01984242|470441076|FG001|Overall Study|Withdrawal by Subject|3|||
130676048|NCT01984242|470441077|FG002|Overall Study|Withdrawal by Subject|10|||
130676049|NCT01984242|470441075|FG000|Overall Study|Physician Decision|0|||
130676050|NCT01984242|470441076|FG001|Overall Study|Physician Decision|0|||
130676051|NCT01984242|470441077|FG002|Overall Study|Physician Decision|1|||
130676052|NCT01984242|470441075|FG000|Overall Study|Lost to Follow-up|4|||
130676053|NCT01984242|470441076|FG001|Overall Study|Lost to Follow-up|0|||
130676054|NCT01984242|470441077|FG002|Overall Study|Lost to Follow-up|3|||
130676055|NCT01984242|470441075|FG000|Overall Study|Sponsor Decision|1|||
130676056|NCT01984242|470441076|FG001|Overall Study|Sponsor Decision|0|||
130676057|NCT01984242|470441077|FG002|Overall Study|Sponsor Decision|0|||
130676058|NCT01984242|470441075|FG000|Overall Study|Non-Compliance|1|||
130676059|NCT01984242|470441076|FG001|Overall Study|Non-Compliance|0|||
130676060|NCT01984242|470441077|FG002|Overall Study|Non-Compliance|0|||
130676061|NCT01984242|470441075|FG000|Overall Study|Study terminated by Sponsor|38|||
130676062|NCT01984242|470441076|FG001|Overall Study|Study terminated by Sponsor|50|||
130676063|NCT01984242|470441077|FG002|Overall Study|Study terminated by Sponsor|34|||
130676064|NCT01984242|470441075|FG000|Overall Study|Disease Progression|0|||
130676065|NCT01984242|470441076|FG001|Overall Study|Disease Progression|0|||
130676066|NCT01984242|470441077|FG002|Overall Study|Disease Progression|1|||
130676067|NCT04543136|470441080|FG000|Overall Study|Withdrawal by Subject|0|||
130676068|NCT04543136|470441081|FG001|Overall Study|Withdrawal by Subject|1|||
130676069|NCT04543136|470441082|FG002|Overall Study|Withdrawal by Subject|0|||
130676070|NCT04543136|470441083|FG003|Overall Study|Withdrawal by Subject|1|||
130676071|NCT04543136|470441084|FG004|Overall Study|Withdrawal by Subject|0|||
130676072|NCT04543136|470441085|FG005|Overall Study|Withdrawal by Subject|0|||
130676073|NCT01626079|470441088|FG000|Overall Study|Death|167|||
130676074|NCT01626079|470441089|FG001|Overall Study|Death|192|||
130676075|NCT01626079|470441090|FG002|Overall Study|Death|39|||
130676076|NCT01626079|470441088|FG000|Overall Study|Withdrawal by Subject|23|||
130676077|NCT01626079|470441089|FG001|Overall Study|Withdrawal by Subject|37|||
130676078|NCT01626079|470441090|FG002|Overall Study|Withdrawal by Subject|5|||
130676079|NCT01626079|470441088|FG000|Overall Study|Lost to Follow-up|7|||
130676080|NCT01626079|470441089|FG001|Overall Study|Lost to Follow-up|4|||
130676081|NCT01626079|470441090|FG002|Overall Study|Lost to Follow-up|2|||
130676082|NCT01626079|470441088|FG000|Overall Study|Missed Visits|1|||
130676083|NCT01626079|470441089|FG001|Overall Study|Missed Visits|4|||
130676084|NCT01626079|470441090|FG002|Overall Study|Missed Visits|6|||
130676085|NCT02430870|470441091|FG000|Part 2|Voluntary Withdrawal|0|||
130676086|NCT02430870|470441092|FG001|Part 2|Voluntary Withdrawal|0|||
130676087|NCT02430870|470441093|FG002|Part 2|Voluntary Withdrawal|0|||
130676088|NCT02430870|470441094|FG003|Part 2|Voluntary Withdrawal|0|||
130676089|NCT02430870|470441095|FG004|Part 2|Voluntary Withdrawal|0|||
130676090|NCT02430870|470441096|FG005|Part 2|Voluntary Withdrawal|0|||
130676091|NCT02430870|470441097|FG006|Part 2|Voluntary Withdrawal|1|||
130676092|NCT02430870|470441098|FG007|Part 2|Voluntary Withdrawal|0|||
130676093|NCT02430870|470441091|FG000|Part 2|Other Reason Not Specified|0|||
130676094|NCT02430870|470441092|FG001|Part 2|Other Reason Not Specified|0|||
130676095|NCT02430870|470441093|FG002|Part 2|Other Reason Not Specified|0|||
130676096|NCT02430870|470441094|FG003|Part 2|Other Reason Not Specified|0|||
130676097|NCT02430870|470441095|FG004|Part 2|Other Reason Not Specified|0|||
130676098|NCT02430870|470441096|FG005|Part 2|Other Reason Not Specified|0|||
130676099|NCT02430870|470441097|FG006|Part 2|Other Reason Not Specified|0|||
130676100|NCT02430870|470441098|FG007|Part 2|Other Reason Not Specified|1|||
130676101|NCT03982433|470441099|FG000|Overall Study|Lost to Follow-up|1|||
130676102|NCT00865709|470441100|FG000|Treatment|Adverse Event|9|||
130676103|NCT00865709|470441101|FG001|Treatment|Adverse Event|6|||
130676104|NCT00865709|470441100|FG000|Treatment|Withdrawal by Subject|10|||
130676105|NCT00865709|470441101|FG001|Treatment|Withdrawal by Subject|7|||
130676106|NCT00865709|470441100|FG000|Treatment|Physician Decision|3|||
130676107|NCT00865709|470441101|FG001|Treatment|Physician Decision|2|||
130676108|NCT00865709|470441100|FG000|Treatment|Surgery|8|||
130676109|NCT00865709|470441101|FG001|Treatment|Surgery|3|||
130676110|NCT00429923|470441102|FG000|Overall Study|Adverse Event|0|||
130676111|NCT00429923|470441103|FG001|Overall Study|Adverse Event|2|||
130676112|NCT00429923|470441104|FG002|Overall Study|Adverse Event|3|||
130676113|NCT00429923|470441102|FG000|Overall Study|Lack of Efficacy|4|||
130676114|NCT00429923|470441103|FG001|Overall Study|Lack of Efficacy|1|||
130676115|NCT00429923|470441104|FG002|Overall Study|Lack of Efficacy|33|||
130676116|NCT00429923|470441102|FG000|Overall Study|Lost to Follow-up|0|||
130676117|NCT00429923|470441103|FG001|Overall Study|Lost to Follow-up|0|||
130676118|NCT00429923|470441104|FG002|Overall Study|Lost to Follow-up|2|||
130676119|NCT00429923|470441102|FG000|Overall Study|Withdrew Consent|1|||
130676120|NCT00429923|470441103|FG001|Overall Study|Withdrew Consent|0|||
130676121|NCT00429923|470441104|FG002|Overall Study|Withdrew Consent|1|||
130676122|NCT00429923|470441102|FG000|Overall Study|Early Termination|0|||
130676123|NCT00429923|470441103|FG001|Overall Study|Early Termination|1|||
130676124|NCT00429923|470441104|FG002|Overall Study|Early Termination|0|||
130676125|NCT03922477|470441107|FG000|Overall Study|Death|9|||
130676126|NCT03922477|470441107|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
130676127|NCT03922477|470441107|FG000|Overall Study|Physician Decision|1|||
130676128|NCT03922477|470441107|FG000|Overall Study|Withdrawal by Subject|2|||
130676129|NCT03387098|470441115|FG000|Overall Study|progressive disease|1|||
130676130|NCT03387098|470441115|FG000|Overall Study|Withdrawal by Subject|2|||
130676131|NCT03387098|470441115|FG000|Overall Study|study terminated by sponsor|1|||
130676132|NCT00662129|470441116|FG000|Overall Study|Protocol Violation|1|||
130676133|NCT00662129|470441116|FG000|Overall Study|Cancel prior to beginning treatment|1|||
130676134|NCT00662129|470441116|FG000|Overall Study|Ineligible|1|||
130676135|NCT02799602|470441118|FG000|Overall Study|Protocol Violation|1|||
130676136|NCT02799602|470441119|FG001|Overall Study|Protocol Violation|0|||
130676137|NCT02799602|470441118|FG000|Overall Study|Physician Decision|5|||
130676138|NCT02799602|470441119|FG001|Overall Study|Physician Decision|6|||
130676139|NCT02799602|470441118|FG000|Overall Study|Lost to Follow-up|4|||
130676140|NCT02799602|470441119|FG001|Overall Study|Lost to Follow-up|2|||
130676141|NCT02799602|470441118|FG000|Overall Study|Additional primary malignancy|11|||
130676142|NCT02799602|470441119|FG001|Overall Study|Additional primary malignancy|6|||
130676143|NCT02799602|470441118|FG000|Overall Study|Non-compliance with study drug|14|||
130676144|NCT02799602|470441119|FG001|Overall Study|Non-compliance with study drug|12|||
130676145|NCT02799602|470441118|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
130676146|NCT02799602|470441119|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
130676147|NCT02799602|470441118|FG000|Overall Study|Withdrawal by Subject|26|||
130676148|NCT02799602|470441119|FG001|Overall Study|Withdrawal by Subject|40|||
130676149|NCT02799602|470441118|FG000|Overall Study|Progressive disease - clinical progression|131|||
130676150|NCT02799602|470441119|FG001|Overall Study|Progressive disease - clinical progression|276|||
130676151|NCT02799602|470441118|FG000|Overall Study|Progressive disease - radiological progression|90|||
130676152|NCT02799602|470441119|FG001|Overall Study|Progressive disease - radiological progression|133|||
130676153|NCT02799602|470441118|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
130676154|NCT02799602|470441119|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
130676155|NCT02799602|470441118|FG000|Overall Study|Death|9|||
130676156|NCT02799602|470441119|FG001|Overall Study|Death|5|||
130676157|NCT02799602|470441118|FG000|Overall Study|Other|287|||
130676158|NCT02799602|470441119|FG001|Overall Study|Other|118|||
130676159|NCT02799602|470441118|FG000|Overall Study|Study drug never administered|0|||
130676160|NCT02799602|470441119|FG001|Overall Study|Study drug never administered|3|||
130676161|NCT03072459|470441124|FG000|Overall Study|Device revised/removed|1|||
130676162|NCT03072459|470441124|FG000|Overall Study|Subject not able to return|1|||
130676163|NCT02275364|470441125|FG000|Period 1|Withdrawal by Subject|1|||
130676164|NCT02275364|470441126|FG001|Period 1|Withdrawal by Subject|0|||
130676165|NCT02275364|470441125|FG000|Period 1|Other reason|1|||
130676166|NCT02275364|470441126|FG001|Period 1|Other reason|0|||
130676167|NCT02579096|470441127|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
130676168|NCT02579096|470441128|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
130676169|NCT02579096|470441127|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
130676170|NCT02579096|470441128|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
130676171|NCT02579096|470441127|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
130676172|NCT02579096|470441128|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
130676173|NCT02579096|470441127|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
130676174|NCT02579096|470441128|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
130676175|NCT02579096|470441127|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
130676176|NCT02579096|470441128|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
130676177|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Death|2|||
130676178|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Death|4|||
130676179|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
130676180|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
130676181|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
130676182|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
130676183|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
130676184|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
130676185|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
130676186|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
130676187|NCT02579096|470441127|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
130676188|NCT02579096|470441128|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
130676189|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Death|3|||
130676190|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Death|2|||
130676191|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
130676192|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
130676193|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
130676194|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
130676195|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
130676196|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
130342031|NCT01451437|469223219|FG003|Overall Study|Withdrawal by Subject|0|||
130342032|NCT01451437|469223220|FG004|Overall Study|Withdrawal by Subject|1|||
130342033|NCT01451437|469223221|FG005|Overall Study|Withdrawal by Subject|0|||
130552759|NCT02720536|469991528|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
130552760|NCT02720536|469991528|FG000|Overall Study|PR - death|1|||
130676197|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
130676198|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
130676199|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
130676200|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
130676201|NCT02579096|470441127|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
130676202|NCT02579096|470441128|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
130676203|NCT02097121|470441133|FG000|Overall Study|Other, not specified|4|||
130676204|NCT02097121|470441134|FG001|Overall Study|Other, not specified|2|||
130676205|NCT02097121|470441135|FG002|Overall Study|Other, not specified|3|||
130676206|NCT02097121|470441133|FG000|Overall Study|Lack of Efficacy|2|||
130676207|NCT02097121|470441134|FG001|Overall Study|Lack of Efficacy|1|||
130676208|NCT02097121|470441135|FG002|Overall Study|Lack of Efficacy|3|||
130676209|NCT02097121|470441133|FG000|Overall Study|Withdrawal by Subject|0|||
130676210|NCT02097121|470441134|FG001|Overall Study|Withdrawal by Subject|1|||
130676211|NCT02097121|470441135|FG002|Overall Study|Withdrawal by Subject|2|||
130676212|NCT02097121|470441133|FG000|Overall Study|Adverse Event|0|||
130676213|NCT02097121|470441134|FG001|Overall Study|Adverse Event|1|||
130676214|NCT02097121|470441135|FG002|Overall Study|Adverse Event|0|||
130676215|NCT02097121|470441133|FG000|Overall Study|Lost to Follow-up|1|||
130676216|NCT02097121|470441134|FG001|Overall Study|Lost to Follow-up|1|||
130676217|NCT02097121|470441135|FG002|Overall Study|Lost to Follow-up|2|||
130676218|NCT03066999|470441136|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
130676219|NCT03066999|470441137|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
130676220|NCT00661999|470441138|FG000|Overall Study|Adverse Event|11|||
130676221|NCT00661999|470441139|FG001|Overall Study|Adverse Event|5|||
130676222|NCT00661999|470441140|FG002|Overall Study|Adverse Event|8|||
130676223|NCT00661999|470441138|FG000|Overall Study|Death|8|||
130676224|NCT00661999|470441139|FG001|Overall Study|Death|6|||
130676225|NCT00661999|470441140|FG002|Overall Study|Death|3|||
130676226|NCT00661999|470441138|FG000|Overall Study|Other Reasons|5|||
130676227|NCT00661999|470441139|FG001|Overall Study|Other Reasons|12|||
130676228|NCT00661999|470441140|FG002|Overall Study|Other Reasons|23|||
130676229|NCT00661999|470441138|FG000|Overall Study|Withdrawal by Subject|30|||
130676230|NCT00661999|470441139|FG001|Overall Study|Withdrawal by Subject|23|||
130676231|NCT00661999|470441140|FG002|Overall Study|Withdrawal by Subject|14|||
130676232|NCT00661999|470441138|FG000|Overall Study|Alternative Treatment|1|||
130676233|NCT00661999|470441139|FG001|Overall Study|Alternative Treatment|0|||
130676234|NCT00661999|470441140|FG002|Overall Study|Alternative Treatment|0|||
130676235|NCT00661999|470441138|FG000|Overall Study|Other Medical Problems|4|||
130676236|NCT00661999|470441139|FG001|Overall Study|Other Medical Problems|4|||
130676237|NCT00661999|470441140|FG002|Overall Study|Other Medical Problems|9|||
130676238|NCT00510510|470441141|FG000|Overall Study|Adverse Event|4|||
130676239|NCT00510510|470441142|FG001|Overall Study|Adverse Event|3|||
130676240|NCT00510510|470441143|FG002|Overall Study|Adverse Event|6|||
130676241|NCT00510510|470441141|FG000|Overall Study|Lack of Efficacy|0|||
130676242|NCT00510510|470441142|FG001|Overall Study|Lack of Efficacy|1|||
130676243|NCT00510510|470441143|FG002|Overall Study|Lack of Efficacy|1|||
130676244|NCT00510510|470441141|FG000|Overall Study|Subjects no longer requires study drug|0|||
130676245|NCT00510510|470441142|FG001|Overall Study|Subjects no longer requires study drug|0|||
130676246|NCT00510510|470441143|FG002|Overall Study|Subjects no longer requires study drug|2|||
130342034|NCT01451437|469223222|FG006|Overall Study|Withdrawal by Subject|1|||
130342035|NCT01451437|469223223|FG007|Overall Study|Withdrawal by Subject|0|||
130342036|NCT01451437|469223224|FG008|Overall Study|Withdrawal by Subject|0|||
130342037|NCT03472547|469223230|FG000|Overall Study|Withdrawal by Subject|30|||
130342038|NCT02043899|469224541|FG000|Overall Study|Adverse Event|3|||
130342039|NCT02043899|469224541|FG000|Overall Study|Physician Decision|1|||
130342040|NCT02043899|469224541|FG000|Overall Study|Withdrawal by Subject|2|||
130342041|NCT02043899|469224541|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
130342042|NCT02043899|469224541|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
130342043|NCT02043899|469224541|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
130342044|NCT02043899|469224541|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
130342045|NCT02043899|469224541|FG000|Overall Study|Treatment delayed|1|||
130342046|NCT01325337|469224542|FG000|Overall Study|Adverse Event|0|||
130676247|NCT00510510|470441141|FG000|Overall Study|Withdrawal by Subject|1|||
130676248|NCT00510510|470441142|FG001|Overall Study|Withdrawal by Subject|2|||
130676249|NCT00510510|470441143|FG002|Overall Study|Withdrawal by Subject|3|||
130342047|NCT01325337|469224543|FG001|Overall Study|Adverse Event|2|||
130342048|NCT01325337|469224544|FG002|Overall Study|Adverse Event|2|||
130342049|NCT01325337|469224545|FG003|Overall Study|Adverse Event|1|||
130342050|NCT01325337|469224546|FG004|Overall Study|Adverse Event|2|||
130342051|NCT01325337|469224542|FG000|Overall Study|Lost to Follow-up|2|||
130342052|NCT01325337|469224543|FG001|Overall Study|Lost to Follow-up|2|||
130676250|NCT00510510|470441141|FG000|Overall Study|Lost to Follow-up|0|||
130676251|NCT00510510|470441142|FG001|Overall Study|Lost to Follow-up|0|||
130676252|NCT00510510|470441143|FG002|Overall Study|Lost to Follow-up|1|||
130676253|NCT00510510|470441141|FG000|Overall Study|Protocol Violation|0|||
130676254|NCT00510510|470441142|FG001|Overall Study|Protocol Violation|3|||
130676255|NCT00510510|470441143|FG002|Overall Study|Protocol Violation|4|||
130676256|NCT03595657|470441144|FG000|Overall Study|Adverse Event|14|||
130676257|NCT03595657|470441144|FG000|Overall Study|Death|1|||
130676258|NCT03595657|470441144|FG000|Overall Study|Lack of Efficacy|40|||
130676259|NCT03595657|470441144|FG000|Overall Study|Withdrawal by Subject|10|||
130676260|NCT03595657|470441144|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
130676261|NCT03595657|470441144|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
130676262|NCT01361126|470441145|FG000|Overall Study|Sponsor decision|0|||
130676263|NCT01361126|470441146|FG001|Overall Study|Sponsor decision|2|||
130676264|NCT00663871|470441148|FG000|Overall Study|Lost to Follow-up|5|||
130676265|NCT00663871|470441149|FG001|Overall Study|Lost to Follow-up|5|||
130676266|NCT00663871|470441148|FG000|Overall Study|Withdrawal by Subject|5|||
130676267|NCT00663871|470441149|FG001|Overall Study|Withdrawal by Subject|2|||
130676268|NCT04094870|470441150|FG000|Overall Study|Lost to Follow-up|1|||
130676269|NCT04094870|470441151|FG001|Overall Study|Lost to Follow-up|1|||
130676270|NCT03384745|470441152|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130676271|NCT03384745|470441153|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130676272|NCT03384745|470441154|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
130676273|NCT03384745|470441155|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
130676274|NCT03384745|470441156|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130676275|NCT03384745|470441157|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130676276|NCT03384745|470441152|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130676277|NCT03384745|470441153|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130676278|NCT03384745|470441154|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130676279|NCT03384745|470441155|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130676280|NCT03384745|470441156|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
130676281|NCT03384745|470441157|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
130676282|NCT03384745|470441152|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130676283|NCT03384745|470441153|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130676284|NCT03384745|470441154|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130676285|NCT03384745|470441155|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130676286|NCT03384745|470441156|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130676287|NCT03384745|470441157|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130676288|NCT03384745|470441152|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130676289|NCT03384745|470441153|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130676290|NCT03384745|470441154|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
130676291|NCT03384745|470441155|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130676292|NCT03384745|470441156|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130676293|NCT03384745|470441157|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130676294|NCT03384745|470441152|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130676295|NCT03384745|470441153|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130676296|NCT03384745|470441154|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130676297|NCT03384745|470441155|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
130676298|NCT03384745|470441156|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
130676299|NCT03384745|470441157|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130676300|NCT03384745|470441152|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130676301|NCT03384745|470441153|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130676302|NCT03384745|470441154|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130676303|NCT03384745|470441155|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130676304|NCT03384745|470441156|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
130676305|NCT03384745|470441157|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130676306|NCT03384745|470441152|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130676307|NCT03384745|470441153|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130676308|NCT03384745|470441154|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
130676309|NCT03384745|470441155|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
130676310|NCT03384745|470441156|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130676311|NCT03384745|470441157|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130676312|NCT03384745|470441152|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130676313|NCT03384745|470441153|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130676314|NCT03384745|470441154|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
130676315|NCT03384745|470441155|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
130676316|NCT03384745|470441156|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130676317|NCT03384745|470441157|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
130676318|NCT03384745|470441152|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
130676319|NCT03384745|470441153|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
130676320|NCT03384745|470441154|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
130676321|NCT03384745|470441155|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
130676322|NCT03384745|470441156|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
130342053|NCT01325337|469224544|FG002|Overall Study|Lost to Follow-up|2|||
130676323|NCT03384745|470441157|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
130676324|NCT03384745|470441152|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130676325|NCT03384745|470441153|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130676326|NCT03384745|470441154|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130676327|NCT03384745|470441155|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
130676328|NCT03384745|470441156|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130676329|NCT03384745|470441157|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130676330|NCT03384745|470441152|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
130676331|NCT03384745|470441153|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
130676332|NCT03384745|470441154|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
130676333|NCT03384745|470441155|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
130676334|NCT03384745|470441156|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
130676335|NCT03384745|470441157|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
130676336|NCT02984683|470441162|FG000|Overall Study|Adverse Event|3|||
130676337|NCT02984683|470441163|FG001|Overall Study|Adverse Event|3|||
130676338|NCT02984683|470441162|FG000|Overall Study|Withdrawal by Subject|1|||
130676339|NCT02984683|470441163|FG001|Overall Study|Withdrawal by Subject|0|||
130676340|NCT02984683|470441162|FG000|Overall Study|Disease progression|7|||
130676341|NCT02984683|470441163|FG001|Overall Study|Disease progression|9|||
130676342|NCT02742181|470441164|FG000|Overall Study|Physician Decision|1|||
130676343|NCT02742181|470441165|FG001|Overall Study|Physician Decision|0|||
130676344|NCT02739984|470441166|FG000|Overall Study|Sponsor Decision|1|||
130676345|NCT02739984|470441167|FG001|Overall Study|Sponsor Decision|0|||
130676346|NCT02739984|470441166|FG000|Overall Study|Withdrawal by Subject|1|||
130676347|NCT02739984|470441167|FG001|Overall Study|Withdrawal by Subject|1|||
130676348|NCT02739984|470441166|FG000|Overall Study|Death|0|||
130676349|NCT02739984|470441167|FG001|Overall Study|Death|1|||
130676350|NCT02739984|470441166|FG000|Overall Study|Lost to Follow-up|3|||
130676351|NCT02739984|470441167|FG001|Overall Study|Lost to Follow-up|0|||
130676352|NCT00634179|470441175|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
130676353|NCT00767325|470441176|FG000|Overall Study|Lack of Efficacy|2|||
130676354|NCT00767325|470441176|FG000|Overall Study|Adverse Event|7|||
130676355|NCT00767325|470441176|FG000|Overall Study|Lost to Follow-up|3|||
130676356|NCT00767325|470441176|FG000|Overall Study|No longer met study criteria|2|||
130676357|NCT00767325|470441176|FG000|Overall Study|Missed visit due to family reasons|1|||
130676358|NCT03538756|470441177|FG000|Long-Term Follow-up|Adverse Event|0|||
130676359|NCT03538756|470441178|FG001|Long-Term Follow-up|Adverse Event|0|||
130676360|NCT03538756|470441179|FG002|Long-Term Follow-up|Adverse Event|6|||
130342054|NCT01325337|469224545|FG003|Overall Study|Lost to Follow-up|1|||
130342055|NCT01325337|469224546|FG004|Overall Study|Lost to Follow-up|2|||
130342056|NCT01325337|469224542|FG000|Overall Study|Personal Reasons|2|||
130342057|NCT01325337|469224543|FG001|Overall Study|Personal Reasons|5|||
130342058|NCT01325337|469224544|FG002|Overall Study|Personal Reasons|4|||
130342059|NCT01325337|469224545|FG003|Overall Study|Personal Reasons|8|||
130342060|NCT01325337|469224546|FG004|Overall Study|Personal Reasons|3|||
130342061|NCT01325337|469224542|FG000|Overall Study|Withdrawal by Subject|1|||
130676361|NCT03538756|470441177|FG000|Long-Term Follow-up|Death|0|||
130676362|NCT03538756|470441178|FG001|Long-Term Follow-up|Death|0|||
130676363|NCT03538756|470441179|FG002|Long-Term Follow-up|Death|1|||
130676364|NCT03538756|470441177|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
130676365|NCT03538756|470441178|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
130676366|NCT03538756|470441179|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
130676367|NCT03538756|470441177|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
130676368|NCT03538756|470441178|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
130676369|NCT03538756|470441179|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
130676370|NCT03538756|470441177|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
130676371|NCT03538756|470441178|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
130676372|NCT03538756|470441179|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
130676373|NCT00752856|470441180|FG000|Overall Study|randomized but did not do viral kinetics|0|||
130676374|NCT00752856|470441181|FG001|Overall Study|randomized but did not do viral kinetics|1|||
130676375|NCT03131999|470441182|FG000|Overall Study|Withdrawal by Subject|0|||
130676376|NCT03131999|470441183|FG001|Overall Study|Withdrawal by Subject|1|||
130676377|NCT02260492|470441184|FG000|Overall Study|Adverse Event|6|||
130676378|NCT02260492|470441185|FG001|Overall Study|Adverse Event|1|||
130676379|NCT02260492|470441186|FG002|Overall Study|Adverse Event|2|||
130676380|NCT02260492|470441184|FG000|Overall Study|Death|0|||
130676381|NCT02260492|470441185|FG001|Overall Study|Death|1|||
130676382|NCT02260492|470441186|FG002|Overall Study|Death|0|||
130342062|NCT01325337|469224543|FG001|Overall Study|Withdrawal by Subject|0|||
130342063|NCT01325337|469224544|FG002|Overall Study|Withdrawal by Subject|1|||
130342064|NCT01325337|469224545|FG003|Overall Study|Withdrawal by Subject|0|||
130676383|NCT02260492|470441184|FG000|Overall Study|Lost to Follow-up|12|||
130676384|NCT02260492|470441185|FG001|Overall Study|Lost to Follow-up|9|||
130676385|NCT02260492|470441186|FG002|Overall Study|Lost to Follow-up|0|||
130676386|NCT02260492|470441184|FG000|Overall Study|Physician Decision|2|||
130676387|NCT02260492|470441185|FG001|Overall Study|Physician Decision|0|||
130676388|NCT02260492|470441186|FG002|Overall Study|Physician Decision|1|||
130676389|NCT02260492|470441184|FG000|Overall Study|Withdrawal by Subject|3|||
130676390|NCT02260492|470441185|FG001|Overall Study|Withdrawal by Subject|2|||
130676391|NCT02260492|470441186|FG002|Overall Study|Withdrawal by Subject|2|||
130676392|NCT00996736|470441192|FG000|Overall Study|Death|1|||
130676393|NCT00996736|470441193|FG001|Overall Study|Death|1|||
130676394|NCT00996736|470441192|FG000|Overall Study|Lost to Follow-up|15|||
130676395|NCT00996736|470441193|FG001|Overall Study|Lost to Follow-up|14|||
130676396|NCT00996736|470441192|FG000|Overall Study|Visit not within 3-month window|5|||
130676397|NCT00996736|470441193|FG001|Overall Study|Visit not within 3-month window|3|||
130676398|NCT02688608|470441194|FG000|Overall Study|Lost to Follow-up|1|||
130676399|NCT00365352|470441195|FG000|Overall Study|Adverse Event|6|||
130676400|NCT00365352|470441196|FG001|Overall Study|Adverse Event|7|||
130676401|NCT00365352|470441197|FG002|Overall Study|Adverse Event|8|||
130676402|NCT00365352|470441195|FG000|Overall Study|Participant Withdrew Consent|8|||
130676403|NCT00365352|470441196|FG001|Overall Study|Participant Withdrew Consent|3|||
130676404|NCT00365352|470441197|FG002|Overall Study|Participant Withdrew Consent|4|||
130676405|NCT00365352|470441195|FG000|Overall Study|Lack of Efficacy|3|||
130676406|NCT00365352|470441196|FG001|Overall Study|Lack of Efficacy|0|||
130676407|NCT00365352|470441197|FG002|Overall Study|Lack of Efficacy|0|||
130676408|NCT00365352|470441195|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
130676409|NCT00365352|470441196|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
130676410|NCT00365352|470441197|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
130676411|NCT00365352|470441195|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
130676412|NCT00365352|470441196|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
130676413|NCT00365352|470441197|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
130676414|NCT00365352|470441195|FG000|Overall Study|Lost to Follow-up|1|||
130676415|NCT00365352|470441196|FG001|Overall Study|Lost to Follow-up|1|||
130676416|NCT00365352|470441197|FG002|Overall Study|Lost to Follow-up|0|||
130676417|NCT00365352|470441195|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
130676418|NCT00365352|470441196|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
130676419|NCT00365352|470441197|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
130676420|NCT00409578|470441202|FG000|Overall Study|Adverse Event|27|||
130676421|NCT00409578|470441203|FG001|Overall Study|Adverse Event|37|||
130676422|NCT00409578|470441204|FG002|Overall Study|Adverse Event|25|||
130676423|NCT00409578|470441205|FG003|Overall Study|Adverse Event|33|||
130676424|NCT00409578|470441202|FG000|Overall Study|Abnormal laboratory value(s)|2|||
130676425|NCT00409578|470441203|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130676426|NCT00409578|470441204|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130676427|NCT00409578|470441205|FG003|Overall Study|Abnormal laboratory value(s)|4|||
130676428|NCT00409578|470441202|FG000|Overall Study|Lack of Efficacy|0|||
130676429|NCT00409578|470441203|FG001|Overall Study|Lack of Efficacy|0|||
130676430|NCT00409578|470441204|FG002|Overall Study|Lack of Efficacy|0|||
130676431|NCT00409578|470441205|FG003|Overall Study|Lack of Efficacy|2|||
130676432|NCT00409578|470441202|FG000|Overall Study|Subject no longer requires study drug|0|||
130676433|NCT00409578|470441203|FG001|Overall Study|Subject no longer requires study drug|0|||
130676434|NCT00409578|470441204|FG002|Overall Study|Subject no longer requires study drug|0|||
130676435|NCT00409578|470441205|FG003|Overall Study|Subject no longer requires study drug|1|||
130676436|NCT00409578|470441202|FG000|Overall Study|Withdrawal by Subject|8|||
130676437|NCT00409578|470441203|FG001|Overall Study|Withdrawal by Subject|15|||
130676438|NCT00409578|470441204|FG002|Overall Study|Withdrawal by Subject|16|||
130676439|NCT00409578|470441205|FG003|Overall Study|Withdrawal by Subject|17|||
130676440|NCT00409578|470441202|FG000|Overall Study|Lost to Follow-up|2|||
130676441|NCT00409578|470441203|FG001|Overall Study|Lost to Follow-up|0|||
130676442|NCT00409578|470441204|FG002|Overall Study|Lost to Follow-up|2|||
130676443|NCT00409578|470441205|FG003|Overall Study|Lost to Follow-up|2|||
130676444|NCT00409578|470441202|FG000|Overall Study|Administrative problems|8|||
130676445|NCT00409578|470441203|FG001|Overall Study|Administrative problems|9|||
130676446|NCT00409578|470441204|FG002|Overall Study|Administrative problems|2|||
130676447|NCT00409578|470441205|FG003|Overall Study|Administrative problems|4|||
130676448|NCT00409578|470441202|FG000|Overall Study|Death|2|||
130676449|NCT00409578|470441203|FG001|Overall Study|Death|4|||
130676450|NCT00409578|470441204|FG002|Overall Study|Death|4|||
130676451|NCT00409578|470441205|FG003|Overall Study|Death|2|||
130676452|NCT00409578|470441202|FG000|Overall Study|Protocol Violation|3|||
130676453|NCT00409578|470441203|FG001|Overall Study|Protocol Violation|2|||
130676454|NCT00409578|470441204|FG002|Overall Study|Protocol Violation|3|||
130676455|NCT00409578|470441205|FG003|Overall Study|Protocol Violation|1|||
130676456|NCT00409578|470441202|FG000|Overall Study|Missing|0|||
130676457|NCT00409578|470441203|FG001|Overall Study|Missing|1|||
130676458|NCT00409578|470441204|FG002|Overall Study|Missing|0|||
130676459|NCT00409578|470441205|FG003|Overall Study|Missing|1|||
130676460|NCT02109133|470441208|FG000|Overall Study|Lost to Follow-up|1|||
130676461|NCT02109133|470441209|FG001|Overall Study|Lost to Follow-up|0|||
130676462|NCT02016300|470443167|FG000|Overall Study|Lost to Follow-up|0|||
130676463|NCT02016300|470443168|FG001|Overall Study|Lost to Follow-up|3|||
130676464|NCT02309099|470443169|FG000|Overall Study|Adverse Event|2|||
130676465|NCT02309099|470443170|FG001|Overall Study|Adverse Event|0|||
130676466|NCT06165744|470443171|FG000|Overall Study|Non device-related adverse event|1|||
130676467|NCT05456529|470443172|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
130676468|NCT05456529|470443172|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
130676469|NCT05456529|470443172|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
130342065|NCT01325337|469224546|FG004|Overall Study|Withdrawal by Subject|1|||
130342066|NCT02184455|469224554|FG000|Overall Study|Lost to Follow-up|1|||
130676470|NCT05456529|470443172|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
130676471|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
130676472|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
130676473|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Physician Decision|2|||
130676474|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
130676475|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
130676476|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
130676477|NCT05456529|470443172|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
130676478|NCT00797108|470443173|FG000|Overall Study|Adverse Event|1|||
130676479|NCT00797108|470443174|FG001|Overall Study|Adverse Event|0|||
130676480|NCT00797108|470443175|FG002|Overall Study|Adverse Event|3|||
130676481|NCT00797108|470443173|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
130676482|NCT00797108|470443174|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
130676483|NCT00797108|470443175|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
130676484|NCT00797108|470443173|FG000|Overall Study|Global Deterioration of Health Status|0|||
130676485|NCT00797108|470443174|FG001|Overall Study|Global Deterioration of Health Status|1|||
130676486|NCT00797108|470443175|FG002|Overall Study|Global Deterioration of Health Status|0|||
130676487|NCT00797108|470443173|FG000|Overall Study|Lack of Efficacy|1|||
130676488|NCT00797108|470443174|FG001|Overall Study|Lack of Efficacy|0|||
130676489|NCT00797108|470443175|FG002|Overall Study|Lack of Efficacy|1|||
130676490|NCT00797108|470443173|FG000|Overall Study|Other|0|||
130676491|NCT00797108|470443174|FG001|Overall Study|Other|0|||
130676492|NCT00797108|470443175|FG002|Overall Study|Other|2|||
130676493|NCT00797108|470443173|FG000|Overall Study|Randomized but not Treated|2|||
130676494|NCT00797108|470443174|FG001|Overall Study|Randomized but not Treated|0|||
130676495|NCT00797108|470443175|FG002|Overall Study|Randomized but not Treated|0|||
130676496|NCT02518113|470443176|FG000|Overall Study|Adverse Event|1|||
130676497|NCT02518113|470443177|FG001|Overall Study|Adverse Event|0|||
130676498|NCT02518113|470443178|FG002|Overall Study|Adverse Event|1|||
130676499|NCT02518113|470443179|FG003|Overall Study|Adverse Event|0|||
130676500|NCT02518113|470443176|FG000|Overall Study|Death|1|||
130676501|NCT02518113|470443177|FG001|Overall Study|Death|2|||
130676502|NCT02518113|470443178|FG002|Overall Study|Death|0|||
130676503|NCT02518113|470443179|FG003|Overall Study|Death|0|||
130676504|NCT02518113|470443176|FG000|Overall Study|Physician Decision|0|||
130676505|NCT02518113|470443177|FG001|Overall Study|Physician Decision|1|||
130676506|NCT02518113|470443178|FG002|Overall Study|Physician Decision|0|||
130676507|NCT02518113|470443179|FG003|Overall Study|Physician Decision|0|||
130676508|NCT02518113|470443176|FG000|Overall Study|Progressive Disease|1|||
130676509|NCT02518113|470443177|FG001|Overall Study|Progressive Disease|2|||
130676510|NCT02518113|470443178|FG002|Overall Study|Progressive Disease|3|||
130676511|NCT02518113|470443179|FG003|Overall Study|Progressive Disease|0|||
130676512|NCT02270736|470443180|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130676513|NCT02270736|470443181|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
130676514|NCT02270736|470443182|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130676515|NCT02270736|470443183|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130676516|NCT02270736|470443184|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130676517|NCT02270736|470443180|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
130676518|NCT02270736|470443181|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130676519|NCT02270736|470443182|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
130676520|NCT02270736|470443183|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130676521|NCT02270736|470443184|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130676522|NCT02270736|470443180|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130676523|NCT02270736|470443181|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
130676524|NCT02270736|470443182|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130676525|NCT02270736|470443183|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130676526|NCT02270736|470443184|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130342067|NCT01347580|469224555|FG000|Overall Study|Withdrawal by Subject|13|||
130676527|NCT02270736|470443180|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130342068|NCT01347580|469224556|FG001|Overall Study|Withdrawal by Subject|23|||
130676528|NCT02270736|470443181|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130676529|NCT02270736|470443182|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
130676530|NCT02270736|470443183|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130676531|NCT02270736|470443184|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130676532|NCT02270736|470443180|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130676533|NCT02270736|470443181|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130676534|NCT02270736|470443182|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130342069|NCT01347580|469224555|FG000|Overall Study|Death|30|||
130676535|NCT02270736|470443183|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
130342070|NCT01347580|469224556|FG001|Overall Study|Death|19|||
130342071|NCT01347580|469224555|FG000|Overall Study|Protocol Violation|10|||
130676536|NCT02270736|470443184|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130676537|NCT02270736|470443180|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130342072|NCT01347580|469224556|FG001|Overall Study|Protocol Violation|7|||
130342073|NCT01347580|469224555|FG000|Overall Study|Lost to Follow-up|3|||
130342074|NCT01347580|469224556|FG001|Overall Study|Lost to Follow-up|1|||
130342075|NCT01347580|469224555|FG000|Overall Study|Had other reason|9|||
130342076|NCT01347580|469224556|FG001|Overall Study|Had other reason|6|||
130342077|NCT01964755|469224559|FG000|Overall Study|Death|2|||
130342078|NCT02894502|469224560|FG000|Baseline|Withdrawal by Subject|24|||
130342079|NCT02894502|469224561|FG001|Baseline|Withdrawal by Subject|31|||
130342080|NCT02894502|469224562|FG002|Baseline|Withdrawal by Subject|36|||
130342081|NCT02894502|469224560|FG000|Baseline|Death|3|||
130342082|NCT02894502|469224561|FG001|Baseline|Death|1|||
130342083|NCT02894502|469224562|FG002|Baseline|Death|9|||
130342084|NCT02894502|469224560|FG000|First Follow up|Withdrawal by Subject|32|||
130342085|NCT02894502|469224561|FG001|First Follow up|Withdrawal by Subject|29|||
130342086|NCT02894502|469224562|FG002|First Follow up|Withdrawal by Subject|37|||
130342087|NCT02894502|469224560|FG000|First Follow up|Death|2|||
130342088|NCT02894502|469224561|FG001|First Follow up|Death|2|||
130676538|NCT02270736|470443181|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130676539|NCT02270736|470443182|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130676540|NCT02270736|470443183|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
130676541|NCT02270736|470443184|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130676542|NCT02270736|470443180|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130676543|NCT02270736|470443181|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130676544|NCT02270736|470443182|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130676545|NCT02270736|470443183|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
130676546|NCT02270736|470443184|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130676547|NCT02270736|470443180|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130676548|NCT02270736|470443181|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130676549|NCT02270736|470443182|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130676550|NCT02270736|470443183|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
130676551|NCT02270736|470443184|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130676552|NCT02270736|470443180|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130676553|NCT02270736|470443181|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130676554|NCT02270736|470443182|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130676555|NCT02270736|470443183|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
130676556|NCT02270736|470443184|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130676557|NCT01631864|470443185|FG000|Overall Study|Withdrawal by Subject|0|||
130676558|NCT01631864|470443186|FG001|Overall Study|Withdrawal by Subject|1|||
130676559|NCT01631864|470443185|FG000|Overall Study|Adverse Event|2|||
130676560|NCT01631864|470443186|FG001|Overall Study|Adverse Event|3|||
130676561|NCT03702621|470443209|FG000|Overall Study|Physician Decision|6|||
130676562|NCT03702621|470443210|FG001|Overall Study|Physician Decision|6|||
130676563|NCT00527423|470443211|FG000|Overall Study|Protocol Violation|1|||
130676564|NCT00527423|470443211|FG000|Overall Study|Adverse Event|5|||
130676565|NCT00527423|470443211|FG000|Overall Study|Physician Decision|4|||
130676566|NCT00527423|470443211|FG000|Overall Study|Withdrawal by Subject|10|||
130676567|NCT00527423|470443211|FG000|Overall Study|Lost to Follow-up|4|||
130676568|NCT00527423|470443211|FG000|Overall Study|OTHER|4|||
130676569|NCT00527423|470443211|FG000|Overall Study|Death|9|||
130676570|NCT03194464|470443213|FG000|Overall Study|data not usable|2|||
130676571|NCT03103100|470443214|FG000|Overall Study|Adverse Event|1|||
130676572|NCT03103100|470443215|FG001|Overall Study|Adverse Event|0|||
130676573|NCT03103100|470443216|FG002|Overall Study|Adverse Event|0|||
130676574|NCT03103100|470443214|FG000|Overall Study|Physician Decision|1|||
130676575|NCT03103100|470443215|FG001|Overall Study|Physician Decision|0|||
130676576|NCT03103100|470443216|FG002|Overall Study|Physician Decision|2|||
130676577|NCT00436007|470443219|FG000|Overall Study|Withdrawal by Subject|5|||
130676578|NCT00436007|470443220|FG001|Overall Study|Withdrawal by Subject|3|||
130342089|NCT02894502|469224562|FG002|First Follow up|Death|3|||
130342090|NCT02894502|469224560|FG000|Second Follow up|Withdrawal by Subject|13|||
130676579|NCT00436007|470443221|FG002|Overall Study|Withdrawal by Subject|4|||
130676580|NCT00436007|470443219|FG000|Overall Study|Lost to Follow-up|14|||
130342091|NCT02894502|469224561|FG001|Second Follow up|Withdrawal by Subject|15|||
130342092|NCT02894502|469224562|FG002|Second Follow up|Withdrawal by Subject|13|||
130342093|NCT02894502|469224560|FG000|Second Follow up|Death|2|||
130676581|NCT00436007|470443220|FG001|Overall Study|Lost to Follow-up|10|||
130676582|NCT00436007|470443221|FG002|Overall Study|Lost to Follow-up|13|||
130676583|NCT00436007|470443219|FG000|Overall Study|Physician Decision|0|||
130676584|NCT00436007|470443220|FG001|Overall Study|Physician Decision|0|||
130342094|NCT02894502|469224561|FG001|Second Follow up|Death|3|||
130676585|NCT00436007|470443221|FG002|Overall Study|Physician Decision|2|||
130676586|NCT00436007|470443219|FG000|Overall Study|Death|0|||
130342095|NCT02894502|469224562|FG002|Second Follow up|Death|1|||
130342096|NCT02894502|469224560|FG000|Third Follow up|Withdrawal by Subject|5|||
130342097|NCT02894502|469224561|FG001|Third Follow up|Withdrawal by Subject|6|||
130342098|NCT02894502|469224562|FG002|Third Follow up|Withdrawal by Subject|3|||
130342099|NCT02894502|469224560|FG000|Third Follow up|Death|1|||
130342100|NCT02894502|469224561|FG001|Third Follow up|Death|1|||
130342101|NCT02894502|469224562|FG002|Third Follow up|Death|0|||
130342102|NCT01332799|469224566|FG000|Overall Study|Insufficient funding|10|||
130342103|NCT01332799|469224567|FG001|Overall Study|Insufficient funding|10|||
130342104|NCT02168387|469224570|FG000|Overall Study|Planned exubation|6|||
130342105|NCT02168387|469224571|FG001|Overall Study|Planned exubation|3|||
130342106|NCT02168387|469224570|FG000|Overall Study|Death|1|||
130342107|NCT02168387|469224571|FG001|Overall Study|Death|0|||
130342108|NCT03467152|469224572|FG000|Overall Study|Adverse Event|4|||
130342109|NCT03467152|469224573|FG001|Overall Study|Adverse Event|5|||
130342110|NCT03467152|469224574|FG002|Overall Study|Adverse Event|0|||
130342111|NCT03467152|469224572|FG000|Overall Study|Subject Choice|1|||
130342112|NCT03467152|469224573|FG001|Overall Study|Subject Choice|3|||
130342113|NCT03467152|469224574|FG002|Overall Study|Subject Choice|0|||
130342114|NCT03467152|469224572|FG000|Overall Study|Lost to Follow-up|1|||
130342115|NCT03467152|469224573|FG001|Overall Study|Lost to Follow-up|0|||
130342116|NCT03467152|469224574|FG002|Overall Study|Lost to Follow-up|0|||
130342117|NCT03467152|469224572|FG000|Overall Study|Withdrawal by Subject|4|||
130342118|NCT03467152|469224573|FG001|Overall Study|Withdrawal by Subject|2|||
130342119|NCT03467152|469224574|FG002|Overall Study|Withdrawal by Subject|0|||
130342120|NCT03467152|469224572|FG000|Overall Study|Others|3|||
130342121|NCT03467152|469224573|FG001|Overall Study|Others|0|||
130342122|NCT03467152|469224574|FG002|Overall Study|Others|0|||
130342123|NCT03467152|469224572|FG000|Overall Study|Not treated|3|||
130342124|NCT03467152|469224573|FG001|Overall Study|Not treated|1|||
130342125|NCT03467152|469224574|FG002|Overall Study|Not treated|6|||
130676587|NCT00436007|470443220|FG001|Overall Study|Death|1|||
130676588|NCT00436007|470443221|FG002|Overall Study|Death|3|||
130676589|NCT00436007|470443219|FG000|Overall Study|Other|0|||
130676590|NCT00436007|470443220|FG001|Overall Study|Other|0|||
130676591|NCT00436007|470443221|FG002|Overall Study|Other|1|||
130676592|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
130676593|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130676594|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
130676595|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
130676596|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130676597|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130676598|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
130676599|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
130676600|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
130676601|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
130676602|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
130676603|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
130676604|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
130676605|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
130676606|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
130676607|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
130676608|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
130676609|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
130676610|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130676611|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130676612|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130676613|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130676614|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130676615|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
130676616|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130676617|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130676618|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130676619|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130676620|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
130676621|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130676622|NCT01957488|470443222|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
130342126|NCT01236547|469224575|FG000|Overall Study|Protocol Violation|0|||
130342127|NCT01236547|469224576|FG001|Overall Study|Protocol Violation|1|||
130342128|NCT01236547|469224577|FG002|Overall Study|Protocol Violation|1|||
130342129|NCT01236547|469224578|FG003|Overall Study|Protocol Violation|6|||
130342130|NCT01236547|469224579|FG004|Overall Study|Protocol Violation|12|||
130342131|NCT00910624|469224581|FG000|Treatment Phase|Adverse Event|2|||
130342132|NCT00910624|469224582|FG001|Treatment Phase|Adverse Event|6|||
130342133|NCT00910624|469224583|FG002|Treatment Phase|Adverse Event|6|||
130342134|NCT00910624|469224584|FG003|Treatment Phase|Adverse Event|0|||
130676623|NCT01957488|470443223|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
130676624|NCT01957488|470443224|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
130342135|NCT00910624|469224581|FG000|Treatment Phase|Treatment Failure|23|||
130342136|NCT00910624|469224582|FG001|Treatment Phase|Treatment Failure|10|||
130342137|NCT00910624|469224583|FG002|Treatment Phase|Treatment Failure|0|||
130342138|NCT00910624|469224584|FG003|Treatment Phase|Treatment Failure|0|||
130342139|NCT00910624|469224581|FG000|Treatment Phase|Lost to Follow-up|0|||
130342140|NCT00910624|469224582|FG001|Treatment Phase|Lost to Follow-up|0|||
130342141|NCT00910624|469224583|FG002|Treatment Phase|Lost to Follow-up|1|||
130342142|NCT00910624|469224584|FG003|Treatment Phase|Lost to Follow-up|0|||
130342143|NCT00910624|469224581|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130342144|NCT00910624|469224582|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130342145|NCT00910624|469224583|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
130342146|NCT00910624|469224584|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
130342147|NCT00910624|469224581|FG000|Treatment Phase|Withdrawal by Subject|2|||
130342148|NCT00910624|469224582|FG001|Treatment Phase|Withdrawal by Subject|1|||
130342149|NCT00910624|469224583|FG002|Treatment Phase|Withdrawal by Subject|0|||
130342150|NCT00910624|469224584|FG003|Treatment Phase|Withdrawal by Subject|0|||
130342151|NCT00910624|469224581|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
130342152|NCT00910624|469224582|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
130342153|NCT00910624|469224583|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
130342154|NCT00910624|469224584|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
130342155|NCT00910624|469224581|FG000|Follow-Up Phase|Adverse Event|0|||
130342156|NCT00910624|469224582|FG001|Follow-Up Phase|Adverse Event|0|||
130342157|NCT00910624|469224583|FG002|Follow-Up Phase|Adverse Event|1|||
130342158|NCT00910624|469224584|FG003|Follow-Up Phase|Adverse Event|0|||
130342159|NCT00910624|469224581|FG000|Follow-Up Phase|Lost to Follow-up|3|||
130342160|NCT00910624|469224582|FG001|Follow-Up Phase|Lost to Follow-up|1|||
130342161|NCT00910624|469224583|FG002|Follow-Up Phase|Lost to Follow-up|2|||
130342162|NCT00910624|469224584|FG003|Follow-Up Phase|Lost to Follow-up|0|||
130342163|NCT00910624|469224581|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
130342164|NCT00910624|469224582|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
130342165|NCT00910624|469224583|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130342166|NCT00910624|469224584|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130342167|NCT00910624|469224581|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
130342168|NCT00910624|469224582|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130342169|NCT00910624|469224583|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
130342170|NCT00910624|469224584|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
130342171|NCT00910624|469224581|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
130342172|NCT00910624|469224582|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342173|NCT00910624|469224583|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342174|NCT00910624|469224584|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342175|NCT00910624|469224581|FG000|Follow-Up Phase|Administrative|0|||
130342176|NCT00910624|469224582|FG001|Follow-Up Phase|Administrative|1|||
130342177|NCT00910624|469224583|FG002|Follow-Up Phase|Administrative|1|||
130342178|NCT00910624|469224584|FG003|Follow-Up Phase|Administrative|0|||
130342179|NCT03005873|469224585|FG000|Overall Study|Prohibited medication use post radnomization|1|||
130342180|NCT03005873|469224586|FG001|Overall Study|Prohibited medication use post radnomization|1|||
130676625|NCT01957488|470443225|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
130676626|NCT01957488|470443226|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
130676627|NCT01957488|470443227|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
130676628|NCT01957488|470443222|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
130676629|NCT01957488|470443223|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
130676630|NCT01957488|470443224|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
130676631|NCT01957488|470443225|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
130676632|NCT01957488|470443226|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
130676633|NCT01957488|470443227|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
130676634|NCT01957488|470443222|FG000|Test Period 2 (2 Weeks)|Other|1|||
130676635|NCT01957488|470443223|FG001|Test Period 2 (2 Weeks)|Other|0|||
130676636|NCT01957488|470443224|FG002|Test Period 2 (2 Weeks)|Other|0|||
130676637|NCT01957488|470443225|FG003|Test Period 2 (2 Weeks)|Other|0|||
130676638|NCT01957488|470443226|FG004|Test Period 2 (2 Weeks)|Other|0|||
130676639|NCT01957488|470443227|FG005|Test Period 2 (2 Weeks)|Other|0|||
130676640|NCT01957488|470443222|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130676641|NCT01957488|470443223|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
130676642|NCT01957488|470443224|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130676643|NCT01957488|470443225|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130676644|NCT01957488|470443226|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130676645|NCT01957488|470443227|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130676646|NCT01957488|470443222|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
130676647|NCT01957488|470443223|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
130342181|NCT03005873|469224587|FG002|Overall Study|Prohibited medication use post radnomization|1|||
130342182|NCT03005873|469224585|FG000|Overall Study|Withdrew consent|0|||
130342183|NCT03005873|469224586|FG001|Overall Study|Withdrew consent|1|||
130342184|NCT03005873|469224587|FG002|Overall Study|Withdrew consent|2|||
130342185|NCT03005873|469224585|FG000|Overall Study|Lost to Follow-up|0|||
130676648|NCT01957488|470443224|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
130676649|NCT01957488|470443225|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
130676650|NCT01957488|470443226|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
130342186|NCT03005873|469224586|FG001|Overall Study|Lost to Follow-up|1|||
130342187|NCT03005873|469224587|FG002|Overall Study|Lost to Follow-up|0|||
130342188|NCT03005873|469224585|FG000|Overall Study|Ineligible post randomization|0|||
130342189|NCT03005873|469224586|FG001|Overall Study|Ineligible post randomization|0|||
130342190|NCT03005873|469224587|FG002|Overall Study|Ineligible post randomization|1|||
130342191|NCT04140227|469224588|FG000|Overall Study|Withdrawal by Subject|26|||
130342192|NCT04140227|469224588|FG000|Overall Study|Lost to Follow-up|8|||
130342193|NCT04140227|469224588|FG000|Overall Study|Adverse Event|8|||
130342194|NCT04140227|469224588|FG000|Overall Study|Death|1|||
130342195|NCT04140227|469224588|FG000|Overall Study|Other|3|||
130342196|NCT04140227|469224588|FG000|Overall Study|Protocol Violation|2|||
130342197|NCT01713933|469224589|FG000|Overall Study|Lost to Follow-up|2|||
130342198|NCT01713933|469224589|FG000|Overall Study|Withdrawal by Subject|3|||
130342199|NCT01713933|469224589|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
130342200|NCT00412373|469224592|FG000|Overall Study|Adverse Event|8|||
130342201|NCT00412373|469224593|FG001|Overall Study|Adverse Event|13|||
130342202|NCT00412373|469224592|FG000|Overall Study|Lack of Efficacy|16|||
130676651|NCT01957488|470443227|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
130676652|NCT01957488|470443222|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130676653|NCT01957488|470443223|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130676654|NCT01957488|470443224|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130676655|NCT01957488|470443225|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130676656|NCT01957488|470443226|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130676657|NCT01957488|470443227|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
130676658|NCT01957488|470443222|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
130676659|NCT01957488|470443223|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130676660|NCT01957488|470443224|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130676661|NCT01957488|470443225|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130342203|NCT00412373|469224593|FG001|Overall Study|Lack of Efficacy|22|||
130342204|NCT00412373|469224592|FG000|Overall Study|Lost to Follow-up|7|||
130342205|NCT00412373|469224593|FG001|Overall Study|Lost to Follow-up|13|||
130342206|NCT00412373|469224592|FG000|Overall Study|Withdrawal by Subject|8|||
130342207|NCT00412373|469224593|FG001|Overall Study|Withdrawal by Subject|27|||
130342208|NCT00412373|469224592|FG000|Overall Study|Other|2|||
130342209|NCT00412373|469224593|FG001|Overall Study|Other|2|||
130342210|NCT01009840|469224596|FG000|Overall Study|Lost to Follow-up|1|||
130342211|NCT01009840|469224596|FG000|Overall Study|Adverse Event|4|||
130342212|NCT01009840|469224596|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
130342213|NCT01009840|469224596|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
130342214|NCT01009840|469224596|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
130342215|NCT04022733|469224597|FG000|Overall Study|conversion to open surgery|3|||
130342216|NCT04022733|469224598|FG001|Overall Study|conversion to open surgery|2|||
130342217|NCT04022733|469224597|FG000|Overall Study|bradycardia|0|||
130342218|NCT04022733|469224598|FG001|Overall Study|bradycardia|1|||
130342219|NCT01104376|469224601|FG000|Overall Study|Withdrawal by Subject|15|||
130342220|NCT01104376|469224601|FG000|Overall Study|Consented but excluded after labs|13|||
130342221|NCT00797966|469224602|FG000|Phase A|Lost to Follow-up|0|||
130342222|NCT00797966|469224603|FG001|Phase A|Lost to Follow-up|0|||
130342223|NCT00797966|469224604|FG002|Phase A|Lost to Follow-up|0|||
130342224|NCT00797966|469224605|FG003|Phase A|Lost to Follow-up|0|||
130342225|NCT00797966|469224606|FG004|Phase A|Lost to Follow-up|33|||
130342226|NCT00797966|469224607|FG005|Phase A|Lost to Follow-up|0|||
130342227|NCT00797966|469224602|FG000|Phase A|Adverse Event|0|||
130342228|NCT00797966|469224603|FG001|Phase A|Adverse Event|0|||
130342229|NCT00797966|469224604|FG002|Phase A|Adverse Event|0|||
130342230|NCT00797966|469224605|FG003|Phase A|Adverse Event|0|||
130342231|NCT00797966|469224606|FG004|Phase A|Adverse Event|46|||
130342232|NCT00797966|469224607|FG005|Phase A|Adverse Event|0|||
130342233|NCT00797966|469224602|FG000|Phase A|Met withdrawal criteria|0|||
130342234|NCT00797966|469224603|FG001|Phase A|Met withdrawal criteria|0|||
130342235|NCT00797966|469224604|FG002|Phase A|Met withdrawal criteria|0|||
130342236|NCT00797966|469224605|FG003|Phase A|Met withdrawal criteria|0|||
130342237|NCT00797966|469224606|FG004|Phase A|Met withdrawal criteria|4|||
130342238|NCT00797966|469224607|FG005|Phase A|Met withdrawal criteria|0|||
130342239|NCT00797966|469224602|FG000|Phase A|Physician Decision|0|||
130342240|NCT00797966|469224603|FG001|Phase A|Physician Decision|0|||
130342241|NCT00797966|469224604|FG002|Phase A|Physician Decision|0|||
130342242|NCT00797966|469224605|FG003|Phase A|Physician Decision|0|||
130342243|NCT00797966|469224606|FG004|Phase A|Physician Decision|13|||
130342244|NCT00797966|469224607|FG005|Phase A|Physician Decision|0|||
130342245|NCT00797966|469224602|FG000|Phase A|Withdrawal by Subject|0|||
130342246|NCT00797966|469224603|FG001|Phase A|Withdrawal by Subject|0|||
130342247|NCT00797966|469224604|FG002|Phase A|Withdrawal by Subject|0|||
130342248|NCT00797966|469224605|FG003|Phase A|Withdrawal by Subject|0|||
130676662|NCT01957488|470443226|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130676663|NCT01957488|470443227|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130676664|NCT01957488|470443222|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130676665|NCT01957488|470443223|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
130676666|NCT01957488|470443224|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130676667|NCT01957488|470443225|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130676668|NCT01957488|470443226|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130676669|NCT01957488|470443227|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130676670|NCT01439165|470443229|FG000|Overall Study|Protocol Violation|3|||
130676671|NCT01439165|470443230|FG001|Overall Study|Protocol Violation|0|||
130676672|NCT01439165|470443229|FG000|Overall Study|Lost to Follow-up|11|||
130676673|NCT01439165|470443230|FG001|Overall Study|Lost to Follow-up|1|||
130676674|NCT01439165|470443229|FG000|Overall Study|Withdrawal by Subject|7|||
130676675|NCT01439165|470443230|FG001|Overall Study|Withdrawal by Subject|1|||
130676676|NCT00810368|470443231|FG000|Overall Study|Lost to Follow-up|4|||
130676677|NCT00810368|470443232|FG001|Overall Study|Lost to Follow-up|2|||
130676678|NCT00810368|470443231|FG000|Overall Study|Lack of Efficacy|2|||
130676679|NCT00810368|470443232|FG001|Overall Study|Lack of Efficacy|0|||
130676680|NCT02433678|470443233|FG000|Overall Study|Lost to Follow-up|1|||
130676681|NCT02433678|470443234|FG001|Overall Study|Lost to Follow-up|2|||
130676682|NCT03365375|470443240|FG000|Overall Study|Withdrawal by Subject|0|||
130676683|NCT03365375|470443241|FG001|Overall Study|Withdrawal by Subject|1|||
130676684|NCT03365375|470443240|FG000|Overall Study|Lost to Follow-up|0|||
130676685|NCT03365375|470443241|FG001|Overall Study|Lost to Follow-up|4|||
130676686|NCT01966042|470443245|FG000|Overall Study|Death|2|||
130676687|NCT00266409|470443247|FG000|Overall Study|Lack of Efficacy|2|||
130676688|NCT00266409|470443248|FG001|Overall Study|Lack of Efficacy|6|||
130676689|NCT00266409|470443249|FG002|Overall Study|Lack of Efficacy|1|||
130676690|NCT00266409|470443250|FG003|Overall Study|Lack of Efficacy|2|||
130676691|NCT00266409|470443247|FG000|Overall Study|Adverse Event|7|||
130676692|NCT00266409|470443248|FG001|Overall Study|Adverse Event|2|||
130676693|NCT00266409|470443249|FG002|Overall Study|Adverse Event|1|||
130676694|NCT00266409|470443250|FG003|Overall Study|Adverse Event|1|||
130676695|NCT00266409|470443247|FG000|Overall Study|Lost to Follow-up|18|||
130676696|NCT00266409|470443248|FG001|Overall Study|Lost to Follow-up|21|||
130676697|NCT00266409|470443249|FG002|Overall Study|Lost to Follow-up|6|||
130676698|NCT00266409|470443250|FG003|Overall Study|Lost to Follow-up|8|||
130676699|NCT00266409|470443247|FG000|Overall Study|Withdrawal by Subject|6|||
130676700|NCT00266409|470443248|FG001|Overall Study|Withdrawal by Subject|10|||
130676701|NCT00266409|470443249|FG002|Overall Study|Withdrawal by Subject|3|||
130676702|NCT00266409|470443250|FG003|Overall Study|Withdrawal by Subject|9|||
130676703|NCT00266409|470443247|FG000|Overall Study|Protocol Violation|5|||
130676704|NCT00266409|470443248|FG001|Overall Study|Protocol Violation|3|||
130676705|NCT00266409|470443249|FG002|Overall Study|Protocol Violation|4|||
130676706|NCT00266409|470443250|FG003|Overall Study|Protocol Violation|2|||
130676707|NCT00266409|470443247|FG000|Overall Study|Other|7|||
130676708|NCT00266409|470443248|FG001|Overall Study|Other|4|||
130676709|NCT00266409|470443249|FG002|Overall Study|Other|2|||
130676710|NCT00266409|470443250|FG003|Overall Study|Other|0|||
130676711|NCT00635154|470443254|FG000|Overall Study|Alternative Treatment|8|||
130676712|NCT00635154|470443254|FG000|Overall Study|Other|4|||
130676713|NCT00635154|470443254|FG000|Overall Study|Still on treatment|21|||
130676714|NCT01399736|470443255|FG000|Overall Study|Withdrawal by Subject|4|||
130676715|NCT01399736|470443256|FG001|Overall Study|Withdrawal by Subject|2|||
130342249|NCT00797966|469224606|FG004|Phase A|Withdrawal by Subject|33|||
130342250|NCT00797966|469224607|FG005|Phase A|Withdrawal by Subject|0|||
130342251|NCT00797966|469224602|FG000|Phase A|Protocol deviation|0|||
130342252|NCT00797966|469224603|FG001|Phase A|Protocol deviation|0|||
130342253|NCT00797966|469224604|FG002|Phase A|Protocol deviation|0|||
130342254|NCT00797966|469224605|FG003|Phase A|Protocol deviation|0|||
130342255|NCT00797966|469224606|FG004|Phase A|Protocol deviation|56|||
130342256|NCT00797966|469224607|FG005|Phase A|Protocol deviation|0|||
130342257|NCT00797966|469224602|FG000|Phase B|Lost to Follow-up|0|||
130342258|NCT00797966|469224603|FG001|Phase B|Lost to Follow-up|1|||
130676716|NCT01399736|470443255|FG000|Overall Study|Lost to Follow-up|0|||
130676717|NCT01399736|470443256|FG001|Overall Study|Lost to Follow-up|2|||
130676718|NCT03500484|470443257|FG000|Overall Study|Adverse Event|2|||
130676719|NCT03500484|470443258|FG001|Overall Study|Adverse Event|0|||
130676720|NCT03500484|470443257|FG000|Overall Study|Physician Decision|1|||
130676721|NCT03500484|470443258|FG001|Overall Study|Physician Decision|0|||
130676722|NCT03500484|470443257|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
130676723|NCT03500484|470443258|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
130676724|NCT02795104|470443259|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
130342259|NCT00797966|469224604|FG002|Phase B|Lost to Follow-up|3|||
130342260|NCT00797966|469224605|FG003|Phase B|Lost to Follow-up|0|||
130342261|NCT00797966|469224606|FG004|Phase B|Lost to Follow-up|0|||
130676725|NCT02795104|470443260|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
130676726|NCT02795104|470443261|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
130676727|NCT02795104|470443259|FG000|Overall Study|Withdrawal by Subject|0|||
130676728|NCT02795104|470443260|FG001|Overall Study|Withdrawal by Subject|2|||
130676729|NCT02795104|470443261|FG002|Overall Study|Withdrawal by Subject|0|||
130676730|NCT02795104|470443259|FG000|Overall Study|Lost to Follow-up|0|||
130676731|NCT02795104|470443260|FG001|Overall Study|Lost to Follow-up|0|||
130676732|NCT02795104|470443261|FG002|Overall Study|Lost to Follow-up|1|||
130676733|NCT00948675|470443262|FG000|Overall Study|Lost to Follow-up|1|||
130676734|NCT00948675|470443263|FG001|Overall Study|Lost to Follow-up|0|||
130676735|NCT00536575|470443266|FG000|Overall Study|Withdrawal by Subject|1|||
130676736|NCT00536575|470443266|FG000|Overall Study|Death|1|||
130676737|NCT00927810|470443270|FG000|Overall Study|Withdrawal by Subject|0|||
130676738|NCT00927810|470443271|FG001|Overall Study|Withdrawal by Subject|3|||
130676739|NCT00927810|470443272|FG002|Overall Study|Withdrawal by Subject|0|||
130676740|NCT00927810|470443273|FG003|Overall Study|Withdrawal by Subject|1|||
130676741|NCT00927810|470443270|FG000|Overall Study|Lost to Follow-up|0|||
130676742|NCT00927810|470443271|FG001|Overall Study|Lost to Follow-up|2|||
130676743|NCT00927810|470443272|FG002|Overall Study|Lost to Follow-up|1|||
130676744|NCT00927810|470443273|FG003|Overall Study|Lost to Follow-up|1|||
130676745|NCT00927810|470443270|FG000|Overall Study|Death|0|||
130676746|NCT00927810|470443271|FG001|Overall Study|Death|2|||
130676747|NCT00927810|470443272|FG002|Overall Study|Death|0|||
130676748|NCT00927810|470443273|FG003|Overall Study|Death|0|||
130676749|NCT00927810|470443270|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130676750|NCT00927810|470443271|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130676751|NCT00927810|470443272|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130676752|NCT00927810|470443273|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130676753|NCT00198029|470443277|FG000|Overall Study|Withdrawal by Subject|4|||
130676754|NCT04128007|470443278|FG000|Overall Study|Withdrawal by Subject|9|||
130676755|NCT04128007|470443279|FG001|Overall Study|Withdrawal by Subject|6|||
130676756|NCT04128007|470443278|FG000|Overall Study|Protocol Violation|1|||
130676757|NCT04128007|470443279|FG001|Overall Study|Protocol Violation|0|||
130676758|NCT04128007|470443278|FG000|Overall Study|Lost to Follow-up|8|||
130676759|NCT04128007|470443279|FG001|Overall Study|Lost to Follow-up|7|||
130676760|NCT04128007|470443278|FG000|Overall Study|Adverse Event|5|||
130676761|NCT04128007|470443279|FG001|Overall Study|Adverse Event|2|||
130676762|NCT04128007|470443278|FG000|Overall Study|Not reported|0|||
130676763|NCT04128007|470443279|FG001|Overall Study|Not reported|2|||
130676764|NCT04117607|470443280|FG000|Overall Study|Early Termination|0|||
130676765|NCT04117607|470443281|FG001|Overall Study|Early Termination|1|||
130676766|NCT04117607|470443282|FG002|Overall Study|Early Termination|0|||
130676767|NCT04117607|470443283|FG003|Overall Study|Early Termination|0|||
130676768|NCT04117607|470443284|FG004|Overall Study|Early Termination|0|||
130676769|NCT04117607|470443285|FG005|Overall Study|Early Termination|0|||
130676770|NCT04117607|470443286|FG006|Overall Study|Early Termination|1|||
130676771|NCT04117607|470443287|FG007|Overall Study|Early Termination|0|||
130676772|NCT04117607|470443288|FG008|Overall Study|Early Termination|0|||
130676773|NCT04117607|470443289|FG009|Overall Study|Early Termination|0|||
130676774|NCT04117607|470443290|FG010|Overall Study|Early Termination|0|||
130676775|NCT04117607|470443291|FG011|Overall Study|Early Termination|0|||
130676776|NCT04117607|470443292|FG012|Overall Study|Early Termination|0|||
130676777|NCT04117607|470443293|FG013|Overall Study|Early Termination|0|||
130676778|NCT00814463|470443295|FG000|Overall Study|Lost to Follow-up|1|||
130676779|NCT01265784|470443299|FG000|Overall Study|Lost to Follow-up|5|||
130676780|NCT01265784|470443300|FG001|Overall Study|Lost to Follow-up|3|||
130676781|NCT01265784|470443301|FG002|Overall Study|Lost to Follow-up|2|||
130342262|NCT00797966|469224607|FG005|Phase B|Lost to Follow-up|0|||
130676782|NCT01265784|470443299|FG000|Overall Study|Withdrawal by Subject|0|||
130676783|NCT01265784|470443300|FG001|Overall Study|Withdrawal by Subject|5|||
130676784|NCT01265784|470443301|FG002|Overall Study|Withdrawal by Subject|0|||
130676785|NCT01265784|470443299|FG000|Overall Study|Physician Decision|1|||
130342263|NCT00797966|469224602|FG000|Phase B|Adverse Event|2|||
130342264|NCT00797966|469224603|FG001|Phase B|Adverse Event|1|||
130342265|NCT00797966|469224604|FG002|Phase B|Adverse Event|3|||
130676786|NCT01265784|470443300|FG001|Overall Study|Physician Decision|0|||
130676787|NCT01265784|470443301|FG002|Overall Study|Physician Decision|1|||
130676788|NCT01265784|470443299|FG000|Overall Study|Adverse Event|1|||
130676789|NCT01265784|470443300|FG001|Overall Study|Adverse Event|0|||
130676790|NCT01265784|470443301|FG002|Overall Study|Adverse Event|0|||
130676791|NCT01265784|470443299|FG000|Overall Study|Death|3|||
130676792|NCT01265784|470443300|FG001|Overall Study|Death|0|||
130676793|NCT01265784|470443301|FG002|Overall Study|Death|0|||
130676794|NCT01265784|470443299|FG000|Overall Study|Protocol Violation|2|||
130676795|NCT01265784|470443300|FG001|Overall Study|Protocol Violation|0|||
130676796|NCT01265784|470443301|FG002|Overall Study|Protocol Violation|0|||
130676797|NCT01265784|470443299|FG000|Overall Study|Incorrectly Randomized|0|||
130676798|NCT01265784|470443300|FG001|Overall Study|Incorrectly Randomized|0|||
130676799|NCT01265784|470443301|FG002|Overall Study|Incorrectly Randomized|1|||
130676800|NCT00984295|470443306|FG000|Overall Study|Lost to Follow-up|31|||
130676801|NCT00984295|470443307|FG001|Overall Study|Lost to Follow-up|12|||
130676802|NCT00984295|470443308|FG002|Overall Study|Lost to Follow-up|13|||
130342266|NCT00797966|469224605|FG003|Phase B|Adverse Event|1|||
130342267|NCT00797966|469224606|FG004|Phase B|Adverse Event|0|||
130342268|NCT00797966|469224607|FG005|Phase B|Adverse Event|0|||
130342269|NCT00797966|469224602|FG000|Phase B|Met Withdrawal Criteria|3|||
130342270|NCT00797966|469224603|FG001|Phase B|Met Withdrawal Criteria|3|||
130342271|NCT00797966|469224604|FG002|Phase B|Met Withdrawal Criteria|6|||
130342272|NCT00797966|469224605|FG003|Phase B|Met Withdrawal Criteria|1|||
130342273|NCT00797966|469224606|FG004|Phase B|Met Withdrawal Criteria|0|||
130342274|NCT00797966|469224607|FG005|Phase B|Met Withdrawal Criteria|0|||
130342275|NCT00797966|469224602|FG000|Phase B|Physician Decision|1|||
130342276|NCT00797966|469224603|FG001|Phase B|Physician Decision|0|||
130342277|NCT00797966|469224604|FG002|Phase B|Physician Decision|3|||
130342278|NCT00797966|469224605|FG003|Phase B|Physician Decision|1|||
130676803|NCT00984295|470443306|FG000|Overall Study|Protocol Violation|2|||
130676804|NCT00984295|470443307|FG001|Overall Study|Protocol Violation|1|||
130676805|NCT00984295|470443308|FG002|Overall Study|Protocol Violation|4|||
130676806|NCT00984295|470443306|FG000|Overall Study|Withdrawal by Subject|18|||
130676807|NCT00984295|470443307|FG001|Overall Study|Withdrawal by Subject|9|||
130676808|NCT00984295|470443308|FG002|Overall Study|Withdrawal by Subject|12|||
130676809|NCT00984295|470443306|FG000|Overall Study|CAE - discontinued test vaccine|0|||
130676810|NCT00984295|470443307|FG001|Overall Study|CAE - discontinued test vaccine|1|||
130676811|NCT00984295|470443308|FG002|Overall Study|CAE - discontinued test vaccine|3|||
130676812|NCT00984295|470443306|FG000|Overall Study|Missed one or more blood samplings|3|||
130676813|NCT00984295|470443307|FG001|Overall Study|Missed one or more blood samplings|7|||
130676814|NCT00984295|470443308|FG002|Overall Study|Missed one or more blood samplings|2|||
130676815|NCT00984295|470443306|FG000|Overall Study|Incomplete safety follow-up|11|||
130676816|NCT00984295|470443307|FG001|Overall Study|Incomplete safety follow-up|2|||
130676817|NCT00984295|470443308|FG002|Overall Study|Incomplete safety follow-up|3|||
130676818|NCT04799158|470443309|FG000|Run-In Period|Adverse Event|6|||
130676819|NCT04799158|470443310|FG001|Run-In Period|Adverse Event|0|||
130676820|NCT04799158|470443311|FG002|Run-In Period|Adverse Event|0|||
130676821|NCT04799158|470443312|FG003|Run-In Period|Adverse Event|0|||
130676822|NCT04799158|470443313|FG004|Run-In Period|Adverse Event|0|||
130676823|NCT04799158|470443309|FG000|Run-In Period|Lost to Follow-up|4|||
130676824|NCT04799158|470443310|FG001|Run-In Period|Lost to Follow-up|0|||
130676825|NCT04799158|470443311|FG002|Run-In Period|Lost to Follow-up|0|||
130676826|NCT04799158|470443312|FG003|Run-In Period|Lost to Follow-up|0|||
130676827|NCT04799158|470443313|FG004|Run-In Period|Lost to Follow-up|0|||
130676828|NCT04799158|470443309|FG000|Run-In Period|Significant Protocol Deviation|1|||
130676829|NCT04799158|470443310|FG001|Run-In Period|Significant Protocol Deviation|0|||
130676830|NCT04799158|470443311|FG002|Run-In Period|Significant Protocol Deviation|0|||
130676831|NCT04799158|470443312|FG003|Run-In Period|Significant Protocol Deviation|0|||
130676832|NCT04799158|470443313|FG004|Run-In Period|Significant Protocol Deviation|0|||
130676833|NCT04799158|470443309|FG000|Run-In Period|Withdrawal by Subject|11|||
130676834|NCT04799158|470443310|FG001|Run-In Period|Withdrawal by Subject|0|||
130676835|NCT04799158|470443311|FG002|Run-In Period|Withdrawal by Subject|0|||
130676836|NCT04799158|470443312|FG003|Run-In Period|Withdrawal by Subject|0|||
130676837|NCT04799158|470443313|FG004|Run-In Period|Withdrawal by Subject|0|||
130676838|NCT04799158|470443309|FG000|Run-In Period|Miscellaneous|3|||
130676839|NCT04799158|470443310|FG001|Run-In Period|Miscellaneous|0|||
130676840|NCT04799158|470443311|FG002|Run-In Period|Miscellaneous|0|||
130676841|NCT04799158|470443312|FG003|Run-In Period|Miscellaneous|0|||
130676842|NCT04799158|470443313|FG004|Run-In Period|Miscellaneous|0|||
130676843|NCT04799158|470443309|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
130676844|NCT04799158|470443310|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
130676845|NCT04799158|470443311|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
130676846|NCT04799158|470443312|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
130676847|NCT04799158|470443313|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
130676848|NCT04799158|470443309|FG000|On-Demand Treatment Period|Adverse Event|0|||
130676849|NCT04799158|470443310|FG001|On-Demand Treatment Period|Adverse Event|1|||
130676850|NCT04799158|470443311|FG002|On-Demand Treatment Period|Adverse Event|0|||
130342279|NCT00797966|469224606|FG004|Phase B|Physician Decision|0|||
130676851|NCT04799158|470443312|FG003|On-Demand Treatment Period|Adverse Event|0|||
130676852|NCT04799158|470443313|FG004|On-Demand Treatment Period|Adverse Event|1|||
130676853|NCT04799158|470443309|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
130676854|NCT04799158|470443310|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
130676855|NCT04799158|470443311|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
130676856|NCT04799158|470443312|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
130676857|NCT04799158|470443313|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
130676858|NCT04799158|470443309|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130676859|NCT04799158|470443310|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130676860|NCT04799158|470443311|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130342280|NCT00797966|469224607|FG005|Phase B|Physician Decision|0|||
130342281|NCT00797966|469224602|FG000|Phase B|Withdrawal by Subject|1|||
130342282|NCT00797966|469224603|FG001|Phase B|Withdrawal by Subject|4|||
130342283|NCT00797966|469224604|FG002|Phase B|Withdrawal by Subject|3|||
130676861|NCT04799158|470443312|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
130676862|NCT04799158|470443313|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130676863|NCT04799158|470443309|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
130676864|NCT04799158|470443310|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
130676865|NCT04799158|470443311|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
130676866|NCT04799158|470443312|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
130676867|NCT04799158|470443313|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
130676868|NCT04799158|470443309|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
130676869|NCT04799158|470443310|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
130676870|NCT04799158|470443311|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
130676871|NCT04799158|470443312|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
130676872|NCT04799158|470443313|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
130676873|NCT04799158|470443309|FG000|On-Demand Treatment Period|Miscellaneous|0|||
130676874|NCT04799158|470443310|FG001|On-Demand Treatment Period|Miscellaneous|0|||
130676875|NCT04799158|470443311|FG002|On-Demand Treatment Period|Miscellaneous|0|||
130676876|NCT04799158|470443312|FG003|On-Demand Treatment Period|Miscellaneous|0|||
130676877|NCT04799158|470443313|FG004|On-Demand Treatment Period|Miscellaneous|1|||
130676878|NCT00788957|470443314|FG000|Part 1|Death|8|||
130676879|NCT00788957|470443315|FG001|Part 1|Death|0|||
130676880|NCT00788957|470443316|FG002|Part 1|Death|0|||
130676881|NCT00788957|470443317|FG003|Part 1|Death|0|||
130676882|NCT00788957|470443318|FG004|Part 1|Death|0|||
130676883|NCT00788957|470443319|FG005|Part 1|Death|0|||
130676884|NCT00788957|470443314|FG000|Part 1|Lost to Follow-up|1|||
130676885|NCT00788957|470443315|FG001|Part 1|Lost to Follow-up|0|||
130342284|NCT00797966|469224605|FG003|Phase B|Withdrawal by Subject|3|||
130342285|NCT00797966|469224606|FG004|Phase B|Withdrawal by Subject|0|||
130342286|NCT00797966|469224607|FG005|Phase B|Withdrawal by Subject|0|||
130342287|NCT00797966|469224602|FG000|Phase B|Protocol Deviation|4|||
130342288|NCT00797966|469224603|FG001|Phase B|Protocol Deviation|8|||
130342289|NCT00797966|469224604|FG002|Phase B|Protocol Deviation|2|||
130342290|NCT00797966|469224605|FG003|Phase B|Protocol Deviation|6|||
130342291|NCT00797966|469224606|FG004|Phase B|Protocol Deviation|0|||
130342292|NCT00797966|469224607|FG005|Phase B|Protocol Deviation|0|||
130342293|NCT00797966|469224602|FG000|Phase B|Lack of Efficacy|0|||
130342294|NCT00797966|469224603|FG001|Phase B|Lack of Efficacy|1|||
130342295|NCT00797966|469224604|FG002|Phase B|Lack of Efficacy|1|||
130342296|NCT00797966|469224605|FG003|Phase B|Lack of Efficacy|4|||
130342297|NCT00797966|469224606|FG004|Phase B|Lack of Efficacy|0|||
130342298|NCT00797966|469224607|FG005|Phase B|Lack of Efficacy|0|||
130342299|NCT00797966|469224602|FG000|Phase A+|Lost to Follow-up|0|||
130342300|NCT00797966|469224603|FG001|Phase A+|Lost to Follow-up|0|||
130342301|NCT00797966|469224604|FG002|Phase A+|Lost to Follow-up|0|||
130342302|NCT00797966|469224605|FG003|Phase A+|Lost to Follow-up|0|||
130342303|NCT00797966|469224606|FG004|Phase A+|Lost to Follow-up|0|||
130342304|NCT00797966|469224607|FG005|Phase A+|Lost to Follow-up|9|||
130342305|NCT00797966|469224602|FG000|Phase A+|Met withdrawal criteria|0|||
130342306|NCT00797966|469224603|FG001|Phase A+|Met withdrawal criteria|0|||
130342307|NCT00797966|469224604|FG002|Phase A+|Met withdrawal criteria|0|||
130342308|NCT00797966|469224605|FG003|Phase A+|Met withdrawal criteria|0|||
130342309|NCT00797966|469224606|FG004|Phase A+|Met withdrawal criteria|0|||
130342310|NCT00797966|469224607|FG005|Phase A+|Met withdrawal criteria|5|||
130342311|NCT00797966|469224602|FG000|Phase A+|Withdrawal by Subject|0|||
130342312|NCT00797966|469224603|FG001|Phase A+|Withdrawal by Subject|0|||
130342313|NCT00797966|469224604|FG002|Phase A+|Withdrawal by Subject|0|||
130342314|NCT00797966|469224605|FG003|Phase A+|Withdrawal by Subject|0|||
130342315|NCT00797966|469224606|FG004|Phase A+|Withdrawal by Subject|0|||
130342316|NCT00797966|469224607|FG005|Phase A+|Withdrawal by Subject|6|||
130342317|NCT00797966|469224602|FG000|Phase A+|Adverse Event|0|||
130342318|NCT00797966|469224603|FG001|Phase A+|Adverse Event|0|||
130342319|NCT00797966|469224604|FG002|Phase A+|Adverse Event|0|||
130342320|NCT00797966|469224605|FG003|Phase A+|Adverse Event|0|||
130676886|NCT00788957|470443316|FG002|Part 1|Lost to Follow-up|0|||
130676887|NCT00788957|470443317|FG003|Part 1|Lost to Follow-up|0|||
130342321|NCT00797966|469224606|FG004|Phase A+|Adverse Event|0|||
130676888|NCT00788957|470443318|FG004|Part 1|Lost to Follow-up|0|||
130216591|NCT03762681|468755610|FG007|Part 2a|Pandemic Travel Restrictions|1|||
130342322|NCT00797966|469224607|FG005|Phase A+|Adverse Event|4|||
130342323|NCT00797966|469224602|FG000|Phase A+|Protocol deviation|0|||
130342324|NCT00797966|469224603|FG001|Phase A+|Protocol deviation|0|||
130342325|NCT00797966|469224604|FG002|Phase A+|Protocol deviation|0|||
130342326|NCT00797966|469224605|FG003|Phase A+|Protocol deviation|0|||
130342327|NCT00797966|469224606|FG004|Phase A+|Protocol deviation|0|||
130342328|NCT00797966|469224607|FG005|Phase A+|Protocol deviation|4|||
130342329|NCT01883453|469224613|FG000|Overall Study|No episode of common cold|25|||
130676889|NCT00788957|470443319|FG005|Part 1|Lost to Follow-up|0|||
130676890|NCT00788957|470443314|FG000|Part 2|Withdrawal by Subject|0|||
130676891|NCT00788957|470443315|FG001|Part 2|Withdrawal by Subject|9|||
130676892|NCT00788957|470443316|FG002|Part 2|Withdrawal by Subject|5|||
130342330|NCT01883453|469224614|FG001|Overall Study|No episode of common cold|23|||
130342331|NCT00913458|469224617|FG000|Phase 1|Non-Responder|54|||
130676893|NCT00788957|470443317|FG003|Part 2|Withdrawal by Subject|3|||
130676894|NCT00788957|470443318|FG004|Part 2|Withdrawal by Subject|0|||
130676895|NCT00788957|470443319|FG005|Part 2|Withdrawal by Subject|0|||
130676896|NCT00788957|470443314|FG000|Part 2|Death|0|||
130676897|NCT00788957|470443315|FG001|Part 2|Death|32|||
130676898|NCT00788957|470443316|FG002|Part 2|Death|35|||
130676899|NCT00788957|470443317|FG003|Part 2|Death|37|||
130676900|NCT00788957|470443318|FG004|Part 2|Death|0|||
130676901|NCT00788957|470443319|FG005|Part 2|Death|0|||
130676902|NCT00788957|470443314|FG000|Part 2|Lost to Follow-up|0|||
130676903|NCT00788957|470443315|FG001|Part 2|Lost to Follow-up|0|||
130676904|NCT00788957|470443316|FG002|Part 2|Lost to Follow-up|3|||
130676905|NCT00788957|470443317|FG003|Part 2|Lost to Follow-up|0|||
130676906|NCT00788957|470443318|FG004|Part 2|Lost to Follow-up|0|||
130676907|NCT00788957|470443319|FG005|Part 2|Lost to Follow-up|0|||
130676908|NCT00788957|470443314|FG000|Part 2|On-study at time of data cut-off|0|||
130676909|NCT00788957|470443315|FG001|Part 2|On-study at time of data cut-off|1|||
130676910|NCT00788957|470443316|FG002|Part 2|On-study at time of data cut-off|1|||
130676911|NCT00788957|470443317|FG003|Part 2|On-study at time of data cut-off|1|||
130676912|NCT00788957|470443318|FG004|Part 2|On-study at time of data cut-off|0|||
130676913|NCT00788957|470443319|FG005|Part 2|On-study at time of data cut-off|0|||
130676914|NCT00788957|470443314|FG000|Part 3|Withdrawal by Subject|0|||
130676915|NCT00788957|470443315|FG001|Part 3|Withdrawal by Subject|0|||
130676916|NCT00788957|470443316|FG002|Part 3|Withdrawal by Subject|0|||
130676917|NCT00788957|470443317|FG003|Part 3|Withdrawal by Subject|0|||
130676918|NCT00788957|470443318|FG004|Part 3|Withdrawal by Subject|0|||
130676919|NCT00788957|470443319|FG005|Part 3|Withdrawal by Subject|2|||
130676920|NCT00788957|470443314|FG000|Part 3|Death|0|||
130676921|NCT00788957|470443315|FG001|Part 3|Death|0|||
130676922|NCT00788957|470443316|FG002|Part 3|Death|0|||
130676923|NCT00788957|470443317|FG003|Part 3|Death|0|||
130676924|NCT00788957|470443318|FG004|Part 3|Death|8|||
130676925|NCT00788957|470443319|FG005|Part 3|Death|8|||
130676926|NCT00788957|470443314|FG000|Part 3|On-study at time of data cut-off|0|||
130676927|NCT00788957|470443315|FG001|Part 3|On-study at time of data cut-off|0|||
130676928|NCT00788957|470443316|FG002|Part 3|On-study at time of data cut-off|0|||
130676929|NCT00788957|470443317|FG003|Part 3|On-study at time of data cut-off|0|||
130676930|NCT00788957|470443318|FG004|Part 3|On-study at time of data cut-off|1|||
130342332|NCT00913458|469224618|FG001|Phase 1|Non-Responder|0|||
130342333|NCT00913458|469224619|FG002|Phase 1|Non-Responder|0|||
130342334|NCT00913458|469224620|FG003|Phase 1|Non-Responder|0|||
130342335|NCT00913458|469224621|FG004|Phase 1|Non-Responder|0|||
130342336|NCT00913458|469224622|FG005|Phase 1|Non-Responder|0|||
130342337|NCT00913458|469224623|FG006|Phase 1|Non-Responder|0|||
130676931|NCT00788957|470443319|FG005|Part 3|On-study at time of data cut-off|0|||
130676932|NCT03276975|470443320|FG000|Overall Study|Withdrawal by Subject|1|||
130676933|NCT03276975|470443321|FG001|Overall Study|Withdrawal by Subject|0|||
130676934|NCT00918567|470443324|FG000|Overall Study|Lack of Efficacy|3|||
130676935|NCT00918567|470443325|FG001|Overall Study|Lack of Efficacy|1|||
130676936|NCT00918567|470443324|FG000|Overall Study|Withdrawal by Subject|1|||
130676937|NCT00918567|470443325|FG001|Overall Study|Withdrawal by Subject|1|||
130676938|NCT00918567|470443324|FG000|Overall Study|Adverse Event|1|||
130676939|NCT00918567|470443325|FG001|Overall Study|Adverse Event|0|||
130676940|NCT02153736|470443330|FG000|Overall Study|Lost to Follow-up|1|||
130676941|NCT02153736|470443331|FG001|Overall Study|Lost to Follow-up|0|||
130676942|NCT02153736|470443330|FG000|Overall Study|Medical status change made ineligible|1|||
130676943|NCT02153736|470443331|FG001|Overall Study|Medical status change made ineligible|0|||
130676944|NCT02153736|470443330|FG000|Overall Study|Death|0|||
130676945|NCT02153736|470443331|FG001|Overall Study|Death|1|||
130676946|NCT02153736|470443330|FG000|Overall Study|Withdrawal by Subject|0|||
130676947|NCT02153736|470443331|FG001|Overall Study|Withdrawal by Subject|1|||
130676948|NCT02568384|470443336|FG000|Overall Study|Mobile devices incompatible with App|2|||
130676949|NCT01485536|470443337|FG000|Overall Study|Withdrawal by Subject|3|||
130676950|NCT01485536|470443337|FG000|Overall Study|Adverse Event|1|||
130676951|NCT00796510|470443338|FG000|Overall Study|Death|1|||
130676952|NCT00796510|470443339|FG001|Overall Study|Death|0|||
130676953|NCT00796510|470443338|FG000|Overall Study|Study Terminated|2|||
130676954|NCT00796510|470443339|FG001|Overall Study|Study Terminated|0|||
130676955|NCT00720122|470443343|FG000|Overall Study|Lost to Follow-up|1|||
130676956|NCT00720122|470443343|FG000|Overall Study|Physician Decision|1|||
130676957|NCT00720122|470443343|FG000|Overall Study|Withdrawal by Subject|7|||
130676958|NCT03008460|470443344|FG000|Overall Study|Protocol deviation|0|||
130342338|NCT00913458|469224617|FG000|Phase 1|Subject Request|17|||
130342339|NCT00913458|469224618|FG001|Phase 1|Subject Request|0|||
130676959|NCT03008460|470443345|FG001|Overall Study|Protocol deviation|2|||
130676960|NCT03008460|470443344|FG000|Overall Study|Study drug not dispensed|0|||
130676961|NCT03008460|470443345|FG001|Overall Study|Study drug not dispensed|1|||
130676962|NCT03008460|470443344|FG000|Overall Study|Adverse Event|0|||
130676963|NCT03008460|470443345|FG001|Overall Study|Adverse Event|1|||
130676964|NCT03008460|470443344|FG000|Overall Study|Withdrawal by Subject|5|||
130676965|NCT03008460|470443345|FG001|Overall Study|Withdrawal by Subject|6|||
130342340|NCT00913458|469224619|FG002|Phase 1|Subject Request|0|||
130342341|NCT00913458|469224620|FG003|Phase 1|Subject Request|0|||
130342342|NCT00913458|469224621|FG004|Phase 1|Subject Request|0|||
130676966|NCT03008460|470443344|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
130676967|NCT03008460|470443345|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
130676968|NCT03008460|470443344|FG000|Overall Study|End of study visit outside permitted time window|0|||
130676969|NCT03008460|470443345|FG001|Overall Study|End of study visit outside permitted time window|1|||
130676970|NCT03008460|470443344|FG000|Overall Study|Lost to Follow-up|1|||
130676971|NCT03008460|470443345|FG001|Overall Study|Lost to Follow-up|3|||
130676972|NCT01919190|470445152|FG000|Overall Study|Intra-op findings, etc.|3|||
130676973|NCT01919190|470445153|FG001|Overall Study|Intra-op findings, etc.|0|||
130676974|NCT02322047|470445159|FG000|Overall Study|Physician Decision|1|||
130676975|NCT02322047|470445160|FG001|Overall Study|Physician Decision|0|||
130676976|NCT02322047|470445161|FG002|Overall Study|Physician Decision|0|||
130676977|NCT02322047|470445162|FG003|Overall Study|Physician Decision|0|||
130676978|NCT02322047|470445159|FG000|Overall Study|Withdrawal by Subject|1|||
130676979|NCT02322047|470445160|FG001|Overall Study|Withdrawal by Subject|0|||
130676980|NCT02322047|470445161|FG002|Overall Study|Withdrawal by Subject|0|||
130676981|NCT02322047|470445162|FG003|Overall Study|Withdrawal by Subject|1|||
130676982|NCT02322047|470445159|FG000|Overall Study|Adverse Event|0|||
130676983|NCT02322047|470445160|FG001|Overall Study|Adverse Event|1|||
130676984|NCT02322047|470445161|FG002|Overall Study|Adverse Event|0|||
130676985|NCT02322047|470445162|FG003|Overall Study|Adverse Event|0|||
130676986|NCT02322047|470445159|FG000|Overall Study|Lost to Follow-up|0|||
130676987|NCT02322047|470445160|FG001|Overall Study|Lost to Follow-up|0|||
130676988|NCT02322047|470445161|FG002|Overall Study|Lost to Follow-up|1|||
130676989|NCT02322047|470445162|FG003|Overall Study|Lost to Follow-up|1|||
130676990|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
130676991|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
130676992|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
130676993|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
130676994|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
130676995|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
130676996|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
130676997|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
130676998|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130676999|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130677000|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130677001|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
130677002|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
130677003|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
130677004|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
130677005|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
130677006|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130677007|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130677008|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
130677009|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130677010|NCT02207231|470445163|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
130677011|NCT02207231|470445164|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
130677012|NCT02207231|470445165|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
130677013|NCT02207231|470445166|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
130677014|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
130677015|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
130677016|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
130677017|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
130677018|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130677019|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130677020|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
130677021|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130677022|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
130677023|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
130677024|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
130677025|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
130677026|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
130677027|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
130677028|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
130677029|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
130677030|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
130677031|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
130342343|NCT00913458|469224622|FG005|Phase 1|Subject Request|0|||
130677032|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
130677033|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
130677034|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130677035|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
130677036|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130677037|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130677038|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
130677039|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
130677040|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
130677041|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
130677042|NCT02207231|470445163|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
130677043|NCT02207231|470445164|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
130677044|NCT02207231|470445165|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
130677045|NCT02207231|470445166|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
130677046|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
130677047|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
130677048|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
130677049|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
130677050|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
130677051|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
130677052|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
130677053|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
130677054|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
130677055|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
130677056|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
130677057|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
130677058|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
130677059|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
130677060|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
130677061|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
130677062|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
130677063|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
130677064|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
130677065|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
130677066|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
130677067|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
130677068|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
130677069|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
130677070|NCT02207231|470445163|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
130677071|NCT02207231|470445164|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
130677072|NCT02207231|470445165|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
130677073|NCT02207231|470445166|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
130677074|NCT00502775|470445170|FG000|Overall Study|Adverse Event|1|||
130677075|NCT00502775|470445171|FG001|Overall Study|Adverse Event|2|||
130677076|NCT00502775|470445172|FG002|Overall Study|Adverse Event|1|||
130677077|NCT00502775|470445170|FG000|Overall Study|Protocol Violation|1|||
130677078|NCT00502775|470445171|FG001|Overall Study|Protocol Violation|5|||
130677079|NCT00502775|470445172|FG002|Overall Study|Protocol Violation|2|||
130677080|NCT00502775|470445170|FG000|Overall Study|Withdrawal by Subject|1|||
130677081|NCT00502775|470445171|FG001|Overall Study|Withdrawal by Subject|1|||
130677082|NCT00502775|470445172|FG002|Overall Study|Withdrawal by Subject|2|||
130677083|NCT00502775|470445170|FG000|Overall Study|Sponsor Terminated Study|1|||
130677084|NCT00502775|470445171|FG001|Overall Study|Sponsor Terminated Study|0|||
130677085|NCT00502775|470445172|FG002|Overall Study|Sponsor Terminated Study|1|||
130677086|NCT00502775|470445170|FG000|Overall Study|Non-compliance with eDiary|4|||
130677087|NCT00502775|470445171|FG001|Overall Study|Non-compliance with eDiary|1|||
130677088|NCT00502775|470445172|FG002|Overall Study|Non-compliance with eDiary|1|||
130677089|NCT00502775|470445170|FG000|Overall Study|Subject unable to swallow capsule|1|||
130677090|NCT00502775|470445171|FG001|Overall Study|Subject unable to swallow capsule|0|||
130677091|NCT00502775|470445172|FG002|Overall Study|Subject unable to swallow capsule|1|||
130677092|NCT00502775|470445170|FG000|Overall Study|Logpad compliance <80%|1|||
130677093|NCT00502775|470445171|FG001|Overall Study|Logpad compliance <80%|0|||
130677094|NCT00502775|470445172|FG002|Overall Study|Logpad compliance <80%|0|||
130677095|NCT00502775|470445170|FG000|Overall Study|Randomized in error|0|||
130677096|NCT00502775|470445171|FG001|Overall Study|Randomized in error|1|||
130677097|NCT00502775|470445172|FG002|Overall Study|Randomized in error|1|||
130677098|NCT00502775|470445170|FG000|Overall Study|Non-compliance|0|||
130677099|NCT00502775|470445171|FG001|Overall Study|Non-compliance|2|||
130677100|NCT00502775|470445172|FG002|Overall Study|Non-compliance|2|||
130216592|NCT03148067|468755611|FG000|Overall Study|Lost to Follow-up|3|||
130677101|NCT00502775|470445170|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
130677102|NCT00502775|470445171|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
130677103|NCT00502775|470445172|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
130677104|NCT00502775|470445170|FG000|Overall Study|Declining pollen counts|0|||
130677105|NCT00502775|470445171|FG001|Overall Study|Declining pollen counts|1|||
130677106|NCT00502775|470445172|FG002|Overall Study|Declining pollen counts|1|||
130677107|NCT00502775|470445170|FG000|Overall Study|Subject in jail|0|||
130677108|NCT00502775|470445171|FG001|Overall Study|Subject in jail|1|||
130677109|NCT00502775|470445172|FG002|Overall Study|Subject in jail|0|||
130677110|NCT00502775|470445170|FG000|Overall Study|Subject took disallowed drug|0|||
130677111|NCT00502775|470445171|FG001|Overall Study|Subject took disallowed drug|0|||
130677112|NCT00502775|470445172|FG002|Overall Study|Subject took disallowed drug|1|||
130677113|NCT00287118|470445181|FG000|Overall Study|Adverse Event|30|||
130677114|NCT00287118|470445181|FG000|Overall Study|Death|1|||
130677115|NCT00287118|470445181|FG000|Overall Study|Lack of Efficacy|11|||
130677116|NCT00287118|470445181|FG000|Overall Study|Lost to Follow-up|1|||
130677117|NCT00287118|470445181|FG000|Overall Study|Protocol Violation|2|||
130677118|NCT00287118|470445181|FG000|Overall Study|Other|7|||
130677119|NCT00262600|470445182|FG000|Overall Study|Lost to Follow-up|17|||
130677120|NCT00262600|470445183|FG001|Overall Study|Lost to Follow-up|31|||
130677121|NCT00262600|470445184|FG002|Overall Study|Lost to Follow-up|41|||
130677122|NCT00262600|470445182|FG000|Overall Study|Withdrawal by Subject|128|||
130677123|NCT00262600|470445183|FG001|Overall Study|Withdrawal by Subject|145|||
130677124|NCT00262600|470445184|FG002|Overall Study|Withdrawal by Subject|139|||
130677125|NCT00262600|470445182|FG000|Overall Study|Not Treated|32|||
130677126|NCT00262600|470445183|FG001|Overall Study|Not Treated|17|||
130677127|NCT00262600|470445184|FG002|Overall Study|Not Treated|24|||
130677128|NCT00262600|470445182|FG000|Overall Study|Other|58|||
130677129|NCT00262600|470445183|FG001|Overall Study|Other|59|||
130677130|NCT00262600|470445184|FG002|Overall Study|Other|62|||
130677131|NCT02906709|470445185|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
130677132|NCT02906709|470445186|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
130677133|NCT02906709|470445185|FG000|Phase A (Week 0 to Week 16)|Death|0|||
130677134|NCT02906709|470445186|FG001|Phase A (Week 0 to Week 16)|Death|1|||
130677135|NCT02906709|470445185|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
130677136|NCT02906709|470445186|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
130677137|NCT02906709|470445185|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
130677138|NCT02906709|470445186|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
130677139|NCT02402166|470445187|FG000|Overall Study|Adverse Event|2|||
130677140|NCT02402166|470445187|FG000|Overall Study|Withdrawal by Subject|2|||
130677141|NCT02402166|470445187|FG000|Overall Study|Lost to Follow-up|1|||
130677142|NCT02428699|470445189|FG000|Washout Period 1|Screen Failure|1|||
130677143|NCT02428699|470445190|FG001|Washout Period 1|Screen Failure|2|||
130677144|NCT00995410|470445193|FG000|Overall Study|Adverse Event|51|||
130677145|NCT00995410|470445193|FG000|Overall Study|Withdrawal by Subject|7|||
130677146|NCT00995410|470445193|FG000|Overall Study|Lost to Follow-up|2|||
130677147|NCT00995410|470445193|FG000|Overall Study|Misc|28|||
130677148|NCT02483975|470445194|FG000|Overall Study|Adverse Event|0|||
130677149|NCT02483975|470445195|FG001|Overall Study|Adverse Event|1|||
130677150|NCT02483975|470445194|FG000|Overall Study|Lost to Follow-up|0|||
130677151|NCT02483975|470445195|FG001|Overall Study|Lost to Follow-up|1|||
130677152|NCT02483975|470445194|FG000|Overall Study|Physician Decision|2|||
130342344|NCT00913458|469224623|FG006|Phase 1|Subject Request|0|||
130677153|NCT02483975|470445195|FG001|Overall Study|Physician Decision|0|||
130677154|NCT01505530|470445196|FG000|Overall Study|Progressive Disease|19|||
130677155|NCT01505530|470445197|FG001|Overall Study|Progressive Disease|17|||
130677156|NCT01505530|470445198|FG002|Overall Study|Progressive Disease|18|||
130677157|NCT01505530|470445196|FG000|Overall Study|Adverse Event|1|||
130677158|NCT01505530|470445197|FG001|Overall Study|Adverse Event|1|||
130677159|NCT01505530|470445198|FG002|Overall Study|Adverse Event|0|||
130677160|NCT01505530|470445196|FG000|Overall Study|Withdrawal by Subject|7|||
130677161|NCT01505530|470445197|FG001|Overall Study|Withdrawal by Subject|8|||
130677162|NCT01505530|470445198|FG002|Overall Study|Withdrawal by Subject|6|||
130342345|NCT00913458|469224617|FG000|Phase 1|Adverse Event|20|||
130342346|NCT00913458|469224618|FG001|Phase 1|Adverse Event|0|||
130677163|NCT01505530|470445196|FG000|Overall Study|Physician Decision|6|||
130677164|NCT01505530|470445197|FG001|Overall Study|Physician Decision|2|||
130677165|NCT01505530|470445198|FG002|Overall Study|Physician Decision|5|||
130677166|NCT01505530|470445196|FG000|Overall Study|Sponsor Decision|1|||
130677167|NCT01505530|470445197|FG001|Overall Study|Sponsor Decision|8|||
130342347|NCT00913458|469224619|FG002|Phase 1|Adverse Event|0|||
130342348|NCT00913458|469224620|FG003|Phase 1|Adverse Event|0|||
130677168|NCT01505530|470445198|FG002|Overall Study|Sponsor Decision|7|||
130677169|NCT01505530|470445196|FG000|Overall Study|Death|7|||
130677170|NCT01505530|470445197|FG001|Overall Study|Death|6|||
130677171|NCT01505530|470445198|FG002|Overall Study|Death|5|||
130342349|NCT00913458|469224621|FG004|Phase 1|Adverse Event|0|||
130677172|NCT01505530|470445196|FG000|Overall Study|entry criteria not met|0|||
130677173|NCT01505530|470445197|FG001|Overall Study|entry criteria not met|1|||
130677174|NCT01505530|470445198|FG002|Overall Study|entry criteria not met|0|||
130677175|NCT02492958|470445199|FG000|Overall Study|Withdrawal by Subject|0|||
130677176|NCT02492958|470445200|FG001|Overall Study|Withdrawal by Subject|0|||
130677177|NCT02492958|470445201|FG002|Overall Study|Withdrawal by Subject|1|||
130677178|NCT02492958|470445202|FG003|Overall Study|Withdrawal by Subject|0|||
130677179|NCT02492958|470445199|FG000|Overall Study|Adverse Event|1|||
130677180|NCT02492958|470445200|FG001|Overall Study|Adverse Event|0|||
130677181|NCT02492958|470445201|FG002|Overall Study|Adverse Event|1|||
130677182|NCT02492958|470445202|FG003|Overall Study|Adverse Event|0|||
130677183|NCT01901055|470445203|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
130677184|NCT01901055|470445204|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
130677185|NCT01901055|470445203|FG000|Randomization But Not Titrated|Physician Decision|0|||
130677186|NCT01901055|470445204|FG001|Randomization But Not Titrated|Physician Decision|1|||
130677187|NCT01901055|470445203|FG000|Started Protocol to Week 6|Physician Decision|2|||
130677188|NCT01901055|470445204|FG001|Started Protocol to Week 6|Physician Decision|1|||
130677189|NCT01901055|470445203|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
130677190|NCT01901055|470445204|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
130677191|NCT01901055|470445203|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
130677192|NCT01901055|470445204|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
130677193|NCT01901055|470445203|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
130677194|NCT01901055|470445204|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
130677195|NCT01901055|470445203|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
130677196|NCT01901055|470445204|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
130677197|NCT01901055|470445203|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
130677198|NCT01901055|470445204|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
130677199|NCT01901055|470445203|FG000|Week 24|Withdrawal by Subject|13|||
130677200|NCT01901055|470445204|FG001|Week 24|Withdrawal by Subject|19|||
130677201|NCT01901055|470445203|FG000|Week 24|Physician Decision|1|||
130677202|NCT01901055|470445204|FG001|Week 24|Physician Decision|0|||
130677203|NCT01901055|470445203|FG000|Week 36|Withdrawal by Subject|0|||
130677204|NCT01901055|470445204|FG001|Week 36|Withdrawal by Subject|5|||
130677205|NCT02660242|470445211|FG000|Glucose Tabs|Lost to Follow-up|1|||
130677206|NCT02660242|470445211|FG000|Glucagon Injection|Lost to Follow-up|1|||
130677207|NCT00770510|470445212|FG000|Overall Study|Lost to Follow-up|2|||
130677208|NCT00770510|470445212|FG000|Overall Study|Pregnancy|1|||
130677209|NCT00770510|470445212|FG000|Overall Study|Withdrawal by Subject|2|||
130677210|NCT02192099|470445215|FG000|Overall Study|Adverse Event|1|||
130677211|NCT02192099|470445215|FG000|Overall Study|Lost to Follow-up|2|||
130677212|NCT02192099|470445215|FG000|Overall Study|Physician Decision|1|||
130677213|NCT02192099|470445215|FG000|Overall Study|Pregnancy|1|||
130677214|NCT02192099|470445215|FG000|Overall Study|Protocol Violation|8|||
130677215|NCT02192099|470445215|FG000|Overall Study|Study Terminated by Sponsor|32|||
130677216|NCT02192099|470445215|FG000|Overall Study|Withdrawal by Subject|11|||
130677217|NCT02192099|470445215|FG000|Overall Study|Miscellaneous Reasons|5|||
130677218|NCT02001558|470445216|FG000|Overall Study|Lost to Follow-up|8|||
130677219|NCT02001558|470445217|FG001|Overall Study|Lost to Follow-up|14|||
130677220|NCT02780687|470445226|FG000|Overall Study|Adverse Event|1|||
130677221|NCT02780687|470445227|FG001|Overall Study|Adverse Event|1|||
130677222|NCT02780687|470445226|FG000|Overall Study|Withdrawal by Subject|2|||
130677223|NCT02780687|470445227|FG001|Overall Study|Withdrawal by Subject|1|||
130677224|NCT02780687|470445226|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
130677225|NCT02780687|470445227|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
130342350|NCT00913458|469224622|FG005|Phase 1|Adverse Event|0|||
130342351|NCT00913458|469224623|FG006|Phase 1|Adverse Event|0|||
130342352|NCT00913458|469224617|FG000|Phase 1|Lost to Follow-up|2|||
130677226|NCT02780687|470445226|FG000|Overall Study|progressive disease|29|||
130677227|NCT02780687|470445227|FG001|Overall Study|progressive disease|6|||
130342353|NCT00913458|469224618|FG001|Phase 1|Lost to Follow-up|0|||
130342354|NCT00913458|469224619|FG002|Phase 1|Lost to Follow-up|0|||
130677228|NCT00368277|470445228|FG000|Overall Study|Adverse Event|33|||
130677229|NCT00368277|470445229|FG001|Overall Study|Adverse Event|49|||
130677230|NCT00368277|470445228|FG000|Overall Study|Death|2|||
130677231|NCT00368277|470445229|FG001|Overall Study|Death|1|||
130677232|NCT00368277|470445228|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
130342355|NCT00913458|469224620|FG003|Phase 1|Lost to Follow-up|0|||
130342356|NCT00913458|469224621|FG004|Phase 1|Lost to Follow-up|0|||
130342357|NCT00913458|469224622|FG005|Phase 1|Lost to Follow-up|0|||
130677233|NCT00368277|470445229|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
130677234|NCT00368277|470445228|FG000|Overall Study|Protocol deviation|7|||
130342358|NCT00913458|469224623|FG006|Phase 1|Lost to Follow-up|0|||
130677235|NCT00368277|470445229|FG001|Overall Study|Protocol deviation|0|||
130677236|NCT00368277|470445228|FG000|Overall Study|Patient withdrew consent|32|||
130677237|NCT00368277|470445229|FG001|Overall Study|Patient withdrew consent|28|||
130342359|NCT00913458|469224617|FG000|Phase 1|Protocol Violation|10|||
130342360|NCT00913458|469224618|FG001|Phase 1|Protocol Violation|0|||
130677238|NCT00368277|470445228|FG000|Overall Study|Lost to Follow-up|8|||
130677239|NCT00368277|470445229|FG001|Overall Study|Lost to Follow-up|6|||
130677240|NCT03283709|470445241|FG000|Overall Study|trial terminated|0|||
130677241|NCT03283709|470445242|FG001|Overall Study|trial terminated|1|||
130677242|NCT01734772|470445243|FG000|Overall Study|Adverse Event|1|||
130677243|NCT01734772|470445244|FG001|Overall Study|Adverse Event|2|||
130677244|NCT01734772|470445243|FG000|Overall Study|Withdrawal by Subject|0|||
130677245|NCT01734772|470445244|FG001|Overall Study|Withdrawal by Subject|1|||
130677246|NCT01867242|470445245|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
130677247|NCT01867242|470445246|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
130677248|NCT01867242|470445247|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
130677249|NCT01790568|470445253|FG000|Overall Study|Progression prior to transplant|0|||
130677250|NCT01790568|470445254|FG001|Overall Study|Progression prior to transplant|1|||
130677251|NCT00264810|470445255|FG000|Baseline|Withdrawal by Subject|10|||
130677252|NCT00264810|470445256|FG001|Baseline|Withdrawal by Subject|10|||
130677253|NCT00264810|470445255|FG000|Baseline|Physician Decision|7|||
130677254|NCT00264810|470445256|FG001|Baseline|Physician Decision|8|||
130677255|NCT00264810|470445255|FG000|Baseline|Subject Compliance Failure|3|||
130677256|NCT00264810|470445256|FG001|Baseline|Subject Compliance Failure|3|||
130677257|NCT00264810|470445255|FG000|Baseline|Insufficient Seizure Frequency|2|||
130677258|NCT00264810|470445256|FG001|Baseline|Insufficient Seizure Frequency|2|||
130677259|NCT00264810|470445255|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
130677260|NCT00264810|470445256|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
130677261|NCT00264810|470445255|FG000|Baseline|Other|0|||
130677262|NCT00264810|470445256|FG001|Baseline|Other|1|||
130677263|NCT00264810|470445255|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
130677264|NCT00264810|470445256|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
130677265|NCT00264810|470445255|FG000|Stimulation Optimization Period|Death|0|||
130677266|NCT00264810|470445256|FG001|Stimulation Optimization Period|Death|1|||
130677267|NCT00264810|470445255|FG000|Blinded Evaluation Period|Explant due to infection|1|||
130677268|NCT00264810|470445256|FG001|Blinded Evaluation Period|Explant due to infection|1|||
130677269|NCT00264810|470445255|FG000|Open Label Evaluation Period|Explant due to infection|1|||
130677270|NCT00264810|470445256|FG001|Open Label Evaluation Period|Explant due to infection|1|||
130677271|NCT00264810|470445255|FG000|Open Label Evaluation Period|Death|3|||
130677272|NCT00264810|470445256|FG001|Open Label Evaluation Period|Death|2|||
130677273|NCT00264810|470445255|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
130677274|NCT00264810|470445256|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
130677275|NCT02994056|470445257|FG000|Overall Study|Death|8|||
130677276|NCT02994056|470445257|FG000|Overall Study|Withdrew Consent|1|||
130677277|NCT02199509|470445260|FG000|Overall Study|Suicidal Ideation|0|||
130677278|NCT02199509|470445261|FG001|Overall Study|Suicidal Ideation|1|||
130677279|NCT02199509|470445260|FG000|Overall Study|Misunderstood titration schedule|1|||
130677280|NCT02199509|470445261|FG001|Overall Study|Misunderstood titration schedule|0|||
130677281|NCT02093689|470445262|FG000|Overall Study|Physician Decision|4|||
130677282|NCT02093689|470445263|FG001|Overall Study|Physician Decision|0|||
130677283|NCT02093689|470445264|FG002|Overall Study|Physician Decision|0|||
130677284|NCT04947579|470445268|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130677285|NCT04947579|470445269|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130677286|NCT04947579|470445270|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130677287|NCT04947579|470445271|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
130677288|NCT04947579|470445272|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130677289|NCT04947579|470445273|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130677290|NCT04947579|470445268|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130677291|NCT04947579|470445269|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130677292|NCT04947579|470445270|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
130677293|NCT04947579|470445271|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130342361|NCT00913458|469224619|FG002|Phase 1|Protocol Violation|0|||
130342362|NCT00913458|469224620|FG003|Phase 1|Protocol Violation|0|||
130677294|NCT04947579|470445272|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130677295|NCT04947579|470445273|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130677296|NCT04947579|470445268|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
130342363|NCT00913458|469224621|FG004|Phase 1|Protocol Violation|0|||
130342364|NCT00913458|469224622|FG005|Phase 1|Protocol Violation|0|||
130342365|NCT00913458|469224623|FG006|Phase 1|Protocol Violation|0|||
130677297|NCT04947579|470445269|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
130677298|NCT04947579|470445270|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
130677299|NCT04947579|470445271|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
130677300|NCT04947579|470445272|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
130677301|NCT04947579|470445273|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
130677302|NCT04947579|470445268|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
130342366|NCT00913458|469224617|FG000|Phase 1|Sponsor|2|||
130677303|NCT04947579|470445269|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
130677304|NCT04947579|470445270|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
130677305|NCT04947579|470445271|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
130677306|NCT04947579|470445272|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
130677307|NCT04947579|470445273|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
130677308|NCT04947579|470445268|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
130677309|NCT04947579|470445269|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130677310|NCT04947579|470445270|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130677311|NCT04947579|470445271|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130677312|NCT04947579|470445272|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130677313|NCT04947579|470445273|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130677314|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130677315|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130677316|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
130677317|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130677318|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130677319|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130677320|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130677321|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
130677322|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130677323|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130677324|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130677325|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
130677326|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130677327|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130677328|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
130677329|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130677330|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130677331|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130677332|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
130677333|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
130677334|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
130677335|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
130677336|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
130677337|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
130677338|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
130677339|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
130677340|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
130677341|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
130677342|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
130677343|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
130677344|NCT04947579|470445268|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
130677345|NCT04947579|470445269|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
130677346|NCT04947579|470445270|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
130677347|NCT04947579|470445271|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
130677348|NCT04947579|470445272|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
130677349|NCT04947579|470445273|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
130677350|NCT01575054|470445274|FG000|Overall Study|Other Reasons|5|||
130677351|NCT01575054|470445275|FG001|Overall Study|Other Reasons|3|||
130677352|NCT01575054|470445274|FG000|Overall Study|Protocol Violation|2|||
130677353|NCT01575054|470445275|FG001|Overall Study|Protocol Violation|1|||
130677354|NCT01575054|470445274|FG000|Overall Study|Personal Reasons|10|||
130677355|NCT01575054|470445275|FG001|Overall Study|Personal Reasons|11|||
130677356|NCT01575054|470445274|FG000|Overall Study|Lost to Follow-up|3|||
130677357|NCT01575054|470445275|FG001|Overall Study|Lost to Follow-up|3|||
130677358|NCT01575054|470445274|FG000|Overall Study|Adverse Event|9|||
130677359|NCT01575054|470445275|FG001|Overall Study|Adverse Event|8|||
130677360|NCT03481309|470445276|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
130677361|NCT03481309|470445277|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130677362|NCT03481309|470445278|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130677363|NCT03481309|470445279|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130677364|NCT03481309|470445280|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130677365|NCT03481309|470445281|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130677366|NCT03309956|470445282|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
130677367|NCT03495869|470445285|FG000|Overall Study|Lost to Follow-up|4|||
130677368|NCT03495869|470445286|FG001|Overall Study|Lost to Follow-up|17|||
130677369|NCT03495869|470445287|FG002|Overall Study|Lost to Follow-up|8|||
130677370|NCT03495869|470445288|FG003|Overall Study|Lost to Follow-up|14|||
130677371|NCT03495869|470445285|FG000|Overall Study|Withdrawal by Subject|0|||
130677372|NCT03495869|470445286|FG001|Overall Study|Withdrawal by Subject|3|||
130677373|NCT03495869|470445287|FG002|Overall Study|Withdrawal by Subject|0|||
130677374|NCT03495869|470445288|FG003|Overall Study|Withdrawal by Subject|3|||
130677375|NCT03495869|470445285|FG000|Overall Study|Dropped from study|0|||
130677376|NCT03495869|470445286|FG001|Overall Study|Dropped from study|7|||
130677377|NCT03495869|470445287|FG002|Overall Study|Dropped from study|2|||
130677378|NCT03495869|470445288|FG003|Overall Study|Dropped from study|4|||
130677379|NCT02768298|470445289|FG000|Overall Study|Adverse Event|1|||
130677380|NCT02768298|470445290|FG001|Overall Study|Adverse Event|4|||
130677381|NCT02768298|470445289|FG000|Overall Study|Death|2|||
130677382|NCT02768298|470445290|FG001|Overall Study|Death|1|||
130677383|NCT02768298|470445289|FG000|Overall Study|Non-compliance with study treatment|0|||
130677384|NCT02768298|470445290|FG001|Overall Study|Non-compliance with study treatment|1|||
130677385|NCT02768298|470445289|FG000|Overall Study|Subject/guardian decision|1|||
130677386|NCT02768298|470445290|FG001|Overall Study|Subject/guardian decision|0|||
130677387|NCT02768298|470445289|FG000|Overall Study|Withdrawal of informed consent|0|||
130677388|NCT02768298|470445290|FG001|Overall Study|Withdrawal of informed consent|1|||
130677389|NCT04634409|470445291|FG000|Overall Study|Death|0|||
130677390|NCT04634409|470445292|FG001|Overall Study|Death|0|||
130677391|NCT04634409|470445293|FG002|Overall Study|Death|0|||
130677392|NCT04634409|470445294|FG003|Overall Study|Death|0|||
130677393|NCT04634409|470445295|FG004|Overall Study|Death|0|||
130677394|NCT04634409|470445296|FG005|Overall Study|Death|0|||
130677395|NCT04634409|470445297|FG006|Overall Study|Death|0|||
130677396|NCT04634409|470445298|FG007|Overall Study|Death|0|||
130677397|NCT04634409|470445299|FG008|Overall Study|Death|0|||
130677398|NCT04634409|470445300|FG009|Overall Study|Death|0|||
130677399|NCT04634409|470445301|FG010|Overall Study|Death|1|||
130677400|NCT04634409|470445302|FG011|Overall Study|Death|0|||
130677401|NCT04634409|470445303|FG012|Overall Study|Death|1|||
130677402|NCT04634409|470445304|FG013|Overall Study|Death|0|||
130677403|NCT04634409|470445305|FG014|Overall Study|Death|0|||
130677404|NCT04634409|470445306|FG015|Overall Study|Death|0|||
130677405|NCT04634409|470445307|FG016|Overall Study|Death|0|||
130677406|NCT04634409|470445308|FG017|Overall Study|Death|0|||
130677407|NCT04634409|470445309|FG018|Overall Study|Death|0|||
130677408|NCT04634409|470445310|FG019|Overall Study|Death|0|||
130677409|NCT04634409|470445311|FG020|Overall Study|Death|0|||
130677410|NCT04634409|470445312|FG021|Overall Study|Death|0|||
130677411|NCT04634409|470445313|FG022|Overall Study|Death|0|||
130677412|NCT04634409|470445314|FG023|Overall Study|Death|0|||
130677413|NCT04634409|470445315|FG024|Overall Study|Death|0|||
130677414|NCT04634409|470445316|FG025|Overall Study|Death|0|||
130677415|NCT04634409|470445317|FG026|Overall Study|Death|0|||
130677416|NCT04634409|470445291|FG000|Overall Study|Adverse Event|0|||
130677417|NCT04634409|470445292|FG001|Overall Study|Adverse Event|0|||
130677418|NCT04634409|470445293|FG002|Overall Study|Adverse Event|1|||
130677419|NCT04634409|470445294|FG003|Overall Study|Adverse Event|0|||
130677420|NCT04634409|470445295|FG004|Overall Study|Adverse Event|0|||
130677421|NCT04634409|470445296|FG005|Overall Study|Adverse Event|1|||
130677422|NCT04634409|470445297|FG006|Overall Study|Adverse Event|0|||
130677423|NCT04634409|470445298|FG007|Overall Study|Adverse Event|0|||
130677424|NCT04634409|470445299|FG008|Overall Study|Adverse Event|0|||
130677425|NCT04634409|470445300|FG009|Overall Study|Adverse Event|0|||
130677426|NCT04634409|470445301|FG010|Overall Study|Adverse Event|0|||
130677427|NCT04634409|470445302|FG011|Overall Study|Adverse Event|0|||
130677428|NCT04634409|470445303|FG012|Overall Study|Adverse Event|0|||
130677429|NCT04634409|470445304|FG013|Overall Study|Adverse Event|0|||
130677430|NCT04634409|470445305|FG014|Overall Study|Adverse Event|0|||
130677431|NCT04634409|470445306|FG015|Overall Study|Adverse Event|0|||
130677432|NCT04634409|470445307|FG016|Overall Study|Adverse Event|0|||
130677433|NCT04634409|470445308|FG017|Overall Study|Adverse Event|0|||
130677434|NCT04634409|470445309|FG018|Overall Study|Adverse Event|0|||
130677435|NCT04634409|470445310|FG019|Overall Study|Adverse Event|0|||
130677436|NCT04634409|470445311|FG020|Overall Study|Adverse Event|0|||
130677437|NCT04634409|470445312|FG021|Overall Study|Adverse Event|0|||
130677438|NCT04634409|470445313|FG022|Overall Study|Adverse Event|0|||
130677439|NCT04634409|470445314|FG023|Overall Study|Adverse Event|0|||
130677440|NCT04634409|470445315|FG024|Overall Study|Adverse Event|0|||
130677441|NCT04634409|470445316|FG025|Overall Study|Adverse Event|0|||
130677442|NCT04634409|470445317|FG026|Overall Study|Adverse Event|0|||
130677443|NCT04634409|470445291|FG000|Overall Study|Lost to Follow-up|3|||
130552761|NCT02720536|469991528|FG000|Overall Study|PR - adverse event|1|||
130677444|NCT04634409|470445292|FG001|Overall Study|Lost to Follow-up|1|||
130677445|NCT04634409|470445293|FG002|Overall Study|Lost to Follow-up|1|||
130677446|NCT04634409|470445294|FG003|Overall Study|Lost to Follow-up|3|||
130677447|NCT04634409|470445295|FG004|Overall Study|Lost to Follow-up|1|||
130677448|NCT04634409|470445296|FG005|Overall Study|Lost to Follow-up|1|||
130677449|NCT04634409|470445297|FG006|Overall Study|Lost to Follow-up|1|||
130677450|NCT04634409|470445298|FG007|Overall Study|Lost to Follow-up|3|||
130677451|NCT04634409|470445299|FG008|Overall Study|Lost to Follow-up|3|||
130677452|NCT04634409|470445300|FG009|Overall Study|Lost to Follow-up|11|||
130677453|NCT04634409|470445301|FG010|Overall Study|Lost to Follow-up|8|||
130677454|NCT04634409|470445302|FG011|Overall Study|Lost to Follow-up|15|||
130677455|NCT04634409|470445303|FG012|Overall Study|Lost to Follow-up|3|||
130677456|NCT04634409|470445304|FG013|Overall Study|Lost to Follow-up|2|||
130677457|NCT04634409|470445305|FG014|Overall Study|Lost to Follow-up|7|||
130342367|NCT00913458|469224618|FG001|Phase 1|Sponsor|0|||
130342368|NCT00913458|469224619|FG002|Phase 1|Sponsor|0|||
130342369|NCT00913458|469224620|FG003|Phase 1|Sponsor|0|||
130342370|NCT00913458|469224621|FG004|Phase 1|Sponsor|0|||
130342371|NCT00913458|469224622|FG005|Phase 1|Sponsor|0|||
130342372|NCT00913458|469224623|FG006|Phase 1|Sponsor|0|||
130677458|NCT04634409|470445306|FG015|Overall Study|Lost to Follow-up|0|||
130677459|NCT04634409|470445307|FG016|Overall Study|Lost to Follow-up|0|||
130677460|NCT04634409|470445308|FG017|Overall Study|Lost to Follow-up|0|||
130677461|NCT04634409|470445309|FG018|Overall Study|Lost to Follow-up|0|||
130677462|NCT04634409|470445310|FG019|Overall Study|Lost to Follow-up|0|||
130677463|NCT04634409|470445311|FG020|Overall Study|Lost to Follow-up|0|||
130677464|NCT04634409|470445312|FG021|Overall Study|Lost to Follow-up|0|||
130677465|NCT04634409|470445313|FG022|Overall Study|Lost to Follow-up|0|||
130677466|NCT04634409|470445314|FG023|Overall Study|Lost to Follow-up|0|||
130677467|NCT04634409|470445315|FG024|Overall Study|Lost to Follow-up|0|||
130677468|NCT04634409|470445316|FG025|Overall Study|Lost to Follow-up|0|||
130677469|NCT04634409|470445317|FG026|Overall Study|Lost to Follow-up|0|||
130677470|NCT04634409|470445291|FG000|Overall Study|Withdrawal by Subject|3|||
130677471|NCT04634409|470445292|FG001|Overall Study|Withdrawal by Subject|1|||
130677472|NCT04634409|470445293|FG002|Overall Study|Withdrawal by Subject|6|||
130677473|NCT04634409|470445294|FG003|Overall Study|Withdrawal by Subject|4|||
130677474|NCT04634409|470445295|FG004|Overall Study|Withdrawal by Subject|2|||
130677475|NCT04634409|470445296|FG005|Overall Study|Withdrawal by Subject|0|||
130677476|NCT04634409|470445297|FG006|Overall Study|Withdrawal by Subject|0|||
130677477|NCT04634409|470445298|FG007|Overall Study|Withdrawal by Subject|2|||
130677478|NCT04634409|470445299|FG008|Overall Study|Withdrawal by Subject|3|||
130677479|NCT04634409|470445300|FG009|Overall Study|Withdrawal by Subject|2|||
130677480|NCT04634409|470445301|FG010|Overall Study|Withdrawal by Subject|3|||
130677481|NCT04634409|470445302|FG011|Overall Study|Withdrawal by Subject|2|||
130677482|NCT04634409|470445303|FG012|Overall Study|Withdrawal by Subject|2|||
130677483|NCT04634409|470445304|FG013|Overall Study|Withdrawal by Subject|1|||
130677484|NCT04634409|470445305|FG014|Overall Study|Withdrawal by Subject|5|||
130677485|NCT04634409|470445306|FG015|Overall Study|Withdrawal by Subject|0|||
130677486|NCT04634409|470445307|FG016|Overall Study|Withdrawal by Subject|0|||
130677487|NCT04634409|470445308|FG017|Overall Study|Withdrawal by Subject|1|||
130677488|NCT04634409|470445309|FG018|Overall Study|Withdrawal by Subject|0|||
130677489|NCT04634409|470445310|FG019|Overall Study|Withdrawal by Subject|0|||
130677490|NCT04634409|470445311|FG020|Overall Study|Withdrawal by Subject|0|||
130677491|NCT04634409|470445312|FG021|Overall Study|Withdrawal by Subject|0|||
130677492|NCT04634409|470445313|FG022|Overall Study|Withdrawal by Subject|0|||
130677493|NCT04634409|470445314|FG023|Overall Study|Withdrawal by Subject|1|||
130677494|NCT04634409|470445315|FG024|Overall Study|Withdrawal by Subject|0|||
130677495|NCT04634409|470445316|FG025|Overall Study|Withdrawal by Subject|0|||
130677496|NCT04634409|470445317|FG026|Overall Study|Withdrawal by Subject|0|||
130677497|NCT04634409|470445291|FG000|Overall Study|Other - As reported by Investigator|1|||
130677498|NCT04634409|470445292|FG001|Overall Study|Other - As reported by Investigator|0|||
130677499|NCT04634409|470445293|FG002|Overall Study|Other - As reported by Investigator|0|||
130677500|NCT04634409|470445294|FG003|Overall Study|Other - As reported by Investigator|0|||
130677501|NCT04634409|470445295|FG004|Overall Study|Other - As reported by Investigator|0|||
130677502|NCT04634409|470445296|FG005|Overall Study|Other - As reported by Investigator|0|||
130677503|NCT04634409|470445297|FG006|Overall Study|Other - As reported by Investigator|0|||
130677504|NCT04634409|470445298|FG007|Overall Study|Other - As reported by Investigator|6|||
130677505|NCT04634409|470445299|FG008|Overall Study|Other - As reported by Investigator|4|||
130677506|NCT04634409|470445300|FG009|Overall Study|Other - As reported by Investigator|0|||
130677507|NCT04634409|470445301|FG010|Overall Study|Other - As reported by Investigator|1|||
130677508|NCT04634409|470445302|FG011|Overall Study|Other - As reported by Investigator|2|||
130677509|NCT04634409|470445303|FG012|Overall Study|Other - As reported by Investigator|2|||
130677510|NCT04634409|470445304|FG013|Overall Study|Other - As reported by Investigator|1|||
130677511|NCT04634409|470445305|FG014|Overall Study|Other - As reported by Investigator|0|||
130677512|NCT04634409|470445306|FG015|Overall Study|Other - As reported by Investigator|0|||
130677513|NCT04634409|470445307|FG016|Overall Study|Other - As reported by Investigator|0|||
130677514|NCT04634409|470445308|FG017|Overall Study|Other - As reported by Investigator|0|||
130677515|NCT04634409|470445309|FG018|Overall Study|Other - As reported by Investigator|0|||
130216593|NCT03148067|468755611|FG000|Overall Study|Death|1|||
130342373|NCT00913458|469224617|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
130552762|NCT02720536|469991528|FG000|Overall Study|PR - abnormal lab value(s)|1|||
130342374|NCT00913458|469224618|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
130677516|NCT04634409|470445310|FG019|Overall Study|Other - As reported by Investigator|0|||
130677517|NCT04634409|470445311|FG020|Overall Study|Other - As reported by Investigator|0|||
130677518|NCT04634409|470445312|FG021|Overall Study|Other - As reported by Investigator|0|||
130677519|NCT04634409|470445313|FG022|Overall Study|Other - As reported by Investigator|0|||
130677520|NCT04634409|470445314|FG023|Overall Study|Other - As reported by Investigator|0|||
130677521|NCT04634409|470445315|FG024|Overall Study|Other - As reported by Investigator|0|||
130677522|NCT04634409|470445316|FG025|Overall Study|Other - As reported by Investigator|0|||
130677523|NCT04634409|470445317|FG026|Overall Study|Other - As reported by Investigator|0|||
130677524|NCT02346201|470445319|FG000|Overall Study|Adverse Event|3|||
130677525|NCT02346201|470445320|FG001|Overall Study|Adverse Event|2|||
130677526|NCT02346201|470445319|FG000|Overall Study|Lost to Follow-up|1|||
130677527|NCT02346201|470445320|FG001|Overall Study|Lost to Follow-up|0|||
130677528|NCT02346201|470445319|FG000|Overall Study|Withdrawal by Subject|6|||
130677529|NCT02346201|470445320|FG001|Overall Study|Withdrawal by Subject|3|||
130677530|NCT02346201|470445319|FG000|Overall Study|Unavailable for future follow-up|0|||
130677531|NCT02346201|470445320|FG001|Overall Study|Unavailable for future follow-up|1|||
130677532|NCT02346201|470445319|FG000|Overall Study|Physician Decision|0|||
130677533|NCT02346201|470445320|FG001|Overall Study|Physician Decision|1|||
130677534|NCT02346201|470445319|FG000|Overall Study|Missed final visit|0|||
130677535|NCT02346201|470445320|FG001|Overall Study|Missed final visit|2|||
130677536|NCT03708211|470445322|FG000|Overall Study|Progressive Disease|10|||
130677537|NCT03708211|470445323|FG001|Overall Study|Progressive Disease|7|||
130677538|NCT03708211|470445322|FG000|Overall Study|Withdrawal by Subject|0|||
130677539|NCT03708211|470445323|FG001|Overall Study|Withdrawal by Subject|1|||
130677540|NCT03708211|470445322|FG000|Overall Study|Other|2|||
130677541|NCT03708211|470445323|FG001|Overall Study|Other|0|||
130677542|NCT01508936|470445325|FG000|Overall Study|Adverse Event|11|||
130677543|NCT01508936|470445326|FG001|Overall Study|Adverse Event|32|||
130677544|NCT01508936|470445325|FG000|Overall Study|Lack of Efficacy|0|||
130677545|NCT01508936|470445326|FG001|Overall Study|Lack of Efficacy|1|||
130677546|NCT01508936|470445325|FG000|Overall Study|Withdrawal by Subject|4|||
130677547|NCT01508936|470445326|FG001|Overall Study|Withdrawal by Subject|18|||
130677548|NCT01508936|470445325|FG000|Overall Study|Protocol Violation|2|||
130677549|NCT01508936|470445326|FG001|Overall Study|Protocol Violation|3|||
130677550|NCT01508936|470445325|FG000|Overall Study|Lost to Follow-up|2|||
130677551|NCT01508936|470445326|FG001|Overall Study|Lost to Follow-up|9|||
130677552|NCT01508936|470445325|FG000|Overall Study|Other|0|||
130677553|NCT01508936|470445326|FG001|Overall Study|Other|5|||
130677554|NCT01508936|470445325|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
130677555|NCT01508936|470445326|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
130216594|NCT05305989|468755616|FG000|Overall Study|Other|3|||
130342375|NCT00913458|469224619|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
130342376|NCT00913458|469224620|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
130342377|NCT00913458|469224621|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
130342378|NCT00913458|469224622|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
130342379|NCT00913458|469224623|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
130342380|NCT00913458|469224617|FG000|Phase 2|Non-Responder|0|||
130342381|NCT00913458|469224618|FG001|Phase 2|Non-Responder|5|||
130342382|NCT00913458|469224619|FG002|Phase 2|Non-Responder|7|||
130342383|NCT00913458|469224620|FG003|Phase 2|Non-Responder|12|||
130342384|NCT00913458|469224621|FG004|Phase 2|Non-Responder|0|||
130342385|NCT00913458|469224622|FG005|Phase 2|Non-Responder|0|||
130342386|NCT00913458|469224623|FG006|Phase 2|Non-Responder|0|||
130342387|NCT00913458|469224617|FG000|Phase 2|Subject Request|0|||
130342388|NCT00913458|469224618|FG001|Phase 2|Subject Request|0|||
130342389|NCT00913458|469224619|FG002|Phase 2|Subject Request|1|||
130342390|NCT00913458|469224620|FG003|Phase 2|Subject Request|2|||
130342391|NCT00913458|469224621|FG004|Phase 2|Subject Request|0|||
130342392|NCT00913458|469224622|FG005|Phase 2|Subject Request|0|||
130342393|NCT00913458|469224623|FG006|Phase 2|Subject Request|0|||
130342394|NCT00913458|469224617|FG000|Phase 2|Adverse Event|0|||
130342395|NCT00913458|469224618|FG001|Phase 2|Adverse Event|3|||
130342396|NCT00913458|469224619|FG002|Phase 2|Adverse Event|0|||
130342397|NCT00913458|469224620|FG003|Phase 2|Adverse Event|1|||
130342398|NCT00913458|469224621|FG004|Phase 2|Adverse Event|0|||
130342399|NCT00913458|469224622|FG005|Phase 2|Adverse Event|0|||
130342400|NCT00913458|469224623|FG006|Phase 2|Adverse Event|0|||
130342401|NCT00913458|469224617|FG000|Phase 2|Lost to Follow-up|0|||
130342402|NCT00913458|469224618|FG001|Phase 2|Lost to Follow-up|0|||
130342403|NCT00913458|469224619|FG002|Phase 2|Lost to Follow-up|0|||
130342404|NCT00913458|469224620|FG003|Phase 2|Lost to Follow-up|1|||
130677556|NCT00462982|470445327|FG000|Overall Study|Adverse Event|1|||
130677557|NCT00462982|470445327|FG000|Overall Study|Patient Not Treated|2|||
130677558|NCT00679367|470445328|FG000|Overall Study|Adverse Event|7|||
130677559|NCT00679367|470445328|FG000|Overall Study|inability to swallow oral drugs|1|||
130342405|NCT00913458|469224621|FG004|Phase 2|Lost to Follow-up|0|||
130342406|NCT00913458|469224622|FG005|Phase 2|Lost to Follow-up|0|||
130342407|NCT00913458|469224623|FG006|Phase 2|Lost to Follow-up|0|||
130342408|NCT00913458|469224617|FG000|Phase 2|Protocol Violation|0|||
130342409|NCT00913458|469224618|FG001|Phase 2|Protocol Violation|2|||
130342410|NCT00913458|469224619|FG002|Phase 2|Protocol Violation|0|||
130342411|NCT00913458|469224620|FG003|Phase 2|Protocol Violation|0|||
130342412|NCT00913458|469224621|FG004|Phase 2|Protocol Violation|0|||
130342413|NCT00913458|469224622|FG005|Phase 2|Protocol Violation|0|||
130342414|NCT00913458|469224623|FG006|Phase 2|Protocol Violation|0|||
130342415|NCT00913458|469224617|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
130342416|NCT00913458|469224618|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
130342417|NCT00913458|469224619|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
130342418|NCT00913458|469224620|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
130342419|NCT00913458|469224621|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
130342420|NCT00913458|469224622|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
130342421|NCT00913458|469224623|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
130342422|NCT00913458|469224617|FG000|Phase 3|Adverse Event|0|||
130342423|NCT00913458|469224618|FG001|Phase 3|Adverse Event|0|||
130342424|NCT00913458|469224619|FG002|Phase 3|Adverse Event|0|||
130342425|NCT00913458|469224620|FG003|Phase 3|Adverse Event|0|||
130342426|NCT00913458|469224621|FG004|Phase 3|Adverse Event|5|||
130342427|NCT00913458|469224622|FG005|Phase 3|Adverse Event|4|||
130342428|NCT00913458|469224623|FG006|Phase 3|Adverse Event|1|||
130342429|NCT00913458|469224617|FG000|Phase 3|Lost to Follow-up|0|||
130342430|NCT00913458|469224618|FG001|Phase 3|Lost to Follow-up|0|||
130342431|NCT00913458|469224619|FG002|Phase 3|Lost to Follow-up|0|||
130342432|NCT00913458|469224620|FG003|Phase 3|Lost to Follow-up|0|||
130342433|NCT00913458|469224621|FG004|Phase 3|Lost to Follow-up|2|||
130342434|NCT00913458|469224622|FG005|Phase 3|Lost to Follow-up|0|||
130342435|NCT00913458|469224623|FG006|Phase 3|Lost to Follow-up|0|||
130342436|NCT00913458|469224617|FG000|Phase 3|Non-Responder|0|||
130342437|NCT00913458|469224618|FG001|Phase 3|Non-Responder|0|||
130342438|NCT00913458|469224619|FG002|Phase 3|Non-Responder|0|||
130342439|NCT00913458|469224620|FG003|Phase 3|Non-Responder|0|||
130342440|NCT00913458|469224621|FG004|Phase 3|Non-Responder|0|||
130342441|NCT00913458|469224622|FG005|Phase 3|Non-Responder|1|||
130342442|NCT00913458|469224623|FG006|Phase 3|Non-Responder|3|||
130342443|NCT00913458|469224617|FG000|Phase 3|Withdrawal by Subject|0|||
130342444|NCT00913458|469224618|FG001|Phase 3|Withdrawal by Subject|0|||
130342445|NCT00913458|469224619|FG002|Phase 3|Withdrawal by Subject|0|||
130342446|NCT00913458|469224620|FG003|Phase 3|Withdrawal by Subject|0|||
130342447|NCT00913458|469224621|FG004|Phase 3|Withdrawal by Subject|1|||
130342448|NCT00913458|469224622|FG005|Phase 3|Withdrawal by Subject|2|||
130342449|NCT00913458|469224623|FG006|Phase 3|Withdrawal by Subject|0|||
130342450|NCT00913458|469224617|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
130342451|NCT00913458|469224618|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
130342452|NCT00913458|469224619|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
130342453|NCT00913458|469224620|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
130342454|NCT00913458|469224621|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
130342455|NCT00913458|469224622|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
130342456|NCT00913458|469224623|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
130342457|NCT00357760|469224627|FG000|Overall Study|Disease progression|44|||
130342458|NCT00357760|469224628|FG001|Overall Study|Disease progression|17|||
130342459|NCT00357760|469224627|FG000|Overall Study|Adverse Event|10|||
130342460|NCT00357760|469224628|FG001|Overall Study|Adverse Event|7|||
130342461|NCT00357760|469224627|FG000|Overall Study|Death|0|||
130342462|NCT00357760|469224628|FG001|Overall Study|Death|3|||
130342463|NCT00357760|469224627|FG000|Overall Study|Alternative therapy|1|||
130342464|NCT00357760|469224628|FG001|Overall Study|Alternative therapy|0|||
130342465|NCT00357760|469224627|FG000|Overall Study|Withdrawal by Subject|0|||
130342466|NCT00357760|469224628|FG001|Overall Study|Withdrawal by Subject|2|||
130342467|NCT00357760|469224627|FG000|Overall Study|Never started treatment|2|||
130342468|NCT00357760|469224628|FG001|Overall Study|Never started treatment|1|||
130342469|NCT00357760|469224627|FG000|Overall Study|Ineligible|0|||
130342470|NCT00357760|469224628|FG001|Overall Study|Ineligible|2|||
130342471|NCT00357760|469224627|FG000|Overall Study|Physician Decision|2|||
130342472|NCT00357760|469224628|FG001|Overall Study|Physician Decision|1|||
130342473|NCT00357760|469224627|FG000|Overall Study|Protocol Violation|0|||
130342474|NCT00357760|469224628|FG001|Overall Study|Protocol Violation|1|||
130342475|NCT00357760|469224627|FG000|Overall Study|To receive hospice care|0|||
130342476|NCT00357760|469224628|FG001|Overall Study|To receive hospice care|1|||
130342477|NCT04136444|469224629|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
130342478|NCT04136444|469224630|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
130342479|NCT02238067|469224631|FG000|Overall Study|Not completed survey at Month 6|45|||
130342480|NCT00869778|469224632|FG000|Overall Study|Adverse Event|2|||
130342481|NCT00869778|469224633|FG001|Overall Study|Adverse Event|0|||
130342482|NCT00869778|469224634|FG002|Overall Study|Adverse Event|0|||
130342483|NCT00869778|469224632|FG000|Overall Study|Withdrawal by Subject|3|||
130342484|NCT00869778|469224633|FG001|Overall Study|Withdrawal by Subject|4|||
130342485|NCT00869778|469224634|FG002|Overall Study|Withdrawal by Subject|5|||
130342486|NCT00869778|469224632|FG000|Overall Study|Pregnancy|1|||
130342487|NCT00869778|469224633|FG001|Overall Study|Pregnancy|0|||
130342488|NCT00869778|469224634|FG002|Overall Study|Pregnancy|0|||
130342489|NCT00869778|469224632|FG000|Overall Study|Protocol Violation|5|||
130342490|NCT00869778|469224633|FG001|Overall Study|Protocol Violation|3|||
130342491|NCT00869778|469224634|FG002|Overall Study|Protocol Violation|5|||
130342492|NCT00869778|469224632|FG000|Overall Study|Unblinding|1|||
130342493|NCT00869778|469224633|FG001|Overall Study|Unblinding|0|||
130342494|NCT00869778|469224634|FG002|Overall Study|Unblinding|0|||
130342495|NCT03726996|469224637|FG000|Overall Study|Parent's decision|2|||
130342496|NCT03726996|469224637|FG000|Overall Study|Study early termination|2|||
130342497|NCT03180619|469224638|FG000|Overall Study|Withdrew Consent|5|||
130342498|NCT03180619|469224639|FG001|Overall Study|Withdrew Consent|0|||
130342499|NCT03180619|469224640|FG002|Overall Study|Withdrew Consent|2|||
130342500|NCT03180619|469224638|FG000|Overall Study|Death|2|||
130342501|NCT03180619|469224639|FG001|Overall Study|Death|1|||
130342502|NCT03180619|469224640|FG002|Overall Study|Death|2|||
130342503|NCT03180619|469224638|FG000|Overall Study|Adverse Event|2|||
130342504|NCT03180619|469224639|FG001|Overall Study|Adverse Event|0|||
130342505|NCT03180619|469224640|FG002|Overall Study|Adverse Event|1|||
130342506|NCT03180619|469224638|FG000|Overall Study|Investigator's discretion|2|||
130342507|NCT03180619|469224639|FG001|Overall Study|Investigator's discretion|0|||
130342508|NCT03180619|469224640|FG002|Overall Study|Investigator's discretion|1|||
130342509|NCT02743611|469224641|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
130342510|NCT02743611|469224642|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
130342511|NCT02743611|469224643|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
130342512|NCT02743611|469224644|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
130342513|NCT00402740|469224653|FG000|Overall Study|Withdrawal by Subject|18|||
130342514|NCT00402740|469224653|FG000|Overall Study|Death|50|||
130342515|NCT00402740|469224653|FG000|Overall Study|Lost to Follow-up|6|||
130342516|NCT00402740|469224653|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
130342517|NCT00402740|469224653|FG000|Overall Study|Subject disposition unknown.|1|||
130342518|NCT02342418|469224656|FG000|Overall Study|Adverse Event|0|||
130342519|NCT02342418|469224657|FG001|Overall Study|Adverse Event|1|||
130342520|NCT04255394|469224658|FG000|Overall Study|Death|35|||
130342521|NCT04255394|469224659|FG001|Overall Study|Death|25|||
130342522|NCT04255394|469224658|FG000|Overall Study|Device removed|2|||
130342523|NCT04255394|469224659|FG001|Overall Study|Device removed|10|||
130342524|NCT04255394|469224658|FG000|Overall Study|Withdrawal by Subject|9|||
130342525|NCT04255394|469224659|FG001|Overall Study|Withdrawal by Subject|8|||
130342526|NCT04255394|469224658|FG000|Overall Study|Screen Failure/Not treated|12|||
130342527|NCT04255394|469224659|FG001|Overall Study|Screen Failure/Not treated|8|||
130342528|NCT04255394|469224658|FG000|Overall Study|Lost to Follow-up|123|||
130342529|NCT04255394|469224659|FG001|Overall Study|Lost to Follow-up|265|||
130342530|NCT04255394|469224658|FG000|Overall Study|Adverse Event|1|||
130342531|NCT04255394|469224659|FG001|Overall Study|Adverse Event|3|||
130342532|NCT01159431|469224663|FG000|Overall Study|Adverse Event|1|||
130342533|NCT01159431|469224664|FG001|Overall Study|Adverse Event|2|||
130342534|NCT01159431|469224663|FG000|Overall Study|non-compliance|1|||
130342535|NCT01159431|469224664|FG001|Overall Study|non-compliance|1|||
130342536|NCT01159431|469224663|FG000|Overall Study|Lack of Efficacy|0|||
130342537|NCT01159431|469224664|FG001|Overall Study|Lack of Efficacy|3|||
130342538|NCT00534599|469224670|FG000|Overall Study|Adverse Event|25|||
130342539|NCT00534599|469224671|FG001|Overall Study|Adverse Event|4|||
130342540|NCT00534599|469224670|FG000|Overall Study|Incorrect enrollment|2|||
130342541|NCT00534599|469224671|FG001|Overall Study|Incorrect enrollment|1|||
130342542|NCT00534599|469224670|FG000|Overall Study|Mis-randomization|2|||
130342543|NCT00534599|469224671|FG001|Overall Study|Mis-randomization|2|||
130342544|NCT00534599|469224670|FG000|Overall Study|Developed study-specific d/c criteria|5|||
130342545|NCT00534599|469224671|FG001|Overall Study|Developed study-specific d/c criteria|0|||
130342546|NCT00534599|469224670|FG000|Overall Study|Lack of Efficacy|0|||
130342547|NCT00534599|469224671|FG001|Overall Study|Lack of Efficacy|1|||
130342548|NCT00534599|469224670|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
130342549|NCT00534599|469224671|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
130342550|NCT00534599|469224670|FG000|Overall Study|Protocol Violation|1|||
130342551|NCT00534599|469224671|FG001|Overall Study|Protocol Violation|3|||
130342552|NCT00534599|469224670|FG000|Overall Study|Lost to Follow-up|11|||
130342553|NCT00534599|469224671|FG001|Overall Study|Lost to Follow-up|14|||
130342554|NCT00534599|469224670|FG000|Overall Study|Withdrawal by Subject|4|||
130342555|NCT00534599|469224671|FG001|Overall Study|Withdrawal by Subject|6|||
130342556|NCT00534599|469224670|FG000|Overall Study|Other|7|||
130342557|NCT00534599|469224671|FG001|Overall Study|Other|0|||
130342558|NCT03645434|469224673|FG000|Period 1|Adverse Event|0|||
130342559|NCT03645434|469224674|FG001|Period 1|Adverse Event|0|||
130342560|NCT03645434|469224675|FG002|Period 1|Adverse Event|0|||
130342561|NCT03645434|469224676|FG003|Period 1|Adverse Event|1|||
130342562|NCT03645434|469224677|FG004|Period 1|Adverse Event|0|||
130342563|NCT03645434|469224678|FG005|Period 1|Adverse Event|0|||
130342564|NCT03645434|469224673|FG000|Period 1|COPD exacerbation|0|||
130342565|NCT03645434|469224674|FG001|Period 1|COPD exacerbation|0|||
130216595|NCT05305989|468755617|FG001|Overall Study|Other|2|||
130342566|NCT03645434|469224675|FG002|Period 1|COPD exacerbation|0|||
130342567|NCT03645434|469224676|FG003|Period 1|COPD exacerbation|0|||
130342568|NCT03645434|469224677|FG004|Period 1|COPD exacerbation|1|||
130342569|NCT03645434|469224678|FG005|Period 1|COPD exacerbation|0|||
130342570|NCT03865316|469227125|FG000|Overall Study|Procedure Cancelled|4|||
130342571|NCT03865316|469227125|FG000|Overall Study|Equipment failure|4|||
130342572|NCT03137069|469227130|FG000|Overall Study|Withdrawal by Subject|1|||
130342573|NCT03137069|469227131|FG001|Overall Study|Withdrawal by Subject|2|||
130342574|NCT03137069|469227132|FG002|Overall Study|Withdrawal by Subject|2|||
130342575|NCT03137069|469227133|FG003|Overall Study|Withdrawal by Subject|2|||
130342576|NCT03137069|469227134|FG004|Overall Study|Withdrawal by Subject|0|||
130342577|NCT03137069|469227135|FG005|Overall Study|Withdrawal by Subject|0|||
130342578|NCT03137069|469227130|FG000|Overall Study|Adverse Event|0|||
130342579|NCT03137069|469227131|FG001|Overall Study|Adverse Event|3|||
130342580|NCT03137069|469227132|FG002|Overall Study|Adverse Event|1|||
130342581|NCT03137069|469227133|FG003|Overall Study|Adverse Event|1|||
130342582|NCT03137069|469227134|FG004|Overall Study|Adverse Event|0|||
130342583|NCT03137069|469227135|FG005|Overall Study|Adverse Event|1|||
130342584|NCT03137069|469227130|FG000|Overall Study|Protocol Violation|0|||
130342585|NCT03137069|469227131|FG001|Overall Study|Protocol Violation|1|||
130342586|NCT03137069|469227132|FG002|Overall Study|Protocol Violation|0|||
130342587|NCT03137069|469227133|FG003|Overall Study|Protocol Violation|1|||
130342588|NCT03137069|469227134|FG004|Overall Study|Protocol Violation|1|||
130342589|NCT03137069|469227135|FG005|Overall Study|Protocol Violation|1|||
130342590|NCT03137069|469227130|FG000|Overall Study|Physician Decision|0|||
130342591|NCT03137069|469227131|FG001|Overall Study|Physician Decision|0|||
130342592|NCT03137069|469227132|FG002|Overall Study|Physician Decision|0|||
130342593|NCT03137069|469227133|FG003|Overall Study|Physician Decision|1|||
130342594|NCT03137069|469227134|FG004|Overall Study|Physician Decision|0|||
130342595|NCT03137069|469227135|FG005|Overall Study|Physician Decision|0|||
130342596|NCT03137069|469227130|FG000|Overall Study|Study Terminated by Sponsor|0|||
130342597|NCT03137069|469227131|FG001|Overall Study|Study Terminated by Sponsor|0|||
130342598|NCT03137069|469227132|FG002|Overall Study|Study Terminated by Sponsor|0|||
130342599|NCT03137069|469227133|FG003|Overall Study|Study Terminated by Sponsor|0|||
130342600|NCT03137069|469227134|FG004|Overall Study|Study Terminated by Sponsor|1|||
130342601|NCT03137069|469227135|FG005|Overall Study|Study Terminated by Sponsor|0|||
130342602|NCT03137069|469227130|FG000|Overall Study|Data Entry Error|0|||
130342603|NCT03137069|469227131|FG001|Overall Study|Data Entry Error|0|||
130342604|NCT03137069|469227132|FG002|Overall Study|Data Entry Error|0|||
130342605|NCT03137069|469227133|FG003|Overall Study|Data Entry Error|1|||
130342606|NCT03137069|469227134|FG004|Overall Study|Data Entry Error|0|||
130342607|NCT03137069|469227135|FG005|Overall Study|Data Entry Error|0|||
130342608|NCT00336856|469227136|FG000|Overall Study|Withdrawal by Subject|3|||
130342609|NCT00336856|469227136|FG000|Overall Study|Found ineligible at time of analysis|1|||
130342610|NCT00362180|469227138|FG000|Treated Period|Withdrawal by Subject|1|||
130342611|NCT00362180|469227139|FG001|Treated Period|Withdrawal by Subject|0|||
130342612|NCT00362180|469227140|FG002|Treated Period|Withdrawal by Subject|0|||
130342613|NCT00362180|469227141|FG003|Treated Period|Withdrawal by Subject|0|||
130342614|NCT00362180|469227142|FG004|Treated Period|Withdrawal by Subject|0|||
130342615|NCT00362180|469227143|FG005|Treated Period|Withdrawal by Subject|0|||
130342616|NCT00362180|469227144|FG006|Treated Period|Withdrawal by Subject|0|||
130342617|NCT00362180|469227145|FG007|Treated Period|Withdrawal by Subject|0|||
130342618|NCT00362180|469227146|FG008|Treated Period|Withdrawal by Subject|0|||
130342619|NCT00362180|469227138|FG000|Treated Period|Adverse Event|0|||
130342620|NCT00362180|469227139|FG001|Treated Period|Adverse Event|0|||
130342621|NCT00362180|469227140|FG002|Treated Period|Adverse Event|0|||
130342622|NCT00362180|469227141|FG003|Treated Period|Adverse Event|0|||
130342623|NCT00362180|469227142|FG004|Treated Period|Adverse Event|0|||
130342624|NCT00362180|469227143|FG005|Treated Period|Adverse Event|1|||
130342625|NCT00362180|469227144|FG006|Treated Period|Adverse Event|0|||
130342626|NCT00362180|469227145|FG007|Treated Period|Adverse Event|1|||
130342627|NCT00362180|469227146|FG008|Treated Period|Adverse Event|0|||
130342628|NCT02434471|469227149|FG000|Overall Study|Physician Decision|9|||
130342629|NCT00843778|469227150|FG000|Overall Study|Adverse Event|15|||
130342630|NCT00843778|469227150|FG000|Overall Study|Lack of Efficacy|14|||
130342631|NCT00843778|469227150|FG000|Overall Study|Loss of efficacy|2|||
130342632|NCT00843778|469227150|FG000|Overall Study|Withdrawal by Subject|4|||
130342633|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130342634|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130342635|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130342636|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130342637|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342638|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342639|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
130342640|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342641|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
130342642|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342643|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342644|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342645|NCT00369629|469227151|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
130342646|NCT00369629|469227152|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
130342647|NCT00369629|469227153|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
130342648|NCT00369629|469227154|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
130342649|NCT00369629|469227151|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
130342650|NCT00369629|469227152|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
130342651|NCT00369629|469227153|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
130342652|NCT00369629|469227154|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
130342653|NCT00369629|469227151|FG000|Completed 4 More Cycles|Progressive disease|2|||
130342654|NCT00369629|469227152|FG001|Completed 4 More Cycles|Progressive disease|1|||
130342655|NCT00369629|469227153|FG002|Completed 4 More Cycles|Progressive disease|2|||
130342656|NCT00369629|469227154|FG003|Completed 4 More Cycles|Progressive disease|0|||
130342657|NCT00369629|469227151|FG000|Follow up for 1 Year|Death|2|||
130342658|NCT00369629|469227152|FG001|Follow up for 1 Year|Death|1|||
130342659|NCT00369629|469227153|FG002|Follow up for 1 Year|Death|1|||
130342660|NCT00369629|469227154|FG003|Follow up for 1 Year|Death|0|||
130342661|NCT00369629|469227151|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
130342662|NCT00369629|469227152|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
130342663|NCT00369629|469227153|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
130342664|NCT00369629|469227154|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
130342665|NCT00369629|469227151|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
130342666|NCT00369629|469227152|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
130342667|NCT00369629|469227153|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
130342668|NCT00369629|469227154|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
130342669|NCT00538785|469227156|FG000|Overall Study|Death|9|||
130342670|NCT00538785|469227157|FG001|Overall Study|Death|10|||
130342671|NCT00538785|469227156|FG000|Overall Study|Withdrawal of consent|9|||
130342672|NCT00538785|469227157|FG001|Overall Study|Withdrawal of consent|7|||
130342673|NCT00538785|469227156|FG000|Overall Study|Lost to Follow-up|1|||
130342674|NCT00538785|469227157|FG001|Overall Study|Lost to Follow-up|0|||
130342675|NCT01478048|469227160|FG000|Overall Study|Disease Progression|52|||
130342676|NCT01478048|469227161|FG001|Overall Study|Disease Progression|35|||
130342677|NCT01478048|469227160|FG000|Overall Study|study drug toxicity|11|||
130342678|NCT01478048|469227161|FG001|Overall Study|study drug toxicity|14|||
130342679|NCT01478048|469227160|FG000|Overall Study|Adverse Event|2|||
130342680|NCT01478048|469227161|FG001|Overall Study|Adverse Event|11|||
130342681|NCT01478048|469227160|FG000|Overall Study|subject request to discontinue treatment|3|||
130342682|NCT01478048|469227161|FG001|Overall Study|subject request to discontinue treatment|5|||
130342683|NCT01478048|469227160|FG000|Overall Study|Withdrawal by Subject|2|||
130342684|NCT01478048|469227161|FG001|Overall Study|Withdrawal by Subject|5|||
130342685|NCT01478048|469227160|FG000|Overall Study|non-specified|6|||
130342686|NCT01478048|469227161|FG001|Overall Study|non-specified|4|||
130342687|NCT01478048|469227160|FG000|Overall Study|poor/non-compliance|0|||
130342688|NCT01478048|469227161|FG001|Overall Study|poor/non-compliance|1|||
130342689|NCT01478048|469227160|FG000|Overall Study|no longer meets study criteria|1|||
130342690|NCT01478048|469227161|FG001|Overall Study|no longer meets study criteria|0|||
130342691|NCT03642132|469227167|FG000|Chemotherapy Period|Adverse Event|1|||
130342692|NCT03642132|469227168|FG001|Chemotherapy Period|Adverse Event|1|||
130342693|NCT03642132|469227169|FG002|Chemotherapy Period|Adverse Event|0|||
130342694|NCT03642132|469227167|FG000|Chemotherapy Period|Physician's decision|4|||
130342695|NCT03642132|469227168|FG001|Chemotherapy Period|Physician's decision|1|||
130342696|NCT03642132|469227169|FG002|Chemotherapy Period|Physician's decision|0|||
130342697|NCT03642132|469227167|FG000|Chemotherapy Period|Progressive disease|0|||
130342698|NCT03642132|469227168|FG001|Chemotherapy Period|Progressive disease|0|||
130342699|NCT03642132|469227169|FG002|Chemotherapy Period|Progressive disease|1|||
130342700|NCT03642132|469227167|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
130342701|NCT03642132|469227168|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
130342702|NCT03642132|469227169|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
130342703|NCT03642132|469227167|FG000|Chemotherapy Period|Other|1|||
130342704|NCT03642132|469227168|FG001|Chemotherapy Period|Other|0|||
130342705|NCT03642132|469227169|FG002|Chemotherapy Period|Other|2|||
130342706|NCT03642132|469227167|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
130342707|NCT03642132|469227168|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
130342708|NCT03642132|469227169|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
130342709|NCT03642132|469227167|FG000|Maintenance Period|Adverse Event|1|||
130342710|NCT03642132|469227168|FG001|Maintenance Period|Adverse Event|2|||
130342711|NCT03642132|469227169|FG002|Maintenance Period|Adverse Event|0|||
130342712|NCT03642132|469227167|FG000|Maintenance Period|Non-compliance with study drug|0|||
130342713|NCT03642132|469227168|FG001|Maintenance Period|Non-compliance with study drug|0|||
130342714|NCT03642132|469227169|FG002|Maintenance Period|Non-compliance with study drug|1|||
130342715|NCT03642132|469227167|FG000|Maintenance Period|Physician's decision|2|||
130342716|NCT03642132|469227168|FG001|Maintenance Period|Physician's decision|2|||
130342717|NCT03642132|469227169|FG002|Maintenance Period|Physician's decision|2|||
130216596|NCT05305989|468755618|FG002|Overall Study|Other|0|||
130342718|NCT03642132|469227167|FG000|Maintenance Period|Progressive disease|9|||
130342719|NCT03642132|469227168|FG001|Maintenance Period|Progressive disease|3|||
130342720|NCT03642132|469227169|FG002|Maintenance Period|Progressive disease|6|||
130342721|NCT03642132|469227167|FG000|Maintenance Period|Other|0|||
130342722|NCT03642132|469227168|FG001|Maintenance Period|Other|0|||
130342723|NCT03642132|469227169|FG002|Maintenance Period|Other|3|||
130342724|NCT03642132|469227167|FG000|Maintenance Period|Withdrawal by Subject|1|||
130342725|NCT03642132|469227168|FG001|Maintenance Period|Withdrawal by Subject|1|||
130342726|NCT03642132|469227169|FG002|Maintenance Period|Withdrawal by Subject|2|||
130342727|NCT03642132|469227167|FG000|Follow-up Period|Other|0|||
130342728|NCT03642132|469227168|FG001|Follow-up Period|Other|0|||
130342729|NCT03642132|469227169|FG002|Follow-up Period|Other|1|||
130342730|NCT03642132|469227167|FG000|Follow-up Period|Withdrawal by Subject|1|||
130342731|NCT03642132|469227168|FG001|Follow-up Period|Withdrawal by Subject|2|||
130342732|NCT03642132|469227169|FG002|Follow-up Period|Withdrawal by Subject|0|||
130342733|NCT03642132|469227167|FG000|Follow-up Period|Study terminated by sponsor|1|||
130342734|NCT03642132|469227168|FG001|Follow-up Period|Study terminated by sponsor|0|||
130342735|NCT03642132|469227169|FG002|Follow-up Period|Study terminated by sponsor|1|||
130342736|NCT03642132|469227167|FG000|Follow-up Period|Lack of Efficacy|1|||
130342737|NCT03642132|469227168|FG001|Follow-up Period|Lack of Efficacy|0|||
130342738|NCT03642132|469227169|FG002|Follow-up Period|Lack of Efficacy|0|||
130342739|NCT03642132|469227167|FG000|Follow-up Period|Death|1|||
130342740|NCT03642132|469227168|FG001|Follow-up Period|Death|0|||
130342741|NCT03642132|469227169|FG002|Follow-up Period|Death|2|||
130342742|NCT03642132|469227167|FG000|Follow-up Period|Adverse Event|1|||
130342743|NCT03642132|469227168|FG001|Follow-up Period|Adverse Event|0|||
130342744|NCT03642132|469227169|FG002|Follow-up Period|Adverse Event|0|||
130342745|NCT03337490|469227170|FG000|Overall Study|Withdrawal by Subject|1|||
130342746|NCT03337490|469227171|FG001|Overall Study|Withdrawal by Subject|0|||
130342747|NCT03337490|469227172|FG002|Overall Study|Withdrawal by Subject|0|||
130342748|NCT03337490|469227170|FG000|Overall Study|Lack of Efficacy|10|||
130342749|NCT03337490|469227171|FG001|Overall Study|Lack of Efficacy|12|||
130342750|NCT03337490|469227172|FG002|Overall Study|Lack of Efficacy|35|||
130342751|NCT03337490|469227170|FG000|Overall Study|Physician Decision|0|||
130342752|NCT03337490|469227171|FG001|Overall Study|Physician Decision|1|||
130342753|NCT03337490|469227172|FG002|Overall Study|Physician Decision|0|||
130342754|NCT03337490|469227170|FG000|Overall Study|Lost to Follow-up|0|||
130342755|NCT03337490|469227171|FG001|Overall Study|Lost to Follow-up|1|||
130342756|NCT03337490|469227172|FG002|Overall Study|Lost to Follow-up|0|||
130342757|NCT01541397|469227173|FG000|Overall Study|Study ended prior to data collection|4|||
130342758|NCT01541397|469227174|FG001|Overall Study|Study ended prior to data collection|2|||
130342759|NCT02577887|469227175|FG000|Overall Study|Death|93|||
130342760|NCT02577887|469227175|FG000|Overall Study|Protocol Violation|125|||
130342761|NCT02577887|469227175|FG000|Overall Study|Withdrawal by Subject|80|||
130342762|NCT03560518|469227176|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
130342763|NCT03560518|469227177|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130342764|NCT03560518|469227178|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130342765|NCT03560518|469227176|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
130342766|NCT03560518|469227177|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
130342767|NCT03560518|469227178|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
130342768|NCT03560518|469227176|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130342769|NCT03560518|469227177|FG001|Double Blind Treatment Period|Protocol Violation|2|||
130342770|NCT03560518|469227178|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130342771|NCT03560518|469227176|FG000|Double Blind Treatment Period|Pregnancy|0|||
130342772|NCT03560518|469227177|FG001|Double Blind Treatment Period|Pregnancy|2|||
130342773|NCT03560518|469227178|FG002|Double Blind Treatment Period|Pregnancy|0|||
130342774|NCT03560518|469227176|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
130342775|NCT03560518|469227177|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
130342776|NCT03560518|469227178|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
130342777|NCT03560518|469227176|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
130342778|NCT03560518|469227177|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
130342779|NCT03560518|469227178|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
130342780|NCT03560518|469227176|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130342781|NCT03560518|469227177|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
130342782|NCT03560518|469227178|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
130342783|NCT03560518|469227176|FG000|Double Blind Treatment Period|Adverse Event|0|||
130342784|NCT03560518|469227177|FG001|Double Blind Treatment Period|Adverse Event|3|||
130342785|NCT03560518|469227178|FG002|Double Blind Treatment Period|Adverse Event|1|||
130342786|NCT01689532|469227179|FG000|Overall Study|Adverse Event|9|||
130342787|NCT01689532|469227180|FG001|Overall Study|Adverse Event|5|||
130342788|NCT01689532|469227179|FG000|Overall Study|Lack of Efficacy|2|||
130342789|NCT01689532|469227180|FG001|Overall Study|Lack of Efficacy|2|||
130342790|NCT01689532|469227179|FG000|Overall Study|Withdrawal by Subject|1|||
130342791|NCT01689532|469227180|FG001|Overall Study|Withdrawal by Subject|2|||
130342792|NCT01689532|469227179|FG000|Overall Study|Physician Decision|2|||
130342793|NCT01689532|469227180|FG001|Overall Study|Physician Decision|0|||
130342794|NCT01363349|469227181|FG000|Overall Study|Adverse Event|6|||
130342795|NCT01363349|469227182|FG001|Overall Study|Adverse Event|7|||
130342796|NCT01363349|469227181|FG000|Overall Study|Lack of Efficacy|3|||
130342797|NCT01363349|469227182|FG001|Overall Study|Lack of Efficacy|10|||
130342798|NCT01363349|469227181|FG000|Overall Study|Non compliance/Protocol deviations|2|||
130342799|NCT01363349|469227182|FG001|Overall Study|Non compliance/Protocol deviations|2|||
130342800|NCT01363349|469227181|FG000|Overall Study|Withdrawal by Subject|14|||
130342801|NCT01363349|469227182|FG001|Overall Study|Withdrawal by Subject|6|||
130342802|NCT01363349|469227181|FG000|Overall Study|Lost to Follow-up|5|||
130342803|NCT01363349|469227182|FG001|Overall Study|Lost to Follow-up|6|||
130342804|NCT01363349|469227181|FG000|Overall Study|Not reported|36|||
130342805|NCT01363349|469227182|FG001|Overall Study|Not reported|37|||
130342806|NCT01363349|469227181|FG000|Overall Study|missing|1|||
130342807|NCT01363349|469227182|FG001|Overall Study|missing|2|||
130342808|NCT01958489|469227183|FG000|Period 2|Adverse Event|0|||
130342809|NCT01958489|469227184|FG001|Period 2|Adverse Event|1|||
130342810|NCT03595618|469227185|FG000|Overall Study|Adverse Event|16|||
130342811|NCT03595618|469227186|FG001|Overall Study|Adverse Event|17|||
130342812|NCT03595618|469227187|FG002|Overall Study|Adverse Event|20|||
130342813|NCT03595618|469227188|FG003|Overall Study|Adverse Event|8|||
130342814|NCT03595618|469227185|FG000|Overall Study|Withdrawal by Subject|12|||
130342815|NCT03595618|469227186|FG001|Overall Study|Withdrawal by Subject|14|||
130342816|NCT03595618|469227187|FG002|Overall Study|Withdrawal by Subject|14|||
130342817|NCT03595618|469227188|FG003|Overall Study|Withdrawal by Subject|10|||
130342818|NCT03595618|469227185|FG000|Overall Study|Lost to Follow-up|6|||
130342819|NCT03595618|469227186|FG001|Overall Study|Lost to Follow-up|4|||
130342820|NCT03595618|469227187|FG002|Overall Study|Lost to Follow-up|5|||
130342821|NCT03595618|469227188|FG003|Overall Study|Lost to Follow-up|6|||
130342822|NCT03595618|469227185|FG000|Overall Study|Protocol Violation|2|||
130342823|NCT03595618|469227186|FG001|Overall Study|Protocol Violation|0|||
130342824|NCT03595618|469227187|FG002|Overall Study|Protocol Violation|6|||
130342825|NCT03595618|469227188|FG003|Overall Study|Protocol Violation|2|||
130342826|NCT03595618|469227185|FG000|Overall Study|Physician Decision|0|||
130342827|NCT03595618|469227186|FG001|Overall Study|Physician Decision|0|||
130342828|NCT03595618|469227187|FG002|Overall Study|Physician Decision|1|||
130342829|NCT03595618|469227188|FG003|Overall Study|Physician Decision|2|||
130342830|NCT03595618|469227185|FG000|Overall Study|Miscellaneous|7|||
130342831|NCT03595618|469227186|FG001|Overall Study|Miscellaneous|5|||
130342832|NCT03595618|469227187|FG002|Overall Study|Miscellaneous|10|||
130342833|NCT03595618|469227188|FG003|Overall Study|Miscellaneous|6|||
130342834|NCT02338232|469227189|FG000|Overall Study|Screen Failure|3|||
130342835|NCT02338232|469227189|FG000|Overall Study|Withdrawal by Subject|6|||
130342836|NCT02338232|469227189|FG000|Overall Study|Adverse Event|2|||
130342837|NCT02279407|469227190|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342838|NCT02279407|469227191|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342839|NCT02279407|469227192|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
130342840|NCT02279407|469227193|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342841|NCT02279407|469227190|FG000|Overall Study|Withdrawal by Subject|1|||
130342842|NCT02279407|469227191|FG001|Overall Study|Withdrawal by Subject|0|||
130342843|NCT02279407|469227192|FG002|Overall Study|Withdrawal by Subject|1|||
130342844|NCT02279407|469227193|FG003|Overall Study|Withdrawal by Subject|1|||
130342845|NCT02279407|469227190|FG000|Overall Study|Adverse Event|1|||
130342846|NCT02279407|469227191|FG001|Overall Study|Adverse Event|1|||
130342847|NCT02279407|469227192|FG002|Overall Study|Adverse Event|2|||
130342848|NCT02279407|469227193|FG003|Overall Study|Adverse Event|0|||
130342849|NCT02500056|469227194|FG000|Overall Study|Lost to Follow-up|3|||
130342850|NCT02500056|469227195|FG001|Overall Study|Lost to Follow-up|7|||
130342851|NCT02500056|469227194|FG000|Overall Study|Recurrence|1|||
130342852|NCT02500056|469227195|FG001|Overall Study|Recurrence|0|||
130342853|NCT02500056|469227194|FG000|Overall Study|Death|3|||
130342854|NCT02500056|469227195|FG001|Overall Study|Death|1|||
130342855|NCT00864916|469227196|FG000|Overall Study|Lost to Follow-up|4|||
130342856|NCT00864916|469227197|FG001|Overall Study|Lost to Follow-up|4|||
130342857|NCT00864916|469227196|FG000|Overall Study|Protocol Violation|1|||
130342858|NCT00864916|469227197|FG001|Overall Study|Protocol Violation|0|||
130342859|NCT00864916|469227196|FG000|Overall Study|Withdrawal by Subject|1|||
130342860|NCT00864916|469227197|FG001|Overall Study|Withdrawal by Subject|0|||
130342861|NCT03996369|469227198|FG000|Overall Study|Protocol deviation|1|||
130342862|NCT03996369|469227199|FG001|Overall Study|Protocol deviation|1|||
130342863|NCT03996369|469227198|FG000|Overall Study|Physician Decision|4|||
130342864|NCT03996369|469227199|FG001|Overall Study|Physician Decision|2|||
130342865|NCT03996369|469227198|FG000|Overall Study|Participant decision|0|||
130342866|NCT03996369|469227199|FG001|Overall Study|Participant decision|1|||
130342867|NCT03996369|469227198|FG000|Overall Study|Lack of Efficacy|4|||
130342868|NCT03996369|469227199|FG001|Overall Study|Lack of Efficacy|0|||
130342869|NCT03996369|469227198|FG000|Overall Study|Adverse Event|9|||
130342870|NCT03996369|469227199|FG001|Overall Study|Adverse Event|0|||
130342871|NCT03996369|469227198|FG000|Overall Study|Withdrawal by Subject|6|||
130342872|NCT03996369|469227199|FG001|Overall Study|Withdrawal by Subject|8|||
130342873|NCT03996369|469227198|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
130342874|NCT03996369|469227199|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
130342875|NCT03996369|469227198|FG000|Overall Study|Lost to Follow-up|0|||
130342876|NCT03996369|469227199|FG001|Overall Study|Lost to Follow-up|1|||
130342877|NCT01185301|469227203|FG000|Overall Study|Adverse Event|3|||
130342878|NCT01185301|469227204|FG001|Overall Study|Adverse Event|0|||
130342879|NCT01185301|469227205|FG002|Overall Study|Adverse Event|2|||
130342880|NCT01185301|469227206|FG003|Overall Study|Adverse Event|3|||
130342881|NCT01185301|469227203|FG000|Overall Study|Withdrawal by Subject|7|||
130342882|NCT01185301|469227204|FG001|Overall Study|Withdrawal by Subject|5|||
130342883|NCT01185301|469227205|FG002|Overall Study|Withdrawal by Subject|2|||
130342884|NCT01185301|469227206|FG003|Overall Study|Withdrawal by Subject|3|||
130342885|NCT01185301|469227203|FG000|Overall Study|Lost to Follow-up|2|||
130342886|NCT01185301|469227204|FG001|Overall Study|Lost to Follow-up|0|||
130342887|NCT01185301|469227205|FG002|Overall Study|Lost to Follow-up|0|||
130342888|NCT01185301|469227206|FG003|Overall Study|Lost to Follow-up|1|||
130342889|NCT01185301|469227203|FG000|Overall Study|Other Reason|3|||
130342890|NCT01185301|469227204|FG001|Overall Study|Other Reason|2|||
130342891|NCT01185301|469227205|FG002|Overall Study|Other Reason|2|||
130342892|NCT01185301|469227206|FG003|Overall Study|Other Reason|2|||
130342893|NCT02683746|469227207|FG000|Overall Study|Adverse Event|3|||
130342894|NCT02683746|469227208|FG001|Overall Study|Adverse Event|2|||
130342895|NCT02683746|469227207|FG000|Overall Study|Lost to Follow-up|5|||
130342896|NCT02683746|469227208|FG001|Overall Study|Lost to Follow-up|6|||
130342897|NCT02683746|469227207|FG000|Overall Study|Withdrawal by Subject|6|||
130342898|NCT02683746|469227208|FG001|Overall Study|Withdrawal by Subject|5|||
130342899|NCT02683746|469227207|FG000|Overall Study|Physician Decision|2|||
130342900|NCT02683746|469227208|FG001|Overall Study|Physician Decision|1|||
130342901|NCT04987944|469227209|FG000|Overall Study|Adverse Event|0|||
130342902|NCT04987944|469227210|FG001|Overall Study|Adverse Event|1|||
130342903|NCT04987944|469227209|FG000|Overall Study|Withdrawal by Subject|0|||
130342904|NCT04987944|469227210|FG001|Overall Study|Withdrawal by Subject|1|||
130342905|NCT03077087|469227217|FG000|Overall Study|Physician Decision|2|||
130342906|NCT01989468|469227218|FG000|Overall Study|Adverse Event|10|||
130342907|NCT01989468|469227219|FG001|Overall Study|Adverse Event|15|||
130342908|NCT01989468|469227220|FG002|Overall Study|Adverse Event|4|||
130342909|NCT01989468|469227221|FG003|Overall Study|Adverse Event|5|||
130342910|NCT01989468|469227222|FG004|Overall Study|Adverse Event|4|||
130342911|NCT01989468|469227218|FG000|Overall Study|Lack of Efficacy|11|||
130342912|NCT01989468|469227219|FG001|Overall Study|Lack of Efficacy|11|||
130342913|NCT01989468|469227220|FG002|Overall Study|Lack of Efficacy|7|||
130342914|NCT01989468|469227221|FG003|Overall Study|Lack of Efficacy|4|||
130342915|NCT01989468|469227222|FG004|Overall Study|Lack of Efficacy|2|||
130342916|NCT01989468|469227218|FG000|Overall Study|Lost to Follow-up|5|||
130342917|NCT01989468|469227219|FG001|Overall Study|Lost to Follow-up|2|||
130342918|NCT01989468|469227220|FG002|Overall Study|Lost to Follow-up|0|||
130342919|NCT01989468|469227221|FG003|Overall Study|Lost to Follow-up|1|||
130342920|NCT01989468|469227222|FG004|Overall Study|Lost to Follow-up|1|||
130342921|NCT01989468|469227218|FG000|Overall Study|Physician Decision|4|||
130342922|NCT01989468|469227219|FG001|Overall Study|Physician Decision|1|||
130342923|NCT01989468|469227220|FG002|Overall Study|Physician Decision|0|||
130342924|NCT01989468|469227221|FG003|Overall Study|Physician Decision|1|||
130342925|NCT01989468|469227222|FG004|Overall Study|Physician Decision|0|||
130342926|NCT01989468|469227218|FG000|Overall Study|Pregnancy|0|||
130342927|NCT01989468|469227219|FG001|Overall Study|Pregnancy|1|||
130342928|NCT01989468|469227220|FG002|Overall Study|Pregnancy|0|||
130342929|NCT01989468|469227221|FG003|Overall Study|Pregnancy|0|||
130342930|NCT01989468|469227222|FG004|Overall Study|Pregnancy|0|||
130342931|NCT01989468|469227218|FG000|Overall Study|Technical Problems|3|||
130342932|NCT01989468|469227219|FG001|Overall Study|Technical Problems|1|||
130342933|NCT01989468|469227220|FG002|Overall Study|Technical Problems|3|||
130342934|NCT01989468|469227221|FG003|Overall Study|Technical Problems|1|||
130342935|NCT01989468|469227222|FG004|Overall Study|Technical Problems|0|||
130342936|NCT01989468|469227218|FG000|Overall Study|Subject Guardian Decision|11|||
130342937|NCT01989468|469227219|FG001|Overall Study|Subject Guardian Decision|6|||
130342938|NCT01989468|469227220|FG002|Overall Study|Subject Guardian Decision|4|||
130342939|NCT01989468|469227221|FG003|Overall Study|Subject Guardian Decision|4|||
130342940|NCT01989468|469227222|FG004|Overall Study|Subject Guardian Decision|1|||
130342941|NCT01989468|469227218|FG000|Overall Study|Death|3|||
130342942|NCT01989468|469227219|FG001|Overall Study|Death|0|||
130342943|NCT01989468|469227220|FG002|Overall Study|Death|1|||
130342944|NCT01989468|469227221|FG003|Overall Study|Death|0|||
130342945|NCT01989468|469227222|FG004|Overall Study|Death|0|||
130342946|NCT02112045|469227230|FG000|Overall Study|Withdrawal by Subject|1|||
130342947|NCT02112045|469227231|FG001|Overall Study|Withdrawal by Subject|0|||
130342948|NCT00977080|469227232|FG000|Overall Study|Adverse Event|2|||
130342949|NCT00977080|469227233|FG001|Overall Study|Adverse Event|7|||
130342950|NCT00977080|469227234|FG002|Overall Study|Adverse Event|7|||
130342951|NCT00977080|469227235|FG003|Overall Study|Adverse Event|7|||
130342952|NCT00977080|469227232|FG000|Overall Study|Withdrawal by Subject|1|||
130342953|NCT00977080|469227233|FG001|Overall Study|Withdrawal by Subject|5|||
130342954|NCT00977080|469227234|FG002|Overall Study|Withdrawal by Subject|1|||
130342955|NCT00977080|469227235|FG003|Overall Study|Withdrawal by Subject|5|||
130342956|NCT00977080|469227232|FG000|Overall Study|Protocol Violation|7|||
130342957|NCT00977080|469227233|FG001|Overall Study|Protocol Violation|3|||
130342958|NCT00977080|469227234|FG002|Overall Study|Protocol Violation|4|||
130342959|NCT00977080|469227235|FG003|Overall Study|Protocol Violation|3|||
130342960|NCT00977080|469227232|FG000|Overall Study|Noncompliance|0|||
130342961|NCT00977080|469227233|FG001|Overall Study|Noncompliance|2|||
130342962|NCT00977080|469227234|FG002|Overall Study|Noncompliance|1|||
130342963|NCT00977080|469227235|FG003|Overall Study|Noncompliance|0|||
130342964|NCT00977080|469227232|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342965|NCT00977080|469227233|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342966|NCT00977080|469227234|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342967|NCT00977080|469227235|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
130342968|NCT00977080|469227232|FG000|Overall Study|Required kidney transplantation|1|||
130342969|NCT00977080|469227233|FG001|Overall Study|Required kidney transplantation|3|||
130342970|NCT00977080|469227234|FG002|Overall Study|Required kidney transplantation|3|||
130342971|NCT00977080|469227235|FG003|Overall Study|Required kidney transplantation|1|||
130342972|NCT00977080|469227232|FG000|Overall Study|Travel for family reasons|1|||
130342973|NCT00977080|469227233|FG001|Overall Study|Travel for family reasons|0|||
130342974|NCT00977080|469227234|FG002|Overall Study|Travel for family reasons|0|||
130342975|NCT00977080|469227235|FG003|Overall Study|Travel for family reasons|0|||
130342976|NCT00441116|469227238|FG000|Overall Study|Adverse Event|1|||
130342977|NCT00441116|469227239|FG001|Overall Study|Adverse Event|1|||
130342978|NCT00441116|469227238|FG000|Overall Study|Withdrawal by Subject|1|||
130342979|NCT00441116|469227239|FG001|Overall Study|Withdrawal by Subject|0|||
130342980|NCT00441116|469227238|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
130342981|NCT00441116|469227239|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
130342982|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342983|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
130342984|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342985|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342986|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342987|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342988|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342989|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342990|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342991|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342992|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342993|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342994|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342995|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342996|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342997|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342998|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342999|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130343000|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130343001|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
130343002|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343003|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343004|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343005|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343006|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343007|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343008|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343009|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343010|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343011|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
130343012|NCT00548184|469227255|FG000|Overall Study|Adverse Event|3|||
130343013|NCT00548184|469227255|FG000|Overall Study|took other drug|1|||
130343014|NCT00548184|469227255|FG000|Overall Study|Found Her2 negative|1|||
130343015|NCT01765218|469227264|FG000|Overall Study|Protocol Violation|1|||
130343016|NCT01765218|469227265|FG001|Overall Study|Protocol Violation|2|||
130343017|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
130343018|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
130343019|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
130343020|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
130343021|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
130343022|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
130343023|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
130343024|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
130343025|NCT00946985|469227266|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
130343026|NCT03148691|469227267|FG000|Overall Study|Protocol Violation|1|||
130343027|NCT03148691|469227268|FG001|Overall Study|Protocol Violation|2|||
130343028|NCT03148691|469227269|FG002|Overall Study|Protocol Violation|7|||
130343029|NCT03148691|469227267|FG000|Overall Study|Lost to Follow-up|0|||
130343030|NCT03148691|469227268|FG001|Overall Study|Lost to Follow-up|0|||
130343031|NCT03148691|469227269|FG002|Overall Study|Lost to Follow-up|1|||
130343032|NCT03148691|469227267|FG000|Overall Study|Other|1|||
130343033|NCT03148691|469227268|FG001|Overall Study|Other|0|||
130343034|NCT03148691|469227269|FG002|Overall Study|Other|0|||
130343035|NCT03148691|469227267|FG000|Overall Study|Withdrawal by Subject|1|||
130343036|NCT03148691|469227268|FG001|Overall Study|Withdrawal by Subject|0|||
130343037|NCT03148691|469227269|FG002|Overall Study|Withdrawal by Subject|0|||
130343038|NCT00171834|469227270|FG000|Overall Study|Adverse Event|2|||
130343039|NCT00171834|469227271|FG001|Overall Study|Adverse Event|1|||
130343040|NCT00171834|469227272|FG002|Overall Study|Adverse Event|3|||
130343041|NCT00171834|469227273|FG003|Overall Study|Adverse Event|2|||
130343042|NCT00171834|469227274|FG004|Overall Study|Adverse Event|2|||
130343043|NCT00171834|469227275|FG005|Overall Study|Adverse Event|15|||
130343044|NCT00171834|469227276|FG006|Overall Study|Adverse Event|1|||
130343045|NCT00171834|469227270|FG000|Overall Study|Withdrawal by Subject|0|||
130343046|NCT00171834|469227271|FG001|Overall Study|Withdrawal by Subject|2|||
130343047|NCT00171834|469227272|FG002|Overall Study|Withdrawal by Subject|0|||
130343048|NCT00171834|469227273|FG003|Overall Study|Withdrawal by Subject|1|||
130343049|NCT00171834|469227274|FG004|Overall Study|Withdrawal by Subject|1|||
130343050|NCT00171834|469227275|FG005|Overall Study|Withdrawal by Subject|1|||
130343051|NCT00171834|469227276|FG006|Overall Study|Withdrawal by Subject|0|||
130343052|NCT00171834|469227270|FG000|Overall Study|Death from study indication|0|||
130343053|NCT00171834|469227271|FG001|Overall Study|Death from study indication|1|||
130343054|NCT00171834|469227272|FG002|Overall Study|Death from study indication|0|||
130343055|NCT00171834|469227273|FG003|Overall Study|Death from study indication|0|||
130343056|NCT00171834|469227274|FG004|Overall Study|Death from study indication|1|||
130343057|NCT00171834|469227275|FG005|Overall Study|Death from study indication|0|||
130343058|NCT00171834|469227276|FG006|Overall Study|Death from study indication|0|||
130343059|NCT00171834|469227270|FG000|Overall Study|Disease Progression|4|||
130343060|NCT00171834|469227271|FG001|Overall Study|Disease Progression|8|||
130343061|NCT00171834|469227272|FG002|Overall Study|Disease Progression|8|||
130343062|NCT00171834|469227273|FG003|Overall Study|Disease Progression|9|||
130343063|NCT00171834|469227274|FG004|Overall Study|Disease Progression|2|||
130343064|NCT00171834|469227275|FG005|Overall Study|Disease Progression|18|||
130343065|NCT00171834|469227276|FG006|Overall Study|Disease Progression|3|||
130343066|NCT00171834|469227270|FG000|Overall Study|Treatment Duration Completed|0|||
130343067|NCT00171834|469227271|FG001|Overall Study|Treatment Duration Completed|0|||
130343068|NCT00171834|469227272|FG002|Overall Study|Treatment Duration Completed|1|||
130343069|NCT00171834|469227273|FG003|Overall Study|Treatment Duration Completed|0|||
130343070|NCT00171834|469227274|FG004|Overall Study|Treatment Duration Completed|2|||
130343071|NCT00171834|469227275|FG005|Overall Study|Treatment Duration Completed|1|||
130343072|NCT00171834|469227276|FG006|Overall Study|Treatment Duration Completed|0|||
130343073|NCT04345367|469227277|FG000|Overall Study|Other|3|||
130343074|NCT04345367|469227278|FG001|Overall Study|Other|4|||
130343075|NCT04345367|469227277|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
130343076|NCT04345367|469227278|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
130343077|NCT04345367|469227277|FG000|Overall Study|Withdrawal by Subject|11|||
130343078|NCT04345367|469227278|FG001|Overall Study|Withdrawal by Subject|11|||
130343079|NCT04345367|469227277|FG000|Overall Study|Protocol Violation|4|||
130343080|NCT04345367|469227278|FG001|Overall Study|Protocol Violation|3|||
130343081|NCT04345367|469227277|FG000|Overall Study|Lost to Follow-up|2|||
130343082|NCT04345367|469227278|FG001|Overall Study|Lost to Follow-up|4|||
130343083|NCT04345367|469227277|FG000|Overall Study|Lack of Efficacy|2|||
130343084|NCT04345367|469227278|FG001|Overall Study|Lack of Efficacy|0|||
130343085|NCT04345367|469227277|FG000|Overall Study|Death|2|||
130343086|NCT04345367|469227278|FG001|Overall Study|Death|0|||
130343087|NCT04345367|469227277|FG000|Overall Study|Adverse Event|10|||
130343088|NCT04345367|469227278|FG001|Overall Study|Adverse Event|9|||
130343089|NCT00796523|469227279|FG000|Overall Study|Lost to Follow-up|9|||
130343090|NCT00796523|469227280|FG001|Overall Study|Lost to Follow-up|7|||
130343091|NCT02431260|469227282|FG000|Overall Study|Subject Decision|0|||
130343092|NCT02431260|469227283|FG001|Overall Study|Subject Decision|1|||
130343093|NCT02431260|469227284|FG002|Overall Study|Subject Decision|1|||
130343094|NCT02431260|469227285|FG003|Overall Study|Subject Decision|0|||
130343095|NCT02431260|469227286|FG004|Overall Study|Subject Decision|0|||
130343096|NCT02431260|469227287|FG005|Overall Study|Subject Decision|0|||
130343097|NCT02431260|469227288|FG006|Overall Study|Subject Decision|0|||
130343098|NCT02431260|469227289|FG007|Overall Study|Subject Decision|0|||
130343099|NCT02431260|469227290|FG008|Overall Study|Subject Decision|1|||
130343100|NCT02431260|469227291|FG009|Overall Study|Subject Decision|1|||
130343101|NCT02431260|469227292|FG010|Overall Study|Subject Decision|0|||
130343102|NCT02431260|469227293|FG011|Overall Study|Subject Decision|1|||
130343103|NCT02431260|469227294|FG012|Overall Study|Subject Decision|0|||
130343104|NCT02431260|469227295|FG013|Overall Study|Subject Decision|0|||
130343105|NCT02431260|469227282|FG000|Overall Study|Death|4|||
130343106|NCT02431260|469227283|FG001|Overall Study|Death|4|||
130343107|NCT02431260|469227284|FG002|Overall Study|Death|3|||
130343108|NCT02431260|469227285|FG003|Overall Study|Death|4|||
130343109|NCT02431260|469227286|FG004|Overall Study|Death|2|||
130343110|NCT02431260|469227287|FG005|Overall Study|Death|2|||
130343111|NCT02431260|469227288|FG006|Overall Study|Death|3|||
130343112|NCT02431260|469227289|FG007|Overall Study|Death|1|||
130343113|NCT02431260|469227290|FG008|Overall Study|Death|6|||
130343114|NCT02431260|469227291|FG009|Overall Study|Death|6|||
130343115|NCT02431260|469227292|FG010|Overall Study|Death|3|||
130343116|NCT02431260|469227293|FG011|Overall Study|Death|2|||
130343117|NCT02431260|469227294|FG012|Overall Study|Death|5|||
130343118|NCT02431260|469227295|FG013|Overall Study|Death|1|||
130343119|NCT02431260|469227282|FG000|Overall Study|Lost to Follow-up|0|||
130343120|NCT02431260|469227283|FG001|Overall Study|Lost to Follow-up|0|||
130343121|NCT02431260|469227284|FG002|Overall Study|Lost to Follow-up|0|||
130433420|NCT04043962|469550435|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
130433421|NCT04615182|469550436|FG000|Overall Study|Re-transplanted|2|||
130433422|NCT04615182|469550436|FG000|Overall Study|Protocol Violation|6|||
130433423|NCT04615182|469550436|FG000|Overall Study|Death|6|||
130433424|NCT04615182|469550436|FG000|Overall Study|Death and protocol violation|1|||
130433425|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
130433426|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
130433427|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
130433428|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
130433429|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
130433430|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
130433431|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
130433432|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
130433433|NCT01336621|469550437|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
130433434|NCT01336621|469550437|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
130433435|NCT01336621|469550437|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
130433436|NCT01336621|469550437|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
130433437|NCT01336621|469550437|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
130433438|NCT01336621|469550437|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
130433439|NCT01126060|469550440|FG000|Overall Study|Protocol Violation|0|||
130433440|NCT01126060|469550441|FG001|Overall Study|Protocol Violation|2|||
130433441|NCT01874145|469550442|FG000|Core Period|Non-compliance|1|||
130433442|NCT01874145|469550443|FG001|Core Period|Non-compliance|0|||
130433443|NCT01874145|469550442|FG000|Core Period|Protocol Violation|1|||
130433444|NCT01874145|469550443|FG001|Core Period|Protocol Violation|1|||
130433445|NCT01874145|469550442|FG000|Core Period|Physician Decision|1|||
130343122|NCT02431260|469227285|FG003|Overall Study|Lost to Follow-up|0|||
130343123|NCT02431260|469227286|FG004|Overall Study|Lost to Follow-up|0|||
130343124|NCT02431260|469227287|FG005|Overall Study|Lost to Follow-up|1|||
130343125|NCT02431260|469227288|FG006|Overall Study|Lost to Follow-up|0|||
130343126|NCT02431260|469227289|FG007|Overall Study|Lost to Follow-up|0|||
130343127|NCT02431260|469227290|FG008|Overall Study|Lost to Follow-up|0|||
130343128|NCT02431260|469227291|FG009|Overall Study|Lost to Follow-up|0|||
130343129|NCT02431260|469227292|FG010|Overall Study|Lost to Follow-up|0|||
130343130|NCT02431260|469227293|FG011|Overall Study|Lost to Follow-up|0|||
130343131|NCT02431260|469227294|FG012|Overall Study|Lost to Follow-up|0|||
130343132|NCT02431260|469227295|FG013|Overall Study|Lost to Follow-up|0|||
130343133|NCT02431260|469227282|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130343134|NCT02431260|469227283|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130343135|NCT02431260|469227284|FG002|Overall Study|Study Terminated by the Sponsor|2|||
130343136|NCT02431260|469227285|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130343137|NCT02431260|469227286|FG004|Overall Study|Study Terminated by the Sponsor|1|||
130343138|NCT02431260|469227287|FG005|Overall Study|Study Terminated by the Sponsor|0|||
130343139|NCT02431260|469227288|FG006|Overall Study|Study Terminated by the Sponsor|1|||
130343140|NCT02431260|469227289|FG007|Overall Study|Study Terminated by the Sponsor|2|||
130343141|NCT02431260|469227290|FG008|Overall Study|Study Terminated by the Sponsor|1|||
130343142|NCT02431260|469227291|FG009|Overall Study|Study Terminated by the Sponsor|1|||
130343143|NCT02431260|469227292|FG010|Overall Study|Study Terminated by the Sponsor|1|||
130343144|NCT02431260|469227293|FG011|Overall Study|Study Terminated by the Sponsor|0|||
130343145|NCT02431260|469227294|FG012|Overall Study|Study Terminated by the Sponsor|4|||
130343146|NCT02431260|469227295|FG013|Overall Study|Study Terminated by the Sponsor|0|||
130343147|NCT02431260|469227282|FG000|Overall Study|Physician Decision|0|||
130343148|NCT02431260|469227283|FG001|Overall Study|Physician Decision|0|||
130343149|NCT02431260|469227284|FG002|Overall Study|Physician Decision|0|||
130343150|NCT02431260|469227285|FG003|Overall Study|Physician Decision|0|||
130343151|NCT02431260|469227286|FG004|Overall Study|Physician Decision|0|||
130343152|NCT02431260|469227287|FG005|Overall Study|Physician Decision|1|||
130343153|NCT02431260|469227288|FG006|Overall Study|Physician Decision|0|||
130343154|NCT02431260|469227289|FG007|Overall Study|Physician Decision|0|||
130343155|NCT02431260|469227290|FG008|Overall Study|Physician Decision|0|||
130343156|NCT02431260|469227291|FG009|Overall Study|Physician Decision|0|||
130343157|NCT02431260|469227292|FG010|Overall Study|Physician Decision|0|||
130343158|NCT02431260|469227293|FG011|Overall Study|Physician Decision|0|||
130343159|NCT02431260|469227294|FG012|Overall Study|Physician Decision|0|||
130343160|NCT02431260|469227295|FG013|Overall Study|Physician Decision|0|||
130343161|NCT02431260|469227282|FG000|Overall Study|Other Unspecified|0|||
130343162|NCT02431260|469227283|FG001|Overall Study|Other Unspecified|0|||
130343163|NCT02431260|469227284|FG002|Overall Study|Other Unspecified|0|||
130343164|NCT02431260|469227285|FG003|Overall Study|Other Unspecified|0|||
130343165|NCT02431260|469227286|FG004|Overall Study|Other Unspecified|0|||
130343166|NCT02431260|469227287|FG005|Overall Study|Other Unspecified|0|||
130343167|NCT02431260|469227288|FG006|Overall Study|Other Unspecified|0|||
130343168|NCT02431260|469227289|FG007|Overall Study|Other Unspecified|0|||
130343169|NCT02431260|469227290|FG008|Overall Study|Other Unspecified|0|||
130343170|NCT02431260|469227291|FG009|Overall Study|Other Unspecified|0|||
130343171|NCT02431260|469227292|FG010|Overall Study|Other Unspecified|0|||
130343172|NCT02431260|469227293|FG011|Overall Study|Other Unspecified|1|||
130343173|NCT02431260|469227294|FG012|Overall Study|Other Unspecified|1|||
130343174|NCT02431260|469227295|FG013|Overall Study|Other Unspecified|0|||
130343175|NCT00439738|469227299|FG000|Overall Study|Withdrawal by Subject|16|||
130343176|NCT00439738|469227300|FG001|Overall Study|Withdrawal by Subject|13|||
130343177|NCT00439738|469227299|FG000|Overall Study|Adverse Event|6|||
130343178|NCT00439738|469227300|FG001|Overall Study|Adverse Event|4|||
130343179|NCT00439738|469227299|FG000|Overall Study|Lost to Follow-up|5|||
130343180|NCT00439738|469227300|FG001|Overall Study|Lost to Follow-up|6|||
130343181|NCT00439738|469227299|FG000|Overall Study|Protocol Violation|6|||
130343182|NCT00439738|469227300|FG001|Overall Study|Protocol Violation|3|||
130343183|NCT00439738|469227299|FG000|Overall Study|Lack of Efficacy|2|||
130343184|NCT00439738|469227300|FG001|Overall Study|Lack of Efficacy|2|||
130343185|NCT00439738|469227299|FG000|Overall Study|Abnormal Lab Values|1|||
130343186|NCT00439738|469227300|FG001|Overall Study|Abnormal Lab Values|0|||
130343187|NCT00978757|469227301|FG000|Overall Study|Physician Decision|1|||
130343188|NCT00978757|469227302|FG001|Overall Study|Physician Decision|3|||
130343189|NCT01700387|469227303|FG000|Overall Study|Withdrawal by Subject|1|||
130343190|NCT01700387|469227304|FG001|Overall Study|Withdrawal by Subject|2|||
130343191|NCT01700387|469227303|FG000|Overall Study|Adverse Event|1|||
130343192|NCT01700387|469227304|FG001|Overall Study|Adverse Event|1|||
130343193|NCT01700387|469227303|FG000|Overall Study|Lost to Follow-up|2|||
130343194|NCT01700387|469227304|FG001|Overall Study|Lost to Follow-up|1|||
130343195|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343196|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343197|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343198|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343199|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
130343200|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343201|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343202|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343203|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343204|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343205|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343206|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130433446|NCT01874145|469550443|FG001|Core Period|Physician Decision|1|||
130433447|NCT01874145|469550442|FG000|Core Period|Adverse Event|0|||
130433448|NCT01874145|469550443|FG001|Core Period|Adverse Event|1|||
130433449|NCT01874145|469550442|FG000|Core Period|Withdrawal by Subject|0|||
130433450|NCT01874145|469550443|FG001|Core Period|Withdrawal by Subject|4|||
130433451|NCT01874145|469550442|FG000|Extension Period|Adverse Event|3|||
130433452|NCT01874145|469550443|FG001|Extension Period|Adverse Event|2|||
130433453|NCT01874145|469550442|FG000|Extension Period|Withdrawal by Subject|2|||
130433454|NCT01874145|469550443|FG001|Extension Period|Withdrawal by Subject|1|||
130433455|NCT01874145|469550442|FG000|Extension Period|Lost to Follow-up|1|||
130433456|NCT01874145|469550443|FG001|Extension Period|Lost to Follow-up|1|||
130343207|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343208|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343209|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
130343210|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343211|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343212|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343213|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343214|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130433457|NCT00402337|469550449|FG000|Overall Study|Adverse Event|0|||
130433458|NCT00402337|469550450|FG001|Overall Study|Adverse Event|2|||
130433459|NCT00402337|469550451|FG002|Overall Study|Adverse Event|2|||
130433460|NCT00402337|469550452|FG003|Overall Study|Adverse Event|3|||
130433461|NCT00402337|469550453|FG004|Overall Study|Adverse Event|2|||
130433462|NCT00402337|469550449|FG000|Overall Study|Noncompliance|0|||
130433463|NCT00402337|469550450|FG001|Overall Study|Noncompliance|0|||
130433464|NCT00402337|469550451|FG002|Overall Study|Noncompliance|0|||
130433465|NCT00402337|469550452|FG003|Overall Study|Noncompliance|0|||
130433466|NCT00402337|469550453|FG004|Overall Study|Noncompliance|2|||
130433467|NCT00402337|469550449|FG000|Overall Study|Withdrawal by Subject|5|||
130433468|NCT00402337|469550450|FG001|Overall Study|Withdrawal by Subject|3|||
130433469|NCT00402337|469550451|FG002|Overall Study|Withdrawal by Subject|1|||
130433470|NCT00402337|469550452|FG003|Overall Study|Withdrawal by Subject|6|||
130433471|NCT00402337|469550453|FG004|Overall Study|Withdrawal by Subject|4|||
130433472|NCT00402337|469550449|FG000|Overall Study|Lost to Follow-up|0|||
130433473|NCT00402337|469550450|FG001|Overall Study|Lost to Follow-up|0|||
130433474|NCT00402337|469550451|FG002|Overall Study|Lost to Follow-up|1|||
130433475|NCT00402337|469550452|FG003|Overall Study|Lost to Follow-up|2|||
130433476|NCT00402337|469550453|FG004|Overall Study|Lost to Follow-up|0|||
130433477|NCT00402337|469550449|FG000|Overall Study|Physician Decision|0|||
130433478|NCT00402337|469550450|FG001|Overall Study|Physician Decision|0|||
130343215|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
130343216|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343217|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343218|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343219|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
130343220|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343221|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343222|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343223|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343224|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343225|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343226|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343227|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
130343228|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343229|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
130343230|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343231|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343232|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343233|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343234|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343235|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343236|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343237|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343238|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343239|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
130343240|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343241|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343242|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343243|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343244|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343245|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
130343246|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343247|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343248|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343249|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
130343250|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343251|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343252|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343253|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343254|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343255|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343256|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343257|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130343258|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343259|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343260|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130343261|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343262|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343263|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343264|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130433479|NCT00402337|469550451|FG002|Overall Study|Physician Decision|0|||
130433480|NCT00402337|469550452|FG003|Overall Study|Physician Decision|1|||
130343265|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343266|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130343267|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343268|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130343269|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343270|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343271|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343272|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343273|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343274|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343275|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343276|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343277|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343278|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130343279|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343280|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343281|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130343282|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343283|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343284|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343285|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343286|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343287|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
130343288|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
130343289|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343290|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
130343291|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
130343292|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343293|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343294|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343295|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343296|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343297|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343298|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343299|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343300|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343301|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
130343302|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343303|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343304|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343305|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343306|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343307|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343308|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343309|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343310|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343311|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343312|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
130343313|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130343314|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130343315|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343316|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343317|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343318|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343319|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343320|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343321|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343322|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
130343323|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130343324|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130343325|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343326|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343327|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343328|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343329|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343330|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343331|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130433481|NCT00402337|469550453|FG004|Overall Study|Physician Decision|0|||
130343332|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
130343333|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130343334|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130343335|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343336|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343337|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343338|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130433482|NCT00402337|469550449|FG000|Overall Study|Other Reason|0|||
130433483|NCT00402337|469550450|FG001|Overall Study|Other Reason|1|||
130433484|NCT00402337|469550451|FG002|Overall Study|Other Reason|0|||
130433485|NCT00402337|469550452|FG003|Overall Study|Other Reason|0|||
130343339|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343340|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343341|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343342|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343343|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
130343344|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343345|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Death|0|||
130343346|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Death|0|||
130343347|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Death|0|||
130343348|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Death|0|||
130343349|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Death|0|||
130343350|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Death|0|||
130343351|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Death|0|||
130343352|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Death|0|||
130343353|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Death|0|||
130343354|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Death|1|||
130343355|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343356|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343357|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343358|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343359|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343360|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343361|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343362|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343363|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343364|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
130343365|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343366|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343367|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343368|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343369|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343370|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343371|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343372|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343373|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343374|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
130343375|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343376|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343377|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343378|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343379|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343380|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
130433486|NCT00402337|469550453|FG004|Overall Study|Other Reason|0|||
130433487|NCT02178566|469550454|FG000|Overall Study|patient did not complete due to noncompliance|0|||
130433488|NCT02178566|469550455|FG001|Overall Study|patient did not complete due to noncompliance|1|||
130433489|NCT04631705|469550460|FG000|Overall Study|Withdrawal by Subject|0|||
130433490|NCT04631705|469550461|FG001|Overall Study|Withdrawal by Subject|0|||
130433491|NCT04631705|469550462|FG002|Overall Study|Withdrawal by Subject|0|||
130433492|NCT04631705|469550463|FG003|Overall Study|Withdrawal by Subject|0|||
130433493|NCT04631705|469550464|FG004|Overall Study|Withdrawal by Subject|0|||
130433494|NCT04631705|469550465|FG005|Overall Study|Withdrawal by Subject|0|||
130433495|NCT04631705|469550466|FG006|Overall Study|Withdrawal by Subject|1|||
130433496|NCT04631705|469550467|FG007|Overall Study|Withdrawal by Subject|0|||
130433497|NCT04631705|469550468|FG008|Overall Study|Withdrawal by Subject|0|||
130433498|NCT02658630|469550471|FG000|Overall Study|Withdrawal by Subject|4|||
130343381|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343382|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343383|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
130343384|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343385|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343386|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343387|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343388|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343389|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343390|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343391|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343392|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
130343393|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
130343394|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343395|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343396|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343397|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343398|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343399|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343400|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343401|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343402|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130343403|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
130343404|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130343405|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343406|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130216597|NCT05305989|468755616|FG000|Overall Study|Sponsor decision|2|||
130343407|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343408|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343409|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343410|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343411|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343412|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
130343413|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
130343414|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343415|NCT02270944|469227316|FG000|Overall Study|Lost to Follow-up|9|||
130343416|NCT02270944|469227317|FG001|Overall Study|Lost to Follow-up|4|||
130343417|NCT02270944|469227316|FG000|Overall Study|Withdrawal by Subject|2|||
130343418|NCT02270944|469227317|FG001|Overall Study|Withdrawal by Subject|1|||
130343419|NCT01978938|469227318|FG000|Overall Study|Lost to Follow-up|12|||
130343420|NCT01978938|469227319|FG001|Overall Study|Lost to Follow-up|6|||
130343421|NCT01978938|469227318|FG000|Overall Study|Withdrawal by Subject|8|||
130343422|NCT01978938|469227319|FG001|Overall Study|Withdrawal by Subject|4|||
130343423|NCT01978938|469227318|FG000|Overall Study|Adverse Event, non-fatal|2|||
130343424|NCT01978938|469227319|FG001|Overall Study|Adverse Event, non-fatal|1|||
130343425|NCT01978938|469227318|FG000|Overall Study|Participant noncompliance|1|||
130343426|NCT01978938|469227319|FG001|Overall Study|Participant noncompliance|1|||
130343427|NCT01978938|469227318|FG000|Overall Study|Did not meet inclusion criteria|0|||
130343428|NCT01978938|469227319|FG001|Overall Study|Did not meet inclusion criteria|1|||
130343429|NCT01978938|469227318|FG000|Overall Study|Previously scheduled procedure|0|||
130343430|NCT01978938|469227319|FG001|Overall Study|Previously scheduled procedure|1|||
130343431|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
130343432|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
130343433|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
130343434|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
130343435|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
130343436|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
130343437|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
130343438|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
130343439|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130343440|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130343441|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130343442|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130343443|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
130343444|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130343445|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130343446|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130343447|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130343448|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343449|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343450|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343451|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130343452|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343453|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130343454|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343455|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343456|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130343457|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130343458|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343459|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343460|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343461|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
130343462|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
130343463|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
130343464|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
130343465|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
130343466|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
130343467|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
130343468|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343469|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343470|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343471|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
130343472|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
130343473|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130343474|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
130343475|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130343476|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
130343477|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
130343478|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343479|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343480|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343481|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130343482|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343483|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343484|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130343485|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343486|NCT00095147|469227320|FG000|Long-term Extension Period|Death|0|||
130343487|NCT00095147|469227321|FG001|Long-term Extension Period|Death|0|||
130343488|NCT00095147|469227322|FG002|Long-term Extension Period|Death|0|||
130343489|NCT00095147|469227323|FG003|Long-term Extension Period|Death|0|||
130343490|NCT00095147|469227324|FG004|Long-term Extension Period|Death|3|||
130343491|NCT00095147|469227320|FG000|Long-term Extension Period|Adverse Event|0|||
130343492|NCT00095147|469227321|FG001|Long-term Extension Period|Adverse Event|0|||
130343493|NCT00095147|469227322|FG002|Long-term Extension Period|Adverse Event|0|||
130343494|NCT00095147|469227323|FG003|Long-term Extension Period|Adverse Event|0|||
130343495|NCT00095147|469227324|FG004|Long-term Extension Period|Adverse Event|11|||
130343496|NCT00095147|469227320|FG000|Long-term Extension Period|Lack of Efficacy|0|||
130343497|NCT00095147|469227321|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130343498|NCT00095147|469227322|FG002|Long-term Extension Period|Lack of Efficacy|0|||
130343499|NCT00095147|469227323|FG003|Long-term Extension Period|Lack of Efficacy|0|||
130343500|NCT00095147|469227324|FG004|Long-term Extension Period|Lack of Efficacy|9|||
130433499|NCT02130284|469550472|FG000|Overall Study|Withdrawal by Subject|3|||
130433500|NCT02130284|469550472|FG000|Overall Study|Subject Withdrew Consent|1|||
130433501|NCT02130284|469550472|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
130433502|NCT02130284|469550472|FG000|Overall Study|Subject was screened as backup for study|3|||
130433503|NCT02130284|469550472|FG000|Overall Study|Screen Failure|1|||
130433504|NCT01521884|469550474|FG000|Overall Study|Non Responders|10|||
130433505|NCT01521884|469550474|FG000|Overall Study|Adverse Event|5|||
130433506|NCT01521884|469550474|FG000|Overall Study|Pregnancy|1|||
130433507|NCT01521884|469550474|FG000|Overall Study|Withdrawal by Subject|1|||
130433508|NCT01521884|469550474|FG000|Overall Study|Physician Decision|2|||
130433509|NCT01521884|469550474|FG000|Overall Study|Protocol Violation|3|||
130433510|NCT01521884|469550474|FG000|Overall Study|Participant non-eligible|1|||
130433511|NCT01521884|469550474|FG000|Overall Study|Lost to Follow-up|4|||
130433512|NCT02821819|469550475|FG000|Overall Study|Protocol Violation|1|||
130433513|NCT03565068|469550476|FG000|Overall Study|Protocol Violation|0|||
130433514|NCT03565068|469550477|FG001|Overall Study|Protocol Violation|0|||
130433515|NCT03565068|469550478|FG002|Overall Study|Protocol Violation|0|||
130433516|NCT03565068|469550479|FG003|Overall Study|Protocol Violation|0|||
130433517|NCT03565068|469550480|FG004|Overall Study|Protocol Violation|1|||
130552763|NCT02720536|469991528|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
130343501|NCT00095147|469227320|FG000|Long-term Extension Period|Lost to Follow-up|0|||
130343502|NCT00095147|469227321|FG001|Long-term Extension Period|Lost to Follow-up|0|||
130343503|NCT00095147|469227322|FG002|Long-term Extension Period|Lost to Follow-up|0|||
130343504|NCT00095147|469227323|FG003|Long-term Extension Period|Lost to Follow-up|0|||
130433518|NCT03565068|469550481|FG005|Overall Study|Protocol Violation|0|||
130433519|NCT03565068|469550482|FG006|Overall Study|Protocol Violation|0|||
130433520|NCT03565068|469550483|FG007|Overall Study|Protocol Violation|1|||
130433521|NCT03565068|469550484|FG008|Overall Study|Protocol Violation|0|||
130433522|NCT03565068|469550476|FG000|Overall Study|Sponsor decision|0|||
130433523|NCT03565068|469550477|FG001|Overall Study|Sponsor decision|0|||
130433524|NCT03565068|469550478|FG002|Overall Study|Sponsor decision|0|||
130433525|NCT03565068|469550479|FG003|Overall Study|Sponsor decision|0|||
130433526|NCT03565068|469550480|FG004|Overall Study|Sponsor decision|1|||
130433527|NCT03565068|469550481|FG005|Overall Study|Sponsor decision|1|||
130433528|NCT03565068|469550482|FG006|Overall Study|Sponsor decision|0|||
130433529|NCT03565068|469550483|FG007|Overall Study|Sponsor decision|0|||
130433530|NCT03565068|469550484|FG008|Overall Study|Sponsor decision|0|||
130433531|NCT03565068|469550476|FG000|Overall Study|Withdrawal by Subject|0|||
130433532|NCT03565068|469550477|FG001|Overall Study|Withdrawal by Subject|0|||
130433533|NCT03565068|469550478|FG002|Overall Study|Withdrawal by Subject|1|||
130433534|NCT03565068|469550479|FG003|Overall Study|Withdrawal by Subject|0|||
130433535|NCT03565068|469550480|FG004|Overall Study|Withdrawal by Subject|2|||
130433536|NCT03565068|469550481|FG005|Overall Study|Withdrawal by Subject|0|||
130433537|NCT03565068|469550482|FG006|Overall Study|Withdrawal by Subject|1|||
130433538|NCT03565068|469550483|FG007|Overall Study|Withdrawal by Subject|5|||
130433539|NCT03565068|469550484|FG008|Overall Study|Withdrawal by Subject|1|||
130433540|NCT03565068|469550476|FG000|Overall Study|Physician Decision|0|||
130433541|NCT03565068|469550477|FG001|Overall Study|Physician Decision|0|||
130433542|NCT03565068|469550478|FG002|Overall Study|Physician Decision|0|||
130433543|NCT03565068|469550479|FG003|Overall Study|Physician Decision|0|||
130433544|NCT03565068|469550480|FG004|Overall Study|Physician Decision|0|||
130433545|NCT03565068|469550481|FG005|Overall Study|Physician Decision|0|||
130433546|NCT03565068|469550482|FG006|Overall Study|Physician Decision|0|||
130433547|NCT03565068|469550483|FG007|Overall Study|Physician Decision|1|||
130433548|NCT03565068|469550484|FG008|Overall Study|Physician Decision|0|||
130433549|NCT03565068|469550476|FG000|Overall Study|Lost to Follow-up|0|||
130433550|NCT03565068|469550477|FG001|Overall Study|Lost to Follow-up|0|||
130433551|NCT03565068|469550478|FG002|Overall Study|Lost to Follow-up|0|||
130433552|NCT03565068|469550479|FG003|Overall Study|Lost to Follow-up|0|||
130433553|NCT03565068|469550480|FG004|Overall Study|Lost to Follow-up|0|||
130433554|NCT03565068|469550481|FG005|Overall Study|Lost to Follow-up|0|||
130433555|NCT03565068|469550482|FG006|Overall Study|Lost to Follow-up|0|||
130433556|NCT03565068|469550483|FG007|Overall Study|Lost to Follow-up|1|||
130433557|NCT03565068|469550484|FG008|Overall Study|Lost to Follow-up|0|||
130433558|NCT00085202|469550485|FG000|Overall Study|Still on therapy|2|||
130433559|NCT00085202|469550486|FG001|Overall Study|Still on therapy|0|||
130433560|NCT00085202|469550485|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
130433561|NCT00085202|469550486|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
130433562|NCT00085202|469550485|FG000|Overall Study|Excessive toxicity|6|||
130433563|NCT00085202|469550486|FG001|Overall Study|Excessive toxicity|5|||
130433564|NCT00085202|469550485|FG000|Overall Study|Non-specified|3|||
130433565|NCT00085202|469550486|FG001|Overall Study|Non-specified|5|||
130433566|NCT00085202|469550485|FG000|Overall Study|Withdrawal by Subject|2|||
130433567|NCT00085202|469550486|FG001|Overall Study|Withdrawal by Subject|1|||
130433568|NCT00085202|469550485|FG000|Overall Study|Physician Decision|4|||
130433569|NCT00085202|469550486|FG001|Overall Study|Physician Decision|1|||
130433570|NCT00085202|469550485|FG000|Overall Study|Progressive disease|1|||
130433571|NCT00085202|469550486|FG001|Overall Study|Progressive disease|11|||
130433572|NCT01436201|469550492|FG000|Overall Study|Adverse Event|2|||
130433573|NCT01436201|469550492|FG000|Overall Study|Withdrawal by Subject|1|||
130433574|NCT01436201|469550492|FG000|Overall Study|Protocol Violation|1|||
130433575|NCT01435655|469550493|FG000|Overall Study|Death|2|||
130433576|NCT01435655|469550493|FG000|Overall Study|Other|1|||
130433577|NCT00110890|469550494|FG000|Overall Study|Adverse Event|30|||
130433578|NCT00110890|469550495|FG001|Overall Study|Adverse Event|7|||
130433579|NCT00110890|469550494|FG000|Overall Study|Death|16|||
130433580|NCT00110890|469550495|FG001|Overall Study|Death|9|||
130433581|NCT00110890|469550494|FG000|Overall Study|Lost to Follow-up|3|||
130433582|NCT00110890|469550495|FG001|Overall Study|Lost to Follow-up|1|||
130433583|NCT00110890|469550494|FG000|Overall Study|Physician Decision|4|||
130433584|NCT00110890|469550495|FG001|Overall Study|Physician Decision|5|||
130433585|NCT00110890|469550494|FG000|Overall Study|Withdrawal by Subject|17|||
130433586|NCT00110890|469550495|FG001|Overall Study|Withdrawal by Subject|5|||
130433587|NCT00110890|469550494|FG000|Overall Study|Protocol Deviation|1|||
130433588|NCT00110890|469550495|FG001|Overall Study|Protocol Deviation|0|||
130433589|NCT00110890|469550494|FG000|Overall Study|Noncompliance|10|||
130433590|NCT00110890|469550495|FG001|Overall Study|Noncompliance|0|||
130433591|NCT00110890|469550494|FG000|Overall Study|Kidney Transplant|16|||
130433592|NCT00110890|469550495|FG001|Overall Study|Kidney Transplant|12|||
130433593|NCT00110890|469550494|FG000|Overall Study|Invest. Product Commercially Available|217|||
130433594|NCT00110890|469550495|FG001|Overall Study|Invest. Product Commercially Available|110|||
130433595|NCT00110890|469550494|FG000|Overall Study|Other|34|||
130433596|NCT00110890|469550495|FG001|Overall Study|Other|23|||
130433597|NCT00110890|469550494|FG000|Overall Study|Ineligibility determined|3|||
130552764|NCT00719563|469991530|FG000|Overall Study|Adverse Event|16|||
130343505|NCT00095147|469227324|FG004|Long-term Extension Period|Lost to Follow-up|6|||
130433598|NCT00110890|469550495|FG001|Overall Study|Ineligibility determined|0|||
130433599|NCT00110890|469550494|FG000|Overall Study|Requirement for alternative therapy|0|||
130433600|NCT00110890|469550495|FG001|Overall Study|Requirement for alternative therapy|1|||
130433601|NCT00110890|469550494|FG000|Overall Study|Disease progression|0|||
130433602|NCT00110890|469550495|FG001|Overall Study|Disease progression|1|||
130433603|NCT00110890|469550494|FG000|Overall Study|Parathyroidectomy|0|||
130433604|NCT00110890|469550495|FG001|Overall Study|Parathyroidectomy|1|||
130433605|NCT00110890|469550494|FG000|Overall Study|Did not enter follow-up phase|10|||
130433606|NCT00110890|469550495|FG001|Overall Study|Did not enter follow-up phase|4|||
130433607|NCT01975220|469550496|FG000|Test Period 1|Not treated|0|||
130433608|NCT01975220|469550497|FG001|Test Period 1|Not treated|1|||
130433609|NCT01975220|469550498|FG002|Test Period 1|Not treated|0|||
130433610|NCT01975220|469550499|FG003|Test Period 1|Not treated|0|||
130433611|NCT01975220|469550500|FG004|Test Period 1|Not treated|0|||
130433612|NCT01975220|469550501|FG005|Test Period 1|Not treated|0|||
130433613|NCT02839343|469550502|FG000|Overall Study|Withdrawal by Subject|3|||
130433614|NCT02839343|469550503|FG001|Overall Study|Withdrawal by Subject|1|||
130433615|NCT02839343|469550502|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
130433616|NCT02839343|469550503|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
130433617|NCT02839343|469550502|FG000|Overall Study|Adverse Event|1|||
130433618|NCT02839343|469550503|FG001|Overall Study|Adverse Event|0|||
130433619|NCT00263328|469550504|FG000|Overall Study|Death|0|||
130433620|NCT00263328|469550505|FG001|Overall Study|Death|0|||
130433621|NCT00263328|469550506|FG002|Overall Study|Death|1|||
130433622|NCT00263328|469550504|FG000|Overall Study|Lost to Follow-up|1|||
130433623|NCT00263328|469550505|FG001|Overall Study|Lost to Follow-up|1|||
130433624|NCT00263328|469550506|FG002|Overall Study|Lost to Follow-up|0|||
130433625|NCT00263328|469550504|FG000|Overall Study|Withdrawal by Subject|3|||
130433626|NCT00263328|469550505|FG001|Overall Study|Withdrawal by Subject|0|||
130433627|NCT00263328|469550506|FG002|Overall Study|Withdrawal by Subject|1|||
130433628|NCT00263328|469550504|FG000|Overall Study|Other|3|||
130433629|NCT00263328|469550505|FG001|Overall Study|Other|0|||
130433630|NCT00263328|469550506|FG002|Overall Study|Other|1|||
130433631|NCT00263328|469550504|FG000|Overall Study|Adverse Event|1|||
130433632|NCT00263328|469550505|FG001|Overall Study|Adverse Event|1|||
130433633|NCT00263328|469550506|FG002|Overall Study|Adverse Event|4|||
130433634|NCT01301274|469550510|FG000|Overall Study|Physician Decision|2|||
130433635|NCT01301274|469550511|FG001|Overall Study|Physician Decision|1|||
130433636|NCT00661661|469550512|FG000|Overall Study|Adverse Event|99|||
130433637|NCT00661661|469550513|FG001|Overall Study|Adverse Event|24|||
130433638|NCT00661661|469550512|FG000|Overall Study|Lack of Efficacy|3|||
130433639|NCT00661661|469550513|FG001|Overall Study|Lack of Efficacy|2|||
130433640|NCT00661661|469550512|FG000|Overall Study|Lost to Follow-up|0|||
130433641|NCT00661661|469550513|FG001|Overall Study|Lost to Follow-up|1|||
130433642|NCT00661661|469550512|FG000|Overall Study|Withdrawal by Subject|15|||
130433643|NCT00661661|469550513|FG001|Overall Study|Withdrawal by Subject|5|||
130433644|NCT00661661|469550512|FG000|Overall Study|Other|22|||
130433645|NCT00661661|469550513|FG001|Overall Study|Other|7|||
130433646|NCT00661661|469550512|FG000|Overall Study|Not assigned treatment|1|||
130433647|NCT00661661|469550513|FG001|Overall Study|Not assigned treatment|0|||
130433648|NCT04512066|469550516|FG000|Double-blind Treatment Period|Adverse Event|6|||
130433649|NCT04512066|469550517|FG001|Double-blind Treatment Period|Adverse Event|4|||
130433650|NCT04512066|469550518|FG002|Double-blind Treatment Period|Adverse Event|5|||
130433651|NCT04512066|469550519|FG003|Double-blind Treatment Period|Adverse Event|1|||
130433652|NCT04512066|469550520|FG004|Double-blind Treatment Period|Adverse Event|0|||
130433653|NCT04512066|469550521|FG005|Double-blind Treatment Period|Adverse Event|0|||
130433654|NCT04512066|469550516|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
130433655|NCT04512066|469550517|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
130433656|NCT04512066|469550518|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
130433657|NCT04512066|469550519|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
130433658|NCT04512066|469550520|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
130343506|NCT00095147|469227320|FG000|Long-term Extension Period|Withdrawal of consent|0|||
130343507|NCT00095147|469227321|FG001|Long-term Extension Period|Withdrawal of consent|0|||
130343508|NCT00095147|469227322|FG002|Long-term Extension Period|Withdrawal of consent|0|||
130343509|NCT00095147|469227323|FG003|Long-term Extension Period|Withdrawal of consent|0|||
130343510|NCT00095147|469227324|FG004|Long-term Extension Period|Withdrawal of consent|12|||
130343511|NCT00095147|469227320|FG000|Long-term Extension Period|Pregnancy|0|||
130343512|NCT00095147|469227321|FG001|Long-term Extension Period|Pregnancy|0|||
130433659|NCT04512066|469550521|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
130433660|NCT04512066|469550516|FG000|Double-blind Treatment Period|Physician Decision|1|||
130433661|NCT04512066|469550517|FG001|Double-blind Treatment Period|Physician Decision|0|||
130433662|NCT04512066|469550518|FG002|Double-blind Treatment Period|Physician Decision|1|||
130433663|NCT04512066|469550519|FG003|Double-blind Treatment Period|Physician Decision|0|||
130433664|NCT04512066|469550520|FG004|Double-blind Treatment Period|Physician Decision|0|||
130433665|NCT04512066|469550521|FG005|Double-blind Treatment Period|Physician Decision|0|||
130343513|NCT00095147|469227322|FG002|Long-term Extension Period|Pregnancy|0|||
130343514|NCT00095147|469227323|FG003|Long-term Extension Period|Pregnancy|0|||
130343515|NCT00095147|469227324|FG004|Long-term Extension Period|Pregnancy|1|||
130343516|NCT00095147|469227320|FG000|Long-term Extension Period|No longer meets study criteria|0|||
130343517|NCT00095147|469227321|FG001|Long-term Extension Period|No longer meets study criteria|0|||
130343518|NCT00095147|469227322|FG002|Long-term Extension Period|No longer meets study criteria|0|||
130343519|NCT00095147|469227323|FG003|Long-term Extension Period|No longer meets study criteria|0|||
130343520|NCT00095147|469227324|FG004|Long-term Extension Period|No longer meets study criteria|1|||
130343521|NCT00095147|469227320|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
130343522|NCT00095147|469227321|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
130343523|NCT00095147|469227322|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
130343524|NCT00095147|469227323|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
130343525|NCT00095147|469227324|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
130343526|NCT00095147|469227320|FG000|Long-term Extension Period|Leaving country|0|||
130343527|NCT00095147|469227321|FG001|Long-term Extension Period|Leaving country|0|||
130343528|NCT00095147|469227322|FG002|Long-term Extension Period|Leaving country|0|||
130343529|NCT00095147|469227323|FG003|Long-term Extension Period|Leaving country|0|||
130343530|NCT00095147|469227324|FG004|Long-term Extension Period|Leaving country|1|||
130343531|NCT03678870|469227328|FG000|Overall Study|prescribed non- protocol medications|10|||
130343532|NCT03678870|469227329|FG001|Overall Study|prescribed non- protocol medications|6|||
130343533|NCT03678870|469227328|FG000|Overall Study|Lost to Follow-up|3|||
130343534|NCT03678870|469227329|FG001|Overall Study|Lost to Follow-up|2|||
130343535|NCT03104816|469227331|FG000|Overall Study|Lack of Efficacy|0|||
130433666|NCT04512066|469550516|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130433667|NCT04512066|469550517|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
130433668|NCT04512066|469550518|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
130433669|NCT04512066|469550519|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
130677560|NCT00679367|470445328|FG000|Overall Study|Lack of Efficacy|3|||
130677561|NCT00679367|470445328|FG000|Overall Study|Withdrawal by Subject|1|||
130677562|NCT04603937|470445331|FG000|Overall Study|Adverse Event|9|||
130677563|NCT04603937|470445332|FG001|Overall Study|Adverse Event|10|||
130677564|NCT04603937|470445331|FG000|Overall Study|Withdrawal by Subject|7|||
130677565|NCT04603937|470445332|FG001|Overall Study|Withdrawal by Subject|6|||
130677566|NCT04603937|470445331|FG000|Overall Study|Lost to Follow-up|5|||
130677567|NCT04603937|470445332|FG001|Overall Study|Lost to Follow-up|6|||
130677568|NCT04603937|470445331|FG000|Overall Study|Physician Decision|0|||
130677569|NCT04603937|470445332|FG001|Overall Study|Physician Decision|1|||
130677570|NCT04603937|470445331|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
130677571|NCT04603937|470445332|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
130677572|NCT02518685|470445333|FG000|Overall Study|Adverse Event|29|||
130677573|NCT02518685|470445334|FG001|Overall Study|Adverse Event|1|||
130677574|NCT02518685|470445333|FG000|Overall Study|Withdrawal by Subject|10|||
130677575|NCT02518685|470445334|FG001|Overall Study|Withdrawal by Subject|3|||
130677576|NCT02518685|470445333|FG000|Overall Study|relocation, study fatigue|7|||
130677577|NCT02518685|470445334|FG001|Overall Study|relocation, study fatigue|2|||
130677578|NCT02518685|470445333|FG000|Overall Study|Pregnancy|1|||
130677579|NCT02518685|470445334|FG001|Overall Study|Pregnancy|0|||
130677580|NCT02518685|470445333|FG000|Overall Study|Physician Decision|1|||
130677581|NCT02518685|470445334|FG001|Overall Study|Physician Decision|0|||
130677582|NCT02518685|470445333|FG000|Overall Study|Lost to Follow-up|1|||
130677583|NCT02518685|470445334|FG001|Overall Study|Lost to Follow-up|4|||
130677584|NCT00922779|470445335|FG000|Overall Study|Adverse Event|67|||
130677585|NCT00922779|470445335|FG000|Overall Study|Pregnancy|7|||
130677586|NCT00922779|470445335|FG000|Overall Study|Withdrawal by Subject|308|||
130677587|NCT00922779|470445335|FG000|Overall Study|Lost to Follow-up|44|||
130677588|NCT00922779|470445335|FG000|Overall Study|Other|27|||
130677589|NCT00922779|470445335|FG000|Overall Study|Missing|1874|||
130677590|NCT01922349|470445336|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130677591|NCT01922349|470445337|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130677592|NCT01922349|470445338|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130677593|NCT01922349|470445339|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
130677594|NCT01611090|470445340|FG000|Randomized Period|Lost to Follow-up|8|||
130677595|NCT01611090|470445341|FG001|Randomized Period|Lost to Follow-up|3|||
130216598|NCT05305989|468755617|FG001|Overall Study|Sponsor decision|1|||
130343536|NCT03104816|469227332|FG001|Overall Study|Lack of Efficacy|2|||
130433670|NCT04512066|469550520|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130433671|NCT04512066|469550521|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
130677596|NCT01611090|470445342|FG002|Randomized Period|Lost to Follow-up|0|||
130677597|NCT01611090|470445340|FG000|Randomized Period|Withdrawal by Subject|22|||
130677598|NCT01611090|470445341|FG001|Randomized Period|Withdrawal by Subject|26|||
130677599|NCT01611090|470445342|FG002|Randomized Period|Withdrawal by Subject|0|||
130677600|NCT01611090|470445340|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
130677601|NCT01611090|470445341|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
130677602|NCT01611090|470445342|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
130677603|NCT01611090|470445340|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
130677604|NCT01611090|470445341|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
130677605|NCT01611090|470445342|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
130677606|NCT02448771|470445343|FG000|Overall Study|Disease Progression|30|||
130677607|NCT02448771|470445343|FG000|Overall Study|Unacceptable Toxicity|1|||
130677608|NCT02448771|470445343|FG000|Overall Study|Physician Decision|3|||
130677609|NCT02448771|470445343|FG000|Overall Study|Started new therapy|2|||
130677610|NCT02683187|470445344|FG000|Overall Study|Failed IV access|3|||
130677611|NCT02683187|470445344|FG000|Overall Study|Withdrawal by Subject|5|||
130677612|NCT00770315|470445345|FG000|Overall Study|Adverse Event|11|||
130677613|NCT00770315|470445346|FG001|Overall Study|Adverse Event|17|||
130677614|NCT00770315|470445347|FG002|Overall Study|Adverse Event|16|||
130677615|NCT00770315|470445348|FG003|Overall Study|Adverse Event|6|||
130677616|NCT00770315|470445345|FG000|Overall Study|Lost to Follow-up|9|||
130677617|NCT00770315|470445346|FG001|Overall Study|Lost to Follow-up|5|||
130677618|NCT00770315|470445347|FG002|Overall Study|Lost to Follow-up|10|||
130677619|NCT00770315|470445348|FG003|Overall Study|Lost to Follow-up|3|||
130677620|NCT00770315|470445345|FG000|Overall Study|Withdrawal by Subject|13|||
130677621|NCT00770315|470445346|FG001|Overall Study|Withdrawal by Subject|17|||
130677622|NCT00770315|470445347|FG002|Overall Study|Withdrawal by Subject|24|||
130677623|NCT00770315|470445348|FG003|Overall Study|Withdrawal by Subject|20|||
130677624|NCT00770315|470445345|FG000|Overall Study|Noncompliance with Protocol|7|||
130677625|NCT00770315|470445346|FG001|Overall Study|Noncompliance with Protocol|4|||
130677626|NCT00770315|470445347|FG002|Overall Study|Noncompliance with Protocol|7|||
130677627|NCT00770315|470445348|FG003|Overall Study|Noncompliance with Protocol|9|||
130677628|NCT02585258|470445349|FG000|Overall Study|Adverse Event|28|||
130677629|NCT02585258|470445350|FG001|Overall Study|Adverse Event|29|||
130677630|NCT02585258|470445349|FG000|Overall Study|Death|3|||
130677631|NCT02585258|470445350|FG001|Overall Study|Death|2|||
130677632|NCT02585258|470445349|FG000|Overall Study|Lack of Efficacy|7|||
130677633|NCT02585258|470445350|FG001|Overall Study|Lack of Efficacy|9|||
130677634|NCT02585258|470445349|FG000|Overall Study|includes covid-related access problems|42|||
130677635|NCT02585258|470445350|FG001|Overall Study|includes covid-related access problems|46|||
130677636|NCT02585258|470445349|FG000|Overall Study|Lost to Follow-up|5|||
130677637|NCT02585258|470445350|FG001|Overall Study|Lost to Follow-up|2|||
130677638|NCT01298570|470447200|FG000|Overall Study|Disease progression, relapse during acti|64|||
130677639|NCT01298570|470447201|FG001|Overall Study|Disease progression, relapse during acti|40|||
130677640|NCT01298570|470447200|FG000|Overall Study|Adverse Event|20|||
130677641|NCT01298570|470447201|FG001|Overall Study|Adverse Event|2|||
130677642|NCT01298570|470447200|FG000|Overall Study|Withdrawal by Subject|21|||
130677643|NCT01298570|470447201|FG001|Overall Study|Withdrawal by Subject|6|||
130677644|NCT01298570|470447200|FG000|Overall Study|Treatment delay > 4 weeks|4|||
130677645|NCT01298570|470447201|FG001|Overall Study|Treatment delay > 4 weeks|5|||
130677646|NCT01298570|470447200|FG000|Overall Study|Physician Decision|4|||
130677647|NCT01298570|470447201|FG001|Overall Study|Physician Decision|2|||
130677648|NCT01298570|470447200|FG000|Overall Study|Other complicating disease|2|||
130677649|NCT01298570|470447201|FG001|Overall Study|Other complicating disease|1|||
130677650|NCT01298570|470447200|FG000|Overall Study|Surgery|2|||
130677651|NCT01298570|470447201|FG001|Overall Study|Surgery|1|||
130677652|NCT01298570|470447200|FG000|Overall Study|Symptomatic progression/deterioration|3|||
130677653|NCT01298570|470447201|FG001|Overall Study|Symptomatic progression/deterioration|2|||
130677654|NCT01298570|470447200|FG000|Overall Study|Death|0|||
130677655|NCT01298570|470447201|FG001|Overall Study|Death|1|||
130677656|NCT01298570|470447200|FG000|Overall Study|Ineligibility|0|||
130677657|NCT01298570|470447201|FG001|Overall Study|Ineligibility|1|||
130677658|NCT01210001|470447202|FG000|Overall Study|Not treated|1|||
130677659|NCT01210001|470447203|FG001|Overall Study|Not treated|0|||
130677660|NCT01210001|470447204|FG002|Overall Study|Not treated|0|||
130677661|NCT01210001|470447202|FG000|Overall Study|Adverse Event|4|||
130677662|NCT01210001|470447203|FG001|Overall Study|Adverse Event|2|||
130677663|NCT01210001|470447204|FG002|Overall Study|Adverse Event|5|||
130677664|NCT01210001|470447202|FG000|Overall Study|Non compliant with protocol|2|||
130216599|NCT05305989|468755618|FG002|Overall Study|Sponsor decision|0|||
130677665|NCT01210001|470447203|FG001|Overall Study|Non compliant with protocol|2|||
130677666|NCT01210001|470447204|FG002|Overall Study|Non compliant with protocol|3|||
130677667|NCT01210001|470447202|FG000|Overall Study|Lost to Follow-up|4|||
130677668|NCT01210001|470447203|FG001|Overall Study|Lost to Follow-up|3|||
130677669|NCT01210001|470447204|FG002|Overall Study|Lost to Follow-up|2|||
130677670|NCT01210001|470447202|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
130677671|NCT01210001|470447203|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
130677672|NCT01210001|470447204|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
130677673|NCT01210001|470447202|FG000|Overall Study|Other reason not defined above|2|||
130677674|NCT01210001|470447203|FG001|Overall Study|Other reason not defined above|2|||
130677675|NCT01210001|470447204|FG002|Overall Study|Other reason not defined above|1|||
130677676|NCT01451762|470447208|FG000|Overall Study|Lost to Follow-up|3|||
130677677|NCT01451762|470447209|FG001|Overall Study|Lost to Follow-up|6|||
130677678|NCT01451762|470447210|FG002|Overall Study|Lost to Follow-up|6|||
130677679|NCT04471207|470447211|FG000|Overall Study|Lost to Follow-up|4|||
130677680|NCT04471207|470447212|FG001|Overall Study|Lost to Follow-up|1|||
130677681|NCT04471207|470447211|FG000|Overall Study|Medication Contraindication|0|||
130677682|NCT04471207|470447212|FG001|Overall Study|Medication Contraindication|1|||
130677683|NCT04471207|470447211|FG000|Overall Study|Loss of Interest|2|||
130677684|NCT04471207|470447212|FG001|Overall Study|Loss of Interest|1|||
130677685|NCT04471207|470447211|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
130677686|NCT04471207|470447212|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
130677687|NCT04471207|470447211|FG000|Overall Study|Scheduling Conflicts|3|||
130677688|NCT04471207|470447212|FG001|Overall Study|Scheduling Conflicts|1|||
130677689|NCT04471207|470447211|FG000|Overall Study|Physician Decision|1|||
130677690|NCT04471207|470447212|FG001|Overall Study|Physician Decision|0|||
130677691|NCT04471207|470447211|FG000|Overall Study|Unwilling to Use System|0|||
130677692|NCT04471207|470447212|FG001|Overall Study|Unwilling to Use System|1|||
130677693|NCT00561730|470447213|FG000|Overall Study|Adverse Event|2|||
130677694|NCT00561730|470447213|FG000|Overall Study|Handling of the drug|1|||
130677695|NCT00561730|470447213|FG000|Overall Study|Lost to Follow-up|5|||
130677696|NCT00561730|470447213|FG000|Overall Study|Not specified reasons|1|||
130677697|NCT02153398|470447222|FG000|Overall Study|Withdrawal by Subject|1|||
130677698|NCT02153398|470447223|FG001|Overall Study|Withdrawal by Subject|0|||
130677699|NCT02153398|470447224|FG002|Overall Study|Withdrawal by Subject|0|||
130677700|NCT02153398|470447225|FG003|Overall Study|Withdrawal by Subject|0|||
130677701|NCT02153398|470447226|FG004|Overall Study|Withdrawal by Subject|0|||
130677702|NCT02153398|470447222|FG000|Overall Study|Adverse Event|0|||
130677703|NCT02153398|470447223|FG001|Overall Study|Adverse Event|0|||
130677704|NCT02153398|470447224|FG002|Overall Study|Adverse Event|1|||
130677705|NCT02153398|470447225|FG003|Overall Study|Adverse Event|1|||
130677706|NCT02153398|470447226|FG004|Overall Study|Adverse Event|0|||
130677707|NCT00721409|470447227|FG000|Overall Study|Global deterioration of health status|2|||
130677708|NCT00721409|470447228|FG001|Overall Study|Global deterioration of health status|6|||
130677709|NCT00721409|470447229|FG002|Overall Study|Global deterioration of health status|3|||
130677710|NCT00721409|470447227|FG000|Overall Study|Death|0|||
130677711|NCT00721409|470447228|FG001|Overall Study|Death|1|||
130677712|NCT00721409|470447229|FG002|Overall Study|Death|0|||
130677713|NCT00721409|470447227|FG000|Overall Study|Randomized not Treated|0|||
130677714|NCT00721409|470447228|FG001|Overall Study|Randomized not Treated|1|||
130677715|NCT00721409|470447229|FG002|Overall Study|Randomized not Treated|4|||
130677716|NCT00721409|470447227|FG000|Overall Study|Reason not specified|1|||
130677717|NCT00721409|470447228|FG001|Overall Study|Reason not specified|0|||
130677718|NCT00721409|470447229|FG002|Overall Study|Reason not specified|2|||
130677719|NCT00721409|470447227|FG000|Overall Study|Adverse Event|0|||
130677720|NCT00721409|470447228|FG001|Overall Study|Adverse Event|13|||
130677721|NCT00721409|470447229|FG002|Overall Study|Adverse Event|2|||
130677722|NCT00721409|470447227|FG000|Overall Study|Lost to Follow-up|0|||
130677723|NCT00721409|470447228|FG001|Overall Study|Lost to Follow-up|0|||
130677724|NCT00721409|470447229|FG002|Overall Study|Lost to Follow-up|1|||
130343537|NCT03104816|469227333|FG002|Overall Study|Lack of Efficacy|0|||
130343538|NCT03104816|469227331|FG000|Overall Study|Protocol Violation|2|||
130343539|NCT03104816|469227332|FG001|Overall Study|Protocol Violation|0|||
130343540|NCT03104816|469227333|FG002|Overall Study|Protocol Violation|2|||
130343541|NCT01227629|469227335|FG000|Overall Study|Adverse Event|2|||
130343542|NCT01227629|469227336|FG001|Overall Study|Adverse Event|2|||
130343543|NCT01227629|469227337|FG002|Overall Study|Adverse Event|1|||
130343544|NCT01227629|469227338|FG003|Overall Study|Adverse Event|6|||
130343545|NCT01227629|469227339|FG004|Overall Study|Adverse Event|1|||
130343546|NCT01227629|469227340|FG005|Overall Study|Adverse Event|1|||
130552765|NCT00719563|469991531|FG001|Overall Study|Adverse Event|13|||
130677725|NCT00721409|470447227|FG000|Overall Study|Withdrawal by Subject|1|||
130677726|NCT00721409|470447228|FG001|Overall Study|Withdrawal by Subject|6|||
130677727|NCT00721409|470447229|FG002|Overall Study|Withdrawal by Subject|5|||
130677728|NCT00721409|470447227|FG000|Overall Study|Objective progression or relapse|8|||
130677729|NCT00721409|470447228|FG001|Overall Study|Objective progression or relapse|55|||
130677730|NCT00721409|470447229|FG002|Overall Study|Objective progression or relapse|62|||
130677731|NCT03331042|470447233|FG000|Overall Study|Protocol Violation|1|||
130677732|NCT03331042|470447234|FG001|Overall Study|Protocol Violation|0|||
130677733|NCT03331042|470447235|FG002|Overall Study|Protocol Violation|0|||
130677734|NCT03331042|470447236|FG003|Overall Study|Protocol Violation|0|||
130677735|NCT03331042|470447233|FG000|Overall Study|Physician Decision|0|||
130343547|NCT01227629|469227341|FG006|Overall Study|Adverse Event|6|||
130343548|NCT01227629|469227342|FG007|Overall Study|Adverse Event|6|||
130343549|NCT01227629|469227343|FG008|Overall Study|Adverse Event|4|||
130677736|NCT03331042|470447234|FG001|Overall Study|Physician Decision|0|||
130677737|NCT03331042|470447235|FG002|Overall Study|Physician Decision|1|||
130677738|NCT03331042|470447236|FG003|Overall Study|Physician Decision|0|||
130677739|NCT03331042|470447233|FG000|Overall Study|Lost to Follow-up|0|||
130677740|NCT03331042|470447234|FG001|Overall Study|Lost to Follow-up|0|||
130677741|NCT03331042|470447235|FG002|Overall Study|Lost to Follow-up|0|||
130677742|NCT03331042|470447236|FG003|Overall Study|Lost to Follow-up|1|||
130677743|NCT00322491|470447239|FG000|Overall Study|Adverse Event|1|||
130677744|NCT00322491|470447240|FG001|Overall Study|Adverse Event|0|||
130677745|NCT00322491|470447239|FG000|Overall Study|Death|1|||
130677746|NCT00322491|470447240|FG001|Overall Study|Death|2|||
130677747|NCT00001849|470447242|FG000|Overall Study|Death|4|||
130677748|NCT00001849|470447242|FG000|Overall Study|Lost to Follow-up|2|||
130677749|NCT00001849|470447242|FG000|Overall Study|Withdrawal by Subject|2|||
130677750|NCT00001849|470447242|FG000|Overall Study|tumor remained occult|6|||
130677751|NCT00524459|470447243|FG000|Overall Study|Withdrawal by Subject|1|||
130677752|NCT00524459|470447243|FG000|Overall Study|Other|1|||
130677753|NCT01574248|470447244|FG000|Overall Study|Withdrawal by Subject|2|||
130677754|NCT01574248|470447245|FG001|Overall Study|Withdrawal by Subject|0|||
130677755|NCT01574248|470447244|FG000|Overall Study|Missing primary endpoint data|1|||
130677756|NCT01574248|470447245|FG001|Overall Study|Missing primary endpoint data|0|||
130677757|NCT01424722|470447246|FG000|Overall Study|Sponsor terminated investigation|2258|||
130677758|NCT01781286|470447247|FG000|Overall Study|Lost to Follow-up|0|||
130677759|NCT01781286|470447248|FG001|Overall Study|Lost to Follow-up|0|||
130343550|NCT01227629|469227344|FG009|Overall Study|Adverse Event|0|||
130343551|NCT01227629|469227335|FG000|Overall Study|Protocol Violation|0|||
130677760|NCT01781286|470447249|FG002|Overall Study|Lost to Follow-up|0|||
130677761|NCT01781286|470447250|FG003|Overall Study|Lost to Follow-up|0|||
130677762|NCT01781286|470447251|FG004|Overall Study|Lost to Follow-up|0|||
130677763|NCT01781286|470447252|FG005|Overall Study|Lost to Follow-up|1|||
130677764|NCT01781286|470447247|FG000|Overall Study|Time Constraints|2|||
130677765|NCT01781286|470447248|FG001|Overall Study|Time Constraints|0|||
130677766|NCT01781286|470447249|FG002|Overall Study|Time Constraints|2|||
130677767|NCT01781286|470447250|FG003|Overall Study|Time Constraints|0|||
130677768|NCT01781286|470447251|FG004|Overall Study|Time Constraints|0|||
130677769|NCT01781286|470447252|FG005|Overall Study|Time Constraints|0|||
130677770|NCT01781286|470447247|FG000|Overall Study|Noncompliance|0|||
130677771|NCT01781286|470447248|FG001|Overall Study|Noncompliance|0|||
130677772|NCT01781286|470447249|FG002|Overall Study|Noncompliance|0|||
130677773|NCT01781286|470447250|FG003|Overall Study|Noncompliance|1|||
130677774|NCT01781286|470447251|FG004|Overall Study|Noncompliance|0|||
130677775|NCT01781286|470447252|FG005|Overall Study|Noncompliance|0|||
130677776|NCT03594123|470447253|FG000|Overall Study|Lost to Follow-up|0|||
130677777|NCT03594123|470447254|FG001|Overall Study|Lost to Follow-up|1|||
130677778|NCT03594123|470447253|FG000|Overall Study|Adverse Event|8|||
130677779|NCT03594123|470447254|FG001|Overall Study|Adverse Event|5|||
130677780|NCT03594123|470447253|FG000|Overall Study|Site Terminated by Sponsor|4|||
130677781|NCT03594123|470447254|FG001|Overall Study|Site Terminated by Sponsor|1|||
130677782|NCT03594123|470447253|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
130677783|NCT03594123|470447254|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
130677784|NCT03594123|470447253|FG000|Overall Study|Lack of Efficacy|1|||
130677785|NCT03594123|470447254|FG001|Overall Study|Lack of Efficacy|0|||
130677786|NCT03594123|470447253|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
130677787|NCT03594123|470447254|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
130677788|NCT00818883|470447255|FG000|Overall Study|Adverse Event|28|||
130677789|NCT00818883|470447256|FG001|Overall Study|Adverse Event|19|||
130677790|NCT00818883|470447255|FG000|Overall Study|Protocol Violation|2|||
130677791|NCT00818883|470447256|FG001|Overall Study|Protocol Violation|2|||
130343552|NCT01227629|469227336|FG001|Overall Study|Protocol Violation|0|||
130343553|NCT01227629|469227337|FG002|Overall Study|Protocol Violation|0|||
130343554|NCT01227629|469227338|FG003|Overall Study|Protocol Violation|1|||
130343555|NCT01227629|469227339|FG004|Overall Study|Protocol Violation|0|||
130343556|NCT01227629|469227340|FG005|Overall Study|Protocol Violation|0|||
130343557|NCT01227629|469227341|FG006|Overall Study|Protocol Violation|0|||
130343558|NCT01227629|469227342|FG007|Overall Study|Protocol Violation|0|||
130343559|NCT01227629|469227343|FG008|Overall Study|Protocol Violation|0|||
130343560|NCT01227629|469227344|FG009|Overall Study|Protocol Violation|0|||
130343561|NCT01227629|469227335|FG000|Overall Study|Lost to Follow-up|0|||
130343562|NCT01227629|469227336|FG001|Overall Study|Lost to Follow-up|0|||
130677792|NCT00818883|470447255|FG000|Overall Study|Lost to Follow-up|3|||
130677793|NCT00818883|470447256|FG001|Overall Study|Lost to Follow-up|2|||
130677794|NCT00818883|470447255|FG000|Overall Study|Withdrawal by Subject|16|||
130677795|NCT00818883|470447256|FG001|Overall Study|Withdrawal by Subject|14|||
130677796|NCT00818883|470447255|FG000|Overall Study|Lack of Efficacy|0|||
130677797|NCT00818883|470447256|FG001|Overall Study|Lack of Efficacy|2|||
130677798|NCT00818883|470447255|FG000|Overall Study|Other|2|||
130677799|NCT00818883|470447256|FG001|Overall Study|Other|7|||
130677800|NCT00973700|470447259|FG000|Overall Study|Withdrawal by Subject|2|||
130677801|NCT00973700|470447260|FG001|Overall Study|Withdrawal by Subject|2|||
130677802|NCT00973700|470447261|FG002|Overall Study|Withdrawal by Subject|8|||
130343563|NCT01227629|469227337|FG002|Overall Study|Lost to Follow-up|0|||
130343564|NCT01227629|469227338|FG003|Overall Study|Lost to Follow-up|0|||
130343565|NCT01227629|469227339|FG004|Overall Study|Lost to Follow-up|1|||
130343566|NCT01227629|469227340|FG005|Overall Study|Lost to Follow-up|0|||
130433672|NCT04512066|469550516|FG000|Extension Period|Adverse Event|0|||
130433673|NCT04512066|469550517|FG001|Extension Period|Adverse Event|1|||
130433674|NCT04512066|469550518|FG002|Extension Period|Adverse Event|4|||
130433675|NCT04512066|469550519|FG003|Extension Period|Adverse Event|3|||
130433676|NCT04512066|469550520|FG004|Extension Period|Adverse Event|1|||
130433677|NCT04512066|469550521|FG005|Extension Period|Adverse Event|3|||
130433678|NCT04512066|469550516|FG000|Extension Period|Death|0|||
130433679|NCT04512066|469550517|FG001|Extension Period|Death|0|||
130433680|NCT04512066|469550518|FG002|Extension Period|Death|0|||
130433681|NCT04512066|469550519|FG003|Extension Period|Death|0|||
130433682|NCT04512066|469550520|FG004|Extension Period|Death|0|||
130433683|NCT04512066|469550521|FG005|Extension Period|Death|1|||
130433684|NCT04512066|469550516|FG000|Extension Period|Lack of Efficacy|0|||
130433685|NCT04512066|469550517|FG001|Extension Period|Lack of Efficacy|4|||
130433686|NCT04512066|469550518|FG002|Extension Period|Lack of Efficacy|4|||
130433687|NCT04512066|469550519|FG003|Extension Period|Lack of Efficacy|1|||
130433688|NCT04512066|469550520|FG004|Extension Period|Lack of Efficacy|3|||
130677803|NCT00973700|470447262|FG003|Overall Study|Withdrawal by Subject|4|||
130677804|NCT00973700|470447263|FG004|Overall Study|Withdrawal by Subject|4|||
130677805|NCT00973700|470447259|FG000|Overall Study|Lost to Follow-up|5|||
130677806|NCT00973700|470447260|FG001|Overall Study|Lost to Follow-up|0|||
130677807|NCT00973700|470447261|FG002|Overall Study|Lost to Follow-up|1|||
130677808|NCT00973700|470447262|FG003|Overall Study|Lost to Follow-up|8|||
130677809|NCT00973700|470447263|FG004|Overall Study|Lost to Follow-up|5|||
130677810|NCT00973700|470447259|FG000|Overall Study|Inappropriate enrolment|0|||
130677811|NCT00973700|470447260|FG001|Overall Study|Inappropriate enrolment|0|||
130677812|NCT00973700|470447261|FG002|Overall Study|Inappropriate enrolment|0|||
130677813|NCT00973700|470447262|FG003|Overall Study|Inappropriate enrolment|4|||
130677814|NCT00973700|470447263|FG004|Overall Study|Inappropriate enrolment|0|||
130677815|NCT00973700|470447259|FG000|Overall Study|Unable to Classify|0|||
130677816|NCT00973700|470447260|FG001|Overall Study|Unable to Classify|0|||
130677817|NCT00973700|470447261|FG002|Overall Study|Unable to Classify|1|||
130677818|NCT00973700|470447262|FG003|Overall Study|Unable to Classify|2|||
130677819|NCT00973700|470447263|FG004|Overall Study|Unable to Classify|1|||
130677820|NCT05518487|470447264|FG000|Overall Study|Withdrawal by Subject|3|||
130677821|NCT02752776|470447266|FG000|Overall Study|Adverse Event|15|||
130677822|NCT02752776|470447267|FG001|Overall Study|Adverse Event|23|||
130677823|NCT02752776|470447268|FG002|Overall Study|Adverse Event|11|||
130677824|NCT02752776|470447266|FG000|Overall Study|Lack of Efficacy|2|||
130677825|NCT02752776|470447267|FG001|Overall Study|Lack of Efficacy|6|||
130677826|NCT02752776|470447268|FG002|Overall Study|Lack of Efficacy|14|||
130677827|NCT02752776|470447266|FG000|Overall Study|Lost to Follow-up|11|||
130677828|NCT02752776|470447267|FG001|Overall Study|Lost to Follow-up|12|||
130677829|NCT02752776|470447268|FG002|Overall Study|Lost to Follow-up|4|||
130677830|NCT02752776|470447266|FG000|Overall Study|Non-compliance with study treatment|0|||
130677831|NCT02752776|470447267|FG001|Overall Study|Non-compliance with study treatment|0|||
130677832|NCT02752776|470447268|FG002|Overall Study|Non-compliance with study treatment|1|||
130677833|NCT02752776|470447266|FG000|Overall Study|Physician Decision|2|||
130677834|NCT02752776|470447267|FG001|Overall Study|Physician Decision|6|||
130677835|NCT02752776|470447268|FG002|Overall Study|Physician Decision|2|||
130677836|NCT02752776|470447266|FG000|Overall Study|Pregnancy|1|||
130677837|NCT02752776|470447267|FG001|Overall Study|Pregnancy|6|||
130677838|NCT02752776|470447268|FG002|Overall Study|Pregnancy|3|||
130677839|NCT02752776|470447266|FG000|Overall Study|Protocol Violation|10|||
130677840|NCT02752776|470447267|FG001|Overall Study|Protocol Violation|13|||
130677841|NCT02752776|470447268|FG002|Overall Study|Protocol Violation|6|||
130677842|NCT02752776|470447266|FG000|Overall Study|Subject/guardian decision|8|||
130677843|NCT02752776|470447267|FG001|Overall Study|Subject/guardian decision|6|||
130677844|NCT02752776|470447268|FG002|Overall Study|Subject/guardian decision|4|||
130677845|NCT02752776|470447266|FG000|Overall Study|Death|0|||
130677846|NCT02752776|470447267|FG001|Overall Study|Death|0|||
130677847|NCT02752776|470447268|FG002|Overall Study|Death|1|||
130677848|NCT02752776|470447266|FG000|Overall Study|Withdrawal by Subject|3|||
130677849|NCT02752776|470447267|FG001|Overall Study|Withdrawal by Subject|4|||
130677850|NCT02752776|470447268|FG002|Overall Study|Withdrawal by Subject|2|||
130677851|NCT01193608|470447269|FG000|Overall Study|Other|0|||
130677852|NCT01193608|470447270|FG001|Overall Study|Other|1|||
130552766|NCT00719563|469991530|FG000|Overall Study|Medical condition changed|3|||
130677853|NCT01193608|470447271|FG002|Overall Study|Other|0|||
130677854|NCT01193608|470447272|FG003|Overall Study|Other|0|||
130433689|NCT04512066|469550521|FG005|Extension Period|Lack of Efficacy|3|||
130433690|NCT04512066|469550516|FG000|Extension Period|Lost to Follow-up|0|||
130433691|NCT04512066|469550517|FG001|Extension Period|Lost to Follow-up|1|||
130433692|NCT04512066|469550518|FG002|Extension Period|Lost to Follow-up|5|||
130677855|NCT01193608|470447273|FG004|Overall Study|Other|0|||
130677856|NCT01193608|470447274|FG005|Overall Study|Other|0|||
130677857|NCT01193608|470447269|FG000|Overall Study|Withdrawal by Subject|0|||
130677858|NCT01193608|470447270|FG001|Overall Study|Withdrawal by Subject|1|||
130677859|NCT01193608|470447271|FG002|Overall Study|Withdrawal by Subject|2|||
130677860|NCT01193608|470447272|FG003|Overall Study|Withdrawal by Subject|3|||
130552767|NCT00719563|469991531|FG001|Overall Study|Medical condition changed|5|||
130677861|NCT01193608|470447273|FG004|Overall Study|Withdrawal by Subject|3|||
130677862|NCT01193608|470447274|FG005|Overall Study|Withdrawal by Subject|0|||
130677863|NCT01193608|470447269|FG000|Overall Study|Lost to Follow-up|0|||
130677864|NCT01193608|470447270|FG001|Overall Study|Lost to Follow-up|0|||
130677865|NCT01193608|470447271|FG002|Overall Study|Lost to Follow-up|0|||
130677866|NCT01193608|470447272|FG003|Overall Study|Lost to Follow-up|0|||
130677867|NCT01193608|470447273|FG004|Overall Study|Lost to Follow-up|1|||
130677868|NCT01193608|470447274|FG005|Overall Study|Lost to Follow-up|2|||
130343567|NCT01227629|469227341|FG006|Overall Study|Lost to Follow-up|0|||
130343568|NCT01227629|469227342|FG007|Overall Study|Lost to Follow-up|0|||
130343569|NCT01227629|469227343|FG008|Overall Study|Lost to Follow-up|0|||
130343570|NCT01227629|469227344|FG009|Overall Study|Lost to Follow-up|0|||
130343571|NCT01227629|469227335|FG000|Overall Study|Withdrawal by Subject|0|||
130343572|NCT01227629|469227336|FG001|Overall Study|Withdrawal by Subject|0|||
130343573|NCT01227629|469227337|FG002|Overall Study|Withdrawal by Subject|0|||
130343574|NCT01227629|469227338|FG003|Overall Study|Withdrawal by Subject|0|||
130343575|NCT01227629|469227339|FG004|Overall Study|Withdrawal by Subject|0|||
130343576|NCT01227629|469227340|FG005|Overall Study|Withdrawal by Subject|0|||
130343577|NCT01227629|469227341|FG006|Overall Study|Withdrawal by Subject|2|||
130343578|NCT01227629|469227342|FG007|Overall Study|Withdrawal by Subject|0|||
130343579|NCT01227629|469227343|FG008|Overall Study|Withdrawal by Subject|0|||
130343580|NCT01227629|469227344|FG009|Overall Study|Withdrawal by Subject|1|||
130343581|NCT01227629|469227335|FG000|Overall Study|Other|0|||
130343582|NCT01227629|469227336|FG001|Overall Study|Other|0|||
130343583|NCT01227629|469227337|FG002|Overall Study|Other|0|||
130343584|NCT01227629|469227338|FG003|Overall Study|Other|1|||
130343585|NCT01227629|469227339|FG004|Overall Study|Other|0|||
130343586|NCT01227629|469227340|FG005|Overall Study|Other|0|||
130343587|NCT01227629|469227341|FG006|Overall Study|Other|0|||
130343588|NCT01227629|469227342|FG007|Overall Study|Other|0|||
130343589|NCT01227629|469227343|FG008|Overall Study|Other|2|||
130343590|NCT01227629|469227344|FG009|Overall Study|Other|1|||
130343591|NCT03338959|469229033|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
130343592|NCT03338959|469229033|FG000|Overall Study|Physician Decision|1|||
130343593|NCT01604278|469229034|FG000|Overall Study|Lack of Efficacy|0|||
130343594|NCT01604278|469229035|FG001|Overall Study|Lack of Efficacy|1|||
130343595|NCT01604278|469229034|FG000|Overall Study|Lost to Follow-up|1|||
130343596|NCT01604278|469229035|FG001|Overall Study|Lost to Follow-up|0|||
130343597|NCT01604278|469229034|FG000|Overall Study|Administrative problems|2|||
130343598|NCT01604278|469229035|FG001|Overall Study|Administrative problems|1|||
130343599|NCT01604278|469229034|FG000|Overall Study|Withdrawal by Subject|3|||
130343600|NCT01604278|469229035|FG001|Overall Study|Withdrawal by Subject|3|||
130343601|NCT01604278|469229034|FG000|Overall Study|Adverse Event|3|||
130343602|NCT01604278|469229035|FG001|Overall Study|Adverse Event|5|||
130343603|NCT01604278|469229034|FG000|Overall Study|Protocol Deviation|5|||
130343604|NCT01604278|469229035|FG001|Overall Study|Protocol Deviation|3|||
130343605|NCT03328182|469229038|FG000|Overall Study|Withdrawal by Subject|1|||
130343606|NCT03328182|469229038|FG000|Overall Study|Protocol Violation|2|||
130343607|NCT03328182|469229038|FG000|Overall Study|No Product Evaluated|1|||
130343608|NCT00874939|469229042|FG000|Overall Study|Study terminated|4|||
130343609|NCT02870933|469229043|FG000|Overall Study|Death|2|||
130343610|NCT02870933|469229044|FG001|Overall Study|Death|1|||
130343611|NCT02870933|469229043|FG000|Overall Study|Withdrawal by Subject|0|||
130343612|NCT02870933|469229044|FG001|Overall Study|Withdrawal by Subject|1|||
130343613|NCT01250496|469229045|FG000|Overall Study|Study terminated|124|||
130343614|NCT01250496|469229046|FG001|Overall Study|Study terminated|124|||
130343615|NCT01425463|469229052|FG000|Overall Study|Adverse Event|5|||
130343616|NCT01425463|469229053|FG001|Overall Study|Adverse Event|7|||
130343617|NCT01425463|469229052|FG000|Overall Study|Lack of Efficacy|1|||
130343618|NCT01425463|469229053|FG001|Overall Study|Lack of Efficacy|1|||
130343619|NCT01425463|469229052|FG000|Overall Study|Protocol Violation|2|||
130343620|NCT01425463|469229053|FG001|Overall Study|Protocol Violation|2|||
130343621|NCT01425463|469229052|FG000|Overall Study|Lost to Follow-up|5|||
130343622|NCT01425463|469229053|FG001|Overall Study|Lost to Follow-up|2|||
130677869|NCT01193608|470447269|FG000|Overall Study|Adverse Event|0|||
130343623|NCT01425463|469229052|FG000|Overall Study|Withdrawal by Subject|7|||
130343624|NCT01425463|469229053|FG001|Overall Study|Withdrawal by Subject|5|||
130343625|NCT01425463|469229052|FG000|Overall Study|Unknown Reason|4|||
130343626|NCT01425463|469229053|FG001|Overall Study|Unknown Reason|7|||
130343627|NCT01328366|469229058|FG000|Overall Study|Death|1|||
130343628|NCT01328366|469229058|FG000|Overall Study|Withdrawal by Subject|2|||
130343629|NCT01328366|469229058|FG000|Overall Study|Lost to Follow-up|7|||
130343630|NCT01122264|469229059|FG000|Overall Study|Adverse Event|6|||
130343631|NCT01122264|469229060|FG001|Overall Study|Adverse Event|5|||
130343632|NCT01122264|469229061|FG002|Overall Study|Adverse Event|7|||
130343633|NCT01122264|469229059|FG000|Overall Study|Death|1|||
130343634|NCT01122264|469229060|FG001|Overall Study|Death|0|||
130343635|NCT01122264|469229061|FG002|Overall Study|Death|0|||
130343636|NCT01122264|469229059|FG000|Overall Study|Lost to Follow-up|5|||
130433693|NCT04512066|469550519|FG003|Extension Period|Lost to Follow-up|2|||
130433694|NCT04512066|469550520|FG004|Extension Period|Lost to Follow-up|3|||
130433695|NCT04512066|469550521|FG005|Extension Period|Lost to Follow-up|2|||
130433696|NCT04512066|469550516|FG000|Extension Period|Non-compliance with study drug|0|||
130433697|NCT04512066|469550517|FG001|Extension Period|Non-compliance with study drug|1|||
130433698|NCT04512066|469550518|FG002|Extension Period|Non-compliance with study drug|0|||
130552768|NCT00719563|469991530|FG000|Overall Study|Lack of Efficacy|3|||
130677870|NCT01193608|470447270|FG001|Overall Study|Adverse Event|0|||
130677871|NCT01193608|470447271|FG002|Overall Study|Adverse Event|0|||
130677872|NCT01193608|470447272|FG003|Overall Study|Adverse Event|0|||
130677873|NCT01193608|470447273|FG004|Overall Study|Adverse Event|1|||
130677874|NCT01193608|470447274|FG005|Overall Study|Adverse Event|0|||
130677875|NCT00712010|470447275|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
130677876|NCT01946165|470447276|FG000|Overall Study|Physician Decision|2|||
130677877|NCT01946165|470447277|FG001|Overall Study|Physician Decision|0|||
130677878|NCT01946165|470447276|FG000|Overall Study|Withdrawal by Subject|0|||
130677879|NCT01946165|470447277|FG001|Overall Study|Withdrawal by Subject|2|||
130677880|NCT01400113|470447278|FG000|Overall Study|Withdrawal by Subject|1|||
130677881|NCT01400113|470447279|FG001|Overall Study|Withdrawal by Subject|1|||
130677882|NCT01179919|470447280|FG000|Overall Study|Protocol Violation|1|||
130677883|NCT01179919|470447280|FG000|Overall Study|Adverse Event|1|||
130677884|NCT00806156|470447284|FG000|Overall Study|Death|35|||
130677885|NCT00806156|470447285|FG001|Overall Study|Death|95|||
130677886|NCT00806156|470447284|FG000|Overall Study|Did not meet eligibility criteria|1|||
130677887|NCT00806156|470447285|FG001|Overall Study|Did not meet eligibility criteria|0|||
130677888|NCT00806156|470447284|FG000|Overall Study|Study terminated by Sponsor|2|||
130677889|NCT00806156|470447285|FG001|Overall Study|Study terminated by Sponsor|40|||
130677890|NCT00806156|470447284|FG000|Overall Study|Consent withdrawn by subject|1|||
130677891|NCT00806156|470447285|FG001|Overall Study|Consent withdrawn by subject|3|||
130677892|NCT00806156|470447284|FG000|Overall Study|Lost to Follow-up|0|||
130677893|NCT00806156|470447285|FG001|Overall Study|Lost to Follow-up|1|||
130677894|NCT00525590|470447289|FG000|Overall Study|Adverse Event|3|||
130677895|NCT00525590|470447289|FG000|Overall Study|Physician Decision|3|||
130677896|NCT00525590|470447289|FG000|Overall Study|Withdrawal by Subject|16|||
130677897|NCT00525590|470447289|FG000|Overall Study|Lost to Follow-up|1|||
130677898|NCT00525590|470447289|FG000|Overall Study|Death|9|||
130677899|NCT00525590|470447289|FG000|Overall Study|Other|13|||
130677900|NCT01025037|470447290|FG000|Overall Study|Adverse Event|3|||
130677901|NCT01025037|470447290|FG000|Overall Study|Lost to Follow-up|7|||
130677902|NCT01025037|470447290|FG000|Overall Study|Withdrawal by Subject|1|||
130677903|NCT00337571|470447291|FG000|Overall Study|Lack of Efficacy|3|||
130677904|NCT00337571|470447292|FG001|Overall Study|Lack of Efficacy|0|||
130677905|NCT00337571|470447293|FG002|Overall Study|Lack of Efficacy|0|||
130677906|NCT00337571|470447294|FG003|Overall Study|Lack of Efficacy|0|||
130677907|NCT00337571|470447291|FG000|Overall Study|Adverse Event|4|||
130677908|NCT00337571|470447292|FG001|Overall Study|Adverse Event|5|||
130677909|NCT00337571|470447293|FG002|Overall Study|Adverse Event|8|||
130677910|NCT00337571|470447294|FG003|Overall Study|Adverse Event|4|||
130677911|NCT00337571|470447291|FG000|Overall Study|Withdrawal by Subject|2|||
130677912|NCT00337571|470447292|FG001|Overall Study|Withdrawal by Subject|2|||
130677913|NCT00337571|470447293|FG002|Overall Study|Withdrawal by Subject|1|||
130677914|NCT00337571|470447294|FG003|Overall Study|Withdrawal by Subject|0|||
130677915|NCT00337571|470447291|FG000|Overall Study|Lost to Follow-up|3|||
130677916|NCT00337571|470447292|FG001|Overall Study|Lost to Follow-up|1|||
130677917|NCT00337571|470447293|FG002|Overall Study|Lost to Follow-up|0|||
130677918|NCT00337571|470447294|FG003|Overall Study|Lost to Follow-up|1|||
130677919|NCT00337571|470447291|FG000|Overall Study|Poor/noncompliance|1|||
130677920|NCT00337571|470447292|FG001|Overall Study|Poor/noncompliance|1|||
130677921|NCT00337571|470447293|FG002|Overall Study|Poor/noncompliance|1|||
130677922|NCT00337571|470447294|FG003|Overall Study|Poor/noncompliance|1|||
130677923|NCT00337571|470447291|FG000|Overall Study|No longer met study criteria|1|||
130677924|NCT00337571|470447292|FG001|Overall Study|No longer met study criteria|0|||
130677925|NCT00337571|470447293|FG002|Overall Study|No longer met study criteria|0|||
130677926|NCT00337571|470447294|FG003|Overall Study|No longer met study criteria|0|||
130677927|NCT00337571|470447291|FG000|Overall Study|High Potassium level|0|||
130677928|NCT00337571|470447292|FG001|Overall Study|High Potassium level|0|||
130677929|NCT00337571|470447293|FG002|Overall Study|High Potassium level|0|||
130677930|NCT00337571|470447294|FG003|Overall Study|High Potassium level|1|||
130216600|NCT05305989|468755616|FG000|Overall Study|Protocol Violation|0|||
130677931|NCT02114697|470447295|FG000|Overall Study|Study terminated|5|||
130677932|NCT02114697|470447296|FG001|Overall Study|Study terminated|4|||
130677933|NCT03552757|470447303|FG000|Overall Study|Withdrawal by Subject|10|||
130677934|NCT03552757|470447304|FG001|Overall Study|Withdrawal by Subject|5|||
130677935|NCT03552757|470447305|FG002|Overall Study|Withdrawal by Subject|12|||
130677936|NCT03552757|470447303|FG000|Overall Study|Lost to Follow-up|2|||
130677937|NCT03552757|470447304|FG001|Overall Study|Lost to Follow-up|7|||
130433699|NCT04512066|469550519|FG003|Extension Period|Non-compliance with study drug|0|||
130552769|NCT00719563|469991531|FG001|Overall Study|Lack of Efficacy|7|||
130677938|NCT03552757|470447305|FG002|Overall Study|Lost to Follow-up|7|||
130677939|NCT03552757|470447303|FG000|Overall Study|Death|1|||
130677940|NCT03552757|470447304|FG001|Overall Study|Death|1|||
130677941|NCT03552757|470447305|FG002|Overall Study|Death|1|||
130677942|NCT00449150|470447306|FG000|Overall Study|Adverse Event|11|||
130677943|NCT00449150|470447307|FG001|Overall Study|Adverse Event|18|||
130677944|NCT00449150|470447308|FG002|Overall Study|Adverse Event|9|||
130677945|NCT00449150|470447306|FG000|Overall Study|Lack of Efficacy|1|||
130677946|NCT00449150|470447307|FG001|Overall Study|Lack of Efficacy|2|||
130677947|NCT00449150|470447308|FG002|Overall Study|Lack of Efficacy|2|||
130677948|NCT00449150|470447306|FG000|Overall Study|Other|16|||
130677949|NCT00449150|470447307|FG001|Overall Study|Other|13|||
130677950|NCT00449150|470447308|FG002|Overall Study|Other|14|||
130677951|NCT00449150|470447306|FG000|Overall Study|Withdrawal by Subject|17|||
130677952|NCT00449150|470447307|FG001|Overall Study|Withdrawal by Subject|18|||
130677953|NCT00449150|470447308|FG002|Overall Study|Withdrawal by Subject|21|||
130677954|NCT00449150|470447306|FG000|Overall Study|Protocol Violation|1|||
130677955|NCT00449150|470447307|FG001|Overall Study|Protocol Violation|2|||
130677956|NCT00449150|470447308|FG002|Overall Study|Protocol Violation|1|||
130677957|NCT02674334|470447309|FG000|Overall Study|Lost to Follow-up|5|||
130677958|NCT02674334|470447310|FG001|Overall Study|Lost to Follow-up|3|||
130677959|NCT02674334|470447309|FG000|Overall Study|participant difficulty breathing|1|||
130677960|NCT02674334|470447310|FG001|Overall Study|participant difficulty breathing|0|||
130677961|NCT02674334|470447309|FG000|Overall Study|NIRS not recording|1|||
130677962|NCT02674334|470447310|FG001|Overall Study|NIRS not recording|0|||
130677963|NCT01345019|470447318|FG000|Blinded Treatment Phase|Death|147|||
130677964|NCT01345019|470447319|FG001|Blinded Treatment Phase|Death|137|||
130677965|NCT01345019|470447318|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
130677966|NCT01345019|470447319|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
130677967|NCT01345019|470447318|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
130677968|NCT01345019|470447319|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
130677969|NCT01345019|470447318|FG000|Blinded Treatment Phase|Disease Progression|12|||
130677970|NCT01345019|470447319|FG001|Blinded Treatment Phase|Disease Progression|10|||
130677971|NCT01345019|470447318|FG000|Blinded Treatment Phase|Adverse Event|6|||
130677972|NCT01345019|470447319|FG001|Blinded Treatment Phase|Adverse Event|13|||
130677973|NCT01345019|470447318|FG000|Blinded Treatment Phase|Administrative Decision|10|||
130677974|NCT01345019|470447319|FG001|Blinded Treatment Phase|Administrative Decision|8|||
130677975|NCT01345019|470447318|FG000|Blinded Treatment Phase|Noncompliance|5|||
130677976|NCT01345019|470447319|FG001|Blinded Treatment Phase|Noncompliance|3|||
130677977|NCT01345019|470447318|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
130677978|NCT01345019|470447319|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
130677979|NCT01345019|470447318|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
130677980|NCT01345019|470447319|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
130677981|NCT01345019|470447318|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
130677982|NCT01345019|470447319|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
130677983|NCT01345019|470447318|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
130677984|NCT01345019|470447319|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
130677985|NCT01345019|470447318|FG000|Open Label Treatment Phase|Death|49|||
130677986|NCT01345019|470447319|FG001|Open Label Treatment Phase|Death|48|||
130677987|NCT01345019|470447318|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
130677988|NCT01345019|470447319|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
130677989|NCT01345019|470447318|FG000|Open Label Treatment Phase|Adverse Event|30|||
130677990|NCT01345019|470447319|FG001|Open Label Treatment Phase|Adverse Event|51|||
130677991|NCT01345019|470447318|FG000|Open Label Treatment Phase|Administrative Decision|30|||
130677992|NCT01345019|470447319|FG001|Open Label Treatment Phase|Administrative Decision|15|||
130677993|NCT01345019|470447318|FG000|Open Label Treatment Phase|Disease Progression|17|||
130677994|NCT01345019|470447319|FG001|Open Label Treatment Phase|Disease Progression|18|||
130677995|NCT01345019|470447318|FG000|Open Label Treatment Phase|Noncompliance|5|||
130677996|NCT01345019|470447319|FG001|Open Label Treatment Phase|Noncompliance|4|||
130677997|NCT01345019|470447318|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
130677998|NCT01345019|470447319|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
130677999|NCT01345019|470447318|FG000|Open Label Treatment Phase|Pregnancy|1|||
130678000|NCT01345019|470447319|FG001|Open Label Treatment Phase|Pregnancy|0|||
130343637|NCT01122264|469229060|FG001|Overall Study|Lost to Follow-up|9|||
130343638|NCT01122264|469229061|FG002|Overall Study|Lost to Follow-up|13|||
130343639|NCT01122264|469229059|FG000|Overall Study|Entry Criteria Not Met|1|||
130343640|NCT01122264|469229060|FG001|Overall Study|Entry Criteria Not Met|0|||
130343641|NCT01122264|469229061|FG002|Overall Study|Entry Criteria Not Met|0|||
130678001|NCT01345019|470447318|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
130343642|NCT01122264|469229059|FG000|Overall Study|Protocol Violation|7|||
130678002|NCT01345019|470447319|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
130678003|NCT01345019|470447318|FG000|Open Label Treatment Phase|Protocol Violation|0|||
130678004|NCT01345019|470447319|FG001|Open Label Treatment Phase|Protocol Violation|1|||
130678005|NCT03830164|470447323|FG000|Overall Study|Adverse Event|0|||
130343643|NCT01122264|469229060|FG001|Overall Study|Protocol Violation|7|||
130678006|NCT03830164|470447324|FG001|Overall Study|Adverse Event|2|||
130678007|NCT03830164|470447325|FG002|Overall Study|Adverse Event|0|||
130678008|NCT03830164|470447323|FG000|Overall Study|Lack of Efficacy|1|||
130678009|NCT03830164|470447324|FG001|Overall Study|Lack of Efficacy|5|||
130678010|NCT03830164|470447325|FG002|Overall Study|Lack of Efficacy|0|||
130678011|NCT03830164|470447323|FG000|Overall Study|Lost to Follow-up|0|||
130678012|NCT03830164|470447324|FG001|Overall Study|Lost to Follow-up|1|||
130678013|NCT03830164|470447325|FG002|Overall Study|Lost to Follow-up|0|||
130678014|NCT03830164|470447323|FG000|Overall Study|Withdrawal by Subject|1|||
130678015|NCT03830164|470447324|FG001|Overall Study|Withdrawal by Subject|0|||
130678016|NCT03830164|470447325|FG002|Overall Study|Withdrawal by Subject|0|||
130678017|NCT02796664|470447328|FG000|Overall Study|Withdrawal by Subject|0|||
130678018|NCT02796664|470447329|FG001|Overall Study|Withdrawal by Subject|3|||
130678019|NCT02796664|470447328|FG000|Overall Study|Noncompliance|1|||
130678020|NCT02796664|470447329|FG001|Overall Study|Noncompliance|1|||
130678021|NCT02796664|470447328|FG000|Overall Study|Death|0|||
130678022|NCT02796664|470447329|FG001|Overall Study|Death|1|||
130678023|NCT02246478|470447330|FG000|Multiple-dose Phase|Protocol Violation|1|||
130678024|NCT02246478|470447331|FG001|Multiple-dose Phase|Protocol Violation|0|||
130678025|NCT02246478|470447332|FG002|Multiple-dose Phase|Protocol Violation|0|||
130678026|NCT02246478|470447333|FG003|Multiple-dose Phase|Protocol Violation|1|||
130678027|NCT01531205|470447336|FG000|Overall Study|Did not proceed to surgery|1|||
130678028|NCT00995553|470447337|FG000|Overall Study|Withdrawal by Subject|2|||
130678029|NCT00995553|470447338|FG001|Overall Study|Withdrawal by Subject|6|||
130678030|NCT01089647|470447339|FG000|Overall Study|Lost to Follow-up|2|||
130678031|NCT01089647|470447340|FG001|Overall Study|Lost to Follow-up|2|||
130343644|NCT01122264|469229061|FG002|Overall Study|Protocol Violation|9|||
130343645|NCT01122264|469229059|FG000|Overall Study|Withdrawal by Subject|6|||
130343646|NCT01122264|469229060|FG001|Overall Study|Withdrawal by Subject|6|||
130343647|NCT01122264|469229061|FG002|Overall Study|Withdrawal by Subject|16|||
130343648|NCT01122264|469229059|FG000|Overall Study|Physician Decision|3|||
130343649|NCT01122264|469229060|FG001|Overall Study|Physician Decision|1|||
130343650|NCT01122264|469229061|FG002|Overall Study|Physician Decision|1|||
130343651|NCT01122264|469229059|FG000|Overall Study|Lack of Efficacy|3|||
130343652|NCT01122264|469229060|FG001|Overall Study|Lack of Efficacy|1|||
130343653|NCT01122264|469229061|FG002|Overall Study|Lack of Efficacy|1|||
130343654|NCT04585009|469229070|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
130343655|NCT04585009|469229071|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343656|NCT04585009|469229072|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343657|NCT04585009|469229073|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343658|NCT04585009|469229074|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343659|NCT04585009|469229075|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343660|NCT04585009|469229076|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343661|NCT04585009|469229077|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343662|NCT04585009|469229078|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343663|NCT04585009|469229079|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343664|NCT04585009|469229080|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343665|NCT04585009|469229081|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343666|NCT04585009|469229070|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
130343667|NCT04585009|469229071|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343668|NCT04585009|469229072|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343669|NCT04585009|469229073|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343670|NCT04585009|469229074|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343671|NCT04585009|469229075|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343672|NCT04585009|469229076|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343673|NCT04585009|469229077|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343674|NCT04585009|469229078|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343675|NCT04585009|469229079|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343676|NCT04585009|469229080|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343677|NCT04585009|469229081|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343678|NCT04585009|469229070|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343679|NCT04585009|469229071|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343680|NCT04585009|469229072|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343681|NCT04585009|469229073|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343682|NCT04585009|469229074|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130552770|NCT00719563|469991530|FG000|Overall Study|Personal reasons|6|||
130678032|NCT01089647|470447339|FG000|Overall Study|Withdrawal by Subject|2|||
130678033|NCT01089647|470447340|FG001|Overall Study|Withdrawal by Subject|1|||
130678034|NCT01089647|470447339|FG000|Overall Study|Adverse Event|0|||
130678035|NCT01089647|470447340|FG001|Overall Study|Adverse Event|1|||
130678036|NCT00950807|470447347|FG000|Treatment Period 1|Lack of Efficacy|1|||
130678037|NCT00950807|470447348|FG001|Treatment Period 1|Lack of Efficacy|0|||
130678038|NCT00950807|470447349|FG002|Treatment Period 1|Lack of Efficacy|0|||
130678039|NCT00950807|470447350|FG003|Treatment Period 1|Lack of Efficacy|0|||
130678040|NCT00950807|470447351|FG004|Treatment Period 1|Lack of Efficacy|0|||
130678041|NCT00950807|470447352|FG005|Treatment Period 1|Lack of Efficacy|1|||
130678042|NCT00950807|470447353|FG006|Treatment Period 1|Lack of Efficacy|0|||
130678043|NCT00950807|470447354|FG007|Treatment Period 1|Lack of Efficacy|0|||
130678044|NCT00950807|470447355|FG008|Treatment Period 1|Lack of Efficacy|0|||
130678045|NCT00950807|470447356|FG009|Treatment Period 1|Lack of Efficacy|0|||
130678046|NCT00950807|470447347|FG000|Treatment Period 1|Protocol Violation|1|||
130678047|NCT00950807|470447348|FG001|Treatment Period 1|Protocol Violation|0|||
130678048|NCT00950807|470447349|FG002|Treatment Period 1|Protocol Violation|0|||
130678049|NCT00950807|470447350|FG003|Treatment Period 1|Protocol Violation|0|||
130678050|NCT00950807|470447351|FG004|Treatment Period 1|Protocol Violation|0|||
130678051|NCT00950807|470447352|FG005|Treatment Period 1|Protocol Violation|0|||
130678052|NCT00950807|470447353|FG006|Treatment Period 1|Protocol Violation|0|||
130678053|NCT00950807|470447354|FG007|Treatment Period 1|Protocol Violation|0|||
130678054|NCT00950807|470447355|FG008|Treatment Period 1|Protocol Violation|0|||
130678055|NCT00950807|470447356|FG009|Treatment Period 1|Protocol Violation|0|||
130678056|NCT00950807|470447347|FG000|Treatment Period 1|Lost to Follow-up|0|||
130678057|NCT00950807|470447348|FG001|Treatment Period 1|Lost to Follow-up|0|||
130678058|NCT00950807|470447349|FG002|Treatment Period 1|Lost to Follow-up|1|||
130678059|NCT00950807|470447350|FG003|Treatment Period 1|Lost to Follow-up|0|||
130678060|NCT00950807|470447351|FG004|Treatment Period 1|Lost to Follow-up|0|||
130678061|NCT00950807|470447352|FG005|Treatment Period 1|Lost to Follow-up|0|||
130678062|NCT00950807|470447353|FG006|Treatment Period 1|Lost to Follow-up|0|||
130678063|NCT00950807|470447354|FG007|Treatment Period 1|Lost to Follow-up|0|||
130678064|NCT00950807|470447355|FG008|Treatment Period 1|Lost to Follow-up|0|||
130678065|NCT00950807|470447356|FG009|Treatment Period 1|Lost to Follow-up|0|||
130678066|NCT00950807|470447347|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130678067|NCT00950807|470447348|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130678068|NCT00950807|470447349|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130678069|NCT00950807|470447350|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130678070|NCT00950807|470447351|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130678071|NCT00950807|470447352|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130678072|NCT00950807|470447353|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130678073|NCT00950807|470447354|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130678074|NCT00950807|470447355|FG008|Treatment Period 1|Withdrawal by Subject|1|||
130678075|NCT00950807|470447356|FG009|Treatment Period 1|Withdrawal by Subject|0|||
130678076|NCT00950807|470447347|FG000|Treatment Period 1|Adverse Event|0|||
130678077|NCT00950807|470447348|FG001|Treatment Period 1|Adverse Event|0|||
130678078|NCT00950807|470447349|FG002|Treatment Period 1|Adverse Event|0|||
130678079|NCT00950807|470447350|FG003|Treatment Period 1|Adverse Event|0|||
130678080|NCT00950807|470447351|FG004|Treatment Period 1|Adverse Event|0|||
130678081|NCT00950807|470447352|FG005|Treatment Period 1|Adverse Event|1|||
130678082|NCT00950807|470447353|FG006|Treatment Period 1|Adverse Event|0|||
130678083|NCT00950807|470447354|FG007|Treatment Period 1|Adverse Event|0|||
130678084|NCT00950807|470447355|FG008|Treatment Period 1|Adverse Event|0|||
130678085|NCT00950807|470447356|FG009|Treatment Period 1|Adverse Event|0|||
130678086|NCT00950807|470447347|FG000|Washout Period 1|Lack of Efficacy|0|||
130678087|NCT00950807|470447348|FG001|Washout Period 1|Lack of Efficacy|0|||
130678088|NCT00950807|470447349|FG002|Washout Period 1|Lack of Efficacy|0|||
130678089|NCT00950807|470447350|FG003|Washout Period 1|Lack of Efficacy|0|||
130678090|NCT00950807|470447351|FG004|Washout Period 1|Lack of Efficacy|0|||
130678091|NCT00950807|470447352|FG005|Washout Period 1|Lack of Efficacy|0|||
130678092|NCT00950807|470447353|FG006|Washout Period 1|Lack of Efficacy|1|||
130343683|NCT04585009|469229075|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130678093|NCT00950807|470447354|FG007|Washout Period 1|Lack of Efficacy|0|||
130678094|NCT00950807|470447355|FG008|Washout Period 1|Lack of Efficacy|0|||
130678095|NCT00950807|470447356|FG009|Washout Period 1|Lack of Efficacy|0|||
130343684|NCT04585009|469229076|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343685|NCT04585009|469229077|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
130343686|NCT04585009|469229078|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343687|NCT04585009|469229079|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343688|NCT04585009|469229080|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343689|NCT04585009|469229081|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130678096|NCT00950807|470447347|FG000|Washout Period 1|Withdrawal by Subject|0|||
130678097|NCT00950807|470447348|FG001|Washout Period 1|Withdrawal by Subject|0|||
130343690|NCT04585009|469229070|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130678098|NCT00950807|470447349|FG002|Washout Period 1|Withdrawal by Subject|0|||
130678099|NCT00950807|470447350|FG003|Washout Period 1|Withdrawal by Subject|0|||
130678100|NCT00950807|470447351|FG004|Washout Period 1|Withdrawal by Subject|0|||
130678101|NCT00950807|470447352|FG005|Washout Period 1|Withdrawal by Subject|0|||
130678102|NCT00950807|470447353|FG006|Washout Period 1|Withdrawal by Subject|0|||
130678103|NCT00950807|470447354|FG007|Washout Period 1|Withdrawal by Subject|0|||
130433700|NCT04512066|469550520|FG004|Extension Period|Non-compliance with study drug|0|||
130433701|NCT04512066|469550521|FG005|Extension Period|Non-compliance with study drug|1|||
130433702|NCT04512066|469550516|FG000|Extension Period|Other|0|||
130433703|NCT04512066|469550517|FG001|Extension Period|Other|2|||
130433704|NCT04512066|469550518|FG002|Extension Period|Other|0|||
130433705|NCT04512066|469550519|FG003|Extension Period|Other|0|||
130433706|NCT04512066|469550520|FG004|Extension Period|Other|0|||
130433707|NCT04512066|469550521|FG005|Extension Period|Other|0|||
130433708|NCT04512066|469550516|FG000|Extension Period|Physician Decision|0|||
130433709|NCT04512066|469550517|FG001|Extension Period|Physician Decision|2|||
130678104|NCT00950807|470447355|FG008|Washout Period 1|Withdrawal by Subject|1|||
130678105|NCT00950807|470447356|FG009|Washout Period 1|Withdrawal by Subject|0|||
130678106|NCT00950807|470447347|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
130678107|NCT00950807|470447348|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678108|NCT00950807|470447349|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678109|NCT00950807|470447350|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678110|NCT00950807|470447351|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678111|NCT00950807|470447352|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678112|NCT00950807|470447353|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
130678113|NCT00950807|470447354|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
130678114|NCT00950807|470447355|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678115|NCT00950807|470447356|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130678116|NCT00950807|470447347|FG000|Washout Period 1|Adverse Event|2|||
130678117|NCT00950807|470447348|FG001|Washout Period 1|Adverse Event|0|||
130678118|NCT00950807|470447349|FG002|Washout Period 1|Adverse Event|0|||
130678119|NCT00950807|470447350|FG003|Washout Period 1|Adverse Event|1|||
130678120|NCT00950807|470447351|FG004|Washout Period 1|Adverse Event|1|||
130678121|NCT00950807|470447352|FG005|Washout Period 1|Adverse Event|0|||
130678122|NCT00950807|470447353|FG006|Washout Period 1|Adverse Event|0|||
130678123|NCT00950807|470447354|FG007|Washout Period 1|Adverse Event|0|||
130678124|NCT00950807|470447355|FG008|Washout Period 1|Adverse Event|0|||
130678125|NCT00950807|470447356|FG009|Washout Period 1|Adverse Event|0|||
130678126|NCT00950807|470447347|FG000|Treatment Period 2|Lack of Efficacy|1|||
130678127|NCT00950807|470447348|FG001|Treatment Period 2|Lack of Efficacy|0|||
130678128|NCT00950807|470447349|FG002|Treatment Period 2|Lack of Efficacy|0|||
130678129|NCT00950807|470447350|FG003|Treatment Period 2|Lack of Efficacy|0|||
130678130|NCT00950807|470447351|FG004|Treatment Period 2|Lack of Efficacy|0|||
130678131|NCT00950807|470447352|FG005|Treatment Period 2|Lack of Efficacy|0|||
130678132|NCT00950807|470447353|FG006|Treatment Period 2|Lack of Efficacy|0|||
130678133|NCT00950807|470447354|FG007|Treatment Period 2|Lack of Efficacy|0|||
130678134|NCT00950807|470447355|FG008|Treatment Period 2|Lack of Efficacy|0|||
130678135|NCT00950807|470447356|FG009|Treatment Period 2|Lack of Efficacy|0|||
130678136|NCT00950807|470447347|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130678137|NCT00950807|470447348|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130678138|NCT00950807|470447349|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130678139|NCT00950807|470447350|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130678140|NCT00950807|470447351|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130678141|NCT00950807|470447352|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130678142|NCT00950807|470447353|FG006|Treatment Period 2|Withdrawal by Subject|1|||
130678143|NCT00950807|470447354|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130678144|NCT00950807|470447355|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130678145|NCT00950807|470447356|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130678146|NCT00950807|470447347|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
130678147|NCT00950807|470447348|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678148|NCT00950807|470447349|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678149|NCT00950807|470447350|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678150|NCT00950807|470447351|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678151|NCT00950807|470447352|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678152|NCT00950807|470447353|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678153|NCT00950807|470447354|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678154|NCT00950807|470447355|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678155|NCT00950807|470447356|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130678156|NCT00950807|470447347|FG000|Treatment Period 2|Adverse Event|0|||
130678157|NCT00950807|470447348|FG001|Treatment Period 2|Adverse Event|1|||
130678158|NCT00950807|470447349|FG002|Treatment Period 2|Adverse Event|0|||
130678159|NCT00950807|470447350|FG003|Treatment Period 2|Adverse Event|1|||
130678160|NCT00950807|470447351|FG004|Treatment Period 2|Adverse Event|0|||
130433710|NCT04512066|469550518|FG002|Extension Period|Physician Decision|0|||
130433711|NCT04512066|469550519|FG003|Extension Period|Physician Decision|1|||
130433712|NCT04512066|469550520|FG004|Extension Period|Physician Decision|1|||
130678161|NCT00950807|470447352|FG005|Treatment Period 2|Adverse Event|1|||
130678162|NCT00950807|470447353|FG006|Treatment Period 2|Adverse Event|0|||
130678163|NCT00950807|470447354|FG007|Treatment Period 2|Adverse Event|1|||
130678164|NCT00950807|470447355|FG008|Treatment Period 2|Adverse Event|0|||
130433713|NCT04512066|469550521|FG005|Extension Period|Physician Decision|0|||
130433714|NCT04512066|469550516|FG000|Extension Period|Withdrawal by Subject|0|||
130433715|NCT04512066|469550517|FG001|Extension Period|Withdrawal by Subject|3|||
130678165|NCT00950807|470447356|FG009|Treatment Period 2|Adverse Event|0|||
130678166|NCT00950807|470447347|FG000|Washout Period 2|Lack of Efficacy|1|||
130678167|NCT00950807|470447348|FG001|Washout Period 2|Lack of Efficacy|0|||
130678168|NCT00950807|470447349|FG002|Washout Period 2|Lack of Efficacy|0|||
130678169|NCT00950807|470447350|FG003|Washout Period 2|Lack of Efficacy|0|||
130678170|NCT00950807|470447351|FG004|Washout Period 2|Lack of Efficacy|0|||
130678171|NCT00950807|470447352|FG005|Washout Period 2|Lack of Efficacy|0|||
130678172|NCT00950807|470447353|FG006|Washout Period 2|Lack of Efficacy|0|||
130678173|NCT00950807|470447354|FG007|Washout Period 2|Lack of Efficacy|0|||
130678174|NCT00950807|470447355|FG008|Washout Period 2|Lack of Efficacy|0|||
130678175|NCT00950807|470447356|FG009|Washout Period 2|Lack of Efficacy|0|||
130678176|NCT00950807|470447347|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678177|NCT00950807|470447348|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130678178|NCT00950807|470447349|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678179|NCT00950807|470447350|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678180|NCT00950807|470447351|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130678181|NCT00950807|470447352|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678182|NCT00950807|470447353|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130678183|NCT00950807|470447354|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130678184|NCT00950807|470447355|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678185|NCT00950807|470447356|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130678186|NCT00950807|470447347|FG000|Washout Period 2|Adverse Event|3|||
130678187|NCT00950807|470447348|FG001|Washout Period 2|Adverse Event|0|||
130678188|NCT00950807|470447349|FG002|Washout Period 2|Adverse Event|0|||
130678189|NCT00950807|470447350|FG003|Washout Period 2|Adverse Event|1|||
130678190|NCT00950807|470447351|FG004|Washout Period 2|Adverse Event|0|||
130678191|NCT00950807|470447352|FG005|Washout Period 2|Adverse Event|0|||
130678192|NCT00950807|470447353|FG006|Washout Period 2|Adverse Event|0|||
130678193|NCT00950807|470447354|FG007|Washout Period 2|Adverse Event|0|||
130678194|NCT00950807|470447355|FG008|Washout Period 2|Adverse Event|0|||
130678195|NCT00950807|470447356|FG009|Washout Period 2|Adverse Event|0|||
130678196|NCT00950807|470447347|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130678197|NCT00950807|470447348|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130678198|NCT00950807|470447349|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130678199|NCT00950807|470447350|FG003|Treatment Period 3|Withdrawal by Subject|0|||
130678200|NCT00950807|470447351|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130678201|NCT00950807|470447352|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130678202|NCT00950807|470447353|FG006|Treatment Period 3|Withdrawal by Subject|0|||
130678203|NCT00950807|470447354|FG007|Treatment Period 3|Withdrawal by Subject|0|||
130678204|NCT00950807|470447355|FG008|Treatment Period 3|Withdrawal by Subject|0|||
130678205|NCT00950807|470447356|FG009|Treatment Period 3|Withdrawal by Subject|1|||
130678206|NCT00950807|470447347|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130678207|NCT00950807|470447348|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678208|NCT00950807|470447349|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678209|NCT00950807|470447350|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678210|NCT00950807|470447351|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678211|NCT00950807|470447352|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678212|NCT00950807|470447353|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678213|NCT00950807|470447354|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130678214|NCT00950807|470447355|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678215|NCT00950807|470447356|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130678216|NCT00950807|470447347|FG000|Treatment Period 3|Adverse Event|0|||
130678217|NCT00950807|470447348|FG001|Treatment Period 3|Adverse Event|0|||
130678218|NCT00950807|470447349|FG002|Treatment Period 3|Adverse Event|0|||
130678219|NCT00950807|470447350|FG003|Treatment Period 3|Adverse Event|0|||
130678220|NCT00950807|470447351|FG004|Treatment Period 3|Adverse Event|0|||
130678221|NCT00950807|470447352|FG005|Treatment Period 3|Adverse Event|0|||
130433716|NCT04512066|469550518|FG002|Extension Period|Withdrawal by Subject|7|||
130678222|NCT00950807|470447353|FG006|Treatment Period 3|Adverse Event|1|||
130678223|NCT00950807|470447354|FG007|Treatment Period 3|Adverse Event|0|||
130678224|NCT00950807|470447355|FG008|Treatment Period 3|Adverse Event|0|||
130433717|NCT04512066|469550519|FG003|Extension Period|Withdrawal by Subject|11|||
130433718|NCT04512066|469550520|FG004|Extension Period|Withdrawal by Subject|8|||
130433719|NCT04512066|469550521|FG005|Extension Period|Withdrawal by Subject|4|||
130433720|NCT03520400|469550522|FG000|Overall Study|Physician Decision|15|||
130678225|NCT00950807|470447356|FG009|Treatment Period 3|Adverse Event|0|||
130678226|NCT00337077|470447357|FG000|Overall Study|Progressive disease|25|||
130678227|NCT00337077|470447358|FG001|Overall Study|Progressive disease|37|||
130678228|NCT00337077|470447359|FG002|Overall Study|Progressive disease|19|||
130678229|NCT00337077|470447357|FG000|Overall Study|Adverse Event|7|||
130678230|NCT00337077|470447358|FG001|Overall Study|Adverse Event|7|||
130678231|NCT00337077|470447359|FG002|Overall Study|Adverse Event|1|||
130678232|NCT00337077|470447357|FG000|Overall Study|Death|0|||
130678233|NCT00337077|470447358|FG001|Overall Study|Death|1|||
130678234|NCT00337077|470447359|FG002|Overall Study|Death|0|||
130678235|NCT00337077|470447357|FG000|Overall Study|Withdrawal by Subject|7|||
130678236|NCT00337077|470447358|FG001|Overall Study|Withdrawal by Subject|2|||
130678237|NCT00337077|470447359|FG002|Overall Study|Withdrawal by Subject|2|||
130678238|NCT00337077|470447357|FG000|Overall Study|Alternative therapy|1|||
130678239|NCT00337077|470447358|FG001|Overall Study|Alternative therapy|0|||
130678240|NCT00337077|470447359|FG002|Overall Study|Alternative therapy|0|||
130678241|NCT00337077|470447357|FG000|Overall Study|Physician Decision|1|||
130678242|NCT00337077|470447358|FG001|Overall Study|Physician Decision|4|||
130678243|NCT00337077|470447359|FG002|Overall Study|Physician Decision|2|||
130678244|NCT00337077|470447357|FG000|Overall Study|Never started treatment|1|||
130678245|NCT00337077|470447358|FG001|Overall Study|Never started treatment|1|||
130678246|NCT00337077|470447359|FG002|Overall Study|Never started treatment|0|||
130678247|NCT00337077|470447357|FG000|Overall Study|Ineligible|1|||
130678248|NCT00337077|470447358|FG001|Overall Study|Ineligible|1|||
130678249|NCT00337077|470447359|FG002|Overall Study|Ineligible|1|||
130678250|NCT04646109|470447368|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
130678251|NCT04646109|470447369|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
130678252|NCT03815942|470449156|FG000|Overall Study|Withdrawal by Subject|0|||
130678253|NCT03815942|470449157|FG001|Overall Study|Withdrawal by Subject|17|||
130678254|NCT02785913|470449158|FG000|Overall Study|Adverse Event|5|||
130678255|NCT02785913|470449158|FG000|Overall Study|Death|2|||
130678256|NCT02785913|470449158|FG000|Overall Study|Progression|18|||
130678257|NCT02785913|470449158|FG000|Overall Study|Not protocol specified|1|||
130678258|NCT03717064|470449159|FG000|Period 2|Adverse Event|1|||
130678259|NCT02841709|470449160|FG000|5th Intervention|Adverse Event|2|||
130678260|NCT02841709|470449161|FG001|5th Intervention|Adverse Event|0|||
130678261|NCT02841709|470449162|FG002|5th Intervention|Adverse Event|0|||
130678262|NCT02841709|470449163|FG003|5th Intervention|Adverse Event|0|||
130678263|NCT02841709|470449164|FG004|5th Intervention|Adverse Event|2|||
130678264|NCT01929109|470449165|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
130343691|NCT04585009|469229071|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130678265|NCT01929109|470449166|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
130678266|NCT01929109|470449167|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
130678267|NCT01929109|470449168|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
130678268|NCT01929109|470449169|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
130678269|NCT00076102|470449170|FG000|Overall Study|Clinical progression|1|||
130678270|NCT00076102|470449170|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
130678271|NCT00076102|470449170|FG000|Overall Study|plexiform neurofibroma surgery|1|||
130678272|NCT00076102|470449170|FG000|Overall Study|refusal of further therapy|2|||
130678273|NCT01402908|470449172|FG000|Overall Study|Withdrawal by Subject|30|||
130678274|NCT01402908|470449173|FG001|Overall Study|Withdrawal by Subject|17|||
130678275|NCT01402908|470449172|FG000|Overall Study|Lost to Follow-up|3|||
130678276|NCT01402908|470449173|FG001|Overall Study|Lost to Follow-up|1|||
130678277|NCT01402908|470449172|FG000|Overall Study|Physician Decision|1|||
130678278|NCT01402908|470449173|FG001|Overall Study|Physician Decision|0|||
130678279|NCT01739790|470449175|FG000|Overall Study|Early Trial Termination|2|||
130678280|NCT01739790|470449176|FG001|Overall Study|Early Trial Termination|4|||
130678281|NCT02581345|470449177|FG000|Part 1: up to Week 16|Adverse Event|3|||
130678282|NCT02581345|470449178|FG001|Part 1: up to Week 16|Adverse Event|8|||
130678283|NCT02581345|470449179|FG002|Part 1: up to Week 16|Adverse Event|0|||
130678284|NCT02581345|470449180|FG003|Part 1: up to Week 16|Adverse Event|0|||
130678285|NCT02581345|470449177|FG000|Part 1: up to Week 16|Physician Decision|2|||
130678286|NCT02581345|470449178|FG001|Part 1: up to Week 16|Physician Decision|4|||
130678287|NCT02581345|470449179|FG002|Part 1: up to Week 16|Physician Decision|0|||
130678288|NCT02581345|470449180|FG003|Part 1: up to Week 16|Physician Decision|0|||
130678289|NCT02581345|470449177|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
130678290|NCT02581345|470449178|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
130678291|NCT02581345|470449179|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
130678292|NCT02581345|470449180|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
130678293|NCT02581345|470449177|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
130343692|NCT04585009|469229072|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343693|NCT04585009|469229073|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343694|NCT04585009|469229074|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
130678294|NCT02581345|470449178|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
130678295|NCT02581345|470449179|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
130678296|NCT02581345|470449180|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
130678297|NCT02581345|470449177|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
130678298|NCT02581345|470449178|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
130678299|NCT02581345|470449179|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
130678300|NCT02581345|470449180|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
130678301|NCT02581345|470449177|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
130678302|NCT02581345|470449178|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
130678303|NCT02581345|470449179|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130678304|NCT02581345|470449180|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130678305|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
130678306|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
130678307|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
130678308|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
130678309|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
130678310|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
130678311|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
130678312|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
130678313|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
130678314|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
130678315|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
130678316|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
130678317|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
130678318|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
130678319|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
130678320|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
130678321|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
130678322|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130678323|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130678324|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
130678325|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
130678326|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
130678327|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130678328|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130678329|NCT00376220|470449181|FG000|Overall Study|Lost to Follow-up|7|||
130678330|NCT00376220|470449182|FG001|Overall Study|Lost to Follow-up|10|||
130678331|NCT00376220|470449181|FG000|Overall Study|Withdrawal by Subject|3|||
130678332|NCT00376220|470449182|FG001|Overall Study|Withdrawal by Subject|2|||
130678333|NCT00531206|470449185|FG000|Overall Study|Adverse Event related|5|||
130678334|NCT00531206|470449185|FG000|Overall Study|Lack of Efficacy|2|||
130678335|NCT00531206|470449185|FG000|Overall Study|Lost to Follow-up|5|||
130678336|NCT00531206|470449185|FG000|Overall Study|including non-related adverse events|8|||
130678337|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
130678338|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
130678339|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678340|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678341|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678342|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
130678343|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
130678344|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678345|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678346|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678347|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678348|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
130678349|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678350|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678351|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678352|NCT00920140|470449187|FG000|Phase 2|Adverse Event|0|||
130678353|NCT00920140|470449188|FG001|Phase 2|Adverse Event|0|||
130678354|NCT00920140|470449189|FG002|Phase 2|Adverse Event|14|||
130678355|NCT00920140|470449190|FG003|Phase 2|Adverse Event|2|||
130678356|NCT00920140|470449191|FG004|Phase 2|Adverse Event|3|||
130678357|NCT00920140|470449187|FG000|Phase 2|Lack of Efficacy|0|||
130678358|NCT00920140|470449188|FG001|Phase 2|Lack of Efficacy|0|||
130678359|NCT00920140|470449189|FG002|Phase 2|Lack of Efficacy|29|||
130678360|NCT00920140|470449190|FG003|Phase 2|Lack of Efficacy|14|||
130678361|NCT00920140|470449191|FG004|Phase 2|Lack of Efficacy|5|||
130343695|NCT04585009|469229075|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130678362|NCT00920140|470449187|FG000|Phase 2|Lost to Follow-up|0|||
130678363|NCT00920140|470449188|FG001|Phase 2|Lost to Follow-up|0|||
130678364|NCT00920140|470449189|FG002|Phase 2|Lost to Follow-up|0|||
130678365|NCT00920140|470449190|FG003|Phase 2|Lost to Follow-up|1|||
130678366|NCT00920140|470449191|FG004|Phase 2|Lost to Follow-up|0|||
130678367|NCT00920140|470449187|FG000|Phase 2|Physician Decision|0|||
130678368|NCT00920140|470449188|FG001|Phase 2|Physician Decision|0|||
130678369|NCT00920140|470449189|FG002|Phase 2|Physician Decision|3|||
130678370|NCT00920140|470449190|FG003|Phase 2|Physician Decision|3|||
130678371|NCT00920140|470449191|FG004|Phase 2|Physician Decision|2|||
130678372|NCT00920140|470449187|FG000|Phase 2|Withdrawal by Subject|0|||
130678373|NCT00920140|470449188|FG001|Phase 2|Withdrawal by Subject|0|||
130678374|NCT00920140|470449189|FG002|Phase 2|Withdrawal by Subject|4|||
130678375|NCT00920140|470449190|FG003|Phase 2|Withdrawal by Subject|2|||
130678376|NCT00920140|470449191|FG004|Phase 2|Withdrawal by Subject|1|||
130433721|NCT03520400|469550523|FG001|Overall Study|Physician Decision|7|||
130433722|NCT00445679|469550524|FG000|Overall Study|Adverse Event|22|||
130433723|NCT00445679|469550525|FG001|Overall Study|Adverse Event|12|||
130433724|NCT00445679|469550526|FG002|Overall Study|Adverse Event|30|||
130433725|NCT00445679|469550527|FG003|Overall Study|Adverse Event|19|||
130433726|NCT00445679|469550524|FG000|Overall Study|Failed to return|1|||
130433727|NCT00445679|469550525|FG001|Overall Study|Failed to return|3|||
130433728|NCT00445679|469550526|FG002|Overall Study|Failed to return|2|||
130433729|NCT00445679|469550527|FG003|Overall Study|Failed to return|2|||
130433730|NCT00445679|469550524|FG000|Overall Study|Physician Decision|0|||
130678377|NCT01124149|470449192|FG000|Acute Phase|Withdrawal by Subject|22|||
130678378|NCT01124149|470449192|FG000|Acute Phase|Adverse Event|21|||
130678379|NCT01124149|470449192|FG000|Acute Phase|Lack of Efficacy|17|||
130678380|NCT01124149|470449192|FG000|Acute Phase|Protocol Violation|14|||
130678381|NCT01124149|470449192|FG000|Acute Phase|Lost to Follow-up|2|||
130678382|NCT01124149|470449192|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
130678383|NCT01124149|470449192|FG000|Acute Phase|Sponsor request|1|||
130678384|NCT01124149|470449192|FG000|Acute Phase|UC symptoms not ameliorated|1|||
130678385|NCT01124149|470449192|FG000|Acute Phase|Non-compliance|1|||
130678386|NCT01124149|470449192|FG000|Acute Phase|Low hemoglobin|1|||
130678387|NCT01124149|470449192|FG000|Acute Phase|Travelling to another country|1|||
130678388|NCT01124149|470449192|FG000|Acute Phase|Sponsor decision|1|||
130678389|NCT01124149|470449192|FG000|Maintenance Phase|Lack of Efficacy|40|||
130678390|NCT01124149|470449192|FG000|Maintenance Phase|Adverse Event|24|||
130678391|NCT01124149|470449192|FG000|Maintenance Phase|Lost to Follow-up|15|||
130678392|NCT01124149|470449192|FG000|Maintenance Phase|Withdrawal by Subject|10|||
130678393|NCT01124149|470449192|FG000|Maintenance Phase|Protocol Violation|5|||
130678394|NCT01124149|470449192|FG000|Maintenance Phase|Coordinator error|1|||
130678395|NCT01124149|470449192|FG000|Maintenance Phase|Non-compliance|1|||
130678396|NCT00977106|470449193|FG000|Overall Study|Adverse Event|5|||
130678397|NCT00977106|470449194|FG001|Overall Study|Adverse Event|6|||
130678398|NCT00977106|470449193|FG000|Overall Study|Withdrawal by Subject|2|||
130678399|NCT00977106|470449194|FG001|Overall Study|Withdrawal by Subject|2|||
130678400|NCT00977106|470449193|FG000|Overall Study|Lack of Efficacy|2|||
130678401|NCT00977106|470449194|FG001|Overall Study|Lack of Efficacy|2|||
130678402|NCT00977106|470449193|FG000|Overall Study|Protocol Violation|0|||
130678403|NCT00977106|470449194|FG001|Overall Study|Protocol Violation|1|||
130678404|NCT00977106|470449193|FG000|Overall Study|Other|1|||
130678405|NCT00977106|470449194|FG001|Overall Study|Other|0|||
130678406|NCT01644500|470449195|FG000|Overall Study|Adverse Event|6|||
130678407|NCT01644500|470449196|FG001|Overall Study|Adverse Event|1|||
130678408|NCT01644500|470449197|FG002|Overall Study|Adverse Event|2|||
130678409|NCT01644500|470449195|FG000|Overall Study|Death|0|||
130678410|NCT01644500|470449196|FG001|Overall Study|Death|1|||
130678411|NCT01644500|470449197|FG002|Overall Study|Death|0|||
130678412|NCT01644500|470449195|FG000|Overall Study|Lost to Follow-up|3|||
130678413|NCT01644500|470449196|FG001|Overall Study|Lost to Follow-up|8|||
130678414|NCT01644500|470449197|FG002|Overall Study|Lost to Follow-up|0|||
130678415|NCT01644500|470449195|FG000|Overall Study|Protocol Violation|1|||
130678416|NCT01644500|470449196|FG001|Overall Study|Protocol Violation|1|||
130678417|NCT01644500|470449197|FG002|Overall Study|Protocol Violation|0|||
130678418|NCT01644500|470449195|FG000|Overall Study|Withdrawal by Subject|11|||
130678419|NCT01644500|470449196|FG001|Overall Study|Withdrawal by Subject|12|||
130678420|NCT01644500|470449197|FG002|Overall Study|Withdrawal by Subject|12|||
130678421|NCT01644500|470449195|FG000|Overall Study|Physician Decision|1|||
130678422|NCT01644500|470449196|FG001|Overall Study|Physician Decision|1|||
130678423|NCT01644500|470449197|FG002|Overall Study|Physician Decision|1|||
130678424|NCT01400425|470449206|FG000|Overall Study|Withdrawal by Subject|10|||
130678425|NCT00688064|470449207|FG000|Overall Study|Protocol Violation|0|||
130678426|NCT00688064|470449208|FG001|Overall Study|Protocol Violation|1|||
130678427|NCT00688064|470449207|FG000|Overall Study|Adverse Event|2|||
130678428|NCT00688064|470449208|FG001|Overall Study|Adverse Event|4|||
130433731|NCT00445679|469550525|FG001|Overall Study|Physician Decision|0|||
130433732|NCT00445679|469550526|FG002|Overall Study|Physician Decision|1|||
130433733|NCT00445679|469550527|FG003|Overall Study|Physician Decision|0|||
130678429|NCT00688064|470449207|FG000|Overall Study|Withdrawal by Subject|7|||
130678430|NCT00688064|470449208|FG001|Overall Study|Withdrawal by Subject|7|||
130678431|NCT00688064|470449207|FG000|Overall Study|Lost to Follow-up|10|||
130678432|NCT00688064|470449208|FG001|Overall Study|Lost to Follow-up|10|||
130678433|NCT00688064|470449207|FG000|Overall Study|Lack of Efficacy|0|||
130678434|NCT00688064|470449208|FG001|Overall Study|Lack of Efficacy|1|||
130678435|NCT00688064|470449207|FG000|Overall Study|Pregnancy|1|||
130678436|NCT00688064|470449208|FG001|Overall Study|Pregnancy|0|||
130678437|NCT00688064|470449207|FG000|Overall Study|Any other reasons|1|||
130678438|NCT00688064|470449208|FG001|Overall Study|Any other reasons|3|||
130678439|NCT00720096|470449209|FG000|Overall Study|Withdrawal by Subject|0|||
130678440|NCT00720096|470449210|FG001|Overall Study|Withdrawal by Subject|2|||
130678441|NCT00442936|470449211|FG000|Overall Study|Protocol Violation|1|||
130678442|NCT00442936|470449212|FG001|Overall Study|Protocol Violation|0|||
130678443|NCT00442936|470449213|FG002|Overall Study|Protocol Violation|1|||
130678444|NCT00442936|470449214|FG003|Overall Study|Protocol Violation|1|||
130678445|NCT03992196|470449215|FG000|Enrollment|lost to follow-up prior dosing|1|||
130678446|NCT03992196|470449216|FG001|Enrollment|lost to follow-up prior dosing|0|||
130678447|NCT03992196|470449217|FG002|Enrollment|lost to follow-up prior dosing|0|||
130678448|NCT03992196|470449215|FG000|Treatment|Protocol Violation|0|||
130678449|NCT03992196|470449216|FG001|Treatment|Protocol Violation|0|||
130678450|NCT03992196|470449217|FG002|Treatment|Protocol Violation|1|||
130678451|NCT03992196|470449215|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130678452|NCT03992196|470449216|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130678453|NCT03992196|470449217|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
130678454|NCT03992196|470449215|FG000|Treatment|Withdrawal due to non-compliance|0|||
130343696|NCT04585009|469229076|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343697|NCT04585009|469229077|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343698|NCT04585009|469229078|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343699|NCT04585009|469229079|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343700|NCT04585009|469229080|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343701|NCT04585009|469229081|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343702|NCT04585009|469229070|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343703|NCT04585009|469229071|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343704|NCT04585009|469229072|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343705|NCT04585009|469229073|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343706|NCT04585009|469229074|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343707|NCT04585009|469229075|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343708|NCT04585009|469229076|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343709|NCT04585009|469229077|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343710|NCT04585009|469229078|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343711|NCT04585009|469229079|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
130343712|NCT04585009|469229080|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343713|NCT04585009|469229081|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343714|NCT04585009|469229070|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343715|NCT04585009|469229071|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343716|NCT04585009|469229072|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343717|NCT04585009|469229073|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343718|NCT04585009|469229074|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343719|NCT04585009|469229075|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343720|NCT04585009|469229076|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343721|NCT04585009|469229077|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343722|NCT04585009|469229078|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343723|NCT04585009|469229079|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343724|NCT04585009|469229080|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343725|NCT04585009|469229081|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
130343726|NCT00097981|469229082|FG000|Overall Study|Adverse Event|31|||
130343727|NCT00097981|469229083|FG001|Overall Study|Adverse Event|44|||
130343728|NCT00097981|469229082|FG000|Overall Study|Withdrawal by Subject|10|||
130343729|NCT00097981|469229083|FG001|Overall Study|Withdrawal by Subject|8|||
130343730|NCT00097981|469229082|FG000|Overall Study|Protocol Violation|1|||
130343731|NCT00097981|469229083|FG001|Overall Study|Protocol Violation|1|||
130343732|NCT00097981|469229082|FG000|Overall Study|Death|2|||
130343733|NCT00097981|469229083|FG001|Overall Study|Death|4|||
130343734|NCT00097981|469229082|FG000|Overall Study|Physician Decision|7|||
130343735|NCT00097981|469229083|FG001|Overall Study|Physician Decision|1|||
130343736|NCT00097981|469229082|FG000|Overall Study|Disease Progression|8|||
130343737|NCT00097981|469229083|FG001|Overall Study|Disease Progression|2|||
130343738|NCT00097981|469229082|FG000|Overall Study|Transplant planned|28|||
130343739|NCT00097981|469229083|FG001|Overall Study|Transplant planned|27|||
130343740|NCT00097981|469229082|FG000|Overall Study|Other|19|||
130343741|NCT00097981|469229083|FG001|Overall Study|Other|13|||
130343742|NCT01002820|469229086|FG000|Overall Study|Adverse Event|1|||
130343743|NCT01002820|469229086|FG000|Overall Study|Withdrawal by Subject|2|||
130343744|NCT01002820|469229086|FG000|Overall Study|Lack of Efficacy|1|||
130678455|NCT03992196|470449216|FG001|Treatment|Withdrawal due to non-compliance|0|||
130678456|NCT03992196|470449217|FG002|Treatment|Withdrawal due to non-compliance|1|||
130343745|NCT01673347|469229088|FG000|Overall Study|failure of allograft|7|||
130343746|NCT00895011|469229092|FG000|Overall Study|Withdrawal by Subject|14|||
130343747|NCT00895011|469229093|FG001|Overall Study|Withdrawal by Subject|7|||
130343748|NCT00895011|469229094|FG002|Overall Study|Withdrawal by Subject|2|||
130343749|NCT00895011|469229092|FG000|Overall Study|Lost to Follow-up|5|||
130343750|NCT00895011|469229093|FG001|Overall Study|Lost to Follow-up|4|||
130343751|NCT00895011|469229094|FG002|Overall Study|Lost to Follow-up|1|||
130343752|NCT00895011|469229092|FG000|Overall Study|Protocol Violation|3|||
130343753|NCT00895011|469229093|FG001|Overall Study|Protocol Violation|1|||
130678457|NCT03992196|470449215|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
130678458|NCT03992196|470449216|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
130678459|NCT03992196|470449217|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
130216601|NCT05305989|468755617|FG001|Overall Study|Protocol Violation|1|||
130343754|NCT00895011|469229094|FG002|Overall Study|Protocol Violation|3|||
130343755|NCT00895011|469229092|FG000|Overall Study|Adverse Event|1|||
130343756|NCT00895011|469229093|FG001|Overall Study|Adverse Event|2|||
130343757|NCT00895011|469229094|FG002|Overall Study|Adverse Event|2|||
130343758|NCT00895011|469229092|FG000|Overall Study|schedule conflict|1|||
130343759|NCT00895011|469229093|FG001|Overall Study|schedule conflict|0|||
130343760|NCT00895011|469229094|FG002|Overall Study|schedule conflict|0|||
130343761|NCT02661178|469229095|FG000|Part 1|Protocol Violation|1|||
130343762|NCT02661178|469229096|FG001|Part 1|Protocol Violation|0|||
130343763|NCT02661178|469229097|FG002|Part 1|Protocol Violation|0|||
130343764|NCT02661178|469229098|FG003|Part 1|Protocol Violation|0|||
130343765|NCT02661178|469229099|FG004|Part 1|Protocol Violation|0|||
130343766|NCT02661178|469229100|FG005|Part 1|Protocol Violation|0|||
130343767|NCT02661178|469229101|FG006|Part 1|Protocol Violation|0|||
130343768|NCT02661178|469229102|FG007|Part 1|Protocol Violation|0|||
130343769|NCT02661178|469229103|FG008|Part 1|Protocol Violation|0|||
130343770|NCT02661178|469229104|FG009|Part 1|Protocol Violation|0|||
130343771|NCT02661178|469229105|FG010|Part 1|Protocol Violation|0|||
130343772|NCT02661178|469229106|FG011|Part 1|Protocol Violation|0|||
130343773|NCT02661178|469229107|FG012|Part 1|Protocol Violation|0|||
130343774|NCT02661178|469229108|FG013|Part 1|Protocol Violation|0|||
130343775|NCT02661178|469229109|FG014|Part 1|Protocol Violation|0|||
130343776|NCT01369329|469229111|FG000|Overall Study|Withdrawal by Subject|8|||
130343777|NCT01369329|469229112|FG001|Overall Study|Withdrawal by Subject|6|||
130343778|NCT01369329|469229113|FG002|Overall Study|Withdrawal by Subject|10|||
130343779|NCT01369329|469229111|FG000|Overall Study|Lost to Follow-up|2|||
130343780|NCT01369329|469229112|FG001|Overall Study|Lost to Follow-up|2|||
130343781|NCT01369329|469229113|FG002|Overall Study|Lost to Follow-up|2|||
130343782|NCT01369329|469229111|FG000|Overall Study|Other|2|||
130343783|NCT01369329|469229112|FG001|Overall Study|Other|3|||
130343784|NCT01369329|469229113|FG002|Overall Study|Other|2|||
130343785|NCT01101308|469229114|FG000|Period 1|Adverse Event|2|||
130343786|NCT01101308|469229115|FG001|Period 1|Adverse Event|1|||
130343787|NCT01101308|469229114|FG000|Period 1|Positive for cotinine|1|||
130343788|NCT01101308|469229115|FG001|Period 1|Positive for cotinine|0|||
130343789|NCT01579812|469229116|FG000|Overall Study|Ineligible after treatment start|40|||
130343790|NCT01579812|469229116|FG000|Overall Study|Patient choice|3|||
130343791|NCT01579812|469229116|FG000|Overall Study|Noncompliance|3|||
130343792|NCT01579812|469229116|FG000|Overall Study|Withdrawal by Subject|6|||
130343793|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
130343794|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343795|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343796|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343797|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343798|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343799|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
130343800|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343801|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343802|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343803|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343804|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343805|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130343806|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343807|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343808|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343809|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343810|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343811|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
130343812|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343813|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343814|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343815|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343816|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343817|NCT05277337|469229125|FG000|Overall Study|Lost to Follow-up|2|||
130343818|NCT05277337|469229126|FG001|Overall Study|Lost to Follow-up|0|||
130343819|NCT05277337|469229125|FG000|Overall Study|Withdrawal by Subject|1|||
130343820|NCT05277337|469229126|FG001|Overall Study|Withdrawal by Subject|0|||
130343821|NCT02282345|469229128|FG000|Overall Study|Progression|0|||
130343822|NCT02282345|469229129|FG001|Overall Study|Progression|1|||
130433734|NCT00445679|469550524|FG000|Overall Study|Lost to Follow-up|10|||
130343823|NCT01038869|469229130|FG000|Overall Study|Withdrawal by Subject|1|||
130343824|NCT01038869|469229130|FG000|Overall Study|Lost to Follow-up|6|||
130343825|NCT04905498|469229133|FG000|Overall Study|Lost to Follow-up|0|||
130678460|NCT03992196|470449215|FG000|Treatment|Withdrawal by parent/guardian|0|||
130678461|NCT03992196|470449216|FG001|Treatment|Withdrawal by parent/guardian|0|||
130433735|NCT00445679|469550525|FG001|Overall Study|Lost to Follow-up|6|||
130433736|NCT00445679|469550526|FG002|Overall Study|Lost to Follow-up|6|||
130433737|NCT00445679|469550527|FG003|Overall Study|Lost to Follow-up|5|||
130433738|NCT00445679|469550524|FG000|Overall Study|Compliance|3|||
130433739|NCT00445679|469550525|FG001|Overall Study|Compliance|2|||
130433740|NCT00445679|469550526|FG002|Overall Study|Compliance|1|||
130433741|NCT00445679|469550527|FG003|Overall Study|Compliance|2|||
130433742|NCT00445679|469550524|FG000|Overall Study|Withdrawal of Informed Consent|0|||
130433743|NCT00445679|469550525|FG001|Overall Study|Withdrawal of Informed Consent|0|||
130433744|NCT00445679|469550526|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130433745|NCT00445679|469550527|FG003|Overall Study|Withdrawal of Informed Consent|0|||
130433746|NCT00445679|469550524|FG000|Overall Study|Protocol Violation|2|||
130433747|NCT00445679|469550525|FG001|Overall Study|Protocol Violation|3|||
130433748|NCT00445679|469550526|FG002|Overall Study|Protocol Violation|3|||
130433749|NCT00445679|469550527|FG003|Overall Study|Protocol Violation|1|||
130433750|NCT00445679|469550524|FG000|Overall Study|Withdrawal by Subject|8|||
130433751|NCT00445679|469550525|FG001|Overall Study|Withdrawal by Subject|14|||
130433752|NCT00445679|469550526|FG002|Overall Study|Withdrawal by Subject|20|||
130433753|NCT00445679|469550527|FG003|Overall Study|Withdrawal by Subject|18|||
130433754|NCT00445679|469550524|FG000|Overall Study|Lack of Efficacy|2|||
130433755|NCT00445679|469550525|FG001|Overall Study|Lack of Efficacy|6|||
130433756|NCT00445679|469550526|FG002|Overall Study|Lack of Efficacy|2|||
130433757|NCT00445679|469550527|FG003|Overall Study|Lack of Efficacy|0|||
130433758|NCT01654601|469550533|FG000|1st Administration|Withdrawal by Subject|2|||
130433759|NCT01654601|469550534|FG001|1st Administration|Withdrawal by Subject|0|||
130433760|NCT01654601|469550533|FG000|1st Administration|Protocol Violation|0|||
130433761|NCT01654601|469550534|FG001|1st Administration|Protocol Violation|2|||
130433762|NCT01654601|469550533|FG000|2nd Administration|Adverse Event|1|||
130433763|NCT01654601|469550534|FG001|2nd Administration|Adverse Event|0|||
130433764|NCT01654601|469550533|FG000|2nd Administration|Protocol Violation|0|||
130433765|NCT01654601|469550534|FG001|2nd Administration|Protocol Violation|1|||
130433766|NCT03535337|469550537|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
130433767|NCT03535337|469550538|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
130433768|NCT03535337|469550539|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
130433769|NCT03535337|469550540|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
130433770|NCT03535337|469550541|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
130433771|NCT03535337|469550542|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
130433772|NCT03535337|469550543|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
130433773|NCT03535337|469550544|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
130433774|NCT03535337|469550545|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
130433775|NCT03535337|469550546|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
130433776|NCT02272725|469550547|FG000|Overall Study|equipment malfunction|2|||
130433777|NCT02272725|469550548|FG001|Overall Study|equipment malfunction|0|||
130433778|NCT02392611|469551976|FG000|Overall Study|Adverse Event|0|||
130433779|NCT02392611|469551977|FG001|Overall Study|Adverse Event|0|||
130433780|NCT02392611|469551978|FG002|Overall Study|Adverse Event|0|||
130433781|NCT02392611|469551979|FG003|Overall Study|Adverse Event|1|||
130433782|NCT02392611|469551980|FG004|Overall Study|Adverse Event|0|||
130433783|NCT02392611|469551981|FG005|Overall Study|Adverse Event|0|||
130433784|NCT02392611|469551982|FG006|Overall Study|Adverse Event|0|||
130678462|NCT03992196|470449217|FG002|Treatment|Withdrawal by parent/guardian|2|||
130678463|NCT00048048|470449218|FG000|Core Treatment|Withdrawal by Subject|0|||
130678464|NCT00048048|470449219|FG001|Core Treatment|Withdrawal by Subject|0|||
130678465|NCT00048048|470449220|FG002|Core Treatment|Withdrawal by Subject|1|||
130678466|NCT00048048|470449221|FG003|Core Treatment|Withdrawal by Subject|0|||
130678467|NCT00048048|470449222|FG004|Core Treatment|Withdrawal by Subject|0|||
130678468|NCT00048048|470449223|FG005|Core Treatment|Withdrawal by Subject|0|||
130678469|NCT00048048|470449224|FG006|Core Treatment|Withdrawal by Subject|0|||
130678470|NCT00048048|470449225|FG007|Core Treatment|Withdrawal by Subject|0|||
130678471|NCT00048048|470449226|FG008|Core Treatment|Withdrawal by Subject|0|||
130678472|NCT00048048|470449227|FG009|Core Treatment|Withdrawal by Subject|0|||
130678473|NCT00048048|470449228|FG010|Core Treatment|Withdrawal by Subject|0|||
130678474|NCT00048048|470449229|FG011|Core Treatment|Withdrawal by Subject|0|||
130678475|NCT00048048|470449218|FG000|Core Treatment|Adverse Event|0|||
130678476|NCT00048048|470449219|FG001|Core Treatment|Adverse Event|0|||
130678477|NCT00048048|470449220|FG002|Core Treatment|Adverse Event|0|||
130433785|NCT02392611|469551983|FG007|Overall Study|Adverse Event|0|||
130433786|NCT02392611|469551984|FG008|Overall Study|Adverse Event|0|||
130433787|NCT02392611|469551976|FG000|Overall Study|Progressive disease|0|||
130433788|NCT02392611|469551977|FG001|Overall Study|Progressive disease|0|||
130433789|NCT02392611|469551978|FG002|Overall Study|Progressive disease|0|||
130433790|NCT02392611|469551979|FG003|Overall Study|Progressive disease|2|||
130678478|NCT00048048|470449221|FG003|Core Treatment|Adverse Event|0|||
130433791|NCT02392611|469551980|FG004|Overall Study|Progressive disease|1|||
130433792|NCT02392611|469551981|FG005|Overall Study|Progressive disease|0|||
130678479|NCT00048048|470449222|FG004|Core Treatment|Adverse Event|0|||
130678480|NCT00048048|470449223|FG005|Core Treatment|Adverse Event|0|||
130678481|NCT00048048|470449224|FG006|Core Treatment|Adverse Event|0|||
130678482|NCT00048048|470449225|FG007|Core Treatment|Adverse Event|1|||
130678483|NCT00048048|470449226|FG008|Core Treatment|Adverse Event|0|||
130678484|NCT00048048|470449227|FG009|Core Treatment|Adverse Event|0|||
130343826|NCT04905498|469229134|FG001|Overall Study|Lost to Follow-up|2|||
130343827|NCT04905498|469229133|FG000|Overall Study|COVID lockdown|1|||
130343828|NCT04905498|469229134|FG001|Overall Study|COVID lockdown|0|||
130343829|NCT03222492|469229137|FG000|Overall Study|Withdrawal by Subject|0|||
130343830|NCT03222492|469229138|FG001|Overall Study|Withdrawal by Subject|0|||
130343831|NCT03222492|469229139|FG002|Overall Study|Withdrawal by Subject|1|||
130343832|NCT03222492|469229140|FG003|Overall Study|Withdrawal by Subject|0|||
130343833|NCT03222492|469229137|FG000|Overall Study|COVID-19 related|0|||
130343834|NCT03222492|469229138|FG001|Overall Study|COVID-19 related|0|||
130343835|NCT03222492|469229139|FG002|Overall Study|COVID-19 related|1|||
130343836|NCT03222492|469229140|FG003|Overall Study|COVID-19 related|0|||
130343837|NCT01224782|469229143|FG000|Overall Study|Lost to Follow-up|177|||
130343838|NCT01224782|469229143|FG000|Overall Study|Withdrawal by Subject|16|||
130343839|NCT01224782|469229143|FG000|Overall Study|Death|14|||
130343840|NCT01224782|469229143|FG000|Overall Study|Improvement|13|||
130343841|NCT01224782|469229143|FG000|Overall Study|Adverse Event|12|||
130343842|NCT01224782|469229143|FG000|Overall Study|Adverse Reaction|11|||
130343843|NCT01224782|469229143|FG000|Overall Study|Noncompliance|10|||
130343844|NCT01224782|469229143|FG000|Overall Study|Other|4|||
130343845|NCT01224782|469229143|FG000|Overall Study|Start of Dialysis|3|||
130343846|NCT01224782|469229143|FG000|Overall Study|Change of Treatment|1|||
130343847|NCT01224782|469229143|FG000|Overall Study|Financial Reasons|1|||
130343848|NCT01224782|469229143|FG000|Overall Study|Deterioration|1|||
130343849|NCT01224782|469229143|FG000|Overall Study|Transplantation|1|||
130343850|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343851|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343852|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343853|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343854|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343855|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
130343856|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343857|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343858|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343859|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
130343860|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343861|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343862|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343863|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343864|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
130343865|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343866|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343867|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343868|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343869|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343870|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343871|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
130343872|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
130343873|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
130343874|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
130343875|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
130343876|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
130343877|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
130343878|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343879|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343880|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343881|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130343882|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343883|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130343884|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
130343885|NCT00065429|469229146|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343886|NCT00065429|469229147|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343887|NCT00065429|469229148|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130678485|NCT00048048|470449228|FG010|Core Treatment|Adverse Event|0|||
130343888|NCT00065429|469229149|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343889|NCT00065429|469229150|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
130343890|NCT00065429|469229151|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343891|NCT00065429|469229152|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343892|NCT00065429|469229146|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343893|NCT00065429|469229147|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130678486|NCT00048048|470449229|FG011|Core Treatment|Adverse Event|0|||
130678487|NCT00048048|470449218|FG000|Extension Year 1|Early withdrawals|0|||
130678488|NCT00048048|470449219|FG001|Extension Year 1|Early withdrawals|0|||
130678489|NCT00048048|470449220|FG002|Extension Year 1|Early withdrawals|0|||
130678490|NCT00048048|470449221|FG003|Extension Year 1|Early withdrawals|0|||
130678491|NCT00048048|470449222|FG004|Extension Year 1|Early withdrawals|0|||
130678492|NCT00048048|470449223|FG005|Extension Year 1|Early withdrawals|0|||
130678493|NCT00048048|470449224|FG006|Extension Year 1|Early withdrawals|0|||
130678494|NCT00048048|470449225|FG007|Extension Year 1|Early withdrawals|0|||
130678495|NCT00048048|470449226|FG008|Extension Year 1|Early withdrawals|0|||
130678496|NCT00048048|470449227|FG009|Extension Year 1|Early withdrawals|2|||
130678497|NCT00048048|470449228|FG010|Extension Year 1|Early withdrawals|2|||
130678498|NCT00048048|470449229|FG011|Extension Year 1|Early withdrawals|4|||
130678499|NCT00048048|470449218|FG000|Extension Year 2|Early withdrawals|0|||
130678500|NCT00048048|470449219|FG001|Extension Year 2|Early withdrawals|0|||
130678501|NCT00048048|470449220|FG002|Extension Year 2|Early withdrawals|0|||
130678502|NCT00048048|470449221|FG003|Extension Year 2|Early withdrawals|0|||
130678503|NCT00048048|470449222|FG004|Extension Year 2|Early withdrawals|0|||
130678504|NCT00048048|470449223|FG005|Extension Year 2|Early withdrawals|0|||
130678505|NCT00048048|470449224|FG006|Extension Year 2|Early withdrawals|0|||
130678506|NCT00048048|470449225|FG007|Extension Year 2|Early withdrawals|0|||
130678507|NCT00048048|470449226|FG008|Extension Year 2|Early withdrawals|0|||
130678508|NCT00048048|470449227|FG009|Extension Year 2|Early withdrawals|0|||
130343894|NCT00065429|469229148|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343895|NCT00065429|469229149|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343896|NCT00065429|469229150|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
130343897|NCT00065429|469229151|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343898|NCT00065429|469229152|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343899|NCT00781885|469229154|FG000|Overall Study|Physician Decision|1|||
130343900|NCT01755026|469229155|FG000|Overall Study|Adverse Event|1|||
130343901|NCT01755026|469229156|FG001|Overall Study|Adverse Event|0|||
130343902|NCT01755026|469229155|FG000|Overall Study|Withdrawal by Subject|1|||
130343903|NCT01755026|469229156|FG001|Overall Study|Withdrawal by Subject|1|||
130343904|NCT01806662|469229163|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
130343905|NCT01806662|469229164|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
130343906|NCT01806662|469229163|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
130343907|NCT01806662|469229164|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
130343908|NCT01806662|469229163|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
130343909|NCT01806662|469229164|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
130343910|NCT01806662|469229163|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
130343911|NCT01806662|469229164|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
130343912|NCT01917656|469229172|FG000|Overall Study|Adverse Event|11|||
130343913|NCT01917656|469229173|FG001|Overall Study|Adverse Event|0|||
130343914|NCT01917656|469229172|FG000|Overall Study|Withdrawal criteria|8|||
130343915|NCT01917656|469229173|FG001|Overall Study|Withdrawal criteria|14|||
130343916|NCT01917656|469229172|FG000|Overall Study|Unclassified|0|||
130343917|NCT01917656|469229173|FG001|Overall Study|Unclassified|3|||
130343918|NCT01917656|469229172|FG000|Overall Study|Withdrawal by Subject|4|||
130343919|NCT01917656|469229173|FG001|Overall Study|Withdrawal by Subject|3|||
130343920|NCT01917656|469229172|FG000|Overall Study|Lost to Follow-up|3|||
130343921|NCT01917656|469229173|FG001|Overall Study|Lost to Follow-up|4|||
130343922|NCT02081859|469229174|FG000|Overall Study|No fertilization|2|||
130343923|NCT02081859|469229175|FG001|Overall Study|No fertilization|2|||
130343924|NCT02081859|469229174|FG000|Overall Study|No sperm|1|||
130343925|NCT02081859|469229175|FG001|Overall Study|No sperm|0|||
130343926|NCT02081859|469229174|FG000|Overall Study|Unanticipated freeze all cycle|2|||
130343927|NCT02081859|469229175|FG001|Overall Study|Unanticipated freeze all cycle|6|||
130343928|NCT02081859|469229174|FG000|Overall Study|< 4 embryos|27|||
130343929|NCT02081859|469229175|FG001|Overall Study|< 4 embryos|23|||
130343930|NCT02081859|469229174|FG000|Overall Study|Other reasons|2|||
130343931|NCT02081859|469229175|FG001|Overall Study|Other reasons|0|||
130343932|NCT02285062|469229176|FG000|Pre-Treatment Period|Protocol Violation|0|||
130343933|NCT02285062|469229177|FG001|Pre-Treatment Period|Protocol Violation|2|||
130343934|NCT02285062|469229176|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130343935|NCT02285062|469229177|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130343936|NCT02015221|469229178|FG000|Overall Study|Withdrawal by Subject|8|||
130343937|NCT02015221|469229179|FG001|Overall Study|Withdrawal by Subject|6|||
130343938|NCT02015221|469229178|FG000|Overall Study|Lost to Follow-up|1|||
130343939|NCT02015221|469229179|FG001|Overall Study|Lost to Follow-up|0|||
130678509|NCT00048048|470449228|FG010|Extension Year 2|Early withdrawals|4|||
130678510|NCT00048048|470449229|FG011|Extension Year 2|Early withdrawals|2|||
130678511|NCT02684578|470449230|FG000|Overall Study|Withdrawal by Subject|10|||
130343940|NCT01870076|469229186|FG000|Overall Study|Withdrawal by Subject|1|||
130343941|NCT01870076|469229187|FG001|Overall Study|Withdrawal by Subject|0|||
130343942|NCT01870076|469229188|FG002|Overall Study|Withdrawal by Subject|1|||
130678512|NCT02684578|470449231|FG001|Overall Study|Withdrawal by Subject|7|||
130678513|NCT02684578|470449230|FG000|Overall Study|Lost to Follow-up|0|||
130678514|NCT02684578|470449231|FG001|Overall Study|Lost to Follow-up|3|||
130678515|NCT02684578|470449230|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
130678516|NCT02684578|470449231|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
130678517|NCT02684578|470449230|FG000|Overall Study|Missing follow-up data|0|||
130678518|NCT02684578|470449231|FG001|Overall Study|Missing follow-up data|1|||
130678519|NCT02388763|470449234|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130678520|NCT02388763|470449235|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130678521|NCT02388763|470449234|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130678522|NCT02388763|470449235|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130678523|NCT01458405|470449246|FG000|Phase 1 (up to 12 Months)|Other|0|||
130678524|NCT01458405|470449247|FG001|Phase 1 (up to 12 Months)|Other|1|||
130678525|NCT01458405|470449248|FG002|Phase 1 (up to 12 Months)|Other|0|||
130678526|NCT01458405|470449249|FG003|Phase 1 (up to 12 Months)|Other|0|||
130678527|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130678528|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130678529|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
130678530|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
130678531|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678532|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678533|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678534|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
130678535|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678536|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678537|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678538|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
130678539|NCT02194998|470449250|FG000|On-HCV Treatment|Did not pick up study medication|0|||
130678540|NCT02194998|470449251|FG001|On-HCV Treatment|Did not pick up study medication|1|||
130678541|NCT02194998|470449252|FG002|On-HCV Treatment|Did not pick up study medication|0|||
130678542|NCT02194998|470449253|FG003|On-HCV Treatment|Did not pick up study medication|0|||
130678543|NCT02194998|470449250|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130678544|NCT02194998|470449251|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130678545|NCT02194998|470449252|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130678546|NCT02194998|470449253|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130678547|NCT02497781|470449254|FG000|Overall Study|Withdrawal by Subject|2|||
130678548|NCT02497781|470449255|FG001|Overall Study|Withdrawal by Subject|0|||
130678549|NCT02497781|470449254|FG000|Overall Study|Lack of Efficacy|0|||
130678550|NCT02497781|470449255|FG001|Overall Study|Lack of Efficacy|1|||
130678551|NCT02497781|470449254|FG000|Overall Study|Randomised but not treated|1|||
130678552|NCT02497781|470449255|FG001|Overall Study|Randomised but not treated|1|||
130678553|NCT02497781|470449254|FG000|Overall Study|Lost to Follow-up|1|||
130678554|NCT02497781|470449255|FG001|Overall Study|Lost to Follow-up|1|||
130678555|NCT02236130|470449256|FG000|Overall Study|Lost to Follow-up|7|||
130678556|NCT02236130|470449257|FG001|Overall Study|Lost to Follow-up|12|||
130678557|NCT00454636|470449258|FG000|Overall Study|Adverse Event|10|||
130678558|NCT00454636|470449259|FG001|Overall Study|Adverse Event|6|||
130343943|NCT01870076|469229189|FG003|Overall Study|Withdrawal by Subject|0|||
130343944|NCT00492063|469229190|FG000|Overall Study|Death|0|||
130343945|NCT00492063|469229191|FG001|Overall Study|Death|0|||
130343946|NCT00492063|469229192|FG002|Overall Study|Death|1|||
130343947|NCT00492063|469229193|FG003|Overall Study|Death|2|||
130343948|NCT00492063|469229190|FG000|Overall Study|Withdrawal by Subject|4|||
130343949|NCT00492063|469229191|FG001|Overall Study|Withdrawal by Subject|3|||
130343950|NCT00492063|469229192|FG002|Overall Study|Withdrawal by Subject|5|||
130343951|NCT00492063|469229193|FG003|Overall Study|Withdrawal by Subject|4|||
130343952|NCT00492063|469229190|FG000|Overall Study|Lost to Follow-up|6|||
130343953|NCT00492063|469229191|FG001|Overall Study|Lost to Follow-up|11|||
130343954|NCT00492063|469229192|FG002|Overall Study|Lost to Follow-up|5|||
130343955|NCT00492063|469229193|FG003|Overall Study|Lost to Follow-up|3|||
130343956|NCT00492063|469229190|FG000|Overall Study|Protocol Violation|0|||
130343957|NCT00492063|469229191|FG001|Overall Study|Protocol Violation|0|||
130343958|NCT00492063|469229192|FG002|Overall Study|Protocol Violation|0|||
130343959|NCT00492063|469229193|FG003|Overall Study|Protocol Violation|1|||
130678559|NCT00454636|470449260|FG002|Overall Study|Adverse Event|9|||
130678560|NCT00454636|470449261|FG003|Overall Study|Adverse Event|15|||
130678561|NCT00454636|470449258|FG000|Overall Study|Disease Progression|11|||
130343960|NCT03041129|469229196|FG000|Overall Study|Withdrawal by Subject|2|||
130678562|NCT00454636|470449259|FG001|Overall Study|Disease Progression|12|||
130678563|NCT00454636|470449260|FG002|Overall Study|Disease Progression|4|||
130678564|NCT00454636|470449261|FG003|Overall Study|Disease Progression|11|||
130678565|NCT00454636|470449258|FG000|Overall Study|Protocol Violation|3|||
130678566|NCT00454636|470449259|FG001|Overall Study|Protocol Violation|2|||
130678567|NCT00454636|470449260|FG002|Overall Study|Protocol Violation|3|||
130343961|NCT03041129|469229197|FG001|Overall Study|Withdrawal by Subject|0|||
130343962|NCT03041129|469229198|FG002|Overall Study|Withdrawal by Subject|0|||
130678568|NCT00454636|470449261|FG003|Overall Study|Protocol Violation|3|||
130678569|NCT00454636|470449258|FG000|Overall Study|Death|6|||
130678570|NCT00454636|470449259|FG001|Overall Study|Death|1|||
130678571|NCT00454636|470449260|FG002|Overall Study|Death|1|||
130678572|NCT00454636|470449261|FG003|Overall Study|Death|1|||
130678573|NCT00454636|470449258|FG000|Overall Study|Patient refusal|1|||
130678574|NCT00454636|470449259|FG001|Overall Study|Patient refusal|1|||
130678575|NCT00454636|470449260|FG002|Overall Study|Patient refusal|3|||
130678576|NCT00454636|470449261|FG003|Overall Study|Patient refusal|2|||
130678577|NCT00454636|470449258|FG000|Overall Study|Lost to Follow-up|0|||
130678578|NCT00454636|470449259|FG001|Overall Study|Lost to Follow-up|1|||
130678579|NCT00454636|470449260|FG002|Overall Study|Lost to Follow-up|0|||
130678580|NCT00454636|470449261|FG003|Overall Study|Lost to Follow-up|0|||
130678581|NCT01890915|470449267|FG000|Overall Study|Adverse Event|1|||
130678582|NCT01890915|470449268|FG001|Overall Study|Adverse Event|0|||
130678583|NCT01890915|470449267|FG000|Overall Study|Protocol Violation|2|||
130678584|NCT01890915|470449268|FG001|Overall Study|Protocol Violation|0|||
130678585|NCT01890915|470449267|FG000|Overall Study|Equipment Malfunction|0|||
130678586|NCT01890915|470449268|FG001|Overall Study|Equipment Malfunction|1|||
130678587|NCT00424489|470449269|FG000|Overall Study|Death|3|||
130678588|NCT00386009|470449273|FG000|Overall Study|Adverse Event|0|||
130678589|NCT00386009|470449274|FG001|Overall Study|Adverse Event|2|||
130678590|NCT00386009|470449273|FG000|Overall Study|Death|1|||
130678591|NCT00386009|470449274|FG001|Overall Study|Death|0|||
130678592|NCT00386009|470449273|FG000|Overall Study|Entry Criteria Not Met|0|||
130678593|NCT00386009|470449274|FG001|Overall Study|Entry Criteria Not Met|2|||
130678594|NCT00386009|470449273|FG000|Overall Study|Lost to Follow-up|1|||
130678595|NCT00386009|470449274|FG001|Overall Study|Lost to Follow-up|1|||
130678596|NCT00386009|470449273|FG000|Overall Study|Protocol Violation|1|||
130678597|NCT00386009|470449274|FG001|Overall Study|Protocol Violation|0|||
130678598|NCT00386009|470449273|FG000|Overall Study|Sponsor Decision|1|||
130678599|NCT00386009|470449274|FG001|Overall Study|Sponsor Decision|1|||
130678600|NCT00386009|470449273|FG000|Overall Study|Withdrawal by Subject|5|||
130678601|NCT00386009|470449274|FG001|Overall Study|Withdrawal by Subject|4|||
130678602|NCT02465567|470449275|FG000|Overall Study|Adverse Event|118|||
130678603|NCT02465567|470449276|FG001|Overall Study|Adverse Event|113|||
130678604|NCT02465567|470449277|FG002|Overall Study|Adverse Event|147|||
130678605|NCT02465567|470449278|FG003|Overall Study|Adverse Event|138|||
130678606|NCT02465567|470449275|FG000|Overall Study|Lack of Efficacy|103|||
130678607|NCT02465567|470449276|FG001|Overall Study|Lack of Efficacy|102|||
130343963|NCT03041129|469229199|FG003|Overall Study|Withdrawal by Subject|0|||
130343964|NCT00510653|469229200|FG000|Overall Study|Withdrawal by Subject|8|||
130343965|NCT00510653|469229200|FG000|Overall Study|Monetary|3|||
130343966|NCT01947855|469229201|FG000|Overall Study|Withdrawal by Subject|1|||
130343967|NCT01947855|469229202|FG001|Overall Study|Withdrawal by Subject|0|||
130343968|NCT01947855|469229203|FG002|Overall Study|Withdrawal by Subject|0|||
130343969|NCT00821509|469229204|FG000|Overall Study|Withdrawal by Subject|12|||
130343970|NCT00821509|469229205|FG001|Overall Study|Withdrawal by Subject|11|||
130343971|NCT00821509|469229206|FG002|Overall Study|Withdrawal by Subject|34|||
130343972|NCT01246466|469230904|FG000|Overall Study|Death|1|||
130343973|NCT01246466|469230904|FG000|Overall Study|Withdrawal by Subject|1|||
130343974|NCT00877773|469230905|FG000|Overall Study|Disease Progression|44|||
130343975|NCT01012219|469230908|FG000|Period 1|Withdrawal by Subject|1|||
130343976|NCT01012219|469230908|FG000|Period 2|Withdrawal by Subject|1|||
130343977|NCT00003590|469230911|FG000|Overall Study|Ineligible Patient|1|||
130343978|NCT00003590|469230911|FG000|Overall Study|Adverse Event|7|||
130343979|NCT00003590|469230911|FG000|Overall Study|Withdrawal by Subject|1|||
130343980|NCT00003590|469230911|FG000|Overall Study|Lack of Efficacy|11|||
130678608|NCT02465567|470449277|FG002|Overall Study|Lack of Efficacy|171|||
130678609|NCT02465567|470449278|FG003|Overall Study|Lack of Efficacy|135|||
130678610|NCT02465567|470449275|FG000|Overall Study|Withdrawal by Subject|104|||
130678611|NCT02465567|470449276|FG001|Overall Study|Withdrawal by Subject|94|||
130678612|NCT02465567|470449277|FG002|Overall Study|Withdrawal by Subject|123|||
130678613|NCT02465567|470449278|FG003|Overall Study|Withdrawal by Subject|130|||
130678614|NCT02465567|470449275|FG000|Overall Study|Physician Decision|23|||
130678615|NCT02465567|470449276|FG001|Overall Study|Physician Decision|33|||
130678616|NCT02465567|470449277|FG002|Overall Study|Physician Decision|38|||
130678617|NCT02465567|470449278|FG003|Overall Study|Physician Decision|28|||
130678618|NCT02465567|470449275|FG000|Overall Study|Major Protocol Deviation|24|||
130678619|NCT02465567|470449276|FG001|Overall Study|Major Protocol Deviation|26|||
130343981|NCT00003590|469230911|FG000|Overall Study|Death|1|||
130678620|NCT02465567|470449277|FG002|Overall Study|Major Protocol Deviation|22|||
130678621|NCT02465567|470449278|FG003|Overall Study|Major Protocol Deviation|25|||
130678622|NCT02465567|470449275|FG000|Overall Study|Lost to Follow-up|25|||
130678623|NCT02465567|470449276|FG001|Overall Study|Lost to Follow-up|21|||
130678624|NCT02465567|470449277|FG002|Overall Study|Lost to Follow-up|19|||
130343982|NCT00003590|469230911|FG000|Overall Study|Physician Decision|1|||
130343983|NCT00883688|469230912|FG000|Overall Study|Ineligible|2|||
130678625|NCT02465567|470449278|FG003|Overall Study|Lost to Follow-up|15|||
130678626|NCT02465567|470449275|FG000|Overall Study|Protocol Specified Criteria|20|||
130678627|NCT02465567|470449276|FG001|Overall Study|Protocol Specified Criteria|10|||
130678628|NCT02465567|470449277|FG002|Overall Study|Protocol Specified Criteria|9|||
130678629|NCT02465567|470449278|FG003|Overall Study|Protocol Specified Criteria|12|||
130678630|NCT02465567|470449275|FG000|Overall Study|Administrative Reasons|12|||
130678631|NCT02465567|470449276|FG001|Overall Study|Administrative Reasons|9|||
130678632|NCT02465567|470449277|FG002|Overall Study|Administrative Reasons|11|||
130678633|NCT02465567|470449278|FG003|Overall Study|Administrative Reasons|5|||
130678634|NCT02465567|470449275|FG000|Overall Study|Randomized but not treated|1|||
130678635|NCT02465567|470449276|FG001|Overall Study|Randomized but not treated|5|||
130678636|NCT02465567|470449277|FG002|Overall Study|Randomized but not treated|4|||
130678637|NCT02465567|470449278|FG003|Overall Study|Randomized but not treated|5|||
130678638|NCT02465567|470449275|FG000|Overall Study|enrolled in >1 studies|18|||
130678639|NCT02465567|470449276|FG001|Overall Study|enrolled in >1 studies|11|||
130678640|NCT02465567|470449277|FG002|Overall Study|enrolled in >1 studies|19|||
130678641|NCT02465567|470449278|FG003|Overall Study|enrolled in >1 studies|15|||
130678642|NCT02465567|470449275|FG000|Overall Study|missing PI Signature|1|||
130678643|NCT02465567|470449276|FG001|Overall Study|missing PI Signature|0|||
130678644|NCT02465567|470449277|FG002|Overall Study|missing PI Signature|0|||
130678645|NCT02465567|470449278|FG003|Overall Study|missing PI Signature|0|||
130678646|NCT00497796|470449279|FG000|Overall Study|Adverse event (not related)|9|||
130678647|NCT00497796|470449280|FG001|Overall Study|Adverse event (not related)|9|||
130678648|NCT00497796|470449279|FG000|Overall Study|Adverse event (related)|5|||
130678649|NCT00497796|470449280|FG001|Overall Study|Adverse event (related)|4|||
130678650|NCT00497796|470449279|FG000|Overall Study|CMV infection or disease treatment|30|||
130678651|NCT00497796|470449280|FG001|Overall Study|CMV infection or disease treatment|4|||
130678652|NCT00497796|470449279|FG000|Overall Study|Consent withdrawn|10|||
130678653|NCT00497796|470449280|FG001|Overall Study|Consent withdrawn|3|||
130678654|NCT00497796|470449279|FG000|Overall Study|Investigator/sponsor discretion|31|||
130678655|NCT00497796|470449280|FG001|Overall Study|Investigator/sponsor discretion|34|||
130678656|NCT00497796|470449279|FG000|Overall Study|Lost to Follow-up|0|||
130678657|NCT00497796|470449280|FG001|Overall Study|Lost to Follow-up|1|||
130678658|NCT00497796|470449279|FG000|Overall Study|Not applicable (randomized not treated)|0|||
130678659|NCT00497796|470449280|FG001|Overall Study|Not applicable (randomized not treated)|4|||
130678660|NCT00604500|470449281|FG000|Overall Study|Adverse Event|2|||
130678661|NCT00604500|470449281|FG000|Overall Study|Protocol Violation|2|||
130678662|NCT00604500|470449281|FG000|Overall Study|Treatment Failure|1|||
130216602|NCT05305989|468755618|FG002|Overall Study|Protocol Violation|0|||
130343984|NCT01350544|469230916|FG000|Overall Study|Administrative Withdrawal|0|||
130343985|NCT01350544|469230917|FG001|Overall Study|Administrative Withdrawal|1|||
130343986|NCT01350544|469230916|FG000|Overall Study|Death|1|||
130343987|NCT01350544|469230917|FG001|Overall Study|Death|2|||
130343988|NCT01350544|469230916|FG000|Overall Study|Moved out of LA County|2|||
130343989|NCT01350544|469230917|FG001|Overall Study|Moved out of LA County|2|||
130343990|NCT01350544|469230916|FG000|Overall Study|Medical Issues|1|||
130343991|NCT01350544|469230917|FG001|Overall Study|Medical Issues|1|||
130343992|NCT01350544|469230916|FG000|Overall Study|Withdrawal by Subject|0|||
130343993|NCT01350544|469230917|FG001|Overall Study|Withdrawal by Subject|1|||
130343994|NCT01350544|469230916|FG000|Overall Study|Incarceration|1|||
130343995|NCT01350544|469230917|FG001|Overall Study|Incarceration|0|||
130343996|NCT01350544|469230916|FG000|Overall Study|Lost to Follow-up|18|||
130343997|NCT01350544|469230917|FG001|Overall Study|Lost to Follow-up|15|||
130343998|NCT01444092|469230918|FG000|Overall Study|Adverse Event|8|||
130343999|NCT01444092|469230918|FG000|Overall Study|Protocol Violation|1|||
130344000|NCT01444092|469230918|FG000|Overall Study|Withdrawal by Subject|1|||
130344001|NCT01444092|469230918|FG000|Overall Study|Other Eligibility criteria|7|||
130344002|NCT03085914|469230923|FG000|Overall Study|Death|6|||
130344003|NCT03085914|469230924|FG001|Overall Study|Death|6|||
130344004|NCT03085914|469230925|FG002|Overall Study|Death|4|||
130344005|NCT03085914|469230926|FG003|Overall Study|Death|1|||
130344006|NCT03085914|469230927|FG004|Overall Study|Death|5|||
130344007|NCT03085914|469230928|FG005|Overall Study|Death|2|||
130344008|NCT03085914|469230929|FG006|Overall Study|Death|2|||
130678663|NCT00604500|470449281|FG000|Overall Study|Withdrawal by Subject|4|||
130678664|NCT00604500|470449281|FG000|Overall Study|Administrative|1|||
130678665|NCT00604500|470449281|FG000|Overall Study|Did not meet protocol eligibility|1|||
130678666|NCT01492400|470449282|FG000|Overall Study|Miscellaneous Reasons|2|||
130678667|NCT01492400|470449283|FG001|Overall Study|Miscellaneous Reasons|3|||
130216603|NCT05305989|468755616|FG000|Overall Study|Investigator decision|1|||
130344009|NCT03085914|469230923|FG000|Overall Study|Withdrawal by Subject|1|||
130344010|NCT03085914|469230924|FG001|Overall Study|Withdrawal by Subject|1|||
130344011|NCT03085914|469230925|FG002|Overall Study|Withdrawal by Subject|2|||
130433793|NCT02392611|469551982|FG006|Overall Study|Progressive disease|0|||
130678668|NCT01492400|470449282|FG000|Overall Study|Personal Reasons|0|||
130344012|NCT03085914|469230926|FG003|Overall Study|Withdrawal by Subject|2|||
130344013|NCT03085914|469230927|FG004|Overall Study|Withdrawal by Subject|2|||
130344014|NCT03085914|469230928|FG005|Overall Study|Withdrawal by Subject|0|||
130344015|NCT03085914|469230929|FG006|Overall Study|Withdrawal by Subject|1|||
130678669|NCT01492400|470449283|FG001|Overall Study|Personal Reasons|5|||
130678670|NCT01492400|470449282|FG000|Overall Study|Lost to Follow-up|3|||
130678671|NCT01492400|470449283|FG001|Overall Study|Lost to Follow-up|1|||
130678672|NCT01492400|470449282|FG000|Overall Study|Pregnancy|0|||
130678673|NCT01492400|470449283|FG001|Overall Study|Pregnancy|1|||
130678674|NCT01492400|470449282|FG000|Overall Study|Lack of Efficacy|1|||
130678675|NCT01492400|470449283|FG001|Overall Study|Lack of Efficacy|1|||
130678676|NCT01492400|470449282|FG000|Overall Study|Adverse Event|10|||
130678677|NCT01492400|470449283|FG001|Overall Study|Adverse Event|5|||
130678678|NCT00320112|470449285|FG000|Overall Study|Lost to Follow-up|3|||
130678679|NCT00320112|470449286|FG001|Overall Study|Lost to Follow-up|4|||
130678680|NCT00320112|470449285|FG000|Overall Study|Withdrawal by Subject|3|||
130344016|NCT03085914|469230923|FG000|Overall Study|Lost to Follow-up|0|||
130433794|NCT02392611|469551983|FG007|Overall Study|Progressive disease|0|||
130433795|NCT02392611|469551984|FG008|Overall Study|Progressive disease|0|||
130433796|NCT02392611|469551976|FG000|Overall Study|Death|1|||
130433797|NCT02392611|469551977|FG001|Overall Study|Death|0|||
130433798|NCT02392611|469551978|FG002|Overall Study|Death|0|||
130433799|NCT02392611|469551979|FG003|Overall Study|Death|0|||
130433800|NCT02392611|469551980|FG004|Overall Study|Death|0|||
130433801|NCT02392611|469551981|FG005|Overall Study|Death|1|||
130433802|NCT02392611|469551982|FG006|Overall Study|Death|0|||
130433803|NCT02392611|469551983|FG007|Overall Study|Death|0|||
130433804|NCT02392611|469551984|FG008|Overall Study|Death|0|||
130433805|NCT02392611|469551976|FG000|Overall Study|Withdrawal by Subject|0|||
130433806|NCT02392611|469551977|FG001|Overall Study|Withdrawal by Subject|0|||
130433807|NCT02392611|469551978|FG002|Overall Study|Withdrawal by Subject|0|||
130433808|NCT02392611|469551979|FG003|Overall Study|Withdrawal by Subject|1|||
130433809|NCT02392611|469551980|FG004|Overall Study|Withdrawal by Subject|0|||
130433810|NCT02392611|469551981|FG005|Overall Study|Withdrawal by Subject|0|||
130433811|NCT02392611|469551982|FG006|Overall Study|Withdrawal by Subject|0|||
130433812|NCT02392611|469551983|FG007|Overall Study|Withdrawal by Subject|0|||
130433813|NCT02392611|469551984|FG008|Overall Study|Withdrawal by Subject|0|||
130433814|NCT02392611|469551976|FG000|Overall Study|Lost to Follow-up|0|||
130433815|NCT02392611|469551977|FG001|Overall Study|Lost to Follow-up|0|||
130433816|NCT02392611|469551978|FG002|Overall Study|Lost to Follow-up|0|||
130433817|NCT02392611|469551979|FG003|Overall Study|Lost to Follow-up|0|||
130433818|NCT02392611|469551980|FG004|Overall Study|Lost to Follow-up|0|||
130433819|NCT02392611|469551981|FG005|Overall Study|Lost to Follow-up|0|||
130433820|NCT02392611|469551982|FG006|Overall Study|Lost to Follow-up|1|||
130433821|NCT02392611|469551983|FG007|Overall Study|Lost to Follow-up|0|||
130433822|NCT02392611|469551984|FG008|Overall Study|Lost to Follow-up|0|||
130433823|NCT02392611|469551976|FG000|Overall Study|Enrolled, not treated|0|||
130344017|NCT03085914|469230924|FG001|Overall Study|Lost to Follow-up|0|||
130344018|NCT03085914|469230925|FG002|Overall Study|Lost to Follow-up|1|||
130344019|NCT03085914|469230926|FG003|Overall Study|Lost to Follow-up|0|||
130344020|NCT03085914|469230927|FG004|Overall Study|Lost to Follow-up|0|||
130344021|NCT03085914|469230928|FG005|Overall Study|Lost to Follow-up|1|||
130344022|NCT03085914|469230929|FG006|Overall Study|Lost to Follow-up|1|||
130344023|NCT03085914|469230923|FG000|Overall Study|Reason was not specified,|2|||
130344024|NCT03085914|469230924|FG001|Overall Study|Reason was not specified,|2|||
130344025|NCT03085914|469230925|FG002|Overall Study|Reason was not specified,|2|||
130344026|NCT03085914|469230926|FG003|Overall Study|Reason was not specified,|3|||
130344027|NCT03085914|469230927|FG004|Overall Study|Reason was not specified,|3|||
130344028|NCT03085914|469230928|FG005|Overall Study|Reason was not specified,|3|||
130344029|NCT03085914|469230929|FG006|Overall Study|Reason was not specified,|6|||
130344030|NCT03085914|469230923|FG000|Overall Study|Progressive Disease|0|||
130344031|NCT03085914|469230924|FG001|Overall Study|Progressive Disease|0|||
130344032|NCT03085914|469230925|FG002|Overall Study|Progressive Disease|2|||
130344033|NCT03085914|469230926|FG003|Overall Study|Progressive Disease|2|||
130344034|NCT03085914|469230927|FG004|Overall Study|Progressive Disease|1|||
130433824|NCT02392611|469551977|FG001|Overall Study|Enrolled, not treated|0|||
130433825|NCT02392611|469551978|FG002|Overall Study|Enrolled, not treated|0|||
130433826|NCT02392611|469551979|FG003|Overall Study|Enrolled, not treated|2|||
130433827|NCT02392611|469551980|FG004|Overall Study|Enrolled, not treated|0|||
130433828|NCT02392611|469551981|FG005|Overall Study|Enrolled, not treated|0|||
130433829|NCT02392611|469551982|FG006|Overall Study|Enrolled, not treated|0|||
130344035|NCT03085914|469230928|FG005|Overall Study|Progressive Disease|1|||
130344036|NCT03085914|469230929|FG006|Overall Study|Progressive Disease|1|||
130344037|NCT03085914|469230923|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130344038|NCT03085914|469230924|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130344039|NCT03085914|469230925|FG002|Overall Study|Study Terminated by the Sponsor|0|||
130433830|NCT02392611|469551983|FG007|Overall Study|Enrolled, not treated|0|||
130433831|NCT02392611|469551984|FG008|Overall Study|Enrolled, not treated|0|||
130552771|NCT00719563|469991531|FG001|Overall Study|Personal reasons|7|||
130678681|NCT00320112|470449286|FG001|Overall Study|Withdrawal by Subject|0|||
130678682|NCT00320112|470449285|FG000|Overall Study|Death|2|||
130678683|NCT00320112|470449286|FG001|Overall Study|Death|1|||
130678684|NCT02899338|470449287|FG000|Overall Study|Adverse Event|1|||
130678685|NCT02899338|470449288|FG001|Overall Study|Adverse Event|2|||
130344040|NCT03085914|469230926|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130344041|NCT03085914|469230927|FG004|Overall Study|Study Terminated by the Sponsor|2|||
130344042|NCT03085914|469230928|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130344043|NCT03085914|469230929|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130344044|NCT01242813|469230930|FG000|Overall Study|Lost to Follow-up|2|||
130344045|NCT01252667|469230932|FG000|Overall Study|Transplant aborted post-conditioning|0|||
130344046|NCT01252667|469230933|FG001|Overall Study|Transplant aborted post-conditioning|0|||
130344047|NCT01252667|469230934|FG002|Overall Study|Transplant aborted post-conditioning|0|||
130344048|NCT01252667|469230935|FG003|Overall Study|Transplant aborted post-conditioning|0|||
130344049|NCT01252667|469230936|FG004|Overall Study|Transplant aborted post-conditioning|0|||
130344050|NCT01252667|469230937|FG005|Overall Study|Transplant aborted post-conditioning|1|||
130344051|NCT04644315|469230938|FG000|Overall Study|Subject withdrawal of consent|1|||
130344052|NCT01836276|469230939|FG000|Overall Study|Lost to Follow-up|28|||
130344053|NCT01836276|469230940|FG001|Overall Study|Lost to Follow-up|51|||
130344054|NCT00331552|469230943|FG000|Period 3: Phase II|Neurological Symptoms|1|||
130344055|NCT00331552|469230944|FG001|Period 3: Phase II|Neurological Symptoms|0|||
130344056|NCT00331552|469230943|FG000|Period 3: Phase II|Severe Nausea|1|||
130344057|NCT00331552|469230944|FG001|Period 3: Phase II|Severe Nausea|0|||
130344058|NCT01445548|469230945|FG000|Overall Study|Adverse Event|1|||
130344059|NCT02122783|469230952|FG000|Overall Study|Adverse Event|0|||
130344060|NCT02122783|469230953|FG001|Overall Study|Adverse Event|1|||
130344061|NCT02353143|469230959|FG000|Overall Study|Withdrawal by Subject|1|||
130344062|NCT02353143|469230960|FG001|Overall Study|Withdrawal by Subject|0|||
130344063|NCT02353143|469230961|FG002|Overall Study|Withdrawal by Subject|0|||
130344064|NCT02353143|469230962|FG003|Overall Study|Withdrawal by Subject|0|||
130344065|NCT02353143|469230963|FG004|Overall Study|Withdrawal by Subject|1|||
130344066|NCT02353143|469230964|FG005|Overall Study|Withdrawal by Subject|0|||
130344067|NCT02353143|469230965|FG006|Overall Study|Withdrawal by Subject|0|||
130344068|NCT02353143|469230966|FG007|Overall Study|Withdrawal by Subject|1|||
130344069|NCT02353143|469230967|FG008|Overall Study|Withdrawal by Subject|1|||
130344070|NCT02353143|469230959|FG000|Overall Study|Lack of Efficacy|2|||
130344071|NCT02353143|469230960|FG001|Overall Study|Lack of Efficacy|1|||
130344072|NCT02353143|469230961|FG002|Overall Study|Lack of Efficacy|2|||
130344073|NCT02353143|469230962|FG003|Overall Study|Lack of Efficacy|4|||
130344074|NCT02353143|469230963|FG004|Overall Study|Lack of Efficacy|13|||
130344075|NCT02353143|469230964|FG005|Overall Study|Lack of Efficacy|2|||
130344076|NCT02353143|469230965|FG006|Overall Study|Lack of Efficacy|2|||
130344077|NCT02353143|469230966|FG007|Overall Study|Lack of Efficacy|2|||
130344078|NCT02353143|469230967|FG008|Overall Study|Lack of Efficacy|1|||
130344079|NCT02353143|469230959|FG000|Overall Study|reason not specified|1|||
130344080|NCT02353143|469230960|FG001|Overall Study|reason not specified|2|||
130344081|NCT02353143|469230961|FG002|Overall Study|reason not specified|0|||
130344082|NCT02353143|469230962|FG003|Overall Study|reason not specified|0|||
130344083|NCT02353143|469230963|FG004|Overall Study|reason not specified|6|||
130344084|NCT02353143|469230964|FG005|Overall Study|reason not specified|1|||
130344085|NCT02353143|469230965|FG006|Overall Study|reason not specified|0|||
130344086|NCT02353143|469230966|FG007|Overall Study|reason not specified|3|||
130344087|NCT02353143|469230967|FG008|Overall Study|reason not specified|1|||
130344088|NCT02353143|469230959|FG000|Overall Study|Physician Decision|0|||
130344089|NCT02353143|469230960|FG001|Overall Study|Physician Decision|4|||
130344090|NCT02353143|469230961|FG002|Overall Study|Physician Decision|2|||
130344091|NCT02353143|469230962|FG003|Overall Study|Physician Decision|3|||
130344092|NCT02353143|469230963|FG004|Overall Study|Physician Decision|4|||
130344093|NCT02353143|469230964|FG005|Overall Study|Physician Decision|0|||
130344094|NCT02353143|469230965|FG006|Overall Study|Physician Decision|1|||
130344095|NCT02353143|469230966|FG007|Overall Study|Physician Decision|2|||
130344096|NCT02353143|469230967|FG008|Overall Study|Physician Decision|0|||
130344097|NCT02353143|469230959|FG000|Overall Study|Adverse Event|0|||
130344098|NCT02353143|469230960|FG001|Overall Study|Adverse Event|0|||
130344099|NCT02353143|469230961|FG002|Overall Study|Adverse Event|1|||
130344100|NCT02353143|469230962|FG003|Overall Study|Adverse Event|0|||
130433832|NCT00597714|469551996|FG000|Overall Study|Death|56|||
130344101|NCT02353143|469230963|FG004|Overall Study|Adverse Event|1|||
130344102|NCT02353143|469230964|FG005|Overall Study|Adverse Event|1|||
130344103|NCT02353143|469230965|FG006|Overall Study|Adverse Event|0|||
130344104|NCT02353143|469230966|FG007|Overall Study|Adverse Event|0|||
130344105|NCT02353143|469230967|FG008|Overall Study|Adverse Event|0|||
130344106|NCT02353143|469230959|FG000|Overall Study|patient receiving other treatment for AML|0|||
130344107|NCT02353143|469230960|FG001|Overall Study|patient receiving other treatment for AML|0|||
130344108|NCT02353143|469230961|FG002|Overall Study|patient receiving other treatment for AML|1|||
130344109|NCT02353143|469230962|FG003|Overall Study|patient receiving other treatment for AML|0|||
130344110|NCT02353143|469230963|FG004|Overall Study|patient receiving other treatment for AML|0|||
130344111|NCT02353143|469230964|FG005|Overall Study|patient receiving other treatment for AML|0|||
130344112|NCT02353143|469230965|FG006|Overall Study|patient receiving other treatment for AML|0|||
130344113|NCT02353143|469230966|FG007|Overall Study|patient receiving other treatment for AML|0|||
130433833|NCT00597714|469551997|FG001|Overall Study|Death|46|||
130344114|NCT02353143|469230967|FG008|Overall Study|patient receiving other treatment for AML|0|||
130344115|NCT02353143|469230959|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130344116|NCT02353143|469230960|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130344117|NCT02353143|469230961|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130344118|NCT02353143|469230962|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
130344119|NCT02353143|469230963|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
130344120|NCT02353143|469230964|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
130344121|NCT02353143|469230965|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130344122|NCT02353143|469230966|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130344123|NCT02353143|469230967|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
130344124|NCT02946931|469230976|FG000|Overall Study|Did not require collection of CRFs|588|||
130344125|NCT02946931|469230976|FG000|Overall Study|Other than listed|37|||
130344126|NCT02946931|469230976|FG000|Overall Study|Discharge from hospital|118|||
130344127|NCT02946931|469230976|FG000|Overall Study|Adverse Event|81|||
130344128|NCT02946931|469230976|FG000|Overall Study|CRFs not valid|1|||
130344129|NCT02946931|469230976|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
130344130|NCT03339297|469230977|FG000|Overall Study|Relapse of Hematologic Disease|1|||
130344131|NCT03339297|469230978|FG001|Overall Study|Relapse of Hematologic Disease|0|||
130344132|NCT03339297|469230977|FG000|Overall Study|Death|10|||
130344133|NCT03339297|469230978|FG001|Overall Study|Death|7|||
130344134|NCT03339297|469230977|FG000|Overall Study|Hepatic Candidosis|1|||
130344135|NCT03339297|469230978|FG001|Overall Study|Hepatic Candidosis|0|||
130344136|NCT03339297|469230977|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130344137|NCT03339297|469230978|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
130344138|NCT03339297|469230977|FG000|Overall Study|Consent Withdrawn by Participant|3|||
130344139|NCT03339297|469230978|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130344140|NCT03339297|469230977|FG000|Overall Study|Disease Relapse|2|||
130344141|NCT03339297|469230978|FG001|Overall Study|Disease Relapse|0|||
130344142|NCT03339297|469230977|FG000|Overall Study|Physician Decision|1|||
130344143|NCT03339297|469230978|FG001|Overall Study|Physician Decision|1|||
130344144|NCT03339297|469230977|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
130344145|NCT03339297|469230978|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
130344146|NCT03339297|469230977|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
130344147|NCT03339297|469230978|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
130344148|NCT03339297|469230977|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
130344149|NCT03339297|469230978|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
130344150|NCT03339297|469230977|FG000|Overall Study|Adverse Event, Non-fatal|1|||
130344151|NCT03339297|469230978|FG001|Overall Study|Adverse Event, Non-fatal|0|||
130344152|NCT03339297|469230977|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
130344153|NCT03339297|469230978|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
130344154|NCT03339297|469230977|FG000|Overall Study|Patient Was Not Eligible|1|||
130344155|NCT03339297|469230978|FG001|Overall Study|Patient Was Not Eligible|0|||
130344156|NCT02213133|469230979|FG000|Overall Study|Participant discontinued study therapy|2|||
130344157|NCT02213133|469230980|FG001|Overall Study|Participant discontinued study therapy|0|||
130344158|NCT02213133|469230981|FG002|Overall Study|Participant discontinued study therapy|0|||
130344159|NCT02213133|469230979|FG000|Overall Study|Participant withdrew informed consent|2|||
130344160|NCT02213133|469230980|FG001|Overall Study|Participant withdrew informed consent|1|||
130344161|NCT02213133|469230981|FG002|Overall Study|Participant withdrew informed consent|2|||
130433834|NCT00597714|469551998|FG002|Overall Study|Death|0|||
130433835|NCT00597714|469551996|FG000|Overall Study|Recipient death|0|||
130433836|NCT00597714|469551997|FG001|Overall Study|Recipient death|0|||
130433837|NCT00597714|469551998|FG002|Overall Study|Recipient death|10|||
130433838|NCT01350141|469551999|FG000|Overall Study|Lost to Follow-up|1|||
130433839|NCT01350141|469552000|FG001|Overall Study|Lost to Follow-up|0|||
130433840|NCT01350141|469552001|FG002|Overall Study|Lost to Follow-up|1|||
130433841|NCT01350141|469551999|FG000|Overall Study|Withdrawal by Subject|1|||
130433842|NCT01350141|469552000|FG001|Overall Study|Withdrawal by Subject|0|||
130433843|NCT01350141|469552001|FG002|Overall Study|Withdrawal by Subject|0|||
130433844|NCT01350141|469551999|FG000|Overall Study|Randomized but not treated|1|||
130433845|NCT01350141|469552000|FG001|Overall Study|Randomized but not treated|0|||
130433846|NCT01350141|469552001|FG002|Overall Study|Randomized but not treated|0|||
130433847|NCT00519896|469552002|FG000|Overall Study|Protocol Violation|1|||
130433848|NCT00519896|469552002|FG000|Overall Study|Adverse Event|1|||
130433849|NCT01588990|469552003|FG000|Phase A|Withdrawal by Subject|5|||
130433850|NCT01588990|469552003|FG000|Phase A|Physician Decision|11|||
130344162|NCT02213133|469230979|FG000|Overall Study|Disease progression|11|||
130344163|NCT02213133|469230980|FG001|Overall Study|Disease progression|2|||
130344164|NCT02213133|469230981|FG002|Overall Study|Disease progression|0|||
130344165|NCT02213133|469230979|FG000|Overall Study|Adverse Event (AE)|1|||
130344166|NCT02213133|469230980|FG001|Overall Study|Adverse Event (AE)|0|||
130344167|NCT02213133|469230981|FG002|Overall Study|Adverse Event (AE)|0|||
130344168|NCT02213133|469230979|FG000|Overall Study|Death|16|||
130344169|NCT02213133|469230980|FG001|Overall Study|Death|2|||
130433851|NCT01588990|469552003|FG000|Phase A|Other|14|||
130433852|NCT01588990|469552003|FG000|Phase A|Lost to Follow-up|1|||
130433853|NCT01588990|469552003|FG000|Phase A|Death|5|||
130433854|NCT01588990|469552003|FG000|Phase A|Adverse Event|28|||
130433855|NCT01588990|469552003|FG000|Phase A|Still on therapy at end of study|6|||
130433856|NCT01588990|469552003|FG000|Phase B|Adverse Event|2|||
130433857|NCT01588990|469552003|FG000|Phase B|Still on therapy at end of study|5|||
130433858|NCT01588990|469552003|FG000|Phase B|Withdrawal by Subject|3|||
130433859|NCT01588990|469552003|FG000|Phase B|Physician Decision|4|||
130433860|NCT01588990|469552003|FG000|Phase B|Other|2|||
130433861|NCT02367716|469552004|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
130433862|NCT00539643|469552009|FG000|Overall Study|Adverse Event|1|||
130433863|NCT00539643|469552010|FG001|Overall Study|Adverse Event|0|||
130433864|NCT00539643|469552009|FG000|Overall Study|Death|2|||
130433865|NCT00539643|469552010|FG001|Overall Study|Death|1|||
130433866|NCT00539643|469552009|FG000|Overall Study|Physician Decision|3|||
130433867|NCT00539643|469552010|FG001|Overall Study|Physician Decision|1|||
130433868|NCT00539643|469552009|FG000|Overall Study|Withdrawal by Subject|0|||
130433869|NCT00539643|469552010|FG001|Overall Study|Withdrawal by Subject|1|||
130433870|NCT02343003|469552013|FG000|Overall Study|Withdrawal by Subject|9|||
130433871|NCT02343003|469552014|FG001|Overall Study|Withdrawal by Subject|4|||
130433872|NCT02343003|469552013|FG000|Overall Study|Lost to Follow-up|5|||
130433873|NCT02343003|469552014|FG001|Overall Study|Lost to Follow-up|1|||
130433874|NCT02343003|469552013|FG000|Overall Study|Protocol Violation|1|||
130433875|NCT02343003|469552014|FG001|Overall Study|Protocol Violation|0|||
130433876|NCT02343003|469552013|FG000|Overall Study|Death|0|||
130433877|NCT02343003|469552014|FG001|Overall Study|Death|1|||
130433878|NCT02343003|469552013|FG000|Overall Study|exclusion criteria met|1|||
130433879|NCT02343003|469552014|FG001|Overall Study|exclusion criteria met|1|||
130433880|NCT02343003|469552013|FG000|Overall Study|terminated by sponsor|2|||
130433881|NCT02343003|469552014|FG001|Overall Study|terminated by sponsor|0|||
130433882|NCT01576367|469552020|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130433883|NCT01576367|469552020|FG000|Overall Study|Moved to commercial use after 6 months|1|||
130433884|NCT04359771|469552021|FG000|Overall Study|Lack of Efficacy|2|||
130433885|NCT04359771|469552022|FG001|Overall Study|Lack of Efficacy|2|||
130433886|NCT03592277|469552023|FG000|Overall Study|Withdrawal by Subject|6|||
130433887|NCT03592277|469552024|FG001|Overall Study|Withdrawal by Subject|8|||
130433888|NCT01462162|469552025|FG000|Overall Study|Adverse Event|5|||
130433889|NCT01462162|469552025|FG000|Overall Study|Lack of Efficacy|4|||
130433890|NCT01462162|469552025|FG000|Overall Study|Abnormal laboratory parameters|1|||
130433891|NCT01462162|469552025|FG000|Overall Study|Other|2|||
130433892|NCT01346514|469552026|FG000|Overall Study|Lost to Follow-up|19|||
130433893|NCT01346514|469552027|FG001|Overall Study|Lost to Follow-up|30|||
130433894|NCT01346514|469552026|FG000|Overall Study|Withdrawal by Subject|7|||
130433895|NCT01346514|469552027|FG001|Overall Study|Withdrawal by Subject|3|||
130433896|NCT01346514|469552026|FG000|Overall Study|Death|3|||
130678686|NCT02899338|470449287|FG000|Overall Study|Withdrawal by Subject|2|||
130678687|NCT02899338|470449288|FG001|Overall Study|Withdrawal by Subject|0|||
130678688|NCT02353169|470449291|FG000|Overall Study|QTc > 450 msec|1|||
130678689|NCT02353169|470449292|FG001|Overall Study|QTc > 450 msec|1|||
130433897|NCT01346514|469552027|FG001|Overall Study|Death|4|||
130678690|NCT02353169|470449293|FG002|Overall Study|QTc > 450 msec|1|||
130678691|NCT02353169|470449294|FG003|Overall Study|QTc > 450 msec|1|||
130678692|NCT02353169|470449291|FG000|Overall Study|OR team declined|2|||
130678693|NCT02353169|470449292|FG001|Overall Study|OR team declined|0|||
130678694|NCT02353169|470449293|FG002|Overall Study|OR team declined|0|||
130678695|NCT02353169|470449294|FG003|Overall Study|OR team declined|0|||
130678696|NCT02353169|470449291|FG000|Overall Study|Inhalational induction|0|||
130678697|NCT02353169|470449292|FG001|Overall Study|Inhalational induction|2|||
130678698|NCT02353169|470449293|FG002|Overall Study|Inhalational induction|0|||
130678699|NCT02353169|470449294|FG003|Overall Study|Inhalational induction|0|||
130678700|NCT02353169|470449291|FG000|Overall Study|ECG data error|0|||
130678701|NCT02353169|470449292|FG001|Overall Study|ECG data error|3|||
130678702|NCT02353169|470449293|FG002|Overall Study|ECG data error|2|||
130433898|NCT00909480|469552028|FG000|Overall Study|Adverse Event|5|||
130433899|NCT00909480|469552029|FG001|Overall Study|Adverse Event|3|||
130433900|NCT00909480|469552028|FG000|Overall Study|Protocol Violation|6|||
130433901|NCT00909480|469552029|FG001|Overall Study|Protocol Violation|8|||
130433902|NCT00909480|469552028|FG000|Overall Study|Withdrawal criteria|9|||
130433903|NCT00909480|469552029|FG001|Overall Study|Withdrawal criteria|11|||
130433904|NCT00909480|469552028|FG000|Overall Study|Unclassified|18|||
130433905|NCT00909480|469552029|FG001|Overall Study|Unclassified|19|||
130433906|NCT01215357|469552033|FG000|Overall Study|Withdrawal by Subject|3|||
130433907|NCT01215357|469552033|FG000|Overall Study|Protocol Violation|9|||
130433908|NCT04772053|469552048|FG000|Overall Study|Physician Decision|2|||
130678703|NCT02353169|470449294|FG003|Overall Study|ECG data error|2|||
130433909|NCT04772053|469552048|FG000|Overall Study|Withdrawal by Subject|3|||
130678704|NCT02353169|470449291|FG000|Overall Study|Pre-op medication|0|||
130678705|NCT02353169|470449292|FG001|Overall Study|Pre-op medication|0|||
130678706|NCT02353169|470449293|FG002|Overall Study|Pre-op medication|1|||
130678707|NCT02353169|470449294|FG003|Overall Study|Pre-op medication|0|||
130678708|NCT00117949|470449295|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
130678709|NCT00117949|470449296|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
130678710|NCT00117949|470449297|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
130678711|NCT00117949|470449298|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
130678712|NCT00117949|470449295|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
130678713|NCT00117949|470449296|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
130678714|NCT00117949|470449297|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
130678715|NCT00117949|470449298|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
130678716|NCT00117949|470449295|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
130678717|NCT00117949|470449296|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
130678718|NCT00117949|470449297|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
130678719|NCT00117949|470449298|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
130678720|NCT00117949|470449295|FG000|Overall Study|PSA increase >=10ng/mL|0|||
130678721|NCT00117949|470449296|FG001|Overall Study|PSA increase >=10ng/mL|1|||
130678722|NCT00117949|470449297|FG002|Overall Study|PSA increase >=10ng/mL|1|||
130678723|NCT00117949|470449298|FG003|Overall Study|PSA increase >=10ng/mL|0|||
130678724|NCT00117949|470449295|FG000|Overall Study|PSA reduction <=50%|0|||
130678725|NCT00117949|470449296|FG001|Overall Study|PSA reduction <=50%|2|||
130678726|NCT00117949|470449297|FG002|Overall Study|PSA reduction <=50%|2|||
130344170|NCT02213133|469230981|FG002|Overall Study|Death|1|||
130433910|NCT04772053|469552048|FG000|Overall Study|Study Terminated by Sponsor|1|||
130344171|NCT02213133|469230979|FG000|Overall Study|Other|5|||
130344172|NCT02213133|469230980|FG001|Overall Study|Other|0|||
130344173|NCT02213133|469230981|FG002|Overall Study|Other|0|||
130344174|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130344175|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
130344176|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
130344177|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130344178|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130344179|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
130344180|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
130344181|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130344182|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130344183|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
130344184|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
130344185|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
130344186|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
130344187|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
130344188|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
130344189|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
130344190|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
130344191|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
130344192|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130344193|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130344194|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
130344195|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
130344196|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
130344197|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
130344198|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
130344199|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
130344200|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
130344201|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
130344202|NCT03051620|469230992|FG000|Overall Study|Lost to Follow-up|6|||
130344203|NCT03051620|469230992|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
130344204|NCT00393510|469230993|FG000|Overall Study|Physician Decision|3|||
130344205|NCT00393510|469230994|FG001|Overall Study|Physician Decision|9|||
130344206|NCT02412488|469230998|FG000|Overall Study|Lost to Follow-up|10|||
130344207|NCT02412488|469230998|FG000|Overall Study|Withdrawal by Subject|5|||
130344208|NCT02412488|469230998|FG000|Overall Study|Physician Decision|1|||
130344209|NCT02412488|469230998|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
130344210|NCT02412488|469230998|FG000|Overall Study|Reveal LINQ explant|1|||
130344211|NCT00796991|469230999|FG000|Overall Study|Adverse Event|0|||
130344212|NCT00796991|469231000|FG001|Overall Study|Adverse Event|0|||
130433911|NCT04599101|469552049|FG000|Overall Study|Lost to Follow-up|5|||
130552772|NCT00719563|469991530|FG000|Overall Study|Unknown reasons|4|||
130678727|NCT00117949|470449298|FG003|Overall Study|PSA reduction <=50%|4|||
130678728|NCT00117949|470449295|FG000|Overall Study|Hepatic abnormalities|0|||
130678729|NCT00117949|470449296|FG001|Overall Study|Hepatic abnormalities|1|||
130344213|NCT00796991|469231001|FG002|Overall Study|Adverse Event|1|||
130344214|NCT00796991|469230999|FG000|Overall Study|Death|2|||
130344215|NCT00796991|469231000|FG001|Overall Study|Death|0|||
130344216|NCT00796991|469231001|FG002|Overall Study|Death|0|||
130344217|NCT00796991|469230999|FG000|Overall Study|Disease Progression|10|||
130678730|NCT00117949|470449297|FG002|Overall Study|Hepatic abnormalities|0|||
130678731|NCT00117949|470449298|FG003|Overall Study|Hepatic abnormalities|1|||
130678732|NCT03184441|470449304|FG000|Overall Study|Withdrawal by Subject|1|||
130678733|NCT01868009|470449307|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
130678734|NCT01868009|470449308|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
130344218|NCT00796991|469231000|FG001|Overall Study|Disease Progression|9|||
130344219|NCT00796991|469231001|FG002|Overall Study|Disease Progression|7|||
130344220|NCT00796991|469230999|FG000|Overall Study|Study Drug Toxicity|3|||
130344221|NCT00796991|469231000|FG001|Overall Study|Study Drug Toxicity|3|||
130344222|NCT00796991|469231001|FG002|Overall Study|Study Drug Toxicity|5|||
130344223|NCT00796991|469230999|FG000|Overall Study|Withdrawal by Subject|0|||
130344224|NCT00796991|469231000|FG001|Overall Study|Withdrawal by Subject|0|||
130344225|NCT00796991|469231001|FG002|Overall Study|Withdrawal by Subject|1|||
130344226|NCT00029146|469231002|FG000|Overall Study|Lost to Follow-up|2|||
130344227|NCT00029146|469231003|FG001|Overall Study|Lost to Follow-up|1|||
130344228|NCT00313781|469231004|FG000|Before Crossover|Death|22|||
130344229|NCT00313781|469231005|FG001|Before Crossover|Death|8|||
130344230|NCT00313781|469231006|FG002|Before Crossover|Death|0|||
130344231|NCT00313781|469231004|FG000|Before Crossover|Lost to Follow-up|0|||
130344232|NCT00313781|469231005|FG001|Before Crossover|Lost to Follow-up|3|||
130344233|NCT00313781|469231006|FG002|Before Crossover|Lost to Follow-up|0|||
130344234|NCT00313781|469231004|FG000|Before Crossover|Withdrawal by Subject|3|||
130344235|NCT00313781|469231005|FG001|Before Crossover|Withdrawal by Subject|1|||
130344236|NCT00313781|469231006|FG002|Before Crossover|Withdrawal by Subject|0|||
130344237|NCT00313781|469231004|FG000|Before Crossover|Other|45|||
130344238|NCT00313781|469231005|FG001|Before Crossover|Other|30|||
130344239|NCT00313781|469231006|FG002|Before Crossover|Other|0|||
130344240|NCT00313781|469231004|FG000|Before Crossover|Crossover|0|||
130344241|NCT00313781|469231005|FG001|Before Crossover|Crossover|37|||
130344242|NCT00313781|469231006|FG002|Before Crossover|Crossover|0|||
130344243|NCT00313781|469231004|FG000|Before Crossover|Randomized, not treated|5|||
130344244|NCT00313781|469231005|FG001|Before Crossover|Randomized, not treated|0|||
130344245|NCT00313781|469231006|FG002|Before Crossover|Randomized, not treated|0|||
130344246|NCT00313781|469231004|FG000|After Crossover|Death|0|||
130344247|NCT00313781|469231005|FG001|After Crossover|Death|0|||
130344248|NCT00313781|469231006|FG002|After Crossover|Death|6|||
130344249|NCT00313781|469231004|FG000|After Crossover|Withdrawal by Subject|0|||
130344250|NCT00313781|469231005|FG001|After Crossover|Withdrawal by Subject|0|||
130344251|NCT00313781|469231006|FG002|After Crossover|Withdrawal by Subject|3|||
130344252|NCT00313781|469231004|FG000|After Crossover|Other|0|||
130344253|NCT00313781|469231005|FG001|After Crossover|Other|0|||
130344254|NCT00313781|469231006|FG002|After Crossover|Other|18|||
130344255|NCT03567343|469231007|FG000|Overall Study|Lost to Follow-up|2|||
130344256|NCT03567343|469231008|FG001|Overall Study|Lost to Follow-up|1|||
130344257|NCT03567343|469231007|FG000|Overall Study|No longer eligible|2|||
130344258|NCT03567343|469231008|FG001|Overall Study|No longer eligible|1|||
130344259|NCT03567343|469231007|FG000|Overall Study|Adverse Event|1|||
130344260|NCT03567343|469231008|FG001|Overall Study|Adverse Event|0|||
130344261|NCT03567343|469231007|FG000|Overall Study|Protocol Violation|1|||
130344262|NCT03567343|469231008|FG001|Overall Study|Protocol Violation|1|||
130344263|NCT00834080|469231009|FG000|Overall Study|Adverse Event|7|||
130344264|NCT00834080|469231009|FG000|Overall Study|Lost to Follow-up|7|||
130344265|NCT00834080|469231009|FG000|Overall Study|Withdrawal by Subject|5|||
130344266|NCT00834080|469231009|FG000|Overall Study|Other - Pregnancy|1|||
130344267|NCT00834080|469231009|FG000|Overall Study|Other - False positive tests of the UDS|1|||
130344268|NCT00834080|469231009|FG000|Overall Study|Physician Decision|1|||
130344269|NCT00834080|469231009|FG000|Overall Study|Subject Relocated|1|||
130344270|NCT00392379|469231012|FG000|Overall Study|Withdrawal by Subject|17|||
130344271|NCT00392379|469231013|FG001|Overall Study|Withdrawal by Subject|28|||
130344272|NCT00392379|469231012|FG000|Overall Study|Lost to Follow-up|4|||
130344273|NCT00392379|469231013|FG001|Overall Study|Lost to Follow-up|9|||
130344274|NCT00392379|469231012|FG000|Overall Study|Adverse Event|1|||
130344275|NCT00392379|469231013|FG001|Overall Study|Adverse Event|1|||
130344276|NCT02365233|469231017|FG000|Overall Study|IRB withheld the data|1|||
130678735|NCT01868009|470449307|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
130344277|NCT02365233|469231018|FG001|Overall Study|IRB withheld the data|2|||
130344278|NCT02365233|469231019|FG002|Overall Study|IRB withheld the data|2|||
130344279|NCT00827931|469231020|FG000|Overall Study|Death|3|||
130344280|NCT00827931|469231021|FG001|Overall Study|Death|5|||
130344281|NCT00827931|469231020|FG000|Overall Study|Adverse Event|1|||
130344282|NCT00827931|469231021|FG001|Overall Study|Adverse Event|0|||
130344283|NCT00827931|469231020|FG000|Overall Study|Lost to Follow-up|1|||
130344284|NCT00827931|469231021|FG001|Overall Study|Lost to Follow-up|0|||
130344285|NCT00827931|469231020|FG000|Overall Study|Withdrawal by Subject|0|||
130344286|NCT00827931|469231021|FG001|Overall Study|Withdrawal by Subject|1|||
130344287|NCT00827931|469231020|FG000|Overall Study|Other|1|||
130344288|NCT00827931|469231021|FG001|Overall Study|Other|0|||
130344289|NCT00995566|469231022|FG000|Overall Study|Adverse Event|2|||
130344290|NCT00995566|469231022|FG000|Overall Study|Early study termination|52|||
130344291|NCT00608569|469231023|FG000|Overall Study|Death|4|||
130433912|NCT04599101|469552050|FG001|Overall Study|Lost to Follow-up|5|||
130433913|NCT00098254|469552055|FG000|Overall Study|Adverse Event|2|||
130433914|NCT00098254|469552055|FG000|Overall Study|Death|1|||
130433915|NCT02118337|469552056|FG000|Overall Study|Other|1|||
130433916|NCT02118337|469552057|FG001|Overall Study|Other|0|||
130433917|NCT02118337|469552058|FG002|Overall Study|Other|0|||
130433918|NCT02118337|469552059|FG003|Overall Study|Other|0|||
130433919|NCT02118337|469552060|FG004|Overall Study|Other|2|||
130433920|NCT02118337|469552061|FG005|Overall Study|Other|3|||
130433921|NCT02118337|469552062|FG006|Overall Study|Other|1|||
130433922|NCT02118337|469552063|FG007|Overall Study|Other|28|||
130433923|NCT02118337|469552064|FG008|Overall Study|Other|15|||
130433924|NCT02118337|469552056|FG000|Overall Study|Lost to Follow-up|0|||
130433925|NCT02118337|469552057|FG001|Overall Study|Lost to Follow-up|0|||
130433926|NCT02118337|469552058|FG002|Overall Study|Lost to Follow-up|0|||
130433927|NCT02118337|469552059|FG003|Overall Study|Lost to Follow-up|0|||
130433928|NCT02118337|469552060|FG004|Overall Study|Lost to Follow-up|0|||
130433929|NCT02118337|469552061|FG005|Overall Study|Lost to Follow-up|0|||
130678736|NCT01868009|470449308|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
130678737|NCT01868009|470449307|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
130678738|NCT01868009|470449308|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
130344292|NCT00608569|469231024|FG001|Overall Study|Death|3|||
130344293|NCT00608569|469231023|FG000|Overall Study|Lost to Follow-up|4|||
130344294|NCT00608569|469231024|FG001|Overall Study|Lost to Follow-up|5|||
130344295|NCT00608569|469231023|FG000|Overall Study|Withdrawal by Subject|1|||
130344296|NCT00608569|469231024|FG001|Overall Study|Withdrawal by Subject|0|||
130344297|NCT00608569|469231023|FG000|Overall Study|Adverse Event|1|||
130344298|NCT00608569|469231024|FG001|Overall Study|Adverse Event|0|||
130344299|NCT00608569|469231023|FG000|Overall Study|Unable to adhere with study requirements|0|||
130344300|NCT00608569|469231024|FG001|Overall Study|Unable to adhere with study requirements|1|||
130344301|NCT03011892|469231025|FG000|Double Blind (DB) Period|Adverse Event|0|||
130344302|NCT03011892|469231026|FG001|Double Blind (DB) Period|Adverse Event|1|||
130344303|NCT03011892|469231027|FG002|Double Blind (DB) Period|Adverse Event|1|||
130344304|NCT03011892|469231028|FG003|Double Blind (DB) Period|Adverse Event|0|||
130344305|NCT03011892|469231029|FG004|Double Blind (DB) Period|Adverse Event|0|||
130344306|NCT03011892|469231030|FG005|Double Blind (DB) Period|Adverse Event|0|||
130344307|NCT03011892|469231031|FG006|Double Blind (DB) Period|Adverse Event|0|||
130344308|NCT03011892|469231032|FG007|Double Blind (DB) Period|Adverse Event|0|||
130344309|NCT03011892|469231033|FG008|Double Blind (DB) Period|Adverse Event|0|||
130344310|NCT03011892|469231034|FG009|Double Blind (DB) Period|Adverse Event|0|||
130344311|NCT03011892|469231035|FG010|Double Blind (DB) Period|Adverse Event|0|||
130344312|NCT03011892|469231036|FG011|Double Blind (DB) Period|Adverse Event|0|||
130344313|NCT03011892|469231025|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
130344314|NCT03011892|469231026|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
130344315|NCT03011892|469231027|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
130344316|NCT03011892|469231028|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
130344317|NCT03011892|469231029|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
130344318|NCT03011892|469231030|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
130344319|NCT03011892|469231031|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
130344320|NCT03011892|469231032|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
130344321|NCT03011892|469231033|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
130344322|NCT03011892|469231034|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
130344323|NCT03011892|469231035|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
130344324|NCT03011892|469231036|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
130344325|NCT03011892|469231025|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
130344326|NCT03011892|469231026|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
130344327|NCT03011892|469231027|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
130344328|NCT03011892|469231028|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
130344329|NCT03011892|469231029|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
130344330|NCT03011892|469231030|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
130344331|NCT03011892|469231031|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
130344332|NCT03011892|469231032|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
130344333|NCT03011892|469231033|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
130344334|NCT03011892|469231034|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
130433930|NCT02118337|469552062|FG006|Overall Study|Lost to Follow-up|0|||
130433931|NCT02118337|469552063|FG007|Overall Study|Lost to Follow-up|1|||
130678739|NCT04803357|470449311|FG000|Overall Study|Withdrawal by Subject|31|||
130678740|NCT04803357|470449312|FG001|Overall Study|Withdrawal by Subject|5|||
130344335|NCT03011892|469231035|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
130344336|NCT03011892|469231036|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
130344337|NCT03011892|469231025|FG000|Double Blind (DB) Period|Other|1|||
130344338|NCT03011892|469231026|FG001|Double Blind (DB) Period|Other|1|||
130344339|NCT03011892|469231027|FG002|Double Blind (DB) Period|Other|1|||
130678741|NCT00182091|470449313|FG000|Overall Study|Withdrawal by Subject|1|||
130433932|NCT02118337|469552064|FG008|Overall Study|Lost to Follow-up|0|||
130433933|NCT02118337|469552056|FG000|Overall Study|Withdrawal by Subject|1|||
130433934|NCT02118337|469552057|FG001|Overall Study|Withdrawal by Subject|3|||
130552773|NCT00719563|469991531|FG001|Overall Study|Unknown reasons|6|||
130678742|NCT00182091|470449314|FG001|Overall Study|Withdrawal by Subject|0|||
130344340|NCT03011892|469231028|FG003|Double Blind (DB) Period|Other|0|||
130344341|NCT03011892|469231029|FG004|Double Blind (DB) Period|Other|1|||
130344342|NCT03011892|469231030|FG005|Double Blind (DB) Period|Other|0|||
130344343|NCT03011892|469231031|FG006|Double Blind (DB) Period|Other|0|||
130344344|NCT03011892|469231032|FG007|Double Blind (DB) Period|Other|0|||
130344345|NCT03011892|469231033|FG008|Double Blind (DB) Period|Other|0|||
130344346|NCT03011892|469231034|FG009|Double Blind (DB) Period|Other|0|||
130344347|NCT03011892|469231035|FG010|Double Blind (DB) Period|Other|0|||
130344348|NCT03011892|469231036|FG011|Double Blind (DB) Period|Other|0|||
130344349|NCT03011892|469231025|FG000|Double Blind (DB) Period|Physician Decision|1|||
130344350|NCT03011892|469231026|FG001|Double Blind (DB) Period|Physician Decision|0|||
130344351|NCT03011892|469231027|FG002|Double Blind (DB) Period|Physician Decision|1|||
130344352|NCT03011892|469231028|FG003|Double Blind (DB) Period|Physician Decision|0|||
130344353|NCT03011892|469231029|FG004|Double Blind (DB) Period|Physician Decision|0|||
130344354|NCT03011892|469231030|FG005|Double Blind (DB) Period|Physician Decision|0|||
130344355|NCT03011892|469231031|FG006|Double Blind (DB) Period|Physician Decision|0|||
130344356|NCT03011892|469231032|FG007|Double Blind (DB) Period|Physician Decision|0|||
130344357|NCT03011892|469231033|FG008|Double Blind (DB) Period|Physician Decision|0|||
130344358|NCT03011892|469231034|FG009|Double Blind (DB) Period|Physician Decision|0|||
130344359|NCT03011892|469231035|FG010|Double Blind (DB) Period|Physician Decision|0|||
130344360|NCT03011892|469231036|FG011|Double Blind (DB) Period|Physician Decision|0|||
130344361|NCT03011892|469231025|FG000|Double Blind (DB) Period|Pregnancy|0|||
130344362|NCT03011892|469231026|FG001|Double Blind (DB) Period|Pregnancy|0|||
130344363|NCT03011892|469231027|FG002|Double Blind (DB) Period|Pregnancy|0|||
130344364|NCT03011892|469231028|FG003|Double Blind (DB) Period|Pregnancy|0|||
130344365|NCT03011892|469231029|FG004|Double Blind (DB) Period|Pregnancy|1|||
130344366|NCT03011892|469231030|FG005|Double Blind (DB) Period|Pregnancy|0|||
130344367|NCT03011892|469231031|FG006|Double Blind (DB) Period|Pregnancy|0|||
130344368|NCT03011892|469231032|FG007|Double Blind (DB) Period|Pregnancy|0|||
130344369|NCT03011892|469231033|FG008|Double Blind (DB) Period|Pregnancy|0|||
130344370|NCT03011892|469231034|FG009|Double Blind (DB) Period|Pregnancy|0|||
130344371|NCT03011892|469231035|FG010|Double Blind (DB) Period|Pregnancy|0|||
130344372|NCT03011892|469231036|FG011|Double Blind (DB) Period|Pregnancy|0|||
130344373|NCT03011892|469231025|FG000|Double Blind (DB) Period|Protocol Violation|1|||
130344374|NCT03011892|469231026|FG001|Double Blind (DB) Period|Protocol Violation|0|||
130344375|NCT03011892|469231027|FG002|Double Blind (DB) Period|Protocol Violation|0|||
130344376|NCT03011892|469231028|FG003|Double Blind (DB) Period|Protocol Violation|0|||
130344377|NCT03011892|469231029|FG004|Double Blind (DB) Period|Protocol Violation|0|||
130344378|NCT03011892|469231030|FG005|Double Blind (DB) Period|Protocol Violation|0|||
130344379|NCT03011892|469231031|FG006|Double Blind (DB) Period|Protocol Violation|0|||
130344380|NCT03011892|469231032|FG007|Double Blind (DB) Period|Protocol Violation|0|||
130344381|NCT03011892|469231033|FG008|Double Blind (DB) Period|Protocol Violation|0|||
130344382|NCT03011892|469231034|FG009|Double Blind (DB) Period|Protocol Violation|0|||
130344383|NCT03011892|469231035|FG010|Double Blind (DB) Period|Protocol Violation|0|||
130344384|NCT03011892|469231036|FG011|Double Blind (DB) Period|Protocol Violation|0|||
130344385|NCT03011892|469231025|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
130344386|NCT03011892|469231026|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
130344387|NCT03011892|469231027|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
130344388|NCT03011892|469231028|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
130344389|NCT03011892|469231029|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
130344390|NCT03011892|469231030|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
130344391|NCT03011892|469231031|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344392|NCT03011892|469231032|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344393|NCT03011892|469231033|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344394|NCT03011892|469231034|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344395|NCT03011892|469231035|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344396|NCT03011892|469231036|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344397|NCT03011892|469231025|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
130344398|NCT03011892|469231026|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
130344399|NCT03011892|469231027|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
130344400|NCT03011892|469231028|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
130344401|NCT03011892|469231029|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
130344402|NCT03011892|469231030|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
130344403|NCT03011892|469231031|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
130344404|NCT03011892|469231032|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
130344405|NCT03011892|469231033|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
130344406|NCT03011892|469231034|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
130678743|NCT00182091|470449315|FG002|Overall Study|Withdrawal by Subject|0|||
130678744|NCT00182091|470449316|FG003|Overall Study|Withdrawal by Subject|0|||
130344407|NCT03011892|469231035|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
130344408|NCT03011892|469231036|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
130344409|NCT03011892|469231025|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
130344410|NCT03011892|469231026|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
130344411|NCT03011892|469231027|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
130344412|NCT03011892|469231028|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
130344413|NCT03011892|469231029|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
130344414|NCT03011892|469231030|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
130344415|NCT03011892|469231031|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
130344416|NCT03011892|469231032|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
130344417|NCT03011892|469231033|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
130344418|NCT03011892|469231034|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
130344419|NCT03011892|469231035|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
130344420|NCT03011892|469231036|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
130344421|NCT03011892|469231025|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
130344422|NCT03011892|469231026|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
130344423|NCT03011892|469231027|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
130344424|NCT03011892|469231028|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
130344425|NCT03011892|469231029|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
130344426|NCT03011892|469231030|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
130344427|NCT03011892|469231031|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
130344428|NCT03011892|469231032|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
130344429|NCT03011892|469231033|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
130344430|NCT03011892|469231034|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
130344431|NCT03011892|469231035|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
130344432|NCT03011892|469231036|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
130344433|NCT03011892|469231025|FG000|Open Label (OL) Period|Reason not specified|0|||
130344434|NCT03011892|469231026|FG001|Open Label (OL) Period|Reason not specified|0|||
130344435|NCT03011892|469231027|FG002|Open Label (OL) Period|Reason not specified|0|||
130344436|NCT03011892|469231028|FG003|Open Label (OL) Period|Reason not specified|0|||
130344437|NCT03011892|469231029|FG004|Open Label (OL) Period|Reason not specified|0|||
130344438|NCT03011892|469231030|FG005|Open Label (OL) Period|Reason not specified|0|||
130344439|NCT03011892|469231031|FG006|Open Label (OL) Period|Reason not specified|0|||
130344440|NCT03011892|469231032|FG007|Open Label (OL) Period|Reason not specified|1|||
130344441|NCT03011892|469231033|FG008|Open Label (OL) Period|Reason not specified|0|||
130344442|NCT03011892|469231034|FG009|Open Label (OL) Period|Reason not specified|0|||
130344443|NCT03011892|469231035|FG010|Open Label (OL) Period|Reason not specified|0|||
130344444|NCT03011892|469231036|FG011|Open Label (OL) Period|Reason not specified|0|||
130344445|NCT02282293|469231037|FG000|Overall Study|Lost to Follow-up|2|||
130344446|NCT02282293|469231038|FG001|Overall Study|Lost to Follow-up|2|||
130344447|NCT02282293|469231037|FG000|Overall Study|Unable to comply with study procedures|1|||
130344448|NCT02282293|469231038|FG001|Overall Study|Unable to comply with study procedures|0|||
130344449|NCT02282293|469231037|FG000|Overall Study|Moved out of study area|0|||
130344450|NCT02282293|469231038|FG001|Overall Study|Moved out of study area|1|||
130344451|NCT02312687|469231040|FG000|Overall Study|Other, Not Specified|1|||
130344452|NCT00384111|469231041|FG000|Overall Study|Disease Progression|3|||
130344453|NCT00384111|469231041|FG000|Overall Study|Adverse Event|1|||
130344454|NCT00384111|469231041|FG000|Overall Study|Investigator Decision|3|||
130344455|NCT00384111|469231041|FG000|Overall Study|Study Terminated by the Sponsor|19|||
130344456|NCT03612856|469231042|FG000|Pre-dose Period|Physician Decision|0|||
130344457|NCT03612856|469231043|FG001|Pre-dose Period|Physician Decision|1|||
130344458|NCT03612856|469231044|FG002|Pre-dose Period|Physician Decision|1|||
130344459|NCT03612856|469231042|FG000|Pre-dose Period|Withdrawal by Subject|0|||
130344460|NCT03612856|469231043|FG001|Pre-dose Period|Withdrawal by Subject|1|||
130344461|NCT03612856|469231044|FG002|Pre-dose Period|Withdrawal by Subject|0|||
130344462|NCT03720652|469231047|FG000|Overall Study|Withdrawal by Subject|2|||
130344463|NCT03720652|469231048|FG001|Overall Study|Withdrawal by Subject|7|||
130344464|NCT03720652|469231047|FG000|Overall Study|Lost to Follow-up|0|||
130344465|NCT03720652|469231048|FG001|Overall Study|Lost to Follow-up|4|||
130344466|NCT01454778|469231053|FG000|Overall Study|Lost to Follow-up|2|||
130344467|NCT01454778|469231053|FG000|Overall Study|Death|1|||
130344468|NCT00348881|469231054|FG000|Overall Study|Lost to Follow-up|12|||
130344469|NCT00348881|469231055|FG001|Overall Study|Lost to Follow-up|6|||
130344470|NCT00348881|469231054|FG000|Overall Study|Withdrawal by Subject|3|||
130344471|NCT00348881|469231055|FG001|Overall Study|Withdrawal by Subject|4|||
130678745|NCT01244126|470450839|FG000|Overall Study|Protocol Violation|3|||
130344472|NCT00348881|469231054|FG000|Overall Study|Adverse Event|2|||
130344473|NCT00348881|469231055|FG001|Overall Study|Adverse Event|0|||
130344474|NCT00348881|469231054|FG000|Overall Study|Serious Adverse Event|0|||
130344475|NCT00348881|469231055|FG001|Overall Study|Serious Adverse Event|2|||
130344476|NCT03658876|469232929|FG000|Overall Study|Protocol Violation|3|||
130344477|NCT03658876|469232930|FG001|Overall Study|Protocol Violation|2|||
130433935|NCT02118337|469552058|FG002|Overall Study|Withdrawal by Subject|2|||
130433936|NCT02118337|469552059|FG003|Overall Study|Withdrawal by Subject|1|||
130433937|NCT02118337|469552060|FG004|Overall Study|Withdrawal by Subject|2|||
130433938|NCT02118337|469552061|FG005|Overall Study|Withdrawal by Subject|2|||
130678746|NCT01244126|470450840|FG001|Overall Study|Protocol Violation|3|||
130678747|NCT01244126|470450841|FG002|Overall Study|Protocol Violation|9|||
130678748|NCT00863746|470450844|FG000|Treatment|Not treated|4|||
130678749|NCT00863746|470450845|FG001|Treatment|Not treated|2|||
130678750|NCT00863746|470450844|FG000|Treatment|Adverse Event|41|||
130678751|NCT00863746|470450845|FG001|Treatment|Adverse Event|16|||
130678752|NCT00863746|470450844|FG000|Treatment|non-compliant with study medication|4|||
130678753|NCT00863746|470450845|FG001|Treatment|non-compliant with study medication|0|||
130678754|NCT00863746|470450844|FG000|Treatment|Consent withdrawn|15|||
130678755|NCT00863746|470450845|FG001|Treatment|Consent withdrawn|14|||
130344478|NCT03658876|469232929|FG000|Overall Study|Withdrawal by Subject|2|||
130344479|NCT03658876|469232930|FG001|Overall Study|Withdrawal by Subject|0|||
130344480|NCT03658876|469232929|FG000|Overall Study|Death|0|||
130344481|NCT03658876|469232930|FG001|Overall Study|Death|1|||
130344482|NCT03658876|469232929|FG000|Overall Study|Intercurrent illness|6|||
130344483|NCT03658876|469232930|FG001|Overall Study|Intercurrent illness|4|||
130344484|NCT03658876|469232929|FG000|Overall Study|Transplantation/other operation|1|||
130344485|NCT03658876|469232930|FG001|Overall Study|Transplantation/other operation|5|||
130344486|NCT01330017|469232931|FG000|Overall Study|Adverse Event|0|||
130344487|NCT01330017|469232932|FG001|Overall Study|Adverse Event|1|||
130344488|NCT01330017|469232933|FG002|Overall Study|Adverse Event|1|||
130344489|NCT01330017|469232934|FG003|Overall Study|Adverse Event|4|||
130344490|NCT01330017|469232935|FG004|Overall Study|Adverse Event|0|||
130344491|NCT01330017|469232931|FG000|Overall Study|Withdrawal by Subject|0|||
130344492|NCT01330017|469232932|FG001|Overall Study|Withdrawal by Subject|0|||
130344493|NCT01330017|469232933|FG002|Overall Study|Withdrawal by Subject|1|||
130344494|NCT01330017|469232934|FG003|Overall Study|Withdrawal by Subject|0|||
130344495|NCT01330017|469232935|FG004|Overall Study|Withdrawal by Subject|1|||
130344496|NCT01330017|469232931|FG000|Overall Study|Lost to Follow-up|0|||
130344497|NCT01330017|469232932|FG001|Overall Study|Lost to Follow-up|0|||
130344498|NCT01330017|469232933|FG002|Overall Study|Lost to Follow-up|1|||
130344499|NCT01330017|469232934|FG003|Overall Study|Lost to Follow-up|0|||
130344500|NCT01330017|469232935|FG004|Overall Study|Lost to Follow-up|0|||
130344501|NCT01330017|469232931|FG000|Overall Study|Protocol Violation|0|||
130344502|NCT01330017|469232932|FG001|Overall Study|Protocol Violation|0|||
130344503|NCT01330017|469232933|FG002|Overall Study|Protocol Violation|0|||
130344504|NCT01330017|469232934|FG003|Overall Study|Protocol Violation|1|||
130344505|NCT01330017|469232935|FG004|Overall Study|Protocol Violation|0|||
130344506|NCT01330017|469232931|FG000|Overall Study|Unknown Reason|5|||
130344507|NCT01330017|469232932|FG001|Overall Study|Unknown Reason|3|||
130344508|NCT01330017|469232933|FG002|Overall Study|Unknown Reason|5|||
130344509|NCT01330017|469232934|FG003|Overall Study|Unknown Reason|7|||
130344510|NCT01330017|469232935|FG004|Overall Study|Unknown Reason|2|||
130344511|NCT02616146|469232937|FG000|Overall Study|Adverse Event|64|||
130344512|NCT02616146|469232938|FG001|Overall Study|Adverse Event|24|||
130344513|NCT02616146|469232937|FG000|Overall Study|Lost to Follow-up|23|||
130344514|NCT02616146|469232938|FG001|Overall Study|Lost to Follow-up|13|||
130344515|NCT02616146|469232937|FG000|Overall Study|Non-compliance with study protocol|2|||
130344516|NCT02616146|469232938|FG001|Overall Study|Non-compliance with study protocol|0|||
130344517|NCT02616146|469232937|FG000|Overall Study|Non-compliance with study drug|4|||
130344518|NCT02616146|469232938|FG001|Overall Study|Non-compliance with study drug|2|||
130344519|NCT02616146|469232937|FG000|Overall Study|Pregnancy|2|||
130344520|NCT02616146|469232938|FG001|Overall Study|Pregnancy|2|||
130344521|NCT02616146|469232937|FG000|Overall Study|Pregnancy wish|3|||
130344522|NCT02616146|469232938|FG001|Overall Study|Pregnancy wish|0|||
130344523|NCT02616146|469232937|FG000|Overall Study|Protocol Violation|6|||
130344524|NCT02616146|469232938|FG001|Overall Study|Protocol Violation|3|||
130344525|NCT02616146|469232937|FG000|Overall Study|Study terminated by sponsor|1372|||
130344526|NCT02616146|469232938|FG001|Overall Study|Study terminated by sponsor|432|||
130344527|NCT02616146|469232937|FG000|Overall Study|Participant moved|4|||
130678756|NCT00863746|470450844|FG000|Treatment|Lost to Follow-up|1|||
130678757|NCT00863746|470450845|FG001|Treatment|Lost to Follow-up|0|||
130344528|NCT02616146|469232938|FG001|Overall Study|Participant moved|3|||
130344529|NCT02616146|469232937|FG000|Overall Study|Withdrawal by Subject|30|||
130344530|NCT02616146|469232938|FG001|Overall Study|Withdrawal by Subject|24|||
130344531|NCT02616146|469232937|FG000|Overall Study|Physician Decision|2|||
130344532|NCT02616146|469232938|FG001|Overall Study|Physician Decision|1|||
130344533|NCT01221272|469232939|FG000|Period 1|Adverse Event|2|||
130344534|NCT01221272|469232940|FG001|Period 1|Adverse Event|0|||
130344535|NCT01221272|469232939|FG000|Period 1|Consent Withdrawal|0|||
130344536|NCT01221272|469232940|FG001|Period 1|Consent Withdrawal|1|||
130344537|NCT01221272|469232939|FG000|Period 1|Significant Dosing Noncompliance|0|||
130433939|NCT02118337|469552062|FG006|Overall Study|Withdrawal by Subject|1|||
130678758|NCT00863746|470450844|FG000|Treatment|Protocol Violation|5|||
130678759|NCT00863746|470450845|FG001|Treatment|Protocol Violation|3|||
130216604|NCT05305989|468755617|FG001|Overall Study|Investigator decision|2|||
130216605|NCT05305989|468755618|FG002|Overall Study|Investigator decision|0|||
130216606|NCT05305989|468755616|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
130344538|NCT01221272|469232940|FG001|Period 1|Significant Dosing Noncompliance|1|||
130344539|NCT01221272|469232939|FG000|Period 2|Adverse Event|0|||
130344540|NCT01221272|469232940|FG001|Period 2|Adverse Event|2|||
130344541|NCT01106092|469232943|FG000|Overall Study|Withdrawal by Subject|0|||
130344542|NCT01106092|469232944|FG001|Overall Study|Withdrawal by Subject|0|||
130344543|NCT01106092|469232945|FG002|Overall Study|Withdrawal by Subject|0|||
130344544|NCT01106092|469232946|FG003|Overall Study|Withdrawal by Subject|1|||
130344545|NCT04839562|469232953|FG000|Overall Study|Withdrawal by Subject|0|||
130344546|NCT04839562|469232954|FG001|Overall Study|Withdrawal by Subject|1|||
130344547|NCT04839562|469232953|FG000|Overall Study|Physician Decision|0|||
130344548|NCT04839562|469232954|FG001|Overall Study|Physician Decision|1|||
130344549|NCT00730028|469232955|FG000|Overall Study|Adverse Event|23|||
130344550|NCT00730028|469232956|FG001|Overall Study|Adverse Event|26|||
130344551|NCT00730028|469232957|FG002|Overall Study|Adverse Event|16|||
130344552|NCT00730028|469232958|FG003|Overall Study|Adverse Event|20|||
130344553|NCT00730028|469232959|FG004|Overall Study|Adverse Event|43|||
130344554|NCT00730028|469232955|FG000|Overall Study|Lost to Follow-up|13|||
130344555|NCT00730028|469232956|FG001|Overall Study|Lost to Follow-up|26|||
130344556|NCT00730028|469232957|FG002|Overall Study|Lost to Follow-up|22|||
130344557|NCT00730028|469232958|FG003|Overall Study|Lost to Follow-up|26|||
130344558|NCT00730028|469232959|FG004|Overall Study|Lost to Follow-up|25|||
130344559|NCT00730028|469232955|FG000|Overall Study|Protocol Violation|6|||
130344560|NCT00730028|469232956|FG001|Overall Study|Protocol Violation|1|||
130344561|NCT00730028|469232957|FG002|Overall Study|Protocol Violation|1|||
130344562|NCT00730028|469232958|FG003|Overall Study|Protocol Violation|2|||
130344563|NCT00730028|469232959|FG004|Overall Study|Protocol Violation|0|||
130344564|NCT00730028|469232955|FG000|Overall Study|Withdrawal by Subject|9|||
130344565|NCT00730028|469232956|FG001|Overall Study|Withdrawal by Subject|5|||
130344566|NCT00730028|469232957|FG002|Overall Study|Withdrawal by Subject|4|||
130344567|NCT00730028|469232958|FG003|Overall Study|Withdrawal by Subject|5|||
130344568|NCT00730028|469232959|FG004|Overall Study|Withdrawal by Subject|9|||
130344569|NCT00730028|469232955|FG000|Overall Study|Physician Decision|3|||
130344570|NCT00730028|469232956|FG001|Overall Study|Physician Decision|3|||
130344571|NCT00730028|469232957|FG002|Overall Study|Physician Decision|2|||
130344572|NCT00730028|469232958|FG003|Overall Study|Physician Decision|3|||
130344573|NCT00730028|469232959|FG004|Overall Study|Physician Decision|2|||
130344574|NCT00730028|469232955|FG000|Overall Study|Treatment Failure|5|||
130344575|NCT00730028|469232956|FG001|Overall Study|Treatment Failure|5|||
130344576|NCT00730028|469232957|FG002|Overall Study|Treatment Failure|0|||
130344577|NCT00730028|469232958|FG003|Overall Study|Treatment Failure|0|||
130344578|NCT00730028|469232959|FG004|Overall Study|Treatment Failure|1|||
130344579|NCT00730028|469232955|FG000|Overall Study|Randomization Error|1|||
130344580|NCT00730028|469232956|FG001|Overall Study|Randomization Error|0|||
130344581|NCT00730028|469232957|FG002|Overall Study|Randomization Error|0|||
130344582|NCT00730028|469232958|FG003|Overall Study|Randomization Error|0|||
130344583|NCT00730028|469232959|FG004|Overall Study|Randomization Error|2|||
130344584|NCT00003472|469232960|FG000|Overall Study|Not evaluable|3|||
130344585|NCT00528970|469232961|FG000|Overall Study|Adverse Event|6|||
130344586|NCT00528970|469232962|FG001|Overall Study|Adverse Event|8|||
130344587|NCT00528970|469232963|FG002|Overall Study|Adverse Event|5|||
130344588|NCT00528970|469232961|FG000|Overall Study|Lost to Follow-up|0|||
130344589|NCT00528970|469232962|FG001|Overall Study|Lost to Follow-up|0|||
130344590|NCT00528970|469232963|FG002|Overall Study|Lost to Follow-up|1|||
130344591|NCT00528970|469232961|FG000|Overall Study|Other than specified|2|||
130344592|NCT00528970|469232962|FG001|Overall Study|Other than specified|3|||
130344593|NCT00528970|469232963|FG002|Overall Study|Other than specified|3|||
130344594|NCT00528970|469232961|FG000|Overall Study|Protocol Violation|2|||
130344595|NCT00528970|469232962|FG001|Overall Study|Protocol Violation|1|||
130344596|NCT00528970|469232963|FG002|Overall Study|Protocol Violation|4|||
130344597|NCT00528970|469232961|FG000|Overall Study|Lack of Efficacy|0|||
130344598|NCT00528970|469232962|FG001|Overall Study|Lack of Efficacy|0|||
130344599|NCT00528970|469232963|FG002|Overall Study|Lack of Efficacy|1|||
130344600|NCT00528970|469232961|FG000|Overall Study|Withdrawal by Subject|4|||
130344601|NCT00528970|469232962|FG001|Overall Study|Withdrawal by Subject|3|||
130344602|NCT00528970|469232963|FG002|Overall Study|Withdrawal by Subject|5|||
130344603|NCT00528970|469232961|FG000|Overall Study|Randomized but not treated|0|||
130344604|NCT00528970|469232962|FG001|Overall Study|Randomized but not treated|0|||
130344605|NCT00528970|469232963|FG002|Overall Study|Randomized but not treated|1|||
130344606|NCT03316911|469232969|FG000|Overall Study|Lost to Follow-up|33|||
130344607|NCT03316911|469232970|FG001|Overall Study|Lost to Follow-up|29|||
130344608|NCT01119937|469232971|FG000|Overall Study|Adverse Event|11|||
130344609|NCT01119937|469232972|FG001|Overall Study|Adverse Event|5|||
130344610|NCT01119937|469232971|FG000|Overall Study|Protocol deviation|3|||
130344611|NCT01119937|469232972|FG001|Overall Study|Protocol deviation|1|||
130344612|NCT01119937|469232971|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130552774|NCT00719563|469991530|FG000|Overall Study|Noncompliant|1|||
130216607|NCT05305989|468755617|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130216608|NCT05305989|468755618|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130216609|NCT05305989|468755616|FG000|Overall Study|Adverse Event|1|||
130344613|NCT01119937|469232972|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130433940|NCT02118337|469552063|FG007|Overall Study|Withdrawal by Subject|4|||
130433941|NCT02118337|469552064|FG008|Overall Study|Withdrawal by Subject|2|||
130433942|NCT02118337|469552056|FG000|Overall Study|Death|2|||
130433943|NCT02118337|469552057|FG001|Overall Study|Death|2|||
130433944|NCT02118337|469552058|FG002|Overall Study|Death|1|||
130433945|NCT02118337|469552059|FG003|Overall Study|Death|2|||
130433946|NCT02118337|469552060|FG004|Overall Study|Death|5|||
130433947|NCT02118337|469552061|FG005|Overall Study|Death|1|||
130433948|NCT02118337|469552062|FG006|Overall Study|Death|2|||
130433949|NCT02118337|469552063|FG007|Overall Study|Death|9|||
130433950|NCT02118337|469552064|FG008|Overall Study|Death|4|||
130433951|NCT00943306|469552069|FG000|Overall Study|Physician Decision|1|||
130433952|NCT00943306|469552069|FG000|Overall Study|Death|1|||
130433953|NCT00943306|469552069|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
130433954|NCT01395823|469552082|FG000|Overall Study|Death|4|||
130433955|NCT01395823|469552083|FG001|Overall Study|Death|4|||
130433956|NCT01395823|469552082|FG000|Overall Study|Physician Decision|3|||
130433957|NCT01395823|469552083|FG001|Overall Study|Physician Decision|1|||
130433958|NCT01395823|469552082|FG000|Overall Study|Lost to Follow-up|1|||
130433959|NCT01395823|469552083|FG001|Overall Study|Lost to Follow-up|0|||
130433960|NCT01395823|469552082|FG000|Overall Study|Transplant|1|||
130433961|NCT01395823|469552083|FG001|Overall Study|Transplant|0|||
130433962|NCT01395823|469552082|FG000|Overall Study|GI symptoms|1|||
130433963|NCT01395823|469552083|FG001|Overall Study|GI symptoms|0|||
130433964|NCT01395823|469552082|FG000|Overall Study|Withdrawal by Subject|5|||
130433965|NCT01395823|469552083|FG001|Overall Study|Withdrawal by Subject|4|||
130433966|NCT01036022|469552084|FG000|Overall Study|Adverse Event|1|||
130433967|NCT01036022|469552085|FG001|Overall Study|Adverse Event|3|||
130433968|NCT01036022|469552086|FG002|Overall Study|Adverse Event|2|||
130433969|NCT01036022|469552087|FG003|Overall Study|Adverse Event|1|||
130433970|NCT01036022|469552088|FG004|Overall Study|Adverse Event|0|||
130433971|NCT01036022|469552089|FG005|Overall Study|Adverse Event|2|||
130433972|NCT01036022|469552084|FG000|Overall Study|Lack of Efficacy|1|||
130433973|NCT01036022|469552085|FG001|Overall Study|Lack of Efficacy|1|||
130433974|NCT01036022|469552086|FG002|Overall Study|Lack of Efficacy|1|||
130433975|NCT01036022|469552087|FG003|Overall Study|Lack of Efficacy|0|||
130433976|NCT01036022|469552088|FG004|Overall Study|Lack of Efficacy|1|||
130433977|NCT01036022|469552089|FG005|Overall Study|Lack of Efficacy|1|||
130433978|NCT01036022|469552084|FG000|Overall Study|Physician Decision|0|||
130433979|NCT01036022|469552085|FG001|Overall Study|Physician Decision|0|||
130433980|NCT01036022|469552086|FG002|Overall Study|Physician Decision|1|||
130433981|NCT01036022|469552087|FG003|Overall Study|Physician Decision|0|||
130433982|NCT01036022|469552088|FG004|Overall Study|Physician Decision|0|||
130433983|NCT01036022|469552089|FG005|Overall Study|Physician Decision|0|||
130433984|NCT01036022|469552084|FG000|Overall Study|Withdrawal by Subject|0|||
130433985|NCT01036022|469552085|FG001|Overall Study|Withdrawal by Subject|0|||
130433986|NCT01036022|469552086|FG002|Overall Study|Withdrawal by Subject|0|||
130433987|NCT01036022|469552087|FG003|Overall Study|Withdrawal by Subject|1|||
130433988|NCT01036022|469552088|FG004|Overall Study|Withdrawal by Subject|2|||
130433989|NCT01036022|469552089|FG005|Overall Study|Withdrawal by Subject|0|||
130433990|NCT03300570|469552090|FG000|Overall Study|Adverse Event|0|||
130344614|NCT01119937|469232971|FG000|Overall Study|Withdrawal by Subject|2|||
130344615|NCT01119937|469232972|FG001|Overall Study|Withdrawal by Subject|1|||
130344616|NCT02536404|469232974|FG000|Overall Study|Adverse Event|5|||
130344617|NCT02536404|469232975|FG001|Overall Study|Adverse Event|0|||
130344618|NCT02536404|469232974|FG000|Overall Study|Withdrawal by Subject|4|||
130344619|NCT02536404|469232975|FG001|Overall Study|Withdrawal by Subject|1|||
130344620|NCT02536404|469232974|FG000|Overall Study|Physician Decision|10|||
130344621|NCT02536404|469232975|FG001|Overall Study|Physician Decision|0|||
130344622|NCT02536404|469232974|FG000|Overall Study|Sponsor decision|1|||
130433991|NCT03300570|469552091|FG001|Overall Study|Adverse Event|1|||
130344623|NCT02536404|469232975|FG001|Overall Study|Sponsor decision|0|||
130433992|NCT03300570|469552090|FG000|Overall Study|Withdrawal by Subject|1|||
130433993|NCT03300570|469552091|FG001|Overall Study|Withdrawal by Subject|0|||
130433994|NCT03300570|469552090|FG000|Overall Study|Inadequate bowel prep|1|||
130433995|NCT03300570|469552091|FG001|Overall Study|Inadequate bowel prep|0|||
130433996|NCT00576732|469552092|FG000|DOUBLE BLIND|Adverse Event|0|||
130433997|NCT00576732|469552093|FG001|DOUBLE BLIND|Adverse Event|0|||
130433998|NCT00576732|469552094|FG002|DOUBLE BLIND|Adverse Event|1|||
130433999|NCT00576732|469552095|FG003|DOUBLE BLIND|Adverse Event|0|||
130434000|NCT00576732|469552096|FG004|DOUBLE BLIND|Adverse Event|0|||
130434001|NCT00576732|469552097|FG005|DOUBLE BLIND|Adverse Event|0|||
130434002|NCT00576732|469552092|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
130434003|NCT00576732|469552093|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
130434004|NCT00576732|469552094|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
130434005|NCT00576732|469552095|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
130434006|NCT00576732|469552096|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
130434007|NCT00576732|469552097|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
130434008|NCT00576732|469552092|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
130434009|NCT00576732|469552093|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
130434010|NCT00576732|469552094|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
130434011|NCT00576732|469552095|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
130434012|NCT00576732|469552096|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
130434013|NCT00576732|469552097|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
130434014|NCT00576732|469552092|FG000|DOUBLE BLIND|OTHER|0|||
130434015|NCT00576732|469552093|FG001|DOUBLE BLIND|OTHER|2|||
130434016|NCT00576732|469552094|FG002|DOUBLE BLIND|OTHER|1|||
130434017|NCT00576732|469552095|FG003|DOUBLE BLIND|OTHER|0|||
130434018|NCT00576732|469552096|FG004|DOUBLE BLIND|OTHER|0|||
130434019|NCT00576732|469552097|FG005|DOUBLE BLIND|OTHER|0|||
130434020|NCT00576732|469552092|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
130434021|NCT00576732|469552093|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
130434022|NCT00576732|469552094|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
130434023|NCT00576732|469552095|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
130434024|NCT00576732|469552096|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
130434025|NCT00576732|469552097|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
130434026|NCT00576732|469552092|FG000|DOUBLE BLIND|Protocol Violation|1|||
130434027|NCT00576732|469552093|FG001|DOUBLE BLIND|Protocol Violation|0|||
130434028|NCT00576732|469552094|FG002|DOUBLE BLIND|Protocol Violation|0|||
130434029|NCT00576732|469552095|FG003|DOUBLE BLIND|Protocol Violation|0|||
130434030|NCT00576732|469552096|FG004|DOUBLE BLIND|Protocol Violation|0|||
130434031|NCT00576732|469552097|FG005|DOUBLE BLIND|Protocol Violation|0|||
130678760|NCT00863746|470450844|FG000|Treatment|Other|1|||
130678761|NCT00863746|470450845|FG001|Treatment|Other|0|||
130434032|NCT00576732|469552092|FG000|OPEN LABEL|Adverse Event|0|||
130434033|NCT00576732|469552093|FG001|OPEN LABEL|Adverse Event|0|||
130434034|NCT00576732|469552094|FG002|OPEN LABEL|Adverse Event|0|||
130434035|NCT00576732|469552095|FG003|OPEN LABEL|Adverse Event|4|||
130434036|NCT00576732|469552096|FG004|OPEN LABEL|Adverse Event|0|||
130434037|NCT00576732|469552097|FG005|OPEN LABEL|Adverse Event|1|||
130434038|NCT00576732|469552092|FG000|OPEN LABEL|Lost to Follow-up|0|||
130434039|NCT00576732|469552093|FG001|OPEN LABEL|Lost to Follow-up|0|||
130434040|NCT00576732|469552094|FG002|OPEN LABEL|Lost to Follow-up|0|||
130434041|NCT00576732|469552095|FG003|OPEN LABEL|Lost to Follow-up|2|||
130434042|NCT00576732|469552096|FG004|OPEN LABEL|Lost to Follow-up|1|||
130434043|NCT00576732|469552097|FG005|OPEN LABEL|Lost to Follow-up|1|||
130434044|NCT00576732|469552092|FG000|OPEN LABEL|Withdrawal by Subject|0|||
130434045|NCT00576732|469552093|FG001|OPEN LABEL|Withdrawal by Subject|0|||
130434046|NCT00576732|469552094|FG002|OPEN LABEL|Withdrawal by Subject|0|||
130434047|NCT00576732|469552095|FG003|OPEN LABEL|Withdrawal by Subject|1|||
130434048|NCT00576732|469552096|FG004|OPEN LABEL|Withdrawal by Subject|0|||
130434049|NCT00576732|469552097|FG005|OPEN LABEL|Withdrawal by Subject|1|||
130434050|NCT00576732|469552092|FG000|OPEN LABEL|OTHER|0|||
130434051|NCT00576732|469552093|FG001|OPEN LABEL|OTHER|0|||
130434052|NCT00576732|469552094|FG002|OPEN LABEL|OTHER|0|||
130434053|NCT00576732|469552095|FG003|OPEN LABEL|OTHER|0|||
130434054|NCT00576732|469552096|FG004|OPEN LABEL|OTHER|0|||
130434055|NCT00576732|469552097|FG005|OPEN LABEL|OTHER|2|||
130434056|NCT00576732|469552092|FG000|OPEN LABEL|Lack of Efficacy|0|||
130434057|NCT00576732|469552093|FG001|OPEN LABEL|Lack of Efficacy|0|||
130434058|NCT00576732|469552094|FG002|OPEN LABEL|Lack of Efficacy|0|||
130434059|NCT00576732|469552095|FG003|OPEN LABEL|Lack of Efficacy|2|||
130434060|NCT00576732|469552096|FG004|OPEN LABEL|Lack of Efficacy|2|||
130434061|NCT00576732|469552097|FG005|OPEN LABEL|Lack of Efficacy|3|||
130434062|NCT00576732|469552092|FG000|OPEN LABEL|Protocol Violation|0|||
130434063|NCT00576732|469552093|FG001|OPEN LABEL|Protocol Violation|0|||
130678762|NCT00863746|470450844|FG000|Survival Follow up|Death|244|||
130678763|NCT00863746|470450845|FG001|Survival Follow up|Death|271|||
130678764|NCT00863746|470450844|FG000|Survival Follow up|Lost to Follow-up|2|||
130678765|NCT00863746|470450845|FG001|Survival Follow up|Lost to Follow-up|1|||
130678766|NCT00863746|470450844|FG000|Survival Follow up|Consent Withdrawn|7|||
130434064|NCT00576732|469552094|FG002|OPEN LABEL|Protocol Violation|0|||
130434065|NCT00576732|469552095|FG003|OPEN LABEL|Protocol Violation|2|||
130434066|NCT00576732|469552096|FG004|OPEN LABEL|Protocol Violation|1|||
130434067|NCT00576732|469552097|FG005|OPEN LABEL|Protocol Violation|0|||
130434068|NCT03188120|469552099|FG000|Overall Study|Adverse Event|4|||
130434069|NCT03188120|469552099|FG000|Overall Study|Insufficient Effectiveness|8|||
130434070|NCT03188120|469552099|FG000|Overall Study|Improved|12|||
130434071|NCT03188120|469552099|FG000|Overall Study|Lost to Follow-up|7|||
130678767|NCT00863746|470450845|FG001|Survival Follow up|Consent Withdrawn|8|||
130678768|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
130434072|NCT03188120|469552099|FG000|Overall Study|Other than specified|3|||
130434073|NCT03188120|469552099|FG000|Overall Study|No visit after the first visit|13|||
130434074|NCT02978443|469552102|FG000|Overall Study|Withdrawal by Subject|1|||
130434075|NCT02978443|469552102|FG000|Overall Study|Adverse Event|3|||
130434076|NCT02978443|469552102|FG000|Overall Study|Disease Progression on study|6|||
130678769|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
130434077|NCT02978443|469552102|FG000|Overall Study|Death|1|||
130434078|NCT02978443|469552102|FG000|Overall Study|Physician Decision|1|||
130434079|NCT02978443|469552102|FG000|Overall Study|Switch to alternative therapy|1|||
130434080|NCT02978443|469552102|FG000|Overall Study|Refused further treatment|1|||
130434081|NCT03238300|469552107|FG000|Baseline (Before Intervention)|Physician Decision|0|||
130434082|NCT03238300|469552108|FG001|Baseline (Before Intervention)|Physician Decision|1|||
130434083|NCT03238300|469552107|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
130434084|NCT03238300|469552108|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
130434085|NCT03238300|469552107|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
130434086|NCT03238300|469552108|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
130434087|NCT03238300|469552107|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
130434088|NCT03238300|469552108|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
130434089|NCT01893827|469552110|FG000|Overall Study|Lost to Follow-up|19|||
130434090|NCT01893827|469552111|FG001|Overall Study|Lost to Follow-up|26|||
130434091|NCT02089230|469552113|FG000|Overall Study|Death|0|||
130434092|NCT02089230|469552114|FG001|Overall Study|Death|0|||
130434093|NCT02089230|469552115|FG002|Overall Study|Death|2|||
130434094|NCT02089230|469552113|FG000|Overall Study|Seeking Alternative Therapy|0|||
130434095|NCT02089230|469552114|FG001|Overall Study|Seeking Alternative Therapy|0|||
130434096|NCT02089230|469552115|FG002|Overall Study|Seeking Alternative Therapy|4|||
130434097|NCT03585296|469553748|FG000|Overall Study|Adverse Event|1|||
130434098|NCT03585296|469553748|FG000|Overall Study|Lost to Follow-up|2|||
130434099|NCT03585296|469553748|FG000|Overall Study|Withdrawal by Subject|2|||
130434100|NCT00462670|469553749|FG000|Overall Study|Adverse Event|3|||
130434101|NCT00462670|469553750|FG001|Overall Study|Adverse Event|5|||
130434102|NCT00462670|469553749|FG000|Overall Study|Lack of Efficacy|1|||
130434103|NCT00462670|469553750|FG001|Overall Study|Lack of Efficacy|0|||
130434104|NCT00462670|469553749|FG000|Overall Study|Protocol Violation|1|||
130434105|NCT00462670|469553750|FG001|Overall Study|Protocol Violation|0|||
130434106|NCT00462670|469553749|FG000|Overall Study|Resolution of signs and symptoms|0|||
130434107|NCT00462670|469553750|FG001|Overall Study|Resolution of signs and symptoms|2|||
130434108|NCT02110732|469553751|FG000|Overall Study|Physician Decision|5|||
130434109|NCT02110732|469553752|FG001|Overall Study|Physician Decision|2|||
130434110|NCT02110732|469553751|FG000|Overall Study|Lost to Follow-up|1|||
130434111|NCT02110732|469553752|FG001|Overall Study|Lost to Follow-up|1|||
130434112|NCT00633932|469553753|FG000|Overall Study|Adverse Event|1|||
130434113|NCT00633932|469553754|FG001|Overall Study|Adverse Event|3|||
130434114|NCT00633932|469553755|FG002|Overall Study|Adverse Event|4|||
130434115|NCT00633932|469553753|FG000|Overall Study|Withdrawal by Subject|3|||
130434116|NCT00633932|469553754|FG001|Overall Study|Withdrawal by Subject|9|||
130434117|NCT00633932|469553755|FG002|Overall Study|Withdrawal by Subject|1|||
130434118|NCT00633932|469553753|FG000|Overall Study|Lost to Follow-up|1|||
130434119|NCT00633932|469553754|FG001|Overall Study|Lost to Follow-up|0|||
130434120|NCT00633932|469553755|FG002|Overall Study|Lost to Follow-up|2|||
130434121|NCT00633932|469553753|FG000|Overall Study|Protocol Violation|5|||
130434122|NCT00633932|469553754|FG001|Overall Study|Protocol Violation|2|||
130434123|NCT00633932|469553755|FG002|Overall Study|Protocol Violation|3|||
130434124|NCT00633932|469553753|FG000|Overall Study|Physician Decision|0|||
130434125|NCT00633932|469553754|FG001|Overall Study|Physician Decision|0|||
130434126|NCT00633932|469553755|FG002|Overall Study|Physician Decision|1|||
130434127|NCT00633932|469553753|FG000|Overall Study|Doctor's judgement|1|||
130434128|NCT00633932|469553754|FG001|Overall Study|Doctor's judgement|0|||
130434129|NCT00633932|469553755|FG002|Overall Study|Doctor's judgement|0|||
130434130|NCT00633932|469553753|FG000|Overall Study|Moved Away|1|||
130434131|NCT00633932|469553754|FG001|Overall Study|Moved Away|0|||
130434132|NCT00633932|469553755|FG002|Overall Study|Moved Away|0|||
130434133|NCT00482274|469553757|FG000|Overall Study|Adverse Event|1|||
130434134|NCT04836858|469553758|FG000|Overall Study|Adverse Event|0|||
130678770|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
130678771|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
130678772|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
130678773|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
130678774|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
130678775|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
130678776|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
130434135|NCT04836858|469553759|FG001|Overall Study|Adverse Event|0|||
130434136|NCT04836858|469553760|FG002|Overall Study|Adverse Event|0|||
130434137|NCT04836858|469553761|FG003|Overall Study|Adverse Event|1|||
130434138|NCT04836858|469553758|FG000|Overall Study|Lost to Follow-up|1|||
130434139|NCT04836858|469553759|FG001|Overall Study|Lost to Follow-up|0|||
130434140|NCT04836858|469553760|FG002|Overall Study|Lost to Follow-up|0|||
130434141|NCT04836858|469553761|FG003|Overall Study|Lost to Follow-up|0|||
130434142|NCT04836858|469553758|FG000|Overall Study|Subject/Guardian decision|3|||
130434143|NCT04836858|469553759|FG001|Overall Study|Subject/Guardian decision|0|||
130434144|NCT04836858|469553760|FG002|Overall Study|Subject/Guardian decision|0|||
130434145|NCT04836858|469553761|FG003|Overall Study|Subject/Guardian decision|1|||
130434146|NCT04836858|469553758|FG000|Overall Study|Randomized but not treated|4|||
130552775|NCT00719563|469991531|FG001|Overall Study|Noncompliant|1|||
130678777|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
130344624|NCT00770146|469232976|FG000|Treatment Period|Withdrawal by Subject|6|||
130344625|NCT00770146|469232977|FG001|Treatment Period|Withdrawal by Subject|13|||
130344626|NCT00770146|469232976|FG000|Treatment Period|Adverse Event|2|||
130344627|NCT00770146|469232977|FG001|Treatment Period|Adverse Event|26|||
130344628|NCT00770146|469232976|FG000|Treatment Period|Other|1|||
130344629|NCT00770146|469232977|FG001|Treatment Period|Other|5|||
130344630|NCT00770146|469232976|FG000|Treatment Period|Protocol non-compliance|0|||
130344631|NCT00770146|469232977|FG001|Treatment Period|Protocol non-compliance|1|||
130344632|NCT00770146|469232976|FG000|Follow-up Period|Withdrawal by Subject|7|||
130344633|NCT00770146|469232977|FG001|Follow-up Period|Withdrawal by Subject|13|||
130344634|NCT00770146|469232976|FG000|Follow-up Period|Adverse Event|0|||
130344635|NCT00770146|469232977|FG001|Follow-up Period|Adverse Event|2|||
130344636|NCT00770146|469232976|FG000|Follow-up Period|Other|4|||
130344637|NCT00770146|469232977|FG001|Follow-up Period|Other|5|||
130344638|NCT00816023|469232981|FG000|Overall Study|Lost to Follow-up|1|||
130344639|NCT00816023|469232982|FG001|Overall Study|Lost to Follow-up|1|||
130344640|NCT00816023|469232983|FG002|Overall Study|Lost to Follow-up|0|||
130344641|NCT00816023|469232984|FG003|Overall Study|Lost to Follow-up|0|||
130344642|NCT00816023|469232981|FG000|Overall Study|Withdrawal by Subject|1|||
130344643|NCT00816023|469232982|FG001|Overall Study|Withdrawal by Subject|0|||
130344644|NCT00816023|469232983|FG002|Overall Study|Withdrawal by Subject|0|||
130344645|NCT00816023|469232984|FG003|Overall Study|Withdrawal by Subject|0|||
130344646|NCT00816023|469232981|FG000|Overall Study|Physician Decision|0|||
130344647|NCT00816023|469232982|FG001|Overall Study|Physician Decision|0|||
130344648|NCT00816023|469232983|FG002|Overall Study|Physician Decision|1|||
130344649|NCT00816023|469232984|FG003|Overall Study|Physician Decision|0|||
130344650|NCT00816023|469232981|FG000|Overall Study|assessments complete prior to window|1|||
130344651|NCT00816023|469232982|FG001|Overall Study|assessments complete prior to window|1|||
130344652|NCT00816023|469232983|FG002|Overall Study|assessments complete prior to window|2|||
130344653|NCT00816023|469232984|FG003|Overall Study|assessments complete prior to window|1|||
130344654|NCT00816023|469232981|FG000|Overall Study|Randomized Not Treated|6|||
130344655|NCT00816023|469232982|FG001|Overall Study|Randomized Not Treated|4|||
130344656|NCT00816023|469232983|FG002|Overall Study|Randomized Not Treated|6|||
130344657|NCT00816023|469232984|FG003|Overall Study|Randomized Not Treated|11|||
130344658|NCT01525901|469232985|FG000|Period 2: 12 Weeks|Adverse Event|0|||
130344659|NCT01525901|469232986|FG001|Period 2: 12 Weeks|Adverse Event|1|||
130344660|NCT01525901|469232987|FG002|Period 2: 12 Weeks|Adverse Event|0|||
130344661|NCT01525901|469232988|FG003|Period 2: 12 Weeks|Adverse Event|0|||
130344662|NCT05027971|469232993|FG000|Overall Study|Physician Decision|7|||
130344663|NCT05027971|469232994|FG001|Overall Study|Physician Decision|3|||
130344664|NCT05027971|469232993|FG000|Overall Study|Lost to Follow-up|1|||
130344665|NCT05027971|469232994|FG001|Overall Study|Lost to Follow-up|1|||
130344666|NCT05027971|469232993|FG000|Overall Study|Withdrawal by Subject|0|||
130344667|NCT05027971|469232994|FG001|Overall Study|Withdrawal by Subject|2|||
130344668|NCT05027971|469232993|FG000|Overall Study|Non-study fiber used.|0|||
130344669|NCT05027971|469232994|FG001|Overall Study|Non-study fiber used.|1|||
130344670|NCT05027971|469232993|FG000|Overall Study|Protocol Violation|0|||
130344671|NCT05027971|469232994|FG001|Overall Study|Protocol Violation|2|||
130344672|NCT02486627|469232995|FG000|Overall Study|Death|1|||
130344673|NCT02486627|469232996|FG001|Overall Study|Death|0|||
130344674|NCT02486627|469232995|FG000|Overall Study|Other Unspecified|0|||
130344675|NCT02486627|469232996|FG001|Overall Study|Other Unspecified|2|||
130344676|NCT02486627|469232995|FG000|Overall Study|Consent Withdrawn by Participant|4|||
130344677|NCT02486627|469232996|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130344678|NCT02486627|469232995|FG000|Overall Study|Significant Participant Noncompliance|1|||
130344679|NCT02486627|469232996|FG001|Overall Study|Significant Participant Noncompliance|1|||
130344680|NCT02486627|469232995|FG000|Overall Study|Lost to Follow-up|1|||
130344681|NCT02486627|469232996|FG001|Overall Study|Lost to Follow-up|3|||
130344682|NCT01073462|469232998|FG000|Overall Study|Death|14|||
130344683|NCT01073462|469232998|FG000|Overall Study|Kidney transplant|10|||
130344684|NCT01073462|469232998|FG000|Overall Study|Low parathyroid hormone levels|8|||
130344685|NCT01073462|469232998|FG000|Overall Study|Serious adverse event|2|||
130344686|NCT01073462|469232998|FG000|Overall Study|Lost to Follow-up|7|||
130344687|NCT01238588|469232999|FG000|Overall Study|Withdrawal by Subject|1|||
130344688|NCT01238588|469232999|FG000|Overall Study|Physician Decision|2|||
130434147|NCT04836858|469553759|FG001|Overall Study|Randomized but not treated|0|||
130434148|NCT04836858|469553760|FG002|Overall Study|Randomized but not treated|0|||
130434149|NCT04836858|469553761|FG003|Overall Study|Randomized but not treated|0|||
130344689|NCT05395091|469233002|FG000|Baseline to Month 12|Adverse Event|7|||
130344690|NCT05395091|469233003|FG001|Baseline to Month 12|Adverse Event|2|||
130344691|NCT05395091|469233004|FG002|Baseline to Month 12|Adverse Event|0|||
130344692|NCT05395091|469233002|FG000|Baseline to Month 12|Death|3|||
130344693|NCT05395091|469233003|FG001|Baseline to Month 12|Death|1|||
130344694|NCT05395091|469233004|FG002|Baseline to Month 12|Death|0|||
130344695|NCT05395091|469233002|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
130344696|NCT05395091|469233003|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
130344697|NCT05395091|469233004|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
130344698|NCT05395091|469233002|FG000|Baseline to Month 12|Protocol Violation|2|||
130344699|NCT05395091|469233003|FG001|Baseline to Month 12|Protocol Violation|3|||
130344700|NCT05395091|469233004|FG002|Baseline to Month 12|Protocol Violation|0|||
130344701|NCT05395091|469233002|FG000|Baseline to Month 12|Physician Decision|1|||
130344702|NCT05395091|469233003|FG001|Baseline to Month 12|Physician Decision|0|||
130344703|NCT05395091|469233004|FG002|Baseline to Month 12|Physician Decision|0|||
130344704|NCT05395091|469233002|FG000|Month 12 to Month 18|Death|1|||
130344705|NCT05395091|469233003|FG001|Month 12 to Month 18|Death|0|||
130344706|NCT05395091|469233004|FG002|Month 12 to Month 18|Death|0|||
130344707|NCT05395091|469233002|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
130344708|NCT05395091|469233003|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
130344709|NCT05395091|469233004|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
130344710|NCT05395091|469233002|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
130344711|NCT05395091|469233003|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
130344712|NCT05395091|469233004|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
130344713|NCT05395091|469233002|FG000|Month 12 to Month 18|Other reasons|0|||
130344714|NCT05395091|469233003|FG001|Month 12 to Month 18|Other reasons|0|||
130344715|NCT05395091|469233004|FG002|Month 12 to Month 18|Other reasons|1|||
130344716|NCT03554486|469233005|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
130344717|NCT03554486|469233006|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130344718|NCT03554486|469233007|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130344719|NCT03554486|469233005|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
130344720|NCT03554486|469233006|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130344721|NCT03554486|469233007|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130344722|NCT03554486|469233005|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130344723|NCT03554486|469233006|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130344724|NCT03554486|469233007|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130344725|NCT01509053|469233008|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
130344726|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
130344727|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
130344728|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
130344729|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
130344730|NCT01509053|469233008|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
130344731|NCT01915303|469233009|FG000|Core Phase|Adverse Event|7|||
130344732|NCT01915303|469233009|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
130344733|NCT01915303|469233009|FG000|Core Phase|Death|2|||
130344734|NCT01915303|469233009|FG000|Core Phase|Protocol Violation|2|||
130344735|NCT01915303|469233009|FG000|Core Phase|Abnormal lab value|1|||
130344736|NCT01915303|469233009|FG000|Core Phase|Withdrawal by Subject|1|||
130344737|NCT01915303|469233009|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130344738|NCT01915303|469233009|FG000|Extension Phase|Withdrawal by Subject|4|||
130344739|NCT01915303|469233009|FG000|Extension Phase|Adverse Event|3|||
130344740|NCT01915303|469233009|FG000|Extension Phase|Death|1|||
130344741|NCT01915303|469233009|FG000|Extension Phase|Protocol Violation|1|||
130344742|NCT02925338|469233010|FG000|Overall Study|Death|0|||
130344743|NCT02925338|469233011|FG001|Overall Study|Death|2|||
130344744|NCT02925338|469233012|FG002|Overall Study|Death|1|||
130344745|NCT02925338|469233013|FG003|Overall Study|Death|0|||
130344746|NCT02925338|469233014|FG004|Overall Study|Death|0|||
130344747|NCT02925338|469233010|FG000|Overall Study|Lost to Follow-up|30|||
130344748|NCT02925338|469233011|FG001|Overall Study|Lost to Follow-up|10|||
130344749|NCT02925338|469233012|FG002|Overall Study|Lost to Follow-up|1|||
130344750|NCT02925338|469233013|FG003|Overall Study|Lost to Follow-up|16|||
130344751|NCT02925338|469233014|FG004|Overall Study|Lost to Follow-up|3|||
130344752|NCT02925338|469233010|FG000|Overall Study|Withdrawal by Subject|3|||
130344753|NCT02925338|469233011|FG001|Overall Study|Withdrawal by Subject|0|||
130344754|NCT02925338|469233012|FG002|Overall Study|Withdrawal by Subject|3|||
130344755|NCT02925338|469233013|FG003|Overall Study|Withdrawal by Subject|2|||
130344756|NCT02925338|469233014|FG004|Overall Study|Withdrawal by Subject|2|||
130344757|NCT02925338|469233010|FG000|Overall Study|Missing|38|||
130344758|NCT02925338|469233011|FG001|Overall Study|Missing|27|||
130344759|NCT02925338|469233012|FG002|Overall Study|Missing|0|||
130344760|NCT02925338|469233013|FG003|Overall Study|Missing|3|||
130344761|NCT02925338|469233014|FG004|Overall Study|Missing|2|||
130344762|NCT02925338|469233010|FG000|Overall Study|Participant's Decision|11|||
130344763|NCT02925338|469233011|FG001|Overall Study|Participant's Decision|7|||
130344764|NCT02925338|469233012|FG002|Overall Study|Participant's Decision|3|||
130344765|NCT02925338|469233013|FG003|Overall Study|Participant's Decision|8|||
130344766|NCT02925338|469233014|FG004|Overall Study|Participant's Decision|1|||
130344767|NCT02925338|469233010|FG000|Overall Study|Treatment Discontinuation|144|||
130344768|NCT02925338|469233011|FG001|Overall Study|Treatment Discontinuation|65|||
130344769|NCT02925338|469233012|FG002|Overall Study|Treatment Discontinuation|56|||
130344770|NCT02925338|469233013|FG003|Overall Study|Treatment Discontinuation|131|||
130344771|NCT02925338|469233014|FG004|Overall Study|Treatment Discontinuation|22|||
130678778|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
130678779|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
130678780|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
130678781|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
130678782|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
130678783|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
130678784|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678785|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678786|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678787|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678788|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
130678789|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130344772|NCT00636363|469233017|FG000|Overall Study|Conjunctivitis|0|||
130344773|NCT00636363|469233018|FG001|Overall Study|Conjunctivitis|0|||
130344774|NCT00636363|469233019|FG002|Overall Study|Conjunctivitis|1|||
130344775|NCT00636363|469233017|FG000|Overall Study|Adverse Event|0|||
130344776|NCT00636363|469233018|FG001|Overall Study|Adverse Event|0|||
130344777|NCT00636363|469233019|FG002|Overall Study|Adverse Event|1|||
130344778|NCT00636363|469233017|FG000|Overall Study|Positive slit lamp finding|0|||
130344779|NCT00636363|469233018|FG001|Overall Study|Positive slit lamp finding|2|||
130344780|NCT00636363|469233019|FG002|Overall Study|Positive slit lamp finding|1|||
130344781|NCT00636363|469233017|FG000|Overall Study|Study related symptoms/complaints|8|||
130344782|NCT00636363|469233018|FG001|Overall Study|Study related symptoms/complaints|7|||
130344783|NCT00636363|469233019|FG002|Overall Study|Study related symptoms/complaints|4|||
130344784|NCT00636363|469233017|FG000|Overall Study|Met ineligibility criteria|0|||
130344785|NCT00636363|469233018|FG001|Overall Study|Met ineligibility criteria|0|||
130344786|NCT00636363|469233019|FG002|Overall Study|Met ineligibility criteria|3|||
130344787|NCT00636363|469233017|FG000|Overall Study|Missed > 1 visit|0|||
130344788|NCT00636363|469233018|FG001|Overall Study|Missed > 1 visit|1|||
130344789|NCT00636363|469233019|FG002|Overall Study|Missed > 1 visit|3|||
130344790|NCT00636363|469233017|FG000|Overall Study|Lack of motivation|1|||
130344791|NCT00636363|469233018|FG001|Overall Study|Lack of motivation|0|||
130344792|NCT00636363|469233019|FG002|Overall Study|Lack of motivation|1|||
130344793|NCT00636363|469233017|FG000|Overall Study|Protocol Violation|0|||
130344794|NCT00636363|469233018|FG001|Overall Study|Protocol Violation|3|||
130344795|NCT00636363|469233019|FG002|Overall Study|Protocol Violation|0|||
130344796|NCT00636363|469233017|FG000|Overall Study|Lost to Follow-up|3|||
130344797|NCT00636363|469233018|FG001|Overall Study|Lost to Follow-up|4|||
130344798|NCT00636363|469233019|FG002|Overall Study|Lost to Follow-up|2|||
130344799|NCT00636363|469233017|FG000|Overall Study|Withdrawal by Subject|1|||
130344800|NCT00636363|469233018|FG001|Overall Study|Withdrawal by Subject|3|||
130344801|NCT00636363|469233019|FG002|Overall Study|Withdrawal by Subject|2|||
130344802|NCT00280748|469233021|FG000|Overall Study|Decline in performance|3|||
130344803|NCT00280748|469233021|FG000|Overall Study|Extra-cranial disease progression|1|||
130344804|NCT01433250|469233023|FG000|Overall Study|Protocol Violation|0|||
130344805|NCT01433250|469233024|FG001|Overall Study|Protocol Violation|1|||
130344806|NCT01433250|469233023|FG000|Overall Study|Withdrawal by Subject|3|||
130344807|NCT01433250|469233024|FG001|Overall Study|Withdrawal by Subject|2|||
130344808|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130344809|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
130344810|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
130344811|NCT02730793|469233029|FG000|Overall Study|Physician Decision|0|||
130344812|NCT02730793|469233030|FG001|Overall Study|Physician Decision|1|||
130344813|NCT02730793|469233029|FG000|Overall Study|Withdrawal by Subject|0|||
130344814|NCT02730793|469233030|FG001|Overall Study|Withdrawal by Subject|1|||
130344815|NCT00534313|469233032|FG000|Short-term Period|Adverse Event|1|||
130344816|NCT00534313|469233033|FG001|Short-term Period|Adverse Event|2|||
130344817|NCT00534313|469233034|FG002|Short-term Period|Adverse Event|1|||
130344818|NCT00534313|469233035|FG003|Short-term Period|Adverse Event|3|||
130344819|NCT00534313|469233032|FG000|Short-term Period|Lack of Efficacy|3|||
130344820|NCT00534313|469233033|FG001|Short-term Period|Lack of Efficacy|4|||
130344821|NCT00534313|469233034|FG002|Short-term Period|Lack of Efficacy|0|||
130344822|NCT00534313|469233035|FG003|Short-term Period|Lack of Efficacy|3|||
130434150|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
130434151|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
130344823|NCT00534313|469233032|FG000|Short-term Period|Participant not meeting study criteria|0|||
130344824|NCT00534313|469233033|FG001|Short-term Period|Participant not meeting study criteria|0|||
130344825|NCT00534313|469233034|FG002|Short-term Period|Participant not meeting study criteria|0|||
130344826|NCT00534313|469233035|FG003|Short-term Period|Participant not meeting study criteria|1|||
130344827|NCT00534313|469233032|FG000|Short-term Period|Participant withdrew consent|2|||
130344828|NCT00534313|469233033|FG001|Short-term Period|Participant withdrew consent|0|||
130344829|NCT00534313|469233034|FG002|Short-term Period|Participant withdrew consent|0|||
130344830|NCT00534313|469233035|FG003|Short-term Period|Participant withdrew consent|2|||
130434152|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Adverse Event|2|||
130434153|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Adverse Event|5|||
130434154|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
130434155|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
130434156|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
130434157|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
130434158|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Randomized by error|0|||
130434159|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Randomized by error|5|||
130434160|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
130434161|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
130434162|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
130434163|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
130434164|NCT02948959|469553762|FG000|52 Weeks Treatment Period|Change of residence location|0|||
130434165|NCT02948959|469553763|FG001|52 Weeks Treatment Period|Change of residence location|1|||
130434166|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
130434167|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
130434168|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
130434169|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
130434170|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
130434171|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
130434172|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
130434173|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
130434174|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
130434175|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
130434176|NCT02948959|469553762|FG000|12 Weeks Follow-up Period|Study site closure|1|||
130434177|NCT02948959|469553763|FG001|12 Weeks Follow-up Period|Study site closure|0|||
130434178|NCT00810082|469553766|FG000|Overall Study|Lost to Follow-up|0|||
130434179|NCT00810082|469553767|FG001|Overall Study|Lost to Follow-up|4|||
130434180|NCT02508532|469553770|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434181|NCT02508532|469553771|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434182|NCT02508532|469553772|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434183|NCT02508532|469553773|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434184|NCT02508532|469553774|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434185|NCT02508532|469553775|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434186|NCT02508532|469553776|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
130434187|NCT02508532|469553777|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434188|NCT02508532|469553778|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130434189|NCT02508532|469553770|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434190|NCT02508532|469553771|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434191|NCT02508532|469553772|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434192|NCT02508532|469553773|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434193|NCT02508532|469553774|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434194|NCT02508532|469553775|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434195|NCT02508532|469553776|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434196|NCT02508532|469553777|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
130434197|NCT02508532|469553778|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
130434198|NCT02508532|469553770|FG000|Part 2 - Treatment|Disease Progression|0|||
130434199|NCT02508532|469553771|FG001|Part 2 - Treatment|Disease Progression|0|||
130434200|NCT02508532|469553772|FG002|Part 2 - Treatment|Disease Progression|0|||
130434201|NCT02508532|469553773|FG003|Part 2 - Treatment|Disease Progression|0|||
130434202|NCT02508532|469553774|FG004|Part 2 - Treatment|Disease Progression|0|||
130434203|NCT02508532|469553775|FG005|Part 2 - Treatment|Disease Progression|0|||
130434204|NCT02508532|469553776|FG006|Part 2 - Treatment|Disease Progression|0|||
130434205|NCT02508532|469553777|FG007|Part 2 - Treatment|Disease Progression|0|||
130434206|NCT02508532|469553778|FG008|Part 2 - Treatment|Disease Progression|118|||
130434207|NCT02508532|469553770|FG000|Part 2 - Treatment|Adverse Event|0|||
130434208|NCT02508532|469553771|FG001|Part 2 - Treatment|Adverse Event|0|||
130434209|NCT02508532|469553772|FG002|Part 2 - Treatment|Adverse Event|0|||
130434210|NCT02508532|469553773|FG003|Part 2 - Treatment|Adverse Event|0|||
130434211|NCT02508532|469553774|FG004|Part 2 - Treatment|Adverse Event|0|||
130434212|NCT02508532|469553775|FG005|Part 2 - Treatment|Adverse Event|0|||
130434213|NCT02508532|469553776|FG006|Part 2 - Treatment|Adverse Event|0|||
130434214|NCT02508532|469553777|FG007|Part 2 - Treatment|Adverse Event|0|||
130434215|NCT02508532|469553778|FG008|Part 2 - Treatment|Adverse Event|49|||
130434216|NCT02508532|469553770|FG000|Part 2 - Treatment|Physician Decision|0|||
130678790|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130434217|NCT02508532|469553771|FG001|Part 2 - Treatment|Physician Decision|0|||
130434218|NCT02508532|469553772|FG002|Part 2 - Treatment|Physician Decision|0|||
130678791|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130678792|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130678793|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678794|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678795|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678796|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
130678797|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678798|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130678799|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
130678800|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
130678801|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
130678802|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130678803|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130678804|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
130344831|NCT00534313|469233032|FG000|Short-term Period|Pregnancy|0|||
130344832|NCT00534313|469233033|FG001|Short-term Period|Pregnancy|0|||
130344833|NCT00534313|469233034|FG002|Short-term Period|Pregnancy|1|||
130344834|NCT00534313|469233035|FG003|Short-term Period|Pregnancy|0|||
130344835|NCT00534313|469233032|FG000|Long-term Period|Adverse Event|2|||
130344836|NCT00534313|469233033|FG001|Long-term Period|Adverse Event|1|||
130344837|NCT00534313|469233034|FG002|Long-term Period|Adverse Event|0|||
130344838|NCT00534313|469233035|FG003|Long-term Period|Adverse Event|1|||
130344839|NCT00534313|469233032|FG000|Long-term Period|Lack of Efficacy|14|||
130344840|NCT00534313|469233033|FG001|Long-term Period|Lack of Efficacy|10|||
130344841|NCT00534313|469233034|FG002|Long-term Period|Lack of Efficacy|14|||
130344842|NCT00534313|469233035|FG003|Long-term Period|Lack of Efficacy|12|||
130344843|NCT00534313|469233032|FG000|Long-term Period|Lost to Follow-up|1|||
130344844|NCT00534313|469233033|FG001|Long-term Period|Lost to Follow-up|2|||
130344845|NCT00534313|469233034|FG002|Long-term Period|Lost to Follow-up|0|||
130344846|NCT00534313|469233035|FG003|Long-term Period|Lost to Follow-up|0|||
130344847|NCT00534313|469233032|FG000|Long-term Period|Withdrawal by Subject|2|||
130344848|NCT00534313|469233033|FG001|Long-term Period|Withdrawal by Subject|2|||
130344849|NCT00534313|469233034|FG002|Long-term Period|Withdrawal by Subject|0|||
130344850|NCT00534313|469233035|FG003|Long-term Period|Withdrawal by Subject|0|||
130344851|NCT00534313|469233032|FG000|Long-term Period|No longer meets study criteria|0|||
130344852|NCT00534313|469233033|FG001|Long-term Period|No longer meets study criteria|1|||
130344853|NCT00534313|469233034|FG002|Long-term Period|No longer meets study criteria|0|||
130344854|NCT00534313|469233035|FG003|Long-term Period|No longer meets study criteria|0|||
130344855|NCT00534313|469233032|FG000|Long-term Period|Poor compliance/noncompliance|0|||
130344856|NCT00534313|469233033|FG001|Long-term Period|Poor compliance/noncompliance|1|||
130344857|NCT00534313|469233034|FG002|Long-term Period|Poor compliance/noncompliance|1|||
130344858|NCT00534313|469233035|FG003|Long-term Period|Poor compliance/noncompliance|0|||
130344859|NCT00534313|469233032|FG000|Long-term Period|Administrative reason by sponsor|17|||
130344860|NCT00534313|469233033|FG001|Long-term Period|Administrative reason by sponsor|15|||
130344861|NCT00534313|469233034|FG002|Long-term Period|Administrative reason by sponsor|26|||
130344862|NCT00534313|469233035|FG003|Long-term Period|Administrative reason by sponsor|18|||
130344863|NCT00534313|469233032|FG000|Long-term Period|Other|1|||
130344864|NCT00534313|469233033|FG001|Long-term Period|Other|2|||
130344865|NCT00534313|469233034|FG002|Long-term Period|Other|2|||
130344866|NCT00534313|469233035|FG003|Long-term Period|Other|2|||
130344867|NCT00927940|469233037|FG000|Overall Study|Death|1|||
130344868|NCT03007888|469233038|FG000|First Intervention (14 Days)|Adverse Event|1|||
130344869|NCT03007888|469233039|FG001|First Intervention (14 Days)|Adverse Event|0|||
130344870|NCT00043550|469233042|FG000|Overall Study|Withdrawal by Subject|22|||
130344871|NCT00043550|469233043|FG001|Overall Study|Withdrawal by Subject|12|||
130344872|NCT00043550|469233044|FG002|Overall Study|Withdrawal by Subject|20|||
130344873|NCT00436501|469233048|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
130344874|NCT00436501|469233049|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
130344875|NCT00436501|469233048|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
130344876|NCT00436501|469233049|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
130344877|NCT00217464|469233053|FG000|Overall Study|Progression|15|||
130344878|NCT00217464|469233053|FG000|Overall Study|Other|2|||
130678805|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
130678806|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130216610|NCT05305989|468755617|FG001|Overall Study|Adverse Event|1|||
130344879|NCT01089361|469233054|FG000|Overall Study|Death|1|||
130344880|NCT01089361|469233055|FG001|Overall Study|Death|0|||
130344881|NCT01576159|469233056|FG000|Overall Study|Withdrawal by Subject|0|||
130344882|NCT01576159|469233057|FG001|Overall Study|Withdrawal by Subject|1|||
130344883|NCT01576159|469233058|FG002|Overall Study|Withdrawal by Subject|0|||
130344884|NCT01576159|469233059|FG003|Overall Study|Withdrawal by Subject|0|||
130678807|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130344885|NCT01576159|469233056|FG000|Overall Study|Physician Decision|0|||
130344886|NCT01576159|469233057|FG001|Overall Study|Physician Decision|0|||
130344887|NCT01576159|469233058|FG002|Overall Study|Physician Decision|1|||
130678808|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130678809|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
130678810|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
130678811|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
130678812|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130678813|NCT03444038|470450852|FG000|Overall Study|Adverse Event|12|||
130678814|NCT03444038|470450852|FG000|Overall Study|Withdrawal by Subject|7|||
130678815|NCT03444038|470450852|FG000|Overall Study|Lost to Follow-up|1|||
130678816|NCT03444038|470450852|FG000|Overall Study|Physician Decision|2|||
130678817|NCT03444038|470450852|FG000|Overall Study|Lack of Efficacy|7|||
130678818|NCT00264797|470450856|FG000|Overall Study|Withdrawal by Subject|11|||
130678819|NCT00264797|470450857|FG001|Overall Study|Withdrawal by Subject|11|||
130678820|NCT00264797|470450856|FG000|Overall Study|Lost to Follow-up|9|||
130678821|NCT00264797|470450857|FG001|Overall Study|Lost to Follow-up|17|||
130678822|NCT00264797|470450856|FG000|Overall Study|Moved from area|3|||
130678823|NCT00264797|470450857|FG001|Overall Study|Moved from area|1|||
130678824|NCT00264797|470450856|FG000|Overall Study|Practical Problems|2|||
130678825|NCT00264797|470450857|FG001|Overall Study|Practical Problems|3|||
130678826|NCT00264797|470450856|FG000|Overall Study|Incarceration|4|||
130678827|NCT00264797|470450857|FG001|Overall Study|Incarceration|5|||
130678828|NCT00264797|470450856|FG000|Overall Study|Pressure/advice from Outsiders|1|||
130434219|NCT02508532|469553773|FG003|Part 2 - Treatment|Physician Decision|0|||
130434220|NCT02508532|469553774|FG004|Part 2 - Treatment|Physician Decision|0|||
130434221|NCT02508532|469553775|FG005|Part 2 - Treatment|Physician Decision|0|||
130434222|NCT02508532|469553776|FG006|Part 2 - Treatment|Physician Decision|0|||
130434223|NCT02508532|469553777|FG007|Part 2 - Treatment|Physician Decision|0|||
130434224|NCT02508532|469553778|FG008|Part 2 - Treatment|Physician Decision|12|||
130434225|NCT02508532|469553770|FG000|Part 2 - Treatment|Administrative|0|||
130434226|NCT02508532|469553771|FG001|Part 2 - Treatment|Administrative|0|||
130434227|NCT02508532|469553772|FG002|Part 2 - Treatment|Administrative|0|||
130678829|NCT00264797|470450857|FG001|Overall Study|Pressure/advice from Outsiders|1|||
130678830|NCT00264797|470450856|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
130678831|NCT00264797|470450857|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
130678832|NCT00264797|470450856|FG000|Overall Study|Other|3|||
130678833|NCT00264797|470450857|FG001|Overall Study|Other|4|||
130678834|NCT01153984|470450858|FG000|Overall Study|Withdrawal by Subject|1|||
130434228|NCT02508532|469553773|FG003|Part 2 - Treatment|Administrative|0|||
130434229|NCT02508532|469553774|FG004|Part 2 - Treatment|Administrative|0|||
130434230|NCT02508532|469553775|FG005|Part 2 - Treatment|Administrative|0|||
130434231|NCT02508532|469553776|FG006|Part 2 - Treatment|Administrative|0|||
130434232|NCT02508532|469553777|FG007|Part 2 - Treatment|Administrative|0|||
130434233|NCT02508532|469553778|FG008|Part 2 - Treatment|Administrative|3|||
130434234|NCT02508532|469553770|FG000|Part 2 - Treatment|Sponsor Decision|0|||
130434235|NCT02508532|469553771|FG001|Part 2 - Treatment|Sponsor Decision|0|||
130434236|NCT02508532|469553772|FG002|Part 2 - Treatment|Sponsor Decision|0|||
130434237|NCT02508532|469553773|FG003|Part 2 - Treatment|Sponsor Decision|0|||
130434238|NCT02508532|469553774|FG004|Part 2 - Treatment|Sponsor Decision|0|||
130434239|NCT02508532|469553775|FG005|Part 2 - Treatment|Sponsor Decision|0|||
130434240|NCT02508532|469553776|FG006|Part 2 - Treatment|Sponsor Decision|0|||
130434241|NCT02508532|469553777|FG007|Part 2 - Treatment|Sponsor Decision|0|||
130434242|NCT02508532|469553778|FG008|Part 2 - Treatment|Sponsor Decision|28|||
130434243|NCT02508532|469553770|FG000|Part 2 - Treatment|Death|0|||
130434244|NCT02508532|469553771|FG001|Part 2 - Treatment|Death|0|||
130434245|NCT02508532|469553772|FG002|Part 2 - Treatment|Death|0|||
130434246|NCT02508532|469553773|FG003|Part 2 - Treatment|Death|0|||
130434247|NCT02508532|469553774|FG004|Part 2 - Treatment|Death|0|||
130434248|NCT02508532|469553775|FG005|Part 2 - Treatment|Death|0|||
130434249|NCT02508532|469553776|FG006|Part 2 - Treatment|Death|0|||
130434250|NCT02508532|469553777|FG007|Part 2 - Treatment|Death|0|||
130434251|NCT02508532|469553778|FG008|Part 2 - Treatment|Death|1|||
130434252|NCT02508532|469553770|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
130434253|NCT02508532|469553771|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
130678835|NCT01153984|470450858|FG000|Overall Study|Adverse Event|1|||
130678836|NCT02460159|470450859|FG000|Overall Study|Adverse Event|4|||
130678837|NCT02460159|470450860|FG001|Overall Study|Adverse Event|1|||
130678838|NCT02460159|470450859|FG000|Overall Study|Withdrawal by Subject|2|||
130678839|NCT02460159|470450860|FG001|Overall Study|Withdrawal by Subject|0|||
130434254|NCT02508532|469553772|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
130434255|NCT02508532|469553773|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
130434256|NCT02508532|469553774|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
130434257|NCT02508532|469553775|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
130434258|NCT02508532|469553776|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
130434259|NCT02508532|469553777|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
130434260|NCT02508532|469553778|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
130678840|NCT00762086|470450861|FG000|Overall Study|Adverse Event|2|||
130434261|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
130434262|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
130678841|NCT00762086|470450862|FG001|Overall Study|Adverse Event|0|||
130678842|NCT00762086|470450861|FG000|Overall Study|Lost to Follow-up|0|||
130678843|NCT00762086|470450862|FG001|Overall Study|Lost to Follow-up|2|||
130678844|NCT00762086|470450861|FG000|Overall Study|Non compliance|1|||
130678845|NCT00762086|470450862|FG001|Overall Study|Non compliance|0|||
130678846|NCT00762086|470450861|FG000|Overall Study|Withdrawal by Subject|2|||
130678847|NCT00762086|470450862|FG001|Overall Study|Withdrawal by Subject|2|||
130678848|NCT00762086|470450861|FG000|Overall Study|Ineligible to participate in the study|1|||
130678849|NCT00762086|470450862|FG001|Overall Study|Ineligible to participate in the study|0|||
130678850|NCT00860405|470450867|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
130678851|NCT00860405|470450868|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
130678852|NCT01370408|470450871|FG000|Overall Study|treatment failure|9|||
130344888|NCT01576159|469233059|FG003|Overall Study|Physician Decision|0|||
130344889|NCT01576159|469233056|FG000|Overall Study|Lost to Follow-up|0|||
130344890|NCT01576159|469233057|FG001|Overall Study|Lost to Follow-up|0|||
130344891|NCT01576159|469233058|FG002|Overall Study|Lost to Follow-up|0|||
130344892|NCT01576159|469233059|FG003|Overall Study|Lost to Follow-up|1|||
130344893|NCT01576159|469233056|FG000|Overall Study|Protocol Violation|1|||
130344894|NCT01576159|469233057|FG001|Overall Study|Protocol Violation|0|||
130344895|NCT01576159|469233058|FG002|Overall Study|Protocol Violation|0|||
130344896|NCT01576159|469233059|FG003|Overall Study|Protocol Violation|0|||
130344897|NCT00169442|469233060|FG000|Overall Study|Withdrawal by Subject|0|||
130344898|NCT00169442|469233061|FG001|Overall Study|Withdrawal by Subject|0|||
130344899|NCT00169442|469233062|FG002|Overall Study|Withdrawal by Subject|1|||
130344900|NCT00169442|469233063|FG003|Overall Study|Withdrawal by Subject|0|||
130344901|NCT00169442|469233064|FG004|Overall Study|Withdrawal by Subject|0|||
130344902|NCT00169442|469233065|FG005|Overall Study|Withdrawal by Subject|0|||
130344903|NCT00169442|469233060|FG000|Overall Study|Migrated/moved from study area|0|||
130344904|NCT00169442|469233061|FG001|Overall Study|Migrated/moved from study area|0|||
130344905|NCT00169442|469233062|FG002|Overall Study|Migrated/moved from study area|0|||
130344906|NCT00169442|469233063|FG003|Overall Study|Migrated/moved from study area|0|||
130344907|NCT00169442|469233064|FG004|Overall Study|Migrated/moved from study area|0|||
130344908|NCT00169442|469233065|FG005|Overall Study|Migrated/moved from study area|2|||
130344909|NCT00169442|469233060|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344910|NCT00169442|469233061|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344911|NCT00169442|469233062|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344912|NCT00169442|469233063|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344913|NCT00169442|469233064|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
130344914|NCT00169442|469233065|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344915|NCT00169442|469233060|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344916|NCT00169442|469233061|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130344917|NCT00169442|469233062|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344918|NCT00169442|469233063|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344919|NCT00169442|469233064|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344920|NCT00169442|469233065|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344921|NCT01426789|469233066|FG000|Part 1|Protocol deviation|0|||
130344922|NCT01426789|469233067|FG001|Part 1|Protocol deviation|1|||
130344923|NCT01426789|469233068|FG002|Part 1|Protocol deviation|0|||
130344924|NCT01426789|469233069|FG003|Part 1|Protocol deviation|0|||
130344925|NCT01426789|469233070|FG004|Part 1|Protocol deviation|0|||
130344926|NCT01426789|469233071|FG005|Part 1|Protocol deviation|0|||
130344927|NCT01426789|469233066|FG000|Part 1|Lost to Follow-up|1|||
130344928|NCT01426789|469233067|FG001|Part 1|Lost to Follow-up|2|||
130344929|NCT01426789|469233068|FG002|Part 1|Lost to Follow-up|0|||
130344930|NCT01426789|469233069|FG003|Part 1|Lost to Follow-up|0|||
130344931|NCT01426789|469233070|FG004|Part 1|Lost to Follow-up|0|||
130344932|NCT01426789|469233071|FG005|Part 1|Lost to Follow-up|0|||
130344933|NCT01426789|469233066|FG000|Part 1|Lack of Efficacy|2|||
130344934|NCT01426789|469233067|FG001|Part 1|Lack of Efficacy|1|||
130344935|NCT01426789|469233068|FG002|Part 1|Lack of Efficacy|0|||
130344936|NCT01426789|469233069|FG003|Part 1|Lack of Efficacy|0|||
130344937|NCT01426789|469233070|FG004|Part 1|Lack of Efficacy|0|||
130344938|NCT01426789|469233071|FG005|Part 1|Lack of Efficacy|0|||
130344939|NCT01426789|469233066|FG000|Part 1|Adverse Event|3|||
130344940|NCT01426789|469233067|FG001|Part 1|Adverse Event|0|||
130344941|NCT01426789|469233068|FG002|Part 1|Adverse Event|0|||
130344942|NCT01426789|469233069|FG003|Part 1|Adverse Event|0|||
130344943|NCT01426789|469233070|FG004|Part 1|Adverse Event|0|||
130344944|NCT01426789|469233071|FG005|Part 1|Adverse Event|0|||
130344945|NCT01426789|469233066|FG000|Part 2|Protocol deviation|0|||
130678853|NCT01062256|470450872|FG000|Overall Study|Adverse Event|1|||
130678854|NCT01062256|470450873|FG001|Overall Study|Adverse Event|0|||
130344946|NCT01426789|469233067|FG001|Part 2|Protocol deviation|0|||
130344947|NCT01426789|469233068|FG002|Part 2|Protocol deviation|1|||
130344948|NCT01426789|469233069|FG003|Part 2|Protocol deviation|0|||
130344949|NCT01426789|469233070|FG004|Part 2|Protocol deviation|0|||
130344950|NCT01426789|469233071|FG005|Part 2|Protocol deviation|0|||
130344951|NCT01426789|469233066|FG000|Part 2|Death|0|||
130678855|NCT01062256|470450874|FG002|Overall Study|Adverse Event|0|||
130678856|NCT01062256|470450872|FG000|Overall Study|Withdrawal by Subject|1|||
130678857|NCT01062256|470450873|FG001|Overall Study|Withdrawal by Subject|1|||
130678858|NCT01062256|470450874|FG002|Overall Study|Withdrawal by Subject|1|||
130678859|NCT01062256|470450872|FG000|Overall Study|Ineligible|1|||
130678860|NCT01062256|470450873|FG001|Overall Study|Ineligible|4|||
130678861|NCT01062256|470450874|FG002|Overall Study|Ineligible|3|||
130678862|NCT01062256|470450872|FG000|Overall Study|Administrative|0|||
130678863|NCT01062256|470450873|FG001|Overall Study|Administrative|2|||
130678864|NCT01062256|470450874|FG002|Overall Study|Administrative|0|||
130678865|NCT03049488|470450875|FG000|Overall Study|Lost to Follow-up|1|||
130678866|NCT03049488|470450876|FG001|Overall Study|Lost to Follow-up|1|||
130678867|NCT03049488|470450877|FG002|Overall Study|Lost to Follow-up|0|||
130678868|NCT03049488|470450878|FG003|Overall Study|Lost to Follow-up|0|||
130678869|NCT03049488|470450879|FG004|Overall Study|Lost to Follow-up|0|||
130678870|NCT03049488|470450880|FG005|Overall Study|Lost to Follow-up|0|||
130678871|NCT03049488|470450875|FG000|Overall Study|Moved from Area|1|||
130678872|NCT03049488|470450876|FG001|Overall Study|Moved from Area|0|||
130678873|NCT03049488|470450877|FG002|Overall Study|Moved from Area|0|||
130678874|NCT03049488|470450878|FG003|Overall Study|Moved from Area|1|||
130678875|NCT03049488|470450879|FG004|Overall Study|Moved from Area|1|||
130678876|NCT03049488|470450880|FG005|Overall Study|Moved from Area|0|||
130678877|NCT03049488|470450875|FG000|Overall Study|Physician Decision|0|||
130678878|NCT03049488|470450876|FG001|Overall Study|Physician Decision|1|||
130678879|NCT03049488|470450877|FG002|Overall Study|Physician Decision|0|||
130678880|NCT03049488|470450878|FG003|Overall Study|Physician Decision|0|||
130678881|NCT03049488|470450879|FG004|Overall Study|Physician Decision|0|||
130678882|NCT03049488|470450880|FG005|Overall Study|Physician Decision|0|||
130678883|NCT03049488|470450875|FG000|Overall Study|Withdrawal by Subject|0|||
130678884|NCT03049488|470450876|FG001|Overall Study|Withdrawal by Subject|0|||
130434263|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
130434264|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
130434265|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
130434266|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
130434267|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
130434268|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
130434269|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
130434270|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
130434271|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434272|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
130434273|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434274|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434275|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434276|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434277|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
130434278|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
130434279|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Death|0|||
130434280|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Death|4|||
130434281|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Death|2|||
130434282|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Death|4|||
130434283|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Death|3|||
130434284|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Death|0|||
130434285|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Death|0|||
130434286|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Death|1|||
130434287|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Death|111|||
130434288|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130434289|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130434290|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130434291|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130434292|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130216611|NCT05305989|468755618|FG002|Overall Study|Adverse Event|0|||
130434293|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130434294|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130434295|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130434296|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
130678885|NCT03049488|470450877|FG002|Overall Study|Withdrawal by Subject|0|||
130678886|NCT03049488|470450878|FG003|Overall Study|Withdrawal by Subject|1|||
130552776|NCT00719563|469991530|FG000|Overall Study|Lost to Follow-up|5|||
130678887|NCT03049488|470450879|FG004|Overall Study|Withdrawal by Subject|1|||
130678888|NCT03049488|470450880|FG005|Overall Study|Withdrawal by Subject|0|||
130678889|NCT00891293|470450881|FG000|Overall Study|Adverse Event|2|||
130678890|NCT00891293|470450881|FG000|Overall Study|Protocol Violation|2|||
130678891|NCT00891293|470450881|FG000|Overall Study|Laboratory abnormality|4|||
130678892|NCT00891293|470450881|FG000|Overall Study|Lost to Follow-up|7|||
130678893|NCT00891293|470450881|FG000|Overall Study|Subject withdrew consent|7|||
130678894|NCT00891293|470450881|FG000|Overall Study|Sponsor termination|62|||
130434297|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434298|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434299|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434300|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434301|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434302|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434303|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434304|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130434305|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
130434306|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434307|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434308|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
130434309|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434310|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
130434311|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434312|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434313|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
130434314|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
130434315|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434316|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434317|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434318|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434319|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434320|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434321|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434322|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130434323|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
130434324|NCT02508532|469553770|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130434325|NCT02508532|469553771|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130434326|NCT02508532|469553772|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130678895|NCT01448057|470450882|FG000|Overall Study|Protocol Violation|3|||
130678896|NCT01448057|470450883|FG001|Overall Study|Protocol Violation|2|||
130678897|NCT01448057|470450882|FG000|Overall Study|Lost to Follow-up|3|||
130678898|NCT01448057|470450883|FG001|Overall Study|Lost to Follow-up|0|||
130678899|NCT01448057|470450882|FG000|Overall Study|Adverse Event|0|||
130678900|NCT01448057|470450883|FG001|Overall Study|Adverse Event|2|||
130678901|NCT01448057|470450882|FG000|Overall Study|Withdrawal by Subject|2|||
130678902|NCT01448057|470450883|FG001|Overall Study|Withdrawal by Subject|0|||
130678903|NCT03883906|470450887|FG000|Overall Study|Withdrawal by Subject|2|||
130678904|NCT03883906|470450887|FG000|Overall Study|Physician Decision|5|||
130678905|NCT00486837|470450888|FG000|Overall Study|Withdrawal by Subject|1|||
130678906|NCT00486837|470450889|FG001|Overall Study|Withdrawal by Subject|0|||
130344952|NCT01426789|469233067|FG001|Part 2|Death|0|||
130344953|NCT01426789|469233068|FG002|Part 2|Death|1|||
130344954|NCT01426789|469233069|FG003|Part 2|Death|0|||
130344955|NCT01426789|469233070|FG004|Part 2|Death|1|||
130344956|NCT01426789|469233071|FG005|Part 2|Death|0|||
130344957|NCT01426789|469233066|FG000|Part 2|Administrative problems|0|||
130344958|NCT01426789|469233067|FG001|Part 2|Administrative problems|0|||
130344959|NCT01426789|469233068|FG002|Part 2|Administrative problems|2|||
130344960|NCT01426789|469233069|FG003|Part 2|Administrative problems|0|||
130344961|NCT01426789|469233070|FG004|Part 2|Administrative problems|1|||
130344962|NCT01426789|469233071|FG005|Part 2|Administrative problems|0|||
130344963|NCT01426789|469233066|FG000|Part 2|Lost to Follow-up|0|||
130344964|NCT01426789|469233067|FG001|Part 2|Lost to Follow-up|0|||
130344965|NCT01426789|469233068|FG002|Part 2|Lost to Follow-up|4|||
130344966|NCT01426789|469233069|FG003|Part 2|Lost to Follow-up|0|||
130344967|NCT01426789|469233070|FG004|Part 2|Lost to Follow-up|1|||
130344968|NCT01426789|469233071|FG005|Part 2|Lost to Follow-up|0|||
130344969|NCT01426789|469233066|FG000|Part 2|Withdrawal by Subject|0|||
130344970|NCT01426789|469233067|FG001|Part 2|Withdrawal by Subject|0|||
130344971|NCT01426789|469233068|FG002|Part 2|Withdrawal by Subject|0|||
130344972|NCT01426789|469233069|FG003|Part 2|Withdrawal by Subject|1|||
130344973|NCT01426789|469233070|FG004|Part 2|Withdrawal by Subject|2|||
130344974|NCT01426789|469233071|FG005|Part 2|Withdrawal by Subject|0|||
130344975|NCT01426789|469233066|FG000|Part 2|Lack of Efficacy|0|||
130344976|NCT01426789|469233067|FG001|Part 2|Lack of Efficacy|0|||
130344977|NCT01426789|469233068|FG002|Part 2|Lack of Efficacy|5|||
130344978|NCT01426789|469233069|FG003|Part 2|Lack of Efficacy|0|||
130344979|NCT01426789|469233070|FG004|Part 2|Lack of Efficacy|2|||
130344980|NCT01426789|469233071|FG005|Part 2|Lack of Efficacy|0|||
130344981|NCT01426789|469233066|FG000|Part 2|Adverse Event|0|||
130344982|NCT01426789|469233067|FG001|Part 2|Adverse Event|0|||
130344983|NCT01426789|469233068|FG002|Part 2|Adverse Event|2|||
130344984|NCT01426789|469233069|FG003|Part 2|Adverse Event|0|||
130678907|NCT00486837|470450888|FG000|Overall Study|Adverse Event|1|||
130678908|NCT00486837|470450889|FG001|Overall Study|Adverse Event|1|||
130678909|NCT00486837|470450888|FG000|Overall Study|Protocol Violation|4|||
130678910|NCT00486837|470450889|FG001|Overall Study|Protocol Violation|2|||
130678911|NCT00486837|470450888|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
130678912|NCT00486837|470450889|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
130678913|NCT00796822|470450899|FG000|Overall Study|Lost to Follow-up|2|||
130678914|NCT00796822|470450900|FG001|Overall Study|Lost to Follow-up|0|||
130678915|NCT00796822|470450899|FG000|Overall Study|Adverse Event|1|||
130678916|NCT00796822|470450900|FG001|Overall Study|Adverse Event|0|||
130678917|NCT00906347|470450901|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
130678918|NCT00906347|470450902|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
130678919|NCT00906347|470450901|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
130678920|NCT00906347|470450902|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
130678921|NCT00906347|470450901|FG000|Received Study Drug|Refused study drug|1|||
130678922|NCT00906347|470450902|FG001|Received Study Drug|Refused study drug|0|||
130434327|NCT02508532|469553773|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130434328|NCT02508532|469553774|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130434329|NCT02508532|469553775|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
130678923|NCT00906347|470450901|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
130678924|NCT00906347|470450902|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
130678925|NCT00680121|470450904|FG000|Overall Study|Lost to Follow-up|27|||
130678926|NCT00680121|470450905|FG001|Overall Study|Lost to Follow-up|23|||
130344985|NCT01426789|469233070|FG004|Part 2|Adverse Event|1|||
130344986|NCT01426789|469233071|FG005|Part 2|Adverse Event|0|||
130344987|NCT01181986|469233072|FG000|Phase 1|Lost to Follow-up|0|||
130344988|NCT01181986|469233073|FG001|Phase 1|Lost to Follow-up|1|||
130344989|NCT01181986|469233074|FG002|Phase 1|Lost to Follow-up|1|||
130344990|NCT01181986|469233072|FG000|Phase 1|Adverse Event|0|||
130344991|NCT01181986|469233073|FG001|Phase 1|Adverse Event|0|||
130344992|NCT01181986|469233074|FG002|Phase 1|Adverse Event|1|||
130344993|NCT01181986|469233072|FG000|Phase 1|Protocol Violation|1|||
130344994|NCT01181986|469233073|FG001|Phase 1|Protocol Violation|0|||
130344995|NCT01181986|469233074|FG002|Phase 1|Protocol Violation|0|||
130344996|NCT01181986|469233072|FG000|Phase 2|Adverse Event|0|||
130344997|NCT01181986|469233073|FG001|Phase 2|Adverse Event|3|||
130344998|NCT01181986|469233074|FG002|Phase 2|Adverse Event|0|||
130344999|NCT01181986|469233072|FG000|Phase 2|Medical condition|0|||
130345000|NCT01181986|469233073|FG001|Phase 2|Medical condition|1|||
130345001|NCT01181986|469233074|FG002|Phase 2|Medical condition|0|||
130345002|NCT00311584|469233077|FG000|Overall Study|Death|1|||
130345003|NCT00311584|469233078|FG001|Overall Study|Death|0|||
130345004|NCT00311584|469233077|FG000|Overall Study|Lack of Efficacy|12|||
130345005|NCT00311584|469233078|FG001|Overall Study|Lack of Efficacy|15|||
130345006|NCT00311584|469233077|FG000|Overall Study|Physician Decision|4|||
130345007|NCT00311584|469233078|FG001|Overall Study|Physician Decision|5|||
130345008|NCT00311584|469233077|FG000|Overall Study|Withdrawal by Subject|1|||
130345009|NCT00311584|469233078|FG001|Overall Study|Withdrawal by Subject|1|||
130345010|NCT00311584|469233077|FG000|Overall Study|ineligible|2|||
130345011|NCT00311584|469233078|FG001|Overall Study|ineligible|2|||
130345012|NCT03073733|469233079|FG000|Overall Study|Lost to Follow-up|1|||
130345013|NCT03073733|469233080|FG001|Overall Study|Lost to Follow-up|0|||
130345014|NCT03073733|469233081|FG002|Overall Study|Lost to Follow-up|0|||
130345015|NCT03073733|469233079|FG000|Overall Study|Physician Decision|0|||
130345016|NCT03073733|469233080|FG001|Overall Study|Physician Decision|1|||
130345017|NCT03073733|469233081|FG002|Overall Study|Physician Decision|0|||
130345018|NCT03073733|469233079|FG000|Overall Study|Withdrawal by Subject|0|||
130345019|NCT03073733|469233080|FG001|Overall Study|Withdrawal by Subject|0|||
130345020|NCT03073733|469233081|FG002|Overall Study|Withdrawal by Subject|1|||
130345021|NCT00835731|469233082|FG000|Overall Study|Withdrawal by Subject|1|||
130345022|NCT00835731|469233083|FG001|Overall Study|Withdrawal by Subject|0|||
130345023|NCT00835731|469233082|FG000|Overall Study|Physician Decision|1|||
130345024|NCT00835731|469233083|FG001|Overall Study|Physician Decision|1|||
130345025|NCT01155167|469233084|FG000|Overall Study|Insufficient ultrasound data|2|||
130345026|NCT01155167|469233085|FG001|Overall Study|Insufficient ultrasound data|0|||
130345027|NCT01155167|469233084|FG000|Overall Study|Access site changed to femoral artery|1|||
130345028|NCT01155167|469233085|FG001|Overall Study|Access site changed to femoral artery|0|||
130345029|NCT00167778|469233086|FG000|Overall Study|Withdrawal by Subject|1|||
130345030|NCT02654717|469233087|FG000|Overall Study|Adverse Event|2|||
130345031|NCT02654717|469233088|FG001|Overall Study|Adverse Event|2|||
130345032|NCT02654717|469233087|FG000|Overall Study|Protocol Violation|1|||
130345033|NCT02654717|469233088|FG001|Overall Study|Protocol Violation|2|||
130345034|NCT02654717|469233087|FG000|Overall Study|Withdrawal by Subject|0|||
130345035|NCT02654717|469233088|FG001|Overall Study|Withdrawal by Subject|1|||
130678927|NCT02603952|470450908|FG000|Overall Study|Withdrawal by Subject|1|||
130345036|NCT02654717|469233087|FG000|Overall Study|Non-permitted medication|3|||
130345037|NCT02654717|469233088|FG001|Overall Study|Non-permitted medication|0|||
130345038|NCT02880956|469233090|FG000|Overall Study|Adverse Event|3|||
130678928|NCT02603952|470450909|FG001|Overall Study|Withdrawal by Subject|0|||
130678929|NCT02603952|470450910|FG002|Overall Study|Withdrawal by Subject|0|||
130678930|NCT02603952|470450911|FG003|Overall Study|Withdrawal by Subject|0|||
130678931|NCT02603952|470450908|FG000|Overall Study|Received oseltamivir by error|0|||
130678932|NCT02603952|470450909|FG001|Overall Study|Received oseltamivir by error|0|||
130678933|NCT02603952|470450910|FG002|Overall Study|Received oseltamivir by error|0|||
130678934|NCT02603952|470450911|FG003|Overall Study|Received oseltamivir by error|1|||
130678935|NCT00577460|470450914|FG000|Overall Study|Adverse Event|11|||
130678936|NCT00577460|470450915|FG001|Overall Study|Adverse Event|7|||
130678937|NCT00577460|470450916|FG002|Overall Study|Adverse Event|14|||
130678938|NCT00577460|470450914|FG000|Overall Study|Protocol Violation|0|||
130678939|NCT00577460|470450915|FG001|Overall Study|Protocol Violation|1|||
130678940|NCT00577460|470450916|FG002|Overall Study|Protocol Violation|1|||
130678941|NCT00577460|470450914|FG000|Overall Study|Lost to Follow-up|0|||
130678942|NCT00577460|470450915|FG001|Overall Study|Lost to Follow-up|3|||
130678943|NCT00577460|470450916|FG002|Overall Study|Lost to Follow-up|4|||
130678944|NCT00577460|470450914|FG000|Overall Study|Withdrawal by Subject|5|||
130678945|NCT00577460|470450915|FG001|Overall Study|Withdrawal by Subject|5|||
130678946|NCT00577460|470450916|FG002|Overall Study|Withdrawal by Subject|6|||
130434330|NCT02508532|469553776|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
130434331|NCT02508532|469553777|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130434332|NCT02508532|469553778|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
130434333|NCT03097861|469553779|FG000|Overall Study|Adverse Event|3|||
130434334|NCT03097861|469553780|FG001|Overall Study|Adverse Event|8|||
130434335|NCT03097861|469553781|FG002|Overall Study|Adverse Event|4|||
130434336|NCT03097861|469553779|FG000|Overall Study|Investigator Decision|0|||
130434337|NCT03097861|469553780|FG001|Overall Study|Investigator Decision|1|||
130434338|NCT03097861|469553781|FG002|Overall Study|Investigator Decision|0|||
130434339|NCT03097861|469553779|FG000|Overall Study|Lost to Follow-up|0|||
130434340|NCT03097861|469553780|FG001|Overall Study|Lost to Follow-up|7|||
130434341|NCT03097861|469553781|FG002|Overall Study|Lost to Follow-up|1|||
130434342|NCT03097861|469553779|FG000|Overall Study|Withdrawal by Subject|1|||
130434343|NCT03097861|469553780|FG001|Overall Study|Withdrawal by Subject|5|||
130434344|NCT03097861|469553781|FG002|Overall Study|Withdrawal by Subject|3|||
130434345|NCT03097861|469553779|FG000|Overall Study|Reason not provided|3|||
130434346|NCT03097861|469553780|FG001|Overall Study|Reason not provided|1|||
130434347|NCT03097861|469553781|FG002|Overall Study|Reason not provided|1|||
130434348|NCT01834222|469553788|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
130434349|NCT04251065|469553789|FG000|Overall Study|Death|2|||
130434350|NCT04251065|469553789|FG000|Overall Study|Lack of Efficacy|3|||
130434351|NCT04251065|469553789|FG000|Overall Study|Death|1|||
130434352|NCT01054573|469553790|FG000|Overall Study|Adverse Event|1|||
130434353|NCT01054573|469553791|FG001|Overall Study|Adverse Event|0|||
130434354|NCT01054573|469553792|FG002|Overall Study|Adverse Event|1|||
130434355|NCT01054573|469553793|FG003|Overall Study|Adverse Event|1|||
130434356|NCT01054573|469553790|FG000|Overall Study|Lost to Follow-up|0|||
130434357|NCT01054573|469553791|FG001|Overall Study|Lost to Follow-up|2|||
130434358|NCT01054573|469553792|FG002|Overall Study|Lost to Follow-up|0|||
130434359|NCT01054573|469553793|FG003|Overall Study|Lost to Follow-up|0|||
130434360|NCT01054573|469553790|FG000|Overall Study|Withdrawal by Subject|0|||
130678947|NCT00577460|470450914|FG000|Overall Study|Other|0|||
130678948|NCT00577460|470450915|FG001|Overall Study|Other|3|||
130678949|NCT00577460|470450916|FG002|Overall Study|Other|2|||
130678950|NCT01318499|470450917|FG000|Overall Study|Adverse Event|16|||
130678951|NCT01318499|470450918|FG001|Overall Study|Adverse Event|11|||
130678952|NCT01318499|470450919|FG002|Overall Study|Adverse Event|6|||
130678953|NCT01318499|470450917|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130678954|NCT01318499|470450918|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130678955|NCT01318499|470450919|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
130678956|NCT01318499|470450917|FG000|Overall Study|Noncompliance|2|||
130678957|NCT01318499|470450918|FG001|Overall Study|Noncompliance|3|||
130678958|NCT01318499|470450919|FG002|Overall Study|Noncompliance|0|||
130216612|NCT05305989|468755616|FG000|Overall Study|Enrolled but never dosed|3|||
130216613|NCT05305989|468755617|FG001|Overall Study|Enrolled but never dosed|2|||
130678959|NCT01318499|470450917|FG000|Overall Study|Treatment Failure|19|||
130678960|NCT01318499|470450918|FG001|Overall Study|Treatment Failure|19|||
130678961|NCT01318499|470450919|FG002|Overall Study|Treatment Failure|101|||
130678962|NCT01318499|470450917|FG000|Overall Study|Protocol Violation|2|||
130216614|NCT05305989|468755618|FG002|Overall Study|Enrolled but never dosed|1|||
130434361|NCT01054573|469553791|FG001|Overall Study|Withdrawal by Subject|2|||
130434362|NCT01054573|469553792|FG002|Overall Study|Withdrawal by Subject|2|||
130434363|NCT01054573|469553793|FG003|Overall Study|Withdrawal by Subject|1|||
130434364|NCT01725386|469553797|FG000|Overall Study|Death|84|||
130434365|NCT01725386|469553798|FG001|Overall Study|Death|40|||
130434366|NCT01725386|469553797|FG000|Overall Study|Lost to Follow-up|81|||
130434367|NCT01725386|469553798|FG001|Overall Study|Lost to Follow-up|6|||
130434368|NCT01725386|469553797|FG000|Overall Study|Withdrawal by Subject|10|||
130552777|NCT00719563|469991531|FG001|Overall Study|Lost to Follow-up|3|||
130678963|NCT01318499|470450918|FG001|Overall Study|Protocol Violation|4|||
130678964|NCT01318499|470450919|FG002|Overall Study|Protocol Violation|2|||
130678965|NCT01318499|470450917|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
130678966|NCT01318499|470450918|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
130678967|NCT01318499|470450919|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
130678968|NCT01318499|470450917|FG000|Overall Study|Other|7|||
130678969|NCT01318499|470450918|FG001|Overall Study|Other|10|||
130678970|NCT01318499|470450919|FG002|Overall Study|Other|22|||
130678971|NCT01347710|470450923|FG000|Overall Study|Withdrawal by Subject|2|||
130678972|NCT01347710|470450923|FG000|Overall Study|Adverse Event|4|||
130678973|NCT01347710|470450923|FG000|Overall Study|Angio or SPECT not completed|18|||
130678974|NCT01347710|470450923|FG000|Overall Study|issue with vitals prior to dosing|1|||
130678975|NCT01347710|470450923|FG000|Overall Study|Lost to Follow-up|1|||
130678976|NCT01347710|470450923|FG000|Overall Study|Physician Decision|2|||
130678977|NCT01347710|470450923|FG000|Overall Study|Other|3|||
130678978|NCT04591626|470450924|FG000|Overall Study|Adverse Event|4|||
130678979|NCT04591626|470450925|FG001|Overall Study|Adverse Event|0|||
130678980|NCT04591626|470450924|FG000|Overall Study|Withdrawal by Subject|5|||
130678981|NCT04591626|470450925|FG001|Overall Study|Withdrawal by Subject|3|||
130678982|NCT04591626|470450924|FG000|Overall Study|Physician Decision|0|||
130678983|NCT04591626|470450925|FG001|Overall Study|Physician Decision|1|||
130678984|NCT04591626|470450924|FG000|Overall Study|Death|0|||
130678985|NCT04591626|470450925|FG001|Overall Study|Death|1|||
130678986|NCT04591626|470450924|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130678987|NCT04591626|470450925|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130678988|NCT02672553|470450927|FG000|Overall Study|Death|3|||
130678989|NCT02672553|470450928|FG001|Overall Study|Death|5|||
130678990|NCT02672553|470450927|FG000|Overall Study|Valve Explant|1|||
130678991|NCT02672553|470450928|FG001|Overall Study|Valve Explant|0|||
130678992|NCT02672553|470450927|FG000|Overall Study|Conversion to Commercial Valve|3|||
130678993|NCT02672553|470450928|FG001|Overall Study|Conversion to Commercial Valve|0|||
130678994|NCT02672553|470450927|FG000|Overall Study|Withdrawal by Subject|3|||
130678995|NCT02672553|470450928|FG001|Overall Study|Withdrawal by Subject|3|||
130678996|NCT02672553|470450927|FG000|Overall Study|Intraoperative screen failure|2|||
130678997|NCT02672553|470450928|FG001|Overall Study|Intraoperative screen failure|0|||
130678998|NCT01606306|470450929|FG000|Overall Study|Lack of Efficacy|2|||
130678999|NCT01606306|470450930|FG001|Overall Study|Lack of Efficacy|1|||
130679000|NCT01606306|470450931|FG002|Overall Study|Lack of Efficacy|4|||
130679001|NCT01606306|470450932|FG003|Overall Study|Lack of Efficacy|4|||
130679002|NCT01606306|470450933|FG004|Overall Study|Lack of Efficacy|1|||
130679003|NCT01606306|470450934|FG005|Overall Study|Lack of Efficacy|2|||
130679004|NCT01606306|470450929|FG000|Overall Study|Adverse Event|1|||
130679005|NCT01606306|470450930|FG001|Overall Study|Adverse Event|0|||
130679006|NCT01606306|470450931|FG002|Overall Study|Adverse Event|1|||
130679007|NCT01606306|470450932|FG003|Overall Study|Adverse Event|1|||
130679008|NCT01606306|470450933|FG004|Overall Study|Adverse Event|2|||
130679009|NCT01606306|470450934|FG005|Overall Study|Adverse Event|0|||
130679010|NCT01606306|470450929|FG000|Overall Study|Lost to Follow-up|7|||
130679011|NCT01606306|470450930|FG001|Overall Study|Lost to Follow-up|4|||
130679012|NCT01606306|470450931|FG002|Overall Study|Lost to Follow-up|5|||
130679013|NCT01606306|470450932|FG003|Overall Study|Lost to Follow-up|4|||
130679014|NCT01606306|470450933|FG004|Overall Study|Lost to Follow-up|3|||
130679015|NCT01606306|470450934|FG005|Overall Study|Lost to Follow-up|5|||
130679016|NCT01606306|470450929|FG000|Overall Study|Withdrawal by Subject|4|||
130679017|NCT01606306|470450930|FG001|Overall Study|Withdrawal by Subject|3|||
130679018|NCT01606306|470450931|FG002|Overall Study|Withdrawal by Subject|4|||
130679019|NCT01606306|470450932|FG003|Overall Study|Withdrawal by Subject|4|||
130679020|NCT01606306|470450933|FG004|Overall Study|Withdrawal by Subject|5|||
130679021|NCT01606306|470450934|FG005|Overall Study|Withdrawal by Subject|4|||
130679022|NCT01606306|470450929|FG000|Overall Study|Physician Decision|1|||
130679023|NCT01606306|470450930|FG001|Overall Study|Physician Decision|2|||
130679024|NCT01606306|470450931|FG002|Overall Study|Physician Decision|0|||
130679025|NCT01606306|470450932|FG003|Overall Study|Physician Decision|0|||
130679026|NCT01606306|470450933|FG004|Overall Study|Physician Decision|0|||
130345039|NCT02880956|469233091|FG001|Overall Study|Adverse Event|6|||
130679027|NCT01606306|470450934|FG005|Overall Study|Physician Decision|0|||
130679028|NCT00408902|470450937|FG000|Overall Study|Lack of Efficacy|7|||
130679029|NCT00408902|470450937|FG000|Overall Study|Adverse Event|3|||
130679030|NCT00970281|470450938|FG000|Overall Study|Lack of Efficacy|1|||
130679031|NCT00970281|470450939|FG001|Overall Study|Lack of Efficacy|14|||
130679032|NCT00970281|470450938|FG000|Overall Study|Withdrawal by Subject|0|||
130679033|NCT00970281|470450939|FG001|Overall Study|Withdrawal by Subject|1|||
130679034|NCT00970281|470450938|FG000|Overall Study|Physician Decision|1|||
130679035|NCT00970281|470450939|FG001|Overall Study|Physician Decision|1|||
130679036|NCT00878995|470450942|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
130679037|NCT00878995|470450943|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
130679038|NCT00841100|470450944|FG000|Phase 1 (28 Days)|Adverse Event|1|||
130679039|NCT00841100|470450944|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
130679040|NCT03338972|470450945|FG000|Overall Study|Death|1|||
130679041|NCT03338972|470450946|FG001|Overall Study|Death|1|||
130345040|NCT02880956|469233092|FG002|Overall Study|Adverse Event|5|||
130345041|NCT02880956|469233093|FG003|Overall Study|Adverse Event|4|||
130345042|NCT02880956|469233090|FG000|Overall Study|Withdrawal by Subject|9|||
130345043|NCT02880956|469233091|FG001|Overall Study|Withdrawal by Subject|4|||
130345044|NCT02880956|469233092|FG002|Overall Study|Withdrawal by Subject|6|||
130345045|NCT02880956|469233093|FG003|Overall Study|Withdrawal by Subject|11|||
130345046|NCT02880956|469233090|FG000|Overall Study|Lost to Follow-up|0|||
130345047|NCT02880956|469233091|FG001|Overall Study|Lost to Follow-up|1|||
130345048|NCT02880956|469233092|FG002|Overall Study|Lost to Follow-up|0|||
130345049|NCT02880956|469233093|FG003|Overall Study|Lost to Follow-up|0|||
130345050|NCT02880956|469233090|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130345051|NCT02880956|469233091|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
130345052|NCT02880956|469233092|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130345053|NCT02880956|469233093|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130345054|NCT02880956|469233090|FG000|Overall Study|Other, Not Specified|4|||
130345055|NCT02880956|469233091|FG001|Overall Study|Other, Not Specified|2|||
130345056|NCT02880956|469233092|FG002|Overall Study|Other, Not Specified|0|||
130345057|NCT02880956|469233093|FG003|Overall Study|Other, Not Specified|3|||
130345058|NCT00576420|469235274|FG000|Overall Study|Death|0|||
130345059|NCT00576420|469235275|FG001|Overall Study|Death|0|||
130345060|NCT00576420|469235276|FG002|Overall Study|Death|1|||
130345061|NCT01340872|469235278|FG000|Double-blind Phase|Adverse Event|6|||
130345062|NCT01340872|469235279|FG001|Double-blind Phase|Adverse Event|4|||
130345063|NCT01340872|469235280|FG002|Double-blind Phase|Adverse Event|0|||
130345064|NCT01340872|469235281|FG003|Double-blind Phase|Adverse Event|0|||
130345065|NCT01340872|469235278|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130345066|NCT01340872|469235279|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130345067|NCT01340872|469235280|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130345068|NCT01340872|469235281|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130345069|NCT01340872|469235278|FG000|Double-blind Phase|Lost to Follow-up|0|||
130345070|NCT01340872|469235279|FG001|Double-blind Phase|Lost to Follow-up|1|||
130345071|NCT01340872|469235280|FG002|Double-blind Phase|Lost to Follow-up|0|||
130345072|NCT01340872|469235281|FG003|Double-blind Phase|Lost to Follow-up|0|||
130345073|NCT01340872|469235278|FG000|Double-blind Phase|Protocol Violation|0|||
130345074|NCT01340872|469235279|FG001|Double-blind Phase|Protocol Violation|1|||
130345075|NCT01340872|469235280|FG002|Double-blind Phase|Protocol Violation|0|||
130345076|NCT01340872|469235281|FG003|Double-blind Phase|Protocol Violation|0|||
130345077|NCT01340872|469235278|FG000|Open-label Phase|Physician Decision|0|||
130345078|NCT01340872|469235279|FG001|Open-label Phase|Physician Decision|0|||
130345079|NCT01340872|469235280|FG002|Open-label Phase|Physician Decision|2|||
130345080|NCT01340872|469235281|FG003|Open-label Phase|Physician Decision|1|||
130345081|NCT01340872|469235278|FG000|Open-label Phase|Pregnancy|0|||
130345082|NCT01340872|469235279|FG001|Open-label Phase|Pregnancy|0|||
130345083|NCT01340872|469235280|FG002|Open-label Phase|Pregnancy|1|||
130345084|NCT01340872|469235281|FG003|Open-label Phase|Pregnancy|0|||
130345085|NCT01340872|469235278|FG000|Open-label Phase|Adverse Event|0|||
130345086|NCT01340872|469235279|FG001|Open-label Phase|Adverse Event|0|||
130345087|NCT01340872|469235280|FG002|Open-label Phase|Adverse Event|8|||
130345088|NCT01340872|469235281|FG003|Open-label Phase|Adverse Event|4|||
130345089|NCT01340872|469235278|FG000|Open-label Phase|Withdrawal by Subject|0|||
130345090|NCT01340872|469235279|FG001|Open-label Phase|Withdrawal by Subject|0|||
130345091|NCT01340872|469235280|FG002|Open-label Phase|Withdrawal by Subject|1|||
130345092|NCT01340872|469235281|FG003|Open-label Phase|Withdrawal by Subject|6|||
130345093|NCT01340872|469235278|FG000|Open-label Phase|Worsening of IBD|0|||
130345094|NCT01340872|469235279|FG001|Open-label Phase|Worsening of IBD|0|||
130345095|NCT01340872|469235280|FG002|Open-label Phase|Worsening of IBD|1|||
130345096|NCT01340872|469235281|FG003|Open-label Phase|Worsening of IBD|0|||
130345097|NCT01771809|469235284|FG000|Overall Study|Adverse Event|4|||
130345098|NCT01771809|469235285|FG001|Overall Study|Adverse Event|12|||
130345099|NCT01771809|469235284|FG000|Overall Study|Protocol Violation|0|||
130345100|NCT01771809|469235285|FG001|Overall Study|Protocol Violation|1|||
130345101|NCT01771809|469235284|FG000|Overall Study|Withdrawal by Subject|34|||
130345102|NCT01771809|469235285|FG001|Overall Study|Withdrawal by Subject|42|||
130345103|NCT01771809|469235284|FG000|Overall Study|Lost to Follow-up|1|||
130345104|NCT01771809|469235285|FG001|Overall Study|Lost to Follow-up|3|||
130345105|NCT01771809|469235284|FG000|Overall Study|Other (Insufficient clinical response)|22|||
130679042|NCT03338972|470450947|FG002|Overall Study|Death|0|||
130345106|NCT01771809|469235285|FG001|Overall Study|Other (Insufficient clinical response)|20|||
130345107|NCT01771809|469235284|FG000|Overall Study|Death|1|||
130345108|NCT01771809|469235285|FG001|Overall Study|Death|0|||
130345109|NCT01771809|469235284|FG000|Overall Study|Other (other)|9|||
130345110|NCT01771809|469235285|FG001|Overall Study|Other (other)|5|||
130345111|NCT01142089|469235297|FG000|Overall Study|Physician Decision|1|||
130345112|NCT01142089|469235298|FG001|Overall Study|Physician Decision|0|||
130345113|NCT01142089|469235297|FG000|Overall Study|Withdrawal by Subject|1|||
130345114|NCT01142089|469235298|FG001|Overall Study|Withdrawal by Subject|2|||
130434369|NCT01725386|469553798|FG001|Overall Study|Withdrawal by Subject|0|||
130434370|NCT03812536|469553799|FG000|Overall Study|Protocol Violation|2|||
130434371|NCT03812536|469553800|FG001|Overall Study|Protocol Violation|0|||
130434372|NCT03812536|469553799|FG000|Overall Study|Withdrawal by Subject|1|||
130434373|NCT03812536|469553800|FG001|Overall Study|Withdrawal by Subject|1|||
130434374|NCT00152009|469553801|FG000|Overall Study|Adverse Event|9|||
130434375|NCT00152009|469553802|FG001|Overall Study|Adverse Event|13|||
130434376|NCT00152009|469553803|FG002|Overall Study|Adverse Event|20|||
130434377|NCT00152009|469553804|FG003|Overall Study|Adverse Event|1|||
130434378|NCT00152009|469553801|FG000|Overall Study|Protocol Violation|3|||
130434379|NCT00152009|469553802|FG001|Overall Study|Protocol Violation|0|||
130434380|NCT00152009|469553803|FG002|Overall Study|Protocol Violation|0|||
130434381|NCT00152009|469553804|FG003|Overall Study|Protocol Violation|1|||
130434382|NCT00152009|469553801|FG000|Overall Study|Withdrawal by Subject|2|||
130434383|NCT00152009|469553802|FG001|Overall Study|Withdrawal by Subject|3|||
130434384|NCT00152009|469553803|FG002|Overall Study|Withdrawal by Subject|4|||
130434385|NCT00152009|469553804|FG003|Overall Study|Withdrawal by Subject|9|||
130434386|NCT00152009|469553801|FG000|Overall Study|Lost to Follow-up|2|||
130434387|NCT00152009|469553802|FG001|Overall Study|Lost to Follow-up|4|||
130434388|NCT00152009|469553803|FG002|Overall Study|Lost to Follow-up|3|||
130434389|NCT00152009|469553804|FG003|Overall Study|Lost to Follow-up|3|||
130434390|NCT00152009|469553801|FG000|Overall Study|Lack of Efficacy|8|||
130434391|NCT00152009|469553802|FG001|Overall Study|Lack of Efficacy|6|||
130434392|NCT00152009|469553803|FG002|Overall Study|Lack of Efficacy|7|||
130434393|NCT00152009|469553804|FG003|Overall Study|Lack of Efficacy|15|||
130434394|NCT00152009|469553801|FG000|Overall Study|ECG abnormalities|2|||
130679043|NCT03338972|470450948|FG003|Overall Study|Death|0|||
130679044|NCT03338972|470450945|FG000|Overall Study|Withdrawal by Subject|1|||
130434395|NCT00152009|469553802|FG001|Overall Study|ECG abnormalities|2|||
130434396|NCT00152009|469553803|FG002|Overall Study|ECG abnormalities|2|||
130434397|NCT00152009|469553804|FG003|Overall Study|ECG abnormalities|1|||
130434398|NCT00152009|469553801|FG000|Overall Study|Sponsor's decision|3|||
130434399|NCT00152009|469553802|FG001|Overall Study|Sponsor's decision|3|||
130434400|NCT00152009|469553803|FG002|Overall Study|Sponsor's decision|1|||
130434401|NCT00152009|469553804|FG003|Overall Study|Sponsor's decision|3|||
130434402|NCT01306201|469553806|FG000|Overall Study|Arrhythmia|4|||
130434403|NCT01306201|469553806|FG000|Overall Study|Files could not be processed|3|||
130434404|NCT01306201|469553806|FG000|Overall Study|Files unreadable|3|||
130434405|NCT05672680|469553807|FG000|Overall Study|Patient Did Not Complete the Form|5|||
130434406|NCT05672680|469553808|FG001|Overall Study|Patient Did Not Complete the Form|4|||
130434407|NCT05672680|469553807|FG000|Overall Study|Procedure Aborted|1|||
130434408|NCT05672680|469553808|FG001|Overall Study|Procedure Aborted|0|||
130434409|NCT05076149|469553809|FG000|Overall Study|Adverse Event|3|||
130434410|NCT05076149|469553810|FG001|Overall Study|Adverse Event|9|||
130434411|NCT05076149|469553809|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130434412|NCT05076149|469553810|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
130434413|NCT05076149|469553809|FG000|Overall Study|Lost to Follow-up|0|||
130434414|NCT05076149|469553810|FG001|Overall Study|Lost to Follow-up|1|||
130434415|NCT05076149|469553809|FG000|Overall Study|Commercial drug is available for participant|0|||
130434416|NCT05076149|469553810|FG001|Overall Study|Commercial drug is available for participant|1|||
130434417|NCT05076149|469553809|FG000|Overall Study|Other non compliance|1|||
130679045|NCT03338972|470450946|FG001|Overall Study|Withdrawal by Subject|0|||
130679046|NCT03338972|470450947|FG002|Overall Study|Withdrawal by Subject|0|||
130679047|NCT03338972|470450948|FG003|Overall Study|Withdrawal by Subject|0|||
130679048|NCT01355081|470450949|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
130679049|NCT01355081|470450950|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130679050|NCT01355081|470450951|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130679051|NCT01355081|470450949|FG000|Overall Study|Major Protocol Deviation|0|||
130434418|NCT05076149|469553810|FG001|Overall Study|Other non compliance|1|||
130434419|NCT05076149|469553809|FG000|Overall Study|Physician Decision|0|||
130434420|NCT05076149|469553810|FG001|Overall Study|Physician Decision|1|||
130434421|NCT05076149|469553809|FG000|Overall Study|Other|5|||
130434422|NCT05076149|469553810|FG001|Overall Study|Other|4|||
130434423|NCT05096208|469553811|FG000|Overall Study|Lost to Follow-up|3|||
130679052|NCT01355081|470450950|FG001|Overall Study|Major Protocol Deviation|1|||
130679053|NCT01355081|470450951|FG002|Overall Study|Major Protocol Deviation|0|||
130679054|NCT01355081|470450949|FG000|Overall Study|Lost to Follow-up|0|||
130679055|NCT01355081|470450950|FG001|Overall Study|Lost to Follow-up|0|||
130434424|NCT05096208|469553812|FG001|Overall Study|Lost to Follow-up|5|||
130434425|NCT05096208|469553813|FG002|Overall Study|Lost to Follow-up|5|||
130434426|NCT05096208|469553814|FG003|Overall Study|Lost to Follow-up|2|||
130434427|NCT05096208|469553811|FG000|Overall Study|Withdrawal by Subject|0|||
130434428|NCT05096208|469553812|FG001|Overall Study|Withdrawal by Subject|1|||
130434429|NCT05096208|469553813|FG002|Overall Study|Withdrawal by Subject|2|||
130434430|NCT05096208|469553814|FG003|Overall Study|Withdrawal by Subject|3|||
130434431|NCT05096208|469553811|FG000|Overall Study|No longer met eligibility criteria|1|||
130434432|NCT05096208|469553812|FG001|Overall Study|No longer met eligibility criteria|0|||
130679056|NCT01355081|470450951|FG002|Overall Study|Lost to Follow-up|1|||
130679057|NCT01355081|470450949|FG000|Overall Study|Withdrawal of Consent|2|||
130679058|NCT01355081|470450950|FG001|Overall Study|Withdrawal of Consent|3|||
130679059|NCT01355081|470450951|FG002|Overall Study|Withdrawal of Consent|3|||
130345115|NCT01142089|469235297|FG000|Overall Study|Use of prohibited medications|0|||
130345116|NCT01142089|469235298|FG001|Overall Study|Use of prohibited medications|1|||
130345117|NCT01142089|469235297|FG000|Overall Study|Noncompliance with study procedures|2|||
130345118|NCT01142089|469235298|FG001|Overall Study|Noncompliance with study procedures|1|||
130345119|NCT01142089|469235297|FG000|Overall Study|Patient required rescue medication|8|||
130345120|NCT01142089|469235298|FG001|Overall Study|Patient required rescue medication|17|||
130345121|NCT02907892|469235303|FG000|Overall Study|Lost to Follow-up|27|||
130345122|NCT02907892|469235304|FG001|Overall Study|Lost to Follow-up|40|||
130345123|NCT01974765|469235305|FG000|Overall Study|Withdrawal by Subject|1|||
130345124|NCT01974765|469235305|FG000|Overall Study|Death|1|||
130345125|NCT01974765|469235305|FG000|Overall Study|Adverse Event|2|||
130345126|NCT03860935|469235309|FG000|Overall Study|Withdrawal of Consent|15|||
130345127|NCT03860935|469235310|FG001|Overall Study|Withdrawal of Consent|6|||
130345128|NCT03860935|469235309|FG000|Overall Study|Death|75|||
130345129|NCT03860935|469235310|FG001|Overall Study|Death|51|||
130345130|NCT03086967|469235311|FG000|Overall Study|Screen Failure|2|||
130345131|NCT03086967|469235312|FG001|Overall Study|Screen Failure|2|||
130345132|NCT01430754|469235315|FG000|Run-In Phase|Circadian Period Ineligible|24|||
130345133|NCT01430754|469235316|FG001|Run-In Phase|Circadian Period Ineligible|0|||
130345134|NCT01430754|469235315|FG000|Run-In Phase|Protocol Violation|6|||
130345135|NCT01430754|469235316|FG001|Run-In Phase|Protocol Violation|0|||
130345136|NCT01430754|469235315|FG000|Run-In Phase|Adverse Event|2|||
130345137|NCT01430754|469235316|FG001|Run-In Phase|Adverse Event|0|||
130345138|NCT01430754|469235315|FG000|Run-In Phase|Other|2|||
130345139|NCT01430754|469235316|FG001|Run-In Phase|Other|0|||
130345140|NCT01430754|469235315|FG000|Run-In Phase|Withdrawal by Subject|2|||
130345141|NCT01430754|469235316|FG001|Run-In Phase|Withdrawal by Subject|0|||
130345142|NCT01430754|469235315|FG000|Run-In Phase|Lost to Follow-up|1|||
130345143|NCT01430754|469235316|FG001|Run-In Phase|Lost to Follow-up|0|||
130345144|NCT02230527|469235318|FG000|Overall Study|Withdrawal by Subject|1|||
130345145|NCT02230527|469235319|FG001|Overall Study|Withdrawal by Subject|1|||
130345146|NCT02230527|469235318|FG000|Overall Study|Death|1|||
130345147|NCT02230527|469235319|FG001|Overall Study|Death|0|||
130345148|NCT02230527|469235318|FG000|Overall Study|Lost to Follow-up|2|||
130345149|NCT02230527|469235319|FG001|Overall Study|Lost to Follow-up|1|||
130345150|NCT02230527|469235318|FG000|Overall Study|Other|1|||
130345151|NCT02230527|469235319|FG001|Overall Study|Other|0|||
130345152|NCT04461600|469235320|FG000|Overall Study|Death|6|||
130345153|NCT04461600|469235321|FG001|Overall Study|Death|5|||
130345154|NCT04461600|469235320|FG000|Overall Study|Withdrawal by Subject|0|||
130345155|NCT04461600|469235321|FG001|Overall Study|Withdrawal by Subject|1|||
130345156|NCT00775203|469235327|FG000|Overall Study|Adverse Event|25|||
130345157|NCT00775203|469235328|FG001|Overall Study|Adverse Event|6|||
130345158|NCT00775203|469235327|FG000|Overall Study|Lack of Efficacy|8|||
130345159|NCT00775203|469235328|FG001|Overall Study|Lack of Efficacy|9|||
130345160|NCT00775203|469235327|FG000|Overall Study|Withdrawal by Subject|11|||
130345161|NCT00775203|469235328|FG001|Overall Study|Withdrawal by Subject|9|||
130345162|NCT00775203|469235327|FG000|Overall Study|Lost to Follow-up|11|||
130345163|NCT00775203|469235328|FG001|Overall Study|Lost to Follow-up|15|||
130345164|NCT00775203|469235327|FG000|Overall Study|Administrative reason|2|||
130345165|NCT00775203|469235328|FG001|Overall Study|Administrative reason|0|||
130345166|NCT00775203|469235327|FG000|Overall Study|Noncompliance|4|||
130345167|NCT00775203|469235328|FG001|Overall Study|Noncompliance|2|||
130345168|NCT00775203|469235327|FG000|Overall Study|Protocol Violation|0|||
130345169|NCT00775203|469235328|FG001|Overall Study|Protocol Violation|1|||
130345170|NCT00775203|469235327|FG000|Overall Study|Entered other study|1|||
130345171|NCT00775203|469235328|FG001|Overall Study|Entered other study|0|||
130345172|NCT00775203|469235327|FG000|Overall Study|Physician Decision|0|||
130345173|NCT00775203|469235328|FG001|Overall Study|Physician Decision|1|||
130679060|NCT01355081|470450949|FG000|Overall Study|Lack of Efficacy|2|||
130679061|NCT01355081|470450950|FG001|Overall Study|Lack of Efficacy|1|||
130345174|NCT00704522|469235329|FG000|Overall Study|Lack of Efficacy|65|||
130345175|NCT00704522|469235330|FG001|Overall Study|Lack of Efficacy|17|||
130345176|NCT00704522|469235329|FG000|Overall Study|Failure to appear again at hospital|56|||
130345177|NCT00704522|469235330|FG001|Overall Study|Failure to appear again at hospital|10|||
130345178|NCT00704522|469235329|FG000|Overall Study|Withdrawal by Subject|17|||
130345179|NCT00704522|469235330|FG001|Overall Study|Withdrawal by Subject|8|||
130345180|NCT00704522|469235329|FG000|Overall Study|Adverse Event|9|||
130679062|NCT01355081|470450951|FG002|Overall Study|Lack of Efficacy|1|||
130679063|NCT01355081|470450949|FG000|Overall Study|Non Compliance with Study Medication|0|||
130345181|NCT00704522|469235330|FG001|Overall Study|Adverse Event|1|||
130345182|NCT00704522|469235329|FG000|Overall Study|Undefined causes|9|||
130345183|NCT00704522|469235330|FG001|Overall Study|Undefined causes|7|||
130345184|NCT00704522|469235329|FG000|Overall Study|No information on therapy end|27|||
130345185|NCT00704522|469235330|FG001|Overall Study|No information on therapy end|2|||
130434433|NCT05096208|469553813|FG002|Overall Study|No longer met eligibility criteria|0|||
130434434|NCT05096208|469553814|FG003|Overall Study|No longer met eligibility criteria|0|||
130434435|NCT05096208|469553811|FG000|Overall Study|Other|0|||
130434436|NCT05096208|469553812|FG001|Overall Study|Other|0|||
130434437|NCT05096208|469553813|FG002|Overall Study|Other|1|||
130434438|NCT05096208|469553814|FG003|Overall Study|Other|0|||
130434439|NCT02087501|469553815|FG000|Overall Study|Death|7|||
130434440|NCT02087501|469553815|FG000|Overall Study|Open repair of aneurysm|1|||
130434441|NCT02087501|469553815|FG000|Overall Study|Lost to Follow-up|2|||
130434442|NCT00094328|469553816|FG000|Overall Study|Lost to Follow-up|1|||
130434443|NCT01483937|469553817|FG000|Overall Study|Withdrawal by Subject|4|||
130434444|NCT01483937|469553818|FG001|Overall Study|Withdrawal by Subject|3|||
130434445|NCT01875185|469553820|FG000|Overall Study|study was terminated|52|||
130434446|NCT01875185|469553821|FG001|Overall Study|study was terminated|48|||
130434447|NCT04838613|469553822|FG000|Overall Study|Withdrawal by Subject|3|||
130434448|NCT04838613|469553823|FG001|Overall Study|Withdrawal by Subject|6|||
130434449|NCT04838613|469553822|FG000|Overall Study|Protocol Deviation|3|||
130434450|NCT04838613|469553823|FG001|Overall Study|Protocol Deviation|2|||
130434451|NCT04838613|469553822|FG000|Overall Study|Technical Problems|0|||
130434452|NCT04838613|469553823|FG001|Overall Study|Technical Problems|5|||
130434453|NCT04838613|469553822|FG000|Overall Study|Physician Decision|2|||
130434454|NCT04838613|469553823|FG001|Overall Study|Physician Decision|0|||
130434455|NCT01686581|469553824|FG000|Overall Study|Side-effects or Health Problems|15|||
130434456|NCT01686581|469553824|FG000|Overall Study|Lack of Efficacy|90|||
130434457|NCT01686581|469553824|FG000|Overall Study|Participant Concerned about Risks|6|||
130434458|NCT01686581|469553824|FG000|Overall Study|Thinks Injections Too Painful|8|||
130434459|NCT01686581|469553824|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
130434460|NCT01686581|469553824|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
130434461|NCT01686581|469553824|FG000|Overall Study|Thinks it is Inconvenient|17|||
130434462|NCT01686581|469553824|FG000|Overall Study|Other Miscellaneous Reasons|36|||
130434463|NCT01686581|469553824|FG000|Overall Study|Reason Missing|1|||
130434464|NCT00399763|469553825|FG000|Overall Study|Lost to Follow-up|2|||
130434465|NCT00399763|469553826|FG001|Overall Study|Lost to Follow-up|3|||
130434466|NCT04182880|469553827|FG000|Overall Study|Pregnancy|1|||
130434467|NCT04182880|469553828|FG001|Overall Study|Pregnancy|0|||
130434468|NCT03389477|469553829|FG000|Step 1|Withdrawal by Subject|1|||
130434469|NCT03389477|469553830|FG001|Step 1|Withdrawal by Subject|0|||
130434470|NCT03389477|469553829|FG000|Step 2|Withdrawal by Subject|1|||
130434471|NCT03389477|469553830|FG001|Step 2|Withdrawal by Subject|2|||
130434472|NCT03389477|469553829|FG000|Step 2|Disease progression|1|||
130434473|NCT03389477|469553830|FG001|Step 2|Disease progression|0|||
130434474|NCT03389477|469553829|FG000|Step 2|Death|0|||
130434475|NCT03389477|469553830|FG001|Step 2|Death|1|||
130434476|NCT03389477|469553829|FG000|Step 2|Poor performance status and nutrition|0|||
130434477|NCT03389477|469553830|FG001|Step 2|Poor performance status and nutrition|1|||
130434478|NCT03389477|469553829|FG000|Step 3|Withdrawal after 3 cycles|0|||
130434479|NCT03389477|469553830|FG001|Step 3|Withdrawal after 3 cycles|1|||
130434480|NCT03389477|469553829|FG000|Step 3|Still receiving active treatment|4|||
130434481|NCT03389477|469553830|FG001|Step 3|Still receiving active treatment|0|||
130434482|NCT03389477|469553829|FG000|Step 3|Progressive disease after 2 cycles|1|||
130434483|NCT03389477|469553830|FG001|Step 3|Progressive disease after 2 cycles|0|||
130434484|NCT03403426|469553833|FG000|Overall Study|Death|1|||
130434485|NCT03403426|469553833|FG000|Overall Study|Lost to Follow-up|2|||
130434486|NCT01657266|469553836|FG000|Overall Study|Lost to Follow-up|2|||
130434487|NCT01657266|469553837|FG001|Overall Study|Lost to Follow-up|2|||
130434488|NCT01657266|469553836|FG000|Overall Study|Adverse Event|2|||
130434489|NCT01657266|469553837|FG001|Overall Study|Adverse Event|3|||
130434490|NCT00909428|469553838|FG000|Overall Study|Lost to Follow-up|13|||
130434491|NCT00909428|469553839|FG001|Overall Study|Lost to Follow-up|10|||
130434492|NCT00909428|469553840|FG002|Overall Study|Lost to Follow-up|9|||
130434493|NCT03021668|469553841|FG000|Overall Study|Physician Decision|0|||
130679064|NCT01355081|470450950|FG001|Overall Study|Non Compliance with Study Medication|1|||
130679065|NCT01355081|470450951|FG002|Overall Study|Non Compliance with Study Medication|0|||
130679066|NCT02480764|470450952|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130434494|NCT03021668|469553842|FG001|Overall Study|Physician Decision|1|||
130434495|NCT01122381|469553843|FG000|Overall Study|study terminated early|0|||
130434496|NCT01122381|469553844|FG001|Overall Study|study terminated early|1|||
130434497|NCT02217280|469553845|FG000|Overall Study|Withdrawal by Subject|2|||
130434498|NCT02217280|469553845|FG000|Overall Study|Post-consent sceen fail|2|||
130434499|NCT00116844|469553848|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
130434500|NCT00116844|469553849|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
130434501|NCT00116844|469553848|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
130434502|NCT00116844|469553849|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
130434503|NCT00116844|469553848|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
130434504|NCT00116844|469553849|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
130434505|NCT00116844|469553848|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
130434506|NCT00116844|469553849|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
130679067|NCT02480764|470450953|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130679068|NCT02480764|470450954|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
130679069|NCT02480764|470450952|FG000|Overall Study|Major Protocol Deviation|1|||
130679070|NCT02480764|470450953|FG001|Overall Study|Major Protocol Deviation|4|||
130345186|NCT00701662|469235331|FG000|Overall Study|Lack of Efficacy|1|||
130345187|NCT00635024|469235332|FG000|Overall Study|Adverse Event|1|||
130345188|NCT01105065|469235333|FG000|Overall Study|Adverse Event|5|||
130345189|NCT01105065|469235333|FG000|Overall Study|Technical Problems|1|||
130345190|NCT02984943|469235334|FG000|Overall Study|Withdrawal by Subject|3|||
130345191|NCT02984943|469235334|FG000|Overall Study|Physician Decision|1|||
130345192|NCT04575597|469235337|FG000|Overall Study|Death|0|||
130345193|NCT04575597|469235338|FG001|Overall Study|Death|0|||
130345194|NCT04575597|469235339|FG002|Overall Study|Death|0|||
130345195|NCT04575597|469235340|FG003|Overall Study|Death|1|||
130345196|NCT04575597|469235341|FG004|Overall Study|Death|3|||
130345197|NCT04575597|469235342|FG005|Overall Study|Death|14|||
130345198|NCT04575597|469235337|FG000|Overall Study|Lost to Follow-up|2|||
130345199|NCT04575597|469235338|FG001|Overall Study|Lost to Follow-up|1|||
130345200|NCT04575597|469235339|FG002|Overall Study|Lost to Follow-up|1|||
130345201|NCT04575597|469235340|FG003|Overall Study|Lost to Follow-up|2|||
130345202|NCT04575597|469235341|FG004|Overall Study|Lost to Follow-up|10|||
130345203|NCT04575597|469235342|FG005|Overall Study|Lost to Follow-up|8|||
130345204|NCT04575597|469235337|FG000|Overall Study|Withdrawal by Subject|2|||
130345205|NCT04575597|469235338|FG001|Overall Study|Withdrawal by Subject|2|||
130345206|NCT04575597|469235339|FG002|Overall Study|Withdrawal by Subject|4|||
130345207|NCT04575597|469235340|FG003|Overall Study|Withdrawal by Subject|2|||
130345208|NCT04575597|469235341|FG004|Overall Study|Withdrawal by Subject|25|||
130345209|NCT04575597|469235342|FG005|Overall Study|Withdrawal by Subject|28|||
130345210|NCT04575597|469235337|FG000|Overall Study|Not Recorded|0|||
130345211|NCT04575597|469235338|FG001|Overall Study|Not Recorded|0|||
130345212|NCT04575597|469235339|FG002|Overall Study|Not Recorded|0|||
130345213|NCT04575597|469235340|FG003|Overall Study|Not Recorded|0|||
130345214|NCT04575597|469235341|FG004|Overall Study|Not Recorded|0|||
130345215|NCT04575597|469235342|FG005|Overall Study|Not Recorded|2|||
130345216|NCT04575597|469235337|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345217|NCT04575597|469235338|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345218|NCT04575597|469235339|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345219|NCT04575597|469235340|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345220|NCT04575597|469235341|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
130345221|NCT04575597|469235342|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130345222|NCT01587898|469235356|FG000|Overall Study|Adverse Event|1|||
130345223|NCT01587898|469235357|FG001|Overall Study|Adverse Event|1|||
130345224|NCT01587898|469235358|FG002|Overall Study|Adverse Event|0|||
130345225|NCT01587898|469235359|FG003|Overall Study|Adverse Event|0|||
130345226|NCT01587898|469235356|FG000|Overall Study|Protocol Violation|0|||
130345227|NCT01587898|469235357|FG001|Overall Study|Protocol Violation|2|||
130345228|NCT01587898|469235358|FG002|Overall Study|Protocol Violation|1|||
130345229|NCT01587898|469235359|FG003|Overall Study|Protocol Violation|1|||
130345230|NCT01587898|469235356|FG000|Overall Study|Lost to Follow-up|0|||
130345231|NCT01587898|469235357|FG001|Overall Study|Lost to Follow-up|0|||
130345232|NCT01587898|469235358|FG002|Overall Study|Lost to Follow-up|0|||
130345233|NCT01587898|469235359|FG003|Overall Study|Lost to Follow-up|1|||
130345234|NCT01587898|469235356|FG000|Overall Study|Withdrawal by Subject|2|||
130345235|NCT01587898|469235357|FG001|Overall Study|Withdrawal by Subject|1|||
130345236|NCT01587898|469235358|FG002|Overall Study|Withdrawal by Subject|0|||
130345237|NCT01587898|469235359|FG003|Overall Study|Withdrawal by Subject|0|||
130345238|NCT01587898|469235356|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
130345239|NCT01587898|469235357|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
130345240|NCT01587898|469235358|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
130345241|NCT01587898|469235359|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
130345242|NCT01738477|469235360|FG000|Overall Study|Lost to Follow-up|1|||
130345243|NCT01738477|469235361|FG001|Overall Study|Lost to Follow-up|4|||
130345244|NCT02437110|469235362|FG000|Screening|Lost to Follow-up|3|||
130345245|NCT02437110|469235362|FG000|Screening|Physician Decision|1|||
130345246|NCT02437110|469235362|FG000|ART|Adverse Event|3|||
130679071|NCT02480764|470450954|FG002|Overall Study|Major Protocol Deviation|3|||
130345247|NCT02437110|469235362|FG000|ART|Protocol Violation|3|||
130345248|NCT02437110|469235362|FG000|ART|Withdrawal by Subject|4|||
130345249|NCT02437110|469235362|FG000|ART|Lost to follow-up prior to start of intervention|1|||
130345250|NCT02437110|469235362|FG000|ART|Physician decision prior to start of intervention|2|||
130345251|NCT02437110|469235362|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
130345252|NCT02437110|469235362|FG000|Post-ART|Lost to Follow-up|3|||
130345253|NCT02437110|469235362|FG000|Post-ART|Protocol Violation|4|||
130345254|NCT02437110|469235362|FG000|Post-ART|Withdrawal by Subject|3|||
130345255|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
130345256|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
130434507|NCT00116844|469553848|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
130434508|NCT00116844|469553849|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
130434509|NCT00116844|469553848|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
130434510|NCT00116844|469553849|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
130434511|NCT00116844|469553848|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
130434512|NCT00116844|469553849|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
130434513|NCT00116844|469553848|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
130434514|NCT00116844|469553849|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
130434515|NCT00116844|469553848|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
130434516|NCT00116844|469553849|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
130434517|NCT01933880|469553850|FG000|Overall Study|Withdrawal by Subject|5|||
130434518|NCT01933880|469553851|FG001|Overall Study|Withdrawal by Subject|0|||
130434519|NCT01933880|469553850|FG000|Overall Study|Lack of Efficacy|1|||
130434520|NCT01933880|469553851|FG001|Overall Study|Lack of Efficacy|0|||
130434521|NCT01933880|469553850|FG000|Overall Study|Concomitant medication Interference|0|||
130434522|NCT01933880|469553851|FG001|Overall Study|Concomitant medication Interference|1|||
130434523|NCT01933880|469553850|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
130434524|NCT01933880|469553851|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
130434525|NCT01933880|469553850|FG000|Overall Study|Other|4|||
130434526|NCT01933880|469553851|FG001|Overall Study|Other|0|||
130434527|NCT01933880|469553850|FG000|Overall Study|Protocol Violation|1|||
130434528|NCT01933880|469553851|FG001|Overall Study|Protocol Violation|0|||
130434529|NCT02395133|469553852|FG000|Overall Study|Adverse Event|4|||
130434530|NCT02395133|469553853|FG001|Overall Study|Adverse Event|1|||
130434531|NCT02395133|469553854|FG002|Overall Study|Adverse Event|3|||
130434532|NCT02395133|469553855|FG003|Overall Study|Adverse Event|0|||
130679072|NCT02480764|470450952|FG000|Overall Study|Lost to Follow-up|0|||
130679073|NCT02480764|470450953|FG001|Overall Study|Lost to Follow-up|1|||
130679074|NCT02480764|470450954|FG002|Overall Study|Lost to Follow-up|2|||
130679075|NCT02480764|470450952|FG000|Overall Study|Voluntary Withdrawal|6|||
130679076|NCT02480764|470450953|FG001|Overall Study|Voluntary Withdrawal|5|||
130345257|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
130345258|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
130345259|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
130345260|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
130345261|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
130345262|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
130345263|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
130345264|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
130345265|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
130345266|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
130345267|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
130345268|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
130345269|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
130345270|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
130345271|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
130345272|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
130345273|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
130345274|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
130345275|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
130345276|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
130345277|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130345278|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130345279|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130345280|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130345281|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
130345282|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130345283|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130345284|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
130345285|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130345286|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130345287|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
130345288|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130345289|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130434533|NCT02395133|469553852|FG000|Overall Study|Lack of Efficacy|1|||
130434534|NCT02395133|469553853|FG001|Overall Study|Lack of Efficacy|0|||
130434535|NCT02395133|469553854|FG002|Overall Study|Lack of Efficacy|1|||
130434536|NCT02395133|469553855|FG003|Overall Study|Lack of Efficacy|1|||
130434537|NCT02395133|469553852|FG000|Overall Study|Protocol Violation|1|||
130434538|NCT02395133|469553853|FG001|Overall Study|Protocol Violation|1|||
130434539|NCT02395133|469553854|FG002|Overall Study|Protocol Violation|0|||
130434540|NCT02395133|469553855|FG003|Overall Study|Protocol Violation|3|||
130434541|NCT02395133|469553852|FG000|Overall Study|Lost to Follow-up|0|||
130434542|NCT02395133|469553853|FG001|Overall Study|Lost to Follow-up|1|||
130434543|NCT02395133|469553854|FG002|Overall Study|Lost to Follow-up|1|||
130434544|NCT02395133|469553855|FG003|Overall Study|Lost to Follow-up|0|||
130434545|NCT02395133|469553852|FG000|Overall Study|Pregnancy|0|||
130434546|NCT02395133|469553853|FG001|Overall Study|Pregnancy|0|||
130434547|NCT02395133|469553854|FG002|Overall Study|Pregnancy|3|||
130434548|NCT02395133|469553855|FG003|Overall Study|Pregnancy|0|||
130434549|NCT02395133|469553852|FG000|Overall Study|Consent withdrawn with no reason given|1|||
130434550|NCT02395133|469553853|FG001|Overall Study|Consent withdrawn with no reason given|3|||
130434551|NCT02395133|469553854|FG002|Overall Study|Consent withdrawn with no reason given|0|||
130434552|NCT02395133|469553855|FG003|Overall Study|Consent withdrawn with no reason given|2|||
130679077|NCT02480764|470450954|FG002|Overall Study|Voluntary Withdrawal|10|||
130679078|NCT02480764|470450952|FG000|Overall Study|Lack of Efficacy|0|||
130345290|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
130345291|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130345292|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130345293|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
130345294|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130345295|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130345296|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
130345297|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130345298|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130345299|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
130345300|NCT02576145|469235369|FG000|Overall Study|Adverse Event|1|||
130345301|NCT02576145|469235370|FG001|Overall Study|Adverse Event|0|||
130345302|NCT02576145|469235369|FG000|Overall Study|Withdrawal by Subject|1|||
130345303|NCT02576145|469235370|FG001|Overall Study|Withdrawal by Subject|0|||
130345304|NCT02576145|469235369|FG000|Overall Study|Acute rejection|1|||
130345305|NCT02576145|469235370|FG001|Overall Study|Acute rejection|0|||
130345306|NCT02576145|469235369|FG000|Overall Study|Tetanus Titers Decreased|0|||
130345307|NCT02576145|469235370|FG001|Overall Study|Tetanus Titers Decreased|1|||
130345308|NCT02660138|469235371|FG000|Overall Study|Adverse Event|0|||
130345309|NCT02660138|469235372|FG001|Overall Study|Adverse Event|3|||
130345310|NCT02660138|469235373|FG002|Overall Study|Adverse Event|2|||
130345311|NCT02660138|469235371|FG000|Overall Study|Lack of Efficacy|1|||
130345312|NCT02660138|469235372|FG001|Overall Study|Lack of Efficacy|2|||
130345313|NCT02660138|469235373|FG002|Overall Study|Lack of Efficacy|1|||
130345314|NCT02660138|469235371|FG000|Overall Study|Withdrawal by Subject|7|||
130345315|NCT02660138|469235372|FG001|Overall Study|Withdrawal by Subject|6|||
130345316|NCT02660138|469235373|FG002|Overall Study|Withdrawal by Subject|6|||
130345317|NCT02660138|469235371|FG000|Overall Study|Lost to Follow-up|4|||
130345318|NCT02660138|469235372|FG001|Overall Study|Lost to Follow-up|4|||
130345319|NCT02660138|469235373|FG002|Overall Study|Lost to Follow-up|1|||
130345320|NCT02660138|469235371|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
130345321|NCT02660138|469235372|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
130345322|NCT02660138|469235373|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
130345323|NCT02660138|469235371|FG000|Overall Study|Other|1|||
130345324|NCT02660138|469235372|FG001|Overall Study|Other|1|||
130345325|NCT02660138|469235373|FG002|Overall Study|Other|0|||
130345326|NCT02660138|469235371|FG000|Overall Study|Not treated|0|||
130345327|NCT02660138|469235372|FG001|Overall Study|Not treated|1|||
130345328|NCT02660138|469235373|FG002|Overall Study|Not treated|0|||
130345329|NCT00308581|469235378|FG000|Induction Phase|Adverse Event|0|||
130345330|NCT00308581|469235379|FG001|Induction Phase|Adverse Event|0|||
130679079|NCT02480764|470450953|FG001|Overall Study|Lack of Efficacy|3|||
130679080|NCT02480764|470450954|FG002|Overall Study|Lack of Efficacy|3|||
130679081|NCT02480764|470450952|FG000|Overall Study|Reason not Specified|0|||
130679082|NCT02480764|470450953|FG001|Overall Study|Reason not Specified|1|||
130679083|NCT02480764|470450954|FG002|Overall Study|Reason not Specified|0|||
130679084|NCT01475474|470450955|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
130345331|NCT00308581|469235380|FG002|Induction Phase|Adverse Event|37|||
130345332|NCT00308581|469235378|FG000|Induction Phase|Lack of Efficacy|0|||
130345333|NCT00308581|469235379|FG001|Induction Phase|Lack of Efficacy|0|||
130434553|NCT02395133|469553852|FG000|Overall Study|Consent withdrawn with personal reason|0|||
130679085|NCT01475474|470450955|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
130345334|NCT00308581|469235380|FG002|Induction Phase|Lack of Efficacy|121|||
130345335|NCT00308581|469235378|FG000|Induction Phase|Withdrawal by Subject|0|||
130345336|NCT00308581|469235379|FG001|Induction Phase|Withdrawal by Subject|0|||
130345337|NCT00308581|469235380|FG002|Induction Phase|Withdrawal by Subject|5|||
130345338|NCT00308581|469235378|FG000|Induction Phase|Unknown reason|0|||
130345339|NCT00308581|469235379|FG001|Induction Phase|Unknown reason|0|||
130434554|NCT02395133|469553853|FG001|Overall Study|Consent withdrawn with personal reason|1|||
130679086|NCT01046253|470450956|FG000|Second Intervention|Adverse Event|0|||
130679087|NCT01046253|470450957|FG001|Second Intervention|Adverse Event|1|||
130679088|NCT01046253|470450956|FG000|Second Intervention|Protocol Violation|0|||
130679089|NCT01046253|470450957|FG001|Second Intervention|Protocol Violation|1|||
130679090|NCT02339909|470450960|FG000|Overall Study|Became ineligible after randomisation|89|||
130679091|NCT02339909|470450961|FG001|Overall Study|Became ineligible after randomisation|63|||
130679092|NCT02339909|470450962|FG002|Overall Study|Became ineligible after randomisation|71|||
130679093|NCT00860028|470450970|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
130679094|NCT00860028|470450971|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
130679095|NCT01658943|470450973|FG000|Overall Study|Adverse Event|6|||
130679096|NCT01658943|470450974|FG001|Overall Study|Adverse Event|13|||
130679097|NCT01658943|470450973|FG000|Overall Study|Withdrawal by Subject|9|||
130679098|NCT01658943|470450974|FG001|Overall Study|Withdrawal by Subject|2|||
130679099|NCT01658943|470450973|FG000|Overall Study|Progression/Relapse|39|||
130679100|NCT01658943|470450974|FG001|Overall Study|Progression/Relapse|40|||
130679101|NCT01658943|470450973|FG000|Overall Study|Death|4|||
130679102|NCT01658943|470450974|FG001|Overall Study|Death|2|||
130679103|NCT01658943|470450973|FG000|Overall Study|not protocol specified|4|||
130679104|NCT01658943|470450974|FG001|Overall Study|not protocol specified|1|||
130679105|NCT01658943|470450973|FG000|Overall Study|Not eligible|7|||
130679106|NCT01658943|470450974|FG001|Overall Study|Not eligible|9|||
130679107|NCT01658943|470450973|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
130679108|NCT01658943|470450974|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
130679109|NCT00475020|470450976|FG000|Overall Study|Physician Decision|3|||
130679110|NCT00475020|470450976|FG000|Overall Study|Insurance Denial|1|||
130679111|NCT00475020|470450976|FG000|Overall Study|Donor not able to donate the last minute|1|||
130679112|NCT02514174|470450980|FG000|Overall Study|Patient refused to continue medication|1|||
130679113|NCT02514174|470450980|FG000|Overall Study|Adverse Event|2|||
130679114|NCT02514174|470450980|FG000|Overall Study|Study closed by sponsor|9|||
130679115|NCT02514174|470450980|FG000|Overall Study|Progressive disease|11|||
130679116|NCT02514174|470450980|FG000|Overall Study|Treatment change|1|||
130679117|NCT02514174|470450980|FG000|Overall Study|Treated off study with Afatinib.|1|||
130679118|NCT02130466|470450981|FG000|Overall Study|Death|4|||
130679119|NCT02130466|470450982|FG001|Overall Study|Death|1|||
130679120|NCT02130466|470450983|FG002|Overall Study|Death|1|||
130679121|NCT02130466|470450984|FG003|Overall Study|Death|3|||
130679122|NCT02130466|470450985|FG004|Overall Study|Death|2|||
130679123|NCT02130466|470450986|FG005|Overall Study|Death|30|||
130679124|NCT02130466|470450987|FG006|Overall Study|Death|45|||
130679125|NCT02130466|470450988|FG007|Overall Study|Death|2|||
130679126|NCT02130466|470450989|FG008|Overall Study|Death|3|||
130679127|NCT02130466|470450990|FG009|Overall Study|Death|4|||
130679128|NCT02130466|470450991|FG010|Overall Study|Death|5|||
130679129|NCT02130466|470450992|FG011|Overall Study|Death|3|||
130679130|NCT02130466|470450993|FG012|Overall Study|Death|11|||
130679131|NCT02130466|470450994|FG013|Overall Study|Death|7|||
130679132|NCT02130466|470450981|FG000|Overall Study|Lost to Follow-up|1|||
130679133|NCT02130466|470450982|FG001|Overall Study|Lost to Follow-up|0|||
130679134|NCT02130466|470450983|FG002|Overall Study|Lost to Follow-up|0|||
130679135|NCT02130466|470450984|FG003|Overall Study|Lost to Follow-up|0|||
130679136|NCT02130466|470450985|FG004|Overall Study|Lost to Follow-up|0|||
130679137|NCT02130466|470450986|FG005|Overall Study|Lost to Follow-up|1|||
130679138|NCT02130466|470450987|FG006|Overall Study|Lost to Follow-up|0|||
130679139|NCT02130466|470450988|FG007|Overall Study|Lost to Follow-up|0|||
130345340|NCT00308581|469235380|FG002|Induction Phase|Unknown reason|3|||
130345341|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Adverse Event|10|||
130345342|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Adverse Event|17|||
130345343|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Adverse Event|0|||
130345344|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
130345345|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
130345346|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
130345347|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
130345348|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
130345349|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
130345350|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
130345351|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
130345352|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
130345353|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
130345354|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
130345355|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
130345356|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Unknown reason|3|||
130345357|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Unknown reason|0|||
130345358|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Unknown reason|0|||
130345359|NCT00899353|469235381|FG000|Overall Study|Adverse Event|2|||
130345360|NCT00899353|469235381|FG000|Overall Study|Lost to Follow-up|1|||
130434555|NCT02395133|469553854|FG002|Overall Study|Consent withdrawn with personal reason|0|||
130434556|NCT02395133|469553855|FG003|Overall Study|Consent withdrawn with personal reason|3|||
130434557|NCT02395133|469553852|FG000|Overall Study|Sponsor decision|2|||
130434558|NCT02395133|469553853|FG001|Overall Study|Sponsor decision|0|||
130679140|NCT02130466|470450989|FG008|Overall Study|Lost to Follow-up|0|||
130679141|NCT02130466|470450990|FG009|Overall Study|Lost to Follow-up|0|||
130679142|NCT02130466|470450991|FG010|Overall Study|Lost to Follow-up|0|||
130679143|NCT02130466|470450992|FG011|Overall Study|Lost to Follow-up|0|||
130679144|NCT02130466|470450993|FG012|Overall Study|Lost to Follow-up|1|||
130679145|NCT02130466|470450994|FG013|Overall Study|Lost to Follow-up|0|||
130679146|NCT02130466|470450981|FG000|Overall Study|Physician Decision|0|||
130679147|NCT02130466|470450982|FG001|Overall Study|Physician Decision|0|||
130679148|NCT02130466|470450983|FG002|Overall Study|Physician Decision|0|||
130679149|NCT02130466|470450984|FG003|Overall Study|Physician Decision|0|||
130679150|NCT02130466|470450985|FG004|Overall Study|Physician Decision|0|||
130679151|NCT02130466|470450986|FG005|Overall Study|Physician Decision|1|||
130679152|NCT02130466|470450987|FG006|Overall Study|Physician Decision|1|||
130679153|NCT02130466|470450988|FG007|Overall Study|Physician Decision|0|||
130679154|NCT02130466|470450989|FG008|Overall Study|Physician Decision|0|||
130679155|NCT02130466|470450990|FG009|Overall Study|Physician Decision|0|||
130679156|NCT02130466|470450991|FG010|Overall Study|Physician Decision|0|||
130679157|NCT02130466|470450992|FG011|Overall Study|Physician Decision|0|||
130679158|NCT02130466|470450993|FG012|Overall Study|Physician Decision|0|||
130679159|NCT02130466|470450994|FG013|Overall Study|Physician Decision|0|||
130434559|NCT02395133|469553854|FG002|Overall Study|Sponsor decision|0|||
130434560|NCT02395133|469553855|FG003|Overall Study|Sponsor decision|1|||
130434561|NCT02395133|469553852|FG000|Overall Study|Other than specified above|5|||
130434562|NCT02395133|469553853|FG001|Overall Study|Other than specified above|2|||
130434563|NCT02395133|469553854|FG002|Overall Study|Other than specified above|2|||
130434564|NCT02395133|469553855|FG003|Overall Study|Other than specified above|4|||
130434565|NCT00962247|469553856|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
130434566|NCT00962247|469553856|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
130434567|NCT01125722|469553857|FG000|Overall Study|Withdrawal by Subject|2|||
130434568|NCT01125722|469553858|FG001|Overall Study|Withdrawal by Subject|1|||
130434569|NCT01125722|469553857|FG000|Overall Study|Lost to Follow-up|1|||
130434570|NCT01125722|469553858|FG001|Overall Study|Lost to Follow-up|0|||
130434571|NCT03474549|469553859|FG000|Overall Study|Death|31|||
130434572|NCT03474549|469553859|FG000|Overall Study|Lost to Follow-up|4|||
130434573|NCT03474549|469553859|FG000|Overall Study|Withdrawal by Subject|2|||
130434574|NCT00738101|469553864|FG000|Overall Study|Physician Decision|5|||
130434575|NCT00738101|469553864|FG000|Overall Study|Death|1|||
130434576|NCT00738101|469553864|FG000|Overall Study|Repeat enrollment|1|||
130434577|NCT00709059|469553871|FG000|Overall Study|Lost to Follow-up|34|||
130434578|NCT00709059|469553871|FG000|Overall Study|Withdrawal by Subject|19|||
130434579|NCT00709059|469553871|FG000|Overall Study|Physician Decision|7|||
130434580|NCT00709059|469553871|FG000|Overall Study|Disease complication|3|||
130434581|NCT00709059|469553871|FG000|Overall Study|Side effects|20|||
130434582|NCT00709059|469553871|FG000|Overall Study|Serious side effects|11|||
130434583|NCT01786330|469553872|FG000|Overall Study|Withdrawal by Subject|0|||
130434584|NCT01786330|469553873|FG001|Overall Study|Withdrawal by Subject|1|||
130434585|NCT01786330|469553872|FG000|Overall Study|Lost to Follow-up|0|||
130434586|NCT01786330|469553873|FG001|Overall Study|Lost to Follow-up|1|||
130434587|NCT01786330|469553872|FG000|Overall Study|Excluded intraoperatively|0|||
130434588|NCT01786330|469553873|FG001|Overall Study|Excluded intraoperatively|1|||
130434589|NCT01786330|469553872|FG000|Overall Study|Protocol Violation|1|||
130434590|NCT01786330|469553873|FG001|Overall Study|Protocol Violation|0|||
130434591|NCT02969525|469553878|FG000|Double-Blind Period|Adverse Event|0|||
130434592|NCT02969525|469553879|FG001|Double-Blind Period|Adverse Event|0|||
130434593|NCT02969525|469553880|FG002|Double-Blind Period|Adverse Event|1|||
130679160|NCT02130466|470450981|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679161|NCT02130466|470450982|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130679162|NCT02130466|470450983|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679163|NCT02130466|470450984|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
130679164|NCT02130466|470450985|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679165|NCT02130466|470450986|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
130434594|NCT02969525|469553881|FG003|Double-Blind Period|Adverse Event|1|||
130434595|NCT02969525|469553882|FG004|Double-Blind Period|Adverse Event|0|||
130434596|NCT02969525|469553883|FG005|Double-Blind Period|Adverse Event|0|||
130434597|NCT02969525|469553884|FG006|Double-Blind Period|Adverse Event|0|||
130434598|NCT02969525|469553885|FG007|Double-Blind Period|Adverse Event|0|||
130434599|NCT02969525|469553886|FG008|Double-Blind Period|Adverse Event|0|||
130434600|NCT02969525|469553887|FG009|Double-Blind Period|Adverse Event|0|||
130434601|NCT02969525|469553888|FG010|Double-Blind Period|Adverse Event|0|||
130434602|NCT02969525|469553889|FG011|Double-Blind Period|Adverse Event|0|||
130434603|NCT02969525|469553878|FG000|Double-Blind Period|LOW EGFR|0|||
130434604|NCT02969525|469553879|FG001|Double-Blind Period|LOW EGFR|0|||
130679166|NCT02130466|470450987|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
130679167|NCT02130466|470450988|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679168|NCT02130466|470450989|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679169|NCT02130466|470450990|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679170|NCT02130466|470450991|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679171|NCT02130466|470450992|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679172|NCT02130466|470450993|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679173|NCT02130466|470450994|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130679174|NCT02130466|470450981|FG000|Overall Study|Withdrawal by Subject|1|||
130679175|NCT02130466|470450982|FG001|Overall Study|Withdrawal by Subject|0|||
130679176|NCT02130466|470450983|FG002|Overall Study|Withdrawal by Subject|0|||
130679177|NCT02130466|470450984|FG003|Overall Study|Withdrawal by Subject|0|||
130679178|NCT02130466|470450985|FG004|Overall Study|Withdrawal by Subject|0|||
130679179|NCT02130466|470450986|FG005|Overall Study|Withdrawal by Subject|1|||
130434605|NCT02969525|469553880|FG002|Double-Blind Period|LOW EGFR|0|||
130434606|NCT02969525|469553881|FG003|Double-Blind Period|LOW EGFR|1|||
130434607|NCT02969525|469553882|FG004|Double-Blind Period|LOW EGFR|0|||
130434608|NCT02969525|469553883|FG005|Double-Blind Period|LOW EGFR|0|||
130434609|NCT02969525|469553884|FG006|Double-Blind Period|LOW EGFR|0|||
130434610|NCT02969525|469553885|FG007|Double-Blind Period|LOW EGFR|0|||
130434611|NCT02969525|469553886|FG008|Double-Blind Period|LOW EGFR|0|||
130434612|NCT02969525|469553887|FG009|Double-Blind Period|LOW EGFR|0|||
130434613|NCT02969525|469553888|FG010|Double-Blind Period|LOW EGFR|0|||
130434614|NCT02969525|469553889|FG011|Double-Blind Period|LOW EGFR|0|||
130434615|NCT02969525|469553878|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
130434616|NCT02969525|469553879|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434617|NCT02969525|469553880|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434618|NCT02969525|469553881|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
130434619|NCT02969525|469553882|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434620|NCT02969525|469553883|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434621|NCT02969525|469553884|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434622|NCT02969525|469553885|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434623|NCT02969525|469553886|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434624|NCT02969525|469553887|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434625|NCT02969525|469553888|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434626|NCT02969525|469553889|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130434627|NCT02969525|469553878|FG000|Dose-Blind Period|Adverse Event|0|||
130434628|NCT02969525|469553879|FG001|Dose-Blind Period|Adverse Event|0|||
130434629|NCT02969525|469553880|FG002|Dose-Blind Period|Adverse Event|0|||
130434630|NCT02969525|469553881|FG003|Dose-Blind Period|Adverse Event|0|||
130434631|NCT02969525|469553882|FG004|Dose-Blind Period|Adverse Event|0|||
130434632|NCT02969525|469553883|FG005|Dose-Blind Period|Adverse Event|0|||
130434633|NCT02969525|469553884|FG006|Dose-Blind Period|Adverse Event|0|||
130434634|NCT02969525|469553885|FG007|Dose-Blind Period|Adverse Event|0|||
130434635|NCT02969525|469553886|FG008|Dose-Blind Period|Adverse Event|0|||
130434636|NCT02969525|469553887|FG009|Dose-Blind Period|Adverse Event|1|||
130434637|NCT02969525|469553888|FG010|Dose-Blind Period|Adverse Event|1|||
130434638|NCT02969525|469553889|FG011|Dose-Blind Period|Adverse Event|1|||
130434639|NCT02969525|469553878|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
130434640|NCT02969525|469553879|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
130434641|NCT02969525|469553880|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
130434642|NCT02969525|469553881|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
130434643|NCT02969525|469553882|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
130434644|NCT02969525|469553883|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
130434645|NCT02969525|469553884|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
130434646|NCT02969525|469553885|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
130434647|NCT02969525|469553886|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
130434648|NCT02969525|469553887|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
130434649|NCT02969525|469553888|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
130434650|NCT02969525|469553889|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
130434651|NCT02969525|469553878|FG000|Dose-Blind Period|Non-cooperating patient|0|||
130434652|NCT02969525|469553879|FG001|Dose-Blind Period|Non-cooperating patient|0|||
130679180|NCT02130466|470450987|FG006|Overall Study|Withdrawal by Subject|0|||
130679181|NCT02130466|470450988|FG007|Overall Study|Withdrawal by Subject|0|||
130679182|NCT02130466|470450989|FG008|Overall Study|Withdrawal by Subject|1|||
130679183|NCT02130466|470450990|FG009|Overall Study|Withdrawal by Subject|0|||
130434653|NCT02969525|469553880|FG002|Dose-Blind Period|Non-cooperating patient|0|||
130434654|NCT02969525|469553881|FG003|Dose-Blind Period|Non-cooperating patient|0|||
130434655|NCT02969525|469553882|FG004|Dose-Blind Period|Non-cooperating patient|0|||
130434656|NCT02969525|469553883|FG005|Dose-Blind Period|Non-cooperating patient|0|||
130434657|NCT02969525|469553884|FG006|Dose-Blind Period|Non-cooperating patient|0|||
130434658|NCT02969525|469553885|FG007|Dose-Blind Period|Non-cooperating patient|0|||
130434659|NCT02969525|469553886|FG008|Dose-Blind Period|Non-cooperating patient|0|||
130434660|NCT02969525|469553887|FG009|Dose-Blind Period|Non-cooperating patient|0|||
130434661|NCT02969525|469553888|FG010|Dose-Blind Period|Non-cooperating patient|0|||
130434662|NCT02969525|469553889|FG011|Dose-Blind Period|Non-cooperating patient|1|||
130434663|NCT02969525|469553878|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434664|NCT02969525|469553879|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434665|NCT02969525|469553880|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434666|NCT02969525|469553881|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434667|NCT02969525|469553882|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434668|NCT02969525|469553883|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434669|NCT02969525|469553884|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434670|NCT02969525|469553885|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434671|NCT02969525|469553886|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434672|NCT02969525|469553887|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434673|NCT02969525|469553888|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
130434674|NCT02969525|469553889|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130434675|NCT03445065|469553890|FG000|Overall Study|Withdrawal by Subject|3|||
130434676|NCT03445065|469553891|FG001|Overall Study|Withdrawal by Subject|6|||
130434677|NCT03445065|469553892|FG002|Overall Study|Withdrawal by Subject|2|||
130434678|NCT03445065|469553893|FG003|Overall Study|Withdrawal by Subject|2|||
130434679|NCT03445065|469553890|FG000|Overall Study|Other|4|||
130434680|NCT03445065|469553891|FG001|Overall Study|Other|3|||
130434681|NCT03445065|469553892|FG002|Overall Study|Other|3|||
130434682|NCT03445065|469553893|FG003|Overall Study|Other|1|||
130434683|NCT02172625|469553894|FG000|Overall Study|Adverse Event|0|||
130434684|NCT02172625|469553895|FG001|Overall Study|Adverse Event|1|||
130434685|NCT02172625|469553894|FG000|Overall Study|Pregnancy|0|||
130434686|NCT02172625|469553895|FG001|Overall Study|Pregnancy|1|||
130434687|NCT02172625|469553894|FG000|Overall Study|car accident|0|||
130434688|NCT02172625|469553895|FG001|Overall Study|car accident|1|||
130434689|NCT00524030|469553896|FG000|Overall Study|Lack of Efficacy|10|||
130434690|NCT00524030|469553897|FG001|Overall Study|Lack of Efficacy|24|||
130434691|NCT00524030|469553896|FG000|Overall Study|Lost to Follow-up|0|||
130434692|NCT00524030|469553897|FG001|Overall Study|Lost to Follow-up|2|||
130434693|NCT00524030|469553896|FG000|Overall Study|Withdrawal by Subject|3|||
130434694|NCT00524030|469553897|FG001|Overall Study|Withdrawal by Subject|8|||
130434695|NCT00524030|469553896|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
130434696|NCT00524030|469553897|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
130434697|NCT00524030|469553896|FG000|Overall Study|Protocol Violation|0|||
130434698|NCT00524030|469553897|FG001|Overall Study|Protocol Violation|1|||
130434699|NCT00524030|469553896|FG000|Overall Study|Pregnancy|1|||
130434700|NCT00524030|469553897|FG001|Overall Study|Pregnancy|0|||
130434701|NCT00524030|469553896|FG000|Overall Study|Adverse Event|3|||
130434702|NCT00524030|469553897|FG001|Overall Study|Adverse Event|21|||
130434703|NCT00524030|469553896|FG000|Overall Study|Death|0|||
130434704|NCT00524030|469553897|FG001|Overall Study|Death|1|||
130434705|NCT03315130|469553898|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130434706|NCT03315130|469553899|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
130434707|NCT03315130|469553900|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130434708|NCT03315130|469553901|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130434709|NCT03315130|469553898|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130434710|NCT03315130|469553899|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
130434711|NCT03315130|469553900|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130434712|NCT03315130|469553901|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130679184|NCT02130466|470450991|FG010|Overall Study|Withdrawal by Subject|0|||
130679185|NCT02130466|470450992|FG011|Overall Study|Withdrawal by Subject|0|||
130679186|NCT02130466|470450993|FG012|Overall Study|Withdrawal by Subject|0|||
130679187|NCT02130466|470450994|FG013|Overall Study|Withdrawal by Subject|0|||
130679188|NCT04529109|470450995|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130679189|NCT04529109|470450996|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130679190|NCT00993616|470450997|FG000|Overall Study|No tumor at entry|1|||
130679191|NCT00993616|470450997|FG000|Overall Study|Never treated|1|||
130679192|NCT00788125|470452198|FG000|Overall Study|Death|6|||
130679193|NCT00453362|470452205|FG000|Overall Study|Adverse Event|5|||
130679194|NCT00453362|470452205|FG000|Overall Study|Death|7|||
130679195|NCT00453362|470452205|FG000|Overall Study|Physician Decision|2|||
130679196|NCT00453362|470452205|FG000|Overall Study|Withdrawal by Subject|3|||
130434713|NCT03315130|469553898|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
130434714|NCT03315130|469553899|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130434715|NCT03315130|469553900|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130434716|NCT03315130|469553901|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130434717|NCT03315130|469553898|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130434718|NCT03315130|469553899|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
130434719|NCT03315130|469553900|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130679197|NCT00453362|470452205|FG000|Overall Study|Progression of disease|56|||
130679198|NCT00453362|470452205|FG000|Overall Study|Screening Failure|14|||
130679199|NCT04885296|470452208|FG000|Period 1|Covid-19 Related|1|||
130679200|NCT04885296|470452209|FG001|Period 1|Covid-19 Related|0|||
130679201|NCT04885296|470452208|FG000|Period 1|Adverse Event|0|||
130679202|NCT04885296|470452209|FG001|Period 1|Adverse Event|1|||
130679203|NCT04885296|470452208|FG000|Period 1|Withdrawal by Subject|1|||
130679204|NCT04885296|470452209|FG001|Period 1|Withdrawal by Subject|1|||
130679205|NCT04885296|470452208|FG000|Period 1|Test Article No Longer Available|1|||
130679206|NCT04885296|470452209|FG001|Period 1|Test Article No Longer Available|0|||
130679207|NCT04885296|470452208|FG000|Period 1|Dispensed Study lens in Error|1|||
130679208|NCT04885296|470452209|FG001|Period 1|Dispensed Study lens in Error|0|||
130345361|NCT00899353|469235381|FG000|Overall Study|Withdrawal by Subject|2|||
130345362|NCT01284491|469235385|FG000|Overall Study|Study termination|13|||
130345363|NCT02694757|469235388|FG000|Overall Study|Lack of Efficacy|3|||
130345364|NCT02650921|469235389|FG000|Overall Study|Withdrawal by Subject|4|||
130345365|NCT02650921|469235389|FG000|Overall Study|Lost to Follow-up|2|||
130345366|NCT02650921|469235389|FG000|Overall Study|Adverse Event|1|||
130345367|NCT02650921|469235389|FG000|Overall Study|Due to Medical Condition|1|||
130345368|NCT00783302|469235390|FG000|Overall Study|Lost to Follow-up|17|||
130345369|NCT00783302|469235390|FG000|Overall Study|Technical Problems|11|||
130345370|NCT00783302|469235390|FG000|Overall Study|Protocol Violation|3|||
130345371|NCT00783302|469235390|FG000|Overall Study|Physician Decision|1|||
130345372|NCT00783302|469235390|FG000|Overall Study|Withdrawal by Subject|3|||
130345373|NCT04604132|469235391|FG000|Overall Study|Adverse Event|2|||
130345374|NCT04604132|469235392|FG001|Overall Study|Adverse Event|0|||
130345375|NCT04604132|469235393|FG002|Overall Study|Adverse Event|0|||
130345376|NCT04604132|469235394|FG003|Overall Study|Adverse Event|1|||
130345377|NCT04604132|469235395|FG004|Overall Study|Adverse Event|2|||
130345378|NCT04604132|469235391|FG000|Overall Study|Study terminated by sponsor|0|||
130345379|NCT04604132|469235392|FG001|Overall Study|Study terminated by sponsor|0|||
130345380|NCT04604132|469235393|FG002|Overall Study|Study terminated by sponsor|0|||
130345381|NCT04604132|469235394|FG003|Overall Study|Study terminated by sponsor|0|||
130345382|NCT04604132|469235395|FG004|Overall Study|Study terminated by sponsor|1|||
130345383|NCT04604132|469235391|FG000|Overall Study|Progressive disease: Clinical progression|0|||
130345384|NCT04604132|469235392|FG001|Overall Study|Progressive disease: Clinical progression|0|||
130345385|NCT04604132|469235393|FG002|Overall Study|Progressive disease: Clinical progression|1|||
130345386|NCT04604132|469235394|FG003|Overall Study|Progressive disease: Clinical progression|0|||
130345387|NCT04604132|469235395|FG004|Overall Study|Progressive disease: Clinical progression|0|||
130345388|NCT04604132|469235391|FG000|Overall Study|Progressive disease: Radiological progression|8|||
130345389|NCT04604132|469235392|FG001|Overall Study|Progressive disease: Radiological progression|7|||
130345390|NCT04604132|469235393|FG002|Overall Study|Progressive disease: Radiological progression|10|||
130345391|NCT04604132|469235394|FG003|Overall Study|Progressive disease: Radiological progression|4|||
130345392|NCT04604132|469235395|FG004|Overall Study|Progressive disease: Radiological progression|3|||
130345393|NCT04604132|469235391|FG000|Overall Study|Death|3|||
130345394|NCT04604132|469235392|FG001|Overall Study|Death|1|||
130345395|NCT04604132|469235393|FG002|Overall Study|Death|2|||
130345396|NCT04604132|469235394|FG003|Overall Study|Death|1|||
130345397|NCT04604132|469235395|FG004|Overall Study|Death|0|||
130345398|NCT00952380|469235396|FG000|Overall Study|Other|0|||
130345399|NCT00952380|469235397|FG001|Overall Study|Other|0|||
130345400|NCT00952380|469235398|FG002|Overall Study|Other|0|||
130345401|NCT00952380|469235399|FG003|Overall Study|Other|0|||
130345402|NCT00952380|469235400|FG004|Overall Study|Other|1|||
130345403|NCT00952380|469235396|FG000|Overall Study|Withdrawal by Subject|0|||
130345404|NCT00952380|469235397|FG001|Overall Study|Withdrawal by Subject|0|||
130345405|NCT00952380|469235398|FG002|Overall Study|Withdrawal by Subject|1|||
130345406|NCT00952380|469235399|FG003|Overall Study|Withdrawal by Subject|0|||
130345407|NCT00952380|469235400|FG004|Overall Study|Withdrawal by Subject|2|||
130345408|NCT00952380|469235396|FG000|Overall Study|Adverse Event|0|||
130345409|NCT00952380|469235397|FG001|Overall Study|Adverse Event|1|||
130345410|NCT00952380|469235398|FG002|Overall Study|Adverse Event|0|||
130345411|NCT00952380|469235399|FG003|Overall Study|Adverse Event|0|||
130345412|NCT00952380|469235400|FG004|Overall Study|Adverse Event|3|||
130345413|NCT00952380|469235396|FG000|Overall Study|Physician Decision|0|||
130345414|NCT00952380|469235397|FG001|Overall Study|Physician Decision|0|||
130345415|NCT00952380|469235398|FG002|Overall Study|Physician Decision|1|||
130345416|NCT00952380|469235399|FG003|Overall Study|Physician Decision|2|||
130345417|NCT00952380|469235400|FG004|Overall Study|Physician Decision|0|||
130345418|NCT00952380|469235396|FG000|Overall Study|Non-compliant to protocol|0|||
130345419|NCT00952380|469235397|FG001|Overall Study|Non-compliant to protocol|0|||
130345420|NCT00952380|469235398|FG002|Overall Study|Non-compliant to protocol|0|||
130345421|NCT00952380|469235399|FG003|Overall Study|Non-compliant to protocol|1|||
130345422|NCT00952380|469235400|FG004|Overall Study|Non-compliant to protocol|0|||
130345423|NCT03400956|469235401|FG000|Treatment Period 1|Adverse Event|0|||
130345424|NCT03400956|469235402|FG001|Treatment Period 1|Adverse Event|1|||
130345425|NCT03400956|469235403|FG002|Treatment Period 1|Adverse Event|0|||
130679209|NCT04885296|470452208|FG000|Period 1|Lost to Follow-up|1|||
130679210|NCT04885296|470452209|FG001|Period 1|Lost to Follow-up|0|||
130679211|NCT04885296|470452208|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130679212|NCT04885296|470452209|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130679213|NCT00862979|470452210|FG000|Overall Study|Adverse Event|6|||
130679214|NCT00862979|470452211|FG001|Overall Study|Adverse Event|3|||
130679215|NCT00862979|470452210|FG000|Overall Study|Protocol Violation|0|||
130679216|NCT00862979|470452211|FG001|Overall Study|Protocol Violation|1|||
130679217|NCT00862979|470452210|FG000|Overall Study|Patient withdrew consent|2|||
130679218|NCT00862979|470452211|FG001|Overall Study|Patient withdrew consent|1|||
130679219|NCT00862979|470452210|FG000|Overall Study|Administrative problems|0|||
130679220|NCT00862979|470452211|FG001|Overall Study|Administrative problems|1|||
130679221|NCT00862979|470452210|FG000|Overall Study|Death|0|||
130679222|NCT00862979|470452211|FG001|Overall Study|Death|1|||
130679223|NCT03100903|470452212|FG000|Overall Study|Withdrawal by Subject|0|||
130679224|NCT03100903|470452213|FG001|Overall Study|Withdrawal by Subject|0|||
130679225|NCT03100903|470452214|FG002|Overall Study|Withdrawal by Subject|1|||
130679226|NCT00433147|470452215|FG000|Overall Study|Adverse Event|0|||
130345426|NCT03400956|469235401|FG000|Treatment Period 1|Lost to Follow-up|0|||
130345427|NCT03400956|469235402|FG001|Treatment Period 1|Lost to Follow-up|0|||
130345428|NCT03400956|469235403|FG002|Treatment Period 1|Lost to Follow-up|1|||
130345429|NCT03400956|469235401|FG000|Treatment Period 1|Protocol Violation|0|||
130345430|NCT03400956|469235402|FG001|Treatment Period 1|Protocol Violation|2|||
130345431|NCT03400956|469235403|FG002|Treatment Period 1|Protocol Violation|0|||
130345432|NCT03400956|469235401|FG000|Treatment Period 1|Study terminated by sponsor|3|||
130345433|NCT03400956|469235402|FG001|Treatment Period 1|Study terminated by sponsor|1|||
130345434|NCT03400956|469235403|FG002|Treatment Period 1|Study terminated by sponsor|1|||
130345435|NCT03400956|469235401|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130345436|NCT03400956|469235402|FG001|Treatment Period 1|Withdrawal by Subject|2|||
130345437|NCT03400956|469235403|FG002|Treatment Period 1|Withdrawal by Subject|4|||
130345438|NCT03400956|469235401|FG000|Treatment Period 1|Other|1|||
130345439|NCT03400956|469235402|FG001|Treatment Period 1|Other|2|||
130345440|NCT03400956|469235403|FG002|Treatment Period 1|Other|3|||
130345441|NCT03400956|469235401|FG000|Post-treatment Period 1|Adverse Event|0|||
130345442|NCT03400956|469235402|FG001|Post-treatment Period 1|Adverse Event|0|||
130345443|NCT03400956|469235403|FG002|Post-treatment Period 1|Adverse Event|1|||
130345444|NCT03400956|469235401|FG000|Post-treatment Period 1|Physician Decision|2|||
130345445|NCT03400956|469235402|FG001|Post-treatment Period 1|Physician Decision|3|||
130345446|NCT03400956|469235403|FG002|Post-treatment Period 1|Physician Decision|0|||
130345447|NCT03400956|469235401|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
130345448|NCT03400956|469235402|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
130345449|NCT03400956|469235403|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
130345450|NCT03400956|469235401|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
130345451|NCT03400956|469235402|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130345452|NCT03400956|469235403|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
130345453|NCT03400956|469235401|FG000|Post-treatment Period 1|Other|4|||
130345454|NCT03400956|469235402|FG001|Post-treatment Period 1|Other|3|||
130345455|NCT03400956|469235403|FG002|Post-treatment Period 1|Other|4|||
130345456|NCT03400956|469235401|FG000|Treatment Period 2|Adverse Event|2|||
130345457|NCT03400956|469235402|FG001|Treatment Period 2|Adverse Event|1|||
130345458|NCT03400956|469235403|FG002|Treatment Period 2|Adverse Event|1|||
130345459|NCT03400956|469235401|FG000|Treatment Period 2|Lost to Follow-up|1|||
130345460|NCT03400956|469235402|FG001|Treatment Period 2|Lost to Follow-up|1|||
130345461|NCT03400956|469235403|FG002|Treatment Period 2|Lost to Follow-up|0|||
130345462|NCT03400956|469235401|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130345463|NCT03400956|469235402|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130345464|NCT03400956|469235403|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130345465|NCT03400956|469235401|FG000|Treatment Period 2|Other|1|||
130345466|NCT03400956|469235402|FG001|Treatment Period 2|Other|1|||
130345467|NCT03400956|469235403|FG002|Treatment Period 2|Other|0|||
130345468|NCT03400956|469235401|FG000|Follow-up Period|Withdrawal by Subject|0|||
130345469|NCT03400956|469235402|FG001|Follow-up Period|Withdrawal by Subject|0|||
130345470|NCT03400956|469235403|FG002|Follow-up Period|Withdrawal by Subject|1|||
130345471|NCT03400956|469235401|FG000|Follow-up Period|Other|0|||
130345472|NCT03400956|469235402|FG001|Follow-up Period|Other|0|||
130345473|NCT03400956|469235403|FG002|Follow-up Period|Other|1|||
130345474|NCT00160667|469235404|FG000|Overall Study|Adverse Event|3|||
130345475|NCT00160667|469235405|FG001|Overall Study|Adverse Event|1|||
130345476|NCT00160667|469235406|FG002|Overall Study|Adverse Event|4|||
130345477|NCT00160667|469235404|FG000|Overall Study|Withdrawal by Subject|2|||
130345478|NCT00160667|469235405|FG001|Overall Study|Withdrawal by Subject|0|||
130345479|NCT00160667|469235406|FG002|Overall Study|Withdrawal by Subject|1|||
130345480|NCT00160667|469235404|FG000|Overall Study|Lack of Efficacy|0|||
130345481|NCT00160667|469235405|FG001|Overall Study|Lack of Efficacy|1|||
130345482|NCT00160667|469235406|FG002|Overall Study|Lack of Efficacy|0|||
130345483|NCT00160667|469235404|FG000|Overall Study|Protocol Violation|0|||
130679227|NCT00433147|470452216|FG001|Overall Study|Adverse Event|1|||
130679228|NCT00433147|470452217|FG002|Overall Study|Adverse Event|0|||
130679229|NCT00433147|470452218|FG003|Overall Study|Adverse Event|0|||
130434720|NCT03315130|469553901|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130434721|NCT03315130|469553898|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130434722|NCT03315130|469553899|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
130434723|NCT03315130|469553900|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130434724|NCT03315130|469553901|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130434725|NCT03315130|469553898|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
130434726|NCT03315130|469553899|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
130434727|NCT03315130|469553900|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
130434728|NCT03315130|469553901|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
130434729|NCT00118898|469553909|FG000|Overall Study|Death|6|||
130434730|NCT00118898|469553910|FG001|Overall Study|Death|11|||
130434731|NCT00118898|469553911|FG002|Overall Study|Death|6|||
130434732|NCT00118898|469553912|FG003|Overall Study|Death|8|||
130434733|NCT00118898|469553909|FG000|Overall Study|Lost to Follow-up|26|||
130434734|NCT00118898|469553910|FG001|Overall Study|Lost to Follow-up|34|||
130434735|NCT00118898|469553911|FG002|Overall Study|Lost to Follow-up|33|||
130434736|NCT00118898|469553912|FG003|Overall Study|Lost to Follow-up|33|||
130434737|NCT00118898|469553909|FG000|Overall Study|Withdrawal by Subject|10|||
130434738|NCT00118898|469553910|FG001|Overall Study|Withdrawal by Subject|5|||
130434739|NCT00118898|469553911|FG002|Overall Study|Withdrawal by Subject|8|||
130434740|NCT00118898|469553912|FG003|Overall Study|Withdrawal by Subject|8|||
130434741|NCT00118898|469553909|FG000|Overall Study|Site Closure|33|||
130434742|NCT00118898|469553910|FG001|Overall Study|Site Closure|31|||
130434743|NCT00118898|469553911|FG002|Overall Study|Site Closure|28|||
130434744|NCT00118898|469553912|FG003|Overall Study|Site Closure|37|||
130434745|NCT00118898|469553909|FG000|Overall Study|Severe debilitation|1|||
130434746|NCT00118898|469553910|FG001|Overall Study|Severe debilitation|4|||
130434747|NCT00118898|469553911|FG002|Overall Study|Severe debilitation|6|||
130434748|NCT00118898|469553912|FG003|Overall Study|Severe debilitation|4|||
130434749|NCT00118898|469553909|FG000|Overall Study|Not compliant with requirements|11|||
130434750|NCT00118898|469553910|FG001|Overall Study|Not compliant with requirements|13|||
130434751|NCT00118898|469553911|FG002|Overall Study|Not compliant with requirements|11|||
130434752|NCT00118898|469553912|FG003|Overall Study|Not compliant with requirements|11|||
130434753|NCT00118898|469553909|FG000|Overall Study|Not able to get to clinic|34|||
130434754|NCT00118898|469553910|FG001|Overall Study|Not able to get to clinic|43|||
130434755|NCT00118898|469553911|FG002|Overall Study|Not able to get to clinic|31|||
130434756|NCT00118898|469553912|FG003|Overall Study|Not able to get to clinic|40|||
130434757|NCT00429494|469555197|FG000|Overall Study|Withdrawal by Subject|9|||
130434758|NCT00429494|469555197|FG000|Overall Study|Death|6|||
130679230|NCT01882647|470452219|FG000|Overall Study|Lost to Follow-up|2|||
130679231|NCT01882647|470452220|FG001|Overall Study|Lost to Follow-up|2|||
130679232|NCT01882647|470452219|FG000|Overall Study|Withdrawal by Subject|0|||
130679233|NCT01882647|470452220|FG001|Overall Study|Withdrawal by Subject|4|||
130679234|NCT01027143|470452223|FG000|Overall Study|Lost to Follow-up|9|||
130679235|NCT01027143|470452224|FG001|Overall Study|Lost to Follow-up|4|||
130679236|NCT03292653|470452226|FG000|Overall Study|Adverse Event|0|||
130345484|NCT00160667|469235405|FG001|Overall Study|Protocol Violation|1|||
130345485|NCT00160667|469235406|FG002|Overall Study|Protocol Violation|0|||
130345486|NCT00160667|469235404|FG000|Overall Study|Patient decision|0|||
130345487|NCT00160667|469235405|FG001|Overall Study|Patient decision|0|||
130345488|NCT00160667|469235406|FG002|Overall Study|Patient decision|1|||
130345489|NCT01306929|469235411|FG000|Overall Study|Withdrawal by Subject|23|||
130345490|NCT01306929|469235411|FG000|Overall Study|Adverse Event|21|||
130345491|NCT01306929|469235411|FG000|Overall Study|Physician Decision|13|||
130345492|NCT01306929|469235411|FG000|Overall Study|Death|8|||
130345493|NCT01306929|469235411|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130345494|NCT01306929|469235411|FG000|Overall Study|Protocol Violation|3|||
130345495|NCT01306929|469235411|FG000|Overall Study|Non-compliance with study drug|2|||
130345496|NCT01306929|469235411|FG000|Overall Study|Lost to Follow-up|2|||
130345497|NCT01306929|469235411|FG000|Overall Study|Various|17|||
130345498|NCT03709576|469235412|FG000|Overall Study|progression prior to enrollment|1|||
130345499|NCT00890045|469235418|FG000|Overall Study|Death|0|||
130345500|NCT00890045|469235419|FG001|Overall Study|Death|1|||
130345501|NCT00890045|469235418|FG000|Overall Study|Did not receive HeRO Graft|0|||
130345502|NCT00890045|469235419|FG001|Overall Study|Did not receive HeRO Graft|2|||
130345503|NCT00890045|469235418|FG000|Overall Study|Lost to Follow-up|5|||
130345504|NCT00890045|469235419|FG001|Overall Study|Lost to Follow-up|7|||
130345505|NCT00483756|469235424|FG000|Overall Study|Death|2|||
130345506|NCT00483756|469235425|FG001|Overall Study|Death|0|||
130345507|NCT00483756|469235426|FG002|Overall Study|Death|1|||
130345508|NCT00483756|469235424|FG000|Overall Study|Adverse Event|19|||
130345509|NCT00483756|469235425|FG001|Overall Study|Adverse Event|38|||
130434759|NCT00976703|469555198|FG000|Overall Study|Physician Decision|1|||
130434760|NCT00976703|469555199|FG001|Overall Study|Physician Decision|1|||
130434761|NCT00976703|469555198|FG000|Overall Study|ineligible for study|2|||
130434762|NCT00976703|469555199|FG001|Overall Study|ineligible for study|2|||
130679237|NCT03292653|470452227|FG001|Overall Study|Adverse Event|0|||
130679238|NCT03292653|470452228|FG002|Overall Study|Adverse Event|1|||
130434763|NCT03075501|469555202|FG000|Overall Study|Scheduling difficulties|15|||
130434764|NCT03075501|469555203|FG001|Overall Study|Scheduling difficulties|9|||
130434765|NCT00957931|469555206|FG000|Overall Study|Death|4|||
130434766|NCT00857805|469555207|FG000|Overall Study|Withdrawal by Subject|1|||
130434767|NCT00857805|469555208|FG001|Overall Study|Withdrawal by Subject|1|||
130434768|NCT04867785|469555209|FG000|Overall Study|Adverse Event|1|||
130434769|NCT04867785|469555210|FG001|Overall Study|Adverse Event|0|||
130434770|NCT04867785|469555211|FG002|Overall Study|Adverse Event|1|||
130434771|NCT04867785|469555212|FG003|Overall Study|Adverse Event|0|||
130434772|NCT04867785|469555213|FG004|Overall Study|Adverse Event|0|||
130434773|NCT04867785|469555214|FG005|Overall Study|Adverse Event|0|||
130434774|NCT04867785|469555215|FG006|Overall Study|Adverse Event|0|||
130434775|NCT04867785|469555216|FG007|Overall Study|Adverse Event|2|||
130434776|NCT04867785|469555209|FG000|Overall Study|Lost to Follow-up|4|||
130434777|NCT04867785|469555210|FG001|Overall Study|Lost to Follow-up|4|||
130434778|NCT04867785|469555211|FG002|Overall Study|Lost to Follow-up|3|||
130434779|NCT04867785|469555212|FG003|Overall Study|Lost to Follow-up|2|||
130434780|NCT04867785|469555213|FG004|Overall Study|Lost to Follow-up|0|||
130434781|NCT04867785|469555214|FG005|Overall Study|Lost to Follow-up|1|||
130434782|NCT04867785|469555215|FG006|Overall Study|Lost to Follow-up|0|||
130434783|NCT04867785|469555216|FG007|Overall Study|Lost to Follow-up|1|||
130434784|NCT04867785|469555209|FG000|Overall Study|Withdrawal by Subject|6|||
130434785|NCT04867785|469555210|FG001|Overall Study|Withdrawal by Subject|2|||
130434786|NCT04867785|469555211|FG002|Overall Study|Withdrawal by Subject|2|||
130434787|NCT04867785|469555212|FG003|Overall Study|Withdrawal by Subject|1|||
130434788|NCT04867785|469555213|FG004|Overall Study|Withdrawal by Subject|2|||
130434789|NCT04867785|469555214|FG005|Overall Study|Withdrawal by Subject|0|||
130434790|NCT04867785|469555215|FG006|Overall Study|Withdrawal by Subject|2|||
130434791|NCT04867785|469555216|FG007|Overall Study|Withdrawal by Subject|5|||
130434792|NCT04867785|469555209|FG000|Overall Study|Physician Decision|0|||
130434793|NCT04867785|469555210|FG001|Overall Study|Physician Decision|0|||
130434794|NCT04867785|469555211|FG002|Overall Study|Physician Decision|0|||
130434795|NCT04867785|469555212|FG003|Overall Study|Physician Decision|0|||
130434796|NCT04867785|469555213|FG004|Overall Study|Physician Decision|0|||
130434797|NCT04867785|469555214|FG005|Overall Study|Physician Decision|0|||
130434798|NCT04867785|469555215|FG006|Overall Study|Physician Decision|0|||
130434799|NCT04867785|469555216|FG007|Overall Study|Physician Decision|1|||
130434800|NCT04867785|469555209|FG000|Overall Study|Inadvertent Enrollment|0|||
130434801|NCT04867785|469555210|FG001|Overall Study|Inadvertent Enrollment|0|||
130434802|NCT04867785|469555211|FG002|Overall Study|Inadvertent Enrollment|0|||
130434803|NCT04867785|469555212|FG003|Overall Study|Inadvertent Enrollment|1|||
130434804|NCT04867785|469555213|FG004|Overall Study|Inadvertent Enrollment|1|||
130434805|NCT04867785|469555214|FG005|Overall Study|Inadvertent Enrollment|0|||
130434806|NCT04867785|469555215|FG006|Overall Study|Inadvertent Enrollment|0|||
130434807|NCT04867785|469555216|FG007|Overall Study|Inadvertent Enrollment|1|||
130434808|NCT04867785|469555209|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130434809|NCT04867785|469555210|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130434810|NCT04867785|469555211|FG002|Overall Study|Eligibility Criteria Not Met|0|||
130434811|NCT04867785|469555212|FG003|Overall Study|Eligibility Criteria Not Met|0|||
130434812|NCT04867785|469555213|FG004|Overall Study|Eligibility Criteria Not Met|0|||
130434813|NCT04867785|469555214|FG005|Overall Study|Eligibility Criteria Not Met|0|||
130434814|NCT04867785|469555215|FG006|Overall Study|Eligibility Criteria Not Met|0|||
130434815|NCT04867785|469555216|FG007|Overall Study|Eligibility Criteria Not Met|1|||
130434816|NCT01289041|469555217|FG000|Overall Study|Adverse Event|24|||
130434817|NCT01289041|469555217|FG000|Overall Study|Physician Decision|1|||
130434818|NCT01289041|469555217|FG000|Overall Study|Progressive Disease|41|||
130434819|NCT01289041|469555217|FG000|Overall Study|Withdrawal by Subject|3|||
130434820|NCT01289041|469555217|FG000|Overall Study|Death|1|||
130434821|NCT01062763|469555218|FG000|Overall Study|Adverse Event|3|||
130434822|NCT01062763|469555219|FG001|Overall Study|Adverse Event|4|||
130434823|NCT02494921|469555221|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
130434824|NCT02494921|469555222|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
130434825|NCT02494921|469555223|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
130434826|NCT02494921|469555224|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
130434827|NCT02494921|469555225|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
130434828|NCT02494921|469555221|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
130434829|NCT02494921|469555222|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
130434830|NCT02494921|469555223|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
130434831|NCT02494921|469555224|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
130434832|NCT02494921|469555225|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
130434833|NCT02494921|469555221|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
130434834|NCT02494921|469555222|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
130434835|NCT02494921|469555223|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
130434836|NCT02494921|469555224|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
130434837|NCT02494921|469555225|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
130434838|NCT02714868|469555233|FG000|Overall Study|Withdrawal by Subject|3|||
130434839|NCT02714868|469555234|FG001|Overall Study|Withdrawal by Subject|0|||
130679239|NCT03292653|470452226|FG000|Overall Study|Did not Receive Treatment|1|||
130679240|NCT03292653|470452227|FG001|Overall Study|Did not Receive Treatment|0|||
130679241|NCT03292653|470452228|FG002|Overall Study|Did not Receive Treatment|0|||
130679242|NCT01367275|470452231|FG000|Overall Study|Ineligible|1|||
130679243|NCT01367275|470452231|FG000|Overall Study|Disease Progression|2|||
130679244|NCT05346055|470452232|FG000|Overall Study|Withdrawal by Subject|1|||
130679245|NCT05346055|470452232|FG000|Overall Study|Protocol Violation|1|||
130679246|NCT05346055|470452232|FG000|Overall Study|Therapist decision|1|||
130679247|NCT02564263|470452235|FG000|Overall Study|Adverse Event|31|||
130679248|NCT02564263|470452236|FG001|Overall Study|Adverse Event|29|||
130679249|NCT02564263|470452235|FG000|Overall Study|Death|270|||
130679250|NCT02564263|470452236|FG001|Overall Study|Death|262|||
130216615|NCT03162328|468755619|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
130345510|NCT00483756|469235426|FG002|Overall Study|Adverse Event|40|||
130345511|NCT00483756|469235424|FG000|Overall Study|Lack of Efficacy|1|||
130345512|NCT00483756|469235425|FG001|Overall Study|Lack of Efficacy|0|||
130345513|NCT00483756|469235426|FG002|Overall Study|Lack of Efficacy|0|||
130345514|NCT00483756|469235424|FG000|Overall Study|Lost to Follow-up|3|||
130345515|NCT00483756|469235425|FG001|Overall Study|Lost to Follow-up|1|||
130345516|NCT00483756|469235426|FG002|Overall Study|Lost to Follow-up|0|||
130345517|NCT00483756|469235424|FG000|Overall Study|Withdrawal by Subject|5|||
130345518|NCT00483756|469235425|FG001|Overall Study|Withdrawal by Subject|3|||
130345519|NCT00483756|469235426|FG002|Overall Study|Withdrawal by Subject|4|||
130345520|NCT00483756|469235424|FG000|Overall Study|Other|2|||
130345521|NCT00483756|469235425|FG001|Overall Study|Other|4|||
130345522|NCT00483756|469235426|FG002|Overall Study|Other|3|||
130345523|NCT00483756|469235424|FG000|Overall Study|Randomized, Not Treated|1|||
130345524|NCT00483756|469235425|FG001|Overall Study|Randomized, Not Treated|4|||
130345525|NCT00483756|469235426|FG002|Overall Study|Randomized, Not Treated|4|||
130345526|NCT04463069|469235427|FG000|Overall Study|Withdrawal by Subject|2|||
130345527|NCT04463069|469235428|FG001|Overall Study|Withdrawal by Subject|10|||
130345528|NCT04463069|469235427|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
130345529|NCT04463069|469235428|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
130345530|NCT03603509|469237127|FG000|Overall Study|Lost to Follow-up|3|||
130345531|NCT03603509|469237128|FG001|Overall Study|Lost to Follow-up|4|||
130345532|NCT02656680|469237131|FG000|Overall Study|Lost to Follow-up|0|||
130345533|NCT02656680|469237132|FG001|Overall Study|Lost to Follow-up|1|||
130345534|NCT02656680|469237133|FG002|Overall Study|Lost to Follow-up|7|||
130345535|NCT04966910|469237134|FG000|Baseline|Participant did not complete measure|0|||
130345536|NCT04966910|469237135|FG001|Baseline|Participant did not complete measure|0|||
130345537|NCT04966910|469237136|FG002|Baseline|Participant did not complete measure|1|||
130345538|NCT04966910|469237137|FG003|Baseline|Participant did not complete measure|0|||
130345539|NCT04966910|469237134|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
130345540|NCT04966910|469237135|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
130345541|NCT04966910|469237136|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130345542|NCT04966910|469237137|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130345543|NCT04966910|469237134|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
130345544|NCT04966910|469237135|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
130345545|NCT04966910|469237136|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
130345546|NCT04966910|469237137|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
130345547|NCT04966910|469237134|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
130345548|NCT04966910|469237135|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
130345549|NCT04966910|469237136|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
130345550|NCT04966910|469237137|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
130345551|NCT04531462|469237141|FG000|Overall Study|Withdrawal by Subject|3|||
130345552|NCT04531462|469237142|FG001|Overall Study|Withdrawal by Subject|1|||
130345553|NCT04531462|469237141|FG000|Overall Study|Adverse Event|3|||
130345554|NCT04531462|469237142|FG001|Overall Study|Adverse Event|3|||
130345555|NCT00504582|469237143|FG000|Overall Study|Lost to Follow-up|1|||
130345556|NCT00504582|469237144|FG001|Overall Study|Lost to Follow-up|0|||
130345557|NCT00504582|469237145|FG002|Overall Study|Lost to Follow-up|0|||
130345558|NCT00348933|469237148|FG000|Overall Study|Withdrawal by Subject|10|||
130345559|NCT00348933|469237148|FG000|Overall Study|Lost to Follow-up|6|||
130345560|NCT00348933|469237148|FG000|Overall Study|Protocol Violation|2|||
130345561|NCT00348933|469237148|FG000|Overall Study|Adverse Event|7|||
130345562|NCT01489111|469237149|FG000|Overall Study|Withdrawal criterion|1|||
130345563|NCT00711516|469237155|FG000|Overall Study|Adverse Event|1|||
130345564|NCT00711516|469237156|FG001|Overall Study|Adverse Event|1|||
130345565|NCT00711516|469237155|FG000|Overall Study|Withdrawal by Subject|0|||
130345566|NCT00711516|469237156|FG001|Overall Study|Withdrawal by Subject|1|||
130345567|NCT00711516|469237155|FG000|Overall Study|Protocol Violation|0|||
130345568|NCT00711516|469237156|FG001|Overall Study|Protocol Violation|1|||
130679251|NCT02564263|470452235|FG000|Overall Study|Withdrawal by Subject|4|||
130345569|NCT01029405|469237160|FG000|Overall Study|Withdrawal by Subject|0|||
130679252|NCT02564263|470452236|FG001|Overall Study|Withdrawal by Subject|19|||
130679253|NCT02564263|470452235|FG000|Overall Study|Sponsor's decision|9|||
130679254|NCT02564263|470452236|FG001|Overall Study|Sponsor's decision|4|||
130679255|NCT03311646|470452237|FG000|Overall Study|Physician Decision|1|||
130679256|NCT03311646|470452237|FG000|Overall Study|Withdrawal by Subject|5|||
130679257|NCT03311646|470452237|FG000|Overall Study|Lost to Follow-up|5|||
130679258|NCT03311646|470452237|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
130679259|NCT00728949|470452243|FG000|Overall Study|Adverse Event|8|||
130679260|NCT00728949|470452244|FG001|Overall Study|Adverse Event|0|||
130679261|NCT00728949|470452243|FG000|Overall Study|Withdrawal by Subject|2|||
130345570|NCT01029405|469237161|FG001|Overall Study|Withdrawal by Subject|1|||
130345571|NCT01029405|469237162|FG002|Overall Study|Withdrawal by Subject|2|||
130345572|NCT01029405|469237163|FG003|Overall Study|Withdrawal by Subject|0|||
130345573|NCT01029405|469237160|FG000|Overall Study|Protocol Violation|0|||
130345574|NCT01029405|469237161|FG001|Overall Study|Protocol Violation|0|||
130345575|NCT01029405|469237162|FG002|Overall Study|Protocol Violation|0|||
130345576|NCT01029405|469237163|FG003|Overall Study|Protocol Violation|1|||
130345577|NCT01029405|469237160|FG000|Overall Study|Adverse Event|0|||
130345578|NCT01029405|469237161|FG001|Overall Study|Adverse Event|0|||
130345579|NCT01029405|469237162|FG002|Overall Study|Adverse Event|1|||
130345580|NCT01029405|469237163|FG003|Overall Study|Adverse Event|1|||
130345581|NCT01029405|469237160|FG000|Overall Study|Lost to Follow-up|2|||
130345582|NCT01029405|469237161|FG001|Overall Study|Lost to Follow-up|1|||
130345583|NCT01029405|469237162|FG002|Overall Study|Lost to Follow-up|1|||
130345584|NCT01029405|469237163|FG003|Overall Study|Lost to Follow-up|2|||
130345585|NCT01029405|469237160|FG000|Overall Study|Other|0|||
130345586|NCT01029405|469237161|FG001|Overall Study|Other|1|||
130345587|NCT01029405|469237162|FG002|Overall Study|Other|0|||
130345588|NCT01029405|469237163|FG003|Overall Study|Other|1|||
130345589|NCT01534182|469237166|FG000|Overall Study|Administrative problems|1|||
130345590|NCT01534182|469237167|FG001|Overall Study|Administrative problems|0|||
130345591|NCT01534182|469237166|FG000|Overall Study|Withdrawal by Subject|4|||
130345592|NCT01534182|469237167|FG001|Overall Study|Withdrawal by Subject|7|||
130345593|NCT01534182|469237166|FG000|Overall Study|Adverse Event|7|||
130345594|NCT01534182|469237167|FG001|Overall Study|Adverse Event|3|||
130345595|NCT00924170|469237168|FG000|Overall Study|Refused further treatment|0|||
130345596|NCT00924170|469237169|FG001|Overall Study|Refused further treatment|1|||
130345597|NCT00924170|469237168|FG000|Overall Study|Physician Decision|0|||
130345598|NCT00924170|469237169|FG001|Overall Study|Physician Decision|1|||
130345599|NCT00924170|469237168|FG000|Overall Study|Progressive disease|3|||
130345600|NCT00924170|469237169|FG001|Overall Study|Progressive disease|6|||
130345601|NCT00924170|469237168|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
130345602|NCT00924170|469237169|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
130345603|NCT00924170|469237168|FG000|Overall Study|Death|1|||
130345604|NCT00924170|469237169|FG001|Overall Study|Death|0|||
130345605|NCT04449029|469237173|FG000|Overall Study|Adverse Event|0|||
130345606|NCT04449029|469237174|FG001|Overall Study|Adverse Event|1|||
130345607|NCT04449029|469237175|FG002|Overall Study|Adverse Event|1|||
130345608|NCT04449029|469237176|FG003|Overall Study|Adverse Event|0|||
130345609|NCT04449029|469237177|FG004|Overall Study|Adverse Event|1|||
130345610|NCT04449029|469237178|FG005|Overall Study|Adverse Event|0|||
130345611|NCT04449029|469237179|FG006|Overall Study|Adverse Event|1|||
130345612|NCT04449029|469237180|FG007|Overall Study|Adverse Event|0|||
130345613|NCT04449029|469237173|FG000|Overall Study|Lost to Follow-up|0|||
130345614|NCT04449029|469237174|FG001|Overall Study|Lost to Follow-up|1|||
130345615|NCT04449029|469237175|FG002|Overall Study|Lost to Follow-up|0|||
130345616|NCT04449029|469237176|FG003|Overall Study|Lost to Follow-up|0|||
130345617|NCT04449029|469237177|FG004|Overall Study|Lost to Follow-up|0|||
130345618|NCT04449029|469237178|FG005|Overall Study|Lost to Follow-up|0|||
130345619|NCT04449029|469237179|FG006|Overall Study|Lost to Follow-up|0|||
130345620|NCT04449029|469237180|FG007|Overall Study|Lost to Follow-up|0|||
130345621|NCT04449029|469237173|FG000|Overall Study|Protocol Violation|0|||
130345622|NCT04449029|469237174|FG001|Overall Study|Protocol Violation|1|||
130345623|NCT04449029|469237175|FG002|Overall Study|Protocol Violation|0|||
130345624|NCT04449029|469237176|FG003|Overall Study|Protocol Violation|0|||
130345625|NCT04449029|469237177|FG004|Overall Study|Protocol Violation|0|||
130345626|NCT04449029|469237178|FG005|Overall Study|Protocol Violation|0|||
130345627|NCT04449029|469237179|FG006|Overall Study|Protocol Violation|0|||
130345628|NCT04449029|469237180|FG007|Overall Study|Protocol Violation|0|||
130345629|NCT04449029|469237173|FG000|Overall Study|Physician Decision|0|||
130345630|NCT04449029|469237174|FG001|Overall Study|Physician Decision|0|||
130345631|NCT04449029|469237175|FG002|Overall Study|Physician Decision|0|||
130345632|NCT04449029|469237176|FG003|Overall Study|Physician Decision|0|||
130345633|NCT04449029|469237177|FG004|Overall Study|Physician Decision|0|||
130345634|NCT04449029|469237178|FG005|Overall Study|Physician Decision|1|||
130345635|NCT04449029|469237179|FG006|Overall Study|Physician Decision|0|||
130345636|NCT04449029|469237180|FG007|Overall Study|Physician Decision|0|||
130345637|NCT04449029|469237173|FG000|Overall Study|Withdrawal by Subject|3|||
130679262|NCT00728949|470452244|FG001|Overall Study|Withdrawal by Subject|2|||
130679263|NCT00728949|470452243|FG000|Overall Study|Abnormal Lab Results|0|||
130345638|NCT04449029|469237174|FG001|Overall Study|Withdrawal by Subject|0|||
130434840|NCT02714868|469555233|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
130434841|NCT02714868|469555234|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
130434842|NCT02714868|469555233|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
130434843|NCT02714868|469555234|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
130434844|NCT00255346|469555238|FG000|Overall Study|Adverse Event|1|||
130434845|NCT00255346|469555239|FG001|Overall Study|Adverse Event|0|||
130434846|NCT00255346|469555240|FG002|Overall Study|Adverse Event|0|||
130434847|NCT00255346|469555241|FG003|Overall Study|Adverse Event|0|||
130434848|NCT00255346|469555242|FG004|Overall Study|Adverse Event|0|||
130434849|NCT00674323|469555243|FG000|Overall Study|Adverse Event|0|||
130434850|NCT00674323|469555244|FG001|Overall Study|Adverse Event|1|||
130434851|NCT00674323|469555245|FG002|Overall Study|Adverse Event|0|||
130434852|NCT00674323|469555243|FG000|Overall Study|Protocol Violation|1|||
130434853|NCT00674323|469555244|FG001|Overall Study|Protocol Violation|0|||
130434854|NCT00674323|469555245|FG002|Overall Study|Protocol Violation|0|||
130434855|NCT02045433|469555252|FG000|Overall Study|Withdrawal by Subject|1|||
130434856|NCT00409786|469555256|FG000|Overall Study|Withdrawal by Subject|3|||
130434857|NCT00154310|469555257|FG000|Overall Study|Adverse Event|19|||
130679264|NCT00728949|470452244|FG001|Overall Study|Abnormal Lab Results|2|||
130679265|NCT00728949|470452243|FG000|Overall Study|On treatment at cutoff date|1|||
130679266|NCT00728949|470452244|FG001|Overall Study|On treatment at cutoff date|0|||
130679267|NCT03127137|470452246|FG000|Overall Study|Requested sedation after consent|1|||
130679268|NCT03127137|470452247|FG001|Overall Study|Requested sedation after consent|0|||
130679269|NCT03127137|470452246|FG000|Overall Study|Malfunction in electronic data collection|1|||
130679270|NCT03127137|470452247|FG001|Overall Study|Malfunction in electronic data collection|0|||
130679271|NCT03127137|470452246|FG000|Overall Study|Post procedure testing could not be obtained|0|||
130679272|NCT03127137|470452247|FG001|Overall Study|Post procedure testing could not be obtained|1|||
130679273|NCT02319148|470452252|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130679274|NCT02319148|470452253|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130679275|NCT02319148|470452254|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130679276|NCT02319148|470452255|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130679277|NCT02319148|470452252|FG000|Second Intervention Period|No longer willing to participate|0|||
130679278|NCT02319148|470452253|FG001|Second Intervention Period|No longer willing to participate|1|||
130434858|NCT00154310|469555258|FG001|Overall Study|Adverse Event|9|||
130434859|NCT00154310|469555257|FG000|Overall Study|Lack of Efficacy|5|||
130434860|NCT00154310|469555258|FG001|Overall Study|Lack of Efficacy|4|||
130434861|NCT00154310|469555257|FG000|Overall Study|Protocol Violation|4|||
130434862|NCT00154310|469555258|FG001|Overall Study|Protocol Violation|2|||
130434863|NCT00154310|469555257|FG000|Overall Study|Withdrawal by Subject|9|||
130434864|NCT00154310|469555258|FG001|Overall Study|Withdrawal by Subject|3|||
130434865|NCT00154310|469555257|FG000|Overall Study|Lost to Follow-up|0|||
130434866|NCT00154310|469555258|FG001|Overall Study|Lost to Follow-up|8|||
130434867|NCT00154310|469555257|FG000|Overall Study|Administrative problems|0|||
130434868|NCT00154310|469555258|FG001|Overall Study|Administrative problems|1|||
130434869|NCT00154310|469555257|FG000|Overall Study|Death|0|||
130434870|NCT00154310|469555258|FG001|Overall Study|Death|1|||
130434871|NCT04399356|469555259|FG000|Overall Study|Lost to Follow-up|1|||
130434872|NCT04399356|469555260|FG001|Overall Study|Lost to Follow-up|1|||
130434873|NCT04399356|469555259|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
130679279|NCT02319148|470452254|FG002|Second Intervention Period|No longer willing to participate|0|||
130679280|NCT02319148|470452255|FG003|Second Intervention Period|No longer willing to participate|0|||
130679281|NCT02319148|470452252|FG000|Second Intervention Period|Other|0|||
130679282|NCT02319148|470452253|FG001|Second Intervention Period|Other|0|||
130679283|NCT02319148|470452254|FG002|Second Intervention Period|Other|0|||
130679284|NCT02319148|470452255|FG003|Second Intervention Period|Other|1|||
130679285|NCT01087970|470452257|FG000|Overall Study|Protocol Violation|2|||
130679286|NCT00543309|470452258|FG000|Overall Study|Physician Decision|0|||
130434874|NCT04399356|469555260|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
130434875|NCT04399356|469555259|FG000|Overall Study|Withdrawal by Subject|1|||
130679287|NCT00543309|470452259|FG001|Overall Study|Physician Decision|1|||
130679288|NCT00543309|470452260|FG002|Overall Study|Physician Decision|0|||
130679289|NCT01249664|470452261|FG000|Overall Study|Withdrawal by Subject|5|||
130679290|NCT01249664|470452262|FG001|Overall Study|Withdrawal by Subject|0|||
130679291|NCT01249664|470452261|FG000|Overall Study|Adverse Event|1|||
130434876|NCT04399356|469555260|FG001|Overall Study|Withdrawal by Subject|0|||
130434877|NCT01678820|469555261|FG000|Overall Study|Study Terminated by Sponsor|45|||
130679292|NCT01249664|470452262|FG001|Overall Study|Adverse Event|0|||
130434878|NCT01678820|469555262|FG001|Overall Study|Study Terminated by Sponsor|43|||
130434879|NCT01678820|469555263|FG002|Overall Study|Study Terminated by Sponsor|43|||
130434880|NCT01678820|469555261|FG000|Overall Study|Withdrawal by Subject|2|||
130434881|NCT01678820|469555262|FG001|Overall Study|Withdrawal by Subject|5|||
130434882|NCT01678820|469555263|FG002|Overall Study|Withdrawal by Subject|2|||
130434883|NCT01678820|469555261|FG000|Overall Study|Protocol Specified Criteria|2|||
130434884|NCT01678820|469555262|FG001|Overall Study|Protocol Specified Criteria|3|||
130679293|NCT02636907|470452265|FG000|Autoinjector Assessment Period|Adverse Event|2|||
130679294|NCT02636907|470452265|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
130679295|NCT02636907|470452265|FG000|Extension Phase|Adverse Event|2|||
130679296|NCT02636907|470452265|FG000|Extension Phase|Withdrawal by Subject|4|||
130679297|NCT02636907|470452265|FG000|Extension Phase|Physician Decision|1|||
130679298|NCT02636907|470452265|FG000|Extension Phase|Lost to Follow-up|2|||
130679299|NCT02636907|470452265|FG000|Extension Phase|Lack of Efficacy|1|||
130679300|NCT01682083|470452272|FG000|Overall Study|Lost to Follow-up|11|||
130679301|NCT01682083|470452273|FG001|Overall Study|Lost to Follow-up|18|||
130679302|NCT01682083|470452272|FG000|Overall Study|Withdrawal by Subject|31|||
130679303|NCT01682083|470452273|FG001|Overall Study|Withdrawal by Subject|40|||
130679304|NCT01682083|470452272|FG000|Overall Study|Death|60|||
130679305|NCT01682083|470452273|FG001|Overall Study|Death|93|||
130679306|NCT01682083|470452272|FG000|Overall Study|Physician Decision|5|||
130679307|NCT01682083|470452273|FG001|Overall Study|Physician Decision|4|||
130679308|NCT01074554|470452277|FG000|Overall Study|Adverse Event|3|||
130679309|NCT01074554|470452278|FG001|Overall Study|Adverse Event|3|||
130679310|NCT01074554|470452277|FG000|Overall Study|Lost to Follow-up|0|||
130679311|NCT01074554|470452278|FG001|Overall Study|Lost to Follow-up|1|||
130679312|NCT01239121|470452279|FG000|Overall Study|Withdrawal by Subject|2|||
130679313|NCT01239121|470452280|FG001|Overall Study|Withdrawal by Subject|4|||
130679314|NCT01239121|470452281|FG002|Overall Study|Withdrawal by Subject|0|||
130679315|NCT04276883|470452282|FG000|Overall Study|Withdrawal by Subject|2|||
130679316|NCT04276883|470452283|FG001|Overall Study|Withdrawal by Subject|3|||
130434885|NCT01678820|469555263|FG002|Overall Study|Protocol Specified Criteria|1|||
130434886|NCT01678820|469555261|FG000|Overall Study|Adverse Event|2|||
130434887|NCT01678820|469555262|FG001|Overall Study|Adverse Event|2|||
130434888|NCT01678820|469555263|FG002|Overall Study|Adverse Event|2|||
130434889|NCT01678820|469555261|FG000|Overall Study|Lost to Follow-up|7|||
130679317|NCT04276883|470452284|FG002|Overall Study|Withdrawal by Subject|6|||
130679318|NCT04276883|470452282|FG000|Overall Study|Lost to Follow-up|1|||
130679319|NCT04276883|470452283|FG001|Overall Study|Lost to Follow-up|3|||
130434890|NCT01678820|469555262|FG001|Overall Study|Lost to Follow-up|2|||
130434891|NCT01678820|469555263|FG002|Overall Study|Lost to Follow-up|2|||
130434892|NCT01678820|469555261|FG000|Overall Study|Non-compliance with study drug|0|||
130434893|NCT01678820|469555262|FG001|Overall Study|Non-compliance with study drug|1|||
130434894|NCT01678820|469555263|FG002|Overall Study|Non-compliance with study drug|0|||
130434895|NCT01678820|469555261|FG000|Overall Study|Physician Decision|0|||
130434896|NCT01678820|469555262|FG001|Overall Study|Physician Decision|0|||
130434897|NCT01678820|469555263|FG002|Overall Study|Physician Decision|1|||
130434898|NCT01678820|469555261|FG000|Overall Study|Protocol Violation|4|||
130434899|NCT01678820|469555262|FG001|Overall Study|Protocol Violation|5|||
130434900|NCT01678820|469555263|FG002|Overall Study|Protocol Violation|4|||
130434901|NCT01678820|469555261|FG000|Overall Study|Not treated with double-blind study drug|0|||
130434902|NCT01678820|469555262|FG001|Overall Study|Not treated with double-blind study drug|2|||
130434903|NCT01678820|469555263|FG002|Overall Study|Not treated with double-blind study drug|2|||
130434904|NCT03447730|469555264|FG000|Overall Study|Adverse Event|0|||
130434905|NCT03447730|469555265|FG001|Overall Study|Adverse Event|2|||
130434906|NCT03447730|469555266|FG002|Overall Study|Adverse Event|0|||
130434907|NCT01350505|469555269|FG000|Overall Study|Lost to Follow-up|4|||
130434908|NCT05266963|469555270|FG000|Drug Period A|Withdrawal by Subject|0|||
130434909|NCT05266963|469555271|FG001|Drug Period A|Withdrawal by Subject|1|||
130434910|NCT04702568|469555272|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
130434911|NCT04702568|469555273|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
130434912|NCT04702568|469555272|FG000|Overall Study|Pregnancy|1|||
130434913|NCT04702568|469555273|FG001|Overall Study|Pregnancy|0|||
130434914|NCT04702568|469555272|FG000|Overall Study|Bone marrow transplant|1|||
130434915|NCT04702568|469555273|FG001|Overall Study|Bone marrow transplant|0|||
130434916|NCT04702568|469555272|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
130679320|NCT04276883|470452284|FG002|Overall Study|Lost to Follow-up|0|||
130679321|NCT04276883|470452282|FG000|Overall Study|Adverse Event|0|||
130679322|NCT04276883|470452283|FG001|Overall Study|Adverse Event|1|||
130679323|NCT04276883|470452284|FG002|Overall Study|Adverse Event|0|||
130679324|NCT04276883|470452282|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
130679325|NCT04276883|470452283|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
130434917|NCT04702568|469555273|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
130679326|NCT04276883|470452284|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
130679327|NCT01876706|470452285|FG000|Overall Study|BPH Intervention|9|||
130434918|NCT04702568|469555272|FG000|Overall Study|Withdrawal by Subject|0|||
130434919|NCT04702568|469555273|FG001|Overall Study|Withdrawal by Subject|2|||
130434920|NCT00393523|469555274|FG000|Overall Study|Lost to Follow-up|0|||
130434921|NCT00393523|469555275|FG001|Overall Study|Lost to Follow-up|0|||
130434922|NCT00393523|469555276|FG002|Overall Study|Lost to Follow-up|0|||
130434923|NCT00393523|469555277|FG003|Overall Study|Lost to Follow-up|2|||
130679328|NCT01876706|470452285|FG000|Overall Study|Lost to Follow-up|7|||
130679329|NCT01876706|470452285|FG000|Overall Study|Withdrawals|6|||
130679330|NCT01876706|470452285|FG000|Overall Study|Death|3|||
130679331|NCT00659607|470452286|FG000|Overall Study|No blood pressure recorded|147|||
130679332|NCT00659607|470452286|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
130679333|NCT00659607|470452286|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
130679334|NCT00659607|470452286|FG000|Overall Study|No recorded efficacy data|15|||
130679335|NCT00659607|470452286|FG000|Overall Study|Inconsistent BP measuring date|2|||
130679336|NCT02073643|470452289|FG000|Overall Study|Lost to Follow-up|24|||
130679337|NCT02468778|470452295|FG000|Overall Study|Death|2|||
130679338|NCT02468778|470452296|FG001|Overall Study|Death|1|||
130434924|NCT00393523|469555278|FG004|Overall Study|Lost to Follow-up|1|||
130434925|NCT00393523|469555274|FG000|Overall Study|Protocol Violation|6|||
130434926|NCT00393523|469555275|FG001|Overall Study|Protocol Violation|2|||
130434927|NCT00393523|469555276|FG002|Overall Study|Protocol Violation|0|||
130434928|NCT00393523|469555277|FG003|Overall Study|Protocol Violation|1|||
130434929|NCT00393523|469555278|FG004|Overall Study|Protocol Violation|0|||
130434930|NCT00393523|469555274|FG000|Overall Study|Withdrawal by Subject|6|||
130434931|NCT00393523|469555275|FG001|Overall Study|Withdrawal by Subject|7|||
130434932|NCT00393523|469555276|FG002|Overall Study|Withdrawal by Subject|2|||
130434933|NCT00393523|469555277|FG003|Overall Study|Withdrawal by Subject|3|||
130434934|NCT00393523|469555278|FG004|Overall Study|Withdrawal by Subject|0|||
130434935|NCT00393523|469555274|FG000|Overall Study|Difficulties in specimen collection|0|||
130434936|NCT00393523|469555275|FG001|Overall Study|Difficulties in specimen collection|0|||
130434937|NCT00393523|469555276|FG002|Overall Study|Difficulties in specimen collection|1|||
130434938|NCT00393523|469555277|FG003|Overall Study|Difficulties in specimen collection|0|||
130434939|NCT00393523|469555278|FG004|Overall Study|Difficulties in specimen collection|0|||
130434940|NCT00393523|469555274|FG000|Overall Study|Vaccine supply issue|0|||
130434941|NCT00393523|469555275|FG001|Overall Study|Vaccine supply issue|0|||
130434942|NCT00393523|469555276|FG002|Overall Study|Vaccine supply issue|1|||
130434943|NCT00393523|469555277|FG003|Overall Study|Vaccine supply issue|0|||
130434944|NCT00393523|469555278|FG004|Overall Study|Vaccine supply issue|0|||
130434945|NCT04091360|469555279|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434946|NCT04091360|469555280|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434947|NCT04091360|469555281|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434948|NCT04091360|469555282|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434949|NCT04091360|469555283|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434950|NCT04091360|469555284|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434951|NCT04091360|469555285|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434952|NCT04091360|469555286|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130434953|NCT04091360|469555287|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
130434954|NCT04091360|469555288|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
130434955|NCT04091360|469555279|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434956|NCT04091360|469555280|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434957|NCT04091360|469555281|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434958|NCT04091360|469555282|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434959|NCT04091360|469555283|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434960|NCT04091360|469555284|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434961|NCT04091360|469555285|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
130434962|NCT04091360|469555286|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
130434963|NCT04091360|469555287|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434964|NCT04091360|469555288|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130434965|NCT04091360|469555279|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434966|NCT04091360|469555280|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434967|NCT04091360|469555281|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434968|NCT04091360|469555282|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434969|NCT04091360|469555283|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434970|NCT04091360|469555284|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434971|NCT04091360|469555285|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
130434972|NCT04091360|469555286|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434973|NCT04091360|469555287|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130434974|NCT04091360|469555288|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
130434975|NCT00423852|469555289|FG000|Overall Study|Removed pior to the high-dose portion|3|||
130434976|NCT00572624|469555290|FG000|Overall Study|Lost to Follow-up|10|||
130434977|NCT00572624|469555291|FG001|Overall Study|Lost to Follow-up|4|||
130552778|NCT00792805|469991534|FG000|Overall Study|Adverse Event|12|||
130679339|NCT02468778|470452297|FG002|Overall Study|Death|0|||
130679340|NCT02468778|470452295|FG000|Overall Study|Lost to Follow-up|1|||
130679341|NCT02468778|470452296|FG001|Overall Study|Lost to Follow-up|2|||
130679342|NCT02468778|470452297|FG002|Overall Study|Lost to Follow-up|2|||
130679343|NCT02468778|470452295|FG000|Overall Study|Withdrawal by Subject|0|||
130679344|NCT02468778|470452296|FG001|Overall Study|Withdrawal by Subject|1|||
130679345|NCT02468778|470452297|FG002|Overall Study|Withdrawal by Subject|1|||
130434978|NCT00572624|469555290|FG000|Overall Study|Wanted to do a different diet program|1|||
130434979|NCT00572624|469555291|FG001|Overall Study|Wanted to do a different diet program|0|||
130679346|NCT00414765|470452300|FG000|Overall Study|Adverse Event|5|||
130679347|NCT00414765|470452301|FG001|Overall Study|Adverse Event|9|||
130679348|NCT00414765|470452300|FG000|Overall Study|Withdrawal by Subject|1|||
130679349|NCT00414765|470452301|FG001|Overall Study|Withdrawal by Subject|1|||
130434980|NCT00572624|469555290|FG000|Overall Study|Medication change|1|||
130434981|NCT00572624|469555291|FG001|Overall Study|Medication change|0|||
130434982|NCT00572624|469555290|FG000|Overall Study|Started a new job-- no time for study|1|||
130679350|NCT00414765|470452300|FG000|Overall Study|Disease Progression|0|||
130679351|NCT00414765|470452301|FG001|Overall Study|Disease Progression|1|||
130679352|NCT03130699|470452302|FG000|Overall Study|Lost to Follow-up|34|||
130679353|NCT03130699|470452303|FG001|Overall Study|Lost to Follow-up|37|||
130679354|NCT03130699|470452304|FG002|Overall Study|Lost to Follow-up|26|||
130679355|NCT03130699|470452302|FG000|Overall Study|Withdrawal by Subject|5|||
130679356|NCT03130699|470452303|FG001|Overall Study|Withdrawal by Subject|1|||
130679357|NCT03130699|470452304|FG002|Overall Study|Withdrawal by Subject|0|||
130679358|NCT03130699|470452302|FG000|Overall Study|Withdrawal by PI|1|||
130679359|NCT03130699|470452303|FG001|Overall Study|Withdrawal by PI|2|||
130679360|NCT03130699|470452304|FG002|Overall Study|Withdrawal by PI|5|||
130679361|NCT03130699|470452302|FG000|Overall Study|Death|0|||
130679362|NCT03130699|470452303|FG001|Overall Study|Death|0|||
130434983|NCT00572624|469555291|FG001|Overall Study|Started a new job-- no time for study|0|||
130434984|NCT00572624|469555290|FG000|Overall Study|Admitted to being a smoker|1|||
130434985|NCT00572624|469555291|FG001|Overall Study|Admitted to being a smoker|0|||
130434986|NCT00572624|469555290|FG000|Overall Study|Refused to do the stress test|1|||
130434987|NCT00572624|469555291|FG001|Overall Study|Refused to do the stress test|0|||
130434988|NCT00572624|469555290|FG000|Overall Study|Problem with vascular access|1|||
130434989|NCT00572624|469555291|FG001|Overall Study|Problem with vascular access|0|||
130434990|NCT00572624|469555290|FG000|Overall Study|Health issues unrelated to the study|1|||
130434991|NCT00572624|469555291|FG001|Overall Study|Health issues unrelated to the study|0|||
130434992|NCT00744263|469555292|FG000|Overall Study|Death|3006|||
130434993|NCT00744263|469555293|FG001|Overall Study|Death|3005|||
130434994|NCT00744263|469555292|FG000|Overall Study|Lost to Follow-up|2038|||
130434995|NCT00744263|469555293|FG001|Overall Study|Lost to Follow-up|2135|||
130434996|NCT00744263|469555292|FG000|Overall Study|Withdrawal by Subject|166|||
130434997|NCT00744263|469555293|FG001|Overall Study|Withdrawal by Subject|150|||
130434998|NCT00744263|469555292|FG000|Overall Study|Physician Decision|20|||
130434999|NCT00744263|469555293|FG001|Overall Study|Physician Decision|23|||
130435000|NCT00744263|469555292|FG000|Overall Study|Protocol Violation|3|||
130435001|NCT00744263|469555293|FG001|Overall Study|Protocol Violation|5|||
130435002|NCT00744263|469555292|FG000|Overall Study|Adverse Event|1|||
130435003|NCT00744263|469555293|FG001|Overall Study|Adverse Event|0|||
130435004|NCT00744263|469555292|FG000|Overall Study|Other|2|||
130435005|NCT00744263|469555293|FG001|Overall Study|Other|2|||
130435006|NCT01515189|469555297|FG000|Induction|Disease Progression|109|||
130435007|NCT01515189|469555298|FG001|Induction|Disease Progression|155|||
130435008|NCT01515189|469555297|FG000|Induction|Study drug toxicity|86|||
130435009|NCT01515189|469555298|FG001|Induction|Study drug toxicity|36|||
130435010|NCT01515189|469555297|FG000|Induction|Death|24|||
130435011|NCT01515189|469555298|FG001|Induction|Death|17|||
130435012|NCT01515189|469555297|FG000|Induction|Adverse Event|14|||
130435013|NCT01515189|469555298|FG001|Induction|Adverse Event|9|||
130435014|NCT01515189|469555297|FG000|Induction|Withdrawal by Subject|3|||
130435015|NCT01515189|469555298|FG001|Induction|Withdrawal by Subject|9|||
130435016|NCT01515189|469555297|FG000|Induction|No longer meets study criteria|0|||
130435017|NCT01515189|469555298|FG001|Induction|No longer meets study criteria|2|||
130435018|NCT01515189|469555297|FG000|Induction|Lost to Follow-up|1|||
130435019|NCT01515189|469555298|FG001|Induction|Lost to Follow-up|0|||
130435020|NCT01515189|469555297|FG000|Induction|Other|0|||
130435021|NCT01515189|469555298|FG001|Induction|Other|4|||
130435022|NCT01515189|469555297|FG000|First Re-Induction Phase|Disease progression|6|||
130435023|NCT01515189|469555298|FG001|First Re-Induction Phase|Disease progression|14|||
130679363|NCT03130699|470452304|FG002|Overall Study|Death|1|||
130679364|NCT01199861|470452305|FG000|Overall Study|Administrative problems|1|||
130679365|NCT01199861|470452306|FG001|Overall Study|Administrative problems|0|||
130679366|NCT01199861|470452305|FG000|Overall Study|Adverse Event|1|||
130679367|NCT01199861|470452306|FG001|Overall Study|Adverse Event|0|||
130679368|NCT04534283|470452307|FG000|Overall Study|Physician Decision|2|||
130435024|NCT01515189|469555297|FG000|First Re-Induction Phase|Study drug toxicity|5|||
130435025|NCT01515189|469555298|FG001|First Re-Induction Phase|Study drug toxicity|0|||
130435026|NCT01515189|469555297|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
130435027|NCT01515189|469555298|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
130435028|NCT01515189|469555297|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
130435029|NCT01515189|469555298|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
130435030|NCT01515189|469555297|FG000|First Re-Induction Phase|Other|1|||
130435031|NCT01515189|469555298|FG001|First Re-Induction Phase|Other|0|||
130435032|NCT03787680|469555299|FG000|Overall Study|Physician Decision|2|||
130679369|NCT04534283|470452307|FG000|Overall Study|Withdrawal by Subject|1|||
130679370|NCT04534283|470452307|FG000|Overall Study|Disease Progression|12|||
130679371|NCT04534283|470452307|FG000|Overall Study|Adverse Event|1|||
130679372|NCT00661505|470452308|FG000|Overall Study|Adverse Event|3|||
130679373|NCT00661505|470452308|FG000|Overall Study|Protocol Violation|14|||
130679374|NCT00661505|470452308|FG000|Overall Study|Withdrawal by Subject|8|||
130679375|NCT00661505|470452308|FG000|Overall Study|Lost to Follow-up|3|||
130679376|NCT00661505|470452308|FG000|Overall Study|Other|2|||
130679377|NCT00669864|470452309|FG000|Overall Study|Lost to Follow-up|2|||
130679378|NCT00669864|470452309|FG000|Overall Study|Protocol Violation|2|||
130679379|NCT00669864|470452309|FG000|Overall Study|Withdrawal by Subject|3|||
130679380|NCT00669864|470452309|FG000|Overall Study|Other|2|||
130679381|NCT02545998|470452320|FG000|Overall Study|Lost to Follow-up|12|||
130679382|NCT02545998|470452321|FG001|Overall Study|Lost to Follow-up|3|||
130679383|NCT02545998|470452320|FG000|Overall Study|Withdrawal by Subject|3|||
130679384|NCT02545998|470452321|FG001|Overall Study|Withdrawal by Subject|2|||
130679385|NCT00444145|470454089|FG000|Overall Study|Withdrawal by Subject|2|||
130679386|NCT00444145|470454089|FG000|Overall Study|Lost to Follow-up|1|||
130679387|NCT00444145|470454089|FG000|Overall Study|non-compliant|11|||
130679388|NCT00444145|470454089|FG000|Overall Study|Screen Failures|5|||
130679390|NCT00630305|470454091|FG000|Overall Study|Withdrawal by Subject|1|||
130679391|NCT00630305|470454091|FG000|Overall Study|Inability to insert contact lens|1|||
130679392|NCT01494506|470454092|FG000|Overall Study|Lack of Efficacy|77|||
130679393|NCT01494506|470454093|FG001|Overall Study|Lack of Efficacy|83|||
130679394|NCT01494506|470454094|FG002|Overall Study|Lack of Efficacy|57|||
130679395|NCT01494506|470454092|FG000|Overall Study|Adverse Event|17|||
130679396|NCT01494506|470454093|FG001|Overall Study|Adverse Event|10|||
130679397|NCT01494506|470454094|FG002|Overall Study|Adverse Event|11|||
130679398|NCT01494506|470454092|FG000|Overall Study|Death|9|||
130679399|NCT01494506|470454093|FG001|Overall Study|Death|5|||
130679400|NCT01494506|470454094|FG002|Overall Study|Death|2|||
130679401|NCT01494506|470454092|FG000|Overall Study|Physician Decision|7|||
130679402|NCT01494506|470454093|FG001|Overall Study|Physician Decision|5|||
130679403|NCT01494506|470454094|FG002|Overall Study|Physician Decision|4|||
130679404|NCT01494506|470454092|FG000|Overall Study|Withdrawal by Subject|17|||
130679405|NCT01494506|470454093|FG001|Overall Study|Withdrawal by Subject|20|||
130679406|NCT01494506|470454094|FG002|Overall Study|Withdrawal by Subject|14|||
130679407|NCT01494506|470454092|FG000|Overall Study|Clinical Deterioration|21|||
130679408|NCT01494506|470454093|FG001|Overall Study|Clinical Deterioration|17|||
130679409|NCT01494506|470454094|FG002|Overall Study|Clinical Deterioration|13|||
130679410|NCT01494506|470454092|FG000|Overall Study|Sponsor Decision|0|||
130679411|NCT01494506|470454093|FG001|Overall Study|Sponsor Decision|0|||
130679412|NCT01494506|470454094|FG002|Overall Study|Sponsor Decision|1|||
130679413|NCT01494506|470454092|FG000|Overall Study|Other|0|||
130679414|NCT01494506|470454093|FG001|Overall Study|Other|3|||
130679415|NCT01494506|470454094|FG002|Overall Study|Other|1|||
130679416|NCT03471078|470454108|FG000|Overall Study|Withdrawal by Subject|9|||
130679417|NCT03471078|470454109|FG001|Overall Study|Withdrawal by Subject|1|||
130679418|NCT03471078|470454108|FG000|Overall Study|Adverse Event|4|||
130679419|NCT03471078|470454109|FG001|Overall Study|Adverse Event|1|||
130679420|NCT03471078|470454108|FG000|Overall Study|Physician Decision|3|||
130679421|NCT03471078|470454109|FG001|Overall Study|Physician Decision|2|||
130679422|NCT03471078|470454108|FG000|Overall Study|Death|2|||
130679423|NCT03471078|470454109|FG001|Overall Study|Death|0|||
130679424|NCT03471078|470454108|FG000|Overall Study|Other|3|||
130679425|NCT03471078|470454109|FG001|Overall Study|Other|2|||
130679426|NCT02473640|470454113|FG000|Treatment Period 1|Adverse Event|1|||
130679427|NCT02395822|470454116|FG000|Overall Study|Withdrawal by Subject|1|||
130345639|NCT04449029|469237175|FG002|Overall Study|Withdrawal by Subject|1|||
130345640|NCT04449029|469237176|FG003|Overall Study|Withdrawal by Subject|1|||
130345641|NCT04449029|469237177|FG004|Overall Study|Withdrawal by Subject|5|||
130345642|NCT04449029|469237178|FG005|Overall Study|Withdrawal by Subject|1|||
130679428|NCT02395822|470454116|FG000|Overall Study|Death|1|||
130679429|NCT02777528|470454117|FG000|Overall Study|Still in study|24|||
130679430|NCT02777528|470454118|FG001|Overall Study|Still in study|10|||
130679431|NCT02777528|470454119|FG002|Overall Study|Still in study|1|||
130679432|NCT02777528|470454117|FG000|Overall Study|Study Device Explanted|1|||
130679433|NCT02777528|470454118|FG001|Overall Study|Study Device Explanted|0|||
130345643|NCT04449029|469237179|FG006|Overall Study|Withdrawal by Subject|4|||
130679434|NCT02777528|470454119|FG002|Overall Study|Study Device Explanted|0|||
130679435|NCT02777528|470454117|FG000|Overall Study|Death|14|||
130679436|NCT02777528|470454118|FG001|Overall Study|Death|7|||
130345644|NCT04449029|469237180|FG007|Overall Study|Withdrawal by Subject|0|||
130679437|NCT02777528|470454119|FG002|Overall Study|Death|1|||
130679438|NCT02777528|470454117|FG000|Overall Study|Withdrawal by Subject|2|||
130679439|NCT02777528|470454118|FG001|Overall Study|Withdrawal by Subject|2|||
130679440|NCT02777528|470454119|FG002|Overall Study|Withdrawal by Subject|1|||
130679441|NCT02777528|470454117|FG000|Overall Study|Physician Decision|2|||
130679442|NCT02777528|470454118|FG001|Overall Study|Physician Decision|1|||
130435033|NCT03787680|469555300|FG001|Overall Study|Physician Decision|3|||
130435034|NCT03787680|469555299|FG000|Overall Study|Adverse Event|7|||
130435035|NCT03787680|469555300|FG001|Overall Study|Adverse Event|3|||
130435036|NCT03787680|469555299|FG000|Overall Study|Withdrawal by Subject|2|||
130435037|NCT03787680|469555300|FG001|Overall Study|Withdrawal by Subject|1|||
130435038|NCT05458024|469555303|FG000|Overall Study|Withdrawal by Subject|1|||
130435039|NCT05458024|469555304|FG001|Overall Study|Withdrawal by Subject|1|||
130435040|NCT05229653|469555308|FG000|Overall Study|Lost to Follow-up|1|||
130435041|NCT05229653|469555309|FG001|Overall Study|Lost to Follow-up|0|||
130435042|NCT02667886|469555310|FG000|Dose Escalation (Part A)|Adverse Event|1|||
130435043|NCT02667886|469555311|FG001|Dose Escalation (Part A)|Adverse Event|3|||
130435044|NCT02667886|469555312|FG002|Dose Escalation (Part A)|Adverse Event|1|||
130435045|NCT02667886|469555313|FG003|Dose Escalation (Part A)|Adverse Event|0|||
130435046|NCT02667886|469555314|FG004|Dose Escalation (Part A)|Adverse Event|0|||
130435047|NCT02667886|469555310|FG000|Dose Escalation (Part A)|Disease Progression|1|||
130435048|NCT02667886|469555311|FG001|Dose Escalation (Part A)|Disease Progression|4|||
130435049|NCT02667886|469555312|FG002|Dose Escalation (Part A)|Disease Progression|3|||
130435050|NCT02667886|469555313|FG003|Dose Escalation (Part A)|Disease Progression|0|||
130435051|NCT02667886|469555314|FG004|Dose Escalation (Part A)|Disease Progression|0|||
130435052|NCT02667886|469555310|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130435053|NCT02667886|469555311|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130435054|NCT02667886|469555312|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
130435055|NCT02667886|469555313|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130435056|NCT02667886|469555314|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130435057|NCT02667886|469555310|FG000|Dose Expansion (Part B)|Adverse Event|0|||
130435058|NCT02667886|469555311|FG001|Dose Expansion (Part B)|Adverse Event|0|||
130435059|NCT02667886|469555312|FG002|Dose Expansion (Part B)|Adverse Event|0|||
130435060|NCT02667886|469555313|FG003|Dose Expansion (Part B)|Adverse Event|9|||
130435061|NCT02667886|469555314|FG004|Dose Expansion (Part B)|Adverse Event|0|||
130435062|NCT02667886|469555310|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
130435063|NCT02667886|469555311|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
130435064|NCT02667886|469555312|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
130435065|NCT02667886|469555313|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
130435066|NCT02667886|469555314|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
130435067|NCT02667886|469555310|FG000|Dose Expansion (Part B)|Disease Progression|0|||
130435068|NCT02667886|469555311|FG001|Dose Expansion (Part B)|Disease Progression|0|||
130435069|NCT02667886|469555312|FG002|Dose Expansion (Part B)|Disease Progression|0|||
130435070|NCT02667886|469555313|FG003|Dose Expansion (Part B)|Disease Progression|38|||
130435071|NCT02667886|469555314|FG004|Dose Expansion (Part B)|Disease Progression|0|||
130435072|NCT02667886|469555310|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130435073|NCT02667886|469555311|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130435074|NCT02667886|469555312|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130435075|NCT02667886|469555313|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
130435076|NCT02667886|469555314|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130435077|NCT02667886|469555310|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130435078|NCT02667886|469555311|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130435079|NCT02667886|469555312|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130435080|NCT02667886|469555313|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130435081|NCT02667886|469555314|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
130435082|NCT02667886|469555310|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
130435083|NCT02667886|469555311|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
130435084|NCT02667886|469555312|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
130435085|NCT02667886|469555313|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
130435086|NCT02667886|469555314|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
130435087|NCT00594217|469555315|FG000|Overall Study|Withdrawal by Subject|1|||
130435088|NCT00594217|469555316|FG001|Overall Study|Withdrawal by Subject|3|||
130435089|NCT00747123|469555317|FG000|Overall Study|Investigator's request|0|||
130435090|NCT00747123|469555318|FG001|Overall Study|Investigator's request|0|||
130435091|NCT00747123|469555319|FG002|Overall Study|Investigator's request|1|||
130435092|NCT00747123|469555320|FG003|Overall Study|Investigator's request|0|||
130435093|NCT00747123|469555317|FG000|Overall Study|Withdrew consent|0|||
130435094|NCT00747123|469555318|FG001|Overall Study|Withdrew consent|1|||
130435095|NCT00747123|469555319|FG002|Overall Study|Withdrew consent|0|||
130435096|NCT00747123|469555320|FG003|Overall Study|Withdrew consent|0|||
130435097|NCT00747123|469555317|FG000|Overall Study|Adverse Event|0|||
130435098|NCT00747123|469555318|FG001|Overall Study|Adverse Event|1|||
130435099|NCT00747123|469555319|FG002|Overall Study|Adverse Event|0|||
130435100|NCT00747123|469555320|FG003|Overall Study|Adverse Event|1|||
130435101|NCT03635489|469555321|FG000|Overall Study|Death|19|||
130435102|NCT03635489|469555322|FG001|Overall Study|Death|13|||
130435103|NCT03635489|469555321|FG000|Overall Study|Lost to Follow-up|1|||
130679443|NCT02777528|470454119|FG002|Overall Study|Physician Decision|0|||
130435104|NCT03635489|469555322|FG001|Overall Study|Lost to Follow-up|2|||
130435105|NCT03635489|469555321|FG000|Overall Study|Withdrawal by Subject|1|||
130435106|NCT03635489|469555322|FG001|Overall Study|Withdrawal by Subject|2|||
130435107|NCT03635489|469555321|FG000|Overall Study|Study Ended by Sponsor|28|||
130435108|NCT03635489|469555322|FG001|Overall Study|Study Ended by Sponsor|34|||
130435109|NCT02213328|469555324|FG000|Overall Study|Withdrawal by Subject|10|||
130435110|NCT02213328|469555324|FG000|Overall Study|Physician Decision|2|||
130435111|NCT02213328|469555324|FG000|Overall Study|Lost to Follow-up|16|||
130435112|NCT01807650|469555328|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
130435113|NCT01807650|469555328|FG000|Overall Study|Adverse Event|5|||
130435114|NCT01807650|469555328|FG000|Overall Study|Other|2|||
130435115|NCT00736489|469555329|FG000|Period 1|Lost to Follow-up|1|||
130435116|NCT00736489|469555330|FG001|Period 1|Lost to Follow-up|0|||
130435117|NCT00736489|469555331|FG002|Period 1|Lost to Follow-up|0|||
130435118|NCT00736489|469555332|FG003|Period 1|Lost to Follow-up|0|||
130435119|NCT00736489|469555333|FG004|Period 1|Lost to Follow-up|0|||
130435120|NCT00736489|469555334|FG005|Period 1|Lost to Follow-up|0|||
130435121|NCT00736489|469555329|FG000|Period 1|Withdrawal by Subject|0|||
130345645|NCT02025556|469237181|FG000|Overall Study|Adverse Event|0|||
130345646|NCT02025556|469237182|FG001|Overall Study|Adverse Event|4|||
130345647|NCT02025556|469237183|FG002|Overall Study|Adverse Event|2|||
130345648|NCT02025556|469237181|FG000|Overall Study|Lack of Efficacy|2|||
130345649|NCT02025556|469237182|FG001|Overall Study|Lack of Efficacy|1|||
130345650|NCT02025556|469237183|FG002|Overall Study|Lack of Efficacy|0|||
130345651|NCT02025556|469237181|FG000|Overall Study|Protocol Violation|2|||
130345652|NCT02025556|469237182|FG001|Overall Study|Protocol Violation|1|||
130345653|NCT02025556|469237183|FG002|Overall Study|Protocol Violation|0|||
130345654|NCT02025556|469237181|FG000|Overall Study|Withdrawal by Subject|0|||
130345655|NCT02025556|469237182|FG001|Overall Study|Withdrawal by Subject|3|||
130345656|NCT02025556|469237183|FG002|Overall Study|Withdrawal by Subject|6|||
130345657|NCT02025556|469237181|FG000|Overall Study|Lost to Follow-up|2|||
130345658|NCT02025556|469237182|FG001|Overall Study|Lost to Follow-up|4|||
130345659|NCT02025556|469237183|FG002|Overall Study|Lost to Follow-up|0|||
130345660|NCT02025556|469237181|FG000|Overall Study|Reason not reported|0|||
130345661|NCT02025556|469237182|FG001|Overall Study|Reason not reported|0|||
130345662|NCT02025556|469237183|FG002|Overall Study|Reason not reported|1|||
130345663|NCT00627445|469237184|FG000|Overall Study|Adverse Event|3|||
130345664|NCT00627445|469237185|FG001|Overall Study|Adverse Event|3|||
130345665|NCT00627445|469237184|FG000|Overall Study|Lack of Efficacy|0|||
130345666|NCT00627445|469237185|FG001|Overall Study|Lack of Efficacy|1|||
130345667|NCT00627445|469237184|FG000|Overall Study|Other|6|||
130345668|NCT00627445|469237185|FG001|Overall Study|Other|8|||
130345669|NCT04098224|469237186|FG000|Overall Study|Adverse Event|1|||
130345670|NCT04098224|469237187|FG001|Overall Study|Adverse Event|0|||
130345671|NCT04098224|469237186|FG000|Overall Study|Physician Decision|1|||
130345672|NCT04098224|469237187|FG001|Overall Study|Physician Decision|0|||
130345673|NCT04098224|469237186|FG000|Overall Study|Patient not required enteral feeding|1|||
130345674|NCT04098224|469237187|FG001|Overall Study|Patient not required enteral feeding|0|||
130345675|NCT04098224|469237186|FG000|Overall Study|Patient failure nasogastric tube|1|||
130345676|NCT04098224|469237187|FG001|Overall Study|Patient failure nasogastric tube|0|||
130345677|NCT04098224|469237186|FG000|Overall Study|Patient early extubation|1|||
130345678|NCT04098224|469237187|FG001|Overall Study|Patient early extubation|3|||
130345679|NCT01203852|469237191|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
130345680|NCT01203852|469237191|FG000|Washout 2 Weeks|Physician Decision|46|||
130345681|NCT00247611|469237197|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
130345682|NCT00247611|469237198|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
130345683|NCT00247611|469237197|FG000|Baselined|Completed baseline only|9|||
130345684|NCT00247611|469237198|FG001|Baselined|Completed baseline only|8|||
130345685|NCT02395302|469237208|FG000|Overall Study|Screen Failure|3|||
130345686|NCT02395302|469237208|FG000|Overall Study|Run In Failure|7|||
130345687|NCT02395302|469237208|FG000|Overall Study|Withdrawal by Subject|2|||
130345688|NCT02395302|469237208|FG000|Overall Study|Physician Decision|2|||
130345689|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
130345690|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
130345691|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
130345692|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
130345693|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
130345694|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
130345695|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
130345696|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
130345697|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
130345698|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
130345699|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
130345700|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
130345701|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
130435122|NCT00736489|469555330|FG001|Period 1|Withdrawal by Subject|0|||
130435123|NCT00736489|469555331|FG002|Period 1|Withdrawal by Subject|0|||
130435124|NCT00736489|469555332|FG003|Period 1|Withdrawal by Subject|0|||
130345702|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
130345703|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
130345704|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
130345705|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
130345706|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
130345707|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130345708|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
130345709|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130345710|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
130345711|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
130345712|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
130345713|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
130345714|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130345715|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130345716|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130345717|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
130345718|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130345719|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130345720|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
130345721|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130345722|NCT01087788|469237209|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130345723|NCT01087788|469237210|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130345724|NCT01087788|469237211|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
130345725|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
130345726|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
130345727|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
130345728|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
130345729|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
130345730|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
130345731|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
130345732|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130345733|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130345734|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
130345735|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
130345736|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
130345737|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130345738|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
130345739|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130345740|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
130345741|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130345742|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130345743|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
130345744|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130345745|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130345746|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Patient moved|0|||
130345747|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Patient moved|0|||
130345748|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Patient moved|1|||
130345749|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
130345750|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
130345751|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
130345752|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
130345753|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
130345754|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
130345755|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
130345756|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
130345757|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
130345758|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
130345759|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
130345760|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
130345761|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
130345762|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
130345763|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
130345764|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
130345765|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
130345766|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
130345767|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
130435125|NCT00736489|469555333|FG004|Period 1|Withdrawal by Subject|0|||
130435126|NCT00736489|469555334|FG005|Period 1|Withdrawal by Subject|1|||
130435127|NCT01816763|469557022|FG000|Overall Study|The main reason for an incomplete survey|4|||
130435128|NCT01816763|469557023|FG001|Overall Study|The main reason for an incomplete survey|15|||
130435129|NCT01816763|469557024|FG002|Overall Study|The main reason for an incomplete survey|11|||
130435130|NCT00663117|469557027|FG000|Overall Study|Lack of Efficacy|1|||
130435131|NCT00663117|469557028|FG001|Overall Study|Lack of Efficacy|0|||
130435132|NCT00311155|469557029|FG000|Overall Study|Adverse Event|21|||
130435133|NCT00311155|469557029|FG000|Overall Study|Withdrawal by Subject|17|||
130435134|NCT00311155|469557029|FG000|Overall Study|Did not meet entry criteria|55|||
130435135|NCT02243631|469557032|FG000|Overall Study|no synovial fluid on second aspirate|0|||
130435136|NCT02243631|469557033|FG001|Overall Study|no synovial fluid on second aspirate|1|||
130435137|NCT01785628|469557036|FG000|Overall Study|Lost to Follow-up|2|||
130435138|NCT01785628|469557037|FG001|Overall Study|Lost to Follow-up|3|||
130435139|NCT00840996|469557038|FG000|Overall Study|Withdrawal by Subject|1|||
130435140|NCT00840996|469557039|FG001|Overall Study|Withdrawal by Subject|0|||
130435141|NCT03285295|469557040|FG000|Alinity s HBsAg|Protocol Violation|11|||
130435142|NCT03285295|469557041|FG001|Alinity s HBsAg|Protocol Violation|0|||
130435143|NCT03285295|469557042|FG002|Alinity s HBsAg|Protocol Violation|0|||
130435144|NCT03285295|469557043|FG003|Alinity s HBsAg|Protocol Violation|0|||
130435145|NCT03285295|469557044|FG004|Alinity s HBsAg|Protocol Violation|0|||
130435146|NCT03285295|469557040|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
130435147|NCT03285295|469557041|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
130435148|NCT03285295|469557042|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
130435149|NCT03285295|469557043|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
130435150|NCT03285295|469557044|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
130435151|NCT03285295|469557040|FG000|Alinity s HBsAg|No Results Generated|74|||
130435152|NCT03285295|469557041|FG001|Alinity s HBsAg|No Results Generated|6|||
130435153|NCT03285295|469557042|FG002|Alinity s HBsAg|No Results Generated|0|||
130435154|NCT03285295|469557043|FG003|Alinity s HBsAg|No Results Generated|0|||
130435155|NCT03285295|469557044|FG004|Alinity s HBsAg|No Results Generated|0|||
130435156|NCT03285295|469557040|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
130435157|NCT03285295|469557041|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
130435158|NCT03285295|469557042|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
130435159|NCT03285295|469557043|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
130435160|NCT03285295|469557044|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
130435161|NCT03285295|469557040|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
130435162|NCT03285295|469557041|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130435163|NCT03285295|469557042|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130435164|NCT03285295|469557043|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130435165|NCT03285295|469557044|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130435166|NCT03285295|469557040|FG000|Alinity s HTLV I/II|No Results Generated|70|||
130435167|NCT03285295|469557041|FG001|Alinity s HTLV I/II|No Results Generated|0|||
130435168|NCT03285295|469557042|FG002|Alinity s HTLV I/II|No Results Generated|0|||
130435169|NCT03285295|469557043|FG003|Alinity s HTLV I/II|No Results Generated|0|||
130435170|NCT03285295|469557044|FG004|Alinity s HTLV I/II|No Results Generated|0|||
130435171|NCT03285295|469557040|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
130435172|NCT03285295|469557041|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130435173|NCT03285295|469557042|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130435174|NCT03285295|469557043|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130435175|NCT03285295|469557044|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130435176|NCT03285295|469557040|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
130435177|NCT03285295|469557041|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
130435178|NCT03285295|469557042|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
130435179|NCT03285295|469557043|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
130435180|NCT03285295|469557044|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
130435181|NCT03285295|469557040|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
130435182|NCT03285295|469557041|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130435183|NCT03285295|469557042|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130435184|NCT03285295|469557043|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130435185|NCT03285295|469557044|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130435186|NCT03285295|469557040|FG000|Alinity s Anti-HCV|No Results Generated|71|||
130435187|NCT03285295|469557041|FG001|Alinity s Anti-HCV|No Results Generated|0|||
130435188|NCT03285295|469557042|FG002|Alinity s Anti-HCV|No Results Generated|0|||
130435189|NCT03285295|469557043|FG003|Alinity s Anti-HCV|No Results Generated|0|||
130435190|NCT03285295|469557044|FG004|Alinity s Anti-HCV|No Results Generated|0|||
130435191|NCT03285295|469557040|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
130435192|NCT03285295|469557041|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130435193|NCT03285295|469557042|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130435194|NCT03285295|469557043|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130435195|NCT03285295|469557044|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130435196|NCT03285295|469557040|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
130435197|NCT03285295|469557041|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130679444|NCT02777528|470454117|FG000|Overall Study|Lost to Follow-up|2|||
130435198|NCT03285295|469557042|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130435199|NCT03285295|469557043|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130435200|NCT03285295|469557044|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130435201|NCT03285295|469557040|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
130435202|NCT03285295|469557041|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130435203|NCT03285295|469557042|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130435204|NCT03285295|469557043|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130435205|NCT03285295|469557044|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130435206|NCT03285295|469557040|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
130435207|NCT03285295|469557041|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130435208|NCT03285295|469557042|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130435209|NCT03285295|469557043|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130435210|NCT03285295|469557044|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130435211|NCT03285295|469557040|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
130435212|NCT03285295|469557041|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130435213|NCT03285295|469557042|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130435214|NCT03285295|469557043|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130435215|NCT03285295|469557044|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130435216|NCT03285295|469557040|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
130435217|NCT03285295|469557041|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
130435218|NCT03285295|469557042|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
130435219|NCT03285295|469557043|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
130435220|NCT03285295|469557044|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
130435221|NCT03285295|469557040|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
130435222|NCT03285295|469557041|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
130435223|NCT03285295|469557042|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130435224|NCT03285295|469557043|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130435225|NCT03285295|469557044|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130435226|NCT03285295|469557040|FG000|Alinity s Anti-HBc|No Results Generated|70|||
130435227|NCT03285295|469557041|FG001|Alinity s Anti-HBc|No Results Generated|0|||
130435228|NCT03285295|469557042|FG002|Alinity s Anti-HBc|No Results Generated|0|||
130435229|NCT03285295|469557043|FG003|Alinity s Anti-HBc|No Results Generated|0|||
130435230|NCT03285295|469557044|FG004|Alinity s Anti-HBc|No Results Generated|0|||
130435231|NCT03285295|469557040|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
130435232|NCT03285295|469557041|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130435233|NCT03285295|469557042|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130435234|NCT03285295|469557043|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130435235|NCT03285295|469557044|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130435236|NCT03285295|469557040|FG000|Alinity s Chagas|Protocol Violation|76|||
130435237|NCT03285295|469557041|FG001|Alinity s Chagas|Protocol Violation|0|||
130435238|NCT03285295|469557042|FG002|Alinity s Chagas|Protocol Violation|0|||
130435239|NCT03285295|469557043|FG003|Alinity s Chagas|Protocol Violation|0|||
130435240|NCT03285295|469557044|FG004|Alinity s Chagas|Protocol Violation|0|||
130435241|NCT03285295|469557040|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
130435242|NCT03285295|469557041|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
130435243|NCT03285295|469557042|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
130435244|NCT03285295|469557043|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
130435245|NCT03285295|469557044|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
130435246|NCT03285295|469557040|FG000|Alinity s Chagas|No Results Generated|105|||
130435247|NCT03285295|469557041|FG001|Alinity s Chagas|No Results Generated|0|||
130435248|NCT03285295|469557042|FG002|Alinity s Chagas|No Results Generated|0|||
130435249|NCT03285295|469557043|FG003|Alinity s Chagas|No Results Generated|0|||
130435250|NCT03285295|469557044|FG004|Alinity s Chagas|No Results Generated|0|||
130435251|NCT03285295|469557040|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
130435252|NCT03285295|469557041|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130435253|NCT03285295|469557042|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130435254|NCT03285295|469557043|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130435255|NCT03285295|469557044|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130435256|NCT02200939|469557045|FG000|Overall Study|Participant withdrew consent|0|||
130435257|NCT02200939|469557046|FG001|Overall Study|Participant withdrew consent|1|||
130435258|NCT02200939|469557045|FG000|Overall Study|Lost to Follow-up|2|||
130679445|NCT02777528|470454118|FG001|Overall Study|Lost to Follow-up|0|||
130679446|NCT02777528|470454119|FG002|Overall Study|Lost to Follow-up|0|||
130679447|NCT02777528|470454117|FG000|Overall Study|Discontinued due to Other|1|||
130679448|NCT02777528|470454118|FG001|Overall Study|Discontinued due to Other|0|||
130435259|NCT02200939|469557046|FG001|Overall Study|Lost to Follow-up|9|||
130435260|NCT02200939|469557045|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
130679449|NCT02777528|470454119|FG002|Overall Study|Discontinued due to Other|0|||
130466710|NCT02544074|469676363|FG001|Overall Study|Withdrawal by Subject|1|||
130679450|NCT02127281|470454120|FG000|Overall Study|Lost to Follow-up|1|||
130679451|NCT02127281|470454121|FG001|Overall Study|Lost to Follow-up|0|||
130679452|NCT02937701|470454122|FG000|Day 1 to Week 22|Adverse Event|11|||
130435261|NCT02200939|469557046|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
130435262|NCT02746575|469557047|FG000|Overall Study|Surgery cancelled or time chaned|13|||
130435263|NCT02746575|469557047|FG000|Overall Study|Received epidural|10|||
130435264|NCT02746575|469557047|FG000|Overall Study|Withdrawal by Subject|3|||
130435265|NCT02746575|469557047|FG000|Overall Study|Bradycardia/hypotension|9|||
130435266|NCT02746575|469557047|FG000|Overall Study|Study paused|8|||
130435267|NCT02746575|469557047|FG000|Overall Study|put on beta-blocker|3|||
130435268|NCT02746575|469557047|FG000|Overall Study|type of surgery|1|||
130435269|NCT02746575|469557047|FG000|Overall Study|typ of surgery|1|||
130435270|NCT02746575|469557047|FG000|Overall Study|PI unavailable|1|||
130435271|NCT02746575|469557047|FG000|Overall Study|Unknown history of CVA|1|||
130435272|NCT03239873|469557048|FG000|Overall Study|Lost to Follow-up|15|||
130435273|NCT03239873|469557049|FG001|Overall Study|Lost to Follow-up|16|||
130435274|NCT03239873|469557048|FG000|Overall Study|Physician Decision|1|||
130435275|NCT03239873|469557049|FG001|Overall Study|Physician Decision|0|||
130435276|NCT03239873|469557048|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
130435277|NCT03239873|469557049|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
130435278|NCT03239873|469557048|FG000|Overall Study|Withdrawal by Subject|2|||
130435279|NCT03239873|469557049|FG001|Overall Study|Withdrawal by Subject|0|||
130435280|NCT03239873|469557048|FG000|Overall Study|Contraindication to study medication|1|||
130435281|NCT03239873|469557049|FG001|Overall Study|Contraindication to study medication|0|||
130435282|NCT03239873|469557048|FG000|Overall Study|Protocol Violation|1|||
130435283|NCT03239873|469557049|FG001|Overall Study|Protocol Violation|0|||
130435284|NCT00605319|469557054|FG000|Overall Study|Adverse Event|6|||
130435285|NCT01250119|469557055|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
130435286|NCT01250119|469557056|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
130435287|NCT01250119|469557055|FG000|Diagnostic Phase|Participants Not Tested|44|||
130435288|NCT01250119|469557056|FG001|Diagnostic Phase|Participants Not Tested|0|||
130435289|NCT01250119|469557055|FG000|Treatment Phase|Progressive Disease|0|||
130435290|NCT01250119|469557056|FG001|Treatment Phase|Progressive Disease|32|||
130435291|NCT01250119|469557055|FG000|Treatment Phase|Death|0|||
130435292|NCT01250119|469557056|FG001|Treatment Phase|Death|2|||
130435293|NCT01250119|469557055|FG000|Treatment Phase|Withdrawal by Subject|0|||
130435294|NCT01250119|469557056|FG001|Treatment Phase|Withdrawal by Subject|1|||
130435295|NCT01250119|469557055|FG000|Treatment Phase|Adverse Event|0|||
130435296|NCT01250119|469557056|FG001|Treatment Phase|Adverse Event|2|||
130435297|NCT01250119|469557055|FG000|Treatment Phase|Unknown reason|0|||
130435298|NCT01250119|469557056|FG001|Treatment Phase|Unknown reason|4|||
130435299|NCT02670538|469557057|FG000|Overall Study|Withdrawal of Consent|8|||
130435300|NCT02670538|469557058|FG001|Overall Study|Withdrawal of Consent|6|||
130435301|NCT02670538|469557059|FG002|Overall Study|Withdrawal of Consent|5|||
130435302|NCT02670538|469557057|FG000|Overall Study|Lost to Follow-up|8|||
130435303|NCT02670538|469557058|FG001|Overall Study|Lost to Follow-up|12|||
130435304|NCT02670538|469557059|FG002|Overall Study|Lost to Follow-up|7|||
130435305|NCT02670538|469557057|FG000|Overall Study|Adverse Event|5|||
130435306|NCT02670538|469557058|FG001|Overall Study|Adverse Event|5|||
130435307|NCT02670538|469557059|FG002|Overall Study|Adverse Event|11|||
130435308|NCT02670538|469557057|FG000|Overall Study|Lack of Efficacy|7|||
130435309|NCT02670538|469557058|FG001|Overall Study|Lack of Efficacy|1|||
130435310|NCT02670538|469557059|FG002|Overall Study|Lack of Efficacy|2|||
130435311|NCT02670538|469557057|FG000|Overall Study|Protocol Violation|3|||
130435312|NCT02670538|469557058|FG001|Overall Study|Protocol Violation|4|||
130435313|NCT02670538|469557059|FG002|Overall Study|Protocol Violation|1|||
130435314|NCT02670538|469557057|FG000|Overall Study|Noncompliance with Study Drug|1|||
130435315|NCT02670538|469557058|FG001|Overall Study|Noncompliance with Study Drug|3|||
130435316|NCT02670538|469557059|FG002|Overall Study|Noncompliance with Study Drug|2|||
130435317|NCT02670538|469557057|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130435318|NCT02670538|469557058|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130435319|NCT02670538|469557059|FG002|Overall Study|Other Miscellaneous Reasons|2|||
130435320|NCT02887989|469557063|FG000|Overall Study|Withdrawal by Subject|8|||
130435321|NCT02887989|469557064|FG001|Overall Study|Withdrawal by Subject|11|||
130435322|NCT02887989|469557063|FG000|Overall Study|Death|1|||
130435323|NCT02887989|469557064|FG001|Overall Study|Death|0|||
130435324|NCT05648357|469557065|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
130435325|NCT02176421|469557066|FG000|Overall Study|Lost to Follow-up|4|||
130435326|NCT02176421|469557066|FG000|Overall Study|Adverse Event|1|||
130435327|NCT02341456|469557069|FG000|Overall Study|Disease progression|2|||
130435328|NCT02341456|469557070|FG001|Overall Study|Disease progression|3|||
130435329|NCT02341456|469557071|FG002|Overall Study|Disease progression|1|||
130435330|NCT02341456|469557069|FG000|Overall Study|Death|1|||
130435331|NCT02341456|469557070|FG001|Overall Study|Death|1|||
130435332|NCT02341456|469557071|FG002|Overall Study|Death|1|||
130435333|NCT02341456|469557069|FG000|Overall Study|Withdrawal by Subject|0|||
130435334|NCT02341456|469557070|FG001|Overall Study|Withdrawal by Subject|1|||
130435335|NCT02341456|469557071|FG002|Overall Study|Withdrawal by Subject|1|||
130435336|NCT02341456|469557069|FG000|Overall Study|Moved to local access programme.|0|||
130435337|NCT02341456|469557070|FG001|Overall Study|Moved to local access programme.|1|||
130679453|NCT02937701|470454123|FG001|Day 1 to Week 22|Adverse Event|14|||
130679454|NCT02937701|470454124|FG002|Day 1 to Week 22|Adverse Event|0|||
130679455|NCT02937701|470454125|FG003|Day 1 to Week 22|Adverse Event|0|||
130679456|NCT02937701|470454126|FG004|Day 1 to Week 22|Adverse Event|0|||
130679457|NCT02937701|470454122|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
130679458|NCT02937701|470454123|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
130679459|NCT02937701|470454124|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679460|NCT02937701|470454125|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679461|NCT02937701|470454126|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679462|NCT02937701|470454122|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
130679463|NCT02937701|470454123|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
130345768|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130345769|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130345770|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130345771|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
130345772|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130345773|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
130345774|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130345775|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130345776|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
130345777|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
130345778|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
130345779|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
130345780|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
130345781|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
130345782|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
130345783|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
130345784|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
130345785|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
130345786|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
130345787|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
130345788|NCT03044574|469237219|FG000|Overall Study|Lost to Follow-up|37|||
130345789|NCT03044574|469237220|FG001|Overall Study|Lost to Follow-up|45|||
130345790|NCT00710762|469237221|FG000|Overall Study|Progressive disease|27|||
130345791|NCT00710762|469237222|FG001|Overall Study|Progressive disease|30|||
130345792|NCT00710762|469237221|FG000|Overall Study|Adverse Event other disease worsening|2|||
130345793|NCT00710762|469237222|FG001|Overall Study|Adverse Event other disease worsening|1|||
130345794|NCT00710762|469237221|FG000|Overall Study|Other Adverse Event|7|||
130345795|NCT00710762|469237222|FG001|Overall Study|Other Adverse Event|7|||
130345796|NCT00710762|469237221|FG000|Overall Study|Lost to Follow-up|1|||
130345797|NCT00710762|469237222|FG001|Overall Study|Lost to Follow-up|0|||
130345798|NCT00710762|469237221|FG000|Overall Study|Reason other than listed above|2|||
130345799|NCT00710762|469237222|FG001|Overall Study|Reason other than listed above|2|||
130345800|NCT00495040|469237224|FG000|Overall Study|Withdrawal by Subject|3|||
130345801|NCT00592774|469237228|FG000|Overall Study|Adverse Event|5|||
130345802|NCT00592774|469237229|FG001|Overall Study|Adverse Event|19|||
130345803|NCT00592774|469237230|FG002|Overall Study|Adverse Event|2|||
130345804|NCT00592774|469237231|FG003|Overall Study|Adverse Event|14|||
130345805|NCT00592774|469237232|FG004|Overall Study|Adverse Event|8|||
130345806|NCT00592774|469237228|FG000|Overall Study|Protocol Violation|0|||
130345807|NCT00592774|469237229|FG001|Overall Study|Protocol Violation|1|||
130345808|NCT00592774|469237230|FG002|Overall Study|Protocol Violation|0|||
130345809|NCT00592774|469237231|FG003|Overall Study|Protocol Violation|0|||
130345810|NCT00592774|469237232|FG004|Overall Study|Protocol Violation|1|||
130345811|NCT00592774|469237228|FG000|Overall Study|Withdrawal by Subject|3|||
130345812|NCT00592774|469237229|FG001|Overall Study|Withdrawal by Subject|7|||
130345813|NCT00592774|469237230|FG002|Overall Study|Withdrawal by Subject|0|||
130345814|NCT00592774|469237231|FG003|Overall Study|Withdrawal by Subject|0|||
130345815|NCT00592774|469237232|FG004|Overall Study|Withdrawal by Subject|0|||
130345816|NCT00592774|469237228|FG000|Overall Study|Lack of Efficacy|3|||
130345817|NCT00592774|469237229|FG001|Overall Study|Lack of Efficacy|3|||
130345818|NCT00592774|469237230|FG002|Overall Study|Lack of Efficacy|0|||
130345819|NCT00592774|469237231|FG003|Overall Study|Lack of Efficacy|0|||
130345820|NCT00592774|469237232|FG004|Overall Study|Lack of Efficacy|2|||
130345821|NCT00592774|469237228|FG000|Overall Study|Physician Decision|0|||
130345822|NCT00592774|469237229|FG001|Overall Study|Physician Decision|1|||
130679464|NCT02937701|470454124|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130345823|NCT00592774|469237230|FG002|Overall Study|Physician Decision|1|||
130345824|NCT00592774|469237231|FG003|Overall Study|Physician Decision|0|||
130345825|NCT00592774|469237232|FG004|Overall Study|Physician Decision|1|||
130345826|NCT00592774|469237228|FG000|Overall Study|Other|0|||
130345827|NCT00592774|469237229|FG001|Overall Study|Other|1|||
130345828|NCT00592774|469237230|FG002|Overall Study|Other|1|||
130345829|NCT00592774|469237231|FG003|Overall Study|Other|0|||
130435338|NCT02341456|469557071|FG002|Overall Study|Moved to local access programme.|1|||
130435339|NCT02341456|469557069|FG000|Overall Study|Physician Decision|1|||
130435340|NCT02341456|469557070|FG001|Overall Study|Physician Decision|0|||
130435341|NCT02341456|469557071|FG002|Overall Study|Physician Decision|0|||
130435342|NCT00301080|469557072|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
130435343|NCT00301080|469557073|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130435344|NCT00301080|469557074|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130435345|NCT00301080|469557075|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130435346|NCT00301080|469557076|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130435347|NCT01641926|469557077|FG000|Overall Study|Adverse Event|5|||
130435348|NCT01641926|469557078|FG001|Overall Study|Adverse Event|2|||
130435349|NCT01641926|469557079|FG002|Overall Study|Adverse Event|3|||
130435350|NCT01641926|469557080|FG003|Overall Study|Adverse Event|1|||
130435351|NCT01641926|469557077|FG000|Overall Study|Lost to Follow-up|2|||
130345830|NCT00592774|469237232|FG004|Overall Study|Other|2|||
130345831|NCT01700439|469237233|FG000|Overall Study|Lost to Follow-up|47|||
130345832|NCT01700439|469237233|FG000|Overall Study|Withdrawal by Subject|183|||
130345833|NCT01700439|469237233|FG000|Overall Study|Death|186|||
130345834|NCT01892384|469237234|FG000|Overall Study|Withdrawal by Subject|1|||
130345835|NCT01892384|469237235|FG001|Overall Study|Withdrawal by Subject|1|||
130345836|NCT01892384|469237236|FG002|Overall Study|Withdrawal by Subject|0|||
130345837|NCT01892384|469237237|FG003|Overall Study|Withdrawal by Subject|0|||
130345838|NCT00621621|469237248|FG000|Overall Study|Subjects were exited at EP study|30|||
130345839|NCT00621621|469237249|FG001|Overall Study|Subjects were exited at EP study|0|||
130345840|NCT01829243|469237250|FG000|First Intervention|Screen Failure|4|||
130345841|NCT01829243|469237251|FG001|First Intervention|Screen Failure|2|||
130345842|NCT00053898|469237271|FG000|Overall Study|No follow-up data from any source|9|||
130345843|NCT00053898|469237272|FG001|Overall Study|No follow-up data from any source|12|||
130345844|NCT00053898|469237271|FG000|Overall Study|Follow-up from telephone contact only|5|||
130345845|NCT00053898|469237272|FG001|Overall Study|Follow-up from telephone contact only|1|||
130345846|NCT01077375|469237277|FG000|Overall Study|Adverse Event|2|||
130345847|NCT01077375|469237278|FG001|Overall Study|Adverse Event|15|||
130345848|NCT01077375|469237277|FG000|Overall Study|Lack of Efficacy|6|||
130345849|NCT01077375|469237278|FG001|Overall Study|Lack of Efficacy|8|||
130345850|NCT01077375|469237277|FG000|Overall Study|Withdrawal by Subject|0|||
130345851|NCT01077375|469237278|FG001|Overall Study|Withdrawal by Subject|6|||
130345852|NCT01077375|469237277|FG000|Overall Study|Lost to Follow-up|2|||
130345853|NCT01077375|469237278|FG001|Overall Study|Lost to Follow-up|5|||
130345854|NCT01077375|469237277|FG000|Overall Study|Other Reason|0|||
130345855|NCT01077375|469237278|FG001|Overall Study|Other Reason|1|||
130345856|NCT01924429|469237281|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
130345857|NCT01924429|469237282|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
130345858|NCT00906971|469237283|FG000|Overall Study|Withdrawal by Subject|8|||
130345859|NCT00906971|469237284|FG001|Overall Study|Withdrawal by Subject|2|||
130345860|NCT00906971|469237283|FG000|Overall Study|Lost to Follow-up|0|||
130345861|NCT00906971|469237284|FG001|Overall Study|Lost to Follow-up|1|||
130345862|NCT00545129|469237285|FG000|Overall Study|Lack of Efficacy|2|||
130345863|NCT00545129|469237286|FG001|Overall Study|Lack of Efficacy|5|||
130345864|NCT00545129|469237285|FG000|Overall Study|Death|2|||
130345865|NCT00545129|469237286|FG001|Overall Study|Death|1|||
130345866|NCT00545129|469237285|FG000|Overall Study|Adverse Event|1|||
130345867|NCT00545129|469237286|FG001|Overall Study|Adverse Event|1|||
130345868|NCT00545129|469237285|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
130345869|NCT00545129|469237286|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
130345870|NCT00545129|469237285|FG000|Overall Study|Other|3|||
130345871|NCT00545129|469237286|FG001|Overall Study|Other|3|||
130345872|NCT01894568|469237287|FG000|Overall Study|Adverse Event|2|||
130345873|NCT01894568|469237288|FG001|Overall Study|Adverse Event|3|||
130345874|NCT01894568|469237287|FG000|Overall Study|Protocol required discontinuation|2|||
130345875|NCT01894568|469237288|FG001|Overall Study|Protocol required discontinuation|1|||
130345876|NCT01894568|469237287|FG000|Overall Study|Withdrawal by Subject|5|||
130345877|NCT01894568|469237288|FG001|Overall Study|Withdrawal by Subject|5|||
130345878|NCT01894568|469237287|FG000|Overall Study|Physician Decision|1|||
130345879|NCT01894568|469237288|FG001|Overall Study|Physician Decision|0|||
130345880|NCT01894568|469237287|FG000|Overall Study|Lost to Follow-up|0|||
130345881|NCT01894568|469237288|FG001|Overall Study|Lost to Follow-up|1|||
130345882|NCT00807573|469237289|FG000|Overall Study|Withdrawal by Subject|1|||
130345883|NCT00807573|469237289|FG000|Overall Study|Adverse Event|1|||
130345884|NCT01514370|469237292|FG000|Overall Study|Protocol Violation|2|||
130345885|NCT01514370|469237293|FG001|Overall Study|Protocol Violation|3|||
130345886|NCT01514370|469237292|FG000|Overall Study|Lost to Follow-up|0|||
130435352|NCT01641926|469557078|FG001|Overall Study|Lost to Follow-up|2|||
130435353|NCT01641926|469557079|FG002|Overall Study|Lost to Follow-up|1|||
130435354|NCT01641926|469557080|FG003|Overall Study|Lost to Follow-up|0|||
130345887|NCT01514370|469237293|FG001|Overall Study|Lost to Follow-up|2|||
130345888|NCT01514370|469237292|FG000|Overall Study|Withdrawal by Subject|2|||
130679465|NCT02937701|470454125|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130435355|NCT01641926|469557077|FG000|Overall Study|Physician Decision|6|||
130435356|NCT01641926|469557078|FG001|Overall Study|Physician Decision|5|||
130435357|NCT01641926|469557079|FG002|Overall Study|Physician Decision|0|||
130435358|NCT01641926|469557080|FG003|Overall Study|Physician Decision|1|||
130435359|NCT01641926|469557077|FG000|Overall Study|Protocol Violation|1|||
130435360|NCT01641926|469557078|FG001|Overall Study|Protocol Violation|0|||
130435361|NCT01641926|469557079|FG002|Overall Study|Protocol Violation|0|||
130435362|NCT01641926|469557080|FG003|Overall Study|Protocol Violation|1|||
130435363|NCT01641926|469557077|FG000|Overall Study|Withdrawal by Subject|13|||
130435364|NCT01641926|469557078|FG001|Overall Study|Withdrawal by Subject|5|||
130435365|NCT01641926|469557079|FG002|Overall Study|Withdrawal by Subject|6|||
130435366|NCT01641926|469557080|FG003|Overall Study|Withdrawal by Subject|1|||
130435367|NCT01641926|469557077|FG000|Overall Study|Not Treated|1|||
130435368|NCT01641926|469557078|FG001|Overall Study|Not Treated|1|||
130435369|NCT01641926|469557079|FG002|Overall Study|Not Treated|1|||
130435370|NCT01641926|469557080|FG003|Overall Study|Not Treated|0|||
130435371|NCT02567825|469557087|FG000|Overall Study|No follow-up post-randomization|5|||
130435372|NCT02567825|469557088|FG001|Overall Study|No follow-up post-randomization|1|||
130435373|NCT02567825|469557087|FG000|Overall Study|Follow-up less than 23 months|16|||
130435374|NCT02567825|469557088|FG001|Overall Study|Follow-up less than 23 months|20|||
130435375|NCT01540565|469557090|FG000|Overall Study|Ineligible|2|||
130435376|NCT02306265|469557091|FG000|Overall Study|Withdrawal by Subject|1|||
130435377|NCT04488003|469557092|FG000|Assessed for Eligibility|Screen Failure|24|||
130435378|NCT04488003|469557093|FG001|Assessed for Eligibility|Screen Failure|0|||
130435379|NCT04488003|469557094|FG002|Assessed for Eligibility|Screen Failure|0|||
130435380|NCT04488003|469557092|FG000|Assessed for Eligibility|Adverse Event|1|||
130435381|NCT04488003|469557093|FG001|Assessed for Eligibility|Adverse Event|0|||
130435382|NCT04488003|469557094|FG002|Assessed for Eligibility|Adverse Event|0|||
130435383|NCT04488003|469557092|FG000|Assessed for Eligibility|Death|1|||
130435384|NCT04488003|469557093|FG001|Assessed for Eligibility|Death|0|||
130435385|NCT04488003|469557094|FG002|Assessed for Eligibility|Death|0|||
130435386|NCT04488003|469557092|FG000|Assessed for Eligibility|Physician Decision|1|||
130435387|NCT04488003|469557093|FG001|Assessed for Eligibility|Physician Decision|0|||
130435388|NCT04488003|469557094|FG002|Assessed for Eligibility|Physician Decision|0|||
130435389|NCT04488003|469557092|FG000|Allocated to Treatment|Progressive Disease|51|||
130435390|NCT04488003|469557093|FG001|Allocated to Treatment|Progressive Disease|0|||
130435391|NCT04488003|469557094|FG002|Allocated to Treatment|Progressive Disease|0|||
130435392|NCT04488003|469557092|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
130435393|NCT04488003|469557093|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
130435394|NCT04488003|469557094|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
130435395|NCT04488003|469557092|FG000|Allocated to Treatment|Adverse Event|6|||
130435396|NCT04488003|469557093|FG001|Allocated to Treatment|Adverse Event|0|||
130435397|NCT04488003|469557094|FG002|Allocated to Treatment|Adverse Event|0|||
130435398|NCT04488003|469557092|FG000|Allocated to Treatment|Other|5|||
130435399|NCT04488003|469557093|FG001|Allocated to Treatment|Other|0|||
130435400|NCT04488003|469557094|FG002|Allocated to Treatment|Other|0|||
130435401|NCT04488003|469557092|FG000|Allocated to Treatment|Physician Decision|4|||
130435402|NCT04488003|469557093|FG001|Allocated to Treatment|Physician Decision|0|||
130435403|NCT04488003|469557094|FG002|Allocated to Treatment|Physician Decision|0|||
130435404|NCT04488003|469557092|FG000|Allocated to Treatment|Death|4|||
130435405|NCT04488003|469557093|FG001|Allocated to Treatment|Death|0|||
130435406|NCT04488003|469557094|FG002|Allocated to Treatment|Death|0|||
130435407|NCT04145037|469557100|FG000|Overall Study|Study terminated|2|||
130435408|NCT04145037|469557101|FG001|Overall Study|Study terminated|0|||
130435409|NCT04145037|469557100|FG000|Overall Study|Withdrawal by Subject|1|||
130435410|NCT04145037|469557101|FG001|Overall Study|Withdrawal by Subject|0|||
130435411|NCT04145037|469557100|FG000|Overall Study|Lost to Follow-up|1|||
130435412|NCT04145037|469557101|FG001|Overall Study|Lost to Follow-up|0|||
130435413|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
130435414|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
130435415|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
130679466|NCT02937701|470454126|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130679467|NCT02937701|470454122|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
130435416|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
130435417|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
130435418|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
130435419|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
130435420|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
130435421|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
130435422|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
130435423|NCT02307513|469557104|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
130679468|NCT02937701|470454123|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
130679469|NCT02937701|470454124|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
130552779|NCT00792805|469991535|FG001|Overall Study|Adverse Event|10|||
130679470|NCT02937701|470454125|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
130679471|NCT02937701|470454126|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
130679472|NCT02937701|470454122|FG000|Day 1 to Week 22|Death|1|||
130679473|NCT02937701|470454123|FG001|Day 1 to Week 22|Death|1|||
130679474|NCT02937701|470454124|FG002|Day 1 to Week 22|Death|0|||
130345889|NCT01514370|469237293|FG001|Overall Study|Withdrawal by Subject|1|||
130345890|NCT01514370|469237292|FG000|Overall Study|Adverse Event|1|||
130345891|NCT01514370|469237293|FG001|Overall Study|Adverse Event|3|||
130345892|NCT01514370|469237292|FG000|Overall Study|Other|6|||
130345893|NCT01514370|469237293|FG001|Overall Study|Other|7|||
130345894|NCT01551420|469237294|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
130345895|NCT01551420|469237295|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
130345896|NCT01551420|469237294|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
130345897|NCT01551420|469237295|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
130345898|NCT01551420|469237294|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
130345899|NCT01551420|469237295|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
130345900|NCT01551420|469237294|FG000|Screened for Part B Eligibility|Declined participation|8|||
130345901|NCT01551420|469237295|FG001|Screened for Part B Eligibility|Declined participation|1|||
130345902|NCT01551420|469237294|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
130345903|NCT01551420|469237295|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
130345904|NCT01551420|469237294|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
130345905|NCT01551420|469237295|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
130345906|NCT01551420|469237294|FG000|Home Use (Part B)|Withdrawal by staff|0|||
130345907|NCT01551420|469237295|FG001|Home Use (Part B)|Withdrawal by staff|1|||
130345908|NCT04054947|469237296|FG000|Overall Study|Withdrawal by Subject|1|||
130345909|NCT04054947|469237297|FG001|Overall Study|Withdrawal by Subject|0|||
130345910|NCT04054947|469237296|FG000|Overall Study|Lost to Follow-up|2|||
130345911|NCT04054947|469237297|FG001|Overall Study|Lost to Follow-up|5|||
130345912|NCT00853970|469237302|FG000|Overall Study|Withdrawal by Subject|2|||
130345913|NCT00853970|469237303|FG001|Overall Study|Withdrawal by Subject|1|||
130345914|NCT00853970|469237302|FG000|Overall Study|Cancelled surgery|4|||
130345915|NCT00853970|469237303|FG001|Overall Study|Cancelled surgery|2|||
130345916|NCT02055365|469238779|FG000|Overall Study|Prematurely Withdrawn|1|||
130345917|NCT01258998|469238780|FG000|Overall Study|Ineligible|1|||
130345918|NCT01143389|469238781|FG000|Overall Study|Lost to Follow-up|26|||
130345919|NCT01143389|469238782|FG001|Overall Study|Lost to Follow-up|25|||
130345920|NCT02276027|469238785|FG000|Overall Study|Death|1|||
130345921|NCT02276027|469238786|FG001|Overall Study|Death|0|||
130345922|NCT02276027|469238787|FG002|Overall Study|Death|0|||
130345923|NCT02276027|469238788|FG003|Overall Study|Death|2|||
130345924|NCT02276027|469238785|FG000|Overall Study|Physician Decision|0|||
130345925|NCT02276027|469238786|FG001|Overall Study|Physician Decision|0|||
130345926|NCT02276027|469238787|FG002|Overall Study|Physician Decision|0|||
130345927|NCT02276027|469238788|FG003|Overall Study|Physician Decision|1|||
130345928|NCT02276027|469238785|FG000|Overall Study|Progressive disease|1|||
130345929|NCT02276027|469238786|FG001|Overall Study|Progressive disease|13|||
130345930|NCT02276027|469238787|FG002|Overall Study|Progressive disease|12|||
130345931|NCT02276027|469238788|FG003|Overall Study|Progressive disease|14|||
130345932|NCT02276027|469238785|FG000|Overall Study|Subject/guardian decision|0|||
130345933|NCT02276027|469238786|FG001|Overall Study|Subject/guardian decision|1|||
130345934|NCT02276027|469238787|FG002|Overall Study|Subject/guardian decision|0|||
130345935|NCT02276027|469238788|FG003|Overall Study|Subject/guardian decision|3|||
130345936|NCT02276027|469238785|FG000|Overall Study|Adverse Event|0|||
130345937|NCT02276027|469238786|FG001|Overall Study|Adverse Event|2|||
130345938|NCT02276027|469238787|FG002|Overall Study|Adverse Event|8|||
130345939|NCT02276027|469238788|FG003|Overall Study|Adverse Event|2|||
130345940|NCT03224598|469238789|FG000|Overall Study|Lost to Follow-up|0|||
130345941|NCT03224598|469238790|FG001|Overall Study|Lost to Follow-up|2|||
130345942|NCT03224598|469238791|FG002|Overall Study|Lost to Follow-up|0|||
130345943|NCT03224598|469238789|FG000|Overall Study|Other|0|||
130345944|NCT03224598|469238790|FG001|Overall Study|Other|1|||
130345945|NCT03224598|469238791|FG002|Overall Study|Other|0|||
130345946|NCT01527357|469238793|FG000|Overall Study|Death|8|||
130345947|NCT01527357|469238794|FG001|Overall Study|Death|2|||
130345948|NCT01527357|469238793|FG000|Overall Study|Lost to Follow-up|6|||
130345949|NCT01527357|469238794|FG001|Overall Study|Lost to Follow-up|4|||
130345950|NCT01527357|469238793|FG000|Overall Study|Withdrew Consent|1|||
130345951|NCT01527357|469238794|FG001|Overall Study|Withdrew Consent|1|||
130345952|NCT01527357|469238793|FG000|Overall Study|Non-compliance|0|||
130345953|NCT01527357|469238794|FG001|Overall Study|Non-compliance|1|||
130345954|NCT01527357|469238793|FG000|Overall Study|No Day 29 Visit|0|||
130345955|NCT01527357|469238794|FG001|Overall Study|No Day 29 Visit|1|||
130345956|NCT01527357|469238793|FG000|Overall Study|Did Not Receive Treatment|2|||
130345957|NCT01527357|469238794|FG001|Overall Study|Did Not Receive Treatment|0|||
130345958|NCT02446171|469238795|FG000|Overall Study|Withdrawal by Subject|0|||
130345959|NCT02446171|469238796|FG001|Overall Study|Withdrawal by Subject|0|||
130345960|NCT02446171|469238797|FG002|Overall Study|Withdrawal by Subject|2|||
130345961|NCT02446171|469238798|FG003|Overall Study|Withdrawal by Subject|0|||
130679475|NCT02937701|470454125|FG003|Day 1 to Week 22|Death|0|||
130679476|NCT02937701|470454126|FG004|Day 1 to Week 22|Death|0|||
130679477|NCT02937701|470454122|FG000|Day 1 to Week 22|Protocol Violation|1|||
130679478|NCT02937701|470454123|FG001|Day 1 to Week 22|Protocol Violation|1|||
130679479|NCT02937701|470454124|FG002|Day 1 to Week 22|Protocol Violation|0|||
130679480|NCT02937701|470454125|FG003|Day 1 to Week 22|Protocol Violation|0|||
130679481|NCT02937701|470454126|FG004|Day 1 to Week 22|Protocol Violation|0|||
130679482|NCT02937701|470454122|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
130679483|NCT02937701|470454123|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
130679484|NCT02937701|470454124|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
130679485|NCT02937701|470454125|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
130679486|NCT02937701|470454126|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
130679487|NCT02937701|470454122|FG000|Day 1 to Week 22|Physician Decision|2|||
130679488|NCT02937701|470454123|FG001|Day 1 to Week 22|Physician Decision|0|||
130679489|NCT02937701|470454124|FG002|Day 1 to Week 22|Physician Decision|0|||
130679490|NCT02937701|470454125|FG003|Day 1 to Week 22|Physician Decision|0|||
130679491|NCT02937701|470454126|FG004|Day 1 to Week 22|Physician Decision|0|||
130679492|NCT02937701|470454122|FG000|Day 1 to Week 22|Other|1|||
130679493|NCT02937701|470454123|FG001|Day 1 to Week 22|Other|0|||
130679494|NCT02937701|470454124|FG002|Day 1 to Week 22|Other|0|||
130679495|NCT02937701|470454125|FG003|Day 1 to Week 22|Other|0|||
130679496|NCT02937701|470454126|FG004|Day 1 to Week 22|Other|0|||
130679497|NCT02937701|470454122|FG000|Week 22 to Week 50|Adverse Event|0|||
130679498|NCT02937701|470454123|FG001|Week 22 to Week 50|Adverse Event|0|||
130679499|NCT02937701|470454124|FG002|Week 22 to Week 50|Adverse Event|10|||
130679500|NCT02937701|470454125|FG003|Week 22 to Week 50|Adverse Event|3|||
130679501|NCT02937701|470454126|FG004|Week 22 to Week 50|Adverse Event|3|||
130679502|NCT02937701|470454122|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130679503|NCT02937701|470454123|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130679504|NCT02937701|470454124|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
130679505|NCT02937701|470454125|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
130679506|NCT02937701|470454126|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
130679507|NCT02937701|470454122|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
130679508|NCT02937701|470454123|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
130345962|NCT03811093|469238800|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
130345963|NCT03811093|469238801|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
130345964|NCT03811093|469238800|FG000|Overall Study|Unable to measure body fat percentage|2|||
130345965|NCT03811093|469238801|FG001|Overall Study|Unable to measure body fat percentage|0|||
130345966|NCT00464490|469238802|FG000|Overall Study|Physician Decision|11|||
130345967|NCT00464490|469238803|FG001|Overall Study|Physician Decision|11|||
130345968|NCT03188042|469238804|FG000|Overall Study|Withdrawal by Subject|1|||
130345969|NCT03188042|469238805|FG001|Overall Study|Withdrawal by Subject|1|||
130345970|NCT00603590|469238806|FG000|Overall Study|Did not attend study clinic|39|||
130345971|NCT00603590|469238807|FG001|Overall Study|Did not attend study clinic|30|||
130345972|NCT00603590|469238806|FG000|Overall Study|Refused blood test|5|||
130345973|NCT00603590|469238807|FG001|Overall Study|Refused blood test|1|||
130345974|NCT00603590|469238806|FG000|Overall Study|Patient discontinued study drug|22|||
130345975|NCT00603590|469238807|FG001|Overall Study|Patient discontinued study drug|15|||
130345976|NCT00603590|469238806|FG000|Overall Study|Adverse Event|2|||
130345977|NCT00603590|469238807|FG001|Overall Study|Adverse Event|0|||
130345978|NCT00603590|469238806|FG000|Overall Study|Lost to Follow-up|8|||
130345979|NCT00603590|469238807|FG001|Overall Study|Lost to Follow-up|4|||
130345980|NCT00603590|469238806|FG000|Overall Study|Cardiovascular event|0|||
130345981|NCT00603590|469238807|FG001|Overall Study|Cardiovascular event|1|||
130345982|NCT01475071|469238811|FG000|Overall Study|Physician Decision|1|||
130345983|NCT01475071|469238811|FG000|Overall Study|Withdrawal by Subject|6|||
130345984|NCT01475071|469238811|FG000|Overall Study|Lost to Follow-up|1|||
130345985|NCT01343823|469238812|FG000|Overall Study|Study Terminated|1|||
130345986|NCT01343823|469238813|FG001|Overall Study|Study Terminated|0|||
130345987|NCT01343823|469238814|FG002|Overall Study|Study Terminated|0|||
130345988|NCT01343823|469238815|FG003|Overall Study|Study Terminated|1|||
130345989|NCT01343823|469238812|FG000|Overall Study|Withdrawal by Subject|1|||
130345990|NCT01343823|469238813|FG001|Overall Study|Withdrawal by Subject|0|||
130345991|NCT01343823|469238814|FG002|Overall Study|Withdrawal by Subject|0|||
130345992|NCT01343823|469238815|FG003|Overall Study|Withdrawal by Subject|0|||
130345993|NCT00923364|469238816|FG000|Overall Study|Death|3|||
130435424|NCT02307513|469557105|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
130679509|NCT02937701|470454124|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
130345994|NCT00923364|469238817|FG001|Overall Study|Death|0|||
130345995|NCT00923364|469238816|FG000|Overall Study|Did not go to transplant|1|||
130345996|NCT00923364|469238817|FG001|Overall Study|Did not go to transplant|0|||
130679510|NCT02937701|470454125|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
130679511|NCT02937701|470454126|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
130679512|NCT02937701|470454122|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
130679513|NCT02937701|470454123|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
130679514|NCT02937701|470454124|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
130679515|NCT02937701|470454125|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
130679516|NCT02937701|470454126|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
130679517|NCT02937701|470454122|FG000|Week 22 to Week 50|Physician Decision|0|||
130435425|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
130679518|NCT02937701|470454123|FG001|Week 22 to Week 50|Physician Decision|0|||
130679519|NCT02937701|470454124|FG002|Week 22 to Week 50|Physician Decision|2|||
130679520|NCT02937701|470454125|FG003|Week 22 to Week 50|Physician Decision|0|||
130679521|NCT02937701|470454126|FG004|Week 22 to Week 50|Physician Decision|1|||
130679522|NCT02937701|470454122|FG000|Week 22 to Week 50|Other|0|||
130679523|NCT02937701|470454123|FG001|Week 22 to Week 50|Other|0|||
130679524|NCT02937701|470454124|FG002|Week 22 to Week 50|Other|0|||
130679525|NCT02937701|470454125|FG003|Week 22 to Week 50|Other|0|||
130679526|NCT02937701|470454126|FG004|Week 22 to Week 50|Other|1|||
130679527|NCT04720664|470454127|FG000|Overall Study|Adverse Event|2|||
130679528|NCT04720664|470454127|FG000|Overall Study|Lack of Efficacy|9|||
130679529|NCT01866319|470454131|FG000|Overall Study|Adverse Event|12|||
130679530|NCT01866319|470454132|FG001|Overall Study|Adverse Event|5|||
130679531|NCT01866319|470454133|FG002|Overall Study|Adverse Event|9|||
130679532|NCT01866319|470454131|FG000|Overall Study|Clinical progression|3|||
130679533|NCT01866319|470454132|FG001|Overall Study|Clinical progression|2|||
130679534|NCT01866319|470454133|FG002|Overall Study|Clinical progression|2|||
130679535|NCT01866319|470454131|FG000|Overall Study|Death|153|||
130679536|NCT01866319|470454132|FG001|Overall Study|Death|154|||
130679537|NCT01866319|470454133|FG002|Overall Study|Death|147|||
130679538|NCT01866319|470454131|FG000|Overall Study|Lost to Follow-up|6|||
130679539|NCT01866319|470454132|FG001|Overall Study|Lost to Follow-up|3|||
130679540|NCT01866319|470454133|FG002|Overall Study|Lost to Follow-up|8|||
130679541|NCT01866319|470454131|FG000|Overall Study|Physician Decision|1|||
130679542|NCT01866319|470454132|FG001|Overall Study|Physician Decision|0|||
130679543|NCT01866319|470454133|FG002|Overall Study|Physician Decision|1|||
130679544|NCT01866319|470454131|FG000|Overall Study|Protocol Violation|0|||
130679545|NCT01866319|470454132|FG001|Overall Study|Protocol Violation|0|||
130679546|NCT01866319|470454133|FG002|Overall Study|Protocol Violation|1|||
130679547|NCT01866319|470454131|FG000|Overall Study|Withdrawal by Subject|32|||
130679548|NCT01866319|470454132|FG001|Overall Study|Withdrawal by Subject|14|||
130679549|NCT01866319|470454133|FG002|Overall Study|Withdrawal by Subject|12|||
130435426|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
130435427|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
130435428|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
130435429|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
130679550|NCT03980483|470454135|FG000|Overall Study|Adverse Event|13|||
130679551|NCT03980483|470454136|FG001|Overall Study|Adverse Event|29|||
130435430|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
130435431|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
130435432|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
130435433|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
130435434|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
130435435|NCT02307513|469557104|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
130435436|NCT02307513|469557105|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
130435437|NCT02307513|469557104|FG000|Long-term Extension|Physician Decision|1|||
130435438|NCT02307513|469557105|FG001|Long-term Extension|Physician Decision|0|||
130435439|NCT00130793|469557106|FG000|Overall Study|Lost to Follow-up|1|||
130435440|NCT00130793|469557107|FG001|Overall Study|Lost to Follow-up|4|||
130435441|NCT00130793|469557106|FG000|Overall Study|Withdrew consent|2|||
130435442|NCT00130793|469557107|FG001|Overall Study|Withdrew consent|0|||
130435443|NCT00453102|469557110|FG000|Overall Study|Withdrawal by Subject|2|||
130435444|NCT03500640|469557116|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
130435445|NCT03500640|469557117|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
130435446|NCT03500640|469557118|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
130435447|NCT03500640|469557116|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
130435448|NCT03500640|469557117|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
130435449|NCT03500640|469557118|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
130435450|NCT03500640|469557116|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
130435451|NCT03500640|469557117|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
130435452|NCT03500640|469557118|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
130679552|NCT03980483|470454137|FG002|Overall Study|Adverse Event|11|||
130679553|NCT03980483|470454138|FG003|Overall Study|Adverse Event|2|||
130679554|NCT03980483|470454139|FG004|Overall Study|Adverse Event|2|||
130679555|NCT03980483|470454140|FG005|Overall Study|Adverse Event|2|||
130679556|NCT03980483|470454135|FG000|Overall Study|Lack of Efficacy|7|||
130679557|NCT03980483|470454136|FG001|Overall Study|Lack of Efficacy|6|||
130679558|NCT03980483|470454137|FG002|Overall Study|Lack of Efficacy|0|||
130435453|NCT03500640|469557116|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
130435454|NCT03500640|469557117|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
130679559|NCT03980483|470454138|FG003|Overall Study|Lack of Efficacy|3|||
130679560|NCT03980483|470454139|FG004|Overall Study|Lack of Efficacy|1|||
130679561|NCT03980483|470454140|FG005|Overall Study|Lack of Efficacy|1|||
130679562|NCT03980483|470454135|FG000|Overall Study|Lost to Follow-up|2|||
130679563|NCT03980483|470454136|FG001|Overall Study|Lost to Follow-up|4|||
130679564|NCT03980483|470454137|FG002|Overall Study|Lost to Follow-up|2|||
130679565|NCT03980483|470454138|FG003|Overall Study|Lost to Follow-up|1|||
130679566|NCT03980483|470454139|FG004|Overall Study|Lost to Follow-up|2|||
130679567|NCT03980483|470454140|FG005|Overall Study|Lost to Follow-up|0|||
130679568|NCT03980483|470454135|FG000|Overall Study|Protocol Violation|4|||
130679569|NCT03980483|470454136|FG001|Overall Study|Protocol Violation|2|||
130679570|NCT03980483|470454137|FG002|Overall Study|Protocol Violation|1|||
130679571|NCT03980483|470454138|FG003|Overall Study|Protocol Violation|1|||
130679572|NCT03980483|470454139|FG004|Overall Study|Protocol Violation|0|||
130679573|NCT03980483|470454140|FG005|Overall Study|Protocol Violation|0|||
130679574|NCT03980483|470454135|FG000|Overall Study|Physician Decision|14|||
130679575|NCT03980483|470454136|FG001|Overall Study|Physician Decision|10|||
130679576|NCT03980483|470454137|FG002|Overall Study|Physician Decision|7|||
130679577|NCT03980483|470454138|FG003|Overall Study|Physician Decision|4|||
130679578|NCT03980483|470454139|FG004|Overall Study|Physician Decision|4|||
130679579|NCT03980483|470454140|FG005|Overall Study|Physician Decision|2|||
130679580|NCT03980483|470454135|FG000|Overall Study|Withdrawal by Subject|38|||
130679581|NCT03980483|470454136|FG001|Overall Study|Withdrawal by Subject|21|||
130679582|NCT03980483|470454137|FG002|Overall Study|Withdrawal by Subject|15|||
130679583|NCT03980483|470454138|FG003|Overall Study|Withdrawal by Subject|5|||
130679584|NCT03980483|470454139|FG004|Overall Study|Withdrawal by Subject|3|||
130679585|NCT03980483|470454140|FG005|Overall Study|Withdrawal by Subject|4|||
130679586|NCT03980483|470454135|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
130679587|NCT03980483|470454136|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130679588|NCT03980483|470454137|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679589|NCT03980483|470454138|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130679590|NCT03980483|470454139|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679591|NCT03980483|470454140|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679592|NCT03980483|470454135|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679593|NCT03980483|470454136|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
130679594|NCT03980483|470454137|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679595|NCT03980483|470454138|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679596|NCT03980483|470454139|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679597|NCT03980483|470454140|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679598|NCT03980483|470454135|FG000|Overall Study|Other|0|||
130679599|NCT03980483|470454136|FG001|Overall Study|Other|1|||
130679600|NCT03980483|470454137|FG002|Overall Study|Other|0|||
130679601|NCT03980483|470454138|FG003|Overall Study|Other|0|||
130679602|NCT03980483|470454139|FG004|Overall Study|Other|0|||
130679603|NCT03980483|470454140|FG005|Overall Study|Other|0|||
130679604|NCT01225146|470454142|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
130679605|NCT01225146|470454143|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
130679606|NCT00623779|470454147|FG000|Overall Study|Adverse Event|1|||
130679607|NCT00623779|470454148|FG001|Overall Study|Adverse Event|3|||
130679608|NCT00623779|470454149|FG002|Overall Study|Adverse Event|0|||
130679609|NCT00623779|470454147|FG000|Overall Study|Criteria from CSR|2|||
130679610|NCT00623779|470454148|FG001|Overall Study|Criteria from CSR|0|||
130679611|NCT00623779|470454149|FG002|Overall Study|Criteria from CSR|1|||
130435455|NCT03500640|469557118|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
130435456|NCT03500640|469557116|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
130435457|NCT03500640|469557117|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
130435458|NCT03500640|469557118|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
130435459|NCT03500640|469557116|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
130679612|NCT00220337|470454152|FG000|Overall Study|Adverse Event|70|||
130679613|NCT00220337|470454152|FG000|Overall Study|Lack of Efficacy|17|||
130679614|NCT00220337|470454152|FG000|Overall Study|Withdrawal by Subject|68|||
130679615|NCT00220337|470454152|FG000|Overall Study|Protocol Violation|2|||
130679616|NCT00220337|470454152|FG000|Overall Study|Lost to Follow-up|5|||
130679617|NCT00220337|470454152|FG000|Overall Study|Other|12|||
130679618|NCT00220337|470454152|FG000|Overall Study|Unsatisfactory compliance|5|||
130679619|NCT00944697|470454153|FG000|Overall Study|Withdrawal by Subject|1|||
130679620|NCT00944697|470454154|FG001|Overall Study|Withdrawal by Subject|1|||
130679621|NCT00944697|470454153|FG000|Overall Study|Adverse Event|0|||
130679622|NCT00944697|470454154|FG001|Overall Study|Adverse Event|3|||
130679623|NCT00944697|470454153|FG000|Overall Study|Administrative|1|||
130679624|NCT00944697|470454154|FG001|Overall Study|Administrative|1|||
130679625|NCT02732210|470454155|FG000|Overall Study|Site Closed|0|||
130679626|NCT02732210|470454156|FG001|Overall Study|Site Closed|11|||
130679627|NCT02732210|470454155|FG000|Overall Study|Study Ended|13|||
130679628|NCT02732210|470454156|FG001|Overall Study|Study Ended|13|||
130679629|NCT02732210|470454155|FG000|Overall Study|Withdrawal by Subject|28|||
130679630|NCT02732210|470454156|FG001|Overall Study|Withdrawal by Subject|87|||
130679631|NCT02732210|470454155|FG000|Overall Study|Lost to Follow-up|5|||
130679632|NCT02732210|470454156|FG001|Overall Study|Lost to Follow-up|57|||
130679633|NCT02732210|470454155|FG000|Overall Study|Death|4|||
130679634|NCT02732210|470454156|FG001|Overall Study|Death|15|||
130679635|NCT02732210|470454155|FG000|Overall Study|Other|35|||
130679636|NCT02732210|470454156|FG001|Overall Study|Other|103|||
130679637|NCT02732210|470454155|FG000|Overall Study|Missing|0|||
130679638|NCT02732210|470454156|FG001|Overall Study|Missing|8|||
130345997|NCT01011478|469238818|FG000|Overall Study|No follow up data|12|||
130345998|NCT01011478|469238819|FG001|Overall Study|No follow up data|7|||
130345999|NCT04352127|469238821|FG000|Overall Study|Unable to obtain readings|4|||
130346000|NCT04352127|469238822|FG001|Overall Study|Unable to obtain readings|1|||
130346001|NCT05338671|469238823|FG000|Overall Study|Lost to Follow-up|2|||
130346002|NCT05338671|469238824|FG001|Overall Study|Lost to Follow-up|2|||
130346003|NCT05338671|469238823|FG000|Overall Study|Root canal completed in a single visit|1|||
130552780|NCT00792805|469991536|FG002|Overall Study|Adverse Event|10|||
130552781|NCT00792805|469991534|FG000|Overall Study|Subject withdrew consent|5|||
130346004|NCT05338671|469238824|FG001|Overall Study|Root canal completed in a single visit|0|||
130346005|NCT04456673|469238825|FG000|Overall Study|Adverse Event|7|||
130346006|NCT04456673|469238826|FG001|Overall Study|Adverse Event|14|||
130346007|NCT04456673|469238825|FG000|Overall Study|Poor compliance to protocol|1|||
130346008|NCT04456673|469238826|FG001|Overall Study|Poor compliance to protocol|0|||
130346009|NCT04456673|469238825|FG000|Overall Study|Withdrawal by Subject|31|||
130346010|NCT04456673|469238826|FG001|Overall Study|Withdrawal by Subject|23|||
130346011|NCT04456673|469238825|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
130346012|NCT04456673|469238826|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
130346013|NCT04391049|469238827|FG000|Overall Study|Protocol Violation|1|||
130346014|NCT03874429|469238828|FG000|Overall Study|Adverse Event|2|||
130346015|NCT03874429|469238829|FG001|Overall Study|Adverse Event|2|||
130346016|NCT03874429|469238828|FG000|Overall Study|Lack of Efficacy|0|||
130346017|NCT03874429|469238829|FG001|Overall Study|Lack of Efficacy|1|||
130346018|NCT03874429|469238828|FG000|Overall Study|Covid-19 pandemic|4|||
130346019|NCT03874429|469238829|FG001|Overall Study|Covid-19 pandemic|2|||
130346020|NCT00992589|469238833|FG000|Open-Label Phase|Adverse Event|4|||
130346021|NCT00992589|469238834|FG001|Open-Label Phase|Adverse Event|0|||
130346022|NCT00992589|469238835|FG002|Open-Label Phase|Adverse Event|0|||
130346023|NCT00992589|469238836|FG003|Open-Label Phase|Adverse Event|0|||
130346024|NCT00992589|469238833|FG000|Open-Label Phase|Withdrawal by Subject|20|||
130346025|NCT00992589|469238834|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130346026|NCT00992589|469238835|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130346027|NCT00992589|469238836|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130346028|NCT00992589|469238833|FG000|Open-Label Phase|Lost to Follow-up|1|||
130346029|NCT00992589|469238834|FG001|Open-Label Phase|Lost to Follow-up|0|||
130346030|NCT00992589|469238835|FG002|Open-Label Phase|Lost to Follow-up|0|||
130346031|NCT00992589|469238836|FG003|Open-Label Phase|Lost to Follow-up|0|||
130346032|NCT00992589|469238833|FG000|Open-Label Phase|Protocol Violation|3|||
130346033|NCT00992589|469238834|FG001|Open-Label Phase|Protocol Violation|0|||
130346034|NCT00992589|469238835|FG002|Open-Label Phase|Protocol Violation|0|||
130346035|NCT00992589|469238836|FG003|Open-Label Phase|Protocol Violation|0|||
130346036|NCT00992589|469238833|FG000|Open-Label Phase|Physician Decision|4|||
130346037|NCT00992589|469238834|FG001|Open-Label Phase|Physician Decision|0|||
130346038|NCT00992589|469238835|FG002|Open-Label Phase|Physician Decision|0|||
130346039|NCT00992589|469238836|FG003|Open-Label Phase|Physician Decision|0|||
130346040|NCT00992589|469238833|FG000|Open-Label Phase|Other|45|||
130346041|NCT00992589|469238834|FG001|Open-Label Phase|Other|0|||
130346042|NCT00992589|469238835|FG002|Open-Label Phase|Other|0|||
130346043|NCT00992589|469238836|FG003|Open-Label Phase|Other|0|||
130346044|NCT00992589|469238833|FG000|Double-Blind Phase|Adverse Event|0|||
130346045|NCT00992589|469238834|FG001|Double-Blind Phase|Adverse Event|6|||
130346046|NCT00992589|469238835|FG002|Double-Blind Phase|Adverse Event|2|||
130346047|NCT00992589|469238836|FG003|Double-Blind Phase|Adverse Event|3|||
130346048|NCT00992589|469238833|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130346049|NCT00992589|469238834|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130346050|NCT00992589|469238835|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130346051|NCT00992589|469238836|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130346052|NCT00992589|469238833|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130346053|NCT00992589|469238834|FG001|Double-Blind Phase|Lost to Follow-up|0|||
130346054|NCT00992589|469238835|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130346055|NCT00992589|469238836|FG003|Double-Blind Phase|Lost to Follow-up|2|||
130216616|NCT03162328|468755620|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
130346056|NCT00992589|469238833|FG000|Double-Blind Phase|Other|0|||
130346057|NCT00992589|469238834|FG001|Double-Blind Phase|Other|1|||
130346058|NCT00992589|469238835|FG002|Double-Blind Phase|Other|6|||
130346059|NCT00992589|469238836|FG003|Double-Blind Phase|Other|3|||
130346060|NCT01215916|469238837|FG000|Overall Study|Progressive Disease|0|||
130346061|NCT01215916|469238838|FG001|Overall Study|Progressive Disease|2|||
130346062|NCT01215916|469238839|FG002|Overall Study|Progressive Disease|1|||
130346063|NCT01215916|469238840|FG003|Overall Study|Progressive Disease|2|||
130346064|NCT01215916|469238841|FG004|Overall Study|Progressive Disease|5|||
130346065|NCT01215916|469238842|FG005|Overall Study|Progressive Disease|4|||
130679639|NCT02191891|470454159|FG000|Overall Study|Withdrawal by Subject|0|||
130435460|NCT03500640|469557117|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
130435461|NCT03500640|469557118|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
130435462|NCT03500640|469557116|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
130435463|NCT03500640|469557117|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
130435464|NCT03500640|469557118|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
130435465|NCT03500640|469557116|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
130435466|NCT03500640|469557117|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
130435467|NCT03500640|469557118|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
130435468|NCT03500640|469557116|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
130435469|NCT03500640|469557117|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
130435470|NCT03500640|469557118|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
130435471|NCT03500640|469557116|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
130435472|NCT03500640|469557117|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
130435473|NCT03500640|469557118|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
130435474|NCT01650519|469557119|FG000|Overall Study|Withdrawal by Subject|1|||
130435475|NCT01650519|469557120|FG001|Overall Study|Withdrawal by Subject|0|||
130435476|NCT02487095|469557126|FG000|Dose Expansion|Unable to scan/restage participant|0|||
130435477|NCT02487095|469557127|FG001|Dose Expansion|Unable to scan/restage participant|0|||
130435478|NCT02487095|469557128|FG002|Dose Expansion|Unable to scan/restage participant|0|||
130435479|NCT02487095|469557129|FG003|Dose Expansion|Unable to scan/restage participant|0|||
130435480|NCT02487095|469557130|FG004|Dose Expansion|Unable to scan/restage participant|1|||
130435481|NCT05778526|469557133|FG000|Overall Study|Lost to Follow-up|0|||
130435482|NCT05778526|469557134|FG001|Overall Study|Lost to Follow-up|1|||
130435483|NCT05778526|469557135|FG002|Overall Study|Lost to Follow-up|3|||
130435484|NCT05778526|469557133|FG000|Overall Study|Protocol Violation|0|||
130435485|NCT05778526|469557134|FG001|Overall Study|Protocol Violation|0|||
130435486|NCT05778526|469557135|FG002|Overall Study|Protocol Violation|8|||
130435487|NCT03108157|469557136|FG000|Overall Study|Protocol Violation|15|||
130435488|NCT03108157|469557137|FG001|Overall Study|Protocol Violation|4|||
130435489|NCT01279343|469557140|FG000|Overall Study|Did not receive treatment|2|||
130435490|NCT01279343|469557141|FG001|Overall Study|Did not receive treatment|6|||
130435491|NCT04534114|469557142|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130435492|NCT04534114|469557143|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
130435493|NCT04534114|469557144|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130435494|NCT04534114|469557145|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130435495|NCT04534114|469557142|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
130435496|NCT04534114|469557143|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
130435497|NCT04534114|469557144|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
130435498|NCT04534114|469557145|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
130435499|NCT04534114|469557142|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
130435500|NCT04534114|469557143|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
130435501|NCT04534114|469557144|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
130435502|NCT04534114|469557145|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
130435503|NCT04534114|469557142|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130435504|NCT04534114|469557143|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
130435505|NCT04534114|469557144|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
130435506|NCT04534114|469557145|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130435507|NCT04534114|469557142|FG000|Main Treatment Period|Physician Decision|0|||
130435508|NCT04534114|469557143|FG001|Main Treatment Period|Physician Decision|0|||
130435509|NCT04534114|469557144|FG002|Main Treatment Period|Physician Decision|0|||
130435510|NCT04534114|469557145|FG003|Main Treatment Period|Physician Decision|1|||
130435511|NCT04534114|469557142|FG000|Main Treatment Period|Death|1|||
130435512|NCT04534114|469557143|FG001|Main Treatment Period|Death|0|||
130435513|NCT04534114|469557144|FG002|Main Treatment Period|Death|0|||
130435514|NCT04534114|469557145|FG003|Main Treatment Period|Death|1|||
130679640|NCT02191891|470454160|FG001|Overall Study|Withdrawal by Subject|1|||
130435515|NCT04534114|469557142|FG000|Main Treatment Period|Other reason|1|||
130435516|NCT04534114|469557143|FG001|Main Treatment Period|Other reason|1|||
130435517|NCT04534114|469557144|FG002|Main Treatment Period|Other reason|0|||
130435518|NCT04534114|469557145|FG003|Main Treatment Period|Other reason|0|||
130435519|NCT04534114|469557142|FG000|Main Treatment Period|Participant decision|1|||
130679641|NCT02191891|470454161|FG002|Overall Study|Withdrawal by Subject|0|||
130679642|NCT02191891|470454162|FG003|Overall Study|Withdrawal by Subject|0|||
130435520|NCT04534114|469557143|FG001|Main Treatment Period|Participant decision|3|||
130435521|NCT04534114|469557144|FG002|Main Treatment Period|Participant decision|3|||
130435522|NCT04534114|469557145|FG003|Main Treatment Period|Participant decision|1|||
130435523|NCT04534114|469557142|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
130679643|NCT02191891|470454163|FG004|Overall Study|Withdrawal by Subject|1|||
130679644|NCT02191891|470454159|FG000|Overall Study|Adverse Event|0|||
130679645|NCT02191891|470454160|FG001|Overall Study|Adverse Event|1|||
130679646|NCT02191891|470454161|FG002|Overall Study|Adverse Event|0|||
130435524|NCT04534114|469557143|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
130679647|NCT02191891|470454162|FG003|Overall Study|Adverse Event|0|||
130435525|NCT04534114|469557144|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
130435526|NCT04534114|469557145|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
130435527|NCT04534114|469557142|FG000|Main Treatment Period|Adverse Event|4|||
130435528|NCT04534114|469557143|FG001|Main Treatment Period|Adverse Event|2|||
130435529|NCT04534114|469557144|FG002|Main Treatment Period|Adverse Event|1|||
130435530|NCT04534114|469557145|FG003|Main Treatment Period|Adverse Event|2|||
130435531|NCT04534114|469557142|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130435532|NCT04534114|469557143|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130435533|NCT04534114|469557144|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130435534|NCT04534114|469557145|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
130435535|NCT04534114|469557142|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130435536|NCT04534114|469557143|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130435537|NCT04534114|469557144|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130435538|NCT04534114|469557145|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130435539|NCT04534114|469557142|FG000|Extension Treatment Period|Other reason|0|||
130435540|NCT04534114|469557143|FG001|Extension Treatment Period|Other reason|1|||
130435541|NCT04534114|469557144|FG002|Extension Treatment Period|Other reason|0|||
130435542|NCT04534114|469557145|FG003|Extension Treatment Period|Other reason|0|||
130435543|NCT04534114|469557142|FG000|Extension Treatment Period|Death|0|||
130435544|NCT04534114|469557143|FG001|Extension Treatment Period|Death|0|||
130435545|NCT04534114|469557144|FG002|Extension Treatment Period|Death|1|||
130435546|NCT04534114|469557145|FG003|Extension Treatment Period|Death|2|||
130435547|NCT04534114|469557142|FG000|Extension Treatment Period|Adverse Event|0|||
130435548|NCT04534114|469557143|FG001|Extension Treatment Period|Adverse Event|1|||
130435549|NCT04534114|469557144|FG002|Extension Treatment Period|Adverse Event|0|||
130435550|NCT04534114|469557145|FG003|Extension Treatment Period|Adverse Event|1|||
130435551|NCT04534114|469557142|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
130435552|NCT04534114|469557143|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
130435553|NCT04534114|469557144|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
130435554|NCT04534114|469557145|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
130435555|NCT03287414|469557146|FG000|Treatment Epoch|Adverse Event|0|||
130435556|NCT03287414|469557147|FG001|Treatment Epoch|Adverse Event|1|||
130435557|NCT03287414|469557146|FG000|Treatment Epoch|Study terminated by sponsor|2|||
130435558|NCT03287414|469557147|FG001|Treatment Epoch|Study terminated by sponsor|2|||
130435559|NCT03287414|469557146|FG000|Treatment Epoch|Subject/Guardian decision|4|||
130435560|NCT03287414|469557147|FG001|Treatment Epoch|Subject/Guardian decision|0|||
130435561|NCT03287414|469557146|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
130435562|NCT03287414|469557147|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
130435563|NCT03287414|469557146|FG000|Treatment Epoch|Withdrawal by Subject|1|||
130435564|NCT03287414|469557147|FG001|Treatment Epoch|Withdrawal by Subject|0|||
130435565|NCT03287414|469557146|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
130435566|NCT03287414|469557147|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
130435567|NCT03287414|469557146|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
130435568|NCT03287414|469557147|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
130435569|NCT02759185|469557148|FG000|Stage 1|Adverse Event|0|||
130435570|NCT02759185|469557149|FG001|Stage 1|Adverse Event|1|||
130435571|NCT02759185|469557150|FG002|Stage 1|Adverse Event|3|||
130435572|NCT02759185|469557151|FG003|Stage 1|Adverse Event|0|||
130435573|NCT02759185|469557152|FG004|Stage 1|Adverse Event|0|||
130435574|NCT02759185|469557153|FG005|Stage 1|Adverse Event|0|||
130435575|NCT02759185|469557154|FG006|Stage 1|Adverse Event|0|||
130435576|NCT02759185|469557148|FG000|Stage 1|Withdrawal by Subject|1|||
130435577|NCT02759185|469557149|FG001|Stage 1|Withdrawal by Subject|0|||
130435578|NCT02759185|469557150|FG002|Stage 1|Withdrawal by Subject|0|||
130435579|NCT02759185|469557151|FG003|Stage 1|Withdrawal by Subject|0|||
130435580|NCT02759185|469557152|FG004|Stage 1|Withdrawal by Subject|0|||
130435581|NCT02759185|469557153|FG005|Stage 1|Withdrawal by Subject|0|||
130435582|NCT02759185|469557154|FG006|Stage 1|Withdrawal by Subject|0|||
130435583|NCT02759185|469557148|FG000|Stage 2|Adverse Event|0|||
130435584|NCT02759185|469557149|FG001|Stage 2|Adverse Event|0|||
130435585|NCT02759185|469557150|FG002|Stage 2|Adverse Event|0|||
130679648|NCT02191891|470454163|FG004|Overall Study|Adverse Event|2|||
130679649|NCT02191891|470454159|FG000|Overall Study|Disease Progression|4|||
130679650|NCT02191891|470454160|FG001|Overall Study|Disease Progression|10|||
130435586|NCT02759185|469557151|FG003|Stage 2|Adverse Event|0|||
130679651|NCT02191891|470454161|FG002|Overall Study|Disease Progression|4|||
130679652|NCT02191891|470454162|FG003|Overall Study|Disease Progression|2|||
130679653|NCT02191891|470454163|FG004|Overall Study|Disease Progression|7|||
130435587|NCT02759185|469557152|FG004|Stage 2|Adverse Event|1|||
130435588|NCT02759185|469557153|FG005|Stage 2|Adverse Event|2|||
130435589|NCT02759185|469557154|FG006|Stage 2|Adverse Event|0|||
130679654|NCT01226797|470454174|FG000|Overall Study|Adverse Event|1|||
130346066|NCT01215916|469238843|FG006|Overall Study|Progressive Disease|5|||
130346067|NCT01215916|469238844|FG007|Overall Study|Progressive Disease|3|||
130346068|NCT01215916|469238845|FG008|Overall Study|Progressive Disease|1|||
130346069|NCT01215916|469238837|FG000|Overall Study|Adverse Event|1|||
130346070|NCT01215916|469238838|FG001|Overall Study|Adverse Event|1|||
130346071|NCT01215916|469238839|FG002|Overall Study|Adverse Event|0|||
130346072|NCT01215916|469238840|FG003|Overall Study|Adverse Event|1|||
130346073|NCT01215916|469238841|FG004|Overall Study|Adverse Event|0|||
130346074|NCT01215916|469238842|FG005|Overall Study|Adverse Event|0|||
130346075|NCT01215916|469238843|FG006|Overall Study|Adverse Event|3|||
130346076|NCT01215916|469238844|FG007|Overall Study|Adverse Event|0|||
130346077|NCT01215916|469238845|FG008|Overall Study|Adverse Event|0|||
130346078|NCT01215916|469238837|FG000|Overall Study|Withdrawal by Subject|0|||
130346079|NCT01215916|469238838|FG001|Overall Study|Withdrawal by Subject|1|||
130346080|NCT01215916|469238839|FG002|Overall Study|Withdrawal by Subject|1|||
130346081|NCT01215916|469238840|FG003|Overall Study|Withdrawal by Subject|2|||
130346082|NCT01215916|469238841|FG004|Overall Study|Withdrawal by Subject|0|||
130346083|NCT01215916|469238842|FG005|Overall Study|Withdrawal by Subject|0|||
130346084|NCT01215916|469238843|FG006|Overall Study|Withdrawal by Subject|1|||
130346085|NCT01215916|469238844|FG007|Overall Study|Withdrawal by Subject|0|||
130346086|NCT01215916|469238845|FG008|Overall Study|Withdrawal by Subject|0|||
130346087|NCT01215916|469238837|FG000|Overall Study|Death|0|||
130346088|NCT01215916|469238838|FG001|Overall Study|Death|1|||
130346089|NCT01215916|469238839|FG002|Overall Study|Death|0|||
130346090|NCT01215916|469238840|FG003|Overall Study|Death|0|||
130346091|NCT01215916|469238841|FG004|Overall Study|Death|1|||
130346092|NCT01215916|469238842|FG005|Overall Study|Death|0|||
130346093|NCT01215916|469238843|FG006|Overall Study|Death|0|||
130346094|NCT01215916|469238844|FG007|Overall Study|Death|0|||
130346095|NCT01215916|469238845|FG008|Overall Study|Death|1|||
130346096|NCT01215916|469238837|FG000|Overall Study|Physician Decision|0|||
130346097|NCT01215916|469238838|FG001|Overall Study|Physician Decision|0|||
130346098|NCT01215916|469238839|FG002|Overall Study|Physician Decision|1|||
130346099|NCT01215916|469238840|FG003|Overall Study|Physician Decision|1|||
130346100|NCT01215916|469238841|FG004|Overall Study|Physician Decision|0|||
130346101|NCT01215916|469238842|FG005|Overall Study|Physician Decision|0|||
130346102|NCT01215916|469238843|FG006|Overall Study|Physician Decision|0|||
130346103|NCT01215916|469238844|FG007|Overall Study|Physician Decision|0|||
130346104|NCT01215916|469238845|FG008|Overall Study|Physician Decision|0|||
130435590|NCT02759185|469557148|FG000|Stage 2|Withdrawal by Subject|0|||
130435591|NCT02759185|469557149|FG001|Stage 2|Withdrawal by Subject|0|||
130435592|NCT02759185|469557150|FG002|Stage 2|Withdrawal by Subject|0|||
130435593|NCT02759185|469557151|FG003|Stage 2|Withdrawal by Subject|0|||
130435594|NCT02759185|469557152|FG004|Stage 2|Withdrawal by Subject|1|||
130435595|NCT02759185|469557153|FG005|Stage 2|Withdrawal by Subject|1|||
130435596|NCT02759185|469557154|FG006|Stage 2|Withdrawal by Subject|1|||
130435597|NCT02613221|469557160|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
130435598|NCT02613221|469557160|FG000|Overall Study|Adverse Event|2|||
130435599|NCT02613221|469557160|FG000|Overall Study|Voluntary Discontinuation|1|||
130679655|NCT01226797|470454175|FG001|Overall Study|Adverse Event|0|||
130679656|NCT01226797|470454174|FG000|Overall Study|No longer willing to participate|1|||
130346105|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
130346106|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346107|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346108|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346109|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346110|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346111|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346112|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346113|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346114|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Adverse Event|5|||
130346115|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Adverse Event|0|||
130346116|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Adverse Event|0|||
130346117|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Adverse Event|0|||
130346118|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Adverse Event|0|||
130346119|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Adverse Event|0|||
130435600|NCT02613221|469557160|FG000|Overall Study|Delayed Treatment|1|||
130435601|NCT02613221|469557160|FG000|Overall Study|Enrolled but Not Treated|1|||
130679657|NCT01226797|470454175|FG001|Overall Study|No longer willing to participate|0|||
130346120|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Adverse Event|0|||
130346121|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Adverse Event|0|||
130346122|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Adverse Event|0|||
130346123|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
130346124|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346125|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346126|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346127|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346128|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346129|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
130435602|NCT01008475|469557163|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
130435603|NCT01008475|469557164|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
130435604|NCT01008475|469557165|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
130435605|NCT01008475|469557166|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
130435606|NCT01008475|469557167|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
130435607|NCT01008475|469557168|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
130435608|NCT01008475|469557169|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
130435609|NCT02668016|469557170|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
130435610|NCT02668016|469557170|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
130435611|NCT02668016|469557170|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
130435612|NCT02668016|469557170|FG000|Month 4|Withdrawal due to severe symptoms|1|||
130435613|NCT02668016|469557170|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
130435614|NCT02668016|469557170|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
130435615|NCT02668016|469557170|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
130435616|NCT02668016|469557170|FG000|Month 6|Withdrawal due to severe symptoms|2|||
130435617|NCT02668016|469557170|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
130435618|NCT02668016|469557170|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
130435619|NCT02668016|469557170|FG000|Month 8|Withdrawal due to severe symptoms|1|||
130435620|NCT02668016|469557170|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
130435621|NCT02668016|469557170|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
130435622|NCT02668016|469557170|FG000|Month 10|Withdrawal due to severe symptoms|1|||
130435623|NCT02668016|469557170|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
130435624|NCT02917941|469557172|FG000|Treatment Period|Adverse Event|11|||
130435625|NCT02917941|469557172|FG000|Treatment Period|Progressive Disease|11|||
130435626|NCT02917941|469557172|FG000|Treatment Period|Reason not Specified|2|||
130435627|NCT02917941|469557172|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
130435628|NCT02917941|469557172|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
130435629|NCT05067933|469557183|FG000|Overall Study|Withdrawal by Subject|2|||
130435630|NCT05067933|469557184|FG001|Overall Study|Withdrawal by Subject|0|||
130435631|NCT05067933|469557185|FG002|Overall Study|Withdrawal by Subject|0|||
130435632|NCT05067933|469557186|FG003|Overall Study|Withdrawal by Subject|0|||
130435633|NCT05067933|469557187|FG004|Overall Study|Withdrawal by Subject|0|||
130435634|NCT05067933|469557188|FG005|Overall Study|Withdrawal by Subject|0|||
130435635|NCT05067933|469557183|FG000|Overall Study|Lost to Follow-up|1|||
130435636|NCT05067933|469557184|FG001|Overall Study|Lost to Follow-up|1|||
130435637|NCT05067933|469557185|FG002|Overall Study|Lost to Follow-up|1|||
130435638|NCT05067933|469557186|FG003|Overall Study|Lost to Follow-up|2|||
130435639|NCT05067933|469557187|FG004|Overall Study|Lost to Follow-up|1|||
130435640|NCT05067933|469557188|FG005|Overall Study|Lost to Follow-up|0|||
130435641|NCT05067933|469557183|FG000|Overall Study|Miscellaneous|1|||
130435642|NCT05067933|469557184|FG001|Overall Study|Miscellaneous|0|||
130435643|NCT05067933|469557185|FG002|Overall Study|Miscellaneous|0|||
130435644|NCT05067933|469557186|FG003|Overall Study|Miscellaneous|0|||
130435645|NCT05067933|469557187|FG004|Overall Study|Miscellaneous|0|||
130435646|NCT05067933|469557188|FG005|Overall Study|Miscellaneous|0|||
130435647|NCT05067933|469557183|FG000|Overall Study|Death|0|||
130435648|NCT05067933|469557184|FG001|Overall Study|Death|0|||
130435649|NCT05067933|469557185|FG002|Overall Study|Death|0|||
130435650|NCT05067933|469557186|FG003|Overall Study|Death|1|||
130435651|NCT05067933|469557187|FG004|Overall Study|Death|0|||
130435652|NCT05067933|469557188|FG005|Overall Study|Death|0|||
130435653|NCT02946918|469557200|FG000|Overall Study|Patient unblinded himself|1|||
130435654|NCT02946918|469557201|FG001|Overall Study|Patient unblinded himself|0|||
130435655|NCT02946918|469557200|FG000|Overall Study|Physician Decision|0|||
130435656|NCT02946918|469557201|FG001|Overall Study|Physician Decision|2|||
130435657|NCT02946918|469557200|FG000|Overall Study|Ran out of study medication|0|||
130435658|NCT02946918|469557201|FG001|Overall Study|Ran out of study medication|1|||
130435659|NCT00069784|469557202|FG000|Overall Study|Adverse Event|105|||
130435660|NCT00069784|469557203|FG001|Overall Study|Adverse Event|0|||
130435661|NCT00069784|469557202|FG000|Overall Study|Withdrawal by Subject|1090|||
130435662|NCT00069784|469557203|FG001|Overall Study|Withdrawal by Subject|0|||
130435663|NCT00069784|469557202|FG000|Overall Study|Other|17|||
130435664|NCT00069784|469557203|FG001|Overall Study|Other|0|||
130435665|NCT01672853|469557208|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
130435666|NCT01672853|469557209|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
130435667|NCT01672853|469557210|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
130435668|NCT01672853|469557208|FG000|Overall Study|Pregnancy|0|||
130435669|NCT01672853|469557209|FG001|Overall Study|Pregnancy|1|||
130435670|NCT01672853|469557210|FG002|Overall Study|Pregnancy|0|||
130435671|NCT01672853|469557208|FG000|Overall Study|Investigator's Discretion|1|||
130435672|NCT01672853|469557209|FG001|Overall Study|Investigator's Discretion|0|||
130435673|NCT01672853|469557210|FG002|Overall Study|Investigator's Discretion|0|||
130679658|NCT01226797|470454174|FG000|Overall Study|Protocol Violation|0|||
130679659|NCT01226797|470454175|FG001|Overall Study|Protocol Violation|1|||
130679660|NCT01974141|470454178|FG000|Overall Study|Other Reasons|28|||
130679661|NCT01974141|470454179|FG001|Overall Study|Other Reasons|18|||
130346130|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346131|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346132|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Death|1|||
130346133|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Death|0|||
130346134|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Death|0|||
130346135|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Death|0|||
130346136|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Death|0|||
130346137|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Death|0|||
130346138|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Death|0|||
130346139|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Death|0|||
130346140|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Death|0|||
130346141|NCT00045942|469238846|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
130346142|NCT00045942|469238847|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
130346143|NCT00045942|469238848|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
130346144|NCT00045942|469238849|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
130346145|NCT00045942|469238850|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
130346146|NCT00045942|469238851|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
130346147|NCT00045942|469238852|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
130346148|NCT00045942|469238853|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
130346149|NCT00045942|469238854|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
130346150|NCT00045942|469238846|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
130346151|NCT00045942|469238847|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
130346152|NCT00045942|469238848|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
130346153|NCT00045942|469238849|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
130346154|NCT00045942|469238850|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
130346155|NCT00045942|469238851|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
130346156|NCT00045942|469238852|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
130346157|NCT00045942|469238853|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
130346158|NCT00045942|469238854|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
130346159|NCT00045942|469238846|FG000|PKC412A2104E1|Lack of Efficacy|0|||
130346160|NCT00045942|469238847|FG001|PKC412A2104E1|Lack of Efficacy|11|||
130346161|NCT00045942|469238848|FG002|PKC412A2104E1|Lack of Efficacy|11|||
130346162|NCT00045942|469238849|FG003|PKC412A2104E1|Lack of Efficacy|23|||
130346163|NCT00045942|469238850|FG004|PKC412A2104E1|Lack of Efficacy|17|||
130346164|NCT00045942|469238851|FG005|PKC412A2104E1|Lack of Efficacy|0|||
130346165|NCT00045942|469238852|FG006|PKC412A2104E1|Lack of Efficacy|0|||
130346166|NCT00045942|469238853|FG007|PKC412A2104E1|Lack of Efficacy|0|||
130346167|NCT00045942|469238854|FG008|PKC412A2104E1|Lack of Efficacy|0|||
130346168|NCT00045942|469238846|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
130346169|NCT00045942|469238847|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
130346170|NCT00045942|469238848|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
130346171|NCT00045942|469238849|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
130346172|NCT00045942|469238850|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
130346173|NCT00045942|469238851|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
130346174|NCT00045942|469238852|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
130346175|NCT00045942|469238853|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
130346176|NCT00045942|469238854|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
130346177|NCT00045942|469238846|FG000|PKC412A2104E1|Adverse Event|0|||
130346178|NCT00045942|469238847|FG001|PKC412A2104E1|Adverse Event|1|||
130346179|NCT00045942|469238848|FG002|PKC412A2104E1|Adverse Event|1|||
130346180|NCT00045942|469238849|FG003|PKC412A2104E1|Adverse Event|3|||
130346181|NCT00045942|469238850|FG004|PKC412A2104E1|Adverse Event|6|||
130346182|NCT00045942|469238851|FG005|PKC412A2104E1|Adverse Event|0|||
130346183|NCT00045942|469238852|FG006|PKC412A2104E1|Adverse Event|0|||
130346184|NCT00045942|469238853|FG007|PKC412A2104E1|Adverse Event|0|||
130346185|NCT00045942|469238854|FG008|PKC412A2104E1|Adverse Event|0|||
130679662|NCT01974141|470454178|FG000|Overall Study|Protocol Violation|2|||
130346186|NCT00045942|469238846|FG000|PKC412A2104E1|Death|0|||
130346187|NCT00045942|469238847|FG001|PKC412A2104E1|Death|4|||
130346188|NCT00045942|469238848|FG002|PKC412A2104E1|Death|1|||
130346189|NCT00045942|469238849|FG003|PKC412A2104E1|Death|1|||
130346190|NCT00045942|469238850|FG004|PKC412A2104E1|Death|1|||
130346191|NCT00045942|469238851|FG005|PKC412A2104E1|Death|0|||
130346192|NCT00045942|469238852|FG006|PKC412A2104E1|Death|0|||
130346193|NCT00045942|469238853|FG007|PKC412A2104E1|Death|0|||
130346194|NCT00045942|469238854|FG008|PKC412A2104E1|Death|0|||
130346195|NCT00045942|469238846|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346196|NCT00045942|469238847|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346197|NCT00045942|469238848|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130346198|NCT00045942|469238849|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130346199|NCT00045942|469238850|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346200|NCT00045942|469238851|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346201|NCT00045942|469238852|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130679663|NCT01974141|470454179|FG001|Overall Study|Protocol Violation|6|||
130679664|NCT01974141|470454178|FG000|Overall Study|Personal Reasons|21|||
130679665|NCT01974141|470454179|FG001|Overall Study|Personal Reasons|20|||
130679666|NCT01974141|470454178|FG000|Overall Study|Lost to Follow-up|38|||
130679667|NCT01974141|470454179|FG001|Overall Study|Lost to Follow-up|29|||
130679668|NCT01974141|470454178|FG000|Overall Study|Pregnancy|3|||
130679669|NCT01974141|470454179|FG001|Overall Study|Pregnancy|3|||
130679670|NCT01974141|470454178|FG000|Overall Study|Lack of Efficacy|0|||
130679671|NCT01974141|470454179|FG001|Overall Study|Lack of Efficacy|1|||
130346202|NCT00045942|469238853|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346203|NCT00045942|469238854|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346204|NCT00045942|469238846|FG000|PKC412A2104E2|Lost to Follow-up|0|||
130346205|NCT00045942|469238847|FG001|PKC412A2104E2|Lost to Follow-up|0|||
130346206|NCT00045942|469238848|FG002|PKC412A2104E2|Lost to Follow-up|0|||
130346207|NCT00045942|469238849|FG003|PKC412A2104E2|Lost to Follow-up|0|||
130346208|NCT00045942|469238850|FG004|PKC412A2104E2|Lost to Follow-up|0|||
130346209|NCT00045942|469238851|FG005|PKC412A2104E2|Lost to Follow-up|0|||
130346210|NCT00045942|469238852|FG006|PKC412A2104E2|Lost to Follow-up|0|||
130346211|NCT00045942|469238853|FG007|PKC412A2104E2|Lost to Follow-up|3|||
130346212|NCT00045942|469238854|FG008|PKC412A2104E2|Lost to Follow-up|0|||
130346213|NCT00045942|469238846|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
130346214|NCT00045942|469238847|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
130346215|NCT00045942|469238848|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
130346216|NCT00045942|469238849|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
130346217|NCT00045942|469238850|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
130346218|NCT00045942|469238851|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
130346219|NCT00045942|469238852|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
130346220|NCT00045942|469238853|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
130346221|NCT00045942|469238854|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
130346222|NCT00045942|469238846|FG000|PKC412A2104E2|Lack of Efficacy|0|||
130346223|NCT00045942|469238847|FG001|PKC412A2104E2|Lack of Efficacy|0|||
130346224|NCT00045942|469238848|FG002|PKC412A2104E2|Lack of Efficacy|0|||
130346225|NCT00045942|469238849|FG003|PKC412A2104E2|Lack of Efficacy|0|||
130346226|NCT00045942|469238850|FG004|PKC412A2104E2|Lack of Efficacy|0|||
130346227|NCT00045942|469238851|FG005|PKC412A2104E2|Lack of Efficacy|3|||
130346228|NCT00045942|469238852|FG006|PKC412A2104E2|Lack of Efficacy|2|||
130346229|NCT00045942|469238853|FG007|PKC412A2104E2|Lack of Efficacy|2|||
130346230|NCT00045942|469238854|FG008|PKC412A2104E2|Lack of Efficacy|6|||
130346231|NCT00045942|469238846|FG000|PKC412A2104E2|Adverse Event|0|||
130346232|NCT00045942|469238847|FG001|PKC412A2104E2|Adverse Event|0|||
130346233|NCT00045942|469238848|FG002|PKC412A2104E2|Adverse Event|0|||
130346234|NCT00045942|469238849|FG003|PKC412A2104E2|Adverse Event|0|||
130346235|NCT00045942|469238850|FG004|PKC412A2104E2|Adverse Event|0|||
130346236|NCT00045942|469238851|FG005|PKC412A2104E2|Adverse Event|4|||
130346237|NCT00045942|469238852|FG006|PKC412A2104E2|Adverse Event|3|||
130346238|NCT00045942|469238853|FG007|PKC412A2104E2|Adverse Event|1|||
130346239|NCT00045942|469238854|FG008|PKC412A2104E2|Adverse Event|0|||
130346240|NCT00045942|469238846|FG000|PKC412A2104E2|Death|0|||
130346241|NCT00045942|469238847|FG001|PKC412A2104E2|Death|0|||
130346242|NCT00045942|469238848|FG002|PKC412A2104E2|Death|0|||
130346243|NCT00045942|469238849|FG003|PKC412A2104E2|Death|0|||
130346244|NCT00045942|469238850|FG004|PKC412A2104E2|Death|0|||
130346245|NCT00045942|469238851|FG005|PKC412A2104E2|Death|1|||
130346246|NCT00045942|469238852|FG006|PKC412A2104E2|Death|2|||
130346247|NCT00045942|469238853|FG007|PKC412A2104E2|Death|0|||
130346248|NCT00045942|469238854|FG008|PKC412A2104E2|Death|0|||
130346249|NCT02142387|469238855|FG000|Overall Study|<19 years old|49|||
130346250|NCT02142387|469238856|FG001|Overall Study|<19 years old|326|||
130346251|NCT02142387|469238855|FG000|Overall Study|non-cardiac etiology|504|||
130346252|NCT02142387|469238856|FG001|Overall Study|non-cardiac etiology|3431|||
130346253|NCT02142387|469238855|FG000|Overall Study|CPR not performed|74|||
130346254|NCT02142387|469238856|FG001|Overall Study|CPR not performed|473|||
130346255|NCT02142387|469238855|FG000|Overall Study|witnessed by paramedic|139|||
130346256|NCT02142387|469238856|FG001|Overall Study|witnessed by paramedic|917|||
130346257|NCT02142387|469238855|FG000|Overall Study|incomplete data|1|||
130679672|NCT01974141|470454178|FG000|Overall Study|Adverse Event|4|||
130679673|NCT01974141|470454179|FG001|Overall Study|Adverse Event|5|||
130346258|NCT02142387|469238856|FG001|Overall Study|incomplete data|9|||
130346259|NCT02142387|469238855|FG000|Overall Study|occurred not at home|298|||
130346260|NCT02142387|469238856|FG001|Overall Study|occurred not at home|2474|||
130346261|NCT05028361|469238857|FG000|Overall Study|Withdrawal by Subject|1|||
130346262|NCT05028361|469238858|FG001|Overall Study|Withdrawal by Subject|0|||
130346263|NCT00779259|469238859|FG000|Quinine Alone|Adverse Event|2|||
130346264|NCT02047318|469238863|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
130346265|NCT02047318|469238863|FG000|Core Study Period|Adverse Event|1|||
130346266|NCT02047318|469238863|FG000|Core Study Period|Withdrawal by caregiver|3|||
130346267|NCT02047318|469238863|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
130346268|NCT02095132|469238864|FG000|Overall Study|Adverse Event|0|||
130346269|NCT02095132|469238865|FG001|Overall Study|Adverse Event|0|||
130346270|NCT02095132|469238866|FG002|Overall Study|Adverse Event|0|||
130679674|NCT04977336|470454180|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130679675|NCT04977336|470454181|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130679676|NCT04977336|470454182|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130679677|NCT04977336|470454183|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130679678|NCT04977336|470454184|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130679679|NCT04977336|470454180|FG000|Overall Study|Lost to Follow-up|0|||
130679680|NCT04977336|470454181|FG001|Overall Study|Lost to Follow-up|0|||
130679681|NCT04977336|470454182|FG002|Overall Study|Lost to Follow-up|1|||
130679682|NCT04977336|470454183|FG003|Overall Study|Lost to Follow-up|0|||
130679683|NCT04977336|470454184|FG004|Overall Study|Lost to Follow-up|0|||
130679684|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in CNS Only|16|||
130679685|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
130679686|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
130679687|NCT01004172|470454189|FG000|Overall Study|Adverse Event|1|||
130679688|NCT01004172|470454189|FG000|Overall Study|Physician Decision|1|||
130679689|NCT01004172|470454189|FG000|Overall Study|Symptomatic Deterioration|2|||
130679690|NCT00950872|470454190|FG000|Overall Study|Withdrawal by Subject|1|||
130679691|NCT00950872|470454190|FG000|Overall Study|Did not have surgery|2|||
130679692|NCT01139164|470454191|FG000|Overall Study|Withdrawn prior to study start|0|||
130679693|NCT01139164|470454192|FG001|Overall Study|Withdrawn prior to study start|2|||
130679694|NCT01139164|470454193|FG002|Overall Study|Withdrawn prior to study start|0|||
130679695|NCT02003183|470454194|FG000|Overall Study|Lost to Follow-up|0|||
130679696|NCT02003183|470454195|FG001|Overall Study|Lost to Follow-up|2|||
130679697|NCT01759290|470454196|FG000|Overall Study|Subjects withdrawn consent|5|||
130679698|NCT01759290|470454196|FG000|Overall Study|Physician Decision|2|||
130679699|NCT01759290|470454196|FG000|Overall Study|Death|17|||
130679700|NCT01759290|470454196|FG000|Overall Study|Lost to Follow-up|53|||
130679701|NCT01759290|470454196|FG000|Overall Study|Unknown reason|4|||
130679702|NCT00406848|470454197|FG000|Overall Study|Withdrawal by Subject|27|||
130679703|NCT00406848|470454198|FG001|Overall Study|Withdrawal by Subject|22|||
130679704|NCT00406848|470454197|FG000|Overall Study|Adverse Event|38|||
130679705|NCT00406848|470454198|FG001|Overall Study|Adverse Event|7|||
130679706|NCT00406848|470454197|FG000|Overall Study|Lack of Efficacy|9|||
130679707|NCT00406848|470454198|FG001|Overall Study|Lack of Efficacy|14|||
130679708|NCT00406848|470454197|FG000|Overall Study|Protocol Violation|10|||
130679709|NCT00406848|470454198|FG001|Overall Study|Protocol Violation|6|||
130679710|NCT00406848|470454197|FG000|Overall Study|Lost to Follow-up|6|||
130679711|NCT00406848|470454198|FG001|Overall Study|Lost to Follow-up|2|||
130679712|NCT00406848|470454197|FG000|Overall Study|Physician Decision|2|||
130679713|NCT00406848|470454198|FG001|Overall Study|Physician Decision|2|||
130679714|NCT00406848|470454197|FG000|Overall Study|Sponsor Decision|1|||
130679715|NCT00406848|470454198|FG001|Overall Study|Sponsor Decision|1|||
130679716|NCT03629249|470454199|FG000|Overall Study|Study terminated by sponsor|197|||
130346271|NCT02095132|469238867|FG003|Overall Study|Adverse Event|0|||
130346272|NCT02095132|469238868|FG004|Overall Study|Adverse Event|1|||
130346273|NCT02095132|469238869|FG005|Overall Study|Adverse Event|0|||
130346274|NCT02095132|469238870|FG006|Overall Study|Adverse Event|1|||
130679717|NCT03629249|470454200|FG001|Overall Study|Study terminated by sponsor|197|||
130679718|NCT03629249|470454201|FG002|Overall Study|Study terminated by sponsor|194|||
130679719|NCT03629249|470454199|FG000|Overall Study|Protocol deviation|0|||
130679720|NCT03629249|470454200|FG001|Overall Study|Protocol deviation|2|||
130679721|NCT03629249|470454201|FG002|Overall Study|Protocol deviation|5|||
130679722|NCT03629249|470454199|FG000|Overall Study|Subject decision|1|||
130346275|NCT02095132|469238871|FG007|Overall Study|Adverse Event|0|||
130346276|NCT02095132|469238872|FG008|Overall Study|Adverse Event|0|||
130346277|NCT02095132|469238864|FG000|Overall Study|Death|0|||
130346278|NCT02095132|469238865|FG001|Overall Study|Death|0|||
130346279|NCT02095132|469238866|FG002|Overall Study|Death|0|||
130346280|NCT02095132|469238867|FG003|Overall Study|Death|0|||
130346281|NCT02095132|469238868|FG004|Overall Study|Death|0|||
130346282|NCT02095132|469238869|FG005|Overall Study|Death|0|||
130346283|NCT02095132|469238870|FG006|Overall Study|Death|1|||
130346284|NCT02095132|469238871|FG007|Overall Study|Death|0|||
130346285|NCT02095132|469238872|FG008|Overall Study|Death|0|||
130346286|NCT02095132|469238864|FG000|Overall Study|Lack of Efficacy|3|||
130346287|NCT02095132|469238865|FG001|Overall Study|Lack of Efficacy|5|||
130346288|NCT02095132|469238866|FG002|Overall Study|Lack of Efficacy|2|||
130346289|NCT02095132|469238867|FG003|Overall Study|Lack of Efficacy|8|||
130346290|NCT02095132|469238868|FG004|Overall Study|Lack of Efficacy|3|||
130346291|NCT02095132|469238869|FG005|Overall Study|Lack of Efficacy|6|||
130679723|NCT03629249|470454200|FG001|Overall Study|Subject decision|1|||
130679724|NCT03629249|470454201|FG002|Overall Study|Subject decision|3|||
130679725|NCT03629249|470454199|FG000|Overall Study|Adverse Event|1|||
130679726|NCT03629249|470454200|FG001|Overall Study|Adverse Event|1|||
130679727|NCT03629249|470454201|FG002|Overall Study|Adverse Event|0|||
130679728|NCT03629249|470454199|FG000|Overall Study|Death|1|||
130679729|NCT03629249|470454200|FG001|Overall Study|Death|0|||
130679730|NCT03629249|470454201|FG002|Overall Study|Death|0|||
130679731|NCT03629249|470454199|FG000|Overall Study|Physician Decision|1|||
130679732|NCT03629249|470454200|FG001|Overall Study|Physician Decision|0|||
130679733|NCT03629249|470454201|FG002|Overall Study|Physician Decision|0|||
130679734|NCT00352690|470454202|FG000|Overall Study|Determined to be ineligible|2|||
130679735|NCT00352690|470454203|FG001|Overall Study|Determined to be ineligible|0|||
130679736|NCT02719522|470454206|FG000|Overall Study|Implant Failure|4|||
130679737|NCT02719522|470454206|FG000|Overall Study|Death|2|||
130346292|NCT02095132|469238870|FG006|Overall Study|Lack of Efficacy|10|||
130346293|NCT02095132|469238871|FG007|Overall Study|Lack of Efficacy|9|||
130346294|NCT02095132|469238872|FG008|Overall Study|Lack of Efficacy|8|||
130346295|NCT02095132|469238864|FG000|Overall Study|Physician Decision|1|||
130346296|NCT02095132|469238865|FG001|Overall Study|Physician Decision|0|||
130346297|NCT02095132|469238866|FG002|Overall Study|Physician Decision|0|||
130346298|NCT02095132|469238867|FG003|Overall Study|Physician Decision|0|||
130346299|NCT02095132|469238868|FG004|Overall Study|Physician Decision|0|||
130346300|NCT02095132|469238869|FG005|Overall Study|Physician Decision|0|||
130346301|NCT02095132|469238870|FG006|Overall Study|Physician Decision|1|||
130346302|NCT02095132|469238871|FG007|Overall Study|Physician Decision|0|||
130346303|NCT02095132|469238872|FG008|Overall Study|Physician Decision|2|||
130346304|NCT02095132|469238864|FG000|Overall Study|Withdrawal by Subject|0|||
130346305|NCT02095132|469238865|FG001|Overall Study|Withdrawal by Subject|0|||
130346306|NCT02095132|469238866|FG002|Overall Study|Withdrawal by Subject|2|||
130346307|NCT02095132|469238867|FG003|Overall Study|Withdrawal by Subject|2|||
130346308|NCT02095132|469238868|FG004|Overall Study|Withdrawal by Subject|3|||
130346309|NCT02095132|469238869|FG005|Overall Study|Withdrawal by Subject|0|||
130346310|NCT02095132|469238870|FG006|Overall Study|Withdrawal by Subject|5|||
130346311|NCT02095132|469238871|FG007|Overall Study|Withdrawal by Subject|0|||
130346312|NCT02095132|469238872|FG008|Overall Study|Withdrawal by Subject|0|||
130346313|NCT00409175|469238873|FG000|Overall Study|Adverse Event|4|||
130346314|NCT00409175|469238874|FG001|Overall Study|Adverse Event|3|||
130346315|NCT00409175|469238873|FG000|Overall Study|Withdrawal by Subject|1|||
130346316|NCT00409175|469238874|FG001|Overall Study|Withdrawal by Subject|2|||
130346317|NCT00409175|469238873|FG000|Overall Study|Negative genotype|0|||
130346318|NCT00409175|469238874|FG001|Overall Study|Negative genotype|1|||
130346319|NCT00409175|469238873|FG000|Overall Study|Liver transplantation|13|||
130346320|NCT00409175|469238874|FG001|Overall Study|Liver transplantation|13|||
130346321|NCT02108262|469238877|FG000|Overall Study|Non-compliance|0|||
130346322|NCT02108262|469238878|FG001|Overall Study|Non-compliance|2|||
130346323|NCT02108262|469238879|FG002|Overall Study|Non-compliance|1|||
130346324|NCT02108262|469238880|FG003|Overall Study|Non-compliance|1|||
130346325|NCT02108262|469238877|FG000|Overall Study|Randomized by error/screen failure|0|||
130346326|NCT02108262|469238878|FG001|Overall Study|Randomized by error/screen failure|0|||
130346327|NCT02108262|469238879|FG002|Overall Study|Randomized by error/screen failure|1|||
130346328|NCT02108262|469238880|FG003|Overall Study|Randomized by error/screen failure|0|||
130346329|NCT02108262|469238877|FG000|Overall Study|Distance to center|0|||
130346330|NCT02108262|469238878|FG001|Overall Study|Distance to center|1|||
130346331|NCT02108262|469238879|FG002|Overall Study|Distance to center|1|||
130346332|NCT02108262|469238880|FG003|Overall Study|Distance to center|0|||
130346333|NCT02108262|469238877|FG000|Overall Study|Adverse Event|0|||
130346334|NCT02108262|469238878|FG001|Overall Study|Adverse Event|11|||
130346335|NCT02108262|469238879|FG002|Overall Study|Adverse Event|6|||
130346336|NCT02108262|469238880|FG003|Overall Study|Adverse Event|12|||
130346337|NCT02108262|469238877|FG000|Overall Study|Death|0|||
130346338|NCT02108262|469238878|FG001|Overall Study|Death|2|||
130346339|NCT02108262|469238879|FG002|Overall Study|Death|2|||
130346340|NCT02108262|469238880|FG003|Overall Study|Death|1|||
130346341|NCT02108262|469238877|FG000|Overall Study|Lost to Follow-up|0|||
130346342|NCT02108262|469238878|FG001|Overall Study|Lost to Follow-up|0|||
130346343|NCT02108262|469238879|FG002|Overall Study|Lost to Follow-up|1|||
130346344|NCT02108262|469238880|FG003|Overall Study|Lost to Follow-up|0|||
130346345|NCT02108262|469238877|FG000|Overall Study|Physician Decision|0|||
130346346|NCT02108262|469238878|FG001|Overall Study|Physician Decision|0|||
130346347|NCT02108262|469238879|FG002|Overall Study|Physician Decision|2|||
130346348|NCT02108262|469238880|FG003|Overall Study|Physician Decision|0|||
130346349|NCT02108262|469238877|FG000|Overall Study|Withdrawal by Subject|0|||
130346350|NCT02108262|469238878|FG001|Overall Study|Withdrawal by Subject|7|||
130346351|NCT02108262|469238879|FG002|Overall Study|Withdrawal by Subject|3|||
130346352|NCT02108262|469238880|FG003|Overall Study|Withdrawal by Subject|4|||
130346353|NCT02108262|469238877|FG000|Overall Study|Due to key hepatic values|0|||
130346354|NCT02108262|469238878|FG001|Overall Study|Due to key hepatic values|1|||
130346355|NCT02108262|469238879|FG002|Overall Study|Due to key hepatic values|0|||
130346356|NCT02108262|469238880|FG003|Overall Study|Due to key hepatic values|0|||
130346357|NCT02108262|469238877|FG000|Overall Study|Unable to contact patient|0|||
130346358|NCT02108262|469238878|FG001|Overall Study|Unable to contact patient|3|||
130346359|NCT02108262|469238879|FG002|Overall Study|Unable to contact patient|1|||
130346360|NCT02108262|469238880|FG003|Overall Study|Unable to contact patient|2|||
130346361|NCT02108262|469238877|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
130346362|NCT02108262|469238878|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
130346363|NCT02108262|469238879|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
130346364|NCT02108262|469238880|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
130679738|NCT02719522|470454206|FG000|Overall Study|Lost to Follow-up|5|||
130679739|NCT01030965|470454209|FG000|Overall Study|Lack of Efficacy|3|||
130679740|NCT01030965|470454210|FG001|Overall Study|Lack of Efficacy|2|||
130679741|NCT01030965|470454211|FG002|Overall Study|Lack of Efficacy|0|||
130679742|NCT01030965|470454212|FG003|Overall Study|Lack of Efficacy|3|||
130679743|NCT01030965|470454209|FG000|Overall Study|Protocol Violation|1|||
130679744|NCT01030965|470454210|FG001|Overall Study|Protocol Violation|1|||
130679745|NCT01030965|470454211|FG002|Overall Study|Protocol Violation|1|||
130679746|NCT01030965|470454212|FG003|Overall Study|Protocol Violation|1|||
130679747|NCT01030965|470454209|FG000|Overall Study|Adverse Event|0|||
130679748|NCT01030965|470454210|FG001|Overall Study|Adverse Event|1|||
130679749|NCT01030965|470454211|FG002|Overall Study|Adverse Event|2|||
130679750|NCT01030965|470454212|FG003|Overall Study|Adverse Event|1|||
130679751|NCT01030965|470454209|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
130346365|NCT02108262|469238877|FG000|Overall Study|Patient did not want another infusion|0|||
130346366|NCT02108262|469238878|FG001|Overall Study|Patient did not want another infusion|3|||
130435674|NCT01672853|469557208|FG000|Overall Study|Withdrew Consent|5|||
130435675|NCT01672853|469557209|FG001|Overall Study|Withdrew Consent|5|||
130435676|NCT01672853|469557210|FG002|Overall Study|Withdrew Consent|5|||
130346367|NCT02108262|469238879|FG002|Overall Study|Patient did not want another infusion|3|||
130346368|NCT02108262|469238880|FG003|Overall Study|Patient did not want another infusion|2|||
130346369|NCT02108262|469238877|FG000|Overall Study|Vacation|0|||
130346370|NCT02108262|469238878|FG001|Overall Study|Vacation|1|||
130346371|NCT02108262|469238879|FG002|Overall Study|Vacation|0|||
130346372|NCT02108262|469238880|FG003|Overall Study|Vacation|0|||
130346373|NCT02108262|469238877|FG000|Overall Study|Patient decision|0|||
130346374|NCT02108262|469238878|FG001|Overall Study|Patient decision|7|||
130346375|NCT02108262|469238879|FG002|Overall Study|Patient decision|9|||
130346376|NCT02108262|469238880|FG003|Overall Study|Patient decision|14|||
130346377|NCT02108262|469238877|FG000|Overall Study|Missed IV due to pharmacy error|0|||
130346378|NCT02108262|469238878|FG001|Overall Study|Missed IV due to pharmacy error|0|||
130346379|NCT02108262|469238879|FG002|Overall Study|Missed IV due to pharmacy error|1|||
130346380|NCT02108262|469238880|FG003|Overall Study|Missed IV due to pharmacy error|0|||
130346381|NCT01895361|469238881|FG000|Overall Study|Adverse Event|1|||
130346382|NCT01895361|469238882|FG001|Overall Study|Adverse Event|1|||
130346383|NCT01895361|469238883|FG002|Overall Study|Adverse Event|3|||
130346384|NCT01895361|469238881|FG000|Overall Study|Death|2|||
130346385|NCT01895361|469238882|FG001|Overall Study|Death|1|||
130346386|NCT01895361|469238883|FG002|Overall Study|Death|2|||
130346387|NCT01895361|469238881|FG000|Overall Study|Lost to Follow-up|4|||
130346388|NCT01895361|469238882|FG001|Overall Study|Lost to Follow-up|4|||
130346389|NCT01895361|469238883|FG002|Overall Study|Lost to Follow-up|6|||
130346390|NCT01895361|469238881|FG000|Overall Study|Non-compliance with study|1|||
130346391|NCT01895361|469238882|FG001|Overall Study|Non-compliance with study|3|||
130346392|NCT01895361|469238883|FG002|Overall Study|Non-compliance with study|1|||
130346393|NCT01895361|469238881|FG000|Overall Study|Physician Decision|2|||
130346394|NCT01895361|469238882|FG001|Overall Study|Physician Decision|2|||
130346395|NCT01895361|469238883|FG002|Overall Study|Physician Decision|2|||
130346396|NCT01895361|469238881|FG000|Overall Study|Withdrawal by Subject|7|||
130346397|NCT01895361|469238882|FG001|Overall Study|Withdrawal by Subject|6|||
130346398|NCT01895361|469238883|FG002|Overall Study|Withdrawal by Subject|6|||
130346399|NCT01895361|469238881|FG000|Overall Study|Lack of Efficacy|0|||
130346400|NCT01895361|469238882|FG001|Overall Study|Lack of Efficacy|1|||
130346401|NCT01895361|469238883|FG002|Overall Study|Lack of Efficacy|0|||
130346402|NCT01895361|469238881|FG000|Overall Study|Reasons different from categories above|7|||
130346403|NCT01895361|469238882|FG001|Overall Study|Reasons different from categories above|3|||
130346404|NCT01895361|469238883|FG002|Overall Study|Reasons different from categories above|4|||
130346405|NCT02586506|469238887|FG000|Overall Study|Protocol Violation|6|||
130346406|NCT02586506|469238887|FG000|Overall Study|Lost to Follow-up|1|||
130346407|NCT02586506|469238887|FG000|Overall Study|Other Reason|2|||
130346408|NCT00674154|469238888|FG000|Overall Study|Withdrawal by Subject|3|||
130346409|NCT00674154|469238889|FG001|Overall Study|Withdrawal by Subject|1|||
130346410|NCT00674154|469238888|FG000|Overall Study|Did not want parathyroidectomy|0|||
130346411|NCT00674154|469238889|FG001|Overall Study|Did not want parathyroidectomy|2|||
130679752|NCT01030965|470454210|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
130679753|NCT01030965|470454211|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
130679754|NCT01030965|470454212|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
130679755|NCT01030965|470454209|FG000|Overall Study|Withdrawal by Subject|0|||
130346412|NCT05093790|469238890|FG000|Overall Study|Failure to meet continuation criteria|0|||
130679756|NCT01030965|470454210|FG001|Overall Study|Withdrawal by Subject|1|||
130679757|NCT01030965|470454211|FG002|Overall Study|Withdrawal by Subject|0|||
130679758|NCT01030965|470454212|FG003|Overall Study|Withdrawal by Subject|2|||
130679759|NCT02097290|470454213|FG000|Overall Study|Death|6|||
130346413|NCT05093790|469238891|FG001|Overall Study|Failure to meet continuation criteria|0|||
130346414|NCT05093790|469238892|FG002|Overall Study|Failure to meet continuation criteria|1|||
130346415|NCT05093790|469238893|FG003|Overall Study|Failure to meet continuation criteria|0|||
130346416|NCT05093790|469238890|FG000|Overall Study|Adverse Event|1|||
130679760|NCT02097290|470454213|FG000|Overall Study|Total Withdrawals|3|||
130679761|NCT02097290|470454213|FG000|Overall Study|Attempt|8|||
130679762|NCT03144687|470454216|FG000|Overall Study|Death|0|||
130679763|NCT03144687|470454217|FG001|Overall Study|Death|2|||
130679764|NCT03144687|470454216|FG000|Overall Study|Lost to Follow-up|0|||
130679765|NCT03144687|470454217|FG001|Overall Study|Lost to Follow-up|1|||
130679766|NCT03144687|470454216|FG000|Overall Study|Physician Decision|0|||
130679767|NCT03144687|470454217|FG001|Overall Study|Physician Decision|1|||
130679768|NCT03144687|470454216|FG000|Overall Study|Withdrawal by Subject|1|||
130679769|NCT03144687|470454217|FG001|Overall Study|Withdrawal by Subject|3|||
130679770|NCT03144687|470454216|FG000|Overall Study|Not Reported|2|||
130679771|NCT03144687|470454217|FG001|Overall Study|Not Reported|0|||
130679772|NCT01054599|470454218|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
130679773|NCT01054599|470454219|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
130435677|NCT01672853|469557208|FG000|Overall Study|Adverse Event|4|||
130435678|NCT01672853|469557209|FG001|Overall Study|Adverse Event|6|||
130435679|NCT01672853|469557210|FG002|Overall Study|Adverse Event|8|||
130435680|NCT01672853|469557208|FG000|Overall Study|Lost to Follow-up|0|||
130435681|NCT01672853|469557209|FG001|Overall Study|Lost to Follow-up|1|||
130435682|NCT01672853|469557210|FG002|Overall Study|Lost to Follow-up|0|||
130435683|NCT01672853|469557208|FG000|Overall Study|Randomized but Never Treated|0|||
130435684|NCT01672853|469557209|FG001|Overall Study|Randomized but Never Treated|0|||
130435685|NCT01672853|469557210|FG002|Overall Study|Randomized but Never Treated|1|||
130435686|NCT01992549|469558382|FG000|Overall Study|Lost to Follow-up|2|||
130435687|NCT01992549|469558382|FG000|Overall Study|Serious Adverse Event|1|||
130435688|NCT01992549|469558382|FG000|Overall Study|Product Switch to Extend Half Life|1|||
130435689|NCT01590771|469558383|FG000|Overall Study|Other Protocol Specified Criteria|5|||
130435690|NCT01590771|469558384|FG001|Overall Study|Other Protocol Specified Criteria|14|||
130435691|NCT01590771|469558383|FG000|Overall Study|Withdrawal by Subject|8|||
130435692|NCT01590771|469558384|FG001|Overall Study|Withdrawal by Subject|15|||
130435693|NCT01590771|469558383|FG000|Overall Study|Protocol Violation|1|||
130435694|NCT01590771|469558384|FG001|Overall Study|Protocol Violation|2|||
130435695|NCT01590771|469558383|FG000|Overall Study|Lost to Follow-up|1|||
130435696|NCT01590771|469558384|FG001|Overall Study|Lost to Follow-up|1|||
130435697|NCT01590771|469558383|FG000|Overall Study|Lack of Efficacy|1|||
130435698|NCT01590771|469558384|FG001|Overall Study|Lack of Efficacy|0|||
130435699|NCT01590771|469558383|FG000|Overall Study|Adverse Event|3|||
130435700|NCT01590771|469558384|FG001|Overall Study|Adverse Event|7|||
130435701|NCT00767104|469558390|FG000|Overall Study|Lost to Follow-up|1|||
130435702|NCT00767104|469558391|FG001|Overall Study|Lost to Follow-up|2|||
130435703|NCT01900054|469558399|FG000|Overall Study|Physician Decision|1|||
130435704|NCT01900054|469558399|FG000|Overall Study|Withdrawal by Subject|1|||
130435705|NCT01186328|469558400|FG000|Overall Study|Death|1|||
130435706|NCT01186328|469558401|FG001|Overall Study|Death|0|||
130679774|NCT01054599|470454218|FG000|Overall Study|Protocol Violation|1|||
130679775|NCT01054599|470454219|FG001|Overall Study|Protocol Violation|0|||
130679776|NCT01054599|470454218|FG000|Overall Study|Spells/seizure-like episodes|1|||
130679777|NCT01054599|470454219|FG001|Overall Study|Spells/seizure-like episodes|1|||
130679778|NCT01054599|470454218|FG000|Overall Study|Timing/scheduling difficulties|1|||
130679779|NCT01054599|470454219|FG001|Overall Study|Timing/scheduling difficulties|1|||
130679780|NCT01054599|470454218|FG000|Overall Study|Visual impairment, WTAR <80|0|||
130679781|NCT01054599|470454219|FG001|Overall Study|Visual impairment, WTAR <80|1|||
130679782|NCT01054599|470454218|FG000|Overall Study|Lost to Follow-up|0|||
130679783|NCT01054599|470454219|FG001|Overall Study|Lost to Follow-up|2|||
130679784|NCT01054599|470454218|FG000|Overall Study|Adverse Event|0|||
130679785|NCT01054599|470454219|FG001|Overall Study|Adverse Event|1|||
130679786|NCT01054599|470454218|FG000|Overall Study|Withdrawal by Subject|0|||
130679787|NCT01054599|470454219|FG001|Overall Study|Withdrawal by Subject|1|||
130346417|NCT05093790|469238891|FG001|Overall Study|Adverse Event|0|||
130346418|NCT05093790|469238892|FG002|Overall Study|Adverse Event|0|||
130346419|NCT05093790|469238893|FG003|Overall Study|Adverse Event|0|||
130346420|NCT01903252|469238895|FG000|Double-Blind Induction|Adverse Event|20|||
130346421|NCT01903252|469238896|FG001|Double-Blind Induction|Adverse Event|18|||
130346422|NCT01903252|469238897|FG002|Double-Blind Induction|Adverse Event|0|||
130346423|NCT01903252|469238898|FG003|Double-Blind Induction|Adverse Event|0|||
130346424|NCT01903252|469238899|FG004|Double-Blind Induction|Adverse Event|0|||
130346425|NCT01903252|469238900|FG005|Double-Blind Induction|Adverse Event|0|||
130346426|NCT01903252|469238895|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
130679788|NCT00743197|470454220|FG000|Overall Study|Study terminated due to departure of PI.|1|||
130679789|NCT00743197|470454221|FG001|Overall Study|Study terminated due to departure of PI.|2|||
130679790|NCT04025879|470454224|FG000|Randomization|Participant withdrew consent|0|||
130346427|NCT01903252|469238896|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
130435707|NCT01186328|469558402|FG002|Overall Study|Death|0|||
130435708|NCT03015116|469558407|FG000|Overall Study|Lost to Follow-up|3|||
130435709|NCT03015116|469558408|FG001|Overall Study|Lost to Follow-up|0|||
130435710|NCT03015116|469558409|FG002|Overall Study|Lost to Follow-up|2|||
130679791|NCT04025879|470454225|FG001|Randomization|Participant withdrew consent|1|||
130679792|NCT04025879|470454224|FG000|Randomization|Participant no longer met study criteria|1|||
130346428|NCT01903252|469238897|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
130346429|NCT01903252|469238898|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
130346430|NCT01903252|469238899|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
130346431|NCT01903252|469238900|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
130346432|NCT01903252|469238895|FG000|Double-Blind Induction|Physician Decision|2|||
130346433|NCT01903252|469238896|FG001|Double-Blind Induction|Physician Decision|3|||
130346434|NCT01903252|469238897|FG002|Double-Blind Induction|Physician Decision|0|||
130346435|NCT01903252|469238898|FG003|Double-Blind Induction|Physician Decision|0|||
130346436|NCT01903252|469238899|FG004|Double-Blind Induction|Physician Decision|0|||
130346437|NCT01903252|469238900|FG005|Double-Blind Induction|Physician Decision|0|||
130346438|NCT01903252|469238895|FG000|Double-Blind Induction|non-compliance,|7|||
130346439|NCT01903252|469238896|FG001|Double-Blind Induction|non-compliance,|7|||
130346440|NCT01903252|469238897|FG002|Double-Blind Induction|non-compliance,|0|||
130346441|NCT01903252|469238898|FG003|Double-Blind Induction|non-compliance,|0|||
130346442|NCT01903252|469238899|FG004|Double-Blind Induction|non-compliance,|0|||
130346443|NCT01903252|469238900|FG005|Double-Blind Induction|non-compliance,|0|||
130346444|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Adverse Event|0|||
130346445|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Adverse Event|0|||
130346446|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Adverse Event|17|||
130346447|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Adverse Event|0|||
130346448|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Adverse Event|0|||
130346449|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Adverse Event|0|||
130346450|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346451|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346452|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
130346453|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346454|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346455|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346456|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Physician Decision|0|||
130346457|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Physician Decision|0|||
130346458|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Physician Decision|1|||
130346459|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Physician Decision|0|||
130346460|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Physician Decision|0|||
130346461|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Physician Decision|0|||
130346462|NCT01903252|469238895|FG000|Maintenance, Open-Label|Adverse Event|0|||
130346463|NCT01903252|469238896|FG001|Maintenance, Open-Label|Adverse Event|0|||
130346464|NCT01903252|469238897|FG002|Maintenance, Open-Label|Adverse Event|0|||
130346465|NCT01903252|469238898|FG003|Maintenance, Open-Label|Adverse Event|3|||
130346466|NCT01903252|469238899|FG004|Maintenance, Open-Label|Adverse Event|9|||
130346467|NCT01903252|469238900|FG005|Maintenance, Open-Label|Adverse Event|14|||
130346468|NCT01903252|469238895|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346469|NCT01903252|469238896|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346470|NCT01903252|469238897|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346471|NCT01903252|469238898|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
130346472|NCT01903252|469238899|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
130346473|NCT01903252|469238900|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
130346474|NCT01903252|469238895|FG000|Maintenance, Open-Label|Other|0|||
130346475|NCT01903252|469238896|FG001|Maintenance, Open-Label|Other|0|||
130346476|NCT01903252|469238897|FG002|Maintenance, Open-Label|Other|0|||
130346477|NCT01903252|469238898|FG003|Maintenance, Open-Label|Other|2|||
130346478|NCT01903252|469238899|FG004|Maintenance, Open-Label|Other|6|||
130346479|NCT01903252|469238900|FG005|Maintenance, Open-Label|Other|2|||
130346480|NCT01381562|469238901|FG000|Overall Study|Adverse Event|0|||
130346481|NCT01381562|469238902|FG001|Overall Study|Adverse Event|1|||
130346482|NCT01381562|469238903|FG002|Overall Study|Adverse Event|0|||
130346483|NCT01642732|469238904|FG000|Overall Study|Withdrawal by Subject|1|||
130346484|NCT01606878|469238907|FG000|Overall Study|Adverse Event|1|||
130346485|NCT01606878|469238908|FG001|Overall Study|Adverse Event|1|||
130346486|NCT01606878|469238909|FG002|Overall Study|Adverse Event|0|||
130346487|NCT01606878|469238910|FG003|Overall Study|Adverse Event|0|||
130346488|NCT01606878|469238911|FG004|Overall Study|Adverse Event|0|||
130346489|NCT01606878|469238912|FG005|Overall Study|Adverse Event|0|||
130346490|NCT01606878|469238913|FG006|Overall Study|Adverse Event|1|||
130346491|NCT01606878|469238914|FG007|Overall Study|Adverse Event|0|||
130346492|NCT01606878|469238915|FG008|Overall Study|Adverse Event|1|||
130346493|NCT01606878|469238916|FG009|Overall Study|Adverse Event|3|||
130346494|NCT01606878|469238917|FG010|Overall Study|Adverse Event|0|||
130346495|NCT01606878|469238907|FG000|Overall Study|Lack of Efficacy|1|||
130346496|NCT01606878|469238908|FG001|Overall Study|Lack of Efficacy|1|||
130346497|NCT01606878|469238909|FG002|Overall Study|Lack of Efficacy|1|||
130346498|NCT01606878|469238910|FG003|Overall Study|Lack of Efficacy|2|||
130346499|NCT01606878|469238911|FG004|Overall Study|Lack of Efficacy|1|||
130346500|NCT01606878|469238912|FG005|Overall Study|Lack of Efficacy|2|||
130346501|NCT01606878|469238913|FG006|Overall Study|Lack of Efficacy|1|||
130346502|NCT01606878|469238914|FG007|Overall Study|Lack of Efficacy|2|||
130435711|NCT03015116|469558407|FG000|Overall Study|Withdrawal by Subject|3|||
130435712|NCT03015116|469558408|FG001|Overall Study|Withdrawal by Subject|1|||
130435713|NCT03015116|469558409|FG002|Overall Study|Withdrawal by Subject|0|||
130435714|NCT03015116|469558407|FG000|Overall Study|Subject has New Medical Status|1|||
130435715|NCT03015116|469558408|FG001|Overall Study|Subject has New Medical Status|0|||
130435716|NCT03015116|469558409|FG002|Overall Study|Subject has New Medical Status|0|||
130435717|NCT03015116|469558407|FG000|Overall Study|Physician Decision|0|||
130435718|NCT03015116|469558408|FG001|Overall Study|Physician Decision|1|||
130435719|NCT03015116|469558409|FG002|Overall Study|Physician Decision|0|||
130435720|NCT02762981|469558414|FG000|Overall Study|Adverse Event|2|||
130435721|NCT02762981|469558415|FG001|Overall Study|Adverse Event|3|||
130435722|NCT02762981|469558416|FG002|Overall Study|Adverse Event|1|||
130435723|NCT02762981|469558417|FG003|Overall Study|Adverse Event|1|||
130435724|NCT02762981|469558418|FG004|Overall Study|Adverse Event|3|||
130435725|NCT02762981|469558414|FG000|Overall Study|Physician Decision|0|||
130435726|NCT02762981|469558415|FG001|Overall Study|Physician Decision|1|||
130435727|NCT02762981|469558416|FG002|Overall Study|Physician Decision|0|||
130435728|NCT02762981|469558417|FG003|Overall Study|Physician Decision|0|||
130435729|NCT02762981|469558418|FG004|Overall Study|Physician Decision|1|||
130435730|NCT02762981|469558414|FG000|Overall Study|Disease progression|11|||
130435731|NCT02762981|469558415|FG001|Overall Study|Disease progression|23|||
130435732|NCT02762981|469558416|FG002|Overall Study|Disease progression|4|||
130435733|NCT02762981|469558417|FG003|Overall Study|Disease progression|10|||
130435734|NCT02762981|469558418|FG004|Overall Study|Disease progression|1|||
130435735|NCT02762981|469558414|FG000|Overall Study|Enrolled not treated|1|||
130435736|NCT02762981|469558415|FG001|Overall Study|Enrolled not treated|5|||
130435737|NCT02762981|469558416|FG002|Overall Study|Enrolled not treated|0|||
130435738|NCT02762981|469558417|FG003|Overall Study|Enrolled not treated|2|||
130435739|NCT02762981|469558418|FG004|Overall Study|Enrolled not treated|0|||
130435740|NCT02762981|469558414|FG000|Overall Study|Other|2|||
130435741|NCT02762981|469558415|FG001|Overall Study|Other|3|||
130435742|NCT02762981|469558416|FG002|Overall Study|Other|1|||
130435743|NCT02762981|469558417|FG003|Overall Study|Other|0|||
130435744|NCT02762981|469558418|FG004|Overall Study|Other|0|||
130435745|NCT02762981|469558414|FG000|Overall Study|Missing|1|||
130435746|NCT02762981|469558415|FG001|Overall Study|Missing|0|||
130435747|NCT02762981|469558416|FG002|Overall Study|Missing|0|||
130435748|NCT02762981|469558417|FG003|Overall Study|Missing|0|||
130435749|NCT02762981|469558418|FG004|Overall Study|Missing|0|||
130435750|NCT02762981|469558414|FG000|Overall Study|Withdrawal by Subject|0|||
130435751|NCT02762981|469558415|FG001|Overall Study|Withdrawal by Subject|5|||
130435752|NCT02762981|469558416|FG002|Overall Study|Withdrawal by Subject|1|||
130435753|NCT02762981|469558417|FG003|Overall Study|Withdrawal by Subject|3|||
130435754|NCT02762981|469558418|FG004|Overall Study|Withdrawal by Subject|0|||
130435755|NCT00584805|469558419|FG000|Overall Study|No longer at risk of exposure|39|||
130435756|NCT00584805|469558419|FG000|Overall Study|Relocation|36|||
130435757|NCT00584805|469558419|FG000|Overall Study|Withdrawal by Subject|18|||
130435758|NCT00584805|469558419|FG000|Overall Study|Non-compliance|1|||
130435759|NCT00584805|469558419|FG000|Overall Study|Lost to follow up|3|||
130435760|NCT00584805|469558419|FG000|Overall Study|Screen failures|2|||
130435761|NCT01077362|469558423|FG000|Overall Study|Lack of Efficacy|13|||
130435762|NCT01077362|469558424|FG001|Overall Study|Lack of Efficacy|8|||
130435763|NCT01077362|469558425|FG002|Overall Study|Lack of Efficacy|10|||
130435764|NCT01077362|469558423|FG000|Overall Study|Lost to Follow-up|1|||
130435765|NCT01077362|469558424|FG001|Overall Study|Lost to Follow-up|0|||
130435766|NCT01077362|469558425|FG002|Overall Study|Lost to Follow-up|3|||
130435767|NCT01077362|469558423|FG000|Overall Study|Adverse Event|12|||
130435768|NCT01077362|469558424|FG001|Overall Study|Adverse Event|7|||
130435769|NCT01077362|469558425|FG002|Overall Study|Adverse Event|4|||
130435770|NCT01077362|469558423|FG000|Overall Study|Withdrawal by Subject|5|||
130435771|NCT01077362|469558424|FG001|Overall Study|Withdrawal by Subject|3|||
130435772|NCT01077362|469558425|FG002|Overall Study|Withdrawal by Subject|5|||
130435773|NCT01077362|469558423|FG000|Overall Study|Other|0|||
130435774|NCT01077362|469558424|FG001|Overall Study|Other|1|||
130679793|NCT04025879|470454225|FG001|Randomization|Participant no longer met study criteria|1|||
130435775|NCT01077362|469558425|FG002|Overall Study|Other|2|||
130435776|NCT04041440|469558426|FG000|Overall Study|Withdrawal by Subject|0|||
130435777|NCT04041440|469558427|FG001|Overall Study|Withdrawal by Subject|1|||
130435778|NCT04041440|469558426|FG000|Overall Study|Lost to Follow-up|0|||
130435779|NCT04041440|469558427|FG001|Overall Study|Lost to Follow-up|1|||
130435780|NCT02247804|469558432|FG000|Treatment Period 1|Adverse Event|9|||
130435781|NCT02247804|469558433|FG001|Treatment Period 1|Adverse Event|2|||
130435782|NCT02247804|469558434|FG002|Treatment Period 1|Adverse Event|0|||
130435783|NCT02247804|469558432|FG000|Treatment Period 1|Lack of Efficacy|0|||
130435784|NCT02247804|469558433|FG001|Treatment Period 1|Lack of Efficacy|0|||
130435785|NCT02247804|469558434|FG002|Treatment Period 1|Lack of Efficacy|2|||
130435786|NCT02247804|469558432|FG000|Treatment Period 1|Lost to Follow-up|1|||
130435787|NCT02247804|469558433|FG001|Treatment Period 1|Lost to Follow-up|0|||
130435788|NCT02247804|469558434|FG002|Treatment Period 1|Lost to Follow-up|2|||
130435789|NCT02247804|469558432|FG000|Treatment Period 1|Personal Reasons|7|||
130435790|NCT02247804|469558433|FG001|Treatment Period 1|Personal Reasons|1|||
130435791|NCT02247804|469558434|FG002|Treatment Period 1|Personal Reasons|2|||
130435792|NCT02247804|469558432|FG000|Treatment Period 1|Protocol Deviation|0|||
130435793|NCT02247804|469558433|FG001|Treatment Period 1|Protocol Deviation|0|||
130435794|NCT02247804|469558434|FG002|Treatment Period 1|Protocol Deviation|1|||
130435795|NCT02247804|469558432|FG000|Treatment Period 1|Randomized but not Treated|5|||
130435796|NCT02247804|469558433|FG001|Treatment Period 1|Randomized but not Treated|1|||
130435797|NCT02247804|469558434|FG002|Treatment Period 1|Randomized but not Treated|1|||
130435798|NCT02247804|469558432|FG000|Treatment Period 2|Adverse Event|6|||
130435799|NCT02247804|469558433|FG001|Treatment Period 2|Adverse Event|3|||
130435800|NCT02247804|469558434|FG002|Treatment Period 2|Adverse Event|3|||
130435801|NCT02247804|469558432|FG000|Treatment Period 2|Lack of Efficacy|0|||
130435802|NCT02247804|469558433|FG001|Treatment Period 2|Lack of Efficacy|0|||
130435803|NCT02247804|469558434|FG002|Treatment Period 2|Lack of Efficacy|1|||
130435804|NCT02247804|469558432|FG000|Treatment Period 2|Lost to Follow-up|0|||
130435805|NCT02247804|469558433|FG001|Treatment Period 2|Lost to Follow-up|1|||
130435806|NCT02247804|469558434|FG002|Treatment Period 2|Lost to Follow-up|1|||
130435807|NCT02247804|469558432|FG000|Treatment Period 2|Personal Reasons|2|||
130435808|NCT02247804|469558433|FG001|Treatment Period 2|Personal Reasons|1|||
130435809|NCT02247804|469558434|FG002|Treatment Period 2|Personal Reasons|1|||
130435810|NCT02247804|469558432|FG000|Treatment Period 2|Reason not Specified|0|||
130435811|NCT02247804|469558433|FG001|Treatment Period 2|Reason not Specified|0|||
130435812|NCT02247804|469558434|FG002|Treatment Period 2|Reason not Specified|2|||
130435813|NCT02247804|469558432|FG000|Treatment Period 3|Adverse Event|4|||
130435814|NCT02247804|469558433|FG001|Treatment Period 3|Adverse Event|3|||
130435815|NCT02247804|469558434|FG002|Treatment Period 3|Adverse Event|3|||
130435816|NCT02247804|469558432|FG000|Treatment Period 3|Lack of Efficacy|0|||
130435817|NCT02247804|469558433|FG001|Treatment Period 3|Lack of Efficacy|1|||
130435818|NCT02247804|469558434|FG002|Treatment Period 3|Lack of Efficacy|0|||
130435819|NCT02247804|469558432|FG000|Treatment Period 3|Lost to Follow-up|1|||
130435820|NCT02247804|469558433|FG001|Treatment Period 3|Lost to Follow-up|2|||
130435821|NCT02247804|469558434|FG002|Treatment Period 3|Lost to Follow-up|2|||
130435822|NCT02247804|469558432|FG000|Treatment Period 3|Personal Reasons|4|||
130435823|NCT02247804|469558433|FG001|Treatment Period 3|Personal Reasons|3|||
130435824|NCT02247804|469558434|FG002|Treatment Period 3|Personal Reasons|2|||
130435825|NCT02247804|469558432|FG000|Treatment Period 3|Reason not Specified|2|||
130435826|NCT02247804|469558433|FG001|Treatment Period 3|Reason not Specified|1|||
130435827|NCT02247804|469558434|FG002|Treatment Period 3|Reason not Specified|3|||
130435828|NCT02917265|469558435|FG000|Overall Study|Physician Decision|1|||
130435829|NCT02917265|469558436|FG001|Overall Study|Physician Decision|0|||
130435830|NCT02917265|469558435|FG000|Overall Study|Withdrawal by Subject|1|||
130435831|NCT02917265|469558436|FG001|Overall Study|Withdrawal by Subject|0|||
130435832|NCT00980005|469558437|FG000|Overall Study|Withdrawal by Subject|6|||
130435833|NCT00980005|469558438|FG001|Overall Study|Withdrawal by Subject|17|||
130435834|NCT00980005|469558437|FG000|Overall Study|Lost to Follow-up|37|||
130435835|NCT00980005|469558438|FG001|Overall Study|Lost to Follow-up|43|||
130435836|NCT00980005|469558437|FG000|Overall Study|Other|4|||
130679794|NCT04025879|470454224|FG000|Treatment|Ongoing treatment|10|||
130679795|NCT04025879|470454225|FG001|Treatment|Ongoing treatment|8|||
130679796|NCT04025879|470454224|FG000|Treatment|Disease progression/recurrence|36|||
130435837|NCT00980005|469558438|FG001|Overall Study|Other|3|||
130435838|NCT00692406|469558439|FG000|Overall Study|PI dropped, bad data|57|||
130435839|NCT01617005|469558440|FG000|Overall Study|Pregnancy|1|||
130435840|NCT01617005|469558440|FG000|Overall Study|Lack of motivation for treatment|1|||
130435841|NCT02954458|469558450|FG000|Overall Study|Adverse Event|0|||
130435842|NCT02954458|469558451|FG001|Overall Study|Adverse Event|0|||
130435843|NCT02954458|469558452|FG002|Overall Study|Adverse Event|0|||
130435844|NCT02954458|469558453|FG003|Overall Study|Adverse Event|1|||
130435845|NCT02954458|469558450|FG000|Overall Study|Withdrawal by Subject|0|||
130435846|NCT02954458|469558451|FG001|Overall Study|Withdrawal by Subject|0|||
130435847|NCT02954458|469558452|FG002|Overall Study|Withdrawal by Subject|0|||
130679797|NCT04025879|470454225|FG001|Treatment|Disease progression/recurrence|72|||
130435848|NCT02954458|469558453|FG003|Overall Study|Withdrawal by Subject|1|||
130435849|NCT02954458|469558450|FG000|Overall Study|Physician Decision|0|||
130679798|NCT04025879|470454224|FG000|Treatment|Study drug toxicity|36|||
130435850|NCT02954458|469558451|FG001|Overall Study|Physician Decision|0|||
130435851|NCT02954458|469558452|FG002|Overall Study|Physician Decision|1|||
130679799|NCT04025879|470454225|FG001|Treatment|Study drug toxicity|13|||
130435852|NCT02954458|469558453|FG003|Overall Study|Physician Decision|1|||
130679800|NCT04025879|470454224|FG000|Treatment|Death|2|||
130435853|NCT02954458|469558450|FG000|Overall Study|Lost to Follow-up|1|||
130679801|NCT04025879|470454225|FG001|Treatment|Death|0|||
130679802|NCT04025879|470454224|FG000|Treatment|Adverse event unrelated to study drug|21|||
130435854|NCT02954458|469558451|FG001|Overall Study|Lost to Follow-up|0|||
130435855|NCT02954458|469558452|FG002|Overall Study|Lost to Follow-up|0|||
130435856|NCT02954458|469558453|FG003|Overall Study|Lost to Follow-up|1|||
130679803|NCT04025879|470454225|FG001|Treatment|Adverse event unrelated to study drug|14|||
130435857|NCT02954458|469558450|FG000|Overall Study|Death|0|||
130346503|NCT01606878|469238915|FG008|Overall Study|Lack of Efficacy|2|||
130346504|NCT01606878|469238916|FG009|Overall Study|Lack of Efficacy|0|||
130346505|NCT01606878|469238917|FG010|Overall Study|Lack of Efficacy|1|||
130346506|NCT01606878|469238907|FG000|Overall Study|Physician Decision|1|||
130346507|NCT01606878|469238908|FG001|Overall Study|Physician Decision|0|||
130346508|NCT01606878|469238909|FG002|Overall Study|Physician Decision|2|||
130346509|NCT01606878|469238910|FG003|Overall Study|Physician Decision|1|||
130346510|NCT01606878|469238911|FG004|Overall Study|Physician Decision|1|||
130346511|NCT01606878|469238912|FG005|Overall Study|Physician Decision|1|||
130346512|NCT01606878|469238913|FG006|Overall Study|Physician Decision|2|||
130346513|NCT01606878|469238914|FG007|Overall Study|Physician Decision|0|||
130346514|NCT01606878|469238915|FG008|Overall Study|Physician Decision|1|||
130346515|NCT01606878|469238916|FG009|Overall Study|Physician Decision|0|||
130346516|NCT01606878|469238917|FG010|Overall Study|Physician Decision|0|||
130346517|NCT01606878|469238907|FG000|Overall Study|Withdrawal by Subject|3|||
130346518|NCT01606878|469238908|FG001|Overall Study|Withdrawal by Subject|2|||
130346519|NCT01606878|469238909|FG002|Overall Study|Withdrawal by Subject|2|||
130346520|NCT01606878|469238910|FG003|Overall Study|Withdrawal by Subject|0|||
130346521|NCT01606878|469238911|FG004|Overall Study|Withdrawal by Subject|1|||
130346522|NCT01606878|469238912|FG005|Overall Study|Withdrawal by Subject|1|||
130346523|NCT01606878|469238913|FG006|Overall Study|Withdrawal by Subject|2|||
130346524|NCT01606878|469238914|FG007|Overall Study|Withdrawal by Subject|1|||
130346525|NCT01606878|469238915|FG008|Overall Study|Withdrawal by Subject|2|||
130346526|NCT01606878|469238916|FG009|Overall Study|Withdrawal by Subject|0|||
130346527|NCT01606878|469238917|FG010|Overall Study|Withdrawal by Subject|2|||
130376475|NCT05353985|469343706|FG001|Overall Study|Reason Not Specified|0|||
130376476|NCT05353985|469343705|FG000|Overall Study|Randomized in Error & Not Treated|0|||
130376477|NCT05353985|469343706|FG001|Overall Study|Randomized in Error & Not Treated|1|||
130376478|NCT02700815|469345842|FG000|Overall Study|Adverse Event|0|||
130376479|NCT02700815|469345843|FG001|Overall Study|Adverse Event|6|||
130376480|NCT02700815|469345844|FG002|Overall Study|Adverse Event|2|||
130376481|NCT02700815|469345845|FG003|Overall Study|Adverse Event|3|||
130376482|NCT02700815|469345842|FG000|Overall Study|Lack of Efficacy|0|||
130376483|NCT02700815|469345843|FG001|Overall Study|Lack of Efficacy|0|||
130376484|NCT02700815|469345844|FG002|Overall Study|Lack of Efficacy|1|||
130376485|NCT02700815|469345845|FG003|Overall Study|Lack of Efficacy|2|||
130376486|NCT02700815|469345842|FG000|Overall Study|Lost to Follow-up|1|||
130376487|NCT02700815|469345843|FG001|Overall Study|Lost to Follow-up|0|||
130376488|NCT02700815|469345844|FG002|Overall Study|Lost to Follow-up|0|||
130376489|NCT02700815|469345845|FG003|Overall Study|Lost to Follow-up|1|||
130376490|NCT02700815|469345842|FG000|Overall Study|Refusal to continue medication|0|||
130376491|NCT02700815|469345843|FG001|Overall Study|Refusal to continue medication|1|||
130376492|NCT02700815|469345844|FG002|Overall Study|Refusal to continue medication|0|||
130376493|NCT02700815|469345845|FG003|Overall Study|Refusal to continue medication|1|||
130376494|NCT02700815|469345842|FG000|Overall Study|Withdrawal by Subject|0|||
130376495|NCT02700815|469345843|FG001|Overall Study|Withdrawal by Subject|0|||
130376496|NCT02700815|469345844|FG002|Overall Study|Withdrawal by Subject|1|||
130376497|NCT02700815|469345845|FG003|Overall Study|Withdrawal by Subject|0|||
130376498|NCT00793403|469345848|FG000|Overall Study|Other|73|||
130376499|NCT00842712|469345849|FG000|Safety Run-in Part|Adverse Event|0|||
130376500|NCT00842712|469345850|FG001|Safety Run-in Part|Adverse Event|1|||
130376501|NCT00842712|469345851|FG002|Safety Run-in Part|Adverse Event|0|||
130376502|NCT00842712|469345852|FG003|Safety Run-in Part|Adverse Event|0|||
130376503|NCT00842712|469345853|FG004|Safety Run-in Part|Adverse Event|0|||
130376504|NCT00842712|469345854|FG005|Safety Run-in Part|Adverse Event|0|||
130376505|NCT00842712|469345855|FG006|Safety Run-in Part|Adverse Event|0|||
130376506|NCT00842712|469345849|FG000|Safety Run-in Part|Progressive disease|3|||
130435858|NCT02954458|469558451|FG001|Overall Study|Death|0|||
130435859|NCT02954458|469558452|FG002|Overall Study|Death|0|||
130376507|NCT00842712|469345850|FG001|Safety Run-in Part|Progressive disease|1|||
130376508|NCT00842712|469345851|FG002|Safety Run-in Part|Progressive disease|0|||
130376509|NCT00842712|469345852|FG003|Safety Run-in Part|Progressive disease|1|||
130376510|NCT00842712|469345853|FG004|Safety Run-in Part|Progressive disease|0|||
130376511|NCT00842712|469345854|FG005|Safety Run-in Part|Progressive disease|0|||
130376512|NCT00842712|469345855|FG006|Safety Run-in Part|Progressive disease|0|||
130376513|NCT00842712|469345849|FG000|Randomized Part|Randomized but not treated|0|||
130376514|NCT00842712|469345850|FG001|Randomized Part|Randomized but not treated|0|||
130376515|NCT00842712|469345851|FG002|Randomized Part|Randomized but not treated|0|||
130376516|NCT00842712|469345852|FG003|Randomized Part|Randomized but not treated|0|||
130376517|NCT00842712|469345853|FG004|Randomized Part|Randomized but not treated|0|||
130376518|NCT00842712|469345854|FG005|Randomized Part|Randomized but not treated|1|||
130376519|NCT00842712|469345855|FG006|Randomized Part|Randomized but not treated|4|||
130376520|NCT00842712|469345849|FG000|Randomized Part|Ongoing at cut-off date|0|||
130435860|NCT02954458|469558453|FG003|Overall Study|Death|1|||
130376521|NCT00842712|469345850|FG001|Randomized Part|Ongoing at cut-off date|0|||
130376522|NCT00842712|469345851|FG002|Randomized Part|Ongoing at cut-off date|0|||
130435861|NCT02954458|469558450|FG000|Overall Study|Other|0|||
130435862|NCT02954458|469558451|FG001|Overall Study|Other|0|||
130435863|NCT02954458|469558452|FG002|Overall Study|Other|0|||
130435864|NCT02954458|469558453|FG003|Overall Study|Other|7|||
130435865|NCT02690077|469558454|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
130435866|NCT02690077|469558455|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
130435867|NCT02690077|469558454|FG000|Overall Study|Withdrawal by Subject|0|||
130435868|NCT02690077|469558455|FG001|Overall Study|Withdrawal by Subject|5|||
130435869|NCT02690077|469558454|FG000|Overall Study|Excluded by IRB|0|||
130435870|NCT02690077|469558455|FG001|Overall Study|Excluded by IRB|2|||
130435871|NCT01845974|469558456|FG000|Overall Study|screen failure|1|||
130435872|NCT01845974|469558457|FG001|Overall Study|screen failure|0|||
130435873|NCT05408468|469558458|FG000|Overall Study|Lost to Follow-up|3|||
130435874|NCT05408468|469558459|FG001|Overall Study|Lost to Follow-up|1|||
130435875|NCT05408468|469558458|FG000|Overall Study|Physician Decision|1|||
130435876|NCT05408468|469558459|FG001|Overall Study|Physician Decision|0|||
130435877|NCT05408468|469558458|FG000|Overall Study|Overwhelmed by clinical situation|3|||
130435878|NCT05408468|469558459|FG001|Overall Study|Overwhelmed by clinical situation|0|||
130435879|NCT05408468|469558458|FG000|Overall Study|Personal illness precluding participation|1|||
130435880|NCT05408468|469558459|FG001|Overall Study|Personal illness precluding participation|0|||
130435881|NCT05408468|469558458|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
130435882|NCT05408468|469558459|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
130435883|NCT04186403|469558460|FG000|Overall Study|Adverse Event|1|||
130435884|NCT04186403|469558461|FG001|Overall Study|Adverse Event|8|||
130435885|NCT04186403|469558460|FG000|Overall Study|Lost to Follow-up|7|||
130435886|NCT04186403|469558461|FG001|Overall Study|Lost to Follow-up|3|||
130435887|NCT04186403|469558460|FG000|Overall Study|Physician Decision|1|||
130435888|NCT04186403|469558461|FG001|Overall Study|Physician Decision|0|||
130435889|NCT04186403|469558460|FG000|Overall Study|Withdrawal by Subject|7|||
130679804|NCT04025879|470454224|FG000|Treatment|Participant request to discontinue study treatment|16|||
130435890|NCT04186403|469558461|FG001|Overall Study|Withdrawal by Subject|8|||
130435891|NCT04186403|469558460|FG000|Overall Study|Other: Not Related to Covid-19|3|||
130435892|NCT04186403|469558461|FG001|Overall Study|Other: Not Related to Covid-19|0|||
130435893|NCT00405639|469558464|FG000|Overall Study|Withdrawal by Subject|1|||
130435894|NCT00405639|469558465|FG001|Overall Study|Withdrawal by Subject|0|||
130435895|NCT00405639|469558464|FG000|Overall Study|Adverse Event|1|||
130435896|NCT00405639|469558465|FG001|Overall Study|Adverse Event|0|||
130435897|NCT00405639|469558464|FG000|Overall Study|Seizure prior to receiving BNP|1|||
130435898|NCT00405639|469558465|FG001|Overall Study|Seizure prior to receiving BNP|0|||
130435899|NCT00612534|469558466|FG000|Overall Study|Adverse Event|0|||
130679805|NCT04025879|470454225|FG001|Treatment|Participant request to discontinue study treatment|8|||
130679806|NCT04025879|470454224|FG000|Treatment|Participant withdrew consent|1|||
130679807|NCT04025879|470454225|FG001|Treatment|Participant withdrew consent|3|||
130679808|NCT04025879|470454224|FG000|Treatment|Participant no longer meets study criteria|3|||
130679809|NCT04025879|470454225|FG001|Treatment|Participant no longer meets study criteria|2|||
130679810|NCT04025879|470454224|FG000|Treatment|Lost to Follow-up|1|||
130679811|NCT04025879|470454225|FG001|Treatment|Lost to Follow-up|0|||
130435900|NCT00612534|469558467|FG001|Overall Study|Adverse Event|4|||
130435901|NCT00612534|469558468|FG002|Overall Study|Adverse Event|2|||
130679812|NCT04025879|470454224|FG000|Treatment|Other reasons|15|||
130679813|NCT04025879|470454225|FG001|Treatment|Other reasons|17|||
130679814|NCT04025879|470454224|FG000|Treatment|Administrative reason by sponsor|0|||
130679815|NCT04025879|470454225|FG001|Treatment|Administrative reason by sponsor|1|||
130679816|NCT04025879|470454224|FG000|Treatment|Not reported|2|||
130435902|NCT00612534|469558469|FG003|Overall Study|Adverse Event|1|||
130435903|NCT00612534|469558466|FG000|Overall Study|Lack of Efficacy|13|||
130435904|NCT00612534|469558467|FG001|Overall Study|Lack of Efficacy|12|||
130435905|NCT00612534|469558468|FG002|Overall Study|Lack of Efficacy|5|||
130435906|NCT00612534|469558469|FG003|Overall Study|Lack of Efficacy|16|||
130435907|NCT00612534|469558466|FG000|Overall Study|Other Reason|0|||
130435908|NCT00612534|469558467|FG001|Overall Study|Other Reason|1|||
130679817|NCT04025879|470454225|FG001|Treatment|Not reported|0|||
130679818|NCT02888171|470454226|FG000|Overall Study|Lost to Follow-up|2|||
130679819|NCT02888171|470454227|FG001|Overall Study|Lost to Follow-up|1|||
130679820|NCT02888171|470454226|FG000|Overall Study|Withdrawal by Subject|3|||
130435909|NCT00612534|469558468|FG002|Overall Study|Other Reason|0|||
130435910|NCT00612534|469558469|FG003|Overall Study|Other Reason|0|||
130679821|NCT02888171|470454227|FG001|Overall Study|Withdrawal by Subject|2|||
130435911|NCT00265330|469558470|FG000|Overall Study|Adverse Event|41|||
130435912|NCT00265330|469558470|FG000|Overall Study|Lost to Follow-up|8|||
130435913|NCT00265330|469558470|FG000|Overall Study|Withdrawal by Subject|34|||
130435914|NCT00265330|469558470|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
130679822|NCT02888171|470454226|FG000|Overall Study|Adverse Event|0|||
130435915|NCT00265330|469558470|FG000|Overall Study|Lack of Efficacy|4|||
130435916|NCT00265330|469558470|FG000|Overall Study|Family Scheduling Conflicts|1|||
130679823|NCT02888171|470454227|FG001|Overall Study|Adverse Event|1|||
130346528|NCT03039621|469240150|FG000|Overall Study|Violation of inclusion criteria|3|||
130346529|NCT03039621|469240151|FG001|Overall Study|Violation of inclusion criteria|2|||
130346530|NCT03039621|469240150|FG000|Overall Study|Non-compliance with protocol requirement|4|||
130346531|NCT03039621|469240151|FG001|Overall Study|Non-compliance with protocol requirement|5|||
130346532|NCT03039621|469240150|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
130346533|NCT03039621|469240151|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
130346534|NCT03039621|469240150|FG000|Overall Study|Violation of non-inclusion criteria|1|||
130346535|NCT03039621|469240151|FG001|Overall Study|Violation of non-inclusion criteria|2|||
130346536|NCT00002931|469240154|FG000|Overall Study|rapidly progressing disease during|2|||
130346537|NCT01879579|469240156|FG000|Overall Study|Phone incompatible with texting platform|3|||
130346538|NCT01879579|469240157|FG001|Overall Study|Phone incompatible with texting platform|0|||
130346539|NCT01879579|469240156|FG000|Overall Study|Did not enroll in texting platform|1|||
130346540|NCT01879579|469240157|FG001|Overall Study|Did not enroll in texting platform|0|||
130346541|NCT01879579|469240156|FG000|Overall Study|Did not initiate insulin treatment|1|||
130346542|NCT01879579|469240157|FG001|Overall Study|Did not initiate insulin treatment|0|||
130346543|NCT01879579|469240156|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
130346544|NCT01879579|469240157|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
130346545|NCT01879579|469240156|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
130346546|NCT01879579|469240157|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
130346547|NCT02292784|469240158|FG000|Overall Study|Lost to Follow-up|1|||
130346548|NCT02292784|469240159|FG001|Overall Study|Lost to Follow-up|17|||
130346549|NCT02292784|469240160|FG002|Overall Study|Lost to Follow-up|18|||
130346550|NCT02292784|469240158|FG000|Overall Study|Withdrawal by Subject|0|||
130346551|NCT02292784|469240159|FG001|Overall Study|Withdrawal by Subject|3|||
130346552|NCT02292784|469240160|FG002|Overall Study|Withdrawal by Subject|3|||
130346553|NCT01264081|469240161|FG000|Participants Screened|Screening failures|30|||
130346554|NCT01264081|469240161|FG000|Started Treatment|Withdrawal by Subject|1|||
130346555|NCT01264081|469240161|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
130346556|NCT00134784|469240162|FG000|Overall Study|Withdrawal by Subject|2|||
130346557|NCT00134784|469240163|FG001|Overall Study|Withdrawal by Subject|2|||
130346558|NCT00134784|469240164|FG002|Overall Study|Withdrawal by Subject|2|||
130346559|NCT00134784|469240165|FG003|Overall Study|Withdrawal by Subject|1|||
130346560|NCT02716896|469240166|FG000|Overall Study|Physician Decision|0|||
130346561|NCT02716896|469240167|FG001|Overall Study|Physician Decision|1|||
130346562|NCT03565367|469240171|FG000|Overall Study|No scan due to technical issues|4|||
130346563|NCT03565367|469240172|FG001|Overall Study|No scan due to technical issues|0|||
130346564|NCT03699475|469240178|FG000|Overall Study|Death|1|||
130346565|NCT00137839|469240179|FG000|Overall Study|Adverse Event|7|||
130346566|NCT00137839|469240179|FG000|Overall Study|Physician Decision|7|||
130346567|NCT00137839|469240179|FG000|Overall Study|Death|8|||
130346568|NCT00137839|469240179|FG000|Overall Study|Disease Progression|60|||
130346569|NCT00137839|469240179|FG000|Overall Study|Not Start Treatment|1|||
130346570|NCT00137839|469240179|FG000|Overall Study|Prolonged Treatment Delay|1|||
130346571|NCT02882152|469240184|FG000|Overall Study|Lost to Follow-up|1|||
130346572|NCT02882152|469240185|FG001|Overall Study|Lost to Follow-up|0|||
130346573|NCT01752036|469240188|FG000|Overall Study|Death|2|||
130346574|NCT03468543|469240189|FG000|Overall Study|Protocol stopping rules met|3|||
130346575|NCT01437995|469240190|FG000|Overall Study|Lost to Follow-up|11|||
130346576|NCT01437995|469240191|FG001|Overall Study|Lost to Follow-up|18|||
130346577|NCT01437995|469240192|FG002|Overall Study|Lost to Follow-up|20|||
130346578|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
130346579|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Adverse Event|9|||
130346580|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Death|4|||
130346581|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
130346582|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
130346583|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
130346584|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Death|1|||
130346585|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
130346586|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
130346587|NCT00275821|469240195|FG000|Overall Study|Adverse Event|4|||
130346588|NCT00275821|469240196|FG001|Overall Study|Adverse Event|12|||
130346589|NCT00275821|469240197|FG002|Overall Study|Adverse Event|5|||
130346590|NCT00275821|469240195|FG000|Overall Study|Administrative problems|3|||
130346591|NCT00275821|469240196|FG001|Overall Study|Administrative problems|4|||
130346592|NCT00275821|469240197|FG002|Overall Study|Administrative problems|4|||
130346593|NCT00275821|469240195|FG000|Overall Study|Withdrawal by Subject|0|||
130346594|NCT00275821|469240196|FG001|Overall Study|Withdrawal by Subject|2|||
130346595|NCT00275821|469240197|FG002|Overall Study|Withdrawal by Subject|1|||
130346596|NCT00275821|469240195|FG000|Overall Study|Lost to Follow-up|0|||
130346597|NCT00275821|469240196|FG001|Overall Study|Lost to Follow-up|1|||
130346598|NCT00275821|469240197|FG002|Overall Study|Lost to Follow-up|1|||
130346599|NCT00275821|469240195|FG000|Overall Study|Death|0|||
130346600|NCT00275821|469240196|FG001|Overall Study|Death|2|||
130346601|NCT00275821|469240197|FG002|Overall Study|Death|1|||
130346602|NCT00275821|469240195|FG000|Overall Study|Lack of Efficacy|2|||
130679824|NCT02170688|470454228|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
130679825|NCT02170688|470454229|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130679826|NCT02170688|470454230|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
130679827|NCT02170688|470454231|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130679828|NCT02170688|470454232|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
130679829|NCT02170688|470454228|FG000|Overall Study|Full dose not received|0|||
130679830|NCT02170688|470454229|FG001|Overall Study|Full dose not received|1|||
130679831|NCT02170688|470454230|FG002|Overall Study|Full dose not received|0|||
130679832|NCT02170688|470454231|FG003|Overall Study|Full dose not received|0|||
130679833|NCT02170688|470454232|FG004|Overall Study|Full dose not received|0|||
130679834|NCT02170688|470454228|FG000|Overall Study|Physician Decision|0|||
130679835|NCT02170688|470454229|FG001|Overall Study|Physician Decision|0|||
130679836|NCT02170688|470454230|FG002|Overall Study|Physician Decision|1|||
130679837|NCT02170688|470454231|FG003|Overall Study|Physician Decision|0|||
130679838|NCT02170688|470454232|FG004|Overall Study|Physician Decision|0|||
130679839|NCT01471522|470454235|FG000|Overall Study|Withdrawal by Subject|28|||
130679840|NCT01471522|470454236|FG001|Overall Study|Withdrawal by Subject|22|||
130679841|NCT01471522|470454235|FG000|Overall Study|Lost to Follow-up|36|||
130679842|NCT01471522|470454236|FG001|Overall Study|Lost to Follow-up|26|||
130679843|NCT02507375|470454238|FG000|Overall Study|Progressive Disease|4|||
130679844|NCT02507375|470454239|FG001|Overall Study|Progressive Disease|5|||
130679845|NCT02507375|470454238|FG000|Overall Study|Death|0|||
130679846|NCT02507375|470454239|FG001|Overall Study|Death|1|||
130679847|NCT02507375|470454238|FG000|Overall Study|Refused treatment|0|||
130679848|NCT02507375|470454239|FG001|Overall Study|Refused treatment|1|||
130679849|NCT02507375|470454238|FG000|Overall Study|Adverse Event|0|||
130679850|NCT02507375|470454239|FG001|Overall Study|Adverse Event|1|||
130679851|NCT00522457|470454240|FG000|Overall Study|Due to disease progression|16|||
130679852|NCT00522457|470454240|FG000|Overall Study|Adverse Event|2|||
130679853|NCT01691248|470454241|FG000|Overall Study|Protocol Violation|43|||
130679854|NCT01691248|470454242|FG001|Overall Study|Protocol Violation|27|||
130679855|NCT01691248|470454241|FG000|Overall Study|Adverse Event|24|||
130679856|NCT01691248|470454242|FG001|Overall Study|Adverse Event|22|||
130679857|NCT01691248|470454241|FG000|Overall Study|Withdrawal by Subject|20|||
130679858|NCT01691248|470454242|FG001|Overall Study|Withdrawal by Subject|18|||
130679859|NCT01691248|470454241|FG000|Overall Study|Confirmed CDAD|14|||
130679860|NCT01691248|470454242|FG001|Overall Study|Confirmed CDAD|31|||
130679861|NCT01691248|470454241|FG000|Overall Study|Lost to Follow-up|2|||
130679862|NCT01691248|470454242|FG001|Overall Study|Lost to Follow-up|5|||
130679863|NCT01691248|470454241|FG000|Overall Study|Reason not provided|4|||
130679864|NCT01691248|470454242|FG001|Overall Study|Reason not provided|4|||
130679865|NCT01691248|470454241|FG000|Overall Study|Not Treated|4|||
130679866|NCT01691248|470454242|FG001|Overall Study|Not Treated|7|||
130679867|NCT02863575|470454243|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
130679868|NCT02863575|470454244|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
130679869|NCT02863575|470454245|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
130679870|NCT02863575|470454243|FG000|Overall Study|Withdrawal by Subject|0|||
130679871|NCT02863575|470454244|FG001|Overall Study|Withdrawal by Subject|1|||
130679872|NCT02863575|470454245|FG002|Overall Study|Withdrawal by Subject|1|||
130679873|NCT02863575|470454243|FG000|Overall Study|Adverse Event|0|||
130679874|NCT02863575|470454244|FG001|Overall Study|Adverse Event|1|||
130679875|NCT02863575|470454245|FG002|Overall Study|Adverse Event|0|||
130679876|NCT03805438|470455829|FG000|Overall Study|Lack of Efficacy|1|||
130679877|NCT03805438|470455829|FG000|Overall Study|Protocol Violation|1|||
130679878|NCT00366899|470455830|FG000|Infant Series|Withdrawal by Subject|4|||
130679879|NCT00366899|470455831|FG001|Infant Series|Withdrawal by Subject|7|||
130679880|NCT00366899|470455830|FG000|Infant Series|Protocol Violation|2|||
130679881|NCT00366899|470455831|FG001|Infant Series|Protocol Violation|1|||
130679882|NCT00366899|470455830|FG000|Infant Series|Failed to return|1|||
130679883|NCT00366899|470455831|FG001|Infant Series|Failed to return|1|||
130679884|NCT00366899|470455830|FG000|Infant Series|Lost to Follow-up|0|||
130346603|NCT00275821|469240196|FG001|Overall Study|Lack of Efficacy|1|||
130346604|NCT00275821|469240197|FG002|Overall Study|Lack of Efficacy|0|||
130679885|NCT00366899|470455831|FG001|Infant Series|Lost to Follow-up|2|||
130679886|NCT00366899|470455830|FG000|Infant Series|Adverse Event|0|||
130679887|NCT00366899|470455831|FG001|Infant Series|Adverse Event|1|||
130679888|NCT00366899|470455830|FG000|Infant Series|Physician Decision|1|||
130679889|NCT00366899|470455831|FG001|Infant Series|Physician Decision|0|||
130679890|NCT00366899|470455830|FG000|Infant Series|Randomized but not consented|1|||
130679891|NCT00366899|470455831|FG001|Infant Series|Randomized but not consented|0|||
130679892|NCT00366899|470455830|FG000|After Infant Series|Lost to Follow-up|4|||
130679893|NCT00366899|470455831|FG001|After Infant Series|Lost to Follow-up|3|||
130679894|NCT00366899|470455830|FG000|After Infant Series|Withdrawal by Subject|1|||
130679895|NCT00366899|470455831|FG001|After Infant Series|Withdrawal by Subject|4|||
130679896|NCT00366899|470455830|FG000|After Infant Series|Adverse Event|1|||
130679897|NCT00366899|470455831|FG001|After Infant Series|Adverse Event|2|||
130679898|NCT00366899|470455830|FG000|After Infant Series|Protocol Violation|1|||
130679899|NCT00366899|470455831|FG001|After Infant Series|Protocol Violation|0|||
130435917|NCT00265330|469558470|FG000|Overall Study|Began Taking Formulary Geodon|1|||
130435918|NCT00265330|469558470|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
130679900|NCT00366899|470455830|FG000|Toddler Dose|Withdrawal by Subject|1|||
130679901|NCT00366899|470455831|FG001|Toddler Dose|Withdrawal by Subject|1|||
130679902|NCT00366899|470455830|FG000|Toddler Dose|Protocol Violation|1|||
130679903|NCT00366899|470455831|FG001|Toddler Dose|Protocol Violation|0|||
130679904|NCT01619800|470455832|FG000|Overall Study|study terminated|2|||
130679905|NCT01619800|470455833|FG001|Overall Study|study terminated|0|||
130679906|NCT00419770|470455835|FG000|Overall Study|Withdrawal by Subject|5|||
130679907|NCT00419770|470455836|FG001|Overall Study|Withdrawal by Subject|1|||
130679908|NCT02848326|470455837|FG000|Treatment Period|Adverse Event|5|||
130679909|NCT02848326|470455838|FG001|Treatment Period|Adverse Event|4|||
130679910|NCT02848326|470455839|FG002|Treatment Period|Adverse Event|11|||
130679911|NCT02848326|470455840|FG003|Treatment Period|Adverse Event|6|||
130679912|NCT02848326|470455841|FG004|Treatment Period|Adverse Event|5|||
130679913|NCT02848326|470455842|FG005|Treatment Period|Adverse Event|7|||
130679914|NCT02848326|470455837|FG000|Treatment Period|Withdrawal of Consent|20|||
130679915|NCT02848326|470455838|FG001|Treatment Period|Withdrawal of Consent|6|||
130679916|NCT02848326|470455839|FG002|Treatment Period|Withdrawal of Consent|9|||
130679917|NCT02848326|470455840|FG003|Treatment Period|Withdrawal of Consent|6|||
130679918|NCT02848326|470455841|FG004|Treatment Period|Withdrawal of Consent|9|||
130679919|NCT02848326|470455842|FG005|Treatment Period|Withdrawal of Consent|6|||
130679920|NCT02848326|470455837|FG000|Treatment Period|Lost to Follow-up|5|||
130679921|NCT02848326|470455838|FG001|Treatment Period|Lost to Follow-up|1|||
130679922|NCT02848326|470455839|FG002|Treatment Period|Lost to Follow-up|11|||
130679923|NCT02848326|470455840|FG003|Treatment Period|Lost to Follow-up|7|||
130679924|NCT02848326|470455841|FG004|Treatment Period|Lost to Follow-up|2|||
130679925|NCT02848326|470455842|FG005|Treatment Period|Lost to Follow-up|3|||
130679926|NCT02848326|470455837|FG000|Treatment Period|Pregnancy|0|||
130435919|NCT00265330|469558470|FG000|Overall Study|Site Closed by Sponsor|1|||
130435920|NCT00265330|469558470|FG000|Overall Study|Principal Investigators Request|1|||
130435921|NCT00265330|469558470|FG000|Overall Study|Withdrew Consent|1|||
130435922|NCT00265330|469558470|FG000|Overall Study|Protocol Violation|1|||
130435923|NCT02234063|469558481|FG000|Overall Study|Lost to Follow-up|235|||
130435924|NCT02234063|469558482|FG001|Overall Study|Lost to Follow-up|42|||
130435925|NCT02234063|469558481|FG000|Overall Study|Withdrawal by Subject|20|||
130435926|NCT02234063|469558482|FG001|Overall Study|Withdrawal by Subject|1|||
130435927|NCT02669095|469558485|FG000|Overall Study|Adverse Event|1|||
130435928|NCT02669095|469558486|FG001|Overall Study|Adverse Event|0|||
130679927|NCT02848326|470455838|FG001|Treatment Period|Pregnancy|0|||
130679928|NCT02848326|470455839|FG002|Treatment Period|Pregnancy|1|||
130679929|NCT02848326|470455840|FG003|Treatment Period|Pregnancy|1|||
130679930|NCT02848326|470455841|FG004|Treatment Period|Pregnancy|0|||
130679931|NCT02848326|470455842|FG005|Treatment Period|Pregnancy|1|||
130679932|NCT02848326|470455837|FG000|Treatment Period|Protocol Violation|4|||
130679933|NCT02848326|470455838|FG001|Treatment Period|Protocol Violation|3|||
130679934|NCT02848326|470455839|FG002|Treatment Period|Protocol Violation|4|||
130679935|NCT02848326|470455840|FG003|Treatment Period|Protocol Violation|2|||
130679936|NCT02848326|470455841|FG004|Treatment Period|Protocol Violation|3|||
130679937|NCT02848326|470455842|FG005|Treatment Period|Protocol Violation|3|||
130679938|NCT02848326|470455837|FG000|Treatment Period|Non-compliance with Study Drug|4|||
130679939|NCT02848326|470455838|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130679940|NCT02848326|470455839|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130679941|NCT02848326|470455840|FG003|Treatment Period|Non-compliance with Study Drug|1|||
130679942|NCT02848326|470455841|FG004|Treatment Period|Non-compliance with Study Drug|0|||
130679943|NCT02848326|470455842|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130679944|NCT02848326|470455837|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
130679945|NCT02848326|470455838|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
130679946|NCT02848326|470455839|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
130679947|NCT02848326|470455840|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
130679948|NCT02848326|470455841|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
130679949|NCT02848326|470455842|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
130679950|NCT02848326|470455837|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
130679951|NCT02848326|470455838|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130679952|NCT02848326|470455839|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
130679953|NCT02848326|470455840|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
130679954|NCT02848326|470455841|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
130679955|NCT02848326|470455842|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
130435929|NCT02669095|469558485|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130435930|NCT02669095|469558486|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130679956|NCT00414466|470455849|FG000|Overall Study|Adverse Event|0|||
130679957|NCT00414466|470455850|FG001|Overall Study|Adverse Event|0|||
130679958|NCT00414466|470455851|FG002|Overall Study|Adverse Event|1|||
130679959|NCT00414466|470455852|FG003|Overall Study|Adverse Event|1|||
130679960|NCT00414466|470455849|FG000|Overall Study|Lack of Efficacy|1|||
130679961|NCT00414466|470455850|FG001|Overall Study|Lack of Efficacy|0|||
130679962|NCT00414466|470455851|FG002|Overall Study|Lack of Efficacy|0|||
130679963|NCT00414466|470455852|FG003|Overall Study|Lack of Efficacy|0|||
130679964|NCT00414466|470455849|FG000|Overall Study|Withdrawn by Sponsor|1|||
130679965|NCT00414466|470455850|FG001|Overall Study|Withdrawn by Sponsor|0|||
130679966|NCT00414466|470455851|FG002|Overall Study|Withdrawn by Sponsor|0|||
130679967|NCT00414466|470455852|FG003|Overall Study|Withdrawn by Sponsor|0|||
130679968|NCT02999178|470455853|FG000|Overall Study|Adverse Event|85|||
130679969|NCT02999178|470455854|FG001|Overall Study|Adverse Event|62|||
130679970|NCT02999178|470455853|FG000|Overall Study|Protocol Violation|1|||
130679971|NCT02999178|470455854|FG001|Overall Study|Protocol Violation|2|||
130679972|NCT02999178|470455853|FG000|Overall Study|Lost to Follow-up|0|||
130679973|NCT02999178|470455854|FG001|Overall Study|Lost to Follow-up|2|||
130679974|NCT02999178|470455853|FG000|Overall Study|Withdrawal by Subject|21|||
130679975|NCT02999178|470455854|FG001|Overall Study|Withdrawal by Subject|21|||
130679976|NCT02999178|470455853|FG000|Overall Study|Other reason not defined above|7|||
130679977|NCT02999178|470455854|FG001|Overall Study|Other reason not defined above|13|||
130679978|NCT03480425|470455855|FG000|Overall Study|Force transducer technical failure|1|||
130679979|NCT02424188|470455857|FG000|Overall Study|Death|2|||
130679980|NCT02424188|470455858|FG001|Overall Study|Death|2|||
130679981|NCT02424188|470455857|FG000|Overall Study|Lost to Follow-up|1|||
130679982|NCT02424188|470455858|FG001|Overall Study|Lost to Follow-up|3|||
130679983|NCT02424188|470455857|FG000|Overall Study|Incarceration|1|||
130679984|NCT02424188|470455858|FG001|Overall Study|Incarceration|0|||
130679985|NCT01085045|470455859|FG000|Part A|Withdrawal by Subject|4|||
130679986|NCT01085045|470455859|FG000|Part A|Adverse Event|6|||
130679987|NCT01085045|470455859|FG000|Part A|Protocol Violation|1|||
130679988|NCT01085045|470455859|FG000|Part A|Protocol Specified Criteria|7|||
130679989|NCT01085045|470455859|FG000|Part B|Withdrawal by Subject|2|||
130679990|NCT01085045|470455859|FG000|Part B|Protocol Specified Criteria|6|||
130679991|NCT01085045|470455859|FG000|Part B|Lost to Follow-up|1|||
130679992|NCT01085045|470455859|FG000|Part B|Adverse Event|6|||
130679993|NCT00416520|470455864|FG000|Open-label Period|Adverse Event|28|||
130679994|NCT00416520|470455865|FG001|Open-label Period|Adverse Event|10|||
130679995|NCT00416520|470455866|FG002|Open-label Period|Adverse Event|0|||
130679996|NCT00416520|470455867|FG003|Open-label Period|Adverse Event|0|||
130679997|NCT00416520|470455864|FG000|Open-label Period|Death|2|||
130679998|NCT00416520|470455865|FG001|Open-label Period|Death|1|||
130679999|NCT00416520|470455866|FG002|Open-label Period|Death|0|||
130680000|NCT00416520|470455867|FG003|Open-label Period|Death|0|||
130680001|NCT00416520|470455864|FG000|Open-label Period|Lack of Efficacy|8|||
130680002|NCT00416520|470455865|FG001|Open-label Period|Lack of Efficacy|1|||
130680003|NCT00416520|470455866|FG002|Open-label Period|Lack of Efficacy|0|||
130680004|NCT00416520|470455867|FG003|Open-label Period|Lack of Efficacy|0|||
130680005|NCT00416520|470455864|FG000|Open-label Period|Protocol Violation|3|||
130680006|NCT00416520|470455865|FG001|Open-label Period|Protocol Violation|3|||
130680007|NCT00416520|470455866|FG002|Open-label Period|Protocol Violation|0|||
130680008|NCT00416520|470455867|FG003|Open-label Period|Protocol Violation|0|||
130680009|NCT00416520|470455864|FG000|Open-label Period|Withdrawal by Subject|16|||
130680010|NCT00416520|470455865|FG001|Open-label Period|Withdrawal by Subject|5|||
130680011|NCT00416520|470455866|FG002|Open-label Period|Withdrawal by Subject|0|||
130680012|NCT00416520|470455867|FG003|Open-label Period|Withdrawal by Subject|0|||
130680013|NCT00416520|470455864|FG000|Open-label Period|Other Reasons|3|||
130680014|NCT00416520|470455865|FG001|Open-label Period|Other Reasons|12|||
130680015|NCT00416520|470455866|FG002|Open-label Period|Other Reasons|0|||
130680016|NCT00416520|470455867|FG003|Open-label Period|Other Reasons|0|||
130680017|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680018|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680019|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680020|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
130680021|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680022|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680023|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680024|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
130680025|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130680026|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130680027|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130680028|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130680029|NCT01492361|470455868|FG000|Overall Study|Withdrawal by Subject|281|||
130680030|NCT01492361|470455869|FG001|Overall Study|Withdrawal by Subject|297|||
130680031|NCT01492361|470455868|FG000|Overall Study|Physician Decision|12|||
130680032|NCT01492361|470455869|FG001|Overall Study|Physician Decision|12|||
130680033|NCT01492361|470455868|FG000|Overall Study|Lost to Follow-up|6|||
130680034|NCT01492361|470455869|FG001|Overall Study|Lost to Follow-up|13|||
130680035|NCT01492361|470455868|FG000|Overall Study|Other than specified above|106|||
130680036|NCT01492361|470455869|FG001|Overall Study|Other than specified above|138|||
130680037|NCT01996033|470455875|FG000|Overall Study|Death|1|||
130680038|NCT01996033|470455875|FG000|Overall Study|Physician Decision|1|||
130680039|NCT01996033|470455875|FG000|Overall Study|Withdrawal by Subject|4|||
130680040|NCT01996033|470455875|FG000|Overall Study|Lost to Follow-up|3|||
130680041|NCT03227445|470455880|FG000|Period 1 (28 Days)|Adverse Event|1|||
130680042|NCT03227445|470455881|FG001|Period 1 (28 Days)|Adverse Event|2|||
130680043|NCT03227445|470455882|FG002|Period 1 (28 Days)|Adverse Event|0|||
130680044|NCT03227445|470455883|FG003|Period 1 (28 Days)|Adverse Event|1|||
130680045|NCT03227445|470455880|FG000|Period 1 (28 Days)|Protocol Violation|1|||
130680046|NCT03227445|470455881|FG001|Period 1 (28 Days)|Protocol Violation|0|||
130680047|NCT03227445|470455882|FG002|Period 1 (28 Days)|Protocol Violation|0|||
130680048|NCT03227445|470455883|FG003|Period 1 (28 Days)|Protocol Violation|0|||
130680049|NCT03227445|470455880|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
130680050|NCT03227445|470455881|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
130680051|NCT03227445|470455882|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
130680052|NCT03227445|470455883|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
130680053|NCT03227445|470455880|FG000|Period 2 (28 Days)|Adverse Event|1|||
130680054|NCT03227445|470455881|FG001|Period 2 (28 Days)|Adverse Event|0|||
130680055|NCT03227445|470455882|FG002|Period 2 (28 Days)|Adverse Event|2|||
130680056|NCT03227445|470455883|FG003|Period 2 (28 Days)|Adverse Event|1|||
130680057|NCT03227445|470455880|FG000|Period 2 (28 Days)|Protocol Violation|0|||
130680058|NCT03227445|470455881|FG001|Period 2 (28 Days)|Protocol Violation|0|||
130680059|NCT03227445|470455882|FG002|Period 2 (28 Days)|Protocol Violation|0|||
130346605|NCT00275821|469240195|FG000|Overall Study|Protocol Violation|5|||
130346606|NCT00275821|469240196|FG001|Overall Study|Protocol Violation|1|||
130346607|NCT00275821|469240197|FG002|Overall Study|Protocol Violation|0|||
130346608|NCT00329901|469240198|FG000|Overall Study|Withdrawal by Subject|4|||
130346609|NCT00329901|469240199|FG001|Overall Study|Withdrawal by Subject|3|||
130346610|NCT00329901|469240200|FG002|Overall Study|Withdrawal by Subject|2|||
130346611|NCT00329901|469240198|FG000|Overall Study|Lost to Follow-up|2|||
130346612|NCT00329901|469240199|FG001|Overall Study|Lost to Follow-up|0|||
130346613|NCT00329901|469240200|FG002|Overall Study|Lost to Follow-up|1|||
130346614|NCT00329901|469240198|FG000|Overall Study|Protocol Violation|1|||
130346615|NCT00329901|469240199|FG001|Overall Study|Protocol Violation|0|||
130346616|NCT00329901|469240200|FG002|Overall Study|Protocol Violation|1|||
130346617|NCT00329901|469240198|FG000|Overall Study|Unable to classify|2|||
130346618|NCT00329901|469240199|FG001|Overall Study|Unable to classify|2|||
130346619|NCT00329901|469240200|FG002|Overall Study|Unable to classify|0|||
130346620|NCT02296138|469240201|FG000|Overall Study|Adverse Event|348|||
130346621|NCT02296138|469240202|FG001|Overall Study|Adverse Event|259|||
130346622|NCT02296138|469240201|FG000|Overall Study|Lack of Efficacy|59|||
130346623|NCT02296138|469240202|FG001|Overall Study|Lack of Efficacy|37|||
130346624|NCT02296138|469240201|FG000|Overall Study|Protocol Violation|35|||
130346625|NCT02296138|469240202|FG001|Overall Study|Protocol Violation|36|||
130346626|NCT02296138|469240201|FG000|Overall Study|Lost to Follow-up|9|||
130346627|NCT02296138|469240202|FG001|Overall Study|Lost to Follow-up|12|||
130346628|NCT02296138|469240201|FG000|Overall Study|Withdrawal by Subject|184|||
130346629|NCT02296138|469240202|FG001|Overall Study|Withdrawal by Subject|131|||
130346630|NCT02296138|469240201|FG000|Overall Study|Not Treated|1|||
130346631|NCT02296138|469240202|FG001|Overall Study|Not Treated|1|||
130346632|NCT02296138|469240201|FG000|Overall Study|Patients with data irregularities|10|||
130346633|NCT02296138|469240202|FG001|Overall Study|Patients with data irregularities|11|||
130346634|NCT02296138|469240201|FG000|Overall Study|Other than specified|15|||
130346635|NCT02296138|469240202|FG001|Overall Study|Other than specified|13|||
130346636|NCT01209832|469240209|FG000|Period 1|Sponsor Decision and was not dosed|1|||
130346637|NCT01209832|469240209|FG000|Period 2|Sponsor Decision|1|||
130346638|NCT01268579|469240210|FG000|Overall Study|Adverse Event|1|||
130346639|NCT01268579|469240210|FG000|Overall Study|Withdrawal by Subject|2|||
130346640|NCT00761150|469240211|FG000|Open-label Period|Adverse Event|36|||
130346641|NCT00761150|469240212|FG001|Open-label Period|Adverse Event|0|||
130346642|NCT00761150|469240213|FG002|Open-label Period|Adverse Event|0|||
130346643|NCT00761150|469240211|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
130346644|NCT00761150|469240212|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
130346645|NCT00761150|469240213|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
130346646|NCT00761150|469240211|FG000|Open-label Period|Lost to Follow-up|7|||
130346647|NCT00761150|469240212|FG001|Open-label Period|Lost to Follow-up|0|||
130346648|NCT00761150|469240213|FG002|Open-label Period|Lost to Follow-up|0|||
130346649|NCT00761150|469240211|FG000|Open-label Period|Lack of Efficacy|4|||
130346650|NCT00761150|469240212|FG001|Open-label Period|Lack of Efficacy|0|||
130346651|NCT00761150|469240213|FG002|Open-label Period|Lack of Efficacy|0|||
130346652|NCT00761150|469240211|FG000|Open-label Period|Withdrawal by Subject|5|||
130346653|NCT00761150|469240212|FG001|Open-label Period|Withdrawal by Subject|0|||
130346654|NCT00761150|469240213|FG002|Open-label Period|Withdrawal by Subject|0|||
130346655|NCT00761150|469240211|FG000|Open-label Period|Noncompliance|2|||
130346656|NCT00761150|469240212|FG001|Open-label Period|Noncompliance|0|||
130346657|NCT00761150|469240213|FG002|Open-label Period|Noncompliance|0|||
130346658|NCT00761150|469240211|FG000|Open-label Period|Other|5|||
130346659|NCT00761150|469240212|FG001|Open-label Period|Other|0|||
130346660|NCT00761150|469240213|FG002|Open-label Period|Other|0|||
130680060|NCT03227445|470455883|FG003|Period 2 (28 Days)|Protocol Violation|1|||
130346661|NCT00761150|469240211|FG000|Double-blind Period|Lack of Efficacy|0|||
130346662|NCT00761150|469240212|FG001|Double-blind Period|Lack of Efficacy|2|||
130346663|NCT00761150|469240213|FG002|Double-blind Period|Lack of Efficacy|19|||
130346664|NCT00761150|469240211|FG000|Double-blind Period|Adverse Event|0|||
130346665|NCT00761150|469240212|FG001|Double-blind Period|Adverse Event|3|||
130346666|NCT00761150|469240213|FG002|Double-blind Period|Adverse Event|3|||
130346667|NCT00761150|469240211|FG000|Double-blind Period|Withdrawal by Subject|0|||
130346668|NCT00761150|469240212|FG001|Double-blind Period|Withdrawal by Subject|3|||
130346669|NCT00761150|469240213|FG002|Double-blind Period|Withdrawal by Subject|2|||
130346670|NCT00761150|469240211|FG000|Double-blind Period|Lost to Follow-up|0|||
130346671|NCT00761150|469240212|FG001|Double-blind Period|Lost to Follow-up|2|||
130346672|NCT00761150|469240213|FG002|Double-blind Period|Lost to Follow-up|1|||
130346673|NCT00761150|469240211|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
130346674|NCT00761150|469240212|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
130346675|NCT00761150|469240213|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
130346676|NCT00761150|469240211|FG000|Double-blind Period|Noncompliance|0|||
130346677|NCT00761150|469240212|FG001|Double-blind Period|Noncompliance|1|||
130346678|NCT00761150|469240213|FG002|Double-blind Period|Noncompliance|0|||
130346679|NCT00761150|469240211|FG000|Double-blind Period|Other|0|||
130346680|NCT00761150|469240212|FG001|Double-blind Period|Other|3|||
130346681|NCT00761150|469240213|FG002|Double-blind Period|Other|3|||
130346682|NCT02692651|469240214|FG000|Study Treatment|Death|7|||
130346683|NCT02692651|469240215|FG001|Study Treatment|Death|3|||
130346684|NCT02692651|469240214|FG000|Study Treatment|comfort care|1|||
130346685|NCT02692651|469240215|FG001|Study Treatment|comfort care|1|||
130346686|NCT02692651|469240214|FG000|Study Treatment|Protocol violation per treating team preference|8|||
130346687|NCT02692651|469240215|FG001|Study Treatment|Protocol violation per treating team preference|6|||
130346688|NCT02692651|469240214|FG000|Post Study Treatment Follow-up|Death|4|||
130346689|NCT02692651|469240215|FG001|Post Study Treatment Follow-up|Death|4|||
130346690|NCT02480712|469240216|FG000|Overall Study|Enrolled but Never Treated|1|||
130346691|NCT02480712|469240216|FG000|Overall Study|Lost to Follow-up|5|||
130346692|NCT02480712|469240216|FG000|Overall Study|Withdrew Consent|3|||
130346693|NCT02480712|469240216|FG000|Overall Study|Death|1|||
130346694|NCT02480712|469240216|FG000|Overall Study|Lack of Efficacy|1|||
130346695|NCT00475423|469240217|FG000|Overall Study|Protocol Violation|5|||
130346696|NCT00475423|469240217|FG000|Overall Study|Adverse Event|4|||
130346697|NCT00475423|469240217|FG000|Overall Study|Withdrawal by Subject|6|||
130346698|NCT00475423|469240217|FG000|Overall Study|Lack of Efficacy|8|||
130346699|NCT00475423|469240217|FG000|Overall Study|Death|1|||
130346700|NCT00475423|469240217|FG000|Overall Study|Reason not specified|1|||
130346701|NCT00475423|469240217|FG000|Overall Study|Lost to Follow-up|7|||
130346702|NCT01860846|469240218|FG000|Overall Study|Lost to Follow-up|33|||
130346703|NCT05463198|469240219|FG000|Overall Study|Withdrawal by Subject|19|||
130346704|NCT05463198|469240219|FG000|Overall Study|Procedure Notes Missing|18|||
130346705|NCT02239120|469240222|FG000|Overall Study|Death|56|||
130346706|NCT02239120|469240223|FG001|Overall Study|Death|58|||
130346707|NCT02239120|469240222|FG000|Overall Study|Lost to Follow-up|19|||
130346708|NCT02239120|469240223|FG001|Overall Study|Lost to Follow-up|14|||
130346709|NCT00466687|469240224|FG000|Overall Study|Adverse Event|1|||
130346710|NCT00466687|469240224|FG000|Overall Study|Other complicating illness|3|||
130346711|NCT00466687|469240224|FG000|Overall Study|Withdrawal by Subject|1|||
130346712|NCT00466687|469240224|FG000|Overall Study|Disease progression|29|||
130346713|NCT01925989|469240225|FG000|Period 1|Sponsor Decision|1|||
130346714|NCT01925989|469240226|FG001|Period 1|Sponsor Decision|1|||
130346715|NCT01925989|469240227|FG002|Period 1|Sponsor Decision|0|||
130346716|NCT01925989|469240225|FG000|Period 1|Withdrawal by Subject|0|||
130346717|NCT01925989|469240226|FG001|Period 1|Withdrawal by Subject|1|||
130346718|NCT01925989|469240227|FG002|Period 1|Withdrawal by Subject|0|||
130346719|NCT00868517|469240232|FG000|Overall Study|Withdrawal by Subject|3|||
130346720|NCT00868517|469240233|FG001|Overall Study|Withdrawal by Subject|3|||
130346721|NCT00868517|469240234|FG002|Overall Study|Withdrawal by Subject|2|||
130346722|NCT00868517|469240232|FG000|Overall Study|Protocol Violation|1|||
130346723|NCT00868517|469240233|FG001|Overall Study|Protocol Violation|1|||
130346724|NCT00868517|469240234|FG002|Overall Study|Protocol Violation|0|||
130346725|NCT00420641|469240236|FG000|Overall Study|Adverse Event|3|||
130346726|NCT00420641|469240237|FG001|Overall Study|Adverse Event|25|||
130346727|NCT00420641|469240238|FG002|Overall Study|Adverse Event|10|||
130346728|NCT00420641|469240236|FG000|Overall Study|Lost to Follow-up|2|||
130346729|NCT00420641|469240237|FG001|Overall Study|Lost to Follow-up|4|||
130346730|NCT00420641|469240238|FG002|Overall Study|Lost to Follow-up|2|||
130346731|NCT00420641|469240236|FG000|Overall Study|Protocol Violation|8|||
130346732|NCT00420641|469240237|FG001|Overall Study|Protocol Violation|8|||
130346733|NCT00420641|469240238|FG002|Overall Study|Protocol Violation|7|||
130346734|NCT00420641|469240236|FG000|Overall Study|Withdrawal by Subject|15|||
130346735|NCT00420641|469240237|FG001|Overall Study|Withdrawal by Subject|21|||
130346736|NCT00420641|469240238|FG002|Overall Study|Withdrawal by Subject|14|||
130346737|NCT00420641|469240236|FG000|Overall Study|Lack of Efficacy|6|||
130346738|NCT00420641|469240237|FG001|Overall Study|Lack of Efficacy|5|||
130346739|NCT00420641|469240238|FG002|Overall Study|Lack of Efficacy|4|||
130680061|NCT03227445|470455880|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
130680062|NCT03227445|470455881|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
130680063|NCT03227445|470455882|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
130680064|NCT03227445|470455883|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
130680065|NCT00755196|470455884|FG000|Overall Study|Lost to Follow-up|1|||
130680066|NCT00755196|470455884|FG000|Overall Study|Lack of Efficiency|1|||
130680067|NCT01703832|470455885|FG000|Overall Study|Withdrawal by Subject|1|||
130680068|NCT01703832|470455886|FG001|Overall Study|Withdrawal by Subject|0|||
130680069|NCT01991470|470455887|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
130680070|NCT01991470|470455887|FG000|Enlite 1 Period|Adverse Event|1|||
130680071|NCT01991470|470455887|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
130680072|NCT01991470|470455887|FG000|Enlite 3 Period|Lost to Follow-up|1|||
130680073|NCT01991470|470455887|FG000|Enlite 3 Period|Physician Decision|2|||
130680074|NCT01991470|470455887|FG000|Enlite 3 Period|Physician Decision|8|||
130680075|NCT01991470|470455887|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
130346740|NCT00420641|469240236|FG000|Overall Study|Non-compliance|7|||
130346741|NCT00420641|469240237|FG001|Overall Study|Non-compliance|5|||
130346742|NCT00420641|469240238|FG002|Overall Study|Non-compliance|4|||
130346743|NCT00420641|469240236|FG000|Overall Study|Other|4|||
130346744|NCT00420641|469240237|FG001|Overall Study|Other|4|||
130346745|NCT00420641|469240238|FG002|Overall Study|Other|3|||
130346746|NCT03459690|469240239|FG000|Overall Study|Lost to Follow-up|0|||
130346747|NCT03459690|469240240|FG001|Overall Study|Lost to Follow-up|1|||
130346748|NCT03459690|469240239|FG000|Overall Study|Withdrawal by Subject|1|||
130346749|NCT03459690|469240240|FG001|Overall Study|Withdrawal by Subject|1|||
130346750|NCT02815280|469240241|FG000|Double-Blind Phase|Adverse Event|1|||
130346751|NCT02815280|469240242|FG001|Double-Blind Phase|Adverse Event|1|||
130346752|NCT02815280|469240241|FG000|Double-Blind Phase|Lost to Follow-up|10|||
130346753|NCT02815280|469240242|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130346754|NCT02815280|469240241|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
130346755|NCT02815280|469240242|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
130346756|NCT02815280|469240241|FG000|Double-Blind Phase|Protocol Violation|2|||
130346757|NCT02815280|469240242|FG001|Double-Blind Phase|Protocol Violation|2|||
130346758|NCT02815280|469240241|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
130346759|NCT02815280|469240242|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
130346760|NCT02815280|469240241|FG000|Open-Label Phase|Adverse Event|2|||
130346761|NCT02815280|469240242|FG001|Open-Label Phase|Adverse Event|3|||
130346762|NCT02815280|469240241|FG000|Open-Label Phase|Lost to Follow-up|18|||
130346763|NCT02815280|469240242|FG001|Open-Label Phase|Lost to Follow-up|9|||
130346764|NCT02815280|469240241|FG000|Open-Label Phase|Withdrawal by Subject|33|||
130346765|NCT02815280|469240242|FG001|Open-Label Phase|Withdrawal by Subject|18|||
130346766|NCT02815280|469240241|FG000|Open-Label Phase|Protocol Violation|3|||
130346767|NCT02815280|469240242|FG001|Open-Label Phase|Protocol Violation|0|||
130346768|NCT02815280|469240241|FG000|Open-Label Phase|Administrative|26|||
130346769|NCT02815280|469240242|FG001|Open-Label Phase|Administrative|12|||
130346770|NCT02815280|469240241|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
130346771|NCT02815280|469240242|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
130346772|NCT02514473|469240257|FG000|Overall Study|Adverse Event|0|||
130346773|NCT02514473|469240258|FG001|Overall Study|Adverse Event|2|||
130346774|NCT02514473|469240257|FG000|Overall Study|Withdrawal by Subject|2|||
130346775|NCT02514473|469240258|FG001|Overall Study|Withdrawal by Subject|1|||
130346776|NCT02514473|469240257|FG000|Overall Study|Lost to Follow-up|0|||
130346777|NCT02514473|469240258|FG001|Overall Study|Lost to Follow-up|1|||
130346778|NCT02514473|469240257|FG000|Overall Study|Other|1|||
130346779|NCT02514473|469240258|FG001|Overall Study|Other|1|||
130346780|NCT02158364|469240259|FG000|Overall Study|Case report forms uncollected|10|||
130346781|NCT02158364|469240259|FG000|Overall Study|Protocol Deviation|50|||
130346782|NCT01944839|469240260|FG000|Overall Study|Physician Decision|2|||
130346783|NCT01944839|469240261|FG001|Overall Study|Physician Decision|2|||
130346784|NCT01944839|469240260|FG000|Overall Study|Protocol Violation|0|||
130346785|NCT01944839|469240261|FG001|Overall Study|Protocol Violation|1|||
130346786|NCT01944839|469240260|FG000|Overall Study|Adverse Event|10|||
130680076|NCT00243932|470455888|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
130680077|NCT00243932|470455889|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
130346787|NCT01944839|469240261|FG001|Overall Study|Adverse Event|5|||
130346788|NCT01944839|469240260|FG000|Overall Study|Withdrawal by Subject|9|||
130346789|NCT01944839|469240261|FG001|Overall Study|Withdrawal by Subject|17|||
130346790|NCT01944839|469240260|FG000|Overall Study|Lost to Follow-up|1|||
130346791|NCT01944839|469240261|FG001|Overall Study|Lost to Follow-up|0|||
130346792|NCT01944839|469240260|FG000|Overall Study|Subject non-compliance|0|||
130346793|NCT01944839|469240261|FG001|Overall Study|Subject non-compliance|3|||
130346794|NCT02217527|469240262|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
130346795|NCT02217527|469240263|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
130346796|NCT02217527|469240262|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
130680078|NCT00243932|470455890|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
130680079|NCT02143102|470455891|FG000|Overall Study|Lost to Follow-up|11|||
130680080|NCT02143102|470455892|FG001|Overall Study|Lost to Follow-up|0|||
130680081|NCT03247556|470455893|FG000|Overall Study|Adverse Event|1|||
130680082|NCT03247556|470455894|FG001|Overall Study|Adverse Event|4|||
130680083|NCT03247556|470455895|FG002|Overall Study|Adverse Event|5|||
130680084|NCT03247556|470455893|FG000|Overall Study|Lost to Follow-up|5|||
130680085|NCT03247556|470455894|FG001|Overall Study|Lost to Follow-up|5|||
130680086|NCT03247556|470455895|FG002|Overall Study|Lost to Follow-up|4|||
130680087|NCT03247556|470455893|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
130680088|NCT03247556|470455894|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
130680089|NCT03247556|470455895|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
130680090|NCT03247556|470455893|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
130680091|NCT03247556|470455894|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
130680092|NCT03247556|470455895|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
130680093|NCT03247556|470455893|FG000|Overall Study|Protocol Violation|2|||
130680094|NCT03247556|470455894|FG001|Overall Study|Protocol Violation|0|||
130680095|NCT03247556|470455895|FG002|Overall Study|Protocol Violation|1|||
130680096|NCT03247556|470455893|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
130680097|NCT03247556|470455894|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
130680098|NCT03247556|470455895|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
130680099|NCT03952143|470455896|FG000|Lead-In Period|Adverse Event|2|||
130680100|NCT03952143|470455897|FG001|Lead-In Period|Adverse Event|0|||
130680101|NCT03952143|470455898|FG002|Lead-In Period|Adverse Event|0|||
130680102|NCT03952143|470455896|FG000|Lead-In Period|Lack of Efficacy|2|||
130680103|NCT03952143|470455897|FG001|Lead-In Period|Lack of Efficacy|0|||
130680104|NCT03952143|470455898|FG002|Lead-In Period|Lack of Efficacy|0|||
130680105|NCT03952143|470455896|FG000|Lead-In Period|Physician Decision|5|||
130680106|NCT03952143|470455897|FG001|Lead-In Period|Physician Decision|0|||
130680107|NCT03952143|470455898|FG002|Lead-In Period|Physician Decision|0|||
130680108|NCT03952143|470455896|FG000|Lead-In Period|Protocol Violation|5|||
130680109|NCT03952143|470455897|FG001|Lead-In Period|Protocol Violation|0|||
130680110|NCT03952143|470455898|FG002|Lead-In Period|Protocol Violation|0|||
130680111|NCT03952143|470455896|FG000|Lead-In Period|Withdrawal by Subject|19|||
130680112|NCT03952143|470455897|FG001|Lead-In Period|Withdrawal by Subject|0|||
130680113|NCT03952143|470455898|FG002|Lead-In Period|Withdrawal by Subject|0|||
130680114|NCT03952143|470455896|FG000|Treatment Period|Adverse Event|0|||
130680115|NCT03952143|470455897|FG001|Treatment Period|Adverse Event|0|||
130680116|NCT03952143|470455898|FG002|Treatment Period|Adverse Event|1|||
130680117|NCT03952143|470455896|FG000|Treatment Period|Lost to Follow-up|0|||
130680118|NCT03952143|470455897|FG001|Treatment Period|Lost to Follow-up|2|||
130680119|NCT03952143|470455898|FG002|Treatment Period|Lost to Follow-up|0|||
130680120|NCT03952143|470455896|FG000|Treatment Period|Physician Decision|0|||
130680121|NCT03952143|470455897|FG001|Treatment Period|Physician Decision|0|||
130680122|NCT03952143|470455898|FG002|Treatment Period|Physician Decision|2|||
130680123|NCT03952143|470455896|FG000|Treatment Period|Protocol Violation|0|||
130680124|NCT03952143|470455897|FG001|Treatment Period|Protocol Violation|0|||
130680125|NCT03952143|470455898|FG002|Treatment Period|Protocol Violation|1|||
130680126|NCT03952143|470455896|FG000|Treatment Period|Withdrawal by Subject|0|||
130680127|NCT03952143|470455897|FG001|Treatment Period|Withdrawal by Subject|5|||
130680128|NCT03952143|470455898|FG002|Treatment Period|Withdrawal by Subject|26|||
130680129|NCT03952143|470455896|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
130680130|NCT03952143|470455897|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
130680131|NCT03952143|470455898|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
130680132|NCT03952143|470455896|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130680133|NCT03952143|470455897|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130680134|NCT03952143|470455898|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
130346797|NCT02217527|469240263|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
130346798|NCT01878149|469240264|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
130346799|NCT01878149|469240265|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130346800|NCT00502203|469240273|FG000|Overall Study|Inevaluable|1|||
130346801|NCT02241889|469240276|FG000|Overall Study|device issues|0|||
130346802|NCT02241889|469240277|FG001|Overall Study|device issues|0|||
130680135|NCT00760266|470455902|FG000|Overall Study|Adverse Event|13|||
130680136|NCT00760266|470455903|FG001|Overall Study|Adverse Event|7|||
130680137|NCT00760266|470455902|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130680138|NCT00760266|470455903|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130680139|NCT00760266|470455902|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130680140|NCT00760266|470455903|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130680141|NCT00760266|470455902|FG000|Overall Study|Lack of Efficacy|2|||
130680142|NCT00760266|470455903|FG001|Overall Study|Lack of Efficacy|2|||
130680143|NCT00760266|470455902|FG000|Overall Study|Protocol deviation|2|||
130680144|NCT00760266|470455903|FG001|Overall Study|Protocol deviation|4|||
130680145|NCT00760266|470455902|FG000|Overall Study|Patient withdrew consent|3|||
130680146|NCT00760266|470455903|FG001|Overall Study|Patient withdrew consent|3|||
130680147|NCT00760266|470455902|FG000|Overall Study|Lost to Follow-up|2|||
130680148|NCT00760266|470455903|FG001|Overall Study|Lost to Follow-up|1|||
130680149|NCT00760266|470455902|FG000|Overall Study|Administrative Problems|0|||
130680150|NCT00760266|470455903|FG001|Overall Study|Administrative Problems|1|||
130680151|NCT01273181|470455904|FG000|Phase I, Dose 1|Study termination|1|||
130680152|NCT01273181|470455905|FG001|Phase I, Dose 1|Study termination|0|||
130680153|NCT01273181|470455906|FG002|Phase I, Dose 1|Study termination|0|||
130680154|NCT01273181|470455907|FG003|Phase I, Dose 1|Study termination|0|||
130680155|NCT01273181|470455904|FG000|Phase I, Dose 2|Death during treatment|0|||
130680156|NCT01273181|470455905|FG001|Phase I, Dose 2|Death during treatment|1|||
130680157|NCT01273181|470455906|FG002|Phase I, Dose 2|Death during treatment|0|||
130680158|NCT01273181|470455907|FG003|Phase I, Dose 2|Death during treatment|0|||
130680159|NCT01273181|470455904|FG000|Phase 2, Dose 1|Study termination|0|||
130680160|NCT01273181|470455905|FG001|Phase 2, Dose 1|Study termination|0|||
130680161|NCT01273181|470455906|FG002|Phase 2, Dose 1|Study termination|1|||
130680162|NCT01273181|470455907|FG003|Phase 2, Dose 1|Study termination|0|||
130680163|NCT01273181|470455904|FG000|Phase 2, Dose 2|Death during treatment|0|||
130680164|NCT01273181|470455905|FG001|Phase 2, Dose 2|Death during treatment|0|||
130680165|NCT01273181|470455906|FG002|Phase 2, Dose 2|Death during treatment|0|||
130680166|NCT01273181|470455907|FG003|Phase 2, Dose 2|Death during treatment|1|||
130680167|NCT04638153|470455908|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130680168|NCT04638153|470455909|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130680169|NCT04638153|470455910|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130680170|NCT04638153|470455908|FG000|Overall Study|Study terminated by sponsor|4|||
130680171|NCT04638153|470455909|FG001|Overall Study|Study terminated by sponsor|2|||
130680172|NCT04638153|470455910|FG002|Overall Study|Study terminated by sponsor|14|||
130680173|NCT00874237|470455915|FG000|Overall Study|Physician Decision|0|||
130680174|NCT00874237|470455916|FG001|Overall Study|Physician Decision|1|||
130680175|NCT00874237|470455917|FG002|Overall Study|Physician Decision|0|||
130680176|NCT00874237|470455918|FG003|Overall Study|Physician Decision|0|||
130680177|NCT00874237|470455919|FG004|Overall Study|Physician Decision|0|||
130680178|NCT00874237|470455920|FG005|Overall Study|Physician Decision|0|||
130680179|NCT00874237|470455915|FG000|Overall Study|Withdrawal by Subject|0|||
130680180|NCT00874237|470455916|FG001|Overall Study|Withdrawal by Subject|0|||
130680181|NCT00874237|470455917|FG002|Overall Study|Withdrawal by Subject|1|||
130680182|NCT00874237|470455918|FG003|Overall Study|Withdrawal by Subject|0|||
130680183|NCT00874237|470455919|FG004|Overall Study|Withdrawal by Subject|0|||
130346803|NCT02241889|469240278|FG002|Overall Study|device issues|1|||
130346804|NCT02241889|469240279|FG003|Overall Study|device issues|0|||
130346805|NCT02241889|469240280|FG004|Overall Study|device issues|0|||
130346806|NCT02241889|469240281|FG005|Overall Study|device issues|0|||
130346807|NCT02241889|469240276|FG000|Overall Study|Withdrawal by Subject|0|||
130346808|NCT02241889|469240277|FG001|Overall Study|Withdrawal by Subject|0|||
130346809|NCT02241889|469240278|FG002|Overall Study|Withdrawal by Subject|0|||
130346810|NCT02241889|469240279|FG003|Overall Study|Withdrawal by Subject|0|||
130346811|NCT02241889|469240280|FG004|Overall Study|Withdrawal by Subject|0|||
130346812|NCT02241889|469240281|FG005|Overall Study|Withdrawal by Subject|1|||
130346813|NCT03836001|469240282|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
130346814|NCT03836001|469240283|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
130346815|NCT03836001|469240284|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
130346816|NCT03836001|469240282|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
130346817|NCT03836001|469240283|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
130346818|NCT03836001|469240284|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
130346819|NCT03836001|469240282|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130346820|NCT03836001|469240283|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130346821|NCT03836001|469240284|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
130346822|NCT03836001|469240282|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130346823|NCT03836001|469240283|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130346824|NCT03836001|469240284|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
130346825|NCT03353740|469240296|FG000|Overall Study|Images for these participants not viable|52|||
130346826|NCT01395784|469240297|FG000|Overall Study|Lost to Follow-up|7|||
130346827|NCT01395784|469240297|FG000|Overall Study|Withdrawal by Subject|3|||
130346828|NCT01395784|469240297|FG000|Overall Study|Physician Decision|5|||
130346829|NCT04268823|469240298|FG000|Overall Study|Adverse Event|1|||
130346830|NCT04268823|469240299|FG001|Overall Study|Adverse Event|0|||
130346831|NCT04268823|469240298|FG000|Overall Study|Participant Decision|1|||
130346832|NCT04268823|469240299|FG001|Overall Study|Participant Decision|0|||
130346833|NCT02519855|469241793|FG000|Overall Study|Adverse Event|0|||
130346834|NCT02519855|469241794|FG001|Overall Study|Adverse Event|1|||
130346835|NCT02519855|469241793|FG000|Overall Study|Lost to Follow-up|3|||
130346836|NCT02519855|469241794|FG001|Overall Study|Lost to Follow-up|3|||
130346837|NCT00003830|469241808|FG000|Overall Study|No follow up data|3|||
130346838|NCT00003830|469241809|FG001|Overall Study|No follow up data|0|||
130346839|NCT00003830|469241808|FG000|Overall Study|Sentinel node positive patients|829|||
130346840|NCT00003830|469241809|FG001|Overall Study|Sentinel node positive patients|793|||
130680184|NCT00874237|470455920|FG005|Overall Study|Withdrawal by Subject|0|||
130680185|NCT03912337|470455921|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130680186|NCT03912337|470455922|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130680187|NCT03912337|470455921|FG000|Overall Study|Lost to Follow-up|1|||
130680188|NCT03912337|470455922|FG001|Overall Study|Lost to Follow-up|1|||
130680189|NCT03752528|470455923|FG000|Part A|Lost to Follow-up|1|||
130680190|NCT03752528|470455923|FG000|Part A|Protocol Violation|1|||
130435931|NCT02669095|469558485|FG000|Overall Study|Torn Lens|0|||
130435932|NCT02669095|469558486|FG001|Overall Study|Torn Lens|1|||
130435933|NCT02669095|469558485|FG000|Overall Study|Visit 5 assessments not completed|0|||
130435934|NCT02669095|469558486|FG001|Overall Study|Visit 5 assessments not completed|1|||
130435935|NCT00926003|469558487|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
130435936|NCT00926003|469558488|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
130435937|NCT00926003|469558489|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
130435938|NCT00926003|469558487|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
130435939|NCT00926003|469558488|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
130435940|NCT00926003|469558489|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
130435941|NCT01396317|469558490|FG000|Overall Study|Adverse Event|1|||
130435942|NCT01396317|469558491|FG001|Overall Study|Adverse Event|0|||
130435943|NCT02294474|469558492|FG000|Overall Study|Adverse Event|7|||
130435944|NCT02294474|469558493|FG001|Overall Study|Adverse Event|7|||
130435945|NCT02294474|469558492|FG000|Overall Study|Lack of Efficacy|2|||
130435946|NCT02294474|469558493|FG001|Overall Study|Lack of Efficacy|1|||
130435947|NCT02294474|469558492|FG000|Overall Study|Protocol Violation|4|||
130435948|NCT02294474|469558493|FG001|Overall Study|Protocol Violation|2|||
130435949|NCT02294474|469558492|FG000|Overall Study|Other than specified above|12|||
130435950|NCT02294474|469558493|FG001|Overall Study|Other than specified above|12|||
130435951|NCT05200936|469558495|FG000|Overall Study|Withdrawal by Subject|2|||
130435952|NCT05200936|469558496|FG001|Overall Study|Withdrawal by Subject|2|||
130435953|NCT05200936|469558495|FG000|Overall Study|Lost to Follow-up|2|||
130435954|NCT05200936|469558496|FG001|Overall Study|Lost to Follow-up|0|||
130435955|NCT05200936|469558495|FG000|Overall Study|Pregnancy|0|||
130435956|NCT05200936|469558496|FG001|Overall Study|Pregnancy|1|||
130435957|NCT03443713|469558497|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
130435958|NCT03443713|469558498|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
130435959|NCT03443713|469558499|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
130435960|NCT02944656|469558501|FG000|Overall Study|No longer eligible|3|||
130435961|NCT02944656|469558502|FG001|Overall Study|No longer eligible|0|||
130435962|NCT02944656|469558501|FG000|Overall Study|Lost to Follow-up|7|||
130435963|NCT02944656|469558502|FG001|Overall Study|Lost to Follow-up|10|||
130680191|NCT03752528|470455923|FG000|Part B|Protocol Violation|1|||
130680192|NCT03752528|470455923|FG000|Part B|Study terminated by sponsor|3|||
130680193|NCT00537030|470455924|FG000|Overall Study|Physician Decision|2|||
130680194|NCT00537030|470455924|FG000|Overall Study|Withdrawal by Subject|2|||
130680195|NCT00537030|470455924|FG000|Overall Study|≥ Grade 2 allergy|7|||
130680196|NCT00537030|470455924|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
130680197|NCT00537030|470455924|FG000|Overall Study|Ineligible|2|||
130680198|NCT00537030|470455924|FG000|Overall Study|Inevaluable|2|||
130680199|NCT02458469|470455925|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680200|NCT02458469|470455926|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130435964|NCT05879198|469558505|FG000|Overall Study|Lost to Follow-up|1|||
130435965|NCT02073097|469558506|FG000|Overall Study|Adverse Event|0|||
130435966|NCT02073097|469558507|FG001|Overall Study|Adverse Event|0|||
130435967|NCT02073097|469558508|FG002|Overall Study|Adverse Event|0|||
130435968|NCT02073097|469558509|FG003|Overall Study|Adverse Event|0|||
130435969|NCT02073097|469558510|FG004|Overall Study|Adverse Event|0|||
130435970|NCT02073097|469558511|FG005|Overall Study|Adverse Event|0|||
130435971|NCT02073097|469558512|FG006|Overall Study|Adverse Event|0|||
130680201|NCT02458469|470455927|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130680202|NCT02458469|470455928|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680203|NCT02458469|470455929|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680204|NCT02458469|470455930|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680205|NCT02458469|470455925|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
130680206|NCT02458469|470455926|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
130680207|NCT02458469|470455927|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
130680208|NCT02458469|470455928|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
130435972|NCT02073097|469558513|FG007|Overall Study|Adverse Event|2|||
130435973|NCT02073097|469558506|FG000|Overall Study|Withdrawal by Subject|0|||
130435974|NCT02073097|469558507|FG001|Overall Study|Withdrawal by Subject|0|||
130435975|NCT02073097|469558508|FG002|Overall Study|Withdrawal by Subject|0|||
130435976|NCT02073097|469558509|FG003|Overall Study|Withdrawal by Subject|0|||
130435977|NCT02073097|469558510|FG004|Overall Study|Withdrawal by Subject|0|||
130435978|NCT02073097|469558511|FG005|Overall Study|Withdrawal by Subject|0|||
130435979|NCT02073097|469558512|FG006|Overall Study|Withdrawal by Subject|0|||
130435980|NCT02073097|469558513|FG007|Overall Study|Withdrawal by Subject|2|||
130435981|NCT02073097|469558506|FG000|Overall Study|Death|0|||
130680209|NCT02458469|470455929|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
130680210|NCT02458469|470455930|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
130680211|NCT02458469|470455925|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680212|NCT02458469|470455926|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680213|NCT02458469|470455927|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680214|NCT02458469|470455928|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680215|NCT02458469|470455929|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680216|NCT02458469|470455930|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
130680217|NCT03561883|470455931|FG000|Overall Study|Adverse Event|10|||
130680218|NCT03561883|470455932|FG001|Overall Study|Adverse Event|13|||
130680219|NCT03561883|470455931|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130680220|NCT03561883|470455932|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130680221|NCT03561883|470455931|FG000|Overall Study|Protocol Violation|2|||
130680222|NCT03561883|470455932|FG001|Overall Study|Protocol Violation|3|||
130680223|NCT03561883|470455931|FG000|Overall Study|Withdrawal by Subject|14|||
130680224|NCT03561883|470455932|FG001|Overall Study|Withdrawal by Subject|6|||
130680225|NCT03561883|470455931|FG000|Overall Study|Lost to Follow-up|2|||
130680226|NCT03561883|470455932|FG001|Overall Study|Lost to Follow-up|6|||
130680227|NCT03561883|470455931|FG000|Overall Study|Study Terminated by Sponsor|12|||
130680228|NCT03561883|470455932|FG001|Overall Study|Study Terminated by Sponsor|11|||
130680229|NCT03561883|470455931|FG000|Overall Study|Physician Decision|1|||
130346841|NCT03739242|469241813|FG000|Overall Study|Withdrawal by Subject|1|||
130346842|NCT03739242|469241814|FG001|Overall Study|Withdrawal by Subject|1|||
130346843|NCT03739242|469241813|FG000|Overall Study|Protocol Violation|0|||
130346844|NCT03739242|469241814|FG001|Overall Study|Protocol Violation|1|||
130346845|NCT01992159|469241815|FG000|Overall Study|Withdrawal by Subject|4|||
130346846|NCT01992159|469241816|FG001|Overall Study|Withdrawal by Subject|7|||
130346847|NCT01992159|469241817|FG002|Overall Study|Withdrawal by Subject|0|||
130346848|NCT01992159|469241818|FG003|Overall Study|Withdrawal by Subject|3|||
130346849|NCT01992159|469241815|FG000|Overall Study|Adverse Event|0|||
130346850|NCT01992159|469241816|FG001|Overall Study|Adverse Event|1|||
130346851|NCT01992159|469241817|FG002|Overall Study|Adverse Event|0|||
130346852|NCT01992159|469241818|FG003|Overall Study|Adverse Event|1|||
130346853|NCT01992159|469241815|FG000|Overall Study|Death|0|||
130346854|NCT01992159|469241816|FG001|Overall Study|Death|0|||
130346855|NCT01992159|469241817|FG002|Overall Study|Death|1|||
130346856|NCT01992159|469241818|FG003|Overall Study|Death|0|||
130346857|NCT01205581|469241819|FG000|Overall Study|Withdrawal by Subject|1|||
130346858|NCT01205581|469241820|FG001|Overall Study|Withdrawal by Subject|0|||
130346859|NCT01205581|469241821|FG002|Overall Study|Withdrawal by Subject|0|||
130346860|NCT01205581|469241822|FG003|Overall Study|Withdrawal by Subject|0|||
130346861|NCT01205581|469241823|FG004|Overall Study|Withdrawal by Subject|0|||
130346862|NCT01205581|469241824|FG005|Overall Study|Withdrawal by Subject|0|||
130346863|NCT02278471|469241825|FG000|Overall Study|Lost to Follow-up|6|||
130346864|NCT02278471|469241826|FG001|Overall Study|Lost to Follow-up|15|||
130346865|NCT02278471|469241825|FG000|Overall Study|Death|2|||
130346866|NCT02278471|469241826|FG001|Overall Study|Death|2|||
130346867|NCT02278471|469241825|FG000|Overall Study|Withdrawal by Subject|0|||
130346868|NCT02278471|469241826|FG001|Overall Study|Withdrawal by Subject|3|||
130346869|NCT00640835|469241827|FG000|Overall Study|Adverse Event|5|||
130346870|NCT00640835|469241828|FG001|Overall Study|Adverse Event|3|||
130346871|NCT00640835|469241827|FG000|Overall Study|Withdrawal by Subject|12|||
130346872|NCT00640835|469241828|FG001|Overall Study|Withdrawal by Subject|14|||
130346873|NCT00640835|469241827|FG000|Overall Study|Physician Decision|10|||
130346874|NCT00640835|469241828|FG001|Overall Study|Physician Decision|14|||
130346875|NCT00640835|469241827|FG000|Overall Study|Sponsor's Decision|11|||
130346876|NCT00640835|469241828|FG001|Overall Study|Sponsor's Decision|7|||
130346877|NCT00640835|469241827|FG000|Overall Study|Protocol Violation|2|||
130346878|NCT00640835|469241828|FG001|Overall Study|Protocol Violation|2|||
130346879|NCT00640835|469241827|FG000|Overall Study|Lost to Follow-up|17|||
130346880|NCT00640835|469241828|FG001|Overall Study|Lost to Follow-up|13|||
130346881|NCT00640835|469241827|FG000|Overall Study|Other Reason|19|||
130346882|NCT00640835|469241828|FG001|Overall Study|Other Reason|4|||
130346883|NCT04535167|469241831|FG000|Treatment|Adverse Event|0|||
130346884|NCT04535167|469241832|FG001|Treatment|Adverse Event|0|||
130346885|NCT04535167|469241833|FG002|Treatment|Adverse Event|0|||
130680230|NCT03561883|470455932|FG001|Overall Study|Physician Decision|0|||
130346886|NCT04535167|469241834|FG003|Treatment|Adverse Event|0|||
130346887|NCT04535167|469241835|FG004|Treatment|Adverse Event|0|||
130346888|NCT04535167|469241836|FG005|Treatment|Adverse Event|0|||
130680231|NCT03561883|470455931|FG000|Overall Study|Randomized by Mistake|1|||
130680232|NCT03561883|470455932|FG001|Overall Study|Randomized by Mistake|0|||
130346889|NCT04535167|469241837|FG006|Treatment|Adverse Event|1|||
130680233|NCT03561883|470455931|FG000|Overall Study|Other, Not Specified|3|||
130346890|NCT04535167|469241831|FG000|Follow-Up|Death|0|||
130346891|NCT04535167|469241832|FG001|Follow-Up|Death|0|||
130346892|NCT04535167|469241833|FG002|Follow-Up|Death|0|||
130346893|NCT04535167|469241834|FG003|Follow-Up|Death|0|||
130346894|NCT04535167|469241835|FG004|Follow-Up|Death|0|||
130680234|NCT03561883|470455932|FG001|Overall Study|Other, Not Specified|2|||
130680235|NCT06354270|470455933|FG000|Overall Study|Withdrawal by Subject|1|||
130680236|NCT06354270|470455934|FG001|Overall Study|Withdrawal by Subject|0|||
130680237|NCT01939197|470455935|FG000|Overall Study|Withdrawal by Subject|1|||
130680238|NCT01939197|470455936|FG001|Overall Study|Withdrawal by Subject|0|||
130680239|NCT01939197|470455937|FG002|Overall Study|Withdrawal by Subject|0|||
130680240|NCT01939197|470455938|FG003|Overall Study|Withdrawal by Subject|0|||
130680241|NCT01939197|470455939|FG004|Overall Study|Withdrawal by Subject|1|||
130680242|NCT01939197|470455940|FG005|Overall Study|Withdrawal by Subject|0|||
130680243|NCT01939197|470455941|FG006|Overall Study|Withdrawal by Subject|0|||
130680244|NCT01939197|470455935|FG000|Overall Study|Lost to Follow-up|0|||
130680245|NCT01939197|470455936|FG001|Overall Study|Lost to Follow-up|1|||
130680246|NCT01939197|470455937|FG002|Overall Study|Lost to Follow-up|0|||
130680247|NCT01939197|470455938|FG003|Overall Study|Lost to Follow-up|1|||
130680248|NCT01939197|470455939|FG004|Overall Study|Lost to Follow-up|3|||
130680249|NCT01939197|470455940|FG005|Overall Study|Lost to Follow-up|1|||
130680250|NCT01939197|470455941|FG006|Overall Study|Lost to Follow-up|2|||
130680251|NCT00745095|470455942|FG000|Overall Study|Declined to participate|1|||
130680252|NCT00745095|470455943|FG001|Overall Study|Declined to participate|0|||
130680253|NCT00745095|470455944|FG002|Overall Study|Declined to participate|0|||
130680254|NCT00745095|470455945|FG003|Overall Study|Declined to participate|0|||
130680255|NCT00745095|470455946|FG004|Overall Study|Declined to participate|92|||
130680256|NCT00745095|470455947|FG005|Overall Study|Declined to participate|95|||
130680257|NCT00745095|470455942|FG000|Overall Study|Ineligible due to GFR criteria|0|||
130680258|NCT00745095|470455943|FG001|Overall Study|Ineligible due to GFR criteria|2|||
130680259|NCT00745095|470455944|FG002|Overall Study|Ineligible due to GFR criteria|3|||
130680260|NCT00745095|470455945|FG003|Overall Study|Ineligible due to GFR criteria|3|||
130680261|NCT00745095|470455946|FG004|Overall Study|Ineligible due to GFR criteria|30|||
130680262|NCT00745095|470455947|FG005|Overall Study|Ineligible due to GFR criteria|28|||
130680263|NCT00958243|470455948|FG000|Overall Study|Withdrawal by Subject|0|||
130680264|NCT00958243|470455949|FG001|Overall Study|Withdrawal by Subject|1|||
130680265|NCT00958243|470455950|FG002|Overall Study|Withdrawal by Subject|3|||
130680266|NCT00958243|470455951|FG003|Overall Study|Withdrawal by Subject|1|||
130680267|NCT00958243|470455952|FG004|Overall Study|Withdrawal by Subject|1|||
130680268|NCT00958243|470455953|FG005|Overall Study|Withdrawal by Subject|5|||
130680269|NCT00958243|470455948|FG000|Overall Study|Lost to Follow-up|2|||
130680270|NCT00958243|470455949|FG001|Overall Study|Lost to Follow-up|5|||
130680271|NCT00958243|470455950|FG002|Overall Study|Lost to Follow-up|11|||
130680272|NCT00958243|470455951|FG003|Overall Study|Lost to Follow-up|2|||
130680273|NCT00958243|470455952|FG004|Overall Study|Lost to Follow-up|8|||
130680274|NCT00958243|470455953|FG005|Overall Study|Lost to Follow-up|5|||
130680275|NCT05277389|470455962|FG000|Overall Study|Lost to Follow-up|1|||
130680276|NCT05277389|470455963|FG001|Overall Study|Lost to Follow-up|4|||
130680277|NCT06096168|470455964|FG000|Overall Study|Death|30|||
130680278|NCT06096168|470455964|FG000|Overall Study|Revision|2|||
130680279|NCT03544138|470455967|FG000|Overall Study|Lost to Follow-up|29|||
130680280|NCT01766778|470455968|FG000|Overall Study|Adverse Event|4|||
130680281|NCT01766778|470455969|FG001|Overall Study|Adverse Event|4|||
130680282|NCT01766778|470455968|FG000|Overall Study|Withdrawal by Subject|1|||
130680283|NCT01766778|470455969|FG001|Overall Study|Withdrawal by Subject|0|||
130680284|NCT01478620|470455970|FG000|Overall Study|Lost to Follow-up|6|||
130680285|NCT01411332|470455973|FG000|Enrollment|Protocol Violation|0|||
130680286|NCT01411332|470455974|FG001|Enrollment|Protocol Violation|1|||
130680287|NCT01411332|470455973|FG000|Enrollment|Withdrawal by Subject|0|||
130680288|NCT01411332|470455974|FG001|Enrollment|Withdrawal by Subject|1|||
130680289|NCT01411332|470455973|FG000|Treatment|Lost to Follow-up|1|||
130680290|NCT01411332|470455974|FG001|Treatment|Lost to Follow-up|0|||
130680291|NCT04526210|470457204|FG000|Overall Study|Sponsor decision|7|||
130680292|NCT04526210|470457205|FG001|Overall Study|Sponsor decision|5|||
130680293|NCT04526210|470457204|FG000|Overall Study|Withdrawal by Subject|3|||
130680294|NCT04526210|470457205|FG001|Overall Study|Withdrawal by Subject|2|||
130680295|NCT02637232|470457206|FG000|Overall Study|Lost to Follow-up|42|||
130680296|NCT02637232|470457206|FG000|Overall Study|Adverse Event|11|||
130680297|NCT02637232|470457206|FG000|Overall Study|patient 's decision|2|||
130680298|NCT01781637|470457207|FG000|Overall Study|Adverse Event|1|||
130680299|NCT01781637|470457208|FG001|Overall Study|Adverse Event|0|||
130680300|NCT01781637|470457207|FG000|Overall Study|Lack of Efficacy|2|||
130680301|NCT01781637|470457208|FG001|Overall Study|Lack of Efficacy|6|||
130680302|NCT01781637|470457207|FG000|Overall Study|Withdrawal by Subject|1|||
130680303|NCT01781637|470457208|FG001|Overall Study|Withdrawal by Subject|0|||
130680304|NCT00090857|470457209|FG000|Overall Study|Lost to Follow-up|0|||
130680305|NCT00090857|470457210|FG001|Overall Study|Lost to Follow-up|1|||
130680306|NCT00090857|470457209|FG000|Overall Study|Withdrawal by Subject|2|||
130680307|NCT00090857|470457210|FG001|Overall Study|Withdrawal by Subject|0|||
130680308|NCT00090857|470457209|FG000|Overall Study|Adverse Event|2|||
130680309|NCT00090857|470457210|FG001|Overall Study|Adverse Event|2|||
130680310|NCT05097326|470457212|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
130435982|NCT02073097|469558507|FG001|Overall Study|Death|0|||
130435983|NCT02073097|469558508|FG002|Overall Study|Death|0|||
130435984|NCT02073097|469558509|FG003|Overall Study|Death|0|||
130435985|NCT02073097|469558510|FG004|Overall Study|Death|0|||
130435986|NCT02073097|469558511|FG005|Overall Study|Death|0|||
130435987|NCT02073097|469558512|FG006|Overall Study|Death|0|||
130435988|NCT02073097|469558513|FG007|Overall Study|Death|1|||
130435989|NCT02073097|469558506|FG000|Overall Study|Physician Decision|0|||
130435990|NCT02073097|469558507|FG001|Overall Study|Physician Decision|0|||
130435991|NCT02073097|469558508|FG002|Overall Study|Physician Decision|0|||
130435992|NCT02073097|469558509|FG003|Overall Study|Physician Decision|0|||
130435993|NCT02073097|469558510|FG004|Overall Study|Physician Decision|0|||
130435994|NCT02073097|469558511|FG005|Overall Study|Physician Decision|0|||
130435995|NCT02073097|469558512|FG006|Overall Study|Physician Decision|0|||
130435996|NCT02073097|469558513|FG007|Overall Study|Physician Decision|1|||
130435997|NCT02769065|469560499|FG000|Overall Study|Voluntary Withdrawal|1|||
130435998|NCT02769065|469560500|FG001|Overall Study|Voluntary Withdrawal|0|||
130435999|NCT02769065|469560501|FG002|Overall Study|Voluntary Withdrawal|0|||
130436000|NCT02769065|469560502|FG003|Overall Study|Voluntary Withdrawal|0|||
130680311|NCT05097326|470457213|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
130346895|NCT04535167|469241836|FG005|Follow-Up|Death|0|||
130346896|NCT04535167|469241837|FG006|Follow-Up|Death|1|||
130346897|NCT04535167|469241831|FG000|Follow-Up|Lost to Follow-up|0|||
130346898|NCT04535167|469241832|FG001|Follow-Up|Lost to Follow-up|0|||
130346899|NCT04535167|469241833|FG002|Follow-Up|Lost to Follow-up|0|||
130346900|NCT04535167|469241834|FG003|Follow-Up|Lost to Follow-up|1|||
130346901|NCT04535167|469241835|FG004|Follow-Up|Lost to Follow-up|0|||
130346902|NCT04535167|469241836|FG005|Follow-Up|Lost to Follow-up|0|||
130346903|NCT04535167|469241837|FG006|Follow-Up|Lost to Follow-up|0|||
130346904|NCT00978432|469241838|FG000|Overall Study|Withdrawal by Subject|0|||
130346905|NCT00978432|469241839|FG001|Overall Study|Withdrawal by Subject|0|||
130346906|NCT00978432|469241840|FG002|Overall Study|Withdrawal by Subject|1|||
130346907|NCT00978432|469241838|FG000|Overall Study|Lack of Efficacy|1|||
130346908|NCT00978432|469241839|FG001|Overall Study|Lack of Efficacy|1|||
130346909|NCT00978432|469241840|FG002|Overall Study|Lack of Efficacy|3|||
130346910|NCT00978432|469241838|FG000|Overall Study|Adverse Event|2|||
130346911|NCT00978432|469241839|FG001|Overall Study|Adverse Event|0|||
130346912|NCT00978432|469241840|FG002|Overall Study|Adverse Event|1|||
130346913|NCT04618770|469241841|FG000|Overall Study|Censored from Analysis|12|||
130346914|NCT04618770|469241841|FG000|Overall Study|Early Termination|25|||
130346915|NCT04972630|469241844|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130346916|NCT04972630|469241845|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130346917|NCT04972630|469241846|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
130346918|NCT00075270|469241849|FG000|Overall Study|Withdrawal by Subject|28|||
130346919|NCT00075270|469241850|FG001|Overall Study|Withdrawal by Subject|21|||
130346920|NCT00075270|469241849|FG000|Overall Study|Lost to Follow-up|25|||
130346921|NCT00075270|469241850|FG001|Overall Study|Lost to Follow-up|28|||
130346922|NCT00075270|469241849|FG000|Overall Study|Protocol Violation|0|||
130346923|NCT00075270|469241850|FG001|Overall Study|Protocol Violation|2|||
130346924|NCT00075270|469241849|FG000|Overall Study|Death|198|||
130346925|NCT00075270|469241850|FG001|Overall Study|Death|215|||
130346926|NCT00075270|469241849|FG000|Overall Study|Other/Unknown|9|||
130346927|NCT00075270|469241850|FG001|Overall Study|Other/Unknown|5|||
130346928|NCT00075270|469241849|FG000|Overall Study|Missing|26|||
130346929|NCT00075270|469241850|FG001|Overall Study|Missing|13|||
130346930|NCT02160002|469241851|FG000|Overall Study|Withdrawal by Subject|2|||
130346931|NCT02160002|469241852|FG001|Overall Study|Withdrawal by Subject|1|||
130346932|NCT04896229|469241853|FG000|Overall Study|Lost to Follow-up|113|||
130346933|NCT04896229|469241854|FG001|Overall Study|Lost to Follow-up|113|||
130346934|NCT04418661|469241855|FG000|Overall Study|Adverse Event|0|||
130346935|NCT04418661|469241856|FG001|Overall Study|Adverse Event|1|||
130346936|NCT04418661|469241857|FG002|Overall Study|Adverse Event|5|||
130436001|NCT02769065|469560503|FG004|Overall Study|Voluntary Withdrawal|0|||
130436002|NCT02769065|469560504|FG005|Overall Study|Voluntary Withdrawal|0|||
130436003|NCT02769065|469560505|FG006|Overall Study|Voluntary Withdrawal|0|||
130436004|NCT02769065|469560506|FG007|Overall Study|Voluntary Withdrawal|0|||
130680312|NCT02684344|470457215|FG000|Overall Study|Withdrawal by Subject|0|||
130346937|NCT04418661|469241858|FG003|Overall Study|Adverse Event|3|||
130346938|NCT04418661|469241859|FG004|Overall Study|Adverse Event|0|||
130346939|NCT04418661|469241860|FG005|Overall Study|Adverse Event|2|||
130346940|NCT04418661|469241855|FG000|Overall Study|Progressive disease|4|||
130436005|NCT02769065|469560507|FG008|Overall Study|Voluntary Withdrawal|0|||
130436006|NCT02769065|469560508|FG009|Overall Study|Voluntary Withdrawal|0|||
130436007|NCT02769065|469560509|FG010|Overall Study|Voluntary Withdrawal|0|||
130680313|NCT02684344|470457216|FG001|Overall Study|Withdrawal by Subject|1|||
130346941|NCT04418661|469241856|FG001|Overall Study|Progressive disease|11|||
130346942|NCT04418661|469241857|FG002|Overall Study|Progressive disease|6|||
130346943|NCT04418661|469241858|FG003|Overall Study|Progressive disease|11|||
130346944|NCT04418661|469241859|FG004|Overall Study|Progressive disease|1|||
130680314|NCT00560235|470457221|FG000|Phase 1|Discontinued|8|||
130680315|NCT00560235|470457222|FG001|Phase 1|Discontinued|0|||
130680316|NCT00560235|470457223|FG002|Phase 1|Discontinued|0|||
130680317|NCT00560235|470457221|FG000|Phase 1B|Discontinued|0|||
130680318|NCT00560235|470457222|FG001|Phase 1B|Discontinued|19|||
130680319|NCT00560235|470457223|FG002|Phase 1B|Discontinued|0|||
130680320|NCT00560235|470457221|FG000|Phase 2|Discontinued|0|||
130680321|NCT00560235|470457222|FG001|Phase 2|Discontinued|0|||
130680322|NCT00560235|470457223|FG002|Phase 2|Discontinued|96|||
130680323|NCT00560235|470457221|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
130680324|NCT00560235|470457222|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
130680325|NCT00560235|470457223|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
130680326|NCT01203878|470457227|FG000|Overall Study|Withdrawal by Subject|0|||
130680327|NCT01203878|470457228|FG001|Overall Study|Withdrawal by Subject|0|||
130680328|NCT01203878|470457229|FG002|Overall Study|Withdrawal by Subject|1|||
130680329|NCT01203878|470457227|FG000|Overall Study|Adverse Event|0|||
130680330|NCT01203878|470457228|FG001|Overall Study|Adverse Event|0|||
130680331|NCT01203878|470457229|FG002|Overall Study|Adverse Event|2|||
130680332|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
130680333|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
130680334|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
130680335|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
130680336|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
130680337|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
130680338|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
130680339|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130680340|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130680341|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
130680342|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680343|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
130680344|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680345|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
130680346|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680347|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
130680348|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130680349|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130680350|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130680351|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
130680352|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130680353|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
130680354|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
130680355|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
130680356|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
130680357|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
130680358|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
130680359|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
130680360|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680361|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680362|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680363|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
130680364|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
130680365|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
130680366|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130680367|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130680368|NCT04407806|470457233|FG000|Overall Study|Withdrawal by Subject|1|||
130680369|NCT04407806|470457234|FG001|Overall Study|Withdrawal by Subject|2|||
130680370|NCT02731157|470457235|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
130680371|NCT05150964|470457238|FG000|Overall Study|Lost to Follow-up|2|||
130680372|NCT01856309|470457239|FG000|Overall Study|Death|4|||
130680373|NCT01856309|470457240|FG001|Overall Study|Death|6|||
130680374|NCT01856309|470457241|FG002|Overall Study|Death|11|||
130680375|NCT01856309|470457242|FG003|Overall Study|Death|6|||
130680376|NCT01856309|470457239|FG000|Overall Study|Lost to Follow-up|6|||
130680377|NCT01856309|470457240|FG001|Overall Study|Lost to Follow-up|2|||
130680378|NCT01856309|470457241|FG002|Overall Study|Lost to Follow-up|4|||
130680379|NCT01856309|470457242|FG003|Overall Study|Lost to Follow-up|8|||
130680380|NCT01856309|470457239|FG000|Overall Study|Withdrawal by Subject|11|||
130680381|NCT01856309|470457240|FG001|Overall Study|Withdrawal by Subject|13|||
130680382|NCT01856309|470457241|FG002|Overall Study|Withdrawal by Subject|28|||
130680383|NCT01856309|470457242|FG003|Overall Study|Withdrawal by Subject|26|||
130680384|NCT01856309|470457239|FG000|Overall Study|Other|227|||
130680385|NCT01856309|470457240|FG001|Overall Study|Other|225|||
130680386|NCT01856309|470457241|FG002|Overall Study|Other|447|||
130680387|NCT01856309|470457242|FG003|Overall Study|Other|469|||
130680388|NCT01856309|470457239|FG000|Overall Study|Lack of Efficacy|14|||
130680389|NCT01856309|470457240|FG001|Overall Study|Lack of Efficacy|9|||
130680390|NCT01856309|470457241|FG002|Overall Study|Lack of Efficacy|40|||
130680391|NCT01856309|470457242|FG003|Overall Study|Lack of Efficacy|25|||
130680392|NCT01856309|470457239|FG000|Overall Study|Adverse Event|31|||
130680393|NCT01856309|470457240|FG001|Overall Study|Adverse Event|31|||
130680394|NCT01856309|470457241|FG002|Overall Study|Adverse Event|55|||
130680395|NCT01856309|470457242|FG003|Overall Study|Adverse Event|65|||
130680396|NCT01856309|470457239|FG000|Overall Study|Pregnancy|0|||
130680397|NCT01856309|470457240|FG001|Overall Study|Pregnancy|0|||
130680398|NCT01856309|470457241|FG002|Overall Study|Pregnancy|0|||
130680399|NCT01856309|470457242|FG003|Overall Study|Pregnancy|1|||
130680400|NCT01856309|470457239|FG000|Overall Study|Physician Decision|6|||
130680401|NCT01856309|470457240|FG001|Overall Study|Physician Decision|1|||
130680402|NCT01856309|470457241|FG002|Overall Study|Physician Decision|6|||
130680403|NCT01856309|470457242|FG003|Overall Study|Physician Decision|8|||
130680404|NCT01856309|470457239|FG000|Overall Study|Noncompliance With Study Drug|0|||
130680405|NCT01856309|470457240|FG001|Overall Study|Noncompliance With Study Drug|1|||
130680406|NCT01856309|470457241|FG002|Overall Study|Noncompliance With Study Drug|4|||
130680407|NCT01856309|470457242|FG003|Overall Study|Noncompliance With Study Drug|1|||
130680408|NCT03657160|470457243|FG000|Overall Study|Adverse Event|5|||
130680409|NCT03657160|470457244|FG001|Overall Study|Adverse Event|6|||
130436008|NCT02769065|469560510|FG011|Overall Study|Voluntary Withdrawal|0|||
130436009|NCT02769065|469560511|FG012|Overall Study|Voluntary Withdrawal|0|||
130436010|NCT02769065|469560512|FG013|Overall Study|Voluntary Withdrawal|0|||
130436011|NCT02769065|469560513|FG014|Overall Study|Voluntary Withdrawal|0|||
130436012|NCT02769065|469560514|FG015|Overall Study|Voluntary Withdrawal|0|||
130680410|NCT03657160|470457243|FG000|Overall Study|Protocol Deviation|3|||
130680411|NCT03657160|470457244|FG001|Overall Study|Protocol Deviation|0|||
130436013|NCT02769065|469560515|FG016|Overall Study|Voluntary Withdrawal|0|||
130436014|NCT02769065|469560516|FG017|Overall Study|Voluntary Withdrawal|0|||
130436015|NCT02769065|469560517|FG018|Overall Study|Voluntary Withdrawal|0|||
130436016|NCT02769065|469560518|FG019|Overall Study|Voluntary Withdrawal|0|||
130680412|NCT03657160|470457243|FG000|Overall Study|Withdrawal by Subject|18|||
130436017|NCT02769065|469560519|FG020|Overall Study|Voluntary Withdrawal|0|||
130436018|NCT02769065|469560520|FG021|Overall Study|Voluntary Withdrawal|0|||
130436019|NCT02769065|469560521|FG022|Overall Study|Voluntary Withdrawal|0|||
130436020|NCT02769065|469560522|FG023|Overall Study|Voluntary Withdrawal|0|||
130436021|NCT02769065|469560523|FG024|Overall Study|Voluntary Withdrawal|0|||
130436022|NCT02769065|469560524|FG025|Overall Study|Voluntary Withdrawal|0|||
130436023|NCT02769065|469560525|FG026|Overall Study|Voluntary Withdrawal|0|||
130436024|NCT02769065|469560526|FG027|Overall Study|Voluntary Withdrawal|0|||
130436025|NCT02769065|469560527|FG028|Overall Study|Voluntary Withdrawal|0|||
130436026|NCT02769065|469560528|FG029|Overall Study|Voluntary Withdrawal|0|||
130436027|NCT02769065|469560499|FG000|Overall Study|Reason Not Specified|0|||
130436028|NCT02769065|469560500|FG001|Overall Study|Reason Not Specified|0|||
130436029|NCT02769065|469560501|FG002|Overall Study|Reason Not Specified|0|||
130680413|NCT03657160|470457244|FG001|Overall Study|Withdrawal by Subject|16|||
130680414|NCT03657160|470457243|FG000|Overall Study|Site Termination|1|||
130680415|NCT03657160|470457244|FG001|Overall Study|Site Termination|0|||
130680416|NCT03657160|470457243|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
130680417|NCT03657160|470457244|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
130436030|NCT02769065|469560502|FG003|Overall Study|Reason Not Specified|0|||
130436031|NCT02769065|469560503|FG004|Overall Study|Reason Not Specified|0|||
130436032|NCT02769065|469560504|FG005|Overall Study|Reason Not Specified|0|||
130436033|NCT02769065|469560505|FG006|Overall Study|Reason Not Specified|1|||
130436034|NCT02769065|469560506|FG007|Overall Study|Reason Not Specified|0|||
130680418|NCT03657160|470457243|FG000|Overall Study|Death|33|||
130680419|NCT03657160|470457244|FG001|Overall Study|Death|26|||
130680420|NCT03657160|470457243|FG000|Overall Study|Death (COVID-19-Related)|1|||
130680421|NCT03657160|470457244|FG001|Overall Study|Death (COVID-19-Related)|0|||
130680422|NCT03657160|470457243|FG000|Overall Study|Reason Not Specified|5|||
130680423|NCT03657160|470457244|FG001|Overall Study|Reason Not Specified|5|||
130680424|NCT03657160|470457243|FG000|Overall Study|Other (COVID-19-Related)|0|||
130436035|NCT02769065|469560507|FG008|Overall Study|Reason Not Specified|0|||
130436036|NCT02769065|469560508|FG009|Overall Study|Reason Not Specified|0|||
130436037|NCT02769065|469560509|FG010|Overall Study|Reason Not Specified|0|||
130436038|NCT02769065|469560510|FG011|Overall Study|Reason Not Specified|0|||
130436039|NCT02769065|469560511|FG012|Overall Study|Reason Not Specified|0|||
130436040|NCT02769065|469560512|FG013|Overall Study|Reason Not Specified|0|||
130436041|NCT02769065|469560513|FG014|Overall Study|Reason Not Specified|0|||
130680425|NCT03657160|470457244|FG001|Overall Study|Other (COVID-19-Related)|1|||
130680426|NCT01434693|470457247|FG000|Overall Study|Adverse Event|1|||
130680427|NCT01434693|470457248|FG001|Overall Study|Adverse Event|0|||
130680428|NCT01434693|470457249|FG002|Overall Study|Adverse Event|0|||
130680429|NCT01434693|470457250|FG003|Overall Study|Adverse Event|0|||
130680430|NCT01434693|470457247|FG000|Overall Study|Withdrawal by Subject|1|||
130680431|NCT01434693|470457248|FG001|Overall Study|Withdrawal by Subject|0|||
130680432|NCT01434693|470457249|FG002|Overall Study|Withdrawal by Subject|1|||
130680433|NCT01434693|470457250|FG003|Overall Study|Withdrawal by Subject|1|||
130680434|NCT01434693|470457247|FG000|Overall Study|Lost to Follow-up|1|||
130680435|NCT01434693|470457248|FG001|Overall Study|Lost to Follow-up|0|||
130680436|NCT01434693|470457249|FG002|Overall Study|Lost to Follow-up|0|||
130680437|NCT01434693|470457250|FG003|Overall Study|Lost to Follow-up|0|||
130680438|NCT04006171|470457251|FG000|Overall Study|Withdrawal by Subject|8|||
130680439|NCT04006171|470457252|FG001|Overall Study|Withdrawal by Subject|7|||
130680440|NCT04006171|470457251|FG000|Overall Study|missing serum samples|2|||
130680441|NCT04006171|470457252|FG001|Overall Study|missing serum samples|2|||
130680442|NCT04006171|470457251|FG000|Overall Study|insufficient sample volume|2|||
130680443|NCT04006171|470457252|FG001|Overall Study|insufficient sample volume|3|||
130680444|NCT01440283|470457253|FG000|Overall Study|Death|3|||
130680445|NCT01440283|470457253|FG000|Overall Study|Withdrawal by Subject|4|||
130680446|NCT01440283|470457253|FG000|Overall Study|Physician Decision|3|||
130680447|NCT00440557|470457255|FG000|Overall Study|Withdrawal by Subject|10|||
130680448|NCT00440557|470457256|FG001|Overall Study|Withdrawal by Subject|5|||
130680449|NCT00440557|470457257|FG002|Overall Study|Withdrawal by Subject|11|||
130680450|NCT00440557|470457255|FG000|Overall Study|Lost to Follow-up|1|||
130680451|NCT00440557|470457256|FG001|Overall Study|Lost to Follow-up|2|||
130680452|NCT00440557|470457257|FG002|Overall Study|Lost to Follow-up|6|||
130680453|NCT00440557|470457255|FG000|Overall Study|Adverse Event|3|||
130680454|NCT00440557|470457256|FG001|Overall Study|Adverse Event|3|||
130680455|NCT00440557|470457257|FG002|Overall Study|Adverse Event|5|||
130680456|NCT00440557|470457255|FG000|Overall Study|Death|2|||
130680457|NCT00440557|470457256|FG001|Overall Study|Death|6|||
130680458|NCT00440557|470457257|FG002|Overall Study|Death|3|||
130436042|NCT02769065|469560514|FG015|Overall Study|Reason Not Specified|0|||
130436043|NCT02769065|469560515|FG016|Overall Study|Reason Not Specified|0|||
130436044|NCT02769065|469560516|FG017|Overall Study|Reason Not Specified|0|||
130436045|NCT02769065|469560517|FG018|Overall Study|Reason Not Specified|0|||
130436046|NCT02769065|469560518|FG019|Overall Study|Reason Not Specified|0|||
130436047|NCT02769065|469560519|FG020|Overall Study|Reason Not Specified|0|||
130436048|NCT02769065|469560520|FG021|Overall Study|Reason Not Specified|0|||
130436049|NCT02769065|469560521|FG022|Overall Study|Reason Not Specified|0|||
130436050|NCT02769065|469560522|FG023|Overall Study|Reason Not Specified|0|||
130436051|NCT02769065|469560523|FG024|Overall Study|Reason Not Specified|0|||
130436052|NCT02769065|469560524|FG025|Overall Study|Reason Not Specified|0|||
130436053|NCT02769065|469560525|FG026|Overall Study|Reason Not Specified|0|||
130436054|NCT02769065|469560526|FG027|Overall Study|Reason Not Specified|0|||
130436055|NCT02769065|469560527|FG028|Overall Study|Reason Not Specified|0|||
130436056|NCT02769065|469560528|FG029|Overall Study|Reason Not Specified|0|||
130436057|NCT02769065|469560499|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436058|NCT02769065|469560500|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436059|NCT02769065|469560501|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436060|NCT02769065|469560502|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436061|NCT02769065|469560503|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436062|NCT02769065|469560504|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436063|NCT02769065|469560505|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436064|NCT02769065|469560506|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436065|NCT02769065|469560507|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436066|NCT02769065|469560508|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436067|NCT02769065|469560509|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
130436068|NCT02769065|469560510|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436069|NCT02769065|469560511|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436070|NCT02769065|469560512|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436071|NCT02769065|469560513|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436072|NCT02769065|469560514|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436073|NCT02769065|469560515|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436074|NCT02769065|469560516|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436075|NCT02769065|469560517|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436076|NCT02769065|469560518|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436077|NCT02769065|469560519|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436078|NCT02769065|469560520|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
130680459|NCT00440557|470457255|FG000|Overall Study|Began Dialysis|4|||
130680460|NCT00440557|470457256|FG001|Overall Study|Began Dialysis|1|||
130680461|NCT00440557|470457257|FG002|Overall Study|Began Dialysis|4|||
130680462|NCT00440557|470457255|FG000|Overall Study|Principal Investigator decision|0|||
130680463|NCT00440557|470457256|FG001|Overall Study|Principal Investigator decision|3|||
130680464|NCT00440557|470457257|FG002|Overall Study|Principal Investigator decision|1|||
130680465|NCT00440557|470457255|FG000|Overall Study|Patient moved|1|||
130680466|NCT00440557|470457256|FG001|Overall Study|Patient moved|2|||
130680467|NCT00440557|470457257|FG002|Overall Study|Patient moved|1|||
130680468|NCT00440557|470457255|FG000|Overall Study|Principal Investigator's office closed|3|||
130680469|NCT00440557|470457256|FG001|Overall Study|Principal Investigator's office closed|6|||
130346945|NCT04418661|469241860|FG005|Overall Study|Progressive disease|12|||
130346946|NCT04418661|469241855|FG000|Overall Study|Withdrawal by Subject|0|||
130346947|NCT04418661|469241856|FG001|Overall Study|Withdrawal by Subject|1|||
130346948|NCT04418661|469241857|FG002|Overall Study|Withdrawal by Subject|0|||
130346949|NCT04418661|469241858|FG003|Overall Study|Withdrawal by Subject|1|||
130346950|NCT04418661|469241859|FG004|Overall Study|Withdrawal by Subject|0|||
130346951|NCT04418661|469241860|FG005|Overall Study|Withdrawal by Subject|0|||
130346952|NCT04418661|469241855|FG000|Overall Study|Other|0|||
130346953|NCT04418661|469241856|FG001|Overall Study|Other|0|||
130346954|NCT04418661|469241857|FG002|Overall Study|Other|1|||
130346955|NCT04418661|469241858|FG003|Overall Study|Other|3|||
130346956|NCT04418661|469241859|FG004|Overall Study|Other|0|||
130346957|NCT04418661|469241860|FG005|Overall Study|Other|1|||
130346958|NCT00046891|469241863|FG000|Overall Study|Cancels|5|||
130346959|NCT00046891|469241864|FG001|Overall Study|Cancels|9|||
130346960|NCT00046891|469241863|FG000|Overall Study|Ineligible|1|||
130346961|NCT00046891|469241864|FG001|Overall Study|Ineligible|1|||
130346962|NCT00046891|469241863|FG000|Overall Study|Withdrawal by Subject|18|||
130346963|NCT00046891|469241864|FG001|Overall Study|Withdrawal by Subject|15|||
130346964|NCT00046891|469241863|FG000|Overall Study|Adverse Event|5|||
130346965|NCT00046891|469241864|FG001|Overall Study|Adverse Event|5|||
130346966|NCT02496676|469241865|FG000|Phase 1 - Period 1|Adverse Event|0|||
130346967|NCT02496676|469241866|FG001|Phase 1 - Period 1|Adverse Event|1|||
130346968|NCT02496676|469241865|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
130346969|NCT02496676|469241866|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
130346970|NCT04381988|469241877|FG000|Overall Study|The study was terminated|4|||
130346971|NCT04381988|469241878|FG001|Overall Study|The study was terminated|0|||
130346972|NCT01107379|469241879|FG000|Overall Study|Withdrawal by Subject|18|||
130346973|NCT01107379|469241879|FG000|Overall Study|Lost to Follow-up|3|||
130346974|NCT00609362|469241880|FG000|Overall Study|Withdrawal by Subject|2|||
130346975|NCT00609362|469241881|FG001|Overall Study|Withdrawal by Subject|1|||
130346976|NCT00609362|469241880|FG000|Overall Study|Adverse Event|1|||
130346977|NCT00609362|469241881|FG001|Overall Study|Adverse Event|0|||
130346978|NCT04559529|469241882|FG000|First Intervention (1 Day)|Adverse Event|0|||
130346979|NCT04559529|469241883|FG001|First Intervention (1 Day)|Adverse Event|0|||
130346980|NCT04559529|469241884|FG002|First Intervention (1 Day)|Adverse Event|0|||
130346981|NCT04559529|469241885|FG003|First Intervention (1 Day)|Adverse Event|1|||
130346982|NCT04559529|469241882|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346983|NCT04559529|469241883|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346984|NCT04559529|469241884|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
130346985|NCT04559529|469241885|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346986|NCT04559529|469241882|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346987|NCT04559529|469241883|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346988|NCT04559529|469241884|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
130346989|NCT04559529|469241885|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346990|NCT01009281|469241886|FG000|Overall Study|Administrative problems|7|||
130346991|NCT00548405|469241887|FG000|Overall Study|Adverse Event|6|||
130346992|NCT00548405|469241888|FG001|Overall Study|Adverse Event|2|||
130346993|NCT00548405|469241889|FG002|Overall Study|Adverse Event|0|||
130346994|NCT00548405|469241887|FG000|Overall Study|Lack of Efficacy|6|||
130680470|NCT00440557|470457257|FG002|Overall Study|Principal Investigator's office closed|4|||
130680471|NCT00440557|470457255|FG000|Overall Study|Patient transferred to nursing home|0|||
130680472|NCT00440557|470457256|FG001|Overall Study|Patient transferred to nursing home|1|||
130680473|NCT00440557|470457257|FG002|Overall Study|Patient transferred to nursing home|0|||
130680474|NCT00440557|470457255|FG000|Overall Study|Patient had surgery|1|||
130680475|NCT00440557|470457256|FG001|Overall Study|Patient had surgery|0|||
130680476|NCT00440557|470457257|FG002|Overall Study|Patient had surgery|0|||
130680477|NCT00669942|470457259|FG000|Parts 2 and 3|Adverse Event|0|||
130680478|NCT00669942|470457260|FG001|Parts 2 and 3|Adverse Event|0|||
130680479|NCT00669942|470457261|FG002|Parts 2 and 3|Adverse Event|0|||
130680480|NCT00669942|470457262|FG003|Parts 2 and 3|Adverse Event|0|||
130680481|NCT00669942|470457263|FG004|Parts 2 and 3|Adverse Event|0|||
130680482|NCT00669942|470457264|FG005|Parts 2 and 3|Adverse Event|0|||
130346995|NCT00548405|469241888|FG001|Overall Study|Lack of Efficacy|0|||
130346996|NCT00548405|469241889|FG002|Overall Study|Lack of Efficacy|0|||
130346997|NCT00548405|469241887|FG000|Overall Study|Physician Decision|3|||
130346998|NCT00548405|469241888|FG001|Overall Study|Physician Decision|4|||
130346999|NCT00548405|469241889|FG002|Overall Study|Physician Decision|1|||
130347000|NCT00548405|469241887|FG000|Overall Study|Pregnancy|1|||
130680483|NCT00669942|470457265|FG006|Parts 2 and 3|Adverse Event|0|||
130680484|NCT00669942|470457266|FG007|Parts 2 and 3|Adverse Event|2|||
130680485|NCT00669942|470457267|FG008|Parts 2 and 3|Adverse Event|1|||
130680486|NCT00669942|470457268|FG009|Parts 2 and 3|Adverse Event|0|||
130347001|NCT00548405|469241888|FG001|Overall Study|Pregnancy|0|||
130347002|NCT00548405|469241889|FG002|Overall Study|Pregnancy|0|||
130347003|NCT00548405|469241887|FG000|Overall Study|Protocol Violation|1|||
130347004|NCT00548405|469241888|FG001|Overall Study|Protocol Violation|0|||
130347005|NCT00548405|469241889|FG002|Overall Study|Protocol Violation|0|||
130680487|NCT00669942|470457269|FG010|Parts 2 and 3|Adverse Event|0|||
130680488|NCT00669942|470457270|FG011|Parts 2 and 3|Adverse Event|0|||
130680489|NCT00669942|470457259|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
130680490|NCT00669942|470457260|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
130680491|NCT00669942|470457261|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
130680492|NCT00669942|470457262|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
130680493|NCT00669942|470457263|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
130680494|NCT00669942|470457264|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
130680495|NCT00669942|470457265|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
130680496|NCT00669942|470457266|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
130680497|NCT00669942|470457267|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
130680498|NCT00669942|470457268|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
130680499|NCT00669942|470457269|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
130680500|NCT00669942|470457270|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
130680501|NCT00669942|470457259|FG000|Parts 2 and 3|Protocol Violation|0|||
130680502|NCT00669942|470457260|FG001|Parts 2 and 3|Protocol Violation|0|||
130680503|NCT00669942|470457261|FG002|Parts 2 and 3|Protocol Violation|0|||
130680504|NCT00669942|470457262|FG003|Parts 2 and 3|Protocol Violation|0|||
130680505|NCT00669942|470457263|FG004|Parts 2 and 3|Protocol Violation|0|||
130680506|NCT00669942|470457264|FG005|Parts 2 and 3|Protocol Violation|1|||
130680507|NCT00669942|470457265|FG006|Parts 2 and 3|Protocol Violation|0|||
130680508|NCT00669942|470457266|FG007|Parts 2 and 3|Protocol Violation|0|||
130680509|NCT00669942|470457267|FG008|Parts 2 and 3|Protocol Violation|0|||
130680510|NCT00669942|470457268|FG009|Parts 2 and 3|Protocol Violation|0|||
130680511|NCT00669942|470457269|FG010|Parts 2 and 3|Protocol Violation|0|||
130680512|NCT00669942|470457270|FG011|Parts 2 and 3|Protocol Violation|0|||
130680513|NCT00162123|470457283|FG000|Overall Study|Disease progression|27|||
130680514|NCT00162123|470457284|FG001|Overall Study|Disease progression|19|||
130680515|NCT00162123|470457285|FG002|Overall Study|Disease progression|10|||
130680516|NCT00162123|470457286|FG003|Overall Study|Disease progression|4|||
130680517|NCT00162123|470457287|FG004|Overall Study|Disease progression|8|||
130680518|NCT00162123|470457288|FG005|Overall Study|Disease progression|3|||
130680519|NCT00162123|470457289|FG006|Overall Study|Disease progression|1|||
130680520|NCT00162123|470457290|FG007|Overall Study|Disease progression|0|||
130680521|NCT00162123|470457283|FG000|Overall Study|Study drug toxicity|6|||
130680522|NCT00162123|470457284|FG001|Overall Study|Study drug toxicity|1|||
130347006|NCT00548405|469241887|FG000|Overall Study|Withdrawal by Subject|36|||
130347007|NCT00548405|469241888|FG001|Overall Study|Withdrawal by Subject|12|||
130347008|NCT00548405|469241889|FG002|Overall Study|Withdrawal by Subject|5|||
130347009|NCT00548405|469241887|FG000|Overall Study|Lost to Follow-up|1|||
130347010|NCT00548405|469241888|FG001|Overall Study|Lost to Follow-up|1|||
130347011|NCT00548405|469241889|FG002|Overall Study|Lost to Follow-up|2|||
130347012|NCT00548405|469241887|FG000|Overall Study|Death|0|||
130347013|NCT00548405|469241888|FG001|Overall Study|Death|1|||
130347014|NCT00548405|469241889|FG002|Overall Study|Death|1|||
130347015|NCT00548405|469241887|FG000|Overall Study|Sponsor decision|1|||
130347016|NCT00548405|469241888|FG001|Overall Study|Sponsor decision|0|||
130347017|NCT00548405|469241889|FG002|Overall Study|Sponsor decision|0|||
130347018|NCT00548405|469241887|FG000|Overall Study|Randomized but not treated|1|||
130347019|NCT00548405|469241888|FG001|Overall Study|Randomized but not treated|0|||
130347020|NCT00548405|469241889|FG002|Overall Study|Randomized but not treated|0|||
130347021|NCT02582684|469241891|FG000|Overall Study|Unable to contact subject/parent|4|||
130347022|NCT02582684|469241891|FG000|Overall Study|Subject not able to get to clinic|10|||
130347023|NCT02582684|469241891|FG000|Overall Study|Subject withdrew consent|1|||
130347024|NCT02582684|469241891|FG000|Overall Study|Found to be ineligible after enrollment|2|||
130347025|NCT03025035|469241892|FG000|Overall Study|Death|2|||
130347026|NCT03025035|469241892|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
130347027|NCT02048241|469241893|FG000|Overall Study|Withdrawal by Subject|0|||
130347028|NCT02048241|469241894|FG001|Overall Study|Withdrawal by Subject|1|||
130347029|NCT00402233|469241895|FG000|Overall Study|Adverse Event|1|||
130347030|NCT00402233|469241896|FG001|Overall Study|Adverse Event|7|||
130347031|NCT00402233|469241897|FG002|Overall Study|Adverse Event|9|||
130347032|NCT00402233|469241898|FG003|Overall Study|Adverse Event|9|||
130347033|NCT00402233|469241895|FG000|Overall Study|Protocol Violation|0|||
130347034|NCT00402233|469241896|FG001|Overall Study|Protocol Violation|1|||
130680523|NCT00162123|470457285|FG002|Overall Study|Study drug toxicity|5|||
130680524|NCT00162123|470457286|FG003|Overall Study|Study drug toxicity|0|||
130347035|NCT00402233|469241897|FG002|Overall Study|Protocol Violation|0|||
130347036|NCT00402233|469241898|FG003|Overall Study|Protocol Violation|0|||
130347037|NCT00402233|469241895|FG000|Overall Study|Withdrawal by Subject|2|||
130680525|NCT00162123|470457287|FG004|Overall Study|Study drug toxicity|4|||
130680526|NCT00162123|470457288|FG005|Overall Study|Study drug toxicity|1|||
130680527|NCT00162123|470457289|FG006|Overall Study|Study drug toxicity|1|||
130680528|NCT00162123|470457290|FG007|Overall Study|Study drug toxicity|0|||
130680529|NCT00162123|470457283|FG000|Overall Study|Death|3|||
130680530|NCT00162123|470457284|FG001|Overall Study|Death|3|||
130680531|NCT00162123|470457285|FG002|Overall Study|Death|1|||
130680532|NCT00162123|470457286|FG003|Overall Study|Death|1|||
130680533|NCT00162123|470457287|FG004|Overall Study|Death|1|||
130680534|NCT00162123|470457288|FG005|Overall Study|Death|1|||
130680535|NCT00162123|470457289|FG006|Overall Study|Death|0|||
130680536|NCT00162123|470457290|FG007|Overall Study|Death|0|||
130680537|NCT00162123|470457283|FG000|Overall Study|Withdrawal by Subject|2|||
130680538|NCT00162123|470457284|FG001|Overall Study|Withdrawal by Subject|0|||
130680539|NCT00162123|470457285|FG002|Overall Study|Withdrawal by Subject|2|||
130680540|NCT00162123|470457286|FG003|Overall Study|Withdrawal by Subject|1|||
130680541|NCT00162123|470457287|FG004|Overall Study|Withdrawal by Subject|1|||
130680542|NCT00162123|470457288|FG005|Overall Study|Withdrawal by Subject|2|||
130680543|NCT00162123|470457289|FG006|Overall Study|Withdrawal by Subject|1|||
130680544|NCT00162123|470457290|FG007|Overall Study|Withdrawal by Subject|0|||
130680545|NCT00162123|470457283|FG000|Overall Study|Deterioration without progression|2|||
130680546|NCT00162123|470457284|FG001|Overall Study|Deterioration without progression|2|||
130680547|NCT00162123|470457285|FG002|Overall Study|Deterioration without progression|3|||
130680548|NCT00162123|470457286|FG003|Overall Study|Deterioration without progression|0|||
130680549|NCT00162123|470457287|FG004|Overall Study|Deterioration without progression|1|||
130680550|NCT00162123|470457288|FG005|Overall Study|Deterioration without progression|0|||
130680551|NCT00162123|470457289|FG006|Overall Study|Deterioration without progression|0|||
130680552|NCT00162123|470457290|FG007|Overall Study|Deterioration without progression|0|||
130680553|NCT00162123|470457283|FG000|Overall Study|Adverse Event|1|||
130680554|NCT00162123|470457284|FG001|Overall Study|Adverse Event|2|||
130680555|NCT00162123|470457285|FG002|Overall Study|Adverse Event|0|||
130680556|NCT00162123|470457286|FG003|Overall Study|Adverse Event|2|||
130680557|NCT00162123|470457287|FG004|Overall Study|Adverse Event|1|||
130680558|NCT00162123|470457288|FG005|Overall Study|Adverse Event|0|||
130680559|NCT00162123|470457289|FG006|Overall Study|Adverse Event|0|||
130680560|NCT00162123|470457290|FG007|Overall Study|Adverse Event|0|||
130680561|NCT00162123|470457283|FG000|Overall Study|Not specified (before treatment)|2|||
130680562|NCT00162123|470457284|FG001|Overall Study|Not specified (before treatment)|0|||
130680563|NCT00162123|470457285|FG002|Overall Study|Not specified (before treatment)|0|||
130680564|NCT00162123|470457286|FG003|Overall Study|Not specified (before treatment)|0|||
130680565|NCT00162123|470457287|FG004|Overall Study|Not specified (before treatment)|12|||
130680566|NCT00162123|470457288|FG005|Overall Study|Not specified (before treatment)|1|||
130680567|NCT00162123|470457289|FG006|Overall Study|Not specified (before treatment)|0|||
130680568|NCT00162123|470457290|FG007|Overall Study|Not specified (before treatment)|0|||
130680569|NCT00162123|470457283|FG000|Overall Study|Not specified (after start of treatment)|0|||
130680570|NCT00162123|470457284|FG001|Overall Study|Not specified (after start of treatment)|0|||
130680571|NCT00162123|470457285|FG002|Overall Study|Not specified (after start of treatment)|0|||
130680572|NCT00162123|470457286|FG003|Overall Study|Not specified (after start of treatment)|0|||
130680573|NCT00162123|470457287|FG004|Overall Study|Not specified (after start of treatment)|3|||
130680574|NCT00162123|470457288|FG005|Overall Study|Not specified (after start of treatment)|0|||
130680575|NCT00162123|470457289|FG006|Overall Study|Not specified (after start of treatment)|0|||
130680576|NCT00162123|470457290|FG007|Overall Study|Not specified (after start of treatment)|0|||
130680577|NCT00162123|470457283|FG000|Overall Study|Physician Decision|1|||
130680578|NCT00162123|470457284|FG001|Overall Study|Physician Decision|2|||
130680579|NCT00162123|470457285|FG002|Overall Study|Physician Decision|0|||
130680580|NCT00162123|470457286|FG003|Overall Study|Physician Decision|0|||
130680581|NCT00162123|470457287|FG004|Overall Study|Physician Decision|0|||
130680582|NCT00162123|470457288|FG005|Overall Study|Physician Decision|1|||
130680583|NCT00162123|470457289|FG006|Overall Study|Physician Decision|1|||
130680584|NCT00162123|470457290|FG007|Overall Study|Physician Decision|0|||
130680585|NCT00162123|470457283|FG000|Overall Study|Tumor assessment only (not treated)|0|||
130680586|NCT00162123|470457284|FG001|Overall Study|Tumor assessment only (not treated)|0|||
130680587|NCT00162123|470457285|FG002|Overall Study|Tumor assessment only (not treated)|0|||
130680588|NCT00162123|470457286|FG003|Overall Study|Tumor assessment only (not treated)|0|||
130680589|NCT00162123|470457287|FG004|Overall Study|Tumor assessment only (not treated)|0|||
130680590|NCT00162123|470457288|FG005|Overall Study|Tumor assessment only (not treated)|0|||
130680591|NCT00162123|470457289|FG006|Overall Study|Tumor assessment only (not treated)|0|||
130680592|NCT00162123|470457290|FG007|Overall Study|Tumor assessment only (not treated)|1|||
130680593|NCT00162123|470457283|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
130680594|NCT00162123|470457284|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
130680595|NCT00162123|470457285|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
130680596|NCT00162123|470457286|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
130680597|NCT00162123|470457287|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
130680598|NCT00162123|470457288|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
130680599|NCT00162123|470457289|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
130680600|NCT00162123|470457290|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
130680601|NCT02016170|470457291|FG000|Overall Study|Adverse Event|1|||
130680602|NCT02016170|470457292|FG001|Overall Study|Adverse Event|1|||
130680603|NCT02016170|470457293|FG002|Overall Study|Adverse Event|0|||
130680604|NCT02016170|470457291|FG000|Overall Study|Protocol Violation|1|||
130680605|NCT02016170|470457292|FG001|Overall Study|Protocol Violation|0|||
130680606|NCT02016170|470457293|FG002|Overall Study|Protocol Violation|0|||
130680607|NCT02327130|470457294|FG000|Overall Study|Discharged in less than 5 days|5|||
130680608|NCT02327130|470457294|FG000|Overall Study|Physician Decision|2|||
130680609|NCT02327130|470457294|FG000|Overall Study|Unable to provide breath sample|1|||
130680610|NCT02327130|470457294|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
130680611|NCT02327130|470457294|FG000|Overall Study|Met exclusion criteria|3|||
130680612|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
130680613|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
130680614|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
130680615|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
130680616|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
130680617|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Death|1|||
130680618|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Death|2|||
130680619|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Death|2|||
130680620|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Death|2|||
130680621|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Death|1|||
130680622|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
130680623|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680624|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680625|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680626|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680627|NCT02343120|470457299|FG000|Part 2: Expansion|Sponsor decision|0|||
130680628|NCT02343120|470457300|FG001|Part 2: Expansion|Sponsor decision|0|||
130680629|NCT02343120|470457301|FG002|Part 2: Expansion|Sponsor decision|0|||
130680630|NCT02343120|470457302|FG003|Part 2: Expansion|Sponsor decision|165|||
130680631|NCT02343120|470457303|FG004|Part 2: Expansion|Sponsor decision|67|||
130680632|NCT02343120|470457299|FG000|Part 2: Expansion|Death|0|||
130680633|NCT02343120|470457300|FG001|Part 2: Expansion|Death|0|||
130680634|NCT02343120|470457301|FG002|Part 2: Expansion|Death|0|||
130680635|NCT02343120|470457302|FG003|Part 2: Expansion|Death|74|||
130680636|NCT02343120|470457303|FG004|Part 2: Expansion|Death|17|||
130680637|NCT02343120|470457299|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
130680638|NCT02343120|470457300|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
130680639|NCT02343120|470457301|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
130680640|NCT02343120|470457302|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
130680641|NCT02343120|470457303|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
130680642|NCT02343120|470457299|FG000|Part 2: Expansion|Lost to Follow-up|0|||
130680643|NCT02343120|470457300|FG001|Part 2: Expansion|Lost to Follow-up|0|||
130680644|NCT02343120|470457301|FG002|Part 2: Expansion|Lost to Follow-up|0|||
130680645|NCT02343120|470457302|FG003|Part 2: Expansion|Lost to Follow-up|5|||
130680646|NCT02343120|470457303|FG004|Part 2: Expansion|Lost to Follow-up|2|||
130680647|NCT02343120|470457299|FG000|Part 2: Expansion|Other|0|||
130680648|NCT02343120|470457300|FG001|Part 2: Expansion|Other|0|||
130680649|NCT02343120|470457301|FG002|Part 2: Expansion|Other|0|||
130680650|NCT02343120|470457302|FG003|Part 2: Expansion|Other|1|||
130680651|NCT02343120|470457303|FG004|Part 2: Expansion|Other|5|||
130680652|NCT02343120|470457299|FG000|Part 2: Expansion|Adverse Event|0|||
130680653|NCT02343120|470457300|FG001|Part 2: Expansion|Adverse Event|0|||
130680654|NCT02343120|470457301|FG002|Part 2: Expansion|Adverse Event|0|||
130680655|NCT02343120|470457302|FG003|Part 2: Expansion|Adverse Event|1|||
130680656|NCT02343120|470457303|FG004|Part 2: Expansion|Adverse Event|1|||
130680657|NCT02534493|470457306|FG000|Overall Study|Lost to Follow-up|1|||
130680658|NCT02534493|470457306|FG000|Overall Study|Withdrawal by Subject|1|||
130680659|NCT01104662|470457309|FG000|Overall Study|Adverse Event|2|||
130680660|NCT01104662|470457310|FG001|Overall Study|Adverse Event|2|||
130680661|NCT01104662|470457311|FG002|Overall Study|Adverse Event|0|||
130680662|NCT01104662|470457312|FG003|Overall Study|Adverse Event|1|||
130680663|NCT01104662|470457313|FG004|Overall Study|Adverse Event|1|||
130680664|NCT01104662|470457314|FG005|Overall Study|Adverse Event|1|||
130680665|NCT01104662|470457315|FG006|Overall Study|Adverse Event|0|||
130680666|NCT01104662|470457316|FG007|Overall Study|Adverse Event|0|||
130680667|NCT01104662|470457309|FG000|Overall Study|Clinical Failure|1|||
130680668|NCT01104662|470457310|FG001|Overall Study|Clinical Failure|0|||
130680669|NCT01104662|470457311|FG002|Overall Study|Clinical Failure|0|||
130680670|NCT01104662|470457312|FG003|Overall Study|Clinical Failure|0|||
130680671|NCT01104662|470457313|FG004|Overall Study|Clinical Failure|0|||
130347038|NCT00402233|469241896|FG001|Overall Study|Withdrawal by Subject|1|||
130347039|NCT00402233|469241897|FG002|Overall Study|Withdrawal by Subject|2|||
130347040|NCT00402233|469241898|FG003|Overall Study|Withdrawal by Subject|2|||
130347041|NCT00402233|469241895|FG000|Overall Study|Worsening of disease under study|2|||
130347042|NCT00402233|469241896|FG001|Overall Study|Worsening of disease under study|0|||
130347043|NCT00402233|469241897|FG002|Overall Study|Worsening of disease under study|0|||
130347044|NCT00402233|469241898|FG003|Overall Study|Worsening of disease under study|0|||
130347045|NCT00402233|469241895|FG000|Overall Study|Worsening of other pre-existing disease|0|||
130347046|NCT00402233|469241896|FG001|Overall Study|Worsening of other pre-existing disease|1|||
130347047|NCT00402233|469241897|FG002|Overall Study|Worsening of other pre-existing disease|0|||
130680672|NCT01104662|470457314|FG005|Overall Study|Clinical Failure|1|||
130680673|NCT01104662|470457315|FG006|Overall Study|Clinical Failure|0|||
130680674|NCT01104662|470457316|FG007|Overall Study|Clinical Failure|0|||
130680675|NCT01104662|470457309|FG000|Overall Study|Participant left investigator's care|1|||
130680676|NCT01104662|470457310|FG001|Overall Study|Participant left investigator's care|1|||
130680677|NCT01104662|470457311|FG002|Overall Study|Participant left investigator's care|0|||
130680678|NCT01104662|470457312|FG003|Overall Study|Participant left investigator's care|0|||
130680679|NCT01104662|470457313|FG004|Overall Study|Participant left investigator's care|0|||
130436079|NCT02769065|469560521|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436080|NCT02769065|469560522|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436081|NCT02769065|469560523|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436082|NCT02769065|469560524|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436083|NCT02769065|469560525|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436084|NCT02769065|469560526|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436085|NCT02769065|469560527|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436086|NCT02769065|469560528|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
130436087|NCT02764775|469560531|FG000|Overall Study|Death|1|||
130436088|NCT02764775|469560531|FG000|Overall Study|Lost to Follow-up|2|||
130436089|NCT02764775|469560531|FG000|Overall Study|Withdrawal by Subject|3|||
130436090|NCT04022889|469560534|FG000|Stage 1: Period 1|Adverse Event|1|||
130436091|NCT04022889|469560535|FG001|Stage 1: Period 1|Adverse Event|0|||
130436092|NCT04022889|469560536|FG002|Stage 1: Period 1|Adverse Event|0|||
130436093|NCT04022889|469560534|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
130436094|NCT04022889|469560535|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
130436095|NCT04022889|469560536|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
130436096|NCT04022889|469560534|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
130436097|NCT04022889|469560535|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
130436098|NCT04022889|469560536|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
130436099|NCT04022889|469560534|FG000|Stage 2|Screen Failure|0|||
130436100|NCT04022889|469560535|FG001|Stage 2|Screen Failure|0|||
130436101|NCT04022889|469560536|FG002|Stage 2|Screen Failure|3|||
130436102|NCT04022889|469560534|FG000|Stage 2|Ineligible for apheresis donation|0|||
130436103|NCT04022889|469560535|FG001|Stage 2|Ineligible for apheresis donation|0|||
130436104|NCT04022889|469560536|FG002|Stage 2|Ineligible for apheresis donation|2|||
130680680|NCT01104662|470457314|FG005|Overall Study|Participant left investigator's care|0|||
130680681|NCT01104662|470457315|FG006|Overall Study|Participant left investigator's care|0|||
130680682|NCT01104662|470457316|FG007|Overall Study|Participant left investigator's care|0|||
130680683|NCT01104662|470457309|FG000|Overall Study|Reason not specified|3|||
130347048|NCT00402233|469241898|FG003|Overall Study|Worsening of other pre-existing disease|0|||
130347049|NCT04658940|469241899|FG000|Overall Study|Withdrawal by Subject|1|||
130347050|NCT03579602|469241900|FG000|Overall Study|Subject unable to receive study drug|0|||
130347051|NCT03579602|469241901|FG001|Overall Study|Subject unable to receive study drug|2|||
130347052|NCT03579602|469241900|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
130347053|NCT03579602|469241901|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
130347054|NCT02518464|469241902|FG000|Overall Study|Adverse Event|2|||
130347055|NCT01120067|469241903|FG000|Overall Study|Lost to Follow-up|3|||
130347056|NCT01120067|469241904|FG001|Overall Study|Lost to Follow-up|1|||
130347057|NCT01120067|469241903|FG000|Overall Study|fail to engage >3 sessions|2|||
130347058|NCT01120067|469241904|FG001|Overall Study|fail to engage >3 sessions|0|||
130347059|NCT00266877|469241905|FG000|Overall Study|Death|1|||
130347060|NCT00266877|469241906|FG001|Overall Study|Death|1|||
130347061|NCT00266877|469241907|FG002|Overall Study|Death|1|||
130347062|NCT00266877|469241905|FG000|Overall Study|Adverse Event|6|||
130347063|NCT00266877|469241906|FG001|Overall Study|Adverse Event|4|||
130347064|NCT00266877|469241907|FG002|Overall Study|Adverse Event|1|||
130347065|NCT00266877|469241905|FG000|Overall Study|Physician Decision|2|||
130347066|NCT00266877|469241906|FG001|Overall Study|Physician Decision|1|||
130347067|NCT00266877|469241907|FG002|Overall Study|Physician Decision|1|||
130347068|NCT00266877|469241905|FG000|Overall Study|Withdrawal by Subject|3|||
130347069|NCT00266877|469241906|FG001|Overall Study|Withdrawal by Subject|1|||
130347070|NCT00266877|469241907|FG002|Overall Study|Withdrawal by Subject|1|||
130347071|NCT00266877|469241905|FG000|Overall Study|Disease Progression|72|||
130347072|NCT00266877|469241906|FG001|Overall Study|Disease Progression|37|||
130347073|NCT00266877|469241907|FG002|Overall Study|Disease Progression|23|||
130347074|NCT00266877|469241905|FG000|Overall Study|Symptomatic Deterioration|6|||
130347075|NCT00266877|469241906|FG001|Overall Study|Symptomatic Deterioration|3|||
130347076|NCT00266877|469241907|FG002|Overall Study|Symptomatic Deterioration|1|||
130347077|NCT00266877|469241905|FG000|Overall Study|Hospitalization|1|||
130347078|NCT00266877|469241906|FG001|Overall Study|Hospitalization|0|||
130347079|NCT00266877|469241907|FG002|Overall Study|Hospitalization|0|||
130347080|NCT00266877|469241905|FG000|Overall Study|Concomitant Radiotherapy|0|||
130436105|NCT04022889|469560534|FG000|Stage 2|Adverse Event|0|||
130436106|NCT04022889|469560535|FG001|Stage 2|Adverse Event|0|||
130436107|NCT04022889|469560536|FG002|Stage 2|Adverse Event|2|||
130436108|NCT04022889|469560534|FG000|Stage 2|Protocol Violation|0|||
130436109|NCT04022889|469560535|FG001|Stage 2|Protocol Violation|0|||
130436110|NCT04022889|469560536|FG002|Stage 2|Protocol Violation|1|||
130680684|NCT01104662|470457310|FG001|Overall Study|Reason not specified|3|||
130680685|NCT01104662|470457311|FG002|Overall Study|Reason not specified|0|||
130680686|NCT01104662|470457312|FG003|Overall Study|Reason not specified|0|||
130680687|NCT01104662|470457313|FG004|Overall Study|Reason not specified|0|||
130680688|NCT01104662|470457314|FG005|Overall Study|Reason not specified|1|||
130680689|NCT01104662|470457315|FG006|Overall Study|Reason not specified|0|||
130680690|NCT01104662|470457316|FG007|Overall Study|Reason not specified|0|||
130680691|NCT01104662|470457309|FG000|Overall Study|Randomized but not treated|3|||
130680692|NCT01104662|470457310|FG001|Overall Study|Randomized but not treated|4|||
130680693|NCT01104662|470457311|FG002|Overall Study|Randomized but not treated|1|||
130680694|NCT01104662|470457312|FG003|Overall Study|Randomized but not treated|0|||
130680695|NCT01104662|470457313|FG004|Overall Study|Randomized but not treated|0|||
130680696|NCT01104662|470457314|FG005|Overall Study|Randomized but not treated|1|||
130680697|NCT01104662|470457315|FG006|Overall Study|Randomized but not treated|0|||
130680698|NCT01104662|470457316|FG007|Overall Study|Randomized but not treated|0|||
130680699|NCT02079532|470457317|FG000|Overall Study|Adverse Event|7|||
130680700|NCT02079532|470457317|FG000|Overall Study|Additional or changed therapy|2|||
130680701|NCT02079532|470457317|FG000|Overall Study|Lack of Efficacy|9|||
130680702|NCT02079532|470457317|FG000|Overall Study|Protocol Violation|3|||
130680703|NCT02079532|470457317|FG000|Overall Study|Withdrawal by Subject|1|||
130680704|NCT02079532|470457317|FG000|Overall Study|Administrative problems|1|||
130680705|NCT02079532|470457317|FG000|Overall Study|Inclusion into ReFIRST|3|||
130680706|NCT02079532|470457317|FG000|Overall Study|Other|3|||
130680707|NCT02158936|470457320|FG000|Overall Study|Study closed/ terminated|57|||
130680708|NCT02158936|470457321|FG001|Overall Study|Study closed/ terminated|77|||
130680709|NCT02158936|470457320|FG000|Overall Study|Azacitidine tx discontinued|53|||
130680710|NCT02158936|470457321|FG001|Overall Study|Azacitidine tx discontinued|46|||
130680711|NCT02158936|470457320|FG000|Overall Study|Adverse Event|39|||
130680712|NCT02158936|470457321|FG001|Overall Study|Adverse Event|24|||
130680713|NCT02158936|470457320|FG000|Overall Study|Withdrawal by Subject|15|||
130680714|NCT02158936|470457321|FG001|Overall Study|Withdrawal by Subject|16|||
130680715|NCT02158936|470457320|FG000|Overall Study|Physician Decision|15|||
130680716|NCT02158936|470457321|FG001|Overall Study|Physician Decision|13|||
130680717|NCT02158936|470457320|FG000|Overall Study|Lost to Follow-up|0|||
130680718|NCT02158936|470457321|FG001|Overall Study|Lost to Follow-up|1|||
130680719|NCT01432171|470457322|FG000|Overall Study|Death|1|||
130680720|NCT01432171|470457323|FG001|Overall Study|Death|2|||
130680721|NCT01432171|470457322|FG000|Overall Study|Lost to Follow-up|6|||
130680722|NCT01432171|470457323|FG001|Overall Study|Lost to Follow-up|5|||
130680723|NCT01432171|470457322|FG000|Overall Study|Withdrawal by Subject|3|||
130680724|NCT01432171|470457323|FG001|Overall Study|Withdrawal by Subject|1|||
130680725|NCT01432171|470457322|FG000|Overall Study|Noncompliance|2|||
130680726|NCT01432171|470457323|FG001|Overall Study|Noncompliance|3|||
130680727|NCT01432171|470457322|FG000|Overall Study|Insurance denial trial coverage|1|||
130680728|NCT01432171|470457323|FG001|Overall Study|Insurance denial trial coverage|0|||
130680729|NCT01432171|470457322|FG000|Overall Study|Patient moved to palliative care|1|||
130680730|NCT01432171|470457323|FG001|Overall Study|Patient moved to palliative care|0|||
130680731|NCT01706926|470457324|FG000|Overall Study|Lost to Follow-up|0|||
130680732|NCT01706926|470457325|FG001|Overall Study|Lost to Follow-up|0|||
130680733|NCT01706926|470457326|FG002|Overall Study|Lost to Follow-up|1|||
130680734|NCT01706926|470457327|FG003|Overall Study|Lost to Follow-up|0|||
130680735|NCT01706926|470457324|FG000|Overall Study|Withdrawal by Subject|2|||
130680736|NCT01706926|470457325|FG001|Overall Study|Withdrawal by Subject|0|||
130680737|NCT01706926|470457326|FG002|Overall Study|Withdrawal by Subject|1|||
130680738|NCT01706926|470457327|FG003|Overall Study|Withdrawal by Subject|2|||
130680739|NCT01706926|470457324|FG000|Overall Study|Other|4|||
130680740|NCT01706926|470457325|FG001|Overall Study|Other|4|||
130680741|NCT01706926|470457326|FG002|Overall Study|Other|4|||
130680742|NCT01706926|470457327|FG003|Overall Study|Other|3|||
130720827|NCT04524364|470601531|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
130720828|NCT04524364|470601530|FG000|Overall Study|Low International normalized ratio (INR)|1|||
130720829|NCT04524364|470601531|FG001|Overall Study|Low International normalized ratio (INR)|0|||
130720830|NCT04480710|470601538|FG000|Overall Study|Adverse Event|0|||
130720831|NCT04480710|470601539|FG001|Overall Study|Adverse Event|2|||
130720832|NCT04480710|470601540|FG002|Overall Study|Adverse Event|0|||
130720833|NCT04480710|470601541|FG003|Overall Study|Adverse Event|0|||
130720834|NCT04480710|470601538|FG000|Overall Study|Withdrawal by Subject|0|||
130720835|NCT04480710|470601539|FG001|Overall Study|Withdrawal by Subject|1|||
130720836|NCT04480710|470601540|FG002|Overall Study|Withdrawal by Subject|0|||
130720837|NCT04480710|470601541|FG003|Overall Study|Withdrawal by Subject|0|||
130720838|NCT04480710|470601538|FG000|Overall Study|Physician Decision|0|||
130720839|NCT04480710|470601539|FG001|Overall Study|Physician Decision|0|||
130720840|NCT04480710|470601540|FG002|Overall Study|Physician Decision|1|||
130720841|NCT04480710|470601541|FG003|Overall Study|Physician Decision|0|||
130720842|NCT04126213|470601545|FG000|Overall Study|Lost to Follow-up|9|||
130347081|NCT00266877|469241906|FG001|Overall Study|Concomitant Radiotherapy|1|||
130347082|NCT00266877|469241907|FG002|Overall Study|Concomitant Radiotherapy|0|||
130436111|NCT04022889|469560534|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
130436112|NCT04022889|469560535|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
130436113|NCT04022889|469560536|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
130436114|NCT02254408|469560539|FG000|Overall Study|Randomized But Not Treated|1|||
130436115|NCT02254408|469560540|FG001|Overall Study|Randomized But Not Treated|3|||
130436116|NCT02254408|469560539|FG000|Overall Study|Adverse Event|1|||
130436117|NCT02254408|469560540|FG001|Overall Study|Adverse Event|0|||
130436118|NCT02254408|469560539|FG000|Overall Study|Death|2|||
130436119|NCT02254408|469560540|FG001|Overall Study|Death|3|||
130436120|NCT02254408|469560539|FG000|Overall Study|Investigator's Discretion|0|||
130436121|NCT02254408|469560540|FG001|Overall Study|Investigator's Discretion|1|||
130436122|NCT02254408|469560539|FG000|Overall Study|Withdrawal by Subject|3|||
130347083|NCT03985878|469241909|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
130347084|NCT03985878|469241909|FG000|Overall Study|Study Terminated by Sponsor|12|||
130347085|NCT03985878|469241909|FG000|Overall Study|Withdrawal by Subject|1|||
130347086|NCT00278915|469241912|FG000|Overall Study|Disease progression|1|||
130347087|NCT02520089|469241913|FG000|Overall Study|Lost to Follow-up|3|||
130347088|NCT02520089|469241914|FG001|Overall Study|Lost to Follow-up|4|||
130347089|NCT03473548|469241917|FG000|Overall Study|Did not attempt HST testing|3|||
130347090|NCT03473548|469241918|FG001|Overall Study|Did not attempt HST testing|0|||
130347091|NCT00129311|469241920|FG000|Overall Study|Withdrawal by Subject|12|||
130347092|NCT00129311|469241921|FG001|Overall Study|Withdrawal by Subject|19|||
130436123|NCT02254408|469560540|FG001|Overall Study|Withdrawal by Subject|3|||
130436124|NCT02254408|469560539|FG000|Overall Study|Lost to Follow-up|1|||
130436125|NCT02254408|469560540|FG001|Overall Study|Lost to Follow-up|0|||
130436126|NCT02291432|469560543|FG000|Overall Study|Withdrawal by Subject|2|||
130436127|NCT02145078|469560544|FG000|Overall Study|Death|1|||
130436128|NCT02145078|469560544|FG000|Overall Study|Reason not given|3|||
130436129|NCT03327402|469560545|FG000|Overall Study|Withdrawal by Subject|1|||
130436130|NCT03327402|469560545|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
130436131|NCT02440594|469560549|FG000|Overall Study|Lost to Follow-up|34|||
130436132|NCT02440594|469560550|FG001|Overall Study|Lost to Follow-up|33|||
130436133|NCT02440594|469560551|FG002|Overall Study|Lost to Follow-up|54|||
130436134|NCT02440594|469560552|FG003|Overall Study|Lost to Follow-up|47|||
130436135|NCT02440594|469560553|FG004|Overall Study|Lost to Follow-up|5|||
130436136|NCT02440594|469560554|FG005|Overall Study|Lost to Follow-up|4|||
130436137|NCT02440594|469560555|FG006|Overall Study|Lost to Follow-up|28|||
130436138|NCT02440594|469560556|FG007|Overall Study|Lost to Follow-up|48|||
130436139|NCT02440594|469560549|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
130436140|NCT02440594|469560550|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
130680743|NCT00883090|470458676|FG000|Overall Study|Sponsor's decision|1|||
130347093|NCT02232880|469241922|FG000|Overall Study|study stopped prior to randomization|1|||
130347094|NCT02545543|469241923|FG000|Overall Study|Lost to Follow-up|67|||
130347095|NCT02545543|469241924|FG001|Overall Study|Lost to Follow-up|25|||
130347096|NCT02545543|469241923|FG000|Overall Study|Physician Decision|3|||
130347097|NCT02545543|469241924|FG001|Overall Study|Physician Decision|0|||
130347098|NCT02545543|469241923|FG000|Overall Study|Withdrawal by Subject|9|||
130347099|NCT02545543|469241924|FG001|Overall Study|Withdrawal by Subject|8|||
130347100|NCT02545543|469241923|FG000|Overall Study|Noncomplaince|1|||
130347101|NCT02545543|469241924|FG001|Overall Study|Noncomplaince|0|||
130347102|NCT02545543|469241923|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
130347103|NCT02545543|469241924|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
130347104|NCT02829944|469241928|FG000|Overall Study|Physician Decision|0|||
130347105|NCT02829944|469241929|FG001|Overall Study|Physician Decision|1|||
130347106|NCT02829944|469241928|FG000|Overall Study|Screen Failure|2|||
130347107|NCT02829944|469241929|FG001|Overall Study|Screen Failure|2|||
130347108|NCT02829944|469241928|FG000|Overall Study|Inadequate Neuraxial Block|1|||
130347109|NCT02829944|469241929|FG001|Overall Study|Inadequate Neuraxial Block|1|||
130347110|NCT02829944|469241928|FG000|Overall Study|Withdrawal by Subject|2|||
130436141|NCT02440594|469560551|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
130680744|NCT00883090|470458676|FG000|Overall Study|Withdrawal by Subject|1|||
130680745|NCT01475838|470458679|FG000|Randomized Phase|Randomized but Not Treated|0|||
130680746|NCT01475838|470458680|FG001|Randomized Phase|Randomized but Not Treated|5|||
130680747|NCT01475838|470458679|FG000|Randomized Phase|Adverse Event|6|||
130680748|NCT01475838|470458680|FG001|Randomized Phase|Adverse Event|1|||
130680749|NCT01475838|470458679|FG000|Randomized Phase|Pregnancy|0|||
130347111|NCT02829944|469241929|FG001|Overall Study|Withdrawal by Subject|1|||
130347112|NCT02829944|469241928|FG000|Overall Study|Catheter Displacement|1|||
130347113|NCT02829944|469241929|FG001|Overall Study|Catheter Displacement|0|||
130347114|NCT02829944|469241928|FG000|Overall Study|Catheter broke|0|||
130436142|NCT02440594|469560552|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
130680750|NCT01475838|470458680|FG001|Randomized Phase|Pregnancy|1|||
130436143|NCT02440594|469560553|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
130436144|NCT02440594|469560554|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
130436145|NCT02440594|469560555|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
130436146|NCT02440594|469560556|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
130347115|NCT02829944|469241929|FG001|Overall Study|Catheter broke|1|||
130347116|NCT02829944|469241928|FG000|Overall Study|Staff unavailable|0|||
130347117|NCT02829944|469241929|FG001|Overall Study|Staff unavailable|1|||
130347118|NCT00336583|469243525|FG000|Overall Study|Lost to Follow-up|1|||
130347119|NCT00336583|469243525|FG000|Overall Study|Death|1|||
130347120|NCT00910247|469243526|FG000|Overall Study|Adverse Event|15|||
130347121|NCT00910247|469243526|FG000|Overall Study|Death|2|||
130347122|NCT00910247|469243526|FG000|Overall Study|Lost to Follow-up|10|||
130347123|NCT00910247|469243526|FG000|Overall Study|Physician Decision|3|||
130347124|NCT00910247|469243526|FG000|Overall Study|Protocol Violation|10|||
130347125|NCT00910247|469243526|FG000|Overall Study|Withdrawal by Subject|25|||
130347126|NCT00910247|469243526|FG000|Overall Study|Not collected|4|||
130347127|NCT02927067|469243527|FG000|Overall Study|Withdrawn Consent|20|||
130347128|NCT02927067|469243528|FG001|Overall Study|Withdrawn Consent|12|||
130347129|NCT02927067|469243527|FG000|Overall Study|Death|18|||
130347130|NCT02927067|469243528|FG001|Overall Study|Death|31|||
130347131|NCT02927067|469243527|FG000|Overall Study|Adverse Event|13|||
130347132|NCT02927067|469243528|FG001|Overall Study|Adverse Event|10|||
130347133|NCT02927067|469243527|FG000|Overall Study|Noncompliance|5|||
130347134|NCT02927067|469243528|FG001|Overall Study|Noncompliance|2|||
130347135|NCT02927067|469243527|FG000|Overall Study|Reason not Specified|4|||
130680751|NCT01475838|470458679|FG000|Randomized Phase|Investigators Discretion|1|||
130680752|NCT01475838|470458680|FG001|Randomized Phase|Investigators Discretion|2|||
130680753|NCT01475838|470458679|FG000|Randomized Phase|Withdrew Consent|10|||
130680754|NCT01475838|470458680|FG001|Randomized Phase|Withdrew Consent|14|||
130680755|NCT01475838|470458679|FG000|Randomized Phase|Lost to Follow-up|3|||
130680756|NCT01475838|470458680|FG001|Randomized Phase|Lost to Follow-up|4|||
130680757|NCT01475838|470458679|FG000|Randomized Phase|Participant Noncompliance|1|||
130680758|NCT01475838|470458680|FG001|Randomized Phase|Participant Noncompliance|5|||
130680759|NCT01475838|470458679|FG000|Randomized Phase|Protocol Violation|9|||
130680760|NCT01475838|470458680|FG001|Randomized Phase|Protocol Violation|4|||
130680761|NCT01475838|470458679|FG000|Extension Phase|Participant Noncompliance|1|||
130680762|NCT01475838|470458680|FG001|Extension Phase|Participant Noncompliance|0|||
130680763|NCT01717976|470458681|FG000|Overall Study|Protocol Violation|0|||
130680764|NCT01717976|470458682|FG001|Overall Study|Protocol Violation|1|||
130680765|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
130680766|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
130680767|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
130680768|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
130680769|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
130680770|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
130680771|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130680772|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130680773|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
130680774|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
130680775|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
130680776|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
130680777|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
130680778|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
130680779|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
130680780|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Death|1|||
130680781|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Death|1|||
130680782|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Death|0|||
130680783|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
130680784|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
130680785|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
130680786|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
130680787|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
130680788|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
130680789|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
130680790|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
130680791|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
130680792|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
130347136|NCT02927067|469243528|FG001|Overall Study|Reason not Specified|6|||
130347137|NCT01727700|469243531|FG000|Overall Study|Adverse Event|0|||
130680793|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
130680794|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
130347138|NCT01727700|469243532|FG001|Overall Study|Adverse Event|7|||
130347139|NCT01727700|469243533|FG002|Overall Study|Adverse Event|1|||
130680795|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
130680796|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
130347140|NCT01727700|469243531|FG000|Overall Study|Particpant withdrew consent|0|||
130347141|NCT01727700|469243532|FG001|Overall Study|Particpant withdrew consent|3|||
130347142|NCT01727700|469243533|FG002|Overall Study|Particpant withdrew consent|1|||
130680797|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
130680798|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130680799|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130680800|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
130680801|NCT00048568|470458683|FG000|Open-Label Period|Death|0|||
130680802|NCT00048568|470458684|FG001|Open-Label Period|Death|0|||
130680803|NCT00048568|470458685|FG002|Open-Label Period|Death|13|||
130680804|NCT00048568|470458683|FG000|Open-Label Period|Adverse Event|0|||
130680805|NCT00048568|470458684|FG001|Open-Label Period|Adverse Event|0|||
130680806|NCT00048568|470458685|FG002|Open-Label Period|Adverse Event|49|||
130680807|NCT00048568|470458683|FG000|Open-Label Period|Lack of Efficacy|0|||
130680808|NCT00048568|470458684|FG001|Open-Label Period|Lack of Efficacy|0|||
130680809|NCT00048568|470458685|FG002|Open-Label Period|Lack of Efficacy|32|||
130680810|NCT00048568|470458683|FG000|Open-Label Period|Withdrawal by Subject|0|||
130680811|NCT00048568|470458684|FG001|Open-Label Period|Withdrawal by Subject|0|||
130680812|NCT00048568|470458685|FG002|Open-Label Period|Withdrawal by Subject|26|||
130680813|NCT00048568|470458683|FG000|Open-Label Period|Pregnancy|0|||
130680814|NCT00048568|470458684|FG001|Open-Label Period|Pregnancy|0|||
130216617|NCT03162328|468755621|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
130347143|NCT01727700|469243531|FG000|Overall Study|Protocol Violation|2|||
130347144|NCT01727700|469243532|FG001|Overall Study|Protocol Violation|0|||
130347145|NCT01727700|469243533|FG002|Overall Study|Protocol Violation|0|||
130347146|NCT01757691|469243537|FG000|Overall Study|Administrative problems|2|||
130347147|NCT01757691|469243538|FG001|Overall Study|Administrative problems|0|||
130347148|NCT02054481|469243541|FG000|Overall Study|Adverse Event|1|||
130347149|NCT02054481|469243542|FG001|Overall Study|Adverse Event|1|||
130347150|NCT02054481|469243543|FG002|Overall Study|Adverse Event|0|||
130347151|NCT02054481|469243544|FG003|Overall Study|Adverse Event|1|||
130347152|NCT02054481|469243541|FG000|Overall Study|Lost to Follow-up|1|||
130347153|NCT02054481|469243542|FG001|Overall Study|Lost to Follow-up|0|||
130347154|NCT02054481|469243543|FG002|Overall Study|Lost to Follow-up|0|||
130347155|NCT02054481|469243544|FG003|Overall Study|Lost to Follow-up|0|||
130347156|NCT02054481|469243541|FG000|Overall Study|Other reason|2|||
130347157|NCT02054481|469243542|FG001|Overall Study|Other reason|1|||
130347158|NCT02054481|469243543|FG002|Overall Study|Other reason|2|||
130347159|NCT02054481|469243544|FG003|Overall Study|Other reason|0|||
130347160|NCT02320903|469243545|FG000|Overall Study|Withdrawal by Subject|0|||
130347161|NCT02320903|469243546|FG001|Overall Study|Withdrawal by Subject|9|||
130347162|NCT02320903|469243547|FG002|Overall Study|Withdrawal by Subject|9|||
130347163|NCT02320903|469243545|FG000|Overall Study|Exited therapy; no longer eligible|8|||
130347164|NCT02320903|469243546|FG001|Overall Study|Exited therapy; no longer eligible|2|||
130347165|NCT02320903|469243547|FG002|Overall Study|Exited therapy; no longer eligible|2|||
130347166|NCT02320903|469243545|FG000|Overall Study|Lost to Follow-up|0|||
130347167|NCT02320903|469243546|FG001|Overall Study|Lost to Follow-up|5|||
130347168|NCT02320903|469243547|FG002|Overall Study|Lost to Follow-up|5|||
130347169|NCT01095094|469243551|FG000|Overall Study|Withdrawal by Subject|1|||
130347170|NCT01095094|469243551|FG000|Overall Study|Death|1|||
130347171|NCT01095094|469243551|FG000|Overall Study|Physician Decision|1|||
130347172|NCT05347147|469243552|FG000|Overall Study|Lost to Follow-up|0|||
130347173|NCT05347147|469243553|FG001|Overall Study|Lost to Follow-up|1|||
130347174|NCT05347147|469243552|FG000|Overall Study|Sponsor request|3|||
130347175|NCT05347147|469243553|FG001|Overall Study|Sponsor request|3|||
130347176|NCT05347147|469243552|FG000|Overall Study|Study termination|2|||
130347177|NCT05347147|469243553|FG001|Overall Study|Study termination|1|||
130347178|NCT01122394|469243558|FG000|Overall Study|Withdrawal by Subject|1|||
130347179|NCT01122394|469243559|FG001|Overall Study|Withdrawal by Subject|1|||
130347180|NCT01122394|469243558|FG000|Overall Study|Lost to Follow-up|2|||
130347181|NCT01122394|469243559|FG001|Overall Study|Lost to Follow-up|2|||
130347182|NCT01122394|469243558|FG000|Overall Study|Adverse Event|0|||
130347183|NCT01122394|469243559|FG001|Overall Study|Adverse Event|1|||
130347184|NCT02446743|469243560|FG000|Overall Study|Withdrawal by Subject|1|||
130347185|NCT02446743|469243561|FG001|Overall Study|Withdrawal by Subject|1|||
130347186|NCT02446743|469243560|FG000|Overall Study|Lost to Follow-up|1|||
130347187|NCT02446743|469243561|FG001|Overall Study|Lost to Follow-up|0|||
130347188|NCT02446743|469243560|FG000|Overall Study|Adverse Event|1|||
130347189|NCT02446743|469243561|FG001|Overall Study|Adverse Event|1|||
130347190|NCT02446743|469243560|FG000|Overall Study|Other|2|||
130347191|NCT02446743|469243561|FG001|Overall Study|Other|3|||
130347192|NCT03361176|469243562|FG000|Overall Study|Lost to Follow-up|1|||
130347193|NCT03361176|469243563|FG001|Overall Study|Lost to Follow-up|2|||
130347194|NCT03361176|469243562|FG000|Overall Study|Adverse Event|0|||
130347195|NCT03361176|469243563|FG001|Overall Study|Adverse Event|2|||
130347196|NCT03361176|469243562|FG000|Overall Study|Withdrawal by Subject|0|||
130347197|NCT03361176|469243563|FG001|Overall Study|Withdrawal by Subject|1|||
130347198|NCT03718299|469243564|FG000|Overall Study|Adverse Event|1|||
130347199|NCT03718299|469243564|FG000|Overall Study|Withdrawal by Subject|6|||
130347200|NCT03718299|469243564|FG000|Overall Study|Physician Decision|2|||
130347201|NCT03718299|469243564|FG000|Overall Study|Lost to Follow-up|1|||
130347202|NCT04389970|469243565|FG000|Overall Study|Lost to Follow-up|1|||
130347203|NCT01931670|469243567|FG000|Treatment Period|Exclusionary Medication Received|1|||
130347204|NCT01931670|469243568|FG001|Treatment Period|Exclusionary Medication Received|1|||
130347205|NCT01931670|469243569|FG002|Treatment Period|Exclusionary Medication Received|1|||
130347206|NCT01931670|469243567|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
130347207|NCT01931670|469243568|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
130347208|NCT01931670|469243569|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
130347209|NCT01931670|469243567|FG000|Treatment Period|Subject Noncompliant|4|||
130347210|NCT01931670|469243568|FG001|Treatment Period|Subject Noncompliant|9|||
130680815|NCT00048568|470458685|FG002|Open-Label Period|Pregnancy|5|||
130680816|NCT00048568|470458683|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
130680817|NCT00048568|470458684|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
130680818|NCT00048568|470458685|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
130347211|NCT01931670|469243569|FG002|Treatment Period|Subject Noncompliant|5|||
130347212|NCT01931670|469243567|FG000|Treatment Period|Adverse Event|19|||
130347213|NCT01931670|469243568|FG001|Treatment Period|Adverse Event|8|||
130347214|NCT01931670|469243569|FG002|Treatment Period|Adverse Event|21|||
130347215|NCT01931670|469243567|FG000|Treatment Period|Lack of Efficacy|11|||
130347216|NCT01931670|469243568|FG001|Treatment Period|Lack of Efficacy|2|||
130347217|NCT01931670|469243569|FG002|Treatment Period|Lack of Efficacy|2|||
130347218|NCT01931670|469243567|FG000|Treatment Period|Pregnancy|7|||
130347219|NCT01931670|469243568|FG001|Treatment Period|Pregnancy|2|||
130347220|NCT01931670|469243569|FG002|Treatment Period|Pregnancy|0|||
130347221|NCT01931670|469243567|FG000|Treatment Period|Other|8|||
130347222|NCT01931670|469243568|FG001|Treatment Period|Other|7|||
130347223|NCT01931670|469243569|FG002|Treatment Period|Other|2|||
130347224|NCT01931670|469243567|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
130347225|NCT01931670|469243568|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
130347226|NCT01931670|469243569|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
130347227|NCT01931670|469243567|FG000|Treatment Period|Lost to Follow-up|19|||
130347228|NCT01931670|469243568|FG001|Treatment Period|Lost to Follow-up|5|||
130347229|NCT01931670|469243569|FG002|Treatment Period|Lost to Follow-up|7|||
130347230|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
130347231|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130347232|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130347233|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
130347234|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
130347235|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
130347236|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130347237|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130347238|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
130347239|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
130347240|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130347241|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130347242|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
130347243|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
130347244|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
130347245|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130680819|NCT00048568|470458683|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
130680820|NCT00048568|470458684|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
130680821|NCT00048568|470458685|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
130680822|NCT00048568|470458683|FG000|Open-Label Period|Unknown Reasons|0|||
130680823|NCT00048568|470458684|FG001|Open-Label Period|Unknown Reasons|0|||
130680824|NCT00048568|470458685|FG002|Open-Label Period|Unknown Reasons|25|||
130680825|NCT00048568|470458683|FG000|Open-Label Period|Lost to Follow-up|0|||
130680826|NCT00048568|470458684|FG001|Open-Label Period|Lost to Follow-up|0|||
130347246|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130347247|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
130347248|NCT00976508|469243570|FG000|Overall Study|Death|7|||
130347249|NCT00976508|469243571|FG001|Overall Study|Death|1|||
130347250|NCT00976508|469243570|FG000|Overall Study|Lost to Follow-up|1|||
130347251|NCT00976508|469243571|FG001|Overall Study|Lost to Follow-up|0|||
130347252|NCT00976508|469243570|FG000|Overall Study|Withdrawal by Subject|1|||
130347253|NCT00976508|469243571|FG001|Overall Study|Withdrawal by Subject|0|||
130347254|NCT00976508|469243570|FG000|Overall Study|Disease Progression|4|||
130680827|NCT00048568|470458685|FG002|Open-Label Period|Lost to Follow-up|7|||
130347255|NCT00976508|469243571|FG001|Overall Study|Disease Progression|4|||
130347256|NCT00976508|469243570|FG000|Overall Study|Subject Enrolled in Hospice|1|||
130347257|NCT00976508|469243571|FG001|Overall Study|Subject Enrolled in Hospice|0|||
130347258|NCT00976508|469243570|FG000|Overall Study|Terminated by the Sponsor|0|||
130680828|NCT03831048|470458686|FG000|Overall Study|Protocol Violation|9|||
130680829|NCT03831048|470458687|FG001|Overall Study|Protocol Violation|3|||
130216618|NCT03162328|468755619|FG000|Screening Period|Withdrawal by Subject|1|||
130216619|NCT03162328|468755620|FG001|Screening Period|Withdrawal by Subject|0|||
130347259|NCT00976508|469243571|FG001|Overall Study|Terminated by the Sponsor|1|||
130347260|NCT03023046|469243575|FG000|Overall Study|Withdrawal by Subject|1|||
130347261|NCT00246571|469243578|FG000|Overall Study|Adverse Event|7|||
130347262|NCT00246571|469243579|FG001|Overall Study|Adverse Event|0|||
130347263|NCT00246571|469243578|FG000|Overall Study|Protocol Violation|0|||
130347264|NCT00246571|469243579|FG001|Overall Study|Protocol Violation|1|||
130347265|NCT00246571|469243578|FG000|Overall Study|Withdrawal by Subject|2|||
130347266|NCT00246571|469243579|FG001|Overall Study|Withdrawal by Subject|3|||
130347267|NCT00246571|469243578|FG000|Overall Study|Lack of Efficacy|84|||
130347268|NCT00246571|469243579|FG001|Overall Study|Lack of Efficacy|21|||
130347269|NCT00246571|469243578|FG000|Overall Study|Death|17|||
130347270|NCT00246571|469243579|FG001|Overall Study|Death|3|||
130347271|NCT00246571|469243578|FG000|Overall Study|Sponsor|0|||
130347272|NCT00246571|469243579|FG001|Overall Study|Sponsor|1|||
130347273|NCT00246571|469243578|FG000|Overall Study|Did not meet entrance criteria|2|||
130347274|NCT00246571|469243579|FG001|Overall Study|Did not meet entrance criteria|1|||
130347275|NCT00246571|469243578|FG000|Overall Study|Laboratory abnormalities|1|||
130347276|NCT00246571|469243579|FG001|Overall Study|Laboratory abnormalities|0|||
130347277|NCT00246571|469243578|FG000|Overall Study|Crossover participants|0|||
130347278|NCT00246571|469243579|FG001|Overall Study|Crossover participants|74|||
130347279|NCT00713310|469243586|FG000|Overall Study|Adverse Event|5|||
130347280|NCT00713310|469243587|FG001|Overall Study|Adverse Event|2|||
130347281|NCT00713310|469243586|FG000|Overall Study|Lack of Efficacy|0|||
130347282|NCT00713310|469243587|FG001|Overall Study|Lack of Efficacy|2|||
130347283|NCT00713310|469243586|FG000|Overall Study|Withdrawal by Subject|0|||
130347284|NCT00713310|469243587|FG001|Overall Study|Withdrawal by Subject|2|||
130347285|NCT00686634|469243592|FG000|Overall Study|Protocol Violation|6|||
130347286|NCT02361580|469243595|FG000|Overall Study|Lost to Follow-up|6|||
130347287|NCT02361580|469243596|FG001|Overall Study|Lost to Follow-up|3|||
130347288|NCT00924781|469243597|FG000|Overall Study|Study terminated by sponsor|12|||
130347289|NCT00924781|469243598|FG001|Overall Study|Study terminated by sponsor|10|||
130347290|NCT00708201|469243599|FG000|Overall Study|Adverse Event|4|||
130347291|NCT00708201|469243600|FG001|Overall Study|Adverse Event|4|||
130347292|NCT00708201|469243599|FG000|Overall Study|Withdrawal by Subject|1|||
130347293|NCT00708201|469243600|FG001|Overall Study|Withdrawal by Subject|1|||
130347294|NCT00708201|469243599|FG000|Overall Study|Lost to Follow-up|2|||
130347295|NCT00708201|469243600|FG001|Overall Study|Lost to Follow-up|0|||
130347296|NCT00708201|469243599|FG000|Overall Study|Protocol Violation|0|||
130347297|NCT00708201|469243600|FG001|Overall Study|Protocol Violation|1|||
130347298|NCT01653132|469243601|FG000|First Intervention|Protocol Violation|1|||
130347299|NCT01653132|469243602|FG001|First Intervention|Protocol Violation|0|||
130347300|NCT00761748|469243603|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
130347301|NCT00761748|469243604|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
130347302|NCT00761748|469243603|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
130347303|NCT00761748|469243604|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
130347304|NCT03312751|469243605|FG000|Overall Study|Death|7|||
130347305|NCT03312751|469243606|FG001|Overall Study|Death|9|||
130347306|NCT03312751|469243605|FG000|Overall Study|Study discontinuation due to other reason|0|||
130347307|NCT03312751|469243606|FG001|Overall Study|Study discontinuation due to other reason|1|||
130347308|NCT03490981|469243607|FG000|Overall Study|Lost to Follow-up|1|||
130347309|NCT03490981|469243608|FG001|Overall Study|Lost to Follow-up|2|||
130347310|NCT00282464|469243615|FG000|Overall Study|Adverse Event|26|||
130347311|NCT00282464|469243616|FG001|Overall Study|Adverse Event|20|||
130347312|NCT00282464|469243615|FG000|Overall Study|Lack of Efficacy|8|||
130347313|NCT00282464|469243616|FG001|Overall Study|Lack of Efficacy|8|||
130347314|NCT00282464|469243615|FG000|Overall Study|Lost to Follow-up|10|||
130347315|NCT00282464|469243616|FG001|Overall Study|Lost to Follow-up|10|||
130347316|NCT00282464|469243615|FG000|Overall Study|Withdrawal by Subject|24|||
130347317|NCT00282464|469243616|FG001|Overall Study|Withdrawal by Subject|10|||
130347318|NCT00282464|469243615|FG000|Overall Study|laboratory abnormality|1|||
130347319|NCT00282464|469243616|FG001|Overall Study|laboratory abnormality|2|||
130347320|NCT00282464|469243615|FG000|Overall Study|Protocol Violation|0|||
130347321|NCT00282464|469243616|FG001|Overall Study|Protocol Violation|7|||
130347322|NCT00282464|469243615|FG000|Overall Study|Patient moved|1|||
130347323|NCT00282464|469243616|FG001|Overall Study|Patient moved|0|||
130347324|NCT00282464|469243615|FG000|Overall Study|patient non-compliant|3|||
130347325|NCT00282464|469243616|FG001|Overall Study|patient non-compliant|0|||
130347326|NCT00282464|469243615|FG000|Overall Study|patient no show|0|||
130436147|NCT02440594|469560549|FG000|Overall Study|Withdrawal by Subject|81|||
130680830|NCT03831048|470458686|FG000|Overall Study|Death|4|||
130347327|NCT00282464|469243616|FG001|Overall Study|patient no show|1|||
130347328|NCT00282464|469243615|FG000|Overall Study|patient incarcerated|0|||
130347329|NCT00282464|469243616|FG001|Overall Study|patient incarcerated|1|||
130347330|NCT00282464|469243615|FG000|Overall Study|family crisis|0|||
130216620|NCT03162328|468755621|FG002|Screening Period|Withdrawal by Subject|0|||
130216621|NCT03162328|468755619|FG000|Study Period|Withdrawal by Subject|0|||
130216622|NCT03162328|468755620|FG001|Study Period|Withdrawal by Subject|0|||
130216623|NCT03162328|468755621|FG002|Study Period|Withdrawal by Subject|1|||
130216624|NCT00792116|468755622|FG000|Overall Study|Lost to Follow-up|0|||
130216625|NCT00792116|468755623|FG001|Overall Study|Lost to Follow-up|1|||
130216626|NCT00792116|468755622|FG000|Overall Study|Discontnued intervention|1|||
130216627|NCT00792116|468755623|FG001|Overall Study|Discontnued intervention|0|||
130216628|NCT00492232|468755624|FG000|Placebo Run-in|Adverse Event|0|||
130216629|NCT00492232|468755625|FG001|Placebo Run-in|Adverse Event|2|||
130216630|NCT00492232|468755624|FG000|Placebo Run-in|Protocol Violation|0|||
130216631|NCT00492232|468755625|FG001|Placebo Run-in|Protocol Violation|3|||
130216632|NCT00492232|468755624|FG000|Placebo Run-in|Lost to Follow-up|0|||
130216633|NCT00492232|468755625|FG001|Placebo Run-in|Lost to Follow-up|3|||
130216634|NCT00492232|468755624|FG000|Placebo Run-in|Withdrawal by Subject|0|||
130216635|NCT00492232|468755625|FG001|Placebo Run-in|Withdrawal by Subject|8|||
130216636|NCT00492232|468755624|FG000|Placebo Run-in|Pregnancy|0|||
130216637|NCT00492232|468755625|FG001|Placebo Run-in|Pregnancy|1|||
130216638|NCT00492232|468755624|FG000|Placebo Run-in|Entrance criteria not met|0|||
130216639|NCT00492232|468755625|FG001|Placebo Run-in|Entrance criteria not met|45|||
130216640|NCT00492232|468755624|FG000|Placebo Run-in|Other|0|||
130216641|NCT00492232|468755625|FG001|Placebo Run-in|Other|6|||
130216642|NCT00492232|468755624|FG000|Placebo Run-in|Missing|0|||
130216643|NCT00492232|468755625|FG001|Placebo Run-in|Missing|2|||
130216644|NCT00492232|468755624|FG000|Double-Blind Treatment|Adverse Event|1|||
130680831|NCT03831048|470458687|FG001|Overall Study|Death|9|||
130680832|NCT03831048|470458686|FG000|Overall Study|Re-transplant|0|||
130680833|NCT03831048|470458687|FG001|Overall Study|Re-transplant|2|||
130680834|NCT03831048|470458686|FG000|Overall Study|Protocol violation and death|1|||
130680835|NCT03831048|470458687|FG001|Overall Study|Protocol violation and death|1|||
130680836|NCT01315249|470458694|FG000|Overall Study|Adverse Event|22|||
130680837|NCT01315249|470458695|FG001|Overall Study|Adverse Event|26|||
130680838|NCT01315249|470458694|FG000|Overall Study|Withdrawal by Subject|11|||
130680839|NCT01315249|470458695|FG001|Overall Study|Withdrawal by Subject|10|||
130680840|NCT01315249|470458694|FG000|Overall Study|Protocol Violation|8|||
130680841|NCT01315249|470458695|FG001|Overall Study|Protocol Violation|5|||
130680842|NCT01315249|470458694|FG000|Overall Study|Abnormal test results|1|||
130680843|NCT01315249|470458695|FG001|Overall Study|Abnormal test results|2|||
130680844|NCT01315249|470458694|FG000|Overall Study|Administrative problems|1|||
130680845|NCT01315249|470458695|FG001|Overall Study|Administrative problems|0|||
130680846|NCT01315249|470458694|FG000|Overall Study|inability to use device|1|||
130680847|NCT01315249|470458695|FG001|Overall Study|inability to use device|0|||
130680848|NCT01315249|470458694|FG000|Overall Study|Lack of Efficacy|0|||
130680849|NCT01315249|470458695|FG001|Overall Study|Lack of Efficacy|1|||
130680850|NCT01315249|470458694|FG000|Overall Study|Lost to Follow-up|0|||
130680851|NCT01315249|470458695|FG001|Overall Study|Lost to Follow-up|2|||
130680852|NCT01315249|470458694|FG000|Overall Study|Death|0|||
130680853|NCT01315249|470458695|FG001|Overall Study|Death|1|||
130680854|NCT04099888|470458716|FG000|Overall Study|Study terminated by sponsor|9|||
130680855|NCT04099888|470458717|FG001|Overall Study|Study terminated by sponsor|11|||
130680856|NCT04099888|470458716|FG000|Overall Study|Lost to Follow-up|1|||
130680857|NCT04099888|470458717|FG001|Overall Study|Lost to Follow-up|1|||
130680858|NCT04099888|470458716|FG000|Overall Study|Withdrawal by Subject|5|||
130680859|NCT04099888|470458717|FG001|Overall Study|Withdrawal by Subject|6|||
130680860|NCT04099888|470458716|FG000|Overall Study|Death|5|||
130680861|NCT04099888|470458717|FG001|Overall Study|Death|2|||
130680862|NCT04099888|470458716|FG000|Overall Study|Other|1|||
130680863|NCT04099888|470458717|FG001|Overall Study|Other|0|||
130680864|NCT04538170|470458718|FG000|Overall Study|Withdrawal by Subject|104|||
130680865|NCT04538170|470458719|FG001|Overall Study|Withdrawal by Subject|210|||
130680866|NCT00274937|470458723|FG000|Overall Study|Physician Decision|10|||
130680867|NCT00274937|470458723|FG000|Overall Study|Withdrawal by Subject|6|||
130216645|NCT00492232|468755625|FG001|Double-Blind Treatment|Adverse Event|2|||
130216646|NCT00492232|468755624|FG000|Double-Blind Treatment|Protocol Violation|3|||
130216647|NCT00492232|468755625|FG001|Double-Blind Treatment|Protocol Violation|7|||
130436148|NCT02440594|469560550|FG001|Overall Study|Withdrawal by Subject|67|||
130436149|NCT02440594|469560551|FG002|Overall Study|Withdrawal by Subject|59|||
130436150|NCT02440594|469560552|FG003|Overall Study|Withdrawal by Subject|38|||
130436151|NCT02440594|469560553|FG004|Overall Study|Withdrawal by Subject|2|||
130436152|NCT02440594|469560554|FG005|Overall Study|Withdrawal by Subject|2|||
130680868|NCT00274937|470458723|FG000|Overall Study|Progressive Disease|4|||
130680869|NCT00864097|470458726|FG000|Overall Study|Death|0|||
130680870|NCT00864097|470458727|FG001|Overall Study|Death|1|||
130680871|NCT00864097|470458728|FG002|Overall Study|Death|0|||
130436153|NCT02440594|469560555|FG006|Overall Study|Withdrawal by Subject|7|||
130680872|NCT00864097|470458729|FG003|Overall Study|Death|0|||
130680873|NCT00864097|470458726|FG000|Overall Study|Adverse Event|6|||
130680874|NCT00864097|470458727|FG001|Overall Study|Adverse Event|8|||
130216648|NCT00492232|468755624|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
130436154|NCT02440594|469560556|FG007|Overall Study|Withdrawal by Subject|7|||
130436155|NCT02440594|469560549|FG000|Overall Study|Administratively w/drawn|3|||
130436156|NCT02440594|469560550|FG001|Overall Study|Administratively w/drawn|2|||
130436157|NCT02440594|469560551|FG002|Overall Study|Administratively w/drawn|0|||
130436158|NCT02440594|469560552|FG003|Overall Study|Administratively w/drawn|0|||
130436159|NCT02440594|469560553|FG004|Overall Study|Administratively w/drawn|0|||
130436160|NCT02440594|469560554|FG005|Overall Study|Administratively w/drawn|0|||
130436161|NCT02440594|469560555|FG006|Overall Study|Administratively w/drawn|2|||
130436162|NCT02440594|469560556|FG007|Overall Study|Administratively w/drawn|1|||
130436163|NCT03810313|469560557|FG000|Overall Study|Study terminated by sponsor|164|||
130436164|NCT03810313|469560558|FG001|Overall Study|Study terminated by sponsor|159|||
130436165|NCT03810313|469560557|FG000|Overall Study|Subject decision|10|||
130436166|NCT03810313|469560558|FG001|Overall Study|Subject decision|11|||
130436167|NCT03810313|469560557|FG000|Overall Study|Lost to Follow-up|3|||
130436168|NCT03810313|469560558|FG001|Overall Study|Lost to Follow-up|3|||
130436169|NCT03810313|469560557|FG000|Overall Study|Adverse Event|2|||
130436170|NCT03810313|469560558|FG001|Overall Study|Adverse Event|1|||
130436171|NCT03810313|469560557|FG000|Overall Study|Death|2|||
130436172|NCT03810313|469560558|FG001|Overall Study|Death|1|||
130436173|NCT03810313|469560557|FG000|Overall Study|Physician Decision|0|||
130436174|NCT03810313|469560558|FG001|Overall Study|Physician Decision|1|||
130436175|NCT03029780|469560561|FG000|Overall Study|Disease Progression|20|||
130436176|NCT03029780|469560562|FG001|Overall Study|Disease Progression|22|||
130436177|NCT03029780|469560561|FG000|Overall Study|Study Drug Toxicity|15|||
130436178|NCT03029780|469560562|FG001|Overall Study|Study Drug Toxicity|11|||
130436179|NCT03029780|469560561|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130436180|NCT03029780|469560562|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130436181|NCT03029780|469560561|FG000|Overall Study|Participant request to discontinue study treatment|4|||
130436182|NCT03029780|469560562|FG001|Overall Study|Participant request to discontinue study treatment|1|||
130436183|NCT03029780|469560561|FG000|Overall Study|Maximum clinical benefit|1|||
130436184|NCT03029780|469560562|FG001|Overall Study|Maximum clinical benefit|0|||
130436185|NCT03029780|469560561|FG000|Overall Study|Participant no longer meets study criteria|0|||
130436186|NCT03029780|469560562|FG001|Overall Study|Participant no longer meets study criteria|1|||
130436187|NCT03029780|469560561|FG000|Overall Study|Other reasons|6|||
130436188|NCT03029780|469560562|FG001|Overall Study|Other reasons|6|||
130436189|NCT03029780|469560561|FG000|Overall Study|Not reported|1|||
130436190|NCT03029780|469560562|FG001|Overall Study|Not reported|1|||
130436191|NCT03029780|469560561|FG000|Overall Study|Death|2|||
130436192|NCT03029780|469560562|FG001|Overall Study|Death|6|||
130436193|NCT03066622|469560563|FG000|Overall Study|Lost to Follow-up|24|||
130436194|NCT03066622|469560564|FG001|Overall Study|Lost to Follow-up|25|||
130436195|NCT03066622|469560563|FG000|Overall Study|Withdrawal by Subject|2|||
130436196|NCT03066622|469560564|FG001|Overall Study|Withdrawal by Subject|1|||
130436197|NCT01111838|469560565|FG000|Overall Study|Patient Ineligible|2|||
130436198|NCT01111838|469560565|FG000|Overall Study|Not Treated|3|||
130436199|NCT01111838|469560565|FG000|Overall Study|Clinical deterioration|1|||
130436200|NCT01111838|469560565|FG000|Overall Study|Other Complicating Disease|1|||
130436201|NCT00641719|469560566|FG000|Overall Study|Lack of Efficacy|1|||
130436202|NCT00641719|469560567|FG001|Overall Study|Lack of Efficacy|2|||
130680875|NCT00864097|470458728|FG002|Overall Study|Adverse Event|11|||
130436203|NCT00641719|469560566|FG000|Overall Study|Adverse Event|24|||
130436204|NCT00641719|469560567|FG001|Overall Study|Adverse Event|29|||
130436205|NCT00641719|469560566|FG000|Overall Study|Withdrawal by Subject|4|||
130436206|NCT00641719|469560567|FG001|Overall Study|Withdrawal by Subject|4|||
130436207|NCT00641719|469560566|FG000|Overall Study|Reason Not Specified|1|||
130436208|NCT00641719|469560567|FG001|Overall Study|Reason Not Specified|2|||
130680876|NCT00864097|470458729|FG003|Overall Study|Adverse Event|9|||
130680877|NCT00864097|470458726|FG000|Overall Study|Lack of Efficacy|9|||
130680878|NCT00864097|470458727|FG001|Overall Study|Lack of Efficacy|3|||
130436209|NCT03303469|469560568|FG000|Overall Study|Lost to Follow-up|2|||
130436210|NCT04741802|469560570|FG000|Overall Study|Death|1|||
130436211|NCT04741802|469560570|FG000|Overall Study|Lost to Follow-up|11|||
130216649|NCT00492232|468755625|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
130680879|NCT00864097|470458728|FG002|Overall Study|Lack of Efficacy|7|||
130436212|NCT01785563|469560572|FG000|Overall Study|Physician Decision|10|||
130436213|NCT01785563|469560572|FG000|Overall Study|Withdrawal by Subject|1|||
130436214|NCT01785563|469560572|FG000|Overall Study|Protocol Violation|2|||
130436215|NCT01872910|469560573|FG000|Overall Study|Lost to Follow-up|2|||
130436216|NCT01872910|469560574|FG001|Overall Study|Lost to Follow-up|0|||
130436217|NCT01872910|469560575|FG002|Overall Study|Lost to Follow-up|2|||
130436218|NCT01872910|469560576|FG003|Overall Study|Lost to Follow-up|0|||
130436219|NCT01872910|469560577|FG004|Overall Study|Lost to Follow-up|0|||
130680880|NCT00864097|470458729|FG003|Overall Study|Lack of Efficacy|2|||
130436220|NCT01872910|469560578|FG005|Overall Study|Lost to Follow-up|0|||
130436221|NCT00100932|469560579|FG000|Overall Study|Adverse Event|11|||
130436222|NCT00100932|469560580|FG001|Overall Study|Adverse Event|2|||
130436223|NCT00100932|469560579|FG000|Overall Study|Withdrawal by Subject|6|||
130216650|NCT00492232|468755624|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
130680881|NCT00864097|470458726|FG000|Overall Study|Lost to Follow-up|0|||
130680882|NCT00864097|470458727|FG001|Overall Study|Lost to Follow-up|1|||
130680883|NCT00864097|470458728|FG002|Overall Study|Lost to Follow-up|0|||
130680884|NCT00864097|470458729|FG003|Overall Study|Lost to Follow-up|1|||
130680885|NCT00864097|470458726|FG000|Overall Study|Withdrawal by Subject|15|||
130680886|NCT00864097|470458727|FG001|Overall Study|Withdrawal by Subject|11|||
130680887|NCT00864097|470458728|FG002|Overall Study|Withdrawal by Subject|11|||
130680888|NCT00864097|470458729|FG003|Overall Study|Withdrawal by Subject|12|||
130680889|NCT00864097|470458726|FG000|Overall Study|Protocol Violation|2|||
130680890|NCT00864097|470458727|FG001|Overall Study|Protocol Violation|1|||
130680891|NCT00864097|470458728|FG002|Overall Study|Protocol Violation|0|||
130680892|NCT00864097|470458729|FG003|Overall Study|Protocol Violation|1|||
130680893|NCT00864097|470458726|FG000|Overall Study|Terminated by sponsor|105|||
130680894|NCT00864097|470458727|FG001|Overall Study|Terminated by sponsor|112|||
130680895|NCT00864097|470458728|FG002|Overall Study|Terminated by sponsor|102|||
130680896|NCT00864097|470458729|FG003|Overall Study|Terminated by sponsor|99|||
130347331|NCT00282464|469243616|FG001|Overall Study|family crisis|1|||
130347332|NCT00282464|469243615|FG000|Overall Study|dispensed wrong kit|0|||
130347333|NCT00282464|469243616|FG001|Overall Study|dispensed wrong kit|1|||
130347334|NCT00282464|469243615|FG000|Overall Study|dropped due to missed visits|0|||
130347335|NCT00282464|469243616|FG001|Overall Study|dropped due to missed visits|1|||
130347336|NCT01624870|469243617|FG000|Overall Study|Death|19|||
130347337|NCT01624870|469243617|FG000|Overall Study|Withdrawal by Subject|1|||
130347338|NCT01624870|469243617|FG000|Overall Study|CoreValve not implanted|6|||
130347339|NCT01624870|469243617|FG000|Overall Study|Lost to follow up|1|||
130347340|NCT04672252|469243621|FG000|Overall Study|Protocol Violation|1|||
130347341|NCT04672252|469243622|FG001|Overall Study|Protocol Violation|0|||
130347342|NCT04391569|469243623|FG000|Overall Study|Death|15|||
130347343|NCT04391569|469243624|FG001|Overall Study|Death|10|||
130347344|NCT04391569|469243623|FG000|Overall Study|Withdrawal by Subject|1|||
130347345|NCT04391569|469243624|FG001|Overall Study|Withdrawal by Subject|0|||
130347346|NCT04391569|469243623|FG000|Overall Study|Lost to Follow-up|3|||
130347347|NCT04391569|469243624|FG001|Overall Study|Lost to Follow-up|2|||
130347348|NCT04391569|469243623|FG000|Overall Study|Lack of Efficacy|0|||
130347349|NCT04391569|469243624|FG001|Overall Study|Lack of Efficacy|1|||
130347350|NCT04391569|469243623|FG000|Overall Study|Participant discharged to hospice facility|0|||
130347351|NCT04391569|469243624|FG001|Overall Study|Participant discharged to hospice facility|1|||
130347352|NCT04391569|469243623|FG000|Overall Study|Participant family decision|1|||
130347353|NCT04391569|469243624|FG001|Overall Study|Participant family decision|0|||
130347354|NCT04391569|469243623|FG000|Overall Study|Participant discharged prematurely|1|||
130347355|NCT04391569|469243624|FG001|Overall Study|Participant discharged prematurely|0|||
130347356|NCT00899392|469243625|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
130347357|NCT00899392|469243626|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
130347358|NCT01431638|469243633|FG000|Overall Study|Adverse Event|1|||
130347359|NCT01431638|469243634|FG001|Overall Study|Adverse Event|3|||
130347360|NCT01431638|469243635|FG002|Overall Study|Adverse Event|1|||
130347361|NCT01431638|469243633|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130347362|NCT01431638|469243634|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130347363|NCT01431638|469243635|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130347364|NCT01431638|469243633|FG000|Overall Study|Participants condition no longer requires study drug|0|||
130347365|NCT01431638|469243634|FG001|Overall Study|Participants condition no longer requires study drug|1|||
130347366|NCT01431638|469243635|FG002|Overall Study|Participants condition no longer requires study drug|0|||
130347367|NCT01431638|469243633|FG000|Overall Study|Participant withdrew consent|14|||
130347368|NCT01431638|469243634|FG001|Overall Study|Participant withdrew consent|5|||
130347369|NCT01431638|469243635|FG002|Overall Study|Participant withdrew consent|8|||
130347370|NCT01431638|469243633|FG000|Overall Study|Lost to Follow-up|7|||
130347371|NCT01431638|469243634|FG001|Overall Study|Lost to Follow-up|9|||
130347372|NCT01431638|469243635|FG002|Overall Study|Lost to Follow-up|7|||
130347373|NCT01431638|469243633|FG000|Overall Study|Administrative problems|1|||
130347374|NCT01431638|469243634|FG001|Overall Study|Administrative problems|4|||
130347375|NCT01431638|469243635|FG002|Overall Study|Administrative problems|6|||
130347376|NCT01431638|469243633|FG000|Overall Study|Death|1|||
130347377|NCT01431638|469243634|FG001|Overall Study|Death|0|||
130347378|NCT01431638|469243635|FG002|Overall Study|Death|0|||
130347379|NCT01431638|469243633|FG000|Overall Study|Protocol deviation|1|||
130347380|NCT01431638|469243634|FG001|Overall Study|Protocol deviation|1|||
130347381|NCT01431638|469243635|FG002|Overall Study|Protocol deviation|4|||
130680897|NCT00864097|470458726|FG000|Overall Study|Randomized but not treated|2|||
130680898|NCT00864097|470458727|FG001|Overall Study|Randomized but not treated|0|||
130216651|NCT00492232|468755625|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
130347382|NCT01431638|469243633|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
130347383|NCT01431638|469243634|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
130347384|NCT01431638|469243635|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
130347385|NCT01239732|469243636|FG000|Overall Study|Termination of study per protocol|667|||
130347386|NCT01239732|469243636|FG000|Overall Study|Death|226|||
130436224|NCT00100932|469560580|FG001|Overall Study|Withdrawal by Subject|0|||
130436225|NCT00100932|469560579|FG000|Overall Study|Progressive Disease|44|||
130436226|NCT00100932|469560580|FG001|Overall Study|Progressive Disease|18|||
130436227|NCT00100932|469560579|FG000|Overall Study|Physician Decision|7|||
130436228|NCT00100932|469560580|FG001|Overall Study|Physician Decision|5|||
130436229|NCT00100932|469560579|FG000|Overall Study|Other|5|||
130436230|NCT00100932|469560580|FG001|Overall Study|Other|2|||
130436231|NCT01616771|469560581|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
130436232|NCT00744328|469560582|FG000|Overall Study|Lost to Follow-up|2|||
130680899|NCT00864097|470458728|FG002|Overall Study|Randomized but not treated|1|||
130680900|NCT00864097|470458729|FG003|Overall Study|Randomized but not treated|0|||
130680901|NCT00864097|470458726|FG000|Overall Study|Other|0|||
130680902|NCT00864097|470458727|FG001|Overall Study|Other|0|||
130680903|NCT00864097|470458728|FG002|Overall Study|Other|0|||
130680904|NCT00864097|470458729|FG003|Overall Study|Other|1|||
130680905|NCT00880568|470458730|FG000|Overall Study|Disease progression|3|||
130680906|NCT00880568|470458731|FG001|Overall Study|Disease progression|3|||
130680907|NCT00880568|470458732|FG002|Overall Study|Disease progression|3|||
130436233|NCT00744328|469560583|FG001|Overall Study|Lost to Follow-up|5|||
130436234|NCT00744328|469560584|FG002|Overall Study|Lost to Follow-up|3|||
130436235|NCT00744328|469560582|FG000|Overall Study|Withdrawal by Subject|5|||
130436236|NCT00744328|469560583|FG001|Overall Study|Withdrawal by Subject|3|||
130436237|NCT00744328|469560584|FG002|Overall Study|Withdrawal by Subject|4|||
130436238|NCT00744328|469560582|FG000|Overall Study|Found ineligible after randomization|0|||
130436239|NCT00744328|469560583|FG001|Overall Study|Found ineligible after randomization|0|||
130436240|NCT00744328|469560584|FG002|Overall Study|Found ineligible after randomization|1|||
130680908|NCT00880568|470458733|FG003|Overall Study|Disease progression|1|||
130680909|NCT00880568|470458734|FG004|Overall Study|Disease progression|3|||
130680910|NCT00880568|470458735|FG005|Overall Study|Disease progression|3|||
130680911|NCT00880568|470458736|FG006|Overall Study|Disease progression|5|||
130680912|NCT00880568|470458737|FG007|Overall Study|Disease progression|0|||
130680913|NCT00880568|470458738|FG008|Overall Study|Disease progression|3|||
130680914|NCT00880568|470458730|FG000|Overall Study|Adverse Event|0|||
130680915|NCT00880568|470458731|FG001|Overall Study|Adverse Event|0|||
130680916|NCT00880568|470458732|FG002|Overall Study|Adverse Event|0|||
130680917|NCT00880568|470458733|FG003|Overall Study|Adverse Event|0|||
130680918|NCT00880568|470458734|FG004|Overall Study|Adverse Event|0|||
130680919|NCT00880568|470458735|FG005|Overall Study|Adverse Event|0|||
130680920|NCT00880568|470458736|FG006|Overall Study|Adverse Event|1|||
130680921|NCT00880568|470458737|FG007|Overall Study|Adverse Event|1|||
130680922|NCT00880568|470458738|FG008|Overall Study|Adverse Event|0|||
130680923|NCT00880568|470458730|FG000|Overall Study|Withdrawal by Subject|0|||
130680924|NCT00880568|470458731|FG001|Overall Study|Withdrawal by Subject|0|||
130680925|NCT00880568|470458732|FG002|Overall Study|Withdrawal by Subject|0|||
130680926|NCT00880568|470458733|FG003|Overall Study|Withdrawal by Subject|0|||
130680927|NCT00880568|470458734|FG004|Overall Study|Withdrawal by Subject|0|||
130680928|NCT00880568|470458735|FG005|Overall Study|Withdrawal by Subject|0|||
130680929|NCT00880568|470458736|FG006|Overall Study|Withdrawal by Subject|0|||
130680930|NCT00880568|470458737|FG007|Overall Study|Withdrawal by Subject|1|||
130680931|NCT00880568|470458738|FG008|Overall Study|Withdrawal by Subject|0|||
130680932|NCT00849901|470458742|FG000|Acute Treatment Phase|Adverse Event|9|||
130680933|NCT00849901|470458743|FG001|Acute Treatment Phase|Adverse Event|1|||
130680934|NCT00849901|470458744|FG002|Acute Treatment Phase|Adverse Event|3|||
130680935|NCT00849901|470458742|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
130680936|NCT00849901|470458743|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
130680937|NCT00849901|470458744|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
130680938|NCT00849901|470458742|FG000|Acute Treatment Phase|Protocol Violation|0|||
130680939|NCT00849901|470458743|FG001|Acute Treatment Phase|Protocol Violation|2|||
130680940|NCT00849901|470458744|FG002|Acute Treatment Phase|Protocol Violation|1|||
130680941|NCT00849901|470458742|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
130680942|NCT00849901|470458743|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130680943|NCT00849901|470458744|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
130680944|NCT00849901|470458742|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
130680945|NCT00849901|470458743|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
130680946|NCT00849901|470458744|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
130680947|NCT00849901|470458742|FG000|Acute Treatment Phase|Physician Decision|1|||
130436241|NCT02387216|469560589|FG000|Overall Study|Progressive disease|2|||
130436242|NCT02387216|469560590|FG001|Overall Study|Progressive disease|0|||
130436243|NCT02387216|469560589|FG000|Overall Study|Withdrawal by Subject|3|||
130436244|NCT02387216|469560590|FG001|Overall Study|Withdrawal by Subject|5|||
130436245|NCT02387216|469560589|FG000|Overall Study|Physician Decision|2|||
130680948|NCT00849901|470458743|FG001|Acute Treatment Phase|Physician Decision|1|||
130680949|NCT00849901|470458744|FG002|Acute Treatment Phase|Physician Decision|1|||
130680950|NCT00849901|470458742|FG000|Acute Treatment Phase|Sponsor Decision|1|||
130680951|NCT00849901|470458743|FG001|Acute Treatment Phase|Sponsor Decision|0|||
130436246|NCT02387216|469560590|FG001|Overall Study|Physician Decision|0|||
130680952|NCT00849901|470458744|FG002|Acute Treatment Phase|Sponsor Decision|0|||
130680953|NCT00849901|470458742|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130680954|NCT00849901|470458743|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
130680955|NCT00849901|470458744|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
130680956|NCT00849901|470458742|FG000|Extension Phase|Adverse Event|2|||
130680957|NCT00849901|470458743|FG001|Extension Phase|Adverse Event|8|||
130680958|NCT00849901|470458744|FG002|Extension Phase|Adverse Event|4|||
130680959|NCT00849901|470458742|FG000|Extension Phase|Lost to Follow-up|3|||
130680960|NCT00849901|470458743|FG001|Extension Phase|Lost to Follow-up|0|||
130680961|NCT00849901|470458744|FG002|Extension Phase|Lost to Follow-up|1|||
130680962|NCT00849901|470458742|FG000|Extension Phase|Protocol Violation|2|||
130680963|NCT00849901|470458743|FG001|Extension Phase|Protocol Violation|2|||
130680964|NCT00849901|470458744|FG002|Extension Phase|Protocol Violation|4|||
130680965|NCT00849901|470458742|FG000|Extension Phase|Withdrawal by Subject|7|||
130680966|NCT00849901|470458743|FG001|Extension Phase|Withdrawal by Subject|6|||
130680967|NCT00849901|470458744|FG002|Extension Phase|Withdrawal by Subject|3|||
130680968|NCT00849901|470458742|FG000|Extension Phase|Parent or Caregiver Decision|10|||
130680969|NCT00849901|470458743|FG001|Extension Phase|Parent or Caregiver Decision|4|||
130680970|NCT00849901|470458744|FG002|Extension Phase|Parent or Caregiver Decision|4|||
130680971|NCT00849901|470458742|FG000|Extension Phase|Physician Decision|1|||
130680972|NCT00849901|470458743|FG001|Extension Phase|Physician Decision|2|||
130680973|NCT00849901|470458744|FG002|Extension Phase|Physician Decision|0|||
130680974|NCT00849901|470458742|FG000|Extension Phase|Lack of Efficacy|2|||
130680975|NCT00849901|470458743|FG001|Extension Phase|Lack of Efficacy|4|||
130680976|NCT00849901|470458744|FG002|Extension Phase|Lack of Efficacy|1|||
130680977|NCT00262223|470458745|FG000|Treatment Phase|Withdrawal by Subject|3|||
130680978|NCT00262223|470458746|FG001|Treatment Phase|Withdrawal by Subject|6|||
130680979|NCT00262223|470458745|FG000|Treatment Phase|Adverse Event|1|||
130680980|NCT00262223|470458746|FG001|Treatment Phase|Adverse Event|2|||
130680981|NCT00262223|470458745|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130680982|NCT00262223|470458746|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130680983|NCT00262223|470458745|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
130680984|NCT00262223|470458746|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
130680985|NCT00262223|470458745|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130680986|NCT00262223|470458746|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130680987|NCT01804270|470458749|FG000|Overall Study|Withdrawal by Subject|1|||
130680988|NCT01804270|470458750|FG001|Overall Study|Withdrawal by Subject|1|||
130680989|NCT02152566|470458752|FG000|Overall Study|Lost to Follow-up|1|||
130680990|NCT02152566|470458752|FG000|Overall Study|Withdrawal by Subject|2|||
130680991|NCT01328093|470458756|FG000|Double-Blind Phase|Adverse Event|78|||
130680992|NCT01328093|470458757|FG001|Double-Blind Phase|Adverse Event|15|||
130680993|NCT01328093|470458756|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
130680994|NCT01328093|470458757|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
130680995|NCT01328093|470458756|FG000|Double-Blind Phase|Lost to Follow-up|39|||
130680996|NCT01328093|470458757|FG001|Double-Blind Phase|Lost to Follow-up|14|||
130680997|NCT01328093|470458756|FG000|Double-Blind Phase|Protocol Violation|30|||
130680998|NCT01328093|470458757|FG001|Double-Blind Phase|Protocol Violation|10|||
130680999|NCT01328093|470458756|FG000|Double-Blind Phase|Lack of Efficacy|55|||
130681000|NCT01328093|470458757|FG001|Double-Blind Phase|Lack of Efficacy|13|||
130681001|NCT01328093|470458756|FG000|Double-Blind Phase|Sponsor Decision|17|||
130681002|NCT01328093|470458757|FG001|Double-Blind Phase|Sponsor Decision|3|||
130681003|NCT01328093|470458756|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
130681004|NCT01328093|470458757|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
130681005|NCT01328093|470458756|FG000|Double-Blind Phase|Scheduling conflict|8|||
130681006|NCT01328093|470458757|FG001|Double-Blind Phase|Scheduling conflict|3|||
130681007|NCT01328093|470458756|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
130681008|NCT01328093|470458757|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
130681009|NCT01328093|470458756|FG000|Double-Blind Phase|Death|1|||
130681010|NCT01328093|470458757|FG001|Double-Blind Phase|Death|0|||
130681011|NCT01328093|470458756|FG000|Open-Label Phase|Sponsor Decision|98|||
130681012|NCT01328093|470458757|FG001|Open-Label Phase|Sponsor Decision|34|||
130681013|NCT01328093|470458756|FG000|Open-Label Phase|Protocol Violation|8|||
130681014|NCT01328093|470458757|FG001|Open-Label Phase|Protocol Violation|3|||
130681015|NCT01328093|470458756|FG000|Open-Label Phase|Lost to Follow-up|10|||
130681016|NCT01328093|470458757|FG001|Open-Label Phase|Lost to Follow-up|1|||
130681017|NCT01328093|470458756|FG000|Open-Label Phase|Adverse Event|10|||
130681018|NCT01328093|470458757|FG001|Open-Label Phase|Adverse Event|4|||
130347387|NCT01239732|469243636|FG000|Overall Study|Withdrawal by Subject|87|||
130347388|NCT01239732|469243636|FG000|Overall Study|Adverse Event|6|||
130347389|NCT01239732|469243636|FG000|Overall Study|Protocol Violation|3|||
130681019|NCT01328093|470458756|FG000|Open-Label Phase|Lack of Efficacy|5|||
130681020|NCT01328093|470458757|FG001|Open-Label Phase|Lack of Efficacy|6|||
130681021|NCT01328093|470458756|FG000|Open-Label Phase|Withdrawal by Subject|4|||
130681022|NCT01328093|470458757|FG001|Open-Label Phase|Withdrawal by Subject|1|||
130347390|NCT01239732|469243636|FG000|Overall Study|Participant non compliance|5|||
130681023|NCT01328093|470458756|FG000|Open-Label Phase|Scheduling conflict|2|||
130681024|NCT01328093|470458757|FG001|Open-Label Phase|Scheduling conflict|1|||
130681025|NCT01328093|470458756|FG000|Open-Label Phase|Subject is moving or has moved|2|||
130681026|NCT01328093|470458757|FG001|Open-Label Phase|Subject is moving or has moved|0|||
130681027|NCT01328093|470458756|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
130681028|NCT01328093|470458757|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
130681029|NCT00832377|470458758|FG000|Overall Study|Protocol Violation|1|||
130681030|NCT03661528|470458759|FG000|Overall Study|Death|1|||
130681031|NCT03661528|470458760|FG001|Overall Study|Death|0|||
130681032|NCT03661528|470458759|FG000|Overall Study|Physician Decision|3|||
130681033|NCT03661528|470458760|FG001|Overall Study|Physician Decision|1|||
130681034|NCT03661528|470458759|FG000|Overall Study|Other than Specified|5|||
130681035|NCT03661528|470458760|FG001|Overall Study|Other than Specified|2|||
130681036|NCT03661528|470458759|FG000|Overall Study|Withdrawal by Subject|5|||
130681037|NCT03661528|470458760|FG001|Overall Study|Withdrawal by Subject|3|||
130681038|NCT03661528|470458759|FG000|Overall Study|Disease Progression|8|||
130681039|NCT03661528|470458760|FG001|Overall Study|Disease Progression|13|||
130681040|NCT03661528|470458759|FG000|Overall Study|Adverse Event|61|||
130681041|NCT03661528|470458760|FG001|Overall Study|Adverse Event|55|||
130681042|NCT00925769|470458762|FG000|Overall Study|Major toxicity|1|||
130681043|NCT00925769|470458763|FG001|Overall Study|Major toxicity|0|||
130681044|NCT00925769|470458764|FG002|Overall Study|Major toxicity|1|||
130681045|NCT00925769|470458765|FG003|Overall Study|Major toxicity|1|||
130681046|NCT00925769|470458766|FG004|Overall Study|Major toxicity|0|||
130681047|NCT00925769|470458767|FG005|Overall Study|Major toxicity|0|||
130681048|NCT00925769|470458762|FG000|Overall Study|Disease progression|4|||
130681049|NCT00925769|470458763|FG001|Overall Study|Disease progression|5|||
130681050|NCT00925769|470458764|FG002|Overall Study|Disease progression|3|||
130681051|NCT00925769|470458765|FG003|Overall Study|Disease progression|4|||
130681052|NCT00925769|470458766|FG004|Overall Study|Disease progression|2|||
130681053|NCT00925769|470458767|FG005|Overall Study|Disease progression|3|||
130681054|NCT00925769|470458762|FG000|Overall Study|Death|0|||
130681055|NCT00925769|470458763|FG001|Overall Study|Death|0|||
130681056|NCT00925769|470458764|FG002|Overall Study|Death|1|||
130681057|NCT00925769|470458765|FG003|Overall Study|Death|0|||
130681058|NCT00925769|470458766|FG004|Overall Study|Death|0|||
130681059|NCT00925769|470458767|FG005|Overall Study|Death|0|||
130681060|NCT00925769|470458762|FG000|Overall Study|Physician Decision|1|||
130681061|NCT00925769|470458763|FG001|Overall Study|Physician Decision|0|||
130681062|NCT00925769|470458764|FG002|Overall Study|Physician Decision|0|||
130681063|NCT00925769|470458765|FG003|Overall Study|Physician Decision|0|||
130681064|NCT00925769|470458766|FG004|Overall Study|Physician Decision|0|||
130681065|NCT00925769|470458767|FG005|Overall Study|Physician Decision|0|||
130681066|NCT00925769|470458762|FG000|Overall Study|Missing documentation|0|||
130681067|NCT00925769|470458763|FG001|Overall Study|Missing documentation|1|||
130681068|NCT00925769|470458764|FG002|Overall Study|Missing documentation|0|||
130681069|NCT00925769|470458765|FG003|Overall Study|Missing documentation|0|||
130681070|NCT00925769|470458766|FG004|Overall Study|Missing documentation|0|||
130681071|NCT00925769|470458767|FG005|Overall Study|Missing documentation|0|||
130681072|NCT00925769|470458762|FG000|Overall Study|End of study visit not done|0|||
130681073|NCT00925769|470458763|FG001|Overall Study|End of study visit not done|0|||
130681074|NCT00925769|470458764|FG002|Overall Study|End of study visit not done|1|||
130681075|NCT00925769|470458765|FG003|Overall Study|End of study visit not done|0|||
130681076|NCT00925769|470458766|FG004|Overall Study|End of study visit not done|0|||
130681077|NCT00925769|470458767|FG005|Overall Study|End of study visit not done|0|||
130681078|NCT00925769|470458762|FG000|Overall Study|Participant is unable to swallow drug|0|||
130681079|NCT00925769|470458763|FG001|Overall Study|Participant is unable to swallow drug|0|||
130681080|NCT00925769|470458764|FG002|Overall Study|Participant is unable to swallow drug|0|||
130681081|NCT00925769|470458765|FG003|Overall Study|Participant is unable to swallow drug|1|||
130681082|NCT00925769|470458766|FG004|Overall Study|Participant is unable to swallow drug|0|||
130681083|NCT00925769|470458767|FG005|Overall Study|Participant is unable to swallow drug|0|||
130681084|NCT00925769|470458762|FG000|Overall Study|Adverse Event|0|||
130681085|NCT00925769|470458763|FG001|Overall Study|Adverse Event|0|||
130681086|NCT00925769|470458764|FG002|Overall Study|Adverse Event|0|||
130681087|NCT00925769|470458765|FG003|Overall Study|Adverse Event|0|||
130681088|NCT00925769|470458766|FG004|Overall Study|Adverse Event|1|||
130681089|NCT00925769|470458767|FG005|Overall Study|Adverse Event|0|||
130681090|NCT02017964|470458768|FG000|Overall Study|Patient deemed ineligible|1|||
130681091|NCT01449630|470458770|FG000|Period 1|Physician Decision|1|||
130681092|NCT01449630|470458771|FG001|Period 1|Physician Decision|0|||
130681093|NCT01449630|470458772|FG002|Period 1|Physician Decision|0|||
130681094|NCT01449630|470458773|FG003|Period 1|Physician Decision|1|||
130681095|NCT01449630|470458774|FG004|Period 1|Physician Decision|0|||
130681096|NCT01449630|470458775|FG005|Period 1|Physician Decision|0|||
130681097|NCT01449630|470458776|FG006|Period 1|Physician Decision|0|||
130681098|NCT01449630|470458777|FG007|Period 1|Physician Decision|0|||
130681099|NCT01449630|470458778|FG008|Period 1|Physician Decision|0|||
130681100|NCT01449630|470458770|FG000|Period 1|Sponsor Decision|0|||
130681101|NCT01449630|470458771|FG001|Period 1|Sponsor Decision|0|||
130681102|NCT01449630|470458772|FG002|Period 1|Sponsor Decision|0|||
130681103|NCT01449630|470458773|FG003|Period 1|Sponsor Decision|0|||
130436247|NCT02387216|469560589|FG000|Overall Study|Sponsor Decision|28|||
130436248|NCT02387216|469560590|FG001|Overall Study|Sponsor Decision|12|||
130436249|NCT02387216|469560589|FG000|Overall Study|Death|60|||
130436250|NCT02387216|469560590|FG001|Overall Study|Death|23|||
130436251|NCT02387216|469560589|FG000|Overall Study|Other|5|||
130436252|NCT02387216|469560590|FG001|Overall Study|Other|4|||
130436253|NCT02387216|469560589|FG000|Overall Study|Lost to Follow-up|0|||
130436254|NCT02387216|469560590|FG001|Overall Study|Lost to Follow-up|3|||
130436255|NCT05952297|469560592|FG000|Overall Study|Withdrawal by Subject|1|||
130436256|NCT05952297|469560593|FG001|Overall Study|Withdrawal by Subject|0|||
130436257|NCT00525265|469560596|FG000|Overall Study|Protocol Violation|1|||
130436258|NCT00525265|469560597|FG001|Overall Study|Protocol Violation|0|||
130436259|NCT03107377|469560598|FG000|Overall Study|Adverse Event|3|||
130436260|NCT03107377|469560599|FG001|Overall Study|Adverse Event|3|||
130436261|NCT03107377|469560598|FG000|Overall Study|Protocol Violation|9|||
130681104|NCT01449630|470458774|FG004|Period 1|Sponsor Decision|0|||
130681105|NCT01449630|470458775|FG005|Period 1|Sponsor Decision|1|||
130681106|NCT01449630|470458776|FG006|Period 1|Sponsor Decision|0|||
130216652|NCT00492232|468755624|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
130216653|NCT00492232|468755625|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
130681107|NCT01449630|470458777|FG007|Period 1|Sponsor Decision|0|||
130681108|NCT01449630|470458778|FG008|Period 1|Sponsor Decision|0|||
130681109|NCT01449630|470458770|FG000|Period 2|Sponsor Decision|0|||
130681110|NCT01449630|470458771|FG001|Period 2|Sponsor Decision|0|||
130681111|NCT01449630|470458772|FG002|Period 2|Sponsor Decision|0|||
130216654|NCT00492232|468755624|FG000|Double-Blind Treatment|Other|6|||
130216655|NCT00492232|468755625|FG001|Double-Blind Treatment|Other|5|||
130216656|NCT00492232|468755624|FG000|Double-Blind Treatment|Randomized not treated|1|||
130216657|NCT00492232|468755625|FG001|Double-Blind Treatment|Randomized not treated|0|||
130681112|NCT01449630|470458773|FG003|Period 2|Sponsor Decision|0|||
130681113|NCT01449630|470458774|FG004|Period 2|Sponsor Decision|0|||
130681114|NCT01449630|470458775|FG005|Period 2|Sponsor Decision|0|||
130681115|NCT01449630|470458776|FG006|Period 2|Sponsor Decision|1|||
130681116|NCT01449630|470458777|FG007|Period 2|Sponsor Decision|0|||
130681117|NCT01449630|470458778|FG008|Period 2|Sponsor Decision|0|||
130681118|NCT01735630|470458783|FG000|Overall Study|Adverse Event|8|||
130681119|NCT01735630|470458784|FG001|Overall Study|Adverse Event|7|||
130681120|NCT01735630|470458783|FG000|Overall Study|Lost to Follow-up|1|||
130681121|NCT01735630|470458784|FG001|Overall Study|Lost to Follow-up|0|||
130681122|NCT01735630|470458783|FG000|Overall Study|Physician Decision|0|||
130681123|NCT01735630|470458784|FG001|Overall Study|Physician Decision|1|||
130681124|NCT01735630|470458783|FG000|Overall Study|Sponsor Decision|2|||
130681125|NCT01735630|470458784|FG001|Overall Study|Sponsor Decision|1|||
130681126|NCT01735630|470458783|FG000|Overall Study|Withdrawal by Subject|7|||
130681127|NCT01735630|470458784|FG001|Overall Study|Withdrawal by Subject|9|||
130681128|NCT03099538|470458785|FG000|Overall Study|Lack of Efficacy|3|||
130681129|NCT01720264|470458786|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
130681130|NCT01720264|470458786|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
130681131|NCT01720264|470458786|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
130681132|NCT00615069|470458796|FG000|Overall Study|Death|10|||
130681133|NCT00615069|470458796|FG000|Overall Study|Physician Decision|2|||
130681134|NCT00615069|470458796|FG000|Overall Study|Withdrawal by Subject|4|||
130681135|NCT00259012|470458798|FG000|Overall Study|Adverse Event|0|||
130681136|NCT00259012|470458799|FG001|Overall Study|Adverse Event|1|||
130681137|NCT00259012|470458798|FG000|Overall Study|Withdrawal by Subject|1|||
130681138|NCT00259012|470458799|FG001|Overall Study|Withdrawal by Subject|0|||
130681139|NCT00259012|470458798|FG000|Overall Study|Physician Decision|0|||
130681140|NCT00259012|470458799|FG001|Overall Study|Physician Decision|1|||
130681141|NCT00259012|470458798|FG000|Overall Study|Lost to Follow-up|0|||
130681142|NCT00259012|470458799|FG001|Overall Study|Lost to Follow-up|1|||
130681143|NCT00259012|470458798|FG000|Overall Study|Protocol Violation|1|||
130681144|NCT00259012|470458799|FG001|Overall Study|Protocol Violation|1|||
130216658|NCT00492232|468755624|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
130216659|NCT00492232|468755625|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130216660|NCT01216332|468755626|FG000|Overall Study|Withdrawal by Subject|4|||
130681145|NCT01941030|470458805|FG000|Overall Study|Death|3|||
130681146|NCT01941030|470458806|FG001|Overall Study|Death|2|||
130681147|NCT01941030|470458805|FG000|Overall Study|Lost to Follow-up|6|||
130681148|NCT01941030|470458806|FG001|Overall Study|Lost to Follow-up|5|||
130681149|NCT01941030|470458805|FG000|Overall Study|Withdrawal by Subject|4|||
130216661|NCT01216332|468755627|FG001|Overall Study|Withdrawal by Subject|0|||
130216662|NCT00636636|468755628|FG000|Overall Study|Other reason|4|||
130436262|NCT03107377|469560599|FG001|Overall Study|Protocol Violation|12|||
130436263|NCT03107377|469560598|FG000|Overall Study|Physician Decision|3|||
130436264|NCT03107377|469560599|FG001|Overall Study|Physician Decision|6|||
130436265|NCT03107377|469560598|FG000|Overall Study|Pregnancy|7|||
130436266|NCT03107377|469560599|FG001|Overall Study|Pregnancy|7|||
130436267|NCT03107377|469560598|FG000|Overall Study|Withdrawal by Subject|16|||
130681150|NCT01941030|470458806|FG001|Overall Study|Withdrawal by Subject|6|||
130681151|NCT01479439|470458810|FG000|Overall Study|Adverse Event|1|||
130681152|NCT01479439|470458811|FG001|Overall Study|Adverse Event|0|||
130216663|NCT00636636|468755629|FG001|Overall Study|Other reason|6|||
130216664|NCT00636636|468755628|FG000|Overall Study|Adverse Event|19|||
130216665|NCT00636636|468755629|FG001|Overall Study|Adverse Event|8|||
130216666|NCT00636636|468755628|FG000|Overall Study|Lack of Efficacy|7|||
130216667|NCT00636636|468755629|FG001|Overall Study|Lack of Efficacy|12|||
130216668|NCT00636636|468755628|FG000|Overall Study|Protocol Violation|2|||
130216669|NCT00636636|468755629|FG001|Overall Study|Protocol Violation|2|||
130216670|NCT00636636|468755628|FG000|Overall Study|Lost to Follow-up|0|||
130216671|NCT00636636|468755629|FG001|Overall Study|Lost to Follow-up|1|||
130216672|NCT00636636|468755628|FG000|Overall Study|Death|0|||
130216673|NCT00636636|468755629|FG001|Overall Study|Death|1|||
130216674|NCT00636636|468755628|FG000|Overall Study|Withdrawal by Subject|4|||
130216675|NCT00636636|468755629|FG001|Overall Study|Withdrawal by Subject|9|||
130216676|NCT00524173|468755630|FG000|Overall Study|Lost to Follow-up|0|||
130216677|NCT00524173|468755631|FG001|Overall Study|Lost to Follow-up|1|||
130216678|NCT00524173|468755630|FG000|Overall Study|Death|1|||
130216679|NCT00524173|468755631|FG001|Overall Study|Death|0|||
130216680|NCT00524173|468755630|FG000|Overall Study|Had not reached endpoint at study close|4|||
130216681|NCT00524173|468755631|FG001|Overall Study|Had not reached endpoint at study close|1|||
130216682|NCT01025284|468757178|FG000|Overall Study|Investigator Decision|0|||
130216683|NCT01025284|468757179|FG001|Overall Study|Investigator Decision|1|||
130216684|NCT01025284|468757180|FG002|Overall Study|Investigator Decision|0|||
130216685|NCT01025284|468757178|FG000|Overall Study|Withdrawal by Subject|0|||
130216686|NCT01025284|468757179|FG001|Overall Study|Withdrawal by Subject|1|||
130216687|NCT01025284|468757180|FG002|Overall Study|Withdrawal by Subject|0|||
130216688|NCT02753816|468757182|FG000|Overall Study|Protocol Violation|0|||
130216689|NCT02753816|468757183|FG001|Overall Study|Protocol Violation|1|||
130216690|NCT02753816|468757184|FG002|Overall Study|Protocol Violation|0|||
130216691|NCT01465230|468757185|FG000|Overall Study|Withdrawal by Subject|2|||
130216692|NCT00905567|468757186|FG000|Washout|Withdrawal by Subject|0|||
130216693|NCT00905567|468757187|FG001|Washout|Withdrawal by Subject|1|||
130216694|NCT02542397|468757188|FG000|Overall Study|Death|2|||
130216695|NCT02542397|468757188|FG000|Overall Study|Physician Decision|6|||
130216696|NCT02542397|468757188|FG000|Overall Study|Withdrawal by Subject|6|||
130216697|NCT02542397|468757188|FG000|Overall Study|Lost to Follow-up|2|||
130216698|NCT01738919|468757195|FG000|Overall Study|Lost to Follow-up|1|||
130681153|NCT01479439|470458812|FG002|Overall Study|Adverse Event|0|||
130681154|NCT01479439|470458810|FG000|Overall Study|Lost to Follow-up|0|||
130681155|NCT01479439|470458811|FG001|Overall Study|Lost to Follow-up|1|||
130681156|NCT01479439|470458812|FG002|Overall Study|Lost to Follow-up|0|||
130681157|NCT01479439|470458810|FG000|Overall Study|Protocol Violation|0|||
130681158|NCT01479439|470458811|FG001|Overall Study|Protocol Violation|0|||
130681159|NCT01479439|470458812|FG002|Overall Study|Protocol Violation|2|||
130681160|NCT01936948|470458813|FG000|Overall Study|no 30-day follow-up data|0|||
130216699|NCT01738919|468757196|FG001|Overall Study|Lost to Follow-up|0|||
130216700|NCT01738919|468757195|FG000|Overall Study|Immigrated|0|||
130216701|NCT01738919|468757196|FG001|Overall Study|Immigrated|1|||
130216702|NCT01738919|468757195|FG000|Overall Study|Withdrawal by Subject|0|||
130216703|NCT01738919|468757196|FG001|Overall Study|Withdrawal by Subject|1|||
130216704|NCT01738919|468757195|FG000|Overall Study|Not treated in accordance to guidelines|0|||
130216705|NCT01738919|468757196|FG001|Overall Study|Not treated in accordance to guidelines|1|||
130216706|NCT01473940|468757200|FG000|Induction Therapy|Death|0|||
130216707|NCT01473940|468757201|FG001|Induction Therapy|Death|0|||
130216708|NCT01473940|468757202|FG002|Induction Therapy|Death|1|||
130216709|NCT01473940|468757203|FG003|Induction Therapy|Death|1|||
130681161|NCT01936948|470458814|FG001|Overall Study|no 30-day follow-up data|3|||
130681162|NCT01936948|470458815|FG002|Overall Study|no 30-day follow-up data|3|||
130681163|NCT01936948|470458816|FG003|Overall Study|no 30-day follow-up data|3|||
130681164|NCT02365207|470458817|FG000|Overall Study|Withdrawal by Subject|1|||
130681165|NCT02365207|470458817|FG000|Overall Study|Physician Decision|1|||
130681166|NCT02930005|470458818|FG000|Overall Study|Lost to Follow-up|1|||
130681167|NCT02930005|470458819|FG001|Overall Study|Lost to Follow-up|5|||
130681168|NCT02781727|470458820|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
130216710|NCT01473940|468757200|FG000|Induction Therapy|Progressive Disease|0|||
130681169|NCT02781727|470458821|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
130681170|NCT02781727|470458820|FG000|Treatment Period|Withdrawal by Subject|1|||
130216711|NCT01473940|468757201|FG001|Induction Therapy|Progressive Disease|1|||
130216712|NCT01473940|468757202|FG002|Induction Therapy|Progressive Disease|1|||
130216713|NCT01473940|468757203|FG003|Induction Therapy|Progressive Disease|0|||
130347391|NCT01239732|469243636|FG000|Overall Study|Study termination by sponsor|2|||
130216714|NCT01473940|468757200|FG000|Maintenance Therapy|Progressive Disease|1|||
130216715|NCT01473940|468757201|FG001|Maintenance Therapy|Progressive Disease|2|||
130216716|NCT01473940|468757202|FG002|Maintenance Therapy|Progressive Disease|1|||
130681171|NCT02781727|470458821|FG001|Treatment Period|Withdrawal by Subject|0|||
130216717|NCT01473940|468757203|FG003|Maintenance Therapy|Progressive Disease|4|||
130216718|NCT00547248|468757204|FG000|Overall Study|Protocol Violation|0|||
130216719|NCT00547248|468757205|FG001|Overall Study|Protocol Violation|0|||
130216720|NCT00547248|468757206|FG002|Overall Study|Protocol Violation|1|||
130681172|NCT02781727|470458820|FG000|Treatment Period|Lost to Follow-up|0|||
130216721|NCT00547248|468757207|FG003|Overall Study|Protocol Violation|1|||
130216722|NCT00547248|468757204|FG000|Overall Study|Migrated/moved from study area|0|||
130216723|NCT00547248|468757205|FG001|Overall Study|Migrated/moved from study area|0|||
130216724|NCT00547248|468757206|FG002|Overall Study|Migrated/moved from study area|2|||
130216725|NCT00547248|468757207|FG003|Overall Study|Migrated/moved from study area|0|||
130216726|NCT00547248|468757204|FG000|Overall Study|Withdrawal by Subject|0|||
130216727|NCT00547248|468757205|FG001|Overall Study|Withdrawal by Subject|0|||
130216728|NCT00547248|468757206|FG002|Overall Study|Withdrawal by Subject|7|||
130216729|NCT00547248|468757207|FG003|Overall Study|Withdrawal by Subject|1|||
130216730|NCT00534248|468757210|FG000|Overall Study|Adverse Event|19|||
130216731|NCT00534248|468757211|FG001|Overall Study|Adverse Event|29|||
130216732|NCT00534248|468757210|FG000|Overall Study|Lost to Follow-up|353|||
130216733|NCT00534248|468757211|FG001|Overall Study|Lost to Follow-up|375|||
130216734|NCT00534248|468757210|FG000|Overall Study|Other protocol specified criteria|13|||
130216735|NCT00534248|468757211|FG001|Overall Study|Other protocol specified criteria|3|||
130216736|NCT00534248|468757210|FG000|Overall Study|Physician Decision|10|||
130216737|NCT00534248|468757211|FG001|Overall Study|Physician Decision|7|||
130216738|NCT00534248|468757210|FG000|Overall Study|Protocol Violation|3|||
130216739|NCT00534248|468757211|FG001|Overall Study|Protocol Violation|4|||
130216740|NCT00534248|468757210|FG000|Overall Study|Withdrawal by Subject|263|||
130216741|NCT00534248|468757211|FG001|Overall Study|Withdrawal by Subject|255|||
130216742|NCT02532257|468757212|FG000|Overall Study|Adverse Event|2|||
130216743|NCT02532257|468757212|FG000|Overall Study|Physician Decision|4|||
130216744|NCT02532257|468757212|FG000|Overall Study|Withdrawal by Subject|3|||
130216745|NCT02532257|468757212|FG000|Overall Study|Progressive Disease|10|||
130216746|NCT02849171|468757213|FG000|Overall Study|Withdrawal by Subject|1|||
130216747|NCT02849171|468757213|FG000|Overall Study|Not treated|1|||
130216748|NCT02259400|468757216|FG000|Overall Study|Death|0|||
130216749|NCT02259400|468757217|FG001|Overall Study|Death|2|||
130216750|NCT00697593|468757221|FG000|Overall Study|Adverse Event|3|||
130216751|NCT00697593|468757221|FG000|Overall Study|Protocol Violation|1|||
130216752|NCT00697593|468757221|FG000|Overall Study|Lack of Efficacy|3|||
130216753|NCT00697593|468757221|FG000|Overall Study|Suspension of the study by sponsor|12|||
130216754|NCT02964338|468757225|FG000|Overall Study|Sponsor terminated study for futility|12|||
130216755|NCT02964338|468757226|FG001|Overall Study|Sponsor terminated study for futility|15|||
130216756|NCT02964338|468757227|FG002|Overall Study|Sponsor terminated study for futility|14|||
130216757|NCT02964338|468757225|FG000|Overall Study|Lack of Efficacy|0|||
130216758|NCT02964338|468757226|FG001|Overall Study|Lack of Efficacy|3|||
130216759|NCT02964338|468757227|FG002|Overall Study|Lack of Efficacy|0|||
130216760|NCT02964338|468757225|FG000|Overall Study|Lost to Follow-up|1|||
130216761|NCT02964338|468757226|FG001|Overall Study|Lost to Follow-up|0|||
130216762|NCT02964338|468757227|FG002|Overall Study|Lost to Follow-up|3|||
130216763|NCT02964338|468757225|FG000|Overall Study|Protocol Violation|0|||
130216764|NCT02964338|468757226|FG001|Overall Study|Protocol Violation|1|||
130216765|NCT02964338|468757227|FG002|Overall Study|Protocol Violation|0|||
130216766|NCT02964338|468757225|FG000|Overall Study|Withdrawal by Subject|1|||
130216767|NCT02964338|468757226|FG001|Overall Study|Withdrawal by Subject|3|||
130216768|NCT02964338|468757227|FG002|Overall Study|Withdrawal by Subject|1|||
130216769|NCT02964338|468757225|FG000|Overall Study|Adverse Event|2|||
130216770|NCT02964338|468757226|FG001|Overall Study|Adverse Event|1|||
130216771|NCT02964338|468757227|FG002|Overall Study|Adverse Event|1|||
130216772|NCT02964338|468757225|FG000|Overall Study|Non-compliant with e-diary|0|||
130216773|NCT02964338|468757226|FG001|Overall Study|Non-compliant with e-diary|1|||
130216774|NCT02964338|468757227|FG002|Overall Study|Non-compliant with e-diary|0|||
130216775|NCT02964338|468757225|FG000|Overall Study|Did not meet criteria|1|||
130216776|NCT02964338|468757226|FG001|Overall Study|Did not meet criteria|0|||
130681173|NCT02781727|470458821|FG001|Treatment Period|Lost to Follow-up|1|||
130681174|NCT01378975|470458825|FG000|Overall Study|Death|77|||
130681175|NCT01378975|470458826|FG001|Overall Study|Death|46|||
130681176|NCT01378975|470458825|FG000|Overall Study|Investigator Request|1|||
130681177|NCT01378975|470458826|FG001|Overall Study|Investigator Request|0|||
130681178|NCT01378975|470458825|FG000|Overall Study|Lost to Follow-up|4|||
130681179|NCT01378975|470458826|FG001|Overall Study|Lost to Follow-up|1|||
130681180|NCT01378975|470458825|FG000|Overall Study|Withdrew Consent|4|||
130681181|NCT01378975|470458826|FG001|Overall Study|Withdrew Consent|3|||
130681182|NCT03991494|470458829|FG000|Overall Study|Progressive Disease|4|||
130681183|NCT02924038|470460234|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130216777|NCT02964338|468757227|FG002|Overall Study|Did not meet criteria|0|||
130216778|NCT02239640|468757230|FG000|Overall Study|Withdrawal by Subject|3|||
130216779|NCT02239640|468757230|FG000|Overall Study|Lost to Follow-up|72|||
130216780|NCT02239640|468757230|FG000|Overall Study|Death|142|||
130216781|NCT02630563|468757231|FG000|Overall Study|Administrative|1|||
130216782|NCT02372383|468757232|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
130216783|NCT02372383|468757233|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
130216784|NCT02372383|468757234|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
130216785|NCT00621257|468757235|FG000|Overall Study|Lost to Follow-up|4|||
130216786|NCT00621257|468757236|FG001|Overall Study|Lost to Follow-up|0|||
130681184|NCT02924038|470460235|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130681185|NCT01108094|470460236|FG000|Overall Study|Adverse Event|2|||
130681186|NCT01108094|470460237|FG001|Overall Study|Adverse Event|0|||
130681187|NCT01108094|470460238|FG002|Overall Study|Adverse Event|0|||
130681188|NCT01108094|470460239|FG003|Overall Study|Adverse Event|0|||
130681189|NCT01108094|470460236|FG000|Overall Study|Withdrawal by Subject|1|||
130681190|NCT01108094|470460237|FG001|Overall Study|Withdrawal by Subject|0|||
130681191|NCT01108094|470460238|FG002|Overall Study|Withdrawal by Subject|0|||
130681192|NCT01108094|470460239|FG003|Overall Study|Withdrawal by Subject|0|||
130681193|NCT01101022|470460250|FG000|Overall Study|Adverse Event|6|||
130681194|NCT01101022|470460251|FG001|Overall Study|Adverse Event|2|||
130681195|NCT01101022|470460250|FG000|Overall Study|Protocol Violation|4|||
130681196|NCT01101022|470460251|FG001|Overall Study|Protocol Violation|3|||
130681197|NCT01101022|470460250|FG000|Overall Study|Withdrawal by Subject|3|||
130681198|NCT01101022|470460251|FG001|Overall Study|Withdrawal by Subject|8|||
130681199|NCT01101022|470460250|FG000|Overall Study|Lost to Follow-up|1|||
130681200|NCT01101022|470460251|FG001|Overall Study|Lost to Follow-up|4|||
130681201|NCT01101022|470460250|FG000|Overall Study|Lack of Efficacy|0|||
130681202|NCT01101022|470460251|FG001|Overall Study|Lack of Efficacy|7|||
130681203|NCT01101022|470460250|FG000|Overall Study|Sponsor decision|1|||
130681204|NCT01101022|470460251|FG001|Overall Study|Sponsor decision|1|||
130681205|NCT01101022|470460250|FG000|Overall Study|Non-compliance|1|||
130681206|NCT01101022|470460251|FG001|Overall Study|Non-compliance|0|||
130681207|NCT01101022|470460250|FG000|Overall Study|Work schedule|1|||
130681208|NCT01101022|470460251|FG001|Overall Study|Work schedule|1|||
130681209|NCT01101022|470460250|FG000|Overall Study|Vacation|0|||
130681210|NCT01101022|470460251|FG001|Overall Study|Vacation|1|||
130681211|NCT01519661|470460252|FG000|Overall Study|Protocol deviation|6|||
130681212|NCT01519661|470460252|FG000|Overall Study|Lost to Follow-up|3|||
130681213|NCT01519661|470460252|FG000|Overall Study|Withdrawal by Subject|17|||
130681214|NCT01519661|470460252|FG000|Overall Study|Lack of Efficacy|6|||
130681215|NCT01519661|470460252|FG000|Overall Study|Adverse Event|29|||
130681216|NCT01139047|470460253|FG000|Overall Study|Withdrawal by Subject|1|||
130681217|NCT05628675|470460254|FG000|Overall Study|Lost to Follow-up|2|||
130681218|NCT05628675|470460254|FG000|Overall Study|Withdrawal by Subject|1|||
130681219|NCT01941095|470460255|FG000|Overall Study|Insufficient therapeutic response|13|||
130681220|NCT01941095|470460255|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
130681221|NCT01941095|470460255|FG000|Overall Study|Adverse Event|11|||
130681222|NCT01941095|470460255|FG000|Overall Study|Physician Decision|3|||
130681223|NCT01941095|470460255|FG000|Overall Study|Withdrawal by Subject|17|||
130681224|NCT01941095|470460255|FG000|Overall Study|Lost to Follow-up|10|||
130681225|NCT02918877|470460258|FG000|Overall Study|Withdrawal by Subject|2|||
130681226|NCT02918877|470460259|FG001|Overall Study|Withdrawal by Subject|2|||
130681227|NCT02918877|470460258|FG000|Overall Study|Surgery cancelled|1|||
130681228|NCT02918877|470460259|FG001|Overall Study|Surgery cancelled|0|||
130681229|NCT02918877|470460258|FG000|Overall Study|Physician Decision|1|||
130681230|NCT02918877|470460259|FG001|Overall Study|Physician Decision|0|||
130681231|NCT02918877|470460258|FG000|Overall Study|Received intraoperative steroids|1|||
130681232|NCT02918877|470460259|FG001|Overall Study|Received intraoperative steroids|0|||
130681233|NCT02918877|470460258|FG000|Overall Study|Unable to obtain lab samples|1|||
130681234|NCT02918877|470460259|FG001|Overall Study|Unable to obtain lab samples|0|||
130681235|NCT02918877|470460258|FG000|Overall Study|Unsafe to perform BAL|0|||
130681236|NCT02918877|470460259|FG001|Overall Study|Unsafe to perform BAL|1|||
130681237|NCT05818137|470460260|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130681238|NCT05818137|470460260|FG000|Extension Treatment Period|Ongoing participants|44|||
130681239|NCT01648166|470460263|FG000|Overall Study|inadequate toenail samples|53|||
130681240|NCT01648166|470460264|FG001|Overall Study|inadequate toenail samples|100|||
130347392|NCT01239732|469243636|FG000|Overall Study|Investigator's decision|4|||
130347393|NCT01239732|469243636|FG000|Overall Study|Treatment failure|2|||
130347394|NCT01239732|469243636|FG000|Overall Study|Other|19|||
130347395|NCT02216812|469243654|FG000|Overall Study|Lost to Follow-up|10|||
130347396|NCT02216812|469243655|FG001|Overall Study|Lost to Follow-up|5|||
130347397|NCT00527488|469243660|FG000|Overall Study|Withdrawn prior to dosing|0|||
130347398|NCT00527488|469243661|FG001|Overall Study|Withdrawn prior to dosing|1|||
130347399|NCT00527488|469243662|FG002|Overall Study|Withdrawn prior to dosing|1|||
130681241|NCT02532764|470460265|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681242|NCT02532764|470460266|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681243|NCT02532764|470460267|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681244|NCT02532764|470460268|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681245|NCT02532764|470460269|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681246|NCT02532764|470460270|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130720843|NCT04126213|470601546|FG001|Overall Study|Lost to Follow-up|1|||
130216787|NCT00621257|468757237|FG002|Overall Study|Lost to Follow-up|2|||
130347400|NCT00527488|469243663|FG003|Overall Study|Withdrawn prior to dosing|0|||
130347401|NCT01958827|469243664|FG000|Overall Study|Adverse Event|3|||
130347402|NCT01958827|469243664|FG000|Overall Study|Lack of Efficacy|6|||
130216788|NCT00621257|468757238|FG003|Overall Study|Lost to Follow-up|4|||
130216789|NCT00621257|468757239|FG004|Overall Study|Lost to Follow-up|7|||
130216790|NCT00621257|468757235|FG000|Overall Study|Adverse Event|0|||
130216791|NCT00621257|468757236|FG001|Overall Study|Adverse Event|1|||
130216792|NCT00621257|468757237|FG002|Overall Study|Adverse Event|1|||
130216793|NCT00621257|468757238|FG003|Overall Study|Adverse Event|0|||
130216794|NCT00621257|468757239|FG004|Overall Study|Adverse Event|0|||
130681247|NCT02532764|470460271|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681248|NCT02532764|470460272|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130681249|NCT02532764|470460273|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130216795|NCT00621257|468757235|FG000|Overall Study|Physician Decision|0|||
130216796|NCT00621257|468757236|FG001|Overall Study|Physician Decision|2|||
130216797|NCT00621257|468757237|FG002|Overall Study|Physician Decision|0|||
130216798|NCT00621257|468757238|FG003|Overall Study|Physician Decision|1|||
130347403|NCT01958827|469243664|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
130347404|NCT00604214|469243669|FG000|Baseline to Day 28|Death|223|||
130347405|NCT00604214|469243670|FG001|Baseline to Day 28|Death|202|||
130347406|NCT00604214|469243669|FG000|Baseline to Day 28|Lost to Follow-up|2|||
130347407|NCT00604214|469243670|FG001|Baseline to Day 28|Lost to Follow-up|4|||
130347408|NCT00604214|469243669|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
130347409|NCT00604214|469243670|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
130347410|NCT00604214|469243669|FG000|Day 29 to Day 90|Death|64|||
130347411|NCT00604214|469243670|FG001|Day 29 to Day 90|Death|67|||
130347412|NCT00604214|469243669|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
130347413|NCT00604214|469243670|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
130347414|NCT00604214|469243669|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
130347415|NCT00604214|469243670|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
130347416|NCT00604214|469243669|FG000|Day 91 to Day 180|Death|19|||
130347417|NCT00604214|469243670|FG001|Day 91 to Day 180|Death|23|||
130347418|NCT00604214|469243669|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
130347419|NCT00604214|469243670|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
130347420|NCT00604214|469243669|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
130347421|NCT00604214|469243670|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
130681250|NCT02532764|470460274|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130681251|NCT03527745|470460275|FG000|Overall Study|Lost to Follow-up|3|||
130681252|NCT03527745|470460276|FG001|Overall Study|Lost to Follow-up|6|||
130347470|NCT03595124|469246665|FG000|Overall Study|Physician Decision|1|||
130347471|NCT03595124|469246666|FG001|Overall Study|Physician Decision|1|||
130347472|NCT03595124|469246667|FG002|Overall Study|Physician Decision|1|||
130347473|NCT03595124|469246665|FG000|Overall Study|Ineligible|1|||
130347474|NCT03595124|469246666|FG001|Overall Study|Ineligible|1|||
130347475|NCT03595124|469246667|FG002|Overall Study|Ineligible|0|||
130347476|NCT03595124|469246665|FG000|Overall Study|Disease Progression|4|||
130347477|NCT03595124|469246666|FG001|Overall Study|Disease Progression|1|||
130347478|NCT03595124|469246667|FG002|Overall Study|Disease Progression|4|||
130347485|NCT03404960|469246680|FG000|Overall Study|Adverse Event|0|||
130347486|NCT03404960|469246681|FG001|Overall Study|Adverse Event|2|||
130347487|NCT03404960|469246680|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
130347488|NCT03404960|469246681|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
130347489|NCT03404960|469246680|FG000|Overall Study|Bowel obstruction|0|||
130347490|NCT03404960|469246681|FG001|Overall Study|Bowel obstruction|1|||
130347491|NCT03404960|469246680|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
130347492|NCT03404960|469246681|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
130347533|NCT04395001|469246696|FG000|Overall Study|Lost to Follow-up|8|||
130347534|NCT04395001|469246697|FG001|Overall Study|Lost to Follow-up|9|||
130347535|NCT04395001|469246698|FG002|Overall Study|Lost to Follow-up|5|||
130347536|NCT04395001|469246696|FG000|Overall Study|Withdrawal by Subject|3|||
130347537|NCT04395001|469246697|FG001|Overall Study|Withdrawal by Subject|1|||
130347538|NCT04395001|469246698|FG002|Overall Study|Withdrawal by Subject|3|||
130347539|NCT04395001|469246696|FG000|Overall Study|missed appointment|7|||
130681253|NCT03527745|470460277|FG002|Overall Study|Lost to Follow-up|7|||
130681254|NCT03527745|470460278|FG003|Overall Study|Lost to Follow-up|9|||
130681255|NCT03527745|470460279|FG004|Overall Study|Lost to Follow-up|0|||
130681256|NCT03527745|470460280|FG005|Overall Study|Lost to Follow-up|2|||
130681257|NCT03527745|470460281|FG006|Overall Study|Lost to Follow-up|3|||
130681258|NCT03527745|470460282|FG007|Overall Study|Lost to Follow-up|2|||
130681259|NCT03527745|470460283|FG008|Overall Study|Lost to Follow-up|3|||
130681260|NCT03527745|470460284|FG009|Overall Study|Lost to Follow-up|2|||
130681261|NCT03527745|470460285|FG010|Overall Study|Lost to Follow-up|1|||
130681262|NCT03527745|470460286|FG011|Overall Study|Lost to Follow-up|1|||
130681263|NCT03527745|470460287|FG012|Overall Study|Lost to Follow-up|0|||
130681264|NCT03527745|470460288|FG013|Overall Study|Lost to Follow-up|0|||
130681265|NCT03527745|470460289|FG014|Overall Study|Lost to Follow-up|0|||
130681266|NCT03527745|470460290|FG015|Overall Study|Lost to Follow-up|0|||
130681267|NCT03527745|470460291|FG016|Overall Study|Lost to Follow-up|1|||
130681268|NCT03527745|470460292|FG017|Overall Study|Lost to Follow-up|0|||
130681269|NCT03527745|470460293|FG018|Overall Study|Lost to Follow-up|0|||
130681270|NCT03527745|470460294|FG019|Overall Study|Lost to Follow-up|1|||
130681271|NCT03527745|470460295|FG020|Overall Study|Lost to Follow-up|1|||
130681272|NCT03527745|470460296|FG021|Overall Study|Lost to Follow-up|5|||
130681273|NCT03527745|470460297|FG022|Overall Study|Lost to Follow-up|6|||
130681274|NCT03527745|470460298|FG023|Overall Study|Lost to Follow-up|8|||
130681275|NCT03527745|470460299|FG024|Overall Study|Lost to Follow-up|1|||
130681276|NCT03527745|470460300|FG025|Overall Study|Lost to Follow-up|3|||
130681277|NCT01604850|470460301|FG000|Overall Study|Enrolled but never treated|0|||
130681278|NCT01604850|470460302|FG001|Overall Study|Enrolled but never treated|1|||
130681279|NCT01604850|470460301|FG000|Overall Study|Efficacy Failure|50|||
130681280|NCT01604850|470460302|FG001|Overall Study|Efficacy Failure|29|||
130681281|NCT01604850|470460301|FG000|Overall Study|Lost to Follow-up|1|||
130681282|NCT01604850|470460302|FG001|Overall Study|Lost to Follow-up|0|||
130347540|NCT04395001|469246697|FG001|Overall Study|missed appointment|4|||
130347541|NCT04395001|469246698|FG002|Overall Study|missed appointment|1|||
130347550|NCT04251156|469246709|FG000|Overall Study|Lost to Follow-up|1|||
130347551|NCT04251156|469246710|FG001|Overall Study|Lost to Follow-up|1|||
130347552|NCT04251156|469246709|FG000|Overall Study|Withdrawal by Subject|4|||
130347553|NCT04251156|469246710|FG001|Overall Study|Withdrawal by Subject|4|||
130347569|NCT02455557|469246715|FG000|Overall Study|Withdrawal by Subject|2|||
130347570|NCT00807027|469246716|FG000|Overall Study|Withdrawal by Subject|13|||
130347571|NCT00807027|469246717|FG001|Overall Study|Withdrawal by Subject|14|||
130347572|NCT00807027|469246716|FG000|Overall Study|Protocol Violation|1|||
130347573|NCT00807027|469246717|FG001|Overall Study|Protocol Violation|1|||
130347574|NCT00807027|469246716|FG000|Overall Study|Adverse Event|2|||
130347575|NCT00807027|469246717|FG001|Overall Study|Adverse Event|2|||
130552782|NCT00792805|469991535|FG001|Overall Study|Subject withdrew consent|6|||
130681283|NCT01604850|470460301|FG000|Overall Study|Subject withdrew consent|1|||
130681284|NCT01604850|470460302|FG001|Overall Study|Subject withdrew consent|0|||
130681285|NCT01471093|470460304|FG000|Overall Study|Adverse Event|1|||
130681286|NCT01471093|470460305|FG001|Overall Study|Adverse Event|0|||
130681287|NCT01471093|470460306|FG002|Overall Study|Adverse Event|0|||
130681288|NCT01471093|470460307|FG003|Overall Study|Adverse Event|0|||
130347580|NCT05508074|469246722|FG000|Overall Study|Death|2|||
130347581|NCT05508074|469246723|FG001|Overall Study|Death|5|||
130720844|NCT04126213|470601547|FG002|Overall Study|Lost to Follow-up|5|||
130436268|NCT03107377|469560599|FG001|Overall Study|Withdrawal by Subject|22|||
130436269|NCT03107377|469560598|FG000|Overall Study|Lost to Follow-up|37|||
130436270|NCT03107377|469560599|FG001|Overall Study|Lost to Follow-up|34|||
130436271|NCT03107377|469560598|FG000|Overall Study|Other reason not specified|16|||
130216799|NCT00621257|468757239|FG004|Overall Study|Physician Decision|1|||
130216800|NCT00621257|468757235|FG000|Overall Study|Withdrawal by Subject|0|||
130216801|NCT00621257|468757236|FG001|Overall Study|Withdrawal by Subject|0|||
130216802|NCT00621257|468757237|FG002|Overall Study|Withdrawal by Subject|0|||
130216803|NCT00621257|468757238|FG003|Overall Study|Withdrawal by Subject|1|||
130216804|NCT00621257|468757239|FG004|Overall Study|Withdrawal by Subject|1|||
130216805|NCT01255904|468757240|FG000|Overall Study|Physician Decision|1|||
130216806|NCT01255904|468757241|FG001|Overall Study|Physician Decision|4|||
130216807|NCT02061813|468757245|FG000|Overall Study|Withdrawal by Subject|1|||
130216808|NCT02061813|468757245|FG000|Overall Study|Protocol Violation|2|||
130216809|NCT01705080|468757248|FG000|Overall Study|Missed visit|10|||
130216810|NCT01705080|468757249|FG001|Overall Study|Missed visit|4|||
130216811|NCT01705080|468757250|FG002|Overall Study|Missed visit|1|||
130216812|NCT01705080|468757248|FG000|Overall Study|Death|4|||
130436272|NCT03107377|469560599|FG001|Overall Study|Other reason not specified|15|||
130216813|NCT01705080|468757249|FG001|Overall Study|Death|4|||
130216814|NCT01705080|468757250|FG002|Overall Study|Death|6|||
130216815|NCT01705080|468757248|FG000|Overall Study|Withdrawal by Subject|61|||
130216816|NCT01705080|468757249|FG001|Overall Study|Withdrawal by Subject|44|||
130216817|NCT01705080|468757250|FG002|Overall Study|Withdrawal by Subject|9|||
130216818|NCT00206427|468757252|FG000|Overall Study|Adverse Event|2|||
130216819|NCT00741598|468757253|FG000|Overall Study|Lost to Follow-up|3|||
130216820|NCT00741598|468757254|FG001|Overall Study|Lost to Follow-up|4|||
130216821|NCT00741598|468757253|FG000|Overall Study|Lack of Efficacy|1|||
130216822|NCT00741598|468757254|FG001|Overall Study|Lack of Efficacy|2|||
130216823|NCT00741598|468757253|FG000|Overall Study|Physician Decision|1|||
130216824|NCT00741598|468757254|FG001|Overall Study|Physician Decision|1|||
130216825|NCT00741598|468757253|FG000|Overall Study|Pregnancy|1|||
130681289|NCT02475954|470460308|FG000|Overall Study|Withdrawal by Subject|2|||
130681290|NCT02475954|470460309|FG001|Overall Study|Withdrawal by Subject|2|||
130681291|NCT02475954|470460308|FG000|Overall Study|Lost to Follow-up|11|||
130681292|NCT02475954|470460309|FG001|Overall Study|Lost to Follow-up|9|||
130681293|NCT02475954|470460308|FG000|Overall Study|Death|1|||
130681294|NCT02475954|470460309|FG001|Overall Study|Death|1|||
130681295|NCT02932878|470460310|FG000|Overall Study|Due to Lab Results|2|||
130681296|NCT02932878|470460311|FG001|Overall Study|Due to Lab Results|1|||
130681297|NCT01918397|470460312|FG000|Overall Study|Never started treatment|2|||
130681298|NCT01918397|470460313|FG001|Overall Study|Never started treatment|1|||
130681299|NCT01918397|470460314|FG002|Overall Study|Never started treatment|0|||
130681300|NCT01918397|470460315|FG003|Overall Study|Never started treatment|0|||
130681301|NCT01918397|470460312|FG000|Overall Study|Adverse Event|1|||
130681302|NCT01918397|470460313|FG001|Overall Study|Adverse Event|1|||
130681303|NCT01918397|470460314|FG002|Overall Study|Adverse Event|1|||
130681304|NCT01918397|470460315|FG003|Overall Study|Adverse Event|0|||
130681305|NCT01918397|470460312|FG000|Overall Study|Lack of compliance|2|||
130681306|NCT01918397|470460313|FG001|Overall Study|Lack of compliance|2|||
130681307|NCT01918397|470460314|FG002|Overall Study|Lack of compliance|3|||
130681308|NCT01918397|470460315|FG003|Overall Study|Lack of compliance|0|||
130681309|NCT01918397|470460312|FG000|Overall Study|Pregnancy|0|||
130681310|NCT01918397|470460313|FG001|Overall Study|Pregnancy|1|||
130681311|NCT01918397|470460314|FG002|Overall Study|Pregnancy|0|||
130681312|NCT01918397|470460315|FG003|Overall Study|Pregnancy|0|||
130681313|NCT01918397|470460312|FG000|Overall Study|Rifampin susceptible|0|||
130681314|NCT01918397|470460313|FG001|Overall Study|Rifampin susceptible|0|||
130681315|NCT01918397|470460314|FG002|Overall Study|Rifampin susceptible|0|||
130681316|NCT01918397|470460315|FG003|Overall Study|Rifampin susceptible|2|||
130681317|NCT01918397|470460312|FG000|Overall Study|Treatment failure|0|||
130681318|NCT01918397|470460313|FG001|Overall Study|Treatment failure|0|||
130681319|NCT01918397|470460314|FG002|Overall Study|Treatment failure|0|||
130681320|NCT01918397|470460315|FG003|Overall Study|Treatment failure|1|||
130681321|NCT01918397|470460312|FG000|Overall Study|Withdrawal by Subject|3|||
130681322|NCT01918397|470460313|FG001|Overall Study|Withdrawal by Subject|2|||
130681323|NCT01918397|470460314|FG002|Overall Study|Withdrawal by Subject|1|||
130216826|NCT00741598|468757254|FG001|Overall Study|Pregnancy|0|||
130216827|NCT00741598|468757253|FG000|Overall Study|Withdrawal by Subject|3|||
130216828|NCT00741598|468757254|FG001|Overall Study|Withdrawal by Subject|2|||
130216829|NCT00313586|468757255|FG000|Overall Study|Disease progression|14|||
130216830|NCT00313586|468757256|FG001|Overall Study|Disease progression|19|||
130216831|NCT00313586|468757257|FG002|Overall Study|Disease progression|10|||
130216832|NCT00313586|468757258|FG003|Overall Study|Disease progression|3|||
130436273|NCT00211237|469560600|FG000|Baseline|Withdrew|1|||
130436274|NCT00211237|469560601|FG001|Baseline|Withdrew|3|||
130436275|NCT00211237|469560602|FG002|Baseline|Withdrew|0|||
130681324|NCT01918397|470460315|FG003|Overall Study|Withdrawal by Subject|1|||
130681325|NCT01918397|470460312|FG000|Overall Study|XDR at baseline|0|||
130681326|NCT01918397|470460313|FG001|Overall Study|XDR at baseline|0|||
130681327|NCT01918397|470460314|FG002|Overall Study|XDR at baseline|1|||
130681328|NCT01918397|470460315|FG003|Overall Study|XDR at baseline|0|||
130681329|NCT01918397|470460312|FG000|Overall Study|Lost to Follow-up|2|||
130681330|NCT01918397|470460313|FG001|Overall Study|Lost to Follow-up|1|||
130681331|NCT01918397|470460314|FG002|Overall Study|Lost to Follow-up|1|||
130681332|NCT01918397|470460315|FG003|Overall Study|Lost to Follow-up|1|||
130681333|NCT01918397|470460312|FG000|Overall Study|Increased QTc|1|||
130681334|NCT01918397|470460313|FG001|Overall Study|Increased QTc|0|||
130681335|NCT01918397|470460314|FG002|Overall Study|Increased QTc|0|||
130681336|NCT01918397|470460315|FG003|Overall Study|Increased QTc|1|||
130681337|NCT01918397|470460312|FG000|Overall Study|Death|0|||
130681338|NCT01918397|470460313|FG001|Overall Study|Death|0|||
130681339|NCT01918397|470460314|FG002|Overall Study|Death|1|||
130681340|NCT01918397|470460315|FG003|Overall Study|Death|0|||
130216833|NCT00313586|468757255|FG000|Overall Study|Adverse Event|12|||
130216834|NCT00313586|468757256|FG001|Overall Study|Adverse Event|18|||
130216835|NCT00313586|468757257|FG002|Overall Study|Adverse Event|3|||
130681341|NCT01918397|470460312|FG000|Overall Study|Involved in another investigative trial|0|||
130681342|NCT01918397|470460313|FG001|Overall Study|Involved in another investigative trial|0|||
130681343|NCT01918397|470460314|FG002|Overall Study|Involved in another investigative trial|0|||
130681344|NCT01918397|470460315|FG003|Overall Study|Involved in another investigative trial|1|||
130681345|NCT00620022|470460316|FG000|Treatment Period 1|Adverse Event|4|||
130681346|NCT00620022|470460317|FG001|Treatment Period 1|Adverse Event|6|||
130681347|NCT00620022|470460316|FG000|Treatment Period 1|Subject withdrew consent|1|||
130681348|NCT00620022|470460317|FG001|Treatment Period 1|Subject withdrew consent|0|||
130681349|NCT00620022|470460316|FG000|Treatment Period 2|Adverse Event|2|||
130681350|NCT00620022|470460317|FG001|Treatment Period 2|Adverse Event|2|||
130681351|NCT03478397|470460318|FG000|Overall Study|Refused to participate|31|||
130681352|NCT03478397|470460319|FG001|Overall Study|Refused to participate|7|||
130681353|NCT02942264|470460320|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681354|NCT02942264|470460321|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130681355|NCT02942264|470460322|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681356|NCT02942264|470460323|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681357|NCT02942264|470460324|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681358|NCT02942264|470460325|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681359|NCT02942264|470460326|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130681360|NCT02942264|470460327|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681361|NCT02942264|470460328|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681362|NCT02942264|470460320|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681363|NCT02942264|470460321|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681364|NCT02942264|470460322|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681365|NCT02942264|470460323|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681366|NCT02942264|470460324|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681367|NCT02942264|470460325|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681368|NCT02942264|470460326|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681369|NCT02942264|470460327|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681370|NCT02942264|470460328|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
130681371|NCT02334722|470460329|FG000|Overall Study|Lost to Follow-up|4|||
130216836|NCT00313586|468757258|FG003|Overall Study|Adverse Event|10|||
130216837|NCT00313586|468757255|FG000|Overall Study|Death|11|||
130216838|NCT00313586|468757256|FG001|Overall Study|Death|8|||
130216839|NCT00313586|468757257|FG002|Overall Study|Death|1|||
130216840|NCT00313586|468757258|FG003|Overall Study|Death|7|||
130216841|NCT00313586|468757255|FG000|Overall Study|Withdrawal by Subject|13|||
130216842|NCT00313586|468757256|FG001|Overall Study|Withdrawal by Subject|6|||
130216843|NCT00313586|468757257|FG002|Overall Study|Withdrawal by Subject|6|||
130216844|NCT00313586|468757258|FG003|Overall Study|Withdrawal by Subject|2|||
130216845|NCT00313586|468757255|FG000|Overall Study|Alternative therapy|3|||
130681372|NCT02334722|470460330|FG001|Overall Study|Lost to Follow-up|0|||
130681373|NCT02334722|470460329|FG000|Overall Study|6 week questionnaire not completed|2|||
130681374|NCT02334722|470460330|FG001|Overall Study|6 week questionnaire not completed|0|||
130216846|NCT00313586|468757256|FG001|Overall Study|Alternative therapy|6|||
130216847|NCT00313586|468757257|FG002|Overall Study|Alternative therapy|2|||
130681375|NCT02334722|470460329|FG000|Overall Study|Unable to obtain medication|1|||
130681376|NCT02334722|470460330|FG001|Overall Study|Unable to obtain medication|1|||
130681377|NCT02334722|470460329|FG000|Overall Study|Withdrawal by Subject|0|||
130681378|NCT02334722|470460330|FG001|Overall Study|Withdrawal by Subject|3|||
130216848|NCT00313586|468757258|FG003|Overall Study|Alternative therapy|0|||
130681379|NCT02334722|470460329|FG000|Overall Study|Adverse Event|0|||
130681380|NCT02334722|470460330|FG001|Overall Study|Adverse Event|2|||
130681381|NCT02334722|470460329|FG000|Overall Study|Physician Decision|0|||
130216849|NCT00313586|468757255|FG000|Overall Study|Other complicating disease|2|||
130216850|NCT00313586|468757256|FG001|Overall Study|Other complicating disease|2|||
130216851|NCT00313586|468757257|FG002|Overall Study|Other complicating disease|0|||
130216852|NCT00313586|468757258|FG003|Overall Study|Other complicating disease|0|||
130216853|NCT00313586|468757255|FG000|Overall Study|Did not achieve HI-major/better response|10|||
130216854|NCT00313586|468757256|FG001|Overall Study|Did not achieve HI-major/better response|7|||
130216855|NCT00313586|468757257|FG002|Overall Study|Did not achieve HI-major/better response|2|||
130216856|NCT00313586|468757258|FG003|Overall Study|Did not achieve HI-major/better response|1|||
130216857|NCT00313586|468757255|FG000|Overall Study|Physician Decision|2|||
130216858|NCT00313586|468757256|FG001|Overall Study|Physician Decision|1|||
130216859|NCT00313586|468757257|FG002|Overall Study|Physician Decision|0|||
130216860|NCT00313586|468757258|FG003|Overall Study|Physician Decision|0|||
130216861|NCT00313586|468757255|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
130216862|NCT00313586|468757256|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
130216863|NCT00313586|468757257|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
130216864|NCT00313586|468757258|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
130216865|NCT00313586|468757255|FG000|Overall Study|Lost insurance|0|||
130216866|NCT00313586|468757256|FG001|Overall Study|Lost insurance|1|||
130216867|NCT00313586|468757257|FG002|Overall Study|Lost insurance|0|||
130216868|NCT00313586|468757258|FG003|Overall Study|Lost insurance|0|||
130216869|NCT00313586|468757255|FG000|Overall Study|Moved|0|||
130216870|NCT00313586|468757256|FG001|Overall Study|Moved|1|||
130216871|NCT00313586|468757257|FG002|Overall Study|Moved|0|||
130216872|NCT00313586|468757258|FG003|Overall Study|Moved|0|||
130216873|NCT00313586|468757255|FG000|Overall Study|Death before starting treatment|1|||
130216874|NCT00313586|468757256|FG001|Overall Study|Death before starting treatment|0|||
130216875|NCT00313586|468757257|FG002|Overall Study|Death before starting treatment|0|||
130216876|NCT00313586|468757258|FG003|Overall Study|Death before starting treatment|0|||
130216877|NCT03076996|468757259|FG000|Overall Study|Withdrawal by Subject|2|||
130216878|NCT03076996|468757259|FG000|Overall Study|Lost to Follow-up|3|||
130216879|NCT03076996|468757259|FG000|Overall Study|Literacy precluded participation|1|||
130216880|NCT01247350|468757260|FG000|Overall Study|Adverse Event|0|||
130216881|NCT01247350|468757261|FG001|Overall Study|Adverse Event|0|||
130216882|NCT01247350|468757262|FG002|Overall Study|Adverse Event|1|||
130216883|NCT01247350|468757263|FG003|Overall Study|Adverse Event|0|||
130216884|NCT01247350|468757264|FG004|Overall Study|Adverse Event|0|||
130216885|NCT01247350|468757260|FG000|Overall Study|Withdrawal by Subject|0|||
130216886|NCT01247350|468757261|FG001|Overall Study|Withdrawal by Subject|0|||
130216887|NCT01247350|468757262|FG002|Overall Study|Withdrawal by Subject|0|||
130216888|NCT01247350|468757263|FG003|Overall Study|Withdrawal by Subject|1|||
130216889|NCT01247350|468757264|FG004|Overall Study|Withdrawal by Subject|0|||
130216890|NCT01247350|468757260|FG000|Overall Study|Entry criteria not met|0|||
130216891|NCT01247350|468757261|FG001|Overall Study|Entry criteria not met|0|||
130216892|NCT01247350|468757262|FG002|Overall Study|Entry criteria not met|0|||
130216893|NCT01247350|468757263|FG003|Overall Study|Entry criteria not met|0|||
130216894|NCT01247350|468757264|FG004|Overall Study|Entry criteria not met|1|||
130216895|NCT01398358|468757273|FG000|Overall Study|Lost to Follow-up|11|||
130216896|NCT01398358|468757274|FG001|Overall Study|Lost to Follow-up|21|||
130216897|NCT01398358|468757275|FG002|Overall Study|Lost to Follow-up|18|||
130216898|NCT01398358|468757273|FG000|Overall Study|Withdrawal by Subject|3|||
130681382|NCT02334722|470460330|FG001|Overall Study|Physician Decision|1|||
130681383|NCT00856388|470460331|FG000|Overall Study|Other|1|||
130681384|NCT01617668|470460334|FG000|Overall Study|Adverse Event|7|||
130681385|NCT01617668|470460335|FG001|Overall Study|Adverse Event|0|||
130681386|NCT01617668|470460336|FG002|Overall Study|Adverse Event|12|||
130216899|NCT01398358|468757274|FG001|Overall Study|Withdrawal by Subject|2|||
130216900|NCT01398358|468757275|FG002|Overall Study|Withdrawal by Subject|2|||
130216901|NCT01398358|468757273|FG000|Overall Study|no longer eligible|1|||
130216902|NCT01398358|468757274|FG001|Overall Study|no longer eligible|0|||
130216903|NCT01398358|468757275|FG002|Overall Study|no longer eligible|1|||
130216904|NCT00003896|468757278|FG000|Overall Study|Adverse Event|16|||
130216905|NCT00003896|468757278|FG000|Overall Study|Withdrawal by Subject|1|||
130216906|NCT00003896|468757278|FG000|Overall Study|Lack of Efficacy|1|||
130216907|NCT00003896|468757278|FG000|Overall Study|Death|3|||
130216908|NCT00003896|468757278|FG000|Overall Study|not protocol specified|3|||
130216909|NCT00003896|468757278|FG000|Overall Study|ineligible|5|||
130216910|NCT00985686|468757280|FG000|Overall Study|Lost to Follow-up|1|||
130216911|NCT00985686|468757281|FG001|Overall Study|Lost to Follow-up|1|||
130216912|NCT00985686|468757282|FG002|Overall Study|Lost to Follow-up|0|||
130216913|NCT00985686|468757283|FG003|Overall Study|Lost to Follow-up|2|||
130216914|NCT01670045|468757284|FG000|Overall Study|Withdrawal by Subject|3|||
130216915|NCT01670045|468757284|FG000|Overall Study|Adverse Event|1|||
130216916|NCT01670045|468757284|FG000|Overall Study|Death|1|||
130216917|NCT01670045|468757284|FG000|Overall Study|Lost to Follow-up|11|||
130216918|NCT02559570|468757286|FG000|Overall Study|Adverse Event|0|||
130216919|NCT02559570|468757287|FG001|Overall Study|Adverse Event|2|||
130347582|NCT05508074|469246722|FG000|Overall Study|Withdrawal by Subject|1|||
130347583|NCT05508074|469246723|FG001|Overall Study|Withdrawal by Subject|2|||
130347584|NCT05508074|469246722|FG000|Overall Study|Adverse Event|0|||
130347585|NCT05508074|469246723|FG001|Overall Study|Adverse Event|1|||
130347586|NCT05508074|469246722|FG000|Overall Study|Physician Decision|0|||
130347587|NCT05508074|469246723|FG001|Overall Study|Physician Decision|1|||
130216920|NCT02559570|468757288|FG002|Overall Study|Adverse Event|0|||
130216921|NCT02559570|468757289|FG003|Overall Study|Adverse Event|1|||
130216922|NCT02559570|468757290|FG004|Overall Study|Adverse Event|0|||
130216923|NCT02559570|468757286|FG000|Overall Study|Withdrawal of Consent|0|||
130216924|NCT02559570|468757287|FG001|Overall Study|Withdrawal of Consent|0|||
130216925|NCT02559570|468757288|FG002|Overall Study|Withdrawal of Consent|1|||
130216926|NCT02559570|468757289|FG003|Overall Study|Withdrawal of Consent|2|||
130216927|NCT02559570|468757290|FG004|Overall Study|Withdrawal of Consent|1|||
130216928|NCT02559570|468757286|FG000|Overall Study|Lost to Follow-up|1|||
130216929|NCT02559570|468757287|FG001|Overall Study|Lost to Follow-up|0|||
130216930|NCT02559570|468757288|FG002|Overall Study|Lost to Follow-up|0|||
130216931|NCT02559570|468757289|FG003|Overall Study|Lost to Follow-up|0|||
130216932|NCT02559570|468757290|FG004|Overall Study|Lost to Follow-up|0|||
130216933|NCT02559570|468757286|FG000|Overall Study|Protocol Violation|1|||
130216934|NCT02559570|468757287|FG001|Overall Study|Protocol Violation|0|||
130216935|NCT02559570|468757288|FG002|Overall Study|Protocol Violation|0|||
130216936|NCT02559570|468757289|FG003|Overall Study|Protocol Violation|0|||
130216937|NCT02559570|468757290|FG004|Overall Study|Protocol Violation|1|||
130216938|NCT02559570|468757286|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130216939|NCT02559570|468757287|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130216940|NCT02559570|468757288|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130216941|NCT02559570|468757289|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130216942|NCT02559570|468757290|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130216943|NCT00420628|468757294|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
130216944|NCT00420628|468757295|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
130216945|NCT00420628|468757294|FG000|Overall Study|Lost to Follow-up|3|||
130216946|NCT00420628|468757295|FG001|Overall Study|Lost to Follow-up|2|||
130216947|NCT00420628|468757294|FG000|Overall Study|Adverse Event|1|||
130216948|NCT00420628|468757295|FG001|Overall Study|Adverse Event|0|||
130216949|NCT00396383|468757302|FG000|Overall Study|Death|2|||
130216950|NCT00396383|468757302|FG000|Overall Study|Lost to Follow-up|1|||
130216951|NCT00282152|468757303|FG000|Overall Study|Withdrawal by Subject|1|||
130216952|NCT00282152|468757304|FG001|Overall Study|Withdrawal by Subject|0|||
130216953|NCT00585325|468757305|FG000|Overall Study|Withdrawal by Subject|1|||
130216954|NCT00585325|468757306|FG001|Overall Study|Withdrawal by Subject|1|||
130216955|NCT03301831|468757307|FG000|Overall Study|Lost to Follow-up|5|||
130216956|NCT03301831|468757308|FG001|Overall Study|Lost to Follow-up|3|||
130216957|NCT03301831|468757307|FG000|Overall Study|Protocol Violation|4|||
130216958|NCT03301831|468757308|FG001|Overall Study|Protocol Violation|0|||
130216959|NCT03301831|468757307|FG000|Overall Study|Withdrawal by Subject|11|||
130216960|NCT03301831|468757308|FG001|Overall Study|Withdrawal by Subject|0|||
130216961|NCT03092791|468757309|FG000|Overall Study|Lost to Follow-up|0|||
130216962|NCT03092791|468757310|FG001|Overall Study|Lost to Follow-up|0|||
130216963|NCT03092791|468757311|FG002|Overall Study|Lost to Follow-up|0|||
130216964|NCT03092791|468757312|FG003|Overall Study|Lost to Follow-up|0|||
130216965|NCT03092791|468757313|FG004|Overall Study|Lost to Follow-up|0|||
130216966|NCT03092791|468757314|FG005|Overall Study|Lost to Follow-up|0|||
130216967|NCT03092791|468757315|FG006|Overall Study|Lost to Follow-up|1|||
130216968|NCT03092791|468757316|FG007|Overall Study|Lost to Follow-up|0|||
130216969|NCT03092791|468757309|FG000|Overall Study|Withdrawal of Consent|0|||
130216970|NCT03092791|468757310|FG001|Overall Study|Withdrawal of Consent|0|||
130216971|NCT03092791|468757311|FG002|Overall Study|Withdrawal of Consent|0|||
130216972|NCT03092791|468757312|FG003|Overall Study|Withdrawal of Consent|0|||
130216973|NCT03092791|468757313|FG004|Overall Study|Withdrawal of Consent|4|||
130216974|NCT03092791|468757314|FG005|Overall Study|Withdrawal of Consent|12|||
130216975|NCT03092791|468757315|FG006|Overall Study|Withdrawal of Consent|6|||
130216976|NCT03092791|468757316|FG007|Overall Study|Withdrawal of Consent|4|||
130216977|NCT03092791|468757309|FG000|Overall Study|Study Termination|0|||
130216978|NCT03092791|468757310|FG001|Overall Study|Study Termination|0|||
130216979|NCT03092791|468757311|FG002|Overall Study|Study Termination|0|||
130216980|NCT03092791|468757312|FG003|Overall Study|Study Termination|0|||
130216981|NCT03092791|468757313|FG004|Overall Study|Study Termination|55|||
130216982|NCT03092791|468757314|FG005|Overall Study|Study Termination|46|||
130216983|NCT03092791|468757315|FG006|Overall Study|Study Termination|53|||
130216984|NCT03092791|468757316|FG007|Overall Study|Study Termination|55|||
130681387|NCT01617668|470460337|FG003|Overall Study|Adverse Event|5|||
130681388|NCT01617668|470460334|FG000|Overall Study|Physician Decision|1|||
130216985|NCT03092791|468757309|FG000|Overall Study|Death|0|||
130216986|NCT03092791|468757310|FG001|Overall Study|Death|0|||
130216987|NCT03092791|468757311|FG002|Overall Study|Death|0|||
130216988|NCT03092791|468757312|FG003|Overall Study|Death|0|||
130216989|NCT03092791|468757313|FG004|Overall Study|Death|0|||
130216990|NCT03092791|468757314|FG005|Overall Study|Death|1|||
130216991|NCT03092791|468757315|FG006|Overall Study|Death|0|||
130681389|NCT01617668|470460335|FG001|Overall Study|Physician Decision|2|||
130216992|NCT03092791|468757316|FG007|Overall Study|Death|1|||
130216993|NCT03092791|468757309|FG000|Overall Study|Reason Not Specified|0|||
130216994|NCT03092791|468757310|FG001|Overall Study|Reason Not Specified|0|||
130216995|NCT03092791|468757311|FG002|Overall Study|Reason Not Specified|0|||
130347588|NCT05508074|469246722|FG000|Overall Study|wrongly randomized|0|||
130347589|NCT05508074|469246723|FG001|Overall Study|wrongly randomized|1|||
130347590|NCT05508074|469246722|FG000|Overall Study|non-compliance|0|||
130347591|NCT05508074|469246723|FG001|Overall Study|non-compliance|1|||
130347610|NCT05040971|469246730|FG000|Overall Study|Withdrawal by Subject|0|||
130347611|NCT05040971|469246731|FG001|Overall Study|Withdrawal by Subject|2|||
130347612|NCT05040971|469246730|FG000|Overall Study|Lost to Follow-up|8|||
130347613|NCT05040971|469246731|FG001|Overall Study|Lost to Follow-up|3|||
130347614|NCT05040971|469246730|FG000|Overall Study|Death|2|||
130347615|NCT05040971|469246731|FG001|Overall Study|Death|0|||
130681390|NCT01617668|470460336|FG002|Overall Study|Physician Decision|3|||
130216996|NCT03092791|468757312|FG003|Overall Study|Reason Not Specified|0|||
130216997|NCT03092791|468757313|FG004|Overall Study|Reason Not Specified|1|||
130216998|NCT03092791|468757314|FG005|Overall Study|Reason Not Specified|1|||
130216999|NCT03092791|468757315|FG006|Overall Study|Reason Not Specified|0|||
130217000|NCT03092791|468757316|FG007|Overall Study|Reason Not Specified|0|||
130217001|NCT00980655|468757318|FG000|Overall Study|Adverse Event|13|||
130217002|NCT00980655|468757319|FG001|Overall Study|Adverse Event|31|||
130217003|NCT00980655|468757318|FG000|Overall Study|Death|0|||
130217004|NCT00980655|468757319|FG001|Overall Study|Death|7|||
130217005|NCT00980655|468757318|FG000|Overall Study|Protocol Violation|2|||
130217006|NCT00980655|468757319|FG001|Overall Study|Protocol Violation|7|||
130681391|NCT01617668|470460337|FG003|Overall Study|Physician Decision|0|||
130681392|NCT01617668|470460334|FG000|Overall Study|Progressive Disease|4|||
130681393|NCT01617668|470460335|FG001|Overall Study|Progressive Disease|4|||
130681394|NCT01617668|470460336|FG002|Overall Study|Progressive Disease|6|||
130681395|NCT01617668|470460337|FG003|Overall Study|Progressive Disease|9|||
130681396|NCT01617668|470460334|FG000|Overall Study|Subject/guardian decision|1|||
130681397|NCT01617668|470460335|FG001|Overall Study|Subject/guardian decision|3|||
130681398|NCT01617668|470460336|FG002|Overall Study|Subject/guardian decision|2|||
130681399|NCT01617668|470460337|FG003|Overall Study|Subject/guardian decision|1|||
130681400|NCT00686959|470460338|FG000|Overall Study|Participants censored (no death events)|124|||
130681401|NCT00686959|470460339|FG001|Overall Study|Participants censored (no death events)|117|||
130681402|NCT00150462|470460342|FG000|Overall Study|Disease Progression or Relapse|3|||
130681403|NCT00150462|470460343|FG001|Overall Study|Disease Progression or Relapse|1|||
130681404|NCT00150462|470460344|FG002|Overall Study|Disease Progression or Relapse|2|||
130681405|NCT00150462|470460345|FG003|Overall Study|Disease Progression or Relapse|1|||
130681406|NCT00150462|470460346|FG004|Overall Study|Disease Progression or Relapse|2|||
130681407|NCT00150462|470460347|FG005|Overall Study|Disease Progression or Relapse|2|||
130681408|NCT00150462|470460348|FG006|Overall Study|Disease Progression or Relapse|3|||
130681409|NCT00150462|470460349|FG007|Overall Study|Disease Progression or Relapse|5|||
130681410|NCT00150462|470460350|FG008|Overall Study|Disease Progression or Relapse|5|||
130681411|NCT00150462|470460351|FG009|Overall Study|Disease Progression or Relapse|3|||
130681412|NCT00150462|470460352|FG010|Overall Study|Disease Progression or Relapse|2|||
130681413|NCT00150462|470460342|FG000|Overall Study|Withdrawal by Subject|0|||
130681414|NCT00150462|470460343|FG001|Overall Study|Withdrawal by Subject|1|||
130681415|NCT00150462|470460344|FG002|Overall Study|Withdrawal by Subject|1|||
130681416|NCT00150462|470460345|FG003|Overall Study|Withdrawal by Subject|0|||
130681417|NCT00150462|470460346|FG004|Overall Study|Withdrawal by Subject|1|||
130681418|NCT00150462|470460347|FG005|Overall Study|Withdrawal by Subject|2|||
130681419|NCT00150462|470460348|FG006|Overall Study|Withdrawal by Subject|0|||
130681420|NCT00150462|470460349|FG007|Overall Study|Withdrawal by Subject|1|||
130681421|NCT00150462|470460350|FG008|Overall Study|Withdrawal by Subject|0|||
130681422|NCT00150462|470460351|FG009|Overall Study|Withdrawal by Subject|1|||
130681423|NCT00150462|470460352|FG010|Overall Study|Withdrawal by Subject|0|||
130681424|NCT00150462|470460342|FG000|Overall Study|Death|0|||
130217007|NCT00980655|468757318|FG000|Overall Study|Withdrawal by Subject|0|||
130681425|NCT00150462|470460343|FG001|Overall Study|Death|1|||
130681426|NCT00150462|470460344|FG002|Overall Study|Death|0|||
130681427|NCT00150462|470460345|FG003|Overall Study|Death|0|||
130681428|NCT00150462|470460346|FG004|Overall Study|Death|0|||
130681429|NCT00150462|470460347|FG005|Overall Study|Death|0|||
130681430|NCT00150462|470460348|FG006|Overall Study|Death|0|||
130681431|NCT00150462|470460349|FG007|Overall Study|Death|0|||
130681432|NCT00150462|470460350|FG008|Overall Study|Death|1|||
130681433|NCT00150462|470460351|FG009|Overall Study|Death|0|||
130681434|NCT00150462|470460352|FG010|Overall Study|Death|0|||
130681435|NCT00150462|470460342|FG000|Overall Study|Adverse Event|0|||
130681436|NCT00150462|470460343|FG001|Overall Study|Adverse Event|0|||
130681437|NCT00150462|470460344|FG002|Overall Study|Adverse Event|0|||
130681438|NCT00150462|470460345|FG003|Overall Study|Adverse Event|1|||
130681439|NCT00150462|470460346|FG004|Overall Study|Adverse Event|0|||
130681440|NCT00150462|470460347|FG005|Overall Study|Adverse Event|0|||
130681441|NCT00150462|470460348|FG006|Overall Study|Adverse Event|0|||
130681442|NCT00150462|470460349|FG007|Overall Study|Adverse Event|2|||
130681443|NCT00150462|470460350|FG008|Overall Study|Adverse Event|0|||
130681444|NCT00150462|470460351|FG009|Overall Study|Adverse Event|1|||
130681445|NCT00150462|470460352|FG010|Overall Study|Adverse Event|0|||
130681446|NCT00150462|470460342|FG000|Overall Study|Physician Decision|0|||
130681447|NCT00150462|470460343|FG001|Overall Study|Physician Decision|0|||
130681448|NCT00150462|470460344|FG002|Overall Study|Physician Decision|1|||
130681449|NCT00150462|470460345|FG003|Overall Study|Physician Decision|1|||
130681450|NCT00150462|470460346|FG004|Overall Study|Physician Decision|0|||
130681451|NCT00150462|470460347|FG005|Overall Study|Physician Decision|0|||
130681452|NCT00150462|470460348|FG006|Overall Study|Physician Decision|0|||
130681453|NCT00150462|470460349|FG007|Overall Study|Physician Decision|0|||
130681454|NCT00150462|470460350|FG008|Overall Study|Physician Decision|0|||
130681455|NCT00150462|470460351|FG009|Overall Study|Physician Decision|0|||
130681456|NCT00150462|470460352|FG010|Overall Study|Physician Decision|0|||
130681457|NCT00150462|470460342|FG000|Overall Study|Other|0|||
130681458|NCT00150462|470460343|FG001|Overall Study|Other|0|||
130681459|NCT00150462|470460344|FG002|Overall Study|Other|0|||
130681460|NCT00150462|470460345|FG003|Overall Study|Other|0|||
130681461|NCT00150462|470460346|FG004|Overall Study|Other|0|||
130681462|NCT00150462|470460347|FG005|Overall Study|Other|0|||
130681463|NCT00150462|470460348|FG006|Overall Study|Other|0|||
130681464|NCT00150462|470460349|FG007|Overall Study|Other|0|||
130681465|NCT00150462|470460350|FG008|Overall Study|Other|0|||
130681466|NCT00150462|470460351|FG009|Overall Study|Other|1|||
130681467|NCT00150462|470460352|FG010|Overall Study|Other|1|||
130681468|NCT00569374|470460355|FG000|Overall Study|Withdrawal by Subject|4|||
130681469|NCT00912288|470460356|FG000|Overall Study|Death|0|||
130681470|NCT00912288|470460357|FG001|Overall Study|Death|1|||
130681471|NCT00912288|470460356|FG000|Overall Study|Adverse Event|1|||
130681472|NCT00912288|470460357|FG001|Overall Study|Adverse Event|1|||
130681473|NCT00912288|470460356|FG000|Overall Study|Lost to Follow-up|1|||
130681474|NCT00912288|470460357|FG001|Overall Study|Lost to Follow-up|0|||
130681475|NCT00912288|470460356|FG000|Overall Study|Protocol Violation|1|||
130681476|NCT00912288|470460357|FG001|Overall Study|Protocol Violation|0|||
130681477|NCT00912288|470460356|FG000|Overall Study|Withdrawal by Subject|3|||
130681478|NCT00912288|470460357|FG001|Overall Study|Withdrawal by Subject|3|||
130681479|NCT00912288|470460356|FG000|Overall Study|Study terminated by sponsor|34|||
130681480|NCT00912288|470460357|FG001|Overall Study|Study terminated by sponsor|35|||
130681481|NCT00912288|470460356|FG000|Overall Study|Other|1|||
130681482|NCT00912288|470460357|FG001|Overall Study|Other|0|||
130681483|NCT00877032|470460360|FG000|Overall Study|Did not meet entrance criteria|0|||
130681484|NCT00877032|470460361|FG001|Overall Study|Did not meet entrance criteria|0|||
130681485|NCT00877032|470460362|FG002|Overall Study|Did not meet entrance criteria|0|||
130681486|NCT00877032|470460363|FG003|Overall Study|Did not meet entrance criteria|1|||
130681487|NCT00877032|470460364|FG004|Overall Study|Did not meet entrance criteria|0|||
130681488|NCT00877032|470460365|FG005|Overall Study|Did not meet entrance criteria|0|||
130681489|NCT00877032|470460366|FG006|Overall Study|Did not meet entrance criteria|2|||
130681490|NCT05067647|470460375|FG000|Overall Study|Lost to Follow-up|1|||
130681491|NCT00870870|470460378|FG000|Overall Study|Withdrawal by Subject|0|||
130681492|NCT00870870|470460379|FG001|Overall Study|Withdrawal by Subject|1|||
130681493|NCT00870870|470460380|FG002|Overall Study|Withdrawal by Subject|1|||
130681494|NCT00870870|470460381|FG003|Overall Study|Withdrawal by Subject|3|||
130681495|NCT00870870|470460378|FG000|Overall Study|Adverse Event|0|||
130681496|NCT00870870|470460379|FG001|Overall Study|Adverse Event|0|||
130681497|NCT00870870|470460380|FG002|Overall Study|Adverse Event|2|||
130681498|NCT00870870|470460381|FG003|Overall Study|Adverse Event|2|||
130681499|NCT00822926|470460385|FG000|Second Injection Visit|Lost to Follow-up|1|||
130681500|NCT00822926|470460386|FG001|Second Injection Visit|Lost to Follow-up|0|||
130681501|NCT00822926|470460385|FG000|Second Injection Visit|Withdrawal by Subject|0|||
130681502|NCT00822926|470460386|FG001|Second Injection Visit|Withdrawal by Subject|1|||
130681503|NCT01706536|470460399|FG000|Overall Study|Withdrawal by Subject|1|||
130681504|NCT01706536|470460400|FG001|Overall Study|Withdrawal by Subject|0|||
130681505|NCT01706536|470460401|FG002|Overall Study|Withdrawal by Subject|1|||
130681506|NCT01706536|470460402|FG003|Overall Study|Withdrawal by Subject|0|||
130681507|NCT01706536|470460403|FG004|Overall Study|Withdrawal by Subject|0|||
130681508|NCT01706536|470460399|FG000|Overall Study|Adverse Event|2|||
130681509|NCT01706536|470460400|FG001|Overall Study|Adverse Event|3|||
130681510|NCT01706536|470460401|FG002|Overall Study|Adverse Event|4|||
130681511|NCT01706536|470460402|FG003|Overall Study|Adverse Event|3|||
130681512|NCT01706536|470460403|FG004|Overall Study|Adverse Event|2|||
130681513|NCT01706536|470460399|FG000|Overall Study|Lack of Efficacy|1|||
130681514|NCT01706536|470460400|FG001|Overall Study|Lack of Efficacy|0|||
130681515|NCT01706536|470460401|FG002|Overall Study|Lack of Efficacy|0|||
130681516|NCT01706536|470460402|FG003|Overall Study|Lack of Efficacy|1|||
130681517|NCT01706536|470460403|FG004|Overall Study|Lack of Efficacy|0|||
130681518|NCT01706536|470460399|FG000|Overall Study|non compliance|0|||
130681519|NCT01706536|470460400|FG001|Overall Study|non compliance|1|||
130681520|NCT01706536|470460401|FG002|Overall Study|non compliance|0|||
130681521|NCT01706536|470460402|FG003|Overall Study|non compliance|0|||
130681522|NCT01706536|470460403|FG004|Overall Study|non compliance|0|||
130681523|NCT00683293|470460412|FG000|Overall Study|Withdrawal by Subject|2|||
130217008|NCT00980655|468757319|FG001|Overall Study|Withdrawal by Subject|4|||
130681524|NCT00683293|470460413|FG001|Overall Study|Withdrawal by Subject|3|||
130681525|NCT03262012|470460414|FG000|Overall Study|Withdrawal by Subject|15|||
130681526|NCT03262012|470460415|FG001|Overall Study|Withdrawal by Subject|13|||
130681527|NCT03262012|470460416|FG002|Overall Study|Withdrawal by Subject|8|||
130681528|NCT03262012|470460417|FG003|Overall Study|Withdrawal by Subject|7|||
130681529|NCT03262012|470460414|FG000|Overall Study|Adverse Event|10|||
130681530|NCT03262012|470460415|FG001|Overall Study|Adverse Event|12|||
130681531|NCT03262012|470460416|FG002|Overall Study|Adverse Event|4|||
130681532|NCT03262012|470460417|FG003|Overall Study|Adverse Event|6|||
130681533|NCT03262012|470460414|FG000|Overall Study|Physician Decision|2|||
130681534|NCT03262012|470460415|FG001|Overall Study|Physician Decision|5|||
130681535|NCT03262012|470460416|FG002|Overall Study|Physician Decision|1|||
130681536|NCT03262012|470460417|FG003|Overall Study|Physician Decision|0|||
130681537|NCT03262012|470460414|FG000|Overall Study|Lack of Efficacy|0|||
130681538|NCT03262012|470460415|FG001|Overall Study|Lack of Efficacy|5|||
130217009|NCT00980655|468757318|FG000|Overall Study|Lost to Follow-up|0|||
130217010|NCT00980655|468757319|FG001|Overall Study|Lost to Follow-up|1|||
130217011|NCT00980655|468757318|FG000|Overall Study|Parent/legal guardian request|1|||
130217012|NCT00980655|468757319|FG001|Overall Study|Parent/legal guardian request|0|||
130217013|NCT00980655|468757318|FG000|Overall Study|Other|0|||
130436276|NCT00211237|469560600|FG000|Baseline|Refused random assignment|1|||
130436277|NCT00211237|469560601|FG001|Baseline|Refused random assignment|0|||
130436278|NCT00211237|469560602|FG002|Baseline|Refused random assignment|0|||
130436279|NCT00211237|469560600|FG000|1 Month|Death|2|||
130681539|NCT03262012|470460416|FG002|Overall Study|Lack of Efficacy|1|||
130217014|NCT00980655|468757319|FG001|Overall Study|Other|1|||
130217015|NCT00845676|468757325|FG000|Overall Study|Virologic breakthrough at week 20|1|||
130217016|NCT00845676|468757325|FG000|Overall Study|Adverse Event|1|||
130217017|NCT00481767|468757327|FG000|Overall Study|Withdrawal by Subject|16|||
130217018|NCT00481767|468757328|FG001|Overall Study|Withdrawal by Subject|11|||
130217019|NCT00481767|468757327|FG000|Overall Study|Lost to Follow-up|16|||
130217020|NCT00481767|468757328|FG001|Overall Study|Lost to Follow-up|10|||
130217021|NCT01941537|468757329|FG000|Overall Study|Lack of Efficacy|1|||
130217022|NCT01941537|468757330|FG001|Overall Study|Lack of Efficacy|2|||
130217023|NCT01941537|468757329|FG000|Overall Study|Lost to Follow-up|1|||
130217024|NCT01941537|468757330|FG001|Overall Study|Lost to Follow-up|0|||
130217025|NCT01941537|468757329|FG000|Overall Study|Pregnancy|1|||
130217026|NCT01941537|468757330|FG001|Overall Study|Pregnancy|0|||
130217027|NCT01941537|468757329|FG000|Overall Study|Adverse Event|1|||
130217028|NCT01941537|468757330|FG001|Overall Study|Adverse Event|0|||
130217029|NCT01941537|468757329|FG000|Overall Study|Withdrawal by Subject|0|||
130217030|NCT01941537|468757330|FG001|Overall Study|Withdrawal by Subject|1|||
130217031|NCT02557516|468757332|FG000|Overall Study|Adverse Event|1|||
130217032|NCT02557516|468757333|FG001|Overall Study|Adverse Event|0|||
130217033|NCT02557516|468757334|FG002|Overall Study|Adverse Event|2|||
130217034|NCT02557516|468757335|FG003|Overall Study|Adverse Event|1|||
130217035|NCT02557516|468757332|FG000|Overall Study|Disease progression|0|||
130217036|NCT02557516|468757333|FG001|Overall Study|Disease progression|2|||
130217037|NCT02557516|468757334|FG002|Overall Study|Disease progression|0|||
130217038|NCT02557516|468757335|FG003|Overall Study|Disease progression|0|||
130217039|NCT02557516|468757332|FG000|Overall Study|Physician Decision|0|||
130217040|NCT02557516|468757333|FG001|Overall Study|Physician Decision|2|||
130217041|NCT02557516|468757334|FG002|Overall Study|Physician Decision|0|||
130217042|NCT02557516|468757335|FG003|Overall Study|Physician Decision|0|||
130217043|NCT02557516|468757332|FG000|Overall Study|Sponsor decision|0|||
130217044|NCT02557516|468757333|FG001|Overall Study|Sponsor decision|1|||
130217045|NCT02557516|468757334|FG002|Overall Study|Sponsor decision|2|||
130217046|NCT02557516|468757335|FG003|Overall Study|Sponsor decision|8|||
130217047|NCT00632125|468759436|FG000|Overall Study|Death|82|||
130217048|NCT00632125|468759436|FG000|Overall Study|Withdrawal by Subject|44|||
130217049|NCT00632125|468759436|FG000|Overall Study|Adverse Event|36|||
130217050|NCT00632125|468759436|FG000|Overall Study|Renal transplantation|17|||
130217051|NCT00632125|468759436|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
130217052|NCT00632125|468759436|FG000|Overall Study|Non-compliance|8|||
130217053|NCT00632125|468759436|FG000|Overall Study|Development of uncontrolled hypertension|5|||
130217054|NCT00632125|468759436|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
130217055|NCT03130959|468759449|FG000|Overall Study|Disease progression|19|||
130217056|NCT03130959|468759450|FG001|Overall Study|Disease progression|7|||
130217057|NCT03130959|468759451|FG002|Overall Study|Disease progression|12|||
130217058|NCT03130959|468759452|FG003|Overall Study|Disease progression|7|||
130217059|NCT03130959|468759453|FG004|Overall Study|Disease progression|12|||
130217060|NCT03130959|468759454|FG005|Overall Study|Disease progression|3|||
130217061|NCT03130959|468759455|FG006|Overall Study|Disease progression|6|||
130217062|NCT03130959|468759456|FG007|Overall Study|Disease progression|3|||
130217063|NCT03130959|468759457|FG008|Overall Study|Disease progression|15|||
130217064|NCT03130959|468759458|FG009|Overall Study|Disease progression|8|||
130217065|NCT03130959|468759449|FG000|Overall Study|Study drug toxicity|2|||
130681540|NCT03262012|470460417|FG003|Overall Study|Lack of Efficacy|2|||
130681541|NCT03262012|470460414|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
130681542|NCT03262012|470460415|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
130681543|NCT03262012|470460416|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
130681544|NCT03262012|470460417|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
130681545|NCT01469546|470460418|FG000|Received 5 mg Dose|Adverse Event|13|||
130217066|NCT03130959|468759450|FG001|Overall Study|Study drug toxicity|2|||
130436280|NCT00211237|469560601|FG001|1 Month|Death|1|||
130217067|NCT03130959|468759451|FG002|Overall Study|Study drug toxicity|1|||
130217068|NCT03130959|468759452|FG003|Overall Study|Study drug toxicity|2|||
130217069|NCT03130959|468759453|FG004|Overall Study|Study drug toxicity|1|||
130217070|NCT03130959|468759454|FG005|Overall Study|Study drug toxicity|1|||
130217071|NCT03130959|468759455|FG006|Overall Study|Study drug toxicity|3|||
130217072|NCT03130959|468759456|FG007|Overall Study|Study drug toxicity|0|||
130217073|NCT03130959|468759457|FG008|Overall Study|Study drug toxicity|3|||
130217074|NCT03130959|468759458|FG009|Overall Study|Study drug toxicity|3|||
130217075|NCT03130959|468759449|FG000|Overall Study|Other reasons|0|||
130436281|NCT00211237|469560602|FG002|1 Month|Death|0|||
130217076|NCT03130959|468759450|FG001|Overall Study|Other reasons|0|||
130217077|NCT03130959|468759451|FG002|Overall Study|Other reasons|0|||
130217078|NCT03130959|468759452|FG003|Overall Study|Other reasons|0|||
130217079|NCT03130959|468759453|FG004|Overall Study|Other reasons|0|||
130217080|NCT03130959|468759454|FG005|Overall Study|Other reasons|1|||
130217081|NCT03130959|468759455|FG006|Overall Study|Other reasons|1|||
130217082|NCT03130959|468759456|FG007|Overall Study|Other reasons|0|||
130217083|NCT03130959|468759457|FG008|Overall Study|Other reasons|0|||
130217084|NCT03130959|468759458|FG009|Overall Study|Other reasons|0|||
130217085|NCT03130959|468759449|FG000|Overall Study|Subject request to discontinue therapy|0|||
130217086|NCT03130959|468759450|FG001|Overall Study|Subject request to discontinue therapy|0|||
130217087|NCT03130959|468759451|FG002|Overall Study|Subject request to discontinue therapy|1|||
130217088|NCT03130959|468759452|FG003|Overall Study|Subject request to discontinue therapy|1|||
130217089|NCT03130959|468759453|FG004|Overall Study|Subject request to discontinue therapy|0|||
130217090|NCT03130959|468759454|FG005|Overall Study|Subject request to discontinue therapy|0|||
130217091|NCT03130959|468759455|FG006|Overall Study|Subject request to discontinue therapy|1|||
130217092|NCT03130959|468759456|FG007|Overall Study|Subject request to discontinue therapy|1|||
130217093|NCT03130959|468759457|FG008|Overall Study|Subject request to discontinue therapy|0|||
130217094|NCT03130959|468759458|FG009|Overall Study|Subject request to discontinue therapy|0|||
130217095|NCT03130959|468759449|FG000|Overall Study|Not reported|0|||
130217096|NCT03130959|468759450|FG001|Overall Study|Not reported|0|||
130217097|NCT03130959|468759451|FG002|Overall Study|Not reported|0|||
130217098|NCT03130959|468759452|FG003|Overall Study|Not reported|1|||
130436282|NCT00211237|469560600|FG000|1 Month|Lost to Follow-up|0|||
130436283|NCT00211237|469560601|FG001|1 Month|Lost to Follow-up|2|||
130436284|NCT00211237|469560602|FG002|1 Month|Lost to Follow-up|0|||
130436285|NCT00211237|469560600|FG000|1 Month|Withdrew|0|||
130436286|NCT00211237|469560601|FG001|1 Month|Withdrew|4|||
130681546|NCT01469546|470460418|FG000|Received 5 mg Dose|Death|2|||
130681547|NCT01469546|470460418|FG000|Received 5 mg Dose|Protocol Violation|2|||
130681548|NCT01469546|470460418|FG000|Received 5 mg Dose|Progressive Disease|3|||
130436287|NCT00211237|469560602|FG002|1 Month|Withdrew|0|||
130436288|NCT00211237|469560600|FG000|1 Month|Additional surgery needed|1|||
130436289|NCT00211237|469560601|FG001|1 Month|Additional surgery needed|0|||
130436290|NCT00211237|469560602|FG002|1 Month|Additional surgery needed|0|||
130436291|NCT00211237|469560600|FG000|1 Month|Non-medical problem|0|||
130436292|NCT00211237|469560601|FG001|1 Month|Non-medical problem|2|||
130436293|NCT00211237|469560602|FG002|1 Month|Non-medical problem|0|||
130436294|NCT00211237|469560600|FG000|3 Months|Death|7|||
130681549|NCT01469546|470460418|FG000|Received 5 mg Dose|Physician Decision|3|||
130681550|NCT03601637|470461998|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
130681551|NCT03601637|470461999|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
130681552|NCT03601637|470461998|FG000|Overall Study|Adverse Event|1|||
130681553|NCT03601637|470461999|FG001|Overall Study|Adverse Event|1|||
130217099|NCT03130959|468759453|FG004|Overall Study|Not reported|0|||
130217100|NCT03130959|468759454|FG005|Overall Study|Not reported|1|||
130217101|NCT03130959|468759455|FG006|Overall Study|Not reported|0|||
130217102|NCT03130959|468759456|FG007|Overall Study|Not reported|0|||
130217103|NCT03130959|468759457|FG008|Overall Study|Not reported|0|||
130217104|NCT03130959|468759458|FG009|Overall Study|Not reported|1|||
130217105|NCT03130959|468759449|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130217106|NCT03130959|468759450|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130217107|NCT03130959|468759451|FG002|Overall Study|Adverse Event unrelated to drug|1|||
130217108|NCT03130959|468759452|FG003|Overall Study|Adverse Event unrelated to drug|1|||
130217109|NCT03130959|468759453|FG004|Overall Study|Adverse Event unrelated to drug|1|||
130217110|NCT03130959|468759454|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130217111|NCT03130959|468759455|FG006|Overall Study|Adverse Event unrelated to drug|1|||
130217112|NCT03130959|468759456|FG007|Overall Study|Adverse Event unrelated to drug|0|||
130681554|NCT03601637|470461998|FG000|Overall Study|Other|0|||
130681555|NCT03601637|470461999|FG001|Overall Study|Other|1|||
130681556|NCT01507051|470462005|FG000|Overall Study|Withdrawal by Subject|1|||
130217113|NCT03130959|468759457|FG008|Overall Study|Adverse Event unrelated to drug|1|||
130217114|NCT03130959|468759458|FG009|Overall Study|Adverse Event unrelated to drug|1|||
130217115|NCT03130959|468759449|FG000|Overall Study|Participant withdrew consent|0|||
130217116|NCT03130959|468759450|FG001|Overall Study|Participant withdrew consent|1|||
130217117|NCT03130959|468759451|FG002|Overall Study|Participant withdrew consent|0|||
130217118|NCT03130959|468759452|FG003|Overall Study|Participant withdrew consent|2|||
130217119|NCT03130959|468759453|FG004|Overall Study|Participant withdrew consent|1|||
130217120|NCT03130959|468759454|FG005|Overall Study|Participant withdrew consent|0|||
130217121|NCT03130959|468759455|FG006|Overall Study|Participant withdrew consent|0|||
130436295|NCT00211237|469560601|FG001|3 Months|Death|3|||
130436296|NCT00211237|469560602|FG002|3 Months|Death|0|||
130436297|NCT00211237|469560600|FG000|3 Months|Could not comply with protocol|1|||
130681557|NCT01507051|470462006|FG001|Overall Study|Withdrawal by Subject|3|||
130436298|NCT00211237|469560601|FG001|3 Months|Could not comply with protocol|0|||
130436299|NCT00211237|469560602|FG002|3 Months|Could not comply with protocol|0|||
130681558|NCT01507051|470462007|FG002|Overall Study|Withdrawal by Subject|1|||
130681559|NCT01507051|470462008|FG003|Overall Study|Withdrawal by Subject|6|||
130681560|NCT01507051|470462005|FG000|Overall Study|Physician Decision|0|||
130681561|NCT01507051|470462006|FG001|Overall Study|Physician Decision|0|||
130681562|NCT01507051|470462007|FG002|Overall Study|Physician Decision|0|||
130681563|NCT01507051|470462008|FG003|Overall Study|Physician Decision|1|||
130681564|NCT01507051|470462005|FG000|Overall Study|Adverse Event|1|||
130681565|NCT01507051|470462006|FG001|Overall Study|Adverse Event|0|||
130681566|NCT01507051|470462007|FG002|Overall Study|Adverse Event|0|||
130681567|NCT01507051|470462008|FG003|Overall Study|Adverse Event|0|||
130681568|NCT00420303|470462009|FG000|Overall Study|Serious Adverse Event|1|||
130681569|NCT00420303|470462010|FG001|Overall Study|Serious Adverse Event|0|||
130681570|NCT00420303|470462009|FG000|Overall Study|Lack of Efficacy|0|||
130681571|NCT00420303|470462010|FG001|Overall Study|Lack of Efficacy|3|||
130681572|NCT00420303|470462009|FG000|Overall Study|Physician Decision|0|||
130681573|NCT00420303|470462010|FG001|Overall Study|Physician Decision|1|||
130681574|NCT00745420|470462012|FG000|Overall Study|Ineligible|1|||
130681575|NCT00088829|470462017|FG000|Overall Study|PI left institution and study was close|22|||
130681576|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
130681577|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
130681578|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
130681579|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130681580|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130681581|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
130681582|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
130681583|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130681584|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130681585|NCT04455633|470462018|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
130681586|NCT04455633|470462019|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130681587|NCT04455633|470462020|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130681588|NCT00727571|470462021|FG000|Overall Study|Ineligibility determined|1|||
130681589|NCT00727571|470462022|FG001|Overall Study|Ineligibility determined|1|||
130681590|NCT00727571|470462023|FG002|Overall Study|Ineligibility determined|1|||
130217122|NCT03130959|468759456|FG007|Overall Study|Participant withdrew consent|0|||
130217123|NCT03130959|468759457|FG008|Overall Study|Participant withdrew consent|0|||
130217124|NCT03130959|468759458|FG009|Overall Study|Participant withdrew consent|2|||
130217125|NCT03130959|468759449|FG000|Overall Study|Administrative reason by sponsor|1|||
130217126|NCT03130959|468759450|FG001|Overall Study|Administrative reason by sponsor|0|||
130217127|NCT03130959|468759451|FG002|Overall Study|Administrative reason by sponsor|1|||
130217128|NCT03130959|468759452|FG003|Overall Study|Administrative reason by sponsor|0|||
130217129|NCT03130959|468759453|FG004|Overall Study|Administrative reason by sponsor|0|||
130217130|NCT03130959|468759454|FG005|Overall Study|Administrative reason by sponsor|0|||
130217131|NCT03130959|468759455|FG006|Overall Study|Administrative reason by sponsor|0|||
130217132|NCT03130959|468759456|FG007|Overall Study|Administrative reason by sponsor|0|||
130217133|NCT03130959|468759457|FG008|Overall Study|Administrative reason by sponsor|0|||
130217134|NCT03130959|468759458|FG009|Overall Study|Administrative reason by sponsor|0|||
130217135|NCT03130959|468759449|FG000|Overall Study|Lost to Follow-up|1|||
130217136|NCT03130959|468759450|FG001|Overall Study|Lost to Follow-up|0|||
130217137|NCT03130959|468759451|FG002|Overall Study|Lost to Follow-up|0|||
130217138|NCT03130959|468759452|FG003|Overall Study|Lost to Follow-up|0|||
130217139|NCT03130959|468759453|FG004|Overall Study|Lost to Follow-up|0|||
130217140|NCT03130959|468759454|FG005|Overall Study|Lost to Follow-up|0|||
130217141|NCT03130959|468759455|FG006|Overall Study|Lost to Follow-up|0|||
130217142|NCT03130959|468759456|FG007|Overall Study|Lost to Follow-up|0|||
130217143|NCT03130959|468759457|FG008|Overall Study|Lost to Follow-up|0|||
130217144|NCT03130959|468759458|FG009|Overall Study|Lost to Follow-up|0|||
130217145|NCT02384538|468759459|FG000|Overall Study|Adverse Event|1|||
130217146|NCT02384538|468759460|FG001|Overall Study|Adverse Event|4|||
130217147|NCT02384538|468759459|FG000|Overall Study|Lack of Efficacy|4|||
130217148|NCT02384538|468759460|FG001|Overall Study|Lack of Efficacy|4|||
130217149|NCT02384538|468759459|FG000|Overall Study|Withdrew Consent|0|||
130217150|NCT02384538|468759460|FG001|Overall Study|Withdrew Consent|4|||
130217151|NCT02384538|468759459|FG000|Overall Study|Other|1|||
130217152|NCT02384538|468759460|FG001|Overall Study|Other|3|||
130217153|NCT03117361|468759464|FG000|Overall Study|Progressive disease|5|||
130217154|NCT03117361|468759464|FG000|Overall Study|Death|1|||
130681591|NCT00727571|470462024|FG003|Overall Study|Ineligibility determined|0|||
130681592|NCT00727571|470462021|FG000|Overall Study|Death|0|||
130681593|NCT00727571|470462022|FG001|Overall Study|Death|19|||
130681594|NCT00727571|470462023|FG002|Overall Study|Death|5|||
130217155|NCT03117361|468759464|FG000|Overall Study|Physician Decision|2|||
130217156|NCT03117361|468759464|FG000|Overall Study|On study treatment at the end of study|1|||
130217157|NCT03117361|468759464|FG000|Overall Study|Treatment-related adverse event|1|||
130681595|NCT00727571|470462024|FG003|Overall Study|Death|1|||
130217158|NCT00540644|468759468|FG000|Overall Study|Adverse Event|3|||
130217159|NCT00540644|468759469|FG001|Overall Study|Adverse Event|1|||
130217160|NCT00540644|468759468|FG000|Overall Study|Disease Progression|3|||
130217161|NCT00540644|468759469|FG001|Overall Study|Disease Progression|1|||
130217162|NCT00540644|468759468|FG000|Overall Study|Physician Decision|0|||
130217163|NCT00540644|468759469|FG001|Overall Study|Physician Decision|5|||
130217164|NCT00540644|468759468|FG000|Overall Study|Withdrawal by Subject|2|||
130217165|NCT00540644|468759469|FG001|Overall Study|Withdrawal by Subject|2|||
130217166|NCT00540644|468759468|FG000|Overall Study|Noncomplilance|1|||
130217167|NCT00540644|468759469|FG001|Overall Study|Noncomplilance|0|||
130217168|NCT03280056|468759470|FG000|Overall Study|Withdrawal by Subject|12|||
130217169|NCT03280056|468759471|FG001|Overall Study|Withdrawal by Subject|14|||
130217170|NCT03280056|468759470|FG000|Overall Study|Death|9|||
130217171|NCT03280056|468759471|FG001|Overall Study|Death|2|||
130217172|NCT03280056|468759470|FG000|Overall Study|Adverse Event|1|||
130217173|NCT03280056|468759471|FG001|Overall Study|Adverse Event|3|||
130217174|NCT03280056|468759470|FG000|Overall Study|Lost to Follow-up|1|||
130217175|NCT03280056|468759471|FG001|Overall Study|Lost to Follow-up|1|||
130217176|NCT03280056|468759470|FG000|Overall Study|Physician Decision|0|||
130681596|NCT00727571|470462021|FG000|Overall Study|Physician Decision|0|||
130217177|NCT03280056|468759471|FG001|Overall Study|Physician Decision|1|||
130217178|NCT03280056|468759470|FG000|Overall Study|Early Discontinuation|1|||
130681597|NCT00727571|470462022|FG001|Overall Study|Physician Decision|5|||
130681598|NCT00727571|470462023|FG002|Overall Study|Physician Decision|0|||
130681599|NCT00727571|470462024|FG003|Overall Study|Physician Decision|0|||
130681600|NCT00727571|470462021|FG000|Overall Study|Withdrawal by Subject|0|||
130681601|NCT00727571|470462022|FG001|Overall Study|Withdrawal by Subject|10|||
130681602|NCT00727571|470462023|FG002|Overall Study|Withdrawal by Subject|11|||
130681603|NCT00727571|470462024|FG003|Overall Study|Withdrawal by Subject|0|||
130681604|NCT00727571|470462021|FG000|Overall Study|Subject Non Compliance|0|||
130681605|NCT00727571|470462022|FG001|Overall Study|Subject Non Compliance|6|||
130681606|NCT00727571|470462023|FG002|Overall Study|Subject Non Compliance|0|||
130681607|NCT00727571|470462024|FG003|Overall Study|Subject Non Compliance|4|||
130681608|NCT00727571|470462021|FG000|Overall Study|Dismissed from nursing home|0|||
130681609|NCT00727571|470462022|FG001|Overall Study|Dismissed from nursing home|9|||
130681610|NCT00727571|470462023|FG002|Overall Study|Dismissed from nursing home|5|||
130681611|NCT00727571|470462024|FG003|Overall Study|Dismissed from nursing home|0|||
130681612|NCT00727571|470462021|FG000|Overall Study|Hospitalization|0|||
130681613|NCT00727571|470462022|FG001|Overall Study|Hospitalization|1|||
130681614|NCT00727571|470462023|FG002|Overall Study|Hospitalization|0|||
130681615|NCT00727571|470462024|FG003|Overall Study|Hospitalization|1|||
130681616|NCT00727571|470462021|FG000|Overall Study|AE not leading to hospitalization|0|||
130681617|NCT00727571|470462022|FG001|Overall Study|AE not leading to hospitalization|0|||
130681618|NCT00727571|470462023|FG002|Overall Study|AE not leading to hospitalization|2|||
130681619|NCT00727571|470462024|FG003|Overall Study|AE not leading to hospitalization|0|||
130681620|NCT00727571|470462021|FG000|Overall Study|Other|0|||
130681621|NCT00727571|470462022|FG001|Overall Study|Other|4|||
130681622|NCT00727571|470462023|FG002|Overall Study|Other|6|||
130681623|NCT00727571|470462024|FG003|Overall Study|Other|0|||
130681624|NCT03164772|470462026|FG000|Overall Study|Death|4|||
130681625|NCT03164772|470462027|FG001|Overall Study|Death|2|||
130681626|NCT03164772|470462026|FG000|Overall Study|Adverse Event|1|||
130681627|NCT03164772|470462027|FG001|Overall Study|Adverse Event|4|||
130681628|NCT03164772|470462026|FG000|Overall Study|Progressive Disease|11|||
130681629|NCT03164772|470462027|FG001|Overall Study|Progressive Disease|21|||
130681630|NCT03164772|470462026|FG000|Overall Study|Physician Decision|2|||
130681631|NCT03164772|470462027|FG001|Overall Study|Physician Decision|0|||
130681632|NCT03164772|470462026|FG000|Overall Study|Withdrawal by Subject|0|||
130681633|NCT03164772|470462027|FG001|Overall Study|Withdrawal by Subject|4|||
130681634|NCT00051025|470462028|FG000|Overall Study|Progressive Disease|1|||
130681635|NCT00051025|470462029|FG001|Overall Study|Progressive Disease|1|||
130217179|NCT03280056|468759471|FG001|Overall Study|Early Discontinuation|0|||
130217180|NCT02144077|468759472|FG000|Overall Study|Withdrawal by Subject|3|||
130217181|NCT02144077|468759473|FG001|Overall Study|Withdrawal by Subject|3|||
130217182|NCT02144077|468759472|FG000|Overall Study|Adverse Event|2|||
130681636|NCT00051025|470462028|FG000|Overall Study|Adverse Event|1|||
130681637|NCT00051025|470462029|FG001|Overall Study|Adverse Event|1|||
130681638|NCT00051025|470462028|FG000|Overall Study|Withdrawal by Subject|0|||
130681639|NCT00051025|470462029|FG001|Overall Study|Withdrawal by Subject|1|||
130681640|NCT00051025|470462028|FG000|Overall Study|Death|0|||
130681641|NCT00051025|470462029|FG001|Overall Study|Death|1|||
130681642|NCT02189941|470462030|FG000|Overall Study|Non-compliance|0|||
130217183|NCT02144077|468759473|FG001|Overall Study|Adverse Event|3|||
130217184|NCT02144077|468759472|FG000|Overall Study|Lost to Follow-up|2|||
130681643|NCT02189941|470462031|FG001|Overall Study|Non-compliance|0|||
130681644|NCT02189941|470462032|FG002|Overall Study|Non-compliance|1|||
130217185|NCT02144077|468759473|FG001|Overall Study|Lost to Follow-up|2|||
130681645|NCT00445003|470462033|FG000|Overall Study|Death|1|||
130217186|NCT02144077|468759472|FG000|Overall Study|Protocol Violation|1|||
130681646|NCT00445003|470462034|FG001|Overall Study|Death|2|||
130217187|NCT02144077|468759473|FG001|Overall Study|Protocol Violation|2|||
130217188|NCT02144077|468759472|FG000|Overall Study|Death|0|||
130217189|NCT02144077|468759473|FG001|Overall Study|Death|1|||
130217190|NCT02144077|468759472|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
130681647|NCT00445003|470462035|FG002|Overall Study|Death|1|||
130681648|NCT00445003|470462033|FG000|Overall Study|Missed Visit|3|||
130681649|NCT00445003|470462034|FG001|Overall Study|Missed Visit|5|||
130681650|NCT00445003|470462035|FG002|Overall Study|Missed Visit|1|||
130681651|NCT00445003|470462033|FG000|Overall Study|Dropped|1|||
130681652|NCT00445003|470462034|FG001|Overall Study|Dropped|3|||
130681653|NCT00445003|470462035|FG002|Overall Study|Dropped|2|||
130681654|NCT01196052|470462036|FG000|Overall Study|Adverse Event|9|||
130217191|NCT02144077|468759473|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
130217192|NCT00610168|468759474|FG000|Overall Study|Withdrawal by Subject|2|||
130217193|NCT00610168|468759475|FG001|Overall Study|Withdrawal by Subject|0|||
130217194|NCT00943592|468759476|FG000|Overall Study|Death|3|||
130217195|NCT00169104|468759477|FG000|Overall Study|Withdrawal by Subject|2|||
130217196|NCT00169104|468759478|FG001|Overall Study|Withdrawal by Subject|0|||
130217197|NCT00169104|468759477|FG000|Overall Study|Protocol Violation|0|||
130217198|NCT00169104|468759478|FG001|Overall Study|Protocol Violation|1|||
130217199|NCT00169104|468759477|FG000|Overall Study|Physician Decision|0|||
130217200|NCT00169104|468759478|FG001|Overall Study|Physician Decision|1|||
130217201|NCT00715299|468759484|FG000|Overall Study|Withdrawal by Subject|1|||
130681655|NCT01196052|470462036|FG000|Overall Study|Lost to Follow-up|1|||
130681656|NCT01196052|470462036|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
130681657|NCT01196052|470462036|FG000|Overall Study|Reason not Specified|5|||
130681658|NCT01196052|470462036|FG000|Overall Study|Withdrawal by Subject|6|||
130681659|NCT02178722|470462037|FG000|Overall Study|Withdrawal by Subject|0|||
130681660|NCT02178722|470462038|FG001|Overall Study|Withdrawal by Subject|0|||
130681661|NCT02178722|470462039|FG002|Overall Study|Withdrawal by Subject|0|||
130681662|NCT02178722|470462040|FG003|Overall Study|Withdrawal by Subject|2|||
130681663|NCT02178722|470462041|FG004|Overall Study|Withdrawal by Subject|33|||
130681664|NCT02178722|470462037|FG000|Overall Study|Death|2|||
130681665|NCT02178722|470462038|FG001|Overall Study|Death|13|||
130681666|NCT02178722|470462039|FG002|Overall Study|Death|12|||
130681667|NCT02178722|470462040|FG003|Overall Study|Death|12|||
130217202|NCT00715299|468759484|FG000|Overall Study|Adverse Event|3|||
130217203|NCT00715299|468759484|FG000|Overall Study|failed the pre-screen exercise test|2|||
130217204|NCT01540981|468759485|FG000|Overall Study|Withdrawal by Subject|1|||
130217205|NCT01540981|468759486|FG001|Overall Study|Withdrawal by Subject|0|||
130217206|NCT00809094|468759488|FG000|Overall Study|Lost to Follow-up|0|||
130217207|NCT00809094|468759489|FG001|Overall Study|Lost to Follow-up|1|||
130217208|NCT00397189|468759490|FG000|3 Weeks Period|Lost to Follow-up|5|||
130217209|NCT00397189|468759491|FG001|3 Weeks Period|Lost to Follow-up|4|||
130217210|NCT00397189|468759490|FG000|3 Weeks Period|Adverse Event|3|||
130217211|NCT00397189|468759491|FG001|3 Weeks Period|Adverse Event|2|||
130217212|NCT00397189|468759490|FG000|3 Weeks Period|Withdrawal by Subject|13|||
130217213|NCT00397189|468759491|FG001|3 Weeks Period|Withdrawal by Subject|9|||
130217214|NCT00397189|468759490|FG000|3 Weeks Period|Physician Decision|0|||
130217215|NCT00397189|468759491|FG001|3 Weeks Period|Physician Decision|2|||
130217216|NCT00397189|468759490|FG000|3 Weeks Period|Protocol Violation|0|||
130217217|NCT00397189|468759491|FG001|3 Weeks Period|Protocol Violation|3|||
130217218|NCT00397189|468759490|FG000|3 Weeks Period|Other|0|||
130217219|NCT00397189|468759491|FG001|3 Weeks Period|Other|2|||
130217220|NCT01535443|468759494|FG000|Overall Study|Physician Decision|3|||
130217221|NCT00232557|468759495|FG000|Overall Study|Lost to Follow-up|3|||
130217222|NCT00232557|468759496|FG001|Overall Study|Lost to Follow-up|5|||
130217223|NCT01059773|468759497|FG000|Overall Study|Adverse Event|2|||
130217224|NCT01059773|468759498|FG001|Overall Study|Adverse Event|2|||
130217225|NCT01059773|468759497|FG000|Overall Study|Withdrawal by Subject|1|||
130217226|NCT01059773|468759498|FG001|Overall Study|Withdrawal by Subject|5|||
130217227|NCT01059773|468759497|FG000|Overall Study|Lost to Follow-up|1|||
130217228|NCT01059773|468759498|FG001|Overall Study|Lost to Follow-up|1|||
130217229|NCT01059773|468759497|FG000|Overall Study|Pregnancy|1|||
130217230|NCT01059773|468759498|FG001|Overall Study|Pregnancy|1|||
130217231|NCT01059773|468759497|FG000|Overall Study|Protocol Violation|6|||
130217232|NCT01059773|468759498|FG001|Overall Study|Protocol Violation|2|||
130681668|NCT02178722|470462041|FG004|Overall Study|Death|205|||
130217233|NCT01059773|468759497|FG000|Overall Study|Physician Decision|5|||
130217234|NCT01059773|468759498|FG001|Overall Study|Physician Decision|4|||
130681669|NCT02178722|470462037|FG000|Overall Study|Lost to Follow-up|0|||
130681670|NCT02178722|470462038|FG001|Overall Study|Lost to Follow-up|0|||
130217235|NCT01059773|468759497|FG000|Overall Study|Lack of Efficacy|3|||
130217236|NCT01059773|468759498|FG001|Overall Study|Lack of Efficacy|3|||
130217237|NCT01059773|468759497|FG000|Overall Study|Death|0|||
130217238|NCT01059773|468759498|FG001|Overall Study|Death|1|||
130217239|NCT01059773|468759497|FG000|Overall Study|Malignancy including squamous cell skin|0|||
130217240|NCT01059773|468759498|FG001|Overall Study|Malignancy including squamous cell skin|1|||
130681671|NCT02178722|470462039|FG002|Overall Study|Lost to Follow-up|0|||
130681672|NCT02178722|470462040|FG003|Overall Study|Lost to Follow-up|2|||
130217241|NCT01059773|468759497|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
130217242|NCT01059773|468759498|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
130217243|NCT01059773|468759497|FG000|Overall Study|Other|1|||
130217244|NCT01059773|468759498|FG001|Overall Study|Other|3|||
130217245|NCT00141518|468759502|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
130217246|NCT00141518|468759503|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
130217247|NCT00141518|468759504|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
130217248|NCT00141518|468759502|FG000|Overall Study|Adverse Event|7|||
130217249|NCT00141518|468759503|FG001|Overall Study|Adverse Event|5|||
130217250|NCT00141518|468759504|FG002|Overall Study|Adverse Event|2|||
130217251|NCT00141518|468759502|FG000|Overall Study|Withdrawal by Subject|2|||
130217252|NCT00141518|468759503|FG001|Overall Study|Withdrawal by Subject|0|||
130217253|NCT00141518|468759504|FG002|Overall Study|Withdrawal by Subject|2|||
130217254|NCT00141518|468759502|FG000|Overall Study|Protocol Violation|1|||
130217255|NCT00141518|468759503|FG001|Overall Study|Protocol Violation|1|||
130217256|NCT00141518|468759504|FG002|Overall Study|Protocol Violation|2|||
130217257|NCT00141518|468759502|FG000|Overall Study|Lack of Efficacy|5|||
130217258|NCT00141518|468759503|FG001|Overall Study|Lack of Efficacy|0|||
130217259|NCT00141518|468759504|FG002|Overall Study|Lack of Efficacy|0|||
130217260|NCT01806168|468759506|FG000|Overall Study|Adverse Event|1|||
130217261|NCT01806168|468759507|FG001|Overall Study|Adverse Event|0|||
130217262|NCT01806168|468759508|FG002|Overall Study|Adverse Event|0|||
130217263|NCT01806168|468759506|FG000|Overall Study|Withdrawal by Subject|0|||
130217264|NCT01806168|468759507|FG001|Overall Study|Withdrawal by Subject|1|||
130217265|NCT01806168|468759508|FG002|Overall Study|Withdrawal by Subject|2|||
130217266|NCT01806168|468759506|FG000|Overall Study|Protocol Violation|0|||
130217267|NCT01806168|468759507|FG001|Overall Study|Protocol Violation|0|||
130217268|NCT01806168|468759508|FG002|Overall Study|Protocol Violation|1|||
130217269|NCT01029262|468759511|FG000|Overall Study|Adverse Event|9|||
130217270|NCT01029262|468759512|FG001|Overall Study|Adverse Event|52|||
130217271|NCT01029262|468759511|FG000|Overall Study|Lack of therapeutic effect|57|||
130217272|NCT01029262|468759512|FG001|Overall Study|Lack of therapeutic effect|76|||
130217273|NCT01029262|468759511|FG000|Overall Study|Withdrawal by Subject|10|||
130217274|NCT01029262|468759512|FG001|Overall Study|Withdrawal by Subject|17|||
130217275|NCT01029262|468759511|FG000|Overall Study|Protocol Violation|2|||
130217276|NCT01029262|468759512|FG001|Overall Study|Protocol Violation|3|||
130217277|NCT01029262|468759511|FG000|Overall Study|Miscellaneous|1|||
130217278|NCT01029262|468759512|FG001|Overall Study|Miscellaneous|9|||
130217279|NCT01029262|468759511|FG000|Overall Study|Death|0|||
130217280|NCT01029262|468759512|FG001|Overall Study|Death|3|||
130217281|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217282|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
130217283|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217284|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217285|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217286|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217287|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130681673|NCT02178722|470462041|FG004|Overall Study|Lost to Follow-up|11|||
130217288|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217289|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217290|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217291|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217292|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
130217293|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
130681674|NCT02178722|470462037|FG000|Overall Study|Study terminated by Sponsor|2|||
130681675|NCT02178722|470462038|FG001|Overall Study|Study terminated by Sponsor|7|||
130681676|NCT02178722|470462039|FG002|Overall Study|Study terminated by Sponsor|6|||
130681677|NCT02178722|470462040|FG003|Overall Study|Study terminated by Sponsor|4|||
130681678|NCT02178722|470462041|FG004|Overall Study|Study terminated by Sponsor|128|||
130681679|NCT02178722|470462037|FG000|Overall Study|Physician Decision|0|||
130681680|NCT02178722|470462038|FG001|Overall Study|Physician Decision|0|||
130681681|NCT02178722|470462039|FG002|Overall Study|Physician Decision|0|||
130681682|NCT02178722|470462040|FG003|Overall Study|Physician Decision|0|||
130217294|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217295|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217296|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217297|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217298|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217299|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217300|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217301|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130436300|NCT00211237|469560600|FG000|3 Months|Withdrew|0|||
130681683|NCT02178722|470462041|FG004|Overall Study|Physician Decision|3|||
130681684|NCT02178722|470462037|FG000|Overall Study|Other|0|||
130681685|NCT02178722|470462038|FG001|Overall Study|Other|0|||
130681686|NCT02178722|470462039|FG002|Overall Study|Other|0|||
130681687|NCT02178722|470462040|FG003|Overall Study|Other|0|||
130681688|NCT02178722|470462041|FG004|Overall Study|Other|2|||
130681689|NCT03340727|470462042|FG000|Overall Study|Death|1|||
130681690|NCT03340727|470462043|FG001|Overall Study|Death|0|||
130681691|NCT03340727|470462042|FG000|Overall Study|Lost to Follow-up|31|||
130681692|NCT03340727|470462043|FG001|Overall Study|Lost to Follow-up|35|||
130681693|NCT03340727|470462042|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130681694|NCT03340727|470462043|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130681695|NCT03340727|470462042|FG000|Overall Study|Transferred to another facility|10|||
130681696|NCT03340727|470462043|FG001|Overall Study|Transferred to another facility|7|||
130681697|NCT03340727|470462042|FG000|Overall Study|Withdrawal by Subject|28|||
130681698|NCT03340727|470462043|FG001|Overall Study|Withdrawal by Subject|17|||
130681699|NCT03553823|470462044|FG000|Overall Study|Physician Decision|0|||
130681700|NCT03553823|470462045|FG001|Overall Study|Physician Decision|1|||
130681701|NCT01572948|470462046|FG000|Overall Study|Lost to Follow-up|1|||
130681702|NCT01572948|470462047|FG001|Overall Study|Lost to Follow-up|0|||
130681703|NCT01572948|470462046|FG000|Overall Study|unable to contact|0|||
130681704|NCT01572948|470462047|FG001|Overall Study|unable to contact|1|||
130681705|NCT03603314|470462048|FG000|Overall Study|Lost to Follow-up|0|||
130681706|NCT03603314|470462049|FG001|Overall Study|Lost to Follow-up|3|||
130681707|NCT03603314|470462050|FG002|Overall Study|Lost to Follow-up|0|||
130681708|NCT03603314|470462048|FG000|Overall Study|Protocol Violation|0|||
130681709|NCT03603314|470462049|FG001|Overall Study|Protocol Violation|1|||
130681710|NCT03603314|470462050|FG002|Overall Study|Protocol Violation|0|||
130681711|NCT03603314|470462048|FG000|Overall Study|Adverse Event|2|||
130681712|NCT03603314|470462049|FG001|Overall Study|Adverse Event|0|||
130681713|NCT03603314|470462050|FG002|Overall Study|Adverse Event|0|||
130681714|NCT03603314|470462048|FG000|Overall Study|Physician Decision|1|||
130681715|NCT03603314|470462049|FG001|Overall Study|Physician Decision|1|||
130681716|NCT03603314|470462050|FG002|Overall Study|Physician Decision|0|||
130681717|NCT03603314|470462048|FG000|Overall Study|Withdrawal by Subject|4|||
130681718|NCT03603314|470462049|FG001|Overall Study|Withdrawal by Subject|5|||
130681719|NCT03603314|470462050|FG002|Overall Study|Withdrawal by Subject|3|||
130681720|NCT03603314|470462048|FG000|Overall Study|Other|0|||
130681721|NCT03603314|470462049|FG001|Overall Study|Other|1|||
130681722|NCT03603314|470462050|FG002|Overall Study|Other|0|||
130681723|NCT03450070|470462051|FG000|Overall Study|Withdrawal by Subject|8|||
130681724|NCT01496183|470462059|FG000|Overall Study|Physician Decision|3|||
130681725|NCT01496183|470462060|FG001|Overall Study|Physician Decision|1|||
130681726|NCT01496183|470462059|FG000|Overall Study|Withdrawal by Subject|0|||
130681727|NCT01496183|470462060|FG001|Overall Study|Withdrawal by Subject|1|||
130681728|NCT03002077|470462061|FG000|Overall Study|Non-compliance with Study Drug|4|||
130681729|NCT03002077|470462061|FG000|Overall Study|Non-compliance w/Background ADT|1|||
130681730|NCT03002077|470462061|FG000|Overall Study|Study Terminated by Sponsor|257|||
130681731|NCT03002077|470462061|FG000|Overall Study|Site Terminated by Sponsor|5|||
130681732|NCT03002077|470462061|FG000|Overall Study|Miscellaneous Reasons|10|||
130681733|NCT03002077|470462061|FG000|Overall Study|Adverse Event|23|||
130681734|NCT03002077|470462061|FG000|Overall Study|Lack of Efficacy|20|||
130681735|NCT03002077|470462061|FG000|Overall Study|Withdrawal by Subject|72|||
130681736|NCT03002077|470462061|FG000|Overall Study|Lost to Follow-up|21|||
130681737|NCT03002077|470462061|FG000|Overall Study|Pregnancy|4|||
130681738|NCT03002077|470462061|FG000|Overall Study|Protocol Violation|21|||
130681739|NCT04625114|470462062|FG000|Overall Study|Adverse Event|3|||
130681740|NCT04625114|470462063|FG001|Overall Study|Adverse Event|1|||
130681741|NCT04625114|470462062|FG000|Overall Study|Withdrawal by Subject|2|||
130681742|NCT04625114|470462063|FG001|Overall Study|Withdrawal by Subject|0|||
130681743|NCT02849652|470462066|FG000|Overall Study|Lost to Follow-up|104|||
130681744|NCT02849652|470462067|FG001|Overall Study|Lost to Follow-up|35|||
130681745|NCT02849652|470462068|FG002|Overall Study|Lost to Follow-up|116|||
130681746|NCT02849652|470462069|FG003|Overall Study|Lost to Follow-up|22|||
130681747|NCT02849652|470462066|FG000|Overall Study|Withdrawal by Subject|10|||
130681748|NCT02849652|470462067|FG001|Overall Study|Withdrawal by Subject|2|||
130681749|NCT02849652|470462068|FG002|Overall Study|Withdrawal by Subject|8|||
130681750|NCT02849652|470462069|FG003|Overall Study|Withdrawal by Subject|4|||
130681751|NCT01863745|470462070|FG000|Overall Study|Disease Progression|9|||
130681752|NCT01863745|470462070|FG000|Overall Study|Adverse Event|2|||
130681753|NCT01863745|470462070|FG000|Overall Study|Death|1|||
130681754|NCT01863745|470462070|FG000|Overall Study|Withdrawal by Subject|1|||
130681755|NCT00472290|470462071|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
130681756|NCT00472290|470462071|FG000|Overall Study|Protocol Specified Criteria|7|||
130681757|NCT00472290|470462071|FG000|Overall Study|Administrative Decision|37|||
130681758|NCT00472290|470462071|FG000|Overall Study|Death|3|||
130681759|NCT00472290|470462071|FG000|Overall Study|Lost to Follow-up|1|||
130681760|NCT00472290|470462071|FG000|Overall Study|Lack of Efficacy|1|||
130681761|NCT00472290|470462071|FG000|Overall Study|Disease Progression|4|||
130681762|NCT00472290|470462071|FG000|Overall Study|Withdrawal by Subject|5|||
130681763|NCT00472290|470462071|FG000|Overall Study|Adverse Event|6|||
130681764|NCT00472290|470462071|FG000|Overall Study|Requirement for alternative therapy|7|||
130217302|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217303|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
130217304|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
130217305|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217306|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217307|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217308|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217309|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217310|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217311|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217312|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217313|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217314|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
130217315|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217316|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217317|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217318|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217319|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217320|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217321|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217322|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217323|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217324|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217325|NCT03410992|468759513|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
130217326|NCT03410992|468759514|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
130217327|NCT03410992|468759515|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130436301|NCT00211237|469560601|FG001|3 Months|Withdrew|1|||
130436302|NCT00211237|469560602|FG002|3 Months|Withdrew|0|||
130436303|NCT00211237|469560600|FG000|3 Months|Non-medical problem|0|||
130436304|NCT00211237|469560601|FG001|3 Months|Non-medical problem|0|||
130681765|NCT00777829|470462072|FG000|Overall Study|Withdrawal by Subject|0|||
130681766|NCT00777829|470462073|FG001|Overall Study|Withdrawal by Subject|2|||
130217328|NCT03410992|468759516|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130681767|NCT00336479|470462078|FG000|Overall Study|Adverse Event|8|||
130681768|NCT00336479|470462079|FG001|Overall Study|Adverse Event|11|||
130681769|NCT00336479|470462080|FG002|Overall Study|Adverse Event|18|||
130681770|NCT00336479|470462081|FG003|Overall Study|Adverse Event|4|||
130681771|NCT00336479|470462078|FG000|Overall Study|Noncompliant|1|||
130681772|NCT00336479|470462079|FG001|Overall Study|Noncompliant|7|||
130681773|NCT00336479|470462080|FG002|Overall Study|Noncompliant|3|||
130681774|NCT00336479|470462081|FG003|Overall Study|Noncompliant|0|||
130681775|NCT00336479|470462078|FG000|Overall Study|Physician Decision|2|||
130681776|NCT00336479|470462079|FG001|Overall Study|Physician Decision|3|||
130681777|NCT00336479|470462080|FG002|Overall Study|Physician Decision|1|||
130681778|NCT00336479|470462081|FG003|Overall Study|Physician Decision|0|||
130681779|NCT00336479|470462078|FG000|Overall Study|Lost to Follow-up|3|||
130681780|NCT00336479|470462079|FG001|Overall Study|Lost to Follow-up|2|||
130681781|NCT00336479|470462080|FG002|Overall Study|Lost to Follow-up|0|||
130681782|NCT00336479|470462081|FG003|Overall Study|Lost to Follow-up|0|||
130681783|NCT00336479|470462078|FG000|Overall Study|Withdrawal by Subject|3|||
130681784|NCT00336479|470462079|FG001|Overall Study|Withdrawal by Subject|2|||
130681785|NCT00336479|470462080|FG002|Overall Study|Withdrawal by Subject|3|||
130681786|NCT00336479|470462081|FG003|Overall Study|Withdrawal by Subject|0|||
130681787|NCT00336479|470462078|FG000|Overall Study|Other|0|||
130681788|NCT00336479|470462079|FG001|Overall Study|Other|0|||
130681789|NCT00336479|470462080|FG002|Overall Study|Other|1|||
130681790|NCT00336479|470462081|FG003|Overall Study|Other|0|||
130681791|NCT00336479|470462078|FG000|Overall Study|Virologic Stopping Rule|20|||
130681792|NCT00336479|470462079|FG001|Overall Study|Virologic Stopping Rule|0|||
130681793|NCT00336479|470462080|FG002|Overall Study|Virologic Stopping Rule|0|||
130681794|NCT00336479|470462081|FG003|Overall Study|Virologic Stopping Rule|0|||
130681795|NCT01722877|470462082|FG000|Overall Study|Death|1|||
130681796|NCT01722877|470462082|FG000|Overall Study|Lost to Follow-up|1|||
130681797|NCT01395030|470462085|FG000|Overall Study|Did not complete FCH PET/CT|7|||
130681798|NCT02079766|470462086|FG000|Overall Study|Physician Decision|1|||
130217329|NCT03410992|468759517|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130436305|NCT00211237|469560602|FG002|3 Months|Non-medical problem|1|||
130681799|NCT02079766|470462087|FG001|Overall Study|Physician Decision|0|||
130681800|NCT02079766|470462086|FG000|Overall Study|Withdrawal by Subject|1|||
130436306|NCT00211237|469560600|FG000|6 Months|Death|6|||
130681801|NCT02079766|470462087|FG001|Overall Study|Withdrawal by Subject|0|||
130681802|NCT02373098|470462088|FG000|Overall Study|Lost to Follow-up|1|||
130681803|NCT02373098|470462089|FG001|Overall Study|Lost to Follow-up|0|||
130681804|NCT02373098|470462088|FG000|Overall Study|Protocol Violation|3|||
130217330|NCT03410992|468759518|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217331|NCT03410992|468759519|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217332|NCT03410992|468759520|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217333|NCT03410992|468759521|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217334|NCT03410992|468759522|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217335|NCT03410992|468759523|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217336|NCT03410992|468759513|FG000|Week 16 Assessment|Incorrect escapers|0|||
130217337|NCT03410992|468759514|FG001|Week 16 Assessment|Incorrect escapers|6|||
130217338|NCT03410992|468759515|FG002|Week 16 Assessment|Incorrect escapers|0|||
130217339|NCT03410992|468759516|FG003|Week 16 Assessment|Incorrect escapers|0|||
130217340|NCT03410992|468759517|FG004|Week 16 Assessment|Incorrect escapers|0|||
130217341|NCT03410992|468759518|FG005|Week 16 Assessment|Incorrect escapers|0|||
130217342|NCT03410992|468759519|FG006|Week 16 Assessment|Incorrect escapers|0|||
130217343|NCT03410992|468759520|FG007|Week 16 Assessment|Incorrect escapers|0|||
130217344|NCT03410992|468759521|FG008|Week 16 Assessment|Incorrect escapers|0|||
130217345|NCT03410992|468759522|FG009|Week 16 Assessment|Incorrect escapers|0|||
130217346|NCT03410992|468759523|FG010|Week 16 Assessment|Incorrect escapers|0|||
130217347|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217348|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217349|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217350|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
130217351|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
130217352|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217353|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217354|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217355|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217356|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217357|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217358|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217359|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217360|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217361|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130217362|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
130217363|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130217364|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217365|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217366|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217367|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217368|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217369|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217370|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217371|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217372|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217373|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217374|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
130217375|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217376|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217377|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217378|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217379|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217380|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217381|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217382|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217383|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
130217384|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
130217385|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
130217386|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217387|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217388|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217389|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130436307|NCT00211237|469560601|FG001|6 Months|Death|0|||
130681805|NCT02373098|470462089|FG001|Overall Study|Protocol Violation|0|||
130681806|NCT02373098|470462088|FG000|Overall Study|Withdrawal by Subject|5|||
130681807|NCT02373098|470462089|FG001|Overall Study|Withdrawal by Subject|0|||
130681808|NCT02373098|470462088|FG000|Overall Study|Adverse Event|3|||
130681809|NCT02373098|470462089|FG001|Overall Study|Adverse Event|0|||
130681810|NCT05214560|470462094|FG000|Overall Study|Screening Failure|1|||
130681811|NCT05214560|470462094|FG000|Overall Study|Physician Decision|4|||
130681812|NCT05214560|470462094|FG000|Overall Study|Withdrawal by Subject|1|||
130681813|NCT05214560|470462094|FG000|Overall Study|Lost to Follow-up|2|||
130681814|NCT05214560|470462094|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
130681815|NCT05214560|470462094|FG000|Overall Study|Study physician not available for the anesthesia|3|||
130681816|NCT05214560|470462094|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
130681817|NCT05214560|470462094|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
130681818|NCT05214560|470462094|FG000|Overall Study|Surgery not performed|3|||
130681819|NCT03639311|470462097|FG000|Maintenance Phase|Lost to Follow-up|1|||
130681820|NCT03639311|470462098|FG001|Maintenance Phase|Lost to Follow-up|0|||
130681821|NCT03639311|470462099|FG002|Maintenance Phase|Lost to Follow-up|0|||
130681822|NCT03639311|470462097|FG000|Maintenance Phase|Adverse Event|1|||
130681823|NCT03639311|470462098|FG001|Maintenance Phase|Adverse Event|0|||
130681824|NCT03639311|470462099|FG002|Maintenance Phase|Adverse Event|0|||
130681825|NCT03639311|470462097|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
130681826|NCT03639311|470462098|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130681827|NCT03639311|470462099|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130681828|NCT03639311|470462097|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
130681829|NCT03639311|470462098|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130681830|NCT03639311|470462099|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130681831|NCT03639311|470462097|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
130681832|NCT03639311|470462098|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130681833|NCT03639311|470462099|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130681834|NCT03639311|470462097|FG000|Maintenance Phase|Lack of Efficacy|1|||
130681835|NCT03639311|470462098|FG001|Maintenance Phase|Lack of Efficacy|0|||
130681836|NCT03639311|470462099|FG002|Maintenance Phase|Lack of Efficacy|0|||
130681837|NCT03018249|470462100|FG000|Overall Study|Withdrawal by Subject|2|||
130681838|NCT03018249|470462101|FG001|Overall Study|Withdrawal by Subject|2|||
130681839|NCT03125200|470462111|FG000|Overall Study|Study Termination|0|||
130681840|NCT03125200|470462112|FG001|Overall Study|Study Termination|0|||
130681841|NCT03125200|470462113|FG002|Overall Study|Study Termination|0|||
130681842|NCT03125200|470462114|FG003|Overall Study|Study Termination|1|||
130681843|NCT03125200|470462115|FG004|Overall Study|Study Termination|1|||
130681844|NCT03125200|470462116|FG005|Overall Study|Study Termination|2|||
130681845|NCT03125200|470462117|FG006|Overall Study|Study Termination|1|||
130681846|NCT03125200|470462111|FG000|Overall Study|Clinical Progression|0|||
130681847|NCT03125200|470462112|FG001|Overall Study|Clinical Progression|0|||
130681848|NCT03125200|470462113|FG002|Overall Study|Clinical Progression|0|||
130681849|NCT03125200|470462114|FG003|Overall Study|Clinical Progression|1|||
130681850|NCT03125200|470462115|FG004|Overall Study|Clinical Progression|0|||
130681851|NCT03125200|470462116|FG005|Overall Study|Clinical Progression|1|||
130681852|NCT03125200|470462117|FG006|Overall Study|Clinical Progression|0|||
130681853|NCT03125200|470462111|FG000|Overall Study|Progressive Disease|2|||
130681854|NCT03125200|470462112|FG001|Overall Study|Progressive Disease|1|||
130681855|NCT03125200|470462113|FG002|Overall Study|Progressive Disease|2|||
130681856|NCT03125200|470462114|FG003|Overall Study|Progressive Disease|1|||
130681857|NCT03125200|470462115|FG004|Overall Study|Progressive Disease|2|||
130217390|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217391|NCT03410992|468759513|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217392|NCT03410992|468759514|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217393|NCT03410992|468759515|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
130681858|NCT03125200|470462116|FG005|Overall Study|Progressive Disease|0|||
130681859|NCT03125200|470462117|FG006|Overall Study|Progressive Disease|1|||
130681860|NCT03125200|470462111|FG000|Overall Study|Lack of Efficacy|0|||
130681861|NCT03125200|470462112|FG001|Overall Study|Lack of Efficacy|0|||
130681862|NCT03125200|470462113|FG002|Overall Study|Lack of Efficacy|0|||
130681863|NCT03125200|470462114|FG003|Overall Study|Lack of Efficacy|1|||
130681864|NCT03125200|470462115|FG004|Overall Study|Lack of Efficacy|0|||
130681865|NCT03125200|470462116|FG005|Overall Study|Lack of Efficacy|0|||
130681866|NCT03125200|470462117|FG006|Overall Study|Lack of Efficacy|0|||
130681867|NCT03125200|470462111|FG000|Overall Study|Toxicity|0|||
130681868|NCT03125200|470462112|FG001|Overall Study|Toxicity|0|||
130681869|NCT03125200|470462113|FG002|Overall Study|Toxicity|0|||
130681870|NCT03125200|470462114|FG003|Overall Study|Toxicity|1|||
130681871|NCT03125200|470462115|FG004|Overall Study|Toxicity|0|||
130681872|NCT03125200|470462116|FG005|Overall Study|Toxicity|0|||
130217394|NCT03410992|468759516|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217395|NCT03410992|468759517|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
130681873|NCT03125200|470462117|FG006|Overall Study|Toxicity|0|||
130681874|NCT03125200|470462111|FG000|Overall Study|Consent Withdrawn by Subject|0|||
130681875|NCT03125200|470462112|FG001|Overall Study|Consent Withdrawn by Subject|1|||
130681876|NCT03125200|470462113|FG002|Overall Study|Consent Withdrawn by Subject|0|||
130681877|NCT03125200|470462114|FG003|Overall Study|Consent Withdrawn by Subject|0|||
130681878|NCT03125200|470462115|FG004|Overall Study|Consent Withdrawn by Subject|1|||
130347764|NCT02720094|469246776|FG000|Overall Study|Ongoing|2210|||
130347765|NCT02720094|469246777|FG001|Overall Study|Ongoing|2203|||
130347766|NCT02720094|469246776|FG000|Overall Study|Scheduled exit visit/end of study|2|||
130347767|NCT02720094|469246777|FG001|Overall Study|Scheduled exit visit/end of study|1|||
130347768|NCT02720094|469246776|FG000|Overall Study|Death|4|||
130347769|NCT02720094|469246777|FG001|Overall Study|Death|7|||
130347770|NCT02720094|469246776|FG000|Overall Study|Withdrawal by Subject|55|||
130347771|NCT02720094|469246777|FG001|Overall Study|Withdrawal by Subject|56|||
130347772|NCT02720094|469246776|FG000|Overall Study|Lost to Follow-up|2|||
130347773|NCT02720094|469246777|FG001|Overall Study|Lost to Follow-up|7|||
130347774|NCT02720094|469246776|FG000|Overall Study|Physician Decision|1|||
130347775|NCT02720094|469246777|FG001|Overall Study|Physician Decision|3|||
130347776|NCT02720094|469246776|FG000|Overall Study|Inappropriate enrollment|1|||
130347777|NCT02720094|469246777|FG001|Overall Study|Inappropriate enrollment|3|||
130347778|NCT02720094|469246776|FG000|Overall Study|Relocation|1|||
130347779|NCT02720094|469246777|FG001|Overall Study|Relocation|1|||
130436308|NCT00211237|469560602|FG002|6 Months|Death|3|||
130436309|NCT00211237|469560600|FG000|6 Months|Lost to Follow-up|2|||
130217396|NCT03410992|468759518|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217397|NCT03410992|468759519|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217398|NCT03410992|468759520|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
130217399|NCT03410992|468759521|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217400|NCT03410992|468759522|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217401|NCT03410992|468759523|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217402|NCT03410992|468759513|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217403|NCT03410992|468759514|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217404|NCT03410992|468759515|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217405|NCT03410992|468759516|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130681879|NCT03125200|470462116|FG005|Overall Study|Consent Withdrawn by Subject|0|||
130681880|NCT03125200|470462117|FG006|Overall Study|Consent Withdrawn by Subject|1|||
130681881|NCT00119379|470462118|FG000|Overall Study|Adverse Event|4|||
130681882|NCT00119379|470462119|FG001|Overall Study|Adverse Event|1|||
130681883|NCT00694551|470462123|FG000|Overall Study|Disease Progression|1|||
130217406|NCT03410992|468759517|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217407|NCT03410992|468759518|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217408|NCT03410992|468759519|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217409|NCT03410992|468759520|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217410|NCT03410992|468759521|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
130217411|NCT03410992|468759522|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217412|NCT03410992|468759523|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217413|NCT02438280|468759524|FG000|Overall Study|Physician Decision|1|||
130217414|NCT02438280|468759525|FG001|Overall Study|Physician Decision|0|||
130217415|NCT02260817|468759526|FG000|Overall Study|Lost to Follow-up|0|||
130217416|NCT02260817|468759527|FG001|Overall Study|Lost to Follow-up|14|||
130217417|NCT02260817|468759526|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
130217418|NCT02260817|468759527|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
130217419|NCT02260817|468759526|FG000|Overall Study|Observation, no biopsy|0|||
130217420|NCT02260817|468759527|FG001|Overall Study|Observation, no biopsy|1|||
130217421|NCT02260817|468759526|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
130217422|NCT02260817|468759527|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
130217423|NCT02260817|468759526|FG000|Overall Study|Protocol Violation|0|||
130217424|NCT02260817|468759527|FG001|Overall Study|Protocol Violation|14|||
130217425|NCT03299101|468759528|FG000|Overall Study|Lost to Follow-up|1|||
130217426|NCT03299101|468759528|FG000|Overall Study|Withdrawal by Subject|5|||
130217427|NCT03299101|468759528|FG000|Overall Study|Surgery was changed|3|||
130217428|NCT03299101|468759528|FG000|Overall Study|Not enough time to complete prehab|1|||
130217429|NCT01882803|468759530|FG000|Overall Study|Disease Progression|1|||
130217430|NCT01882803|468759530|FG000|Overall Study|Withdrawal by Subject|9|||
130217431|NCT01882803|468759530|FG000|Overall Study|Death|68|||
130681884|NCT00694551|470462124|FG001|Overall Study|Disease Progression|0|||
130217432|NCT01882803|468759530|FG000|Overall Study|Physician Decision|3|||
130217433|NCT01882803|468759530|FG000|Overall Study|Lost to Follow-up|3|||
130217434|NCT01882803|468759530|FG000|Overall Study|Follow-up Completed|39|||
130552783|NCT00792805|469991536|FG002|Overall Study|Subject withdrew consent|5|||
130552784|NCT00792805|469991534|FG000|Overall Study|Administrative problems|2|||
130552785|NCT00792805|469991535|FG001|Overall Study|Administrative problems|0|||
130552786|NCT00792805|469991536|FG002|Overall Study|Administrative problems|4|||
130681885|NCT00694551|470462125|FG002|Overall Study|Disease Progression|1|||
130681886|NCT01937390|470462128|FG000|Overall Study|Death|2|||
130681887|NCT01937390|470462128|FG000|Overall Study|Lost to Follow-up|7|||
130681888|NCT01937390|470462128|FG000|Overall Study|Withdrawal by Subject|5|||
130552787|NCT00792805|469991534|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130681889|NCT01937390|470462128|FG000|Overall Study|Fail to return|21|||
130217435|NCT01882803|468759530|FG000|Overall Study|Study Terminated by the Sponsor|6|||
130217436|NCT01563913|468759531|FG000|Overall Study|Physician Decision|1|||
130217437|NCT01563913|468759532|FG001|Overall Study|Physician Decision|0|||
130217438|NCT01563913|468759531|FG000|Overall Study|Spouse Passed Away|1|||
130552788|NCT00792805|469991535|FG001|Overall Study|Abnormal test procedure result(s)|2|||
130217439|NCT01563913|468759532|FG001|Overall Study|Spouse Passed Away|0|||
130217440|NCT03066778|468759533|FG000|Overall Study|Death|195|||
130217441|NCT03066778|468759534|FG001|Overall Study|Death|205|||
130217442|NCT03066778|468759533|FG000|Overall Study|Withdrawal by Subject|5|||
130217443|NCT03066778|468759534|FG001|Overall Study|Withdrawal by Subject|7|||
130217444|NCT02091414|468759535|FG000|Overall Study|Withdrawal by Subject|2|||
130681890|NCT02920996|470462135|FG000|Overall Study|Adverse Event|8|||
130681891|NCT02920996|470462136|FG001|Overall Study|Adverse Event|0|||
130681892|NCT02920996|470462135|FG000|Overall Study|Physician Decision|1|||
130681893|NCT02920996|470462136|FG001|Overall Study|Physician Decision|0|||
130681894|NCT02920996|470462135|FG000|Overall Study|Death|1|||
130681895|NCT02920996|470462136|FG001|Overall Study|Death|0|||
130681896|NCT02920996|470462135|FG000|Overall Study|Missing|1|||
130681897|NCT02920996|470462136|FG001|Overall Study|Missing|0|||
130681898|NCT02920996|470462135|FG000|Overall Study|Subject Non-Compliance|1|||
130681899|NCT02920996|470462136|FG001|Overall Study|Subject Non-Compliance|0|||
130681900|NCT01402947|470462139|FG000|First Intervention|Adverse Event|0|||
130681901|NCT01402947|470462140|FG001|First Intervention|Adverse Event|1|||
130681902|NCT00385684|470462141|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
130681903|NCT00385684|470462142|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
130681904|NCT00385684|470462141|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
130681905|NCT00385684|470462142|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
130681906|NCT00385684|470462141|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
130681907|NCT00385684|470462142|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
130681908|NCT02801877|470462143|FG000|Overall Study|Lost to Follow-up|1|||
130681909|NCT02801877|470462144|FG001|Overall Study|Lost to Follow-up|1|||
130681910|NCT02801877|470462145|FG002|Overall Study|Lost to Follow-up|2|||
130681911|NCT02801877|470462146|FG003|Overall Study|Lost to Follow-up|0|||
130681912|NCT02801877|470462143|FG000|Overall Study|Never Started Treatment|2|||
130681913|NCT02801877|470462144|FG001|Overall Study|Never Started Treatment|0|||
130681914|NCT02801877|470462145|FG002|Overall Study|Never Started Treatment|4|||
130681915|NCT02801877|470462146|FG003|Overall Study|Never Started Treatment|0|||
130681916|NCT00154102|470462147|FG000|Overall Study|investigational study phase ongoing|7|||
130681917|NCT00154102|470462148|FG001|Overall Study|investigational study phase ongoing|2|||
130681918|NCT01248247|470463808|FG000|Overall Study|Adverse Event|2|||
130681919|NCT01248247|470463809|FG001|Overall Study|Adverse Event|4|||
130681920|NCT01248247|470463810|FG002|Overall Study|Adverse Event|4|||
130681921|NCT01248247|470463811|FG003|Overall Study|Adverse Event|2|||
130681922|NCT01248247|470463808|FG000|Overall Study|Death|0|||
130681923|NCT01248247|470463809|FG001|Overall Study|Death|1|||
130681924|NCT01248247|470463810|FG002|Overall Study|Death|4|||
130681925|NCT01248247|470463811|FG003|Overall Study|Death|7|||
130681926|NCT01248247|470463808|FG000|Overall Study|Lost to Follow-up|0|||
130681927|NCT01248247|470463809|FG001|Overall Study|Lost to Follow-up|1|||
130681928|NCT01248247|470463810|FG002|Overall Study|Lost to Follow-up|1|||
130681929|NCT01248247|470463811|FG003|Overall Study|Lost to Follow-up|0|||
130681930|NCT01248247|470463808|FG000|Overall Study|Alternative treatment|0|||
130681931|NCT01248247|470463809|FG001|Overall Study|Alternative treatment|1|||
130681932|NCT01248247|470463810|FG002|Overall Study|Alternative treatment|0|||
130681933|NCT01248247|470463811|FG003|Overall Study|Alternative treatment|0|||
130681934|NCT01248247|470463808|FG000|Overall Study|Other|2|||
130681935|NCT01248247|470463809|FG001|Overall Study|Other|8|||
130681936|NCT01248247|470463810|FG002|Overall Study|Other|8|||
130681937|NCT01248247|470463811|FG003|Overall Study|Other|5|||
130217445|NCT02091414|468759535|FG000|Overall Study|Death|2|||
130217446|NCT03665077|468759536|FG000|Overall Study|Lost to Follow-up|2|||
130217447|NCT03665077|468759536|FG000|Overall Study|Physician Decision|2|||
130217448|NCT00435461|468759539|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
130217449|NCT00435461|468759540|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130217450|NCT00435461|468759541|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130217451|NCT00435461|468759539|FG000|Overall Study|Protocol Violation|6|||
130217452|NCT00435461|468759540|FG001|Overall Study|Protocol Violation|9|||
130217453|NCT00435461|468759541|FG002|Overall Study|Protocol Violation|10|||
130217454|NCT00435461|468759539|FG000|Overall Study|Participant randomized(inadequate score)|1|||
130217455|NCT00435461|468759540|FG001|Overall Study|Participant randomized(inadequate score)|0|||
130217456|NCT00435461|468759541|FG002|Overall Study|Participant randomized(inadequate score)|0|||
130217457|NCT00435461|468759539|FG000|Overall Study|Compliance less than 80 percent|1|||
130217458|NCT00435461|468759540|FG001|Overall Study|Compliance less than 80 percent|0|||
130681938|NCT01248247|470463808|FG000|Overall Study|Progression|18|||
130681939|NCT01248247|470463809|FG001|Overall Study|Progression|27|||
130681940|NCT01248247|470463810|FG002|Overall Study|Progression|56|||
130681941|NCT01248247|470463811|FG003|Overall Study|Progression|44|||
130681942|NCT01248247|470463808|FG000|Overall Study|Refuse further treatment|0|||
130681943|NCT01248247|470463809|FG001|Overall Study|Refuse further treatment|0|||
130681944|NCT01248247|470463810|FG002|Overall Study|Refuse further treatment|1|||
130681945|NCT01248247|470463811|FG003|Overall Study|Refuse further treatment|2|||
130681946|NCT01248247|470463808|FG000|Overall Study|Complicating disease|0|||
130681947|NCT01248247|470463809|FG001|Overall Study|Complicating disease|0|||
130681948|NCT01248247|470463810|FG002|Overall Study|Complicating disease|1|||
130217459|NCT00435461|468759541|FG002|Overall Study|Compliance less than 80 percent|0|||
130217460|NCT00435461|468759539|FG000|Overall Study|In error, two study medications switched|1|||
130681949|NCT01248247|470463811|FG003|Overall Study|Complicating disease|1|||
130681950|NCT04349917|470463812|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
130681951|NCT04349917|470463813|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
130217461|NCT00435461|468759540|FG001|Overall Study|In error, two study medications switched|0|||
130217462|NCT00435461|468759541|FG002|Overall Study|In error, two study medications switched|0|||
130217463|NCT00435461|468759539|FG000|Overall Study|Lack of Efficacy|2|||
130217464|NCT00435461|468759540|FG001|Overall Study|Lack of Efficacy|1|||
130217465|NCT00435461|468759541|FG002|Overall Study|Lack of Efficacy|0|||
130217466|NCT00435461|468759539|FG000|Overall Study|Withdrawal by Subject|1|||
130217467|NCT00435461|468759540|FG001|Overall Study|Withdrawal by Subject|0|||
130217468|NCT00435461|468759541|FG002|Overall Study|Withdrawal by Subject|2|||
130217469|NCT00435461|468759539|FG000|Overall Study|Randomized in error|1|||
130217470|NCT00435461|468759540|FG001|Overall Study|Randomized in error|0|||
130217471|NCT00435461|468759541|FG002|Overall Study|Randomized in error|0|||
130217472|NCT00435461|468759539|FG000|Overall Study|Participant could not tolerate symptoms|0|||
130217473|NCT00435461|468759540|FG001|Overall Study|Participant could not tolerate symptoms|0|||
130217474|NCT00435461|468759541|FG002|Overall Study|Participant could not tolerate symptoms|1|||
130217475|NCT00435461|468759539|FG000|Overall Study|Participant could not swallow capsule|0|||
130217476|NCT00435461|468759540|FG001|Overall Study|Participant could not swallow capsule|0|||
130217477|NCT00435461|468759541|FG002|Overall Study|Participant could not swallow capsule|1|||
130217478|NCT00435461|468759539|FG000|Overall Study|Pregnancy|2|||
130217479|NCT00435461|468759540|FG001|Overall Study|Pregnancy|0|||
130217480|NCT00435461|468759541|FG002|Overall Study|Pregnancy|0|||
130217481|NCT00435461|468759539|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
130217482|NCT00435461|468759540|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
130681952|NCT04349917|470463812|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
130681953|NCT04349917|470463813|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
130681954|NCT00441467|470463814|FG000|Overall Study|Adverse Event|6|||
130681955|NCT00441467|470463814|FG000|Overall Study|Withdrawal by Subject|3|||
130681956|NCT00441467|470463814|FG000|Overall Study|Progressive disease|9|||
130681957|NCT01042522|470463815|FG000|Overall Study|Adverse Event|1|||
130681958|NCT01042522|470463816|FG001|Overall Study|Adverse Event|2|||
130681959|NCT01042522|470463815|FG000|Overall Study|Disease Progression|5|||
130681960|NCT01042522|470463816|FG001|Overall Study|Disease Progression|0|||
130681961|NCT01042522|470463815|FG000|Overall Study|Death|1|||
130681962|NCT01042522|470463816|FG001|Overall Study|Death|0|||
130681963|NCT01042522|470463815|FG000|Overall Study|Patient Refused|0|||
130681964|NCT01042522|470463816|FG001|Overall Study|Patient Refused|3|||
130681965|NCT01042522|470463815|FG000|Overall Study|Withdrawal by Subject|1|||
130217483|NCT00435461|468759541|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
130217484|NCT00435461|468759539|FG000|Overall Study|Participant ended study one day early|1|||
130217485|NCT00435461|468759540|FG001|Overall Study|Participant ended study one day early|0|||
130217486|NCT00435461|468759541|FG002|Overall Study|Participant ended study one day early|0|||
130217487|NCT00435461|468759539|FG000|Overall Study|Noncompliance with study requirements|1|||
130217488|NCT00435461|468759540|FG001|Overall Study|Noncompliance with study requirements|1|||
130217489|NCT00435461|468759541|FG002|Overall Study|Noncompliance with study requirements|1|||
130217490|NCT00435461|468759539|FG000|Overall Study|Adverse Event|1|||
130217491|NCT00435461|468759540|FG001|Overall Study|Adverse Event|2|||
130217492|NCT00435461|468759541|FG002|Overall Study|Adverse Event|6|||
130217493|NCT00435461|468759539|FG000|Overall Study|Non-Compliance of diary|2|||
130217494|NCT00435461|468759540|FG001|Overall Study|Non-Compliance of diary|0|||
130217495|NCT00435461|468759541|FG002|Overall Study|Non-Compliance of diary|1|||
130217496|NCT00435461|468759539|FG000|Overall Study|Lost to Follow-up|1|||
130217497|NCT00435461|468759540|FG001|Overall Study|Lost to Follow-up|1|||
130217498|NCT00435461|468759541|FG002|Overall Study|Lost to Follow-up|2|||
130217499|NCT02306850|468759544|FG000|Overall Study|Lack of Efficacy|2|||
130217500|NCT00237692|468759545|FG000|Overall Study|Lost to Follow-up|9|||
130217501|NCT00237692|468759546|FG001|Overall Study|Lost to Follow-up|3|||
130681966|NCT01042522|470463816|FG001|Overall Study|Withdrawal by Subject|1|||
130681967|NCT00485472|470463817|FG000|Overall Study|Adverse Event|8|||
130681968|NCT00485472|470463818|FG001|Overall Study|Adverse Event|5|||
130681969|NCT00485472|470463817|FG000|Overall Study|Lack of Efficacy|5|||
130681970|NCT00485472|470463818|FG001|Overall Study|Lack of Efficacy|4|||
130681971|NCT00485472|470463817|FG000|Overall Study|Withdrawal by Subject|1|||
130217502|NCT00237692|468759547|FG002|Overall Study|Lost to Follow-up|5|||
130217503|NCT00237692|468759548|FG003|Overall Study|Lost to Follow-up|3|||
130217504|NCT00237692|468759545|FG000|Overall Study|Death|1|||
130217505|NCT00237692|468759546|FG001|Overall Study|Death|2|||
130217506|NCT00237692|468759547|FG002|Overall Study|Death|2|||
130217507|NCT00237692|468759548|FG003|Overall Study|Death|3|||
130217508|NCT00237692|468759545|FG000|Overall Study|Excluded - did not meet criteria|4|||
130217509|NCT00237692|468759546|FG001|Overall Study|Excluded - did not meet criteria|3|||
130217510|NCT00237692|468759547|FG002|Overall Study|Excluded - did not meet criteria|5|||
130217511|NCT00237692|468759548|FG003|Overall Study|Excluded - did not meet criteria|9|||
130217512|NCT00237692|468759545|FG000|Overall Study|Withdrawal by Subject|4|||
130217513|NCT00237692|468759546|FG001|Overall Study|Withdrawal by Subject|6|||
130681972|NCT00485472|470463818|FG001|Overall Study|Withdrawal by Subject|0|||
130681973|NCT00485472|470463817|FG000|Overall Study|Protocol Violation|0|||
130681974|NCT00485472|470463818|FG001|Overall Study|Protocol Violation|1|||
130217514|NCT00237692|468759547|FG002|Overall Study|Withdrawal by Subject|10|||
130217515|NCT00237692|468759548|FG003|Overall Study|Withdrawal by Subject|4|||
130217516|NCT02420262|468759549|FG000|Overall Study|Adverse Event|1|||
130681975|NCT00485472|470463817|FG000|Overall Study|Other|2|||
130217517|NCT02420262|468759550|FG001|Overall Study|Adverse Event|0|||
130217518|NCT02420262|468759549|FG000|Overall Study|Withdrawal by Subject|1|||
130217519|NCT02420262|468759550|FG001|Overall Study|Withdrawal by Subject|4|||
130217520|NCT02420262|468759549|FG000|Overall Study|Unclassified|0|||
130217521|NCT02420262|468759550|FG001|Overall Study|Unclassified|1|||
130217522|NCT05446142|468759566|FG000|Period 2|Adverse Event|1|||
130217523|NCT05446142|468759567|FG001|Period 2|Adverse Event|0|||
130217524|NCT05446142|468759568|FG002|Period 2|Adverse Event|0|||
130217525|NCT05446142|468759569|FG003|Period 2|Adverse Event|0|||
130217526|NCT05446142|468759570|FG004|Period 2|Adverse Event|0|||
130217527|NCT05446142|468759571|FG005|Period 2|Adverse Event|0|||
130217528|NCT02098395|468759572|FG000|Overall Study|Protocol Violation|2|||
130217529|NCT02098395|468759573|FG001|Overall Study|Protocol Violation|2|||
130217530|NCT02098395|468759574|FG002|Overall Study|Protocol Violation|0|||
130217531|NCT02098395|468759575|FG003|Overall Study|Protocol Violation|7|||
130217532|NCT02098395|468759572|FG000|Overall Study|Withdrawal by Subject|10|||
130217533|NCT02098395|468759573|FG001|Overall Study|Withdrawal by Subject|10|||
130217534|NCT02098395|468759574|FG002|Overall Study|Withdrawal by Subject|5|||
130217535|NCT02098395|468759575|FG003|Overall Study|Withdrawal by Subject|13|||
130217536|NCT02098395|468759572|FG000|Overall Study|Adverse Event|12|||
130217537|NCT02098395|468759573|FG001|Overall Study|Adverse Event|19|||
130217538|NCT02098395|468759574|FG002|Overall Study|Adverse Event|34|||
130217539|NCT02098395|468759575|FG003|Overall Study|Adverse Event|2|||
130217540|NCT02098395|468759572|FG000|Overall Study|Lost to Follow-up|2|||
130217541|NCT02098395|468759573|FG001|Overall Study|Lost to Follow-up|1|||
130217542|NCT02098395|468759574|FG002|Overall Study|Lost to Follow-up|0|||
130217543|NCT02098395|468759575|FG003|Overall Study|Lost to Follow-up|3|||
130217544|NCT02098395|468759572|FG000|Overall Study|Unclassified|0|||
130217545|NCT02098395|468759573|FG001|Overall Study|Unclassified|0|||
130217546|NCT02098395|468759574|FG002|Overall Study|Unclassified|3|||
130217547|NCT02098395|468759575|FG003|Overall Study|Unclassified|2|||
130217548|NCT00110357|468759578|FG000|Overall Study|Deterioration without progression|2|||
130217549|NCT00110357|468759579|FG001|Overall Study|Deterioration without progression|0|||
130217550|NCT00110357|468759578|FG000|Overall Study|Disease progression/relapse|20|||
130217551|NCT00110357|468759579|FG001|Overall Study|Disease progression/relapse|15|||
130217552|NCT00110357|468759578|FG000|Overall Study|Study Closure|1|||
130217553|NCT00110357|468759579|FG001|Overall Study|Study Closure|0|||
130217554|NCT00110357|468759578|FG000|Overall Study|Study Drug Toxicity|1|||
130217555|NCT00110357|468759579|FG001|Overall Study|Study Drug Toxicity|3|||
130217556|NCT00110357|468759578|FG000|Overall Study|Withdrawal by Subject|3|||
130217557|NCT00110357|468759579|FG001|Overall Study|Withdrawal by Subject|1|||
130217558|NCT03382418|468759580|FG000|Overall Study|Withdrawal by Subject|1|||
130217559|NCT03382418|468759581|FG001|Overall Study|Withdrawal by Subject|0|||
130217560|NCT03382418|468759582|FG002|Overall Study|Withdrawal by Subject|0|||
130217561|NCT03382418|468759580|FG000|Overall Study|Lost to Follow-up|2|||
130217562|NCT03382418|468759581|FG001|Overall Study|Lost to Follow-up|3|||
130217563|NCT03382418|468759582|FG002|Overall Study|Lost to Follow-up|0|||
130217564|NCT04633226|468759583|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130217565|NCT04633226|468759583|FG000|Overall Study|Randomized by mistake without study treatment|1|||
130217566|NCT01151345|468759584|FG000|First Intervention Period|Protocol Violation|0|||
130217567|NCT01151345|468759585|FG001|First Intervention Period|Protocol Violation|1|||
130217568|NCT01348100|468759588|FG000|Overall Study|Subject Withdrew Consent|0|||
130217569|NCT01348100|468759589|FG001|Overall Study|Subject Withdrew Consent|0|||
130347825|NCT01302834|469246787|FG000|Overall Study|Protocol Violation|17|||
130347826|NCT01302834|469246788|FG001|Overall Study|Protocol Violation|23|||
130347827|NCT01302834|469246787|FG000|Overall Study|HIV positive|1|||
130347828|NCT01302834|469246788|FG001|Overall Study|HIV positive|3|||
130681976|NCT00485472|470463818|FG001|Overall Study|Other|1|||
130681977|NCT00485472|470463817|FG000|Overall Study|Lost to Follow-up|0|||
130681978|NCT00485472|470463818|FG001|Overall Study|Lost to Follow-up|1|||
130681979|NCT04015232|470463820|FG000|Overall Study|Withdrawal by Subject|7|||
130681980|NCT04015232|470463821|FG001|Overall Study|Withdrawal by Subject|4|||
130681981|NCT04015232|470463820|FG000|Overall Study|Protocol Violation|1|||
130681982|NCT04015232|470463821|FG001|Overall Study|Protocol Violation|0|||
130681983|NCT04015232|470463820|FG000|Overall Study|Medical Grounds|3|||
130681984|NCT04015232|470463821|FG001|Overall Study|Medical Grounds|3|||
130681985|NCT01029353|470463823|FG000|Overall Study|Lost to Follow-up|4|||
130681986|NCT01029353|470463824|FG001|Overall Study|Lost to Follow-up|5|||
130681987|NCT01029353|470463825|FG002|Overall Study|Lost to Follow-up|5|||
130681988|NCT01029353|470463826|FG003|Overall Study|Lost to Follow-up|4|||
130681989|NCT01029353|470463823|FG000|Overall Study|Consent Withdrawn|2|||
130681990|NCT01029353|470463824|FG001|Overall Study|Consent Withdrawn|0|||
130681991|NCT01029353|470463825|FG002|Overall Study|Consent Withdrawn|0|||
130681992|NCT01029353|470463826|FG003|Overall Study|Consent Withdrawn|0|||
130681993|NCT01029353|470463823|FG000|Overall Study|Primary Outcome Indeterminate|1|||
130681994|NCT01029353|470463824|FG001|Overall Study|Primary Outcome Indeterminate|3|||
130681995|NCT01029353|470463825|FG002|Overall Study|Primary Outcome Indeterminate|2|||
130681996|NCT01029353|470463826|FG003|Overall Study|Primary Outcome Indeterminate|0|||
130681997|NCT01287013|470463828|FG000|Overall Study|Non-evaluable|3|||
130681998|NCT01287013|470463829|FG001|Overall Study|Non-evaluable|5|||
130681999|NCT01287013|470463830|FG002|Overall Study|Non-evaluable|21|||
130682000|NCT01900730|470463831|FG000|Overall Study|Withdrawal by Subject|1|||
130682001|NCT01900730|470463832|FG001|Overall Study|Withdrawal by Subject|0|||
130682002|NCT01900730|470463831|FG000|Overall Study|Screen Failure|1|||
130682003|NCT01900730|470463832|FG001|Overall Study|Screen Failure|0|||
130682004|NCT02109042|470463833|FG000|Overall Study|Sponsor Decision|15|||
130682005|NCT03203447|470463834|FG000|Overall Study|Withdrawal by Subject|2|||
130682006|NCT03203447|470463835|FG001|Overall Study|Withdrawal by Subject|1|||
130682007|NCT03203447|470463834|FG000|Overall Study|Lost to Follow-up|1|||
130682008|NCT03203447|470463835|FG001|Overall Study|Lost to Follow-up|10|||
130682009|NCT03203447|470463834|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
130682010|NCT03203447|470463835|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
130682011|NCT00528606|470463836|FG000|Overall Study|Withdrew consent|4|||
130682012|NCT00528606|470463837|FG001|Overall Study|Withdrew consent|3|||
130682013|NCT00528606|470463836|FG000|Overall Study|Lost to Follow-up|4|||
130682014|NCT00528606|470463837|FG001|Overall Study|Lost to Follow-up|1|||
130682015|NCT00528606|470463836|FG000|Overall Study|Adverse Event|3|||
130682016|NCT00528606|470463837|FG001|Overall Study|Adverse Event|0|||
130682017|NCT00528606|470463836|FG000|Overall Study|Other|2|||
130682018|NCT00528606|470463837|FG001|Overall Study|Other|0|||
130682019|NCT00050778|470463842|FG000|Overall Study|Adverse Event|13|||
130682020|NCT00050778|470463843|FG001|Overall Study|Adverse Event|3|||
130682021|NCT00050778|470463844|FG002|Overall Study|Adverse Event|2|||
130682022|NCT00050778|470463842|FG000|Overall Study|Death|0|||
130682023|NCT00050778|470463843|FG001|Overall Study|Death|1|||
130682024|NCT00050778|470463844|FG002|Overall Study|Death|1|||
130682025|NCT00050778|470463842|FG000|Overall Study|Lack of Efficacy|16|||
130682026|NCT00050778|470463843|FG001|Overall Study|Lack of Efficacy|2|||
130682027|NCT00050778|470463844|FG002|Overall Study|Lack of Efficacy|2|||
130682028|NCT00050778|470463842|FG000|Overall Study|Lost to Follow-up|0|||
130682029|NCT00050778|470463843|FG001|Overall Study|Lost to Follow-up|2|||
130682030|NCT00050778|470463844|FG002|Overall Study|Lost to Follow-up|4|||
130682031|NCT00050778|470463842|FG000|Overall Study|Physician Decision|3|||
130682032|NCT00050778|470463843|FG001|Overall Study|Physician Decision|0|||
130682033|NCT00050778|470463844|FG002|Overall Study|Physician Decision|2|||
130682034|NCT00050778|470463842|FG000|Overall Study|Protocol Violation|2|||
130682035|NCT00050778|470463843|FG001|Overall Study|Protocol Violation|0|||
130682036|NCT00050778|470463844|FG002|Overall Study|Protocol Violation|1|||
130682037|NCT00050778|470463842|FG000|Overall Study|Withdrawal by Subject|6|||
130682038|NCT00050778|470463843|FG001|Overall Study|Withdrawal by Subject|8|||
130682039|NCT00050778|470463844|FG002|Overall Study|Withdrawal by Subject|4|||
130682040|NCT00050778|470463842|FG000|Overall Study|Randomized but not treated|4|||
130682041|NCT00050778|470463843|FG001|Overall Study|Randomized but not treated|5|||
130682042|NCT00050778|470463844|FG002|Overall Study|Randomized but not treated|2|||
130682043|NCT00050778|470463842|FG000|Overall Study|Familial and personal reasons|1|||
130682044|NCT00050778|470463843|FG001|Overall Study|Familial and personal reasons|0|||
130682045|NCT00050778|470463844|FG002|Overall Study|Familial and personal reasons|0|||
130682046|NCT00064753|470463847|FG000|Overall Study|Death|251|||
130682047|NCT00064753|470463848|FG001|Overall Study|Death|242|||
130682048|NCT00064753|470463847|FG000|Overall Study|Withdrawal by Subject|198|||
130682049|NCT00064753|470463848|FG001|Overall Study|Withdrawal by Subject|171|||
130682050|NCT00064753|470463847|FG000|Overall Study|Lost to Follow-up|225|||
130682051|NCT00064753|470463848|FG001|Overall Study|Lost to Follow-up|235|||
130682052|NCT04869787|470463853|FG000|Screening|Physician Decision|1|||
130682053|NCT04869787|470463853|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
130217570|NCT01348100|468759590|FG002|Overall Study|Subject Withdrew Consent|2|||
130217571|NCT01348100|468759591|FG003|Overall Study|Subject Withdrew Consent|0|||
130217572|NCT01348100|468759592|FG004|Overall Study|Subject Withdrew Consent|1|||
130217573|NCT01348100|468759593|FG005|Overall Study|Subject Withdrew Consent|0|||
130217574|NCT01348100|468759594|FG006|Overall Study|Subject Withdrew Consent|1|||
130217575|NCT01348100|468759588|FG000|Overall Study|Protocol Deviation|0|||
130217576|NCT01348100|468759589|FG001|Overall Study|Protocol Deviation|0|||
130217577|NCT01348100|468759590|FG002|Overall Study|Protocol Deviation|0|||
130217578|NCT01348100|468759591|FG003|Overall Study|Protocol Deviation|1|||
130217579|NCT01348100|468759592|FG004|Overall Study|Protocol Deviation|0|||
130217580|NCT01348100|468759593|FG005|Overall Study|Protocol Deviation|0|||
130217581|NCT01348100|468759594|FG006|Overall Study|Protocol Deviation|0|||
130217582|NCT01348100|468759588|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217583|NCT01348100|468759589|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217584|NCT01348100|468759590|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217585|NCT01348100|468759591|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217586|NCT01348100|468759592|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217587|NCT01348100|468759593|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130217588|NCT01348100|468759594|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217589|NCT01348100|468759588|FG000|Overall Study|Lost to Follow-up|0|||
130217590|NCT01348100|468759589|FG001|Overall Study|Lost to Follow-up|0|||
130217591|NCT01348100|468759590|FG002|Overall Study|Lost to Follow-up|0|||
130347829|NCT03735238|469246789|FG000|Overall Study|Did not want to participate in research|3|||
130347830|NCT03735238|469246789|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
130436310|NCT00211237|469560601|FG001|6 Months|Lost to Follow-up|0|||
130682054|NCT00813293|470463855|FG000|Overall Study|Intercurrent illness|1|||
130682055|NCT00813293|470463856|FG001|Overall Study|Intercurrent illness|0|||
130682056|NCT00813293|470463855|FG000|Overall Study|Adverse Event|0|||
130682057|NCT00813293|470463856|FG001|Overall Study|Adverse Event|1|||
130436311|NCT00211237|469560602|FG002|6 Months|Lost to Follow-up|0|||
130436312|NCT00211237|469560600|FG000|6 Months|Could not comply with protocol|0|||
130436313|NCT00211237|469560601|FG001|6 Months|Could not comply with protocol|2|||
130682058|NCT02914600|470463857|FG000|Overall Study|Adverse Event|298|||
130682059|NCT02914600|470463858|FG001|Overall Study|Adverse Event|35|||
130682060|NCT02914600|470463859|FG002|Overall Study|Adverse Event|25|||
130682061|NCT02914600|470463857|FG000|Overall Study|Sponsors decision|287|||
130682062|NCT02914600|470463858|FG001|Overall Study|Sponsors decision|41|||
130682063|NCT02914600|470463859|FG002|Overall Study|Sponsors decision|12|||
130682064|NCT02914600|470463857|FG000|Overall Study|Withdrawal by Subject|158|||
130682065|NCT02914600|470463858|FG001|Overall Study|Withdrawal by Subject|20|||
130682066|NCT02914600|470463859|FG002|Overall Study|Withdrawal by Subject|18|||
130682067|NCT02914600|470463857|FG000|Overall Study|Investigators discretion|169|||
130682068|NCT02914600|470463858|FG001|Overall Study|Investigators discretion|14|||
130682069|NCT02914600|470463859|FG002|Overall Study|Investigators discretion|13|||
130682070|NCT02914600|470463857|FG000|Overall Study|Lost to Follow-up|10|||
130682071|NCT02914600|470463858|FG001|Overall Study|Lost to Follow-up|4|||
130682072|NCT02914600|470463859|FG002|Overall Study|Lost to Follow-up|0|||
130682073|NCT02914600|470463857|FG000|Overall Study|Pregnancy|8|||
130682074|NCT02914600|470463858|FG001|Overall Study|Pregnancy|0|||
130682075|NCT02914600|470463859|FG002|Overall Study|Pregnancy|0|||
130682076|NCT02914600|470463857|FG000|Overall Study|Protocol Violation|5|||
130682077|NCT02914600|470463858|FG001|Overall Study|Protocol Violation|3|||
130436314|NCT00211237|469560602|FG002|6 Months|Could not comply with protocol|0|||
130436315|NCT00211237|469560600|FG000|12 Months|Death|8|||
130436316|NCT00211237|469560601|FG001|12 Months|Death|2|||
130436317|NCT00211237|469560602|FG002|12 Months|Death|3|||
130436318|NCT00211237|469560600|FG000|12 Months|Lost to Follow-up|1|||
130436319|NCT00211237|469560601|FG001|12 Months|Lost to Follow-up|0|||
130436320|NCT00211237|469560602|FG002|12 Months|Lost to Follow-up|1|||
130436321|NCT00211237|469560600|FG000|12 Months|Withdrew|0|||
130436322|NCT00211237|469560601|FG001|12 Months|Withdrew|0|||
130682078|NCT02914600|470463859|FG002|Overall Study|Protocol Violation|0|||
130436323|NCT00211237|469560602|FG002|12 Months|Withdrew|1|||
130436324|NCT00211237|469560600|FG000|12 Months|unrelated medical problem|0|||
130436325|NCT00211237|469560601|FG001|12 Months|unrelated medical problem|0|||
130436326|NCT00211237|469560602|FG002|12 Months|unrelated medical problem|1|||
130682079|NCT02914600|470463857|FG000|Overall Study|Non-compliance with study drug|6|||
130682080|NCT02914600|470463858|FG001|Overall Study|Non-compliance with study drug|1|||
130682081|NCT02914600|470463859|FG002|Overall Study|Non-compliance with study drug|0|||
130682082|NCT02914600|470463857|FG000|Overall Study|Death|3|||
130217592|NCT01348100|468759591|FG003|Overall Study|Lost to Follow-up|0|||
130217593|NCT01348100|468759592|FG004|Overall Study|Lost to Follow-up|0|||
130217594|NCT01348100|468759593|FG005|Overall Study|Lost to Follow-up|0|||
130682083|NCT02914600|470463858|FG001|Overall Study|Death|1|||
130682084|NCT02914600|470463859|FG002|Overall Study|Death|1|||
130682085|NCT02914600|470463857|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130682086|NCT02914600|470463858|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130682087|NCT02914600|470463859|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
130682088|NCT02914600|470463857|FG000|Overall Study|Enrolled but not treated|1|||
130682089|NCT02914600|470463858|FG001|Overall Study|Enrolled but not treated|0|||
130682090|NCT02914600|470463859|FG002|Overall Study|Enrolled but not treated|0|||
130682091|NCT03522675|470463860|FG000|Overall Study|Screen fail|1|||
130682092|NCT03522675|470463860|FG000|Overall Study|Non-reactive to histamine|1|||
130682093|NCT00707161|470463861|FG000|Overall Study|Physician Decision|6|||
130682094|NCT02661295|470463870|FG000|Overall Study|Death|1|||
130682095|NCT02661295|470463870|FG000|Overall Study|Transferred Out|1|||
130682096|NCT02661295|470463870|FG000|Overall Study|Kidney Transplant|1|||
130682097|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to side effects|8|||
130682098|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to access type|1|||
130682099|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to allergies|1|||
130682100|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to non-compliance|1|||
130682101|NCT02661295|470463870|FG000|Overall Study|Withdrawal by Subject|3|||
130682102|NCT02661295|470463870|FG000|Overall Study|Failed screening|2|||
130682103|NCT04213326|470463871|FG000|Overall Study|Consent withdrawn|51|||
130682104|NCT04213326|470463872|FG001|Overall Study|Consent withdrawn|241|||
130682105|NCT04213326|470463871|FG000|Overall Study|Lost to Follow-up|50|||
130682106|NCT04213326|470463872|FG001|Overall Study|Lost to Follow-up|902|||
130682107|NCT04213326|470463871|FG000|Overall Study|Protocol Violation|3|||
130682108|NCT04213326|470463872|FG001|Overall Study|Protocol Violation|25|||
130682109|NCT04213326|470463871|FG000|Overall Study|Participant eligibility changed|106|||
130682110|NCT04213326|470463872|FG001|Overall Study|Participant eligibility changed|19|||
130682111|NCT04213326|470463871|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
130682112|NCT04213326|470463872|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
130682113|NCT04213326|470463871|FG000|Overall Study|Incomplete study visit|0|||
130682114|NCT04213326|470463872|FG001|Overall Study|Incomplete study visit|367|||
130682115|NCT02549092|470463873|FG000|Treatment Period|Adverse Event|2|||
130682116|NCT02549092|470463874|FG001|Treatment Period|Adverse Event|2|||
130682117|NCT02549092|470463873|FG000|Treatment Period|Withdrawal by Subject|1|||
130682118|NCT02549092|470463874|FG001|Treatment Period|Withdrawal by Subject|3|||
130682119|NCT02549092|470463873|FG000|Treatment Period|Lack of Efficacy|0|||
130682120|NCT02549092|470463874|FG001|Treatment Period|Lack of Efficacy|2|||
130682121|NCT02549092|470463873|FG000|Extension/Transition Period|Adverse Event|1|||
130682122|NCT02549092|470463874|FG001|Extension/Transition Period|Adverse Event|1|||
130682123|NCT02549092|470463873|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
130682124|NCT02549092|470463874|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
130682125|NCT02549092|470463873|FG000|Extension/Transition Period|Other, Not Specified|4|||
130682126|NCT02549092|470463874|FG001|Extension/Transition Period|Other, Not Specified|2|||
130682127|NCT03627091|470463875|FG000|Overall Study|Adverse Event|0|||
130682128|NCT03627091|470463876|FG001|Overall Study|Adverse Event|0|||
130682129|NCT03627091|470463877|FG002|Overall Study|Adverse Event|2|||
130682130|NCT03627091|470463875|FG000|Overall Study|Withdrawal by Subject|2|||
130682131|NCT03627091|470463876|FG001|Overall Study|Withdrawal by Subject|0|||
130682132|NCT03627091|470463877|FG002|Overall Study|Withdrawal by Subject|2|||
130217595|NCT01348100|468759594|FG006|Overall Study|Lost to Follow-up|1|||
130217596|NCT01348100|468759588|FG000|Overall Study|Administrative Problems|0|||
130217597|NCT01348100|468759589|FG001|Overall Study|Administrative Problems|0|||
130217598|NCT01348100|468759590|FG002|Overall Study|Administrative Problems|0|||
130217599|NCT01348100|468759591|FG003|Overall Study|Administrative Problems|0|||
130217600|NCT01348100|468759592|FG004|Overall Study|Administrative Problems|0|||
130217601|NCT01348100|468759593|FG005|Overall Study|Administrative Problems|1|||
130217602|NCT01348100|468759594|FG006|Overall Study|Administrative Problems|1|||
130682133|NCT03627091|470463875|FG000|Overall Study|Physician Decision|2|||
130682134|NCT03627091|470463876|FG001|Overall Study|Physician Decision|0|||
130682135|NCT03627091|470463877|FG002|Overall Study|Physician Decision|0|||
130682136|NCT03627091|470463875|FG000|Overall Study|Site terminated by sponsor|0|||
130682137|NCT03627091|470463876|FG001|Overall Study|Site terminated by sponsor|1|||
130682138|NCT03627091|470463877|FG002|Overall Study|Site terminated by sponsor|0|||
130682139|NCT03627091|470463875|FG000|Overall Study|Disease relapse|7|||
130217603|NCT03882957|468759597|FG000|Overall Study|Did not complete all three arms|1|||
130682140|NCT03627091|470463876|FG001|Overall Study|Disease relapse|5|||
130682141|NCT03627091|470463877|FG002|Overall Study|Disease relapse|1|||
130682142|NCT03627091|470463875|FG000|Overall Study|Other|1|||
130682143|NCT03627091|470463876|FG001|Overall Study|Other|0|||
130682144|NCT03627091|470463877|FG002|Overall Study|Other|0|||
130682145|NCT02193165|470463884|FG000|4 Week Product Use|Lost to Follow-up|1|||
130217604|NCT01134393|468759599|FG000|Overall Study|Adverse Event|18|||
130217605|NCT01134393|468759599|FG000|Overall Study|Lack of Efficacy|2|||
130682146|NCT02193165|470463885|FG001|4 Week Product Use|Lost to Follow-up|1|||
130682147|NCT02193165|470463886|FG002|4 Week Product Use|Lost to Follow-up|1|||
130217606|NCT01134393|468759599|FG000|Overall Study|Protocol Violation|12|||
130217607|NCT01134393|468759599|FG000|Overall Study|Lost to Follow-up|3|||
130217608|NCT01134393|468759599|FG000|Overall Study|Withdrawal by Subject|11|||
130217609|NCT01134393|468759599|FG000|Overall Study|Other|6|||
130217610|NCT03134911|468759600|FG000|Overall Study|Screen failure|31|||
130217611|NCT03134911|468759600|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
130217612|NCT02787083|468759606|FG000|Overall Study|Adverse Event|1|||
130217613|NCT02787083|468759607|FG001|Overall Study|Adverse Event|0|||
130217614|NCT02787083|468759606|FG000|Overall Study|Withdrawal by Subject|2|||
130217615|NCT02787083|468759607|FG001|Overall Study|Withdrawal by Subject|2|||
130217616|NCT02710084|468759608|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
130217617|NCT02710084|468759609|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
130217618|NCT02182830|468759610|FG000|Overall Study|Not Treated|1|||
130217619|NCT02182830|468759611|FG001|Overall Study|Not Treated|1|||
130217620|NCT02182830|468759610|FG000|Overall Study|Trial stopped, reason missing|3|||
130217621|NCT02182830|468759611|FG001|Overall Study|Trial stopped, reason missing|3|||
130217622|NCT02182830|468759610|FG000|Overall Study|Consent withdrawn|8|||
130217623|NCT02182830|468759611|FG001|Overall Study|Consent withdrawn|8|||
130217624|NCT02182830|468759610|FG000|Overall Study|Lost to Follow-up|3|||
130217625|NCT02182830|468759611|FG001|Overall Study|Lost to Follow-up|3|||
130217626|NCT00154375|468759612|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
130217627|NCT00154375|468759613|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
130217628|NCT00154375|468759612|FG000|Overall Study|Adverse Event|18|||
130217629|NCT00154375|468759613|FG001|Overall Study|Adverse Event|20|||
130217630|NCT00154375|468759612|FG000|Overall Study|Withdrawal by Subject|14|||
130217631|NCT00154375|468759613|FG001|Overall Study|Withdrawal by Subject|10|||
130217632|NCT00154375|468759612|FG000|Overall Study|Death|5|||
130217633|NCT00154375|468759613|FG001|Overall Study|Death|13|||
130217634|NCT00154375|468759612|FG000|Overall Study|Study drug no longer required|5|||
130217635|NCT00154375|468759613|FG001|Overall Study|Study drug no longer required|3|||
130436327|NCT04078035|469560603|FG000|Session 2|Lost to Follow-up|3|||
130436328|NCT04078035|469560604|FG001|Session 2|Lost to Follow-up|1|||
130436329|NCT04078035|469560603|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
130436330|NCT04078035|469560604|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
130217636|NCT00154375|468759612|FG000|Overall Study|Lost to Follow-up|2|||
130217637|NCT00154375|468759613|FG001|Overall Study|Lost to Follow-up|1|||
130217638|NCT00154375|468759612|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130217639|NCT00154375|468759613|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130217640|NCT00154375|468759612|FG000|Overall Study|Protocol Violation|0|||
130217641|NCT00154375|468759613|FG001|Overall Study|Protocol Violation|1|||
130217642|NCT00154375|468759612|FG000|Overall Study|Suspected progression of disease|44|||
130436331|NCT01013792|469560605|FG000|Overall Study|Study suspended|2|||
130436332|NCT01013792|469560606|FG001|Overall Study|Study suspended|1|||
130436333|NCT01013792|469560605|FG000|Overall Study|Adverse Event|0|||
130436334|NCT01013792|469560606|FG001|Overall Study|Adverse Event|3|||
130436335|NCT01013792|469560605|FG000|Overall Study|Lost to Follow-up|0|||
130682148|NCT02193165|470463884|FG000|6 Week Product Use|Lost to Follow-up|0|||
130682149|NCT02193165|470463885|FG001|6 Week Product Use|Lost to Follow-up|1|||
130682150|NCT02193165|470463886|FG002|6 Week Product Use|Lost to Follow-up|0|||
130682151|NCT01498120|470463892|FG000|Overall Study|Lost to Follow-up|1|||
130682152|NCT01498120|470463892|FG000|Overall Study|Withdrawal by Subject|5|||
130682153|NCT01498120|470463892|FG000|Overall Study|AE, non-serious non-fatal|3|||
130682154|NCT01498120|470463892|FG000|Overall Study|Other|4|||
130682155|NCT01173692|470463893|FG000|Overall Study|Adverse Event|1|||
130682156|NCT01173692|470463894|FG001|Overall Study|Adverse Event|2|||
130682157|NCT01173692|470463893|FG000|Overall Study|Withdrawal by Subject|1|||
130682158|NCT01173692|470463894|FG001|Overall Study|Withdrawal by Subject|3|||
130682159|NCT00678639|470463895|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
130682160|NCT00678639|470463896|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
130682161|NCT00986245|470463899|FG000|First Intervention|Poor compliance|8|||
130682162|NCT00986245|470463900|FG001|First Intervention|Poor compliance|4|||
130682163|NCT00986245|470463899|FG000|First Intervention|Lack of Efficacy|1|||
130682164|NCT00986245|470463900|FG001|First Intervention|Lack of Efficacy|2|||
130682165|NCT00986245|470463899|FG000|First Intervention|Withdrawal by Subject|0|||
130682166|NCT00986245|470463900|FG001|First Intervention|Withdrawal by Subject|1|||
130682167|NCT00986245|470463899|FG000|First Intervention|Protocol Violation|0|||
130682168|NCT00986245|470463900|FG001|First Intervention|Protocol Violation|1|||
130682169|NCT00986245|470463899|FG000|First Intervention|Out of indication|1|||
130682170|NCT00986245|470463900|FG001|First Intervention|Out of indication|0|||
130682171|NCT00986245|470463899|FG000|Second Intervention|Poor compliance|1|||
130217643|NCT00154375|468759613|FG001|Overall Study|Suspected progression of disease|30|||
130217644|NCT02348008|468759614|FG000|Overall Study|Adverse Event|2|||
130217645|NCT02348008|468759615|FG001|Overall Study|Adverse Event|3|||
130217646|NCT02348008|468759616|FG002|Overall Study|Adverse Event|3|||
130217647|NCT02348008|468759614|FG000|Overall Study|Disease Progression|1|||
130217648|NCT02348008|468759615|FG001|Overall Study|Disease Progression|5|||
130217649|NCT02348008|468759616|FG002|Overall Study|Disease Progression|16|||
130682172|NCT00986245|470463900|FG001|Second Intervention|Poor compliance|0|||
130682173|NCT00986245|470463899|FG000|Second Intervention|Lost to Follow-up|1|||
130682174|NCT00986245|470463900|FG001|Second Intervention|Lost to Follow-up|0|||
130682175|NCT00986245|470463899|FG000|Second Intervention|Protocol Violation|0|||
130682176|NCT00986245|470463900|FG001|Second Intervention|Protocol Violation|1|||
130682177|NCT01214850|470463903|FG000|Overall Study|Withdrawal by Subject|38|||
130682178|NCT01214850|470463904|FG001|Overall Study|Withdrawal by Subject|31|||
130682179|NCT01214850|470463905|FG002|Overall Study|Withdrawal by Subject|28|||
130682180|NCT01214850|470463903|FG000|Overall Study|Lost to Follow-up|124|||
130682181|NCT01214850|470463904|FG001|Overall Study|Lost to Follow-up|98|||
130682182|NCT01214850|470463905|FG002|Overall Study|Lost to Follow-up|123|||
130682183|NCT01214850|470463903|FG000|Overall Study|Protocol Violation|5|||
130682184|NCT01214850|470463904|FG001|Overall Study|Protocol Violation|5|||
130682185|NCT01214850|470463905|FG002|Overall Study|Protocol Violation|6|||
130682186|NCT01214850|470463903|FG000|Overall Study|Adverse event or death|11|||
130682187|NCT01214850|470463904|FG001|Overall Study|Adverse event or death|8|||
130682188|NCT01214850|470463905|FG002|Overall Study|Adverse event or death|3|||
130682189|NCT01214850|470463903|FG000|Overall Study|Inappropriate enrollment|2|||
130682190|NCT01214850|470463904|FG001|Overall Study|Inappropriate enrollment|1|||
130682191|NCT01214850|470463905|FG002|Overall Study|Inappropriate enrollment|0|||
130682192|NCT01214850|470463903|FG000|Overall Study|Administrative reason|1|||
130682193|NCT01214850|470463904|FG001|Overall Study|Administrative reason|0|||
130682194|NCT01214850|470463905|FG002|Overall Study|Administrative reason|0|||
130682195|NCT01214850|470463903|FG000|Overall Study|Unable to classify|2|||
130682196|NCT01214850|470463904|FG001|Overall Study|Unable to classify|1|||
130682197|NCT01214850|470463905|FG002|Overall Study|Unable to classify|1|||
130682198|NCT00565448|470463909|FG000|Overall Study|Adverse Event|1|||
130682199|NCT00565448|470463910|FG001|Overall Study|Adverse Event|2|||
130682200|NCT00565448|470463909|FG000|Overall Study|Disease progression|1|||
130682201|NCT00565448|470463910|FG001|Overall Study|Disease progression|0|||
130682202|NCT00565448|470463909|FG000|Overall Study|Withdrawal by Subject|1|||
130682203|NCT00565448|470463910|FG001|Overall Study|Withdrawal by Subject|0|||
130682204|NCT00193609|470463911|FG000|Overall Study|Lack of Efficacy|2|||
130682205|NCT00193609|470463911|FG000|Overall Study|Adverse Event|2|||
130682206|NCT00854308|470463913|FG000|Overall Study|Disease progression|42|||
130682207|NCT00854308|470463914|FG001|Overall Study|Disease progression|50|||
130682208|NCT00854308|470463913|FG000|Overall Study|Adverse Event|8|||
130682209|NCT00854308|470463914|FG001|Overall Study|Adverse Event|3|||
130682210|NCT00854308|470463913|FG000|Overall Study|Death|2|||
130682211|NCT00854308|470463914|FG001|Overall Study|Death|5|||
130682212|NCT00854308|470463913|FG000|Overall Study|Physician Decision|6|||
130682213|NCT00854308|470463914|FG001|Overall Study|Physician Decision|6|||
130682214|NCT00854308|470463913|FG000|Overall Study|Withdrawal by Subject|4|||
130682215|NCT00854308|470463914|FG001|Overall Study|Withdrawal by Subject|2|||
130682216|NCT00854308|470463913|FG000|Overall Study|Sponsor's decision to terminate study|0|||
130682217|NCT00854308|470463914|FG001|Overall Study|Sponsor's decision to terminate study|1|||
130682218|NCT00610363|470463915|FG000|Overall Study|Non-compliance with protocol|0|||
130682219|NCT00610363|470463916|FG001|Overall Study|Non-compliance with protocol|1|||
130682220|NCT00610363|470463915|FG000|Overall Study|Adverse Event|3|||
130682221|NCT00610363|470463916|FG001|Overall Study|Adverse Event|1|||
130682222|NCT00610363|470463915|FG000|Overall Study|Lack of Efficacy|2|||
130682223|NCT00610363|470463916|FG001|Overall Study|Lack of Efficacy|0|||
130682224|NCT00610363|470463915|FG000|Overall Study|Lost to Follow-up|4|||
130682225|NCT00610363|470463916|FG001|Overall Study|Lost to Follow-up|0|||
130682226|NCT00610363|470463915|FG000|Overall Study|Withdrawal by Subject|1|||
130682227|NCT00610363|470463916|FG001|Overall Study|Withdrawal by Subject|0|||
130682228|NCT00610363|470463915|FG000|Overall Study|Other than specified above|1|||
130682229|NCT00610363|470463916|FG001|Overall Study|Other than specified above|1|||
130682230|NCT03048500|470463917|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
130682231|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
130682232|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Death|1|||
130682233|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
130682234|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
130682235|NCT03048500|470463917|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
130682236|NCT03048500|470463917|FG000|Follow up for 3 Years|Death|12|||
130682237|NCT00302952|470463918|FG000|Overall Study|Physician Decision|1|||
130682238|NCT00302952|470463919|FG001|Overall Study|Physician Decision|1|||
130682239|NCT00302952|470463918|FG000|Overall Study|Withdrawal by Subject|2|||
130682240|NCT00302952|470463919|FG001|Overall Study|Withdrawal by Subject|3|||
130682241|NCT00302952|470463918|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
130682242|NCT00302952|470463919|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
130682243|NCT02008565|470463928|FG000|Overall Study|Protocol Violation|1|||
130682244|NCT02008565|470463929|FG001|Overall Study|Protocol Violation|1|||
130682245|NCT02008565|470463930|FG002|Overall Study|Protocol Violation|2|||
130682246|NCT02008565|470463931|FG003|Overall Study|Protocol Violation|0|||
130682247|NCT00857623|470463932|FG000|Overall Study|Adverse Event|5|||
130436336|NCT01013792|469560606|FG001|Overall Study|Lost to Follow-up|1|||
130436337|NCT02100722|469560607|FG000|Overall Study|Withdrawal pre-procedure|4|||
130436338|NCT02100722|469560608|FG001|Overall Study|Withdrawal pre-procedure|9|||
130436339|NCT02100722|469560607|FG000|Overall Study|Withdrawal post-procedure|0|||
130436340|NCT02100722|469560608|FG001|Overall Study|Withdrawal post-procedure|3|||
130436341|NCT02100722|469560607|FG000|Overall Study|Lost to Follow-up|2|||
130436342|NCT02100722|469560608|FG001|Overall Study|Lost to Follow-up|2|||
130436343|NCT02100722|469560607|FG000|Overall Study|Continuing on study|751|||
130436344|NCT02100722|469560608|FG001|Overall Study|Continuing on study|729|||
130436345|NCT02541383|469560610|FG000|Overall Study|Death|50|||
130436346|NCT02541383|469560611|FG001|Overall Study|Death|37|||
130436347|NCT02541383|469560612|FG002|Overall Study|Death|48|||
130436348|NCT02541383|469560613|FG003|Overall Study|Death|41|||
130436349|NCT02541383|469560614|FG004|Overall Study|Death|21|||
130436350|NCT02541383|469560615|FG005|Overall Study|Death|25|||
130436351|NCT02541383|469560610|FG000|Overall Study|Lost to Follow-up|5|||
130436352|NCT02541383|469560611|FG001|Overall Study|Lost to Follow-up|3|||
130217650|NCT02348008|468759614|FG000|Overall Study|Withdrawal by Subject|0|||
130217651|NCT02348008|468759615|FG001|Overall Study|Withdrawal by Subject|1|||
130217652|NCT02348008|468759616|FG002|Overall Study|Withdrawal by Subject|0|||
130217653|NCT02348008|468759614|FG000|Overall Study|Symptomatic Deterioration|0|||
130217654|NCT02348008|468759615|FG001|Overall Study|Symptomatic Deterioration|1|||
130217655|NCT02348008|468759616|FG002|Overall Study|Symptomatic Deterioration|0|||
130217656|NCT00334295|468759621|FG000|Overall Study|Patients received fewer than 3 injection|5|||
130217657|NCT03268005|468759622|FG000|Overall Study|Death|2|||
130217658|NCT03268005|468759623|FG001|Overall Study|Death|1|||
130217659|NCT03268005|468759622|FG000|Overall Study|Lost to Follow-up|2|||
130217660|NCT03268005|468759623|FG001|Overall Study|Lost to Follow-up|2|||
130217661|NCT03268005|468759622|FG000|Overall Study|Withdrawal by Subject|11|||
130217662|NCT03268005|468759623|FG001|Overall Study|Withdrawal by Subject|11|||
130217663|NCT04378569|468761358|FG000|Overall Study|Adverse Event|0|||
130217664|NCT04378569|468761359|FG001|Overall Study|Adverse Event|0|||
130217665|NCT04378569|468761360|FG002|Overall Study|Adverse Event|2|||
130217666|NCT04378569|468761361|FG003|Overall Study|Adverse Event|0|||
130217667|NCT04378569|468761362|FG004|Overall Study|Adverse Event|3|||
130217668|NCT04378569|468761363|FG005|Overall Study|Adverse Event|3|||
130217669|NCT04378569|468761358|FG000|Overall Study|Lost to Follow-up|0|||
130217670|NCT04378569|468761359|FG001|Overall Study|Lost to Follow-up|3|||
130217671|NCT04378569|468761360|FG002|Overall Study|Lost to Follow-up|1|||
130217672|NCT04378569|468761361|FG003|Overall Study|Lost to Follow-up|0|||
130217673|NCT04378569|468761362|FG004|Overall Study|Lost to Follow-up|1|||
130217674|NCT04378569|468761363|FG005|Overall Study|Lost to Follow-up|1|||
130217675|NCT04378569|468761358|FG000|Overall Study|Protocol Violation|0|||
130217676|NCT04378569|468761359|FG001|Overall Study|Protocol Violation|0|||
130217677|NCT04378569|468761360|FG002|Overall Study|Protocol Violation|0|||
130217678|NCT04378569|468761361|FG003|Overall Study|Protocol Violation|0|||
130217679|NCT04378569|468761362|FG004|Overall Study|Protocol Violation|0|||
130217680|NCT04378569|468761363|FG005|Overall Study|Protocol Violation|1|||
130217681|NCT04378569|468761358|FG000|Overall Study|Withdrawal by Subject|0|||
130217682|NCT04378569|468761359|FG001|Overall Study|Withdrawal by Subject|6|||
130217683|NCT04378569|468761360|FG002|Overall Study|Withdrawal by Subject|7|||
130217684|NCT04378569|468761361|FG003|Overall Study|Withdrawal by Subject|4|||
130217685|NCT04378569|468761362|FG004|Overall Study|Withdrawal by Subject|5|||
130217686|NCT04378569|468761363|FG005|Overall Study|Withdrawal by Subject|4|||
130217687|NCT04378569|468761358|FG000|Overall Study|Lack of response|0|||
130436353|NCT02541383|469560612|FG002|Overall Study|Lost to Follow-up|1|||
130436354|NCT02541383|469560613|FG003|Overall Study|Lost to Follow-up|1|||
130436355|NCT02541383|469560614|FG004|Overall Study|Lost to Follow-up|3|||
130436356|NCT02541383|469560615|FG005|Overall Study|Lost to Follow-up|0|||
130436357|NCT02541383|469560610|FG000|Overall Study|Consent withdrawn|5|||
130436358|NCT02541383|469560611|FG001|Overall Study|Consent withdrawn|6|||
130436359|NCT02541383|469560612|FG002|Overall Study|Consent withdrawn|1|||
130436360|NCT02541383|469560613|FG003|Overall Study|Consent withdrawn|1|||
130436361|NCT02541383|469560614|FG004|Overall Study|Consent withdrawn|0|||
130217688|NCT04378569|468761359|FG001|Overall Study|Lack of response|0|||
130217689|NCT04378569|468761360|FG002|Overall Study|Lack of response|1|||
130436362|NCT02541383|469560615|FG005|Overall Study|Consent withdrawn|0|||
130217690|NCT04378569|468761361|FG003|Overall Study|Lack of response|0|||
130217691|NCT04378569|468761362|FG004|Overall Study|Lack of response|1|||
130217692|NCT04378569|468761363|FG005|Overall Study|Lack of response|1|||
130217693|NCT01962948|468761364|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130217694|NCT01962948|468761365|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130217695|NCT01962948|468761366|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
130316107|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
130436363|NCT02541383|469560610|FG000|Overall Study|Sponsor's decision|1|||
130436364|NCT02541383|469560611|FG001|Overall Study|Sponsor's decision|1|||
130436365|NCT02541383|469560612|FG002|Overall Study|Sponsor's decision|0|||
130436366|NCT02541383|469560613|FG003|Overall Study|Sponsor's decision|0|||
130682248|NCT00857623|470463933|FG001|Overall Study|Adverse Event|2|||
130682249|NCT00857623|470463932|FG000|Overall Study|Study-specific discontinuation criteria|5|||
130682250|NCT00857623|470463933|FG001|Overall Study|Study-specific discontinuation criteria|3|||
130682251|NCT00857623|470463932|FG000|Overall Study|Withdrawal by Subject|2|||
130682252|NCT00857623|470463933|FG001|Overall Study|Withdrawal by Subject|1|||
130682253|NCT00857623|470463932|FG000|Overall Study|Lack of Efficacy|1|||
130682254|NCT00857623|470463933|FG001|Overall Study|Lack of Efficacy|1|||
130682255|NCT00857623|470463932|FG000|Overall Study|Severe non-compliance to protocol|1|||
130682256|NCT00857623|470463933|FG001|Overall Study|Severe non-compliance to protocol|1|||
130682257|NCT00857623|470463932|FG000|Overall Study|Intake of prohibited medication|0|||
130682258|NCT00857623|470463933|FG001|Overall Study|Intake of prohibited medication|1|||
130682259|NCT00857623|470463932|FG000|Overall Study|Positive for HEP C|0|||
130682260|NCT00857623|470463933|FG001|Overall Study|Positive for HEP C|1|||
130682261|NCT03435081|470463934|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
130682262|NCT03435081|470463935|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
130682263|NCT03435081|470463936|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
130682264|NCT03435081|470463934|FG000|Week 0 to Week 16|Adverse Event|2|||
130682265|NCT03435081|470463935|FG001|Week 0 to Week 16|Adverse Event|2|||
130682266|NCT03435081|470463936|FG002|Week 0 to Week 16|Adverse Event|2|||
130682267|NCT03435081|470463934|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
130682268|NCT03435081|470463935|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
130682269|NCT03435081|470463936|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
130682270|NCT03435081|470463934|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
130682271|NCT03435081|470463935|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
130682272|NCT03435081|470463936|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
130682273|NCT03435081|470463934|FG000|Week 0 to Week 16|Pregnancy|1|||
130682274|NCT03435081|470463935|FG001|Week 0 to Week 16|Pregnancy|0|||
130682275|NCT03435081|470463936|FG002|Week 0 to Week 16|Pregnancy|0|||
130682276|NCT03435081|470463934|FG000|Week 0 to Week 16|Non-compliance|1|||
130682277|NCT03435081|470463935|FG001|Week 0 to Week 16|Non-compliance|0|||
130682278|NCT03435081|470463936|FG002|Week 0 to Week 16|Non-compliance|2|||
130682279|NCT03435081|470463934|FG000|Week 0 to Week 16|Inadequate Response|0|||
130682280|NCT03435081|470463935|FG001|Week 0 to Week 16|Inadequate Response|1|||
130682281|NCT03435081|470463936|FG002|Week 0 to Week 16|Inadequate Response|0|||
130682282|NCT03435081|470463934|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
130682283|NCT03435081|470463935|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
130682284|NCT03435081|470463936|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
130217696|NCT01962948|468761367|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
130436367|NCT02541383|469560614|FG004|Overall Study|Sponsor's decision|0|||
130436368|NCT02541383|469560615|FG005|Overall Study|Sponsor's decision|0|||
130436369|NCT05796518|469560616|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
130436370|NCT01065350|469560621|FG000|Overall Study|Received incorrect drug allocation|0|||
130436371|NCT01065350|469560622|FG001|Overall Study|Received incorrect drug allocation|1|||
130436372|NCT00510458|469560629|FG000|Overall Study|5 year not evaluable/missed|21|||
130436373|NCT00510458|469560629|FG000|Overall Study|Death|1|||
130436374|NCT00510458|469560629|FG000|Overall Study|Terminated|14|||
130436375|NCT00510458|469560629|FG000|Overall Study|Lost to Follow-up|6|||
130436376|NCT00510458|469560629|FG000|Overall Study|Withdrawal by Subject|3|||
130436377|NCT00510458|469560629|FG000|Overall Study|Revision|2|||
130436378|NCT02569710|469560630|FG000|Overall Study|Adverse Event|1|||
130436379|NCT02569710|469560631|FG001|Overall Study|Adverse Event|0|||
130436380|NCT02569710|469560632|FG002|Overall Study|Adverse Event|0|||
130436381|NCT02569710|469560633|FG003|Overall Study|Adverse Event|0|||
130436382|NCT02569710|469560634|FG004|Overall Study|Adverse Event|0|||
130436383|NCT02569710|469560635|FG005|Overall Study|Adverse Event|0|||
130436384|NCT02569710|469560636|FG006|Overall Study|Adverse Event|0|||
130682285|NCT03435081|470463934|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
130682286|NCT03435081|470463935|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
130682287|NCT03435081|470463936|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
130682288|NCT03435081|470463934|FG000|Week 16 to Week 104|Adverse Event|1|||
130682289|NCT03435081|470463935|FG001|Week 16 to Week 104|Adverse Event|0|||
130682290|NCT03435081|470463936|FG002|Week 16 to Week 104|Adverse Event|2|||
130682291|NCT03435081|470463934|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
130682292|NCT03435081|470463935|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
130682293|NCT03435081|470463936|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
130682294|NCT03435081|470463934|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
130682295|NCT03435081|470463935|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
130682296|NCT03435081|470463936|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
130436385|NCT02569710|469560637|FG007|Overall Study|Adverse Event|0|||
130436386|NCT02569710|469560638|FG008|Overall Study|Adverse Event|0|||
130436387|NCT02569710|469560639|FG009|Overall Study|Adverse Event|0|||
130682297|NCT03435081|470463934|FG000|Week 16 to Week 104|Non--Compliance|0|||
130682298|NCT03435081|470463935|FG001|Week 16 to Week 104|Non--Compliance|0|||
130682299|NCT03435081|470463936|FG002|Week 16 to Week 104|Non--Compliance|1|||
130682300|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
130217697|NCT00281697|468761372|FG000|Overall Study|> 60 days since last dose of study drug|4|||
130217698|NCT00281697|468761373|FG001|Overall Study|> 60 days since last dose of study drug|4|||
130217699|NCT00281697|468761372|FG000|Overall Study|Adverse Event|54|||
130217700|NCT00281697|468761373|FG001|Overall Study|Adverse Event|15|||
130217701|NCT00281697|468761372|FG000|Overall Study|Death|8|||
130217702|NCT00281697|468761373|FG001|Overall Study|Death|3|||
130217703|NCT00281697|468761372|FG000|Overall Study|Disease progression|279|||
130217704|NCT00281697|468761373|FG001|Overall Study|Disease progression|149|||
130217705|NCT00281697|468761372|FG000|Overall Study|Other|5|||
130217706|NCT00281697|468761373|FG001|Overall Study|Other|6|||
130217707|NCT00281697|468761372|FG000|Overall Study|Physician's decision to withdraw|15|||
130217708|NCT00281697|468761373|FG001|Overall Study|Physician's decision to withdraw|12|||
130217709|NCT00281697|468761372|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
130436388|NCT02569710|469560630|FG000|Overall Study|Lost to Follow-up|0|||
130436389|NCT02569710|469560631|FG001|Overall Study|Lost to Follow-up|0|||
130436390|NCT02569710|469560632|FG002|Overall Study|Lost to Follow-up|0|||
130436391|NCT02569710|469560633|FG003|Overall Study|Lost to Follow-up|0|||
130436392|NCT02569710|469560634|FG004|Overall Study|Lost to Follow-up|0|||
130436393|NCT02569710|469560635|FG005|Overall Study|Lost to Follow-up|0|||
130436394|NCT02569710|469560636|FG006|Overall Study|Lost to Follow-up|1|||
130436395|NCT02569710|469560637|FG007|Overall Study|Lost to Follow-up|0|||
130436396|NCT02569710|469560638|FG008|Overall Study|Lost to Follow-up|1|||
130436397|NCT02569710|469560639|FG009|Overall Study|Lost to Follow-up|0|||
130436398|NCT02569710|469560630|FG000|Overall Study|Virologic failure|0|||
130436399|NCT02569710|469560631|FG001|Overall Study|Virologic failure|0|||
130436400|NCT02569710|469560632|FG002|Overall Study|Virologic failure|0|||
130436401|NCT02569710|469560633|FG003|Overall Study|Virologic failure|0|||
130436402|NCT02569710|469560634|FG004|Overall Study|Virologic failure|1|||
130436403|NCT02569710|469560635|FG005|Overall Study|Virologic failure|0|||
130436404|NCT02569710|469560636|FG006|Overall Study|Virologic failure|1|||
130436405|NCT02569710|469560637|FG007|Overall Study|Virologic failure|0|||
130436406|NCT02569710|469560638|FG008|Overall Study|Virologic failure|0|||
130436407|NCT02569710|469560639|FG009|Overall Study|Virologic failure|0|||
130436408|NCT02569710|469560630|FG000|Overall Study|Withdrawal by Subject|0|||
130436409|NCT02569710|469560631|FG001|Overall Study|Withdrawal by Subject|0|||
130436410|NCT02569710|469560632|FG002|Overall Study|Withdrawal by Subject|0|||
130436411|NCT02569710|469560633|FG003|Overall Study|Withdrawal by Subject|0|||
130436412|NCT02569710|469560634|FG004|Overall Study|Withdrawal by Subject|0|||
130436413|NCT02569710|469560635|FG005|Overall Study|Withdrawal by Subject|1|||
130217710|NCT00281697|468761373|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
130217711|NCT00281697|468761372|FG000|Overall Study|Did not receive study drug|3|||
130217712|NCT00281697|468761373|FG001|Overall Study|Did not receive study drug|2|||
130217713|NCT04446429|468761374|FG000|Overall Study|Lost to Follow-up|6|||
130217714|NCT04446429|468761375|FG001|Overall Study|Lost to Follow-up|0|||
130217715|NCT02256917|468761376|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
130217716|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
130217717|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
130217718|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
130217719|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
130217720|NCT01896193|468761380|FG000|Overall Study|Lack of Efficacy|20|||
130217721|NCT01896193|468761381|FG001|Overall Study|Lack of Efficacy|11|||
130217722|NCT01896193|468761380|FG000|Overall Study|Protocol Violation|0|||
130217723|NCT01896193|468761381|FG001|Overall Study|Protocol Violation|1|||
130217724|NCT01896193|468761380|FG000|Overall Study|Withdrew Consent|1|||
130217725|NCT01896193|468761381|FG001|Overall Study|Withdrew Consent|0|||
130217726|NCT01300247|468761383|FG000|Overall Study|Death|1|||
130217727|NCT01300247|468761384|FG001|Overall Study|Death|1|||
130217728|NCT01300247|468761383|FG000|Overall Study|Lost to Follow-up|2|||
130217729|NCT01300247|468761384|FG001|Overall Study|Lost to Follow-up|0|||
130217730|NCT01300247|468761383|FG000|Overall Study|Withdrawal by Subject|1|||
130217731|NCT01300247|468761384|FG001|Overall Study|Withdrawal by Subject|0|||
130217732|NCT01300247|468761383|FG000|Overall Study|Non-Compliance|0|||
130217733|NCT01300247|468761384|FG001|Overall Study|Non-Compliance|1|||
130217734|NCT05359952|468761385|FG000|Overall Study|Lost to Follow-up|1|||
130217735|NCT05359952|468761386|FG001|Overall Study|Lost to Follow-up|0|||
130217736|NCT01556932|468761387|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
130217737|NCT01556932|468761388|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
130217738|NCT02328937|468761389|FG000|Period 1|Lost to Follow-up|0|||
130217739|NCT02328937|468761390|FG001|Period 1|Lost to Follow-up|0|||
130217740|NCT02328937|468761391|FG002|Period 1|Lost to Follow-up|0|||
130217741|NCT02328937|468761392|FG003|Period 1|Lost to Follow-up|1|||
130217742|NCT02328937|468761393|FG004|Period 1|Lost to Follow-up|0|||
130217743|NCT02328937|468761394|FG005|Period 1|Lost to Follow-up|0|||
130217744|NCT02328937|468761389|FG000|Period 2|Adverse Event|0|||
130217745|NCT02328937|468761390|FG001|Period 2|Adverse Event|0|||
130217746|NCT02328937|468761391|FG002|Period 2|Adverse Event|1|||
130217747|NCT02328937|468761392|FG003|Period 2|Adverse Event|0|||
130436414|NCT02569710|469560636|FG006|Overall Study|Withdrawal by Subject|0|||
130682301|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
130682302|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
130682303|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
130682304|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130682305|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130682306|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
130682307|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
130682308|NCT00420238|470463937|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
130682309|NCT00420238|470463938|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
130682310|NCT00420238|470463937|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
130682311|NCT00420238|470463938|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
130682312|NCT00304083|470463940|FG000|Overall Study|Withdrawal by Subject|4|||
130682313|NCT00304083|470463941|FG001|Overall Study|Withdrawal by Subject|2|||
130682314|NCT00304083|470463940|FG000|Overall Study|Physician Decision|8|||
130682315|NCT00304083|470463941|FG001|Overall Study|Physician Decision|3|||
130682316|NCT00304083|470463940|FG000|Overall Study|Disease Progression|5|||
130682317|NCT00304083|470463941|FG001|Overall Study|Disease Progression|1|||
130682318|NCT00304083|470463940|FG000|Overall Study|Other|5|||
130682319|NCT00304083|470463941|FG001|Overall Study|Other|2|||
130682320|NCT03966365|470463944|FG000|Overall Study|Protocol Violation|1|||
130682321|NCT03966365|470463945|FG001|Overall Study|Protocol Violation|0|||
130682322|NCT01044732|470463946|FG000|Overall Study|Lost to Follow-up|2|||
130682323|NCT01044732|470463947|FG001|Overall Study|Lost to Follow-up|1|||
130682324|NCT01044732|470463946|FG000|Overall Study|Physician Decision|5|||
130682325|NCT01044732|470463947|FG001|Overall Study|Physician Decision|3|||
130682326|NCT01044732|470463946|FG000|Overall Study|Protocol Violation|11|||
130682327|NCT01044732|470463947|FG001|Overall Study|Protocol Violation|12|||
130682328|NCT01044732|470463946|FG000|Overall Study|Withdrawal by Subject|0|||
130682329|NCT01044732|470463947|FG001|Overall Study|Withdrawal by Subject|1|||
130682330|NCT01044732|470463946|FG000|Overall Study|Inadequate bowel preparation|11|||
130682331|NCT01044732|470463947|FG001|Overall Study|Inadequate bowel preparation|17|||
130682332|NCT01044732|470463946|FG000|Overall Study|Inability to reach cecum|5|||
130347854|NCT05214573|469246800|FG000|Overall Study|Physician Decision|5924|||
130347855|NCT05214573|469246801|FG001|Overall Study|Physician Decision|0|||
130347862|NCT02486718|469246810|FG000|Enrollment Phase|Death|19|||
130347863|NCT02486718|469246811|FG001|Enrollment Phase|Death|0|||
130347864|NCT02486718|469246812|FG002|Enrollment Phase|Death|0|||
130347865|NCT02486718|469246810|FG000|Enrollment Phase|Symptomatic deterioration|1|||
130347866|NCT02486718|469246811|FG001|Enrollment Phase|Symptomatic deterioration|0|||
130347867|NCT02486718|469246812|FG002|Enrollment Phase|Symptomatic deterioration|0|||
130347868|NCT02486718|469246810|FG000|Enrollment Phase|Withdrawal by Subject|86|||
130347869|NCT02486718|469246811|FG001|Enrollment Phase|Withdrawal by Subject|0|||
130347870|NCT02486718|469246812|FG002|Enrollment Phase|Withdrawal by Subject|0|||
130347871|NCT02486718|469246810|FG000|Enrollment Phase|Protocol Violation|18|||
130347872|NCT02486718|469246811|FG001|Enrollment Phase|Protocol Violation|0|||
130347873|NCT02486718|469246812|FG002|Enrollment Phase|Protocol Violation|0|||
130682333|NCT01044732|470463947|FG001|Overall Study|Inability to reach cecum|2|||
130347874|NCT02486718|469246810|FG000|Enrollment Phase|Physician Decision|18|||
130682334|NCT01044732|470463946|FG000|Overall Study|Technical error or malfunction|15|||
130682335|NCT01044732|470463947|FG001|Overall Study|Technical error or malfunction|14|||
130347875|NCT02486718|469246811|FG001|Enrollment Phase|Physician Decision|0|||
130682336|NCT01569152|470463948|FG000|Phase IIa, Period 1|Early Escape|5|||
130682337|NCT01569152|470463949|FG001|Phase IIa, Period 1|Early Escape|22|||
130682338|NCT01569152|470463950|FG002|Phase IIa, Period 1|Early Escape|0|||
130682339|NCT01569152|470463948|FG000|Phase IIa, Period 1|Adverse Event|4|||
130682340|NCT01569152|470463949|FG001|Phase IIa, Period 1|Adverse Event|0|||
130682341|NCT01569152|470463950|FG002|Phase IIa, Period 1|Adverse Event|0|||
130682342|NCT01569152|470463948|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
130217748|NCT02328937|468761393|FG004|Period 2|Adverse Event|0|||
130682343|NCT01569152|470463949|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
130682344|NCT01569152|470463950|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
130682345|NCT01569152|470463948|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
130682346|NCT01569152|470463949|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
130682347|NCT01569152|470463950|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
130682348|NCT01569152|470463948|FG000|Phase IIa, Period 1|Protocol Violation|0|||
130682349|NCT01569152|470463949|FG001|Phase IIa, Period 1|Protocol Violation|1|||
130682350|NCT01569152|470463950|FG002|Phase IIa, Period 1|Protocol Violation|0|||
130682351|NCT01569152|470463948|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
130682352|NCT01569152|470463949|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
130682353|NCT01569152|470463950|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
130682354|NCT01569152|470463948|FG000|Safety Extension, Period 3|Adverse Event|0|||
130682355|NCT01569152|470463949|FG001|Safety Extension, Period 3|Adverse Event|0|||
130682356|NCT01569152|470463950|FG002|Safety Extension, Period 3|Adverse Event|4|||
130682357|NCT01569152|470463948|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
130682358|NCT01569152|470463949|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
130682359|NCT01569152|470463950|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
130682360|NCT01569152|470463948|FG000|Safety Extension, Period 3|Physician Decision|0|||
130682361|NCT01569152|470463949|FG001|Safety Extension, Period 3|Physician Decision|0|||
130682362|NCT01569152|470463950|FG002|Safety Extension, Period 3|Physician Decision|2|||
130682363|NCT01569152|470463948|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
130682364|NCT01569152|470463949|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
130682365|NCT01569152|470463950|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
130682366|NCT00824265|470463955|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
130682367|NCT00824265|470463956|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
130682368|NCT00824265|470463955|FG000|Treatment Phase|Protocol Violation|1|||
130682369|NCT00824265|470463956|FG001|Treatment Phase|Protocol Violation|0|||
130682370|NCT00824265|470463955|FG000|Treatment Phase|Lost to Follow-up|1|||
130682371|NCT00824265|470463956|FG001|Treatment Phase|Lost to Follow-up|1|||
130682372|NCT00824265|470463955|FG000|Treatment Phase|Physician Decision|6|||
130682373|NCT00824265|470463956|FG001|Treatment Phase|Physician Decision|12|||
130682374|NCT00824265|470463955|FG000|Treatment Phase|Withdrawal by Subject|6|||
130682375|NCT00824265|470463956|FG001|Treatment Phase|Withdrawal by Subject|15|||
130682376|NCT00824265|470463955|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
130682377|NCT00824265|470463956|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
130682378|NCT00824265|470463955|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
130682379|NCT00824265|470463956|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
130682380|NCT00591630|470463957|FG000|Overall Study|Death|0|||
130682381|NCT00591630|470463958|FG001|Overall Study|Death|0|||
130682382|NCT00591630|470463959|FG002|Overall Study|Death|1|||
130682383|NCT00591630|470463960|FG003|Overall Study|Death|0|||
130682384|NCT00463606|470463961|FG000|Overall Study|Adverse Event|21|||
130682385|NCT00463606|470463962|FG001|Overall Study|Adverse Event|18|||
130682386|NCT00463606|470463963|FG002|Overall Study|Adverse Event|11|||
130682387|NCT00463606|470463961|FG000|Overall Study|Withdrawal by Subject|11|||
130682388|NCT00463606|470463962|FG001|Overall Study|Withdrawal by Subject|11|||
130682389|NCT00463606|470463963|FG002|Overall Study|Withdrawal by Subject|5|||
130682390|NCT00463606|470463961|FG000|Overall Study|Lost to Follow-up|2|||
130682391|NCT00463606|470463962|FG001|Overall Study|Lost to Follow-up|2|||
130682392|NCT00463606|470463963|FG002|Overall Study|Lost to Follow-up|3|||
130682393|NCT00463606|470463961|FG000|Overall Study|Subject noncompliance|1|||
130682394|NCT00463606|470463962|FG001|Overall Study|Subject noncompliance|1|||
130682395|NCT00463606|470463963|FG002|Overall Study|Subject noncompliance|0|||
130682396|NCT00463606|470463961|FG000|Overall Study|Subject moved out of town|1|||
130682397|NCT00463606|470463962|FG001|Overall Study|Subject moved out of town|0|||
130682398|NCT00463606|470463963|FG002|Overall Study|Subject moved out of town|0|||
130682399|NCT00463606|470463961|FG000|Overall Study|Physician Decision|0|||
130682400|NCT00463606|470463962|FG001|Overall Study|Physician Decision|1|||
130682401|NCT00463606|470463963|FG002|Overall Study|Physician Decision|0|||
130682402|NCT00463606|470463961|FG000|Overall Study|Sponsor request|0|||
130682403|NCT00463606|470463962|FG001|Overall Study|Sponsor request|1|||
130682404|NCT00463606|470463963|FG002|Overall Study|Sponsor request|0|||
130682405|NCT00463606|470463961|FG000|Overall Study|Exclusion criteria violation|2|||
130682406|NCT00463606|470463962|FG001|Overall Study|Exclusion criteria violation|0|||
130682407|NCT00463606|470463963|FG002|Overall Study|Exclusion criteria violation|0|||
130682408|NCT00463606|470463961|FG000|Overall Study|Coordinator error|1|||
130682409|NCT00463606|470463962|FG001|Overall Study|Coordinator error|0|||
130682410|NCT00463606|470463963|FG002|Overall Study|Coordinator error|0|||
130682411|NCT00463606|470463961|FG000|Overall Study|Patient randomized in error|1|||
130682412|NCT00463606|470463962|FG001|Overall Study|Patient randomized in error|0|||
130682413|NCT00463606|470463963|FG002|Overall Study|Patient randomized in error|0|||
130682414|NCT00463606|470463961|FG000|Overall Study|Participation in another ABT-335 trial|1|||
130682415|NCT00463606|470463962|FG001|Overall Study|Participation in another ABT-335 trial|0|||
130682416|NCT00463606|470463963|FG002|Overall Study|Participation in another ABT-335 trial|0|||
130682417|NCT00463606|470463961|FG000|Overall Study|Protocol Violation|0|||
130682418|NCT00463606|470463962|FG001|Overall Study|Protocol Violation|0|||
130682419|NCT00463606|470463963|FG002|Overall Study|Protocol Violation|1|||
130682420|NCT02682602|470463965|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
130682421|NCT02682602|470463966|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
130682422|NCT02682602|470463965|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
130682423|NCT02682602|470463966|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
130682424|NCT02311361|470465869|FG000|Overall Study|Did not receive treatment|0|||
130682425|NCT02311361|470465870|FG001|Overall Study|Did not receive treatment|1|||
130682426|NCT02311361|470465871|FG002|Overall Study|Did not receive treatment|0|||
130682427|NCT02311361|470465872|FG003|Overall Study|Did not receive treatment|1|||
130682428|NCT00365300|470465873|FG000|Open-label Phase|Adverse Event|4|||
130682429|NCT00365300|470465874|FG001|Open-label Phase|Adverse Event|0|||
130682430|NCT00365300|470465873|FG000|Open-label Phase|Failed to Return|1|||
130682431|NCT00365300|470465874|FG001|Open-label Phase|Failed to Return|0|||
130682432|NCT00365300|470465873|FG000|Open-label Phase|Physician Decision|1|||
130682433|NCT00365300|470465874|FG001|Open-label Phase|Physician Decision|0|||
130682434|NCT00365300|470465873|FG000|Open-label Phase|Noncompliance|9|||
130682435|NCT00365300|470465874|FG001|Open-label Phase|Noncompliance|0|||
130682436|NCT00365300|470465873|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
130682437|NCT00365300|470465874|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
130682438|NCT00365300|470465873|FG000|Open-label Phase|Protocol Violation|1|||
130682439|NCT00365300|470465874|FG001|Open-label Phase|Protocol Violation|0|||
130682440|NCT00365300|470465873|FG000|Open-label Phase|Lack of Efficacy|1|||
130682441|NCT00365300|470465874|FG001|Open-label Phase|Lack of Efficacy|0|||
130682442|NCT00365300|470465873|FG000|Open-label Phase|Patient skipped open label phase|1|||
130682443|NCT00365300|470465874|FG001|Open-label Phase|Patient skipped open label phase|0|||
130682444|NCT00365300|470465873|FG000|Double-blind Phase|Failed to return|1|||
130682445|NCT00365300|470465874|FG001|Double-blind Phase|Failed to return|0|||
130682446|NCT00365300|470465873|FG000|Double-blind Phase|Noncompliance|1|||
130682447|NCT00365300|470465874|FG001|Double-blind Phase|Noncompliance|1|||
130682448|NCT00365300|470465873|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130347876|NCT02486718|469246812|FG002|Enrollment Phase|Physician Decision|0|||
130347877|NCT02486718|469246810|FG000|Enrollment Phase|Reason not provided|41|||
130347878|NCT02486718|469246811|FG001|Enrollment Phase|Reason not provided|0|||
130347879|NCT02486718|469246812|FG002|Enrollment Phase|Reason not provided|0|||
130347880|NCT02486718|469246810|FG000|Enrollment Phase|Disease relapse|54|||
130347881|NCT02486718|469246811|FG001|Enrollment Phase|Disease relapse|0|||
130347882|NCT02486718|469246812|FG002|Enrollment Phase|Disease relapse|0|||
130347883|NCT02486718|469246810|FG000|Enrollment Phase|Lost to Follow-up|4|||
130347884|NCT02486718|469246811|FG001|Enrollment Phase|Lost to Follow-up|0|||
130347885|NCT02486718|469246812|FG002|Enrollment Phase|Lost to Follow-up|0|||
130347886|NCT02486718|469246810|FG000|Enrollment Phase|Adverse Event|34|||
130347887|NCT02486718|469246811|FG001|Enrollment Phase|Adverse Event|0|||
130347888|NCT02486718|469246812|FG002|Enrollment Phase|Adverse Event|0|||
130347889|NCT02486718|469246810|FG000|Randomized Phase|Withdrawal by Subject|0|||
130347890|NCT02486718|469246811|FG001|Randomized Phase|Withdrawal by Subject|44|||
130347891|NCT02486718|469246812|FG002|Randomized Phase|Withdrawal by Subject|47|||
130347892|NCT02486718|469246810|FG000|Randomized Phase|Protocol Violation|0|||
130347893|NCT02486718|469246811|FG001|Randomized Phase|Protocol Violation|2|||
130347894|NCT02486718|469246812|FG002|Randomized Phase|Protocol Violation|0|||
130347895|NCT02486718|469246810|FG000|Randomized Phase|Physician Decision|0|||
130347896|NCT02486718|469246811|FG001|Randomized Phase|Physician Decision|0|||
130347897|NCT02486718|469246812|FG002|Randomized Phase|Physician Decision|3|||
130347898|NCT02486718|469246810|FG000|Randomized Phase|Lost to Follow-up|0|||
130347899|NCT02486718|469246811|FG001|Randomized Phase|Lost to Follow-up|5|||
130347900|NCT02486718|469246812|FG002|Randomized Phase|Lost to Follow-up|11|||
130347901|NCT02486718|469246810|FG000|Randomized Phase|Disease Relapse|0|||
130347902|NCT02486718|469246811|FG001|Randomized Phase|Disease Relapse|1|||
130347903|NCT02486718|469246812|FG002|Randomized Phase|Disease Relapse|0|||
130347904|NCT02486718|469246810|FG000|Randomized Phase|Death|0|||
130347905|NCT02486718|469246811|FG001|Randomized Phase|Death|154|||
130347906|NCT02486718|469246812|FG002|Randomized Phase|Death|155|||
130682449|NCT00365300|470465874|FG001|Double-blind Phase|Withdrawal by Subject|1|||
130347907|NCT02486718|469246810|FG000|Randomized Phase|Ongoing|0|||
130347908|NCT02486718|469246811|FG001|Randomized Phase|Ongoing|301|||
130347909|NCT02486718|469246812|FG002|Randomized Phase|Ongoing|282|||
130217749|NCT02328937|468761394|FG005|Period 2|Adverse Event|0|||
130217750|NCT00996034|468761397|FG000|Overall Study|Lost to Follow-up|2|||
130217751|NCT00996034|468761397|FG000|Overall Study|withdrawn by PI|1|||
130217752|NCT03231306|468761398|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
130217753|NCT03231306|468761398|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
130217754|NCT03231306|468761398|FG000|Overall Study|Treatment delay > 21 days|2|||
130217755|NCT03231306|468761398|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
130217756|NCT03231306|468761398|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
130217757|NCT03231306|468761398|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
130217758|NCT03231306|468761398|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
130217759|NCT03231306|468761398|FG000|Overall Study|More than 1 Reason|2|||
130217760|NCT00685360|468761399|FG000|Overall Study|Lost to Follow-up|0|||
130217761|NCT00685360|468761400|FG001|Overall Study|Lost to Follow-up|1|||
130217762|NCT00685360|468761401|FG002|Overall Study|Lost to Follow-up|2|||
130217763|NCT00685360|468761399|FG000|Overall Study|Adverse Event|4|||
130217764|NCT00685360|468761400|FG001|Overall Study|Adverse Event|6|||
130217765|NCT00685360|468761401|FG002|Overall Study|Adverse Event|4|||
130217766|NCT00685360|468761399|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
130217767|NCT00685360|468761400|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
130217768|NCT00685360|468761401|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
130217769|NCT00685360|468761399|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
130682450|NCT00365300|470465873|FG000|Double-blind Phase|Protocol Violation|3|||
130682451|NCT00365300|470465874|FG001|Double-blind Phase|Protocol Violation|1|||
130682452|NCT00365300|470465873|FG000|Double-blind Phase|Lack of Efficacy|6|||
130682453|NCT00365300|470465874|FG001|Double-blind Phase|Lack of Efficacy|6|||
130682454|NCT02896361|470465875|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
130682455|NCT02896361|470465876|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
130682456|NCT02896361|470465877|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
130682457|NCT02896361|470465875|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130682458|NCT02896361|470465876|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
130682459|NCT02896361|470465877|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130682460|NCT01179048|470465879|FG000|Overall Study|Withdrawn - does not allow contact|4|||
130682461|NCT01179048|470465880|FG001|Overall Study|Withdrawn - does not allow contact|8|||
130682462|NCT01179048|470465879|FG000|Overall Study|Lost to Follow-up|8|||
130682463|NCT01179048|470465880|FG001|Overall Study|Lost to Follow-up|9|||
130682464|NCT01179048|470465879|FG000|Overall Study|Alive|127|||
130682465|NCT01179048|470465880|FG001|Overall Study|Alive|142|||
130682466|NCT01520909|470465892|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
130682467|NCT01520909|470465893|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
130682468|NCT01520909|470465894|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
130682469|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130682470|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130682471|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
130682472|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130682473|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130682474|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
130682475|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130682476|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130682477|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
130682478|NCT02188303|470465895|FG000|Overall Study|Adverse Event|0|||
130682479|NCT02188303|470465896|FG001|Overall Study|Adverse Event|0|||
130682480|NCT02188303|470465897|FG002|Overall Study|Adverse Event|0|||
130682481|NCT02188303|470465898|FG003|Overall Study|Adverse Event|0|||
130682482|NCT02188303|470465899|FG004|Overall Study|Adverse Event|0|||
130682483|NCT02188303|470465900|FG005|Overall Study|Adverse Event|2|||
130682484|NCT02188303|470465901|FG006|Overall Study|Adverse Event|0|||
130682485|NCT02188303|470465902|FG007|Overall Study|Adverse Event|2|||
130682486|NCT02188303|470465895|FG000|Overall Study|Dose Termination Criteria Met|0|||
130682487|NCT02188303|470465896|FG001|Overall Study|Dose Termination Criteria Met|0|||
130682488|NCT02188303|470465897|FG002|Overall Study|Dose Termination Criteria Met|0|||
130682489|NCT02188303|470465898|FG003|Overall Study|Dose Termination Criteria Met|0|||
130682490|NCT02188303|470465899|FG004|Overall Study|Dose Termination Criteria Met|0|||
130682491|NCT02188303|470465900|FG005|Overall Study|Dose Termination Criteria Met|0|||
130682492|NCT02188303|470465901|FG006|Overall Study|Dose Termination Criteria Met|2|||
130682493|NCT02188303|470465902|FG007|Overall Study|Dose Termination Criteria Met|4|||
130682494|NCT04206332|470465904|FG000|Part A|Lost to Follow-up|0|||
130682495|NCT04206332|470465905|FG001|Part A|Lost to Follow-up|1|||
130682496|NCT04206332|470465906|FG002|Part A|Lost to Follow-up|0|||
130682497|NCT04206332|470465907|FG003|Part A|Lost to Follow-up|0|||
130682498|NCT04206332|470465908|FG004|Part A|Lost to Follow-up|0|||
130682499|NCT04206332|470465909|FG005|Part A|Lost to Follow-up|0|||
130682500|NCT04206332|470465910|FG006|Part A|Lost to Follow-up|0|||
130682501|NCT04206332|470465911|FG007|Part A|Lost to Follow-up|0|||
130682502|NCT04206332|470465912|FG008|Part A|Lost to Follow-up|0|||
130682503|NCT04206332|470465913|FG009|Part A|Lost to Follow-up|0|||
130682504|NCT04206332|470465914|FG010|Part A|Lost to Follow-up|0|||
130682505|NCT04206332|470465915|FG011|Part A|Lost to Follow-up|0|||
130682506|NCT04206332|470465916|FG012|Part A|Lost to Follow-up|0|||
130682507|NCT04206332|470465917|FG013|Part A|Lost to Follow-up|0|||
130682508|NCT04206332|470465918|FG014|Part A|Lost to Follow-up|0|||
130682509|NCT04206332|470465919|FG015|Part A|Lost to Follow-up|0|||
130682510|NCT04206332|470465920|FG016|Part A|Lost to Follow-up|0|||
130682511|NCT04206332|470465904|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682512|NCT04206332|470465905|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682513|NCT04206332|470465906|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682514|NCT04206332|470465907|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682515|NCT04206332|470465908|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682516|NCT04206332|470465909|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
130682517|NCT04206332|470465910|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682518|NCT04206332|470465911|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130217770|NCT00685360|468761400|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
130217771|NCT00685360|468761401|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
130217772|NCT00685360|468761399|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
130217773|NCT00685360|468761400|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
130217774|NCT00685360|468761401|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
130217775|NCT00685360|468761399|FG000|Overall Study|Protocol Deviation|0|||
130217776|NCT00685360|468761400|FG001|Overall Study|Protocol Deviation|1|||
130682519|NCT04206332|470465912|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682520|NCT04206332|470465913|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682521|NCT04206332|470465914|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130217777|NCT00685360|468761401|FG002|Overall Study|Protocol Deviation|1|||
130720845|NCT04126213|470601548|FG003|Overall Study|Lost to Follow-up|10|||
130217778|NCT04865419|468761402|FG000|Overall Study|Other|1|||
130217779|NCT04865419|468761403|FG001|Overall Study|Other|2|||
130217780|NCT04865419|468761404|FG002|Overall Study|Other|2|||
130217781|NCT04865419|468761405|FG003|Overall Study|Other|1|||
130217782|NCT04865419|468761406|FG004|Overall Study|Other|3|||
130217783|NCT04865419|468761407|FG005|Overall Study|Other|0|||
130217784|NCT04865419|468761408|FG006|Overall Study|Other|0|||
130217785|NCT04865419|468761409|FG007|Overall Study|Other|1|||
130217786|NCT04865419|468761410|FG008|Overall Study|Other|0|||
130217787|NCT04865419|468761411|FG009|Overall Study|Other|0|||
130217788|NCT04865419|468761412|FG010|Overall Study|Other|0|||
130217789|NCT04865419|468761402|FG000|Overall Study|Withdrawal by Subject|0|||
130217790|NCT04865419|468761403|FG001|Overall Study|Withdrawal by Subject|1|||
130217791|NCT04865419|468761404|FG002|Overall Study|Withdrawal by Subject|1|||
130217792|NCT04865419|468761405|FG003|Overall Study|Withdrawal by Subject|0|||
130217793|NCT04865419|468761406|FG004|Overall Study|Withdrawal by Subject|0|||
130217794|NCT04865419|468761407|FG005|Overall Study|Withdrawal by Subject|0|||
130217795|NCT04865419|468761408|FG006|Overall Study|Withdrawal by Subject|0|||
130217796|NCT04865419|468761409|FG007|Overall Study|Withdrawal by Subject|1|||
130217797|NCT04865419|468761410|FG008|Overall Study|Withdrawal by Subject|2|||
130217798|NCT04865419|468761411|FG009|Overall Study|Withdrawal by Subject|1|||
130347916|NCT04803214|469246816|FG000|Overall Study|Adverse Event|1|||
130347917|NCT04803214|469246817|FG001|Overall Study|Adverse Event|0|||
130347918|NCT04803214|469246816|FG000|Overall Study|Withdrawal by Subject|1|||
130347919|NCT04803214|469246817|FG001|Overall Study|Withdrawal by Subject|2|||
130347920|NCT04803214|469246816|FG000|Overall Study|Lost to Follow-up|2|||
130347921|NCT04803214|469246817|FG001|Overall Study|Lost to Follow-up|4|||
130347922|NCT04803214|469246816|FG000|Overall Study|Physician Decision|1|||
130347923|NCT04803214|469246817|FG001|Overall Study|Physician Decision|1|||
130347924|NCT04803214|469246816|FG000|Overall Study|Missed 12 month visit|0|||
130347925|NCT04803214|469246817|FG001|Overall Study|Missed 12 month visit|3|||
130436415|NCT02569710|469560637|FG007|Overall Study|Withdrawal by Subject|0|||
130436416|NCT02569710|469560638|FG008|Overall Study|Withdrawal by Subject|0|||
130436417|NCT02569710|469560639|FG009|Overall Study|Withdrawal by Subject|0|||
130436418|NCT02716038|469560640|FG000|Overall Study|Not evaluable|1|||
130436419|NCT02716038|469560640|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
130436420|NCT02716038|469560640|FG000|Overall Study|Unresectable|3|||
130436421|NCT03573908|469560641|FG000|Treatment Period|Adverse Event|4|||
130436422|NCT03573908|469560642|FG001|Treatment Period|Adverse Event|9|||
130436423|NCT03573908|469560643|FG002|Treatment Period|Adverse Event|0|||
130436424|NCT03573908|469560644|FG003|Treatment Period|Adverse Event|0|||
130436425|NCT03573908|469560645|FG004|Treatment Period|Adverse Event|0|||
130436426|NCT03573908|469560641|FG000|Treatment Period|Protocol Violation|1|||
130436427|NCT03573908|469560642|FG001|Treatment Period|Protocol Violation|0|||
130436428|NCT03573908|469560643|FG002|Treatment Period|Protocol Violation|0|||
130436429|NCT03573908|469560644|FG003|Treatment Period|Protocol Violation|0|||
130436430|NCT03573908|469560645|FG004|Treatment Period|Protocol Violation|0|||
130436431|NCT03573908|469560641|FG000|Treatment Period|Withdrawal by Subject|7|||
130436432|NCT03573908|469560642|FG001|Treatment Period|Withdrawal by Subject|5|||
130436433|NCT03573908|469560643|FG002|Treatment Period|Withdrawal by Subject|0|||
130436434|NCT03573908|469560644|FG003|Treatment Period|Withdrawal by Subject|0|||
130436435|NCT03573908|469560645|FG004|Treatment Period|Withdrawal by Subject|0|||
130436436|NCT03573908|469560641|FG000|Treatment Period|Lost to Follow-up|7|||
130436437|NCT03573908|469560642|FG001|Treatment Period|Lost to Follow-up|6|||
130682522|NCT04206332|470465915|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682523|NCT04206332|470465916|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682524|NCT04206332|470465917|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130436438|NCT03573908|469560643|FG002|Treatment Period|Lost to Follow-up|0|||
130436439|NCT03573908|469560644|FG003|Treatment Period|Lost to Follow-up|0|||
130436440|NCT03573908|469560645|FG004|Treatment Period|Lost to Follow-up|0|||
130436441|NCT03573908|469560641|FG000|Treatment Period|Pregnancy|1|||
130436442|NCT03573908|469560642|FG001|Treatment Period|Pregnancy|0|||
130436443|NCT03573908|469560643|FG002|Treatment Period|Pregnancy|0|||
130436444|NCT03573908|469560644|FG003|Treatment Period|Pregnancy|0|||
130436445|NCT03573908|469560645|FG004|Treatment Period|Pregnancy|0|||
130436446|NCT03573908|469560641|FG000|Treatment Period|Other, Not Specified|4|||
130436447|NCT03573908|469560642|FG001|Treatment Period|Other, Not Specified|6|||
130436448|NCT03573908|469560643|FG002|Treatment Period|Other, Not Specified|0|||
130436449|NCT03573908|469560644|FG003|Treatment Period|Other, Not Specified|0|||
130436450|NCT03573908|469560645|FG004|Treatment Period|Other, Not Specified|0|||
130436451|NCT03573908|469560641|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130436452|NCT03573908|469560642|FG001|Randomized Withdrawal Period|Adverse Event|0|||
130436453|NCT03573908|469560643|FG002|Randomized Withdrawal Period|Adverse Event|3|||
130436454|NCT03573908|469560644|FG003|Randomized Withdrawal Period|Adverse Event|0|||
130436455|NCT03573908|469560645|FG004|Randomized Withdrawal Period|Adverse Event|0|||
130436456|NCT03573908|469560641|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130436457|NCT03573908|469560642|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130436458|NCT03573908|469560643|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130436459|NCT03573908|469560644|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130436460|NCT03573908|469560645|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
130436461|NCT03573908|469560641|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
130436462|NCT03573908|469560642|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
130436463|NCT03573908|469560643|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
130436464|NCT03573908|469560644|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
130436465|NCT03573908|469560645|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
130436466|NCT03573908|469560641|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
130682525|NCT04206332|470465918|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682526|NCT04206332|470465919|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682527|NCT04206332|470465920|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682528|NCT04206332|470465904|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682529|NCT04206332|470465905|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130436467|NCT03573908|469560642|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
130436468|NCT03573908|469560643|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
130436469|NCT03573908|469560644|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
130436470|NCT03573908|469560645|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
130436471|NCT04006925|469560646|FG000|Overall Study|Side effects|2|||
130436472|NCT04006925|469560647|FG001|Overall Study|Side effects|0|||
130682530|NCT04206332|470465906|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130436473|NCT01555164|469560651|FG000|Overall Study|Adverse Event|5|||
130217799|NCT04865419|468761412|FG010|Overall Study|Withdrawal by Subject|0|||
130682531|NCT04206332|470465907|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682532|NCT04206332|470465908|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682533|NCT04206332|470465909|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682534|NCT04206332|470465910|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682535|NCT04206332|470465911|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
130682536|NCT04206332|470465912|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682537|NCT04206332|470465913|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682538|NCT04206332|470465914|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130682539|NCT04206332|470465915|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682540|NCT04206332|470465916|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682541|NCT04206332|470465917|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682542|NCT04206332|470465918|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682543|NCT04206332|470465919|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682544|NCT04206332|470465920|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682545|NCT04206332|470465904|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682546|NCT04206332|470465905|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682547|NCT04206332|470465906|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682548|NCT04206332|470465907|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682549|NCT04206332|470465908|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682550|NCT04206332|470465909|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682551|NCT04206332|470465910|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682552|NCT04206332|470465911|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682553|NCT04206332|470465912|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682554|NCT04206332|470465913|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682555|NCT04206332|470465914|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682556|NCT04206332|470465915|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682557|NCT04206332|470465916|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682558|NCT04206332|470465917|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682559|NCT04206332|470465918|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682560|NCT04206332|470465919|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682561|NCT04206332|470465920|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130682562|NCT04206332|470465904|FG000|Part C|Withdrawal by Subject|0|||
130682563|NCT04206332|470465905|FG001|Part C|Withdrawal by Subject|0|||
130682564|NCT04206332|470465906|FG002|Part C|Withdrawal by Subject|0|||
130682565|NCT04206332|470465907|FG003|Part C|Withdrawal by Subject|0|||
130682566|NCT04206332|470465908|FG004|Part C|Withdrawal by Subject|0|||
130682567|NCT04206332|470465909|FG005|Part C|Withdrawal by Subject|0|||
130682568|NCT04206332|470465910|FG006|Part C|Withdrawal by Subject|0|||
130682569|NCT04206332|470465911|FG007|Part C|Withdrawal by Subject|0|||
130682570|NCT04206332|470465912|FG008|Part C|Withdrawal by Subject|0|||
130682571|NCT04206332|470465913|FG009|Part C|Withdrawal by Subject|0|||
130682572|NCT04206332|470465914|FG010|Part C|Withdrawal by Subject|0|||
130682573|NCT04206332|470465915|FG011|Part C|Withdrawal by Subject|0|||
130682574|NCT04206332|470465916|FG012|Part C|Withdrawal by Subject|0|||
130682575|NCT04206332|470465917|FG013|Part C|Withdrawal by Subject|0|||
130682576|NCT04206332|470465918|FG014|Part C|Withdrawal by Subject|2|||
130682577|NCT04206332|470465919|FG015|Part C|Withdrawal by Subject|0|||
130682578|NCT04206332|470465920|FG016|Part C|Withdrawal by Subject|0|||
130682579|NCT01038856|470465928|FG000|Overall Study|Adverse Event|2|||
130682580|NCT02087904|470465929|FG000|Overall Study|Did Not Receive Study Drug|0|||
130682581|NCT02087904|470465930|FG001|Overall Study|Did Not Receive Study Drug|0|||
130682582|NCT02087904|470465931|FG002|Overall Study|Did Not Receive Study Drug|2|||
130682583|NCT02087904|470465932|FG003|Overall Study|Did Not Receive Study Drug|1|||
130682584|NCT02087904|470465929|FG000|Overall Study|Adverse Event|8|||
130682585|NCT02087904|470465930|FG001|Overall Study|Adverse Event|4|||
130682586|NCT02087904|470465931|FG002|Overall Study|Adverse Event|4|||
130682587|NCT02087904|470465932|FG003|Overall Study|Adverse Event|12|||
130682588|NCT02087904|470465929|FG000|Overall Study|Lack of Efficacy|3|||
130682589|NCT02087904|470465930|FG001|Overall Study|Lack of Efficacy|6|||
130682590|NCT02087904|470465931|FG002|Overall Study|Lack of Efficacy|3|||
130682591|NCT02087904|470465932|FG003|Overall Study|Lack of Efficacy|2|||
130682592|NCT02087904|470465929|FG000|Overall Study|Other|6|||
130682593|NCT02087904|470465930|FG001|Overall Study|Other|2|||
130682594|NCT02087904|470465931|FG002|Overall Study|Other|4|||
130682595|NCT02087904|470465932|FG003|Overall Study|Other|4|||
130682596|NCT02087904|470465929|FG000|Overall Study|Withdrawal by Subject|8|||
130682597|NCT02087904|470465930|FG001|Overall Study|Withdrawal by Subject|3|||
130682598|NCT02087904|470465931|FG002|Overall Study|Withdrawal by Subject|7|||
130682599|NCT02087904|470465932|FG003|Overall Study|Withdrawal by Subject|4|||
130682600|NCT02087904|470465929|FG000|Overall Study|Lost to Follow-up|0|||
130682601|NCT02087904|470465930|FG001|Overall Study|Lost to Follow-up|4|||
130682602|NCT02087904|470465931|FG002|Overall Study|Lost to Follow-up|2|||
130682603|NCT02087904|470465932|FG003|Overall Study|Lost to Follow-up|2|||
130682604|NCT02910037|470465933|FG000|Overall Study|Withdrawal by Subject|4|||
130682605|NCT02910037|470465933|FG000|Overall Study|Lost to Follow-up|6|||
130682606|NCT01126736|470465941|FG000|Overall Study|Death|2|||
130682607|NCT01126736|470465942|FG001|Overall Study|Death|2|||
130682608|NCT01126736|470465943|FG002|Overall Study|Death|1|||
130682609|NCT01126736|470465944|FG003|Overall Study|Death|19|||
130682610|NCT01126736|470465945|FG004|Overall Study|Death|19|||
130682611|NCT01126736|470465941|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682612|NCT01126736|470465942|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682613|NCT01126736|470465943|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682614|NCT01126736|470465944|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130682615|NCT01126736|470465945|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130682616|NCT01126736|470465941|FG000|Overall Study|Lost to Follow-up|0|||
130682617|NCT01126736|470465942|FG001|Overall Study|Lost to Follow-up|0|||
130682618|NCT01126736|470465943|FG002|Overall Study|Lost to Follow-up|0|||
130682619|NCT01126736|470465944|FG003|Overall Study|Lost to Follow-up|1|||
130682620|NCT01126736|470465945|FG004|Overall Study|Lost to Follow-up|1|||
130682621|NCT01126736|470465941|FG000|Overall Study|Administrative reasons|0|||
130682622|NCT01126736|470465942|FG001|Overall Study|Administrative reasons|0|||
130682623|NCT01126736|470465943|FG002|Overall Study|Administrative reasons|0|||
130682624|NCT01126736|470465944|FG003|Overall Study|Administrative reasons|0|||
130682625|NCT01126736|470465945|FG004|Overall Study|Administrative reasons|1|||
130682626|NCT01126736|470465941|FG000|Overall Study|Progressive disease|0|||
130682627|NCT01126736|470465942|FG001|Overall Study|Progressive disease|0|||
130682628|NCT01126736|470465943|FG002|Overall Study|Progressive disease|0|||
130682629|NCT01126736|470465944|FG003|Overall Study|Progressive disease|2|||
130682630|NCT01126736|470465945|FG004|Overall Study|Progressive disease|1|||
130682631|NCT01126736|470465941|FG000|Overall Study|Withdrawal by Subject|0|||
130682632|NCT01126736|470465942|FG001|Overall Study|Withdrawal by Subject|0|||
130682633|NCT01126736|470465943|FG002|Overall Study|Withdrawal by Subject|0|||
130682634|NCT01126736|470465944|FG003|Overall Study|Withdrawal by Subject|1|||
130682635|NCT01126736|470465945|FG004|Overall Study|Withdrawal by Subject|1|||
130682636|NCT01126736|470465941|FG000|Overall Study|Other|2|||
130682637|NCT01126736|470465942|FG001|Overall Study|Other|4|||
130682638|NCT01126736|470465943|FG002|Overall Study|Other|4|||
130682639|NCT01126736|470465944|FG003|Overall Study|Other|16|||
130682640|NCT01126736|470465945|FG004|Overall Study|Other|15|||
130682641|NCT02015390|470465946|FG000|Overall Study|Lost to Follow-up|1|||
130682642|NCT02015390|470465947|FG001|Overall Study|Lost to Follow-up|0|||
130682643|NCT02015390|470465946|FG000|Overall Study|Adverse Event|0|||
130682644|NCT02015390|470465947|FG001|Overall Study|Adverse Event|3|||
130682645|NCT02015390|470465946|FG000|Overall Study|Physician Decision|0|||
130682646|NCT02015390|470465947|FG001|Overall Study|Physician Decision|1|||
130682647|NCT02193880|470465948|FG000|Overall Study|patients did not collect enough HPC|3|||
130682648|NCT03136380|470465949|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682649|NCT03136380|470465950|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
130682650|NCT03136380|470465951|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682651|NCT03136380|470465952|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682652|NCT03136380|470465953|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682653|NCT01661686|470465957|FG000|Overall Study|Lost to Follow-up|2|||
130682654|NCT01661686|470465958|FG001|Overall Study|Lost to Follow-up|1|||
130682655|NCT01661686|470465957|FG000|Overall Study|did not receive allocated intervention|0|||
130682656|NCT01661686|470465958|FG001|Overall Study|did not receive allocated intervention|1|||
130682657|NCT02419937|470465962|FG000|Overall Study|Lost to Follow-up|1|||
130682658|NCT02419937|470465963|FG001|Overall Study|Lost to Follow-up|0|||
130682659|NCT00553280|470465964|FG000|Overall Study|Adverse Event|19|||
130682660|NCT00553280|470465964|FG000|Overall Study|Lack of Efficacy|3|||
130682661|NCT00553280|470465964|FG000|Overall Study|Withdrawal by Subject|3|||
130436474|NCT01555164|469560652|FG001|Overall Study|Adverse Event|7|||
130436475|NCT01555164|469560651|FG000|Overall Study|Hyperglycemia|0|||
130436476|NCT01555164|469560652|FG001|Overall Study|Hyperglycemia|1|||
130436477|NCT01555164|469560651|FG000|Overall Study|Investigator's Discretion|2|||
130436478|NCT01555164|469560652|FG001|Overall Study|Investigator's Discretion|2|||
130436479|NCT01555164|469560651|FG000|Overall Study|Lost to Follow-up|4|||
130682662|NCT00553280|470465964|FG000|Overall Study|Physician Decision|1|||
130682663|NCT01544127|470465965|FG000|Overall Study|Lost to Follow-up|4|||
130682664|NCT01544127|470465966|FG001|Overall Study|Lost to Follow-up|2|||
130682665|NCT01544127|470465967|FG002|Overall Study|Lost to Follow-up|9|||
130682666|NCT01544127|470465965|FG000|Overall Study|Withdrawal by Subject|2|||
130682667|NCT01544127|470465966|FG001|Overall Study|Withdrawal by Subject|2|||
130682668|NCT01544127|470465967|FG002|Overall Study|Withdrawal by Subject|1|||
130682669|NCT01544127|470465965|FG000|Overall Study|Discharged out of catchment area|1|||
130682670|NCT01544127|470465966|FG001|Overall Study|Discharged out of catchment area|1|||
130682671|NCT01544127|470465967|FG002|Overall Study|Discharged out of catchment area|1|||
130682672|NCT01544127|470465965|FG000|Overall Study|Death|1|||
130682673|NCT01544127|470465966|FG001|Overall Study|Death|0|||
130682674|NCT01544127|470465967|FG002|Overall Study|Death|0|||
130682675|NCT01544127|470465965|FG000|Overall Study|Jail or Prison|1|||
130682676|NCT01544127|470465966|FG001|Overall Study|Jail or Prison|1|||
130682677|NCT01544127|470465967|FG002|Overall Study|Jail or Prison|2|||
130682678|NCT01544127|470465965|FG000|Overall Study|Became Psychotic|1|||
130682679|NCT01544127|470465966|FG001|Overall Study|Became Psychotic|0|||
130682680|NCT01544127|470465967|FG002|Overall Study|Became Psychotic|0|||
130682681|NCT01544127|470465965|FG000|Overall Study|Researcher withdrew|1|||
130682682|NCT01544127|470465966|FG001|Overall Study|Researcher withdrew|0|||
130682683|NCT01544127|470465967|FG002|Overall Study|Researcher withdrew|0|||
130682684|NCT01544127|470465965|FG000|Overall Study|Went active duty|0|||
130682685|NCT01544127|470465966|FG001|Overall Study|Went active duty|0|||
130682686|NCT01544127|470465967|FG002|Overall Study|Went active duty|1|||
130682687|NCT02794974|470465968|FG000|Overall Study|Physician Decision|0|||
130682688|NCT02794974|470465969|FG001|Overall Study|Physician Decision|1|||
130682689|NCT00533273|470465970|FG000|Double-blind|Withdrew consent|0|||
130682690|NCT00533273|470465971|FG001|Double-blind|Withdrew consent|2|||
130682691|NCT00533273|470465970|FG000|Open-label|Withdrawal by Subject|6|||
130682692|NCT00533273|470465971|FG001|Open-label|Withdrawal by Subject|0|||
130682693|NCT02202850|470465975|FG000|Overall Study|Other|2|||
130682694|NCT02202850|470465976|FG001|Overall Study|Other|2|||
130682695|NCT02202850|470465975|FG000|Overall Study|Enbrel treatment discontinued|15|||
130682696|NCT02202850|470465976|FG001|Overall Study|Enbrel treatment discontinued|3|||
130682697|NCT02202850|470465975|FG000|Overall Study|Lost to Follow-up|7|||
130682698|NCT02202850|470465976|FG001|Overall Study|Lost to Follow-up|1|||
130682699|NCT01873586|470465977|FG000|Overall Study|Lost to Follow-up|3|||
130682700|NCT00454909|470465978|FG000|Overall Study|Withdrawal by Subject|1|||
130436480|NCT01555164|469560652|FG001|Overall Study|Lost to Follow-up|3|||
130682701|NCT00454909|470465979|FG001|Overall Study|Withdrawal by Subject|0|||
130682702|NCT00454909|470465980|FG002|Overall Study|Withdrawal by Subject|0|||
130682703|NCT00454909|470465978|FG000|Overall Study|Migrated/moved from study area|0|||
130682704|NCT00454909|470465979|FG001|Overall Study|Migrated/moved from study area|0|||
130682705|NCT00454909|470465980|FG002|Overall Study|Migrated/moved from study area|1|||
130217800|NCT04865419|468761402|FG000|Overall Study|Study terminated by Sponsor|0|||
130682706|NCT00454909|470465978|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
130682707|NCT00454909|470465979|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
130436481|NCT01555164|469560651|FG000|Overall Study|Protocol Violation|9|||
130682708|NCT00454909|470465980|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
130682709|NCT00454909|470465978|FG000|Overall Study|Others|1|||
130682710|NCT00454909|470465979|FG001|Overall Study|Others|0|||
130682711|NCT00454909|470465980|FG002|Overall Study|Others|0|||
130682712|NCT02996682|470465981|FG000|Overall Study|Death|0|||
130682713|NCT02996682|470465982|FG001|Overall Study|Death|3|||
130682714|NCT02457520|470465983|FG000|Active Treatment Phase|Adverse Event|10|||
130682715|NCT02457520|470465983|FG000|Active Treatment Phase|Lost to Follow-up|8|||
130682716|NCT02457520|470465983|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
130682717|NCT02457520|470465983|FG000|Active Treatment Phase|other|4|||
130682718|NCT02457520|470465983|FG000|Active Treatment Phase|Physician Decision|1|||
130682719|NCT02457520|470465983|FG000|Active Treatment Phase|Protocol Violation|1|||
130682720|NCT02457520|470465983|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
130682721|NCT02457520|470465983|FG000|Post-treatment Period|Other: Retreatment Required|7|||
130682722|NCT02457520|470465983|FG000|Post-treatment Period|Lost to Follow-up|23|||
130682723|NCT02457520|470465983|FG000|Post-treatment Period|Other|3|||
130682724|NCT02457520|470465983|FG000|Post-treatment Period|Physician Decision|1|||
130682725|NCT02457520|470465983|FG000|Post-treatment Period|Withdrawal by Subject|14|||
130682726|NCT02107092|470465984|FG000|Overall Study|Miscellaneous|3|||
130682727|NCT02107092|470465984|FG000|Overall Study|Subject compliance|3|||
130682728|NCT02107092|470465984|FG000|Overall Study|Hypo-or hyperkalemia|2|||
130682729|NCT02107092|470465984|FG000|Overall Study|Met ECG withdrawal criteria|3|||
130682730|NCT02107092|470465984|FG000|Overall Study|Physician Decision|3|||
130682731|NCT02107092|470465984|FG000|Overall Study|Lost to Follow-up|2|||
130682732|NCT02107092|470465984|FG000|Overall Study|Withdrawal by Subject|9|||
130682733|NCT02107092|470465984|FG000|Overall Study|Adverse Event|7|||
130682734|NCT02107092|470465984|FG000|Overall Study|Expected progression of CKD|12|||
130682735|NCT00282048|470465985|FG000|Overall Study|Lack of Efficacy|30|||
130682736|NCT00282048|470465985|FG000|Overall Study|Adverse Event|22|||
130682737|NCT00282048|470465985|FG000|Overall Study|Withdrawal by Subject|1|||
130682738|NCT00282048|470465985|FG000|Overall Study|Other|8|||
130436482|NCT01555164|469560652|FG001|Overall Study|Protocol Violation|5|||
130682739|NCT00282048|470465985|FG000|Overall Study|Ongoing|1|||
130682740|NCT00624065|470465987|FG000|Overall Study|Adverse Event|5|||
130682741|NCT00624065|470465988|FG001|Overall Study|Adverse Event|6|||
130682742|NCT00624065|470465987|FG000|Overall Study|Lost to Follow-up|4|||
130682743|NCT00624065|470465988|FG001|Overall Study|Lost to Follow-up|1|||
130682744|NCT00624065|470465987|FG000|Overall Study|Consent withdrawn|6|||
130436483|NCT01555164|469560651|FG000|Overall Study|Subject Non-compliance|14|||
130436484|NCT01555164|469560652|FG001|Overall Study|Subject Non-compliance|6|||
130436485|NCT01555164|469560651|FG000|Overall Study|Subject Withdrew Consent|6|||
130436486|NCT01555164|469560652|FG001|Overall Study|Subject Withdrew Consent|11|||
130436487|NCT01709305|469560655|FG000|Phase 1|Clinical Adverse Event|80|||
130436488|NCT01709305|469560656|FG001|Phase 1|Clinical Adverse Event|0|||
130436489|NCT01709305|469560657|FG002|Phase 1|Clinical Adverse Event|0|||
130436490|NCT01709305|469560658|FG003|Phase 1|Clinical Adverse Event|0|||
130436491|NCT01709305|469560659|FG004|Phase 1|Clinical Adverse Event|0|||
130436492|NCT01709305|469560655|FG000|Phase 1|Death|2|||
130436493|NCT01709305|469560656|FG001|Phase 1|Death|0|||
130436494|NCT01709305|469560657|FG002|Phase 1|Death|0|||
130436495|NCT01709305|469560658|FG003|Phase 1|Death|0|||
130436496|NCT01709305|469560659|FG004|Phase 1|Death|0|||
130436497|NCT01709305|469560655|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
130436498|NCT01709305|469560656|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130436499|NCT01709305|469560657|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130436500|NCT01709305|469560658|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130436501|NCT01709305|469560659|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130436502|NCT01709305|469560655|FG000|Phase 1|Laboratory Adverse Event|16|||
130436503|NCT01709305|469560656|FG001|Phase 1|Laboratory Adverse Event|0|||
130436504|NCT01709305|469560657|FG002|Phase 1|Laboratory Adverse Event|0|||
130436505|NCT01709305|469560658|FG003|Phase 1|Laboratory Adverse Event|0|||
130436506|NCT01709305|469560659|FG004|Phase 1|Laboratory Adverse Event|0|||
130436507|NCT01709305|469560655|FG000|Phase 1|Lost to Follow-up|147|||
130436508|NCT01709305|469560656|FG001|Phase 1|Lost to Follow-up|0|||
130436509|NCT01709305|469560657|FG002|Phase 1|Lost to Follow-up|0|||
130436510|NCT01709305|469560658|FG003|Phase 1|Lost to Follow-up|0|||
130436511|NCT01709305|469560659|FG004|Phase 1|Lost to Follow-up|0|||
130436512|NCT01709305|469560655|FG000|Phase 1|Travel, moving, etc.|30|||
130436513|NCT01709305|469560656|FG001|Phase 1|Travel, moving, etc.|0|||
130436514|NCT01709305|469560657|FG002|Phase 1|Travel, moving, etc.|0|||
130436515|NCT01709305|469560658|FG003|Phase 1|Travel, moving, etc.|0|||
130436516|NCT01709305|469560659|FG004|Phase 1|Travel, moving, etc.|0|||
130436517|NCT01709305|469560655|FG000|Phase 1|Physician Decision|13|||
130436518|NCT01709305|469560656|FG001|Phase 1|Physician Decision|0|||
130436519|NCT01709305|469560657|FG002|Phase 1|Physician Decision|0|||
130436520|NCT01709305|469560658|FG003|Phase 1|Physician Decision|0|||
130436521|NCT01709305|469560659|FG004|Phase 1|Physician Decision|0|||
130436522|NCT01709305|469560655|FG000|Phase 1|Protocol Violation|118|||
130436523|NCT01709305|469560656|FG001|Phase 1|Protocol Violation|0|||
130436524|NCT01709305|469560657|FG002|Phase 1|Protocol Violation|0|||
130436525|NCT01709305|469560658|FG003|Phase 1|Protocol Violation|0|||
130436526|NCT01709305|469560659|FG004|Phase 1|Protocol Violation|0|||
130436527|NCT01709305|469560655|FG000|Phase 1|Withdrawal by Subject|218|||
130436528|NCT01709305|469560656|FG001|Phase 1|Withdrawal by Subject|0|||
130436529|NCT01709305|469560657|FG002|Phase 1|Withdrawal by Subject|0|||
130436530|NCT01709305|469560658|FG003|Phase 1|Withdrawal by Subject|0|||
130436531|NCT01709305|469560659|FG004|Phase 1|Withdrawal by Subject|0|||
130436532|NCT01709305|469560655|FG000|Phase 2|Clinical Adverse Event|0|||
130436533|NCT01709305|469560656|FG001|Phase 2|Clinical Adverse Event|10|||
130436534|NCT01709305|469560657|FG002|Phase 2|Clinical Adverse Event|10|||
130436535|NCT01709305|469560658|FG003|Phase 2|Clinical Adverse Event|6|||
130436536|NCT01709305|469560659|FG004|Phase 2|Clinical Adverse Event|11|||
130436537|NCT01709305|469560655|FG000|Phase 2|Death|0|||
130682745|NCT00624065|470465988|FG001|Overall Study|Consent withdrawn|5|||
130682746|NCT00624065|470465987|FG000|Overall Study|Lack of Efficacy|0|||
130436538|NCT01709305|469560656|FG001|Phase 2|Death|0|||
130436539|NCT01709305|469560657|FG002|Phase 2|Death|1|||
130436540|NCT01709305|469560658|FG003|Phase 2|Death|0|||
130436541|NCT01709305|469560659|FG004|Phase 2|Death|0|||
130436542|NCT01709305|469560655|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130436543|NCT01709305|469560656|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130436544|NCT01709305|469560657|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130436545|NCT01709305|469560658|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130436546|NCT01709305|469560659|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
130436547|NCT01709305|469560655|FG000|Phase 2|Laboratory Adverse Event|0|||
130436548|NCT01709305|469560656|FG001|Phase 2|Laboratory Adverse Event|1|||
130436549|NCT01709305|469560657|FG002|Phase 2|Laboratory Adverse Event|0|||
130436550|NCT01709305|469560658|FG003|Phase 2|Laboratory Adverse Event|1|||
130552789|NCT00792805|469991536|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130682747|NCT00624065|470465988|FG001|Overall Study|Lack of Efficacy|3|||
130436551|NCT01709305|469560659|FG004|Phase 2|Laboratory Adverse Event|1|||
130436552|NCT01709305|469560655|FG000|Phase 2|Lost to Follow-up|0|||
130436553|NCT01709305|469560656|FG001|Phase 2|Lost to Follow-up|10|||
130436554|NCT01709305|469560657|FG002|Phase 2|Lost to Follow-up|6|||
130436555|NCT01709305|469560658|FG003|Phase 2|Lost to Follow-up|9|||
130436556|NCT01709305|469560659|FG004|Phase 2|Lost to Follow-up|5|||
130436557|NCT01709305|469560655|FG000|Phase 2|Travel, moving, etc.|0|||
130436558|NCT01709305|469560656|FG001|Phase 2|Travel, moving, etc.|2|||
130436559|NCT01709305|469560657|FG002|Phase 2|Travel, moving, etc.|3|||
130436560|NCT01709305|469560658|FG003|Phase 2|Travel, moving, etc.|3|||
130436561|NCT01709305|469560659|FG004|Phase 2|Travel, moving, etc.|5|||
130436562|NCT01709305|469560655|FG000|Phase 2|Physician Decision|0|||
130436563|NCT01709305|469560656|FG001|Phase 2|Physician Decision|2|||
130436564|NCT01709305|469560657|FG002|Phase 2|Physician Decision|0|||
130436565|NCT01709305|469560658|FG003|Phase 2|Physician Decision|1|||
130436566|NCT01709305|469560659|FG004|Phase 2|Physician Decision|2|||
130436567|NCT01709305|469560655|FG000|Phase 2|Protocol Violation|0|||
130436568|NCT01709305|469560656|FG001|Phase 2|Protocol Violation|19|||
130436569|NCT01709305|469560657|FG002|Phase 2|Protocol Violation|19|||
130436570|NCT01709305|469560658|FG003|Phase 2|Protocol Violation|13|||
130436571|NCT01709305|469560659|FG004|Phase 2|Protocol Violation|9|||
130436572|NCT01709305|469560655|FG000|Phase 2|Withdrawal by Subject|0|||
130436573|NCT01709305|469560656|FG001|Phase 2|Withdrawal by Subject|8|||
130436574|NCT01709305|469560657|FG002|Phase 2|Withdrawal by Subject|6|||
130436575|NCT01709305|469560658|FG003|Phase 2|Withdrawal by Subject|15|||
130436576|NCT01709305|469560659|FG004|Phase 2|Withdrawal by Subject|12|||
130436577|NCT00171873|469560664|FG000|Overall Study|Withdrawal by Subject|4|||
130436578|NCT00171873|469560665|FG001|Overall Study|Withdrawal by Subject|2|||
130436579|NCT00171873|469560664|FG000|Overall Study|Adverse Event|5|||
130436580|NCT00171873|469560665|FG001|Overall Study|Adverse Event|0|||
130436581|NCT00171873|469560664|FG000|Overall Study|Switched to Octreotide|0|||
130436582|NCT00171873|469560665|FG001|Overall Study|Switched to Octreotide|1|||
130436583|NCT00539279|469560667|FG000|Treatment|Withdrawal by Subject|10|||
130436584|NCT00539279|469560668|FG001|Treatment|Withdrawal by Subject|8|||
130436585|NCT00539279|469560667|FG000|Treatment|Death|1|||
130436586|NCT00539279|469560668|FG001|Treatment|Death|0|||
130436587|NCT00539279|469560667|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
130436588|NCT00539279|469560668|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
130436589|NCT00539279|469560667|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
130436590|NCT00539279|469560668|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
130436591|NCT01338012|469560671|FG000|Overall Study|Death|4|||
130436592|NCT01338012|469560671|FG000|Overall Study|Study terminated|4|||
130436593|NCT02714205|469560672|FG000|Overall Study|Cannot tolerate medication|1|||
130436594|NCT02714205|469560673|FG001|Overall Study|Cannot tolerate medication|0|||
130436595|NCT02714205|469560672|FG000|Overall Study|Adverse Event|2|||
130436596|NCT02714205|469560673|FG001|Overall Study|Adverse Event|0|||
130436597|NCT02714205|469560672|FG000|Overall Study|Too busy|1|||
130436598|NCT02714205|469560673|FG001|Overall Study|Too busy|0|||
130436599|NCT02714205|469560672|FG000|Overall Study|Incomplete outcome data|0|||
130436600|NCT02714205|469560673|FG001|Overall Study|Incomplete outcome data|1|||
130436601|NCT01382940|469562374|FG000|Overall Study|Adverse Event|19|||
130436602|NCT01382940|469562374|FG000|Overall Study|Lost to Follow-up|4|||
130436603|NCT01382940|469562374|FG000|Overall Study|Physician Decision|7|||
130436604|NCT01382940|469562374|FG000|Overall Study|Withdrawal by Subject|23|||
130436605|NCT01382940|469562374|FG000|Overall Study|Protocol Violation|20|||
130436606|NCT00976482|469562377|FG000|Overall Study|Death|208|||
130436607|NCT00976482|469562377|FG000|Overall Study|Withdrawal by Subject|45|||
130436608|NCT00976482|469562377|FG000|Overall Study|Center terminated|1|||
130436609|NCT00976482|469562377|FG000|Overall Study|Protocol Violation|5|||
130436610|NCT00720902|469562380|FG000|Overall Study|Withdrawal by Subject|1|||
130436611|NCT00720902|469562381|FG001|Overall Study|Withdrawal by Subject|0|||
130436612|NCT00720902|469562380|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
130436613|NCT00720902|469562381|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
130436614|NCT01486758|469562382|FG000|Overall Study|Lost to Follow-up|0|||
130436615|NCT01486758|469562383|FG001|Overall Study|Lost to Follow-up|1|||
130436616|NCT02914184|469562392|FG000|Overall Study|Lost to Follow-up|7|||
130436617|NCT02914184|469562393|FG001|Overall Study|Lost to Follow-up|10|||
130436618|NCT02914184|469562394|FG002|Overall Study|Lost to Follow-up|8|||
130436619|NCT02914184|469562395|FG003|Overall Study|Lost to Follow-up|7|||
130436620|NCT02914184|469562392|FG000|Overall Study|Withdrawal by Subject|4|||
130436621|NCT02914184|469562393|FG001|Overall Study|Withdrawal by Subject|2|||
130436622|NCT02914184|469562394|FG002|Overall Study|Withdrawal by Subject|7|||
130436623|NCT02914184|469562395|FG003|Overall Study|Withdrawal by Subject|3|||
130436624|NCT02914184|469562392|FG000|Overall Study|Other|1|||
130436625|NCT02914184|469562393|FG001|Overall Study|Other|0|||
130436626|NCT02914184|469562394|FG002|Overall Study|Other|0|||
130436627|NCT02914184|469562395|FG003|Overall Study|Other|0|||
130436628|NCT02914184|469562392|FG000|Overall Study|Migrated/moved from the study area|2|||
130436629|NCT02914184|469562393|FG001|Overall Study|Migrated/moved from the study area|1|||
130682748|NCT00624065|470465987|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
130682749|NCT00624065|470465988|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
130682750|NCT00696020|470465989|FG000|Overall Study|Adverse Event|3|||
130682751|NCT00696020|470465990|FG001|Overall Study|Adverse Event|1|||
130682752|NCT00696020|470465991|FG002|Overall Study|Adverse Event|2|||
130436630|NCT02914184|469562394|FG002|Overall Study|Migrated/moved from the study area|2|||
130436631|NCT02914184|469562395|FG003|Overall Study|Migrated/moved from the study area|1|||
130436632|NCT00798174|469562396|FG000|Overall Study|inability to implant azygos coil|3|||
130436633|NCT00798174|469562397|FG001|Overall Study|inability to implant azygos coil|3|||
130436634|NCT00798174|469562396|FG000|Overall Study|Inability to sedate for DFT testing|1|||
130436635|NCT00798174|469562397|FG001|Overall Study|Inability to sedate for DFT testing|0|||
130436636|NCT01478113|469562401|FG000|Overall Study|Withdrawal by Subject|0|||
130436637|NCT01478113|469562402|FG001|Overall Study|Withdrawal by Subject|1|||
130436638|NCT01478113|469562401|FG000|Overall Study|Physician Decision|1|||
130436639|NCT01478113|469562402|FG001|Overall Study|Physician Decision|0|||
130436640|NCT03093428|469562410|FG000|Overall Study|Not eligible for treatment|2|||
130436641|NCT03093428|469562411|FG001|Overall Study|Not eligible for treatment|1|||
130436642|NCT03093428|469562410|FG000|Overall Study|Progression|14|||
130436643|NCT03093428|469562411|FG001|Overall Study|Progression|4|||
130436644|NCT03093428|469562410|FG000|Overall Study|Death|1|||
130436645|NCT03093428|469562411|FG001|Overall Study|Death|0|||
130436646|NCT03093428|469562410|FG000|Overall Study|Adverse Event|1|||
130436647|NCT03093428|469562411|FG001|Overall Study|Adverse Event|0|||
130436648|NCT03093428|469562410|FG000|Overall Study|Withdrawal by Subject|1|||
130436649|NCT03093428|469562411|FG001|Overall Study|Withdrawal by Subject|1|||
130436650|NCT00041756|469562412|FG000|Overall Study|Adverse Event|4|||
130436651|NCT00041756|469562413|FG001|Overall Study|Adverse Event|10|||
130436652|NCT00041756|469562414|FG002|Overall Study|Adverse Event|6|||
130436653|NCT00041756|469562415|FG003|Overall Study|Adverse Event|11|||
130436654|NCT00041756|469562416|FG004|Overall Study|Adverse Event|34|||
130436655|NCT00041756|469562412|FG000|Overall Study|Protocol Violation|1|||
130436656|NCT00041756|469562413|FG001|Overall Study|Protocol Violation|1|||
130436657|NCT00041756|469562414|FG002|Overall Study|Protocol Violation|2|||
130436658|NCT00041756|469562415|FG003|Overall Study|Protocol Violation|2|||
130436659|NCT00041756|469562416|FG004|Overall Study|Protocol Violation|1|||
130436660|NCT00041756|469562412|FG000|Overall Study|Withdrawal by Subject|3|||
130436661|NCT00041756|469562413|FG001|Overall Study|Withdrawal by Subject|3|||
130436662|NCT00041756|469562414|FG002|Overall Study|Withdrawal by Subject|4|||
130436663|NCT00041756|469562415|FG003|Overall Study|Withdrawal by Subject|2|||
130436664|NCT00041756|469562416|FG004|Overall Study|Withdrawal by Subject|3|||
130436665|NCT00041756|469562412|FG000|Overall Study|Lost to Follow-up|0|||
130436666|NCT00041756|469562413|FG001|Overall Study|Lost to Follow-up|1|||
130436667|NCT00041756|469562414|FG002|Overall Study|Lost to Follow-up|0|||
130436668|NCT00041756|469562415|FG003|Overall Study|Lost to Follow-up|1|||
130436669|NCT00041756|469562416|FG004|Overall Study|Lost to Follow-up|0|||
130436670|NCT00041756|469562412|FG000|Overall Study|Unable to meet protocol criteria|0|||
130436671|NCT00041756|469562413|FG001|Overall Study|Unable to meet protocol criteria|0|||
130436672|NCT00041756|469562414|FG002|Overall Study|Unable to meet protocol criteria|1|||
130436673|NCT00041756|469562415|FG003|Overall Study|Unable to meet protocol criteria|0|||
130436674|NCT00041756|469562416|FG004|Overall Study|Unable to meet protocol criteria|1|||
130436675|NCT00041756|469562412|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
130436676|NCT00041756|469562413|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
130436677|NCT00041756|469562414|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
130436678|NCT00041756|469562415|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
130436679|NCT00041756|469562416|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
130436680|NCT03980184|469562417|FG000|Overall Study|Dropped out before treatment|2|||
130436681|NCT03980184|469562418|FG001|Overall Study|Dropped out before treatment|2|||
130436682|NCT03980184|469562417|FG000|Overall Study|Lost to Follow-up|11|||
130436683|NCT03980184|469562418|FG001|Overall Study|Lost to Follow-up|13|||
130436684|NCT00603265|469562419|FG000|Overall Study|Adverse Event|2|||
130436685|NCT00603265|469562420|FG001|Overall Study|Adverse Event|11|||
130436686|NCT00603265|469562421|FG002|Overall Study|Adverse Event|1|||
130436687|NCT00603265|469562419|FG000|Overall Study|Withdrawal by Subject|1|||
130436688|NCT00603265|469562420|FG001|Overall Study|Withdrawal by Subject|2|||
130436689|NCT00603265|469562421|FG002|Overall Study|Withdrawal by Subject|1|||
130436690|NCT00603265|469562419|FG000|Overall Study|Lack of Efficacy|3|||
130436691|NCT00603265|469562420|FG001|Overall Study|Lack of Efficacy|0|||
130436692|NCT00603265|469562421|FG002|Overall Study|Lack of Efficacy|3|||
130436693|NCT00603265|469562419|FG000|Overall Study|Lost to Follow-up|0|||
130436694|NCT00603265|469562420|FG001|Overall Study|Lost to Follow-up|1|||
130436695|NCT00603265|469562421|FG002|Overall Study|Lost to Follow-up|0|||
130436696|NCT00603265|469562419|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
130436697|NCT00603265|469562420|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
130436698|NCT00603265|469562421|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
130436699|NCT00603265|469562419|FG000|Overall Study|Participant Left Country, No Responses|0|||
130436700|NCT00603265|469562420|FG001|Overall Study|Participant Left Country, No Responses|1|||
130436701|NCT00603265|469562421|FG002|Overall Study|Participant Left Country, No Responses|0|||
130436702|NCT00603265|469562419|FG000|Overall Study|Protocol Violation|1|||
130436703|NCT00603265|469562420|FG001|Overall Study|Protocol Violation|0|||
130436704|NCT00603265|469562421|FG002|Overall Study|Protocol Violation|0|||
130436705|NCT02002884|469562422|FG000|Main Period (MP)|Other|0|||
130436706|NCT02002884|469562423|FG001|Main Period (MP)|Other|3|||
130436707|NCT02002884|469562424|FG002|Main Period (MP)|Other|3|||
130436708|NCT02002884|469562425|FG003|Main Period (MP)|Other|0|||
130436709|NCT02002884|469562422|FG000|Main Period (MP)|Adverse Event|0|||
130436710|NCT02002884|469562423|FG001|Main Period (MP)|Adverse Event|1|||
130436711|NCT02002884|469562424|FG002|Main Period (MP)|Adverse Event|1|||
130436712|NCT02002884|469562425|FG003|Main Period (MP)|Adverse Event|0|||
130436713|NCT02002884|469562422|FG000|Main Period (MP)|Withdrawal by Subject|6|||
130436714|NCT02002884|469562423|FG001|Main Period (MP)|Withdrawal by Subject|2|||
130436715|NCT02002884|469562424|FG002|Main Period (MP)|Withdrawal by Subject|2|||
130436716|NCT02002884|469562425|FG003|Main Period (MP)|Withdrawal by Subject|0|||
130682753|NCT00696020|470465992|FG003|Overall Study|Adverse Event|1|||
130682754|NCT00696020|470465989|FG000|Overall Study|Lack of Efficacy|1|||
130682755|NCT00696020|470465990|FG001|Overall Study|Lack of Efficacy|0|||
130682756|NCT00696020|470465991|FG002|Overall Study|Lack of Efficacy|0|||
130682757|NCT00696020|470465992|FG003|Overall Study|Lack of Efficacy|0|||
130682758|NCT00696020|470465989|FG000|Overall Study|Protocol Violation|0|||
130682759|NCT00696020|470465990|FG001|Overall Study|Protocol Violation|0|||
130682760|NCT00696020|470465991|FG002|Overall Study|Protocol Violation|0|||
130682761|NCT00696020|470465992|FG003|Overall Study|Protocol Violation|1|||
130682762|NCT00696020|470465989|FG000|Overall Study|Withdrawal by Subject|0|||
130682763|NCT00696020|470465990|FG001|Overall Study|Withdrawal by Subject|1|||
130682764|NCT00696020|470465991|FG002|Overall Study|Withdrawal by Subject|0|||
130682765|NCT00696020|470465992|FG003|Overall Study|Withdrawal by Subject|1|||
130682766|NCT00696020|470465989|FG000|Overall Study|Other not stated above|0|||
130682767|NCT00696020|470465990|FG001|Overall Study|Other not stated above|0|||
130682768|NCT00696020|470465991|FG002|Overall Study|Other not stated above|1|||
130682769|NCT00696020|470465992|FG003|Overall Study|Other not stated above|1|||
130682770|NCT01387022|470465993|FG000|Overall Study|Death|1|||
130682771|NCT01387022|470465994|FG001|Overall Study|Death|1|||
130682772|NCT01387022|470465993|FG000|Overall Study|Lost to Follow-up|0|||
130682773|NCT01387022|470465994|FG001|Overall Study|Lost to Follow-up|3|||
130682774|NCT02076022|470465995|FG000|Overall Study|Withdrawal by Subject|2|||
130682775|NCT02076022|470465996|FG001|Overall Study|Withdrawal by Subject|0|||
130682776|NCT00312663|470465997|FG000|Immunization Phase|Adverse Event|0|||
130436717|NCT02002884|469562422|FG000|Main Period (MP)|Lost to Follow-up|0|||
130436718|NCT02002884|469562423|FG001|Main Period (MP)|Lost to Follow-up|0|||
130436719|NCT02002884|469562424|FG002|Main Period (MP)|Lost to Follow-up|2|||
130436720|NCT02002884|469562425|FG003|Main Period (MP)|Lost to Follow-up|0|||
130436721|NCT02002884|469562422|FG000|Open-Label Extension Period (OLEX)|Other|0|||
130436722|NCT02002884|469562423|FG001|Open-Label Extension Period (OLEX)|Other|0|||
130436723|NCT02002884|469562424|FG002|Open-Label Extension Period (OLEX)|Other|0|||
130436724|NCT02002884|469562425|FG003|Open-Label Extension Period (OLEX)|Other|24|||
130436725|NCT02002884|469562422|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130436726|NCT02002884|469562423|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130436727|NCT02002884|469562424|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130436728|NCT02002884|469562425|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
130436729|NCT02002884|469562422|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130436730|NCT02002884|469562423|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130436731|NCT02002884|469562424|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130436732|NCT02002884|469562425|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
130436733|NCT02002884|469562422|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130436734|NCT02002884|469562423|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130436735|NCT02002884|469562424|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130436736|NCT02002884|469562425|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
130436737|NCT02002884|469562422|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130436738|NCT02002884|469562423|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130436739|NCT02002884|469562424|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130436740|NCT02002884|469562425|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
130436741|NCT02966002|469562426|FG000|Overall Study|Withdrawal by Subject|2|||
130436742|NCT02966002|469562426|FG000|Overall Study|Adverse Event|1|||
130436743|NCT02966002|469562426|FG000|Overall Study|Lost to Follow-up|1|||
130436744|NCT01642602|469562427|FG000|Overall Study|Adverse Event|2|||
130436745|NCT03377790|469562428|FG000|Overall Study|Withdrawal by Subject|1|||
130436746|NCT03377790|469562429|FG001|Overall Study|Withdrawal by Subject|0|||
130682777|NCT00312663|470465998|FG001|Immunization Phase|Adverse Event|1|||
130682778|NCT00312663|470465999|FG002|Immunization Phase|Adverse Event|0|||
130682779|NCT00301366|470466000|FG000|Overall Study|Adverse Event|1|||
130682780|NCT02511782|470466003|FG000|Overall Study|Withdrawal by Subject|1|||
130682781|NCT02511782|470466004|FG001|Overall Study|Withdrawal by Subject|0|||
130682782|NCT02511782|470466005|FG002|Overall Study|Withdrawal by Subject|0|||
130682783|NCT00450190|470466006|FG000|Overall Study|Withdrawal by Subject|2|||
130436747|NCT03377790|469562428|FG000|Overall Study|Adverse Event|1|||
130436748|NCT03377790|469562429|FG001|Overall Study|Adverse Event|0|||
130682784|NCT01536574|470466007|FG000|Overall Study|Adverse Event|4|||
130682785|NCT01536574|470466008|FG001|Overall Study|Adverse Event|5|||
130436749|NCT03377790|469562428|FG000|Overall Study|Lost to Follow-up|0|||
130436750|NCT03377790|469562429|FG001|Overall Study|Lost to Follow-up|2|||
130436751|NCT03377790|469562428|FG000|Overall Study|Randomized but not treated|1|||
130436752|NCT03377790|469562429|FG001|Overall Study|Randomized but not treated|0|||
130436753|NCT03377790|469562428|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
130436754|NCT03377790|469562429|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
130436755|NCT03101241|469562434|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
130436756|NCT03101241|469562435|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
130436757|NCT03101241|469562434|FG000|Overall Study|Participant withdrew consent|3|||
130436758|NCT03101241|469562435|FG001|Overall Study|Participant withdrew consent|1|||
130436759|NCT03101241|469562434|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
130436760|NCT03101241|469562435|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
130436761|NCT03101241|469562434|FG000|Overall Study|Lost to Follow-up|2|||
130436762|NCT03101241|469562435|FG001|Overall Study|Lost to Follow-up|0|||
130436763|NCT03101241|469562434|FG000|Overall Study|Lack of Efficacy|0|||
130436764|NCT03101241|469562435|FG001|Overall Study|Lack of Efficacy|1|||
130436765|NCT03101241|469562434|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
130436766|NCT03101241|469562435|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
130436767|NCT04498247|469562436|FG000|Overall Study|Lost to Follow-up|0|||
130436768|NCT04498247|469562437|FG001|Overall Study|Lost to Follow-up|0|||
130436769|NCT04498247|469562438|FG002|Overall Study|Lost to Follow-up|0|||
130436770|NCT04498247|469562439|FG003|Overall Study|Lost to Follow-up|1|||
130436771|NCT04498247|469562440|FG004|Overall Study|Lost to Follow-up|0|||
130436772|NCT04498247|469562441|FG005|Overall Study|Lost to Follow-up|0|||
130436773|NCT04498247|469562442|FG006|Overall Study|Lost to Follow-up|0|||
130436774|NCT04498247|469562443|FG007|Overall Study|Lost to Follow-up|0|||
130436775|NCT04498247|469562436|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
130436776|NCT04498247|469562437|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436777|NCT04498247|469562438|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436778|NCT04498247|469562439|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436779|NCT04498247|469562440|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436780|NCT04498247|469562441|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436781|NCT04498247|469562442|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436782|NCT04498247|469562443|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
130436783|NCT04498247|469562436|FG000|Overall Study|Withdrawal by Subject|0|||
130436784|NCT04498247|469562437|FG001|Overall Study|Withdrawal by Subject|8|||
130436785|NCT04498247|469562438|FG002|Overall Study|Withdrawal by Subject|0|||
130436786|NCT04498247|469562439|FG003|Overall Study|Withdrawal by Subject|7|||
130436787|NCT04498247|469562440|FG004|Overall Study|Withdrawal by Subject|0|||
130436788|NCT04498247|469562441|FG005|Overall Study|Withdrawal by Subject|0|||
130436789|NCT04498247|469562442|FG006|Overall Study|Withdrawal by Subject|1|||
130436790|NCT04498247|469562443|FG007|Overall Study|Withdrawal by Subject|0|||
130436791|NCT04498247|469562436|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130436792|NCT04498247|469562437|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
130436793|NCT04498247|469562438|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130436794|NCT04498247|469562439|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
130436795|NCT04498247|469562440|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130436796|NCT04498247|469562441|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130436797|NCT04498247|469562442|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
130436798|NCT04498247|469562443|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130436799|NCT03469349|469562444|FG000|Overall Study|Withdrawal by Subject|1|||
130436800|NCT03469349|469562445|FG001|Overall Study|Withdrawal by Subject|3|||
130436801|NCT03469349|469562444|FG000|Overall Study|Progressive Disease|0|||
130436802|NCT03469349|469562445|FG001|Overall Study|Progressive Disease|1|||
130436803|NCT03469349|469562444|FG000|Overall Study|Lost to Follow-up|2|||
130436804|NCT03469349|469562445|FG001|Overall Study|Lost to Follow-up|2|||
130436805|NCT03469349|469562444|FG000|Overall Study|Adverse Event|2|||
130436806|NCT03469349|469562445|FG001|Overall Study|Adverse Event|4|||
130436807|NCT01381874|469562447|FG000|Overall Study|Lost to Follow-up|1|||
130436808|NCT01381874|469562448|FG001|Overall Study|Lost to Follow-up|1|||
130436809|NCT01381874|469562449|FG002|Overall Study|Lost to Follow-up|0|||
130682786|NCT01536574|470466007|FG000|Overall Study|Withdrawal by Subject|1|||
130682787|NCT01536574|470466008|FG001|Overall Study|Withdrawal by Subject|2|||
130682788|NCT01536574|470466007|FG000|Overall Study|Lack of Efficacy|1|||
130682789|NCT01536574|470466008|FG001|Overall Study|Lack of Efficacy|0|||
130682790|NCT01376167|470466009|FG000|Overall Study|Lost to Follow-up|2|||
130682791|NCT01376167|470466010|FG001|Overall Study|Lost to Follow-up|4|||
130682792|NCT01376167|470466011|FG002|Overall Study|Lost to Follow-up|2|||
130682793|NCT01376167|470466009|FG000|Overall Study|Physician Decision|1|||
130436810|NCT01381874|469562447|FG000|Overall Study|Withdrawal by Subject|9|||
130436811|NCT01381874|469562448|FG001|Overall Study|Withdrawal by Subject|10|||
130436812|NCT01381874|469562449|FG002|Overall Study|Withdrawal by Subject|9|||
130682794|NCT01376167|470466010|FG001|Overall Study|Physician Decision|1|||
130682795|NCT01376167|470466011|FG002|Overall Study|Physician Decision|0|||
130682796|NCT01376167|470466009|FG000|Overall Study|Withdrawal by Subject|1|||
130682797|NCT01376167|470466010|FG001|Overall Study|Withdrawal by Subject|5|||
130682798|NCT01376167|470466011|FG002|Overall Study|Withdrawal by Subject|4|||
130682799|NCT03361228|470466014|FG000|Overall Study|Other|1|||
130682800|NCT03361228|470466015|FG001|Overall Study|Other|1|||
130682801|NCT03361228|470466014|FG000|Overall Study|Death|3|||
130682802|NCT03361228|470466015|FG001|Overall Study|Death|0|||
130682803|NCT02193178|470466021|FG000|Overall Study|Lost to Follow-up|1|||
130682804|NCT02193178|470466021|FG000|Overall Study|Dry eyes|1|||
130682805|NCT04320849|470466024|FG000|Overall Study|Withdrawal by Subject|4|||
130682806|NCT04320849|470466024|FG000|Overall Study|Imaging data unavailable|2|||
130348157|NCT03370276|469246829|FG000|Overall Study|Death|0|||
130348158|NCT03370276|469246830|FG001|Overall Study|Death|2|||
130348159|NCT03370276|469246831|FG002|Overall Study|Death|5|||
130217801|NCT04865419|468761403|FG001|Overall Study|Study terminated by Sponsor|0|||
130682807|NCT04320849|470466024|FG000|Overall Study|Incomplete imaging|2|||
130682808|NCT00214422|470466025|FG000|Overall Study|Physician Decision|2|||
130682809|NCT00214422|470466026|FG001|Overall Study|Physician Decision|0|||
130436813|NCT01381874|469562447|FG000|Overall Study|Other|67|||
130436814|NCT01381874|469562448|FG001|Overall Study|Other|52|||
130436815|NCT01381874|469562449|FG002|Overall Study|Other|67|||
130436816|NCT01737996|469562453|FG000|Overall Study|Adverse Event|0|||
130436817|NCT01737996|469562454|FG001|Overall Study|Adverse Event|1|||
130436818|NCT01737996|469562455|FG002|Overall Study|Adverse Event|1|||
130436819|NCT01737996|469562453|FG000|Overall Study|Withdrawal by Subject|0|||
130436820|NCT01737996|469562454|FG001|Overall Study|Withdrawal by Subject|0|||
130436821|NCT01737996|469562455|FG002|Overall Study|Withdrawal by Subject|1|||
130436822|NCT00452413|469562456|FG000|Overall Study|Progressive Disease|4|||
130436823|NCT00452413|469562457|FG001|Overall Study|Progressive Disease|11|||
130436824|NCT00452413|469562458|FG002|Overall Study|Progressive Disease|30|||
130436825|NCT00452413|469562456|FG000|Overall Study|Withdrawal by Subject|0|||
130436826|NCT00452413|469562457|FG001|Overall Study|Withdrawal by Subject|1|||
130436827|NCT00452413|469562458|FG002|Overall Study|Withdrawal by Subject|4|||
130436828|NCT00452413|469562456|FG000|Overall Study|Adverse Event|0|||
130436829|NCT00452413|469562457|FG001|Overall Study|Adverse Event|0|||
130436830|NCT00452413|469562458|FG002|Overall Study|Adverse Event|5|||
130436831|NCT00452413|469562456|FG000|Overall Study|Physician Decision|0|||
130436832|NCT00452413|469562457|FG001|Overall Study|Physician Decision|0|||
130436833|NCT00452413|469562458|FG002|Overall Study|Physician Decision|4|||
130436834|NCT00452413|469562456|FG000|Overall Study|Death due to study disease|0|||
130436835|NCT00452413|469562457|FG001|Overall Study|Death due to study disease|0|||
130436836|NCT00452413|469562458|FG002|Overall Study|Death due to study disease|2|||
130436837|NCT00452413|469562456|FG000|Overall Study|Death due to adverse event (AE)|0|||
130436838|NCT00452413|469562457|FG001|Overall Study|Death due to adverse event (AE)|0|||
130436839|NCT00452413|469562458|FG002|Overall Study|Death due to adverse event (AE)|1|||
130436840|NCT00452413|469562456|FG000|Overall Study|On treatment|0|||
130436841|NCT00452413|469562457|FG001|Overall Study|On treatment|0|||
130436842|NCT00452413|469562458|FG002|Overall Study|On treatment|3|||
130436843|NCT01027364|469562459|FG000|Overall Study|Adverse Event|1|||
130436844|NCT01027364|469562460|FG001|Overall Study|Adverse Event|0|||
130436845|NCT01027364|469562461|FG002|Overall Study|Adverse Event|1|||
130436846|NCT01027364|469562462|FG003|Overall Study|Adverse Event|0|||
130436847|NCT01027364|469562459|FG000|Overall Study|Lost to Follow-up|1|||
130682810|NCT00214422|470466027|FG002|Overall Study|Physician Decision|0|||
130682811|NCT00214422|470466025|FG000|Overall Study|Developed esophageal ca|1|||
130682812|NCT00214422|470466026|FG001|Overall Study|Developed esophageal ca|0|||
130682813|NCT00214422|470466027|FG002|Overall Study|Developed esophageal ca|0|||
130682814|NCT00214422|470466025|FG000|Overall Study|Pt taken off study|1|||
130682815|NCT00214422|470466026|FG001|Overall Study|Pt taken off study|1|||
130682816|NCT00214422|470466027|FG002|Overall Study|Pt taken off study|0|||
130682817|NCT00214422|470466025|FG000|Overall Study|Disease progression on study|1|||
130682818|NCT00214422|470466026|FG001|Overall Study|Disease progression on study|0|||
130682819|NCT00214422|470466027|FG002|Overall Study|Disease progression on study|0|||
130682820|NCT00214422|470466025|FG000|Overall Study|Unable to make a radiation treatment|0|||
130682821|NCT00214422|470466026|FG001|Overall Study|Unable to make a radiation treatment|0|||
130682822|NCT00214422|470466027|FG002|Overall Study|Unable to make a radiation treatment|1|||
130682823|NCT03929393|470466028|FG000|Overall Study|Death|1|||
130682824|NCT03929393|470466029|FG001|Overall Study|Death|0|||
130682825|NCT03929393|470466028|FG000|Overall Study|Time Commitment|2|||
130682826|NCT03929393|470466029|FG001|Overall Study|Time Commitment|5|||
130682827|NCT03929393|470466028|FG000|Overall Study|Motor Vehicle Accident|0|||
130682828|NCT03929393|470466029|FG001|Overall Study|Motor Vehicle Accident|1|||
130682829|NCT03929393|470466028|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
130682830|NCT03929393|470466029|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
130682831|NCT03929393|470466028|FG000|Overall Study|Other|1|||
130682832|NCT03929393|470466029|FG001|Overall Study|Other|3|||
130682833|NCT00705536|470468060|FG000|Start Period 1|Withdrawal by Subject|0|||
130682834|NCT00705536|470468061|FG001|Start Period 1|Withdrawal by Subject|0|||
130682835|NCT00705536|470468062|FG002|Start Period 1|Withdrawal by Subject|0|||
130682836|NCT00705536|470468063|FG003|Start Period 1|Withdrawal by Subject|1|||
130682837|NCT04188106|470468064|FG000|Overall Study|Lost to Follow-up|5|||
130682838|NCT04188106|470468064|FG000|Overall Study|Non-Compliance|1|||
130682839|NCT02289963|470468065|FG000|Overall Study|Adverse Event|1|||
130682840|NCT02289963|470468066|FG001|Overall Study|Adverse Event|2|||
130436848|NCT01027364|469562460|FG001|Overall Study|Lost to Follow-up|0|||
130436849|NCT01027364|469562461|FG002|Overall Study|Lost to Follow-up|0|||
130436850|NCT01027364|469562462|FG003|Overall Study|Lost to Follow-up|0|||
130682841|NCT02289963|470468065|FG000|Overall Study|Poor compliance to protocol|1|||
130682842|NCT02289963|470468066|FG001|Overall Study|Poor compliance to protocol|0|||
130682843|NCT02289963|470468065|FG000|Overall Study|Withdrawal by Subject|1|||
130682844|NCT02289963|470468066|FG001|Overall Study|Withdrawal by Subject|0|||
130682845|NCT02289963|470468065|FG000|Overall Study|Last injection missed|2|||
130436851|NCT01027364|469562459|FG000|Overall Study|Protocol Violation|1|||
130436852|NCT01027364|469562460|FG001|Overall Study|Protocol Violation|0|||
130682846|NCT02289963|470468066|FG001|Overall Study|Last injection missed|2|||
130720846|NCT04126213|470601549|FG004|Overall Study|Lost to Follow-up|4|||
130682847|NCT02289963|470468065|FG000|Overall Study|End treatment visit outside visit window|0|||
130682848|NCT02289963|470468066|FG001|Overall Study|End treatment visit outside visit window|4|||
130682849|NCT02289963|470468065|FG000|Overall Study|Other than specified above|0|||
130682850|NCT02289963|470468066|FG001|Overall Study|Other than specified above|2|||
130682851|NCT00549718|470468069|FG000|Overall Study|Insufficient clinical response|20|||
130436853|NCT01027364|469562461|FG002|Overall Study|Protocol Violation|0|||
130436854|NCT01027364|469562462|FG003|Overall Study|Protocol Violation|1|||
130436855|NCT01027364|469562459|FG000|Overall Study|Withdrawal by Subject|1|||
130436856|NCT01027364|469562460|FG001|Overall Study|Withdrawal by Subject|2|||
130436857|NCT01027364|469562461|FG002|Overall Study|Withdrawal by Subject|0|||
130436858|NCT01027364|469562462|FG003|Overall Study|Withdrawal by Subject|0|||
130436859|NCT01248962|469562463|FG000|Overall Study|Withdrawal by Subject|1|||
130436860|NCT01248962|469562464|FG001|Overall Study|Withdrawal by Subject|1|||
130436861|NCT01248962|469562463|FG000|Overall Study|Adverse Event|2|||
130436862|NCT01248962|469562464|FG001|Overall Study|Adverse Event|1|||
130436863|NCT01248962|469562463|FG000|Overall Study|Complete Response after 4 Cycles|1|||
130436864|NCT01248962|469562464|FG001|Overall Study|Complete Response after 4 Cycles|0|||
130436865|NCT01248962|469562463|FG000|Overall Study|Complete Response after 3 Cycles|0|||
130436866|NCT01248962|469562464|FG001|Overall Study|Complete Response after 3 Cycles|1|||
130436867|NCT01248962|469562463|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
130436868|NCT01248962|469562464|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
130436869|NCT03119610|469562466|FG000|Overall Study|Adverse Event|1|||
130436870|NCT03119610|469562467|FG001|Overall Study|Adverse Event|0|||
130436871|NCT03119610|469562466|FG000|Overall Study|Lost to Follow-up|0|||
130436872|NCT03119610|469562467|FG001|Overall Study|Lost to Follow-up|1|||
130436873|NCT00114634|469562468|FG000|Overall Study|failure to return forms|3|||
130436874|NCT03283696|469562469|FG000|Overall Study|Physician Decision|5|||
130436875|NCT03283696|469562470|FG001|Overall Study|Physician Decision|6|||
130436876|NCT03283696|469562469|FG000|Overall Study|Withdrawal by Subject|2|||
130436877|NCT03283696|469562470|FG001|Overall Study|Withdrawal by Subject|0|||
130436878|NCT00557622|469562474|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
130436879|NCT00557622|469562475|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
130436880|NCT00557622|469562474|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
130436881|NCT00557622|469562475|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
130436882|NCT00557622|469562474|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
130436883|NCT00557622|469562475|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
130436884|NCT01539863|469562476|FG000|Overall Study|Lost to Follow-up|5|||
130436885|NCT01539863|469562477|FG001|Overall Study|Lost to Follow-up|4|||
130436886|NCT02765490|469562480|FG000|Overall Study|Lost to Follow-up|1|||
130436887|NCT02765490|469562481|FG001|Overall Study|Lost to Follow-up|1|||
130436888|NCT02765490|469562480|FG000|Overall Study|Other|0|||
130436889|NCT02765490|469562481|FG001|Overall Study|Other|1|||
130436890|NCT02765490|469562480|FG000|Overall Study|Death|0|||
130436891|NCT02765490|469562481|FG001|Overall Study|Death|1|||
130436892|NCT01468922|469562482|FG000|Overall Study|Screening failure|0|||
130436893|NCT01468922|469562483|FG001|Overall Study|Screening failure|0|||
130436894|NCT01468922|469562484|FG002|Overall Study|Screening failure|0|||
130436895|NCT01468922|469562485|FG003|Overall Study|Screening failure|0|||
130436896|NCT01468922|469562486|FG004|Overall Study|Screening failure|0|||
130436897|NCT01468922|469562487|FG005|Overall Study|Screening failure|0|||
130436898|NCT01468922|469562488|FG006|Overall Study|Screening failure|0|||
130682852|NCT00549718|470468070|FG001|Overall Study|Insufficient clinical response|7|||
130682853|NCT00549718|470468071|FG002|Overall Study|Insufficient clinical response|18|||
130682854|NCT00549718|470468072|FG003|Overall Study|Insufficient clinical response|32|||
130682855|NCT00549718|470468069|FG000|Overall Study|Adverse Event|6|||
130682856|NCT00549718|470468070|FG001|Overall Study|Adverse Event|8|||
130682857|NCT00549718|470468071|FG002|Overall Study|Adverse Event|7|||
130682858|NCT00549718|470468072|FG003|Overall Study|Adverse Event|3|||
130682859|NCT00549718|470468069|FG000|Overall Study|Lost to Follow-up|4|||
130682860|NCT00549718|470468070|FG001|Overall Study|Lost to Follow-up|2|||
130682861|NCT00549718|470468071|FG002|Overall Study|Lost to Follow-up|0|||
130682862|NCT00549718|470468072|FG003|Overall Study|Lost to Follow-up|6|||
130682863|NCT00549718|470468069|FG000|Overall Study|Withdrawal by Subject|9|||
130682864|NCT00549718|470468070|FG001|Overall Study|Withdrawal by Subject|18|||
130682865|NCT00549718|470468071|FG002|Overall Study|Withdrawal by Subject|12|||
130682866|NCT00549718|470468072|FG003|Overall Study|Withdrawal by Subject|13|||
130682867|NCT00549718|470468069|FG000|Overall Study|Administrative|2|||
130682868|NCT00549718|470468070|FG001|Overall Study|Administrative|2|||
130682869|NCT00549718|470468071|FG002|Overall Study|Administrative|2|||
130436899|NCT01468922|469562489|FG007|Overall Study|Screening failure|0|||
130436900|NCT01468922|469562490|FG008|Overall Study|Screening failure|1|||
130436901|NCT01468922|469562482|FG000|Overall Study|Per patient choice|1|||
130436902|NCT01468922|469562483|FG001|Overall Study|Per patient choice|0|||
130436903|NCT01468922|469562484|FG002|Overall Study|Per patient choice|0|||
130436904|NCT01468922|469562485|FG003|Overall Study|Per patient choice|0|||
130436905|NCT01468922|469562486|FG004|Overall Study|Per patient choice|0|||
130436906|NCT01468922|469562487|FG005|Overall Study|Per patient choice|0|||
130436907|NCT01468922|469562488|FG006|Overall Study|Per patient choice|0|||
130682870|NCT00549718|470468072|FG003|Overall Study|Administrative|1|||
130682871|NCT01675622|470468075|FG000|Overall Study|Withdrawal by Subject|2|||
130682872|NCT01675622|470468076|FG001|Overall Study|Withdrawal by Subject|2|||
130682873|NCT01675622|470468075|FG000|Overall Study|Adverse Event|12|||
130682874|NCT01675622|470468076|FG001|Overall Study|Adverse Event|10|||
130682875|NCT01675622|470468075|FG000|Overall Study|Protocol Violation|4|||
130682876|NCT01675622|470468076|FG001|Overall Study|Protocol Violation|1|||
130682877|NCT01675622|470468075|FG000|Overall Study|Lack of Efficacy|2|||
130682878|NCT01675622|470468076|FG001|Overall Study|Lack of Efficacy|4|||
130682879|NCT01675622|470468075|FG000|Overall Study|Lost to Follow-up|1|||
130682880|NCT01675622|470468076|FG001|Overall Study|Lost to Follow-up|3|||
130682881|NCT01675622|470468075|FG000|Overall Study|Other|5|||
130682882|NCT01675622|470468076|FG001|Overall Study|Other|4|||
130682883|NCT04032977|470468077|FG000|Overall Study|Withdrawal by Subject|6|||
130682884|NCT04032977|470468078|FG001|Overall Study|Withdrawal by Subject|1|||
130682885|NCT04032977|470468077|FG000|Overall Study|Lost to Follow-up|2|||
130682886|NCT04032977|470468078|FG001|Overall Study|Lost to Follow-up|7|||
130682887|NCT04032977|470468077|FG000|Overall Study|Pregnancy|1|||
130682888|NCT04032977|470468078|FG001|Overall Study|Pregnancy|0|||
130436908|NCT01468922|469562489|FG007|Overall Study|Per patient choice|0|||
130436909|NCT01468922|469562490|FG008|Overall Study|Per patient choice|0|||
130436910|NCT01468922|469562482|FG000|Overall Study|Switched to alternative treatment|1|||
130682889|NCT02880761|470468080|FG000|Overall Study|Death|6|||
130348302|NCT04675151|469246857|FG000|Overall Study|Protocol Violation|1|||
130348303|NCT04675151|469246858|FG001|Overall Study|Protocol Violation|0|||
130348304|NCT04675151|469246859|FG002|Overall Study|Protocol Violation|0|||
130348305|NCT04675151|469246860|FG003|Overall Study|Protocol Violation|1|||
130348306|NCT04035486|469246861|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
130348307|NCT04035486|469246862|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
130348308|NCT04035486|469246863|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
130348309|NCT04035486|469246864|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
130348310|NCT04035486|469246861|FG000|Overall Study|Death|6|||
130348311|NCT04035486|469246862|FG001|Overall Study|Death|3|||
130348312|NCT04035486|469246863|FG002|Overall Study|Death|70|||
130348313|NCT04035486|469246864|FG003|Overall Study|Death|77|||
130348314|NCT04035486|469246861|FG000|Overall Study|Screen Failure|0|||
130436911|NCT01468922|469562483|FG001|Overall Study|Switched to alternative treatment|0|||
130682890|NCT02880761|470468081|FG001|Overall Study|Death|8|||
130682891|NCT02880761|470468080|FG000|Overall Study|Withdrawal by Subject|3|||
130348315|NCT04035486|469246862|FG001|Overall Study|Screen Failure|0|||
130348316|NCT04035486|469246863|FG002|Overall Study|Screen Failure|1|||
130348317|NCT04035486|469246864|FG003|Overall Study|Screen Failure|1|||
130348318|NCT04035486|469246861|FG000|Overall Study|Withdrawal by Subject|1|||
130348319|NCT04035486|469246862|FG001|Overall Study|Withdrawal by Subject|1|||
130682892|NCT02880761|470468081|FG001|Overall Study|Withdrawal by Subject|6|||
130682893|NCT02880761|470468080|FG000|Overall Study|Protocol Violation|4|||
130682894|NCT02880761|470468081|FG001|Overall Study|Protocol Violation|3|||
130682895|NCT02880761|470468080|FG000|Overall Study|Lost to Follow-up|3|||
130682896|NCT02880761|470468081|FG001|Overall Study|Lost to Follow-up|4|||
130682897|NCT03075761|470468082|FG000|Overall Study|Lost to Follow-up|1|||
130682898|NCT03075761|470468083|FG001|Overall Study|Lost to Follow-up|6|||
130682899|NCT03597256|470468084|FG000|Overall Study|Lost to Follow-up|3|||
130682900|NCT03597256|470468085|FG001|Overall Study|Lost to Follow-up|1|||
130682901|NCT03597256|470468084|FG000|Overall Study|Withdrawal by Subject|0|||
130682902|NCT03597256|470468085|FG001|Overall Study|Withdrawal by Subject|1|||
130682903|NCT03597256|470468084|FG000|Overall Study|Could not return for treatment|0|||
130682904|NCT03597256|470468085|FG001|Overall Study|Could not return for treatment|1|||
130682905|NCT03597256|470468084|FG000|Overall Study|Moved from location|0|||
130682906|NCT03597256|470468085|FG001|Overall Study|Moved from location|1|||
130682907|NCT03597256|470468084|FG000|Overall Study|Not accepted the treatment|0|||
130682908|NCT03597256|470468085|FG001|Overall Study|Not accepted the treatment|1|||
130682909|NCT02106156|470468086|FG000|Overall Study|Patient Died|19|||
130682910|NCT02106156|470468087|FG001|Overall Study|Patient Died|0|||
130682911|NCT02106156|470468088|FG002|Overall Study|Patient Died|0|||
130682912|NCT02106156|470468086|FG000|Overall Study|Lack of Tolerability|305|||
130682913|NCT02106156|470468087|FG001|Overall Study|Lack of Tolerability|3|||
130682914|NCT02106156|470468088|FG002|Overall Study|Lack of Tolerability|0|||
130682915|NCT02106156|470468086|FG000|Overall Study|Lack of Virological Response|1044|||
130682916|NCT02106156|470468087|FG001|Overall Study|Lack of Virological Response|8|||
130682917|NCT02106156|470468088|FG002|Overall Study|Lack of Virological Response|0|||
130682918|NCT02106156|470468086|FG000|Overall Study|Concomitant Disease|74|||
130682919|NCT02106156|470468087|FG001|Overall Study|Concomitant Disease|2|||
130682920|NCT02106156|470468088|FG002|Overall Study|Concomitant Disease|0|||
130682921|NCT02106156|470468086|FG000|Overall Study|Lack of Compliance|211|||
130682922|NCT02106156|470468087|FG001|Overall Study|Lack of Compliance|7|||
130682923|NCT02106156|470468088|FG002|Overall Study|Lack of Compliance|0|||
130682924|NCT02106156|470468086|FG000|Overall Study|Patients Request|307|||
130682925|NCT02106156|470468087|FG001|Overall Study|Patients Request|9|||
130682926|NCT02106156|470468088|FG002|Overall Study|Patients Request|0|||
130682927|NCT02106156|470468086|FG000|Overall Study|Lost to Follow-up|451|||
130682928|NCT02106156|470468087|FG001|Overall Study|Lost to Follow-up|8|||
130682929|NCT02106156|470468088|FG002|Overall Study|Lost to Follow-up|0|||
130682930|NCT02106156|470468086|FG000|Overall Study|Unplanned Event|82|||
130682931|NCT02106156|470468087|FG001|Overall Study|Unplanned Event|2|||
130682932|NCT02106156|470468088|FG002|Overall Study|Unplanned Event|0|||
130436912|NCT01468922|469562484|FG002|Overall Study|Switched to alternative treatment|0|||
130436913|NCT01468922|469562485|FG003|Overall Study|Switched to alternative treatment|0|||
130436914|NCT01468922|469562486|FG004|Overall Study|Switched to alternative treatment|1|||
130436915|NCT01468922|469562487|FG005|Overall Study|Switched to alternative treatment|0|||
130436916|NCT01468922|469562488|FG006|Overall Study|Switched to alternative treatment|0|||
130436917|NCT01468922|469562489|FG007|Overall Study|Switched to alternative treatment|0|||
130436918|NCT01468922|469562490|FG008|Overall Study|Switched to alternative treatment|0|||
130436919|NCT01468922|469562482|FG000|Overall Study|Enrolled on new protocol|0|||
130436920|NCT01468922|469562483|FG001|Overall Study|Enrolled on new protocol|0|||
130436921|NCT01468922|469562484|FG002|Overall Study|Enrolled on new protocol|0|||
130436922|NCT01468922|469562485|FG003|Overall Study|Enrolled on new protocol|0|||
130436923|NCT01468922|469562486|FG004|Overall Study|Enrolled on new protocol|1|||
130436924|NCT01468922|469562487|FG005|Overall Study|Enrolled on new protocol|0|||
130436925|NCT01468922|469562488|FG006|Overall Study|Enrolled on new protocol|0|||
130436926|NCT01468922|469562489|FG007|Overall Study|Enrolled on new protocol|0|||
130436927|NCT01468922|469562490|FG008|Overall Study|Enrolled on new protocol|0|||
130436928|NCT01468922|469562482|FG000|Overall Study|Adverse Event|0|||
130436929|NCT01468922|469562483|FG001|Overall Study|Adverse Event|0|||
130436930|NCT01468922|469562484|FG002|Overall Study|Adverse Event|0|||
130436931|NCT01468922|469562485|FG003|Overall Study|Adverse Event|0|||
130436932|NCT01468922|469562486|FG004|Overall Study|Adverse Event|0|||
130436933|NCT01468922|469562487|FG005|Overall Study|Adverse Event|0|||
130436934|NCT01468922|469562488|FG006|Overall Study|Adverse Event|0|||
130436935|NCT01468922|469562489|FG007|Overall Study|Adverse Event|1|||
130436936|NCT01468922|469562490|FG008|Overall Study|Adverse Event|0|||
130682933|NCT02106156|470468086|FG000|Overall Study|Change of Laboratory Parameter|10|||
130436937|NCT01468922|469562482|FG000|Overall Study|Infection of blood|0|||
130436938|NCT01468922|469562483|FG001|Overall Study|Infection of blood|0|||
130436939|NCT01468922|469562484|FG002|Overall Study|Infection of blood|0|||
130436940|NCT01468922|469562485|FG003|Overall Study|Infection of blood|0|||
130436941|NCT01468922|469562486|FG004|Overall Study|Infection of blood|0|||
130682934|NCT02106156|470468087|FG001|Overall Study|Change of Laboratory Parameter|0|||
130436942|NCT01468922|469562487|FG005|Overall Study|Infection of blood|0|||
130682935|NCT02106156|470468088|FG002|Overall Study|Change of Laboratory Parameter|0|||
130682936|NCT02106156|470468086|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
130682937|NCT02106156|470468087|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
130682938|NCT02106156|470468088|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
130682939|NCT02106156|470468086|FG000|Overall Study|Relocation/Change of Physician|40|||
130720847|NCT04126213|470601550|FG005|Overall Study|Lost to Follow-up|7|||
130682940|NCT02106156|470468087|FG001|Overall Study|Relocation/Change of Physician|1|||
130682941|NCT02106156|470468088|FG002|Overall Study|Relocation/Change of Physician|0|||
130682942|NCT05017480|470468098|FG000|Stage 1 Study|Withdrawal by Subject|8|||
130682943|NCT05017480|470468099|FG001|Stage 1 Study|Withdrawal by Subject|6|||
130682944|NCT05017480|470468100|FG002|Stage 1 Study|Withdrawal by Subject|0|||
130682945|NCT05017480|470468101|FG003|Stage 1 Study|Withdrawal by Subject|0|||
130682946|NCT05017480|470468102|FG004|Stage 1 Study|Withdrawal by Subject|0|||
130682947|NCT05017480|470468098|FG000|Stage 1 Study|Adverse Event|1|||
130682948|NCT05017480|470468099|FG001|Stage 1 Study|Adverse Event|1|||
130682949|NCT05017480|470468100|FG002|Stage 1 Study|Adverse Event|0|||
130682950|NCT05017480|470468101|FG003|Stage 1 Study|Adverse Event|0|||
130682951|NCT05017480|470468102|FG004|Stage 1 Study|Adverse Event|0|||
130682952|NCT05017480|470468098|FG000|Stage 1 Study|Poor Compliance|1|||
130682953|NCT05017480|470468099|FG001|Stage 1 Study|Poor Compliance|1|||
130682954|NCT05017480|470468100|FG002|Stage 1 Study|Poor Compliance|0|||
130682955|NCT05017480|470468101|FG003|Stage 1 Study|Poor Compliance|0|||
130682956|NCT05017480|470468102|FG004|Stage 1 Study|Poor Compliance|0|||
130348320|NCT04035486|469246863|FG002|Overall Study|Withdrawal by Subject|11|||
130348321|NCT04035486|469246864|FG003|Overall Study|Withdrawal by Subject|9|||
130348322|NCT01730937|469246865|FG000|Overall Study|Protocol Violation|5|||
130348323|NCT01730937|469246866|FG001|Overall Study|Protocol Violation|11|||
130348324|NCT03947684|469246869|FG000|Overall Study|Lost to Follow-up|13|||
130348325|NCT03947684|469246870|FG001|Overall Study|Lost to Follow-up|5|||
130348326|NCT03947684|469246871|FG002|Overall Study|Lost to Follow-up|1|||
130348327|NCT03947684|469246869|FG000|Overall Study|Withdrawal by Subject|11|||
130348328|NCT03947684|469246870|FG001|Overall Study|Withdrawal by Subject|4|||
130348329|NCT03947684|469246871|FG002|Overall Study|Withdrawal by Subject|0|||
130348330|NCT03947684|469246869|FG000|Overall Study|Physician Decision|1|||
130348331|NCT03947684|469246870|FG001|Overall Study|Physician Decision|0|||
130348332|NCT03947684|469246871|FG002|Overall Study|Physician Decision|0|||
130348333|NCT03947684|469246869|FG000|Overall Study|Lack of adherence to study protocol|2|||
130348334|NCT03947684|469246870|FG001|Overall Study|Lack of adherence to study protocol|0|||
130348335|NCT03947684|469246871|FG002|Overall Study|Lack of adherence to study protocol|0|||
130682957|NCT05017480|470468098|FG000|Stage 1 Study|Physician Decision|0|||
130682958|NCT05017480|470468099|FG001|Stage 1 Study|Physician Decision|1|||
130682959|NCT05017480|470468100|FG002|Stage 1 Study|Physician Decision|0|||
130682960|NCT05017480|470468101|FG003|Stage 1 Study|Physician Decision|0|||
130436943|NCT01468922|469562488|FG006|Overall Study|Infection of blood|0|||
130436944|NCT01468922|469562489|FG007|Overall Study|Infection of blood|1|||
130436945|NCT01468922|469562490|FG008|Overall Study|Infection of blood|0|||
130436946|NCT01468922|469562482|FG000|Overall Study|Patient choice - surgery|0|||
130436947|NCT01468922|469562483|FG001|Overall Study|Patient choice - surgery|0|||
130436948|NCT01468922|469562484|FG002|Overall Study|Patient choice - surgery|0|||
130436949|NCT01468922|469562485|FG003|Overall Study|Patient choice - surgery|0|||
130436950|NCT01468922|469562486|FG004|Overall Study|Patient choice - surgery|0|||
130436951|NCT01468922|469562487|FG005|Overall Study|Patient choice - surgery|0|||
130436952|NCT01468922|469562488|FG006|Overall Study|Patient choice - surgery|0|||
130436953|NCT01468922|469562489|FG007|Overall Study|Patient choice - surgery|1|||
130436954|NCT01468922|469562490|FG008|Overall Study|Patient choice - surgery|0|||
130436955|NCT01468922|469562482|FG000|Overall Study|Refused further treatment|0|||
130436956|NCT01468922|469562483|FG001|Overall Study|Refused further treatment|0|||
130436957|NCT01468922|469562484|FG002|Overall Study|Refused further treatment|0|||
130436958|NCT01468922|469562485|FG003|Overall Study|Refused further treatment|0|||
130436959|NCT01468922|469562486|FG004|Overall Study|Refused further treatment|0|||
130436960|NCT01468922|469562487|FG005|Overall Study|Refused further treatment|0|||
130436961|NCT01468922|469562488|FG006|Overall Study|Refused further treatment|0|||
130436962|NCT01468922|469562489|FG007|Overall Study|Refused further treatment|1|||
130436963|NCT01468922|469562490|FG008|Overall Study|Refused further treatment|0|||
130436964|NCT03662997|469562497|FG000|Overall Study|Adverse Event|0|||
130436965|NCT03662997|469562498|FG001|Overall Study|Adverse Event|2|||
130436966|NCT03662997|469562499|FG002|Overall Study|Adverse Event|0|||
130436967|NCT03662997|469562500|FG003|Overall Study|Adverse Event|0|||
130436968|NCT00007475|469562501|FG000|Overall Study|Withdrawal by Subject|1|||
130436969|NCT00007475|469562502|FG001|Overall Study|Withdrawal by Subject|0|||
130436970|NCT00007475|469562503|FG002|Overall Study|Withdrawal by Subject|0|||
130436971|NCT00007475|469562504|FG003|Overall Study|Withdrawal by Subject|0|||
130436972|NCT00007475|469562501|FG000|Overall Study|Adverse Event|3|||
130436973|NCT00007475|469562502|FG001|Overall Study|Adverse Event|0|||
130436974|NCT00007475|469562503|FG002|Overall Study|Adverse Event|0|||
130436975|NCT00007475|469562504|FG003|Overall Study|Adverse Event|0|||
130436976|NCT01719224|469562505|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
130436977|NCT01719224|469562506|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
130436978|NCT03000673|469562507|FG000|Overall Study|Withdrawal by Subject|1|||
130436979|NCT03000673|469562508|FG001|Overall Study|Withdrawal by Subject|0|||
130436980|NCT03000673|469562509|FG002|Overall Study|Withdrawal by Subject|0|||
130436981|NCT03000673|469562510|FG003|Overall Study|Withdrawal by Subject|0|||
130436982|NCT01121484|469562511|FG000|Overall Study|Adverse Event|12|||
130436983|NCT01121484|469562512|FG001|Overall Study|Adverse Event|5|||
130436984|NCT01121484|469562511|FG000|Overall Study|Lack of Efficacy|3|||
130436985|NCT01121484|469562512|FG001|Overall Study|Lack of Efficacy|11|||
130436986|NCT01121484|469562511|FG000|Overall Study|Lost to Follow-up|5|||
130436987|NCT01121484|469562512|FG001|Overall Study|Lost to Follow-up|9|||
130436988|NCT01121484|469562511|FG000|Overall Study|Physician Decision|0|||
130436989|NCT01121484|469562512|FG001|Overall Study|Physician Decision|3|||
130436990|NCT01121484|469562511|FG000|Overall Study|Protocol Violation|1|||
130436991|NCT01121484|469562512|FG001|Overall Study|Protocol Violation|0|||
130682961|NCT05017480|470468102|FG004|Stage 1 Study|Physician Decision|0|||
130436992|NCT01121484|469562511|FG000|Overall Study|Withdrawal by Subject|8|||
130436993|NCT01121484|469562512|FG001|Overall Study|Withdrawal by Subject|7|||
130436994|NCT01121484|469562511|FG000|Overall Study|Discontinuation of study by sponsor|0|||
130436995|NCT01121484|469562512|FG001|Overall Study|Discontinuation of study by sponsor|1|||
130682962|NCT05017480|470468098|FG000|Stage 2 Study|Withdrawal by Subject|0|||
130682963|NCT05017480|470468099|FG001|Stage 2 Study|Withdrawal by Subject|0|||
130682964|NCT05017480|470468100|FG002|Stage 2 Study|Withdrawal by Subject|6|||
130436996|NCT01121484|469562511|FG000|Overall Study|Other|3|||
130436997|NCT01121484|469562512|FG001|Overall Study|Other|3|||
130436998|NCT01121484|469562511|FG000|Overall Study|Randomized, not treated|1|||
130436999|NCT01121484|469562512|FG001|Overall Study|Randomized, not treated|4|||
130437000|NCT01512745|469562514|FG000|Overall Study|Adverse Event|22|||
130682965|NCT05017480|470468101|FG003|Stage 2 Study|Withdrawal by Subject|9|||
130682966|NCT05017480|470468102|FG004|Stage 2 Study|Withdrawal by Subject|11|||
130682967|NCT05017480|470468098|FG000|Stage 2 Study|Lost to Follow-up|0|||
130437001|NCT01512745|469562515|FG001|Overall Study|Adverse Event|3|||
130437002|NCT01512745|469562514|FG000|Overall Study|Death|9|||
130437003|NCT01512745|469562515|FG001|Overall Study|Death|13|||
130682968|NCT05017480|470468099|FG001|Stage 2 Study|Lost to Follow-up|0|||
130682969|NCT05017480|470468100|FG002|Stage 2 Study|Lost to Follow-up|0|||
130437004|NCT01512745|469562514|FG000|Overall Study|Withdrawal by Subject|2|||
130437005|NCT01512745|469562515|FG001|Overall Study|Withdrawal by Subject|2|||
130437006|NCT01512745|469562514|FG000|Overall Study|Lost to Follow-up|4|||
130437007|NCT01512745|469562515|FG001|Overall Study|Lost to Follow-up|0|||
130437008|NCT01512745|469562514|FG000|Overall Study|Lack of Efficacy|2|||
130437009|NCT01512745|469562515|FG001|Overall Study|Lack of Efficacy|2|||
130682970|NCT05017480|470468101|FG003|Stage 2 Study|Lost to Follow-up|2|||
130682971|NCT05017480|470468102|FG004|Stage 2 Study|Lost to Follow-up|1|||
130348408|NCT03875235|469246880|FG000|Overall Study|Ongoing study treatment|63|||
130348409|NCT03875235|469246881|FG001|Overall Study|Ongoing study treatment|20|||
130348410|NCT03875235|469246880|FG000|Overall Study|Off treatment|77|||
130348411|NCT03875235|469246881|FG001|Overall Study|Off treatment|91|||
130348412|NCT03875235|469246880|FG000|Overall Study|Withdrawal by Subject|3|||
130348413|NCT03875235|469246881|FG001|Overall Study|Withdrawal by Subject|10|||
130348414|NCT03875235|469246880|FG000|Overall Study|Death|198|||
130348415|NCT03875235|469246881|FG001|Overall Study|Death|223|||
130348416|NCT04526665|469246884|FG000|Overall Study|Withdrawal by Subject|6|||
130348417|NCT04526665|469246885|FG001|Overall Study|Withdrawal by Subject|3|||
130348418|NCT04526665|469246884|FG000|Overall Study|Adverse Event|4|||
130348419|NCT04526665|469246885|FG001|Overall Study|Adverse Event|1|||
130348420|NCT04526665|469246884|FG000|Overall Study|Physician Decision|2|||
130348421|NCT04526665|469246885|FG001|Overall Study|Physician Decision|2|||
130348422|NCT04526665|469246884|FG000|Overall Study|Death|2|||
130348423|NCT04526665|469246885|FG001|Overall Study|Death|0|||
130348424|NCT04526665|469246884|FG000|Overall Study|Other|0|||
130348425|NCT04526665|469246885|FG001|Overall Study|Other|1|||
130682972|NCT05017480|470468098|FG000|Stage 2 Study|Adverse Event|0|||
130682973|NCT05017480|470468099|FG001|Stage 2 Study|Adverse Event|0|||
130682974|NCT05017480|470468100|FG002|Stage 2 Study|Adverse Event|0|||
130682975|NCT05017480|470468101|FG003|Stage 2 Study|Adverse Event|1|||
130682976|NCT05017480|470468102|FG004|Stage 2 Study|Adverse Event|0|||
130348440|NCT03587727|469247492|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
130348441|NCT03587727|469247492|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
130348442|NCT04102189|469247496|FG000|Overall Study|Withdrawal by Subject|1|||
130348443|NCT04102189|469247497|FG001|Overall Study|Withdrawal by Subject|2|||
130437010|NCT01512745|469562514|FG000|Overall Study|Protocol Violation|1|||
130437011|NCT01512745|469562515|FG001|Overall Study|Protocol Violation|0|||
130437012|NCT02357810|469562516|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
130437013|NCT02357810|469562516|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
130437014|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Adverse Event|5|||
130437015|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
130437016|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
130437017|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
130437018|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Death|1|||
130437019|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Physician Decision|1|||
130437020|NCT02357810|469562516|FG000|Reached 12 Weeks Response|Other|1|||
130437021|NCT02357810|469562516|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
130437022|NCT02357810|469562516|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
130437023|NCT02357810|469562516|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
130437024|NCT02357810|469562516|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
130437025|NCT02357810|469562516|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
130437026|NCT02357810|469562516|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
130437027|NCT00675506|469562520|FG000|Overall Study|Lost to Follow-up|1|||
130437028|NCT00675506|469562521|FG001|Overall Study|Lost to Follow-up|5|||
130437029|NCT00675506|469562520|FG000|Overall Study|Lost interest|3|||
130437030|NCT00675506|469562521|FG001|Overall Study|Lost interest|5|||
130437031|NCT00675506|469562520|FG000|Overall Study|Elevated fasting glucose|2|||
130437032|NCT00675506|469562521|FG001|Overall Study|Elevated fasting glucose|1|||
130437033|NCT00675506|469562520|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
130437034|NCT00675506|469562521|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
130437035|NCT00675506|469562520|FG000|Overall Study|Elevated IGF-1|2|||
130437036|NCT00675506|469562521|FG001|Overall Study|Elevated IGF-1|0|||
130437037|NCT00675506|469562520|FG000|Overall Study|Hypersensitivity Reaction|1|||
130437038|NCT00675506|469562521|FG001|Overall Study|Hypersensitivity Reaction|0|||
130437039|NCT00675506|469562520|FG000|Overall Study|Disclosed history of cancer|1|||
130437040|NCT00675506|469562521|FG001|Overall Study|Disclosed history of cancer|0|||
130437041|NCT00675506|469562520|FG000|Overall Study|Declined participation|1|||
130437042|NCT00675506|469562521|FG001|Overall Study|Declined participation|0|||
130437043|NCT00675506|469562520|FG000|Overall Study|Schedule conflict|0|||
130437044|NCT00675506|469562521|FG001|Overall Study|Schedule conflict|1|||
130437045|NCT00936221|469562522|FG000|Overall Study|Withdrawal by Subject|1|||
130437046|NCT00936221|469562523|FG001|Overall Study|Withdrawal by Subject|1|||
130437047|NCT03820323|469562524|FG000|Overall Study|Lost to Follow-up|2|||
130437048|NCT03820323|469562525|FG001|Overall Study|Lost to Follow-up|1|||
130437049|NCT03820323|469562524|FG000|Overall Study|Missed 12-month visit|22|||
130437050|NCT03820323|469562525|FG001|Overall Study|Missed 12-month visit|14|||
130437051|NCT03820323|469562524|FG000|Overall Study|Death|2|||
130437052|NCT03820323|469562525|FG001|Overall Study|Death|1|||
130437053|NCT03820323|469562524|FG000|Overall Study|Transferred out|13|||
130437054|NCT03820323|469562525|FG001|Overall Study|Transferred out|11|||
130437055|NCT03820323|469562524|FG000|Overall Study|Terminated|0|||
130437056|NCT03820323|469562525|FG001|Overall Study|Terminated|3|||
130437057|NCT03820323|469562524|FG000|Overall Study|Withdrawal by Subject|1|||
130437058|NCT03820323|469562525|FG001|Overall Study|Withdrawal by Subject|6|||
130437059|NCT03151395|469562526|FG000|Overall Study|Adverse Event|2|||
130437060|NCT03151395|469562526|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
130437061|NCT03151395|469562526|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
130437062|NCT03151395|469562526|FG000|Overall Study|Unspecified reason|4|||
130437063|NCT00879996|469562527|FG000|Overall Study|Lost to Follow-up|7|||
130437064|NCT00879996|469562528|FG001|Overall Study|Lost to Follow-up|6|||
130437065|NCT00879996|469562527|FG000|Overall Study|non-compliance|6|||
130437066|NCT00879996|469562528|FG001|Overall Study|non-compliance|4|||
130437067|NCT00879996|469562527|FG000|Overall Study|Physician Decision|1|||
130437068|NCT00879996|469562528|FG001|Overall Study|Physician Decision|2|||
130437069|NCT00879996|469562527|FG000|Overall Study|psychiatric problem|0|||
130437070|NCT00879996|469562528|FG001|Overall Study|psychiatric problem|1|||
130437071|NCT00879996|469562527|FG000|Overall Study|put on parole|1|||
130437072|NCT00879996|469562528|FG001|Overall Study|put on parole|0|||
130437073|NCT02912468|469562533|FG000|Overall Study|Adverse Event|3|||
130437074|NCT02912468|469562534|FG001|Overall Study|Adverse Event|2|||
130437075|NCT02912468|469562533|FG000|Overall Study|Withdrawal by Subject|6|||
130437076|NCT02912468|469562534|FG001|Overall Study|Withdrawal by Subject|2|||
130437077|NCT02912468|469562533|FG000|Overall Study|Randomized and not treated|0|||
130437078|NCT02912468|469562534|FG001|Overall Study|Randomized and not treated|1|||
130682977|NCT05017480|470468098|FG000|Stage 2 Study|COVID-19|0|||
130437079|NCT02597933|469562536|FG000|Overall Study|Withdrawal by Subject|7|||
130437080|NCT02597933|469562537|FG001|Overall Study|Withdrawal by Subject|5|||
130437081|NCT02597933|469562536|FG000|Overall Study|Protocol Violation|2|||
130437082|NCT02597933|469562537|FG001|Overall Study|Protocol Violation|2|||
130437083|NCT02597933|469562536|FG000|Overall Study|Adverse Event|20|||
130437084|NCT02597933|469562537|FG001|Overall Study|Adverse Event|28|||
130682978|NCT05017480|470468099|FG001|Stage 2 Study|COVID-19|0|||
130437085|NCT02597933|469562536|FG000|Overall Study|Not treated|2|||
130437086|NCT02597933|469562537|FG001|Overall Study|Not treated|2|||
130437087|NCT02597933|469562536|FG000|Overall Study|Other than stated above|7|||
130437088|NCT02597933|469562537|FG001|Overall Study|Other than stated above|14|||
130437089|NCT01320735|469562540|FG000|Overall Study|Adverse Event|3|||
130437090|NCT01320735|469562540|FG000|Overall Study|Withdrawal by Subject|3|||
130437091|NCT01320735|469562540|FG000|Overall Study|Lost to Follow-up|13|||
130437092|NCT01320735|469562540|FG000|Overall Study|Administrative Reason|6|||
130437093|NCT01320735|469562540|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
130437094|NCT01320735|469562540|FG000|Overall Study|Protocol Violation|1|||
130437095|NCT01320735|469562540|FG000|Overall Study|Other|1|||
130437096|NCT01320735|469562540|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
130437097|NCT01320735|469562540|FG000|Overall Study|Investigator Unable to be Contacted|17|||
130437098|NCT01913639|469562543|FG000|Overall Study|Not Eligible|3|||
130437099|NCT01225822|469562553|FG000|Overall Study|Adverse Event|13|||
130437100|NCT01225822|469562554|FG001|Overall Study|Adverse Event|31|||
130437101|NCT01225822|469562555|FG002|Overall Study|Adverse Event|18|||
130682979|NCT05017480|470468100|FG002|Stage 2 Study|COVID-19|0|||
130682980|NCT05017480|470468101|FG003|Stage 2 Study|COVID-19|1|||
130682981|NCT05017480|470468102|FG004|Stage 2 Study|COVID-19|0|||
130437102|NCT01225822|469562556|FG003|Overall Study|Adverse Event|23|||
130437103|NCT01225822|469562557|FG004|Overall Study|Adverse Event|14|||
130437104|NCT01225822|469562553|FG000|Overall Study|Protocol Violation|6|||
130437105|NCT01225822|469562554|FG001|Overall Study|Protocol Violation|8|||
130437106|NCT01225822|469562555|FG002|Overall Study|Protocol Violation|6|||
130437107|NCT01225822|469562556|FG003|Overall Study|Protocol Violation|7|||
130437108|NCT01225822|469562557|FG004|Overall Study|Protocol Violation|4|||
130437109|NCT01225822|469562553|FG000|Overall Study|Lost to Follow-up|0|||
130437110|NCT01225822|469562554|FG001|Overall Study|Lost to Follow-up|0|||
130437111|NCT01225822|469562555|FG002|Overall Study|Lost to Follow-up|0|||
130437112|NCT01225822|469562556|FG003|Overall Study|Lost to Follow-up|1|||
130437113|NCT01225822|469562557|FG004|Overall Study|Lost to Follow-up|0|||
130437114|NCT01225822|469562553|FG000|Overall Study|Withdrawal by Subject|6|||
130437115|NCT01225822|469562554|FG001|Overall Study|Withdrawal by Subject|7|||
130437116|NCT01225822|469562555|FG002|Overall Study|Withdrawal by Subject|7|||
130437117|NCT01225822|469562556|FG003|Overall Study|Withdrawal by Subject|11|||
130437118|NCT01225822|469562557|FG004|Overall Study|Withdrawal by Subject|6|||
130437119|NCT01225822|469562553|FG000|Overall Study|Other|13|||
130437120|NCT01225822|469562554|FG001|Overall Study|Other|10|||
130437121|NCT01225822|469562555|FG002|Overall Study|Other|7|||
130437122|NCT01225822|469562556|FG003|Overall Study|Other|10|||
130437123|NCT01225822|469562557|FG004|Overall Study|Other|7|||
130437124|NCT01290822|469562558|FG000|Overall Study|Withdrawal by Subject|1|||
130437125|NCT01290822|469562558|FG000|Overall Study|Physician Decision|10|||
130437126|NCT02223754|469562562|FG000|Period 1|Adverse Event|1|||
130437127|NCT02223754|469562563|FG001|Period 1|Adverse Event|0|||
130437128|NCT02223754|469562562|FG000|Period 1|Lost to Follow-up|0|||
130437129|NCT02223754|469562563|FG001|Period 1|Lost to Follow-up|1|||
130437130|NCT02223754|469562562|FG000|Period 1|Protocol Violation|2|||
130437131|NCT02223754|469562563|FG001|Period 1|Protocol Violation|4|||
130437132|NCT02223754|469562562|FG000|Period 1|Withdrawal by Subject|0|||
130437133|NCT02223754|469562563|FG001|Period 1|Withdrawal by Subject|4|||
130437134|NCT02223754|469562562|FG000|Period 1|Test Article No Longer Available|1|||
130437135|NCT02223754|469562563|FG001|Period 1|Test Article No Longer Available|5|||
130437136|NCT02223754|469562562|FG000|Period 1|Unsatisfactory Visual Response|0|||
130437137|NCT02223754|469562563|FG001|Period 1|Unsatisfactory Visual Response|1|||
130437138|NCT02223754|469562562|FG000|Period 2|Adverse Event|0|||
130437139|NCT02223754|469562563|FG001|Period 2|Adverse Event|1|||
130437140|NCT02223754|469562562|FG000|Period 2|Protocol Violation|1|||
130437141|NCT02223754|469562563|FG001|Period 2|Protocol Violation|0|||
130682982|NCT05017480|470468098|FG000|Stage 2 Study|Pregnancy|0|||
130682983|NCT05017480|470468099|FG001|Stage 2 Study|Pregnancy|0|||
130682984|NCT05017480|470468100|FG002|Stage 2 Study|Pregnancy|0|||
130437142|NCT02223754|469562562|FG000|Period 2|Lens Discomfort|1|||
130437143|NCT02223754|469562563|FG001|Period 2|Lens Discomfort|1|||
130437144|NCT02223754|469562562|FG000|Period 2|Lost to Follow-up|1|||
130437145|NCT02223754|469562563|FG001|Period 2|Lost to Follow-up|0|||
130437146|NCT02223754|469562562|FG000|Period 2|Test Article No Longer Available|0|||
130437147|NCT02223754|469562563|FG001|Period 2|Test Article No Longer Available|1|||
130437148|NCT04395183|469562564|FG000|Overall Study|Withdrawal by Subject|1|||
130437149|NCT04395183|469562565|FG001|Overall Study|Withdrawal by Subject|0|||
130437150|NCT04395183|469562566|FG002|Overall Study|Withdrawal by Subject|2|||
130437151|NCT04395183|469562567|FG003|Overall Study|Withdrawal by Subject|2|||
130437152|NCT01693692|469562571|FG000|Overall Study|Withdrawal by Subject|12|||
130437153|NCT01693692|469562572|FG001|Overall Study|Withdrawal by Subject|10|||
130437154|NCT01693692|469562573|FG002|Overall Study|Withdrawal by Subject|11|||
130437155|NCT01693692|469562571|FG000|Overall Study|Adverse Event|7|||
130437156|NCT01693692|469562572|FG001|Overall Study|Adverse Event|14|||
130437157|NCT01693692|469562573|FG002|Overall Study|Adverse Event|9|||
130682985|NCT05017480|470468101|FG003|Stage 2 Study|Pregnancy|0|||
130682986|NCT05017480|470468102|FG004|Stage 2 Study|Pregnancy|1|||
130682987|NCT01136382|470468103|FG000|Overall Study|Other|8|||
130682988|NCT01136382|470468104|FG001|Overall Study|Other|3|||
130682989|NCT01136382|470468103|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
130682990|NCT01136382|470468104|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
130682991|NCT01136382|470468103|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130682992|NCT01136382|470468104|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130682993|NCT01136382|470468103|FG000|Overall Study|Withdrawal by Subject|4|||
130682994|NCT01136382|470468104|FG001|Overall Study|Withdrawal by Subject|1|||
130682995|NCT02653664|470468109|FG000|Post-Treatment|Withdrawal by Subject|6|||
130682996|NCT02653664|470468110|FG001|Post-Treatment|Withdrawal by Subject|5|||
130682997|NCT02653664|470468111|FG002|Post-Treatment|Withdrawal by Subject|7|||
130348444|NCT04102189|469247496|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130348445|NCT04102189|469247497|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130348446|NCT04102189|469247496|FG000|Overall Study|Lost to Follow-up|1|||
130348447|NCT04102189|469247497|FG001|Overall Study|Lost to Follow-up|0|||
130682998|NCT02653664|470468109|FG000|Post-Treatment|Lost to Follow-up|8|||
130217802|NCT04865419|468761404|FG002|Overall Study|Study terminated by Sponsor|0|||
130437158|NCT01693692|469562571|FG000|Overall Study|Physician Decision|0|||
130682999|NCT02653664|470468110|FG001|Post-Treatment|Lost to Follow-up|1|||
130437159|NCT01693692|469562572|FG001|Overall Study|Physician Decision|0|||
130437160|NCT01693692|469562573|FG002|Overall Study|Physician Decision|1|||
130437161|NCT01693692|469562571|FG000|Overall Study|Protocol Violation|5|||
130437162|NCT01693692|469562572|FG001|Overall Study|Protocol Violation|4|||
130437163|NCT01693692|469562573|FG002|Overall Study|Protocol Violation|6|||
130437164|NCT01693692|469562571|FG000|Overall Study|Lost to Follow-up|2|||
130437165|NCT01693692|469562572|FG001|Overall Study|Lost to Follow-up|2|||
130437166|NCT01693692|469562573|FG002|Overall Study|Lost to Follow-up|3|||
130437167|NCT01693692|469562571|FG000|Overall Study|Other|4|||
130437168|NCT01693692|469562572|FG001|Overall Study|Other|4|||
130437169|NCT01693692|469562573|FG002|Overall Study|Other|6|||
130437170|NCT04567693|469564308|FG000|Overall Study|Death|0|||
130437171|NCT04567693|469564309|FG001|Overall Study|Death|0|||
130437172|NCT04567693|469564310|FG002|Overall Study|Death|2|||
130437173|NCT04567693|469564308|FG000|Overall Study|Lost to Follow-up|1|||
130437174|NCT04567693|469564309|FG001|Overall Study|Lost to Follow-up|0|||
130437175|NCT04567693|469564310|FG002|Overall Study|Lost to Follow-up|2|||
130437176|NCT04567693|469564308|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
130437177|NCT04567693|469564309|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
130437178|NCT04567693|469564310|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
130437179|NCT03722264|469564311|FG000|Overall Study|Physician Decision|3|||
130437180|NCT02959671|469564312|FG000|Overall Study|Adverse Event|2|||
130437181|NCT02959671|469564312|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
130437182|NCT03462706|469564315|FG000|Overall Study|Polyp was pedunculated|1|||
130437183|NCT03462706|469564316|FG001|Overall Study|Polyp was pedunculated|0|||
130437184|NCT03462706|469564317|FG002|Overall Study|Polyp was pedunculated|1|||
130437185|NCT03462706|469564318|FG003|Overall Study|Polyp was pedunculated|0|||
130437186|NCT03462706|469564315|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
130437187|NCT03462706|469564316|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
130437188|NCT03462706|469564317|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
130437189|NCT03462706|469564318|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
130437190|NCT04105972|469564323|FG000|Overall Study|Adverse Event|2|||
130437191|NCT04105972|469564324|FG001|Overall Study|Adverse Event|1|||
130437192|NCT00553202|469564329|FG000|Overall Study|Death|16|||
130437193|NCT00553202|469564329|FG000|Overall Study|Lost to Follow-up|1|||
130437194|NCT00553202|469564329|FG000|Overall Study|Physician Decision|28|||
130437195|NCT00553202|469564329|FG000|Overall Study|Withdrawal by Subject|1|||
130437196|NCT00553202|469564329|FG000|Overall Study|No donor identified|16|||
130437197|NCT00553202|469564329|FG000|Overall Study|Fails to meet organ function|6|||
130437198|NCT02593305|469564332|FG000|Post 1|Comparison only group. No intervention.|0|||
130437199|NCT02593305|469564333|FG001|Post 1|Comparison only group. No intervention.|0|||
130437200|NCT02593305|469564334|FG002|Post 1|Comparison only group. No intervention.|10|||
130437201|NCT01190215|469564335|FG000|Up to Month 6|Lost to Follow-up|2|||
130437202|NCT01190215|469564336|FG001|Up to Month 6|Lost to Follow-up|0|||
130437203|NCT01161472|469564338|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
130437204|NCT01161472|469564339|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130437205|NCT01161472|469564340|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130437206|NCT01161472|469564341|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130437207|NCT00768430|469564361|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
130437208|NCT00768430|469564362|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
130437209|NCT01112514|469564366|FG000|Overall Study|Lost to Follow-up|1|||
130437210|NCT01118455|469564367|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
130437211|NCT01118455|469564368|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
130437212|NCT02632786|469564379|FG000|Overall Study|Adverse Event|2|||
130683000|NCT02653664|470468111|FG002|Post-Treatment|Lost to Follow-up|7|||
130683001|NCT02653664|470468109|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
130683002|NCT02653664|470468110|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
130683003|NCT02653664|470468111|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
130683004|NCT02653664|470468109|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
130683005|NCT02653664|470468110|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
130683006|NCT02653664|470468111|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
130683007|NCT02653664|470468109|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683008|NCT02653664|470468110|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
130683009|NCT02653664|470468111|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683010|NCT02653664|470468109|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
130683011|NCT02653664|470468110|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
130437213|NCT02632786|469564380|FG001|Overall Study|Adverse Event|1|||
130437214|NCT02632786|469564379|FG000|Overall Study|Death|3|||
130437215|NCT02632786|469564380|FG001|Overall Study|Death|2|||
130437216|NCT02632786|469564379|FG000|Overall Study|Physician Decision|5|||
130437217|NCT02632786|469564380|FG001|Overall Study|Physician Decision|4|||
130437218|NCT02632786|469564379|FG000|Overall Study|Withdrawal by Subject|1|||
130437219|NCT02632786|469564380|FG001|Overall Study|Withdrawal by Subject|0|||
130683012|NCT02653664|470468111|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
130683013|NCT02653664|470468109|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
130683014|NCT02653664|470468110|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
130683015|NCT02653664|470468111|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
130683016|NCT02653664|470468109|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
130683017|NCT02653664|470468110|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
130683018|NCT02653664|470468111|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
130683019|NCT02653664|470468109|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683020|NCT02653664|470468110|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
130683021|NCT02653664|470468111|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683022|NCT02653664|470468109|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130683023|NCT02653664|470468110|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
130683024|NCT02653664|470468111|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130683025|NCT00746798|470468112|FG000|Overall Study|Protocol Violation|0|||
130683026|NCT00746798|470468113|FG001|Overall Study|Protocol Violation|1|||
130683027|NCT00746798|470468114|FG002|Overall Study|Protocol Violation|0|||
130683028|NCT00746798|470468115|FG003|Overall Study|Protocol Violation|0|||
130683029|NCT00746798|470468112|FG000|Overall Study|Withdrawal by Subject|0|||
130683030|NCT00746798|470468113|FG001|Overall Study|Withdrawal by Subject|1|||
130683031|NCT00746798|470468114|FG002|Overall Study|Withdrawal by Subject|1|||
130683032|NCT00746798|470468115|FG003|Overall Study|Withdrawal by Subject|0|||
130683033|NCT00746798|470468112|FG000|Overall Study|Death|0|||
130683034|NCT00746798|470468113|FG001|Overall Study|Death|0|||
130683035|NCT00746798|470468114|FG002|Overall Study|Death|2|||
130683036|NCT00746798|470468115|FG003|Overall Study|Death|0|||
130683037|NCT00746798|470468112|FG000|Overall Study|Participant unable to return for visit|1|||
130683038|NCT00746798|470468113|FG001|Overall Study|Participant unable to return for visit|0|||
130683039|NCT00746798|470468114|FG002|Overall Study|Participant unable to return for visit|0|||
130683040|NCT00746798|470468115|FG003|Overall Study|Participant unable to return for visit|0|||
130683041|NCT00633594|470468116|FG000|Overall Study|Adverse Event|0|||
130683042|NCT00633594|470468117|FG001|Overall Study|Adverse Event|4|||
130683043|NCT00633594|470468118|FG002|Overall Study|Adverse Event|7|||
130683044|NCT00633594|470468116|FG000|Overall Study|Death|0|||
130683045|NCT00633594|470468117|FG001|Overall Study|Death|1|||
130683046|NCT00633594|470468118|FG002|Overall Study|Death|2|||
130683047|NCT00633594|470468116|FG000|Overall Study|Disease Progression|0|||
130683048|NCT00633594|470468117|FG001|Overall Study|Disease Progression|0|||
130683049|NCT00633594|470468118|FG002|Overall Study|Disease Progression|1|||
130683050|NCT01045096|470468122|FG000|Overall Study|Withdrawal by Subject|2|||
130683051|NCT01045096|470468123|FG001|Overall Study|Withdrawal by Subject|0|||
130683052|NCT01045096|470468124|FG002|Overall Study|Withdrawal by Subject|0|||
130683053|NCT01045096|470468122|FG000|Overall Study|Other|1|||
130683054|NCT01045096|470468123|FG001|Overall Study|Other|0|||
130683055|NCT01045096|470468124|FG002|Overall Study|Other|0|||
130683056|NCT01511939|470468126|FG000|Overall Study|Withdrawal by Subject|2|||
130683057|NCT01511939|470468127|FG001|Overall Study|Withdrawal by Subject|1|||
130683058|NCT01511939|470468128|FG002|Overall Study|Withdrawal by Subject|0|||
130683059|NCT00324168|470468133|FG000|Overall Study|Lost to Follow-up|19|||
130683060|NCT00324168|470468134|FG001|Overall Study|Lost to Follow-up|18|||
130437220|NCT01928225|469564381|FG000|Overall Study|Pregnancy|1|||
130683061|NCT00324168|470468133|FG000|Overall Study|Death|3|||
130683062|NCT00324168|470468134|FG001|Overall Study|Death|3|||
130683063|NCT00324168|470468133|FG000|Overall Study|Patient did not visit in f/u window|6|||
130437221|NCT01928225|469564382|FG001|Overall Study|Pregnancy|0|||
130437222|NCT01928225|469564381|FG000|Overall Study|basaloid cervical cancer|1|||
130437223|NCT01928225|469564382|FG001|Overall Study|basaloid cervical cancer|0|||
130437224|NCT01928225|469564381|FG000|Overall Study|Lost to Follow-up|1|||
130437225|NCT01928225|469564382|FG001|Overall Study|Lost to Follow-up|3|||
130437226|NCT01454830|469564386|FG000|Overall Study|Withdrawal by Subject|4|||
130437227|NCT01454830|469564387|FG001|Overall Study|Withdrawal by Subject|4|||
130437228|NCT01454830|469564386|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
130437229|NCT01454830|469564387|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
130437230|NCT01454830|469564386|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
130437231|NCT01454830|469564387|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
130437232|NCT01454830|469564386|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
130437233|NCT01454830|469564387|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
130437234|NCT01454830|469564386|FG000|Overall Study|Withdrawal - no polysomnography|3|||
130437235|NCT01454830|469564387|FG001|Overall Study|Withdrawal - no polysomnography|2|||
130437236|NCT00152763|469564388|FG000|Overall Study|Death|4|||
130437237|NCT00152763|469564389|FG001|Overall Study|Death|1|||
130437238|NCT00152763|469564390|FG002|Overall Study|Death|2|||
130437239|NCT00152763|469564391|FG003|Overall Study|Death|1|||
130437240|NCT00152763|469564388|FG000|Overall Study|Lost to Follow-up|6|||
130437241|NCT00152763|469564389|FG001|Overall Study|Lost to Follow-up|4|||
130437242|NCT00152763|469564390|FG002|Overall Study|Lost to Follow-up|2|||
130437243|NCT00152763|469564391|FG003|Overall Study|Lost to Follow-up|13|||
130437244|NCT00569803|469564394|FG000|Overall Study|Lost to Follow-up|1|||
130437245|NCT00569803|469564395|FG001|Overall Study|Lost to Follow-up|0|||
130437246|NCT00569803|469564396|FG002|Overall Study|Lost to Follow-up|0|||
130437247|NCT00569803|469564397|FG003|Overall Study|Lost to Follow-up|0|||
130437248|NCT00569803|469564398|FG004|Overall Study|Lost to Follow-up|0|||
130437249|NCT00569803|469564399|FG005|Overall Study|Lost to Follow-up|0|||
130437250|NCT00569803|469564400|FG006|Overall Study|Lost to Follow-up|0|||
130437251|NCT00569803|469564401|FG007|Overall Study|Lost to Follow-up|0|||
130437252|NCT00569803|469564394|FG000|Overall Study|injection syringe leaked during dosing|0|||
130437253|NCT00569803|469564395|FG001|Overall Study|injection syringe leaked during dosing|0|||
130437254|NCT00569803|469564396|FG002|Overall Study|injection syringe leaked during dosing|0|||
130437255|NCT00569803|469564397|FG003|Overall Study|injection syringe leaked during dosing|1|||
130437256|NCT00569803|469564398|FG004|Overall Study|injection syringe leaked during dosing|0|||
130437257|NCT00569803|469564399|FG005|Overall Study|injection syringe leaked during dosing|0|||
130437258|NCT00569803|469564400|FG006|Overall Study|injection syringe leaked during dosing|0|||
130437259|NCT00569803|469564401|FG007|Overall Study|injection syringe leaked during dosing|0|||
130437260|NCT00569803|469564394|FG000|Overall Study|Withdrawal by Subject|0|||
130437261|NCT00569803|469564395|FG001|Overall Study|Withdrawal by Subject|0|||
130437262|NCT00569803|469564396|FG002|Overall Study|Withdrawal by Subject|0|||
130437263|NCT00569803|469564397|FG003|Overall Study|Withdrawal by Subject|0|||
130437264|NCT00569803|469564398|FG004|Overall Study|Withdrawal by Subject|0|||
130437265|NCT00569803|469564399|FG005|Overall Study|Withdrawal by Subject|0|||
130437266|NCT00569803|469564400|FG006|Overall Study|Withdrawal by Subject|0|||
130437267|NCT00569803|469564401|FG007|Overall Study|Withdrawal by Subject|1|||
130683064|NCT00324168|470468134|FG001|Overall Study|Patient did not visit in f/u window|9|||
130683065|NCT03497897|470468136|FG000|Overall Study|Adverse Event|1|||
130683066|NCT03497897|470468137|FG001|Overall Study|Adverse Event|1|||
130683067|NCT03497897|470468138|FG002|Overall Study|Adverse Event|1|||
130683068|NCT03497897|470468136|FG000|Overall Study|Lost to Follow-up|2|||
130683069|NCT03497897|470468137|FG001|Overall Study|Lost to Follow-up|0|||
130683070|NCT03497897|470468138|FG002|Overall Study|Lost to Follow-up|2|||
130437268|NCT01993823|469564402|FG000|Overall Study|Requested by the patient|6|||
130683071|NCT03497897|470468136|FG000|Overall Study|Physician Decision|1|||
130683072|NCT03497897|470468137|FG001|Overall Study|Physician Decision|0|||
130683073|NCT03497897|470468138|FG002|Overall Study|Physician Decision|0|||
130437269|NCT01993823|469564403|FG001|Overall Study|Requested by the patient|11|||
130437270|NCT01993823|469564402|FG000|Overall Study|Protocol Violation|0|||
130437271|NCT01993823|469564403|FG001|Overall Study|Protocol Violation|1|||
130437272|NCT01993823|469564402|FG000|Overall Study|Lost to Follow-up|1|||
130437273|NCT01993823|469564403|FG001|Overall Study|Lost to Follow-up|4|||
130437274|NCT01235975|469564404|FG000|Overall Study|Serious Adverse Event|0|||
130683074|NCT03497897|470468136|FG000|Overall Study|Subject/Guardian Decision|2|||
130683075|NCT03497897|470468137|FG001|Overall Study|Subject/Guardian Decision|1|||
130437275|NCT01235975|469564405|FG001|Overall Study|Serious Adverse Event|1|||
130437276|NCT01235975|469564404|FG000|Overall Study|Withdrawal by Subject|8|||
130437277|NCT01235975|469564405|FG001|Overall Study|Withdrawal by Subject|2|||
130683076|NCT03497897|470468138|FG002|Overall Study|Subject/Guardian Decision|3|||
130683077|NCT00358449|470468143|FG000|Overall Study|Adverse Event|1|||
130683078|NCT00358449|470468144|FG001|Overall Study|Adverse Event|0|||
130683079|NCT00358449|470468145|FG002|Overall Study|Adverse Event|1|||
130683080|NCT00358449|470468143|FG000|Overall Study|Lost to Follow-up|1|||
130683081|NCT00358449|470468144|FG001|Overall Study|Lost to Follow-up|0|||
130683082|NCT00358449|470468145|FG002|Overall Study|Lost to Follow-up|0|||
130683083|NCT00358449|470468143|FG000|Overall Study|Withdrawal by Subject|2|||
130683084|NCT00358449|470468144|FG001|Overall Study|Withdrawal by Subject|0|||
130683085|NCT00358449|470468145|FG002|Overall Study|Withdrawal by Subject|0|||
130683086|NCT00358449|470468143|FG000|Overall Study|Lack of Efficacy|0|||
130683087|NCT00358449|470468144|FG001|Overall Study|Lack of Efficacy|1|||
130683088|NCT00358449|470468145|FG002|Overall Study|Lack of Efficacy|0|||
130683089|NCT00358449|470468143|FG000|Overall Study|Steriod Inhaler was Increased|0|||
130683090|NCT00358449|470468144|FG001|Overall Study|Steriod Inhaler was Increased|0|||
130683091|NCT00358449|470468145|FG002|Overall Study|Steriod Inhaler was Increased|1|||
130683092|NCT01367457|470468146|FG000|Overall Study|Death|2|||
130683093|NCT01367457|470468147|FG001|Overall Study|Death|0|||
130683094|NCT01367457|470468148|FG002|Overall Study|Death|0|||
130683095|NCT01367457|470468146|FG000|Overall Study|Investigator's decision|2|||
130683096|NCT01367457|470468147|FG001|Overall Study|Investigator's decision|0|||
130683097|NCT01367457|470468148|FG002|Overall Study|Investigator's decision|0|||
130683098|NCT01367457|470468146|FG000|Overall Study|Clinical decline (CD)|2|||
130683099|NCT01367457|470468147|FG001|Overall Study|Clinical decline (CD)|0|||
130683100|NCT01367457|470468148|FG002|Overall Study|Clinical decline (CD)|0|||
130683101|NCT01367457|470468146|FG000|Overall Study|Progression and death|8|||
130683102|NCT01367457|470468147|FG001|Overall Study|Progression and death|0|||
130683103|NCT01367457|470468148|FG002|Overall Study|Progression and death|0|||
130683104|NCT01367457|470468146|FG000|Overall Study|Toxicity|16|||
130683105|NCT01367457|470468147|FG001|Overall Study|Toxicity|0|||
130683106|NCT01367457|470468148|FG002|Overall Study|Toxicity|0|||
130683107|NCT01367457|470468146|FG000|Overall Study|Progression|137|||
130683108|NCT01367457|470468147|FG001|Overall Study|Progression|0|||
130683109|NCT01367457|470468148|FG002|Overall Study|Progression|0|||
130683110|NCT01367457|470468146|FG000|Overall Study|Patient asks for rest + slow progression|1|||
130683111|NCT01367457|470468147|FG001|Overall Study|Patient asks for rest + slow progression|0|||
130683112|NCT01367457|470468148|FG002|Overall Study|Patient asks for rest + slow progression|0|||
130683113|NCT01367457|470468146|FG000|Overall Study|Investigator's opinion, stable disease|1|||
130683114|NCT01367457|470468147|FG001|Overall Study|Investigator's opinion, stable disease|0|||
130683115|NCT01367457|470468148|FG002|Overall Study|Investigator's opinion, stable disease|0|||
130683116|NCT01367457|470468146|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
130683117|NCT01367457|470468147|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
130683118|NCT01367457|470468148|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
130683119|NCT01367457|470468146|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
130683120|NCT01367457|470468147|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130683121|NCT01367457|470468148|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130683122|NCT01367457|470468146|FG000|Overall Study|low grade toxicities + stable disease|1|||
130683123|NCT01367457|470468147|FG001|Overall Study|low grade toxicities + stable disease|0|||
130683124|NCT01367457|470468148|FG002|Overall Study|low grade toxicities + stable disease|0|||
130683125|NCT01367457|470468146|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
130683126|NCT01367457|470468147|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
130683127|NCT01367457|470468148|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
130683128|NCT01367457|470468146|FG000|Overall Study|Withdrawal by Subject|1|||
130683129|NCT01367457|470468147|FG001|Overall Study|Withdrawal by Subject|0|||
130683130|NCT01367457|470468148|FG002|Overall Study|Withdrawal by Subject|0|||
130683131|NCT01367457|470468146|FG000|Overall Study|CD, associated leukaemia|1|||
130683132|NCT01367457|470468147|FG001|Overall Study|CD, associated leukaemia|0|||
130683133|NCT01367457|470468148|FG002|Overall Study|CD, associated leukaemia|0|||
130683134|NCT01367457|470468146|FG000|Overall Study|Uncontrolled pain|1|||
130683135|NCT01367457|470468147|FG001|Overall Study|Uncontrolled pain|0|||
130683136|NCT01367457|470468148|FG002|Overall Study|Uncontrolled pain|0|||
130683137|NCT01367457|470468146|FG000|Overall Study|Overall status worsens to grade 4|1|||
130683138|NCT01367457|470468147|FG001|Overall Study|Overall status worsens to grade 4|0|||
130683139|NCT01367457|470468148|FG002|Overall Study|Overall status worsens to grade 4|0|||
130683140|NCT01367457|470468146|FG000|Overall Study|Stabilisation + frequent infections|1|||
130683141|NCT01367457|470468147|FG001|Overall Study|Stabilisation + frequent infections|0|||
130683142|NCT01367457|470468148|FG002|Overall Study|Stabilisation + frequent infections|0|||
130683143|NCT01367457|470468146|FG000|Overall Study|No clinical benefit|1|||
130683144|NCT01367457|470468147|FG001|Overall Study|No clinical benefit|0|||
130683145|NCT01367457|470468148|FG002|Overall Study|No clinical benefit|0|||
130683146|NCT01367457|470468146|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
130683147|NCT01367457|470468147|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
130683148|NCT01367457|470468148|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
130683149|NCT01367457|470468146|FG000|Overall Study|Overall decline|1|||
130683150|NCT01367457|470468147|FG001|Overall Study|Overall decline|0|||
130683151|NCT01367457|470468148|FG002|Overall Study|Overall decline|0|||
130437278|NCT01235975|469564404|FG000|Overall Study|Migrated/moved from study area|2|||
130437279|NCT01235975|469564405|FG001|Overall Study|Migrated/moved from study area|1|||
130437280|NCT01235975|469564404|FG000|Overall Study|Lost to Follow-up|7|||
130437281|NCT01235975|469564405|FG001|Overall Study|Lost to Follow-up|3|||
130437282|NCT00791921|469564408|FG000|Overall Study|Protocol planed|24|||
130437283|NCT00791921|469564409|FG001|Overall Study|Protocol planed|88|||
130437284|NCT00791921|469564408|FG000|Overall Study|Withdrawal by Subject|1|||
130437285|NCT00791921|469564409|FG001|Overall Study|Withdrawal by Subject|2|||
130437286|NCT00791921|469564408|FG000|Overall Study|Adverse Event|8|||
130437287|NCT00791921|469564409|FG001|Overall Study|Adverse Event|2|||
130437288|NCT00791921|469564408|FG000|Overall Study|Lack of Efficacy|0|||
130683152|NCT01367457|470468146|FG000|Overall Study|Rejection of treatment|1|||
130683153|NCT01367457|470468147|FG001|Overall Study|Rejection of treatment|0|||
130348594|NCT03576274|469247507|FG000|Overall Study|Lost to Follow-up|3|||
130348595|NCT03576274|469247508|FG001|Overall Study|Lost to Follow-up|2|||
130348596|NCT03576274|469247509|FG002|Overall Study|Lost to Follow-up|3|||
130348597|NCT03576274|469247510|FG003|Overall Study|Lost to Follow-up|1|||
130348598|NCT03576274|469247511|FG004|Overall Study|Lost to Follow-up|3|||
130348599|NCT03576274|469247507|FG000|Overall Study|Withdrawal by Subject|5|||
130348600|NCT03576274|469247508|FG001|Overall Study|Withdrawal by Subject|3|||
130348601|NCT03576274|469247509|FG002|Overall Study|Withdrawal by Subject|2|||
130348602|NCT03576274|469247510|FG003|Overall Study|Withdrawal by Subject|8|||
130348603|NCT03576274|469247511|FG004|Overall Study|Withdrawal by Subject|6|||
130348604|NCT03976323|469247512|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
130348605|NCT03976323|469247513|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130348606|NCT03976323|469247514|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130348607|NCT03976323|469247512|FG000|Induction Phase|Death|80|||
130348608|NCT03976323|469247513|FG001|Induction Phase|Death|0|||
130348609|NCT03976323|469247514|FG002|Induction Phase|Death|0|||
130348610|NCT03976323|469247512|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
130348611|NCT03976323|469247513|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
130348612|NCT03976323|469247514|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
130348613|NCT03976323|469247512|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130348614|NCT03976323|469247513|FG001|Maintenance Phase|Withdrawal by Subject|9|||
130348615|NCT03976323|469247514|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130348616|NCT03976323|469247512|FG000|Maintenance Phase|Physician Decision|0|||
130348617|NCT03976323|469247513|FG001|Maintenance Phase|Physician Decision|0|||
130348618|NCT03976323|469247514|FG002|Maintenance Phase|Physician Decision|1|||
130348619|NCT03976323|469247512|FG000|Maintenance Phase|Death|0|||
130348620|NCT03976323|469247513|FG001|Maintenance Phase|Death|228|||
130348621|NCT03976323|469247514|FG002|Maintenance Phase|Death|234|||
130376523|NCT00842712|469345852|FG003|Randomized Part|Ongoing at cut-off date|0|||
130376524|NCT00842712|469345853|FG004|Randomized Part|Ongoing at cut-off date|0|||
130376525|NCT00842712|469345854|FG005|Randomized Part|Ongoing at cut-off date|0|||
130376526|NCT00842712|469345855|FG006|Randomized Part|Ongoing at cut-off date|2|||
130376527|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130683154|NCT01367457|470468148|FG002|Overall Study|Rejection of treatment|0|||
130683155|NCT01367457|470468146|FG000|Overall Study|Lost to Follow-up|1|||
130376528|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130376529|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130376530|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130376531|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
130376532|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
130437289|NCT00791921|469564409|FG001|Overall Study|Lack of Efficacy|2|||
130437290|NCT00791921|469564408|FG000|Overall Study|Lack of study drug administration|1|||
130376533|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130437291|NCT00791921|469564409|FG001|Overall Study|Lack of study drug administration|1|||
130683156|NCT01367457|470468147|FG001|Overall Study|Lost to Follow-up|0|||
130683157|NCT01367457|470468148|FG002|Overall Study|Lost to Follow-up|0|||
130683158|NCT01367457|470468146|FG000|Overall Study|Death from septic shock|1|||
130683159|NCT01367457|470468147|FG001|Overall Study|Death from septic shock|0|||
130683160|NCT01367457|470468148|FG002|Overall Study|Death from septic shock|0|||
130683161|NCT01367457|470468146|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
130683162|NCT01367457|470468147|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
130683163|NCT01367457|470468148|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
130683164|NCT01367457|470468146|FG000|Overall Study|Patient's Wish|1|||
130348627|NCT04085367|469248524|FG000|Overall Study|Adverse Event|1|||
130348628|NCT04085367|469248525|FG001|Overall Study|Adverse Event|1|||
130348629|NCT04085367|469248524|FG000|Overall Study|Withdrawal by Subject|13|||
130348630|NCT04085367|469248525|FG001|Overall Study|Withdrawal by Subject|4|||
130348631|NCT04085367|469248524|FG000|Overall Study|Lost to Follow-up|3|||
130348632|NCT04085367|469248525|FG001|Overall Study|Lost to Follow-up|1|||
130348633|NCT04085367|469248524|FG000|Overall Study|Other unspecified|2|||
130348634|NCT04085367|469248525|FG001|Overall Study|Other unspecified|1|||
130348635|NCT04085367|469248524|FG000|Overall Study|Status Unknown|1|||
130348636|NCT04085367|469248525|FG001|Overall Study|Status Unknown|1|||
130348637|NCT00130442|469248528|FG000|Overall Study|Withdrawal by Subject|0|||
130348638|NCT00130442|469248529|FG001|Overall Study|Withdrawal by Subject|1|||
130348639|NCT00130442|469248528|FG000|Overall Study|did not meet criteria|1|||
130348640|NCT00130442|469248529|FG001|Overall Study|did not meet criteria|1|||
130348641|NCT00814333|469248530|FG000|Enrollment|Lost to Follow-up|1|||
130348642|NCT00814333|469248531|FG001|Enrollment|Lost to Follow-up|0|||
130348643|NCT02233946|469248532|FG000|Baseline|Withdrawal by Subject|2|||
130348644|NCT02233946|469248533|FG001|Baseline|Withdrawal by Subject|0|||
130348645|NCT02233946|469248532|FG000|3-months Follow-up|Lost to Follow-up|53|||
130348646|NCT02233946|469248533|FG001|3-months Follow-up|Lost to Follow-up|29|||
130348647|NCT02233946|469248532|FG000|6-months Follow-up|Lost to Follow-up|21|||
130348648|NCT02233946|469248533|FG001|6-months Follow-up|Lost to Follow-up|2|||
130348649|NCT02233946|469248532|FG000|9-month Follow-up|Lost to Follow-up|20|||
130348650|NCT02233946|469248533|FG001|9-month Follow-up|Lost to Follow-up|11|||
130348651|NCT02233946|469248532|FG000|12-month Follow-up|Lost to Follow-up|28|||
130348652|NCT02233946|469248533|FG001|12-month Follow-up|Lost to Follow-up|11|||
130348653|NCT00773383|469248534|FG000|Overall Study|Adverse Event|4|||
130348654|NCT00773383|469248534|FG000|Overall Study|Death|1|||
130348655|NCT00773383|469248534|FG000|Overall Study|Progression of Disease|23|||
130348656|NCT00773383|469248534|FG000|Overall Study|Other|2|||
130348657|NCT00773383|469248534|FG000|Overall Study|No study dose received|1|||
130348658|NCT03384693|469248535|FG000|Overall Study|Adverse Event|3|||
130348659|NCT02919969|469248538|FG000|Overall Study|Lack of Efficacy|22|||
130348660|NCT02919969|469248538|FG000|Overall Study|Death|4|||
130348661|NCT02919969|469248538|FG000|Overall Study|Physician Decision|3|||
130348662|NCT02919969|469248538|FG000|Overall Study|Withdrawal by Subject|2|||
130348663|NCT01842633|469248539|FG000|Overall Study|Screen Failure|1|||
130348664|NCT01842633|469248540|FG001|Overall Study|Screen Failure|0|||
130348665|NCT01842633|469248541|FG002|Overall Study|Screen Failure|0|||
130348666|NCT01842633|469248539|FG000|Overall Study|Adverse Event|1|||
130348667|NCT01842633|469248540|FG001|Overall Study|Adverse Event|1|||
130348668|NCT01842633|469248541|FG002|Overall Study|Adverse Event|0|||
130348669|NCT01842633|469248539|FG000|Overall Study|Withdrawal by Subject|0|||
130348670|NCT01842633|469248540|FG001|Overall Study|Withdrawal by Subject|1|||
130348671|NCT01842633|469248541|FG002|Overall Study|Withdrawal by Subject|0|||
130348672|NCT01842633|469248539|FG000|Overall Study|Technical issues|1|||
130348673|NCT01842633|469248540|FG001|Overall Study|Technical issues|0|||
130348674|NCT01842633|469248541|FG002|Overall Study|Technical issues|0|||
130348675|NCT02093351|469248542|FG000|Part A|Adverse Event|0|||
130348676|NCT02093351|469248543|FG001|Part A|Adverse Event|1|||
130348677|NCT02093351|469248544|FG002|Part A|Adverse Event|1|||
130348678|NCT02093351|469248545|FG003|Part A|Adverse Event|0|||
130348679|NCT02093351|469248542|FG000|Part A|Condition under investigation worsened|2|||
130348680|NCT02093351|469248543|FG001|Part A|Condition under investigation worsened|0|||
130348681|NCT02093351|469248544|FG002|Part A|Condition under investigation worsened|2|||
130348682|NCT02093351|469248545|FG003|Part A|Condition under investigation worsened|0|||
130348683|NCT02093351|469248542|FG000|Part A|Death|0|||
130348684|NCT02093351|469248543|FG001|Part A|Death|1|||
130348685|NCT02093351|469248544|FG002|Part A|Death|0|||
130348686|NCT02093351|469248545|FG003|Part A|Death|0|||
130348687|NCT02093351|469248542|FG000|Part B|Patient decision|0|||
130348688|NCT02093351|469248543|FG001|Part B|Patient decision|0|||
130348689|NCT02093351|469248544|FG002|Part B|Patient decision|0|||
130348690|NCT02093351|469248545|FG003|Part B|Patient decision|3|||
130348691|NCT02093351|469248542|FG000|Part B|Disease progression|0|||
130348692|NCT02093351|469248543|FG001|Part B|Disease progression|0|||
130348693|NCT02093351|469248544|FG002|Part B|Disease progression|0|||
130348694|NCT02093351|469248545|FG003|Part B|Disease progression|4|||
130348695|NCT02093351|469248542|FG000|Part B|Complete response|0|||
130348696|NCT02093351|469248543|FG001|Part B|Complete response|0|||
130348697|NCT02093351|469248544|FG002|Part B|Complete response|0|||
130348698|NCT02093351|469248545|FG003|Part B|Complete response|1|||
130348699|NCT02093351|469248542|FG000|Part B|Adverse event + disease progression|0|||
130348700|NCT02093351|469248543|FG001|Part B|Adverse event + disease progression|0|||
130348701|NCT02093351|469248544|FG002|Part B|Adverse event + disease progression|0|||
130348702|NCT02093351|469248545|FG003|Part B|Adverse event + disease progression|1|||
130348703|NCT02093351|469248542|FG000|Part B|Lack of therapeutic response|0|||
130348704|NCT02093351|469248543|FG001|Part B|Lack of therapeutic response|0|||
130348705|NCT02093351|469248544|FG002|Part B|Lack of therapeutic response|0|||
130348706|NCT02093351|469248545|FG003|Part B|Lack of therapeutic response|12|||
130348707|NCT02093351|469248542|FG000|Part B|Condition under investigation worsened|0|||
130348708|NCT02093351|469248543|FG001|Part B|Condition under investigation worsened|0|||
130348709|NCT02093351|469248544|FG002|Part B|Condition under investigation worsened|0|||
130348710|NCT02093351|469248545|FG003|Part B|Condition under investigation worsened|39|||
130348711|NCT02093351|469248542|FG000|Part B|Adverse Event|0|||
130348712|NCT02093351|469248543|FG001|Part B|Adverse Event|0|||
130348713|NCT02093351|469248544|FG002|Part B|Adverse Event|0|||
130348714|NCT02093351|469248545|FG003|Part B|Adverse Event|2|||
130348715|NCT02093351|469248542|FG000|Part B|Death|0|||
130348716|NCT02093351|469248543|FG001|Part B|Death|0|||
130348717|NCT02093351|469248544|FG002|Part B|Death|0|||
130348718|NCT02093351|469248545|FG003|Part B|Death|1|||
130348719|NCT01099709|469248546|FG000|Period 1|Withdrawal by Subject|0|||
130348720|NCT01099709|469248547|FG001|Period 1|Withdrawal by Subject|1|||
130348721|NCT01099709|469248546|FG000|Period 1|Positive cotinine test|0|||
130348722|NCT01099709|469248547|FG001|Period 1|Positive cotinine test|1|||
130348723|NCT01099709|469248546|FG000|Period 1|Adverse Event|1|||
130348724|NCT01099709|469248547|FG001|Period 1|Adverse Event|0|||
130348725|NCT00718081|469248553|FG000|Overall Study|Adverse Event|0|||
130348726|NCT00718081|469248554|FG001|Overall Study|Adverse Event|1|||
130348727|NCT00718081|469248555|FG002|Overall Study|Adverse Event|0|||
130348728|NCT00718081|469248553|FG000|Overall Study|Lack of Efficacy|7|||
130348729|NCT00718081|469248554|FG001|Overall Study|Lack of Efficacy|3|||
130348730|NCT00718081|469248555|FG002|Overall Study|Lack of Efficacy|21|||
130348731|NCT01397825|469248556|FG000|Overall Study|Progressive Disease|10|||
130348732|NCT01397825|469248557|FG001|Overall Study|Progressive Disease|3|||
130348733|NCT01397825|469248558|FG002|Overall Study|Progressive Disease|11|||
130348734|NCT01397825|469248559|FG003|Overall Study|Progressive Disease|1|||
130348735|NCT01397825|469248560|FG004|Overall Study|Progressive Disease|0|||
130348736|NCT01397825|469248556|FG000|Overall Study|Symptomatic Deterioration|2|||
130348737|NCT01397825|469248557|FG001|Overall Study|Symptomatic Deterioration|0|||
130348738|NCT01397825|469248558|FG002|Overall Study|Symptomatic Deterioration|4|||
130348739|NCT01397825|469248559|FG003|Overall Study|Symptomatic Deterioration|0|||
130348740|NCT01397825|469248560|FG004|Overall Study|Symptomatic Deterioration|0|||
130348741|NCT01397825|469248556|FG000|Overall Study|Adverse Event|0|||
130348742|NCT01397825|469248557|FG001|Overall Study|Adverse Event|1|||
130348743|NCT01397825|469248558|FG002|Overall Study|Adverse Event|5|||
130348744|NCT01397825|469248559|FG003|Overall Study|Adverse Event|1|||
130348745|NCT01397825|469248560|FG004|Overall Study|Adverse Event|0|||
130348746|NCT01397825|469248556|FG000|Overall Study|Withdrawal by Subject|1|||
130348747|NCT01397825|469248557|FG001|Overall Study|Withdrawal by Subject|0|||
130348748|NCT01397825|469248558|FG002|Overall Study|Withdrawal by Subject|5|||
130348749|NCT01397825|469248559|FG003|Overall Study|Withdrawal by Subject|1|||
130348750|NCT01397825|469248560|FG004|Overall Study|Withdrawal by Subject|0|||
130348751|NCT00815516|469248561|FG000|Overall Study|Death|3|||
130348752|NCT00815516|469248562|FG001|Overall Study|Death|1|||
130348753|NCT00815516|469248561|FG000|Overall Study|Physician Decision|1|||
130348754|NCT00815516|469248562|FG001|Overall Study|Physician Decision|0|||
130348755|NCT01741012|469248568|FG000|Overall Study|Lost to Follow-up|1|||
130348756|NCT01741012|469248568|FG000|Overall Study|Withdrawal by Subject|2|||
130348757|NCT00470158|469248569|FG000|Overall Study|Death|0|||
130348758|NCT00470158|469248570|FG001|Overall Study|Death|0|||
130348759|NCT00470158|469248571|FG002|Overall Study|Death|0|||
130348760|NCT00470158|469248572|FG003|Overall Study|Death|0|||
130348761|NCT00470158|469248573|FG004|Overall Study|Death|2|||
130348762|NCT00470158|469248569|FG000|Overall Study|Lost to Follow-up|7|||
130348763|NCT00470158|469248570|FG001|Overall Study|Lost to Follow-up|8|||
130348764|NCT00470158|469248571|FG002|Overall Study|Lost to Follow-up|8|||
130348765|NCT00470158|469248572|FG003|Overall Study|Lost to Follow-up|5|||
130348766|NCT00470158|469248573|FG004|Overall Study|Lost to Follow-up|4|||
130348767|NCT00470158|469248569|FG000|Overall Study|Protocol Violation|1|||
130348768|NCT00470158|469248570|FG001|Overall Study|Protocol Violation|0|||
130348769|NCT00470158|469248571|FG002|Overall Study|Protocol Violation|0|||
130348770|NCT00470158|469248572|FG003|Overall Study|Protocol Violation|0|||
130348771|NCT00470158|469248573|FG004|Overall Study|Protocol Violation|0|||
130348772|NCT01236118|469248574|FG000|Overall Study|Adverse Event|2|||
130348773|NCT01236118|469248575|FG001|Overall Study|Adverse Event|0|||
130348774|NCT01236118|469248576|FG002|Overall Study|Adverse Event|2|||
130348775|NCT01236118|469248574|FG000|Overall Study|Physician Decision|0|||
130348776|NCT01236118|469248575|FG001|Overall Study|Physician Decision|1|||
130348777|NCT01236118|469248576|FG002|Overall Study|Physician Decision|0|||
130437292|NCT00791921|469564408|FG000|Overall Study|Reason other than those above|0|||
130437293|NCT00791921|469564409|FG001|Overall Study|Reason other than those above|1|||
130437294|NCT00474175|469564411|FG000|Overall Study|Lack of Efficacy|0|||
130437295|NCT00474175|469564412|FG001|Overall Study|Lack of Efficacy|0|||
130437296|NCT00474175|469564413|FG002|Overall Study|Lack of Efficacy|1|||
130437297|NCT00474175|469564411|FG000|Overall Study|Withdrawal by Subject|0|||
130437298|NCT00474175|469564412|FG001|Overall Study|Withdrawal by Subject|1|||
130437299|NCT00474175|469564413|FG002|Overall Study|Withdrawal by Subject|1|||
130437300|NCT00474175|469564411|FG000|Overall Study|Ineligible|1|||
130437301|NCT00474175|469564412|FG001|Overall Study|Ineligible|3|||
130437302|NCT00474175|469564413|FG002|Overall Study|Ineligible|1|||
130437303|NCT00474175|469564411|FG000|Overall Study|Protocol Violation|0|||
130437304|NCT00474175|469564412|FG001|Overall Study|Protocol Violation|2|||
130437305|NCT00474175|469564413|FG002|Overall Study|Protocol Violation|1|||
130437306|NCT00474175|469564411|FG000|Overall Study|Administrative|0|||
130437307|NCT00474175|469564412|FG001|Overall Study|Administrative|1|||
130437308|NCT00474175|469564413|FG002|Overall Study|Administrative|0|||
130437309|NCT01460160|469564415|FG000|Treatment Phase|Lack of Efficacy|3|||
130437310|NCT01460160|469564415|FG000|Treatment Phase|Study Drug Toxicity|2|||
130437311|NCT01460160|469564415|FG000|Treatment Phase|Adverse Event|8|||
130437312|NCT01460160|469564415|FG000|Treatment Phase|Withdrawal by Subject|4|||
130437313|NCT01460160|469564415|FG000|Treatment Phase|Death|2|||
130437314|NCT01460160|469564415|FG000|Treatment Phase|Other reasons|9|||
130437315|NCT01460160|469564415|FG000|Follow-up Phase|Withdrawal by Subject|4|||
130437316|NCT01460160|469564415|FG000|Follow-up Phase|Death|14|||
130437317|NCT01460160|469564415|FG000|Follow-up Phase|Lost to Follow-up|7|||
130437318|NCT01460160|469564415|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
130437319|NCT01460160|469564415|FG000|Follow-up Phase|Other and not reported reasons|5|||
130437320|NCT02091739|469564417|FG000|MP: 16 Weeks|Adverse Event|1|||
130437321|NCT02091739|469564418|FG001|MP: 16 Weeks|Adverse Event|1|||
130437322|NCT02091739|469564419|FG002|MP: 16 Weeks|Adverse Event|1|||
130437323|NCT02091739|469564420|FG003|MP: 16 Weeks|Adverse Event|0|||
130437324|NCT02091739|469564421|FG004|MP: 16 Weeks|Adverse Event|0|||
130437325|NCT02091739|469564417|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
130437326|NCT02091739|469564418|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
130437327|NCT02091739|469564419|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
130437328|NCT02091739|469564420|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
130437329|NCT02091739|469564421|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
130437330|NCT02091739|469564417|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
130437331|NCT02091739|469564418|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
130437332|NCT02091739|469564419|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
130437333|NCT02091739|469564420|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
130437334|NCT02091739|469564421|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
130437335|NCT02091739|469564417|FG000|EP: 48 Weeks|Other|0|||
130437336|NCT02091739|469564418|FG001|EP: 48 Weeks|Other|0|||
130437337|NCT02091739|469564419|FG002|EP: 48 Weeks|Other|0|||
130437338|NCT02091739|469564420|FG003|EP: 48 Weeks|Other|1|||
130437339|NCT02091739|469564421|FG004|EP: 48 Weeks|Other|0|||
130437340|NCT02091739|469564417|FG000|EP: 48 Weeks|Death|0|||
130437341|NCT02091739|469564418|FG001|EP: 48 Weeks|Death|0|||
130437342|NCT02091739|469564419|FG002|EP: 48 Weeks|Death|0|||
130437343|NCT02091739|469564420|FG003|EP: 48 Weeks|Death|3|||
130437344|NCT02091739|469564421|FG004|EP: 48 Weeks|Death|2|||
130437345|NCT02091739|469564417|FG000|EP: 48 Weeks|Adverse Event|0|||
130437346|NCT02091739|469564418|FG001|EP: 48 Weeks|Adverse Event|0|||
130437347|NCT02091739|469564419|FG002|EP: 48 Weeks|Adverse Event|0|||
130437348|NCT02091739|469564420|FG003|EP: 48 Weeks|Adverse Event|2|||
130437349|NCT02091739|469564421|FG004|EP: 48 Weeks|Adverse Event|6|||
130437350|NCT02091739|469564417|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
130437351|NCT02091739|469564418|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
130437352|NCT02091739|469564419|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
130437353|NCT02091739|469564420|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
130437354|NCT02091739|469564421|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
130437355|NCT00192023|469564422|FG000|Period III - Double-Blind|Adverse Event|3|||
130437356|NCT00192023|469564423|FG001|Period III - Double-Blind|Adverse Event|0|||
130437357|NCT00192023|469564422|FG000|Period III - Double-Blind|Physician Decision|2|||
130437358|NCT00192023|469564423|FG001|Period III - Double-Blind|Physician Decision|0|||
130437359|NCT00192023|469564422|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
130437360|NCT00192023|469564423|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
130437361|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
130437362|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
130437363|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
130437364|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
130437365|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
130437366|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
130437367|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
130437368|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
130552790|NCT00792805|469991534|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130683165|NCT01367457|470468147|FG001|Overall Study|Patient's Wish|0|||
130683166|NCT01367457|470468148|FG002|Overall Study|Patient's Wish|0|||
130437369|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
130437370|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
130437371|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
130437372|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
130437373|NCT00192023|469564422|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
130437374|NCT00192023|469564423|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
130437375|NCT02086162|469564427|FG000|Overall Study|Withdrawal by Subject|4|||
130437376|NCT02086162|469564428|FG001|Overall Study|Withdrawal by Subject|4|||
130437377|NCT02086162|469564427|FG000|Overall Study|moved|1|||
130437378|NCT02086162|469564428|FG001|Overall Study|moved|1|||
130437379|NCT02086162|469564427|FG000|Overall Study|Lost to Follow-up|4|||
130437380|NCT02086162|469564428|FG001|Overall Study|Lost to Follow-up|2|||
130437381|NCT02086162|469564427|FG000|Overall Study|Death|1|||
130437382|NCT02086162|469564428|FG001|Overall Study|Death|0|||
130437383|NCT00308737|469564431|FG000|Overall Study|Adverse Event|104|||
130437384|NCT00308737|469564432|FG001|Overall Study|Adverse Event|9|||
130437385|NCT00308737|469564433|FG002|Overall Study|Adverse Event|0|||
130437386|NCT00308737|469564431|FG000|Overall Study|Death|4|||
130437387|NCT00308737|469564432|FG001|Overall Study|Death|3|||
130437388|NCT00308737|469564433|FG002|Overall Study|Death|0|||
130437389|NCT00308737|469564431|FG000|Overall Study|Lost to Follow-up|56|||
130437390|NCT00308737|469564432|FG001|Overall Study|Lost to Follow-up|80|||
130437391|NCT00308737|469564433|FG002|Overall Study|Lost to Follow-up|5|||
130437392|NCT00308737|469564431|FG000|Overall Study|Physician Decision|15|||
130437393|NCT00308737|469564432|FG001|Overall Study|Physician Decision|2|||
130437394|NCT00308737|469564433|FG002|Overall Study|Physician Decision|1|||
130437395|NCT00308737|469564431|FG000|Overall Study|Protocol Violation|34|||
130683167|NCT01367457|470468146|FG000|Overall Study|Palliative. Overall decline|1|||
130437396|NCT00308737|469564432|FG001|Overall Study|Protocol Violation|9|||
130437397|NCT00308737|469564433|FG002|Overall Study|Protocol Violation|5|||
130437398|NCT00308737|469564431|FG000|Overall Study|Withdrawal by Subject|218|||
130437399|NCT00308737|469564432|FG001|Overall Study|Withdrawal by Subject|166|||
130437400|NCT00308737|469564433|FG002|Overall Study|Withdrawal by Subject|18|||
130437401|NCT00308737|469564431|FG000|Overall Study|Various|32|||
130437402|NCT00308737|469564432|FG001|Overall Study|Various|20|||
130437403|NCT00308737|469564433|FG002|Overall Study|Various|8|||
130437404|NCT00089895|469564434|FG000|Overall Study|Consent Withdrawn|11|||
130437405|NCT00089895|469564435|FG001|Overall Study|Consent Withdrawn|14|||
130437406|NCT00089895|469564434|FG000|Overall Study|Technical reason|7|||
130437407|NCT00089895|469564435|FG001|Overall Study|Technical reason|2|||
130437408|NCT00089895|469564434|FG000|Overall Study|Surgery|0|||
130437409|NCT00089895|469564435|FG001|Overall Study|Surgery|1|||
130437410|NCT00089895|469564434|FG000|Overall Study|Bleeding|0|||
130437411|NCT00089895|469564435|FG001|Overall Study|Bleeding|2|||
130437412|NCT00089895|469564434|FG000|Overall Study|Physician Decision|3|||
130437413|NCT00089895|469564435|FG001|Overall Study|Physician Decision|7|||
130437414|NCT00089895|469564434|FG000|Overall Study|Exclusion criteria met|6|||
130437415|NCT00089895|469564435|FG001|Overall Study|Exclusion criteria met|6|||
130437416|NCT00089895|469564434|FG000|Overall Study|Not otherwise specified|4|||
130437417|NCT00089895|469564435|FG001|Overall Study|Not otherwise specified|8|||
130437418|NCT00089895|469564434|FG000|Overall Study|Missing|4|||
130437419|NCT00089895|469564435|FG001|Overall Study|Missing|2|||
130437420|NCT05644353|469564436|FG000|Overall Study|Physician Decision|1|||
130437421|NCT05644353|469564437|FG001|Overall Study|Physician Decision|0|||
130437422|NCT05644353|469564438|FG002|Overall Study|Physician Decision|0|||
130437423|NCT05644353|469564439|FG003|Overall Study|Physician Decision|0|||
130437424|NCT05644353|469564440|FG004|Overall Study|Physician Decision|0|||
130437425|NCT05644353|469564441|FG005|Overall Study|Physician Decision|0|||
130683168|NCT01367457|470468147|FG001|Overall Study|Palliative. Overall decline|0|||
130683169|NCT01367457|470468148|FG002|Overall Study|Palliative. Overall decline|0|||
130683170|NCT01367457|470468146|FG000|Overall Study|Suspected DP/suspected active infection|1|||
130683171|NCT01367457|470468147|FG001|Overall Study|Suspected DP/suspected active infection|0|||
130683172|NCT01367457|470468148|FG002|Overall Study|Suspected DP/suspected active infection|0|||
130437426|NCT05644353|469564436|FG000|Overall Study|Protocol Violation|1|||
130437427|NCT05644353|469564437|FG001|Overall Study|Protocol Violation|0|||
130437428|NCT05644353|469564438|FG002|Overall Study|Protocol Violation|0|||
130437429|NCT05644353|469564439|FG003|Overall Study|Protocol Violation|0|||
130437430|NCT05644353|469564440|FG004|Overall Study|Protocol Violation|0|||
130437431|NCT05644353|469564441|FG005|Overall Study|Protocol Violation|0|||
130437432|NCT05644353|469564436|FG000|Overall Study|Withdrawal by Subject|0|||
130437433|NCT05644353|469564437|FG001|Overall Study|Withdrawal by Subject|2|||
130437434|NCT05644353|469564438|FG002|Overall Study|Withdrawal by Subject|0|||
130437435|NCT05644353|469564439|FG003|Overall Study|Withdrawal by Subject|0|||
130437436|NCT05644353|469564440|FG004|Overall Study|Withdrawal by Subject|1|||
130437437|NCT05644353|469564441|FG005|Overall Study|Withdrawal by Subject|0|||
130437438|NCT05644353|469564436|FG000|Overall Study|Lost to Follow-up|0|||
130683173|NCT02300103|470468152|FG000|Overall Study|Lack of Efficacy|3|||
130683174|NCT02300103|470468152|FG000|Overall Study|Protocol Violation|1|||
130683175|NCT02300103|470468152|FG000|Overall Study|Withdrew Consent|2|||
130683176|NCT04091971|470468153|FG000|Overall Study|Withdrawal by Subject|1|||
130683177|NCT04091971|470468153|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
130683178|NCT04091971|470468153|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
130683179|NCT01666730|470468156|FG000|Overall Study|Adverse Event|16|||
130683180|NCT01666730|470468156|FG000|Overall Study|Death|2|||
130683181|NCT01666730|470468156|FG000|Overall Study|Physician Decision|5|||
130348778|NCT01236118|469248574|FG000|Overall Study|Withdrawal by Subject|0|||
130348779|NCT01236118|469248575|FG001|Overall Study|Withdrawal by Subject|0|||
130348780|NCT01236118|469248576|FG002|Overall Study|Withdrawal by Subject|1|||
130348781|NCT01129024|469248581|FG000|Overall Study|Physician Decision|5|||
130348782|NCT01129024|469248581|FG000|Overall Study|Study Terminated by Sponsor|8|||
130348783|NCT01129024|469248581|FG000|Overall Study|Withdrawal by Subject|2|||
130348784|NCT01129024|469248581|FG000|Overall Study|Lack of Efficacy|3|||
130348785|NCT01129024|469248581|FG000|Overall Study|Needed a Platelet Transfusion|1|||
130348786|NCT01993836|469248582|FG000|Overall Study|Surgery Cancelled|3|||
130348787|NCT01993836|469248583|FG001|Overall Study|Surgery Cancelled|0|||
130348788|NCT01993836|469248584|FG002|Overall Study|Surgery Cancelled|0|||
130348789|NCT01993836|469248582|FG000|Overall Study|Physician Decision|2|||
130348790|NCT01993836|469248583|FG001|Overall Study|Physician Decision|1|||
130348791|NCT01993836|469248584|FG002|Overall Study|Physician Decision|0|||
130348792|NCT01993836|469248582|FG000|Overall Study|Death|0|||
130348793|NCT01993836|469248583|FG001|Overall Study|Death|2|||
130348794|NCT01993836|469248584|FG002|Overall Study|Death|0|||
130348795|NCT01993836|469248582|FG000|Overall Study|Withdrawal by Subject|12|||
130348796|NCT01993836|469248583|FG001|Overall Study|Withdrawal by Subject|10|||
130348797|NCT01993836|469248584|FG002|Overall Study|Withdrawal by Subject|5|||
130348798|NCT02195687|469248586|FG000|Overall Study|Personal Reasons|1|||
130348799|NCT02195687|469248587|FG001|Overall Study|Personal Reasons|1|||
130348800|NCT02195687|469248586|FG000|Overall Study|Lost to Follow-up|4|||
130348801|NCT02195687|469248587|FG001|Overall Study|Lost to Follow-up|1|||
130348802|NCT04369924|469248590|FG000|Overall Study|Lost to Follow-up|302|||
130348803|NCT04369924|469248591|FG001|Overall Study|Lost to Follow-up|339|||
130348804|NCT02677324|469248592|FG000|Overall Study|Disease Progression|6|||
130348805|NCT02677324|469248592|FG000|Overall Study|Inability to Swallow pills|1|||
130348806|NCT02677324|469248592|FG000|Overall Study|Non-compliance|1|||
130348807|NCT02677324|469248592|FG000|Overall Study|Lack of Efficacy|1|||
130348808|NCT02677324|469248592|FG000|Overall Study|Medical insurance coverage|1|||
130348809|NCT02677324|469248592|FG000|Overall Study|Adverse Event|1|||
130348810|NCT02677324|469248592|FG000|Overall Study|IgM Myeloma diagnosis|1|||
130348811|NCT02106923|469248597|FG000|Overall Study|Protocol Violation|0|||
130348812|NCT02106923|469248598|FG001|Overall Study|Protocol Violation|0|||
130348813|NCT02106923|469248599|FG002|Overall Study|Protocol Violation|0|||
130348814|NCT02106923|469248600|FG003|Overall Study|Protocol Violation|0|||
130348815|NCT02106923|469248601|FG004|Overall Study|Protocol Violation|0|||
130348816|NCT02106923|469248602|FG005|Overall Study|Protocol Violation|1|||
130348817|NCT03485495|469248603|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
130348818|NCT03485495|469248604|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
130348819|NCT01056380|469248607|FG000|Overall Study|Lost to Follow-up|2|||
130348820|NCT01056380|469248608|FG001|Overall Study|Lost to Follow-up|3|||
130348821|NCT03901456|469248609|FG000|Overall Study|Withdrawal by Subject|0|||
130348822|NCT03901456|469248610|FG001|Overall Study|Withdrawal by Subject|0|||
130348823|NCT03901456|469248611|FG002|Overall Study|Withdrawal by Subject|1|||
130348824|NCT03901456|469248609|FG000|Overall Study|Lost to Follow-up|0|||
130348825|NCT03901456|469248610|FG001|Overall Study|Lost to Follow-up|1|||
130348826|NCT03901456|469248611|FG002|Overall Study|Lost to Follow-up|0|||
130348827|NCT01261780|469248613|FG000|Overall Study|Withdrawal by Subject|1|||
130348828|NCT01261780|469248614|FG001|Overall Study|Withdrawal by Subject|0|||
130348829|NCT01261780|469248613|FG000|Overall Study|Event not related to subject|1|||
130348830|NCT01261780|469248614|FG001|Overall Study|Event not related to subject|2|||
130348831|NCT00732940|469248615|FG000|Overall Study|Withdrawal by Subject|1|||
130348832|NCT00732940|469248616|FG001|Overall Study|Withdrawal by Subject|2|||
130348833|NCT00732940|469248615|FG000|Overall Study|Adverse Event|0|||
130348834|NCT00732940|469248616|FG001|Overall Study|Adverse Event|1|||
130348835|NCT00732940|469248615|FG000|Overall Study|Lost to Follow-up|1|||
130348836|NCT00732940|469248616|FG001|Overall Study|Lost to Follow-up|0|||
130348837|NCT00773838|469248617|FG000|Overall Study|Adverse Event|29|||
130348838|NCT00773838|469248617|FG000|Overall Study|Lost to Follow-up|1|||
130348839|NCT00773838|469248617|FG000|Overall Study|Physician Decision|8|||
130348840|NCT00773838|469248617|FG000|Overall Study|Progressive Disease|82|||
130348841|NCT00773838|469248617|FG000|Overall Study|Protocol Violation|2|||
130348842|NCT00773838|469248617|FG000|Overall Study|Withdrawal by Subject|21|||
130348843|NCT03562767|469248623|FG000|Overall Study|Physician Decision|2|||
130348844|NCT03562767|469248624|FG001|Overall Study|Physician Decision|0|||
130348845|NCT03562767|469248625|FG002|Overall Study|Physician Decision|0|||
130683182|NCT01666730|470468156|FG000|Overall Study|Withdrawal by Subject|9|||
130683183|NCT01666730|470468156|FG000|Overall Study|Disease progression/relapse|18|||
130437439|NCT05644353|469564437|FG001|Overall Study|Lost to Follow-up|0|||
130437440|NCT05644353|469564438|FG002|Overall Study|Lost to Follow-up|1|||
130437441|NCT05644353|469564439|FG003|Overall Study|Lost to Follow-up|0|||
130437442|NCT05644353|469564440|FG004|Overall Study|Lost to Follow-up|0|||
130437443|NCT05644353|469564441|FG005|Overall Study|Lost to Follow-up|0|||
130437444|NCT01535274|469564442|FG000|Overall Study|Determined to be ineligible|0|||
130437445|NCT01535274|469564443|FG001|Overall Study|Determined to be ineligible|1|||
130437446|NCT01535274|469564442|FG000|Overall Study|Misallocated to propofol intervention|0|||
130437447|NCT01535274|469564443|FG001|Overall Study|Misallocated to propofol intervention|1|||
130437448|NCT03679767|469564444|FG000|Overall Study|Death|16|||
130437449|NCT03679767|469564445|FG001|Overall Study|Death|11|||
130437450|NCT03679767|469564446|FG002|Overall Study|Death|17|||
130437451|NCT03679767|469564447|FG003|Overall Study|Death|10|||
130437452|NCT03679767|469564444|FG000|Overall Study|Lost to Follow-up|1|||
130437453|NCT03679767|469564445|FG001|Overall Study|Lost to Follow-up|1|||
130437454|NCT03679767|469564446|FG002|Overall Study|Lost to Follow-up|1|||
130437455|NCT03679767|469564447|FG003|Overall Study|Lost to Follow-up|1|||
130437456|NCT03679767|469564444|FG000|Overall Study|Withdrawal by Subject|0|||
130437457|NCT03679767|469564445|FG001|Overall Study|Withdrawal by Subject|0|||
130437458|NCT03679767|469564446|FG002|Overall Study|Withdrawal by Subject|0|||
130437459|NCT03679767|469564447|FG003|Overall Study|Withdrawal by Subject|1|||
130437460|NCT03679767|469564444|FG000|Overall Study|Follow-up Completed|18|||
130437461|NCT03679767|469564445|FG001|Overall Study|Follow-up Completed|11|||
130437462|NCT03679767|469564446|FG002|Overall Study|Follow-up Completed|11|||
130437463|NCT03679767|469564447|FG003|Overall Study|Follow-up Completed|20|||
130437464|NCT03679767|469564444|FG000|Overall Study|Entered Hospice Care|0|||
130437465|NCT03679767|469564445|FG001|Overall Study|Entered Hospice Care|0|||
130437466|NCT03679767|469564446|FG002|Overall Study|Entered Hospice Care|0|||
130437467|NCT03679767|469564447|FG003|Overall Study|Entered Hospice Care|1|||
130437468|NCT03679767|469564444|FG000|Overall Study|Progressive Disease|0|||
130437469|NCT03679767|469564445|FG001|Overall Study|Progressive Disease|0|||
130437470|NCT03679767|469564446|FG002|Overall Study|Progressive Disease|0|||
130437471|NCT03679767|469564447|FG003|Overall Study|Progressive Disease|1|||
130437472|NCT01407354|469564449|FG000|First Intervention|Withdrawal by Subject|0|||
130437473|NCT01407354|469564450|FG001|First Intervention|Withdrawal by Subject|2|||
130437474|NCT01407354|469564449|FG000|First Intervention|Adverse Event|1|||
130437475|NCT01407354|469564450|FG001|First Intervention|Adverse Event|0|||
130437476|NCT01407354|469564449|FG000|First Intervention|Physician Decision|1|||
130437477|NCT01407354|469564450|FG001|First Intervention|Physician Decision|0|||
130437478|NCT02204579|469564451|FG000|Overall Study|Screen failures|2|||
130437479|NCT02778399|469564452|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
130437480|NCT02778399|469564453|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
130437481|NCT02778399|469564454|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
130437482|NCT02778399|469564455|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
130437483|NCT02778399|469564456|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
130437484|NCT02778399|469564457|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
130437485|NCT02778399|469564452|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
130437486|NCT02778399|469564453|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
130437487|NCT02778399|469564454|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
130437488|NCT02778399|469564455|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
130437489|NCT02778399|469564456|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
130437490|NCT02778399|469564457|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
130437491|NCT02778399|469564452|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
130437492|NCT02778399|469564453|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
130437493|NCT02778399|469564454|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
130437494|NCT02778399|469564455|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
130437495|NCT02778399|469564456|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
130437496|NCT02778399|469564457|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
130437497|NCT02778399|469564452|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
130437498|NCT02778399|469564453|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130437499|NCT02778399|469564454|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130437500|NCT02778399|469564455|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130437501|NCT02778399|469564456|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130437502|NCT02778399|469564457|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
130437503|NCT02778399|469564452|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
130437504|NCT02778399|469564453|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
130437505|NCT02778399|469564454|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
130437506|NCT02778399|469564455|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
130437507|NCT02778399|469564456|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
130437508|NCT02778399|469564457|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
130437509|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130437510|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
130437511|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130683184|NCT04466111|470468157|FG000|Prior to Trial Phase|Physician Decision|1|||
130683185|NCT00893464|470468161|FG000|Overall Study|Did not complete therapy/experience PD|0|||
130683186|NCT00893464|470468162|FG001|Overall Study|Did not complete therapy/experience PD|0|||
130683187|NCT00893464|470468163|FG002|Overall Study|Did not complete therapy/experience PD|0|||
130683188|NCT00893464|470468164|FG003|Overall Study|Did not complete therapy/experience PD|0|||
130683189|NCT00893464|470468165|FG004|Overall Study|Did not complete therapy/experience PD|0|||
130683190|NCT00893464|470468166|FG005|Overall Study|Did not complete therapy/experience PD|0|||
130683191|NCT00893464|470468167|FG006|Overall Study|Did not complete therapy/experience PD|2|||
130683192|NCT00893464|470468168|FG007|Overall Study|Did not complete therapy/experience PD|2|||
130683193|NCT01389102|470468169|FG000|Overall Study|Adverse Event|1|||
130683194|NCT01389102|470468170|FG001|Overall Study|Adverse Event|3|||
130683195|NCT01389102|470468171|FG002|Overall Study|Adverse Event|2|||
130683196|NCT01389102|470468172|FG003|Overall Study|Adverse Event|2|||
130683197|NCT01389102|470468173|FG004|Overall Study|Adverse Event|2|||
130683198|NCT01389102|470468174|FG005|Overall Study|Adverse Event|2|||
130683199|NCT01389102|470468169|FG000|Overall Study|Hurricane Katrina|4|||
130683200|NCT01389102|470468170|FG001|Overall Study|Hurricane Katrina|2|||
130683201|NCT01389102|470468171|FG002|Overall Study|Hurricane Katrina|3|||
130683202|NCT01389102|470468172|FG003|Overall Study|Hurricane Katrina|0|||
130683203|NCT01389102|470468173|FG004|Overall Study|Hurricane Katrina|3|||
130683204|NCT01389102|470468174|FG005|Overall Study|Hurricane Katrina|1|||
130683205|NCT01389102|470468169|FG000|Overall Study|Lost to Follow-up|4|||
130683206|NCT01389102|470468170|FG001|Overall Study|Lost to Follow-up|1|||
130683207|NCT01389102|470468171|FG002|Overall Study|Lost to Follow-up|1|||
130683208|NCT01389102|470468172|FG003|Overall Study|Lost to Follow-up|2|||
130683209|NCT01389102|470468173|FG004|Overall Study|Lost to Follow-up|4|||
130683210|NCT01389102|470468174|FG005|Overall Study|Lost to Follow-up|1|||
130683211|NCT01389102|470468169|FG000|Overall Study|Protocol Violation|0|||
130683212|NCT01389102|470468170|FG001|Overall Study|Protocol Violation|0|||
130683213|NCT01389102|470468171|FG002|Overall Study|Protocol Violation|3|||
130683214|NCT01389102|470468172|FG003|Overall Study|Protocol Violation|0|||
130683215|NCT01389102|470468173|FG004|Overall Study|Protocol Violation|1|||
130683216|NCT01389102|470468174|FG005|Overall Study|Protocol Violation|1|||
130683217|NCT01389102|470468169|FG000|Overall Study|Withdrawal by Subject|7|||
130683218|NCT01389102|470468170|FG001|Overall Study|Withdrawal by Subject|4|||
130683219|NCT01389102|470468171|FG002|Overall Study|Withdrawal by Subject|9|||
130683220|NCT01389102|470468172|FG003|Overall Study|Withdrawal by Subject|2|||
130683221|NCT01389102|470468173|FG004|Overall Study|Withdrawal by Subject|3|||
130683222|NCT01389102|470468174|FG005|Overall Study|Withdrawal by Subject|3|||
130683223|NCT01389102|470468169|FG000|Overall Study|Subject Traveling Out of Country|0|||
130683224|NCT01389102|470468170|FG001|Overall Study|Subject Traveling Out of Country|0|||
130683225|NCT01389102|470468171|FG002|Overall Study|Subject Traveling Out of Country|0|||
130683226|NCT01389102|470468172|FG003|Overall Study|Subject Traveling Out of Country|1|||
130683227|NCT01389102|470468173|FG004|Overall Study|Subject Traveling Out of Country|0|||
130683228|NCT01389102|470468174|FG005|Overall Study|Subject Traveling Out of Country|0|||
130683229|NCT01389102|470468169|FG000|Overall Study|Subject Moved|2|||
130683230|NCT01389102|470468170|FG001|Overall Study|Subject Moved|0|||
130348846|NCT03562767|469248623|FG000|Overall Study|Logistic Reason|1|||
130348847|NCT03562767|469248624|FG001|Overall Study|Logistic Reason|3|||
130348848|NCT03562767|469248625|FG002|Overall Study|Logistic Reason|0|||
130348849|NCT00509262|469248626|FG000|Overall Study|Adverse Event|16|||
130348850|NCT00509262|469248627|FG001|Overall Study|Adverse Event|18|||
130348851|NCT00509262|469248626|FG000|Overall Study|Other|2|||
130348852|NCT00509262|469248627|FG001|Overall Study|Other|2|||
130683231|NCT01389102|470468171|FG002|Overall Study|Subject Moved|1|||
130683232|NCT01389102|470468172|FG003|Overall Study|Subject Moved|0|||
130683233|NCT01389102|470468173|FG004|Overall Study|Subject Moved|0|||
130683234|NCT01389102|470468174|FG005|Overall Study|Subject Moved|0|||
130683235|NCT01389102|470468169|FG000|Overall Study|Unavailable due to husband's illness|0|||
130683236|NCT01389102|470468170|FG001|Overall Study|Unavailable due to husband's illness|1|||
130683237|NCT01389102|470468171|FG002|Overall Study|Unavailable due to husband's illness|0|||
130683238|NCT01389102|470468172|FG003|Overall Study|Unavailable due to husband's illness|0|||
130683239|NCT01389102|470468173|FG004|Overall Study|Unavailable due to husband's illness|0|||
130683240|NCT01389102|470468174|FG005|Overall Study|Unavailable due to husband's illness|0|||
130683241|NCT01389102|470468169|FG000|Overall Study|Investigator Judgement|0|||
130683242|NCT01389102|470468170|FG001|Overall Study|Investigator Judgement|1|||
130683243|NCT01389102|470468171|FG002|Overall Study|Investigator Judgement|0|||
130683244|NCT01389102|470468172|FG003|Overall Study|Investigator Judgement|0|||
130683245|NCT01389102|470468173|FG004|Overall Study|Investigator Judgement|0|||
130683246|NCT01389102|470468174|FG005|Overall Study|Investigator Judgement|0|||
130683247|NCT00436553|470468175|FG000|Overall Study|Adverse Event|4|||
130348853|NCT00509262|469248626|FG000|Overall Study|Lack of Efficacy|1|||
130683248|NCT00436553|470468176|FG001|Overall Study|Adverse Event|3|||
130683249|NCT00436553|470468177|FG002|Overall Study|Adverse Event|4|||
130683250|NCT00436553|470468175|FG000|Overall Study|Death|3|||
130348854|NCT00509262|469248627|FG001|Overall Study|Lack of Efficacy|0|||
130683251|NCT00436553|470468176|FG001|Overall Study|Death|1|||
130683252|NCT00436553|470468177|FG002|Overall Study|Death|3|||
130683253|NCT00436553|470468175|FG000|Overall Study|Lost to Follow-up|0|||
130683254|NCT00436553|470468176|FG001|Overall Study|Lost to Follow-up|2|||
130348855|NCT00509262|469248626|FG000|Overall Study|Lost to Follow-up|1|||
130348856|NCT00509262|469248627|FG001|Overall Study|Lost to Follow-up|6|||
130348857|NCT00509262|469248626|FG000|Overall Study|Physician Decision|1|||
130348858|NCT00509262|469248627|FG001|Overall Study|Physician Decision|3|||
130348859|NCT00509262|469248626|FG000|Overall Study|Protocol Violation|2|||
130348860|NCT00509262|469248627|FG001|Overall Study|Protocol Violation|2|||
130348861|NCT00509262|469248626|FG000|Overall Study|Withdrawal by Subject|24|||
130348862|NCT00509262|469248627|FG001|Overall Study|Withdrawal by Subject|11|||
130348863|NCT01589770|469248628|FG000|Overall Study|EGFR <60ml/min|6|||
130348864|NCT01589770|469248629|FG001|Overall Study|EGFR <60ml/min|4|||
130348865|NCT01589770|469248628|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
130348866|NCT01589770|469248629|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
130348867|NCT01658813|469248634|FG000|Overall Study|Disease progression|3|||
130348868|NCT00938886|469248635|FG000|Overall Study|Death|0|||
130348869|NCT00938886|469248636|FG001|Overall Study|Death|1|||
130348870|NCT00938886|469248635|FG000|Overall Study|Withdrawal by Subject|4|||
130348871|NCT00938886|469248636|FG001|Overall Study|Withdrawal by Subject|7|||
130348872|NCT00938886|469248635|FG000|Overall Study|Lost to Follow-up|3|||
130348873|NCT00938886|469248636|FG001|Overall Study|Lost to Follow-up|2|||
130348874|NCT02674854|469248641|FG000|Overall Study|Adverse Event|17|||
130348875|NCT02674854|469248642|FG001|Overall Study|Adverse Event|15|||
130348876|NCT02674854|469248643|FG002|Overall Study|Adverse Event|5|||
130348877|NCT02674854|469248641|FG000|Overall Study|Withdrawal by Subject|1|||
130348878|NCT02674854|469248642|FG001|Overall Study|Withdrawal by Subject|5|||
130348879|NCT02674854|469248643|FG002|Overall Study|Withdrawal by Subject|4|||
130348880|NCT02674854|469248641|FG000|Overall Study|No-compliant subject|1|||
130348881|NCT02674854|469248642|FG001|Overall Study|No-compliant subject|0|||
130348882|NCT02674854|469248643|FG002|Overall Study|No-compliant subject|1|||
130348883|NCT02674854|469248641|FG000|Overall Study|Lost to Follow-up|1|||
130348884|NCT02674854|469248642|FG001|Overall Study|Lost to Follow-up|0|||
130348885|NCT02674854|469248643|FG002|Overall Study|Lost to Follow-up|2|||
130348886|NCT02674854|469248641|FG000|Overall Study|Lack of Efficacy|0|||
130348887|NCT02674854|469248642|FG001|Overall Study|Lack of Efficacy|3|||
130348888|NCT02674854|469248643|FG002|Overall Study|Lack of Efficacy|0|||
130348889|NCT02674854|469248641|FG000|Overall Study|Disallowed Concurrent Medication|2|||
130348890|NCT02674854|469248642|FG001|Overall Study|Disallowed Concurrent Medication|2|||
130348891|NCT02674854|469248643|FG002|Overall Study|Disallowed Concurrent Medication|0|||
130348892|NCT02674854|469248641|FG000|Overall Study|Protocol Violation|1|||
130348893|NCT02674854|469248642|FG001|Overall Study|Protocol Violation|1|||
130348894|NCT02674854|469248643|FG002|Overall Study|Protocol Violation|2|||
130348895|NCT02674854|469248641|FG000|Overall Study|Death|0|||
130348896|NCT02674854|469248642|FG001|Overall Study|Death|1|||
130348897|NCT02674854|469248643|FG002|Overall Study|Death|0|||
130348898|NCT02674854|469248641|FG000|Overall Study|Subject missed V6.2|1|||
130348899|NCT02674854|469248642|FG001|Overall Study|Subject missed V6.2|0|||
130348900|NCT02674854|469248643|FG002|Overall Study|Subject missed V6.2|0|||
130348901|NCT00913692|469248644|FG000|Screening (4 Months)|Physician Decision|3|||
130348902|NCT00913692|469248644|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
130348903|NCT00913692|469248644|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
130348904|NCT04738318|469248645|FG000|Overall Study|Protocol Violation|1|||
130348905|NCT04738318|469248646|FG001|Overall Study|Protocol Violation|0|||
130348906|NCT04231981|469248647|FG000|Overall Study|Adverse Event|1|||
130348907|NCT04231981|469248647|FG000|Overall Study|Death|16|||
130348908|NCT04231981|469248647|FG000|Overall Study|Lost to Follow-up|1|||
130348909|NCT02889562|469248648|FG000|Overall Study|Physician Decision|0|||
130348910|NCT02889562|469248649|FG001|Overall Study|Physician Decision|1|||
130348911|NCT02889562|469248648|FG000|Overall Study|Withdrawal by Subject|0|||
130348912|NCT02889562|469248649|FG001|Overall Study|Withdrawal by Subject|1|||
130348913|NCT01470989|469248652|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
130348914|NCT01470989|469248653|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
130348915|NCT01470989|469248652|FG000|Overall Study|Adverse Event|2|||
130348916|NCT01470989|469248653|FG001|Overall Study|Adverse Event|5|||
130348917|NCT01470989|469248652|FG000|Overall Study|Abnormal laboratory value|1|||
130348918|NCT01470989|469248653|FG001|Overall Study|Abnormal laboratory value|1|||
130683255|NCT00436553|470468177|FG002|Overall Study|Lost to Follow-up|0|||
130683256|NCT00436553|470468175|FG000|Overall Study|Protocol Violation|1|||
130348919|NCT01470989|469248652|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130348920|NCT01470989|469248653|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130348921|NCT01470989|469248652|FG000|Overall Study|Withdrawal by Subject|19|||
130348922|NCT01470989|469248653|FG001|Overall Study|Withdrawal by Subject|17|||
130348923|NCT01470989|469248652|FG000|Overall Study|Lost to Follow-up|18|||
130348924|NCT01470989|469248653|FG001|Overall Study|Lost to Follow-up|13|||
130348925|NCT01470989|469248652|FG000|Overall Study|Administrative problems|2|||
130683257|NCT00436553|470468176|FG001|Overall Study|Protocol Violation|0|||
130437512|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
130437513|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
130437514|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130437515|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
130437516|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130437517|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
130437518|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
130437519|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130437520|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130437521|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130437522|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
130683258|NCT00436553|470468177|FG002|Overall Study|Protocol Violation|0|||
130683259|NCT00436553|470468175|FG000|Overall Study|Withdrawal by Subject|5|||
130683260|NCT00436553|470468176|FG001|Overall Study|Withdrawal by Subject|6|||
130683261|NCT00436553|470468177|FG002|Overall Study|Withdrawal by Subject|3|||
130683262|NCT01035060|470468182|FG000|Overall Study|Lost to Follow-up|0|||
130683263|NCT01035060|470468183|FG001|Overall Study|Lost to Follow-up|7|||
130348926|NCT01470989|469248653|FG001|Overall Study|Administrative problems|4|||
130348927|NCT01470989|469248652|FG000|Overall Study|Death|2|||
130348928|NCT01470989|469248653|FG001|Overall Study|Death|2|||
130348929|NCT01470989|469248652|FG000|Overall Study|Protocol deviation|1|||
130348930|NCT01470989|469248653|FG001|Overall Study|Protocol deviation|2|||
130348931|NCT00969280|469248654|FG000|Overall Study|Protocol Violation|2|||
130348932|NCT00969280|469248655|FG001|Overall Study|Protocol Violation|1|||
130348933|NCT00969280|469248654|FG000|Overall Study|Withdrawal by Subject|0|||
130348934|NCT00969280|469248655|FG001|Overall Study|Withdrawal by Subject|1|||
130348935|NCT00969280|469248654|FG000|Overall Study|infection of influenza A(H1N1)|0|||
130348936|NCT00969280|469248655|FG001|Overall Study|infection of influenza A(H1N1)|1|||
130348937|NCT05985980|469248656|FG000|Overall Study|Withdrawal by Subject|1|||
130348938|NCT05985980|469248656|FG000|Overall Study|Withdrawal by Subject|1|||
130348939|NCT05985980|469248656|FG000|Overall Study|Withdrawal by Subject|1|||
130348940|NCT05985980|469248656|FG000|Overall Study|Withdrawal by Subject|1|||
130348941|NCT03621475|469250192|FG000|Overall Study|No longer required restraints at initiation|0|||
130348942|NCT03621475|469250193|FG001|Overall Study|No longer required restraints at initiation|1|||
130348943|NCT00706849|469250200|FG000|Treatment Period|Adverse Event|0|||
130348944|NCT00706849|469250201|FG001|Treatment Period|Adverse Event|9|||
130348945|NCT00706849|469250200|FG000|Treatment Period|Other|0|||
130348946|NCT00706849|469250201|FG001|Treatment Period|Other|1|||
130348947|NCT00706849|469250200|FG000|Follow-up Period|Withdrawal by Subject|0|||
130348948|NCT00706849|469250201|FG001|Follow-up Period|Withdrawal by Subject|2|||
130348949|NCT00706849|469250200|FG000|Follow-up Period|Protocol non-compliance|0|||
130348950|NCT00706849|469250201|FG001|Follow-up Period|Protocol non-compliance|1|||
130348951|NCT01611454|469250203|FG000|Overall Study|Lack of Efficacy|18|||
130348952|NCT01611454|469250204|FG001|Overall Study|Lack of Efficacy|10|||
130348953|NCT03269552|469250205|FG000|Overall Study|Adverse Event|2|||
130348954|NCT00920907|469250206|FG000|Induction Period|Adverse Event|0|||
130348955|NCT00920907|469250207|FG001|Induction Period|Adverse Event|2|||
130348956|NCT00920907|469250206|FG000|Induction Period|Death|1|||
130348957|NCT00920907|469250207|FG001|Induction Period|Death|1|||
130348958|NCT00920907|469250206|FG000|Induction Period|Disease Progression|12|||
130348959|NCT00920907|469250207|FG001|Induction Period|Disease Progression|11|||
130348960|NCT00920907|469250206|FG000|Induction Period|Study Drug Toxicity|8|||
130348961|NCT00920907|469250207|FG001|Induction Period|Study Drug Toxicity|6|||
130348962|NCT00920907|469250206|FG000|Induction Period|No longer meets study criteria|0|||
130348963|NCT00920907|469250207|FG001|Induction Period|No longer meets study criteria|1|||
130348964|NCT00920907|469250206|FG000|Induction Period|Withdrawal by Subject|1|||
130348965|NCT00920907|469250207|FG001|Induction Period|Withdrawal by Subject|1|||
130348966|NCT00920907|469250206|FG000|Maintenance Period|Disease Progression|3|||
130348967|NCT00920907|469250207|FG001|Maintenance Period|Disease Progression|7|||
130348968|NCT00920907|469250206|FG000|Maintenance Period|Administrative (study closure)|7|||
130348969|NCT00920907|469250207|FG001|Maintenance Period|Administrative (study closure)|2|||
130348970|NCT00920907|469250206|FG000|Maintenance Period|Study Drug Toxicity|0|||
130348971|NCT00920907|469250207|FG001|Maintenance Period|Study Drug Toxicity|2|||
130348972|NCT00920907|469250206|FG000|Maintenance Period|Death|1|||
130437523|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130437524|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130683264|NCT01035060|470468182|FG000|Overall Study|Did not quality after 2nd screening|14|||
130348973|NCT00920907|469250207|FG001|Maintenance Period|Death|1|||
130348974|NCT00920907|469250206|FG000|Maintenance Period|Withdrawal by Subject|1|||
130348975|NCT00920907|469250207|FG001|Maintenance Period|Withdrawal by Subject|0|||
130348976|NCT00920907|469250206|FG000|Maintenance Period|Adverse Event|0|||
130348977|NCT00920907|469250207|FG001|Maintenance Period|Adverse Event|1|||
130348978|NCT02616601|469250208|FG000|Overall Study|Withdrawal by Subject|4|||
130348979|NCT02616601|469250209|FG001|Overall Study|Withdrawal by Subject|4|||
130348980|NCT02616601|469250210|FG002|Overall Study|Withdrawal by Subject|3|||
130683265|NCT01035060|470468183|FG001|Overall Study|Did not quality after 2nd screening|1|||
130683266|NCT01035060|470468182|FG000|Overall Study|Withdrawal by Subject|8|||
130683267|NCT01035060|470468183|FG001|Overall Study|Withdrawal by Subject|6|||
130683268|NCT01035060|470468182|FG000|Overall Study|Physician Decision|2|||
130683269|NCT01035060|470468183|FG001|Overall Study|Physician Decision|0|||
130683270|NCT01981720|470468188|FG000|Overall Study|Adverse Event|1|||
130683271|NCT01981720|470468188|FG000|Overall Study|Withdrawal by Subject|3|||
130683272|NCT01981720|470468188|FG000|Overall Study|Pregnancy|1|||
130683273|NCT02674477|470468189|FG000|Overall Study|Protocol Violation|8|||
130683274|NCT02674477|470468190|FG001|Overall Study|Protocol Violation|2|||
130683275|NCT01536405|470468193|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
130683276|NCT01536405|470468194|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
130683277|NCT01536405|470468193|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
130683278|NCT01536405|470468194|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
130683279|NCT01536405|470468193|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
130683280|NCT01536405|470468194|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
130683281|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
130683282|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
130683283|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130683284|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130683285|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
130683286|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
130683287|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130683288|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130683289|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
130683290|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
130683291|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
130683292|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
130683293|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
130683294|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
130683295|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
130683296|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
130683297|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
130683298|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
130683299|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
130683300|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
130348981|NCT02616601|469250208|FG000|Overall Study|Adverse Event|2|||
130348982|NCT02616601|469250209|FG001|Overall Study|Adverse Event|0|||
130348983|NCT02616601|469250210|FG002|Overall Study|Adverse Event|2|||
130348984|NCT02616601|469250208|FG000|Overall Study|Death|1|||
130348985|NCT02616601|469250209|FG001|Overall Study|Death|0|||
130348986|NCT02616601|469250210|FG002|Overall Study|Death|0|||
130348987|NCT02616601|469250208|FG000|Overall Study|Lost to Follow-up|1|||
130348988|NCT02616601|469250209|FG001|Overall Study|Lost to Follow-up|0|||
130348989|NCT02616601|469250210|FG002|Overall Study|Lost to Follow-up|1|||
130348990|NCT02616601|469250208|FG000|Overall Study|Non-Compliance with Test Article|1|||
130348991|NCT02616601|469250209|FG001|Overall Study|Non-Compliance with Test Article|0|||
130348992|NCT02616601|469250210|FG002|Overall Study|Non-Compliance with Test Article|1|||
130348993|NCT00039871|469250211|FG000|Overall Study|Adverse Event|165|||
130348994|NCT00039871|469250211|FG000|Overall Study|Lost to Follow-up|18|||
130348995|NCT00039871|469250211|FG000|Overall Study|Protocol Violation|24|||
130348996|NCT00039871|469250211|FG000|Overall Study|Withdrawal by Subject|97|||
130348997|NCT00039871|469250211|FG000|Overall Study|Did not meet eligibility criteria|11|||
130348998|NCT00039871|469250211|FG000|Overall Study|Administrative|1|||
130348999|NCT00039871|469250211|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
130349000|NCT00039871|469250211|FG000|Overall Study|Never entered follow-up|7|||
130349001|NCT02186301|469250212|FG000|Overall Study|Progressive Disease|7|||
130349002|NCT02186301|469250213|FG001|Overall Study|Progressive Disease|22|||
130349003|NCT02186301|469250214|FG002|Overall Study|Progressive Disease|27|||
130349004|NCT02186301|469250212|FG000|Overall Study|Adverse Event|5|||
130349005|NCT02186301|469250213|FG001|Overall Study|Adverse Event|5|||
130349006|NCT02186301|469250214|FG002|Overall Study|Adverse Event|5|||
130683301|NCT02514122|470468195|FG000|Overall Study|Withdrawal by Subject|2|||
130683302|NCT02514122|470468196|FG001|Overall Study|Withdrawal by Subject|0|||
130683303|NCT01472341|470468197|FG000|Overall Study|Started insulin therapy|55|||
130683304|NCT01472341|470468197|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
130683305|NCT01472341|470468197|FG000|Overall Study|Withdrawal by Subject|39|||
130683306|NCT01472341|470468197|FG000|Overall Study|Lost to Follow-up|52|||
130683307|NCT01472341|470468197|FG000|Overall Study|Laboratory parameters unavailable|25|||
130349007|NCT02186301|469250212|FG000|Overall Study|Death|1|||
130683308|NCT01472341|470468197|FG000|Overall Study|Death|9|||
130349008|NCT02186301|469250213|FG001|Overall Study|Death|0|||
130349009|NCT02186301|469250214|FG002|Overall Study|Death|0|||
130349010|NCT02186301|469250212|FG000|Overall Study|Withdrawal by Subject|5|||
130683309|NCT00112463|470468200|FG000|Overall Study|Physician Decision|1|||
130683310|NCT00112463|470468200|FG000|Overall Study|Progression|30|||
130683311|NCT00112463|470468200|FG000|Overall Study|Second Primary|1|||
130683312|NCT00112463|470468200|FG000|Overall Study|Toxicity|3|||
130683313|NCT00112463|470468200|FG000|Overall Study|Withdrawal by Subject|2|||
130683314|NCT00112463|470468200|FG000|Overall Study|Never started treatment|2|||
130683315|NCT01118312|470468207|FG000|Overall Study|Lost to Follow-up|33|||
130683316|NCT01118312|470468208|FG001|Overall Study|Lost to Follow-up|32|||
130683317|NCT01118312|470468207|FG000|Overall Study|Withdrawal by Subject|1|||
130683318|NCT01118312|470468208|FG001|Overall Study|Withdrawal by Subject|3|||
130349011|NCT02186301|469250213|FG001|Overall Study|Withdrawal by Subject|1|||
130349012|NCT02186301|469250214|FG002|Overall Study|Withdrawal by Subject|3|||
130349013|NCT02186301|469250212|FG000|Overall Study|Physician Decision|1|||
130349014|NCT02186301|469250213|FG001|Overall Study|Physician Decision|0|||
130349015|NCT02186301|469250214|FG002|Overall Study|Physician Decision|1|||
130349016|NCT02186301|469250212|FG000|Overall Study|Study Terminated by Sponsor|1|||
130349017|NCT02186301|469250213|FG001|Overall Study|Study Terminated by Sponsor|0|||
130349018|NCT02186301|469250214|FG002|Overall Study|Study Terminated by Sponsor|11|||
130349019|NCT02186301|469250212|FG000|Overall Study|Protocol Deviation|0|||
130349020|NCT02186301|469250213|FG001|Overall Study|Protocol Deviation|2|||
130349021|NCT02186301|469250214|FG002|Overall Study|Protocol Deviation|0|||
130349022|NCT02186301|469250212|FG000|Overall Study|Missing|0|||
130349023|NCT02186301|469250213|FG001|Overall Study|Missing|0|||
130349024|NCT02186301|469250214|FG002|Overall Study|Missing|2|||
130349025|NCT02186301|469250212|FG000|Overall Study|Other|0|||
130349026|NCT02186301|469250213|FG001|Overall Study|Other|0|||
130349027|NCT02186301|469250214|FG002|Overall Study|Other|1|||
130349028|NCT01275339|469250216|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
130349029|NCT01275339|469250217|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
130349030|NCT01275339|469250218|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
130349031|NCT01275339|469250219|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
130349032|NCT01275339|469250216|FG000|Overall Study|Withdrawal by Subject|0|||
130349033|NCT01275339|469250217|FG001|Overall Study|Withdrawal by Subject|0|||
130349034|NCT01275339|469250218|FG002|Overall Study|Withdrawal by Subject|1|||
130349035|NCT01275339|469250219|FG003|Overall Study|Withdrawal by Subject|0|||
130349036|NCT03560739|469250220|FG000|Overall Study|Adverse Event|0|||
130349037|NCT03560739|469250221|FG001|Overall Study|Adverse Event|1|||
130349038|NCT03560739|469250222|FG002|Overall Study|Adverse Event|0|||
130349039|NCT03560739|469250223|FG003|Overall Study|Adverse Event|0|||
130349040|NCT02478398|469250224|FG000|Overall Study|Adverse Event|20|||
130349041|NCT02478398|469250225|FG001|Overall Study|Adverse Event|5|||
130349042|NCT02478398|469250224|FG000|Overall Study|Lost to Follow-up|5|||
130349043|NCT02478398|469250225|FG001|Overall Study|Lost to Follow-up|4|||
130349044|NCT02478398|469250224|FG000|Overall Study|Non-Compliance With Study Drug|5|||
130349045|NCT02478398|469250225|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130349046|NCT02478398|469250224|FG000|Overall Study|Protocol Violation|3|||
130349047|NCT02478398|469250225|FG001|Overall Study|Protocol Violation|1|||
130349048|NCT02478398|469250224|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
130349049|NCT02478398|469250225|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130349050|NCT02478398|469250224|FG000|Overall Study|Withdrawal By Participant|10|||
130349051|NCT02478398|469250225|FG001|Overall Study|Withdrawal By Participant|4|||
130349052|NCT03123185|469250226|FG000|Overall Study|Withdrawal by Subject|0|||
130349053|NCT03123185|469250227|FG001|Overall Study|Withdrawal by Subject|0|||
130349054|NCT03123185|469250228|FG002|Overall Study|Withdrawal by Subject|0|||
130349055|NCT03123185|469250229|FG003|Overall Study|Withdrawal by Subject|0|||
130349056|NCT03123185|469250230|FG004|Overall Study|Withdrawal by Subject|0|||
130349057|NCT03123185|469250231|FG005|Overall Study|Withdrawal by Subject|0|||
130349058|NCT03123185|469250232|FG006|Overall Study|Withdrawal by Subject|0|||
130349059|NCT03123185|469250233|FG007|Overall Study|Withdrawal by Subject|0|||
130349060|NCT03123185|469250234|FG008|Overall Study|Withdrawal by Subject|0|||
130349061|NCT03123185|469250235|FG009|Overall Study|Withdrawal by Subject|0|||
130349062|NCT03123185|469250236|FG010|Overall Study|Withdrawal by Subject|0|||
130349063|NCT03123185|469250237|FG011|Overall Study|Withdrawal by Subject|0|||
130349064|NCT03123185|469250238|FG012|Overall Study|Withdrawal by Subject|1|||
130349065|NCT03123185|469250239|FG013|Overall Study|Withdrawal by Subject|0|||
130349066|NCT00880685|469250243|FG000|Memantine 10mg|Lost to Follow-up|2|||
130349067|NCT00880685|469250243|FG000|Memantine 20mg|Withdrawal by Subject|1|||
130349068|NCT01249118|469250244|FG000|First Washout Period|Physician Decision|0|||
130349069|NCT01249118|469250245|FG001|First Washout Period|Physician Decision|1|||
130349070|NCT01249118|469250246|FG002|First Washout Period|Physician Decision|0|||
130349071|NCT04179890|469250247|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
130349072|NCT04179890|469250248|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
130349073|NCT04179890|469250247|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
130683319|NCT00296647|470468209|FG000|Overall Study|Death|4|||
130683320|NCT00296647|470468210|FG001|Overall Study|Death|1|||
130683321|NCT00296647|470468211|FG002|Overall Study|Death|2|||
130683322|NCT00296647|470468212|FG003|Overall Study|Death|1|||
130683323|NCT00296647|470468213|FG004|Overall Study|Death|1|||
130683324|NCT00296647|470468209|FG000|Overall Study|Withdrawal by Subject|28|||
130683325|NCT00296647|470468210|FG001|Overall Study|Withdrawal by Subject|27|||
130683326|NCT00296647|470468211|FG002|Overall Study|Withdrawal by Subject|32|||
130683327|NCT00296647|470468212|FG003|Overall Study|Withdrawal by Subject|16|||
130683328|NCT00296647|470468213|FG004|Overall Study|Withdrawal by Subject|19|||
130683329|NCT01629381|470468214|FG000|Overall Study|Withdrawal by Subject|2|||
130683330|NCT01629381|470468215|FG001|Overall Study|Withdrawal by Subject|5|||
130683331|NCT00735904|470468216|FG000|Overall Study|Adverse Event|3|||
130683332|NCT00735904|470468216|FG000|Overall Study|Death|20|||
130683333|NCT00735904|470468216|FG000|Overall Study|Protocol Violation|1|||
130683334|NCT00735904|470468216|FG000|Overall Study|Withdrawal by Subject|1|||
130683335|NCT00735904|470468216|FG000|Overall Study|Study Terminated by Sponsor|5|||
130683336|NCT00735904|470468216|FG000|Overall Study|Other|8|||
130683337|NCT01390844|470468219|FG000|Treatment Phase|Adverse Event|12|||
130683338|NCT01390844|470468220|FG001|Treatment Phase|Adverse Event|2|||
130683339|NCT01390844|470468221|FG002|Treatment Phase|Adverse Event|3|||
130683340|NCT01390844|470468222|FG003|Treatment Phase|Adverse Event|2|||
130683341|NCT01390844|470468219|FG000|Treatment Phase|Treatment Failure|23|||
130349074|NCT04179890|469250248|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
130349075|NCT04179890|469250247|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
130349076|NCT04179890|469250248|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
130349077|NCT04179890|469250247|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
130349078|NCT04179890|469250248|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
130349079|NCT04179890|469250247|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
130349080|NCT04179890|469250248|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
130349081|NCT04179890|469250247|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
130349082|NCT04179890|469250248|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
130349083|NCT04179890|469250247|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
130349084|NCT04179890|469250248|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
130349085|NCT04179890|469250247|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
130349086|NCT04179890|469250248|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
130349087|NCT04179890|469250247|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
130349088|NCT04179890|469250248|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
130349089|NCT00095238|469250249|FG000|Overall Study|Lack of Efficacy|9|||
130349090|NCT00095238|469250250|FG001|Overall Study|Lack of Efficacy|9|||
130349091|NCT00095238|469250249|FG000|Overall Study|Adverse Event|331|||
130349092|NCT00095238|469250250|FG001|Overall Study|Adverse Event|287|||
130349093|NCT00095238|469250249|FG000|Overall Study|Subject Withdrew Consent|208|||
130349094|NCT00095238|469250250|FG001|Overall Study|Subject Withdrew Consent|223|||
130349095|NCT00095238|469250249|FG000|Overall Study|Death|154|||
130349096|NCT00095238|469250250|FG001|Overall Study|Death|170|||
130349097|NCT00095238|469250249|FG000|Overall Study|Lost to Follow-up|19|||
130349098|NCT00095238|469250250|FG001|Overall Study|Lost to Follow-up|24|||
130349099|NCT00095238|469250249|FG000|Overall Study|Noncompliance|44|||
130349100|NCT00095238|469250250|FG001|Overall Study|Noncompliance|45|||
130349101|NCT00095238|469250249|FG000|Overall Study|No longer met study criteria|4|||
130349102|NCT00095238|469250250|FG001|Overall Study|No longer met study criteria|5|||
130349103|NCT00095238|469250249|FG000|Overall Study|Study terminated by sponsor|0|||
130349104|NCT00095238|469250250|FG001|Overall Study|Study terminated by sponsor|1|||
130349105|NCT00095238|469250249|FG000|Overall Study|Missing|1|||
130349106|NCT00095238|469250250|FG001|Overall Study|Missing|0|||
130349107|NCT00095238|469250249|FG000|Overall Study|Other Reasons|87|||
130349108|NCT00095238|469250250|FG001|Overall Study|Other Reasons|88|||
130349109|NCT04393298|469250253|FG000|Overall Study|Adverse Event|0|||
130349110|NCT04393298|469250254|FG001|Overall Study|Adverse Event|0|||
130349111|NCT04393298|469250255|FG002|Overall Study|Adverse Event|0|||
130349112|NCT04393298|469250256|FG003|Overall Study|Adverse Event|0|||
130349113|NCT04393298|469250257|FG004|Overall Study|Adverse Event|1|||
130349114|NCT04393298|469250258|FG005|Overall Study|Adverse Event|0|||
130349115|NCT04393298|469250259|FG006|Overall Study|Adverse Event|0|||
130683342|NCT01390844|470468220|FG001|Treatment Phase|Treatment Failure|25|||
130683343|NCT01390844|470468221|FG002|Treatment Phase|Treatment Failure|10|||
130683344|NCT01390844|470468222|FG003|Treatment Phase|Treatment Failure|13|||
130683345|NCT01390844|470468219|FG000|Treatment Phase|Non-Medical Reasons|5|||
130683346|NCT01390844|470468220|FG001|Treatment Phase|Non-Medical Reasons|1|||
130683347|NCT01390844|470468221|FG002|Treatment Phase|Non-Medical Reasons|8|||
130683348|NCT01390844|470468222|FG003|Treatment Phase|Non-Medical Reasons|1|||
130683349|NCT01390844|470468219|FG000|Treatment Phase|Non-GCP Compliant|0|||
130683350|NCT01390844|470468220|FG001|Treatment Phase|Non-GCP Compliant|0|||
130437525|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130437526|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130437527|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
130437528|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
130437529|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
130437530|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
130437531|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
130437532|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
130437533|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
130437534|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130437535|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
130349116|NCT04393298|469250260|FG007|Overall Study|Adverse Event|0|||
130349117|NCT04393298|469250261|FG008|Overall Study|Adverse Event|2|||
130349118|NCT04393298|469250262|FG009|Overall Study|Adverse Event|0|||
130349119|NCT04393298|469250263|FG010|Overall Study|Adverse Event|0|||
130349120|NCT04393298|469250264|FG011|Overall Study|Adverse Event|0|||
130437536|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130437537|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130437538|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130437539|NCT02778399|469564452|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130437540|NCT02778399|469564453|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130437541|NCT02778399|469564454|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130437542|NCT02778399|469564455|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130437543|NCT02778399|469564456|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130437544|NCT02778399|469564457|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130437545|NCT00447954|469564462|FG000|Overall Study|Adverse Event|0|||
130437546|NCT00447954|469564463|FG001|Overall Study|Adverse Event|2|||
130437547|NCT00447954|469564464|FG002|Overall Study|Adverse Event|0|||
130437548|NCT00447954|469564462|FG000|Overall Study|Withdrawal by Subject|0|||
130437549|NCT00447954|469564463|FG001|Overall Study|Withdrawal by Subject|1|||
130437550|NCT00447954|469564464|FG002|Overall Study|Withdrawal by Subject|1|||
130437551|NCT00447954|469564462|FG000|Overall Study|Lost to Follow-up|0|||
130437552|NCT00447954|469564463|FG001|Overall Study|Lost to Follow-up|1|||
130437553|NCT00447954|469564464|FG002|Overall Study|Lost to Follow-up|0|||
130437554|NCT00447954|469564462|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
130437555|NCT00447954|469564463|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
130437556|NCT00447954|469564464|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
130437557|NCT03556358|469564467|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
130437558|NCT03556358|469564468|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
130437559|NCT03556358|469564467|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
130437560|NCT03556358|469564468|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
130437561|NCT03556358|469564467|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
130683351|NCT01390844|470468221|FG002|Treatment Phase|Non-GCP Compliant|10|||
130683352|NCT01390844|470468222|FG003|Treatment Phase|Non-GCP Compliant|3|||
130349121|NCT04393298|469250265|FG012|Overall Study|Adverse Event|1|||
130349122|NCT04393298|469250266|FG013|Overall Study|Adverse Event|1|||
130349123|NCT04393298|469250267|FG014|Overall Study|Adverse Event|0|||
130349124|NCT04393298|469250253|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349125|NCT04393298|469250254|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349126|NCT04393298|469250255|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
130349127|NCT04393298|469250256|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349128|NCT04393298|469250257|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349129|NCT04393298|469250258|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349130|NCT04393298|469250259|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349131|NCT04393298|469250260|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349132|NCT04393298|469250261|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349133|NCT04393298|469250262|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349134|NCT04393298|469250263|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349135|NCT04393298|469250264|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349136|NCT04393298|469250265|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349137|NCT04393298|469250266|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130349138|NCT04393298|469250267|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
130349139|NCT04393298|469250253|FG000|Overall Study|Lack of Efficacy|0|||
130349140|NCT04393298|469250254|FG001|Overall Study|Lack of Efficacy|0|||
130437562|NCT03556358|469564468|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
130437563|NCT03556358|469564467|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
130437564|NCT03556358|469564468|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
130683353|NCT01390844|470468219|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
130683354|NCT01390844|470468220|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
130683355|NCT01390844|470468221|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
130683356|NCT01390844|470468222|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
130683357|NCT03204539|470468225|FG000|Overall Study|Loss of funding|0|||
130683358|NCT03204539|470468226|FG001|Overall Study|Loss of funding|1|||
130683359|NCT01171963|470468227|FG000|Overall Study|Adverse Event|10|||
130683360|NCT01171963|470468228|FG001|Overall Study|Adverse Event|15|||
130683361|NCT01171963|470468227|FG000|Overall Study|Lost to Follow-up|23|||
130683362|NCT01171963|470468228|FG001|Overall Study|Lost to Follow-up|24|||
130683363|NCT01171963|470468227|FG000|Overall Study|Other - diarrhoea|1|||
130683364|NCT01171963|470468228|FG001|Overall Study|Other - diarrhoea|0|||
130683365|NCT01171963|470468227|FG000|Overall Study|Withdrawal by Subject|114|||
130683366|NCT01171963|470468228|FG001|Overall Study|Withdrawal by Subject|129|||
130683367|NCT05093205|470468229|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
130683368|NCT05093205|470468230|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
130683369|NCT05093205|470468231|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
130683370|NCT05093205|470468232|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
130683371|NCT05093205|470468233|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
130683372|NCT05093205|470468234|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
130683373|NCT05093205|470468235|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
130683374|NCT05093205|470468236|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
130683375|NCT05093205|470468237|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
130683376|NCT05093205|470468238|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
130683377|NCT05093205|470468239|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
130683378|NCT05093205|470468240|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
130683379|NCT05093205|470468241|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
130349141|NCT04393298|469250255|FG002|Overall Study|Lack of Efficacy|0|||
130349142|NCT04393298|469250256|FG003|Overall Study|Lack of Efficacy|0|||
130349143|NCT04393298|469250257|FG004|Overall Study|Lack of Efficacy|0|||
130349144|NCT04393298|469250258|FG005|Overall Study|Lack of Efficacy|0|||
130349145|NCT04393298|469250259|FG006|Overall Study|Lack of Efficacy|0|||
130349146|NCT04393298|469250260|FG007|Overall Study|Lack of Efficacy|0|||
130349147|NCT04393298|469250261|FG008|Overall Study|Lack of Efficacy|0|||
130349148|NCT04393298|469250262|FG009|Overall Study|Lack of Efficacy|0|||
130349149|NCT04393298|469250263|FG010|Overall Study|Lack of Efficacy|0|||
130349150|NCT04393298|469250264|FG011|Overall Study|Lack of Efficacy|0|||
130349151|NCT04393298|469250265|FG012|Overall Study|Lack of Efficacy|0|||
130349152|NCT04393298|469250266|FG013|Overall Study|Lack of Efficacy|0|||
130349153|NCT04393298|469250267|FG014|Overall Study|Lack of Efficacy|1|||
130349154|NCT04393298|469250253|FG000|Overall Study|Progression|1|||
130349155|NCT04393298|469250254|FG001|Overall Study|Progression|0|||
130349156|NCT04393298|469250255|FG002|Overall Study|Progression|0|||
130349157|NCT04393298|469250256|FG003|Overall Study|Progression|0|||
130349158|NCT04393298|469250257|FG004|Overall Study|Progression|0|||
130349159|NCT04393298|469250258|FG005|Overall Study|Progression|0|||
130349160|NCT04393298|469250259|FG006|Overall Study|Progression|0|||
130349161|NCT04393298|469250260|FG007|Overall Study|Progression|0|||
130349162|NCT04393298|469250261|FG008|Overall Study|Progression|0|||
130349163|NCT04393298|469250262|FG009|Overall Study|Progression|0|||
130349164|NCT04393298|469250263|FG010|Overall Study|Progression|1|||
130349165|NCT04393298|469250264|FG011|Overall Study|Progression|1|||
130349166|NCT04393298|469250265|FG012|Overall Study|Progression|0|||
130349167|NCT04393298|469250266|FG013|Overall Study|Progression|0|||
130349168|NCT04393298|469250267|FG014|Overall Study|Progression|0|||
130349169|NCT04393298|469250253|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
130349170|NCT04393298|469250254|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349171|NCT04393298|469250255|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349172|NCT04393298|469250256|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349173|NCT04393298|469250257|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349174|NCT04393298|469250258|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349175|NCT04393298|469250259|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349176|NCT04393298|469250260|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349177|NCT04393298|469250261|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349178|NCT04393298|469250262|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349179|NCT04393298|469250263|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
130683380|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130349180|NCT04393298|469250264|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349181|NCT04393298|469250265|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349182|NCT04393298|469250266|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349183|NCT04393298|469250267|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
130349184|NCT04393298|469250253|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349185|NCT04393298|469250254|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
130683381|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683382|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
130683383|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683384|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683385|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683386|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683387|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683388|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683389|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683390|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683391|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683392|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130349186|NCT04393298|469250255|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349187|NCT04393298|469250256|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349188|NCT04393298|469250257|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349189|NCT04393298|469250258|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349190|NCT04393298|469250259|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349191|NCT04393298|469250260|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349192|NCT04393298|469250261|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349193|NCT04393298|469250262|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349194|NCT04393298|469250263|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349195|NCT04393298|469250264|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349196|NCT04393298|469250265|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349197|NCT04393298|469250266|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349198|NCT04393298|469250267|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130349199|NCT04393298|469250253|FG000|Overall Study|Clinical Progression|0|||
130349200|NCT04393298|469250254|FG001|Overall Study|Clinical Progression|2|||
130349201|NCT04393298|469250255|FG002|Overall Study|Clinical Progression|0|||
130349202|NCT04393298|469250256|FG003|Overall Study|Clinical Progression|0|||
130349203|NCT04393298|469250257|FG004|Overall Study|Clinical Progression|0|||
130349204|NCT04393298|469250258|FG005|Overall Study|Clinical Progression|0|||
130349205|NCT04393298|469250259|FG006|Overall Study|Clinical Progression|0|||
130349206|NCT04393298|469250260|FG007|Overall Study|Clinical Progression|0|||
130349207|NCT04393298|469250261|FG008|Overall Study|Clinical Progression|0|||
130349208|NCT04393298|469250262|FG009|Overall Study|Clinical Progression|0|||
130349209|NCT04393298|469250263|FG010|Overall Study|Clinical Progression|0|||
130349210|NCT04393298|469250264|FG011|Overall Study|Clinical Progression|0|||
130349211|NCT04393298|469250265|FG012|Overall Study|Clinical Progression|0|||
130349212|NCT04393298|469250266|FG013|Overall Study|Clinical Progression|0|||
130349213|NCT04393298|469250267|FG014|Overall Study|Clinical Progression|0|||
130349214|NCT04393298|469250253|FG000|Overall Study|Disease Progression|0|||
130349215|NCT04393298|469250254|FG001|Overall Study|Disease Progression|1|||
130349216|NCT04393298|469250255|FG002|Overall Study|Disease Progression|0|||
130349217|NCT04393298|469250256|FG003|Overall Study|Disease Progression|0|||
130349218|NCT04393298|469250257|FG004|Overall Study|Disease Progression|0|||
130349219|NCT04393298|469250258|FG005|Overall Study|Disease Progression|3|||
130349220|NCT04393298|469250259|FG006|Overall Study|Disease Progression|2|||
130349221|NCT04393298|469250260|FG007|Overall Study|Disease Progression|1|||
130349222|NCT04393298|469250261|FG008|Overall Study|Disease Progression|2|||
130349223|NCT04393298|469250262|FG009|Overall Study|Disease Progression|1|||
130349224|NCT04393298|469250263|FG010|Overall Study|Disease Progression|0|||
130349225|NCT04393298|469250264|FG011|Overall Study|Disease Progression|3|||
130349226|NCT04393298|469250265|FG012|Overall Study|Disease Progression|0|||
130349227|NCT04393298|469250266|FG013|Overall Study|Disease Progression|0|||
130349228|NCT04393298|469250267|FG014|Overall Study|Disease Progression|1|||
130349229|NCT04393298|469250253|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349230|NCT04393298|469250254|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349231|NCT04393298|469250255|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
130349232|NCT04393298|469250256|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349233|NCT04393298|469250257|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349234|NCT04393298|469250258|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349235|NCT04393298|469250259|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349236|NCT04393298|469250260|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349237|NCT04393298|469250261|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349238|NCT04393298|469250262|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349239|NCT04393298|469250263|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349240|NCT04393298|469250264|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349241|NCT04393298|469250265|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349242|NCT04393298|469250266|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130349243|NCT04393298|469250267|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130683393|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
130683394|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
130683395|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
130683396|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
130683397|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
130683398|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
130683399|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
130683400|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
130683401|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
130683402|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
130683403|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
130683404|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
130683405|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
130683406|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
130683407|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
130683408|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
130349244|NCT04393298|469250253|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349245|NCT04393298|469250254|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349246|NCT04393298|469250255|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
130349247|NCT04393298|469250256|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349248|NCT04393298|469250257|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349249|NCT04393298|469250258|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349250|NCT04393298|469250259|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349251|NCT04393298|469250260|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349252|NCT04393298|469250261|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349253|NCT04393298|469250262|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349254|NCT04393298|469250263|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349255|NCT04393298|469250264|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349256|NCT04393298|469250265|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349257|NCT04393298|469250266|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349258|NCT04393298|469250267|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
130349259|NCT04393298|469250253|FG000|Overall Study|Progressive Disease (PD)|0|||
130349260|NCT04393298|469250254|FG001|Overall Study|Progressive Disease (PD)|0|||
130349261|NCT04393298|469250255|FG002|Overall Study|Progressive Disease (PD)|0|||
130349262|NCT04393298|469250256|FG003|Overall Study|Progressive Disease (PD)|3|||
130349263|NCT04393298|469250257|FG004|Overall Study|Progressive Disease (PD)|0|||
130349264|NCT04393298|469250258|FG005|Overall Study|Progressive Disease (PD)|0|||
130349265|NCT04393298|469250259|FG006|Overall Study|Progressive Disease (PD)|0|||
130349266|NCT04393298|469250260|FG007|Overall Study|Progressive Disease (PD)|0|||
130349267|NCT04393298|469250261|FG008|Overall Study|Progressive Disease (PD)|0|||
130349268|NCT04393298|469250262|FG009|Overall Study|Progressive Disease (PD)|0|||
130349269|NCT04393298|469250263|FG010|Overall Study|Progressive Disease (PD)|0|||
130349270|NCT04393298|469250264|FG011|Overall Study|Progressive Disease (PD)|0|||
130349271|NCT04393298|469250265|FG012|Overall Study|Progressive Disease (PD)|0|||
130349272|NCT04393298|469250266|FG013|Overall Study|Progressive Disease (PD)|0|||
130349273|NCT04393298|469250267|FG014|Overall Study|Progressive Disease (PD)|0|||
130349274|NCT04393298|469250253|FG000|Overall Study|Started a New Cancer Treatment|0|||
130349275|NCT04393298|469250254|FG001|Overall Study|Started a New Cancer Treatment|0|||
130349276|NCT04393298|469250255|FG002|Overall Study|Started a New Cancer Treatment|0|||
130349277|NCT04393298|469250256|FG003|Overall Study|Started a New Cancer Treatment|0|||
130349278|NCT04393298|469250257|FG004|Overall Study|Started a New Cancer Treatment|1|||
130349279|NCT04393298|469250258|FG005|Overall Study|Started a New Cancer Treatment|0|||
130349280|NCT04393298|469250259|FG006|Overall Study|Started a New Cancer Treatment|0|||
130349281|NCT04393298|469250260|FG007|Overall Study|Started a New Cancer Treatment|0|||
130349282|NCT04393298|469250261|FG008|Overall Study|Started a New Cancer Treatment|0|||
130349283|NCT04393298|469250262|FG009|Overall Study|Started a New Cancer Treatment|0|||
130349284|NCT04393298|469250263|FG010|Overall Study|Started a New Cancer Treatment|0|||
130349285|NCT04393298|469250264|FG011|Overall Study|Started a New Cancer Treatment|0|||
130349286|NCT04393298|469250265|FG012|Overall Study|Started a New Cancer Treatment|0|||
130349287|NCT04393298|469250266|FG013|Overall Study|Started a New Cancer Treatment|0|||
130349288|NCT04393298|469250267|FG014|Overall Study|Started a New Cancer Treatment|0|||
130349289|NCT04393298|469250253|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349290|NCT04393298|469250254|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349291|NCT04393298|469250255|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349292|NCT04393298|469250256|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130683409|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
130349293|NCT04393298|469250257|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
130683410|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
130683411|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
130683412|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
130683413|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
130437565|NCT03556358|469564467|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
130683414|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
130683415|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
130683416|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
130683417|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
130683418|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
130683419|NCT05093205|470468229|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
130683420|NCT05093205|470468230|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
130683421|NCT05093205|470468231|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
130683422|NCT05093205|470468232|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
130683423|NCT05093205|470468233|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
130683424|NCT05093205|470468234|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
130683425|NCT05093205|470468235|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
130217803|NCT04865419|468761405|FG003|Overall Study|Study terminated by Sponsor|2|||
130349294|NCT04393298|469250258|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349295|NCT04393298|469250259|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349296|NCT04393298|469250260|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349297|NCT04393298|469250261|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349298|NCT04393298|469250262|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349299|NCT04393298|469250263|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349300|NCT04393298|469250264|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130437566|NCT03556358|469564468|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
130437567|NCT03556358|469564467|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
130437568|NCT03556358|469564468|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
130437569|NCT03556358|469564467|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
130437570|NCT03556358|469564468|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
130683426|NCT05093205|470468236|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
130349301|NCT04393298|469250265|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349302|NCT04393298|469250266|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349303|NCT04393298|469250267|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130349304|NCT04393298|469250253|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349305|NCT04393298|469250254|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349306|NCT04393298|469250255|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349307|NCT04393298|469250256|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349308|NCT04393298|469250257|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349309|NCT04393298|469250258|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
130349310|NCT04393298|469250259|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349311|NCT04393298|469250260|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349312|NCT04393298|469250261|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349313|NCT04393298|469250262|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349314|NCT04393298|469250263|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349315|NCT04393298|469250264|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349316|NCT04393298|469250265|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349317|NCT04393298|469250266|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349318|NCT04393298|469250267|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130349319|NCT04393298|469250253|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349320|NCT04393298|469250254|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349321|NCT04393298|469250255|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349322|NCT04393298|469250256|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349323|NCT04393298|469250257|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349324|NCT04393298|469250258|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
130349325|NCT04393298|469250259|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349326|NCT04393298|469250260|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349327|NCT04393298|469250261|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349328|NCT04393298|469250262|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349329|NCT04393298|469250263|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349330|NCT04393298|469250264|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349331|NCT04393298|469250265|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349332|NCT04393298|469250266|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130349333|NCT04393298|469250267|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
130349334|NCT04393298|469250253|FG000|Overall Study|Death|0|||
130349335|NCT04393298|469250254|FG001|Overall Study|Death|0|||
130683427|NCT05093205|470468237|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
130217804|NCT04865419|468761406|FG004|Overall Study|Study terminated by Sponsor|2|||
130349336|NCT04393298|469250255|FG002|Overall Study|Death|0|||
130349337|NCT04393298|469250256|FG003|Overall Study|Death|0|||
130437571|NCT01351025|469564469|FG000|Week 0 - 20|Lost to Follow-up|2|||
130437572|NCT01351025|469564470|FG001|Week 0 - 20|Lost to Follow-up|1|||
130437573|NCT01351025|469564469|FG000|Week 0 - 20|Withdrawal by Subject|1|||
130437574|NCT01351025|469564470|FG001|Week 0 - 20|Withdrawal by Subject|0|||
130437575|NCT01351025|469564469|FG000|Week 24 - 44|Lost to Follow-up|0|||
130437576|NCT01351025|469564470|FG001|Week 24 - 44|Lost to Follow-up|2|||
130437577|NCT01351025|469564469|FG000|Week 24 - 44|Site closed|0|||
130437578|NCT01351025|469564470|FG001|Week 24 - 44|Site closed|1|||
130437579|NCT01351025|469564469|FG000|Week 24 - 44|unable to get to clinic|1|||
130437580|NCT01351025|469564470|FG001|Week 24 - 44|unable to get to clinic|1|||
130437581|NCT01861522|469564475|FG000|Overall Study|Adverse Event|1|||
130437582|NCT01861522|469564476|FG001|Overall Study|Adverse Event|0|||
130437583|NCT01861522|469564475|FG000|Overall Study|Withdrawal by Subject|2|||
130437584|NCT01861522|469564476|FG001|Overall Study|Withdrawal by Subject|0|||
130437585|NCT00550550|469564477|FG000|Overall Study|Adverse Event|13|||
130437586|NCT00550550|469564478|FG001|Overall Study|Adverse Event|5|||
130437587|NCT00550550|469564477|FG000|Overall Study|Treatment Failure|0|||
130437588|NCT00550550|469564478|FG001|Overall Study|Treatment Failure|1|||
130437589|NCT00550550|469564477|FG000|Overall Study|Lost to Follow-up|4|||
130437590|NCT00550550|469564478|FG001|Overall Study|Lost to Follow-up|0|||
130437591|NCT00550550|469564477|FG000|Overall Study|Withdrawal by Subject|10|||
130349338|NCT04393298|469250257|FG004|Overall Study|Death|0|||
130349339|NCT04393298|469250258|FG005|Overall Study|Death|1|||
130349340|NCT04393298|469250259|FG006|Overall Study|Death|1|||
130349341|NCT04393298|469250260|FG007|Overall Study|Death|0|||
130349342|NCT04393298|469250261|FG008|Overall Study|Death|1|||
130349343|NCT04393298|469250262|FG009|Overall Study|Death|1|||
130349344|NCT04393298|469250263|FG010|Overall Study|Death|0|||
130349345|NCT04393298|469250264|FG011|Overall Study|Death|1|||
130349346|NCT04393298|469250265|FG012|Overall Study|Death|1|||
130349347|NCT04393298|469250266|FG013|Overall Study|Death|0|||
130349348|NCT04393298|469250267|FG014|Overall Study|Death|1|||
130349349|NCT04393298|469250253|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349350|NCT04393298|469250254|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349351|NCT04393298|469250255|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349352|NCT04393298|469250256|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349353|NCT04393298|469250257|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349354|NCT04393298|469250258|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
130349355|NCT04393298|469250259|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349356|NCT04393298|469250260|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349357|NCT04393298|469250261|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349358|NCT04393298|469250262|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349359|NCT04393298|469250263|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349360|NCT04393298|469250264|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349361|NCT04393298|469250265|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349362|NCT04393298|469250266|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349363|NCT04393298|469250267|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130349364|NCT04393298|469250253|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
130349365|NCT04393298|469250254|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
130349366|NCT04393298|469250255|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
130349367|NCT04393298|469250256|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
130349368|NCT04393298|469250257|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
130349369|NCT04393298|469250258|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
130349370|NCT04393298|469250259|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
130349371|NCT04393298|469250260|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
130349372|NCT04393298|469250261|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
130349373|NCT04393298|469250262|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
130349374|NCT04393298|469250263|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
130349375|NCT04393298|469250264|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
130349376|NCT04393298|469250265|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
130349377|NCT04393298|469250266|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
130349378|NCT04393298|469250267|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
130349379|NCT04393298|469250253|FG000|Overall Study|Patient Passed Away|0|||
130349380|NCT04393298|469250254|FG001|Overall Study|Patient Passed Away|0|||
130349381|NCT04393298|469250255|FG002|Overall Study|Patient Passed Away|0|||
130349382|NCT04393298|469250256|FG003|Overall Study|Patient Passed Away|0|||
130349383|NCT04393298|469250257|FG004|Overall Study|Patient Passed Away|0|||
130349384|NCT04393298|469250258|FG005|Overall Study|Patient Passed Away|0|||
130437592|NCT00550550|469564478|FG001|Overall Study|Withdrawal by Subject|8|||
130437593|NCT00550550|469564477|FG000|Overall Study|Protocol Violation|5|||
130437594|NCT00550550|469564478|FG001|Overall Study|Protocol Violation|14|||
130437595|NCT00550550|469564477|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130437596|NCT00550550|469564478|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130437597|NCT00550550|469564477|FG000|Overall Study|Randomized But Not Treated|1|||
130437598|NCT00550550|469564478|FG001|Overall Study|Randomized But Not Treated|0|||
130437599|NCT00381641|469564481|FG000|Overall Study|Withdrawal by Subject|0|||
130437600|NCT00381641|469564482|FG001|Overall Study|Withdrawal by Subject|2|||
130437601|NCT01598298|469564483|FG000|Overall Study|Not eligible|5|||
130437602|NCT01598298|469564484|FG001|Overall Study|Not eligible|5|||
130437603|NCT01598298|469564483|FG000|Overall Study|Adverse Event|21|||
130437604|NCT01598298|469564484|FG001|Overall Study|Adverse Event|19|||
130437605|NCT01598298|469564483|FG000|Overall Study|Progression/relapse|0|||
130437606|NCT01598298|469564484|FG001|Overall Study|Progression/relapse|2|||
130437607|NCT01598298|469564483|FG000|Overall Study|Withdrawal by Subject|10|||
130437608|NCT01598298|469564484|FG001|Overall Study|Withdrawal by Subject|15|||
130437609|NCT01598298|469564483|FG000|Overall Study|Other reason (not protocol specified)|4|||
130437610|NCT01598298|469564484|FG001|Overall Study|Other reason (not protocol specified)|0|||
130437611|NCT03813147|469564485|FG000|Overall Study|Lack of Efficacy|4|||
130437612|NCT03813147|469564486|FG001|Overall Study|Lack of Efficacy|4|||
130437613|NCT03813147|469564485|FG000|Overall Study|Physician Decision|2|||
130437614|NCT03813147|469564486|FG001|Overall Study|Physician Decision|1|||
130437615|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
130437616|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
130437617|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
130437618|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
130437619|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
130437620|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
130437621|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Death|0|||
130437622|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Death|1|||
130437623|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Adverse Event|11|||
130437624|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Adverse Event|11|||
130437625|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
130437626|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
130683428|NCT05093205|470468238|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
130683429|NCT05093205|470468239|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
130683430|NCT05093205|470468240|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
130683431|NCT05093205|470468241|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
130683432|NCT05093205|470468229|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
130683433|NCT05093205|470468230|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
130683434|NCT05093205|470468231|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
130683435|NCT05093205|470468232|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
130683436|NCT05093205|470468233|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
130683437|NCT05093205|470468234|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
130683438|NCT05093205|470468235|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
130683439|NCT05093205|470468236|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
130683440|NCT05093205|470468237|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
130683441|NCT05093205|470468238|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
130683442|NCT05093205|470468239|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
130683443|NCT05093205|470468240|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
130683444|NCT05093205|470468241|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
130683445|NCT05093205|470468229|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
130683446|NCT05093205|470468230|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
130683447|NCT05093205|470468231|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
130683448|NCT05093205|470468232|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
130683449|NCT05093205|470468233|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
130683450|NCT05093205|470468234|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
130349385|NCT04393298|469250259|FG006|Overall Study|Patient Passed Away|0|||
130349386|NCT04393298|469250260|FG007|Overall Study|Patient Passed Away|1|||
130349387|NCT04393298|469250261|FG008|Overall Study|Patient Passed Away|0|||
130349388|NCT04393298|469250262|FG009|Overall Study|Patient Passed Away|0|||
130349389|NCT04393298|469250263|FG010|Overall Study|Patient Passed Away|0|||
130349390|NCT04393298|469250264|FG011|Overall Study|Patient Passed Away|0|||
130349391|NCT04393298|469250265|FG012|Overall Study|Patient Passed Away|0|||
130349392|NCT04393298|469250266|FG013|Overall Study|Patient Passed Away|0|||
130349393|NCT04393298|469250267|FG014|Overall Study|Patient Passed Away|0|||
130349394|NCT04393298|469250253|FG000|Overall Study|Patient Deceased|0|||
130349395|NCT04393298|469250254|FG001|Overall Study|Patient Deceased|0|||
130437627|NCT02936037|469566107|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130349396|NCT04393298|469250255|FG002|Overall Study|Patient Deceased|0|||
130349397|NCT04393298|469250256|FG003|Overall Study|Patient Deceased|0|||
130437628|NCT02936037|469566108|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130437629|NCT02936037|469566107|FG000|Open Label Extension|Adverse Event|0|||
130437630|NCT02936037|469566108|FG001|Open Label Extension|Adverse Event|3|||
130683451|NCT05093205|470468235|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
130683452|NCT05093205|470468236|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
130683453|NCT05093205|470468237|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
130683454|NCT05093205|470468238|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
130683455|NCT05093205|470468239|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
130683456|NCT05093205|470468240|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
130683457|NCT05093205|470468241|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
130683458|NCT05093205|470468229|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
130683459|NCT05093205|470468230|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
130683460|NCT05093205|470468231|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
130683461|NCT05093205|470468232|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
130683462|NCT05093205|470468233|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
130683463|NCT05093205|470468234|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
130683464|NCT05093205|470468235|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
130683465|NCT05093205|470468236|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
130683466|NCT05093205|470468237|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
130683467|NCT05093205|470468238|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
130683468|NCT05093205|470468239|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
130683469|NCT05093205|470468240|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
130683470|NCT05093205|470468241|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
130349398|NCT04393298|469250257|FG004|Overall Study|Patient Deceased|0|||
130349399|NCT04393298|469250258|FG005|Overall Study|Patient Deceased|0|||
130349400|NCT04393298|469250259|FG006|Overall Study|Patient Deceased|0|||
130349401|NCT04393298|469250260|FG007|Overall Study|Patient Deceased|1|||
130349402|NCT04393298|469250261|FG008|Overall Study|Patient Deceased|0|||
130349403|NCT04393298|469250262|FG009|Overall Study|Patient Deceased|0|||
130349404|NCT04393298|469250263|FG010|Overall Study|Patient Deceased|0|||
130349405|NCT04393298|469250264|FG011|Overall Study|Patient Deceased|0|||
130349406|NCT04393298|469250265|FG012|Overall Study|Patient Deceased|0|||
130349407|NCT04393298|469250266|FG013|Overall Study|Patient Deceased|0|||
130349408|NCT04393298|469250267|FG014|Overall Study|Patient Deceased|0|||
130349409|NCT04393298|469250253|FG000|Overall Study|Patient Discharged to Hospice|0|||
130349410|NCT04393298|469250254|FG001|Overall Study|Patient Discharged to Hospice|0|||
130349411|NCT04393298|469250255|FG002|Overall Study|Patient Discharged to Hospice|0|||
130349412|NCT04393298|469250256|FG003|Overall Study|Patient Discharged to Hospice|0|||
130349413|NCT04393298|469250257|FG004|Overall Study|Patient Discharged to Hospice|0|||
130349414|NCT04393298|469250258|FG005|Overall Study|Patient Discharged to Hospice|0|||
130349415|NCT04393298|469250259|FG006|Overall Study|Patient Discharged to Hospice|0|||
130349416|NCT04393298|469250260|FG007|Overall Study|Patient Discharged to Hospice|0|||
130349417|NCT04393298|469250261|FG008|Overall Study|Patient Discharged to Hospice|1|||
130349418|NCT04393298|469250262|FG009|Overall Study|Patient Discharged to Hospice|0|||
130349419|NCT04393298|469250263|FG010|Overall Study|Patient Discharged to Hospice|0|||
130349420|NCT04393298|469250264|FG011|Overall Study|Patient Discharged to Hospice|0|||
130349421|NCT04393298|469250265|FG012|Overall Study|Patient Discharged to Hospice|0|||
130349422|NCT04393298|469250266|FG013|Overall Study|Patient Discharged to Hospice|0|||
130349423|NCT04393298|469250267|FG014|Overall Study|Patient Discharged to Hospice|0|||
130349424|NCT04393298|469250253|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349425|NCT04393298|469250254|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349426|NCT04393298|469250255|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349427|NCT04393298|469250256|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349428|NCT04393298|469250257|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349429|NCT04393298|469250258|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349430|NCT04393298|469250259|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349431|NCT04393298|469250260|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349432|NCT04393298|469250261|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349433|NCT04393298|469250262|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
130349434|NCT04393298|469250263|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349435|NCT04393298|469250264|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349436|NCT04393298|469250265|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349437|NCT04393298|469250266|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349438|NCT04393298|469250267|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130349439|NCT04393298|469250253|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
130349440|NCT04393298|469250254|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
130349441|NCT04393298|469250255|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
130349442|NCT04393298|469250256|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
130349443|NCT04393298|469250257|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
130349444|NCT04393298|469250258|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
130349445|NCT04393298|469250259|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
130349446|NCT04393298|469250260|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
130349447|NCT04393298|469250261|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
130349448|NCT04393298|469250262|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
130349449|NCT04393298|469250263|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
130683471|NCT05093205|470468229|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683472|NCT05093205|470468230|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683473|NCT05093205|470468231|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683474|NCT05093205|470468232|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683475|NCT05093205|470468233|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683476|NCT05093205|470468234|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683477|NCT05093205|470468235|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683478|NCT05093205|470468236|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683479|NCT05093205|470468237|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683480|NCT05093205|470468238|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
130683481|NCT05093205|470468239|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683482|NCT05093205|470468240|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683483|NCT05093205|470468241|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683484|NCT05093205|470468229|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
130683485|NCT05093205|470468230|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
130683486|NCT05093205|470468231|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
130683487|NCT05093205|470468232|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
130683488|NCT05093205|470468233|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
130683489|NCT05093205|470468234|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
130683490|NCT05093205|470468235|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
130683491|NCT05093205|470468236|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
130683492|NCT05093205|470468237|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
130683493|NCT05093205|470468238|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
130683494|NCT05093205|470468239|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
130683495|NCT05093205|470468240|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
130683496|NCT05093205|470468241|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
130683497|NCT05093205|470468229|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683498|NCT05093205|470468230|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683499|NCT05093205|470468231|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683500|NCT05093205|470468232|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683501|NCT05093205|470468233|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683502|NCT05093205|470468234|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683503|NCT05093205|470468235|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683504|NCT05093205|470468236|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683505|NCT05093205|470468237|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683506|NCT05093205|470468238|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683507|NCT05093205|470468239|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
130683508|NCT05093205|470468240|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683509|NCT05093205|470468241|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683510|NCT05093205|470468229|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683511|NCT05093205|470468230|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683512|NCT05093205|470468231|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683513|NCT05093205|470468232|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683514|NCT05093205|470468233|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683515|NCT05093205|470468234|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683516|NCT05093205|470468235|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683517|NCT05093205|470468236|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683518|NCT05093205|470468237|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683519|NCT05093205|470468238|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683520|NCT05093205|470468239|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683521|NCT05093205|470468240|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
130683522|NCT05093205|470468241|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683523|NCT05093205|470468229|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
130683524|NCT05093205|470468230|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
130683525|NCT05093205|470468231|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
130683526|NCT05093205|470468232|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
130683527|NCT05093205|470468233|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
130683528|NCT05093205|470468234|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
130437631|NCT02936037|469566107|FG000|Open Label Extension|Other|0|||
130437632|NCT02936037|469566108|FG001|Open Label Extension|Other|3|||
130437633|NCT02936037|469566107|FG000|Open Label Extension|Withdrawal by Subject|0|||
130437634|NCT02936037|469566108|FG001|Open Label Extension|Withdrawal by Subject|4|||
130437635|NCT04666922|469566109|FG000|Overall Study|Withdrawal by Subject|1|||
130437636|NCT04666922|469566110|FG001|Overall Study|Withdrawal by Subject|0|||
130437637|NCT04666922|469566111|FG002|Overall Study|Withdrawal by Subject|0|||
130683529|NCT05093205|470468235|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
130683530|NCT05093205|470468236|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
130683531|NCT05093205|470468237|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
130683532|NCT05093205|470468238|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
130683533|NCT05093205|470468239|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
130683534|NCT05093205|470468240|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
130683535|NCT05093205|470468241|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
130683536|NCT05093205|470468229|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683537|NCT05093205|470468230|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683538|NCT05093205|470468231|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130437638|NCT04666922|469566112|FG003|Overall Study|Withdrawal by Subject|0|||
130683539|NCT05093205|470468232|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683540|NCT05093205|470468233|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683541|NCT05093205|470468234|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683542|NCT05093205|470468235|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683543|NCT05093205|470468236|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683544|NCT05093205|470468237|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683545|NCT05093205|470468238|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683546|NCT05093205|470468239|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683547|NCT05093205|470468240|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
130683548|NCT05093205|470468241|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683549|NCT04185909|470468243|FG000|Overall Study|Lost to Follow-up|1|||
130683550|NCT01417078|470468244|FG000|Overall Study|Withdrawal by Subject|1|||
130683551|NCT00626548|470468245|FG000|Overall Study|Adverse Event|164|||
130683552|NCT00626548|470468246|FG001|Overall Study|Adverse Event|44|||
130683553|NCT00626548|470468245|FG000|Overall Study|Withdrawal by Subject|42|||
130683554|NCT00626548|470468246|FG001|Overall Study|Withdrawal by Subject|46|||
130683555|NCT00626548|470468245|FG000|Overall Study|Protocol Violation|4|||
130683556|NCT00626548|470468246|FG001|Overall Study|Protocol Violation|11|||
130683557|NCT00626548|470468245|FG000|Overall Study|Lost to Follow-up|2|||
130683558|NCT00626548|470468246|FG001|Overall Study|Lost to Follow-up|2|||
130683559|NCT00626548|470468245|FG000|Overall Study|Other termination reason|493|||
130683560|NCT00626548|470468246|FG001|Overall Study|Other termination reason|613|||
130683561|NCT00048581|470468247|FG000|Double-Blind Period|Adverse Event|9|||
130683562|NCT00048581|470468248|FG001|Double-Blind Period|Adverse Event|5|||
130683563|NCT00048581|470468249|FG002|Double-Blind Period|Adverse Event|0|||
130683564|NCT00048581|470468247|FG000|Double-Blind Period|Lack of Efficacy|14|||
130683565|NCT00048581|470468248|FG001|Double-Blind Period|Lack of Efficacy|27|||
130683566|NCT00048581|470468249|FG002|Double-Blind Period|Lack of Efficacy|0|||
130683567|NCT00048581|470468247|FG000|Double-Blind Period|Lost to Follow-up|5|||
130683568|NCT00048581|470468248|FG001|Double-Blind Period|Lost to Follow-up|0|||
130683569|NCT00048581|470468249|FG002|Double-Blind Period|Lost to Follow-up|0|||
130683570|NCT00048581|470468247|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130683571|NCT00048581|470468248|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130683572|NCT00048581|470468249|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130683573|NCT00048581|470468247|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
130683574|NCT00048581|470468248|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130683575|NCT00048581|470468249|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130683576|NCT00048581|470468247|FG000|Double-Blind Period|Investigator Decision|1|||
130683577|NCT00048581|470468248|FG001|Double-Blind Period|Investigator Decision|0|||
130683578|NCT00048581|470468249|FG002|Double-Blind Period|Investigator Decision|0|||
130683579|NCT00048581|470468247|FG000|Open-Label Period|Death|0|||
130683580|NCT00048581|470468248|FG001|Open-Label Period|Death|0|||
130683581|NCT00048581|470468249|FG002|Open-Label Period|Death|4|||
130683582|NCT00048581|470468247|FG000|Open-Label Period|Adverse Event|0|||
130683583|NCT00048581|470468248|FG001|Open-Label Period|Adverse Event|0|||
130683584|NCT00048581|470468249|FG002|Open-Label Period|Adverse Event|37|||
130683585|NCT00048581|470468247|FG000|Open-Label Period|Lack of Efficacy|0|||
130349450|NCT04393298|469250264|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
130349451|NCT04393298|469250265|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
130349452|NCT04393298|469250266|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
130349453|NCT04393298|469250267|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
130349454|NCT03754972|469250268|FG000|Overall Study|Protocol Violation|25|||
130349455|NCT02311582|469250269|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130683586|NCT00048581|470468248|FG001|Open-Label Period|Lack of Efficacy|0|||
130349456|NCT02311582|469250270|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130349457|NCT02311582|469250271|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130349458|NCT02311582|469250272|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
130349459|NCT02311582|469250273|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
130349460|NCT03422627|469250274|FG000|Overall Study|Protocol-specified Criteria|1|||
130349461|NCT03422627|469250275|FG001|Overall Study|Protocol-specified Criteria|1|||
130349462|NCT03422627|469250276|FG002|Overall Study|Protocol-specified Criteria|0|||
130683587|NCT00048581|470468249|FG002|Open-Label Period|Lack of Efficacy|69|||
130683588|NCT00048581|470468247|FG000|Open-Label Period|Lost to Follow-up|0|||
130683589|NCT00048581|470468248|FG001|Open-Label Period|Lost to Follow-up|0|||
130683590|NCT00048581|470468249|FG002|Open-Label Period|Lost to Follow-up|14|||
130349463|NCT03422627|469250277|FG003|Overall Study|Protocol-specified Criteria|0|||
130683591|NCT00048581|470468247|FG000|Open-Label Period|Withdrawal by Subject|0|||
130683592|NCT00048581|470468248|FG001|Open-Label Period|Withdrawal by Subject|0|||
130683593|NCT00048581|470468249|FG002|Open-Label Period|Withdrawal by Subject|20|||
130349464|NCT03422627|469250278|FG004|Overall Study|Protocol-specified Criteria|2|||
130683594|NCT00048581|470468247|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
130683595|NCT00048581|470468248|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
130683596|NCT00048581|470468249|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
130437639|NCT04666922|469566113|FG004|Overall Study|Withdrawal by Subject|0|||
130437640|NCT04666922|469566114|FG005|Overall Study|Withdrawal by Subject|0|||
130437641|NCT04666922|469566115|FG006|Overall Study|Withdrawal by Subject|0|||
130437642|NCT00244374|469566116|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
130437643|NCT00244374|469566117|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130437644|NCT00244374|469566118|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130437645|NCT00244374|469566119|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130437646|NCT00244374|469566120|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130437647|NCT00244374|469566116|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
130437648|NCT00244374|469566117|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130437649|NCT00244374|469566118|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130437650|NCT00244374|469566119|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130437651|NCT00244374|469566120|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130437652|NCT00244374|469566116|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
130437653|NCT00244374|469566117|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130437654|NCT00244374|469566118|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130437655|NCT00244374|469566119|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130437656|NCT00244374|469566120|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130437657|NCT00244374|469566116|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
130437658|NCT00244374|469566117|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130437659|NCT00244374|469566118|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130437660|NCT00244374|469566119|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130437661|NCT00244374|469566120|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130437662|NCT00244374|469566116|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
130437663|NCT00244374|469566117|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130437664|NCT00244374|469566118|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130437665|NCT00244374|469566119|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130437666|NCT00244374|469566120|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130437667|NCT00244374|469566116|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
130437668|NCT00244374|469566117|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130437669|NCT00244374|469566118|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130437670|NCT00244374|469566119|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130437671|NCT00244374|469566120|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130437672|NCT00244374|469566116|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
130437673|NCT00244374|469566117|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130683597|NCT00048581|470468247|FG000|Open-Label Period|Poor/Non-compliance|0|||
130683598|NCT00048581|470468248|FG001|Open-Label Period|Poor/Non-compliance|0|||
130683599|NCT00048581|470468249|FG002|Open-Label Period|Poor/Non-compliance|5|||
130683600|NCT00048581|470468247|FG000|Open-Label Period|Pregnancy|0|||
130683601|NCT00048581|470468248|FG001|Open-Label Period|Pregnancy|0|||
130683602|NCT00048581|470468249|FG002|Open-Label Period|Pregnancy|7|||
130683603|NCT00048581|470468247|FG000|Open-Label Period|Study Site Closure|0|||
130683604|NCT00048581|470468248|FG001|Open-Label Period|Study Site Closure|0|||
130683605|NCT00048581|470468249|FG002|Open-Label Period|Study Site Closure|2|||
130683606|NCT00048581|470468247|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130683607|NCT00048581|470468248|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130683608|NCT00048581|470468249|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
130683609|NCT00048581|470468247|FG000|Open-Label Period|Problem With Transportation To Site|0|||
130683610|NCT00048581|470468248|FG001|Open-Label Period|Problem With Transportation To Site|0|||
130683611|NCT00048581|470468249|FG002|Open-Label Period|Problem With Transportation To Site|1|||
130683612|NCT00048581|470468247|FG000|Open-Label Period|Primary Investigator Retired|0|||
130683613|NCT00048581|470468248|FG001|Open-Label Period|Primary Investigator Retired|0|||
130683614|NCT00048581|470468249|FG002|Open-Label Period|Primary Investigator Retired|2|||
130683615|NCT00048581|470468247|FG000|Open-Label Period|Study Ended By Sponsor|0|||
130683616|NCT00048581|470468248|FG001|Open-Label Period|Study Ended By Sponsor|0|||
130683617|NCT00048581|470468249|FG002|Open-Label Period|Study Ended By Sponsor|1|||
130683618|NCT01059903|470468251|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130683619|NCT01059903|470468252|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130683620|NCT00385593|470468255|FG000|Overall Study|Adverse Event|3|||
130683621|NCT00385593|470468256|FG001|Overall Study|Adverse Event|2|||
130683622|NCT00385593|470468255|FG000|Overall Study|Withdrawal by Subject|17|||
130683623|NCT00385593|470468256|FG001|Overall Study|Withdrawal by Subject|7|||
130683624|NCT00385593|470468255|FG000|Overall Study|Lost to Follow-up|12|||
130683625|NCT00385593|470468256|FG001|Overall Study|Lost to Follow-up|8|||
130683626|NCT00385593|470468255|FG000|Overall Study|Protocol Violation|7|||
130683627|NCT00385593|470468256|FG001|Overall Study|Protocol Violation|4|||
130683628|NCT00385593|470468255|FG000|Overall Study|Several reasons|17|||
130683629|NCT00385593|470468256|FG001|Overall Study|Several reasons|15|||
130683630|NCT00385593|470468255|FG000|Overall Study|Incorrect inclusion|2|||
130683631|NCT00385593|470468256|FG001|Overall Study|Incorrect inclusion|0|||
130683632|NCT00385593|470468255|FG000|Overall Study|Incorrect randomization|0|||
130683633|NCT00385593|470468256|FG001|Overall Study|Incorrect randomization|1|||
130683634|NCT02100228|470468257|FG000|Overall Study|Other|19|||
130683635|NCT02100228|470468258|FG001|Overall Study|Other|19|||
130683636|NCT02100228|470468257|FG000|Overall Study|Administrative reason|0|||
130683637|NCT02100228|470468258|FG001|Overall Study|Administrative reason|1|||
130683638|NCT02100228|470468257|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
130683639|NCT02100228|470468258|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
130683640|NCT02100228|470468257|FG000|Overall Study|Non-compliance|0|||
130683641|NCT02100228|470468258|FG001|Overall Study|Non-compliance|3|||
130683642|NCT02100228|470468257|FG000|Overall Study|Lost to Follow-up|0|||
130683643|NCT02100228|470468258|FG001|Overall Study|Lost to Follow-up|1|||
130683644|NCT02100228|470468257|FG000|Overall Study|Withdrawal by Subject|27|||
130683645|NCT02100228|470468258|FG001|Overall Study|Withdrawal by Subject|37|||
130683646|NCT02100228|470468257|FG000|Overall Study|Adverse Event|16|||
130683647|NCT02100228|470468258|FG001|Overall Study|Adverse Event|12|||
130683648|NCT02100228|470468257|FG000|Overall Study|Death|1|||
130683649|NCT02100228|470468258|FG001|Overall Study|Death|1|||
130683650|NCT04149964|470468259|FG000|Overall Study|Lost to Follow-up|19|||
130683651|NCT04149964|470468260|FG001|Overall Study|Lost to Follow-up|18|||
130683652|NCT01223365|470468261|FG000|Open-label Titration Period|Enrolled but not treated|1|||
130683653|NCT01223365|470468261|FG000|Open-label Titration Period|Adverse Event|23|||
130683654|NCT01223365|470468261|FG000|Open-label Titration Period|Lack of Efficacy|3|||
130683655|NCT01223365|470468261|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
130683656|NCT01223365|470468261|FG000|Open-label Titration Period|Protocol Violation|1|||
130683657|NCT01223365|470468261|FG000|Open-label Titration Period|Lost to Follow-up|2|||
130683658|NCT01223365|470468261|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
130683659|NCT01223365|470468261|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
130683660|NCT01223365|470468261|FG000|Open-label Titration Period|Starting physical therapy|1|||
130683661|NCT01223365|470468261|FG000|Open-label Treatment Period|Adverse Event|39|||
130683662|NCT01223365|470468261|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
130683663|NCT01223365|470468261|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
130683664|NCT01223365|470468261|FG000|Open-label Treatment Period|Protocol Violation|15|||
130683665|NCT01223365|470468261|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
130683666|NCT01223365|470468261|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
130683667|NCT01223365|470468261|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
130683668|NCT01223365|470468261|FG000|Open-label Treatment Period|Moved out of area|2|||
130683669|NCT01223365|470468261|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
130683670|NCT01223365|470468261|FG000|Open-label Treatment Period|"Out of window"|1|||
130683671|NCT01223365|470468261|FG000|Open-label Treatment Period|Starting physical therapy|1|||
130683672|NCT01223365|470468261|FG000|Open-label Treatment Period|Physician Decision|2|||
130683673|NCT03567174|470468262|FG000|Overall Study|Death|24|||
130683674|NCT03567174|470468263|FG001|Overall Study|Death|31|||
130683675|NCT03567174|470468262|FG000|Overall Study|Lost to Follow-up|165|||
130683676|NCT03567174|470468263|FG001|Overall Study|Lost to Follow-up|174|||
130683677|NCT02817841|470469892|FG000|Overall Study|Lost to Follow-up|287|||
130683678|NCT02817841|470469892|FG000|Overall Study|Withdrawal by Subject|183|||
130683679|NCT02817841|470469892|FG000|Overall Study|Adverse event not related to bleeding|131|||
130683680|NCT02817841|470469892|FG000|Overall Study|Adverse event related to bleeding|51|||
130683681|NCT02817841|470469892|FG000|Overall Study|Pregnancy|32|||
130683682|NCT02817841|470469892|FG000|Overall Study|Pregnancy wish|17|||
130683683|NCT02817841|470469892|FG000|Overall Study|Other reasons|53|||
130683684|NCT02817841|470469892|FG000|Overall Study|Protocol Violation|94|||
130683685|NCT01746017|470469895|FG000|Period 1|Withdrawal by Subject|0|||
130683686|NCT01746017|470469896|FG001|Period 1|Withdrawal by Subject|0|||
130683687|NCT01746017|470469897|FG002|Period 1|Withdrawal by Subject|0|||
130683688|NCT01746017|470469898|FG003|Period 1|Withdrawal by Subject|0|||
130683689|NCT01746017|470469899|FG004|Period 1|Withdrawal by Subject|0|||
130683690|NCT01746017|470469900|FG005|Period 1|Withdrawal by Subject|0|||
130683691|NCT01746017|470469901|FG006|Period 1|Withdrawal by Subject|1|||
130683692|NCT01746017|470469902|FG007|Period 1|Withdrawal by Subject|0|||
130683693|NCT01746017|470469903|FG008|Period 1|Withdrawal by Subject|0|||
130683694|NCT01746017|470469904|FG009|Period 1|Withdrawal by Subject|0|||
130683695|NCT01746017|470469905|FG010|Period 1|Withdrawal by Subject|0|||
130683696|NCT01746017|470469895|FG000|Period 3|Withdrawal by Subject|0|||
130683697|NCT01746017|470469896|FG001|Period 3|Withdrawal by Subject|0|||
130683698|NCT01746017|470469897|FG002|Period 3|Withdrawal by Subject|0|||
130683699|NCT01746017|470469898|FG003|Period 3|Withdrawal by Subject|0|||
130683700|NCT01746017|470469899|FG004|Period 3|Withdrawal by Subject|0|||
130683701|NCT01746017|470469900|FG005|Period 3|Withdrawal by Subject|1|||
130683702|NCT01746017|470469901|FG006|Period 3|Withdrawal by Subject|0|||
130683703|NCT01746017|470469902|FG007|Period 3|Withdrawal by Subject|0|||
130683704|NCT01746017|470469903|FG008|Period 3|Withdrawal by Subject|0|||
130683705|NCT01746017|470469904|FG009|Period 3|Withdrawal by Subject|0|||
130683706|NCT01746017|470469905|FG010|Period 3|Withdrawal by Subject|0|||
130683707|NCT00397488|470469906|FG000|Overall Study|Withdrawal by Subject|3|||
130683708|NCT00397488|470469906|FG000|Overall Study|Adverse Event|3|||
130683709|NCT00397488|470469906|FG000|Overall Study|Death|1|||
130683710|NCT02424097|470469907|FG000|Overall Study|Lost to Follow-up|1|||
130683711|NCT02424097|470469908|FG001|Overall Study|Lost to Follow-up|2|||
130683712|NCT02943447|470469909|FG000|Blinded Study Phase|Withdrew Consent|1|||
130683713|NCT02943447|470469910|FG001|Blinded Study Phase|Withdrew Consent|2|||
130683714|NCT02943447|470469911|FG002|Blinded Study Phase|Withdrew Consent|1|||
130683715|NCT02943447|470469909|FG000|Blinded Study Phase|Adverse Event|3|||
130683716|NCT02943447|470469910|FG001|Blinded Study Phase|Adverse Event|0|||
130683717|NCT02943447|470469911|FG002|Blinded Study Phase|Adverse Event|0|||
130683718|NCT02943447|470469909|FG000|Blinded Study Phase|Investigator's discretion|1|||
130683719|NCT02943447|470469910|FG001|Blinded Study Phase|Investigator's discretion|0|||
130683720|NCT02943447|470469911|FG002|Blinded Study Phase|Investigator's discretion|0|||
130683721|NCT02943447|470469909|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
130683722|NCT02943447|470469910|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
130683723|NCT02943447|470469911|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
130683724|NCT02943447|470469909|FG000|Open-Label Extension Phase|Adverse Event|4|||
130683725|NCT02943447|470469910|FG001|Open-Label Extension Phase|Adverse Event|7|||
130683726|NCT02943447|470469911|FG002|Open-Label Extension Phase|Adverse Event|3|||
130683727|NCT02943447|470469909|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
130683728|NCT02943447|470469910|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
130683729|NCT02943447|470469911|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
130683730|NCT02943447|470469909|FG000|Open-Label Extension Phase|Withdrew consent|1|||
130683731|NCT02943447|470469910|FG001|Open-Label Extension Phase|Withdrew consent|1|||
130683732|NCT02943447|470469911|FG002|Open-Label Extension Phase|Withdrew consent|1|||
130683733|NCT02943447|470469909|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130683734|NCT02943447|470469910|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130683735|NCT02943447|470469911|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130683736|NCT04657770|470469919|FG000|Overall Study|Withdrawal by Subject|3|||
130683737|NCT04657770|470469919|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
130683738|NCT03655106|470469920|FG000|Overall Study|Withdrawal by Subject|3|||
130683739|NCT03655106|470469921|FG001|Overall Study|Withdrawal by Subject|2|||
130683740|NCT03655106|470469920|FG000|Overall Study|Lost to Follow-up|2|||
130683741|NCT03655106|470469921|FG001|Overall Study|Lost to Follow-up|1|||
130683742|NCT03655106|470469920|FG000|Overall Study|Duplicate Enrollment|1|||
130683743|NCT03655106|470469921|FG001|Overall Study|Duplicate Enrollment|1|||
130683744|NCT03655106|470469920|FG000|Overall Study|Protocol Violation|3|||
130683745|NCT03655106|470469921|FG001|Overall Study|Protocol Violation|0|||
130683746|NCT00496964|470469924|FG000|Overall Study|Withdrawal by Subject|0|||
130683747|NCT00496964|470469925|FG001|Overall Study|Withdrawal by Subject|1|||
130683748|NCT02058498|470469926|FG000|Overall Study|Withdrawal by Subject|4|||
130683749|NCT05327491|470469927|FG000|Periods 1 & 2|Miscellaneous|0|||
130683750|NCT05327491|470469928|FG001|Periods 1 & 2|Miscellaneous|1|||
130683751|NCT05327491|470469929|FG002|Periods 1 & 2|Miscellaneous|0|||
130683752|NCT05327491|470469930|FG003|Periods 1 & 2|Miscellaneous|0|||
130683753|NCT05327491|470469927|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
130683754|NCT05327491|470469928|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
130683755|NCT05327491|470469929|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
130683756|NCT05327491|470469930|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
130683757|NCT05038293|470469931|FG000|Overall Study|device was not operating properly for one subject.|1|||
130683758|NCT05038293|470469932|FG001|Overall Study|device was not operating properly for one subject.|0|||
130683759|NCT05038293|470469931|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
130683760|NCT05038293|470469932|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
130683761|NCT01171989|470469933|FG000|Overall Study|Lost to Follow-up|0|||
130683762|NCT01171989|470469934|FG001|Overall Study|Lost to Follow-up|0|||
130683763|NCT01171989|470469935|FG002|Overall Study|Lost to Follow-up|1|||
130349465|NCT03422627|469250274|FG000|Overall Study|Requirement for Alternative Therapy|1|||
130349466|NCT03422627|469250275|FG001|Overall Study|Requirement for Alternative Therapy|1|||
130349467|NCT03422627|469250276|FG002|Overall Study|Requirement for Alternative Therapy|2|||
130349468|NCT03422627|469250277|FG003|Overall Study|Requirement for Alternative Therapy|0|||
130349469|NCT03422627|469250278|FG004|Overall Study|Requirement for Alternative Therapy|0|||
130349470|NCT03422627|469250274|FG000|Overall Study|Disease Progression|1|||
130349471|NCT03422627|469250275|FG001|Overall Study|Disease Progression|0|||
130349472|NCT03422627|469250276|FG002|Overall Study|Disease Progression|1|||
130349473|NCT03422627|469250277|FG003|Overall Study|Disease Progression|2|||
130349474|NCT03422627|469250278|FG004|Overall Study|Disease Progression|0|||
130437674|NCT00244374|469566118|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130437675|NCT00244374|469566119|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130683764|NCT01247701|470469938|FG000|Overall Study|Death|2|||
130683765|NCT01247701|470469938|FG000|Overall Study|Relapsed|8|||
130683766|NCT04166630|470469939|FG000|Overall Study|Withdrawal by Subject|0|||
130683767|NCT04166630|470469940|FG001|Overall Study|Withdrawal by Subject|1|||
130683768|NCT00096447|470469941|FG000|Overall Study|Never treated|1|||
130683769|NCT04088760|470469942|FG000|Overall Study|Physician Decision|1|||
130437676|NCT00244374|469566120|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130437677|NCT00244374|469566116|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
130683770|NCT01391793|470469943|FG000|Overall Study|Ineligible|3|||
130683771|NCT01391793|470469944|FG001|Overall Study|Ineligible|0|||
130683772|NCT01391793|470469943|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
130683773|NCT01391793|470469944|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
130683774|NCT01391793|470469943|FG000|Overall Study|No DMSA|73|||
130437678|NCT00244374|469566117|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130437679|NCT00244374|469566118|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130683775|NCT01391793|470469944|FG001|Overall Study|No DMSA|57|||
130683776|NCT00105196|470469945|FG000|Overall Study|Lack of Efficacy|2|||
130683777|NCT00105196|470469946|FG001|Overall Study|Lack of Efficacy|3|||
130683778|NCT00105196|470469945|FG000|Overall Study|Adverse Event|11|||
130683779|NCT00105196|470469946|FG001|Overall Study|Adverse Event|3|||
130683780|NCT00105196|470469945|FG000|Overall Study|Withdrawal by Subject|6|||
130683781|NCT00105196|470469946|FG001|Overall Study|Withdrawal by Subject|6|||
130683782|NCT00105196|470469945|FG000|Overall Study|Lost to Follow-up|3|||
130683783|NCT00105196|470469946|FG001|Overall Study|Lost to Follow-up|2|||
130683784|NCT00105196|470469945|FG000|Overall Study|Poor/noncompliance|3|||
130683785|NCT00105196|470469946|FG001|Overall Study|Poor/noncompliance|4|||
130683786|NCT00105196|470469945|FG000|Overall Study|Protocol Violation|5|||
130683787|NCT00105196|470469946|FG001|Overall Study|Protocol Violation|2|||
130683788|NCT00105196|470469945|FG000|Overall Study|pending surgery|0|||
130683789|NCT00105196|470469946|FG001|Overall Study|pending surgery|1|||
130683790|NCT00105196|470469945|FG000|Overall Study|marijuana use|0|||
130683791|NCT00105196|470469946|FG001|Overall Study|marijuana use|1|||
130683792|NCT00105196|470469945|FG000|Overall Study|Subject became unblinded|0|||
130683793|NCT00105196|470469946|FG001|Overall Study|Subject became unblinded|1|||
130683794|NCT03025880|470469947|FG000|Overall Study|Adverse Event|1|||
130683795|NCT03025880|470469948|FG001|Overall Study|Adverse Event|0|||
130683796|NCT03025880|470469947|FG000|Overall Study|Death|1|||
130683797|NCT03025880|470469948|FG001|Overall Study|Death|1|||
130683798|NCT03025880|470469947|FG000|Overall Study|Withdrawal by Subject|0|||
130683799|NCT03025880|470469948|FG001|Overall Study|Withdrawal by Subject|1|||
130683800|NCT03025880|470469947|FG000|Overall Study|Physician Decision|0|||
130683801|NCT03025880|470469948|FG001|Overall Study|Physician Decision|1|||
130683802|NCT03025880|470469947|FG000|Overall Study|Progressive Disease|12|||
130683803|NCT03025880|470469948|FG001|Overall Study|Progressive Disease|19|||
130683804|NCT00184600|470469949|FG000|Overall Study|Adverse Event|9|||
130683805|NCT00184600|470469950|FG001|Overall Study|Adverse Event|0|||
130683806|NCT00184600|470469951|FG002|Overall Study|Adverse Event|5|||
130683807|NCT00184600|470469949|FG000|Overall Study|Death|3|||
130683808|NCT00184600|470469950|FG001|Overall Study|Death|9|||
130683809|NCT00184600|470469951|FG002|Overall Study|Death|7|||
130683810|NCT00184600|470469949|FG000|Overall Study|Lack of Efficacy|3|||
130349475|NCT03422627|469250274|FG000|Overall Study|Adverse Event|2|||
130349476|NCT03422627|469250275|FG001|Overall Study|Adverse Event|1|||
130349477|NCT03422627|469250276|FG002|Overall Study|Adverse Event|0|||
130349478|NCT03422627|469250277|FG003|Overall Study|Adverse Event|0|||
130349479|NCT03422627|469250278|FG004|Overall Study|Adverse Event|2|||
130349480|NCT03422627|469250274|FG000|Overall Study|Ineligibility Determined|0|||
130349481|NCT03422627|469250275|FG001|Overall Study|Ineligibility Determined|1|||
130349482|NCT03422627|469250276|FG002|Overall Study|Ineligibility Determined|0|||
130349483|NCT03422627|469250277|FG003|Overall Study|Ineligibility Determined|0|||
130683811|NCT00184600|470469950|FG001|Overall Study|Lack of Efficacy|1|||
130683812|NCT00184600|470469951|FG002|Overall Study|Lack of Efficacy|3|||
130683813|NCT00184600|470469949|FG000|Overall Study|Lost to Follow-up|4|||
130683814|NCT00184600|470469950|FG001|Overall Study|Lost to Follow-up|6|||
130683815|NCT00184600|470469951|FG002|Overall Study|Lost to Follow-up|1|||
130683816|NCT00184600|470469949|FG000|Overall Study|Protocol Violation|2|||
130683817|NCT00184600|470469950|FG001|Overall Study|Protocol Violation|2|||
130683818|NCT00184600|470469951|FG002|Overall Study|Protocol Violation|3|||
130683819|NCT00184600|470469949|FG000|Overall Study|Withdrawal by Subject|20|||
130683820|NCT00184600|470469950|FG001|Overall Study|Withdrawal by Subject|28|||
130349484|NCT03422627|469250278|FG004|Overall Study|Ineligibility Determined|0|||
130349485|NCT03422627|469250274|FG000|Overall Study|Death|0|||
130349486|NCT03422627|469250275|FG001|Overall Study|Death|1|||
130349487|NCT03422627|469250276|FG002|Overall Study|Death|1|||
130349488|NCT03422627|469250277|FG003|Overall Study|Death|0|||
130349489|NCT03422627|469250278|FG004|Overall Study|Death|0|||
130349490|NCT03422627|469250274|FG000|Overall Study|Withdrawal by Subject|0|||
130349491|NCT03422627|469250275|FG001|Overall Study|Withdrawal by Subject|0|||
130349492|NCT03422627|469250276|FG002|Overall Study|Withdrawal by Subject|0|||
130349493|NCT03422627|469250277|FG003|Overall Study|Withdrawal by Subject|1|||
130349494|NCT03422627|469250278|FG004|Overall Study|Withdrawal by Subject|0|||
130349495|NCT04656275|469250281|FG000|Overall Study|Study terminated by sponsor|2|||
130349496|NCT04656275|469250282|FG001|Overall Study|Study terminated by sponsor|4|||
130349497|NCT00934648|469250285|FG000|Overall Study|Failure to return|8|||
130349498|NCT00934648|469250285|FG000|Overall Study|Withdrawal by Subject|1|||
130349499|NCT03828370|469250286|FG000|3 Month Follow-up|Lost to Follow-up|4|||
130349500|NCT03828370|469250287|FG001|3 Month Follow-up|Lost to Follow-up|12|||
130349501|NCT03828370|469250286|FG000|9 Month Follow up|Lost to Follow-up|12|||
130349502|NCT03828370|469250287|FG001|9 Month Follow up|Lost to Follow-up|20|||
130349503|NCT02554279|469250290|FG000|Overall Study|Adverse Event|2|||
130349504|NCT02554279|469250291|FG001|Overall Study|Adverse Event|5|||
130349505|NCT02554279|469250290|FG000|Overall Study|Lost to Follow-up|3|||
130349506|NCT02554279|469250291|FG001|Overall Study|Lost to Follow-up|2|||
130349507|NCT02554279|469250290|FG000|Overall Study|Withdrawal by Subject|6|||
130349508|NCT02554279|469250291|FG001|Overall Study|Withdrawal by Subject|4|||
130349509|NCT02554279|469250290|FG000|Overall Study|Protocol Violation|2|||
130349510|NCT02554279|469250291|FG001|Overall Study|Protocol Violation|1|||
130349511|NCT02554279|469250290|FG000|Overall Study|Other reason|19|||
130349512|NCT02554279|469250291|FG001|Overall Study|Other reason|6|||
130349513|NCT00812487|469250292|FG000|Overall Study|Lost to Follow-up|2|||
130349514|NCT00812487|469250293|FG001|Overall Study|Lost to Follow-up|0|||
130349515|NCT00812487|469250292|FG000|Overall Study|Withdrawal by Subject|3|||
130349516|NCT00812487|469250293|FG001|Overall Study|Withdrawal by Subject|2|||
130349517|NCT00812487|469250292|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
130349518|NCT00812487|469250293|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
130349519|NCT00812487|469250292|FG000|Overall Study|Protocol Violation|0|||
130349520|NCT00812487|469250293|FG001|Overall Study|Protocol Violation|1|||
130349521|NCT02360605|469250294|FG000|Overall Study|Withdrawal by Subject|4|||
130349522|NCT02360605|469250295|FG001|Overall Study|Withdrawal by Subject|9|||
130349523|NCT02360605|469250294|FG000|Overall Study|Lost to Follow-up|7|||
130349524|NCT02360605|469250295|FG001|Overall Study|Lost to Follow-up|8|||
130349525|NCT02360605|469250294|FG000|Overall Study|Death|0|||
130349526|NCT02360605|469250295|FG001|Overall Study|Death|1|||
130349527|NCT00290407|469250298|FG000|Overall Study|Physician Decision|2|||
130349528|NCT00723203|469250299|FG000|Overall Study|Withdrawal by Subject|3|||
130349529|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
130349530|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
130349531|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
130349532|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
130349533|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
130349534|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
130349535|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
130349536|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
130349537|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
130349538|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
130349539|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
130349540|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
130349541|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
130349542|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
130349543|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
130349544|NCT00274924|469250300|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
130349545|NCT00274924|469250301|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
130349546|NCT00274924|469250302|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
130349547|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
130349548|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
130349549|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
130349550|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
130349551|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
130349552|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
130349553|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
130349554|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
130349555|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
130349556|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
130349557|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
130349558|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
130349559|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
130349560|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
130437680|NCT00244374|469566119|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130437681|NCT00244374|469566120|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130437682|NCT00244374|469566116|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
130437683|NCT00244374|469566117|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130437684|NCT00244374|469566118|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130437685|NCT00244374|469566119|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130437686|NCT00244374|469566120|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130437687|NCT04651114|469566123|FG000|Overall Study|Withdrawal by Subject|8|||
130437688|NCT01923896|469566128|FG000|Overall Study|Adverse Event|1|||
130437689|NCT01923896|469566129|FG001|Overall Study|Adverse Event|0|||
130437690|NCT00474929|469566132|FG000|Overall Study|Withdrawal by Subject|0|||
130437691|NCT00474929|469566133|FG001|Overall Study|Withdrawal by Subject|1|||
130437692|NCT00474929|469566134|FG002|Overall Study|Withdrawal by Subject|0|||
130437693|NCT00474929|469566135|FG003|Overall Study|Withdrawal by Subject|0|||
130437694|NCT00474929|469566136|FG004|Overall Study|Withdrawal by Subject|0|||
130437695|NCT00474929|469566132|FG000|Overall Study|Unrelated medical condition|0|||
130437696|NCT00474929|469566133|FG001|Overall Study|Unrelated medical condition|0|||
130437697|NCT00474929|469566134|FG002|Overall Study|Unrelated medical condition|1|||
130437698|NCT00474929|469566135|FG003|Overall Study|Unrelated medical condition|0|||
130437699|NCT00474929|469566136|FG004|Overall Study|Unrelated medical condition|0|||
130437700|NCT00474929|469566132|FG000|Overall Study|Physician Decision|0|||
130437701|NCT00474929|469566133|FG001|Overall Study|Physician Decision|0|||
130437702|NCT00474929|469566134|FG002|Overall Study|Physician Decision|1|||
130437703|NCT00474929|469566135|FG003|Overall Study|Physician Decision|2|||
130437704|NCT00474929|469566136|FG004|Overall Study|Physician Decision|0|||
130437705|NCT03661996|469566139|FG000|Overall Study|Adverse Event|0|||
130437706|NCT03661996|469566140|FG001|Overall Study|Adverse Event|0|||
130437707|NCT03661996|469566141|FG002|Overall Study|Adverse Event|1|||
130437708|NCT03661996|469566142|FG003|Overall Study|Adverse Event|1|||
130437709|NCT03661996|469566143|FG004|Overall Study|Adverse Event|0|||
130437710|NCT03661996|469566139|FG000|Overall Study|Lost to Follow-up|5|||
130437711|NCT03661996|469566140|FG001|Overall Study|Lost to Follow-up|1|||
130437712|NCT03661996|469566141|FG002|Overall Study|Lost to Follow-up|2|||
130437713|NCT03661996|469566142|FG003|Overall Study|Lost to Follow-up|2|||
130437714|NCT03661996|469566143|FG004|Overall Study|Lost to Follow-up|6|||
130437715|NCT03661996|469566139|FG000|Overall Study|Physician Decision|1|||
130437716|NCT03661996|469566140|FG001|Overall Study|Physician Decision|1|||
130437717|NCT03661996|469566141|FG002|Overall Study|Physician Decision|1|||
130437718|NCT03661996|469566142|FG003|Overall Study|Physician Decision|2|||
130437719|NCT03661996|469566143|FG004|Overall Study|Physician Decision|0|||
130437720|NCT03661996|469566139|FG000|Overall Study|Protocol Violation|0|||
130437721|NCT03661996|469566140|FG001|Overall Study|Protocol Violation|0|||
130437722|NCT03661996|469566141|FG002|Overall Study|Protocol Violation|0|||
130437723|NCT03661996|469566142|FG003|Overall Study|Protocol Violation|0|||
130437724|NCT03661996|469566143|FG004|Overall Study|Protocol Violation|1|||
130437725|NCT03661996|469566139|FG000|Overall Study|Withdrawal by Subject|3|||
130437726|NCT03661996|469566140|FG001|Overall Study|Withdrawal by Subject|5|||
130437727|NCT03661996|469566141|FG002|Overall Study|Withdrawal by Subject|1|||
130437728|NCT03661996|469566142|FG003|Overall Study|Withdrawal by Subject|7|||
130437729|NCT03661996|469566143|FG004|Overall Study|Withdrawal by Subject|7|||
130437730|NCT03661996|469566139|FG000|Overall Study|Sponsors Decision|2|||
130437731|NCT03661996|469566140|FG001|Overall Study|Sponsors Decision|0|||
130437732|NCT03661996|469566141|FG002|Overall Study|Sponsors Decision|0|||
130437733|NCT03661996|469566142|FG003|Overall Study|Sponsors Decision|0|||
130437734|NCT03661996|469566143|FG004|Overall Study|Sponsors Decision|0|||
130437735|NCT03661996|469566139|FG000|Overall Study|Other|1|||
130437736|NCT03661996|469566140|FG001|Overall Study|Other|1|||
130437737|NCT03661996|469566141|FG002|Overall Study|Other|1|||
130437738|NCT03661996|469566142|FG003|Overall Study|Other|1|||
130437739|NCT03661996|469566143|FG004|Overall Study|Other|0|||
130437740|NCT00068380|469566144|FG000|Overall Study|Withdrawal by Subject|3|||
130437741|NCT00068380|469566144|FG000|Overall Study|Adverse Event|2|||
130683821|NCT00184600|470469951|FG002|Overall Study|Withdrawal by Subject|12|||
130683822|NCT00184600|470469949|FG000|Overall Study|Unclassified|4|||
130437742|NCT00067990|469566159|FG000|Overall Study|Death|5|||
130437743|NCT00067990|469566160|FG001|Overall Study|Death|7|||
130437744|NCT00067990|469566159|FG000|Overall Study|ESRD, Non IF/TA|1|||
130437745|NCT00067990|469566160|FG001|Overall Study|ESRD, Non IF/TA|3|||
130437746|NCT00067990|469566159|FG000|Overall Study|Withdrawal by Subject|4|||
130437747|NCT00067990|469566160|FG001|Overall Study|Withdrawal by Subject|12|||
130437748|NCT01973491|469566161|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
130437749|NCT01973491|469566161|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
130437750|NCT01973491|469566161|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
130437751|NCT00422799|469566162|FG000|Overall Study|Withdrawal by Subject|6|||
130437752|NCT00422799|469566162|FG000|Overall Study|Adverse Event|7|||
130437753|NCT01965158|469566163|FG000|Overall Study|Adverse Event|14|||
130683823|NCT00184600|470469950|FG001|Overall Study|Unclassified|5|||
130683824|NCT00184600|470469951|FG002|Overall Study|Unclassified|3|||
130683825|NCT00286754|470469952|FG000|Overall Study|Adverse Event|2|||
130683826|NCT00286754|470469953|FG001|Overall Study|Adverse Event|2|||
130683827|NCT00286754|470469954|FG002|Overall Study|Adverse Event|3|||
130683828|NCT00286754|470469952|FG000|Overall Study|Withdrawal by Subject|6|||
130683829|NCT00286754|470469953|FG001|Overall Study|Withdrawal by Subject|2|||
130683830|NCT00286754|470469954|FG002|Overall Study|Withdrawal by Subject|0|||
130683831|NCT00286754|470469952|FG000|Overall Study|Lost to Follow-up|12|||
130683832|NCT00286754|470469953|FG001|Overall Study|Lost to Follow-up|14|||
130683833|NCT00286754|470469954|FG002|Overall Study|Lost to Follow-up|6|||
130683834|NCT00286754|470469952|FG000|Overall Study|Moved out of state|0|||
130683835|NCT00286754|470469953|FG001|Overall Study|Moved out of state|0|||
130349561|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
130349562|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
130349563|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
130349564|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
130349565|NCT00274924|469250300|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
130349566|NCT00274924|469250301|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
130349567|NCT00274924|469250302|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
130349568|NCT00740051|469250303|FG000|Overall Study|Lack of Efficacy|2|||
130349569|NCT00740051|469250304|FG001|Overall Study|Lack of Efficacy|5|||
130349570|NCT00740051|469250303|FG000|Overall Study|Adverse Event|1|||
130349571|NCT00740051|469250304|FG001|Overall Study|Adverse Event|4|||
130349572|NCT00740051|469250303|FG000|Overall Study|Protocol Violation|2|||
130349573|NCT00740051|469250304|FG001|Overall Study|Protocol Violation|6|||
130349574|NCT00740051|469250303|FG000|Overall Study|Lost to Follow-up|3|||
130349575|NCT00740051|469250304|FG001|Overall Study|Lost to Follow-up|8|||
130349576|NCT00740051|469250303|FG000|Overall Study|Withdrawal by Subject|6|||
130349577|NCT00740051|469250304|FG001|Overall Study|Withdrawal by Subject|8|||
130349578|NCT00740051|469250303|FG000|Overall Study|Other reason (not specified)|4|||
130349579|NCT00740051|469250304|FG001|Overall Study|Other reason (not specified)|1|||
130349580|NCT01055496|469250306|FG000|Overall Study|Withdrawal by Subject|2|||
130349581|NCT01055496|469250307|FG001|Overall Study|Withdrawal by Subject|4|||
130349582|NCT01055496|469250306|FG000|Overall Study|Death|13|||
130349583|NCT01055496|469250307|FG001|Overall Study|Death|23|||
130349584|NCT01055496|469250306|FG000|Overall Study|Lost to Follow-up|0|||
130349585|NCT01055496|469250307|FG001|Overall Study|Lost to Follow-up|2|||
130349586|NCT01055496|469250306|FG000|Overall Study|Other - Unspecified|0|||
130349587|NCT01055496|469250307|FG001|Overall Study|Other - Unspecified|1|||
130349588|NCT01673282|469250309|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
130349589|NCT01673282|469250310|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
130349590|NCT01673282|469250309|FG000|Overall Study|Lack of Efficacy|9|||
130349591|NCT01673282|469250310|FG001|Overall Study|Lack of Efficacy|2|||
130349592|NCT01673282|469250309|FG000|Overall Study|Lost to Follow-up|11|||
130349593|NCT01673282|469250310|FG001|Overall Study|Lost to Follow-up|10|||
130349594|NCT01673282|469250309|FG000|Overall Study|Withdrawal by Subject|3|||
130349595|NCT01673282|469250310|FG001|Overall Study|Withdrawal by Subject|3|||
130349596|NCT01673282|469250309|FG000|Overall Study|Other|1|||
130349597|NCT01673282|469250310|FG001|Overall Study|Other|6|||
130349598|NCT01323920|469250316|FG000|Overall Study|Death|5|||
130349599|NCT01323920|469250316|FG000|Overall Study|Withdrawal by Subject|1|||
130349600|NCT02915874|469250317|FG000|Overall Study|Lost to Follow-up|5|||
130349601|NCT02915874|469250318|FG001|Overall Study|Lost to Follow-up|4|||
130349602|NCT02915874|469250317|FG000|Overall Study|Withdrawal by Subject|1|||
130349603|NCT02915874|469250318|FG001|Overall Study|Withdrawal by Subject|1|||
130349604|NCT02915874|469250317|FG000|Overall Study|Started New Anxiety Medication|0|||
130349605|NCT02915874|469250318|FG001|Overall Study|Started New Anxiety Medication|1|||
130349606|NCT02290431|469250319|FG000|Overall Study|Adverse Event|20|||
130349607|NCT02290431|469250319|FG000|Overall Study|Progressive disease|4|||
130349608|NCT02290431|469250319|FG000|Overall Study|Study terminated by Sponsor|1|||
130349609|NCT02290431|469250319|FG000|Overall Study|Physician Decision|2|||
130349610|NCT00821327|469250320|FG000|Overall Study|Adverse Event|13|||
130349611|NCT00821327|469250320|FG000|Overall Study|Patient Request|1|||
130349612|NCT00821327|469250320|FG000|Overall Study|Investigator Request|2|||
130349613|NCT00821327|469250320|FG000|Overall Study|Sponsor Request|1|||
130349614|NCT00821327|469250320|FG000|Overall Study|Disease Progression|13|||
130349615|NCT00821327|469250320|FG000|Overall Study|Other/Unknown|5|||
130349616|NCT02119676|469250321|FG000|Overall Study|Adverse Event|9|||
130349617|NCT02119676|469250322|FG001|Overall Study|Adverse Event|17|||
130349618|NCT02119676|469250323|FG002|Overall Study|Adverse Event|10|||
130349619|NCT02119676|469250324|FG003|Overall Study|Adverse Event|10|||
130349620|NCT02119676|469250321|FG000|Overall Study|Disease progression|53|||
130349621|NCT02119676|469250322|FG001|Overall Study|Disease progression|55|||
130349622|NCT02119676|469250323|FG002|Overall Study|Disease progression|68|||
130349623|NCT02119676|469250324|FG003|Overall Study|Disease progression|73|||
130683836|NCT00286754|470469954|FG002|Overall Study|Moved out of state|1|||
130683837|NCT02336165|470469955|FG000|Overall Study|Death|3|||
130437754|NCT01965158|469566164|FG001|Overall Study|Adverse Event|5|||
130437755|NCT01965158|469566163|FG000|Overall Study|Withdrawal by Subject|16|||
130437756|NCT01965158|469566164|FG001|Overall Study|Withdrawal by Subject|24|||
130437757|NCT01965158|469566163|FG000|Overall Study|Lost to Follow-up|7|||
130437758|NCT01965158|469566164|FG001|Overall Study|Lost to Follow-up|5|||
130437759|NCT01965158|469566163|FG000|Overall Study|Protocol Violation|1|||
130437760|NCT01965158|469566164|FG001|Overall Study|Protocol Violation|1|||
130437761|NCT01965158|469566163|FG000|Overall Study|Other - Miscellaneous|3|||
130437762|NCT01965158|469566164|FG001|Overall Study|Other - Miscellaneous|0|||
130437763|NCT01619787|469566165|FG000|Overall Study|Lost to Follow-up|5|||
130437764|NCT03321006|469566168|FG000|Overall Study|Death|1|||
130437765|NCT03321006|469566169|FG001|Overall Study|Death|0|||
130437766|NCT03321006|469566168|FG000|Overall Study|Lack of Efficacy|1|||
130437767|NCT03321006|469566169|FG001|Overall Study|Lack of Efficacy|0|||
130437768|NCT03560258|469566170|FG000|Overall Study|Lost to Follow-up|3|||
130437769|NCT03560258|469566171|FG001|Overall Study|Lost to Follow-up|0|||
130437770|NCT03560258|469566172|FG002|Overall Study|Lost to Follow-up|0|||
130437771|NCT03560258|469566170|FG000|Overall Study|Protocol Violation|0|||
130437772|NCT03560258|469566171|FG001|Overall Study|Protocol Violation|1|||
130437773|NCT03560258|469566172|FG002|Overall Study|Protocol Violation|0|||
130437774|NCT03560258|469566170|FG000|Overall Study|Withdrawal by Subject|0|||
130437775|NCT03560258|469566171|FG001|Overall Study|Withdrawal by Subject|0|||
130437776|NCT03560258|469566172|FG002|Overall Study|Withdrawal by Subject|1|||
130437777|NCT02006121|469566173|FG000|Double Blind Phase|Adverse Event|6|||
130437778|NCT02006121|469566174|FG001|Double Blind Phase|Adverse Event|0|||
130437779|NCT02006121|469566173|FG000|Double Blind Phase|Lack of Efficacy|1|||
130437780|NCT02006121|469566174|FG001|Double Blind Phase|Lack of Efficacy|16|||
130437781|NCT02006121|469566173|FG000|Double Blind Phase|Withdrawal by Subject|3|||
130437782|NCT02006121|469566174|FG001|Double Blind Phase|Withdrawal by Subject|4|||
130437783|NCT02006121|469566173|FG000|Double Blind Phase|Non-compliance with study drug|1|||
130437784|NCT02006121|469566174|FG001|Double Blind Phase|Non-compliance with study drug|3|||
130437785|NCT02006121|469566173|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
130437786|NCT02006121|469566174|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
130437787|NCT02006121|469566173|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
130437788|NCT02006121|469566174|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
130437789|NCT02006121|469566173|FG000|Open Label Phase|Adverse Event|15|||
130437790|NCT02006121|469566174|FG001|Open Label Phase|Adverse Event|0|||
130437791|NCT02006121|469566173|FG000|Open Label Phase|Lack of Efficacy|2|||
130437792|NCT02006121|469566174|FG001|Open Label Phase|Lack of Efficacy|0|||
130437793|NCT02006121|469566173|FG000|Open Label Phase|Protocol Violation|2|||
130437794|NCT02006121|469566174|FG001|Open Label Phase|Protocol Violation|0|||
130437795|NCT02006121|469566173|FG000|Open Label Phase|Withdrawal by Subject|3|||
130437796|NCT02006121|469566174|FG001|Open Label Phase|Withdrawal by Subject|0|||
130437797|NCT02006121|469566173|FG000|Open Label Phase|Non-compliance with study drug|3|||
130437798|NCT02006121|469566174|FG001|Open Label Phase|Non-compliance with study drug|0|||
130437799|NCT00245856|469566190|FG000|Period Two|Withdrawal by Subject|0|||
130437800|NCT00245856|469566191|FG001|Period Two|Withdrawal by Subject|1|||
130437801|NCT01003184|469566192|FG000|Overall Study|Adverse Event|12|||
130437802|NCT01003184|469566193|FG001|Overall Study|Adverse Event|5|||
130437803|NCT01003184|469566192|FG000|Overall Study|Lost to Follow-up|1|||
130437804|NCT01003184|469566193|FG001|Overall Study|Lost to Follow-up|0|||
130437805|NCT01003184|469566192|FG000|Overall Study|Loss of glucose control|1|||
130437806|NCT01003184|469566193|FG001|Overall Study|Loss of glucose control|1|||
130437807|NCT01003184|469566192|FG000|Overall Study|Protocol Violation|3|||
130437808|NCT01003184|469566193|FG001|Overall Study|Protocol Violation|0|||
130437809|NCT01003184|469566192|FG000|Overall Study|Withdrawal by Subject|1|||
130437810|NCT01003184|469566193|FG001|Overall Study|Withdrawal by Subject|6|||
130437811|NCT01003184|469566192|FG000|Overall Study|Physician Decision|1|||
130437812|NCT01003184|469566193|FG001|Overall Study|Physician Decision|0|||
130437813|NCT02693834|469566195|FG000|Baseline Measurement|Withdrawal by Subject|1|||
130437814|NCT02693834|469566196|FG001|Baseline Measurement|Withdrawal by Subject|0|||
130437815|NCT02693834|469566195|FG000|Baseline Measurement|Adverse Event|1|||
130437816|NCT02693834|469566196|FG001|Baseline Measurement|Adverse Event|0|||
130437817|NCT02693834|469566195|FG000|Week 2 Practice|Adverse Event|0|||
130437818|NCT02693834|469566196|FG001|Week 2 Practice|Adverse Event|1|||
130437819|NCT04848662|469566197|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
130437820|NCT04848662|469566198|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
130437821|NCT01107743|469566205|FG000|Overall Study|Protocol Violation|46|||
130437822|NCT02494206|469566219|FG000|Overall Study|Adverse Event|1|||
130437823|NCT02494206|469566219|FG000|Overall Study|Disease Progression|1|||
130437824|NCT04986982|469566221|FG000|Overall Study|Withdrawal by Subject|3|||
130437825|NCT04986982|469566222|FG001|Overall Study|Withdrawal by Subject|1|||
130437826|NCT04986982|469566221|FG000|Overall Study|Lack of Efficacy|0|||
130437827|NCT04986982|469566222|FG001|Overall Study|Lack of Efficacy|2|||
130437828|NCT04986982|469566221|FG000|Overall Study|Ineligibility|3|||
130437829|NCT04986982|469566222|FG001|Overall Study|Ineligibility|0|||
130437830|NCT04986982|469566221|FG000|Overall Study|Adverse Event|4|||
130683838|NCT02336165|470469956|FG001|Overall Study|Death|0|||
130683839|NCT02336165|470469957|FG002|Overall Study|Death|0|||
130683840|NCT02336165|470469958|FG003|Overall Study|Death|0|||
130683841|NCT02336165|470469959|FG004|Overall Study|Death|1|||
130683842|NCT02336165|470469955|FG000|Overall Study|Physician Decision|2|||
130683843|NCT02336165|470469956|FG001|Overall Study|Physician Decision|2|||
130683844|NCT02336165|470469957|FG002|Overall Study|Physician Decision|1|||
130683845|NCT02336165|470469958|FG003|Overall Study|Physician Decision|1|||
130683846|NCT02336165|470469959|FG004|Overall Study|Physician Decision|0|||
130683847|NCT02336165|470469955|FG000|Overall Study|Withdrawal by Subject|0|||
130683848|NCT02336165|470469956|FG001|Overall Study|Withdrawal by Subject|0|||
130683849|NCT02336165|470469957|FG002|Overall Study|Withdrawal by Subject|1|||
130683850|NCT02336165|470469958|FG003|Overall Study|Withdrawal by Subject|0|||
130683851|NCT02336165|470469959|FG004|Overall Study|Withdrawal by Subject|1|||
130683852|NCT02336165|470469955|FG000|Overall Study|Adverse Event|4|||
130683853|NCT02336165|470469956|FG001|Overall Study|Adverse Event|1|||
130683854|NCT02336165|470469957|FG002|Overall Study|Adverse Event|2|||
130683855|NCT02336165|470469958|FG003|Overall Study|Adverse Event|4|||
130683856|NCT02336165|470469959|FG004|Overall Study|Adverse Event|1|||
130683857|NCT02336165|470469955|FG000|Overall Study|Progressive disease|23|||
130683858|NCT02336165|470469956|FG001|Overall Study|Progressive disease|22|||
130683859|NCT02336165|470469957|FG002|Overall Study|Progressive disease|27|||
130683860|NCT02336165|470469958|FG003|Overall Study|Progressive disease|24|||
130683861|NCT02336165|470469959|FG004|Overall Study|Progressive disease|19|||
130683862|NCT02336165|470469955|FG000|Overall Study|Non-compliance|1|||
130683863|NCT02336165|470469956|FG001|Overall Study|Non-compliance|0|||
130683864|NCT02336165|470469957|FG002|Overall Study|Non-compliance|0|||
130683865|NCT02336165|470469958|FG003|Overall Study|Non-compliance|1|||
130683866|NCT02336165|470469959|FG004|Overall Study|Non-compliance|0|||
130683867|NCT02336165|470469955|FG000|Overall Study|Other|1|||
130683868|NCT02336165|470469956|FG001|Overall Study|Other|0|||
130683869|NCT02336165|470469957|FG002|Overall Study|Other|0|||
130683870|NCT02336165|470469958|FG003|Overall Study|Other|1|||
130683871|NCT02336165|470469959|FG004|Overall Study|Other|0|||
130683872|NCT02726581|470469962|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130683873|NCT02726581|470469963|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130683874|NCT02726581|470469964|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130683875|NCT02726581|470469962|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
130683876|NCT02726581|470469963|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
130683877|NCT02726581|470469964|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
130683878|NCT02726581|470469962|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130683879|NCT02726581|470469963|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130683880|NCT02726581|470469964|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130683881|NCT02726581|470469962|FG000|Treatment Period|Disease progression|47|||
130683882|NCT02726581|470469963|FG001|Treatment Period|Disease progression|50|||
130683883|NCT02726581|470469964|FG002|Treatment Period|Disease progression|16|||
130683884|NCT02726581|470469962|FG000|Treatment Period|Other reasons|9|||
130683885|NCT02726581|470469963|FG001|Treatment Period|Other reasons|8|||
130683886|NCT02726581|470469964|FG002|Treatment Period|Other reasons|2|||
130683887|NCT02726581|470469962|FG000|Treatment Period|Study drug toxicity|6|||
130349624|NCT02119676|469250321|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
130349625|NCT02119676|469250322|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
130349626|NCT02119676|469250323|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
130349627|NCT02119676|469250324|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
130349628|NCT02119676|469250321|FG000|Overall Study|Physician Decision|4|||
130349629|NCT02119676|469250322|FG001|Overall Study|Physician Decision|2|||
130349630|NCT02119676|469250323|FG002|Overall Study|Physician Decision|3|||
130349631|NCT02119676|469250324|FG003|Overall Study|Physician Decision|2|||
130349632|NCT02119676|469250321|FG000|Overall Study|Death|9|||
130349633|NCT02119676|469250322|FG001|Overall Study|Death|3|||
130349634|NCT02119676|469250323|FG002|Overall Study|Death|2|||
130349635|NCT02119676|469250324|FG003|Overall Study|Death|1|||
130349636|NCT02119676|469250321|FG000|Overall Study|Noncompliance|0|||
130349637|NCT02119676|469250322|FG001|Overall Study|Noncompliance|1|||
130349638|NCT02119676|469250323|FG002|Overall Study|Noncompliance|0|||
130349639|NCT02119676|469250324|FG003|Overall Study|Noncompliance|0|||
130349640|NCT02119676|469250321|FG000|Overall Study|Lost to Follow-up|0|||
130683888|NCT02726581|470469963|FG001|Treatment Period|Study drug toxicity|3|||
130683889|NCT02726581|470469964|FG002|Treatment Period|Study drug toxicity|2|||
130683890|NCT02726581|470469962|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
130683891|NCT02726581|470469963|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
130683892|NCT02726581|470469964|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130683893|NCT02726581|470469962|FG000|Treatment Period|Participant withdrew consent|3|||
130349641|NCT02119676|469250322|FG001|Overall Study|Lost to Follow-up|0|||
130349642|NCT02119676|469250323|FG002|Overall Study|Lost to Follow-up|1|||
130683894|NCT02726581|470469963|FG001|Treatment Period|Participant withdrew consent|1|||
130683895|NCT02726581|470469964|FG002|Treatment Period|Participant withdrew consent|1|||
130683896|NCT02726581|470469962|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
130683897|NCT02726581|470469963|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
130683898|NCT02726581|470469964|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
130683899|NCT02726581|470469962|FG000|Treatment Period|Maximum clinical benefit|0|||
130683900|NCT02726581|470469963|FG001|Treatment Period|Maximum clinical benefit|2|||
130349643|NCT02119676|469250324|FG003|Overall Study|Lost to Follow-up|0|||
130437831|NCT04986982|469566222|FG001|Overall Study|Adverse Event|4|||
130437832|NCT04986982|469566221|FG000|Overall Study|Lost to Follow-up|0|||
130349644|NCT02119676|469250321|FG000|Overall Study|Protocol deviation|0|||
130349645|NCT02119676|469250322|FG001|Overall Study|Protocol deviation|0|||
130349646|NCT02119676|469250323|FG002|Overall Study|Protocol deviation|1|||
130349647|NCT02119676|469250324|FG003|Overall Study|Protocol deviation|0|||
130349648|NCT02119676|469250321|FG000|Overall Study|Other, unspecified|2|||
130349649|NCT02119676|469250322|FG001|Overall Study|Other, unspecified|1|||
130349650|NCT02119676|469250323|FG002|Overall Study|Other, unspecified|3|||
130349651|NCT02119676|469250324|FG003|Overall Study|Other, unspecified|4|||
130349652|NCT02119676|469250321|FG000|Overall Study|Did not receive study med|2|||
130349653|NCT02119676|469250322|FG001|Overall Study|Did not receive study med|2|||
130349654|NCT02119676|469250323|FG002|Overall Study|Did not receive study med|4|||
130349655|NCT02119676|469250324|FG003|Overall Study|Did not receive study med|5|||
130349656|NCT00219544|469250325|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
130349657|NCT00219544|469250326|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
130349658|NCT00219544|469250325|FG000|Single Blind Treatment Period|Adverse Event|9|||
130349659|NCT00219544|469250326|FG001|Single Blind Treatment Period|Adverse Event|0|||
130349660|NCT00219544|469250325|FG000|Single Blind Treatment Period|Protocol Violation|4|||
130349661|NCT00219544|469250326|FG001|Single Blind Treatment Period|Protocol Violation|0|||
130349662|NCT00219544|469250325|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
130349663|NCT00219544|469250326|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
130349664|NCT00219544|469250325|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
130349665|NCT00219544|469250326|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
130349666|NCT00219544|469250325|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
130349667|NCT00219544|469250326|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
130349668|NCT01007253|469250329|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
130349669|NCT01007253|469250330|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130349670|NCT01007253|469250331|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130349671|NCT01007253|469250332|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130349672|NCT00814801|469250333|FG000|Overall Study|Adverse Event|15|||
130349673|NCT00814801|469250334|FG001|Overall Study|Adverse Event|16|||
130349674|NCT00814801|469250335|FG002|Overall Study|Adverse Event|19|||
130349675|NCT00814801|469250333|FG000|Overall Study|Withdrawal by Subject|9|||
130349676|NCT00814801|469250334|FG001|Overall Study|Withdrawal by Subject|11|||
130349677|NCT00814801|469250335|FG002|Overall Study|Withdrawal by Subject|14|||
130349678|NCT00814801|469250333|FG000|Overall Study|Inappropriate as a subject|1|||
130349679|NCT00814801|469250334|FG001|Overall Study|Inappropriate as a subject|1|||
130349680|NCT00814801|469250335|FG002|Overall Study|Inappropriate as a subject|1|||
130349681|NCT00814801|469250333|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
130349682|NCT00814801|469250334|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
130349683|NCT00814801|469250335|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
130349684|NCT00814801|469250333|FG000|Overall Study|Missing or change of caregiver|6|||
130349685|NCT00814801|469250334|FG001|Overall Study|Missing or change of caregiver|2|||
130349686|NCT00814801|469250335|FG002|Overall Study|Missing or change of caregiver|4|||
130349687|NCT00814801|469250333|FG000|Overall Study|Non-compliance|0|||
130349688|NCT00814801|469250334|FG001|Overall Study|Non-compliance|1|||
130349689|NCT00814801|469250335|FG002|Overall Study|Non-compliance|1|||
130349690|NCT00814801|469250333|FG000|Overall Study|Other|2|||
130349691|NCT00814801|469250334|FG001|Overall Study|Other|6|||
130349692|NCT00814801|469250335|FG002|Overall Study|Other|4|||
130349693|NCT00586664|469250336|FG000|Overall Study|Withdrawal by Subject|3|||
130349694|NCT00586664|469250337|FG001|Overall Study|Withdrawal by Subject|7|||
130437833|NCT04986982|469566222|FG001|Overall Study|Lost to Follow-up|1|||
130683901|NCT02726581|470469964|FG002|Treatment Period|Maximum clinical benefit|0|||
130683902|NCT02726581|470469962|FG000|Treatment Period|Death|1|||
130349695|NCT00586664|469250338|FG002|Overall Study|Withdrawal by Subject|1|||
130349696|NCT00586664|469250336|FG000|Overall Study|Exclusion criteria met|2|||
130437834|NCT04986982|469566221|FG000|Overall Study|Sponsor's discretion|1|||
130349697|NCT00586664|469250337|FG001|Overall Study|Exclusion criteria met|0|||
130349698|NCT00586664|469250338|FG002|Overall Study|Exclusion criteria met|0|||
130349699|NCT02751931|469250339|FG000|Overall Study|Adverse Event|3|||
130349700|NCT02751931|469250340|FG001|Overall Study|Adverse Event|0|||
130349701|NCT02751931|469250339|FG000|Overall Study|Other: Miscelleneous|10|||
130349702|NCT02751931|469250340|FG001|Overall Study|Other: Miscelleneous|8|||
130349703|NCT01037088|469250341|FG000|Overall Study|Withdrawal by Subject|3|||
130349704|NCT01585584|469250342|FG000|Overall Study|Lack of Efficacy|1|||
130437835|NCT04986982|469566222|FG001|Overall Study|Sponsor's discretion|0|||
130437836|NCT01155661|469566223|FG000|Overall Study|Adverse Event|101|||
130437837|NCT01155661|469566223|FG000|Overall Study|Death|1|||
130437838|NCT01155661|469566223|FG000|Overall Study|Lack of Efficacy|32|||
130437839|NCT01155661|469566223|FG000|Overall Study|Lost to Follow-up|22|||
130437840|NCT01155661|469566223|FG000|Overall Study|Physician Decision|3|||
130437841|NCT01155661|469566223|FG000|Overall Study|Protocol Violation|35|||
130437842|NCT01155661|469566223|FG000|Overall Study|Withdrawal by Subject|73|||
130437843|NCT01155661|469566223|FG000|Overall Study|Sponsor Decision|13|||
130437844|NCT01396395|469566227|FG000|Overall Study|Withdrawal by Subject|10|||
130437845|NCT01396395|469566228|FG001|Overall Study|Withdrawal by Subject|12|||
130437846|NCT01396395|469566227|FG000|Overall Study|Protocol Violation|3|||
130437847|NCT01396395|469566228|FG001|Overall Study|Protocol Violation|1|||
130437848|NCT01396395|469566227|FG000|Overall Study|Adverse Event|10|||
130437849|NCT01396395|469566228|FG001|Overall Study|Adverse Event|2|||
130437850|NCT01396395|469566227|FG000|Overall Study|Lost to Follow-up|17|||
130437851|NCT01396395|469566228|FG001|Overall Study|Lost to Follow-up|11|||
130683903|NCT02726581|470469963|FG001|Treatment Period|Death|0|||
130683904|NCT02726581|470469964|FG002|Treatment Period|Death|0|||
130683905|NCT02726581|470469962|FG000|Treatment Period|Poor/non-compliance|1|||
130683906|NCT02726581|470469963|FG001|Treatment Period|Poor/non-compliance|0|||
130683907|NCT02726581|470469964|FG002|Treatment Period|Poor/non-compliance|0|||
130683908|NCT02726581|470469962|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130683909|NCT02726581|470469963|FG001|Treatment Period|Participant no longer meets study criteria|1|||
130683910|NCT02726581|470469964|FG002|Treatment Period|Participant no longer meets study criteria|0|||
130683911|NCT00552669|470469968|FG000|Overall Study|Death|3|||
130683912|NCT00552669|470469969|FG001|Overall Study|Death|7|||
130683913|NCT01844375|470469970|FG000|Overall Study|Protocol Violation|1|||
130683914|NCT01844375|470469971|FG001|Overall Study|Protocol Violation|1|||
130683915|NCT03020615|470469972|FG000|Overall Study|Physician Decision|3|||
130683916|NCT03020615|470469973|FG001|Overall Study|Physician Decision|1|||
130683917|NCT03020615|470469974|FG002|Overall Study|Physician Decision|2|||
130683918|NCT03020615|470469972|FG000|Overall Study|Parent/guardian/patient choice|3|||
130683919|NCT03020615|470469973|FG001|Overall Study|Parent/guardian/patient choice|0|||
130683920|NCT03020615|470469974|FG002|Overall Study|Parent/guardian/patient choice|4|||
130683921|NCT03020615|470469972|FG000|Overall Study|Screen failure|0|||
130683922|NCT03020615|470469973|FG001|Overall Study|Screen failure|0|||
130683923|NCT03020615|470469974|FG002|Overall Study|Screen failure|1|||
130683924|NCT03020615|470469972|FG000|Overall Study|Death|1|||
130683925|NCT03020615|470469973|FG001|Overall Study|Death|0|||
130683926|NCT03020615|470469974|FG002|Overall Study|Death|0|||
130683927|NCT03020615|470469972|FG000|Overall Study|Lost to Follow-up|0|||
130683928|NCT03020615|470469973|FG001|Overall Study|Lost to Follow-up|1|||
130683929|NCT03020615|470469974|FG002|Overall Study|Lost to Follow-up|0|||
130683930|NCT04239872|470469976|FG000|Overall Study|Lost to Follow-up|0|||
130683931|NCT04239872|470469977|FG001|Overall Study|Lost to Follow-up|1|||
130349705|NCT01585584|469250342|FG000|Overall Study|Withdrawal by Subject|1|||
130349706|NCT01585584|469250342|FG000|Overall Study|Physician Decision|2|||
130349707|NCT00266864|469250343|FG000|Overall Study|Lost to Follow-up|4|||
130349708|NCT00266864|469250344|FG001|Overall Study|Lost to Follow-up|1|||
130349709|NCT00266864|469250343|FG000|Overall Study|Withdrawal by Subject|1|||
130349710|NCT00266864|469250344|FG001|Overall Study|Withdrawal by Subject|1|||
130349711|NCT03036800|469250345|FG000|Overall Study|Protocol Violation|1|||
130349712|NCT03036800|469250346|FG001|Overall Study|Protocol Violation|0|||
130349713|NCT03036800|469250345|FG000|Overall Study|Non-compliance|1|||
130349714|NCT03036800|469250346|FG001|Overall Study|Non-compliance|0|||
130349715|NCT03036800|469250345|FG000|Overall Study|Lost to Follow-up|1|||
130349716|NCT03036800|469250346|FG001|Overall Study|Lost to Follow-up|0|||
130349717|NCT03036800|469250345|FG000|Overall Study|Death|1|||
130349718|NCT03036800|469250346|FG001|Overall Study|Death|0|||
130349719|NCT03036800|469250345|FG000|Overall Study|Tolerance|5|||
130349720|NCT03036800|469250346|FG001|Overall Study|Tolerance|0|||
130349721|NCT03036800|469250345|FG000|Overall Study|Unknown/no reason given|50|||
130349722|NCT03036800|469250346|FG001|Overall Study|Unknown/no reason given|39|||
130349723|NCT01077154|469250347|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
130349724|NCT01077154|469250348|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
130349725|NCT01077154|469250347|FG000|Overall Study|Withdrawal by Subject|369|||
130437852|NCT01396395|469566227|FG000|Overall Study|Other|0|||
130437853|NCT01396395|469566228|FG001|Overall Study|Other|1|||
130437854|NCT00882921|469566233|FG000|Overall Study|Death|2|||
130437855|NCT00882921|469566233|FG000|Overall Study|Other|3|||
130683932|NCT04060147|470469978|FG000|Overall Study|Withdrew consent|1|||
130683933|NCT02057458|470469982|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
130349726|NCT01077154|469250348|FG001|Overall Study|Withdrawal by Subject|385|||
130349727|NCT01077154|469250347|FG000|Overall Study|Death|215|||
130349728|NCT01077154|469250348|FG001|Overall Study|Death|214|||
130349729|NCT01077154|469250347|FG000|Overall Study|Lost to Follow-up|43|||
130349730|NCT01077154|469250348|FG001|Overall Study|Lost to Follow-up|35|||
130437856|NCT00882921|469566233|FG000|Overall Study|Lost to Follow-up|2|||
130683934|NCT02057458|470469983|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
130437857|NCT00882921|469566233|FG000|Overall Study|Termination By Investigator|3|||
130437858|NCT00882921|469566233|FG000|Overall Study|Withdrawal Of Consent|1|||
130437859|NCT01370005|469566234|FG000|Overall Study|Not treated|1|||
130437860|NCT01370005|469566235|FG001|Overall Study|Not treated|0|||
130437861|NCT01370005|469566236|FG002|Overall Study|Not treated|0|||
130437862|NCT01370005|469566234|FG000|Overall Study|Adverse Event|5|||
130437863|NCT01370005|469566235|FG001|Overall Study|Adverse Event|5|||
130437864|NCT01370005|469566236|FG002|Overall Study|Adverse Event|6|||
130437865|NCT01370005|469566234|FG000|Overall Study|Lack of Efficacy|1|||
130437866|NCT01370005|469566235|FG001|Overall Study|Lack of Efficacy|0|||
130437867|NCT01370005|469566236|FG002|Overall Study|Lack of Efficacy|0|||
130437868|NCT01370005|469566234|FG000|Overall Study|Non compliant with protocol|0|||
130437869|NCT01370005|469566235|FG001|Overall Study|Non compliant with protocol|1|||
130437870|NCT01370005|469566236|FG002|Overall Study|Non compliant with protocol|2|||
130437871|NCT01370005|469566234|FG000|Overall Study|Lost to Follow-up|1|||
130437872|NCT01370005|469566235|FG001|Overall Study|Lost to Follow-up|1|||
130437873|NCT01370005|469566236|FG002|Overall Study|Lost to Follow-up|1|||
130437874|NCT01370005|469566234|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
130683935|NCT02057458|470469984|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
130683936|NCT02057458|470469982|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
130437875|NCT01370005|469566235|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
130437876|NCT01370005|469566236|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
130437877|NCT01370005|469566234|FG000|Overall Study|Other reason not defined above|3|||
130437878|NCT01370005|469566235|FG001|Overall Study|Other reason not defined above|0|||
130437879|NCT01370005|469566236|FG002|Overall Study|Other reason not defined above|2|||
130437880|NCT02009696|469566237|FG000|Overall Study|Withdrawal by Subject|2|||
130437881|NCT05490329|469566238|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
130437882|NCT05490329|469566239|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
130437883|NCT05490329|469566238|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
130437884|NCT05490329|469566239|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
130437885|NCT05490329|469566238|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
130683937|NCT02057458|470469983|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130683938|NCT02057458|470469984|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130683939|NCT02057458|470469982|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
130683940|NCT02057458|470469983|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
130683941|NCT02057458|470469984|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
130683942|NCT03693430|470469985|FG000|Overall Study|Lost to Follow-up|3|||
130683943|NCT03693430|470469986|FG001|Overall Study|Lost to Follow-up|14|||
130683944|NCT03693430|470469985|FG000|Overall Study|Death|1|||
130683945|NCT03693430|470469986|FG001|Overall Study|Death|0|||
130683946|NCT03693430|470469985|FG000|Overall Study|Withdrawal by Subject|0|||
130683947|NCT03693430|470469986|FG001|Overall Study|Withdrawal by Subject|4|||
130683948|NCT00585689|470469987|FG000|Overall Study|Received different ABI-007 schedule|3|||
130683949|NCT00585689|470469987|FG000|Overall Study|Adverse Event|1|||
130683950|NCT00585689|470469987|FG000|Overall Study|Patient Declined Surgery|1|||
130683951|NCT00585689|470469987|FG000|Overall Study|Patient had unresectable disease|1|||
130683952|NCT00585689|470469987|FG000|Overall Study|Death|1|||
130683953|NCT00319735|470469992|FG000|Overall Study|Death|2|||
130683954|NCT02421952|470469999|FG000|Overall Study|Diary Not Returned|93|||
130683955|NCT02421952|470469999|FG000|Overall Study|Failed seriation task|13|||
130683956|NCT02421952|470469999|FG000|Overall Study|Subject uncooperative for baseline test|2|||
130683957|NCT02421952|470469999|FG000|Overall Study|Surgery cancelled|1|||
130683958|NCT00854100|470470002|FG000|Overall Study|Inability to complete the study visits|0|||
130683959|NCT00854100|470470003|FG001|Overall Study|Inability to complete the study visits|0|||
130683960|NCT00854100|470470004|FG002|Overall Study|Inability to complete the study visits|1|||
130683961|NCT00854100|470470002|FG000|Overall Study|Lost to Follow-up|2|||
130683962|NCT00854100|470470003|FG001|Overall Study|Lost to Follow-up|0|||
130683963|NCT00854100|470470004|FG002|Overall Study|Lost to Follow-up|3|||
130683964|NCT00854100|470470002|FG000|Overall Study|Withdrawal by Subject|3|||
130683965|NCT00854100|470470003|FG001|Overall Study|Withdrawal by Subject|1|||
130683966|NCT00854100|470470004|FG002|Overall Study|Withdrawal by Subject|2|||
130683967|NCT00854100|470470002|FG000|Overall Study|Protocol Violation|2|||
130437886|NCT05490329|469566239|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
130437887|NCT00856661|469566240|FG000|Overall Study|Death|15|||
130437888|NCT00856661|469566241|FG001|Overall Study|Death|18|||
130437889|NCT00856661|469566240|FG000|Overall Study|Protocol Violation|2|||
130437890|NCT00856661|469566241|FG001|Overall Study|Protocol Violation|1|||
130683968|NCT00854100|470470003|FG001|Overall Study|Protocol Violation|4|||
130683969|NCT00854100|470470004|FG002|Overall Study|Protocol Violation|3|||
130683970|NCT00854100|470470002|FG000|Overall Study|Adverse Event|2|||
130683971|NCT00854100|470470003|FG001|Overall Study|Adverse Event|1|||
130683972|NCT00854100|470470004|FG002|Overall Study|Adverse Event|2|||
130683973|NCT02216071|470470014|FG000|Overall Study|Withdrawal by Subject|7|||
130437891|NCT00856661|469566240|FG000|Overall Study|Withdrawal by Subject|1|||
130437892|NCT00856661|469566241|FG001|Overall Study|Withdrawal by Subject|2|||
130437893|NCT00856661|469566240|FG000|Overall Study|Lost to Follow-up|1|||
130437894|NCT00856661|469566241|FG001|Overall Study|Lost to Follow-up|3|||
130437895|NCT00856661|469566240|FG000|Overall Study|Physician Judgement|8|||
130437896|NCT00856661|469566241|FG001|Overall Study|Physician Judgement|5|||
130437897|NCT02120664|469566242|FG000|Overall Study|Withdrawal by Subject|0|||
130683974|NCT02216071|470470015|FG001|Overall Study|Withdrawal by Subject|2|||
130683975|NCT02216071|470470014|FG000|Overall Study|Lost to Follow-up|3|||
130683976|NCT02216071|470470015|FG001|Overall Study|Lost to Follow-up|3|||
130683977|NCT02216071|470470014|FG000|Overall Study|Protocol Violation|3|||
130683978|NCT02216071|470470015|FG001|Overall Study|Protocol Violation|5|||
130683979|NCT02216071|470470014|FG000|Overall Study|Other|2|||
130349731|NCT01077154|469250347|FG000|Overall Study|Noncompliance|22|||
130437898|NCT02120664|469566243|FG001|Overall Study|Withdrawal by Subject|0|||
130437899|NCT02120664|469566244|FG002|Overall Study|Withdrawal by Subject|0|||
130437900|NCT02120664|469566245|FG003|Overall Study|Withdrawal by Subject|1|||
130437901|NCT02120664|469566246|FG004|Overall Study|Withdrawal by Subject|0|||
130437902|NCT02460263|469566247|FG000|Transition Period|Withdrawal by Subject|1|||
130437903|NCT02460263|469566247|FG000|Transition Period|Death|1|||
130437904|NCT03916744|469566248|FG000|Overall Study|Withdrawal by Subject|0|||
130437905|NCT03916744|469566249|FG001|Overall Study|Withdrawal by Subject|1|||
130683980|NCT02216071|470470015|FG001|Overall Study|Other|2|||
130349732|NCT01077154|469250348|FG001|Overall Study|Noncompliance|20|||
130349733|NCT01077154|469250347|FG000|Overall Study|Disease Progression|18|||
130349734|NCT01077154|469250348|FG001|Overall Study|Disease Progression|20|||
130349735|NCT01077154|469250347|FG000|Overall Study|Ineligibility Determined|10|||
130349736|NCT01077154|469250348|FG001|Overall Study|Ineligibility Determined|14|||
130349737|NCT01077154|469250347|FG000|Overall Study|Other|14|||
130349738|NCT01077154|469250348|FG001|Overall Study|Other|11|||
130349739|NCT01077154|469250347|FG000|Overall Study|Adverse Event|9|||
130349740|NCT01077154|469250348|FG001|Overall Study|Adverse Event|9|||
130349741|NCT01077154|469250347|FG000|Overall Study|Administrative Decision|1|||
130349742|NCT01077154|469250348|FG001|Overall Study|Administrative Decision|6|||
130349743|NCT01077154|469250347|FG000|Overall Study|Protocol Deviation|1|||
130349744|NCT01077154|469250348|FG001|Overall Study|Protocol Deviation|0|||
130349745|NCT00686998|469250349|FG000|Overall Study|Adverse Event|3|||
130349746|NCT00686998|469250350|FG001|Overall Study|Adverse Event|2|||
130349747|NCT00686998|469250351|FG002|Overall Study|Adverse Event|1|||
130349748|NCT00686998|469250349|FG000|Overall Study|Withdrawal by Subject|2|||
130349749|NCT00686998|469250350|FG001|Overall Study|Withdrawal by Subject|1|||
130349750|NCT00686998|469250351|FG002|Overall Study|Withdrawal by Subject|2|||
130349751|NCT00686998|469250349|FG000|Overall Study|Lack of Efficacy|7|||
130349752|NCT00686998|469250350|FG001|Overall Study|Lack of Efficacy|5|||
130349753|NCT00686998|469250351|FG002|Overall Study|Lack of Efficacy|0|||
130349754|NCT00686998|469250349|FG000|Overall Study|Other|0|||
130349755|NCT00686998|469250350|FG001|Overall Study|Other|0|||
130349756|NCT00686998|469250351|FG002|Overall Study|Other|1|||
130349757|NCT00686998|469250349|FG000|Overall Study|Safety Reasons|1|||
130349758|NCT00686998|469250350|FG001|Overall Study|Safety Reasons|0|||
130349759|NCT00686998|469250351|FG002|Overall Study|Safety Reasons|0|||
130349760|NCT00371761|469251815|FG000|Overall Study|Adverse Event|1|||
130349761|NCT00371761|469251816|FG001|Overall Study|Adverse Event|1|||
130349762|NCT00371761|469251815|FG000|Overall Study|Withdrawal by Subject|1|||
130349763|NCT00371761|469251816|FG001|Overall Study|Withdrawal by Subject|3|||
130349764|NCT00371761|469251815|FG000|Overall Study|Investigator Judgment|2|||
130349765|NCT00371761|469251816|FG001|Overall Study|Investigator Judgment|3|||
130349766|NCT00371761|469251815|FG000|Overall Study|Study termination|4|||
130349767|NCT00371761|469251816|FG001|Overall Study|Study termination|3|||
130349768|NCT01736657|469251823|FG000|Overall Study|insufficient vascular access|1|||
130349769|NCT00997438|469251834|FG000|Overall Study|Blood draw difficulty|2|||
130349770|NCT00997438|469251835|FG001|Overall Study|Blood draw difficulty|0|||
130349771|NCT00997438|469251836|FG002|Overall Study|Blood draw difficulty|1|||
130349772|NCT00997438|469251834|FG000|Overall Study|Withdrawal by Subject|1|||
130683981|NCT00389064|470470016|FG000|Overall Study|Adverse Event|11|||
130683982|NCT00389064|470470017|FG001|Overall Study|Adverse Event|3|||
130349773|NCT00997438|469251835|FG001|Overall Study|Withdrawal by Subject|1|||
130349774|NCT00997438|469251836|FG002|Overall Study|Withdrawal by Subject|0|||
130349775|NCT00997438|469251834|FG000|Overall Study|Exclusion criteria at visit 1|2|||
130349776|NCT00997438|469251835|FG001|Overall Study|Exclusion criteria at visit 1|2|||
130349777|NCT00997438|469251836|FG002|Overall Study|Exclusion criteria at visit 1|3|||
130349778|NCT03505671|469251837|FG000|Overall Study|Withdrawal by Subject|2|||
130349779|NCT03505671|469251838|FG001|Overall Study|Withdrawal by Subject|1|||
130349780|NCT03505671|469251837|FG000|Overall Study|Lost to Follow-up|1|||
130437906|NCT03916744|469566250|FG002|Overall Study|Withdrawal by Subject|2|||
130683983|NCT00389064|470470016|FG000|Overall Study|Lack of Efficacy|3|||
130349781|NCT03505671|469251838|FG001|Overall Study|Lost to Follow-up|0|||
130349782|NCT02038829|469251841|FG000|Washout Period 1|Death|0|||
130437907|NCT03176238|469566251|FG000|Overall Study|Unacceptable AEs|15|||
130683984|NCT00389064|470470017|FG001|Overall Study|Lack of Efficacy|14|||
130683985|NCT00389064|470470016|FG000|Overall Study|Withdrawal by Subject|17|||
130349783|NCT02038829|469251842|FG001|Washout Period 1|Death|0|||
130349784|NCT02038829|469251843|FG002|Washout Period 1|Death|0|||
130349785|NCT02038829|469251844|FG003|Washout Period 1|Death|0|||
130349786|NCT02038829|469251845|FG004|Washout Period 1|Death|1|||
130349787|NCT02038829|469251846|FG005|Washout Period 1|Death|0|||
130349788|NCT02038829|469251847|FG006|Washout Period 1|Death|0|||
130349789|NCT02038829|469251848|FG007|Washout Period 1|Death|0|||
130349790|NCT02038829|469251849|FG008|Washout Period 1|Death|0|||
130349791|NCT02038829|469251850|FG009|Washout Period 1|Death|0|||
130349792|NCT02038829|469251851|FG010|Washout Period 1|Death|0|||
130349793|NCT02038829|469251852|FG011|Washout Period 1|Death|0|||
130349794|NCT02038829|469251841|FG000|Treatment Period 2|Adverse Event|0|||
130349795|NCT02038829|469251842|FG001|Treatment Period 2|Adverse Event|0|||
130349796|NCT02038829|469251843|FG002|Treatment Period 2|Adverse Event|0|||
130349797|NCT02038829|469251844|FG003|Treatment Period 2|Adverse Event|0|||
130349798|NCT02038829|469251845|FG004|Treatment Period 2|Adverse Event|0|||
130349799|NCT02038829|469251846|FG005|Treatment Period 2|Adverse Event|0|||
130349800|NCT02038829|469251847|FG006|Treatment Period 2|Adverse Event|0|||
130349801|NCT02038829|469251848|FG007|Treatment Period 2|Adverse Event|0|||
130349802|NCT02038829|469251849|FG008|Treatment Period 2|Adverse Event|0|||
130349803|NCT02038829|469251850|FG009|Treatment Period 2|Adverse Event|0|||
130349804|NCT02038829|469251851|FG010|Treatment Period 2|Adverse Event|1|||
130349805|NCT02038829|469251852|FG011|Treatment Period 2|Adverse Event|0|||
130349806|NCT02038829|469251841|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130349807|NCT02038829|469251842|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130349808|NCT02038829|469251843|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130349809|NCT02038829|469251844|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130349810|NCT02038829|469251845|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130349811|NCT02038829|469251846|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130349812|NCT02038829|469251847|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130349813|NCT02038829|469251848|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130349814|NCT02038829|469251849|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130349815|NCT02038829|469251850|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130349816|NCT02038829|469251851|FG010|Treatment Period 2|Withdrawal by Subject|0|||
130349817|NCT02038829|469251852|FG011|Treatment Period 2|Withdrawal by Subject|0|||
130349818|NCT02038829|469251841|FG000|Washout Period 2|Adverse Event|0|||
130349819|NCT02038829|469251842|FG001|Washout Period 2|Adverse Event|0|||
130349820|NCT02038829|469251843|FG002|Washout Period 2|Adverse Event|0|||
130349821|NCT02038829|469251844|FG003|Washout Period 2|Adverse Event|0|||
130349822|NCT02038829|469251845|FG004|Washout Period 2|Adverse Event|0|||
130349823|NCT02038829|469251846|FG005|Washout Period 2|Adverse Event|0|||
130349824|NCT02038829|469251847|FG006|Washout Period 2|Adverse Event|0|||
130349825|NCT02038829|469251848|FG007|Washout Period 2|Adverse Event|0|||
130349826|NCT02038829|469251849|FG008|Washout Period 2|Adverse Event|1|||
130349827|NCT02038829|469251850|FG009|Washout Period 2|Adverse Event|0|||
130349828|NCT02038829|469251851|FG010|Washout Period 2|Adverse Event|0|||
130349829|NCT02038829|469251852|FG011|Washout Period 2|Adverse Event|0|||
130349830|NCT02038829|469251841|FG000|Washout Period 2|Withdrawal by Subject|0|||
130349831|NCT02038829|469251842|FG001|Washout Period 2|Withdrawal by Subject|0|||
130349832|NCT02038829|469251843|FG002|Washout Period 2|Withdrawal by Subject|0|||
130349833|NCT02038829|469251844|FG003|Washout Period 2|Withdrawal by Subject|0|||
130349834|NCT02038829|469251845|FG004|Washout Period 2|Withdrawal by Subject|0|||
130349835|NCT02038829|469251846|FG005|Washout Period 2|Withdrawal by Subject|1|||
130349836|NCT02038829|469251847|FG006|Washout Period 2|Withdrawal by Subject|0|||
130349837|NCT02038829|469251848|FG007|Washout Period 2|Withdrawal by Subject|0|||
130349838|NCT02038829|469251849|FG008|Washout Period 2|Withdrawal by Subject|0|||
130349839|NCT02038829|469251850|FG009|Washout Period 2|Withdrawal by Subject|0|||
130437908|NCT03176238|469566252|FG001|Overall Study|Unacceptable AEs|8|||
130683986|NCT00389064|470470017|FG001|Overall Study|Withdrawal by Subject|27|||
130683987|NCT00389064|470470016|FG000|Overall Study|Physician Decision|2|||
130349840|NCT02038829|469251851|FG010|Washout Period 2|Withdrawal by Subject|0|||
130349841|NCT02038829|469251852|FG011|Washout Period 2|Withdrawal by Subject|0|||
130349842|NCT02038829|469251841|FG000|Treatment Period 4|Adverse Event|0|||
130349843|NCT02038829|469251842|FG001|Treatment Period 4|Adverse Event|1|||
130349844|NCT02038829|469251843|FG002|Treatment Period 4|Adverse Event|0|||
130349845|NCT02038829|469251844|FG003|Treatment Period 4|Adverse Event|0|||
130349846|NCT02038829|469251845|FG004|Treatment Period 4|Adverse Event|0|||
130349847|NCT02038829|469251846|FG005|Treatment Period 4|Adverse Event|0|||
130349848|NCT02038829|469251847|FG006|Treatment Period 4|Adverse Event|0|||
130349849|NCT02038829|469251848|FG007|Treatment Period 4|Adverse Event|0|||
130349850|NCT02038829|469251849|FG008|Treatment Period 4|Adverse Event|0|||
130349851|NCT02038829|469251850|FG009|Treatment Period 4|Adverse Event|0|||
130349852|NCT02038829|469251851|FG010|Treatment Period 4|Adverse Event|0|||
130349853|NCT02038829|469251852|FG011|Treatment Period 4|Adverse Event|0|||
130349854|NCT02038829|469251841|FG000|Washout Period 4|Adverse Event|0|||
130349855|NCT02038829|469251842|FG001|Washout Period 4|Adverse Event|0|||
130349856|NCT02038829|469251843|FG002|Washout Period 4|Adverse Event|0|||
130349857|NCT02038829|469251844|FG003|Washout Period 4|Adverse Event|0|||
130349858|NCT02038829|469251845|FG004|Washout Period 4|Adverse Event|0|||
130349859|NCT02038829|469251846|FG005|Washout Period 4|Adverse Event|0|||
130349860|NCT02038829|469251847|FG006|Washout Period 4|Adverse Event|1|||
130349861|NCT02038829|469251848|FG007|Washout Period 4|Adverse Event|0|||
130349862|NCT02038829|469251849|FG008|Washout Period 4|Adverse Event|0|||
130349863|NCT02038829|469251850|FG009|Washout Period 4|Adverse Event|0|||
130349864|NCT02038829|469251851|FG010|Washout Period 4|Adverse Event|0|||
130349865|NCT02038829|469251852|FG011|Washout Period 4|Adverse Event|0|||
130349866|NCT02038829|469251841|FG000|Treatment Period 6|Adverse Event|0|||
130349867|NCT02038829|469251842|FG001|Treatment Period 6|Adverse Event|0|||
130349868|NCT02038829|469251843|FG002|Treatment Period 6|Adverse Event|1|||
130349869|NCT02038829|469251844|FG003|Treatment Period 6|Adverse Event|0|||
130349870|NCT02038829|469251845|FG004|Treatment Period 6|Adverse Event|0|||
130349871|NCT02038829|469251846|FG005|Treatment Period 6|Adverse Event|0|||
130349872|NCT02038829|469251847|FG006|Treatment Period 6|Adverse Event|0|||
130349873|NCT02038829|469251848|FG007|Treatment Period 6|Adverse Event|0|||
130349874|NCT02038829|469251849|FG008|Treatment Period 6|Adverse Event|0|||
130349875|NCT02038829|469251850|FG009|Treatment Period 6|Adverse Event|0|||
130349876|NCT02038829|469251851|FG010|Treatment Period 6|Adverse Event|0|||
130349877|NCT02038829|469251852|FG011|Treatment Period 6|Adverse Event|0|||
130349878|NCT02579928|469251853|FG000|Overall Study|Withdrawal by Subject|1|||
130349879|NCT02579928|469251854|FG001|Overall Study|Withdrawal by Subject|0|||
130349880|NCT00998764|469251855|FG000|Overall Study|Lack of Efficacy|3|||
130349881|NCT00998764|469251856|FG001|Overall Study|Lack of Efficacy|6|||
130349882|NCT00998764|469251855|FG000|Overall Study|Adverse Event|17|||
130349883|NCT00998764|469251856|FG001|Overall Study|Adverse Event|12|||
130349884|NCT00998764|469251855|FG000|Overall Study|Withdrawal by Subject|19|||
130349885|NCT00998764|469251856|FG001|Overall Study|Withdrawal by Subject|25|||
130349886|NCT00998764|469251855|FG000|Overall Study|Physician Decision|3|||
130349887|NCT00998764|469251856|FG001|Overall Study|Physician Decision|3|||
130349888|NCT00998764|469251855|FG000|Overall Study|Death|3|||
130349889|NCT00998764|469251856|FG001|Overall Study|Death|1|||
130349890|NCT00998764|469251855|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
130349891|NCT00998764|469251856|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
130349892|NCT00998764|469251855|FG000|Overall Study|Protocol Violation|0|||
130349893|NCT00998764|469251856|FG001|Overall Study|Protocol Violation|1|||
130349894|NCT00998764|469251855|FG000|Overall Study|Failed to Return|1|||
130349895|NCT00998764|469251856|FG001|Overall Study|Failed to Return|1|||
130349896|NCT00998764|469251855|FG000|Overall Study|Lost to Follow-up|1|||
130349897|NCT00998764|469251856|FG001|Overall Study|Lost to Follow-up|1|||
130349898|NCT00998764|469251855|FG000|Overall Study|Loss of Caregiver|0|||
130349899|NCT00998764|469251856|FG001|Overall Study|Loss of Caregiver|3|||
130349900|NCT00998764|469251855|FG000|Overall Study|Other|4|||
130349901|NCT00998764|469251856|FG001|Overall Study|Other|4|||
130349902|NCT00998764|469251855|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
130349903|NCT00998764|469251856|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
130349904|NCT01214174|469251857|FG000|Overall Study|Withdrawal by Subject|0|||
130349905|NCT01214174|469251858|FG001|Overall Study|Withdrawal by Subject|0|||
130349906|NCT01214174|469251859|FG002|Overall Study|Withdrawal by Subject|1|||
130349907|NCT01933789|469251868|FG000|Overall Study|Death|0|||
130349908|NCT01933789|469251869|FG001|Overall Study|Death|0|||
130349909|NCT01933789|469251870|FG002|Overall Study|Death|0|||
130349910|NCT01933789|469251871|FG003|Overall Study|Death|0|||
130349911|NCT01933789|469251872|FG004|Overall Study|Death|21|||
130349912|NCT01933789|469251873|FG005|Overall Study|Death|32|||
130349913|NCT01933789|469251874|FG006|Overall Study|Death|0|||
130349914|NCT01933789|469251875|FG007|Overall Study|Death|0|||
130349915|NCT01933789|469251876|FG008|Overall Study|Death|0|||
130349916|NCT01933789|469251868|FG000|Overall Study|Lost to Follow-up|0|||
130349917|NCT01933789|469251869|FG001|Overall Study|Lost to Follow-up|0|||
130349918|NCT01933789|469251870|FG002|Overall Study|Lost to Follow-up|0|||
130349919|NCT01933789|469251871|FG003|Overall Study|Lost to Follow-up|1|||
130349920|NCT01933789|469251872|FG004|Overall Study|Lost to Follow-up|8|||
130349921|NCT01933789|469251873|FG005|Overall Study|Lost to Follow-up|9|||
130349922|NCT01933789|469251874|FG006|Overall Study|Lost to Follow-up|1|||
130349923|NCT01933789|469251875|FG007|Overall Study|Lost to Follow-up|4|||
130349924|NCT01933789|469251876|FG008|Overall Study|Lost to Follow-up|0|||
130349925|NCT01933789|469251868|FG000|Overall Study|Withdrawal by Subject|2|||
130349926|NCT01933789|469251869|FG001|Overall Study|Withdrawal by Subject|1|||
130349927|NCT01933789|469251870|FG002|Overall Study|Withdrawal by Subject|0|||
130349928|NCT01933789|469251871|FG003|Overall Study|Withdrawal by Subject|0|||
130349929|NCT01933789|469251872|FG004|Overall Study|Withdrawal by Subject|17|||
130349930|NCT01933789|469251873|FG005|Overall Study|Withdrawal by Subject|16|||
130349931|NCT01933789|469251874|FG006|Overall Study|Withdrawal by Subject|1|||
130349932|NCT01933789|469251875|FG007|Overall Study|Withdrawal by Subject|4|||
130349933|NCT01933789|469251876|FG008|Overall Study|Withdrawal by Subject|0|||
130349934|NCT01933789|469251868|FG000|Overall Study|Became Ineligible|4|||
130349935|NCT01933789|469251869|FG001|Overall Study|Became Ineligible|0|||
130349936|NCT01933789|469251870|FG002|Overall Study|Became Ineligible|0|||
130349937|NCT01933789|469251871|FG003|Overall Study|Became Ineligible|0|||
130349938|NCT01933789|469251872|FG004|Overall Study|Became Ineligible|13|||
130683988|NCT00389064|470470017|FG001|Overall Study|Physician Decision|2|||
130683989|NCT00389064|470470016|FG000|Overall Study|Lost to Follow-up|1|||
130683990|NCT00389064|470470017|FG001|Overall Study|Lost to Follow-up|2|||
130683991|NCT00389064|470470016|FG000|Overall Study|Protocol Violation|2|||
130683992|NCT00389064|470470017|FG001|Overall Study|Protocol Violation|0|||
130683993|NCT00389064|470470016|FG000|Overall Study|Multiple Reasons|9|||
130683994|NCT00389064|470470017|FG001|Overall Study|Multiple Reasons|11|||
130349939|NCT01933789|469251873|FG005|Overall Study|Became Ineligible|10|||
130349940|NCT01933789|469251874|FG006|Overall Study|Became Ineligible|13|||
130349941|NCT01933789|469251875|FG007|Overall Study|Became Ineligible|6|||
130349942|NCT01933789|469251876|FG008|Overall Study|Became Ineligible|0|||
130349943|NCT01117792|469251882|FG000|Overall Study|Death|1|||
130349944|NCT01117792|469251882|FG000|Overall Study|Adverse Event|3|||
130349945|NCT01721577|469251883|FG000|Overall Study|Lack of Efficacy|1|||
130349946|NCT01721577|469251884|FG001|Overall Study|Lack of Efficacy|0|||
130349947|NCT01721577|469251883|FG000|Overall Study|Death|1|||
130349948|NCT01721577|469251884|FG001|Overall Study|Death|0|||
130349949|NCT01721577|469251883|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
130349950|NCT01721577|469251884|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
130349951|NCT01721577|469251883|FG000|Overall Study|Adverse Event|0|||
130349952|NCT01721577|469251884|FG001|Overall Study|Adverse Event|2|||
130349953|NCT02497976|469251887|FG000|Overall Study|Withdrawal by Subject|2|||
130349954|NCT02497976|469251888|FG001|Overall Study|Withdrawal by Subject|0|||
130349955|NCT02497976|469251887|FG000|Overall Study|Moved out of area|0|||
130349956|NCT02497976|469251888|FG001|Overall Study|Moved out of area|1|||
130349957|NCT01966432|469251891|FG000|Overall Study|Lost to Follow-up|3|||
130349958|NCT01966432|469251892|FG001|Overall Study|Lost to Follow-up|2|||
130349959|NCT01966432|469251893|FG002|Overall Study|Lost to Follow-up|5|||
130349960|NCT01966432|469251891|FG000|Overall Study|Withdrawal by Subject|1|||
130349961|NCT01966432|469251892|FG001|Overall Study|Withdrawal by Subject|3|||
130349962|NCT01966432|469251893|FG002|Overall Study|Withdrawal by Subject|0|||
130349963|NCT01966432|469251891|FG000|Overall Study|Subject Incarcerated|0|||
130349964|NCT01966432|469251892|FG001|Overall Study|Subject Incarcerated|0|||
130349965|NCT01966432|469251893|FG002|Overall Study|Subject Incarcerated|1|||
130349966|NCT01966432|469251891|FG000|Overall Study|SBIRT program ended|1|||
130349967|NCT01966432|469251892|FG001|Overall Study|SBIRT program ended|8|||
130349968|NCT01966432|469251893|FG002|Overall Study|SBIRT program ended|20|||
130349969|NCT00584740|469251896|FG000|Overall Study|Adverse Event|1|||
130349970|NCT00584740|469251897|FG001|Overall Study|Adverse Event|1|||
130349971|NCT00584740|469251896|FG000|Overall Study|Lack of Efficacy|8|||
130349972|NCT00584740|469251897|FG001|Overall Study|Lack of Efficacy|2|||
130349973|NCT00584740|469251896|FG000|Overall Study|Withdrawal by Subject|3|||
130349974|NCT00584740|469251897|FG001|Overall Study|Withdrawal by Subject|2|||
130349975|NCT00584740|469251896|FG000|Overall Study|Lost to Follow-up|0|||
130349976|NCT00584740|469251897|FG001|Overall Study|Lost to Follow-up|1|||
130349977|NCT01903525|469251898|FG000|Overall Study|Lost to Follow-up|5|||
130349978|NCT01903525|469251899|FG001|Overall Study|Lost to Follow-up|9|||
130349979|NCT01903525|469251898|FG000|Overall Study|Adverse Event|0|||
130349980|NCT01903525|469251899|FG001|Overall Study|Adverse Event|1|||
130349981|NCT00930982|469251900|FG000|Overall Study|Adverse Event|19|||
130349982|NCT00930982|469251901|FG001|Overall Study|Adverse Event|23|||
130349983|NCT00930982|469251900|FG000|Overall Study|Protocol Violation|1|||
130349984|NCT00930982|469251901|FG001|Overall Study|Protocol Violation|5|||
130349985|NCT00930982|469251900|FG000|Overall Study|Withdrawal by Subject|1|||
130349986|NCT00930982|469251901|FG001|Overall Study|Withdrawal by Subject|1|||
130349987|NCT03915860|469251902|FG000|Overall Study|Adverse Event|3|||
130349988|NCT03915860|469251902|FG000|Overall Study|Withdrawal by Subject|6|||
130349989|NCT03915860|469251902|FG000|Overall Study|Lost to Follow-up|2|||
130349990|NCT03915860|469251902|FG000|Overall Study|Other than specified|3|||
130349991|NCT02195011|469251903|FG000|Overall Study|Adverse Event|4|||
130349992|NCT02195011|469251904|FG001|Overall Study|Adverse Event|0|||
130349993|NCT02195011|469251903|FG000|Overall Study|Progressive Disease|18|||
130349994|NCT02195011|469251904|FG001|Overall Study|Progressive Disease|1|||
130349995|NCT02195011|469251903|FG000|Overall Study|Withdrawal by Subject|3|||
130349996|NCT02195011|469251904|FG001|Overall Study|Withdrawal by Subject|0|||
130349997|NCT01853618|469251905|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
130349998|NCT01853618|469251906|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
130349999|NCT01853618|469251907|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
130350000|NCT01853618|469251908|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
130350001|NCT01853618|469251909|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
130350002|NCT01853618|469251905|FG000|Overall Study|Progressive disease|1|||
130350003|NCT01853618|469251906|FG001|Overall Study|Progressive disease|1|||
130350004|NCT01853618|469251907|FG002|Overall Study|Progressive disease|1|||
130350005|NCT01853618|469251908|FG003|Overall Study|Progressive disease|1|||
130350006|NCT01853618|469251909|FG004|Overall Study|Progressive disease|2|||
130350007|NCT01853618|469251905|FG000|Overall Study|Physician Decision|0|||
130350008|NCT01853618|469251906|FG001|Overall Study|Physician Decision|1|||
130683995|NCT04753437|470470018|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130683996|NCT04753437|470470019|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130683997|NCT04753437|470470018|FG000|Overall Study|Liver Function Test Abnormalities|2|||
130683998|NCT04753437|470470019|FG001|Overall Study|Liver Function Test Abnormalities|4|||
130683999|NCT03243630|470470020|FG000|Overall Study|Protocol Violation|1|||
130684000|NCT03243630|470470020|FG000|Overall Study|Physician Decision|1|||
130684001|NCT02140060|470470021|FG000|Overall Study|Adverse Event|0|||
130684002|NCT02140060|470470022|FG001|Overall Study|Adverse Event|0|||
130684003|NCT02140060|470470023|FG002|Overall Study|Adverse Event|0|||
130684004|NCT02140060|470470024|FG003|Overall Study|Adverse Event|1|||
130684005|NCT02140060|470470025|FG004|Overall Study|Adverse Event|1|||
130684006|NCT02140060|470470026|FG005|Overall Study|Adverse Event|1|||
130684007|NCT02140060|470470021|FG000|Overall Study|Lack of Efficacy|0|||
130684008|NCT02140060|470470022|FG001|Overall Study|Lack of Efficacy|0|||
130684009|NCT02140060|470470023|FG002|Overall Study|Lack of Efficacy|0|||
130684010|NCT02140060|470470024|FG003|Overall Study|Lack of Efficacy|1|||
130684011|NCT02140060|470470025|FG004|Overall Study|Lack of Efficacy|0|||
130684012|NCT02140060|470470026|FG005|Overall Study|Lack of Efficacy|0|||
130684013|NCT01387737|470471275|FG000|Overall Study|Adverse Event|20|||
130684014|NCT01387737|470471276|FG001|Overall Study|Adverse Event|30|||
130684015|NCT01387737|470471275|FG000|Overall Study|Lack of Efficacy|1|||
130684016|NCT01387737|470471276|FG001|Overall Study|Lack of Efficacy|0|||
130684017|NCT01387737|470471275|FG000|Overall Study|Physician Decision|3|||
130684018|NCT01387737|470471276|FG001|Overall Study|Physician Decision|10|||
130684019|NCT01387737|470471275|FG000|Overall Study|Withdrawal by Subject|27|||
130684020|NCT01387737|470471276|FG001|Overall Study|Withdrawal by Subject|31|||
130684021|NCT01387737|470471275|FG000|Overall Study|Clearly not eligible for the study|1|||
130684022|NCT01387737|470471276|FG001|Overall Study|Clearly not eligible for the study|3|||
130684023|NCT01215981|470471279|FG000|Overall Study|Physician Decision|0|||
130684024|NCT01215981|470471280|FG001|Overall Study|Physician Decision|1|||
130684025|NCT01215981|470471279|FG000|Overall Study|Protocol Violation|1|||
130684026|NCT01215981|470471280|FG001|Overall Study|Protocol Violation|0|||
130684027|NCT01215981|470471279|FG000|Overall Study|Withdrawal by Subject|1|||
130684028|NCT01215981|470471280|FG001|Overall Study|Withdrawal by Subject|0|||
130684029|NCT00840632|470471286|FG000|First Intervention|Withdrawal by Subject|0|||
130684030|NCT00840632|470471287|FG001|First Intervention|Withdrawal by Subject|1|||
130684031|NCT00840632|470471286|FG000|Washout|Withdrawal by Subject|1|||
130684032|NCT00840632|470471287|FG001|Washout|Withdrawal by Subject|1|||
130684033|NCT01294787|470471288|FG000|Period 1|Adverse Event|0|||
130684034|NCT01294787|470471289|FG001|Period 1|Adverse Event|0|||
130684035|NCT01294787|470471290|FG002|Period 1|Adverse Event|0|||
130217805|NCT04865419|468761407|FG005|Overall Study|Study terminated by Sponsor|0|||
130350009|NCT01853618|469251907|FG002|Overall Study|Physician Decision|1|||
130350010|NCT01853618|469251908|FG003|Overall Study|Physician Decision|0|||
130350011|NCT01853618|469251909|FG004|Overall Study|Physician Decision|0|||
130350012|NCT01853618|469251905|FG000|Overall Study|Refused further treatment|0|||
130350013|NCT01853618|469251906|FG001|Overall Study|Refused further treatment|0|||
130350014|NCT01853618|469251907|FG002|Overall Study|Refused further treatment|0|||
130350015|NCT01853618|469251908|FG003|Overall Study|Refused further treatment|0|||
130350016|NCT01853618|469251909|FG004|Overall Study|Refused further treatment|1|||
130350017|NCT01146860|469251912|FG000|Overall Study|Withdrawal by Subject|0|||
130350018|NCT01146860|469251913|FG001|Overall Study|Withdrawal by Subject|1|||
130350019|NCT01075191|469251914|FG000|Overall Study|Death|1|||
130350020|NCT01075191|469251914|FG000|Overall Study|Intensification|3|||
130350021|NCT01075191|469251914|FG000|Overall Study|Co-morbidities|1|||
130350022|NCT01075191|469251914|FG000|Overall Study|Adverse Event|4|||
130350023|NCT01075191|469251914|FG000|Overall Study|Noncompliance|3|||
130350024|NCT01075191|469251914|FG000|Overall Study|Therapy Break|3|||
130350025|NCT01075191|469251914|FG000|Overall Study|Patient's Wish|2|||
130350026|NCT01075191|469251914|FG000|Overall Study|Unknown Reasons|1|||
130350027|NCT02635646|469251920|FG000|Overall Study|Lost to Follow-up|24|||
130350028|NCT02635646|469251921|FG001|Overall Study|Lost to Follow-up|25|||
130350029|NCT02635646|469251920|FG000|Overall Study|Pregnancy|1|||
130350030|NCT02635646|469251921|FG001|Overall Study|Pregnancy|1|||
130350031|NCT00645788|469251922|FG000|Overall Study|Did not receive study drug|1|||
130350032|NCT00645788|469251923|FG001|Overall Study|Did not receive study drug|1|||
130350033|NCT00645788|469251924|FG002|Overall Study|Did not receive study drug|0|||
130350034|NCT00645788|469251925|FG003|Overall Study|Did not receive study drug|0|||
130437909|NCT03176238|469566251|FG000|Overall Study|Abnormal lab value(s)|2|||
130684036|NCT01294787|470471291|FG003|Period 1|Adverse Event|0|||
130684037|NCT01294787|470471292|FG004|Period 1|Adverse Event|1|||
130684038|NCT01294787|470471293|FG005|Period 1|Adverse Event|0|||
130684039|NCT01294787|470471288|FG000|Period 1|Withdrawal by Subject|0|||
130217806|NCT04865419|468761408|FG006|Overall Study|Study terminated by Sponsor|0|||
130684040|NCT01294787|470471289|FG001|Period 1|Withdrawal by Subject|0|||
130684041|NCT01294787|470471290|FG002|Period 1|Withdrawal by Subject|0|||
130684042|NCT01294787|470471291|FG003|Period 1|Withdrawal by Subject|1|||
130684043|NCT01294787|470471292|FG004|Period 1|Withdrawal by Subject|1|||
130684044|NCT01294787|470471293|FG005|Period 1|Withdrawal by Subject|1|||
130684045|NCT01294787|470471288|FG000|Period 1|Administrative problem|0|||
130684046|NCT01294787|470471289|FG001|Period 1|Administrative problem|0|||
130437910|NCT03176238|469566252|FG001|Overall Study|Abnormal lab value(s)|0|||
130437911|NCT03176238|469566251|FG000|Overall Study|Inter-current illness|0|||
130437912|NCT03176238|469566252|FG001|Overall Study|Inter-current illness|1|||
130437913|NCT03176238|469566251|FG000|Overall Study|Consent withdrawal|14|||
130437914|NCT03176238|469566252|FG001|Overall Study|Consent withdrawal|2|||
130437915|NCT03176238|469566251|FG000|Overall Study|Lost to Follow-up|3|||
130437916|NCT03176238|469566252|FG001|Overall Study|Lost to Follow-up|0|||
130437917|NCT03176238|469566251|FG000|Overall Study|Administrative problems|1|||
130684047|NCT01294787|470471290|FG002|Period 1|Administrative problem|1|||
130684048|NCT01294787|470471291|FG003|Period 1|Administrative problem|0|||
130437918|NCT03176238|469566252|FG001|Overall Study|Administrative problems|0|||
130437919|NCT03176238|469566251|FG000|Overall Study|Death|3|||
130437920|NCT03176238|469566252|FG001|Overall Study|Death|0|||
130437921|NCT03176238|469566251|FG000|Overall Study|Disease Progression|133|||
130437922|NCT03176238|469566252|FG001|Overall Study|Disease Progression|22|||
130684049|NCT01294787|470471292|FG004|Period 1|Administrative problem|0|||
130684050|NCT01294787|470471293|FG005|Period 1|Administrative problem|1|||
130684051|NCT01294787|470471288|FG000|Period 2|Adverse Event|0|||
130684052|NCT01294787|470471289|FG001|Period 2|Adverse Event|3|||
130684053|NCT01294787|470471290|FG002|Period 2|Adverse Event|0|||
130437923|NCT03176238|469566251|FG000|Overall Study|Tx duration completed per EAP|0|||
130437924|NCT03176238|469566252|FG001|Overall Study|Tx duration completed per EAP|1|||
130437925|NCT03176238|469566251|FG000|Overall Study|Patient is switched to commercial drug|16|||
130437926|NCT03176238|469566252|FG001|Overall Study|Patient is switched to commercial drug|1|||
130437927|NCT03176238|469566251|FG000|Overall Study|Protocol Violation|1|||
130437928|NCT03176238|469566252|FG001|Overall Study|Protocol Violation|0|||
130437929|NCT03176238|469566251|FG000|Overall Study|Changes in the patient's condition|2|||
130437930|NCT03176238|469566252|FG001|Overall Study|Changes in the patient's condition|1|||
130437931|NCT03176238|469566251|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
130437932|NCT03176238|469566252|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
130437933|NCT04524598|469566253|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
130437934|NCT04524598|469566254|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
130437935|NCT04524598|469566255|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
130437936|NCT04524598|469566256|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
130437937|NCT04524598|469566257|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
130437938|NCT04524598|469566253|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
130437939|NCT04524598|469566254|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
130437940|NCT04524598|469566255|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130684054|NCT01294787|470471291|FG003|Period 2|Adverse Event|1|||
130684055|NCT01294787|470471292|FG004|Period 2|Adverse Event|0|||
130684056|NCT01294787|470471293|FG005|Period 2|Adverse Event|0|||
130684057|NCT01294787|470471288|FG000|Period 2|No longer needs study drug|0|||
130684058|NCT01294787|470471289|FG001|Period 2|No longer needs study drug|0|||
130684059|NCT01294787|470471290|FG002|Period 2|No longer needs study drug|0|||
130684060|NCT01294787|470471291|FG003|Period 2|No longer needs study drug|1|||
130684061|NCT01294787|470471292|FG004|Period 2|No longer needs study drug|0|||
130684062|NCT01294787|470471293|FG005|Period 2|No longer needs study drug|0|||
130684063|NCT01294787|470471288|FG000|Period 3|Adverse Event|0|||
130684064|NCT01294787|470471289|FG001|Period 3|Adverse Event|0|||
130684065|NCT01294787|470471290|FG002|Period 3|Adverse Event|0|||
130684066|NCT01294787|470471291|FG003|Period 3|Adverse Event|0|||
130684067|NCT01294787|470471292|FG004|Period 3|Adverse Event|1|||
130684068|NCT01294787|470471293|FG005|Period 3|Adverse Event|0|||
130684069|NCT01725529|470471296|FG000|Overall Study|Adverse Event|1|||
130684070|NCT01725529|470471297|FG001|Overall Study|Adverse Event|0|||
130684071|NCT01725529|470471298|FG002|Overall Study|Adverse Event|0|||
130684072|NCT01725529|470471296|FG000|Overall Study|Lost to Follow-up|2|||
130684073|NCT01725529|470471297|FG001|Overall Study|Lost to Follow-up|1|||
130684074|NCT01725529|470471298|FG002|Overall Study|Lost to Follow-up|1|||
130684075|NCT01725529|470471296|FG000|Overall Study|Protocol Violation|0|||
130684076|NCT01725529|470471297|FG001|Overall Study|Protocol Violation|1|||
130684077|NCT01725529|470471298|FG002|Overall Study|Protocol Violation|1|||
130684078|NCT01725529|470471296|FG000|Overall Study|Withdrawal by Subject|12|||
130684079|NCT01725529|470471297|FG001|Overall Study|Withdrawal by Subject|14|||
130684080|NCT01725529|470471298|FG002|Overall Study|Withdrawal by Subject|8|||
130684081|NCT01948258|470471300|FG000|Overall Study|Pregnancy|41|||
130684082|NCT01948258|470471300|FG000|Overall Study|Did not complete by cut-off date|35|||
130684083|NCT01948258|470471300|FG000|Overall Study|Lost to Follow-up|27|||
130684084|NCT01948258|470471300|FG000|Overall Study|Withdrawal by SPD|8|||
130684085|NCT01948258|470471300|FG000|Overall Study|Withdrawal by Subject|6|||
130684086|NCT01948258|470471300|FG000|Overall Study|Health Care Professional|43|||
130437941|NCT04524598|469566256|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437942|NCT04524598|469566257|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437943|NCT04524598|469566253|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
130684087|NCT01948258|470471300|FG000|Overall Study|Removed from statistical analysis|2|||
130684088|NCT03785548|470471303|FG000|Overall Study|age > 80|1|||
130684089|NCT03785548|470471304|FG001|Overall Study|age > 80|0|||
130350035|NCT00645788|469251922|FG000|Overall Study|Adverse Event|4|||
130350036|NCT00645788|469251923|FG001|Overall Study|Adverse Event|9|||
130350037|NCT00645788|469251924|FG002|Overall Study|Adverse Event|5|||
130684090|NCT03785548|470471303|FG000|Overall Study|no Postop queries|1|||
130684091|NCT03785548|470471304|FG001|Overall Study|no Postop queries|0|||
130684092|NCT01049334|470471307|FG000|Overall Study|Withdrawal by Subject|5|||
130684093|NCT01049334|470471308|FG001|Overall Study|Withdrawal by Subject|3|||
130684094|NCT01049334|470471307|FG000|Overall Study|Adverse Event|2|||
130684095|NCT01049334|470471308|FG001|Overall Study|Adverse Event|3|||
130684096|NCT01049334|470471307|FG000|Overall Study|Physician Decision|2|||
130684097|NCT01049334|470471308|FG001|Overall Study|Physician Decision|0|||
130684098|NCT01049334|470471307|FG000|Overall Study|Protocol Violation|0|||
130684099|NCT01049334|470471308|FG001|Overall Study|Protocol Violation|1|||
130684100|NCT00667095|470471321|FG000|Overall Study|Withdrawal by Subject|0|||
130684101|NCT00667095|470471322|FG001|Overall Study|Withdrawal by Subject|1|||
130684102|NCT03447262|470471323|FG000|Overall Study|Adverse Event|7|||
130684103|NCT03447262|470471323|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130684104|NCT03447262|470471323|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
130684105|NCT03447262|470471323|FG000|Overall Study|Death|2|||
130684106|NCT03447262|470471323|FG000|Overall Study|Study Termination by Sponsor|455|||
130684107|NCT03447262|470471323|FG000|Overall Study|Other|4|||
130350038|NCT00645788|469251925|FG003|Overall Study|Adverse Event|3|||
130350039|NCT00645788|469251922|FG000|Overall Study|Lost to Follow-up|1|||
130350040|NCT00645788|469251923|FG001|Overall Study|Lost to Follow-up|0|||
130350041|NCT00645788|469251924|FG002|Overall Study|Lost to Follow-up|0|||
130350042|NCT00645788|469251925|FG003|Overall Study|Lost to Follow-up|0|||
130350043|NCT00645788|469251922|FG000|Overall Study|Protocol Violation|1|||
130350044|NCT00645788|469251923|FG001|Overall Study|Protocol Violation|0|||
130350045|NCT00645788|469251924|FG002|Overall Study|Protocol Violation|2|||
130350046|NCT00645788|469251925|FG003|Overall Study|Protocol Violation|0|||
130350047|NCT00645788|469251922|FG000|Overall Study|Withdrawal by Subject|0|||
130350048|NCT00645788|469251923|FG001|Overall Study|Withdrawal by Subject|1|||
130350049|NCT00645788|469251924|FG002|Overall Study|Withdrawal by Subject|0|||
130350050|NCT00645788|469251925|FG003|Overall Study|Withdrawal by Subject|2|||
130350051|NCT00645788|469251922|FG000|Overall Study|Pulmonary exacerbation|13|||
130350052|NCT00645788|469251923|FG001|Overall Study|Pulmonary exacerbation|16|||
130350053|NCT00645788|469251924|FG002|Overall Study|Pulmonary exacerbation|11|||
130350054|NCT00645788|469251925|FG003|Overall Study|Pulmonary exacerbation|9|||
130350055|NCT00459979|469251927|FG000|Overall Study|Withdrawal by Subject|1|||
130350056|NCT00459979|469251927|FG000|Overall Study|Protocol Violation|1|||
130350057|NCT00570232|469251928|FG000|Overall Study|Adverse Event|10|||
130350058|NCT00570232|469251928|FG000|Overall Study|discontinued due to medical condition|3|||
130350059|NCT00570232|469251928|FG000|Overall Study|discontinued due to recurrence|8|||
130350060|NCT00570232|469251928|FG000|Overall Study|discontinued due to noncompliance|2|||
130350061|NCT02207946|469251932|FG000|Overall Study|Lost to Follow-up|1|||
130350062|NCT02207946|469251933|FG001|Overall Study|Lost to Follow-up|0|||
130350063|NCT02207946|469251932|FG000|Overall Study|Adverse Event|0|||
130350064|NCT02207946|469251933|FG001|Overall Study|Adverse Event|1|||
130350065|NCT02361346|469251945|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350066|NCT02361346|469251946|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350067|NCT02361346|469251947|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350068|NCT02361346|469251948|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
130350069|NCT02361346|469251949|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350070|NCT02361346|469251950|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350071|NCT02361346|469251951|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350072|NCT02361346|469251952|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350073|NCT02361346|469251953|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
130350074|NCT02361346|469251945|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350075|NCT02361346|469251946|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350076|NCT02361346|469251947|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350077|NCT02361346|469251948|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350078|NCT02361346|469251949|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
130350079|NCT02361346|469251950|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350080|NCT02361346|469251951|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350081|NCT02361346|469251952|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350082|NCT02361346|469251953|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130350083|NCT02361346|469251945|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
130437944|NCT04524598|469566254|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
130350084|NCT02361346|469251946|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
130350085|NCT02361346|469251947|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
130350086|NCT02361346|469251948|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
130684108|NCT01882257|470471325|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
130684109|NCT01882257|470471326|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
130684110|NCT01882257|470471327|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
130350087|NCT02361346|469251949|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
130350088|NCT02361346|469251950|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
130350089|NCT02361346|469251951|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
130350090|NCT02361346|469251952|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
130350091|NCT02361346|469251953|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
130350092|NCT02361346|469251945|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350093|NCT02361346|469251946|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350094|NCT02361346|469251947|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350095|NCT02361346|469251948|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350096|NCT02361346|469251949|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350097|NCT02361346|469251950|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350098|NCT02361346|469251951|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350099|NCT02361346|469251952|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
130350100|NCT02361346|469251953|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130350101|NCT02361346|469251945|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350102|NCT02361346|469251946|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350103|NCT02361346|469251947|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350104|NCT02361346|469251948|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350105|NCT02361346|469251949|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350106|NCT02361346|469251950|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350107|NCT02361346|469251951|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350108|NCT02361346|469251952|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
130350109|NCT02361346|469251953|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130350110|NCT02361346|469251945|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350111|NCT02361346|469251946|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350112|NCT02361346|469251947|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350113|NCT02361346|469251948|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350114|NCT02361346|469251949|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350115|NCT02361346|469251950|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350116|NCT02361346|469251951|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350117|NCT02361346|469251952|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
130684111|NCT01882257|470471325|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
130684112|NCT01882257|470471326|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
130684113|NCT01882257|470471327|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
130684114|NCT03351335|470471332|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
130684115|NCT03351335|470471333|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
130684116|NCT03351335|470471334|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
130684117|NCT00469417|470471335|FG000|Overall Study|Treatment failure all lesions|18|||
130684118|NCT00469417|470471336|FG001|Overall Study|Treatment failure all lesions|11|||
130684119|NCT00469417|470471335|FG000|Overall Study|Consent withdrawn|1|||
130684120|NCT00469417|470471336|FG001|Overall Study|Consent withdrawn|1|||
130684121|NCT00469417|470471335|FG000|Overall Study|Adverse Event|8|||
130684122|NCT00469417|470471336|FG001|Overall Study|Adverse Event|2|||
130684123|NCT00469417|470471335|FG000|Overall Study|Lost to Follow-up|1|||
130684124|NCT00469417|470471336|FG001|Overall Study|Lost to Follow-up|2|||
130684125|NCT00469417|470471335|FG000|Overall Study|Intercurrent disease|0|||
130684126|NCT00469417|470471336|FG001|Overall Study|Intercurrent disease|1|||
130684127|NCT00469417|470471335|FG000|Overall Study|Randomized but not treated|2|||
130684128|NCT00469417|470471336|FG001|Overall Study|Randomized but not treated|0|||
130684129|NCT00834743|470471339|FG000|Second Intervention|Withdrawal by Subject|1|||
130684130|NCT00834743|470471340|FG001|Second Intervention|Withdrawal by Subject|0|||
130684131|NCT00086996|470471342|FG000|Overall Study|Adverse Event|29|||
130684132|NCT00086996|470471342|FG000|Overall Study|Death|4|||
130684133|NCT00086996|470471342|FG000|Overall Study|progression/relapse|7|||
130684134|NCT00086996|470471342|FG000|Overall Study|Withdrawal by Subject|13|||
130684135|NCT00086996|470471342|FG000|Overall Study|Other|6|||
130684136|NCT00086996|470471342|FG000|Overall Study|not eligible|5|||
130684137|NCT00004562|470471343|FG000|Overall Study|Lost to Follow-up|102|||
130684138|NCT00004562|470471344|FG001|Overall Study|Lost to Follow-up|91|||
130684139|NCT04274686|470471346|FG000|Overall Study|Physician Decision|1|||
130684140|NCT04274686|470471347|FG001|Overall Study|Physician Decision|0|||
130684141|NCT00376623|470471348|FG000|Overall Study|Progressive disease|35|||
130684142|NCT00376623|470471349|FG001|Overall Study|Progressive disease|22|||
130350118|NCT02361346|469251953|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130350119|NCT01163318|469251954|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
130684143|NCT00376623|470471350|FG002|Overall Study|Progressive disease|17|||
130684144|NCT00376623|470471348|FG000|Overall Study|Lost to Follow-up|0|||
130684145|NCT00376623|470471349|FG001|Overall Study|Lost to Follow-up|1|||
130684146|NCT00376623|470471350|FG002|Overall Study|Lost to Follow-up|0|||
130684147|NCT00376623|470471348|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
130684148|NCT00376623|470471349|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
130684149|NCT00376623|470471350|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
130684150|NCT00376623|470471348|FG000|Overall Study|Not treated with BI 2536|1|||
130684151|NCT00376623|470471349|FG001|Overall Study|Not treated with BI 2536|0|||
130684152|NCT00376623|470471350|FG002|Overall Study|Not treated with BI 2536|0|||
130684153|NCT00376623|470471348|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130684154|NCT00376623|470471349|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684155|NCT00376623|470471350|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684156|NCT00376623|470471348|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
130684157|NCT00376623|470471349|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130684158|NCT00376623|470471350|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130684159|NCT00376623|470471348|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
130350120|NCT01163318|469251954|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
130350121|NCT01163318|469251954|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
130350122|NCT01163318|469251954|FG000|Overall Study|Participants Without Case Report Form|7|||
130684160|NCT00376623|470471349|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684161|NCT00376623|470471350|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684162|NCT00376623|470471348|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130684163|NCT00376623|470471349|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
130684164|NCT00376623|470471350|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130684165|NCT00376623|470471348|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684166|NCT00376623|470471349|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684167|NCT00376623|470471350|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130684168|NCT00376623|470471348|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
130684169|NCT00376623|470471349|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
130684170|NCT00376623|470471350|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
130684171|NCT00376623|470471348|FG000|Overall Study|Increase of tumour markers|0|||
130684172|NCT00376623|470471349|FG001|Overall Study|Increase of tumour markers|1|||
130350123|NCT01163318|469251954|FG000|Overall Study|Multiple Reasons Per Participant|224|||
130684173|NCT00376623|470471350|FG002|Overall Study|Increase of tumour markers|0|||
130684174|NCT00376623|470471348|FG000|Overall Study|Bone metastasis|1|||
130684175|NCT00376623|470471349|FG001|Overall Study|Bone metastasis|0|||
130684176|NCT00376623|470471350|FG002|Overall Study|Bone metastasis|0|||
130684177|NCT00910663|470471355|FG000|Period 1|Withdrawal by Subject|0|||
130684178|NCT00910663|470471356|FG001|Period 1|Withdrawal by Subject|1|||
130684179|NCT02865850|470471357|FG000|Overall Study|Death|15|||
130684180|NCT02865850|470471358|FG001|Overall Study|Death|19|||
130684181|NCT02865850|470471357|FG000|Overall Study|Withdrawal by Subject|3|||
130684182|NCT02865850|470471358|FG001|Overall Study|Withdrawal by Subject|2|||
130684183|NCT02865850|470471357|FG000|Overall Study|Lost to Follow-up|3|||
130684184|NCT02865850|470471358|FG001|Overall Study|Lost to Follow-up|2|||
130684185|NCT01772537|470471360|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
130350124|NCT01006603|469251955|FG000|Overall Study|Withdrawal by Subject|17|||
130350125|NCT01006603|469251956|FG001|Overall Study|Withdrawal by Subject|19|||
130350126|NCT01006603|469251955|FG000|Overall Study|Lost to Follow-up|0|||
130350127|NCT01006603|469251956|FG001|Overall Study|Lost to Follow-up|1|||
130350128|NCT01006603|469251955|FG000|Overall Study|Safety reason|1|||
130350129|NCT01006603|469251956|FG001|Overall Study|Safety reason|1|||
130350130|NCT01006603|469251955|FG000|Overall Study|Protocol Violation|1|||
130350131|NCT01006603|469251956|FG001|Overall Study|Protocol Violation|3|||
130350132|NCT01006603|469251955|FG000|Overall Study|Incorrect enrolment|0|||
130350133|NCT01006603|469251956|FG001|Overall Study|Incorrect enrolment|2|||
130350134|NCT01006603|469251955|FG000|Overall Study|Adverse Event|15|||
130350135|NCT01006603|469251956|FG001|Overall Study|Adverse Event|7|||
130350136|NCT01006603|469251955|FG000|Overall Study|Death|1|||
130350137|NCT01006603|469251956|FG001|Overall Study|Death|1|||
130350138|NCT01006603|469251955|FG000|Overall Study|Study specific discontinuation criteria|33|||
130350139|NCT01006603|469251956|FG001|Overall Study|Study specific discontinuation criteria|34|||
130684186|NCT01772537|470471361|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
130684187|NCT01772537|470471362|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
130684188|NCT03195491|470471363|FG000|Overall Study|Study drug toxicity|25|||
130350140|NCT01006603|469251955|FG000|Overall Study|Other|3|||
130350141|NCT01006603|469251956|FG001|Overall Study|Other|7|||
130350142|NCT05772702|469251964|FG000|Overall Study|Adverse Event|1|||
130350143|NCT00884377|469253925|FG000|Overall Study|Withdrawal by Subject|1|||
130350144|NCT00884377|469253926|FG001|Overall Study|Withdrawal by Subject|0|||
130350145|NCT00884377|469253925|FG000|Overall Study|Could not confirm diagnosis|1|||
130350146|NCT00884377|469253926|FG001|Overall Study|Could not confirm diagnosis|0|||
130350147|NCT00884377|469253925|FG000|Overall Study|Physician Decision|0|||
130350148|NCT00884377|469253926|FG001|Overall Study|Physician Decision|1|||
130350149|NCT02003365|469253927|FG000|Overall Study|Lost to Follow-up|0|||
130350150|NCT02003365|469253928|FG001|Overall Study|Lost to Follow-up|0|||
130350151|NCT02003365|469253929|FG002|Overall Study|Lost to Follow-up|1|||
130350152|NCT00622739|469253930|FG000|Overall Study|Physician Decision|1|||
130350153|NCT00622739|469253931|FG001|Overall Study|Physician Decision|0|||
130350154|NCT00622739|469253930|FG000|Overall Study|Adverse Event|1|||
130350155|NCT00622739|469253931|FG001|Overall Study|Adverse Event|2|||
130350156|NCT00622739|469253930|FG000|Overall Study|Lack of Efficacy|0|||
130350157|NCT00622739|469253931|FG001|Overall Study|Lack of Efficacy|2|||
130350158|NCT00622739|469253930|FG000|Overall Study|Withdrawal by Subject|0|||
130350159|NCT00622739|469253931|FG001|Overall Study|Withdrawal by Subject|1|||
130350160|NCT00622739|469253930|FG000|Overall Study|Lost to Follow-up|0|||
130350161|NCT00622739|469253931|FG001|Overall Study|Lost to Follow-up|1|||
130350162|NCT03387150|469253932|FG000|Overall Study|Withdrawal by Subject|3|||
130350163|NCT03387150|469253933|FG001|Overall Study|Withdrawal by Subject|0|||
130350164|NCT03387150|469253934|FG002|Overall Study|Withdrawal by Subject|3|||
130350165|NCT03387150|469253935|FG003|Overall Study|Withdrawal by Subject|4|||
130350166|NCT03387150|469253936|FG004|Overall Study|Withdrawal by Subject|1|||
130350167|NCT03387150|469253937|FG005|Overall Study|Withdrawal by Subject|2|||
130350168|NCT03387150|469253938|FG006|Overall Study|Withdrawal by Subject|0|||
130350169|NCT03387150|469253932|FG000|Overall Study|Lost to Follow-up|3|||
130350170|NCT03387150|469253933|FG001|Overall Study|Lost to Follow-up|2|||
130350171|NCT03387150|469253934|FG002|Overall Study|Lost to Follow-up|2|||
130350172|NCT03387150|469253935|FG003|Overall Study|Lost to Follow-up|3|||
130350173|NCT03387150|469253936|FG004|Overall Study|Lost to Follow-up|3|||
130350174|NCT03387150|469253937|FG005|Overall Study|Lost to Follow-up|3|||
130350175|NCT03387150|469253938|FG006|Overall Study|Lost to Follow-up|0|||
130350176|NCT03387150|469253932|FG000|Overall Study|Participant unable to adhere to visit|0|||
130350177|NCT03387150|469253933|FG001|Overall Study|Participant unable to adhere to visit|1|||
130350178|NCT03387150|469253934|FG002|Overall Study|Participant unable to adhere to visit|0|||
130350179|NCT03387150|469253935|FG003|Overall Study|Participant unable to adhere to visit|0|||
130350180|NCT03387150|469253936|FG004|Overall Study|Participant unable to adhere to visit|2|||
130350181|NCT03387150|469253937|FG005|Overall Study|Participant unable to adhere to visit|2|||
130350182|NCT03387150|469253938|FG006|Overall Study|Participant unable to adhere to visit|0|||
130350183|NCT02448680|469253940|FG000|Overall Study|Physician Decision|1|||
130350184|NCT02448680|469253941|FG001|Overall Study|Physician Decision|1|||
130350185|NCT02448680|469253940|FG000|Overall Study|Withdrawal by Subject|0|||
130350186|NCT02448680|469253941|FG001|Overall Study|Withdrawal by Subject|2|||
130350187|NCT01857310|469253942|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
130350188|NCT01857310|469253943|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
130350189|NCT04761627|469253944|FG000|Run-in Period|Death|1|||
130350190|NCT04761627|469253945|FG001|Run-in Period|Death|0|||
130350191|NCT04761627|469253946|FG002|Run-in Period|Death|0|||
130350192|NCT04761627|469253944|FG000|Run-in Period|Required alternative therapy|2|||
130350193|NCT04761627|469253945|FG001|Run-in Period|Required alternative therapy|0|||
130350194|NCT04761627|469253946|FG002|Run-in Period|Required alternative therapy|0|||
130350195|NCT04761627|469253944|FG000|Run-in Period|Lost to Follow-up|2|||
130350196|NCT04761627|469253945|FG001|Run-in Period|Lost to Follow-up|0|||
130350197|NCT04761627|469253946|FG002|Run-in Period|Lost to Follow-up|0|||
130350198|NCT04761627|469253944|FG000|Run-in Period|Protocol Violation|3|||
130350199|NCT04761627|469253945|FG001|Run-in Period|Protocol Violation|0|||
130350200|NCT04761627|469253946|FG002|Run-in Period|Protocol Violation|0|||
130350201|NCT04761627|469253944|FG000|Run-in Period|Abnormal liver function|1|||
130350202|NCT04761627|469253945|FG001|Run-in Period|Abnormal liver function|0|||
130350203|NCT04761627|469253946|FG002|Run-in Period|Abnormal liver function|0|||
130350204|NCT04761627|469253944|FG000|Run-in Period|Adverse Event|6|||
130350205|NCT04761627|469253945|FG001|Run-in Period|Adverse Event|0|||
130350206|NCT04761627|469253946|FG002|Run-in Period|Adverse Event|0|||
130350207|NCT04761627|469253944|FG000|Run-in Period|Withdrawal by Subject|7|||
130350208|NCT04761627|469253945|FG001|Run-in Period|Withdrawal by Subject|0|||
130350209|NCT04761627|469253946|FG002|Run-in Period|Withdrawal by Subject|0|||
130350210|NCT04761627|469253944|FG000|Run-in Period|Did not meet PASI 50|15|||
130350211|NCT04761627|469253945|FG001|Run-in Period|Did not meet PASI 50|0|||
130350212|NCT04761627|469253946|FG002|Run-in Period|Did not meet PASI 50|0|||
130350213|NCT04761627|469253944|FG000|Run-in Period|Study site closure|2|||
130350214|NCT04761627|469253945|FG001|Run-in Period|Study site closure|0|||
130350215|NCT04761627|469253946|FG002|Run-in Period|Study site closure|0|||
130350216|NCT04761627|469253944|FG000|Run-in Period|Pregnancy|2|||
130350217|NCT04761627|469253945|FG001|Run-in Period|Pregnancy|0|||
130350218|NCT04761627|469253946|FG002|Run-in Period|Pregnancy|0|||
130350219|NCT04761627|469253944|FG000|Post-randomization Period|Military service|0|||
130350220|NCT04761627|469253945|FG001|Post-randomization Period|Military service|1|||
130350221|NCT04761627|469253946|FG002|Post-randomization Period|Military service|0|||
130350222|NCT04761627|469253944|FG000|Post-randomization Period|Adverse Event|0|||
130350223|NCT04761627|469253945|FG001|Post-randomization Period|Adverse Event|4|||
130684189|NCT03195491|470471364|FG001|Overall Study|Study drug toxicity|3|||
130684190|NCT03195491|470471363|FG000|Overall Study|Maximum clinical benefit|5|||
130684191|NCT03195491|470471364|FG001|Overall Study|Maximum clinical benefit|0|||
130684192|NCT03195491|470471363|FG000|Overall Study|Lost to Follow-up|1|||
130684193|NCT03195491|470471364|FG001|Overall Study|Lost to Follow-up|0|||
130684194|NCT03195491|470471363|FG000|Overall Study|Death|3|||
130684195|NCT03195491|470471364|FG001|Overall Study|Death|0|||
130684196|NCT03195491|470471363|FG000|Overall Study|Adverse event unrelated to study drug|19|||
130684197|NCT03195491|470471364|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130684198|NCT03195491|470471363|FG000|Overall Study|Disease progression|266|||
130684199|NCT03195491|470471364|FG001|Overall Study|Disease progression|8|||
130684200|NCT03195491|470471363|FG000|Overall Study|Other reasons|10|||
130684201|NCT03195491|470471364|FG001|Overall Study|Other reasons|0|||
130684202|NCT03195491|470471363|FG000|Overall Study|Participant withdrew consent|8|||
130684203|NCT03195491|470471364|FG001|Overall Study|Participant withdrew consent|1|||
130684204|NCT03195491|470471363|FG000|Overall Study|Participant no longer meets study criteria|0|||
130684205|NCT03195491|470471364|FG001|Overall Study|Participant no longer meets study criteria|1|||
130684206|NCT03195491|470471363|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130684207|NCT03195491|470471364|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130684208|NCT01263704|470471365|FG000|Overall Study|Progressive disease|18|||
130684209|NCT01263704|470471365|FG000|Overall Study|Adverse Event|3|||
130684210|NCT01263704|470471365|FG000|Overall Study|Death|2|||
130684211|NCT01263704|470471365|FG000|Overall Study|Patient withdrew consent|2|||
130684212|NCT01263704|470471365|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130684213|NCT01263704|470471365|FG000|Overall Study|Lost to Follow-up|1|||
130684214|NCT01263704|470471365|FG000|Overall Study|Colon metastases|1|||
130684215|NCT01263704|470471365|FG000|Overall Study|Principal Investigator (PI) decision|1|||
130684216|NCT00252720|470471367|FG000|Overall Study|Withdrawal by Subject|95|||
130684217|NCT00252720|470471368|FG001|Overall Study|Withdrawal by Subject|97|||
130684218|NCT00252720|470471367|FG000|Overall Study|Death|7|||
130684219|NCT00252720|470471368|FG001|Overall Study|Death|8|||
130684220|NCT00252720|470471367|FG000|Overall Study|Moving|23|||
130684221|NCT00252720|470471368|FG001|Overall Study|Moving|42|||
130684222|NCT00252720|470471367|FG000|Overall Study|Mainly patients lost to follow-up|7|||
130684223|NCT00252720|470471368|FG001|Overall Study|Mainly patients lost to follow-up|18|||
130684224|NCT01185821|470471379|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130684225|NCT01185821|470471380|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130684226|NCT01185821|470471381|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130684227|NCT01185821|470471382|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130684228|NCT01185821|470471383|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130684229|NCT01185821|470471379|FG000|Overall Study|Protocol Violation|0|||
130684230|NCT01185821|470471380|FG001|Overall Study|Protocol Violation|0|||
130684231|NCT01185821|470471381|FG002|Overall Study|Protocol Violation|0|||
130684232|NCT01185821|470471382|FG003|Overall Study|Protocol Violation|1|||
130684233|NCT01185821|470471383|FG004|Overall Study|Protocol Violation|1|||
130684234|NCT01185821|470471379|FG000|Overall Study|Abnormal test procedure result|0|||
130684235|NCT01185821|470471380|FG001|Overall Study|Abnormal test procedure result|0|||
130684236|NCT01185821|470471381|FG002|Overall Study|Abnormal test procedure result|0|||
130684237|NCT01185821|470471382|FG003|Overall Study|Abnormal test procedure result|0|||
130684238|NCT01185821|470471383|FG004|Overall Study|Abnormal test procedure result|1|||
130684239|NCT01185821|470471379|FG000|Overall Study|Death|0|||
130684240|NCT01185821|470471380|FG001|Overall Study|Death|1|||
130684241|NCT01185821|470471381|FG002|Overall Study|Death|0|||
130684242|NCT01185821|470471382|FG003|Overall Study|Death|0|||
130684243|NCT01185821|470471383|FG004|Overall Study|Death|0|||
130684244|NCT01185821|470471379|FG000|Overall Study|Condition no longer required study drug|0|||
130684245|NCT01185821|470471380|FG001|Overall Study|Condition no longer required study drug|0|||
130684246|NCT01185821|470471381|FG002|Overall Study|Condition no longer required study drug|0|||
130684247|NCT01185821|470471382|FG003|Overall Study|Condition no longer required study drug|0|||
130684248|NCT01185821|470471383|FG004|Overall Study|Condition no longer required study drug|1|||
130684249|NCT01185821|470471379|FG000|Overall Study|Adverse Event|2|||
130684250|NCT01185821|470471380|FG001|Overall Study|Adverse Event|3|||
130684251|NCT01185821|470471381|FG002|Overall Study|Adverse Event|1|||
130684252|NCT01185821|470471382|FG003|Overall Study|Adverse Event|2|||
130684253|NCT01185821|470471383|FG004|Overall Study|Adverse Event|5|||
130684254|NCT01185821|470471379|FG000|Overall Study|Lack of Efficacy|0|||
130684255|NCT01185821|470471380|FG001|Overall Study|Lack of Efficacy|0|||
130684256|NCT01185821|470471381|FG002|Overall Study|Lack of Efficacy|3|||
130684257|NCT01185821|470471382|FG003|Overall Study|Lack of Efficacy|0|||
130684258|NCT01185821|470471383|FG004|Overall Study|Lack of Efficacy|9|||
130684259|NCT01185821|470471379|FG000|Overall Study|Withdrawal by Subject|3|||
130684260|NCT01185821|470471380|FG001|Overall Study|Withdrawal by Subject|2|||
130684261|NCT01185821|470471381|FG002|Overall Study|Withdrawal by Subject|2|||
130684262|NCT01185821|470471382|FG003|Overall Study|Withdrawal by Subject|1|||
130684263|NCT01185821|470471383|FG004|Overall Study|Withdrawal by Subject|3|||
130684264|NCT01185821|470471379|FG000|Overall Study|Lost to Follow-up|1|||
130437945|NCT04524598|469566255|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
130437946|NCT04524598|469566256|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
130684265|NCT01185821|470471380|FG001|Overall Study|Lost to Follow-up|1|||
130684266|NCT01185821|470471381|FG002|Overall Study|Lost to Follow-up|2|||
130684267|NCT01185821|470471382|FG003|Overall Study|Lost to Follow-up|1|||
130684268|NCT01185821|470471383|FG004|Overall Study|Lost to Follow-up|2|||
130684269|NCT01185821|470471379|FG000|Overall Study|Administrative problems|0|||
130684270|NCT01185821|470471380|FG001|Overall Study|Administrative problems|0|||
130684271|NCT01185821|470471381|FG002|Overall Study|Administrative problems|1|||
130684272|NCT01185821|470471382|FG003|Overall Study|Administrative problems|1|||
130684273|NCT01185821|470471383|FG004|Overall Study|Administrative problems|2|||
130684274|NCT01546545|470471384|FG000|Overall Study|Withdrawal by Subject|1|||
130684275|NCT02979353|470471385|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
130684276|NCT02979353|470471386|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
130684277|NCT02979353|470471385|FG000|Overall Study|Withdrawal by Subject|16|||
130684278|NCT02979353|470471386|FG001|Overall Study|Withdrawal by Subject|12|||
130684279|NCT02979353|470471385|FG000|Overall Study|Death|10|||
130684280|NCT02979353|470471386|FG001|Overall Study|Death|11|||
130684281|NCT02979353|470471385|FG000|Overall Study|Transfer to Hospice Care|19|||
130684282|NCT02979353|470471386|FG001|Overall Study|Transfer to Hospice Care|14|||
130684283|NCT02979353|470471385|FG000|Overall Study|Lost to Follow-up|1|||
130684284|NCT02979353|470471386|FG001|Overall Study|Lost to Follow-up|5|||
130684285|NCT00550537|470471387|FG000|Overall Study|Death|18|||
130684286|NCT00550537|470471387|FG000|Overall Study|Adverse Event|20|||
130684287|NCT00550537|470471387|FG000|Overall Study|Disease progression before|46|||
130684288|NCT00550537|470471387|FG000|Overall Study|Withdrawal by Subject|7|||
130684289|NCT00550537|470471387|FG000|Overall Study|Change in treatment plan|4|||
130684290|NCT00550537|470471387|FG000|Overall Study|Other complicating ilness|3|||
130684291|NCT00550537|470471387|FG000|Overall Study|Declining performance status|2|||
130684292|NCT00550537|470471387|FG000|Overall Study|Treated closer to home|4|||
130684293|NCT00268905|470471388|FG000|Overall Study|Adverse Event|3|||
130684294|NCT00268905|470471389|FG001|Overall Study|Adverse Event|0|||
130684295|NCT00268905|470471390|FG002|Overall Study|Adverse Event|4|||
130684296|NCT00268905|470471388|FG000|Overall Study|Lost to Follow-up|0|||
130684297|NCT00268905|470471389|FG001|Overall Study|Lost to Follow-up|1|||
130684298|NCT00268905|470471390|FG002|Overall Study|Lost to Follow-up|0|||
130684299|NCT00268905|470471388|FG000|Overall Study|Withdrawal by Subject|0|||
130684300|NCT00268905|470471389|FG001|Overall Study|Withdrawal by Subject|0|||
130684301|NCT00268905|470471390|FG002|Overall Study|Withdrawal by Subject|3|||
130684302|NCT00268905|470471388|FG000|Overall Study|Progressive Disease|28|||
130684303|NCT00268905|470471389|FG001|Overall Study|Progressive Disease|4|||
130684304|NCT00268905|470471390|FG002|Overall Study|Progressive Disease|3|||
130684305|NCT00268905|470471388|FG000|Overall Study|Physician Decision|3|||
130684306|NCT00268905|470471389|FG001|Overall Study|Physician Decision|0|||
130684307|NCT00268905|470471390|FG002|Overall Study|Physician Decision|1|||
130684308|NCT00268905|470471388|FG000|Overall Study|Clinical Progression|9|||
130684309|NCT00268905|470471389|FG001|Overall Study|Clinical Progression|4|||
130684310|NCT00268905|470471390|FG002|Overall Study|Clinical Progression|1|||
130684311|NCT00617305|470471391|FG000|Overall Study|Adverse Event|4|||
130684312|NCT00617305|470471392|FG001|Overall Study|Adverse Event|0|||
130684313|NCT00617305|470471393|FG002|Overall Study|Adverse Event|0|||
130684314|NCT00617305|470471391|FG000|Overall Study|Death|1|||
130684315|NCT00617305|470471392|FG001|Overall Study|Death|0|||
130684316|NCT00617305|470471393|FG002|Overall Study|Death|0|||
130684317|NCT00617305|470471391|FG000|Overall Study|Physician Decision|1|||
130684318|NCT00617305|470471392|FG001|Overall Study|Physician Decision|0|||
130684319|NCT00617305|470471393|FG002|Overall Study|Physician Decision|0|||
130684320|NCT00617305|470471391|FG000|Overall Study|Protocol Violation|1|||
130684321|NCT00617305|470471392|FG001|Overall Study|Protocol Violation|0|||
130684322|NCT00617305|470471393|FG002|Overall Study|Protocol Violation|1|||
130684323|NCT00617305|470471391|FG000|Overall Study|Withdrawal by Subject|1|||
130684324|NCT00617305|470471392|FG001|Overall Study|Withdrawal by Subject|0|||
130684325|NCT00617305|470471393|FG002|Overall Study|Withdrawal by Subject|0|||
130437947|NCT04524598|469566257|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
130437948|NCT04524598|469566253|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
130684326|NCT04510285|470471394|FG000|Overall Study|Death|1|||
130684327|NCT01406795|470471395|FG000|Overall Study|Withdrawal by Subject|1|||
130684328|NCT03897088|470471396|FG000|Overall Study|Withdrawal by Subject|12|||
130684329|NCT03897088|470471397|FG001|Overall Study|Withdrawal by Subject|12|||
130437949|NCT04524598|469566254|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
130684330|NCT03897088|470471396|FG000|Overall Study|Lost to Follow-up|7|||
130684331|NCT03897088|470471397|FG001|Overall Study|Lost to Follow-up|15|||
130684332|NCT03897088|470471396|FG000|Overall Study|Sponsor Decision|1|||
130684333|NCT03897088|470471397|FG001|Overall Study|Sponsor Decision|2|||
130684334|NCT03897088|470471396|FG000|Overall Study|COVID-19|2|||
130684335|NCT03897088|470471397|FG001|Overall Study|COVID-19|0|||
130684336|NCT03897088|470471396|FG000|Overall Study|Other|3|||
130684337|NCT03897088|470471397|FG001|Overall Study|Other|0|||
130350224|NCT04761627|469253946|FG002|Post-randomization Period|Adverse Event|2|||
130350225|NCT04761627|469253944|FG000|Post-randomization Period|Lost to Follow-up|0|||
130350226|NCT04761627|469253945|FG001|Post-randomization Period|Lost to Follow-up|6|||
130350227|NCT04761627|469253946|FG002|Post-randomization Period|Lost to Follow-up|6|||
130350228|NCT04761627|469253944|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130350229|NCT04761627|469253945|FG001|Post-randomization Period|Withdrawal by Subject|7|||
130350230|NCT04761627|469253946|FG002|Post-randomization Period|Withdrawal by Subject|6|||
130350231|NCT04761627|469253944|FG000|Post-randomization Period|Pregnancy|0|||
130350232|NCT04761627|469253945|FG001|Post-randomization Period|Pregnancy|0|||
130350233|NCT04761627|469253946|FG002|Post-randomization Period|Pregnancy|1|||
130350234|NCT04761627|469253944|FG000|Post-randomization Period|Study site closure|0|||
130350235|NCT04761627|469253945|FG001|Post-randomization Period|Study site closure|0|||
130350236|NCT04761627|469253946|FG002|Post-randomization Period|Study site closure|1|||
130350237|NCT04761627|469253944|FG000|Post-randomization Period|Family planning|0|||
130350238|NCT04761627|469253945|FG001|Post-randomization Period|Family planning|1|||
130350239|NCT04761627|469253946|FG002|Post-randomization Period|Family planning|0|||
130350240|NCT01634178|469253949|FG000|Treatment Period 1|Adverse Event|0|||
130350241|NCT01634178|469253950|FG001|Treatment Period 1|Adverse Event|1|||
130350242|NCT01634178|469253949|FG000|Treatment Period 2|Adverse Event|1|||
130350243|NCT01634178|469253950|FG001|Treatment Period 2|Adverse Event|0|||
130350244|NCT05867342|469253951|FG000|Overall Study|Investigator Decision|3|||
130350245|NCT05867342|469253952|FG001|Overall Study|Investigator Decision|3|||
130350246|NCT00991952|469253954|FG000|Overall Study|Adverse Event|0|||
130350247|NCT00991952|469253955|FG001|Overall Study|Adverse Event|1|||
130350248|NCT00582816|469253956|FG000|Overall Study|Engraftment Failure|3|||
130350249|NCT01609478|469253959|FG000|Overall Study|Adverse Event|3|||
130350250|NCT01609478|469253960|FG001|Overall Study|Adverse Event|1|||
130350251|NCT01609478|469253961|FG002|Overall Study|Adverse Event|5|||
130350252|NCT01609478|469253959|FG000|Overall Study|Protocol Deviation|0|||
130350253|NCT01609478|469253960|FG001|Overall Study|Protocol Deviation|1|||
130350254|NCT01609478|469253961|FG002|Overall Study|Protocol Deviation|1|||
130350255|NCT01609478|469253959|FG000|Overall Study|Non-Compliance with study treatment|1|||
130350256|NCT01609478|469253960|FG001|Overall Study|Non-Compliance with study treatment|0|||
130437950|NCT04524598|469566255|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
130437951|NCT04524598|469566256|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
130437952|NCT04524598|469566257|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
130437953|NCT04524598|469566253|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437954|NCT04524598|469566254|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130684338|NCT03897088|470471396|FG000|Overall Study|Non-compliance with Study Drug|1|||
130684339|NCT03897088|470471397|FG001|Overall Study|Non-compliance with Study Drug|1|||
130684340|NCT03897088|470471396|FG000|Overall Study|Pregnancy|0|||
130684341|NCT03897088|470471397|FG001|Overall Study|Pregnancy|1|||
130684342|NCT00855738|470471398|FG000|Overall Study|Lost to Follow-up|2|||
130684343|NCT00855738|470471398|FG000|Overall Study|Adverse Event|1|||
130684344|NCT00855738|470471398|FG000|Overall Study|Subject Defaulted|1|||
130684345|NCT00855738|470471398|FG000|Overall Study|Death|1|||
130684346|NCT04384978|470471401|FG000|Overall Study|Withdrawal by Subject|4|||
130684347|NCT04384978|470471402|FG001|Overall Study|Withdrawal by Subject|0|||
130684348|NCT01811953|470472795|FG000|Overall Study|Adverse Event|0|||
130684349|NCT01811953|470472796|FG001|Overall Study|Adverse Event|0|||
130684350|NCT01811953|470472797|FG002|Overall Study|Adverse Event|0|||
130437955|NCT04524598|469566255|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
130437956|NCT04524598|469566256|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
130437957|NCT04524598|469566257|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437958|NCT04524598|469566253|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
130437959|NCT04524598|469566254|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
130437960|NCT04524598|469566255|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
130437961|NCT04524598|469566256|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
130437962|NCT04524598|469566257|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
130437963|NCT04524598|469566253|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437964|NCT04524598|469566254|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437965|NCT04524598|469566255|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437966|NCT04524598|469566256|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130437967|NCT04524598|469566257|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
130437968|NCT02301156|469566258|FG000|Overall Study|Adverse Event|13|||
130437969|NCT02301156|469566259|FG001|Overall Study|Adverse Event|14|||
130437970|NCT02301156|469566258|FG000|Overall Study|Death|1|||
130437971|NCT02301156|469566259|FG001|Overall Study|Death|5|||
130350257|NCT01609478|469253961|FG002|Overall Study|Non-Compliance with study treatment|0|||
130350258|NCT01609478|469253959|FG000|Overall Study|Physician Decision|1|||
130350259|NCT01609478|469253960|FG001|Overall Study|Physician Decision|0|||
130350260|NCT01609478|469253961|FG002|Overall Study|Physician Decision|1|||
130684351|NCT01811953|470472798|FG003|Overall Study|Adverse Event|1|||
130684352|NCT01811953|470472799|FG004|Overall Study|Adverse Event|0|||
130684353|NCT01811953|470472800|FG005|Overall Study|Adverse Event|1|||
130684354|NCT01811953|470472795|FG000|Overall Study|Protocol Violation|0|||
130684355|NCT01811953|470472796|FG001|Overall Study|Protocol Violation|0|||
130684356|NCT01811953|470472797|FG002|Overall Study|Protocol Violation|0|||
130684357|NCT01811953|470472798|FG003|Overall Study|Protocol Violation|0|||
130684358|NCT01811953|470472799|FG004|Overall Study|Protocol Violation|1|||
130684359|NCT01811953|470472800|FG005|Overall Study|Protocol Violation|0|||
130684360|NCT02262377|470472802|FG000|Overall Study|Lost to Follow-up|5|||
130684361|NCT02262377|470472803|FG001|Overall Study|Lost to Follow-up|6|||
130684362|NCT02262377|470472802|FG000|Overall Study|Found ineligible after enrollment|3|||
130684363|NCT02262377|470472803|FG001|Overall Study|Found ineligible after enrollment|0|||
130684364|NCT02262377|470472802|FG000|Overall Study|Withdrawal by Subject|4|||
130684365|NCT02262377|470472803|FG001|Overall Study|Withdrawal by Subject|0|||
130684366|NCT00371839|470472805|FG000|Overall Study|Death|4|||
130684367|NCT00371839|470472806|FG001|Overall Study|Death|0|||
130684368|NCT00371839|470472807|FG002|Overall Study|Death|0|||
130684369|NCT00371839|470472805|FG000|Overall Study|Withdrawal by Subject|7|||
130684370|NCT00371839|470472806|FG001|Overall Study|Withdrawal by Subject|4|||
130684371|NCT00371839|470472807|FG002|Overall Study|Withdrawal by Subject|0|||
130684372|NCT00371839|470472805|FG000|Overall Study|Lost to Follow-up|6|||
130684373|NCT00371839|470472806|FG001|Overall Study|Lost to Follow-up|3|||
130684374|NCT00371839|470472807|FG002|Overall Study|Lost to Follow-up|2|||
130684375|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684376|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684377|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
130684378|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684379|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684380|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
130437972|NCT02301156|469566258|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
130437973|NCT02301156|469566259|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
130437974|NCT02301156|469566258|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
130437975|NCT02301156|469566259|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
130437976|NCT02301156|469566258|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
130437977|NCT02301156|469566259|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
130437978|NCT02301156|469566258|FG000|Overall Study|Reason not Specified|6|||
130437979|NCT02301156|469566259|FG001|Overall Study|Reason not Specified|3|||
130437980|NCT02638623|469566261|FG000|Overall Study|Surgery timing|5|||
130437981|NCT02638623|469566262|FG001|Overall Study|Surgery timing|6|||
130437982|NCT02638623|469566261|FG000|Overall Study|Not given intervention|2|||
130437983|NCT02638623|469566262|FG001|Overall Study|Not given intervention|0|||
130437984|NCT04152343|469566263|FG000|Overall Study|Transplanted|5|||
130437985|NCT04152343|469566263|FG000|Overall Study|Death|20|||
130437986|NCT04152343|469566263|FG000|Overall Study|Lost to Follow-up|3|||
130437987|NCT01965938|469566268|FG000|Overall Study|Withdrawal by Subject|1|||
130437988|NCT01965938|469566269|FG001|Overall Study|Withdrawal by Subject|0|||
130437989|NCT02090634|469566270|FG000|Overall Study|Lost to Follow-up|0|||
130437990|NCT02090634|469566271|FG001|Overall Study|Lost to Follow-up|1|||
130437991|NCT02090634|469566270|FG000|Overall Study|Death|0|||
130437992|NCT02090634|469566271|FG001|Overall Study|Death|1|||
130437993|NCT02090634|469566270|FG000|Overall Study|Protocol Violation|3|||
130437994|NCT02090634|469566271|FG001|Overall Study|Protocol Violation|1|||
130437995|NCT02090634|469566270|FG000|Overall Study|Adverse Event|2|||
130437996|NCT02090634|469566271|FG001|Overall Study|Adverse Event|0|||
130437997|NCT01164228|469566272|FG000|Overall Study|Progression|24|||
130437998|NCT01164228|469566273|FG001|Overall Study|Progression|25|||
130437999|NCT01164228|469566272|FG000|Overall Study|Adverse Event|13|||
130438000|NCT01164228|469566273|FG001|Overall Study|Adverse Event|7|||
130438001|NCT01164228|469566272|FG000|Overall Study|Death|1|||
130438002|NCT01164228|469566273|FG001|Overall Study|Death|1|||
130438003|NCT01164228|469566272|FG000|Overall Study|Withdrawal by Subject|2|||
130438004|NCT01164228|469566273|FG001|Overall Study|Withdrawal by Subject|0|||
130438005|NCT01164228|469566272|FG000|Overall Study|Physician Decision|1|||
130684381|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684382|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
130684383|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684384|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684385|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684386|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130438006|NCT01164228|469566273|FG001|Overall Study|Physician Decision|2|||
130438007|NCT01164228|469566272|FG000|Overall Study|Symptomatic deterioration|1|||
130438008|NCT01164228|469566273|FG001|Overall Study|Symptomatic deterioration|0|||
130684387|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684388|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684389|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684390|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684391|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
130684392|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684393|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684394|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684395|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684396|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684397|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684398|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
130684399|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684400|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684401|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684402|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684403|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
130684404|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130438009|NCT01164228|469566272|FG000|Overall Study|Never started treatment|1|||
130438010|NCT01164228|469566273|FG001|Overall Study|Never started treatment|3|||
130438011|NCT01164228|469566272|FG000|Overall Study|Ineligible|1|||
130438012|NCT01164228|469566273|FG001|Overall Study|Ineligible|0|||
130438013|NCT03757234|469566274|FG000|Overall Study|Adverse Event|0|||
130438014|NCT03757234|469566275|FG001|Overall Study|Adverse Event|0|||
130438015|NCT03757234|469566276|FG002|Overall Study|Adverse Event|0|||
130438016|NCT03757234|469566277|FG003|Overall Study|Adverse Event|0|||
130438017|NCT03757234|469566278|FG004|Overall Study|Adverse Event|1|||
130438018|NCT03757234|469566274|FG000|Overall Study|Lost to Follow-up|1|||
130438019|NCT03757234|469566275|FG001|Overall Study|Lost to Follow-up|0|||
130438020|NCT03757234|469566276|FG002|Overall Study|Lost to Follow-up|0|||
130438021|NCT03757234|469566277|FG003|Overall Study|Lost to Follow-up|0|||
130438022|NCT03757234|469566278|FG004|Overall Study|Lost to Follow-up|1|||
130438023|NCT03757234|469566274|FG000|Overall Study|Withdrawal by Subject|1|||
130438024|NCT03757234|469566275|FG001|Overall Study|Withdrawal by Subject|1|||
130438025|NCT03757234|469566276|FG002|Overall Study|Withdrawal by Subject|0|||
130438026|NCT03757234|469566277|FG003|Overall Study|Withdrawal by Subject|1|||
130438027|NCT03757234|469566278|FG004|Overall Study|Withdrawal by Subject|2|||
130438028|NCT03757234|469566274|FG000|Overall Study|Other|1|||
130438029|NCT03757234|469566275|FG001|Overall Study|Other|1|||
130438030|NCT03757234|469566276|FG002|Overall Study|Other|0|||
130438031|NCT03757234|469566277|FG003|Overall Study|Other|0|||
130438032|NCT03757234|469566278|FG004|Overall Study|Other|0|||
130438033|NCT00886639|469566281|FG000|Overall Study|acute exacerbation|14|||
130438034|NCT00886639|469566281|FG000|Overall Study|non-compliance|2|||
130438035|NCT01871558|469566282|FG000|Overall Study|Other reason|0|||
130438036|NCT01871558|469566283|FG001|Overall Study|Other reason|1|||
130438037|NCT01871558|469566282|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
130438038|NCT01871558|469566283|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
130438039|NCT01871558|469566282|FG000|Overall Study|Withdrawal by Subject|2|||
130438040|NCT01871558|469566283|FG001|Overall Study|Withdrawal by Subject|0|||
130438041|NCT03203694|469566284|FG000|Overall Study|Withdrawal by Subject|2|||
130438042|NCT03203694|469566285|FG001|Overall Study|Withdrawal by Subject|0|||
130438043|NCT03203694|469566286|FG002|Overall Study|Withdrawal by Subject|0|||
130438044|NCT03203694|469566287|FG003|Overall Study|Withdrawal by Subject|0|||
130438045|NCT03203694|469566288|FG004|Overall Study|Withdrawal by Subject|0|||
130438046|NCT03203694|469566289|FG005|Overall Study|Withdrawal by Subject|0|||
130438047|NCT01103960|469566295|FG000|Overall Study|Adverse Event|2|||
130438048|NCT01103960|469566296|FG001|Overall Study|Adverse Event|1|||
130438049|NCT01103960|469566295|FG000|Overall Study|Withdrawal by Subject|2|||
130438050|NCT01103960|469566296|FG001|Overall Study|Withdrawal by Subject|1|||
130438051|NCT01103960|469566295|FG000|Overall Study|Other|1|||
130438052|NCT01103960|469566296|FG001|Overall Study|Other|0|||
130438053|NCT04287868|469566303|FG000|Overall Study|Screening fail|1|||
130438054|NCT04287868|469566304|FG001|Overall Study|Screening fail|0|||
130438055|NCT01167179|469568187|FG000|Overall Study|disease recurrence|4|||
130438056|NCT01167179|469568188|FG001|Overall Study|disease recurrence|4|||
130438057|NCT01167179|469568187|FG000|Overall Study|Death|4|||
130438058|NCT01167179|469568188|FG001|Overall Study|Death|10|||
130438059|NCT01167179|469568187|FG000|Overall Study|Withdrawal by Subject|1|||
130438060|NCT01167179|469568188|FG001|Overall Study|Withdrawal by Subject|2|||
130438061|NCT01167179|469568187|FG000|Overall Study|diverse|6|||
130438062|NCT01167179|469568188|FG001|Overall Study|diverse|5|||
130438063|NCT02781506|469568189|FG000|Overall Study|Adverse Event|5|||
130438064|NCT01158378|469568190|FG000|Overall Study|Death|4|||
130438065|NCT01158378|469568191|FG001|Overall Study|Death|5|||
130438066|NCT01158378|469568190|FG000|Overall Study|Lost to Follow-up|2|||
130438067|NCT01158378|469568191|FG001|Overall Study|Lost to Follow-up|4|||
130350261|NCT01609478|469253959|FG000|Overall Study|Withdrawal by Subject|2|||
130350262|NCT01609478|469253960|FG001|Overall Study|Withdrawal by Subject|0|||
130350263|NCT01609478|469253961|FG002|Overall Study|Withdrawal by Subject|2|||
130350264|NCT04966741|469253962|FG000|Overall Study|Lost to Follow-up|1|||
130350265|NCT04966741|469253963|FG001|Overall Study|Lost to Follow-up|0|||
130350266|NCT02953509|469253971|FG000|Overall Study|Death|1|||
130350267|NCT02953509|469253972|FG001|Overall Study|Death|3|||
130350268|NCT02953509|469253973|FG002|Overall Study|Death|3|||
130350269|NCT02953509|469253974|FG003|Overall Study|Death|4|||
130350270|NCT02953509|469253975|FG004|Overall Study|Death|12|||
130350271|NCT02953509|469253976|FG005|Overall Study|Death|3|||
130350272|NCT02953509|469253977|FG006|Overall Study|Death|25|||
130350273|NCT02953509|469253978|FG007|Overall Study|Death|10|||
130350274|NCT02953509|469253979|FG008|Overall Study|Death|21|||
130350275|NCT02953509|469253980|FG009|Overall Study|Death|20|||
130350276|NCT02953509|469253971|FG000|Overall Study|Reason Not Specified|0|||
130350277|NCT02953509|469253972|FG001|Overall Study|Reason Not Specified|2|||
130350278|NCT02953509|469253973|FG002|Overall Study|Reason Not Specified|8|||
130350279|NCT02953509|469253974|FG003|Overall Study|Reason Not Specified|2|||
130350280|NCT02953509|469253975|FG004|Overall Study|Reason Not Specified|11|||
130350281|NCT02953509|469253976|FG005|Overall Study|Reason Not Specified|4|||
130350282|NCT02953509|469253977|FG006|Overall Study|Reason Not Specified|12|||
130438068|NCT01158378|469568190|FG000|Overall Study|Withdrawal by Subject|4|||
130438069|NCT01158378|469568191|FG001|Overall Study|Withdrawal by Subject|0|||
130438070|NCT03017235|469568192|FG000|Overall Study|Withdrawal by Subject|4|||
130438071|NCT03017235|469568193|FG001|Overall Study|Withdrawal by Subject|3|||
130438072|NCT03017235|469568192|FG000|Overall Study|Lost to Follow-up|2|||
130438073|NCT03017235|469568193|FG001|Overall Study|Lost to Follow-up|7|||
130438074|NCT03017235|469568192|FG000|Overall Study|Adverse Event|0|||
130438075|NCT03017235|469568193|FG001|Overall Study|Adverse Event|1|||
130438076|NCT03017235|469568192|FG000|Overall Study|Protocol Violation|2|||
130438077|NCT03017235|469568193|FG001|Overall Study|Protocol Violation|1|||
130438078|NCT03017235|469568192|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
130438079|NCT03017235|469568193|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
130438080|NCT02105636|469568201|FG000|Pre-Treatment|Disease Progression|1|||
130438081|NCT02105636|469568202|FG001|Pre-Treatment|Disease Progression|0|||
130438082|NCT02105636|469568201|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
130438083|NCT02105636|469568202|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
130438084|NCT02105636|469568201|FG000|Pre-Treatment|Participant withdrew consent|0|||
130438085|NCT02105636|469568202|FG001|Pre-Treatment|Participant withdrew consent|6|||
130438086|NCT02105636|469568201|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130438087|NCT02105636|469568202|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
130438088|NCT02105636|469568201|FG000|Treatment|Study Drug Toxicity|14|||
130438089|NCT02105636|469568202|FG001|Treatment|Study Drug Toxicity|10|||
130438090|NCT02105636|469568201|FG000|Treatment|Adverse event unrelated to study drug|19|||
130684405|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
130684406|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130438091|NCT02105636|469568202|FG001|Treatment|Adverse event unrelated to study drug|3|||
130438092|NCT02105636|469568201|FG000|Treatment|Participant request to discontinue study treatment|8|||
130438093|NCT02105636|469568202|FG001|Treatment|Participant request to discontinue study treatment|6|||
130438094|NCT02105636|469568201|FG000|Treatment|Participant withdrew consent|5|||
130438095|NCT02105636|469568202|FG001|Treatment|Participant withdrew consent|1|||
130438096|NCT02105636|469568201|FG000|Treatment|Lost to Follow-up|1|||
130438097|NCT02105636|469568202|FG001|Treatment|Lost to Follow-up|0|||
130438098|NCT02105636|469568201|FG000|Treatment|Maximum Clinical Benefit|1|||
130438099|NCT02105636|469568202|FG001|Treatment|Maximum Clinical Benefit|3|||
130438100|NCT02105636|469568201|FG000|Treatment|Poor/Non-compliance|0|||
130438101|NCT02105636|469568202|FG001|Treatment|Poor/Non-compliance|1|||
130438102|NCT02105636|469568201|FG000|Treatment|Participant no longer meets study criteria|1|||
130438103|NCT02105636|469568202|FG001|Treatment|Participant no longer meets study criteria|0|||
130438104|NCT02105636|469568201|FG000|Treatment|Other reasons|1|||
130438105|NCT02105636|469568202|FG001|Treatment|Other reasons|0|||
130438106|NCT02105636|469568201|FG000|Treatment|Disease Progression|185|||
130438107|NCT02105636|469568202|FG001|Treatment|Disease Progression|87|||
130438108|NCT00235443|469568204|FG000|Overall Study|Adverse Event|4|||
130438109|NCT00235443|469568205|FG001|Overall Study|Adverse Event|12|||
130438110|NCT00235443|469568206|FG002|Overall Study|Adverse Event|17|||
130350283|NCT02953509|469253978|FG007|Overall Study|Reason Not Specified|2|||
130350284|NCT02953509|469253979|FG008|Overall Study|Reason Not Specified|7|||
130350285|NCT02953509|469253980|FG009|Overall Study|Reason Not Specified|2|||
130350286|NCT02953509|469253971|FG000|Overall Study|Consent Withdrawn|1|||
130350287|NCT02953509|469253972|FG001|Overall Study|Consent Withdrawn|1|||
130350288|NCT02953509|469253973|FG002|Overall Study|Consent Withdrawn|2|||
130350289|NCT02953509|469253974|FG003|Overall Study|Consent Withdrawn|1|||
130350290|NCT02953509|469253975|FG004|Overall Study|Consent Withdrawn|3|||
130438111|NCT00235443|469568207|FG003|Overall Study|Adverse Event|44|||
130350291|NCT02953509|469253976|FG005|Overall Study|Consent Withdrawn|0|||
130350292|NCT02953509|469253977|FG006|Overall Study|Consent Withdrawn|4|||
130350293|NCT02953509|469253978|FG007|Overall Study|Consent Withdrawn|1|||
130350294|NCT02953509|469253979|FG008|Overall Study|Consent Withdrawn|1|||
130350295|NCT02953509|469253980|FG009|Overall Study|Consent Withdrawn|4|||
130350296|NCT02953509|469253971|FG000|Overall Study|Lost to Follow-up|0|||
130350297|NCT02953509|469253972|FG001|Overall Study|Lost to Follow-up|0|||
130350298|NCT02953509|469253973|FG002|Overall Study|Lost to Follow-up|0|||
130350299|NCT02953509|469253974|FG003|Overall Study|Lost to Follow-up|0|||
130350300|NCT02953509|469253975|FG004|Overall Study|Lost to Follow-up|0|||
130350301|NCT02953509|469253976|FG005|Overall Study|Lost to Follow-up|0|||
130350302|NCT02953509|469253977|FG006|Overall Study|Lost to Follow-up|1|||
130438112|NCT00235443|469568208|FG004|Overall Study|Adverse Event|10|||
130720848|NCT04126213|470601545|FG000|Overall Study|Withdrawal by Subject|3|||
130350303|NCT02953509|469253978|FG007|Overall Study|Lost to Follow-up|1|||
130350304|NCT02953509|469253979|FG008|Overall Study|Lost to Follow-up|1|||
130350305|NCT02953509|469253980|FG009|Overall Study|Lost to Follow-up|1|||
130350306|NCT02953509|469253971|FG000|Overall Study|Study terminated by sponsor|1|||
130350307|NCT02953509|469253972|FG001|Overall Study|Study terminated by sponsor|0|||
130350308|NCT02953509|469253973|FG002|Overall Study|Study terminated by sponsor|0|||
130350309|NCT02953509|469253974|FG003|Overall Study|Study terminated by sponsor|0|||
130350310|NCT02953509|469253975|FG004|Overall Study|Study terminated by sponsor|0|||
130350311|NCT02953509|469253976|FG005|Overall Study|Study terminated by sponsor|0|||
130350312|NCT02953509|469253977|FG006|Overall Study|Study terminated by sponsor|1|||
130350313|NCT02953509|469253978|FG007|Overall Study|Study terminated by sponsor|0|||
130350314|NCT02953509|469253979|FG008|Overall Study|Study terminated by sponsor|1|||
130350315|NCT02953509|469253980|FG009|Overall Study|Study terminated by sponsor|1|||
130350316|NCT02522871|469253981|FG000|Overall Study|Protocol Violation|1|||
130350317|NCT02522871|469253982|FG001|Overall Study|Protocol Violation|4|||
130350318|NCT02522871|469253981|FG000|Overall Study|Treated without randomization|1|||
130350319|NCT02522871|469253982|FG001|Overall Study|Treated without randomization|0|||
130350320|NCT02522871|469253981|FG000|Overall Study|Death|9|||
130350321|NCT02522871|469253982|FG001|Overall Study|Death|9|||
130350322|NCT02522871|469253981|FG000|Overall Study|Died in operating room prior to transplant|0|||
130350323|NCT02522871|469253982|FG001|Overall Study|Died in operating room prior to transplant|1|||
130350324|NCT00725842|469253983|FG000|Overall Study|Lost to Follow-up|19|||
130350325|NCT00725842|469253983|FG000|Overall Study|Death|1|||
130350326|NCT00725842|469253983|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
130350327|NCT00725842|469253983|FG000|Overall Study|Consent date prior to study start date|5|||
130350328|NCT00725842|469253983|FG000|Overall Study|Inclusion criterion not met|1|||
130350329|NCT00725842|469253983|FG000|Overall Study|No Visit 1 data|1|||
130350330|NCT01715129|469253984|FG000|Overall Study|Adverse Event, fatal|1|||
130350331|NCT01715129|469253984|FG000|Overall Study|Lack of Efficacy|3|||
130350332|NCT01715129|469253984|FG000|Overall Study|Protocol Violation|1|||
130350333|NCT01715129|469253984|FG000|Overall Study|Consent Withdrawn|2|||
130350334|NCT01715129|469253984|FG000|Overall Study|Lost to Follow-up|1|||
130350335|NCT01715129|469253984|FG000|Overall Study|Other|1|||
130350336|NCT02793622|469253985|FG000|Overall Study|Lost to Follow-up|31|||
130350337|NCT02793622|469253986|FG001|Overall Study|Lost to Follow-up|19|||
130350338|NCT02793622|469253985|FG000|Overall Study|Withdrawal by Subject|21|||
130350339|NCT02793622|469253986|FG001|Overall Study|Withdrawal by Subject|17|||
130350340|NCT02793622|469253985|FG000|Overall Study|Adverse Event|0|||
130438113|NCT00235443|469568209|FG005|Overall Study|Adverse Event|15|||
130350341|NCT02793622|469253986|FG001|Overall Study|Adverse Event|1|||
130350342|NCT02793622|469253985|FG000|Overall Study|Protocol Violation|1|||
130350343|NCT02793622|469253986|FG001|Overall Study|Protocol Violation|5|||
130350344|NCT00722371|469253987|FG000|Overall Study|Adverse Event|6|||
130350345|NCT00722371|469253988|FG001|Overall Study|Adverse Event|13|||
130350346|NCT00722371|469253989|FG002|Overall Study|Adverse Event|9|||
130350347|NCT00722371|469253990|FG003|Overall Study|Adverse Event|10|||
130350348|NCT00722371|469253991|FG004|Overall Study|Adverse Event|6|||
130350349|NCT00722371|469253992|FG005|Overall Study|Adverse Event|8|||
130350350|NCT00722371|469253993|FG006|Overall Study|Adverse Event|4|||
130350351|NCT00722371|469253987|FG000|Overall Study|Contraindication|0|||
130350352|NCT00722371|469253988|FG001|Overall Study|Contraindication|0|||
130350353|NCT00722371|469253989|FG002|Overall Study|Contraindication|1|||
130350354|NCT00722371|469253990|FG003|Overall Study|Contraindication|0|||
130350355|NCT00722371|469253991|FG004|Overall Study|Contraindication|0|||
130350356|NCT00722371|469253992|FG005|Overall Study|Contraindication|0|||
130350357|NCT00722371|469253993|FG006|Overall Study|Contraindication|0|||
130350358|NCT00722371|469253987|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
130350359|NCT00722371|469253988|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
130350360|NCT00722371|469253989|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
130350361|NCT00722371|469253990|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
130350362|NCT00722371|469253991|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
130350363|NCT00722371|469253992|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
130350364|NCT00722371|469253993|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
130350365|NCT00722371|469253987|FG000|Overall Study|Excluded medication|0|||
130438114|NCT00235443|469568204|FG000|Overall Study|Lack of Efficacy|0|||
130438115|NCT00235443|469568205|FG001|Overall Study|Lack of Efficacy|1|||
130438116|NCT00235443|469568206|FG002|Overall Study|Lack of Efficacy|5|||
130438117|NCT00235443|469568207|FG003|Overall Study|Lack of Efficacy|12|||
130438118|NCT00235443|469568208|FG004|Overall Study|Lack of Efficacy|2|||
130438119|NCT00235443|469568209|FG005|Overall Study|Lack of Efficacy|9|||
130438120|NCT00235443|469568204|FG000|Overall Study|Withdrawal by Subject|3|||
130438121|NCT00235443|469568205|FG001|Overall Study|Withdrawal by Subject|9|||
130438122|NCT00235443|469568206|FG002|Overall Study|Withdrawal by Subject|25|||
130438123|NCT00235443|469568207|FG003|Overall Study|Withdrawal by Subject|24|||
130438124|NCT00235443|469568208|FG004|Overall Study|Withdrawal by Subject|10|||
130438125|NCT00235443|469568209|FG005|Overall Study|Withdrawal by Subject|12|||
130438126|NCT00235443|469568204|FG000|Overall Study|Lost to Follow-up|0|||
130438127|NCT00235443|469568205|FG001|Overall Study|Lost to Follow-up|8|||
130438128|NCT00235443|469568206|FG002|Overall Study|Lost to Follow-up|6|||
130438129|NCT00235443|469568207|FG003|Overall Study|Lost to Follow-up|6|||
130438130|NCT00235443|469568208|FG004|Overall Study|Lost to Follow-up|4|||
130438131|NCT00235443|469568209|FG005|Overall Study|Lost to Follow-up|3|||
130438132|NCT00235443|469568204|FG000|Overall Study|Unsatisfactory compliance|0|||
130438133|NCT00235443|469568205|FG001|Overall Study|Unsatisfactory compliance|2|||
130438134|NCT00235443|469568206|FG002|Overall Study|Unsatisfactory compliance|3|||
130438135|NCT00235443|469568207|FG003|Overall Study|Unsatisfactory compliance|4|||
130438136|NCT00235443|469568208|FG004|Overall Study|Unsatisfactory compliance|1|||
130438137|NCT00235443|469568209|FG005|Overall Study|Unsatisfactory compliance|0|||
130438138|NCT00235443|469568204|FG000|Overall Study|Other reasons for premature termination|1|||
130438139|NCT00235443|469568205|FG001|Overall Study|Other reasons for premature termination|6|||
130438140|NCT00235443|469568206|FG002|Overall Study|Other reasons for premature termination|6|||
130438141|NCT00235443|469568207|FG003|Overall Study|Other reasons for premature termination|7|||
130438142|NCT00235443|469568208|FG004|Overall Study|Other reasons for premature termination|3|||
130438143|NCT00235443|469568209|FG005|Overall Study|Other reasons for premature termination|6|||
130438144|NCT03029247|469568210|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
130438145|NCT03029247|469568211|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
130438146|NCT03029247|469568210|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
130438147|NCT03029247|469568211|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
130438148|NCT03029247|469568210|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
130438149|NCT03029247|469568211|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
130438150|NCT03029247|469568210|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
130438151|NCT03029247|469568211|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
130438152|NCT01976364|469568214|FG000|Main Study (36 Months)|Adverse Event|63|||
130438153|NCT01976364|469568215|FG001|Main Study (36 Months)|Adverse Event|0|||
130438154|NCT01976364|469568216|FG002|Main Study (36 Months)|Adverse Event|0|||
130438155|NCT01976364|469568214|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
130438156|NCT01976364|469568215|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
130438157|NCT01976364|469568216|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
130438158|NCT01976364|469568214|FG000|Main Study (36 Months)|Other|13|||
130438159|NCT01976364|469568215|FG001|Main Study (36 Months)|Other|0|||
130438160|NCT01976364|469568216|FG002|Main Study (36 Months)|Other|0|||
130438161|NCT01976364|469568214|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
130438162|NCT01976364|469568215|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
130438163|NCT01976364|469568216|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
130438164|NCT01976364|469568214|FG000|Main Study (36 Months)|Medication error|1|||
130438165|NCT01976364|469568215|FG001|Main Study (36 Months)|Medication error|0|||
130438166|NCT01976364|469568216|FG002|Main Study (36 Months)|Medication error|0|||
130438167|NCT01976364|469568214|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
130438168|NCT01976364|469568215|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
130438169|NCT01976364|469568216|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
130438170|NCT01976364|469568214|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
130438171|NCT01976364|469568215|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
130438172|NCT01976364|469568216|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
130438173|NCT01976364|469568214|FG000|Main Study (36 Months)|Protocol Violation|13|||
130438174|NCT01976364|469568215|FG001|Main Study (36 Months)|Protocol Violation|0|||
130438175|NCT01976364|469568216|FG002|Main Study (36 Months)|Protocol Violation|0|||
130438176|NCT01976364|469568214|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
130438177|NCT01976364|469568215|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
130438178|NCT01976364|469568216|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
130438179|NCT01976364|469568214|FG000|Main Study (36 Months)|Death|5|||
130438180|NCT01976364|469568215|FG001|Main Study (36 Months)|Death|0|||
130684407|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130684408|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130684409|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130438181|NCT01976364|469568216|FG002|Main Study (36 Months)|Death|0|||
130438182|NCT01976364|469568214|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
130350366|NCT00722371|469253988|FG001|Overall Study|Excluded medication|1|||
130350367|NCT00722371|469253989|FG002|Overall Study|Excluded medication|1|||
130350368|NCT00722371|469253990|FG003|Overall Study|Excluded medication|0|||
130350369|NCT00722371|469253991|FG004|Overall Study|Excluded medication|0|||
130350370|NCT00722371|469253992|FG005|Overall Study|Excluded medication|0|||
130350371|NCT00722371|469253993|FG006|Overall Study|Excluded medication|1|||
130350372|NCT00722371|469253987|FG000|Overall Study|Hyperglycemia|2|||
130350373|NCT00722371|469253988|FG001|Overall Study|Hyperglycemia|6|||
130350374|NCT00722371|469253989|FG002|Overall Study|Hyperglycemia|4|||
130350375|NCT00722371|469253990|FG003|Overall Study|Hyperglycemia|2|||
130350376|NCT00722371|469253991|FG004|Overall Study|Hyperglycemia|5|||
130350377|NCT00722371|469253992|FG005|Overall Study|Hyperglycemia|1|||
130350378|NCT00722371|469253993|FG006|Overall Study|Hyperglycemia|1|||
130350379|NCT00722371|469253987|FG000|Overall Study|Hypoglycemia|1|||
130350380|NCT00722371|469253988|FG001|Overall Study|Hypoglycemia|0|||
130350381|NCT00722371|469253989|FG002|Overall Study|Hypoglycemia|0|||
130350382|NCT00722371|469253990|FG003|Overall Study|Hypoglycemia|0|||
130350383|NCT00722371|469253991|FG004|Overall Study|Hypoglycemia|0|||
130350384|NCT00722371|469253992|FG005|Overall Study|Hypoglycemia|0|||
130350385|NCT00722371|469253993|FG006|Overall Study|Hypoglycemia|0|||
130350386|NCT00722371|469253987|FG000|Overall Study|Lack of Efficacy|4|||
130350387|NCT00722371|469253988|FG001|Overall Study|Lack of Efficacy|6|||
130350388|NCT00722371|469253989|FG002|Overall Study|Lack of Efficacy|6|||
130350389|NCT00722371|469253990|FG003|Overall Study|Lack of Efficacy|6|||
130350390|NCT00722371|469253991|FG004|Overall Study|Lack of Efficacy|2|||
130350391|NCT00722371|469253992|FG005|Overall Study|Lack of Efficacy|3|||
130350392|NCT00722371|469253993|FG006|Overall Study|Lack of Efficacy|0|||
130350393|NCT00722371|469253987|FG000|Overall Study|Lost to Follow-up|11|||
130350394|NCT00722371|469253988|FG001|Overall Study|Lost to Follow-up|14|||
130350395|NCT00722371|469253989|FG002|Overall Study|Lost to Follow-up|21|||
130350396|NCT00722371|469253990|FG003|Overall Study|Lost to Follow-up|13|||
130350397|NCT00722371|469253991|FG004|Overall Study|Lost to Follow-up|8|||
130350398|NCT00722371|469253992|FG005|Overall Study|Lost to Follow-up|16|||
130350399|NCT00722371|469253993|FG006|Overall Study|Lost to Follow-up|13|||
130350400|NCT00722371|469253987|FG000|Overall Study|Physician Decision|5|||
130350401|NCT00722371|469253988|FG001|Overall Study|Physician Decision|2|||
130350402|NCT00722371|469253989|FG002|Overall Study|Physician Decision|2|||
130350403|NCT00722371|469253990|FG003|Overall Study|Physician Decision|5|||
130350404|NCT00722371|469253991|FG004|Overall Study|Physician Decision|2|||
130350405|NCT00722371|469253992|FG005|Overall Study|Physician Decision|3|||
130350406|NCT00722371|469253993|FG006|Overall Study|Physician Decision|4|||
130350407|NCT00722371|469253987|FG000|Overall Study|Pregnancy|1|||
130350408|NCT00722371|469253988|FG001|Overall Study|Pregnancy|1|||
130350409|NCT00722371|469253989|FG002|Overall Study|Pregnancy|0|||
130350410|NCT00722371|469253990|FG003|Overall Study|Pregnancy|0|||
130350411|NCT00722371|469253991|FG004|Overall Study|Pregnancy|0|||
130350412|NCT00722371|469253992|FG005|Overall Study|Pregnancy|1|||
130350413|NCT00722371|469253993|FG006|Overall Study|Pregnancy|0|||
130350414|NCT00722371|469253987|FG000|Overall Study|Protocol Violation|6|||
130350415|NCT00722371|469253988|FG001|Overall Study|Protocol Violation|1|||
130350416|NCT00722371|469253989|FG002|Overall Study|Protocol Violation|0|||
130350417|NCT00722371|469253990|FG003|Overall Study|Protocol Violation|1|||
130350418|NCT00722371|469253991|FG004|Overall Study|Protocol Violation|4|||
130350419|NCT00722371|469253992|FG005|Overall Study|Protocol Violation|2|||
130350420|NCT00722371|469253993|FG006|Overall Study|Protocol Violation|1|||
130350421|NCT00722371|469253987|FG000|Overall Study|Withdrawal by Subject|18|||
130350422|NCT00722371|469253988|FG001|Overall Study|Withdrawal by Subject|27|||
130350423|NCT00722371|469253989|FG002|Overall Study|Withdrawal by Subject|19|||
130350424|NCT00722371|469253990|FG003|Overall Study|Withdrawal by Subject|23|||
130350425|NCT00722371|469253991|FG004|Overall Study|Withdrawal by Subject|19|||
130350426|NCT00722371|469253992|FG005|Overall Study|Withdrawal by Subject|18|||
130438183|NCT01976364|469568215|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
130684410|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130350427|NCT00722371|469253993|FG006|Overall Study|Withdrawal by Subject|26|||
130350428|NCT01092832|469253994|FG000|Overall Study|Other|1|||
130350429|NCT01092832|469253995|FG001|Overall Study|Other|0|||
130350430|NCT02068768|469253996|FG000|Overall Study|Lost to Follow-up|5|||
130350431|NCT02068768|469253996|FG000|Overall Study|Early Termination by Sponsor|2|||
130350432|NCT00555425|469253997|FG000|Overall Study|Missed Medication > 1 wk|34|||
130350433|NCT00555425|469253998|FG001|Overall Study|Missed Medication > 1 wk|15|||
130350434|NCT00555425|469253997|FG000|Overall Study|Missed 3 physician management visits|1|||
130350435|NCT00555425|469253998|FG001|Overall Study|Missed 3 physician management visits|0|||
130350436|NCT00555425|469253997|FG000|Overall Study|Met criteria for protective transfer|16|||
130350437|NCT00555425|469253998|FG001|Overall Study|Met criteria for protective transfer|3|||
130350438|NCT00555425|469253997|FG000|Overall Study|Became pregnant and transferred care|0|||
130350439|NCT00555425|469253998|FG001|Overall Study|Became pregnant and transferred care|1|||
130350440|NCT03149848|469254005|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
130350441|NCT03149848|469254005|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
130350442|NCT01244490|469254006|FG000|Overall Study|Lack of Efficacy|14|||
130438184|NCT01976364|469568216|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
130438185|NCT01976364|469568214|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
130438186|NCT01976364|469568215|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
130438187|NCT01976364|469568216|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
130438188|NCT01976364|469568214|FG000|Sub-study (12 Months)|Protocol Violation|0|||
130438189|NCT01976364|469568215|FG001|Sub-study (12 Months)|Protocol Violation|1|||
130438190|NCT01976364|469568216|FG002|Sub-study (12 Months)|Protocol Violation|1|||
130684411|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130684412|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130684413|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684414|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130438191|NCT01976364|469568214|FG000|Sub-study (12 Months)|Adverse Event|0|||
130438192|NCT01976364|469568215|FG001|Sub-study (12 Months)|Adverse Event|4|||
130438193|NCT01976364|469568216|FG002|Sub-study (12 Months)|Adverse Event|3|||
130438194|NCT02318719|469568218|FG000|Double-blind Phase|Adverse Event|7|||
130438195|NCT02318719|469568219|FG001|Double-blind Phase|Adverse Event|6|||
130438196|NCT02318719|469568220|FG002|Double-blind Phase|Adverse Event|12|||
130438197|NCT02318719|469568221|FG003|Double-blind Phase|Adverse Event|4|||
130438198|NCT02318719|469568222|FG004|Double-blind Phase|Adverse Event|0|||
130438199|NCT02318719|469568218|FG000|Double-blind Phase|Lack of Efficacy|5|||
130438200|NCT02318719|469568219|FG001|Double-blind Phase|Lack of Efficacy|0|||
130438201|NCT02318719|469568220|FG002|Double-blind Phase|Lack of Efficacy|1|||
130438202|NCT02318719|469568221|FG003|Double-blind Phase|Lack of Efficacy|1|||
130438203|NCT02318719|469568222|FG004|Double-blind Phase|Lack of Efficacy|0|||
130438204|NCT02318719|469568218|FG000|Double-blind Phase|Protocol Violation|0|||
130438205|NCT02318719|469568219|FG001|Double-blind Phase|Protocol Violation|1|||
130438206|NCT02318719|469568220|FG002|Double-blind Phase|Protocol Violation|3|||
130438207|NCT02318719|469568221|FG003|Double-blind Phase|Protocol Violation|0|||
130438208|NCT02318719|469568222|FG004|Double-blind Phase|Protocol Violation|0|||
130438209|NCT02318719|469568218|FG000|Double-blind Phase|Withdrawal by Subject|25|||
130438210|NCT02318719|469568219|FG001|Double-blind Phase|Withdrawal by Subject|7|||
130438211|NCT02318719|469568220|FG002|Double-blind Phase|Withdrawal by Subject|9|||
130438212|NCT02318719|469568221|FG003|Double-blind Phase|Withdrawal by Subject|10|||
130438213|NCT02318719|469568222|FG004|Double-blind Phase|Withdrawal by Subject|0|||
130438214|NCT02318719|469568218|FG000|Double-blind Phase|Other|1|||
130438215|NCT02318719|469568219|FG001|Double-blind Phase|Other|2|||
130438216|NCT02318719|469568220|FG002|Double-blind Phase|Other|0|||
130438217|NCT02318719|469568221|FG003|Double-blind Phase|Other|0|||
130438218|NCT02318719|469568222|FG004|Double-blind Phase|Other|0|||
130438219|NCT02318719|469568218|FG000|Open-label Extension Phase|Adverse Event|0|||
130438220|NCT02318719|469568219|FG001|Open-label Extension Phase|Adverse Event|0|||
130438221|NCT02318719|469568220|FG002|Open-label Extension Phase|Adverse Event|0|||
130438222|NCT02318719|469568221|FG003|Open-label Extension Phase|Adverse Event|0|||
130438223|NCT02318719|469568222|FG004|Open-label Extension Phase|Adverse Event|15|||
130438224|NCT02318719|469568218|FG000|Open-label Extension Phase|Death|0|||
130438225|NCT02318719|469568219|FG001|Open-label Extension Phase|Death|0|||
130438226|NCT02318719|469568220|FG002|Open-label Extension Phase|Death|0|||
130438227|NCT02318719|469568221|FG003|Open-label Extension Phase|Death|0|||
130438228|NCT02318719|469568222|FG004|Open-label Extension Phase|Death|1|||
130438229|NCT02318719|469568218|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
130438230|NCT02318719|469568219|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130438231|NCT02318719|469568220|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
130438232|NCT02318719|469568221|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
130438233|NCT02318719|469568222|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
130438234|NCT02318719|469568218|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
130438235|NCT02318719|469568219|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130438236|NCT02318719|469568220|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
130438237|NCT02318719|469568221|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
130438238|NCT02318719|469568222|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
130438239|NCT02318719|469568218|FG000|Open-label Extension Phase|Other|0|||
130438240|NCT02318719|469568219|FG001|Open-label Extension Phase|Other|0|||
130438241|NCT02318719|469568220|FG002|Open-label Extension Phase|Other|0|||
130438242|NCT02318719|469568221|FG003|Open-label Extension Phase|Other|0|||
130438243|NCT02318719|469568222|FG004|Open-label Extension Phase|Other|7|||
130438244|NCT01868035|469568223|FG000|Overall Study|Lost to Follow-up|3|||
130438245|NCT01868035|469568223|FG000|Overall Study|Withdrawal by Subject|1|||
130438246|NCT01868035|469568223|FG000|Overall Study|Progressive Disease|2|||
130438247|NCT01868035|469568223|FG000|Overall Study|Non-compliance|1|||
130438248|NCT00432835|469568224|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
130438249|NCT00432835|469568225|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
130438250|NCT00423293|469568226|FG000|Overall Study|Ineligible / No protocol treatment|11|||
130438251|NCT01912222|469568227|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
130438252|NCT01912222|469568228|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
130438253|NCT01912222|469568229|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
130438254|NCT01912222|469568227|FG000|Part B: Treatment Period|Progressive disease|10|||
130684415|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684416|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684417|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684418|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684419|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684420|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684421|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684422|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
130684423|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684424|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Other|0|||
130684425|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Other|0|||
130684426|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Other|0|||
130684427|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Other|0|||
130684428|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Other|1|||
130684429|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Other|4|||
130684430|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Other|0|||
130684431|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Adverse Event|0|||
130684432|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Adverse Event|0|||
130684433|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Adverse Event|0|||
130684434|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Adverse Event|0|||
130684435|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Adverse Event|1|||
130684436|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Adverse Event|0|||
130684437|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Adverse Event|1|||
130684438|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684439|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684440|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684441|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684442|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684443|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684444|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
130684445|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684446|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684447|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684448|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684449|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684450|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684451|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
130684452|NCT01993030|470472815|FG000|Overall Study|Adverse Event|0|||
130684453|NCT01993030|470472816|FG001|Overall Study|Adverse Event|4|||
130684454|NCT01710657|470472817|FG000|Overall Study|Lost to Follow-up|2|||
130684455|NCT01710657|470472818|FG001|Overall Study|Lost to Follow-up|0|||
130684456|NCT01710657|470472819|FG002|Overall Study|Lost to Follow-up|1|||
130350443|NCT01244490|469254007|FG001|Overall Study|Lack of Efficacy|5|||
130350444|NCT01244490|469254008|FG002|Overall Study|Lack of Efficacy|5|||
130350445|NCT01244490|469254006|FG000|Overall Study|Withdrawal by Subject|4|||
130350446|NCT01244490|469254007|FG001|Overall Study|Withdrawal by Subject|4|||
130350447|NCT01244490|469254008|FG002|Overall Study|Withdrawal by Subject|9|||
130350448|NCT01244490|469254006|FG000|Overall Study|Adverse Event|1|||
130350449|NCT01244490|469254007|FG001|Overall Study|Adverse Event|9|||
130350450|NCT01244490|469254008|FG002|Overall Study|Adverse Event|5|||
130350451|NCT01244490|469254006|FG000|Overall Study|Lost to Follow-up|0|||
130350452|NCT01244490|469254007|FG001|Overall Study|Lost to Follow-up|6|||
130350453|NCT01244490|469254008|FG002|Overall Study|Lost to Follow-up|3|||
130350454|NCT01244490|469254006|FG000|Overall Study|Other|0|||
130350455|NCT01244490|469254007|FG001|Overall Study|Other|0|||
130350456|NCT01244490|469254008|FG002|Overall Study|Other|1|||
130350457|NCT00400153|469254010|FG000|Overall Study|AE due to study disease worsening|14|||
130350458|NCT00400153|469254011|FG001|Overall Study|AE due to study disease worsening|19|||
130350459|NCT00400153|469254012|FG002|Overall Study|AE due to study disease worsening|20|||
130350460|NCT00400153|469254010|FG000|Overall Study|AE due to other disease worsening|2|||
130350461|NCT00400153|469254011|FG001|Overall Study|AE due to other disease worsening|1|||
130350462|NCT00400153|469254012|FG002|Overall Study|AE due to other disease worsening|0|||
130350463|NCT00400153|469254010|FG000|Overall Study|AE due to other condition|3|||
130350464|NCT00400153|469254011|FG001|Overall Study|AE due to other condition|14|||
130350465|NCT00400153|469254012|FG002|Overall Study|AE due to other condition|15|||
130350466|NCT00400153|469254010|FG000|Overall Study|Protocol Violation|7|||
130350467|NCT00400153|469254011|FG001|Overall Study|Protocol Violation|4|||
130350468|NCT00400153|469254012|FG002|Overall Study|Protocol Violation|9|||
130350469|NCT00400153|469254010|FG000|Overall Study|Lost to Follow-up|2|||
130350470|NCT00400153|469254011|FG001|Overall Study|Lost to Follow-up|1|||
130350471|NCT00400153|469254012|FG002|Overall Study|Lost to Follow-up|4|||
130350472|NCT00400153|469254010|FG000|Overall Study|Withdrawal by Subject|12|||
130350473|NCT00400153|469254011|FG001|Overall Study|Withdrawal by Subject|11|||
130350474|NCT00400153|469254012|FG002|Overall Study|Withdrawal by Subject|10|||
130350475|NCT00400153|469254010|FG000|Overall Study|Other reasons - not mentioned above|8|||
130350476|NCT00400153|469254011|FG001|Overall Study|Other reasons - not mentioned above|5|||
130350477|NCT00400153|469254012|FG002|Overall Study|Other reasons - not mentioned above|3|||
130350478|NCT00393042|469254015|FG000|First Intervention|Withdrawal by Subject|1|||
130350479|NCT00393042|469254016|FG001|First Intervention|Withdrawal by Subject|2|||
130350480|NCT00393042|469254015|FG000|First Intervention|Lost to Follow-up|3|||
130350481|NCT00393042|469254016|FG001|First Intervention|Lost to Follow-up|3|||
130350482|NCT00393042|469254015|FG000|First Intervention|Protocol Violation|1|||
130350483|NCT00393042|469254016|FG001|First Intervention|Protocol Violation|0|||
130350484|NCT00393042|469254015|FG000|First Intervention|Adverse Event|0|||
130350485|NCT00393042|469254016|FG001|First Intervention|Adverse Event|1|||
130350486|NCT00393042|469254015|FG000|Second Intervetion|Adverse Event|0|||
130350487|NCT00393042|469254016|FG001|Second Intervetion|Adverse Event|3|||
130350488|NCT00393042|469254015|FG000|Second Intervetion|Withdrawal by Subject|0|||
130350489|NCT00393042|469254016|FG001|Second Intervetion|Withdrawal by Subject|2|||
130350490|NCT00393042|469254015|FG000|Second Intervetion|Lack of Efficacy|1|||
130350491|NCT00393042|469254016|FG001|Second Intervetion|Lack of Efficacy|0|||
130350492|NCT00393042|469254015|FG000|Second Intervetion|Lost to Follow-up|0|||
130350493|NCT00393042|469254016|FG001|Second Intervetion|Lost to Follow-up|2|||
130350494|NCT00393042|469254015|FG000|Second Intervetion|Protocol Violation|1|||
130350495|NCT00393042|469254016|FG001|Second Intervetion|Protocol Violation|1|||
130350496|NCT01150474|469254021|FG000|Overall Study|Withdrawal by Subject|5|||
130350497|NCT01150474|469254022|FG001|Overall Study|Withdrawal by Subject|2|||
130350498|NCT01150474|469254021|FG000|Overall Study|Cancer found|1|||
130350499|NCT01150474|469254022|FG001|Overall Study|Cancer found|0|||
130350500|NCT01150474|469254021|FG000|Overall Study|Multiple Studies|0|||
130350501|NCT01150474|469254022|FG001|Overall Study|Multiple Studies|1|||
130350502|NCT01150474|469254021|FG000|Overall Study|Rectotomy|1|||
130350503|NCT01150474|469254022|FG001|Overall Study|Rectotomy|0|||
130350504|NCT01150474|469254021|FG000|Overall Study|Drug did not arrive in time|1|||
130350505|NCT01150474|469254022|FG001|Overall Study|Drug did not arrive in time|0|||
130350506|NCT01150474|469254021|FG000|Overall Study|Drug not administered|1|||
130350507|NCT01150474|469254022|FG001|Overall Study|Drug not administered|0|||
130350508|NCT01150474|469254021|FG000|Overall Study|Surgery Changed|1|||
130350509|NCT01150474|469254022|FG001|Overall Study|Surgery Changed|0|||
130350510|NCT01423604|469254023|FG000|Safety Run-In|Adverse Event|3|||
130350511|NCT01423604|469254024|FG001|Safety Run-In|Adverse Event|0|||
130350512|NCT01423604|469254023|FG000|Safety Run-In|Death|1|||
130350513|NCT01423604|469254024|FG001|Safety Run-In|Death|0|||
130350514|NCT01423604|469254023|FG000|Safety Run-In|Physician Decision|1|||
130350515|NCT01423604|469254024|FG001|Safety Run-In|Physician Decision|0|||
130350516|NCT01423604|469254023|FG000|Safety Run-In|Disease progression|3|||
130350517|NCT01423604|469254024|FG001|Safety Run-In|Disease progression|0|||
130350518|NCT01423604|469254023|FG000|Safety Run-In|Patient decision|1|||
130350519|NCT01423604|469254024|FG001|Safety Run-In|Patient decision|0|||
130350520|NCT01423604|469254023|FG000|Randomized|Adverse Event|4|||
130350521|NCT01423604|469254024|FG001|Randomized|Adverse Event|10|||
130350522|NCT01423604|469254023|FG000|Randomized|Death|1|||
130350523|NCT01423604|469254024|FG001|Randomized|Death|0|||
130350524|NCT01423604|469254023|FG000|Randomized|Physician Decision|16|||
130350525|NCT01423604|469254024|FG001|Randomized|Physician Decision|13|||
130350526|NCT01423604|469254023|FG000|Randomized|Other - unspecified|37|||
130350527|NCT01423604|469254024|FG001|Randomized|Other - unspecified|31|||
130350528|NCT01423604|469254023|FG000|Randomized|Patient decision|5|||
130350529|NCT01423604|469254024|FG001|Randomized|Patient decision|9|||
130350530|NCT00424255|469254025|FG000|Overall Study|Death|115|||
130350531|NCT00424255|469254026|FG001|Overall Study|Death|111|||
130350532|NCT00424255|469254025|FG000|Overall Study|Lost to Follow-up|26|||
130350533|NCT00424255|469254026|FG001|Overall Study|Lost to Follow-up|20|||
130350534|NCT00424255|469254025|FG000|Overall Study|Protocol Violation|0|||
130350535|NCT00424255|469254026|FG001|Overall Study|Protocol Violation|1|||
130350536|NCT00424255|469254025|FG000|Overall Study|Withdrawal by Subject|34|||
130350537|NCT00424255|469254026|FG001|Overall Study|Withdrawal by Subject|38|||
130350538|NCT00424255|469254025|FG000|Overall Study|Physician Decision|3|||
130350539|NCT00424255|469254026|FG001|Overall Study|Physician Decision|7|||
130350540|NCT00424255|469254025|FG000|Overall Study|Cognitive Disturbance|1|||
130350541|NCT00424255|469254026|FG001|Overall Study|Cognitive Disturbance|0|||
130350542|NCT00424255|469254025|FG000|Overall Study|Non-compliance by Participants|1|||
130350543|NCT00424255|469254026|FG001|Overall Study|Non-compliance by Participants|0|||
130350544|NCT00424255|469254025|FG000|Overall Study|Fatigue|1|||
130350545|NCT00424255|469254026|FG001|Overall Study|Fatigue|0|||
130350546|NCT00424255|469254025|FG000|Overall Study|Disease Progression|0|||
130350547|NCT00424255|469254026|FG001|Overall Study|Disease Progression|2|||
130438255|NCT01912222|469568228|FG001|Part B: Treatment Period|Progressive disease|12|||
130438256|NCT01912222|469568229|FG002|Part B: Treatment Period|Progressive disease|15|||
130438257|NCT01912222|469568227|FG000|Part B: Treatment Period|Adverse Event|1|||
130438258|NCT01912222|469568228|FG001|Part B: Treatment Period|Adverse Event|2|||
130438259|NCT01912222|469568229|FG002|Part B: Treatment Period|Adverse Event|3|||
130438260|NCT01912222|469568227|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
130438261|NCT01912222|469568228|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
130438262|NCT01912222|469568229|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
130438263|NCT03154359|469568230|FG000|Overall Study|Adverse Event|1|||
130438264|NCT03154359|469568230|FG000|Overall Study|Lack of Efficacy|2|||
130438265|NCT03154359|469568230|FG000|Overall Study|Lost to Follow-up|3|||
130438266|NCT03154359|469568230|FG000|Overall Study|Physician Decision|3|||
130438267|NCT03154359|469568230|FG000|Overall Study|Protocol Violation|4|||
130438268|NCT03154359|469568230|FG000|Overall Study|Withdrawal by Subject|5|||
130438269|NCT03154359|469568230|FG000|Overall Study|Disruption of study due to COVID-19|4|||
130438270|NCT00885352|469568231|FG000|Overall Study|Adverse Event|2|||
130438271|NCT00885352|469568232|FG001|Overall Study|Adverse Event|3|||
130438272|NCT00885352|469568231|FG000|Overall Study|Lost to Follow-up|2|||
130438273|NCT00885352|469568232|FG001|Overall Study|Lost to Follow-up|2|||
130438274|NCT00885352|469568231|FG000|Overall Study|Physician Decision|0|||
130438275|NCT00885352|469568232|FG001|Overall Study|Physician Decision|3|||
130438276|NCT00885352|469568231|FG000|Overall Study|Protocol Violation|0|||
130438277|NCT00885352|469568232|FG001|Overall Study|Protocol Violation|2|||
130438278|NCT00885352|469568231|FG000|Overall Study|Withdrawal by Subject|1|||
130438279|NCT00885352|469568232|FG001|Overall Study|Withdrawal by Subject|5|||
130438280|NCT00885352|469568231|FG000|Overall Study|Contradiction to study medication|0|||
130438281|NCT00885352|469568232|FG001|Overall Study|Contradiction to study medication|2|||
130438282|NCT00885352|469568231|FG000|Overall Study|Excluded medication|2|||
130438283|NCT00885352|469568232|FG001|Overall Study|Excluded medication|2|||
130438284|NCT00885352|469568231|FG000|Overall Study|Lab abnormalities|1|||
130438285|NCT00885352|469568232|FG001|Overall Study|Lab abnormalities|1|||
130438286|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
130438287|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
130438288|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130438289|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
130438290|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
130438291|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
130438292|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
130438293|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
130438294|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
130438295|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
130438296|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
130438297|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
130438298|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
130438299|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
130438300|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
130438301|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
130438302|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
130438303|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
130438304|NCT00365378|469568233|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
130438305|NCT00365378|469568234|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
130438306|NCT00365378|469568235|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
130438307|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
130438308|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
130438309|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
130438310|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
130438311|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
130438312|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
130438313|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
130438314|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
130438315|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
130438316|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
130438317|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
130684457|NCT01710657|470472817|FG000|Overall Study|Protocol Violation|2|||
130684458|NCT01710657|470472818|FG001|Overall Study|Protocol Violation|2|||
130684459|NCT01710657|470472819|FG002|Overall Study|Protocol Violation|0|||
130438318|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
130438319|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
130438320|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
130438321|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
130438322|NCT00365378|469568233|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
130438323|NCT00365378|469568234|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
130684460|NCT01710657|470472817|FG000|Overall Study|Adverse Event|14|||
130438324|NCT00365378|469568235|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
130438325|NCT00365378|469568233|FG000|Extension|Adverse Event|0|||
130438326|NCT00365378|469568234|FG001|Extension|Adverse Event|0|||
130438327|NCT00365378|469568235|FG002|Extension|Adverse Event|1|||
130684461|NCT01710657|470472818|FG001|Overall Study|Adverse Event|8|||
130684462|NCT01710657|470472819|FG002|Overall Study|Adverse Event|28|||
130684463|NCT01710657|470472817|FG000|Overall Study|Withdrawal by Subject|0|||
130684464|NCT01710657|470472818|FG001|Overall Study|Withdrawal by Subject|1|||
130684465|NCT01710657|470472819|FG002|Overall Study|Withdrawal by Subject|2|||
130684466|NCT01710657|470472817|FG000|Overall Study|Lack of Efficacy|0|||
130684467|NCT01710657|470472818|FG001|Overall Study|Lack of Efficacy|1|||
130438328|NCT00365378|469568233|FG000|Extension|Moved|0|||
130438329|NCT00365378|469568234|FG001|Extension|Moved|0|||
130438330|NCT00365378|469568235|FG002|Extension|Moved|8|||
130438331|NCT00365378|469568233|FG000|Extension|Lost to Follow-up|0|||
130438332|NCT00365378|469568234|FG001|Extension|Lost to Follow-up|0|||
130438333|NCT00365378|469568235|FG002|Extension|Lost to Follow-up|57|||
130438334|NCT00365378|469568233|FG000|Extension|Protocol Violation|0|||
130438335|NCT00365378|469568234|FG001|Extension|Protocol Violation|0|||
130438336|NCT00365378|469568235|FG002|Extension|Protocol Violation|2|||
130438337|NCT00365378|469568233|FG000|Extension|Withdrawal by Subject|0|||
130438338|NCT00365378|469568234|FG001|Extension|Withdrawal by Subject|0|||
130438339|NCT00365378|469568235|FG002|Extension|Withdrawal by Subject|98|||
130438340|NCT00365378|469568233|FG000|Extension|Other|0|||
130438341|NCT00365378|469568234|FG001|Extension|Other|0|||
130438342|NCT00365378|469568235|FG002|Extension|Other|31|||
130438343|NCT04161807|469568241|FG000|Overall Study|Withdrawal by Subject|2|||
130438344|NCT04161807|469568241|FG000|Overall Study|Performed only 1 treatment|2|||
130438345|NCT00669903|469568244|FG000|Overall Study|Adverse Event|0|||
130438346|NCT00669903|469568245|FG001|Overall Study|Adverse Event|1|||
130438347|NCT00669903|469568246|FG002|Overall Study|Adverse Event|3|||
130438348|NCT00669903|469568247|FG003|Overall Study|Adverse Event|1|||
130438349|NCT00669903|469568244|FG000|Overall Study|Withdrawal by Subject|0|||
130684468|NCT01710657|470472819|FG002|Overall Study|Lack of Efficacy|1|||
130684469|NCT01591785|470472822|FG000|Overall Study|worsening condition|1|||
130350548|NCT00424255|469254025|FG000|Overall Study|Sponsor Terminated Study|161|||
130350549|NCT00424255|469254026|FG001|Overall Study|Sponsor Terminated Study|167|||
130350550|NCT00327470|469254027|FG000|Overall Study|Randomized, but not treated|0|||
130350551|NCT00327470|469254028|FG001|Overall Study|Randomized, but not treated|2|||
130350552|NCT00327470|469254027|FG000|Overall Study|Adverse Event|9|||
130350553|NCT00327470|469254028|FG001|Overall Study|Adverse Event|14|||
130350554|NCT00327470|469254027|FG000|Overall Study|Lack of Efficacy|7|||
130350555|NCT00327470|469254028|FG001|Overall Study|Lack of Efficacy|19|||
130350556|NCT00327470|469254027|FG000|Overall Study|Other|5|||
130350557|NCT00327470|469254028|FG001|Overall Study|Other|9|||
130350558|NCT00327470|469254027|FG000|Overall Study|Lost to Follow-up|1|||
130350559|NCT00327470|469254028|FG001|Overall Study|Lost to Follow-up|3|||
130350560|NCT00327470|469254027|FG000|Overall Study|Withdrawal by Subject|6|||
130350561|NCT00327470|469254028|FG001|Overall Study|Withdrawal by Subject|12|||
130350562|NCT00327470|469254027|FG000|Overall Study|Death|1|||
130350563|NCT00327470|469254028|FG001|Overall Study|Death|4|||
130350564|NCT01226121|469254029|FG000|Overall Study|Lost to Follow-up|2|||
130350565|NCT01226121|469254030|FG001|Overall Study|Lost to Follow-up|0|||
130350566|NCT01226121|469254031|FG002|Overall Study|Lost to Follow-up|1|||
130350567|NCT02581943|469254032|FG000|Overall Study|Death|5|||
130350568|NCT02581943|469254033|FG001|Overall Study|Death|2|||
130350569|NCT02581943|469254032|FG000|Overall Study|Disease Progression|12|||
130350570|NCT02581943|469254033|FG001|Overall Study|Disease Progression|15|||
130350571|NCT02581943|469254032|FG000|Overall Study|Withdrawal by Subject|1|||
130438350|NCT00669903|469568245|FG001|Overall Study|Withdrawal by Subject|2|||
130438351|NCT00669903|469568246|FG002|Overall Study|Withdrawal by Subject|2|||
130684470|NCT01591785|470472823|FG001|Overall Study|worsening condition|2|||
130684471|NCT01591785|470472822|FG000|Overall Study|Protocol Violation|2|||
130684472|NCT01591785|470472823|FG001|Overall Study|Protocol Violation|0|||
130350572|NCT02581943|469254033|FG001|Overall Study|Withdrawal by Subject|2|||
130350573|NCT03021564|469254034|FG000|Overall Study|Death|84|||
130438352|NCT00669903|469568247|FG003|Overall Study|Withdrawal by Subject|2|||
130350574|NCT03021564|469254035|FG001|Overall Study|Death|466|||
130350575|NCT03021564|469254034|FG000|Overall Study|Lost to Follow-up|0|||
130350576|NCT03021564|469254035|FG001|Overall Study|Lost to Follow-up|2|||
130350577|NCT00745615|469254044|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
130350578|NCT00745615|469254045|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
130350579|NCT00745615|469254046|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
130438353|NCT00669903|469568244|FG000|Overall Study|Lost to Follow-up|1|||
130438354|NCT00669903|469568245|FG001|Overall Study|Lost to Follow-up|1|||
130438355|NCT00669903|469568246|FG002|Overall Study|Lost to Follow-up|0|||
130438356|NCT00669903|469568247|FG003|Overall Study|Lost to Follow-up|1|||
130438357|NCT00669903|469568244|FG000|Overall Study|Protocol Violation|0|||
130684473|NCT01591785|470472822|FG000|Overall Study|Lost to Follow-up|1|||
130684474|NCT01591785|470472823|FG001|Overall Study|Lost to Follow-up|0|||
130684475|NCT00667862|470472824|FG000|Overall Study|Adverse Event|9|||
130438358|NCT00669903|469568245|FG001|Overall Study|Protocol Violation|1|||
130438359|NCT00669903|469568246|FG002|Overall Study|Protocol Violation|0|||
130438360|NCT00669903|469568247|FG003|Overall Study|Protocol Violation|0|||
130438361|NCT04789577|469568248|FG000|Overall Study|Withdrawal by Subject|1|||
130438362|NCT04789577|469568249|FG001|Overall Study|Withdrawal by Subject|1|||
130438363|NCT04789577|469568250|FG002|Overall Study|Withdrawal by Subject|1|||
130438364|NCT04789577|469568251|FG003|Overall Study|Withdrawal by Subject|3|||
130438365|NCT04789577|469568252|FG004|Overall Study|Withdrawal by Subject|1|||
130438366|NCT04789577|469568253|FG005|Overall Study|Withdrawal by Subject|7|||
130438367|NCT04789577|469568254|FG006|Overall Study|Withdrawal by Subject|1|||
130438368|NCT04789577|469568248|FG000|Overall Study|Lost to Follow-up|7|||
130438369|NCT04789577|469568249|FG001|Overall Study|Lost to Follow-up|12|||
130438370|NCT04789577|469568250|FG002|Overall Study|Lost to Follow-up|7|||
130438371|NCT04789577|469568251|FG003|Overall Study|Lost to Follow-up|10|||
130684476|NCT00667862|470472824|FG000|Overall Study|Death|1|||
130684477|NCT00667862|470472824|FG000|Overall Study|Disease Progression|22|||
130684478|NCT00667862|470472824|FG000|Overall Study|Withdrawal by Subject|3|||
130684479|NCT00905346|470472828|FG000|Period 1|Withdrawal by Subject|1|||
130684480|NCT00905346|470472829|FG001|Period 1|Withdrawal by Subject|0|||
130684481|NCT01435265|470472830|FG000|Overall Study|Lost to Follow-up|0|||
130684482|NCT01435265|470472831|FG001|Overall Study|Lost to Follow-up|1|||
130684483|NCT00909610|470472834|FG000|Period: First Intervention|Adverse Event|0|||
130684484|NCT00909610|470472835|FG001|Period: First Intervention|Adverse Event|1|||
130684485|NCT00909610|470472834|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
130684486|NCT00909610|470472835|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
130684487|NCT00909610|470472834|FG000|Period: Second Intervention|Adverse Event|1|||
130684488|NCT00909610|470472835|FG001|Period: Second Intervention|Adverse Event|0|||
130684489|NCT05612724|470472842|FG000|Overall Study|Lost to Follow-up|4|||
130350580|NCT00745615|469254047|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
130350581|NCT00745615|469254048|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
130438372|NCT04789577|469568252|FG004|Overall Study|Lost to Follow-up|8|||
130438373|NCT04789577|469568253|FG005|Overall Study|Lost to Follow-up|6|||
130438374|NCT04789577|469568254|FG006|Overall Study|Lost to Follow-up|10|||
130438375|NCT04789577|469568248|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
130438376|NCT04789577|469568249|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
130438377|NCT04789577|469568250|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
130438378|NCT04789577|469568251|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
130438379|NCT04789577|469568252|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
130438380|NCT04789577|469568253|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
130438381|NCT04789577|469568254|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
130438382|NCT04789577|469568248|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
130438383|NCT04789577|469568249|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
130438384|NCT04789577|469568250|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
130438385|NCT04789577|469568251|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
130438386|NCT04789577|469568252|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
130438387|NCT04789577|469568253|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
130438388|NCT04789577|469568254|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
130438389|NCT01827254|469568258|FG000|Overall Study|Death|10|||
130438390|NCT01827254|469568258|FG000|Overall Study|Case report form not completed|4|||
130438391|NCT01827254|469568258|FG000|Overall Study|Invalidated centre|3|||
130438392|NCT01827254|469568258|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
130438393|NCT01827254|469568258|FG000|Overall Study|Did not complete re-challenge|1|||
130438394|NCT01827254|469568258|FG000|Overall Study|Disease progression|36|||
130438395|NCT01827254|469568258|FG000|Overall Study|Intolerance to treatment|4|||
130438396|NCT00562978|469568259|FG000|Overall Study|Patient had imaging dose only|1|||
130438397|NCT00562978|469568260|FG001|Overall Study|Patient had imaging dose only|11|||
130438398|NCT00152971|469568262|FG000|Overall Study|Adverse Event|12|||
130438399|NCT00152971|469568263|FG001|Overall Study|Adverse Event|10|||
130438400|NCT00152971|469568264|FG002|Overall Study|Adverse Event|9|||
130438401|NCT00152971|469568262|FG000|Overall Study|Protocol Violation|10|||
130438402|NCT00152971|469568263|FG001|Overall Study|Protocol Violation|11|||
130438403|NCT00152971|469568264|FG002|Overall Study|Protocol Violation|8|||
130350582|NCT00745615|469254049|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
130350583|NCT00745615|469254044|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130350584|NCT00745615|469254045|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
130350585|NCT00745615|469254046|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130350586|NCT00745615|469254047|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130350587|NCT00745615|469254048|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130438404|NCT00152971|469568262|FG000|Overall Study|Lost to Follow-up|17|||
130438405|NCT00152971|469568263|FG001|Overall Study|Lost to Follow-up|14|||
130438406|NCT00152971|469568264|FG002|Overall Study|Lost to Follow-up|13|||
130438407|NCT00152971|469568262|FG000|Overall Study|Withdrawal by Subject|9|||
130438408|NCT00152971|469568263|FG001|Overall Study|Withdrawal by Subject|8|||
130438409|NCT00152971|469568264|FG002|Overall Study|Withdrawal by Subject|14|||
130684490|NCT02128997|470472843|FG000|Overall Study|Lost to Follow-up|6|||
130684491|NCT02128997|470472844|FG001|Overall Study|Lost to Follow-up|11|||
130684492|NCT04000815|470472851|FG000|Overall Study|Lost to Follow-up|9|||
130350588|NCT00745615|469254049|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130350589|NCT00745615|469254044|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
130350590|NCT00745615|469254045|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
130684493|NCT04000815|470472852|FG001|Overall Study|Lost to Follow-up|2|||
130684494|NCT04000815|470472853|FG002|Overall Study|Lost to Follow-up|3|||
130684495|NCT04000815|470472851|FG000|Overall Study|Withdrawal by Subject|4|||
130684496|NCT04000815|470472852|FG001|Overall Study|Withdrawal by Subject|3|||
130684497|NCT04000815|470472853|FG002|Overall Study|Withdrawal by Subject|2|||
130684498|NCT04000815|470472851|FG000|Overall Study|Right ovarian cyst occured|1|||
130684499|NCT04000815|470472852|FG001|Overall Study|Right ovarian cyst occured|0|||
130684500|NCT04000815|470472853|FG002|Overall Study|Right ovarian cyst occured|0|||
130684501|NCT04000815|470472851|FG000|Overall Study|Hypertension occured on follow up|0|||
130350591|NCT00745615|469254046|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
130350592|NCT00745615|469254047|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
130350593|NCT00745615|469254048|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
130350594|NCT00745615|469254049|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
130350595|NCT00745615|469254044|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130350596|NCT00745615|469254045|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
130350597|NCT00745615|469254046|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130350598|NCT00745615|469254047|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130350599|NCT00745615|469254048|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130350600|NCT00745615|469254049|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130350601|NCT00745615|469254044|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130350602|NCT00745615|469254045|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
130350603|NCT00745615|469254046|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130350604|NCT00745615|469254047|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130350605|NCT00745615|469254048|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130350606|NCT00745615|469254049|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130350607|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130350608|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130350609|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130350610|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130350611|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
130350612|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
130350613|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130350614|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130350615|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130350616|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130350617|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
130350618|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
130350619|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130350620|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130350621|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130350622|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130350623|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
130350624|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
130350625|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130350626|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130350627|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130350628|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130350629|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
130350630|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
130350631|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130350632|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130350633|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130350634|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130350635|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
130350636|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
130350637|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130350638|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130350639|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130350640|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130350641|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
130350642|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
130350643|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130438410|NCT00152971|469568262|FG000|Overall Study|Other|3|||
130438411|NCT00152971|469568263|FG001|Overall Study|Other|5|||
130438412|NCT00152971|469568264|FG002|Overall Study|Other|5|||
130350644|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130350645|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130350646|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130350647|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130350648|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
130350649|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
130350650|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
130350651|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
130350652|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
130350653|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
130350654|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
130350655|NCT00745615|469254044|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130350656|NCT00745615|469254045|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130350657|NCT00745615|469254046|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130350658|NCT00745615|469254047|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130350659|NCT00745615|469254048|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
130350660|NCT00745615|469254049|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
130350661|NCT01163032|469254055|FG000|Randomization Phase|Withdrawal by Subject|2|||
130350662|NCT01163032|469254056|FG001|Randomization Phase|Withdrawal by Subject|3|||
130350663|NCT01163032|469254057|FG002|Randomization Phase|Withdrawal by Subject|0|||
130350664|NCT01163032|469254055|FG000|Randomization Phase|Adverse Event|3|||
130350665|NCT01163032|469254056|FG001|Randomization Phase|Adverse Event|3|||
130350666|NCT01163032|469254057|FG002|Randomization Phase|Adverse Event|0|||
130350667|NCT01163032|469254055|FG000|Randomization Phase|Protocol Violation|0|||
130350668|NCT01163032|469254056|FG001|Randomization Phase|Protocol Violation|1|||
130350669|NCT01163032|469254057|FG002|Randomization Phase|Protocol Violation|0|||
130350670|NCT01163032|469254055|FG000|Randomization Phase|Various*|5|||
130350671|NCT01163032|469254056|FG001|Randomization Phase|Various*|4|||
130350672|NCT01163032|469254057|FG002|Randomization Phase|Various*|0|||
130350673|NCT01163032|469254055|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
130350674|NCT01163032|469254056|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
130350675|NCT01163032|469254057|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
130350676|NCT01163032|469254055|FG000|Open Label Extension Phase|Adverse Event|0|||
130350677|NCT01163032|469254056|FG001|Open Label Extension Phase|Adverse Event|0|||
130350678|NCT01163032|469254057|FG002|Open Label Extension Phase|Adverse Event|3|||
130350679|NCT01163032|469254055|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
130350680|NCT01163032|469254056|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
130350681|NCT01163032|469254057|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
130350682|NCT01163032|469254055|FG000|Open Label Extension Phase|Protocol Violation|0|||
130350683|NCT01163032|469254056|FG001|Open Label Extension Phase|Protocol Violation|0|||
130350684|NCT01163032|469254057|FG002|Open Label Extension Phase|Protocol Violation|1|||
130350685|NCT01163032|469254055|FG000|Open Label Extension Phase|Study Termination|0|||
130350686|NCT01163032|469254056|FG001|Open Label Extension Phase|Study Termination|0|||
130350687|NCT01163032|469254057|FG002|Open Label Extension Phase|Study Termination|7|||
130350688|NCT01163032|469254055|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
130350689|NCT01163032|469254056|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
130350690|NCT01163032|469254057|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
130350691|NCT01307020|469254060|FG000|Overall Study|Lost to Follow-up|0|||
130350692|NCT01307020|469254061|FG001|Overall Study|Lost to Follow-up|0|||
130350693|NCT01307020|469254062|FG002|Overall Study|Lost to Follow-up|1|||
130350694|NCT01307020|469254063|FG003|Overall Study|Lost to Follow-up|1|||
130350695|NCT01307020|469254064|FG004|Overall Study|Lost to Follow-up|0|||
130350696|NCT01307020|469254065|FG005|Overall Study|Lost to Follow-up|0|||
130350697|NCT01307020|469254066|FG006|Overall Study|Lost to Follow-up|1|||
130350698|NCT01307020|469254067|FG007|Overall Study|Lost to Follow-up|0|||
130350699|NCT01307020|469254068|FG008|Overall Study|Lost to Follow-up|0|||
130350700|NCT01307020|469254069|FG009|Overall Study|Lost to Follow-up|0|||
130350701|NCT01307020|469254060|FG000|Overall Study|Electronic data capture failure|0|||
130350702|NCT01307020|469254061|FG001|Overall Study|Electronic data capture failure|1|||
130350703|NCT01307020|469254062|FG002|Overall Study|Electronic data capture failure|0|||
130438413|NCT00152971|469568262|FG000|Treatment|Adverse Event|49|||
130438414|NCT00152971|469568263|FG001|Treatment|Adverse Event|40|||
130438415|NCT00152971|469568264|FG002|Treatment|Adverse Event|54|||
130438416|NCT00152971|469568262|FG000|Treatment|Protocol Violation|8|||
130350704|NCT01307020|469254063|FG003|Overall Study|Electronic data capture failure|0|||
130350705|NCT01307020|469254064|FG004|Overall Study|Electronic data capture failure|0|||
130350706|NCT01307020|469254065|FG005|Overall Study|Electronic data capture failure|0|||
130438417|NCT00152971|469568263|FG001|Treatment|Protocol Violation|6|||
130438418|NCT00152971|469568264|FG002|Treatment|Protocol Violation|10|||
130438419|NCT00152971|469568262|FG000|Treatment|Lost to Follow-up|1|||
130438420|NCT00152971|469568263|FG001|Treatment|Lost to Follow-up|2|||
130438421|NCT00152971|469568264|FG002|Treatment|Lost to Follow-up|1|||
130438422|NCT00152971|469568262|FG000|Treatment|Withdrawal by Subject|4|||
130438423|NCT00152971|469568263|FG001|Treatment|Withdrawal by Subject|4|||
130438424|NCT00152971|469568264|FG002|Treatment|Withdrawal by Subject|5|||
130438425|NCT00152971|469568262|FG000|Treatment|Other|9|||
130438426|NCT00152971|469568263|FG001|Treatment|Other|11|||
130438427|NCT00152971|469568264|FG002|Treatment|Other|10|||
130438428|NCT03125941|469568271|FG000|Overall Study|did not receive intervention|1|||
130438429|NCT03125941|469568272|FG001|Overall Study|did not receive intervention|2|||
130438430|NCT03853317|469568273|FG000|Overall Study|Progressive Disease|5|||
130438431|NCT03853317|469568273|FG000|Overall Study|Adverse Event|1|||
130438432|NCT03853317|469568273|FG000|Overall Study|Death|1|||
130438433|NCT03853317|469568273|FG000|Overall Study|other event|2|||
130438434|NCT00779584|469568274|FG000|Overall Study|Protocol Violation|0|||
130684502|NCT04000815|470472852|FG001|Overall Study|Hypertension occured on follow up|0|||
130438435|NCT00779584|469568275|FG001|Overall Study|Protocol Violation|0|||
130438436|NCT00779584|469568276|FG002|Overall Study|Protocol Violation|0|||
130438437|NCT00779584|469568277|FG003|Overall Study|Protocol Violation|0|||
130438438|NCT00779584|469568278|FG004|Overall Study|Protocol Violation|0|||
130438439|NCT00779584|469568279|FG005|Overall Study|Protocol Violation|1|||
130438440|NCT00779584|469568280|FG006|Overall Study|Protocol Violation|0|||
130438441|NCT00779584|469568281|FG007|Overall Study|Protocol Violation|0|||
130438442|NCT00779584|469568282|FG008|Overall Study|Protocol Violation|0|||
130438443|NCT00779584|469568274|FG000|Overall Study|Withdrawal by Subject|1|||
130438444|NCT00779584|469568275|FG001|Overall Study|Withdrawal by Subject|1|||
130438445|NCT00779584|469568276|FG002|Overall Study|Withdrawal by Subject|2|||
130438446|NCT00779584|469568277|FG003|Overall Study|Withdrawal by Subject|0|||
130438447|NCT00779584|469568278|FG004|Overall Study|Withdrawal by Subject|0|||
130438448|NCT00779584|469568279|FG005|Overall Study|Withdrawal by Subject|2|||
130438449|NCT00779584|469568280|FG006|Overall Study|Withdrawal by Subject|1|||
130438450|NCT00779584|469568281|FG007|Overall Study|Withdrawal by Subject|0|||
130438451|NCT00779584|469568282|FG008|Overall Study|Withdrawal by Subject|0|||
130438452|NCT00779584|469568274|FG000|Overall Study|Lost to Follow-up|0|||
130438453|NCT00779584|469568275|FG001|Overall Study|Lost to Follow-up|0|||
130438454|NCT00779584|469568276|FG002|Overall Study|Lost to Follow-up|0|||
130438455|NCT00779584|469568277|FG003|Overall Study|Lost to Follow-up|0|||
130438456|NCT00779584|469568278|FG004|Overall Study|Lost to Follow-up|1|||
130438457|NCT00779584|469568279|FG005|Overall Study|Lost to Follow-up|0|||
130438458|NCT00779584|469568280|FG006|Overall Study|Lost to Follow-up|0|||
130438459|NCT00779584|469568281|FG007|Overall Study|Lost to Follow-up|0|||
130438460|NCT00779584|469568282|FG008|Overall Study|Lost to Follow-up|0|||
130438461|NCT00779584|469568274|FG000|Overall Study|Progression of Disease|0|||
130438462|NCT00779584|469568275|FG001|Overall Study|Progression of Disease|1|||
130438463|NCT00779584|469568276|FG002|Overall Study|Progression of Disease|2|||
130438464|NCT00779584|469568277|FG003|Overall Study|Progression of Disease|6|||
130438465|NCT00779584|469568278|FG004|Overall Study|Progression of Disease|5|||
130438466|NCT00779584|469568279|FG005|Overall Study|Progression of Disease|1|||
130438467|NCT00779584|469568280|FG006|Overall Study|Progression of Disease|4|||
130438468|NCT00779584|469568281|FG007|Overall Study|Progression of Disease|2|||
130438469|NCT00779584|469568282|FG008|Overall Study|Progression of Disease|1|||
130438470|NCT00779584|469568274|FG000|Overall Study|Adverse Event|1|||
130350707|NCT01307020|469254066|FG006|Overall Study|Electronic data capture failure|0|||
130350708|NCT01307020|469254067|FG007|Overall Study|Electronic data capture failure|0|||
130350709|NCT01307020|469254068|FG008|Overall Study|Electronic data capture failure|0|||
130350710|NCT01307020|469254069|FG009|Overall Study|Electronic data capture failure|0|||
130350711|NCT02380690|469254070|FG000|Overall Study|Lost to Follow-up|14|||
130350712|NCT02380690|469254071|FG001|Overall Study|Lost to Follow-up|4|||
130350713|NCT02380690|469254070|FG000|Overall Study|Withdrawal by Subject|20|||
130350714|NCT02380690|469254071|FG001|Overall Study|Withdrawal by Subject|8|||
130350715|NCT00727532|469254072|FG000|Overall Study|Adverse Event|1|||
130350716|NCT00727532|469254072|FG000|Overall Study|Withdrawal by Subject|1|||
130350717|NCT00829933|469254073|FG000|Overall Study|Adverse Event|2|||
130350718|NCT00829933|469254074|FG001|Overall Study|Adverse Event|3|||
130438471|NCT00779584|469568275|FG001|Overall Study|Adverse Event|0|||
130684503|NCT04000815|470472853|FG002|Overall Study|Hypertension occured on follow up|2|||
130684504|NCT00239577|470472854|FG000|Primary Phase|Adverse Event|0|||
130350719|NCT00829933|469254075|FG002|Overall Study|Adverse Event|2|||
130438472|NCT00779584|469568276|FG002|Overall Study|Adverse Event|2|||
130438473|NCT00779584|469568277|FG003|Overall Study|Adverse Event|0|||
130438474|NCT00779584|469568278|FG004|Overall Study|Adverse Event|0|||
130438475|NCT00779584|469568279|FG005|Overall Study|Adverse Event|0|||
130438476|NCT00779584|469568280|FG006|Overall Study|Adverse Event|2|||
130438477|NCT00779584|469568281|FG007|Overall Study|Adverse Event|1|||
130438478|NCT00779584|469568282|FG008|Overall Study|Adverse Event|1|||
130438479|NCT00779584|469568274|FG000|Overall Study|Symptomatic Deterioration|1|||
130438480|NCT00779584|469568275|FG001|Overall Study|Symptomatic Deterioration|1|||
130438481|NCT00779584|469568276|FG002|Overall Study|Symptomatic Deterioration|1|||
130438482|NCT00779584|469568277|FG003|Overall Study|Symptomatic Deterioration|0|||
130350720|NCT00829933|469254076|FG003|Overall Study|Adverse Event|1|||
130350721|NCT00829933|469254073|FG000|Overall Study|Death|0|||
130684505|NCT00239577|470472855|FG001|Primary Phase|Adverse Event|0|||
130684506|NCT00239577|470472856|FG002|Primary Phase|Adverse Event|1|||
130684507|NCT00239577|470472857|FG003|Primary Phase|Adverse Event|0|||
130684508|NCT00239577|470472854|FG000|Primary Phase|Other|5|||
130684509|NCT00239577|470472855|FG001|Primary Phase|Other|3|||
130684510|NCT00239577|470472856|FG002|Primary Phase|Other|2|||
130684511|NCT00239577|470472857|FG003|Primary Phase|Other|0|||
130684512|NCT02736721|470472860|FG000|Overall Study|Adverse Event|8|||
130684513|NCT02736721|470472860|FG000|Overall Study|Lost to Follow-up|3|||
130684514|NCT02736721|470472860|FG000|Overall Study|Other|5|||
130684515|NCT03988803|470472861|FG000|Period 2|Prematurely discontinued from medication|2|||
130684516|NCT03988803|470472861|FG000|Period 2|Adverse Event|1|||
130684517|NCT03021018|470472863|FG000|Overall Study|Adverse Event|1|||
130684518|NCT03021018|470472864|FG001|Overall Study|Adverse Event|0|||
130684519|NCT03021018|470472865|FG002|Overall Study|Adverse Event|0|||
130684520|NCT03021018|470472863|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
130684521|NCT03021018|470472864|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
130684522|NCT03021018|470472865|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
130684523|NCT04123548|470472876|FG000|Overall Study|Withdrawal by Subject|1|||
130684524|NCT04123548|470472876|FG000|Overall Study|Lost to Follow-up|8|||
130684525|NCT04123548|470472876|FG000|Overall Study|Death|4|||
130684526|NCT04123548|470472876|FG000|Overall Study|Reason Not Specified|1|||
130684527|NCT00418184|470472879|FG000|Double-blind Phase|Withdrawal by Subject|22|||
130684528|NCT00418184|470472880|FG001|Double-blind Phase|Withdrawal by Subject|9|||
130684529|NCT00418184|470472879|FG000|Double-blind Phase|Adverse Event|2|||
130684530|NCT00418184|470472880|FG001|Double-blind Phase|Adverse Event|1|||
130684531|NCT00418184|470472879|FG000|Double-blind Phase|Poor compliance|3|||
130684532|NCT00418184|470472880|FG001|Double-blind Phase|Poor compliance|1|||
130684533|NCT00620074|470472881|FG000|Overall Study|Adverse Event|1|||
130684534|NCT01838941|470472882|FG000|Overall Study|Adverse Event|1|||
130684535|NCT01838941|470472882|FG000|Overall Study|Withdrawal by Subject|1|||
130350722|NCT00829933|469254074|FG001|Overall Study|Death|0|||
130350723|NCT00829933|469254075|FG002|Overall Study|Death|1|||
130350724|NCT00829933|469254076|FG003|Overall Study|Death|1|||
130350725|NCT00829933|469254073|FG000|Overall Study|Lack of Efficacy|0|||
130350726|NCT00829933|469254074|FG001|Overall Study|Lack of Efficacy|1|||
130350727|NCT00829933|469254075|FG002|Overall Study|Lack of Efficacy|0|||
130350728|NCT00829933|469254076|FG003|Overall Study|Lack of Efficacy|0|||
130350729|NCT00829933|469254073|FG000|Overall Study|Physician Decision|5|||
130350730|NCT00829933|469254074|FG001|Overall Study|Physician Decision|7|||
130350731|NCT00829933|469254075|FG002|Overall Study|Physician Decision|8|||
130350732|NCT00829933|469254076|FG003|Overall Study|Physician Decision|1|||
130350733|NCT00829933|469254073|FG000|Overall Study|Pregnancy|0|||
130350734|NCT00829933|469254074|FG001|Overall Study|Pregnancy|0|||
130350735|NCT00829933|469254075|FG002|Overall Study|Pregnancy|0|||
130350736|NCT00829933|469254076|FG003|Overall Study|Pregnancy|2|||
130350737|NCT00829933|469254073|FG000|Overall Study|Protocol Violation|2|||
130350738|NCT00829933|469254074|FG001|Overall Study|Protocol Violation|1|||
130350739|NCT00829933|469254075|FG002|Overall Study|Protocol Violation|0|||
130350740|NCT00829933|469254076|FG003|Overall Study|Protocol Violation|0|||
130350741|NCT00829933|469254073|FG000|Overall Study|withdrew before treatment started|5|||
130350742|NCT00829933|469254074|FG001|Overall Study|withdrew before treatment started|1|||
130350743|NCT00829933|469254075|FG002|Overall Study|withdrew before treatment started|2|||
130350744|NCT00829933|469254076|FG003|Overall Study|withdrew before treatment started|9|||
130350745|NCT01986933|469254081|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
130350746|NCT01986933|469254082|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
130350747|NCT01986933|469254083|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
130350748|NCT01986933|469254084|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
130350749|NCT01986933|469254085|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
130350750|NCT01986933|469254081|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
130350751|NCT01986933|469254082|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
130350752|NCT01986933|469254083|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
130350753|NCT01986933|469254084|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
130350754|NCT01986933|469254085|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
130350755|NCT01986933|469254081|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
130350756|NCT01986933|469254082|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
130684536|NCT02822235|470472883|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
130350757|NCT01986933|469254083|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
130350758|NCT01986933|469254084|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
130350759|NCT01986933|469254085|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
130684537|NCT02822235|470472884|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
130684538|NCT02822235|470472883|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
130684539|NCT02822235|470472884|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
130350760|NCT01986933|469254081|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130350761|NCT01986933|469254082|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
130684540|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
130684541|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
130684542|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
130684543|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
130684544|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
130684545|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
130684546|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
130684547|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
130684548|NCT03214952|470472885|FG000|Overall Study|Protocol Deviation|45|||
130684549|NCT03214952|470472885|FG000|Overall Study|Case Report Forms Uncollected|13|||
130684550|NCT03769896|470472888|FG000|Open-label Phase|Lack of Efficacy|5|||
130684551|NCT03769896|470472889|FG001|Open-label Phase|Lack of Efficacy|0|||
130684552|NCT03769896|470472888|FG000|Open-label Phase|Adverse Event|3|||
130684553|NCT03769896|470472889|FG001|Open-label Phase|Adverse Event|0|||
130684554|NCT03769896|470472888|FG000|Open-label Phase|Withdrawal by Subject|1|||
130684555|NCT03769896|470472889|FG001|Open-label Phase|Withdrawal by Subject|0|||
130684556|NCT00829530|470472890|FG000|First Intervention|Adverse Event|0|||
130684557|NCT00829530|470472891|FG001|First Intervention|Adverse Event|1|||
130684558|NCT00829530|470472890|FG000|First Intervention|Intolerance to Venopuncture|0|||
130684559|NCT00829530|470472891|FG001|First Intervention|Intolerance to Venopuncture|1|||
130684560|NCT00829530|470472890|FG000|Second Intervention|Intolerance to Venopuncture|1|||
130684561|NCT00829530|470472891|FG001|Second Intervention|Intolerance to Venopuncture|0|||
130684562|NCT01015625|470472894|FG000|Overall Study|Lost to Follow-up|3|||
130684563|NCT01015625|470472895|FG001|Overall Study|Lost to Follow-up|1|||
130684564|NCT01015625|470472894|FG000|Overall Study|Withdrawal by Subject|2|||
130684565|NCT01015625|470472895|FG001|Overall Study|Withdrawal by Subject|3|||
130684566|NCT01015625|470472894|FG000|Overall Study|Physician Decision|2|||
130684567|NCT01015625|470472895|FG001|Overall Study|Physician Decision|0|||
130684568|NCT01015625|470472894|FG000|Overall Study|Death|30|||
130684569|NCT01015625|470472895|FG001|Overall Study|Death|22|||
130684570|NCT04112823|470472896|FG000|Overall Study|Lost to Follow-up|2|||
130684571|NCT04112823|470472897|FG001|Overall Study|Lost to Follow-up|3|||
130684572|NCT00625443|470472898|FG000|Overall Study|Adverse Event|1|||
130684573|NCT00625443|470472899|FG001|Overall Study|Adverse Event|4|||
130684574|NCT00625443|470472900|FG002|Overall Study|Adverse Event|0|||
130684575|NCT00625443|470472898|FG000|Overall Study|Non-compliance with protocol|0|||
130684576|NCT00625443|470472899|FG001|Overall Study|Non-compliance with protocol|1|||
130684577|NCT00625443|470472900|FG002|Overall Study|Non-compliance with protocol|0|||
130684578|NCT00625443|470472898|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
130684579|NCT00625443|470472899|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
130684580|NCT00625443|470472900|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
130684581|NCT00625443|470472898|FG000|Overall Study|Withdrawal by Subject|0|||
130684582|NCT00625443|470472899|FG001|Overall Study|Withdrawal by Subject|1|||
130684583|NCT00625443|470472900|FG002|Overall Study|Withdrawal by Subject|2|||
130684584|NCT00625443|470472898|FG000|Overall Study|Physician Decision|0|||
130684585|NCT00625443|470472899|FG001|Overall Study|Physician Decision|4|||
130684586|NCT00625443|470472900|FG002|Overall Study|Physician Decision|2|||
130684587|NCT00625443|470472898|FG000|Overall Study|Other|0|||
130684588|NCT00625443|470472899|FG001|Overall Study|Other|1|||
130684589|NCT00625443|470472900|FG002|Overall Study|Other|1|||
130684590|NCT02472366|470472901|FG000|Overall Study|Lost to Follow-up|1|||
130684591|NCT02472366|470472902|FG001|Overall Study|Lost to Follow-up|0|||
130684592|NCT02728102|470472903|FG000|Overall Study|Death|3|||
130684593|NCT02728102|470472904|FG001|Overall Study|Death|0|||
130684594|NCT02728102|470472905|FG002|Overall Study|Death|1|||
130684595|NCT02728102|470472903|FG000|Overall Study|Withdrawal by Subject|0|||
130684596|NCT02728102|470472904|FG001|Overall Study|Withdrawal by Subject|2|||
130684597|NCT02728102|470472905|FG002|Overall Study|Withdrawal by Subject|3|||
130438483|NCT00779584|469568278|FG004|Overall Study|Symptomatic Deterioration|0|||
130438484|NCT00779584|469568279|FG005|Overall Study|Symptomatic Deterioration|1|||
130438485|NCT00779584|469568280|FG006|Overall Study|Symptomatic Deterioration|1|||
130438486|NCT00779584|469568281|FG007|Overall Study|Symptomatic Deterioration|0|||
130438487|NCT00779584|469568282|FG008|Overall Study|Symptomatic Deterioration|0|||
130684598|NCT02728102|470472903|FG000|Overall Study|Physician Decision|1|||
130684599|NCT02728102|470472904|FG001|Overall Study|Physician Decision|1|||
130684600|NCT02728102|470472905|FG002|Overall Study|Physician Decision|0|||
130684601|NCT02728102|470472903|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
130684602|NCT02728102|470472904|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
130684603|NCT02728102|470472905|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
130684604|NCT02728102|470472903|FG000|Overall Study|Covid|0|||
130684605|NCT02728102|470472904|FG001|Overall Study|Covid|0|||
130684606|NCT02728102|470472905|FG002|Overall Study|Covid|1|||
130438488|NCT00779584|469568274|FG000|Overall Study|Ongoing in Study|0|||
130684607|NCT01182415|470472906|FG000|Overall Study|Lost to Follow-up|1|||
130684608|NCT02587962|470472908|FG000|Overall Study|Adverse Event|0|||
130684609|NCT02587962|470472909|FG001|Overall Study|Adverse Event|0|||
130684610|NCT02587962|470472910|FG002|Overall Study|Adverse Event|1|||
130684611|NCT02587962|470472911|FG003|Overall Study|Adverse Event|0|||
130684612|NCT02587962|470472912|FG004|Overall Study|Adverse Event|0|||
130684613|NCT02587962|470472908|FG000|Overall Study|Withdrawal by Subject|0|||
130684614|NCT02587962|470472909|FG001|Overall Study|Withdrawal by Subject|0|||
130684615|NCT02587962|470472910|FG002|Overall Study|Withdrawal by Subject|1|||
130684616|NCT02587962|470472911|FG003|Overall Study|Withdrawal by Subject|1|||
130684617|NCT02587962|470472912|FG004|Overall Study|Withdrawal by Subject|4|||
130684618|NCT02587962|470472908|FG000|Overall Study|Radiological progression|2|||
130684619|NCT02587962|470472909|FG001|Overall Study|Radiological progression|2|||
130684620|NCT02587962|470472910|FG002|Overall Study|Radiological progression|2|||
130684621|NCT02587962|470472911|FG003|Overall Study|Radiological progression|5|||
130684622|NCT02587962|470472912|FG004|Overall Study|Radiological progression|10|||
130684623|NCT02587962|470472908|FG000|Overall Study|Clinical progression|0|||
130684624|NCT02587962|470472909|FG001|Overall Study|Clinical progression|1|||
130684625|NCT02587962|470472910|FG002|Overall Study|Clinical progression|2|||
130684626|NCT02587962|470472911|FG003|Overall Study|Clinical progression|0|||
130684627|NCT02587962|470472912|FG004|Overall Study|Clinical progression|1|||
130684628|NCT01422538|470472916|FG000|Overall Study|Lost to Follow-up|0|||
130684629|NCT01422538|470472917|FG001|Overall Study|Lost to Follow-up|1|||
130684630|NCT01422538|470472918|FG002|Overall Study|Lost to Follow-up|1|||
130684631|NCT01422538|470472916|FG000|Overall Study|Missed visit|0|||
130684632|NCT01422538|470472917|FG001|Overall Study|Missed visit|1|||
130684633|NCT01422538|470472918|FG002|Overall Study|Missed visit|1|||
130684634|NCT02770820|470472919|FG000|Overall Study|Death|1|||
130684635|NCT02770820|470472919|FG000|Overall Study|Physician Decision|2|||
130684636|NCT03555305|470472920|FG000|Period 1|Physician Decision|0|||
130684637|NCT03555305|470472921|FG001|Period 1|Physician Decision|1|||
130350762|NCT01986933|469254083|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130350763|NCT01986933|469254084|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
130350764|NCT01986933|469254085|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130350765|NCT01986933|469254081|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130350766|NCT01986933|469254082|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130350767|NCT01986933|469254083|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130350768|NCT01986933|469254084|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130350769|NCT01986933|469254085|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
130350770|NCT01986933|469254081|FG000|Active-to-active (Part B)|Adverse Event|0|||
130350771|NCT01986933|469254082|FG001|Active-to-active (Part B)|Adverse Event|2|||
130350772|NCT01986933|469254083|FG002|Active-to-active (Part B)|Adverse Event|0|||
130350773|NCT01986933|469254084|FG003|Active-to-active (Part B)|Adverse Event|1|||
130350774|NCT01986933|469254085|FG004|Active-to-active (Part B)|Adverse Event|3|||
130350775|NCT01986933|469254081|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
130350776|NCT01986933|469254082|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
130350777|NCT01986933|469254083|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
130350778|NCT01986933|469254084|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
130350779|NCT01986933|469254085|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
130350780|NCT01986933|469254081|FG000|Active-to-active (Part B)|Pregnancy|0|||
130350781|NCT01986933|469254082|FG001|Active-to-active (Part B)|Pregnancy|0|||
130350782|NCT01986933|469254083|FG002|Active-to-active (Part B)|Pregnancy|0|||
130350783|NCT01986933|469254084|FG003|Active-to-active (Part B)|Pregnancy|0|||
130350784|NCT01986933|469254085|FG004|Active-to-active (Part B)|Pregnancy|1|||
130350785|NCT01986933|469254081|FG000|Active-to-active (Part B)|Physician Decision|0|||
130684638|NCT03555305|470472920|FG000|Period 1|Adverse Event|0|||
130350786|NCT01986933|469254082|FG001|Active-to-active (Part B)|Physician Decision|0|||
130350787|NCT01986933|469254083|FG002|Active-to-active (Part B)|Physician Decision|1|||
130350788|NCT01986933|469254084|FG003|Active-to-active (Part B)|Physician Decision|1|||
130350789|NCT01986933|469254085|FG004|Active-to-active (Part B)|Physician Decision|0|||
130350790|NCT01986933|469254081|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
130350791|NCT01986933|469254082|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
130350792|NCT01986933|469254083|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
130684639|NCT03555305|470472921|FG001|Period 1|Adverse Event|1|||
130684640|NCT03586726|470472929|FG000|Overall Study|Withdrawal by Subject|1|||
130684641|NCT03420300|470472932|FG000|Overall Study|Death|2|||
130684642|NCT03500692|470472947|FG000|Overall Study|Death|163|||
130684643|NCT03500692|470472947|FG000|Overall Study|Lost to Follow-up|75|||
130684644|NCT03500692|470472947|FG000|Overall Study|Termination Reasons|3|||
130684645|NCT06358820|470474310|FG000|Overall Study|Adverse Event|11|||
130684646|NCT06358820|470474310|FG000|Overall Study|kidney transplantation|3|||
130684647|NCT06358820|470474310|FG000|Overall Study|patient voluntary withdrawal|6|||
130684648|NCT06358820|470474310|FG000|Overall Study|Physician Decision|1|||
130684649|NCT01066143|470474311|FG000|Overall Study|ineligible for the study|8|||
130684650|NCT05376319|470474312|FG000|Overall Study|Funding termination|2|||
130684651|NCT05376319|470474313|FG001|Overall Study|Funding termination|4|||
130684652|NCT01124175|470474314|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130684653|NCT01124175|470474315|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
130684654|NCT00942968|470474318|FG000|Overall Study|Adverse Event|60|||
130684655|NCT00942968|470474318|FG000|Overall Study|Death|76|||
130684656|NCT00942968|470474318|FG000|Overall Study|Protocol Violation|9|||
130684657|NCT00942968|470474318|FG000|Overall Study|Lost to Follow-up|4|||
130684658|NCT00942968|470474318|FG000|Overall Study|Withdrawal by Subject|44|||
130684659|NCT00942968|470474318|FG000|Overall Study|Sponsor request|5|||
130684660|NCT00942968|470474318|FG000|Overall Study|Physician Decision|11|||
130684661|NCT00942968|470474318|FG000|Overall Study|Progression of disease|12|||
130684662|NCT00942968|470474318|FG000|Overall Study|Inferior vena cava filter placement|4|||
130684663|NCT00942968|470474318|FG000|Overall Study|Pulmonary embolism (PE)|1|||
130684664|NCT00942968|470474318|FG000|Overall Study|Participant required pancreatic biopsy|1|||
130684665|NCT00942968|470474318|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
130684666|NCT00218257|470474324|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
130684667|NCT00218257|470474325|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
130684668|NCT01466166|470474326|FG000|Overall Study|Death|1|||
130684669|NCT01466166|470474326|FG000|Overall Study|Lost to Follow-up|7|||
130684670|NCT01466166|470474326|FG000|Overall Study|Infusion Reaction (IR)|27|||
130684671|NCT01466166|470474326|FG000|Overall Study|Adverse Event (Other than IR)|11|||
130684672|NCT01466166|470474326|FG000|Overall Study|Elevated Serum Uric Acid|78|||
130684673|NCT01466166|470474326|FG000|Overall Study|Withdrawal by Subject|13|||
130684674|NCT01466166|470474326|FG000|Overall Study|Sponsor Decision|4|||
130684675|NCT01466166|470474326|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
130350793|NCT01986933|469254084|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
130350794|NCT01986933|469254085|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
130684676|NCT01466166|470474326|FG000|Overall Study|Other|20|||
130684677|NCT01340495|470474333|FG000|Overall Study|Withdrawal by Subject|1|||
130684678|NCT00070291|470474334|FG000|Step 1|Withdrawal by Subject|1|||
130350795|NCT01986933|469254081|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
130350796|NCT01986933|469254082|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
130350797|NCT01986933|469254083|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
130350798|NCT01986933|469254084|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
130350799|NCT01986933|469254085|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
130350800|NCT01986933|469254081|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
130350801|NCT01986933|469254082|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130350802|NCT01986933|469254083|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
130350803|NCT01986933|469254084|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130350804|NCT01986933|469254085|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130350805|NCT01986933|469254081|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
130350806|NCT01986933|469254082|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
130350807|NCT01986933|469254083|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
130350808|NCT01986933|469254084|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
130350809|NCT01986933|469254085|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
130350810|NCT01986933|469254081|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130350811|NCT01986933|469254082|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130350812|NCT01986933|469254083|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130350813|NCT01986933|469254084|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
130350814|NCT01986933|469254085|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130684679|NCT00070291|470474334|FG000|Step 1|Adverse Event|1|||
130684680|NCT00070291|470474334|FG000|Step 2|Adverse Event|1|||
130684681|NCT02028715|470474337|FG000|Overall Study|Adverse Event|2|||
130684682|NCT02028715|470474338|FG001|Overall Study|Adverse Event|2|||
130684683|NCT02028715|470474337|FG000|Overall Study|Physician Decision|1|||
130684684|NCT02028715|470474338|FG001|Overall Study|Physician Decision|0|||
130350815|NCT01986933|469254081|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
130684685|NCT02028715|470474337|FG000|Overall Study|Did not complete satisfaction surveys|2|||
130684686|NCT02028715|470474338|FG001|Overall Study|Did not complete satisfaction surveys|2|||
130684687|NCT00520130|470474341|FG000|Overall Study|Disease progression on study|4|||
130684688|NCT00520130|470474342|FG001|Overall Study|Disease progression on study|0|||
130684689|NCT00520130|470474341|FG000|Overall Study|Physician Decision|1|||
130684690|NCT00520130|470474342|FG001|Overall Study|Physician Decision|1|||
130684691|NCT04915755|470474343|FG000|Overall Study|Physician Decision|3|||
130684692|NCT04915755|470474344|FG001|Overall Study|Physician Decision|2|||
130350816|NCT01986933|469254082|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
130350817|NCT01986933|469254083|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
130350818|NCT01986933|469254084|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
130350819|NCT01986933|469254085|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
130350820|NCT01986933|469254081|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
130350821|NCT01986933|469254082|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
130350822|NCT01986933|469254083|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
130350823|NCT01986933|469254084|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
130350824|NCT01986933|469254085|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
130350825|NCT01986933|469254081|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130350826|NCT01986933|469254082|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
130350827|NCT01986933|469254083|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130350828|NCT01986933|469254084|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130350829|NCT01986933|469254085|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130350830|NCT03119701|469254086|FG000|6-day Dosing|Death|4|||
130350831|NCT03119701|469254087|FG001|6-day Dosing|Death|1|||
130350832|NCT03119701|469254086|FG000|6-day Dosing|Adverse Event|3|||
130350833|NCT03119701|469254087|FG001|6-day Dosing|Adverse Event|0|||
130350834|NCT03119701|469254086|FG000|6-day Dosing|Physician Decision|0|||
130350835|NCT03119701|469254087|FG001|6-day Dosing|Physician Decision|1|||
130350836|NCT03119701|469254086|FG000|6-day Dosing|Withdrawal by Subject|0|||
130350837|NCT03119701|469254087|FG001|6-day Dosing|Withdrawal by Subject|1|||
130350838|NCT03119701|469254086|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
130350839|NCT03119701|469254087|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
130350840|NCT00811642|469254096|FG000|Overall Study|Adverse Event|3|||
130350841|NCT00811642|469254096|FG000|Overall Study|Protocol Violation|1|||
130350842|NCT00811642|469254096|FG000|Overall Study|Death|2|||
130350843|NCT00811642|469254096|FG000|Overall Study|Withdrawal by Subject|7|||
130350844|NCT00811642|469254096|FG000|Overall Study|Cumulative use of antifungal agent|2|||
130350845|NCT00782795|469254097|FG000|Overall Study|Withdrawal by Subject|1|||
130350846|NCT00782795|469254098|FG001|Overall Study|Withdrawal by Subject|2|||
130350847|NCT04854642|469255625|FG000|Overall Study|Adverse Event|1|||
130350848|NCT04854642|469255626|FG001|Overall Study|Adverse Event|2|||
130350849|NCT04854642|469255625|FG000|Overall Study|Withdrawal by Subject|0|||
130350850|NCT04854642|469255626|FG001|Overall Study|Withdrawal by Subject|1|||
130350851|NCT00562627|469255627|FG000|Overall Study|Protocol Violation|1|||
130350852|NCT00562627|469255628|FG001|Overall Study|Protocol Violation|1|||
130350853|NCT00562627|469255629|FG002|Overall Study|Protocol Violation|1|||
130350854|NCT00625742|469255630|FG000|Overall Study|Disease Progression|2|||
130350855|NCT00625742|469255630|FG000|Overall Study|Withdrawal by Subject|1|||
130350856|NCT00625742|469255630|FG000|Overall Study|Adverse Event|4|||
130350857|NCT00625742|469255630|FG000|Overall Study|Lost to Follow-up|4|||
130350858|NCT00625742|469255630|FG000|Overall Study|Ineligible|1|||
130350859|NCT01709578|469255631|FG000|Overall Study|Rescued and entered in long term safety|63|||
130350860|NCT01709578|469255632|FG001|Overall Study|Rescued and entered in long term safety|25|||
130350861|NCT01709578|469255633|FG002|Overall Study|Rescued and entered in long term safety|26|||
130350862|NCT01709578|469255631|FG000|Overall Study|Adverse Event|9|||
130350863|NCT01709578|469255632|FG001|Overall Study|Adverse Event|18|||
130350864|NCT01709578|469255633|FG002|Overall Study|Adverse Event|17|||
130350865|NCT01709578|469255631|FG000|Overall Study|Lack of Efficacy|5|||
130350866|NCT01709578|469255632|FG001|Overall Study|Lack of Efficacy|4|||
130350867|NCT01709578|469255633|FG002|Overall Study|Lack of Efficacy|2|||
130350868|NCT01709578|469255631|FG000|Overall Study|Poor compliance to protocol|1|||
130350869|NCT01709578|469255632|FG001|Overall Study|Poor compliance to protocol|2|||
130350870|NCT01709578|469255633|FG002|Overall Study|Poor compliance to protocol|1|||
130350871|NCT01709578|469255631|FG000|Overall Study|Other, not related to safety or efficacy|2|||
130350872|NCT01709578|469255632|FG001|Overall Study|Other, not related to safety or efficacy|7|||
130350873|NCT01709578|469255633|FG002|Overall Study|Other, not related to safety or efficacy|5|||
130350874|NCT04050371|469255634|FG000|Overall Study|Withdrawal by Subject|1|||
130350875|NCT04050371|469255635|FG001|Overall Study|Withdrawal by Subject|0|||
130350876|NCT01107418|469255636|FG000|Overall Study|Disease Progression|45|||
130350877|NCT01107418|469255636|FG000|Overall Study|Adverse Event|3|||
130350878|NCT01107418|469255636|FG000|Overall Study|Withdrawal by Subject|1|||
130350879|NCT01107418|469255636|FG000|Overall Study|Study Closing|1|||
130350880|NCT01107418|469255636|FG000|Overall Study|Started Other Therapy|1|||
130350881|NCT01107418|469255636|FG000|Overall Study|Entered Extension Study|1|||
130438489|NCT00779584|469568275|FG001|Overall Study|Ongoing in Study|0|||
130438490|NCT00779584|469568276|FG002|Overall Study|Ongoing in Study|0|||
130438491|NCT00779584|469568277|FG003|Overall Study|Ongoing in Study|0|||
130684693|NCT04915755|470474343|FG000|Overall Study|Withdrawal by Subject|1|||
130684694|NCT04915755|470474344|FG001|Overall Study|Withdrawal by Subject|1|||
130684695|NCT04915755|470474343|FG000|Overall Study|Ongoing for PACT|3|||
130684696|NCT04915755|470474344|FG001|Overall Study|Ongoing for PACT|2|||
130684697|NCT04915755|470474343|FG000|Overall Study|Other|7|||
130438492|NCT00779584|469568278|FG004|Overall Study|Ongoing in Study|1|||
130438493|NCT00779584|469568279|FG005|Overall Study|Ongoing in Study|1|||
130438494|NCT00779584|469568280|FG006|Overall Study|Ongoing in Study|0|||
130438495|NCT00779584|469568281|FG007|Overall Study|Ongoing in Study|0|||
130438496|NCT00779584|469568282|FG008|Overall Study|Ongoing in Study|0|||
130438497|NCT00406419|469568285|FG000|Overall Study|Death|3|||
130438498|NCT00406419|469568286|FG001|Overall Study|Death|1|||
130438499|NCT00406419|469568287|FG002|Overall Study|Death|4|||
130438500|NCT00406419|469568285|FG000|Overall Study|Protocol Violation|6|||
130438501|NCT00406419|469568286|FG001|Overall Study|Protocol Violation|2|||
130438502|NCT00406419|469568287|FG002|Overall Study|Protocol Violation|5|||
130438503|NCT00406419|469568285|FG000|Overall Study|Study Terminated by Sponsor|260|||
130438504|NCT00406419|469568286|FG001|Overall Study|Study Terminated by Sponsor|288|||
130438505|NCT00406419|469568287|FG002|Overall Study|Study Terminated by Sponsor|282|||
130438506|NCT00406419|469568285|FG000|Overall Study|Withdrawal by Subject|17|||
130438507|NCT00406419|469568286|FG001|Overall Study|Withdrawal by Subject|24|||
130438508|NCT00406419|469568287|FG002|Overall Study|Withdrawal by Subject|26|||
130438509|NCT00406419|469568285|FG000|Overall Study|Lack of Efficacy|12|||
130438510|NCT00406419|469568286|FG001|Overall Study|Lack of Efficacy|1|||
130438511|NCT00406419|469568287|FG002|Overall Study|Lack of Efficacy|6|||
130438512|NCT00406419|469568285|FG000|Overall Study|Non-Compliance with Study Drug|5|||
130438513|NCT00406419|469568286|FG001|Overall Study|Non-Compliance with Study Drug|6|||
130438514|NCT00406419|469568287|FG002|Overall Study|Non-Compliance with Study Drug|3|||
130438515|NCT00406419|469568285|FG000|Overall Study|Adverse Event|10|||
130438516|NCT00406419|469568286|FG001|Overall Study|Adverse Event|12|||
130438517|NCT00406419|469568287|FG002|Overall Study|Adverse Event|16|||
130438518|NCT00406419|469568285|FG000|Overall Study|Lost to Follow-up|11|||
130684698|NCT04915755|470474344|FG001|Overall Study|Other|11|||
130684699|NCT02533258|470474345|FG000|Overall Study|Adverse Event|1|||
130684700|NCT02533258|470474345|FG000|Overall Study|Death|2|||
130684701|NCT02533258|470474345|FG000|Overall Study|Other|1|||
130684702|NCT02533258|470474345|FG000|Overall Study|Economic factor|1|||
130684703|NCT02533258|470474345|FG000|Overall Study|Progression of pleural effusion|1|||
130684704|NCT02533258|470474345|FG000|Overall Study|Lack of Efficacy|2|||
130684705|NCT02495857|470474347|FG000|Overall Study|Adverse Event|5|||
130684706|NCT02495857|470474348|FG001|Overall Study|Adverse Event|0|||
130684707|NCT02495857|470474349|FG002|Overall Study|Adverse Event|1|||
130684708|NCT02495857|470474347|FG000|Overall Study|Withdrawal by Subject|9|||
130684709|NCT02495857|470474348|FG001|Overall Study|Withdrawal by Subject|6|||
130438519|NCT00406419|469568286|FG001|Overall Study|Lost to Follow-up|10|||
130438520|NCT00406419|469568287|FG002|Overall Study|Lost to Follow-up|5|||
130438521|NCT02878213|469568288|FG000|Overall Study|Withdrawal by Subject|2|||
130438522|NCT02878213|469568288|FG000|Overall Study|Adverse Event|1|||
130438523|NCT02302066|469568291|FG000|Overall Study|Adverse Event|1|||
130438524|NCT02302066|469568292|FG001|Overall Study|Adverse Event|1|||
130438525|NCT02302066|469568293|FG002|Overall Study|Adverse Event|3|||
130438526|NCT02302066|469568294|FG003|Overall Study|Adverse Event|0|||
130438527|NCT02302066|469568291|FG000|Overall Study|Lost to Follow-up|4|||
130438528|NCT02302066|469568292|FG001|Overall Study|Lost to Follow-up|5|||
130684710|NCT02495857|470474349|FG002|Overall Study|Withdrawal by Subject|10|||
130684711|NCT02495857|470474347|FG000|Overall Study|Physician Decision|0|||
130684712|NCT02495857|470474348|FG001|Overall Study|Physician Decision|1|||
130684713|NCT02495857|470474349|FG002|Overall Study|Physician Decision|0|||
130684714|NCT02495857|470474347|FG000|Overall Study|Protocol Violation|1|||
130684715|NCT02495857|470474348|FG001|Overall Study|Protocol Violation|1|||
130438529|NCT02302066|469568293|FG002|Overall Study|Lost to Follow-up|24|||
130438530|NCT02302066|469568294|FG003|Overall Study|Lost to Follow-up|7|||
130438531|NCT02302066|469568291|FG000|Overall Study|Withdrawal by Subject|25|||
130684716|NCT02495857|470474349|FG002|Overall Study|Protocol Violation|2|||
130684717|NCT02495857|470474347|FG000|Overall Study|Lost to Follow-up|4|||
130438532|NCT02302066|469568292|FG001|Overall Study|Withdrawal by Subject|58|||
130438533|NCT02302066|469568293|FG002|Overall Study|Withdrawal by Subject|124|||
130438534|NCT02302066|469568294|FG003|Overall Study|Withdrawal by Subject|33|||
130438535|NCT02302066|469568291|FG000|Overall Study|Pregnancy|2|||
130438536|NCT02302066|469568292|FG001|Overall Study|Pregnancy|10|||
130438537|NCT02302066|469568293|FG002|Overall Study|Pregnancy|12|||
130438538|NCT02302066|469568294|FG003|Overall Study|Pregnancy|0|||
130438539|NCT02302066|469568291|FG000|Overall Study|Reason Not Specified|1|||
130438540|NCT02302066|469568292|FG001|Overall Study|Reason Not Specified|1|||
130684718|NCT02495857|470474348|FG001|Overall Study|Lost to Follow-up|5|||
130438541|NCT02302066|469568293|FG002|Overall Study|Reason Not Specified|9|||
130438542|NCT02302066|469568294|FG003|Overall Study|Reason Not Specified|1|||
130438543|NCT02875834|469568295|FG000|Open-label Phase|Withdrawal by Subject|3|||
130438544|NCT02875834|469568296|FG001|Open-label Phase|Withdrawal by Subject|0|||
130438545|NCT02875834|469568297|FG002|Open-label Phase|Withdrawal by Subject|0|||
130438546|NCT02875834|469568298|FG003|Open-label Phase|Withdrawal by Subject|0|||
130438547|NCT02875834|469568295|FG000|Open-label Phase|(Not collected)|4|||
130438548|NCT02875834|469568296|FG001|Open-label Phase|(Not collected)|0|||
130438549|NCT02875834|469568297|FG002|Open-label Phase|(Not collected)|0|||
130438550|NCT02875834|469568298|FG003|Open-label Phase|(Not collected)|0|||
130438551|NCT02875834|469568295|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
130438552|NCT02875834|469568296|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
130438553|NCT02875834|469568297|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
130438554|NCT02875834|469568298|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
130438555|NCT02875834|469568295|FG000|Randomized Treatment Phase|Protocol Violation|0|||
130438556|NCT02875834|469568296|FG001|Randomized Treatment Phase|Protocol Violation|2|||
130438557|NCT02875834|469568297|FG002|Randomized Treatment Phase|Protocol Violation|0|||
130438558|NCT02875834|469568298|FG003|Randomized Treatment Phase|Protocol Violation|0|||
130438559|NCT02875834|469568295|FG000|Randomized Treatment Phase|(Not collected)|0|||
130438560|NCT02875834|469568296|FG001|Randomized Treatment Phase|(Not collected)|9|||
130438561|NCT02875834|469568297|FG002|Randomized Treatment Phase|(Not collected)|10|||
130684719|NCT02495857|470474349|FG002|Overall Study|Lost to Follow-up|3|||
130684720|NCT02495857|470474347|FG000|Overall Study|Other|3|||
130684721|NCT02495857|470474348|FG001|Overall Study|Other|3|||
130438562|NCT02875834|469568298|FG003|Randomized Treatment Phase|(Not collected)|9|||
130438563|NCT01032044|469568299|FG000|Overall Study|Protocol Violation|14|||
130438564|NCT01032044|469568300|FG001|Overall Study|Protocol Violation|8|||
130438565|NCT01032044|469568299|FG000|Overall Study|Adverse Event|0|||
130438566|NCT01032044|469568300|FG001|Overall Study|Adverse Event|1|||
130438567|NCT01032044|469568299|FG000|Overall Study|Lost to Follow-up|11|||
130438568|NCT01032044|469568300|FG001|Overall Study|Lost to Follow-up|11|||
130438569|NCT03311230|469568301|FG000|Overall Study|Withdrawal by Subject|1|||
130438570|NCT03311230|469568302|FG001|Overall Study|Withdrawal by Subject|4|||
130438571|NCT03311230|469568303|FG002|Overall Study|Withdrawal by Subject|2|||
130438572|NCT03311230|469568304|FG003|Overall Study|Withdrawal by Subject|7|||
130438573|NCT03311230|469568301|FG000|Overall Study|Unrelated injury|0|||
130438574|NCT03311230|469568302|FG001|Overall Study|Unrelated injury|1|||
130438575|NCT03311230|469568303|FG002|Overall Study|Unrelated injury|0|||
130438576|NCT03311230|469568304|FG003|Overall Study|Unrelated injury|0|||
130438577|NCT03342053|469568305|FG000|Overall Study|Adverse Event|2|||
130438578|NCT03342053|469568306|FG001|Overall Study|Adverse Event|0|||
130438579|NCT03342053|469568305|FG000|Overall Study|Withdrawal by Subject|0|||
130438580|NCT03342053|469568306|FG001|Overall Study|Withdrawal by Subject|1|||
130438581|NCT01302938|469568307|FG000|Overall Study|Withdrawal by Subject|1|||
130438582|NCT01302938|469568308|FG001|Overall Study|Withdrawal by Subject|0|||
130438583|NCT01302938|469568307|FG000|Overall Study|Adverse Event|1|||
130438584|NCT01302938|469568308|FG001|Overall Study|Adverse Event|0|||
130438585|NCT01233609|469568309|FG000|Overall Study|Death|1|||
130438586|NCT01233609|469568310|FG001|Overall Study|Death|0|||
130438587|NCT01233609|469568309|FG000|Overall Study|Lost to Follow-up|3|||
130438588|NCT01233609|469568310|FG001|Overall Study|Lost to Follow-up|1|||
130438589|NCT01233609|469568309|FG000|Overall Study|Adverse Event|2|||
130438590|NCT01233609|469568310|FG001|Overall Study|Adverse Event|1|||
130438591|NCT01233609|469568309|FG000|Overall Study|Withdrawal by Subject|3|||
130438592|NCT01233609|469568310|FG001|Overall Study|Withdrawal by Subject|0|||
130438593|NCT02961374|469568311|FG000|Overall Study|Adverse Event|4|||
130438594|NCT00735644|469568312|FG000|Overall Study|Did not receive study vaccine|0|||
130438595|NCT00735644|469568313|FG001|Overall Study|Did not receive study vaccine|1|||
130438596|NCT00735644|469568314|FG002|Overall Study|Did not receive study vaccine|0|||
130438597|NCT00735644|469568315|FG003|Overall Study|Did not receive study vaccine|0|||
130438598|NCT00735644|469568316|FG004|Overall Study|Did not receive study vaccine|0|||
130438599|NCT00735644|469568312|FG000|Overall Study|Withdrawal by Subject|0|||
130438600|NCT00735644|469568313|FG001|Overall Study|Withdrawal by Subject|1|||
130438601|NCT00735644|469568314|FG002|Overall Study|Withdrawal by Subject|1|||
130438602|NCT00735644|469568315|FG003|Overall Study|Withdrawal by Subject|1|||
130438603|NCT00735644|469568316|FG004|Overall Study|Withdrawal by Subject|0|||
130438604|NCT02041923|469568319|FG000|Overall Study|Lost to Follow-up|26|||
130438605|NCT02041923|469568320|FG001|Overall Study|Lost to Follow-up|30|||
130438606|NCT00874432|469568328|FG000|Overall Study|Withdrawal by Subject|1|||
130438607|NCT00874432|469568329|FG001|Overall Study|Withdrawal by Subject|0|||
130438608|NCT00874432|469568330|FG002|Overall Study|Withdrawal by Subject|0|||
130438609|NCT00874432|469568331|FG003|Overall Study|Withdrawal by Subject|0|||
130684722|NCT02495857|470474349|FG002|Overall Study|Other|2|||
130684723|NCT00396279|470474350|FG000|Overall Study|Ongoing in study|26|||
130438610|NCT00874432|469568328|FG000|Overall Study|Physician Decision|1|||
130438611|NCT00874432|469568329|FG001|Overall Study|Physician Decision|0|||
130438612|NCT00874432|469568330|FG002|Overall Study|Physician Decision|0|||
130438613|NCT00874432|469568331|FG003|Overall Study|Physician Decision|0|||
130438614|NCT00874432|469568328|FG000|Overall Study|Other|1|||
130438615|NCT00874432|469568329|FG001|Overall Study|Other|2|||
130438616|NCT00874432|469568330|FG002|Overall Study|Other|8|||
130438617|NCT00874432|469568331|FG003|Overall Study|Other|3|||
130438618|NCT01518946|469568332|FG000|Open-label Phase|Other|4|||
130438619|NCT01518946|469568333|FG001|Open-label Phase|Other|0|||
130438620|NCT01518946|469568334|FG002|Open-label Phase|Other|0|||
130438621|NCT01518946|469568332|FG000|Randomized Phase (First Intervention)|Other|0|||
130438622|NCT01518946|469568333|FG001|Randomized Phase (First Intervention)|Other|1|||
130438623|NCT01518946|469568334|FG002|Randomized Phase (First Intervention)|Other|0|||
130684724|NCT00396279|470474350|FG000|Overall Study|Disease progression|2|||
130684725|NCT00396279|470474350|FG000|Overall Study|Withdrawal by Subject|1|||
130684726|NCT00396279|470474350|FG000|Overall Study|Physician Decision|1|||
130684727|NCT02883452|470474351|FG000|Overall Study|Withdrawal by Subject|1|||
130684728|NCT02883452|470474352|FG001|Overall Study|Withdrawal by Subject|1|||
130684729|NCT02883452|470474353|FG002|Overall Study|Withdrawal by Subject|3|||
130438624|NCT00384059|469568335|FG000|Infant Series|Not consented|2|||
130438625|NCT00384059|469568336|FG001|Infant Series|Not consented|6|||
130438626|NCT00384059|469568335|FG000|Infant Series|Withdrawal by Subject|2|||
130438627|NCT00384059|469568336|FG001|Infant Series|Withdrawal by Subject|2|||
130438628|NCT00384059|469568335|FG000|Infant Series|Adverse Event|1|||
130438629|NCT00384059|469568336|FG001|Infant Series|Adverse Event|2|||
130684730|NCT02883452|470474354|FG003|Overall Study|Withdrawal by Subject|0|||
130684731|NCT02883452|470474355|FG004|Overall Study|Withdrawal by Subject|2|||
130684732|NCT02883452|470474356|FG005|Overall Study|Withdrawal by Subject|5|||
130684733|NCT02883452|470474351|FG000|Overall Study|Disease progression|1|||
130684734|NCT02883452|470474352|FG001|Overall Study|Disease progression|0|||
130684735|NCT02883452|470474353|FG002|Overall Study|Disease progression|0|||
130350882|NCT00597701|469255637|FG000|Overall Study|Withdrawal by Subject|5|||
130350883|NCT00597701|469255638|FG001|Overall Study|Withdrawal by Subject|5|||
130350884|NCT00597701|469255637|FG000|Overall Study|Death|0|||
130350885|NCT00597701|469255638|FG001|Overall Study|Death|1|||
130350886|NCT00597701|469255637|FG000|Overall Study|Physician Decision|2|||
130350887|NCT00597701|469255638|FG001|Overall Study|Physician Decision|0|||
130350888|NCT00597701|469255637|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
130350889|NCT00597701|469255638|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
130350890|NCT00301821|469255645|FG000|Overall Study|Ineligible|25|||
130350891|NCT00301821|469255645|FG000|Overall Study|Cancel|1|||
130350892|NCT01314911|469255648|FG000|Overall Study|Lost to Follow-up|3|||
130350893|NCT01314911|469255649|FG001|Overall Study|Lost to Follow-up|2|||
130350894|NCT01314911|469255648|FG000|Overall Study|Withdrawal by Subject|1|||
130350895|NCT01314911|469255649|FG001|Overall Study|Withdrawal by Subject|3|||
130350896|NCT01314911|469255648|FG000|Overall Study|Received Non-randomized Study Drug|0|||
130350897|NCT01314911|469255649|FG001|Overall Study|Received Non-randomized Study Drug|1|||
130350898|NCT01314911|469255648|FG000|Overall Study|Never Started Treatment|1|||
130350899|NCT01314911|469255649|FG001|Overall Study|Never Started Treatment|0|||
130350900|NCT03150485|469255653|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130350901|NCT03150485|469255654|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130350902|NCT03150485|469255655|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
130350903|NCT03150485|469255656|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
130350904|NCT03150485|469255657|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
130350905|NCT03150485|469255658|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
130350906|NCT01394718|469255661|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
130350907|NCT01394718|469255662|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
130350908|NCT01362595|469255669|FG000|Overall Study|Screen failure|10|||
130350909|NCT01362595|469255669|FG000|Overall Study|Withdrawal by Subject|2|||
130350910|NCT02469038|469255670|FG000|Overall Study|Physician Decision|4|||
130350911|NCT02469038|469255671|FG001|Overall Study|Physician Decision|5|||
130350912|NCT00636987|469255672|FG000|Overall Study|Death|44|||
130350913|NCT00636987|469255672|FG000|Overall Study|Explanted|13|||
130350914|NCT00636987|469255672|FG000|Overall Study|Lost to Follow-up|63|||
130350915|NCT00636987|469255672|FG000|Overall Study|5 year visit window not complete|69|||
130350916|NCT01251146|469255673|FG000|Overall Study|Lost to Follow-up|3|||
130350917|NCT01251146|469255674|FG001|Overall Study|Lost to Follow-up|10|||
130350918|NCT01739400|469255675|FG000|Overall Study|Physician Decision|3|||
130350919|NCT01739400|469255676|FG001|Overall Study|Physician Decision|0|||
130350920|NCT01739400|469255675|FG000|Overall Study|Lost to Follow-up|2|||
130438630|NCT00384059|469568335|FG000|Infant Series|Protocol Violation|1|||
130438631|NCT00384059|469568336|FG001|Infant Series|Protocol Violation|2|||
130684736|NCT02883452|470474354|FG003|Overall Study|Disease progression|1|||
130684737|NCT02883452|470474355|FG004|Overall Study|Disease progression|4|||
130350921|NCT01739400|469255676|FG001|Overall Study|Lost to Follow-up|0|||
130350922|NCT01739400|469255675|FG000|Overall Study|Death|5|||
130350923|NCT01739400|469255676|FG001|Overall Study|Death|2|||
130350924|NCT01739400|469255675|FG000|Overall Study|Withdrawal by Subject|7|||
130350925|NCT01739400|469255676|FG001|Overall Study|Withdrawal by Subject|7|||
130438632|NCT00384059|469568335|FG000|Infant Series|Lost to Follow-up|0|||
130684738|NCT02883452|470474356|FG005|Overall Study|Disease progression|5|||
130684739|NCT02883452|470474351|FG000|Overall Study|Adverse Event|2|||
130684740|NCT02883452|470474352|FG001|Overall Study|Adverse Event|1|||
130684741|NCT02883452|470474353|FG002|Overall Study|Adverse Event|1|||
130684742|NCT02883452|470474354|FG003|Overall Study|Adverse Event|1|||
130684743|NCT02883452|470474355|FG004|Overall Study|Adverse Event|1|||
130684744|NCT02883452|470474356|FG005|Overall Study|Adverse Event|3|||
130684745|NCT02883452|470474351|FG000|Overall Study|Physician Decision|0|||
130350926|NCT01083173|469255683|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
130350927|NCT01083173|469255684|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
130350928|NCT01083173|469255683|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
130350929|NCT01083173|469255684|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
130350930|NCT01083173|469255683|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
130350931|NCT01083173|469255684|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
130350932|NCT01083173|469255683|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
130350933|NCT01083173|469255684|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
130350934|NCT01083173|469255683|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
130350935|NCT01083173|469255684|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
130350936|NCT01083173|469255683|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
130350937|NCT01083173|469255684|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
130350938|NCT01083173|469255683|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
130350939|NCT01083173|469255684|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
130350940|NCT01083173|469255683|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
130350941|NCT01083173|469255684|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
130350942|NCT01083173|469255683|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
130350943|NCT01083173|469255684|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
130350944|NCT01083173|469255683|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
130350945|NCT01083173|469255684|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
130350946|NCT01083173|469255683|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
130350947|NCT01083173|469255684|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
130350948|NCT03410823|469255685|FG000|Overall Study|Death|1|||
130350949|NCT03410823|469255685|FG000|Overall Study|Withdrawal by Subject|2|||
130350950|NCT03410823|469255685|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
130350981|NCT05128929|469255693|FG000|Overall Study|Adverse Event|0|||
130350982|NCT05128929|469255694|FG001|Overall Study|Adverse Event|1|||
130350983|NCT02742246|469255695|FG000|Overall Study|Never initiated treatment|5|||
130684746|NCT02883452|470474352|FG001|Overall Study|Physician Decision|0|||
130684747|NCT02883452|470474353|FG002|Overall Study|Physician Decision|0|||
130350984|NCT02742246|469255696|FG001|Overall Study|Never initiated treatment|3|||
130350985|NCT02742246|469255697|FG002|Overall Study|Never initiated treatment|1|||
130350986|NCT02742246|469255695|FG000|Overall Study|dropped out during treatment|7|||
130684748|NCT02883452|470474354|FG003|Overall Study|Physician Decision|0|||
130684749|NCT02883452|470474355|FG004|Overall Study|Physician Decision|4|||
130684750|NCT02883452|470474356|FG005|Overall Study|Physician Decision|1|||
130684751|NCT02883452|470474351|FG000|Overall Study|Death|1|||
130684752|NCT02883452|470474352|FG001|Overall Study|Death|0|||
130684753|NCT02883452|470474353|FG002|Overall Study|Death|1|||
130684754|NCT02883452|470474354|FG003|Overall Study|Death|0|||
130684755|NCT02883452|470474355|FG004|Overall Study|Death|0|||
130684756|NCT02883452|470474356|FG005|Overall Study|Death|0|||
130684757|NCT02883452|470474351|FG000|Overall Study|Other|0|||
130684758|NCT02883452|470474352|FG001|Overall Study|Other|0|||
130684759|NCT02883452|470474353|FG002|Overall Study|Other|0|||
130684760|NCT02883452|470474354|FG003|Overall Study|Other|0|||
130684761|NCT02883452|470474355|FG004|Overall Study|Other|0|||
130684762|NCT02883452|470474356|FG005|Overall Study|Other|1|||
130684763|NCT00830206|470474357|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130684764|NCT00830206|470474358|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
130684765|NCT04605094|470474360|FG000|Overall Study|Adverse Event|2|||
130684766|NCT04605094|470474361|FG001|Overall Study|Adverse Event|2|||
130684767|NCT04605094|470474360|FG000|Overall Study|Lost to Follow-up|1|||
130684768|NCT04605094|470474361|FG001|Overall Study|Lost to Follow-up|4|||
130684769|NCT04605094|470474360|FG000|Overall Study|Physician Decision|2|||
130684770|NCT04605094|470474361|FG001|Overall Study|Physician Decision|2|||
130684771|NCT04605094|470474360|FG000|Overall Study|Study terminated by Sponsor|31|||
130684772|NCT04605094|470474361|FG001|Overall Study|Study terminated by Sponsor|33|||
130684773|NCT04605094|470474360|FG000|Overall Study|Withdrawal by Subject|22|||
130684774|NCT04605094|470474361|FG001|Overall Study|Withdrawal by Subject|19|||
130684775|NCT04605094|470474360|FG000|Overall Study|Other|1|||
130684776|NCT04605094|470474361|FG001|Overall Study|Other|1|||
130684777|NCT01900691|470474362|FG000|Overall Study|Death|7|||
130684778|NCT01900691|470474362|FG000|Overall Study|Lost to Follow-up|4|||
130684779|NCT01900691|470474362|FG000|Overall Study|Study Device Not Placed|3|||
130684780|NCT01900691|470474362|FG000|Overall Study|Non study stent placed|2|||
130684781|NCT01900691|470474362|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
130684782|NCT01900691|470474362|FG000|Overall Study|Complete stent migration through digestive tract|1|||
130684783|NCT02724462|470474363|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
130684784|NCT02724462|470474364|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
130684785|NCT02724462|470474363|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684786|NCT02724462|470474364|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130684787|NCT02724462|470474363|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
130684788|NCT02724462|470474364|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
130684789|NCT02724462|470474363|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684790|NCT02724462|470474364|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130350987|NCT02742246|469255696|FG001|Overall Study|dropped out during treatment|13|||
130350988|NCT02742246|469255697|FG002|Overall Study|dropped out during treatment|10|||
130350989|NCT02742246|469255695|FG000|Overall Study|Death|1|||
130350990|NCT02742246|469255696|FG001|Overall Study|Death|0|||
130684791|NCT02724462|470474363|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
130684792|NCT02724462|470474364|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
130684793|NCT02724462|470474363|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684794|NCT02724462|470474364|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130684795|NCT01954394|470474367|FG000|Overall Study|Enrolled but not treated|1|||
130684796|NCT01954394|470474368|FG001|Overall Study|Enrolled but not treated|0|||
130684797|NCT01954394|470474367|FG000|Overall Study|Adverse Event|10|||
130684798|NCT01954394|470474368|FG001|Overall Study|Adverse Event|23|||
130684799|NCT01954394|470474367|FG000|Overall Study|Poor compliance to protocol|7|||
130350991|NCT02742246|469255697|FG002|Overall Study|Death|0|||
130350992|NCT03553836|469255699|FG000|Overall Study|Ongoing in Study|460|||
130350993|NCT03553836|469255700|FG001|Overall Study|Ongoing in Study|459|||
130350994|NCT03553836|469255699|FG000|Overall Study|Withdrawal by Subject|9|||
130350995|NCT03553836|469255700|FG001|Overall Study|Withdrawal by Subject|10|||
130350996|NCT03553836|469255699|FG000|Overall Study|Lost to Follow-up|1|||
130350997|NCT03553836|469255700|FG001|Overall Study|Lost to Follow-up|3|||
130684800|NCT01954394|470474368|FG001|Overall Study|Poor compliance to protocol|7|||
130684801|NCT01954394|470474367|FG000|Overall Study|Participant Moved|0|||
130684802|NCT01954394|470474368|FG001|Overall Study|Participant Moved|4|||
130684803|NCT01954394|470474367|FG000|Overall Study|Related to Study Drug administration|2|||
130684804|NCT01954394|470474368|FG001|Overall Study|Related to Study Drug administration|2|||
130350998|NCT03553836|469255699|FG000|Overall Study|Death|17|||
130350999|NCT03553836|469255700|FG001|Overall Study|Death|17|||
130351000|NCT03220438|469255701|FG000|Overall Study|Lost to Follow-up|0|||
130684805|NCT01954394|470474367|FG000|Overall Study|Other than specified above|10|||
130438633|NCT00384059|469568336|FG001|Infant Series|Lost to Follow-up|1|||
130684806|NCT01954394|470474368|FG001|Overall Study|Other than specified above|21|||
130684807|NCT02422264|470474378|FG000|Overall Study|Serious Adverse Event|1|||
130684808|NCT02422264|470474379|FG001|Overall Study|Serious Adverse Event|0|||
130351001|NCT03220438|469255702|FG001|Overall Study|Lost to Follow-up|0|||
130684809|NCT02422264|470474378|FG000|Overall Study|Withdrawal by Subject|1|||
130684810|NCT02422264|470474379|FG001|Overall Study|Withdrawal by Subject|2|||
130684811|NCT02422264|470474378|FG000|Overall Study|Migrated/moved from study area|3|||
130351002|NCT03220438|469255703|FG002|Overall Study|Lost to Follow-up|1|||
130351003|NCT03220438|469255704|FG003|Overall Study|Lost to Follow-up|0|||
130351004|NCT04062123|469255705|FG000|Overall Study|Withdrawal by Subject|0|||
130351005|NCT04062123|469255706|FG001|Overall Study|Withdrawal by Subject|1|||
130351006|NCT04062123|469255707|FG002|Overall Study|Withdrawal by Subject|0|||
130351007|NCT01479985|469255710|FG000|Overall Study|Tablet malfunction, no data saved|1|||
130351008|NCT01479985|469255711|FG001|Overall Study|Tablet malfunction, no data saved|1|||
130351009|NCT01479985|469255710|FG000|Overall Study|No decisional conflict scale responses|0|||
130351010|NCT01479985|469255711|FG001|Overall Study|No decisional conflict scale responses|2|||
130351011|NCT01479985|469255710|FG000|Overall Study|No post-visit survey|5|||
130351012|NCT01479985|469255711|FG001|Overall Study|No post-visit survey|3|||
130351013|NCT00662532|469255717|FG000|Overall Study|Adverse Event|0|||
130351014|NCT00662532|469255718|FG001|Overall Study|Adverse Event|1|||
130351015|NCT00662532|469255717|FG000|Overall Study|Lost to Follow-up|0|||
130351016|NCT00662532|469255718|FG001|Overall Study|Lost to Follow-up|1|||
130351017|NCT01850602|469255719|FG000|Overall Study|Adverse Event|7|||
130351018|NCT01850602|469255720|FG001|Overall Study|Adverse Event|10|||
130351019|NCT01850602|469255719|FG000|Overall Study|Physician Decision|2|||
130351020|NCT01850602|469255720|FG001|Overall Study|Physician Decision|1|||
130351021|NCT01850602|469255719|FG000|Overall Study|Withdrawal by Subject|2|||
130351022|NCT01850602|469255720|FG001|Overall Study|Withdrawal by Subject|4|||
130351023|NCT01850602|469255719|FG000|Overall Study|Decrease in serum calcium|2|||
130351024|NCT01850602|469255720|FG001|Overall Study|Decrease in serum calcium|3|||
130351025|NCT01850602|469255719|FG000|Overall Study|Increase in serum ferritin|1|||
130351026|NCT01850602|469255720|FG001|Overall Study|Increase in serum ferritin|0|||
130351027|NCT00367770|469255721|FG000|Overall Study|Adverse Event|1|||
130351028|NCT00367770|469255721|FG000|Overall Study|Withdrawal by Subject|1|||
130351029|NCT01155479|469255722|FG000|Part I|Adverse Event|13|||
130351030|NCT01155479|469255723|FG001|Part I|Adverse Event|8|||
130351031|NCT01155479|469255724|FG002|Part I|Adverse Event|18|||
130351032|NCT01155479|469255725|FG003|Part I|Adverse Event|7|||
130351033|NCT01155479|469255726|FG004|Part I|Adverse Event|6|||
130351034|NCT01155479|469255722|FG000|Part I|Administrative|2|||
130351035|NCT01155479|469255723|FG001|Part I|Administrative|2|||
130351036|NCT01155479|469255724|FG002|Part I|Administrative|2|||
130351037|NCT01155479|469255725|FG003|Part I|Administrative|0|||
130351038|NCT01155479|469255726|FG004|Part I|Administrative|0|||
130351039|NCT01155479|469255722|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
130351040|NCT01155479|469255723|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
130351041|NCT01155479|469255724|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
130351042|NCT01155479|469255725|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
130351043|NCT01155479|469255726|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
130351044|NCT01155479|469255722|FG000|Part I|Withdrawal by Subject|11|||
130351045|NCT01155479|469255723|FG001|Part I|Withdrawal by Subject|13|||
130351046|NCT01155479|469255724|FG002|Part I|Withdrawal by Subject|8|||
130351047|NCT01155479|469255725|FG003|Part I|Withdrawal by Subject|8|||
130351048|NCT01155479|469255726|FG004|Part I|Withdrawal by Subject|9|||
130351049|NCT01155479|469255722|FG000|Part I|Lost to Follow-up|0|||
130351050|NCT01155479|469255723|FG001|Part I|Lost to Follow-up|0|||
130351051|NCT01155479|469255724|FG002|Part I|Lost to Follow-up|1|||
130351052|NCT01155479|469255725|FG003|Part I|Lost to Follow-up|1|||
130351053|NCT01155479|469255726|FG004|Part I|Lost to Follow-up|0|||
130351054|NCT01155479|469255722|FG000|Part I|Treatment Failure|3|||
130351055|NCT01155479|469255723|FG001|Part I|Treatment Failure|0|||
130351056|NCT01155479|469255724|FG002|Part I|Treatment Failure|3|||
130351057|NCT01155479|469255725|FG003|Part I|Treatment Failure|1|||
130351058|NCT01155479|469255726|FG004|Part I|Treatment Failure|2|||
130351059|NCT01155479|469255722|FG000|Part I|Did Not Receive Treatment|4|||
130351060|NCT01155479|469255723|FG001|Part I|Did Not Receive Treatment|2|||
130351061|NCT01155479|469255724|FG002|Part I|Did Not Receive Treatment|2|||
130351062|NCT01155479|469255725|FG003|Part I|Did Not Receive Treatment|6|||
130351063|NCT01155479|469255726|FG004|Part I|Did Not Receive Treatment|1|||
130684812|NCT02422264|470474379|FG001|Overall Study|Migrated/moved from study area|1|||
130351064|NCT01155479|469255722|FG000|Part I|Non-Compliance with Protocol|2|||
130351065|NCT01155479|469255723|FG001|Part I|Non-Compliance with Protocol|1|||
130351066|NCT01155479|469255724|FG002|Part I|Non-Compliance with Protocol|3|||
130351067|NCT01155479|469255725|FG003|Part I|Non-Compliance with Protocol|3|||
130351068|NCT01155479|469255726|FG004|Part I|Non-Compliance with Protocol|2|||
130351069|NCT01155479|469255722|FG000|Part II|Adverse Event|7|||
130351070|NCT01155479|469255723|FG001|Part II|Adverse Event|6|||
130351071|NCT01155479|469255724|FG002|Part II|Adverse Event|8|||
130351072|NCT01155479|469255725|FG003|Part II|Adverse Event|3|||
130351073|NCT01155479|469255726|FG004|Part II|Adverse Event|4|||
130351074|NCT01155479|469255722|FG000|Part II|Administrative|43|||
130351075|NCT01155479|469255723|FG001|Part II|Administrative|49|||
130684813|NCT02422264|470474378|FG000|Overall Study|Subject vaccinated outside of the study|0|||
130684814|NCT02422264|470474379|FG001|Overall Study|Subject vaccinated outside of the study|1|||
130684815|NCT00328926|470474380|FG000|Overall Study|Pregnancy|2|||
130684816|NCT00328926|470474381|FG001|Overall Study|Pregnancy|1|||
130684817|NCT00328926|470474382|FG002|Overall Study|Pregnancy|0|||
130684818|NCT00328926|470474380|FG000|Overall Study|Lost to Follow-up|0|||
130684819|NCT00328926|470474381|FG001|Overall Study|Lost to Follow-up|1|||
130684820|NCT00328926|470474382|FG002|Overall Study|Lost to Follow-up|0|||
130684821|NCT00328926|470474380|FG000|Overall Study|Death|0|||
130684822|NCT00328926|470474381|FG001|Overall Study|Death|0|||
130684823|NCT00328926|470474382|FG002|Overall Study|Death|1|||
130684824|NCT00328926|470474380|FG000|Overall Study|In vitro fertilization treatment|0|||
130684825|NCT00328926|470474381|FG001|Overall Study|In vitro fertilization treatment|0|||
130684826|NCT00328926|470474382|FG002|Overall Study|In vitro fertilization treatment|1|||
130684827|NCT00328926|470474380|FG000|Overall Study|Lack of ovarian response|0|||
130684828|NCT00328926|470474381|FG001|Overall Study|Lack of ovarian response|1|||
130684829|NCT00328926|470474382|FG002|Overall Study|Lack of ovarian response|0|||
130684830|NCT02269657|470474383|FG000|Overall Study|Protocol Violation|3|||
130684831|NCT00851877|470474386|FG000|Phase I-1|Death|1|||
130684832|NCT00851877|470474387|FG001|Phase I-1|Death|0|||
130684833|NCT00851877|470474388|FG002|Phase I-1|Death|0|||
130684834|NCT00851877|470474386|FG000|Phase II|Withdrawal by Subject|0|||
130684835|NCT00851877|470474387|FG001|Phase II|Withdrawal by Subject|0|||
130438634|NCT00384059|469568335|FG000|After Infant Series|Protocol Violation|2|||
130438635|NCT00384059|469568336|FG001|After Infant Series|Protocol Violation|3|||
130438636|NCT00384059|469568335|FG000|After Infant Series|Withdrawal by Subject|2|||
130438637|NCT00384059|469568336|FG001|After Infant Series|Withdrawal by Subject|2|||
130438638|NCT00384059|469568335|FG000|After Infant Series|Failed to Return|0|||
130438639|NCT00384059|469568336|FG001|After Infant Series|Failed to Return|2|||
130438640|NCT00384059|469568335|FG000|After Infant Series|Adverse Event|0|||
130438641|NCT00384059|469568336|FG001|After Infant Series|Adverse Event|1|||
130438642|NCT00384059|469568335|FG000|After Infant Series|Physician Decision|0|||
130438643|NCT00384059|469568336|FG001|After Infant Series|Physician Decision|1|||
130438644|NCT00384059|469568335|FG000|After Infant Series|Lost to Follow-up|0|||
130438645|NCT00384059|469568336|FG001|After Infant Series|Lost to Follow-up|1|||
130438646|NCT00384059|469568335|FG000|Toddler Dose|Lost to Follow-up|1|||
130438647|NCT00384059|469568336|FG001|Toddler Dose|Lost to Follow-up|1|||
130438648|NCT00384059|469568335|FG000|Toddler Dose|Failed to return|0|||
130438649|NCT00384059|469568336|FG001|Toddler Dose|Failed to return|1|||
130438650|NCT02593539|469569875|FG000|Overall Study|Adverse Event|1|||
130438651|NCT00649389|469569876|FG000|Overall Study|Adverse Event|22|||
130438652|NCT00649389|469569877|FG001|Overall Study|Adverse Event|46|||
130438653|NCT00649389|469569878|FG002|Overall Study|Adverse Event|38|||
130438654|NCT00649389|469569879|FG003|Overall Study|Adverse Event|48|||
130438655|NCT00649389|469569876|FG000|Overall Study|Lost to Follow-up|15|||
130438656|NCT00649389|469569877|FG001|Overall Study|Lost to Follow-up|17|||
130438657|NCT00649389|469569878|FG002|Overall Study|Lost to Follow-up|21|||
130438658|NCT00649389|469569879|FG003|Overall Study|Lost to Follow-up|26|||
130438659|NCT00649389|469569876|FG000|Overall Study|Protocol Violation|11|||
130438660|NCT00649389|469569877|FG001|Overall Study|Protocol Violation|13|||
130438661|NCT00649389|469569878|FG002|Overall Study|Protocol Violation|9|||
130438662|NCT00649389|469569879|FG003|Overall Study|Protocol Violation|8|||
130438663|NCT00649389|469569876|FG000|Overall Study|Withdrawal by Subject|20|||
130438664|NCT00649389|469569877|FG001|Overall Study|Withdrawal by Subject|21|||
130438665|NCT00649389|469569878|FG002|Overall Study|Withdrawal by Subject|19|||
130438666|NCT00649389|469569879|FG003|Overall Study|Withdrawal by Subject|23|||
130438667|NCT00649389|469569876|FG000|Overall Study|Other|3|||
130438668|NCT00649389|469569877|FG001|Overall Study|Other|9|||
130684836|NCT00851877|470474388|FG002|Phase II|Withdrawal by Subject|3|||
130684837|NCT00829673|470474389|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130684838|NCT00829673|470474390|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130684839|NCT03450057|470474391|FG000|Overall Study|Death|17|||
130684840|NCT03450057|470474391|FG000|Overall Study|ICF withdrawal|4|||
130438669|NCT00649389|469569878|FG002|Overall Study|Other|1|||
130438670|NCT00649389|469569879|FG003|Overall Study|Other|6|||
130438671|NCT01806740|469569880|FG000|Overall Study|Withdrawal by Subject|4|||
130438672|NCT01806740|469569880|FG000|Overall Study|Physician Decision|1|||
130438673|NCT01806740|469569880|FG000|Overall Study|Patient's refusal of treatment|1|||
130438674|NCT01984424|469569883|FG000|Overall Study|Withdrawal by Subject|3|||
130438675|NCT01984424|469569884|FG001|Overall Study|Withdrawal by Subject|5|||
130438676|NCT01984424|469569883|FG000|Overall Study|Sponsor Decision|0|||
130438677|NCT01984424|469569884|FG001|Overall Study|Sponsor Decision|1|||
130684841|NCT03450057|470474391|FG000|Overall Study|Lost to Follow-up|2|||
130684842|NCT00573066|470474392|FG000|Overall Study|Exclusion criteria|18|||
130684843|NCT00573066|470474392|FG000|Overall Study|IV malfunction|1|||
130684844|NCT00573066|470474392|FG000|Overall Study|Postoperative bleeding|1|||
130684845|NCT01034358|470474393|FG000|Overall Study|Withdrawal by Subject|1|||
130684846|NCT01034358|470474393|FG000|Overall Study|Protocol Violation|1|||
130684847|NCT00829790|470474396|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
130684848|NCT00829790|470474397|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
130684849|NCT02246166|470474398|FG000|Overall Study|Protocol Violation|1|||
130351076|NCT01155479|469255724|FG002|Part II|Administrative|36|||
130351077|NCT01155479|469255725|FG003|Part II|Administrative|38|||
130351078|NCT01155479|469255726|FG004|Part II|Administrative|46|||
130351079|NCT01155479|469255722|FG000|Part II|Withdrawal by Subject|8|||
130351080|NCT01155479|469255723|FG001|Part II|Withdrawal by Subject|4|||
130351081|NCT01155479|469255724|FG002|Part II|Withdrawal by Subject|12|||
130351082|NCT01155479|469255725|FG003|Part II|Withdrawal by Subject|7|||
130351083|NCT01155479|469255726|FG004|Part II|Withdrawal by Subject|3|||
130351084|NCT01155479|469255722|FG000|Part II|Lost to Follow-up|1|||
130351085|NCT01155479|469255723|FG001|Part II|Lost to Follow-up|0|||
130351086|NCT01155479|469255724|FG002|Part II|Lost to Follow-up|0|||
130351087|NCT01155479|469255725|FG003|Part II|Lost to Follow-up|0|||
130351088|NCT01155479|469255726|FG004|Part II|Lost to Follow-up|1|||
130351089|NCT01155479|469255722|FG000|Part II|Treatment Failure|0|||
130351090|NCT01155479|469255723|FG001|Part II|Treatment Failure|1|||
130351091|NCT01155479|469255724|FG002|Part II|Treatment Failure|2|||
130351092|NCT01155479|469255725|FG003|Part II|Treatment Failure|0|||
130351093|NCT01155479|469255726|FG004|Part II|Treatment Failure|1|||
130351094|NCT01155479|469255722|FG000|Part II|Non-Compliance with Protocol|0|||
130351095|NCT01155479|469255723|FG001|Part II|Non-Compliance with Protocol|1|||
130351096|NCT01155479|469255724|FG002|Part II|Non-Compliance with Protocol|0|||
130351097|NCT01155479|469255725|FG003|Part II|Non-Compliance with Protocol|2|||
130351098|NCT01155479|469255726|FG004|Part II|Non-Compliance with Protocol|0|||
130351099|NCT00470184|469255727|FG000|Overall Study|Not Treated(became ineligible)|4|||
130351100|NCT00470184|469255727|FG000|Overall Study|Not treated (other)|1|||
130351101|NCT00470184|469255727|FG000|Overall Study|disease Progression|4|||
130351102|NCT00470184|469255727|FG000|Overall Study|Adverse Event|3|||
130351103|NCT00470184|469255727|FG000|Overall Study|Withdrawal by Subject|4|||
130351104|NCT00470184|469255727|FG000|Overall Study|other|5|||
130351105|NCT00470184|469255727|FG000|Overall Study|recurrence|1|||
130351106|NCT02483533|469255729|FG000|Overall Study|Lack of Efficacy|50|||
130351107|NCT02483533|469255730|FG001|Overall Study|Lack of Efficacy|50|||
130351108|NCT00768469|469255732|FG000|Overall Study|Adverse Event|0|||
130351109|NCT00768469|469255733|FG001|Overall Study|Adverse Event|2|||
130351110|NCT00768469|469255732|FG000|Overall Study|Disease Progression|3|||
130351111|NCT00768469|469255733|FG001|Overall Study|Disease Progression|4|||
130438678|NCT01984424|469569883|FG000|Overall Study|Lost to Follow-up|0|||
130438679|NCT01984424|469569884|FG001|Overall Study|Lost to Follow-up|1|||
130438680|NCT02802319|469569885|FG000|Overall Study|Physician Decision|2|||
130438681|NCT02802319|469569886|FG001|Overall Study|Physician Decision|1|||
130684850|NCT02246166|470474399|FG001|Overall Study|Protocol Violation|0|||
130684851|NCT00627016|470474400|FG000|Overall Study|Adverse Event|1|||
130684852|NCT00627016|470474401|FG001|Overall Study|Adverse Event|1|||
130684853|NCT00627016|470474400|FG000|Overall Study|Protocol Violation|0|||
130684854|NCT00627016|470474401|FG001|Overall Study|Protocol Violation|2|||
130684855|NCT00627016|470474400|FG000|Overall Study|Lost to Follow-up|0|||
130684856|NCT00627016|470474401|FG001|Overall Study|Lost to Follow-up|1|||
130684857|NCT00627016|470474400|FG000|Overall Study|Withdrawal by Subject|2|||
130684858|NCT00627016|470474401|FG001|Overall Study|Withdrawal by Subject|1|||
130684859|NCT00627016|470474400|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130684860|NCT00627016|470474401|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
130684861|NCT00627016|470474400|FG000|Overall Study|Lack of Efficacy|1|||
130684862|NCT00627016|470474401|FG001|Overall Study|Lack of Efficacy|0|||
130684863|NCT00627016|470474400|FG000|Overall Study|Placed on Excluded Drugs|1|||
130684864|NCT00627016|470474401|FG001|Overall Study|Placed on Excluded Drugs|0|||
130684865|NCT00627016|470474400|FG000|Overall Study|Pregnancy|1|||
130684866|NCT00627016|470474401|FG001|Overall Study|Pregnancy|0|||
130684867|NCT01534663|470474402|FG000|Overall Study|Lost to Follow-up|0|||
130684868|NCT01534663|470474403|FG001|Overall Study|Lost to Follow-up|2|||
130684869|NCT01534663|470474402|FG000|Overall Study|Adverse Event|2|||
130684870|NCT01534663|470474403|FG001|Overall Study|Adverse Event|1|||
130684871|NCT00377260|470474404|FG000|Overall Study|Lost to Follow-up|0|||
130684872|NCT00377260|470474405|FG001|Overall Study|Lost to Follow-up|1|||
130684873|NCT00377260|470474404|FG000|Overall Study|Withdrawal by Subject|2|||
130684874|NCT00377260|470474405|FG001|Overall Study|Withdrawal by Subject|4|||
130684875|NCT03107091|470474406|FG000|Overall Study|Physician Decision|1|||
130438682|NCT02802319|469569885|FG000|Overall Study|Lost to Follow-up|0|||
130684876|NCT04567186|470474411|FG000|Period 1|COVID-19 related|1|||
130684877|NCT04567186|470474412|FG001|Period 1|COVID-19 related|0|||
130684878|NCT04567186|470474411|FG000|Period 1|Protocol Violation|0|||
130684879|NCT04567186|470474412|FG001|Period 1|Protocol Violation|1|||
130684880|NCT04567186|470474411|FG000|Period 1|Adverse Event|0|||
130351112|NCT00768469|469255732|FG000|Overall Study|Withdrawal by Subject|0|||
130351113|NCT00768469|469255733|FG001|Overall Study|Withdrawal by Subject|1|||
130351114|NCT00484185|469255736|FG000|Overall Study|Lost to Follow-up|44|||
130351115|NCT00484185|469255736|FG000|Overall Study|Other|20|||
130351116|NCT00484185|469255736|FG000|Overall Study|Randomized but not treated|5|||
130351117|NCT00484185|469255736|FG000|Overall Study|Death|2|||
130438683|NCT02802319|469569886|FG001|Overall Study|Lost to Follow-up|4|||
130684881|NCT04567186|470474412|FG001|Period 1|Adverse Event|2|||
130684882|NCT04567186|470474411|FG000|Period 2|COVID-19 Related|0|||
130684883|NCT04567186|470474412|FG001|Period 2|COVID-19 Related|1|||
130351118|NCT00459056|469255737|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
130351119|NCT00459056|469255738|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
130351120|NCT02283177|469255739|FG000|Overall Study|Withdrawal by Subject|1|||
130351121|NCT02283177|469255740|FG001|Overall Study|Withdrawal by Subject|1|||
130351122|NCT01101191|469255741|FG000|Period 1|Withdrawal by Subject|1|||
130351123|NCT01101191|469255742|FG001|Period 1|Withdrawal by Subject|0|||
130351124|NCT01101191|469255741|FG000|Period 1|Adverse Event|1|||
130351125|NCT01101191|469255742|FG001|Period 1|Adverse Event|2|||
130351126|NCT03761797|469255743|FG000|Overall Study|Changing hospital|11|||
130351127|NCT03761797|469255743|FG000|Overall Study|Improvement/remission|6|||
130351128|NCT03761797|469255743|FG000|Overall Study|Withdrawal by Subject|19|||
130351129|NCT03761797|469255743|FG000|Overall Study|Lost to Follow-up|33|||
130351130|NCT03761797|469255743|FG000|Overall Study|Adverse Event|37|||
130351131|NCT03761797|469255743|FG000|Overall Study|Case report form (CRF) not collected|5|||
130351132|NCT03761797|469255743|FG000|Overall Study|No patient visit after entry|13|||
130351133|NCT03761797|469255743|FG000|Overall Study|Switch to other diabetes medication|10|||
130351134|NCT03761797|469255743|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
130351135|NCT03761797|469255743|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
130351136|NCT03761797|469255743|FG000|Overall Study|Insufficient effectives|2|||
130351137|NCT03761797|469255743|FG000|Overall Study|Excessive alcohol intake|1|||
130351138|NCT00879879|469255744|FG000|Overall Study|Death|1|||
130351139|NCT00879879|469255744|FG000|Overall Study|Withdrawal by Subject|1|||
130351140|NCT00879879|469255744|FG000|Overall Study|Physician Decision|1|||
130351141|NCT00989573|469255748|FG000|Overall Study|Adverse Event|8|||
130351142|NCT00989573|469255749|FG001|Overall Study|Adverse Event|12|||
130351143|NCT00989573|469255750|FG002|Overall Study|Adverse Event|4|||
130351144|NCT00989573|469255748|FG000|Overall Study|Physician Decision|0|||
130351145|NCT00989573|469255749|FG001|Overall Study|Physician Decision|2|||
130351146|NCT00989573|469255750|FG002|Overall Study|Physician Decision|0|||
130351147|NCT00989573|469255748|FG000|Overall Study|Protocol Violation|1|||
130351148|NCT00989573|469255749|FG001|Overall Study|Protocol Violation|1|||
130351149|NCT00989573|469255750|FG002|Overall Study|Protocol Violation|1|||
130351150|NCT00989573|469255748|FG000|Overall Study|Withdrawal by Subject|4|||
130351151|NCT00989573|469255749|FG001|Overall Study|Withdrawal by Subject|7|||
130351152|NCT00989573|469255750|FG002|Overall Study|Withdrawal by Subject|3|||
130351153|NCT03687970|469255751|FG000|Overall Study|visit scheduling conflicts|2|||
130351154|NCT03687970|469255752|FG001|Overall Study|visit scheduling conflicts|0|||
130351155|NCT00817479|469255753|FG000|Overall Study|Physician Decision|1|||
130351156|NCT00817479|469255754|FG001|Overall Study|Physician Decision|1|||
130351157|NCT04030026|469255756|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
130351158|NCT04030026|469255757|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
130351159|NCT04030026|469255756|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
130351160|NCT04030026|469255757|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
130351161|NCT04030026|469255756|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
130351162|NCT04030026|469255757|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
130351163|NCT04030026|469255756|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
130351164|NCT04030026|469255757|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
130351165|NCT04030026|469255756|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
130351166|NCT04030026|469255757|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
130351167|NCT04030026|469255756|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
130351168|NCT04030026|469255757|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
130351169|NCT04030026|469255756|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
130351170|NCT04030026|469255757|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
130351171|NCT00523367|469255758|FG000|Overall Study|19 screen failures|19|||
130351172|NCT00523367|469255758|FG000|Overall Study|4 Withdrawn by PI|4|||
130351173|NCT04480424|469255759|FG000|Overall Study|Withdrawal by Subject|0|||
130351174|NCT04480424|469255760|FG001|Overall Study|Withdrawal by Subject|2|||
130351175|NCT04480424|469255759|FG000|Overall Study|Lost to Follow-up|3|||
130351176|NCT04480424|469255760|FG001|Overall Study|Lost to Follow-up|3|||
130351177|NCT04480424|469255759|FG000|Overall Study|Death|14|||
130684884|NCT04567186|470474411|FG000|Period 2|Protocol Violation|0|||
130351178|NCT04480424|469255760|FG001|Overall Study|Death|16|||
130351179|NCT04480424|469255759|FG000|Overall Study|Reason not Specified|5|||
130351180|NCT04480424|469255760|FG001|Overall Study|Reason not Specified|5|||
130351181|NCT02782923|469255761|FG000|Overall Study|Lost to Follow-up|15|||
130351182|NCT02418156|469255762|FG000|Overall Study|Lost to Follow-up|12|||
130351183|NCT02418156|469255762|FG000|Overall Study|Death|2|||
130351184|NCT02418156|469255762|FG000|Overall Study|Physician Decision|1|||
130351185|NCT02418156|469255762|FG000|Overall Study|Withdrawal by Subject|1|||
130351186|NCT02418156|469255762|FG000|Overall Study|Subject refused to return|1|||
130351187|NCT04078178|469257509|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
130351188|NCT04078178|469257510|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
130351189|NCT04078178|469257509|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
130351190|NCT04078178|469257510|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
130351191|NCT04078178|469257509|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
130438684|NCT00077636|469569887|FG000|Overall Study|Refused Treatment|9|||
130438685|NCT00077636|469569888|FG001|Overall Study|Refused Treatment|31|||
130438686|NCT00077636|469569887|FG000|Overall Study|Admin|3|||
130438687|NCT00077636|469569888|FG001|Overall Study|Admin|3|||
130684885|NCT04567186|470474412|FG001|Period 2|Protocol Violation|1|||
130684886|NCT04567186|470474411|FG000|Period 2|Lost to Follow-up|0|||
130684887|NCT04567186|470474412|FG001|Period 2|Lost to Follow-up|1|||
130684888|NCT04567186|470474411|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
130684889|NCT04567186|470474412|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
130684890|NCT02924883|470474413|FG000|Overall Study|Death|39|||
130684891|NCT02924883|470474414|FG001|Overall Study|Death|20|||
130684892|NCT02924883|470474413|FG000|Overall Study|Lost to Follow-up|1|||
130684893|NCT02924883|470474414|FG001|Overall Study|Lost to Follow-up|0|||
130684894|NCT02924883|470474413|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
130684895|NCT02924883|470474414|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
130684896|NCT02924883|470474413|FG000|Overall Study|Protocol Violation|1|||
130684897|NCT02924883|470474414|FG001|Overall Study|Protocol Violation|0|||
130684898|NCT02924883|470474413|FG000|Overall Study|Withdrawal by Subject|22|||
130684899|NCT02924883|470474414|FG001|Overall Study|Withdrawal by Subject|16|||
130684900|NCT02924883|470474413|FG000|Overall Study|Progressive Disease|1|||
130684901|NCT02924883|470474414|FG001|Overall Study|Progressive Disease|0|||
130684902|NCT02924883|470474413|FG000|Overall Study|Study Terminated by Sponsor|69|||
130684903|NCT02924883|470474414|FG001|Overall Study|Study Terminated by Sponsor|32|||
130684904|NCT01256684|470474419|FG000|Overall Study|Adverse Event|1|||
130684905|NCT01256684|470474420|FG001|Overall Study|Adverse Event|4|||
130217807|NCT04865419|468761409|FG007|Overall Study|Study terminated by Sponsor|0|||
130217808|NCT04865419|468761410|FG008|Overall Study|Study terminated by Sponsor|0|||
130217809|NCT04865419|468761411|FG009|Overall Study|Study terminated by Sponsor|0|||
130217810|NCT04865419|468761412|FG010|Overall Study|Study terminated by Sponsor|1|||
130684906|NCT01256684|470474421|FG002|Overall Study|Adverse Event|2|||
130684907|NCT01256684|470474419|FG000|Overall Study|Withdrawal by Subject|4|||
130684908|NCT01256684|470474420|FG001|Overall Study|Withdrawal by Subject|0|||
130684909|NCT01256684|470474421|FG002|Overall Study|Withdrawal by Subject|2|||
130684910|NCT01256684|470474419|FG000|Overall Study|Physician Decision|0|||
130684911|NCT01256684|470474420|FG001|Overall Study|Physician Decision|1|||
130684912|NCT01256684|470474421|FG002|Overall Study|Physician Decision|0|||
130684913|NCT01256684|470474419|FG000|Overall Study|Lack of Efficacy|0|||
130684914|NCT01256684|470474420|FG001|Overall Study|Lack of Efficacy|1|||
130684915|NCT01256684|470474421|FG002|Overall Study|Lack of Efficacy|1|||
130684916|NCT01256684|470474419|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
130684917|NCT01256684|470474420|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
130684918|NCT01256684|470474421|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
130684919|NCT01185548|470474424|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
130684920|NCT02678286|470474425|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
130684921|NCT02678286|470474426|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
130684922|NCT02678286|470474425|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
130684923|NCT02678286|470474426|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
130684924|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
130684925|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
130684926|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
130684927|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
130684928|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130684929|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130684930|NCT02098876|470474430|FG000|Overall Study|Withdrawal by Subject|5|||
130684931|NCT02098876|470474431|FG001|Overall Study|Withdrawal by Subject|5|||
130684932|NCT01061866|470474432|FG000|Overall Study|Adverse Event|2|||
130684933|NCT00772941|470474433|FG000|Overall Study|CRFs not available|195|||
130684934|NCT00772941|470474433|FG000|Overall Study|Study not completed|16|||
130684935|NCT00772941|470474433|FG000|Overall Study|Missed Visits|374|||
130684936|NCT00772941|470474433|FG000|Overall Study|Poor Compliance|7|||
130684937|NCT00772941|470474433|FG000|Overall Study|GPSP Violation|90|||
130684938|NCT04786184|470474434|FG000|Overall Study|Adverse Event|4|||
130684939|NCT04786184|470474435|FG001|Overall Study|Adverse Event|0|||
130684940|NCT04786184|470474434|FG000|Overall Study|Withdrawal by Subject|3|||
130684941|NCT04786184|470474435|FG001|Overall Study|Withdrawal by Subject|1|||
130684942|NCT04786184|470474434|FG000|Overall Study|Lost to Follow-up|4|||
130684943|NCT04786184|470474435|FG001|Overall Study|Lost to Follow-up|2|||
130684944|NCT00834756|470474436|FG000|First Intervention|Adverse Event|1|||
130684945|NCT00834756|470474437|FG001|First Intervention|Adverse Event|0|||
130684946|NCT00834756|470474436|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130684947|NCT00834756|470474437|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130684948|NCT02017223|470474450|FG000|Overall Study|Algorithm problems|2|||
130438688|NCT00077636|469569887|FG000|Overall Study|Withdrawal by Subject|2|||
130684949|NCT04263649|470474452|FG000|Overall Study|Adverse Event|53|||
130684950|NCT04263649|470474452|FG000|Overall Study|Lost to Follow-up|3|||
130684951|NCT04263649|470474452|FG000|Overall Study|Death|29|||
130438689|NCT00077636|469569888|FG001|Overall Study|Withdrawal by Subject|2|||
130438690|NCT00077636|469569887|FG000|Overall Study|Adverse Event|17|||
130438691|NCT00077636|469569888|FG001|Overall Study|Adverse Event|34|||
130438692|NCT00077636|469569887|FG000|Overall Study|Protocol Violation|0|||
130438693|NCT00077636|469569888|FG001|Overall Study|Protocol Violation|2|||
130438694|NCT00077636|469569887|FG000|Overall Study|Lost to Follow-up|10|||
130438695|NCT00077636|469569888|FG001|Overall Study|Lost to Follow-up|18|||
130438696|NCT00077636|469569887|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
130438697|NCT00077636|469569888|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
130438698|NCT00592319|469569889|FG000|Overall Study|Lost to Follow-up|0|||
130438699|NCT00592319|469569890|FG001|Overall Study|Lost to Follow-up|3|||
130438700|NCT02032173|469569891|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
130438701|NCT03321513|469569897|FG000|Overall Study|Death|11|||
130438702|NCT03321513|469569898|FG001|Overall Study|Death|5|||
130438703|NCT03321513|469569897|FG000|Overall Study|Withdrawal by Subject|5|||
130438704|NCT03321513|469569898|FG001|Overall Study|Withdrawal by Subject|10|||
130438705|NCT03321513|469569897|FG000|Overall Study|Lost to Follow-up|10|||
130438706|NCT03321513|469569898|FG001|Overall Study|Lost to Follow-up|11|||
130438707|NCT01993017|469569899|FG000|Overall Study|Death|23|||
130438708|NCT01993017|469569900|FG001|Overall Study|Death|26|||
130438709|NCT01993017|469569901|FG002|Overall Study|Death|18|||
130438710|NCT01993017|469569899|FG000|Overall Study|Could not be contacted|43|||
130438711|NCT01993017|469569900|FG001|Overall Study|Could not be contacted|42|||
130438712|NCT01993017|469569901|FG002|Overall Study|Could not be contacted|38|||
130438713|NCT01993017|469569899|FG000|Overall Study|Dropped out|19|||
130438714|NCT01993017|469569900|FG001|Overall Study|Dropped out|6|||
130438715|NCT01993017|469569901|FG002|Overall Study|Dropped out|11|||
130438716|NCT01993017|469569899|FG000|Overall Study|Other reasons|17|||
130438717|NCT01993017|469569900|FG001|Overall Study|Other reasons|11|||
130438718|NCT01993017|469569901|FG002|Overall Study|Other reasons|7|||
130438719|NCT01993017|469569899|FG000|Overall Study|Ineligible after randomization|4|||
130438720|NCT01993017|469569900|FG001|Overall Study|Ineligible after randomization|5|||
130438721|NCT01993017|469569901|FG002|Overall Study|Ineligible after randomization|5|||
130438722|NCT02757521|469569902|FG000|Overall Study|Adverse Event|1|||
130438723|NCT02757521|469569903|FG001|Overall Study|Adverse Event|0|||
130438724|NCT00003511|469569904|FG000|Overall Study|Not evaluable|4|||
130438725|NCT01683994|469569911|FG000|Overall Study|Withdrawal by Subject|1|||
130438726|NCT01683994|469569912|FG001|Overall Study|Withdrawal by Subject|0|||
130438727|NCT01683994|469569913|FG002|Overall Study|Withdrawal by Subject|0|||
130438728|NCT01683994|469569914|FG003|Overall Study|Withdrawal by Subject|1|||
130438729|NCT01683994|469569915|FG004|Overall Study|Withdrawal by Subject|0|||
130438730|NCT01683994|469569911|FG000|Overall Study|Intercurrent illness|0|||
130438731|NCT01683994|469569912|FG001|Overall Study|Intercurrent illness|0|||
130438732|NCT01683994|469569913|FG002|Overall Study|Intercurrent illness|0|||
130438733|NCT01683994|469569914|FG003|Overall Study|Intercurrent illness|2|||
130438734|NCT01683994|469569915|FG004|Overall Study|Intercurrent illness|1|||
130438735|NCT00999661|469569919|FG000|Overall Study|Lost to Follow-up|59|||
130438736|NCT00999661|469569919|FG000|Overall Study|Adverse Event|1|||
130438737|NCT00999661|469569919|FG000|Overall Study|Withdrawal by Subject|1|||
130438738|NCT00999661|469569919|FG000|Overall Study|Not meeting eligibility criteria|9|||
130438739|NCT00917267|469569920|FG000|Overall Study|Adverse Event|15|||
130438740|NCT00917267|469569921|FG001|Overall Study|Adverse Event|36|||
130438741|NCT00917267|469569920|FG000|Overall Study|Physician Decision|2|||
130438742|NCT00917267|469569921|FG001|Overall Study|Physician Decision|4|||
130438743|NCT00917267|469569920|FG000|Overall Study|Protocol Violation|9|||
130438744|NCT00917267|469569921|FG001|Overall Study|Protocol Violation|18|||
130438745|NCT00917267|469569920|FG000|Overall Study|Withdrawal by Subject|5|||
130438746|NCT00917267|469569921|FG001|Overall Study|Withdrawal by Subject|12|||
130438747|NCT00917267|469569920|FG000|Overall Study|Lost to follow up|0|||
130438748|NCT00917267|469569921|FG001|Overall Study|Lost to follow up|2|||
130438749|NCT00917267|469569920|FG000|Overall Study|Entry Criteria Not Met|1|||
130438750|NCT00917267|469569921|FG001|Overall Study|Entry Criteria Not Met|0|||
130438751|NCT00917267|469569920|FG000|Overall Study|Sponsor Decision|5|||
130438752|NCT00917267|469569921|FG001|Overall Study|Sponsor Decision|5|||
130438753|NCT00917267|469569920|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
130438754|NCT00917267|469569921|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
130438755|NCT02960763|469569923|FG000|Step 1|Withdrawal by Subject|10|||
130684952|NCT04263649|470474452|FG000|Overall Study|Device deficiency|19|||
130438756|NCT02960763|469569924|FG001|Step 1|Withdrawal by Subject|8|||
130684953|NCT04263649|470474452|FG000|Overall Study|other reasons|11|||
130684954|NCT01534520|470474453|FG000|Overall Study|Adverse Event|0|||
130438757|NCT02960763|469569925|FG002|Step 1|Withdrawal by Subject|13|||
130684955|NCT01534520|470474454|FG001|Overall Study|Adverse Event|1|||
130438758|NCT02960763|469569926|FG003|Step 1|Withdrawal by Subject|0|||
130438759|NCT02960763|469569927|FG004|Step 1|Withdrawal by Subject|0|||
130438760|NCT02960763|469569923|FG000|Step 1|Lost to Follow-up|7|||
130438761|NCT02960763|469569924|FG001|Step 1|Lost to Follow-up|9|||
130438762|NCT02960763|469569925|FG002|Step 1|Lost to Follow-up|12|||
130438763|NCT02960763|469569926|FG003|Step 1|Lost to Follow-up|0|||
130684956|NCT01079988|470474457|FG000|Overall Study|Lost to Follow-up|0|||
130684957|NCT01079988|470474458|FG001|Overall Study|Lost to Follow-up|0|||
130684958|NCT01079988|470474459|FG002|Overall Study|Lost to Follow-up|0|||
130684959|NCT01079988|470474460|FG003|Overall Study|Lost to Follow-up|1|||
130684960|NCT01079988|470474461|FG004|Overall Study|Lost to Follow-up|0|||
130684961|NCT01079988|470474457|FG000|Overall Study|Lack of Efficacy|1|||
130684962|NCT01079988|470474458|FG001|Overall Study|Lack of Efficacy|0|||
130684963|NCT01079988|470474459|FG002|Overall Study|Lack of Efficacy|0|||
130684964|NCT01079988|470474460|FG003|Overall Study|Lack of Efficacy|0|||
130684965|NCT01079988|470474461|FG004|Overall Study|Lack of Efficacy|0|||
130684966|NCT01079988|470474457|FG000|Overall Study|Other|0|||
130684967|NCT01079988|470474458|FG001|Overall Study|Other|0|||
130684968|NCT01079988|470474459|FG002|Overall Study|Other|0|||
130684969|NCT01079988|470474460|FG003|Overall Study|Other|2|||
130684970|NCT01079988|470474461|FG004|Overall Study|Other|1|||
130684971|NCT02392000|470474466|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
130684972|NCT02392000|470474466|FG000|Overall Study|Withdrawal by Subject|1|||
130684973|NCT02392000|470474466|FG000|Overall Study|Lost to Follow-up|8|||
130684974|NCT02331394|470476215|FG000|Overall Study|Disease progression|1|||
130684975|NCT01313273|470476216|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
130684976|NCT01313273|470476217|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
130684977|NCT01313273|470476216|FG000|Overall Study|Withdrawal by Subject|1|||
130684978|NCT01313273|470476217|FG001|Overall Study|Withdrawal by Subject|0|||
130684979|NCT01313273|470476216|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
130684980|NCT01313273|470476217|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
130684981|NCT03687736|470476218|FG000|Overall Study|Lost to Follow-up|7|||
130438764|NCT02960763|469569927|FG004|Step 1|Lost to Follow-up|0|||
130438765|NCT02960763|469569923|FG000|Step 1|Death|1|||
130438766|NCT02960763|469569924|FG001|Step 1|Death|1|||
130438767|NCT02960763|469569925|FG002|Step 1|Death|1|||
130438768|NCT02960763|469569926|FG003|Step 1|Death|0|||
130438769|NCT02960763|469569927|FG004|Step 1|Death|0|||
130438770|NCT02960763|469569923|FG000|Step 1|Investigator discretion|1|||
130684982|NCT03687736|470476218|FG000|Overall Study|Withdrawal by Subject|3|||
130438771|NCT02960763|469569924|FG001|Step 1|Investigator discretion|0|||
130438772|NCT02960763|469569925|FG002|Step 1|Investigator discretion|1|||
130438773|NCT02960763|469569926|FG003|Step 1|Investigator discretion|0|||
130438774|NCT02960763|469569927|FG004|Step 1|Investigator discretion|0|||
130438775|NCT02960763|469569923|FG000|Step 1|Other|0|||
130438776|NCT02960763|469569924|FG001|Step 1|Other|0|||
130438777|NCT02960763|469569925|FG002|Step 1|Other|1|||
130438778|NCT02960763|469569926|FG003|Step 1|Other|0|||
130438779|NCT02960763|469569927|FG004|Step 1|Other|0|||
130438780|NCT02960763|469569923|FG000|Step 2|Withdrawal by Subject|0|||
130438781|NCT02960763|469569924|FG001|Step 2|Withdrawal by Subject|0|||
130438782|NCT02960763|469569925|FG002|Step 2|Withdrawal by Subject|0|||
130438783|NCT02960763|469569926|FG003|Step 2|Withdrawal by Subject|7|||
130438784|NCT02960763|469569927|FG004|Step 2|Withdrawal by Subject|3|||
130438785|NCT02960763|469569923|FG000|Step 2|Lost to Follow-up|0|||
130438786|NCT02960763|469569924|FG001|Step 2|Lost to Follow-up|0|||
130438787|NCT02960763|469569925|FG002|Step 2|Lost to Follow-up|0|||
130438788|NCT02960763|469569926|FG003|Step 2|Lost to Follow-up|4|||
130438789|NCT02960763|469569927|FG004|Step 2|Lost to Follow-up|1|||
130438790|NCT02960763|469569923|FG000|Step 2|Investigator discretion|0|||
130438791|NCT02960763|469569924|FG001|Step 2|Investigator discretion|0|||
130438792|NCT02960763|469569925|FG002|Step 2|Investigator discretion|0|||
130438793|NCT02960763|469569926|FG003|Step 2|Investigator discretion|0|||
130438794|NCT02960763|469569927|FG004|Step 2|Investigator discretion|1|||
130438795|NCT00312858|469569930|FG000|Overall Study|Adverse Event|0|||
130438796|NCT00312858|469569931|FG001|Overall Study|Adverse Event|1|||
130438797|NCT00312858|469569930|FG000|Overall Study|Lost to Follow-up|25|||
130438798|NCT00312858|469569931|FG001|Overall Study|Lost to Follow-up|42|||
130438799|NCT00312858|469569930|FG000|Overall Study|Protocol Violation|3|||
130438800|NCT00312858|469569931|FG001|Overall Study|Protocol Violation|8|||
130438801|NCT00312858|469569930|FG000|Overall Study|Withdraw by Participant|20|||
130438802|NCT00312858|469569931|FG001|Overall Study|Withdraw by Participant|20|||
130438803|NCT00312858|469569930|FG000|Overall Study|Participant Moved|11|||
130438804|NCT00312858|469569931|FG001|Overall Study|Participant Moved|10|||
130684983|NCT01270503|470476219|FG000|Overall Study|Lost to Follow-up|1|||
130684984|NCT02459951|470476220|FG000|Overall Study|Unable to meet holding requirement|1|||
130438805|NCT00312858|469569930|FG000|Overall Study|Other|9|||
130438806|NCT00312858|469569931|FG001|Overall Study|Other|12|||
130684985|NCT02481830|470476224|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
130684986|NCT02481830|470476225|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
130684987|NCT02481830|470476224|FG000|Pre-treatment|Withdrawal by Subject|0|||
130438807|NCT03638635|469569933|FG000|Initial Hospitalization|Study terminated prematurely|0|||
130438808|NCT03638635|469569934|FG001|Initial Hospitalization|Study terminated prematurely|1|||
130438809|NCT03638635|469569933|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
130438810|NCT03638635|469569934|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
130438811|NCT03638635|469569933|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
130438812|NCT03638635|469569934|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
130438813|NCT00802659|469569940|FG000|Overall Study|Physician Decision|0|||
130438814|NCT00802659|469569941|FG001|Overall Study|Physician Decision|1|||
130438815|NCT00802659|469569942|FG002|Overall Study|Physician Decision|0|||
130438816|NCT00802659|469569943|FG003|Overall Study|Physician Decision|0|||
130438817|NCT00289770|469569944|FG000|Year 15|Withdrawal by Subject|1|||
130684988|NCT02481830|470476225|FG001|Pre-treatment|Withdrawal by Subject|10|||
130684989|NCT02481830|470476224|FG000|Pre-treatment|Disease Progression|1|||
130684990|NCT02481830|470476225|FG001|Pre-treatment|Disease Progression|1|||
130684991|NCT02481830|470476224|FG000|Pre-treatment|Other reasons|0|||
130684992|NCT02481830|470476225|FG001|Pre-treatment|Other reasons|1|||
130684993|NCT02481830|470476224|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
130684994|NCT02481830|470476225|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
130684995|NCT02481830|470476224|FG000|Treatment|Disease Progression|233|||
130684996|NCT02481830|470476225|FG001|Treatment|Disease Progression|171|||
130684997|NCT02481830|470476224|FG000|Treatment|Study drug toxicity|18|||
130684998|NCT02481830|470476225|FG001|Treatment|Study drug toxicity|38|||
130684999|NCT02481830|470476224|FG000|Treatment|Death|1|||
130685000|NCT02481830|470476225|FG001|Treatment|Death|1|||
130685001|NCT02481830|470476224|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
130685002|NCT02481830|470476225|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
130351192|NCT04078178|469257510|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
130351193|NCT04078178|469257509|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
130351194|NCT04078178|469257510|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
130351195|NCT04078178|469257509|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
130351196|NCT04078178|469257510|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
130351197|NCT04006119|469257511|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
130351198|NCT04006119|469257511|FG000|End of Treatment Veledimex|Adverse Event|2|||
130351199|NCT04006119|469257511|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
130351200|NCT04006119|469257511|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
130351201|NCT04006119|469257511|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
130351202|NCT04006119|469257511|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
130351203|NCT04617795|469257512|FG000|Main Study|Lost to Follow-up|1|||
130351204|NCT04617795|469257513|FG001|Main Study|Lost to Follow-up|0|||
130351205|NCT00472459|469257514|FG000|Overall Study|Adverse Event|13|||
130351206|NCT00472459|469257515|FG001|Overall Study|Adverse Event|13|||
130351207|NCT00472459|469257514|FG000|Overall Study|Withdrawal by Subject|5|||
130351208|NCT00472459|469257515|FG001|Overall Study|Withdrawal by Subject|5|||
130351209|NCT00472459|469257514|FG000|Overall Study|Protocol Violation|3|||
130351210|NCT00472459|469257515|FG001|Overall Study|Protocol Violation|3|||
130351211|NCT00472459|469257514|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
130351212|NCT00472459|469257515|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
130351213|NCT00472459|469257514|FG000|Overall Study|Lost to Follow-up|1|||
130351214|NCT00472459|469257515|FG001|Overall Study|Lost to Follow-up|1|||
130351215|NCT03442764|469257516|FG000|Overall Study|Adverse Event|1|||
130351216|NCT03442764|469257517|FG001|Overall Study|Adverse Event|0|||
130351217|NCT03442764|469257518|FG002|Overall Study|Adverse Event|0|||
130351218|NCT04850313|469257519|FG000|Overall Study|Withdrawal by Subject|0|||
130351219|NCT04850313|469257520|FG001|Overall Study|Withdrawal by Subject|1|||
130351220|NCT02395016|469257521|FG000|Overall Study|Adverse Event|4|||
130351221|NCT02395016|469257522|FG001|Overall Study|Adverse Event|3|||
130351222|NCT02395016|469257521|FG000|Overall Study|Withdrawal by Subject|9|||
130351223|NCT02395016|469257522|FG001|Overall Study|Withdrawal by Subject|6|||
130351224|NCT02395016|469257521|FG000|Overall Study|Protocol Violation|2|||
130351225|NCT02395016|469257522|FG001|Overall Study|Protocol Violation|3|||
130351226|NCT01547780|469257523|FG000|Baseline PET Scan|Physician Decision|1|||
130351227|NCT01547780|469257524|FG001|Baseline PET Scan|Physician Decision|0|||
130351228|NCT01547780|469257525|FG002|Baseline PET Scan|Physician Decision|1|||
130351229|NCT01547780|469257526|FG003|Baseline PET Scan|Physician Decision|0|||
130351230|NCT01547780|469257523|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
130351231|NCT01547780|469257524|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
130351232|NCT01547780|469257525|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
130351233|NCT01547780|469257526|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
130351234|NCT00814879|469257528|FG000|By Week 24|Cancer Diagnosis|1|||
130351235|NCT00814879|469257529|FG001|By Week 24|Cancer Diagnosis|0|||
130351236|NCT00814879|469257528|FG000|By Week 24|Incarceration|0|||
130351237|NCT00814879|469257529|FG001|By Week 24|Incarceration|1|||
130351238|NCT00814879|469257528|FG000|By Week 48|Lost to Follow-up|2|||
130351239|NCT00814879|469257529|FG001|By Week 48|Lost to Follow-up|2|||
130351240|NCT00814879|469257528|FG000|By Week 48|Death|0|||
130351241|NCT00814879|469257529|FG001|By Week 48|Death|1|||
130351242|NCT01277042|469257530|FG000|Overall Study|Adverse Event|4|||
130685003|NCT02481830|470476224|FG000|Treatment|Participants request to discontinue Study treatment|6|||
130351243|NCT01277042|469257531|FG001|Overall Study|Adverse Event|3|||
130685004|NCT02481830|470476225|FG001|Treatment|Participants request to discontinue Study treatment|34|||
130685005|NCT02481830|470476224|FG000|Treatment|Withdrawal by Subject|2|||
130685006|NCT02481830|470476225|FG001|Treatment|Withdrawal by Subject|3|||
130685007|NCT02481830|470476224|FG000|Treatment|Lost to Follow-up|1|||
130685008|NCT02481830|470476225|FG001|Treatment|Lost to Follow-up|0|||
130685009|NCT02481830|470476224|FG000|Treatment|Maximum Clinical Benefit|0|||
130685010|NCT02481830|470476225|FG001|Treatment|Maximum Clinical Benefit|5|||
130685011|NCT02481830|470476224|FG000|Treatment|Administrative reason by sponsor|1|||
130685012|NCT02481830|470476225|FG001|Treatment|Administrative reason by sponsor|1|||
130685013|NCT02481830|470476224|FG000|Treatment|Other reasons|6|||
130685014|NCT02481830|470476225|FG001|Treatment|Other reasons|1|||
130685015|NCT00102440|470476226|FG000|Overall Study|Lost to Follow-up|25|||
130685016|NCT00102440|470476227|FG001|Overall Study|Lost to Follow-up|18|||
130685017|NCT00102440|470476228|FG002|Overall Study|Lost to Follow-up|21|||
130685018|NCT00102440|470476226|FG000|Overall Study|Adverse Event|16|||
130685019|NCT00102440|470476227|FG001|Overall Study|Adverse Event|23|||
130685020|NCT00102440|470476228|FG002|Overall Study|Adverse Event|8|||
130685021|NCT00102440|470476226|FG000|Overall Study|Gout Flare|10|||
130685022|NCT00102440|470476227|FG001|Overall Study|Gout Flare|28|||
130685023|NCT00102440|470476228|FG002|Overall Study|Gout Flare|9|||
130685024|NCT00102440|470476226|FG000|Overall Study|Personal Reason(s)|19|||
130685025|NCT00102440|470476227|FG001|Overall Study|Personal Reason(s)|13|||
130351244|NCT01277042|469257530|FG000|Overall Study|Lost to Follow-up|2|||
130351245|NCT01277042|469257531|FG001|Overall Study|Lost to Follow-up|2|||
130685026|NCT00102440|470476228|FG002|Overall Study|Personal Reason(s)|13|||
130685027|NCT00102440|470476226|FG000|Overall Study|Other|11|||
130685028|NCT00102440|470476227|FG001|Overall Study|Other|14|||
130351246|NCT01277042|469257530|FG000|Overall Study|Withdrawal by Subject|2|||
130351247|NCT01277042|469257531|FG001|Overall Study|Withdrawal by Subject|0|||
130351248|NCT00588952|469257532|FG000|Overall Study|Adverse Event|0|||
130351249|NCT00588952|469257533|FG001|Overall Study|Adverse Event|2|||
130351250|NCT00588952|469257532|FG000|Overall Study|Withdrawal by Subject|3|||
130351251|NCT00588952|469257533|FG001|Overall Study|Withdrawal by Subject|5|||
130351252|NCT01461057|469257534|FG000|Overall Study|Death|10|||
130351253|NCT01461057|469257535|FG001|Overall Study|Death|9|||
130351254|NCT01461057|469257534|FG000|Overall Study|Withdrawal by Subject|2|||
130351255|NCT01461057|469257535|FG001|Overall Study|Withdrawal by Subject|3|||
130351256|NCT01461057|469257534|FG000|Overall Study|Physician Decision|0|||
130351257|NCT01461057|469257535|FG001|Overall Study|Physician Decision|2|||
130351258|NCT01461057|469257534|FG000|Overall Study|Adverse Event|0|||
130351259|NCT01461057|469257535|FG001|Overall Study|Adverse Event|1|||
130351260|NCT01461057|469257534|FG000|Overall Study|Progression of Disease|1|||
130351261|NCT01461057|469257535|FG001|Overall Study|Progression of Disease|0|||
130351262|NCT01461057|469257534|FG000|Overall Study|Study Terminated by Sponsor|2|||
130351263|NCT01461057|469257535|FG001|Overall Study|Study Terminated by Sponsor|0|||
130351264|NCT01288976|469257536|FG000|Overall Study|Withdrawal by Subject|58|||
130351265|NCT01288976|469257537|FG001|Overall Study|Withdrawal by Subject|12|||
130351266|NCT01288976|469257538|FG002|Overall Study|Withdrawal by Subject|9|||
130685029|NCT00102440|470476228|FG002|Overall Study|Other|14|||
130685030|NCT00102440|470476226|FG000|Overall Study|Protocol Violation|7|||
130685031|NCT00102440|470476227|FG001|Overall Study|Protocol Violation|2|||
130685032|NCT00102440|470476228|FG002|Overall Study|Protocol Violation|1|||
130685033|NCT04627038|470476229|FG000|Overall Study|Adverse Event|36|||
130685034|NCT04627038|470476230|FG001|Overall Study|Adverse Event|8|||
130685035|NCT04627038|470476229|FG000|Overall Study|Lost to Follow-up|1|||
130685036|NCT04627038|470476230|FG001|Overall Study|Lost to Follow-up|0|||
130685037|NCT04627038|470476229|FG000|Overall Study|Physician Decision|0|||
130685038|NCT04627038|470476230|FG001|Overall Study|Physician Decision|1|||
130685039|NCT04627038|470476229|FG000|Overall Study|Protocol Violation|3|||
130685040|NCT04627038|470476230|FG001|Overall Study|Protocol Violation|1|||
130685041|NCT04627038|470476229|FG000|Overall Study|Withdrawal by Subject|13|||
130351267|NCT01288976|469257536|FG000|Overall Study|Death|98|||
130351268|NCT01288976|469257537|FG001|Overall Study|Death|6|||
130351269|NCT01288976|469257538|FG002|Overall Study|Death|4|||
130351270|NCT01288976|469257536|FG000|Overall Study|Data unavailable|22|||
130351271|NCT01288976|469257537|FG001|Overall Study|Data unavailable|9|||
130351272|NCT01288976|469257538|FG002|Overall Study|Data unavailable|7|||
130685042|NCT04627038|470476230|FG001|Overall Study|Withdrawal by Subject|3|||
130351273|NCT00959374|469257541|FG000|Overall Study|Withdrawal by Subject|2|||
130351274|NCT00959374|469257541|FG000|Overall Study|Lost to Follow-up|14|||
130351275|NCT00959374|469257541|FG000|Overall Study|Death|1|||
130351276|NCT00959374|469257541|FG000|Overall Study|Protocol Violation|1|||
130351277|NCT00959374|469257541|FG000|Overall Study|Implant Removed/Not Replaced|4|||
130351278|NCT00959374|469257541|FG000|Overall Study|Physician Decision|1|||
130351279|NCT02284178|469257542|FG000|Overall Study|Met exclusion criteria|49|||
130685043|NCT04627038|470476229|FG000|Overall Study|Non-compliance with study drug|0|||
130685044|NCT04627038|470476230|FG001|Overall Study|Non-compliance with study drug|1|||
130685045|NCT04627038|470476229|FG000|Overall Study|Prohibited Concomitant Medication|1|||
130685046|NCT04627038|470476230|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130685047|NCT02255097|470476231|FG000|Overall Study|Death|151|||
130685048|NCT02255097|470476231|FG000|Overall Study|Lost to Follow-up|5|||
130217811|NCT04865419|468761402|FG000|Overall Study|Death|3|||
130217812|NCT04865419|468761403|FG001|Overall Study|Death|1|||
130351280|NCT02284178|469257543|FG001|Overall Study|Met exclusion criteria|54|||
130351281|NCT01483690|469257547|FG000|Overall Study|Adverse Event|1|||
130351282|NCT01483690|469257548|FG001|Overall Study|Adverse Event|2|||
130351283|NCT01483690|469257547|FG000|Overall Study|clinical deterioration|1|||
130351284|NCT01483690|469257548|FG001|Overall Study|clinical deterioration|0|||
130351285|NCT01483690|469257547|FG000|Overall Study|Physician Decision|0|||
130351286|NCT01483690|469257548|FG001|Overall Study|Physician Decision|2|||
130351287|NCT01483690|469257547|FG000|Overall Study|exclusionary procedure|0|||
130351288|NCT01483690|469257548|FG001|Overall Study|exclusionary procedure|1|||
130351289|NCT00478881|469257554|FG000|Overall Study|Adverse Event|31|||
130351290|NCT00478881|469257555|FG001|Overall Study|Adverse Event|12|||
130351291|NCT00478881|469257554|FG000|Overall Study|Lack of Efficacy|0|||
130351292|NCT00478881|469257555|FG001|Overall Study|Lack of Efficacy|3|||
130351293|NCT00478881|469257554|FG000|Overall Study|Lost to Follow-up|0|||
130351294|NCT00478881|469257555|FG001|Overall Study|Lost to Follow-up|1|||
130351295|NCT00478881|469257554|FG000|Overall Study|Protocol Violation|2|||
130351296|NCT00478881|469257555|FG001|Overall Study|Protocol Violation|2|||
130351297|NCT00478881|469257554|FG000|Overall Study|Withdrawal by Subject|6|||
130351298|NCT00478881|469257555|FG001|Overall Study|Withdrawal by Subject|2|||
130351299|NCT00478881|469257554|FG000|Overall Study|Non-Compliance with Study Medication|0|||
130351300|NCT00478881|469257555|FG001|Overall Study|Non-Compliance with Study Medication|2|||
130351301|NCT00737464|469257556|FG000|Overall Study|Adverse Event|1|||
130351302|NCT00737464|469257556|FG000|Overall Study|Death|6|||
130351303|NCT00737464|469257556|FG000|Overall Study|Other - Failure to Return|1|||
130351304|NCT00737464|469257556|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
130351305|NCT00737464|469257556|FG000|Overall Study|Other reasons|4|||
130351306|NCT01041495|469257562|FG000|Overall Study|Withdrawal by Subject|2|||
130351307|NCT01041495|469257563|FG001|Overall Study|Withdrawal by Subject|5|||
130351308|NCT01041495|469257562|FG000|Overall Study|Adverse Event|2|||
130351309|NCT01041495|469257563|FG001|Overall Study|Adverse Event|1|||
130351310|NCT01041495|469257562|FG000|Overall Study|Lost to Follow-up|0|||
130351311|NCT01041495|469257563|FG001|Overall Study|Lost to Follow-up|1|||
130351312|NCT03584373|469257564|FG000|Overall Study|Lost to Follow-up|7|||
130351313|NCT03584373|469257565|FG001|Overall Study|Lost to Follow-up|8|||
130351314|NCT01487577|469257566|FG000|Overall Study|Became ineligible after signing consent|1|||
130351315|NCT03780400|469257568|FG000|Overall Study|Lost to Follow-up|5|||
130351316|NCT03780400|469257568|FG000|Overall Study|Withdrawal by Subject|2|||
130351317|NCT03823378|469257569|FG000|Overall Study|Adverse Event|2|||
130351318|NCT03823378|469257570|FG001|Overall Study|Adverse Event|2|||
130351319|NCT03823378|469257571|FG002|Overall Study|Adverse Event|0|||
130351320|NCT03823378|469257572|FG003|Overall Study|Adverse Event|0|||
130351321|NCT03823378|469257573|FG004|Overall Study|Adverse Event|0|||
130351322|NCT03823378|469257574|FG005|Overall Study|Adverse Event|0|||
130351323|NCT03823378|469257569|FG000|Overall Study|Lost to Follow-up|0|||
130351324|NCT03823378|469257570|FG001|Overall Study|Lost to Follow-up|1|||
130351325|NCT03823378|469257571|FG002|Overall Study|Lost to Follow-up|0|||
130351326|NCT03823378|469257572|FG003|Overall Study|Lost to Follow-up|0|||
130351327|NCT03823378|469257573|FG004|Overall Study|Lost to Follow-up|1|||
130351328|NCT03823378|469257574|FG005|Overall Study|Lost to Follow-up|0|||
130351329|NCT03823378|469257569|FG000|Overall Study|Withdrawal by Subject|0|||
130351330|NCT03823378|469257570|FG001|Overall Study|Withdrawal by Subject|1|||
130351331|NCT03823378|469257571|FG002|Overall Study|Withdrawal by Subject|4|||
130351332|NCT03823378|469257572|FG003|Overall Study|Withdrawal by Subject|2|||
130351333|NCT03823378|469257573|FG004|Overall Study|Withdrawal by Subject|0|||
130351334|NCT03823378|469257574|FG005|Overall Study|Withdrawal by Subject|1|||
130351335|NCT03823378|469257569|FG000|Overall Study|Other, not specified|19|||
130351336|NCT03823378|469257570|FG001|Overall Study|Other, not specified|12|||
130351337|NCT03823378|469257571|FG002|Overall Study|Other, not specified|6|||
130351338|NCT03823378|469257572|FG003|Overall Study|Other, not specified|8|||
130351339|NCT03823378|469257573|FG004|Overall Study|Other, not specified|17|||
130351340|NCT03823378|469257574|FG005|Overall Study|Other, not specified|7|||
130351341|NCT01282203|469257575|FG000|Overall Study|Adverse Event|1|||
130351342|NCT00058539|469257578|FG000|Overall Study|Disease progression|24|||
130351343|NCT00058539|469257578|FG000|Overall Study|Adverse Event|3|||
130351344|NCT00058539|469257578|FG000|Overall Study|Withdrawal by Subject|5|||
130351345|NCT00058539|469257578|FG000|Overall Study|Physician Decision|9|||
130351346|NCT00058539|469257578|FG000|Overall Study|Death|1|||
130351347|NCT02963831|469257579|FG000|Overall Study|Progressive Disease|3|||
130351348|NCT02963831|469257580|FG001|Overall Study|Progressive Disease|3|||
130351349|NCT02963831|469257581|FG002|Overall Study|Progressive Disease|16|||
130351350|NCT02963831|469257582|FG003|Overall Study|Progressive Disease|27|||
130351351|NCT02963831|469257579|FG000|Overall Study|Withdrawal by Subject|1|||
130351352|NCT02963831|469257580|FG001|Overall Study|Withdrawal by Subject|0|||
130351353|NCT02963831|469257581|FG002|Overall Study|Withdrawal by Subject|2|||
130351354|NCT02963831|469257582|FG003|Overall Study|Withdrawal by Subject|4|||
130351355|NCT02963831|469257579|FG000|Overall Study|Adverse Event|0|||
130438818|NCT05340751|469569950|FG000|Overall Study|Physician Decision|3|||
130438819|NCT04399551|469569951|FG000|Overall Study|Adverse Event|15|||
130438820|NCT04399551|469569951|FG000|Overall Study|Withdrawal by Subject|6|||
130438821|NCT04399551|469569951|FG000|Overall Study|Physician Decision|3|||
130438822|NCT04399551|469569951|FG000|Overall Study|Lost to Follow-up|2|||
130438823|NCT04399551|469569951|FG000|Overall Study|Protocol Deviation|2|||
130438824|NCT01014975|469569952|FG000|Overall Study|Withdrawal by Subject|1|||
130438825|NCT01014975|469569953|FG001|Overall Study|Withdrawal by Subject|0|||
130438826|NCT01014975|469569954|FG002|Overall Study|Withdrawal by Subject|1|||
130438827|NCT01014975|469569952|FG000|Overall Study|Death|3|||
130438828|NCT01014975|469569953|FG001|Overall Study|Death|3|||
130438829|NCT01014975|469569954|FG002|Overall Study|Death|4|||
130438830|NCT01014975|469569952|FG000|Overall Study|Lost to Follow-up|0|||
130438831|NCT01014975|469569953|FG001|Overall Study|Lost to Follow-up|0|||
130438832|NCT01014975|469569954|FG002|Overall Study|Lost to Follow-up|1|||
130438833|NCT01336634|469569957|FG000|Overall Study|Study closed/terminated|5|||
130438834|NCT01336634|469569958|FG001|Overall Study|Study closed/terminated|6|||
130685049|NCT02255097|470476231|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
130685050|NCT02255097|470476231|FG000|Overall Study|Withdrawal by Subject|7|||
130685051|NCT02255097|470476231|FG000|Overall Study|Allocated but not treated|1|||
130685052|NCT01010542|470476233|FG000|Overall Study|Adverse Event|0|||
130685053|NCT01010542|470476234|FG001|Overall Study|Adverse Event|1|||
130685054|NCT01010542|470476235|FG002|Overall Study|Adverse Event|0|||
130685055|NCT01010542|470476233|FG000|Overall Study|Lost to Follow-up|0|||
130685056|NCT01010542|470476234|FG001|Overall Study|Lost to Follow-up|1|||
130685057|NCT01010542|470476235|FG002|Overall Study|Lost to Follow-up|0|||
130685058|NCT01010542|470476233|FG000|Overall Study|Withdrawal by Subject|0|||
130685059|NCT01010542|470476234|FG001|Overall Study|Withdrawal by Subject|3|||
130685060|NCT01010542|470476235|FG002|Overall Study|Withdrawal by Subject|2|||
130685061|NCT01745120|470476240|FG000|Overall Study|Investigator decision|1|||
130685062|NCT01745120|470476241|FG001|Overall Study|Investigator decision|0|||
130685063|NCT03956862|470476242|FG000|Overall Study|Lost to Follow-up|1|||
130685064|NCT03956862|470476243|FG001|Overall Study|Lost to Follow-up|1|||
130685065|NCT03956862|470476242|FG000|Overall Study|Withdrawal by Subject|1|||
130685066|NCT03956862|470476243|FG001|Overall Study|Withdrawal by Subject|1|||
130685067|NCT00579670|470476247|FG000|Overall Study|Death|1|||
130685068|NCT00579670|470476248|FG001|Overall Study|Death|0|||
130685069|NCT00579670|470476249|FG002|Overall Study|Death|0|||
130438835|NCT01336634|469569959|FG002|Overall Study|Study closed/terminated|6|||
130438836|NCT01336634|469569957|FG000|Overall Study|Lost to Follow-up|2|||
130438837|NCT01336634|469569958|FG001|Overall Study|Lost to Follow-up|1|||
130438838|NCT01336634|469569959|FG002|Overall Study|Lost to Follow-up|1|||
130438839|NCT01336634|469569957|FG000|Overall Study|Physician Decision|1|||
130438840|NCT01336634|469569958|FG001|Overall Study|Physician Decision|1|||
130438841|NCT01336634|469569959|FG002|Overall Study|Physician Decision|0|||
130438842|NCT01336634|469569957|FG000|Overall Study|Withdrawal by Subject|6|||
130438843|NCT01336634|469569958|FG001|Overall Study|Withdrawal by Subject|0|||
130438844|NCT01336634|469569959|FG002|Overall Study|Withdrawal by Subject|2|||
130438845|NCT02961881|469569960|FG000|Overall Study|Adverse Event|1|||
130438846|NCT02961881|469569961|FG001|Overall Study|Adverse Event|2|||
130438847|NCT02961881|469569962|FG002|Overall Study|Adverse Event|2|||
130438848|NCT02961881|469569963|FG003|Overall Study|Adverse Event|0|||
130685070|NCT00579670|470476250|FG003|Overall Study|Death|0|||
130685071|NCT00579670|470476251|FG004|Overall Study|Death|0|||
130685072|NCT00579670|470476247|FG000|Overall Study|Adverse Event|1|||
130685073|NCT00579670|470476248|FG001|Overall Study|Adverse Event|0|||
130685074|NCT00579670|470476249|FG002|Overall Study|Adverse Event|1|||
130685075|NCT00579670|470476250|FG003|Overall Study|Adverse Event|2|||
130685076|NCT00579670|470476251|FG004|Overall Study|Adverse Event|0|||
130685077|NCT00579670|470476247|FG000|Overall Study|Lack of Efficacy|0|||
130685078|NCT00579670|470476248|FG001|Overall Study|Lack of Efficacy|0|||
130685079|NCT00579670|470476249|FG002|Overall Study|Lack of Efficacy|1|||
130685080|NCT00579670|470476250|FG003|Overall Study|Lack of Efficacy|14|||
130685081|NCT00579670|470476251|FG004|Overall Study|Lack of Efficacy|0|||
130438849|NCT02961881|469569964|FG004|Overall Study|Adverse Event|1|||
130438850|NCT02961881|469569960|FG000|Overall Study|Participant request|0|||
130438851|NCT02961881|469569961|FG001|Overall Study|Participant request|2|||
130438852|NCT02961881|469569962|FG002|Overall Study|Participant request|0|||
130438853|NCT02961881|469569963|FG003|Overall Study|Participant request|0|||
130438854|NCT02961881|469569964|FG004|Overall Study|Participant request|0|||
130438855|NCT02961881|469569960|FG000|Overall Study|Disease progression|1|||
130438856|NCT02961881|469569961|FG001|Overall Study|Disease progression|0|||
130438857|NCT02961881|469569962|FG002|Overall Study|Disease progression|1|||
130438858|NCT02961881|469569963|FG003|Overall Study|Disease progression|0|||
130685082|NCT00579670|470476247|FG000|Overall Study|Lost to Follow-up|0|||
130685083|NCT00579670|470476248|FG001|Overall Study|Lost to Follow-up|1|||
130685084|NCT00579670|470476249|FG002|Overall Study|Lost to Follow-up|0|||
130685085|NCT00579670|470476250|FG003|Overall Study|Lost to Follow-up|4|||
130685086|NCT00579670|470476251|FG004|Overall Study|Lost to Follow-up|0|||
130685087|NCT00579670|470476247|FG000|Overall Study|Other|0|||
130438859|NCT02961881|469569964|FG004|Overall Study|Disease progression|0|||
130438860|NCT01863043|469569966|FG000|Overall Study|Death|6|||
130438861|NCT01863043|469569967|FG001|Overall Study|Death|1|||
130438862|NCT01863043|469569966|FG000|Overall Study|Withdrawal by Subject|0|||
130438863|NCT01863043|469569967|FG001|Overall Study|Withdrawal by Subject|2|||
130438864|NCT01863043|469569966|FG000|Overall Study|Adverse Event|7|||
130438865|NCT01863043|469569967|FG001|Overall Study|Adverse Event|8|||
130438866|NCT01863043|469569966|FG000|Overall Study|exclusion criteria found after enrollment|0|||
130438867|NCT01863043|469569967|FG001|Overall Study|exclusion criteria found after enrollment|1|||
130438868|NCT00313911|469569968|FG000|Overall Study|Serious adverse event|6|||
130438869|NCT00313911|469569969|FG001|Overall Study|Serious adverse event|1|||
130438870|NCT00313911|469569968|FG000|Overall Study|Adverse Event|2|||
130438871|NCT00313911|469569969|FG001|Overall Study|Adverse Event|3|||
130438872|NCT00313911|469569968|FG000|Overall Study|Protocol Violation|19|||
130438873|NCT00313911|469569969|FG001|Overall Study|Protocol Violation|10|||
130438874|NCT00313911|469569968|FG000|Overall Study|Lost to Follow-up|27|||
130438875|NCT00313911|469569969|FG001|Overall Study|Lost to Follow-up|14|||
130438876|NCT00313911|469569968|FG000|Overall Study|Withdrawal by Subject|39|||
130438877|NCT00313911|469569969|FG001|Overall Study|Withdrawal by Subject|12|||
130438878|NCT00313911|469569968|FG000|Overall Study|Did not meet age criteria|1|||
130438879|NCT00313911|469569969|FG001|Overall Study|Did not meet age criteria|1|||
130438880|NCT01912781|469569972|FG000|Overall Study|Withdrawal by Subject|2|||
130438881|NCT01912781|469569973|FG001|Overall Study|Withdrawal by Subject|0|||
130438882|NCT00854295|469569976|FG000|Overall Study|Death|7|||
130438883|NCT00854295|469569977|FG001|Overall Study|Death|0|||
130438884|NCT00854295|469569978|FG002|Overall Study|Death|1|||
130438885|NCT00854295|469569979|FG003|Overall Study|Death|1|||
130438886|NCT00854295|469569976|FG000|Overall Study|Adverse Event|6|||
130438887|NCT00854295|469569977|FG001|Overall Study|Adverse Event|1|||
130438888|NCT00854295|469569978|FG002|Overall Study|Adverse Event|1|||
130438889|NCT00854295|469569979|FG003|Overall Study|Adverse Event|3|||
130438890|NCT00854295|469569976|FG000|Overall Study|Lost to Follow-up|18|||
130438891|NCT00854295|469569977|FG001|Overall Study|Lost to Follow-up|5|||
130438892|NCT00854295|469569978|FG002|Overall Study|Lost to Follow-up|21|||
130438893|NCT00854295|469569979|FG003|Overall Study|Lost to Follow-up|21|||
130438894|NCT00854295|469569976|FG000|Overall Study|Physician Decision|10|||
130438895|NCT00854295|469569977|FG001|Overall Study|Physician Decision|0|||
130438896|NCT00854295|469569978|FG002|Overall Study|Physician Decision|0|||
130438897|NCT00854295|469569979|FG003|Overall Study|Physician Decision|0|||
130438898|NCT04250337|469569980|FG000|Overall Study|Adverse Event|0|||
130438899|NCT04250337|469569981|FG001|Overall Study|Adverse Event|3|||
130438900|NCT04250337|469569980|FG000|Overall Study|Lack of Efficacy|1|||
130438901|NCT04250337|469569981|FG001|Overall Study|Lack of Efficacy|3|||
130438902|NCT04250337|469569980|FG000|Overall Study|Physician Decision|1|||
130438903|NCT04250337|469569981|FG001|Overall Study|Physician Decision|0|||
130438904|NCT04250337|469569980|FG000|Overall Study|Protocol Deviation|2|||
130438905|NCT04250337|469569981|FG001|Overall Study|Protocol Deviation|2|||
130438906|NCT04250337|469569980|FG000|Overall Study|Withdrawal by Subject|4|||
130438907|NCT04250337|469569981|FG001|Overall Study|Withdrawal by Subject|3|||
130438908|NCT05033743|469569987|FG000|Overall Study|Lost to Follow-up|1|||
130438909|NCT05033743|469569987|FG000|Overall Study|Protocol Violation|2|||
130438910|NCT05033743|469569987|FG000|Overall Study|Withdrawal by Subject|1|||
130438911|NCT04537897|469569988|FG000|Overall Study|Other than listed|0|||
130438912|NCT04537897|469569989|FG001|Overall Study|Other than listed|0|||
130438913|NCT04537897|469569990|FG002|Overall Study|Other than listed|0|||
130438914|NCT04537897|469569991|FG003|Overall Study|Other than listed|0|||
130438915|NCT04537897|469569992|FG004|Overall Study|Other than listed|0|||
130438916|NCT04537897|469569993|FG005|Overall Study|Other than listed|0|||
130438917|NCT04537897|469569994|FG006|Overall Study|Other than listed|1|||
130438918|NCT04537897|469569995|FG007|Overall Study|Other than listed|0|||
130438919|NCT04537897|469569996|FG008|Overall Study|Other than listed|0|||
130438920|NCT04537897|469569988|FG000|Overall Study|Adverse Event|0|||
130438921|NCT04537897|469569989|FG001|Overall Study|Adverse Event|0|||
130438922|NCT04537897|469569990|FG002|Overall Study|Adverse Event|0|||
130438923|NCT04537897|469569991|FG003|Overall Study|Adverse Event|1|||
130438924|NCT04537897|469569992|FG004|Overall Study|Adverse Event|0|||
130438925|NCT04537897|469569993|FG005|Overall Study|Adverse Event|0|||
130438926|NCT04537897|469569994|FG006|Overall Study|Adverse Event|0|||
130438927|NCT04537897|469569995|FG007|Overall Study|Adverse Event|0|||
130438928|NCT04537897|469569996|FG008|Overall Study|Adverse Event|0|||
130438929|NCT04537897|469569988|FG000|Overall Study|Withdrawal by Subject|0|||
130685088|NCT00579670|470476248|FG001|Overall Study|Other|0|||
130438930|NCT04537897|469569989|FG001|Overall Study|Withdrawal by Subject|1|||
130438931|NCT04537897|469569990|FG002|Overall Study|Withdrawal by Subject|0|||
130438932|NCT04537897|469569991|FG003|Overall Study|Withdrawal by Subject|0|||
130438933|NCT04537897|469569992|FG004|Overall Study|Withdrawal by Subject|0|||
130438934|NCT04537897|469569993|FG005|Overall Study|Withdrawal by Subject|0|||
130438935|NCT04537897|469569994|FG006|Overall Study|Withdrawal by Subject|0|||
130438936|NCT04537897|469569995|FG007|Overall Study|Withdrawal by Subject|0|||
130685089|NCT00579670|470476249|FG002|Overall Study|Other|1|||
130685090|NCT00579670|470476250|FG003|Overall Study|Other|2|||
130685091|NCT00579670|470476251|FG004|Overall Study|Other|0|||
130685092|NCT00579670|470476247|FG000|Overall Study|Withdrawal by Subject|0|||
130685093|NCT00579670|470476248|FG001|Overall Study|Withdrawal by Subject|0|||
130685094|NCT00579670|470476249|FG002|Overall Study|Withdrawal by Subject|1|||
130685095|NCT00579670|470476250|FG003|Overall Study|Withdrawal by Subject|0|||
130685096|NCT00579670|470476251|FG004|Overall Study|Withdrawal by Subject|0|||
130685097|NCT00850174|470476255|FG000|Washout: One Week|Withdrawal by Subject|0|||
130685098|NCT00850174|470476256|FG001|Washout: One Week|Withdrawal by Subject|2|||
130685099|NCT00850174|470476255|FG000|Second Intervention|Withdrawal by Subject|1|||
130685100|NCT00850174|470476256|FG001|Second Intervention|Withdrawal by Subject|0|||
130685101|NCT01363765|470476259|FG000|Overall Study|non-diagnostic|2621|||
130351356|NCT02963831|469257580|FG001|Overall Study|Adverse Event|1|||
130351357|NCT02963831|469257581|FG002|Overall Study|Adverse Event|1|||
130351358|NCT02963831|469257582|FG003|Overall Study|Adverse Event|2|||
130351359|NCT02963831|469257579|FG000|Overall Study|Death|0|||
130351360|NCT02963831|469257580|FG001|Overall Study|Death|0|||
130351361|NCT02963831|469257581|FG002|Overall Study|Death|0|||
130351362|NCT02963831|469257582|FG003|Overall Study|Death|2|||
130351363|NCT03977454|469257583|FG000|Overall Study|immediate postoperative revision|2|||
130351364|NCT03977454|469257584|FG001|Overall Study|immediate postoperative revision|2|||
130351365|NCT04365257|469257585|FG000|Overall Study|Physician Decision|1|||
130351366|NCT04365257|469257586|FG001|Overall Study|Physician Decision|0|||
130351367|NCT04365257|469257585|FG000|Overall Study|Patient Noncompliance|1|||
130351368|NCT04365257|469257586|FG001|Overall Study|Patient Noncompliance|0|||
130351369|NCT04365257|469257585|FG000|Overall Study|Withdrawal by Subject|0|||
130351370|NCT04365257|469257586|FG001|Overall Study|Withdrawal by Subject|1|||
130351371|NCT03452527|469257587|FG000|Overall Study|Withdrawal by Subject|1|||
130351372|NCT03452527|469257588|FG001|Overall Study|Withdrawal by Subject|1|||
130351373|NCT03452527|469257587|FG000|Overall Study|Study Terminated|2|||
130351374|NCT03452527|469257588|FG001|Overall Study|Study Terminated|3|||
130351375|NCT02129777|469257589|FG000|Double-Blind Period|Adverse Event|0|||
130351376|NCT02129777|469257590|FG001|Double-Blind Period|Adverse Event|0|||
130351377|NCT02129777|469257591|FG002|Double-Blind Period|Adverse Event|0|||
130351378|NCT02129777|469257592|FG003|Double-Blind Period|Adverse Event|0|||
130351379|NCT02129777|469257593|FG004|Double-Blind Period|Adverse Event|1|||
130351380|NCT02129777|469257594|FG005|Double-Blind Period|Adverse Event|0|||
130351381|NCT02129777|469257595|FG006|Double-Blind Period|Adverse Event|0|||
130351382|NCT02129777|469257589|FG000|Double-Blind Period|Lost to Follow-up|1|||
130351383|NCT02129777|469257590|FG001|Double-Blind Period|Lost to Follow-up|1|||
130351384|NCT02129777|469257591|FG002|Double-Blind Period|Lost to Follow-up|1|||
130351385|NCT02129777|469257592|FG003|Double-Blind Period|Lost to Follow-up|2|||
130351386|NCT02129777|469257593|FG004|Double-Blind Period|Lost to Follow-up|0|||
130351387|NCT02129777|469257594|FG005|Double-Blind Period|Lost to Follow-up|0|||
130351388|NCT02129777|469257595|FG006|Double-Blind Period|Lost to Follow-up|0|||
130351389|NCT02129777|469257589|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130351390|NCT02129777|469257590|FG001|Double-Blind Period|Withdrawal by Subject|4|||
130351391|NCT02129777|469257591|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130351392|NCT02129777|469257592|FG003|Double-Blind Period|Withdrawal by Subject|2|||
130351393|NCT02129777|469257593|FG004|Double-Blind Period|Withdrawal by Subject|3|||
130351394|NCT02129777|469257594|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130351395|NCT02129777|469257595|FG006|Double-Blind Period|Withdrawal by Subject|0|||
130351396|NCT02129777|469257589|FG000|Double-Blind Period|Pregnancy|0|||
130351397|NCT02129777|469257590|FG001|Double-Blind Period|Pregnancy|0|||
130351398|NCT02129777|469257591|FG002|Double-Blind Period|Pregnancy|0|||
130351399|NCT02129777|469257592|FG003|Double-Blind Period|Pregnancy|0|||
130351400|NCT02129777|469257593|FG004|Double-Blind Period|Pregnancy|1|||
130351401|NCT02129777|469257594|FG005|Double-Blind Period|Pregnancy|0|||
130351402|NCT02129777|469257595|FG006|Double-Blind Period|Pregnancy|0|||
130351403|NCT02129777|469257589|FG000|Double-Blind Period|Lack of Efficacy|3|||
130351404|NCT02129777|469257590|FG001|Double-Blind Period|Lack of Efficacy|1|||
130351405|NCT02129777|469257591|FG002|Double-Blind Period|Lack of Efficacy|0|||
130351406|NCT02129777|469257592|FG003|Double-Blind Period|Lack of Efficacy|3|||
130685102|NCT01363765|470476260|FG001|Overall Study|non-diagnostic|1124|||
130685103|NCT01363765|470476259|FG000|Overall Study|duplicate records|736|||
130685104|NCT01363765|470476260|FG001|Overall Study|duplicate records|3177|||
130685105|NCT01363765|470476259|FG000|Overall Study|non-resident|156|||
130685106|NCT01363765|470476260|FG001|Overall Study|non-resident|76|||
130685107|NCT01363765|470476259|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
130685108|NCT01363765|470476260|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
130685109|NCT01363765|470476259|FG000|Overall Study|smear during intervention|2170|||
130351407|NCT02129777|469257593|FG004|Double-Blind Period|Lack of Efficacy|2|||
130351408|NCT02129777|469257594|FG005|Double-Blind Period|Lack of Efficacy|0|||
130351409|NCT02129777|469257595|FG006|Double-Blind Period|Lack of Efficacy|0|||
130351410|NCT02129777|469257589|FG000|Double-Blind Period|Other|1|||
130351411|NCT02129777|469257590|FG001|Double-Blind Period|Other|2|||
130685110|NCT01363765|470476260|FG001|Overall Study|smear during intervention|0|||
130685111|NCT01900626|470476261|FG000|Overall Study|study was closed due to low enrollment|1|||
130685112|NCT01900626|470476262|FG001|Overall Study|study was closed due to low enrollment|1|||
130685113|NCT00635492|470476263|FG000|Overall Study|Death|12|||
130685114|NCT00635492|470476264|FG001|Overall Study|Death|40|||
130685115|NCT00635492|470476263|FG000|Overall Study|Lost to Follow-up|151|||
130685116|NCT00635492|470476264|FG001|Overall Study|Lost to Follow-up|172|||
130685117|NCT00635492|470476263|FG000|Overall Study|Physician Decision|32|||
130685118|NCT00635492|470476264|FG001|Overall Study|Physician Decision|22|||
130685119|NCT00635492|470476263|FG000|Overall Study|Sponsor decision|2|||
130685120|NCT00635492|470476264|FG001|Overall Study|Sponsor decision|3|||
130685121|NCT00635492|470476263|FG000|Overall Study|Withdrawal by Subject|82|||
130685122|NCT00635492|470476264|FG001|Overall Study|Withdrawal by Subject|45|||
130685123|NCT02682784|470476265|FG000|Overall Study|Withdrawal by Subject|0|||
130685124|NCT02682784|470476266|FG001|Overall Study|Withdrawal by Subject|2|||
130685125|NCT02682784|470476267|FG002|Overall Study|Withdrawal by Subject|1|||
130685126|NCT02682784|470476268|FG003|Overall Study|Withdrawal by Subject|2|||
130685127|NCT02682784|470476265|FG000|Overall Study|Physician Decision|1|||
130685128|NCT02682784|470476266|FG001|Overall Study|Physician Decision|0|||
130685129|NCT02682784|470476267|FG002|Overall Study|Physician Decision|1|||
130685130|NCT02682784|470476268|FG003|Overall Study|Physician Decision|1|||
130685131|NCT01702987|470476269|FG000|Overall Study|Withdrawal by Subject|1|||
130685132|NCT01702987|470476270|FG001|Overall Study|Withdrawal by Subject|0|||
130685133|NCT04533594|470476271|FG000|Overall Study|Death|26|||
130685134|NCT03138967|470476278|FG000|Overall Study|Death|0|||
130685135|NCT03138967|470476279|FG001|Overall Study|Death|1|||
130685136|NCT03138967|470476278|FG000|Overall Study|Physician Decision|1|||
130685137|NCT03138967|470476279|FG001|Overall Study|Physician Decision|3|||
130685138|NCT05169710|470476280|FG000|Overall Study|Adverse Event|1|||
130685139|NCT05169710|470476281|FG001|Overall Study|Adverse Event|2|||
130685140|NCT05169710|470476282|FG002|Overall Study|Adverse Event|2|||
130685141|NCT05169710|470476280|FG000|Overall Study|Lost to Follow-up|0|||
130685142|NCT05169710|470476281|FG001|Overall Study|Lost to Follow-up|0|||
130685143|NCT05169710|470476282|FG002|Overall Study|Lost to Follow-up|1|||
130685144|NCT05169710|470476280|FG000|Overall Study|Withdrawal by Subject|2|||
130685145|NCT05169710|470476281|FG001|Overall Study|Withdrawal by Subject|1|||
130685146|NCT05169710|470476282|FG002|Overall Study|Withdrawal by Subject|0|||
130685147|NCT05169710|470476280|FG000|Overall Study|Other Study Discontinuation Reason|0|||
130685148|NCT05169710|470476281|FG001|Overall Study|Other Study Discontinuation Reason|2|||
130685149|NCT05169710|470476282|FG002|Overall Study|Other Study Discontinuation Reason|0|||
130685150|NCT00836056|470476295|FG000|First Intervention|Adverse Event|1|||
130685151|NCT00836056|470476296|FG001|First Intervention|Adverse Event|0|||
130685152|NCT00846495|470476297|FG000|Overall Study|Lost to Follow-up|1|||
130685153|NCT00846495|470476298|FG001|Overall Study|Lost to Follow-up|0|||
130685154|NCT00846495|470476297|FG000|Overall Study|Adverse Event|5|||
130685155|NCT00846495|470476298|FG001|Overall Study|Adverse Event|1|||
130685156|NCT00846495|470476297|FG000|Overall Study|Lack of Efficacy|1|||
130685157|NCT00846495|470476298|FG001|Overall Study|Lack of Efficacy|2|||
130685158|NCT00846495|470476297|FG000|Overall Study|Physician Decision|1|||
130685159|NCT00846495|470476298|FG001|Overall Study|Physician Decision|0|||
130685160|NCT01686438|470476299|FG000|Overall Study|Lost to Follow-up|8|||
130685161|NCT01686438|470476300|FG001|Overall Study|Lost to Follow-up|9|||
130351412|NCT02129777|469257591|FG002|Double-Blind Period|Other|0|||
130351413|NCT02129777|469257592|FG003|Double-Blind Period|Other|0|||
130351414|NCT02129777|469257593|FG004|Double-Blind Period|Other|0|||
130351415|NCT02129777|469257594|FG005|Double-Blind Period|Other|0|||
130351416|NCT02129777|469257595|FG006|Double-Blind Period|Other|0|||
130351417|NCT02129777|469257589|FG000|Open-Label Period|Lack of Efficacy|0|||
130351418|NCT02129777|469257590|FG001|Open-Label Period|Lack of Efficacy|0|||
130351419|NCT02129777|469257591|FG002|Open-Label Period|Lack of Efficacy|0|||
130351420|NCT02129777|469257592|FG003|Open-Label Period|Lack of Efficacy|0|||
130351421|NCT02129777|469257593|FG004|Open-Label Period|Lack of Efficacy|0|||
130351422|NCT02129777|469257594|FG005|Open-Label Period|Lack of Efficacy|0|||
130351423|NCT02129777|469257595|FG006|Open-Label Period|Lack of Efficacy|5|||
130685162|NCT01686438|470476301|FG002|Overall Study|Lost to Follow-up|10|||
130685163|NCT01686438|470476299|FG000|Overall Study|Adverse Event|0|||
130351424|NCT02129777|469257589|FG000|Open-Label Period|Lost to Follow-up|0|||
130351425|NCT02129777|469257590|FG001|Open-Label Period|Lost to Follow-up|0|||
130351426|NCT02129777|469257591|FG002|Open-Label Period|Lost to Follow-up|0|||
130351427|NCT02129777|469257592|FG003|Open-Label Period|Lost to Follow-up|0|||
130685164|NCT01686438|470476300|FG001|Overall Study|Adverse Event|0|||
130685165|NCT01686438|470476301|FG002|Overall Study|Adverse Event|1|||
130685166|NCT01686438|470476299|FG000|Overall Study|Protocol Violation|0|||
130685167|NCT01686438|470476300|FG001|Overall Study|Protocol Violation|0|||
130685168|NCT01686438|470476301|FG002|Overall Study|Protocol Violation|1|||
130685169|NCT01686438|470476299|FG000|Overall Study|Withdrawal by Subject|0|||
130685170|NCT01686438|470476300|FG001|Overall Study|Withdrawal by Subject|0|||
130685171|NCT01686438|470476301|FG002|Overall Study|Withdrawal by Subject|1|||
130685172|NCT01029340|470476304|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
130685173|NCT01029340|470476305|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
130685174|NCT01029340|470476306|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
130438937|NCT04537897|469569996|FG008|Overall Study|Withdrawal by Subject|0|||
130438938|NCT00197028|469570000|FG000|Overall Study|Adverse Event|2|||
130438939|NCT00197028|469570001|FG001|Overall Study|Adverse Event|2|||
130438940|NCT00197028|469570000|FG000|Overall Study|Protocol Violation|2|||
130438941|NCT00197028|469570001|FG001|Overall Study|Protocol Violation|1|||
130438942|NCT00197028|469570000|FG000|Overall Study|Withdrawal by Subject|8|||
130438943|NCT00197028|469570001|FG001|Overall Study|Withdrawal by Subject|12|||
130438944|NCT00197028|469570000|FG000|Overall Study|Lost to Follow-up|1|||
130438945|NCT00197028|469570001|FG001|Overall Study|Lost to Follow-up|0|||
130438946|NCT00197028|469570000|FG000|Overall Study|Other|3|||
130438947|NCT00197028|469570001|FG001|Overall Study|Other|6|||
130438948|NCT01923389|469570013|FG000|Overall Study|Protocol Violation|1|||
130438949|NCT01923389|469570014|FG001|Overall Study|Protocol Violation|0|||
130438950|NCT03292146|469570020|FG000|Baseline to 12 Months|Relocation|1|||
130438951|NCT03292146|469570021|FG001|Baseline to 12 Months|Relocation|0|||
130438952|NCT03292146|469570020|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
130438953|NCT03292146|469570021|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
130685175|NCT01029340|470476307|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
130685176|NCT01029340|470476308|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
130685177|NCT01029340|470476309|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
130685178|NCT01029340|470476304|FG000|Part B Treatment Period|Protocol Violation|0|||
130685179|NCT01029340|470476305|FG001|Part B Treatment Period|Protocol Violation|0|||
130685180|NCT01029340|470476306|FG002|Part B Treatment Period|Protocol Violation|1|||
130685181|NCT01029340|470476307|FG003|Part B Treatment Period|Protocol Violation|0|||
130685182|NCT01029340|470476308|FG004|Part B Treatment Period|Protocol Violation|0|||
130685183|NCT01029340|470476309|FG005|Part B Treatment Period|Protocol Violation|0|||
130685184|NCT01029340|470476304|FG000|Extension Period|Adverse Event|0|||
130685185|NCT01029340|470476305|FG001|Extension Period|Adverse Event|0|||
130685186|NCT01029340|470476306|FG002|Extension Period|Adverse Event|0|||
130685187|NCT01029340|470476307|FG003|Extension Period|Adverse Event|0|||
130685188|NCT01029340|470476308|FG004|Extension Period|Adverse Event|0|||
130685189|NCT01029340|470476309|FG005|Extension Period|Adverse Event|1|||
130685190|NCT01029340|470476304|FG000|Extension Period|starting another study|0|||
130685191|NCT01029340|470476305|FG001|Extension Period|starting another study|0|||
130685192|NCT01029340|470476306|FG002|Extension Period|starting another study|0|||
130685193|NCT01029340|470476307|FG003|Extension Period|starting another study|0|||
130438954|NCT03292146|469570020|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
130438955|NCT03292146|469570021|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
130685194|NCT01029340|470476308|FG004|Extension Period|starting another study|0|||
130685195|NCT01029340|470476309|FG005|Extension Period|starting another study|8|||
130685196|NCT01029340|470476304|FG000|Extension Period|non-compliance|0|||
130685197|NCT01029340|470476305|FG001|Extension Period|non-compliance|0|||
130685198|NCT01029340|470476306|FG002|Extension Period|non-compliance|0|||
130685199|NCT01029340|470476307|FG003|Extension Period|non-compliance|0|||
130685200|NCT01029340|470476308|FG004|Extension Period|non-compliance|0|||
130685201|NCT01029340|470476309|FG005|Extension Period|non-compliance|1|||
130685202|NCT01029340|470476304|FG000|Extension Period|Withdrawal by Subject|0|||
130685203|NCT01029340|470476305|FG001|Extension Period|Withdrawal by Subject|0|||
130685204|NCT01029340|470476306|FG002|Extension Period|Withdrawal by Subject|0|||
130438956|NCT03292146|469570020|FG000|12 Months to 24 Months|Planning pregnancy|2|||
130438957|NCT03292146|469570021|FG001|12 Months to 24 Months|Planning pregnancy|2|||
130438958|NCT03292146|469570020|FG000|12 Months to 24 Months|Personal reasons|1|||
130438959|NCT03292146|469570021|FG001|12 Months to 24 Months|Personal reasons|0|||
130438960|NCT03292146|469570020|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
130438961|NCT03292146|469570021|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
130438962|NCT00545363|469570024|FG000|Overall Study|Adverse Event|6|||
130438963|NCT00545363|469570025|FG001|Overall Study|Adverse Event|7|||
130438964|NCT00545363|469570024|FG000|Overall Study|Withdrawal by Subject|6|||
130438965|NCT00545363|469570025|FG001|Overall Study|Withdrawal by Subject|5|||
130685205|NCT01029340|470476307|FG003|Extension Period|Withdrawal by Subject|0|||
130685206|NCT01029340|470476308|FG004|Extension Period|Withdrawal by Subject|0|||
130685207|NCT01029340|470476309|FG005|Extension Period|Withdrawal by Subject|1|||
130685208|NCT01029340|470476304|FG000|Extension Period|Physician Decision|0|||
130438966|NCT00545363|469570024|FG000|Overall Study|Non-compliance|3|||
130438967|NCT00545363|469570025|FG001|Overall Study|Non-compliance|1|||
130438968|NCT00545363|469570024|FG000|Overall Study|Did not meet entry criteria|1|||
130438969|NCT00545363|469570025|FG001|Overall Study|Did not meet entry criteria|1|||
130438970|NCT00545363|469570024|FG000|Overall Study|Lost to Follow-up|2|||
130438971|NCT00545363|469570025|FG001|Overall Study|Lost to Follow-up|0|||
130438972|NCT00545363|469570024|FG000|Overall Study|Other|1|||
130438973|NCT00545363|469570025|FG001|Overall Study|Other|1|||
130685209|NCT01029340|470476305|FG001|Extension Period|Physician Decision|0|||
130685210|NCT01029340|470476306|FG002|Extension Period|Physician Decision|0|||
130685211|NCT01029340|470476307|FG003|Extension Period|Physician Decision|0|||
130685212|NCT01029340|470476308|FG004|Extension Period|Physician Decision|0|||
130685213|NCT01029340|470476309|FG005|Extension Period|Physician Decision|1|||
130685214|NCT02648347|470476310|FG000|Overall Study|Death|174|||
130685215|NCT02648347|470476311|FG001|Overall Study|Death|167|||
130685216|NCT02648347|470476310|FG000|Overall Study|Withdrawal by Subject|16|||
130685217|NCT02648347|470476311|FG001|Overall Study|Withdrawal by Subject|9|||
130685218|NCT02648347|470476310|FG000|Overall Study|Lost to Follow-up|18|||
130685219|NCT02648347|470476311|FG001|Overall Study|Lost to Follow-up|21|||
130685220|NCT02648347|470476310|FG000|Overall Study|Missing|1|||
130685221|NCT02648347|470476311|FG001|Overall Study|Missing|0|||
130685222|NCT01265056|470476315|FG000|Initial Study Period|Withdrawal by Subject|1|||
130685223|NCT01265056|470476316|FG001|Initial Study Period|Withdrawal by Subject|1|||
130685224|NCT01265056|470476315|FG000|Initial Study Period|Withdrawal by Subject|1|||
130685225|NCT01265056|470476316|FG001|Initial Study Period|Withdrawal by Subject|1|||
130685226|NCT01265056|470476315|FG000|Follow up|Lost to Follow-up|7|||
130685227|NCT01265056|470476316|FG001|Follow up|Lost to Follow-up|3|||
130685228|NCT02601560|470476321|FG000|Overall Study|Other|0|||
130685229|NCT02601560|470476322|FG001|Overall Study|Other|0|||
130685230|NCT02601560|470476323|FG002|Overall Study|Other|0|||
130685231|NCT02601560|470476324|FG003|Overall Study|Other|0|||
130351428|NCT02129777|469257593|FG004|Open-Label Period|Lost to Follow-up|0|||
130351429|NCT02129777|469257594|FG005|Open-Label Period|Lost to Follow-up|1|||
130351430|NCT02129777|469257595|FG006|Open-Label Period|Lost to Follow-up|1|||
130351431|NCT02129777|469257589|FG000|Open-Label Period|Withdrawal by Subject|0|||
130351432|NCT02129777|469257590|FG001|Open-Label Period|Withdrawal by Subject|0|||
130351433|NCT02129777|469257591|FG002|Open-Label Period|Withdrawal by Subject|0|||
130351434|NCT02129777|469257592|FG003|Open-Label Period|Withdrawal by Subject|0|||
130351435|NCT02129777|469257593|FG004|Open-Label Period|Withdrawal by Subject|0|||
130351436|NCT02129777|469257594|FG005|Open-Label Period|Withdrawal by Subject|1|||
130351437|NCT02129777|469257595|FG006|Open-Label Period|Withdrawal by Subject|3|||
130351438|NCT02129777|469257589|FG000|Open-Label Period|Study Termination|0|||
130351439|NCT02129777|469257590|FG001|Open-Label Period|Study Termination|0|||
130351440|NCT02129777|469257591|FG002|Open-Label Period|Study Termination|0|||
130351441|NCT02129777|469257592|FG003|Open-Label Period|Study Termination|0|||
130351442|NCT02129777|469257593|FG004|Open-Label Period|Study Termination|0|||
130351443|NCT02129777|469257594|FG005|Open-Label Period|Study Termination|10|||
130351444|NCT02129777|469257595|FG006|Open-Label Period|Study Termination|39|||
130351445|NCT01001299|469257596|FG000|Overall Study|Insufficient Therapeutic Response|20|||
130351446|NCT01001299|469257596|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
130351447|NCT01001299|469257596|FG000|Overall Study|Death|1|||
130351448|NCT01001299|469257596|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
130351449|NCT01001299|469257596|FG000|Overall Study|Withdrew Consent|1|||
130351450|NCT01565499|469257597|FG000|Overall Study|Physician Decision|1|||
130351451|NCT01565499|469257597|FG000|Overall Study|Adverse Event|5|||
130351452|NCT01565499|469257597|FG000|Overall Study|Withdrawal by Subject|2|||
130351453|NCT03116347|469257598|FG000|Overall Study|Withdrawal by Subject|1|||
130351454|NCT03116347|469257599|FG001|Overall Study|Withdrawal by Subject|2|||
130351455|NCT01255787|469257600|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
130351456|NCT01255787|469257601|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
130351457|NCT01255787|469257602|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
130351458|NCT01255787|469257603|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
130351459|NCT01255787|469257600|FG000|Overall Study|Major Protocol Deviation|1|||
130351460|NCT01255787|469257601|FG001|Overall Study|Major Protocol Deviation|1|||
130351461|NCT01255787|469257602|FG002|Overall Study|Major Protocol Deviation|0|||
130351462|NCT01255787|469257603|FG003|Overall Study|Major Protocol Deviation|4|||
130351463|NCT01255787|469257600|FG000|Overall Study|Lost to Follow-up|1|||
130351464|NCT01255787|469257601|FG001|Overall Study|Lost to Follow-up|2|||
130351465|NCT01255787|469257602|FG002|Overall Study|Lost to Follow-up|4|||
130351466|NCT01255787|469257603|FG003|Overall Study|Lost to Follow-up|2|||
130351467|NCT01255787|469257600|FG000|Overall Study|Withdrawal of Consent|3|||
130351468|NCT01255787|469257601|FG001|Overall Study|Withdrawal of Consent|9|||
130685232|NCT02601560|470476325|FG004|Overall Study|Other|0|||
130685233|NCT02601560|470476326|FG005|Overall Study|Other|0|||
130685234|NCT02601560|470476327|FG006|Overall Study|Other|1|||
130685235|NCT02601560|470476328|FG007|Overall Study|Other|0|||
130685236|NCT03459807|470476329|FG000|Overall Study|Withdrawal due to transplant|0|||
130351469|NCT01255787|469257602|FG002|Overall Study|Withdrawal of Consent|3|||
130351470|NCT01255787|469257603|FG003|Overall Study|Withdrawal of Consent|4|||
130351471|NCT01255787|469257600|FG000|Overall Study|Pregnancy|0|||
130351472|NCT01255787|469257601|FG001|Overall Study|Pregnancy|0|||
130351473|NCT01255787|469257602|FG002|Overall Study|Pregnancy|0|||
130351474|NCT01255787|469257603|FG003|Overall Study|Pregnancy|1|||
130351475|NCT01255787|469257600|FG000|Overall Study|Lack of Efficacy|2|||
130351476|NCT01255787|469257601|FG001|Overall Study|Lack of Efficacy|2|||
130351477|NCT01255787|469257602|FG002|Overall Study|Lack of Efficacy|2|||
130351478|NCT01255787|469257603|FG003|Overall Study|Lack of Efficacy|2|||
130685237|NCT03459807|470476330|FG001|Overall Study|Withdrawal due to transplant|1|||
130685238|NCT00833937|470476336|FG000|Washout|Withdrawal by Subject|1|||
130685239|NCT00833937|470476337|FG001|Washout|Withdrawal by Subject|0|||
130685240|NCT03725605|470476338|FG000|Overall Study|Unsuccessful TIL expansion|2|||
130685241|NCT03135834|470476346|FG000|Stage 1|Adverse Event|1|||
130685242|NCT03135834|470476347|FG001|Stage 1|Adverse Event|2|||
130685243|NCT03135834|470476348|FG002|Stage 1|Adverse Event|2|||
130685244|NCT03135834|470476349|FG003|Stage 1|Adverse Event|1|||
130685245|NCT03135834|470476346|FG000|Stage 1|Death|1|||
130685246|NCT03135834|470476347|FG001|Stage 1|Death|0|||
130685247|NCT03135834|470476348|FG002|Stage 1|Death|0|||
130685248|NCT03135834|470476349|FG003|Stage 1|Death|0|||
130685249|NCT03135834|470476346|FG000|Stage 1|Lost to Follow-up|17|||
130685250|NCT03135834|470476347|FG001|Stage 1|Lost to Follow-up|24|||
130685251|NCT03135834|470476348|FG002|Stage 1|Lost to Follow-up|21|||
130685252|NCT03135834|470476349|FG003|Stage 1|Lost to Follow-up|38|||
130685253|NCT03135834|470476346|FG000|Stage 1|No longer met eligibility criteria|1|||
130685254|NCT03135834|470476347|FG001|Stage 1|No longer met eligibility criteria|6|||
130685255|NCT03135834|470476348|FG002|Stage 1|No longer met eligibility criteria|2|||
130685256|NCT03135834|470476349|FG003|Stage 1|No longer met eligibility criteria|5|||
130685257|NCT03135834|470476346|FG000|Stage 1|Other|0|||
130685258|NCT03135834|470476347|FG001|Stage 1|Other|2|||
130685259|NCT03135834|470476348|FG002|Stage 1|Other|1|||
130685260|NCT03135834|470476349|FG003|Stage 1|Other|0|||
130685261|NCT03135834|470476346|FG000|Stage 1|Physician Decision|0|||
130685262|NCT03135834|470476347|FG001|Stage 1|Physician Decision|1|||
130685263|NCT03135834|470476348|FG002|Stage 1|Physician Decision|0|||
130685264|NCT03135834|470476349|FG003|Stage 1|Physician Decision|0|||
130685265|NCT03135834|470476346|FG000|Stage 1|Pregnancy|0|||
130685266|NCT03135834|470476347|FG001|Stage 1|Pregnancy|4|||
130685267|NCT03135834|470476348|FG002|Stage 1|Pregnancy|2|||
130685268|NCT03135834|470476349|FG003|Stage 1|Pregnancy|4|||
130685269|NCT03135834|470476346|FG000|Stage 1|Protocol Violation|1|||
130685270|NCT03135834|470476347|FG001|Stage 1|Protocol Violation|1|||
130685271|NCT03135834|470476348|FG002|Stage 1|Protocol Violation|2|||
130685272|NCT03135834|470476349|FG003|Stage 1|Protocol Violation|1|||
130351479|NCT01255787|469257600|FG000|Overall Study|Noncompliance with Study Drug|3|||
130351480|NCT01255787|469257601|FG001|Overall Study|Noncompliance with Study Drug|1|||
130351481|NCT01255787|469257602|FG002|Overall Study|Noncompliance with Study Drug|0|||
130351482|NCT01255787|469257603|FG003|Overall Study|Noncompliance with Study Drug|0|||
130685273|NCT03135834|470476346|FG000|Stage 1|Withdrawal by parent/guardian|2|||
130685274|NCT03135834|470476347|FG001|Stage 1|Withdrawal by parent/guardian|10|||
130685275|NCT03135834|470476348|FG002|Stage 1|Withdrawal by parent/guardian|2|||
130351483|NCT00476047|469257604|FG000|Overall Study|Lost to Follow-up|1|||
130351484|NCT03170232|469257605|FG000|Overall Study|Adverse Event|0|||
130351485|NCT03170232|469257606|FG001|Overall Study|Adverse Event|1|||
130351486|NCT03170232|469257605|FG000|Overall Study|Protocol Violation|0|||
130351487|NCT03170232|469257606|FG001|Overall Study|Protocol Violation|1|||
130351488|NCT03170232|469257605|FG000|Overall Study|Lack of Efficacy|0|||
130351489|NCT03170232|469257606|FG001|Overall Study|Lack of Efficacy|1|||
130351490|NCT03170232|469257605|FG000|Overall Study|Study closed/terminated|26|||
130351491|NCT03170232|469257606|FG001|Overall Study|Study closed/terminated|23|||
130351492|NCT03170232|469257605|FG000|Overall Study|Lost to Follow-up|1|||
130351493|NCT03170232|469257606|FG001|Overall Study|Lost to Follow-up|0|||
130351494|NCT03170232|469257605|FG000|Overall Study|Withdrawal by Subject|0|||
130351495|NCT03170232|469257606|FG001|Overall Study|Withdrawal by Subject|1|||
130351496|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
130351497|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
130351498|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
130351499|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
130351500|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
130351501|NCT00586326|469257607|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
130685276|NCT03135834|470476349|FG003|Stage 1|Withdrawal by parent/guardian|1|||
130685277|NCT03135834|470476346|FG000|Stage 1|Withdrawal by Subject|16|||
130351502|NCT00586326|469257607|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
130685278|NCT03135834|470476347|FG001|Stage 1|Withdrawal by Subject|22|||
130685279|NCT03135834|470476348|FG002|Stage 1|Withdrawal by Subject|7|||
130685280|NCT03135834|470476349|FG003|Stage 1|Withdrawal by Subject|10|||
130685281|NCT03135834|470476346|FG000|Stage 1|Randomized but not Vaccinated|0|||
130685282|NCT03135834|470476347|FG001|Stage 1|Randomized but not Vaccinated|3|||
130685283|NCT03135834|470476348|FG002|Stage 1|Randomized but not Vaccinated|1|||
130685284|NCT03135834|470476349|FG003|Stage 1|Randomized but not Vaccinated|6|||
130685285|NCT03135834|470476346|FG000|Stage 2|Lost to Follow-up|0|||
130685286|NCT03135834|470476347|FG001|Stage 2|Lost to Follow-up|1|||
130685287|NCT03135834|470476348|FG002|Stage 2|Lost to Follow-up|0|||
130685288|NCT03135834|470476349|FG003|Stage 2|Lost to Follow-up|0|||
130685289|NCT03135834|470476346|FG000|Stage 2|Withdrawal by Subject|0|||
130685290|NCT03135834|470476347|FG001|Stage 2|Withdrawal by Subject|1|||
130685291|NCT03135834|470476348|FG002|Stage 2|Withdrawal by Subject|0|||
130685292|NCT03135834|470476349|FG003|Stage 2|Withdrawal by Subject|0|||
130685293|NCT03135834|470476346|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
130685294|NCT03135834|470476347|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
130685295|NCT03135834|470476348|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
130685296|NCT03135834|470476349|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
130685297|NCT03135834|470476346|FG000|Stage 2|Did not receive Booster Vaccination|1|||
130685298|NCT03135834|470476347|FG001|Stage 2|Did not receive Booster Vaccination|1|||
130685299|NCT03135834|470476348|FG002|Stage 2|Did not receive Booster Vaccination|0|||
130685300|NCT03135834|470476349|FG003|Stage 2|Did not receive Booster Vaccination|0|||
130685301|NCT00965185|470476350|FG000|Overall Study|Lost to Follow-up|2|||
130685302|NCT00965185|470476351|FG001|Overall Study|Lost to Follow-up|0|||
130685303|NCT00965185|470476350|FG000|Overall Study|Withdrawal by Subject|0|||
130685304|NCT00965185|470476351|FG001|Overall Study|Withdrawal by Subject|1|||
130685305|NCT03707912|470476354|FG000|Overall Study|Violation of inclusion criteria|1|||
130685306|NCT03707912|470476355|FG001|Overall Study|Violation of inclusion criteria|0|||
130685307|NCT02039908|470476356|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
130685308|NCT02039908|470476357|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
130685309|NCT02039908|470476358|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
130685310|NCT02039908|470476359|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
130685311|NCT02039908|470476356|FG000|Phase 1-Summer|Protocol Violation|6|||
130685312|NCT02039908|470476357|FG001|Phase 1-Summer|Protocol Violation|0|||
130685313|NCT02039908|470476358|FG002|Phase 1-Summer|Protocol Violation|0|||
130685314|NCT02039908|470476359|FG003|Phase 1-Summer|Protocol Violation|0|||
130685315|NCT02039908|470476356|FG000|Phase 2-School Year|Lost to Follow-up|0|||
130685316|NCT02039908|470476357|FG001|Phase 2-School Year|Lost to Follow-up|0|||
130685317|NCT02039908|470476358|FG002|Phase 2-School Year|Lost to Follow-up|1|||
130685318|NCT02039908|470476359|FG003|Phase 2-School Year|Lost to Follow-up|3|||
130685319|NCT02039908|470476356|FG000|Phase 2-School Year|Protocol Violation|0|||
130685320|NCT02039908|470476357|FG001|Phase 2-School Year|Protocol Violation|0|||
130685321|NCT02039908|470476358|FG002|Phase 2-School Year|Protocol Violation|3|||
130685322|NCT02039908|470476359|FG003|Phase 2-School Year|Protocol Violation|0|||
130685323|NCT02039908|470476356|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
130685324|NCT02039908|470476357|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
130685325|NCT02039908|470476358|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
130685326|NCT02039908|470476359|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
130685327|NCT01802320|470476360|FG000|Overall Study|Death|1|||
130685328|NCT01802320|470476360|FG000|Overall Study|Withdrawal by Subject|1|||
130685329|NCT02956460|470477797|FG000|Lens 1|Lost to Follow-up|1|||
130685330|NCT02956460|470477798|FG001|Lens 1|Lost to Follow-up|0|||
130685331|NCT04129346|470477799|FG000|Overall Study|Death|1|||
130685332|NCT04129346|470477800|FG001|Overall Study|Death|0|||
130685333|NCT02077465|470477801|FG000|Overall Study|Withdrew Consent|0|||
130685334|NCT02077465|470477802|FG001|Overall Study|Withdrew Consent|1|||
130685335|NCT02077465|470477801|FG000|Overall Study|Lost to Follow-up|1|||
130685336|NCT02077465|470477802|FG001|Overall Study|Lost to Follow-up|0|||
130685337|NCT01827163|470477803|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
130685338|NCT01827163|470477803|FG000|Overall Study|Adverse Event|9|||
130685339|NCT03375463|470477804|FG000|Period 1|Lost to Follow-up|0|||
130685340|NCT03375463|470477805|FG001|Period 1|Lost to Follow-up|0|||
130685341|NCT03375463|470477806|FG002|Period 1|Lost to Follow-up|1|||
130685342|NCT03375463|470477807|FG003|Period 1|Lost to Follow-up|0|||
130685343|NCT03375463|470477808|FG004|Period 1|Lost to Follow-up|0|||
130685344|NCT03375463|470477809|FG005|Period 1|Lost to Follow-up|0|||
130685345|NCT03375463|470477804|FG000|Period 1|Adverse Event|0|||
130685346|NCT03375463|470477805|FG001|Period 1|Adverse Event|0|||
130685347|NCT03375463|470477806|FG002|Period 1|Adverse Event|0|||
130685348|NCT03375463|470477807|FG003|Period 1|Adverse Event|0|||
130351503|NCT00586326|469257607|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
130351504|NCT00586326|469257607|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
130351505|NCT00586326|469257607|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
130351506|NCT00586326|469257607|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
130351507|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
130351508|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
130351509|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
130685349|NCT03375463|470477808|FG004|Period 1|Adverse Event|1|||
130685350|NCT03375463|470477809|FG005|Period 1|Adverse Event|0|||
130685351|NCT03375463|470477804|FG000|Period 2|Lost to Follow-up|1|||
130685352|NCT03375463|470477805|FG001|Period 2|Lost to Follow-up|1|||
130685353|NCT03375463|470477806|FG002|Period 2|Lost to Follow-up|0|||
130685354|NCT03375463|470477807|FG003|Period 2|Lost to Follow-up|0|||
130685355|NCT03375463|470477808|FG004|Period 2|Lost to Follow-up|0|||
130351510|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
130685356|NCT03375463|470477809|FG005|Period 2|Lost to Follow-up|0|||
130685357|NCT01602419|470477810|FG000|Overall Study|Not treated with Wilate|9|||
130685358|NCT01602419|470477810|FG000|Overall Study|Adverse Drug Reaction|4|||
130685359|NCT01602419|470477810|FG000|Overall Study|Insurance issues|3|||
130685360|NCT01602419|470477810|FG000|Overall Study|Changed treatment centre|1|||
130685361|NCT01602419|470477810|FG000|Overall Study|Treatment centre closed|1|||
130685362|NCT01602419|470477810|FG000|Overall Study|Withdrawal by Subject|5|||
130685363|NCT01602419|470477810|FG000|Overall Study|Lost to Follow-up|6|||
130685364|NCT01792635|470477811|FG000|Part B|Adverse Event|0|||
130685365|NCT01792635|470477812|FG001|Part B|Adverse Event|0|||
130685366|NCT01792635|470477813|FG002|Part B|Adverse Event|1|||
130685367|NCT01792635|470477811|FG000|Part B|Study terminated|0|||
130685368|NCT01792635|470477812|FG001|Part B|Study terminated|4|||
130685369|NCT01792635|470477813|FG002|Part B|Study terminated|3|||
130685370|NCT01513174|470477816|FG000|Overall Study|Inclusion Error|1|||
130685371|NCT01513174|470477817|FG001|Overall Study|Inclusion Error|7|||
130685372|NCT01513174|470477816|FG000|Overall Study|Not receive study treatment|3|||
130685373|NCT01513174|470477817|FG001|Overall Study|Not receive study treatment|1|||
130685374|NCT00467363|470477818|FG000|Overall Study|Lost to Follow-up|80|||
130685375|NCT00467363|470477819|FG001|Overall Study|Lost to Follow-up|70|||
130685376|NCT00365846|470477820|FG000|Overall Study|Lost to Follow-up|1|||
130685377|NCT04400890|470477821|FG000|Overall Study|Withdrawal by Subject|3|||
130685378|NCT04400890|470477822|FG001|Overall Study|Withdrawal by Subject|2|||
130685379|NCT00723710|470477823|FG000|Overall Study|Disease progression|48|||
130685380|NCT00723710|470477823|FG000|Overall Study|Adverse Event|88|||
130685381|NCT00723710|470477823|FG000|Overall Study|Withdrawal by Subject|36|||
130685382|NCT00723710|470477823|FG000|Overall Study|Physician Decision|2|||
130685383|NCT04405570|470477824|FG000|Overall Study|Adverse Event|0|||
130685384|NCT04405570|470477825|FG001|Overall Study|Adverse Event|1|||
130685385|NCT04405570|470477826|FG002|Overall Study|Adverse Event|1|||
130685386|NCT04405570|470477827|FG003|Overall Study|Adverse Event|1|||
130685387|NCT04405570|470477824|FG000|Overall Study|Lost to Follow-up|0|||
130685388|NCT04405570|470477825|FG001|Overall Study|Lost to Follow-up|1|||
130685389|NCT04405570|470477826|FG002|Overall Study|Lost to Follow-up|0|||
130685390|NCT04405570|470477827|FG003|Overall Study|Lost to Follow-up|0|||
130685391|NCT04405570|470477824|FG000|Overall Study|Physician Decision|0|||
130685392|NCT04405570|470477825|FG001|Overall Study|Physician Decision|0|||
130685393|NCT04405570|470477826|FG002|Overall Study|Physician Decision|1|||
130685394|NCT04405570|470477827|FG003|Overall Study|Physician Decision|0|||
130685395|NCT04405570|470477824|FG000|Overall Study|Withdrawal by Subject|0|||
130685396|NCT04405570|470477825|FG001|Overall Study|Withdrawal by Subject|1|||
130685397|NCT04405570|470477826|FG002|Overall Study|Withdrawal by Subject|1|||
130685398|NCT04405570|470477827|FG003|Overall Study|Withdrawal by Subject|0|||
130685399|NCT04405570|470477824|FG000|Overall Study|Randomized not dosed|0|||
130685400|NCT04405570|470477825|FG001|Overall Study|Randomized not dosed|2|||
130685401|NCT04405570|470477826|FG002|Overall Study|Randomized not dosed|0|||
130685402|NCT04405570|470477827|FG003|Overall Study|Randomized not dosed|0|||
130685403|NCT04499963|470477828|FG000|Overall Study|Adverse Event|3|||
130685404|NCT04499963|470477829|FG001|Overall Study|Adverse Event|0|||
130685405|NCT04499963|470477828|FG000|Overall Study|Death|3|||
130685406|NCT04499963|470477829|FG001|Overall Study|Death|0|||
130685407|NCT04499963|470477828|FG000|Overall Study|Lack of Efficacy|7|||
130685408|NCT04499963|470477829|FG001|Overall Study|Lack of Efficacy|0|||
130351511|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
130351512|NCT00586326|469257607|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
130351513|NCT03882008|469257608|FG000|Overall Study|Withdrawal by Subject|1|||
130351514|NCT03882008|469257608|FG000|Overall Study|Lost to Follow-up|1|||
130685409|NCT04499963|470477828|FG000|Overall Study|Lost to Follow-up|2|||
130685410|NCT04499963|470477829|FG001|Overall Study|Lost to Follow-up|0|||
130685411|NCT02711852|470477836|FG000|Overall Study|Death|5|||
130685412|NCT02711852|470477836|FG000|Overall Study|Lost to Follow-up|1|||
130685413|NCT02711852|470477836|FG000|Overall Study|Completed follow-up|3|||
130685414|NCT02711852|470477836|FG000|Overall Study|Withdrawal by Subject|1|||
130685415|NCT03233724|470477837|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685416|NCT03233724|470477838|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685417|NCT03233724|470477839|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685418|NCT03233724|470477840|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685419|NCT03233724|470477841|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
130685420|NCT03233724|470477837|FG000|Phase I Dose Escalation|Best interest of participant|1|||
130685421|NCT03233724|470477838|FG001|Phase I Dose Escalation|Best interest of participant|1|||
130685422|NCT03233724|470477839|FG002|Phase I Dose Escalation|Best interest of participant|1|||
130685423|NCT03233724|470477840|FG003|Phase I Dose Escalation|Best interest of participant|0|||
130685424|NCT03233724|470477841|FG004|Phase I Dose Escalation|Best interest of participant|0|||
130685425|NCT03233724|470477837|FG000|Phase I Dose Escalation|Physician Decision|0|||
130685426|NCT03233724|470477838|FG001|Phase I Dose Escalation|Physician Decision|0|||
130685427|NCT03233724|470477839|FG002|Phase I Dose Escalation|Physician Decision|1|||
130685428|NCT03233724|470477840|FG003|Phase I Dose Escalation|Physician Decision|0|||
130685429|NCT03233724|470477841|FG004|Phase I Dose Escalation|Physician Decision|0|||
130685430|NCT03233724|470477837|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130351515|NCT02009384|469257609|FG000|Overall Study|Death|2|||
130685431|NCT03233724|470477838|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685432|NCT03233724|470477839|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
130685433|NCT03233724|470477840|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685434|NCT03233724|470477841|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685435|NCT02388191|470477843|FG000|Overall Study|Patient did not receive IUD|1|||
130685436|NCT02388191|470477844|FG001|Overall Study|Patient did not receive IUD|0|||
130685437|NCT03686033|470477845|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685438|NCT03686033|470477846|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685439|NCT03686033|470477847|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
130438974|NCT00366301|469570026|FG000|Overall Study|Lost to Follow-up|4|||
130438975|NCT00366301|469570027|FG001|Overall Study|Lost to Follow-up|4|||
130438976|NCT00366301|469570028|FG002|Overall Study|Lost to Follow-up|3|||
130685440|NCT03686033|470477848|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685441|NCT03686033|470477849|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
130685442|NCT03686033|470477850|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685443|NCT03197883|470477851|FG000|Overall Study|Adverse Event|1|||
130685444|NCT03197883|470477852|FG001|Overall Study|Adverse Event|1|||
130685445|NCT03197883|470477851|FG000|Overall Study|Lost to Follow-up|1|||
130685446|NCT03197883|470477852|FG001|Overall Study|Lost to Follow-up|0|||
130685447|NCT03197883|470477851|FG000|Overall Study|Protocol Violation|1|||
130685448|NCT03197883|470477852|FG001|Overall Study|Protocol Violation|0|||
130685449|NCT03197883|470477851|FG000|Overall Study|Other (Not Specified)|0|||
130685450|NCT03197883|470477852|FG001|Overall Study|Other (Not Specified)|5|||
130685451|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
130685452|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
130685453|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
130685454|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
130685455|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
130685456|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
130685457|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
130685458|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
130685459|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
130685460|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
130685461|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
130685462|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
130685463|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685464|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685465|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685466|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130685467|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
130685468|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130685469|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130685470|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130685471|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
130685472|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
130685473|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
130685474|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
130685475|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130685476|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130685477|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
130685478|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
130685479|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130685480|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130685481|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130685482|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
130685483|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130685484|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
130685485|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
130685486|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
130685487|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130685488|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
130685489|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130685490|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
130685491|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
130685492|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
130685493|NCT03031847|470477856|FG000|Overall Study|Death|1|||
130685494|NCT03031847|470477857|FG001|Overall Study|Death|1|||
130685495|NCT03031847|470477858|FG002|Overall Study|Death|2|||
130351516|NCT00718237|469257611|FG000|Overall Study|Adverse Event|1|||
130351517|NCT00718237|469257612|FG001|Overall Study|Adverse Event|3|||
130685496|NCT03031847|470477859|FG003|Overall Study|Death|3|||
130685497|NCT03031847|470477856|FG000|Overall Study|Lost to Follow-up|1|||
130685498|NCT03031847|470477857|FG001|Overall Study|Lost to Follow-up|1|||
130685499|NCT03031847|470477858|FG002|Overall Study|Lost to Follow-up|2|||
130685500|NCT03031847|470477859|FG003|Overall Study|Lost to Follow-up|3|||
130685501|NCT01353664|470477862|FG000|Overall Study|Other|3|||
130685502|NCT01353664|470477862|FG000|Overall Study|Disease Progression|16|||
130685503|NCT02612337|470477867|FG000|Overall Study|Lack of Efficacy|1|||
130685504|NCT02612337|470477868|FG001|Overall Study|Lack of Efficacy|0|||
130685505|NCT02612337|470477867|FG000|Overall Study|Withdrawal by Subject|2|||
130685506|NCT02612337|470477868|FG001|Overall Study|Withdrawal by Subject|2|||
130685507|NCT02612337|470477867|FG000|Overall Study|Did not receive study drug|0|||
130685508|NCT02612337|470477868|FG001|Overall Study|Did not receive study drug|1|||
130685509|NCT02242201|470477869|FG000|Overall Study|preoperative identified neuropathy|2|||
130685510|NCT02242201|470477870|FG001|Overall Study|preoperative identified neuropathy|0|||
130685511|NCT02242201|470477871|FG002|Overall Study|preoperative identified neuropathy|0|||
130685512|NCT02242201|470477869|FG000|Overall Study|planned post-op anticoagulation|1|||
130685513|NCT02242201|470477870|FG001|Overall Study|planned post-op anticoagulation|0|||
130685514|NCT02242201|470477871|FG002|Overall Study|planned post-op anticoagulation|0|||
130685515|NCT02242201|470477869|FG000|Overall Study|changed surgical procedure|1|||
130685516|NCT02242201|470477870|FG001|Overall Study|changed surgical procedure|0|||
130685517|NCT02242201|470477871|FG002|Overall Study|changed surgical procedure|0|||
130685518|NCT02242201|470477869|FG000|Overall Study|postponed surgery|0|||
130685519|NCT02242201|470477870|FG001|Overall Study|postponed surgery|0|||
130685520|NCT02242201|470477871|FG002|Overall Study|postponed surgery|1|||
130685521|NCT02242201|470477869|FG000|Overall Study|preoperative opioid consumption|0|||
130685522|NCT02242201|470477870|FG001|Overall Study|preoperative opioid consumption|1|||
130685523|NCT02242201|470477871|FG002|Overall Study|preoperative opioid consumption|0|||
130685524|NCT01424644|470477874|FG000|Overall Study|Adverse Event|2|||
130685525|NCT01424644|470477875|FG001|Overall Study|Adverse Event|0|||
130685526|NCT01424644|470477874|FG000|Overall Study|Withdrawal by Subject|9|||
130685527|NCT01424644|470477875|FG001|Overall Study|Withdrawal by Subject|12|||
130685528|NCT01424644|470477874|FG000|Overall Study|Lost to Follow-up|16|||
130685529|NCT01424644|470477875|FG001|Overall Study|Lost to Follow-up|12|||
130685530|NCT01424644|470477874|FG000|Overall Study|Protocol Violation|4|||
130685531|NCT01424644|470477875|FG001|Overall Study|Protocol Violation|3|||
130685532|NCT01424644|470477874|FG000|Overall Study|Administrative Reason|1|||
130685533|NCT01424644|470477875|FG001|Overall Study|Administrative Reason|0|||
130685534|NCT01424644|470477874|FG000|Overall Study|Unable to Classify|1|||
130685535|NCT01424644|470477875|FG001|Overall Study|Unable to Classify|0|||
130685536|NCT01880593|470477876|FG000|Overall Study|Adverse Event|1|||
130685537|NCT01880593|470477877|FG001|Overall Study|Adverse Event|0|||
130685538|NCT01880593|470477876|FG000|Overall Study|Lack of Efficacy|1|||
130685539|NCT01880593|470477877|FG001|Overall Study|Lack of Efficacy|5|||
130685540|NCT01880593|470477876|FG000|Overall Study|Withdrawal by Subject|6|||
130685541|NCT01880593|470477877|FG001|Overall Study|Withdrawal by Subject|1|||
130685542|NCT02272777|470477878|FG000|Overall Study|Adverse Event|0|||
130685543|NCT02272777|470477879|FG001|Overall Study|Adverse Event|1|||
130685544|NCT02272777|470477878|FG000|Overall Study|Withdrawal by Subject|0|||
130685545|NCT02272777|470477879|FG001|Overall Study|Withdrawal by Subject|3|||
130685546|NCT02272777|470477878|FG000|Overall Study|Lost to Follow-up|2|||
130685547|NCT02272777|470477879|FG001|Overall Study|Lost to Follow-up|0|||
130685548|NCT02272777|470477878|FG000|Overall Study|Other|2|||
130685549|NCT02272777|470477879|FG001|Overall Study|Other|0|||
130685550|NCT05275205|470477885|FG000|Overall Study|Adverse Event|1|||
130685551|NCT05275205|470477886|FG001|Overall Study|Adverse Event|2|||
130685552|NCT05275205|470477885|FG000|Overall Study|Physician Decision|1|||
130685553|NCT05275205|470477886|FG001|Overall Study|Physician Decision|1|||
130685554|NCT05275205|470477885|FG000|Overall Study|Withdrawal by Subject|2|||
130685555|NCT05275205|470477886|FG001|Overall Study|Withdrawal by Subject|3|||
130685556|NCT05275205|470477885|FG000|Overall Study|Death|1|||
130685557|NCT05275205|470477886|FG001|Overall Study|Death|0|||
130685558|NCT05275205|470477885|FG000|Overall Study|Patient unable to attend visits|1|||
130685559|NCT05275205|470477886|FG001|Overall Study|Patient unable to attend visits|0|||
130685560|NCT02066922|470477887|FG000|Overall Study|Adverse Event|1|||
130685561|NCT00440297|470477888|FG000|Overall Study|Adverse Event|8|||
130351518|NCT00718237|469257611|FG000|Overall Study|Lost to Follow-up|2|||
130351519|NCT00718237|469257612|FG001|Overall Study|Lost to Follow-up|2|||
130685562|NCT00440297|470477889|FG001|Overall Study|Adverse Event|5|||
130685563|NCT00440297|470477888|FG000|Overall Study|Lost to Follow-up|1|||
130685564|NCT00440297|470477889|FG001|Overall Study|Lost to Follow-up|0|||
130685565|NCT00440297|470477888|FG000|Overall Study|Physician Decision|1|||
130685566|NCT00440297|470477889|FG001|Overall Study|Physician Decision|0|||
130685567|NCT00440297|470477888|FG000|Overall Study|Protocol Violation|11|||
130685568|NCT00440297|470477889|FG001|Overall Study|Protocol Violation|7|||
130685569|NCT00440297|470477888|FG000|Overall Study|Withdrawal by Subject|1|||
130217813|NCT04865419|468761404|FG002|Overall Study|Death|4|||
130217814|NCT04865419|468761405|FG003|Overall Study|Death|2|||
130217815|NCT04865419|468761406|FG004|Overall Study|Death|5|||
130217816|NCT04865419|468761407|FG005|Overall Study|Death|2|||
130217817|NCT04865419|468761408|FG006|Overall Study|Death|1|||
130217818|NCT04865419|468761409|FG007|Overall Study|Death|1|||
130217819|NCT04865419|468761410|FG008|Overall Study|Death|2|||
130217820|NCT04865419|468761411|FG009|Overall Study|Death|2|||
130217821|NCT04865419|468761412|FG010|Overall Study|Death|1|||
130217822|NCT04865419|468761402|FG000|Overall Study|Lost to Follow-up|0|||
130217823|NCT04865419|468761403|FG001|Overall Study|Lost to Follow-up|0|||
130217824|NCT04865419|468761404|FG002|Overall Study|Lost to Follow-up|0|||
130217825|NCT04865419|468761405|FG003|Overall Study|Lost to Follow-up|0|||
130217826|NCT04865419|468761406|FG004|Overall Study|Lost to Follow-up|0|||
130217827|NCT04865419|468761407|FG005|Overall Study|Lost to Follow-up|0|||
130217828|NCT04865419|468761408|FG006|Overall Study|Lost to Follow-up|0|||
130217829|NCT04865419|468761409|FG007|Overall Study|Lost to Follow-up|0|||
130217830|NCT04865419|468761410|FG008|Overall Study|Lost to Follow-up|0|||
130217831|NCT04865419|468761411|FG009|Overall Study|Lost to Follow-up|1|||
130438977|NCT00366301|469570029|FG003|Overall Study|Lost to Follow-up|7|||
130438978|NCT00366301|469570026|FG000|Overall Study|Withdrawal by Subject|4|||
130438979|NCT00366301|469570027|FG001|Overall Study|Withdrawal by Subject|2|||
130438980|NCT00366301|469570028|FG002|Overall Study|Withdrawal by Subject|1|||
130438981|NCT00366301|469570029|FG003|Overall Study|Withdrawal by Subject|1|||
130438982|NCT01372605|469570034|FG000|Overall Study|Death|1|||
130438983|NCT01372605|469570035|FG001|Overall Study|Death|2|||
130438984|NCT01372605|469570034|FG000|Overall Study|Lost to Follow-up|2|||
130438985|NCT01372605|469570035|FG001|Overall Study|Lost to Follow-up|1|||
130438986|NCT01372605|469570034|FG000|Overall Study|Withdrawal by Subject|4|||
130438987|NCT01372605|469570035|FG001|Overall Study|Withdrawal by Subject|7|||
130438988|NCT01372605|469570034|FG000|Overall Study|Moved|3|||
130438989|NCT01372605|469570035|FG001|Overall Study|Moved|0|||
130438990|NCT01372605|469570034|FG000|Overall Study|Changed medical home|2|||
130438991|NCT01372605|469570035|FG001|Overall Study|Changed medical home|0|||
130438992|NCT01348776|469570036|FG000|Overall Study|Lost to Follow-up|3|||
130438993|NCT01463293|469570037|FG000|Overall Study|Lost to Follow-up|1|||
130438994|NCT01463293|469570038|FG001|Overall Study|Lost to Follow-up|4|||
130438995|NCT01463293|469570039|FG002|Overall Study|Lost to Follow-up|5|||
130438996|NCT01463293|469570037|FG000|Overall Study|Adverse Event|1|||
130438997|NCT01463293|469570038|FG001|Overall Study|Adverse Event|2|||
130438998|NCT01463293|469570039|FG002|Overall Study|Adverse Event|0|||
130438999|NCT01463293|469570037|FG000|Overall Study|Withdrawal by Subject|4|||
130439000|NCT01463293|469570038|FG001|Overall Study|Withdrawal by Subject|10|||
130439001|NCT01463293|469570039|FG002|Overall Study|Withdrawal by Subject|5|||
130439002|NCT01463293|469570037|FG000|Overall Study|Other|0|||
130439003|NCT01463293|469570038|FG001|Overall Study|Other|0|||
130439004|NCT01463293|469570039|FG002|Overall Study|Other|2|||
130439005|NCT00951509|469570040|FG000|Overall Study|Withdrawal by Subject|2|||
130439006|NCT00309608|469570047|FG000|Overall Study|Adverse Event|1|||
130439007|NCT00309608|469570048|FG001|Overall Study|Adverse Event|5|||
130439008|NCT00309608|469570049|FG002|Overall Study|Adverse Event|3|||
130439009|NCT00309608|469570050|FG003|Overall Study|Adverse Event|2|||
130439010|NCT00309608|469570051|FG004|Overall Study|Adverse Event|3|||
130439011|NCT00309608|469570047|FG000|Overall Study|Protocol Violation|2|||
130439012|NCT00309608|469570048|FG001|Overall Study|Protocol Violation|0|||
130439013|NCT00309608|469570049|FG002|Overall Study|Protocol Violation|0|||
130439014|NCT00309608|469570050|FG003|Overall Study|Protocol Violation|0|||
130439015|NCT00309608|469570051|FG004|Overall Study|Protocol Violation|0|||
130439016|NCT00309608|469570047|FG000|Overall Study|Lost to Follow-up|0|||
130439017|NCT00309608|469570048|FG001|Overall Study|Lost to Follow-up|0|||
130439018|NCT00309608|469570049|FG002|Overall Study|Lost to Follow-up|2|||
130439019|NCT00309608|469570050|FG003|Overall Study|Lost to Follow-up|0|||
130439020|NCT00309608|469570051|FG004|Overall Study|Lost to Follow-up|1|||
130439021|NCT00309608|469570047|FG000|Overall Study|Withdrawal by Subject|1|||
130439022|NCT00309608|469570048|FG001|Overall Study|Withdrawal by Subject|4|||
130217832|NCT04865419|468761412|FG010|Overall Study|Lost to Follow-up|0|||
130439023|NCT00309608|469570049|FG002|Overall Study|Withdrawal by Subject|2|||
130439024|NCT00309608|469570050|FG003|Overall Study|Withdrawal by Subject|0|||
130439025|NCT00309608|469570051|FG004|Overall Study|Withdrawal by Subject|0|||
130439026|NCT00309608|469570047|FG000|Overall Study|Other incl. Lack of efficacy|10|||
130439027|NCT00309608|469570048|FG001|Overall Study|Other incl. Lack of efficacy|4|||
130439028|NCT00309608|469570049|FG002|Overall Study|Other incl. Lack of efficacy|3|||
130439029|NCT00309608|469570050|FG003|Overall Study|Other incl. Lack of efficacy|4|||
130439030|NCT00309608|469570051|FG004|Overall Study|Other incl. Lack of efficacy|0|||
130439031|NCT00621296|469570052|FG000|Overall Study|Adverse Event|2|||
130217833|NCT00547157|468761413|FG000|Overall Study|Other|1|||
130217834|NCT00547157|468761414|FG001|Overall Study|Other|0|||
130217835|NCT00547157|468761413|FG000|Overall Study|Death|38|||
130217836|NCT00547157|468761414|FG001|Overall Study|Death|18|||
130217837|NCT00547157|468761413|FG000|Overall Study|Withdrawal by Subject|3|||
130439032|NCT00621296|469570052|FG000|Overall Study|Lack of Efficacy|1|||
130217838|NCT00547157|468761414|FG001|Overall Study|Withdrawal by Subject|1|||
130217839|NCT00547157|468761413|FG000|Overall Study|Administrative decision|3|||
130217840|NCT00547157|468761414|FG001|Overall Study|Administrative decision|2|||
130351520|NCT00718237|469257611|FG000|Overall Study|Physician Decision|1|||
130351521|NCT00718237|469257612|FG001|Overall Study|Physician Decision|0|||
130351522|NCT00718237|469257611|FG000|Overall Study|Withdrawal by Subject|9|||
130351523|NCT00718237|469257612|FG001|Overall Study|Withdrawal by Subject|10|||
130351524|NCT03189381|469257613|FG000|Overall Study|Death|1|||
130351525|NCT03189381|469257614|FG001|Overall Study|Death|0|||
130351526|NCT00251004|469257615|FG000|Overall Study|Withdrawal by Subject|23|||
130351527|NCT00251004|469257616|FG001|Overall Study|Withdrawal by Subject|16|||
130351528|NCT00251004|469257617|FG002|Overall Study|Withdrawal by Subject|14|||
130351529|NCT00251004|469257615|FG000|Overall Study|Death|9|||
130351530|NCT00251004|469257616|FG001|Overall Study|Death|10|||
130351531|NCT00251004|469257617|FG002|Overall Study|Death|8|||
130351532|NCT00251004|469257615|FG000|Overall Study|Lost to Follow-up|1|||
130351533|NCT00251004|469257616|FG001|Overall Study|Lost to Follow-up|2|||
130351534|NCT00251004|469257617|FG002|Overall Study|Lost to Follow-up|1|||
130351535|NCT00251004|469257615|FG000|Overall Study|Graft Loss|12|||
130351536|NCT00251004|469257616|FG001|Overall Study|Graft Loss|13|||
130351537|NCT00251004|469257617|FG002|Overall Study|Graft Loss|8|||
130351538|NCT00322153|469257618|FG000|Overall Study|Adverse Event|21|||
130351539|NCT00322153|469257619|FG001|Overall Study|Adverse Event|34|||
130351540|NCT00322153|469257618|FG000|Overall Study|Protocol Violation|6|||
130351541|NCT00322153|469257619|FG001|Overall Study|Protocol Violation|14|||
130351542|NCT00322153|469257618|FG000|Overall Study|Withdrawal by Subject|18|||
130351543|NCT00322153|469257619|FG001|Overall Study|Withdrawal by Subject|10|||
130351544|NCT00322153|469257618|FG000|Overall Study|Lack of Efficacy|8|||
130351545|NCT00322153|469257619|FG001|Overall Study|Lack of Efficacy|3|||
130351546|NCT00322153|469257618|FG000|Overall Study|Lost to Follow-up|5|||
130351547|NCT00322153|469257619|FG001|Overall Study|Lost to Follow-up|4|||
130351548|NCT00322153|469257618|FG000|Overall Study|Withdrawn for other reasons|5|||
130351549|NCT00322153|469257619|FG001|Overall Study|Withdrawn for other reasons|4|||
130351550|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
130351551|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
130351552|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
130351553|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
130351554|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
130351555|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
130351556|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
130351557|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
130351558|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
130351559|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130351560|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130351561|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130351562|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
130351563|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
130351564|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130351565|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
130351566|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
130351567|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
130351568|NCT00591578|469257620|FG000|Double-Blind Treatment Phase|Other|4|||
130351569|NCT00591578|469257621|FG001|Double-Blind Treatment Phase|Other|9|||
130351570|NCT00591578|469257622|FG002|Double-Blind Treatment Phase|Other|4|||
130351571|NCT00591578|469257620|FG000|Open-Label Extension Phase|Adverse Event|3|||
130351572|NCT00591578|469257621|FG001|Open-Label Extension Phase|Adverse Event|5|||
130351573|NCT00591578|469257622|FG002|Open-Label Extension Phase|Adverse Event|0|||
130351574|NCT00591578|469257620|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
130351575|NCT00591578|469257621|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
130351576|NCT00591578|469257622|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130351577|NCT00591578|469257620|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
130351578|NCT00591578|469257621|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
130351579|NCT00591578|469257622|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130351580|NCT00591578|469257620|FG000|Open-Label Extension Phase|Other|1|||
130351581|NCT00591578|469257621|FG001|Open-Label Extension Phase|Other|0|||
130351582|NCT00591578|469257622|FG002|Open-Label Extension Phase|Other|0|||
130351583|NCT03455764|469257625|FG000|Overall Study|Adverse Event|1|||
130351584|NCT03455764|469257626|FG001|Overall Study|Adverse Event|0|||
130351585|NCT03455764|469257627|FG002|Overall Study|Adverse Event|0|||
130351586|NCT03455764|469257628|FG003|Overall Study|Adverse Event|0|||
130351587|NCT03455764|469257629|FG004|Overall Study|Adverse Event|0|||
130217841|NCT00547157|468761413|FG000|Overall Study|Lost to Follow-up|4|||
130351588|NCT03455764|469257625|FG000|Overall Study|Disease Progression|4|||
130351589|NCT03455764|469257626|FG001|Overall Study|Disease Progression|0|||
130351590|NCT03455764|469257627|FG002|Overall Study|Disease Progression|0|||
130351591|NCT03455764|469257628|FG003|Overall Study|Disease Progression|0|||
130351592|NCT03455764|469257629|FG004|Overall Study|Disease Progression|0|||
130685570|NCT00440297|470477889|FG001|Overall Study|Withdrawal by Subject|6|||
130685571|NCT00440297|470477888|FG000|Overall Study|Randomized by mistake|1|||
130685572|NCT00440297|470477889|FG001|Overall Study|Randomized by mistake|0|||
130685573|NCT02024932|470477890|FG000|Overall Study|Adverse Event|2|||
130685574|NCT02024932|470477891|FG001|Overall Study|Adverse Event|3|||
130685575|NCT02024932|470477892|FG002|Overall Study|Adverse Event|0|||
130685576|NCT02024932|470477893|FG003|Overall Study|Adverse Event|0|||
130685577|NCT02024932|470477894|FG004|Overall Study|Adverse Event|2|||
130685578|NCT02024932|470477895|FG005|Overall Study|Adverse Event|0|||
130685579|NCT02024932|470477890|FG000|Overall Study|Abnormal laboratory value|0|||
130685580|NCT02024932|470477891|FG001|Overall Study|Abnormal laboratory value|0|||
130685581|NCT02024932|470477892|FG002|Overall Study|Abnormal laboratory value|0|||
130685582|NCT02024932|470477893|FG003|Overall Study|Abnormal laboratory value|2|||
130685583|NCT02024932|470477894|FG004|Overall Study|Abnormal laboratory value|0|||
130685584|NCT02024932|470477895|FG005|Overall Study|Abnormal laboratory value|0|||
130685585|NCT02445339|470477896|FG000|Overall Study|Physician Decision|1|||
130685586|NCT02445339|470477897|FG001|Overall Study|Physician Decision|0|||
130685587|NCT02445339|470477896|FG000|Overall Study|Lost to Follow-up|11|||
130685588|NCT02445339|470477897|FG001|Overall Study|Lost to Follow-up|15|||
130685589|NCT03020641|470477898|FG000|Overall Study|Lost to Follow-up|0|||
130685590|NCT03020641|470477899|FG001|Overall Study|Lost to Follow-up|1|||
130685591|NCT03020641|470477898|FG000|Overall Study|Converted to open surgery|2|||
130685592|NCT03020641|470477899|FG001|Overall Study|Converted to open surgery|1|||
130685593|NCT03020641|470477898|FG000|Overall Study|for surgery not performed|0|||
130685594|NCT03020641|470477899|FG001|Overall Study|for surgery not performed|1|||
130685595|NCT03041025|470477900|FG000|Overall Study|Adverse Event|0|||
130685596|NCT03041025|470477901|FG001|Overall Study|Adverse Event|0|||
130685597|NCT03041025|470477902|FG002|Overall Study|Adverse Event|1|||
130685598|NCT03041025|470477900|FG000|Overall Study|Lost to Follow-up|1|||
130685599|NCT03041025|470477901|FG001|Overall Study|Lost to Follow-up|0|||
130685600|NCT03041025|470477902|FG002|Overall Study|Lost to Follow-up|0|||
130685601|NCT03041025|470477900|FG000|Overall Study|Withdrawal by Subject|0|||
130685602|NCT03041025|470477901|FG001|Overall Study|Withdrawal by Subject|0|||
130685603|NCT03041025|470477902|FG002|Overall Study|Withdrawal by Subject|1|||
130685604|NCT00939003|470477905|FG000|Double-blind Treatment Period|Adverse Event|1|||
130685605|NCT00939003|470477906|FG001|Double-blind Treatment Period|Adverse Event|1|||
130685606|NCT00939003|470477905|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130685607|NCT00939003|470477906|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130685608|NCT00939003|470477905|FG000|Double-blind Treatment Period|Pregnancy|0|||
130351593|NCT03455764|469257625|FG000|Overall Study|On Treatment|1|||
130351594|NCT03455764|469257626|FG001|Overall Study|On Treatment|0|||
130351595|NCT03455764|469257627|FG002|Overall Study|On Treatment|0|||
130351596|NCT03455764|469257628|FG003|Overall Study|On Treatment|0|||
130351597|NCT03455764|469257629|FG004|Overall Study|On Treatment|0|||
130351598|NCT04221230|469257640|FG000|Overall Study|Lost to Follow-up|12|||
130351599|NCT04221230|469257641|FG001|Overall Study|Lost to Follow-up|12|||
130351600|NCT04221230|469257640|FG000|Overall Study|Protocol Violation|2|||
130351601|NCT04221230|469257641|FG001|Overall Study|Protocol Violation|2|||
130351602|NCT04221230|469257640|FG000|Overall Study|Adverse Event|0|||
130351603|NCT04221230|469257641|FG001|Overall Study|Adverse Event|8|||
130351604|NCT04221230|469257640|FG000|Overall Study|Physician Decision|1|||
130351605|NCT04221230|469257641|FG001|Overall Study|Physician Decision|0|||
130351606|NCT04221230|469257640|FG000|Overall Study|Withdrawal by Subject|13|||
130351607|NCT04221230|469257641|FG001|Overall Study|Withdrawal by Subject|11|||
130351608|NCT04221230|469257640|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130351609|NCT04221230|469257641|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130351610|NCT04221230|469257640|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130351611|NCT04221230|469257641|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130351612|NCT04221230|469257640|FG000|Overall Study|Pregnancy|0|||
130351613|NCT04221230|469257641|FG001|Overall Study|Pregnancy|1|||
130351614|NCT04221230|469257640|FG000|Overall Study|Other|1|||
130351615|NCT04221230|469257641|FG001|Overall Study|Other|2|||
130351616|NCT02021656|469257643|FG000|Overall Study|Adverse Event|1|||
130351617|NCT02021656|469257643|FG000|Overall Study|Lack of Efficacy|2|||
130439033|NCT00621296|469570052|FG000|Overall Study|Physician Decision|7|||
130685609|NCT00939003|470477906|FG001|Double-blind Treatment Period|Pregnancy|1|||
130351618|NCT02021656|469257643|FG000|Overall Study|Lost to Follow-up|1|||
130351619|NCT02021656|469257643|FG000|Overall Study|Withdrew Consent|2|||
130351620|NCT00596362|469257644|FG000|Overall Study|Progressive Disease|1|||
130685610|NCT00939003|470477905|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130685611|NCT00939003|470477906|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130685612|NCT00939003|470477905|FG000|Open-label Treatment Period|Adverse Event|4|||
130685613|NCT00939003|470477906|FG001|Open-label Treatment Period|Adverse Event|8|||
130685614|NCT00939003|470477905|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
130685615|NCT00939003|470477906|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
130685616|NCT00939003|470477905|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
130351621|NCT00282347|469257647|FG000|Treatment Period|Death|2|||
130351622|NCT00282347|469257648|FG001|Treatment Period|Death|0|||
130439034|NCT00621296|469570052|FG000|Overall Study|Unmatch Criteria|1|||
130439035|NCT00621296|469570052|FG000|Overall Study|Stopping Criteria|3|||
130439036|NCT02049710|469570053|FG000|Overall Study|Lost to Follow-up|319|||
130439037|NCT02049710|469570054|FG001|Overall Study|Lost to Follow-up|324|||
130439038|NCT00386308|469571467|FG000|Overall Study|Adverse Event|3|||
130439039|NCT00386308|469571468|FG001|Overall Study|Adverse Event|3|||
130439040|NCT00386308|469571467|FG000|Overall Study|Protocol Violation|2|||
130439041|NCT00386308|469571468|FG001|Overall Study|Protocol Violation|5|||
130439042|NCT00386308|469571467|FG000|Overall Study|Lack of Efficacy|0|||
130439043|NCT00386308|469571468|FG001|Overall Study|Lack of Efficacy|2|||
130439044|NCT00386308|469571467|FG000|Overall Study|Lost to Follow-up|10|||
130439045|NCT00386308|469571468|FG001|Overall Study|Lost to Follow-up|6|||
130439046|NCT00386308|469571467|FG000|Overall Study|Withdrawal by Subject|6|||
130439047|NCT00386308|469571468|FG001|Overall Study|Withdrawal by Subject|2|||
130439048|NCT00386308|469571467|FG000|Overall Study|Other Event|8|||
130439049|NCT00386308|469571468|FG001|Overall Study|Other Event|1|||
130439050|NCT02906683|469571469|FG000|Overall Study|Adverse Event|0|||
130439051|NCT02906683|469571470|FG001|Overall Study|Adverse Event|1|||
130439052|NCT02906683|469571471|FG002|Overall Study|Adverse Event|0|||
130685617|NCT00939003|470477906|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
130685618|NCT00939003|470477905|FG000|Open-label Treatment Period|Pregnancy|1|||
130685619|NCT00939003|470477906|FG001|Open-label Treatment Period|Pregnancy|1|||
130685620|NCT00939003|470477905|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
130685621|NCT00939003|470477906|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
130685622|NCT00939003|470477905|FG000|Open-label Treatment Period|Site Closure|3|||
130685623|NCT00939003|470477906|FG001|Open-label Treatment Period|Site Closure|4|||
130685624|NCT02131129|470477907|FG000|Overall Study|Withdrawal by Subject|1|||
130685625|NCT02131129|470477908|FG001|Overall Study|Withdrawal by Subject|0|||
130685626|NCT02865122|470477909|FG000|Overall Study|Adverse Event|1|||
130685627|NCT02865122|470477910|FG001|Overall Study|Adverse Event|0|||
130685628|NCT02865122|470477911|FG002|Overall Study|Adverse Event|0|||
130685629|NCT00837486|470477916|FG000|Blinded-treatment Phase|Physician Decision|1|||
130685630|NCT00837486|470477917|FG001|Blinded-treatment Phase|Physician Decision|0|||
130685631|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
130685632|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
130685633|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
130685634|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
130685635|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
130685636|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
130439053|NCT02906683|469571469|FG000|Overall Study|Physician Decision|0|||
130439054|NCT02906683|469571470|FG001|Overall Study|Physician Decision|1|||
130439055|NCT02906683|469571471|FG002|Overall Study|Physician Decision|1|||
130439056|NCT02906683|469571469|FG000|Overall Study|Withdrawal by Subject|0|||
130439057|NCT02906683|469571470|FG001|Overall Study|Withdrawal by Subject|2|||
130439058|NCT02906683|469571471|FG002|Overall Study|Withdrawal by Subject|1|||
130439059|NCT02906683|469571469|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
130439060|NCT02906683|469571470|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
130439061|NCT02906683|469571471|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
130439062|NCT02906683|469571469|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
130439063|NCT02906683|469571470|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
130439064|NCT02906683|469571471|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
130439065|NCT01340482|469571472|FG000|Overall Study|Adverse Event|2|||
130439066|NCT01340482|469571473|FG001|Overall Study|Adverse Event|0|||
130439067|NCT01340482|469571474|FG002|Overall Study|Adverse Event|0|||
130439068|NCT01282476|469571475|FG000|Overall Study|Death|11|||
130439069|NCT00437125|469571478|FG000|Overall Study|Adverse Event|12|||
130439070|NCT00437125|469571478|FG000|Overall Study|Death|1|||
130439071|NCT00437125|469571478|FG000|Overall Study|Clinical Relapse|1|||
130439072|NCT00437125|469571478|FG000|Overall Study|Lack of Efficacy|1|||
130439073|NCT00437125|469571478|FG000|Overall Study|Lost to Follow-up|1|||
130685637|NCT01577381|470477919|FG000|Overall Study|Discontinued|2|||
130439074|NCT00437125|469571478|FG000|Overall Study|Withdrawal by Subject|13|||
130439075|NCT00437125|469571478|FG000|Overall Study|Withdrawal by Caregiver|2|||
130439076|NCT00437125|469571478|FG000|Overall Study|Physician Decision|1|||
130439077|NCT02248961|469571479|FG000|Overall Study|Adverse Event|1|||
130439078|NCT02248961|469571480|FG001|Overall Study|Adverse Event|0|||
130439079|NCT02248961|469571479|FG000|Overall Study|Withdrawal by Subject|1|||
130439080|NCT02248961|469571480|FG001|Overall Study|Withdrawal by Subject|2|||
130439081|NCT02248961|469571479|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
130439082|NCT02248961|469571480|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
130685638|NCT01577381|470477920|FG001|Overall Study|Discontinued|1|||
130685639|NCT01577381|470477921|FG002|Overall Study|Discontinued|2|||
130685640|NCT01577381|470477922|FG003|Overall Study|Discontinued|2|||
130685641|NCT01577381|470477919|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
130217842|NCT00547157|468761414|FG001|Overall Study|Lost to Follow-up|2|||
130217843|NCT01383018|468761415|FG000|Overall Study|Adverse Event|14|||
130217844|NCT01383018|468761415|FG000|Overall Study|Death|10|||
130217845|NCT01383018|468761415|FG000|Overall Study|Lost to Follow-up|5|||
130217846|NCT01383018|468761415|FG000|Overall Study|Physician Decision|5|||
130217847|NCT01383018|468761415|FG000|Overall Study|Withdrawal by Subject|9|||
130217848|NCT01383018|468761415|FG000|Overall Study|Subject not implanted|76|||
130217849|NCT01383018|468761415|FG000|Overall Study|Missed Visit|247|||
130217850|NCT01383018|468761415|FG000|Overall Study|Site closed early-not compliance related|7|||
130217851|NCT01383018|468761415|FG000|Overall Study|Patient moved away from site|1|||
130217852|NCT01383018|468761415|FG000|Overall Study|Subject Incarcerated|1|||
130217853|NCT01765569|468761417|FG000|Period B|Withdrawal by Subject|1|||
130217854|NCT01765569|468761417|FG000|Period C|Death|1|||
130217855|NCT04208412|468761418|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
130217856|NCT04208412|468761419|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
130217857|NCT04208412|468761418|FG000|Overall Study|Withdrawal by Subject|1|||
130217858|NCT04208412|468761419|FG001|Overall Study|Withdrawal by Subject|0|||
130217859|NCT04208412|468761418|FG000|Overall Study|Lost to Follow-up|0|||
130217860|NCT04208412|468761419|FG001|Overall Study|Lost to Follow-up|1|||
130217861|NCT05415462|468761422|FG000|Overall Study|Death|18|||
130217862|NCT05415462|468761423|FG001|Overall Study|Death|10|||
130217863|NCT05415462|468761422|FG000|Overall Study|Lost to Follow-up|72|||
130217864|NCT05415462|468761423|FG001|Overall Study|Lost to Follow-up|64|||
130217865|NCT05415462|468761422|FG000|Overall Study|Physician Decision|5|||
130217866|NCT05415462|468761423|FG001|Overall Study|Physician Decision|5|||
130217867|NCT05415462|468761422|FG000|Overall Study|Protocol Deviation|1|||
130217868|NCT05415462|468761423|FG001|Overall Study|Protocol Deviation|0|||
130217869|NCT05415462|468761422|FG000|Overall Study|Withdrawal by Subject|129|||
130217870|NCT05415462|468761423|FG001|Overall Study|Withdrawal by Subject|101|||
130217871|NCT05415462|468761422|FG000|Overall Study|Other Than Specified|8|||
130217872|NCT05415462|468761423|FG001|Overall Study|Other Than Specified|8|||
130217873|NCT04186221|468761426|FG000|Overall Study|Death|1|||
130217874|NCT01904032|468761433|FG000|Overall Study|Adverse Event|3|||
130217875|NCT01904032|468761434|FG001|Overall Study|Adverse Event|1|||
130217876|NCT01904032|468761433|FG000|Overall Study|Lost to Follow-up|4|||
130217877|NCT01904032|468761434|FG001|Overall Study|Lost to Follow-up|2|||
130217878|NCT00531947|468761435|FG000|Overall Study|Adverse Event|5|||
130217879|NCT00531947|468761436|FG001|Overall Study|Adverse Event|10|||
130217880|NCT00531947|468761435|FG000|Overall Study|Lost to Follow-up|12|||
130217881|NCT00531947|468761436|FG001|Overall Study|Lost to Follow-up|9|||
130217882|NCT00531947|468761435|FG000|Overall Study|Withdrawal by Subject|14|||
130217883|NCT00531947|468761436|FG001|Overall Study|Withdrawal by Subject|19|||
130217884|NCT00531947|468761435|FG000|Overall Study|Protocol Violation|2|||
130217885|NCT00531947|468761436|FG001|Overall Study|Protocol Violation|1|||
130351623|NCT00282347|469257647|FG000|Treatment Period|Lost to Follow-up|2|||
130351624|NCT00282347|469257648|FG001|Treatment Period|Lost to Follow-up|5|||
130685642|NCT01577381|470477920|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
130685643|NCT01577381|470477921|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
130685644|NCT01577381|470477922|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
130685645|NCT02186821|470477923|FG000|Overall Study|Adverse Event|9|||
130685646|NCT02186821|470477923|FG000|Overall Study|Death|2|||
130685647|NCT02186821|470477923|FG000|Overall Study|Disease progression|32|||
130685648|NCT02186821|470477923|FG000|Overall Study|Protocol Violation|1|||
130685649|NCT02186821|470477923|FG000|Overall Study|Physician Decision|1|||
130685650|NCT02186821|470477923|FG000|Overall Study|Study terminated by sponsor|2|||
130685651|NCT00819741|470477926|FG000|Overall Study|Adverse Event|5|||
130685652|NCT00819741|470477927|FG001|Overall Study|Adverse Event|2|||
130685653|NCT00819741|470477926|FG000|Overall Study|Lack of Efficacy|0|||
130685654|NCT00819741|470477927|FG001|Overall Study|Lack of Efficacy|2|||
130685655|NCT00819741|470477926|FG000|Overall Study|Lost to Follow-up|3|||
130685656|NCT00819741|470477927|FG001|Overall Study|Lost to Follow-up|1|||
130685657|NCT00819741|470477926|FG000|Overall Study|Protocol Violation|3|||
130685658|NCT00819741|470477927|FG001|Overall Study|Protocol Violation|4|||
130685659|NCT00819741|470477926|FG000|Overall Study|Withdrawal by Subject|2|||
130685660|NCT00819741|470477927|FG001|Overall Study|Withdrawal by Subject|2|||
130685661|NCT00819741|470477926|FG000|Overall Study|Unclassified|6|||
130217886|NCT00531947|468761435|FG000|Overall Study|Non-Compliance|4|||
130217887|NCT00531947|468761436|FG001|Overall Study|Non-Compliance|7|||
130217888|NCT00531947|468761435|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130685662|NCT00819741|470477927|FG001|Overall Study|Unclassified|0|||
130685663|NCT00819741|470477926|FG000|Overall Study|Reasons unknown|3|||
130217889|NCT00531947|468761436|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130217890|NCT01087203|468761441|FG000|Overall Study|Lost to Follow-up|2|||
130217891|NCT01087203|468761442|FG001|Overall Study|Lost to Follow-up|0|||
130217892|NCT01087203|468761441|FG000|Overall Study|Withdrawal by Subject|2|||
130217893|NCT01087203|468761442|FG001|Overall Study|Withdrawal by Subject|6|||
130351625|NCT00282347|469257647|FG000|Treatment Period|Withdrawal by Subject|1|||
130217894|NCT01087203|468761441|FG000|Overall Study|Lack of Efficacy|1|||
130217895|NCT01087203|468761442|FG001|Overall Study|Lack of Efficacy|2|||
130217896|NCT01087203|468761441|FG000|Overall Study|Study terminated by sponsor|27|||
130217897|NCT01087203|468761442|FG001|Overall Study|Study terminated by sponsor|27|||
130217898|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
130217899|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
130217900|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
130217901|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
130217902|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
130217903|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
130217904|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
130217905|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
130217906|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
130217907|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
130217908|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217909|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217910|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217911|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
130217912|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217913|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217914|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
130217915|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217916|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217917|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217918|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217919|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217920|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
130217921|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217922|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217923|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217924|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217925|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217926|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217927|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217928|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217929|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217930|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217931|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217932|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217933|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
130217934|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217935|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
130685664|NCT00819741|470477927|FG001|Overall Study|Reasons unknown|3|||
130685665|NCT00119015|470477928|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
130685666|NCT00119015|470477929|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130685667|NCT00119015|470477930|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130685668|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
130685669|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130685670|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130685671|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
130685672|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685673|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685674|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685675|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685676|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685677|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685678|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685679|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685680|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685681|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685682|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685683|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685684|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685685|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685686|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685687|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130351626|NCT00282347|469257648|FG001|Treatment Period|Withdrawal by Subject|3|||
130351627|NCT00282347|469257647|FG000|Treatment Period|Physician Decision|0|||
130351628|NCT00282347|469257648|FG001|Treatment Period|Physician Decision|1|||
130351629|NCT00282347|469257647|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
130351630|NCT00282347|469257648|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
130351631|NCT00282347|469257647|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
130351632|NCT00282347|469257648|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
130351633|NCT00282347|469257647|FG000|Safety Follow-up Period|Physician Decision|1|||
130351634|NCT00282347|469257648|FG001|Safety Follow-up Period|Physician Decision|1|||
130351635|NCT00282347|469257647|FG000|Safety Follow-up Period|Protocol Deviation|0|||
130351636|NCT00282347|469257648|FG001|Safety Follow-up Period|Protocol Deviation|2|||
130351637|NCT00282347|469257647|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
130351638|NCT00282347|469257648|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
130351639|NCT00282347|469257647|FG000|B Cell Follow-up Period|Physician Decision|1|||
130351640|NCT00282347|469257648|FG001|B Cell Follow-up Period|Physician Decision|0|||
130351641|NCT00282347|469257647|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
130351642|NCT00282347|469257648|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
130351643|NCT00356122|469257649|FG000|TREATMENT|Lack of Efficacy|26|||
130351644|NCT00356122|469257649|FG000|TREATMENT|Adverse Event|10|||
130351645|NCT00356122|469257649|FG000|TREATMENT|Subject's request|4|||
130351646|NCT00356122|469257649|FG000|TREATMENT|Other|4|||
130351647|NCT00356122|469257649|FG000|TREATMENT|Did not receive study medication|1|||
130351648|NCT00356122|469257649|FG000|FOLLOW-UP|Death|37|||
130351649|NCT00356122|469257649|FG000|FOLLOW-UP|Lost to Follow-up|2|||
130685688|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685689|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130685690|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
130685691|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
130685692|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130685693|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685694|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685695|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685696|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685697|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685698|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685699|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685700|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685701|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685702|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685703|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685704|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685705|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685706|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685707|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685708|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685709|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685710|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130685711|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
130685712|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
130685713|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130685714|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685715|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685716|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685717|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685718|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685719|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685720|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685721|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685722|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685723|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685724|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685725|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685726|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685727|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130351650|NCT00356122|469257649|FG000|FOLLOW-UP|Other|2|||
130351651|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
130351652|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
130351653|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
130685728|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685729|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685730|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685731|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
130685732|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
130685733|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
130685734|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685735|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130217936|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217937|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217938|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217939|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217940|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217941|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217942|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
130217943|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130351654|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
130351655|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
130351656|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
130351657|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
130351658|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
130351659|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
130351660|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
130351661|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
130351662|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
130351663|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
130351664|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
130351665|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
130351666|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
130351667|NCT00491556|469257650|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
130351668|NCT00491556|469257651|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
130351669|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
130351670|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
130351671|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
130351672|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
130351673|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
130351674|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
130351675|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
130351676|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
130351677|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
130351678|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
130351679|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
130351680|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
130351681|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
130351682|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
130351683|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
130351684|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
130351685|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
130351686|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
130351687|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
130351688|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
130351689|NCT00491556|469257650|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
130351690|NCT00491556|469257651|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
130351691|NCT00993044|469257653|FG000|Irinotecan 50 mg|Physician Decision|1|||
130351692|NCT00734747|469257654|FG000|SRS Procedure|No staples placed|3|||
130351693|NCT00734747|469257654|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
130351694|NCT01909453|469257658|FG000|Overall Study|Ongoing|118|||
130351695|NCT01909453|469257659|FG001|Overall Study|Ongoing|103|||
130351696|NCT01909453|469257660|FG002|Overall Study|Ongoing|83|||
130351697|NCT01909453|469257661|FG003|Overall Study|Ongoing|164|||
130351698|NCT01909453|469257662|FG004|Overall Study|Ongoing|50|||
130351699|NCT01909453|469257658|FG000|Overall Study|Death|69|||
130351700|NCT01909453|469257659|FG001|Overall Study|Death|74|||
130351701|NCT01909453|469257660|FG002|Overall Study|Death|88|||
130351702|NCT01909453|469257661|FG003|Overall Study|Death|86|||
130351703|NCT01909453|469257662|FG004|Overall Study|Death|29|||
130351704|NCT01909453|469257658|FG000|Overall Study|Lost to Follow-up|3|||
130351705|NCT01909453|469257659|FG001|Overall Study|Lost to Follow-up|4|||
130217944|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217945|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217946|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217947|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130351706|NCT01909453|469257660|FG002|Overall Study|Lost to Follow-up|4|||
130351707|NCT01909453|469257661|FG003|Overall Study|Lost to Follow-up|3|||
130351708|NCT01909453|469257662|FG004|Overall Study|Lost to Follow-up|3|||
130351709|NCT01909453|469257658|FG000|Overall Study|Withdrawal by Subject|2|||
130351710|NCT01909453|469257659|FG001|Overall Study|Withdrawal by Subject|13|||
130351711|NCT01909453|469257660|FG002|Overall Study|Withdrawal by Subject|16|||
130351712|NCT01909453|469257661|FG003|Overall Study|Withdrawal by Subject|5|||
130351713|NCT01909453|469257662|FG004|Overall Study|Withdrawal by Subject|4|||
130351714|NCT04285580|469259031|FG000|Overall Study|Protocol Violation|0|||
130351715|NCT04285580|469259032|FG001|Overall Study|Protocol Violation|1|||
130351716|NCT00076024|469259033|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
130351717|NCT00076024|469259034|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
130351718|NCT00076024|469259035|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
130351719|NCT00076024|469259036|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
130351720|NCT00076024|469259033|FG000|Phase 1, Lead-in|Adverse Event|1|||
130351721|NCT00076024|469259034|FG001|Phase 1, Lead-in|Adverse Event|0|||
130351722|NCT00076024|469259035|FG002|Phase 1, Lead-in|Adverse Event|0|||
130351723|NCT00076024|469259036|FG003|Phase 1, Lead-in|Adverse Event|0|||
130351724|NCT00076024|469259033|FG000|Phase 1, Lead-in|Clinical progression|1|||
130351725|NCT00076024|469259034|FG001|Phase 1, Lead-in|Clinical progression|0|||
130351726|NCT00076024|469259035|FG002|Phase 1, Lead-in|Clinical progression|0|||
130351727|NCT00076024|469259036|FG003|Phase 1, Lead-in|Clinical progression|0|||
130351728|NCT00076024|469259033|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
130351729|NCT00076024|469259034|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
130351730|NCT00076024|469259035|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
130351731|NCT00076024|469259036|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
130351732|NCT00076024|469259033|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
130351733|NCT00076024|469259034|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
130351734|NCT00076024|469259035|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
130351735|NCT00076024|469259036|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
130351736|NCT00076024|469259033|FG000|Phase 2, Double-blind|Adverse Event|0|||
130351737|NCT00076024|469259034|FG001|Phase 2, Double-blind|Adverse Event|25|||
130351738|NCT00076024|469259035|FG002|Phase 2, Double-blind|Adverse Event|6|||
130351739|NCT00076024|469259036|FG003|Phase 2, Double-blind|Adverse Event|0|||
130351740|NCT00076024|469259033|FG000|Phase 2, Double-blind|Un-specified|0|||
130351741|NCT00076024|469259034|FG001|Phase 2, Double-blind|Un-specified|14|||
130351742|NCT00076024|469259035|FG002|Phase 2, Double-blind|Un-specified|6|||
130351743|NCT00076024|469259036|FG003|Phase 2, Double-blind|Un-specified|0|||
130351744|NCT00076024|469259033|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
130351745|NCT00076024|469259034|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
130351746|NCT00076024|469259035|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
130351747|NCT00076024|469259036|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
130351748|NCT00076024|469259033|FG000|Phase 2, Open-label|Adverse Event|0|||
130351749|NCT00076024|469259034|FG001|Phase 2, Open-label|Adverse Event|0|||
130351750|NCT00076024|469259035|FG002|Phase 2, Open-label|Adverse Event|0|||
130351751|NCT00076024|469259036|FG003|Phase 2, Open-label|Adverse Event|2|||
130351752|NCT00076024|469259033|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
130351753|NCT00076024|469259034|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
130351754|NCT00076024|469259035|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
130351755|NCT00076024|469259036|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
130351756|NCT00076024|469259033|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
130351757|NCT00076024|469259034|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
130351758|NCT00076024|469259035|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
130351759|NCT00076024|469259036|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
130351760|NCT00076024|469259033|FG000|Phase 2, Open-label|Other|0|||
130351761|NCT00076024|469259034|FG001|Phase 2, Open-label|Other|0|||
130351762|NCT00076024|469259035|FG002|Phase 2, Open-label|Other|0|||
130351763|NCT00076024|469259036|FG003|Phase 2, Open-label|Other|2|||
130351764|NCT01155219|469259037|FG000|Overall Study|Adverse Event|3|||
130351765|NCT01155219|469259038|FG001|Overall Study|Adverse Event|1|||
130351766|NCT01155219|469259037|FG000|Overall Study|non-medical reason|1|||
130351767|NCT01155219|469259038|FG001|Overall Study|non-medical reason|2|||
130351768|NCT03350984|469259039|FG000|Overall Study|Death|1|||
130351769|NCT03350984|469259040|FG001|Overall Study|Death|0|||
130351770|NCT03350984|469259039|FG000|Overall Study|Lost to Follow-up|5|||
130351771|NCT03350984|469259040|FG001|Overall Study|Lost to Follow-up|6|||
130351772|NCT03350984|469259039|FG000|Overall Study|Protocol Violation|1|||
130351773|NCT03350984|469259040|FG001|Overall Study|Protocol Violation|2|||
130351774|NCT03350984|469259039|FG000|Overall Study|Physician Decision|1|||
130351775|NCT03350984|469259040|FG001|Overall Study|Physician Decision|0|||
130351776|NCT00642473|469259041|FG000|Overall Study|Withdrawal by Subject|0|||
130351777|NCT00642473|469259042|FG001|Overall Study|Withdrawal by Subject|5|||
130217948|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217949|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217950|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217951|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217952|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217953|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217954|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217955|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217956|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217957|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217958|NCT04074330|468761454|FG000|Dose Expansion (up to 42 Months)|Death|0|||
130217959|NCT04074330|468761455|FG001|Dose Expansion (up to 42 Months)|Death|0|||
130217960|NCT04074330|468761456|FG002|Dose Expansion (up to 42 Months)|Death|0|||
130217961|NCT04074330|468761457|FG003|Dose Expansion (up to 42 Months)|Death|0|||
130217962|NCT04074330|468761458|FG004|Dose Expansion (up to 42 Months)|Death|0|||
130685736|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685737|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685738|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685739|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685740|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685741|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685742|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685743|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685744|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685745|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685746|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685747|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685748|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685749|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685750|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685751|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685752|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130685753|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685754|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685755|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130685756|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685757|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685758|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130217963|NCT04074330|468761459|FG005|Dose Expansion (up to 42 Months)|Death|0|||
130217964|NCT04074330|468761460|FG006|Dose Expansion (up to 42 Months)|Death|0|||
130217965|NCT04074330|468761461|FG007|Dose Expansion (up to 42 Months)|Death|0|||
130217966|NCT04074330|468761462|FG008|Dose Expansion (up to 42 Months)|Death|1|||
130217967|NCT04074330|468761463|FG009|Dose Expansion (up to 42 Months)|Death|0|||
130217968|NCT04074330|468761454|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217969|NCT04074330|468761455|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217970|NCT04074330|468761456|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217971|NCT04074330|468761457|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217972|NCT04074330|468761458|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217973|NCT04074330|468761459|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217974|NCT04074330|468761460|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217975|NCT04074330|468761461|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217976|NCT04074330|468761462|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130217977|NCT04074330|468761463|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130217978|NCT00184093|468761464|FG000|Overall Study|Adverse Event|3|||
130217979|NCT00184093|468761464|FG000|Overall Study|Lost to Follow-up|3|||
130217980|NCT00184093|468761464|FG000|Overall Study|Physician Decision|1|||
130217981|NCT00184093|468761464|FG000|Overall Study|Withdrawal by Subject|2|||
130217982|NCT05095311|468761467|FG000|Overall Study|Lost to Follow-up|7|||
130217983|NCT05095311|468761468|FG001|Overall Study|Lost to Follow-up|0|||
130217984|NCT05095311|468761469|FG002|Overall Study|Lost to Follow-up|0|||
130351778|NCT00642473|469259041|FG000|Overall Study|Progression or death|2|||
130351779|NCT00642473|469259042|FG001|Overall Study|Progression or death|4|||
130351780|NCT00642473|469259041|FG000|Overall Study|Other|2|||
130351781|NCT00642473|469259042|FG001|Overall Study|Other|2|||
130351782|NCT03981822|469259048|FG000|Overall Study|Lost to Follow-up|0|||
130351783|NCT03981822|469259049|FG001|Overall Study|Lost to Follow-up|1|||
130351784|NCT03981822|469259050|FG002|Overall Study|Lost to Follow-up|1|||
130351785|NCT03981822|469259051|FG003|Overall Study|Lost to Follow-up|0|||
130351786|NCT03981822|469259052|FG004|Overall Study|Lost to Follow-up|6|||
130685759|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685760|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685761|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685762|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685763|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685764|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685765|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685766|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685767|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685768|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685769|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685770|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685771|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685772|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685773|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130685774|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130685775|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
130685776|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685777|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685778|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685779|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685780|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685781|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685782|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685783|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685784|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685785|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685786|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685787|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685788|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685789|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685790|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685791|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685792|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685793|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685794|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685795|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685796|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685797|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685798|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685799|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130685800|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130685801|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685802|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685803|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685804|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685805|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685806|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685807|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685808|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685809|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685810|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685811|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685812|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685813|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685814|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685815|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685816|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130439083|NCT00453310|469571485|FG000|Overall Study|Progression of Disease|10|||
130685817|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685818|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685819|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
130439084|NCT01267825|469571486|FG000|Overall Study|study terminated. no data collected.|1|||
130439085|NCT01267825|469571487|FG001|Overall Study|study terminated. no data collected.|0|||
130439086|NCT00871351|469571490|FG000|Overall Study|Withdrawal by Subject|1|||
130439087|NCT00871351|469571491|FG001|Overall Study|Withdrawal by Subject|0|||
130439088|NCT00871351|469571492|FG002|Overall Study|Withdrawal by Subject|0|||
130439089|NCT00871351|469571490|FG000|Overall Study|Adverse Event|3|||
130439090|NCT00871351|469571491|FG001|Overall Study|Adverse Event|1|||
130685820|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
130439091|NCT00871351|469571492|FG002|Overall Study|Adverse Event|0|||
130439092|NCT00744237|469571493|FG000|Overall Study|Lack of Efficacy|1|||
130439093|NCT00744237|469571494|FG001|Overall Study|Lack of Efficacy|1|||
130439094|NCT00744237|469571495|FG002|Overall Study|Lack of Efficacy|0|||
130439095|NCT00744237|469571493|FG000|Overall Study|Withdrawal by Subject|9|||
130439096|NCT00744237|469571494|FG001|Overall Study|Withdrawal by Subject|5|||
130439097|NCT00744237|469571495|FG002|Overall Study|Withdrawal by Subject|3|||
130439098|NCT00744237|469571493|FG000|Overall Study|Lost to Follow-up|1|||
130439099|NCT00744237|469571494|FG001|Overall Study|Lost to Follow-up|1|||
130439100|NCT00744237|469571495|FG002|Overall Study|Lost to Follow-up|1|||
130439101|NCT00744237|469571493|FG000|Overall Study|Protocol Violation|3|||
130685821|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
130685822|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
130685823|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685824|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
130685825|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685826|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685827|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685828|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685829|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685830|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685831|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685832|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685833|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685834|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685835|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685836|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685837|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685838|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685839|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685840|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685841|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
130685842|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685843|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685844|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
130685845|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685846|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
130685847|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
130685848|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
130685849|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685850|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685851|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685852|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685853|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685854|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685855|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685856|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685857|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685858|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685859|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685860|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685861|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
130685862|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130685863|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130685864|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130685865|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
130685866|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130685867|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
130439102|NCT00744237|469571494|FG001|Overall Study|Protocol Violation|4|||
130439103|NCT00744237|469571495|FG002|Overall Study|Protocol Violation|3|||
130439104|NCT00744237|469571493|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
130439105|NCT00744237|469571494|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
130439106|NCT00744237|469571495|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
130217985|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
130217986|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
130217987|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
130217988|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
130217989|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
130217990|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
130217991|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
130217992|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
130217993|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
130217994|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
130217995|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
130217996|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
130217997|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130217998|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130217999|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
130218000|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
130218001|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
130218002|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
130218003|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
130218004|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
130218005|NCT01868165|468761476|FG000|Overall Study|Withdrawal by Subject|36|||
130218006|NCT01868165|468761476|FG000|Overall Study|Physician Decision|2|||
130218007|NCT01868165|468761476|FG000|Overall Study|Lost to Follow-up|3|||
130218008|NCT01868165|468761476|FG000|Overall Study|Death|4|||
130218009|NCT02588664|468761479|FG000|Overall Study|Death|56|||
130218010|NCT02588664|468761480|FG001|Overall Study|Death|55|||
130218011|NCT02588664|468761479|FG000|Overall Study|Lost to Follow-up|1305|||
130218012|NCT02588664|468761480|FG001|Overall Study|Lost to Follow-up|990|||
130218013|NCT01429298|468761481|FG000|Overall Study|Protocol Violation|4|||
130218014|NCT01429298|468761482|FG001|Overall Study|Protocol Violation|6|||
130218015|NCT02903420|468761483|FG000|Overall Study|Death|3|||
130218016|NCT01124292|468761487|FG000|Overall Study|Lost to Follow-up|2|||
130218017|NCT01124292|468761488|FG001|Overall Study|Lost to Follow-up|4|||
130218018|NCT01124292|468761489|FG002|Overall Study|Lost to Follow-up|3|||
130218019|NCT01124292|468761487|FG000|Overall Study|Physician Decision|0|||
130218020|NCT01124292|468761488|FG001|Overall Study|Physician Decision|3|||
130218021|NCT01124292|468761489|FG002|Overall Study|Physician Decision|2|||
130218022|NCT01124292|468761487|FG000|Overall Study|Withdrawal by Subject|0|||
130218023|NCT01124292|468761488|FG001|Overall Study|Withdrawal by Subject|6|||
130218024|NCT01124292|468761489|FG002|Overall Study|Withdrawal by Subject|2|||
130218025|NCT01124292|468761487|FG000|Overall Study|medical issue unrelated to the study|0|||
130218026|NCT01124292|468761488|FG001|Overall Study|medical issue unrelated to the study|0|||
130218027|NCT01124292|468761489|FG002|Overall Study|medical issue unrelated to the study|2|||
130218028|NCT01124292|468761487|FG000|Overall Study|piercing track closed|0|||
130218029|NCT01124292|468761488|FG001|Overall Study|piercing track closed|2|||
130218030|NCT01124292|468761489|FG002|Overall Study|piercing track closed|1|||
130218031|NCT03373461|468761490|FG000|Part 2|Adverse Event|0|||
130218032|NCT03373461|468761491|FG001|Part 2|Adverse Event|1|||
130218033|NCT03373461|468761492|FG002|Part 2|Adverse Event|0|||
130218034|NCT03373461|468761493|FG003|Part 2|Adverse Event|0|||
130218035|NCT03373461|468761494|FG004|Part 2|Adverse Event|1|||
130218036|NCT03300180|468761495|FG000|Baseline|Withdrawal by Subject|4|||
130218037|NCT03300180|468761496|FG001|Baseline|Withdrawal by Subject|6|||
130218038|NCT03300180|468761497|FG002|Baseline|Withdrawal by Subject|4|||
130218039|NCT03300180|468761495|FG000|6 Month Outcome|Withdrawal by Subject|12|||
130218040|NCT03300180|468761496|FG001|6 Month Outcome|Withdrawal by Subject|12|||
130218041|NCT03300180|468761497|FG002|6 Month Outcome|Withdrawal by Subject|19|||
130439107|NCT00744237|469571493|FG000|Overall Study|Dosing Error|1|||
130439108|NCT00744237|469571494|FG001|Overall Study|Dosing Error|0|||
130218042|NCT03300180|468761495|FG000|6 Month Outcome|Death|2|||
130218043|NCT03300180|468761496|FG001|6 Month Outcome|Death|4|||
130218044|NCT03300180|468761497|FG002|6 Month Outcome|Death|3|||
130439109|NCT00744237|469571495|FG002|Overall Study|Dosing Error|1|||
130218045|NCT03300180|468761495|FG000|6 Month Outcome|Missed Assessment|43|||
130218046|NCT03300180|468761496|FG001|6 Month Outcome|Missed Assessment|52|||
130218047|NCT03300180|468761497|FG002|6 Month Outcome|Missed Assessment|46|||
130218048|NCT03300180|468761495|FG000|12 Month Outcome|Withdrawal by Subject|3|||
130218049|NCT03300180|468761496|FG001|12 Month Outcome|Withdrawal by Subject|6|||
130218050|NCT03300180|468761497|FG002|12 Month Outcome|Withdrawal by Subject|6|||
130218051|NCT03300180|468761495|FG000|12 Month Outcome|Death|9|||
130218052|NCT03300180|468761496|FG001|12 Month Outcome|Death|6|||
130218053|NCT03300180|468761497|FG002|12 Month Outcome|Death|6|||
130218054|NCT03300180|468761495|FG000|12 Month Outcome|Missed Assessment|62|||
130218055|NCT03300180|468761496|FG001|12 Month Outcome|Missed Assessment|59|||
130439110|NCT00744237|469571493|FG000|Overall Study|Study Drug Error|1|||
130439111|NCT00744237|469571494|FG001|Overall Study|Study Drug Error|0|||
130218056|NCT03300180|468761497|FG002|12 Month Outcome|Missed Assessment|58|||
130218057|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
130218058|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
130218059|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
130218060|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Death|8|||
130218061|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Death|5|||
130218062|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Death|5|||
130218063|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
130218064|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
130218065|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
130218066|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
130218067|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
130218068|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
130218069|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Death|13|||
130218070|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Death|13|||
130218071|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Death|3|||
130218072|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
130218073|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
130218074|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
130218075|NCT03654729|468763327|FG000|Overall Study|Death|9|||
130218076|NCT03654729|468763328|FG001|Overall Study|Death|9|||
130218077|NCT03654729|468763329|FG002|Overall Study|Death|16|||
130218078|NCT03654729|468763327|FG000|Overall Study|Withdrawal by Subject|8|||
130218079|NCT03654729|468763328|FG001|Overall Study|Withdrawal by Subject|6|||
130218080|NCT03654729|468763329|FG002|Overall Study|Withdrawal by Subject|4|||
130218081|NCT03654729|468763327|FG000|Overall Study|Study terminated by Sponsor|3|||
130218082|NCT03654729|468763328|FG001|Overall Study|Study terminated by Sponsor|5|||
130218083|NCT03654729|468763329|FG002|Overall Study|Study terminated by Sponsor|4|||
130218084|NCT03654729|468763327|FG000|Overall Study|Not reported|2|||
130218085|NCT03654729|468763328|FG001|Overall Study|Not reported|4|||
130218086|NCT03654729|468763329|FG002|Overall Study|Not reported|5|||
130218087|NCT03654729|468763327|FG000|Overall Study|Progressive disease|3|||
130218088|NCT03654729|468763328|FG001|Overall Study|Progressive disease|0|||
130218089|NCT03654729|468763329|FG002|Overall Study|Progressive disease|0|||
130218090|NCT03654729|468763327|FG000|Overall Study|Lost to Follow-up|2|||
130218091|NCT03654729|468763328|FG001|Overall Study|Lost to Follow-up|0|||
130218092|NCT03654729|468763329|FG002|Overall Study|Lost to Follow-up|0|||
130218093|NCT03654729|468763327|FG000|Overall Study|Physician Decision|2|||
130218094|NCT03654729|468763328|FG001|Overall Study|Physician Decision|0|||
130218095|NCT03654729|468763329|FG002|Overall Study|Physician Decision|0|||
130218096|NCT03654729|468763327|FG000|Overall Study|Protocol Violation|1|||
130218097|NCT03654729|468763328|FG001|Overall Study|Protocol Violation|1|||
130218098|NCT03654729|468763329|FG002|Overall Study|Protocol Violation|0|||
130218099|NCT03654729|468763327|FG000|Overall Study|Non-compliance with study drug|0|||
130218100|NCT03654729|468763328|FG001|Overall Study|Non-compliance with study drug|1|||
130218101|NCT03654729|468763329|FG002|Overall Study|Non-compliance with study drug|0|||
130218102|NCT03654729|468763327|FG000|Overall Study|Site terminated by Sponsor|1|||
130218103|NCT03654729|468763328|FG001|Overall Study|Site terminated by Sponsor|0|||
130218104|NCT03654729|468763329|FG002|Overall Study|Site terminated by Sponsor|0|||
130218105|NCT04530838|468763330|FG000|Overall Study|Other|2|||
130218106|NCT04530838|468763331|FG001|Overall Study|Other|1|||
130218107|NCT04530838|468763332|FG002|Overall Study|Other|0|||
130218108|NCT04530838|468763330|FG000|Overall Study|Physician Decision|0|||
130218109|NCT04530838|468763331|FG001|Overall Study|Physician Decision|0|||
130218110|NCT04530838|468763332|FG002|Overall Study|Physician Decision|1|||
130439112|NCT00744237|469571495|FG002|Overall Study|Study Drug Error|0|||
130439113|NCT00744237|469571493|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130439114|NCT00744237|469571494|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130439115|NCT00744237|469571495|FG002|Overall Study|Prohibited Concomitant Medication|1|||
130439116|NCT00744237|469571493|FG000|Overall Study|Poor Compliance|0|||
130439117|NCT00744237|469571494|FG001|Overall Study|Poor Compliance|2|||
130218111|NCT04530838|468763330|FG000|Overall Study|Death|0|||
130218112|NCT04530838|468763331|FG001|Overall Study|Death|0|||
130218113|NCT04530838|468763332|FG002|Overall Study|Death|1|||
130218114|NCT04530838|468763330|FG000|Overall Study|Adverse Event|0|||
130218115|NCT04530838|468763331|FG001|Overall Study|Adverse Event|1|||
130218116|NCT04530838|468763332|FG002|Overall Study|Adverse Event|0|||
130218117|NCT04530838|468763330|FG000|Overall Study|No longer meets eligibility criteria|1|||
130218118|NCT04530838|468763331|FG001|Overall Study|No longer meets eligibility criteria|0|||
130218119|NCT04530838|468763332|FG002|Overall Study|No longer meets eligibility criteria|2|||
130218120|NCT04530838|468763330|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130218121|NCT04530838|468763331|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130218122|NCT04530838|468763332|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130218123|NCT00803712|468763333|FG000|Overall Study|Noncompliance|3|||
130218124|NCT00803712|468763334|FG001|Overall Study|Noncompliance|0|||
130218125|NCT00803712|468763333|FG000|Overall Study|Adverse Event|5|||
130439118|NCT00744237|469571495|FG002|Overall Study|Poor Compliance|0|||
130218126|NCT00803712|468763334|FG001|Overall Study|Adverse Event|0|||
130218127|NCT00803712|468763333|FG000|Overall Study|Death|8|||
130218128|NCT00803712|468763334|FG001|Overall Study|Death|7|||
130218129|NCT00803712|468763333|FG000|Overall Study|Lost to Follow-up|3|||
130218130|NCT00803712|468763334|FG001|Overall Study|Lost to Follow-up|1|||
130218131|NCT00803712|468763333|FG000|Overall Study|Withdrawal by Subject|2|||
130218132|NCT00803712|468763334|FG001|Overall Study|Withdrawal by Subject|4|||
130218133|NCT00803712|468763333|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
130218134|NCT00803712|468763334|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
130218135|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (other)|0|||
130218136|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (other)|2|||
130218137|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
130218138|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
130218139|NCT00803712|468763333|FG000|Overall Study|Administrative decision|2|||
130218140|NCT00803712|468763334|FG001|Overall Study|Administrative decision|3|||
130218141|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
130218142|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
130218143|NCT01919164|468763345|FG000|Overall Study|Adverse Event|6|||
130218144|NCT01919164|468763346|FG001|Overall Study|Adverse Event|4|||
130218145|NCT01919164|468763347|FG002|Overall Study|Adverse Event|9|||
130218146|NCT01919164|468763348|FG003|Overall Study|Adverse Event|3|||
130218147|NCT01919164|468763349|FG004|Overall Study|Adverse Event|2|||
130218148|NCT01919164|468763345|FG000|Overall Study|Lost to Follow-up|2|||
130218149|NCT01919164|468763346|FG001|Overall Study|Lost to Follow-up|2|||
130218150|NCT01919164|468763347|FG002|Overall Study|Lost to Follow-up|2|||
130218151|NCT01919164|468763348|FG003|Overall Study|Lost to Follow-up|0|||
130218152|NCT01919164|468763349|FG004|Overall Study|Lost to Follow-up|4|||
130218153|NCT01919164|468763345|FG000|Overall Study|Death|1|||
130218154|NCT01919164|468763346|FG001|Overall Study|Death|0|||
130218155|NCT01919164|468763347|FG002|Overall Study|Death|0|||
130218156|NCT01919164|468763348|FG003|Overall Study|Death|0|||
130218157|NCT01919164|468763349|FG004|Overall Study|Death|0|||
130218158|NCT01919164|468763345|FG000|Overall Study|Protocol Violation|6|||
130218159|NCT01919164|468763346|FG001|Overall Study|Protocol Violation|0|||
130218160|NCT01919164|468763347|FG002|Overall Study|Protocol Violation|3|||
130218161|NCT01919164|468763348|FG003|Overall Study|Protocol Violation|2|||
130218162|NCT01919164|468763349|FG004|Overall Study|Protocol Violation|2|||
130218163|NCT01919164|468763345|FG000|Overall Study|Disease progression|2|||
130218164|NCT01919164|468763346|FG001|Overall Study|Disease progression|2|||
130218165|NCT01919164|468763347|FG002|Overall Study|Disease progression|1|||
130218166|NCT01919164|468763348|FG003|Overall Study|Disease progression|2|||
130218167|NCT01919164|468763349|FG004|Overall Study|Disease progression|1|||
130218168|NCT01919164|468763345|FG000|Overall Study|Withdrew consent|13|||
130218169|NCT01919164|468763346|FG001|Overall Study|Withdrew consent|13|||
130218170|NCT01919164|468763347|FG002|Overall Study|Withdrew consent|14|||
130218171|NCT01919164|468763348|FG003|Overall Study|Withdrew consent|14|||
130218172|NCT01919164|468763349|FG004|Overall Study|Withdrew consent|9|||
130218173|NCT01919164|468763345|FG000|Overall Study|Other Un-specified|13|||
130218174|NCT01919164|468763346|FG001|Overall Study|Other Un-specified|9|||
130218175|NCT01919164|468763347|FG002|Overall Study|Other Un-specified|8|||
130218176|NCT01919164|468763348|FG003|Overall Study|Other Un-specified|7|||
130218177|NCT01919164|468763349|FG004|Overall Study|Other Un-specified|15|||
130218178|NCT00588146|468763351|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
130218179|NCT00588146|468763352|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
130218180|NCT02100839|468763353|FG000|Multiple Ascending Dose|Adverse Event|2|||
130218181|NCT02100839|468763354|FG001|Multiple Ascending Dose|Adverse Event|0|||
130218182|NCT02100839|468763353|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
130218183|NCT02100839|468763354|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
130218184|NCT02823470|468763355|FG000|Overall Study|Adverse Event|1|||
130218185|NCT02823470|468763356|FG001|Overall Study|Adverse Event|0|||
130218186|NCT02823470|468763355|FG000|Overall Study|Study terminated by sponsor|8|||
130218187|NCT02823470|468763356|FG001|Overall Study|Study terminated by sponsor|15|||
130218188|NCT00463801|468763362|FG000|Overall Study|Protocol Violation|1|||
130218189|NCT00463801|468763362|FG000|Overall Study|Lack of Efficacy|2|||
130218190|NCT00463801|468763362|FG000|Overall Study|Adverse Event|4|||
130218191|NCT00463801|468763362|FG000|Overall Study|Lost to Follow-up|5|||
130351787|NCT03981822|469259053|FG005|Overall Study|Lost to Follow-up|4|||
130351788|NCT03981822|469259054|FG006|Overall Study|Lost to Follow-up|4|||
130351789|NCT03981822|469259055|FG007|Overall Study|Lost to Follow-up|2|||
130351790|NCT03981822|469259048|FG000|Overall Study|Withdrawal by Subject|0|||
130351791|NCT03981822|469259049|FG001|Overall Study|Withdrawal by Subject|1|||
130351792|NCT03981822|469259050|FG002|Overall Study|Withdrawal by Subject|0|||
130351793|NCT03981822|469259051|FG003|Overall Study|Withdrawal by Subject|0|||
130351794|NCT03981822|469259052|FG004|Overall Study|Withdrawal by Subject|0|||
130685868|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130685869|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130351795|NCT03981822|469259053|FG005|Overall Study|Withdrawal by Subject|1|||
130218192|NCT00463801|468763362|FG000|Overall Study|No longer require therapy|1|||
130218193|NCT00669318|468763363|FG000|Overall Study|Withdrawal by Subject|2|||
130218194|NCT02315664|468763364|FG000|Overall Study|Lost to Follow-up|1|||
130218195|NCT02315664|468763365|FG001|Overall Study|Lost to Follow-up|1|||
130218196|NCT02315664|468763364|FG000|Overall Study|Withdrawal by Subject|0|||
130218197|NCT02315664|468763365|FG001|Overall Study|Withdrawal by Subject|3|||
130218198|NCT02501161|468763366|FG000|Overall Study|Adverse Event|2|||
130218199|NCT02501161|468763367|FG001|Overall Study|Adverse Event|6|||
130218200|NCT02501161|468763366|FG000|Overall Study|Lost to Follow-up|7|||
130218201|NCT02501161|468763367|FG001|Overall Study|Lost to Follow-up|4|||
130218202|NCT02501161|468763366|FG000|Overall Study|Withdrawal by Subject|10|||
130218203|NCT02501161|468763367|FG001|Overall Study|Withdrawal by Subject|15|||
130218204|NCT02501161|468763366|FG000|Overall Study|Other|3|||
130218205|NCT02501161|468763367|FG001|Overall Study|Other|0|||
130218206|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130218207|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130218208|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
130218209|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130218210|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218211|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218212|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
130218213|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
130218214|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218215|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218216|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
130218217|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
130218218|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130218219|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130218220|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
130218221|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
130218222|NCT00667992|468763370|FG000|Wash-out|Not within one doubling dilution|4|||
130218223|NCT00667992|468763371|FG001|Wash-out|Not within one doubling dilution|3|||
130218224|NCT00667992|468763370|FG000|Wash-out|Failure to wash-out|2|||
130218225|NCT00667992|468763371|FG001|Wash-out|Failure to wash-out|2|||
130218226|NCT00667992|468763370|FG000|Wash-out|Withdrawal by Subject|1|||
130218227|NCT00667992|468763371|FG001|Wash-out|Withdrawal by Subject|0|||
130218228|NCT00667992|468763370|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
130218229|NCT00667992|468763371|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130218230|NCT00667992|468763370|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218231|NCT00667992|468763371|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218232|NCT02748057|468763375|FG000|Overall Study|Adverse Event|1|||
130218233|NCT02748057|468763376|FG001|Overall Study|Adverse Event|0|||
130218234|NCT02748057|468763375|FG000|Overall Study|Physician Decision|0|||
130218235|NCT02748057|468763376|FG001|Overall Study|Physician Decision|1|||
130218236|NCT02748057|468763375|FG000|Overall Study|Protocol Violation|2|||
130218237|NCT02748057|468763376|FG001|Overall Study|Protocol Violation|1|||
130218238|NCT02748057|468763375|FG000|Overall Study|Participant Moved|1|||
130218239|NCT02748057|468763376|FG001|Overall Study|Participant Moved|0|||
130218240|NCT02748057|468763375|FG000|Overall Study|Withdrawal by Subject|1|||
130218241|NCT02748057|468763376|FG001|Overall Study|Withdrawal by Subject|0|||
130218242|NCT01990573|468763377|FG000|Overall Study|Physician Decision|0|||
130351796|NCT03981822|469259054|FG006|Overall Study|Withdrawal by Subject|0|||
130351797|NCT03981822|469259055|FG007|Overall Study|Withdrawal by Subject|2|||
130351798|NCT03981822|469259048|FG000|Overall Study|COVID-19 Related|0|||
130351799|NCT03981822|469259049|FG001|Overall Study|COVID-19 Related|0|||
130351800|NCT03981822|469259050|FG002|Overall Study|COVID-19 Related|0|||
130351801|NCT03981822|469259051|FG003|Overall Study|COVID-19 Related|0|||
130685870|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685871|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130218243|NCT01990573|468763378|FG001|Overall Study|Physician Decision|0|||
130218244|NCT01990573|468763379|FG002|Overall Study|Physician Decision|1|||
130218245|NCT03335813|468763384|FG000|Overall Study|Withdrawal by Subject|1|||
130218246|NCT00524771|468763387|FG000|Overall Study|Protocol Violation|220|||
130218247|NCT00524771|468763388|FG001|Overall Study|Protocol Violation|585|||
130218248|NCT02492165|468763389|FG000|Overall Study|Withdrawal by Subject|0|||
130218249|NCT02492165|468763390|FG001|Overall Study|Withdrawal by Subject|1|||
130218250|NCT02492165|468763391|FG002|Overall Study|Withdrawal by Subject|0|||
130218251|NCT02492165|468763392|FG003|Overall Study|Withdrawal by Subject|0|||
130218252|NCT01957579|468763394|FG000|Overall Study|Withdrawal of concent|0|||
130218253|NCT01957579|468763395|FG001|Overall Study|Withdrawal of concent|1|||
130351802|NCT03981822|469259052|FG004|Overall Study|COVID-19 Related|2|||
130351803|NCT03981822|469259053|FG005|Overall Study|COVID-19 Related|1|||
130351804|NCT03981822|469259054|FG006|Overall Study|COVID-19 Related|2|||
130218254|NCT01957579|468763396|FG002|Overall Study|Withdrawal of concent|0|||
130218255|NCT01957579|468763397|FG003|Overall Study|Withdrawal of concent|0|||
130218256|NCT01957579|468763394|FG000|Overall Study|Death|0|||
130218257|NCT01957579|468763395|FG001|Overall Study|Death|0|||
130218258|NCT01957579|468763396|FG002|Overall Study|Death|2|||
130218259|NCT01957579|468763397|FG003|Overall Study|Death|0|||
130218260|NCT01000974|468763398|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
130218261|NCT01000974|468763399|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
130218262|NCT01000974|468763400|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
130218263|NCT01000974|468763398|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
130218264|NCT01000974|468763399|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
130218265|NCT01000974|468763400|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
130218266|NCT01000974|468763398|FG000|Primary Vaccination Phase|Protocol Violation|40|||
130218267|NCT01000974|468763399|FG001|Primary Vaccination Phase|Protocol Violation|3|||
130218268|NCT01000974|468763400|FG002|Primary Vaccination Phase|Protocol Violation|2|||
130218269|NCT01000974|468763398|FG000|Primary Vaccination Phase|Adverse Event|14|||
130218270|NCT01000974|468763399|FG001|Primary Vaccination Phase|Adverse Event|2|||
130218271|NCT01000974|468763400|FG002|Primary Vaccination Phase|Adverse Event|2|||
130218272|NCT01000974|468763398|FG000|Primary Vaccination Phase|Other|4|||
130218273|NCT01000974|468763399|FG001|Primary Vaccination Phase|Other|9|||
130218274|NCT01000974|468763400|FG002|Primary Vaccination Phase|Other|12|||
130218275|NCT01000974|468763398|FG000|Booster Vaccination Phase|Protocol Violation|0|||
130218276|NCT01000974|468763399|FG001|Booster Vaccination Phase|Protocol Violation|0|||
130218277|NCT01000974|468763400|FG002|Booster Vaccination Phase|Protocol Violation|2|||
130218278|NCT01000974|468763398|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
130218279|NCT01000974|468763399|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
130218280|NCT01000974|468763400|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
130218281|NCT01000974|468763398|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
130218282|NCT01000974|468763399|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
130218283|NCT01000974|468763400|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
130218284|NCT01000974|468763398|FG000|Booster Vaccination Phase|Other|24|||
130218285|NCT01000974|468763399|FG001|Booster Vaccination Phase|Other|6|||
130218286|NCT01000974|468763400|FG002|Booster Vaccination Phase|Other|4|||
130218287|NCT01639144|468763403|FG000|Overall Study|Withdrawal by Subject|4|||
130218288|NCT01639144|468763404|FG001|Overall Study|Withdrawal by Subject|2|||
130218289|NCT01639144|468763403|FG000|Overall Study|Physician Decision|2|||
130218290|NCT01639144|468763404|FG001|Overall Study|Physician Decision|0|||
130218291|NCT01639144|468763403|FG000|Overall Study|Met postoperative exclusion criteria|4|||
130218292|NCT01639144|468763404|FG001|Overall Study|Met postoperative exclusion criteria|3|||
130218293|NCT02750332|468763405|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130218294|NCT02750332|468763406|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130218295|NCT02485483|468763411|FG000|Overall Study|Depression at baseline|15|||
130218296|NCT02485483|468763412|FG001|Overall Study|Depression at baseline|0|||
130218297|NCT02485483|468763411|FG000|Overall Study|Discontinued after baseline|39|||
130218298|NCT02485483|468763412|FG001|Overall Study|Discontinued after baseline|0|||
130218299|NCT01724177|468763414|FG000|Overall Study|Adverse Event|8|||
130218300|NCT01724177|468763414|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
130218301|NCT01724177|468763414|FG000|Overall Study|Nervous participant|1|||
130218302|NCT01724177|468763414|FG000|Overall Study|Serious Adverse Event Related|1|||
130218303|NCT02982863|468763419|FG000|Overall Study|Not eligible patients|809|||
130218304|NCT02982863|468763420|FG001|Overall Study|Not eligible patients|4261|||
130218305|NCT02982863|468763421|FG002|Overall Study|Not eligible patients|1852|||
130351805|NCT03981822|469259055|FG007|Overall Study|COVID-19 Related|1|||
130351806|NCT06460493|469259056|FG000|Overall Study|Withdrawal by Subject|2|||
130351807|NCT02987660|469259061|FG000|Overall Study|Study terminated by sponsor|10|||
130351808|NCT02987660|469259062|FG001|Overall Study|Study terminated by sponsor|10|||
130351809|NCT03707184|469259063|FG000|Overall Study|Withdrawal by Subject|2|||
130351810|NCT04704154|469259064|FG000|Overall Study|Adverse Event|3|||
130218306|NCT02982863|468763422|FG003|Overall Study|Not eligible patients|1400|||
130218307|NCT02982863|468763423|FG004|Overall Study|Not eligible patients|492|||
130218308|NCT02457195|468763424|FG000|Overall Study|Adverse Event|3|||
130218309|NCT02457195|468763424|FG000|Overall Study|Protocol Violation|2|||
130218310|NCT02457195|468763424|FG000|Overall Study|Withdrawal by Subject|4|||
130351811|NCT04704154|469259065|FG001|Overall Study|Adverse Event|2|||
130218311|NCT00158262|468763427|FG000|Overall Study|Lost to Follow-up|1|||
130218312|NCT00158262|468763428|FG001|Overall Study|Lost to Follow-up|1|||
130218313|NCT02959918|468763429|FG000|Overall Study|Adverse Event|1|||
130218314|NCT02959918|468763430|FG001|Overall Study|Adverse Event|1|||
130218315|NCT02959918|468763431|FG002|Overall Study|Adverse Event|2|||
130218316|NCT02959918|468763432|FG003|Overall Study|Adverse Event|0|||
130218317|NCT02959918|468763433|FG004|Overall Study|Adverse Event|0|||
130218318|NCT02959918|468763434|FG005|Overall Study|Adverse Event|2|||
130218319|NCT02959918|468763435|FG006|Overall Study|Adverse Event|2|||
130218320|NCT02959918|468763436|FG007|Overall Study|Adverse Event|1|||
130351812|NCT04704154|469259066|FG002|Overall Study|Adverse Event|4|||
130351813|NCT04704154|469259067|FG003|Overall Study|Adverse Event|2|||
130218321|NCT02959918|468763437|FG008|Overall Study|Adverse Event|2|||
130218322|NCT02959918|468763438|FG009|Overall Study|Adverse Event|1|||
130218323|NCT02959918|468763439|FG010|Overall Study|Adverse Event|1|||
130218324|NCT02959918|468763440|FG011|Overall Study|Adverse Event|3|||
130218325|NCT02959918|468763441|FG012|Overall Study|Adverse Event|2|||
130218326|NCT02959918|468763442|FG013|Overall Study|Adverse Event|4|||
130218327|NCT02959918|468763429|FG000|Overall Study|Lost to Follow-up|0|||
130218328|NCT02959918|468763430|FG001|Overall Study|Lost to Follow-up|0|||
130218329|NCT02959918|468763431|FG002|Overall Study|Lost to Follow-up|0|||
130218330|NCT02959918|468763432|FG003|Overall Study|Lost to Follow-up|0|||
130218331|NCT02959918|468763433|FG004|Overall Study|Lost to Follow-up|0|||
130218332|NCT02959918|468763434|FG005|Overall Study|Lost to Follow-up|0|||
130218333|NCT02959918|468763435|FG006|Overall Study|Lost to Follow-up|0|||
130218334|NCT02959918|468763436|FG007|Overall Study|Lost to Follow-up|0|||
130218335|NCT02959918|468763437|FG008|Overall Study|Lost to Follow-up|0|||
130218336|NCT02959918|468763438|FG009|Overall Study|Lost to Follow-up|1|||
130218337|NCT02959918|468763439|FG010|Overall Study|Lost to Follow-up|0|||
130218338|NCT02959918|468763440|FG011|Overall Study|Lost to Follow-up|0|||
130218339|NCT02959918|468763441|FG012|Overall Study|Lost to Follow-up|1|||
130218340|NCT02959918|468763442|FG013|Overall Study|Lost to Follow-up|0|||
130218341|NCT02959918|468763429|FG000|Overall Study|Withdrawal by Subject|0|||
130218342|NCT02959918|468763430|FG001|Overall Study|Withdrawal by Subject|0|||
130218343|NCT02959918|468763431|FG002|Overall Study|Withdrawal by Subject|1|||
130218344|NCT02959918|468763432|FG003|Overall Study|Withdrawal by Subject|2|||
130218345|NCT02959918|468763433|FG004|Overall Study|Withdrawal by Subject|0|||
130218346|NCT02959918|468763434|FG005|Overall Study|Withdrawal by Subject|0|||
130218347|NCT02959918|468763435|FG006|Overall Study|Withdrawal by Subject|1|||
130218348|NCT02959918|468763436|FG007|Overall Study|Withdrawal by Subject|0|||
130218349|NCT02959918|468763437|FG008|Overall Study|Withdrawal by Subject|1|||
130218350|NCT02959918|468763438|FG009|Overall Study|Withdrawal by Subject|1|||
130218351|NCT02959918|468763439|FG010|Overall Study|Withdrawal by Subject|2|||
130218352|NCT02959918|468763440|FG011|Overall Study|Withdrawal by Subject|3|||
130218353|NCT02959918|468763441|FG012|Overall Study|Withdrawal by Subject|1|||
130218354|NCT02959918|468763442|FG013|Overall Study|Withdrawal by Subject|1|||
130218355|NCT02959918|468763429|FG000|Overall Study|Protocol Violation|0|||
130218356|NCT02959918|468763430|FG001|Overall Study|Protocol Violation|0|||
130218357|NCT02959918|468763431|FG002|Overall Study|Protocol Violation|1|||
130218358|NCT02959918|468763432|FG003|Overall Study|Protocol Violation|0|||
130218359|NCT02959918|468763433|FG004|Overall Study|Protocol Violation|0|||
130218360|NCT02959918|468763434|FG005|Overall Study|Protocol Violation|1|||
130218361|NCT02959918|468763435|FG006|Overall Study|Protocol Violation|0|||
130218362|NCT02959918|468763436|FG007|Overall Study|Protocol Violation|0|||
130218363|NCT02959918|468763437|FG008|Overall Study|Protocol Violation|2|||
130218364|NCT02959918|468763438|FG009|Overall Study|Protocol Violation|1|||
130218365|NCT02959918|468763439|FG010|Overall Study|Protocol Violation|0|||
130218366|NCT02959918|468763440|FG011|Overall Study|Protocol Violation|1|||
130218367|NCT02959918|468763441|FG012|Overall Study|Protocol Violation|1|||
130218368|NCT02959918|468763442|FG013|Overall Study|Protocol Violation|0|||
130218369|NCT02959918|468763429|FG000|Overall Study|Stopping Rule Met|1|||
130218370|NCT02959918|468763430|FG001|Overall Study|Stopping Rule Met|0|||
130218371|NCT02959918|468763431|FG002|Overall Study|Stopping Rule Met|3|||
130218372|NCT02959918|468763432|FG003|Overall Study|Stopping Rule Met|4|||
130218373|NCT02959918|468763433|FG004|Overall Study|Stopping Rule Met|5|||
130218374|NCT02959918|468763434|FG005|Overall Study|Stopping Rule Met|3|||
130218375|NCT02959918|468763435|FG006|Overall Study|Stopping Rule Met|2|||
130218376|NCT02959918|468763436|FG007|Overall Study|Stopping Rule Met|4|||
130218377|NCT02959918|468763437|FG008|Overall Study|Stopping Rule Met|1|||
130218378|NCT02959918|468763438|FG009|Overall Study|Stopping Rule Met|1|||
130218379|NCT02959918|468763439|FG010|Overall Study|Stopping Rule Met|3|||
130218380|NCT02959918|468763440|FG011|Overall Study|Stopping Rule Met|5|||
130218381|NCT02959918|468763441|FG012|Overall Study|Stopping Rule Met|2|||
130218382|NCT02959918|468763442|FG013|Overall Study|Stopping Rule Met|1|||
130218383|NCT02959918|468763429|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130218384|NCT02959918|468763430|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
130218385|NCT02959918|468763431|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130218386|NCT02959918|468763432|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
130218387|NCT02959918|468763433|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218388|NCT02959918|468763434|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218389|NCT02959918|468763435|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218390|NCT02959918|468763436|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218391|NCT02959918|468763437|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218392|NCT02959918|468763438|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218393|NCT02959918|468763439|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218394|NCT02959918|468763440|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218395|NCT02959918|468763441|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130351814|NCT04704154|469259068|FG004|Overall Study|Adverse Event|3|||
130351815|NCT04704154|469259069|FG005|Overall Study|Adverse Event|0|||
130218396|NCT02959918|468763442|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218397|NCT02959918|468763429|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218398|NCT02959918|468763430|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218399|NCT02959918|468763431|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218400|NCT02959918|468763432|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218401|NCT02959918|468763433|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218402|NCT02959918|468763434|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218403|NCT02959918|468763435|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218404|NCT02959918|468763436|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
130218405|NCT02959918|468763437|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218406|NCT02959918|468763438|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218407|NCT02959918|468763439|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218408|NCT02959918|468763440|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218409|NCT02959918|468763441|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218410|NCT02959918|468763442|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218411|NCT02959918|468763429|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218412|NCT02959918|468763430|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218413|NCT02959918|468763431|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218414|NCT02959918|468763432|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218415|NCT02959918|468763433|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218416|NCT02959918|468763434|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218417|NCT02959918|468763435|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218418|NCT02959918|468763436|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218419|NCT02959918|468763437|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
130218420|NCT02959918|468763438|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218421|NCT02959918|468763439|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218422|NCT02959918|468763440|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218423|NCT02959918|468763441|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218424|NCT02959918|468763442|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218425|NCT02959918|468763429|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218426|NCT02959918|468763430|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218427|NCT02959918|468763431|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218428|NCT02959918|468763432|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218429|NCT02959918|468763433|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218430|NCT02959918|468763434|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218431|NCT02959918|468763435|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218432|NCT02959918|468763436|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218433|NCT02959918|468763437|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218434|NCT02959918|468763438|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
130218435|NCT02959918|468763439|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218436|NCT02959918|468763440|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218437|NCT02959918|468763441|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218438|NCT02959918|468763442|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218439|NCT02585713|468763444|FG000|Overall Study|Withdrew prior to treatment|2|||
130218440|NCT02585713|468763445|FG001|Overall Study|Withdrew prior to treatment|7|||
130218441|NCT02585713|468763444|FG000|Overall Study|Other|3|||
130218442|NCT02585713|468763445|FG001|Overall Study|Other|1|||
130218443|NCT03173456|468763450|FG000|Baseline|Medication dispensing system malfunction'|0|||
130218444|NCT03173456|468763451|FG001|Baseline|Medication dispensing system malfunction'|1|||
130218445|NCT03173456|468763452|FG002|Baseline|Medication dispensing system malfunction'|0|||
130351816|NCT04704154|469259064|FG000|Overall Study|Death|3|||
130351817|NCT04704154|469259065|FG001|Overall Study|Death|0|||
130351818|NCT04704154|469259066|FG002|Overall Study|Death|0|||
130351819|NCT04704154|469259067|FG003|Overall Study|Death|0|||
130351820|NCT04704154|469259068|FG004|Overall Study|Death|3|||
130351821|NCT04704154|469259069|FG005|Overall Study|Death|0|||
130351822|NCT04704154|469259064|FG000|Overall Study|Physician Decision|1|||
130351823|NCT04704154|469259065|FG001|Overall Study|Physician Decision|0|||
130351824|NCT04704154|469259066|FG002|Overall Study|Physician Decision|1|||
130351825|NCT04704154|469259067|FG003|Overall Study|Physician Decision|0|||
130351826|NCT04704154|469259068|FG004|Overall Study|Physician Decision|2|||
130351827|NCT04704154|469259069|FG005|Overall Study|Physician Decision|0|||
130685872|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685873|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685874|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130218446|NCT03173456|468763453|FG003|Baseline|Medication dispensing system malfunction'|0|||
130218447|NCT03173456|468763454|FG004|Baseline|Medication dispensing system malfunction'|2|||
130218448|NCT03173456|468763450|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
130218449|NCT03173456|468763451|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
130218450|NCT03173456|468763452|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
130218451|NCT03173456|468763453|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
130218452|NCT03173456|468763454|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
130218453|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
130218454|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
130218455|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
130218456|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
130218457|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
130218458|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
130218459|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130218460|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
130218461|NCT04501952|468763465|FG000|Overall Study|Adverse Event|0|||
130218462|NCT04501952|468763466|FG001|Overall Study|Adverse Event|3|||
130218463|NCT04501952|468763465|FG000|Overall Study|Investigator's Discretion|0|||
130218464|NCT04501952|468763466|FG001|Overall Study|Investigator's Discretion|1|||
130218465|NCT04501952|468763465|FG000|Overall Study|Protocol Violation|1|||
130218466|NCT04501952|468763466|FG001|Overall Study|Protocol Violation|1|||
130218467|NCT04501952|468763465|FG000|Overall Study|Withdrew Consent|5|||
130218468|NCT04501952|468763466|FG001|Overall Study|Withdrew Consent|4|||
130218469|NCT04501952|468763465|FG000|Overall Study|Lost to Follow-up|7|||
130218470|NCT04501952|468763466|FG001|Overall Study|Lost to Follow-up|2|||
130218471|NCT04501952|468763465|FG000|Overall Study|Randomized and Never Treated|13|||
130218472|NCT04501952|468763466|FG001|Overall Study|Randomized and Never Treated|9|||
130218473|NCT00941304|468763467|FG000|Overall Study|Lost to Follow-up|1|||
130218474|NCT00941304|468763468|FG001|Overall Study|Lost to Follow-up|0|||
130218475|NCT00941304|468763469|FG002|Overall Study|Lost to Follow-up|0|||
130218476|NCT00941304|468763470|FG003|Overall Study|Lost to Follow-up|0|||
130218477|NCT00941304|468763471|FG004|Overall Study|Lost to Follow-up|0|||
130218478|NCT00784719|468763472|FG000|Overall Study|Adverse Event|0|||
130218479|NCT00784719|468763473|FG001|Overall Study|Adverse Event|2|||
130218480|NCT00784719|468763474|FG002|Overall Study|Adverse Event|0|||
130218481|NCT00784719|468763475|FG003|Overall Study|Adverse Event|0|||
130218482|NCT00784719|468763476|FG004|Overall Study|Adverse Event|1|||
130218483|NCT00784719|468763477|FG005|Overall Study|Adverse Event|1|||
130218484|NCT00784719|468763478|FG006|Overall Study|Adverse Event|1|||
130218485|NCT00784719|468763472|FG000|Overall Study|Lost to Follow-up|0|||
130218486|NCT00784719|468763473|FG001|Overall Study|Lost to Follow-up|0|||
130218487|NCT00784719|468763474|FG002|Overall Study|Lost to Follow-up|0|||
130218488|NCT00784719|468763475|FG003|Overall Study|Lost to Follow-up|0|||
130218489|NCT00784719|468763476|FG004|Overall Study|Lost to Follow-up|1|||
130218490|NCT00784719|468763477|FG005|Overall Study|Lost to Follow-up|1|||
130218491|NCT00784719|468763478|FG006|Overall Study|Lost to Follow-up|0|||
130218492|NCT00784719|468763472|FG000|Overall Study|Other|2|||
130218493|NCT00784719|468763473|FG001|Overall Study|Other|1|||
130218494|NCT00784719|468763474|FG002|Overall Study|Other|1|||
130351828|NCT04704154|469259064|FG000|Overall Study|Participant Decision|1|||
130351829|NCT04704154|469259065|FG001|Overall Study|Participant Decision|1|||
130351830|NCT04704154|469259066|FG002|Overall Study|Participant Decision|0|||
130351831|NCT04704154|469259067|FG003|Overall Study|Participant Decision|0|||
130351832|NCT04704154|469259068|FG004|Overall Study|Participant Decision|0|||
130351833|NCT04704154|469259069|FG005|Overall Study|Participant Decision|0|||
130351834|NCT04704154|469259064|FG000|Overall Study|Progressive Disease|19|||
130351835|NCT04704154|469259065|FG001|Overall Study|Progressive Disease|17|||
130351836|NCT04704154|469259066|FG002|Overall Study|Progressive Disease|20|||
130351837|NCT04704154|469259067|FG003|Overall Study|Progressive Disease|18|||
130351838|NCT04704154|469259068|FG004|Overall Study|Progressive Disease|36|||
130351839|NCT04704154|469259069|FG005|Overall Study|Progressive Disease|30|||
130351840|NCT04704154|469259064|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
130351841|NCT04704154|469259065|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130218495|NCT00784719|468763475|FG003|Overall Study|Other|0|||
130218496|NCT00784719|468763476|FG004|Overall Study|Other|2|||
130351842|NCT04704154|469259066|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
130351843|NCT04704154|469259067|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130685875|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130218497|NCT00784719|468763477|FG005|Overall Study|Other|1|||
130218498|NCT00784719|468763478|FG006|Overall Study|Other|3|||
130218499|NCT00784719|468763472|FG000|Overall Study|Withdrawal by Subject|1|||
130218500|NCT00784719|468763473|FG001|Overall Study|Withdrawal by Subject|0|||
130218501|NCT00784719|468763474|FG002|Overall Study|Withdrawal by Subject|0|||
130218502|NCT00784719|468763475|FG003|Overall Study|Withdrawal by Subject|0|||
130218503|NCT00784719|468763476|FG004|Overall Study|Withdrawal by Subject|2|||
130218504|NCT00784719|468763477|FG005|Overall Study|Withdrawal by Subject|0|||
130218505|NCT00784719|468763478|FG006|Overall Study|Withdrawal by Subject|1|||
130218506|NCT01408901|468763479|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
130218507|NCT01408901|468763480|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
130218508|NCT01408901|468763481|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
130218509|NCT01408901|468763482|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
130218510|NCT01408901|468763479|FG000|6-Week Follow-Up|Death|1|||
130218511|NCT01408901|468763480|FG001|6-Week Follow-Up|Death|0|||
130218512|NCT01408901|468763481|FG002|6-Week Follow-Up|Death|0|||
130218513|NCT01408901|468763482|FG003|6-Week Follow-Up|Death|0|||
130218514|NCT01408901|468763479|FG000|6-Week Follow-Up|Cancelled visit|0|||
130218515|NCT01408901|468763480|FG001|6-Week Follow-Up|Cancelled visit|1|||
130218516|NCT01408901|468763481|FG002|6-Week Follow-Up|Cancelled visit|0|||
130218517|NCT01408901|468763482|FG003|6-Week Follow-Up|Cancelled visit|2|||
130218518|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218519|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218520|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218521|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
130218522|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
130218523|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218524|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218525|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218526|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130218527|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
130218528|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130218529|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
130218530|NCT01408901|468763479|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
130218531|NCT01408901|468763480|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
130218532|NCT01408901|468763481|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
130218533|NCT01408901|468763482|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
130218534|NCT01408901|468763479|FG000|26-Week Follow-Up|Death|0|||
130218535|NCT01408901|468763480|FG001|26-Week Follow-Up|Death|1|||
130218536|NCT01408901|468763481|FG002|26-Week Follow-Up|Death|0|||
130218537|NCT01408901|468763482|FG003|26-Week Follow-Up|Death|0|||
130218538|NCT04004260|468763489|FG000|Overall Study|Withdrawal by Subject|7|||
130218539|NCT04004260|468763490|FG001|Overall Study|Withdrawal by Subject|3|||
130218540|NCT04004260|468763489|FG000|Overall Study|Lost to Follow-up|22|||
130218541|NCT04004260|468763490|FG001|Overall Study|Lost to Follow-up|12|||
130218542|NCT04004260|468763489|FG000|Overall Study|Did not engage in intervention|13|||
130218543|NCT04004260|468763490|FG001|Overall Study|Did not engage in intervention|17|||
130218544|NCT05464420|468763491|FG000|Overall Study|Death|0|||
130218545|NCT05464420|468763492|FG001|Overall Study|Death|0|||
130218546|NCT05464420|468763493|FG002|Overall Study|Death|0|||
130218547|NCT05464420|468763494|FG003|Overall Study|Death|1|||
130218548|NCT05464420|468763491|FG000|Overall Study|Lost to Follow-up|16|||
130218549|NCT05464420|468763492|FG001|Overall Study|Lost to Follow-up|11|||
130218550|NCT05464420|468763493|FG002|Overall Study|Lost to Follow-up|11|||
130218551|NCT05464420|468763494|FG003|Overall Study|Lost to Follow-up|11|||
130218552|NCT05464420|468763491|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
130218553|NCT05464420|468763492|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
130218554|NCT05464420|468763493|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
130218555|NCT05464420|468763494|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
130218556|NCT05464420|468763491|FG000|Overall Study|Withdrawal by Subject|4|||
130218557|NCT05464420|468763492|FG001|Overall Study|Withdrawal by Subject|8|||
130218558|NCT05464420|468763493|FG002|Overall Study|Withdrawal by Subject|3|||
130218559|NCT05464420|468763494|FG003|Overall Study|Withdrawal by Subject|1|||
130218560|NCT05464420|468763491|FG000|Overall Study|Protocol Violation|0|||
130218561|NCT05464420|468763492|FG001|Overall Study|Protocol Violation|0|||
130218562|NCT05464420|468763493|FG002|Overall Study|Protocol Violation|1|||
130218563|NCT05464420|468763494|FG003|Overall Study|Protocol Violation|1|||
130218564|NCT05464420|468763491|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
130218565|NCT05464420|468763492|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
130218566|NCT05464420|468763493|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
130218567|NCT05464420|468763494|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
130218568|NCT03414229|468763495|FG000|Overall Study|Adverse Event|1|||
130218569|NCT03414229|468763496|FG001|Overall Study|Adverse Event|0|||
130218570|NCT03414229|468763497|FG002|Overall Study|Adverse Event|2|||
130218571|NCT03414229|468763498|FG003|Overall Study|Adverse Event|1|||
130218572|NCT03414229|468763495|FG000|Overall Study|Lack of Efficacy|7|||
130218573|NCT03414229|468763496|FG001|Overall Study|Lack of Efficacy|4|||
130218574|NCT03414229|468763497|FG002|Overall Study|Lack of Efficacy|1|||
130218575|NCT03414229|468763498|FG003|Overall Study|Lack of Efficacy|9|||
130218576|NCT03414229|468763495|FG000|Overall Study|Change in therapy|1|||
130685876|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130218577|NCT03414229|468763496|FG001|Overall Study|Change in therapy|0|||
130218578|NCT03414229|468763497|FG002|Overall Study|Change in therapy|0|||
130218579|NCT03414229|468763498|FG003|Overall Study|Change in therapy|0|||
130218580|NCT03414229|468763495|FG000|Overall Study|Pregnancy|0|||
130218581|NCT03414229|468763496|FG001|Overall Study|Pregnancy|0|||
130218582|NCT03414229|468763497|FG002|Overall Study|Pregnancy|1|||
130218583|NCT03414229|468763498|FG003|Overall Study|Pregnancy|0|||
130218584|NCT03414229|468763495|FG000|Overall Study|Withdrawal by Subject|0|||
130218585|NCT03414229|468763496|FG001|Overall Study|Withdrawal by Subject|1|||
130218586|NCT03414229|468763497|FG002|Overall Study|Withdrawal by Subject|1|||
130351844|NCT04704154|469259068|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
130351845|NCT04704154|469259069|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130351846|NCT04704154|469259064|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
130351847|NCT04704154|469259065|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
130351848|NCT04704154|469259066|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
130351849|NCT04704154|469259067|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
130351850|NCT04704154|469259068|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
130351851|NCT04704154|469259069|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
130351852|NCT01653782|469259072|FG000|Overall Study|Withdrawal by Subject|9|||
130351853|NCT01653782|469259073|FG001|Overall Study|Withdrawal by Subject|15|||
130351854|NCT01653782|469259074|FG002|Overall Study|Withdrawal by Subject|4|||
130351855|NCT01653782|469259072|FG000|Overall Study|Lost to Follow-up|7|||
130351856|NCT01653782|469259073|FG001|Overall Study|Lost to Follow-up|3|||
130351857|NCT01653782|469259074|FG002|Overall Study|Lost to Follow-up|2|||
130351858|NCT01142128|469259075|FG000|Overall Study|Physician Decision|1|||
130351859|NCT01142128|469259075|FG000|Overall Study|Lost to Follow-up|1|||
130351860|NCT01142128|469259075|FG000|Overall Study|Withdrawal by Subject|2|||
130351861|NCT05442775|469259078|FG000|Overall Study|Trial terminated|61|||
130351862|NCT05442775|469259078|FG000|Overall Study|Lack of Efficacy|4|||
130351863|NCT05442775|469259078|FG000|Overall Study|Withdrawal by Subject|4|||
130351864|NCT05442775|469259078|FG000|Overall Study|Death|1|||
130351865|NCT05442775|469259078|FG000|Overall Study|Participant removed at Sponsor request|1|||
130351866|NCT01606254|469259079|FG000|Overall Study|Withdrawal by Subject|1|||
130351867|NCT01606254|469259080|FG001|Overall Study|Withdrawal by Subject|3|||
130351868|NCT01606254|469259081|FG002|Overall Study|Withdrawal by Subject|0|||
130351869|NCT01606254|469259082|FG003|Overall Study|Withdrawal by Subject|2|||
130351870|NCT01606254|469259079|FG000|Overall Study|Adverse Event|1|||
130351871|NCT01606254|469259080|FG001|Overall Study|Adverse Event|1|||
130351872|NCT01606254|469259081|FG002|Overall Study|Adverse Event|0|||
130351873|NCT01606254|469259082|FG003|Overall Study|Adverse Event|1|||
130351874|NCT04543409|469259083|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130351875|NCT04543409|469259084|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130351876|NCT04543409|469259083|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
130351877|NCT04543409|469259084|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
130351878|NCT04543409|469259083|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
130351879|NCT04543409|469259084|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130351880|NCT04543409|469259083|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
130351881|NCT04543409|469259084|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
130351882|NCT04543409|469259083|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
130351883|NCT04543409|469259084|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
130351884|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
130351885|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
130351886|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
130351887|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
130351888|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
130351889|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
130351890|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
130351891|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
130351892|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
130351893|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
130351894|NCT04543409|469259083|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
130351895|NCT04543409|469259084|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
130218587|NCT03414229|468763498|FG003|Overall Study|Withdrawal by Subject|0|||
130351896|NCT02093026|469259085|FG000|Overall Study|Adverse Event|26|||
130351897|NCT02093026|469259085|FG000|Overall Study|Death|10|||
130351898|NCT02093026|469259085|FG000|Overall Study|Other|157|||
130351899|NCT00518973|469259086|FG000|Overall Study|Withdrawal by Subject|3|||
130351900|NCT00518973|469259087|FG001|Overall Study|Withdrawal by Subject|2|||
130218588|NCT04533438|468763499|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
130351901|NCT00174291|469259104|FG000|Overall Study|Lost to Follow-up|1|||
130218589|NCT04533438|468763500|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
130685877|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685878|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685879|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685880|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130439119|NCT00744237|469571493|FG000|Overall Study|Administrative. Site Closed|1|||
130439120|NCT00744237|469571494|FG001|Overall Study|Administrative. Site Closed|1|||
130439121|NCT00744237|469571495|FG002|Overall Study|Administrative. Site Closed|1|||
130439122|NCT00744237|469571493|FG000|Overall Study|Adverse Event|9|||
130439123|NCT00744237|469571494|FG001|Overall Study|Adverse Event|13|||
130439124|NCT00744237|469571495|FG002|Overall Study|Adverse Event|5|||
130439125|NCT02791490|469571497|FG000|Overall Study|Lost to Follow-up|1|||
130439126|NCT02791490|469571498|FG001|Overall Study|Lost to Follow-up|2|||
130439127|NCT02791490|469571497|FG000|Overall Study|Withdrawal by Subject|2|||
130439128|NCT02791490|469571498|FG001|Overall Study|Withdrawal by Subject|6|||
130439129|NCT00582491|469571500|FG000|Overall Study|Withdrawal by Subject|1|||
130439130|NCT00582491|469571501|FG001|Overall Study|Withdrawal by Subject|0|||
130439131|NCT01775930|469571508|FG000|Overall Study|Futility stopping boundary met|1|||
130439132|NCT01208415|469571511|FG000|Overall Study|Death|1|||
130439133|NCT01208415|469571511|FG000|Overall Study|Lost to Follow-up|2|||
130439134|NCT01208415|469571511|FG000|Overall Study|Withdrawal by Subject|3|||
130439135|NCT01208415|469571511|FG000|Overall Study|Device not placed|1|||
130439136|NCT01208415|469571511|FG000|Overall Study|Still be eligible for follow-up|33|||
130439137|NCT01115491|469571512|FG000|Overall Study|Death|22|||
130439138|NCT01115491|469571512|FG000|Overall Study|Adverse Event|3|||
130439139|NCT01115491|469571512|FG000|Overall Study|Lost to Follow-up|3|||
130439140|NCT01115491|469571512|FG000|Overall Study|Withdrawal by Subject|1|||
130439141|NCT01115491|469571512|FG000|Overall Study|Physician Decision|1|||
130439142|NCT04297241|469571513|FG000|Overall Study|Withdrawal by Subject|1|||
130439143|NCT04297241|469571513|FG000|Overall Study|Adverse Event|1|||
130439144|NCT04297241|469571513|FG000|Overall Study|Physician Decision|3|||
130439145|NCT03856996|469571514|FG000|Overall Study|Withdrawal by Subject|1|||
130439146|NCT03856996|469571515|FG001|Overall Study|Withdrawal by Subject|0|||
130439147|NCT03856996|469571514|FG000|Overall Study|Lost to Follow-up|0|||
130439148|NCT03856996|469571515|FG001|Overall Study|Lost to Follow-up|1|||
130439149|NCT03856996|469571514|FG000|Overall Study|Adverse Event|1|||
130439150|NCT03856996|469571515|FG001|Overall Study|Adverse Event|1|||
130439151|NCT03856996|469571514|FG000|Overall Study|Other|1|||
130439152|NCT03856996|469571515|FG001|Overall Study|Other|0|||
130439153|NCT02340520|469571518|FG000|Overall Study|Lost to Follow-up|1|||
130439154|NCT02340520|469571518|FG000|Overall Study|Patient did not take drug as specified|1|||
130439155|NCT02340520|469571518|FG000|Overall Study|Withdrawal by Subject|1|||
130685881|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685882|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130685883|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130685884|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
130351902|NCT00174291|469259105|FG001|Overall Study|Lost to Follow-up|1|||
130351903|NCT00174291|469259104|FG000|Overall Study|Protocol Violation|0|||
130351904|NCT00174291|469259105|FG001|Overall Study|Protocol Violation|2|||
130351905|NCT00174291|469259104|FG000|Overall Study|Study terminated by sponsor|1|||
130351906|NCT00174291|469259105|FG001|Overall Study|Study terminated by sponsor|0|||
130351907|NCT00174291|469259104|FG000|Overall Study|Withdrawal by Subject|3|||
130351908|NCT00174291|469259105|FG001|Overall Study|Withdrawal by Subject|3|||
130351909|NCT01923168|469259108|FG000|Overall Study|Protocol Violation|1|||
130351910|NCT01923168|469259109|FG001|Overall Study|Protocol Violation|1|||
130351911|NCT01923168|469259110|FG002|Overall Study|Protocol Violation|0|||
130351912|NCT01923168|469259108|FG000|Overall Study|Subject/guardian decision|14|||
130351913|NCT01923168|469259109|FG001|Overall Study|Subject/guardian decision|14|||
130351914|NCT01923168|469259110|FG002|Overall Study|Subject/guardian decision|4|||
130351915|NCT01923168|469259108|FG000|Overall Study|Adverse Event|12|||
130351916|NCT01923168|469259109|FG001|Overall Study|Adverse Event|12|||
130351917|NCT01923168|469259110|FG002|Overall Study|Adverse Event|0|||
130351918|NCT01923168|469259108|FG000|Overall Study|Physician Decision|6|||
130351919|NCT01923168|469259109|FG001|Overall Study|Physician Decision|9|||
130351920|NCT01923168|469259110|FG002|Overall Study|Physician Decision|5|||
130439156|NCT01003639|469571519|FG000|Overall Study|Lost to Follow-up|6|||
130439157|NCT01003639|469571520|FG001|Overall Study|Lost to Follow-up|9|||
130439158|NCT01003639|469571519|FG000|Overall Study|Withdrawal by Subject|9|||
130439159|NCT01003639|469571520|FG001|Overall Study|Withdrawal by Subject|5|||
130439160|NCT01003639|469571519|FG000|Overall Study|Lack of Efficacy|1|||
130439161|NCT01003639|469571520|FG001|Overall Study|Lack of Efficacy|6|||
130439162|NCT01003639|469571519|FG000|Overall Study|Adverse Event|0|||
130439163|NCT01003639|469571520|FG001|Overall Study|Adverse Event|1|||
130439164|NCT01003639|469571519|FG000|Overall Study|Protocol Violation|0|||
130351921|NCT01923168|469259108|FG000|Overall Study|Progressive disease|4|||
130351922|NCT01923168|469259109|FG001|Overall Study|Progressive disease|3|||
130439165|NCT01003639|469571520|FG001|Overall Study|Protocol Violation|1|||
130218590|NCT02716584|468763505|FG000|Overall Study|Lost to Follow-up|8|||
130218591|NCT02716584|468763506|FG001|Overall Study|Lost to Follow-up|5|||
130218592|NCT01903993|468763507|FG000|Overall Study|Death|118|||
130218593|NCT01903993|468763508|FG001|Overall Study|Death|121|||
130218594|NCT01903993|468763507|FG000|Overall Study|Withdrawal by Subject|15|||
130218595|NCT01903993|468763508|FG001|Overall Study|Withdrawal by Subject|4|||
130218596|NCT01903993|468763507|FG000|Overall Study|Lost to Follow-up|2|||
130685885|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685886|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130685887|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
130685888|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
130685889|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
130685890|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130685891|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685892|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685893|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685894|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685895|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685896|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685897|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685898|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685899|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685900|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685901|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685902|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685903|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685904|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685905|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685906|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685907|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
130685908|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685909|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
130685910|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685911|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685912|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685913|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685914|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685915|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685916|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130218597|NCT01903993|468763508|FG001|Overall Study|Lost to Follow-up|3|||
130218598|NCT01903993|468763507|FG000|Overall Study|Study Terminated by Sponsor|8|||
130351923|NCT01923168|469259110|FG002|Overall Study|Progressive disease|7|||
130351924|NCT01923168|469259108|FG000|Overall Study|Death|0|||
130351925|NCT01923168|469259109|FG001|Overall Study|Death|0|||
130351926|NCT01923168|469259110|FG002|Overall Study|Death|1|||
130351927|NCT03418571|469259113|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
130351928|NCT03418571|469259114|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
130351929|NCT02376829|469259115|FG000|Overall Study|Withdrawal by Subject|27|||
130351930|NCT02376829|469259116|FG001|Overall Study|Withdrawal by Subject|44|||
130351931|NCT01439347|469259117|FG000|Overall Study|Death|10|||
130351932|NCT01439347|469259118|FG001|Overall Study|Death|9|||
130351933|NCT01439347|469259117|FG000|Overall Study|Withdrawal by Subject|0|||
130351934|NCT01439347|469259118|FG001|Overall Study|Withdrawal by Subject|1|||
130351935|NCT01439347|469259117|FG000|Overall Study|Physician Decision|1|||
130351936|NCT01439347|469259118|FG001|Overall Study|Physician Decision|0|||
130351937|NCT01439347|469259117|FG000|Overall Study|Sponsor Terminated Study|2|||
130351938|NCT01439347|469259118|FG001|Overall Study|Sponsor Terminated Study|3|||
130351939|NCT04068896|469259119|FG000|Overall Study|Adverse Event|2|||
130351940|NCT04068896|469259120|FG001|Overall Study|Adverse Event|0|||
130351941|NCT04068896|469259121|FG002|Overall Study|Adverse Event|1|||
130351942|NCT04068896|469259122|FG003|Overall Study|Adverse Event|0|||
130218599|NCT01903993|468763508|FG001|Overall Study|Study Terminated by Sponsor|14|||
130351943|NCT04068896|469259123|FG004|Overall Study|Adverse Event|0|||
130351944|NCT04068896|469259124|FG005|Overall Study|Adverse Event|0|||
130351945|NCT04068896|469259119|FG000|Overall Study|Death|3|||
130351946|NCT04068896|469259120|FG001|Overall Study|Death|1|||
130218600|NCT01903993|468763507|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
130351947|NCT04068896|469259121|FG002|Overall Study|Death|3|||
130351948|NCT04068896|469259122|FG003|Overall Study|Death|19|||
130351949|NCT04068896|469259123|FG004|Overall Study|Death|17|||
130218601|NCT01903993|468763508|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
130218602|NCT01588405|468763509|FG000|Overall Study|Adverse Event|1|||
130218603|NCT01588405|468763509|FG000|Overall Study|Clinical Worsening|1|||
130218604|NCT01243177|468763512|FG000|Overall Study|Lack of Efficacy|47|||
130218605|NCT01243177|468763513|FG001|Overall Study|Lack of Efficacy|31|||
130218606|NCT01243177|468763512|FG000|Overall Study|Protocol Violation|11|||
130218607|NCT01243177|468763513|FG001|Overall Study|Protocol Violation|10|||
130218608|NCT01243177|468763512|FG000|Overall Study|Lost to Follow-up|15|||
130218609|NCT01243177|468763513|FG001|Overall Study|Lost to Follow-up|18|||
130218610|NCT01243177|468763512|FG000|Overall Study|Withdrawal by Subject|46|||
130218611|NCT01243177|468763513|FG001|Overall Study|Withdrawal by Subject|38|||
130218612|NCT01243177|468763512|FG000|Overall Study|AE, serious fatal|0|||
130439166|NCT01003639|469571519|FG000|Overall Study|Physician Decision|1|||
130439167|NCT01003639|469571520|FG001|Overall Study|Physician Decision|0|||
130439168|NCT01586338|469571522|FG000|Overall Study|Adverse Event|3|||
130439169|NCT01586338|469571522|FG000|Overall Study|Lost to Follow-up|1|||
130439170|NCT01586338|469571522|FG000|Overall Study|Withdrawal by participant|3|||
130439171|NCT01586338|469571522|FG000|Overall Study|Other|1|||
130439172|NCT00284089|469571523|FG000|Multiple Dose Phase|Adverse Event|1|||
130439173|NCT00284089|469571524|FG001|Multiple Dose Phase|Adverse Event|0|||
130439174|NCT00284089|469571525|FG002|Multiple Dose Phase|Adverse Event|1|||
130439175|NCT00284089|469571526|FG003|Multiple Dose Phase|Adverse Event|1|||
130439176|NCT00284089|469571523|FG000|Multiple Dose Phase|Protocol Violation|0|||
130685917|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685918|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130218613|NCT01243177|468763513|FG001|Overall Study|AE, serious fatal|1|||
130351950|NCT04068896|469259124|FG005|Overall Study|Death|0|||
130351951|NCT04068896|469259119|FG000|Overall Study|Physician Decision|0|||
130351952|NCT04068896|469259120|FG001|Overall Study|Physician Decision|0|||
130351953|NCT04068896|469259121|FG002|Overall Study|Physician Decision|0|||
130351954|NCT04068896|469259122|FG003|Overall Study|Physician Decision|1|||
130351955|NCT04068896|469259123|FG004|Overall Study|Physician Decision|0|||
130351956|NCT04068896|469259124|FG005|Overall Study|Physician Decision|0|||
130351957|NCT04068896|469259119|FG000|Overall Study|progressive disease|3|||
130351958|NCT04068896|469259120|FG001|Overall Study|progressive disease|5|||
130351959|NCT04068896|469259121|FG002|Overall Study|progressive disease|3|||
130351960|NCT04068896|469259122|FG003|Overall Study|progressive disease|2|||
130351961|NCT04068896|469259123|FG004|Overall Study|progressive disease|1|||
130351962|NCT04068896|469259124|FG005|Overall Study|progressive disease|2|||
130351963|NCT04068896|469259119|FG000|Overall Study|Study terminated by sponsor|0|||
130351964|NCT04068896|469259120|FG001|Overall Study|Study terminated by sponsor|0|||
130351965|NCT04068896|469259121|FG002|Overall Study|Study terminated by sponsor|1|||
130351966|NCT04068896|469259122|FG003|Overall Study|Study terminated by sponsor|2|||
130351967|NCT04068896|469259123|FG004|Overall Study|Study terminated by sponsor|1|||
130351968|NCT04068896|469259124|FG005|Overall Study|Study terminated by sponsor|4|||
130351969|NCT04068896|469259119|FG000|Overall Study|Protocol Violation|0|||
130351970|NCT04068896|469259120|FG001|Overall Study|Protocol Violation|0|||
130351971|NCT04068896|469259121|FG002|Overall Study|Protocol Violation|0|||
130351972|NCT04068896|469259122|FG003|Overall Study|Protocol Violation|1|||
130351973|NCT04068896|469259123|FG004|Overall Study|Protocol Violation|0|||
130351974|NCT04068896|469259124|FG005|Overall Study|Protocol Violation|0|||
130351975|NCT04068896|469259119|FG000|Overall Study|Withdrawal by Subject|0|||
130351976|NCT04068896|469259120|FG001|Overall Study|Withdrawal by Subject|3|||
130351977|NCT04068896|469259121|FG002|Overall Study|Withdrawal by Subject|0|||
130351978|NCT04068896|469259122|FG003|Overall Study|Withdrawal by Subject|2|||
130351979|NCT04068896|469259123|FG004|Overall Study|Withdrawal by Subject|1|||
130351980|NCT04068896|469259124|FG005|Overall Study|Withdrawal by Subject|0|||
130351981|NCT04068896|469259119|FG000|Overall Study|Symptomatic deterioration|2|||
130351982|NCT04068896|469259120|FG001|Overall Study|Symptomatic deterioration|0|||
130351983|NCT04068896|469259121|FG002|Overall Study|Symptomatic deterioration|0|||
130351984|NCT04068896|469259122|FG003|Overall Study|Symptomatic deterioration|0|||
130351985|NCT04068896|469259123|FG004|Overall Study|Symptomatic deterioration|0|||
130351986|NCT04068896|469259124|FG005|Overall Study|Symptomatic deterioration|0|||
130351987|NCT02398227|469259125|FG000|Overall Study|Lost to Follow-up|21|||
130351988|NCT02398227|469259126|FG001|Overall Study|Lost to Follow-up|12|||
130351989|NCT02398227|469259125|FG000|Overall Study|Withdrawal by Subject|5|||
130351990|NCT02398227|469259126|FG001|Overall Study|Withdrawal by Subject|6|||
130351991|NCT02398227|469259125|FG000|Overall Study|Removed from treatment and dropped out|1|||
130351992|NCT02398227|469259126|FG001|Overall Study|Removed from treatment and dropped out|0|||
130351993|NCT02694718|469259128|FG000|Overall Study|Death|1|||
130351994|NCT02694718|469259128|FG000|Overall Study|Withdrawal by Subject|1|||
130351995|NCT02925793|469259129|FG000|Overall Study|Adverse Event|3|||
130351996|NCT02925793|469259130|FG001|Overall Study|Adverse Event|3|||
130351997|NCT02925793|469259131|FG002|Overall Study|Adverse Event|6|||
130439177|NCT00284089|469571524|FG001|Multiple Dose Phase|Protocol Violation|0|||
130439178|NCT00284089|469571525|FG002|Multiple Dose Phase|Protocol Violation|1|||
130218614|NCT01243177|468763512|FG000|Overall Study|SAE, non-fatal|7|||
130218615|NCT01243177|468763513|FG001|Overall Study|SAE, non-fatal|9|||
130218616|NCT01243177|468763512|FG000|Overall Study|AE, non-serious non-fatal|40|||
130218617|NCT01243177|468763513|FG001|Overall Study|AE, non-serious non-fatal|58|||
130218618|NCT01243177|468763512|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130218619|NCT01243177|468763513|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130218620|NCT01243177|468763512|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130218621|NCT01243177|468763513|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130218622|NCT01243177|468763512|FG000|Overall Study|Other Reason|11|||
130218623|NCT01243177|468763513|FG001|Overall Study|Other Reason|12|||
130218624|NCT01073163|468765012|FG000|Overall Study|Adverse Event|1|||
130218625|NCT01073163|468765012|FG000|Overall Study|Disease Progression|1|||
130218626|NCT01073163|468765012|FG000|Overall Study|Early termination|1|||
130218627|NCT00703677|468765013|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
130218628|NCT00940888|468765014|FG000|Overall Study|Unsuccessful Implant|4|||
130218629|NCT00940888|468765014|FG000|Overall Study|Death|461|||
130218630|NCT00940888|468765014|FG000|Overall Study|Withdrawn - Non-Death|364|||
130218631|NCT00940888|468765014|FG000|Overall Study|Lost to Follow-up|6|||
130218632|NCT04441788|468765017|FG000|Overall Study|Voluntary Withdrawl|0|||
130218633|NCT04441788|468765018|FG001|Overall Study|Voluntary Withdrawl|1|||
130218634|NCT04441788|468765019|FG002|Overall Study|Voluntary Withdrawl|0|||
130218635|NCT04441788|468765017|FG000|Overall Study|Ineligibility|1|||
130218636|NCT04441788|468765018|FG001|Overall Study|Ineligibility|0|||
130218637|NCT04441788|468765019|FG002|Overall Study|Ineligibility|0|||
130218638|NCT04441788|468765017|FG000|Overall Study|Adverse Event|0|||
130218639|NCT04441788|468765018|FG001|Overall Study|Adverse Event|0|||
130218640|NCT04441788|468765019|FG002|Overall Study|Adverse Event|4|||
130218641|NCT04441788|468765017|FG000|Overall Study|Study Terminated by Sponsor|16|||
130218642|NCT04441788|468765018|FG001|Overall Study|Study Terminated by Sponsor|16|||
130218643|NCT04441788|468765019|FG002|Overall Study|Study Terminated by Sponsor|12|||
130218644|NCT03859648|468765024|FG000|Overall Study|Lost to Follow-up|1|||
130218645|NCT03859648|468765024|FG000|Overall Study|Adverse Event|1|||
130218646|NCT01677182|468765025|FG000|Overall Study|Adverse Event|2|||
130218647|NCT01677182|468765026|FG001|Overall Study|Adverse Event|1|||
130351998|NCT02925793|469259129|FG000|Overall Study|Withdrawal by Subject|16|||
130351999|NCT02925793|469259130|FG001|Overall Study|Withdrawal by Subject|15|||
130352000|NCT02925793|469259131|FG002|Overall Study|Withdrawal by Subject|13|||
130352001|NCT02925793|469259129|FG000|Overall Study|Investigator Discretion|0|||
130352002|NCT02925793|469259130|FG001|Overall Study|Investigator Discretion|1|||
130352003|NCT02925793|469259131|FG002|Overall Study|Investigator Discretion|1|||
130352004|NCT02925793|469259129|FG000|Overall Study|Lost to Follow-up|2|||
130352005|NCT02925793|469259130|FG001|Overall Study|Lost to Follow-up|3|||
130352006|NCT02925793|469259131|FG002|Overall Study|Lost to Follow-up|1|||
130352007|NCT02925793|469259129|FG000|Overall Study|Lack of Efficacy|2|||
130352008|NCT02925793|469259130|FG001|Overall Study|Lack of Efficacy|6|||
130352009|NCT02925793|469259131|FG002|Overall Study|Lack of Efficacy|4|||
130352010|NCT02925793|469259129|FG000|Overall Study|Other:|2|||
130352011|NCT02925793|469259130|FG001|Overall Study|Other:|1|||
130352012|NCT02925793|469259131|FG002|Overall Study|Other:|3|||
130352013|NCT00256282|469259133|FG000|Overall Study|Disease progression, relapse during acti|12|||
130352014|NCT00256282|469259133|FG000|Overall Study|Adverse Event|3|||
130352015|NCT00256282|469259133|FG000|Overall Study|Physician Decision|1|||
130352016|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
130352017|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
130352018|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Other|2|||
130352019|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Other|2|||
130352020|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Personal reasons|2|||
130352021|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Personal reasons|2|||
130352022|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
130352023|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
130352024|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
130352025|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
130439179|NCT00284089|469571526|FG003|Multiple Dose Phase|Protocol Violation|0|||
130439180|NCT00284089|469571523|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
130218648|NCT01677182|468765027|FG002|Overall Study|Adverse Event|8|||
130352026|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
130352027|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
130218649|NCT01677182|468765025|FG000|Overall Study|Protocol Violation|5|||
130352028|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
130352029|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
130439181|NCT00284089|469571524|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
130218650|NCT01677182|468765026|FG001|Overall Study|Protocol Violation|1|||
130218651|NCT01677182|468765027|FG002|Overall Study|Protocol Violation|4|||
130218652|NCT01677182|468765025|FG000|Overall Study|Lost to Follow-up|4|||
130218653|NCT01677182|468765026|FG001|Overall Study|Lost to Follow-up|0|||
130439182|NCT00284089|469571525|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
130218654|NCT01677182|468765027|FG002|Overall Study|Lost to Follow-up|3|||
130218655|NCT01677182|468765025|FG000|Overall Study|Withdrawal by Subject|7|||
130218656|NCT01677182|468765026|FG001|Overall Study|Withdrawal by Subject|12|||
130218657|NCT01677182|468765027|FG002|Overall Study|Withdrawal by Subject|10|||
130218658|NCT01677182|468765025|FG000|Overall Study|Study termination|12|||
130218659|NCT01677182|468765026|FG001|Overall Study|Study termination|9|||
130218660|NCT01677182|468765027|FG002|Overall Study|Study termination|11|||
130218661|NCT01677182|468765025|FG000|Overall Study|Lack of Efficacy|3|||
130218662|NCT01677182|468765026|FG001|Overall Study|Lack of Efficacy|0|||
130218663|NCT01677182|468765027|FG002|Overall Study|Lack of Efficacy|1|||
130218664|NCT01677182|468765025|FG000|Overall Study|Other reasons|1|||
130218665|NCT01677182|468765026|FG001|Overall Study|Other reasons|5|||
130218666|NCT01677182|468765027|FG002|Overall Study|Other reasons|2|||
130218667|NCT00762762|468765032|FG000|Overall Study|Did not return for appointments|6|||
130218668|NCT00762762|468765033|FG001|Overall Study|Did not return for appointments|8|||
130218669|NCT02489448|468765034|FG000|Overall Study|Death|3|||
130218670|NCT02489448|468765034|FG000|Overall Study|Withdrawal by Subject|2|||
130218671|NCT01239394|468765043|FG000|Overall Study|Adverse Event|1|||
130218672|NCT02861664|468765044|FG000|Overall Study|Withdrawal of Consent|0|||
130218673|NCT02861664|468765045|FG001|Overall Study|Withdrawal of Consent|1|||
130218674|NCT02781818|468765047|FG000|Overall Study|Lost to Follow-up|4|||
130218675|NCT02781818|468765048|FG001|Overall Study|Lost to Follow-up|2|||
130218676|NCT02781818|468765049|FG002|Overall Study|Lost to Follow-up|1|||
130218677|NCT01223404|468765050|FG000|First Intervention (1 Day)|Adverse Event|0|||
130218678|NCT01223404|468765051|FG001|First Intervention (1 Day)|Adverse Event|0|||
130218679|NCT01223404|468765052|FG002|First Intervention (1 Day)|Adverse Event|0|||
130218680|NCT01223404|468765053|FG003|First Intervention (1 Day)|Adverse Event|1|||
130218681|NCT01223404|468765054|FG004|First Intervention (1 Day)|Adverse Event|0|||
130218682|NCT01223404|468765055|FG005|First Intervention (1 Day)|Adverse Event|0|||
130218683|NCT01223404|468765050|FG000|Second Intervention (1 Day)|Adverse Event|1|||
130218684|NCT01223404|468765051|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130218685|NCT01223404|468765052|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130218686|NCT01223404|468765053|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130218687|NCT01223404|468765054|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130218688|NCT01223404|468765055|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130218689|NCT01223404|468765050|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218690|NCT01223404|468765051|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218691|NCT01223404|468765052|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218692|NCT01223404|468765053|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
130218693|NCT01223404|468765054|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218694|NCT01223404|468765055|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218695|NCT00707057|468765056|FG000|Overall Study|Withdrawal by Subject|8|||
130218696|NCT00707057|468765057|FG001|Overall Study|Withdrawal by Subject|3|||
130218697|NCT00707057|468765056|FG000|Overall Study|Dosed incorrectly|0|||
130218698|NCT00707057|468765057|FG001|Overall Study|Dosed incorrectly|1|||
130218699|NCT00577772|468765063|FG000|Overall Study|Lost to Follow-up|0|||
130218700|NCT00577772|468765064|FG001|Overall Study|Lost to Follow-up|1|||
130218701|NCT00572455|468765065|FG000|Stage I (14 Days)|Adverse Event|0|||
130218702|NCT00572455|468765066|FG001|Stage I (14 Days)|Adverse Event|0|||
130218703|NCT00572455|468765067|FG002|Stage I (14 Days)|Adverse Event|0|||
130218704|NCT00572455|468765068|FG003|Stage I (14 Days)|Adverse Event|0|||
130218705|NCT00572455|468765069|FG004|Stage I (14 Days)|Adverse Event|0|||
130218706|NCT00572455|468765070|FG005|Stage I (14 Days)|Adverse Event|3|||
130218707|NCT00572455|468765071|FG006|Stage I (14 Days)|Adverse Event|0|||
130218708|NCT00572455|468765072|FG007|Stage I (14 Days)|Adverse Event|0|||
130218709|NCT00572455|468765073|FG008|Stage I (14 Days)|Adverse Event|0|||
130218710|NCT00572455|468765074|FG009|Stage I (14 Days)|Adverse Event|0|||
130218711|NCT00572455|468765075|FG010|Stage I (14 Days)|Adverse Event|0|||
130352030|NCT00667446|469259134|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
130352031|NCT00667446|469259135|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
130352032|NCT00667446|469259134|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
130352033|NCT00667446|469259135|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
130352034|NCT02632838|469259139|FG000|Overall Study|Withdrawal by Subject|3|||
130352035|NCT02632838|469259140|FG001|Overall Study|Withdrawal by Subject|0|||
130352036|NCT02632838|469259139|FG000|Overall Study|Lost to Follow-up|0|||
130218712|NCT00572455|468765076|FG011|Stage I (14 Days)|Adverse Event|0|||
130218713|NCT00572455|468765077|FG012|Stage I (14 Days)|Adverse Event|0|||
130352037|NCT02632838|469259140|FG001|Overall Study|Lost to Follow-up|2|||
130218714|NCT00572455|468765078|FG013|Stage I (14 Days)|Adverse Event|0|||
130218715|NCT00572455|468765065|FG000|Stage I (14 Days)|Other|0|||
130218716|NCT00572455|468765066|FG001|Stage I (14 Days)|Other|0|||
130218717|NCT00572455|468765067|FG002|Stage I (14 Days)|Other|0|||
130218718|NCT00572455|468765068|FG003|Stage I (14 Days)|Other|0|||
130218719|NCT00572455|468765069|FG004|Stage I (14 Days)|Other|1|||
130218720|NCT00572455|468765070|FG005|Stage I (14 Days)|Other|0|||
130218721|NCT00572455|468765071|FG006|Stage I (14 Days)|Other|0|||
130218722|NCT00572455|468765072|FG007|Stage I (14 Days)|Other|0|||
130218723|NCT00572455|468765073|FG008|Stage I (14 Days)|Other|0|||
130218724|NCT00572455|468765074|FG009|Stage I (14 Days)|Other|0|||
130218725|NCT00572455|468765075|FG010|Stage I (14 Days)|Other|0|||
130218726|NCT00572455|468765076|FG011|Stage I (14 Days)|Other|0|||
130218727|NCT00572455|468765077|FG012|Stage I (14 Days)|Other|0|||
130218728|NCT00572455|468765078|FG013|Stage I (14 Days)|Other|0|||
130218729|NCT00572455|468765065|FG000|Stage II (28 Days)|Adverse Event|0|||
130218730|NCT00572455|468765066|FG001|Stage II (28 Days)|Adverse Event|0|||
130218731|NCT00572455|468765067|FG002|Stage II (28 Days)|Adverse Event|0|||
130218732|NCT00572455|468765068|FG003|Stage II (28 Days)|Adverse Event|0|||
130218733|NCT00572455|468765069|FG004|Stage II (28 Days)|Adverse Event|0|||
130218734|NCT00572455|468765070|FG005|Stage II (28 Days)|Adverse Event|0|||
130218735|NCT00572455|468765071|FG006|Stage II (28 Days)|Adverse Event|0|||
130218736|NCT00572455|468765072|FG007|Stage II (28 Days)|Adverse Event|0|||
130218737|NCT00572455|468765073|FG008|Stage II (28 Days)|Adverse Event|1|||
130218738|NCT00572455|468765074|FG009|Stage II (28 Days)|Adverse Event|3|||
130218739|NCT00572455|468765075|FG010|Stage II (28 Days)|Adverse Event|3|||
130218740|NCT00572455|468765076|FG011|Stage II (28 Days)|Adverse Event|4|||
130218741|NCT00572455|468765077|FG012|Stage II (28 Days)|Adverse Event|5|||
130218742|NCT00572455|468765078|FG013|Stage II (28 Days)|Adverse Event|1|||
130218743|NCT00572455|468765065|FG000|Stage II (28 Days)|Death|0|||
130218744|NCT00572455|468765066|FG001|Stage II (28 Days)|Death|0|||
130218745|NCT00572455|468765067|FG002|Stage II (28 Days)|Death|0|||
130218746|NCT00572455|468765068|FG003|Stage II (28 Days)|Death|0|||
130218747|NCT00572455|468765069|FG004|Stage II (28 Days)|Death|0|||
130218748|NCT00572455|468765070|FG005|Stage II (28 Days)|Death|0|||
130218749|NCT00572455|468765071|FG006|Stage II (28 Days)|Death|0|||
130218750|NCT00572455|468765072|FG007|Stage II (28 Days)|Death|0|||
130218751|NCT00572455|468765073|FG008|Stage II (28 Days)|Death|1|||
130218752|NCT00572455|468765074|FG009|Stage II (28 Days)|Death|0|||
130218753|NCT00572455|468765075|FG010|Stage II (28 Days)|Death|0|||
130218754|NCT00572455|468765076|FG011|Stage II (28 Days)|Death|0|||
130218755|NCT00572455|468765077|FG012|Stage II (28 Days)|Death|0|||
130218756|NCT00572455|468765078|FG013|Stage II (28 Days)|Death|0|||
130218757|NCT00572455|468765065|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
130218758|NCT00572455|468765066|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
130218759|NCT00572455|468765067|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
130218760|NCT00572455|468765068|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
130218761|NCT00572455|468765069|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
130218762|NCT00572455|468765070|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
130218763|NCT00572455|468765071|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
130218764|NCT00572455|468765072|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
130218765|NCT00572455|468765073|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
130218766|NCT00572455|468765074|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
130218767|NCT00572455|468765075|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
130218768|NCT00572455|468765076|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
130218769|NCT00572455|468765077|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
130218770|NCT00572455|468765078|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
130218771|NCT00572455|468765065|FG000|Stage II (28 Days)|Other|0|||
130218772|NCT00572455|468765066|FG001|Stage II (28 Days)|Other|0|||
130218773|NCT00572455|468765067|FG002|Stage II (28 Days)|Other|0|||
130218774|NCT00572455|468765068|FG003|Stage II (28 Days)|Other|0|||
130218775|NCT00572455|468765069|FG004|Stage II (28 Days)|Other|0|||
130218776|NCT00572455|468765070|FG005|Stage II (28 Days)|Other|0|||
130218777|NCT00572455|468765071|FG006|Stage II (28 Days)|Other|0|||
130218778|NCT00572455|468765072|FG007|Stage II (28 Days)|Other|0|||
130218779|NCT00572455|468765073|FG008|Stage II (28 Days)|Other|1|||
130218780|NCT00572455|468765074|FG009|Stage II (28 Days)|Other|0|||
130218781|NCT00572455|468765075|FG010|Stage II (28 Days)|Other|0|||
130218782|NCT00572455|468765076|FG011|Stage II (28 Days)|Other|0|||
130218783|NCT00572455|468765077|FG012|Stage II (28 Days)|Other|0|||
130218784|NCT00572455|468765078|FG013|Stage II (28 Days)|Other|0|||
130218785|NCT00572455|468765065|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
130218786|NCT00572455|468765066|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
130218787|NCT00572455|468765067|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
130218788|NCT00572455|468765068|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
130218789|NCT00572455|468765069|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
130218790|NCT00572455|468765070|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
130218791|NCT00572455|468765071|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
130685919|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130218792|NCT00572455|468765072|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
130218793|NCT00572455|468765073|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
130218794|NCT00572455|468765074|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
130218795|NCT00572455|468765075|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
130218796|NCT00572455|468765076|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
130218797|NCT00572455|468765077|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
130218798|NCT00572455|468765078|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
130218799|NCT02821416|468765081|FG000|Overall Study|Adverse Event|0|||
130218800|NCT02821416|468765082|FG001|Overall Study|Adverse Event|1|||
130218801|NCT02821416|468765081|FG000|Overall Study|Withdrawal by Subject|2|||
130218802|NCT02821416|468765082|FG001|Overall Study|Withdrawal by Subject|0|||
130218803|NCT02821416|468765081|FG000|Overall Study|Lost to Follow-up|1|||
130218804|NCT02821416|468765082|FG001|Overall Study|Lost to Follow-up|0|||
130218805|NCT04152083|468765083|FG000|Overall Study|Lost to Follow-up|2|||
130218806|NCT04152083|468765084|FG001|Overall Study|Lost to Follow-up|1|||
130218807|NCT04152083|468765083|FG000|Overall Study|Adverse Event|1|||
130218808|NCT04152083|468765084|FG001|Overall Study|Adverse Event|0|||
130218809|NCT04152083|468765083|FG000|Overall Study|Randomized but not treated|3|||
130218810|NCT04152083|468765084|FG001|Overall Study|Randomized but not treated|2|||
130218811|NCT00856999|468765085|FG000|Overall Study|Withdrawal by Subject|5|||
130218812|NCT00872521|468765086|FG000|Completed PAD Induction|Patient choice|0|||
130218813|NCT00872521|468765087|FG001|Completed PAD Induction|Patient choice|1|||
130218814|NCT00872521|468765088|FG002|Completed PAD Induction|Patient choice|0|||
130218815|NCT00872521|468765086|FG000|Completed PAD Induction|Disease progression|0|||
130218816|NCT00872521|468765087|FG001|Completed PAD Induction|Disease progression|2|||
130218817|NCT00872521|468765088|FG002|Completed PAD Induction|Disease progression|0|||
130218818|NCT00872521|468765086|FG000|Completed PAD Induction|Adverse Event|4|||
130218819|NCT00872521|468765087|FG001|Completed PAD Induction|Adverse Event|0|||
130218820|NCT00872521|468765088|FG002|Completed PAD Induction|Adverse Event|0|||
130218821|NCT00872521|468765086|FG000|Completed PAD Induction|Death|1|||
130218822|NCT00872521|468765087|FG001|Completed PAD Induction|Death|1|||
130218823|NCT00872521|468765088|FG002|Completed PAD Induction|Death|0|||
130218824|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Other|1|||
130218825|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Other|2|||
130218826|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Other|0|||
130218827|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Patient choice|0|||
130218828|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Patient choice|1|||
130218829|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Patient choice|0|||
130218830|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130218831|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
130352038|NCT01343901|469259141|FG000|Overall Study|Death|85|||
130352039|NCT01343901|469259141|FG000|Overall Study|Physician Decision|4|||
130352040|NCT01343901|469259141|FG000|Overall Study|Lost to Follow-up|12|||
130352041|NCT01343901|469259141|FG000|Overall Study|Management by another medical team|11|||
130352042|NCT01343901|469259141|FG000|Overall Study|Participant decision|1|||
130352043|NCT02810340|469259142|FG000|Overall Study|Withdrawal by Subject|1|||
130352044|NCT02810340|469259143|FG001|Overall Study|Withdrawal by Subject|0|||
130352045|NCT02810340|469259144|FG002|Overall Study|Withdrawal by Subject|0|||
130352046|NCT02810340|469259142|FG000|Overall Study|Incarceration|0|||
130352047|NCT02810340|469259143|FG001|Overall Study|Incarceration|1|||
130352048|NCT02810340|469259144|FG002|Overall Study|Incarceration|0|||
130352049|NCT02810340|469259142|FG000|Overall Study|Lost to Follow-up|0|||
130352050|NCT02810340|469259143|FG001|Overall Study|Lost to Follow-up|0|||
130352051|NCT02810340|469259144|FG002|Overall Study|Lost to Follow-up|1|||
130352052|NCT03945175|469259145|FG000|Overall Study|Did not meet inclusion criteria|31|||
130352053|NCT03945175|469259145|FG000|Overall Study|Withdrew consent|2|||
130352054|NCT03945175|469259145|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
130352055|NCT03945175|469259145|FG000|Overall Study|Early termination during Mydayis treatment|1|||
130352056|NCT00870233|469259146|FG000|Overall Study|Withdrawal by Subject|18|||
130352057|NCT00870233|469259146|FG000|Overall Study|Did not undergo laparotomy|3|||
130352058|NCT00870233|469259146|FG000|Overall Study|Incompatible internet browser|2|||
130352059|NCT00870233|469259146|FG000|Overall Study|Death|1|||
130352060|NCT00378079|469259150|FG000|Overall Study|Lost to Follow-up|6|||
130352061|NCT00378079|469259151|FG001|Overall Study|Lost to Follow-up|1|||
130352062|NCT00378079|469259152|FG002|Overall Study|Lost to Follow-up|0|||
130352063|NCT01233687|469259153|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
130352064|NCT01233687|469259153|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
130352065|NCT01233687|469259153|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
130218832|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130218833|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Patient response missing|0|||
130218834|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Patient response missing|0|||
130352066|NCT03324581|469259157|FG000|Overall Study|Adverse Event|18|||
130352067|NCT03324581|469259158|FG001|Overall Study|Adverse Event|11|||
130352068|NCT03324581|469259159|FG002|Overall Study|Adverse Event|7|||
130352069|NCT03324581|469259157|FG000|Overall Study|Lack of Efficacy|0|||
130352070|NCT03324581|469259158|FG001|Overall Study|Lack of Efficacy|1|||
130352071|NCT03324581|469259159|FG002|Overall Study|Lack of Efficacy|0|||
130352072|NCT03324581|469259157|FG000|Overall Study|Lost to Follow-up|5|||
130352073|NCT03324581|469259158|FG001|Overall Study|Lost to Follow-up|3|||
130352074|NCT03324581|469259159|FG002|Overall Study|Lost to Follow-up|6|||
130439183|NCT00284089|469571526|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
130218835|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Patient response missing|1|||
130352075|NCT03324581|469259157|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
130439184|NCT00284089|469571523|FG000|Multiple Dose Phase|Death|0|||
130218836|NCT00872521|468765086|FG000|Completed 3-month Follow up|Other|0|||
130218837|NCT00872521|468765087|FG001|Completed 3-month Follow up|Other|2|||
130218838|NCT00872521|468765088|FG002|Completed 3-month Follow up|Other|0|||
130218839|NCT00872521|468765086|FG000|Completed 3-month Follow up|Physician Decision|0|||
130218840|NCT00872521|468765087|FG001|Completed 3-month Follow up|Physician Decision|1|||
130218841|NCT00872521|468765088|FG002|Completed 3-month Follow up|Physician Decision|0|||
130218842|NCT00872521|468765086|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
130218843|NCT00872521|468765087|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
130218844|NCT00872521|468765088|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
130218845|NCT04819438|468765089|FG000|Overall Study|Withdrawal by Subject|1|||
130218846|NCT04819438|468765090|FG001|Overall Study|Withdrawal by Subject|0|||
130218847|NCT04819438|468765089|FG000|Overall Study|Adverse Event|0|||
130218848|NCT04819438|468765090|FG001|Overall Study|Adverse Event|1|||
130218849|NCT04819438|468765089|FG000|Overall Study|Protocol Violation|0|||
130218850|NCT04819438|468765090|FG001|Overall Study|Protocol Violation|1|||
130218851|NCT03465709|468765091|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
130218852|NCT03465709|468765091|FG000|Overall Study|Withdrawal by Subject|3|||
130218853|NCT03060291|468765092|FG000|3-month Follow-up|Declined to respond|8|||
130218854|NCT03060291|468765093|FG001|3-month Follow-up|Declined to respond|10|||
130218855|NCT03060291|468765094|FG002|3-month Follow-up|Declined to respond|2|||
130218856|NCT03060291|468765092|FG000|6-month Follow-up|Declined to respond|7|||
130218857|NCT03060291|468765093|FG001|6-month Follow-up|Declined to respond|13|||
130218858|NCT03060291|468765094|FG002|6-month Follow-up|Declined to respond|4|||
130218859|NCT03060291|468765092|FG000|12-month Follow-up|Declined to respond|7|||
130218860|NCT03060291|468765093|FG001|12-month Follow-up|Declined to respond|16|||
130218861|NCT03060291|468765094|FG002|12-month Follow-up|Declined to respond|6|||
130218862|NCT01720524|468765095|FG000|Part A|Insufficient Clinical Response|2|||
130218863|NCT01720524|468765096|FG001|Part A|Insufficient Clinical Response|4|||
130218864|NCT01720524|468765095|FG000|Part A|Adverse Event|2|||
130218865|NCT01720524|468765096|FG001|Part A|Adverse Event|2|||
130218866|NCT01720524|468765095|FG000|Part A|Death|2|||
130218867|NCT01720524|468765096|FG001|Part A|Death|1|||
130218868|NCT01720524|468765095|FG000|Part A|Lost to Follow-up|0|||
130218869|NCT01720524|468765096|FG001|Part A|Lost to Follow-up|1|||
130218870|NCT01720524|468765095|FG000|Part A|Missed 28 day follow-up visit|1|||
130218871|NCT01720524|468765096|FG001|Part A|Missed 28 day follow-up visit|1|||
130218872|NCT01720524|468765095|FG000|Part A|Withdrawal by Subject|0|||
130218873|NCT01720524|468765096|FG001|Part A|Withdrawal by Subject|1|||
130218874|NCT01720524|468765095|FG000|Part A|Other|0|||
130218875|NCT01720524|468765096|FG001|Part A|Other|1|||
130218876|NCT01720524|468765095|FG000|Part A|Lost to Follow-up|0|||
130218877|NCT01720524|468765096|FG001|Part A|Lost to Follow-up|1|||
130218878|NCT01720524|468765095|FG000|Part B|No longer willing to participate in study|1|||
130218879|NCT01720524|468765096|FG001|Part B|No longer willing to participate in study|4|||
130218880|NCT01720524|468765095|FG000|Part B|Other|2|||
130218881|NCT01720524|468765096|FG001|Part B|Other|0|||
130218882|NCT01720524|468765095|FG000|Part B|Lost to Follow-up|2|||
130218883|NCT01720524|468765096|FG001|Part B|Lost to Follow-up|3|||
130218884|NCT01720524|468765095|FG000|Part B|Death|0|||
130218885|NCT01720524|468765096|FG001|Part B|Death|2|||
130218886|NCT02105285|468765102|FG000|Overall Study|Adverse Event|1|||
130218887|NCT02105285|468765103|FG001|Overall Study|Adverse Event|1|||
130218888|NCT02105285|468765104|FG002|Overall Study|Adverse Event|0|||
130218889|NCT02105285|468765102|FG000|Overall Study|Protocol Violation|0|||
130218890|NCT02105285|468765103|FG001|Overall Study|Protocol Violation|1|||
130218891|NCT02105285|468765104|FG002|Overall Study|Protocol Violation|0|||
130218892|NCT02105285|468765102|FG000|Overall Study|Withdrawal by Subject|1|||
130218893|NCT02105285|468765103|FG001|Overall Study|Withdrawal by Subject|0|||
130352076|NCT03324581|469259158|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
130352077|NCT03324581|469259159|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
130352078|NCT03324581|469259157|FG000|Overall Study|Physician Decision|0|||
130352079|NCT03324581|469259158|FG001|Overall Study|Physician Decision|1|||
130352080|NCT03324581|469259159|FG002|Overall Study|Physician Decision|2|||
130352081|NCT03324581|469259157|FG000|Overall Study|Protocol Deviation|8|||
130352082|NCT03324581|469259158|FG001|Overall Study|Protocol Deviation|9|||
130352083|NCT03324581|469259159|FG002|Overall Study|Protocol Deviation|4|||
130352084|NCT03324581|469259157|FG000|Overall Study|Withdrawal by Subject|6|||
130352085|NCT03324581|469259158|FG001|Overall Study|Withdrawal by Subject|8|||
130685920|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130218894|NCT02105285|468765104|FG002|Overall Study|Withdrawal by Subject|0|||
130218895|NCT01421641|468765105|FG000|Overall Study|Protocol Violation|2|||
130218896|NCT01421641|468765106|FG001|Overall Study|Protocol Violation|2|||
130218897|NCT03061188|468765108|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130218898|NCT03061188|468765109|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130218899|NCT03061188|468765110|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130218900|NCT03061188|468765111|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130218901|NCT03061188|468765108|FG000|On Follow-up for 3 Years|Death|0|||
130218902|NCT03061188|468765109|FG001|On Follow-up for 3 Years|Death|3|||
130218903|NCT03061188|468765110|FG002|On Follow-up for 3 Years|Death|5|||
130218904|NCT03061188|468765111|FG003|On Follow-up for 3 Years|Death|4|||
130218905|NCT03061188|468765108|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130352086|NCT03324581|469259159|FG002|Overall Study|Withdrawal by Subject|6|||
130218906|NCT03061188|468765109|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130218907|NCT03061188|468765110|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130218908|NCT03061188|468765111|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
130218909|NCT02609984|468765112|FG000|Overall Study|Death|29|||
130218910|NCT02609984|468765113|FG001|Overall Study|Death|26|||
130218911|NCT02609984|468765112|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
130218912|NCT02609984|468765113|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
130218913|NCT02609984|468765112|FG000|Overall Study|Lost to Follow-up|1|||
130218914|NCT02609984|468765113|FG001|Overall Study|Lost to Follow-up|2|||
130218915|NCT02609984|468765112|FG000|Overall Study|Withdrawal by Subject|0|||
130218916|NCT02609984|468765113|FG001|Overall Study|Withdrawal by Subject|1|||
130218917|NCT02609984|468765112|FG000|Overall Study|Disease Progression|2|||
130218918|NCT02609984|468765113|FG001|Overall Study|Disease Progression|0|||
130218919|NCT02504320|468765114|FG000|Treatment Period 1|Positive Drug Screen|0|||
130218920|NCT02504320|468765115|FG001|Treatment Period 1|Positive Drug Screen|0|||
130218921|NCT02504320|468765116|FG002|Treatment Period 1|Positive Drug Screen|1|||
130218922|NCT02504320|468765117|FG003|Treatment Period 1|Positive Drug Screen|0|||
130218923|NCT02504320|468765114|FG000|Treatment Period 2|Positive Drug Screen|0|||
130218924|NCT02504320|468765115|FG001|Treatment Period 2|Positive Drug Screen|1|||
130218925|NCT02504320|468765116|FG002|Treatment Period 2|Positive Drug Screen|0|||
130218926|NCT02504320|468765117|FG003|Treatment Period 2|Positive Drug Screen|0|||
130218927|NCT02504320|468765114|FG000|Treatment Period 3|Positive Drug Screen|0|||
130218928|NCT02504320|468765115|FG001|Treatment Period 3|Positive Drug Screen|0|||
130218929|NCT02504320|468765116|FG002|Treatment Period 3|Positive Drug Screen|0|||
130218930|NCT02504320|468765117|FG003|Treatment Period 3|Positive Drug Screen|1|||
130218931|NCT02504320|468765114|FG000|Treatment Period 3|Adverse Event|0|||
130218932|NCT02504320|468765115|FG001|Treatment Period 3|Adverse Event|0|||
130218933|NCT02504320|468765116|FG002|Treatment Period 3|Adverse Event|1|||
130218934|NCT02504320|468765117|FG003|Treatment Period 3|Adverse Event|0|||
130218935|NCT01210222|468765118|FG000|Overall Study|Ineligible|2|||
130218936|NCT01210222|468765118|FG000|Overall Study|Never treated|1|||
130218937|NCT03293394|468765119|FG000|Follow-up (6 Months)|Adverse Event|4|||
130218938|NCT03293394|468765120|FG001|Follow-up (6 Months)|Adverse Event|2|||
130218939|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Adverse Event|2|||
130218940|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Adverse Event|0|||
130218941|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Adverse Event|0|||
130218942|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Adverse Event|0|||
130218943|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Adverse Event|0|||
130352087|NCT03324581|469259157|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
130218944|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Adverse Event|0|||
130352088|NCT03324581|469259158|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
130352089|NCT03324581|469259159|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
130352090|NCT02274038|469259160|FG000|Overall Study|Death|1|||
130352091|NCT03783702|469259161|FG000|Overall Study|Lost to Follow-up|6|||
130352092|NCT03783702|469259162|FG001|Overall Study|Lost to Follow-up|8|||
130352093|NCT03783702|469259161|FG000|Overall Study|Protocol Violation|1|||
130352094|NCT03783702|469259162|FG001|Overall Study|Protocol Violation|3|||
130352095|NCT04473482|469259163|FG000|Overall Study|Death|0|||
130352096|NCT04473482|469259164|FG001|Overall Study|Death|3|||
130352097|NCT04473482|469259163|FG000|Overall Study|Lost to Follow-up|9|||
130352098|NCT04473482|469259164|FG001|Overall Study|Lost to Follow-up|7|||
130352099|NCT04473482|469259163|FG000|Overall Study|Withdrawal by Subject|2|||
130352100|NCT04473482|469259164|FG001|Overall Study|Withdrawal by Subject|1|||
130352101|NCT01306877|469259165|FG000|Overall Study|Lost to Follow-up|3|||
130352102|NCT01306877|469259166|FG001|Overall Study|Lost to Follow-up|3|||
130352103|NCT01306877|469259165|FG000|Overall Study|Physician Decision|0|||
130352104|NCT01306877|469259166|FG001|Overall Study|Physician Decision|1|||
130352105|NCT00006389|469259167|FG000|Overall Study|Adverse Event|1|||
130352106|NCT01076075|469259173|FG000|Overall Study|Adverse Event|3|||
130352107|NCT01076075|469259174|FG001|Overall Study|Adverse Event|9|||
130352108|NCT01076075|469259173|FG000|Overall Study|Lack of Efficacy|5|||
130218945|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
130218946|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
130218947|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
130218948|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
130352109|NCT01076075|469259174|FG001|Overall Study|Lack of Efficacy|4|||
130352110|NCT01076075|469259173|FG000|Overall Study|Lost to Follow-up|6|||
130352111|NCT01076075|469259174|FG001|Overall Study|Lost to Follow-up|5|||
130218949|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
130685921|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130218950|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
130218951|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Other|10|||
130352112|NCT01076075|469259173|FG000|Overall Study|other|19|||
130352113|NCT01076075|469259174|FG001|Overall Study|other|9|||
130352114|NCT01076075|469259173|FG000|Overall Study|Protocol Violation|0|||
130352115|NCT01076075|469259174|FG001|Overall Study|Protocol Violation|1|||
130352116|NCT01076075|469259173|FG000|Overall Study|Withdrawal by Subject|8|||
130439185|NCT00284089|469571524|FG001|Multiple Dose Phase|Death|0|||
130439186|NCT00284089|469571525|FG002|Multiple Dose Phase|Death|1|||
130439187|NCT00284089|469571526|FG003|Multiple Dose Phase|Death|1|||
130439188|NCT00284089|469571523|FG000|Extension Phase|Adverse Event|0|||
130439189|NCT00284089|469571524|FG001|Extension Phase|Adverse Event|0|||
130439190|NCT00284089|469571525|FG002|Extension Phase|Adverse Event|2|||
130439191|NCT00284089|469571526|FG003|Extension Phase|Adverse Event|2|||
130439192|NCT00284089|469571523|FG000|Extension Phase|condition no longer requires study drug|2|||
130439193|NCT00284089|469571524|FG001|Extension Phase|condition no longer requires study drug|0|||
130439194|NCT00284089|469571525|FG002|Extension Phase|condition no longer requires study drug|2|||
130685922|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685923|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685924|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
130685925|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
130685926|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130685927|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130439195|NCT00284089|469571526|FG003|Extension Phase|condition no longer requires study drug|7|||
130439196|NCT00284089|469571523|FG000|Extension Phase|Protocol Violation|0|||
130439197|NCT00284089|469571524|FG001|Extension Phase|Protocol Violation|0|||
130439198|NCT00284089|469571525|FG002|Extension Phase|Protocol Violation|1|||
130439199|NCT00284089|469571526|FG003|Extension Phase|Protocol Violation|0|||
130439200|NCT00284089|469571523|FG000|Extension Phase|Withdrawal by Subject|0|||
130439201|NCT00284089|469571524|FG001|Extension Phase|Withdrawal by Subject|0|||
130439202|NCT00284089|469571525|FG002|Extension Phase|Withdrawal by Subject|1|||
130439203|NCT00284089|469571526|FG003|Extension Phase|Withdrawal by Subject|3|||
130439204|NCT04362137|469571529|FG000|Overall Study|Death|9|||
130439205|NCT04362137|469571530|FG001|Overall Study|Death|3|||
130439206|NCT04362137|469571529|FG000|Overall Study|Patient decision|6|||
130439207|NCT04362137|469571530|FG001|Overall Study|Patient decision|3|||
130439208|NCT04362137|469571529|FG000|Overall Study|Adverse Event|1|||
130439209|NCT04362137|469571530|FG001|Overall Study|Adverse Event|0|||
130439210|NCT04362137|469571529|FG000|Overall Study|Lost to Follow-up|1|||
130439211|NCT04362137|469571530|FG001|Overall Study|Lost to Follow-up|0|||
130439212|NCT04362137|469571529|FG000|Overall Study|Protocol deviation|1|||
130439213|NCT04362137|469571530|FG001|Overall Study|Protocol deviation|0|||
130439214|NCT03306043|469571534|FG000|Overall Study|Adverse Event|1|||
130439215|NCT03306043|469571534|FG000|Overall Study|Lost to Follow-up|1|||
130439216|NCT03306043|469571534|FG000|Overall Study|Withdrawal by Subject|2|||
130439217|NCT00785538|469571535|FG000|Treatment Period|Adverse Event|1|||
130439218|NCT00785538|469571536|FG001|Treatment Period|Adverse Event|2|||
130439219|NCT00785538|469571537|FG002|Treatment Period|Adverse Event|2|||
130439220|NCT00785538|469571538|FG003|Treatment Period|Adverse Event|0|||
130439221|NCT00785538|469571535|FG000|Treatment Period|Withdrawal by Subject|0|||
130439222|NCT00785538|469571536|FG001|Treatment Period|Withdrawal by Subject|0|||
130439223|NCT00785538|469571537|FG002|Treatment Period|Withdrawal by Subject|0|||
130439224|NCT00785538|469571538|FG003|Treatment Period|Withdrawal by Subject|1|||
130439225|NCT04276090|469571539|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
130439226|NCT04276090|469571540|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
130685928|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130218952|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Other|11|||
130439227|NCT01799720|469571541|FG000|Overall Study|Withdrawal by Subject|3|||
130439228|NCT01799720|469571542|FG001|Overall Study|Withdrawal by Subject|0|||
130439229|NCT01799720|469571543|FG002|Overall Study|Withdrawal by Subject|0|||
130439230|NCT01799720|469571541|FG000|Overall Study|Protocol Violation|0|||
130439231|NCT01799720|469571542|FG001|Overall Study|Protocol Violation|1|||
130439232|NCT01799720|469571543|FG002|Overall Study|Protocol Violation|0|||
130439233|NCT01799720|469571541|FG000|Overall Study|Pregnancy|0|||
130439234|NCT01799720|469571542|FG001|Overall Study|Pregnancy|0|||
130439235|NCT01799720|469571543|FG002|Overall Study|Pregnancy|1|||
130439236|NCT01234649|469571544|FG000|Overall Study|Withdrawal by Subject|32|||
130439237|NCT01234649|469571545|FG001|Overall Study|Withdrawal by Subject|26|||
130439238|NCT01234649|469571544|FG000|Overall Study|Pregnancy|6|||
130439239|NCT01234649|469571545|FG001|Overall Study|Pregnancy|6|||
130439240|NCT01234649|469571544|FG000|Overall Study|intolerant to side effects|4|||
130439241|NCT01234649|469571545|FG001|Overall Study|intolerant to side effects|3|||
130439242|NCT01234649|469571544|FG000|Overall Study|Allergic reaction|1|||
130439243|NCT01234649|469571545|FG001|Overall Study|Allergic reaction|0|||
130439244|NCT01234649|469571544|FG000|Overall Study|Lack of Efficacy|0|||
130439245|NCT01234649|469571545|FG001|Overall Study|Lack of Efficacy|3|||
130439246|NCT00318149|469571548|FG000|Overall Study|Adverse Event|0|||
130439247|NCT00318149|469571549|FG001|Overall Study|Adverse Event|0|||
130439248|NCT00318149|469571550|FG002|Overall Study|Adverse Event|0|||
130439249|NCT00318149|469571551|FG003|Overall Study|Adverse Event|0|||
130439250|NCT00318149|469571552|FG004|Overall Study|Adverse Event|0|||
130439251|NCT00318149|469571553|FG005|Overall Study|Adverse Event|2|||
130439252|NCT00785707|469571559|FG000|Overall Study|Lost to Follow-up|7|||
130218953|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Other|0|||
130218954|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Other|0|||
130218955|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Other|0|||
130218956|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Other|0|||
130218957|NCT00436826|468765123|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218958|NCT00436826|468765124|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218959|NCT00436826|468765125|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218960|NCT00436826|468765126|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
130218961|NCT00436826|468765127|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218962|NCT00436826|468765128|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218963|NCT00436826|468765123|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218964|NCT00436826|468765124|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218965|NCT00436826|468765125|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
130218966|NCT00436826|468765126|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
130218967|NCT00436826|468765127|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218968|NCT00436826|468765128|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218969|NCT00436826|468765123|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218970|NCT00436826|468765124|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218971|NCT00436826|468765125|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218972|NCT00436826|468765126|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218973|NCT00436826|468765127|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
130218974|NCT00436826|468765128|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
130218975|NCT04978337|468765129|FG000|Overall Study|Withdrawal by Subject|0|||
130218976|NCT04978337|468765130|FG001|Overall Study|Withdrawal by Subject|1|||
130218977|NCT01436227|468765132|FG000|Overall Study|Adverse Event|7|||
130218978|NCT01436227|468765132|FG000|Overall Study|Death|1|||
130218979|NCT01436227|468765132|FG000|Overall Study|Lack of Efficacy|1|||
130218980|NCT01436227|468765132|FG000|Overall Study|Lost to Follow-up|3|||
130218981|NCT01436227|468765132|FG000|Overall Study|Physician Decision|1|||
130218982|NCT01436227|468765132|FG000|Overall Study|Withdrawal by Subject|7|||
130218983|NCT01436227|468765132|FG000|Overall Study|Disease progression, relapse|6|||
130218984|NCT00869128|468765138|FG000|Overall Study|lack of Compliance|6|||
130218985|NCT00869128|468765139|FG001|Overall Study|lack of Compliance|6|||
130218986|NCT02282163|468765151|FG000|Overall Study|Protocol Violation|1|||
130218987|NCT01603407|468765152|FG000|Overall Study|Adverse Event|1|||
130218988|NCT01603407|468765153|FG001|Overall Study|Adverse Event|1|||
130218989|NCT01603407|468765154|FG002|Overall Study|Adverse Event|1|||
130218990|NCT01603407|468765152|FG000|Overall Study|Protocol Violation|2|||
130218991|NCT01603407|468765153|FG001|Overall Study|Protocol Violation|2|||
130218992|NCT01603407|468765154|FG002|Overall Study|Protocol Violation|0|||
130218993|NCT01603407|468765152|FG000|Overall Study|Withdrawal by Subject|8|||
130218994|NCT01603407|468765153|FG001|Overall Study|Withdrawal by Subject|5|||
130218995|NCT01603407|468765154|FG002|Overall Study|Withdrawal by Subject|7|||
130218996|NCT01603407|468765152|FG000|Overall Study|Lost to Follow-up|0|||
130218997|NCT01603407|468765153|FG001|Overall Study|Lost to Follow-up|3|||
130218998|NCT01603407|468765154|FG002|Overall Study|Lost to Follow-up|2|||
130218999|NCT02500719|468765155|FG000|Overall Study|Lost to Follow-up|2|||
130219000|NCT02500719|468765156|FG001|Overall Study|Lost to Follow-up|3|||
130219001|NCT02500719|468765155|FG000|Overall Study|Trauma history|1|||
130219002|NCT02500719|468765156|FG001|Overall Study|Trauma history|0|||
130219003|NCT02500719|468765155|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
130219004|NCT02500719|468765156|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
130219005|NCT02500719|468765155|FG000|Overall Study|Did not meet criteria for PTSD|0|||
130219006|NCT02500719|468765156|FG001|Overall Study|Did not meet criteria for PTSD|1|||
130219007|NCT02500719|468765155|FG000|Overall Study|Claustrophobia|0|||
130219008|NCT02500719|468765156|FG001|Overall Study|Claustrophobia|1|||
130219009|NCT02500719|468765155|FG000|Overall Study|History of head trauma|0|||
130219010|NCT02500719|468765156|FG001|Overall Study|History of head trauma|1|||
130219011|NCT01990768|468765157|FG000|Intervention Started|Found to be ineligible|14|||
130219012|NCT01990768|468765158|FG001|Intervention Started|Found to be ineligible|13|||
130219013|NCT01990768|468765159|FG002|Intervention Started|Found to be ineligible|11|||
130219014|NCT01990768|468765157|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
130219015|NCT01990768|468765158|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
130219016|NCT01990768|468765159|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
130219017|NCT01990768|468765157|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
130219018|NCT01990768|468765158|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
130219019|NCT01990768|468765159|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
130352117|NCT01076075|469259174|FG001|Overall Study|Withdrawal by Subject|19|||
130352118|NCT01445886|469259177|FG000|Overall Study|Lost to Follow-up|2|||
130352119|NCT01445886|469259177|FG000|Overall Study|Protocol Violation|3|||
130219020|NCT01990768|468765157|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
130219021|NCT01990768|468765158|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
130685929|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130219022|NCT01990768|468765159|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
130219023|NCT01990768|468765157|FG000|Intervention Started|Patient care priority|1|||
130219024|NCT01990768|468765158|FG001|Intervention Started|Patient care priority|2|||
130219025|NCT01990768|468765159|FG002|Intervention Started|Patient care priority|3|||
130219026|NCT01990768|468765157|FG000|Intervention Started|IV lost|2|||
130219027|NCT01990768|468765158|FG001|Intervention Started|IV lost|2|||
130219028|NCT01990768|468765159|FG002|Intervention Started|IV lost|2|||
130219029|NCT01990768|468765157|FG000|Intervention Started|Required CPR|1|||
130219030|NCT01990768|468765158|FG001|Intervention Started|Required CPR|1|||
130219031|NCT01990768|468765159|FG002|Intervention Started|Required CPR|0|||
130219032|NCT01990768|468765157|FG000|Intervention Started|Seizure or hx of seizure|0|||
130219033|NCT01990768|468765158|FG001|Intervention Started|Seizure or hx of seizure|0|||
130219034|NCT01990768|468765159|FG002|Intervention Started|Seizure or hx of seizure|2|||
130219035|NCT01990768|468765157|FG000|Intervention Started|Discovered to be pregnant|0|||
130219036|NCT01990768|468765158|FG001|Intervention Started|Discovered to be pregnant|1|||
130219037|NCT01990768|468765159|FG002|Intervention Started|Discovered to be pregnant|0|||
130219038|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
130219039|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
130219040|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
130219041|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130219042|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
130219043|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130219044|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
130219045|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
130219046|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
130219047|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
130219048|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
130219049|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
130219050|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Death|3|||
130219051|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Death|1|||
130219052|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Death|1|||
130219053|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Discharged|2|||
130219054|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Discharged|1|||
130219055|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Discharged|0|||
130219056|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
130219057|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130219058|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130219059|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130219060|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130219061|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
130219062|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
130219063|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
130219064|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
130219065|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
130219066|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
130352120|NCT00995865|469259180|FG000|Overall Study|Protocol Violation|2|||
130352121|NCT00995865|469259181|FG001|Overall Study|Protocol Violation|0|||
130352122|NCT00995865|469259182|FG002|Overall Study|Protocol Violation|0|||
130352123|NCT00995865|469259180|FG000|Overall Study|Lost to Follow-up|0|||
130352124|NCT00995865|469259181|FG001|Overall Study|Lost to Follow-up|0|||
130352125|NCT00995865|469259182|FG002|Overall Study|Lost to Follow-up|1|||
130352126|NCT05080660|469259183|FG000|Overall Study|Adverse Event|4|||
130352127|NCT05080660|469259184|FG001|Overall Study|Adverse Event|0|||
130352128|NCT05080660|469259183|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
130352129|NCT05080660|469259184|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
130352130|NCT05080660|469259183|FG000|Overall Study|Physician Decision|1|||
130352131|NCT05080660|469259184|FG001|Overall Study|Physician Decision|0|||
130352132|NCT05080660|469259183|FG000|Overall Study|Protocol Deviation|2|||
130352133|NCT05080660|469259184|FG001|Overall Study|Protocol Deviation|0|||
130352134|NCT05080660|469259183|FG000|Overall Study|Withdrawal by Subject|5|||
130352135|NCT05080660|469259184|FG001|Overall Study|Withdrawal by Subject|2|||
130352136|NCT00719264|469260971|FG000|Overall Study|Adverse Event|41|||
130352137|NCT00719264|469260972|FG001|Overall Study|Adverse Event|49|||
130352138|NCT00719264|469260971|FG000|Overall Study|Death|13|||
130352139|NCT00719264|469260972|FG001|Overall Study|Death|10|||
130352140|NCT00719264|469260971|FG000|Overall Study|Administrative Problems|6|||
130352141|NCT00719264|469260972|FG001|Overall Study|Administrative Problems|4|||
130352142|NCT00719264|469260971|FG000|Overall Study|Lost to Follow-up|1|||
130352143|NCT00719264|469260972|FG001|Overall Study|Lost to Follow-up|1|||
130352144|NCT00719264|469260971|FG000|Overall Study|Withdrawal by Subject|12|||
130352145|NCT00719264|469260972|FG001|Overall Study|Withdrawal by Subject|7|||
130352146|NCT00719264|469260971|FG000|Overall Study|Protocol Deviation|1|||
130352147|NCT00719264|469260972|FG001|Overall Study|Protocol Deviation|3|||
130352148|NCT00719264|469260971|FG000|Overall Study|New Cancer Therapy|4|||
130352149|NCT00719264|469260972|FG001|Overall Study|New Cancer Therapy|2|||
130352150|NCT00719264|469260971|FG000|Overall Study|Disease Progression|104|||
130352151|NCT00719264|469260972|FG001|Overall Study|Disease Progression|107|||
130352152|NCT02278341|469260974|FG000|Overall Study|Randomized but never received study drug|1|||
130352153|NCT02278341|469260975|FG001|Overall Study|Randomized but never received study drug|1|||
130352154|NCT02278341|469260974|FG000|Overall Study|Adverse Event|3|||
130352155|NCT02278341|469260975|FG001|Overall Study|Adverse Event|0|||
130352156|NCT02278341|469260974|FG000|Overall Study|Death|68|||
130352157|NCT02278341|469260975|FG001|Overall Study|Death|56|||
130352158|NCT02278341|469260974|FG000|Overall Study|Withdrawal by Subject|30|||
130352159|NCT02278341|469260975|FG001|Overall Study|Withdrawal by Subject|19|||
130352160|NCT02278341|469260974|FG000|Overall Study|Lost to Follow-up|0|||
130352161|NCT02278341|469260975|FG001|Overall Study|Lost to Follow-up|1|||
130352162|NCT02278341|469260974|FG000|Overall Study|Physician Decision|1|||
130352163|NCT02278341|469260975|FG001|Overall Study|Physician Decision|1|||
130352164|NCT02278341|469260974|FG000|Overall Study|Miscellaneous|15|||
130352165|NCT02278341|469260975|FG001|Overall Study|Miscellaneous|14|||
130352166|NCT04902326|469260976|FG000|Overall Study|Withdrawal by Subject|1|||
130352167|NCT04902326|469260977|FG001|Overall Study|Withdrawal by Subject|3|||
130352168|NCT04902326|469260978|FG002|Overall Study|Withdrawal by Subject|0|||
130352169|NCT04902326|469260979|FG003|Overall Study|Withdrawal by Subject|1|||
130352170|NCT04902326|469260976|FG000|Overall Study|Lost to Follow-up|14|||
130352171|NCT04902326|469260977|FG001|Overall Study|Lost to Follow-up|14|||
130352172|NCT04902326|469260978|FG002|Overall Study|Lost to Follow-up|14|||
130352173|NCT04902326|469260979|FG003|Overall Study|Lost to Follow-up|6|||
130352174|NCT02604017|469260980|FG000|Overall Study|Withdrew Consent|0|||
130352175|NCT02604017|469260981|FG001|Overall Study|Withdrew Consent|2|||
130352176|NCT02604017|469260980|FG000|Overall Study|Lost to Follow-up|5|||
130352177|NCT02604017|469260981|FG001|Overall Study|Lost to Follow-up|6|||
130352178|NCT02604017|469260980|FG000|Overall Study|Other|1|||
130352179|NCT02604017|469260981|FG001|Overall Study|Other|0|||
130352180|NCT00740246|469260982|FG000|Overall Study|Received Blood Transfusion|0|||
130352181|NCT00740246|469260983|FG001|Overall Study|Received Blood Transfusion|1|||
130352182|NCT00740246|469260982|FG000|Overall Study|Adverse Event|1|||
130352183|NCT00740246|469260983|FG001|Overall Study|Adverse Event|2|||
130352184|NCT00740246|469260982|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
130352185|NCT00740246|469260983|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
130352186|NCT00740246|469260982|FG000|Overall Study|Lost to Follow-up|2|||
130352187|NCT00740246|469260983|FG001|Overall Study|Lost to Follow-up|2|||
130352188|NCT00740246|469260982|FG000|Overall Study|Withdrawal by Subject|4|||
130352189|NCT00740246|469260983|FG001|Overall Study|Withdrawal by Subject|3|||
130352190|NCT00740246|469260982|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
130352191|NCT00740246|469260983|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
130352192|NCT00740246|469260982|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
130352193|NCT00740246|469260983|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
130352194|NCT00740246|469260982|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
130352195|NCT00740246|469260983|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
130352196|NCT00740246|469260982|FG000|Overall Study|Unable To Comply With Study Visits|2|||
130352197|NCT00740246|469260983|FG001|Overall Study|Unable To Comply With Study Visits|0|||
130352198|NCT00740246|469260982|FG000|Overall Study|Unable to Access Vein|0|||
130352199|NCT00740246|469260983|FG001|Overall Study|Unable to Access Vein|2|||
130352200|NCT00740246|469260982|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
130352201|NCT00740246|469260983|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
130352202|NCT01117051|469260984|FG000|Overall Study|Withdrawal by Subject|5|||
130352203|NCT01117051|469260985|FG001|Overall Study|Withdrawal by Subject|3|||
130352204|NCT01117051|469260984|FG000|Overall Study|Adverse Event|4|||
130352205|NCT01117051|469260985|FG001|Overall Study|Adverse Event|3|||
130352206|NCT01117051|469260984|FG000|Overall Study|Lost to Follow-up|0|||
130352207|NCT01117051|469260985|FG001|Overall Study|Lost to Follow-up|1|||
130352208|NCT01117051|469260984|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
130352209|NCT01117051|469260985|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
130352210|NCT01117051|469260984|FG000|Overall Study|Sponsor's decision|3|||
130352211|NCT01117051|469260985|FG001|Overall Study|Sponsor's decision|1|||
130352212|NCT01117051|469260984|FG000|Overall Study|Surgical procedure|0|||
130352213|NCT01117051|469260985|FG001|Overall Study|Surgical procedure|1|||
130352214|NCT01117051|469260984|FG000|Overall Study|Randomized by mistake|0|||
130352215|NCT01117051|469260985|FG001|Overall Study|Randomized by mistake|1|||
130352216|NCT01117051|469260984|FG000|Overall Study|Convenience issue|1|||
130352217|NCT01117051|469260985|FG001|Overall Study|Convenience issue|0|||
130352218|NCT00366340|469260986|FG000|Infant Series|Protocol Violation|3|||
130219067|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
130219068|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
130219069|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
130219070|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
130219071|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
130219072|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
130219073|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
130219074|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
130352219|NCT00366340|469260987|FG001|Infant Series|Protocol Violation|4|||
130352220|NCT00366340|469260986|FG000|Infant Series|Withdrawal by Subject|3|||
130352221|NCT00366340|469260987|FG001|Infant Series|Withdrawal by Subject|3|||
130352222|NCT00366340|469260986|FG000|Infant Series|Adverse Event|0|||
130352223|NCT00366340|469260987|FG001|Infant Series|Adverse Event|2|||
130352224|NCT00366340|469260986|FG000|Infant Series|Lost to Follow-up|1|||
130352225|NCT00366340|469260987|FG001|Infant Series|Lost to Follow-up|1|||
130352226|NCT00366340|469260986|FG000|Infant Series|Failure to return|1|||
130352227|NCT00366340|469260987|FG001|Infant Series|Failure to return|0|||
130352228|NCT00366340|469260986|FG000|After the Infant Series|Parent/legal guardian request|1|||
130352229|NCT00366340|469260987|FG001|After the Infant Series|Parent/legal guardian request|1|||
130352230|NCT00366340|469260986|FG000|After the Infant Series|Failed to return|0|||
130352231|NCT00366340|469260987|FG001|After the Infant Series|Failed to return|1|||
130352232|NCT00366340|469260986|FG000|After the Infant Series|Protocol Violation|2|||
130352233|NCT00366340|469260987|FG001|After the Infant Series|Protocol Violation|2|||
130352234|NCT00366340|469260986|FG000|After the Infant Series|Adverse Event|0|||
130352235|NCT00366340|469260987|FG001|After the Infant Series|Adverse Event|1|||
130352236|NCT00366340|469260986|FG000|After the Infant Series|Lost to Follow-up|0|||
130352237|NCT00366340|469260987|FG001|After the Infant Series|Lost to Follow-up|1|||
130352238|NCT00366340|469260986|FG000|Toddler Dose|Failed to return|1|||
130352239|NCT00366340|469260987|FG001|Toddler Dose|Failed to return|0|||
130352240|NCT00366340|469260986|FG000|Toddler Dose|Parent/legal guardian request|0|||
130352241|NCT00366340|469260987|FG001|Toddler Dose|Parent/legal guardian request|1|||
130352242|NCT01315236|469260991|FG000|Double-blind Phase|Death|1|||
130352243|NCT01315236|469260992|FG001|Double-blind Phase|Death|0|||
130352244|NCT01315236|469260991|FG000|Double-blind Phase|Adverse Event|1|||
130352245|NCT01315236|469260992|FG001|Double-blind Phase|Adverse Event|0|||
130352246|NCT01315236|469260991|FG000|Double-blind Phase|Withdrawal of Consent|1|||
130352247|NCT01315236|469260992|FG001|Double-blind Phase|Withdrawal of Consent|0|||
130352248|NCT01315236|469260991|FG000|Double-blind Phase|Lost to Follow-up|1|||
130352249|NCT01315236|469260992|FG001|Double-blind Phase|Lost to Follow-up|0|||
130352250|NCT01315236|469260991|FG000|Open-label Phase|Death|1|||
130352251|NCT01315236|469260992|FG001|Open-label Phase|Death|0|||
130352252|NCT01315236|469260991|FG000|Open-label Phase|Adverse Event|0|||
130352253|NCT01315236|469260992|FG001|Open-label Phase|Adverse Event|1|||
130352254|NCT01315236|469260991|FG000|Open-label Phase|Other|0|||
130352255|NCT01315236|469260992|FG001|Open-label Phase|Other|1|||
130352256|NCT01315236|469260991|FG000|12-Month Follow-up Period|Death|0|||
130352257|NCT01315236|469260992|FG001|12-Month Follow-up Period|Death|1|||
130352258|NCT01315236|469260991|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
130352259|NCT01315236|469260992|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
130352260|NCT00442468|469260993|FG000|Overall Study|Adverse Event|4|||
130352261|NCT00442468|469260993|FG000|Overall Study|Withdrawal by Subject|91|||
130352262|NCT00442468|469260993|FG000|Overall Study|Did not complete all study procedures|88|||
130352263|NCT00589784|469260996|FG000|Overall Study|Withdrawal by Subject|0|||
130352264|NCT00589784|469260997|FG001|Overall Study|Withdrawal by Subject|6|||
130352265|NCT00589784|469260996|FG000|Overall Study|Patient inevaluable|1|||
130352266|NCT00589784|469260997|FG001|Overall Study|Patient inevaluable|0|||
130352267|NCT00589784|469260996|FG000|Overall Study|Adverse Event|0|||
130352268|NCT00589784|469260997|FG001|Overall Study|Adverse Event|4|||
130352269|NCT00521001|469260999|FG000|Overall Study|Ineligible|1|||
130352270|NCT02821910|469261000|FG000|Overall Study|Withdrawal by Subject|0|||
130352271|NCT02821910|469261001|FG001|Overall Study|Withdrawal by Subject|0|||
130352272|NCT02821910|469261002|FG002|Overall Study|Withdrawal by Subject|1|||
130352273|NCT02821910|469261003|FG003|Overall Study|Withdrawal by Subject|0|||
130352274|NCT02821910|469261004|FG004|Overall Study|Withdrawal by Subject|0|||
130352275|NCT02821910|469261005|FG005|Overall Study|Withdrawal by Subject|1|||
130352276|NCT02821910|469261000|FG000|Overall Study|Other than specified|1|||
130219075|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
130352277|NCT02821910|469261001|FG001|Overall Study|Other than specified|0|||
130352278|NCT02821910|469261002|FG002|Overall Study|Other than specified|1|||
130352279|NCT02821910|469261003|FG003|Overall Study|Other than specified|0|||
130352280|NCT02821910|469261004|FG004|Overall Study|Other than specified|0|||
130352281|NCT02821910|469261005|FG005|Overall Study|Other than specified|0|||
130352282|NCT01289782|469261006|FG000|Overall Study|Lost to Follow-up|14|||
130352283|NCT01289782|469261007|FG001|Overall Study|Lost to Follow-up|7|||
130352284|NCT01289782|469261006|FG000|Overall Study|Protocol Violation|1|||
130352285|NCT01289782|469261007|FG001|Overall Study|Protocol Violation|1|||
130219076|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
130219077|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
130219078|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
130219079|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
130219080|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
130219081|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
130219082|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
130219083|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130219084|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130219085|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
130219086|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
130219087|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
130219088|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
130219089|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
130219090|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
130219091|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
130219092|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
130219093|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
130219094|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
130219095|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219096|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219097|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219098|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130219099|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130219100|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
130219101|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
130219102|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
130219103|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
130219104|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130219105|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130219106|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
130219107|NCT01990768|468765157|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
130219108|NCT01990768|468765158|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
130219109|NCT01990768|468765159|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
130219110|NCT01990768|468765157|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
130219111|NCT01990768|468765158|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
130219112|NCT01990768|468765159|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
130219113|NCT01990768|468765157|FG000|6-Month Follow-up|No contact information|5|||
130219114|NCT01990768|468765158|FG001|6-Month Follow-up|No contact information|6|||
130219115|NCT01990768|468765159|FG002|6-Month Follow-up|No contact information|5|||
130219116|NCT01990768|468765157|FG000|6-Month Follow-up|Homeless|4|||
130219117|NCT01990768|468765158|FG001|6-Month Follow-up|Homeless|3|||
130219118|NCT01990768|468765159|FG002|6-Month Follow-up|Homeless|6|||
130219119|NCT01990768|468765157|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
130219120|NCT01990768|468765158|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
130219121|NCT01990768|468765159|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
130219122|NCT01990768|468765157|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
130219123|NCT01990768|468765158|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
130219124|NCT01990768|468765159|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
130219125|NCT01990768|468765157|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
130219126|NCT01990768|468765158|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
130219127|NCT01990768|468765159|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
130219128|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
130219129|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219130|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219131|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219132|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
130219133|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130352286|NCT01289782|469261006|FG000|Overall Study|Withdrawal by Subject|8|||
130352287|NCT01289782|469261007|FG001|Overall Study|Withdrawal by Subject|2|||
130219134|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130219135|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130219136|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
130219137|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219138|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219139|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219140|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
130219141|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219142|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219143|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219144|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
130219145|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219146|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219147|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219148|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
130219149|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219150|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219151|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219152|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
130219153|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219154|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219155|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219156|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
130219157|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219158|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219159|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219160|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
130219161|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130219162|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130219163|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130352288|NCT01289782|469261006|FG000|Overall Study|Sponsor's Decision|1|||
130352289|NCT01289782|469261007|FG001|Overall Study|Sponsor's Decision|0|||
130352290|NCT01289782|469261006|FG000|Overall Study|Reason not specified|1|||
130439253|NCT00105586|469571560|FG000|Overall Study|Adverse Event|4|||
130439254|NCT00105586|469571561|FG001|Overall Study|Adverse Event|3|||
130439255|NCT00105586|469571560|FG000|Overall Study|Physician Decision|13|||
130439256|NCT00105586|469571561|FG001|Overall Study|Physician Decision|13|||
130439257|NCT02306122|469571562|FG000|Initial Physician Randomization|Physician Decision|0|||
130439258|NCT02306122|469571563|FG001|Initial Physician Randomization|Physician Decision|0|||
130439259|NCT02306122|469571564|FG002|Initial Physician Randomization|Physician Decision|0|||
130439260|NCT02306122|469571565|FG003|Initial Physician Randomization|Physician Decision|0|||
130439261|NCT02306122|469571566|FG004|Initial Physician Randomization|Physician Decision|0|||
130439262|NCT02306122|469571567|FG005|Initial Physician Randomization|Physician Decision|0|||
130439263|NCT02306122|469571568|FG006|Initial Physician Randomization|Physician Decision|0|||
130352291|NCT01289782|469261007|FG001|Overall Study|Reason not specified|2|||
130352292|NCT01025154|469261011|FG000|Overall Study|Lost to Follow-up|1|||
130352293|NCT01025154|469261011|FG000|Overall Study|Withdrawal by Subject|1|||
130352294|NCT00542451|469261016|FG000|Overall Study|Adverse Event|31|||
130352295|NCT00542451|469261016|FG000|Overall Study|Withdrawal by Subject|30|||
130352296|NCT00542451|469261016|FG000|Overall Study|Physician Decision|4|||
130352297|NCT00542451|469261016|FG000|Overall Study|Recurrent disease|1|||
130352298|NCT00542451|469261016|FG000|Overall Study|unknown reason|1|||
130352299|NCT00542451|469261016|FG000|Overall Study|Death|2|||
130352300|NCT00542451|469261016|FG000|Overall Study|Lost to Follow-up|10|||
130352301|NCT03519386|469261017|FG000|Overall Study|Withdrawal by Subject|4|||
130352302|NCT03519386|469261018|FG001|Overall Study|Withdrawal by Subject|1|||
130352303|NCT03519386|469261019|FG002|Overall Study|Withdrawal by Subject|2|||
130352304|NCT03519386|469261017|FG000|Overall Study|Physician Decision|1|||
130352305|NCT03519386|469261018|FG001|Overall Study|Physician Decision|1|||
130352306|NCT03519386|469261019|FG002|Overall Study|Physician Decision|1|||
130352307|NCT03519386|469261017|FG000|Overall Study|Lost to Follow-up|0|||
130352308|NCT03519386|469261018|FG001|Overall Study|Lost to Follow-up|1|||
130352309|NCT03519386|469261019|FG002|Overall Study|Lost to Follow-up|1|||
130352310|NCT03519386|469261017|FG000|Overall Study|Death|1|||
130352311|NCT03519386|469261018|FG001|Overall Study|Death|0|||
130352312|NCT03519386|469261019|FG002|Overall Study|Death|4|||
130352313|NCT03519386|469261017|FG000|Overall Study|Adverse Event|2|||
130352314|NCT03519386|469261018|FG001|Overall Study|Adverse Event|1|||
130352315|NCT03519386|469261019|FG002|Overall Study|Adverse Event|2|||
130352316|NCT03519386|469261017|FG000|Overall Study|Explanted|2|||
130439264|NCT02306122|469571569|FG007|Initial Physician Randomization|Physician Decision|0|||
130352317|NCT03519386|469261018|FG001|Overall Study|Explanted|1|||
130352318|NCT03519386|469261019|FG002|Overall Study|Explanted|0|||
130352319|NCT03519386|469261017|FG000|Overall Study|Ongoing in study|190|||
130439265|NCT02306122|469571570|FG008|Initial Physician Randomization|Physician Decision|1|||
130219164|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219165|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
130219166|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219167|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219168|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219169|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
130219170|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219171|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219172|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219173|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
130219174|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219175|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219176|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219177|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
130219178|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219179|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219180|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219181|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
130219182|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219183|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219184|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219185|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
130219186|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219187|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219188|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219189|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
130219190|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219191|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219192|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219193|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
130219194|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219195|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219196|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219197|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
130219198|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219199|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219200|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219201|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
130219202|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219203|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219204|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130219205|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130219206|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
130219207|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
130219208|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130219209|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130219210|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130219211|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130219212|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130219213|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130219214|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
130219215|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
130219216|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130219217|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130219218|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
130352320|NCT03519386|469261018|FG001|Overall Study|Ongoing in study|192|||
130352321|NCT03519386|469261019|FG002|Overall Study|Ongoing in study|183|||
130352322|NCT04341662|469261021|FG000|Overall Study|Did not have source-verified blood loss data|423|||
130352323|NCT04341662|469261022|FG001|Overall Study|Did not have source-verified blood loss data|514|||
130352324|NCT01582854|469261023|FG000|Overall Study|Death|8|||
130685930|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130685931|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130685932|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130685933|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219219|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
130219220|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130219221|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130219222|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
130219223|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
130219224|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219225|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219226|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
130219227|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219228|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130219229|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130219230|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
130219231|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
130219232|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219233|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219234|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219235|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
130219236|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219237|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219238|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
130219239|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
130219240|NCT06597084|468765164|FG000|Overall Study|Withdrawal by Subject|4|||
130219241|NCT06597084|468765165|FG001|Overall Study|Withdrawal by Subject|9|||
130219242|NCT06597084|468765164|FG000|Overall Study|Consent was not given by the patient until V2|0|||
130219243|NCT06597084|468765165|FG001|Overall Study|Consent was not given by the patient until V2|3|||
130219244|NCT06597084|468765164|FG000|Overall Study|Physician Decision|1|||
130219245|NCT06597084|468765165|FG001|Overall Study|Physician Decision|0|||
130219246|NCT06597084|468765164|FG000|Overall Study|Adverse Event|3|||
130219247|NCT06597084|468765165|FG001|Overall Study|Adverse Event|2|||
130219248|NCT06597084|468765164|FG000|Overall Study|Death|4|||
130219249|NCT06597084|468765165|FG001|Overall Study|Death|0|||
130219250|NCT06597084|468765164|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
130219251|NCT06597084|468765165|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
130219252|NCT06597084|468765164|FG000|Overall Study|Lost to Follow-up|4|||
130219253|NCT06597084|468765165|FG001|Overall Study|Lost to Follow-up|2|||
130219254|NCT06597084|468765164|FG000|Overall Study|Other. Not specified|1|||
130219255|NCT06597084|468765165|FG001|Overall Study|Other. Not specified|0|||
130219256|NCT02029274|468765171|FG000|Overall Study|Adverse Event|1|||
130219257|NCT02029274|468765172|FG001|Overall Study|Adverse Event|0|||
130219258|NCT02029274|468765173|FG002|Overall Study|Adverse Event|2|||
130219259|NCT02029274|468765174|FG003|Overall Study|Adverse Event|2|||
130219260|NCT05251233|468766829|FG000|Overall Study|Disease progression - did not start treatment|0|||
130219261|NCT05251233|468766830|FG001|Overall Study|Disease progression - did not start treatment|0|||
130219262|NCT05251233|468766831|FG002|Overall Study|Disease progression - did not start treatment|5|||
130219263|NCT05251233|468766829|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
130219264|NCT05251233|468766830|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
130219265|NCT05251233|468766831|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
130219266|NCT05251233|468766829|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130219267|NCT05251233|468766830|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130219268|NCT05251233|468766831|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
130219269|NCT05251233|468766829|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130219270|NCT05251233|468766830|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130219271|NCT05251233|468766831|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
130219272|NCT05251233|468766829|FG000|Overall Study|Death - did not start treatment|3|||
130219273|NCT05251233|468766830|FG001|Overall Study|Death - did not start treatment|0|||
130219274|NCT05251233|468766831|FG002|Overall Study|Death - did not start treatment|0|||
130219275|NCT05251233|468766829|FG000|Overall Study|Withdrawal by Subject|2|||
130219276|NCT05251233|468766830|FG001|Overall Study|Withdrawal by Subject|2|||
130219277|NCT05251233|468766831|FG002|Overall Study|Withdrawal by Subject|0|||
130219278|NCT05251233|468766829|FG000|Overall Study|Other complicating disease|2|||
130352325|NCT01582854|469261024|FG001|Overall Study|Death|5|||
130352326|NCT01582854|469261023|FG000|Overall Study|Adverse Event|2|||
130352327|NCT01582854|469261024|FG001|Overall Study|Adverse Event|3|||
130352328|NCT01582854|469261023|FG000|Overall Study|Withdrawal by Participant|8|||
130352329|NCT01582854|469261024|FG001|Overall Study|Withdrawal by Participant|11|||
130219279|NCT05251233|468766830|FG001|Overall Study|Other complicating disease|1|||
130219280|NCT05251233|468766831|FG002|Overall Study|Other complicating disease|0|||
130219281|NCT05251233|468766829|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130219282|NCT05251233|468766830|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130219283|NCT05251233|468766831|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
130219284|NCT05251233|468766829|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130219285|NCT05251233|468766830|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
130219286|NCT05251233|468766831|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130219287|NCT03272347|468766836|FG000|Overall Study|Death|0|||
130219288|NCT03272347|468766837|FG001|Overall Study|Death|0|||
130219289|NCT03272347|468766838|FG002|Overall Study|Death|0|||
130219290|NCT03272347|468766839|FG003|Overall Study|Death|1|||
130219291|NCT03272347|468766836|FG000|Overall Study|Lost to Follow-up|1|||
130219292|NCT03272347|468766837|FG001|Overall Study|Lost to Follow-up|3|||
130219293|NCT03272347|468766838|FG002|Overall Study|Lost to Follow-up|5|||
130219294|NCT03272347|468766839|FG003|Overall Study|Lost to Follow-up|1|||
130219295|NCT03272347|468766836|FG000|Overall Study|Physician Decision|4|||
130219296|NCT03272347|468766837|FG001|Overall Study|Physician Decision|2|||
130219297|NCT03272347|468766838|FG002|Overall Study|Physician Decision|5|||
130219298|NCT03272347|468766839|FG003|Overall Study|Physician Decision|4|||
130219299|NCT03272347|468766836|FG000|Overall Study|Screen Failure|1|||
130219300|NCT03272347|468766837|FG001|Overall Study|Screen Failure|0|||
130219301|NCT03272347|468766838|FG002|Overall Study|Screen Failure|0|||
130219302|NCT03272347|468766839|FG003|Overall Study|Screen Failure|0|||
130219303|NCT03272347|468766836|FG000|Overall Study|Withdrawal by Subject|5|||
130219304|NCT03272347|468766837|FG001|Overall Study|Withdrawal by Subject|1|||
130219305|NCT03272347|468766838|FG002|Overall Study|Withdrawal by Subject|2|||
130219306|NCT03272347|468766839|FG003|Overall Study|Withdrawal by Subject|1|||
130219307|NCT00391872|468766842|FG000|Overall Study|Protocol Violation|7|||
130219308|NCT00391872|468766843|FG001|Overall Study|Protocol Violation|2|||
130219309|NCT00391872|468766842|FG000|Overall Study|Withdrawal by Subject|296|||
130219310|NCT00391872|468766843|FG001|Overall Study|Withdrawal by Subject|249|||
130219311|NCT00391872|468766842|FG000|Overall Study|Reason unknown|2|||
130219312|NCT00391872|468766843|FG001|Overall Study|Reason unknown|4|||
130219313|NCT00391872|468766842|FG000|Overall Study|Lost to Follow-up|2|||
130219314|NCT00391872|468766843|FG001|Overall Study|Lost to Follow-up|0|||
130219315|NCT00905632|468766845|FG000|Overall Study|Adverse Event|0|||
130219316|NCT00905632|468766846|FG001|Overall Study|Adverse Event|0|||
130219317|NCT00905632|468766847|FG002|Overall Study|Adverse Event|0|||
130219318|NCT00905632|468766848|FG003|Overall Study|Adverse Event|0|||
130219319|NCT00905632|468766849|FG004|Overall Study|Adverse Event|0|||
130219320|NCT00905632|468766850|FG005|Overall Study|Adverse Event|1|||
130219321|NCT00905632|468766851|FG006|Overall Study|Adverse Event|4|||
130219322|NCT01307891|468766853|FG000|Overall Study|Progressive Disease|3|||
130219323|NCT01307891|468766854|FG001|Overall Study|Progressive Disease|1|||
130219324|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
130219325|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
130219326|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
130219327|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
130219328|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
130219329|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
130219330|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
130219331|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
130219332|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
130219333|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
130219334|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
130219335|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
130219336|NCT00305227|468766859|FG000|Overall Study|Lost to Follow-up|7|||
130219337|NCT00305227|468766860|FG001|Overall Study|Lost to Follow-up|6|||
130352330|NCT01582854|469261023|FG000|Overall Study|Lost to Follow-up|1|||
130352331|NCT01582854|469261024|FG001|Overall Study|Lost to Follow-up|2|||
130352332|NCT01582854|469261023|FG000|Overall Study|Physician Decision|0|||
130352333|NCT01582854|469261024|FG001|Overall Study|Physician Decision|1|||
130352334|NCT01582854|469261023|FG000|Overall Study|Recurrent Stroke|13|||
130685934|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685935|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219338|NCT04085601|468766861|FG000|Overall Study|Lost to Follow-up|1|||
130219339|NCT04085601|468766862|FG001|Overall Study|Lost to Follow-up|0|||
130219340|NCT04085601|468766861|FG000|Overall Study|Death|1|||
130219341|NCT04085601|468766862|FG001|Overall Study|Death|1|||
130219342|NCT03492437|468766863|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130352335|NCT01582854|469261024|FG001|Overall Study|Recurrent Stroke|8|||
130685936|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219343|NCT03492437|468766864|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130219344|NCT02915159|468766866|FG000|Overall Study|Participant no longer meets criteria|2|||
130219345|NCT02915159|468766867|FG001|Overall Study|Participant no longer meets criteria|0|||
130219346|NCT02915159|468766866|FG000|Overall Study|poor/non-compliance|1|||
130219347|NCT02915159|468766867|FG001|Overall Study|poor/non-compliance|0|||
130219348|NCT02915159|468766866|FG000|Overall Study|Participant withdrew consent|5|||
130219349|NCT02915159|468766867|FG001|Overall Study|Participant withdrew consent|1|||
130219350|NCT02915159|468766866|FG000|Overall Study|Request to discontinue treatment|1|||
130219351|NCT02915159|468766867|FG001|Overall Study|Request to discontinue treatment|2|||
130219352|NCT02915159|468766866|FG000|Overall Study|Adverse Event|2|||
130219353|NCT02915159|468766867|FG001|Overall Study|Adverse Event|2|||
130219354|NCT02915159|468766866|FG000|Overall Study|Lack of Efficacy|0|||
130219355|NCT02915159|468766867|FG001|Overall Study|Lack of Efficacy|3|||
130219356|NCT04534517|468766868|FG000|Overall Study|Adverse Event|1|||
130219357|NCT04534517|468766868|FG000|Overall Study|Withdrawal by Subject|1|||
130219358|NCT04534517|468766868|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130219359|NCT04534517|468766868|FG000|Overall Study|COVID-19 Related|1|||
130219360|NCT03872843|468766869|FG000|Overall Study|Lost to Follow-up|5|||
130219361|NCT03872843|468766870|FG001|Overall Study|Lost to Follow-up|7|||
130219362|NCT00823264|468766871|FG000|Overall Study|Protocol Violation|2|||
130219363|NCT00823264|468766872|FG001|Overall Study|Protocol Violation|0|||
130219364|NCT05133323|468766873|FG000|Overall Study|Lack of Efficacy|0|||
130219365|NCT05133323|468766874|FG001|Overall Study|Lack of Efficacy|0|||
130219366|NCT05133323|468766875|FG002|Overall Study|Lack of Efficacy|1|||
130219367|NCT05133323|468766873|FG000|Overall Study|Withdrawal by Subject|2|||
130219368|NCT05133323|468766874|FG001|Overall Study|Withdrawal by Subject|1|||
130219369|NCT05133323|468766875|FG002|Overall Study|Withdrawal by Subject|0|||
130219370|NCT00113295|468766876|FG000|Overall Study|Adverse Event|4|||
130219371|NCT00113295|468766877|FG001|Overall Study|Adverse Event|1|||
130219372|NCT00113295|468766876|FG000|Overall Study|Unrelated Medical Illness|1|||
130219373|NCT00113295|468766877|FG001|Overall Study|Unrelated Medical Illness|0|||
130219374|NCT01714544|468766878|FG000|Overall Study|Lost to Follow-up|1|||
130219375|NCT01714544|468766878|FG000|Overall Study|Physician Decision|1|||
130219376|NCT01714544|468766878|FG000|Overall Study|Withdrawal by Subject|1|||
130219377|NCT02824224|468766887|FG000|Overall Study|Discontinued, IUS expulsion|0|||
130219378|NCT02824224|468766888|FG001|Overall Study|Discontinued, IUS expulsion|1|||
130219379|NCT02824224|468766887|FG000|Overall Study|Did not show up for allocation visit|2|||
130219380|NCT02824224|468766888|FG001|Overall Study|Did not show up for allocation visit|0|||
130219381|NCT02465437|468766895|FG000|Overall Study|Physician Decision|0|||
130219382|NCT02465437|468766896|FG001|Overall Study|Physician Decision|0|||
130219383|NCT02465437|468766897|FG002|Overall Study|Physician Decision|1|||
130219384|NCT02465437|468766898|FG003|Overall Study|Physician Decision|0|||
130219385|NCT02465437|468766895|FG000|Overall Study|Withdrawal by Subject|1|||
130219386|NCT02465437|468766896|FG001|Overall Study|Withdrawal by Subject|0|||
130219387|NCT02465437|468766897|FG002|Overall Study|Withdrawal by Subject|0|||
130219388|NCT02465437|468766898|FG003|Overall Study|Withdrawal by Subject|1|||
130219389|NCT02465437|468766895|FG000|Overall Study|Adverse Event|0|||
130219390|NCT02465437|468766896|FG001|Overall Study|Adverse Event|1|||
130219391|NCT02465437|468766897|FG002|Overall Study|Adverse Event|0|||
130219392|NCT02465437|468766898|FG003|Overall Study|Adverse Event|0|||
130219393|NCT00003483|468766899|FG000|Overall Study|Not evaluable|1|||
130219394|NCT02609386|468766902|FG000|Overall Study|Withdrawal by Subject|6|||
130219395|NCT02609386|468766903|FG001|Overall Study|Withdrawal by Subject|1|||
130219396|NCT02609386|468766902|FG000|Overall Study|Lost to Follow-up|3|||
130219397|NCT02609386|468766903|FG001|Overall Study|Lost to Follow-up|5|||
130219398|NCT02609386|468766902|FG000|Overall Study|Death|19|||
130219399|NCT02609386|468766903|FG001|Overall Study|Death|9|||
130352336|NCT01582854|469261023|FG000|Overall Study|Disallowed Concomitant Medication|3|||
130352337|NCT01582854|469261024|FG001|Overall Study|Disallowed Concomitant Medication|2|||
130352338|NCT01582854|469261023|FG000|Overall Study|Carotid or Neurosurgery|0|||
130352339|NCT01582854|469261024|FG001|Overall Study|Carotid or Neurosurgery|1|||
130352340|NCT01582854|469261023|FG000|Overall Study|General Anaesthesia|0|||
130352341|NCT01582854|469261024|FG001|Overall Study|General Anaesthesia|1|||
130352342|NCT01582854|469261023|FG000|Overall Study|Other Miscellaneous Reason|1|||
130352343|NCT01582854|469261024|FG001|Overall Study|Other Miscellaneous Reason|0|||
130352344|NCT03101267|469261025|FG000|Primary Study Period|Withdrawal by Subject|1|||
130352345|NCT03101267|469261026|FG001|Primary Study Period|Withdrawal by Subject|2|||
130352346|NCT03101267|469261027|FG002|Primary Study Period|Withdrawal by Subject|3|||
130352347|NCT03101267|469261025|FG000|Primary Study Period|Miscellaneous|2|||
130219400|NCT02609386|468766902|FG000|Overall Study|Physician Decision|0|||
130352348|NCT03101267|469261026|FG001|Primary Study Period|Miscellaneous|0|||
130219401|NCT02609386|468766903|FG001|Overall Study|Physician Decision|2|||
130219402|NCT01001520|468766913|FG000|Medication Period 1|Withdrawal by Subject|2|||
130219403|NCT01001520|468766914|FG001|Medication Period 1|Withdrawal by Subject|2|||
130219404|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
130219405|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
130219406|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
130352349|NCT03101267|469261027|FG002|Primary Study Period|Miscellaneous|0|||
130219407|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
130219408|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
130219409|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
130219410|NCT01001520|468766913|FG000|Washout Period|Withdrawal by Subject|2|||
130219411|NCT01001520|468766914|FG001|Washout Period|Withdrawal by Subject|1|||
130219412|NCT01001520|468766913|FG000|Medication Period 2|Withdrawal by Subject|0|||
130219413|NCT01001520|468766914|FG001|Medication Period 2|Withdrawal by Subject|3|||
130219414|NCT00878800|468766930|FG000|Overall Study|Adverse Event|0|||
130219415|NCT00878800|468766931|FG001|Overall Study|Adverse Event|0|||
130219416|NCT00878800|468766932|FG002|Overall Study|Adverse Event|2|||
130219417|NCT00878800|468766933|FG003|Overall Study|Adverse Event|0|||
130219418|NCT00878800|468766934|FG004|Overall Study|Adverse Event|1|||
130219419|NCT00878800|468766930|FG000|Overall Study|Progressive disease|1|||
130219420|NCT00878800|468766931|FG001|Overall Study|Progressive disease|5|||
130219421|NCT00878800|468766932|FG002|Overall Study|Progressive disease|6|||
130219422|NCT00878800|468766933|FG003|Overall Study|Progressive disease|5|||
130219423|NCT00878800|468766934|FG004|Overall Study|Progressive disease|13|||
130219424|NCT00878800|468766930|FG000|Overall Study|Withdrew consent|1|||
130219425|NCT00878800|468766931|FG001|Overall Study|Withdrew consent|1|||
130219426|NCT00878800|468766932|FG002|Overall Study|Withdrew consent|0|||
130219427|NCT00878800|468766933|FG003|Overall Study|Withdrew consent|1|||
130219428|NCT00878800|468766934|FG004|Overall Study|Withdrew consent|1|||
130219429|NCT00878800|468766930|FG000|Overall Study|Death|0|||
130219430|NCT00878800|468766931|FG001|Overall Study|Death|0|||
130219431|NCT00878800|468766932|FG002|Overall Study|Death|1|||
130219432|NCT00878800|468766933|FG003|Overall Study|Death|0|||
130219433|NCT00878800|468766934|FG004|Overall Study|Death|0|||
130219434|NCT00878800|468766930|FG000|Overall Study|Other|1|||
130219435|NCT00878800|468766931|FG001|Overall Study|Other|1|||
130219436|NCT00878800|468766932|FG002|Overall Study|Other|0|||
130219437|NCT00878800|468766933|FG003|Overall Study|Other|0|||
130219438|NCT00878800|468766934|FG004|Overall Study|Other|1|||
130219439|NCT00613821|468766935|FG000|Overall Study|Withdrawal by Subject|1|||
130219440|NCT00613821|468766936|FG001|Overall Study|Withdrawal by Subject|0|||
130219441|NCT00613821|468766935|FG000|Overall Study|Physician Decision|1|||
130219442|NCT00613821|468766936|FG001|Overall Study|Physician Decision|1|||
130219443|NCT03318003|468766937|FG000|Overall Study|Withdrawal by Subject|1|||
130219444|NCT03318003|468766938|FG001|Overall Study|Withdrawal by Subject|1|||
130219445|NCT03318003|468766937|FG000|Overall Study|fetal loss|0|||
130219446|NCT03318003|468766938|FG001|Overall Study|fetal loss|1|||
130219447|NCT02302846|468766940|FG000|Overall Study|Withdrawal by Subject|1|||
130219448|NCT01468454|468766941|FG000|Overall Study|Did not have surgery after PET|9|||
130219449|NCT04435808|468766942|FG000|Overall Study|Study stopped by DSMB|0|||
130219450|NCT04435808|468766943|FG001|Overall Study|Study stopped by DSMB|1|||
130219451|NCT02620787|468766944|FG000|Overall Study|Adverse Event|1|||
130219452|NCT02620787|468766945|FG001|Overall Study|Adverse Event|0|||
130219453|NCT02620787|468766944|FG000|Overall Study|Eligibility Criteria Not Met|1|||
130219454|NCT02620787|468766945|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130219455|NCT00807612|468766948|FG000|Overall Study|Death|8|||
130219456|NCT00807612|468766948|FG000|Overall Study|Study early termination|5|||
130219457|NCT00807612|468766948|FG000|Overall Study|Withdrawal by Subject|1|||
130219458|NCT02028507|468766950|FG000|Overall Study|Progressive Disease|122|||
130219459|NCT02028507|468766951|FG001|Overall Study|Progressive Disease|90|||
130219460|NCT02028507|468766952|FG002|Overall Study|Progressive Disease|102|||
130219461|NCT02028507|468766953|FG003|Overall Study|Progressive Disease|89|||
130219462|NCT02028507|468766950|FG000|Overall Study|Adverse Event|8|||
130219463|NCT02028507|468766951|FG001|Overall Study|Adverse Event|25|||
130219464|NCT02028507|468766952|FG002|Overall Study|Adverse Event|3|||
130219465|NCT02028507|468766953|FG003|Overall Study|Adverse Event|16|||
130219466|NCT02028507|468766950|FG000|Overall Study|Withdrawal by Subject|6|||
130219467|NCT02028507|468766951|FG001|Overall Study|Withdrawal by Subject|8|||
130219468|NCT02028507|468766952|FG002|Overall Study|Withdrawal by Subject|5|||
130219469|NCT02028507|468766953|FG003|Overall Study|Withdrawal by Subject|9|||
130219470|NCT02028507|468766950|FG000|Overall Study|Protocol Violation|2|||
130219471|NCT02028507|468766951|FG001|Overall Study|Protocol Violation|4|||
130219472|NCT02028507|468766952|FG002|Overall Study|Protocol Violation|1|||
130219473|NCT02028507|468766953|FG003|Overall Study|Protocol Violation|3|||
130219474|NCT02028507|468766950|FG000|Overall Study|Physician Decision|0|||
130219475|NCT02028507|468766951|FG001|Overall Study|Physician Decision|4|||
130685937|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219476|NCT02028507|468766952|FG002|Overall Study|Physician Decision|0|||
130219477|NCT02028507|468766953|FG003|Overall Study|Physician Decision|0|||
130219478|NCT02028507|468766950|FG000|Overall Study|Death|1|||
130219479|NCT02028507|468766951|FG001|Overall Study|Death|0|||
130219480|NCT02028507|468766952|FG002|Overall Study|Death|1|||
130219481|NCT02028507|468766953|FG003|Overall Study|Death|3|||
130219482|NCT02028507|468766950|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130219483|NCT02028507|468766951|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130219484|NCT02028507|468766952|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130439266|NCT02306122|469571571|FG009|Initial Physician Randomization|Physician Decision|0|||
130352350|NCT01222403|469261028|FG000|Overall Study|Inappropriate enrollment|0|||
130352351|NCT01222403|469261029|FG001|Overall Study|Inappropriate enrollment|2|||
130439267|NCT02306122|469571572|FG010|Initial Physician Randomization|Physician Decision|0|||
130439268|NCT02262260|469571575|FG000|Overall Study|Adverse Event|4|||
130439269|NCT02262260|469571576|FG001|Overall Study|Adverse Event|1|||
130439270|NCT02262260|469571575|FG000|Overall Study|Withdrawal of consent|4|||
130439271|NCT02262260|469571576|FG001|Overall Study|Withdrawal of consent|2|||
130439272|NCT02262260|469571575|FG000|Overall Study|Lost to Follow-up|1|||
130439273|NCT02262260|469571576|FG001|Overall Study|Lost to Follow-up|2|||
130439274|NCT02262260|469571575|FG000|Overall Study|Protocol deviation|2|||
130439275|NCT02262260|469571576|FG001|Overall Study|Protocol deviation|5|||
130439276|NCT01794117|469571578|FG000|Overall Study|Adverse Event|1|||
130439277|NCT01794117|469571579|FG001|Overall Study|Adverse Event|0|||
130439278|NCT01794117|469571580|FG002|Overall Study|Adverse Event|0|||
130439279|NCT01794117|469571581|FG003|Overall Study|Adverse Event|0|||
130439280|NCT01794117|469571578|FG000|Overall Study|Participant noncompliance|0|||
130439281|NCT01794117|469571579|FG001|Overall Study|Participant noncompliance|1|||
130439282|NCT01794117|469571580|FG002|Overall Study|Participant noncompliance|0|||
130439283|NCT01794117|469571581|FG003|Overall Study|Participant noncompliance|0|||
130439284|NCT01794117|469571578|FG000|Overall Study|Refused further treatment|0|||
130439285|NCT01794117|469571579|FG001|Overall Study|Refused further treatment|2|||
130439286|NCT01794117|469571580|FG002|Overall Study|Refused further treatment|0|||
130439287|NCT01794117|469571581|FG003|Overall Study|Refused further treatment|0|||
130439288|NCT03734991|469571582|FG000|Overall Study|Adverse Event|4|||
130439289|NCT03734991|469571583|FG001|Overall Study|Adverse Event|0|||
130439290|NCT03734991|469571582|FG000|Overall Study|Lost to Follow-up|4|||
130439291|NCT03734991|469571583|FG001|Overall Study|Lost to Follow-up|0|||
130439292|NCT03734991|469571582|FG000|Overall Study|Physician Decision|0|||
130439293|NCT03734991|469571583|FG001|Overall Study|Physician Decision|1|||
130439294|NCT03734991|469571582|FG000|Overall Study|Pregnancy|1|||
130439295|NCT03734991|469571583|FG001|Overall Study|Pregnancy|0|||
130439296|NCT03734991|469571582|FG000|Overall Study|Withdrawal by Subject|6|||
130439297|NCT03734991|469571583|FG001|Overall Study|Withdrawal by Subject|3|||
130439298|NCT03734991|469571582|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
130439299|NCT03734991|469571583|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
130439300|NCT03734991|469571582|FG000|Overall Study|Other|2|||
130439301|NCT03734991|469571583|FG001|Overall Study|Other|2|||
130439302|NCT02322814|469571586|FG000|Overall Study|Death|7|||
130439303|NCT02322814|469571587|FG001|Overall Study|Death|29|||
130439304|NCT02322814|469571588|FG002|Overall Study|Death|32|||
130439305|NCT02322814|469571589|FG003|Overall Study|Death|23|||
130439306|NCT02322814|469571590|FG004|Overall Study|Death|14|||
130439307|NCT02322814|469571586|FG000|Overall Study|Lost to Follow-up|1|||
130352352|NCT01028378|469261030|FG000|Overall Study|Lost to Follow-up|12|||
130352353|NCT01028378|469261030|FG000|Overall Study|Withdrawal by Subject|1|||
130352354|NCT01028378|469261030|FG000|Overall Study|Adminstrative Reasons|4|||
130352355|NCT01262352|469261031|FG000|Period 1|Illness after randomization|1|||
130352356|NCT01262352|469261032|FG001|Period 1|Illness after randomization|0|||
130352357|NCT01262352|469261031|FG000|Washout|Adverse Event|1|||
130352358|NCT01262352|469261032|FG001|Washout|Adverse Event|1|||
130352359|NCT01262352|469261031|FG000|Washout|Extended Washout|0|||
130352360|NCT01262352|469261032|FG001|Washout|Extended Washout|1|||
130352361|NCT01185834|469261036|FG000|Overall Study|Lost to Follow-up|2|||
130352362|NCT01185834|469261036|FG000|Overall Study|Discomfort|4|||
130352363|NCT01185834|469261036|FG000|Overall Study|Biomicroscopy|4|||
130352364|NCT01185834|469261036|FG000|Overall Study|Time/Job Conflict|2|||
130352365|NCT01185834|469261036|FG000|Overall Study|Early exit - Site error|2|||
130352366|NCT01975831|469261045|FG000|Overall Study|Adverse Event|1|||
130352367|NCT01975831|469261046|FG001|Overall Study|Adverse Event|2|||
130352368|NCT01975831|469261047|FG002|Overall Study|Adverse Event|2|||
130439308|NCT02322814|469571587|FG001|Overall Study|Lost to Follow-up|3|||
130439309|NCT02322814|469571588|FG002|Overall Study|Lost to Follow-up|3|||
130439310|NCT02322814|469571589|FG003|Overall Study|Lost to Follow-up|1|||
130352369|NCT01975831|469261048|FG003|Overall Study|Adverse Event|0|||
130352370|NCT01975831|469261049|FG004|Overall Study|Adverse Event|1|||
130439311|NCT02322814|469571590|FG004|Overall Study|Lost to Follow-up|0|||
130439312|NCT02322814|469571586|FG000|Overall Study|Various Reasons|2|||
130439313|NCT02322814|469571587|FG001|Overall Study|Various Reasons|0|||
130439314|NCT02322814|469571588|FG002|Overall Study|Various Reasons|1|||
130439315|NCT02322814|469571589|FG003|Overall Study|Various Reasons|1|||
130439316|NCT02322814|469571590|FG004|Overall Study|Various Reasons|0|||
130439317|NCT02322814|469571586|FG000|Overall Study|Progressive Disease|0|||
130439318|NCT02322814|469571587|FG001|Overall Study|Progressive Disease|0|||
130439319|NCT02322814|469571588|FG002|Overall Study|Progressive Disease|0|||
130352371|NCT01975831|469261050|FG005|Overall Study|Adverse Event|1|||
130352372|NCT01975831|469261051|FG006|Overall Study|Adverse Event|3|||
130352373|NCT01975831|469261052|FG007|Overall Study|Adverse Event|4|||
130439320|NCT02322814|469571589|FG003|Overall Study|Progressive Disease|1|||
130439321|NCT02322814|469571590|FG004|Overall Study|Progressive Disease|1|||
130352374|NCT01975831|469261053|FG008|Overall Study|Adverse Event|1|||
130352375|NCT01975831|469261045|FG000|Overall Study|Death|1|||
130352376|NCT01975831|469261046|FG001|Overall Study|Death|1|||
130352377|NCT01975831|469261047|FG002|Overall Study|Death|0|||
130352378|NCT01975831|469261048|FG003|Overall Study|Death|0|||
130352379|NCT01975831|469261049|FG004|Overall Study|Death|1|||
130352380|NCT01975831|469261050|FG005|Overall Study|Death|0|||
130352381|NCT01975831|469261051|FG006|Overall Study|Death|1|||
130352382|NCT01975831|469261052|FG007|Overall Study|Death|0|||
130352383|NCT01975831|469261053|FG008|Overall Study|Death|0|||
130352384|NCT01975831|469261045|FG000|Overall Study|Progressive Disease|1|||
130352385|NCT01975831|469261046|FG001|Overall Study|Progressive Disease|3|||
130352386|NCT01975831|469261047|FG002|Overall Study|Progressive Disease|2|||
130352387|NCT01975831|469261048|FG003|Overall Study|Progressive Disease|4|||
130352388|NCT01975831|469261049|FG004|Overall Study|Progressive Disease|13|||
130352389|NCT01975831|469261050|FG005|Overall Study|Progressive Disease|9|||
130352390|NCT01975831|469261051|FG006|Overall Study|Progressive Disease|10|||
130352391|NCT01975831|469261052|FG007|Overall Study|Progressive Disease|8|||
130352392|NCT01975831|469261053|FG008|Overall Study|Progressive Disease|10|||
130352393|NCT01975831|469261045|FG000|Overall Study|Withdrawal by Subject|0|||
130352394|NCT01975831|469261046|FG001|Overall Study|Withdrawal by Subject|3|||
130352395|NCT01975831|469261047|FG002|Overall Study|Withdrawal by Subject|0|||
130352396|NCT01975831|469261048|FG003|Overall Study|Withdrawal by Subject|0|||
130352397|NCT01975831|469261049|FG004|Overall Study|Withdrawal by Subject|3|||
130352398|NCT01975831|469261050|FG005|Overall Study|Withdrawal by Subject|1|||
130352399|NCT01975831|469261051|FG006|Overall Study|Withdrawal by Subject|1|||
130352400|NCT01975831|469261052|FG007|Overall Study|Withdrawal by Subject|0|||
130352401|NCT01975831|469261053|FG008|Overall Study|Withdrawal by Subject|0|||
130352402|NCT01975831|469261045|FG000|Overall Study|Physician Decision|0|||
130352403|NCT01975831|469261046|FG001|Overall Study|Physician Decision|0|||
130352404|NCT01975831|469261047|FG002|Overall Study|Physician Decision|0|||
130352405|NCT01975831|469261048|FG003|Overall Study|Physician Decision|0|||
130352406|NCT01975831|469261049|FG004|Overall Study|Physician Decision|0|||
130352407|NCT01975831|469261050|FG005|Overall Study|Physician Decision|1|||
130352408|NCT01975831|469261051|FG006|Overall Study|Physician Decision|0|||
130352409|NCT01975831|469261052|FG007|Overall Study|Physician Decision|1|||
130352410|NCT01975831|469261053|FG008|Overall Study|Physician Decision|0|||
130352411|NCT01975831|469261045|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
130352412|NCT01975831|469261046|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
130352413|NCT01975831|469261047|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
130352414|NCT01975831|469261048|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
130352415|NCT01975831|469261049|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
130352416|NCT01975831|469261050|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
130352417|NCT01975831|469261051|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
130352418|NCT01975831|469261052|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
130352419|NCT01975831|469261053|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
130352420|NCT01975831|469261045|FG000|Overall Study|Entered Hospice|0|||
130352421|NCT01975831|469261046|FG001|Overall Study|Entered Hospice|0|||
130352422|NCT01975831|469261047|FG002|Overall Study|Entered Hospice|0|||
130352423|NCT01975831|469261048|FG003|Overall Study|Entered Hospice|0|||
130352424|NCT01975831|469261049|FG004|Overall Study|Entered Hospice|0|||
130352425|NCT01975831|469261050|FG005|Overall Study|Entered Hospice|1|||
130352426|NCT01975831|469261051|FG006|Overall Study|Entered Hospice|0|||
130352427|NCT01975831|469261052|FG007|Overall Study|Entered Hospice|0|||
130352428|NCT01975831|469261053|FG008|Overall Study|Entered Hospice|0|||
130352429|NCT01975831|469261045|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352430|NCT01975831|469261046|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352431|NCT01975831|469261047|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352432|NCT01975831|469261048|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352433|NCT01975831|469261049|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352434|NCT01975831|469261050|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352435|NCT01975831|469261051|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
130352436|NCT01975831|469261052|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
130352437|NCT01975831|469261053|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
130352438|NCT00107952|469261054|FG000|Overall Study|Death|75|||
130352439|NCT00107952|469261055|FG001|Overall Study|Death|61|||
130352440|NCT00107952|469261054|FG000|Overall Study|Lost to Follow-up|0|||
130352441|NCT00107952|469261055|FG001|Overall Study|Lost to Follow-up|3|||
130352442|NCT00107952|469261054|FG000|Overall Study|Withdrawal by Subject|9|||
130352443|NCT00107952|469261055|FG001|Overall Study|Withdrawal by Subject|6|||
130352444|NCT00107952|469261054|FG000|Overall Study|Other|2|||
130352445|NCT00107952|469261055|FG001|Overall Study|Other|5|||
130352446|NCT00107952|469261054|FG000|Overall Study|Never received study treatment|9|||
130352447|NCT00107952|469261055|FG001|Overall Study|Never received study treatment|6|||
130352448|NCT01401959|469261056|FG000|Enrolled|Withdrawal by Subject|1|||
130352449|NCT01401959|469261057|FG001|Enrolled|Withdrawal by Subject|0|||
130352450|NCT01401959|469261058|FG002|Enrolled|Withdrawal by Subject|0|||
130219485|NCT02028507|468766953|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130219486|NCT02028507|468766950|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
130219487|NCT02028507|468766951|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
130219488|NCT02028507|468766952|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
130219489|NCT02028507|468766953|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
130219490|NCT02028507|468766950|FG000|Overall Study|Randomized But Not Treated|3|||
130219491|NCT02028507|468766951|FG001|Overall Study|Randomized But Not Treated|6|||
130219492|NCT02028507|468766952|FG002|Overall Study|Randomized But Not Treated|0|||
130219493|NCT02028507|468766953|FG003|Overall Study|Randomized But Not Treated|4|||
130219494|NCT02028507|468766950|FG000|Overall Study|Enzyme defect|0|||
130219495|NCT02028507|468766951|FG001|Overall Study|Enzyme defect|0|||
130219496|NCT02028507|468766952|FG002|Overall Study|Enzyme defect|0|||
130219497|NCT02028507|468766953|FG003|Overall Study|Enzyme defect|1|||
130219498|NCT02028507|468766950|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219499|NCT02028507|468766951|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219500|NCT02028507|468766952|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219501|NCT02028507|468766953|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
130219502|NCT02028507|468766950|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
130219503|NCT02028507|468766951|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
130219504|NCT02028507|468766952|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
130219505|NCT02028507|468766953|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
130219506|NCT02258659|468766954|FG000|Overall Study|Withdrawal by Subject|1|||
130219507|NCT04892446|468766955|FG000|Overall Study|Death|4|||
130219508|NCT04892446|468766956|FG001|Overall Study|Death|4|||
130219509|NCT04892446|468766957|FG002|Overall Study|Death|0|||
130219510|NCT04892446|468766955|FG000|Overall Study|Withdrew consent|3|||
130219511|NCT04892446|468766956|FG001|Overall Study|Withdrew consent|0|||
130219512|NCT04892446|468766957|FG002|Overall Study|Withdrew consent|1|||
130219513|NCT04892446|468766955|FG000|Overall Study|Investigator's discretion|1|||
130219514|NCT04892446|468766956|FG001|Overall Study|Investigator's discretion|1|||
130219515|NCT04892446|468766957|FG002|Overall Study|Investigator's discretion|0|||
130219516|NCT04892446|468766955|FG000|Overall Study|Study terminated by sponsor|0|||
130219517|NCT04892446|468766956|FG001|Overall Study|Study terminated by sponsor|0|||
130219518|NCT04892446|468766957|FG002|Overall Study|Study terminated by sponsor|2|||
130219519|NCT00272844|468766958|FG000|Overall Study|Withdrawal by Subject|5|||
130219520|NCT00705341|468766962|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
130219521|NCT00705341|468766963|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
130219522|NCT00705341|468766964|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
130219523|NCT00705341|468766965|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
130219524|NCT00705341|468766962|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219525|NCT00705341|468766963|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219526|NCT00705341|468766964|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
130219527|NCT00705341|468766965|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219528|NCT00791700|468766966|FG000|Overall Study|Insufficient clinical response|1|||
130219529|NCT00791700|468766967|FG001|Overall Study|Insufficient clinical response|4|||
130219530|NCT00791700|468766968|FG002|Overall Study|Insufficient clinical response|1|||
130219531|NCT00791700|468766969|FG003|Overall Study|Insufficient clinical response|8|||
130219532|NCT00791700|468766966|FG000|Overall Study|No longer willing to participate|1|||
130219533|NCT00791700|468766967|FG001|Overall Study|No longer willing to participate|1|||
130219534|NCT00791700|468766968|FG002|Overall Study|No longer willing to participate|0|||
130219535|NCT00791700|468766969|FG003|Overall Study|No longer willing to participate|8|||
130219536|NCT00791700|468766966|FG000|Overall Study|Non-compliance with study treatment|0|||
130219537|NCT00791700|468766967|FG001|Overall Study|Non-compliance with study treatment|2|||
130219538|NCT00791700|468766968|FG002|Overall Study|Non-compliance with study treatment|0|||
130219539|NCT00791700|468766969|FG003|Overall Study|Non-compliance with study treatment|4|||
130219540|NCT00791700|468766966|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130219541|NCT00791700|468766967|FG001|Overall Study|Withdrawn due to pregnancy|0|||
130219542|NCT00791700|468766968|FG002|Overall Study|Withdrawn due to pregnancy|0|||
130219543|NCT00791700|468766969|FG003|Overall Study|Withdrawn due to pregnancy|1|||
130219544|NCT00791700|468766966|FG000|Overall Study|Other|0|||
130219545|NCT00791700|468766967|FG001|Overall Study|Other|1|||
130352451|NCT01401959|469261056|FG000|Treated|Disease Progression|2|||
130352452|NCT01401959|469261057|FG001|Treated|Disease Progression|2|||
130352453|NCT01401959|469261058|FG002|Treated|Disease Progression|1|||
130352454|NCT01401959|469261056|FG000|Treated|Adverse Event|4|||
130219546|NCT00791700|468766968|FG002|Overall Study|Other|0|||
130219547|NCT00791700|468766969|FG003|Overall Study|Other|1|||
130352455|NCT01401959|469261057|FG001|Treated|Adverse Event|3|||
130352456|NCT01401959|469261058|FG002|Treated|Adverse Event|2|||
130219548|NCT00791700|468766966|FG000|Overall Study|Death|0|||
130219549|NCT00791700|468766967|FG001|Overall Study|Death|0|||
130219550|NCT00791700|468766968|FG002|Overall Study|Death|0|||
130219551|NCT00791700|468766969|FG003|Overall Study|Death|1|||
130219552|NCT00791700|468766966|FG000|Overall Study|Lost to Follow-up|4|||
130219553|NCT00791700|468766967|FG001|Overall Study|Lost to Follow-up|3|||
130219554|NCT00791700|468766968|FG002|Overall Study|Lost to Follow-up|4|||
130219555|NCT00791700|468766969|FG003|Overall Study|Lost to Follow-up|6|||
130219556|NCT00791700|468766966|FG000|Overall Study|Adverse Event|0|||
130219557|NCT00791700|468766967|FG001|Overall Study|Adverse Event|0|||
130219558|NCT00791700|468766968|FG002|Overall Study|Adverse Event|1|||
130219559|NCT00791700|468766969|FG003|Overall Study|Adverse Event|1|||
130219560|NCT00527826|468766972|FG000|Overall Study|Adverse Event|10|||
130219561|NCT00527826|468766973|FG001|Overall Study|Adverse Event|10|||
130219562|NCT00527826|468766972|FG000|Overall Study|Lost to Follow-up|3|||
130219563|NCT00527826|468766973|FG001|Overall Study|Lost to Follow-up|2|||
130219564|NCT00527826|468766972|FG000|Overall Study|Withdrawal by Subject|5|||
130219565|NCT00527826|468766973|FG001|Overall Study|Withdrawal by Subject|8|||
130219566|NCT00527826|468766972|FG000|Overall Study|Inclusion Criteria Not Met|3|||
130219567|NCT00527826|468766973|FG001|Overall Study|Inclusion Criteria Not Met|3|||
130219568|NCT00527826|468766972|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
130219569|NCT00527826|468766973|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
130219570|NCT00527826|468766972|FG000|Overall Study|Additional Intake of Viani forte|0|||
130219571|NCT00527826|468766973|FG001|Overall Study|Additional Intake of Viani forte|1|||
130219572|NCT00527826|468766972|FG000|Overall Study|Participant moved away|0|||
130219573|NCT00527826|468766973|FG001|Overall Study|Participant moved away|1|||
130219574|NCT01808261|468766974|FG000|Overall Study|Physician Decision|0|||
130219575|NCT01808261|468766975|FG001|Overall Study|Physician Decision|2|||
130219576|NCT01808261|468766974|FG000|Overall Study|Study Closed/Terminated|25|||
130219577|NCT01808261|468766975|FG001|Overall Study|Study Closed/Terminated|23|||
130219578|NCT01808261|468766974|FG000|Overall Study|Adverse event, non-fatal|2|||
130219579|NCT01808261|468766975|FG001|Overall Study|Adverse event, non-fatal|0|||
130219580|NCT01808261|468766974|FG000|Overall Study|Consent withdrawn by subject|6|||
130219581|NCT01808261|468766975|FG001|Overall Study|Consent withdrawn by subject|7|||
130219582|NCT01808261|468766974|FG000|Overall Study|Lost to Follow-up|3|||
130219583|NCT01808261|468766975|FG001|Overall Study|Lost to Follow-up|1|||
130219584|NCT01737879|468766980|FG000|Overall Study|Death|1|||
130219585|NCT01737879|468766980|FG000|Overall Study|Sponsor decision|40|||
130219586|NCT02497404|468766981|FG000|Overall Study|Adverse Event|1|||
130219587|NCT05568797|468766988|FG000|Overall Study|Adverse Event|0|||
130352457|NCT01401959|469261056|FG000|Treated|Withdrawal by Subject|1|||
130352458|NCT01401959|469261057|FG001|Treated|Withdrawal by Subject|2|||
130352459|NCT01401959|469261058|FG002|Treated|Withdrawal by Subject|2|||
130352460|NCT01401959|469261056|FG000|Treated|Protocol Violation|0|||
130352461|NCT01401959|469261057|FG001|Treated|Protocol Violation|1|||
130352462|NCT01401959|469261058|FG002|Treated|Protocol Violation|0|||
130352463|NCT00887744|469261059|FG000|Overall Study|Adverse Event|3|||
130352464|NCT00887744|469261059|FG000|Overall Study|Death|1|||
130352465|NCT00887744|469261059|FG000|Overall Study|Lost to Follow-up|3|||
130352466|NCT00887744|469261059|FG000|Overall Study|Withdrawal by Subject|18|||
130352467|NCT00887744|469261059|FG000|Overall Study|Various reasons|9|||
130352468|NCT00450385|469261066|FG000|Overall Study|Death|3|||
130352469|NCT00450385|469261066|FG000|Overall Study|Protocol Violation|1|||
130352470|NCT00450385|469261066|FG000|Overall Study|Withdrawal by Subject|2|||
130352471|NCT00450385|469261066|FG000|Overall Study|Lack of Efficacy|2|||
130352472|NCT00450385|469261066|FG000|Overall Study|Adverse Event|1|||
130352473|NCT00450385|469261066|FG000|Overall Study|Physician Decision|1|||
130352474|NCT00450385|469261066|FG000|Overall Study|Other|3|||
130352475|NCT01390220|469261072|FG000|Test Dose Phase|Adverse Event|17|||
130352476|NCT01390220|469261073|FG001|Test Dose Phase|Adverse Event|0|||
130352477|NCT01390220|469261074|FG002|Test Dose Phase|Adverse Event|0|||
130352478|NCT01390220|469261072|FG000|Test Dose Phase|Withdrawal by Subject|8|||
130352479|NCT01390220|469261073|FG001|Test Dose Phase|Withdrawal by Subject|0|||
130352480|NCT01390220|469261074|FG002|Test Dose Phase|Withdrawal by Subject|0|||
130219588|NCT05568797|468766989|FG001|Overall Study|Adverse Event|8|||
130219589|NCT05568797|468766988|FG000|Overall Study|Lost to Follow-up|2|||
130219590|NCT05568797|468766989|FG001|Overall Study|Lost to Follow-up|3|||
130219591|NCT05568797|468766988|FG000|Overall Study|Withdrawal by Subject|1|||
130219592|NCT05568797|468766989|FG001|Overall Study|Withdrawal by Subject|10|||
130219593|NCT05568797|468766988|FG000|Overall Study|Other|2|||
130219594|NCT05568797|468766989|FG001|Overall Study|Other|2|||
130352481|NCT01390220|469261072|FG000|Test Dose Phase|Lost to Follow-up|2|||
130352482|NCT01390220|469261073|FG001|Test Dose Phase|Lost to Follow-up|0|||
130352483|NCT01390220|469261074|FG002|Test Dose Phase|Lost to Follow-up|0|||
130352484|NCT01390220|469261072|FG000|Test Dose Phase|Protocol Violation|8|||
130219595|NCT03131687|468766990|FG000|Overall Study|Adverse Event|0|||
130219596|NCT03131687|468766991|FG001|Overall Study|Adverse Event|1|||
130219597|NCT03131687|468766992|FG002|Overall Study|Adverse Event|0|||
130439322|NCT02322814|469571586|FG000|Overall Study|Protocol Violation|1|||
130352485|NCT01390220|469261073|FG001|Test Dose Phase|Protocol Violation|0|||
130352486|NCT01390220|469261074|FG002|Test Dose Phase|Protocol Violation|0|||
130352487|NCT01390220|469261072|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
130219598|NCT03131687|468766993|FG003|Overall Study|Adverse Event|1|||
130219599|NCT03131687|468766994|FG004|Overall Study|Adverse Event|2|||
130219600|NCT03131687|468766995|FG005|Overall Study|Adverse Event|2|||
130219601|NCT03131687|468766990|FG000|Overall Study|Death|1|||
130219602|NCT03131687|468766991|FG001|Overall Study|Death|0|||
130219603|NCT03131687|468766992|FG002|Overall Study|Death|0|||
130219604|NCT03131687|468766993|FG003|Overall Study|Death|0|||
130219605|NCT03131687|468766994|FG004|Overall Study|Death|0|||
130219606|NCT03131687|468766995|FG005|Overall Study|Death|0|||
130219607|NCT03131687|468766990|FG000|Overall Study|Withdrawal by Subject|3|||
130219608|NCT03131687|468766991|FG001|Overall Study|Withdrawal by Subject|3|||
130219609|NCT03131687|468766992|FG002|Overall Study|Withdrawal by Subject|3|||
130219610|NCT03131687|468766993|FG003|Overall Study|Withdrawal by Subject|1|||
130219611|NCT03131687|468766994|FG004|Overall Study|Withdrawal by Subject|2|||
130219612|NCT03131687|468766995|FG005|Overall Study|Withdrawal by Subject|1|||
130219613|NCT03131687|468766990|FG000|Overall Study|Lost to Follow-up|1|||
130219614|NCT03131687|468766991|FG001|Overall Study|Lost to Follow-up|4|||
130219615|NCT03131687|468766992|FG002|Overall Study|Lost to Follow-up|0|||
130219616|NCT03131687|468766993|FG003|Overall Study|Lost to Follow-up|1|||
130219617|NCT03131687|468766994|FG004|Overall Study|Lost to Follow-up|4|||
130219618|NCT03131687|468766995|FG005|Overall Study|Lost to Follow-up|2|||
130219619|NCT03131687|468766990|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
130219620|NCT03131687|468766991|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
130219621|NCT03131687|468766992|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
130219622|NCT03131687|468766993|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
130219623|NCT03131687|468766994|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
130219624|NCT03131687|468766995|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
130219625|NCT03131687|468766990|FG000|Overall Study|Principle Investigator Decision|0|||
130219626|NCT03131687|468766991|FG001|Overall Study|Principle Investigator Decision|1|||
130219627|NCT03131687|468766992|FG002|Overall Study|Principle Investigator Decision|0|||
130219628|NCT03131687|468766993|FG003|Overall Study|Principle Investigator Decision|0|||
130219629|NCT03131687|468766994|FG004|Overall Study|Principle Investigator Decision|0|||
130219630|NCT03131687|468766995|FG005|Overall Study|Principle Investigator Decision|0|||
130219631|NCT03131687|468766990|FG000|Overall Study|Inadvertent Enrollment|0|||
130219632|NCT03131687|468766991|FG001|Overall Study|Inadvertent Enrollment|0|||
130219633|NCT03131687|468766992|FG002|Overall Study|Inadvertent Enrollment|0|||
130219634|NCT03131687|468766993|FG003|Overall Study|Inadvertent Enrollment|1|||
130219635|NCT03131687|468766994|FG004|Overall Study|Inadvertent Enrollment|0|||
130219636|NCT03131687|468766995|FG005|Overall Study|Inadvertent Enrollment|0|||
130219637|NCT02998996|468766996|FG000|Overall Study|Lost to Follow-up|0|||
130219638|NCT02998996|468766997|FG001|Overall Study|Lost to Follow-up|0|||
130219639|NCT02998996|468766998|FG002|Overall Study|Lost to Follow-up|1|||
130219640|NCT02998996|468766999|FG003|Overall Study|Lost to Follow-up|0|||
130219641|NCT02998996|468767000|FG004|Overall Study|Lost to Follow-up|0|||
130219642|NCT02998996|468767001|FG005|Overall Study|Lost to Follow-up|0|||
130219643|NCT02998996|468766996|FG000|Overall Study|Pregnancy|0|||
130219644|NCT02998996|468766997|FG001|Overall Study|Pregnancy|1|||
130219645|NCT02998996|468766998|FG002|Overall Study|Pregnancy|0|||
130219646|NCT02998996|468766999|FG003|Overall Study|Pregnancy|0|||
130219647|NCT02998996|468767000|FG004|Overall Study|Pregnancy|0|||
130219648|NCT02998996|468767001|FG005|Overall Study|Pregnancy|0|||
130219649|NCT02998996|468766996|FG000|Overall Study|Family reasons|0|||
130219650|NCT02998996|468766997|FG001|Overall Study|Family reasons|0|||
130219651|NCT02998996|468766998|FG002|Overall Study|Family reasons|0|||
130219652|NCT02998996|468766999|FG003|Overall Study|Family reasons|0|||
130219653|NCT02998996|468767000|FG004|Overall Study|Family reasons|1|||
130219654|NCT02998996|468767001|FG005|Overall Study|Family reasons|0|||
130219655|NCT01118663|468767002|FG000|Overall Study|Adverse Event|2|||
130219656|NCT01118663|468767003|FG001|Overall Study|Adverse Event|1|||
130219657|NCT01118663|468767002|FG000|Overall Study|Withdrawal by Subject|0|||
130219658|NCT01118663|468767003|FG001|Overall Study|Withdrawal by Subject|1|||
130219659|NCT05279131|468767004|FG000|Overall Study|Lost to Follow-up|1|||
130219660|NCT05279131|468767004|FG000|Overall Study|Death|1|||
130352488|NCT01390220|469261073|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
130352489|NCT01390220|469261074|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
130352490|NCT01390220|469261072|FG000|Test Dose Phase|Study/Site closure|6|||
130352491|NCT01390220|469261073|FG001|Test Dose Phase|Study/Site closure|0|||
130352492|NCT01390220|469261074|FG002|Test Dose Phase|Study/Site closure|0|||
130219661|NCT05279131|468767004|FG000|Overall Study|Physician Decision|1|||
130219662|NCT01066871|468767007|FG000|Overall Study|Lost to Follow-up|0|||
130219663|NCT01066871|468767008|FG001|Overall Study|Lost to Follow-up|2|||
130219664|NCT01066871|468767009|FG002|Overall Study|Lost to Follow-up|2|||
130219665|NCT01066871|468767010|FG003|Overall Study|Lost to Follow-up|0|||
130352493|NCT01390220|469261072|FG000|Test Dose Phase|Caregiver no longer available|5|||
130352494|NCT01390220|469261073|FG001|Test Dose Phase|Caregiver no longer available|0|||
130439323|NCT02322814|469571587|FG001|Overall Study|Protocol Violation|0|||
130219666|NCT01066871|468767007|FG000|Overall Study|Protocol Violation|1|||
130219667|NCT01066871|468767008|FG001|Overall Study|Protocol Violation|0|||
130219668|NCT01066871|468767009|FG002|Overall Study|Protocol Violation|3|||
130219669|NCT01066871|468767010|FG003|Overall Study|Protocol Violation|2|||
130219670|NCT01066871|468767007|FG000|Overall Study|Lack of Efficacy|0|||
130219671|NCT01066871|468767008|FG001|Overall Study|Lack of Efficacy|0|||
130219672|NCT01066871|468767009|FG002|Overall Study|Lack of Efficacy|0|||
130219673|NCT01066871|468767010|FG003|Overall Study|Lack of Efficacy|1|||
130219674|NCT01066871|468767007|FG000|Overall Study|Withdrawal by Subject|3|||
130219675|NCT01066871|468767008|FG001|Overall Study|Withdrawal by Subject|1|||
130219676|NCT01066871|468767009|FG002|Overall Study|Withdrawal by Subject|0|||
130219677|NCT01066871|468767010|FG003|Overall Study|Withdrawal by Subject|0|||
130219678|NCT01066871|468767007|FG000|Overall Study|Other|0|||
130219679|NCT01066871|468767008|FG001|Overall Study|Other|2|||
130219680|NCT01066871|468767009|FG002|Overall Study|Other|1|||
130219681|NCT01066871|468767010|FG003|Overall Study|Other|2|||
130219682|NCT00954122|468768585|FG000|Overall Study|Withdrawal by Subject|5|||
130219683|NCT00954122|468768585|FG000|Overall Study|Adverse Event|1|||
130219684|NCT00954122|468768585|FG000|Overall Study|Safety Reason|1|||
130219685|NCT03365934|468768587|FG000|Overall Study|Adverse Event|1|||
130219686|NCT03365934|468768587|FG000|Overall Study|Withdrawal by Subject|1|||
130219687|NCT02121795|468768596|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
130219688|NCT02121795|468768597|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
130219689|NCT02121795|468768596|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
130219690|NCT02121795|468768597|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
130219691|NCT02121795|468768596|FG000|Double-Blind Phase|Lost to Follow-up|7|||
130219692|NCT02121795|468768597|FG001|Double-Blind Phase|Lost to Follow-up|4|||
130219693|NCT02121795|468768596|FG000|Double-Blind Phase|Physician Decision|2|||
130219694|NCT02121795|468768597|FG001|Double-Blind Phase|Physician Decision|5|||
130219695|NCT02121795|468768596|FG000|Double-Blind Phase|Adverse Event|5|||
130219696|NCT02121795|468768597|FG001|Double-Blind Phase|Adverse Event|0|||
130219697|NCT02121795|468768596|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130219698|NCT02121795|468768597|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130219699|NCT02121795|468768596|FG000|Double-Blind Phase|Protocol Violation|0|||
130219700|NCT02121795|468768597|FG001|Double-Blind Phase|Protocol Violation|3|||
130219701|NCT02121795|468768596|FG000|Double-Blind Phase|Death|1|||
130219702|NCT02121795|468768597|FG001|Double-Blind Phase|Death|1|||
130219703|NCT02121795|468768596|FG000|Open-Label Phase|Physician Decision|8|||
130219704|NCT02121795|468768597|FG001|Open-Label Phase|Physician Decision|8|||
130219705|NCT02121795|468768596|FG000|Open-Label Phase|Withdrawal by Subject|3|||
130219706|NCT02121795|468768597|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130219707|NCT02121795|468768596|FG000|Open-Label Phase|Lost to Follow-up|1|||
130219708|NCT02121795|468768597|FG001|Open-Label Phase|Lost to Follow-up|0|||
130219709|NCT00666211|468768598|FG000|Overall Study|Withdrawal by Subject|10|||
130219710|NCT00666211|468768599|FG001|Overall Study|Withdrawal by Subject|13|||
130219711|NCT00666211|468768598|FG000|Overall Study|went off medication, no more pain|1|||
130219712|NCT00666211|468768599|FG001|Overall Study|went off medication, no more pain|0|||
130219713|NCT00666211|468768598|FG000|Overall Study|patient non-compliant|6|||
130219714|NCT00666211|468768599|FG001|Overall Study|patient non-compliant|6|||
130219715|NCT00666211|468768598|FG000|Overall Study|disease progression|1|||
130219716|NCT00666211|468768599|FG001|Overall Study|disease progression|8|||
130219717|NCT00666211|468768598|FG000|Overall Study|Lost to Follow-up|2|||
130219718|NCT00666211|468768599|FG001|Overall Study|Lost to Follow-up|0|||
130219719|NCT00666211|468768598|FG000|Overall Study|toxicity|0|||
130219720|NCT00666211|468768599|FG001|Overall Study|toxicity|2|||
130219721|NCT00666211|468768598|FG000|Overall Study|hospital admission|0|||
130219722|NCT00666211|468768599|FG001|Overall Study|hospital admission|5|||
130352495|NCT01390220|469261074|FG002|Test Dose Phase|Caregiver no longer available|0|||
130352496|NCT01390220|469261072|FG000|Test Dose Phase|Noncompliance|2|||
130352497|NCT01390220|469261073|FG001|Test Dose Phase|Noncompliance|0|||
130352498|NCT01390220|469261074|FG002|Test Dose Phase|Noncompliance|0|||
130219723|NCT00666211|468768598|FG000|Overall Study|Death|0|||
130219724|NCT00666211|468768599|FG001|Overall Study|Death|2|||
130219725|NCT00666211|468768598|FG000|Overall Study|off tx for other complicating disease|0|||
130219726|NCT00666211|468768599|FG001|Overall Study|off tx for other complicating disease|1|||
130219727|NCT00666211|468768598|FG000|Overall Study|Physician Decision|0|||
130219728|NCT00666211|468768599|FG001|Overall Study|Physician Decision|1|||
130352499|NCT01390220|469261072|FG000|Test Dose Phase|Logistical|6|||
130352500|NCT01390220|469261073|FG001|Test Dose Phase|Logistical|0|||
130352501|NCT01390220|469261074|FG002|Test Dose Phase|Logistical|0|||
130219729|NCT02299388|468768600|FG000|Overall Study|Withdrawal by Subject|0|||
130219730|NCT02299388|468768601|FG001|Overall Study|Withdrawal by Subject|1|||
130219731|NCT03334188|468768604|FG000|Overall Study|Withdrawal by Subject|0|||
130219732|NCT03334188|468768605|FG001|Overall Study|Withdrawal by Subject|1|||
130352502|NCT01390220|469261072|FG000|Comparative Phase|Withdrawal by Subject|0|||
130352503|NCT01390220|469261073|FG001|Comparative Phase|Withdrawal by Subject|1|||
130219733|NCT03334188|468768604|FG000|Overall Study|Death|1|||
130219734|NCT03334188|468768605|FG001|Overall Study|Death|0|||
130219735|NCT03334188|468768604|FG000|Overall Study|Never had qualifying clinic visit|7|||
130219736|NCT03334188|468768605|FG001|Overall Study|Never had qualifying clinic visit|7|||
130352504|NCT01390220|469261074|FG002|Comparative Phase|Withdrawal by Subject|0|||
130219737|NCT03373760|468768606|FG000|Overall Study|Adverse Event|8|||
130219738|NCT03373760|468768606|FG000|Overall Study|Disease Progression|46|||
130219739|NCT03373760|468768606|FG000|Overall Study|Death|4|||
130219740|NCT01093586|468768609|FG000|Overall Study|Failed to engraft|3|||
130219741|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
130219742|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
130219743|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
130219744|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
130219745|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
130219746|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
130219747|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
130219748|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
130219749|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
130219750|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
130219751|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
130219752|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
130219753|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
130219754|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
130219755|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Death|1|||
130219756|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Death|0|||
130219757|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130219758|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130219759|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130219760|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130219761|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
130219762|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
130219763|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
130219764|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
130219765|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
130219766|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
130219767|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
130219768|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
130219769|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
130219770|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
130219771|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
130219772|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
130219773|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
130219774|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
130219775|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Death|0|||
130219776|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Death|0|||
130219777|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
130219778|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
130219779|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130219780|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130219781|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
130219782|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
130219783|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
130219784|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
130219785|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130219786|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130352505|NCT02045303|469261075|FG000|Overall Study|Protocol Violation|2|||
130352506|NCT02045303|469261076|FG001|Overall Study|Protocol Violation|1|||
130352507|NCT02045303|469261077|FG002|Overall Study|Protocol Violation|0|||
130352508|NCT02045303|469261075|FG000|Overall Study|Withdrawal by Subject|0|||
130352509|NCT02045303|469261076|FG001|Overall Study|Withdrawal by Subject|2|||
130352510|NCT02045303|469261077|FG002|Overall Study|Withdrawal by Subject|0|||
130352511|NCT03063203|469261078|FG000|Overall Study|Chose alternative therapy|3|||
130352512|NCT03063203|469261078|FG000|Overall Study|Death|2|||
130352513|NCT03063203|469261078|FG000|Overall Study|Disease progression|4|||
130352514|NCT03063203|469261078|FG000|Overall Study|Physician Decision|5|||
130352515|NCT01856023|469261079|FG000|Overall Study|Death|1|||
130352516|NCT01856023|469261080|FG001|Overall Study|Death|2|||
130439324|NCT02322814|469571588|FG002|Overall Study|Protocol Violation|0|||
130219787|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130219788|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130219789|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
130352517|NCT01856023|469261079|FG000|Overall Study|Adverse Event|2|||
130352518|NCT01856023|469261080|FG001|Overall Study|Adverse Event|1|||
130352519|NCT01856023|469261079|FG000|Overall Study|Lack of Efficacy|5|||
130219790|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
130219791|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
130219792|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
130219793|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
130219794|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
130219795|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
130219796|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
130219797|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
130219798|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
130219799|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130219800|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130219801|NCT03442088|468768612|FG000|Overall Study|Adverse Event|1|||
130219802|NCT03442088|468768612|FG000|Overall Study|Lack of Efficacy|2|||
130219803|NCT03442088|468768612|FG000|Overall Study|Lost to Follow-up|2|||
130219804|NCT00357877|468768613|FG000|Overall Study|Death|2|||
130219805|NCT00357877|468768614|FG001|Overall Study|Death|1|||
130219806|NCT00357877|468768613|FG000|Overall Study|Lost to Follow-up|20|||
130219807|NCT00357877|468768614|FG001|Overall Study|Lost to Follow-up|23|||
130219808|NCT00357877|468768613|FG000|Overall Study|Withdrawal by Subject|3|||
130219809|NCT00357877|468768614|FG001|Overall Study|Withdrawal by Subject|3|||
130219810|NCT00357877|468768613|FG000|Overall Study|Administrative withdrawal|1|||
130219811|NCT00357877|468768614|FG001|Overall Study|Administrative withdrawal|1|||
130219812|NCT00357877|468768613|FG000|Overall Study|Other|0|||
130219813|NCT00357877|468768614|FG001|Overall Study|Other|2|||
130219814|NCT04668209|468768615|FG000|Overall Study|Withdrawal by Subject|2|||
130219815|NCT04668209|468768616|FG001|Overall Study|Withdrawal by Subject|2|||
130219816|NCT04668209|468768615|FG000|Overall Study|Lost to Follow-up|3|||
130219817|NCT04668209|468768616|FG001|Overall Study|Lost to Follow-up|4|||
130219818|NCT04668209|468768615|FG000|Overall Study|Subject Expired|2|||
130219819|NCT04668209|468768616|FG001|Overall Study|Subject Expired|0|||
130219820|NCT04668209|468768615|FG000|Overall Study|Withdrawn from study|0|||
130219821|NCT04668209|468768616|FG001|Overall Study|Withdrawn from study|1|||
130219822|NCT04668209|468768615|FG000|Overall Study|Adverse Event|0|||
130219823|NCT04668209|468768616|FG001|Overall Study|Adverse Event|1|||
130219824|NCT01869777|468768623|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
130219825|NCT00613366|468768626|FG000|Overall Study|Withdrawal by Subject|3|||
130219826|NCT00613366|468768627|FG001|Overall Study|Withdrawal by Subject|2|||
130219827|NCT00766597|468768628|FG000|Overall Study|Unexpected closure of study|4|||
130219828|NCT00766597|468768628|FG000|Overall Study|Without CCR5-tropic virus|5|||
130219829|NCT01135524|468768629|FG000|Overall Study|Withdrawal by Subject|14|||
130219830|NCT01135524|468768629|FG000|Overall Study|Adverse Event|20|||
130219831|NCT01135524|468768629|FG000|Overall Study|Lost to Follow-up|3|||
130219832|NCT01135524|468768629|FG000|Overall Study|Administrative|151|||
130219833|NCT01135524|468768629|FG000|Overall Study|Lack of Efficacy|8|||
130219834|NCT02907463|468768630|FG000|Overall Study|Lost to Follow-up|17|||
130219835|NCT02907463|468768630|FG000|Overall Study|Death|10|||
130219836|NCT02907463|468768630|FG000|Overall Study|Withdrawal by Subject|4|||
130219837|NCT02907463|468768630|FG000|Overall Study|MIS Approach was not used|2|||
130219838|NCT02907463|468768630|FG000|Overall Study|Not Implanted with Study Device|2|||
130219839|NCT02907463|468768630|FG000|Overall Study|Device Explanted|1|||
130219840|NCT02907463|468768630|FG000|Overall Study|Missing Exit Form|1|||
130219841|NCT01266824|468768631|FG000|Overall Study|Study terminated prior to completion|2|||
130219842|NCT01266824|468768632|FG001|Overall Study|Study terminated prior to completion|3|||
130219843|NCT00411450|468768633|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
130219844|NCT01716663|468768634|FG000|Overall Study|Withdrawn prior to procedure|4|||
130219845|NCT01716663|468768634|FG000|Overall Study|Treated with non-study catheter|2|||
130219846|NCT02254772|468768637|FG000|Overall Study|Ineligible|1|||
130219847|NCT02254772|468768637|FG000|Overall Study|Withdrawal by Subject|1|||
130219848|NCT05225558|468768638|FG000|Overall Study|Withdrawal by Subject|4|||
130219849|NCT05225558|468768639|FG001|Overall Study|Withdrawal by Subject|3|||
130219850|NCT05225558|468768638|FG000|Overall Study|Adverse Event|1|||
130219851|NCT05225558|468768639|FG001|Overall Study|Adverse Event|0|||
130219852|NCT05225558|468768638|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
130219853|NCT05225558|468768639|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
130219854|NCT05225558|468768638|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
130219855|NCT05225558|468768639|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
130219856|NCT01001910|468768640|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
130219857|NCT00614874|468768641|FG000|Overall Study|Protocol Violation|1|||
130219858|NCT00614874|468768641|FG000|Overall Study|Withdrawal by Subject|1|||
130219859|NCT03006562|468768642|FG000|Overall Study|Lost to Follow-up|0|||
130685938|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685939|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219860|NCT03006562|468768643|FG001|Overall Study|Lost to Follow-up|1|||
130219861|NCT02427841|468768645|FG000|Overall Study|Lack of Efficacy|5|||
130219862|NCT02427841|468768645|FG000|Overall Study|Physician Decision|2|||
130219863|NCT02427841|468768645|FG000|Overall Study|Withdrawal by Subject|1|||
130219864|NCT00511810|468768646|FG000|Overall Study|Lost to Follow-up|1|||
130219865|NCT00511810|468768647|FG001|Overall Study|Lost to Follow-up|2|||
130219866|NCT00511810|468768646|FG000|Overall Study|Lack of Efficacy|0|||
130219867|NCT00511810|468768647|FG001|Overall Study|Lack of Efficacy|2|||
130219868|NCT00511810|468768646|FG000|Overall Study|Refused second scn|0|||
130219869|NCT00511810|468768647|FG001|Overall Study|Refused second scn|1|||
130219870|NCT01502033|468768650|FG000|Overall Study|1 participant had scalp discomfort|1|||
130219871|NCT01502033|468768650|FG000|Overall Study|1 participant had worsening depression|1|||
130219872|NCT01502033|468768650|FG000|Overall Study|1 participant went back to school|1|||
130219873|NCT05285787|468768652|FG000|Overall Study|Withdrawal by Subject|1|||
130219874|NCT02360280|468768656|FG000|Overall Study|Withdrawal by Subject|2|||
130219875|NCT02360280|468768657|FG001|Overall Study|Withdrawal by Subject|0|||
130219876|NCT02360280|468768656|FG000|Overall Study|Adverse Event|0|||
130219877|NCT02360280|468768657|FG001|Overall Study|Adverse Event|1|||
130219878|NCT02360280|468768656|FG000|Overall Study|Lost to Follow-up|1|||
130219879|NCT02360280|468768657|FG001|Overall Study|Lost to Follow-up|0|||
130219880|NCT02472886|468768658|FG000|Overall Study|Lack of Efficacy|0|||
130219881|NCT02472886|468768659|FG001|Overall Study|Lack of Efficacy|2|||
130219882|NCT02472886|468768660|FG002|Overall Study|Lack of Efficacy|1|||
130219883|NCT00320788|468768661|FG000|Overall Study|Adverse Event|0|||
130219884|NCT00320788|468768662|FG001|Overall Study|Adverse Event|0|||
130219885|NCT00320788|468768663|FG002|Overall Study|Adverse Event|0|||
130219886|NCT00320788|468768664|FG003|Overall Study|Adverse Event|1|||
130219887|NCT00320788|468768665|FG004|Overall Study|Adverse Event|0|||
130219888|NCT00320788|468768661|FG000|Overall Study|Death|0|||
130219889|NCT00320788|468768662|FG001|Overall Study|Death|0|||
130219890|NCT00320788|468768663|FG002|Overall Study|Death|1|||
130219891|NCT00320788|468768664|FG003|Overall Study|Death|0|||
130219892|NCT00320788|468768665|FG004|Overall Study|Death|1|||
130219893|NCT00320788|468768661|FG000|Overall Study|Lost to Follow-up|0|||
130219894|NCT00320788|468768662|FG001|Overall Study|Lost to Follow-up|2|||
130219895|NCT00320788|468768663|FG002|Overall Study|Lost to Follow-up|1|||
130219896|NCT00320788|468768664|FG003|Overall Study|Lost to Follow-up|0|||
130219897|NCT00320788|468768665|FG004|Overall Study|Lost to Follow-up|0|||
130219898|NCT00320788|468768661|FG000|Overall Study|Decision by the Sponsor|1|||
130352520|NCT01856023|469261080|FG001|Overall Study|Lack of Efficacy|5|||
130352521|NCT01856023|469261079|FG000|Overall Study|non compliance, study closure|1|||
130352522|NCT01856023|469261080|FG001|Overall Study|non compliance, study closure|3|||
130352523|NCT01856023|469261079|FG000|Overall Study|Withdrawal by Subject|1|||
130352524|NCT01856023|469261080|FG001|Overall Study|Withdrawal by Subject|1|||
130352525|NCT00829283|469261083|FG000|Overall Study|Lost to Follow-up|7|||
130352526|NCT00829283|469261084|FG001|Overall Study|Lost to Follow-up|25|||
130352527|NCT04718103|469261085|FG000|Overall Study|Adverse Event|1|||
130352528|NCT04718103|469261086|FG001|Overall Study|Adverse Event|1|||
130352529|NCT04718103|469261085|FG000|Overall Study|Lack of Efficacy|4|||
130352530|NCT04718103|469261086|FG001|Overall Study|Lack of Efficacy|1|||
130352531|NCT04718103|469261085|FG000|Overall Study|Lost to Follow-up|2|||
130352532|NCT04718103|469261086|FG001|Overall Study|Lost to Follow-up|2|||
130352533|NCT04718103|469261085|FG000|Overall Study|Physician Decision|2|||
130352534|NCT04718103|469261086|FG001|Overall Study|Physician Decision|0|||
130352535|NCT04718103|469261085|FG000|Overall Study|Pregnancy|0|||
130352536|NCT04718103|469261086|FG001|Overall Study|Pregnancy|1|||
130352537|NCT04718103|469261085|FG000|Overall Study|Withdrawal by Subject|10|||
130352538|NCT04718103|469261086|FG001|Overall Study|Withdrawal by Subject|6|||
130352539|NCT04718103|469261085|FG000|Overall Study|Randomized, not treated|4|||
130352540|NCT04718103|469261086|FG001|Overall Study|Randomized, not treated|1|||
130352541|NCT04718103|469261085|FG000|Overall Study|GCP violations|7|||
130352542|NCT04718103|469261086|FG001|Overall Study|GCP violations|5|||
130352543|NCT00136604|469261087|FG000|Overall Study|Lost to Follow-up|1|||
130352544|NCT00136604|469261088|FG001|Overall Study|Lost to Follow-up|0|||
130352545|NCT00136604|469261089|FG002|Overall Study|Lost to Follow-up|0|||
130352546|NCT00136604|469261090|FG003|Overall Study|Lost to Follow-up|0|||
130685940|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130219899|NCT00320788|468768662|FG001|Overall Study|Decision by the Sponsor|1|||
130219900|NCT00320788|468768663|FG002|Overall Study|Decision by the Sponsor|0|||
130219901|NCT00320788|468768664|FG003|Overall Study|Decision by the Sponsor|0|||
130219902|NCT00320788|468768665|FG004|Overall Study|Decision by the Sponsor|1|||
130219903|NCT00320788|468768661|FG000|Overall Study|Other|1|||
130219904|NCT00320788|468768662|FG001|Overall Study|Other|2|||
130219905|NCT00320788|468768663|FG002|Overall Study|Other|1|||
130352547|NCT00136604|469261091|FG004|Overall Study|Lost to Follow-up|1|||
130352548|NCT00136604|469261087|FG000|Overall Study|Migrated/moved from study area|0|||
130219906|NCT00320788|468768664|FG003|Overall Study|Other|1|||
130219907|NCT00320788|468768665|FG004|Overall Study|Other|1|||
130352549|NCT00136604|469261088|FG001|Overall Study|Migrated/moved from study area|1|||
130219908|NCT00320788|468768661|FG000|Overall Study|Physician Decision|1|||
130219909|NCT00320788|468768662|FG001|Overall Study|Physician Decision|1|||
130219910|NCT00320788|468768663|FG002|Overall Study|Physician Decision|0|||
130219911|NCT00320788|468768664|FG003|Overall Study|Physician Decision|0|||
130219912|NCT00320788|468768665|FG004|Overall Study|Physician Decision|0|||
130219913|NCT00320788|468768661|FG000|Overall Study|Protocol Violation|0|||
130219914|NCT00320788|468768662|FG001|Overall Study|Protocol Violation|0|||
130219915|NCT00320788|468768663|FG002|Overall Study|Protocol Violation|0|||
130219916|NCT00320788|468768664|FG003|Overall Study|Protocol Violation|0|||
130219917|NCT00320788|468768665|FG004|Overall Study|Protocol Violation|1|||
130219918|NCT00320788|468768661|FG000|Overall Study|Withdrawal by Subject|3|||
130219919|NCT00320788|468768662|FG001|Overall Study|Withdrawal by Subject|0|||
130219920|NCT00320788|468768663|FG002|Overall Study|Withdrawal by Subject|0|||
130219921|NCT00320788|468768664|FG003|Overall Study|Withdrawal by Subject|3|||
130219922|NCT00320788|468768665|FG004|Overall Study|Withdrawal by Subject|1|||
130219923|NCT02797678|468768686|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
130219924|NCT02797678|468768687|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219925|NCT02797678|468768688|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219926|NCT02797678|468768689|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219927|NCT02797678|468768686|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219928|NCT02797678|468768687|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
130219929|NCT02797678|468768688|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219930|NCT02797678|468768689|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219931|NCT02797678|468768686|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219932|NCT02797678|468768687|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219933|NCT02797678|468768688|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
130219934|NCT02797678|468768689|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219935|NCT02401035|468768690|FG000|Overall Study|Withdrawal by Subject|1|||
130219936|NCT02401035|468768691|FG001|Overall Study|Withdrawal by Subject|0|||
130219937|NCT03046953|468768693|FG000|Overall Study|Relapse/progressive disease|21|||
130219938|NCT03046953|468768693|FG000|Overall Study|Death|2|||
130219939|NCT03046953|468768693|FG000|Overall Study|Withdrawal by Subject|3|||
130219940|NCT04039204|468768694|FG000|Overall Study|Withdrawal by Subject|0|||
130219941|NCT04039204|468768695|FG001|Overall Study|Withdrawal by Subject|2|||
130219942|NCT01189461|468768696|FG000|Overall Study|Lack of Efficacy|13|||
130219943|NCT01189461|468768696|FG000|Overall Study|Lost to Follow-up|1|||
130219944|NCT01189461|468768696|FG000|Overall Study|Withdrawal by Subject|6|||
130219945|NCT01189461|468768696|FG000|Overall Study|Protocol Violation|1|||
130219946|NCT01189461|468768696|FG000|Overall Study|Adverse Event|2|||
130219947|NCT01189461|468768696|FG000|Overall Study|Did not meet entrance criteria|3|||
130219948|NCT01189461|468768696|FG000|Overall Study|Other|8|||
130219949|NCT00656175|468768698|FG000|Overall Study|Adverse Event|1|||
130219950|NCT00656175|468768699|FG001|Overall Study|Adverse Event|0|||
130219951|NCT00656175|468768698|FG000|Overall Study|Transportation issues|0|||
130219952|NCT00656175|468768699|FG001|Overall Study|Transportation issues|1|||
130219953|NCT00534638|468768708|FG000|Overall Study|Withdrawal by Subject|3|||
130219954|NCT00534638|468768709|FG001|Overall Study|Withdrawal by Subject|4|||
130219955|NCT00534638|468768708|FG000|Overall Study|Migrated/moved from study area|13|||
130219956|NCT00534638|468768709|FG001|Overall Study|Migrated/moved from study area|11|||
130219957|NCT00534638|468768708|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
130219958|NCT00534638|468768709|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
130219959|NCT00534638|468768708|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
130219960|NCT00534638|468768709|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
130219961|NCT00534638|468768708|FG000|Overall Study|Other|1685|||
130219962|NCT00534638|468768709|FG001|Overall Study|Other|902|||
130219963|NCT04162795|468768712|FG000|Overall Study|Other|16|||
130219964|NCT04162795|468768712|FG000|Overall Study|Screen failures|10|||
130219965|NCT05259163|468770069|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
130219966|NCT05259163|468770070|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
130219967|NCT01381926|468770073|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
130219968|NCT01381926|468770074|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
130219969|NCT01381926|468770073|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
130352550|NCT00136604|469261089|FG002|Overall Study|Migrated/moved from study area|0|||
130352551|NCT00136604|469261090|FG003|Overall Study|Migrated/moved from study area|0|||
130352552|NCT00136604|469261091|FG004|Overall Study|Migrated/moved from study area|0|||
130219970|NCT01381926|468770074|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
130219971|NCT02624947|468770075|FG000|Maternal Participants|Adverse Event|5|||
130219972|NCT02624947|468770076|FG001|Maternal Participants|Adverse Event|0|||
130219973|NCT02624947|468770075|FG000|Maternal Participants|Investigator Decision|5|||
130219974|NCT02624947|468770076|FG001|Maternal Participants|Investigator Decision|3|||
130352553|NCT01309893|469261092|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
130219975|NCT02624947|468770075|FG000|Maternal Participants|Lost to Follow-up|54|||
130219976|NCT02624947|468770076|FG001|Maternal Participants|Lost to Follow-up|24|||
130219977|NCT02624947|468770075|FG000|Maternal Participants|Non Compliance|8|||
130219978|NCT02624947|468770076|FG001|Maternal Participants|Non Compliance|5|||
130219979|NCT02624947|468770075|FG000|Maternal Participants|Sponsor Request|1|||
130219980|NCT02624947|468770076|FG001|Maternal Participants|Sponsor Request|1|||
130219981|NCT02624947|468770075|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
130219982|NCT02624947|468770076|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
130219983|NCT02624947|468770075|FG000|Maternal Participants|Miscellaneous|23|||
130219984|NCT02624947|468770076|FG001|Maternal Participants|Miscellaneous|15|||
130219985|NCT02624947|468770075|FG000|Infant Participants|Adverse Event|18|||
130219986|NCT02624947|468770076|FG001|Infant Participants|Adverse Event|11|||
130219987|NCT02624947|468770075|FG000|Infant Participants|Investigator Decision|5|||
130219988|NCT02624947|468770076|FG001|Infant Participants|Investigator Decision|4|||
130219989|NCT02624947|468770075|FG000|Infant Participants|Lost to Follow-up|93|||
130219990|NCT02624947|468770076|FG001|Infant Participants|Lost to Follow-up|58|||
130219991|NCT02624947|468770075|FG000|Infant Participants|Non Compliance|17|||
130352554|NCT01309893|469261093|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
130352555|NCT01309893|469261092|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
130352556|NCT01309893|469261093|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
130352557|NCT00321893|469261096|FG000|Overall Study|Non-Compliance/Refusal|16|||
130352558|NCT00321893|469261097|FG001|Overall Study|Non-Compliance/Refusal|10|||
130352559|NCT00321893|469261096|FG000|Overall Study|Lost to Follow-up|2|||
130352560|NCT00321893|469261097|FG001|Overall Study|Lost to Follow-up|1|||
130352561|NCT00321893|469261096|FG000|Overall Study|Adverse Event|6|||
130352562|NCT00321893|469261097|FG001|Overall Study|Adverse Event|3|||
130352563|NCT00769483|469261098|FG000|Overall Study|Withdrawal by Subject|0|||
130352564|NCT00769483|469261099|FG001|Overall Study|Withdrawal by Subject|1|||
130352565|NCT00769483|469261100|FG002|Overall Study|Withdrawal by Subject|0|||
130352566|NCT00769483|469261101|FG003|Overall Study|Withdrawal by Subject|0|||
130352567|NCT00769483|469261102|FG004|Overall Study|Withdrawal by Subject|1|||
130352568|NCT00769483|469261103|FG005|Overall Study|Withdrawal by Subject|0|||
130352569|NCT00999921|469261107|FG000|Overall Study|Lost to Follow-up|10|||
130352570|NCT00999921|469261108|FG001|Overall Study|Lost to Follow-up|19|||
130352571|NCT03500679|469261115|FG000|Overall Study|Lost to Follow-up|6|||
130352572|NCT03500679|469261116|FG001|Overall Study|Lost to Follow-up|3|||
130352573|NCT03500679|469261115|FG000|Overall Study|Withdrawal by Subject|3|||
130352574|NCT03500679|469261116|FG001|Overall Study|Withdrawal by Subject|0|||
130352575|NCT01962922|469261117|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
130352576|NCT01962922|469261118|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
130352577|NCT01962922|469261117|FG000|PK Portion Day 7|non-compliance|1|||
130352578|NCT01962922|469261118|FG001|PK Portion Day 7|non-compliance|0|||
130352579|NCT01962922|469261117|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
130352580|NCT01962922|469261118|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
130352581|NCT01962922|469261117|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
130352582|NCT01962922|469261118|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
130352583|NCT00495131|469261119|FG000|Overall Study|Adverse Event|6|||
130352584|NCT00495131|469261120|FG001|Overall Study|Adverse Event|2|||
130352585|NCT00495131|469261119|FG000|Overall Study|Lack of Efficacy|0|||
130352586|NCT00495131|469261120|FG001|Overall Study|Lack of Efficacy|2|||
130352587|NCT00495131|469261119|FG000|Overall Study|Lost to Follow-up|0|||
130352588|NCT00495131|469261120|FG001|Overall Study|Lost to Follow-up|2|||
130352589|NCT00495131|469261119|FG000|Overall Study|Withdrawal by Subject|1|||
130352590|NCT00495131|469261120|FG001|Overall Study|Withdrawal by Subject|0|||
130352591|NCT03224546|469261121|FG000|Overall Study|Lost to Follow-up|9|||
130352592|NCT03224546|469261122|FG001|Overall Study|Lost to Follow-up|8|||
130352593|NCT03224546|469261123|FG002|Overall Study|Lost to Follow-up|3|||
130352594|NCT03224546|469261121|FG000|Overall Study|Withdrawal by Subject|7|||
130352595|NCT03224546|469261122|FG001|Overall Study|Withdrawal by Subject|14|||
130352596|NCT03224546|469261123|FG002|Overall Study|Withdrawal by Subject|12|||
130352597|NCT00744471|469261124|FG000|Overall Study|Randomized but not treated|1|||
130352598|NCT00744471|469261125|FG001|Overall Study|Randomized but not treated|1|||
130352599|NCT00744471|469261126|FG002|Overall Study|Randomized but not treated|4|||
130352600|NCT00744471|469261127|FG003|Overall Study|Randomized but not treated|0|||
130219992|NCT02624947|468770076|FG001|Infant Participants|Non Compliance|7|||
130219993|NCT02624947|468770075|FG000|Infant Participants|Sponsor Request|0|||
130219994|NCT02624947|468770076|FG001|Infant Participants|Sponsor Request|1|||
130439325|NCT02322814|469571589|FG003|Overall Study|Protocol Violation|0|||
130439326|NCT02322814|469571590|FG004|Overall Study|Protocol Violation|0|||
130219995|NCT02624947|468770075|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
130219996|NCT02624947|468770076|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
130219997|NCT02624947|468770075|FG000|Infant Participants|Miscellaneous|50|||
130352601|NCT00744471|469261124|FG000|Overall Study|Death|0|||
130352602|NCT00744471|469261125|FG001|Overall Study|Death|0|||
130352603|NCT00744471|469261126|FG002|Overall Study|Death|0|||
130219998|NCT02624947|468770076|FG001|Infant Participants|Miscellaneous|26|||
130219999|NCT01971567|468770090|FG000|Overall Study|Withdrawal by Subject|3|||
130220000|NCT01971567|468770091|FG001|Overall Study|Withdrawal by Subject|2|||
130220001|NCT01971567|468770090|FG000|Overall Study|Lost to Follow-up|1|||
130220002|NCT01971567|468770091|FG001|Overall Study|Lost to Follow-up|0|||
130220003|NCT01409915|468770092|FG000|Overall Study|Adverse Event|0|||
130220004|NCT01409915|468770093|FG001|Overall Study|Adverse Event|2|||
130220005|NCT01409915|468770092|FG000|Overall Study|Withdrawal by Subject|0|||
130220006|NCT01409915|468770093|FG001|Overall Study|Withdrawal by Subject|1|||
130220007|NCT01409915|468770092|FG000|Overall Study|Protocol Violation|1|||
130220008|NCT01409915|468770093|FG001|Overall Study|Protocol Violation|0|||
130220009|NCT04826484|468770094|FG000|Overall Study|Lost to Follow-up|2|||
130220010|NCT04826484|468770095|FG001|Overall Study|Lost to Follow-up|0|||
130220011|NCT02250300|468770099|FG000|Expansion Phase|Death|6|||
130220012|NCT02250300|468770100|FG001|Expansion Phase|Death|7|||
130220013|NCT02250300|468770101|FG002|Expansion Phase|Death|0|||
130220014|NCT02250300|468770102|FG003|Expansion Phase|Death|0|||
130220015|NCT00215644|468770103|FG000|Overall Study|Disease Progression|28|||
130220016|NCT00215644|468770104|FG001|Overall Study|Disease Progression|10|||
130220017|NCT00215644|468770103|FG000|Overall Study|Adverse Event|2|||
130220018|NCT00215644|468770104|FG001|Overall Study|Adverse Event|9|||
130220019|NCT00215644|468770103|FG000|Overall Study|Death|1|||
130220020|NCT00215644|468770104|FG001|Overall Study|Death|2|||
130220021|NCT00215644|468770103|FG000|Overall Study|Withdrawal by Subject|1|||
130220022|NCT00215644|468770104|FG001|Overall Study|Withdrawal by Subject|0|||
130220023|NCT00215644|468770103|FG000|Overall Study|Other|3|||
130220024|NCT00215644|468770104|FG001|Overall Study|Other|15|||
130220025|NCT00215644|468770103|FG000|Overall Study|Randomized but Not Treated|1|||
130220026|NCT00215644|468770104|FG001|Overall Study|Randomized but Not Treated|0|||
130220027|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130220028|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
130220029|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130220030|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
130220031|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
130220032|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
130220033|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130220034|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130220035|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
130220036|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
130220037|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
130220038|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
130220039|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
130352604|NCT00744471|469261127|FG003|Overall Study|Death|1|||
130352605|NCT00744471|469261124|FG000|Overall Study|Adverse Event|6|||
130352606|NCT00744471|469261125|FG001|Overall Study|Adverse Event|7|||
130352607|NCT00744471|469261126|FG002|Overall Study|Adverse Event|5|||
130352608|NCT00744471|469261127|FG003|Overall Study|Adverse Event|9|||
130352609|NCT00744471|469261124|FG000|Overall Study|Withdrawal by Subject|9|||
130352610|NCT00744471|469261125|FG001|Overall Study|Withdrawal by Subject|9|||
130352611|NCT00744471|469261126|FG002|Overall Study|Withdrawal by Subject|15|||
130352612|NCT00744471|469261127|FG003|Overall Study|Withdrawal by Subject|12|||
130352613|NCT00744471|469261124|FG000|Overall Study|Protocol Violation|1|||
130352614|NCT00744471|469261125|FG001|Overall Study|Protocol Violation|4|||
130352615|NCT00744471|469261126|FG002|Overall Study|Protocol Violation|1|||
130352616|NCT00744471|469261127|FG003|Overall Study|Protocol Violation|2|||
130352617|NCT00744471|469261124|FG000|Overall Study|Entered extension study|41|||
130352618|NCT00744471|469261125|FG001|Overall Study|Entered extension study|84|||
130352619|NCT00744471|469261126|FG002|Overall Study|Entered extension study|100|||
130352620|NCT00744471|469261127|FG003|Overall Study|Entered extension study|91|||
130352621|NCT00744471|469261124|FG000|Overall Study|Other|2|||
130352622|NCT00744471|469261125|FG001|Overall Study|Other|3|||
130352623|NCT00744471|469261126|FG002|Overall Study|Other|6|||
130439327|NCT02322814|469571586|FG000|Overall Study|Study Terminated by Sponsor|0|||
130220040|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130352624|NCT00744471|469261127|FG003|Overall Study|Other|2|||
130352625|NCT00744471|469261124|FG000|Overall Study|Lack of Efficacy|83|||
130352626|NCT00744471|469261125|FG001|Overall Study|Lack of Efficacy|37|||
130352627|NCT00744471|469261126|FG002|Overall Study|Lack of Efficacy|19|||
130220041|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130220042|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130220043|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
130220044|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130220045|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Other|1|||
130220046|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Other|0|||
130352628|NCT00744471|469261127|FG003|Overall Study|Lack of Efficacy|31|||
130352629|NCT00744471|469261124|FG000|Overall Study|Lost to Follow-up|0|||
130352630|NCT00744471|469261125|FG001|Overall Study|Lost to Follow-up|0|||
130220047|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Other|1|||
130220048|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130220049|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
130220050|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130220051|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130220052|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
130220053|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130220054|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130220055|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
130220056|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130220057|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130220058|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130220059|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
130220060|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
130220061|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130220062|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130220063|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130220064|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130220065|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
130220066|NCT00758498|468770108|FG000|Overall Study|Adverse Event|2|||
130220067|NCT00758498|468770109|FG001|Overall Study|Adverse Event|2|||
130220068|NCT00758498|468770110|FG002|Overall Study|Adverse Event|3|||
130220069|NCT00758498|468770108|FG000|Overall Study|Subject legally detained out of state|1|||
130220070|NCT00758498|468770109|FG001|Overall Study|Subject legally detained out of state|0|||
130220071|NCT00758498|468770110|FG002|Overall Study|Subject legally detained out of state|0|||
130220072|NCT00758498|468770108|FG000|Overall Study|Withdrawal by Subject|0|||
130220073|NCT00758498|468770109|FG001|Overall Study|Withdrawal by Subject|0|||
130220074|NCT00758498|468770110|FG002|Overall Study|Withdrawal by Subject|1|||
130220075|NCT00758498|468770108|FG000|Overall Study|Noncompliance to study procedures|0|||
130220076|NCT00758498|468770109|FG001|Overall Study|Noncompliance to study procedures|0|||
130220077|NCT00758498|468770110|FG002|Overall Study|Noncompliance to study procedures|1|||
130220078|NCT01516736|468770115|FG000|Overall Study|Withdrawal by Subject|10|||
130220079|NCT01516736|468770116|FG001|Overall Study|Withdrawal by Subject|4|||
130220080|NCT01516736|468770115|FG000|Overall Study|Adverse Event|4|||
130220081|NCT01516736|468770116|FG001|Overall Study|Adverse Event|5|||
130220082|NCT01516736|468770115|FG000|Overall Study|Death|3|||
130220083|NCT01516736|468770116|FG001|Overall Study|Death|1|||
130220084|NCT01516736|468770115|FG000|Overall Study|Physician Decision|2|||
130220085|NCT01516736|468770116|FG001|Overall Study|Physician Decision|1|||
130220086|NCT01516736|468770115|FG000|Overall Study|Lack of Efficacy|1|||
130220087|NCT01516736|468770116|FG001|Overall Study|Lack of Efficacy|0|||
130220088|NCT01516736|468770115|FG000|Overall Study|Protocol Violation|0|||
130220089|NCT01516736|468770116|FG001|Overall Study|Protocol Violation|1|||
130439328|NCT02322814|469571587|FG001|Overall Study|Study Terminated by Sponsor|7|||
130439329|NCT02322814|469571588|FG002|Overall Study|Study Terminated by Sponsor|9|||
130439330|NCT02322814|469571589|FG003|Overall Study|Study Terminated by Sponsor|5|||
130439331|NCT02322814|469571590|FG004|Overall Study|Study Terminated by Sponsor|13|||
130439332|NCT02322814|469571586|FG000|Overall Study|Withdrawal by Subject|5|||
130439333|NCT02322814|469571587|FG001|Overall Study|Withdrawal by Subject|4|||
130439334|NCT02322814|469571588|FG002|Overall Study|Withdrawal by Subject|2|||
130439335|NCT02322814|469571589|FG003|Overall Study|Withdrawal by Subject|1|||
130439336|NCT02322814|469571590|FG004|Overall Study|Withdrawal by Subject|3|||
130439337|NCT00591864|469571591|FG000|Overall Study|Incomplete Imaging|5|||
130439338|NCT02459093|469571592|FG000|Overall Study|Protocol Violation|6|||
130439339|NCT02459093|469571593|FG001|Overall Study|Protocol Violation|11|||
130439340|NCT02459093|469571592|FG000|Overall Study|Lost to Follow-up|6|||
130439341|NCT02459093|469571593|FG001|Overall Study|Lost to Follow-up|7|||
130439342|NCT00118092|469571594|FG000|Overall Study|Withdrawal by Subject|1|||
130439343|NCT00118092|469571594|FG000|Overall Study|Protocol Violation|1|||
130439344|NCT02401308|469571606|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
130439345|NCT02401308|469571607|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
130220090|NCT01516736|468770115|FG000|Overall Study|Other (not specified)|0|||
130220091|NCT01516736|468770116|FG001|Overall Study|Other (not specified)|1|||
130220092|NCT01697800|468770117|FG000|Overall Study|Death|0|||
130220093|NCT01697800|468770118|FG001|Overall Study|Death|1|||
130220094|NCT04194489|468770124|FG000|Overall Study|Withdrawal by Subject|5|||
130220095|NCT04194489|468770124|FG000|Overall Study|Lost to Follow-up|48|||
130220096|NCT00522548|468770125|FG000|Overall Study|Adverse Event|2|||
130220097|NCT00522548|468770126|FG001|Overall Study|Adverse Event|2|||
130439346|NCT02736968|469571608|FG000|Overall Study|Lost to Follow-up|0|||
130439347|NCT02736968|469571609|FG001|Overall Study|Lost to Follow-up|0|||
130439348|NCT02736968|469571610|FG002|Overall Study|Lost to Follow-up|0|||
130439349|NCT02736968|469571611|FG003|Overall Study|Lost to Follow-up|0|||
130685941|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130352631|NCT00744471|469261126|FG002|Overall Study|Lost to Follow-up|2|||
130352632|NCT00744471|469261127|FG003|Overall Study|Lost to Follow-up|0|||
130352633|NCT00976573|469261130|FG000|Overall Study|Ineligible|0|||
130352634|NCT00976573|469261131|FG001|Overall Study|Ineligible|1|||
130352635|NCT00976573|469261130|FG000|Overall Study|Cancel prior to receiving treatment|4|||
130352636|NCT00976573|469261131|FG001|Overall Study|Cancel prior to receiving treatment|2|||
130352637|NCT03670836|469261132|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
130352638|NCT03670836|469261133|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
130352639|NCT03670836|469261132|FG000|Per Protocol Population (PP)|Physician Decision|9|||
130352640|NCT03670836|469261133|FG001|Per Protocol Population (PP)|Physician Decision|10|||
130352641|NCT03670836|469261132|FG000|Per Protocol Population (PP)|Physician Decision|4|||
130352642|NCT03670836|469261133|FG001|Per Protocol Population (PP)|Physician Decision|6|||
130352643|NCT03670836|469261132|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
130352644|NCT03670836|469261133|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
130352645|NCT01683019|469262697|FG000|Overall Study|Withdrawal by Subject|2|||
130352646|NCT01683019|469262698|FG001|Overall Study|Withdrawal by Subject|1|||
130352647|NCT01683019|469262699|FG002|Overall Study|Withdrawal by Subject|4|||
130352648|NCT00543855|469262704|FG000|Overall Study|Adverse Event|3|||
130352649|NCT00543855|469262705|FG001|Overall Study|Adverse Event|1|||
130352650|NCT00543855|469262706|FG002|Overall Study|Adverse Event|3|||
130352651|NCT00543855|469262707|FG003|Overall Study|Adverse Event|4|||
130352652|NCT00543855|469262704|FG000|Overall Study|Lost to Follow-up|0|||
130352653|NCT00543855|469262705|FG001|Overall Study|Lost to Follow-up|0|||
130352654|NCT00543855|469262706|FG002|Overall Study|Lost to Follow-up|1|||
130352655|NCT00543855|469262707|FG003|Overall Study|Lost to Follow-up|0|||
130352656|NCT00543855|469262704|FG000|Overall Study|Withdrawal by Subject|0|||
130352657|NCT00543855|469262705|FG001|Overall Study|Withdrawal by Subject|1|||
130352658|NCT00543855|469262706|FG002|Overall Study|Withdrawal by Subject|2|||
130352659|NCT00543855|469262707|FG003|Overall Study|Withdrawal by Subject|0|||
130352660|NCT00543855|469262704|FG000|Overall Study|Protocol Violation|1|||
130352661|NCT00543855|469262705|FG001|Overall Study|Protocol Violation|0|||
130352662|NCT00543855|469262706|FG002|Overall Study|Protocol Violation|0|||
130352663|NCT00543855|469262707|FG003|Overall Study|Protocol Violation|0|||
130352664|NCT02582255|469262708|FG000|Overall Study|Protocol Violation|0|||
130352665|NCT02582255|469262709|FG001|Overall Study|Protocol Violation|3|||
130352666|NCT03034200|469262714|FG000|Overall Study|Disease progression|8|||
130352667|NCT03034200|469262715|FG001|Overall Study|Disease progression|10|||
130352668|NCT03034200|469262716|FG002|Overall Study|Disease progression|4|||
130352669|NCT03034200|469262714|FG000|Overall Study|Physician Decision|2|||
130352670|NCT03034200|469262715|FG001|Overall Study|Physician Decision|0|||
130352671|NCT03034200|469262716|FG002|Overall Study|Physician Decision|3|||
130352672|NCT03034200|469262714|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
130352673|NCT03034200|469262715|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
130352674|NCT03034200|469262716|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
130352675|NCT03034200|469262714|FG000|Overall Study|Adjuvant Therapy|0|||
130352676|NCT03034200|469262715|FG001|Overall Study|Adjuvant Therapy|0|||
130352677|NCT03034200|469262716|FG002|Overall Study|Adjuvant Therapy|1|||
130352678|NCT01466179|469262717|FG000|Overall Study|Ongoing in core study|2|||
130352679|NCT01466179|469262717|FG000|Overall Study|Physician Decision|46|||
130352680|NCT01466179|469262717|FG000|Overall Study|Progressive disease|43|||
130352681|NCT01466179|469262717|FG000|Overall Study|Adverse Event|32|||
130352682|NCT01466179|469262717|FG000|Overall Study|Disease relapse|23|||
130352683|NCT01466179|469262717|FG000|Overall Study|Lack of Efficacy|14|||
130352684|NCT01466179|469262717|FG000|Overall Study|Death|7|||
130352685|NCT01466179|469262717|FG000|Overall Study|Withdrawal by Subject|7|||
130352686|NCT01466179|469262717|FG000|Overall Study|Protocol Violation|2|||
130352687|NCT01466179|469262717|FG000|Overall Study|Other|3|||
130352688|NCT00749580|469262718|FG000|Overall Study|Lost to Follow-up|4|||
130352689|NCT00749580|469262719|FG001|Overall Study|Lost to Follow-up|8|||
130352690|NCT00749580|469262718|FG000|Overall Study|Adverse Event|0|||
130352691|NCT00749580|469262719|FG001|Overall Study|Adverse Event|1|||
130352692|NCT03489551|469262723|FG000|Overall Study|Withdrawal by Subject|2|||
130352693|NCT00054717|469262724|FG000|Overall Study|Randomized but not treated|2|||
130352694|NCT00054717|469262725|FG001|Overall Study|Randomized but not treated|8|||
130352695|NCT00054717|469262724|FG000|Overall Study|Adverse Event|70|||
130352696|NCT00054717|469262725|FG001|Overall Study|Adverse Event|22|||
130352697|NCT00054717|469262724|FG000|Overall Study|Protocol Violation|18|||
130352698|NCT00054717|469262725|FG001|Overall Study|Protocol Violation|19|||
130352699|NCT00054717|469262724|FG000|Overall Study|Lost to Follow-up|23|||
130352700|NCT00054717|469262725|FG001|Overall Study|Lost to Follow-up|13|||
130352701|NCT00054717|469262724|FG000|Overall Study|Withdrawal by Subject|32|||
130352702|NCT00054717|469262725|FG001|Overall Study|Withdrawal by Subject|20|||
130685942|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685943|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130352703|NCT00054717|469262724|FG000|Overall Study|Other reason not defined above|117|||
130352704|NCT00054717|469262725|FG001|Overall Study|Other reason not defined above|217|||
130439350|NCT02736968|469571612|FG004|Overall Study|Lost to Follow-up|0|||
130439351|NCT02736968|469571613|FG005|Overall Study|Lost to Follow-up|0|||
130439352|NCT02736968|469571614|FG006|Overall Study|Lost to Follow-up|5|||
130439353|NCT02736968|469571615|FG007|Overall Study|Lost to Follow-up|2|||
130439354|NCT02736968|469571608|FG000|Overall Study|COVID-19 Pandemic|0|||
130439355|NCT02736968|469571609|FG001|Overall Study|COVID-19 Pandemic|0|||
130439356|NCT02736968|469571610|FG002|Overall Study|COVID-19 Pandemic|0|||
130439357|NCT02736968|469571611|FG003|Overall Study|COVID-19 Pandemic|0|||
130439358|NCT02736968|469571612|FG004|Overall Study|COVID-19 Pandemic|0|||
130439359|NCT02736968|469571613|FG005|Overall Study|COVID-19 Pandemic|0|||
130439360|NCT02736968|469571614|FG006|Overall Study|COVID-19 Pandemic|2|||
130439361|NCT02736968|469571615|FG007|Overall Study|COVID-19 Pandemic|0|||
130439362|NCT02736968|469571608|FG000|Overall Study|Withdrawal by Subject|0|||
130439363|NCT02736968|469571609|FG001|Overall Study|Withdrawal by Subject|0|||
130439364|NCT02736968|469571610|FG002|Overall Study|Withdrawal by Subject|0|||
130439365|NCT02736968|469571611|FG003|Overall Study|Withdrawal by Subject|0|||
130439366|NCT02736968|469571612|FG004|Overall Study|Withdrawal by Subject|0|||
130439367|NCT02736968|469571613|FG005|Overall Study|Withdrawal by Subject|0|||
130439368|NCT02736968|469571614|FG006|Overall Study|Withdrawal by Subject|1|||
130439369|NCT02736968|469571615|FG007|Overall Study|Withdrawal by Subject|0|||
130439370|NCT00147225|469571616|FG000|Overall Study|Withdrawal by Subject|1|||
130439371|NCT00147225|469571617|FG001|Overall Study|Withdrawal by Subject|0|||
130439372|NCT00147225|469571618|FG002|Overall Study|Withdrawal by Subject|1|||
130439373|NCT00147225|469571619|FG003|Overall Study|Withdrawal by Subject|0|||
130439374|NCT00147225|469571620|FG004|Overall Study|Withdrawal by Subject|0|||
130439375|NCT00147225|469571621|FG005|Overall Study|Withdrawal by Subject|1|||
130439376|NCT00147225|469571616|FG000|Overall Study|Adverse Event|0|||
130439377|NCT00147225|469571617|FG001|Overall Study|Adverse Event|0|||
130439378|NCT00147225|469571618|FG002|Overall Study|Adverse Event|1|||
130439379|NCT00147225|469571619|FG003|Overall Study|Adverse Event|1|||
130439380|NCT00147225|469571620|FG004|Overall Study|Adverse Event|0|||
130439381|NCT00147225|469571621|FG005|Overall Study|Adverse Event|0|||
130439382|NCT00147225|469571616|FG000|Overall Study|Screen Failure|0|||
130439383|NCT00147225|469571617|FG001|Overall Study|Screen Failure|0|||
130439384|NCT00147225|469571618|FG002|Overall Study|Screen Failure|0|||
130439385|NCT00147225|469571619|FG003|Overall Study|Screen Failure|0|||
130439386|NCT00147225|469571620|FG004|Overall Study|Screen Failure|1|||
130439387|NCT00147225|469571621|FG005|Overall Study|Screen Failure|0|||
130439388|NCT00147225|469571616|FG000|Overall Study|Chemotherapy Changed|0|||
130439389|NCT00147225|469571617|FG001|Overall Study|Chemotherapy Changed|0|||
130439390|NCT00147225|469571618|FG002|Overall Study|Chemotherapy Changed|0|||
130439391|NCT00147225|469571619|FG003|Overall Study|Chemotherapy Changed|0|||
130439392|NCT00147225|469571620|FG004|Overall Study|Chemotherapy Changed|0|||
130439393|NCT00147225|469571621|FG005|Overall Study|Chemotherapy Changed|1|||
130439394|NCT02998021|469571622|FG000|Overall Study|Withdrawal by Subject|3|||
130439395|NCT02998021|469571623|FG001|Overall Study|Withdrawal by Subject|1|||
130439396|NCT02998021|469571622|FG000|Overall Study|unsafe home|0|||
130439397|NCT02998021|469571623|FG001|Overall Study|unsafe home|1|||
130439398|NCT00655551|469571624|FG000|All Periods Combined|Adverse Event|0|||
130439399|NCT00655551|469571625|FG001|All Periods Combined|Adverse Event|3|||
130439400|NCT00655551|469571626|FG002|All Periods Combined|Adverse Event|4|||
130439401|NCT00655551|469571624|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
130439402|NCT00655551|469571625|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
130439403|NCT00655551|469571626|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
130439404|NCT00655551|469571624|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
130439405|NCT00655551|469571625|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
130439406|NCT00655551|469571626|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
130439407|NCT00655551|469571624|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
130439408|NCT00655551|469571625|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
130439409|NCT00655551|469571626|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
130439410|NCT01734434|469571629|FG000|Overall Study|Death Infant|3|||
130439411|NCT01734434|469571630|FG001|Overall Study|Death Infant|1|||
130439412|NCT01734434|469571631|FG002|Overall Study|Death Infant|17|||
130439413|NCT01734434|469571632|FG003|Overall Study|Death Infant|5|||
130439414|NCT01734434|469571629|FG000|Overall Study|Lost to Follow-up|2|||
130685944|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130439415|NCT01734434|469571630|FG001|Overall Study|Lost to Follow-up|9|||
130439416|NCT01734434|469571631|FG002|Overall Study|Lost to Follow-up|67|||
130439417|NCT01734434|469571632|FG003|Overall Study|Lost to Follow-up|11|||
130439418|NCT01734434|469571629|FG000|Overall Study|No Live Birth|1|||
130685945|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130439419|NCT01734434|469571630|FG001|Overall Study|No Live Birth|2|||
130439420|NCT01734434|469571631|FG002|Overall Study|No Live Birth|32|||
130439421|NCT01734434|469571632|FG003|Overall Study|No Live Birth|6|||
130439422|NCT01734434|469571629|FG000|Overall Study|Withdrawal by Subject|4|||
130439423|NCT01734434|469571630|FG001|Overall Study|Withdrawal by Subject|0|||
130439424|NCT01734434|469571631|FG002|Overall Study|Withdrawal by Subject|8|||
130439425|NCT01734434|469571632|FG003|Overall Study|Withdrawal by Subject|1|||
130352705|NCT04565236|469262726|FG000|Overall Study|Patient/Guardian Decision|0|||
130352706|NCT04565236|469262727|FG001|Overall Study|Patient/Guardian Decision|0|||
130352707|NCT04565236|469262728|FG002|Overall Study|Patient/Guardian Decision|1|||
130352708|NCT04565236|469262729|FG003|Overall Study|Patient/Guardian Decision|0|||
130352709|NCT04423939|469262730|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
130352710|NCT04423939|469262731|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
130352711|NCT04423939|469262730|FG000|Overall Study|Death|3|||
130352712|NCT04423939|469262731|FG001|Overall Study|Death|0|||
130352713|NCT04423939|469262730|FG000|Overall Study|Withdrawal by Subject|3|||
130352714|NCT04423939|469262731|FG001|Overall Study|Withdrawal by Subject|0|||
130352715|NCT04423939|469262730|FG000|Overall Study|Caregiver to patient who died|0|||
130352716|NCT04423939|469262731|FG001|Overall Study|Caregiver to patient who died|3|||
130352717|NCT04423939|469262730|FG000|Overall Study|Caregiver to patient who withdrew|0|||
130352718|NCT04423939|469262731|FG001|Overall Study|Caregiver to patient who withdrew|3|||
130352719|NCT04626310|469262734|FG000|Overall Study|4-miss from treatment|6|||
130352720|NCT04626310|469262735|FG001|Overall Study|4-miss from treatment|5|||
130352721|NCT04626310|469262736|FG002|Overall Study|4-miss from treatment|5|||
130352722|NCT04626310|469262734|FG000|Overall Study|Withdrawal by Subject|1|||
130352723|NCT04626310|469262735|FG001|Overall Study|Withdrawal by Subject|0|||
130352724|NCT04626310|469262736|FG002|Overall Study|Withdrawal by Subject|3|||
130352725|NCT00287079|469262738|FG000|Overall Study|Qualifying relapse|12|||
130352726|NCT00287079|469262739|FG001|Overall Study|Qualifying relapse|1|||
130352727|NCT00287079|469262738|FG000|Overall Study|Non-qualifying relapse|1|||
130352728|NCT00287079|469262739|FG001|Overall Study|Non-qualifying relapse|0|||
130352729|NCT00287079|469262738|FG000|Overall Study|Adverse Event|5|||
130352730|NCT00287079|469262739|FG001|Overall Study|Adverse Event|0|||
130352731|NCT00287079|469262738|FG000|Overall Study|Protocol Violation|1|||
130352732|NCT00287079|469262739|FG001|Overall Study|Protocol Violation|0|||
130352733|NCT00287079|469262738|FG000|Overall Study|Other|3|||
130352734|NCT00287079|469262739|FG001|Overall Study|Other|0|||
130352735|NCT00423670|469262742|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
130352736|NCT00423670|469262743|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352737|NCT00423670|469262744|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352738|NCT00423670|469262745|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352739|NCT00423670|469262746|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352740|NCT00423670|469262747|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352741|NCT00423670|469262748|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352742|NCT00423670|469262749|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
130352743|NCT00423670|469262742|FG000|Treatment Period|Adverse Event|8|||
130352744|NCT00423670|469262743|FG001|Treatment Period|Adverse Event|12|||
130352745|NCT00423670|469262744|FG002|Treatment Period|Adverse Event|15|||
130352746|NCT00423670|469262745|FG003|Treatment Period|Adverse Event|20|||
130352747|NCT00423670|469262746|FG004|Treatment Period|Adverse Event|9|||
130352748|NCT00423670|469262747|FG005|Treatment Period|Adverse Event|4|||
130352749|NCT00423670|469262748|FG006|Treatment Period|Adverse Event|7|||
130352750|NCT00423670|469262749|FG007|Treatment Period|Adverse Event|2|||
130352751|NCT00423670|469262742|FG000|Treatment Period|Protocol-defined clinical event|0|||
130352752|NCT00423670|469262743|FG001|Treatment Period|Protocol-defined clinical event|7|||
130352753|NCT00423670|469262744|FG002|Treatment Period|Protocol-defined clinical event|4|||
130352754|NCT00423670|469262745|FG003|Treatment Period|Protocol-defined clinical event|12|||
130352755|NCT00423670|469262746|FG004|Treatment Period|Protocol-defined clinical event|5|||
130352756|NCT00423670|469262747|FG005|Treatment Period|Protocol-defined clinical event|4|||
130352757|NCT00423670|469262748|FG006|Treatment Period|Protocol-defined clinical event|16|||
130352758|NCT00423670|469262749|FG007|Treatment Period|Protocol-defined clinical event|15|||
130352759|NCT00423670|469262742|FG000|Treatment Period|Lost to Follow-up|2|||
130352760|NCT00423670|469262743|FG001|Treatment Period|Lost to Follow-up|1|||
130352761|NCT00423670|469262744|FG002|Treatment Period|Lost to Follow-up|3|||
130352762|NCT00423670|469262745|FG003|Treatment Period|Lost to Follow-up|1|||
130352763|NCT00423670|469262746|FG004|Treatment Period|Lost to Follow-up|6|||
130352764|NCT00423670|469262747|FG005|Treatment Period|Lost to Follow-up|0|||
130352765|NCT00423670|469262748|FG006|Treatment Period|Lost to Follow-up|3|||
130352766|NCT00423670|469262749|FG007|Treatment Period|Lost to Follow-up|1|||
130352767|NCT00423670|469262742|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
130352768|NCT00423670|469262743|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
130352769|NCT00423670|469262744|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
130352770|NCT00423670|469262745|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
130352771|NCT00423670|469262746|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
130352772|NCT00423670|469262747|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
130352773|NCT00423670|469262748|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
130352774|NCT00423670|469262749|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
130352775|NCT00423670|469262742|FG000|Treatment Period|Investigator decision|0|||
130352776|NCT00423670|469262743|FG001|Treatment Period|Investigator decision|0|||
130352777|NCT00423670|469262744|FG002|Treatment Period|Investigator decision|0|||
130352778|NCT00423670|469262745|FG003|Treatment Period|Investigator decision|0|||
130439426|NCT01734434|469571629|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
130439427|NCT01734434|469571630|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
130439428|NCT01734434|469571631|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
130439429|NCT01734434|469571632|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
130439430|NCT01734434|469571629|FG000|Overall Study|Subject Not Reachable|0|||
130439431|NCT01734434|469571630|FG001|Overall Study|Subject Not Reachable|0|||
130439432|NCT01734434|469571631|FG002|Overall Study|Subject Not Reachable|1|||
130439433|NCT01734434|469571632|FG003|Overall Study|Subject Not Reachable|0|||
130439434|NCT01734434|469571629|FG000|Overall Study|Treatment Defaulter|0|||
130439435|NCT01734434|469571630|FG001|Overall Study|Treatment Defaulter|0|||
130439436|NCT01734434|469571631|FG002|Overall Study|Treatment Defaulter|1|||
130439437|NCT01734434|469571632|FG003|Overall Study|Treatment Defaulter|0|||
130439438|NCT01734434|469571629|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
130439439|NCT01734434|469571630|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
130439440|NCT01734434|469571631|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
130439441|NCT01734434|469571632|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
130439442|NCT01734434|469571629|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130439443|NCT01734434|469571630|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130439444|NCT01734434|469571631|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
130439445|NCT01734434|469571632|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130439446|NCT03713021|469571637|FG000|Overall Study|Did not have CT sim scan available|6|||
130439447|NCT03713021|469571637|FG000|Overall Study|Not eligible|4|||
130439448|NCT03713021|469571637|FG000|Overall Study|Issues with TraceIT markers|5|||
130439449|NCT03391960|469571638|FG000|Overall Study|Protocol Violation|0|||
130439450|NCT03391960|469571639|FG001|Overall Study|Protocol Violation|0|||
130439451|NCT03545113|469573350|FG000|Overall Study|Surgery Cancelled|1|||
130439452|NCT03545113|469573351|FG001|Overall Study|Surgery Cancelled|0|||
130439453|NCT03545113|469573350|FG000|Overall Study|Death|1|||
130439454|NCT03545113|469573351|FG001|Overall Study|Death|0|||
130439455|NCT03545113|469573350|FG000|Overall Study|Adverse Event|2|||
130439456|NCT03545113|469573351|FG001|Overall Study|Adverse Event|0|||
130439457|NCT03545113|469573350|FG000|Overall Study|Received different surgery|1|||
130439458|NCT03545113|469573351|FG001|Overall Study|Received different surgery|0|||
130439459|NCT01804673|469573352|FG000|Overall Study|Adverse Event|4|||
130439460|NCT01804673|469573352|FG000|Overall Study|Withdrawal by Subject|1|||
130439461|NCT01804673|469573352|FG000|Overall Study|Lack of Efficacy|9|||
130439462|NCT01804673|469573352|FG000|Overall Study|Change to Oral Therapy|37|||
130439463|NCT01804673|469573352|FG000|Overall Study|No Further Therapy Required|84|||
130439464|NCT01804673|469573352|FG000|Overall Study|Use of Prohibited Medication|1|||
130439465|NCT01804673|469573352|FG000|Overall Study|Other|4|||
130439466|NCT01533714|469573353|FG000|Overall Study|Adverse Event|0|||
130439467|NCT01533714|469573354|FG001|Overall Study|Adverse Event|1|||
130439468|NCT01533714|469573355|FG002|Overall Study|Adverse Event|2|||
130439469|NCT01533714|469573356|FG003|Overall Study|Adverse Event|2|||
130439470|NCT01533714|469573357|FG004|Overall Study|Adverse Event|2|||
130439471|NCT01533714|469573358|FG005|Overall Study|Adverse Event|1|||
130439472|NCT01533714|469573353|FG000|Overall Study|Lack of Efficacy|0|||
130439473|NCT01533714|469573354|FG001|Overall Study|Lack of Efficacy|0|||
130439474|NCT01533714|469573355|FG002|Overall Study|Lack of Efficacy|0|||
130439475|NCT01533714|469573356|FG003|Overall Study|Lack of Efficacy|0|||
130439476|NCT01533714|469573357|FG004|Overall Study|Lack of Efficacy|0|||
130439477|NCT01533714|469573358|FG005|Overall Study|Lack of Efficacy|1|||
130439478|NCT01533714|469573353|FG000|Overall Study|Withdrawal by Subject|0|||
130439479|NCT01533714|469573354|FG001|Overall Study|Withdrawal by Subject|1|||
130439480|NCT01533714|469573355|FG002|Overall Study|Withdrawal by Subject|0|||
130439481|NCT01533714|469573356|FG003|Overall Study|Withdrawal by Subject|1|||
130439482|NCT01533714|469573357|FG004|Overall Study|Withdrawal by Subject|1|||
130439483|NCT01533714|469573358|FG005|Overall Study|Withdrawal by Subject|0|||
130439484|NCT01533714|469573353|FG000|Overall Study|Exclusion criteria|0|||
130439485|NCT01533714|469573354|FG001|Overall Study|Exclusion criteria|1|||
130439486|NCT01533714|469573355|FG002|Overall Study|Exclusion criteria|0|||
130439487|NCT01533714|469573356|FG003|Overall Study|Exclusion criteria|0|||
130439488|NCT01533714|469573357|FG004|Overall Study|Exclusion criteria|0|||
130439489|NCT01533714|469573358|FG005|Overall Study|Exclusion criteria|0|||
130439490|NCT01533714|469573353|FG000|Overall Study|Positive for purified protein derivative|0|||
130439491|NCT01533714|469573354|FG001|Overall Study|Positive for purified protein derivative|0|||
130439492|NCT01533714|469573355|FG002|Overall Study|Positive for purified protein derivative|1|||
130439493|NCT01533714|469573356|FG003|Overall Study|Positive for purified protein derivative|0|||
130439494|NCT01533714|469573357|FG004|Overall Study|Positive for purified protein derivative|1|||
130439495|NCT01533714|469573358|FG005|Overall Study|Positive for purified protein derivative|0|||
130439496|NCT01533714|469573353|FG000|Overall Study|Withdrawal criteria|0|||
130439497|NCT01533714|469573354|FG001|Overall Study|Withdrawal criteria|0|||
130439498|NCT01533714|469573355|FG002|Overall Study|Withdrawal criteria|1|||
130439499|NCT01533714|469573356|FG003|Overall Study|Withdrawal criteria|0|||
130439500|NCT01533714|469573357|FG004|Overall Study|Withdrawal criteria|3|||
130439501|NCT01533714|469573358|FG005|Overall Study|Withdrawal criteria|1|||
130439502|NCT01533714|469573353|FG000|Overall Study|Ineligibility reason|0|||
130439503|NCT01533714|469573354|FG001|Overall Study|Ineligibility reason|0|||
130439504|NCT01533714|469573355|FG002|Overall Study|Ineligibility reason|0|||
130439505|NCT01533714|469573356|FG003|Overall Study|Ineligibility reason|1|||
130439506|NCT01533714|469573357|FG004|Overall Study|Ineligibility reason|0|||
130439507|NCT01533714|469573358|FG005|Overall Study|Ineligibility reason|0|||
130439508|NCT00251927|469573365|FG000|Overall Study|Adverse Event|3|||
130439509|NCT00251927|469573366|FG001|Overall Study|Adverse Event|15|||
130439510|NCT00251927|469573365|FG000|Overall Study|Lack of Efficacy|22|||
130439511|NCT00251927|469573366|FG001|Overall Study|Lack of Efficacy|16|||
130352779|NCT00423670|469262746|FG004|Treatment Period|Investigator decision|0|||
130352780|NCT00423670|469262747|FG005|Treatment Period|Investigator decision|0|||
130352781|NCT00423670|469262748|FG006|Treatment Period|Investigator decision|0|||
130352782|NCT00423670|469262749|FG007|Treatment Period|Investigator decision|1|||
130352783|NCT00423670|469262742|FG000|Treatment Period|Non-compliance with protocol|3|||
130352784|NCT00423670|469262743|FG001|Treatment Period|Non-compliance with protocol|1|||
130352785|NCT00423670|469262744|FG002|Treatment Period|Non-compliance with protocol|1|||
130352786|NCT00423670|469262745|FG003|Treatment Period|Non-compliance with protocol|3|||
130352787|NCT00423670|469262746|FG004|Treatment Period|Non-compliance with protocol|2|||
130352788|NCT00423670|469262747|FG005|Treatment Period|Non-compliance with protocol|0|||
130352789|NCT00423670|469262748|FG006|Treatment Period|Non-compliance with protocol|2|||
130352790|NCT00423670|469262749|FG007|Treatment Period|Non-compliance with protocol|2|||
130352791|NCT00423670|469262742|FG000|Follow-up Period|Lost to Follow-up|0|||
130352792|NCT00423670|469262743|FG001|Follow-up Period|Lost to Follow-up|12|||
130352793|NCT00423670|469262744|FG002|Follow-up Period|Lost to Follow-up|8|||
130352794|NCT00423670|469262745|FG003|Follow-up Period|Lost to Follow-up|3|||
130352795|NCT00423670|469262746|FG004|Follow-up Period|Lost to Follow-up|1|||
130352796|NCT00423670|469262747|FG005|Follow-up Period|Lost to Follow-up|0|||
130352797|NCT00423670|469262748|FG006|Follow-up Period|Lost to Follow-up|5|||
130352798|NCT00423670|469262749|FG007|Follow-up Period|Lost to Follow-up|0|||
130352799|NCT00423670|469262742|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
130352800|NCT00423670|469262743|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
130352801|NCT00423670|469262744|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
130352802|NCT00423670|469262745|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
130352803|NCT00423670|469262746|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
130352804|NCT00423670|469262747|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
130352805|NCT00423670|469262748|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
130352806|NCT00423670|469262749|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
130352807|NCT00423670|469262742|FG000|Follow-up Period|Non-compliance with protocol|2|||
130352808|NCT00423670|469262743|FG001|Follow-up Period|Non-compliance with protocol|0|||
130352809|NCT00423670|469262744|FG002|Follow-up Period|Non-compliance with protocol|1|||
130352810|NCT00423670|469262745|FG003|Follow-up Period|Non-compliance with protocol|1|||
130352811|NCT00423670|469262746|FG004|Follow-up Period|Non-compliance with protocol|0|||
130352812|NCT00423670|469262747|FG005|Follow-up Period|Non-compliance with protocol|0|||
130352813|NCT00423670|469262748|FG006|Follow-up Period|Non-compliance with protocol|3|||
130352814|NCT00423670|469262749|FG007|Follow-up Period|Non-compliance with protocol|2|||
130352815|NCT01082640|469262750|FG000|Overall Study|Adverse Event|9|||
130352816|NCT01082640|469262751|FG001|Overall Study|Adverse Event|5|||
130352817|NCT01082640|469262752|FG002|Overall Study|Adverse Event|3|||
130352818|NCT01082640|469262750|FG000|Overall Study|Withdrawal by Subject|3|||
130352819|NCT01082640|469262751|FG001|Overall Study|Withdrawal by Subject|3|||
130352820|NCT01082640|469262752|FG002|Overall Study|Withdrawal by Subject|2|||
130352821|NCT01082640|469262750|FG000|Overall Study|Major protocol deviation|3|||
130352822|NCT01082640|469262751|FG001|Overall Study|Major protocol deviation|3|||
130352823|NCT01082640|469262752|FG002|Overall Study|Major protocol deviation|0|||
130352824|NCT01082640|469262750|FG000|Overall Study|Lost to Follow-up|0|||
130352825|NCT01082640|469262751|FG001|Overall Study|Lost to Follow-up|3|||
130352826|NCT01082640|469262752|FG002|Overall Study|Lost to Follow-up|0|||
130352827|NCT01082640|469262750|FG000|Overall Study|Other|2|||
130352828|NCT01082640|469262751|FG001|Overall Study|Other|1|||
130352829|NCT01082640|469262752|FG002|Overall Study|Other|3|||
130352830|NCT03190369|469262757|FG000|Overall Study|Poor compliance to protocol|0|||
130439512|NCT00251927|469573365|FG000|Overall Study|Lost to Follow-up|22|||
130439513|NCT00251927|469573366|FG001|Overall Study|Lost to Follow-up|8|||
130439514|NCT00251927|469573365|FG000|Overall Study|Protocol Violation|1|||
130439515|NCT00251927|469573366|FG001|Overall Study|Protocol Violation|2|||
130439516|NCT00251927|469573365|FG000|Overall Study|Pregnancy|2|||
130439517|NCT00251927|469573366|FG001|Overall Study|Pregnancy|0|||
130439518|NCT00251927|469573365|FG000|Overall Study|Withdrawal by Subject|40|||
130439519|NCT00251927|469573366|FG001|Overall Study|Withdrawal by Subject|25|||
130352831|NCT03190369|469262758|FG001|Overall Study|Poor compliance to protocol|1|||
130352832|NCT03190369|469262757|FG000|Overall Study|Withdraw before treatment|1|||
130352833|NCT03190369|469262758|FG001|Overall Study|Withdraw before treatment|5|||
130352834|NCT03190369|469262757|FG000|Overall Study|Randomized but not treated|0|||
130352835|NCT03190369|469262758|FG001|Overall Study|Randomized but not treated|2|||
130352836|NCT02011893|469262759|FG000|Enrollment to Randomization|Adverse Event|2|||
130352837|NCT02011893|469262760|FG001|Enrollment to Randomization|Adverse Event|0|||
130352838|NCT02011893|469262761|FG002|Enrollment to Randomization|Adverse Event|0|||
130352839|NCT02011893|469262759|FG000|Enrollment to Randomization|Physician Decision|10|||
130352840|NCT02011893|469262760|FG001|Enrollment to Randomization|Physician Decision|0|||
130352841|NCT02011893|469262761|FG002|Enrollment to Randomization|Physician Decision|0|||
130352842|NCT02011893|469262759|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
130352843|NCT02011893|469262760|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
130352844|NCT02011893|469262761|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
130352845|NCT02011893|469262759|FG000|Enrollment to Randomization|Screening Failure|29|||
130352846|NCT02011893|469262760|FG001|Enrollment to Randomization|Screening Failure|0|||
130352847|NCT02011893|469262761|FG002|Enrollment to Randomization|Screening Failure|0|||
130352848|NCT02011893|469262759|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
130352849|NCT02011893|469262760|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
130352850|NCT02011893|469262761|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
130352851|NCT02011893|469262759|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
130352852|NCT02011893|469262760|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
130352853|NCT02011893|469262761|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
130352854|NCT02011893|469262759|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
130352855|NCT02011893|469262760|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
130352856|NCT02011893|469262761|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
130352857|NCT02011893|469262759|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
130352858|NCT02011893|469262760|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
130352859|NCT02011893|469262761|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
130352860|NCT02011893|469262759|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
130352861|NCT02011893|469262760|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
130352862|NCT02011893|469262761|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
130352863|NCT01241240|469262762|FG000|Overall Study|Adverse Event|5|||
130352864|NCT01241240|469262763|FG001|Overall Study|Adverse Event|4|||
130352865|NCT01241240|469262762|FG000|Overall Study|Lost to Follow-up|2|||
130352866|NCT01241240|469262763|FG001|Overall Study|Lost to Follow-up|4|||
130352867|NCT01241240|469262762|FG000|Overall Study|Personal Reasons|1|||
130352868|NCT01241240|469262763|FG001|Overall Study|Personal Reasons|1|||
130352869|NCT00450112|469262764|FG000|Overall Study|Other Treatment Required|5|||
130352870|NCT00450112|469262765|FG001|Overall Study|Other Treatment Required|1|||
130352871|NCT00450112|469262764|FG000|Overall Study|Withdrawal by Subject|4|||
130352872|NCT00450112|469262765|FG001|Overall Study|Withdrawal by Subject|1|||
130352873|NCT00450112|469262764|FG000|Overall Study|Lost to Follow-up|2|||
130352874|NCT00450112|469262765|FG001|Overall Study|Lost to Follow-up|1|||
130352875|NCT00450112|469262764|FG000|Overall Study|Others|2|||
130352876|NCT00450112|469262765|FG001|Overall Study|Others|3|||
130352877|NCT05153473|469262766|FG000|Overall Study|Death|46|||
130352878|NCT05153473|469262766|FG000|Overall Study|Lost to Follow-up|3|||
130352879|NCT02962765|469262767|FG000|Overall Study|Protocol Violation|9|||
130352880|NCT02962765|469262767|FG000|Overall Study|Withdrawal by Subject|3|||
130352881|NCT02962765|469262767|FG000|Overall Study|Lost to Follow-up|1|||
130352882|NCT02962765|469262767|FG000|Overall Study|Death|1|||
130352883|NCT02962765|469262767|FG000|Overall Study|Limited access to study medication|3|||
130352884|NCT00064298|469262772|FG000|Overall Study|Withdrawal by Subject|2|||
130352885|NCT00064298|469262773|FG001|Overall Study|Withdrawal by Subject|1|||
130352886|NCT00064298|469262772|FG000|Overall Study|Lost to Follow-up|2|||
130352887|NCT00064298|469262773|FG001|Overall Study|Lost to Follow-up|2|||
130352888|NCT00064298|469262772|FG000|Overall Study|Death|0|||
130352889|NCT00064298|469262773|FG001|Overall Study|Death|1|||
130352890|NCT00064298|469262772|FG000|Overall Study|Disease Progression|2|||
130352891|NCT00064298|469262773|FG001|Overall Study|Disease Progression|1|||
130352892|NCT03614975|469262774|FG000|Overall Study|Physician Decision|7|||
130352893|NCT03614975|469262775|FG001|Overall Study|Physician Decision|5|||
130352894|NCT03614975|469262774|FG000|Overall Study|Withdrawal by Subject|2|||
130352895|NCT03614975|469262775|FG001|Overall Study|Withdrawal by Subject|2|||
130352896|NCT03614975|469262774|FG000|Overall Study|Specimens not in lab batch shipment|1|||
130352897|NCT03614975|469262775|FG001|Overall Study|Specimens not in lab batch shipment|1|||
130352898|NCT01569464|469262776|FG000|Overall Study|Adverse Event|4|||
130352899|NCT01569464|469262777|FG001|Overall Study|Adverse Event|0|||
130352900|NCT01569464|469262776|FG000|Overall Study|Lack of Efficacy|1|||
130352901|NCT01569464|469262777|FG001|Overall Study|Lack of Efficacy|0|||
130352902|NCT01569464|469262776|FG000|Overall Study|Protocol Violation|1|||
130352903|NCT01569464|469262777|FG001|Overall Study|Protocol Violation|0|||
130352904|NCT01569464|469262776|FG000|Overall Study|Lost to Follow-up|2|||
130352905|NCT01569464|469262777|FG001|Overall Study|Lost to Follow-up|3|||
130352906|NCT01569464|469262776|FG000|Overall Study|Withdrawal by Subject|1|||
130352907|NCT01569464|469262777|FG001|Overall Study|Withdrawal by Subject|1|||
130352908|NCT01569464|469262776|FG000|Overall Study|Other|1|||
130352909|NCT01569464|469262777|FG001|Overall Study|Other|1|||
130352910|NCT03533686|469262778|FG000|Overall Study|Withdrawal by Subject|1|||
130352911|NCT03533686|469262779|FG001|Overall Study|Withdrawal by Subject|0|||
130352912|NCT03533686|469262780|FG002|Overall Study|Withdrawal by Subject|0|||
130352913|NCT03533686|469262781|FG003|Overall Study|Withdrawal by Subject|3|||
130352914|NCT03533686|469262782|FG004|Overall Study|Withdrawal by Subject|5|||
130352915|NCT03533686|469262783|FG005|Overall Study|Withdrawal by Subject|1|||
130352916|NCT03533686|469262778|FG000|Overall Study|Lost to Follow-up|0|||
130352917|NCT03533686|469262779|FG001|Overall Study|Lost to Follow-up|1|||
130352918|NCT03533686|469262780|FG002|Overall Study|Lost to Follow-up|0|||
130352919|NCT03533686|469262781|FG003|Overall Study|Lost to Follow-up|0|||
130352920|NCT03533686|469262782|FG004|Overall Study|Lost to Follow-up|2|||
130352921|NCT03533686|469262783|FG005|Overall Study|Lost to Follow-up|0|||
130352922|NCT03533686|469262778|FG000|Overall Study|Screen Failure|0|||
130352923|NCT03533686|469262779|FG001|Overall Study|Screen Failure|0|||
130352924|NCT03533686|469262780|FG002|Overall Study|Screen Failure|0|||
130352925|NCT03533686|469262781|FG003|Overall Study|Screen Failure|2|||
130352926|NCT03533686|469262782|FG004|Overall Study|Screen Failure|0|||
130352927|NCT03533686|469262783|FG005|Overall Study|Screen Failure|0|||
130352928|NCT00245583|469262784|FG000|Overall Study|Lost to Follow-up|1|||
130352929|NCT00245583|469262785|FG001|Overall Study|Lost to Follow-up|5|||
130352930|NCT00245583|469262784|FG000|Overall Study|Adverse Event|2|||
130352931|NCT00245583|469262785|FG001|Overall Study|Adverse Event|1|||
130352932|NCT00245583|469262784|FG000|Overall Study|Lack of Efficacy|1|||
130352933|NCT00245583|469262785|FG001|Overall Study|Lack of Efficacy|0|||
130352934|NCT00245583|469262784|FG000|Overall Study|Withdrawal by Subject|2|||
130352935|NCT00245583|469262785|FG001|Overall Study|Withdrawal by Subject|3|||
130352936|NCT02414139|469262786|FG000|Treatment Period|Adverse Event|11|||
130352937|NCT02414139|469262787|FG001|Treatment Period|Adverse Event|6|||
130352938|NCT02414139|469262788|FG002|Treatment Period|Adverse Event|8|||
130352939|NCT02414139|469262789|FG003|Treatment Period|Adverse Event|5|||
130352940|NCT02414139|469262790|FG004|Treatment Period|Adverse Event|14|||
130352941|NCT02414139|469262791|FG005|Treatment Period|Adverse Event|3|||
130352942|NCT02414139|469262792|FG006|Treatment Period|Adverse Event|6|||
130352943|NCT02414139|469262793|FG007|Treatment Period|Adverse Event|1|||
130352944|NCT02414139|469262794|FG008|Treatment Period|Adverse Event|6|||
130352945|NCT02414139|469262795|FG009|Treatment Period|Adverse Event|8|||
130352946|NCT02414139|469262786|FG000|Treatment Period|Death|0|||
130352947|NCT02414139|469262787|FG001|Treatment Period|Death|0|||
130352948|NCT02414139|469262788|FG002|Treatment Period|Death|1|||
130352949|NCT02414139|469262789|FG003|Treatment Period|Death|1|||
130352950|NCT02414139|469262790|FG004|Treatment Period|Death|0|||
130352951|NCT02414139|469262791|FG005|Treatment Period|Death|0|||
130352952|NCT02414139|469262792|FG006|Treatment Period|Death|0|||
130352953|NCT02414139|469262793|FG007|Treatment Period|Death|0|||
130352954|NCT02414139|469262794|FG008|Treatment Period|Death|0|||
130352955|NCT02414139|469262795|FG009|Treatment Period|Death|1|||
130352956|NCT02414139|469262786|FG000|Treatment Period|Physician Decision|5|||
130352957|NCT02414139|469262787|FG001|Treatment Period|Physician Decision|4|||
130352958|NCT02414139|469262788|FG002|Treatment Period|Physician Decision|6|||
130352959|NCT02414139|469262789|FG003|Treatment Period|Physician Decision|1|||
130352960|NCT02414139|469262790|FG004|Treatment Period|Physician Decision|4|||
130352961|NCT02414139|469262791|FG005|Treatment Period|Physician Decision|0|||
130352962|NCT02414139|469262792|FG006|Treatment Period|Physician Decision|2|||
130352963|NCT02414139|469262793|FG007|Treatment Period|Physician Decision|0|||
130352964|NCT02414139|469262794|FG008|Treatment Period|Physician Decision|1|||
130352965|NCT02414139|469262795|FG009|Treatment Period|Physician Decision|4|||
130352966|NCT02414139|469262786|FG000|Treatment Period|Progressive disease|48|||
130352967|NCT02414139|469262787|FG001|Treatment Period|Progressive disease|31|||
130352968|NCT02414139|469262788|FG002|Treatment Period|Progressive disease|37|||
130352969|NCT02414139|469262789|FG003|Treatment Period|Progressive disease|21|||
130352970|NCT02414139|469262790|FG004|Treatment Period|Progressive disease|43|||
130352971|NCT02414139|469262791|FG005|Treatment Period|Progressive disease|12|||
130352972|NCT02414139|469262792|FG006|Treatment Period|Progressive disease|16|||
130352973|NCT02414139|469262793|FG007|Treatment Period|Progressive disease|2|||
130352974|NCT02414139|469262794|FG008|Treatment Period|Progressive disease|20|||
130352975|NCT02414139|469262795|FG009|Treatment Period|Progressive disease|14|||
130352976|NCT02414139|469262786|FG000|Treatment Period|Protocol deviation|0|||
130352977|NCT02414139|469262787|FG001|Treatment Period|Protocol deviation|0|||
130352978|NCT02414139|469262788|FG002|Treatment Period|Protocol deviation|1|||
130352979|NCT02414139|469262789|FG003|Treatment Period|Protocol deviation|0|||
130352980|NCT02414139|469262790|FG004|Treatment Period|Protocol deviation|0|||
130352981|NCT02414139|469262791|FG005|Treatment Period|Protocol deviation|0|||
130352982|NCT02414139|469262792|FG006|Treatment Period|Protocol deviation|0|||
130352983|NCT02414139|469262793|FG007|Treatment Period|Protocol deviation|0|||
130352984|NCT02414139|469262794|FG008|Treatment Period|Protocol deviation|0|||
130352985|NCT02414139|469262795|FG009|Treatment Period|Protocol deviation|0|||
130352986|NCT02414139|469262786|FG000|Treatment Period|Subject/Guardian decision|5|||
130352987|NCT02414139|469262787|FG001|Treatment Period|Subject/Guardian decision|1|||
130439520|NCT00251927|469573365|FG000|Overall Study|Study-specific discont. achieved|13|||
130439521|NCT00251927|469573366|FG001|Overall Study|Study-specific discont. achieved|2|||
130439522|NCT00251927|469573365|FG000|Overall Study|Study procedure non-compliance|5|||
130439523|NCT00251927|469573366|FG001|Overall Study|Study procedure non-compliance|6|||
130439524|NCT02222896|469573378|FG000|Abdomen|Did not qualify|34|||
130439525|NCT02222896|469573379|FG001|Abdomen|Did not qualify|10|||
130439526|NCT02222896|469573380|FG002|Abdomen|Did not qualify|32|||
130439527|NCT02222896|469573378|FG000|Groin|Did not qualify|43|||
130439528|NCT02222896|469573379|FG001|Groin|Did not qualify|9|||
130439529|NCT02222896|469573380|FG002|Groin|Did not qualify|40|||
130439530|NCT02226172|469573383|FG000|Overall Study|Participant refused further follow-up|4|||
130439531|NCT02226172|469573383|FG000|Overall Study|Other|5|||
130439532|NCT02226172|469573383|FG000|Overall Study|Death|1|||
130439533|NCT02226172|469573383|FG000|Overall Study|Study terminated by sponsor|1|||
130439534|NCT02226172|469573383|FG000|Overall Study|Adverse Event|6|||
130439535|NCT01865617|469573384|FG000|Overall Study|Death|27|||
130439536|NCT01865617|469573385|FG001|Overall Study|Death|3|||
130439537|NCT01865617|469573386|FG002|Overall Study|Death|1|||
130439538|NCT01865617|469573387|FG003|Overall Study|Death|1|||
130439539|NCT01865617|469573388|FG004|Overall Study|Death|5|||
130439540|NCT01865617|469573389|FG005|Overall Study|Death|1|||
130439541|NCT01865617|469573390|FG006|Overall Study|Death|11|||
130439542|NCT01865617|469573391|FG007|Overall Study|Death|1|||
130439543|NCT01865617|469573392|FG008|Overall Study|Death|11|||
130439544|NCT01865617|469573393|FG009|Overall Study|Death|3|||
130439545|NCT01865617|469573394|FG010|Overall Study|Death|32|||
130439546|NCT01865617|469573395|FG011|Overall Study|Death|6|||
130439547|NCT01865617|469573396|FG012|Overall Study|Death|13|||
130439548|NCT01865617|469573384|FG000|Overall Study|Lost to Follow-up|2|||
130439549|NCT01865617|469573385|FG001|Overall Study|Lost to Follow-up|0|||
130439550|NCT01865617|469573386|FG002|Overall Study|Lost to Follow-up|0|||
130439551|NCT01865617|469573387|FG003|Overall Study|Lost to Follow-up|0|||
130439552|NCT01865617|469573388|FG004|Overall Study|Lost to Follow-up|0|||
130439553|NCT01865617|469573389|FG005|Overall Study|Lost to Follow-up|0|||
130439554|NCT01865617|469573390|FG006|Overall Study|Lost to Follow-up|0|||
130439555|NCT01865617|469573391|FG007|Overall Study|Lost to Follow-up|0|||
130439556|NCT01865617|469573392|FG008|Overall Study|Lost to Follow-up|0|||
130439557|NCT01865617|469573393|FG009|Overall Study|Lost to Follow-up|0|||
130439558|NCT01865617|469573394|FG010|Overall Study|Lost to Follow-up|0|||
130439559|NCT01865617|469573395|FG011|Overall Study|Lost to Follow-up|0|||
130439560|NCT01865617|469573396|FG012|Overall Study|Lost to Follow-up|0|||
130439561|NCT01865617|469573384|FG000|Overall Study|Withdrawal by Subject|1|||
130439562|NCT01865617|469573385|FG001|Overall Study|Withdrawal by Subject|0|||
130439563|NCT01865617|469573386|FG002|Overall Study|Withdrawal by Subject|0|||
130439564|NCT01865617|469573387|FG003|Overall Study|Withdrawal by Subject|0|||
130439565|NCT01865617|469573388|FG004|Overall Study|Withdrawal by Subject|0|||
130439566|NCT01865617|469573389|FG005|Overall Study|Withdrawal by Subject|0|||
130439567|NCT01865617|469573390|FG006|Overall Study|Withdrawal by Subject|0|||
130439568|NCT01865617|469573391|FG007|Overall Study|Withdrawal by Subject|0|||
130439569|NCT01865617|469573392|FG008|Overall Study|Withdrawal by Subject|0|||
130439570|NCT01865617|469573393|FG009|Overall Study|Withdrawal by Subject|0|||
130439571|NCT01865617|469573394|FG010|Overall Study|Withdrawal by Subject|0|||
130439572|NCT01865617|469573395|FG011|Overall Study|Withdrawal by Subject|0|||
130439573|NCT01865617|469573396|FG012|Overall Study|Withdrawal by Subject|0|||
130439574|NCT01865617|469573384|FG000|Overall Study|Patient proceeded to new therapy|0|||
130439575|NCT01865617|469573385|FG001|Overall Study|Patient proceeded to new therapy|0|||
130439576|NCT01865617|469573386|FG002|Overall Study|Patient proceeded to new therapy|0|||
130439577|NCT01865617|469573387|FG003|Overall Study|Patient proceeded to new therapy|0|||
130439578|NCT01865617|469573388|FG004|Overall Study|Patient proceeded to new therapy|2|||
130439579|NCT01865617|469573389|FG005|Overall Study|Patient proceeded to new therapy|0|||
130439580|NCT01865617|469573390|FG006|Overall Study|Patient proceeded to new therapy|0|||
130439581|NCT01865617|469573391|FG007|Overall Study|Patient proceeded to new therapy|0|||
130439582|NCT01865617|469573392|FG008|Overall Study|Patient proceeded to new therapy|0|||
130439583|NCT01865617|469573393|FG009|Overall Study|Patient proceeded to new therapy|0|||
130439584|NCT01865617|469573394|FG010|Overall Study|Patient proceeded to new therapy|0|||
130439585|NCT01865617|469573395|FG011|Overall Study|Patient proceeded to new therapy|0|||
130439586|NCT01865617|469573396|FG012|Overall Study|Patient proceeded to new therapy|0|||
130685946|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130439587|NCT01865617|469573384|FG000|Overall Study|Other|0|||
130439588|NCT01865617|469573385|FG001|Overall Study|Other|0|||
130439589|NCT01865617|469573386|FG002|Overall Study|Other|0|||
130439590|NCT01865617|469573387|FG003|Overall Study|Other|0|||
130439591|NCT01865617|469573388|FG004|Overall Study|Other|0|||
130439592|NCT01865617|469573389|FG005|Overall Study|Other|0|||
130439593|NCT01865617|469573390|FG006|Overall Study|Other|1|||
130439594|NCT01865617|469573391|FG007|Overall Study|Other|0|||
130439595|NCT01865617|469573392|FG008|Overall Study|Other|0|||
130439596|NCT01865617|469573393|FG009|Overall Study|Other|0|||
130439597|NCT01865617|469573394|FG010|Overall Study|Other|0|||
130439598|NCT01865617|469573395|FG011|Overall Study|Other|0|||
130439599|NCT01865617|469573396|FG012|Overall Study|Other|0|||
130439600|NCT00258440|469573400|FG000|Overall Study|Withdrawal by Subject|0|||
130439601|NCT00258440|469573401|FG001|Overall Study|Withdrawal by Subject|0|||
130439602|NCT00258440|469573402|FG002|Overall Study|Withdrawal by Subject|1|||
130439603|NCT00737061|469573403|FG000|Waiting Period|Lost to Follow-up|6|||
130439604|NCT00737061|469573403|FG000|Waiting Period|Withdrawal by Subject|1|||
130439605|NCT00737061|469573403|FG000|Waiting Period|Bilateral placement failure|34|||
130439606|NCT00737061|469573403|FG000|Waiting Period|Deemed patent following HSG|26|||
130439607|NCT00737061|469573403|FG000|Waiting Period|Alternative contraception failure|3|||
130439608|NCT00737061|469573403|FG000|Waiting Period|Elected surgical tubal ligation|5|||
130439609|NCT00737061|469573403|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
130439610|NCT00737061|469573403|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
130439611|NCT00737061|469573403|FG000|1 Year Wearing Period|Discontinued reilance|3|||
130439612|NCT00737061|469573403|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
130439613|NCT00439179|469573405|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130439614|NCT00439179|469573406|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
130439615|NCT00439179|469573407|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130439616|NCT00439179|469573408|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130439617|NCT01844115|469573412|FG000|Overall Study|Adverse Event|4|||
130439618|NCT01844115|469573413|FG001|Overall Study|Adverse Event|22|||
130439619|NCT01844115|469573412|FG000|Overall Study|Lack of Efficacy|1|||
130439620|NCT01844115|469573413|FG001|Overall Study|Lack of Efficacy|4|||
130439621|NCT01844115|469573412|FG000|Overall Study|Protocol Violation|12|||
130439622|NCT01844115|469573413|FG001|Overall Study|Protocol Violation|10|||
130439623|NCT01844115|469573412|FG000|Overall Study|Withdrawal by Subject|11|||
130439624|NCT01844115|469573413|FG001|Overall Study|Withdrawal by Subject|11|||
130439625|NCT01844115|469573412|FG000|Overall Study|Lost to Follow-up|11|||
130439626|NCT01844115|469573413|FG001|Overall Study|Lost to Follow-up|10|||
130439627|NCT01844115|469573412|FG000|Overall Study|Pregnancy|0|||
130439628|NCT01844115|469573413|FG001|Overall Study|Pregnancy|1|||
130439629|NCT00758160|469573414|FG000|Overall Study|No Longer Requires Study Medication|4|||
130439630|NCT00758160|469573414|FG000|Overall Study|Administration Problems|3|||
130439631|NCT00758160|469573414|FG000|Overall Study|Adverse Event|15|||
130439632|NCT00758160|469573414|FG000|Overall Study|Lack of Efficacy|10|||
130439633|NCT00758160|469573414|FG000|Overall Study|Lost to Follow-up|14|||
130439634|NCT00758160|469573414|FG000|Overall Study|Protocol Violation|12|||
130439635|NCT00758160|469573414|FG000|Overall Study|Withdrawal by Subject|8|||
130439636|NCT01613027|469573415|FG000|Overall Study|Lost to Follow-up|5|||
130439637|NCT01613027|469573415|FG000|Overall Study|Switched Physician|1|||
130439638|NCT01613027|469573415|FG000|Overall Study|Lack of Efficacy|1|||
130439639|NCT01613027|469573415|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
130439640|NCT00993317|469573416|FG000|Overall Study|Adverse Event|2|||
130439641|NCT00993317|469573417|FG001|Overall Study|Adverse Event|4|||
130439642|NCT00993317|469573416|FG000|Overall Study|Lack of Efficacy|18|||
130439643|NCT00993317|469573417|FG001|Overall Study|Lack of Efficacy|18|||
130439644|NCT00993317|469573416|FG000|Overall Study|Withdrawal by Subject|0|||
130439645|NCT00993317|469573417|FG001|Overall Study|Withdrawal by Subject|2|||
130439646|NCT00993317|469573416|FG000|Overall Study|Investigator's opinion|0|||
130439647|NCT00993317|469573417|FG001|Overall Study|Investigator's opinion|1|||
130439648|NCT00993317|469573416|FG000|Overall Study|Early study termination at the site|1|||
130439649|NCT00993317|469573417|FG001|Overall Study|Early study termination at the site|0|||
130439650|NCT02153359|469573418|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
130439651|NCT02153359|469573419|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
130439652|NCT04422639|469573420|FG000|Overall Study|Death|1|||
130439653|NCT04422639|469573421|FG001|Overall Study|Death|0|||
130439654|NCT04422639|469573420|FG000|Overall Study|study closed prior to completion of FU visits|0|||
130439655|NCT04422639|469573421|FG001|Overall Study|study closed prior to completion of FU visits|2|||
130439656|NCT01964521|469573422|FG000|Overall Study|Lost to Follow-up|4|||
130439657|NCT01108510|469573423|FG000|Overall Study|Randomized but Not Treated|5|||
130439658|NCT01108510|469573424|FG001|Overall Study|Randomized but Not Treated|1|||
130439659|NCT01108510|469573423|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
130439660|NCT01108510|469573424|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
130439661|NCT01108510|469573423|FG000|Overall Study|Adverse Event|26|||
130439662|NCT01108510|469573424|FG001|Overall Study|Adverse Event|19|||
130439663|NCT01108510|469573423|FG000|Overall Study|Lost to Follow-up|20|||
130439664|NCT01108510|469573424|FG001|Overall Study|Lost to Follow-up|17|||
130439665|NCT01108510|469573423|FG000|Overall Study|Withdrew Consent|21|||
130439666|NCT01108510|469573424|FG001|Overall Study|Withdrew Consent|15|||
130439667|NCT01108510|469573423|FG000|Overall Study|Investigator's Discretion|12|||
130439668|NCT01108510|469573424|FG001|Overall Study|Investigator's Discretion|10|||
130439669|NCT01108510|469573423|FG000|Overall Study|Participant Noncompliance|5|||
130439670|NCT01108510|469573424|FG001|Overall Study|Participant Noncompliance|7|||
130439671|NCT01108510|469573423|FG000|Overall Study|Lack of Efficacy|3|||
130439672|NCT01108510|469573424|FG001|Overall Study|Lack of Efficacy|0|||
130439673|NCT01108510|469573423|FG000|Overall Study|Pregnancy|0|||
130220098|NCT00522548|468770125|FG000|Overall Study|Withdrawal by Subject|0|||
130220099|NCT00522548|468770126|FG001|Overall Study|Withdrawal by Subject|2|||
130220100|NCT04147247|468770127|FG000|Overall Study|Progressive disease|3|||
130352988|NCT02414139|469262788|FG002|Treatment Period|Subject/Guardian decision|1|||
130352989|NCT02414139|469262789|FG003|Treatment Period|Subject/Guardian decision|2|||
130352990|NCT02414139|469262790|FG004|Treatment Period|Subject/Guardian decision|5|||
130352991|NCT02414139|469262791|FG005|Treatment Period|Subject/Guardian decision|0|||
130352992|NCT02414139|469262792|FG006|Treatment Period|Subject/Guardian decision|2|||
130352993|NCT02414139|469262793|FG007|Treatment Period|Subject/Guardian decision|0|||
130352994|NCT02414139|469262794|FG008|Treatment Period|Subject/Guardian decision|1|||
130352995|NCT02414139|469262795|FG009|Treatment Period|Subject/Guardian decision|1|||
130352996|NCT02414139|469262786|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130352997|NCT02414139|469262787|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130352998|NCT02414139|469262788|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130352999|NCT02414139|469262789|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130353000|NCT02414139|469262790|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
130353001|NCT02414139|469262791|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130353002|NCT02414139|469262792|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
130353003|NCT02414139|469262793|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130353004|NCT02414139|469262794|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
130353005|NCT02414139|469262795|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
130353006|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130353007|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353008|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353009|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353010|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
130353011|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353012|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353013|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353014|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353015|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130353016|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130353017|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130353018|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Death|0|||
130353019|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Death|0|||
130353020|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Death|1|||
130353021|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Death|0|||
130353022|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Death|0|||
130353023|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Death|0|||
130353024|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Death|0|||
130353025|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Death|1|||
130353026|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
130353027|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353028|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353029|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353030|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353031|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353032|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353033|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353034|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353035|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130353036|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130353037|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130353038|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130353039|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130353040|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130353041|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130353042|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130353043|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130353044|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130353045|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130353046|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
130353047|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130353048|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
130353049|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130353050|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
130220101|NCT04147247|468770128|FG001|Overall Study|Progressive disease|3|||
130353051|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
130439674|NCT01108510|469573424|FG001|Overall Study|Pregnancy|3|||
130439675|NCT01108510|469573423|FG000|Overall Study|Death|1|||
130439676|NCT01108510|469573424|FG001|Overall Study|Death|1|||
130439677|NCT02796963|469573425|FG000|Overall Study|Lost to Follow-up|89|||
130439678|NCT02796963|469573426|FG001|Overall Study|Lost to Follow-up|76|||
130439679|NCT02796963|469573427|FG002|Overall Study|Lost to Follow-up|69|||
130439680|NCT02796963|469573428|FG003|Overall Study|Lost to Follow-up|72|||
130439681|NCT01258660|469573430|FG000|Overall Study|Adverse Event|2|||
130439682|NCT01258660|469573431|FG001|Overall Study|Adverse Event|4|||
130439683|NCT01258660|469573430|FG000|Overall Study|Withdrawal by Subject|3|||
130439684|NCT01258660|469573431|FG001|Overall Study|Withdrawal by Subject|0|||
130685947|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685948|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685949|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685950|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685951|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685952|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130439685|NCT01258660|469573430|FG000|Overall Study|due to relocation|2|||
130439686|NCT01258660|469573431|FG001|Overall Study|due to relocation|0|||
130439687|NCT01258660|469573430|FG000|Overall Study|Protocol Violation|0|||
130439688|NCT01258660|469573431|FG001|Overall Study|Protocol Violation|1|||
130439689|NCT01258660|469573430|FG000|Overall Study|Invalid for primary analysis data set|4|||
130439690|NCT01258660|469573431|FG001|Overall Study|Invalid for primary analysis data set|6|||
130439691|NCT04192630|469573432|FG000|Overall Study|Discontinued before surgery|2|||
130439692|NCT04192630|469573433|FG001|Overall Study|Discontinued before surgery|0|||
130439693|NCT04192630|469573432|FG000|Overall Study|Discontinued after surgery|5|||
130439694|NCT04192630|469573433|FG001|Overall Study|Discontinued after surgery|3|||
130439695|NCT01193582|469573434|FG000|Vaccination Series|Withdrawal by Subject|11|||
130439696|NCT01193582|469573435|FG001|Vaccination Series|Withdrawal by Subject|13|||
130439697|NCT01193582|469573436|FG002|Vaccination Series|Withdrawal by Subject|8|||
130439698|NCT01193582|469573437|FG003|Vaccination Series|Withdrawal by Subject|3|||
130439699|NCT01193582|469573434|FG000|12 Month Follow-up|Death|0|||
130439700|NCT01193582|469573435|FG001|12 Month Follow-up|Death|0|||
130439701|NCT01193582|469573436|FG002|12 Month Follow-up|Death|1|||
130439702|NCT01193582|469573437|FG003|12 Month Follow-up|Death|0|||
130439703|NCT01193582|469573434|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
130439704|NCT01193582|469573435|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
130439705|NCT01193582|469573436|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
130439706|NCT01193582|469573437|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
130439707|NCT01425632|469573438|FG000|Overall Study|Adverse Event|0|||
130439708|NCT01425632|469573439|FG001|Overall Study|Adverse Event|1|||
130439709|NCT01425632|469573440|FG002|Overall Study|Adverse Event|1|||
130439710|NCT01425632|469573438|FG000|Overall Study|Physician Decision|1|||
130439711|NCT01425632|469573439|FG001|Overall Study|Physician Decision|0|||
130439712|NCT01425632|469573440|FG002|Overall Study|Physician Decision|0|||
130439713|NCT01425632|469573438|FG000|Overall Study|Protocol Violation|0|||
130439714|NCT01425632|469573439|FG001|Overall Study|Protocol Violation|0|||
130439715|NCT01425632|469573440|FG002|Overall Study|Protocol Violation|2|||
130439716|NCT01425632|469573438|FG000|Overall Study|Withdrawal by Subject|0|||
130439717|NCT01425632|469573439|FG001|Overall Study|Withdrawal by Subject|0|||
130439718|NCT01425632|469573440|FG002|Overall Study|Withdrawal by Subject|1|||
130439719|NCT01464255|469573444|FG000|Overall Study|unresolve corneal staining|0|||
130439720|NCT01464255|469573445|FG001|Overall Study|unresolve corneal staining|1|||
130439721|NCT01231503|469573446|FG000|Overall Study|Adverse Event|0|||
130439722|NCT01231503|469573447|FG001|Overall Study|Adverse Event|0|||
130439723|NCT01231503|469573448|FG002|Overall Study|Adverse Event|0|||
130439724|NCT01231503|469573449|FG003|Overall Study|Adverse Event|0|||
130439725|NCT01231503|469573450|FG004|Overall Study|Adverse Event|0|||
130439726|NCT01231503|469573451|FG005|Overall Study|Adverse Event|1|||
130439727|NCT01231503|469573452|FG006|Overall Study|Adverse Event|0|||
130439728|NCT01231503|469573453|FG007|Overall Study|Adverse Event|0|||
130439729|NCT01231503|469573446|FG000|Overall Study|Adverse event, serious fatal|0|||
130439730|NCT01231503|469573447|FG001|Overall Study|Adverse event, serious fatal|0|||
130439731|NCT01231503|469573448|FG002|Overall Study|Adverse event, serious fatal|1|||
130439732|NCT01231503|469573449|FG003|Overall Study|Adverse event, serious fatal|1|||
130439733|NCT01231503|469573450|FG004|Overall Study|Adverse event, serious fatal|0|||
130439734|NCT01231503|469573451|FG005|Overall Study|Adverse event, serious fatal|1|||
130439735|NCT01231503|469573452|FG006|Overall Study|Adverse event, serious fatal|0|||
130439736|NCT01231503|469573453|FG007|Overall Study|Adverse event, serious fatal|0|||
130439737|NCT01231503|469573446|FG000|Overall Study|Withdrawal by Subject|6|||
130685953|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130439738|NCT01231503|469573447|FG001|Overall Study|Withdrawal by Subject|3|||
130439739|NCT01231503|469573448|FG002|Overall Study|Withdrawal by Subject|3|||
130439740|NCT01231503|469573449|FG003|Overall Study|Withdrawal by Subject|1|||
130439741|NCT01231503|469573450|FG004|Overall Study|Withdrawal by Subject|3|||
130439742|NCT01231503|469573451|FG005|Overall Study|Withdrawal by Subject|5|||
130439743|NCT01231503|469573452|FG006|Overall Study|Withdrawal by Subject|1|||
130439744|NCT01231503|469573453|FG007|Overall Study|Withdrawal by Subject|2|||
130439745|NCT01231503|469573446|FG000|Overall Study|Lost to Follow-up|8|||
130439746|NCT01231503|469573447|FG001|Overall Study|Lost to Follow-up|10|||
130439747|NCT01231503|469573448|FG002|Overall Study|Lost to Follow-up|8|||
130439748|NCT01231503|469573449|FG003|Overall Study|Lost to Follow-up|5|||
130439749|NCT01231503|469573450|FG004|Overall Study|Lost to Follow-up|7|||
130439750|NCT01231503|469573451|FG005|Overall Study|Lost to Follow-up|9|||
130439751|NCT01231503|469573452|FG006|Overall Study|Lost to Follow-up|6|||
130439752|NCT01231503|469573453|FG007|Overall Study|Lost to Follow-up|6|||
130439753|NCT01231503|469573446|FG000|Overall Study|Protocol Violation|0|||
130439754|NCT01231503|469573447|FG001|Overall Study|Protocol Violation|0|||
130439755|NCT01231503|469573448|FG002|Overall Study|Protocol Violation|0|||
130439756|NCT01231503|469573449|FG003|Overall Study|Protocol Violation|1|||
130439757|NCT01231503|469573450|FG004|Overall Study|Protocol Violation|0|||
130439758|NCT01231503|469573451|FG005|Overall Study|Protocol Violation|0|||
130439759|NCT01231503|469573452|FG006|Overall Study|Protocol Violation|0|||
130439760|NCT01231503|469573453|FG007|Overall Study|Protocol Violation|0|||
130439761|NCT01868074|469573456|FG000|Overall Study|Lost to Follow-up|3|||
130439762|NCT01868074|469573457|FG001|Overall Study|Lost to Follow-up|2|||
130439763|NCT01868074|469573456|FG000|Overall Study|Withdrawal by Subject|4|||
130439764|NCT01868074|469573457|FG001|Overall Study|Withdrawal by Subject|2|||
130439765|NCT04642469|469573460|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
130439766|NCT04642469|469573461|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
130439767|NCT04642469|469573460|FG000|Overall Study|Death|1|||
130439768|NCT04642469|469573461|FG001|Overall Study|Death|2|||
130439769|NCT04642469|469573460|FG000|Overall Study|Study/site closed following amendment 1|11|||
130439770|NCT04642469|469573461|FG001|Overall Study|Study/site closed following amendment 1|11|||
130439771|NCT04642469|469573460|FG000|Overall Study|Other|1|||
130439772|NCT04642469|469573461|FG001|Overall Study|Other|1|||
130439773|NCT04642469|469573460|FG000|Overall Study|Withdrawal by Subject|1|||
130439774|NCT04642469|469573461|FG001|Overall Study|Withdrawal by Subject|0|||
130439775|NCT01461993|469573462|FG000|Overall Study|Withdrawal by Subject|60|||
130439776|NCT01461993|469573463|FG001|Overall Study|Withdrawal by Subject|53|||
130439777|NCT01461993|469573464|FG002|Overall Study|Withdrawal by Subject|16|||
130439778|NCT01461993|469573462|FG000|Overall Study|Lost to Follow-up|44|||
130439779|NCT01461993|469573463|FG001|Overall Study|Lost to Follow-up|48|||
130439780|NCT01461993|469573464|FG002|Overall Study|Lost to Follow-up|22|||
130439781|NCT01461993|469573462|FG000|Overall Study|Protocol Violation|10|||
130439782|NCT01461993|469573463|FG001|Overall Study|Protocol Violation|9|||
130439783|NCT01461993|469573464|FG002|Overall Study|Protocol Violation|7|||
130439784|NCT01461993|469573462|FG000|Overall Study|Adverse Event|9|||
130439785|NCT01461993|469573463|FG001|Overall Study|Adverse Event|11|||
130439786|NCT01461993|469573464|FG002|Overall Study|Adverse Event|3|||
130439787|NCT01461993|469573462|FG000|Overall Study|No longer met eligibility criteria|13|||
130439788|NCT01461993|469573463|FG001|Overall Study|No longer met eligibility criteria|18|||
130439789|NCT01461993|469573464|FG002|Overall Study|No longer met eligibility criteria|10|||
130439790|NCT01461993|469573462|FG000|Overall Study|Did not meet entrance criteria|2|||
130439791|NCT01461993|469573463|FG001|Overall Study|Did not meet entrance criteria|3|||
130439792|NCT01461993|469573464|FG002|Overall Study|Did not meet entrance criteria|0|||
130439793|NCT01461993|469573462|FG000|Overall Study|Other|13|||
130439794|NCT01461993|469573463|FG001|Overall Study|Other|15|||
130439795|NCT01461993|469573464|FG002|Overall Study|Other|6|||
130439796|NCT00680056|469573466|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
130439797|NCT00680056|469573467|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
130439798|NCT00680056|469573466|FG000|Second Intervention|Protocol Violation|3|||
130439799|NCT00680056|469573467|FG001|Second Intervention|Protocol Violation|1|||
130439800|NCT00219141|469573468|FG000|Overall Study|Adverse Event|4|||
130439801|NCT00219141|469573469|FG001|Overall Study|Adverse Event|10|||
130439802|NCT00219141|469573470|FG002|Overall Study|Adverse Event|5|||
130439803|NCT00219141|469573468|FG000|Overall Study|Lack of Efficacy|3|||
130439804|NCT00219141|469573469|FG001|Overall Study|Lack of Efficacy|2|||
130439805|NCT00219141|469573470|FG002|Overall Study|Lack of Efficacy|0|||
130439806|NCT00219141|469573468|FG000|Overall Study|Administrative problems|0|||
130439807|NCT00219141|469573469|FG001|Overall Study|Administrative problems|1|||
130439808|NCT00219141|469573470|FG002|Overall Study|Administrative problems|0|||
130439809|NCT00219141|469573468|FG000|Overall Study|Lost to Follow-up|2|||
130439810|NCT00219141|469573469|FG001|Overall Study|Lost to Follow-up|4|||
130685954|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130439811|NCT00219141|469573470|FG002|Overall Study|Lost to Follow-up|1|||
130439812|NCT00219141|469573468|FG000|Overall Study|Protocol Violation|3|||
130439813|NCT00219141|469573469|FG001|Overall Study|Protocol Violation|1|||
130439814|NCT00219141|469573470|FG002|Overall Study|Protocol Violation|1|||
130439815|NCT00219141|469573468|FG000|Overall Study|Withdrawal by Subject|1|||
130439816|NCT00219141|469573469|FG001|Overall Study|Withdrawal by Subject|3|||
130439817|NCT00219141|469573470|FG002|Overall Study|Withdrawal by Subject|5|||
130439818|NCT00219141|469573468|FG000|Overall Study|Condition no longer requires study drug|1|||
130439819|NCT00219141|469573469|FG001|Overall Study|Condition no longer requires study drug|0|||
130439820|NCT00219141|469573470|FG002|Overall Study|Condition no longer requires study drug|0|||
130439821|NCT02838628|469573471|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
130439822|NCT02838628|469573472|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
130439823|NCT02838628|469573471|FG000|Recurrence Follow-up Period|Adverse Event|1|||
130439824|NCT02838628|469573472|FG001|Recurrence Follow-up Period|Adverse Event|0|||
130439825|NCT02838628|469573471|FG000|Recurrence Follow-up Period|Non-compliance|0|||
130439826|NCT02838628|469573472|FG001|Recurrence Follow-up Period|Non-compliance|1|||
130439827|NCT02838628|469573471|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
130439828|NCT02838628|469573472|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
130439829|NCT02838628|469573471|FG000|Recurrence Follow-up Period|Other un-specified|1|||
130439830|NCT02838628|469573472|FG001|Recurrence Follow-up Period|Other un-specified|1|||
130439831|NCT02066532|469573473|FG000|Phase II|Withdrawal by Subject|1|||
130439832|NCT02066532|469573474|FG001|Phase II|Withdrawal by Subject|0|||
130439833|NCT02066532|469573475|FG002|Phase II|Withdrawal by Subject|0|||
130439834|NCT02066532|469573476|FG003|Phase II|Withdrawal by Subject|0|||
130439835|NCT01265823|469573477|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
130439836|NCT01265823|469573477|FG000|Overall Study|Failure to Return|4|||
130439837|NCT01265823|469573477|FG000|Overall Study|Protocol Violation|1|||
130439838|NCT01265823|469573477|FG000|Overall Study|Participant Request|1|||
130439839|NCT01018563|469573484|FG000|Overall Study|Termination of the study by Sponsor|2|||
130439840|NCT01018563|469573485|FG001|Overall Study|Termination of the study by Sponsor|1|||
130439841|NCT02344537|469573486|FG000|Overall Study|Protocol Violation|1|||
130439842|NCT02344537|469573487|FG001|Overall Study|Protocol Violation|1|||
130439843|NCT02344537|469573486|FG000|Overall Study|Subject started another treatment after wk 6|1|||
130439844|NCT02344537|469573487|FG001|Overall Study|Subject started another treatment after wk 6|0|||
130439845|NCT02344537|469573486|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
130439846|NCT02344537|469573487|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
130439847|NCT00960752|469573489|FG000|Overall Study|Adverse Event|0|||
130439848|NCT00960752|469573490|FG001|Overall Study|Adverse Event|0|||
130439849|NCT00960752|469573491|FG002|Overall Study|Adverse Event|1|||
130439850|NCT00960752|469573489|FG000|Overall Study|Progression|0|||
130439851|NCT00960752|469573490|FG001|Overall Study|Progression|0|||
130439852|NCT00960752|469573491|FG002|Overall Study|Progression|1|||
130439853|NCT02180438|469573497|FG000|Overall Study|Lost to Follow-up|1|||
130439854|NCT00180713|469573501|FG000|Overall Study|Withdrawal by Subject|2|||
130439855|NCT00180713|469573502|FG001|Overall Study|Withdrawal by Subject|0|||
130439856|NCT00180713|469573501|FG000|Overall Study|Adverse Event|3|||
130439857|NCT00180713|469573502|FG001|Overall Study|Adverse Event|3|||
130439858|NCT01567865|469573504|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
130439859|NCT01567865|469573505|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
130439860|NCT01567865|469573506|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
130439861|NCT01567865|469573507|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
130439862|NCT01567865|469573504|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
130439863|NCT01567865|469573505|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
130439864|NCT01567865|469573506|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
130439865|NCT01567865|469573507|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
130439866|NCT01051063|469573512|FG000|Overall Study|Death|2|||
130439867|NCT01051063|469573513|FG001|Overall Study|Death|2|||
130439868|NCT01051063|469573512|FG000|Overall Study|Withdrawal by Subject|1|||
130439869|NCT01051063|469573513|FG001|Overall Study|Withdrawal by Subject|1|||
130439870|NCT01051063|469573512|FG000|Overall Study|Termination of the study|5|||
130439871|NCT01051063|469573513|FG001|Overall Study|Termination of the study|0|||
130439872|NCT01051063|469573512|FG000|Overall Study|Moved from the study site area|1|||
130439873|NCT01051063|469573513|FG001|Overall Study|Moved from the study site area|0|||
130439874|NCT01051063|469573512|FG000|Overall Study|Other|1|||
130439875|NCT01051063|469573513|FG001|Overall Study|Other|0|||
130439876|NCT01051063|469573512|FG000|Overall Study|Lost to Follow-up|0|||
130439877|NCT01051063|469573513|FG001|Overall Study|Lost to Follow-up|1|||
130439878|NCT03857841|469573515|FG000|Overall Study|Death|1|||
130439879|NCT03857841|469573516|FG001|Overall Study|Death|0|||
130439880|NCT03857841|469573517|FG002|Overall Study|Death|0|||
130439881|NCT03857841|469573518|FG003|Overall Study|Death|0|||
130439882|NCT03857841|469573515|FG000|Overall Study|Study Terminated by Sponsor|1|||
130439883|NCT03857841|469573516|FG001|Overall Study|Study Terminated by Sponsor|0|||
130439884|NCT03857841|469573517|FG002|Overall Study|Study Terminated by Sponsor|0|||
130439885|NCT03857841|469573518|FG003|Overall Study|Study Terminated by Sponsor|0|||
130439886|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130439887|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
130439888|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
130439889|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130439890|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130220102|NCT04147247|468770129|FG002|Overall Study|Progressive disease|4|||
130685955|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130220103|NCT04147247|468770130|FG003|Overall Study|Progressive disease|4|||
130439891|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130685956|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685957|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685958|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685959|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685960|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685961|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685962|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685963|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685964|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685965|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685966|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685967|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685968|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685969|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685970|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685971|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685972|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
130685973|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685974|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130220104|NCT04147247|468770131|FG004|Overall Study|Progressive disease|3|||
130220105|NCT04147247|468770127|FG000|Overall Study|Physician Decision|0|||
130220106|NCT04147247|468770128|FG001|Overall Study|Physician Decision|1|||
130220107|NCT04147247|468770129|FG002|Overall Study|Physician Decision|0|||
130220108|NCT04147247|468770130|FG003|Overall Study|Physician Decision|0|||
130220109|NCT04147247|468770131|FG004|Overall Study|Physician Decision|0|||
130220110|NCT04147247|468770127|FG000|Overall Study|Clinical Disease Progression|0|||
130220111|NCT04147247|468770128|FG001|Overall Study|Clinical Disease Progression|0|||
130220112|NCT04147247|468770129|FG002|Overall Study|Clinical Disease Progression|0|||
130220113|NCT04147247|468770130|FG003|Overall Study|Clinical Disease Progression|0|||
130220114|NCT04147247|468770131|FG004|Overall Study|Clinical Disease Progression|1|||
130220115|NCT04147247|468770127|FG000|Overall Study|Adverse Event|0|||
130220116|NCT04147247|468770128|FG001|Overall Study|Adverse Event|0|||
130220117|NCT04147247|468770129|FG002|Overall Study|Adverse Event|1|||
130220118|NCT04147247|468770130|FG003|Overall Study|Adverse Event|0|||
130220119|NCT04147247|468770131|FG004|Overall Study|Adverse Event|1|||
130220120|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
130220121|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220122|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220123|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220124|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220125|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
130220126|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220127|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220128|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220129|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220130|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
130220131|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220132|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220133|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220134|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220135|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
130220136|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220137|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220138|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220139|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220140|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
130220141|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220142|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220143|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220144|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220145|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
130220146|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220147|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220148|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220149|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220150|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
130220151|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130439892|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130439893|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
130439894|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439895|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439896|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439897|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439898|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439899|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130439900|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
130439901|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130439902|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130439903|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130439904|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130439905|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130439906|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130439907|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130439908|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
130439909|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
130439910|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130439911|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130439912|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130439913|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130439914|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439915|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439916|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
130439917|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439918|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439919|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439920|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130439921|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
130439922|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
130439923|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
130439924|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130439925|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130439926|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130439927|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130439928|NCT04921969|469573519|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
130439929|NCT04921969|469573520|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
130439930|NCT04921969|469573521|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130439931|NCT04921969|469573522|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130439932|NCT04921969|469573523|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130439933|NCT04921969|469573524|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130439934|NCT04921969|469573525|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130439935|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130439936|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130220152|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130439937|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130439938|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130439939|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130439940|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130439941|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
130439942|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130439943|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130439944|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130439945|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130439946|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130439947|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
130439948|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130439949|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130439950|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130220153|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130220154|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130439951|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130439952|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
130439953|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
130220155|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130439954|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
130439955|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
130353052|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130353053|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
130353054|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130353055|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130353056|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353057|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
130353058|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353059|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353060|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353061|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353062|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353063|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353064|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130353065|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
130353066|NCT02414139|469262786|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
130353067|NCT02414139|469262787|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130353068|NCT02414139|469262788|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
130353069|NCT02414139|469262789|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130353070|NCT02414139|469262790|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130353071|NCT02414139|469262791|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130353072|NCT02414139|469262792|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130353073|NCT02414139|469262793|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130353074|NCT02414139|469262794|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130353075|NCT02414139|469262795|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130353076|NCT03631355|469262796|FG000|Overall Study|Lost to Follow-up|1|||
130353077|NCT03631355|469262797|FG001|Overall Study|Lost to Follow-up|2|||
130353078|NCT01369485|469262802|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
130353079|NCT01369485|469262803|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
130353080|NCT01369485|469262802|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
130353081|NCT01369485|469262803|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
130353082|NCT01369485|469262802|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
130353083|NCT01369485|469262803|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
130353084|NCT01369485|469262802|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
130353085|NCT01369485|469262803|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
130353086|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
130353087|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
130353088|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
130353089|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
130353090|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
130353091|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
130353092|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
130353093|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
130353094|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
130353095|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
130353096|NCT01369485|469262802|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
130353097|NCT01369485|469262803|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
130353098|NCT04706416|469262808|FG000|Overall Study|Lost to Follow-up|2|||
130353099|NCT04706416|469262809|FG001|Overall Study|Lost to Follow-up|0|||
130353100|NCT01539317|469262813|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
130353101|NCT01539317|469262814|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
130353102|NCT02117427|469262819|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
130353103|NCT02117427|469262820|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
130353104|NCT02117427|469262821|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
130353105|NCT02117427|469262819|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
130353106|NCT02117427|469262820|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
130353107|NCT02117427|469262821|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
130353108|NCT02117427|469262819|FG000|Overall Study|Physician Decision|0|||
130353109|NCT02117427|469262820|FG001|Overall Study|Physician Decision|2|||
130353110|NCT02117427|469262821|FG002|Overall Study|Physician Decision|0|||
130353111|NCT02117427|469262819|FG000|Overall Study|No longer meets inclusion criteria|0|||
130353112|NCT02117427|469262820|FG001|Overall Study|No longer meets inclusion criteria|1|||
130353113|NCT02117427|469262821|FG002|Overall Study|No longer meets inclusion criteria|0|||
130353114|NCT02117427|469262819|FG000|Overall Study|Death|0|||
130353115|NCT02117427|469262820|FG001|Overall Study|Death|1|||
130685975|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685976|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130353116|NCT02117427|469262821|FG002|Overall Study|Death|0|||
130353117|NCT02730208|469262822|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130353118|NCT02730208|469262823|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130353119|NCT00510952|469262829|FG000|Overall Study|Adverse Event|1|||
130353120|NCT00510952|469262830|FG001|Overall Study|Adverse Event|0|||
130353121|NCT00510952|469262829|FG000|Overall Study|Entry Criteria Not Met|3|||
130353122|NCT00510952|469262830|FG001|Overall Study|Entry Criteria Not Met|1|||
130353123|NCT00510952|469262829|FG000|Overall Study|Lost to Follow-up|5|||
130353124|NCT00510952|469262830|FG001|Overall Study|Lost to Follow-up|3|||
130353125|NCT00510952|469262829|FG000|Overall Study|Physician Decision|1|||
130353126|NCT00510952|469262830|FG001|Overall Study|Physician Decision|1|||
130353127|NCT00510952|469262829|FG000|Overall Study|Protocol Violation|7|||
130353128|NCT00510952|469262830|FG001|Overall Study|Protocol Violation|4|||
130353129|NCT00510952|469262829|FG000|Overall Study|Sponsor Decision|1|||
130353130|NCT00510952|469262830|FG001|Overall Study|Sponsor Decision|0|||
130353131|NCT00510952|469262829|FG000|Overall Study|Withdrawal by Subject|6|||
130353132|NCT00510952|469262830|FG001|Overall Study|Withdrawal by Subject|7|||
130353133|NCT00510952|469262829|FG000|Overall Study|Did Not Receive Study Drug|2|||
130353134|NCT00510952|469262830|FG001|Overall Study|Did Not Receive Study Drug|0|||
130353135|NCT02793128|469262840|FG000|Overall Study|Death|4|||
130353136|NCT02793128|469262840|FG000|Overall Study|Withdrawal by Subject|2|||
130353137|NCT02793128|469262840|FG000|Overall Study|Physician Decision|1|||
130353138|NCT02793128|469262840|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
130353139|NCT02793128|469262840|FG000|Overall Study|Patient elected nephroureterectomy|1|||
130353140|NCT02359851|469262841|FG000|Overall Study|Death|1|||
130353141|NCT02359851|469262841|FG000|Overall Study|Disease progression|1|||
130353142|NCT01888003|469262842|FG000|Overall Study|Study Terminated|5|||
130353143|NCT01888003|469262843|FG001|Overall Study|Study Terminated|6|||
130685977|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685978|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685979|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685980|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685981|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685982|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685983|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685984|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685985|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685986|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685987|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685988|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685989|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685990|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685991|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685992|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685993|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685994|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685995|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685996|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
130685997|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
130685998|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
130685999|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130686000|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130686001|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130353144|NCT01888003|469262844|FG002|Overall Study|Study Terminated|40|||
130353145|NCT00055471|469262845|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
130353146|NCT00055471|469262846|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
130353147|NCT00055471|469262847|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
130353148|NCT00055471|469262845|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
130353149|NCT00055471|469262846|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
130353150|NCT00055471|469262847|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
130353151|NCT00055471|469262845|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
130353152|NCT00055471|469262846|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
130353153|NCT00055471|469262847|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
130353154|NCT01854944|469262848|FG000|Overall Study|Withdrawal by Subject|0|||
130353155|NCT01854944|469262849|FG001|Overall Study|Withdrawal by Subject|0|||
130353156|NCT01854944|469262850|FG002|Overall Study|Withdrawal by Subject|1|||
130353157|NCT02101112|469262851|FG000|Overall Study|Adverse Event|0|||
130353158|NCT02101112|469262852|FG001|Overall Study|Adverse Event|0|||
130353159|NCT02101112|469262853|FG002|Overall Study|Adverse Event|1|||
130353160|NCT02101112|469262854|FG003|Overall Study|Adverse Event|0|||
130353161|NCT02101112|469262855|FG004|Overall Study|Adverse Event|0|||
130353162|NCT02101112|469262856|FG005|Overall Study|Adverse Event|0|||
130353163|NCT02101112|469262851|FG000|Overall Study|Withdrawal by Subject|0|||
130353164|NCT02101112|469262852|FG001|Overall Study|Withdrawal by Subject|0|||
130353165|NCT02101112|469262853|FG002|Overall Study|Withdrawal by Subject|0|||
130353166|NCT02101112|469262854|FG003|Overall Study|Withdrawal by Subject|0|||
130353167|NCT02101112|469262855|FG004|Overall Study|Withdrawal by Subject|1|||
130353168|NCT02101112|469262856|FG005|Overall Study|Withdrawal by Subject|0|||
130353169|NCT02125604|469262857|FG000|Overall Study|Other|4|||
130353170|NCT02125604|469262857|FG000|Overall Study|Investigator Decision|1|||
130353171|NCT02125604|469262857|FG000|Overall Study|Lost to Follow-up|2|||
130353172|NCT02125604|469262857|FG000|Overall Study|Consent Withdrawn|4|||
130353173|NCT02125604|469262857|FG000|Overall Study|Adverse Event|20|||
130353174|NCT04340063|469262858|FG000|Overall Study|Withdrawal by Subject|1|||
130353175|NCT04340063|469262859|FG001|Overall Study|Withdrawal by Subject|2|||
130353176|NCT04340063|469262858|FG000|Overall Study|Lost to Follow-up|3|||
130353177|NCT04340063|469262859|FG001|Overall Study|Lost to Follow-up|1|||
130353178|NCT04340063|469262858|FG000|Overall Study|Protocol Violation|0|||
130353179|NCT04340063|469262859|FG001|Overall Study|Protocol Violation|1|||
130353180|NCT01876810|469262860|FG000|Overall Study|Physician Decision|0|||
130353181|NCT01876810|469262861|FG001|Overall Study|Physician Decision|1|||
130353182|NCT05828095|469264414|FG000|Overall Study|Lost to Follow-up|1|||
130353183|NCT05828095|469264415|FG001|Overall Study|Lost to Follow-up|0|||
130353184|NCT05828095|469264414|FG000|Overall Study|Reactogenicity symptom|0|||
130353185|NCT05828095|469264415|FG001|Overall Study|Reactogenicity symptom|1|||
130353186|NCT03206073|469264416|FG000|Overall Study|Participant Noncompliance|0|||
130353187|NCT03206073|469264417|FG001|Overall Study|Participant Noncompliance|1|||
130353188|NCT03206073|469264418|FG002|Overall Study|Participant Noncompliance|0|||
130353189|NCT03206073|469264419|FG003|Overall Study|Participant Noncompliance|0|||
130353190|NCT03206073|469264416|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
130353191|NCT03206073|469264417|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130353192|NCT03206073|469264418|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130353193|NCT03206073|469264419|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130353194|NCT03206073|469264416|FG000|Overall Study|Death|0|||
130353195|NCT03206073|469264417|FG001|Overall Study|Death|0|||
130353196|NCT03206073|469264418|FG002|Overall Study|Death|1|||
130353197|NCT03206073|469264419|FG003|Overall Study|Death|0|||
130353198|NCT03206073|469264416|FG000|Overall Study|Taken off active treatment|0|||
130353199|NCT03206073|469264417|FG001|Overall Study|Taken off active treatment|0|||
130353200|NCT03206073|469264418|FG002|Overall Study|Taken off active treatment|3|||
130353201|NCT03206073|469264419|FG003|Overall Study|Taken off active treatment|0|||
130353202|NCT03332771|469264420|FG000|Overall Study|Adverse Event|6|||
130353203|NCT03332771|469264421|FG001|Overall Study|Adverse Event|4|||
130353204|NCT03332771|469264422|FG002|Overall Study|Adverse Event|1|||
130353205|NCT03332771|469264423|FG003|Overall Study|Adverse Event|3|||
130353206|NCT03332771|469264420|FG000|Overall Study|Poor Compliance to Protocol|0|||
130353207|NCT03332771|469264421|FG001|Overall Study|Poor Compliance to Protocol|1|||
130353208|NCT03332771|469264422|FG002|Overall Study|Poor Compliance to Protocol|0|||
130353209|NCT03332771|469264423|FG003|Overall Study|Poor Compliance to Protocol|1|||
130353210|NCT03332771|469264420|FG000|Overall Study|Lost to Follow-up|2|||
130353211|NCT03332771|469264421|FG001|Overall Study|Lost to Follow-up|2|||
130353212|NCT03332771|469264422|FG002|Overall Study|Lost to Follow-up|1|||
130353213|NCT03332771|469264423|FG003|Overall Study|Lost to Follow-up|2|||
130353214|NCT03332771|469264420|FG000|Overall Study|At the Participant's own request|20|||
130353215|NCT03332771|469264421|FG001|Overall Study|At the Participant's own request|26|||
130353216|NCT03332771|469264422|FG002|Overall Study|At the Participant's own request|14|||
130353217|NCT03332771|469264423|FG003|Overall Study|At the Participant's own request|23|||
130353218|NCT03332771|469264420|FG000|Overall Study|Reason Not Specified|6|||
130353219|NCT03332771|469264421|FG001|Overall Study|Reason Not Specified|18|||
130353220|NCT03332771|469264422|FG002|Overall Study|Reason Not Specified|16|||
130353221|NCT03332771|469264423|FG003|Overall Study|Reason Not Specified|19|||
130353222|NCT00096954|469264424|FG000|Overall Study|Adverse Event|3|||
130353223|NCT00096954|469264425|FG001|Overall Study|Adverse Event|1|||
130353224|NCT00096954|469264424|FG000|Overall Study|Withdrawal by Subject|9|||
130353225|NCT00096954|469264425|FG001|Overall Study|Withdrawal by Subject|8|||
130353226|NCT00096954|469264424|FG000|Overall Study|Physician Decision|1|||
130353227|NCT00096954|469264425|FG001|Overall Study|Physician Decision|1|||
130353228|NCT00096954|469264424|FG000|Overall Study|Sponsors Decision|1|||
130353229|NCT00096954|469264425|FG001|Overall Study|Sponsors Decision|1|||
130353230|NCT00096954|469264424|FG000|Overall Study|Pregnancy|1|||
130353231|NCT00096954|469264425|FG001|Overall Study|Pregnancy|1|||
130353232|NCT00096954|469264424|FG000|Overall Study|Initiation of immunotherapy|1|||
130353233|NCT00096954|469264425|FG001|Overall Study|Initiation of immunotherapy|0|||
130439956|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130353234|NCT00096954|469264424|FG000|Overall Study|Non-compliance|0|||
130353235|NCT00096954|469264425|FG001|Overall Study|Non-compliance|3|||
130353236|NCT00096954|469264424|FG000|Overall Study|Lost to Follow-up|8|||
130353237|NCT00096954|469264425|FG001|Overall Study|Lost to Follow-up|5|||
130353238|NCT04478123|469264427|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
130353239|NCT04478123|469264427|FG000|Overall Study|NE|1|||
130353240|NCT04444895|469264428|FG000|Overall Study|Adverse Event|2|||
130353241|NCT04444895|469264428|FG000|Overall Study|Lost to Follow-up|2|||
130353242|NCT04444895|469264428|FG000|Overall Study|Withdrawal by Subject|5|||
130353243|NCT03581786|469264431|FG000|Overall Study|Death|67|||
130353244|NCT03581786|469264432|FG001|Overall Study|Death|47|||
130353245|NCT03581786|469264431|FG000|Overall Study|Withdrawal by Subject|2|||
130353246|NCT03581786|469264432|FG001|Overall Study|Withdrawal by Subject|5|||
130353247|NCT03581786|469264431|FG000|Overall Study|Lost to Follow-up|7|||
130353248|NCT03581786|469264432|FG001|Overall Study|Lost to Follow-up|4|||
130353249|NCT03581786|469264431|FG000|Overall Study|reason other than specified above|0|||
130353250|NCT03581786|469264432|FG001|Overall Study|reason other than specified above|1|||
130353251|NCT05523323|469264433|FG000|Overall Study|Death|26|||
130353252|NCT05523323|469264434|FG001|Overall Study|Death|21|||
130353253|NCT05523323|469264433|FG000|Overall Study|Ongoing participants|35|||
130353254|NCT05523323|469264434|FG001|Overall Study|Ongoing participants|30|||
130353255|NCT03435640|469264435|FG000|Overall Study|Withdrawal by Subject|0|||
130353256|NCT03435640|469264436|FG001|Overall Study|Withdrawal by Subject|1|||
130353257|NCT03435640|469264437|FG002|Overall Study|Withdrawal by Subject|0|||
130353258|NCT03435640|469264438|FG003|Overall Study|Withdrawal by Subject|2|||
130353259|NCT03435640|469264439|FG004|Overall Study|Withdrawal by Subject|0|||
130353260|NCT03435640|469264440|FG005|Overall Study|Withdrawal by Subject|0|||
130353261|NCT03435640|469264441|FG006|Overall Study|Withdrawal by Subject|3|||
130353262|NCT03435640|469264442|FG007|Overall Study|Withdrawal by Subject|0|||
130353263|NCT03435640|469264443|FG008|Overall Study|Withdrawal by Subject|0|||
130353264|NCT03435640|469264444|FG009|Overall Study|Withdrawal by Subject|2|||
130353265|NCT03435640|469264445|FG010|Overall Study|Withdrawal by Subject|3|||
130353266|NCT03435640|469264435|FG000|Overall Study|Lost to Follow-up|0|||
130353267|NCT03435640|469264436|FG001|Overall Study|Lost to Follow-up|0|||
130353268|NCT03435640|469264437|FG002|Overall Study|Lost to Follow-up|1|||
130353269|NCT03435640|469264438|FG003|Overall Study|Lost to Follow-up|0|||
130353270|NCT03435640|469264439|FG004|Overall Study|Lost to Follow-up|0|||
130353271|NCT03435640|469264440|FG005|Overall Study|Lost to Follow-up|0|||
130353272|NCT03435640|469264441|FG006|Overall Study|Lost to Follow-up|0|||
130353273|NCT03435640|469264442|FG007|Overall Study|Lost to Follow-up|0|||
130353274|NCT03435640|469264443|FG008|Overall Study|Lost to Follow-up|0|||
130353275|NCT03435640|469264444|FG009|Overall Study|Lost to Follow-up|0|||
130353276|NCT03435640|469264445|FG010|Overall Study|Lost to Follow-up|0|||
130353277|NCT01347307|469264448|FG000|Overall Study|Death|0|||
130353278|NCT01347307|469264449|FG001|Overall Study|Death|4|||
130353279|NCT01347307|469264448|FG000|Overall Study|Physician Decision|0|||
130353280|NCT01347307|469264449|FG001|Overall Study|Physician Decision|1|||
130353281|NCT00920829|469264457|FG000|Allocation|No post randomization data|3|||
130353282|NCT00920829|469264458|FG001|Allocation|No post randomization data|1|||
130353283|NCT00920829|469264459|FG002|Allocation|No post randomization data|0|||
130353284|NCT00920829|469264460|FG003|Allocation|No post randomization data|2|||
130353285|NCT00920829|469264457|FG000|Available for Analysis|Withdrawal by Subject|6|||
130353286|NCT00920829|469264458|FG001|Available for Analysis|Withdrawal by Subject|6|||
130353287|NCT00920829|469264459|FG002|Available for Analysis|Withdrawal by Subject|6|||
130353288|NCT00920829|469264460|FG003|Available for Analysis|Withdrawal by Subject|10|||
130353289|NCT00920829|469264457|FG000|Available for Analysis|Required Medical Treatment|0|||
130353290|NCT00920829|469264458|FG001|Available for Analysis|Required Medical Treatment|1|||
130353291|NCT00920829|469264459|FG002|Available for Analysis|Required Medical Treatment|2|||
130353292|NCT00920829|469264460|FG003|Available for Analysis|Required Medical Treatment|0|||
130353293|NCT00920829|469264457|FG000|Available for Analysis|Adverse Event|1|||
130353294|NCT00920829|469264458|FG001|Available for Analysis|Adverse Event|2|||
130353295|NCT00920829|469264459|FG002|Available for Analysis|Adverse Event|1|||
130353296|NCT00920829|469264460|FG003|Available for Analysis|Adverse Event|0|||
130353297|NCT00920829|469264457|FG000|Available for Analysis|Death|1|||
130353298|NCT00920829|469264458|FG001|Available for Analysis|Death|0|||
130353299|NCT00920829|469264459|FG002|Available for Analysis|Death|0|||
130353300|NCT00920829|469264460|FG003|Available for Analysis|Death|0|||
130353301|NCT00920829|469264457|FG000|Available for Analysis|Protocol Violation|0|||
130686002|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130353302|NCT00920829|469264458|FG001|Available for Analysis|Protocol Violation|0|||
130353303|NCT00920829|469264459|FG002|Available for Analysis|Protocol Violation|1|||
130353304|NCT00920829|469264460|FG003|Available for Analysis|Protocol Violation|0|||
130353305|NCT00920829|469264457|FG000|Available for Analysis|Required more treatment|0|||
130353306|NCT00920829|469264458|FG001|Available for Analysis|Required more treatment|2|||
130353307|NCT00920829|469264459|FG002|Available for Analysis|Required more treatment|0|||
130353308|NCT00920829|469264460|FG003|Available for Analysis|Required more treatment|1|||
130686003|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130353309|NCT04533880|469264461|FG000|Overall Study|Lost to Follow-up|0|||
130353310|NCT04533880|469264462|FG001|Overall Study|Lost to Follow-up|1|||
130353311|NCT04533880|469264463|FG002|Overall Study|Lost to Follow-up|1|||
130353312|NCT01711879|469264468|FG000|Overall Study|Death|1|||
130353313|NCT01711879|469264469|FG001|Overall Study|Death|0|||
130439957|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130439958|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130439959|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130439960|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130439961|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130439962|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130439963|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130439964|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130439965|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130439966|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
130439967|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
130439968|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
130439969|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
130439970|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130353314|NCT02239224|469264472|FG000|Overall Study|Administrative|0|||
130353315|NCT02239224|469264473|FG001|Overall Study|Administrative|0|||
130353316|NCT02239224|469264474|FG002|Overall Study|Administrative|3|||
130353317|NCT02239224|469264475|FG003|Overall Study|Administrative|1|||
130353318|NCT03183778|469264479|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
130353319|NCT00721123|469264480|FG000|Overall Study|Adverse Event|96|||
130353320|NCT00721123|469264480|FG000|Overall Study|Death|10|||
130353321|NCT00721123|469264480|FG000|Overall Study|Insufficient Therapeutic Response|21|||
130353322|NCT00721123|469264480|FG000|Overall Study|Protocol Violation|1|||
130353323|NCT00721123|469264480|FG000|Overall Study|Refused Treatment|41|||
130353324|NCT00721123|469264480|FG000|Overall Study|Failure to Return|9|||
130353325|NCT00721123|469264480|FG000|Overall Study|Withdrawal by Subject|5|||
130353326|NCT03954041|469264489|FG000|Overall Study|Lost to Follow-up|3|||
130353327|NCT03954041|469264490|FG001|Overall Study|Lost to Follow-up|3|||
130353328|NCT03954041|469264491|FG002|Overall Study|Lost to Follow-up|6|||
130353329|NCT03954041|469264489|FG000|Overall Study|Death|4|||
130353330|NCT03954041|469264490|FG001|Overall Study|Death|0|||
130353331|NCT03954041|469264491|FG002|Overall Study|Death|1|||
130353332|NCT03954041|469264489|FG000|Overall Study|Death by neurologic criteria|0|||
130353333|NCT03954041|469264490|FG001|Overall Study|Death by neurologic criteria|0|||
130353334|NCT03954041|469264491|FG002|Overall Study|Death by neurologic criteria|1|||
130353335|NCT03954041|469264489|FG000|Overall Study|Reason not specified|7|||
130353336|NCT03954041|469264490|FG001|Overall Study|Reason not specified|4|||
130353337|NCT03954041|469264491|FG002|Overall Study|Reason not specified|2|||
130353338|NCT03954041|469264489|FG000|Overall Study|Withdrew prior to dosing|4|||
130353339|NCT03954041|469264490|FG001|Overall Study|Withdrew prior to dosing|2|||
130353340|NCT03954041|469264491|FG002|Overall Study|Withdrew prior to dosing|0|||
130353341|NCT03868124|469264492|FG000|Overall Study|Withdrawal by Subject|4|||
130353342|NCT03868124|469264493|FG001|Overall Study|Withdrawal by Subject|0|||
130353343|NCT03868124|469264494|FG002|Overall Study|Withdrawal by Subject|1|||
130353344|NCT03868124|469264492|FG000|Overall Study|Physician Decision|1|||
130353345|NCT03868124|469264493|FG001|Overall Study|Physician Decision|0|||
130353346|NCT03868124|469264494|FG002|Overall Study|Physician Decision|1|||
130353347|NCT03868124|469264492|FG000|Overall Study|Lost to Follow-up|1|||
130353348|NCT03868124|469264493|FG001|Overall Study|Lost to Follow-up|1|||
130353349|NCT03868124|469264494|FG002|Overall Study|Lost to Follow-up|2|||
130353350|NCT03868124|469264492|FG000|Overall Study|Death|1|||
130353351|NCT03868124|469264493|FG001|Overall Study|Death|1|||
130353352|NCT03868124|469264494|FG002|Overall Study|Death|2|||
130353353|NCT03868124|469264492|FG000|Overall Study|Adverse Event|0|||
130353354|NCT03868124|469264493|FG001|Overall Study|Adverse Event|0|||
130353355|NCT03868124|469264494|FG002|Overall Study|Adverse Event|3|||
130353356|NCT03868124|469264492|FG000|Overall Study|Explanted|2|||
130353357|NCT03868124|469264493|FG001|Overall Study|Explanted|1|||
130353358|NCT03868124|469264494|FG002|Overall Study|Explanted|0|||
130353359|NCT03868124|469264492|FG000|Overall Study|Ongoing in study|176|||
130353360|NCT03868124|469264493|FG001|Overall Study|Ongoing in study|180|||
130353361|NCT03868124|469264494|FG002|Overall Study|Ongoing in study|183|||
130353362|NCT04177355|469264495|FG000|Overall Study|Lost to Follow-up|0|||
130353363|NCT04177355|469264496|FG001|Overall Study|Lost to Follow-up|2|||
130353364|NCT04177355|469264497|FG002|Overall Study|Lost to Follow-up|0|||
130353365|NCT04177355|469264498|FG003|Overall Study|Lost to Follow-up|1|||
130439971|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130439972|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130439973|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
130353366|NCT04177355|469264499|FG004|Overall Study|Lost to Follow-up|2|||
130353367|NCT04177355|469264500|FG005|Overall Study|Lost to Follow-up|0|||
130353368|NCT04177355|469264501|FG006|Overall Study|Lost to Follow-up|1|||
130353369|NCT04177355|469264502|FG007|Overall Study|Lost to Follow-up|0|||
130353370|NCT04177355|469264503|FG008|Overall Study|Lost to Follow-up|0|||
130353371|NCT04177355|469264504|FG009|Overall Study|Lost to Follow-up|0|||
130353372|NCT04177355|469264505|FG010|Overall Study|Lost to Follow-up|0|||
130439974|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130439975|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
130439976|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
130439977|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130439978|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130439979|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130439980|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
130439981|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130439982|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130439983|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
130439984|NCT04921969|469573519|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130439985|NCT04921969|469573520|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130439986|NCT04921969|469573521|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130439987|NCT04921969|469573522|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130439988|NCT04921969|469573523|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130439989|NCT04921969|469573524|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
130439990|NCT04921969|469573525|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
130439991|NCT01091428|469575746|FG000|Phase 1|Progressive Disease|24|||
130439992|NCT01091428|469575747|FG001|Phase 1|Progressive Disease|8|||
130439993|NCT01091428|469575748|FG002|Phase 1|Progressive Disease|0|||
130439994|NCT01091428|469575749|FG003|Phase 1|Progressive Disease|0|||
130439995|NCT01091428|469575746|FG000|Phase 1|Symptomatic Deterioration|3|||
130439996|NCT01091428|469575747|FG001|Phase 1|Symptomatic Deterioration|2|||
130439997|NCT01091428|469575748|FG002|Phase 1|Symptomatic Deterioration|0|||
130439998|NCT01091428|469575749|FG003|Phase 1|Symptomatic Deterioration|0|||
130439999|NCT01091428|469575746|FG000|Phase 1|Adverse Event|2|||
130440000|NCT01091428|469575747|FG001|Phase 1|Adverse Event|0|||
130440001|NCT01091428|469575748|FG002|Phase 1|Adverse Event|0|||
130440002|NCT01091428|469575749|FG003|Phase 1|Adverse Event|0|||
130440003|NCT01091428|469575746|FG000|Phase 1|Withdrawal by Subject|7|||
130440004|NCT01091428|469575747|FG001|Phase 1|Withdrawal by Subject|0|||
130440005|NCT01091428|469575748|FG002|Phase 1|Withdrawal by Subject|0|||
130440006|NCT01091428|469575749|FG003|Phase 1|Withdrawal by Subject|0|||
130440007|NCT01091428|469575746|FG000|Phase 1|Reason not specified|0|||
130440008|NCT01091428|469575747|FG001|Phase 1|Reason not specified|1|||
130440009|NCT01091428|469575748|FG002|Phase 1|Reason not specified|0|||
130440010|NCT01091428|469575749|FG003|Phase 1|Reason not specified|0|||
130440011|NCT01091428|469575746|FG000|Phase 1|Single-Patient IND|2|||
130440012|NCT01091428|469575747|FG001|Phase 1|Single-Patient IND|0|||
130440013|NCT01091428|469575748|FG002|Phase 1|Single-Patient IND|0|||
130440014|NCT01091428|469575749|FG003|Phase 1|Single-Patient IND|0|||
130440015|NCT01091428|469575746|FG000|Phase 2|Progressive Disease|0|||
130440016|NCT01091428|469575747|FG001|Phase 2|Progressive Disease|0|||
130440017|NCT01091428|469575748|FG002|Phase 2|Progressive Disease|44|||
130440018|NCT01091428|469575749|FG003|Phase 2|Progressive Disease|46|||
130440019|NCT01091428|469575746|FG000|Phase 2|Symptomatic Deterioration|0|||
130440020|NCT01091428|469575747|FG001|Phase 2|Symptomatic Deterioration|0|||
130440021|NCT01091428|469575748|FG002|Phase 2|Symptomatic Deterioration|1|||
130440022|NCT01091428|469575749|FG003|Phase 2|Symptomatic Deterioration|6|||
130440023|NCT01091428|469575746|FG000|Phase 2|Adverse Event|0|||
130440024|NCT01091428|469575747|FG001|Phase 2|Adverse Event|0|||
130440025|NCT01091428|469575748|FG002|Phase 2|Adverse Event|12|||
130440026|NCT01091428|469575749|FG003|Phase 2|Adverse Event|5|||
130440027|NCT01091428|469575746|FG000|Phase 2|Withdrawal by Subject|0|||
130440028|NCT01091428|469575747|FG001|Phase 2|Withdrawal by Subject|0|||
130440029|NCT01091428|469575748|FG002|Phase 2|Withdrawal by Subject|9|||
130440030|NCT01091428|469575749|FG003|Phase 2|Withdrawal by Subject|8|||
130440031|NCT01091428|469575746|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
130440032|NCT01091428|469575747|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
130440033|NCT01091428|469575748|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
130440034|NCT01091428|469575749|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
130440035|NCT01091428|469575746|FG000|Phase 2|Reason not specified|0|||
130220156|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130220157|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130440036|NCT01091428|469575747|FG001|Phase 2|Reason not specified|0|||
130440037|NCT01091428|469575748|FG002|Phase 2|Reason not specified|4|||
130440038|NCT01091428|469575749|FG003|Phase 2|Reason not specified|3|||
130440039|NCT01091428|469575746|FG000|Phase 2|Physician Decision|0|||
130440040|NCT01091428|469575747|FG001|Phase 2|Physician Decision|0|||
130440041|NCT01091428|469575748|FG002|Phase 2|Physician Decision|2|||
130440042|NCT01091428|469575749|FG003|Phase 2|Physician Decision|0|||
130440043|NCT03518658|469575752|FG000|Overall Study|Other|51|||
130440044|NCT03518658|469575753|FG001|Overall Study|Other|0|||
130440045|NCT02531295|469575754|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
130440046|NCT02531295|469575755|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
130440047|NCT02531295|469575756|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
130440048|NCT02531295|469575757|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
130440049|NCT02531295|469575758|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
130440050|NCT02531295|469575759|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
130440051|NCT03884231|469575762|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
130440052|NCT03884231|469575762|FG000|Overall Study|Subject Withdrew Consent|1|||
130440053|NCT03884231|469575762|FG000|Overall Study|MRI Scan Not Performed|1|||
130440054|NCT01853254|469575763|FG000|Overall Study|Abnormal Laboratory Test|1|||
130440055|NCT01853254|469575763|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
130440056|NCT01853254|469575763|FG000|Overall Study|Death|1|||
130440057|NCT01853254|469575763|FG000|Overall Study|Failure to Return|43|||
130440058|NCT01853254|469575763|FG000|Overall Study|Insufficient Therapeutic Response|22|||
130440059|NCT01853254|469575763|FG000|Overall Study|Refusal of Treatment|1|||
130440060|NCT01853254|469575763|FG000|Overall Study|Other Protocol Violation|1|||
130440061|NCT01853254|469575763|FG000|Overall Study|Withdrawal of Consent|16|||
130440062|NCT01853254|469575763|FG000|Overall Study|Administrative/Other|16|||
130440063|NCT01017120|469575769|FG000|Overall Study|Adverse Event|9|||
130440064|NCT01017120|469575770|FG001|Overall Study|Adverse Event|0|||
130440065|NCT01017120|469575769|FG000|Overall Study|Lost to Follow-up|13|||
130440066|NCT01017120|469575770|FG001|Overall Study|Lost to Follow-up|11|||
130440067|NCT01017120|469575769|FG000|Overall Study|Lack of Efficacy|1|||
130440068|NCT01017120|469575770|FG001|Overall Study|Lack of Efficacy|0|||
130440069|NCT01017120|469575769|FG000|Overall Study|Withdrawal by Subject|39|||
130440070|NCT01017120|469575770|FG001|Overall Study|Withdrawal by Subject|21|||
130440071|NCT01017120|469575769|FG000|Overall Study|Pregnancy|1|||
130440072|NCT01017120|469575770|FG001|Overall Study|Pregnancy|1|||
130440073|NCT01017120|469575769|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130440074|NCT01017120|469575770|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130440075|NCT01017120|469575769|FG000|Overall Study|Relocated Out of Town|0|||
130440076|NCT01017120|469575770|FG001|Overall Study|Relocated Out of Town|2|||
130440077|NCT01017120|469575769|FG000|Overall Study|Protocol Violation|1|||
130440078|NCT01017120|469575770|FG001|Overall Study|Protocol Violation|0|||
130440079|NCT01017120|469575769|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
130440080|NCT01017120|469575770|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
130440081|NCT01087723|469575771|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
130440082|NCT01087723|469575772|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
130440083|NCT01087723|469575771|FG000|Overall Study|Withdrawal by Subject|10|||
130440084|NCT01087723|469575772|FG001|Overall Study|Withdrawal by Subject|13|||
130440085|NCT01087723|469575771|FG000|Overall Study|Physician Decision|2|||
130440086|NCT01087723|469575772|FG001|Overall Study|Physician Decision|0|||
130440087|NCT01087723|469575771|FG000|Overall Study|Lost to Follow-up|1|||
130440088|NCT01087723|469575772|FG001|Overall Study|Lost to Follow-up|4|||
130440089|NCT01087723|469575771|FG000|Overall Study|Reason Not Specified|1|||
130440090|NCT01087723|469575772|FG001|Overall Study|Reason Not Specified|2|||
130440091|NCT00806624|469575773|FG000|Overall Study|Adverse Event|2|||
130440092|NCT00806624|469575774|FG001|Overall Study|Adverse Event|8|||
130440093|NCT00806624|469575775|FG002|Overall Study|Adverse Event|0|||
130440094|NCT00806624|469575773|FG000|Overall Study|Death|0|||
130440095|NCT00806624|469575774|FG001|Overall Study|Death|1|||
130440096|NCT00806624|469575775|FG002|Overall Study|Death|1|||
130440097|NCT00806624|469575773|FG000|Overall Study|Lost to Follow-up|1|||
130440098|NCT00806624|469575774|FG001|Overall Study|Lost to Follow-up|0|||
130440099|NCT00806624|469575775|FG002|Overall Study|Lost to Follow-up|1|||
130440100|NCT00806624|469575773|FG000|Overall Study|Withdrawal by Subject|6|||
130440101|NCT00806624|469575774|FG001|Overall Study|Withdrawal by Subject|3|||
130440102|NCT00806624|469575775|FG002|Overall Study|Withdrawal by Subject|3|||
130440103|NCT00806624|469575773|FG000|Overall Study|discontinued before start of treatment|0|||
130440104|NCT00806624|469575774|FG001|Overall Study|discontinued before start of treatment|0|||
130440105|NCT00806624|469575775|FG002|Overall Study|discontinued before start of treatment|1|||
130440106|NCT01702428|469575777|FG000|Overall Study|Adverse Event|2|||
130440107|NCT01702428|469575778|FG001|Overall Study|Adverse Event|0|||
130440108|NCT01702428|469575779|FG002|Overall Study|Adverse Event|0|||
130440109|NCT01702428|469575780|FG003|Overall Study|Adverse Event|0|||
130440110|NCT01702428|469575777|FG000|Overall Study|Lost to Follow-up|33|||
130440111|NCT01702428|469575778|FG001|Overall Study|Lost to Follow-up|41|||
130440112|NCT01702428|469575779|FG002|Overall Study|Lost to Follow-up|37|||
130440113|NCT01702428|469575780|FG003|Overall Study|Lost to Follow-up|44|||
130440114|NCT01702428|469575777|FG000|Overall Study|Parents cannot assist to site|1|||
130440115|NCT01702428|469575778|FG001|Overall Study|Parents cannot assist to site|0|||
130440116|NCT01702428|469575779|FG002|Overall Study|Parents cannot assist to site|1|||
130440117|NCT01702428|469575780|FG003|Overall Study|Parents cannot assist to site|0|||
130440118|NCT01702428|469575777|FG000|Overall Study|Lost Coverage|0|||
130440119|NCT01702428|469575778|FG001|Overall Study|Lost Coverage|0|||
130440120|NCT01702428|469575779|FG002|Overall Study|Lost Coverage|0|||
130440121|NCT01702428|469575780|FG003|Overall Study|Lost Coverage|1|||
130440122|NCT01702428|469575777|FG000|Overall Study|Lost Health Plan|3|||
130440123|NCT01702428|469575778|FG001|Overall Study|Lost Health Plan|5|||
130440124|NCT01702428|469575779|FG002|Overall Study|Lost Health Plan|0|||
130440125|NCT01702428|469575780|FG003|Overall Study|Lost Health Plan|2|||
130440126|NCT01702428|469575777|FG000|Overall Study|Mother transferred care|0|||
130440127|NCT01702428|469575778|FG001|Overall Study|Mother transferred care|1|||
130440128|NCT01702428|469575779|FG002|Overall Study|Mother transferred care|0|||
130440129|NCT01702428|469575780|FG003|Overall Study|Mother transferred care|0|||
130440130|NCT01702428|469575777|FG000|Overall Study|Parents too busy|1|||
130440131|NCT01702428|469575778|FG001|Overall Study|Parents too busy|0|||
130440132|NCT01702428|469575779|FG002|Overall Study|Parents too busy|0|||
130440133|NCT01702428|469575780|FG003|Overall Study|Parents too busy|0|||
130440134|NCT01702428|469575777|FG000|Overall Study|Protocol Violation|3|||
130440135|NCT01702428|469575778|FG001|Overall Study|Protocol Violation|0|||
130440136|NCT01702428|469575779|FG002|Overall Study|Protocol Violation|1|||
130440137|NCT01702428|469575780|FG003|Overall Study|Protocol Violation|0|||
130440138|NCT01702428|469575777|FG000|Overall Study|Withdrawal by Subject|21|||
130440139|NCT01702428|469575778|FG001|Overall Study|Withdrawal by Subject|23|||
130440140|NCT01702428|469575779|FG002|Overall Study|Withdrawal by Subject|14|||
130440141|NCT01702428|469575780|FG003|Overall Study|Withdrawal by Subject|10|||
130440142|NCT00154063|469575783|FG000|Overall Study|Adverse Event|4|||
130440143|NCT00154063|469575784|FG001|Overall Study|Adverse Event|8|||
130440144|NCT00154063|469575783|FG000|Overall Study|Protocol Violation|1|||
130440145|NCT00154063|469575784|FG001|Overall Study|Protocol Violation|1|||
130440146|NCT00154063|469575783|FG000|Overall Study|Investigator or Sponsor Request|0|||
130440147|NCT00154063|469575784|FG001|Overall Study|Investigator or Sponsor Request|1|||
130440148|NCT00154063|469575783|FG000|Overall Study|Withdrawal by Subject|4|||
130440149|NCT00154063|469575784|FG001|Overall Study|Withdrawal by Subject|9|||
130440150|NCT00154063|469575783|FG000|Overall Study|Other|3|||
130440151|NCT00154063|469575784|FG001|Overall Study|Other|3|||
130440152|NCT02091869|469575785|FG000|Overall Study|Withdrawal by Subject|0|||
130440153|NCT02091869|469575786|FG001|Overall Study|Withdrawal by Subject|3|||
130353373|NCT04177355|469264495|FG000|Overall Study|Withdrawal by Subject|0|||
130353374|NCT04177355|469264496|FG001|Overall Study|Withdrawal by Subject|0|||
130353375|NCT04177355|469264497|FG002|Overall Study|Withdrawal by Subject|0|||
130353376|NCT04177355|469264498|FG003|Overall Study|Withdrawal by Subject|1|||
130353377|NCT04177355|469264499|FG004|Overall Study|Withdrawal by Subject|1|||
130353378|NCT04177355|469264500|FG005|Overall Study|Withdrawal by Subject|0|||
130353379|NCT04177355|469264501|FG006|Overall Study|Withdrawal by Subject|0|||
130353380|NCT04177355|469264502|FG007|Overall Study|Withdrawal by Subject|0|||
130353381|NCT04177355|469264503|FG008|Overall Study|Withdrawal by Subject|1|||
130353382|NCT04177355|469264504|FG009|Overall Study|Withdrawal by Subject|0|||
130353383|NCT04177355|469264505|FG010|Overall Study|Withdrawal by Subject|0|||
130353384|NCT00433511|469264506|FG000|Step 1|Adverse Event|50|||
130353385|NCT00433511|469264507|FG001|Step 1|Adverse Event|157|||
130353386|NCT00433511|469264508|FG002|Step 1|Adverse Event|153|||
130353387|NCT00433511|469264506|FG000|Step 1|Withdrawal by Subject|45|||
130353388|NCT00433511|469264507|FG001|Step 1|Withdrawal by Subject|143|||
130353389|NCT00433511|469264508|FG002|Step 1|Withdrawal by Subject|154|||
130353390|NCT00433511|469264506|FG000|Step 1|Death|3|||
130353391|NCT00433511|469264507|FG001|Step 1|Death|1|||
130353392|NCT00433511|469264508|FG002|Step 1|Death|1|||
130353393|NCT00433511|469264506|FG000|Step 1|Physician Decision|1|||
130353394|NCT00433511|469264507|FG001|Step 1|Physician Decision|4|||
130353395|NCT00433511|469264508|FG002|Step 1|Physician Decision|3|||
130353396|NCT00433511|469264506|FG000|Step 1|Never started protocol therapy|28|||
130353397|NCT00433511|469264507|FG001|Step 1|Never started protocol therapy|64|||
130353398|NCT00433511|469264508|FG002|Step 1|Never started protocol therapy|66|||
130353399|NCT00433511|469264506|FG000|Step 1|Alternative therapy|2|||
130353400|NCT00433511|469264507|FG001|Step 1|Alternative therapy|1|||
130353401|NCT00433511|469264508|FG002|Step 1|Alternative therapy|3|||
130353402|NCT00433511|469264506|FG000|Step 1|Disease progression, relapse|5|||
130353403|NCT00433511|469264507|FG001|Step 1|Disease progression, relapse|3|||
130353404|NCT00433511|469264508|FG002|Step 1|Disease progression, relapse|3|||
130353405|NCT00433511|469264506|FG000|Step 1|Other complicating disease|2|||
130353406|NCT00433511|469264507|FG001|Step 1|Other complicating disease|6|||
130353407|NCT00433511|469264508|FG002|Step 1|Other complicating disease|3|||
130353408|NCT00433511|469264506|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
130353409|NCT00433511|469264507|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
130353410|NCT00433511|469264508|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
130353411|NCT00433511|469264506|FG000|Step 1|Suspected recurrence|0|||
130353412|NCT00433511|469264507|FG001|Step 1|Suspected recurrence|1|||
130353413|NCT00433511|469264508|FG002|Step 1|Suspected recurrence|0|||
130353414|NCT00433511|469264506|FG000|Step 1|Insurance/drug distribution issues|0|||
130353415|NCT00433511|469264507|FG001|Step 1|Insurance/drug distribution issues|1|||
130353416|NCT00433511|469264508|FG002|Step 1|Insurance/drug distribution issues|2|||
130353417|NCT00433511|469264506|FG000|Step 1|Patient moved|0|||
130440154|NCT00451217|469575795|FG000|Overall Study|Lost to Follow-up|0|||
130440155|NCT00451217|469575796|FG001|Overall Study|Lost to Follow-up|1|||
130440156|NCT00451217|469575797|FG002|Overall Study|Lost to Follow-up|1|||
130440157|NCT00451217|469575798|FG003|Overall Study|Lost to Follow-up|1|||
130440158|NCT00451217|469575795|FG000|Overall Study|Withdrawal by Subject|1|||
130440159|NCT00451217|469575796|FG001|Overall Study|Withdrawal by Subject|0|||
130440160|NCT00451217|469575797|FG002|Overall Study|Withdrawal by Subject|0|||
130440161|NCT00451217|469575798|FG003|Overall Study|Withdrawal by Subject|0|||
130440162|NCT00451217|469575795|FG000|Overall Study|Not Treated|1|||
130440163|NCT00451217|469575796|FG001|Overall Study|Not Treated|1|||
130440164|NCT00451217|469575797|FG002|Overall Study|Not Treated|3|||
130440165|NCT00451217|469575798|FG003|Overall Study|Not Treated|4|||
130440166|NCT04668989|469575799|FG000|First Intervention|Covid-19 related self-isolation|0|||
130440167|NCT04668989|469575800|FG001|First Intervention|Covid-19 related self-isolation|1|||
130440168|NCT04668989|469575799|FG000|Second Intervention|Adverse Event|0|||
130440169|NCT04668989|469575800|FG001|Second Intervention|Adverse Event|1|||
130440170|NCT01622348|469575805|FG000|Overall Study|Withdrawal by Subject|1|||
130440171|NCT01622348|469575806|FG001|Overall Study|Withdrawal by Subject|0|||
130440172|NCT01622348|469575807|FG002|Overall Study|Withdrawal by Subject|1|||
130440173|NCT01592695|469575814|FG000|Overall Study|Lost to Follow-up|8|||
130440174|NCT01592695|469575815|FG001|Overall Study|Lost to Follow-up|4|||
130440175|NCT00467142|469575816|FG000|Overall Study|Withdrawal by Subject|1|||
130440176|NCT00467142|469575816|FG000|Overall Study|Adverse Event|1|||
130440177|NCT00467142|469575816|FG000|Overall Study|Protocol Violation|1|||
130440178|NCT00919893|469575817|FG000|Overall Study|Protocol Violation|19|||
130440179|NCT00919893|469575818|FG001|Overall Study|Protocol Violation|9|||
130440180|NCT03893825|469575821|FG000|Overall Study|Death|2|||
130440181|NCT03893825|469575822|FG001|Overall Study|Death|1|||
130440182|NCT03893825|469575821|FG000|Overall Study|Adverse Event|0|||
130440183|NCT03893825|469575822|FG001|Overall Study|Adverse Event|2|||
130440184|NCT03893825|469575821|FG000|Overall Study|Withdrawal by Subject|19|||
130440185|NCT03893825|469575822|FG001|Overall Study|Withdrawal by Subject|21|||
130440186|NCT03893825|469575821|FG000|Overall Study|Protocol deviation|1|||
130440187|NCT03893825|469575822|FG001|Overall Study|Protocol deviation|0|||
130440188|NCT03893825|469575821|FG000|Overall Study|Lost to Follow-up|10|||
130440189|NCT03893825|469575822|FG001|Overall Study|Lost to Follow-up|10|||
130440190|NCT03893825|469575821|FG000|Overall Study|Other than specified|7|||
130440191|NCT03893825|469575822|FG001|Overall Study|Other than specified|6|||
130440192|NCT04012814|469575823|FG000|Overall Study|Lost to Follow-up|4|||
130440193|NCT04012814|469575823|FG000|Overall Study|Withdrawal by Subject|2|||
130440194|NCT04012814|469575823|FG000|Overall Study|Protocol Violation|1|||
130440195|NCT04012814|469575823|FG000|Overall Study|Adverse Event|1|||
130440196|NCT01275196|469575824|FG000|Overall Study|Adverse Event|3|||
130440197|NCT01275196|469575825|FG001|Overall Study|Adverse Event|5|||
130440198|NCT01275196|469575824|FG000|Overall Study|Withdrawal by Subject|4|||
130440199|NCT01275196|469575825|FG001|Overall Study|Withdrawal by Subject|5|||
130440200|NCT01275196|469575824|FG000|Overall Study|Lost to Follow-up|1|||
130440201|NCT01275196|469575825|FG001|Overall Study|Lost to Follow-up|0|||
130440202|NCT01275196|469575824|FG000|Overall Study|Disease Progression|6|||
130440203|NCT01275196|469575825|FG001|Overall Study|Disease Progression|5|||
130440204|NCT01275196|469575824|FG000|Overall Study|Protocol Violation|1|||
130440205|NCT01275196|469575825|FG001|Overall Study|Protocol Violation|0|||
130440206|NCT01275196|469575824|FG000|Overall Study|Suboptimal response/treatment failure|5|||
130440207|NCT01275196|469575825|FG001|Overall Study|Suboptimal response/treatment failure|6|||
130440208|NCT02406261|469575826|FG000|Period 1|Lost to Follow-up|2|||
130440209|NCT02406261|469575827|FG001|Period 1|Lost to Follow-up|0|||
130440210|NCT02406261|469575826|FG000|Period 1|Adverse Event|1|||
130440211|NCT02406261|469575827|FG001|Period 1|Adverse Event|0|||
130440212|NCT02406261|469575826|FG000|Period 2|Physician Decision|0|||
130440213|NCT02406261|469575827|FG001|Period 2|Physician Decision|1|||
130440214|NCT02406261|469575826|FG000|Period 2|Protocol Violation|0|||
130440215|NCT02406261|469575827|FG001|Period 2|Protocol Violation|1|||
130440216|NCT02406261|469575826|FG000|Period 2|Withdrawal by Subject|0|||
130440217|NCT02406261|469575827|FG001|Period 2|Withdrawal by Subject|1|||
130440218|NCT02572817|469575828|FG000|Overall Study|Death|6|||
130440219|NCT02572817|469575829|FG001|Overall Study|Death|3|||
130440220|NCT02572817|469575828|FG000|Overall Study|Lost to Follow-up|3|||
130440221|NCT02572817|469575829|FG001|Overall Study|Lost to Follow-up|3|||
130440222|NCT02761629|469575836|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
130440223|NCT02761629|469575837|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
130440224|NCT02761629|469575836|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130440225|NCT02761629|469575837|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130440226|NCT02761629|469575836|FG000|Overall Study|Failure to Return|2|||
130440227|NCT02761629|469575837|FG001|Overall Study|Failure to Return|4|||
130440228|NCT02761629|469575836|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
130440229|NCT02761629|469575837|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
130440230|NCT02761629|469575836|FG000|Overall Study|Protocol Violation|2|||
130440231|NCT02761629|469575837|FG001|Overall Study|Protocol Violation|2|||
130440232|NCT02761629|469575836|FG000|Overall Study|Withdrawal by Subject|0|||
130440233|NCT02761629|469575837|FG001|Overall Study|Withdrawal by Subject|3|||
130440234|NCT02761629|469575836|FG000|Overall Study|Other|0|||
130440235|NCT02761629|469575837|FG001|Overall Study|Other|2|||
130353418|NCT00433511|469264507|FG001|Step 1|Patient moved|0|||
130353419|NCT00433511|469264508|FG002|Step 1|Patient moved|1|||
130353420|NCT00433511|469264506|FG000|Step 2 (Arm D)|Adverse Event|0|||
130353421|NCT00433511|469264507|FG001|Step 2 (Arm D)|Adverse Event|0|||
130353422|NCT00433511|469264508|FG002|Step 2 (Arm D)|Adverse Event|135|||
130353423|NCT00433511|469264506|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
130353424|NCT00433511|469264507|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
130353425|NCT00433511|469264508|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
130353426|NCT00433511|469264506|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
130353427|NCT00433511|469264507|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
130353428|NCT00433511|469264508|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
130353429|NCT00433511|469264506|FG000|Step 2 (Arm D)|Physician Decision|0|||
130353430|NCT00433511|469264507|FG001|Step 2 (Arm D)|Physician Decision|0|||
130353431|NCT00433511|469264508|FG002|Step 2 (Arm D)|Physician Decision|9|||
130353432|NCT00433511|469264506|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
130353433|NCT00433511|469264507|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
130353434|NCT00433511|469264508|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
130353435|NCT00433511|469264506|FG000|Step 2 (Arm D)|Other complicating disease|0|||
130353436|NCT00433511|469264507|FG001|Step 2 (Arm D)|Other complicating disease|0|||
130353437|NCT00433511|469264508|FG002|Step 2 (Arm D)|Other complicating disease|3|||
130353438|NCT00433511|469264506|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
130353439|NCT00433511|469264507|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
130353440|NCT00433511|469264508|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
130353441|NCT00433511|469264506|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
130353442|NCT00433511|469264507|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
130353443|NCT00433511|469264508|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
130353444|NCT00433511|469264506|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
130353445|NCT00433511|469264507|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
130353446|NCT00433511|469264508|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
130353447|NCT00433511|469264506|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
130353448|NCT00433511|469264507|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
130353449|NCT00433511|469264508|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
130353450|NCT02806973|469264510|FG000|Period 1|Withdrawal by Subject|0|||
130353451|NCT02806973|469264511|FG001|Period 1|Withdrawal by Subject|2|||
130353452|NCT02806973|469264512|FG002|Period 1|Withdrawal by Subject|1|||
130353453|NCT02806973|469264513|FG003|Period 1|Withdrawal by Subject|1|||
130353454|NCT02806973|469264510|FG000|Period 1|Adverse Event|0|||
130353455|NCT02806973|469264511|FG001|Period 1|Adverse Event|0|||
130353456|NCT02806973|469264512|FG002|Period 1|Adverse Event|0|||
130353457|NCT02806973|469264513|FG003|Period 1|Adverse Event|1|||
130353458|NCT02806973|469264510|FG000|Period 3|Withdrawal by Subject|0|||
130353459|NCT02806973|469264511|FG001|Period 3|Withdrawal by Subject|0|||
130353460|NCT02806973|469264512|FG002|Period 3|Withdrawal by Subject|0|||
130353461|NCT02806973|469264513|FG003|Period 3|Withdrawal by Subject|3|||
130353462|NCT02806973|469264510|FG000|Period 3|Adverse Event|0|||
130353463|NCT02806973|469264511|FG001|Period 3|Adverse Event|0|||
130353464|NCT02806973|469264512|FG002|Period 3|Adverse Event|1|||
130353465|NCT02806973|469264513|FG003|Period 3|Adverse Event|0|||
130353466|NCT04209426|469264519|FG000|Overall Study|Lost to Follow-up|3|||
130353467|NCT04209426|469264520|FG001|Overall Study|Lost to Follow-up|2|||
130353468|NCT03355664|469264526|FG000|Overall Study|Adverse Event|1|||
130353469|NCT03355664|469264527|FG001|Overall Study|Adverse Event|2|||
130353470|NCT03355664|469264526|FG000|Overall Study|Lost to Follow-up|11|||
130353471|NCT03355664|469264527|FG001|Overall Study|Lost to Follow-up|7|||
130353472|NCT03355664|469264526|FG000|Overall Study|Protocol Violation|1|||
130353473|NCT03355664|469264527|FG001|Overall Study|Protocol Violation|2|||
130353474|NCT03355664|469264526|FG000|Overall Study|Withdrawal by Subject|2|||
130353475|NCT03355664|469264527|FG001|Overall Study|Withdrawal by Subject|1|||
130353476|NCT01751802|469264530|FG000|Overall Study|Adverse Event|4|||
130353477|NCT01751802|469264531|FG001|Overall Study|Adverse Event|2|||
130353478|NCT01484938|469264532|FG000|Overall Study|Adverse Event|2|||
130353479|NCT01484938|469264532|FG000|Overall Study|Lost to Follow-up|1|||
130353480|NCT01484938|469264532|FG000|Overall Study|Noncompliance|1|||
130353481|NCT01858636|469264533|FG000|Overall Study|No Device Deployment Attempted|24|||
130353482|NCT01858636|469264533|FG000|Overall Study|Physician Decision|1|||
130353483|NCT01858636|469264533|FG000|Overall Study|Death|1|||
130353484|NCT01858636|469264533|FG000|Overall Study|Lost to Follow-up|1|||
130353485|NCT01858636|469264533|FG000|Overall Study|Withdrawal by Subject|1|||
130353486|NCT01227564|469264538|FG000|Overall Study|No Longer Willing to Participate|4|||
130353487|NCT01227564|469264539|FG001|Overall Study|No Longer Willing to Participate|2|||
130353488|NCT01227564|469264540|FG002|Overall Study|No Longer Willing to Participate|5|||
130353489|NCT01227564|469264538|FG000|Overall Study|Participant moved to another town|0|||
130353490|NCT01227564|469264539|FG001|Overall Study|Participant moved to another town|0|||
130353491|NCT01227564|469264540|FG002|Overall Study|Participant moved to another town|1|||
130440236|NCT02761629|469575836|FG000|Overall Study|Lost to Follow-up|4|||
130440237|NCT02761629|469575837|FG001|Overall Study|Lost to Follow-up|1|||
130440238|NCT02761629|469575836|FG000|Overall Study|Randomized But Not Treated|8|||
130440239|NCT02761629|469575837|FG001|Overall Study|Randomized But Not Treated|4|||
130440240|NCT02001974|469575838|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
130440241|NCT02001974|469575839|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
130440242|NCT02001974|469575840|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
130440243|NCT02001974|469575838|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
130440244|NCT02001974|469575839|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
130440245|NCT02001974|469575840|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
130440246|NCT02001974|469575838|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
130440247|NCT02001974|469575839|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
130440248|NCT02001974|469575840|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
130440249|NCT02001974|469575838|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
130440250|NCT02001974|469575839|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
130440251|NCT02001974|469575840|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
130440252|NCT01830881|469575841|FG000|Overall Study|Changed decision to have an abortion|0|||
130440253|NCT01830881|469575842|FG001|Overall Study|Changed decision to have an abortion|1|||
130440254|NCT00119262|469575843|FG000|Overall Study|Lack of Efficacy|0|||
130440255|NCT00119262|469575844|FG001|Overall Study|Lack of Efficacy|3|||
130440256|NCT00119262|469575843|FG000|Overall Study|Withdrawal by Subject|12|||
130440257|NCT00119262|469575844|FG001|Overall Study|Withdrawal by Subject|11|||
130440258|NCT00119262|469575843|FG000|Overall Study|Adverse Event|33|||
130440259|NCT00119262|469575844|FG001|Overall Study|Adverse Event|35|||
130440260|NCT00119262|469575843|FG000|Overall Study|other disease|0|||
130440261|NCT00119262|469575844|FG001|Overall Study|other disease|2|||
130440262|NCT00119262|469575843|FG000|Overall Study|ineligble|1|||
130440263|NCT00119262|469575844|FG001|Overall Study|ineligble|2|||
130440264|NCT00119262|469575843|FG000|Overall Study|others|0|||
130440265|NCT00119262|469575844|FG001|Overall Study|others|5|||
130440266|NCT00734214|469575845|FG000|Overall Study|Withdrawal by Subject|3|||
130440267|NCT00734214|469575846|FG001|Overall Study|Withdrawal by Subject|4|||
130440268|NCT00734214|469575845|FG000|Overall Study|MD withdrawal|1|||
130440269|NCT00734214|469575846|FG001|Overall Study|MD withdrawal|0|||
130440270|NCT02038764|469575847|FG000|Overall Study|Adverse Event|0|||
130440271|NCT02038764|469575848|FG001|Overall Study|Adverse Event|0|||
130440272|NCT02038764|469575849|FG002|Overall Study|Adverse Event|1|||
130440273|NCT02038764|469575850|FG003|Overall Study|Adverse Event|0|||
130440274|NCT02038764|469575851|FG004|Overall Study|Adverse Event|0|||
130440275|NCT02038764|469575847|FG000|Overall Study|Lost to Follow-up|0|||
130440276|NCT02038764|469575848|FG001|Overall Study|Lost to Follow-up|1|||
130440277|NCT02038764|469575849|FG002|Overall Study|Lost to Follow-up|0|||
130440278|NCT02038764|469575850|FG003|Overall Study|Lost to Follow-up|0|||
130440279|NCT02038764|469575851|FG004|Overall Study|Lost to Follow-up|0|||
130440280|NCT02038764|469575847|FG000|Overall Study|Withdrawal by Subject|0|||
130440281|NCT02038764|469575848|FG001|Overall Study|Withdrawal by Subject|0|||
130440282|NCT02038764|469575849|FG002|Overall Study|Withdrawal by Subject|0|||
130440283|NCT02038764|469575850|FG003|Overall Study|Withdrawal by Subject|0|||
130440284|NCT02038764|469575851|FG004|Overall Study|Withdrawal by Subject|1|||
130440285|NCT02038764|469575847|FG000|Overall Study|Other|1|||
130440286|NCT02038764|469575848|FG001|Overall Study|Other|0|||
130440287|NCT02038764|469575849|FG002|Overall Study|Other|1|||
130440288|NCT02038764|469575850|FG003|Overall Study|Other|0|||
130440289|NCT02038764|469575851|FG004|Overall Study|Other|0|||
130440290|NCT03632434|469575854|FG000|Overall Study|Withdrawal by Subject|2|||
130440291|NCT01751113|469575855|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130440292|NCT01751113|469575856|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130440293|NCT01751113|469575857|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130440294|NCT01751113|469575858|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130440295|NCT01751113|469575859|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130440296|NCT01751113|469575860|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130440297|NCT01751113|469575855|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130440298|NCT01751113|469575856|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130440299|NCT01751113|469575857|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130440300|NCT01751113|469575858|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130440301|NCT01751113|469575859|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130220158|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130220159|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130440302|NCT01751113|469575860|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
130440303|NCT01551303|469575862|FG000|Overall Study|failed awareness check on vision test|4|||
130440304|NCT01551303|469575863|FG001|Overall Study|failed awareness check on vision test|7|||
130440305|NCT02743793|469575873|FG000|Overall Study|Death|1|||
130440306|NCT02743793|469575874|FG001|Overall Study|Death|1|||
130440307|NCT02743793|469575873|FG000|Overall Study|Withdrawal by Subject|0|||
130440308|NCT02743793|469575874|FG001|Overall Study|Withdrawal by Subject|1|||
130440309|NCT02743793|469575873|FG000|Overall Study|Screen Failure|4|||
130440310|NCT02743793|469575874|FG001|Overall Study|Screen Failure|0|||
130440311|NCT02743793|469575873|FG000|Overall Study|No Primary Care Physician|0|||
130440312|NCT02743793|469575874|FG001|Overall Study|No Primary Care Physician|1|||
130440313|NCT02743793|469575873|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
130440314|NCT02743793|469575874|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
130440315|NCT02743793|469575873|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
130440316|NCT02743793|469575874|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
130440317|NCT01146574|469575879|FG000|Overall Study|Death|0|||
130440318|NCT01146574|469575880|FG001|Overall Study|Death|1|||
130440319|NCT01146574|469575881|FG002|Overall Study|Death|1|||
130440320|NCT01146574|469575882|FG003|Overall Study|Death|0|||
130440321|NCT01146574|469575883|FG004|Overall Study|Death|0|||
130440322|NCT01146574|469575884|FG005|Overall Study|Death|0|||
130440323|NCT01146574|469575885|FG006|Overall Study|Death|0|||
130440324|NCT01146574|469575879|FG000|Overall Study|Other reasons|0|||
130440325|NCT01146574|469575880|FG001|Overall Study|Other reasons|0|||
130440326|NCT01146574|469575881|FG002|Overall Study|Other reasons|3|||
130440327|NCT01146574|469575882|FG003|Overall Study|Other reasons|0|||
130440328|NCT01146574|469575883|FG004|Overall Study|Other reasons|0|||
130440329|NCT01146574|469575884|FG005|Overall Study|Other reasons|0|||
130440330|NCT01146574|469575885|FG006|Overall Study|Other reasons|0|||
130440331|NCT01146574|469575879|FG000|Overall Study|Kidney transplant|0|||
130440332|NCT01146574|469575880|FG001|Overall Study|Kidney transplant|0|||
130440333|NCT01146574|469575881|FG002|Overall Study|Kidney transplant|1|||
130440334|NCT01146574|469575882|FG003|Overall Study|Kidney transplant|1|||
130440335|NCT01146574|469575883|FG004|Overall Study|Kidney transplant|0|||
130440336|NCT01146574|469575884|FG005|Overall Study|Kidney transplant|0|||
130440337|NCT01146574|469575885|FG006|Overall Study|Kidney transplant|0|||
130440338|NCT01146574|469575879|FG000|Overall Study|Withdrew consent|0|||
130440339|NCT01146574|469575880|FG001|Overall Study|Withdrew consent|0|||
130440340|NCT01146574|469575881|FG002|Overall Study|Withdrew consent|1|||
130440341|NCT01146574|469575882|FG003|Overall Study|Withdrew consent|1|||
130440342|NCT01146574|469575883|FG004|Overall Study|Withdrew consent|2|||
130440343|NCT01146574|469575884|FG005|Overall Study|Withdrew consent|1|||
130440344|NCT01146574|469575885|FG006|Overall Study|Withdrew consent|1|||
130440345|NCT03051659|469575886|FG000|Treatment Period|Withdrawal by Subject|0|||
130440346|NCT03051659|469575887|FG001|Treatment Period|Withdrawal by Subject|2|||
130440347|NCT03051659|469575886|FG000|Survival Follow-up|Lost to Follow-up|23|||
130440348|NCT03051659|469575887|FG001|Survival Follow-up|Lost to Follow-up|22|||
130440349|NCT01076088|469575888|FG000|Overall Study|Adverse Event|1|||
130440350|NCT01076088|469575889|FG001|Overall Study|Adverse Event|6|||
130440351|NCT01076088|469575890|FG002|Overall Study|Adverse Event|3|||
130440352|NCT01076088|469575891|FG003|Overall Study|Adverse Event|2|||
130440353|NCT01076088|469575892|FG004|Overall Study|Adverse Event|3|||
130440354|NCT01076088|469575893|FG005|Overall Study|Adverse Event|3|||
130440355|NCT01076088|469575888|FG000|Overall Study|Lost to Follow-up|1|||
130440356|NCT01076088|469575889|FG001|Overall Study|Lost to Follow-up|1|||
130440357|NCT01076088|469575890|FG002|Overall Study|Lost to Follow-up|0|||
130440358|NCT01076088|469575891|FG003|Overall Study|Lost to Follow-up|1|||
130440359|NCT01076088|469575892|FG004|Overall Study|Lost to Follow-up|1|||
130440360|NCT01076088|469575893|FG005|Overall Study|Lost to Follow-up|2|||
130440361|NCT01076088|469575888|FG000|Overall Study|Non-compliance with study drug|0|||
130440362|NCT01076088|469575889|FG001|Overall Study|Non-compliance with study drug|0|||
130440363|NCT01076088|469575890|FG002|Overall Study|Non-compliance with study drug|0|||
130440364|NCT01076088|469575891|FG003|Overall Study|Non-compliance with study drug|1|||
130440365|NCT01076088|469575892|FG004|Overall Study|Non-compliance with study drug|0|||
130440366|NCT01076088|469575893|FG005|Overall Study|Non-compliance with study drug|0|||
130440367|NCT01076088|469575888|FG000|Overall Study|Physician Decision|1|||
130440368|NCT01076088|469575889|FG001|Overall Study|Physician Decision|3|||
130440369|NCT01076088|469575890|FG002|Overall Study|Physician Decision|0|||
130440370|NCT01076088|469575891|FG003|Overall Study|Physician Decision|1|||
130440371|NCT01076088|469575892|FG004|Overall Study|Physician Decision|1|||
130440372|NCT01076088|469575893|FG005|Overall Study|Physician Decision|0|||
130440373|NCT01076088|469575888|FG000|Overall Study|Withdrawal by Subject|8|||
130440374|NCT01076088|469575889|FG001|Overall Study|Withdrawal by Subject|8|||
130440375|NCT01076088|469575890|FG002|Overall Study|Withdrawal by Subject|14|||
130440376|NCT01076088|469575891|FG003|Overall Study|Withdrawal by Subject|10|||
130440377|NCT01076088|469575892|FG004|Overall Study|Withdrawal by Subject|11|||
130440378|NCT01076088|469575893|FG005|Overall Study|Withdrawal by Subject|17|||
130440379|NCT01076088|469575888|FG000|Overall Study|Other protocol specified criteria|0|||
130440380|NCT01076088|469575889|FG001|Overall Study|Other protocol specified criteria|0|||
130440381|NCT01076088|469575890|FG002|Overall Study|Other protocol specified criteria|0|||
130440382|NCT01076088|469575891|FG003|Overall Study|Other protocol specified criteria|0|||
130440383|NCT01076088|469575892|FG004|Overall Study|Other protocol specified criteria|0|||
130440384|NCT01076088|469575893|FG005|Overall Study|Other protocol specified criteria|1|||
130440385|NCT03053492|469575894|FG000|Overall Study|Adverse Event|1|||
130440386|NCT03053492|469575895|FG001|Overall Study|Adverse Event|1|||
130440387|NCT03053492|469575894|FG000|Overall Study|Withdrawal by Subject|7|||
130440388|NCT03053492|469575895|FG001|Overall Study|Withdrawal by Subject|5|||
130440389|NCT00786474|469575896|FG000|Overall Study|Death|5|||
130440390|NCT00786474|469575897|FG001|Overall Study|Death|4|||
130440391|NCT00786474|469575896|FG000|Overall Study|Withdrawal by Subject|23|||
130440392|NCT00786474|469575897|FG001|Overall Study|Withdrawal by Subject|31|||
130440393|NCT00786474|469575896|FG000|Overall Study|Lost to Follow-up|3|||
130440394|NCT00786474|469575897|FG001|Overall Study|Lost to Follow-up|3|||
130440395|NCT00786474|469575896|FG000|Overall Study|Physician Decision|2|||
130440396|NCT00786474|469575897|FG001|Overall Study|Physician Decision|1|||
130440397|NCT00786474|469575896|FG000|Overall Study|Other|4|||
130440398|NCT00786474|469575897|FG001|Overall Study|Other|4|||
130440399|NCT01544491|469575898|FG000|Overall Study|Withdrawal by Subject|3|||
130440400|NCT01544491|469575899|FG001|Overall Study|Withdrawal by Subject|2|||
130440401|NCT01544491|469575898|FG000|Overall Study|Lost to Follow-up|0|||
130440402|NCT01544491|469575899|FG001|Overall Study|Lost to Follow-up|1|||
130440403|NCT01544491|469575898|FG000|Overall Study|administrative problems|2|||
130440404|NCT01544491|469575899|FG001|Overall Study|administrative problems|0|||
130440405|NCT00967018|469575900|FG000|Overall Study|Adverse Event|2|||
130440406|NCT00967018|469575900|FG000|Overall Study|Physician Decision|7|||
130440407|NCT00967018|469575900|FG000|Overall Study|Lost to Follow-up|2|||
130440408|NCT00967018|469575900|FG000|Overall Study|Withdrawal by Subject|1|||
130440409|NCT00967018|469575900|FG000|Overall Study|Miscellaneous Reasons|9|||
130440410|NCT02733042|469575904|FG000|Overall Study|Adverse Event|1|||
130440411|NCT02733042|469575905|FG001|Overall Study|Adverse Event|0|||
130440412|NCT02733042|469575906|FG002|Overall Study|Adverse Event|1|||
130440413|NCT02733042|469575907|FG003|Overall Study|Adverse Event|1|||
130440414|NCT02733042|469575908|FG004|Overall Study|Adverse Event|0|||
130440415|NCT02733042|469575909|FG005|Overall Study|Adverse Event|0|||
130440416|NCT02733042|469575910|FG006|Overall Study|Adverse Event|0|||
130440417|NCT02733042|469575911|FG007|Overall Study|Adverse Event|0|||
130440418|NCT02733042|469575912|FG008|Overall Study|Adverse Event|0|||
130440419|NCT02733042|469575913|FG009|Overall Study|Adverse Event|0|||
130440420|NCT02733042|469575914|FG010|Overall Study|Adverse Event|2|||
130440421|NCT02733042|469575915|FG011|Overall Study|Adverse Event|2|||
130440422|NCT02733042|469575916|FG012|Overall Study|Adverse Event|0|||
130440423|NCT02733042|469575917|FG013|Overall Study|Adverse Event|2|||
130440424|NCT02733042|469575918|FG014|Overall Study|Adverse Event|0|||
130440425|NCT02733042|469575919|FG015|Overall Study|Adverse Event|0|||
130440426|NCT02733042|469575920|FG016|Overall Study|Adverse Event|0|||
130440427|NCT02733042|469575921|FG017|Overall Study|Adverse Event|1|||
130440428|NCT02733042|469575922|FG018|Overall Study|Adverse Event|0|||
130440429|NCT02733042|469575904|FG000|Overall Study|Progressive Disease|2|||
130440430|NCT02733042|469575905|FG001|Overall Study|Progressive Disease|1|||
130440431|NCT02733042|469575906|FG002|Overall Study|Progressive Disease|3|||
130440432|NCT02733042|469575907|FG003|Overall Study|Progressive Disease|1|||
130440433|NCT02733042|469575908|FG004|Overall Study|Progressive Disease|2|||
130440434|NCT02733042|469575909|FG005|Overall Study|Progressive Disease|3|||
130440435|NCT02733042|469575910|FG006|Overall Study|Progressive Disease|0|||
130440436|NCT02733042|469575911|FG007|Overall Study|Progressive Disease|3|||
130440437|NCT02733042|469575912|FG008|Overall Study|Progressive Disease|3|||
130440438|NCT02733042|469575913|FG009|Overall Study|Progressive Disease|2|||
130440439|NCT02733042|469575914|FG010|Overall Study|Progressive Disease|2|||
130440440|NCT02733042|469575915|FG011|Overall Study|Progressive Disease|2|||
130440441|NCT02733042|469575916|FG012|Overall Study|Progressive Disease|8|||
130440442|NCT02733042|469575917|FG013|Overall Study|Progressive Disease|1|||
130440443|NCT02733042|469575918|FG014|Overall Study|Progressive Disease|4|||
130440444|NCT02733042|469575919|FG015|Overall Study|Progressive Disease|7|||
130440445|NCT02733042|469575920|FG016|Overall Study|Progressive Disease|2|||
130440446|NCT02733042|469575921|FG017|Overall Study|Progressive Disease|3|||
130440447|NCT02733042|469575922|FG018|Overall Study|Progressive Disease|4|||
130440448|NCT02733042|469575904|FG000|Overall Study|Withdrawal by Subject|0|||
130440449|NCT02733042|469575905|FG001|Overall Study|Withdrawal by Subject|1|||
130440450|NCT02733042|469575906|FG002|Overall Study|Withdrawal by Subject|2|||
130440451|NCT02733042|469575907|FG003|Overall Study|Withdrawal by Subject|1|||
130440452|NCT02733042|469575908|FG004|Overall Study|Withdrawal by Subject|1|||
130440453|NCT02733042|469575909|FG005|Overall Study|Withdrawal by Subject|0|||
130440454|NCT02733042|469575910|FG006|Overall Study|Withdrawal by Subject|0|||
130440455|NCT02733042|469575911|FG007|Overall Study|Withdrawal by Subject|0|||
130440456|NCT02733042|469575912|FG008|Overall Study|Withdrawal by Subject|1|||
130440457|NCT02733042|469575913|FG009|Overall Study|Withdrawal by Subject|1|||
130440458|NCT02733042|469575914|FG010|Overall Study|Withdrawal by Subject|0|||
130440459|NCT02733042|469575915|FG011|Overall Study|Withdrawal by Subject|2|||
130440460|NCT02733042|469575916|FG012|Overall Study|Withdrawal by Subject|1|||
130440461|NCT02733042|469575917|FG013|Overall Study|Withdrawal by Subject|1|||
130440462|NCT02733042|469575918|FG014|Overall Study|Withdrawal by Subject|0|||
130440463|NCT02733042|469575919|FG015|Overall Study|Withdrawal by Subject|0|||
130440464|NCT02733042|469575920|FG016|Overall Study|Withdrawal by Subject|0|||
130440465|NCT02733042|469575921|FG017|Overall Study|Withdrawal by Subject|0|||
130440466|NCT02733042|469575922|FG018|Overall Study|Withdrawal by Subject|0|||
130440467|NCT02733042|469575904|FG000|Overall Study|Other Reasons|0|||
130440468|NCT02733042|469575905|FG001|Overall Study|Other Reasons|0|||
130440469|NCT02733042|469575906|FG002|Overall Study|Other Reasons|1|||
130440470|NCT02733042|469575907|FG003|Overall Study|Other Reasons|0|||
130440471|NCT02733042|469575908|FG004|Overall Study|Other Reasons|0|||
130440472|NCT02733042|469575909|FG005|Overall Study|Other Reasons|0|||
130440473|NCT02733042|469575910|FG006|Overall Study|Other Reasons|0|||
130440474|NCT02733042|469575911|FG007|Overall Study|Other Reasons|0|||
130440475|NCT02733042|469575912|FG008|Overall Study|Other Reasons|0|||
130440476|NCT02733042|469575913|FG009|Overall Study|Other Reasons|1|||
130440477|NCT02733042|469575914|FG010|Overall Study|Other Reasons|1|||
130440478|NCT02733042|469575915|FG011|Overall Study|Other Reasons|0|||
130440479|NCT02733042|469575916|FG012|Overall Study|Other Reasons|0|||
130440480|NCT02733042|469575917|FG013|Overall Study|Other Reasons|0|||
130440481|NCT02733042|469575918|FG014|Overall Study|Other Reasons|0|||
130440482|NCT02733042|469575919|FG015|Overall Study|Other Reasons|1|||
130440483|NCT02733042|469575920|FG016|Overall Study|Other Reasons|0|||
130440484|NCT02733042|469575921|FG017|Overall Study|Other Reasons|1|||
130440485|NCT02733042|469575922|FG018|Overall Study|Other Reasons|0|||
130440486|NCT02733042|469575904|FG000|Overall Study|Death|0|||
130440487|NCT02733042|469575905|FG001|Overall Study|Death|0|||
130440488|NCT02733042|469575906|FG002|Overall Study|Death|0|||
130440489|NCT02733042|469575907|FG003|Overall Study|Death|0|||
130440490|NCT02733042|469575908|FG004|Overall Study|Death|0|||
130440491|NCT02733042|469575909|FG005|Overall Study|Death|0|||
130440492|NCT02733042|469575910|FG006|Overall Study|Death|1|||
130440493|NCT02733042|469575911|FG007|Overall Study|Death|0|||
130440494|NCT02733042|469575912|FG008|Overall Study|Death|1|||
130440495|NCT02733042|469575913|FG009|Overall Study|Death|0|||
130440496|NCT02733042|469575914|FG010|Overall Study|Death|1|||
130440497|NCT02733042|469575915|FG011|Overall Study|Death|0|||
130440498|NCT02733042|469575916|FG012|Overall Study|Death|0|||
130440499|NCT02733042|469575917|FG013|Overall Study|Death|0|||
130440500|NCT02733042|469575918|FG014|Overall Study|Death|1|||
130440501|NCT02733042|469575919|FG015|Overall Study|Death|2|||
130440502|NCT02733042|469575920|FG016|Overall Study|Death|0|||
130440503|NCT02733042|469575921|FG017|Overall Study|Death|0|||
130440504|NCT02733042|469575922|FG018|Overall Study|Death|0|||
130440505|NCT01088529|469575924|FG000|Overall Study|Did not receive study treatment|0|||
130440506|NCT01088529|469575925|FG001|Overall Study|Did not receive study treatment|1|||
130440507|NCT01821898|469575927|FG000|Overall Study|Withdrawal by Subject|2|||
130440508|NCT01821898|469575928|FG001|Overall Study|Withdrawal by Subject|1|||
130440509|NCT00337662|469575933|FG000|Study Period II|Lost to Follow-up|0|||
130440510|NCT00337662|469575934|FG001|Study Period II|Lost to Follow-up|0|||
130440511|NCT00337662|469575935|FG002|Study Period II|Lost to Follow-up|0|||
130440512|NCT00337662|469575936|FG003|Study Period II|Lost to Follow-up|35|||
130440513|NCT00337662|469575933|FG000|Study Period II|Withdrawal by Subject|0|||
130440514|NCT00337662|469575934|FG001|Study Period II|Withdrawal by Subject|0|||
130440515|NCT00337662|469575935|FG002|Study Period II|Withdrawal by Subject|0|||
130440516|NCT00337662|469575936|FG003|Study Period II|Withdrawal by Subject|20|||
130440517|NCT00337662|469575933|FG000|Study Period II|Adverse Event|0|||
130440518|NCT00337662|469575934|FG001|Study Period II|Adverse Event|0|||
130440519|NCT00337662|469575935|FG002|Study Period II|Adverse Event|0|||
130440520|NCT00337662|469575936|FG003|Study Period II|Adverse Event|16|||
130440521|NCT00337662|469575933|FG000|Study Period II|Physician Decision|0|||
130440522|NCT00337662|469575934|FG001|Study Period II|Physician Decision|0|||
130440523|NCT00337662|469575935|FG002|Study Period II|Physician Decision|0|||
130440524|NCT00337662|469575936|FG003|Study Period II|Physician Decision|13|||
130440525|NCT00337662|469575933|FG000|Study Period II|Entry Criteria Not Met|0|||
130440526|NCT00337662|469575934|FG001|Study Period II|Entry Criteria Not Met|0|||
130440527|NCT00337662|469575935|FG002|Study Period II|Entry Criteria Not Met|0|||
130440528|NCT00337662|469575936|FG003|Study Period II|Entry Criteria Not Met|6|||
130440529|NCT00337662|469575933|FG000|Study Period II|Protocol Violation|0|||
130440530|NCT00337662|469575934|FG001|Study Period II|Protocol Violation|0|||
130686004|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130440531|NCT00337662|469575935|FG002|Study Period II|Protocol Violation|0|||
130440532|NCT00337662|469575936|FG003|Study Period II|Protocol Violation|6|||
130440533|NCT00337662|469575933|FG000|Study Period II|Lack of Efficacy|0|||
130440534|NCT00337662|469575934|FG001|Study Period II|Lack of Efficacy|0|||
130440535|NCT00337662|469575935|FG002|Study Period II|Lack of Efficacy|0|||
130440536|NCT00337662|469575936|FG003|Study Period II|Lack of Efficacy|7|||
130440537|NCT00337662|469575933|FG000|Study Period II|Sponsor Decision|0|||
130440538|NCT00337662|469575934|FG001|Study Period II|Sponsor Decision|0|||
130440539|NCT00337662|469575935|FG002|Study Period II|Sponsor Decision|0|||
130440540|NCT00337662|469575936|FG003|Study Period II|Sponsor Decision|2|||
130440541|NCT00337662|469575933|FG000|Study Period II|Parent/Caregiver Decision|0|||
130440542|NCT00337662|469575934|FG001|Study Period II|Parent/Caregiver Decision|0|||
130440543|NCT00337662|469575935|FG002|Study Period II|Parent/Caregiver Decision|0|||
130440544|NCT00337662|469575936|FG003|Study Period II|Parent/Caregiver Decision|1|||
130440545|NCT00337662|469575933|FG000|Study Period III|Lost to Follow-up|14|||
130440546|NCT00337662|469575934|FG001|Study Period III|Lost to Follow-up|16|||
130440547|NCT00337662|469575935|FG002|Study Period III|Lost to Follow-up|14|||
130440548|NCT00337662|469575936|FG003|Study Period III|Lost to Follow-up|0|||
130440549|NCT00337662|469575933|FG000|Study Period III|Withdrawal by Subject|18|||
130440550|NCT00337662|469575934|FG001|Study Period III|Withdrawal by Subject|14|||
130440551|NCT00337662|469575935|FG002|Study Period III|Withdrawal by Subject|12|||
130440552|NCT00337662|469575936|FG003|Study Period III|Withdrawal by Subject|0|||
130440553|NCT00337662|469575933|FG000|Study Period III|Adverse Event|9|||
130440554|NCT00337662|469575934|FG001|Study Period III|Adverse Event|10|||
130440555|NCT00337662|469575935|FG002|Study Period III|Adverse Event|8|||
130440556|NCT00337662|469575936|FG003|Study Period III|Adverse Event|0|||
130440557|NCT00337662|469575933|FG000|Study Period III|Protocol Violation|3|||
130440558|NCT00337662|469575934|FG001|Study Period III|Protocol Violation|8|||
130440559|NCT00337662|469575935|FG002|Study Period III|Protocol Violation|2|||
130440560|NCT00337662|469575936|FG003|Study Period III|Protocol Violation|0|||
130440561|NCT00337662|469575933|FG000|Study Period III|Physician Decision|6|||
130440562|NCT00337662|469575934|FG001|Study Period III|Physician Decision|5|||
130440563|NCT00337662|469575935|FG002|Study Period III|Physician Decision|0|||
130440564|NCT00337662|469575936|FG003|Study Period III|Physician Decision|0|||
130440565|NCT00337662|469575933|FG000|Study Period III|Entry Criteria Not Met|4|||
130440566|NCT00337662|469575934|FG001|Study Period III|Entry Criteria Not Met|1|||
130440567|NCT00337662|469575935|FG002|Study Period III|Entry Criteria Not Met|3|||
130440568|NCT00337662|469575936|FG003|Study Period III|Entry Criteria Not Met|0|||
130440569|NCT00337662|469575933|FG000|Study Period III|Lack of Efficacy|4|||
130440570|NCT00337662|469575934|FG001|Study Period III|Lack of Efficacy|4|||
130440571|NCT00337662|469575935|FG002|Study Period III|Lack of Efficacy|2|||
130440572|NCT00337662|469575936|FG003|Study Period III|Lack of Efficacy|0|||
130440573|NCT00337662|469575933|FG000|Study Period III|Parent/Caregiver Decision|0|||
130440574|NCT00337662|469575934|FG001|Study Period III|Parent/Caregiver Decision|0|||
130440575|NCT00337662|469575935|FG002|Study Period III|Parent/Caregiver Decision|2|||
130440576|NCT00337662|469575936|FG003|Study Period III|Parent/Caregiver Decision|0|||
130440577|NCT00337662|469575933|FG000|Study Period III|Sponsor Decision|1|||
130440578|NCT00337662|469575934|FG001|Study Period III|Sponsor Decision|0|||
130440579|NCT00337662|469575935|FG002|Study Period III|Sponsor Decision|1|||
130440580|NCT00337662|469575936|FG003|Study Period III|Sponsor Decision|0|||
130440581|NCT00337662|469575933|FG000|Study Period III|Clinical Relapse|1|||
130440582|NCT00337662|469575934|FG001|Study Period III|Clinical Relapse|0|||
130440583|NCT00337662|469575935|FG002|Study Period III|Clinical Relapse|0|||
130440584|NCT00337662|469575936|FG003|Study Period III|Clinical Relapse|0|||
130440585|NCT03691948|469575937|FG000|Overall Study|Lost to Follow-up|1|||
130440586|NCT03691948|469575938|FG001|Overall Study|Lost to Follow-up|3|||
130440587|NCT03012061|469575948|FG000|Overall Study|Withdrawal by Subject|1|||
130440588|NCT03012061|469575949|FG001|Overall Study|Withdrawal by Subject|5|||
130440589|NCT03012061|469575950|FG002|Overall Study|Withdrawal by Subject|4|||
130440590|NCT03012061|469575948|FG000|Overall Study|Investigator Site Closed|1|||
130440591|NCT03012061|469575949|FG001|Overall Study|Investigator Site Closed|2|||
130440592|NCT03012061|469575950|FG002|Overall Study|Investigator Site Closed|0|||
130440593|NCT03012061|469575948|FG000|Overall Study|Lost to Follow-up|2|||
130440594|NCT03012061|469575949|FG001|Overall Study|Lost to Follow-up|1|||
130440595|NCT03012061|469575950|FG002|Overall Study|Lost to Follow-up|0|||
130440596|NCT03012061|469575948|FG000|Overall Study|Study closed/ Terminated|0|||
130440597|NCT03012061|469575949|FG001|Overall Study|Study closed/ Terminated|0|||
130440598|NCT03012061|469575950|FG002|Overall Study|Study closed/ Terminated|1|||
130440599|NCT03012061|469575948|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
130440600|NCT03012061|469575949|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
130440601|NCT03012061|469575950|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
130440602|NCT03012061|469575948|FG000|Overall Study|Protocol Violation|0|||
130440603|NCT03012061|469575949|FG001|Overall Study|Protocol Violation|0|||
130440604|NCT03012061|469575950|FG002|Overall Study|Protocol Violation|2|||
130440605|NCT03012061|469575948|FG000|Overall Study|Lack of Efficacy|0|||
130440606|NCT03012061|469575949|FG001|Overall Study|Lack of Efficacy|1|||
130440607|NCT03012061|469575950|FG002|Overall Study|Lack of Efficacy|0|||
130440608|NCT03012061|469575948|FG000|Overall Study|Adverse Event|2|||
130440609|NCT03012061|469575949|FG001|Overall Study|Adverse Event|0|||
130440610|NCT03012061|469575950|FG002|Overall Study|Adverse Event|0|||
130440611|NCT02696902|469575951|FG000|Overall Study|Lost to Follow-up|0|||
130440612|NCT02696902|469575952|FG001|Overall Study|Lost to Follow-up|1|||
130440613|NCT02696902|469575953|FG002|Overall Study|Lost to Follow-up|1|||
130440614|NCT02696902|469575951|FG000|Overall Study|Withdrawal by Subject|0|||
130440615|NCT02696902|469575952|FG001|Overall Study|Withdrawal by Subject|0|||
130440616|NCT02696902|469575953|FG002|Overall Study|Withdrawal by Subject|1|||
130440617|NCT02696902|469575951|FG000|Overall Study|Death|19|||
130440618|NCT02696902|469575952|FG001|Overall Study|Death|3|||
130440619|NCT02696902|469575953|FG002|Overall Study|Death|24|||
130440620|NCT02696902|469575951|FG000|Overall Study|Participant not fit post-randomization|0|||
130440621|NCT02696902|469575952|FG001|Overall Study|Participant not fit post-randomization|0|||
130440622|NCT02696902|469575953|FG002|Overall Study|Participant not fit post-randomization|1|||
130440623|NCT02696902|469575951|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
130440624|NCT02696902|469575952|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
130440625|NCT02696902|469575953|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
130440626|NCT02696902|469575951|FG000|Overall Study|Principal investigator's decision|1|||
130440627|NCT02696902|469575952|FG001|Overall Study|Principal investigator's decision|0|||
130440628|NCT02696902|469575953|FG002|Overall Study|Principal investigator's decision|0|||
130440629|NCT02696902|469575951|FG000|Overall Study|Sponsor's decision|1|||
130440630|NCT02696902|469575952|FG001|Overall Study|Sponsor's decision|0|||
130440631|NCT02696902|469575953|FG002|Overall Study|Sponsor's decision|0|||
130440632|NCT02696902|469575951|FG000|Overall Study|Transferred to other hospital|1|||
130440633|NCT02696902|469575952|FG001|Overall Study|Transferred to other hospital|0|||
130440634|NCT02696902|469575953|FG002|Overall Study|Transferred to other hospital|0|||
130440635|NCT00514046|469575954|FG000|Overall Study|transferred to another protocol|2|||
130440636|NCT00514046|469575955|FG001|Overall Study|transferred to another protocol|1|||
130440637|NCT00514046|469575956|FG002|Overall Study|transferred to another protocol|3|||
130440638|NCT00514046|469575957|FG003|Overall Study|transferred to another protocol|0|||
130440639|NCT00514046|469575958|FG004|Overall Study|transferred to another protocol|1|||
130440640|NCT00514046|469575959|FG005|Overall Study|transferred to another protocol|0|||
130440641|NCT00514046|469575960|FG006|Overall Study|transferred to another protocol|0|||
130440642|NCT00514046|469575961|FG007|Overall Study|transferred to another protocol|0|||
130440643|NCT00514046|469575962|FG008|Overall Study|transferred to another protocol|0|||
130440644|NCT00514046|469575954|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
130440645|NCT00514046|469575955|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
130440646|NCT00514046|469575956|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
130440647|NCT00514046|469575957|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
130440648|NCT00514046|469575958|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
130440649|NCT00514046|469575959|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
130440650|NCT00514046|469575960|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
130440651|NCT00514046|469575961|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
130440652|NCT00514046|469575962|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
130440653|NCT00514046|469575954|FG000|Overall Study|Disease progression on study|0|||
130440654|NCT00514046|469575955|FG001|Overall Study|Disease progression on study|0|||
130440655|NCT00514046|469575956|FG002|Overall Study|Disease progression on study|2|||
130440656|NCT00514046|469575957|FG003|Overall Study|Disease progression on study|0|||
130440657|NCT00514046|469575958|FG004|Overall Study|Disease progression on study|0|||
130440658|NCT00514046|469575959|FG005|Overall Study|Disease progression on study|1|||
130440659|NCT00514046|469575960|FG006|Overall Study|Disease progression on study|0|||
130440660|NCT00514046|469575961|FG007|Overall Study|Disease progression on study|0|||
130440661|NCT00514046|469575962|FG008|Overall Study|Disease progression on study|0|||
130440662|NCT00383240|469575964|FG000|Overall Study|Adverse Event|4|||
130440663|NCT00383240|469575965|FG001|Overall Study|Adverse Event|6|||
130440664|NCT00383240|469575966|FG002|Overall Study|Adverse Event|9|||
130440665|NCT00383240|469575967|FG003|Overall Study|Adverse Event|7|||
130440666|NCT00383240|469575964|FG000|Overall Study|Treatment Failure|8|||
130440667|NCT00383240|469575965|FG001|Overall Study|Treatment Failure|13|||
130440668|NCT00383240|469575966|FG002|Overall Study|Treatment Failure|47|||
130440669|NCT00383240|469575967|FG003|Overall Study|Treatment Failure|46|||
130440670|NCT00383240|469575964|FG000|Overall Study|Lost to Follow-up|3|||
130440671|NCT00383240|469575965|FG001|Overall Study|Lost to Follow-up|0|||
130440672|NCT00383240|469575966|FG002|Overall Study|Lost to Follow-up|0|||
130440673|NCT00383240|469575967|FG003|Overall Study|Lost to Follow-up|2|||
130440674|NCT00383240|469575964|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
130440675|NCT00383240|469575965|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
130440676|NCT00383240|469575966|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
130440677|NCT00383240|469575967|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
130440678|NCT00383240|469575964|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
130440679|NCT00383240|469575965|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
130440680|NCT00383240|469575966|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
130440681|NCT00383240|469575967|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
130440682|NCT00383240|469575964|FG000|Overall Study|Protocol Violation|4|||
130440683|NCT00383240|469575965|FG001|Overall Study|Protocol Violation|5|||
130440684|NCT00383240|469575966|FG002|Overall Study|Protocol Violation|9|||
130440685|NCT00383240|469575967|FG003|Overall Study|Protocol Violation|6|||
130440686|NCT00383240|469575964|FG000|Overall Study|Did not meet protocol eligibility|9|||
130440687|NCT00383240|469575965|FG001|Overall Study|Did not meet protocol eligibility|4|||
130440688|NCT00383240|469575966|FG002|Overall Study|Did not meet protocol eligibility|9|||
130440689|NCT00383240|469575967|FG003|Overall Study|Did not meet protocol eligibility|3|||
130440690|NCT00383240|469575964|FG000|Overall Study|Administrative|1|||
130353492|NCT02862600|469264552|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
130353493|NCT02862600|469264552|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
130353494|NCT02862600|469264552|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
130353495|NCT02862600|469264552|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
130353496|NCT00772070|469264568|FG000|Overall Study|Lost to Follow-up|0|||
130353497|NCT00772070|469264569|FG001|Overall Study|Lost to Follow-up|8|||
130353498|NCT00772070|469264568|FG000|Overall Study|Withdrawal by Subject|0|||
130353499|NCT00772070|469264569|FG001|Overall Study|Withdrawal by Subject|2|||
130353500|NCT00772070|469264568|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
130353501|NCT00772070|469264569|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
130353502|NCT01309308|469264570|FG000|Overall Study|Lost to Follow-up|6|||
130353503|NCT01309308|469264571|FG001|Overall Study|Lost to Follow-up|4|||
130353504|NCT01017575|469264572|FG000|Overall Study|Lack of Efficacy|0|||
130353505|NCT01017575|469264573|FG001|Overall Study|Lack of Efficacy|1|||
130353506|NCT01017575|469264574|FG002|Overall Study|Lack of Efficacy|0|||
130353507|NCT01017575|469264575|FG003|Overall Study|Lack of Efficacy|1|||
130353508|NCT01017575|469264576|FG004|Overall Study|Lack of Efficacy|1|||
130353509|NCT01017575|469264572|FG000|Overall Study|Adverse Event|0|||
130353510|NCT01017575|469264573|FG001|Overall Study|Adverse Event|1|||
130353511|NCT01017575|469264574|FG002|Overall Study|Adverse Event|0|||
130353512|NCT01017575|469264575|FG003|Overall Study|Adverse Event|0|||
130353513|NCT01017575|469264576|FG004|Overall Study|Adverse Event|2|||
130353514|NCT01017575|469264572|FG000|Overall Study|Withdrawal by Subject|1|||
130353515|NCT01017575|469264573|FG001|Overall Study|Withdrawal by Subject|0|||
130353516|NCT01017575|469264574|FG002|Overall Study|Withdrawal by Subject|0|||
130353517|NCT01017575|469264575|FG003|Overall Study|Withdrawal by Subject|0|||
130353518|NCT01017575|469264576|FG004|Overall Study|Withdrawal by Subject|0|||
130353519|NCT04271280|469264577|FG000|Overall Study|Lost to Follow-up|300|||
130353520|NCT04271280|469264577|FG000|Overall Study|Death|153|||
130353521|NCT04271280|469264577|FG000|Overall Study|Withdrawal of consent by patient|59|||
130353522|NCT04271280|469264577|FG000|Overall Study|Other|51|||
130353523|NCT04271280|469264577|FG000|Overall Study|No end of study information|42|||
130353524|NCT01857583|469264586|FG000|Overall Study|Adverse Event|0|||
130353525|NCT01857583|469264587|FG001|Overall Study|Adverse Event|0|||
130353526|NCT01857583|469264588|FG002|Overall Study|Adverse Event|1|||
130353527|NCT01857583|469264589|FG003|Overall Study|Adverse Event|1|||
130353528|NCT01857583|469264586|FG000|Overall Study|Death|0|||
130353529|NCT01857583|469264587|FG001|Overall Study|Death|1|||
130353530|NCT01857583|469264588|FG002|Overall Study|Death|1|||
130353531|NCT01857583|469264589|FG003|Overall Study|Death|0|||
130353532|NCT01857583|469264586|FG000|Overall Study|Physician Decision|0|||
130353533|NCT01857583|469264587|FG001|Overall Study|Physician Decision|0|||
130353534|NCT01857583|469264588|FG002|Overall Study|Physician Decision|0|||
130353535|NCT01857583|469264589|FG003|Overall Study|Physician Decision|1|||
130353536|NCT01857583|469264586|FG000|Overall Study|Withdrawal by Subject|1|||
130353537|NCT01857583|469264587|FG001|Overall Study|Withdrawal by Subject|0|||
130353538|NCT01857583|469264588|FG002|Overall Study|Withdrawal by Subject|1|||
130353539|NCT01857583|469264589|FG003|Overall Study|Withdrawal by Subject|2|||
130353540|NCT00458536|469264592|FG000|Overall Study|Disease progression prior to treatment|7|||
130353541|NCT00458536|469264592|FG000|Overall Study|Unable to make vaccine|3|||
130353542|NCT00458536|469264592|FG000|Overall Study|No measurable disease after surgery|2|||
130353543|NCT00458536|469264592|FG000|Overall Study|Did not have renal cell carcinoma|2|||
130353544|NCT00458536|469264592|FG000|Overall Study|Patient did not have surgery|1|||
130353545|NCT00458536|469264592|FG000|Overall Study|Ineligible due to toxicity|1|||
130353546|NCT00458536|469264592|FG000|Overall Study|Withdrawal by Subject|1|||
130353547|NCT00458536|469264592|FG000|Overall Study|Progressive disease during treatment|2|||
130353548|NCT03287635|469264595|FG000|Overall Study|Lost to Follow-up|5|||
130353549|NCT03287635|469264595|FG000|Overall Study|Withdrawal by Subject|1|||
130353550|NCT03287635|469264595|FG000|Overall Study|Physician Decision|1|||
130353551|NCT00323869|469264596|FG000|Overall Study|Death|1|||
130353552|NCT02294773|469266272|FG000|Overall Study|Withdrawal by Subject|0|||
130353553|NCT02294773|469266273|FG001|Overall Study|Withdrawal by Subject|2|||
130353554|NCT03052764|469266274|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130353555|NCT03052764|469266275|FG001|Double-Blind Treatment Period|Adverse Event|0|||
130353556|NCT03052764|469266274|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130353557|NCT03052764|469266275|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130353558|NCT03052764|469266274|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
130353559|NCT03052764|469266275|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
130353560|NCT03052764|469266274|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
130353561|NCT03052764|469266275|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130353562|NCT03052764|469266274|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
130440691|NCT00383240|469575965|FG001|Overall Study|Administrative|1|||
130353563|NCT03052764|469266275|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
130353564|NCT04123665|469266278|FG000|Overall Study|Withdrawal by Subject|7|||
130353565|NCT04123665|469266279|FG001|Overall Study|Withdrawal by Subject|0|||
130353566|NCT04123665|469266278|FG000|Overall Study|Lost to Follow-up|1|||
130440692|NCT00383240|469575966|FG002|Overall Study|Administrative|0|||
130440693|NCT00383240|469575967|FG003|Overall Study|Administrative|0|||
130440694|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
130440695|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
130440696|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
130440697|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
130440698|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
130440699|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
130440700|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
130440701|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
130440702|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
130440703|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
130440704|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
130440705|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
130440706|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
130440707|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
130440708|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
130440709|NCT02023879|469575971|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
130440710|NCT02023879|469575972|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
130440711|NCT02023879|469575973|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
130440712|NCT02023879|469575971|FG000|Extension Open Label Treatment|Adverse Event|1|||
130440713|NCT02023879|469575972|FG001|Extension Open Label Treatment|Adverse Event|7|||
130440714|NCT02023879|469575973|FG002|Extension Open Label Treatment|Adverse Event|3|||
130440715|NCT02023879|469575971|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
130440716|NCT02023879|469575972|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
130440717|NCT02023879|469575973|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
130440718|NCT02023879|469575971|FG000|Extension Open Label Treatment|Participant moved|1|||
130440719|NCT02023879|469575972|FG001|Extension Open Label Treatment|Participant moved|2|||
130440720|NCT02023879|469575973|FG002|Extension Open Label Treatment|Participant moved|0|||
130440721|NCT02023879|469575971|FG000|Extension Open Label Treatment|Other than specified above|2|||
130440722|NCT02023879|469575972|FG001|Extension Open Label Treatment|Other than specified above|7|||
130440723|NCT02023879|469575973|FG002|Extension Open Label Treatment|Other than specified above|2|||
130440724|NCT02924389|469575974|FG000|Overall Study|Lost to Follow-up|1|||
130440725|NCT02924389|469575975|FG001|Overall Study|Lost to Follow-up|0|||
130440726|NCT02924389|469575974|FG000|Overall Study|Physician Decision|2|||
130440727|NCT02924389|469575975|FG001|Overall Study|Physician Decision|0|||
130440728|NCT02924389|469575974|FG000|Overall Study|Withdrawal by Subject|3|||
130440729|NCT02924389|469575975|FG001|Overall Study|Withdrawal by Subject|0|||
130440730|NCT02924389|469575974|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
130440731|NCT02924389|469575975|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
130440732|NCT04424290|469577759|FG000|Overall Study|Not treated|0|||
130440733|NCT04424290|469577760|FG001|Overall Study|Not treated|0|||
130440734|NCT04424290|469577761|FG002|Overall Study|Not treated|1|||
130440735|NCT04424290|469577762|FG003|Overall Study|Not treated|0|||
130440736|NCT04424290|469577763|FG004|Overall Study|Not treated|1|||
130440737|NCT04424290|469577759|FG000|Overall Study|Adverse Event|0|||
130440738|NCT04424290|469577760|FG001|Overall Study|Adverse Event|0|||
130440739|NCT04424290|469577761|FG002|Overall Study|Adverse Event|0|||
130440740|NCT04424290|469577762|FG003|Overall Study|Adverse Event|2|||
130440741|NCT04424290|469577763|FG004|Overall Study|Adverse Event|0|||
130440742|NCT04424290|469577759|FG000|Overall Study|Withdrawal by Subject|0|||
130440743|NCT04424290|469577760|FG001|Overall Study|Withdrawal by Subject|0|||
130440744|NCT04424290|469577761|FG002|Overall Study|Withdrawal by Subject|0|||
130440745|NCT04424290|469577762|FG003|Overall Study|Withdrawal by Subject|0|||
130440746|NCT04424290|469577763|FG004|Overall Study|Withdrawal by Subject|1|||
130440747|NCT04424290|469577759|FG000|Overall Study|Other than listed|0|||
130440748|NCT04424290|469577760|FG001|Overall Study|Other than listed|0|||
130440749|NCT04424290|469577761|FG002|Overall Study|Other than listed|0|||
130440750|NCT04424290|469577762|FG003|Overall Study|Other than listed|1|||
130440751|NCT04424290|469577763|FG004|Overall Study|Other than listed|0|||
130440752|NCT04249336|469577766|FG000|Overall Study|Lost to Follow-up|3|||
130440753|NCT04249336|469577767|FG001|Overall Study|Lost to Follow-up|3|||
130440754|NCT04249336|469577768|FG002|Overall Study|Lost to Follow-up|3|||
130440755|NCT04249336|469577769|FG003|Overall Study|Lost to Follow-up|3|||
130440756|NCT01242176|469577770|FG000|Washout Period of 7 Days|Adverse Event|0|||
130440757|NCT01242176|469577771|FG001|Washout Period of 7 Days|Adverse Event|2|||
130440758|NCT01242176|469577770|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
130440759|NCT01242176|469577771|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
130440760|NCT03390036|469577772|FG000|Overall Study|Lost to Follow-up|1|||
130440761|NCT03390036|469577773|FG001|Overall Study|Lost to Follow-up|0|||
130440762|NCT03390036|469577774|FG002|Overall Study|Lost to Follow-up|0|||
130353567|NCT04123665|469266279|FG001|Overall Study|Lost to Follow-up|0|||
130353568|NCT00206076|469266280|FG000|Overall Study|Physician Decision|2|||
130353569|NCT00206076|469266281|FG001|Overall Study|Physician Decision|0|||
130353570|NCT00206076|469266280|FG000|Overall Study|Withdrawal by Subject|1|||
130353571|NCT00206076|469266281|FG001|Overall Study|Withdrawal by Subject|1|||
130353572|NCT00750880|469266284|FG000|Overall Study|Adverse Event|76|||
130353573|NCT00750880|469266284|FG000|Overall Study|Death|4|||
130353574|NCT00750880|469266284|FG000|Overall Study|Lack of Efficacy|46|||
130353575|NCT00750880|469266284|FG000|Overall Study|Lost to Follow-up|10|||
130353576|NCT00750880|469266284|FG000|Overall Study|Protocol Violation|15|||
130353577|NCT00750880|469266284|FG000|Overall Study|Withdrawal by Subject|33|||
130353578|NCT00750880|469266284|FG000|Overall Study|Physician Decision|20|||
130353579|NCT00750880|469266284|FG000|Overall Study|Administrative|11|||
130353580|NCT02964507|469266290|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353581|NCT02964507|469266291|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
130353582|NCT02964507|469266292|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353583|NCT02964507|469266293|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353584|NCT02964507|469266294|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
130353585|NCT02964507|469266295|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353586|NCT02964507|469266296|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353587|NCT02964507|469266297|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
130353588|NCT02964507|469266290|FG000|Overall Study|Study terminated by Sponsor|9|||
130353589|NCT02964507|469266291|FG001|Overall Study|Study terminated by Sponsor|1|||
130353590|NCT02964507|469266292|FG002|Overall Study|Study terminated by Sponsor|9|||
130353591|NCT02964507|469266293|FG003|Overall Study|Study terminated by Sponsor|3|||
130353592|NCT02964507|469266294|FG004|Overall Study|Study terminated by Sponsor|3|||
130353593|NCT02964507|469266295|FG005|Overall Study|Study terminated by Sponsor|2|||
130353594|NCT02964507|469266296|FG006|Overall Study|Study terminated by Sponsor|0|||
130353595|NCT02964507|469266297|FG007|Overall Study|Study terminated by Sponsor|0|||
130353596|NCT02964507|469266290|FG000|Overall Study|Other|3|||
130353597|NCT02964507|469266291|FG001|Overall Study|Other|0|||
130353598|NCT02964507|469266292|FG002|Overall Study|Other|0|||
130353599|NCT02964507|469266293|FG003|Overall Study|Other|0|||
130353600|NCT02964507|469266294|FG004|Overall Study|Other|1|||
130353601|NCT02964507|469266295|FG005|Overall Study|Other|0|||
130353602|NCT02964507|469266296|FG006|Overall Study|Other|0|||
130353603|NCT02964507|469266297|FG007|Overall Study|Other|0|||
130353604|NCT02964507|469266290|FG000|Overall Study|Death|11|||
130353605|NCT02964507|469266291|FG001|Overall Study|Death|9|||
130353606|NCT02964507|469266292|FG002|Overall Study|Death|12|||
130353607|NCT02964507|469266293|FG003|Overall Study|Death|2|||
130353608|NCT02964507|469266294|FG004|Overall Study|Death|10|||
130353609|NCT02964507|469266295|FG005|Overall Study|Death|5|||
130353610|NCT02964507|469266296|FG006|Overall Study|Death|0|||
130353611|NCT02964507|469266297|FG007|Overall Study|Death|0|||
130353612|NCT02964507|469266290|FG000|Overall Study|Withdrawal by Subject|1|||
130353613|NCT02964507|469266291|FG001|Overall Study|Withdrawal by Subject|0|||
130353614|NCT02964507|469266292|FG002|Overall Study|Withdrawal by Subject|1|||
130353615|NCT02964507|469266293|FG003|Overall Study|Withdrawal by Subject|1|||
130353616|NCT02964507|469266294|FG004|Overall Study|Withdrawal by Subject|0|||
130353617|NCT02964507|469266295|FG005|Overall Study|Withdrawal by Subject|1|||
130353618|NCT02964507|469266296|FG006|Overall Study|Withdrawal by Subject|0|||
130353619|NCT02964507|469266297|FG007|Overall Study|Withdrawal by Subject|0|||
130353620|NCT02964507|469266290|FG000|Overall Study|Physician Decision|2|||
130353621|NCT02964507|469266291|FG001|Overall Study|Physician Decision|0|||
130353622|NCT02964507|469266292|FG002|Overall Study|Physician Decision|3|||
130353623|NCT02964507|469266293|FG003|Overall Study|Physician Decision|0|||
130353624|NCT02964507|469266294|FG004|Overall Study|Physician Decision|1|||
130353625|NCT02964507|469266295|FG005|Overall Study|Physician Decision|0|||
130353626|NCT02964507|469266296|FG006|Overall Study|Physician Decision|0|||
130353627|NCT02964507|469266297|FG007|Overall Study|Physician Decision|0|||
130353628|NCT02495233|469266298|FG000|Overall Study|Miscellaneous|0|||
130353629|NCT02495233|469266299|FG001|Overall Study|Miscellaneous|1|||
130353630|NCT03880461|469266300|FG000|Overall Study|Determined ineligible after enrollment|45|||
130353631|NCT03880461|469266301|FG001|Overall Study|Determined ineligible after enrollment|44|||
130353632|NCT03880461|469266300|FG000|Overall Study|No weight measurement after enrollment|24|||
130353633|NCT03880461|469266301|FG001|Overall Study|No weight measurement after enrollment|17|||
130353634|NCT02652767|469266303|FG000|Overall Study|Death|2|||
130353635|NCT02652767|469266303|FG000|Overall Study|Lost to Follow-up|1|||
130353636|NCT02652767|469266303|FG000|Overall Study|Withdrawal by Subject|1|||
130353637|NCT01115803|469266305|FG000|Overall Study|Withdrawal by Subject|0|||
130353638|NCT01115803|469266306|FG001|Overall Study|Withdrawal by Subject|0|||
130353639|NCT01115803|469266307|FG002|Overall Study|Withdrawal by Subject|0|||
130353640|NCT01115803|469266308|FG003|Overall Study|Withdrawal by Subject|0|||
130353641|NCT01115803|469266309|FG004|Overall Study|Withdrawal by Subject|0|||
130353642|NCT01115803|469266310|FG005|Overall Study|Withdrawal by Subject|0|||
130353643|NCT01115803|469266311|FG006|Overall Study|Withdrawal by Subject|1|||
130353644|NCT01115803|469266305|FG000|Overall Study|Lost to Follow-up|0|||
130220160|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220161|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220162|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
130220163|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220164|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220165|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130220166|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
130220167|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130220168|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
130220169|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130353645|NCT01115803|469266306|FG001|Overall Study|Lost to Follow-up|0|||
130353646|NCT01115803|469266307|FG002|Overall Study|Lost to Follow-up|1|||
130353647|NCT01115803|469266308|FG003|Overall Study|Lost to Follow-up|0|||
130353648|NCT01115803|469266309|FG004|Overall Study|Lost to Follow-up|0|||
130353649|NCT01115803|469266310|FG005|Overall Study|Lost to Follow-up|0|||
130353650|NCT01115803|469266311|FG006|Overall Study|Lost to Follow-up|0|||
130353651|NCT01115803|469266305|FG000|Overall Study|Progressive Disease during Cycle1|0|||
130353652|NCT01115803|469266306|FG001|Overall Study|Progressive Disease during Cycle1|0|||
130353653|NCT01115803|469266307|FG002|Overall Study|Progressive Disease during Cycle1|0|||
130353654|NCT01115803|469266308|FG003|Overall Study|Progressive Disease during Cycle1|0|||
130353655|NCT01115803|469266309|FG004|Overall Study|Progressive Disease during Cycle1|0|||
130353656|NCT01115803|469266310|FG005|Overall Study|Progressive Disease during Cycle1|0|||
130353657|NCT01115803|469266311|FG006|Overall Study|Progressive Disease during Cycle1|1|||
130353658|NCT03475875|469266312|FG000|Period 1|Lost to Follow-up|1|||
130353659|NCT03475875|469266313|FG001|Period 1|Lost to Follow-up|0|||
130353660|NCT03475875|469266312|FG000|Period 1|Adverse Event|2|||
130353661|NCT03475875|469266313|FG001|Period 1|Adverse Event|1|||
130353662|NCT03475875|469266312|FG000|Period 2|Adverse Event|3|||
130353663|NCT03475875|469266313|FG001|Period 2|Adverse Event|0|||
130353664|NCT03475875|469266312|FG000|Period 2|Protocol Violation|0|||
130353665|NCT03475875|469266313|FG001|Period 2|Protocol Violation|1|||
130353666|NCT01642407|469266314|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
130353667|NCT01642407|469266314|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
130353668|NCT01642407|469266314|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
130353669|NCT04025710|469266315|FG000|Overall Study|Death|3|||
130353670|NCT04025710|469266315|FG000|Overall Study|Lost to Follow-up|5|||
130353671|NCT04025710|469266315|FG000|Overall Study|Withdrawal by Subject|1|||
130353672|NCT04025710|469266315|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
130353673|NCT04025710|469266315|FG000|Overall Study|Drop-out according to protocol|34|||
130353674|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
130353675|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
130353676|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
130353677|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
130353678|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
130353679|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
130353680|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
130353681|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
130353682|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
130353683|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
130353684|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
130353685|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
130353686|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
130353687|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
130353688|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
130353689|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
130353690|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
130353691|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
130353692|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
130353693|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
130353694|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
130353695|NCT02431247|469266316|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
130353696|NCT02431247|469266317|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
130220170|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130353697|NCT02431247|469266318|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
130353698|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130353699|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130353700|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
130353701|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130353702|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130220171|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220172|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220173|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
130220174|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220175|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220176|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220177|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220178|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220179|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
130220180|NCT02683239|468770137|FG000|Overall Study|Protocol Violation|35|||
130220181|NCT02683239|468770138|FG001|Overall Study|Protocol Violation|23|||
130220182|NCT02683239|468770139|FG002|Overall Study|Protocol Violation|26|||
130220183|NCT02683239|468770140|FG003|Overall Study|Protocol Violation|4|||
130220184|NCT02683239|468770141|FG004|Overall Study|Protocol Violation|35|||
130220185|NCT02683239|468770142|FG005|Overall Study|Protocol Violation|4|||
130220186|NCT02683239|468770143|FG006|Overall Study|Protocol Violation|5|||
130353703|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
130353704|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130353705|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130353706|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
130353707|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130353708|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130353709|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
130353710|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130353711|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130353712|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
130353713|NCT02431247|469266316|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130353714|NCT02431247|469266317|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130353715|NCT02431247|469266318|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
130353716|NCT01562873|469266319|FG000|Overall Study|Disease Progression per RECIST|10|||
130353717|NCT01562873|469266320|FG001|Overall Study|Disease Progression per RECIST|0|||
130353718|NCT01562873|469266319|FG000|Overall Study|Adverse Event|1|||
130353719|NCT01562873|469266320|FG001|Overall Study|Adverse Event|0|||
130353720|NCT01562873|469266319|FG000|Overall Study|Clinical Disease Progression|9|||
130353721|NCT01562873|469266320|FG001|Overall Study|Clinical Disease Progression|0|||
130353722|NCT01562873|469266319|FG000|Overall Study|Clinical PD and adverse event|1|||
130353723|NCT01562873|469266320|FG001|Overall Study|Clinical PD and adverse event|0|||
130353724|NCT02942576|469266322|FG000|Overall Study|Adverse Event|28|||
130353725|NCT02942576|469266323|FG001|Overall Study|Adverse Event|6|||
130353726|NCT02942576|469266322|FG000|Overall Study|Withdrawal by Subject|7|||
130353727|NCT02942576|469266323|FG001|Overall Study|Withdrawal by Subject|5|||
130353728|NCT02942576|469266322|FG000|Overall Study|Physician Decision|1|||
130353729|NCT02942576|469266323|FG001|Overall Study|Physician Decision|4|||
130353730|NCT02942576|469266322|FG000|Overall Study|Other|10|||
130353731|NCT02942576|469266323|FG001|Overall Study|Other|8|||
130353732|NCT00938964|469266324|FG000|Overall Study|Death|3|||
130353733|NCT00938964|469266325|FG001|Overall Study|Death|3|||
130353734|NCT00938964|469266324|FG000|Overall Study|Lost to Follow-up|2|||
130353735|NCT00938964|469266325|FG001|Overall Study|Lost to Follow-up|3|||
130353736|NCT00938964|469266324|FG000|Overall Study|Withdrawal by Subject|22|||
130353737|NCT00938964|469266325|FG001|Overall Study|Withdrawal by Subject|18|||
130353738|NCT00938964|469266324|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
130353739|NCT00938964|469266325|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
130353740|NCT03523000|469266327|FG000|Overall Study|Withdrawal by Subject|3|||
130353741|NCT03523000|469266328|FG001|Overall Study|Withdrawal by Subject|0|||
130353742|NCT03523000|469266327|FG000|Overall Study|Unsuccessful trial|2|||
130353743|NCT03523000|469266328|FG001|Overall Study|Unsuccessful trial|0|||
130353744|NCT00194675|469266332|FG000|Overall Study|Lost to Follow-up|1|||
130220187|NCT02683239|468770137|FG000|Overall Study|Adverse Event|64|||
130220188|NCT02683239|468770138|FG001|Overall Study|Adverse Event|39|||
130220189|NCT02683239|468770139|FG002|Overall Study|Adverse Event|42|||
130353745|NCT00194675|469266333|FG001|Overall Study|Lost to Follow-up|1|||
130353746|NCT00194675|469266332|FG000|Overall Study|lack of interest|1|||
130353747|NCT00194675|469266333|FG001|Overall Study|lack of interest|1|||
130353748|NCT00194675|469266332|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
130353749|NCT00194675|469266333|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
130353750|NCT00194675|469266332|FG000|Overall Study|Protocol Violation|1|||
130353751|NCT00194675|469266333|FG001|Overall Study|Protocol Violation|0|||
130353752|NCT00194675|469266332|FG000|Overall Study|Death|1|||
130353753|NCT00194675|469266333|FG001|Overall Study|Death|0|||
130353754|NCT00704808|469266334|FG000|Overall Study|Discontinued prior to starting treatment|14|||
130440763|NCT03390036|469577772|FG000|Overall Study|Lack of Efficacy|1|||
130220190|NCT02683239|468770140|FG003|Overall Study|Adverse Event|16|||
130353755|NCT00704808|469266334|FG000|Overall Study|Death|7|||
130353756|NCT00704808|469266334|FG000|Overall Study|Tumor progression|80|||
130353757|NCT00704808|469266334|FG000|Overall Study|Patient's decision|11|||
130353758|NCT00704808|469266334|FG000|Overall Study|Early therapy discontinuation|16|||
130353759|NCT00704808|469266334|FG000|Overall Study|Adverse Event|1|||
130353760|NCT00704808|469266334|FG000|Overall Study|Lost to Follow-up|1|||
130353761|NCT00704808|469266334|FG000|Overall Study|Treatment change|1|||
130353762|NCT01285960|469266335|FG000|Overall Study|Withdrawal by Subject|2|||
130353763|NCT01285960|469266335|FG000|Overall Study|Lost to Follow-up|2|||
130353764|NCT01285960|469266335|FG000|Overall Study|2 subjects received less 10 sonications|2|||
130353765|NCT01476644|469266338|FG000|Overall Study|Death|5|||
130353766|NCT01476644|469266338|FG000|Overall Study|moved to another state|2|||
130440764|NCT03390036|469577773|FG001|Overall Study|Lack of Efficacy|0|||
130440765|NCT03390036|469577774|FG002|Overall Study|Lack of Efficacy|0|||
130440766|NCT00358215|469577775|FG000|Overall Study|Ineligibility determined|4|||
130440767|NCT00358215|469577776|FG001|Overall Study|Ineligibility determined|3|||
130440768|NCT00358215|469577775|FG000|Overall Study|Adverse Event|83|||
130440769|NCT00358215|469577776|FG001|Overall Study|Adverse Event|65|||
130440770|NCT00358215|469577775|FG000|Overall Study|Withdrawal by Subject|111|||
130440771|NCT00358215|469577776|FG001|Overall Study|Withdrawal by Subject|102|||
130440772|NCT00358215|469577775|FG000|Overall Study|Participant request|65|||
130440773|NCT00358215|469577776|FG001|Overall Study|Participant request|64|||
130440774|NCT00358215|469577775|FG000|Overall Study|Physician Decision|47|||
130440775|NCT00358215|469577776|FG001|Overall Study|Physician Decision|39|||
130440776|NCT00358215|469577775|FG000|Overall Study|Lost to Follow-up|16|||
130440777|NCT00358215|469577776|FG001|Overall Study|Lost to Follow-up|22|||
130440778|NCT00358215|469577775|FG000|Overall Study|Death|265|||
130440779|NCT00358215|469577776|FG001|Overall Study|Death|281|||
130440780|NCT00358215|469577775|FG000|Overall Study|Protocol Violation|64|||
130440781|NCT00358215|469577776|FG001|Overall Study|Protocol Violation|59|||
130440782|NCT00358215|469577775|FG000|Overall Study|Pregnancy|1|||
130440783|NCT00358215|469577776|FG001|Overall Study|Pregnancy|0|||
130440784|NCT00358215|469577775|FG000|Overall Study|Other|21|||
130440785|NCT00358215|469577776|FG001|Overall Study|Other|14|||
130440786|NCT00358215|469577775|FG000|Overall Study|Did not receive investigational product|2|||
130440787|NCT00358215|469577776|FG001|Overall Study|Did not receive investigational product|3|||
130440788|NCT04329104|469577783|FG000|Efficacy Study|Withdrawal by Subject|0|||
130440789|NCT04329104|469577784|FG001|Efficacy Study|Withdrawal by Subject|0|||
130440790|NCT04329104|469577785|FG002|Efficacy Study|Withdrawal by Subject|0|||
130440791|NCT04329104|469577786|FG003|Efficacy Study|Withdrawal by Subject|5|||
130440792|NCT04329104|469577787|FG004|Efficacy Study|Withdrawal by Subject|6|||
130440793|NCT04329104|469577788|FG005|Efficacy Study|Withdrawal by Subject|8|||
130440794|NCT01024959|469577792|FG000|Overall Study|ineligible|12|||
130440795|NCT01024959|469577792|FG000|Overall Study|results not evaluable|12|||
130440796|NCT01024959|469577792|FG000|Overall Study|missing results required for analysis|17|||
130440797|NCT00636792|469577793|FG000|Overall Study|Adverse Event|16|||
130440798|NCT00636792|469577793|FG000|Overall Study|Physician Decision|7|||
130440799|NCT00636792|469577793|FG000|Overall Study|Progressive Disease|4|||
130440800|NCT00636792|469577793|FG000|Overall Study|Withdrawal by Subject|3|||
130440801|NCT00636792|469577793|FG000|Overall Study|Other|3|||
130440802|NCT01987596|469577796|FG000|Overall Study|Physician Decision|1|||
130440803|NCT01987596|469577797|FG001|Overall Study|Physician Decision|0|||
130440804|NCT01987596|469577796|FG000|Overall Study|Progressive Disease; missing all period|0|||
130440805|NCT01987596|469577797|FG001|Overall Study|Progressive Disease; missing all period|1|||
130440806|NCT00709592|469577798|FG000|Overall Study|Unable to proceed to transplant|0|||
130686005|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686006|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130220191|NCT02683239|468770141|FG004|Overall Study|Adverse Event|189|||
130440807|NCT00709592|469577799|FG001|Overall Study|Unable to proceed to transplant|1|||
130440808|NCT01129336|469577800|FG000|Overall Study|Protocol Violation|1|||
130440809|NCT01129336|469577801|FG001|Overall Study|Protocol Violation|0|||
130440810|NCT01129336|469577800|FG000|Overall Study|Disease Progression|1|||
130440811|NCT01129336|469577801|FG001|Overall Study|Disease Progression|4|||
130440812|NCT01129336|469577800|FG000|Overall Study|Lost to Follow-up|1|||
130440813|NCT01129336|469577801|FG001|Overall Study|Lost to Follow-up|0|||
130440814|NCT01129336|469577800|FG000|Overall Study|Withdrawal by Subject|7|||
130440815|NCT01129336|469577801|FG001|Overall Study|Withdrawal by Subject|4|||
130440816|NCT01129336|469577800|FG000|Overall Study|Adverse Event|0|||
130440817|NCT01129336|469577801|FG001|Overall Study|Adverse Event|1|||
130440818|NCT01129336|469577800|FG000|Overall Study|Missing Study Completion Status|2|||
130220192|NCT02683239|468770142|FG005|Overall Study|Adverse Event|9|||
130353767|NCT01476644|469266338|FG000|Overall Study|Lost to Follow-up|19|||
130353768|NCT01476644|469266338|FG000|Overall Study|Withdrawal by Subject|13|||
130440819|NCT01129336|469577801|FG001|Overall Study|Missing Study Completion Status|3|||
130440820|NCT01129336|469577800|FG000|Overall Study|Death|0|||
130440821|NCT01129336|469577801|FG001|Overall Study|Death|4|||
130440822|NCT00358150|469577802|FG000|Overall Study|Adverse Event|3|||
130440823|NCT00358150|469577802|FG000|Overall Study|Withdrawal by Subject|1|||
130440824|NCT00358150|469577802|FG000|Overall Study|Undefined|3|||
130220193|NCT02683239|468770143|FG006|Overall Study|Adverse Event|9|||
130220194|NCT02683239|468770137|FG000|Overall Study|Physician Decision|38|||
130353769|NCT00095628|469266340|FG000|Overall Study|Disease progression prior to treatment|1|||
130353770|NCT02280473|469266341|FG000|Overall Study|Adverse Event|1|||
130353771|NCT02280473|469266342|FG001|Overall Study|Adverse Event|1|||
130353772|NCT02280473|469266341|FG000|Overall Study|Lack of Efficacy|0|||
130353773|NCT02280473|469266342|FG001|Overall Study|Lack of Efficacy|1|||
130353774|NCT02280473|469266341|FG000|Overall Study|Lost to Follow-up|0|||
130353775|NCT02280473|469266342|FG001|Overall Study|Lost to Follow-up|1|||
130353776|NCT01484054|469266343|FG000|Period 1|Withdrawal by Subject|0|||
130353777|NCT01484054|469266344|FG001|Period 1|Withdrawal by Subject|1|||
130353778|NCT00410202|469266353|FG000|On-Treatment|Continuing treatment|69|||
130353779|NCT00410202|469266354|FG001|On-Treatment|Continuing treatment|71|||
130353780|NCT00410202|469266355|FG002|On-Treatment|Continuing treatment|66|||
130353781|NCT00410202|469266353|FG000|On-Treatment|Adverse Event|1|||
130353782|NCT00410202|469266354|FG001|On-Treatment|Adverse Event|3|||
130353783|NCT00410202|469266355|FG002|On-Treatment|Adverse Event|2|||
130353784|NCT00410202|469266353|FG000|On-Treatment|Death|1|||
130353785|NCT00410202|469266354|FG001|On-Treatment|Death|0|||
130353786|NCT00410202|469266355|FG002|On-Treatment|Death|0|||
130353787|NCT00410202|469266353|FG000|On-Treatment|Lost to Follow-up|1|||
130353788|NCT00410202|469266354|FG001|On-Treatment|Lost to Follow-up|0|||
130353789|NCT00410202|469266355|FG002|On-Treatment|Lost to Follow-up|1|||
130353790|NCT00410202|469266353|FG000|On-Treatment|Lack of Efficacy|1|||
130353791|NCT00410202|469266354|FG001|On-Treatment|Lack of Efficacy|4|||
130353792|NCT00410202|469266355|FG002|On-Treatment|Lack of Efficacy|0|||
130353793|NCT00410202|469266353|FG000|On-Treatment|Withdrawal by Subject|2|||
130353794|NCT00410202|469266354|FG001|On-Treatment|Withdrawal by Subject|1|||
130353795|NCT00410202|469266355|FG002|On-Treatment|Withdrawal by Subject|1|||
130353796|NCT00410202|469266353|FG000|On-Treatment|Other Reason|0|||
130353797|NCT00410202|469266354|FG001|On-Treatment|Other Reason|0|||
130353798|NCT00410202|469266355|FG002|On-Treatment|Other Reason|1|||
130353799|NCT00410202|469266353|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
130353800|NCT00410202|469266354|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
130353801|NCT00410202|469266355|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
130353802|NCT00410202|469266353|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
130353803|NCT00410202|469266354|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
130353804|NCT00410202|469266355|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
130353805|NCT00410202|469266353|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
130353806|NCT00410202|469266354|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
130353807|NCT00410202|469266355|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
130353808|NCT00937391|469266356|FG000|Stage 2|Withdrawal by Subject|1|||
130353809|NCT03194490|469266369|FG000|Overall Study|Lost to Follow-up|1|||
130353810|NCT03194490|469266370|FG001|Overall Study|Lost to Follow-up|3|||
130353811|NCT03194490|469266369|FG000|Overall Study|participant developed specific neck pain|1|||
130353812|NCT03194490|469266370|FG001|Overall Study|participant developed specific neck pain|0|||
130353813|NCT01758289|469266371|FG000|Overall Study|Premature Study Termination|44|||
130353814|NCT01758289|469266371|FG000|Overall Study|Adverse Event|9|||
130353815|NCT01574079|469266372|FG000|Overall Study|Physician Decision|0|||
130353816|NCT01574079|469266373|FG001|Overall Study|Physician Decision|2|||
130353817|NCT01574079|469266372|FG000|Overall Study|Lost to Follow-up|1|||
130353818|NCT01574079|469266373|FG001|Overall Study|Lost to Follow-up|0|||
130353819|NCT03640559|469266377|FG000|Overall Study|Physician Decision|1|||
130353820|NCT03640559|469266378|FG001|Overall Study|Physician Decision|1|||
130353821|NCT03640559|469266377|FG000|Overall Study|Withdrawal by Subject|1|||
130353822|NCT03640559|469266378|FG001|Overall Study|Withdrawal by Subject|0|||
130353823|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
130353824|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
130353825|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
130353826|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
130353827|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
130353828|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
130220195|NCT02683239|468770138|FG001|Overall Study|Physician Decision|19|||
130353829|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
130353830|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
130220196|NCT02683239|468770139|FG002|Overall Study|Physician Decision|14|||
130353831|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
130353832|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
130353833|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
130353834|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
130353835|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
130353836|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130353837|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130353838|NCT01436162|469266379|FG000|Single-blind Lead-in Phase|Other|107|||
130353839|NCT01436162|469266380|FG001|Single-blind Lead-in Phase|Other|0|||
130353840|NCT01436162|469266381|FG002|Single-blind Lead-in Phase|Other|0|||
130440825|NCT00179010|469577803|FG000|Overall Study|Muscle probe defective|1|||
130440826|NCT00179010|469577804|FG001|Overall Study|Muscle probe defective|1|||
130440827|NCT00179010|469577803|FG000|Overall Study|Failure to place arterial line|0|||
130440828|NCT00179010|469577804|FG001|Overall Study|Failure to place arterial line|1|||
130440829|NCT01375959|469577816|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
130440830|NCT01375959|469577817|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
130440831|NCT01375959|469577816|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130440832|NCT01375959|469577817|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
130440833|NCT01375959|469577816|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130440834|NCT01375959|469577817|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
130440835|NCT00178256|469577818|FG000|Overall Study|Adverse Event|2|||
130440836|NCT00178256|469577819|FG001|Overall Study|Adverse Event|0|||
130440837|NCT00178256|469577820|FG002|Overall Study|Adverse Event|0|||
130440838|NCT00178256|469577821|FG003|Overall Study|Adverse Event|0|||
130440839|NCT00178256|469577818|FG000|Overall Study|Death|0|||
130440840|NCT00178256|469577819|FG001|Overall Study|Death|1|||
130440841|NCT00178256|469577820|FG002|Overall Study|Death|0|||
130440842|NCT00178256|469577821|FG003|Overall Study|Death|1|||
130440843|NCT00178256|469577818|FG000|Overall Study|Cancer progression|2|||
130440844|NCT00178256|469577819|FG001|Overall Study|Cancer progression|0|||
130440845|NCT00178256|469577820|FG002|Overall Study|Cancer progression|0|||
130440846|NCT00178256|469577821|FG003|Overall Study|Cancer progression|1|||
130440847|NCT01763788|469577822|FG000|Overall Study|Lost to Follow-up|0|||
130440848|NCT01763788|469577823|FG001|Overall Study|Lost to Follow-up|0|||
130440849|NCT01763788|469577824|FG002|Overall Study|Lost to Follow-up|1|||
130440850|NCT01763788|469577825|FG003|Overall Study|Lost to Follow-up|0|||
130440851|NCT00708305|469577828|FG000|Period 1|Protocol Violation|1|||
130440852|NCT00708305|469577829|FG001|Period 1|Protocol Violation|0|||
130440853|NCT00708305|469577830|FG002|Period 1|Protocol Violation|1|||
130440854|NCT00708305|469577831|FG003|Period 1|Protocol Violation|0|||
130440855|NCT00708305|469577828|FG000|Period 1|Other Reason|0|||
130440856|NCT00708305|469577829|FG001|Period 1|Other Reason|0|||
130440857|NCT00708305|469577830|FG002|Period 1|Other Reason|0|||
130440858|NCT00708305|469577831|FG003|Period 1|Other Reason|2|||
130440859|NCT00708305|469577828|FG000|Period 2|Lost to Follow-up|0|||
130440860|NCT00708305|469577829|FG001|Period 2|Lost to Follow-up|1|||
130440861|NCT00708305|469577830|FG002|Period 2|Lost to Follow-up|0|||
130440862|NCT00708305|469577831|FG003|Period 2|Lost to Follow-up|0|||
130440863|NCT00708305|469577828|FG000|Period 2|Protocol Violation|0|||
130440864|NCT00708305|469577829|FG001|Period 2|Protocol Violation|1|||
130440865|NCT00708305|469577830|FG002|Period 2|Protocol Violation|0|||
130440866|NCT00708305|469577831|FG003|Period 2|Protocol Violation|0|||
130440867|NCT00708305|469577828|FG000|Period 2|Other Reason|1|||
130440868|NCT00708305|469577829|FG001|Period 2|Other Reason|0|||
130440869|NCT00708305|469577830|FG002|Period 2|Other Reason|0|||
130440870|NCT00708305|469577831|FG003|Period 2|Other Reason|1|||
130440871|NCT00708305|469577828|FG000|Period 3|Protocol Violation|0|||
130440872|NCT00708305|469577829|FG001|Period 3|Protocol Violation|2|||
130440873|NCT00708305|469577830|FG002|Period 3|Protocol Violation|0|||
130440874|NCT00708305|469577831|FG003|Period 3|Protocol Violation|0|||
130440875|NCT00708305|469577828|FG000|Period 3|Other Reason|1|||
130440876|NCT00708305|469577829|FG001|Period 3|Other Reason|0|||
130440877|NCT00708305|469577830|FG002|Period 3|Other Reason|0|||
130440878|NCT00708305|469577831|FG003|Period 3|Other Reason|0|||
130440879|NCT02771210|469577832|FG000|Period 1|Adverse Event|5|||
130440880|NCT02771210|469577833|FG001|Period 1|Adverse Event|3|||
130440881|NCT02771210|469577832|FG000|Period 1|Lack of Efficacy|3|||
130440882|NCT02771210|469577833|FG001|Period 1|Lack of Efficacy|6|||
130440883|NCT02771210|469577832|FG000|Period 1|Lost to Follow-up|2|||
130440884|NCT02771210|469577833|FG001|Period 1|Lost to Follow-up|0|||
130440885|NCT02771210|469577832|FG000|Period 1|Physician Decision|0|||
130440886|NCT02771210|469577833|FG001|Period 1|Physician Decision|1|||
130440887|NCT02771210|469577832|FG000|Period 1|Withdrawal by Subject|0|||
130440888|NCT02771210|469577833|FG001|Period 1|Withdrawal by Subject|3|||
130440889|NCT02771210|469577832|FG000|Period 1|Withdrawal of informed consent|1|||
130440890|NCT02771210|469577833|FG001|Period 1|Withdrawal of informed consent|5|||
130440891|NCT02771210|469577832|FG000|Period 2|Adverse Event|1|||
130440892|NCT02771210|469577833|FG001|Period 2|Adverse Event|0|||
130440893|NCT02771210|469577832|FG000|Period 2|Lack of Efficacy|0|||
130440894|NCT02771210|469577833|FG001|Period 2|Lack of Efficacy|1|||
130440895|NCT02771210|469577832|FG000|Period 2|Withdrawal by Subject|1|||
130220197|NCT02683239|468770140|FG003|Overall Study|Physician Decision|73|||
130440896|NCT02771210|469577833|FG001|Period 2|Withdrawal by Subject|0|||
130440897|NCT02771210|469577832|FG000|Period 2|Withdrawal of informed consent|0|||
130440898|NCT02771210|469577833|FG001|Period 2|Withdrawal of informed consent|2|||
130440899|NCT02310126|469577836|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
130440900|NCT02310126|469577837|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
130440901|NCT02310126|469577836|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
130440902|NCT02310126|469577837|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
130440903|NCT02441946|469577843|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
130440904|NCT02441946|469577844|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
130440905|NCT02441946|469577845|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
130440906|NCT02441946|469577843|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
130440907|NCT02441946|469577844|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
130440908|NCT02441946|469577845|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
130440909|NCT02441946|469577843|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130440910|NCT02441946|469577844|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
130440911|NCT02441946|469577845|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130440912|NCT02441946|469577843|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
130440913|NCT02441946|469577844|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
130440914|NCT02441946|469577845|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
130440915|NCT02441946|469577843|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
130440916|NCT02441946|469577844|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
130440917|NCT02441946|469577845|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
130440918|NCT02441946|469577843|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
130440919|NCT02441946|469577844|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
130440920|NCT02441946|469577845|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
130440921|NCT02441946|469577843|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
130440922|NCT02441946|469577844|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
130440923|NCT02441946|469577845|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
130440924|NCT02441946|469577843|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
130440925|NCT02441946|469577844|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
130440926|NCT02441946|469577845|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
130440927|NCT02441946|469577843|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
130440928|NCT02441946|469577844|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
130440929|NCT02441946|469577845|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
130440930|NCT02441946|469577843|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
130440931|NCT02441946|469577844|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
130440932|NCT02441946|469577845|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
130440933|NCT02441946|469577843|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
130440934|NCT02441946|469577844|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130440935|NCT02441946|469577845|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130440936|NCT02111213|469577846|FG000|Overall Study|Withdrawal by Subject|3|||
130440937|NCT02111213|469577847|FG001|Overall Study|Withdrawal by Subject|2|||
130440938|NCT02111213|469577846|FG000|Overall Study|Lost to Follow-up|3|||
130440939|NCT02111213|469577847|FG001|Overall Study|Lost to Follow-up|4|||
130440940|NCT03237013|469577848|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
130440941|NCT03237013|469577849|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
130440942|NCT03237013|469577850|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
130440943|NCT00210119|469577851|FG000|Overall Study|Protocol Violation|1|||
130440944|NCT00210119|469577851|FG000|Overall Study|Withdrawal by Subject|1|||
130440945|NCT00988351|469577852|FG000|Overall Study|Withdrawal by Subject|8|||
130440946|NCT00988351|469577853|FG001|Overall Study|Withdrawal by Subject|0|||
130440947|NCT00988351|469577852|FG000|Overall Study|Lost to Follow-up|6|||
130440948|NCT00988351|469577853|FG001|Overall Study|Lost to Follow-up|9|||
130440949|NCT00988351|469577852|FG000|Overall Study|not using CPAP|5|||
130440950|NCT00988351|469577853|FG001|Overall Study|not using CPAP|3|||
130440951|NCT04844918|469577856|FG000|Overall Study|Adverse Event|7|||
130440952|NCT04844918|469577857|FG001|Overall Study|Adverse Event|8|||
130440953|NCT04844918|469577858|FG002|Overall Study|Adverse Event|5|||
130440954|NCT04844918|469577856|FG000|Overall Study|Physician Decision|0|||
130440955|NCT04844918|469577857|FG001|Overall Study|Physician Decision|1|||
130440956|NCT04844918|469577858|FG002|Overall Study|Physician Decision|0|||
130440957|NCT04844918|469577856|FG000|Overall Study|Withdrawal by Subject|6|||
130440958|NCT04844918|469577857|FG001|Overall Study|Withdrawal by Subject|3|||
130440959|NCT04844918|469577858|FG002|Overall Study|Withdrawal by Subject|3|||
130440960|NCT04844918|469577856|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
130440961|NCT04844918|469577857|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
130440962|NCT04844918|469577858|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
130440963|NCT00363896|469577868|FG000|Overall Study|Withdrawal by Subject|29|||
130440964|NCT00363896|469577869|FG001|Overall Study|Withdrawal by Subject|16|||
130440965|NCT00363896|469577868|FG000|Overall Study|Adverse Event|24|||
130440966|NCT00363896|469577869|FG001|Overall Study|Adverse Event|13|||
130440967|NCT00363896|469577868|FG000|Overall Study|COPD exacerbation|13|||
130440968|NCT00363896|469577869|FG001|Overall Study|COPD exacerbation|7|||
130440969|NCT00363896|469577868|FG000|Overall Study|Lack of Efficacy|12|||
130440970|NCT00363896|469577869|FG001|Overall Study|Lack of Efficacy|8|||
130440971|NCT00363896|469577868|FG000|Overall Study|Protocol Violation|6|||
130440972|NCT00363896|469577869|FG001|Overall Study|Protocol Violation|1|||
130440973|NCT00363896|469577868|FG000|Overall Study|Lost to Follow-up|3|||
130440974|NCT00363896|469577869|FG001|Overall Study|Lost to Follow-up|0|||
130220198|NCT02683239|468770141|FG004|Overall Study|Physician Decision|143|||
130440975|NCT00363896|469577868|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
130440976|NCT00363896|469577869|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
130220199|NCT02683239|468770142|FG005|Overall Study|Physician Decision|14|||
130220200|NCT02683239|468770143|FG006|Overall Study|Physician Decision|15|||
130220201|NCT02683239|468770137|FG000|Overall Study|Withdrawal by Subject|187|||
130353841|NCT01436162|469266379|FG000|Randomized Phase|Adverse Event|1|||
130353842|NCT01436162|469266380|FG001|Randomized Phase|Adverse Event|5|||
130353843|NCT01436162|469266381|FG002|Randomized Phase|Adverse Event|6|||
130353844|NCT01436162|469266379|FG000|Randomized Phase|Protocol Violation|4|||
130353845|NCT01436162|469266380|FG001|Randomized Phase|Protocol Violation|4|||
130353846|NCT01436162|469266381|FG002|Randomized Phase|Protocol Violation|2|||
130353847|NCT01436162|469266379|FG000|Randomized Phase|Withdrawal by Subject|16|||
130353848|NCT01436162|469266380|FG001|Randomized Phase|Withdrawal by Subject|9|||
130353849|NCT01436162|469266381|FG002|Randomized Phase|Withdrawal by Subject|8|||
130353850|NCT01436162|469266379|FG000|Randomized Phase|Lost to Follow-up|17|||
130353851|NCT01436162|469266380|FG001|Randomized Phase|Lost to Follow-up|5|||
130353852|NCT01436162|469266381|FG002|Randomized Phase|Lost to Follow-up|4|||
130353853|NCT01436162|469266379|FG000|Randomized Phase|Lack of Efficacy|0|||
130353854|NCT01436162|469266380|FG001|Randomized Phase|Lack of Efficacy|1|||
130353855|NCT01436162|469266381|FG002|Randomized Phase|Lack of Efficacy|1|||
130353856|NCT01436162|469266379|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
130353857|NCT01436162|469266380|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130353858|NCT01436162|469266381|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130353859|NCT01436162|469266379|FG000|Randomized Phase|Other|2|||
130353860|NCT01436162|469266380|FG001|Randomized Phase|Other|5|||
130353861|NCT01436162|469266381|FG002|Randomized Phase|Other|4|||
130353862|NCT01931202|469266385|FG000|Overall Study|Withdrawal by Subject|0|||
130353863|NCT01931202|469266386|FG001|Overall Study|Withdrawal by Subject|0|||
130353864|NCT01931202|469266387|FG002|Overall Study|Withdrawal by Subject|2|||
130353865|NCT01931202|469266385|FG000|Overall Study|Lost to Follow-up|0|||
130353866|NCT01931202|469266386|FG001|Overall Study|Lost to Follow-up|5|||
130353867|NCT01931202|469266387|FG002|Overall Study|Lost to Follow-up|2|||
130353868|NCT02211638|469266392|FG000|Overall Study|Case Report Forms Uncollected|291|||
130353869|NCT02211638|469266392|FG000|Overall Study|Protocol Violation|692|||
130353870|NCT02775903|469266393|FG000|Overall Study|Death|7|||
130353871|NCT02775903|469266394|FG001|Overall Study|Death|11|||
130353872|NCT02775903|469266395|FG002|Overall Study|Death|12|||
130353873|NCT02775903|469266396|FG003|Overall Study|Death|11|||
130353874|NCT02775903|469266393|FG000|Overall Study|Adverse Event|0|||
130353875|NCT02775903|469266394|FG001|Overall Study|Adverse Event|1|||
130353876|NCT02775903|469266395|FG002|Overall Study|Adverse Event|12|||
130353877|NCT02775903|469266396|FG003|Overall Study|Adverse Event|3|||
130353878|NCT02775903|469266393|FG000|Overall Study|Progressive disease|15|||
130353879|NCT02775903|469266394|FG001|Overall Study|Progressive disease|14|||
130353880|NCT02775903|469266395|FG002|Overall Study|Progressive disease|30|||
130353881|NCT02775903|469266396|FG003|Overall Study|Progressive disease|20|||
130353882|NCT02775903|469266393|FG000|Overall Study|Lack of Efficacy|2|||
130353883|NCT02775903|469266394|FG001|Overall Study|Lack of Efficacy|2|||
130353884|NCT02775903|469266395|FG002|Overall Study|Lack of Efficacy|2|||
130353885|NCT02775903|469266396|FG003|Overall Study|Lack of Efficacy|6|||
130353886|NCT02775903|469266393|FG000|Overall Study|Withdrawal by Subject|7|||
130353887|NCT02775903|469266394|FG001|Overall Study|Withdrawal by Subject|5|||
130353888|NCT02775903|469266395|FG002|Overall Study|Withdrawal by Subject|5|||
130353889|NCT02775903|469266396|FG003|Overall Study|Withdrawal by Subject|8|||
130353890|NCT02775903|469266393|FG000|Overall Study|Other reasons|7|||
130353891|NCT02775903|469266394|FG001|Overall Study|Other reasons|8|||
130353892|NCT02775903|469266395|FG002|Overall Study|Other reasons|2|||
130353893|NCT02775903|469266396|FG003|Overall Study|Other reasons|12|||
130353894|NCT04041700|469266397|FG000|Overall Study|Pregnancy|1|||
130353895|NCT04041700|469266397|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
130353896|NCT04571515|469266400|FG000|Overall Study|Physician Decision|0|||
130353897|NCT04571515|469266401|FG001|Overall Study|Physician Decision|0|||
130353898|NCT04571515|469266402|FG002|Overall Study|Physician Decision|0|||
130353899|NCT04571515|469266403|FG003|Overall Study|Physician Decision|0|||
130353900|NCT04571515|469266404|FG004|Overall Study|Physician Decision|1|||
130353901|NCT04571515|469266400|FG000|Overall Study|Withdrawal by Subject|0|||
130353902|NCT04571515|469266401|FG001|Overall Study|Withdrawal by Subject|0|||
130353903|NCT04571515|469266402|FG002|Overall Study|Withdrawal by Subject|0|||
130353904|NCT04571515|469266403|FG003|Overall Study|Withdrawal by Subject|0|||
130353905|NCT04571515|469266404|FG004|Overall Study|Withdrawal by Subject|1|||
130353906|NCT04571515|469266400|FG000|Overall Study|insufficient pain|1|||
130353907|NCT04571515|469266401|FG001|Overall Study|insufficient pain|0|||
130353908|NCT04571515|469266402|FG002|Overall Study|insufficient pain|0|||
130353909|NCT04571515|469266403|FG003|Overall Study|insufficient pain|0|||
130353910|NCT04571515|469266404|FG004|Overall Study|insufficient pain|1|||
130353911|NCT05140382|469266405|FG000|Overall Study|Death|3|||
130353912|NCT05140382|469266406|FG001|Overall Study|Death|0|||
130353913|NCT05140382|469266407|FG002|Overall Study|Death|0|||
130353914|NCT05140382|469266405|FG000|Overall Study|Investigator decision|1|||
130353915|NCT05140382|469266406|FG001|Overall Study|Investigator decision|0|||
130353916|NCT05140382|469266407|FG002|Overall Study|Investigator decision|0|||
130440977|NCT00363896|469577868|FG000|Overall Study|Other|1|||
130440978|NCT00363896|469577869|FG001|Overall Study|Other|2|||
130440979|NCT00924469|469577874|FG000|Overall Study|Adverse Event|2|||
130440980|NCT00924469|469577875|FG001|Overall Study|Adverse Event|0|||
130440981|NCT00924469|469577874|FG000|Overall Study|Withdrawal by Subject|0|||
130440982|NCT00924469|469577875|FG001|Overall Study|Withdrawal by Subject|1|||
130440983|NCT00924469|469577874|FG000|Overall Study|Lost to Follow-up|0|||
130440984|NCT00924469|469577875|FG001|Overall Study|Lost to Follow-up|1|||
130440985|NCT00630058|469577876|FG000|Overall Study|Adverse Event|1|||
130440986|NCT00630058|469577877|FG001|Overall Study|Adverse Event|1|||
130440987|NCT00630058|469577876|FG000|Overall Study|Withdrawal by Subject|0|||
130440988|NCT00630058|469577877|FG001|Overall Study|Withdrawal by Subject|1|||
130440989|NCT00630058|469577876|FG000|Overall Study|stopping criteria|3|||
130440990|NCT00630058|469577877|FG001|Overall Study|stopping criteria|2|||
130440991|NCT01651936|469577878|FG000|Base Study|Adverse Event|3|||
130440992|NCT01651936|469577879|FG001|Base Study|Adverse Event|0|||
130440993|NCT01651936|469577880|FG002|Base Study|Adverse Event|0|||
130440994|NCT01651936|469577878|FG000|Base Study|Withdrawal by Subject|1|||
130440995|NCT01651936|469577879|FG001|Base Study|Withdrawal by Subject|1|||
130440996|NCT01651936|469577880|FG002|Base Study|Withdrawal by Subject|0|||
130440997|NCT01651936|469577878|FG000|Base Study|Early Escape|2|||
130440998|NCT01651936|469577879|FG001|Base Study|Early Escape|8|||
130440999|NCT01651936|469577880|FG002|Base Study|Early Escape|0|||
130441000|NCT01651936|469577878|FG000|Base Study|Study terminated by sponsor|21|||
130441001|NCT01651936|469577879|FG001|Base Study|Study terminated by sponsor|16|||
130441002|NCT01651936|469577880|FG002|Base Study|Study terminated by sponsor|0|||
130441003|NCT01651936|469577878|FG000|Extension Study|Lack of Efficacy|0|||
130441004|NCT01651936|469577879|FG001|Extension Study|Lack of Efficacy|0|||
130441005|NCT01651936|469577880|FG002|Extension Study|Lack of Efficacy|1|||
130441006|NCT01651936|469577878|FG000|Extension Study|Study terminated by sponsor|0|||
130441007|NCT01651936|469577879|FG001|Extension Study|Study terminated by sponsor|0|||
130441008|NCT01651936|469577880|FG002|Extension Study|Study terminated by sponsor|13|||
130441009|NCT03044353|469577881|FG000|Overall Study|Adverse Event|0|||
130441010|NCT03044353|469577882|FG001|Overall Study|Adverse Event|1|||
130441011|NCT03044353|469577883|FG002|Overall Study|Adverse Event|0|||
130441012|NCT02141659|469577890|FG000|Overall Study|Major Protocol Deviation|0|||
130441013|NCT02141659|469577891|FG001|Overall Study|Major Protocol Deviation|1|||
130441014|NCT02141659|469577892|FG002|Overall Study|Major Protocol Deviation|0|||
130441015|NCT02141659|469577893|FG003|Overall Study|Major Protocol Deviation|0|||
130441016|NCT02141659|469577894|FG004|Overall Study|Major Protocol Deviation|0|||
130441017|NCT02141659|469577895|FG005|Overall Study|Major Protocol Deviation|0|||
130441018|NCT02141659|469577890|FG000|Overall Study|Lack of Efficacy|0|||
130441019|NCT02141659|469577891|FG001|Overall Study|Lack of Efficacy|0|||
130441020|NCT02141659|469577892|FG002|Overall Study|Lack of Efficacy|0|||
130441021|NCT02141659|469577893|FG003|Overall Study|Lack of Efficacy|0|||
130441022|NCT02141659|469577894|FG004|Overall Study|Lack of Efficacy|0|||
130441023|NCT02141659|469577895|FG005|Overall Study|Lack of Efficacy|1|||
130441024|NCT02141659|469577890|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
130441025|NCT02141659|469577891|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
130441026|NCT02141659|469577892|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
130441027|NCT02141659|469577893|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
130552791|NCT00792805|469991535|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130552792|NCT00792805|469991536|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
130441028|NCT02141659|469577894|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
130441029|NCT02141659|469577895|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
130441030|NCT01927731|469577896|FG000|Overall Study|Graft Failure|1|||
130441031|NCT01927731|469577897|FG001|Overall Study|Graft Failure|2|||
130441032|NCT01927731|469577896|FG000|Overall Study|Physician Decision|2|||
130441033|NCT01927731|469577897|FG001|Overall Study|Physician Decision|3|||
130441034|NCT01927731|469577896|FG000|Overall Study|Withdrawal by Subject|0|||
130441035|NCT01927731|469577897|FG001|Overall Study|Withdrawal by Subject|2|||
130441036|NCT01927731|469577896|FG000|Overall Study|Death|0|||
130441037|NCT01927731|469577897|FG001|Overall Study|Death|3|||
130441038|NCT01388530|469577898|FG000|Overall Study|Lost to Follow-up|5|||
130441039|NCT00305864|469577901|FG000|Overall Study|Ineligible / No protocol treatment|0|||
130441040|NCT00305864|469577902|FG001|Overall Study|Ineligible / No protocol treatment|1|||
130441041|NCT00305864|469577903|FG002|Overall Study|Ineligible / No protocol treatment|1|||
130441042|NCT00305864|469577904|FG003|Overall Study|Ineligible / No protocol treatment|13|||
130552793|NCT00792805|469991534|FG000|Overall Study|Lost to Follow-up|1|||
130441043|NCT02836613|469577907|FG000|Overall Study|Accidental drowning|1|||
130441044|NCT02836613|469577908|FG001|Overall Study|Accidental drowning|0|||
130441045|NCT02836613|469577907|FG000|Overall Study|Lost to Follow-up|0|||
130441046|NCT02836613|469577908|FG001|Overall Study|Lost to Follow-up|1|||
130441047|NCT02836613|469577907|FG000|Overall Study|Withdrawal by Subject|0|||
130441048|NCT02836613|469577908|FG001|Overall Study|Withdrawal by Subject|2|||
130441049|NCT03881059|469577909|FG000|Treatment Period - Part A|Adverse Event|1|||
130552794|NCT00792805|469991535|FG001|Overall Study|Lost to Follow-up|1|||
130441050|NCT03881059|469577910|FG001|Treatment Period - Part A|Adverse Event|3|||
130441051|NCT03881059|469577911|FG002|Treatment Period - Part A|Adverse Event|4|||
130441052|NCT03881059|469577909|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
130441053|NCT03881059|469577910|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
130441054|NCT03881059|469577911|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
130441055|NCT03881059|469577909|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
130441056|NCT03881059|469577910|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
130441057|NCT03881059|469577911|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
130441058|NCT03881059|469577909|FG000|Treatment Period - Part A|Other reasons|2|||
130441059|NCT03881059|469577910|FG001|Treatment Period - Part A|Other reasons|1|||
130441060|NCT03881059|469577911|FG002|Treatment Period - Part A|Other reasons|0|||
130441061|NCT03881059|469577909|FG000|Treatment Period - Part B|Adverse Event|0|||
130441062|NCT03881059|469577910|FG001|Treatment Period - Part B|Adverse Event|0|||
130441063|NCT03881059|469577911|FG002|Treatment Period - Part B|Adverse Event|3|||
130441064|NCT03881059|469577909|FG000|Treatment Period - Part B|Death|0|||
130441065|NCT03881059|469577910|FG001|Treatment Period - Part B|Death|1|||
130441066|NCT03881059|469577911|FG002|Treatment Period - Part B|Death|1|||
130441067|NCT03881059|469577909|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
130441068|NCT03881059|469577910|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
130441069|NCT03881059|469577911|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
130441070|NCT03881059|469577909|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
130441071|NCT03881059|469577910|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
130441072|NCT03881059|469577911|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
130441073|NCT03881059|469577909|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
130441074|NCT03881059|469577910|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
130441075|NCT03881059|469577911|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
130441076|NCT03881059|469577909|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
130441077|NCT03881059|469577910|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
130441078|NCT03881059|469577911|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
130441079|NCT03881059|469577909|FG000|Treatment Period - Part B|Other reasons|4|||
130441080|NCT03881059|469577910|FG001|Treatment Period - Part B|Other reasons|3|||
130441081|NCT03881059|469577911|FG002|Treatment Period - Part B|Other reasons|3|||
130441082|NCT05284019|469577912|FG000|Overall Study|Study terminated|2|||
130441083|NCT05284019|469577913|FG001|Overall Study|Study terminated|2|||
130441084|NCT05284019|469577914|FG002|Overall Study|Study terminated|2|||
130441085|NCT05284019|469577915|FG003|Overall Study|Study terminated|5|||
130441086|NCT05284019|469577916|FG004|Overall Study|Study terminated|15|||
130441087|NCT05284019|469577912|FG000|Overall Study|Withdrawal by Subject|0|||
130441088|NCT05284019|469577913|FG001|Overall Study|Withdrawal by Subject|0|||
130441089|NCT05284019|469577914|FG002|Overall Study|Withdrawal by Subject|0|||
130441090|NCT05284019|469577915|FG003|Overall Study|Withdrawal by Subject|1|||
130441091|NCT05284019|469577916|FG004|Overall Study|Withdrawal by Subject|1|||
130441092|NCT05284019|469577912|FG000|Overall Study|Lost to Follow-up|1|||
130441093|NCT05284019|469577913|FG001|Overall Study|Lost to Follow-up|0|||
130441094|NCT05284019|469577914|FG002|Overall Study|Lost to Follow-up|0|||
130441095|NCT05284019|469577915|FG003|Overall Study|Lost to Follow-up|2|||
130441096|NCT05284019|469577916|FG004|Overall Study|Lost to Follow-up|1|||
130441097|NCT02065570|469577917|FG000|Induction Study|Adverse Event|5|||
130441098|NCT02065570|469577918|FG001|Induction Study|Adverse Event|12|||
130441099|NCT02065570|469577919|FG002|Induction Study|Adverse Event|0|||
130441100|NCT02065570|469577920|FG003|Induction Study|Adverse Event|0|||
130441101|NCT02065570|469577917|FG000|Induction Study|Withdrawal by Subject|2|||
130441102|NCT02065570|469577918|FG001|Induction Study|Withdrawal by Subject|3|||
130441103|NCT02065570|469577919|FG002|Induction Study|Withdrawal by Subject|0|||
130441104|NCT02065570|469577920|FG003|Induction Study|Withdrawal by Subject|0|||
130441105|NCT02065570|469577917|FG000|Induction Study|Lost to Follow-up|1|||
130441106|NCT02065570|469577918|FG001|Induction Study|Lost to Follow-up|1|||
130441107|NCT02065570|469577919|FG002|Induction Study|Lost to Follow-up|0|||
130441108|NCT02065570|469577920|FG003|Induction Study|Lost to Follow-up|0|||
130441109|NCT02065570|469577917|FG000|Induction Study|Other, Not Specified|6|||
130441110|NCT02065570|469577918|FG001|Induction Study|Other, Not Specified|5|||
130441111|NCT02065570|469577919|FG002|Induction Study|Other, Not Specified|0|||
130441112|NCT02065570|469577920|FG003|Induction Study|Other, Not Specified|0|||
130441113|NCT02065570|469577917|FG000|Maintenance Study|Adverse Event|0|||
130441114|NCT02065570|469577918|FG001|Maintenance Study|Adverse Event|0|||
130441115|NCT02065570|469577919|FG002|Maintenance Study|Adverse Event|8|||
130441116|NCT02065570|469577920|FG003|Maintenance Study|Adverse Event|8|||
130441117|NCT02065570|469577917|FG000|Maintenance Study|Withdrawal by Subject|0|||
130441118|NCT02065570|469577918|FG001|Maintenance Study|Withdrawal by Subject|0|||
130441119|NCT02065570|469577919|FG002|Maintenance Study|Withdrawal by Subject|1|||
130441120|NCT02065570|469577920|FG003|Maintenance Study|Withdrawal by Subject|4|||
130441121|NCT02065570|469577917|FG000|Maintenance Study|Lost to Follow-up|0|||
130552795|NCT00792805|469991536|FG002|Overall Study|Lost to Follow-up|6|||
130441122|NCT02065570|469577918|FG001|Maintenance Study|Lost to Follow-up|0|||
130441123|NCT02065570|469577919|FG002|Maintenance Study|Lost to Follow-up|2|||
130441124|NCT02065570|469577920|FG003|Maintenance Study|Lost to Follow-up|2|||
130441125|NCT02065570|469577917|FG000|Maintenance Study|Other, Not Specified|0|||
130441126|NCT02065570|469577918|FG001|Maintenance Study|Other, Not Specified|0|||
130441127|NCT02065570|469577919|FG002|Maintenance Study|Other, Not Specified|11|||
130441128|NCT02065570|469577920|FG003|Maintenance Study|Other, Not Specified|5|||
130441129|NCT01266993|469577921|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
130441130|NCT01266993|469577922|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
130441131|NCT01266993|469577921|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
130441132|NCT01266993|469577922|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
130441133|NCT02293837|469577925|FG000|Overall Study|Lost to Follow-up|0|||
130441134|NCT02293837|469577926|FG001|Overall Study|Lost to Follow-up|2|||
130441135|NCT02293837|469577927|FG002|Overall Study|Lost to Follow-up|1|||
130441136|NCT02293837|469577928|FG003|Overall Study|Lost to Follow-up|0|||
130441137|NCT02293837|469577925|FG000|Overall Study|Withdrawal by Subject|2|||
130441138|NCT02293837|469577926|FG001|Overall Study|Withdrawal by Subject|1|||
130441139|NCT02293837|469577927|FG002|Overall Study|Withdrawal by Subject|2|||
130441140|NCT02293837|469577928|FG003|Overall Study|Withdrawal by Subject|1|||
130441141|NCT02293837|469577925|FG000|Overall Study|COVID-19 Related|1|||
130441142|NCT02293837|469577926|FG001|Overall Study|COVID-19 Related|1|||
130441143|NCT02293837|469577927|FG002|Overall Study|COVID-19 Related|0|||
130441144|NCT02293837|469577928|FG003|Overall Study|COVID-19 Related|0|||
130441145|NCT02293837|469577925|FG000|Overall Study|Participant ill and could not be infused|0|||
130441146|NCT02293837|469577926|FG001|Overall Study|Participant ill and could not be infused|0|||
130441147|NCT02293837|469577927|FG002|Overall Study|Participant ill and could not be infused|1|||
130441148|NCT02293837|469577928|FG003|Overall Study|Participant ill and could not be infused|0|||
130441149|NCT04779242|469577929|FG000|Overall Study|Adverse Event|1|||
130441150|NCT04779242|469577930|FG001|Overall Study|Adverse Event|1|||
130441151|NCT04779242|469577929|FG000|Overall Study|Lost to Follow-up|2|||
130441152|NCT04779242|469577930|FG001|Overall Study|Lost to Follow-up|4|||
130441153|NCT04779242|469577929|FG000|Overall Study|Withdrawal by Subject|7|||
130441154|NCT04779242|469577930|FG001|Overall Study|Withdrawal by Subject|9|||
130441155|NCT04779242|469577929|FG000|Overall Study|Death|6|||
130441156|NCT04779242|469577930|FG001|Overall Study|Death|6|||
130441157|NCT04779242|469577929|FG000|Overall Study|COVID-19 related reasons|2|||
130441158|NCT04779242|469577930|FG001|Overall Study|COVID-19 related reasons|1|||
130441159|NCT04779242|469577929|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
130441160|NCT04779242|469577930|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
130441161|NCT04779242|469577929|FG000|Overall Study|Martial Law in Ukraine|2|||
130441162|NCT04779242|469577930|FG001|Overall Study|Martial Law in Ukraine|3|||
130441163|NCT01680458|469577934|FG000|Overall Study|Protocol Violation|3|||
130441164|NCT01040780|469580009|FG000|Overall Study|Protocol Violation|1|||
130441165|NCT01040780|469580010|FG001|Overall Study|Protocol Violation|3|||
130441166|NCT00802737|469580011|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
130441167|NCT00802737|469580012|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
130441168|NCT00802737|469580013|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
130441169|NCT00802737|469580011|FG000|Overall Study|Death|6|||
130441170|NCT00802737|469580012|FG001|Overall Study|Death|5|||
130441171|NCT00802737|469580013|FG002|Overall Study|Death|1|||
130441172|NCT00802737|469580011|FG000|Overall Study|Adverse Event|1|||
130441173|NCT00802737|469580012|FG001|Overall Study|Adverse Event|0|||
130441174|NCT00802737|469580013|FG002|Overall Study|Adverse Event|0|||
130441175|NCT00802737|469580011|FG000|Overall Study|Received Prohibited Therapy|1|||
130441176|NCT00802737|469580012|FG001|Overall Study|Received Prohibited Therapy|0|||
130441177|NCT00802737|469580013|FG002|Overall Study|Received Prohibited Therapy|0|||
130441178|NCT00802737|469580011|FG000|Overall Study|Ongoing CLL-Treatment|0|||
130441179|NCT00802737|469580012|FG001|Overall Study|Ongoing CLL-Treatment|1|||
130441180|NCT00802737|469580013|FG002|Overall Study|Ongoing CLL-Treatment|0|||
130441181|NCT00802737|469580011|FG000|Overall Study|Participant too Unwell|0|||
130441182|NCT00802737|469580012|FG001|Overall Study|Participant too Unwell|2|||
130441183|NCT00802737|469580013|FG002|Overall Study|Participant too Unwell|0|||
130441184|NCT03864926|469580021|FG000|Overall Study|Death|0|||
130441185|NCT03864926|469580022|FG001|Overall Study|Death|2|||
130441186|NCT00445601|469580023|FG000|Overall Study|Withdrawal by Subject|11|||
130441187|NCT00445601|469580024|FG001|Overall Study|Withdrawal by Subject|11|||
130441188|NCT00445601|469580023|FG000|Overall Study|TURBT Complication|12|||
130441189|NCT00445601|469580024|FG001|Overall Study|TURBT Complication|8|||
130441190|NCT00445601|469580023|FG000|Overall Study|Incorrect Disease Status|6|||
130441191|NCT00445601|469580024|FG001|Overall Study|Incorrect Disease Status|6|||
130441192|NCT00445601|469580023|FG000|Overall Study|Drug Delivery Issue|2|||
130441193|NCT00445601|469580024|FG001|Overall Study|Drug Delivery Issue|2|||
130441194|NCT00445601|469580023|FG000|Overall Study|Adverse Event|2|||
130441195|NCT00445601|469580024|FG001|Overall Study|Adverse Event|0|||
130441196|NCT00445601|469580023|FG000|Overall Study|Death prior to TURBT|0|||
130552796|NCT00792805|469991534|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130552797|NCT00792805|469991535|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130441197|NCT00445601|469580024|FG001|Overall Study|Death prior to TURBT|1|||
130441198|NCT02391038|469580031|FG000|Overall Study|Progressive disease|3|||
130441199|NCT02391038|469580032|FG001|Overall Study|Progressive disease|3|||
130441200|NCT02391038|469580033|FG002|Overall Study|Progressive disease|6|||
130441201|NCT03918239|469580039|FG000|Overall Study|Lost to Follow-up|3|||
130441202|NCT03918239|469580040|FG001|Overall Study|Lost to Follow-up|1|||
130441203|NCT03918239|469580039|FG000|Overall Study|Pregnancy|0|||
130441204|NCT03918239|469580040|FG001|Overall Study|Pregnancy|2|||
130441205|NCT03918239|469580039|FG000|Overall Study|Withdrawal by Subject|3|||
130441206|NCT03918239|469580040|FG001|Overall Study|Withdrawal by Subject|3|||
130441207|NCT03918239|469580039|FG000|Overall Study|positive urine drug screening results|4|||
130441208|NCT03918239|469580040|FG001|Overall Study|positive urine drug screening results|1|||
130441209|NCT01189890|469580043|FG000|Overall Study|Adverse Event|3|||
130441210|NCT01189890|469580044|FG001|Overall Study|Adverse Event|4|||
130441211|NCT01189890|469580043|FG000|Overall Study|Lack of Efficacy|7|||
130441212|NCT01189890|469580044|FG001|Overall Study|Lack of Efficacy|2|||
130441213|NCT01189890|469580043|FG000|Overall Study|Lost to Follow-up|1|||
130441214|NCT01189890|469580044|FG001|Overall Study|Lost to Follow-up|7|||
130441215|NCT01189890|469580043|FG000|Overall Study|Protocol Violation|1|||
130441216|NCT01189890|469580044|FG001|Overall Study|Protocol Violation|5|||
130441217|NCT01189890|469580043|FG000|Overall Study|Withdrawal by Subject|15|||
130441218|NCT01189890|469580044|FG001|Overall Study|Withdrawal by Subject|11|||
130441219|NCT01189890|469580043|FG000|Overall Study|Non Compliance|0|||
130441220|NCT01189890|469580044|FG001|Overall Study|Non Compliance|1|||
130441221|NCT01189890|469580043|FG000|Overall Study|Physician Decision|5|||
130441222|NCT01189890|469580044|FG001|Overall Study|Physician Decision|4|||
130441223|NCT01189890|469580043|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
130441224|NCT01189890|469580044|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
130441225|NCT01807221|469580045|FG000|Overall Study|Progressive disease|1|||
130441226|NCT01807221|469580046|FG001|Overall Study|Progressive disease|0|||
130441227|NCT01807221|469580047|FG002|Overall Study|Progressive disease|1|||
130441228|NCT01807221|469580048|FG003|Overall Study|Progressive disease|0|||
130441229|NCT01807221|469580049|FG004|Overall Study|Progressive disease|0|||
130441230|NCT01807221|469580050|FG005|Overall Study|Progressive disease|0|||
130441231|NCT01807221|469580045|FG000|Overall Study|Death|7|||
130441232|NCT01807221|469580046|FG001|Overall Study|Death|9|||
130441233|NCT01807221|469580047|FG002|Overall Study|Death|4|||
130441234|NCT01807221|469580048|FG003|Overall Study|Death|2|||
130441235|NCT01807221|469580049|FG004|Overall Study|Death|1|||
130441236|NCT01807221|469580050|FG005|Overall Study|Death|6|||
130441237|NCT01807221|469580045|FG000|Overall Study|Physician Decision|2|||
130441238|NCT01807221|469580046|FG001|Overall Study|Physician Decision|1|||
130441239|NCT01807221|469580047|FG002|Overall Study|Physician Decision|0|||
130441240|NCT01807221|469580048|FG003|Overall Study|Physician Decision|0|||
130441241|NCT01807221|469580049|FG004|Overall Study|Physician Decision|0|||
130441242|NCT01807221|469580050|FG005|Overall Study|Physician Decision|0|||
130441243|NCT01807221|469580045|FG000|Overall Study|Adverse Event|33|||
130441244|NCT01807221|469580046|FG001|Overall Study|Adverse Event|22|||
130441245|NCT01807221|469580047|FG002|Overall Study|Adverse Event|26|||
130441246|NCT01807221|469580048|FG003|Overall Study|Adverse Event|25|||
130441247|NCT01807221|469580049|FG004|Overall Study|Adverse Event|18|||
130441248|NCT01807221|469580050|FG005|Overall Study|Adverse Event|21|||
130441249|NCT01807221|469580045|FG000|Overall Study|Protocol Violation|0|||
130441250|NCT01807221|469580046|FG001|Overall Study|Protocol Violation|2|||
130441251|NCT01807221|469580047|FG002|Overall Study|Protocol Violation|1|||
130441252|NCT01807221|469580048|FG003|Overall Study|Protocol Violation|2|||
130441253|NCT01807221|469580049|FG004|Overall Study|Protocol Violation|0|||
130441254|NCT01807221|469580050|FG005|Overall Study|Protocol Violation|1|||
130441255|NCT01807221|469580045|FG000|Overall Study|Non-compliance|1|||
130441256|NCT01807221|469580046|FG001|Overall Study|Non-compliance|2|||
130441257|NCT01807221|469580047|FG002|Overall Study|Non-compliance|0|||
130441258|NCT01807221|469580048|FG003|Overall Study|Non-compliance|1|||
130441259|NCT01807221|469580049|FG004|Overall Study|Non-compliance|0|||
130441260|NCT01807221|469580050|FG005|Overall Study|Non-compliance|0|||
130441261|NCT01807221|469580045|FG000|Overall Study|Logistical difficulties|0|||
130441262|NCT01807221|469580046|FG001|Overall Study|Logistical difficulties|1|||
130441263|NCT01807221|469580047|FG002|Overall Study|Logistical difficulties|0|||
130441264|NCT01807221|469580048|FG003|Overall Study|Logistical difficulties|0|||
130220202|NCT02683239|468770138|FG001|Overall Study|Withdrawal by Subject|99|||
130441265|NCT01807221|469580049|FG004|Overall Study|Logistical difficulties|1|||
130441266|NCT01807221|469580050|FG005|Overall Study|Logistical difficulties|0|||
130441267|NCT01807221|469580045|FG000|Overall Study|Withdrawal by Subject|33|||
130441268|NCT01807221|469580046|FG001|Overall Study|Withdrawal by Subject|15|||
130441269|NCT01807221|469580047|FG002|Overall Study|Withdrawal by Subject|8|||
130441270|NCT01807221|469580048|FG003|Overall Study|Withdrawal by Subject|14|||
130441271|NCT01807221|469580049|FG004|Overall Study|Withdrawal by Subject|16|||
130441272|NCT01807221|469580050|FG005|Overall Study|Withdrawal by Subject|13|||
130441273|NCT01807221|469580045|FG000|Overall Study|Sponsor decision|2|||
130441274|NCT01807221|469580046|FG001|Overall Study|Sponsor decision|0|||
130441275|NCT01807221|469580047|FG002|Overall Study|Sponsor decision|1|||
130441276|NCT01807221|469580048|FG003|Overall Study|Sponsor decision|1|||
130441277|NCT01807221|469580049|FG004|Overall Study|Sponsor decision|0|||
130441278|NCT01807221|469580050|FG005|Overall Study|Sponsor decision|0|||
130441279|NCT01807221|469580045|FG000|Overall Study|Lost to Follow-up|1|||
130441280|NCT01807221|469580046|FG001|Overall Study|Lost to Follow-up|0|||
130441281|NCT01807221|469580047|FG002|Overall Study|Lost to Follow-up|2|||
130441282|NCT01807221|469580048|FG003|Overall Study|Lost to Follow-up|1|||
130441283|NCT01807221|469580049|FG004|Overall Study|Lost to Follow-up|0|||
130441284|NCT01807221|469580050|FG005|Overall Study|Lost to Follow-up|0|||
130441285|NCT02609659|469580051|FG000|Overall Study|Adverse Event|1|||
130441286|NCT02609659|469580051|FG000|Overall Study|Lost to Follow-up|6|||
130441287|NCT02609659|469580051|FG000|Overall Study|Other|1|||
130441288|NCT00593554|469580052|FG000|Overall Study|Death|1|||
130441289|NCT00593554|469580053|FG001|Overall Study|Death|2|||
130441290|NCT00593554|469580052|FG000|Overall Study|Physician Decision|0|||
130441291|NCT00593554|469580053|FG001|Overall Study|Physician Decision|1|||
130220203|NCT02683239|468770139|FG002|Overall Study|Withdrawal by Subject|91|||
130220204|NCT02683239|468770140|FG003|Overall Study|Withdrawal by Subject|18|||
130220205|NCT02683239|468770141|FG004|Overall Study|Withdrawal by Subject|248|||
130220206|NCT02683239|468770142|FG005|Overall Study|Withdrawal by Subject|22|||
130220207|NCT02683239|468770143|FG006|Overall Study|Withdrawal by Subject|28|||
130220208|NCT02683239|468770137|FG000|Overall Study|Lost to Follow-up|77|||
130220209|NCT02683239|468770138|FG001|Overall Study|Lost to Follow-up|24|||
130220210|NCT02683239|468770139|FG002|Overall Study|Lost to Follow-up|25|||
130220211|NCT02683239|468770140|FG003|Overall Study|Lost to Follow-up|7|||
130220212|NCT02683239|468770141|FG004|Overall Study|Lost to Follow-up|88|||
130220213|NCT02683239|468770142|FG005|Overall Study|Lost to Follow-up|8|||
130220214|NCT02683239|468770143|FG006|Overall Study|Lost to Follow-up|11|||
130220215|NCT02683239|468770137|FG000|Overall Study|Death|9|||
130220216|NCT02683239|468770138|FG001|Overall Study|Death|5|||
130220217|NCT02683239|468770139|FG002|Overall Study|Death|8|||
130220218|NCT02683239|468770140|FG003|Overall Study|Death|0|||
130220219|NCT02683239|468770141|FG004|Overall Study|Death|12|||
130220220|NCT02683239|468770142|FG005|Overall Study|Death|1|||
130220221|NCT02683239|468770143|FG006|Overall Study|Death|0|||
130220222|NCT02683239|468770137|FG000|Overall Study|Lack of Efficacy|50|||
130220223|NCT02683239|468770138|FG001|Overall Study|Lack of Efficacy|23|||
130220224|NCT02683239|468770139|FG002|Overall Study|Lack of Efficacy|12|||
130220225|NCT02683239|468770140|FG003|Overall Study|Lack of Efficacy|2|||
130220226|NCT02683239|468770141|FG004|Overall Study|Lack of Efficacy|29|||
130220227|NCT02683239|468770142|FG005|Overall Study|Lack of Efficacy|2|||
130220228|NCT02683239|468770143|FG006|Overall Study|Lack of Efficacy|3|||
130220229|NCT02683239|468770137|FG000|Overall Study|Missing data|0|||
130220230|NCT02683239|468770138|FG001|Overall Study|Missing data|1|||
130220231|NCT02683239|468770139|FG002|Overall Study|Missing data|1|||
130220232|NCT02683239|468770140|FG003|Overall Study|Missing data|0|||
130220233|NCT02683239|468770141|FG004|Overall Study|Missing data|1|||
130220234|NCT02683239|468770142|FG005|Overall Study|Missing data|0|||
130220235|NCT02683239|468770143|FG006|Overall Study|Missing data|0|||
130220236|NCT04131712|468770146|FG000|Overall Study|COVID related|0|||
130220237|NCT04131712|468770147|FG001|Overall Study|COVID related|0|||
130220238|NCT04131712|468770148|FG002|Overall Study|COVID related|2|||
130220239|NCT04131712|468770149|FG003|Overall Study|COVID related|0|||
130220240|NCT04131712|468770146|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220241|NCT04131712|468770147|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220242|NCT04131712|468770148|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
130220243|NCT04131712|468770149|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220244|NCT00873730|468770150|FG000|Overall Study|Protocol Deviation|5|||
130220245|NCT00873730|468770151|FG001|Overall Study|Protocol Deviation|2|||
130220246|NCT00873730|468770150|FG000|Overall Study|Adverse Event|0|||
130220247|NCT00873730|468770151|FG001|Overall Study|Adverse Event|2|||
130220248|NCT00873730|468770150|FG000|Overall Study|Withdrawal by Subject|0|||
130220249|NCT00873730|468770151|FG001|Overall Study|Withdrawal by Subject|1|||
130220250|NCT00873730|468770150|FG000|Overall Study|Sponsor decision|1|||
130441292|NCT00593554|469580052|FG000|Overall Study|Withdrawal by Subject|1|||
130441293|NCT00593554|469580053|FG001|Overall Study|Withdrawal by Subject|0|||
130441294|NCT00593554|469580052|FG000|Overall Study|Disease Progression|1|||
130220251|NCT00873730|468770151|FG001|Overall Study|Sponsor decision|0|||
130441295|NCT00593554|469580053|FG001|Overall Study|Disease Progression|2|||
130220252|NCT00103662|468770152|FG000|Overall Study|Entered Rescue Procedure|0|||
130220253|NCT00103662|468770153|FG001|Overall Study|Entered Rescue Procedure|7|||
130220254|NCT00103662|468770152|FG000|Overall Study|Death|7|||
130220255|NCT00103662|468770153|FG001|Overall Study|Death|7|||
130220256|NCT00103662|468770152|FG000|Overall Study|Elective Withdrawal|5|||
130220257|NCT00103662|468770153|FG001|Overall Study|Elective Withdrawal|5|||
130441296|NCT02086552|469580055|FG000|Overall Study|Withdrawal by Subject|1|||
130441297|NCT02080520|469580061|FG000|Overall Study|Self-reported symptoms|5|||
130441298|NCT02080520|469580062|FG001|Overall Study|Self-reported symptoms|6|||
130441299|NCT02080520|469580061|FG000|Overall Study|Unable to contact|2|||
130220258|NCT00103662|468770152|FG000|Overall Study|Lost to Follow-up|0|||
130220259|NCT00103662|468770153|FG001|Overall Study|Lost to Follow-up|1|||
130220260|NCT00103662|468770152|FG000|Overall Study|Other|6|||
130220261|NCT00103662|468770153|FG001|Overall Study|Other|9|||
130220262|NCT00103662|468770152|FG000|Overall Study|Failed mobilization|0|||
130220263|NCT00103662|468770153|FG001|Overall Study|Failed mobilization|4|||
130220264|NCT00103662|468770152|FG000|Overall Study|Intercurrent illness|1|||
130220265|NCT00103662|468770153|FG001|Overall Study|Intercurrent illness|0|||
130220266|NCT00943397|468770154|FG000|Overall Study|Adverse Event|0|||
130220267|NCT00943397|468770155|FG001|Overall Study|Adverse Event|6|||
130220268|NCT00943397|468770154|FG000|Overall Study|Lost to Follow-up|0|||
130220269|NCT00943397|468770155|FG001|Overall Study|Lost to Follow-up|4|||
130220270|NCT00943397|468770154|FG000|Overall Study|Protocol Violation|2|||
130220271|NCT00943397|468770155|FG001|Overall Study|Protocol Violation|5|||
130220272|NCT00943397|468770154|FG000|Overall Study|Withdrawal by Subject|1|||
130220273|NCT00943397|468770155|FG001|Overall Study|Withdrawal by Subject|1|||
130220274|NCT00943397|468770154|FG000|Overall Study|Site terminated and other|12|||
130220275|NCT00943397|468770155|FG001|Overall Study|Site terminated and other|56|||
130220276|NCT04878055|468770156|FG000|Overall Study|Patient transferred in another department|0|||
130220277|NCT04878055|468770157|FG001|Overall Study|Patient transferred in another department|2|||
130220278|NCT04878055|468770156|FG000|Overall Study|Physician Decision|1|||
130220279|NCT04878055|468770157|FG001|Overall Study|Physician Decision|1|||
130220280|NCT04878055|468770156|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
130220281|NCT04878055|468770157|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
130220282|NCT04878055|468770156|FG000|Overall Study|Adverse Event|12|||
130220283|NCT04878055|468770157|FG001|Overall Study|Adverse Event|7|||
130220284|NCT04878055|468770156|FG000|Overall Study|Other|5|||
130220285|NCT04878055|468770157|FG001|Overall Study|Other|0|||
130220286|NCT04878055|468770156|FG000|Overall Study|Withdrawal by Subject|7|||
130220287|NCT04878055|468770157|FG001|Overall Study|Withdrawal by Subject|3|||
130220288|NCT04878055|468770156|FG000|Overall Study|Lost to Follow-up|10|||
130220289|NCT04878055|468770157|FG001|Overall Study|Lost to Follow-up|1|||
130220290|NCT01968811|468770158|FG000|Overall Study|Protocol Violation|4|||
130220291|NCT01968811|468770158|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
130220292|NCT03904420|468770163|FG000|Overall Study|Study terminated|2|||
130220293|NCT03904420|468770164|FG001|Overall Study|Study terminated|2|||
130220294|NCT01089127|468770169|FG000|Overall Study|Adverse Event|5|||
130220295|NCT01089127|468770170|FG001|Overall Study|Adverse Event|1|||
130220296|NCT01089127|468770171|FG002|Overall Study|Adverse Event|1|||
130220297|NCT01089127|468770172|FG003|Overall Study|Adverse Event|0|||
130220298|NCT01089127|468770173|FG004|Overall Study|Adverse Event|0|||
130220299|NCT01089127|468770174|FG005|Overall Study|Adverse Event|1|||
130220300|NCT01089127|468770169|FG000|Overall Study|Subject withdrew consent|0|||
130220301|NCT01089127|468770170|FG001|Overall Study|Subject withdrew consent|1|||
130220302|NCT01089127|468770171|FG002|Overall Study|Subject withdrew consent|1|||
130220303|NCT01089127|468770172|FG003|Overall Study|Subject withdrew consent|1|||
130220304|NCT01089127|468770173|FG004|Overall Study|Subject withdrew consent|0|||
130220305|NCT01089127|468770174|FG005|Overall Study|Subject withdrew consent|2|||
130220306|NCT01089127|468770169|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130220307|NCT01089127|468770170|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130220308|NCT01089127|468770171|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130220309|NCT01089127|468770172|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130220310|NCT01089127|468770173|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130220311|NCT01089127|468770174|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130220312|NCT01089127|468770169|FG000|Overall Study|Lost to Follow-up|1|||
130220313|NCT01089127|468770170|FG001|Overall Study|Lost to Follow-up|1|||
130220314|NCT01089127|468770171|FG002|Overall Study|Lost to Follow-up|0|||
130220315|NCT01089127|468770172|FG003|Overall Study|Lost to Follow-up|0|||
130220316|NCT01089127|468770173|FG004|Overall Study|Lost to Follow-up|1|||
130220317|NCT01089127|468770174|FG005|Overall Study|Lost to Follow-up|0|||
130220318|NCT01089127|468770169|FG000|Overall Study|Protocol deviation|0|||
130220319|NCT01089127|468770170|FG001|Overall Study|Protocol deviation|1|||
130220320|NCT01089127|468770171|FG002|Overall Study|Protocol deviation|0|||
130220321|NCT01089127|468770172|FG003|Overall Study|Protocol deviation|0|||
130220322|NCT01089127|468770173|FG004|Overall Study|Protocol deviation|1|||
130220323|NCT01089127|468770174|FG005|Overall Study|Protocol deviation|0|||
130220324|NCT01841970|468770177|FG000|Overall Study|Withdrawal by Subject|1|||
130220325|NCT01841970|468770177|FG000|Overall Study|Physician Decision|2|||
130220326|NCT01841970|468770177|FG000|Overall Study|Lost to Follow-up|8|||
130220327|NCT02592447|468770178|FG000|Overall Study|Lost to Follow-up|1|||
130220328|NCT02592447|468770179|FG001|Overall Study|Lost to Follow-up|0|||
130220329|NCT02592447|468770178|FG000|Overall Study|Ineligible after randomization|1|||
130220330|NCT02592447|468770179|FG001|Overall Study|Ineligible after randomization|0|||
130220331|NCT02592447|468770178|FG000|Overall Study|Withdrawal by Subject|0|||
130220332|NCT02592447|468770179|FG001|Overall Study|Withdrawal by Subject|1|||
130220333|NCT01048541|468770188|FG000|Overall Study|Withdrawal by Subject|1|||
130220334|NCT01048541|468770189|FG001|Overall Study|Withdrawal by Subject|0|||
130220335|NCT00627497|468770190|FG000|Overall Study|Lost to Follow-up|1|||
130220336|NCT00627497|468770191|FG001|Overall Study|Lost to Follow-up|1|||
130220337|NCT00627497|468770192|FG002|Overall Study|Lost to Follow-up|0|||
130220338|NCT00627497|468770193|FG003|Overall Study|Lost to Follow-up|0|||
130220339|NCT00327717|468770194|FG000|Overall Study|Adverse Event|6|||
130220340|NCT00327717|468770195|FG001|Overall Study|Adverse Event|6|||
130220341|NCT00327717|468770194|FG000|Overall Study|Lack of Efficacy|0|||
130220342|NCT00327717|468770195|FG001|Overall Study|Lack of Efficacy|1|||
130220343|NCT00327717|468770194|FG000|Overall Study|Withdrawal by Subject|3|||
130220344|NCT00327717|468770195|FG001|Overall Study|Withdrawal by Subject|7|||
130220345|NCT02080364|468770196|FG000|Baseline Period|Protocol Violation|2|||
130220346|NCT02080364|468770197|FG001|Baseline Period|Protocol Violation|1|||
130220347|NCT02080364|468770198|FG002|Baseline Period|Protocol Violation|0|||
130220348|NCT02080364|468770199|FG003|Baseline Period|Protocol Violation|0|||
130220349|NCT02080364|468770196|FG000|Baseline Period|Other|0|||
130220350|NCT02080364|468770197|FG001|Baseline Period|Other|1|||
130220351|NCT02080364|468770198|FG002|Baseline Period|Other|1|||
130220352|NCT02080364|468770199|FG003|Baseline Period|Other|0|||
130220353|NCT02080364|468770196|FG000|Treatment Period|Adverse Event|10|||
130220354|NCT02080364|468770197|FG001|Treatment Period|Adverse Event|15|||
130220355|NCT02080364|468770198|FG002|Treatment Period|Adverse Event|11|||
130220356|NCT02080364|468770199|FG003|Treatment Period|Adverse Event|14|||
130220357|NCT02080364|468770196|FG000|Treatment Period|Lost to Follow-up|2|||
130220358|NCT02080364|468770197|FG001|Treatment Period|Lost to Follow-up|3|||
130220359|NCT02080364|468770198|FG002|Treatment Period|Lost to Follow-up|5|||
130220360|NCT02080364|468770199|FG003|Treatment Period|Lost to Follow-up|0|||
130220361|NCT02080364|468770196|FG000|Treatment Period|Protocol Violation|5|||
130220362|NCT02080364|468770197|FG001|Treatment Period|Protocol Violation|3|||
130220363|NCT02080364|468770198|FG002|Treatment Period|Protocol Violation|5|||
130220364|NCT02080364|468770199|FG003|Treatment Period|Protocol Violation|1|||
130220365|NCT02080364|468770196|FG000|Treatment Period|Withdrawal by Subject|16|||
130220366|NCT02080364|468770197|FG001|Treatment Period|Withdrawal by Subject|16|||
130220367|NCT02080364|468770198|FG002|Treatment Period|Withdrawal by Subject|15|||
130220368|NCT02080364|468770199|FG003|Treatment Period|Withdrawal by Subject|10|||
130220369|NCT02080364|468770196|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130220370|NCT02080364|468770197|FG001|Treatment Period|Study Terminated by Sponsor|0|||
130220371|NCT02080364|468770198|FG002|Treatment Period|Study Terminated by Sponsor|180|||
130220372|NCT02080364|468770199|FG003|Treatment Period|Study Terminated by Sponsor|183|||
130220373|NCT02080364|468770196|FG000|Treatment Period|Other|14|||
130220374|NCT02080364|468770197|FG001|Treatment Period|Other|12|||
130220375|NCT02080364|468770198|FG002|Treatment Period|Other|21|||
130220376|NCT02080364|468770199|FG003|Treatment Period|Other|16|||
130220377|NCT00571662|468770201|FG000|Overall Study|Withdrawal by Subject|2|||
130220378|NCT00571662|468770201|FG000|Overall Study|psychiatric instability|1|||
130220379|NCT00571662|468770201|FG000|Overall Study|Adverse Event|5|||
130220380|NCT00964028|468770202|FG000|Overall Study|Withdrawal by Subject|0|||
130220381|NCT00964028|468770203|FG001|Overall Study|Withdrawal by Subject|1|||
130220382|NCT03472521|468770204|FG000|Overall Study|Lost to Follow-up|3|||
130220383|NCT03472521|468770205|FG001|Overall Study|Lost to Follow-up|2|||
130220384|NCT03472521|468770204|FG000|Overall Study|Discontinued intervention|3|||
130220385|NCT03472521|468770205|FG001|Overall Study|Discontinued intervention|1|||
130220386|NCT02385110|468770206|FG000|Overall Study|Early Death|1|||
130220387|NCT02385110|468770207|FG001|Overall Study|Early Death|0|||
130220388|NCT00181883|468770212|FG000|Overall Study|Lack of Efficacy|2|||
130220389|NCT00181883|468770212|FG000|Overall Study|Treatment Limiting AEs|3|||
130220390|NCT00181883|468770212|FG000|Overall Study|Withdrawal by Subject|4|||
130220391|NCT00181883|468770212|FG000|Overall Study|Lost to Follow-up|1|||
130220392|NCT00765817|468770213|FG000|Overall Study|Adverse Event|13|||
130220393|NCT00765817|468770214|FG001|Overall Study|Adverse Event|1|||
130220394|NCT00765817|468770213|FG000|Overall Study|Death|0|||
130441300|NCT02080520|469580062|FG001|Overall Study|Unable to contact|1|||
130441301|NCT02080520|469580061|FG000|Overall Study|Initiated aspirin|2|||
130441302|NCT02080520|469580062|FG001|Overall Study|Initiated aspirin|0|||
130686007|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130220395|NCT00765817|468770214|FG001|Overall Study|Death|1|||
130220396|NCT00765817|468770213|FG000|Overall Study|Entry criteria not met|2|||
130220397|NCT00765817|468770214|FG001|Overall Study|Entry criteria not met|2|||
130220398|NCT00765817|468770213|FG000|Overall Study|Loss of glucose control|0|||
130220399|NCT00765817|468770214|FG001|Overall Study|Loss of glucose control|2|||
130220400|NCT00765817|468770213|FG000|Overall Study|Lost to Follow-up|1|||
130220401|NCT00765817|468770214|FG001|Overall Study|Lost to Follow-up|3|||
130220402|NCT00765817|468770213|FG000|Overall Study|Physician Decision|2|||
130220403|NCT00765817|468770214|FG001|Overall Study|Physician Decision|1|||
130441303|NCT02080520|469580061|FG000|Overall Study|Atrial fibrillation|1|||
130220404|NCT00765817|468770213|FG000|Overall Study|Protocol Violation|1|||
130220405|NCT00765817|468770214|FG001|Overall Study|Protocol Violation|1|||
130441304|NCT02080520|469580062|FG001|Overall Study|Atrial fibrillation|1|||
130220406|NCT00765817|468770213|FG000|Overall Study|Subject decision|7|||
130220407|NCT00765817|468770214|FG001|Overall Study|Subject decision|11|||
130220408|NCT00103285|468772167|FG000|Induction|Adverse Event|14|||
130220409|NCT00103285|468772168|FG001|Induction|Adverse Event|0|||
130220410|NCT00103285|468772169|FG002|Induction|Adverse Event|0|||
130220411|NCT00103285|468772170|FG003|Induction|Adverse Event|0|||
130220412|NCT00103285|468772171|FG004|Induction|Adverse Event|0|||
130220413|NCT00103285|468772172|FG005|Induction|Adverse Event|0|||
130220414|NCT00103285|468772173|FG006|Induction|Adverse Event|0|||
130220415|NCT00103285|468772174|FG007|Induction|Adverse Event|0|||
130220416|NCT00103285|468772167|FG000|Induction|Death|24|||
130220417|NCT00103285|468772168|FG001|Induction|Death|0|||
130220418|NCT00103285|468772169|FG002|Induction|Death|0|||
130220419|NCT00103285|468772170|FG003|Induction|Death|0|||
130220420|NCT00103285|468772171|FG004|Induction|Death|0|||
130220421|NCT00103285|468772172|FG005|Induction|Death|0|||
130220422|NCT00103285|468772173|FG006|Induction|Death|0|||
130220423|NCT00103285|468772174|FG007|Induction|Death|0|||
130220424|NCT00103285|468772167|FG000|Induction|Physician Decision|103|||
130353917|NCT05140382|469266405|FG000|Overall Study|Other|4|||
130353918|NCT05140382|469266406|FG001|Overall Study|Other|0|||
130353919|NCT05140382|469266407|FG002|Overall Study|Other|1|||
130353920|NCT05140382|469266405|FG000|Overall Study|Progressive disease|20|||
130353921|NCT05140382|469266406|FG001|Overall Study|Progressive disease|1|||
130353922|NCT05140382|469266407|FG002|Overall Study|Progressive disease|12|||
130353923|NCT05140382|469266405|FG000|Overall Study|Subjective disease progression|2|||
130353924|NCT05140382|469266406|FG001|Overall Study|Subjective disease progression|1|||
130353925|NCT05140382|469266407|FG002|Overall Study|Subjective disease progression|0|||
130353926|NCT05140382|469266405|FG000|Overall Study|Unknown at data cut-off|0|||
130353927|NCT05140382|469266406|FG001|Overall Study|Unknown at data cut-off|0|||
130353928|NCT05140382|469266407|FG002|Overall Study|Unknown at data cut-off|1|||
130353929|NCT05140382|469266405|FG000|Overall Study|Withdrawal by Subject|1|||
130353930|NCT05140382|469266406|FG001|Overall Study|Withdrawal by Subject|0|||
130353931|NCT05140382|469266407|FG002|Overall Study|Withdrawal by Subject|4|||
130353932|NCT05140382|469266405|FG000|Overall Study|Withdrawal of consent|0|||
130353933|NCT05140382|469266406|FG001|Overall Study|Withdrawal of consent|0|||
130353934|NCT05140382|469266407|FG002|Overall Study|Withdrawal of consent|1|||
130353935|NCT01994590|469267719|FG000|Overall Study|Adverse Event|1|||
130353936|NCT01994590|469267719|FG000|Overall Study|Trial Terminated|1|||
130353937|NCT02237911|469267720|FG000|Overall Study|Withdrawal by Subject|4|||
130353938|NCT02237911|469267721|FG001|Overall Study|Withdrawal by Subject|7|||
130353939|NCT02237911|469267722|FG002|Overall Study|Withdrawal by Subject|2|||
130353940|NCT02237911|469267720|FG000|Overall Study|Lost to Follow-up|3|||
130353941|NCT02237911|469267721|FG001|Overall Study|Lost to Follow-up|1|||
130353942|NCT02237911|469267722|FG002|Overall Study|Lost to Follow-up|1|||
130353943|NCT00053365|469267723|FG000|Overall Study|Incorrect cell type|1|||
130353944|NCT00053365|469267723|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
130353945|NCT00053365|469267723|FG000|Overall Study|Never treated|4|||
130353946|NCT00958789|469267728|FG000|Overall Study|Death|5|||
130353947|NCT00958789|469267728|FG000|Overall Study|Lost to Follow-up|14|||
130353948|NCT00958789|469267728|FG000|Overall Study|Withdrawal by Subject|17|||
130353949|NCT00958789|469267728|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
130353950|NCT00958789|469267728|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
130353951|NCT00958789|469267728|FG000|Overall Study|Subject terminated|2|||
130353952|NCT00958789|469267728|FG000|Overall Study|Revision|7|||
130353953|NCT05007717|469267730|FG000|Overall Study|Death|3|||
130353954|NCT05007717|469267731|FG001|Overall Study|Death|2|||
130353955|NCT00427960|469267733|FG000|Overall Study|Adverse Event|2|||
130353956|NCT00427960|469267734|FG001|Overall Study|Adverse Event|0|||
130353957|NCT00427960|469267733|FG000|Overall Study|Withdrawal by Subject|0|||
130353958|NCT00427960|469267734|FG001|Overall Study|Withdrawal by Subject|3|||
130353959|NCT00427960|469267733|FG000|Overall Study|Other|0|||
130353960|NCT00427960|469267734|FG001|Overall Study|Other|1|||
130353961|NCT03282565|469267737|FG000|Overall Study|COVID-19 Research Shutdown|0|||
130353962|NCT03282565|469267738|FG001|Overall Study|COVID-19 Research Shutdown|2|||
130353963|NCT03282565|469267739|FG002|Overall Study|COVID-19 Research Shutdown|2|||
130353964|NCT01869725|469267740|FG000|Overall Study|ineligible after registration|1|||
130353965|NCT01869725|469267740|FG000|Overall Study|Death|1|||
130441305|NCT02080520|469580061|FG000|Overall Study|Cancer|1|||
130220425|NCT00103285|468772168|FG001|Induction|Physician Decision|0|||
130220426|NCT00103285|468772169|FG002|Induction|Physician Decision|0|||
130220427|NCT00103285|468772170|FG003|Induction|Physician Decision|0|||
130220428|NCT00103285|468772171|FG004|Induction|Physician Decision|0|||
130353966|NCT01869725|469267740|FG000|Overall Study|Lost to Follow-up|2|||
130353967|NCT01143207|469267741|FG000|Overall Study|Lost to Follow-up|2|||
130353968|NCT04163718|469267742|FG000|Overall Study|Study terminated|12|||
130353969|NCT03463031|469267755|FG000|Overall Study|Withdrawal by Subject|4|||
130353970|NCT03463031|469267756|FG001|Overall Study|Withdrawal by Subject|2|||
130353971|NCT03463031|469267755|FG000|Overall Study|Investigator/Sponsor Decision|0|||
130353972|NCT03463031|469267756|FG001|Overall Study|Investigator/Sponsor Decision|1|||
130353973|NCT03463031|469267755|FG000|Overall Study|Lost to Follow-up|1|||
130353974|NCT03463031|469267756|FG001|Overall Study|Lost to Follow-up|1|||
130353975|NCT03463031|469267755|FG000|Overall Study|Adverse Event|4|||
130353976|NCT03463031|469267756|FG001|Overall Study|Adverse Event|1|||
130441306|NCT02080520|469580062|FG001|Overall Study|Cancer|2|||
130353977|NCT03463031|469267755|FG000|Overall Study|Use of prohibited medication by subject|1|||
130353978|NCT03463031|469267756|FG001|Overall Study|Use of prohibited medication by subject|0|||
130353979|NCT02131532|469267757|FG000|Overall Study|Withdrawal by Subject|1|||
130353980|NCT02131532|469267757|FG000|Overall Study|Physician Decision|1|||
130353981|NCT02131532|469267757|FG000|Overall Study|Other health conditions|2|||
130353982|NCT01466595|469267763|FG000|Overall Study|Withdrawal by Subject|0|||
130353983|NCT01466595|469267764|FG001|Overall Study|Withdrawal by Subject|1|||
130353984|NCT00057954|469267765|FG000|Overall Study|Death|1|||
130353985|NCT00057954|469267765|FG000|Overall Study|Disease progression|1|||
130353986|NCT01264016|469267766|FG000|Overall Study|Withdrawal by Subject|1|||
130353987|NCT01264016|469267766|FG000|Overall Study|Felt faint at sight of blood|1|||
130353988|NCT02147184|469267767|FG000|Overall Study|Lost to Follow-up|28|||
130353989|NCT02147184|469267768|FG001|Overall Study|Lost to Follow-up|15|||
130353990|NCT02147184|469267767|FG000|Overall Study|Study Burden|11|||
130353991|NCT02147184|469267768|FG001|Overall Study|Study Burden|7|||
130353992|NCT02147184|469267767|FG000|Overall Study|Pregnancy|6|||
130353993|NCT02147184|469267768|FG001|Overall Study|Pregnancy|0|||
130353994|NCT02147184|469267767|FG000|Overall Study|Moved out of state|3|||
130353995|NCT02147184|469267768|FG001|Overall Study|Moved out of state|3|||
130353996|NCT02147184|469267767|FG000|Overall Study|Physician Decision|0|||
130353997|NCT02147184|469267768|FG001|Overall Study|Physician Decision|2|||
130353998|NCT02147184|469267767|FG000|Overall Study|Other|1|||
130353999|NCT02147184|469267768|FG001|Overall Study|Other|0|||
130354000|NCT02117414|469267769|FG000|Overall Study|Death|5|||
130354001|NCT02117414|469267770|FG001|Overall Study|Death|2|||
130354002|NCT02117414|469267769|FG000|Overall Study|Withdrawal by Subject|10|||
130354003|NCT02117414|469267770|FG001|Overall Study|Withdrawal by Subject|4|||
130354004|NCT00417482|469267771|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
130354005|NCT00417482|469267772|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
130354006|NCT00417482|469267773|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
130354007|NCT00417482|469267771|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
130354008|NCT00417482|469267772|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
130354009|NCT00417482|469267773|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
130354010|NCT00417482|469267771|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
130354011|NCT00417482|469267772|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
130354012|NCT00417482|469267773|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
130354013|NCT00417482|469267771|FG000|Phase B 1st 16 Weeks|Death|1|||
130354014|NCT00417482|469267772|FG001|Phase B 1st 16 Weeks|Death|0|||
130354015|NCT00417482|469267773|FG002|Phase B 1st 16 Weeks|Death|0|||
130354016|NCT00417482|469267771|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
130354017|NCT00417482|469267772|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
130354018|NCT00417482|469267773|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
130354019|NCT00417482|469267771|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
130354020|NCT00417482|469267772|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
130354021|NCT00417482|469267773|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
130354022|NCT00417482|469267771|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
130354023|NCT00417482|469267772|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
130354024|NCT00417482|469267773|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
130354025|NCT00417482|469267771|FG000|Phase B 2nd 16 Weeks|Death|1|||
130354026|NCT00417482|469267772|FG001|Phase B 2nd 16 Weeks|Death|1|||
130354027|NCT00417482|469267773|FG002|Phase B 2nd 16 Weeks|Death|0|||
130354028|NCT06400979|469267776|FG000|Overall Study|Lost to Follow-up|29|||
130354029|NCT06400979|469267776|FG000|Overall Study|Withdrawal by Subject|1|||
130354030|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
130354031|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
130354032|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
130354033|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
130354034|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130354035|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
130354036|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130354037|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
130354038|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
130354039|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
130354040|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
130354041|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
130220429|NCT00103285|468772172|FG005|Induction|Physician Decision|0|||
130354042|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130354043|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
130354044|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130354045|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130354046|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Program Termination|3|||
130354047|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Program Termination|0|||
130354048|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Program Termination|1|||
130354049|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Program Termination|1|||
130354050|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
130441307|NCT02080520|469580061|FG000|Overall Study|Not interested in study|1|||
130441308|NCT02080520|469580062|FG001|Overall Study|Not interested in study|3|||
130441309|NCT02080520|469580061|FG000|Overall Study|Too busy|1|||
130441310|NCT02080520|469580062|FG001|Overall Study|Too busy|1|||
130441311|NCT02080520|469580061|FG000|Overall Study|Work-related injury|1|||
130441312|NCT02080520|469580062|FG001|Overall Study|Work-related injury|0|||
130441313|NCT02080520|469580061|FG000|Overall Study|Personal reasons|0|||
130441314|NCT02080520|469580062|FG001|Overall Study|Personal reasons|3|||
130441315|NCT04397523|469580063|FG000|Overall Study|Lost to Follow-up|3|||
130441316|NCT04397523|469580063|FG000|Overall Study|Transfer from/to other hospital|8|||
130441317|NCT00684762|469580089|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
130441318|NCT00684762|469580090|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130441319|NCT01394250|469580091|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
130441320|NCT01394250|469580092|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
130441321|NCT01394250|469580091|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
130441322|NCT01394250|469580092|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
130441323|NCT03537261|469580101|FG000|Overall Study|Lost to Follow-up|4|||
130441324|NCT03537261|469580102|FG001|Overall Study|Lost to Follow-up|5|||
130441325|NCT03537261|469580101|FG000|Overall Study|Withdrawal by Subject|4|||
130441326|NCT03537261|469580102|FG001|Overall Study|Withdrawal by Subject|6|||
130441327|NCT03537261|469580101|FG000|Overall Study|Did not return study questionnaires|0|||
130441328|NCT03537261|469580102|FG001|Overall Study|Did not return study questionnaires|1|||
130441329|NCT00502996|469580105|FG000|Overall Study|Lost to Follow-up|9|||
130441330|NCT00502996|469580105|FG000|Overall Study|Protocol Violation|2|||
130441331|NCT00502996|469580105|FG000|Overall Study|Treatment failure|25|||
130441332|NCT00502996|469580105|FG000|Overall Study|Withdrawal Informed Consent|6|||
130441333|NCT00502996|469580105|FG000|Overall Study|Adverse Event|2|||
130441334|NCT01729728|469580106|FG000|Overall Study|Adverse Event|0|||
130441335|NCT01729728|469580107|FG001|Overall Study|Adverse Event|6|||
130441336|NCT01729728|469580108|FG002|Overall Study|Adverse Event|0|||
130441337|NCT01729728|469580106|FG000|Overall Study|Protocol Violation|1|||
130441338|NCT01729728|469580107|FG001|Overall Study|Protocol Violation|0|||
130441339|NCT01729728|469580108|FG002|Overall Study|Protocol Violation|1|||
130441340|NCT04267614|469580109|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
130441341|NCT04267614|469580109|FG000|Overall Study|Lost to Follow-up|115|||
130441342|NCT03382600|469580119|FG000|Overall Study|Adverse Event|3|||
130441343|NCT03382600|469580120|FG001|Overall Study|Adverse Event|3|||
130441344|NCT03382600|469580119|FG000|Overall Study|Clinical Disease Progression|2|||
130441345|NCT03382600|469580120|FG001|Overall Study|Clinical Disease Progression|4|||
130441346|NCT03382600|469580119|FG000|Overall Study|Radiological Progression|40|||
130441347|NCT03382600|469580120|FG001|Overall Study|Radiological Progression|31|||
130441348|NCT03382600|469580119|FG000|Overall Study|Withdrawal by Subject|0|||
130441349|NCT03382600|469580120|FG001|Overall Study|Withdrawal by Subject|1|||
130441350|NCT03382600|469580119|FG000|Overall Study|Other|9|||
130441351|NCT03382600|469580120|FG001|Overall Study|Other|7|||
130441352|NCT01000376|469580121|FG000|Cycle 1 Day 1|Adverse Event|1|||
130441353|NCT01000376|469580122|FG001|Cycle 1 Day 1|Adverse Event|0|||
130441354|NCT01000376|469580121|FG000|Cycle 1 Day 1|Progressive Disease|1|||
130441355|NCT01000376|469580122|FG001|Cycle 1 Day 1|Progressive Disease|0|||
130441356|NCT00896454|469580123|FG000|Overall Study|Death|10|||
130441357|NCT00896454|469580123|FG000|Overall Study|Adverse Event|8|||
130441358|NCT00896454|469580123|FG000|Overall Study|Disease Progression|5|||
130441359|NCT00896454|469580123|FG000|Overall Study|Other|4|||
130441360|NCT00896454|469580123|FG000|Overall Study|Requirement for alternative therapy|3|||
130441361|NCT00896454|469580123|FG000|Overall Study|Ongoing in study|2|||
130441362|NCT00896454|469580123|FG000|Overall Study|Withdrawal by Subject|1|||
130441363|NCT03688711|469580124|FG000|Overall Study|Withdrawal by Subject|0|||
130441364|NCT03688711|469580125|FG001|Overall Study|Withdrawal by Subject|1|||
130441365|NCT05033080|469580134|FG000|Overall Study|Adverse Event|4|||
130441366|NCT05033080|469580135|FG001|Overall Study|Adverse Event|4|||
130441367|NCT05033080|469580134|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
130441368|NCT05033080|469580135|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
130441369|NCT05033080|469580134|FG000|Overall Study|Lost to Follow-up|1|||
130441370|NCT05033080|469580135|FG001|Overall Study|Lost to Follow-up|0|||
130441371|NCT05033080|469580134|FG000|Overall Study|Other non-compliance|0|||
130552798|NCT00792805|469991536|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130441372|NCT05033080|469580135|FG001|Overall Study|Other non-compliance|1|||
130441373|NCT05033080|469580134|FG000|Overall Study|Physician Decision|0|||
130441374|NCT05033080|469580135|FG001|Overall Study|Physician Decision|1|||
130441375|NCT05033080|469580134|FG000|Overall Study|Other|1|||
130441376|NCT05033080|469580135|FG001|Overall Study|Other|1|||
130441377|NCT03560245|469580136|FG000|Overall Study|Withdrawal by Subject|3|||
130552799|NCT00792805|469991534|FG000|Overall Study|Protocol deviation|0|||
130441378|NCT03560245|469580137|FG001|Overall Study|Withdrawal by Subject|2|||
130441379|NCT03560245|469580136|FG000|Overall Study|Adverse Event|1|||
130441380|NCT03560245|469580137|FG001|Overall Study|Adverse Event|1|||
130441381|NCT03560245|469580136|FG000|Overall Study|Protocol Violation|1|||
130686008|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686009|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686010|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686011|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686012|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686013|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686014|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686015|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686016|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686017|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
130354051|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130354052|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130354053|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130354054|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
130354055|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
130354056|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
130354057|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
130354058|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
130354059|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
130354060|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
130354061|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
130354062|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130354063|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
130354064|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130354065|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130354066|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
130354067|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
130354068|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
130354069|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
130354070|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130354071|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
130354072|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130354073|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130354074|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
130354075|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
130354076|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
130354077|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
130354078|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130354079|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130354080|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
130354081|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130354082|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130354083|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130354084|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
130354085|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130354086|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130354087|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130354088|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130354089|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
130354090|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130354091|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130354092|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130354093|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
130354094|NCT03739840|469267777|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130354095|NCT03739840|469267778|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130354096|NCT03739840|469267779|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130354097|NCT03739840|469267780|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
130354098|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
130354099|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130354100|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130354101|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130354102|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130354103|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130354104|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130354105|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
130441382|NCT03560245|469580137|FG001|Overall Study|Protocol Violation|0|||
130220430|NCT00103285|468772173|FG006|Induction|Physician Decision|0|||
130220431|NCT00103285|468772174|FG007|Induction|Physician Decision|0|||
130220432|NCT00103285|468772167|FG000|Induction|Withdrawal by Subject|1|||
130220433|NCT00103285|468772168|FG001|Induction|Withdrawal by Subject|0|||
130220434|NCT00103285|468772169|FG002|Induction|Withdrawal by Subject|0|||
130220435|NCT00103285|468772170|FG003|Induction|Withdrawal by Subject|0|||
130220436|NCT00103285|468772171|FG004|Induction|Withdrawal by Subject|0|||
130220437|NCT00103285|468772172|FG005|Induction|Withdrawal by Subject|0|||
130220438|NCT00103285|468772173|FG006|Induction|Withdrawal by Subject|0|||
130220439|NCT00103285|468772174|FG007|Induction|Withdrawal by Subject|0|||
130220440|NCT00103285|468772167|FG000|Induction|Ineligible|43|||
130220441|NCT00103285|468772168|FG001|Induction|Ineligible|0|||
130220442|NCT00103285|468772169|FG002|Induction|Ineligible|0|||
130220443|NCT00103285|468772170|FG003|Induction|Ineligible|0|||
130220444|NCT00103285|468772171|FG004|Induction|Ineligible|0|||
130220445|NCT00103285|468772172|FG005|Induction|Ineligible|0|||
130220446|NCT00103285|468772173|FG006|Induction|Ineligible|0|||
130220447|NCT00103285|468772174|FG007|Induction|Ineligible|0|||
130220448|NCT00103285|468772167|FG000|Induction|Refusal|906|||
130220449|NCT00103285|468772168|FG001|Induction|Refusal|0|||
130220450|NCT00103285|468772169|FG002|Induction|Refusal|0|||
130220451|NCT00103285|468772170|FG003|Induction|Refusal|0|||
130220452|NCT00103285|468772171|FG004|Induction|Refusal|0|||
130220453|NCT00103285|468772172|FG005|Induction|Refusal|0|||
130220454|NCT00103285|468772173|FG006|Induction|Refusal|0|||
130220455|NCT00103285|468772174|FG007|Induction|Refusal|0|||
130220456|NCT00103285|468772167|FG000|Induction|Other|258|||
130220457|NCT00103285|468772168|FG001|Induction|Other|0|||
130220458|NCT00103285|468772169|FG002|Induction|Other|0|||
130354106|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
130354107|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
130354108|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
130354109|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
130354110|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
130354111|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
130354112|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
130354113|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
130354114|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130354115|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
130354116|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130354117|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130354118|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130552800|NCT00792805|469991535|FG001|Overall Study|Protocol deviation|1|||
130220459|NCT00103285|468772170|FG003|Induction|Other|0|||
130220460|NCT00103285|468772171|FG004|Induction|Other|0|||
130220461|NCT00103285|468772172|FG005|Induction|Other|0|||
130220462|NCT00103285|468772173|FG006|Induction|Other|0|||
130220463|NCT00103285|468772174|FG007|Induction|Other|0|||
130220464|NCT00103285|468772167|FG000|Response Assignment|Adverse Event|0|||
130220465|NCT00103285|468772168|FG001|Response Assignment|Adverse Event|8|||
130220466|NCT00103285|468772169|FG002|Response Assignment|Adverse Event|3|||
130220467|NCT00103285|468772170|FG003|Response Assignment|Adverse Event|2|||
130220468|NCT00103285|468772171|FG004|Response Assignment|Adverse Event|3|||
130220469|NCT00103285|468772172|FG005|Response Assignment|Adverse Event|1|||
130220470|NCT00103285|468772173|FG006|Response Assignment|Adverse Event|1|||
130220471|NCT00103285|468772174|FG007|Response Assignment|Adverse Event|2|||
130220472|NCT00103285|468772167|FG000|Response Assignment|Death|0|||
130220473|NCT00103285|468772168|FG001|Response Assignment|Death|5|||
130220474|NCT00103285|468772169|FG002|Response Assignment|Death|2|||
130220475|NCT00103285|468772170|FG003|Response Assignment|Death|2|||
130220476|NCT00103285|468772171|FG004|Response Assignment|Death|3|||
130220477|NCT00103285|468772172|FG005|Response Assignment|Death|1|||
130220478|NCT00103285|468772173|FG006|Response Assignment|Death|0|||
130220479|NCT00103285|468772174|FG007|Response Assignment|Death|8|||
130220480|NCT00103285|468772167|FG000|Response Assignment|Lost to Follow-up|0|||
130220481|NCT00103285|468772168|FG001|Response Assignment|Lost to Follow-up|9|||
130220482|NCT00103285|468772169|FG002|Response Assignment|Lost to Follow-up|5|||
130220483|NCT00103285|468772170|FG003|Response Assignment|Lost to Follow-up|5|||
130220484|NCT00103285|468772171|FG004|Response Assignment|Lost to Follow-up|1|||
130220485|NCT00103285|468772172|FG005|Response Assignment|Lost to Follow-up|2|||
130220486|NCT00103285|468772173|FG006|Response Assignment|Lost to Follow-up|2|||
130220487|NCT00103285|468772174|FG007|Response Assignment|Lost to Follow-up|5|||
130220488|NCT00103285|468772167|FG000|Response Assignment|Physician Decision|0|||
130220489|NCT00103285|468772168|FG001|Response Assignment|Physician Decision|13|||
130220490|NCT00103285|468772169|FG002|Response Assignment|Physician Decision|14|||
130220491|NCT00103285|468772170|FG003|Response Assignment|Physician Decision|9|||
130220492|NCT00103285|468772171|FG004|Response Assignment|Physician Decision|13|||
130220493|NCT00103285|468772172|FG005|Response Assignment|Physician Decision|7|||
130220494|NCT00103285|468772173|FG006|Response Assignment|Physician Decision|4|||
130686018|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
130686019|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
130220495|NCT00103285|468772174|FG007|Response Assignment|Physician Decision|35|||
130220496|NCT00103285|468772167|FG000|Response Assignment|Protocol Violation|0|||
130220497|NCT00103285|468772168|FG001|Response Assignment|Protocol Violation|2|||
130220498|NCT00103285|468772169|FG002|Response Assignment|Protocol Violation|0|||
130220499|NCT00103285|468772170|FG003|Response Assignment|Protocol Violation|0|||
130220500|NCT00103285|468772171|FG004|Response Assignment|Protocol Violation|0|||
130220501|NCT00103285|468772172|FG005|Response Assignment|Protocol Violation|0|||
130220502|NCT00103285|468772173|FG006|Response Assignment|Protocol Violation|0|||
130686020|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686021|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686022|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686023|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686024|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686025|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686026|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686027|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130220503|NCT00103285|468772174|FG007|Response Assignment|Protocol Violation|0|||
130220504|NCT00103285|468772167|FG000|Response Assignment|Withdrawal by Subject|0|||
130220505|NCT00103285|468772168|FG001|Response Assignment|Withdrawal by Subject|4|||
130220506|NCT00103285|468772169|FG002|Response Assignment|Withdrawal by Subject|1|||
130220507|NCT00103285|468772170|FG003|Response Assignment|Withdrawal by Subject|1|||
130220508|NCT00103285|468772171|FG004|Response Assignment|Withdrawal by Subject|2|||
130220509|NCT00103285|468772172|FG005|Response Assignment|Withdrawal by Subject|2|||
130220510|NCT00103285|468772173|FG006|Response Assignment|Withdrawal by Subject|0|||
130220511|NCT00103285|468772174|FG007|Response Assignment|Withdrawal by Subject|2|||
130220512|NCT00103285|468772167|FG000|Response Assignment|Ineligible|0|||
130220513|NCT00103285|468772168|FG001|Response Assignment|Ineligible|8|||
130220514|NCT00103285|468772169|FG002|Response Assignment|Ineligible|6|||
130220515|NCT00103285|468772170|FG003|Response Assignment|Ineligible|2|||
130220516|NCT00103285|468772171|FG004|Response Assignment|Ineligible|0|||
130354119|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130354120|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
130354121|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130354122|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130354123|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130354124|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
130354125|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130354126|NCT03739840|469267777|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130354127|NCT03739840|469267778|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130354128|NCT03739840|469267779|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
130354129|NCT03739840|469267780|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130354130|NCT01058265|469267783|FG000|Overall Study|Lost to Follow-up|11|||
130354131|NCT01058265|469267784|FG001|Overall Study|Lost to Follow-up|12|||
130354132|NCT02869438|469267785|FG000|Overall Study|Lost to Follow-up|1|||
130354133|NCT02869438|469267786|FG001|Overall Study|Lost to Follow-up|0|||
130354134|NCT02869438|469267785|FG000|Overall Study|Adverse Event|1|||
130354135|NCT02869438|469267786|FG001|Overall Study|Adverse Event|0|||
130354136|NCT02869438|469267785|FG000|Overall Study|Withdrawal by Subject|1|||
130354137|NCT02869438|469267786|FG001|Overall Study|Withdrawal by Subject|2|||
130354138|NCT02169284|469267789|FG000|Overall Study|Physician Decision|0|||
130354139|NCT02169284|469267790|FG001|Overall Study|Physician Decision|1|||
130354140|NCT00984568|469267791|FG000|Overall Study|Withdrawal by Subject|1|||
130354141|NCT00984568|469267792|FG001|Overall Study|Withdrawal by Subject|2|||
130354142|NCT00984568|469267791|FG000|Overall Study|Lack of Efficacy|2|||
130354143|NCT00984568|469267792|FG001|Overall Study|Lack of Efficacy|0|||
130354144|NCT00984568|469267791|FG000|Overall Study|Adverse Event|2|||
130354145|NCT00984568|469267792|FG001|Overall Study|Adverse Event|0|||
130354146|NCT00984568|469267791|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
130354147|NCT00984568|469267792|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
130354148|NCT00984568|469267791|FG000|Overall Study|Lost to Follow-up|0|||
130354149|NCT00984568|469267792|FG001|Overall Study|Lost to Follow-up|1|||
130354150|NCT00984568|469267791|FG000|Overall Study|Opportunistic Infection|1|||
130220517|NCT00103285|468772172|FG005|Response Assignment|Ineligible|3|||
130220518|NCT00103285|468772173|FG006|Response Assignment|Ineligible|1|||
130220519|NCT00103285|468772174|FG007|Response Assignment|Ineligible|5|||
130220520|NCT00103285|468772167|FG000|Response Assignment|Refusal|0|||
130354151|NCT00984568|469267792|FG001|Overall Study|Opportunistic Infection|0|||
130354152|NCT00984568|469267791|FG000|Overall Study|Unknown Reason|1|||
130354153|NCT00984568|469267792|FG001|Overall Study|Unknown Reason|3|||
130354154|NCT03583073|469267793|FG000|Overall Study|Lost to Follow-up|8|||
130354155|NCT03583073|469267794|FG001|Overall Study|Lost to Follow-up|12|||
130354156|NCT01367119|469267795|FG000|Overall Study|Adverse Event|1|||
130354157|NCT01367119|469267796|FG001|Overall Study|Adverse Event|0|||
130354158|NCT01367119|469267795|FG000|Overall Study|Withdrawal by Subject|1|||
130354159|NCT01367119|469267796|FG001|Overall Study|Withdrawal by Subject|1|||
130354160|NCT03180684|469267797|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
130354161|NCT03180684|469267798|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
130354162|NCT03180684|469267797|FG000|Overall Study|Physician Decision|1|||
130354163|NCT03180684|469267798|FG001|Overall Study|Physician Decision|0|||
130354164|NCT03180684|469267797|FG000|Overall Study|Lost to Follow-up|1|||
130354165|NCT03180684|469267798|FG001|Overall Study|Lost to Follow-up|0|||
130354166|NCT03180684|469267797|FG000|Overall Study|Progressive Disease|1|||
130354167|NCT03180684|469267798|FG001|Overall Study|Progressive Disease|0|||
130354168|NCT02675231|469267799|FG000|Overall Study|Withdrawal by Subject|2|||
130354169|NCT02675231|469267800|FG001|Overall Study|Withdrawal by Subject|4|||
130354170|NCT02675231|469267801|FG002|Overall Study|Withdrawal by Subject|2|||
130354171|NCT02675231|469267799|FG000|Overall Study|Lost to Follow-up|3|||
130354172|NCT02675231|469267800|FG001|Overall Study|Lost to Follow-up|4|||
130354173|NCT02675231|469267801|FG002|Overall Study|Lost to Follow-up|3|||
130354174|NCT03370289|469267806|FG000|Overall Study|Screen Failure|1|||
130354175|NCT03370289|469267806|FG000|Overall Study|Sample Size Sufficient|4|||
130354176|NCT02220998|469267808|FG000|Overall Study|Randomized but Never Treated|1|||
130354177|NCT02220998|469267809|FG001|Overall Study|Randomized but Never Treated|2|||
130354178|NCT02220998|469267808|FG000|Overall Study|Death|2|||
130354179|NCT02220998|469267809|FG001|Overall Study|Death|0|||
130354180|NCT02220998|469267808|FG000|Overall Study|Lack of Efficacy|0|||
130354181|NCT02220998|469267809|FG001|Overall Study|Lack of Efficacy|5|||
130354182|NCT02220998|469267808|FG000|Overall Study|Lost to Follow-up|4|||
130354183|NCT02220998|469267809|FG001|Overall Study|Lost to Follow-up|4|||
130354184|NCT00873860|469267810|FG000|Overall Study|Lost to Follow-up|1|||
130354185|NCT00873860|469267811|FG001|Overall Study|Lost to Follow-up|0|||
130354186|NCT00873860|469267812|FG002|Overall Study|Lost to Follow-up|0|||
130354187|NCT00873860|469267813|FG003|Overall Study|Lost to Follow-up|1|||
130354188|NCT00873860|469267810|FG000|Overall Study|Withdrawal by Subject|1|||
130354189|NCT00873860|469267811|FG001|Overall Study|Withdrawal by Subject|0|||
130354190|NCT00873860|469267812|FG002|Overall Study|Withdrawal by Subject|2|||
130354191|NCT00873860|469267813|FG003|Overall Study|Withdrawal by Subject|0|||
130354192|NCT00873860|469267810|FG000|Overall Study|Death|1|||
130354193|NCT00873860|469267811|FG001|Overall Study|Death|0|||
130354194|NCT00873860|469267812|FG002|Overall Study|Death|0|||
130354195|NCT00873860|469267813|FG003|Overall Study|Death|0|||
130354196|NCT00873860|469267810|FG000|Overall Study|Other|1|||
130354197|NCT00873860|469267811|FG001|Overall Study|Other|0|||
130354198|NCT00873860|469267812|FG002|Overall Study|Other|1|||
130354199|NCT00873860|469267813|FG003|Overall Study|Other|0|||
130354200|NCT01610271|469267830|FG000|Overall Study|Surgery not complete|0|||
130354201|NCT01610271|469267831|FG001|Overall Study|Surgery not complete|1|||
130354202|NCT01610271|469267830|FG000|Overall Study|Prosthesis not implanted|2|||
130354203|NCT01610271|469267831|FG001|Overall Study|Prosthesis not implanted|3|||
130354204|NCT00364130|469267832|FG000|Intervention Period|Lost to Follow-up|4|||
130354205|NCT00364130|469267833|FG001|Intervention Period|Lost to Follow-up|3|||
130354206|NCT00364130|469267832|FG000|Intervention Period|Pregnancy|1|||
130354207|NCT00364130|469267833|FG001|Intervention Period|Pregnancy|0|||
130354208|NCT00364130|469267832|FG000|Intervention Period|Withdrawal by Subject|4|||
130354209|NCT00364130|469267833|FG001|Intervention Period|Withdrawal by Subject|5|||
130354210|NCT00364130|469267832|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
130354211|NCT00364130|469267833|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
130354212|NCT05281601|469267834|FG000|Overall Study|Physician Decision|2|||
130354213|NCT05281601|469267835|FG001|Overall Study|Physician Decision|0|||
130354214|NCT05281601|469267834|FG000|Overall Study|Lost to Follow-up|2|||
130354215|NCT05281601|469267835|FG001|Overall Study|Lost to Follow-up|0|||
130354216|NCT05281601|469267834|FG000|Overall Study|Death|1|||
130354217|NCT05281601|469267835|FG001|Overall Study|Death|0|||
130354218|NCT05281601|469267834|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130354219|NCT05281601|469267835|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130354220|NCT00586846|469267836|FG000|Overall Study|Physician Decision|1|||
130686028|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130354221|NCT00586846|469267836|FG000|Overall Study|Death|1|||
130354222|NCT00586846|469267836|FG000|Overall Study|Evaluable for Toxicity Only|4|||
130354223|NCT00144027|469267838|FG000|Overall Study|Lost to Follow-up|1|||
130354224|NCT00144027|469267839|FG001|Overall Study|Lost to Follow-up|3|||
130354225|NCT00144027|469267838|FG000|Overall Study|Withdrawal by Subject|2|||
130354226|NCT00144027|469267839|FG001|Overall Study|Withdrawal by Subject|2|||
130354227|NCT00144027|469267838|FG000|Overall Study|did not complete baseline assessment|0|||
130354228|NCT00144027|469267839|FG001|Overall Study|did not complete baseline assessment|6|||
130354229|NCT04597918|469267840|FG000|Overall Study|Withdrawal by Subject|6|||
130354230|NCT04597918|469267840|FG000|Overall Study|Lost to Follow-up|3|||
130354231|NCT04597918|469267840|FG000|Overall Study|Death|1|||
130220521|NCT00103285|468772168|FG001|Response Assignment|Refusal|53|||
130220522|NCT00103285|468772169|FG002|Response Assignment|Refusal|5|||
130220523|NCT00103285|468772170|FG003|Response Assignment|Refusal|3|||
130220524|NCT00103285|468772171|FG004|Response Assignment|Refusal|25|||
130220525|NCT00103285|468772172|FG005|Response Assignment|Refusal|15|||
130220526|NCT00103285|468772173|FG006|Response Assignment|Refusal|30|||
130220527|NCT00103285|468772174|FG007|Response Assignment|Refusal|10|||
130220528|NCT00103285|468772167|FG000|Response Assignment|Other|0|||
130220529|NCT00103285|468772168|FG001|Response Assignment|Other|30|||
130220530|NCT00103285|468772169|FG002|Response Assignment|Other|48|||
130220531|NCT00103285|468772170|FG003|Response Assignment|Other|38|||
130220532|NCT00103285|468772171|FG004|Response Assignment|Other|37|||
130220533|NCT00103285|468772172|FG005|Response Assignment|Other|17|||
130220534|NCT00103285|468772173|FG006|Response Assignment|Other|11|||
130220535|NCT00103285|468772174|FG007|Response Assignment|Other|53|||
130220536|NCT00452439|468772176|FG000|Overall Study|Lost to Follow-up|1|||
130220537|NCT00452439|468772177|FG001|Overall Study|Lost to Follow-up|1|||
130220538|NCT00452439|468772176|FG000|Overall Study|Refused Treatment|4|||
130220539|NCT00452439|468772177|FG001|Overall Study|Refused Treatment|3|||
130220540|NCT00452439|468772176|FG000|Overall Study|Death|3|||
130220541|NCT00452439|468772177|FG001|Overall Study|Death|1|||
130220542|NCT00452439|468772176|FG000|Overall Study|Bone Marrow Transplant|0|||
130220543|NCT00452439|468772177|FG001|Overall Study|Bone Marrow Transplant|1|||
130220544|NCT00452439|468772176|FG000|Overall Study|Too Ill to Continue|0|||
130220545|NCT00452439|468772177|FG001|Overall Study|Too Ill to Continue|1|||
130220546|NCT00452439|468772176|FG000|Overall Study|Failed to achieve complete response|2|||
130220547|NCT00452439|468772177|FG001|Overall Study|Failed to achieve complete response|0|||
130220548|NCT00452439|468772176|FG000|Overall Study|Relapse|3|||
130220549|NCT00452439|468772177|FG001|Overall Study|Relapse|0|||
130220550|NCT00452439|468772176|FG000|Overall Study|Fracture|1|||
130220551|NCT00452439|468772177|FG001|Overall Study|Fracture|0|||
130220552|NCT01302418|468772179|FG000|Overall Study|Protocol Violation|9|||
130220553|NCT01302418|468772179|FG000|Overall Study|Non-evaluable|9|||
130220554|NCT00377637|468772180|FG000|Induction Phase|Adverse Event|12|||
130220555|NCT00377637|468772181|FG001|Induction Phase|Adverse Event|21|||
130220556|NCT00377637|468772182|FG002|Induction Phase|Adverse Event|0|||
130220557|NCT00377637|468772183|FG003|Induction Phase|Adverse Event|0|||
130220558|NCT00377637|468772180|FG000|Induction Phase|Deterioration/serum creatinine|2|||
130220559|NCT00377637|468772181|FG001|Induction Phase|Deterioration/serum creatinine|0|||
130220560|NCT00377637|468772182|FG002|Induction Phase|Deterioration/serum creatinine|0|||
130220561|NCT00377637|468772183|FG003|Induction Phase|Deterioration/serum creatinine|0|||
130220562|NCT00377637|468772180|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220563|NCT00377637|468772181|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
130220564|NCT00377637|468772182|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220565|NCT00377637|468772183|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220566|NCT00377637|468772180|FG000|Induction Phase|Lost to Follow-up|2|||
130220567|NCT00377637|468772181|FG001|Induction Phase|Lost to Follow-up|1|||
130220568|NCT00377637|468772182|FG002|Induction Phase|Lost to Follow-up|0|||
130220569|NCT00377637|468772183|FG003|Induction Phase|Lost to Follow-up|0|||
130220570|NCT00377637|468772180|FG000|Induction Phase|Death|1|||
130220571|NCT00377637|468772181|FG001|Induction Phase|Death|3|||
130220572|NCT00377637|468772182|FG002|Induction Phase|Death|0|||
130220573|NCT00377637|468772183|FG003|Induction Phase|Death|0|||
130220574|NCT00377637|468772180|FG000|Induction Phase|Withdrawal by Subject|5|||
130220575|NCT00377637|468772181|FG001|Induction Phase|Withdrawal by Subject|6|||
130220576|NCT00377637|468772182|FG002|Induction Phase|Withdrawal by Subject|0|||
130220577|NCT00377637|468772183|FG003|Induction Phase|Withdrawal by Subject|0|||
130220578|NCT00377637|468772180|FG000|Induction Phase|Physician Decision|3|||
130220579|NCT00377637|468772181|FG001|Induction Phase|Physician Decision|1|||
130220580|NCT00377637|468772182|FG002|Induction Phase|Physician Decision|0|||
130220581|NCT00377637|468772183|FG003|Induction Phase|Physician Decision|0|||
130220582|NCT00377637|468772180|FG000|Induction Phase|Sponsor decision|1|||
130220583|NCT00377637|468772181|FG001|Induction Phase|Sponsor decision|2|||
130220584|NCT00377637|468772182|FG002|Induction Phase|Sponsor decision|0|||
130220585|NCT00377637|468772183|FG003|Induction Phase|Sponsor decision|0|||
130220586|NCT00377637|468772180|FG000|Induction Phase|Non-Compliance|1|||
130220587|NCT00377637|468772181|FG001|Induction Phase|Non-Compliance|0|||
130220588|NCT00377637|468772182|FG002|Induction Phase|Non-Compliance|0|||
130220589|NCT00377637|468772183|FG003|Induction Phase|Non-Compliance|0|||
130220590|NCT00377637|468772180|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
130220591|NCT00377637|468772181|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
130220592|NCT00377637|468772182|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
130220593|NCT00377637|468772183|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
130220594|NCT00377637|468772180|FG000|Maintenance Phase|Adverse Event|0|||
130220595|NCT00377637|468772181|FG001|Maintenance Phase|Adverse Event|0|||
130220596|NCT00377637|468772182|FG002|Maintenance Phase|Adverse Event|29|||
130220597|NCT00377637|468772183|FG003|Maintenance Phase|Adverse Event|43|||
130220598|NCT00377637|468772180|FG000|Maintenance Phase|Physician Decision|0|||
130220599|NCT00377637|468772181|FG001|Maintenance Phase|Physician Decision|0|||
130354232|NCT00395538|469267841|FG000|Overall Study|Did not re-consent to revised protocol|1|||
130354233|NCT00395538|469267842|FG001|Overall Study|Did not re-consent to revised protocol|10|||
130354234|NCT00395538|469267843|FG002|Overall Study|Did not re-consent to revised protocol|0|||
130354235|NCT00395538|469267841|FG000|Overall Study|FDA partial hold on PTH|0|||
130354236|NCT00395538|469267842|FG001|Overall Study|FDA partial hold on PTH|0|||
130354237|NCT00395538|469267843|FG002|Overall Study|FDA partial hold on PTH|11|||
130354238|NCT00395538|469267841|FG000|Overall Study|Failed screening|0|||
130354239|NCT00395538|469267842|FG001|Overall Study|Failed screening|0|||
130354240|NCT00395538|469267843|FG002|Overall Study|Failed screening|4|||
130354241|NCT00395538|469267841|FG000|Overall Study|Switch to Natpara|0|||
130354242|NCT00395538|469267842|FG001|Overall Study|Switch to Natpara|0|||
130354243|NCT00395538|469267843|FG002|Overall Study|Switch to Natpara|3|||
130354244|NCT00395538|469267841|FG000|Overall Study|Adverse Event|1|||
130354245|NCT00395538|469267842|FG001|Overall Study|Adverse Event|0|||
130354246|NCT00395538|469267843|FG002|Overall Study|Adverse Event|2|||
130354247|NCT00395538|469267841|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
130354248|NCT00395538|469267842|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
130354249|NCT00395538|469267843|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
130354250|NCT00395538|469267841|FG000|Overall Study|Non-compliance with study protocol|0|||
130354251|NCT00395538|469267842|FG001|Overall Study|Non-compliance with study protocol|1|||
130354252|NCT00395538|469267843|FG002|Overall Study|Non-compliance with study protocol|0|||
130354253|NCT00395538|469267841|FG000|Overall Study|PTH resistance|0|||
130354254|NCT00395538|469267842|FG001|Overall Study|PTH resistance|0|||
130354255|NCT00395538|469267843|FG002|Overall Study|PTH resistance|1|||
130354256|NCT00395538|469267841|FG000|Overall Study|Pregnancy|1|||
130354257|NCT00395538|469267842|FG001|Overall Study|Pregnancy|0|||
130354258|NCT00395538|469267843|FG002|Overall Study|Pregnancy|0|||
130354259|NCT00395538|469267841|FG000|Overall Study|Partial recovery of parathyroid function|0|||
130354260|NCT00395538|469267842|FG001|Overall Study|Partial recovery of parathyroid function|0|||
130354261|NCT00395538|469267843|FG002|Overall Study|Partial recovery of parathyroid function|1|||
130354262|NCT00395538|469267841|FG000|Overall Study|Participant elected to discontinue|0|||
130354263|NCT00395538|469267842|FG001|Overall Study|Participant elected to discontinue|0|||
130354264|NCT00395538|469267843|FG002|Overall Study|Participant elected to discontinue|1|||
130354265|NCT00285207|469267846|FG000|Overall Study|Lost to Follow-up|3|||
130354266|NCT00285207|469267847|FG001|Overall Study|Lost to Follow-up|2|||
130354267|NCT00285207|469267846|FG000|Overall Study|Withdrawal by Subject|5|||
130354268|NCT00285207|469267847|FG001|Overall Study|Withdrawal by Subject|2|||
130354269|NCT00285207|469267846|FG000|Overall Study|Pregnancy|1|||
130354270|NCT00285207|469267847|FG001|Overall Study|Pregnancy|1|||
130354271|NCT00285207|469267846|FG000|Overall Study|non-compliance|0|||
130354272|NCT00285207|469267847|FG001|Overall Study|non-compliance|1|||
130354273|NCT05063318|469267848|FG000|Overall Study|Progressive disease|2|||
130354274|NCT05063318|469267849|FG001|Overall Study|Progressive disease|0|||
130354275|NCT05063318|469267850|FG002|Overall Study|Progressive disease|3|||
130354276|NCT05063318|469267848|FG000|Overall Study|Compassionate use|1|||
130354277|NCT05063318|469267849|FG001|Overall Study|Compassionate use|3|||
130354278|NCT05063318|469267850|FG002|Overall Study|Compassionate use|3|||
130354279|NCT05063318|469267848|FG000|Overall Study|Adverse Event|0|||
130354280|NCT05063318|469267849|FG001|Overall Study|Adverse Event|1|||
130354281|NCT05063318|469267850|FG002|Overall Study|Adverse Event|0|||
130354282|NCT05063318|469267848|FG000|Overall Study|Withdrawal by Subject|0|||
130354283|NCT05063318|469267849|FG001|Overall Study|Withdrawal by Subject|1|||
130354284|NCT05063318|469267850|FG002|Overall Study|Withdrawal by Subject|0|||
130354285|NCT01659658|469269454|FG000|Overall Study|Withdrawal by Patient|18|||
130354286|NCT01659658|469269455|FG001|Overall Study|Withdrawal by Patient|4|||
130354287|NCT01659658|469269456|FG002|Overall Study|Withdrawal by Patient|2|||
130354288|NCT01659658|469269457|FG003|Overall Study|Withdrawal by Patient|0|||
130354289|NCT01659658|469269458|FG004|Overall Study|Withdrawal by Patient|11|||
130354290|NCT01659658|469269454|FG000|Overall Study|Study Terminated by Sponsor|9|||
130354291|NCT01659658|469269455|FG001|Overall Study|Study Terminated by Sponsor|7|||
130354292|NCT01659658|469269456|FG002|Overall Study|Study Terminated by Sponsor|0|||
130354293|NCT01659658|469269457|FG003|Overall Study|Study Terminated by Sponsor|1|||
130354294|NCT01659658|469269458|FG004|Overall Study|Study Terminated by Sponsor|4|||
130354295|NCT01659658|469269454|FG000|Overall Study|Reason not Specified|61|||
130354296|NCT01659658|469269455|FG001|Overall Study|Reason not Specified|15|||
130354297|NCT01659658|469269456|FG002|Overall Study|Reason not Specified|8|||
130354298|NCT01659658|469269457|FG003|Overall Study|Reason not Specified|1|||
130354299|NCT01659658|469269458|FG004|Overall Study|Reason not Specified|34|||
130354300|NCT01659658|469269454|FG000|Overall Study|Lost to Follow-up|2|||
130354301|NCT01659658|469269455|FG001|Overall Study|Lost to Follow-up|0|||
130354302|NCT01659658|469269456|FG002|Overall Study|Lost to Follow-up|0|||
130354303|NCT01659658|469269457|FG003|Overall Study|Lost to Follow-up|0|||
130354304|NCT01659658|469269458|FG004|Overall Study|Lost to Follow-up|0|||
130354305|NCT01083485|469269459|FG000|Overall Study|Adverse Event|0|||
130354306|NCT01083485|469269460|FG001|Overall Study|Adverse Event|1|||
130354307|NCT01083485|469269459|FG000|Overall Study|Protocol Violation|1|||
130354308|NCT01083485|469269460|FG001|Overall Study|Protocol Violation|0|||
130220600|NCT00377637|468772182|FG002|Maintenance Phase|Physician Decision|5|||
130220601|NCT00377637|468772183|FG003|Maintenance Phase|Physician Decision|4|||
130220602|NCT00377637|468772180|FG000|Maintenance Phase|Lost to Follow-up|0|||
130220603|NCT00377637|468772181|FG001|Maintenance Phase|Lost to Follow-up|0|||
130220604|NCT00377637|468772182|FG002|Maintenance Phase|Lost to Follow-up|3|||
130220605|NCT00377637|468772183|FG003|Maintenance Phase|Lost to Follow-up|1|||
130220606|NCT00377637|468772180|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130220607|NCT00377637|468772181|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130220608|NCT00377637|468772182|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130220609|NCT00377637|468772183|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130220610|NCT00377637|468772180|FG000|Maintenance Phase|Sponsor decision|0|||
130220611|NCT00377637|468772181|FG001|Maintenance Phase|Sponsor decision|0|||
130220612|NCT00377637|468772182|FG002|Maintenance Phase|Sponsor decision|2|||
130220613|NCT00377637|468772183|FG003|Maintenance Phase|Sponsor decision|3|||
130220614|NCT00377637|468772180|FG000|Maintenance Phase|Non-compliance|0|||
130220615|NCT00377637|468772181|FG001|Maintenance Phase|Non-compliance|0|||
130220616|NCT00377637|468772182|FG002|Maintenance Phase|Non-compliance|1|||
130220617|NCT00377637|468772183|FG003|Maintenance Phase|Non-compliance|1|||
130220618|NCT00377637|468772180|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
130220619|NCT00377637|468772181|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
130220620|NCT00377637|468772182|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
130220621|NCT00377637|468772183|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
130220622|NCT00377637|468772180|FG000|Maintenance Phase|Death|0|||
130220623|NCT00377637|468772181|FG001|Maintenance Phase|Death|0|||
130220624|NCT00377637|468772182|FG002|Maintenance Phase|Death|0|||
130220625|NCT00377637|468772183|FG003|Maintenance Phase|Death|1|||
130220626|NCT00994110|468772185|FG000|Overall Study|Withdrawal by Subject|9|||
130220627|NCT00994110|468772186|FG001|Overall Study|Withdrawal by Subject|9|||
130220628|NCT00994110|468772185|FG000|Overall Study|Not Treated|4|||
130220629|NCT00994110|468772186|FG001|Overall Study|Not Treated|8|||
130220630|NCT00994110|468772185|FG000|Overall Study|Adverse Event|1|||
130220631|NCT00994110|468772186|FG001|Overall Study|Adverse Event|0|||
130220632|NCT00994110|468772185|FG000|Overall Study|Patient not resected|41|||
130220633|NCT00994110|468772186|FG001|Overall Study|Patient not resected|52|||
130220634|NCT00994110|468772185|FG000|Overall Study|Pt not eligible|10|||
130220635|NCT00994110|468772186|FG001|Overall Study|Pt not eligible|5|||
130220636|NCT00368108|468772187|FG000|Overall Study|Adverse Event|38|||
130220637|NCT00368108|468772188|FG001|Overall Study|Adverse Event|26|||
130220638|NCT00368108|468772189|FG002|Overall Study|Adverse Event|44|||
130220639|NCT00368108|468772187|FG000|Overall Study|Abnormal Laboratory Value|0|||
130220640|NCT00368108|468772188|FG001|Overall Study|Abnormal Laboratory Value|0|||
130220641|NCT00368108|468772189|FG002|Overall Study|Abnormal Laboratory Value|3|||
130220642|NCT00368108|468772187|FG000|Overall Study|Protocol Violation|5|||
130220643|NCT00368108|468772188|FG001|Overall Study|Protocol Violation|9|||
130220644|NCT00368108|468772189|FG002|Overall Study|Protocol Violation|9|||
130220645|NCT00368108|468772187|FG000|Overall Study|Withdrawal by Subject|9|||
130220646|NCT00368108|468772188|FG001|Overall Study|Withdrawal by Subject|3|||
130220647|NCT00368108|468772189|FG002|Overall Study|Withdrawal by Subject|5|||
130220648|NCT00368108|468772187|FG000|Overall Study|Lack of Efficacy|7|||
130220649|NCT00368108|468772188|FG001|Overall Study|Lack of Efficacy|8|||
130220650|NCT00368108|468772189|FG002|Overall Study|Lack of Efficacy|5|||
130220651|NCT00368108|468772187|FG000|Overall Study|Physician Decision|2|||
130220652|NCT00368108|468772188|FG001|Overall Study|Physician Decision|0|||
130220653|NCT00368108|468772189|FG002|Overall Study|Physician Decision|1|||
130220654|NCT00368108|468772187|FG000|Overall Study|Other|3|||
130220655|NCT00368108|468772188|FG001|Overall Study|Other|7|||
130220656|NCT00368108|468772189|FG002|Overall Study|Other|1|||
130220657|NCT00130689|468772190|FG000|Overall Study|Progressive Disease|29|||
130220658|NCT00130689|468772190|FG000|Overall Study|Death|1|||
130220659|NCT00130689|468772190|FG000|Overall Study|Clinical Deterioration|4|||
130220660|NCT00130689|468772190|FG000|Overall Study|Withdrawal by Subject|3|||
130220661|NCT00130689|468772190|FG000|Overall Study|Ineligible|6|||
130220662|NCT01254656|468772191|FG000|Overall Study|Discontinued due to termination of study|40|||
130220663|NCT01254656|468772192|FG001|Overall Study|Discontinued due to termination of study|39|||
130220664|NCT01254656|468772193|FG002|Overall Study|Discontinued due to termination of study|13|||
130220665|NCT01254656|468772191|FG000|Overall Study|Lack of Efficacy|3|||
130220666|NCT01254656|468772192|FG001|Overall Study|Lack of Efficacy|0|||
130220667|NCT01254656|468772193|FG002|Overall Study|Lack of Efficacy|0|||
130220668|NCT01254656|468772191|FG000|Overall Study|Lost to Follow-up|1|||
130220669|NCT01254656|468772192|FG001|Overall Study|Lost to Follow-up|0|||
130220670|NCT01254656|468772193|FG002|Overall Study|Lost to Follow-up|2|||
130220671|NCT01254656|468772191|FG000|Overall Study|Withdrawal by Subject|2|||
130220672|NCT01254656|468772192|FG001|Overall Study|Withdrawal by Subject|2|||
130220673|NCT01254656|468772193|FG002|Overall Study|Withdrawal by Subject|1|||
130220674|NCT01254656|468772191|FG000|Overall Study|Pregnancy|0|||
130220675|NCT01254656|468772192|FG001|Overall Study|Pregnancy|0|||
130220676|NCT01254656|468772193|FG002|Overall Study|Pregnancy|2|||
130220677|NCT01254656|468772191|FG000|Overall Study|Adverse Event|1|||
130220678|NCT01254656|468772192|FG001|Overall Study|Adverse Event|1|||
130220679|NCT01254656|468772193|FG002|Overall Study|Adverse Event|0|||
130220680|NCT01254656|468772191|FG000|Overall Study|Death|0|||
130220681|NCT01254656|468772192|FG001|Overall Study|Death|1|||
130220682|NCT01254656|468772193|FG002|Overall Study|Death|0|||
130220683|NCT03200548|468772198|FG000|Overall Study|Withdrawal by Subject|5|||
130220684|NCT03200548|468772199|FG001|Overall Study|Withdrawal by Subject|11|||
130220685|NCT03200548|468772200|FG002|Overall Study|Withdrawal by Subject|7|||
130220686|NCT03200548|468772201|FG003|Overall Study|Withdrawal by Subject|6|||
130220687|NCT00716456|468772202|FG000|Overall Study|Adverse Event|0|||
130441383|NCT03560245|469580136|FG000|Overall Study|Death|0|||
130441384|NCT03560245|469580137|FG001|Overall Study|Death|1|||
130441385|NCT03560245|469580136|FG000|Overall Study|Lost to Follow-up|0|||
130441386|NCT03560245|469580137|FG001|Overall Study|Lost to Follow-up|1|||
130441387|NCT03560245|469580136|FG000|Overall Study|Physician Decision|0|||
130441388|NCT03560245|469580137|FG001|Overall Study|Physician Decision|1|||
130441389|NCT03560245|469580136|FG000|Overall Study|Other|0|||
130441390|NCT03560245|469580137|FG001|Overall Study|Other|1|||
130441391|NCT01263106|469580138|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
130441392|NCT01263106|469580139|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
130441393|NCT02611830|469580145|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
130441394|NCT02611830|469580146|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130441395|NCT02611830|469580147|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130441396|NCT02611830|469580148|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130441397|NCT02611830|469580145|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
130441398|NCT02611830|469580146|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
130441399|NCT02611830|469580147|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
130441400|NCT02611830|469580148|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
130441401|NCT02611830|469580145|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
130441402|NCT02611830|469580146|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
130441403|NCT02611830|469580147|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
130441404|NCT02611830|469580148|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
130441405|NCT02611830|469580145|FG000|OL Induction Phase|Lack of Efficacy|9|||
130441406|NCT02611830|469580146|FG001|OL Induction Phase|Lack of Efficacy|0|||
130441407|NCT02611830|469580147|FG002|OL Induction Phase|Lack of Efficacy|0|||
130441408|NCT02611830|469580148|FG003|OL Induction Phase|Lack of Efficacy|0|||
130441409|NCT02611830|469580145|FG000|OL Induction Phase|Reason not specified|3|||
130441410|NCT02611830|469580146|FG001|OL Induction Phase|Reason not specified|0|||
130441411|NCT02611830|469580147|FG002|OL Induction Phase|Reason not specified|0|||
130441412|NCT02611830|469580148|FG003|OL Induction Phase|Reason not specified|0|||
130441413|NCT02611830|469580145|FG000|Maintenance Phase|Lack of Efficacy|0|||
130441414|NCT02611830|469580146|FG001|Maintenance Phase|Lack of Efficacy|29|||
130441415|NCT02611830|469580147|FG002|Maintenance Phase|Lack of Efficacy|18|||
130441416|NCT02611830|469580148|FG003|Maintenance Phase|Lack of Efficacy|6|||
130441417|NCT02611830|469580145|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130441418|NCT02611830|469580146|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
130441419|NCT02611830|469580147|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
130441420|NCT02611830|469580148|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
130441421|NCT02611830|469580145|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
130441422|NCT02611830|469580146|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
130441423|NCT02611830|469580147|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
130441424|NCT02611830|469580148|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
130441425|NCT02611830|469580145|FG000|Maintenance Phase|Lost to Follow-up|0|||
130441426|NCT02611830|469580146|FG001|Maintenance Phase|Lost to Follow-up|0|||
130441427|NCT02611830|469580147|FG002|Maintenance Phase|Lost to Follow-up|0|||
130441428|NCT02611830|469580148|FG003|Maintenance Phase|Lost to Follow-up|1|||
130441429|NCT02611830|469580145|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
130441430|NCT02611830|469580146|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
130441431|NCT02611830|469580147|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
130441432|NCT02611830|469580148|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
130441433|NCT02611830|469580145|FG000|Maintenance Phase|Pregnancy|0|||
130220688|NCT00716456|468772203|FG001|Overall Study|Adverse Event|2|||
130220689|NCT00716456|468772204|FG002|Overall Study|Adverse Event|0|||
130220690|NCT00447772|468772205|FG000|Overall Study|Lack of Efficacy|3|||
130441434|NCT02611830|469580146|FG001|Maintenance Phase|Pregnancy|0|||
130441435|NCT02611830|469580147|FG002|Maintenance Phase|Pregnancy|1|||
130441436|NCT02611830|469580148|FG003|Maintenance Phase|Pregnancy|0|||
130441437|NCT02611830|469580145|FG000|Maintenance Phase|Reason not specified|0|||
130441438|NCT02611830|469580146|FG001|Maintenance Phase|Reason not specified|1|||
130441439|NCT02611830|469580147|FG002|Maintenance Phase|Reason not specified|4|||
130441440|NCT02611830|469580148|FG003|Maintenance Phase|Reason not specified|0|||
130441441|NCT02058290|469580149|FG000|Overall Study|Protocol Violation|2|||
130220691|NCT00447772|468772205|FG000|Overall Study|Insufficient compliance|6|||
130220692|NCT00447772|468772205|FG000|Overall Study|Discontinuation of drug therapy|1|||
130220693|NCT00447772|468772205|FG000|Overall Study|Lost to Follow-up|9|||
130220694|NCT00447772|468772205|FG000|Overall Study|Withdrawal by Subject|1|||
130220695|NCT00447772|468772205|FG000|Overall Study|Unable to attend all study visits|2|||
130220696|NCT00447772|468772205|FG000|Overall Study|Adverse Event|1|||
130220697|NCT00447772|468772205|FG000|Overall Study|Patient relocated|1|||
130220698|NCT00447772|468772205|FG000|Overall Study|Incomplete documentation at visit 1|1|||
130220699|NCT00447772|468772205|FG000|Overall Study|Chemotherapy for lung cancer|1|||
130220700|NCT00447772|468772205|FG000|Overall Study|Premature re-injection required|1|||
130220701|NCT00875563|468772210|FG000|Overall Study|Death|4|||
130220702|NCT00875563|468772210|FG000|Overall Study|Withdrawal by Subject|7|||
130220703|NCT00875563|468772210|FG000|Overall Study|No long-term (3-5 year) consent|6|||
130220704|NCT00875563|468772210|FG000|Overall Study|Still be eligible for follow-up|7|||
130220705|NCT02896569|468772213|FG000|Overall Study|Lost to Follow-up|2|||
130220706|NCT02896569|468772214|FG001|Overall Study|Lost to Follow-up|1|||
130220707|NCT02896569|468772213|FG000|Overall Study|Physician Decision|1|||
130220708|NCT02896569|468772214|FG001|Overall Study|Physician Decision|3|||
130220709|NCT02896569|468772213|FG000|Overall Study|Adverse Event|0|||
130220710|NCT02896569|468772214|FG001|Overall Study|Adverse Event|1|||
130220711|NCT02896569|468772213|FG000|Overall Study|Withdrawal by Subject|1|||
130220712|NCT02896569|468772214|FG001|Overall Study|Withdrawal by Subject|0|||
130220713|NCT01462630|468772215|FG000|Overall Study|Did not initiate therapy|3|||
130220714|NCT01462630|468772215|FG000|Overall Study|Death|1|||
130220715|NCT01462630|468772215|FG000|Overall Study|Protocol Violation|2|||
130220716|NCT01462630|468772215|FG000|Overall Study|Adverse Event|1|||
130220717|NCT03257436|468772216|FG000|Overall Study|Withdrawal by Subject|76|||
130220718|NCT03257436|468772216|FG000|Overall Study|Death|19|||
130220719|NCT00970489|468772219|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
130220720|NCT00970489|468772220|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
130220721|NCT05417412|468772221|FG000|Overall Study|Lost to Follow-up|2|||
130220722|NCT03478371|468772224|FG000|Overall Study|non-compliance|1|||
130220723|NCT03478371|468772224|FG000|Overall Study|Lost to Follow-up|4|||
130220724|NCT02849743|468772225|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
130220725|NCT02849743|468772226|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
130220726|NCT02849743|468772225|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130220727|NCT02849743|468772226|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130220728|NCT03874013|468772231|FG000|Overall Study|Adverse Event|0|||
130220729|NCT03874013|468772232|FG001|Overall Study|Adverse Event|1|||
130220730|NCT01096160|468772234|FG000|Overall Study|Adverse Event|0|||
130220731|NCT01096160|468772235|FG001|Overall Study|Adverse Event|0|||
130220732|NCT01096160|468772236|FG002|Overall Study|Adverse Event|1|||
130220733|NCT01096160|468772237|FG003|Overall Study|Adverse Event|0|||
130220734|NCT01096160|468772238|FG004|Overall Study|Adverse Event|0|||
130220735|NCT01096160|468772239|FG005|Overall Study|Adverse Event|0|||
130220736|NCT01096160|468772240|FG006|Overall Study|Adverse Event|0|||
130220737|NCT01096160|468772241|FG007|Overall Study|Adverse Event|0|||
130220738|NCT01096160|468772242|FG008|Overall Study|Adverse Event|0|||
130220739|NCT01096160|468772243|FG009|Overall Study|Adverse Event|1|||
130220740|NCT01096160|468772234|FG000|Overall Study|Met stopping criteria per protocol|0|||
130220741|NCT01096160|468772235|FG001|Overall Study|Met stopping criteria per protocol|0|||
130220742|NCT01096160|468772236|FG002|Overall Study|Met stopping criteria per protocol|0|||
130220743|NCT01096160|468772237|FG003|Overall Study|Met stopping criteria per protocol|0|||
130220744|NCT01096160|468772238|FG004|Overall Study|Met stopping criteria per protocol|1|||
130220745|NCT01096160|468772239|FG005|Overall Study|Met stopping criteria per protocol|0|||
130220746|NCT01096160|468772240|FG006|Overall Study|Met stopping criteria per protocol|2|||
130220747|NCT01096160|468772241|FG007|Overall Study|Met stopping criteria per protocol|0|||
130220748|NCT01096160|468772242|FG008|Overall Study|Met stopping criteria per protocol|2|||
130220749|NCT01096160|468772243|FG009|Overall Study|Met stopping criteria per protocol|0|||
130220750|NCT00922116|468772245|FG000|Overall Study|Adverse Event|4|||
130220751|NCT00922116|468772245|FG000|Overall Study|Death|1|||
130220752|NCT00922116|468772245|FG000|Overall Study|Lost to Follow-up|1|||
130220753|NCT00922116|468772245|FG000|Overall Study|Withdrawal by Subject|4|||
130220754|NCT00922116|468772245|FG000|Overall Study|Other|5|||
130220755|NCT04607135|468772246|FG000|Overall Study|Physician Decision|1|||
130220756|NCT04607135|468772246|FG000|Overall Study|Withdrawal by Subject|1|||
130220757|NCT04607135|468772246|FG000|Overall Study|Equipment not working|3|||
130220758|NCT06060496|468772247|FG000|Overall Study|Withdrawal by Subject|2|||
130220759|NCT06060496|468772247|FG000|Overall Study|Lost to Follow-up|2|||
130220760|NCT03990051|468772248|FG000|Masked Period|Lost to Follow-up|1|||
130220761|NCT03990051|468772249|FG001|Masked Period|Lost to Follow-up|0|||
130220762|NCT03990051|468772248|FG000|Long Term Period|Death|1|||
130220763|NCT03990051|468772249|FG001|Long Term Period|Death|1|||
130220764|NCT03990051|468772248|FG000|Long Term Period|Lost to Follow-up|7|||
130220765|NCT03990051|468772249|FG001|Long Term Period|Lost to Follow-up|2|||
130220766|NCT00618826|468772250|FG000|Overall Study|Adverse Event|1|||
130220767|NCT03193047|468772252|FG000|Overall Study|Physician Decision|1|||
130220768|NCT03193047|468772253|FG001|Overall Study|Physician Decision|0|||
130220769|NCT03193047|468772252|FG000|Overall Study|Participant Left State|1|||
130220770|NCT03193047|468772253|FG001|Overall Study|Participant Left State|0|||
130220771|NCT01509664|468772256|FG000|Overall Study|Lost to Follow-up|15|||
130220772|NCT01509664|468772257|FG001|Overall Study|Lost to Follow-up|21|||
130220773|NCT00149396|468772264|FG000|Overall Study|Death|15|||
130220774|NCT00149396|468772264|FG000|Overall Study|Withdrawal by Subject|1|||
130220775|NCT00149396|468772264|FG000|Overall Study|Subject noncompliance|2|||
130220776|NCT00149396|468772264|FG000|Overall Study|other treatment|5|||
130220777|NCT02364388|468772265|FG000|Overall Study|Protocol Violation|1|||
130220778|NCT02364388|468772265|FG000|Overall Study|Technical Failure|3|||
130220779|NCT02364388|468772265|FG000|Overall Study|No OA/US data|2|||
130220780|NCT02364388|468772265|FG000|Overall Study|No Biopsy|2|||
130220781|NCT00186485|468772268|FG000|Overall Study|Lost to Follow-up|3|||
130220782|NCT00905424|468772269|FG000|Overall Study|Lost to Follow-up|3|||
130220783|NCT00905424|468772270|FG001|Overall Study|Lost to Follow-up|3|||
130220784|NCT00905424|468772269|FG000|Overall Study|Withdrawal by Subject|1|||
130220785|NCT00905424|468772270|FG001|Overall Study|Withdrawal by Subject|2|||
130220786|NCT00905424|468772269|FG000|Overall Study|Adverse Event|4|||
130220787|NCT00905424|468772270|FG001|Overall Study|Adverse Event|2|||
130220788|NCT00905424|468772269|FG000|Overall Study|Non-compliance with study medication|2|||
130220789|NCT00905424|468772270|FG001|Overall Study|Non-compliance with study medication|0|||
130220790|NCT00905424|468772269|FG000|Overall Study|Sponsor decision|1|||
130220791|NCT00905424|468772270|FG001|Overall Study|Sponsor decision|0|||
130220792|NCT00905424|468772269|FG000|Overall Study|Positive urine drug screen|0|||
130220793|NCT00905424|468772270|FG001|Overall Study|Positive urine drug screen|1|||
130220794|NCT00905424|468772269|FG000|Overall Study|Non-adherence to visit schedule|0|||
130220795|NCT00905424|468772270|FG001|Overall Study|Non-adherence to visit schedule|1|||
130220796|NCT00379899|468772271|FG000|Overall Study|Adverse Event|7|||
130220797|NCT00379899|468772272|FG001|Overall Study|Adverse Event|3|||
130220798|NCT00379899|468772271|FG000|Overall Study|Death|10|||
130220799|NCT00379899|468772272|FG001|Overall Study|Death|10|||
130220800|NCT00379899|468772271|FG000|Overall Study|Lost to Follow-up|2|||
130220801|NCT00379899|468772272|FG001|Overall Study|Lost to Follow-up|4|||
130220802|NCT00379899|468772271|FG000|Overall Study|Physician Decision|3|||
130220803|NCT00379899|468772272|FG001|Overall Study|Physician Decision|4|||
130220804|NCT00379899|468772271|FG000|Overall Study|Withdrawal by Subject|5|||
130220805|NCT00379899|468772272|FG001|Overall Study|Withdrawal by Subject|5|||
130220806|NCT00379899|468772271|FG000|Overall Study|Ineligibility determined|0|||
130220807|NCT00379899|468772272|FG001|Overall Study|Ineligibility determined|1|||
130220808|NCT00379899|468772271|FG000|Overall Study|Noncompliance|1|||
130220809|NCT00379899|468772272|FG001|Overall Study|Noncompliance|1|||
130220810|NCT00379899|468772271|FG000|Overall Study|Parathyroidectomy|0|||
130220811|NCT00379899|468772272|FG001|Overall Study|Parathyroidectomy|2|||
130220812|NCT00379899|468772271|FG000|Overall Study|Renal transplantation|5|||
130220813|NCT00379899|468772272|FG001|Overall Study|Renal transplantation|4|||
130220814|NCT00379899|468772271|FG000|Overall Study|Coronary artery bypass graft|1|||
130220815|NCT00379899|468772272|FG001|Overall Study|Coronary artery bypass graft|1|||
130220816|NCT00379899|468772271|FG000|Overall Study|Other protocol-specified criteria|3|||
130220817|NCT00379899|468772272|FG001|Overall Study|Other protocol-specified criteria|4|||
130220818|NCT00379899|468772271|FG000|Overall Study|Other|3|||
130220819|NCT00379899|468772272|FG001|Overall Study|Other|1|||
130220820|NCT05225389|468772273|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
130220821|NCT03311841|468772274|FG000|14-day Wash-out|Adverse Event|0|||
130220822|NCT03311841|468772275|FG001|14-day Wash-out|Adverse Event|1|||
130220823|NCT03311841|468772276|FG002|14-day Wash-out|Adverse Event|0|||
130220824|NCT03311841|468772277|FG003|14-day Wash-out|Adverse Event|0|||
130220825|NCT03311841|468772278|FG004|14-day Wash-out|Adverse Event|0|||
130220826|NCT03311841|468772274|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220827|NCT03311841|468772275|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220828|NCT03311841|468772276|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
130441442|NCT02058290|469580150|FG001|Overall Study|Protocol Violation|1|||
130441443|NCT02058290|469580149|FG000|Overall Study|Physician Decision|1|||
130441444|NCT02058290|469580150|FG001|Overall Study|Physician Decision|0|||
130441445|NCT02058290|469580149|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
130441446|NCT02058290|469580150|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
130441447|NCT02058290|469580149|FG000|Overall Study|Withdrawal by Subject|0|||
130441448|NCT02058290|469580150|FG001|Overall Study|Withdrawal by Subject|1|||
130441449|NCT05822921|469580153|FG000|Overall Study|Lost to Follow-up|1|||
130220829|NCT03311841|468772277|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
130220830|NCT03311841|468772278|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220831|NCT01026948|468772279|FG000|Overall Study|Physician Decision|8|||
130220832|NCT00627926|468772280|FG000|Overall Study|Adverse Event|26|||
130220833|NCT00627926|468772281|FG001|Overall Study|Adverse Event|37|||
130441450|NCT05822921|469580154|FG001|Overall Study|Lost to Follow-up|1|||
130220834|NCT00627926|468772282|FG002|Overall Study|Adverse Event|36|||
130220835|NCT00627926|468772280|FG000|Overall Study|Death|1|||
130220836|NCT00627926|468772281|FG001|Overall Study|Death|0|||
130220837|NCT00627926|468772282|FG002|Overall Study|Death|0|||
130441451|NCT00544544|469580155|FG000|Overall Study|Withdrawal by Subject|1|||
130220838|NCT00627926|468772280|FG000|Overall Study|Lost to Follow-up|4|||
130220839|NCT00627926|468772281|FG001|Overall Study|Lost to Follow-up|3|||
130220840|NCT00627926|468772282|FG002|Overall Study|Lost to Follow-up|4|||
130220841|NCT00627926|468772280|FG000|Overall Study|Withdrawal by Subject|2|||
130220842|NCT00627926|468772281|FG001|Overall Study|Withdrawal by Subject|1|||
130220843|NCT00627926|468772282|FG002|Overall Study|Withdrawal by Subject|0|||
130220844|NCT00627926|468772280|FG000|Overall Study|Lack of Efficacy|118|||
130220845|NCT00627926|468772281|FG001|Overall Study|Lack of Efficacy|40|||
130220846|NCT00627926|468772282|FG002|Overall Study|Lack of Efficacy|38|||
130220847|NCT00627926|468772280|FG000|Overall Study|Noncompliance/unspecified|8|||
130220848|NCT00627926|468772281|FG001|Overall Study|Noncompliance/unspecified|23|||
130220849|NCT00627926|468772282|FG002|Overall Study|Noncompliance/unspecified|17|||
130220850|NCT03360019|468772290|FG000|Overall Study|Withdrawal by Subject|2|||
130441452|NCT00544544|469580155|FG000|Overall Study|Adverse Event|1|||
130441453|NCT00544544|469580155|FG000|Overall Study|Lost to Follow-up|1|||
130441454|NCT03406702|469580156|FG000|Overall Study|Missed Day 27 Dosing|1|||
130441455|NCT01857622|469580162|FG000|Overall Study|Adverse Event|5|||
130441456|NCT01857622|469580163|FG001|Overall Study|Adverse Event|0|||
130441457|NCT01857622|469580164|FG002|Overall Study|Adverse Event|2|||
130441458|NCT01857622|469580162|FG000|Overall Study|Physician Decision|1|||
130441459|NCT01857622|469580163|FG001|Overall Study|Physician Decision|0|||
130686029|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686030|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686031|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686032|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686033|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686034|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686035|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686036|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686037|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686038|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686039|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
130441460|NCT01857622|469580164|FG002|Overall Study|Physician Decision|0|||
130441461|NCT01857622|469580162|FG000|Overall Study|Protocol Violation|4|||
130441462|NCT01857622|469580163|FG001|Overall Study|Protocol Violation|1|||
130441463|NCT01857622|469580164|FG002|Overall Study|Protocol Violation|0|||
130441464|NCT01857622|469580162|FG000|Overall Study|Withdrawal by Subject|1|||
130441465|NCT01857622|469580163|FG001|Overall Study|Withdrawal by Subject|0|||
130441466|NCT01857622|469580164|FG002|Overall Study|Withdrawal by Subject|0|||
130441467|NCT01291225|469580165|FG000|Overall Study|Lost to Follow-up|85|||
130441468|NCT01291225|469580166|FG001|Overall Study|Lost to Follow-up|39|||
130441469|NCT01267253|469580167|FG000|Overall Study|Ineligible - required test not done|1|||
130441470|NCT01267253|469580167|FG000|Overall Study|Inevaluable-never received study treatme|2|||
130441471|NCT04318093|469580170|FG000|Overall Study|Adverse Event|2|||
130686040|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
130686041|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686042|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686043|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686044|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686045|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686046|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686047|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686048|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686049|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686050|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686051|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686052|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686053|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686054|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686055|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686056|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686057|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130220851|NCT03360019|468772291|FG001|Overall Study|Withdrawal by Subject|0|||
130220852|NCT03360019|468772292|FG002|Overall Study|Withdrawal by Subject|0|||
130220853|NCT03360019|468772290|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
130220854|NCT03360019|468772291|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
130220855|NCT03360019|468772292|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
130220856|NCT01462110|468772293|FG000|Overall Study|Adverse Event|1|||
130441472|NCT04318093|469580171|FG001|Overall Study|Adverse Event|2|||
130441473|NCT04318093|469580170|FG000|Overall Study|Participant withdrew consent|1|||
130220857|NCT01462110|468772294|FG001|Overall Study|Adverse Event|0|||
130220858|NCT00753675|468772295|FG000|Overall Study|other reason|11|||
130220859|NCT00753675|468772296|FG001|Overall Study|other reason|12|||
130220860|NCT00753675|468772297|FG002|Overall Study|other reason|13|||
130220861|NCT00753675|468772295|FG000|Overall Study|Death|1|||
130220862|NCT00753675|468772296|FG001|Overall Study|Death|2|||
130220863|NCT00753675|468772297|FG002|Overall Study|Death|4|||
130220864|NCT00753675|468772295|FG000|Overall Study|Adverse Event|11|||
130220865|NCT00753675|468772296|FG001|Overall Study|Adverse Event|9|||
130220866|NCT00753675|468772297|FG002|Overall Study|Adverse Event|4|||
130220867|NCT00753675|468772295|FG000|Overall Study|Objective progression of disease|35|||
130220868|NCT00753675|468772296|FG001|Overall Study|Objective progression of disease|35|||
130220869|NCT00753675|468772297|FG002|Overall Study|Objective progression of disease|35|||
130220870|NCT00753675|468772295|FG000|Overall Study|Withdrawal by Subject|0|||
130220871|NCT00753675|468772296|FG001|Overall Study|Withdrawal by Subject|1|||
130220872|NCT00753675|468772297|FG002|Overall Study|Withdrawal by Subject|0|||
130220873|NCT00753675|468772295|FG000|Overall Study|Lost to Follow-up|1|||
130220874|NCT00753675|468772296|FG001|Overall Study|Lost to Follow-up|0|||
130220875|NCT00753675|468772297|FG002|Overall Study|Lost to Follow-up|0|||
130220876|NCT02149264|468772303|FG000|Overall Study|Withdrawal by Subject|9|||
130220877|NCT02149264|468772303|FG000|Overall Study|Adverse Event|7|||
130220878|NCT02149264|468772303|FG000|Overall Study|Physician Decision|3|||
130220879|NCT02149264|468772303|FG000|Overall Study|Protocol Violation|1|||
130220880|NCT03283930|468772304|FG000|Overall Study|Scheduling conflict|8|||
130220881|NCT03283930|468772305|FG001|Overall Study|Scheduling conflict|10|||
130220882|NCT03283930|468772304|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130220883|NCT03283930|468772305|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130220884|NCT03283930|468772304|FG000|Overall Study|Technical software issue|2|||
130220885|NCT03283930|468772305|FG001|Overall Study|Technical software issue|2|||
130220886|NCT00805129|468772306|FG000|Overall Study|Not treated|1|||
130220887|NCT02499120|468772310|FG000|Overall Study|Death|52|||
130220888|NCT02499120|468772311|FG001|Overall Study|Death|43|||
130220889|NCT02499120|468772310|FG000|Overall Study|Lost to Follow-up|1|||
130220890|NCT02499120|468772311|FG001|Overall Study|Lost to Follow-up|2|||
130220891|NCT02499120|468772310|FG000|Overall Study|Participant refused further follow-up|1|||
130220892|NCT02499120|468772311|FG001|Overall Study|Participant refused further follow-up|0|||
130220893|NCT02499120|468772310|FG000|Overall Study|Withdrawal by Subject|2|||
130220894|NCT02499120|468772311|FG001|Overall Study|Withdrawal by Subject|5|||
130220895|NCT02499120|468772310|FG000|Overall Study|Other|9|||
130220896|NCT02499120|468772311|FG001|Overall Study|Other|10|||
130220897|NCT01839916|468772320|FG000|Overall Study|Death|9|||
130220898|NCT01839916|468772320|FG000|Overall Study|Physician Decision|17|||
130220899|NCT01839916|468772320|FG000|Overall Study|Relapse|12|||
130441474|NCT04318093|469580171|FG001|Overall Study|Participant withdrew consent|0|||
130441475|NCT04318093|469580170|FG000|Overall Study|Other reasons|0|||
130441476|NCT04318093|469580171|FG001|Overall Study|Other reasons|1|||
130441477|NCT02855164|469580172|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130441478|NCT02855164|469580173|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130441479|NCT02855164|469580174|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130441480|NCT02855164|469580175|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
130441481|NCT02855164|469580176|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130441482|NCT02855164|469580177|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130441483|NCT02855164|469580178|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130441484|NCT02855164|469580179|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130441485|NCT02855164|469580172|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
130441486|NCT02855164|469580173|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
130441487|NCT02855164|469580174|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
130441488|NCT02855164|469580175|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
130220900|NCT01839916|468772320|FG000|Overall Study|GVHD|2|||
130220901|NCT01839916|468772320|FG000|Overall Study|Graft Failure|1|||
130220902|NCT04235504|468772325|FG000|Study Phase|Withdrawal by Subject|5|||
130220903|NCT04235504|468772326|FG001|Study Phase|Withdrawal by Subject|2|||
130220904|NCT04235504|468772327|FG002|Study Phase|Withdrawal by Subject|0|||
130220905|NCT04235504|468772328|FG003|Study Phase|Withdrawal by Subject|0|||
130220906|NCT04235504|468772325|FG000|Continuation Phase|Withdrawal by Subject|0|||
130441489|NCT02855164|469580176|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
130441490|NCT02855164|469580177|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
130220907|NCT04235504|468772326|FG001|Continuation Phase|Withdrawal by Subject|4|||
130220908|NCT04235504|468772327|FG002|Continuation Phase|Withdrawal by Subject|0|||
130220909|NCT04235504|468772328|FG003|Continuation Phase|Withdrawal by Subject|0|||
130220910|NCT04235504|468772325|FG000|Continuation Phase|Adverse Event|0|||
130220911|NCT04235504|468772326|FG001|Continuation Phase|Adverse Event|1|||
130220912|NCT04235504|468772327|FG002|Continuation Phase|Adverse Event|0|||
130220913|NCT04235504|468772328|FG003|Continuation Phase|Adverse Event|0|||
130220914|NCT04235504|468772325|FG000|Continuation Phase|Physician Decision|1|||
130220915|NCT04235504|468772326|FG001|Continuation Phase|Physician Decision|2|||
130220916|NCT04235504|468772327|FG002|Continuation Phase|Physician Decision|1|||
130220917|NCT04235504|468772328|FG003|Continuation Phase|Physician Decision|0|||
130220918|NCT02106351|468772335|FG000|Treatment Cycle 1|Adverse Event|2|||
130220919|NCT02106351|468772336|FG001|Treatment Cycle 1|Adverse Event|0|||
130220920|NCT02106351|468772337|FG002|Treatment Cycle 1|Adverse Event|0|||
130220921|NCT02106351|468772335|FG000|Treatment Cycle 1|Consent withdrawn|1|||
130220922|NCT02106351|468772336|FG001|Treatment Cycle 1|Consent withdrawn|0|||
130220923|NCT02106351|468772337|FG002|Treatment Cycle 1|Consent withdrawn|2|||
130220924|NCT02106351|468772335|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130220925|NCT02106351|468772336|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
130220926|NCT02106351|468772337|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
130220927|NCT02106351|468772335|FG000|Treatment Cycle 1|Other|0|||
130220928|NCT02106351|468772336|FG001|Treatment Cycle 1|Other|3|||
130220929|NCT02106351|468772337|FG002|Treatment Cycle 1|Other|1|||
130220930|NCT02106351|468772335|FG000|Treatment Cycle 1|Randomised but not treated|1|||
130220931|NCT02106351|468772336|FG001|Treatment Cycle 1|Randomised but not treated|0|||
130220932|NCT02106351|468772337|FG002|Treatment Cycle 1|Randomised but not treated|1|||
130220933|NCT02106351|468772335|FG000|Treatment Cycle 2|Adverse Event|0|||
130220934|NCT02106351|468772336|FG001|Treatment Cycle 2|Adverse Event|2|||
130220935|NCT02106351|468772337|FG002|Treatment Cycle 2|Adverse Event|0|||
130220936|NCT02106351|468772335|FG000|Treatment Cycle 2|Consent withdrawn|0|||
130220937|NCT02106351|468772336|FG001|Treatment Cycle 2|Consent withdrawn|1|||
130220938|NCT02106351|468772337|FG002|Treatment Cycle 2|Consent withdrawn|1|||
130220939|NCT02106351|468772335|FG000|Treatment Cycle 2|Other|0|||
130220940|NCT02106351|468772336|FG001|Treatment Cycle 2|Other|2|||
130220941|NCT02106351|468772337|FG002|Treatment Cycle 2|Other|2|||
130220942|NCT02106351|468772335|FG000|Treatment Cycle 3|Adverse Event|0|||
130220943|NCT02106351|468772336|FG001|Treatment Cycle 3|Adverse Event|1|||
130220944|NCT02106351|468772337|FG002|Treatment Cycle 3|Adverse Event|0|||
130220945|NCT02106351|468772335|FG000|Treatment Cycle 3|Consent withdrawn|0|||
130220946|NCT02106351|468772336|FG001|Treatment Cycle 3|Consent withdrawn|0|||
130220947|NCT02106351|468772337|FG002|Treatment Cycle 3|Consent withdrawn|2|||
130220948|NCT02106351|468772335|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
130220949|NCT02106351|468772336|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
130220950|NCT02106351|468772337|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
130220951|NCT02106351|468772335|FG000|Treatment Cycle 3|Other|0|||
130220952|NCT02106351|468772336|FG001|Treatment Cycle 3|Other|2|||
130220953|NCT02106351|468772337|FG002|Treatment Cycle 3|Other|3|||
130220954|NCT02106351|468772335|FG000|Treatment Cycle 4|Consent withdrawn|0|||
130220955|NCT02106351|468772336|FG001|Treatment Cycle 4|Consent withdrawn|0|||
130220956|NCT02106351|468772337|FG002|Treatment Cycle 4|Consent withdrawn|2|||
130220957|NCT02106351|468772335|FG000|Treatment Cycle 4|Other|0|||
130220958|NCT02106351|468772336|FG001|Treatment Cycle 4|Other|1|||
130220959|NCT02106351|468772337|FG002|Treatment Cycle 4|Other|0|||
130220960|NCT00101868|468772338|FG000|Overall Study|Death|10|||
130220961|NCT00101868|468772339|FG001|Overall Study|Death|10|||
130220962|NCT00101868|468772338|FG000|Overall Study|Withdrawal by Subject|8|||
130220963|NCT00101868|468772339|FG001|Overall Study|Withdrawal by Subject|9|||
130220964|NCT00101868|468772338|FG000|Overall Study|Protocol Violation|3|||
130220965|NCT00101868|468772339|FG001|Overall Study|Protocol Violation|0|||
130220966|NCT00101868|468772338|FG000|Overall Study|Lost to Follow-up|8|||
130220967|NCT00101868|468772339|FG001|Overall Study|Lost to Follow-up|13|||
130220968|NCT00069823|468772340|FG000|Overall Study|Did not have follow-up diary cards|6|||
130220969|NCT00069823|468772341|FG001|Overall Study|Did not have follow-up diary cards|3|||
130220970|NCT00520039|468772342|FG000|Overall Study|Exclusion criteria met at first visit|7|||
130220971|NCT00520039|468772343|FG001|Overall Study|Exclusion criteria met at first visit|5|||
130220972|NCT02329327|468772344|FG000|Overall Study|Death|78|||
130220973|NCT02329327|468772345|FG001|Overall Study|Death|0|||
130220974|NCT02329327|468772344|FG000|Overall Study|Withdrawal by Subject|3|||
130220975|NCT02329327|468772345|FG001|Overall Study|Withdrawal by Subject|0|||
130220976|NCT02329327|468772344|FG000|Overall Study|Lost to Follow-up|4|||
130220977|NCT02329327|468772345|FG001|Overall Study|Lost to Follow-up|0|||
130220978|NCT03560869|468772346|FG000|Overall Study|Withdrawal by Subject|3|||
130220979|NCT03560869|468772347|FG001|Overall Study|Withdrawal by Subject|4|||
130220980|NCT03560869|468772346|FG000|Overall Study|Screening failure|4|||
130220981|NCT03560869|468772347|FG001|Overall Study|Screening failure|4|||
130220982|NCT03560869|468772346|FG000|Overall Study|Withdrawal by PI|0|||
130220983|NCT03560869|468772347|FG001|Overall Study|Withdrawal by PI|1|||
130220984|NCT01801111|468772348|FG000|Overall Study|Adverse Event|12|||
130220985|NCT01801111|468772348|FG000|Overall Study|Death|8|||
130220986|NCT01801111|468772348|FG000|Overall Study|Physician Decision|5|||
130220987|NCT01801111|468772348|FG000|Overall Study|Other|1|||
130220988|NCT01801111|468772348|FG000|Overall Study|Withdrawal by Subject|4|||
130220989|NCT01801111|468772348|FG000|Overall Study|Study Terminated by Sponsor|27|||
130220990|NCT01801111|468772348|FG000|Overall Study|Progressive Disease|81|||
130220991|NCT01210482|468772349|FG000|Overall Study|Protocol Violation|1|||
130220992|NCT01210482|468772349|FG000|Overall Study|Case Report Forms were not collected|18|||
130220993|NCT01210482|468772349|FG000|Overall Study|Duplicated|2|||
130220994|NCT01210482|468772349|FG000|Overall Study|No Drug Administration|28|||
130220995|NCT01223937|468772350|FG000|Overall Study|Withdrawal by Subject|3|||
130220996|NCT01223937|468772351|FG001|Overall Study|Withdrawal by Subject|2|||
130220997|NCT01223937|468772350|FG000|Overall Study|Lost to Follow-up|1|||
130220998|NCT01223937|468772351|FG001|Overall Study|Lost to Follow-up|4|||
130220999|NCT01223937|468772350|FG000|Overall Study|Adverse Event|1|||
130221000|NCT01223937|468772351|FG001|Overall Study|Adverse Event|4|||
130221001|NCT01223937|468772350|FG000|Overall Study|Protocol Violation|8|||
130221002|NCT01223937|468772351|FG001|Overall Study|Protocol Violation|7|||
130221003|NCT01223937|468772350|FG000|Overall Study|Other|4|||
130221004|NCT01223937|468772351|FG001|Overall Study|Other|1|||
130221005|NCT03284853|468772353|FG000|Overall Study|Adverse Event|40|||
130221006|NCT03284853|468772354|FG001|Overall Study|Adverse Event|4|||
130221007|NCT03284853|468772353|FG000|Overall Study|Withdrawal by Subject|5|||
130221008|NCT03284853|468772354|FG001|Overall Study|Withdrawal by Subject|1|||
130221009|NCT03284853|468772353|FG000|Overall Study|Lost to Follow-up|1|||
130221010|NCT03284853|468772354|FG001|Overall Study|Lost to Follow-up|0|||
130221011|NCT03284853|468772353|FG000|Overall Study|Lack of Efficacy|1|||
130221012|NCT03284853|468772354|FG001|Overall Study|Lack of Efficacy|0|||
130221013|NCT03284853|468772353|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130221014|NCT03284853|468772354|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130221015|NCT03284853|468772353|FG000|Overall Study|Protocol Violation|3|||
130221016|NCT03284853|468772354|FG001|Overall Study|Protocol Violation|3|||
130221017|NCT03284853|468772353|FG000|Overall Study|Death|0|||
130221018|NCT03284853|468772354|FG001|Overall Study|Death|1|||
130221019|NCT03284853|468772353|FG000|Overall Study|Other - Reason not reported in CSR|4|||
130221020|NCT03284853|468772354|FG001|Overall Study|Other - Reason not reported in CSR|3|||
130221021|NCT05176717|468772355|FG000|Overall Study|Sponsor Decision|1|||
130221022|NCT05176717|468772356|FG001|Overall Study|Sponsor Decision|2|||
130221023|NCT05176717|468772357|FG002|Overall Study|Sponsor Decision|2|||
130221024|NCT02308228|468772359|FG000|Overall Study|Adverse Event|3|||
130221025|NCT02308228|468772360|FG001|Overall Study|Adverse Event|4|||
130221026|NCT02308228|468772359|FG000|Overall Study|Withdrawal by Subject|5|||
130221027|NCT02308228|468772360|FG001|Overall Study|Withdrawal by Subject|3|||
130221028|NCT03999749|468772363|FG000|Overall Study|Toxicity|16|||
130221029|NCT03999749|468772363|FG000|Overall Study|Withdrawal by Subject|3|||
130221030|NCT03999749|468772363|FG000|Overall Study|Disease progression|26|||
130221031|NCT03999749|468772363|FG000|Overall Study|Physician Decision|4|||
130221032|NCT03999749|468772363|FG000|Overall Study|Death|5|||
130221033|NCT03999749|468772363|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
130221034|NCT00255164|468772364|FG000|Overall Study|Adverse Event|10|||
130221035|NCT00255164|468772365|FG001|Overall Study|Adverse Event|6|||
130221036|NCT00255164|468772366|FG002|Overall Study|Adverse Event|9|||
130221037|NCT00255164|468772364|FG000|Overall Study|Lost to Follow-up|4|||
130221038|NCT00255164|468772365|FG001|Overall Study|Lost to Follow-up|3|||
130221039|NCT00255164|468772366|FG002|Overall Study|Lost to Follow-up|4|||
130221040|NCT00255164|468772364|FG000|Overall Study|Withdrawal by Subject|18|||
130221041|NCT00255164|468772365|FG001|Overall Study|Withdrawal by Subject|17|||
130221042|NCT00255164|468772366|FG002|Overall Study|Withdrawal by Subject|8|||
130221043|NCT00255164|468772364|FG000|Overall Study|Noncompliance|0|||
130221044|NCT00255164|468772365|FG001|Overall Study|Noncompliance|1|||
130441491|NCT02855164|469580178|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
130221045|NCT00255164|468772366|FG002|Overall Study|Noncompliance|2|||
130221046|NCT00255164|468772364|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130221047|NCT00255164|468772365|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130221048|NCT00255164|468772366|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130221049|NCT00255164|468772364|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130221050|NCT00255164|468772365|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130221051|NCT00255164|468772366|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130221052|NCT00255164|468772364|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130221053|NCT00255164|468772365|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130354309|NCT01083485|469269459|FG000|Overall Study|Withdrawal by Subject|5|||
130354310|NCT01083485|469269460|FG001|Overall Study|Withdrawal by Subject|2|||
130354311|NCT01083485|469269459|FG000|Overall Study|Other|1|||
130354312|NCT01083485|469269460|FG001|Overall Study|Other|0|||
130354313|NCT00084838|469269461|FG000|Overall Study|Death|1|||
130354314|NCT00084838|469269461|FG000|Overall Study|Adverse Event|2|||
130354315|NCT00084838|469269461|FG000|Overall Study|Withdrawal by Subject|1|||
130354316|NCT00084838|469269461|FG000|Overall Study|Progressive Disease|4|||
130354317|NCT00084838|469269461|FG000|Overall Study|Pt Non-Compliance|1|||
130221054|NCT00255164|468772366|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130221055|NCT00255164|468772364|FG000|Overall Study|Esophageal Stricture|0|||
130221056|NCT00255164|468772365|FG001|Overall Study|Esophageal Stricture|0|||
130221057|NCT00255164|468772366|FG002|Overall Study|Esophageal Stricture|1|||
130221058|NCT00255164|468772364|FG000|Overall Study|Therapeutic Failure|11|||
130354318|NCT00084838|469269461|FG000|Overall Study|Ineligible|4|||
130354319|NCT00122278|469269462|FG000|Overall Study|Lost to Follow-up|2|||
130354320|NCT00122278|469269463|FG001|Overall Study|Lost to Follow-up|0|||
130221059|NCT00255164|468772365|FG001|Overall Study|Therapeutic Failure|2|||
130441492|NCT02855164|469580179|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
130441493|NCT02855164|469580172|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
130441494|NCT02855164|469580173|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
130441495|NCT02855164|469580174|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
130441496|NCT02855164|469580175|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
130441497|NCT02855164|469580176|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
130441498|NCT02855164|469580177|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
130441499|NCT02855164|469580178|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
130441500|NCT02855164|469580179|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
130441501|NCT02855164|469580172|FG000|Part C (Randomized Set)|Adverse Event|0|||
130441502|NCT02855164|469580173|FG001|Part C (Randomized Set)|Adverse Event|0|||
130441503|NCT02855164|469580174|FG002|Part C (Randomized Set)|Adverse Event|0|||
130441504|NCT02855164|469580175|FG003|Part C (Randomized Set)|Adverse Event|0|||
130441505|NCT02855164|469580176|FG004|Part C (Randomized Set)|Adverse Event|0|||
130686058|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686059|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686060|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130686061|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130686062|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686063|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686064|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686065|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686066|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686067|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686068|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686069|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686070|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686071|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686072|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686073|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686074|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686075|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686076|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686077|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686078|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686079|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686080|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
130686081|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
130686082|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
130686083|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686084|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686085|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686086|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686087|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686088|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686089|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686090|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686091|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
130221060|NCT00255164|468772366|FG002|Overall Study|Therapeutic Failure|3|||
130221061|NCT05219968|468772367|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
130441506|NCT02855164|469580177|FG005|Part C (Randomized Set)|Adverse Event|5|||
130441507|NCT02855164|469580178|FG006|Part C (Randomized Set)|Adverse Event|9|||
130441508|NCT02855164|469580179|FG007|Part C (Randomized Set)|Adverse Event|2|||
130441509|NCT02855164|469580172|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
130441510|NCT02855164|469580173|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
130441511|NCT02855164|469580174|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
130441512|NCT02855164|469580175|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
130441513|NCT02855164|469580176|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
130441514|NCT02855164|469580177|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
130686092|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686093|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686094|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686095|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686096|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
130441515|NCT02855164|469580178|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
130441516|NCT02855164|469580179|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
130552801|NCT00792805|469991536|FG002|Overall Study|Protocol deviation|1|||
130221062|NCT05219968|468772368|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221063|NCT05219968|468772369|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221064|NCT05219968|468772370|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221065|NCT05219968|468772371|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221066|NCT05219968|468772367|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
130221067|NCT05219968|468772368|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221068|NCT05219968|468772369|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221069|NCT05219968|468772370|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221070|NCT05219968|468772371|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221071|NCT05219968|468772367|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
130221072|NCT05219968|468772368|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
130221073|NCT05219968|468772369|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221074|NCT05219968|468772370|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221075|NCT05219968|468772371|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221076|NCT05219968|468772367|FG000|Week 24 Treatment Period|Adverse Event|3|||
130221077|NCT05219968|468772368|FG001|Week 24 Treatment Period|Adverse Event|0|||
130221078|NCT05219968|468772369|FG002|Week 24 Treatment Period|Adverse Event|0|||
130221079|NCT05219968|468772370|FG003|Week 24 Treatment Period|Adverse Event|0|||
130354321|NCT03607422|469269467|FG000|Overall Study|Adverse Event|7|||
130354322|NCT03607422|469269468|FG001|Overall Study|Adverse Event|3|||
130221080|NCT05219968|468772371|FG004|Week 24 Treatment Period|Adverse Event|0|||
130441517|NCT02855164|469580172|FG000|Part C (Randomized Set)|Physician Decision|0|||
130441518|NCT02855164|469580173|FG001|Part C (Randomized Set)|Physician Decision|0|||
130441519|NCT02855164|469580174|FG002|Part C (Randomized Set)|Physician Decision|0|||
130441520|NCT02855164|469580175|FG003|Part C (Randomized Set)|Physician Decision|0|||
130441521|NCT02855164|469580176|FG004|Part C (Randomized Set)|Physician Decision|0|||
130441522|NCT02855164|469580177|FG005|Part C (Randomized Set)|Physician Decision|1|||
130441523|NCT02855164|469580178|FG006|Part C (Randomized Set)|Physician Decision|0|||
130441524|NCT02855164|469580179|FG007|Part C (Randomized Set)|Physician Decision|1|||
130441525|NCT02855164|469580172|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
130441526|NCT02855164|469580173|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
130441527|NCT02855164|469580174|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
130441528|NCT02855164|469580175|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
130441529|NCT02855164|469580176|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
130441530|NCT02855164|469580177|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
130441531|NCT02855164|469580178|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
130441532|NCT02855164|469580179|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
130441533|NCT00876460|469580180|FG000|Combination Therapy Phase|Progressive disease|2|||
130441534|NCT00876460|469580181|FG001|Combination Therapy Phase|Progressive disease|3|||
130441535|NCT00876460|469580182|FG002|Combination Therapy Phase|Progressive disease|3|||
130441536|NCT00876460|469580183|FG003|Combination Therapy Phase|Progressive disease|3|||
130441537|NCT00876460|469580184|FG004|Combination Therapy Phase|Progressive disease|3|||
130441538|NCT00876460|469580185|FG005|Combination Therapy Phase|Progressive disease|1|||
130441539|NCT00876460|469580186|FG006|Combination Therapy Phase|Progressive disease|1|||
130441540|NCT00876460|469580187|FG007|Combination Therapy Phase|Progressive disease|1|||
130441541|NCT00876460|469580180|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
130441542|NCT00876460|469580181|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
130441543|NCT00876460|469580182|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
130441544|NCT00876460|469580183|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
130441545|NCT00876460|469580184|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
130441546|NCT00876460|469580185|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
130221081|NCT05219968|468772367|FG000|Week 24 Treatment Period|Physician Decision|0|||
130354323|NCT03607422|469269469|FG002|Overall Study|Adverse Event|2|||
130354324|NCT03607422|469269470|FG003|Overall Study|Adverse Event|0|||
130354325|NCT03607422|469269471|FG004|Overall Study|Adverse Event|2|||
130354326|NCT03607422|469269472|FG005|Overall Study|Adverse Event|0|||
130354327|NCT03607422|469269467|FG000|Overall Study|Withdrawal by Subject|11|||
130354328|NCT03607422|469269468|FG001|Overall Study|Withdrawal by Subject|3|||
130354329|NCT03607422|469269469|FG002|Overall Study|Withdrawal by Subject|6|||
130441547|NCT00876460|469580186|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
130441548|NCT00876460|469580187|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
130441549|NCT00876460|469580180|FG000|Combination Therapy Phase|Adverse Event|0|||
130441550|NCT00876460|469580181|FG001|Combination Therapy Phase|Adverse Event|2|||
130441551|NCT00876460|469580182|FG002|Combination Therapy Phase|Adverse Event|0|||
130441552|NCT00876460|469580183|FG003|Combination Therapy Phase|Adverse Event|2|||
130441553|NCT00876460|469580184|FG004|Combination Therapy Phase|Adverse Event|2|||
130221082|NCT05219968|468772368|FG001|Week 24 Treatment Period|Physician Decision|1|||
130221083|NCT05219968|468772369|FG002|Week 24 Treatment Period|Physician Decision|0|||
130354330|NCT03607422|469269470|FG003|Overall Study|Withdrawal by Subject|2|||
130354331|NCT03607422|469269471|FG004|Overall Study|Withdrawal by Subject|0|||
130441554|NCT00876460|469580185|FG005|Combination Therapy Phase|Adverse Event|0|||
130221084|NCT05219968|468772370|FG003|Week 24 Treatment Period|Physician Decision|0|||
130221085|NCT05219968|468772371|FG004|Week 24 Treatment Period|Physician Decision|0|||
130221086|NCT05219968|468772367|FG000|Week 24 Treatment Period|Other, not specified|3|||
130221087|NCT05219968|468772368|FG001|Week 24 Treatment Period|Other, not specified|0|||
130221088|NCT05219968|468772369|FG002|Week 24 Treatment Period|Other, not specified|0|||
130221089|NCT05219968|468772370|FG003|Week 24 Treatment Period|Other, not specified|0|||
130221090|NCT05219968|468772371|FG004|Week 24 Treatment Period|Other, not specified|0|||
130221091|NCT05219968|468772367|FG000|Safety Extension Period|Treatment administration failure|0|||
130221092|NCT05219968|468772368|FG001|Safety Extension Period|Treatment administration failure|0|||
130221093|NCT05219968|468772369|FG002|Safety Extension Period|Treatment administration failure|0|||
130221094|NCT05219968|468772370|FG003|Safety Extension Period|Treatment administration failure|1|||
130221095|NCT05219968|468772371|FG004|Safety Extension Period|Treatment administration failure|4|||
130221096|NCT05219968|468772367|FG000|Safety Extension Period|Bilateral dislodgement|0|||
130221097|NCT05219968|468772368|FG001|Safety Extension Period|Bilateral dislodgement|0|||
130221098|NCT05219968|468772369|FG002|Safety Extension Period|Bilateral dislodgement|4|||
130221099|NCT05219968|468772370|FG003|Safety Extension Period|Bilateral dislodgement|0|||
130221100|NCT05219968|468772371|FG004|Safety Extension Period|Bilateral dislodgement|1|||
130221101|NCT05219968|468772367|FG000|Safety Extension Period|Withdrawal by Subject|0|||
130221102|NCT05219968|468772368|FG001|Safety Extension Period|Withdrawal by Subject|0|||
130221103|NCT05219968|468772369|FG002|Safety Extension Period|Withdrawal by Subject|2|||
130221104|NCT05219968|468772370|FG003|Safety Extension Period|Withdrawal by Subject|0|||
130221105|NCT05219968|468772371|FG004|Safety Extension Period|Withdrawal by Subject|4|||
130221106|NCT05219968|468772367|FG000|Safety Extension Period|Adverse Event|0|||
130221107|NCT05219968|468772368|FG001|Safety Extension Period|Adverse Event|0|||
130221108|NCT05219968|468772369|FG002|Safety Extension Period|Adverse Event|2|||
130221109|NCT05219968|468772370|FG003|Safety Extension Period|Adverse Event|1|||
130221110|NCT05219968|468772371|FG004|Safety Extension Period|Adverse Event|1|||
130221111|NCT05219968|468772367|FG000|Safety Extension Period|Lost to Follow-up|0|||
130221112|NCT05219968|468772368|FG001|Safety Extension Period|Lost to Follow-up|0|||
130221113|NCT05219968|468772369|FG002|Safety Extension Period|Lost to Follow-up|0|||
130221114|NCT05219968|468772370|FG003|Safety Extension Period|Lost to Follow-up|1|||
130221115|NCT05219968|468772371|FG004|Safety Extension Period|Lost to Follow-up|0|||
130221116|NCT04587336|468772372|FG000|Overall Study|Lost to Follow-up|1|||
130221117|NCT04587336|468772373|FG001|Overall Study|Lost to Follow-up|0|||
130221118|NCT03512353|468774323|FG000|Overall Study|Sponsor Decision|3|||
130221119|NCT03512353|468774323|FG000|Overall Study|Death|1|||
130221120|NCT01845597|468774324|FG000|Overall Study|Death|8|||
130221121|NCT01845597|468774324|FG000|Overall Study|Lost to Follow-up|22|||
130221122|NCT02581488|468774328|FG000|Overall Study|Adverse Event|6|||
130221123|NCT02581488|468774329|FG001|Overall Study|Adverse Event|7|||
130221124|NCT02581488|468774328|FG000|Overall Study|Lost to Follow-up|1|||
130221125|NCT02581488|468774329|FG001|Overall Study|Lost to Follow-up|0|||
130221126|NCT02581488|468774328|FG000|Overall Study|Withdrawal by Subject|1|||
130221127|NCT02581488|468774329|FG001|Overall Study|Withdrawal by Subject|0|||
130221128|NCT02581488|468774328|FG000|Overall Study|Non-Compliance|1|||
130221129|NCT02581488|468774329|FG001|Overall Study|Non-Compliance|0|||
130221130|NCT02581488|468774328|FG000|Overall Study|Protocol Violation|0|||
130221131|NCT02581488|468774329|FG001|Overall Study|Protocol Violation|4|||
130221132|NCT01877668|468774330|FG000|Overall Study|Death|0|||
130221133|NCT01877668|468774331|FG001|Overall Study|Death|0|||
130221134|NCT01877668|468774332|FG002|Overall Study|Death|0|||
130221135|NCT01877668|468774333|FG003|Overall Study|Death|1|||
130221136|NCT01877668|468774334|FG004|Overall Study|Death|0|||
130221137|NCT01877668|468774330|FG000|Overall Study|No longer met study criteria|1|||
130221138|NCT01877668|468774331|FG001|Overall Study|No longer met study criteria|0|||
130221139|NCT01877668|468774332|FG002|Overall Study|No longer met study criteria|1|||
130221140|NCT01877668|468774333|FG003|Overall Study|No longer met study criteria|0|||
130221141|NCT01877668|468774334|FG004|Overall Study|No longer met study criteria|0|||
130221142|NCT01877668|468774330|FG000|Overall Study|Insufficient clinical response|0|||
130354332|NCT03607422|469269472|FG005|Overall Study|Withdrawal by Subject|0|||
130354333|NCT03607422|469269467|FG000|Overall Study|Lost to Follow-up|0|||
130354334|NCT03607422|469269468|FG001|Overall Study|Lost to Follow-up|0|||
130354335|NCT03607422|469269469|FG002|Overall Study|Lost to Follow-up|1|||
130354336|NCT03607422|469269470|FG003|Overall Study|Lost to Follow-up|0|||
130354337|NCT03607422|469269471|FG004|Overall Study|Lost to Follow-up|0|||
130221143|NCT01877668|468774331|FG001|Overall Study|Insufficient clinical response|1|||
130221144|NCT01877668|468774332|FG002|Overall Study|Insufficient clinical response|2|||
130221145|NCT01877668|468774333|FG003|Overall Study|Insufficient clinical response|2|||
130221146|NCT01877668|468774334|FG004|Overall Study|Insufficient clinical response|0|||
130221147|NCT01877668|468774330|FG000|Overall Study|Lost to Follow-up|0|||
130221148|NCT01877668|468774331|FG001|Overall Study|Lost to Follow-up|2|||
130221149|NCT01877668|468774332|FG002|Overall Study|Lost to Follow-up|1|||
130354338|NCT03607422|469269472|FG005|Overall Study|Lost to Follow-up|0|||
130354339|NCT03607422|469269467|FG000|Overall Study|Other|12|||
130354340|NCT03607422|469269468|FG001|Overall Study|Other|4|||
130221150|NCT01877668|468774333|FG003|Overall Study|Lost to Follow-up|0|||
130221151|NCT01877668|468774334|FG004|Overall Study|Lost to Follow-up|0|||
130221152|NCT01877668|468774330|FG000|Overall Study|Withdrawal by Subject|2|||
130221153|NCT01877668|468774331|FG001|Overall Study|Withdrawal by Subject|0|||
130221154|NCT01877668|468774332|FG002|Overall Study|Withdrawal by Subject|3|||
130221155|NCT01877668|468774333|FG003|Overall Study|Withdrawal by Subject|2|||
130221156|NCT01877668|468774334|FG004|Overall Study|Withdrawal by Subject|2|||
130221157|NCT01877668|468774330|FG000|Overall Study|Other|1|||
130221158|NCT01877668|468774331|FG001|Overall Study|Other|1|||
130221159|NCT01877668|468774332|FG002|Overall Study|Other|1|||
130221160|NCT01877668|468774333|FG003|Overall Study|Other|1|||
130221161|NCT01877668|468774334|FG004|Overall Study|Other|3|||
130221162|NCT01877668|468774330|FG000|Overall Study|Protocol Violation|1|||
130221163|NCT01877668|468774331|FG001|Overall Study|Protocol Violation|1|||
130221164|NCT01877668|468774332|FG002|Overall Study|Protocol Violation|0|||
130221165|NCT01877668|468774333|FG003|Overall Study|Protocol Violation|0|||
130221166|NCT01877668|468774334|FG004|Overall Study|Protocol Violation|3|||
130221167|NCT01877668|468774330|FG000|Overall Study|Adverse event related to study drug|2|||
130221168|NCT01877668|468774331|FG001|Overall Study|Adverse event related to study drug|2|||
130221169|NCT01877668|468774332|FG002|Overall Study|Adverse event related to study drug|2|||
130221170|NCT01877668|468774333|FG003|Overall Study|Adverse event related to study drug|2|||
130221171|NCT01877668|468774334|FG004|Overall Study|Adverse event related to study drug|1|||
130221172|NCT01877668|468774330|FG000|Overall Study|Adverse event unrelated to study drug|4|||
130221173|NCT01877668|468774331|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130221174|NCT01877668|468774332|FG002|Overall Study|Adverse event unrelated to study drug|2|||
130221175|NCT01877668|468774333|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130221176|NCT01877668|468774334|FG004|Overall Study|Adverse event unrelated to study drug|1|||
130221177|NCT03286218|468774365|FG000|Qualification Phase Period 1|Adverse Event|1|||
130221178|NCT03286218|468774366|FG001|Qualification Phase Period 1|Adverse Event|0|||
130221179|NCT03286218|468774367|FG002|Qualification Phase Period 1|Adverse Event|0|||
130354341|NCT03607422|469269469|FG002|Overall Study|Other|1|||
130354342|NCT03607422|469269470|FG003|Overall Study|Other|2|||
130354343|NCT03607422|469269471|FG004|Overall Study|Other|0|||
130354344|NCT03607422|469269472|FG005|Overall Study|Other|2|||
130354345|NCT03607422|469269467|FG000|Overall Study|Ongoing at Time of Analysis|8|||
130354346|NCT03607422|469269468|FG001|Overall Study|Ongoing at Time of Analysis|0|||
130354347|NCT03607422|469269469|FG002|Overall Study|Ongoing at Time of Analysis|2|||
130354348|NCT03607422|469269470|FG003|Overall Study|Ongoing at Time of Analysis|1|||
130354349|NCT03607422|469269471|FG004|Overall Study|Ongoing at Time of Analysis|1|||
130354350|NCT03607422|469269472|FG005|Overall Study|Ongoing at Time of Analysis|1|||
130354351|NCT03228420|469269479|FG000|Overall Study|Lost to Follow-up|5|||
130354352|NCT03228420|469269480|FG001|Overall Study|Lost to Follow-up|3|||
130354353|NCT03228420|469269479|FG000|Overall Study|Withdrawal by Subject|10|||
130354354|NCT03228420|469269480|FG001|Overall Study|Withdrawal by Subject|0|||
130354355|NCT03228420|469269479|FG000|Overall Study|Adverse Event|5|||
130354356|NCT03228420|469269480|FG001|Overall Study|Adverse Event|2|||
130354357|NCT02428608|469269481|FG000|Overall Study|Pregnancy|2|||
130354358|NCT02428608|469269481|FG000|Overall Study|Lost to Follow-up|37|||
130354359|NCT02428608|469269481|FG000|Overall Study|Withdrawal by Subject|2|||
130354360|NCT02428608|469269481|FG000|Overall Study|scheduling conflicts|15|||
130354361|NCT02428608|469269481|FG000|Overall Study|moved away|10|||
130354362|NCT02428608|469269481|FG000|Overall Study|Death|1|||
130354363|NCT02428608|469269481|FG000|Overall Study|various|16|||
130354364|NCT03468985|469269482|FG000|Overall Study|Adverse Event|0|||
130354365|NCT03468985|469269483|FG001|Overall Study|Adverse Event|2|||
130354366|NCT03468985|469269484|FG002|Overall Study|Adverse Event|0|||
130354367|NCT03468985|469269485|FG003|Overall Study|Adverse Event|0|||
130354368|NCT03468985|469269482|FG000|Overall Study|Withdrawal by Subject|0|||
130354369|NCT03468985|469269483|FG001|Overall Study|Withdrawal by Subject|0|||
130354370|NCT03468985|469269484|FG002|Overall Study|Withdrawal by Subject|0|||
130354371|NCT03468985|469269485|FG003|Overall Study|Withdrawal by Subject|1|||
130354372|NCT00085709|469269486|FG000|Overall Study|Adverse Event|8|||
130354373|NCT00085709|469269487|FG001|Overall Study|Adverse Event|0|||
130354374|NCT00085709|469269486|FG000|Overall Study|Death|8|||
130354375|NCT00085709|469269487|FG001|Overall Study|Death|2|||
130354376|NCT00085709|469269486|FG000|Overall Study|Refusal unrelated to adverse events|1|||
130221180|NCT03286218|468774368|FG003|Qualification Phase Period 1|Adverse Event|0|||
130221181|NCT03286218|468774369|FG004|Qualification Phase Period 1|Adverse Event|0|||
130221182|NCT03286218|468774370|FG005|Qualification Phase Period 1|Adverse Event|0|||
130221183|NCT03286218|468774371|FG006|Qualification Phase Period 1|Adverse Event|0|||
130354377|NCT00085709|469269487|FG001|Overall Study|Refusal unrelated to adverse events|2|||
130354378|NCT00085709|469269486|FG000|Overall Study|Progression|3|||
130354379|NCT00085709|469269487|FG001|Overall Study|Progression|4|||
130354380|NCT00085709|469269486|FG000|Overall Study|Not protocol specified|12|||
130354381|NCT00085709|469269487|FG001|Overall Study|Not protocol specified|22|||
130354382|NCT00085709|469269486|FG000|Overall Study|Not eligible|19|||
130354383|NCT00085709|469269487|FG001|Overall Study|Not eligible|19|||
130221184|NCT03286218|468774372|FG007|Qualification Phase Period 1|Adverse Event|0|||
130221185|NCT03286218|468774373|FG008|Qualification Phase Period 1|Adverse Event|0|||
130221186|NCT03286218|468774374|FG009|Qualification Phase Period 1|Adverse Event|0|||
130221187|NCT03286218|468774375|FG010|Qualification Phase Period 1|Adverse Event|0|||
130221188|NCT03286218|468774376|FG011|Qualification Phase Period 1|Adverse Event|0|||
130221189|NCT03286218|468774365|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221190|NCT03286218|468774366|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
130221191|NCT03286218|468774367|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221192|NCT03286218|468774368|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221193|NCT03286218|468774369|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221194|NCT03286218|468774370|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221195|NCT03286218|468774371|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221196|NCT03286218|468774372|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221197|NCT03286218|468774373|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221198|NCT03286218|468774374|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221199|NCT03286218|468774375|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221200|NCT03286218|468774376|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221201|NCT03286218|468774365|FG000|Qualification Phase Period 2|Adverse Event|0|||
130221202|NCT03286218|468774366|FG001|Qualification Phase Period 2|Adverse Event|1|||
130221203|NCT03286218|468774367|FG002|Qualification Phase Period 2|Adverse Event|0|||
130221204|NCT03286218|468774368|FG003|Qualification Phase Period 2|Adverse Event|0|||
130221205|NCT03286218|468774369|FG004|Qualification Phase Period 2|Adverse Event|0|||
130221206|NCT03286218|468774370|FG005|Qualification Phase Period 2|Adverse Event|0|||
130221207|NCT03286218|468774371|FG006|Qualification Phase Period 2|Adverse Event|0|||
130221208|NCT03286218|468774372|FG007|Qualification Phase Period 2|Adverse Event|0|||
130221209|NCT03286218|468774373|FG008|Qualification Phase Period 2|Adverse Event|0|||
130221210|NCT03286218|468774374|FG009|Qualification Phase Period 2|Adverse Event|0|||
130221211|NCT03286218|468774375|FG010|Qualification Phase Period 2|Adverse Event|0|||
130221212|NCT03286218|468774376|FG011|Qualification Phase Period 2|Adverse Event|0|||
130221213|NCT03286218|468774365|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
130221214|NCT03286218|468774366|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
130221215|NCT03286218|468774367|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221216|NCT03286218|468774368|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221217|NCT03286218|468774369|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221218|NCT03286218|468774370|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221219|NCT03286218|468774371|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221220|NCT03286218|468774372|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221221|NCT03286218|468774373|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221222|NCT03286218|468774374|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221223|NCT03286218|468774375|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221224|NCT03286218|468774376|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221225|NCT03286218|468774365|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
130221226|NCT03286218|468774366|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
130221227|NCT03286218|468774367|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
130221228|NCT03286218|468774368|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
130221229|NCT03286218|468774369|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
130221230|NCT03286218|468774370|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
130221231|NCT03286218|468774371|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
130221232|NCT03286218|468774372|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
130221233|NCT03286218|468774373|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
130354384|NCT00085709|469269486|FG000|Overall Study|Withdrawal by Subject|2|||
130354385|NCT00085709|469269487|FG001|Overall Study|Withdrawal by Subject|1|||
130354386|NCT00397943|469269488|FG000|Overall Study|Unspecified reasons|12|||
130354387|NCT00397943|469269489|FG001|Overall Study|Unspecified reasons|9|||
130354388|NCT00397943|469269490|FG002|Overall Study|Unspecified reasons|0|||
130354389|NCT00397943|469269491|FG003|Overall Study|Unspecified reasons|0|||
130354390|NCT00397943|469269492|FG004|Overall Study|Unspecified reasons|0|||
130354391|NCT04521777|469269493|FG000|Overall Study|Death|2|||
130354392|NCT04521777|469269493|FG000|Overall Study|Withdrawal by Subject|2|||
130354393|NCT03139604|469269496|FG000|Overall Study|Other|7|||
130221234|NCT03286218|468774374|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
130221235|NCT03286218|468774375|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
130221236|NCT03286218|468774376|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
130354394|NCT03139604|469269497|FG001|Overall Study|Other|3|||
130354395|NCT03139604|469269496|FG000|Overall Study|Withdrawal by Subject|16|||
130354396|NCT03139604|469269497|FG001|Overall Study|Withdrawal by Subject|17|||
130354397|NCT03139604|469269496|FG000|Overall Study|Physician Decision|1|||
130441555|NCT00876460|469580186|FG006|Combination Therapy Phase|Adverse Event|3|||
130441556|NCT00876460|469580187|FG007|Combination Therapy Phase|Adverse Event|2|||
130221237|NCT03286218|468774365|FG000|Qualification Phase Period 2|Protocol Violation|2|||
130221238|NCT03286218|468774366|FG001|Qualification Phase Period 2|Protocol Violation|0|||
130221239|NCT03286218|468774367|FG002|Qualification Phase Period 2|Protocol Violation|0|||
130221240|NCT03286218|468774368|FG003|Qualification Phase Period 2|Protocol Violation|0|||
130221241|NCT03286218|468774369|FG004|Qualification Phase Period 2|Protocol Violation|0|||
130221242|NCT03286218|468774370|FG005|Qualification Phase Period 2|Protocol Violation|0|||
130221243|NCT03286218|468774371|FG006|Qualification Phase Period 2|Protocol Violation|0|||
130221244|NCT03286218|468774372|FG007|Qualification Phase Period 2|Protocol Violation|0|||
130221245|NCT03286218|468774373|FG008|Qualification Phase Period 2|Protocol Violation|0|||
130221246|NCT03286218|468774374|FG009|Qualification Phase Period 2|Protocol Violation|0|||
130221247|NCT03286218|468774375|FG010|Qualification Phase Period 2|Protocol Violation|0|||
130221248|NCT03286218|468774376|FG011|Qualification Phase Period 2|Protocol Violation|0|||
130221249|NCT03286218|468774365|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
130221250|NCT03286218|468774366|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
130221251|NCT03286218|468774367|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221252|NCT03286218|468774368|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221253|NCT03286218|468774369|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221254|NCT03286218|468774370|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221255|NCT03286218|468774371|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221256|NCT03286218|468774372|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221257|NCT03286218|468774373|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221258|NCT03286218|468774374|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221259|NCT03286218|468774375|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221260|NCT03286218|468774376|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221261|NCT03286218|468774365|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221262|NCT03286218|468774366|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221263|NCT03286218|468774367|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221264|NCT03286218|468774368|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221265|NCT03286218|468774369|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
130354398|NCT03139604|469269497|FG001|Overall Study|Physician Decision|2|||
130354399|NCT03139604|469269496|FG000|Overall Study|Lost to Follow-up|3|||
130354400|NCT03139604|469269497|FG001|Overall Study|Lost to Follow-up|1|||
130354401|NCT03139604|469269496|FG000|Overall Study|Death|65|||
130441557|NCT00876460|469580180|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
130441558|NCT00876460|469580181|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
130221266|NCT03286218|468774370|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
130354402|NCT03139604|469269497|FG001|Overall Study|Death|67|||
130354403|NCT03139604|469269496|FG000|Overall Study|Study Terminated by Sponsor|122|||
130354404|NCT03139604|469269497|FG001|Overall Study|Study Terminated by Sponsor|127|||
130354405|NCT03139604|469269496|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
130354406|NCT03139604|469269497|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
130354407|NCT04950608|469269498|FG000|Overall Study|Withdrawal by Subject|2|||
130354408|NCT04950608|469269498|FG000|Overall Study|Physician Decision|3|||
130354409|NCT02007512|469269499|FG000|Double Blind Treatment Period|Adverse Event|4|||
130354410|NCT02007512|469269500|FG001|Double Blind Treatment Period|Adverse Event|6|||
130354411|NCT02007512|469269501|FG002|Double Blind Treatment Period|Adverse Event|2|||
130354412|NCT02007512|469269502|FG003|Double Blind Treatment Period|Adverse Event|2|||
130354413|NCT02007512|469269499|FG000|Double Blind Treatment Period|Death|1|||
130354414|NCT02007512|469269500|FG001|Double Blind Treatment Period|Death|0|||
130354415|NCT02007512|469269501|FG002|Double Blind Treatment Period|Death|0|||
130354416|NCT02007512|469269502|FG003|Double Blind Treatment Period|Death|0|||
130354417|NCT02007512|469269499|FG000|Double Blind Treatment Period|Disease progression|51|||
130354418|NCT02007512|469269500|FG001|Double Blind Treatment Period|Disease progression|50|||
130354419|NCT02007512|469269501|FG002|Double Blind Treatment Period|Disease progression|57|||
130354420|NCT02007512|469269502|FG003|Double Blind Treatment Period|Disease progression|52|||
130354421|NCT02007512|469269499|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354422|NCT02007512|469269500|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354423|NCT02007512|469269501|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354424|NCT02007512|469269502|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354425|NCT02007512|469269499|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130354426|NCT02007512|469269500|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130441559|NCT00876460|469580182|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
130221267|NCT03286218|468774371|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221268|NCT03286218|468774372|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
130354427|NCT02007512|469269501|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130354428|NCT02007512|469269502|FG003|Double Blind Treatment Period|Protocol Violation|1|||
130552802|NCT03224325|469991537|FG000|Overall Study|Adverse Event|1|||
130354429|NCT02007512|469269499|FG000|Double Blind Treatment Period|Other|2|||
130354430|NCT02007512|469269500|FG001|Double Blind Treatment Period|Other|1|||
130354431|NCT02007512|469269501|FG002|Double Blind Treatment Period|Other|1|||
130354432|NCT02007512|469269502|FG003|Double Blind Treatment Period|Other|2|||
130354433|NCT02007512|469269499|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
130354434|NCT02007512|469269500|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
130354435|NCT02007512|469269501|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
130354436|NCT02007512|469269502|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
130354437|NCT02007512|469269499|FG000|Open Label Treatment Period|Adverse Event|1|||
130354438|NCT02007512|469269500|FG001|Open Label Treatment Period|Adverse Event|0|||
130354439|NCT02007512|469269501|FG002|Open Label Treatment Period|Adverse Event|0|||
130354440|NCT02007512|469269502|FG003|Open Label Treatment Period|Adverse Event|0|||
130354441|NCT02007512|469269499|FG000|Open Label Treatment Period|Other|1|||
130354442|NCT02007512|469269500|FG001|Open Label Treatment Period|Other|1|||
130354443|NCT02007512|469269501|FG002|Open Label Treatment Period|Other|0|||
130354444|NCT02007512|469269502|FG003|Open Label Treatment Period|Other|0|||
130354445|NCT02007512|469269499|FG000|Open Label Treatment Period|Disease progression|23|||
130354446|NCT02007512|469269500|FG001|Open Label Treatment Period|Disease progression|11|||
130354447|NCT02007512|469269501|FG002|Open Label Treatment Period|Disease progression|0|||
130354448|NCT02007512|469269502|FG003|Open Label Treatment Period|Disease progression|0|||
130354449|NCT00900601|469269507|FG000|Overall Study|Physician Decision|1|||
130354450|NCT00608543|469269508|FG000|Overall Study|Adverse Event|4|||
130354451|NCT03026088|469269509|FG000|Overall Study|Study termination|20|||
130354452|NCT03416374|469269511|FG000|Between Treatment Period I and II|Other|0|||
130354453|NCT03416374|469269512|FG001|Between Treatment Period I and II|Other|9|||
130354454|NCT03416374|469269511|FG000|Treatment Period II|Lack of Efficacy|3|||
130354455|NCT03416374|469269512|FG001|Treatment Period II|Lack of Efficacy|11|||
130354456|NCT03416374|469269511|FG000|Treatment Period II|Adverse Event|1|||
130354457|NCT03416374|469269512|FG001|Treatment Period II|Adverse Event|4|||
130354458|NCT03416374|469269511|FG000|Treatment Period II|Death|0|||
130354459|NCT03416374|469269512|FG001|Treatment Period II|Death|1|||
130354460|NCT03416374|469269511|FG000|Treatment Period II|Other|0|||
130354461|NCT03416374|469269512|FG001|Treatment Period II|Other|2|||
130354462|NCT01052844|469269513|FG000|Overall Study|Adverse Event|0|||
130354463|NCT01052844|469269514|FG001|Overall Study|Adverse Event|1|||
130354464|NCT03583164|469269515|FG000|Overall Study|Death in Main Phase|35|||
130354465|NCT03583164|469269515|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
130354466|NCT03583164|469269515|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
130354467|NCT03583164|469269515|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
130354468|NCT03583164|469269515|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
130354469|NCT03583164|469269515|FG000|Overall Study|Physician decision in Main Phase|1|||
130354470|NCT03583164|469269515|FG000|Overall Study|Physician decision in Extended Phase|2|||
130354471|NCT03583164|469269515|FG000|Overall Study|Death in Extended Phase|13|||
130354472|NCT03583164|469269515|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
130354473|NCT03583164|469269515|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
130354474|NCT03583164|469269515|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
130354475|NCT03583164|469269515|FG000|Overall Study|Treatment failure in Main Phase|2|||
130354476|NCT03583164|469269515|FG000|Overall Study|Treatment failure in Extended Phase|4|||
130354477|NCT03583164|469269515|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
130354478|NCT03583164|469269515|FG000|Overall Study|Other not specified reason in Main Phase|2|||
130354479|NCT00559754|469269516|FG000|Overall Study|Disease progression|1|||
130354480|NCT00559754|469269516|FG000|Overall Study|Adverse Event|5|||
130354481|NCT00559754|469269516|FG000|Overall Study|Protocol Violation|1|||
130354482|NCT00559754|469269516|FG000|Overall Study|Investigator criteria|2|||
130354483|NCT00559754|469269516|FG000|Overall Study|Withdrawal by Subject|2|||
130354484|NCT00214500|469269521|FG000|Treatment Period|Adverse Event|1|||
130354485|NCT00214500|469269521|FG000|Extension Period|Withdrawal by Subject|2|||
130354486|NCT02537574|469269523|FG000|Overall Study|Adverse Event|1|||
130354487|NCT02537574|469269524|FG001|Overall Study|Adverse Event|3|||
130354488|NCT02537574|469269525|FG002|Overall Study|Adverse Event|2|||
130354489|NCT02537574|469269523|FG000|Overall Study|Lost to Follow-up|40|||
130354490|NCT02537574|469269524|FG001|Overall Study|Lost to Follow-up|51|||
130354491|NCT02537574|469269525|FG002|Overall Study|Lost to Follow-up|55|||
130354492|NCT02537574|469269523|FG000|Overall Study|Noncompliance with study drug|0|||
130354493|NCT02537574|469269524|FG001|Overall Study|Noncompliance with study drug|1|||
130354494|NCT02537574|469269525|FG002|Overall Study|Noncompliance with study drug|1|||
130354495|NCT02537574|469269523|FG000|Overall Study|Physician Decision|2|||
130354496|NCT02537574|469269524|FG001|Overall Study|Physician Decision|0|||
130354497|NCT02537574|469269525|FG002|Overall Study|Physician Decision|0|||
130354498|NCT02537574|469269523|FG000|Overall Study|Protocol Violation|4|||
130354499|NCT02537574|469269524|FG001|Overall Study|Protocol Violation|2|||
130354500|NCT02537574|469269525|FG002|Overall Study|Protocol Violation|3|||
130354501|NCT02537574|469269523|FG000|Overall Study|Withdrawal by Subject|37|||
130354502|NCT02537574|469269524|FG001|Overall Study|Withdrawal by Subject|27|||
130354503|NCT02537574|469269525|FG002|Overall Study|Withdrawal by Subject|29|||
130354504|NCT02537574|469269523|FG000|Overall Study|Lack of Efficacy|14|||
130354505|NCT02537574|469269524|FG001|Overall Study|Lack of Efficacy|16|||
130354506|NCT02537574|469269525|FG002|Overall Study|Lack of Efficacy|15|||
130441560|NCT00876460|469580183|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
130441561|NCT00876460|469580184|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
130441562|NCT00876460|469580185|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
130441563|NCT00876460|469580186|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
130441564|NCT00876460|469580187|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
130441565|NCT00876460|469580180|FG000|Combination Therapy Phase|Other reason not defined above|0|||
130441566|NCT00876460|469580181|FG001|Combination Therapy Phase|Other reason not defined above|0|||
130441567|NCT00876460|469580182|FG002|Combination Therapy Phase|Other reason not defined above|0|||
130441568|NCT00876460|469580183|FG003|Combination Therapy Phase|Other reason not defined above|0|||
130441569|NCT00876460|469580184|FG004|Combination Therapy Phase|Other reason not defined above|0|||
130441570|NCT00876460|469580185|FG005|Combination Therapy Phase|Other reason not defined above|0|||
130686097|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686098|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686099|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686100|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
130441571|NCT00876460|469580186|FG006|Combination Therapy Phase|Other reason not defined above|1|||
130441572|NCT00876460|469580187|FG007|Combination Therapy Phase|Other reason not defined above|2|||
130441573|NCT00876460|469580180|FG000|Combination Therapy Phase|Not treated|0|||
130441574|NCT00876460|469580181|FG001|Combination Therapy Phase|Not treated|0|||
130441575|NCT00876460|469580182|FG002|Combination Therapy Phase|Not treated|0|||
130441576|NCT00876460|469580183|FG003|Combination Therapy Phase|Not treated|0|||
130441577|NCT00876460|469580184|FG004|Combination Therapy Phase|Not treated|0|||
130441578|NCT00876460|469580185|FG005|Combination Therapy Phase|Not treated|0|||
130441579|NCT00876460|469580186|FG006|Combination Therapy Phase|Not treated|1|||
130441580|NCT00876460|469580187|FG007|Combination Therapy Phase|Not treated|0|||
130441581|NCT00876460|469580180|FG000|Mono Therapy Phase|Progressive disease|0|||
130441582|NCT00876460|469580181|FG001|Mono Therapy Phase|Progressive disease|0|||
130441583|NCT00876460|469580182|FG002|Mono Therapy Phase|Progressive disease|0|||
130441584|NCT00876460|469580183|FG003|Mono Therapy Phase|Progressive disease|0|||
130441585|NCT00876460|469580184|FG004|Mono Therapy Phase|Progressive disease|2|||
130441586|NCT00876460|469580185|FG005|Mono Therapy Phase|Progressive disease|0|||
130441587|NCT00876460|469580186|FG006|Mono Therapy Phase|Progressive disease|1|||
130441588|NCT00876460|469580187|FG007|Mono Therapy Phase|Progressive disease|3|||
130686101|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686102|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
130686103|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
130686104|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686105|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686106|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686107|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686108|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686109|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686110|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686111|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686112|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686113|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686114|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686115|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686116|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686117|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686118|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686119|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686120|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686121|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686122|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686123|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
130686124|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
130441589|NCT00876460|469580180|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
130441590|NCT00876460|469580181|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
130441591|NCT00876460|469580182|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
130441592|NCT00876460|469580183|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
130441593|NCT00876460|469580184|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
130441594|NCT00876460|469580185|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
130441595|NCT00876460|469580186|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
130441596|NCT00876460|469580187|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
130441597|NCT00876460|469580180|FG000|Mono Therapy Phase|Adverse Event|0|||
130441598|NCT00876460|469580181|FG001|Mono Therapy Phase|Adverse Event|0|||
130441599|NCT00876460|469580182|FG002|Mono Therapy Phase|Adverse Event|0|||
130441600|NCT00876460|469580183|FG003|Mono Therapy Phase|Adverse Event|1|||
130221269|NCT03286218|468774373|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221270|NCT03286218|468774374|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221271|NCT03286218|468774375|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221272|NCT03286218|468774376|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221273|NCT03286218|468774365|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221274|NCT03286218|468774366|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221275|NCT03286218|468774367|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221276|NCT03286218|468774368|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221277|NCT03286218|468774369|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221278|NCT03286218|468774370|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221279|NCT03286218|468774371|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221280|NCT03286218|468774372|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221281|NCT03286218|468774373|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221282|NCT03286218|468774374|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221283|NCT03286218|468774375|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221284|NCT03286218|468774376|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
130221285|NCT02532374|468774379|FG000|Overall Study|Withdrawal by Subject|1|||
130221286|NCT02532374|468774379|FG000|Overall Study|Physician Decision|1|||
130221287|NCT02762084|468774380|FG000|Overall Study|Withdrawal by Subject|1|||
130221288|NCT02762084|468774381|FG001|Overall Study|Withdrawal by Subject|0|||
130221289|NCT02762084|468774382|FG002|Overall Study|Withdrawal by Subject|0|||
130221290|NCT02762084|468774380|FG000|Overall Study|Adverse Event|0|||
130221291|NCT02762084|468774381|FG001|Overall Study|Adverse Event|0|||
130441601|NCT00876460|469580184|FG004|Mono Therapy Phase|Adverse Event|0|||
130441602|NCT00876460|469580185|FG005|Mono Therapy Phase|Adverse Event|0|||
130221292|NCT02762084|468774382|FG002|Overall Study|Adverse Event|1|||
130221293|NCT01348139|468774383|FG000|Period 1|Adverse Event|1|||
130221294|NCT01348139|468774384|FG001|Period 1|Adverse Event|0|||
130221295|NCT01348139|468774385|FG002|Period 1|Adverse Event|0|||
130221296|NCT01348139|468774386|FG003|Period 1|Adverse Event|0|||
130221297|NCT01348139|468774387|FG004|Period 1|Adverse Event|0|||
130221298|NCT01348139|468774388|FG005|Period 1|Adverse Event|0|||
130221299|NCT01781962|468774391|FG000|Overall Study|Other Miscellaneous Reasons|5|||
130221300|NCT01765296|468774392|FG000|Overall Study|Protocol Violation|0|||
130221301|NCT01765296|468774393|FG001|Overall Study|Protocol Violation|5|||
130221302|NCT01765296|468774394|FG002|Overall Study|Protocol Violation|4|||
130221303|NCT01765296|468774392|FG000|Overall Study|Withdrawal by Subject|4|||
130221304|NCT01765296|468774393|FG001|Overall Study|Withdrawal by Subject|2|||
130221305|NCT01765296|468774394|FG002|Overall Study|Withdrawal by Subject|2|||
130221306|NCT01765296|468774392|FG000|Overall Study|Adverse Event|1|||
130221307|NCT01765296|468774393|FG001|Overall Study|Adverse Event|13|||
130221308|NCT01765296|468774394|FG002|Overall Study|Adverse Event|5|||
130221309|NCT01765296|468774392|FG000|Overall Study|Lack of Efficacy|0|||
130221310|NCT01765296|468774393|FG001|Overall Study|Lack of Efficacy|0|||
130221311|NCT01765296|468774394|FG002|Overall Study|Lack of Efficacy|2|||
130221312|NCT01619852|468774395|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
130221313|NCT01619852|468774396|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
130221314|NCT01619852|468774395|FG000|3 Month Follow up|Lost to Follow-up|31|||
130221315|NCT01619852|468774396|FG001|3 Month Follow up|Lost to Follow-up|34|||
130221316|NCT03933449|468774397|FG000|Overall Study|Adverse Event|6|||
130221317|NCT03933449|468774398|FG001|Overall Study|Adverse Event|4|||
130221318|NCT03933449|468774397|FG000|Overall Study|Death|55|||
130221319|NCT03933449|468774398|FG001|Overall Study|Death|57|||
130221320|NCT03933449|468774397|FG000|Overall Study|Sponsor Decision|1|||
130221321|NCT03933449|468774398|FG001|Overall Study|Sponsor Decision|0|||
130221322|NCT02659943|468774399|FG000|Overall Study|Switched to alternative treatment|1|||
130441603|NCT00876460|469580186|FG006|Mono Therapy Phase|Adverse Event|0|||
130441604|NCT00876460|469580187|FG007|Mono Therapy Phase|Adverse Event|0|||
130441605|NCT00127413|469580189|FG000|Overall Study|Lost to Follow-up|6|||
130441606|NCT00127413|469580190|FG001|Overall Study|Lost to Follow-up|4|||
130441607|NCT00127413|469580191|FG002|Overall Study|Lost to Follow-up|8|||
130441608|NCT00127413|469580192|FG003|Overall Study|Lost to Follow-up|2|||
130441609|NCT00547911|469580193|FG000|Overall Study|Adverse Event|0|||
130441610|NCT00547911|469580194|FG001|Overall Study|Adverse Event|0|||
130441611|NCT00547911|469580195|FG002|Overall Study|Adverse Event|0|||
130221323|NCT02659943|468774400|FG001|Overall Study|Switched to alternative treatment|1|||
130221324|NCT02659943|468774401|FG002|Overall Study|Switched to alternative treatment|0|||
130441612|NCT00547911|469580196|FG003|Overall Study|Adverse Event|1|||
130221325|NCT02659943|468774402|FG003|Overall Study|Switched to alternative treatment|2|||
130221326|NCT02659943|468774403|FG004|Overall Study|Switched to alternative treatment|1|||
130221327|NCT02659943|468774404|FG005|Overall Study|Switched to alternative treatment|0|||
130221328|NCT02659943|468774405|FG006|Overall Study|Switched to alternative treatment|1|||
130221329|NCT02659943|468774399|FG000|Overall Study|Disease progression on study|0|||
130221330|NCT02659943|468774400|FG001|Overall Study|Disease progression on study|1|||
130441613|NCT00547911|469580197|FG004|Overall Study|Adverse Event|0|||
130441614|NCT00547911|469580198|FG005|Overall Study|Adverse Event|0|||
130441615|NCT01644474|469580200|FG000|Overall Study|Poor compliance to protocol|1|||
130221331|NCT02659943|468774401|FG002|Overall Study|Disease progression on study|1|||
130221332|NCT02659943|468774402|FG003|Overall Study|Disease progression on study|1|||
130221333|NCT02659943|468774403|FG004|Overall Study|Disease progression on study|1|||
130221334|NCT02659943|468774404|FG005|Overall Study|Disease progression on study|4|||
130221335|NCT02659943|468774405|FG006|Overall Study|Disease progression on study|0|||
130221336|NCT02659943|468774399|FG000|Overall Study|Patient's condition per principal investigator|0|||
130221337|NCT02659943|468774400|FG001|Overall Study|Patient's condition per principal investigator|0|||
130221338|NCT02659943|468774401|FG002|Overall Study|Patient's condition per principal investigator|0|||
130221339|NCT02659943|468774402|FG003|Overall Study|Patient's condition per principal investigator|0|||
130221340|NCT02659943|468774403|FG004|Overall Study|Patient's condition per principal investigator|0|||
130221341|NCT02659943|468774404|FG005|Overall Study|Patient's condition per principal investigator|1|||
130221342|NCT02659943|468774405|FG006|Overall Study|Patient's condition per principal investigator|0|||
130221343|NCT02659943|468774399|FG000|Overall Study|Ineligible|0|||
130221344|NCT02659943|468774400|FG001|Overall Study|Ineligible|0|||
130221345|NCT02659943|468774401|FG002|Overall Study|Ineligible|0|||
130221346|NCT02659943|468774402|FG003|Overall Study|Ineligible|0|||
130221347|NCT02659943|468774403|FG004|Overall Study|Ineligible|0|||
130221348|NCT02659943|468774404|FG005|Overall Study|Ineligible|0|||
130221349|NCT02659943|468774405|FG006|Overall Study|Ineligible|1|||
130221350|NCT02659943|468774399|FG000|Overall Study|No longer meets eligibility|0|||
130221351|NCT02659943|468774400|FG001|Overall Study|No longer meets eligibility|0|||
130221352|NCT02659943|468774401|FG002|Overall Study|No longer meets eligibility|0|||
130221353|NCT02659943|468774402|FG003|Overall Study|No longer meets eligibility|0|||
130221354|NCT02659943|468774403|FG004|Overall Study|No longer meets eligibility|0|||
130221355|NCT02659943|468774404|FG005|Overall Study|No longer meets eligibility|0|||
130221356|NCT02659943|468774405|FG006|Overall Study|No longer meets eligibility|1|||
130221357|NCT02659943|468774399|FG000|Overall Study|No treatment, per protocol|0|||
130221358|NCT02659943|468774400|FG001|Overall Study|No treatment, per protocol|0|||
130221359|NCT02659943|468774401|FG002|Overall Study|No treatment, per protocol|0|||
130221360|NCT02659943|468774402|FG003|Overall Study|No treatment, per protocol|0|||
130221361|NCT02659943|468774403|FG004|Overall Study|No treatment, per protocol|0|||
130221362|NCT02659943|468774404|FG005|Overall Study|No treatment, per protocol|0|||
130221363|NCT02659943|468774405|FG006|Overall Study|No treatment, per protocol|3|||
130221364|NCT01576575|468774406|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
130221365|NCT01576575|468774406|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
130221366|NCT01576575|468774406|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
130221367|NCT01723072|468774407|FG000|Overall Study|Withdrawal by Subject|7|||
130221368|NCT01723072|468774408|FG001|Overall Study|Withdrawal by Subject|13|||
130221369|NCT01723072|468774407|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
130221370|NCT01723072|468774408|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
130221371|NCT01723072|468774407|FG000|Overall Study|Other|4|||
130221372|NCT01723072|468774408|FG001|Overall Study|Other|3|||
130221373|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130221374|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221375|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
130221376|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130221377|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221378|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221379|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221380|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221381|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221382|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221383|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221384|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221385|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221386|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221387|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221388|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221389|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221390|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221391|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221392|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
130221393|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
130221394|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
130221395|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
130221396|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221397|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221398|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221399|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221400|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221401|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221402|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221403|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221404|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221405|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221406|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221407|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130354507|NCT02537574|469269523|FG000|Overall Study|Duplicate Patient|1|||
130354508|NCT02537574|469269524|FG001|Overall Study|Duplicate Patient|0|||
130354509|NCT02537574|469269525|FG002|Overall Study|Duplicate Patient|0|||
130354510|NCT02537574|469269523|FG000|Overall Study|Patient not Stable|0|||
130354511|NCT02537574|469269524|FG001|Overall Study|Patient not Stable|1|||
130354512|NCT02537574|469269525|FG002|Overall Study|Patient not Stable|0|||
130354513|NCT02537574|469269523|FG000|Overall Study|Incarceration|0|||
130354514|NCT02537574|469269524|FG001|Overall Study|Incarceration|1|||
130354515|NCT02537574|469269525|FG002|Overall Study|Incarceration|0|||
130354516|NCT02537574|469269523|FG000|Overall Study|Failed Naloxone Challenge|0|||
130354517|NCT02537574|469269524|FG001|Overall Study|Failed Naloxone Challenge|1|||
130354518|NCT02537574|469269525|FG002|Overall Study|Failed Naloxone Challenge|0|||
130354519|NCT02537574|469269523|FG000|Overall Study|Transportation Issues|0|||
130354520|NCT02537574|469269524|FG001|Overall Study|Transportation Issues|0|||
130354521|NCT02537574|469269525|FG002|Overall Study|Transportation Issues|1|||
130354522|NCT02537574|469269523|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
130354523|NCT02537574|469269524|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
130354524|NCT02537574|469269525|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
130354525|NCT02537574|469269523|FG000|Overall Study|Noncompliance with Protocol|0|||
130354526|NCT02537574|469269524|FG001|Overall Study|Noncompliance with Protocol|0|||
130354527|NCT02537574|469269525|FG002|Overall Study|Noncompliance with Protocol|1|||
130354528|NCT02663687|469269526|FG000|Overall Study|Adverse Event|1|||
130354529|NCT02663687|469269527|FG001|Overall Study|Adverse Event|0|||
130354530|NCT02663687|469269528|FG002|Overall Study|Adverse Event|0|||
130354531|NCT02663687|469269529|FG003|Overall Study|Adverse Event|0|||
130354532|NCT02663687|469269530|FG004|Overall Study|Adverse Event|0|||
130354533|NCT02663687|469269526|FG000|Overall Study|Other|1|||
130354534|NCT02663687|469269527|FG001|Overall Study|Other|0|||
130354535|NCT02663687|469269528|FG002|Overall Study|Other|1|||
130354536|NCT02663687|469269529|FG003|Overall Study|Other|0|||
130354537|NCT02663687|469269530|FG004|Overall Study|Other|0|||
130354538|NCT03595774|469269531|FG000|Overall Study|Adverse Event|1|||
130354539|NCT03595774|469269532|FG001|Overall Study|Adverse Event|0|||
130354540|NCT03595774|469269533|FG002|Overall Study|Adverse Event|1|||
130354541|NCT03595774|469269534|FG003|Overall Study|Adverse Event|0|||
130354542|NCT03595774|469269531|FG000|Overall Study|screen failure|0|||
130354543|NCT03595774|469269532|FG001|Overall Study|screen failure|1|||
130354544|NCT03595774|469269533|FG002|Overall Study|screen failure|0|||
130354545|NCT03595774|469269534|FG003|Overall Study|screen failure|1|||
130354546|NCT00117286|469269535|FG000|Overall Study|Adverse Event|12|||
130354547|NCT00117286|469269536|FG001|Overall Study|Adverse Event|6|||
130354548|NCT00117286|469269535|FG000|Overall Study|Lost to Follow-up|2|||
130354549|NCT00117286|469269536|FG001|Overall Study|Lost to Follow-up|0|||
130354550|NCT00117286|469269535|FG000|Overall Study|Protocol Violation|3|||
130354551|NCT00117286|469269536|FG001|Overall Study|Protocol Violation|3|||
130354552|NCT00117286|469269535|FG000|Overall Study|Withdrawal by Subject|6|||
130354553|NCT00117286|469269536|FG001|Overall Study|Withdrawal by Subject|2|||
130354554|NCT00117286|469269535|FG000|Overall Study|Physician Decision|3|||
130354555|NCT00117286|469269536|FG001|Overall Study|Physician Decision|7|||
130354556|NCT00117286|469269535|FG000|Overall Study|Lack of Efficacy|2|||
130354557|NCT00117286|469269536|FG001|Overall Study|Lack of Efficacy|1|||
130354558|NCT00117286|469269535|FG000|Overall Study|Research site closing|0|||
130354559|NCT00117286|469269536|FG001|Overall Study|Research site closing|2|||
130354560|NCT00048061|469269538|FG000|Overall Study|Adverse Event|41|||
130354561|NCT00048061|469269539|FG001|Overall Study|Adverse Event|32|||
130354562|NCT00048061|469269540|FG002|Overall Study|Adverse Event|44|||
130221408|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130354563|NCT00048061|469269541|FG003|Overall Study|Adverse Event|37|||
130354564|NCT00048061|469269538|FG000|Overall Study|Lost to Follow-up|3|||
130354565|NCT00048061|469269539|FG001|Overall Study|Lost to Follow-up|2|||
130354566|NCT00048061|469269540|FG002|Overall Study|Lost to Follow-up|4|||
130354567|NCT00048061|469269541|FG003|Overall Study|Lost to Follow-up|5|||
130354568|NCT00048061|469269538|FG000|Overall Study|Withdrawal by Subject|20|||
130354569|NCT00048061|469269539|FG001|Overall Study|Withdrawal by Subject|29|||
130354570|NCT00048061|469269540|FG002|Overall Study|Withdrawal by Subject|29|||
130354571|NCT00048061|469269541|FG003|Overall Study|Withdrawal by Subject|32|||
130354572|NCT00048061|469269538|FG000|Overall Study|Did not follow-up|5|||
130354573|NCT00048061|469269539|FG001|Overall Study|Did not follow-up|5|||
130354574|NCT00048061|469269540|FG002|Overall Study|Did not follow-up|4|||
130354575|NCT00048061|469269541|FG003|Overall Study|Did not follow-up|5|||
130354576|NCT00048061|469269538|FG000|Overall Study|Early improvement|6|||
130441616|NCT01644474|469580201|FG001|Overall Study|Poor compliance to protocol|0|||
130441617|NCT01644474|469580200|FG000|Overall Study|Consent withdrawn by participant|0|||
130441618|NCT01644474|469580201|FG001|Overall Study|Consent withdrawn by participant|1|||
130441619|NCT01644474|469580200|FG000|Overall Study|Participant moved|0|||
130441620|NCT01644474|469580201|FG001|Overall Study|Participant moved|1|||
130441621|NCT01644474|469580200|FG000|Overall Study|Adverse Event|4|||
130441622|NCT01644474|469580201|FG001|Overall Study|Adverse Event|5|||
130441623|NCT01644474|469580200|FG000|Overall Study|Site scheduling error|1|||
130441624|NCT01644474|469580201|FG001|Overall Study|Site scheduling error|1|||
130441625|NCT01644474|469580200|FG000|Overall Study|Protocol Violation|1|||
130441626|NCT01644474|469580201|FG001|Overall Study|Protocol Violation|0|||
130441627|NCT02044458|469580205|FG000|Overall Study|Protocol Violation|3|||
130441628|NCT02044458|469580206|FG001|Overall Study|Protocol Violation|8|||
130441629|NCT02601937|469580207|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441630|NCT02601937|469580208|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441631|NCT02601937|469580209|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441632|NCT02601937|469580210|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441633|NCT02601937|469580211|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441634|NCT02601937|469580212|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
130441635|NCT02601937|469580213|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441636|NCT02601937|469580214|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441637|NCT02601937|469580215|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441638|NCT02601937|469580216|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441639|NCT02601937|469580217|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
130441640|NCT02601937|469580207|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
130441641|NCT02601937|469580208|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441642|NCT02601937|469580209|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441643|NCT02601937|469580210|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441644|NCT02601937|469580211|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441645|NCT02601937|469580212|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441646|NCT02601937|469580213|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
130441647|NCT02601937|469580214|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441648|NCT02601937|469580215|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441649|NCT02601937|469580216|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441650|NCT02601937|469580217|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130441651|NCT02601937|469580207|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441652|NCT02601937|469580208|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441653|NCT02601937|469580209|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
130441654|NCT02601937|469580210|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441655|NCT02601937|469580211|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441656|NCT02601937|469580212|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441657|NCT02601937|469580213|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441658|NCT02601937|469580214|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441659|NCT02601937|469580215|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441660|NCT02601937|469580216|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441661|NCT02601937|469580217|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130441662|NCT02601937|469580207|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
130441663|NCT02601937|469580208|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
130441664|NCT02601937|469580209|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
130441665|NCT02601937|469580210|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
130441666|NCT02601937|469580211|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
130441667|NCT02601937|469580212|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
130441668|NCT02601937|469580213|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
130441669|NCT02601937|469580214|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
130441670|NCT02601937|469580215|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
130441671|NCT02601937|469580216|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
130441672|NCT02601937|469580217|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
130441673|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441674|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441675|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441676|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441677|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441678|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441679|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441680|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441681|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441682|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
130221409|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221410|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221411|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221412|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130221413|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130221414|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221415|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221416|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221417|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221418|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221419|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221420|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221421|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221422|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221423|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221424|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221425|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221426|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221427|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221428|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221429|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221430|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
130221431|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221432|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221433|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221434|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221435|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221436|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221437|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221438|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221439|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221440|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221441|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221442|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221443|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221444|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221445|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221446|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221447|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221448|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221449|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221450|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
130221451|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221452|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221453|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221454|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221455|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130354577|NCT00048061|469269539|FG001|Overall Study|Early improvement|5|||
130354578|NCT00048061|469269540|FG002|Overall Study|Early improvement|3|||
130354579|NCT00048061|469269541|FG003|Overall Study|Early improvement|0|||
130354580|NCT03555435|469269542|FG000|Overall Study|Lost to Follow-up|17|||
130354581|NCT03555435|469269543|FG001|Overall Study|Lost to Follow-up|19|||
130354582|NCT03555435|469269544|FG002|Overall Study|Lost to Follow-up|8|||
130354583|NCT01323946|469269545|FG000|Overall Study|Lost to Follow-up|0|||
130354584|NCT01323946|469269546|FG001|Overall Study|Lost to Follow-up|1|||
130354585|NCT01323946|469269547|FG002|Overall Study|Lost to Follow-up|0|||
130354586|NCT01323946|469269545|FG000|Overall Study|Parents refused the last blood draw|1|||
130354587|NCT01323946|469269546|FG001|Overall Study|Parents refused the last blood draw|0|||
130354588|NCT01323946|469269547|FG002|Overall Study|Parents refused the last blood draw|0|||
130354589|NCT01323946|469269545|FG000|Overall Study|Withdrawal by Subject|2|||
130354590|NCT01323946|469269546|FG001|Overall Study|Withdrawal by Subject|2|||
130354591|NCT01323946|469269547|FG002|Overall Study|Withdrawal by Subject|0|||
130354592|NCT01272661|469269550|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
130354593|NCT01272661|469269551|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
130354594|NCT01272661|469269552|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
130221456|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221457|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221458|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221459|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221460|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221461|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221462|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221463|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221464|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221465|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221466|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221467|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221468|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221469|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221470|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221471|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221472|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221473|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
130221474|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221475|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130221476|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221477|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221478|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221479|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221480|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
130221481|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221482|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221483|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221484|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130221485|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221486|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221487|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
130221488|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
130221489|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
130221490|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
130221491|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
130221492|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
130221493|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
130221494|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
130221495|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
130221496|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
130221497|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
130354595|NCT01243671|469269553|FG000|Overall Study|Adverse Event|3|||
130441683|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130441684|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441685|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130686125|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130354596|NCT01243671|469269553|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
130354597|NCT01243671|469269553|FG000|Overall Study|Other|1|||
130354598|NCT00573248|469269559|FG000|Overall Study|scheduling conflicts|15|||
130354599|NCT00573248|469269560|FG001|Overall Study|scheduling conflicts|11|||
130354600|NCT02017171|469269561|FG000|Overall Study|Death|10|||
130354601|NCT02017171|469269562|FG001|Overall Study|Death|4|||
130354602|NCT02017171|469269561|FG000|Overall Study|Withdrawal by Subject|23|||
130354603|NCT02017171|469269562|FG001|Overall Study|Withdrawal by Subject|17|||
130354604|NCT02017171|469269561|FG000|Overall Study|Lost to Follow-up|21|||
130354605|NCT02017171|469269562|FG001|Overall Study|Lost to Follow-up|20|||
130354606|NCT02017171|469269561|FG000|Overall Study|ESKD|6|||
130354607|NCT02017171|469269562|FG001|Overall Study|ESKD|2|||
130354608|NCT02017171|469269561|FG000|Overall Study|Miscellaneous|2|||
130354609|NCT02017171|469269562|FG001|Overall Study|Miscellaneous|3|||
130354610|NCT03091777|469269563|FG000|Overall Study|Pregnancy|2|||
130354611|NCT03091777|469269564|FG001|Overall Study|Pregnancy|1|||
130354612|NCT03091777|469269565|FG002|Overall Study|Pregnancy|0|||
130354613|NCT03091777|469269563|FG000|Overall Study|Adverse Event|2|||
130354614|NCT03091777|469269564|FG001|Overall Study|Adverse Event|1|||
130354615|NCT03091777|469269565|FG002|Overall Study|Adverse Event|4|||
130354616|NCT03091777|469269563|FG000|Overall Study|Withdrawal by Subject|4|||
130354617|NCT03091777|469269564|FG001|Overall Study|Withdrawal by Subject|2|||
130221498|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
130221499|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
130221500|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
130221501|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
130221502|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
130221503|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
130221504|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
130221505|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
130354618|NCT03091777|469269565|FG002|Overall Study|Withdrawal by Subject|6|||
130686126|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686127|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686128|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686129|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686130|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686131|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686132|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686133|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686134|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686135|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686136|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686137|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686138|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686139|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686140|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686141|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686142|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686143|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686144|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130686145|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130686146|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686147|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686148|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686149|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686150|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686151|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686152|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686153|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686154|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686155|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686156|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686157|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130354619|NCT03091777|469269563|FG000|Overall Study|Protocol Violation|2|||
130354620|NCT03091777|469269564|FG001|Overall Study|Protocol Violation|1|||
130354621|NCT03091777|469269565|FG002|Overall Study|Protocol Violation|1|||
130354622|NCT03091777|469269563|FG000|Overall Study|Lost to Follow-up|12|||
130354623|NCT03091777|469269564|FG001|Overall Study|Lost to Follow-up|14|||
130354624|NCT03091777|469269565|FG002|Overall Study|Lost to Follow-up|7|||
130354625|NCT03091777|469269563|FG000|Overall Study|Lack of Efficacy|0|||
130354626|NCT03091777|469269564|FG001|Overall Study|Lack of Efficacy|0|||
130354627|NCT03091777|469269565|FG002|Overall Study|Lack of Efficacy|5|||
130354628|NCT03091777|469269563|FG000|Overall Study|Noncompliance with study drug|2|||
130354629|NCT03091777|469269564|FG001|Overall Study|Noncompliance with study drug|3|||
130354630|NCT03091777|469269565|FG002|Overall Study|Noncompliance with study drug|1|||
130354631|NCT03091777|469269563|FG000|Overall Study|Physician Decision|1|||
130354632|NCT03091777|469269564|FG001|Overall Study|Physician Decision|0|||
130354633|NCT03091777|469269565|FG002|Overall Study|Physician Decision|1|||
130354634|NCT03091777|469269563|FG000|Overall Study|Abnormal Laboratory Value|7|||
130354635|NCT03091777|469269564|FG001|Overall Study|Abnormal Laboratory Value|11|||
130354636|NCT03091777|469269565|FG002|Overall Study|Abnormal Laboratory Value|12|||
130354637|NCT02314143|469269566|FG000|Overall Study|Adverse Event|0|||
130354638|NCT02314143|469269567|FG001|Overall Study|Adverse Event|6|||
130354639|NCT02314143|469269568|FG002|Overall Study|Adverse Event|4|||
130354640|NCT02314143|469269566|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
130354641|NCT02314143|469269567|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
130354642|NCT02314143|469269568|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
130354643|NCT02314143|469269566|FG000|Overall Study|Physician Decision|2|||
130354644|NCT02314143|469269567|FG001|Overall Study|Physician Decision|1|||
130354645|NCT02314143|469269568|FG002|Overall Study|Physician Decision|0|||
130354646|NCT02314143|469269566|FG000|Overall Study|Withdrawal by Subject|1|||
130354647|NCT02314143|469269567|FG001|Overall Study|Withdrawal by Subject|0|||
130441686|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441687|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441688|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441689|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441690|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441691|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
130441692|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441693|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441694|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130441695|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441696|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441697|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441698|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441699|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441700|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441701|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441702|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441703|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130441704|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
130441705|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
130552803|NCT03224325|469991538|FG001|Overall Study|Adverse Event|0|||
130686158|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686159|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686160|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686161|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686162|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686163|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686164|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686165|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130686166|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130686167|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686168|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686169|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686170|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686171|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686172|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686173|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686174|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686175|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686176|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686177|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686178|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686179|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686180|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686181|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686182|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686183|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686184|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686185|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
130686186|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686187|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686188|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686189|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686190|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686191|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686192|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686193|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686194|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686195|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130221506|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221507|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130552804|NCT03224325|469991539|FG002|Overall Study|Adverse Event|0|||
130552805|NCT03224325|469991540|FG003|Overall Study|Adverse Event|0|||
130221508|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221509|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221510|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130221511|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130221512|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130221513|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221514|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221515|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221516|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221517|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221518|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130221519|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130221520|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
130221521|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130221522|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221523|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221524|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
130221525|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221526|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221527|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130441706|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441707|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441708|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130686196|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686197|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686198|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686199|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686200|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686201|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686202|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686203|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686204|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686205|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686206|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686207|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686208|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686209|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
130686210|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
130686211|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
130686212|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
130686213|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
130686214|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686215|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686216|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686217|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686218|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130441709|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441710|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441711|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441712|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130441713|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
130441714|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
130441715|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
130441716|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
130441717|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Other|0|||
130441718|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Other|0|||
130441719|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Other|0|||
130441720|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Other|0|||
130441721|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Other|0|||
130441722|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Other|0|||
130441723|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Other|0|||
130441724|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Other|0|||
130441725|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Other|2|||
130441726|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Other|2|||
130441727|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Other|0|||
130441728|NCT02601937|469580207|FG000|Period 2: Dose Expansion Cohort|Death|0|||
130441729|NCT02601937|469580208|FG001|Period 2: Dose Expansion Cohort|Death|0|||
130441730|NCT02601937|469580209|FG002|Period 2: Dose Expansion Cohort|Death|0|||
130441731|NCT02601937|469580210|FG003|Period 2: Dose Expansion Cohort|Death|0|||
130441732|NCT02601937|469580211|FG004|Period 2: Dose Expansion Cohort|Death|0|||
130441733|NCT02601937|469580212|FG005|Period 2: Dose Expansion Cohort|Death|0|||
130441734|NCT02601937|469580213|FG006|Period 2: Dose Expansion Cohort|Death|0|||
130441735|NCT02601937|469580214|FG007|Period 2: Dose Expansion Cohort|Death|0|||
130441736|NCT02601937|469580215|FG008|Period 2: Dose Expansion Cohort|Death|1|||
130441737|NCT02601937|469580216|FG009|Period 2: Dose Expansion Cohort|Death|0|||
130441738|NCT02601937|469580217|FG010|Period 2: Dose Expansion Cohort|Death|0|||
130441739|NCT04213989|469582082|FG000|Overall Study|Withdrawal by Subject|3|||
130441740|NCT04213989|469582083|FG001|Overall Study|Withdrawal by Subject|2|||
130441741|NCT04213989|469582082|FG000|Overall Study|Physician Decision|1|||
130441742|NCT04213989|469582083|FG001|Overall Study|Physician Decision|0|||
130441743|NCT04213989|469582082|FG000|Overall Study|Lost to Follow-up|0|||
130686219|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686220|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686221|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686222|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686223|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686224|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686225|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686226|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686227|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686228|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686229|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686230|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686231|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130686232|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130686233|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
130686234|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
130686235|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686236|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686237|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686238|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686239|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686240|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686241|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686242|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686243|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686244|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686245|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686246|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686247|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686248|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686249|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686250|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686251|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
130686252|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686253|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686254|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
130686255|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
130686256|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686257|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686258|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686259|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686260|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686261|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686262|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686263|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686264|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130441744|NCT04213989|469582083|FG001|Overall Study|Lost to Follow-up|4|||
130441745|NCT01811563|469582084|FG000|Overall Study|Lost to Follow-up|5|||
130441746|NCT01811563|469582085|FG001|Overall Study|Lost to Follow-up|2|||
130441747|NCT01811563|469582084|FG000|Overall Study|Incorrect Randomization procedure|0|||
130552806|NCT03224325|469991541|FG004|Overall Study|Adverse Event|0|||
130221528|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221529|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221530|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221531|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221532|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221533|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221534|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221535|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221536|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130221537|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221538|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221539|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130221540|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221541|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221542|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221543|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221544|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
130221545|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
130221546|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
130221547|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
130221548|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
130221549|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
130221550|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
130221551|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
130221552|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
130221553|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
130221554|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
130221555|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
130221556|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
130221557|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
130221558|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
130221559|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
130221560|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
130221561|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
130686265|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686266|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686267|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686268|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686269|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686270|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686271|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686272|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686273|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686274|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
130686275|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
130686276|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
130686277|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686278|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686279|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686280|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686281|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686282|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686283|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686284|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130221562|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
130221563|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130354648|NCT02314143|469269568|FG002|Overall Study|Withdrawal by Subject|1|||
130354649|NCT03172910|469271261|FG000|Overall Study|Adverse Event|0|||
130354650|NCT03172910|469271262|FG001|Overall Study|Adverse Event|0|||
130354651|NCT03172910|469271263|FG002|Overall Study|Adverse Event|0|||
130221564|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130354652|NCT03172910|469271264|FG003|Overall Study|Adverse Event|0|||
130221565|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130354653|NCT03172910|469271265|FG004|Overall Study|Adverse Event|1|||
130354654|NCT01927341|469271269|FG000|Phase 1b|Lost to Follow-up|1|||
130354655|NCT01927341|469271270|FG001|Phase 1b|Lost to Follow-up|0|||
130221566|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221567|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221568|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221569|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130221570|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221571|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221572|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221573|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221574|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221575|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221576|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221577|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221578|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221579|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221580|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221581|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130221582|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221583|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221584|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221585|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221586|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
130221587|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
130221588|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221589|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221590|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130221591|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130221592|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130221593|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130221594|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221595|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
130221596|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
130221597|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
130221598|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130221599|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
130221600|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130221601|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221602|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221603|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221604|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221605|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221606|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221607|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221608|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221609|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221610|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
130221611|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
130221612|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221613|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221614|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221615|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
130221616|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130441748|NCT01811563|469582085|FG001|Overall Study|Incorrect Randomization procedure|1|||
130441749|NCT00329719|469582086|FG000|Overall Study|Lost to Follow-up|0|||
130441750|NCT00329719|469582087|FG001|Overall Study|Lost to Follow-up|0|||
130441751|NCT00329719|469582088|FG002|Overall Study|Lost to Follow-up|0|||
130441752|NCT00329719|469582089|FG003|Overall Study|Lost to Follow-up|1|||
130441753|NCT02930122|469582092|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
130441754|NCT02930122|469582093|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
130441755|NCT01681368|469582094|FG000|Overall Study|Refused further treatment|1|||
130441756|NCT01681368|469582094|FG000|Overall Study|Refused further follow up|1|||
130441757|NCT01155388|469582097|FG000|Overall Study|Adverse Event|1|||
130221617|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
130221618|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221619|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221620|NCT04556760|468774428|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221621|NCT04556760|468774429|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
130221622|NCT04556760|468774430|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221623|NCT04556760|468774431|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221624|NCT04556760|468774432|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221625|NCT04556760|468774433|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221626|NCT04556760|468774428|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221627|NCT04556760|468774429|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221628|NCT04556760|468774430|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221629|NCT04556760|468774431|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
130221630|NCT04556760|468774432|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221631|NCT04556760|468774433|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221632|NCT02168491|468774435|FG000|Overall Study|Withdrawal by Subject|1|||
130221633|NCT01610037|468774437|FG000|All Patients|Adverse Event|27|||
130221634|NCT01610037|468774438|FG001|All Patients|Adverse Event|22|||
130221635|NCT01610037|468774439|FG002|All Patients|Adverse Event|26|||
130221636|NCT01610037|468774437|FG000|All Patients|Withdrawal by Subject|12|||
130221637|NCT01610037|468774438|FG001|All Patients|Withdrawal by Subject|10|||
130221638|NCT01610037|468774439|FG002|All Patients|Withdrawal by Subject|20|||
130221639|NCT01610037|468774437|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
130221640|NCT01610037|468774438|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
130221641|NCT01610037|468774439|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
130221642|NCT01610037|468774437|FG000|All Patients|Death|4|||
130221643|NCT01610037|468774438|FG001|All Patients|Death|2|||
130221644|NCT01610037|468774439|FG002|All Patients|Death|1|||
130221645|NCT01610037|468774437|FG000|All Patients|Protocol deviation|4|||
130221646|NCT01610037|468774438|FG001|All Patients|Protocol deviation|3|||
130221647|NCT01610037|468774439|FG002|All Patients|Protocol deviation|3|||
130221648|NCT01610037|468774437|FG000|All Patients|Abnormal laboratory value|1|||
130221649|NCT01610037|468774438|FG001|All Patients|Abnormal laboratory value|1|||
130221650|NCT01610037|468774439|FG002|All Patients|Abnormal laboratory value|0|||
130221651|NCT01610037|468774437|FG000|All Patients|Administrative problems|1|||
130221652|NCT01610037|468774438|FG001|All Patients|Administrative problems|4|||
130221653|NCT01610037|468774439|FG002|All Patients|Administrative problems|4|||
130221654|NCT01610037|468774437|FG000|All Patients|Lost to Follow-up|1|||
130221655|NCT01610037|468774438|FG001|All Patients|Lost to Follow-up|0|||
130221656|NCT01610037|468774439|FG002|All Patients|Lost to Follow-up|0|||
130221657|NCT01610037|468774437|FG000|All Patients|Abnormal test procedure result(s)|0|||
130221658|NCT01610037|468774438|FG001|All Patients|Abnormal test procedure result(s)|1|||
130221659|NCT01610037|468774439|FG002|All Patients|Abnormal test procedure result(s)|3|||
130221660|NCT01610037|468774437|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
130221661|NCT01610037|468774438|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
130221662|NCT01610037|468774439|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
130221663|NCT01610037|468774437|FG000|Treatment and Follow up Period|Death|10|||
130221664|NCT01610037|468774438|FG001|Treatment and Follow up Period|Death|5|||
130221665|NCT01610037|468774439|FG002|Treatment and Follow up Period|Death|4|||
130221666|NCT01610037|468774437|FG000|Treatment and Follow up Period|Administrative problems|1|||
130221667|NCT01610037|468774438|FG001|Treatment and Follow up Period|Administrative problems|3|||
130221668|NCT01610037|468774439|FG002|Treatment and Follow up Period|Administrative problems|2|||
130221669|NCT01610037|468774437|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
130441758|NCT01155388|469582098|FG001|Overall Study|Adverse Event|0|||
130221670|NCT01610037|468774438|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
130221671|NCT01610037|468774439|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
130221672|NCT00705757|468774440|FG000|Overall Study|Lack of Efficacy|5|||
130221673|NCT00705757|468774441|FG001|Overall Study|Lack of Efficacy|1|||
130221674|NCT00705757|468774442|FG002|Overall Study|Lack of Efficacy|3|||
130221675|NCT00705757|468774440|FG000|Overall Study|Lost to Follow-up|7|||
130221676|NCT00705757|468774441|FG001|Overall Study|Lost to Follow-up|6|||
130221677|NCT00705757|468774442|FG002|Overall Study|Lost to Follow-up|6|||
130221678|NCT00705757|468774440|FG000|Overall Study|Withdrawal by Subject|1|||
130221679|NCT00705757|468774441|FG001|Overall Study|Withdrawal by Subject|1|||
130221680|NCT00705757|468774442|FG002|Overall Study|Withdrawal by Subject|2|||
130221681|NCT01411852|468774443|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
130441759|NCT01004250|469582099|FG000|Induction Therapy Period|Adverse Event|10|||
130441760|NCT01004250|469582099|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
130441761|NCT01004250|469582099|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
130441762|NCT01004250|469582099|FG000|Induction Therapy Period|Physician Decision|2|||
130441763|NCT01004250|469582099|FG000|Maintenance Therapy Period|Adverse Event|15|||
130552807|NCT03224325|469991542|FG005|Overall Study|Adverse Event|0|||
130552808|NCT03224325|469991543|FG006|Overall Study|Adverse Event|1|||
130552809|NCT03224325|469991537|FG000|Overall Study|Withdrawal by Subject|0|||
130552810|NCT03224325|469991538|FG001|Overall Study|Withdrawal by Subject|0|||
130552811|NCT03224325|469991539|FG002|Overall Study|Withdrawal by Subject|0|||
130686285|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686286|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686287|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686288|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686289|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686290|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686291|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686292|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686293|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130686294|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686295|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686296|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
130686297|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130686298|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686299|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686300|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686301|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686302|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686303|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686304|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686305|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686306|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686307|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686308|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686309|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686310|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686311|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686312|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686313|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686314|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
130686315|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686316|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686317|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
130686318|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
130686319|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686320|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686321|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686322|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686323|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686324|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686325|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686326|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686327|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686328|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686329|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686330|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686331|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686332|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686333|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686334|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686335|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
130686336|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130552812|NCT03224325|469991540|FG003|Overall Study|Withdrawal by Subject|1|||
130552813|NCT03224325|469991541|FG004|Overall Study|Withdrawal by Subject|0|||
130552814|NCT03224325|469991542|FG005|Overall Study|Withdrawal by Subject|0|||
130552815|NCT03224325|469991543|FG006|Overall Study|Withdrawal by Subject|0|||
130552816|NCT02120625|469991545|FG000|Overall Study|Physician Decision|2|||
130552817|NCT01776424|469991551|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
130686337|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686338|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
130686339|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686340|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686341|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686342|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686343|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686344|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686345|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686346|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686347|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686348|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686349|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686350|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130221682|NCT01411852|468774444|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
130221683|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130221684|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130221685|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Found to be under age|0|||
130221686|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Found to be under age|1|||
130221687|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
130221688|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
130221689|NCT01411852|468774443|FG000|Hospital Intervention Phase|Severe head injury|5|||
130221690|NCT01411852|468774444|FG001|Hospital Intervention Phase|Severe head injury|4|||
130221691|NCT01411852|468774443|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
130221692|NCT01411852|468774444|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
130221693|NCT01411852|468774443|FG000|Hospital Intervention Phase|Miscommunication error|1|||
130221694|NCT01411852|468774444|FG001|Hospital Intervention Phase|Miscommunication error|2|||
130221695|NCT01411852|468774443|FG000|Hospital Intervention Phase|CPR administered|3|||
130221696|NCT01411852|468774444|FG001|Hospital Intervention Phase|CPR administered|1|||
130221697|NCT01411852|468774443|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
130221698|NCT01411852|468774444|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
130221699|NCT01411852|468774443|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
130221700|NCT01411852|468774444|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
130221701|NCT01411852|468774443|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
130221702|NCT01411852|468774444|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
130221703|NCT01411852|468774443|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
130221704|NCT01411852|468774444|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
130221705|NCT01411852|468774443|FG000|Hospital Intervention Phase|Other ineligible|2|||
130221706|NCT01411852|468774444|FG001|Hospital Intervention Phase|Other ineligible|2|||
130221707|NCT01411852|468774443|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
130221708|NCT01411852|468774444|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
130221709|NCT01411852|468774443|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
130221710|NCT01411852|468774444|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
130221711|NCT01411852|468774443|FG000|Hospital Intervention Phase|Vascular access failed|1|||
130221712|NCT01411852|468774444|FG001|Hospital Intervention Phase|Vascular access failed|0|||
130221713|NCT03743025|468774445|FG000|Overall Study|Surgery was cancelled|2|||
130221714|NCT03743025|468774446|FG001|Overall Study|Surgery was cancelled|1|||
130221715|NCT02420119|468774447|FG000|Overall Study|insufficient laboratory data|5|||
130221716|NCT00807885|468774448|FG000|Overall Study|Lost to Follow-up|0|||
130221717|NCT00807885|468774449|FG001|Overall Study|Lost to Follow-up|0|||
130221718|NCT00807885|468774450|FG002|Overall Study|Lost to Follow-up|0|||
130221719|NCT00807885|468774451|FG003|Overall Study|Lost to Follow-up|0|||
130221720|NCT00807885|468774452|FG004|Overall Study|Lost to Follow-up|0|||
130221721|NCT00807885|468774453|FG005|Overall Study|Lost to Follow-up|1|||
130221722|NCT00807885|468774454|FG006|Overall Study|Lost to Follow-up|0|||
130221723|NCT00807885|468774455|FG007|Overall Study|Lost to Follow-up|0|||
130221724|NCT00807885|468774456|FG008|Overall Study|Lost to Follow-up|0|||
130221725|NCT03126786|468774457|FG000|Overall Study|Adverse Event|3|||
130221726|NCT03126786|468774458|FG001|Overall Study|Adverse Event|0|||
130686351|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130221727|NCT03126786|468774457|FG000|Overall Study|Lost to Follow-up|0|||
130221728|NCT03126786|468774458|FG001|Overall Study|Lost to Follow-up|1|||
130221729|NCT03126786|468774457|FG000|Overall Study|Withdrawal by Subject|3|||
130221730|NCT03126786|468774458|FG001|Overall Study|Withdrawal by Subject|1|||
130221731|NCT00227539|468774459|FG000|Overall Study|Protocol Violation|1|||
130221732|NCT00991289|468774460|FG000|Overall Study|Adverse Event|1|||
130221733|NCT00991289|468774460|FG000|Overall Study|Physician Decision|2|||
130221734|NCT00991289|468774460|FG000|Overall Study|Withdrawal by Subject|3|||
130354656|NCT01927341|469271271|FG002|Phase 1b|Lost to Follow-up|0|||
130354657|NCT01927341|469271272|FG003|Phase 1b|Lost to Follow-up|0|||
130552818|NCT01776424|469991552|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
130552819|NCT01776424|469991553|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
130552820|NCT01776424|469991551|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
130552821|NCT01776424|469991552|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
130552822|NCT01776424|469991553|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
130552823|NCT01776424|469991551|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
130552824|NCT01776424|469991552|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
130552825|NCT01776424|469991553|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
130552826|NCT01776424|469991551|FG000|LTOLE Part (Open Label)|Refused|5|||
130441764|NCT01004250|469582099|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
130441765|NCT01004250|469582099|FG000|Maintenance Therapy Period|Protocol Violation|1|||
130441766|NCT01004250|469582099|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
130441767|NCT01004250|469582099|FG000|Maintenance Therapy Period|Physician Decision|4|||
130441768|NCT01004250|469582099|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
130441769|NCT03943589|469582100|FG000|Overall Study|Death|1|||
130441770|NCT03943589|469582100|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
130441771|NCT00900627|469582101|FG000|Overall Study|Condition under investigation worsened|4|||
130441772|NCT00900627|469582102|FG001|Overall Study|Condition under investigation worsened|0|||
130441773|NCT00900627|469582103|FG002|Overall Study|Condition under investigation worsened|5|||
130441774|NCT00900627|469582104|FG003|Overall Study|Condition under investigation worsened|3|||
130552827|NCT01776424|469991552|FG001|LTOLE Part (Open Label)|Refused|2|||
130686352|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686353|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686354|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686355|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686356|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130686357|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686358|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686359|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130686360|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686361|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686362|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686363|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686364|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686365|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686366|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686367|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686368|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686369|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686370|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686371|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686372|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686373|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130354658|NCT01927341|469271273|FG004|Phase 1b|Lost to Follow-up|0|||
130354659|NCT01927341|469271269|FG000|Phase 1b|Death|2|||
130354660|NCT01927341|469271270|FG001|Phase 1b|Death|0|||
130354661|NCT01927341|469271271|FG002|Phase 1b|Death|0|||
130354662|NCT01927341|469271272|FG003|Phase 1b|Death|0|||
130354663|NCT01927341|469271273|FG004|Phase 1b|Death|0|||
130354664|NCT01927341|469271269|FG000|Phase 1b|Follow-up completed|7|||
130354665|NCT01927341|469271270|FG001|Phase 1b|Follow-up completed|0|||
130354666|NCT01927341|469271271|FG002|Phase 1b|Follow-up completed|0|||
130354667|NCT01927341|469271272|FG003|Phase 1b|Follow-up completed|0|||
130354668|NCT01927341|469271273|FG004|Phase 1b|Follow-up completed|0|||
130354669|NCT01927341|469271269|FG000|Phase 2|Lost to Follow-up|0|||
130354670|NCT01927341|469271270|FG001|Phase 2|Lost to Follow-up|1|||
130354671|NCT01927341|469271271|FG002|Phase 2|Lost to Follow-up|0|||
130354672|NCT01927341|469271272|FG003|Phase 2|Lost to Follow-up|0|||
130354673|NCT01927341|469271273|FG004|Phase 2|Lost to Follow-up|0|||
130354674|NCT01927341|469271269|FG000|Phase 2|Participant withdrew consent|0|||
130354675|NCT01927341|469271270|FG001|Phase 2|Participant withdrew consent|2|||
130354676|NCT01927341|469271271|FG002|Phase 2|Participant withdrew consent|1|||
130354677|NCT01927341|469271272|FG003|Phase 2|Participant withdrew consent|2|||
130354678|NCT01927341|469271273|FG004|Phase 2|Participant withdrew consent|3|||
130354679|NCT01927341|469271269|FG000|Phase 2|Death|0|||
130354680|NCT01927341|469271270|FG001|Phase 2|Death|4|||
130354681|NCT01927341|469271271|FG002|Phase 2|Death|0|||
130354682|NCT01927341|469271272|FG003|Phase 2|Death|3|||
130354683|NCT01927341|469271273|FG004|Phase 2|Death|2|||
130354684|NCT01927341|469271269|FG000|Phase 2|New cancer therapy|0|||
130354685|NCT01927341|469271270|FG001|Phase 2|New cancer therapy|1|||
130354686|NCT01927341|469271271|FG002|Phase 2|New cancer therapy|0|||
130441775|NCT00900627|469582105|FG004|Overall Study|Condition under investigation worsened|0|||
130441776|NCT00900627|469582106|FG005|Overall Study|Condition under investigation worsened|0|||
130221735|NCT00991289|468774460|FG000|Overall Study|Lost to Follow-up|4|||
130221736|NCT00991289|468774460|FG000|Overall Study|Protocol Violation|2|||
130221737|NCT00426764|468774461|FG000|Overall Study|Protocol Violation|1|||
130221738|NCT00426764|468774461|FG000|Overall Study|Withdrawal by Subject|4|||
130221739|NCT00426764|468774461|FG000|Overall Study|Physician Decision|6|||
130221740|NCT00426764|468774461|FG000|Overall Study|Compassionate Use|1|||
130221741|NCT00426764|468774461|FG000|Overall Study|Progressive Disease|83|||
130221742|NCT00426764|468774461|FG000|Overall Study|Adverse Event|24|||
130221743|NCT00426764|468774461|FG000|Overall Study|Other|1|||
130221744|NCT00426764|468774461|FG000|Overall Study|Death|1|||
130221745|NCT00426764|468774461|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
130221746|NCT03804268|468774464|FG000|Overall Study|Adverse Event|2|||
130221747|NCT03804268|468774465|FG001|Overall Study|Adverse Event|2|||
130221748|NCT03804268|468774464|FG000|Overall Study|Withdrawal by Subject|2|||
130221749|NCT03804268|468774465|FG001|Overall Study|Withdrawal by Subject|0|||
130221750|NCT03804268|468774464|FG000|Overall Study|Lost to Follow-up|1|||
130221751|NCT03804268|468774465|FG001|Overall Study|Lost to Follow-up|0|||
130221752|NCT03804268|468774464|FG000|Overall Study|Physician Decision|2|||
130221753|NCT03804268|468774465|FG001|Overall Study|Physician Decision|0|||
130221754|NCT02716779|468774466|FG000|Monotherapy|Adverse Event|0|||
130221755|NCT02716779|468774467|FG001|Monotherapy|Adverse Event|1|||
130221756|NCT02716779|468774468|FG002|Monotherapy|Adverse Event|1|||
130221757|NCT02716779|468774466|FG000|Combination Therapy|Adverse Event|0|||
130221758|NCT02716779|468774467|FG001|Combination Therapy|Adverse Event|2|||
130221759|NCT02716779|468774468|FG002|Combination Therapy|Adverse Event|1|||
130221760|NCT01843803|468774471|FG000|Overall Study|not a Veteran, did not see provider|1|||
130221761|NCT01843803|468774472|FG001|Overall Study|not a Veteran, did not see provider|3|||
130221762|NCT01051817|468774480|FG000|Overall Study|Adverse Event|0|||
130221763|NCT01051817|468774481|FG001|Overall Study|Adverse Event|2|||
130221764|NCT01051817|468774480|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
130221765|NCT01051817|468774481|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
130221766|NCT01051817|468774480|FG000|Overall Study|Withdrawal by Subject|3|||
130221767|NCT01051817|468774481|FG001|Overall Study|Withdrawal by Subject|5|||
130221768|NCT01051817|468774480|FG000|Overall Study|Protocol Violation|0|||
130221769|NCT01051817|468774481|FG001|Overall Study|Protocol Violation|1|||
130221770|NCT02989402|468774482|FG000|Overall Study|Adverse event, or serious adverse event|4|||
130221771|NCT02989402|468774482|FG000|Overall Study|Death|2|||
130221772|NCT02989402|468774482|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
130221773|NCT02989402|468774482|FG000|Overall Study|Lost to Follow-up|8|||
130221774|NCT02989402|468774482|FG000|Overall Study|Patient no longer on monotherapy|1|||
130221775|NCT02989402|468774482|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
130221776|NCT02989402|468774482|FG000|Overall Study|Withdrawal by Subject|7|||
130221777|NCT02989402|468774482|FG000|Overall Study|Other|2|||
130221778|NCT02686164|468774484|FG000|Overall Study|Adverse Event|1|||
130221779|NCT02686164|468774484|FG000|Overall Study|Withdrawal of consent|1|||
130354687|NCT01927341|469271272|FG003|Phase 2|New cancer therapy|4|||
130354688|NCT01927341|469271273|FG004|Phase 2|New cancer therapy|1|||
130354689|NCT01927341|469271269|FG000|Phase 2|Disease progression|0|||
130354690|NCT01927341|469271270|FG001|Phase 2|Disease progression|1|||
130354691|NCT01927341|469271271|FG002|Phase 2|Disease progression|1|||
130354692|NCT01927341|469271272|FG003|Phase 2|Disease progression|1|||
130354693|NCT01927341|469271273|FG004|Phase 2|Disease progression|0|||
130354694|NCT01927341|469271269|FG000|Phase 2|Follow-up completed|0|||
130354695|NCT01927341|469271270|FG001|Phase 2|Follow-up completed|6|||
130354696|NCT01927341|469271271|FG002|Phase 2|Follow-up completed|3|||
130354697|NCT01927341|469271272|FG003|Phase 2|Follow-up completed|5|||
130354698|NCT01927341|469271273|FG004|Phase 2|Follow-up completed|2|||
130354699|NCT01397201|469271274|FG000|Overall Study|Not treated|0|||
130354700|NCT01397201|469271275|FG001|Overall Study|Not treated|0|||
130354701|NCT01397201|469271276|FG002|Overall Study|Not treated|1|||
130354702|NCT01397201|469271277|FG003|Overall Study|Not treated|0|||
130441777|NCT00900627|469582101|FG000|Overall Study|Withdrawal by Subject|1|||
130221780|NCT02686164|468774484|FG000|Overall Study|Clinical progression|1|||
130221781|NCT02824627|468774487|FG000|Overall Study|Adverse Event|1|||
130221782|NCT02824627|468774488|FG001|Overall Study|Adverse Event|2|||
130221783|NCT02824627|468774487|FG000|Overall Study|Lost to Follow-up|2|||
130221784|NCT02824627|468774488|FG001|Overall Study|Lost to Follow-up|1|||
130221785|NCT00672633|468774489|FG000|Overall Study|Withdrawal by Subject|0|||
130221786|NCT00672633|468774490|FG001|Overall Study|Withdrawal by Subject|1|||
130221787|NCT01938846|468774491|FG000|Overall Study|Progressive disease|26|||
130221788|NCT01938846|468774492|FG001|Overall Study|Progressive disease|18|||
130221789|NCT01938846|468774493|FG002|Overall Study|Progressive disease|16|||
130354703|NCT01397201|469271278|FG004|Overall Study|Not treated|0|||
130354704|NCT01397201|469271274|FG000|Overall Study|Not yet defined|3|||
130354705|NCT01397201|469271275|FG001|Overall Study|Not yet defined|6|||
130221790|NCT01938846|468774491|FG000|Overall Study|Adverse Event|8|||
130221791|NCT01938846|468774492|FG001|Overall Study|Adverse Event|4|||
130354706|NCT01397201|469271276|FG002|Overall Study|Not yet defined|5|||
130354707|NCT01397201|469271277|FG003|Overall Study|Not yet defined|5|||
130221792|NCT01938846|468774493|FG002|Overall Study|Adverse Event|3|||
130221793|NCT01938846|468774491|FG000|Overall Study|Withdrawal by Subject|2|||
130221794|NCT01938846|468774492|FG001|Overall Study|Withdrawal by Subject|2|||
130221795|NCT01938846|468774493|FG002|Overall Study|Withdrawal by Subject|1|||
130221796|NCT01938846|468774491|FG000|Overall Study|Other than listed|5|||
130221797|NCT01938846|468774492|FG001|Overall Study|Other than listed|1|||
130221798|NCT01938846|468774493|FG002|Overall Study|Other than listed|4|||
130221799|NCT02324361|468774496|FG000|Overall Study|Lost to Follow-up|5|||
130221800|NCT02324361|468774497|FG001|Overall Study|Lost to Follow-up|2|||
130221801|NCT01519817|468776158|FG000|Overall Study|Withdrawal by Subject|1|||
130221802|NCT01519817|468776159|FG001|Overall Study|Withdrawal by Subject|0|||
130221803|NCT01519817|468776160|FG002|Overall Study|Withdrawal by Subject|0|||
130221804|NCT01519817|468776161|FG003|Overall Study|Withdrawal by Subject|0|||
130221805|NCT01519817|468776158|FG000|Overall Study|Off study due to infection|0|||
130221806|NCT01519817|468776159|FG001|Overall Study|Off study due to infection|0|||
130221807|NCT01519817|468776160|FG002|Overall Study|Off study due to infection|0|||
130221808|NCT01519817|468776161|FG003|Overall Study|Off study due to infection|1|||
130221809|NCT02922153|468776162|FG000|Overall Study|Death|8|||
130221810|NCT02922153|468776163|FG001|Overall Study|Death|1|||
130221811|NCT02922153|468776162|FG000|Overall Study|Lost to Follow-up|1|||
130221812|NCT02922153|468776163|FG001|Overall Study|Lost to Follow-up|0|||
130221813|NCT02922153|468776162|FG000|Overall Study|Physician Decision|1|||
130221814|NCT02922153|468776163|FG001|Overall Study|Physician Decision|1|||
130221815|NCT02692586|468776168|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
130221816|NCT02692586|468776168|FG000|Overall Study|Received adjunctive thrombolytics|2|||
130221817|NCT03234036|468776170|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
130221818|NCT03234036|468776171|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
130221819|NCT03234036|468776172|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130221820|NCT03234036|468776173|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130221821|NCT02999789|468776174|FG000|Overall Study|Withdrawal by Subject|0|||
130221822|NCT02999789|468776175|FG001|Overall Study|Withdrawal by Subject|1|||
130221823|NCT02999789|468776174|FG000|Overall Study|Became ineligible|1|||
130221824|NCT02999789|468776175|FG001|Overall Study|Became ineligible|2|||
130221825|NCT04613739|468776178|FG000|Overall Study|Lost to Follow-up|6|||
130221826|NCT04613739|468776179|FG001|Overall Study|Lost to Follow-up|9|||
130221827|NCT04613739|468776178|FG000|Overall Study|potentially duplicative/fraudulent|1|||
130221828|NCT04613739|468776179|FG001|Overall Study|potentially duplicative/fraudulent|3|||
130221829|NCT01447407|468776180|FG000|Overall Study|Withdrawal by Subject|2|||
130221830|NCT01447407|468776181|FG001|Overall Study|Withdrawal by Subject|0|||
130221831|NCT01447407|468776182|FG002|Overall Study|Withdrawal by Subject|0|||
130221832|NCT01447407|468776183|FG003|Overall Study|Withdrawal by Subject|1|||
130221833|NCT01447407|468776180|FG000|Overall Study|Physician Decision|0|||
130221834|NCT01447407|468776181|FG001|Overall Study|Physician Decision|0|||
130221835|NCT01447407|468776182|FG002|Overall Study|Physician Decision|1|||
130221836|NCT01447407|468776183|FG003|Overall Study|Physician Decision|1|||
130221837|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
130221838|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
130221839|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
130221840|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Death|0|||
130221841|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Death|1|||
130221842|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Death|0|||
130221843|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130221844|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130221845|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
130221846|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130221847|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130221848|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130221849|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130221850|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130221851|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130221852|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Other|4|||
130221853|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Other|7|||
130221854|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Other|2|||
130221855|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130221856|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130221857|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130221858|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130221859|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Death|1|||
130221860|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130221861|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130354708|NCT01397201|469271278|FG004|Overall Study|Not yet defined|4|||
130221862|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130221863|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130221864|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130221865|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130221866|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130221867|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130221868|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130221869|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130221870|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
130441778|NCT00900627|469582102|FG001|Overall Study|Withdrawal by Subject|0|||
130441779|NCT00900627|469582103|FG002|Overall Study|Withdrawal by Subject|1|||
130441780|NCT00900627|469582104|FG003|Overall Study|Withdrawal by Subject|0|||
130441781|NCT00900627|469582105|FG004|Overall Study|Withdrawal by Subject|1|||
130441782|NCT00900627|469582106|FG005|Overall Study|Withdrawal by Subject|2|||
130441783|NCT00900627|469582101|FG000|Overall Study|Adverse Event|1|||
130441784|NCT00900627|469582102|FG001|Overall Study|Adverse Event|2|||
130441785|NCT00900627|469582103|FG002|Overall Study|Adverse Event|0|||
130441786|NCT00900627|469582104|FG003|Overall Study|Adverse Event|3|||
130441787|NCT00900627|469582105|FG004|Overall Study|Adverse Event|0|||
130441788|NCT00900627|469582106|FG005|Overall Study|Adverse Event|0|||
130441789|NCT00900627|469582101|FG000|Overall Study|Death|0|||
130441790|NCT00900627|469582102|FG001|Overall Study|Death|0|||
130221871|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130441791|NCT00900627|469582103|FG002|Overall Study|Death|0|||
130686374|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686375|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686376|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686377|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686378|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686379|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686380|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
130686381|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686382|NCT01313780|470477952|FG000|Overall Study|Lack of Efficacy|4|||
130686383|NCT01313780|470477953|FG001|Overall Study|Lack of Efficacy|2|||
130686384|NCT01313780|470477952|FG000|Overall Study|Adverse Event|6|||
130686385|NCT01313780|470477953|FG001|Overall Study|Adverse Event|11|||
130686386|NCT01313780|470477952|FG000|Overall Study|Withdrawal by Subject|2|||
130686387|NCT01313780|470477953|FG001|Overall Study|Withdrawal by Subject|8|||
130686388|NCT01313780|470477952|FG000|Overall Study|Protocol Violation|10|||
130686389|NCT01313780|470477953|FG001|Overall Study|Protocol Violation|4|||
130441792|NCT00900627|469582104|FG003|Overall Study|Death|0|||
130441793|NCT00900627|469582105|FG004|Overall Study|Death|28|||
130441794|NCT00900627|469582106|FG005|Overall Study|Death|24|||
130441795|NCT00373295|469582107|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130441796|NCT00373295|469582108|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
130441797|NCT00373295|469582109|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130441798|NCT00373295|469582110|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130441799|NCT00373295|469582111|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130441800|NCT00373295|469582112|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130441801|NCT00830947|469582113|FG000|Overall Study|Lost to Follow-up|4|||
130441802|NCT00830947|469582114|FG001|Overall Study|Lost to Follow-up|4|||
130441803|NCT02462083|469582115|FG000|Overall Study|Sponsor request|39|||
130441804|NCT02462083|469582115|FG000|Overall Study|Withdrawal by Subject|87|||
130441805|NCT02462083|469582115|FG000|Overall Study|Lost to Follow-up|41|||
130441806|NCT02462083|469582115|FG000|Overall Study|Lack of Efficacy|151|||
130441807|NCT02462083|469582115|FG000|Overall Study|Pregnancy|1|||
130441808|NCT02462083|469582115|FG000|Overall Study|Protocol Violation|6|||
130441809|NCT02462083|469582115|FG000|Overall Study|Adverse Event|33|||
130441810|NCT02462083|469582115|FG000|Overall Study|Worsening condition|16|||
130441811|NCT02462083|469582115|FG000|Overall Study|Other than specified|45|||
130686390|NCT01313780|470477952|FG000|Overall Study|missing data|3|||
130686391|NCT01313780|470477953|FG001|Overall Study|missing data|3|||
130686392|NCT00731783|470477954|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
130441812|NCT02291289|469582116|FG000|Induction Treatment|Withdrawal by Subject|0|||
130441813|NCT02291289|469582117|FG001|Induction Treatment|Withdrawal by Subject|0|||
130441814|NCT02291289|469582118|FG002|Induction Treatment|Withdrawal by Subject|0|||
130441815|NCT02291289|469582119|FG003|Induction Treatment|Withdrawal by Subject|24|||
130441816|NCT02291289|469582120|FG004|Induction Treatment|Withdrawal by Subject|0|||
130441817|NCT02291289|469582121|FG005|Induction Treatment|Withdrawal by Subject|0|||
130441818|NCT02291289|469582122|FG006|Induction Treatment|Withdrawal by Subject|0|||
130441819|NCT02291289|469582123|FG007|Induction Treatment|Withdrawal by Subject|0|||
130686393|NCT00731783|470477955|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
130686394|NCT00731783|470477954|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
130686395|NCT00731783|470477955|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
130686396|NCT00731783|470477954|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
130686397|NCT00731783|470477955|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
130686398|NCT00731783|470477954|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
130441820|NCT02291289|469582124|FG008|Induction Treatment|Withdrawal by Subject|0|||
130441821|NCT02291289|469582125|FG009|Induction Treatment|Withdrawal by Subject|18|||
130441822|NCT02291289|469582126|FG010|Induction Treatment|Withdrawal by Subject|0|||
130441823|NCT02291289|469582127|FG011|Induction Treatment|Withdrawal by Subject|0|||
130441824|NCT02291289|469582128|FG012|Induction Treatment|Withdrawal by Subject|0|||
130441825|NCT02291289|469582116|FG000|Induction Treatment|Adverse Event|0|||
130441826|NCT02291289|469582117|FG001|Induction Treatment|Adverse Event|0|||
130441827|NCT02291289|469582118|FG002|Induction Treatment|Adverse Event|0|||
130441828|NCT02291289|469582119|FG003|Induction Treatment|Adverse Event|3|||
130441829|NCT02291289|469582120|FG004|Induction Treatment|Adverse Event|0|||
130441830|NCT02291289|469582121|FG005|Induction Treatment|Adverse Event|0|||
130441831|NCT02291289|469582122|FG006|Induction Treatment|Adverse Event|0|||
130441832|NCT02291289|469582123|FG007|Induction Treatment|Adverse Event|0|||
130441833|NCT02291289|469582124|FG008|Induction Treatment|Adverse Event|0|||
130441834|NCT02291289|469582125|FG009|Induction Treatment|Adverse Event|1|||
130441835|NCT02291289|469582126|FG010|Induction Treatment|Adverse Event|0|||
130441836|NCT02291289|469582127|FG011|Induction Treatment|Adverse Event|0|||
130441837|NCT02291289|469582128|FG012|Induction Treatment|Adverse Event|0|||
130441838|NCT02291289|469582116|FG000|Induction Treatment|Death|25|||
130686399|NCT00731783|470477955|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
130686400|NCT05369208|470479530|FG000|Core Phase|Prohibited Medication Required|2|||
130686401|NCT05369208|470479530|FG000|Core Phase|Adverse Event|1|||
130686402|NCT05369208|470479530|FG000|Core Phase|Lack of Efficacy|1|||
130686403|NCT03235739|470479531|FG000|Overall Study|Withdrawal by Subject|2|||
130686404|NCT03235739|470479532|FG001|Overall Study|Withdrawal by Subject|2|||
130686405|NCT03235739|470479531|FG000|Overall Study|Physician Decision|0|||
130686406|NCT03235739|470479532|FG001|Overall Study|Physician Decision|1|||
130686407|NCT00467896|470479533|FG000|Overall Study|Consent Withdrawal|18|||
130686408|NCT00467896|470479533|FG000|Overall Study|Adverse Event|7|||
130686409|NCT00467896|470479533|FG000|Overall Study|Serious Adverse Event|13|||
130686410|NCT00467896|470479533|FG000|Overall Study|Non-compliance|3|||
130686411|NCT00467896|470479533|FG000|Overall Study|Changed therapy|2|||
130686412|NCT00467896|470479533|FG000|Overall Study|Patient received transplant|2|||
130686413|NCT00467896|470479533|FG000|Overall Study|Patient had atrial septostomy|1|||
130686414|NCT00467896|470479533|FG000|Overall Study|Patient weaned off iloprost|1|||
130686415|NCT00467896|470479533|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
130686416|NCT00467896|470479533|FG000|Overall Study|Started intravenous prostacyclin|1|||
130686417|NCT00467896|470479533|FG000|Overall Study|Started inhaled Remodulin|1|||
130686418|NCT00467896|470479533|FG000|Overall Study|Patient had no improvement|1|||
130686419|NCT03772522|470479534|FG000|Pre-intervention|Withdrawal by Subject|3|||
130686420|NCT03772522|470479535|FG001|Pre-intervention|Withdrawal by Subject|4|||
130686421|NCT03772522|470479534|FG000|Intervention|Withdrawal by Subject|1|||
130686422|NCT03772522|470479535|FG001|Intervention|Withdrawal by Subject|0|||
130686423|NCT03772522|470479534|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
130686424|NCT03772522|470479535|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
130686425|NCT03818581|470479536|FG000|Overall Study|Adverse Event|1|||
130686426|NCT03818581|470479537|FG001|Overall Study|Adverse Event|0|||
130686427|NCT03818581|470479538|FG002|Overall Study|Adverse Event|0|||
130686428|NCT03818581|470479539|FG003|Overall Study|Adverse Event|0|||
130686429|NCT03818581|470479540|FG004|Overall Study|Adverse Event|0|||
130686430|NCT03818581|470479536|FG000|Overall Study|Covid-19|2|||
130686431|NCT03818581|470479537|FG001|Overall Study|Covid-19|0|||
130686432|NCT03818581|470479538|FG002|Overall Study|Covid-19|0|||
130686433|NCT03818581|470479539|FG003|Overall Study|Covid-19|0|||
130686434|NCT03818581|470479540|FG004|Overall Study|Covid-19|1|||
130686435|NCT03818581|470479536|FG000|Overall Study|Withdrawal by Subject|0|||
130686436|NCT03818581|470479537|FG001|Overall Study|Withdrawal by Subject|0|||
130686437|NCT03818581|470479538|FG002|Overall Study|Withdrawal by Subject|0|||
130686438|NCT03818581|470479539|FG003|Overall Study|Withdrawal by Subject|0|||
130441839|NCT02291289|469582117|FG001|Induction Treatment|Death|0|||
130441840|NCT02291289|469582118|FG002|Induction Treatment|Death|0|||
130441841|NCT02291289|469582119|FG003|Induction Treatment|Death|111|||
130441842|NCT02291289|469582120|FG004|Induction Treatment|Death|0|||
130441843|NCT02291289|469582121|FG005|Induction Treatment|Death|0|||
130441844|NCT02291289|469582122|FG006|Induction Treatment|Death|1|||
130686439|NCT03818581|470479540|FG004|Overall Study|Withdrawal by Subject|1|||
130686440|NCT03818581|470479536|FG000|Overall Study|No longer met study criteria|0|||
130686441|NCT03818581|470479537|FG001|Overall Study|No longer met study criteria|0|||
130686442|NCT03818581|470479538|FG002|Overall Study|No longer met study criteria|0|||
130686443|NCT03818581|470479539|FG003|Overall Study|No longer met study criteria|0|||
130686444|NCT03818581|470479540|FG004|Overall Study|No longer met study criteria|1|||
130686445|NCT00462345|470479541|FG000|Overall Study|Withdrawal by Subject|2|||
130686446|NCT00462345|470479541|FG000|Overall Study|Did not complete second course|1|||
130686447|NCT01149473|470479542|FG000|First Intervention|Adverse Event|1|||
130686448|NCT01149473|470479543|FG001|First Intervention|Adverse Event|1|||
130686449|NCT01149473|470479542|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130686450|NCT01149473|470479543|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130686451|NCT04089735|470479544|FG000|Overall Study|Adverse Event|1|||
130686452|NCT04089735|470479545|FG001|Overall Study|Adverse Event|0|||
130686453|NCT04089735|470479546|FG002|Overall Study|Adverse Event|1|||
130686454|NCT04089735|470479547|FG003|Overall Study|Adverse Event|1|||
130686455|NCT04089735|470479548|FG004|Overall Study|Adverse Event|0|||
130686456|NCT04089735|470479549|FG005|Overall Study|Adverse Event|0|||
130686457|NCT04089735|470479544|FG000|Overall Study|Physician Decision|0|||
130221872|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130221873|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221874|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221875|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221876|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Other|5|||
130221877|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Other|2|||
130221878|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Other|1|||
130221879|NCT00249873|468776187|FG000|Overall Study|Not treated|7|||
130221880|NCT00249873|468776188|FG001|Overall Study|Not treated|8|||
130221881|NCT00249873|468776187|FG000|Overall Study|Significant thrombocytopenia|9|||
130221882|NCT00249873|468776188|FG001|Overall Study|Significant thrombocytopenia|8|||
130221883|NCT00249873|468776187|FG000|Overall Study|Severe allergic reaction|8|||
130221884|NCT00249873|468776188|FG001|Overall Study|Severe allergic reaction|1|||
130221885|NCT00249873|468776187|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
130221886|NCT00249873|468776188|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
130221887|NCT00249873|468776187|FG000|Overall Study|Other Serious Adverse Event|86|||
130221888|NCT00249873|468776188|FG001|Overall Study|Other Serious Adverse Event|97|||
130221889|NCT00249873|468776187|FG000|Overall Study|Qualifying condition not present|20|||
130221890|NCT00249873|468776188|FG001|Overall Study|Qualifying condition not present|23|||
130221891|NCT00249873|468776187|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
130221892|NCT00249873|468776188|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
130221893|NCT00249873|468776187|FG000|Overall Study|Withdrawal by Subject|504|||
130221894|NCT00249873|468776188|FG001|Overall Study|Withdrawal by Subject|466|||
130221895|NCT00249873|468776187|FG000|Overall Study|Lost to Follow-up|4|||
130221896|NCT00249873|468776188|FG001|Overall Study|Lost to Follow-up|7|||
130221897|NCT00249873|468776187|FG000|Overall Study|Minor bleeding|99|||
130221898|NCT00249873|468776188|FG001|Overall Study|Minor bleeding|37|||
130221899|NCT00249873|468776187|FG000|Overall Study|Non-compliance|41|||
130221900|NCT00249873|468776188|FG001|Overall Study|Non-compliance|46|||
130221901|NCT00249873|468776187|FG000|Overall Study|Other non serious Adverse Event|112|||
130221902|NCT00249873|468776188|FG001|Overall Study|Other non serious Adverse Event|108|||
130221903|NCT00249873|468776187|FG000|Overall Study|Other contraindicated medication|1|||
130221904|NCT00249873|468776188|FG001|Overall Study|Other contraindicated medication|0|||
130221905|NCT00249873|468776187|FG000|Overall Study|Patient not wish to continue after May08|3|||
130221906|NCT00249873|468776188|FG001|Overall Study|Patient not wish to continue after May08|4|||
130221907|NCT00249873|468776187|FG000|Overall Study|Physician withdrew consent|59|||
130221908|NCT00249873|468776188|FG001|Overall Study|Physician withdrew consent|60|||
130221909|NCT00249873|468776187|FG000|Overall Study|Open label clopidogrel required|31|||
130221910|NCT00249873|468776188|FG001|Overall Study|Open label clopidogrel required|42|||
130221911|NCT00249873|468776187|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
130221912|NCT00249873|468776188|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
130221913|NCT00249873|468776187|FG000|Overall Study|Oral anticoagulant required|159|||
130221914|NCT00249873|468776188|FG001|Overall Study|Oral anticoagulant required|157|||
130221915|NCT00249873|468776187|FG000|Overall Study|Study drug intolerance|5|||
130221916|NCT00249873|468776188|FG001|Overall Study|Study drug intolerance|0|||
130221917|NCT00249873|468776187|FG000|Overall Study|Surgery/ procedure|9|||
130221918|NCT00249873|468776188|FG001|Overall Study|Surgery/ procedure|9|||
130221919|NCT00249873|468776187|FG000|Overall Study|Event related to cardiac condition|12|||
130221920|NCT00249873|468776188|FG001|Overall Study|Event related to cardiac condition|21|||
130221921|NCT00249873|468776187|FG000|Overall Study|Thromboembolic/outcome event|82|||
130441845|NCT02291289|469582123|FG007|Induction Treatment|Death|0|||
130441846|NCT02291289|469582124|FG008|Induction Treatment|Death|0|||
130441847|NCT02291289|469582125|FG009|Induction Treatment|Death|82|||
130686458|NCT04089735|470479545|FG001|Overall Study|Physician Decision|3|||
130221922|NCT00249873|468776188|FG001|Overall Study|Thromboembolic/outcome event|122|||
130221923|NCT03131167|468776189|FG000|Overall Study|Other (Unspecified)|0|||
130221924|NCT03131167|468776190|FG001|Overall Study|Other (Unspecified)|0|||
130221925|NCT03131167|468776191|FG002|Overall Study|Other (Unspecified)|0|||
130441848|NCT02291289|469582126|FG010|Induction Treatment|Death|0|||
130441849|NCT02291289|469582127|FG011|Induction Treatment|Death|0|||
130441850|NCT02291289|469582128|FG012|Induction Treatment|Death|0|||
130221926|NCT03131167|468776192|FG003|Overall Study|Other (Unspecified)|0|||
130686459|NCT04089735|470479546|FG002|Overall Study|Physician Decision|0|||
130221927|NCT03131167|468776193|FG004|Overall Study|Other (Unspecified)|0|||
130221928|NCT03131167|468776194|FG005|Overall Study|Other (Unspecified)|1|||
130686460|NCT04089735|470479547|FG003|Overall Study|Physician Decision|0|||
130221929|NCT03131167|468776195|FG006|Overall Study|Other (Unspecified)|0|||
130221930|NCT03131167|468776196|FG007|Overall Study|Other (Unspecified)|0|||
130221931|NCT03131167|468776197|FG008|Overall Study|Other (Unspecified)|0|||
130221932|NCT03131167|468776198|FG009|Overall Study|Other (Unspecified)|0|||
130221933|NCT03131167|468776199|FG010|Overall Study|Other (Unspecified)|0|||
130221934|NCT03131167|468776200|FG011|Overall Study|Other (Unspecified)|0|||
130221935|NCT03131167|468776201|FG012|Overall Study|Other (Unspecified)|0|||
130221936|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Death|20|||
130221937|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Death|26|||
130221938|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
130221939|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
130221940|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
130221941|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
130221942|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130221943|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130221944|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
130221945|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
130221946|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
130221947|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
130221948|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
130221949|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
130221950|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130221951|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130221952|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Other|107|||
130221953|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Other|107|||
130221954|NCT00643201|468776202|FG000|Completed Study Follow Up|Death|28|||
130221955|NCT00643201|468776203|FG001|Completed Study Follow Up|Death|34|||
130221956|NCT00643201|468776202|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
130221957|NCT00643201|468776203|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
130221958|NCT00643201|468776202|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
130221959|NCT00643201|468776203|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
130221960|NCT00643201|468776202|FG000|Completed Study Follow Up|non-specified|1|||
130221961|NCT00643201|468776203|FG001|Completed Study Follow Up|non-specified|0|||
130221962|NCT00165503|468776204|FG000|Overall Study|Death|1|||
130221963|NCT00165503|468776204|FG000|Overall Study|Lost to Follow-up|12|||
130221964|NCT00165503|468776204|FG000|Overall Study|Unresectable|3|||
130221965|NCT02976519|468776205|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221966|NCT02976519|468776206|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
130221967|NCT02976519|468776207|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221968|NCT02976519|468776208|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221969|NCT02976519|468776209|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221970|NCT02976519|468776210|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221971|NCT02976519|468776211|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221972|NCT02976519|468776205|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221973|NCT02976519|468776206|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221974|NCT02976519|468776207|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221975|NCT02976519|468776208|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
130221976|NCT02976519|468776209|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221977|NCT02976519|468776210|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221978|NCT02976519|468776211|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221979|NCT02976519|468776205|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221980|NCT02976519|468776206|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221981|NCT02976519|468776207|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221982|NCT02976519|468776208|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221983|NCT02976519|468776209|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221984|NCT02976519|468776210|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221985|NCT02976519|468776211|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
130221986|NCT02976519|468776205|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130354709|NCT01397201|469271274|FG000|Overall Study|Adverse Event|2|||
130354710|NCT01397201|469271275|FG001|Overall Study|Adverse Event|0|||
130354711|NCT01397201|469271276|FG002|Overall Study|Adverse Event|0|||
130354712|NCT01397201|469271277|FG003|Overall Study|Adverse Event|0|||
130354713|NCT01397201|469271278|FG004|Overall Study|Adverse Event|0|||
130354714|NCT00215683|469271279|FG000|Overall Study|Adverse Event|15|||
130354715|NCT00215683|469271280|FG001|Overall Study|Adverse Event|16|||
130354716|NCT00215683|469271281|FG002|Overall Study|Adverse Event|15|||
130354717|NCT00215683|469271279|FG000|Overall Study|Lack of Efficacy|5|||
130354718|NCT00215683|469271280|FG001|Overall Study|Lack of Efficacy|1|||
130354719|NCT00215683|469271281|FG002|Overall Study|Lack of Efficacy|2|||
130221987|NCT02976519|468776206|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221988|NCT02976519|468776207|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221989|NCT02976519|468776208|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221990|NCT02976519|468776209|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221991|NCT02976519|468776210|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221992|NCT02976519|468776211|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
130221993|NCT02976519|468776205|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221994|NCT02976519|468776206|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221995|NCT02976519|468776207|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221996|NCT02976519|468776208|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221997|NCT02976519|468776209|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221998|NCT02976519|468776210|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221999|NCT02976519|468776211|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
130222000|NCT02346708|468776212|FG000|Overall Study|Adverse Event|2|||
130222001|NCT02346708|468776213|FG001|Overall Study|Adverse Event|0|||
130222002|NCT02346708|468776212|FG000|Overall Study|Protocol Violation|0|||
130222003|NCT02346708|468776213|FG001|Overall Study|Protocol Violation|1|||
130222004|NCT00928434|468776214|FG000|Overall Study|Adverse Event|14|||
130222005|NCT00928434|468776215|FG001|Overall Study|Adverse Event|5|||
130222006|NCT00928434|468776216|FG002|Overall Study|Adverse Event|18|||
130222007|NCT00928434|468776214|FG000|Overall Study|Protocol Violation|5|||
130222008|NCT00928434|468776215|FG001|Overall Study|Protocol Violation|0|||
130222009|NCT00928434|468776216|FG002|Overall Study|Protocol Violation|8|||
130222010|NCT00928434|468776214|FG000|Overall Study|Physician Decision|2|||
130222011|NCT00928434|468776215|FG001|Overall Study|Physician Decision|0|||
130222012|NCT00928434|468776216|FG002|Overall Study|Physician Decision|3|||
130222013|NCT00928434|468776214|FG000|Overall Study|Lost to Follow-up|1|||
130222014|NCT00928434|468776215|FG001|Overall Study|Lost to Follow-up|0|||
130222015|NCT00928434|468776216|FG002|Overall Study|Lost to Follow-up|3|||
130222016|NCT00928434|468776214|FG000|Overall Study|Withdrawal by Subject|5|||
130222017|NCT00928434|468776215|FG001|Overall Study|Withdrawal by Subject|3|||
130222018|NCT00928434|468776216|FG002|Overall Study|Withdrawal by Subject|2|||
130222019|NCT00928434|468776214|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
130222020|NCT00928434|468776215|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
130222021|NCT00928434|468776216|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
130222022|NCT00928434|468776214|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
130222023|NCT00928434|468776215|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130222024|NCT00928434|468776216|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130222025|NCT00928434|468776214|FG000|Overall Study|Other (not meeting above criteria)|5|||
130222026|NCT00928434|468776215|FG001|Overall Study|Other (not meeting above criteria)|1|||
130222027|NCT00928434|468776216|FG002|Overall Study|Other (not meeting above criteria)|2|||
130222028|NCT01278342|468776219|FG000|Overall Study|Physician Decision|0|||
130222029|NCT01278342|468776220|FG001|Overall Study|Physician Decision|1|||
130222030|NCT01278342|468776221|FG002|Overall Study|Physician Decision|0|||
130222031|NCT01278342|468776219|FG000|Overall Study|Lost to Follow-up|1|||
130222032|NCT01278342|468776220|FG001|Overall Study|Lost to Follow-up|0|||
130222033|NCT01278342|468776221|FG002|Overall Study|Lost to Follow-up|0|||
130222034|NCT01278342|468776219|FG000|Overall Study|Administrative problems|2|||
130222035|NCT01278342|468776220|FG001|Overall Study|Administrative problems|0|||
130222036|NCT01278342|468776221|FG002|Overall Study|Administrative problems|0|||
130222037|NCT01278342|468776219|FG000|Overall Study|Other|1|||
130222038|NCT01278342|468776220|FG001|Overall Study|Other|0|||
130222039|NCT01278342|468776221|FG002|Overall Study|Other|0|||
130222040|NCT00313846|468776227|FG000|Overall Study|Withdrawal by Subject|2|||
130222041|NCT00313846|468776228|FG001|Overall Study|Withdrawal by Subject|0|||
130222042|NCT00313846|468776227|FG000|Overall Study|Adverse Event|1|||
130222043|NCT00313846|468776228|FG001|Overall Study|Adverse Event|8|||
130222044|NCT00313846|468776227|FG000|Overall Study|Administrative|2|||
130222045|NCT00313846|468776228|FG001|Overall Study|Administrative|3|||
130222046|NCT02221648|468776232|FG000|Overall Study|Withdrawal by Subject|3|||
130222047|NCT02221648|468776233|FG001|Overall Study|Withdrawal by Subject|3|||
130222048|NCT01922258|468776239|FG000|Overall Study|Lost to Follow-up|1|||
130222049|NCT01922258|468776240|FG001|Overall Study|Lost to Follow-up|1|||
130222050|NCT01922258|468776239|FG000|Overall Study|Adverse Event|9|||
130441851|NCT02291289|469582116|FG000|Induction Treatment|Lost to Follow-up|1|||
130441852|NCT02291289|469582117|FG001|Induction Treatment|Lost to Follow-up|0|||
130441853|NCT02291289|469582118|FG002|Induction Treatment|Lost to Follow-up|0|||
130222051|NCT01922258|468776240|FG001|Overall Study|Adverse Event|2|||
130222052|NCT01922258|468776239|FG000|Overall Study|Met Withdrawal Criteria|0|||
130222053|NCT01922258|468776240|FG001|Overall Study|Met Withdrawal Criteria|4|||
130222054|NCT01922258|468776239|FG000|Overall Study|Withdrawn by the Investigator|1|||
130222055|NCT01922258|468776240|FG001|Overall Study|Withdrawn by the Investigator|4|||
130222056|NCT01922258|468776239|FG000|Overall Study|Withdrawal by participant|5|||
130222057|NCT01922258|468776240|FG001|Overall Study|Withdrawal by participant|5|||
130222058|NCT00673257|468776241|FG000|Overall Study|Withdrawal by Subject|4|||
130222059|NCT00673257|468776241|FG000|Overall Study|Unable to obtain specimen|1|||
130222060|NCT04552132|468776242|FG000|Overall Study|Lost to Follow-up|4|||
130222061|NCT04552132|468776243|FG001|Overall Study|Lost to Follow-up|3|||
130222062|NCT04552132|468776242|FG000|Overall Study|Protocol Violation|1|||
130222063|NCT04552132|468776243|FG001|Overall Study|Protocol Violation|0|||
130222064|NCT02256839|468776244|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
130222065|NCT02256839|468776245|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
130222066|NCT01951417|468776260|FG000|Overall Study|Withdrawal by Subject|1|||
130222067|NCT01951417|468776260|FG000|Overall Study|Protocol Violation|2|||
130222068|NCT01951417|468776260|FG000|Overall Study|Lost to Follow-up|6|||
130222069|NCT01497067|468776261|FG000|Overall Study|Lost to Follow-up|56|||
130222070|NCT01497067|468776261|FG000|Overall Study|Adverse Event|3|||
130222071|NCT01497067|468776261|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
130222072|NCT01497067|468776261|FG000|Overall Study|Other|13|||
130222073|NCT01598610|468776266|FG000|Overall Study|Adverse Event|1|||
130222074|NCT04346199|468776267|FG000|Overall Study|Death|8|||
130222075|NCT04346199|468776268|FG001|Overall Study|Death|9|||
130222076|NCT04346199|468776267|FG000|Overall Study|Lost to Follow-up|0|||
130222077|NCT04346199|468776268|FG001|Overall Study|Lost to Follow-up|1|||
130222078|NCT04346199|468776267|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
130222079|NCT04346199|468776268|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
130222080|NCT04346199|468776267|FG000|Overall Study|Withdrawal by Subject|5|||
130222081|NCT04346199|468776268|FG001|Overall Study|Withdrawal by Subject|1|||
130222082|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130222083|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130222084|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Adverse Event|57|||
130222085|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Adverse Event|49|||
130222086|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
130222087|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
130222088|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Site closure|3|||
130222089|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Site closure|2|||
130222090|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
130222091|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
130222092|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Physician Decision|48|||
130354720|NCT00215683|469271279|FG000|Overall Study|Lost to Follow-up|0|||
130354721|NCT00215683|469271280|FG001|Overall Study|Lost to Follow-up|2|||
130354722|NCT00215683|469271281|FG002|Overall Study|Lost to Follow-up|1|||
130354723|NCT00215683|469271279|FG000|Overall Study|Withdrawal by Subject|9|||
130354724|NCT00215683|469271280|FG001|Overall Study|Withdrawal by Subject|4|||
130354725|NCT00215683|469271281|FG002|Overall Study|Withdrawal by Subject|13|||
130354726|NCT00215683|469271279|FG000|Overall Study|Physician Decision|0|||
130354727|NCT00215683|469271280|FG001|Overall Study|Physician Decision|0|||
130354728|NCT00215683|469271281|FG002|Overall Study|Physician Decision|1|||
130354729|NCT00215683|469271279|FG000|Overall Study|Difficult to attend visits|0|||
130354730|NCT00215683|469271280|FG001|Overall Study|Difficult to attend visits|1|||
130354731|NCT00215683|469271281|FG002|Overall Study|Difficult to attend visits|0|||
130354732|NCT00215683|469271279|FG000|Overall Study|No study drug available|0|||
130354733|NCT00215683|469271280|FG001|Overall Study|No study drug available|1|||
130354734|NCT00215683|469271281|FG002|Overall Study|No study drug available|0|||
130354735|NCT00215683|469271279|FG000|Overall Study|Intermittent therapy required|0|||
130354736|NCT00215683|469271280|FG001|Overall Study|Intermittent therapy required|1|||
130354737|NCT00215683|469271281|FG002|Overall Study|Intermittent therapy required|0|||
130354738|NCT04493333|469271288|FG000|Overall Study|Withdrawal by Subject|1|||
130354739|NCT04493333|469271289|FG001|Overall Study|Withdrawal by Subject|1|||
130354740|NCT04493333|469271288|FG000|Overall Study|Ineligible|0|||
130354741|NCT04493333|469271289|FG001|Overall Study|Ineligible|1|||
130354742|NCT04493333|469271288|FG000|Overall Study|Noncompliance|2|||
130354743|NCT04493333|469271289|FG001|Overall Study|Noncompliance|1|||
130354744|NCT00451451|469271292|FG000|Overall Study|Adverse Event|11|||
130354745|NCT00451451|469271293|FG001|Overall Study|Adverse Event|21|||
130354746|NCT00451451|469271294|FG002|Overall Study|Adverse Event|26|||
130354747|NCT00451451|469271295|FG003|Overall Study|Adverse Event|10|||
130354748|NCT00451451|469271292|FG000|Overall Study|Lost to Follow-up|11|||
130354749|NCT00451451|469271293|FG001|Overall Study|Lost to Follow-up|9|||
130354750|NCT00451451|469271294|FG002|Overall Study|Lost to Follow-up|8|||
130354751|NCT00451451|469271295|FG003|Overall Study|Lost to Follow-up|11|||
130222093|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Physician Decision|38|||
130222094|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
130222095|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
130222096|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
130222097|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
130354752|NCT00451451|469271292|FG000|Overall Study|Consent Withdrawn|14|||
130354753|NCT00451451|469271293|FG001|Overall Study|Consent Withdrawn|9|||
130354754|NCT00451451|469271294|FG002|Overall Study|Consent Withdrawn|17|||
130354755|NCT00451451|469271295|FG003|Overall Study|Consent Withdrawn|17|||
130354756|NCT00451451|469271292|FG000|Overall Study|Investigator Decision|6|||
130354757|NCT00451451|469271293|FG001|Overall Study|Investigator Decision|2|||
130222098|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
130222099|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
130222100|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
130222101|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
130222102|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
130222103|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
130222104|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
130222105|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
130222106|NCT03066830|468776273|FG000|Overall Study|At the Participant's own Request|16|||
130222107|NCT03066830|468776274|FG001|Overall Study|At the Participant's own Request|17|||
130222108|NCT03066830|468776273|FG000|Overall Study|Other|3|||
130222109|NCT03066830|468776274|FG001|Overall Study|Other|0|||
130222110|NCT03066830|468776273|FG000|Overall Study|Poor Compliance to Protocol|1|||
130222111|NCT03066830|468776274|FG001|Overall Study|Poor Compliance to Protocol|0|||
130222112|NCT03066830|468776273|FG000|Overall Study|Adverse Event|2|||
130222113|NCT03066830|468776274|FG001|Overall Study|Adverse Event|2|||
130222114|NCT03066830|468776273|FG000|Overall Study|Lost to Follow-up|11|||
130222115|NCT03066830|468776274|FG001|Overall Study|Lost to Follow-up|3|||
130222116|NCT02039778|468776275|FG000|Overall Study|Death|2|||
130222117|NCT02039778|468776275|FG000|Overall Study|Withdrawal by Subject|1|||
130222118|NCT02039778|468776275|FG000|Overall Study|Never started the protocol treatment|1|||
130222119|NCT00096538|468776285|FG000|Overall Study|Withdrawal by Subject|1|||
130222120|NCT01827592|468776288|FG000|Overall Study|Adverse Event|11|||
130222121|NCT01827592|468776289|FG001|Overall Study|Adverse Event|9|||
130222122|NCT01827592|468776290|FG002|Overall Study|Adverse Event|2|||
130222123|NCT01827592|468776288|FG000|Overall Study|Physician Decision|0|||
130222124|NCT01827592|468776289|FG001|Overall Study|Physician Decision|2|||
130222125|NCT01827592|468776290|FG002|Overall Study|Physician Decision|1|||
130222126|NCT01827592|468776288|FG000|Overall Study|Protocol Violation|2|||
130222127|NCT01827592|468776289|FG001|Overall Study|Protocol Violation|1|||
130222128|NCT01827592|468776290|FG002|Overall Study|Protocol Violation|0|||
130222129|NCT01827592|468776288|FG000|Overall Study|Lost to Follow-up|1|||
130222130|NCT01827592|468776289|FG001|Overall Study|Lost to Follow-up|2|||
130222131|NCT01827592|468776290|FG002|Overall Study|Lost to Follow-up|2|||
130222132|NCT01827592|468776288|FG000|Overall Study|Withdrawal by Subject|12|||
130222133|NCT01827592|468776289|FG001|Overall Study|Withdrawal by Subject|11|||
130222134|NCT01827592|468776290|FG002|Overall Study|Withdrawal by Subject|11|||
130222135|NCT01827592|468776288|FG000|Overall Study|Patient's substantial non-compliance|1|||
130222136|NCT01827592|468776289|FG001|Overall Study|Patient's substantial non-compliance|1|||
130222137|NCT01827592|468776290|FG002|Overall Study|Patient's substantial non-compliance|6|||
130222138|NCT01827592|468776288|FG000|Overall Study|Trial terminated by Sponsor|47|||
130222139|NCT01827592|468776289|FG001|Overall Study|Trial terminated by Sponsor|53|||
130222140|NCT01827592|468776290|FG002|Overall Study|Trial terminated by Sponsor|51|||
130222141|NCT01827592|468776288|FG000|Overall Study|Others|0|||
130222142|NCT01827592|468776289|FG001|Overall Study|Others|1|||
130222143|NCT01827592|468776290|FG002|Overall Study|Others|3|||
130222144|NCT01931397|468776299|FG000|Overall Study|Physician Decision|2|||
130222145|NCT01931397|468776299|FG000|Overall Study|Withdrawal by Subject|8|||
130222146|NCT01931397|468776299|FG000|Overall Study|moved out of state|1|||
130222147|NCT02058589|468776303|FG000|Overall Study|Serious Adverse Event|1|||
130222148|NCT02058589|468776304|FG001|Overall Study|Serious Adverse Event|1|||
130222149|NCT02058589|468776303|FG000|Overall Study|Non-Serious Adverse Event|1|||
130222150|NCT02058589|468776304|FG001|Overall Study|Non-Serious Adverse Event|0|||
130686461|NCT04089735|470479548|FG004|Overall Study|Physician Decision|0|||
130686462|NCT04089735|470479549|FG005|Overall Study|Physician Decision|0|||
130686463|NCT04089735|470479544|FG000|Overall Study|Withdrawal by Subject|0|||
130686464|NCT04089735|470479545|FG001|Overall Study|Withdrawal by Subject|0|||
130686465|NCT04089735|470479546|FG002|Overall Study|Withdrawal by Subject|1|||
130686466|NCT04089735|470479547|FG003|Overall Study|Withdrawal by Subject|0|||
130686467|NCT04089735|470479548|FG004|Overall Study|Withdrawal by Subject|0|||
130222151|NCT02058589|468776303|FG000|Overall Study|Withdrawal by Subject|0|||
130222152|NCT02058589|468776304|FG001|Overall Study|Withdrawal by Subject|1|||
130222153|NCT02143024|468776305|FG000|Overall Study|Lost to Follow-up|1|||
130222154|NCT02143024|468776306|FG001|Overall Study|Lost to Follow-up|1|||
130222155|NCT02143024|468776305|FG000|Overall Study|Withdrawal by Subject|1|||
130222156|NCT02143024|468776306|FG001|Overall Study|Withdrawal by Subject|0|||
130222157|NCT01945944|468776307|FG000|Overall Study|Adverse Event|0|||
130686468|NCT04089735|470479549|FG005|Overall Study|Withdrawal by Subject|0|||
130686469|NCT04089735|470479544|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130222158|NCT01945944|468776308|FG001|Overall Study|Adverse Event|2|||
130222159|NCT01945944|468776307|FG000|Overall Study|Physician Decision|1|||
130222160|NCT01945944|468776308|FG001|Overall Study|Physician Decision|0|||
130222161|NCT01945944|468776307|FG000|Overall Study|Withdrawal by Subject|0|||
130222162|NCT01945944|468776308|FG001|Overall Study|Withdrawal by Subject|1|||
130222163|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
130222164|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
130686470|NCT04089735|470479545|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
130686471|NCT04089735|470479546|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130686472|NCT04089735|470479547|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
130686473|NCT04089735|470479548|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
130686474|NCT04089735|470479549|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
130686475|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
130686476|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
130441854|NCT02291289|469582119|FG003|Induction Treatment|Lost to Follow-up|12|||
130441855|NCT02291289|469582120|FG004|Induction Treatment|Lost to Follow-up|0|||
130441856|NCT02291289|469582121|FG005|Induction Treatment|Lost to Follow-up|0|||
130441857|NCT02291289|469582122|FG006|Induction Treatment|Lost to Follow-up|0|||
130441858|NCT02291289|469582123|FG007|Induction Treatment|Lost to Follow-up|0|||
130441859|NCT02291289|469582124|FG008|Induction Treatment|Lost to Follow-up|0|||
130441860|NCT02291289|469582125|FG009|Induction Treatment|Lost to Follow-up|9|||
130441861|NCT02291289|469582126|FG010|Induction Treatment|Lost to Follow-up|0|||
130441862|NCT02291289|469582127|FG011|Induction Treatment|Lost to Follow-up|0|||
130441863|NCT02291289|469582128|FG012|Induction Treatment|Lost to Follow-up|0|||
130441864|NCT02291289|469582116|FG000|Induction Treatment|Non-Compliance|0|||
130441865|NCT02291289|469582117|FG001|Induction Treatment|Non-Compliance|0|||
130441866|NCT02291289|469582118|FG002|Induction Treatment|Non-Compliance|0|||
130441867|NCT02291289|469582119|FG003|Induction Treatment|Non-Compliance|1|||
130441868|NCT02291289|469582120|FG004|Induction Treatment|Non-Compliance|0|||
130441869|NCT02291289|469582121|FG005|Induction Treatment|Non-Compliance|0|||
130441870|NCT02291289|469582122|FG006|Induction Treatment|Non-Compliance|0|||
130441871|NCT02291289|469582123|FG007|Induction Treatment|Non-Compliance|0|||
130441872|NCT02291289|469582124|FG008|Induction Treatment|Non-Compliance|0|||
130441873|NCT02291289|469582125|FG009|Induction Treatment|Non-Compliance|1|||
130441874|NCT02291289|469582126|FG010|Induction Treatment|Non-Compliance|0|||
130441875|NCT02291289|469582127|FG011|Induction Treatment|Non-Compliance|0|||
130441876|NCT02291289|469582128|FG012|Induction Treatment|Non-Compliance|0|||
130441877|NCT02291289|469582116|FG000|Induction Treatment|Reason Not Specified|0|||
130441878|NCT02291289|469582117|FG001|Induction Treatment|Reason Not Specified|0|||
130441879|NCT02291289|469582118|FG002|Induction Treatment|Reason Not Specified|0|||
130441880|NCT02291289|469582119|FG003|Induction Treatment|Reason Not Specified|4|||
130441881|NCT02291289|469582120|FG004|Induction Treatment|Reason Not Specified|0|||
130441882|NCT02291289|469582121|FG005|Induction Treatment|Reason Not Specified|0|||
130441883|NCT02291289|469582122|FG006|Induction Treatment|Reason Not Specified|0|||
130441884|NCT02291289|469582123|FG007|Induction Treatment|Reason Not Specified|0|||
130441885|NCT02291289|469582124|FG008|Induction Treatment|Reason Not Specified|0|||
130441886|NCT02291289|469582125|FG009|Induction Treatment|Reason Not Specified|7|||
130441887|NCT02291289|469582126|FG010|Induction Treatment|Reason Not Specified|0|||
130441888|NCT02291289|469582127|FG011|Induction Treatment|Reason Not Specified|0|||
130441889|NCT02291289|469582128|FG012|Induction Treatment|Reason Not Specified|0|||
130441890|NCT02291289|469582116|FG000|Induction Treatment|Physician Decision|0|||
130441891|NCT02291289|469582117|FG001|Induction Treatment|Physician Decision|0|||
130441892|NCT02291289|469582118|FG002|Induction Treatment|Physician Decision|0|||
130441893|NCT02291289|469582119|FG003|Induction Treatment|Physician Decision|3|||
130441894|NCT02291289|469582120|FG004|Induction Treatment|Physician Decision|0|||
130441895|NCT02291289|469582121|FG005|Induction Treatment|Physician Decision|0|||
130441896|NCT02291289|469582122|FG006|Induction Treatment|Physician Decision|0|||
130441897|NCT02291289|469582123|FG007|Induction Treatment|Physician Decision|0|||
130441898|NCT02291289|469582124|FG008|Induction Treatment|Physician Decision|0|||
130441899|NCT02291289|469582125|FG009|Induction Treatment|Physician Decision|1|||
130686477|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Death|2|||
130686478|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Death|1|||
130686479|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
130686480|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
130686481|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
130686482|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
130686483|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Other|8|||
130441900|NCT02291289|469582126|FG010|Induction Treatment|Physician Decision|0|||
130441901|NCT02291289|469582127|FG011|Induction Treatment|Physician Decision|0|||
130441902|NCT02291289|469582128|FG012|Induction Treatment|Physician Decision|0|||
130441903|NCT02291289|469582116|FG000|Induction Treatment|Protocol Violation|0|||
130441904|NCT02291289|469582117|FG001|Induction Treatment|Protocol Violation|0|||
130552828|NCT01776424|469991553|FG002|LTOLE Part (Open Label)|Refused|11|||
130441905|NCT02291289|469582118|FG002|Induction Treatment|Protocol Violation|0|||
130441906|NCT02291289|469582119|FG003|Induction Treatment|Protocol Violation|3|||
130441907|NCT02291289|469582120|FG004|Induction Treatment|Protocol Violation|0|||
130441908|NCT02291289|469582121|FG005|Induction Treatment|Protocol Violation|0|||
130441909|NCT02291289|469582122|FG006|Induction Treatment|Protocol Violation|0|||
130222165|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
130222166|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
130222167|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
130222168|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
130222169|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
130222170|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
130222171|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
130222172|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
130222173|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
130222174|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
130222175|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130222176|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130222177|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
130222178|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130222179|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130222180|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
130222181|NCT02019550|468778207|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130222182|NCT02019550|468778208|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130222183|NCT04771013|468778212|FG000|Overall Study|Withdrawal by Subject|2|||
130222184|NCT04771013|468778213|FG001|Overall Study|Withdrawal by Subject|0|||
130222185|NCT04771013|468778212|FG000|Overall Study|Death|0|||
130222186|NCT04771013|468778213|FG001|Overall Study|Death|5|||
130222187|NCT04771013|468778212|FG000|Overall Study|Referred to another hospital before day 20|0|||
130222188|NCT04771013|468778213|FG001|Overall Study|Referred to another hospital before day 20|1|||
130222189|NCT00823134|468778214|FG000|Overall Study|Invalid measurement|1|||
130222190|NCT02291029|468778218|FG000|Overall Study|Withdrawal by Subject|0|||
130222191|NCT02291029|468778219|FG001|Overall Study|Withdrawal by Subject|0|||
130222192|NCT02291029|468778220|FG002|Overall Study|Withdrawal by Subject|1|||
130222193|NCT02291029|468778221|FG003|Overall Study|Withdrawal by Subject|0|||
130222194|NCT02291029|468778222|FG004|Overall Study|Withdrawal by Subject|0|||
130222195|NCT02291029|468778223|FG005|Overall Study|Withdrawal by Subject|0|||
130222196|NCT02291029|468778218|FG000|Overall Study|Adverse Event|0|||
130222197|NCT02291029|468778219|FG001|Overall Study|Adverse Event|1|||
130222198|NCT02291029|468778220|FG002|Overall Study|Adverse Event|0|||
130222199|NCT02291029|468778221|FG003|Overall Study|Adverse Event|0|||
130222200|NCT02291029|468778222|FG004|Overall Study|Adverse Event|0|||
130222201|NCT02291029|468778223|FG005|Overall Study|Adverse Event|0|||
130222202|NCT00419757|468778224|FG000|Overall Study|Adverse Event|1|||
130222203|NCT00419757|468778225|FG001|Overall Study|Adverse Event|4|||
130222204|NCT00419757|468778224|FG000|Overall Study|Lost to Follow-up|1|||
130222205|NCT00419757|468778225|FG001|Overall Study|Lost to Follow-up|4|||
130222206|NCT00419757|468778224|FG000|Overall Study|Withdrawal by Subject|7|||
130222207|NCT00419757|468778225|FG001|Overall Study|Withdrawal by Subject|1|||
130222208|NCT00419757|468778224|FG000|Overall Study|Protocol Violation|2|||
130222209|NCT00419757|468778225|FG001|Overall Study|Protocol Violation|3|||
130222210|NCT00419757|468778224|FG000|Overall Study|Study specific discontinuation criteria|4|||
130222211|NCT00419757|468778225|FG001|Overall Study|Study specific discontinuation criteria|8|||
130222212|NCT00419757|468778224|FG000|Overall Study|Multiple reasons|3|||
130222213|NCT00419757|468778225|FG001|Overall Study|Multiple reasons|1|||
130222214|NCT00493012|468778226|FG000|Overall Study|Lost to Follow-up|18|||
130222215|NCT00493012|468778227|FG001|Overall Study|Lost to Follow-up|17|||
130222216|NCT01128296|468778228|FG000|Overall Study|Physician Decision|0|||
130441910|NCT02291289|469582123|FG007|Induction Treatment|Protocol Violation|0|||
130441911|NCT02291289|469582124|FG008|Induction Treatment|Protocol Violation|0|||
130441912|NCT02291289|469582125|FG009|Induction Treatment|Protocol Violation|2|||
130222217|NCT01128296|468778229|FG001|Overall Study|Physician Decision|0|||
130222218|NCT01128296|468778230|FG002|Overall Study|Physician Decision|0|||
130222219|NCT01128296|468778231|FG003|Overall Study|Physician Decision|0|||
130222220|NCT01128296|468778232|FG004|Overall Study|Physician Decision|0|||
130222221|NCT01128296|468778233|FG005|Overall Study|Physician Decision|3|||
130222222|NCT01128296|468778228|FG000|Overall Study|Withdrawal by Subject|0|||
130222223|NCT01128296|468778229|FG001|Overall Study|Withdrawal by Subject|0|||
130222224|NCT01128296|468778230|FG002|Overall Study|Withdrawal by Subject|0|||
130222225|NCT01128296|468778231|FG003|Overall Study|Withdrawal by Subject|0|||
130222226|NCT01128296|468778232|FG004|Overall Study|Withdrawal by Subject|0|||
130222227|NCT01128296|468778233|FG005|Overall Study|Withdrawal by Subject|2|||
130222228|NCT04155463|468778234|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
130222229|NCT04155463|468778235|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
130441913|NCT02291289|469582126|FG010|Induction Treatment|Protocol Violation|0|||
130441914|NCT02291289|469582127|FG011|Induction Treatment|Protocol Violation|0|||
130441915|NCT02291289|469582128|FG012|Induction Treatment|Protocol Violation|0|||
130222230|NCT01914393|468778236|FG000|Overall Study|Protocol Violation|11|||
130222231|NCT01914393|468778237|FG001|Overall Study|Protocol Violation|3|||
130441916|NCT02291289|469582116|FG000|Induction Treatment|Missing|4|||
130222232|NCT01914393|468778238|FG002|Overall Study|Protocol Violation|19|||
130222233|NCT01914393|468778236|FG000|Overall Study|Lack of Efficacy|11|||
130222234|NCT01914393|468778237|FG001|Overall Study|Lack of Efficacy|16|||
130222235|NCT01914393|468778238|FG002|Overall Study|Lack of Efficacy|5|||
130222236|NCT01914393|468778236|FG000|Overall Study|no reason given|14|||
130222237|NCT01914393|468778237|FG001|Overall Study|no reason given|8|||
130222238|NCT01914393|468778238|FG002|Overall Study|no reason given|16|||
130222239|NCT01914393|468778236|FG000|Overall Study|Adverse Event|29|||
130222240|NCT01914393|468778237|FG001|Overall Study|Adverse Event|18|||
130222241|NCT01914393|468778238|FG002|Overall Study|Adverse Event|31|||
130222242|NCT01914393|468778236|FG000|Overall Study|Withdrawal by Subject|38|||
130222243|NCT01914393|468778237|FG001|Overall Study|Withdrawal by Subject|20|||
130222244|NCT01914393|468778238|FG002|Overall Study|Withdrawal by Subject|47|||
130222245|NCT01914393|468778236|FG000|Overall Study|Lost to Follow-up|12|||
130222246|NCT01914393|468778237|FG001|Overall Study|Lost to Follow-up|6|||
130222247|NCT01914393|468778238|FG002|Overall Study|Lost to Follow-up|19|||
130222248|NCT01914393|468778236|FG000|Overall Study|subject never dosed|0|||
130222249|NCT01914393|468778237|FG001|Overall Study|subject never dosed|0|||
130222250|NCT01914393|468778238|FG002|Overall Study|subject never dosed|1|||
130222251|NCT04547140|468778241|FG000|Overall Study|Adverse Event|0|||
130222252|NCT04547140|468778242|FG001|Overall Study|Adverse Event|1|||
130222253|NCT04547140|468778241|FG000|Overall Study|Withdrawal by Subject|0|||
130222254|NCT04547140|468778242|FG001|Overall Study|Withdrawal by Subject|1|||
130222255|NCT04547140|468778241|FG000|Overall Study|Lost to Follow-up|3|||
130222256|NCT04547140|468778242|FG001|Overall Study|Lost to Follow-up|1|||
130441917|NCT02291289|469582117|FG001|Induction Treatment|Missing|0|||
130441918|NCT02291289|469582118|FG002|Induction Treatment|Missing|0|||
130222257|NCT04547140|468778241|FG000|Overall Study|Death|2|||
130441919|NCT02291289|469582119|FG003|Induction Treatment|Missing|14|||
130441920|NCT02291289|469582120|FG004|Induction Treatment|Missing|0|||
130441921|NCT02291289|469582121|FG005|Induction Treatment|Missing|0|||
130441922|NCT02291289|469582122|FG006|Induction Treatment|Missing|0|||
130441923|NCT02291289|469582123|FG007|Induction Treatment|Missing|0|||
130441924|NCT02291289|469582124|FG008|Induction Treatment|Missing|0|||
130441925|NCT02291289|469582125|FG009|Induction Treatment|Missing|54|||
130441926|NCT02291289|469582126|FG010|Induction Treatment|Missing|0|||
130441927|NCT02291289|469582127|FG011|Induction Treatment|Missing|0|||
130441928|NCT02291289|469582128|FG012|Induction Treatment|Missing|0|||
130441929|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441930|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441931|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441932|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441933|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
130441934|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
130441935|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441936|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441937|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441938|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441939|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
130441940|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
130441941|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130441942|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Death|0|||
130441943|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Death|29|||
130441944|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Death|16|||
130441945|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Death|0|||
130441946|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Death|188|||
130441947|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Death|107|||
130441948|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Death|0|||
130441949|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Death|1|||
130441950|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Death|1|||
130441951|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Death|0|||
130222258|NCT04547140|468778242|FG001|Overall Study|Death|1|||
130441952|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Death|46|||
130441953|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Death|19|||
130441954|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Death|0|||
130222259|NCT04547140|468778241|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
130222260|NCT04547140|468778242|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
130222261|NCT04547140|468778241|FG000|Overall Study|Pregnancy|1|||
130222262|NCT04547140|468778242|FG001|Overall Study|Pregnancy|0|||
130222263|NCT04547140|468778241|FG000|Overall Study|Reason Not Specified|4|||
130441955|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130441956|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Adverse Event|0|||
130441957|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Adverse Event|0|||
130222264|NCT04547140|468778242|FG001|Overall Study|Reason Not Specified|1|||
130441958|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Adverse Event|0|||
130441959|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Adverse Event|1|||
130222265|NCT00003537|468778243|FG000|Overall Study|Not evalauable|1|||
130222266|NCT01051557|468778244|FG000|Overall Study|Physician Decision|1|||
130686484|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Other|13|||
130686485|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
130686486|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
130686487|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
130686488|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
130686489|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
130686490|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
130354758|NCT00451451|469271294|FG002|Overall Study|Investigator Decision|1|||
130354759|NCT00451451|469271295|FG003|Overall Study|Investigator Decision|2|||
130354760|NCT00451451|469271292|FG000|Overall Study|Subject Non-Compliance|8|||
130354761|NCT00451451|469271293|FG001|Overall Study|Subject Non-Compliance|4|||
130354762|NCT00451451|469271294|FG002|Overall Study|Subject Non-Compliance|3|||
130354763|NCT00451451|469271295|FG003|Overall Study|Subject Non-Compliance|3|||
130354764|NCT00451451|469271292|FG000|Overall Study|Death|1|||
130354765|NCT00451451|469271293|FG001|Overall Study|Death|0|||
130354766|NCT00451451|469271294|FG002|Overall Study|Death|0|||
130354767|NCT00451451|469271295|FG003|Overall Study|Death|1|||
130354768|NCT00451451|469271292|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
130354769|NCT00451451|469271293|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
130354770|NCT00451451|469271294|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
130354771|NCT00451451|469271295|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
130354772|NCT01002482|469271296|FG000|Overall Study|Withdrawal by Subject|14|||
130354773|NCT01002482|469271297|FG001|Overall Study|Withdrawal by Subject|21|||
130354774|NCT01002482|469271296|FG000|Overall Study|Included twice|1|||
130354775|NCT01002482|469271297|FG001|Overall Study|Included twice|0|||
130354776|NCT01865084|469271298|FG000|Double Blind Period (DB)|Adverse Event|2|||
130354777|NCT01865084|469271299|FG001|Double Blind Period (DB)|Adverse Event|2|||
130354778|NCT01865084|469271300|FG002|Double Blind Period (DB)|Adverse Event|1|||
130354779|NCT01865084|469271298|FG000|Double Blind Period (DB)|Protocol Violation|0|||
130354780|NCT01865084|469271299|FG001|Double Blind Period (DB)|Protocol Violation|0|||
130354781|NCT01865084|469271300|FG002|Double Blind Period (DB)|Protocol Violation|1|||
130354782|NCT01865084|469271298|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
130354783|NCT01865084|469271299|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
130354784|NCT01865084|469271300|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
130354785|NCT01865084|469271298|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
130354786|NCT01865084|469271299|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
130354787|NCT01865084|469271300|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
130354788|NCT01865084|469271298|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
130354789|NCT01865084|469271299|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
130354790|NCT01865084|469271300|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
130354791|NCT01865084|469271298|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
130354792|NCT01865084|469271299|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
130354793|NCT01865084|469271300|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
130354794|NCT01865084|469271298|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
130354795|NCT01865084|469271299|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
130354796|NCT01865084|469271300|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
130354797|NCT01865084|469271298|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
130354798|NCT01865084|469271299|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
130354799|NCT01865084|469271300|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
130354800|NCT01865084|469271298|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
130354801|NCT01865084|469271299|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
130354802|NCT01865084|469271300|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
130354803|NCT03693170|469271301|FG000|Overall Study|Disease Progression|48|||
130354804|NCT03693170|469271301|FG000|Overall Study|Adverse Event|16|||
130354805|NCT03693170|469271301|FG000|Overall Study|Physician Decision|6|||
130354806|NCT03693170|469271301|FG000|Overall Study|Protocol Violation|2|||
130354807|NCT03693170|469271301|FG000|Overall Study|Death|1|||
130354808|NCT03693170|469271301|FG000|Overall Study|Non compliance with study drug|1|||
130354809|NCT03693170|469271301|FG000|Overall Study|Withdrawal by Subject|1|||
130354810|NCT01442038|469271304|FG000|Overall Study|Death|35|||
130354811|NCT01442038|469271305|FG001|Overall Study|Death|29|||
130354812|NCT01442038|469271304|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
130354813|NCT01442038|469271305|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
130354814|NCT01442038|469271304|FG000|Overall Study|Participant Withdrew Consent|137|||
130354815|NCT01442038|469271305|FG001|Overall Study|Participant Withdrew Consent|102|||
130354816|NCT01442038|469271304|FG000|Overall Study|Lost to Follow-up|37|||
130354817|NCT01442038|469271305|FG001|Overall Study|Lost to Follow-up|51|||
130354818|NCT01442038|469271304|FG000|Overall Study|Adverse Event|26|||
130354819|NCT01442038|469271305|FG001|Overall Study|Adverse Event|15|||
130354820|NCT01442038|469271304|FG000|Overall Study|Protocol Deviation|9|||
130441960|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Adverse Event|1|||
130222267|NCT01051557|468778245|FG001|Overall Study|Physician Decision|0|||
130354821|NCT01442038|469271305|FG001|Overall Study|Protocol Deviation|20|||
130354822|NCT01442038|469271304|FG000|Overall Study|Investigator's Discretion|13|||
130354823|NCT01442038|469271305|FG001|Overall Study|Investigator's Discretion|16|||
130354824|NCT01442038|469271304|FG000|Overall Study|Study Terminated By Sponsor|2|||
130354825|NCT01442038|469271305|FG001|Overall Study|Study Terminated By Sponsor|3|||
130354826|NCT00089284|469271306|FG000|Overall Study|Adverse event before starting treatment|0|||
130354827|NCT00089284|469271307|FG001|Overall Study|Adverse event before starting treatment|0|||
130354828|NCT00089284|469271308|FG002|Overall Study|Adverse event before starting treatment|0|||
130354829|NCT00089284|469271309|FG003|Overall Study|Adverse event before starting treatment|0|||
130354830|NCT00089284|469271310|FG004|Overall Study|Adverse event before starting treatment|0|||
130354831|NCT00089284|469271311|FG005|Overall Study|Adverse event before starting treatment|0|||
130354832|NCT00089284|469271312|FG006|Overall Study|Adverse event before starting treatment|1|||
130354833|NCT03646643|469271321|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
130354834|NCT03646643|469271322|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
130354835|NCT03646643|469271321|FG000|Overall Study|Lost to Follow-up|0|||
130354836|NCT03646643|469271322|FG001|Overall Study|Lost to Follow-up|1|||
130354837|NCT04131556|469271323|FG000|Overall Study|Adverse Event|1|||
130354838|NCT04131556|469271323|FG000|Overall Study|Withdrawal by Subject|1|||
130354839|NCT04060862|469271326|FG000|Overall Study|Symptomatic Deterioration|1|||
130354840|NCT04060862|469271326|FG000|Overall Study|Un-specified|6|||
130354841|NCT04060862|469271326|FG000|Overall Study|Progressive disease|12|||
130354842|NCT04060862|469271326|FG000|Overall Study|Physician Decision|1|||
130354843|NCT02545075|469271331|FG000|Randomization|Lost to Follow-up|0|||
130354844|NCT02545075|469271332|FG001|Randomization|Lost to Follow-up|1|||
130354845|NCT02545075|469271331|FG000|Randomization|Withdrawal by Subject|0|||
130354846|NCT02545075|469271332|FG001|Randomization|Withdrawal by Subject|6|||
130354847|NCT02545075|469271331|FG000|Treatment|Disease progression|71|||
130354848|NCT02545075|469271332|FG001|Treatment|Disease progression|32|||
130354849|NCT02545075|469271331|FG000|Treatment|Participant dicontinued study treatment|7|||
130354850|NCT02545075|469271332|FG001|Treatment|Participant dicontinued study treatment|9|||
130354851|NCT02545075|469271331|FG000|Treatment|Withdrawal by Subject|1|||
130354852|NCT02545075|469271332|FG001|Treatment|Withdrawal by Subject|0|||
130354853|NCT02545075|469271331|FG000|Treatment|Adverse event not related to study drug|1|||
130354854|NCT02545075|469271332|FG001|Treatment|Adverse event not related to study drug|0|||
130354855|NCT02545075|469271331|FG000|Treatment|Death|1|||
130354856|NCT02545075|469271332|FG001|Treatment|Death|0|||
130354857|NCT02545075|469271331|FG000|Treatment|Participant drug toxicity|1|||
130354858|NCT02545075|469271332|FG001|Treatment|Participant drug toxicity|0|||
130354859|NCT02545075|469271331|FG000|Treatment|Completed treatment|40|||
130354860|NCT02545075|469271332|FG001|Treatment|Completed treatment|12|||
130354861|NCT01810432|469271333|FG000|Washout|Protocol Violation|0|||
130354862|NCT01810432|469271334|FG001|Washout|Protocol Violation|1|||
130354863|NCT01810432|469271333|FG000|Washout|Adverse Event|1|||
130354864|NCT01810432|469271334|FG001|Washout|Adverse Event|0|||
130354865|NCT01810432|469271333|FG000|Period 2|Withdrawal by Subject|2|||
130354866|NCT01810432|469271334|FG001|Period 2|Withdrawal by Subject|1|||
130354867|NCT01810432|469271333|FG000|Period 2|Physician Decision|1|||
130354868|NCT01810432|469271334|FG001|Period 2|Physician Decision|0|||
130354869|NCT01810432|469271333|FG000|Period 2|Lost to Follow-up|1|||
130354870|NCT01810432|469271334|FG001|Period 2|Lost to Follow-up|1|||
130354871|NCT00736879|469271335|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130354872|NCT00736879|469271336|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130354873|NCT00736879|469271337|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130354874|NCT00736879|469271338|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130354875|NCT00736879|469271335|FG000|Double Blind Treatment Period|Adverse Event|0|||
130354876|NCT00736879|469271336|FG001|Double Blind Treatment Period|Adverse Event|1|||
130354877|NCT00736879|469271337|FG002|Double Blind Treatment Period|Adverse Event|1|||
130354878|NCT00736879|469271338|FG003|Double Blind Treatment Period|Adverse Event|0|||
130354879|NCT00736879|469271335|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
130354880|NCT00736879|469271336|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130354881|NCT00736879|469271337|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354882|NCT00736879|469271338|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
130354883|NCT00736879|469271335|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130354884|NCT00736879|469271336|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130354885|NCT00736879|469271337|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
130354886|NCT00736879|469271338|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
130354887|NCT00736879|469271335|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
130354888|NCT00736879|469271336|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
130354889|NCT00736879|469271337|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
130354890|NCT00736879|469271338|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
130354891|NCT00736879|469271335|FG000|Double Blind Treatment Period|No longer met criteria|0|||
130354892|NCT00736879|469271336|FG001|Double Blind Treatment Period|No longer met criteria|1|||
130354893|NCT00736879|469271337|FG002|Double Blind Treatment Period|No longer met criteria|0|||
130222268|NCT01051557|468778246|FG002|Overall Study|Physician Decision|0|||
130222269|NCT01051557|468778247|FG003|Overall Study|Physician Decision|0|||
130222270|NCT01051557|468778248|FG004|Overall Study|Physician Decision|0|||
130222271|NCT01051557|468778249|FG005|Overall Study|Physician Decision|0|||
130222272|NCT01051557|468778250|FG006|Overall Study|Physician Decision|0|||
130222273|NCT01051557|468778244|FG000|Overall Study|disease progression|3|||
130222274|NCT01051557|468778245|FG001|Overall Study|disease progression|3|||
130222275|NCT01051557|468778246|FG002|Overall Study|disease progression|5|||
130222276|NCT01051557|468778247|FG003|Overall Study|disease progression|2|||
130222277|NCT01051557|468778248|FG004|Overall Study|disease progression|4|||
130222278|NCT01051557|468778249|FG005|Overall Study|disease progression|3|||
130222279|NCT01051557|468778250|FG006|Overall Study|disease progression|1|||
130222280|NCT01051557|468778244|FG000|Overall Study|Withdrawal by Subject|0|||
130222281|NCT01051557|468778245|FG001|Overall Study|Withdrawal by Subject|0|||
130222282|NCT01051557|468778246|FG002|Overall Study|Withdrawal by Subject|1|||
130222283|NCT01051557|468778247|FG003|Overall Study|Withdrawal by Subject|0|||
130222284|NCT01051557|468778248|FG004|Overall Study|Withdrawal by Subject|2|||
130222285|NCT01051557|468778249|FG005|Overall Study|Withdrawal by Subject|0|||
130222286|NCT01051557|468778250|FG006|Overall Study|Withdrawal by Subject|1|||
130222287|NCT01051557|468778244|FG000|Overall Study|Adverse Event|0|||
130222288|NCT01051557|468778245|FG001|Overall Study|Adverse Event|0|||
130222289|NCT01051557|468778246|FG002|Overall Study|Adverse Event|0|||
130222290|NCT01051557|468778247|FG003|Overall Study|Adverse Event|1|||
130222291|NCT01051557|468778248|FG004|Overall Study|Adverse Event|1|||
130222292|NCT01051557|468778249|FG005|Overall Study|Adverse Event|3|||
130222293|NCT01051557|468778250|FG006|Overall Study|Adverse Event|4|||
130222294|NCT04110314|468778252|FG000|Overall Study|Did not meet inclusion criteria|35255|||
130222295|NCT04110314|468778253|FG001|Overall Study|Did not meet inclusion criteria|35104|||
130222296|NCT04110314|468778254|FG002|Overall Study|Did not meet inclusion criteria|35636|||
130222297|NCT04110314|468778255|FG003|Overall Study|Did not meet inclusion criteria|35135|||
130222298|NCT04110314|468778256|FG004|Overall Study|Did not meet inclusion criteria|35247|||
130222299|NCT04110314|468778257|FG005|Overall Study|Did not meet inclusion criteria|35727|||
130222300|NCT01178125|468778266|FG000|Overall Study|Lost to Follow-up|397|||
130222301|NCT01178125|468778266|FG000|Overall Study|Adverse Event|244|||
130222302|NCT01178125|468778266|FG000|Overall Study|Withdrawal by Subject|209|||
130222303|NCT01178125|468778266|FG000|Overall Study|Noncompliance|184|||
130222304|NCT01178125|468778266|FG000|Overall Study|Pregnancy|55|||
130222305|NCT01178125|468778266|FG000|Overall Study|Other Reason|39|||
130222306|NCT01178125|468778266|FG000|Overall Study|Sponsor Decision|28|||
130222307|NCT01178125|468778266|FG000|Overall Study|Protocol Violation|17|||
130222308|NCT01178125|468778266|FG000|Overall Study|Investigator Decision|5|||
130222309|NCT02948829|468778267|FG000|Overall Study|Lost to Follow-up|2|||
130222310|NCT02948829|468778267|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
130222311|NCT02948829|468778267|FG000|Overall Study|Pregnancy|1|||
130222312|NCT02948829|468778267|FG000|Overall Study|Other: Reason not Specified|8|||
130222313|NCT01004978|468778268|FG000|Overall Study|Disease progression|31|||
130222314|NCT01004978|468778269|FG001|Overall Study|Disease progression|48|||
130222315|NCT01004978|468778268|FG000|Overall Study|Adverse Event|42|||
130222316|NCT01004978|468778269|FG001|Overall Study|Adverse Event|22|||
130222317|NCT01004978|468778268|FG000|Overall Study|Death|3|||
130222318|NCT01004978|468778269|FG001|Overall Study|Death|2|||
130222319|NCT01004978|468778268|FG000|Overall Study|Withdrawal by Subject|16|||
130222320|NCT01004978|468778269|FG001|Overall Study|Withdrawal by Subject|16|||
130441961|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Adverse Event|0|||
130441962|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Adverse Event|0|||
130441963|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Adverse Event|0|||
130441964|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Adverse Event|0|||
130441965|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Adverse Event|0|||
130686491|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Death|3|||
130686492|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Death|13|||
130222321|NCT01004978|468778268|FG000|Overall Study|Alternative therapy|4|||
130222322|NCT01004978|468778269|FG001|Overall Study|Alternative therapy|8|||
130222323|NCT01004978|468778268|FG000|Overall Study|Physician Decision|6|||
130222324|NCT01004978|468778269|FG001|Overall Study|Physician Decision|3|||
130222325|NCT01004978|468778268|FG000|Overall Study|Other complicating disease|2|||
130222326|NCT01004978|468778269|FG001|Overall Study|Other complicating disease|2|||
130222327|NCT01004978|468778268|FG000|Overall Study|Protocol Violation|2|||
130222328|NCT01004978|468778269|FG001|Overall Study|Protocol Violation|3|||
130222329|NCT01004978|468778268|FG000|Overall Study|Non-compliance|3|||
130441966|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Adverse Event|0|||
130441967|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Adverse Event|0|||
130441968|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441969|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
130222330|NCT01004978|468778269|FG001|Overall Study|Non-compliance|2|||
130222331|NCT01004978|468778268|FG000|Overall Study|Ineligible|1|||
130222332|NCT01004978|468778269|FG001|Overall Study|Ineligible|0|||
130222333|NCT01004978|468778268|FG000|Overall Study|Unblinded|0|||
130222334|NCT01004978|468778269|FG001|Overall Study|Unblinded|1|||
130222335|NCT01004978|468778268|FG000|Overall Study|Performance status worsening|0|||
130222336|NCT01004978|468778269|FG001|Overall Study|Performance status worsening|1|||
130222337|NCT01004978|468778268|FG000|Overall Study|Never started treatment|8|||
130222338|NCT01004978|468778269|FG001|Overall Study|Never started treatment|9|||
130222339|NCT00369915|468778270|FG000|Overall Study|expected side effects|2|||
130222340|NCT00369915|468778271|FG001|Overall Study|expected side effects|1|||
130222341|NCT00369915|468778270|FG000|Overall Study|Withdrawal by Subject|4|||
130222342|NCT00369915|468778271|FG001|Overall Study|Withdrawal by Subject|1|||
130222343|NCT00369915|468778270|FG000|Overall Study|W/drawl by investigators|0|||
130222344|NCT00369915|468778271|FG001|Overall Study|W/drawl by investigators|1|||
130222345|NCT01711983|468778272|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
130222346|NCT01711983|468778272|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
130222347|NCT01711983|468778272|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
130222348|NCT01711983|468778272|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
130222349|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222350|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
130222351|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130222352|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222353|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222354|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222355|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222356|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222357|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222358|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222359|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222360|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222361|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222362|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222363|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222364|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130222365|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
130222366|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222367|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130354894|NCT00736879|469271338|FG003|Double Blind Treatment Period|No longer met criteria|0|||
130354895|NCT00736879|469271335|FG000|Double Blind Treatment Period|non-specified|0|||
130354896|NCT00736879|469271336|FG001|Double Blind Treatment Period|non-specified|1|||
130354897|NCT00736879|469271337|FG002|Double Blind Treatment Period|non-specified|0|||
130354898|NCT00736879|469271338|FG003|Double Blind Treatment Period|non-specified|0|||
130354899|NCT00736879|469271335|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130354900|NCT00736879|469271336|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
130354901|NCT00736879|469271337|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130354902|NCT00736879|469271338|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130354903|NCT00736879|469271335|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
130354904|NCT00736879|469271336|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
130354905|NCT00736879|469271337|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
130354906|NCT00736879|469271338|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
130354907|NCT02360111|469271341|FG000|Overall Study|Death|2|||
130354908|NCT01933217|469271344|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
130354909|NCT01933217|469271345|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
130354910|NCT01933217|469271344|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
130354911|NCT01933217|469271345|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
130354912|NCT03923738|469271346|FG000|Period 1|Adverse Event|1|||
130354913|NCT03923738|469271346|FG000|Period 1|Withdrawal by Subject|1|||
130354914|NCT00147251|469271352|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
130354915|NCT00147251|469271353|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
130354916|NCT01629706|469271354|FG000|Phase 1 PureVision|Screen Failure|4|||
130354917|NCT01629706|469271354|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
130354918|NCT01629706|469271354|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
130354919|NCT01629706|469271354|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
130354920|NCT01629706|469271354|FG000|Phase 2 Habitual|Screen Failure|6|||
130354921|NCT01629706|469271354|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
130222368|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222369|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222370|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222371|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130354922|NCT01629706|469271354|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
130354923|NCT01629706|469271354|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
130354924|NCT01629706|469271354|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
130354925|NCT01151098|469271355|FG000|Overall Study|Adverse Event|82|||
130441970|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441971|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441972|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
130441973|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
130441974|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441975|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
130441976|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441977|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441978|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
130441979|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
130441980|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
130441981|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
130441982|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
130441983|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
130441984|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
130441985|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
130441986|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
130441987|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
130441988|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
130686493|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
130686494|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
130686495|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Other|14|||
130686496|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Other|31|||
130686497|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
130686498|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
130686499|NCT03874715|470479554|FG000|Overall Study|Adverse Event|2|||
130686500|NCT03874715|470479555|FG001|Overall Study|Adverse Event|0|||
130686501|NCT03874715|470479554|FG000|Overall Study|Poor compliance to protocol|5|||
130686502|NCT03874715|470479555|FG001|Overall Study|Poor compliance to protocol|1|||
130686503|NCT03874715|470479554|FG000|Overall Study|Withdrawal by Subject|1|||
130686504|NCT03874715|470479555|FG001|Overall Study|Withdrawal by Subject|0|||
130686505|NCT03874715|470479554|FG000|Overall Study|Other-unspecified|1|||
130686506|NCT03874715|470479555|FG001|Overall Study|Other-unspecified|0|||
130686507|NCT01083693|470479556|FG000|Overall Study|Adverse Event|1|||
130686508|NCT01083693|470479557|FG001|Overall Study|Adverse Event|1|||
130686509|NCT01083693|470479558|FG002|Overall Study|Adverse Event|0|||
130686510|NCT01083693|470479556|FG000|Overall Study|Lost to Follow-up|2|||
130686511|NCT01083693|470479557|FG001|Overall Study|Lost to Follow-up|0|||
130686512|NCT01083693|470479558|FG002|Overall Study|Lost to Follow-up|2|||
130686513|NCT01083693|470479556|FG000|Overall Study|Lack of effectiveness|13|||
130686514|NCT01083693|470479557|FG001|Overall Study|Lack of effectiveness|2|||
130686515|NCT01083693|470479558|FG002|Overall Study|Lack of effectiveness|2|||
130686516|NCT01083693|470479556|FG000|Overall Study|Patient Moved|0|||
130686517|NCT01083693|470479557|FG001|Overall Study|Patient Moved|1|||
130686518|NCT01083693|470479558|FG002|Overall Study|Patient Moved|0|||
130686519|NCT01083693|470479556|FG000|Overall Study|Complete remission|0|||
130686520|NCT01083693|470479557|FG001|Overall Study|Complete remission|1|||
130686521|NCT01083693|470479558|FG002|Overall Study|Complete remission|0|||
130686522|NCT01083693|470479556|FG000|Overall Study|Other medical condition/surgery|1|||
130686523|NCT01083693|470479557|FG001|Overall Study|Other medical condition/surgery|1|||
130686524|NCT01083693|470479558|FG002|Overall Study|Other medical condition/surgery|0|||
130686525|NCT01083693|470479556|FG000|Overall Study|Withdrawal by Subject|3|||
130686526|NCT01083693|470479557|FG001|Overall Study|Withdrawal by Subject|0|||
130686527|NCT01083693|470479558|FG002|Overall Study|Withdrawal by Subject|2|||
130686528|NCT01083693|470479556|FG000|Overall Study|Reason unknown|0|||
130686529|NCT01083693|470479557|FG001|Overall Study|Reason unknown|0|||
130686530|NCT01083693|470479558|FG002|Overall Study|Reason unknown|1|||
130686531|NCT01401647|470479561|FG000|Overall Study|Withdrawal by Subject|1|||
130686532|NCT01401647|470479562|FG001|Overall Study|Withdrawal by Subject|5|||
130686533|NCT01401647|470479563|FG002|Overall Study|Withdrawal by Subject|2|||
130222372|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222373|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222374|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222375|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222376|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130441989|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
130441990|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
130686534|NCT01401647|470479561|FG000|Overall Study|Lost to Follow-up|3|||
130686535|NCT01401647|470479562|FG001|Overall Study|Lost to Follow-up|3|||
130686536|NCT01401647|470479563|FG002|Overall Study|Lost to Follow-up|1|||
130686537|NCT00473330|470479566|FG000|Core Study|Adverse Event|4|||
130686538|NCT00473330|470479567|FG001|Core Study|Adverse Event|4|||
130686539|NCT00473330|470479568|FG002|Core Study|Adverse Event|1|||
130222377|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222378|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222379|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
130222380|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
130222381|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130222382|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222383|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222384|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222385|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222386|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222387|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222388|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222389|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222390|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222391|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222392|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222393|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222394|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222395|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222396|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
130222397|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222398|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222399|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222400|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222401|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222402|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222403|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222404|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222405|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222406|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222407|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222408|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222409|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222410|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130354926|NCT01151098|469271355|FG000|Overall Study|Lost to Follow-up|6|||
130354927|NCT01151098|469271355|FG000|Overall Study|Lack of Efficacy|15|||
130354928|NCT01151098|469271355|FG000|Overall Study|Protocol Violation|1|||
130354929|NCT01151098|469271355|FG000|Overall Study|Miscellaneous|13|||
130354930|NCT03343067|469271362|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
130354931|NCT03343067|469271363|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
130354932|NCT03343067|469271364|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
130354933|NCT00116168|469271365|FG000|Overall Study|Lost to Follow-up|6|||
130354934|NCT00116168|469271366|FG001|Overall Study|Lost to Follow-up|5|||
130354935|NCT00116168|469271367|FG002|Overall Study|Lost to Follow-up|0|||
130354936|NCT00116168|469271368|FG003|Overall Study|Lost to Follow-up|0|||
130354937|NCT02788474|469271369|FG000|Double Blind Treatment Period|Not treated|1|||
130354938|NCT02788474|469271370|FG001|Double Blind Treatment Period|Not treated|0|||
130354939|NCT02788474|469271369|FG000|Double Blind Treatment Period|Patient's refusal|3|||
130354940|NCT02788474|469271370|FG001|Double Blind Treatment Period|Patient's refusal|0|||
130354941|NCT02788474|469271369|FG000|Double Blind Treatment Period|Adverse Event|6|||
130354942|NCT02788474|469271370|FG001|Double Blind Treatment Period|Adverse Event|4|||
130354943|NCT02788474|469271369|FG000|Open Label Treatment Period|Adverse Event|29|||
130354944|NCT02788474|469271370|FG001|Open Label Treatment Period|Adverse Event|9|||
130354945|NCT02788474|469271369|FG000|Open Label Treatment Period|Other than reason specified|1|||
130354946|NCT02788474|469271370|FG001|Open Label Treatment Period|Other than reason specified|0|||
130354947|NCT02788474|469271369|FG000|Open Label Treatment Period|Patient's refusal|1|||
130354948|NCT02788474|469271370|FG001|Open Label Treatment Period|Patient's refusal|3|||
130354949|NCT02788474|469271369|FG000|Open Label Treatment Period|Non-compliance|1|||
130354950|NCT02788474|469271370|FG001|Open Label Treatment Period|Non-compliance|0|||
130354951|NCT05342532|469271373|FG000|Overall Study|Adverse Event|5|||
130354952|NCT05342532|469271374|FG001|Overall Study|Adverse Event|20|||
130354953|NCT05342532|469271373|FG000|Overall Study|Lost to Follow-up|10|||
130354954|NCT05342532|469271374|FG001|Overall Study|Lost to Follow-up|15|||
130354955|NCT02057393|469271375|FG000|Overall Study|Withdrawal by Subject|1|||
130552829|NCT01776424|469991551|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
130354956|NCT02057393|469271375|FG000|Overall Study|Patient did not meet criteria|1|||
130354957|NCT02273739|469271376|FG000|Overall Study|Progression of Disease|3|||
130354958|NCT02273739|469271377|FG001|Overall Study|Progression of Disease|4|||
130354959|NCT02273739|469271378|FG002|Overall Study|Progression of Disease|5|||
130222411|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
130222412|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222413|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222414|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222415|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222416|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222417|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222418|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222419|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222420|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222421|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222422|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222423|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222424|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222425|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222426|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
130222427|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222428|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222429|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222430|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222431|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222432|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130316108|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
130441991|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
130441992|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
130686540|NCT00473330|470479566|FG000|Core Study|Death|6|||
130686541|NCT00473330|470479567|FG001|Core Study|Death|4|||
130441993|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
130441994|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Physician Decision|0|||
130441995|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Physician Decision|2|||
130441996|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Physician Decision|0|||
130441997|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Physician Decision|0|||
130441998|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Physician Decision|3|||
130441999|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Physician Decision|0|||
130442000|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Physician Decision|0|||
130442001|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Physician Decision|0|||
130442002|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Physician Decision|0|||
130442003|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Physician Decision|0|||
130442004|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Physician Decision|1|||
130442005|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Physician Decision|3|||
130442006|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Physician Decision|0|||
130442007|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Not Treated|0|||
130442008|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Not Treated|0|||
130442009|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Not Treated|2|||
130442010|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Not Treated|0|||
130442011|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Not Treated|0|||
130442012|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Not Treated|0|||
130442013|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Not Treated|0|||
130442014|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Not Treated|0|||
130442015|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Not Treated|0|||
130442016|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Not Treated|0|||
130442017|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Not Treated|0|||
130442018|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Not Treated|0|||
130442019|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Not Treated|0|||
130442020|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442021|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
130442022|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442023|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442024|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442025|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442026|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442027|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442028|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442029|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442030|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442031|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130686542|NCT00473330|470479568|FG002|Core Study|Death|4|||
130686543|NCT00473330|470479566|FG000|Core Study|Lost to Follow-up|5|||
130222433|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222434|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222435|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222436|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222437|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222438|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222439|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222440|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222441|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
130222442|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222443|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222444|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222445|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222446|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222447|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222448|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222449|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222450|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222451|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222452|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222453|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222454|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222455|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222456|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130442032|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130442033|NCT02291289|469582116|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
130442034|NCT02291289|469582117|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
130442035|NCT02291289|469582118|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
130686544|NCT00473330|470479567|FG001|Core Study|Lost to Follow-up|5|||
130686545|NCT00473330|470479568|FG002|Core Study|Lost to Follow-up|10|||
130686546|NCT00473330|470479566|FG000|Core Study|Physician Decision|2|||
130686547|NCT00473330|470479567|FG001|Core Study|Physician Decision|1|||
130686548|NCT00473330|470479568|FG002|Core Study|Physician Decision|3|||
130686549|NCT00473330|470479566|FG000|Core Study|Subject Non-compliance|1|||
130686550|NCT00473330|470479567|FG001|Core Study|Subject Non-compliance|2|||
130686551|NCT00473330|470479568|FG002|Core Study|Subject Non-compliance|1|||
130686552|NCT00473330|470479566|FG000|Core Study|Subject Required Other Therapy|0|||
130686553|NCT00473330|470479567|FG001|Core Study|Subject Required Other Therapy|1|||
130686554|NCT00473330|470479568|FG002|Core Study|Subject Required Other Therapy|3|||
130686555|NCT00473330|470479566|FG000|Core Study|Subject's Decision|9|||
130686556|NCT00473330|470479567|FG001|Core Study|Subject's Decision|8|||
130686557|NCT00473330|470479568|FG002|Core Study|Subject's Decision|19|||
130686558|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130686559|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130686560|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
130686561|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Death|2|||
130686562|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Death|0|||
130686563|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Death|0|||
130686564|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130442036|NCT02291289|469582119|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
130442037|NCT02291289|469582120|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
130442038|NCT02291289|469582121|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
130686565|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
130686566|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130686567|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
130686568|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
130686569|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
130686570|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
130686571|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
130686572|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
130686573|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
130686574|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
130686575|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
130686576|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
130222457|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222458|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130222459|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
130222460|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
130222461|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130222462|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130222463|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222464|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222465|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222466|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222467|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222468|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222469|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222470|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222471|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222472|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222473|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222474|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
130222475|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222476|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222477|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222478|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222479|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222480|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222481|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222482|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222483|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222484|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222485|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222486|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222487|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222488|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222489|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130222490|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222491|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130222492|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222493|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222494|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222495|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222496|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222497|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222498|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222499|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222500|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222501|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222502|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222503|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222504|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
130222505|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222506|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222507|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222508|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222509|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222510|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130354960|NCT02273739|469271379|FG003|Overall Study|Progression of Disease|2|||
130354961|NCT02273739|469271376|FG000|Overall Study|Death|0|||
130354962|NCT02273739|469271377|FG001|Overall Study|Death|0|||
130354963|NCT02273739|469271378|FG002|Overall Study|Death|0|||
130354964|NCT02273739|469271379|FG003|Overall Study|Death|2|||
130354965|NCT02273739|469271376|FG000|Overall Study|Adverse Event|0|||
130354966|NCT02273739|469271377|FG001|Overall Study|Adverse Event|0|||
130354967|NCT02273739|469271378|FG002|Overall Study|Adverse Event|0|||
130354968|NCT02273739|469271379|FG003|Overall Study|Adverse Event|1|||
130354969|NCT02273739|469271376|FG000|Overall Study|Withdrawal by Subject|0|||
130354970|NCT02273739|469271377|FG001|Overall Study|Withdrawal by Subject|0|||
130354971|NCT02273739|469271378|FG002|Overall Study|Withdrawal by Subject|2|||
130442039|NCT02291289|469582122|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
130222511|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222512|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222513|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222514|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130686577|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
130222515|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222516|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222517|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222518|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222519|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222520|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222521|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
130686578|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
130686579|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130686580|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130686581|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
130686582|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130686583|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130686584|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130686585|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Death|2|||
130686586|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Death|2|||
130686587|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Death|1|||
130686588|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130686589|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
130686590|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
130686591|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
130686592|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
130686593|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
130686594|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
130686595|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
130686596|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
130686597|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
130686598|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
130686599|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
130686600|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
130686601|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
130686602|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
130686603|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130686604|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
130686605|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130686606|NCT01975948|470479569|FG000|Overall Study|Withdrawal by Subject|17|||
130686607|NCT01975948|470479570|FG001|Overall Study|Withdrawal by Subject|21|||
130686608|NCT01975948|470479571|FG002|Overall Study|Withdrawal by Subject|7|||
130686609|NCT01975948|470479572|FG003|Overall Study|Withdrawal by Subject|6|||
130686610|NCT01675765|470479573|FG000|Overall Study|Progressive disease|4|||
130686611|NCT01675765|470479574|FG001|Overall Study|Progressive disease|4|||
130686612|NCT01675765|470479573|FG000|Overall Study|Adverse Event|1|||
130686613|NCT01675765|470479574|FG001|Overall Study|Adverse Event|2|||
130686614|NCT01675765|470479573|FG000|Overall Study|Withdrawal by Subject|2|||
130686615|NCT01675765|470479574|FG001|Overall Study|Withdrawal by Subject|0|||
130686616|NCT01675765|470479573|FG000|Overall Study|Death|1|||
130686617|NCT01675765|470479574|FG001|Overall Study|Death|0|||
130686618|NCT01675765|470479573|FG000|Overall Study|Clinical progression|3|||
130686619|NCT01675765|470479574|FG001|Overall Study|Clinical progression|2|||
130686620|NCT03965091|470479576|FG000|Overall Study|Adverse Event|0|||
130686621|NCT03965091|470479577|FG001|Overall Study|Adverse Event|2|||
130686622|NCT03965091|470479578|FG002|Overall Study|Adverse Event|3|||
130686623|NCT03965091|470479576|FG000|Overall Study|Withdrawal by Subject|11|||
130686624|NCT03965091|470479577|FG001|Overall Study|Withdrawal by Subject|3|||
130686625|NCT03965091|470479578|FG002|Overall Study|Withdrawal by Subject|5|||
130686626|NCT03965091|470479576|FG000|Overall Study|Non-compliance with study drug|0|||
130686627|NCT03965091|470479577|FG001|Overall Study|Non-compliance with study drug|0|||
130686628|NCT03965091|470479578|FG002|Overall Study|Non-compliance with study drug|1|||
130686629|NCT03965091|470479576|FG000|Overall Study|Lost to Follow-up|1|||
130686630|NCT03965091|470479577|FG001|Overall Study|Lost to Follow-up|1|||
130686631|NCT03965091|470479578|FG002|Overall Study|Lost to Follow-up|1|||
130686632|NCT03965091|470479576|FG000|Overall Study|Lack of Efficacy|2|||
130222522|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222523|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222524|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222525|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222526|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222527|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222528|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222529|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222530|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222531|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222532|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222533|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222534|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222535|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130222536|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222537|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222538|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222539|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222540|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222541|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222542|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222543|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222544|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222545|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222546|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222547|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222548|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222549|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222550|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222551|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222552|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
130222553|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222554|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222555|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222556|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222557|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222558|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222559|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222560|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222561|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222562|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222563|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222564|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130222565|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130222566|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130222567|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130222568|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222569|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222570|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222571|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222572|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222573|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222574|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222575|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222576|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222577|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222578|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222579|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
130222580|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222581|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130686633|NCT03965091|470479577|FG001|Overall Study|Lack of Efficacy|0|||
130686634|NCT03965091|470479578|FG002|Overall Study|Lack of Efficacy|0|||
130686635|NCT03965091|470479576|FG000|Overall Study|Other than specified|9|||
130222582|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222583|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222584|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222585|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222586|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222587|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222588|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222589|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222590|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222591|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222592|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222593|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222594|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222595|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
130222596|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222597|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222598|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222599|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222600|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222601|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222602|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222603|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222604|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130222605|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130222606|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130222607|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130222608|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130222609|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130222610|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130222611|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130222612|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
130222613|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
130222614|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130222615|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
130222616|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
130222617|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130222618|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
130222619|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222620|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222621|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222622|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222623|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222624|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222625|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222626|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222627|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222628|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222629|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130222630|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
130222631|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130222632|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222633|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130222634|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222635|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222636|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222637|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222638|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222639|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222640|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222641|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222642|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130354972|NCT02273739|469271379|FG003|Overall Study|Withdrawal by Subject|1|||
130354973|NCT02273739|469271376|FG000|Overall Study|Physician Decision|0|||
130354974|NCT02273739|469271377|FG001|Overall Study|Physician Decision|0|||
130442040|NCT02291289|469582123|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
130442041|NCT02291289|469582124|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
130442042|NCT02291289|469582125|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
130442043|NCT02291289|469582126|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
130442044|NCT02291289|469582127|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
130442045|NCT02291289|469582128|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
130442046|NCT02291289|469582116|FG000|Early Disease Progression|Death|0|||
130442047|NCT02291289|469582117|FG001|Early Disease Progression|Death|0|||
130442048|NCT02291289|469582118|FG002|Early Disease Progression|Death|0|||
130442049|NCT02291289|469582119|FG003|Early Disease Progression|Death|0|||
130442050|NCT02291289|469582120|FG004|Early Disease Progression|Death|0|||
130442051|NCT02291289|469582121|FG005|Early Disease Progression|Death|0|||
130442052|NCT02291289|469582122|FG006|Early Disease Progression|Death|0|||
130442053|NCT02291289|469582123|FG007|Early Disease Progression|Death|0|||
130442054|NCT02291289|469582124|FG008|Early Disease Progression|Death|0|||
130442055|NCT02291289|469582125|FG009|Early Disease Progression|Death|0|||
130442056|NCT02291289|469582126|FG010|Early Disease Progression|Death|0|||
130442057|NCT02291289|469582127|FG011|Early Disease Progression|Death|0|||
130442058|NCT02291289|469582128|FG012|Early Disease Progression|Death|10|||
130442059|NCT02291289|469582116|FG000|Early Disease Progression|Lost to Follow-up|0|||
130442060|NCT02291289|469582117|FG001|Early Disease Progression|Lost to Follow-up|0|||
130442061|NCT02291289|469582118|FG002|Early Disease Progression|Lost to Follow-up|0|||
130442062|NCT02291289|469582119|FG003|Early Disease Progression|Lost to Follow-up|0|||
130442063|NCT02291289|469582120|FG004|Early Disease Progression|Lost to Follow-up|0|||
130442064|NCT02291289|469582121|FG005|Early Disease Progression|Lost to Follow-up|0|||
130442065|NCT02291289|469582122|FG006|Early Disease Progression|Lost to Follow-up|0|||
130442066|NCT02291289|469582123|FG007|Early Disease Progression|Lost to Follow-up|0|||
130442067|NCT02291289|469582124|FG008|Early Disease Progression|Lost to Follow-up|0|||
130442068|NCT02291289|469582125|FG009|Early Disease Progression|Lost to Follow-up|0|||
130442069|NCT02291289|469582126|FG010|Early Disease Progression|Lost to Follow-up|0|||
130442070|NCT02291289|469582127|FG011|Early Disease Progression|Lost to Follow-up|0|||
130442071|NCT02291289|469582128|FG012|Early Disease Progression|Lost to Follow-up|1|||
130442072|NCT00962585|469582138|FG000|Overall Study|Adverse Event|0|||
130442073|NCT00962585|469582139|FG001|Overall Study|Adverse Event|2|||
130442074|NCT00962585|469582140|FG002|Overall Study|Adverse Event|1|||
130442075|NCT00962585|469582141|FG003|Overall Study|Adverse Event|0|||
130442076|NCT00962585|469582138|FG000|Overall Study|Lost to Follow-up|3|||
130442077|NCT00962585|469582139|FG001|Overall Study|Lost to Follow-up|0|||
130442078|NCT00962585|469582140|FG002|Overall Study|Lost to Follow-up|1|||
130442079|NCT00962585|469582141|FG003|Overall Study|Lost to Follow-up|0|||
130442080|NCT00962585|469582138|FG000|Overall Study|Protocol Violation|0|||
130442081|NCT00962585|469582139|FG001|Overall Study|Protocol Violation|0|||
130442082|NCT00962585|469582140|FG002|Overall Study|Protocol Violation|1|||
130442083|NCT00962585|469582141|FG003|Overall Study|Protocol Violation|0|||
130442084|NCT00962585|469582138|FG000|Overall Study|Withdrawal by Subject|1|||
130442085|NCT00962585|469582139|FG001|Overall Study|Withdrawal by Subject|0|||
130442086|NCT00962585|469582140|FG002|Overall Study|Withdrawal by Subject|0|||
130442087|NCT00962585|469582141|FG003|Overall Study|Withdrawal by Subject|0|||
130442088|NCT00962585|469582138|FG000|Overall Study|Withdrew Consent|2|||
130442089|NCT00962585|469582139|FG001|Overall Study|Withdrew Consent|0|||
130442090|NCT00962585|469582140|FG002|Overall Study|Withdrew Consent|0|||
130442091|NCT00962585|469582141|FG003|Overall Study|Withdrew Consent|0|||
130442092|NCT00594906|469582146|FG000|Overall Study|Physician Decision|1|||
130442093|NCT00594906|469582147|FG001|Overall Study|Physician Decision|0|||
130442094|NCT00594906|469582146|FG000|Overall Study|Physician Decision|0|||
130442095|NCT00594906|469582147|FG001|Overall Study|Physician Decision|1|||
130442096|NCT00594906|469582146|FG000|Overall Study|Death|0|||
130442097|NCT00594906|469582147|FG001|Overall Study|Death|1|||
130442098|NCT00839917|469582151|FG000|Overall Study|Lost to Follow-up|1|||
130442099|NCT00839917|469582152|FG001|Overall Study|Lost to Follow-up|0|||
130442100|NCT00839917|469582151|FG000|Overall Study|Did not receive vaccine|0|||
130442101|NCT00839917|469582152|FG001|Overall Study|Did not receive vaccine|1|||
130442102|NCT00867490|469582153|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
130442103|NCT00867490|469582153|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
130442104|NCT00867490|469582153|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
130442105|NCT00867490|469582153|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
130442106|NCT00867490|469582153|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
130442107|NCT00472186|469582154|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
130442108|NCT00472186|469582155|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
130442109|NCT01254565|469582156|FG000|Overall Study|Non-compliance to Study Procedures|0|||
130442110|NCT01254565|469582157|FG001|Overall Study|Non-compliance to Study Procedures|0|||
130442111|NCT01254565|469582158|FG002|Overall Study|Non-compliance to Study Procedures|0|||
130442112|NCT01254565|469582159|FG003|Overall Study|Non-compliance to Study Procedures|0|||
130442113|NCT01254565|469582160|FG004|Overall Study|Non-compliance to Study Procedures|1|||
130442114|NCT01254565|469582161|FG005|Overall Study|Non-compliance to Study Procedures|0|||
130686636|NCT03965091|470479577|FG001|Overall Study|Other than specified|11|||
130686637|NCT03965091|470479578|FG002|Overall Study|Other than specified|8|||
130686638|NCT02576938|470479579|FG000|Overall Study|Adverse Event|5|||
130442115|NCT01254565|469582156|FG000|Overall Study|Did not Receive Treatment|1|||
130442116|NCT01254565|469582157|FG001|Overall Study|Did not Receive Treatment|1|||
130442117|NCT01254565|469582158|FG002|Overall Study|Did not Receive Treatment|0|||
130442118|NCT01254565|469582159|FG003|Overall Study|Did not Receive Treatment|0|||
130442119|NCT01254565|469582160|FG004|Overall Study|Did not Receive Treatment|3|||
130442120|NCT01254565|469582161|FG005|Overall Study|Did not Receive Treatment|4|||
130442121|NCT01254565|469582156|FG000|Overall Study|Other|0|||
130442122|NCT01254565|469582157|FG001|Overall Study|Other|0|||
130442123|NCT01254565|469582158|FG002|Overall Study|Other|0|||
130442124|NCT01254565|469582159|FG003|Overall Study|Other|1|||
130442125|NCT01254565|469582160|FG004|Overall Study|Other|0|||
130442126|NCT01254565|469582161|FG005|Overall Study|Other|0|||
130442127|NCT02726399|469582162|FG000|Overall Study|Participant Non-Compliance|1|||
130442128|NCT02726399|469582162|FG000|Overall Study|Adverse Event|2|||
130442129|NCT02726399|469582162|FG000|Overall Study|Progression of disease|4|||
130442130|NCT02564055|469582177|FG000|Overall Study|Adverse Event|1|||
130442131|NCT02564055|469582178|FG001|Overall Study|Adverse Event|0|||
130442132|NCT02564055|469582179|FG002|Overall Study|Adverse Event|4|||
130442133|NCT02564055|469582180|FG003|Overall Study|Adverse Event|1|||
130442134|NCT02564055|469582181|FG004|Overall Study|Adverse Event|4|||
130442135|NCT02564055|469582182|FG005|Overall Study|Adverse Event|1|||
130442136|NCT02564055|469582177|FG000|Overall Study|Protocol Violation|1|||
130442137|NCT02564055|469582178|FG001|Overall Study|Protocol Violation|0|||
130442138|NCT02564055|469582179|FG002|Overall Study|Protocol Violation|0|||
130442139|NCT02564055|469582180|FG003|Overall Study|Protocol Violation|0|||
130442140|NCT02564055|469582181|FG004|Overall Study|Protocol Violation|0|||
130442141|NCT02564055|469582182|FG005|Overall Study|Protocol Violation|0|||
130442142|NCT02564055|469582177|FG000|Overall Study|Reached stopping criteria|0|||
130442143|NCT02564055|469582178|FG001|Overall Study|Reached stopping criteria|0|||
130442144|NCT02564055|469582179|FG002|Overall Study|Reached stopping criteria|0|||
130442145|NCT02564055|469582180|FG003|Overall Study|Reached stopping criteria|0|||
130442146|NCT02564055|469582181|FG004|Overall Study|Reached stopping criteria|0|||
130442147|NCT02564055|469582182|FG005|Overall Study|Reached stopping criteria|1|||
130442148|NCT02564055|469582177|FG000|Overall Study|Lost to Follow-up|0|||
130442149|NCT02564055|469582178|FG001|Overall Study|Lost to Follow-up|1|||
130442150|NCT02564055|469582179|FG002|Overall Study|Lost to Follow-up|4|||
130442151|NCT02564055|469582180|FG003|Overall Study|Lost to Follow-up|2|||
130442152|NCT02564055|469582181|FG004|Overall Study|Lost to Follow-up|1|||
130442153|NCT02564055|469582182|FG005|Overall Study|Lost to Follow-up|0|||
130442154|NCT02564055|469582177|FG000|Overall Study|Physician Decision|0|||
130442155|NCT02564055|469582178|FG001|Overall Study|Physician Decision|0|||
130442156|NCT02564055|469582179|FG002|Overall Study|Physician Decision|1|||
130442157|NCT02564055|469582180|FG003|Overall Study|Physician Decision|0|||
130442158|NCT02564055|469582181|FG004|Overall Study|Physician Decision|0|||
130442159|NCT02564055|469582182|FG005|Overall Study|Physician Decision|0|||
130442160|NCT02564055|469582177|FG000|Overall Study|Withdrawal by Subject|4|||
130442161|NCT02564055|469582178|FG001|Overall Study|Withdrawal by Subject|4|||
130442162|NCT02564055|469582179|FG002|Overall Study|Withdrawal by Subject|3|||
130442163|NCT02564055|469582180|FG003|Overall Study|Withdrawal by Subject|3|||
130442164|NCT02564055|469582181|FG004|Overall Study|Withdrawal by Subject|10|||
130442165|NCT02564055|469582182|FG005|Overall Study|Withdrawal by Subject|10|||
130442166|NCT04747275|469582183|FG000|Overall Study|Study terminated|0|||
130442167|NCT04747275|469582184|FG001|Overall Study|Study terminated|1|||
130442168|NCT00531011|469582188|FG000|Overall Study|Withdrawal by Subject|2|||
130442169|NCT00531011|469582189|FG001|Overall Study|Withdrawal by Subject|4|||
130442170|NCT00531011|469582188|FG000|Overall Study|Death|1|||
130442171|NCT00531011|469582189|FG001|Overall Study|Death|0|||
130442172|NCT00531011|469582188|FG000|Overall Study|Lost to Follow-up|1|||
130442173|NCT00531011|469582189|FG001|Overall Study|Lost to Follow-up|0|||
130552830|NCT01776424|469991552|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
130442174|NCT00531011|469582188|FG000|Overall Study|Physician Decision|0|||
130442175|NCT00531011|469582189|FG001|Overall Study|Physician Decision|3|||
130552831|NCT01776424|469991553|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
130552832|NCT00146757|469991554|FG000|Overall Study|Death|1|||
130686639|NCT02576938|470479580|FG001|Overall Study|Adverse Event|3|||
130686640|NCT02576938|470479581|FG002|Overall Study|Adverse Event|6|||
130686641|NCT02576938|470479579|FG000|Overall Study|Protocol Violation|1|||
130442176|NCT03268590|469582190|FG000|Overall Study|Previously unknown exclusion criteria|1|||
130442177|NCT02139982|469582193|FG000|Overall Study|Lack of Efficacy|0|||
130442178|NCT02139982|469582194|FG001|Overall Study|Lack of Efficacy|1|||
130442179|NCT02139982|469582195|FG002|Overall Study|Lack of Efficacy|0|||
130442180|NCT02139982|469582196|FG003|Overall Study|Lack of Efficacy|1|||
130442181|NCT02139982|469582197|FG004|Overall Study|Lack of Efficacy|0|||
130442182|NCT02139982|469582198|FG005|Overall Study|Lack of Efficacy|0|||
130442183|NCT02139982|469582199|FG006|Overall Study|Lack of Efficacy|0|||
130442184|NCT02139982|469582200|FG007|Overall Study|Lack of Efficacy|0|||
130222643|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222644|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130222645|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222646|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130222647|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222648|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222649|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222650|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222651|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222652|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222653|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222654|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222655|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222656|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222657|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222658|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222659|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222660|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
130222661|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222662|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222663|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222664|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222665|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222666|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222667|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222668|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222669|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222670|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222671|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222672|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222673|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222674|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130222675|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222676|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130222677|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222678|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130222679|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222680|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222681|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222682|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222683|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222684|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222685|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222686|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222687|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222688|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222689|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222690|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
130222691|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222692|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222693|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
130354975|NCT02273739|469271378|FG002|Overall Study|Physician Decision|0|||
130686642|NCT02576938|470479580|FG001|Overall Study|Protocol Violation|1|||
130354976|NCT02273739|469271379|FG003|Overall Study|Physician Decision|1|||
130354977|NCT02536833|469271381|FG000|Overall Study|Discontinued Before Treatment|0|||
130354978|NCT02536833|469271382|FG001|Overall Study|Discontinued Before Treatment|0|||
130354979|NCT02536833|469271383|FG002|Overall Study|Discontinued Before Treatment|1|||
130354980|NCT02536833|469271384|FG003|Overall Study|Discontinued Before Treatment|2|||
130354981|NCT02536833|469271381|FG000|Overall Study|Adverse Event|1|||
130354982|NCT02536833|469271382|FG001|Overall Study|Adverse Event|3|||
130354983|NCT02536833|469271383|FG002|Overall Study|Adverse Event|4|||
130354984|NCT02536833|469271384|FG003|Overall Study|Adverse Event|1|||
130354985|NCT02536833|469271381|FG000|Overall Study|Lost to Follow-up|2|||
130354986|NCT02536833|469271382|FG001|Overall Study|Lost to Follow-up|1|||
130354987|NCT02536833|469271383|FG002|Overall Study|Lost to Follow-up|2|||
130686643|NCT02576938|470479581|FG002|Overall Study|Protocol Violation|1|||
130222694|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222695|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222696|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222697|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222698|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222699|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222700|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222701|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222702|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222703|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222704|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222705|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
130222706|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130222707|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222708|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130222709|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222710|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222711|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222712|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222713|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222714|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222715|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222716|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222717|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222718|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222719|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222720|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
130222721|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222722|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222723|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222724|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222725|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222726|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222727|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222728|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222729|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130354988|NCT02536833|469271384|FG003|Overall Study|Lost to Follow-up|2|||
130442185|NCT02139982|469582201|FG008|Overall Study|Lack of Efficacy|0|||
130442186|NCT02139982|469582202|FG009|Overall Study|Lack of Efficacy|0|||
130222730|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130354989|NCT02536833|469271381|FG000|Overall Study|Physician Decision|0|||
130354990|NCT02536833|469271382|FG001|Overall Study|Physician Decision|0|||
130354991|NCT02536833|469271383|FG002|Overall Study|Physician Decision|0|||
130354992|NCT02536833|469271384|FG003|Overall Study|Physician Decision|1|||
130354993|NCT02536833|469271381|FG000|Overall Study|Site Terminated by Sponsor|2|||
130354994|NCT02536833|469271382|FG001|Overall Study|Site Terminated by Sponsor|2|||
130354995|NCT02536833|469271383|FG002|Overall Study|Site Terminated by Sponsor|2|||
130354996|NCT02536833|469271384|FG003|Overall Study|Site Terminated by Sponsor|2|||
130354997|NCT02536833|469271381|FG000|Overall Study|Subject Non-Compliance|0|||
130354998|NCT02536833|469271382|FG001|Overall Study|Subject Non-Compliance|1|||
130354999|NCT02536833|469271383|FG002|Overall Study|Subject Non-Compliance|1|||
130355000|NCT02536833|469271384|FG003|Overall Study|Subject Non-Compliance|0|||
130355001|NCT02536833|469271381|FG000|Overall Study|Withdrawal by Subject|4|||
130355002|NCT02536833|469271382|FG001|Overall Study|Withdrawal by Subject|3|||
130355003|NCT02536833|469271383|FG002|Overall Study|Withdrawal by Subject|5|||
130355004|NCT02536833|469271384|FG003|Overall Study|Withdrawal by Subject|11|||
130355005|NCT02764190|469271385|FG000|Overall Study|Lost to Follow-up|17|||
130355006|NCT02764190|469271386|FG001|Overall Study|Lost to Follow-up|13|||
130355007|NCT02140775|469271387|FG000|Overall Study|Withdrawal by Subject|30|||
130355008|NCT02140775|469271388|FG001|Overall Study|Withdrawal by Subject|7|||
130355009|NCT01172275|469271389|FG000|Overall Study|Lost to Follow-up|1|||
130355010|NCT01172275|469271390|FG001|Overall Study|Lost to Follow-up|0|||
130442187|NCT04254679|469582235|FG000|Overall Study|Protocol Violation|1|||
130442188|NCT04254679|469582236|FG001|Overall Study|Protocol Violation|1|||
130552833|NCT00146757|469991555|FG001|Overall Study|Death|0|||
130355011|NCT01172275|469271389|FG000|Overall Study|Protocol Violation|1|||
130355012|NCT01172275|469271390|FG001|Overall Study|Protocol Violation|0|||
130355013|NCT04650854|469271395|FG000|Overall Study|Adverse Event|1|||
130355014|NCT04650854|469271396|FG001|Overall Study|Adverse Event|12|||
130355015|NCT04650854|469271397|FG002|Overall Study|Adverse Event|14|||
130355016|NCT04650854|469271395|FG000|Overall Study|Lack of Efficacy|1|||
130222731|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222732|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222733|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222734|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222735|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222736|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
130222737|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222738|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222739|NCT00737100|468778292|FG000|Overall Study|Adverse Event|6|||
130222740|NCT00737100|468778293|FG001|Overall Study|Adverse Event|5|||
130222741|NCT00737100|468778294|FG002|Overall Study|Adverse Event|3|||
130222742|NCT00737100|468778292|FG000|Overall Study|Lost to Follow-up|0|||
130222743|NCT00737100|468778293|FG001|Overall Study|Lost to Follow-up|1|||
130222744|NCT00737100|468778294|FG002|Overall Study|Lost to Follow-up|0|||
130222745|NCT00737100|468778292|FG000|Overall Study|Withdrawal by Subject|0|||
130222746|NCT00737100|468778293|FG001|Overall Study|Withdrawal by Subject|0|||
130222747|NCT00737100|468778294|FG002|Overall Study|Withdrawal by Subject|3|||
130222748|NCT00737100|468778292|FG000|Overall Study|Reason discontinued not explained above|1|||
130222749|NCT00737100|468778293|FG001|Overall Study|Reason discontinued not explained above|1|||
130222750|NCT00737100|468778294|FG002|Overall Study|Reason discontinued not explained above|1|||
130222751|NCT00735943|468778297|FG000|Overall Study|Lost to Follow-up|1|||
130222752|NCT00735943|468778297|FG000|Overall Study|Adverse Event|1|||
130222753|NCT01265394|468778298|FG000|Overall Study|Subjects withdrawn|37|||
130222754|NCT00268983|468778303|FG000|Overall Study|Death|3|||
130222755|NCT00268983|468778304|FG001|Overall Study|Death|0|||
130222756|NCT01719380|468778305|FG000|Overall Study|Adverse Event|0|||
130222757|NCT01719380|468778306|FG001|Overall Study|Adverse Event|0|||
130222758|NCT01719380|468778307|FG002|Overall Study|Adverse Event|1|||
130222759|NCT01719380|468778308|FG003|Overall Study|Adverse Event|2|||
130222760|NCT01719380|468778309|FG004|Overall Study|Adverse Event|0|||
130222761|NCT01719380|468778310|FG005|Overall Study|Adverse Event|1|||
130222762|NCT01719380|468778311|FG006|Overall Study|Adverse Event|0|||
130222763|NCT01719380|468778312|FG007|Overall Study|Adverse Event|1|||
130222764|NCT01719380|468778313|FG008|Overall Study|Adverse Event|4|||
130222765|NCT01719380|468778314|FG009|Overall Study|Adverse Event|3|||
130222766|NCT01719380|468778305|FG000|Overall Study|Death|0|||
130222767|NCT01719380|468778306|FG001|Overall Study|Death|1|||
130222768|NCT01719380|468778307|FG002|Overall Study|Death|0|||
130222769|NCT01719380|468778308|FG003|Overall Study|Death|0|||
130222770|NCT01719380|468778309|FG004|Overall Study|Death|0|||
130222771|NCT01719380|468778310|FG005|Overall Study|Death|0|||
130222772|NCT01719380|468778311|FG006|Overall Study|Death|0|||
130222773|NCT01719380|468778312|FG007|Overall Study|Death|0|||
130222774|NCT01719380|468778313|FG008|Overall Study|Death|3|||
130222775|NCT01719380|468778314|FG009|Overall Study|Death|3|||
130222776|NCT01719380|468778305|FG000|Overall Study|Participant/Guardian Decision|0|||
130222777|NCT01719380|468778306|FG001|Overall Study|Participant/Guardian Decision|0|||
130222778|NCT01719380|468778307|FG002|Overall Study|Participant/Guardian Decision|1|||
130222779|NCT01719380|468778308|FG003|Overall Study|Participant/Guardian Decision|0|||
130222780|NCT01719380|468778309|FG004|Overall Study|Participant/Guardian Decision|0|||
130222781|NCT01719380|468778310|FG005|Overall Study|Participant/Guardian Decision|0|||
130222782|NCT01719380|468778311|FG006|Overall Study|Participant/Guardian Decision|0|||
130222783|NCT01719380|468778312|FG007|Overall Study|Participant/Guardian Decision|0|||
130222784|NCT01719380|468778313|FG008|Overall Study|Participant/Guardian Decision|2|||
130222785|NCT01719380|468778314|FG009|Overall Study|Participant/Guardian Decision|2|||
130222786|NCT01719380|468778305|FG000|Overall Study|Physician Decision|0|||
130686644|NCT02576938|470479579|FG000|Overall Study|Withdrawal by Subject|3|||
130222787|NCT01719380|468778306|FG001|Overall Study|Physician Decision|0|||
130355017|NCT04650854|469271396|FG001|Overall Study|Lack of Efficacy|3|||
130355018|NCT04650854|469271397|FG002|Overall Study|Lack of Efficacy|6|||
130355019|NCT04650854|469271395|FG000|Overall Study|Lost to Follow-up|1|||
130355020|NCT04650854|469271396|FG001|Overall Study|Lost to Follow-up|1|||
130355021|NCT04650854|469271397|FG002|Overall Study|Lost to Follow-up|0|||
130355022|NCT04650854|469271395|FG000|Overall Study|Withdrawal by Subject|2|||
130355023|NCT04650854|469271396|FG001|Overall Study|Withdrawal by Subject|17|||
130355024|NCT04650854|469271397|FG002|Overall Study|Withdrawal by Subject|9|||
130355025|NCT04650854|469271395|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
130222788|NCT01719380|468778307|FG002|Overall Study|Physician Decision|2|||
130222789|NCT01719380|468778308|FG003|Overall Study|Physician Decision|0|||
130355026|NCT04650854|469271396|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
130552834|NCT00146757|469991554|FG000|Overall Study|Adverse Event|1|||
130222790|NCT01719380|468778309|FG004|Overall Study|Physician Decision|0|||
130222791|NCT01719380|468778310|FG005|Overall Study|Physician Decision|0|||
130222792|NCT01719380|468778311|FG006|Overall Study|Physician Decision|0|||
130222793|NCT01719380|468778312|FG007|Overall Study|Physician Decision|0|||
130222794|NCT01719380|468778313|FG008|Overall Study|Physician Decision|1|||
130222795|NCT01719380|468778314|FG009|Overall Study|Physician Decision|1|||
130222796|NCT01719380|468778305|FG000|Overall Study|Lack of Efficacy|2|||
130222797|NCT01719380|468778306|FG001|Overall Study|Lack of Efficacy|6|||
130222798|NCT01719380|468778307|FG002|Overall Study|Lack of Efficacy|5|||
130222799|NCT01719380|468778308|FG003|Overall Study|Lack of Efficacy|6|||
130222800|NCT01719380|468778309|FG004|Overall Study|Lack of Efficacy|3|||
130222801|NCT01719380|468778310|FG005|Overall Study|Lack of Efficacy|7|||
130222802|NCT01719380|468778311|FG006|Overall Study|Lack of Efficacy|10|||
130222803|NCT01719380|468778312|FG007|Overall Study|Lack of Efficacy|6|||
130222804|NCT01719380|468778313|FG008|Overall Study|Lack of Efficacy|39|||
130222805|NCT01719380|468778314|FG009|Overall Study|Lack of Efficacy|42|||
130222806|NCT01719380|468778305|FG000|Overall Study|Progressive Disease|0|||
130222807|NCT01719380|468778306|FG001|Overall Study|Progressive Disease|0|||
130222808|NCT01719380|468778307|FG002|Overall Study|Progressive Disease|0|||
130222809|NCT01719380|468778308|FG003|Overall Study|Progressive Disease|0|||
130222810|NCT01719380|468778309|FG004|Overall Study|Progressive Disease|0|||
130222811|NCT01719380|468778310|FG005|Overall Study|Progressive Disease|0|||
130222812|NCT01719380|468778311|FG006|Overall Study|Progressive Disease|0|||
130222813|NCT01719380|468778312|FG007|Overall Study|Progressive Disease|0|||
130222814|NCT01719380|468778313|FG008|Overall Study|Progressive Disease|1|||
130222815|NCT01719380|468778314|FG009|Overall Study|Progressive Disease|0|||
130222816|NCT00321906|468778322|FG000|Overall Study|Adverse Event|36|||
130222817|NCT00321906|468778323|FG001|Overall Study|Adverse Event|44|||
130222818|NCT00321906|468778322|FG000|Overall Study|Death|9|||
130222819|NCT00321906|468778323|FG001|Overall Study|Death|6|||
130222820|NCT00321906|468778322|FG000|Overall Study|Lost to Follow-up|1|||
130222821|NCT00321906|468778323|FG001|Overall Study|Lost to Follow-up|2|||
130222822|NCT00321906|468778322|FG000|Overall Study|Withdrawal by Subject|0|||
130222823|NCT00321906|468778323|FG001|Overall Study|Withdrawal by Subject|4|||
130222824|NCT00838097|468778326|FG000|Overall Study|Ineligibility determined|6|||
130222825|NCT00838097|468778326|FG000|Overall Study|Adverse Event|2|||
130222826|NCT00838097|468778326|FG000|Overall Study|Withdrawal by Subject|3|||
130222827|NCT00838097|468778326|FG000|Overall Study|Requirement for alternative therapy|2|||
130222828|NCT00838097|468778326|FG000|Overall Study|Physician Decision|4|||
130222829|NCT00838097|468778326|FG000|Overall Study|Lost to Follow-up|11|||
130222830|NCT00838097|468778326|FG000|Overall Study|Death|6|||
130222831|NCT00838097|468778326|FG000|Overall Study|Protocol-specified criteria|142|||
130222832|NCT00871234|468778327|FG000|Overall Study|Adverse Event|2|||
130686645|NCT02576938|470479580|FG001|Overall Study|Withdrawal by Subject|2|||
130686646|NCT02576938|470479581|FG002|Overall Study|Withdrawal by Subject|4|||
130686647|NCT02576938|470479579|FG000|Overall Study|Lack of Efficacy|9|||
130686648|NCT02576938|470479580|FG001|Overall Study|Lack of Efficacy|4|||
130686649|NCT02576938|470479581|FG002|Overall Study|Lack of Efficacy|0|||
130222833|NCT00871234|468778327|FG000|Overall Study|Lost to Follow-up|3|||
130222834|NCT03380377|468778330|FG000|Overall Study|Physician Decision|1|||
130222835|NCT03380377|468778330|FG000|Overall Study|Withdrawal by Subject|1|||
130222836|NCT02600923|468778333|FG000|Overall Study|Death|10|||
130222837|NCT02600923|468778333|FG000|Overall Study|Adverse Event|3|||
130222838|NCT02600923|468778333|FG000|Overall Study|Global deterioration of health status|2|||
130222839|NCT02600923|468778333|FG000|Overall Study|Insufficient clinical response|6|||
130355027|NCT04650854|469271397|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
130552835|NCT00146757|469991555|FG001|Overall Study|Adverse Event|0|||
130222840|NCT02600923|468778333|FG000|Overall Study|Lost to Follow-up|1|||
130222841|NCT02600923|468778333|FG000|Overall Study|Withdrawal by Subject|5|||
130222842|NCT02600923|468778333|FG000|Overall Study|Objective progression or relapse|50|||
130222843|NCT02600923|468778333|FG000|Overall Study|Study terminated by Sponsor|53|||
130222844|NCT02600923|468778333|FG000|Overall Study|Not treated|1|||
130222845|NCT00792909|468778334|FG000|Overall Study|Withdrawal by Subject|0|||
130222846|NCT00792909|468778335|FG001|Overall Study|Withdrawal by Subject|1|||
130222847|NCT00792909|468778336|FG002|Overall Study|Withdrawal by Subject|0|||
130222848|NCT00128661|468778339|FG000|Overall Study|Adverse Event|14|||
130686650|NCT02576938|470479579|FG000|Overall Study|Lost to Follow-up|2|||
130686651|NCT02576938|470479580|FG001|Overall Study|Lost to Follow-up|0|||
130686652|NCT02576938|470479581|FG002|Overall Study|Lost to Follow-up|1|||
130222849|NCT00128661|468778340|FG001|Overall Study|Adverse Event|11|||
130222850|NCT00128661|468778339|FG000|Overall Study|Lost to Follow-up|10|||
130222851|NCT00128661|468778340|FG001|Overall Study|Lost to Follow-up|7|||
130222852|NCT00128661|468778339|FG000|Overall Study|Withdrawal by Subject|243|||
130222853|NCT00128661|468778340|FG001|Overall Study|Withdrawal by Subject|232|||
130222854|NCT00128661|468778339|FG000|Overall Study|Other|7|||
130222855|NCT00128661|468778340|FG001|Overall Study|Other|8|||
130222856|NCT01261390|468778342|FG000|Overall Study|Significant Concurrent Illness|1|||
130222857|NCT01261390|468778343|FG001|Overall Study|Significant Concurrent Illness|0|||
130222858|NCT01261390|468778344|FG002|Overall Study|Significant Concurrent Illness|1|||
130222859|NCT01261390|468778345|FG003|Overall Study|Significant Concurrent Illness|0|||
130222860|NCT01261390|468778342|FG000|Overall Study|Dissatisfaction with Treatment|2|||
130222861|NCT01261390|468778343|FG001|Overall Study|Dissatisfaction with Treatment|1|||
130222862|NCT01261390|468778344|FG002|Overall Study|Dissatisfaction with Treatment|1|||
130222863|NCT01261390|468778345|FG003|Overall Study|Dissatisfaction with Treatment|2|||
130442189|NCT04254679|469582235|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
130686653|NCT02576938|470479579|FG000|Overall Study|Physician Decision|0|||
130686654|NCT02576938|470479580|FG001|Overall Study|Physician Decision|1|||
130686655|NCT02576938|470479581|FG002|Overall Study|Physician Decision|0|||
130686656|NCT02576938|470479579|FG000|Overall Study|Met Exclusion Criteria|0|||
130686657|NCT02576938|470479580|FG001|Overall Study|Met Exclusion Criteria|1|||
130686658|NCT02576938|470479581|FG002|Overall Study|Met Exclusion Criteria|0|||
130686659|NCT03500341|470479582|FG000|Overall Study|Withdrawn prior to Completion|2|||
130686660|NCT00003659|470479592|FG000|Overall Study|Withdrawal by Subject|3|||
130686661|NCT04022954|470479593|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
130686662|NCT04022954|470479593|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
130686663|NCT04022954|470479593|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
130686664|NCT03017885|470479594|FG000|Overall Study|Adverse Event|2|||
130686665|NCT03017885|470479595|FG001|Overall Study|Adverse Event|0|||
130686666|NCT03017885|470479596|FG002|Overall Study|Adverse Event|0|||
130686667|NCT03017885|470479597|FG003|Overall Study|Adverse Event|0|||
130686668|NCT03017885|470479598|FG004|Overall Study|Adverse Event|0|||
130686669|NCT03017885|470479599|FG005|Overall Study|Adverse Event|0|||
130686670|NCT03017885|470479594|FG000|Overall Study|Progression of disease|4|||
130686671|NCT03017885|470479595|FG001|Overall Study|Progression of disease|3|||
130686672|NCT03017885|470479596|FG002|Overall Study|Progression of disease|4|||
130686673|NCT03017885|470479597|FG003|Overall Study|Progression of disease|0|||
130686674|NCT03017885|470479598|FG004|Overall Study|Progression of disease|0|||
130686675|NCT03017885|470479599|FG005|Overall Study|Progression of disease|0|||
130686676|NCT03017885|470479594|FG000|Overall Study|Other than listed|1|||
130686677|NCT03017885|470479595|FG001|Overall Study|Other than listed|2|||
130686678|NCT03017885|470479596|FG002|Overall Study|Other than listed|1|||
130686679|NCT03017885|470479597|FG003|Overall Study|Other than listed|0|||
130686680|NCT03017885|470479598|FG004|Overall Study|Other than listed|0|||
130686681|NCT03017885|470479599|FG005|Overall Study|Other than listed|0|||
130686682|NCT03017885|470479594|FG000|Overall Study|Lost to Follow-up|2|||
130686683|NCT03017885|470479595|FG001|Overall Study|Lost to Follow-up|0|||
130686684|NCT03017885|470479596|FG002|Overall Study|Lost to Follow-up|3|||
130686685|NCT03017885|470479597|FG003|Overall Study|Lost to Follow-up|0|||
130686686|NCT03017885|470479598|FG004|Overall Study|Lost to Follow-up|0|||
130686687|NCT03017885|470479599|FG005|Overall Study|Lost to Follow-up|0|||
130686688|NCT03017885|470479594|FG000|Overall Study|Change to other anti-cancer therapy|0|||
130686689|NCT03017885|470479595|FG001|Overall Study|Change to other anti-cancer therapy|0|||
130686690|NCT03017885|470479596|FG002|Overall Study|Change to other anti-cancer therapy|1|||
130686691|NCT03017885|470479597|FG003|Overall Study|Change to other anti-cancer therapy|0|||
130686692|NCT03017885|470479598|FG004|Overall Study|Change to other anti-cancer therapy|0|||
130686693|NCT03017885|470479599|FG005|Overall Study|Change to other anti-cancer therapy|0|||
130686694|NCT00984126|470479603|FG000|Overall Study|Protocol Violation|0|||
130686695|NCT00984126|470479604|FG001|Overall Study|Protocol Violation|0|||
130686696|NCT00984126|470479605|FG002|Overall Study|Protocol Violation|1|||
130686697|NCT00984126|470479606|FG003|Overall Study|Protocol Violation|2|||
130686698|NCT00984126|470479603|FG000|Overall Study|Adverse Event|0|||
130686699|NCT00984126|470479604|FG001|Overall Study|Adverse Event|0|||
130686700|NCT00984126|470479605|FG002|Overall Study|Adverse Event|0|||
130686701|NCT00984126|470479606|FG003|Overall Study|Adverse Event|2|||
130686702|NCT00984126|470479603|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
130686703|NCT00984126|470479604|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
130686704|NCT00984126|470479605|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
130442190|NCT04254679|469582236|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
130442191|NCT02823964|469582237|FG000|Overall Study|Adverse Event|2|||
130442192|NCT02823964|469582237|FG000|Overall Study|Physician Decision|1|||
130442193|NCT02823964|469582237|FG000|Overall Study|Lack of Efficacy|1|||
130442194|NCT02823964|469582237|FG000|Overall Study|Withdrawal by Subject|1|||
130442195|NCT00390455|469582243|FG000|Overall Study|Adverse Event|17|||
130442196|NCT00390455|469582244|FG001|Overall Study|Adverse Event|3|||
130442197|NCT00390455|469582243|FG000|Overall Study|Withdrawal by Subject|8|||
130442198|NCT00390455|469582244|FG001|Overall Study|Withdrawal by Subject|8|||
130442199|NCT00390455|469582243|FG000|Overall Study|Alternate Treatment|0|||
130442200|NCT00390455|469582244|FG001|Overall Study|Alternate Treatment|1|||
130442201|NCT00390455|469582243|FG000|Overall Study|Other Medical Reasons|7|||
130442202|NCT00390455|469582244|FG001|Overall Study|Other Medical Reasons|11|||
130686705|NCT00984126|470479606|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
130686706|NCT00984126|470479603|FG000|Overall Study|Withdrawal criteria|0|||
130686707|NCT00984126|470479604|FG001|Overall Study|Withdrawal criteria|1|||
130442203|NCT00794820|469582250|FG000|Overall Study|Adverse Event|11|||
130442204|NCT00794820|469582250|FG000|Overall Study|Secondary Malignancies|2|||
130442205|NCT00794820|469582250|FG000|Overall Study|Resistant Disease|2|||
130686708|NCT00984126|470479605|FG002|Overall Study|Withdrawal criteria|3|||
130686709|NCT00984126|470479606|FG003|Overall Study|Withdrawal criteria|9|||
130686710|NCT01001208|470479607|FG000|Overall Study|Adverse Event|10|||
130686711|NCT01001208|470479608|FG001|Overall Study|Adverse Event|5|||
130222864|NCT01261390|468778342|FG000|Overall Study|Relocation|0|||
130222865|NCT01261390|468778343|FG001|Overall Study|Relocation|1|||
130222866|NCT01261390|468778344|FG002|Overall Study|Relocation|0|||
130222867|NCT01261390|468778345|FG003|Overall Study|Relocation|0|||
130222868|NCT01261390|468778342|FG000|Overall Study|Loss of Interest in the Study|3|||
130222869|NCT01261390|468778343|FG001|Overall Study|Loss of Interest in the Study|1|||
130222870|NCT01261390|468778344|FG002|Overall Study|Loss of Interest in the Study|0|||
130222871|NCT01261390|468778345|FG003|Overall Study|Loss of Interest in the Study|0|||
130222872|NCT01261390|468778342|FG000|Overall Study|Lost to Follow-up|1|||
130222873|NCT01261390|468778343|FG001|Overall Study|Lost to Follow-up|6|||
130222874|NCT01261390|468778344|FG002|Overall Study|Lost to Follow-up|5|||
130222875|NCT01261390|468778345|FG003|Overall Study|Lost to Follow-up|6|||
130222876|NCT00977613|468778351|FG000|Overall Study|Lost to Follow-up|16|||
130222877|NCT01691378|468778355|FG000|Overall Study|Withdrawal by Subject|2|||
130222878|NCT01691378|468778356|FG001|Overall Study|Withdrawal by Subject|0|||
130222879|NCT01691378|468778355|FG000|Overall Study|Lost to Follow-up|5|||
130222880|NCT01691378|468778356|FG001|Overall Study|Lost to Follow-up|2|||
130222881|NCT00808067|468778359|FG000|Overall Study|Major/minor bleed|30|||
130222882|NCT00808067|468778360|FG001|Overall Study|Major/minor bleed|44|||
130222883|NCT00808067|468778359|FG000|Overall Study|Outcome event - other|33|||
130222884|NCT00808067|468778360|FG001|Overall Study|Outcome event - other|25|||
130222885|NCT00808067|468778359|FG000|Overall Study|Adverse Event|111|||
130222886|NCT00808067|468778360|FG001|Overall Study|Adverse Event|121|||
130222887|NCT00808067|468778359|FG000|Overall Study|Hospitalization (not including surgery)|18|||
130222888|NCT00808067|468778360|FG001|Overall Study|Hospitalization (not including surgery)|17|||
130222889|NCT00808067|468778359|FG000|Overall Study|Hospitalization due to surgery|37|||
130222890|NCT00808067|468778360|FG001|Overall Study|Hospitalization due to surgery|40|||
130222891|NCT00808067|468778359|FG000|Overall Study|Reduced creatinine clearance|53|||
130222892|NCT00808067|468778360|FG001|Overall Study|Reduced creatinine clearance|55|||
130222893|NCT00808067|468778359|FG000|Overall Study|Elevated LFT results|7|||
130222894|NCT00808067|468778360|FG001|Overall Study|Elevated LFT results|3|||
130222895|NCT00808067|468778359|FG000|Overall Study|Patient refused to take study medication|65|||
130222896|NCT00808067|468778360|FG001|Overall Study|Patient refused to take study medication|76|||
130222897|NCT00808067|468778359|FG000|Overall Study|Missing|1|||
130222898|NCT00808067|468778360|FG001|Overall Study|Missing|0|||
130222899|NCT00808067|468778359|FG000|Overall Study|Death|1|||
130222900|NCT00808067|468778360|FG001|Overall Study|Death|1|||
130222901|NCT00808067|468778359|FG000|Overall Study|Procedure|6|||
130222902|NCT00808067|468778360|FG001|Overall Study|Procedure|7|||
130222903|NCT00808067|468778359|FG000|Overall Study|Withdrawal by Subject|21|||
130222904|NCT00808067|468778360|FG001|Overall Study|Withdrawal by Subject|25|||
130222905|NCT00808067|468778359|FG000|Overall Study|Site closed|4|||
130222906|NCT00808067|468778360|FG001|Overall Study|Site closed|3|||
130222907|NCT00808067|468778359|FG000|Overall Study|Physician Decision|47|||
130222908|NCT00808067|468778360|FG001|Overall Study|Physician Decision|38|||
130222909|NCT00808067|468778359|FG000|Overall Study|Protocol Violation|3|||
130222910|NCT00808067|468778360|FG001|Overall Study|Protocol Violation|11|||
130222911|NCT00808067|468778359|FG000|Overall Study|Patient elected|7|||
130222912|NCT00808067|468778360|FG001|Overall Study|Patient elected|9|||
130222913|NCT00808067|468778359|FG000|Overall Study|Site closed for cause|19|||
130222914|NCT00808067|468778360|FG001|Overall Study|Site closed for cause|19|||
130222915|NCT00808067|468778359|FG000|Overall Study|Other reason not defined above|5|||
130222916|NCT00808067|468778360|FG001|Overall Study|Other reason not defined above|5|||
130355028|NCT04650854|469271395|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
130355029|NCT04650854|469271396|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
130355030|NCT04650854|469271397|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
130355031|NCT04650854|469271395|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
130355032|NCT04650854|469271396|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
130355033|NCT04650854|469271397|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
130355034|NCT04650854|469271395|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
130355035|NCT04650854|469271396|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
130355036|NCT04650854|469271397|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
130355037|NCT04650854|469271395|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
130355038|NCT04650854|469271396|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
130355039|NCT04650854|469271397|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
130222917|NCT00808067|468778359|FG000|Overall Study|Excluded from analysis|13|||
130222918|NCT00808067|468778360|FG001|Overall Study|Excluded from analysis|19|||
130222919|NCT02532283|468778361|FG000|Overall Study|Adverse Event|0|||
130355040|NCT04650854|469271395|FG000|Overall Study|Use of Rescue Medication|0|||
130222920|NCT02532283|468778362|FG001|Overall Study|Adverse Event|1|||
130222921|NCT02532283|468778361|FG000|Overall Study|Death|1|||
130222922|NCT02532283|468778362|FG001|Overall Study|Death|0|||
130222923|NCT02532283|468778361|FG000|Overall Study|Lost to Follow-up|0|||
130222924|NCT02532283|468778362|FG001|Overall Study|Lost to Follow-up|1|||
130222925|NCT02532283|468778361|FG000|Overall Study|Withdrawal by Subject|8|||
130222926|NCT02532283|468778362|FG001|Overall Study|Withdrawal by Subject|3|||
130686712|NCT01001208|470479607|FG000|Overall Study|Lost to Follow-up|5|||
130686713|NCT01001208|470479608|FG001|Overall Study|Lost to Follow-up|9|||
130686714|NCT01001208|470479607|FG000|Overall Study|Physician Decision|1|||
130686715|NCT01001208|470479608|FG001|Overall Study|Physician Decision|0|||
130686716|NCT01001208|470479607|FG000|Overall Study|Withdrawal by Subject|4|||
130686717|NCT01001208|470479608|FG001|Overall Study|Withdrawal by Subject|5|||
130686718|NCT01001208|470479607|FG000|Overall Study|Ineligibility Determined|4|||
130686719|NCT01001208|470479608|FG001|Overall Study|Ineligibility Determined|2|||
130686720|NCT01001208|470479607|FG000|Overall Study|Noncompliance|4|||
130686721|NCT01001208|470479608|FG001|Overall Study|Noncompliance|7|||
130686722|NCT01001208|470479607|FG000|Overall Study|Disease Progression|0|||
130686723|NCT01001208|470479608|FG001|Overall Study|Disease Progression|3|||
130686724|NCT01001208|470479607|FG000|Overall Study|Other|0|||
130686725|NCT01001208|470479608|FG001|Overall Study|Other|2|||
130686726|NCT01864174|470479609|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
130686727|NCT01864174|470479610|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
130686728|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
130686729|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
130686730|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
130686731|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
130686732|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
130686733|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
130686734|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Death|1|||
130686735|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Death|0|||
130686736|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
130686737|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
130686738|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
130686739|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
130686740|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Other|6|||
130686741|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Other|10|||
130686742|NCT01864174|470479609|FG000|Off Treatment Follow-Up|Other|2|||
130686743|NCT01864174|470479610|FG001|Off Treatment Follow-Up|Other|0|||
130686744|NCT01864174|470479609|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
130686745|NCT01864174|470479610|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
130686746|NCT03546842|470479614|FG000|Overall Study|Protocol Violation|1|||
130686747|NCT03546842|470479614|FG000|Overall Study|Withdrawal by Subject|2|||
130686748|NCT01723397|470479619|FG000|Study Period 1|Protocol Violation|0|||
130686749|NCT01723397|470479620|FG001|Study Period 1|Protocol Violation|1|||
130686750|NCT01723397|470479619|FG000|Study Period 2|Protocol Violation|0|||
130686751|NCT01723397|470479620|FG001|Study Period 2|Protocol Violation|1|||
130686752|NCT00468286|470479623|FG000|Overall Study|Adverse Event|1|||
130686753|NCT00468286|470479624|FG001|Overall Study|Adverse Event|6|||
130686754|NCT00468286|470479623|FG000|Overall Study|Protocol Violation|2|||
130686755|NCT00468286|470479624|FG001|Overall Study|Protocol Violation|2|||
130686756|NCT00468286|470479623|FG000|Overall Study|Withdrawal by Subject|4|||
130686757|NCT00468286|470479624|FG001|Overall Study|Withdrawal by Subject|3|||
130686758|NCT00468286|470479623|FG000|Overall Study|Physician Decision|0|||
130686759|NCT00468286|470479624|FG001|Overall Study|Physician Decision|1|||
130686760|NCT02158663|470479625|FG000|Overall Study|Withdrawal by Subject|5|||
130686761|NCT02158663|470479626|FG001|Overall Study|Withdrawal by Subject|4|||
130686762|NCT00537979|470479627|FG000|Overall Study|Adverse Event|2|||
130686763|NCT00537979|470479628|FG001|Overall Study|Adverse Event|2|||
130686764|NCT00537979|470479627|FG000|Overall Study|Withdrawal by Subject|1|||
130686765|NCT00537979|470479628|FG001|Overall Study|Withdrawal by Subject|4|||
130686766|NCT00537979|470479627|FG000|Overall Study|Lost to Follow-up|1|||
130355041|NCT04650854|469271396|FG001|Overall Study|Use of Rescue Medication|0|||
130355042|NCT04650854|469271397|FG002|Overall Study|Use of Rescue Medication|1|||
130355043|NCT04650854|469271395|FG000|Overall Study|Last Treatment Per Sponsor|0|||
130355044|NCT04650854|469271396|FG001|Overall Study|Last Treatment Per Sponsor|0|||
130355045|NCT04650854|469271397|FG002|Overall Study|Last Treatment Per Sponsor|2|||
130355046|NCT04650854|469271395|FG000|Overall Study|Rescue Medication|0|||
130686767|NCT00537979|470479628|FG001|Overall Study|Lost to Follow-up|4|||
130686768|NCT00537979|470479627|FG000|Overall Study|Lack of Efficacy|0|||
130686769|NCT00537979|470479628|FG001|Overall Study|Lack of Efficacy|1|||
130686770|NCT00537979|470479627|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
130686771|NCT00537979|470479628|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
130686772|NCT00537979|470479627|FG000|Overall Study|Death|0|||
130686773|NCT00537979|470479628|FG001|Overall Study|Death|3|||
130686774|NCT00537979|470479627|FG000|Overall Study|Kidney transplant|0|||
130686775|NCT00537979|470479628|FG001|Overall Study|Kidney transplant|3|||
130686776|NCT00537979|470479627|FG000|Overall Study|Heart failure|0|||
130355047|NCT04650854|469271396|FG001|Overall Study|Rescue Medication|0|||
130355048|NCT04650854|469271397|FG002|Overall Study|Rescue Medication|1|||
130222927|NCT00490971|468778365|FG000|Acute/Continuation|Adverse Event|62|||
130222928|NCT00490971|468778366|FG001|Acute/Continuation|Adverse Event|13|||
130222929|NCT00490971|468778367|FG002|Acute/Continuation|Adverse Event|0|||
130222930|NCT00490971|468778368|FG003|Acute/Continuation|Adverse Event|0|||
130222931|NCT00490971|468778369|FG004|Acute/Continuation|Adverse Event|0|||
130222932|NCT00490971|468778365|FG000|Acute/Continuation|Death|2|||
130222933|NCT00490971|468778366|FG001|Acute/Continuation|Death|0|||
130222934|NCT00490971|468778367|FG002|Acute/Continuation|Death|0|||
130222935|NCT00490971|468778368|FG003|Acute/Continuation|Death|0|||
130222936|NCT00490971|468778369|FG004|Acute/Continuation|Death|0|||
130222937|NCT00490971|468778365|FG000|Acute/Continuation|Lack of Efficacy|106|||
130222938|NCT00490971|468778366|FG001|Acute/Continuation|Lack of Efficacy|12|||
130222939|NCT00490971|468778367|FG002|Acute/Continuation|Lack of Efficacy|0|||
130222940|NCT00490971|468778368|FG003|Acute/Continuation|Lack of Efficacy|0|||
130222941|NCT00490971|468778369|FG004|Acute/Continuation|Lack of Efficacy|0|||
130222942|NCT00490971|468778365|FG000|Acute/Continuation|Lost to Follow-up|23|||
130442206|NCT00794820|469582250|FG000|Overall Study|Ineligible/Screen Failure|1|||
130442207|NCT04076020|469582251|FG000|Overall Study|Death|4|||
130442208|NCT04076020|469582252|FG001|Overall Study|Death|6|||
130442209|NCT04076020|469582251|FG000|Overall Study|Withdrawal by Subject|12|||
130442210|NCT04076020|469582252|FG001|Overall Study|Withdrawal by Subject|8|||
130442211|NCT02500979|469582254|FG000|Period 1|Hyperglycemia|1|||
130442212|NCT02500979|469582255|FG001|Period 1|Hyperglycemia|0|||
130442213|NCT02500979|469582254|FG000|Period 1|Severe non-compliance to protocol|0|||
130442214|NCT02500979|469582255|FG001|Period 1|Severe non-compliance to protocol|1|||
130442215|NCT02500979|469582254|FG000|Period 1|Adverse Event|1|||
130442216|NCT02500979|469582255|FG001|Period 1|Adverse Event|0|||
130442217|NCT02500979|469582254|FG000|Period 1|Subject decision|2|||
130442218|NCT02500979|469582255|FG001|Period 1|Subject decision|0|||
130442219|NCT02500979|469582254|FG000|Period 2|Change in risk|1|||
130442220|NCT02500979|469582255|FG001|Period 2|Change in risk|0|||
130442221|NCT00672958|469582258|FG000|Overall Study|Adverse Event|11|||
130442222|NCT00672958|469582259|FG001|Overall Study|Adverse Event|9|||
130442223|NCT00672958|469582258|FG000|Overall Study|Lack of Efficacy|6|||
130442224|NCT00672958|469582259|FG001|Overall Study|Lack of Efficacy|11|||
130442225|NCT00672958|469582258|FG000|Overall Study|Non-compliance with study drug|2|||
130442226|NCT00672958|469582259|FG001|Overall Study|Non-compliance with study drug|3|||
130442227|NCT00672958|469582258|FG000|Overall Study|Protocol deviations|11|||
130442228|NCT00672958|469582259|FG001|Overall Study|Protocol deviations|5|||
130442229|NCT00672958|469582258|FG000|Overall Study|Voluntary withdrawal|12|||
130442230|NCT00672958|469582259|FG001|Overall Study|Voluntary withdrawal|8|||
130442231|NCT00672958|469582258|FG000|Overall Study|Lost to Follow-up|22|||
130442232|NCT00672958|469582259|FG001|Overall Study|Lost to Follow-up|17|||
130442233|NCT00672958|469582258|FG000|Overall Study|Reason not specified|0|||
130442234|NCT00672958|469582259|FG001|Overall Study|Reason not specified|3|||
130442235|NCT01380990|469582260|FG000|Overall Study|Treatment Failure|1|||
130442236|NCT01380990|469582261|FG001|Overall Study|Treatment Failure|0|||
130442237|NCT01380990|469582260|FG000|Overall Study|Death|0|||
130442238|NCT01380990|469582261|FG001|Overall Study|Death|1|||
130442239|NCT01313923|469582268|FG000|Overall Study|Physician Decision|3|||
130442240|NCT02471404|469582269|FG000|Overall Study|Adverse Event|7|||
130442241|NCT02471404|469582270|FG001|Overall Study|Adverse Event|1|||
130442242|NCT02471404|469582271|FG002|Overall Study|Adverse Event|2|||
130442243|NCT02471404|469582269|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
130442244|NCT02471404|469582270|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
130442245|NCT02471404|469582271|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
130442246|NCT02471404|469582269|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
130442247|NCT02471404|469582270|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130222943|NCT00490971|468778366|FG001|Acute/Continuation|Lost to Follow-up|7|||
130222944|NCT00490971|468778367|FG002|Acute/Continuation|Lost to Follow-up|0|||
130222945|NCT00490971|468778368|FG003|Acute/Continuation|Lost to Follow-up|0|||
130222946|NCT00490971|468778369|FG004|Acute/Continuation|Lost to Follow-up|0|||
130222947|NCT00490971|468778365|FG000|Acute/Continuation|Protocol Violation|10|||
130686777|NCT00537979|470479628|FG001|Overall Study|Heart failure|1|||
130222948|NCT00490971|468778366|FG001|Acute/Continuation|Protocol Violation|2|||
130222949|NCT00490971|468778367|FG002|Acute/Continuation|Protocol Violation|0|||
130222950|NCT00490971|468778368|FG003|Acute/Continuation|Protocol Violation|0|||
130442248|NCT02471404|469582271|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
130442249|NCT02471404|469582269|FG000|Overall Study|Lost to Follow-up|1|||
130442250|NCT02471404|469582270|FG001|Overall Study|Lost to Follow-up|1|||
130442251|NCT02471404|469582271|FG002|Overall Study|Lost to Follow-up|3|||
130442252|NCT02471404|469582269|FG000|Overall Study|Protocol Violation|1|||
130442253|NCT02471404|469582270|FG001|Overall Study|Protocol Violation|0|||
130442254|NCT02471404|469582271|FG002|Overall Study|Protocol Violation|0|||
130222951|NCT00490971|468778369|FG004|Acute/Continuation|Protocol Violation|0|||
130222952|NCT00490971|468778365|FG000|Acute/Continuation|Withdrawal by Subject|92|||
130222953|NCT00490971|468778366|FG001|Acute/Continuation|Withdrawal by Subject|24|||
130442255|NCT02471404|469582269|FG000|Overall Study|Withdrawal by Subject|8|||
130442256|NCT02471404|469582270|FG001|Overall Study|Withdrawal by Subject|4|||
130222954|NCT00490971|468778367|FG002|Acute/Continuation|Withdrawal by Subject|0|||
130222955|NCT00490971|468778368|FG003|Acute/Continuation|Withdrawal by Subject|0|||
130222956|NCT00490971|468778369|FG004|Acute/Continuation|Withdrawal by Subject|0|||
130222957|NCT00490971|468778365|FG000|Acute/Continuation|Other|11|||
130222958|NCT00490971|468778366|FG001|Acute/Continuation|Other|4|||
130222959|NCT00490971|468778367|FG002|Acute/Continuation|Other|0|||
130222960|NCT00490971|468778368|FG003|Acute/Continuation|Other|0|||
130222961|NCT00490971|468778369|FG004|Acute/Continuation|Other|0|||
130222962|NCT00490971|468778365|FG000|Maintenance|Adverse Event|0|||
130222963|NCT00490971|468778366|FG001|Maintenance|Adverse Event|0|||
130222964|NCT00490971|468778367|FG002|Maintenance|Adverse Event|4|||
130222965|NCT00490971|468778368|FG003|Maintenance|Adverse Event|5|||
130222966|NCT00490971|468778369|FG004|Maintenance|Adverse Event|7|||
130222967|NCT00490971|468778365|FG000|Maintenance|Death|0|||
130222968|NCT00490971|468778366|FG001|Maintenance|Death|0|||
130222969|NCT00490971|468778367|FG002|Maintenance|Death|0|||
130222970|NCT00490971|468778368|FG003|Maintenance|Death|2|||
130222971|NCT00490971|468778369|FG004|Maintenance|Death|0|||
130222972|NCT00490971|468778365|FG000|Maintenance|Lost to Follow-up|0|||
130222973|NCT00490971|468778366|FG001|Maintenance|Lost to Follow-up|0|||
130222974|NCT00490971|468778367|FG002|Maintenance|Lost to Follow-up|5|||
130222975|NCT00490971|468778368|FG003|Maintenance|Lost to Follow-up|8|||
130222976|NCT00490971|468778369|FG004|Maintenance|Lost to Follow-up|10|||
130222977|NCT00490971|468778365|FG000|Maintenance|Pregnancy|0|||
130222978|NCT00490971|468778366|FG001|Maintenance|Pregnancy|0|||
130222979|NCT00490971|468778367|FG002|Maintenance|Pregnancy|1|||
130222980|NCT00490971|468778368|FG003|Maintenance|Pregnancy|0|||
130222981|NCT00490971|468778369|FG004|Maintenance|Pregnancy|0|||
130222982|NCT00490971|468778365|FG000|Maintenance|Protocol Violation|0|||
130222983|NCT00490971|468778366|FG001|Maintenance|Protocol Violation|0|||
130222984|NCT00490971|468778367|FG002|Maintenance|Protocol Violation|4|||
130222985|NCT00490971|468778368|FG003|Maintenance|Protocol Violation|1|||
130222986|NCT00490971|468778369|FG004|Maintenance|Protocol Violation|1|||
130222987|NCT00490971|468778365|FG000|Maintenance|Withdrawal by Subject|0|||
130222988|NCT00490971|468778366|FG001|Maintenance|Withdrawal by Subject|0|||
130222989|NCT00490971|468778367|FG002|Maintenance|Withdrawal by Subject|26|||
130222990|NCT00490971|468778368|FG003|Maintenance|Withdrawal by Subject|28|||
130222991|NCT00490971|468778369|FG004|Maintenance|Withdrawal by Subject|18|||
130442257|NCT02471404|469582271|FG002|Overall Study|Withdrawal by Subject|5|||
130222992|NCT00490971|468778365|FG000|Maintenance|Other|0|||
130222993|NCT00490971|468778366|FG001|Maintenance|Other|0|||
130222994|NCT00490971|468778367|FG002|Maintenance|Other|11|||
130222995|NCT00490971|468778368|FG003|Maintenance|Other|9|||
130222996|NCT00490971|468778369|FG004|Maintenance|Other|3|||
130222997|NCT04888494|468778371|FG000|Overall Study|Lost to Follow-up|2|||
130222998|NCT04888494|468778372|FG001|Overall Study|Lost to Follow-up|3|||
130222999|NCT04888494|468778371|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
130442258|NCT02471404|469582269|FG000|Overall Study|Other reasons not specified|10|||
130442259|NCT02471404|469582270|FG001|Overall Study|Other reasons not specified|7|||
130442260|NCT02471404|469582271|FG002|Overall Study|Other reasons not specified|12|||
130442261|NCT00065468|469582274|FG000|Overall Study|Death|172|||
130223000|NCT04888494|468778372|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
130223001|NCT00565604|468778378|FG000|Overall Study|Failure to treat|2|||
130223002|NCT00565604|468778378|FG000|Overall Study|Lost to Follow-up|2|||
130223003|NCT04754542|468778379|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130223004|NCT04754542|468778380|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130223005|NCT02317991|468779935|FG000|Overall Study|Adverse Event|12|||
130223006|NCT02317991|468779935|FG000|Overall Study|Death|4|||
130223007|NCT02317991|468779935|FG000|Overall Study|Withdrawal by Subject|8|||
130223008|NCT02317991|468779935|FG000|Overall Study|Progressive Disease|41|||
130442262|NCT00065468|469582275|FG001|Overall Study|Death|169|||
130223009|NCT00327340|468779936|FG000|Overall Study|Withdrawal by Subject|1|||
130223010|NCT00327340|468779937|FG001|Overall Study|Withdrawal by Subject|5|||
130223011|NCT00327340|468779936|FG000|Overall Study|Physician Decision|1|||
130223012|NCT00327340|468779937|FG001|Overall Study|Physician Decision|1|||
130223013|NCT00327340|468779936|FG000|Overall Study|Disease Progression|10|||
130223014|NCT00327340|468779937|FG001|Overall Study|Disease Progression|19|||
130223015|NCT00327340|468779936|FG000|Overall Study|Symptomatic Disease|0|||
130223016|NCT00327340|468779937|FG001|Overall Study|Symptomatic Disease|2|||
130223017|NCT00327340|468779936|FG000|Overall Study|Adverse Event|3|||
130223018|NCT00327340|468779937|FG001|Overall Study|Adverse Event|3|||
130223019|NCT01716806|468779942|FG000|Overall Study|Patient withdrawal of consent|4|||
130223020|NCT01716806|468779943|FG001|Overall Study|Patient withdrawal of consent|2|||
130223021|NCT01716806|468779944|FG002|Overall Study|Patient withdrawal of consent|4|||
130442263|NCT00065468|469582276|FG002|Overall Study|Death|171|||
130442264|NCT00065468|469582274|FG000|Overall Study|Withdrawal by Subject|3|||
130223022|NCT01716806|468779945|FG003|Overall Study|Patient withdrawal of consent|3|||
130223023|NCT01716806|468779946|FG004|Overall Study|Patient withdrawal of consent|2|||
130223024|NCT01716806|468779947|FG005|Overall Study|Patient withdrawal of consent|0|||
130223025|NCT01716806|468779942|FG000|Overall Study|Lost to Follow-up|3|||
130223026|NCT01716806|468779943|FG001|Overall Study|Lost to Follow-up|3|||
130223027|NCT01716806|468779944|FG002|Overall Study|Lost to Follow-up|0|||
130223028|NCT01716806|468779945|FG003|Overall Study|Lost to Follow-up|2|||
130223029|NCT01716806|468779946|FG004|Overall Study|Lost to Follow-up|1|||
130223030|NCT01716806|468779947|FG005|Overall Study|Lost to Follow-up|0|||
130223031|NCT01716806|468779942|FG000|Overall Study|Death|13|||
130223032|NCT01716806|468779943|FG001|Overall Study|Death|9|||
130223033|NCT01716806|468779944|FG002|Overall Study|Death|12|||
130223034|NCT01716806|468779945|FG003|Overall Study|Death|4|||
130223035|NCT01716806|468779946|FG004|Overall Study|Death|10|||
130223036|NCT01716806|468779947|FG005|Overall Study|Death|5|||
130223037|NCT01716806|468779942|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223038|NCT01716806|468779943|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223039|NCT01716806|468779944|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223040|NCT01716806|468779945|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223041|NCT01716806|468779946|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130223042|NCT01716806|468779947|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130223043|NCT01716806|468779942|FG000|Overall Study|PI decision|0|||
130223044|NCT01716806|468779943|FG001|Overall Study|PI decision|0|||
130223045|NCT01716806|468779944|FG002|Overall Study|PI decision|0|||
130223046|NCT01716806|468779945|FG003|Overall Study|PI decision|0|||
130223047|NCT01716806|468779946|FG004|Overall Study|PI decision|1|||
130223048|NCT01716806|468779947|FG005|Overall Study|PI decision|0|||
130223049|NCT01716806|468779942|FG000|Overall Study|Change in performance status|1|||
130223050|NCT01716806|468779943|FG001|Overall Study|Change in performance status|0|||
130223051|NCT01716806|468779944|FG002|Overall Study|Change in performance status|0|||
130223052|NCT01716806|468779945|FG003|Overall Study|Change in performance status|0|||
130223053|NCT01716806|468779946|FG004|Overall Study|Change in performance status|0|||
130223054|NCT01716806|468779947|FG005|Overall Study|Change in performance status|0|||
130223055|NCT01716806|468779942|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223056|NCT01716806|468779943|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223057|NCT01716806|468779944|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
130223058|NCT01716806|468779945|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223059|NCT01716806|468779946|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223060|NCT01716806|468779947|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223061|NCT01716806|468779942|FG000|Overall Study|Sponsor direction|7|||
130223062|NCT01716806|468779943|FG001|Overall Study|Sponsor direction|8|||
130223063|NCT01716806|468779944|FG002|Overall Study|Sponsor direction|5|||
130223064|NCT01716806|468779945|FG003|Overall Study|Sponsor direction|12|||
130223065|NCT01716806|468779946|FG004|Overall Study|Sponsor direction|16|||
130223066|NCT01716806|468779947|FG005|Overall Study|Sponsor direction|1|||
130223067|NCT03506438|468779948|FG000|Overall Study|Lost to Follow-up|8|||
130223068|NCT03506438|468779949|FG001|Overall Study|Lost to Follow-up|7|||
130223069|NCT03506438|468779950|FG002|Overall Study|Lost to Follow-up|8|||
130223070|NCT03506438|468779951|FG003|Overall Study|Lost to Follow-up|7|||
130223071|NCT03506438|468779952|FG004|Overall Study|Lost to Follow-up|0|||
130223072|NCT03506438|468779953|FG005|Overall Study|Lost to Follow-up|0|||
130223073|NCT03527277|468779954|FG000|Overall Study|Withdrawal by Subject|5|||
130223074|NCT03527277|468779955|FG001|Overall Study|Withdrawal by Subject|0|||
130223075|NCT03527277|468779954|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
130223076|NCT03527277|468779955|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
130223077|NCT03527277|468779954|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
130442265|NCT00065468|469582275|FG001|Overall Study|Withdrawal by Subject|4|||
130442266|NCT00065468|469582276|FG002|Overall Study|Withdrawal by Subject|5|||
130686778|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
130686779|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130686780|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130223078|NCT03527277|468779955|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
130442267|NCT00065468|469582274|FG000|Overall Study|Lost to Follow-up|5|||
130442268|NCT00065468|469582275|FG001|Overall Study|Lost to Follow-up|3|||
130442269|NCT00065468|469582276|FG002|Overall Study|Lost to Follow-up|2|||
130442270|NCT00065468|469582274|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
130442271|NCT00065468|469582275|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
130442272|NCT00065468|469582276|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
130442273|NCT00065468|469582274|FG000|Overall Study|Disease progression|0|||
130442274|NCT00065468|469582275|FG001|Overall Study|Disease progression|0|||
130223079|NCT03316586|468779958|FG000|Overall Study|Adverse Event|2|||
130223080|NCT03316586|468779958|FG000|Overall Study|Physician Decision|3|||
130442275|NCT00065468|469582276|FG002|Overall Study|Disease progression|1|||
130442276|NCT00065468|469582274|FG000|Overall Study|Other|14|||
130442277|NCT00065468|469582275|FG001|Overall Study|Other|24|||
130223081|NCT03316586|468779958|FG000|Overall Study|Lack of Efficacy|10|||
130223082|NCT03316586|468779958|FG000|Overall Study|still on treatment|1|||
130223083|NCT03316586|468779958|FG000|Overall Study|Patient needed radiation therapy|1|||
130223084|NCT03316586|468779958|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
130223085|NCT03934216|468779961|FG000|Overall Study|Other Reasons|5|||
130223086|NCT03934216|468779962|FG001|Overall Study|Other Reasons|5|||
130223087|NCT03934216|468779961|FG000|Overall Study|Adverse Event|22|||
130223088|NCT03934216|468779962|FG001|Overall Study|Adverse Event|11|||
130223089|NCT03934216|468779961|FG000|Overall Study|Lack of Efficacy|8|||
130223090|NCT03934216|468779962|FG001|Overall Study|Lack of Efficacy|7|||
130223091|NCT03934216|468779961|FG000|Overall Study|Lost to Follow-up|2|||
130223092|NCT03934216|468779962|FG001|Overall Study|Lost to Follow-up|0|||
130223093|NCT03934216|468779961|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223094|NCT03934216|468779962|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223095|NCT03934216|468779961|FG000|Overall Study|Pregnancy|1|||
130223096|NCT03934216|468779962|FG001|Overall Study|Pregnancy|0|||
130223097|NCT03934216|468779961|FG000|Overall Study|Withdrawal by Subject|18|||
130223098|NCT03934216|468779962|FG001|Overall Study|Withdrawal by Subject|6|||
130223099|NCT03934216|468779961|FG000|Overall Study|Randomized but not treated|1|||
130223100|NCT03934216|468779962|FG001|Overall Study|Randomized but not treated|1|||
130223101|NCT01396083|468779965|FG000|Overall Study|Adverse Event|2|||
130223102|NCT01396083|468779966|FG001|Overall Study|Adverse Event|28|||
130223103|NCT01396083|468779965|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130223104|NCT01396083|468779966|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130223105|NCT01396083|468779965|FG000|Overall Study|Consent withdrawn|4|||
130223106|NCT01396083|468779966|FG001|Overall Study|Consent withdrawn|5|||
130223107|NCT01396083|468779965|FG000|Overall Study|Protocol deviation(s)|0|||
130223108|NCT01396083|468779966|FG001|Overall Study|Protocol deviation(s)|1|||
130223109|NCT01396083|468779965|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130223110|NCT01396083|468779966|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130223111|NCT01396083|468779965|FG000|Overall Study|Administrative problems|1|||
130223112|NCT01396083|468779966|FG001|Overall Study|Administrative problems|0|||
130223113|NCT01396083|468779965|FG000|Overall Study|Lost to Follow-up|1|||
130223114|NCT01396083|468779966|FG001|Overall Study|Lost to Follow-up|0|||
130223115|NCT02806713|468779967|FG000|Overall Study|Urethral injury during procedure|1|||
130223116|NCT02806713|468779968|FG001|Overall Study|Urethral injury during procedure|0|||
130223117|NCT02806713|468779967|FG000|Overall Study|cancelled surgery|1|||
130223118|NCT02806713|468779968|FG001|Overall Study|cancelled surgery|2|||
130223119|NCT00735709|468779969|FG000|Overall Study|Adverse Event|2|||
130223120|NCT00735709|468779970|FG001|Overall Study|Adverse Event|3|||
130223121|NCT00735709|468779971|FG002|Overall Study|Adverse Event|1|||
130355049|NCT04650854|469271395|FG000|Overall Study|Participant Want to Start a Family|0|||
130355050|NCT04650854|469271396|FG001|Overall Study|Participant Want to Start a Family|0|||
130355051|NCT04650854|469271397|FG002|Overall Study|Participant Want to Start a Family|1|||
130355052|NCT04650854|469271395|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
130355053|NCT04650854|469271396|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
130355054|NCT04650854|469271397|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
130355055|NCT04650854|469271395|FG000|Overall Study|Participant Screened For MG0020|0|||
130355056|NCT04650854|469271396|FG001|Overall Study|Participant Screened For MG0020|2|||
130355057|NCT04650854|469271397|FG002|Overall Study|Participant Screened For MG0020|3|||
130355058|NCT04650854|469271395|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
130355059|NCT04650854|469271396|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
130355060|NCT04650854|469271397|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
130355061|NCT04650854|469271395|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
130355062|NCT04650854|469271396|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
130355063|NCT04650854|469271397|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
130355064|NCT04650854|469271395|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
130355065|NCT04650854|469271396|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
130355066|NCT04650854|469271397|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
130355067|NCT04650854|469271395|FG000|Overall Study|End Of Study|0|||
130355068|NCT04650854|469271396|FG001|Overall Study|End Of Study|2|||
130355069|NCT04650854|469271397|FG002|Overall Study|End Of Study|1|||
130355070|NCT04650854|469271395|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
130355071|NCT04650854|469271396|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
130355072|NCT04650854|469271397|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
130442278|NCT00065468|469582276|FG002|Overall Study|Other|18|||
130442279|NCT01225835|469582277|FG000|Overall Study|Completed protocol|2|||
130223122|NCT00735709|468779972|FG003|Overall Study|Adverse Event|5|||
130223123|NCT00735709|468779969|FG000|Overall Study|Lack of Efficacy|8|||
130223124|NCT00735709|468779970|FG001|Overall Study|Lack of Efficacy|4|||
130223125|NCT00735709|468779971|FG002|Overall Study|Lack of Efficacy|2|||
130223126|NCT00735709|468779972|FG003|Overall Study|Lack of Efficacy|3|||
130223127|NCT00735709|468779969|FG000|Overall Study|Noncompliance|0|||
130223128|NCT00735709|468779970|FG001|Overall Study|Noncompliance|0|||
130686781|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
130686782|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130686783|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130686784|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
130686785|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
130686786|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
130686787|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
130686788|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130686789|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130686790|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
130686791|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
130686792|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
130686793|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
130686794|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
130686795|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
130686796|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Other|13|||
130686797|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Other|0|||
130686798|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Other|0|||
130686799|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
130686800|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
130223129|NCT00735709|468779971|FG002|Overall Study|Noncompliance|1|||
130355073|NCT04650854|469271395|FG000|Overall Study|Participant Received Rescue Medication|0|||
130355074|NCT04650854|469271396|FG001|Overall Study|Participant Received Rescue Medication|1|||
130355075|NCT04650854|469271397|FG002|Overall Study|Participant Received Rescue Medication|0|||
130355076|NCT04650854|469271395|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
130355077|NCT04650854|469271396|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
130355078|NCT04650854|469271397|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
130355079|NCT04650854|469271395|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
130355080|NCT04650854|469271396|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
130355081|NCT04650854|469271397|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
130355082|NCT04650854|469271395|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
130355083|NCT04650854|469271396|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
130355084|NCT04650854|469271397|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
130355085|NCT04650854|469271395|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
130355086|NCT04650854|469271396|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
130355087|NCT04650854|469271397|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
130355088|NCT04650854|469271395|FG000|Overall Study|Enrollment Cup|0|||
130355089|NCT04650854|469271396|FG001|Overall Study|Enrollment Cup|0|||
130355090|NCT04650854|469271397|FG002|Overall Study|Enrollment Cup|1|||
130355091|NCT05308290|469271398|FG000|Overall Study|Death|1|||
130355092|NCT05308290|469271399|FG001|Overall Study|Death|0|||
130355093|NCT05308290|469271398|FG000|Overall Study|Lost to Follow-up|2|||
130355094|NCT05308290|469271399|FG001|Overall Study|Lost to Follow-up|1|||
130355095|NCT05308290|469271398|FG000|Overall Study|still in study followup|0|||
130355096|NCT05308290|469271399|FG001|Overall Study|still in study followup|1|||
130355097|NCT04437368|469271400|FG000|Overall Study|Death|3|||
130355098|NCT04437368|469271401|FG001|Overall Study|Death|0|||
130355099|NCT04437368|469271402|FG002|Overall Study|Death|2|||
130355100|NCT04437368|469271400|FG000|Overall Study|Study terminated by sponsor|16|||
130355101|NCT04437368|469271401|FG001|Overall Study|Study terminated by sponsor|1|||
130355102|NCT04437368|469271402|FG002|Overall Study|Study terminated by sponsor|25|||
130355103|NCT04437368|469271400|FG000|Overall Study|Withdrawal by Subject|4|||
130355104|NCT04437368|469271401|FG001|Overall Study|Withdrawal by Subject|0|||
130355105|NCT04437368|469271402|FG002|Overall Study|Withdrawal by Subject|3|||
130355106|NCT04437368|469271400|FG000|Overall Study|Sponsor instructions|23|||
130355107|NCT04437368|469271401|FG001|Overall Study|Sponsor instructions|0|||
130355108|NCT04437368|469271402|FG002|Overall Study|Sponsor instructions|0|||
130355109|NCT01982331|469271403|FG000|Received Vaccination 2|Adverse Event|1|||
130355110|NCT01982331|469271404|FG001|Received Vaccination 2|Adverse Event|2|||
130355111|NCT01982331|469271403|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130355112|NCT01982331|469271404|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
130355113|NCT01982331|469271403|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
130355114|NCT01982331|469271404|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
130355115|NCT01280955|469271414|FG000|Overall Study|Death|2|||
130355116|NCT01280955|469271414|FG000|Overall Study|Withdrawal by Subject|1|||
130355117|NCT04223232|469271416|FG000|Overall Study|Withdrawal by Subject|1|||
130355118|NCT02393690|469271417|FG000|Overall Study|Ineligible|0|||
130355119|NCT02393690|469271418|FG001|Overall Study|Ineligible|1|||
130355120|NCT01674634|469271419|FG000|Overall Study|Withdrawal by Subject|3|||
130552836|NCT02578862|469991563|FG000|Overall Study|Withdrawal by Subject|0|||
130223130|NCT00735709|468779972|FG003|Overall Study|Noncompliance|0|||
130223131|NCT00735709|468779969|FG000|Overall Study|Protocol deviations|1|||
130223132|NCT00735709|468779970|FG001|Overall Study|Protocol deviations|2|||
130223133|NCT00735709|468779971|FG002|Overall Study|Protocol deviations|1|||
130223134|NCT00735709|468779972|FG003|Overall Study|Protocol deviations|1|||
130223135|NCT00735709|468779969|FG000|Overall Study|Voluntary Withdrawal|1|||
130223136|NCT00735709|468779970|FG001|Overall Study|Voluntary Withdrawal|3|||
130223137|NCT00735709|468779971|FG002|Overall Study|Voluntary Withdrawal|5|||
130223138|NCT00735709|468779972|FG003|Overall Study|Voluntary Withdrawal|7|||
130223139|NCT00735709|468779969|FG000|Overall Study|Lost to Follow-up|0|||
130223140|NCT00735709|468779970|FG001|Overall Study|Lost to Follow-up|1|||
130686801|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
130686802|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
130686803|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
130686804|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
130686805|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Adverse Event|0|||
130686806|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Adverse Event|0|||
130686807|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Adverse Event|6|||
130686808|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
130686809|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
130355121|NCT01674634|469271419|FG000|Overall Study|Lost to Follow-up|3|||
130355122|NCT03187756|469271420|FG000|Overall Study|Termination of study|4|||
130355123|NCT02567552|469271421|FG000|Overall Study|Adverse Event|0|||
130355124|NCT02567552|469271422|FG001|Overall Study|Adverse Event|1|||
130355125|NCT01074047|469271423|FG000|Treatment Phase|Adverse Event|89|||
130355126|NCT01074047|469271424|FG001|Treatment Phase|Adverse Event|66|||
130355127|NCT01074047|469271423|FG000|Treatment Phase|Disease Progression|16|||
130355128|NCT01074047|469271424|FG001|Treatment Phase|Disease Progression|21|||
130355129|NCT01074047|469271423|FG000|Treatment Phase|Withdrawal by Subject|27|||
130355130|NCT01074047|469271424|FG001|Treatment Phase|Withdrawal by Subject|48|||
130355131|NCT01074047|469271423|FG000|Treatment Phase|Death|53|||
130355132|NCT01074047|469271424|FG001|Treatment Phase|Death|58|||
130355133|NCT01074047|469271423|FG000|Treatment Phase|Lost to Follow-up|0|||
130355134|NCT01074047|469271424|FG001|Treatment Phase|Lost to Follow-up|1|||
130355135|NCT01074047|469271423|FG000|Treatment Phase|Protocol Violation|0|||
130355136|NCT01074047|469271424|FG001|Treatment Phase|Protocol Violation|1|||
130355137|NCT01074047|469271423|FG000|Treatment Phase|Miscellaneous|32|||
130355138|NCT01074047|469271424|FG001|Treatment Phase|Miscellaneous|39|||
130355139|NCT01074047|469271423|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
130355140|NCT01074047|469271424|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
130355141|NCT01074047|469271423|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
130355142|NCT01074047|469271424|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
130355143|NCT01074047|469271423|FG000|Survival Follow-Up Phase|Death|116|||
130355144|NCT01074047|469271424|FG001|Survival Follow-Up Phase|Death|124|||
130355145|NCT01074047|469271423|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
130355146|NCT01074047|469271424|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
130355147|NCT01074047|469271423|FG000|Extension Phase|Physician Decision|1|||
130355148|NCT01074047|469271424|FG001|Extension Phase|Physician Decision|0|||
130355149|NCT01074047|469271423|FG000|Extension Phase|Adverse Event|5|||
130355150|NCT01074047|469271424|FG001|Extension Phase|Adverse Event|0|||
130355151|NCT01074047|469271423|FG000|Extension Phase|Disease Progression|9|||
130355152|NCT01074047|469271424|FG001|Extension Phase|Disease Progression|0|||
130355153|NCT01074047|469271423|FG000|Extension Phase|Withdrawal by Subject|2|||
130355154|NCT01074047|469271424|FG001|Extension Phase|Withdrawal by Subject|0|||
130355155|NCT01074047|469271423|FG000|Extension Phase|Death|5|||
130355156|NCT01074047|469271424|FG001|Extension Phase|Death|0|||
130355157|NCT01801072|469273309|FG000|Overall Study|Lost to Follow-up|17|||
130355158|NCT01801072|469273310|FG001|Overall Study|Lost to Follow-up|14|||
130355159|NCT01801072|469273309|FG000|Overall Study|Physician Decision|2|||
130355160|NCT01801072|469273310|FG001|Overall Study|Physician Decision|3|||
130355161|NCT01801072|469273309|FG000|Overall Study|Withdrawal by Subject|1|||
130355162|NCT01801072|469273310|FG001|Overall Study|Withdrawal by Subject|0|||
130355163|NCT01801072|469273309|FG000|Overall Study|Protocol Violation|2|||
130355164|NCT01801072|469273310|FG001|Overall Study|Protocol Violation|0|||
130355165|NCT01801072|469273309|FG000|Overall Study|Death|7|||
130355166|NCT01801072|469273310|FG001|Overall Study|Death|8|||
130355167|NCT02247531|469273311|FG000|Overall Study|Adverse Event|3|||
130686810|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
130686811|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
130686812|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
130355168|NCT02247531|469273312|FG001|Overall Study|Adverse Event|4|||
130355169|NCT02247531|469273313|FG002|Overall Study|Adverse Event|9|||
130355170|NCT02247531|469273311|FG000|Overall Study|Death|8|||
130355171|NCT02247531|469273312|FG001|Overall Study|Death|9|||
130355172|NCT02247531|469273313|FG002|Overall Study|Death|5|||
130355173|NCT02247531|469273311|FG000|Overall Study|Lost to Follow-up|1|||
130223141|NCT00735709|468779971|FG002|Overall Study|Lost to Follow-up|1|||
130223142|NCT00735709|468779972|FG003|Overall Study|Lost to Follow-up|1|||
130223143|NCT00735709|468779969|FG000|Overall Study|Excluded medication|1|||
130223144|NCT00735709|468779970|FG001|Overall Study|Excluded medication|0|||
130223145|NCT00735709|468779971|FG002|Overall Study|Excluded medication|0|||
130223146|NCT00735709|468779972|FG003|Overall Study|Excluded medication|1|||
130223147|NCT01165307|468779973|FG000|Overall Study|Lost to Follow-up|11|||
130223148|NCT01165307|468779974|FG001|Overall Study|Lost to Follow-up|3|||
130223149|NCT01165307|468779973|FG000|Overall Study|Withdrawal by Subject|2|||
130223150|NCT01165307|468779974|FG001|Overall Study|Withdrawal by Subject|0|||
130223151|NCT01165307|468779973|FG000|Overall Study|Subject not available for contact|1|||
130223152|NCT01165307|468779974|FG001|Overall Study|Subject not available for contact|0|||
130223153|NCT03113968|468779986|FG000|Overall Study|Withdrawal by Subject|31|||
130223154|NCT03113968|468779987|FG001|Overall Study|Withdrawal by Subject|4|||
130223155|NCT04805671|468779990|FG000|Overall Study|Death|2|||
130223156|NCT04805671|468779991|FG001|Overall Study|Death|7|||
130223157|NCT04805671|468779990|FG000|Overall Study|Lost to Follow-up|1|||
130223158|NCT04805671|468779991|FG001|Overall Study|Lost to Follow-up|0|||
130223159|NCT04805671|468779990|FG000|Overall Study|Withdrawal by Subject|9|||
130223160|NCT04805671|468779991|FG001|Overall Study|Withdrawal by Subject|7|||
130223161|NCT04805671|468779990|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
130223162|NCT04805671|468779991|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
130223163|NCT02111174|468779992|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
130223164|NCT02111174|468779993|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
130223165|NCT02111174|468779992|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
130223166|NCT02111174|468779993|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
130223167|NCT02111174|468779992|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
130223168|NCT02111174|468779993|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
130223169|NCT02111174|468779992|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
130223170|NCT02111174|468779993|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
130223171|NCT01657162|468779998|FG000|Overall Study|Adverse Event|26|||
130223172|NCT01657162|468779999|FG001|Overall Study|Adverse Event|36|||
130223173|NCT01657162|468779998|FG000|Overall Study|Withdrawal by Subject|13|||
130223174|NCT01657162|468779999|FG001|Overall Study|Withdrawal by Subject|13|||
130223175|NCT01657162|468779998|FG000|Overall Study|Continuing Significant Deterioration|9|||
130223176|NCT01657162|468779999|FG001|Overall Study|Continuing Significant Deterioration|3|||
130223177|NCT01657162|468779998|FG000|Overall Study|Refusal of Treatment|4|||
130223178|NCT01657162|468779999|FG001|Overall Study|Refusal of Treatment|6|||
130223179|NCT01657162|468779998|FG000|Overall Study|Lost to Follow-up|3|||
130223180|NCT01657162|468779999|FG001|Overall Study|Lost to Follow-up|4|||
130223181|NCT01657162|468779998|FG000|Overall Study|Death|2|||
130223182|NCT01657162|468779999|FG001|Overall Study|Death|3|||
130223183|NCT01657162|468779998|FG000|Overall Study|Inability to Complete Study Procedures|1|||
130223184|NCT01657162|468779999|FG001|Overall Study|Inability to Complete Study Procedures|7|||
130223185|NCT01657162|468779998|FG000|Overall Study|Protocol Violation|1|||
130223186|NCT01657162|468779999|FG001|Overall Study|Protocol Violation|0|||
130223187|NCT01657162|468779998|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
130223188|NCT01657162|468779999|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
130223189|NCT01657162|468779998|FG000|Overall Study|Other than Specified|0|||
130223190|NCT01657162|468779999|FG001|Overall Study|Other than Specified|2|||
130223191|NCT00901342|468780000|FG000|Overall Study|Adverse Event|1|||
130223192|NCT00901342|468780000|FG000|Overall Study|Death|4|||
130223193|NCT00901342|468780000|FG000|Overall Study|Disease progression|1|||
130223194|NCT00901342|468780000|FG000|Overall Study|Withdrawal by Subject|9|||
130223195|NCT00751140|468780009|FG000|Overall Study|benign angioma excluded from analysis|1|||
130223196|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
130223197|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
130223198|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
130223199|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
130223200|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
130223201|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
130223202|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
130223203|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
130355174|NCT02247531|469273312|FG001|Overall Study|Lost to Follow-up|8|||
130355175|NCT02247531|469273313|FG002|Overall Study|Lost to Follow-up|3|||
130355176|NCT02247531|469273311|FG000|Overall Study|Non-compliance|2|||
130355177|NCT02247531|469273312|FG001|Overall Study|Non-compliance|2|||
130355178|NCT02247531|469273313|FG002|Overall Study|Non-compliance|0|||
130355179|NCT02247531|469273311|FG000|Overall Study|Withdrawal by Subject|26|||
130355180|NCT02247531|469273312|FG001|Overall Study|Withdrawal by Subject|31|||
130355181|NCT02247531|469273313|FG002|Overall Study|Withdrawal by Subject|25|||
130355182|NCT02247531|469273311|FG000|Overall Study|Study Terminated by Sponsor|64|||
130355183|NCT02247531|469273312|FG001|Overall Study|Study Terminated by Sponsor|66|||
130223204|NCT04001803|468780010|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
130223205|NCT04001803|468780010|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
130223206|NCT02493517|468780011|FG000|Overall Study|Protocol Violation|1|||
130223207|NCT02493517|468780012|FG001|Overall Study|Protocol Violation|2|||
130223208|NCT02493517|468780011|FG000|Overall Study|Withdrawal by Subject|1|||
130223209|NCT02493517|468780012|FG001|Overall Study|Withdrawal by Subject|2|||
130223210|NCT02493517|468780011|FG000|Overall Study|Adverse Event|0|||
130223211|NCT02493517|468780012|FG001|Overall Study|Adverse Event|2|||
130223212|NCT02493517|468780011|FG000|Overall Study|Missed study visit|0|||
130223213|NCT02493517|468780012|FG001|Overall Study|Missed study visit|1|||
130223214|NCT03718429|468780013|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130223215|NCT03718429|468780014|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130223216|NCT03718429|468780015|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130223217|NCT03718429|468780016|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130223218|NCT05404711|468780019|FG000|Completed Study Visit|Withdrawal by Subject|1|||
130223219|NCT05404711|468780019|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
130223220|NCT05404711|468780019|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
130223221|NCT05404711|468780019|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
130223222|NCT05404711|468780019|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
130223223|NCT05404711|468780019|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
130223224|NCT00325819|468780020|FG000|Overall Study|Study product lost in mail|2|||
130223225|NCT00325819|468780021|FG001|Overall Study|Study product lost in mail|1|||
130223226|NCT00325819|468780020|FG000|Overall Study|Did not take a dose of study product|4|||
130223227|NCT00325819|468780021|FG001|Overall Study|Did not take a dose of study product|9|||
130223228|NCT00325819|468780020|FG000|Overall Study|Lost to Follow-up|3|||
130223229|NCT00325819|468780021|FG001|Overall Study|Lost to Follow-up|3|||
130223230|NCT02346877|468780022|FG000|Overall Study|Adverse Event|1|||
130223231|NCT02346877|468780023|FG001|Overall Study|Adverse Event|0|||
130223232|NCT02346877|468780022|FG000|Overall Study|Administrative Decision|1|||
130223233|NCT02346877|468780023|FG001|Overall Study|Administrative Decision|0|||
130223234|NCT02346877|468780022|FG000|Overall Study|Sponsor Decision|12|||
130223235|NCT02346877|468780023|FG001|Overall Study|Sponsor Decision|0|||
130223236|NCT02346877|468780022|FG000|Overall Study|Missing|5|||
130223237|NCT02346877|468780023|FG001|Overall Study|Missing|0|||
130442280|NCT01225835|469582278|FG001|Overall Study|Completed protocol|1|||
130442281|NCT01225835|469582277|FG000|Overall Study|Did not meet hCG criterion|2|||
130442282|NCT01225835|469582278|FG001|Overall Study|Did not meet hCG criterion|0|||
130442283|NCT01225835|469582277|FG000|Overall Study|Adverse Event|2|||
130442284|NCT01225835|469582278|FG001|Overall Study|Adverse Event|1|||
130442285|NCT01225835|469582277|FG000|Overall Study|Other|1|||
130223244|NCT04376515|468780032|FG000|Overall Study|Found to have been vaccinated before study start|6|||
130223245|NCT04376515|468780033|FG001|Overall Study|Found to have been vaccinated before study start|6|||
130223246|NCT03811821|468780034|FG000|Overall Study|Adverse Event|1|||
130223247|NCT03811821|468780035|FG001|Overall Study|Adverse Event|1|||
130223248|NCT03811821|468780034|FG000|Overall Study|Withdrawal by Subject|5|||
130223249|NCT03811821|468780035|FG001|Overall Study|Withdrawal by Subject|4|||
130223250|NCT03811821|468780034|FG000|Overall Study|Lost to Follow-up|2|||
130223251|NCT03811821|468780035|FG001|Overall Study|Lost to Follow-up|2|||
130223252|NCT03811821|468780034|FG000|Overall Study|Contraindication for treatment|0|||
130223253|NCT03811821|468780035|FG001|Overall Study|Contraindication for treatment|1|||
130223254|NCT03811821|468780034|FG000|Overall Study|Tolerability|0|||
130223255|NCT03811821|468780035|FG001|Overall Study|Tolerability|3|||
130223256|NCT03811821|468780034|FG000|Overall Study|Comorbidities|0|||
130223257|NCT03811821|468780035|FG001|Overall Study|Comorbidities|2|||
130223258|NCT01683604|468780037|FG000|Overall Study|Adverse Event|2|||
130223259|NCT01683604|468780037|FG000|Overall Study|Lack of Efficacy|1|||
130223260|NCT01683604|468780037|FG000|Overall Study|Other|2|||
130223261|NCT03430856|468780043|FG000|Overall Study|Adverse Event|0|||
130223262|NCT03430856|468780044|FG001|Overall Study|Adverse Event|1|||
130223263|NCT03430856|468780045|FG002|Overall Study|Adverse Event|0|||
130223264|NCT03430856|468780043|FG000|Overall Study|Rescue criteria|1|||
130223265|NCT03430856|468780044|FG001|Overall Study|Rescue criteria|1|||
130686813|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
130223266|NCT03430856|468780045|FG002|Overall Study|Rescue criteria|0|||
130223267|NCT03430856|468780043|FG000|Overall Study|Voluntary withdrawal of consent|1|||
130686814|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Pregnancy|0|||
130223268|NCT03430856|468780044|FG001|Overall Study|Voluntary withdrawal of consent|1|||
130223269|NCT03430856|468780045|FG002|Overall Study|Voluntary withdrawal of consent|1|||
130223270|NCT01949142|468780046|FG000|Overall Study|Withdrawal of consent|1|||
130223271|NCT01949142|468780047|FG001|Overall Study|Withdrawal of consent|0|||
130223272|NCT01949142|468780046|FG000|Overall Study|Lost to Follow-up|1|||
130223273|NCT01949142|468780047|FG001|Overall Study|Lost to Follow-up|1|||
130223274|NCT01949142|468780046|FG000|Overall Study|Parent changed their mind|1|||
130223275|NCT01949142|468780047|FG001|Overall Study|Parent changed their mind|0|||
130223276|NCT01395810|468780048|FG000|Overall Study|Adverse Event|0|||
130442286|NCT01225835|469582278|FG001|Overall Study|Other|1|||
130442287|NCT03285113|469582281|FG000|Overall Study|Unable to implant leads|2|||
130442288|NCT00849680|469582284|FG000|Overall Study|Adverse Event|0|||
130442289|NCT00849680|469582285|FG001|Overall Study|Adverse Event|0|||
130442290|NCT00849680|469582286|FG002|Overall Study|Adverse Event|0|||
130442291|NCT00849680|469582287|FG003|Overall Study|Adverse Event|0|||
130442292|NCT00849680|469582288|FG004|Overall Study|Adverse Event|0|||
130442293|NCT00849680|469582289|FG005|Overall Study|Adverse Event|0|||
130442294|NCT00849680|469582290|FG006|Overall Study|Adverse Event|2|||
130442295|NCT00849680|469582291|FG007|Overall Study|Adverse Event|0|||
130442296|NCT00849680|469582284|FG000|Overall Study|Lost to Follow-up|7|||
130442297|NCT00849680|469582285|FG001|Overall Study|Lost to Follow-up|3|||
130442298|NCT00849680|469582286|FG002|Overall Study|Lost to Follow-up|12|||
130442299|NCT00849680|469582287|FG003|Overall Study|Lost to Follow-up|11|||
130442300|NCT00849680|469582288|FG004|Overall Study|Lost to Follow-up|8|||
130442301|NCT00849680|469582289|FG005|Overall Study|Lost to Follow-up|11|||
130442302|NCT00849680|469582290|FG006|Overall Study|Lost to Follow-up|12|||
130442303|NCT00849680|469582291|FG007|Overall Study|Lost to Follow-up|5|||
130442304|NCT00849680|469582284|FG000|Overall Study|Subject moved|1|||
130442305|NCT00849680|469582285|FG001|Overall Study|Subject moved|0|||
130442306|NCT00849680|469582286|FG002|Overall Study|Subject moved|3|||
130442307|NCT00849680|469582287|FG003|Overall Study|Subject moved|1|||
130442308|NCT00849680|469582288|FG004|Overall Study|Subject moved|0|||
130442309|NCT00849680|469582289|FG005|Overall Study|Subject moved|2|||
130442310|NCT00849680|469582290|FG006|Overall Study|Subject moved|2|||
130442311|NCT00849680|469582291|FG007|Overall Study|Subject moved|2|||
130442312|NCT00849680|469582284|FG000|Overall Study|Withdrawal by Subject|2|||
130442313|NCT00849680|469582285|FG001|Overall Study|Withdrawal by Subject|0|||
130442314|NCT00849680|469582286|FG002|Overall Study|Withdrawal by Subject|0|||
130442315|NCT00849680|469582287|FG003|Overall Study|Withdrawal by Subject|2|||
130442316|NCT00849680|469582288|FG004|Overall Study|Withdrawal by Subject|2|||
130442317|NCT00849680|469582289|FG005|Overall Study|Withdrawal by Subject|2|||
130442318|NCT00849680|469582290|FG006|Overall Study|Withdrawal by Subject|1|||
130442319|NCT00849680|469582291|FG007|Overall Study|Withdrawal by Subject|1|||
130442320|NCT00849680|469582284|FG000|Overall Study|Subject unable to comply with protocol|1|||
130442321|NCT00849680|469582285|FG001|Overall Study|Subject unable to comply with protocol|0|||
130442322|NCT00849680|469582286|FG002|Overall Study|Subject unable to comply with protocol|0|||
130442323|NCT00849680|469582287|FG003|Overall Study|Subject unable to comply with protocol|0|||
130442324|NCT00849680|469582288|FG004|Overall Study|Subject unable to comply with protocol|0|||
130442325|NCT00849680|469582289|FG005|Overall Study|Subject unable to comply with protocol|0|||
130442326|NCT00849680|469582290|FG006|Overall Study|Subject unable to comply with protocol|0|||
130442327|NCT00849680|469582291|FG007|Overall Study|Subject unable to comply with protocol|0|||
130442328|NCT02207374|469582292|FG000|Overall Study|Withdrawal by Subject|5|||
130442329|NCT02207374|469582293|FG001|Overall Study|Withdrawal by Subject|9|||
130442330|NCT02207374|469582294|FG002|Overall Study|Withdrawal by Subject|4|||
130442331|NCT02207374|469582292|FG000|Overall Study|Death|1|||
130442332|NCT02207374|469582293|FG001|Overall Study|Death|0|||
130442333|NCT02207374|469582294|FG002|Overall Study|Death|1|||
130442334|NCT02207374|469582292|FG000|Overall Study|Missing follow-up information|0|||
130442335|NCT02207374|469582293|FG001|Overall Study|Missing follow-up information|1|||
130442336|NCT02207374|469582294|FG002|Overall Study|Missing follow-up information|1|||
130442337|NCT02087150|469582295|FG000|Overall Study|Death|0|||
130442338|NCT02087150|469582296|FG001|Overall Study|Death|1|||
130442339|NCT02087150|469582297|FG002|Overall Study|Death|0|||
130442340|NCT02087150|469582295|FG000|Overall Study|Lost to Follow-up|6|||
130442341|NCT02087150|469582296|FG001|Overall Study|Lost to Follow-up|13|||
130442342|NCT02087150|469582297|FG002|Overall Study|Lost to Follow-up|7|||
130442343|NCT02087150|469582295|FG000|Overall Study|Withdrawal by Subject|2|||
130442344|NCT02087150|469582296|FG001|Overall Study|Withdrawal by Subject|5|||
130442345|NCT02087150|469582297|FG002|Overall Study|Withdrawal by Subject|3|||
130442346|NCT02087150|469582295|FG000|Overall Study|Physician Decision|0|||
130442347|NCT02087150|469582296|FG001|Overall Study|Physician Decision|1|||
130442348|NCT02087150|469582297|FG002|Overall Study|Physician Decision|0|||
130442349|NCT02087150|469582295|FG000|Overall Study|Procedure not done|1|||
130442350|NCT02087150|469582296|FG001|Overall Study|Procedure not done|13|||
130442351|NCT02087150|469582297|FG002|Overall Study|Procedure not done|0|||
130442352|NCT02087150|469582295|FG000|Overall Study|F/U not completed w/in study window|0|||
130442353|NCT02087150|469582296|FG001|Overall Study|F/U not completed w/in study window|0|||
130442354|NCT02087150|469582297|FG002|Overall Study|F/U not completed w/in study window|1|||
130442355|NCT02087150|469582295|FG000|Overall Study|Other|1|||
130442356|NCT02087150|469582296|FG001|Overall Study|Other|0|||
130442357|NCT02087150|469582297|FG002|Overall Study|Other|0|||
130442358|NCT02087150|469582295|FG000|Overall Study|Pt moved out of town|0|||
130442359|NCT02087150|469582296|FG001|Overall Study|Pt moved out of town|1|||
130442360|NCT02087150|469582297|FG002|Overall Study|Pt moved out of town|0|||
130442361|NCT01448044|469582298|FG000|Treatment Period|Adverse Event|4|||
130442362|NCT01448044|469582299|FG001|Treatment Period|Adverse Event|3|||
130223277|NCT01395810|468780049|FG001|Overall Study|Adverse Event|1|||
130355184|NCT02247531|469273313|FG002|Overall Study|Study Terminated by Sponsor|62|||
130355185|NCT02247531|469273311|FG000|Overall Study|Physician Decision|0|||
130355186|NCT02247531|469273312|FG001|Overall Study|Physician Decision|2|||
130355187|NCT02247531|469273313|FG002|Overall Study|Physician Decision|2|||
130355188|NCT02247531|469273311|FG000|Overall Study|Unspecified Reason|2|||
130355189|NCT02247531|469273312|FG001|Overall Study|Unspecified Reason|3|||
130355190|NCT02247531|469273313|FG002|Overall Study|Unspecified Reason|4|||
130355191|NCT02423109|469273314|FG000|Lens 1|Adverse Event|1|||
130355192|NCT02423109|469273315|FG001|Lens 1|Adverse Event|0|||
130355193|NCT01229397|469273316|FG000|Overall Study|Withdrawal by Subject|3|||
130355194|NCT01229397|469273317|FG001|Overall Study|Withdrawal by Subject|3|||
130355195|NCT01229397|469273316|FG000|Overall Study|Lost to Follow-up|7|||
130355196|NCT01229397|469273317|FG001|Overall Study|Lost to Follow-up|6|||
130355197|NCT01229397|469273316|FG000|Overall Study|Migrated/moved from study area|1|||
130355198|NCT01229397|469273317|FG001|Overall Study|Migrated/moved from study area|0|||
130355199|NCT01251744|469273319|FG000|Overall Study|Lost to Follow-up|1|||
130355200|NCT01251744|469273320|FG001|Overall Study|Lost to Follow-up|0|||
130355201|NCT01068652|469273321|FG000|Overall Study|Adverse Event|4|||
130355202|NCT01068652|469273322|FG001|Overall Study|Adverse Event|0|||
130355203|NCT01068652|469273321|FG000|Overall Study|Lack of Efficacy|0|||
130355204|NCT01068652|469273322|FG001|Overall Study|Lack of Efficacy|2|||
130355205|NCT01068652|469273321|FG000|Overall Study|Lost to Follow-up|2|||
130355206|NCT01068652|469273322|FG001|Overall Study|Lost to Follow-up|1|||
130355207|NCT01068652|469273321|FG000|Overall Study|Protocol Violation|3|||
130355208|NCT01068652|469273322|FG001|Overall Study|Protocol Violation|6|||
130355209|NCT01068652|469273321|FG000|Overall Study|Withdrawal criteria|1|||
130355210|NCT01068652|469273322|FG001|Overall Study|Withdrawal criteria|2|||
130355211|NCT01068652|469273321|FG000|Overall Study|Patient was not eligible|1|||
130355212|NCT01068652|469273322|FG001|Overall Study|Patient was not eligible|0|||
130355213|NCT01068652|469273321|FG000|Overall Study|Unclassified|7|||
130355214|NCT01068652|469273322|FG001|Overall Study|Unclassified|4|||
130355215|NCT02694523|469273323|FG000|Part A|Adverse Event|7|||
130355216|NCT02694523|469273324|FG001|Part A|Adverse Event|3|||
130355217|NCT02694523|469273325|FG002|Part A|Adverse Event|0|||
130355218|NCT02694523|469273326|FG003|Part A|Adverse Event|0|||
130355219|NCT02694523|469273327|FG004|Part A|Adverse Event|0|||
130355220|NCT02694523|469273328|FG005|Part A|Adverse Event|0|||
130355221|NCT02694523|469273329|FG006|Part A|Adverse Event|0|||
130355222|NCT02694523|469273323|FG000|Part A|Protocol Violation|1|||
130355223|NCT02694523|469273324|FG001|Part A|Protocol Violation|0|||
130355224|NCT02694523|469273325|FG002|Part A|Protocol Violation|0|||
130355225|NCT02694523|469273326|FG003|Part A|Protocol Violation|0|||
130355226|NCT02694523|469273327|FG004|Part A|Protocol Violation|0|||
130355227|NCT02694523|469273328|FG005|Part A|Protocol Violation|0|||
130355228|NCT02694523|469273329|FG006|Part A|Protocol Violation|0|||
130355229|NCT02694523|469273323|FG000|Part A|Lost to Follow-up|1|||
130355230|NCT02694523|469273324|FG001|Part A|Lost to Follow-up|2|||
130355231|NCT02694523|469273325|FG002|Part A|Lost to Follow-up|0|||
130355232|NCT02694523|469273326|FG003|Part A|Lost to Follow-up|0|||
130355233|NCT02694523|469273327|FG004|Part A|Lost to Follow-up|0|||
130355234|NCT02694523|469273328|FG005|Part A|Lost to Follow-up|0|||
130355235|NCT02694523|469273329|FG006|Part A|Lost to Follow-up|0|||
130355236|NCT02694523|469273323|FG000|Part A|Withdrawal by Subject|3|||
130355237|NCT02694523|469273324|FG001|Part A|Withdrawal by Subject|1|||
130355238|NCT02694523|469273325|FG002|Part A|Withdrawal by Subject|0|||
130355239|NCT02694523|469273326|FG003|Part A|Withdrawal by Subject|0|||
130355240|NCT02694523|469273327|FG004|Part A|Withdrawal by Subject|0|||
130355241|NCT02694523|469273328|FG005|Part A|Withdrawal by Subject|0|||
130355242|NCT02694523|469273329|FG006|Part A|Withdrawal by Subject|0|||
130355243|NCT02694523|469273323|FG000|Part A|Other|1|||
130355244|NCT02694523|469273324|FG001|Part A|Other|1|||
130355245|NCT02694523|469273325|FG002|Part A|Other|0|||
130355246|NCT02694523|469273326|FG003|Part A|Other|0|||
130355247|NCT02694523|469273327|FG004|Part A|Other|0|||
130355248|NCT02694523|469273328|FG005|Part A|Other|0|||
130355249|NCT02694523|469273329|FG006|Part A|Other|0|||
130355250|NCT02694523|469273323|FG000|Part B|Adverse Event|0|||
130355251|NCT02694523|469273324|FG001|Part B|Adverse Event|0|||
130355252|NCT02694523|469273325|FG002|Part B|Adverse Event|7|||
130355253|NCT02694523|469273326|FG003|Part B|Adverse Event|1|||
130355254|NCT02694523|469273327|FG004|Part B|Adverse Event|1|||
130355255|NCT02694523|469273328|FG005|Part B|Adverse Event|2|||
130355256|NCT02694523|469273329|FG006|Part B|Adverse Event|0|||
130355257|NCT02694523|469273323|FG000|Part B|Protocol Violation|0|||
130355258|NCT02694523|469273324|FG001|Part B|Protocol Violation|0|||
130355259|NCT02694523|469273325|FG002|Part B|Protocol Violation|1|||
130355260|NCT02694523|469273326|FG003|Part B|Protocol Violation|0|||
130355261|NCT02694523|469273327|FG004|Part B|Protocol Violation|0|||
130355262|NCT02694523|469273328|FG005|Part B|Protocol Violation|0|||
130355263|NCT02694523|469273329|FG006|Part B|Protocol Violation|0|||
130355264|NCT02694523|469273323|FG000|Part B|Lost to Follow-up|0|||
130355265|NCT02694523|469273324|FG001|Part B|Lost to Follow-up|0|||
130355266|NCT02694523|469273325|FG002|Part B|Lost to Follow-up|2|||
130355267|NCT02694523|469273326|FG003|Part B|Lost to Follow-up|3|||
130223278|NCT01395810|468780050|FG002|Overall Study|Adverse Event|0|||
130223279|NCT01395810|468780051|FG003|Overall Study|Adverse Event|0|||
130223280|NCT01395810|468780048|FG000|Overall Study|Lack of Efficacy|0|||
130223281|NCT01395810|468780049|FG001|Overall Study|Lack of Efficacy|1|||
130223282|NCT01395810|468780050|FG002|Overall Study|Lack of Efficacy|0|||
130223283|NCT01395810|468780051|FG003|Overall Study|Lack of Efficacy|0|||
130223284|NCT01395810|468780048|FG000|Overall Study|Withdrawal criteria|0|||
130223285|NCT01395810|468780049|FG001|Overall Study|Withdrawal criteria|2|||
130223286|NCT01395810|468780050|FG002|Overall Study|Withdrawal criteria|0|||
130223287|NCT01395810|468780051|FG003|Overall Study|Withdrawal criteria|0|||
130223288|NCT01395810|468780048|FG000|Overall Study|Unclassified|2|||
130223289|NCT01395810|468780049|FG001|Overall Study|Unclassified|0|||
130223290|NCT01395810|468780050|FG002|Overall Study|Unclassified|0|||
130223291|NCT01395810|468780051|FG003|Overall Study|Unclassified|0|||
130223292|NCT05027815|468780054|FG000|Overall Study|Death|2|||
130223293|NCT05027815|468780055|FG001|Overall Study|Death|1|||
130223294|NCT03677869|468780059|FG000|Overall Study|Withdrawal by Subject|1|||
130223295|NCT04265261|468780061|FG000|Overall Study|Adverse Event|2|||
130223296|NCT04265261|468780062|FG001|Overall Study|Adverse Event|0|||
130223297|NCT04265261|468780063|FG002|Overall Study|Adverse Event|0|||
130223298|NCT04265261|468780061|FG000|Overall Study|Death|1|||
130223299|NCT04265261|468780062|FG001|Overall Study|Death|0|||
130223300|NCT04265261|468780063|FG002|Overall Study|Death|0|||
130223301|NCT04265261|468780061|FG000|Overall Study|Lost to Follow-up|4|||
130223302|NCT04265261|468780062|FG001|Overall Study|Lost to Follow-up|1|||
130223303|NCT04265261|468780063|FG002|Overall Study|Lost to Follow-up|3|||
130223304|NCT04265261|468780061|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223305|NCT04265261|468780062|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223306|NCT04265261|468780063|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130223307|NCT04265261|468780061|FG000|Overall Study|Physician Decision|0|||
130442363|NCT01448044|469582298|FG000|Treatment Period|Lack of Efficacy|5|||
130442364|NCT01448044|469582299|FG001|Treatment Period|Lack of Efficacy|12|||
130442365|NCT01448044|469582298|FG000|Treatment Period|Subject requested discontinue study drug|1|||
130442366|NCT01448044|469582299|FG001|Treatment Period|Subject requested discontinue study drug|0|||
130442367|NCT01448044|469582298|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
130442368|NCT01448044|469582299|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
130442369|NCT01448044|469582298|FG000|Treatment Period|Participant does not meet study criteria|1|||
130442370|NCT01448044|469582299|FG001|Treatment Period|Participant does not meet study criteria|0|||
130223308|NCT04265261|468780062|FG001|Overall Study|Physician Decision|0|||
130223309|NCT04265261|468780063|FG002|Overall Study|Physician Decision|1|||
130223310|NCT04265261|468780061|FG000|Overall Study|Protocol Deviation|0|||
130223311|NCT04265261|468780062|FG001|Overall Study|Protocol Deviation|2|||
130223312|NCT04265261|468780063|FG002|Overall Study|Protocol Deviation|0|||
130223313|NCT04265261|468780061|FG000|Overall Study|Withdrawal by Subject|2|||
130223314|NCT04265261|468780062|FG001|Overall Study|Withdrawal by Subject|1|||
130223315|NCT04265261|468780063|FG002|Overall Study|Withdrawal by Subject|4|||
130223316|NCT03877224|468780064|FG000|Overall Study|Death|3|||
130355268|NCT02694523|469273327|FG004|Part B|Lost to Follow-up|2|||
130355269|NCT02694523|469273328|FG005|Part B|Lost to Follow-up|0|||
130355270|NCT02694523|469273329|FG006|Part B|Lost to Follow-up|1|||
130355271|NCT02694523|469273323|FG000|Part B|Withdrawal by Subject|0|||
130355272|NCT02694523|469273324|FG001|Part B|Withdrawal by Subject|0|||
130355273|NCT02694523|469273325|FG002|Part B|Withdrawal by Subject|9|||
130355274|NCT02694523|469273326|FG003|Part B|Withdrawal by Subject|0|||
130355275|NCT02694523|469273327|FG004|Part B|Withdrawal by Subject|1|||
130355276|NCT02694523|469273328|FG005|Part B|Withdrawal by Subject|3|||
130355277|NCT02694523|469273329|FG006|Part B|Withdrawal by Subject|0|||
130355278|NCT02694523|469273323|FG000|Part B|Other|0|||
130355279|NCT02694523|469273324|FG001|Part B|Other|0|||
130355280|NCT02694523|469273325|FG002|Part B|Other|1|||
130355281|NCT02694523|469273326|FG003|Part B|Other|0|||
130355282|NCT02694523|469273327|FG004|Part B|Other|0|||
130355283|NCT02694523|469273328|FG005|Part B|Other|0|||
130355284|NCT02694523|469273329|FG006|Part B|Other|1|||
130355285|NCT04505540|469273332|FG000|Baseline|Protocol Violation|10|||
130355286|NCT04505540|469273332|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
130355287|NCT04505540|469273332|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
130355288|NCT04505540|469273332|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
130355289|NCT04505540|469273332|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
130355290|NCT04505540|469273332|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
130355291|NCT04505540|469273332|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
130355292|NCT04505540|469273332|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
130355293|NCT04505540|469273332|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
130442371|NCT01448044|469582298|FG000|Treatment Period|Lost to Follow-up|2|||
130442372|NCT01448044|469582299|FG001|Treatment Period|Lost to Follow-up|1|||
130223317|NCT03877224|468780065|FG001|Overall Study|Death|2|||
130223318|NCT03877224|468780064|FG000|Overall Study|Withdrawal by Subject|1|||
130552837|NCT02578862|469991564|FG001|Overall Study|Withdrawal by Subject|1|||
130552838|NCT02578862|469991563|FG000|Overall Study|Unplanned unilateral procedure|0|||
130552839|NCT02578862|469991564|FG001|Overall Study|Unplanned unilateral procedure|1|||
130552840|NCT02893930|469991567|FG000|Overall Study|Adverse Event|3|||
130552841|NCT02893930|469991567|FG000|Overall Study|Death|1|||
130552842|NCT02893930|469991567|FG000|Overall Study|Disease progression|5|||
130552843|NCT02893930|469991567|FG000|Overall Study|Withdrawal by Subject|2|||
130552844|NCT02893930|469991567|FG000|Overall Study|Physician Decision|1|||
130552845|NCT02893930|469991567|FG000|Overall Study|Ineligible|1|||
130552846|NCT02349360|469991568|FG000|Overall Study|Withdrawal by Subject|0|||
130552847|NCT02349360|469991569|FG001|Overall Study|Withdrawal by Subject|1|||
130552848|NCT01176773|469991570|FG000|Overall Study|Screen Failure|2|||
130552849|NCT01176773|469991570|FG000|Overall Study|Withdrew consent|1|||
130552850|NCT01794923|469991587|FG000|Overall Study|Adverse Event|0|||
130686815|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Pregnancy|0|||
130686816|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Pregnancy|2|||
130686817|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Other|0|||
130686818|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Other|9|||
130686819|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Other|5|||
130686820|NCT02453386|470479636|FG000|Overall Study|Adverse Event|22|||
130686821|NCT02453386|470479637|FG001|Overall Study|Adverse Event|30|||
130686822|NCT02453386|470479638|FG002|Overall Study|Adverse Event|15|||
130686823|NCT02453386|470479636|FG000|Overall Study|Protocol Violation|1|||
130686824|NCT02453386|470479637|FG001|Overall Study|Protocol Violation|0|||
130686825|NCT02453386|470479638|FG002|Overall Study|Protocol Violation|1|||
130686826|NCT02453386|470479636|FG000|Overall Study|Withdrawal by Subject|10|||
130686827|NCT02453386|470479637|FG001|Overall Study|Withdrawal by Subject|9|||
130686828|NCT02453386|470479638|FG002|Overall Study|Withdrawal by Subject|9|||
130686829|NCT02453386|470479636|FG000|Overall Study|Sponsor Terminated Study|14|||
130686830|NCT02453386|470479637|FG001|Overall Study|Sponsor Terminated Study|8|||
130686831|NCT02453386|470479638|FG002|Overall Study|Sponsor Terminated Study|11|||
130686832|NCT02453386|470479636|FG000|Overall Study|Subject Terminated by Sponsor|1|||
130686833|NCT02453386|470479637|FG001|Overall Study|Subject Terminated by Sponsor|1|||
130686834|NCT02453386|470479638|FG002|Overall Study|Subject Terminated by Sponsor|1|||
130686835|NCT02453386|470479636|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
130686836|NCT02453386|470479637|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
130686837|NCT02453386|470479638|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
130686838|NCT02453386|470479636|FG000|Overall Study|Lost to Follow-up|0|||
130686839|NCT02453386|470479637|FG001|Overall Study|Lost to Follow-up|0|||
130686840|NCT02453386|470479638|FG002|Overall Study|Lost to Follow-up|1|||
130686841|NCT02453386|470479636|FG000|Overall Study|Other|1|||
130686842|NCT02453386|470479637|FG001|Overall Study|Other|0|||
130686843|NCT02453386|470479638|FG002|Overall Study|Other|1|||
130686844|NCT01474551|470479642|FG000|Overall Study|Death|1|||
130686845|NCT00465270|470479646|FG000|Overall Study|Death|7|||
130686846|NCT00465270|470479647|FG001|Overall Study|Death|11|||
130686847|NCT00465270|470479646|FG000|Overall Study|Withdrawal by Subject|34|||
130686848|NCT00465270|470479647|FG001|Overall Study|Withdrawal by Subject|78|||
130686849|NCT00465270|470479646|FG000|Overall Study|Lost to Follow-up|60|||
130686850|NCT00465270|470479647|FG001|Overall Study|Lost to Follow-up|67|||
130686851|NCT00465270|470479646|FG000|Overall Study|Investigator request|3|||
130686852|NCT00465270|470479647|FG001|Overall Study|Investigator request|4|||
130686853|NCT00858845|470479655|FG000|Overall Study|Patient underwent heart transplant.|0|||
130686854|NCT00858845|470479656|FG001|Overall Study|Patient underwent heart transplant.|1|||
130686855|NCT02605928|470479657|FG000|Overall Study|Model tuning phase|28|||
130686856|NCT02605928|470479657|FG000|Overall Study|Lack of Efficacy|5|||
130686857|NCT02089997|470479665|FG000|Overall Study|Case report forms uncollected|99|||
130686858|NCT02089997|470479665|FG000|Overall Study|Protocol Violation|147|||
130686859|NCT02374853|470479670|FG000|Overall Study|Surgery Cancelled|5|||
130686860|NCT02374853|470479671|FG001|Overall Study|Surgery Cancelled|11|||
130686861|NCT02281084|470479672|FG000|Overall Study|Death|21|||
130686862|NCT02281084|470479673|FG001|Overall Study|Death|18|||
130686863|NCT02281084|470479674|FG002|Overall Study|Death|3|||
130686864|NCT02281084|470479675|FG003|Overall Study|Death|5|||
130686865|NCT02281084|470479672|FG000|Overall Study|Adverse Event|1|||
130552851|NCT01794923|469991588|FG001|Overall Study|Adverse Event|0|||
130552852|NCT01794923|469991589|FG002|Overall Study|Adverse Event|1|||
130552853|NCT01290601|469991596|FG000|Overall Study|Adverse Event|0|||
130686866|NCT02281084|470479673|FG001|Overall Study|Adverse Event|0|||
130686867|NCT02281084|470479674|FG002|Overall Study|Adverse Event|0|||
130686868|NCT02281084|470479675|FG003|Overall Study|Adverse Event|0|||
130686869|NCT02281084|470479672|FG000|Overall Study|Withdrawal by Subject|2|||
130686870|NCT02281084|470479673|FG001|Overall Study|Withdrawal by Subject|2|||
130686871|NCT02281084|470479674|FG002|Overall Study|Withdrawal by Subject|0|||
130686872|NCT02281084|470479675|FG003|Overall Study|Withdrawal by Subject|0|||
130686873|NCT02281084|470479672|FG000|Overall Study|Site Closure by Sponsor|5|||
130686874|NCT02281084|470479673|FG001|Overall Study|Site Closure by Sponsor|1|||
130686875|NCT02281084|470479674|FG002|Overall Study|Site Closure by Sponsor|2|||
130223319|NCT03877224|468780065|FG001|Overall Study|Withdrawal by Subject|6|||
130223320|NCT03877224|468780064|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
130223321|NCT03877224|468780065|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
130223322|NCT00447902|468780066|FG000|Overall Study|Adverse Event|0|||
130223323|NCT00447902|468780067|FG001|Overall Study|Adverse Event|3|||
130223324|NCT00447902|468780066|FG000|Overall Study|Protocol Violation|1|||
130223325|NCT00447902|468780067|FG001|Overall Study|Protocol Violation|0|||
130223326|NCT00447902|468780066|FG000|Overall Study|Withdrawal by Subject|0|||
130223327|NCT00447902|468780067|FG001|Overall Study|Withdrawal by Subject|1|||
130223328|NCT00447902|468780066|FG000|Overall Study|included patients who discontinued|1|||
130223329|NCT00447902|468780067|FG001|Overall Study|included patients who discontinued|1|||
130223330|NCT00447902|468780066|FG000|Overall Study|Lack of Efficacy|2|||
130223331|NCT00447902|468780067|FG001|Overall Study|Lack of Efficacy|1|||
130223332|NCT00379834|468781626|FG000|Overall Study|Time constraints|2|||
130223333|NCT01001429|468781627|FG000|Overall Study|surgery cancelled|0|||
130223334|NCT01001429|468781628|FG001|Overall Study|surgery cancelled|1|||
130223335|NCT00956839|468781629|FG000|Overall Study|Lost to Follow-up|3|||
130223336|NCT00956839|468781630|FG001|Overall Study|Lost to Follow-up|0|||
130223337|NCT00956839|468781631|FG002|Overall Study|Lost to Follow-up|3|||
130223338|NCT02163395|468781636|FG000|Overall Study|Withdrawal by Subject|1|||
130223339|NCT02163395|468781636|FG000|Overall Study|Lost to Follow-up|3|||
130223340|NCT02163395|468781636|FG000|Overall Study|Adverse Event|1|||
130223341|NCT00521365|468781640|FG000|Overall Study|Adverse Event|3|||
130223342|NCT00521365|468781640|FG000|Overall Study|Lost to Follow-up|6|||
130223343|NCT00521365|468781640|FG000|Overall Study|Protocol deviation|2|||
130223344|NCT00521365|468781640|FG000|Overall Study|Drug compliance|3|||
130223345|NCT00521365|468781640|FG000|Overall Study|Usage of not allowed drugs|6|||
130223346|NCT03627832|468781641|FG000|Overall Study|Withdrawal by Subject|10|||
130223347|NCT03627832|468781642|FG001|Overall Study|Withdrawal by Subject|1|||
130223348|NCT03150082|468781643|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
130223349|NCT03150082|468781644|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
130223350|NCT01718483|468781645|FG000|Overall Study|Withdrawal by Subject|14|||
130223351|NCT01718483|468781646|FG001|Overall Study|Withdrawal by Subject|12|||
130223352|NCT01718483|468781645|FG000|Overall Study|Adverse Event|5|||
130223353|NCT01718483|468781646|FG001|Overall Study|Adverse Event|12|||
130223354|NCT01718483|468781645|FG000|Overall Study|Lost to Follow-up|8|||
130223355|NCT01718483|468781646|FG001|Overall Study|Lost to Follow-up|3|||
130223356|NCT01718483|468781645|FG000|Overall Study|Protocol Violation|4|||
130223357|NCT01718483|468781646|FG001|Overall Study|Protocol Violation|2|||
130223358|NCT01718483|468781645|FG000|Overall Study|Other|1|||
130223359|NCT01718483|468781646|FG001|Overall Study|Other|4|||
130223360|NCT01718483|468781645|FG000|Overall Study|Pregnancy|1|||
130223361|NCT01718483|468781646|FG001|Overall Study|Pregnancy|1|||
130223362|NCT01718483|468781645|FG000|Overall Study|Lack of Efficacy|1|||
130223363|NCT01718483|468781646|FG001|Overall Study|Lack of Efficacy|0|||
130223364|NCT01831427|468781650|FG000|Overall Study|Adverse Event|0|||
130223365|NCT01831427|468781651|FG001|Overall Study|Adverse Event|1|||
130223366|NCT01831427|468781652|FG002|Overall Study|Adverse Event|0|||
130223367|NCT01831427|468781653|FG003|Overall Study|Adverse Event|0|||
130223368|NCT01831427|468781654|FG004|Overall Study|Adverse Event|0|||
130223369|NCT01831427|468781655|FG005|Overall Study|Adverse Event|1|||
130223370|NCT01831427|468781656|FG006|Overall Study|Adverse Event|0|||
130223371|NCT01831427|468781657|FG007|Overall Study|Adverse Event|1|||
130223372|NCT01831427|468781658|FG008|Overall Study|Adverse Event|0|||
130223373|NCT01831427|468781659|FG009|Overall Study|Adverse Event|0|||
130223374|NCT01831427|468781660|FG010|Overall Study|Adverse Event|2|||
130223375|NCT01831427|468781650|FG000|Overall Study|Investigator's Discretion|0|||
130223376|NCT01831427|468781651|FG001|Overall Study|Investigator's Discretion|0|||
130223377|NCT01831427|468781652|FG002|Overall Study|Investigator's Discretion|0|||
130223378|NCT01831427|468781653|FG003|Overall Study|Investigator's Discretion|1|||
130223379|NCT01831427|468781654|FG004|Overall Study|Investigator's Discretion|0|||
130223380|NCT01831427|468781655|FG005|Overall Study|Investigator's Discretion|0|||
130223381|NCT01831427|468781656|FG006|Overall Study|Investigator's Discretion|0|||
130355294|NCT04505540|469273332|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
130355295|NCT04505540|469273332|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
130355296|NCT04505540|469273332|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
130355297|NCT04505540|469273332|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
130355298|NCT05323656|469273335|FG000|Overall Study|Still On-Treatment|6|||
130355299|NCT05323656|469273336|FG001|Overall Study|Still On-Treatment|6|||
130355300|NCT05323656|469273335|FG000|Overall Study|Progressive Disease|15|||
130355301|NCT05323656|469273336|FG001|Overall Study|Progressive Disease|14|||
130223382|NCT01831427|468781657|FG007|Overall Study|Investigator's Discretion|0|||
130223383|NCT01831427|468781658|FG008|Overall Study|Investigator's Discretion|0|||
130223384|NCT01831427|468781659|FG009|Overall Study|Investigator's Discretion|0|||
130223385|NCT01831427|468781660|FG010|Overall Study|Investigator's Discretion|0|||
130223386|NCT01831427|468781650|FG000|Overall Study|Withdrew Consent|0|||
130223387|NCT01831427|468781651|FG001|Overall Study|Withdrew Consent|0|||
130686876|NCT02281084|470479675|FG003|Overall Study|Site Closure by Sponsor|0|||
130686877|NCT02335658|470479676|FG000|Overall Study|Adverse Event|18|||
130686878|NCT02335658|470479677|FG001|Overall Study|Adverse Event|12|||
130686879|NCT02335658|470479676|FG000|Overall Study|Lack of Efficacy|4|||
130686880|NCT02335658|470479677|FG001|Overall Study|Lack of Efficacy|5|||
130686881|NCT02335658|470479676|FG000|Overall Study|Pregnancy|1|||
130223388|NCT01831427|468781652|FG002|Overall Study|Withdrew Consent|0|||
130223389|NCT01831427|468781653|FG003|Overall Study|Withdrew Consent|0|||
130223390|NCT01831427|468781654|FG004|Overall Study|Withdrew Consent|0|||
130223391|NCT01831427|468781655|FG005|Overall Study|Withdrew Consent|0|||
130223392|NCT01831427|468781656|FG006|Overall Study|Withdrew Consent|2|||
130223393|NCT01831427|468781657|FG007|Overall Study|Withdrew Consent|0|||
130223394|NCT01831427|468781658|FG008|Overall Study|Withdrew Consent|0|||
130223395|NCT01831427|468781659|FG009|Overall Study|Withdrew Consent|1|||
130223396|NCT01831427|468781660|FG010|Overall Study|Withdrew Consent|1|||
130223397|NCT00536510|468781661|FG000|Overall Study|Adverse Event|27|||
130223398|NCT00536510|468781662|FG001|Overall Study|Adverse Event|4|||
130223399|NCT00536510|468781661|FG000|Overall Study|Lost to Follow-up|11|||
130223400|NCT00536510|468781662|FG001|Overall Study|Lost to Follow-up|8|||
130223401|NCT00536510|468781661|FG000|Overall Study|Protocol Violation|4|||
130223402|NCT00536510|468781662|FG001|Overall Study|Protocol Violation|5|||
130223403|NCT00536510|468781661|FG000|Overall Study|Withdrawal by Subject|16|||
130223404|NCT00536510|468781662|FG001|Overall Study|Withdrawal by Subject|9|||
130223405|NCT00536510|468781661|FG000|Overall Study|Flushing with Product|20|||
130223406|NCT00536510|468781662|FG001|Overall Study|Flushing with Product|0|||
130223407|NCT00536510|468781661|FG000|Overall Study|Laboratory Adverse Event|2|||
130223408|NCT00536510|468781662|FG001|Overall Study|Laboratory Adverse Event|1|||
130223409|NCT00536510|468781661|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
130223410|NCT00536510|468781662|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
130355302|NCT05323656|469273335|FG000|Overall Study|Adverse Event|2|||
130355303|NCT05323656|469273336|FG001|Overall Study|Adverse Event|3|||
130355304|NCT05323656|469273335|FG000|Overall Study|Death|1|||
130355305|NCT05323656|469273336|FG001|Overall Study|Death|2|||
130355306|NCT05323656|469273335|FG000|Overall Study|Withdrawal by Subject|1|||
130355307|NCT05323656|469273336|FG001|Overall Study|Withdrawal by Subject|0|||
130355308|NCT05323656|469273335|FG000|Overall Study|Clinical disease progression|0|||
130355309|NCT05323656|469273336|FG001|Overall Study|Clinical disease progression|1|||
130355310|NCT05323656|469273335|FG000|Overall Study|Patient and Investigator decision|1|||
130355311|NCT05323656|469273336|FG001|Overall Study|Patient and Investigator decision|0|||
130355312|NCT05323656|469273335|FG000|Overall Study|Physician Decision|0|||
130355313|NCT05323656|469273336|FG001|Overall Study|Physician Decision|1|||
130355314|NCT03953183|469273337|FG000|Overall Study|Physician Decision|0|||
130355315|NCT03953183|469273338|FG001|Overall Study|Physician Decision|1|||
130355316|NCT03953183|469273337|FG000|Overall Study|Withdrawal by Subject|0|||
130355317|NCT03953183|469273338|FG001|Overall Study|Withdrawal by Subject|1|||
130355318|NCT04508140|469273339|FG000|Overall Study|Adverse Event|2|||
130355319|NCT04508140|469273340|FG001|Overall Study|Adverse Event|2|||
130355320|NCT04508140|469273339|FG000|Overall Study|Withdrawal by Subject|0|||
130355321|NCT04508140|469273340|FG001|Overall Study|Withdrawal by Subject|2|||
130355322|NCT04508140|469273339|FG000|Overall Study|progressive disease|9|||
130355323|NCT04508140|469273340|FG001|Overall Study|progressive disease|3|||
130355324|NCT01298193|469273341|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
130355325|NCT01298193|469273341|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
130355326|NCT01298193|469273341|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
130355327|NCT01298193|469273341|FG000|Efficacy Phase (Second Cycle)|Death|1|||
130355328|NCT04010539|469273342|FG000|Overall Study|Withdrawal by Subject|4|||
130355329|NCT04010539|469273343|FG001|Overall Study|Withdrawal by Subject|1|||
130355330|NCT04010539|469273342|FG000|Overall Study|Physician Decision|0|||
130355331|NCT04010539|469273343|FG001|Overall Study|Physician Decision|2|||
130355332|NCT04010539|469273342|FG000|Overall Study|Lost to Follow-up|10|||
130355333|NCT04010539|469273343|FG001|Overall Study|Lost to Follow-up|14|||
130355334|NCT04010539|469273342|FG000|Overall Study|Adverse Event|3|||
130355335|NCT04010539|469273343|FG001|Overall Study|Adverse Event|0|||
130355336|NCT04010539|469273342|FG000|Overall Study|Participant Did Not Receive IP|0|||
130355337|NCT04010539|469273343|FG001|Overall Study|Participant Did Not Receive IP|1|||
130355338|NCT04010539|469273342|FG000|Overall Study|Protocol Deviation|0|||
130355339|NCT04010539|469273343|FG001|Overall Study|Protocol Deviation|1|||
130223411|NCT02169505|468781663|FG000|Overall Study|Withdrawal by Subject|1|||
130223412|NCT00048035|468781664|FG000|Core Period|Early Withdrawals|4|||
130355340|NCT04010539|469273342|FG000|Overall Study|Randomized in Error/ Mistake|2|||
130355341|NCT04010539|469273343|FG001|Overall Study|Randomized in Error/ Mistake|0|||
130355342|NCT04010539|469273342|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
130686882|NCT02335658|470479677|FG001|Overall Study|Pregnancy|0|||
130686883|NCT02335658|470479676|FG000|Overall Study|Withdrawal by Subject|13|||
130223413|NCT00048035|468781665|FG001|Core Period|Early Withdrawals|2|||
130223414|NCT00048035|468781666|FG002|Core Period|Early Withdrawals|1|||
130223415|NCT00048035|468781667|FG003|Core Period|Early Withdrawals|1|||
130442373|NCT01448044|469582298|FG000|Treatment Period|Other reason|2|||
130442374|NCT01448044|469582299|FG001|Treatment Period|Other reason|0|||
130442375|NCT01448044|469582298|FG000|Follow Up Period|Withdrawal by Subject|1|||
130442376|NCT01448044|469582299|FG001|Follow Up Period|Withdrawal by Subject|1|||
130442377|NCT01448044|469582298|FG000|Follow Up Period|Lost to Follow-up|6|||
130442378|NCT01448044|469582299|FG001|Follow Up Period|Lost to Follow-up|2|||
130442379|NCT01448044|469582298|FG000|Follow Up Period|Other|5|||
130442380|NCT01448044|469582299|FG001|Follow Up Period|Other|11|||
130442381|NCT02500316|469582302|FG000|Overall Study|Adverse Event|3|||
130442382|NCT02500316|469582302|FG000|Overall Study|Lost to Follow-up|2|||
130442383|NCT02500316|469582302|FG000|Overall Study|Protocol Violation|1|||
130442384|NCT02500316|469582302|FG000|Overall Study|Withdrawal by Subject|15|||
130442385|NCT02500316|469582302|FG000|Overall Study|Final height achieved|5|||
130442386|NCT02500316|469582302|FG000|Overall Study|Due to war activity|1|||
130442387|NCT00581113|469584286|FG000|Overall Study|Withdrawal by Subject|0|||
130442388|NCT00581113|469584287|FG001|Overall Study|Withdrawal by Subject|1|||
130442389|NCT00619476|469584288|FG000|Overall Study|Adverse Event|12|||
130442390|NCT00619476|469584289|FG001|Overall Study|Adverse Event|6|||
130442391|NCT00619476|469584290|FG002|Overall Study|Adverse Event|12|||
130442392|NCT00619476|469584291|FG003|Overall Study|Adverse Event|16|||
130442393|NCT00619476|469584288|FG000|Overall Study|Lack of Efficacy|6|||
130442394|NCT00619476|469584289|FG001|Overall Study|Lack of Efficacy|1|||
130442395|NCT00619476|469584290|FG002|Overall Study|Lack of Efficacy|1|||
130442396|NCT00619476|469584291|FG003|Overall Study|Lack of Efficacy|4|||
130442397|NCT00619476|469584288|FG000|Overall Study|Protocol Violation|5|||
130442398|NCT00619476|469584289|FG001|Overall Study|Protocol Violation|4|||
130442399|NCT00619476|469584290|FG002|Overall Study|Protocol Violation|4|||
130442400|NCT00619476|469584291|FG003|Overall Study|Protocol Violation|9|||
130442401|NCT00619476|469584288|FG000|Overall Study|Lost to Follow-up|1|||
130442402|NCT00619476|469584289|FG001|Overall Study|Lost to Follow-up|2|||
130442403|NCT00619476|469584290|FG002|Overall Study|Lost to Follow-up|0|||
130442404|NCT00619476|469584291|FG003|Overall Study|Lost to Follow-up|1|||
130442405|NCT00619476|469584288|FG000|Overall Study|Investigator Discretion|2|||
130442406|NCT00619476|469584289|FG001|Overall Study|Investigator Discretion|2|||
130442407|NCT00619476|469584290|FG002|Overall Study|Investigator Discretion|2|||
130442408|NCT00619476|469584291|FG003|Overall Study|Investigator Discretion|0|||
130442409|NCT00619476|469584288|FG000|Overall Study|Withdrawal by Subject|5|||
130442410|NCT00619476|469584289|FG001|Overall Study|Withdrawal by Subject|7|||
130442411|NCT00619476|469584290|FG002|Overall Study|Withdrawal by Subject|5|||
130442412|NCT00619476|469584291|FG003|Overall Study|Withdrawal by Subject|4|||
130442413|NCT01625910|469584292|FG000|Overall Study|Lost to Follow-up|3|||
130442414|NCT01625910|469584293|FG001|Overall Study|Lost to Follow-up|4|||
130442415|NCT02959138|469584294|FG000|Overall Study|Enrolled but Never Treated|0|||
130442416|NCT02959138|469584295|FG001|Overall Study|Enrolled but Never Treated|1|||
130442417|NCT02959138|469584296|FG002|Overall Study|Enrolled but Never Treated|0|||
130442418|NCT01327547|469584297|FG000|Overall Study|Adverse Event|4|||
130442419|NCT01327547|469584298|FG001|Overall Study|Adverse Event|1|||
130442420|NCT01327547|469584297|FG000|Overall Study|Death|1|||
130442421|NCT01327547|469584298|FG001|Overall Study|Death|2|||
130442422|NCT01327547|469584297|FG000|Overall Study|Lost to Follow-up|6|||
130442423|NCT01327547|469584298|FG001|Overall Study|Lost to Follow-up|6|||
130442424|NCT01327547|469584297|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
130442425|NCT01327547|469584298|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
130442426|NCT01327547|469584297|FG000|Overall Study|Withdrawal by Subject|3|||
130442427|NCT01327547|469584298|FG001|Overall Study|Withdrawal by Subject|7|||
130442428|NCT01327547|469584297|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
130442429|NCT01327547|469584298|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
130442430|NCT01327547|469584297|FG000|Overall Study|Protocol Violation|1|||
130442431|NCT01327547|469584298|FG001|Overall Study|Protocol Violation|0|||
130442432|NCT01327547|469584297|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
130442433|NCT01327547|469584298|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
130442434|NCT01327547|469584297|FG000|Overall Study|Required prohibited medication|2|||
130442435|NCT01327547|469584298|FG001|Overall Study|Required prohibited medication|0|||
130442436|NCT01327547|469584297|FG000|Overall Study|Non-compliance with study procedures|1|||
130442437|NCT01327547|469584298|FG001|Overall Study|Non-compliance with study procedures|0|||
130442438|NCT01327547|469584297|FG000|Overall Study|By investigator in subject's interest|0|||
130442439|NCT01327547|469584298|FG001|Overall Study|By investigator in subject's interest|1|||
130442440|NCT01642186|469584302|FG000|Overall Study|Death|0|||
130442441|NCT01642186|469584303|FG001|Overall Study|Death|2|||
130442442|NCT01642186|469584304|FG002|Overall Study|Death|2|||
130442443|NCT01642186|469584302|FG000|Overall Study|Lost to Follow-up|0|||
130442444|NCT01642186|469584303|FG001|Overall Study|Lost to Follow-up|0|||
130442445|NCT01642186|469584304|FG002|Overall Study|Lost to Follow-up|1|||
130442446|NCT00506285|469584306|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
130442447|NCT00506285|469584307|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
130442448|NCT00506285|469584306|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
130442449|NCT00506285|469584307|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
130442450|NCT00506285|469584306|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
130223416|NCT00048035|468781668|FG004|Core Period|Early Withdrawals|1|||
130223417|NCT00048035|468781669|FG005|Core Period|Early Withdrawals|1|||
130223418|NCT00048035|468781670|FG006|Core Period|Early Withdrawals|0|||
130223419|NCT00048035|468781671|FG007|Core Period|Early Withdrawals|0|||
130442451|NCT00506285|469584307|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
130442452|NCT00506285|469584306|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
130442453|NCT00506285|469584307|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
130442454|NCT00506285|469584306|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
130442455|NCT00506285|469584307|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
130442456|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
130442457|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
130442458|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
130442459|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
130442460|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
130442461|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
130442462|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
130442463|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
130442464|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130442465|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130442466|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130442467|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130442468|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
130442469|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
130686884|NCT02335658|470479677|FG001|Overall Study|Withdrawal by Subject|21|||
130686885|NCT02335658|470479676|FG000|Overall Study|non-compliance|2|||
130686886|NCT02335658|470479677|FG001|Overall Study|non-compliance|3|||
130686887|NCT02335658|470479676|FG000|Overall Study|other reason|2|||
130686888|NCT02335658|470479677|FG001|Overall Study|other reason|3|||
130442470|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130442471|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130442472|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130442473|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130442474|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130442475|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
130442476|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130442477|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130442478|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130442479|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130442480|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
130442481|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
130442482|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
130442483|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
130442484|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
130442485|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
130442486|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
130442487|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
130442488|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130442489|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130442490|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130442491|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130442492|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
130442493|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
130442494|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130442495|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130442496|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130442497|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130442498|NCT01089556|469584308|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
130442499|NCT01089556|469584309|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
130442500|NCT01089556|469584310|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130442501|NCT01089556|469584311|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130442502|NCT01089556|469584312|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130442503|NCT01089556|469584313|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130442504|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
130442505|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
130442506|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
130686889|NCT02305758|470479678|FG000|Overall Study|Death|27|||
130686890|NCT02305758|470479679|FG001|Overall Study|Death|27|||
130686891|NCT02305758|470479678|FG000|Overall Study|Withdrew consent|9|||
130223420|NCT00048035|468781664|FG000|Extension Year 1|Early Withdrawals|0|||
130552854|NCT01290601|469991597|FG001|Overall Study|Adverse Event|2|||
130686892|NCT02305758|470479679|FG001|Overall Study|Withdrew consent|2|||
130442507|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
130442508|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
130442509|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
130442510|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
130442511|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
130442512|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130442513|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130442514|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130442515|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130442516|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130442517|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130442518|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130442519|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
130442520|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
130442521|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130442522|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130442523|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130442524|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
130442525|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130442526|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130442527|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130442528|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130442529|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130442530|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130442531|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130442532|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130442533|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130442534|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
130442535|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
130442536|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
130442537|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
130442538|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
130442539|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
130442540|NCT01089556|469584308|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130442541|NCT01089556|469584309|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130442542|NCT01089556|469584310|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
130442543|NCT01089556|469584311|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130442544|NCT01089556|469584312|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
130442545|NCT01089556|469584313|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
130442546|NCT01238575|469584314|FG000|Overall Study|Lack of Efficacy|2|||
130442547|NCT01238575|469584315|FG001|Overall Study|Lack of Efficacy|4|||
130442548|NCT01238575|469584314|FG000|Overall Study|Adverse Event|2|||
130442549|NCT01238575|469584315|FG001|Overall Study|Adverse Event|0|||
130442550|NCT02254421|469584318|FG000|Overall Study|Randomized but Not Treated|1|||
130442551|NCT02254421|469584319|FG001|Overall Study|Randomized but Not Treated|0|||
130442552|NCT02254421|469584318|FG000|Overall Study|Death|0|||
130442553|NCT02254421|469584319|FG001|Overall Study|Death|2|||
130442554|NCT02254421|469584318|FG000|Overall Study|Withdrew Consent|1|||
130442555|NCT02254421|469584319|FG001|Overall Study|Withdrew Consent|1|||
130442556|NCT01950273|469584321|FG000|Overall Study|Protocol Violation|1|||
130442557|NCT01950273|469584322|FG001|Overall Study|Protocol Violation|0|||
130442558|NCT01950273|469584321|FG000|Overall Study|Withdrawal by Subject|2|||
130442559|NCT01950273|469584322|FG001|Overall Study|Withdrawal by Subject|0|||
130442560|NCT01950273|469584321|FG000|Overall Study|Other not defined above|1|||
130442561|NCT01950273|469584322|FG001|Overall Study|Other not defined above|0|||
130442562|NCT03354637|469584327|FG000|Double-blind Period|Protocol Violation|2|||
130442563|NCT03354637|469584328|FG001|Double-blind Period|Protocol Violation|0|||
130442564|NCT03354637|469584329|FG002|Double-blind Period|Protocol Violation|0|||
130442565|NCT03354637|469584327|FG000|Double-blind Period|Adverse Event|1|||
130442566|NCT03354637|469584328|FG001|Double-blind Period|Adverse Event|2|||
130442567|NCT03354637|469584329|FG002|Double-blind Period|Adverse Event|0|||
130442568|NCT03354637|469584327|FG000|Double-blind Period|Lost to Follow-up|3|||
130442569|NCT03354637|469584328|FG001|Double-blind Period|Lost to Follow-up|4|||
130442570|NCT03354637|469584329|FG002|Double-blind Period|Lost to Follow-up|3|||
130442571|NCT03354637|469584327|FG000|Double-blind Period|Withdrawal by Subject|10|||
130442572|NCT03354637|469584328|FG001|Double-blind Period|Withdrawal by Subject|6|||
130442573|NCT03354637|469584329|FG002|Double-blind Period|Withdrawal by Subject|4|||
130442574|NCT03354637|469584327|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
130442575|NCT03354637|469584328|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
130442576|NCT03354637|469584329|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
130442577|NCT03354637|469584327|FG000|Open Label Extension|Adverse Event|0|||
130442578|NCT03354637|469584328|FG001|Open Label Extension|Adverse Event|0|||
130223421|NCT00048035|468781665|FG001|Extension Year 1|Early Withdrawals|0|||
130223422|NCT00048035|468781666|FG002|Extension Year 1|Early Withdrawals|0|||
130223423|NCT00048035|468781667|FG003|Extension Year 1|Early Withdrawals|0|||
130223424|NCT00048035|468781668|FG004|Extension Year 1|Early Withdrawals|0|||
130223425|NCT00048035|468781669|FG005|Extension Year 1|Early Withdrawals|0|||
130223426|NCT00048035|468781670|FG006|Extension Year 1|Early Withdrawals|11|||
130223427|NCT00048035|468781671|FG007|Extension Year 1|Early Withdrawals|11|||
130223428|NCT00048035|468781664|FG000|Extension Year 2|Early Withdrawals|0|||
130223429|NCT00048035|468781665|FG001|Extension Year 2|Early Withdrawals|0|||
130223430|NCT00048035|468781666|FG002|Extension Year 2|Early Withdrawals|0|||
130223431|NCT00048035|468781667|FG003|Extension Year 2|Early Withdrawals|0|||
130223432|NCT00048035|468781668|FG004|Extension Year 2|Early Withdrawals|0|||
130223433|NCT00048035|468781669|FG005|Extension Year 2|Early Withdrawals|0|||
130223434|NCT00048035|468781670|FG006|Extension Year 2|Early Withdrawals|3|||
130223435|NCT00048035|468781671|FG007|Extension Year 2|Early Withdrawals|3|||
130223436|NCT05137717|468781672|FG000|Overall Study|Death|2|||
130223437|NCT05137717|468781672|FG000|Overall Study|Withdrawal by Subject|6|||
130223438|NCT02035553|468781673|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
130223439|NCT02035553|468781674|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
130223440|NCT02035553|468781673|FG000|Overall Study|Adverse Event|10|||
130223441|NCT02035553|468781674|FG001|Overall Study|Adverse Event|6|||
130223442|NCT02035553|468781673|FG000|Overall Study|Physician Decision|3|||
130223443|NCT02035553|468781674|FG001|Overall Study|Physician Decision|2|||
130223444|NCT02035553|468781673|FG000|Overall Study|Lack of Efficacy|1|||
130223445|NCT02035553|468781674|FG001|Overall Study|Lack of Efficacy|1|||
130223446|NCT02035553|468781673|FG000|Overall Study|Withdrawal by Subject|4|||
130223447|NCT02035553|468781674|FG001|Overall Study|Withdrawal by Subject|7|||
130223448|NCT02035553|468781673|FG000|Overall Study|Non-compliance with Study Drug|0|||
130223449|NCT02035553|468781674|FG001|Overall Study|Non-compliance with Study Drug|1|||
130223450|NCT02035553|468781673|FG000|Overall Study|Lost to Follow-up|0|||
130223451|NCT02035553|468781674|FG001|Overall Study|Lost to Follow-up|1|||
130223452|NCT02035553|468781673|FG000|Overall Study|Other Reason|0|||
130223453|NCT02035553|468781674|FG001|Overall Study|Other Reason|4|||
130223454|NCT02735980|468781676|FG000|Overall Study|Adverse Event|0|||
130223455|NCT02735980|468781677|FG001|Overall Study|Adverse Event|4|||
130223456|NCT02735980|468781678|FG002|Overall Study|Adverse Event|1|||
130223457|NCT02735980|468781676|FG000|Overall Study|Death|5|||
130223458|NCT02735980|468781677|FG001|Overall Study|Death|4|||
130223459|NCT02735980|468781678|FG002|Overall Study|Death|0|||
130223460|NCT02735980|468781676|FG000|Overall Study|Physician Decision|3|||
130223461|NCT02735980|468781677|FG001|Overall Study|Physician Decision|1|||
130223462|NCT02735980|468781678|FG002|Overall Study|Physician Decision|0|||
130223463|NCT02735980|468781676|FG000|Overall Study|Screen failure|1|||
130223464|NCT02735980|468781677|FG001|Overall Study|Screen failure|0|||
130223465|NCT02735980|468781678|FG002|Overall Study|Screen failure|0|||
130223466|NCT02735980|468781676|FG000|Overall Study|Withdrawal by Subject|1|||
130223467|NCT02735980|468781677|FG001|Overall Study|Withdrawal by Subject|2|||
130223468|NCT02735980|468781678|FG002|Overall Study|Withdrawal by Subject|0|||
130223469|NCT00509899|468781679|FG000|Overall Study|Progressive disease|1|||
130223470|NCT00509899|468781680|FG001|Overall Study|Progressive disease|3|||
130223471|NCT00509899|468781681|FG002|Overall Study|Progressive disease|5|||
130223472|NCT00509899|468781682|FG003|Overall Study|Progressive disease|1|||
130223473|NCT00509899|468781683|FG004|Overall Study|Progressive disease|0|||
130223474|NCT00509899|468781684|FG005|Overall Study|Progressive disease|1|||
130223475|NCT00509899|468781685|FG006|Overall Study|Progressive disease|0|||
130223476|NCT00509899|468781686|FG007|Overall Study|Progressive disease|0|||
130223477|NCT00509899|468781679|FG000|Overall Study|Unacceptable Toxicity|1|||
130355343|NCT04010539|469273343|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
130355344|NCT00249288|469273344|FG000|Overall Study|Lost to Follow-up|3|||
130355345|NCT00249288|469273345|FG001|Overall Study|Lost to Follow-up|3|||
130355346|NCT00249288|469273344|FG000|Overall Study|Withdrawal by Subject|2|||
130355347|NCT00249288|469273345|FG001|Overall Study|Withdrawal by Subject|2|||
130355348|NCT03059446|469273346|FG000|Overall Study|Adverse Event|11|||
130355349|NCT03059446|469273346|FG000|Overall Study|Withdrawal of Consent|16|||
130355350|NCT03059446|469273346|FG000|Overall Study|Lost to Follow-up|3|||
130355351|NCT03059446|469273346|FG000|Overall Study|Protocol Violation|1|||
130355352|NCT03059446|469273346|FG000|Overall Study|Study Terminated by Sponsor|131|||
130355353|NCT03059446|469273346|FG000|Overall Study|Reason not Specified|5|||
130355354|NCT04795622|469273347|FG000|Overall Study|Adverse Event|1|||
130355355|NCT04795622|469273348|FG001|Overall Study|Adverse Event|0|||
130355356|NCT04795622|469273347|FG000|Overall Study|Withdrawal by Subject|3|||
130355357|NCT04795622|469273348|FG001|Overall Study|Withdrawal by Subject|3|||
130223478|NCT00509899|468781680|FG001|Overall Study|Unacceptable Toxicity|0|||
130223479|NCT00509899|468781681|FG002|Overall Study|Unacceptable Toxicity|0|||
130223480|NCT00509899|468781682|FG003|Overall Study|Unacceptable Toxicity|2|||
130223481|NCT00509899|468781683|FG004|Overall Study|Unacceptable Toxicity|0|||
130223482|NCT00509899|468781684|FG005|Overall Study|Unacceptable Toxicity|0|||
130223483|NCT00509899|468781685|FG006|Overall Study|Unacceptable Toxicity|0|||
130686893|NCT02305758|470479678|FG000|Overall Study|Lost to Follow-up|6|||
130686894|NCT02305758|470479679|FG001|Overall Study|Lost to Follow-up|1|||
130686895|NCT02305758|470479678|FG000|Overall Study|Study Terminated by Sponsor|21|||
130686896|NCT02305758|470479679|FG001|Overall Study|Study Terminated by Sponsor|34|||
130686897|NCT02305758|470479678|FG000|Overall Study|Other, not specified|2|||
130686898|NCT02305758|470479679|FG001|Overall Study|Other, not specified|1|||
130686899|NCT02032888|470479682|FG000|Treatment Period|Poor compliance/noncompliance|1|||
130686900|NCT02032888|470479683|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130686901|NCT02032888|470479684|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130686902|NCT02032888|470479682|FG000|Treatment Period|Other|1|||
130686903|NCT02032888|470479683|FG001|Treatment Period|Other|1|||
130442579|NCT03354637|469584329|FG002|Open Label Extension|Adverse Event|1|||
130442580|NCT03354637|469584327|FG000|Open Label Extension|Lost to Follow-up|0|||
130442581|NCT03354637|469584328|FG001|Open Label Extension|Lost to Follow-up|0|||
130442582|NCT03354637|469584329|FG002|Open Label Extension|Lost to Follow-up|2|||
130442583|NCT03354637|469584327|FG000|Open Label Extension|Withdrawal by Subject|0|||
130442584|NCT03354637|469584328|FG001|Open Label Extension|Withdrawal by Subject|0|||
130442585|NCT03354637|469584329|FG002|Open Label Extension|Withdrawal by Subject|5|||
130442586|NCT03354637|469584327|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
130442587|NCT03354637|469584328|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
130442588|NCT03354637|469584329|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
130442589|NCT03354637|469584327|FG000|Open Label Extension|Subject Noncompliance|0|||
130442590|NCT03354637|469584328|FG001|Open Label Extension|Subject Noncompliance|0|||
130442591|NCT03354637|469584329|FG002|Open Label Extension|Subject Noncompliance|1|||
130442592|NCT03354637|469584327|FG000|Open Label Extension|Lack of Efficacy|0|||
130442593|NCT03354637|469584328|FG001|Open Label Extension|Lack of Efficacy|0|||
130442594|NCT03354637|469584329|FG002|Open Label Extension|Lack of Efficacy|1|||
130442595|NCT03354637|469584327|FG000|Open Label Extension|Physician Decision|0|||
130442596|NCT03354637|469584328|FG001|Open Label Extension|Physician Decision|0|||
130442597|NCT03354637|469584329|FG002|Open Label Extension|Physician Decision|1|||
130442598|NCT02206152|469584330|FG000|Pre-Randomization|Withdrawal by Subject|2|||
130442599|NCT00478608|469584331|FG000|Overall Study|Adverse Event|1|||
130442600|NCT00478608|469584331|FG000|Overall Study|Serious Adverse Event|14|||
130442601|NCT00478608|469584331|FG000|Overall Study|Withdrawal by Subject|2|||
130442602|NCT00478608|469584331|FG000|Overall Study|Protocol Violation|3|||
130442603|NCT01591460|469584337|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
130442604|NCT01591460|469584337|FG000|Overall Study|Futility Rule (Week 12)|7|||
130442605|NCT01591460|469584337|FG000|Overall Study|Futility Rule (Week 24)|3|||
130442606|NCT01591460|469584337|FG000|Overall Study|Rebound or Breakthrough|3|||
130442607|NCT01591460|469584337|FG000|Overall Study|Treatment Discontinued by Error|1|||
130442608|NCT01591460|469584337|FG000|Overall Study|Lost to Follow-up|1|||
130442609|NCT01591460|469584337|FG000|Overall Study|Noncompliance|1|||
130442610|NCT01591460|469584337|FG000|Overall Study|Participant Refusal|3|||
130442611|NCT01591460|469584337|FG000|Overall Study|Withdrawal by Subject|1|||
130442612|NCT01591460|469584337|FG000|Overall Study|Protocol Violation|1|||
130442613|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
130442614|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
130442615|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
130442616|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
130442617|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130442618|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
130442619|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130442620|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130442621|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
130442622|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
130686904|NCT02032888|470479684|FG002|Treatment Period|Other|0|||
130355358|NCT04795622|469273347|FG000|Overall Study|Protocol Violation|0|||
130355359|NCT04795622|469273348|FG001|Overall Study|Protocol Violation|2|||
130355360|NCT04795622|469273347|FG000|Overall Study|Lost to Follow-up|2|||
130355361|NCT04795622|469273348|FG001|Overall Study|Lost to Follow-up|3|||
130355362|NCT04795622|469273347|FG000|Overall Study|Other|7|||
130355363|NCT04795622|469273348|FG001|Overall Study|Other|8|||
130355364|NCT03309046|469273351|FG000|Overall Study|Withdrawal by Subject|4|||
130355365|NCT03309046|469273352|FG001|Overall Study|Withdrawal by Subject|17|||
130355366|NCT00089674|469273354|FG000|Overall Study|Physician Decision|4|||
130355367|NCT00089674|469273355|FG001|Overall Study|Physician Decision|2|||
130355368|NCT00089674|469273354|FG000|Overall Study|Adverse Event|23|||
130355369|NCT00089674|469273355|FG001|Overall Study|Adverse Event|29|||
130355370|NCT00089674|469273354|FG000|Overall Study|Withdrawal by Subject|143|||
130442623|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130442624|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130686905|NCT02032888|470479682|FG000|Follow-up Period|Lost to Follow-up|1|||
130686906|NCT02032888|470479683|FG001|Follow-up Period|Lost to Follow-up|1|||
130355371|NCT00089674|469273355|FG001|Overall Study|Withdrawal by Subject|127|||
130223484|NCT00509899|468781686|FG007|Overall Study|Unacceptable Toxicity|0|||
130223485|NCT00509899|468781679|FG000|Overall Study|Withdrawal by Subject|6|||
130223486|NCT00509899|468781680|FG001|Overall Study|Withdrawal by Subject|2|||
130223487|NCT00509899|468781681|FG002|Overall Study|Withdrawal by Subject|3|||
130223488|NCT00509899|468781682|FG003|Overall Study|Withdrawal by Subject|0|||
130223489|NCT00509899|468781683|FG004|Overall Study|Withdrawal by Subject|3|||
130223490|NCT00509899|468781684|FG005|Overall Study|Withdrawal by Subject|2|||
130223491|NCT00509899|468781685|FG006|Overall Study|Withdrawal by Subject|0|||
130223492|NCT00509899|468781686|FG007|Overall Study|Withdrawal by Subject|0|||
130223493|NCT00509899|468781679|FG000|Overall Study|Physician Decision|4|||
130223494|NCT00509899|468781680|FG001|Overall Study|Physician Decision|2|||
130223495|NCT00509899|468781681|FG002|Overall Study|Physician Decision|7|||
130223496|NCT00509899|468781682|FG003|Overall Study|Physician Decision|0|||
130223497|NCT00509899|468781683|FG004|Overall Study|Physician Decision|1|||
130223498|NCT00509899|468781684|FG005|Overall Study|Physician Decision|4|||
130223499|NCT00509899|468781685|FG006|Overall Study|Physician Decision|0|||
130223500|NCT00509899|468781686|FG007|Overall Study|Physician Decision|0|||
130223501|NCT00509899|468781679|FG000|Overall Study|Intercurrent Illness|1|||
130223502|NCT00509899|468781680|FG001|Overall Study|Intercurrent Illness|0|||
130223503|NCT00509899|468781681|FG002|Overall Study|Intercurrent Illness|0|||
130223504|NCT00509899|468781682|FG003|Overall Study|Intercurrent Illness|1|||
130223505|NCT00509899|468781683|FG004|Overall Study|Intercurrent Illness|0|||
130223506|NCT00509899|468781684|FG005|Overall Study|Intercurrent Illness|1|||
130223507|NCT00509899|468781685|FG006|Overall Study|Intercurrent Illness|0|||
130223508|NCT00509899|468781686|FG007|Overall Study|Intercurrent Illness|0|||
130223509|NCT00509899|468781679|FG000|Overall Study|Death|2|||
130223510|NCT00509899|468781680|FG001|Overall Study|Death|2|||
130223511|NCT00509899|468781681|FG002|Overall Study|Death|3|||
130223512|NCT00509899|468781682|FG003|Overall Study|Death|0|||
130223513|NCT00509899|468781683|FG004|Overall Study|Death|1|||
130223514|NCT00509899|468781684|FG005|Overall Study|Death|1|||
130223515|NCT00509899|468781685|FG006|Overall Study|Death|1|||
130223516|NCT00509899|468781686|FG007|Overall Study|Death|1|||
130223517|NCT00509899|468781679|FG000|Overall Study|Lack of Efficacy|1|||
130223518|NCT00509899|468781680|FG001|Overall Study|Lack of Efficacy|0|||
130223519|NCT00509899|468781681|FG002|Overall Study|Lack of Efficacy|2|||
130223520|NCT00509899|468781682|FG003|Overall Study|Lack of Efficacy|0|||
130223521|NCT00509899|468781683|FG004|Overall Study|Lack of Efficacy|0|||
130223522|NCT00509899|468781684|FG005|Overall Study|Lack of Efficacy|1|||
130223523|NCT00509899|468781685|FG006|Overall Study|Lack of Efficacy|0|||
130223524|NCT00509899|468781686|FG007|Overall Study|Lack of Efficacy|0|||
130223525|NCT03713684|468781687|FG000|Overall Study|Adverse Event|1|||
130223526|NCT03713684|468781688|FG001|Overall Study|Adverse Event|3|||
130223527|NCT03713684|468781689|FG002|Overall Study|Adverse Event|1|||
130223528|NCT03713684|468781690|FG003|Overall Study|Adverse Event|0|||
130223529|NCT03713684|468781687|FG000|Overall Study|Poor compliance to protocol|2|||
130223530|NCT03713684|468781688|FG001|Overall Study|Poor compliance to protocol|1|||
130223531|NCT03713684|468781689|FG002|Overall Study|Poor compliance to protocol|0|||
130223532|NCT03713684|468781690|FG003|Overall Study|Poor compliance to protocol|1|||
130223533|NCT03713684|468781687|FG000|Overall Study|Withdrawal by Subject|14|||
130223534|NCT03713684|468781688|FG001|Overall Study|Withdrawal by Subject|6|||
130223535|NCT03713684|468781689|FG002|Overall Study|Withdrawal by Subject|14|||
130223536|NCT03713684|468781690|FG003|Overall Study|Withdrawal by Subject|16|||
130223537|NCT03713684|468781687|FG000|Overall Study|Other than specified|69|||
130223538|NCT03713684|468781688|FG001|Overall Study|Other than specified|77|||
130223539|NCT03713684|468781689|FG002|Overall Study|Other than specified|73|||
130223540|NCT03713684|468781690|FG003|Overall Study|Other than specified|70|||
130223541|NCT02185417|468781691|FG000|Overall Study|Death|448|||
130223542|NCT02185417|468781692|FG001|Overall Study|Death|446|||
130223543|NCT02185417|468781693|FG002|Overall Study|Death|0|||
130223544|NCT02185417|468781691|FG000|Overall Study|Withdrawal by Subject|7|||
130223545|NCT02185417|468781692|FG001|Overall Study|Withdrawal by Subject|12|||
130223546|NCT02185417|468781693|FG002|Overall Study|Withdrawal by Subject|0|||
130355372|NCT00089674|469273354|FG000|Overall Study|Death|43|||
130355373|NCT00089674|469273355|FG001|Overall Study|Death|43|||
130355374|NCT00089674|469273354|FG000|Overall Study|Disease progression|21|||
130355375|NCT00089674|469273355|FG001|Overall Study|Disease progression|23|||
130355376|NCT00089674|469273354|FG000|Overall Study|Ineligibility determined|8|||
130223547|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
130223548|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
130223549|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Death|561|||
130223550|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Death|298|||
130223551|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
130223552|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
130223553|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
130223554|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
130223555|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Other|1|||
130355377|NCT00089674|469273355|FG001|Overall Study|Ineligibility determined|10|||
130686907|NCT02032888|470479684|FG002|Follow-up Period|Lost to Follow-up|0|||
130686908|NCT02032888|470479682|FG000|Follow-up Period|Death|1|||
130686909|NCT02032888|470479683|FG001|Follow-up Period|Death|1|||
130686910|NCT02032888|470479684|FG002|Follow-up Period|Death|0|||
130686911|NCT02032888|470479682|FG000|Follow-up Period|Other|1|||
130686912|NCT02032888|470479683|FG001|Follow-up Period|Other|0|||
130686913|NCT02032888|470479684|FG002|Follow-up Period|Other|0|||
130686914|NCT01697696|470479685|FG000|Overall Study|Study terminated by sponsor|0|||
130686915|NCT01697696|470479686|FG001|Overall Study|Study terminated by sponsor|3|||
130686916|NCT01697696|470479685|FG000|Overall Study|Protocol deviation|1|||
130686917|NCT01697696|470479686|FG001|Overall Study|Protocol deviation|0|||
130686918|NCT01697696|470479685|FG000|Overall Study|Physician Decision|1|||
130686919|NCT01697696|470479686|FG001|Overall Study|Physician Decision|0|||
130686920|NCT01697696|470479685|FG000|Overall Study|Death|4|||
130686921|NCT01697696|470479686|FG001|Overall Study|Death|2|||
130686922|NCT01697696|470479685|FG000|Overall Study|Lost to Follow-up|10|||
130686923|NCT01697696|470479686|FG001|Overall Study|Lost to Follow-up|7|||
130686924|NCT01697696|470479685|FG000|Overall Study|Subject/guardian decision|31|||
130686925|NCT01697696|470479686|FG001|Overall Study|Subject/guardian decision|35|||
130686926|NCT05593965|470479687|FG000|1st Intervention (1 Day)|Technical error|1|||
130686927|NCT05593965|470479688|FG001|1st Intervention (1 Day)|Technical error|0|||
130686928|NCT03616106|470479703|FG000|Overall Study|Removed by PI|6|||
130686929|NCT03616106|470479704|FG001|Overall Study|Removed by PI|0|||
130686930|NCT03616106|470479703|FG000|Overall Study|Withdrawal by Subject|1|||
130686931|NCT03616106|470479704|FG001|Overall Study|Withdrawal by Subject|1|||
130686932|NCT03616106|470479703|FG000|Overall Study|Lost to Follow-up|7|||
130686933|NCT03616106|470479704|FG001|Overall Study|Lost to Follow-up|0|||
130686934|NCT03206177|470479707|FG000|Overall Study|Withdrawal by Subject|1|||
130686935|NCT02963259|470479709|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
130686936|NCT02963259|470479709|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
130686937|NCT02963259|470479709|FG000|Overall Study|Death|1|||
130686938|NCT02963259|470479709|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
130686939|NCT04611789|470479710|FG000|Overall Study|Lost to Follow-up|1|||
130686940|NCT04611789|470479711|FG001|Overall Study|Lost to Follow-up|0|||
130686941|NCT04611789|470479712|FG002|Overall Study|Lost to Follow-up|0|||
130686942|NCT00727961|470479713|FG000|Overall Study|Lost to Follow-up|1|||
130686943|NCT00727961|470479713|FG000|Overall Study|Adverse Event|4|||
130686944|NCT00727961|470479713|FG000|Overall Study|Patient's refusal|2|||
130686945|NCT00727961|470479713|FG000|Overall Study|Progression|30|||
130686946|NCT03880266|470479714|FG000|Overall Study|Withdrawal by Subject|0|||
130686947|NCT03880266|470479715|FG001|Overall Study|Withdrawal by Subject|1|||
130686948|NCT03880266|470479716|FG002|Overall Study|Withdrawal by Subject|1|||
130686949|NCT03880266|470479717|FG003|Overall Study|Withdrawal by Subject|0|||
130686950|NCT03880266|470479718|FG004|Overall Study|Withdrawal by Subject|0|||
130686951|NCT03880266|470479719|FG005|Overall Study|Withdrawal by Subject|0|||
130686952|NCT03880266|470479720|FG006|Overall Study|Withdrawal by Subject|0|||
130686953|NCT03880266|470479721|FG007|Overall Study|Withdrawal by Subject|0|||
130686954|NCT03161405|470479722|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
130686955|NCT02655679|470479723|FG000|Overall Study|Adverse Event|0|||
130355378|NCT00089674|469273354|FG000|Overall Study|Lost to Follow-up|21|||
130355379|NCT00089674|469273355|FG001|Overall Study|Lost to Follow-up|17|||
130355380|NCT00089674|469273354|FG000|Overall Study|Noncompliance|7|||
130355381|NCT00089674|469273355|FG001|Overall Study|Noncompliance|3|||
130355382|NCT00089674|469273354|FG000|Overall Study|Other|5|||
130355383|NCT00089674|469273355|FG001|Overall Study|Other|9|||
130355384|NCT00089674|469273354|FG000|Overall Study|Requirement for alternative therapy|14|||
130355385|NCT00089674|469273355|FG001|Overall Study|Requirement for alternative therapy|4|||
130355386|NCT03963401|469273356|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
130355387|NCT03963401|469273357|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
130355388|NCT03963401|469273358|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
130355389|NCT03963401|469273359|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
130355390|NCT03963401|469273360|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
130355391|NCT03963401|469273361|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
130355392|NCT03963401|469273356|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130355393|NCT03963401|469273357|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130355394|NCT03963401|469273358|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
130686956|NCT02655679|470479724|FG001|Overall Study|Adverse Event|1|||
130686957|NCT02655679|470479725|FG002|Overall Study|Adverse Event|0|||
130686958|NCT02655679|470479726|FG003|Overall Study|Adverse Event|0|||
130686959|NCT02655679|470479727|FG004|Overall Study|Adverse Event|0|||
130686960|NCT02655679|470479723|FG000|Overall Study|Withdrawal by Subject|1|||
130355395|NCT03963401|469273359|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
130355396|NCT03963401|469273360|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130686961|NCT02655679|470479724|FG001|Overall Study|Withdrawal by Subject|1|||
130686962|NCT02655679|470479725|FG002|Overall Study|Withdrawal by Subject|0|||
130686963|NCT02655679|470479726|FG003|Overall Study|Withdrawal by Subject|3|||
130686964|NCT02655679|470479727|FG004|Overall Study|Withdrawal by Subject|1|||
130223556|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Other|0|||
130223557|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Death|14|||
130223558|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Death|21|||
130223559|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
130223560|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
130223561|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Other|15|||
130223562|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Other|2|||
130223563|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
130223564|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
130223565|NCT02595502|468781696|FG000|Period 1|Adverse Event|0|||
130223566|NCT02595502|468781697|FG001|Period 1|Adverse Event|1|||
130223567|NCT02595502|468781696|FG000|Period 1|Withdrawal by Subject|1|||
130223568|NCT02595502|468781697|FG001|Period 1|Withdrawal by Subject|0|||
130223569|NCT02595502|468781696|FG000|Period 1|Lost to Follow-up|0|||
130223570|NCT02595502|468781697|FG001|Period 1|Lost to Follow-up|1|||
130223571|NCT02595502|468781696|FG000|Period 2|Adverse Event|1|||
130223572|NCT02595502|468781697|FG001|Period 2|Adverse Event|1|||
130223573|NCT02595502|468781696|FG000|Period 2|Received incorrect lens at Period 1|0|||
130223574|NCT02595502|468781697|FG001|Period 2|Received incorrect lens at Period 1|1|||
130223575|NCT02595502|468781696|FG000|Period 3|Protocol Violation|0|||
130223576|NCT02595502|468781697|FG001|Period 3|Protocol Violation|1|||
130223577|NCT02595502|468781696|FG000|Period 3|Lost to Follow-up|1|||
130223578|NCT02595502|468781697|FG001|Period 3|Lost to Follow-up|0|||
130223579|NCT02595502|468781696|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
130223580|NCT02595502|468781697|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
130223581|NCT05556148|468781698|FG000|Overall Study|Early Termination|29|||
130223582|NCT05556148|468781698|FG000|Overall Study|Baseline Tasks Expired|4|||
130223583|NCT05556148|468781698|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
130223584|NCT05556148|468781698|FG000|Overall Study|No Longer Wished to Participate|1|||
130223585|NCT05556148|468781698|FG000|Overall Study|Bacterial Conjunctivitis|1|||
130223586|NCT00458003|468781699|FG000|Overall Study|Non protocol spinal anesthesia|1|||
130223587|NCT00458003|468781700|FG001|Overall Study|Non protocol spinal anesthesia|1|||
130223588|NCT00809445|468781701|FG000|1 Month Follow-up|Lost contact|1|||
130223589|NCT00809445|468781702|FG001|1 Month Follow-up|Lost contact|2|||
130223590|NCT00809445|468781703|FG002|1 Month Follow-up|Lost contact|1|||
130223591|NCT00809445|468781701|FG000|1 Month Follow-up|Withdrew consent|1|||
130223592|NCT00809445|468781702|FG001|1 Month Follow-up|Withdrew consent|1|||
130223593|NCT00809445|468781703|FG002|1 Month Follow-up|Withdrew consent|1|||
130223594|NCT00809445|468781701|FG000|1 Month Follow-up|Death|0|||
130223595|NCT00809445|468781702|FG001|1 Month Follow-up|Death|1|||
130223596|NCT00809445|468781703|FG002|1 Month Follow-up|Death|1|||
130223597|NCT00809445|468781701|FG000|1 Month Follow-up|Incarcerated|0|||
130223598|NCT00809445|468781702|FG001|1 Month Follow-up|Incarcerated|0|||
130223599|NCT00809445|468781703|FG002|1 Month Follow-up|Incarcerated|1|||
130223600|NCT00809445|468781701|FG000|6 Month Follow-up|Lost contact|16|||
130223601|NCT00809445|468781702|FG001|6 Month Follow-up|Lost contact|14|||
130223602|NCT00809445|468781703|FG002|6 Month Follow-up|Lost contact|14|||
130223603|NCT00809445|468781701|FG000|6 Month Follow-up|Death|2|||
130223604|NCT00809445|468781702|FG001|6 Month Follow-up|Death|1|||
130223605|NCT00809445|468781703|FG002|6 Month Follow-up|Death|1|||
130355397|NCT03963401|469273361|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130355398|NCT03963401|469273356|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
130355399|NCT03963401|469273357|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130355400|NCT03963401|469273358|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130355401|NCT03963401|469273359|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130355402|NCT03963401|469273360|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
130355403|NCT03963401|469273361|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
130355404|NCT03963401|469273356|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130355405|NCT03963401|469273357|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
130355406|NCT03963401|469273358|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130355407|NCT03963401|469273359|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130355408|NCT03963401|469273360|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130552855|NCT01290601|469991598|FG002|Overall Study|Adverse Event|0|||
130223606|NCT00809445|468781701|FG000|6 Month Follow-up|Incarcerated|6|||
130223607|NCT00809445|468781702|FG001|6 Month Follow-up|Incarcerated|8|||
130223608|NCT00809445|468781703|FG002|6 Month Follow-up|Incarcerated|8|||
130223609|NCT00809445|468781701|FG000|6 Month Follow-up|Withdrew consent|0|||
130223610|NCT00809445|468781702|FG001|6 Month Follow-up|Withdrew consent|0|||
130223611|NCT00809445|468781703|FG002|6 Month Follow-up|Withdrew consent|1|||
130223612|NCT02048722|468781704|FG000|2 Cycles of Treatment|Adverse Event|2|||
130223613|NCT02048722|468781704|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
130223614|NCT02048722|468781704|FG000|2 Cycles of Treatment|Progressive Disease|2|||
130223615|NCT02048722|468781704|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
130223616|NCT02048722|468781704|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
130223617|NCT02048722|468781704|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
130223618|NCT04144322|468781705|FG000|Overall Study|Lack of Efficacy|2|||
130223619|NCT04144322|468781706|FG001|Overall Study|Lack of Efficacy|2|||
130223620|NCT01272908|468781710|FG000|Initial Treatment Period|Adverse Event|1|||
130223621|NCT01272908|468781710|FG000|Initial Treatment Period|Lack of Efficacy|5|||
130223622|NCT01272908|468781710|FG000|Initial Treatment Period|Protocol Violation|1|||
130223623|NCT01272908|468781710|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130223624|NCT01272908|468781710|FG000|Re-Treatment Period|Adverse Event|2|||
130223625|NCT01272908|468781710|FG000|Re-Treatment Period|Lack of Efficacy|3|||
130223626|NCT01272908|468781710|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
130223627|NCT02131064|468781711|FG000|Overall Study|Death|5|||
130223628|NCT02131064|468781712|FG001|Overall Study|Death|6|||
130223629|NCT02131064|468781711|FG000|Overall Study|Lost to Follow-up|4|||
130223630|NCT02131064|468781712|FG001|Overall Study|Lost to Follow-up|8|||
130223631|NCT02131064|468781711|FG000|Overall Study|Withdrawal by Subject|14|||
130223632|NCT02131064|468781712|FG001|Overall Study|Withdrawal by Subject|18|||
130223633|NCT02131064|468781711|FG000|Overall Study|Other|2|||
130223634|NCT02131064|468781712|FG001|Overall Study|Other|2|||
130223635|NCT03489343|468781715|FG000|Overall Study|Documented progressive disease|1|||
130223636|NCT03489343|468781716|FG001|Overall Study|Documented progressive disease|0|||
130223637|NCT03489343|468781717|FG002|Overall Study|Documented progressive disease|3|||
130223638|NCT03489343|468781718|FG003|Overall Study|Documented progressive disease|1|||
130223639|NCT03489343|468781719|FG004|Overall Study|Documented progressive disease|3|||
130223640|NCT03489343|468781720|FG005|Overall Study|Documented progressive disease|5|||
130223641|NCT03489343|468781721|FG006|Overall Study|Documented progressive disease|4|||
130223642|NCT03489343|468781715|FG000|Overall Study|Adverse Event|0|||
130223643|NCT03489343|468781716|FG001|Overall Study|Adverse Event|1|||
130223644|NCT03489343|468781717|FG002|Overall Study|Adverse Event|0|||
130223645|NCT03489343|468781718|FG003|Overall Study|Adverse Event|0|||
130223646|NCT03489343|468781719|FG004|Overall Study|Adverse Event|0|||
130223647|NCT03489343|468781720|FG005|Overall Study|Adverse Event|1|||
130223648|NCT03489343|468781721|FG006|Overall Study|Adverse Event|0|||
130223649|NCT03489343|468781715|FG000|Overall Study|Withdrawal by Subject|0|||
130223650|NCT03489343|468781716|FG001|Overall Study|Withdrawal by Subject|0|||
130223651|NCT03489343|468781717|FG002|Overall Study|Withdrawal by Subject|0|||
130223652|NCT03489343|468781718|FG003|Overall Study|Withdrawal by Subject|1|||
130223653|NCT03489343|468781719|FG004|Overall Study|Withdrawal by Subject|0|||
130223654|NCT03489343|468781720|FG005|Overall Study|Withdrawal by Subject|1|||
130223655|NCT03489343|468781721|FG006|Overall Study|Withdrawal by Subject|1|||
130223656|NCT03489343|468781715|FG000|Overall Study|Clinical progression|0|||
130223657|NCT03489343|468781716|FG001|Overall Study|Clinical progression|0|||
130223658|NCT03489343|468781717|FG002|Overall Study|Clinical progression|0|||
130223659|NCT03489343|468781718|FG003|Overall Study|Clinical progression|1|||
130223660|NCT03489343|468781719|FG004|Overall Study|Clinical progression|0|||
130223661|NCT03489343|468781720|FG005|Overall Study|Clinical progression|0|||
130223662|NCT03489343|468781721|FG006|Overall Study|Clinical progression|1|||
130223663|NCT01158261|468781722|FG000|Overall Study|Lost to Follow-up|9|||
130223664|NCT01158261|468781722|FG000|Overall Study|Death|7|||
130223665|NCT01158261|468781722|FG000|Overall Study|Withdrawal by Subject|1|||
130223666|NCT03143101|468781723|FG000|Overall Study|Withdrawal by Subject|0|||
130223667|NCT03143101|468781724|FG001|Overall Study|Withdrawal by Subject|1|||
130223668|NCT03143101|468781725|FG002|Overall Study|Withdrawal by Subject|0|||
130223669|NCT03143101|468781723|FG000|Overall Study|Lost to Follow-up|2|||
130223670|NCT03143101|468781724|FG001|Overall Study|Lost to Follow-up|2|||
130355409|NCT03963401|469273361|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130355410|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
130355411|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
130355412|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
130355413|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
130355414|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
130355415|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
130355416|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
130355417|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130355418|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
130355419|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130355420|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130355421|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130223671|NCT03143101|468781725|FG002|Overall Study|Lost to Follow-up|0|||
130223672|NCT01630135|468781729|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
130355422|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130223673|NCT01630135|468781730|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
130223674|NCT02899065|468781732|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
130223675|NCT02899065|468781733|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
130223676|NCT02899065|468781732|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
130355423|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130355424|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
130223677|NCT02899065|468781733|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
130223678|NCT02899065|468781732|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
130223679|NCT02899065|468781733|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
130223680|NCT00971867|468781734|FG000|Overall Study|Adverse Event|4|||
130223681|NCT00971867|468781734|FG000|Overall Study|Participant Withdrew Consent|1|||
130223682|NCT00971867|468781734|FG000|Overall Study|Disease Progression|6|||
130223683|NCT05227118|468781738|FG000|Overall Study|Adverse Event|0|||
130223684|NCT05227118|468781739|FG001|Overall Study|Adverse Event|0|||
130223685|NCT05227118|468781740|FG002|Overall Study|Adverse Event|1|||
130223686|NCT05227118|468781741|FG003|Overall Study|Adverse Event|0|||
130223687|NCT05227118|468781738|FG000|Overall Study|Withdrawal by Subject|0|||
130223688|NCT05227118|468781739|FG001|Overall Study|Withdrawal by Subject|0|||
130223689|NCT05227118|468781740|FG002|Overall Study|Withdrawal by Subject|2|||
130223690|NCT05227118|468781741|FG003|Overall Study|Withdrawal by Subject|0|||
130223691|NCT03727841|468781747|FG000|Overall Study|Physician Decision|3|||
130223692|NCT03727841|468781748|FG001|Overall Study|Physician Decision|1|||
130223693|NCT01601496|468781749|FG000|Overall Study|Physician Decision|1|||
130223694|NCT01601496|468781749|FG000|Overall Study|Withdrawal by Subject|1|||
130223695|NCT01601496|468781749|FG000|Overall Study|Lost to Follow-up|6|||
130223696|NCT01601496|468781749|FG000|Overall Study|Death|4|||
130223697|NCT01601496|468781749|FG000|Overall Study|Other: patient refusal to continue|3|||
130223698|NCT03243305|468781750|FG000|Overall Study|Lost to Follow-up|250|||
130223699|NCT03243305|468781750|FG000|Overall Study|Withdrawal by Subject|170|||
130223700|NCT03243305|468781750|FG000|Overall Study|Pregnancy|104|||
130223701|NCT03243305|468781750|FG000|Overall Study|Non-Compliance with Study Drug|38|||
130223702|NCT03243305|468781750|FG000|Overall Study|Adverse Event|23|||
130223703|NCT03243305|468781750|FG000|Overall Study|No sexually active|26|||
130223704|NCT03243305|468781750|FG000|Overall Study|Physician Decision|22|||
130223705|NCT03243305|468781750|FG000|Overall Study|Protocol Violation|22|||
130223706|NCT03243305|468781750|FG000|Overall Study|Study method no longer primary method|12|||
130223707|NCT03243305|468781750|FG000|Overall Study|Study Terminated by Sponsor|1|||
130223708|NCT03243305|468781750|FG000|Overall Study|Early terminations|267|||
130223709|NCT02689804|468781751|FG000|Overall Study|Withdrawal by Subject|2|||
130223710|NCT02689804|468781752|FG001|Overall Study|Withdrawal by Subject|0|||
130223711|NCT01166750|468781760|FG000|Overall Study|Lost to Follow-up|1|||
130223712|NCT01166750|468781761|FG001|Overall Study|Lost to Follow-up|0|||
130223713|NCT01585246|468781762|FG000|Overall Study|Lost to Follow-up|0|||
130223714|NCT01585246|468781763|FG001|Overall Study|Lost to Follow-up|0|||
130223715|NCT01585246|468781764|FG002|Overall Study|Lost to Follow-up|2|||
130223716|NCT01585246|468781765|FG003|Overall Study|Lost to Follow-up|1|||
130223717|NCT01585246|468781766|FG004|Overall Study|Lost to Follow-up|0|||
130223718|NCT01585246|468781762|FG000|Overall Study|Protocol Violation|0|||
130223719|NCT01585246|468781763|FG001|Overall Study|Protocol Violation|0|||
130223720|NCT01585246|468781764|FG002|Overall Study|Protocol Violation|0|||
130223721|NCT01585246|468781765|FG003|Overall Study|Protocol Violation|0|||
130355425|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130355426|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130355427|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130686965|NCT02655679|470479723|FG000|Overall Study|Inability to Comply with the Protocol|1|||
130355428|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
130355429|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130355430|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130355431|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130355432|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130355433|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130355434|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
130355435|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130355436|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
130442625|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
130442626|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
130223722|NCT01585246|468781766|FG004|Overall Study|Protocol Violation|1|||
130223723|NCT01585246|468781762|FG000|Overall Study|Withdrawal by Subject|0|||
130223724|NCT01585246|468781763|FG001|Overall Study|Withdrawal by Subject|0|||
130223725|NCT01585246|468781764|FG002|Overall Study|Withdrawal by Subject|1|||
130223726|NCT01585246|468781765|FG003|Overall Study|Withdrawal by Subject|2|||
130223727|NCT01585246|468781766|FG004|Overall Study|Withdrawal by Subject|1|||
130223728|NCT01585246|468781762|FG000|Overall Study|Other|0|||
130223729|NCT01585246|468781763|FG001|Overall Study|Other|1|||
130223730|NCT01585246|468781764|FG002|Overall Study|Other|1|||
130223731|NCT01585246|468781765|FG003|Overall Study|Other|1|||
130223732|NCT01585246|468781766|FG004|Overall Study|Other|0|||
130223733|NCT04396626|468781767|FG000|Overall Study|Premature termination of study|975|||
130223734|NCT02417753|468781768|FG000|Overall Study|Death|1|||
130223735|NCT03771963|468781771|FG000|Overall Study|Lost to Follow-up|22|||
130223736|NCT03771963|468781771|FG000|Overall Study|Withdrawal of Consent|10|||
130223737|NCT03014206|468781772|FG000|Overall Study|Registration Violation|12|||
130223738|NCT02998151|468781777|FG000|Overall Study|Withdrawal by Subject|3|||
130223739|NCT02998151|468781777|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
130223740|NCT02998151|468781777|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
130223741|NCT02155985|468781778|FG000|Overall Study|Withdrawal by Subject|0|||
130223742|NCT02155985|468781779|FG001|Overall Study|Withdrawal by Subject|0|||
130223743|NCT02155985|468781780|FG002|Overall Study|Withdrawal by Subject|1|||
130223744|NCT02155985|468781778|FG000|Overall Study|Lost to Follow-up|1|||
130223745|NCT02155985|468781779|FG001|Overall Study|Lost to Follow-up|0|||
130223746|NCT02155985|468781780|FG002|Overall Study|Lost to Follow-up|0|||
130223747|NCT02573259|468781781|FG000|Overall Study|Death|1|||
130223748|NCT02573259|468781782|FG001|Overall Study|Death|6|||
130223749|NCT02573259|468781783|FG002|Overall Study|Death|5|||
130223750|NCT02573259|468781784|FG003|Overall Study|Death|6|||
130223751|NCT02573259|468781785|FG004|Overall Study|Death|9|||
130223752|NCT02573259|468781786|FG005|Overall Study|Death|32|||
130223753|NCT02573259|468781787|FG006|Overall Study|Death|21|||
130223754|NCT02573259|468781781|FG000|Overall Study|Lost to Follow-up|0|||
130223755|NCT02573259|468781782|FG001|Overall Study|Lost to Follow-up|0|||
130223756|NCT02573259|468781783|FG002|Overall Study|Lost to Follow-up|0|||
130223757|NCT02573259|468781784|FG003|Overall Study|Lost to Follow-up|0|||
130223758|NCT02573259|468781785|FG004|Overall Study|Lost to Follow-up|0|||
130223759|NCT02573259|468781786|FG005|Overall Study|Lost to Follow-up|2|||
130223760|NCT02573259|468781787|FG006|Overall Study|Lost to Follow-up|1|||
130223761|NCT02573259|468781781|FG000|Overall Study|Participant refused further follow-up|0|||
130223762|NCT02573259|468781782|FG001|Overall Study|Participant refused further follow-up|2|||
130223763|NCT02573259|468781783|FG002|Overall Study|Participant refused further follow-up|1|||
130223764|NCT02573259|468781784|FG003|Overall Study|Participant refused further follow-up|0|||
130223765|NCT02573259|468781785|FG004|Overall Study|Participant refused further follow-up|3|||
130442627|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130442628|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130442629|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
130442630|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
130442631|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
130442632|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
130442633|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
130442634|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
130442635|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
130442636|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
130442637|NCT03230864|469584338|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
130442638|NCT03230864|469584339|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130442639|NCT03230864|469584340|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130442640|NCT03230864|469584341|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130442641|NCT03230864|469584338|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
130442642|NCT03230864|469584339|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
130442643|NCT03230864|469584340|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
130442644|NCT03230864|469584341|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
130442645|NCT03230864|469584338|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130442646|NCT03230864|469584339|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130442647|NCT03230864|469584340|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
130442648|NCT03230864|469584341|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
130442649|NCT03230864|469584338|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130442650|NCT03230864|469584339|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130552856|NCT01290601|469991599|FG003|Overall Study|Adverse Event|0|||
130223766|NCT02573259|468781786|FG005|Overall Study|Participant refused further follow-up|20|||
130223767|NCT02573259|468781787|FG006|Overall Study|Participant refused further follow-up|7|||
130223768|NCT02573259|468781781|FG000|Overall Study|Other|0|||
130223769|NCT02573259|468781782|FG001|Overall Study|Other|0|||
130223770|NCT02573259|468781783|FG002|Overall Study|Other|0|||
130223771|NCT02573259|468781784|FG003|Overall Study|Other|0|||
130223772|NCT02573259|468781785|FG004|Overall Study|Other|1|||
130223773|NCT02573259|468781786|FG005|Overall Study|Other|4|||
130223774|NCT02573259|468781787|FG006|Overall Study|Other|5|||
130223775|NCT01367249|468781793|FG000|Overall Study|Withdrawal by Subject|6|||
130223776|NCT01367249|468781794|FG001|Overall Study|Withdrawal by Subject|6|||
130223777|NCT01367249|468781793|FG000|Overall Study|Other|3|||
130223778|NCT01367249|468781794|FG001|Overall Study|Other|10|||
130223779|NCT01817075|468781795|FG000|Overall Study|Adverse Event|7|||
130223780|NCT01817075|468781796|FG001|Overall Study|Adverse Event|5|||
130223781|NCT01817075|468781795|FG000|Overall Study|Physician Decision|9|||
130223782|NCT01817075|468781796|FG001|Overall Study|Physician Decision|12|||
130223783|NCT01817075|468781795|FG000|Overall Study|Withdrawal by Subject|31|||
130223784|NCT01817075|468781796|FG001|Overall Study|Withdrawal by Subject|15|||
130223785|NCT01817075|468781795|FG000|Overall Study|Received Sorafenib after enrollment|0|||
130223786|NCT01817075|468781796|FG001|Overall Study|Received Sorafenib after enrollment|1|||
130223787|NCT01817075|468781795|FG000|Overall Study|Ineligible|0|||
130223788|NCT01817075|468781796|FG001|Overall Study|Ineligible|2|||
130223789|NCT02358031|468784300|FG000|Overall Study|Death|253|||
130223790|NCT02358031|468784301|FG001|Overall Study|Death|237|||
130223791|NCT02358031|468784302|FG002|Overall Study|Death|266|||
130223792|NCT02358031|468784300|FG000|Overall Study|Lost to Follow-up|1|||
130223793|NCT02358031|468784301|FG001|Overall Study|Lost to Follow-up|1|||
130223794|NCT02358031|468784302|FG002|Overall Study|Lost to Follow-up|0|||
130223795|NCT02358031|468784300|FG000|Overall Study|Withdrawal by Subject|19|||
130223796|NCT02358031|468784301|FG001|Overall Study|Withdrawal by Subject|14|||
130223797|NCT02358031|468784302|FG002|Overall Study|Withdrawal by Subject|18|||
130223798|NCT02358031|468784300|FG000|Overall Study|Sponsor Decision|26|||
130223799|NCT02358031|468784301|FG001|Overall Study|Sponsor Decision|28|||
130223800|NCT02358031|468784302|FG002|Overall Study|Sponsor Decision|16|||
130223801|NCT05664581|468784303|FG000|Overall Study|Withdrawal by Subject|2|||
130223802|NCT02787304|468784304|FG000|Overall Study|Adverse Event|9|||
130223803|NCT02787304|468784305|FG001|Overall Study|Adverse Event|3|||
130223804|NCT02787304|468784306|FG002|Overall Study|Adverse Event|8|||
130223805|NCT02787304|468784307|FG003|Overall Study|Adverse Event|1|||
130223806|NCT02787304|468784304|FG000|Overall Study|Withdrawal by Subject|1|||
130223807|NCT02787304|468784305|FG001|Overall Study|Withdrawal by Subject|4|||
130223808|NCT02787304|468784306|FG002|Overall Study|Withdrawal by Subject|0|||
130223809|NCT02787304|468784307|FG003|Overall Study|Withdrawal by Subject|0|||
130223810|NCT02787304|468784304|FG000|Overall Study|Lost to Follow-up|1|||
130223811|NCT02787304|468784305|FG001|Overall Study|Lost to Follow-up|0|||
130223812|NCT02787304|468784306|FG002|Overall Study|Lost to Follow-up|0|||
130223813|NCT02787304|468784307|FG003|Overall Study|Lost to Follow-up|1|||
130223814|NCT02787304|468784304|FG000|Overall Study|Noncompliance with study drug|0|||
130223815|NCT02787304|468784305|FG001|Overall Study|Noncompliance with study drug|0|||
130223816|NCT02787304|468784306|FG002|Overall Study|Noncompliance with study drug|1|||
130223817|NCT02787304|468784307|FG003|Overall Study|Noncompliance with study drug|0|||
130223818|NCT02787304|468784304|FG000|Overall Study|Physician Decision|0|||
130223819|NCT02787304|468784305|FG001|Overall Study|Physician Decision|0|||
130223820|NCT02787304|468784306|FG002|Overall Study|Physician Decision|1|||
130223821|NCT02787304|468784307|FG003|Overall Study|Physician Decision|0|||
130223822|NCT02787304|468784304|FG000|Overall Study|Study terminated by sponsor|25|||
130223823|NCT02787304|468784305|FG001|Overall Study|Study terminated by sponsor|31|||
130223824|NCT02787304|468784306|FG002|Overall Study|Study terminated by sponsor|31|||
130223825|NCT02787304|468784307|FG003|Overall Study|Study terminated by sponsor|32|||
130223826|NCT01051921|468784308|FG000|Overall Study|Physician Decision|9|||
130223827|NCT01051921|468784308|FG000|Overall Study|Adverse Event|8|||
130223828|NCT01051921|468784308|FG000|Overall Study|Withdrawal by Subject|7|||
130223829|NCT01051921|468784308|FG000|Overall Study|Lost to Follow-up|4|||
130355437|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
130355438|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130355439|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130686966|NCT02655679|470479724|FG001|Overall Study|Inability to Comply with the Protocol|0|||
130355440|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
130355441|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130355442|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130686967|NCT02655679|470479725|FG002|Overall Study|Inability to Comply with the Protocol|0|||
130223830|NCT01051921|468784308|FG000|Overall Study|virological failure|1|||
130223831|NCT01051921|468784308|FG000|Overall Study|patient moved|1|||
130686968|NCT02655679|470479726|FG003|Overall Study|Inability to Comply with the Protocol|0|||
130686969|NCT02655679|470479727|FG004|Overall Study|Inability to Comply with the Protocol|0|||
130686970|NCT02655679|470479723|FG000|Overall Study|Lost to Follow-up|0|||
130223832|NCT01325350|468784311|FG000|Overall Study|Adverse Event|3|||
130223833|NCT01325350|468784312|FG001|Overall Study|Adverse Event|3|||
130223834|NCT01325350|468784313|FG002|Overall Study|Adverse Event|3|||
130223835|NCT01325350|468784314|FG003|Overall Study|Adverse Event|1|||
130223836|NCT01325350|468784315|FG004|Overall Study|Adverse Event|2|||
130223837|NCT01325350|468784311|FG000|Overall Study|Pregnancy|0|||
130223838|NCT01325350|468784312|FG001|Overall Study|Pregnancy|0|||
130223839|NCT01325350|468784313|FG002|Overall Study|Pregnancy|1|||
130223840|NCT01325350|468784314|FG003|Overall Study|Pregnancy|0|||
130223841|NCT01325350|468784315|FG004|Overall Study|Pregnancy|1|||
130223842|NCT01325350|468784311|FG000|Overall Study|Lost to Follow-up|1|||
130223843|NCT01325350|468784312|FG001|Overall Study|Lost to Follow-up|0|||
130223844|NCT01325350|468784313|FG002|Overall Study|Lost to Follow-up|5|||
130223845|NCT01325350|468784314|FG003|Overall Study|Lost to Follow-up|1|||
130223846|NCT01325350|468784315|FG004|Overall Study|Lost to Follow-up|5|||
130223847|NCT01325350|468784311|FG000|Overall Study|Personal Reasons|2|||
130223848|NCT01325350|468784312|FG001|Overall Study|Personal Reasons|1|||
130223849|NCT01325350|468784313|FG002|Overall Study|Personal Reasons|6|||
130223850|NCT01325350|468784314|FG003|Overall Study|Personal Reasons|5|||
130223851|NCT01325350|468784315|FG004|Overall Study|Personal Reasons|3|||
130223852|NCT01325350|468784311|FG000|Overall Study|Protocol Violation|0|||
130223853|NCT01325350|468784312|FG001|Overall Study|Protocol Violation|0|||
130223854|NCT01325350|468784313|FG002|Overall Study|Protocol Violation|0|||
130223855|NCT01325350|468784314|FG003|Overall Study|Protocol Violation|1|||
130223856|NCT01325350|468784315|FG004|Overall Study|Protocol Violation|0|||
130223857|NCT01325350|468784311|FG000|Overall Study|Withdrawal by Subject|0|||
130223858|NCT01325350|468784312|FG001|Overall Study|Withdrawal by Subject|0|||
130223859|NCT01325350|468784313|FG002|Overall Study|Withdrawal by Subject|1|||
130223860|NCT01325350|468784314|FG003|Overall Study|Withdrawal by Subject|1|||
130223861|NCT01325350|468784315|FG004|Overall Study|Withdrawal by Subject|0|||
130223862|NCT01325350|468784311|FG000|Overall Study|Did Not Receive Treatment|0|||
130223863|NCT01325350|468784312|FG001|Overall Study|Did Not Receive Treatment|1|||
130223864|NCT01325350|468784313|FG002|Overall Study|Did Not Receive Treatment|1|||
130223865|NCT01325350|468784314|FG003|Overall Study|Did Not Receive Treatment|0|||
130223866|NCT01325350|468784315|FG004|Overall Study|Did Not Receive Treatment|1|||
130223867|NCT01053741|468784318|FG000|2nd Study Intervention|Physician Decision|0|||
130223868|NCT01053741|468784319|FG001|2nd Study Intervention|Physician Decision|1|||
130223869|NCT00619827|468784321|FG000|Overall Study|Adverse Event|1|||
130223870|NCT00619827|468784322|FG001|Overall Study|Adverse Event|2|||
130223871|NCT00619827|468784321|FG000|Overall Study|Withdrawal by Subject|2|||
130223872|NCT00619827|468784322|FG001|Overall Study|Withdrawal by Subject|2|||
130442651|NCT03230864|469584340|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
130442652|NCT03230864|469584341|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130442653|NCT00432679|469584346|FG000|Overall Study|Adverse Event|2|||
130442654|NCT00432679|469584347|FG001|Overall Study|Adverse Event|1|||
130442655|NCT00432679|469584346|FG000|Overall Study|Withdrawal by Subject|3|||
130442656|NCT00432679|469584347|FG001|Overall Study|Withdrawal by Subject|2|||
130442657|NCT01744496|469584350|FG000|Titration Period|Adverse Event|2|||
130442658|NCT01744496|469584351|FG001|Titration Period|Adverse Event|1|||
130442659|NCT01744496|469584350|FG000|Titration Period|Personal reasons|0|||
130442660|NCT01744496|469584351|FG001|Titration Period|Personal reasons|1|||
130442661|NCT01744496|469584350|FG000|Maintenance Period|Adverse Event|1|||
130442662|NCT01744496|469584351|FG001|Maintenance Period|Adverse Event|3|||
130442663|NCT01744496|469584350|FG000|Maintenance Period|Protocol Violation|1|||
130442664|NCT01744496|469584351|FG001|Maintenance Period|Protocol Violation|0|||
130442665|NCT01744496|469584350|FG000|Maintenance Period|Withdrawal by Subject|1|||
130223873|NCT01063855|468784323|FG000|Overall Study|Adverse Event|4|||
130223874|NCT01063855|468784324|FG001|Overall Study|Adverse Event|4|||
130223875|NCT01063855|468784323|FG000|Overall Study|Death|0|||
130223876|NCT01063855|468784324|FG001|Overall Study|Death|1|||
130223877|NCT01063855|468784323|FG000|Overall Study|Lost to Follow-up|8|||
130223878|NCT01063855|468784324|FG001|Overall Study|Lost to Follow-up|4|||
130223879|NCT01063855|468784323|FG000|Overall Study|Pregnancy|1|||
130223880|NCT01063855|468784324|FG001|Overall Study|Pregnancy|0|||
130223881|NCT01063855|468784323|FG000|Overall Study|Lack of Efficacy|0|||
130223882|NCT01063855|468784324|FG001|Overall Study|Lack of Efficacy|1|||
130223883|NCT01063855|468784323|FG000|Overall Study|Withdrawal by Subject|11|||
130223884|NCT01063855|468784324|FG001|Overall Study|Withdrawal by Subject|8|||
130223885|NCT01063855|468784323|FG000|Overall Study|Reason not specified|13|||
130223886|NCT01063855|468784324|FG001|Overall Study|Reason not specified|11|||
130223887|NCT02619617|468784346|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
130223888|NCT02619617|468784347|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
130223889|NCT02619617|468784346|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
130223890|NCT02619617|468784347|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
130223891|NCT01854697|468784348|FG000|Overall Study|Adverse Event|1|||
130223892|NCT01854697|468784349|FG001|Overall Study|Adverse Event|0|||
130223893|NCT01854697|468784350|FG002|Overall Study|Adverse Event|0|||
130442666|NCT01744496|469584351|FG001|Maintenance Period|Withdrawal by Subject|1|||
130442667|NCT01744496|469584350|FG000|Maintenance Period|Subject left town|1|||
130442668|NCT01744496|469584351|FG001|Maintenance Period|Subject left town|0|||
130223894|NCT01854697|468784351|FG003|Overall Study|Adverse Event|0|||
130223895|NCT01854697|468784352|FG004|Overall Study|Adverse Event|1|||
130223896|NCT01854697|468784348|FG000|Overall Study|Lost to Follow-up|4|||
130223897|NCT01854697|468784349|FG001|Overall Study|Lost to Follow-up|1|||
130223898|NCT01854697|468784350|FG002|Overall Study|Lost to Follow-up|1|||
130223899|NCT01854697|468784351|FG003|Overall Study|Lost to Follow-up|2|||
130442669|NCT02374593|469584357|FG000|Overall Study|non-compliant|2|||
130442670|NCT02374593|469584358|FG001|Overall Study|non-compliant|0|||
130442671|NCT00579982|469584359|FG000|Overall Study|Adverse Event|4|||
130442672|NCT00579982|469584359|FG000|Overall Study|Protocol Violation|4|||
130223900|NCT01854697|468784352|FG004|Overall Study|Lost to Follow-up|0|||
130223901|NCT01854697|468784348|FG000|Overall Study|To enter another AbbVie study|1|||
130686971|NCT02655679|470479724|FG001|Overall Study|Lost to Follow-up|1|||
130686972|NCT02655679|470479725|FG002|Overall Study|Lost to Follow-up|1|||
130686973|NCT02655679|470479726|FG003|Overall Study|Lost to Follow-up|1|||
130686974|NCT02655679|470479727|FG004|Overall Study|Lost to Follow-up|0|||
130686975|NCT02655679|470479723|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130686976|NCT02655679|470479724|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130686977|NCT02655679|470479725|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130686978|NCT02655679|470479726|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130686979|NCT02655679|470479727|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130686980|NCT01421277|470479728|FG000|Overall Study|Lack of qualifying event|0|||
130686981|NCT01421277|470479729|FG001|Overall Study|Lack of qualifying event|61|||
130686982|NCT01421277|470479728|FG000|Overall Study|Incomplete baseline data|0|||
130686983|NCT01421277|470479729|FG001|Overall Study|Incomplete baseline data|31|||
130686984|NCT05472038|470481323|FG000|Overall Study|Adverse Event|0|||
130686985|NCT05472038|470481324|FG001|Overall Study|Adverse Event|0|||
130686986|NCT05472038|470481325|FG002|Overall Study|Adverse Event|1|||
130686987|NCT05472038|470481326|FG003|Overall Study|Adverse Event|0|||
130686988|NCT05472038|470481327|FG004|Overall Study|Adverse Event|0|||
130686989|NCT05472038|470481328|FG005|Overall Study|Adverse Event|0|||
130686990|NCT05472038|470481329|FG006|Overall Study|Adverse Event|0|||
130686991|NCT05472038|470481330|FG007|Overall Study|Adverse Event|0|||
130686992|NCT05472038|470481331|FG008|Overall Study|Adverse Event|0|||
130686993|NCT05472038|470481332|FG009|Overall Study|Adverse Event|0|||
130686994|NCT05472038|470481333|FG010|Overall Study|Adverse Event|0|||
130686995|NCT05472038|470481334|FG011|Overall Study|Adverse Event|0|||
130686996|NCT05472038|470481323|FG000|Overall Study|Death|0|||
130686997|NCT05472038|470481324|FG001|Overall Study|Death|0|||
130686998|NCT05472038|470481325|FG002|Overall Study|Death|0|||
130223902|NCT01854697|468784349|FG001|Overall Study|To enter another AbbVie study|0|||
130223903|NCT01854697|468784350|FG002|Overall Study|To enter another AbbVie study|0|||
130355443|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130355444|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130355445|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130355446|NCT03963401|469273356|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
130355447|NCT03963401|469273357|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
130355448|NCT03963401|469273358|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
130355449|NCT03963401|469273359|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
130355450|NCT03963401|469273360|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
130355451|NCT03963401|469273361|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
130355452|NCT00667420|469273365|FG000|Overall Study|Adverse Event|2|||
130355453|NCT00667420|469273365|FG000|Overall Study|Lack of Efficacy|5|||
130355454|NCT00667420|469273365|FG000|Overall Study|Physician Decision|1|||
130355455|NCT00667420|469273365|FG000|Overall Study|Withdrawal by Subject|2|||
130355456|NCT02961218|469273366|FG000|Overall Study|Lost to Follow-up|0|||
130355457|NCT02961218|469273367|FG001|Overall Study|Lost to Follow-up|2|||
130355458|NCT02961218|469273366|FG000|Overall Study|Physician Decision|0|||
130355459|NCT02961218|469273367|FG001|Overall Study|Physician Decision|2|||
130355460|NCT02961218|469273366|FG000|Overall Study|Subject/Guardian Decision|3|||
130355461|NCT02961218|469273367|FG001|Overall Study|Subject/Guardian Decision|1|||
130355462|NCT00591266|469273370|FG000|Overall Study|Adverse Event|2|||
130355463|NCT00591266|469273371|FG001|Overall Study|Adverse Event|2|||
130355464|NCT00591266|469273372|FG002|Overall Study|Adverse Event|3|||
130355465|NCT00591266|469273370|FG000|Overall Study|Lost to Follow-up|0|||
130355466|NCT00591266|469273371|FG001|Overall Study|Lost to Follow-up|1|||
130355467|NCT00591266|469273372|FG002|Overall Study|Lost to Follow-up|0|||
130355468|NCT00591266|469273370|FG000|Overall Study|Protocol Violation|0|||
130355469|NCT00591266|469273371|FG001|Overall Study|Protocol Violation|0|||
130355470|NCT00591266|469273372|FG002|Overall Study|Protocol Violation|1|||
130355471|NCT00591266|469273370|FG000|Overall Study|Withdrawal by Subject|6|||
130355472|NCT00591266|469273371|FG001|Overall Study|Withdrawal by Subject|2|||
130223904|NCT01854697|468784351|FG003|Overall Study|To enter another AbbVie study|0|||
130223905|NCT01854697|468784352|FG004|Overall Study|To enter another AbbVie study|1|||
130355473|NCT00591266|469273372|FG002|Overall Study|Withdrawal by Subject|5|||
130355474|NCT00591266|469273370|FG000|Overall Study|Lack of Efficacy|0|||
130686999|NCT05472038|470481326|FG003|Overall Study|Death|0|||
130687000|NCT05472038|470481327|FG004|Overall Study|Death|0|||
130687001|NCT05472038|470481328|FG005|Overall Study|Death|1|||
130355475|NCT00591266|469273371|FG001|Overall Study|Lack of Efficacy|2|||
130355476|NCT00591266|469273372|FG002|Overall Study|Lack of Efficacy|0|||
130442673|NCT04827134|469584360|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130687002|NCT05472038|470481329|FG006|Overall Study|Death|0|||
130687003|NCT05472038|470481330|FG007|Overall Study|Death|0|||
130687004|NCT05472038|470481331|FG008|Overall Study|Death|0|||
130223906|NCT01854697|468784348|FG000|Overall Study|Withdrew Consent|0|||
130355477|NCT00591266|469273370|FG000|Overall Study|Other|1|||
130355478|NCT00591266|469273371|FG001|Overall Study|Other|4|||
130355479|NCT00591266|469273372|FG002|Overall Study|Other|5|||
130687005|NCT05472038|470481332|FG009|Overall Study|Death|0|||
130223907|NCT01854697|468784349|FG001|Overall Study|Withdrew Consent|1|||
130223908|NCT01854697|468784350|FG002|Overall Study|Withdrew Consent|0|||
130223909|NCT01854697|468784351|FG003|Overall Study|Withdrew Consent|1|||
130223910|NCT01854697|468784352|FG004|Overall Study|Withdrew Consent|0|||
130223911|NCT01854697|468784348|FG000|Overall Study|Other|0|||
130223912|NCT01854697|468784349|FG001|Overall Study|Other|1|||
130223913|NCT01854697|468784350|FG002|Overall Study|Other|1|||
130223914|NCT01854697|468784351|FG003|Overall Study|Other|0|||
130223915|NCT01854697|468784352|FG004|Overall Study|Other|0|||
130223916|NCT00115778|468784356|FG000|Overall Study|Withdrawal by Subject|0|||
130223917|NCT00115778|468784357|FG001|Overall Study|Withdrawal by Subject|1|||
130223918|NCT00528424|468784360|FG000|Overall Study|Lost to Follow-up|13|||
130223919|NCT00528424|468784360|FG000|Overall Study|Withdrew consent|2|||
130223920|NCT00528424|468784360|FG000|Overall Study|Administrative reason|2|||
130223921|NCT00528424|468784360|FG000|Overall Study|Other|12|||
130223922|NCT02515630|468784361|FG000|Overall Study|Withdrawal by Subject|5|||
130223923|NCT02515630|468784361|FG000|Overall Study|Adverse Event|4|||
130223924|NCT02515630|468784361|FG000|Overall Study|Physician Decision|4|||
130223925|NCT02515630|468784361|FG000|Overall Study|Death|2|||
130223926|NCT02515630|468784361|FG000|Overall Study|Disease Progression|1|||
130223927|NCT00483652|468784362|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130223928|NCT00483652|468784363|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130223929|NCT00483652|468784362|FG000|Double-blind Treatment Period|Adverse Event|3|||
130223930|NCT00483652|468784363|FG001|Double-blind Treatment Period|Adverse Event|4|||
130223931|NCT00483652|468784362|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
130223932|NCT00483652|468784363|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
130223933|NCT00483652|468784362|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
130223934|NCT00483652|468784363|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
130223935|NCT00468585|468784364|FG000|Overall Study|Patient not treated|1|||
130223936|NCT00468585|468784365|FG001|Overall Study|Patient not treated|0|||
130223937|NCT00468585|468784366|FG002|Overall Study|Patient not treated|1|||
130223938|NCT00468585|468784367|FG003|Overall Study|Patient not treated|0|||
130223939|NCT00468585|468784364|FG000|Overall Study|Patient found to be ineligible|0|||
130223940|NCT00468585|468784365|FG001|Overall Study|Patient found to be ineligible|0|||
130223941|NCT00468585|468784366|FG002|Overall Study|Patient found to be ineligible|1|||
130223942|NCT00468585|468784367|FG003|Overall Study|Patient found to be ineligible|0|||
130223943|NCT00468585|468784364|FG000|Overall Study|Adverse Event|0|||
130223944|NCT00468585|468784365|FG001|Overall Study|Adverse Event|0|||
130223945|NCT00468585|468784366|FG002|Overall Study|Adverse Event|1|||
130223946|NCT00468585|468784367|FG003|Overall Study|Adverse Event|0|||
130223947|NCT00468585|468784364|FG000|Overall Study|Withdrawal by Subject|0|||
130223948|NCT00468585|468784365|FG001|Overall Study|Withdrawal by Subject|0|||
130223949|NCT00468585|468784366|FG002|Overall Study|Withdrawal by Subject|2|||
130223950|NCT00468585|468784367|FG003|Overall Study|Withdrawal by Subject|1|||
130223951|NCT02154139|468784372|FG000|Overall Study|Injection not administered|2|||
130223952|NCT02154139|468784372|FG000|Overall Study|Other|2|||
130223953|NCT02154139|468784372|FG000|Overall Study|Investigator transferred|3|||
130223954|NCT02087774|468784373|FG000|Overall Study|Were absent day of data collection|8|||
130442674|NCT04827134|469584361|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130442675|NCT04827134|469584362|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
130442676|NCT04827134|469584363|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130442677|NCT00287469|469584367|FG000|Overall Study|serious adverse event|1|||
130442678|NCT00287469|469584368|FG001|Overall Study|serious adverse event|6|||
130442679|NCT00287469|469584367|FG000|Overall Study|Adverse Event|1|||
130442680|NCT00287469|469584368|FG001|Overall Study|Adverse Event|1|||
130442681|NCT00287469|469584367|FG000|Overall Study|moved from area|144|||
130442682|NCT00287469|469584368|FG001|Overall Study|moved from area|138|||
130442683|NCT00287469|469584367|FG000|Overall Study|Lost to Follow-up|74|||
130223955|NCT02087774|468784374|FG001|Overall Study|Were absent day of data collection|20|||
130223956|NCT02157519|468784382|FG000|Overall Study|Death|3|||
130223957|NCT02157519|468784383|FG001|Overall Study|Death|1|||
130223958|NCT02157519|468784382|FG000|Overall Study|Withdrawal by Subject|7|||
130223959|NCT02157519|468784383|FG001|Overall Study|Withdrawal by Subject|0|||
130223960|NCT02157519|468784382|FG000|Overall Study|Lost to Follow-up|1|||
130223961|NCT02157519|468784383|FG001|Overall Study|Lost to Follow-up|0|||
130223962|NCT01656395|468784384|FG000|Overall Study|Adverse Event|1|||
130223963|NCT01656395|468784385|FG001|Overall Study|Adverse Event|14|||
130223964|NCT01656395|468784386|FG002|Overall Study|Adverse Event|5|||
130223965|NCT01656395|468784387|FG003|Overall Study|Adverse Event|4|||
130223966|NCT01656395|468784388|FG004|Overall Study|Adverse Event|5|||
130223967|NCT01656395|468784389|FG005|Overall Study|Adverse Event|7|||
130223968|NCT01656395|468784390|FG006|Overall Study|Adverse Event|0|||
130223969|NCT01656395|468784391|FG007|Overall Study|Adverse Event|0|||
130223970|NCT01656395|468784384|FG000|Overall Study|Lack of Efficacy|1|||
130223971|NCT01656395|468784385|FG001|Overall Study|Lack of Efficacy|8|||
130223972|NCT01656395|468784386|FG002|Overall Study|Lack of Efficacy|6|||
130442684|NCT00287469|469584368|FG001|Overall Study|Lost to Follow-up|69|||
130223973|NCT01656395|468784387|FG003|Overall Study|Lack of Efficacy|1|||
130223974|NCT01656395|468784388|FG004|Overall Study|Lack of Efficacy|1|||
130223975|NCT01656395|468784389|FG005|Overall Study|Lack of Efficacy|6|||
130223976|NCT01656395|468784390|FG006|Overall Study|Lack of Efficacy|0|||
130223977|NCT01656395|468784391|FG007|Overall Study|Lack of Efficacy|0|||
130223978|NCT01656395|468784384|FG000|Overall Study|Lost to Follow-up|1|||
130223979|NCT01656395|468784385|FG001|Overall Study|Lost to Follow-up|0|||
130223980|NCT01656395|468784386|FG002|Overall Study|Lost to Follow-up|0|||
130223981|NCT01656395|468784387|FG003|Overall Study|Lost to Follow-up|0|||
130223982|NCT01656395|468784388|FG004|Overall Study|Lost to Follow-up|0|||
130223983|NCT01656395|468784389|FG005|Overall Study|Lost to Follow-up|0|||
130223984|NCT01656395|468784390|FG006|Overall Study|Lost to Follow-up|0|||
130223985|NCT01656395|468784391|FG007|Overall Study|Lost to Follow-up|0|||
130223986|NCT01656395|468784384|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223987|NCT01656395|468784385|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223988|NCT01656395|468784386|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130223989|NCT01656395|468784387|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130223990|NCT01656395|468784388|FG004|Overall Study|Non-Compliance with Study Drug|1|||
130223991|NCT01656395|468784389|FG005|Overall Study|Non-Compliance with Study Drug|1|||
130223992|NCT01656395|468784390|FG006|Overall Study|Non-Compliance with Study Drug|0|||
130223993|NCT01656395|468784391|FG007|Overall Study|Non-Compliance with Study Drug|0|||
130223994|NCT01656395|468784384|FG000|Overall Study|Other|0|||
130223995|NCT01656395|468784385|FG001|Overall Study|Other|0|||
130223996|NCT01656395|468784386|FG002|Overall Study|Other|1|||
130223997|NCT01656395|468784387|FG003|Overall Study|Other|0|||
130223998|NCT01656395|468784388|FG004|Overall Study|Other|0|||
130223999|NCT01656395|468784389|FG005|Overall Study|Other|1|||
130224000|NCT01656395|468784390|FG006|Overall Study|Other|0|||
130224001|NCT01656395|468784391|FG007|Overall Study|Other|0|||
130355480|NCT03488927|469273373|FG000|Overall Study|Withdrawal by Subject|44|||
130355481|NCT03488927|469273374|FG001|Overall Study|Withdrawal by Subject|118|||
130355482|NCT03488927|469273375|FG002|Overall Study|Withdrawal by Subject|217|||
130355483|NCT00901927|469273378|FG000|Overall Study|Lack of Efficacy|1|||
130355484|NCT00901927|469273378|FG000|Overall Study|Protocol Violation|3|||
130355485|NCT00901927|469273378|FG000|Overall Study|Withdrawal by Subject|2|||
130355486|NCT05298306|469273382|FG000|Overall Study|Physician Decision|0|||
130355487|NCT05298306|469273383|FG001|Overall Study|Physician Decision|0|||
130355488|NCT05298306|469273384|FG002|Overall Study|Physician Decision|0|||
130355489|NCT05298306|469273385|FG003|Overall Study|Physician Decision|1|||
130355490|NCT05298306|469273386|FG004|Overall Study|Physician Decision|0|||
130355491|NCT05298306|469273387|FG005|Overall Study|Physician Decision|0|||
130355492|NCT02676466|469273389|FG000|Overall Study|Death|0|||
130355493|NCT02676466|469273390|FG001|Overall Study|Death|2|||
130355494|NCT02676466|469273391|FG002|Overall Study|Death|1|||
130355495|NCT02676466|469273392|FG003|Overall Study|Death|0|||
130355496|NCT02676466|469273393|FG004|Overall Study|Death|0|||
130355497|NCT02676466|469273394|FG005|Overall Study|Death|0|||
130355498|NCT02676466|469273395|FG006|Overall Study|Death|0|||
130355499|NCT02676466|469273396|FG007|Overall Study|Death|0|||
130355500|NCT02676466|469273389|FG000|Overall Study|Withdrawal by Subject|4|||
130355501|NCT02676466|469273390|FG001|Overall Study|Withdrawal by Subject|3|||
130355502|NCT02676466|469273391|FG002|Overall Study|Withdrawal by Subject|1|||
130355503|NCT02676466|469273392|FG003|Overall Study|Withdrawal by Subject|0|||
130355504|NCT02676466|469273393|FG004|Overall Study|Withdrawal by Subject|3|||
130355505|NCT02676466|469273394|FG005|Overall Study|Withdrawal by Subject|1|||
130355506|NCT02676466|469273395|FG006|Overall Study|Withdrawal by Subject|1|||
130355507|NCT02676466|469273396|FG007|Overall Study|Withdrawal by Subject|1|||
130355508|NCT01178073|469273397|FG000|Overall Study|Adverse Event|34|||
130687006|NCT05472038|470481333|FG010|Overall Study|Death|0|||
130224002|NCT01656395|468784384|FG000|Overall Study|Physician Decision|2|||
130224003|NCT01656395|468784385|FG001|Overall Study|Physician Decision|3|||
130355509|NCT01178073|469273398|FG001|Overall Study|Adverse Event|27|||
130355510|NCT01178073|469273399|FG002|Overall Study|Adverse Event|24|||
130355511|NCT01178073|469273397|FG000|Overall Study|Protocol Violation|1|||
130355512|NCT01178073|469273398|FG001|Overall Study|Protocol Violation|1|||
130355513|NCT01178073|469273399|FG002|Overall Study|Protocol Violation|1|||
130552857|NCT01290601|469991596|FG000|Overall Study|Lack of Efficacy|2|||
130355514|NCT01178073|469273397|FG000|Overall Study|Lost to Follow-up|2|||
130224004|NCT01656395|468784386|FG002|Overall Study|Physician Decision|3|||
130224005|NCT01656395|468784387|FG003|Overall Study|Physician Decision|2|||
130224006|NCT01656395|468784388|FG004|Overall Study|Physician Decision|3|||
130224007|NCT01656395|468784389|FG005|Overall Study|Physician Decision|3|||
130224008|NCT01656395|468784390|FG006|Overall Study|Physician Decision|0|||
130355515|NCT01178073|469273398|FG001|Overall Study|Lost to Follow-up|0|||
130355516|NCT01178073|469273399|FG002|Overall Study|Lost to Follow-up|3|||
130224009|NCT01656395|468784391|FG007|Overall Study|Physician Decision|0|||
130224010|NCT01656395|468784384|FG000|Overall Study|Pregnancy|0|||
130355517|NCT01178073|469273397|FG000|Overall Study|Physician Decision|14|||
130355518|NCT01178073|469273398|FG001|Overall Study|Physician Decision|10|||
130355519|NCT01178073|469273399|FG002|Overall Study|Physician Decision|10|||
130224011|NCT01656395|468784385|FG001|Overall Study|Pregnancy|0|||
130224012|NCT01656395|468784386|FG002|Overall Study|Pregnancy|1|||
130224013|NCT01656395|468784387|FG003|Overall Study|Pregnancy|0|||
130224014|NCT01656395|468784388|FG004|Overall Study|Pregnancy|0|||
130224015|NCT01656395|468784389|FG005|Overall Study|Pregnancy|0|||
130224016|NCT01656395|468784390|FG006|Overall Study|Pregnancy|0|||
130224017|NCT01656395|468784391|FG007|Overall Study|Pregnancy|0|||
130224018|NCT01656395|468784384|FG000|Overall Study|Progressive Disease|0|||
130224019|NCT01656395|468784385|FG001|Overall Study|Progressive Disease|0|||
130224020|NCT01656395|468784386|FG002|Overall Study|Progressive Disease|0|||
130224021|NCT01656395|468784387|FG003|Overall Study|Progressive Disease|0|||
130224022|NCT01656395|468784388|FG004|Overall Study|Progressive Disease|0|||
130224023|NCT01656395|468784389|FG005|Overall Study|Progressive Disease|1|||
130224024|NCT01656395|468784390|FG006|Overall Study|Progressive Disease|0|||
130687007|NCT05472038|470481334|FG011|Overall Study|Death|0|||
130687008|NCT05472038|470481323|FG000|Overall Study|Lost to Follow-up|1|||
130224025|NCT01656395|468784391|FG007|Overall Study|Progressive Disease|0|||
130355520|NCT01178073|469273397|FG000|Overall Study|Withdrawal by Subject|10|||
130355521|NCT01178073|469273398|FG001|Overall Study|Withdrawal by Subject|6|||
130355522|NCT01178073|469273399|FG002|Overall Study|Withdrawal by Subject|8|||
130355523|NCT01178073|469273397|FG000|Overall Study|Missing Completion Status|1|||
130355524|NCT01178073|469273398|FG001|Overall Study|Missing Completion Status|0|||
130355525|NCT01178073|469273399|FG002|Overall Study|Missing Completion Status|0|||
130355526|NCT01721070|469273402|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
130355527|NCT03497676|469273403|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
130355528|NCT03497676|469273404|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
130355529|NCT03497676|469273405|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
130355530|NCT03497676|469273406|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
130355531|NCT03497676|469273403|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
130355532|NCT03497676|469273404|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
130355533|NCT03497676|469273405|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
130355534|NCT03497676|469273406|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
130355535|NCT03497676|469273403|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
130355536|NCT03497676|469273404|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
130355537|NCT03497676|469273405|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
130355538|NCT03497676|469273406|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
130355539|NCT03497676|469273403|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130355540|NCT03497676|469273404|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
130355541|NCT03497676|469273405|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130355542|NCT03497676|469273406|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130355543|NCT03497676|469273403|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130355544|NCT03497676|469273404|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130355545|NCT03497676|469273405|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
130355546|NCT03497676|469273406|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130355547|NCT03497676|469273403|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130355548|NCT03497676|469273404|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130355549|NCT03497676|469273405|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
130355550|NCT03497676|469273406|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130355551|NCT03497676|469273403|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130355552|NCT03497676|469273404|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130355553|NCT03497676|469273405|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
130355554|NCT03497676|469273406|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130355555|NCT03497676|469273403|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130355556|NCT03497676|469273404|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130355557|NCT03497676|469273405|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
130355558|NCT03497676|469273406|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130355559|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
130355560|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
130355561|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
130355562|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
130355563|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130355564|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
130442685|NCT00507026|469584374|FG000|Overall Study|Lack of Efficacy|6|||
130687009|NCT05472038|470481324|FG001|Overall Study|Lost to Follow-up|3|||
130224026|NCT01656395|468784384|FG000|Overall Study|Protocol Violation|6|||
130224027|NCT01656395|468784385|FG001|Overall Study|Protocol Violation|6|||
130224028|NCT01656395|468784386|FG002|Overall Study|Protocol Violation|9|||
130224029|NCT01656395|468784387|FG003|Overall Study|Protocol Violation|2|||
130224030|NCT01656395|468784388|FG004|Overall Study|Protocol Violation|4|||
130224031|NCT01656395|468784389|FG005|Overall Study|Protocol Violation|10|||
130442686|NCT00507026|469584375|FG001|Overall Study|Lack of Efficacy|4|||
130442687|NCT00507026|469584376|FG002|Overall Study|Lack of Efficacy|21|||
130442688|NCT00507026|469584374|FG000|Overall Study|Withdrawal by Subject|2|||
130442689|NCT00507026|469584375|FG001|Overall Study|Withdrawal by Subject|0|||
130442690|NCT00507026|469584376|FG002|Overall Study|Withdrawal by Subject|0|||
130442691|NCT00507026|469584374|FG000|Overall Study|Investigator Decision|1|||
130442692|NCT00507026|469584375|FG001|Overall Study|Investigator Decision|0|||
130442693|NCT00507026|469584376|FG002|Overall Study|Investigator Decision|0|||
130442694|NCT00507026|469584374|FG000|Overall Study|Adverse Event|2|||
130442695|NCT00507026|469584375|FG001|Overall Study|Adverse Event|0|||
130442696|NCT00507026|469584376|FG002|Overall Study|Adverse Event|0|||
130442697|NCT00507026|469584374|FG000|Overall Study|Protocol Violation|1|||
130442698|NCT00507026|469584375|FG001|Overall Study|Protocol Violation|0|||
130442699|NCT00507026|469584376|FG002|Overall Study|Protocol Violation|0|||
130442700|NCT00507026|469584374|FG000|Overall Study|Other|1|||
130442701|NCT00507026|469584375|FG001|Overall Study|Other|0|||
130442702|NCT00507026|469584376|FG002|Overall Study|Other|0|||
130442703|NCT02372058|469584377|FG000|Overall Study|Withdrawal by Subject|3|||
130442704|NCT03523871|469584380|FG000|Overall Study|Death|1|||
130442705|NCT00972179|469584382|FG000|Overall Study|Noncompliance|1|||
130442706|NCT00972179|469584383|FG001|Overall Study|Noncompliance|0|||
130442707|NCT00972179|469584384|FG002|Overall Study|Noncompliance|0|||
130442708|NCT00972179|469584385|FG003|Overall Study|Noncompliance|0|||
130442709|NCT00972179|469584386|FG004|Overall Study|Noncompliance|1|||
130442710|NCT00972179|469584387|FG005|Overall Study|Noncompliance|0|||
130442711|NCT00972179|469584388|FG006|Overall Study|Noncompliance|1|||
130442712|NCT00972179|469584382|FG000|Overall Study|Withdrawal by Subject|0|||
130442713|NCT00972179|469584383|FG001|Overall Study|Withdrawal by Subject|3|||
130442714|NCT00972179|469584384|FG002|Overall Study|Withdrawal by Subject|0|||
130442715|NCT00972179|469584385|FG003|Overall Study|Withdrawal by Subject|1|||
130442716|NCT00972179|469584386|FG004|Overall Study|Withdrawal by Subject|0|||
130442717|NCT00972179|469584387|FG005|Overall Study|Withdrawal by Subject|0|||
130442718|NCT00972179|469584388|FG006|Overall Study|Withdrawal by Subject|2|||
130442719|NCT00972179|469584382|FG000|Overall Study|Administrative Decision|0|||
130442720|NCT00972179|469584383|FG001|Overall Study|Administrative Decision|0|||
130442721|NCT00972179|469584384|FG002|Overall Study|Administrative Decision|0|||
130442722|NCT00972179|469584385|FG003|Overall Study|Administrative Decision|0|||
130442723|NCT00972179|469584386|FG004|Overall Study|Administrative Decision|1|||
130442724|NCT00972179|469584387|FG005|Overall Study|Administrative Decision|0|||
130442725|NCT00972179|469584388|FG006|Overall Study|Administrative Decision|0|||
130442726|NCT00972179|469584382|FG000|Overall Study|Lost to Follow-up|0|||
130442727|NCT00972179|469584383|FG001|Overall Study|Lost to Follow-up|0|||
130442728|NCT00972179|469584384|FG002|Overall Study|Lost to Follow-up|1|||
130442729|NCT00972179|469584385|FG003|Overall Study|Lost to Follow-up|0|||
130442730|NCT00972179|469584386|FG004|Overall Study|Lost to Follow-up|0|||
130442731|NCT00972179|469584387|FG005|Overall Study|Lost to Follow-up|3|||
130442732|NCT00972179|469584388|FG006|Overall Study|Lost to Follow-up|1|||
130442733|NCT01994720|469584389|FG000|Overall Study|Withdrawal by Subject|46|||
130442734|NCT01994720|469584390|FG001|Overall Study|Withdrawal by Subject|56|||
130442735|NCT04285229|469584392|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130442736|NCT04285229|469584393|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130442737|NCT04285229|469584394|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130442738|NCT04285229|469584395|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130442739|NCT04285229|469584396|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130442740|NCT04285229|469584397|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130442741|NCT04285229|469584392|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
130442742|NCT04285229|469584393|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
130442743|NCT04285229|469584394|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
130442744|NCT04285229|469584395|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
130442745|NCT04285229|469584396|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
130442746|NCT04285229|469584397|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
130442747|NCT04285229|469584392|FG000|Extended Treatment Period|Adverse Event|0|||
130442748|NCT04285229|469584393|FG001|Extended Treatment Period|Adverse Event|0|||
130442749|NCT04285229|469584394|FG002|Extended Treatment Period|Adverse Event|0|||
130442750|NCT04285229|469584395|FG003|Extended Treatment Period|Adverse Event|1|||
130442751|NCT04285229|469584396|FG004|Extended Treatment Period|Adverse Event|0|||
130442752|NCT04285229|469584397|FG005|Extended Treatment Period|Adverse Event|0|||
130442753|NCT04285229|469584392|FG000|Extended Treatment Period|Physician Decision|0|||
130442754|NCT04285229|469584393|FG001|Extended Treatment Period|Physician Decision|0|||
130442755|NCT04285229|469584394|FG002|Extended Treatment Period|Physician Decision|1|||
130442756|NCT04285229|469584395|FG003|Extended Treatment Period|Physician Decision|0|||
130442757|NCT04285229|469584396|FG004|Extended Treatment Period|Physician Decision|0|||
130442758|NCT04285229|469584397|FG005|Extended Treatment Period|Physician Decision|0|||
130442759|NCT04285229|469584392|FG000|Follow-up Period|Adverse Event|0|||
130442760|NCT04285229|469584393|FG001|Follow-up Period|Adverse Event|0|||
130442761|NCT04285229|469584394|FG002|Follow-up Period|Adverse Event|0|||
130224032|NCT01656395|468784390|FG006|Overall Study|Protocol Violation|0|||
130224033|NCT01656395|468784391|FG007|Overall Study|Protocol Violation|0|||
130224034|NCT01656395|468784384|FG000|Overall Study|Screen Failure|2|||
130224035|NCT01656395|468784385|FG001|Overall Study|Screen Failure|1|||
130224036|NCT01656395|468784386|FG002|Overall Study|Screen Failure|7|||
130224037|NCT01656395|468784387|FG003|Overall Study|Screen Failure|1|||
130224038|NCT01656395|468784388|FG004|Overall Study|Screen Failure|0|||
130224039|NCT01656395|468784389|FG005|Overall Study|Screen Failure|8|||
130224040|NCT01656395|468784390|FG006|Overall Study|Screen Failure|0|||
130224041|NCT01656395|468784391|FG007|Overall Study|Screen Failure|0|||
130224042|NCT01656395|468784384|FG000|Overall Study|Withdrawal by Subject|3|||
130224043|NCT01656395|468784385|FG001|Overall Study|Withdrawal by Subject|1|||
130224044|NCT01656395|468784386|FG002|Overall Study|Withdrawal by Subject|4|||
130224045|NCT01656395|468784387|FG003|Overall Study|Withdrawal by Subject|2|||
130224046|NCT01656395|468784388|FG004|Overall Study|Withdrawal by Subject|0|||
130224047|NCT01656395|468784389|FG005|Overall Study|Withdrawal by Subject|3|||
130224048|NCT01656395|468784390|FG006|Overall Study|Withdrawal by Subject|0|||
130224049|NCT01656395|468784391|FG007|Overall Study|Withdrawal by Subject|0|||
130224050|NCT03075267|468784392|FG000|Overall Study|Protocol Violation|1|||
130224051|NCT03075267|468784393|FG001|Overall Study|Protocol Violation|0|||
130224052|NCT03075267|468784394|FG002|Overall Study|Protocol Violation|0|||
130224053|NCT00676403|468784395|FG000|Overall Study|Adverse Event|1|||
130224054|NCT00676403|468784396|FG001|Overall Study|Adverse Event|2|||
130224055|NCT00676403|468784397|FG002|Overall Study|Adverse Event|0|||
130224056|NCT00676403|468784398|FG003|Overall Study|Adverse Event|5|||
130224057|NCT00676403|468784399|FG004|Overall Study|Adverse Event|1|||
130224058|NCT00676403|468784400|FG005|Overall Study|Adverse Event|2|||
130224059|NCT00676403|468784395|FG000|Overall Study|Lost to Follow-up|0|||
130224060|NCT00676403|468784396|FG001|Overall Study|Lost to Follow-up|0|||
130224061|NCT00676403|468784397|FG002|Overall Study|Lost to Follow-up|0|||
130224062|NCT00676403|468784398|FG003|Overall Study|Lost to Follow-up|0|||
130224063|NCT00676403|468784399|FG004|Overall Study|Lost to Follow-up|0|||
130224064|NCT00676403|468784400|FG005|Overall Study|Lost to Follow-up|1|||
130224065|NCT00676403|468784395|FG000|Overall Study|Reason Unspecified|1|||
130224066|NCT00676403|468784396|FG001|Overall Study|Reason Unspecified|0|||
130224067|NCT00676403|468784397|FG002|Overall Study|Reason Unspecified|1|||
130224068|NCT00676403|468784398|FG003|Overall Study|Reason Unspecified|0|||
130224069|NCT00676403|468784399|FG004|Overall Study|Reason Unspecified|0|||
130224070|NCT00676403|468784400|FG005|Overall Study|Reason Unspecified|1|||
130224071|NCT00676403|468784395|FG000|Overall Study|Withdrawal by Subject|0|||
130224072|NCT00676403|468784396|FG001|Overall Study|Withdrawal by Subject|0|||
130224073|NCT00676403|468784397|FG002|Overall Study|Withdrawal by Subject|0|||
130224074|NCT00676403|468784398|FG003|Overall Study|Withdrawal by Subject|0|||
130224075|NCT00676403|468784399|FG004|Overall Study|Withdrawal by Subject|0|||
130224076|NCT00676403|468784400|FG005|Overall Study|Withdrawal by Subject|1|||
130224077|NCT01746862|468784404|FG000|Overall Study|Withdrawal by Subject|1|||
130224078|NCT01746862|468784405|FG001|Overall Study|Withdrawal by Subject|1|||
130224079|NCT01746862|468784404|FG000|Overall Study|Protocol Violation|1|||
130224080|NCT01746862|468784405|FG001|Overall Study|Protocol Violation|0|||
130224081|NCT01746862|468784404|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
130224082|NCT01746862|468784405|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
130224083|NCT01746862|468784404|FG000|Overall Study|Entered puberty during the study|1|||
130355565|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130355566|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130355567|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
130355568|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130355569|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130355570|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130355571|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
130355572|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
130355573|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
130355574|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
130355575|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130355576|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
130355577|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130224084|NCT01746862|468784405|FG001|Overall Study|Entered puberty during the study|0|||
130224085|NCT04742673|468784406|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
130224086|NCT04742673|468784407|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
130224087|NCT06058390|468784409|FG000|Overall Study|Lost to Follow-up|0|||
130224088|NCT06058390|468784410|FG001|Overall Study|Lost to Follow-up|0|||
130224089|NCT06058390|468784411|FG002|Overall Study|Lost to Follow-up|2|||
130224090|NCT06058390|468784412|FG003|Overall Study|Lost to Follow-up|1|||
130224091|NCT06058390|468784409|FG000|Overall Study|Physician Decision|0|||
130224092|NCT06058390|468784410|FG001|Overall Study|Physician Decision|0|||
130224093|NCT06058390|468784411|FG002|Overall Study|Physician Decision|0|||
130224094|NCT06058390|468784412|FG003|Overall Study|Physician Decision|1|||
130224095|NCT06058390|468784409|FG000|Overall Study|Participants did not receive any study intervention|0|||
130224096|NCT06058390|468784410|FG001|Overall Study|Participants did not receive any study intervention|0|||
130224097|NCT06058390|468784411|FG002|Overall Study|Participants did not receive any study intervention|0|||
130224098|NCT06058390|468784412|FG003|Overall Study|Participants did not receive any study intervention|1|||
130224099|NCT03361306|468784413|FG000|Overall Study|Death|6|||
130224100|NCT04073303|468784414|FG000|Overall Study|Adverse Event|0|||
130442762|NCT04285229|469584395|FG003|Follow-up Period|Adverse Event|0|||
130442763|NCT04285229|469584396|FG004|Follow-up Period|Adverse Event|1|||
130442764|NCT04285229|469584397|FG005|Follow-up Period|Adverse Event|4|||
130442765|NCT04285229|469584392|FG000|Follow-up Period|Withdrawal by Subject|0|||
130224101|NCT04073303|468784415|FG001|Overall Study|Adverse Event|2|||
130224102|NCT04073303|468784414|FG000|Overall Study|Withdrawal by Subject|16|||
130224103|NCT04073303|468784415|FG001|Overall Study|Withdrawal by Subject|36|||
130224104|NCT04073303|468784414|FG000|Overall Study|Lost to Follow-up|6|||
130224105|NCT04073303|468784415|FG001|Overall Study|Lost to Follow-up|1|||
130224106|NCT04073303|468784414|FG000|Overall Study|Protocol Deviation|0|||
130224107|NCT04073303|468784415|FG001|Overall Study|Protocol Deviation|4|||
130224108|NCT04073303|468784414|FG000|Overall Study|Other|1|||
130224109|NCT04073303|468784415|FG001|Overall Study|Other|1|||
130224110|NCT03589807|468784423|FG000|Overall Study|Lost to Follow-up|0|||
130224111|NCT03589807|468784424|FG001|Overall Study|Lost to Follow-up|2|||
130224112|NCT03589807|468784425|FG002|Overall Study|Lost to Follow-up|2|||
130224113|NCT03589807|468784426|FG003|Overall Study|Lost to Follow-up|3|||
130224114|NCT03589807|468784427|FG004|Overall Study|Lost to Follow-up|1|||
130224115|NCT03589807|468784428|FG005|Overall Study|Lost to Follow-up|1|||
130442766|NCT04285229|469584393|FG001|Follow-up Period|Withdrawal by Subject|0|||
130224116|NCT03589807|468784423|FG000|Overall Study|Withdrawal by Subject|0|||
130224117|NCT03589807|468784424|FG001|Overall Study|Withdrawal by Subject|5|||
130224118|NCT03589807|468784425|FG002|Overall Study|Withdrawal by Subject|0|||
130224119|NCT03589807|468784426|FG003|Overall Study|Withdrawal by Subject|0|||
130224120|NCT03589807|468784427|FG004|Overall Study|Withdrawal by Subject|0|||
130224121|NCT03589807|468784428|FG005|Overall Study|Withdrawal by Subject|0|||
130224122|NCT03589807|468784423|FG000|Overall Study|Protocol Violation|0|||
130224123|NCT03589807|468784424|FG001|Overall Study|Protocol Violation|0|||
130224124|NCT03589807|468784425|FG002|Overall Study|Protocol Violation|0|||
130224125|NCT03589807|468784426|FG003|Overall Study|Protocol Violation|1|||
130224126|NCT03589807|468784427|FG004|Overall Study|Protocol Violation|0|||
130224127|NCT03589807|468784428|FG005|Overall Study|Protocol Violation|0|||
130224128|NCT03589807|468784423|FG000|Overall Study|Enrolled but treatment not administered|0|||
130224129|NCT03589807|468784424|FG001|Overall Study|Enrolled but treatment not administered|0|||
130224130|NCT03589807|468784425|FG002|Overall Study|Enrolled but treatment not administered|0|||
130442767|NCT04285229|469584394|FG002|Follow-up Period|Withdrawal by Subject|0|||
130442768|NCT04285229|469584395|FG003|Follow-up Period|Withdrawal by Subject|0|||
130442769|NCT04285229|469584396|FG004|Follow-up Period|Withdrawal by Subject|0|||
130442770|NCT04285229|469584397|FG005|Follow-up Period|Withdrawal by Subject|5|||
130442771|NCT04285229|469584392|FG000|Follow-up Period|Covid-19|0|||
130442772|NCT04285229|469584393|FG001|Follow-up Period|Covid-19|0|||
130442773|NCT04285229|469584394|FG002|Follow-up Period|Covid-19|0|||
130442774|NCT04285229|469584395|FG003|Follow-up Period|Covid-19|0|||
130442775|NCT04285229|469584396|FG004|Follow-up Period|Covid-19|0|||
130442776|NCT04285229|469584397|FG005|Follow-up Period|Covid-19|2|||
130442777|NCT04285229|469584392|FG000|Follow-up Period|Physician Decision|0|||
130442778|NCT04285229|469584393|FG001|Follow-up Period|Physician Decision|0|||
130442779|NCT04285229|469584394|FG002|Follow-up Period|Physician Decision|0|||
130442780|NCT04285229|469584395|FG003|Follow-up Period|Physician Decision|0|||
130442781|NCT04285229|469584396|FG004|Follow-up Period|Physician Decision|0|||
130442782|NCT04285229|469584397|FG005|Follow-up Period|Physician Decision|1|||
130442783|NCT02061761|469584398|FG000|Overall Study|Disease progression|2|||
130442784|NCT02061761|469584399|FG001|Overall Study|Disease progression|8|||
130442785|NCT02061761|469584400|FG002|Overall Study|Disease progression|4|||
130442786|NCT02061761|469584401|FG003|Overall Study|Disease progression|5|||
130442787|NCT02061761|469584402|FG004|Overall Study|Disease progression|9|||
130687010|NCT05472038|470481325|FG002|Overall Study|Lost to Follow-up|3|||
130224131|NCT03589807|468784426|FG003|Overall Study|Enrolled but treatment not administered|0|||
130224132|NCT03589807|468784427|FG004|Overall Study|Enrolled but treatment not administered|1|||
130224133|NCT03589807|468784428|FG005|Overall Study|Enrolled but treatment not administered|0|||
130687011|NCT05472038|470481326|FG003|Overall Study|Lost to Follow-up|9|||
130442788|NCT02061761|469584403|FG005|Overall Study|Disease progression|3|||
130442789|NCT02061761|469584404|FG006|Overall Study|Disease progression|1|||
130442790|NCT02061761|469584405|FG007|Overall Study|Disease progression|2|||
130224134|NCT00810069|468784429|FG000|Lead-in Period I|Adverse Event|43|||
130224135|NCT00810069|468784430|FG001|Lead-in Period I|Adverse Event|0|||
130224136|NCT00810069|468784431|FG002|Lead-in Period I|Adverse Event|0|||
130224137|NCT00810069|468784429|FG000|Lead-in Period I|Lack of Efficacy|1|||
130224138|NCT00810069|468784430|FG001|Lead-in Period I|Lack of Efficacy|0|||
130442791|NCT02061761|469584406|FG008|Overall Study|Disease progression|28|||
130687012|NCT05472038|470481327|FG004|Overall Study|Lost to Follow-up|2|||
130224139|NCT00810069|468784431|FG002|Lead-in Period I|Lack of Efficacy|0|||
130224140|NCT00810069|468784429|FG000|Lead-in Period I|Lost to Follow-up|19|||
130224141|NCT00810069|468784430|FG001|Lead-in Period I|Lost to Follow-up|0|||
130224142|NCT00810069|468784431|FG002|Lead-in Period I|Lost to Follow-up|0|||
130224143|NCT00810069|468784429|FG000|Lead-in Period I|Physician Decision|1|||
130224144|NCT00810069|468784430|FG001|Lead-in Period I|Physician Decision|0|||
130224145|NCT00810069|468784431|FG002|Lead-in Period I|Physician Decision|0|||
130224146|NCT00810069|468784429|FG000|Lead-in Period I|Protocol Violation|1|||
130224147|NCT00810069|468784430|FG001|Lead-in Period I|Protocol Violation|0|||
130224148|NCT00810069|468784431|FG002|Lead-in Period I|Protocol Violation|0|||
130224149|NCT00810069|468784429|FG000|Lead-in Period I|Withdrawal by Subject|46|||
130224150|NCT00810069|468784430|FG001|Lead-in Period I|Withdrawal by Subject|0|||
130224151|NCT00810069|468784431|FG002|Lead-in Period I|Withdrawal by Subject|0|||
130224152|NCT00810069|468784429|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
130224153|NCT00810069|468784430|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
130224154|NCT00810069|468784431|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
130224155|NCT00810069|468784429|FG000|Lead-in Period I|Randomization criteria not met|158|||
130224156|NCT00810069|468784430|FG001|Lead-in Period I|Randomization criteria not met|0|||
130442792|NCT02061761|469584398|FG000|Overall Study|Study Drug toxicity|0|||
130442793|NCT02061761|469584399|FG001|Overall Study|Study Drug toxicity|0|||
130442794|NCT02061761|469584400|FG002|Overall Study|Study Drug toxicity|0|||
130442795|NCT02061761|469584401|FG003|Overall Study|Study Drug toxicity|0|||
130442796|NCT02061761|469584402|FG004|Overall Study|Study Drug toxicity|0|||
130442797|NCT02061761|469584403|FG005|Overall Study|Study Drug toxicity|1|||
130442798|NCT02061761|469584404|FG006|Overall Study|Study Drug toxicity|0|||
130442799|NCT02061761|469584405|FG007|Overall Study|Study Drug toxicity|2|||
130442800|NCT02061761|469584406|FG008|Overall Study|Study Drug toxicity|6|||
130442801|NCT02061761|469584398|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
130442802|NCT02061761|469584399|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
130442803|NCT02061761|469584400|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
130224157|NCT00810069|468784431|FG002|Lead-in Period I|Randomization criteria not met|0|||
130224158|NCT00810069|468784429|FG000|Double-Blind Period II|Adverse Event|0|||
130224159|NCT00810069|468784430|FG001|Double-Blind Period II|Adverse Event|9|||
130224160|NCT00810069|468784431|FG002|Double-Blind Period II|Adverse Event|8|||
130224161|NCT00810069|468784429|FG000|Double-Blind Period II|Lack of Efficacy|0|||
130224162|NCT00810069|468784430|FG001|Double-Blind Period II|Lack of Efficacy|7|||
130224163|NCT00810069|468784431|FG002|Double-Blind Period II|Lack of Efficacy|12|||
130442804|NCT02061761|469584401|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
130442805|NCT02061761|469584402|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
130442806|NCT02061761|469584403|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
130442807|NCT02061761|469584404|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
130442808|NCT02061761|469584405|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
130442809|NCT02061761|469584406|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
130224164|NCT00810069|468784429|FG000|Double-Blind Period II|Lost to Follow-up|0|||
130224165|NCT00810069|468784430|FG001|Double-Blind Period II|Lost to Follow-up|9|||
130224166|NCT00810069|468784431|FG002|Double-Blind Period II|Lost to Follow-up|9|||
130224167|NCT00810069|468784429|FG000|Double-Blind Period II|Physician Decision|0|||
130224168|NCT00810069|468784430|FG001|Double-Blind Period II|Physician Decision|0|||
130224169|NCT00810069|468784431|FG002|Double-Blind Period II|Physician Decision|1|||
130224170|NCT00810069|468784429|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
130224171|NCT00810069|468784430|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
130224172|NCT00810069|468784431|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
130224173|NCT00810069|468784429|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
130224174|NCT00810069|468784430|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
130224175|NCT00810069|468784431|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
130224176|NCT00810069|468784429|FG000|Double-Blind Period II|Clinical relapse|0|||
130224177|NCT00810069|468784430|FG001|Double-Blind Period II|Clinical relapse|3|||
130224178|NCT00810069|468784431|FG002|Double-Blind Period II|Clinical relapse|0|||
130224179|NCT00810069|468784429|FG000|Double-Blind Period II|Protocol Violation|0|||
130224180|NCT00810069|468784430|FG001|Double-Blind Period II|Protocol Violation|7|||
130224181|NCT00810069|468784431|FG002|Double-Blind Period II|Protocol Violation|6|||
130442810|NCT02061761|469584398|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130442811|NCT02061761|469584399|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130442812|NCT02061761|469584400|FG002|Overall Study|Participant request to discontinue study treatment|2|||
130552858|NCT01290601|469991597|FG001|Overall Study|Lack of Efficacy|1|||
130687013|NCT05472038|470481328|FG005|Overall Study|Lost to Follow-up|2|||
130224182|NCT04767373|468784434|FG000|Overall Study|Death|6|||
130224183|NCT04767373|468784435|FG001|Overall Study|Death|3|||
130224184|NCT04767373|468784434|FG000|Overall Study|Lost to Follow-up|67|||
130687014|NCT05472038|470481329|FG006|Overall Study|Lost to Follow-up|1|||
130687015|NCT05472038|470481330|FG007|Overall Study|Lost to Follow-up|0|||
130687016|NCT05472038|470481331|FG008|Overall Study|Lost to Follow-up|1|||
130224185|NCT04767373|468784435|FG001|Overall Study|Lost to Follow-up|35|||
130224186|NCT04767373|468784434|FG000|Overall Study|Physician Decision|15|||
130442813|NCT02061761|469584401|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130442814|NCT02061761|469584402|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130442815|NCT02061761|469584403|FG005|Overall Study|Participant request to discontinue study treatment|1|||
130442816|NCT02061761|469584404|FG006|Overall Study|Participant request to discontinue study treatment|0|||
130442817|NCT02061761|469584405|FG007|Overall Study|Participant request to discontinue study treatment|0|||
130442818|NCT02061761|469584406|FG008|Overall Study|Participant request to discontinue study treatment|2|||
130442819|NCT02061761|469584398|FG000|Overall Study|Withdrawal by Subject|0|||
130442820|NCT02061761|469584399|FG001|Overall Study|Withdrawal by Subject|0|||
130442821|NCT02061761|469584400|FG002|Overall Study|Withdrawal by Subject|0|||
130442822|NCT02061761|469584401|FG003|Overall Study|Withdrawal by Subject|0|||
130442823|NCT02061761|469584402|FG004|Overall Study|Withdrawal by Subject|0|||
130442824|NCT02061761|469584403|FG005|Overall Study|Withdrawal by Subject|0|||
130442825|NCT02061761|469584404|FG006|Overall Study|Withdrawal by Subject|0|||
130442826|NCT02061761|469584405|FG007|Overall Study|Withdrawal by Subject|0|||
130442827|NCT02061761|469584406|FG008|Overall Study|Withdrawal by Subject|2|||
130442828|NCT02061761|469584398|FG000|Overall Study|Maximum clinical benefit|0|||
130442829|NCT02061761|469584399|FG001|Overall Study|Maximum clinical benefit|0|||
130442830|NCT02061761|469584400|FG002|Overall Study|Maximum clinical benefit|0|||
130442831|NCT02061761|469584401|FG003|Overall Study|Maximum clinical benefit|1|||
130442832|NCT02061761|469584402|FG004|Overall Study|Maximum clinical benefit|0|||
130224187|NCT04767373|468784435|FG001|Overall Study|Physician Decision|4|||
130224188|NCT04767373|468784434|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130224189|NCT04767373|468784435|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130224190|NCT04767373|468784434|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
130224191|NCT04767373|468784435|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
130224192|NCT04767373|468784434|FG000|Overall Study|Other|1|||
130224193|NCT04767373|468784435|FG001|Overall Study|Other|2|||
130224194|NCT00593918|468784436|FG000|Overall Study|Withdrawal by Subject|5|||
130224195|NCT00593918|468784437|FG001|Overall Study|Withdrawal by Subject|24|||
130224196|NCT02983045|468784438|FG000|Overall Study|Withdrawal by Subject|0|||
130224197|NCT02983045|468784439|FG001|Overall Study|Withdrawal by Subject|1|||
130442833|NCT02061761|469584403|FG005|Overall Study|Maximum clinical benefit|0|||
130442834|NCT02061761|469584404|FG006|Overall Study|Maximum clinical benefit|0|||
130442835|NCT02061761|469584405|FG007|Overall Study|Maximum clinical benefit|0|||
130442836|NCT02061761|469584406|FG008|Overall Study|Maximum clinical benefit|6|||
130442837|NCT02061761|469584398|FG000|Overall Study|Participant no longer meets study criteria|0|||
130442838|NCT02061761|469584399|FG001|Overall Study|Participant no longer meets study criteria|0|||
130442839|NCT02061761|469584400|FG002|Overall Study|Participant no longer meets study criteria|0|||
130442840|NCT02061761|469584401|FG003|Overall Study|Participant no longer meets study criteria|0|||
130442841|NCT02061761|469584402|FG004|Overall Study|Participant no longer meets study criteria|0|||
130442842|NCT02061761|469584403|FG005|Overall Study|Participant no longer meets study criteria|0|||
130442843|NCT02061761|469584404|FG006|Overall Study|Participant no longer meets study criteria|0|||
130442844|NCT02061761|469584405|FG007|Overall Study|Participant no longer meets study criteria|0|||
130442845|NCT02061761|469584406|FG008|Overall Study|Participant no longer meets study criteria|1|||
130442846|NCT02061761|469584398|FG000|Overall Study|Other reasons|0|||
130442847|NCT02061761|469584399|FG001|Overall Study|Other reasons|0|||
130442848|NCT02061761|469584400|FG002|Overall Study|Other reasons|0|||
130442849|NCT02061761|469584401|FG003|Overall Study|Other reasons|0|||
130442850|NCT02061761|469584402|FG004|Overall Study|Other reasons|2|||
130442851|NCT02061761|469584403|FG005|Overall Study|Other reasons|0|||
130442852|NCT02061761|469584404|FG006|Overall Study|Other reasons|0|||
130442853|NCT02061761|469584405|FG007|Overall Study|Other reasons|0|||
130442854|NCT02061761|469584406|FG008|Overall Study|Other reasons|6|||
130442855|NCT03257995|469584408|FG000|Overall Study|Adverse Event|0|||
130442856|NCT03257995|469584409|FG001|Overall Study|Adverse Event|1|||
130687017|NCT05472038|470481332|FG009|Overall Study|Lost to Follow-up|0|||
130442857|NCT03257995|469584410|FG002|Overall Study|Adverse Event|0|||
130442858|NCT03257995|469584411|FG003|Overall Study|Adverse Event|0|||
130442859|NCT03257995|469584412|FG004|Overall Study|Adverse Event|0|||
130442860|NCT03257995|469584413|FG005|Overall Study|Adverse Event|0|||
130442861|NCT03257995|469584408|FG000|Overall Study|Protocol deviation|0|||
130442862|NCT03257995|469584409|FG001|Overall Study|Protocol deviation|0|||
130442863|NCT03257995|469584410|FG002|Overall Study|Protocol deviation|0|||
130442864|NCT03257995|469584411|FG003|Overall Study|Protocol deviation|0|||
130442865|NCT03257995|469584412|FG004|Overall Study|Protocol deviation|0|||
130687018|NCT05472038|470481333|FG010|Overall Study|Lost to Follow-up|2|||
130442866|NCT03257995|469584413|FG005|Overall Study|Protocol deviation|2|||
130442867|NCT02258464|469584415|FG000|Overall Study|Progressive disease (PD)|9|||
130442868|NCT02258464|469584416|FG001|Overall Study|Progressive disease (PD)|17|||
130224198|NCT02983045|468784440|FG002|Overall Study|Withdrawal by Subject|0|||
130224199|NCT02983045|468784441|FG003|Overall Study|Withdrawal by Subject|5|||
130224200|NCT02983045|468784442|FG004|Overall Study|Withdrawal by Subject|0|||
130442869|NCT02258464|469584415|FG000|Overall Study|Study drug never administered|1|||
130687019|NCT05472038|470481334|FG011|Overall Study|Lost to Follow-up|1|||
130442870|NCT02258464|469584416|FG001|Overall Study|Study drug never administered|1|||
130442871|NCT02258464|469584415|FG000|Overall Study|AE not related to clinical PD|1|||
130442872|NCT02258464|469584416|FG001|Overall Study|AE not related to clinical PD|3|||
130442873|NCT02258464|469584415|FG000|Overall Study|Withdrawal by Subject|5|||
130442874|NCT02258464|469584416|FG001|Overall Study|Withdrawal by Subject|4|||
130442875|NCT02258464|469584415|FG000|Overall Study|AE related to clinical PD|1|||
130442876|NCT02258464|469584416|FG001|Overall Study|AE related to clinical PD|0|||
130442877|NCT02138747|469584417|FG000|Treatment Period 1|Adverse Event|10|||
130442878|NCT02138747|469584418|FG001|Treatment Period 1|Adverse Event|14|||
130442879|NCT02138747|469584419|FG002|Treatment Period 1|Adverse Event|2|||
130442880|NCT02138747|469584420|FG003|Treatment Period 1|Adverse Event|1|||
130442881|NCT02138747|469584417|FG000|Treatment Period 1|Lost to Follow-up|0|||
130224201|NCT02983045|468784443|FG005|Overall Study|Withdrawal by Subject|72|||
130224202|NCT02983045|468784444|FG006|Overall Study|Withdrawal by Subject|0|||
130224203|NCT02983045|468784445|FG007|Overall Study|Withdrawal by Subject|0|||
130224204|NCT02983045|468784446|FG008|Overall Study|Withdrawal by Subject|0|||
130224205|NCT02983045|468784447|FG009|Overall Study|Withdrawal by Subject|2|||
130224206|NCT02983045|468784438|FG000|Overall Study|Lost to Follow-up|0|||
130224207|NCT02983045|468784439|FG001|Overall Study|Lost to Follow-up|0|||
130224208|NCT02983045|468784440|FG002|Overall Study|Lost to Follow-up|0|||
130224209|NCT02983045|468784441|FG003|Overall Study|Lost to Follow-up|0|||
130224210|NCT02983045|468784442|FG004|Overall Study|Lost to Follow-up|0|||
130442882|NCT02138747|469584418|FG001|Treatment Period 1|Lost to Follow-up|1|||
130442883|NCT02138747|469584419|FG002|Treatment Period 1|Lost to Follow-up|1|||
130442884|NCT02138747|469584420|FG003|Treatment Period 1|Lost to Follow-up|0|||
130442885|NCT02138747|469584417|FG000|Treatment Period 1|Protocol Violation|0|||
130442886|NCT02138747|469584418|FG001|Treatment Period 1|Protocol Violation|2|||
130442887|NCT02138747|469584419|FG002|Treatment Period 1|Protocol Violation|0|||
130442888|NCT02138747|469584420|FG003|Treatment Period 1|Protocol Violation|0|||
130442889|NCT02138747|469584417|FG000|Treatment Period 1|Withdrawal by Subject|8|||
130442890|NCT02138747|469584418|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130442891|NCT02138747|469584419|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130442892|NCT02138747|469584420|FG003|Treatment Period 1|Withdrawal by Subject|3|||
130442893|NCT02138747|469584417|FG000|Treatment Period 1|Other - Miscellaneous|2|||
130442894|NCT02138747|469584418|FG001|Treatment Period 1|Other - Miscellaneous|4|||
130442895|NCT02138747|469584419|FG002|Treatment Period 1|Other - Miscellaneous|0|||
130442896|NCT02138747|469584420|FG003|Treatment Period 1|Other - Miscellaneous|0|||
130442897|NCT02138747|469584417|FG000|Treatment Period 2|Adverse Event|6|||
130442898|NCT02138747|469584418|FG001|Treatment Period 2|Adverse Event|3|||
130442899|NCT02138747|469584419|FG002|Treatment Period 2|Adverse Event|1|||
130442900|NCT02138747|469584420|FG003|Treatment Period 2|Adverse Event|1|||
130442901|NCT02138747|469584417|FG000|Treatment Period 2|Lost to Follow-up|2|||
130442902|NCT02138747|469584418|FG001|Treatment Period 2|Lost to Follow-up|0|||
130442903|NCT02138747|469584419|FG002|Treatment Period 2|Lost to Follow-up|0|||
130442904|NCT02138747|469584420|FG003|Treatment Period 2|Lost to Follow-up|0|||
130442905|NCT02138747|469584417|FG000|Treatment Period 2|Protocol Violation|1|||
130442906|NCT02138747|469584418|FG001|Treatment Period 2|Protocol Violation|0|||
130442907|NCT02138747|469584419|FG002|Treatment Period 2|Protocol Violation|0|||
130442908|NCT02138747|469584420|FG003|Treatment Period 2|Protocol Violation|0|||
130442909|NCT02138747|469584417|FG000|Treatment Period 2|Withdrawal by Subject|5|||
130442910|NCT02138747|469584418|FG001|Treatment Period 2|Withdrawal by Subject|4|||
130442911|NCT02138747|469584419|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130442912|NCT02138747|469584420|FG003|Treatment Period 2|Withdrawal by Subject|2|||
130442913|NCT02138747|469584417|FG000|Treatment Period 2|Other - Miscellaneous|3|||
130442914|NCT02138747|469584418|FG001|Treatment Period 2|Other - Miscellaneous|0|||
130442915|NCT02138747|469584419|FG002|Treatment Period 2|Other - Miscellaneous|0|||
130442916|NCT02138747|469584420|FG003|Treatment Period 2|Other - Miscellaneous|0|||
130442917|NCT04170296|469584421|FG000|Overall Study|Adverse Event|1|||
130442918|NCT04170296|469584422|FG001|Overall Study|Adverse Event|0|||
130442919|NCT04170296|469584421|FG000|Overall Study|Withdrawal by Subject|3|||
130442920|NCT04170296|469584422|FG001|Overall Study|Withdrawal by Subject|2|||
130442921|NCT04170296|469584421|FG000|Overall Study|Lost to Follow-up|4|||
130442922|NCT04170296|469584422|FG001|Overall Study|Lost to Follow-up|2|||
130442923|NCT00932646|469584423|FG000|Overall Study|Adverse Event|2|||
130442924|NCT00932646|469584424|FG001|Overall Study|Adverse Event|1|||
130442925|NCT00932646|469584425|FG002|Overall Study|Adverse Event|1|||
130442926|NCT00932646|469584426|FG003|Overall Study|Adverse Event|1|||
130442927|NCT00932646|469584423|FG000|Overall Study|Lost to Follow-up|2|||
130442928|NCT00932646|469584424|FG001|Overall Study|Lost to Follow-up|1|||
130442929|NCT00932646|469584425|FG002|Overall Study|Lost to Follow-up|0|||
130442930|NCT00932646|469584426|FG003|Overall Study|Lost to Follow-up|0|||
130224211|NCT02983045|468784443|FG005|Overall Study|Lost to Follow-up|10|||
130224212|NCT02983045|468784444|FG006|Overall Study|Lost to Follow-up|0|||
130442931|NCT00932646|469584423|FG000|Overall Study|Withdrawal by Subject|1|||
130442932|NCT00932646|469584424|FG001|Overall Study|Withdrawal by Subject|1|||
130442933|NCT00932646|469584425|FG002|Overall Study|Withdrawal by Subject|3|||
130224213|NCT02983045|468784445|FG007|Overall Study|Lost to Follow-up|0|||
130442934|NCT00932646|469584426|FG003|Overall Study|Withdrawal by Subject|0|||
130442935|NCT00653263|469584427|FG000|Overall Study|Withdrawal by Subject|1|||
130442936|NCT00653263|469584427|FG000|Overall Study|Physician Decision|1|||
130442937|NCT03567993|469584435|FG000|Overall Study|Lost to Follow-up|4|||
130442938|NCT03567993|469584436|FG001|Overall Study|Lost to Follow-up|2|||
130442939|NCT03567993|469584435|FG000|Overall Study|Death|1|||
130442940|NCT03567993|469584436|FG001|Overall Study|Death|1|||
130442941|NCT03567993|469584435|FG000|Overall Study|Withdrawal by Subject|1|||
130442942|NCT03567993|469584436|FG001|Overall Study|Withdrawal by Subject|0|||
130442943|NCT00903786|469584440|FG000|Overall Study|Physician Decision|6|||
130442944|NCT00903786|469584440|FG000|Overall Study|Lack of Efficacy|5|||
130442945|NCT00903786|469584440|FG000|Overall Study|Reason other than lack of efficacy|4|||
130442946|NCT01163747|469584445|FG000|Overall Study|Adverse Event|0|||
130442947|NCT01163747|469584446|FG001|Overall Study|Adverse Event|5|||
130442948|NCT01163747|469584445|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130442949|NCT01163747|469584446|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130442950|NCT01163747|469584445|FG000|Overall Study|Protocol Violation|0|||
130442951|NCT01163747|469584446|FG001|Overall Study|Protocol Violation|1|||
130442952|NCT01163747|469584445|FG000|Overall Study|Refused Treatment|6|||
130442953|NCT01163747|469584446|FG001|Overall Study|Refused Treatment|4|||
130442954|NCT03363659|469584447|FG000|Overall Study|Adverse Event|1|||
130442955|NCT03363659|469584447|FG000|Overall Study|Screen fail|1|||
130442956|NCT03363659|469584447|FG000|Overall Study|Withdrawal by Subject|1|||
130442957|NCT03872388|469584448|FG000|Overall Study|Disease Progression|0|||
130442958|NCT03872388|469584449|FG001|Overall Study|Disease Progression|0|||
130442959|NCT03872388|469584450|FG002|Overall Study|Disease Progression|0|||
130442960|NCT03872388|469584451|FG003|Overall Study|Disease Progression|0|||
130442961|NCT03872388|469584452|FG004|Overall Study|Disease Progression|0|||
130442962|NCT03872388|469584453|FG005|Overall Study|Disease Progression|0|||
130442963|NCT03872388|469584454|FG006|Overall Study|Disease Progression|1|||
130442964|NCT03872388|469584455|FG007|Overall Study|Disease Progression|1|||
130442965|NCT03681639|469586762|FG000|Overall Study|Death|4|||
130442966|NCT03681639|469586762|FG000|Overall Study|Lost to Follow-up|2|||
130442967|NCT03681639|469586762|FG000|Overall Study|Withdrawal by Subject|1|||
130442968|NCT03681639|469586762|FG000|Overall Study|Adverse Event|2|||
130442969|NCT00654940|469586763|FG000|Period 1|Adverse Event|0|||
130442970|NCT00654940|469586764|FG001|Period 1|Adverse Event|1|||
130442971|NCT00654940|469586763|FG000|Period 1|Intolerable Pain Level|1|||
130442972|NCT00654940|469586764|FG001|Period 1|Intolerable Pain Level|0|||
130442973|NCT04714216|469586765|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
130442974|NCT04714216|469586765|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
130442975|NCT01818141|469586766|FG000|Overall Study|Withdrawal by Subject|2|||
130442976|NCT01818141|469586767|FG001|Overall Study|Withdrawal by Subject|0|||
130442977|NCT01818141|469586766|FG000|Overall Study|No baseline C.diff colonies|1|||
130442978|NCT01818141|469586767|FG001|Overall Study|No baseline C.diff colonies|1|||
130442979|NCT01818141|469586766|FG000|Overall Study|Lost to Follow-up|0|||
130442980|NCT01818141|469586767|FG001|Overall Study|Lost to Follow-up|2|||
130442981|NCT00742885|469586773|FG000|Overall Study|Lost to Follow-up|1|||
130224214|NCT02983045|468784446|FG008|Overall Study|Lost to Follow-up|0|||
130224215|NCT02983045|468784447|FG009|Overall Study|Lost to Follow-up|0|||
130224216|NCT02658669|468784448|FG000|Overall Study|Lost to Follow-up|7|||
130442982|NCT00742885|469586774|FG001|Overall Study|Lost to Follow-up|0|||
130442983|NCT04781647|469586775|FG000|Overall Study|Study terminated by Sponsor|11|||
130442984|NCT04781647|469586776|FG001|Overall Study|Study terminated by Sponsor|9|||
130442985|NCT04781647|469586777|FG002|Overall Study|Study terminated by Sponsor|9|||
130442986|NCT04781647|469586775|FG000|Overall Study|Withdrawal by Subject|1|||
130442987|NCT04781647|469586776|FG001|Overall Study|Withdrawal by Subject|2|||
130442988|NCT04781647|469586777|FG002|Overall Study|Withdrawal by Subject|0|||
130442989|NCT04781647|469586775|FG000|Overall Study|Adverse Event|0|||
130687020|NCT05472038|470481323|FG000|Overall Study|Physician Decision|0|||
130687021|NCT05472038|470481324|FG001|Overall Study|Physician Decision|0|||
130224217|NCT02658669|468784449|FG001|Overall Study|Lost to Follow-up|5|||
130224218|NCT03421379|468784451|FG000|Period 1|Withdrawal by Subject|0|||
130224219|NCT03421379|468784452|FG001|Period 1|Withdrawal by Subject|1|||
130442990|NCT04781647|469586776|FG001|Overall Study|Adverse Event|1|||
130442991|NCT04781647|469586777|FG002|Overall Study|Adverse Event|1|||
130442992|NCT04781647|469586775|FG000|Overall Study|Protocol Violation|1|||
130442993|NCT04781647|469586776|FG001|Overall Study|Protocol Violation|0|||
130442994|NCT04781647|469586777|FG002|Overall Study|Protocol Violation|0|||
130442995|NCT04781647|469586775|FG000|Overall Study|Pregnancy|0|||
130442996|NCT04781647|469586776|FG001|Overall Study|Pregnancy|0|||
130442997|NCT04781647|469586777|FG002|Overall Study|Pregnancy|1|||
130442998|NCT04781647|469586775|FG000|Overall Study|Virology rebounded|1|||
130442999|NCT04781647|469586776|FG001|Overall Study|Virology rebounded|0|||
130443000|NCT04781647|469586777|FG002|Overall Study|Virology rebounded|0|||
130443001|NCT01755689|469586778|FG000|Overall Study|Withdrawal by Subject|1|||
130443002|NCT01755689|469586779|FG001|Overall Study|Withdrawal by Subject|3|||
130443003|NCT01755689|469586780|FG002|Overall Study|Withdrawal by Subject|2|||
130443004|NCT01755689|469586781|FG003|Overall Study|Withdrawal by Subject|1|||
130687022|NCT05472038|470481325|FG002|Overall Study|Physician Decision|0|||
130687023|NCT05472038|470481326|FG003|Overall Study|Physician Decision|0|||
130687024|NCT05472038|470481327|FG004|Overall Study|Physician Decision|1|||
130687025|NCT05472038|470481328|FG005|Overall Study|Physician Decision|0|||
130687026|NCT05472038|470481329|FG006|Overall Study|Physician Decision|0|||
130687027|NCT05472038|470481330|FG007|Overall Study|Physician Decision|0|||
130687028|NCT05472038|470481331|FG008|Overall Study|Physician Decision|0|||
130687029|NCT05472038|470481332|FG009|Overall Study|Physician Decision|0|||
130687030|NCT05472038|470481333|FG010|Overall Study|Physician Decision|0|||
130687031|NCT05472038|470481334|FG011|Overall Study|Physician Decision|0|||
130687032|NCT05472038|470481323|FG000|Overall Study|Withdrawal by Subject|1|||
130687033|NCT05472038|470481324|FG001|Overall Study|Withdrawal by Subject|3|||
130687034|NCT05472038|470481325|FG002|Overall Study|Withdrawal by Subject|1|||
130687035|NCT05472038|470481326|FG003|Overall Study|Withdrawal by Subject|6|||
130687036|NCT05472038|470481327|FG004|Overall Study|Withdrawal by Subject|1|||
130687037|NCT05472038|470481328|FG005|Overall Study|Withdrawal by Subject|3|||
130687038|NCT05472038|470481329|FG006|Overall Study|Withdrawal by Subject|0|||
130687039|NCT05472038|470481330|FG007|Overall Study|Withdrawal by Subject|2|||
130687040|NCT05472038|470481331|FG008|Overall Study|Withdrawal by Subject|3|||
130687041|NCT05472038|470481332|FG009|Overall Study|Withdrawal by Subject|1|||
130687042|NCT05472038|470481333|FG010|Overall Study|Withdrawal by Subject|2|||
130687043|NCT05472038|470481334|FG011|Overall Study|Withdrawal by Subject|2|||
130687044|NCT05472038|470481323|FG000|Overall Study|Protocol Violation|0|||
130687045|NCT05472038|470481324|FG001|Overall Study|Protocol Violation|0|||
130687046|NCT05472038|470481325|FG002|Overall Study|Protocol Violation|0|||
130687047|NCT05472038|470481326|FG003|Overall Study|Protocol Violation|0|||
130687048|NCT05472038|470481327|FG004|Overall Study|Protocol Violation|0|||
130687049|NCT05472038|470481328|FG005|Overall Study|Protocol Violation|0|||
130687050|NCT05472038|470481329|FG006|Overall Study|Protocol Violation|0|||
130687051|NCT05472038|470481330|FG007|Overall Study|Protocol Violation|1|||
130687052|NCT05472038|470481331|FG008|Overall Study|Protocol Violation|1|||
130687053|NCT05472038|470481332|FG009|Overall Study|Protocol Violation|1|||
130687054|NCT05472038|470481333|FG010|Overall Study|Protocol Violation|1|||
130355578|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130355579|NCT01226043|469273416|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
130355580|NCT01226043|469273417|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
130355581|NCT01226043|469273418|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
130355582|NCT01226043|469273419|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
130355583|NCT01226043|469273416|FG000|6-week Re-randomization Phase|Adverse Event|0|||
130355584|NCT01226043|469273417|FG001|6-week Re-randomization Phase|Adverse Event|0|||
130355585|NCT01226043|469273418|FG002|6-week Re-randomization Phase|Adverse Event|1|||
130355586|NCT01226043|469273419|FG003|6-week Re-randomization Phase|Adverse Event|1|||
130355587|NCT01226043|469273416|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
130355588|NCT01226043|469273417|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
130355589|NCT01226043|469273418|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
130355590|NCT01226043|469273419|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
130355591|NCT01226043|469273416|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
130355592|NCT01226043|469273417|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
130355593|NCT01226043|469273418|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
130355594|NCT01226043|469273419|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
130355595|NCT01226043|469273416|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
130355596|NCT01226043|469273417|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
130355597|NCT01226043|469273418|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
130355598|NCT01226043|469273419|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
130355599|NCT01226043|469273416|FG000|6-week Re-randomization Phase|Physician Decision|0|||
130355600|NCT01226043|469273417|FG001|6-week Re-randomization Phase|Physician Decision|0|||
130355601|NCT01226043|469273418|FG002|6-week Re-randomization Phase|Physician Decision|3|||
130355602|NCT01226043|469273419|FG003|6-week Re-randomization Phase|Physician Decision|2|||
130355603|NCT01226043|469273416|FG000|6-week Re-randomization Phase|completed in error|0|||
130355604|NCT01226043|469273417|FG001|6-week Re-randomization Phase|completed in error|0|||
130355605|NCT01226043|469273418|FG002|6-week Re-randomization Phase|completed in error|0|||
130552859|NCT01290601|469991598|FG002|Overall Study|Lack of Efficacy|0|||
130687055|NCT05472038|470481334|FG011|Overall Study|Protocol Violation|1|||
130687056|NCT05472038|470481323|FG000|Overall Study|Not vaccinated|0|||
130687057|NCT05472038|470481324|FG001|Overall Study|Not vaccinated|0|||
130687058|NCT05472038|470481325|FG002|Overall Study|Not vaccinated|0|||
130687059|NCT05472038|470481326|FG003|Overall Study|Not vaccinated|1|||
130687060|NCT05472038|470481327|FG004|Overall Study|Not vaccinated|0|||
130687061|NCT05472038|470481328|FG005|Overall Study|Not vaccinated|0|||
130687062|NCT05472038|470481329|FG006|Overall Study|Not vaccinated|0|||
130687063|NCT05472038|470481330|FG007|Overall Study|Not vaccinated|0|||
130687064|NCT05472038|470481331|FG008|Overall Study|Not vaccinated|0|||
130687065|NCT05472038|470481332|FG009|Overall Study|Not vaccinated|0|||
130687066|NCT05472038|470481333|FG010|Overall Study|Not vaccinated|0|||
130687067|NCT05472038|470481334|FG011|Overall Study|Not vaccinated|0|||
130224220|NCT03421379|468784451|FG000|Period 1|Physician Decision|1|||
130224221|NCT03421379|468784452|FG001|Period 1|Physician Decision|1|||
130224222|NCT03421379|468784451|FG000|Period 1|Did not receive treatment|1|||
130224223|NCT03421379|468784452|FG001|Period 1|Did not receive treatment|2|||
130224224|NCT02782741|468784453|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130224225|NCT02782741|468784454|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
130224226|NCT02782741|468784455|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130224227|NCT02782741|468784453|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
130224228|NCT02782741|468784454|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
130224229|NCT02782741|468784455|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
130224230|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
130224231|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
130224232|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
130224233|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130224234|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
130224235|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130355606|NCT01226043|469273419|FG003|6-week Re-randomization Phase|completed in error|1|||
130355607|NCT01226043|469273416|FG000|30-week Observational Phase|Adverse Event|0|||
130355608|NCT01226043|469273417|FG001|30-week Observational Phase|Adverse Event|0|||
130355609|NCT01226043|469273418|FG002|30-week Observational Phase|Adverse Event|1|||
130355610|NCT01226043|469273419|FG003|30-week Observational Phase|Adverse Event|1|||
130355611|NCT01226043|469273416|FG000|30-week Observational Phase|Protocol Violation|0|||
130355612|NCT01226043|469273417|FG001|30-week Observational Phase|Protocol Violation|0|||
130355613|NCT01226043|469273418|FG002|30-week Observational Phase|Protocol Violation|0|||
130355614|NCT01226043|469273419|FG003|30-week Observational Phase|Protocol Violation|1|||
130355615|NCT01226043|469273416|FG000|30-week Observational Phase|Lost to Follow-up|0|||
130355616|NCT01226043|469273417|FG001|30-week Observational Phase|Lost to Follow-up|0|||
130355617|NCT01226043|469273418|FG002|30-week Observational Phase|Lost to Follow-up|2|||
130355618|NCT01226043|469273419|FG003|30-week Observational Phase|Lost to Follow-up|2|||
130355619|NCT01226043|469273416|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
130355620|NCT01226043|469273417|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
130355621|NCT01226043|469273418|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
130355622|NCT01226043|469273419|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
130355623|NCT01226043|469273416|FG000|30-week Observational Phase|Physician Decision|0|||
130355624|NCT01226043|469273417|FG001|30-week Observational Phase|Physician Decision|0|||
130355625|NCT01226043|469273418|FG002|30-week Observational Phase|Physician Decision|2|||
130355626|NCT01226043|469273419|FG003|30-week Observational Phase|Physician Decision|2|||
130355627|NCT02204007|469273420|FG000|Overall Study|Surgery Canceled|1|||
130355628|NCT02204007|469273421|FG001|Overall Study|Surgery Canceled|1|||
130355629|NCT00910988|469273422|FG000|Overall Study|Lost to Follow-up|2|||
130355630|NCT00910988|469273423|FG001|Overall Study|Lost to Follow-up|4|||
130355631|NCT00910988|469273424|FG002|Overall Study|Lost to Follow-up|3|||
130355632|NCT00910988|469273425|FG003|Overall Study|Lost to Follow-up|0|||
130355633|NCT03004443|469273426|FG000|Overall Study|Pregnancy|0|||
130355634|NCT03004443|469273427|FG001|Overall Study|Pregnancy|1|||
130355635|NCT00828854|469273428|FG000|Overall Study|Disease Progression|17|||
130355636|NCT00828854|469273428|FG000|Overall Study|Adverse Event|9|||
130355637|NCT00828854|469273428|FG000|Overall Study|Reason not Specified|1|||
130355638|NCT00191646|469273430|FG000|Overall Study|Toxicity|26|||
130355639|NCT00191646|469273431|FG001|Overall Study|Toxicity|37|||
130355640|NCT00191646|469273430|FG000|Overall Study|Disease Progression|5|||
130355641|NCT00191646|469273431|FG001|Overall Study|Disease Progression|6|||
130355642|NCT00191646|469273430|FG000|Overall Study|Physician Decision|20|||
130355643|NCT00191646|469273431|FG001|Overall Study|Physician Decision|11|||
130355644|NCT00191646|469273430|FG000|Overall Study|Withdrawal by Subject|58|||
130355645|NCT00191646|469273431|FG001|Overall Study|Withdrawal by Subject|39|||
130355646|NCT00191646|469273430|FG000|Overall Study|Protocol Violation|5|||
130355647|NCT00191646|469273431|FG001|Overall Study|Protocol Violation|7|||
130355648|NCT00191646|469273430|FG000|Overall Study|Death|6|||
130355649|NCT00191646|469273431|FG001|Overall Study|Death|8|||
130355650|NCT00191646|469273430|FG000|Overall Study|Other|33|||
130355651|NCT00191646|469273431|FG001|Overall Study|Other|34|||
130355652|NCT00191646|469273430|FG000|Overall Study|Missing Data|18|||
130355653|NCT00191646|469273431|FG001|Overall Study|Missing Data|11|||
130224236|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
130224237|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
130224238|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
130355654|NCT05211284|469273436|FG000|Overall Study|Study Terminated|3|||
130355655|NCT05211284|469273437|FG001|Overall Study|Study Terminated|1|||
130355656|NCT03911843|469273438|FG000|Overall Study|Adverse Event|2|||
130355657|NCT03911843|469273439|FG001|Overall Study|Adverse Event|0|||
130355658|NCT03911843|469273438|FG000|Overall Study|Protocol Violation|2|||
130355659|NCT03911843|469273439|FG001|Overall Study|Protocol Violation|0|||
130355660|NCT03911843|469273438|FG000|Overall Study|Lost to Follow-up|0|||
130355661|NCT03911843|469273439|FG001|Overall Study|Lost to Follow-up|1|||
130443005|NCT01755689|469586782|FG004|Overall Study|Withdrawal by Subject|1|||
130443006|NCT01755689|469586778|FG000|Overall Study|Migrated/moved from study area|0|||
130443007|NCT01755689|469586779|FG001|Overall Study|Migrated/moved from study area|1|||
130443008|NCT01755689|469586780|FG002|Overall Study|Migrated/moved from study area|1|||
130443009|NCT01755689|469586781|FG003|Overall Study|Migrated/moved from study area|1|||
130443010|NCT01755689|469586782|FG004|Overall Study|Migrated/moved from study area|1|||
130443011|NCT01755689|469586778|FG000|Overall Study|Lost to Follow-up|1|||
130443012|NCT01755689|469586779|FG001|Overall Study|Lost to Follow-up|0|||
130443013|NCT01755689|469586780|FG002|Overall Study|Lost to Follow-up|1|||
130443014|NCT01755689|469586781|FG003|Overall Study|Lost to Follow-up|0|||
130443015|NCT01755689|469586782|FG004|Overall Study|Lost to Follow-up|2|||
130443016|NCT01755689|469586778|FG000|Overall Study|Pregnancy|1|||
130443017|NCT01755689|469586779|FG001|Overall Study|Pregnancy|1|||
130443018|NCT01755689|469586780|FG002|Overall Study|Pregnancy|2|||
130443019|NCT01755689|469586781|FG003|Overall Study|Pregnancy|4|||
130443020|NCT01755689|469586782|FG004|Overall Study|Pregnancy|2|||
130443021|NCT01567163|469586784|FG000|Overall Study|Progressive Disease|2|||
130443022|NCT01567163|469586784|FG000|Overall Study|Lost to Follow-up|2|||
130443023|NCT03405662|469586785|FG000|Overall Study|COVID-19 restriction|1|||
130443024|NCT03405662|469586786|FG001|Overall Study|COVID-19 restriction|0|||
130443025|NCT03405662|469586785|FG000|Overall Study|unblinding|0|||
130443026|NCT03405662|469586786|FG001|Overall Study|unblinding|1|||
130443027|NCT03405662|469586785|FG000|Overall Study|placement in memory care facility|0|||
130443028|NCT03405662|469586786|FG001|Overall Study|placement in memory care facility|2|||
130443029|NCT01177813|469586787|FG000|Overall Study|Adverse Event|8|||
130443030|NCT01177813|469586788|FG001|Overall Study|Adverse Event|2|||
130443031|NCT01177813|469586789|FG002|Overall Study|Adverse Event|4|||
130443032|NCT01177813|469586790|FG003|Overall Study|Adverse Event|6|||
130443033|NCT01177813|469586791|FG004|Overall Study|Adverse Event|3|||
130443034|NCT01177813|469586787|FG000|Overall Study|Lack of Efficacy|1|||
130443035|NCT01177813|469586788|FG001|Overall Study|Lack of Efficacy|0|||
130443036|NCT01177813|469586789|FG002|Overall Study|Lack of Efficacy|0|||
130443037|NCT01177813|469586790|FG003|Overall Study|Lack of Efficacy|0|||
130443038|NCT01177813|469586791|FG004|Overall Study|Lack of Efficacy|0|||
130443039|NCT01177813|469586787|FG000|Overall Study|Protocol Violation|3|||
130443040|NCT01177813|469586788|FG001|Overall Study|Protocol Violation|2|||
130443041|NCT01177813|469586789|FG002|Overall Study|Protocol Violation|2|||
130443042|NCT01177813|469586790|FG003|Overall Study|Protocol Violation|0|||
130443043|NCT01177813|469586791|FG004|Overall Study|Protocol Violation|1|||
130443044|NCT01177813|469586787|FG000|Overall Study|Lost to Follow-up|12|||
130443045|NCT01177813|469586788|FG001|Overall Study|Lost to Follow-up|5|||
130443046|NCT01177813|469586789|FG002|Overall Study|Lost to Follow-up|6|||
130443047|NCT01177813|469586790|FG003|Overall Study|Lost to Follow-up|3|||
130443048|NCT01177813|469586791|FG004|Overall Study|Lost to Follow-up|0|||
130443049|NCT01177813|469586787|FG000|Overall Study|Withdrawal by Subject|12|||
130687068|NCT02847650|470481339|FG000|Overall Study|Adverse Event|2|||
130687069|NCT02847650|470481340|FG001|Overall Study|Adverse Event|4|||
130687070|NCT02847650|470481339|FG000|Overall Study|Lost to Follow-up|1|||
130687071|NCT02847650|470481340|FG001|Overall Study|Lost to Follow-up|0|||
130687072|NCT02847650|470481339|FG000|Overall Study|Protocol Violation|0|||
130687073|NCT02847650|470481340|FG001|Overall Study|Protocol Violation|1|||
130687074|NCT02847650|470481339|FG000|Overall Study|Withdrawal by Subject|1|||
130687075|NCT02847650|470481340|FG001|Overall Study|Withdrawal by Subject|1|||
130687076|NCT00834249|470481345|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130687077|NCT00834249|470481346|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130443050|NCT01177813|469586788|FG001|Overall Study|Withdrawal by Subject|7|||
130443051|NCT01177813|469586789|FG002|Overall Study|Withdrawal by Subject|6|||
130687078|NCT00834249|470481345|FG000|Second Intervention|Adverse Event|1|||
130687079|NCT00834249|470481346|FG001|Second Intervention|Adverse Event|0|||
130687080|NCT01111461|470481347|FG000|Overall Study|Adverse Event|32|||
130687081|NCT01111461|470481347|FG000|Overall Study|Participant choice|11|||
130687082|NCT01111461|470481347|FG000|Overall Study|Lost to Follow-up|1|||
130687083|NCT01111461|470481347|FG000|Overall Study|Withdrawal by Subject|1|||
130687084|NCT01111461|470481347|FG000|Overall Study|Other|6|||
130687085|NCT00834067|470481350|FG000|Washout of 21 Days|Protocol Violation|0|||
130687086|NCT00834067|470481351|FG001|Washout of 21 Days|Protocol Violation|1|||
130443052|NCT01177813|469586790|FG003|Overall Study|Withdrawal by Subject|5|||
130443053|NCT01177813|469586791|FG004|Overall Study|Withdrawal by Subject|3|||
130443054|NCT01177813|469586787|FG000|Overall Study|Other reason not defined above|5|||
130443055|NCT01177813|469586788|FG001|Overall Study|Other reason not defined above|2|||
130443056|NCT01177813|469586789|FG002|Overall Study|Other reason not defined above|2|||
130443057|NCT01177813|469586790|FG003|Overall Study|Other reason not defined above|3|||
130443058|NCT01177813|469586791|FG004|Overall Study|Other reason not defined above|2|||
130443059|NCT00109928|469586794|FG000|Overall Study|Adverse Event|2|||
130443060|NCT00109928|469586794|FG000|Overall Study|Progression|6|||
130443061|NCT00109928|469586794|FG000|Overall Study|Death|2|||
130443062|NCT00109928|469586794|FG000|Overall Study|not protocol specified|2|||
130443063|NCT00109928|469586794|FG000|Overall Study|not eligible|1|||
130687087|NCT01015703|470481354|FG000|Overall Study|Withdrawal by Subject|0|||
130224239|NCT04157088|468784456|FG000|Overall Study|Study terminated by sponsor|23|||
130224240|NCT04157088|468784456|FG000|Overall Study|Withdrawal by Subject|4|||
130355662|NCT01907100|469273440|FG000|Overall Study|PD based on modified RECIST criteria|31|||
130355663|NCT01907100|469273441|FG001|Overall Study|PD based on modified RECIST criteria|32|||
130355664|NCT01907100|469273442|FG002|Overall Study|PD based on modified RECIST criteria|95|||
130355665|NCT01907100|469273443|FG003|Overall Study|PD based on modified RECIST criteria|92|||
130355666|NCT01907100|469273440|FG000|Overall Study|Withdrawal by Subject|2|||
130355667|NCT01907100|469273441|FG001|Overall Study|Withdrawal by Subject|5|||
130355668|NCT01907100|469273442|FG002|Overall Study|Withdrawal by Subject|10|||
130355669|NCT01907100|469273443|FG003|Overall Study|Withdrawal by Subject|13|||
130355670|NCT01907100|469273440|FG000|Overall Study|Protocol Violation|0|||
130355671|NCT01907100|469273441|FG001|Overall Study|Protocol Violation|0|||
130355672|NCT01907100|469273442|FG002|Overall Study|Protocol Violation|1|||
130355673|NCT01907100|469273443|FG003|Overall Study|Protocol Violation|1|||
130355674|NCT01907100|469273440|FG000|Overall Study|Lost to Follow-up|0|||
130355675|NCT01907100|469273441|FG001|Overall Study|Lost to Follow-up|0|||
130355676|NCT01907100|469273442|FG002|Overall Study|Lost to Follow-up|0|||
130355677|NCT01907100|469273443|FG003|Overall Study|Lost to Follow-up|1|||
130355678|NCT01907100|469273440|FG000|Overall Study|Not treated|2|||
130355679|NCT01907100|469273441|FG001|Overall Study|Not treated|0|||
130355680|NCT01907100|469273442|FG002|Overall Study|Not treated|1|||
130355681|NCT01907100|469273443|FG003|Overall Study|Not treated|2|||
130355682|NCT01907100|469273440|FG000|Overall Study|Other than reasons specified|1|||
130355683|NCT01907100|469273441|FG001|Overall Study|Other than reasons specified|0|||
130355684|NCT01907100|469273442|FG002|Overall Study|Other than reasons specified|10|||
130355685|NCT01907100|469273443|FG003|Overall Study|Other than reasons specified|6|||
130355686|NCT01907100|469273440|FG000|Overall Study|Adverse event (AE)|6|||
130355687|NCT01907100|469273441|FG001|Overall Study|Adverse event (AE)|3|||
130224241|NCT04157088|468784456|FG000|Overall Study|Lost to Follow-up|2|||
130224242|NCT04157088|468784456|FG000|Overall Study|Death|1|||
130224243|NCT00196105|468784459|FG000|Overall Study|Lost to Follow-up|4|||
130224244|NCT00196105|468784460|FG001|Overall Study|Lost to Follow-up|5|||
130224245|NCT00196105|468784461|FG002|Overall Study|Lost to Follow-up|7|||
130224246|NCT04863872|468784462|FG000|Overall Study|Withdrawal by Subject|4|||
130224247|NCT04863872|468784463|FG001|Overall Study|Withdrawal by Subject|15|||
130224248|NCT04863872|468784462|FG000|Overall Study|Death|5|||
130224249|NCT04863872|468784463|FG001|Overall Study|Death|2|||
130355688|NCT01907100|469273442|FG002|Overall Study|Adverse event (AE)|22|||
130355689|NCT01907100|469273443|FG003|Overall Study|Adverse event (AE)|23|||
130355690|NCT01907100|469273440|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
130355691|NCT01907100|469273441|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
130355692|NCT01907100|469273442|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
130355693|NCT01907100|469273443|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
130355694|NCT02059005|469273444|FG000|Overall Study|Death|1|||
130355695|NCT02059005|469273445|FG001|Overall Study|Death|3|||
130355696|NCT02059005|469273444|FG000|Overall Study|Lost to Follow-up|19|||
130355697|NCT02059005|469273445|FG001|Overall Study|Lost to Follow-up|19|||
130355698|NCT02059005|469273444|FG000|Overall Study|Incarceration|0|||
130355699|NCT02059005|469273445|FG001|Overall Study|Incarceration|1|||
130355700|NCT02059005|469273444|FG000|Overall Study|Inpatient|0|||
130355701|NCT02059005|469273445|FG001|Overall Study|Inpatient|1|||
130355702|NCT00908011|469273446|FG000|Overall Study|Withdrawal by Subject|2|||
130355703|NCT00908011|469273447|FG001|Overall Study|Withdrawal by Subject|2|||
130355704|NCT00739596|469273452|FG000|Overall Study|Adverse Event|12|||
130355705|NCT00739596|469273453|FG001|Overall Study|Adverse Event|6|||
130355706|NCT00739596|469273452|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130355707|NCT00739596|469273453|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130355708|NCT00739596|469273452|FG000|Overall Study|Patient Withdrew Consent|8|||
130355709|NCT00739596|469273453|FG001|Overall Study|Patient Withdrew Consent|8|||
130355710|NCT00739596|469273452|FG000|Overall Study|Lost to Follow-up|0|||
130355711|NCT00739596|469273453|FG001|Overall Study|Lost to Follow-up|2|||
130355712|NCT00739596|469273452|FG000|Overall Study|Protocol Deviation|1|||
130355713|NCT00739596|469273453|FG001|Overall Study|Protocol Deviation|1|||
130355714|NCT00644228|469273454|FG000|Randomization & Eligibility|Ineligible|31|||
130355715|NCT00644228|469273455|FG001|Randomization & Eligibility|Ineligible|21|||
130355716|NCT00644228|469273454|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
130355717|NCT00644228|469273455|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
130443064|NCT01196104|469586795|FG000|Overall Study|Lost to Follow-up|1|||
130355718|NCT00644228|469273454|FG000|Randomization & Eligibility|Invalid Consent|0|||
130355719|NCT00644228|469273455|FG001|Randomization & Eligibility|Invalid Consent|1|||
130355720|NCT00644228|469273454|FG000|Induction Therapy|Adverse Event|22|||
130355721|NCT00644228|469273455|FG001|Induction Therapy|Adverse Event|55|||
130355722|NCT00644228|469273454|FG000|Induction Therapy|Withdrawal by Subject|10|||
130355723|NCT00644228|469273455|FG001|Induction Therapy|Withdrawal by Subject|3|||
130355724|NCT00644228|469273454|FG000|Induction Therapy|Progression/Relapse|24|||
130443065|NCT01196104|469586796|FG001|Overall Study|Lost to Follow-up|0|||
130224250|NCT04863872|468784462|FG000|Overall Study|Lost to Follow-up|2|||
130224251|NCT04863872|468784463|FG001|Overall Study|Lost to Follow-up|1|||
130224252|NCT04058028|468784464|FG000|Overall Study|Withdrawal of Consent from Study|12|||
130224253|NCT04058028|468784465|FG001|Overall Study|Withdrawal of Consent from Study|8|||
130224254|NCT04058028|468784466|FG002|Overall Study|Withdrawal of Consent from Study|6|||
130224255|NCT04058028|468784467|FG003|Overall Study|Withdrawal of Consent from Study|7|||
130224256|NCT04058028|468784464|FG000|Overall Study|Decision by Sponsor|13|||
130224257|NCT04058028|468784465|FG001|Overall Study|Decision by Sponsor|4|||
130224258|NCT04058028|468784466|FG002|Overall Study|Decision by Sponsor|1|||
130224259|NCT04058028|468784467|FG003|Overall Study|Decision by Sponsor|35|||
130224260|NCT04058028|468784464|FG000|Overall Study|Lost to Follow-up|1|||
130224261|NCT04058028|468784465|FG001|Overall Study|Lost to Follow-up|1|||
130224262|NCT04058028|468784466|FG002|Overall Study|Lost to Follow-up|1|||
130224263|NCT04058028|468784467|FG003|Overall Study|Lost to Follow-up|0|||
130224264|NCT04058028|468784464|FG000|Overall Study|Death|0|||
130224265|NCT04058028|468784465|FG001|Overall Study|Death|1|||
130224266|NCT04058028|468784466|FG002|Overall Study|Death|0|||
130224267|NCT04058028|468784467|FG003|Overall Study|Death|0|||
130224268|NCT00485069|468784468|FG000|Overall Study|Adverse Event|10|||
130224269|NCT00485069|468784469|FG001|Overall Study|Adverse Event|4|||
130224270|NCT00485069|468784468|FG000|Overall Study|Lack of Efficacy|2|||
130224271|NCT00485069|468784469|FG001|Overall Study|Lack of Efficacy|1|||
130224272|NCT00485069|468784468|FG000|Overall Study|Protocol Violation|0|||
130224273|NCT00485069|468784469|FG001|Overall Study|Protocol Violation|1|||
130224274|NCT00485069|468784468|FG000|Overall Study|Withdrawal by Subject|6|||
130224275|NCT00485069|468784469|FG001|Overall Study|Withdrawal by Subject|6|||
130224276|NCT00992017|468784471|FG000|Overall Study|Lost to Follow-up|2|||
130443066|NCT01196104|469586795|FG000|Overall Study|Physician Decision|0|||
130443067|NCT01196104|469586796|FG001|Overall Study|Physician Decision|1|||
130443068|NCT01196104|469586795|FG000|Overall Study|Withdrawal by Subject|3|||
130443069|NCT01196104|469586796|FG001|Overall Study|Withdrawal by Subject|3|||
130443070|NCT01196104|469586795|FG000|Overall Study|Various|0|||
130443071|NCT01196104|469586796|FG001|Overall Study|Various|1|||
130443072|NCT00610675|469586797|FG000|Overall Study|Untreated|4|||
130443073|NCT00610675|469586797|FG000|Overall Study|Adverse Event|67|||
130443074|NCT00610675|469586797|FG000|Overall Study|Insufficient Effect|31|||
130443075|NCT00610675|469586797|FG000|Overall Study|Withdrawal by Subject|28|||
130443076|NCT00610675|469586797|FG000|Overall Study|Reasons unrelated to trial|27|||
130443077|NCT00610675|469586797|FG000|Overall Study|Lack of Compliance|7|||
130443078|NCT00610675|469586797|FG000|Overall Study|Lost to Follow-up|31|||
130443079|NCT00610675|469586797|FG000|Overall Study|Other reason (not specified)|25|||
130443080|NCT01316692|469586800|FG000|Overall Study|Adverse Event|5|||
130443081|NCT01316692|469586800|FG000|Overall Study|Disease Progression|7|||
130443082|NCT00983619|469586801|FG000|Overall Study|Lost to Follow-up|0|||
130443083|NCT00983619|469586802|FG001|Overall Study|Lost to Follow-up|1|||
130443084|NCT00983619|469586803|FG002|Overall Study|Lost to Follow-up|0|||
130443085|NCT00983619|469586804|FG003|Overall Study|Lost to Follow-up|0|||
130443086|NCT00983619|469586805|FG004|Overall Study|Lost to Follow-up|0|||
130443087|NCT00983619|469586806|FG005|Overall Study|Lost to Follow-up|2|||
130443088|NCT00983619|469586807|FG006|Overall Study|Lost to Follow-up|0|||
130443089|NCT00983619|469586808|FG007|Overall Study|Lost to Follow-up|0|||
130443090|NCT00983619|469586809|FG008|Overall Study|Lost to Follow-up|0|||
130443091|NCT00983619|469586810|FG009|Overall Study|Lost to Follow-up|0|||
130443092|NCT00983619|469586811|FG010|Overall Study|Lost to Follow-up|0|||
130443093|NCT00983619|469586812|FG011|Overall Study|Lost to Follow-up|2|||
130443094|NCT00983619|469586801|FG000|Overall Study|Withdrawal by Subject|2|||
130443095|NCT00983619|469586802|FG001|Overall Study|Withdrawal by Subject|1|||
130443096|NCT00983619|469586803|FG002|Overall Study|Withdrawal by Subject|1|||
130443097|NCT00983619|469586804|FG003|Overall Study|Withdrawal by Subject|3|||
130443098|NCT00983619|469586805|FG004|Overall Study|Withdrawal by Subject|1|||
130224277|NCT00992017|468784471|FG000|Overall Study|Withdrawal by Subject|2|||
130224278|NCT00992017|468784471|FG000|Overall Study|Unable to get to clinic|5|||
130224279|NCT00992017|468784471|FG000|Overall Study|Not adhere to study requirements|1|||
130224280|NCT02864407|468784472|FG000|Overall Study|Protocol Violation|3|||
130224281|NCT02864407|468784472|FG000|Overall Study|Lost to Follow-up|115|||
130443099|NCT00983619|469586806|FG005|Overall Study|Withdrawal by Subject|23|||
130443100|NCT00983619|469586807|FG006|Overall Study|Withdrawal by Subject|0|||
130443101|NCT00983619|469586808|FG007|Overall Study|Withdrawal by Subject|0|||
130443102|NCT00983619|469586809|FG008|Overall Study|Withdrawal by Subject|0|||
130443103|NCT00983619|469586810|FG009|Overall Study|Withdrawal by Subject|0|||
130443104|NCT00983619|469586811|FG010|Overall Study|Withdrawal by Subject|1|||
130443105|NCT00983619|469586812|FG011|Overall Study|Withdrawal by Subject|1|||
130443106|NCT00983619|469586801|FG000|Overall Study|Death|0|||
130443107|NCT00983619|469586802|FG001|Overall Study|Death|2|||
130224282|NCT02864407|468784472|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
130224283|NCT02864407|468784472|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
130224284|NCT02864407|468784472|FG000|Overall Study|Consent prior to the contract date|1|||
130443108|NCT00983619|469586803|FG002|Overall Study|Death|2|||
130443109|NCT00983619|469586804|FG003|Overall Study|Death|1|||
130443110|NCT00983619|469586805|FG004|Overall Study|Death|2|||
130687088|NCT01015703|470481355|FG001|Overall Study|Withdrawal by Subject|1|||
130687089|NCT01015703|470481356|FG002|Overall Study|Withdrawal by Subject|0|||
130687090|NCT01015703|470481357|FG003|Overall Study|Withdrawal by Subject|0|||
130687091|NCT01015703|470481358|FG004|Overall Study|Withdrawal by Subject|0|||
130687092|NCT01015703|470481354|FG000|Overall Study|Adverse Event|1|||
130687093|NCT01015703|470481355|FG001|Overall Study|Adverse Event|0|||
130687094|NCT01015703|470481356|FG002|Overall Study|Adverse Event|0|||
130224285|NCT04577794|468784480|FG000|Overall Study|Adverse Event|1|||
130224286|NCT04577794|468784481|FG001|Overall Study|Adverse Event|1|||
130224287|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
130355725|NCT00644228|469273455|FG001|Induction Therapy|Progression/Relapse|12|||
130355726|NCT00644228|469273454|FG000|Induction Therapy|Death|3|||
130355727|NCT00644228|469273455|FG001|Induction Therapy|Death|7|||
130355728|NCT00644228|469273454|FG000|Induction Therapy|Not Protocol-Specified|24|||
130355729|NCT00644228|469273455|FG001|Induction Therapy|Not Protocol-Specified|28|||
130355730|NCT00644228|469273454|FG000|Maintenance|Adverse Event|27|||
130355731|NCT00644228|469273455|FG001|Maintenance|Adverse Event|31|||
130355732|NCT00644228|469273454|FG000|Maintenance|Withdrawal by Subject|6|||
130355733|NCT00644228|469273455|FG001|Maintenance|Withdrawal by Subject|4|||
130355734|NCT00644228|469273454|FG000|Maintenance|Progression/Relapse|67|||
130355735|NCT00644228|469273455|FG001|Maintenance|Progression/Relapse|42|||
130355736|NCT00644228|469273454|FG000|Maintenance|Death|3|||
130355737|NCT00644228|469273455|FG001|Maintenance|Death|3|||
130355738|NCT00644228|469273454|FG000|Maintenance|Not Protocol-Specified|14|||
130355739|NCT00644228|469273455|FG001|Maintenance|Not Protocol-Specified|15|||
130355740|NCT00644228|469273454|FG000|Maintenance|On Treatment|26|||
130355741|NCT00644228|469273455|FG001|Maintenance|On Treatment|40|||
130355742|NCT00760084|469273456|FG000|Overall Study|Physician Decision|5|||
130355743|NCT00760084|469273456|FG000|Overall Study|Withdrawal by Subject|2|||
130355744|NCT00760084|469273456|FG000|Overall Study|Progressive Disease|3|||
130355745|NCT02142803|469273457|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130355746|NCT02142803|469273458|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130355747|NCT02142803|469273459|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130355748|NCT02142803|469273460|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
130355749|NCT02718300|469273466|FG000|Overall Study|Death|4|||
130355750|NCT02718300|469273467|FG001|Overall Study|Death|5|||
130355751|NCT02718300|469273468|FG002|Overall Study|Death|17|||
130355752|NCT02718300|469273466|FG000|Overall Study|Lost to Follow-up|1|||
130355753|NCT02718300|469273467|FG001|Overall Study|Lost to Follow-up|0|||
130355754|NCT02718300|469273468|FG002|Overall Study|Lost to Follow-up|2|||
130355755|NCT02718300|469273466|FG000|Overall Study|Physician Decision|1|||
130355756|NCT02718300|469273467|FG001|Overall Study|Physician Decision|0|||
130355757|NCT02718300|469273468|FG002|Overall Study|Physician Decision|2|||
130355758|NCT02718300|469273466|FG000|Overall Study|Study Terminated by Sponsor|6|||
130355759|NCT02718300|469273467|FG001|Overall Study|Study Terminated by Sponsor|3|||
130355760|NCT02718300|469273468|FG002|Overall Study|Study Terminated by Sponsor|4|||
130355761|NCT02718300|469273466|FG000|Overall Study|Withdrawal by Subject|0|||
130355762|NCT02718300|469273467|FG001|Overall Study|Withdrawal by Subject|4|||
130355763|NCT02718300|469273468|FG002|Overall Study|Withdrawal by Subject|3|||
130355764|NCT02718300|469273466|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
130355765|NCT02718300|469273467|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
130355766|NCT02718300|469273468|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
130355767|NCT02452697|469273469|FG000|Overall Study|Physician Decision|4|||
130355768|NCT02452697|469273470|FG001|Overall Study|Physician Decision|4|||
130355769|NCT02452697|469273471|FG002|Overall Study|Physician Decision|3|||
130355770|NCT02452697|469273472|FG003|Overall Study|Physician Decision|2|||
130355771|NCT02452697|469273469|FG000|Overall Study|Withdrawal by Subject|1|||
130355772|NCT02452697|469273470|FG001|Overall Study|Withdrawal by Subject|0|||
130355773|NCT02452697|469273471|FG002|Overall Study|Withdrawal by Subject|0|||
130355774|NCT02452697|469273472|FG003|Overall Study|Withdrawal by Subject|0|||
130355775|NCT02452697|469273469|FG000|Overall Study|still in follow-up|2|||
130355776|NCT02452697|469273470|FG001|Overall Study|still in follow-up|2|||
130355777|NCT02452697|469273471|FG002|Overall Study|still in follow-up|1|||
130355778|NCT02452697|469273472|FG003|Overall Study|still in follow-up|3|||
130355779|NCT05419908|469273474|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
130355780|NCT05419908|469273475|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
130355781|NCT05419908|469273474|FG000|Overall Study|Serious Adverse Event|0|||
130355782|NCT05419908|469273475|FG001|Overall Study|Serious Adverse Event|2|||
130355783|NCT05419908|469273474|FG000|Overall Study|Withdrawal by Subject|2|||
130355784|NCT05419908|469273475|FG001|Overall Study|Withdrawal by Subject|0|||
130355785|NCT05419908|469273474|FG000|Overall Study|Miscellaneous|1|||
130355786|NCT05419908|469273475|FG001|Overall Study|Miscellaneous|1|||
130355787|NCT03906461|469274557|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
130687095|NCT01015703|470481357|FG003|Overall Study|Adverse Event|0|||
130355788|NCT03906461|469274557|FG000|Completed 12-month Follow-up|Missed Visit|6|||
130355789|NCT00510874|469274558|FG000|Overall Study|Withdrawal by Subject|1|||
130443111|NCT00983619|469586806|FG005|Overall Study|Death|30|||
130443112|NCT00983619|469586807|FG006|Overall Study|Death|1|||
130443113|NCT00983619|469586808|FG007|Overall Study|Death|0|||
130443114|NCT00983619|469586809|FG008|Overall Study|Death|1|||
130443115|NCT00983619|469586810|FG009|Overall Study|Death|2|||
130443116|NCT00983619|469586811|FG010|Overall Study|Death|9|||
130443117|NCT00983619|469586812|FG011|Overall Study|Death|8|||
130443118|NCT00983619|469586801|FG000|Overall Study|Other|1|||
130443119|NCT00983619|469586802|FG001|Overall Study|Other|0|||
130443120|NCT00983619|469586803|FG002|Overall Study|Other|0|||
130443121|NCT00983619|469586804|FG003|Overall Study|Other|1|||
130443122|NCT00983619|469586805|FG004|Overall Study|Other|0|||
130443123|NCT00983619|469586806|FG005|Overall Study|Other|12|||
130443124|NCT00983619|469586807|FG006|Overall Study|Other|2|||
130443125|NCT00983619|469586808|FG007|Overall Study|Other|2|||
130443126|NCT00983619|469586809|FG008|Overall Study|Other|0|||
130443127|NCT00983619|469586810|FG009|Overall Study|Other|1|||
130443128|NCT00983619|469586811|FG010|Overall Study|Other|1|||
130443129|NCT00983619|469586812|FG011|Overall Study|Other|0|||
130443130|NCT03772314|469586819|FG000|Overall Study|Adverse Event|7|||
130443131|NCT03772314|469586820|FG001|Overall Study|Adverse Event|2|||
130443132|NCT01536145|469586821|FG000|Overall Study|Progressive disease|3|||
130443133|NCT01536145|469586822|FG001|Overall Study|Progressive disease|4|||
130443134|NCT01536145|469586823|FG002|Overall Study|Progressive disease|1|||
130443135|NCT01536145|469586824|FG003|Overall Study|Progressive disease|2|||
130443136|NCT01536145|469586825|FG004|Overall Study|Progressive disease|1|||
130443137|NCT01536145|469586826|FG005|Overall Study|Progressive disease|2|||
130443138|NCT01536145|469586827|FG006|Overall Study|Progressive disease|1|||
130443139|NCT01536145|469586828|FG007|Overall Study|Progressive disease|2|||
130443140|NCT01536145|469586829|FG008|Overall Study|Progressive disease|1|||
130443141|NCT01536145|469586830|FG009|Overall Study|Progressive disease|3|||
130443142|NCT01536145|469586831|FG010|Overall Study|Progressive disease|3|||
130443143|NCT01536145|469586821|FG000|Overall Study|Withdrawal by Subject|0|||
130443144|NCT01536145|469586822|FG001|Overall Study|Withdrawal by Subject|0|||
130443145|NCT01536145|469586823|FG002|Overall Study|Withdrawal by Subject|1|||
130443146|NCT01536145|469586824|FG003|Overall Study|Withdrawal by Subject|0|||
130443147|NCT01536145|469586825|FG004|Overall Study|Withdrawal by Subject|0|||
130443148|NCT01536145|469586826|FG005|Overall Study|Withdrawal by Subject|1|||
130443149|NCT01536145|469586827|FG006|Overall Study|Withdrawal by Subject|0|||
130443150|NCT01536145|469586828|FG007|Overall Study|Withdrawal by Subject|0|||
130443151|NCT01536145|469586829|FG008|Overall Study|Withdrawal by Subject|2|||
130443152|NCT01536145|469586830|FG009|Overall Study|Withdrawal by Subject|0|||
130443153|NCT01536145|469586831|FG010|Overall Study|Withdrawal by Subject|2|||
130443154|NCT01536145|469586821|FG000|Overall Study|Other|0|||
130443155|NCT01536145|469586822|FG001|Overall Study|Other|0|||
130224288|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
130224289|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130224290|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130224291|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
130224292|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
130224293|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130224294|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130443156|NCT01536145|469586823|FG002|Overall Study|Other|0|||
130443157|NCT01536145|469586824|FG003|Overall Study|Other|0|||
130443158|NCT01536145|469586825|FG004|Overall Study|Other|1|||
130443159|NCT01536145|469586826|FG005|Overall Study|Other|0|||
130443160|NCT01536145|469586827|FG006|Overall Study|Other|0|||
130443161|NCT01536145|469586828|FG007|Overall Study|Other|0|||
130443162|NCT01536145|469586829|FG008|Overall Study|Other|0|||
130443163|NCT01536145|469586830|FG009|Overall Study|Other|3|||
130443164|NCT01536145|469586831|FG010|Overall Study|Other|2|||
130443165|NCT01536145|469586821|FG000|Overall Study|Death|0|||
130443166|NCT01536145|469586822|FG001|Overall Study|Death|0|||
130224295|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
130224296|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
130224297|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
130443167|NCT01536145|469586823|FG002|Overall Study|Death|0|||
130443168|NCT01536145|469586824|FG003|Overall Study|Death|0|||
130443169|NCT01536145|469586825|FG004|Overall Study|Death|0|||
130443170|NCT01536145|469586826|FG005|Overall Study|Death|0|||
130443171|NCT01536145|469586827|FG006|Overall Study|Death|1|||
130443172|NCT01536145|469586828|FG007|Overall Study|Death|0|||
130443173|NCT01536145|469586829|FG008|Overall Study|Death|0|||
130443174|NCT01536145|469586830|FG009|Overall Study|Death|0|||
130443175|NCT01536145|469586831|FG010|Overall Study|Death|0|||
130443176|NCT01536145|469586821|FG000|Overall Study|Adverse Event|0|||
130443177|NCT01536145|469586822|FG001|Overall Study|Adverse Event|0|||
130443178|NCT01536145|469586823|FG002|Overall Study|Adverse Event|0|||
130443179|NCT01536145|469586824|FG003|Overall Study|Adverse Event|0|||
130443180|NCT01536145|469586825|FG004|Overall Study|Adverse Event|0|||
130443181|NCT01536145|469586826|FG005|Overall Study|Adverse Event|0|||
130224298|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
130224299|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
130224300|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224301|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224302|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224303|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
130224304|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
130224305|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
130224306|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
130224307|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
130224308|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224309|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224310|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224311|NCT01819727|468784486|FG000|Overall Study|Adverse Event|8|||
130224312|NCT01819727|468784487|FG001|Overall Study|Adverse Event|9|||
130224313|NCT01819727|468784486|FG000|Overall Study|Death|1|||
130224314|NCT01819727|468784487|FG001|Overall Study|Death|0|||
130224315|NCT01819727|468784486|FG000|Overall Study|Lost to Follow-up|1|||
130355790|NCT00510874|469274559|FG001|Overall Study|Withdrawal by Subject|1|||
130355791|NCT00510874|469274560|FG002|Overall Study|Withdrawal by Subject|0|||
130443182|NCT01536145|469586827|FG006|Overall Study|Adverse Event|0|||
130443183|NCT01536145|469586828|FG007|Overall Study|Adverse Event|2|||
130443184|NCT01536145|469586829|FG008|Overall Study|Adverse Event|0|||
130443185|NCT01536145|469586830|FG009|Overall Study|Adverse Event|0|||
130224316|NCT01819727|468784487|FG001|Overall Study|Lost to Follow-up|1|||
130355792|NCT00510874|469274561|FG003|Overall Study|Withdrawal by Subject|0|||
130355793|NCT00510874|469274562|FG004|Overall Study|Withdrawal by Subject|3|||
130355794|NCT00510874|469274563|FG005|Overall Study|Withdrawal by Subject|0|||
130355795|NCT00510874|469274564|FG006|Overall Study|Withdrawal by Subject|0|||
130355796|NCT00510874|469274558|FG000|Overall Study|Lost to Follow-up|2|||
130355797|NCT00510874|469274559|FG001|Overall Study|Lost to Follow-up|3|||
130355798|NCT00510874|469274560|FG002|Overall Study|Lost to Follow-up|1|||
130355799|NCT00510874|469274561|FG003|Overall Study|Lost to Follow-up|3|||
130355800|NCT00510874|469274562|FG004|Overall Study|Lost to Follow-up|4|||
130355801|NCT00510874|469274563|FG005|Overall Study|Lost to Follow-up|0|||
130355802|NCT00510874|469274564|FG006|Overall Study|Lost to Follow-up|1|||
130355803|NCT04622735|469274567|FG000|Overall Study|Lost to Follow-up|1|||
130355804|NCT04622735|469274568|FG001|Overall Study|Lost to Follow-up|2|||
130355805|NCT04622735|469274569|FG002|Overall Study|Lost to Follow-up|1|||
130355806|NCT04622735|469274567|FG000|Overall Study|Adverse Event|0|||
130355807|NCT04622735|469274568|FG001|Overall Study|Adverse Event|0|||
130355808|NCT04622735|469274569|FG002|Overall Study|Adverse Event|1|||
130355809|NCT04622735|469274567|FG000|Overall Study|Protocol Violation|1|||
130355810|NCT04622735|469274568|FG001|Overall Study|Protocol Violation|0|||
130355811|NCT04622735|469274569|FG002|Overall Study|Protocol Violation|0|||
130355812|NCT04073368|469274570|FG000|Overall Study|Adverse Event|2|||
130355813|NCT04073368|469274571|FG001|Overall Study|Adverse Event|0|||
130355814|NCT04073368|469274572|FG002|Overall Study|Adverse Event|1|||
130355815|NCT04073368|469274573|FG003|Overall Study|Adverse Event|1|||
130355816|NCT04073368|469274570|FG000|Overall Study|Withdrawal by Subject|2|||
130355817|NCT04073368|469274571|FG001|Overall Study|Withdrawal by Subject|2|||
130355818|NCT04073368|469274572|FG002|Overall Study|Withdrawal by Subject|1|||
130355819|NCT04073368|469274573|FG003|Overall Study|Withdrawal by Subject|1|||
130355820|NCT04073368|469274570|FG000|Overall Study|Lost to Follow-up|1|||
130355821|NCT04073368|469274571|FG001|Overall Study|Lost to Follow-up|1|||
130355822|NCT04073368|469274572|FG002|Overall Study|Lost to Follow-up|1|||
130355823|NCT04073368|469274573|FG003|Overall Study|Lost to Follow-up|0|||
130355824|NCT04073368|469274570|FG000|Overall Study|Protocol Violation|0|||
130355825|NCT04073368|469274571|FG001|Overall Study|Protocol Violation|1|||
130355826|NCT04073368|469274572|FG002|Overall Study|Protocol Violation|0|||
130355827|NCT04073368|469274573|FG003|Overall Study|Protocol Violation|0|||
130355828|NCT04073368|469274570|FG000|Overall Study|Subject noncompliance|7|||
130355829|NCT04073368|469274571|FG001|Overall Study|Subject noncompliance|4|||
130355830|NCT04073368|469274572|FG002|Overall Study|Subject noncompliance|0|||
130355831|NCT04073368|469274573|FG003|Overall Study|Subject noncompliance|0|||
130224317|NCT01819727|468784486|FG000|Overall Study|Physician Decision|3|||
130224318|NCT01819727|468784487|FG001|Overall Study|Physician Decision|2|||
130224319|NCT01819727|468784486|FG000|Overall Study|Pregnancy|1|||
130355832|NCT03960554|469274582|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
130355833|NCT03960554|469274583|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
130355834|NCT00735254|469274584|FG000|Overall Study|Protocol Violation|1|||
130443186|NCT01536145|469586831|FG010|Overall Study|Adverse Event|3|||
130224320|NCT01819727|468784487|FG001|Overall Study|Pregnancy|0|||
130355835|NCT00735254|469274585|FG001|Overall Study|Protocol Violation|1|||
130355836|NCT00735254|469274586|FG002|Overall Study|Protocol Violation|1|||
130355837|NCT00735254|469274587|FG003|Overall Study|Protocol Violation|0|||
130355838|NCT00751621|469274588|FG000|Overall Study|Adverse Event|1|||
130552860|NCT01290601|469991599|FG003|Overall Study|Lack of Efficacy|0|||
130443187|NCT01284140|469586836|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
130443188|NCT01284140|469586837|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
130443189|NCT01284140|469586836|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
130443190|NCT01284140|469586837|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
130443191|NCT00088205|469586838|FG000|Overall Study|Adverse Event|4|||
130443192|NCT00088205|469586838|FG000|Overall Study|Progressive Disease|51|||
130443193|NCT00088205|469586838|FG000|Overall Study|Physician Decision|1|||
130443194|NCT00088205|469586838|FG000|Overall Study|Death Due to Study Disease|4|||
130443195|NCT03192215|469586839|FG000|Overall Study|Death|28|||
130443196|NCT03192215|469586840|FG001|Overall Study|Death|23|||
130443197|NCT03192215|469586839|FG000|Overall Study|Lost to Follow-up|10|||
130443198|NCT03192215|469586840|FG001|Overall Study|Lost to Follow-up|15|||
130443199|NCT03192215|469586839|FG000|Overall Study|Withdrawal by Subject|49|||
130443200|NCT03192215|469586840|FG001|Overall Study|Withdrawal by Subject|48|||
130443201|NCT03192215|469586839|FG000|Overall Study|Other as reported in analysis|4|||
130443202|NCT03192215|469586840|FG001|Overall Study|Other as reported in analysis|1|||
130443203|NCT05199233|469586843|FG000|Overall Study|Lack of Efficacy|1|||
130443204|NCT02443103|469586850|FG000|Overall Study|Adverse Event|2|||
130443205|NCT02443103|469586850|FG000|Overall Study|Noncompliance|1|||
130443206|NCT01630590|469586851|FG000|Overall Study|Adverse Event|9|||
130443207|NCT01630590|469586851|FG000|Overall Study|Lack of Efficacy|37|||
130443208|NCT01630590|469586851|FG000|Overall Study|Withdrawal by Subject|4|||
130443209|NCT01630590|469586851|FG000|Overall Study|2nd primary tumor|2|||
130443210|NCT01630590|469586851|FG000|Overall Study|Automobile accident|1|||
130443211|NCT01630590|469586851|FG000|Overall Study|Maximum benefit|4|||
130443212|NCT02366936|469586852|FG000|Overall Study|Withdrawal by Subject|2|||
130443213|NCT02366936|469586852|FG000|Overall Study|Lost to Follow-up|4|||
130443214|NCT02366936|469586852|FG000|Overall Study|Physician Decision|2|||
130443215|NCT01555021|469586857|FG000|Overall Study|Lost to Follow-up|1|||
130443216|NCT01555021|469586858|FG001|Overall Study|Lost to Follow-up|2|||
130443217|NCT03358329|469586859|FG000|Overall Study|Lost to Follow-up|2|||
130443218|NCT03358329|469586859|FG000|Overall Study|Withdrawal by Subject|2|||
130443219|NCT02982720|469586860|FG000|Overall Study|Adverse Event|3|||
130443220|NCT02982720|469586860|FG000|Overall Study|Death|1|||
130443221|NCT00750893|469586863|FG000|Overall Study|Adverse Event|5|||
130443222|NCT00750893|469586863|FG000|Overall Study|Withdrawal by Subject|10|||
130443223|NCT00750893|469586863|FG000|Overall Study|Lost to Follow-up|510|||
130443224|NCT00750893|469586863|FG000|Overall Study|Other|17|||
130443225|NCT02420327|469586864|FG000|Overall Study|Adverse Event|7|||
130443226|NCT02420327|469586864|FG000|Overall Study|Pregnancy|1|||
130443227|NCT02420327|469586864|FG000|Overall Study|Withdrawal by Subject|6|||
130443228|NCT02420327|469586864|FG000|Overall Study|Lost to Follow-up|1|||
130443229|NCT02420327|469586864|FG000|Overall Study|Protocol Violation|1|||
130443230|NCT02589392|469586866|FG000|Overall Study|Adverse Event|1|||
130443231|NCT02589392|469586867|FG001|Overall Study|Adverse Event|1|||
130443232|NCT02589392|469586866|FG000|Overall Study|Withdrawal by Subject|1|||
130443233|NCT02589392|469586867|FG001|Overall Study|Withdrawal by Subject|2|||
130443234|NCT02589392|469586866|FG000|Overall Study|Protocol Violation|1|||
130443235|NCT02589392|469586867|FG001|Overall Study|Protocol Violation|1|||
130443236|NCT02589392|469586866|FG000|Overall Study|Lost to Follow-up|2|||
130443237|NCT02589392|469586867|FG001|Overall Study|Lost to Follow-up|2|||
130443238|NCT02589392|469586866|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
130443239|NCT02589392|469586867|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
130443240|NCT00393094|469586872|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
130443241|NCT00393094|469586872|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
130443242|NCT00322374|469586873|FG000|Starting Dose|Physician Decision|2|||
130443243|NCT00322374|469586874|FG001|Starting Dose|Physician Decision|0|||
130443244|NCT00322374|469586875|FG002|Starting Dose|Physician Decision|0|||
130443245|NCT00322374|469586876|FG003|Starting Dose|Physician Decision|0|||
130443246|NCT00322374|469586873|FG000|Starting Dose|Study Drug Toxicity|4|||
130443247|NCT00322374|469586874|FG001|Starting Dose|Study Drug Toxicity|0|||
130443248|NCT00322374|469586875|FG002|Starting Dose|Study Drug Toxicity|0|||
130443249|NCT00322374|469586876|FG003|Starting Dose|Study Drug Toxicity|0|||
130443250|NCT00322374|469586873|FG000|First Escalation|Documented Disease Progression|0|||
130443251|NCT00322374|469586874|FG001|First Escalation|Documented Disease Progression|6|||
130443252|NCT00322374|469586875|FG002|First Escalation|Documented Disease Progression|0|||
130443253|NCT00322374|469586876|FG003|First Escalation|Documented Disease Progression|0|||
130443254|NCT00322374|469586873|FG000|First Escalation|Physician Decision|0|||
130443255|NCT00322374|469586874|FG001|First Escalation|Physician Decision|12|||
130443256|NCT00322374|469586875|FG002|First Escalation|Physician Decision|0|||
130443257|NCT00322374|469586876|FG003|First Escalation|Physician Decision|0|||
130443258|NCT00322374|469586873|FG000|First Escalation|Study Drug Toxicity|0|||
130443259|NCT00322374|469586874|FG001|First Escalation|Study Drug Toxicity|11|||
130443260|NCT00322374|469586875|FG002|First Escalation|Study Drug Toxicity|0|||
130443261|NCT00322374|469586876|FG003|First Escalation|Study Drug Toxicity|0|||
130443262|NCT00322374|469586873|FG000|First Escalation|Participant Request|0|||
130443263|NCT00322374|469586874|FG001|First Escalation|Participant Request|1|||
130443264|NCT00322374|469586875|FG002|First Escalation|Participant Request|0|||
130443265|NCT00322374|469586876|FG003|First Escalation|Participant Request|0|||
130443266|NCT00322374|469586873|FG000|Second Escalation|Physician Decision|0|||
130443267|NCT00322374|469586874|FG001|Second Escalation|Physician Decision|0|||
130443268|NCT00322374|469586875|FG002|Second Escalation|Physician Decision|5|||
130443269|NCT00322374|469586876|FG003|Second Escalation|Physician Decision|0|||
130443270|NCT00322374|469586873|FG000|Second Escalation|Study Drug Toxicity|0|||
130443271|NCT00322374|469586874|FG001|Second Escalation|Study Drug Toxicity|0|||
130443272|NCT00322374|469586875|FG002|Second Escalation|Study Drug Toxicity|1|||
130443273|NCT00322374|469586876|FG003|Second Escalation|Study Drug Toxicity|0|||
130443274|NCT04230980|469586877|FG000|Overall Study|Lost to Follow-up|1|||
130443275|NCT04230980|469586878|FG001|Overall Study|Lost to Follow-up|2|||
130443276|NCT04230980|469586877|FG000|Overall Study|Adverse Event|0|||
130443277|NCT04230980|469586878|FG001|Overall Study|Adverse Event|1|||
130443278|NCT01556763|469586883|FG000|Overall Study|Withdrawal by Subject|0|||
130443279|NCT01556763|469586884|FG001|Overall Study|Withdrawal by Subject|1|||
130443280|NCT01556763|469586885|FG002|Overall Study|Withdrawal by Subject|0|||
130443281|NCT00776100|469586891|FG000|Overall Study|Disease Progression|1|||
130443282|NCT00776100|469586892|FG001|Overall Study|Disease Progression|0|||
130443283|NCT04793464|469586893|FG000|Overall Study|Lost to Follow-up|458|||
130443284|NCT04793464|469586894|FG001|Overall Study|Lost to Follow-up|168|||
130443285|NCT04793464|469586895|FG002|Overall Study|Lost to Follow-up|5|||
130443286|NCT04793464|469586893|FG000|Overall Study|Withdrawal by Subject|43|||
130443287|NCT04793464|469586894|FG001|Overall Study|Withdrawal by Subject|15|||
130443288|NCT04793464|469586895|FG002|Overall Study|Withdrawal by Subject|0|||
130443289|NCT02285595|469586896|FG000|Overall Study|Lost to Follow-up|14|||
130443290|NCT02285595|469586896|FG000|Overall Study|Withdrawal by Subject|1|||
130443291|NCT00195715|469586897|FG000|Overall Study|Adverse Event|122|||
130224321|NCT01819727|468784486|FG000|Overall Study|Protocol Violation|0|||
130224322|NCT01819727|468784487|FG001|Overall Study|Protocol Violation|2|||
130224323|NCT01819727|468784486|FG000|Overall Study|Study Terminated by Sponsor|0|||
130224324|NCT01819727|468784487|FG001|Overall Study|Study Terminated by Sponsor|1|||
130443292|NCT00195715|469586897|FG000|Overall Study|Withdrawal by Subject|58|||
130443293|NCT00195715|469586897|FG000|Overall Study|Lost to Follow-up|27|||
130443294|NCT00195715|469586897|FG000|Overall Study|Protocol Violation|13|||
130443295|NCT00195715|469586897|FG000|Overall Study|Lack of Efficacy|93|||
130443296|NCT00195715|469586897|FG000|Overall Study|Pregnancy|14|||
130687096|NCT01015703|470481358|FG004|Overall Study|Adverse Event|0|||
130687097|NCT01015703|470481354|FG000|Overall Study|Protocol Violation|1|||
130687098|NCT01015703|470481355|FG001|Overall Study|Protocol Violation|0|||
130687099|NCT01015703|470481356|FG002|Overall Study|Protocol Violation|0|||
130687100|NCT01015703|470481357|FG003|Overall Study|Protocol Violation|0|||
130687101|NCT01015703|470481358|FG004|Overall Study|Protocol Violation|0|||
130687102|NCT03122535|470481359|FG000|Overall Study|Lost to Follow-up|68|||
130687103|NCT03122535|470481360|FG001|Overall Study|Lost to Follow-up|68|||
130687104|NCT03122535|470481359|FG000|Overall Study|Physician Decision|3|||
130687105|NCT03122535|470481360|FG001|Overall Study|Physician Decision|3|||
130687106|NCT03122535|470481359|FG000|Overall Study|Withdrawal by Subject|2|||
130687107|NCT03122535|470481360|FG001|Overall Study|Withdrawal by Subject|2|||
130687108|NCT02718326|470481361|FG000|Overall Study|Adverse Event|4|||
130687109|NCT02718326|470481362|FG001|Overall Study|Adverse Event|9|||
130687110|NCT02718326|470481363|FG002|Overall Study|Adverse Event|0|||
130687111|NCT02718326|470481361|FG000|Overall Study|Death|8|||
130687112|NCT02718326|470481362|FG001|Overall Study|Death|1|||
130687113|NCT02718326|470481363|FG002|Overall Study|Death|2|||
130687114|NCT02718326|470481361|FG000|Overall Study|Withdrawal by Subject|4|||
130687115|NCT02718326|470481362|FG001|Overall Study|Withdrawal by Subject|9|||
130224325|NCT01819727|468784486|FG000|Overall Study|Withdrawal by Subject|6|||
130224326|NCT01819727|468784487|FG001|Overall Study|Withdrawal by Subject|11|||
130224327|NCT01819727|468784486|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
130224328|NCT01819727|468784487|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
130224329|NCT01819727|468784486|FG000|Overall Study|Quit due to lack of health benifits|0|||
130224330|NCT01819727|468784487|FG001|Overall Study|Quit due to lack of health benifits|1|||
130224331|NCT03839394|468784491|FG000|Overall Study|Lost to Follow-up|6|||
130443297|NCT00195715|469586897|FG000|Overall Study|Investigative site closure|8|||
130443298|NCT00195715|469586897|FG000|Overall Study|Subject moved/relocated|7|||
130443299|NCT00195715|469586897|FG000|Overall Study|Subject non-compliance|6|||
130443300|NCT00195715|469586897|FG000|Overall Study|Subject started commercial Humira|5|||
130443301|NCT00195715|469586897|FG000|Overall Study|Subject choice|3|||
130443302|NCT00195715|469586897|FG000|Overall Study|Loss of response/no improvement|3|||
130443303|NCT00195715|469586897|FG000|Overall Study|Sponsor stopped study|1|||
130552861|NCT01290601|469991596|FG000|Overall Study|Lost to Follow-up|7|||
130224332|NCT03839394|468784492|FG001|Overall Study|Lost to Follow-up|8|||
130224333|NCT03839394|468784491|FG000|Overall Study|Withdrawal by Subject|0|||
130687116|NCT02718326|470481363|FG002|Overall Study|Withdrawal by Subject|6|||
130687117|NCT02718326|470481361|FG000|Overall Study|Lost to Follow-up|18|||
130687118|NCT02718326|470481362|FG001|Overall Study|Lost to Follow-up|5|||
130443304|NCT00195715|469586897|FG000|Overall Study|Administrative reasons|2|||
130443305|NCT00195715|469586897|FG000|Overall Study|Investigator's decision|2|||
130443306|NCT00195715|469586897|FG000|Overall Study|Subject wants to get pregnant|4|||
130443307|NCT00195715|469586897|FG000|Overall Study|Use of prohibited medication|2|||
130443308|NCT00195715|469586897|FG000|Overall Study|Planned surgery|2|||
130443309|NCT00195715|469586897|FG000|Overall Study|Increased infection rate|1|||
130443310|NCT00195715|469586897|FG000|Overall Study|Ineligible|1|||
130443311|NCT00195715|469586897|FG000|Overall Study|Colonic stricture|1|||
130443312|NCT00195715|469586897|FG000|Overall Study|Sponsor discontinued trial|1|||
130443313|NCT00195715|469586897|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
130443314|NCT00845871|469586902|FG000|Assessment Period|Adverse Event|2|||
130443315|NCT00845871|469586902|FG000|Assessment Period|Abnormal laboratory values|1|||
130443316|NCT00845871|469586902|FG000|Assessment Period|Abnormal test procedure results|1|||
130443317|NCT00845871|469586902|FG000|Assessment Period|Patient withdrew consent|3|||
130443318|NCT00064025|469586912|FG000|Overall Study|Ineligible|4|||
130443319|NCT00064025|469586912|FG000|Overall Study|Inevaluable|3|||
130443320|NCT02468934|469586913|FG000|Overall Study|Withdrawal by Subject|4|||
130443321|NCT02468934|469586913|FG000|Overall Study|Screen Failure|3|||
130443322|NCT01370603|469586916|FG000|Period 1|Adverse Event|5|||
130443323|NCT01370603|469586917|FG001|Period 1|Adverse Event|3|||
130443324|NCT01370603|469586916|FG000|Period 1|Lost to Follow-up|2|||
130443325|NCT01370603|469586917|FG001|Period 1|Lost to Follow-up|0|||
130443326|NCT01370603|469586916|FG000|Period 1|Protocol Violation|2|||
130443327|NCT01370603|469586917|FG001|Period 1|Protocol Violation|2|||
130443328|NCT01370603|469586916|FG000|Period 1|Withdrawal by Subject|5|||
130443329|NCT01370603|469586917|FG001|Period 1|Withdrawal by Subject|5|||
130443330|NCT01370603|469586916|FG000|Crossover Washout|Adverse Event|2|||
130443331|NCT01370603|469586917|FG001|Crossover Washout|Adverse Event|1|||
130443332|NCT01370603|469586916|FG000|Crossover Washout|Lost to Follow-up|2|||
130443333|NCT01370603|469586917|FG001|Crossover Washout|Lost to Follow-up|0|||
130443334|NCT01370603|469586916|FG000|Crossover Washout|Protocol Violation|1|||
130443335|NCT01370603|469586917|FG001|Crossover Washout|Protocol Violation|0|||
130443336|NCT01370603|469586916|FG000|Crossover Washout|Withdrawal by Subject|4|||
130443337|NCT01370603|469586917|FG001|Crossover Washout|Withdrawal by Subject|1|||
130443338|NCT01370603|469586916|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
130443339|NCT01370603|469586917|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
130443340|NCT01370603|469586916|FG000|Period 2|Adverse Event|1|||
130443341|NCT01370603|469586917|FG001|Period 2|Adverse Event|4|||
130443342|NCT01370603|469586916|FG000|Period 2|Lost to Follow-up|1|||
130443343|NCT01370603|469586917|FG001|Period 2|Lost to Follow-up|0|||
130443344|NCT01370603|469586916|FG000|Period 2|Withdrawal by Subject|1|||
130443345|NCT01370603|469586917|FG001|Period 2|Withdrawal by Subject|0|||
130443346|NCT00641186|469586922|FG000|Overall Study|Adverse Event|3|||
130443347|NCT02218489|469586925|FG000|Overall Study|Withdrawal by Subject|4|||
130443348|NCT02218489|469586926|FG001|Overall Study|Withdrawal by Subject|3|||
130443349|NCT02218489|469586925|FG000|Overall Study|Lost to Follow-up|1|||
130443350|NCT02218489|469586926|FG001|Overall Study|Lost to Follow-up|0|||
130443351|NCT05221749|469586927|FG000|Overall Study|Lost to Follow-up|2|||
130443352|NCT05221749|469586928|FG001|Overall Study|Lost to Follow-up|3|||
130443353|NCT02404493|469586929|FG000|Overall Study|Adverse Event|1|||
130443354|NCT02404493|469586930|FG001|Overall Study|Adverse Event|1|||
130443355|NCT01254890|469586931|FG000|Overall Study|Ineligible|0|||
130443356|NCT01254890|469586932|FG001|Overall Study|Ineligible|3|||
130443357|NCT01254890|469586931|FG000|Overall Study|Withdrawal by Subject|1|||
130443358|NCT01254890|469586932|FG001|Overall Study|Withdrawal by Subject|2|||
130443359|NCT01254890|469586931|FG000|Overall Study|Disease Progression|0|||
130443360|NCT01254890|469586932|FG001|Overall Study|Disease Progression|5|||
130443361|NCT04039503|469586938|FG000|Overall Study|Adverse Event|3|||
130687119|NCT02718326|470481363|FG002|Overall Study|Lost to Follow-up|14|||
130687120|NCT02718326|470481361|FG000|Overall Study|Protocol Deviation|1|||
130687121|NCT02718326|470481362|FG001|Overall Study|Protocol Deviation|0|||
130687122|NCT02718326|470481363|FG002|Overall Study|Protocol Deviation|0|||
130687123|NCT02718326|470481361|FG000|Overall Study|Pregnancy|1|||
130687124|NCT02718326|470481362|FG001|Overall Study|Pregnancy|0|||
130443362|NCT04039503|469586939|FG001|Overall Study|Adverse Event|0|||
130443363|NCT04039503|469586940|FG002|Overall Study|Adverse Event|2|||
130443364|NCT04039503|469586941|FG003|Overall Study|Adverse Event|0|||
130443365|NCT04039503|469586938|FG000|Overall Study|Lost to Follow-up|0|||
130443366|NCT04039503|469586939|FG001|Overall Study|Lost to Follow-up|0|||
130443367|NCT04039503|469586940|FG002|Overall Study|Lost to Follow-up|1|||
130443368|NCT04039503|469586941|FG003|Overall Study|Lost to Follow-up|0|||
130443369|NCT04039503|469586938|FG000|Overall Study|Protocol Violation|0|||
130443370|NCT04039503|469586939|FG001|Overall Study|Protocol Violation|1|||
130443371|NCT04039503|469586940|FG002|Overall Study|Protocol Violation|2|||
130443372|NCT04039503|469586941|FG003|Overall Study|Protocol Violation|1|||
130443373|NCT04039503|469586938|FG000|Overall Study|Withdrawal by Subject|4|||
130443374|NCT04039503|469586939|FG001|Overall Study|Withdrawal by Subject|3|||
130443375|NCT04039503|469586940|FG002|Overall Study|Withdrawal by Subject|5|||
130687125|NCT02718326|470481363|FG002|Overall Study|Pregnancy|0|||
130687126|NCT00834418|470481369|FG000|Overall Study|Adverse Event|0|||
130687127|NCT00834418|470481370|FG001|Overall Study|Adverse Event|2|||
130687128|NCT01705574|470481371|FG000|Double-Blind Phase|Lost to Follow-up|12|||
130687129|NCT01705574|470481372|FG001|Double-Blind Phase|Lost to Follow-up|16|||
130687130|NCT01705574|470481373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130687131|NCT01705574|470481374|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130687132|NCT01705574|470481371|FG000|Double-Blind Phase|Adverse Event|3|||
130687133|NCT01705574|470481372|FG001|Double-Blind Phase|Adverse Event|10|||
130687134|NCT01705574|470481373|FG002|Double-Blind Phase|Adverse Event|0|||
130687135|NCT01705574|470481374|FG003|Double-Blind Phase|Adverse Event|0|||
130687136|NCT01705574|470481371|FG000|Double-Blind Phase|Withdrew Consent|8|||
130687137|NCT01705574|470481372|FG001|Double-Blind Phase|Withdrew Consent|5|||
130687138|NCT01705574|470481373|FG002|Double-Blind Phase|Withdrew Consent|0|||
130687139|NCT01705574|470481374|FG003|Double-Blind Phase|Withdrew Consent|0|||
130687140|NCT01705574|470481371|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130687141|NCT01705574|470481372|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
130687142|NCT01705574|470481373|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130687143|NCT01705574|470481374|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130687144|NCT01705574|470481371|FG000|Double-Blind Phase|Pregnancy|1|||
130687145|NCT01705574|470481372|FG001|Double-Blind Phase|Pregnancy|1|||
130687146|NCT01705574|470481373|FG002|Double-Blind Phase|Pregnancy|0|||
130687147|NCT01705574|470481374|FG003|Double-Blind Phase|Pregnancy|0|||
130687148|NCT01705574|470481371|FG000|Double-Blind Phase|Protocol Violation|1|||
130687149|NCT01705574|470481372|FG001|Double-Blind Phase|Protocol Violation|0|||
130687150|NCT01705574|470481373|FG002|Double-Blind Phase|Protocol Violation|0|||
130687151|NCT01705574|470481374|FG003|Double-Blind Phase|Protocol Violation|0|||
130687152|NCT01705574|470481371|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
130687153|NCT01705574|470481372|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
130687154|NCT01705574|470481373|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
130687155|NCT01705574|470481374|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
130687156|NCT01705574|470481371|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
130687157|NCT01705574|470481372|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130687158|NCT01705574|470481373|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
130687159|NCT01705574|470481374|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
130687160|NCT01705574|470481371|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
130687161|NCT01705574|470481372|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
130224334|NCT03839394|468784492|FG001|Overall Study|Withdrawal by Subject|2|||
130224335|NCT03101150|468785798|FG000|Overall Study|Lost to Follow-up|2|||
130355839|NCT00751621|469274588|FG000|Overall Study|Withdrawal by Subject|1|||
130355840|NCT00751621|469274588|FG000|Overall Study|Subject moved to another country|1|||
130355841|NCT00751621|469274588|FG000|Overall Study|Poor adherence to asthma treatment|1|||
130355842|NCT02791594|469274589|FG000|Overall Study|Physician Decision|2|||
130355843|NCT02310321|469274590|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
130355844|NCT02310321|469274591|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130355845|NCT02310321|469274592|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130355846|NCT02310321|469274590|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
130355847|NCT02310321|469274591|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130355848|NCT02310321|469274592|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130355849|NCT02310321|469274590|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
130355850|NCT02310321|469274591|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130355851|NCT02310321|469274592|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130355852|NCT02310321|469274590|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
130355853|NCT02310321|469274591|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
130355854|NCT02310321|469274592|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
130355855|NCT02310321|469274590|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130355856|NCT02310321|469274591|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
130355857|NCT02310321|469274592|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130355858|NCT02310321|469274590|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
130355859|NCT02310321|469274591|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
130355860|NCT02310321|469274592|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
130355861|NCT02310321|469274590|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
130355862|NCT02310321|469274591|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
130355863|NCT02310321|469274592|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
130687162|NCT01705574|470481373|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
130687163|NCT01705574|470481374|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
130687164|NCT01705574|470481371|FG000|Open-Label Extension Phase|Adverse Event|3|||
130687165|NCT01705574|470481372|FG001|Open-Label Extension Phase|Adverse Event|0|||
130687166|NCT01705574|470481373|FG002|Open-Label Extension Phase|Adverse Event|0|||
130687167|NCT01705574|470481374|FG003|Open-Label Extension Phase|Adverse Event|1|||
130687168|NCT01705574|470481371|FG000|Open-Label Extension Phase|Death|2|||
130687169|NCT01705574|470481372|FG001|Open-Label Extension Phase|Death|0|||
130224336|NCT03101150|468785799|FG001|Overall Study|Lost to Follow-up|4|||
130224337|NCT03101150|468785798|FG000|Overall Study|Miscarriage|3|||
130224338|NCT03101150|468785799|FG001|Overall Study|Miscarriage|6|||
130224339|NCT00611806|468785800|FG000|Overall Study|Withdrawal by Subject|8|||
130224340|NCT00611806|468785801|FG001|Overall Study|Withdrawal by Subject|2|||
130224341|NCT00611806|468785800|FG000|Overall Study|Adverse Event|2|||
130224342|NCT00611806|468785801|FG001|Overall Study|Adverse Event|1|||
130224343|NCT00611806|468785800|FG000|Overall Study|Lost to Follow-up|6|||
130224344|NCT00611806|468785801|FG001|Overall Study|Lost to Follow-up|0|||
130224345|NCT00715559|468785802|FG000|Overall Study|medication not tolerated - nausea|1|||
130224346|NCT02063672|468785805|FG000|Overall Study|Ongoing Follow-up|27|||
130224347|NCT02063672|468785806|FG001|Overall Study|Ongoing Follow-up|14|||
130224348|NCT02063672|468785805|FG000|Overall Study|Death|5|||
130224349|NCT02063672|468785806|FG001|Overall Study|Death|3|||
130224350|NCT02063672|468785805|FG000|Overall Study|Lost to Follow-up|1|||
130224351|NCT02063672|468785806|FG001|Overall Study|Lost to Follow-up|3|||
130224352|NCT02063672|468785805|FG000|Overall Study|Withdrawal by Subject|2|||
130224353|NCT02063672|468785806|FG001|Overall Study|Withdrawal by Subject|2|||
130224354|NCT02498678|468785807|FG000|Overall Study|interference from the surgical team|0|||
130224355|NCT02498678|468785808|FG001|Overall Study|interference from the surgical team|2|||
130224356|NCT00230048|468785813|FG000|Overall Study|Lost to Follow-up|13|||
130224357|NCT00230048|468785814|FG001|Overall Study|Lost to Follow-up|18|||
130224358|NCT01566604|468785815|FG000|Overall Study|Patient's inability to use the device|1|||
130224359|NCT01566604|468785816|FG001|Overall Study|Patient's inability to use the device|0|||
130224360|NCT01566604|468785815|FG000|Overall Study|Administrative problems|1|||
130355864|NCT02310321|469274590|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
130355865|NCT02310321|469274591|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
130355866|NCT02310321|469274592|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
130355867|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
130355868|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
130355869|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
130355870|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
130355871|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
130355872|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
130355873|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
130355874|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
130355875|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
130355876|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
130355877|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
130355878|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
130355879|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
130355880|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
130355881|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
130355882|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
130355883|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
130355884|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
130355885|NCT02310321|469274590|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
130355886|NCT02310321|469274591|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
130355887|NCT02310321|469274592|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
130355888|NCT02310321|469274590|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
130355889|NCT02310321|469274591|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
130355890|NCT02310321|469274592|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
130355891|NCT02310321|469274590|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
130355892|NCT02310321|469274591|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
130355893|NCT02310321|469274592|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
130355894|NCT02310321|469274590|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
130355895|NCT02310321|469274591|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
130355896|NCT02310321|469274592|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
130355897|NCT02310321|469274590|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
130355898|NCT02310321|469274591|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
130355899|NCT02310321|469274592|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
130355900|NCT02310321|469274590|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
130355901|NCT02310321|469274591|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
130552862|NCT01290601|469991597|FG001|Overall Study|Lost to Follow-up|2|||
130224361|NCT01566604|468785816|FG001|Overall Study|Administrative problems|0|||
130224362|NCT01566604|468785815|FG000|Overall Study|Lack of Efficacy|1|||
130552863|NCT01290601|469991598|FG002|Overall Study|Lost to Follow-up|0|||
130224363|NCT01566604|468785816|FG001|Overall Study|Lack of Efficacy|2|||
130224364|NCT01566604|468785815|FG000|Overall Study|Protocol deviation|2|||
130224365|NCT01566604|468785816|FG001|Overall Study|Protocol deviation|0|||
130224366|NCT01566604|468785815|FG000|Overall Study|Abnormal laboratory value|2|||
130224367|NCT01566604|468785816|FG001|Overall Study|Abnormal laboratory value|0|||
130224368|NCT01566604|468785815|FG000|Overall Study|Death|4|||
130224369|NCT01566604|468785816|FG001|Overall Study|Death|1|||
130224370|NCT01566604|468785815|FG000|Overall Study|Adverse Event|4|||
130224371|NCT01566604|468785816|FG001|Overall Study|Adverse Event|2|||
130224372|NCT01566604|468785815|FG000|Overall Study|Withdrawal by Subject|9|||
130224373|NCT01566604|468785816|FG001|Overall Study|Withdrawal by Subject|6|||
130224374|NCT03225170|468785817|FG000|Overall Study|Lost to Follow-up|4|||
130224375|NCT03225170|468785818|FG001|Overall Study|Lost to Follow-up|4|||
130224376|NCT03225170|468785819|FG002|Overall Study|Lost to Follow-up|0|||
130224377|NCT03225170|468785817|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
130224378|NCT03225170|468785818|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
130224379|NCT03225170|468785819|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
130224380|NCT00661089|468785826|FG000|Overall Study|1 subject withdrawal|0|||
130224381|NCT00661089|468785827|FG001|Overall Study|1 subject withdrawal|1|||
130224382|NCT00661089|468785826|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
130224383|NCT00661089|468785827|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
130224384|NCT00274742|468785828|FG000|Overall Study|Adverse Event|0|||
130687170|NCT01705574|470481373|FG002|Open-Label Extension Phase|Death|1|||
130687171|NCT01705574|470481374|FG003|Open-Label Extension Phase|Death|0|||
130687172|NCT01705574|470481371|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687173|NCT01705574|470481372|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687174|NCT01705574|470481373|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
130687175|NCT01705574|470481374|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687176|NCT01705574|470481371|FG000|Open-Label Extension Phase|Physician Decision|0|||
130687177|NCT01705574|470481372|FG001|Open-Label Extension Phase|Physician Decision|0|||
130687178|NCT01705574|470481373|FG002|Open-Label Extension Phase|Physician Decision|2|||
130687179|NCT01705574|470481374|FG003|Open-Label Extension Phase|Physician Decision|0|||
130687180|NCT01705574|470481371|FG000|Open-Label Extension Phase|Pregnancy|0|||
130687181|NCT01705574|470481372|FG001|Open-Label Extension Phase|Pregnancy|0|||
130224385|NCT00274742|468785829|FG001|Overall Study|Adverse Event|4|||
130224386|NCT00274742|468785830|FG002|Overall Study|Adverse Event|1|||
130224387|NCT00274742|468785831|FG003|Overall Study|Adverse Event|4|||
130224388|NCT00274742|468785832|FG004|Overall Study|Adverse Event|12|||
130224389|NCT00274742|468785833|FG005|Overall Study|Adverse Event|3|||
130224390|NCT00274742|468785828|FG000|Overall Study|Lost to Follow-up|0|||
130224391|NCT00274742|468785829|FG001|Overall Study|Lost to Follow-up|0|||
130224392|NCT00274742|468785830|FG002|Overall Study|Lost to Follow-up|0|||
130224393|NCT00274742|468785831|FG003|Overall Study|Lost to Follow-up|0|||
130687182|NCT01705574|470481373|FG002|Open-Label Extension Phase|Pregnancy|1|||
130687183|NCT01705574|470481374|FG003|Open-Label Extension Phase|Pregnancy|1|||
130687184|NCT00777023|470481375|FG000|Overall Study|Adverse Event|15|||
130687185|NCT00777023|470481376|FG001|Overall Study|Adverse Event|21|||
130687186|NCT00777023|470481377|FG002|Overall Study|Adverse Event|8|||
130687187|NCT00777023|470481375|FG000|Overall Study|Lack of Efficacy|1|||
130687188|NCT00777023|470481376|FG001|Overall Study|Lack of Efficacy|0|||
130687189|NCT00777023|470481377|FG002|Overall Study|Lack of Efficacy|14|||
130687190|NCT00777023|470481375|FG000|Overall Study|Protocol Violation|2|||
130687191|NCT00777023|470481376|FG001|Overall Study|Protocol Violation|1|||
130687192|NCT00777023|470481377|FG002|Overall Study|Protocol Violation|1|||
130687193|NCT00777023|470481375|FG000|Overall Study|Lost to Follow-up|2|||
130687194|NCT00777023|470481376|FG001|Overall Study|Lost to Follow-up|3|||
130687195|NCT00777023|470481377|FG002|Overall Study|Lost to Follow-up|3|||
130687196|NCT00777023|470481375|FG000|Overall Study|Death|0|||
130687197|NCT00777023|470481376|FG001|Overall Study|Death|1|||
130687198|NCT00777023|470481377|FG002|Overall Study|Death|0|||
130224394|NCT00274742|468785832|FG004|Overall Study|Lost to Follow-up|1|||
130224395|NCT00274742|468785833|FG005|Overall Study|Lost to Follow-up|0|||
130224396|NCT00274742|468785828|FG000|Overall Study|End of Study|0|||
130224397|NCT00274742|468785829|FG001|Overall Study|End of Study|0|||
130443376|NCT04039503|469586941|FG003|Overall Study|Withdrawal by Subject|2|||
130687199|NCT00777023|470481375|FG000|Overall Study|Withdrawal by Subject|7|||
130687200|NCT00777023|470481376|FG001|Overall Study|Withdrawal by Subject|7|||
130687201|NCT00777023|470481377|FG002|Overall Study|Withdrawal by Subject|8|||
130687202|NCT00777023|470481375|FG000|Overall Study|Missing data|1|||
130687203|NCT00777023|470481376|FG001|Overall Study|Missing data|1|||
130687204|NCT00777023|470481377|FG002|Overall Study|Missing data|0|||
130687205|NCT00777023|470481375|FG000|Overall Study|Reasons not specified|4|||
130224398|NCT00274742|468785830|FG002|Overall Study|End of Study|0|||
130224399|NCT00274742|468785831|FG003|Overall Study|End of Study|1|||
130224400|NCT00274742|468785832|FG004|Overall Study|End of Study|0|||
130224401|NCT00274742|468785833|FG005|Overall Study|End of Study|0|||
130687206|NCT00777023|470481376|FG001|Overall Study|Reasons not specified|4|||
130224402|NCT00274742|468785828|FG000|Overall Study|Disease Progression|0|||
130687207|NCT00777023|470481377|FG002|Overall Study|Reasons not specified|2|||
130687208|NCT00777023|470481375|FG000|Overall Study|Last dose date unknown|3|||
130687209|NCT00777023|470481376|FG001|Overall Study|Last dose date unknown|3|||
130687210|NCT00777023|470481377|FG002|Overall Study|Last dose date unknown|1|||
130687211|NCT02659150|470481380|FG000|Subject Enrollment|Physician Decision|3|||
130687212|NCT02659150|470481380|FG000|Subject Enrollment|Withdrawal by Subject|2|||
130687213|NCT02659150|470481380|FG000|Baseline Imaging|Withdrawal by Subject|1|||
130687214|NCT02659150|470481380|FG000|Baseline Imaging|Physician Decision|1|||
130687215|NCT02659150|470481380|FG000|Study Drug Dosing|Adverse Event|1|||
130687216|NCT00448019|470481381|FG000|Overall Study|Withdrawal by Subject|3|||
130687217|NCT00448019|470481381|FG000|Overall Study|Disease progression|1|||
130687218|NCT00448019|470481381|FG000|Overall Study|Death|2|||
130687219|NCT00448019|470481381|FG000|Overall Study|Insurance Issues|1|||
130687220|NCT02543203|470481382|FG000|Overall Study|Unpalatable Fragrance|2|||
130687221|NCT02543203|470481383|FG001|Overall Study|Unpalatable Fragrance|2|||
130687222|NCT02543203|470481382|FG000|Overall Study|Lost to Follow-up|1|||
130687223|NCT02543203|470481383|FG001|Overall Study|Lost to Follow-up|0|||
130687224|NCT02543203|470481382|FG000|Overall Study|Increased Irritability|1|||
130687225|NCT02543203|470481383|FG001|Overall Study|Increased Irritability|0|||
130687226|NCT02543203|470481382|FG000|Overall Study|Family|1|||
130687227|NCT02543203|470481383|FG001|Overall Study|Family|2|||
130687228|NCT02543203|470481382|FG000|Overall Study|Negative Behavior|1|||
130687229|NCT02543203|470481383|FG001|Overall Study|Negative Behavior|0|||
130687230|NCT02543203|470481382|FG000|Overall Study|Withdrawal by Subject|0|||
130687231|NCT02543203|470481383|FG001|Overall Study|Withdrawal by Subject|1|||
130355902|NCT02310321|469274592|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
130355903|NCT02310321|469274590|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
130355904|NCT02310321|469274591|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
130355905|NCT02310321|469274592|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
130355906|NCT02310321|469274590|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
130355907|NCT02310321|469274591|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
130355908|NCT02310321|469274592|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
130355909|NCT02310321|469274590|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
130355910|NCT02310321|469274591|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
130355911|NCT02310321|469274592|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
130355912|NCT01698905|469274593|FG000|Overall Study|Adverse Event|4|||
130355913|NCT01698905|469274593|FG000|Overall Study|Physician Decision|2|||
130355914|NCT01698905|469274593|FG000|Overall Study|Pregnancy|1|||
130355915|NCT01698905|469274593|FG000|Overall Study|Protocol Violation|1|||
130355916|NCT01698905|469274593|FG000|Overall Study|Subject/guardian decision|2|||
130355917|NCT01698905|469274593|FG000|Overall Study|Death|1|||
130355918|NCT05896748|469274594|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
130355919|NCT05896748|469274594|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
130355920|NCT05896748|469274594|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
130355921|NCT05896748|469274594|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
130355922|NCT05896748|469274594|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
130355923|NCT02325791|469274597|FG000|Overall Study|Adverse Event|0|||
130355924|NCT02325791|469274598|FG001|Overall Study|Adverse Event|1|||
130355925|NCT02325791|469274599|FG002|Overall Study|Adverse Event|1|||
130355926|NCT02325791|469274600|FG003|Overall Study|Adverse Event|0|||
130355927|NCT02325791|469274597|FG000|Overall Study|Death|0|||
130355928|NCT02325791|469274598|FG001|Overall Study|Death|3|||
130355929|NCT02325791|469274599|FG002|Overall Study|Death|0|||
130355930|NCT02325791|469274600|FG003|Overall Study|Death|1|||
130355931|NCT02325791|469274597|FG000|Overall Study|Lost to Follow-up|0|||
130355932|NCT02325791|469274598|FG001|Overall Study|Lost to Follow-up|15|||
130355933|NCT02325791|469274599|FG002|Overall Study|Lost to Follow-up|14|||
130355934|NCT02325791|469274600|FG003|Overall Study|Lost to Follow-up|9|||
130355935|NCT02325791|469274597|FG000|Overall Study|Physician Decision|0|||
130355936|NCT02325791|469274598|FG001|Overall Study|Physician Decision|1|||
130355937|NCT02325791|469274599|FG002|Overall Study|Physician Decision|1|||
130355938|NCT02325791|469274600|FG003|Overall Study|Physician Decision|0|||
130355939|NCT02325791|469274597|FG000|Overall Study|Protocol Violation|0|||
130355940|NCT02325791|469274598|FG001|Overall Study|Protocol Violation|0|||
130355941|NCT02325791|469274599|FG002|Overall Study|Protocol Violation|1|||
130355942|NCT02325791|469274600|FG003|Overall Study|Protocol Violation|0|||
130355943|NCT02325791|469274597|FG000|Overall Study|Withdrawal by Subject|0|||
130355944|NCT02325791|469274598|FG001|Overall Study|Withdrawal by Subject|5|||
130687232|NCT00089661|470481384|FG000|Overall Study|Adverse Event|0|||
130687233|NCT00089661|470481385|FG001|Overall Study|Adverse Event|2|||
130355945|NCT02325791|469274599|FG002|Overall Study|Withdrawal by Subject|8|||
130355946|NCT02325791|469274600|FG003|Overall Study|Withdrawal by Subject|16|||
130355947|NCT01437878|469274601|FG000|Overall Study|Withdrawal by Subject|1|||
130355948|NCT01437878|469274602|FG001|Overall Study|Withdrawal by Subject|0|||
130355949|NCT01070043|469274604|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
130687234|NCT00089661|470481384|FG000|Overall Study|Death|1|||
130687235|NCT00089661|470481385|FG001|Overall Study|Death|0|||
130687236|NCT00089661|470481384|FG000|Overall Study|Lost to Follow-up|0|||
130687237|NCT00089661|470481385|FG001|Overall Study|Lost to Follow-up|3|||
130687238|NCT00089661|470481384|FG000|Overall Study|Withdrawal by Subject|11|||
130687239|NCT00089661|470481385|FG001|Overall Study|Withdrawal by Subject|9|||
130687240|NCT00089661|470481384|FG000|Overall Study|Disease progression|1|||
130687241|NCT00089661|470481385|FG001|Overall Study|Disease progression|3|||
130687242|NCT00089661|470481384|FG000|Overall Study|Ineligibility determined|4|||
130687243|NCT00089661|470481385|FG001|Overall Study|Ineligibility determined|4|||
130687244|NCT00089661|470481384|FG000|Overall Study|Noncompliance|2|||
130224403|NCT00274742|468785829|FG001|Overall Study|Disease Progression|1|||
130224404|NCT00274742|468785830|FG002|Overall Study|Disease Progression|1|||
130224405|NCT00274742|468785831|FG003|Overall Study|Disease Progression|0|||
130224406|NCT00274742|468785832|FG004|Overall Study|Disease Progression|1|||
130224407|NCT00274742|468785833|FG005|Overall Study|Disease Progression|0|||
130224408|NCT00274742|468785828|FG000|Overall Study|Other|0|||
130224409|NCT00274742|468785829|FG001|Overall Study|Other|3|||
130224410|NCT00274742|468785830|FG002|Overall Study|Other|0|||
130224411|NCT00274742|468785831|FG003|Overall Study|Other|0|||
130224412|NCT00274742|468785832|FG004|Overall Study|Other|2|||
130224413|NCT00274742|468785833|FG005|Overall Study|Other|0|||
130224414|NCT01529606|468785837|FG000|Overall Study|Lost to Follow-up|21|||
130224415|NCT01529606|468785838|FG001|Overall Study|Lost to Follow-up|18|||
130224416|NCT01900444|468785842|FG000|Overall Study|Protocol Violation|2|||
130224417|NCT01900444|468785842|FG000|Overall Study|Lost to Follow-up|1|||
130224418|NCT00072384|468785845|FG000|Overall Study|Physician Decision|1|||
130224419|NCT00072384|468785845|FG000|Overall Study|Ineligible|8|||
130224420|NCT01825200|468785846|FG000|Overall Study|Lost to Follow-up|5|||
130224421|NCT01825200|468785847|FG001|Overall Study|Lost to Follow-up|6|||
130224422|NCT01825200|468785846|FG000|Overall Study|Withdrawal by Subject|0|||
130224423|NCT01825200|468785847|FG001|Overall Study|Withdrawal by Subject|1|||
130224424|NCT00490035|468785848|FG000|Overall Study|AE, non-serious non-fatal|3|||
130224425|NCT00490035|468785849|FG001|Overall Study|AE, non-serious non-fatal|4|||
130224426|NCT00490035|468785850|FG002|Overall Study|AE, non-serious non-fatal|4|||
130224427|NCT00490035|468785851|FG003|Overall Study|AE, non-serious non-fatal|5|||
130224428|NCT00490035|468785848|FG000|Overall Study|Lost to Follow-up|2|||
130224429|NCT00490035|468785849|FG001|Overall Study|Lost to Follow-up|0|||
130224430|NCT00490035|468785850|FG002|Overall Study|Lost to Follow-up|1|||
130224431|NCT00490035|468785851|FG003|Overall Study|Lost to Follow-up|0|||
130224432|NCT00490035|468785848|FG000|Overall Study|Withdrawal by Subject|2|||
130224433|NCT00490035|468785849|FG001|Overall Study|Withdrawal by Subject|1|||
130224434|NCT00490035|468785850|FG002|Overall Study|Withdrawal by Subject|1|||
130224435|NCT00490035|468785851|FG003|Overall Study|Withdrawal by Subject|0|||
130224436|NCT00490035|468785848|FG000|Overall Study|Other reason|0|||
130224437|NCT00490035|468785849|FG001|Overall Study|Other reason|1|||
130224438|NCT00490035|468785850|FG002|Overall Study|Other reason|3|||
130224439|NCT00490035|468785851|FG003|Overall Study|Other reason|1|||
130224440|NCT00490035|468785848|FG000|Overall Study|AE, serious fatal|1|||
130224441|NCT00490035|468785849|FG001|Overall Study|AE, serious fatal|0|||
130224442|NCT00490035|468785850|FG002|Overall Study|AE, serious fatal|0|||
130224443|NCT00490035|468785851|FG003|Overall Study|AE, serious fatal|0|||
130224444|NCT00490035|468785848|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224445|NCT00490035|468785849|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224446|NCT00490035|468785850|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
130224447|NCT00490035|468785851|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224448|NCT00490035|468785848|FG000|Overall Study|AE of unknown type|0|||
130224449|NCT00490035|468785849|FG001|Overall Study|AE of unknown type|0|||
130224450|NCT00490035|468785850|FG002|Overall Study|AE of unknown type|2|||
130224451|NCT00490035|468785851|FG003|Overall Study|AE of unknown type|0|||
130224452|NCT00731822|468785855|FG000|Overall Study|Adverse Event|2|||
130224453|NCT00731822|468785856|FG001|Overall Study|Adverse Event|1|||
130224454|NCT00731822|468785855|FG000|Overall Study|Protocol Violation|1|||
130224455|NCT00731822|468785856|FG001|Overall Study|Protocol Violation|0|||
130224456|NCT00731822|468785855|FG000|Overall Study|Lost to Follow-up|1|||
130224457|NCT00731822|468785856|FG001|Overall Study|Lost to Follow-up|0|||
130687245|NCT00089661|470481385|FG001|Overall Study|Noncompliance|4|||
130687246|NCT00089661|470481384|FG000|Overall Study|Other|2|||
130687247|NCT00089661|470481385|FG001|Overall Study|Other|1|||
130687248|NCT01273805|470481386|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
130224458|NCT05209880|468785863|FG000|1-Month Follow-up|Spoke with Doctor|5|||
130224459|NCT05209880|468785864|FG001|1-Month Follow-up|Spoke with Doctor|5|||
130224460|NCT05209880|468785863|FG000|1-Month Follow-up|Lost to Follow-up|7|||
130224461|NCT05209880|468785864|FG001|1-Month Follow-up|Lost to Follow-up|9|||
130224462|NCT05209880|468785863|FG000|1-Month Follow-up|Discontinued|0|||
130224463|NCT05209880|468785864|FG001|1-Month Follow-up|Discontinued|1|||
130224464|NCT05209880|468785863|FG000|3-Month Follow-up|Spoke with Doctor|17|||
130224465|NCT05209880|468785864|FG001|3-Month Follow-up|Spoke with Doctor|7|||
130224466|NCT05209880|468785863|FG000|3-Month Follow-up|Lost to Follow-up|8|||
130224467|NCT05209880|468785864|FG001|3-Month Follow-up|Lost to Follow-up|10|||
130687249|NCT01273805|470481387|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
130224468|NCT05209880|468785863|FG000|3-Month Follow-up|Discontinued|1|||
130224469|NCT05209880|468785864|FG001|3-Month Follow-up|Discontinued|3|||
130224470|NCT05209880|468785863|FG000|6-Month Follow-up|Spoke with Doctor|25|||
130224471|NCT05209880|468785864|FG001|6-Month Follow-up|Spoke with Doctor|14|||
130224472|NCT05209880|468785863|FG000|6-Month Follow-up|Lost to Follow-up|9|||
130224473|NCT05209880|468785864|FG001|6-Month Follow-up|Lost to Follow-up|14|||
130224474|NCT05209880|468785863|FG000|6-Month Follow-up|Discontinued|1|||
130224475|NCT05209880|468785864|FG001|6-Month Follow-up|Discontinued|3|||
130224476|NCT04817332|468785865|FG000|Overall Study|Lost to Follow-up|3|||
130224477|NCT04817332|468785866|FG001|Overall Study|Lost to Follow-up|3|||
130224478|NCT04817332|468785865|FG000|Overall Study|Protocol Violation|2|||
130224479|NCT04817332|468785866|FG001|Overall Study|Protocol Violation|0|||
130224480|NCT04795466|468785872|FG000|Overall Study|Adverse Event|3|||
130224481|NCT04795466|468785873|FG001|Overall Study|Adverse Event|1|||
130224482|NCT04795466|468785872|FG000|Overall Study|Physician Decision|1|||
130224483|NCT04795466|468785873|FG001|Overall Study|Physician Decision|0|||
130224484|NCT04795466|468785872|FG000|Overall Study|Withdrawal by Subject|2|||
130224485|NCT04795466|468785873|FG001|Overall Study|Withdrawal by Subject|1|||
130224486|NCT05635045|468785874|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224487|NCT05635045|468785875|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224488|NCT05635045|468785876|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
130224489|NCT05635045|468785877|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224490|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
130224491|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130224492|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130224493|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
130224494|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
130224495|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
130224496|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
130224497|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224498|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224499|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224500|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224501|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224502|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
130224503|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224504|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224505|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224506|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224507|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224508|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
130224509|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224510|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224511|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224512|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224513|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224514|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
130224515|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224516|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224517|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224518|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224519|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224520|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Other|119|||
130224521|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Other|0|||
130224522|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Other|0|||
130224523|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Other|0|||
130224524|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Other|0|||
130687250|NCT02647944|470481388|FG000|Overall Study|Withdrawal by Subject|0|||
130687251|NCT02647944|470481389|FG001|Overall Study|Withdrawal by Subject|3|||
130687252|NCT02647944|470481388|FG000|Overall Study|Adverse Event|2|||
130687253|NCT02647944|470481389|FG001|Overall Study|Adverse Event|0|||
130687254|NCT02760368|470481391|FG000|Overall Study|Withdrawal by Subject|8|||
130687255|NCT02760368|470481392|FG001|Overall Study|Withdrawal by Subject|12|||
130687256|NCT02760368|470481393|FG002|Overall Study|Withdrawal by Subject|9|||
130687257|NCT02760368|470481391|FG000|Overall Study|Screen Failure|0|||
130687258|NCT02760368|470481392|FG001|Overall Study|Screen Failure|0|||
130224525|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Other|0|||
130224526|NCT01435759|468785881|FG000|Double-blind Phase|Adverse Event|7|||
130224527|NCT01435759|468785882|FG001|Double-blind Phase|Adverse Event|0|||
130224528|NCT01435759|468785883|FG002|Double-blind Phase|Adverse Event|1|||
130224529|NCT01435759|468785884|FG003|Double-blind Phase|Adverse Event|1|||
130224530|NCT01435759|468785885|FG004|Double-blind Phase|Adverse Event|1|||
130224531|NCT01435759|468785886|FG005|Double-blind Phase|Adverse Event|3|||
130224532|NCT01435759|468785881|FG000|Double-blind Phase|Protocol Violation|2|||
130224533|NCT01435759|468785882|FG001|Double-blind Phase|Protocol Violation|0|||
130224534|NCT01435759|468785883|FG002|Double-blind Phase|Protocol Violation|1|||
130224535|NCT01435759|468785884|FG003|Double-blind Phase|Protocol Violation|2|||
130224536|NCT01435759|468785885|FG004|Double-blind Phase|Protocol Violation|0|||
130224537|NCT01435759|468785886|FG005|Double-blind Phase|Protocol Violation|1|||
130224538|NCT01435759|468785881|FG000|Double-blind Phase|Withdrawal by Subject|17|||
130224539|NCT01435759|468785882|FG001|Double-blind Phase|Withdrawal by Subject|4|||
130224540|NCT01435759|468785883|FG002|Double-blind Phase|Withdrawal by Subject|3|||
130224541|NCT01435759|468785884|FG003|Double-blind Phase|Withdrawal by Subject|4|||
130224542|NCT01435759|468785885|FG004|Double-blind Phase|Withdrawal by Subject|2|||
130224543|NCT01435759|468785886|FG005|Double-blind Phase|Withdrawal by Subject|2|||
130224544|NCT01435759|468785881|FG000|Double-blind Phase|Lost to Follow-up|31|||
130224545|NCT01435759|468785882|FG001|Double-blind Phase|Lost to Follow-up|1|||
130224546|NCT01435759|468785883|FG002|Double-blind Phase|Lost to Follow-up|2|||
130224547|NCT01435759|468785884|FG003|Double-blind Phase|Lost to Follow-up|0|||
130224548|NCT01435759|468785885|FG004|Double-blind Phase|Lost to Follow-up|3|||
130224549|NCT01435759|468785886|FG005|Double-blind Phase|Lost to Follow-up|3|||
130224550|NCT01435759|468785881|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
130224551|NCT01435759|468785882|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224552|NCT01435759|468785883|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224553|NCT01435759|468785884|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224554|NCT01435759|468785885|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
130224555|NCT01435759|468785886|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224556|NCT01435759|468785881|FG000|Double-blind Phase|Other|8|||
130224557|NCT01435759|468785882|FG001|Double-blind Phase|Other|2|||
130224558|NCT01435759|468785883|FG002|Double-blind Phase|Other|0|||
130224559|NCT01435759|468785884|FG003|Double-blind Phase|Other|2|||
130224560|NCT01435759|468785885|FG004|Double-blind Phase|Other|0|||
130224561|NCT01435759|468785886|FG005|Double-blind Phase|Other|0|||
130224562|NCT02849587|468785889|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130224563|NCT02849587|468785890|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
130224564|NCT02849587|468785891|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130224565|NCT02849587|468785889|FG000|Overall Study|Withdrawal by Subject|0|||
130224566|NCT02849587|468785890|FG001|Overall Study|Withdrawal by Subject|1|||
130224567|NCT02849587|468785891|FG002|Overall Study|Withdrawal by Subject|0|||
130224568|NCT02421419|468785893|FG000|Overall Study|Physician Decision|0|||
130224569|NCT02421419|468785894|FG001|Overall Study|Physician Decision|0|||
130224570|NCT02421419|468785895|FG002|Overall Study|Physician Decision|1|||
130224571|NCT01365130|468785899|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
130224572|NCT00810199|468785901|FG000|Overall Study|Adverse Event|24|||
130224573|NCT00810199|468785902|FG001|Overall Study|Adverse Event|26|||
130224574|NCT00810199|468785901|FG000|Overall Study|Death|4|||
130224575|NCT00810199|468785902|FG001|Overall Study|Death|6|||
130224576|NCT00810199|468785901|FG000|Overall Study|Withdrew consent|9|||
130224577|NCT00810199|468785902|FG001|Overall Study|Withdrew consent|12|||
130224578|NCT00810199|468785901|FG000|Overall Study|Insufficient therapeutic response|5|||
130224579|NCT00810199|468785902|FG001|Overall Study|Insufficient therapeutic response|14|||
130224580|NCT00810199|468785901|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
130224581|NCT00810199|468785902|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
130224582|NCT00810199|468785901|FG000|Overall Study|Administrative/Other|5|||
130224583|NCT00810199|468785902|FG001|Overall Study|Administrative/Other|6|||
130224584|NCT00810199|468785901|FG000|Overall Study|Protocol Violation|2|||
130224585|NCT00810199|468785902|FG001|Overall Study|Protocol Violation|6|||
130224586|NCT00810199|468785901|FG000|Overall Study|Failure to return|1|||
130224587|NCT00810199|468785902|FG001|Overall Study|Failure to return|4|||
130224588|NCT00810199|468785901|FG000|Overall Study|Did not receive study drug|2|||
130224589|NCT00810199|468785902|FG001|Overall Study|Did not receive study drug|1|||
130224590|NCT05502302|468785903|FG000|Overall Study|Lost to Follow-up|6|||
130355950|NCT01070043|469274605|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
130355951|NCT01070043|469274606|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
130355952|NCT01070043|469274604|FG000|Double-Blind Treatment|Adverse Event|0|||
130224591|NCT05502302|468785903|FG000|Overall Study|Death|2|||
130224592|NCT01628848|468785907|FG000|Overall Study|Adverse Event|9|||
130224593|NCT01628848|468785908|FG001|Overall Study|Adverse Event|7|||
130224594|NCT01628848|468785907|FG000|Overall Study|Lack of Efficacy|0|||
130224595|NCT01628848|468785908|FG001|Overall Study|Lack of Efficacy|4|||
130224596|NCT01628848|468785907|FG000|Overall Study|Withdrawal by Subject|0|||
130355953|NCT01070043|469274605|FG001|Double-Blind Treatment|Adverse Event|0|||
130224597|NCT01628848|468785908|FG001|Overall Study|Withdrawal by Subject|2|||
130224598|NCT01628848|468785907|FG000|Overall Study|Physician Decision|3|||
130224599|NCT01628848|468785908|FG001|Overall Study|Physician Decision|1|||
130224600|NCT00003471|468785909|FG000|Overall Study|Not evaluable|4|||
130224601|NCT02104895|468785910|FG000|Overall Study|Withdrawal by Subject|0|||
130224602|NCT02104895|468785911|FG001|Overall Study|Withdrawal by Subject|14|||
130224603|NCT01107925|468785913|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130224604|NCT01107925|468785914|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224605|NCT01107925|468785915|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224606|NCT01107925|468785916|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224607|NCT01107925|468785917|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130224608|NCT01107925|468785918|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224609|NCT01107925|468785913|FG000|Period 2|Withdrawal by Subject|0|||
130224610|NCT01107925|468785914|FG001|Period 2|Withdrawal by Subject|1|||
130224611|NCT01107925|468785915|FG002|Period 2|Withdrawal by Subject|0|||
130224612|NCT01107925|468785916|FG003|Period 2|Withdrawal by Subject|0|||
130224613|NCT01107925|468785917|FG004|Period 2|Withdrawal by Subject|0|||
130224614|NCT01107925|468785918|FG005|Period 2|Withdrawal by Subject|1|||
130224615|NCT03311945|468785919|FG000|Overall Study|Adverse Event|2|||
130224616|NCT03311945|468785919|FG000|Overall Study|Lack of Efficacy|1|||
130224617|NCT01619878|468785920|FG000|6 Week Follow-up Phase|Adverse Event|1|||
130224618|NCT01619878|468785920|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
130224619|NCT01619878|468785920|FG000|Follow-up at 12 Months of Age|Death|2|||
130224620|NCT02895295|468785923|FG000|Overall Study|Survey Non-response|71|||
130224621|NCT02895295|468785924|FG001|Overall Study|Survey Non-response|94|||
130224622|NCT02895295|468785925|FG002|Overall Study|Survey Non-response|92|||
130224623|NCT04821830|468785926|FG000|Overall Study|Withdrawal by Subject|1|||
130224624|NCT04821830|468785927|FG001|Overall Study|Withdrawal by Subject|0|||
130224625|NCT00960804|468785928|FG000|Overall Study|Adverse Event|1|||
130224626|NCT00960804|468785929|FG001|Overall Study|Adverse Event|0|||
130224627|NCT00960804|468785930|FG002|Overall Study|Adverse Event|0|||
130224628|NCT00960804|468785928|FG000|Overall Study|Withdrawal by Subject|1|||
130224629|NCT00960804|468785929|FG001|Overall Study|Withdrawal by Subject|0|||
130224630|NCT00960804|468785930|FG002|Overall Study|Withdrawal by Subject|0|||
130224631|NCT00960804|468785928|FG000|Overall Study|Study terminated by the sponsor|5|||
130224632|NCT00960804|468785929|FG001|Overall Study|Study terminated by the sponsor|4|||
130224633|NCT00960804|468785930|FG002|Overall Study|Study terminated by the sponsor|10|||
130224634|NCT03810456|468785931|FG000|Treatment|Urgent Family Matters|3|||
130224635|NCT03810456|468785932|FG001|Treatment|Urgent Family Matters|0|||
130224636|NCT03810456|468785933|FG002|Treatment|Urgent Family Matters|0|||
130224637|NCT03810456|468785931|FG000|Treatment|Scheduling Conflicts|0|||
130224638|NCT03810456|468785932|FG001|Treatment|Scheduling Conflicts|11|||
130224639|NCT03810456|468785933|FG002|Treatment|Scheduling Conflicts|0|||
130224640|NCT03810456|468785931|FG000|Treatment|No Longer Interested|0|||
130224641|NCT03810456|468785932|FG001|Treatment|No Longer Interested|12|||
130224642|NCT03810456|468785933|FG002|Treatment|No Longer Interested|0|||
130224643|NCT03810456|468785931|FG000|Treatment|Transportation Issues|0|||
130224644|NCT03810456|468785932|FG001|Treatment|Transportation Issues|1|||
130224645|NCT03810456|468785933|FG002|Treatment|Transportation Issues|0|||
130224646|NCT03810456|468785931|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
130224647|NCT03810456|468785932|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
130224648|NCT03810456|468785933|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
130224649|NCT03810456|468785931|FG000|1 Month Follow-Up|Relocated to Different State|1|||
130224650|NCT03810456|468785932|FG001|1 Month Follow-Up|Relocated to Different State|0|||
130224651|NCT03810456|468785933|FG002|1 Month Follow-Up|Relocated to Different State|1|||
130224652|NCT03810456|468785931|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
130224653|NCT03810456|468785932|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
130224654|NCT03810456|468785933|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
130224655|NCT03810456|468785931|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
130224656|NCT03810456|468785932|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
130224657|NCT03810456|468785933|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
130224658|NCT03810456|468785931|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
130224659|NCT03810456|468785932|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
130224660|NCT03810456|468785933|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
130224661|NCT03810456|468785931|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
130224662|NCT03810456|468785932|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
130224663|NCT03810456|468785933|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
130224664|NCT03810456|468785931|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
130224665|NCT03810456|468785932|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
130224666|NCT03810456|468785933|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
130224667|NCT00490919|468785934|FG000|Open-label Run-in Period|Adverse Event|239|||
130224668|NCT00490919|468785935|FG001|Open-label Run-in Period|Adverse Event|0|||
130224669|NCT00490919|468785936|FG002|Open-label Run-in Period|Adverse Event|0|||
130224670|NCT00490919|468785934|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
130224671|NCT00490919|468785935|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130224672|NCT00490919|468785936|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130224673|NCT00490919|468785934|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
130224674|NCT00490919|468785935|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130224675|NCT00490919|468785936|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130224676|NCT00490919|468785934|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
130224677|NCT00490919|468785935|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130224678|NCT00490919|468785936|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130224679|NCT00490919|468785934|FG000|Open-label Run-in Period|Administrative|40|||
130224680|NCT00490919|468785935|FG001|Open-label Run-in Period|Administrative|0|||
130224681|NCT00490919|468785936|FG002|Open-label Run-in Period|Administrative|0|||
130224682|NCT00490919|468785934|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
130224683|NCT00490919|468785935|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130224684|NCT00490919|468785936|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130224685|NCT00490919|468785934|FG000|Double-blind Phase|Adverse Event|0|||
130224686|NCT00490919|468785935|FG001|Double-blind Phase|Adverse Event|40|||
130224687|NCT00490919|468785936|FG002|Double-blind Phase|Adverse Event|20|||
130224688|NCT00490919|468785934|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130224689|NCT00490919|468785935|FG001|Double-blind Phase|Withdrawal by Subject|10|||
130224690|NCT00490919|468785936|FG002|Double-blind Phase|Withdrawal by Subject|11|||
130224691|NCT00490919|468785934|FG000|Double-blind Phase|Lost to Follow-up|0|||
130224692|NCT00490919|468785935|FG001|Double-blind Phase|Lost to Follow-up|8|||
130224693|NCT00490919|468785936|FG002|Double-blind Phase|Lost to Follow-up|11|||
130224694|NCT00490919|468785934|FG000|Double-blind Phase|Lack of Efficacy|0|||
130224695|NCT00490919|468785935|FG001|Double-blind Phase|Lack of Efficacy|22|||
130224696|NCT00490919|468785936|FG002|Double-blind Phase|Lack of Efficacy|36|||
130224697|NCT00490919|468785934|FG000|Double-blind Phase|Administrative|0|||
130224698|NCT00490919|468785935|FG001|Double-blind Phase|Administrative|6|||
130224699|NCT00490919|468785936|FG002|Double-blind Phase|Administrative|6|||
130224700|NCT03163446|468787918|FG000|Overall Study|Unable to return for Day 180 visit|2|||
130224701|NCT03163446|468787919|FG001|Overall Study|Unable to return for Day 180 visit|0|||
130224702|NCT03163446|468787918|FG000|Overall Study|Withdrawal by Subject|2|||
130224703|NCT03163446|468787919|FG001|Overall Study|Withdrawal by Subject|6|||
130224704|NCT03163446|468787918|FG000|Overall Study|Death|16|||
130224705|NCT03163446|468787919|FG001|Overall Study|Death|5|||
130224706|NCT03163446|468787918|FG000|Overall Study|Lost to Follow-up|6|||
130224707|NCT03163446|468787919|FG001|Overall Study|Lost to Follow-up|5|||
130224708|NCT03163446|468787918|FG000|Overall Study|Physician Decision|1|||
130224709|NCT03163446|468787919|FG001|Overall Study|Physician Decision|1|||
130224710|NCT03163446|468787918|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
130224711|NCT03163446|468787919|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
130224712|NCT01317641|468787920|FG000|Overall Study|Not treated|0|||
130224713|NCT01317641|468787921|FG001|Overall Study|Not treated|0|||
130224714|NCT01317641|468787922|FG002|Overall Study|Not treated|0|||
130224715|NCT01317641|468787923|FG003|Overall Study|Not treated|0|||
130224716|NCT01317641|468787924|FG004|Overall Study|Not treated|0|||
130224717|NCT01317641|468787925|FG005|Overall Study|Not treated|0|||
130224718|NCT01317641|468787926|FG006|Overall Study|Not treated|0|||
130224719|NCT01317641|468787927|FG007|Overall Study|Not treated|1|||
130224720|NCT01317641|468787928|FG008|Overall Study|Not treated|1|||
130443377|NCT01216293|469586942|FG000|Main Study|Adverse Event|1|||
130443378|NCT01216293|469586943|FG001|Main Study|Adverse Event|4|||
130443379|NCT01216293|469586944|FG002|Main Study|Adverse Event|2|||
130443380|NCT01216293|469586942|FG000|Main Study|Major Protocol Deviation|1|||
130224721|NCT01317641|468787920|FG000|Overall Study|Adverse Event|0|||
130224722|NCT01317641|468787921|FG001|Overall Study|Adverse Event|1|||
130224723|NCT01317641|468787922|FG002|Overall Study|Adverse Event|0|||
130224724|NCT01317641|468787923|FG003|Overall Study|Adverse Event|1|||
130224725|NCT01317641|468787924|FG004|Overall Study|Adverse Event|0|||
130224726|NCT01317641|468787925|FG005|Overall Study|Adverse Event|0|||
130224727|NCT01317641|468787926|FG006|Overall Study|Adverse Event|2|||
130224728|NCT01317641|468787927|FG007|Overall Study|Adverse Event|1|||
130224729|NCT01317641|468787928|FG008|Overall Study|Adverse Event|0|||
130224730|NCT01317641|468787920|FG000|Overall Study|Protocol Violation|1|||
130224731|NCT01317641|468787921|FG001|Overall Study|Protocol Violation|0|||
130224732|NCT01317641|468787922|FG002|Overall Study|Protocol Violation|0|||
130224733|NCT01317641|468787923|FG003|Overall Study|Protocol Violation|0|||
130224734|NCT01317641|468787924|FG004|Overall Study|Protocol Violation|0|||
130443381|NCT01216293|469586943|FG001|Main Study|Major Protocol Deviation|0|||
130443382|NCT01216293|469586944|FG002|Main Study|Major Protocol Deviation|1|||
130443383|NCT01216293|469586942|FG000|Main Study|Lost to Follow-up|3|||
130224735|NCT01317641|468787925|FG005|Overall Study|Protocol Violation|0|||
130224736|NCT01317641|468787926|FG006|Overall Study|Protocol Violation|0|||
130224737|NCT01317641|468787927|FG007|Overall Study|Protocol Violation|0|||
130224738|NCT01317641|468787928|FG008|Overall Study|Protocol Violation|0|||
130224739|NCT01317641|468787920|FG000|Overall Study|Disease progression|0|||
130224740|NCT01317641|468787921|FG001|Overall Study|Disease progression|0|||
130224741|NCT01317641|468787922|FG002|Overall Study|Disease progression|0|||
130224742|NCT01317641|468787923|FG003|Overall Study|Disease progression|0|||
130443384|NCT01216293|469586943|FG001|Main Study|Lost to Follow-up|1|||
130224743|NCT01317641|468787924|FG004|Overall Study|Disease progression|0|||
130224744|NCT01317641|468787925|FG005|Overall Study|Disease progression|0|||
130224745|NCT01317641|468787926|FG006|Overall Study|Disease progression|0|||
130224746|NCT01317641|468787927|FG007|Overall Study|Disease progression|3|||
130224747|NCT01317641|468787928|FG008|Overall Study|Disease progression|4|||
130224748|NCT01317641|468787920|FG000|Overall Study|Withdrawal by Subject|0|||
130224749|NCT01317641|468787921|FG001|Overall Study|Withdrawal by Subject|0|||
130224750|NCT01317641|468787922|FG002|Overall Study|Withdrawal by Subject|0|||
130224751|NCT01317641|468787923|FG003|Overall Study|Withdrawal by Subject|0|||
130224752|NCT01317641|468787924|FG004|Overall Study|Withdrawal by Subject|0|||
130224753|NCT01317641|468787925|FG005|Overall Study|Withdrawal by Subject|0|||
130224754|NCT01317641|468787926|FG006|Overall Study|Withdrawal by Subject|1|||
130224755|NCT01317641|468787927|FG007|Overall Study|Withdrawal by Subject|0|||
130224756|NCT01317641|468787928|FG008|Overall Study|Withdrawal by Subject|0|||
130224757|NCT01228591|468787929|FG000|Baseline|Lack of Efficacy|1|||
130224758|NCT01228591|468787930|FG001|Baseline|Lack of Efficacy|2|||
130224759|NCT01921517|468787931|FG000|Overall Study|Lost to Follow-up|5|||
130224760|NCT01921517|468787932|FG001|Overall Study|Lost to Follow-up|0|||
130224761|NCT01921517|468787931|FG000|Overall Study|Newly diagnosed health concern|2|||
130224762|NCT01921517|468787932|FG001|Overall Study|Newly diagnosed health concern|0|||
130224763|NCT01921517|468787931|FG000|Overall Study|Physician Decision|0|||
130224764|NCT01921517|468787932|FG001|Overall Study|Physician Decision|2|||
130224765|NCT01921517|468787931|FG000|Overall Study|Withdrawal by Subject|7|||
130224766|NCT01921517|468787932|FG001|Overall Study|Withdrawal by Subject|3|||
130224767|NCT01921517|468787931|FG000|Overall Study|Subject missed final imaging|1|||
130224768|NCT01921517|468787932|FG001|Overall Study|Subject missed final imaging|4|||
130224769|NCT03110354|468787938|FG000|Overall Study|Death|1|||
130224770|NCT03110354|468787939|FG001|Overall Study|Death|0|||
130224771|NCT03110354|468787940|FG002|Overall Study|Death|0|||
130224772|NCT03110354|468787941|FG003|Overall Study|Death|1|||
130224773|NCT03110354|468787942|FG004|Overall Study|Death|0|||
130224774|NCT03110354|468787938|FG000|Overall Study|Start of new therapy|0|||
130224775|NCT03110354|468787939|FG001|Overall Study|Start of new therapy|0|||
130224776|NCT03110354|468787940|FG002|Overall Study|Start of new therapy|0|||
130224777|NCT03110354|468787941|FG003|Overall Study|Start of new therapy|0|||
130224778|NCT03110354|468787942|FG004|Overall Study|Start of new therapy|1|||
130224779|NCT03110354|468787938|FG000|Overall Study|Failure to achieve response|2|||
130224780|NCT03110354|468787939|FG001|Overall Study|Failure to achieve response|3|||
130224781|NCT03110354|468787940|FG002|Overall Study|Failure to achieve response|0|||
130224782|NCT03110354|468787941|FG003|Overall Study|Failure to achieve response|2|||
130224783|NCT03110354|468787942|FG004|Overall Study|Failure to achieve response|1|||
130224784|NCT03110354|468787938|FG000|Overall Study|Progressive disease|1|||
130224785|NCT03110354|468787939|FG001|Overall Study|Progressive disease|1|||
130224786|NCT03110354|468787940|FG002|Overall Study|Progressive disease|3|||
130224787|NCT03110354|468787941|FG003|Overall Study|Progressive disease|4|||
130224788|NCT03110354|468787942|FG004|Overall Study|Progressive disease|2|||
130224789|NCT03110354|468787938|FG000|Overall Study|Adverse Event|0|||
130224790|NCT03110354|468787939|FG001|Overall Study|Adverse Event|0|||
130224791|NCT03110354|468787940|FG002|Overall Study|Adverse Event|0|||
130224792|NCT03110354|468787941|FG003|Overall Study|Adverse Event|2|||
130224793|NCT03110354|468787942|FG004|Overall Study|Adverse Event|2|||
130224794|NCT03110354|468787938|FG000|Overall Study|Other|0|||
130224795|NCT03110354|468787939|FG001|Overall Study|Other|0|||
130224796|NCT03110354|468787940|FG002|Overall Study|Other|0|||
130224797|NCT03110354|468787941|FG003|Overall Study|Other|1|||
130224798|NCT03110354|468787942|FG004|Overall Study|Other|1|||
130224799|NCT00116688|468787948|FG000|Overall Study|Protocol deviation|1|||
130224800|NCT00116688|468787949|FG001|Overall Study|Protocol deviation|0|||
130443385|NCT01216293|469586944|FG002|Main Study|Lost to Follow-up|0|||
130443386|NCT01216293|469586942|FG000|Main Study|Voluntary Withdrawal|2|||
130443387|NCT01216293|469586943|FG001|Main Study|Voluntary Withdrawal|2|||
130443388|NCT01216293|469586944|FG002|Main Study|Voluntary Withdrawal|2|||
130443389|NCT01216293|469586942|FG000|Main Study|Other Reason Not Specified|0|||
130443390|NCT01216293|469586943|FG001|Main Study|Other Reason Not Specified|1|||
130443391|NCT01216293|469586944|FG002|Main Study|Other Reason Not Specified|1|||
130443392|NCT01216293|469586942|FG000|Main Study|Randomized, Not Treated|1|||
130443393|NCT01216293|469586943|FG001|Main Study|Randomized, Not Treated|0|||
130443394|NCT01216293|469586944|FG002|Main Study|Randomized, Not Treated|0|||
130224801|NCT00116688|468787948|FG000|Overall Study|Noncompliance|3|||
130224802|NCT00116688|468787949|FG001|Overall Study|Noncompliance|1|||
130224803|NCT00116688|468787948|FG000|Overall Study|Adverse Event|11|||
130224804|NCT00116688|468787949|FG001|Overall Study|Adverse Event|0|||
130224805|NCT00116688|468787948|FG000|Overall Study|Withdrawal by Subject|26|||
130224806|NCT00116688|468787949|FG001|Overall Study|Withdrawal by Subject|2|||
130224807|NCT00116688|468787948|FG000|Overall Study|Requirement for alternative therapy|11|||
130224808|NCT00116688|468787949|FG001|Overall Study|Requirement for alternative therapy|1|||
130224809|NCT00116688|468787948|FG000|Overall Study|Physician Decision|7|||
130224810|NCT00116688|468787949|FG001|Overall Study|Physician Decision|0|||
130224811|NCT00116688|468787948|FG000|Overall Study|Lost to Follow-up|3|||
130224812|NCT00116688|468787949|FG001|Overall Study|Lost to Follow-up|0|||
130224813|NCT00116688|468787948|FG000|Overall Study|Death|15|||
130224814|NCT00116688|468787949|FG001|Overall Study|Death|0|||
130687259|NCT02760368|470481393|FG002|Overall Study|Screen Failure|1|||
130687260|NCT02760368|470481391|FG000|Overall Study|Death|0|||
130687261|NCT02760368|470481392|FG001|Overall Study|Death|1|||
130687262|NCT02760368|470481393|FG002|Overall Study|Death|0|||
130687263|NCT02760368|470481391|FG000|Overall Study|Withdrawal by Sponsor|0|||
130687264|NCT02760368|470481392|FG001|Overall Study|Withdrawal by Sponsor|0|||
130687265|NCT02760368|470481393|FG002|Overall Study|Withdrawal by Sponsor|1|||
130687266|NCT02714062|470481394|FG000|Overall Study|Adverse Event|0|||
130687267|NCT02714062|470481395|FG001|Overall Study|Adverse Event|0|||
130687268|NCT02714062|470481396|FG002|Overall Study|Adverse Event|2|||
130687269|NCT02714062|470481394|FG000|Overall Study|Withdrawal by Subject|1|||
130687270|NCT02714062|470481395|FG001|Overall Study|Withdrawal by Subject|0|||
130687271|NCT02714062|470481396|FG002|Overall Study|Withdrawal by Subject|1|||
130687272|NCT02714062|470481394|FG000|Overall Study|Protocol Violation|0|||
130687273|NCT02714062|470481395|FG001|Overall Study|Protocol Violation|1|||
130687274|NCT02714062|470481396|FG002|Overall Study|Protocol Violation|0|||
130687275|NCT02294604|470481397|FG000|Overall Study|Did not provide samples for culture|0|||
130687276|NCT02294604|470481398|FG001|Overall Study|Did not provide samples for culture|1|||
130687277|NCT02294604|470481399|FG002|Overall Study|Did not provide samples for culture|0|||
130687278|NCT02294604|470481397|FG000|Overall Study|Culture contamination|1|||
130687279|NCT02294604|470481398|FG001|Overall Study|Culture contamination|2|||
130687280|NCT02294604|470481399|FG002|Overall Study|Culture contamination|0|||
130687281|NCT02902211|470481404|FG000|First Three Months|Withdrawal by Subject|7|||
130687282|NCT02902211|470481405|FG001|First Three Months|Withdrawal by Subject|3|||
130687283|NCT01200810|470481415|FG000|Overall Study|Physician Decision|1|||
130687284|NCT01200810|470481416|FG001|Overall Study|Physician Decision|0|||
130687285|NCT01200810|470481415|FG000|Overall Study|Withdrawal by Subject|1|||
130687286|NCT01200810|470481416|FG001|Overall Study|Withdrawal by Subject|2|||
130687287|NCT01200810|470481415|FG000|Overall Study|Sponsor stopped making study drug|3|||
130687288|NCT01200810|470481416|FG001|Overall Study|Sponsor stopped making study drug|3|||
130687289|NCT00904215|470481418|FG000|Overall Study|Adverse Event|25|||
130687290|NCT00904215|470481418|FG000|Overall Study|Protocol Violation|10|||
130687291|NCT00904215|470481418|FG000|Overall Study|Lost to Follow-up|63|||
130687292|NCT00904215|470481418|FG000|Overall Study|Withdrawal by Subject|9|||
130687293|NCT00904215|470481418|FG000|Overall Study|Other|28|||
130687294|NCT00960297|470481419|FG000|Overall Study|Physician Decision|1|||
130687295|NCT00960297|470481419|FG000|Overall Study|Venous port infection|1|||
130687296|NCT00960297|470481419|FG000|Overall Study|Disease progression|1|||
130687297|NCT00838630|470481428|FG000|First Intervention|Adverse Event|1|||
130687298|NCT00838630|470481429|FG001|First Intervention|Adverse Event|0|||
130687299|NCT00838630|470481428|FG000|Washout: 7 Days|Protocol Violation|1|||
130687300|NCT00838630|470481429|FG001|Washout: 7 Days|Protocol Violation|0|||
130687301|NCT02159950|470481437|FG000|Overall Study|Adverse Event|0|||
130687302|NCT02159950|470481438|FG001|Overall Study|Adverse Event|1|||
130687303|NCT02159950|470481437|FG000|Overall Study|Progression|0|||
130687304|NCT02159950|470481438|FG001|Overall Study|Progression|1|||
130687305|NCT03925532|470481439|FG000|Overall Study|Lost to Follow-up|1|||
130687306|NCT01208337|470481440|FG000|Overall Study|Death|3|||
130687307|NCT03663179|470481444|FG000|Overall Study|Withdrawal by Subject|2|||
130687308|NCT03663179|470481445|FG001|Overall Study|Withdrawal by Subject|0|||
130687309|NCT03663179|470481444|FG000|Overall Study|Lost to Follow-up|1|||
130687310|NCT03663179|470481445|FG001|Overall Study|Lost to Follow-up|1|||
130687311|NCT03663179|470481444|FG000|Overall Study|Revealed exclusionary condition|1|||
130687312|NCT03663179|470481445|FG001|Overall Study|Revealed exclusionary condition|0|||
130687313|NCT01615198|470481446|FG000|Overall Study|Withdrawal by Subject|5|||
130687314|NCT01615198|470481447|FG001|Overall Study|Withdrawal by Subject|5|||
130687315|NCT01615198|470481446|FG000|Overall Study|Protocol deviation|1|||
130687316|NCT01615198|470481447|FG001|Overall Study|Protocol deviation|1|||
130687317|NCT01615198|470481446|FG000|Overall Study|Physician Decision|5|||
130687318|NCT01615198|470481447|FG001|Overall Study|Physician Decision|1|||
130687319|NCT01615198|470481446|FG000|Overall Study|Lost to Follow-up|1|||
130687320|NCT01615198|470481447|FG001|Overall Study|Lost to Follow-up|1|||
130687321|NCT01615198|470481446|FG000|Overall Study|Lack of Efficacy|1|||
130355954|NCT01070043|469274606|FG002|Double-Blind Treatment|Adverse Event|2|||
130552864|NCT01290601|469991599|FG003|Overall Study|Lost to Follow-up|0|||
130687322|NCT01615198|470481447|FG001|Overall Study|Lack of Efficacy|6|||
130687323|NCT01615198|470481446|FG000|Overall Study|Adverse Event|11|||
130687324|NCT01615198|470481447|FG001|Overall Study|Adverse Event|5|||
130687325|NCT02196675|470481448|FG000|Overall Study|Withdrawal by Subject|1|||
130687326|NCT02196675|470481449|FG001|Overall Study|Withdrawal by Subject|0|||
130687327|NCT02196675|470481450|FG002|Overall Study|Withdrawal by Subject|0|||
130687328|NCT02196675|470481448|FG000|Overall Study|Intra-operative surgical exclusion|1|||
130687329|NCT02196675|470481449|FG001|Overall Study|Intra-operative surgical exclusion|1|||
130687330|NCT02196675|470481450|FG002|Overall Study|Intra-operative surgical exclusion|0|||
130687331|NCT02196675|470481448|FG000|Overall Study|Protocol Violation|0|||
130687332|NCT02196675|470481449|FG001|Overall Study|Protocol Violation|1|||
130687333|NCT02196675|470481450|FG002|Overall Study|Protocol Violation|0|||
130687334|NCT02196675|470481448|FG000|Overall Study|Death|0|||
130224815|NCT00116688|468787948|FG000|Overall Study|Protocol-specified criteria|3|||
130224816|NCT00116688|468787949|FG001|Overall Study|Protocol-specified criteria|0|||
130224817|NCT00116688|468787948|FG000|Overall Study|Pregnancy|1|||
130224818|NCT00116688|468787949|FG001|Overall Study|Pregnancy|0|||
130224819|NCT00116688|468787948|FG000|Overall Study|Other|11|||
130224820|NCT00116688|468787949|FG001|Overall Study|Other|0|||
130224821|NCT01775670|468787954|FG000|Overall Study|Lost to Follow-up|1|||
130224822|NCT01775670|468787955|FG001|Overall Study|Lost to Follow-up|1|||
130224823|NCT01298700|468787956|FG000|Overall Study|Adverse Event|50|||
130224824|NCT01298700|468787957|FG001|Overall Study|Adverse Event|51|||
130224825|NCT01298700|468787956|FG000|Overall Study|Lack of Efficacy|9|||
130224826|NCT01298700|468787957|FG001|Overall Study|Lack of Efficacy|14|||
130224827|NCT01298700|468787956|FG000|Overall Study|Lost to Follow-up|5|||
130224828|NCT01298700|468787957|FG001|Overall Study|Lost to Follow-up|2|||
130224829|NCT01298700|468787956|FG000|Overall Study|Withdrawal by Subject|12|||
130224830|NCT01298700|468787957|FG001|Overall Study|Withdrawal by Subject|9|||
130224831|NCT01298700|468787956|FG000|Overall Study|Protocol Violation|6|||
130224832|NCT01298700|468787957|FG001|Overall Study|Protocol Violation|4|||
130224833|NCT01298700|468787956|FG000|Overall Study|Other Miscellaneous Reasons|16|||
130224834|NCT01298700|468787957|FG001|Overall Study|Other Miscellaneous Reasons|15|||
130224835|NCT01298700|468787956|FG000|Overall Study|Did not Receive Study Drug|3|||
130224836|NCT01298700|468787957|FG001|Overall Study|Did not Receive Study Drug|5|||
130224837|NCT04006145|468787960|FG000|Overall Study|Lost to Follow-up|0|||
130224838|NCT04006145|468787961|FG001|Overall Study|Lost to Follow-up|1|||
130224839|NCT04006145|468787960|FG000|Overall Study|Other|1|||
130224840|NCT04006145|468787961|FG001|Overall Study|Other|2|||
130224841|NCT00010257|468787964|FG000|Overall Study|Withdrawal by Subject|1|||
130224842|NCT00010257|468787965|FG001|Overall Study|Withdrawal by Subject|0|||
130224843|NCT00643760|468787966|FG000|Overall Study|Adverse Event|11|||
130224844|NCT00643760|468787967|FG001|Overall Study|Adverse Event|5|||
130224845|NCT00643760|468787968|FG002|Overall Study|Adverse Event|12|||
130224846|NCT00643760|468787969|FG003|Overall Study|Adverse Event|21|||
130224847|NCT00643760|468787970|FG004|Overall Study|Adverse Event|6|||
130224848|NCT00643760|468787966|FG000|Overall Study|Lack of Efficacy|3|||
130224849|NCT00643760|468787967|FG001|Overall Study|Lack of Efficacy|1|||
130224850|NCT00643760|468787968|FG002|Overall Study|Lack of Efficacy|0|||
130224851|NCT00643760|468787969|FG003|Overall Study|Lack of Efficacy|4|||
130224852|NCT00643760|468787970|FG004|Overall Study|Lack of Efficacy|3|||
130224853|NCT00643760|468787966|FG000|Overall Study|Protocol Violation|7|||
130224854|NCT00643760|468787967|FG001|Overall Study|Protocol Violation|6|||
130224855|NCT00643760|468787968|FG002|Overall Study|Protocol Violation|4|||
130224856|NCT00643760|468787969|FG003|Overall Study|Protocol Violation|4|||
130224857|NCT00643760|468787970|FG004|Overall Study|Protocol Violation|6|||
130224858|NCT00643760|468787966|FG000|Overall Study|Lost to Follow-up|6|||
130224859|NCT00643760|468787967|FG001|Overall Study|Lost to Follow-up|2|||
130224860|NCT00643760|468787968|FG002|Overall Study|Lost to Follow-up|1|||
130224861|NCT00643760|468787969|FG003|Overall Study|Lost to Follow-up|3|||
130224862|NCT00643760|468787970|FG004|Overall Study|Lost to Follow-up|3|||
130224863|NCT00643760|468787966|FG000|Overall Study|Investigator Discretion|0|||
130224864|NCT00643760|468787967|FG001|Overall Study|Investigator Discretion|0|||
130224865|NCT00643760|468787968|FG002|Overall Study|Investigator Discretion|0|||
130224866|NCT00643760|468787969|FG003|Overall Study|Investigator Discretion|2|||
130224867|NCT00643760|468787970|FG004|Overall Study|Investigator Discretion|0|||
130224868|NCT00643760|468787966|FG000|Overall Study|Withdrawal by Subject|3|||
130224869|NCT00643760|468787967|FG001|Overall Study|Withdrawal by Subject|1|||
130224870|NCT00643760|468787968|FG002|Overall Study|Withdrawal by Subject|2|||
130224871|NCT00643760|468787969|FG003|Overall Study|Withdrawal by Subject|4|||
130224872|NCT00643760|468787970|FG004|Overall Study|Withdrawal by Subject|1|||
130224873|NCT00104052|468787974|FG000|Overall Study|Adverse Event|1|||
130224874|NCT00104052|468787974|FG000|Overall Study|Lack of Efficacy|26|||
130355955|NCT00473746|469274607|FG000|Period 1 (Phase 1)|Adverse Event|1|||
130224875|NCT00104052|468787974|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
130355956|NCT00473746|469274608|FG001|Period 1 (Phase 1)|Adverse Event|0|||
130224876|NCT01241279|468787979|FG000|Overall Study|Lost to Follow-up|0|||
130224877|NCT01241279|468787980|FG001|Overall Study|Lost to Follow-up|1|||
130224878|NCT00239720|468787981|FG000|Overall Study|Adverse Event|1|||
130355957|NCT00473746|469274609|FG002|Period 1 (Phase 1)|Adverse Event|0|||
130355958|NCT00473746|469274610|FG003|Period 1 (Phase 1)|Adverse Event|0|||
130355959|NCT00473746|469274611|FG004|Period 1 (Phase 1)|Adverse Event|0|||
130224879|NCT00239720|468787982|FG001|Overall Study|Adverse Event|0|||
130224880|NCT00239720|468787981|FG000|Overall Study|Lost to Follow-up|0|||
130224881|NCT00239720|468787982|FG001|Overall Study|Lost to Follow-up|1|||
130224882|NCT01145482|468787983|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130355960|NCT00473746|469274607|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130224883|NCT01145482|468787984|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130355961|NCT00473746|469274608|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
130355962|NCT00473746|469274609|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130224884|NCT01405560|468787987|FG000|Overall Study|Physician Decision|1|||
130224885|NCT01699750|468787989|FG000|Overall Study|Withdrew Consent|0|||
130224886|NCT01699750|468787990|FG001|Overall Study|Withdrew Consent|1|||
130224887|NCT01699750|468787989|FG000|Overall Study|Other|0|||
130224888|NCT01699750|468787990|FG001|Overall Study|Other|2|||
130224889|NCT01484951|468787991|FG000|Overall Study|Adverse Event|3|||
130224890|NCT01484951|468787991|FG000|Overall Study|Personal Reasons|1|||
130224891|NCT01484951|468787991|FG000|Overall Study|Non-Compliance|1|||
130224892|NCT02119299|468787992|FG000|Overall Study|Withdrawal by Subject|7|||
130224893|NCT02119299|468787992|FG000|Overall Study|Lack of Efficacy|1|||
130224894|NCT02119299|468787992|FG000|Overall Study|Pregnancy|1|||
130224895|NCT02452047|468787993|FG000|Overall Study|Adverse Event|0|||
130224896|NCT02452047|468787994|FG001|Overall Study|Adverse Event|1|||
130224897|NCT02452047|468787995|FG002|Overall Study|Adverse Event|1|||
130224898|NCT02452047|468787993|FG000|Overall Study|Death|1|||
130224899|NCT02452047|468787994|FG001|Overall Study|Death|3|||
130224900|NCT02452047|468787995|FG002|Overall Study|Death|1|||
130224901|NCT02452047|468787993|FG000|Overall Study|Physician Decision|1|||
130224902|NCT02452047|468787994|FG001|Overall Study|Physician Decision|0|||
130224903|NCT02452047|468787995|FG002|Overall Study|Physician Decision|0|||
130224904|NCT02452047|468787993|FG000|Overall Study|Lost to Follow-up|1|||
130224905|NCT02452047|468787994|FG001|Overall Study|Lost to Follow-up|1|||
130224906|NCT02452047|468787995|FG002|Overall Study|Lost to Follow-up|0|||
130224907|NCT02452047|468787993|FG000|Overall Study|Withdrawal by Subject|1|||
130224908|NCT02452047|468787994|FG001|Overall Study|Withdrawal by Subject|0|||
130224909|NCT02452047|468787995|FG002|Overall Study|Withdrawal by Subject|0|||
130224910|NCT01249417|468787996|FG000|Randomised Population|Study treatment not received|0|||
130224911|NCT01249417|468787997|FG001|Randomised Population|Study treatment not received|0|||
130224912|NCT01249417|468787998|FG002|Randomised Population|Study treatment not received|2|||
130224913|NCT01249417|468787996|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130224914|NCT01249417|468787997|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130224915|NCT01249417|468787998|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
130224916|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Other|0|||
130224917|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Other|0|||
130224918|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Other|1|||
130224919|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
130224920|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
130224921|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
130224922|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
130224923|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
130224924|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
130224925|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
130224926|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130224927|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130224928|NCT00917124|468787999|FG000|Overall Study|Protocol Violation|4|||
130224929|NCT00917124|468788000|FG001|Overall Study|Protocol Violation|6|||
130224930|NCT00126594|468788002|FG000|Overall Study|Ineligible|2|||
130224931|NCT00126594|468788003|FG001|Overall Study|Ineligible|0|||
130224932|NCT00126594|468788002|FG000|Overall Study|Withdrawal by Subject|0|||
130224933|NCT00126594|468788003|FG001|Overall Study|Withdrawal by Subject|4|||
130224934|NCT00126594|468788002|FG000|Overall Study|Physician Decision|1|||
130224935|NCT00126594|468788003|FG001|Overall Study|Physician Decision|3|||
130224936|NCT00126594|468788002|FG000|Overall Study|Adverse Event|7|||
130224937|NCT00126594|468788003|FG001|Overall Study|Adverse Event|5|||
130224938|NCT00126594|468788002|FG000|Overall Study|Non-compliance|0|||
130224939|NCT00126594|468788003|FG001|Overall Study|Non-compliance|1|||
130224940|NCT00126594|468788002|FG000|Overall Study|Disease Progression|29|||
130224941|NCT00126594|468788003|FG001|Overall Study|Disease Progression|24|||
130224942|NCT03769649|468788004|FG000|Overall Study|Lost to Follow-up|4|||
130224943|NCT01290718|468788007|FG000|Overall Study|Early termination of the study|4|||
130224944|NCT00473655|468788008|FG000|Overall Study|Lost to Follow-up|9|||
130687335|NCT02196675|470481449|FG001|Overall Study|Death|0|||
130687336|NCT02196675|470481450|FG002|Overall Study|Death|1|||
130687337|NCT02414152|470481451|FG000|Overall Study|Withdrawal by Subject|1|||
130224945|NCT00473655|468788009|FG001|Overall Study|Lost to Follow-up|5|||
130224946|NCT00473655|468788010|FG002|Overall Study|Lost to Follow-up|8|||
130224947|NCT00243919|468788011|FG000|Overall Study|Death|3|||
130224948|NCT00243919|468788012|FG001|Overall Study|Death|4|||
130224949|NCT00243919|468788013|FG002|Overall Study|Death|6|||
130224950|NCT00243919|468788011|FG000|Overall Study|Withdrawal by Subject|6|||
130224951|NCT00243919|468788012|FG001|Overall Study|Withdrawal by Subject|6|||
130224952|NCT00243919|468788013|FG002|Overall Study|Withdrawal by Subject|2|||
130224953|NCT00243919|468788011|FG000|Overall Study|Lost to Follow-up|6|||
130224954|NCT00243919|468788012|FG001|Overall Study|Lost to Follow-up|7|||
130224955|NCT00243919|468788013|FG002|Overall Study|Lost to Follow-up|3|||
130224956|NCT00243919|468788011|FG000|Overall Study|Administrative Error|1|||
130224957|NCT00243919|468788012|FG001|Overall Study|Administrative Error|0|||
130224958|NCT00243919|468788013|FG002|Overall Study|Administrative Error|0|||
130687338|NCT02414152|470481451|FG000|Overall Study|Lack of Efficacy|1|||
130224959|NCT00243919|468788011|FG000|Overall Study|Physician Decision|1|||
130224960|NCT00243919|468788012|FG001|Overall Study|Physician Decision|1|||
130224961|NCT00243919|468788013|FG002|Overall Study|Physician Decision|0|||
130224962|NCT01268267|468788014|FG000|Overall Study|Protocol Violation|1|||
130224963|NCT04176939|468788015|FG000|Overall Study|Withdrawal by Subject|5|||
130224964|NCT04176939|468788015|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
130224965|NCT04176939|468788015|FG000|Overall Study|Lost to Follow-up|2|||
130224966|NCT04176939|468788015|FG000|Overall Study|Unspecified reason|4|||
130224967|NCT04176939|468788015|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
130224968|NCT04919317|468788022|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
130224969|NCT04919317|468788023|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
130224970|NCT04919317|468788022|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
130224971|NCT04919317|468788023|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
130224972|NCT02869789|468788024|FG000|Overall Study|Disease progression|184|||
130224973|NCT02869789|468788025|FG001|Overall Study|Disease progression|109|||
130224974|NCT02869789|468788026|FG002|Overall Study|Disease progression|260|||
130224975|NCT02869789|468788027|FG003|Overall Study|Disease progression|19|||
130224976|NCT02869789|468788024|FG000|Overall Study|Study drug toxicity|90|||
130224977|NCT02869789|468788025|FG001|Overall Study|Study drug toxicity|32|||
130224978|NCT02869789|468788026|FG002|Overall Study|Study drug toxicity|55|||
130224979|NCT02869789|468788027|FG003|Overall Study|Study drug toxicity|14|||
130224980|NCT02869789|468788024|FG000|Overall Study|Death|7|||
130224981|NCT02869789|468788025|FG001|Overall Study|Death|3|||
130224982|NCT02869789|468788026|FG002|Overall Study|Death|5|||
130224983|NCT02869789|468788027|FG003|Overall Study|Death|1|||
130224984|NCT02869789|468788024|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
130224985|NCT02869789|468788025|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
130224986|NCT02869789|468788026|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
130224987|NCT02869789|468788027|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
130224988|NCT02869789|468788024|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130224989|NCT02869789|468788025|FG001|Overall Study|Participant request to discontinue study treatment|5|||
130224990|NCT02869789|468788026|FG002|Overall Study|Participant request to discontinue study treatment|5|||
130224991|NCT02869789|468788027|FG003|Overall Study|Participant request to discontinue study treatment|3|||
130224992|NCT02869789|468788024|FG000|Overall Study|Withdrawal by Subject|5|||
130224993|NCT02869789|468788025|FG001|Overall Study|Withdrawal by Subject|2|||
130224994|NCT02869789|468788026|FG002|Overall Study|Withdrawal by Subject|7|||
130224995|NCT02869789|468788027|FG003|Overall Study|Withdrawal by Subject|2|||
130224996|NCT02869789|468788024|FG000|Overall Study|Lost to Follow-up|0|||
130224997|NCT02869789|468788025|FG001|Overall Study|Lost to Follow-up|0|||
130224998|NCT02869789|468788026|FG002|Overall Study|Lost to Follow-up|2|||
130224999|NCT02869789|468788027|FG003|Overall Study|Lost to Follow-up|0|||
130225000|NCT02869789|468788024|FG000|Overall Study|Maximum clinical benefit|5|||
130225001|NCT02869789|468788025|FG001|Overall Study|Maximum clinical benefit|2|||
130225002|NCT02869789|468788026|FG002|Overall Study|Maximum clinical benefit|1|||
130225003|NCT02869789|468788027|FG003|Overall Study|Maximum clinical benefit|0|||
130225004|NCT02869789|468788024|FG000|Overall Study|Poor/Non-compliance|0|||
130225005|NCT02869789|468788025|FG001|Overall Study|Poor/Non-compliance|2|||
130225006|NCT02869789|468788026|FG002|Overall Study|Poor/Non-compliance|1|||
130225007|NCT02869789|468788027|FG003|Overall Study|Poor/Non-compliance|0|||
130225008|NCT02869789|468788024|FG000|Overall Study|Participant no longer meets study criteria|0|||
130225009|NCT02869789|468788025|FG001|Overall Study|Participant no longer meets study criteria|1|||
130225010|NCT02869789|468788026|FG002|Overall Study|Participant no longer meets study criteria|1|||
130225011|NCT02869789|468788027|FG003|Overall Study|Participant no longer meets study criteria|0|||
130225012|NCT02869789|468788024|FG000|Overall Study|Administrative reason by sponsor|0|||
130225013|NCT02869789|468788025|FG001|Overall Study|Administrative reason by sponsor|0|||
130225014|NCT02869789|468788026|FG002|Overall Study|Administrative reason by sponsor|1|||
130225015|NCT02869789|468788027|FG003|Overall Study|Administrative reason by sponsor|0|||
130225016|NCT02869789|468788024|FG000|Overall Study|Other reasons|4|||
130225017|NCT02869789|468788025|FG001|Overall Study|Other reasons|8|||
130225018|NCT02869789|468788026|FG002|Overall Study|Other reasons|6|||
130225019|NCT02869789|468788027|FG003|Overall Study|Other reasons|0|||
130225020|NCT02127658|468788042|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
130225021|NCT02127658|468788043|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
130355963|NCT00473746|469274610|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130355964|NCT00473746|469274611|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130355965|NCT00473746|469274607|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
130355966|NCT00473746|469274608|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
130355967|NCT00473746|469274609|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
130225022|NCT02127658|468788042|FG000|Overall Study|Withdrawal by Subject|0|||
130225023|NCT02127658|468788043|FG001|Overall Study|Withdrawal by Subject|2|||
130225024|NCT02127658|468788042|FG000|Overall Study|Physician Decision|0|||
130225025|NCT02127658|468788043|FG001|Overall Study|Physician Decision|1|||
130225026|NCT01443858|468788044|FG000|Overall Study|Withdrawal by Subject|9|||
130225027|NCT01443858|468788045|FG001|Overall Study|Withdrawal by Subject|8|||
130687339|NCT01289262|470481452|FG000|Overall Study|Lost to Follow-up|29|||
130687340|NCT01289262|470481453|FG001|Overall Study|Lost to Follow-up|16|||
130687341|NCT01289262|470481452|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
130687342|NCT01289262|470481453|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
130687343|NCT00838279|470481454|FG000|Washout|Protocol Violation|1|||
130687344|NCT00838279|470481455|FG001|Washout|Protocol Violation|0|||
130687345|NCT00838279|470481454|FG000|Washout|Withdrawal by Subject|0|||
130687346|NCT00838279|470481455|FG001|Washout|Withdrawal by Subject|1|||
130687347|NCT01218867|470481458|FG000|Overall Study|Death during treatment|0|||
130687348|NCT01218867|470481459|FG001|Overall Study|Death during treatment|0|||
130687349|NCT01218867|470481460|FG002|Overall Study|Death during treatment|0|||
130687350|NCT01218867|470481461|FG003|Overall Study|Death during treatment|0|||
130687351|NCT01218867|470481462|FG004|Overall Study|Death during treatment|0|||
130687352|NCT01218867|470481463|FG005|Overall Study|Death during treatment|0|||
130687353|NCT01218867|470481464|FG006|Overall Study|Death during treatment|1|||
130225028|NCT01443858|468788046|FG002|Overall Study|Withdrawal by Subject|5|||
130225029|NCT01443858|468788044|FG000|Overall Study|Lack of Efficacy|1|||
130355968|NCT00473746|469274610|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
130687354|NCT01218867|470481465|FG007|Overall Study|Death during treatment|0|||
130687355|NCT01218867|470481466|FG008|Overall Study|Death during treatment|0|||
130687356|NCT01218867|470481467|FG009|Overall Study|Death during treatment|0|||
130687357|NCT01218867|470481468|FG010|Overall Study|Death during treatment|0|||
130687358|NCT03792477|470481469|FG000|Overall Study|Adverse Event|0|||
130687359|NCT03792477|470481470|FG001|Overall Study|Adverse Event|0|||
130687360|NCT03792477|470481471|FG002|Overall Study|Adverse Event|0|||
130687361|NCT03792477|470481472|FG003|Overall Study|Adverse Event|1|||
130687362|NCT03792477|470481473|FG004|Overall Study|Adverse Event|0|||
130687363|NCT03792477|470481469|FG000|Overall Study|Lost to Follow-up|0|||
130687364|NCT03792477|470481470|FG001|Overall Study|Lost to Follow-up|0|||
130687365|NCT03792477|470481471|FG002|Overall Study|Lost to Follow-up|2|||
130687366|NCT03792477|470481472|FG003|Overall Study|Lost to Follow-up|0|||
130687367|NCT03792477|470481473|FG004|Overall Study|Lost to Follow-up|0|||
130687368|NCT03792477|470481469|FG000|Overall Study|Other|0|||
130687369|NCT03792477|470481470|FG001|Overall Study|Other|0|||
130687370|NCT03792477|470481471|FG002|Overall Study|Other|0|||
130687371|NCT03792477|470481472|FG003|Overall Study|Other|0|||
130687372|NCT03792477|470481473|FG004|Overall Study|Other|1|||
130687373|NCT00840411|470481474|FG000|First Intervention|Adverse Event|1|||
130687374|NCT00840411|470481475|FG001|First Intervention|Adverse Event|0|||
130687375|NCT00840411|470481474|FG000|Washout|Withdrawal by Subject|1|||
130687376|NCT00840411|470481475|FG001|Washout|Withdrawal by Subject|0|||
130687377|NCT04419311|470481476|FG000|Overall Study|Lost to Follow-up|1|||
130687378|NCT04419311|470481477|FG001|Overall Study|Lost to Follow-up|0|||
130687379|NCT01921062|470481484|FG000|Overall Study|Withdrawal by Subject|0|||
130687380|NCT01921062|470481485|FG001|Overall Study|Withdrawal by Subject|7|||
130687381|NCT01921062|470481484|FG000|Overall Study|Adverse Event|5|||
130687382|NCT01921062|470481485|FG001|Overall Study|Adverse Event|6|||
130687383|NCT01921062|470481484|FG000|Overall Study|Protocol Violation|0|||
130687384|NCT01921062|470481485|FG001|Overall Study|Protocol Violation|1|||
130687385|NCT01921062|470481484|FG000|Overall Study|VMIQ score > 72|4|||
130355969|NCT00473746|469274611|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
130355970|NCT00473746|469274607|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130355971|NCT00473746|469274608|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
130355972|NCT00473746|469274609|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130355973|NCT00473746|469274610|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130355974|NCT00473746|469274611|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130355975|NCT00473746|469274607|FG000|Period 1 (Phase 1)|Reason not specified|0|||
130355976|NCT00473746|469274608|FG001|Period 1 (Phase 1)|Reason not specified|1|||
130355977|NCT00473746|469274609|FG002|Period 1 (Phase 1)|Reason not specified|0|||
130687386|NCT01921062|470481485|FG001|Overall Study|VMIQ score > 72|1|||
130687387|NCT01921062|470481484|FG000|Overall Study|Logistic error|0|||
130687388|NCT01921062|470481485|FG001|Overall Study|Logistic error|1|||
130687389|NCT00576056|470481486|FG000|Overall Study|Adverse Event|1|||
130687390|NCT00576056|470481486|FG000|Overall Study|Death|1|||
130687391|NCT00576056|470481486|FG000|Overall Study|Lack of Efficacy|1|||
130687392|NCT00576056|470481486|FG000|Overall Study|Withdrawal by Subject|2|||
130687393|NCT00576056|470481486|FG000|Overall Study|did not meet eligibility criteria|8|||
130687394|NCT00576056|470481486|FG000|Overall Study|Physician Decision|1|||
130687395|NCT01854047|470481487|FG000|Overall Study|Lack of Efficacy|1|||
130687396|NCT01854047|470481488|FG001|Overall Study|Lack of Efficacy|0|||
130687397|NCT01854047|470481489|FG002|Overall Study|Lack of Efficacy|0|||
130687398|NCT01854047|470481490|FG003|Overall Study|Lack of Efficacy|0|||
130687399|NCT01854047|470481491|FG004|Overall Study|Lack of Efficacy|0|||
130687400|NCT01854047|470481487|FG000|Overall Study|Poor compliance to protocol|3|||
130687401|NCT01854047|470481488|FG001|Overall Study|Poor compliance to protocol|0|||
130687402|NCT01854047|470481489|FG002|Overall Study|Poor compliance to protocol|2|||
130687403|NCT01854047|470481490|FG003|Overall Study|Poor compliance to protocol|0|||
130687404|NCT01854047|470481491|FG004|Overall Study|Poor compliance to protocol|0|||
130687405|NCT01854047|470481487|FG000|Overall Study|Adverse Event|5|||
130687406|NCT01854047|470481488|FG001|Overall Study|Adverse Event|4|||
130687407|NCT01854047|470481489|FG002|Overall Study|Adverse Event|6|||
130687408|NCT01854047|470481490|FG003|Overall Study|Adverse Event|10|||
130687409|NCT01854047|470481491|FG004|Overall Study|Adverse Event|7|||
130687410|NCT01854047|470481487|FG000|Overall Study|Randomized but not treated|0|||
130687411|NCT01854047|470481488|FG001|Overall Study|Randomized but not treated|1|||
130687412|NCT01854047|470481489|FG002|Overall Study|Randomized but not treated|2|||
130687413|NCT01854047|470481490|FG003|Overall Study|Randomized but not treated|0|||
130687414|NCT01854047|470481491|FG004|Overall Study|Randomized but not treated|4|||
130687415|NCT01854047|470481487|FG000|Overall Study|Other than specified above|3|||
130687416|NCT01854047|470481488|FG001|Overall Study|Other than specified above|3|||
130687417|NCT01854047|470481489|FG002|Overall Study|Other than specified above|3|||
130687418|NCT01854047|470481490|FG003|Overall Study|Other than specified above|5|||
130687419|NCT01854047|470481491|FG004|Overall Study|Other than specified above|8|||
130687420|NCT02441309|470481494|FG000|Overall Study|Disease progression|2|||
130687421|NCT02441309|470481495|FG001|Overall Study|Disease progression|1|||
130687422|NCT02441309|470481496|FG002|Overall Study|Disease progression|2|||
130687423|NCT02441309|470481494|FG000|Overall Study|Adverse Event|0|||
130687424|NCT02441309|470481495|FG001|Overall Study|Adverse Event|1|||
130687425|NCT02441309|470481496|FG002|Overall Study|Adverse Event|0|||
130687426|NCT02441309|470481494|FG000|Overall Study|Withdrawal by Subject|1|||
130687427|NCT02441309|470481495|FG001|Overall Study|Withdrawal by Subject|0|||
130687428|NCT02441309|470481496|FG002|Overall Study|Withdrawal by Subject|1|||
130687429|NCT02175095|470483069|FG000|Overall Study|Withdrawal by Subject|3|||
130687430|NCT03255733|470483070|FG000|Overall Study|Lost to Follow-up|4|||
130687431|NCT03653507|470483072|FG000|Overall Study|Miscellaneous|28|||
130687432|NCT03653507|470483073|FG001|Overall Study|Miscellaneous|19|||
130687433|NCT03653507|470483072|FG000|Overall Study|Withdrawal by Subject|37|||
130687434|NCT03653507|470483073|FG001|Overall Study|Withdrawal by Subject|22|||
130687435|NCT03653507|470483072|FG000|Overall Study|Protocol Deviation|2|||
130687436|NCT03653507|470483073|FG001|Overall Study|Protocol Deviation|1|||
130687437|NCT03653507|470483072|FG000|Overall Study|Progressive disease|117|||
130687438|NCT03653507|470483073|FG001|Overall Study|Progressive disease|168|||
130687439|NCT03653507|470483072|FG000|Overall Study|Lost to Follow-up|1|||
130687440|NCT03653507|470483073|FG001|Overall Study|Lost to Follow-up|1|||
130687441|NCT03653507|470483072|FG000|Overall Study|Death|25|||
130687442|NCT03653507|470483073|FG001|Overall Study|Death|22|||
130687443|NCT03653507|470483072|FG000|Overall Study|Adverse Event|35|||
130687444|NCT03653507|470483073|FG001|Overall Study|Adverse Event|14|||
130687445|NCT03697109|470483074|FG000|Open-label (OL) Phase|Adverse Event|24|||
130687446|NCT03697109|470483075|FG001|Open-label (OL) Phase|Adverse Event|0|||
130687447|NCT03697109|470483076|FG002|Open-label (OL) Phase|Adverse Event|0|||
130687448|NCT03697109|470483074|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
130687449|NCT03697109|470483075|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
130687450|NCT03697109|470483076|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
130687451|NCT03697109|470483074|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
130687452|NCT03697109|470483075|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
130687453|NCT03697109|470483076|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
130687454|NCT03697109|470483074|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
130687455|NCT03697109|470483075|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
130687456|NCT03697109|470483076|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
130687457|NCT03697109|470483074|FG000|Open-label (OL) Phase|Physician Decision|2|||
130687458|NCT03697109|470483075|FG001|Open-label (OL) Phase|Physician Decision|0|||
130687459|NCT03697109|470483076|FG002|Open-label (OL) Phase|Physician Decision|0|||
130687460|NCT03697109|470483074|FG000|Open-label (OL) Phase|Death|2|||
130443395|NCT01216293|469586942|FG000|Calcium Absorption Substudy|Adverse Event|0|||
130443396|NCT01216293|469586943|FG001|Calcium Absorption Substudy|Adverse Event|2|||
130443397|NCT01216293|469586944|FG002|Calcium Absorption Substudy|Adverse Event|0|||
130443398|NCT01216293|469586942|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
130443399|NCT01216293|469586943|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
130687461|NCT03697109|470483075|FG001|Open-label (OL) Phase|Death|0|||
130687462|NCT03697109|470483076|FG002|Open-label (OL) Phase|Death|0|||
130687463|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
130687464|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
130687465|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
130443400|NCT01216293|469586944|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
130687466|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
130443401|NCT01216293|469586942|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
130687467|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
130687468|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
130687469|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
130687470|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130687471|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130687472|NCT02096211|470483077|FG000|Overall Study|Death|2|||
130687473|NCT02096211|470483077|FG000|Overall Study|Withdrawal by Subject|8|||
130687474|NCT02096211|470483077|FG000|Overall Study|Revision of implant|7|||
130687475|NCT02096211|470483077|FG000|Overall Study|Lost to Follow-up|43|||
130687476|NCT00834522|470483080|FG000|Washout|Adverse Event|1|||
130687477|NCT00834522|470483081|FG001|Washout|Adverse Event|0|||
130687478|NCT00834522|470483080|FG000|Washout|Withdrawal by Subject|2|||
130687479|NCT00834522|470483081|FG001|Washout|Withdrawal by Subject|1|||
130687480|NCT04516967|470483082|FG000|Core Phase|Adverse Event|2|||
130687481|NCT04516967|470483083|FG001|Core Phase|Adverse Event|1|||
130687482|NCT04516967|470483084|FG002|Core Phase|Adverse Event|0|||
130687483|NCT04516967|470483082|FG000|Core Phase|Physician Decision|1|||
130687484|NCT04516967|470483083|FG001|Core Phase|Physician Decision|1|||
130687485|NCT04516967|470483084|FG002|Core Phase|Physician Decision|0|||
130687486|NCT04516967|470483082|FG000|Core Phase|Lack of Efficacy|7|||
130687487|NCT04516967|470483083|FG001|Core Phase|Lack of Efficacy|18|||
130687488|NCT04516967|470483084|FG002|Core Phase|Lack of Efficacy|0|||
130687489|NCT03165994|470483085|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
130687490|NCT03165994|470483085|FG000|Overall Study|Death|2|||
130687491|NCT03165994|470483085|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
130687492|NCT03165994|470483085|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
130687493|NCT03165994|470483085|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
130687494|NCT03165994|470483085|FG000|Overall Study|Miscellaneous|1|||
130687495|NCT00519194|470483086|FG000|Overall Study|Withdrawal by Subject|9|||
130687496|NCT00519194|470483086|FG000|Overall Study|Death|9|||
130687497|NCT00519194|470483086|FG000|Overall Study|Lost to Follow-up|3|||
130687498|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130687499|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687500|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687501|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130687502|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687503|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687504|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130687505|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
130687506|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130687507|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
130687508|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130687509|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130687510|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687511|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687512|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
130687513|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687514|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687515|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687516|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687517|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687518|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687519|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687520|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
130687521|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687522|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Death|0|||
130687523|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Death|0|||
130687524|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Death|0|||
130687525|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Death|0|||
130687526|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Death|0|||
130355978|NCT00473746|469274610|FG003|Period 1 (Phase 1)|Reason not specified|0|||
130355979|NCT00473746|469274611|FG004|Period 1 (Phase 1)|Reason not specified|0|||
130355980|NCT00473746|469274607|FG000|Period 2 (Phase 2)|Adverse Event|0|||
130355981|NCT00473746|469274608|FG001|Period 2 (Phase 2)|Adverse Event|0|||
130355982|NCT00473746|469274609|FG002|Period 2 (Phase 2)|Adverse Event|0|||
130355983|NCT00473746|469274610|FG003|Period 2 (Phase 2)|Adverse Event|0|||
130355984|NCT00473746|469274611|FG004|Period 2 (Phase 2)|Adverse Event|3|||
130355985|NCT00473746|469274607|FG000|Period 2 (Phase 2)|Death|0|||
130355986|NCT00473746|469274608|FG001|Period 2 (Phase 2)|Death|0|||
130355987|NCT00473746|469274609|FG002|Period 2 (Phase 2)|Death|0|||
130355988|NCT00473746|469274610|FG003|Period 2 (Phase 2)|Death|0|||
130355989|NCT00473746|469274611|FG004|Period 2 (Phase 2)|Death|1|||
130355990|NCT00473746|469274607|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
130355991|NCT00473746|469274608|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
130225030|NCT01443858|468788045|FG001|Overall Study|Lack of Efficacy|0|||
130225031|NCT01443858|468788046|FG002|Overall Study|Lack of Efficacy|0|||
130225032|NCT01443858|468788044|FG000|Overall Study|Lost to Follow-up|5|||
130687527|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Death|1|||
130687528|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687529|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687530|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687531|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687532|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687533|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
130687534|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687535|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687536|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687537|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687538|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
130687539|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
130687540|NCT00461786|470483097|FG000|Overall Study|Entry Criteria Not Met|2|||
130687541|NCT00461786|470483097|FG000|Overall Study|Inevaluable (Never Treated)|1|||
130687542|NCT00835991|470483098|FG000|First Intervention|Adverse Event|0|||
130687543|NCT00835991|470483099|FG001|First Intervention|Adverse Event|1|||
130687544|NCT00835991|470483098|FG000|Washout|Protocol Violation|0|||
130687545|NCT00835991|470483099|FG001|Washout|Protocol Violation|2|||
130687546|NCT00835991|470483098|FG000|Washout|Withdrawal by Subject|3|||
130687547|NCT00835991|470483099|FG001|Washout|Withdrawal by Subject|1|||
130687548|NCT02149420|470483100|FG000|Core Study|Administrative problems|0|||
130687549|NCT02149420|470483101|FG001|Core Study|Administrative problems|1|||
130687550|NCT02149420|470483102|FG002|Core Study|Administrative problems|2|||
130687551|NCT02149420|470483100|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
130687552|NCT02149420|470483101|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130687553|NCT02149420|470483102|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130687554|NCT02378935|470483103|FG000|Overall Study|Lack of Efficacy|10|||
130687555|NCT02378935|470483104|FG001|Overall Study|Lack of Efficacy|0|||
130687556|NCT02378935|470483105|FG002|Overall Study|Lack of Efficacy|2|||
130687557|NCT02378935|470483106|FG003|Overall Study|Lack of Efficacy|6|||
130687558|NCT02378935|470483107|FG004|Overall Study|Lack of Efficacy|0|||
130687559|NCT02378935|470483108|FG005|Overall Study|Lack of Efficacy|0|||
130687560|NCT02378935|470483109|FG006|Overall Study|Lack of Efficacy|0|||
130687561|NCT02378935|470483103|FG000|Overall Study|Death|0|||
130687562|NCT02378935|470483104|FG001|Overall Study|Death|0|||
130687563|NCT02378935|470483105|FG002|Overall Study|Death|1|||
130687564|NCT02378935|470483106|FG003|Overall Study|Death|0|||
130687565|NCT02378935|470483107|FG004|Overall Study|Death|0|||
130687566|NCT02378935|470483108|FG005|Overall Study|Death|0|||
130687567|NCT02378935|470483109|FG006|Overall Study|Death|0|||
130687568|NCT03616535|470483110|FG000|Overall Study|Death|2|||
130687569|NCT03616535|470483111|FG001|Overall Study|Death|0|||
130687570|NCT03616535|470483112|FG002|Overall Study|Death|0|||
130687571|NCT03616535|470483113|FG003|Overall Study|Death|1|||
130687572|NCT03616535|470483110|FG000|Overall Study|Lost to Follow-up|2|||
130687573|NCT03616535|470483111|FG001|Overall Study|Lost to Follow-up|1|||
130687574|NCT03616535|470483112|FG002|Overall Study|Lost to Follow-up|0|||
130687575|NCT03616535|470483113|FG003|Overall Study|Lost to Follow-up|2|||
130687576|NCT03616535|470483110|FG000|Overall Study|Withdrawal by Subject|1|||
130687577|NCT03616535|470483111|FG001|Overall Study|Withdrawal by Subject|2|||
130687578|NCT03616535|470483112|FG002|Overall Study|Withdrawal by Subject|5|||
130687579|NCT03616535|470483113|FG003|Overall Study|Withdrawal by Subject|1|||
130687580|NCT03616535|470483110|FG000|Overall Study|Not specified or change in eligibility|2|||
130687581|NCT03616535|470483111|FG001|Overall Study|Not specified or change in eligibility|3|||
130687582|NCT03616535|470483112|FG002|Overall Study|Not specified or change in eligibility|3|||
130687583|NCT03616535|470483113|FG003|Overall Study|Not specified or change in eligibility|1|||
130687584|NCT02146105|470483116|FG000|Overall Study|Adverse Event|1|||
130687585|NCT02146105|470483116|FG000|Overall Study|Withdrawal by Subject|5|||
130687586|NCT05755282|470483117|FG000|Overall Study|Protocol Violation|0|||
130687587|NCT05755282|470483118|FG001|Overall Study|Protocol Violation|1|||
130687588|NCT03935880|470483120|FG000|Overall Study|Lost to Follow-up|0|||
130225033|NCT01443858|468788045|FG001|Overall Study|Lost to Follow-up|5|||
130687589|NCT03935880|470483121|FG001|Overall Study|Lost to Follow-up|1|||
130687590|NCT02476994|470483122|FG000|Overall Study|Based on feedback from FDA|1|||
130687591|NCT02476994|470483123|FG001|Overall Study|Based on feedback from FDA|0|||
130687592|NCT02563561|470483124|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
130687593|NCT02563561|470483125|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
130687594|NCT02563561|470483126|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
130687595|NCT02563561|470483124|FG000|Overall Study|Withdrew of Consent|1|||
130687596|NCT02563561|470483125|FG001|Overall Study|Withdrew of Consent|1|||
130687597|NCT02563561|470483126|FG002|Overall Study|Withdrew of Consent|2|||
130225034|NCT01443858|468788046|FG002|Overall Study|Lost to Follow-up|2|||
130687598|NCT02563561|470483124|FG000|Overall Study|Lost to Follow-up|1|||
130225035|NCT01867008|468788047|FG000|Overall Study|Withdrawal by Subject|1|||
130687599|NCT02563561|470483125|FG001|Overall Study|Lost to Follow-up|1|||
130687600|NCT02563561|470483126|FG002|Overall Study|Lost to Follow-up|0|||
130687601|NCT02563561|470483124|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
130687602|NCT02563561|470483125|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
130687603|NCT02563561|470483126|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
130687604|NCT02563561|470483124|FG000|Overall Study|Investigator Decision|3|||
130687605|NCT02563561|470483125|FG001|Overall Study|Investigator Decision|4|||
130687606|NCT02563561|470483126|FG002|Overall Study|Investigator Decision|2|||
130687607|NCT02563561|470483124|FG000|Overall Study|Sponsor Decision|5|||
130687608|NCT02563561|470483125|FG001|Overall Study|Sponsor Decision|2|||
130687609|NCT02563561|470483126|FG002|Overall Study|Sponsor Decision|4|||
130687610|NCT02563561|470483124|FG000|Overall Study|Other|1|||
130687611|NCT02563561|470483125|FG001|Overall Study|Other|5|||
130687612|NCT02563561|470483126|FG002|Overall Study|Other|2|||
130687613|NCT02646124|470483129|FG000|Overall Study|Lost to Follow-up|0|||
130687614|NCT02646124|470483130|FG001|Overall Study|Lost to Follow-up|2|||
130687615|NCT03154047|470483131|FG000|Overall Study|Death|1|||
130687616|NCT03154047|470483131|FG000|Overall Study|Study terminated by sponsor|76|||
130687617|NCT03154047|470483131|FG000|Overall Study|Withdrawal by Subject|3|||
130687618|NCT00857454|470483132|FG000|Overall Study|Withdrawal by Subject|2|||
130687619|NCT00857454|470483132|FG000|Overall Study|Lost to Follow-up|1|||
130687620|NCT00857454|470483132|FG000|Overall Study|Adverse Event|2|||
130687621|NCT00857454|470483132|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
130687622|NCT00857454|470483132|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
130687623|NCT00857454|470483132|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
130687624|NCT00365365|470483133|FG000|Overall Study|Randomized but not treated|0|||
130687625|NCT00365365|470483134|FG001|Overall Study|Randomized but not treated|2|||
130687626|NCT00365365|470483135|FG002|Overall Study|Randomized but not treated|0|||
130687627|NCT00365365|470483133|FG000|Overall Study|Poor compliance to protocol|0|||
130687628|NCT00365365|470483134|FG001|Overall Study|Poor compliance to protocol|1|||
130687629|NCT00365365|470483135|FG002|Overall Study|Poor compliance to protocol|0|||
130687630|NCT00365365|470483133|FG000|Overall Study|Lost to Follow-up|3|||
130687631|NCT00365365|470483134|FG001|Overall Study|Lost to Follow-up|3|||
130687632|NCT00365365|470483135|FG002|Overall Study|Lost to Follow-up|3|||
130687633|NCT00365365|470483133|FG000|Overall Study|Death|1|||
130687634|NCT00365365|470483134|FG001|Overall Study|Death|3|||
130687635|NCT00365365|470483135|FG002|Overall Study|Death|0|||
130687636|NCT00365365|470483133|FG000|Overall Study|Subject's request|11|||
130687637|NCT00365365|470483134|FG001|Overall Study|Subject's request|13|||
130687638|NCT00365365|470483135|FG002|Overall Study|Subject's request|1|||
130687639|NCT00365365|470483133|FG000|Overall Study|Disease progression/relapse|9|||
130687640|NCT00365365|470483134|FG001|Overall Study|Disease progression/relapse|6|||
130687641|NCT00365365|470483135|FG002|Overall Study|Disease progression/relapse|7|||
130687642|NCT00365365|470483133|FG000|Overall Study|Adverse Event|6|||
130687643|NCT00365365|470483134|FG001|Overall Study|Adverse Event|6|||
130687644|NCT00365365|470483135|FG002|Overall Study|Adverse Event|3|||
130687645|NCT00365365|470483133|FG000|Overall Study|Moved|2|||
130687646|NCT00365365|470483134|FG001|Overall Study|Moved|0|||
130687647|NCT00365365|470483135|FG002|Overall Study|Moved|0|||
130687648|NCT00365365|470483133|FG000|Overall Study|New cancer|1|||
130687649|NCT00365365|470483134|FG001|Overall Study|New cancer|0|||
130687650|NCT00365365|470483135|FG002|Overall Study|New cancer|0|||
130687651|NCT00365365|470483133|FG000|Overall Study|Withdrew consent|1|||
130687652|NCT00365365|470483134|FG001|Overall Study|Withdrew consent|1|||
130687653|NCT00365365|470483135|FG002|Overall Study|Withdrew consent|0|||
130687654|NCT00365365|470483133|FG000|Overall Study|Second malignancy|0|||
130687655|NCT00365365|470483134|FG001|Overall Study|Second malignancy|1|||
130687656|NCT00365365|470483135|FG002|Overall Study|Second malignancy|0|||
130687657|NCT00365365|470483133|FG000|Overall Study|Patient/physician decision|0|||
130687658|NCT00365365|470483134|FG001|Overall Study|Patient/physician decision|0|||
130687659|NCT00365365|470483135|FG002|Overall Study|Patient/physician decision|1|||
130687660|NCT00984022|470483136|FG000|Overall Study|Lost to Follow-up|10|||
130687661|NCT00984022|470483137|FG001|Overall Study|Lost to Follow-up|14|||
130225036|NCT01534273|468788048|FG000|Period 1|Physician Decision|0|||
130552865|NCT01290601|469991596|FG000|Overall Study|Other|1|||
130687662|NCT00573443|470483141|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130687663|NCT00573443|470483142|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130225037|NCT01534273|468788049|FG001|Period 1|Physician Decision|0|||
130687664|NCT00573443|470483143|FG002|Double-Blind Phase|Lost to Follow-up|2|||
130687665|NCT00573443|470483141|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130687666|NCT00573443|470483142|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
130687667|NCT00573443|470483143|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130687668|NCT00573443|470483141|FG000|Double-Blind Phase|Adverse Event|1|||
130687669|NCT00573443|470483142|FG001|Double-Blind Phase|Adverse Event|5|||
130687670|NCT00573443|470483143|FG002|Double-Blind Phase|Adverse Event|0|||
130687671|NCT00573443|470483141|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
130687672|NCT00573443|470483142|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
130443402|NCT01216293|469586943|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
130443403|NCT01216293|469586944|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
130443404|NCT01671748|469586945|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
130443405|NCT01671748|469586946|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
130443406|NCT01671748|469586945|FG000|4 Week run-in Phase|Adverse Event|1|||
130443407|NCT01671748|469586946|FG001|4 Week run-in Phase|Adverse Event|0|||
130443408|NCT01671748|469586945|FG000|4 Week run-in Phase|Not eligible|9|||
130443409|NCT01671748|469586946|FG001|4 Week run-in Phase|Not eligible|0|||
130443410|NCT02169830|469588442|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
130443411|NCT02169830|469588443|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
130443412|NCT02169830|469588444|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
130443413|NCT02169830|469588442|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
130443414|NCT02169830|469588443|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130443415|NCT02169830|469588444|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130443416|NCT02169830|469588442|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130443417|NCT02169830|469588443|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
130443418|NCT02169830|469588444|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130443419|NCT02169830|469588442|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
130443420|NCT02169830|469588443|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
130443421|NCT02169830|469588444|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
130443422|NCT02169830|469588442|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
130443423|NCT02169830|469588443|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
130443424|NCT02169830|469588444|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
130687673|NCT00573443|470483143|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
130687674|NCT00573443|470483141|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
130687675|NCT00573443|470483142|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
130687676|NCT00573443|470483143|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
130687677|NCT00573443|470483141|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130687678|NCT00573443|470483142|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130687679|NCT00573443|470483143|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
130687680|NCT00573443|470483141|FG000|Double-Blind Phase|Protocol Violation|0|||
130687681|NCT00573443|470483142|FG001|Double-Blind Phase|Protocol Violation|2|||
130687682|NCT00573443|470483143|FG002|Double-Blind Phase|Protocol Violation|1|||
130687683|NCT00573443|470483141|FG000|Double-Blind Phase|Other|0|||
130687684|NCT00573443|470483142|FG001|Double-Blind Phase|Other|2|||
130687685|NCT00573443|470483143|FG002|Double-Blind Phase|Other|3|||
130687686|NCT00573443|470483141|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
130687687|NCT00573443|470483142|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130687688|NCT00573443|470483143|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130687689|NCT00573443|470483141|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
130687690|NCT00573443|470483142|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
130443425|NCT03204695|469588445|FG000|Overall Study|Death|1|||
130443426|NCT03204695|469588445|FG000|Overall Study|Participant was treated with another device|1|||
130443427|NCT03204695|469588445|FG000|Overall Study|Physician Decision|2|||
130443428|NCT04834362|469588446|FG000|Overall Study|Death|1|||
130443429|NCT04834362|469588447|FG001|Overall Study|Death|2|||
130443430|NCT01349829|469588450|FG000|Overall Study|Lost to Follow-up|4|||
130443431|NCT01349829|469588451|FG001|Overall Study|Lost to Follow-up|8|||
130443432|NCT01349829|469588450|FG000|Overall Study|Consent withdrawal|3|||
130443433|NCT01349829|469588451|FG001|Overall Study|Consent withdrawal|8|||
130443434|NCT01349829|469588450|FG000|Overall Study|Migrated/moved|2|||
130443435|NCT01349829|469588451|FG001|Overall Study|Migrated/moved|7|||
130443436|NCT02555371|469588452|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
130443437|NCT02555371|469588453|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130687691|NCT00573443|470483143|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
130687692|NCT00573443|470483141|FG000|Open-Label Extension Phase|Adverse Event|3|||
130687693|NCT00573443|470483142|FG001|Open-Label Extension Phase|Adverse Event|0|||
130687694|NCT00573443|470483143|FG002|Open-Label Extension Phase|Adverse Event|0|||
130687695|NCT00573443|470483141|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
130687696|NCT00573443|470483142|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
130687697|NCT00573443|470483143|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
130687698|NCT00573443|470483141|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
130687699|NCT00573443|470483142|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
130443438|NCT02555371|469588454|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130443439|NCT02555371|469588455|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130443440|NCT02555371|469588456|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130443441|NCT02555371|469588452|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
130443442|NCT02555371|469588453|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130687700|NCT00573443|470483143|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130687701|NCT00573443|470483141|FG000|Open-Label Extension Phase|Protocol Violation|2|||
130687702|NCT00573443|470483142|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130687703|NCT00573443|470483143|FG002|Open-Label Extension Phase|Protocol Violation|0|||
130687704|NCT00573443|470483141|FG000|Open-Label Extension Phase|Other|2|||
130687705|NCT00573443|470483142|FG001|Open-Label Extension Phase|Other|0|||
130687706|NCT00573443|470483143|FG002|Open-Label Extension Phase|Other|0|||
130687707|NCT00905606|470483144|FG000|Period 1|Adverse Event|0|||
130687708|NCT00905606|470483145|FG001|Period 1|Adverse Event|1|||
130687709|NCT00905606|470483144|FG000|Washout|Withdrawal by Subject|1|||
130687710|NCT00905606|470483145|FG001|Washout|Withdrawal by Subject|0|||
130687711|NCT00804856|470483148|FG000|Overall Study|Progressive Disease|3|||
130687712|NCT00804856|470483149|FG001|Overall Study|Progressive Disease|2|||
130687713|NCT00804856|470483150|FG002|Overall Study|Progressive Disease|4|||
130687714|NCT00804856|470483151|FG003|Overall Study|Progressive Disease|6|||
130687715|NCT00804856|470483152|FG004|Overall Study|Progressive Disease|4|||
130687716|NCT00804856|470483153|FG005|Overall Study|Progressive Disease|1|||
130687717|NCT00804856|470483154|FG006|Overall Study|Progressive Disease|8|||
130687718|NCT00804856|470483155|FG007|Overall Study|Progressive Disease|2|||
130687719|NCT00804856|470483156|FG008|Overall Study|Progressive Disease|4|||
130687720|NCT00804856|470483157|FG009|Overall Study|Progressive Disease|5|||
130687721|NCT00804856|470483158|FG010|Overall Study|Progressive Disease|12|||
130687722|NCT00804856|470483159|FG011|Overall Study|Progressive Disease|2|||
130687723|NCT00804856|470483160|FG012|Overall Study|Progressive Disease|2|||
130687724|NCT00804856|470483161|FG013|Overall Study|Progressive Disease|26|||
130687725|NCT00804856|470483162|FG014|Overall Study|Progressive Disease|20|||
130687726|NCT00804856|470483148|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687727|NCT00804856|470483149|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687728|NCT00804856|470483150|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687729|NCT00804856|470483151|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687730|NCT00804856|470483152|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130687731|NCT00804856|470483153|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687732|NCT00804856|470483154|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687733|NCT00804856|470483155|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687734|NCT00804856|470483156|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687735|NCT00804856|470483157|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687736|NCT00804856|470483158|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687737|NCT00804856|470483159|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687738|NCT00804856|470483160|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687739|NCT00804856|470483161|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687740|NCT00804856|470483162|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130687741|NCT00804856|470483148|FG000|Overall Study|Other Adverse Event|1|||
130687742|NCT00804856|470483149|FG001|Overall Study|Other Adverse Event|1|||
130687743|NCT00804856|470483150|FG002|Overall Study|Other Adverse Event|1|||
130687744|NCT00804856|470483151|FG003|Overall Study|Other Adverse Event|2|||
130687745|NCT00804856|470483152|FG004|Overall Study|Other Adverse Event|2|||
130687746|NCT00804856|470483153|FG005|Overall Study|Other Adverse Event|1|||
130687747|NCT00804856|470483154|FG006|Overall Study|Other Adverse Event|3|||
130687748|NCT00804856|470483155|FG007|Overall Study|Other Adverse Event|0|||
130687749|NCT00804856|470483156|FG008|Overall Study|Other Adverse Event|0|||
130687750|NCT00804856|470483157|FG009|Overall Study|Other Adverse Event|1|||
130687751|NCT00804856|470483158|FG010|Overall Study|Other Adverse Event|5|||
130687752|NCT00804856|470483159|FG011|Overall Study|Other Adverse Event|2|||
130687753|NCT00804856|470483160|FG012|Overall Study|Other Adverse Event|0|||
130687754|NCT00804856|470483161|FG013|Overall Study|Other Adverse Event|6|||
130687755|NCT00804856|470483162|FG014|Overall Study|Other Adverse Event|13|||
130687756|NCT00804856|470483148|FG000|Overall Study|Non compliance with protocol|0|||
130687757|NCT00804856|470483149|FG001|Overall Study|Non compliance with protocol|0|||
130687758|NCT00804856|470483150|FG002|Overall Study|Non compliance with protocol|0|||
130687759|NCT00804856|470483151|FG003|Overall Study|Non compliance with protocol|0|||
130687760|NCT00804856|470483152|FG004|Overall Study|Non compliance with protocol|0|||
130687761|NCT00804856|470483153|FG005|Overall Study|Non compliance with protocol|0|||
130687762|NCT00804856|470483154|FG006|Overall Study|Non compliance with protocol|0|||
130687763|NCT00804856|470483155|FG007|Overall Study|Non compliance with protocol|0|||
130225038|NCT01534273|468788050|FG002|Period 1|Physician Decision|0|||
130225039|NCT01534273|468788051|FG003|Period 1|Physician Decision|1|||
130355992|NCT00473746|469274609|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
130355993|NCT00473746|469274610|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
130687764|NCT00804856|470483156|FG008|Overall Study|Non compliance with protocol|0|||
130687765|NCT00804856|470483157|FG009|Overall Study|Non compliance with protocol|0|||
130687766|NCT00804856|470483158|FG010|Overall Study|Non compliance with protocol|0|||
130687767|NCT00804856|470483159|FG011|Overall Study|Non compliance with protocol|0|||
130687768|NCT00804856|470483160|FG012|Overall Study|Non compliance with protocol|0|||
130687769|NCT00804856|470483161|FG013|Overall Study|Non compliance with protocol|2|||
130687770|NCT00804856|470483162|FG014|Overall Study|Non compliance with protocol|0|||
130687771|NCT00804856|470483148|FG000|Overall Study|Refused to continue medication|0|||
130687772|NCT00804856|470483149|FG001|Overall Study|Refused to continue medication|0|||
130355994|NCT00473746|469274611|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
130355995|NCT00473746|469274607|FG000|Period 2 (Phase 2)|Reason not specified|0|||
130355996|NCT00473746|469274608|FG001|Period 2 (Phase 2)|Reason not specified|0|||
130687773|NCT00804856|470483150|FG002|Overall Study|Refused to continue medication|0|||
130687774|NCT00804856|470483151|FG003|Overall Study|Refused to continue medication|1|||
130687775|NCT00804856|470483152|FG004|Overall Study|Refused to continue medication|1|||
130687776|NCT00804856|470483153|FG005|Overall Study|Refused to continue medication|0|||
130687777|NCT00804856|470483154|FG006|Overall Study|Refused to continue medication|0|||
130687778|NCT00804856|470483155|FG007|Overall Study|Refused to continue medication|0|||
130687779|NCT00804856|470483156|FG008|Overall Study|Refused to continue medication|0|||
130687780|NCT00804856|470483157|FG009|Overall Study|Refused to continue medication|0|||
130687781|NCT00804856|470483158|FG010|Overall Study|Refused to continue medication|3|||
130687782|NCT00804856|470483159|FG011|Overall Study|Refused to continue medication|0|||
130687783|NCT00804856|470483160|FG012|Overall Study|Refused to continue medication|1|||
130687784|NCT00804856|470483161|FG013|Overall Study|Refused to continue medication|1|||
130687785|NCT00804856|470483162|FG014|Overall Study|Refused to continue medication|5|||
130687786|NCT00804856|470483148|FG000|Overall Study|Other reason than listed above|0|||
130687787|NCT00804856|470483149|FG001|Overall Study|Other reason than listed above|0|||
130687788|NCT00804856|470483150|FG002|Overall Study|Other reason than listed above|0|||
130687789|NCT00804856|470483151|FG003|Overall Study|Other reason than listed above|0|||
130687790|NCT00804856|470483152|FG004|Overall Study|Other reason than listed above|0|||
130687791|NCT00804856|470483153|FG005|Overall Study|Other reason than listed above|1|||
130687792|NCT00804856|470483154|FG006|Overall Study|Other reason than listed above|0|||
130687793|NCT00804856|470483155|FG007|Overall Study|Other reason than listed above|0|||
130687794|NCT00804856|470483156|FG008|Overall Study|Other reason than listed above|1|||
130687795|NCT00804856|470483157|FG009|Overall Study|Other reason than listed above|0|||
130687796|NCT00804856|470483158|FG010|Overall Study|Other reason than listed above|3|||
130687797|NCT00804856|470483159|FG011|Overall Study|Other reason than listed above|1|||
130687798|NCT00804856|470483160|FG012|Overall Study|Other reason than listed above|1|||
130687799|NCT00804856|470483161|FG013|Overall Study|Other reason than listed above|10|||
130687800|NCT00804856|470483162|FG014|Overall Study|Other reason than listed above|3|||
130687801|NCT01796171|470483163|FG000|Enrolled|Death|0|||
130687802|NCT01796171|470483164|FG001|Enrolled|Death|0|||
130687803|NCT01796171|470483165|FG002|Enrolled|Death|0|||
130225040|NCT01534273|468788052|FG004|Period 1|Physician Decision|0|||
130687804|NCT01796171|470483166|FG003|Enrolled|Death|0|||
130687805|NCT01796171|470483167|FG004|Enrolled|Death|0|||
130687806|NCT01796171|470483168|FG005|Enrolled|Death|0|||
130687807|NCT01796171|470483169|FG006|Enrolled|Death|0|||
130687808|NCT01796171|470483170|FG007|Enrolled|Death|0|||
130687809|NCT01796171|470483171|FG008|Enrolled|Death|0|||
130687810|NCT01796171|470483172|FG009|Enrolled|Death|0|||
130687811|NCT01796171|470483173|FG010|Enrolled|Death|0|||
130687812|NCT01796171|470483174|FG011|Enrolled|Death|0|||
130687813|NCT01796171|470483175|FG012|Enrolled|Death|0|||
130687814|NCT01796171|470483176|FG013|Enrolled|Death|0|||
130687815|NCT01796171|470483177|FG014|Enrolled|Death|1|||
130687816|NCT01796171|470483163|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
130687817|NCT01796171|470483164|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
130687818|NCT01796171|470483165|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
130687819|NCT01796171|470483166|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
130687820|NCT01796171|470483167|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
130687821|NCT01796171|470483168|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
130687822|NCT01796171|470483169|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
130687823|NCT01796171|470483170|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
130687824|NCT01796171|470483171|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
130687825|NCT01796171|470483172|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
130687826|NCT01796171|470483173|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
130687827|NCT01796171|470483174|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
130687828|NCT01796171|470483175|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
130687829|NCT01796171|470483176|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
130687830|NCT01796171|470483177|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
130687831|NCT01796171|470483163|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687832|NCT01796171|470483164|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687833|NCT01796171|470483165|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687834|NCT01796171|470483166|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687835|NCT01796171|470483167|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130225041|NCT01534273|468788053|FG005|Period 1|Physician Decision|0|||
130225042|NCT01534273|468788054|FG006|Period 1|Physician Decision|0|||
130225043|NCT03586050|468788055|FG000|Overall Study|Death|3|||
130225044|NCT03586050|468788055|FG000|Overall Study|Withdrawal by Subject|2|||
130225045|NCT01211145|468788056|FG000|Overall Study|Reason not specified|3|||
130225046|NCT01211145|468788057|FG001|Overall Study|Reason not specified|2|||
130225047|NCT01211145|468788058|FG002|Overall Study|Reason not specified|2|||
130225048|NCT01211145|468788059|FG003|Overall Study|Reason not specified|1|||
130225049|NCT01211145|468788056|FG000|Overall Study|Lost to Follow-up|3|||
130225050|NCT01211145|468788057|FG001|Overall Study|Lost to Follow-up|2|||
130225051|NCT01211145|468788058|FG002|Overall Study|Lost to Follow-up|1|||
130355997|NCT00473746|469274609|FG002|Period 2 (Phase 2)|Reason not specified|0|||
130687836|NCT01796171|470483168|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130355998|NCT00473746|469274610|FG003|Period 2 (Phase 2)|Reason not specified|0|||
130687837|NCT01796171|470483169|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687838|NCT01796171|470483170|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687839|NCT01796171|470483171|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687840|NCT01796171|470483172|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687841|NCT01796171|470483173|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130443443|NCT02555371|469588454|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130443444|NCT02555371|469588455|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130443445|NCT02555371|469588456|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130443446|NCT02555371|469588452|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
130443447|NCT02555371|469588453|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130443448|NCT02555371|469588454|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130443449|NCT02555371|469588455|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130443450|NCT02555371|469588456|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130443451|NCT02555371|469588452|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
130443452|NCT02555371|469588453|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130443453|NCT02555371|469588454|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130443454|NCT02555371|469588455|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130443455|NCT02555371|469588456|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130443456|NCT02555371|469588452|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
130443457|NCT02555371|469588453|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130443458|NCT02555371|469588454|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130443459|NCT02555371|469588455|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130443460|NCT02555371|469588456|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130443461|NCT02555371|469588452|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130443462|NCT02555371|469588453|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
130443463|NCT02555371|469588454|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
130443464|NCT02555371|469588455|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130443465|NCT02555371|469588456|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130443466|NCT02555371|469588452|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130443467|NCT02555371|469588453|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
130443468|NCT02555371|469588454|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
130443469|NCT02555371|469588455|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130443470|NCT02555371|469588456|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130443471|NCT02555371|469588452|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130443472|NCT02555371|469588453|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
130443473|NCT02555371|469588454|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130443474|NCT02555371|469588455|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130443475|NCT02555371|469588456|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130443476|NCT02555371|469588452|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130443477|NCT02555371|469588453|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
130443478|NCT02555371|469588454|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
130443479|NCT02555371|469588455|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130443480|NCT02555371|469588456|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130443481|NCT02555371|469588452|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130443482|NCT02555371|469588453|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130443483|NCT02555371|469588454|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130443484|NCT02555371|469588455|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
130552866|NCT01290601|469991597|FG001|Overall Study|Other|0|||
130225052|NCT01211145|468788059|FG003|Overall Study|Lost to Follow-up|2|||
130687842|NCT01796171|470483174|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687843|NCT01796171|470483175|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687844|NCT01796171|470483176|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
130687845|NCT01796171|470483177|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687846|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Progressive disease|0|||
130687847|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Progressive disease|1|||
130687848|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Progressive disease|0|||
130687849|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Progressive disease|0|||
130687850|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Progressive disease|0|||
130687851|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Progressive disease|0|||
130687852|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Progressive disease|0|||
130687853|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Progressive disease|0|||
130687854|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Progressive disease|0|||
130687855|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Progressive disease|0|||
130687856|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Progressive disease|0|||
130687857|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Progressive disease|0|||
130687858|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Progressive disease|0|||
130687859|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Progressive disease|0|||
130687860|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Progressive disease|0|||
130687861|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687862|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687863|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687864|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687865|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687866|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687867|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687868|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687869|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687870|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687871|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687872|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687873|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687874|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687875|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687876|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Physician Decision|0|||
130687877|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Physician Decision|0|||
130687878|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Physician Decision|0|||
130687879|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Physician Decision|0|||
130687880|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Physician Decision|0|||
130687881|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Physician Decision|0|||
130687882|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Physician Decision|0|||
130687883|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Physician Decision|0|||
130687884|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Physician Decision|0|||
130687885|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Physician Decision|0|||
130687886|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Physician Decision|5|||
130687887|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Physician Decision|1|||
130687888|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Physician Decision|1|||
130687889|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Physician Decision|0|||
130687890|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Physician Decision|0|||
130443485|NCT02555371|469588456|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130443486|NCT02555371|469588452|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130443487|NCT02555371|469588453|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130443488|NCT02555371|469588454|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130443489|NCT02555371|469588455|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
130443490|NCT02555371|469588456|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130443491|NCT02555371|469588452|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130443492|NCT02555371|469588453|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130443493|NCT02555371|469588454|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130443494|NCT02555371|469588455|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130443495|NCT02555371|469588456|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
130443496|NCT02555371|469588452|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130687891|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Death|0|||
130687892|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Death|0|||
130687893|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Death|0|||
130687894|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Death|0|||
130687895|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Death|0|||
130687896|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Death|0|||
130687897|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Death|0|||
130687898|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Death|0|||
130687899|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Death|0|||
130687900|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Death|0|||
130687901|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Death|2|||
130687902|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Death|0|||
130687903|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Death|0|||
130687904|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Death|0|||
130687905|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Death|0|||
130687906|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
130687907|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
130687908|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
130687909|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
130687910|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
130687911|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
130687912|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
130687913|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
130687914|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
130687915|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
130687916|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
130687917|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
130687918|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
130225053|NCT01211145|468788056|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130225054|NCT01211145|468788057|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130225055|NCT01211145|468788058|FG002|Overall Study|Study-specific withdrawal criteria|0|||
130225056|NCT01211145|468788059|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130225057|NCT01211145|468788056|FG000|Overall Study|Severe noncompliance to protocol|1|||
130225058|NCT01211145|468788057|FG001|Overall Study|Severe noncompliance to protocol|0|||
130355999|NCT00473746|469274611|FG004|Period 2 (Phase 2)|Reason not specified|3|||
130356000|NCT01528215|469274612|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
130356001|NCT01528215|469274613|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
130356002|NCT01528215|469274612|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
130356003|NCT01528215|469274613|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
130356004|NCT01528215|469274612|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
130356005|NCT01528215|469274613|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
130356006|NCT01528215|469274612|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
130356007|NCT01528215|469274613|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
130356008|NCT01462227|469274615|FG000|Second Assignment|Lost to Follow-up|1|||
130356009|NCT01462227|469274616|FG001|Second Assignment|Lost to Follow-up|0|||
130356010|NCT01462227|469274617|FG002|Second Assignment|Lost to Follow-up|0|||
130356011|NCT01462227|469274618|FG003|Second Assignment|Lost to Follow-up|0|||
130356012|NCT01462227|469274615|FG000|Second Assignment|Protocol Violation|0|||
130356013|NCT01462227|469274616|FG001|Second Assignment|Protocol Violation|1|||
130356014|NCT01462227|469274617|FG002|Second Assignment|Protocol Violation|1|||
130356015|NCT01462227|469274618|FG003|Second Assignment|Protocol Violation|0|||
130356016|NCT00586066|469274624|FG000|Overall Study|Lost to Follow-up|6|||
130356017|NCT00586066|469274625|FG001|Overall Study|Lost to Follow-up|3|||
130356018|NCT00586066|469274624|FG000|Overall Study|Lack of Efficacy|5|||
130356019|NCT00586066|469274625|FG001|Overall Study|Lack of Efficacy|3|||
130356020|NCT00586066|469274624|FG000|Overall Study|Adverse Event|2|||
130356021|NCT00586066|469274625|FG001|Overall Study|Adverse Event|2|||
130356022|NCT00586066|469274624|FG000|Overall Study|Physician Decision|1|||
130356023|NCT00586066|469274625|FG001|Overall Study|Physician Decision|0|||
130356024|NCT00586066|469274624|FG000|Overall Study|Withdrawal of consent|4|||
130356025|NCT00586066|469274625|FG001|Overall Study|Withdrawal of consent|2|||
130356026|NCT01505647|469274633|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
130356027|NCT01505647|469274634|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
130552867|NCT01290601|469991598|FG002|Overall Study|Other|0|||
130552868|NCT01290601|469991599|FG003|Overall Study|Other|0|||
130552869|NCT01290601|469991596|FG000|Overall Study|Protocol Violation|1|||
130552870|NCT01290601|469991597|FG001|Overall Study|Protocol Violation|0|||
130552871|NCT01290601|469991598|FG002|Overall Study|Protocol Violation|0|||
130552872|NCT01290601|469991599|FG003|Overall Study|Protocol Violation|0|||
130552873|NCT00752622|469991607|FG000|Induction Phase|Adverse Event|3|||
130552874|NCT00752622|469991607|FG000|Induction Phase|Other|3|||
130687919|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
130687920|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
130552875|NCT00752622|469991607|FG000|Induction Phase|Non-responder|14|||
130552876|NCT00752622|469991607|FG000|Induction Phase|Withdrawal by Subject|1|||
130552877|NCT00752622|469991607|FG000|Induction Phase|Premature study termination|14|||
130552878|NCT00752622|469991607|FG000|Observational Phase|Premature Study Termination|36|||
130687921|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687922|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687923|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687924|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687925|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687926|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687927|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687928|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687929|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687930|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687931|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130687932|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130687933|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687934|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687935|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687936|NCT01796171|470483163|FG000|Follow-up Period|Start of further anticancer therapy|4|||
130687937|NCT01796171|470483164|FG001|Follow-up Period|Start of further anticancer therapy|25|||
130687938|NCT01796171|470483165|FG002|Follow-up Period|Start of further anticancer therapy|2|||
130687939|NCT01796171|470483166|FG003|Follow-up Period|Start of further anticancer therapy|1|||
130687940|NCT01796171|470483167|FG004|Follow-up Period|Start of further anticancer therapy|2|||
130687941|NCT01796171|470483168|FG005|Follow-up Period|Start of further anticancer therapy|2|||
130687942|NCT01796171|470483169|FG006|Follow-up Period|Start of further anticancer therapy|1|||
130687943|NCT01796171|470483170|FG007|Follow-up Period|Start of further anticancer therapy|15|||
130687944|NCT01796171|470483171|FG008|Follow-up Period|Start of further anticancer therapy|2|||
130687945|NCT01796171|470483172|FG009|Follow-up Period|Start of further anticancer therapy|0|||
130687946|NCT01796171|470483173|FG010|Follow-up Period|Start of further anticancer therapy|0|||
130687947|NCT01796171|470483174|FG011|Follow-up Period|Start of further anticancer therapy|0|||
130687948|NCT01796171|470483175|FG012|Follow-up Period|Start of further anticancer therapy|0|||
130687949|NCT01796171|470483176|FG013|Follow-up Period|Start of further anticancer therapy|0|||
130687950|NCT01796171|470483177|FG014|Follow-up Period|Start of further anticancer therapy|0|||
130687951|NCT01796171|470483163|FG000|Follow-up Period|Progressive disease|0|||
130687952|NCT01796171|470483164|FG001|Follow-up Period|Progressive disease|1|||
130687953|NCT01796171|470483165|FG002|Follow-up Period|Progressive disease|0|||
130687954|NCT01796171|470483166|FG003|Follow-up Period|Progressive disease|0|||
130687955|NCT01796171|470483167|FG004|Follow-up Period|Progressive disease|0|||
130687956|NCT01796171|470483168|FG005|Follow-up Period|Progressive disease|0|||
130687957|NCT01796171|470483169|FG006|Follow-up Period|Progressive disease|0|||
130687958|NCT01796171|470483170|FG007|Follow-up Period|Progressive disease|3|||
130687959|NCT01796171|470483171|FG008|Follow-up Period|Progressive disease|0|||
130687960|NCT01796171|470483172|FG009|Follow-up Period|Progressive disease|0|||
130443497|NCT02555371|469588453|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130443498|NCT02555371|469588454|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130443499|NCT02555371|469588455|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130443500|NCT02555371|469588456|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
130687961|NCT01796171|470483173|FG010|Follow-up Period|Progressive disease|0|||
130687962|NCT01796171|470483174|FG011|Follow-up Period|Progressive disease|0|||
130687963|NCT01796171|470483175|FG012|Follow-up Period|Progressive disease|0|||
130687964|NCT01796171|470483176|FG013|Follow-up Period|Progressive disease|0|||
130443501|NCT02555371|469588452|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130443502|NCT02555371|469588453|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130443503|NCT02555371|469588454|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130443504|NCT02555371|469588455|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
130443505|NCT02555371|469588456|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130443506|NCT03095599|469588457|FG000|Overall Study|Withdrawal by Subject|1|||
130443507|NCT03095599|469588458|FG001|Overall Study|Withdrawal by Subject|0|||
130443508|NCT03095599|469588457|FG000|Overall Study|Lost to Follow-up|1|||
130443509|NCT03095599|469588458|FG001|Overall Study|Lost to Follow-up|0|||
130443510|NCT03095599|469588457|FG000|Overall Study|Withdrawal prior to vaccination|1|||
130443511|NCT03095599|469588458|FG001|Overall Study|Withdrawal prior to vaccination|0|||
130443512|NCT00513019|469588460|FG000|Overall Study|Adverse Event|1|||
130443513|NCT00513019|469588461|FG001|Overall Study|Adverse Event|0|||
130687965|NCT01796171|470483177|FG014|Follow-up Period|Progressive disease|0|||
130687966|NCT01796171|470483163|FG000|Follow-up Period|Physician Decision|0|||
130687967|NCT01796171|470483164|FG001|Follow-up Period|Physician Decision|2|||
130687968|NCT01796171|470483165|FG002|Follow-up Period|Physician Decision|0|||
130687969|NCT01796171|470483166|FG003|Follow-up Period|Physician Decision|0|||
130687970|NCT01796171|470483167|FG004|Follow-up Period|Physician Decision|0|||
130687971|NCT01796171|470483168|FG005|Follow-up Period|Physician Decision|0|||
130687972|NCT01796171|470483169|FG006|Follow-up Period|Physician Decision|0|||
130687973|NCT01796171|470483170|FG007|Follow-up Period|Physician Decision|0|||
130687974|NCT01796171|470483171|FG008|Follow-up Period|Physician Decision|0|||
130687975|NCT01796171|470483172|FG009|Follow-up Period|Physician Decision|0|||
130687976|NCT01796171|470483173|FG010|Follow-up Period|Physician Decision|5|||
130687977|NCT01796171|470483174|FG011|Follow-up Period|Physician Decision|0|||
130687978|NCT01796171|470483175|FG012|Follow-up Period|Physician Decision|0|||
130687979|NCT01796171|470483176|FG013|Follow-up Period|Physician Decision|0|||
130687980|NCT01796171|470483177|FG014|Follow-up Period|Physician Decision|0|||
130687981|NCT01796171|470483163|FG000|Follow-up Period|Withdrawal by Subject|0|||
130687982|NCT01796171|470483164|FG001|Follow-up Period|Withdrawal by Subject|1|||
130687983|NCT01796171|470483165|FG002|Follow-up Period|Withdrawal by Subject|0|||
130687984|NCT01796171|470483166|FG003|Follow-up Period|Withdrawal by Subject|0|||
130687985|NCT01796171|470483167|FG004|Follow-up Period|Withdrawal by Subject|0|||
130687986|NCT01796171|470483168|FG005|Follow-up Period|Withdrawal by Subject|1|||
130687987|NCT01796171|470483169|FG006|Follow-up Period|Withdrawal by Subject|0|||
130687988|NCT01796171|470483170|FG007|Follow-up Period|Withdrawal by Subject|0|||
130687989|NCT01796171|470483171|FG008|Follow-up Period|Withdrawal by Subject|0|||
130687990|NCT01796171|470483172|FG009|Follow-up Period|Withdrawal by Subject|0|||
130687991|NCT01796171|470483173|FG010|Follow-up Period|Withdrawal by Subject|3|||
130687992|NCT01796171|470483174|FG011|Follow-up Period|Withdrawal by Subject|1|||
130687993|NCT01796171|470483175|FG012|Follow-up Period|Withdrawal by Subject|0|||
130687994|NCT01796171|470483176|FG013|Follow-up Period|Withdrawal by Subject|0|||
130687995|NCT01796171|470483177|FG014|Follow-up Period|Withdrawal by Subject|0|||
130687996|NCT01796171|470483163|FG000|Follow-up Period|Death|0|||
130687997|NCT01796171|470483164|FG001|Follow-up Period|Death|0|||
130687998|NCT01796171|470483165|FG002|Follow-up Period|Death|0|||
130687999|NCT01796171|470483166|FG003|Follow-up Period|Death|0|||
130688000|NCT01796171|470483167|FG004|Follow-up Period|Death|0|||
130688001|NCT01796171|470483168|FG005|Follow-up Period|Death|0|||
130688002|NCT01796171|470483169|FG006|Follow-up Period|Death|1|||
130688003|NCT01796171|470483170|FG007|Follow-up Period|Death|0|||
130688004|NCT01796171|470483171|FG008|Follow-up Period|Death|0|||
130688005|NCT01796171|470483172|FG009|Follow-up Period|Death|0|||
130688006|NCT01796171|470483173|FG010|Follow-up Period|Death|17|||
130688007|NCT01796171|470483174|FG011|Follow-up Period|Death|9|||
130688008|NCT01796171|470483175|FG012|Follow-up Period|Death|1|||
130688009|NCT01796171|470483176|FG013|Follow-up Period|Death|0|||
130688010|NCT01796171|470483177|FG014|Follow-up Period|Death|0|||
130688011|NCT01796171|470483163|FG000|Follow-up Period|Patient transferred to other hospital|0|||
130688012|NCT01796171|470483164|FG001|Follow-up Period|Patient transferred to other hospital|1|||
130688013|NCT01796171|470483165|FG002|Follow-up Period|Patient transferred to other hospital|0|||
130688014|NCT01796171|470483166|FG003|Follow-up Period|Patient transferred to other hospital|0|||
130688015|NCT01796171|470483167|FG004|Follow-up Period|Patient transferred to other hospital|0|||
130688016|NCT01796171|470483168|FG005|Follow-up Period|Patient transferred to other hospital|0|||
130688017|NCT01796171|470483169|FG006|Follow-up Period|Patient transferred to other hospital|0|||
130443514|NCT00513019|469588460|FG000|Overall Study|Withdrawal by Subject|4|||
130443515|NCT00513019|469588461|FG001|Overall Study|Withdrawal by Subject|5|||
130443516|NCT01995357|469588462|FG000|Period 5|Lack of Efficacy|1|||
130443517|NCT01995357|469588463|FG001|Period 5|Lack of Efficacy|0|||
130443518|NCT01995357|469588464|FG002|Period 5|Lack of Efficacy|0|||
130443519|NCT01995357|469588465|FG003|Period 5|Lack of Efficacy|0|||
130443520|NCT01995357|469588466|FG004|Period 5|Lack of Efficacy|0|||
130443521|NCT01995357|469588467|FG005|Period 5|Lack of Efficacy|0|||
130443522|NCT01995357|469588462|FG000|Period 5|Adverse Event|1|||
130443523|NCT01995357|469588463|FG001|Period 5|Adverse Event|0|||
130443524|NCT01995357|469588464|FG002|Period 5|Adverse Event|1|||
130443525|NCT01995357|469588465|FG003|Period 5|Adverse Event|0|||
130443526|NCT01995357|469588466|FG004|Period 5|Adverse Event|0|||
130443527|NCT01995357|469588467|FG005|Period 5|Adverse Event|0|||
130443528|NCT03615482|469588468|FG000|Overall Study|Death|1|||
130443529|NCT03615482|469588469|FG001|Overall Study|Death|0|||
130443530|NCT03615482|469588468|FG000|Overall Study|Lost to Follow-up|7|||
130688018|NCT01796171|470483170|FG007|Follow-up Period|Patient transferred to other hospital|0|||
130688019|NCT01796171|470483171|FG008|Follow-up Period|Patient transferred to other hospital|0|||
130688020|NCT01796171|470483172|FG009|Follow-up Period|Patient transferred to other hospital|0|||
130688021|NCT01796171|470483173|FG010|Follow-up Period|Patient transferred to other hospital|0|||
130688022|NCT01796171|470483174|FG011|Follow-up Period|Patient transferred to other hospital|0|||
130688023|NCT01796171|470483175|FG012|Follow-up Period|Patient transferred to other hospital|0|||
130688024|NCT01796171|470483176|FG013|Follow-up Period|Patient transferred to other hospital|0|||
130688025|NCT01796171|470483177|FG014|Follow-up Period|Patient transferred to other hospital|0|||
130688026|NCT01796171|470483163|FG000|Follow-up Period|Sponsor Decision|0|||
130688027|NCT01796171|470483164|FG001|Follow-up Period|Sponsor Decision|0|||
130688028|NCT01796171|470483165|FG002|Follow-up Period|Sponsor Decision|0|||
130688029|NCT01796171|470483166|FG003|Follow-up Period|Sponsor Decision|0|||
130688030|NCT01796171|470483167|FG004|Follow-up Period|Sponsor Decision|0|||
130443531|NCT03615482|469588469|FG001|Overall Study|Lost to Follow-up|7|||
130443532|NCT03615482|469588468|FG000|Overall Study|Physician Decision|2|||
130443533|NCT03615482|469588469|FG001|Overall Study|Physician Decision|3|||
130552879|NCT00752622|469991607|FG000|Observational Phase|Non-responder|2|||
130443534|NCT03615482|469588468|FG000|Overall Study|Withdrawal by Subject|7|||
130443535|NCT03615482|469588469|FG001|Overall Study|Withdrawal by Subject|7|||
130443536|NCT01500226|469588472|FG000|Overall Study|Adverse Event|31|||
130443537|NCT01500226|469588473|FG001|Overall Study|Adverse Event|38|||
130443538|NCT01500226|469588472|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
130443539|NCT01500226|469588473|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
130443540|NCT01500226|469588472|FG000|Overall Study|Withdrawal by Subject|93|||
130443541|NCT01500226|469588473|FG001|Overall Study|Withdrawal by Subject|96|||
130443542|NCT01500226|469588472|FG000|Overall Study|Death|12|||
130443543|NCT01500226|469588473|FG001|Overall Study|Death|4|||
130443544|NCT01500226|469588472|FG000|Overall Study|Disease Progression|16|||
130443545|NCT01500226|469588473|FG001|Overall Study|Disease Progression|14|||
130443546|NCT01500226|469588472|FG000|Overall Study|Protocol Violation|53|||
130443547|NCT01500226|469588473|FG001|Overall Study|Protocol Violation|39|||
130443548|NCT01500226|469588472|FG000|Overall Study|Physician Decision|17|||
130443549|NCT01500226|469588473|FG001|Overall Study|Physician Decision|15|||
130443550|NCT01500226|469588472|FG000|Overall Study|Lack of Efficacy|14|||
130443551|NCT01500226|469588473|FG001|Overall Study|Lack of Efficacy|30|||
130443552|NCT01500226|469588472|FG000|Overall Study|Lost to Follow-up|9|||
130443553|NCT01500226|469588473|FG001|Overall Study|Lost to Follow-up|5|||
130443554|NCT01500226|469588472|FG000|Overall Study|Other Reasons|19|||
130443555|NCT01500226|469588473|FG001|Overall Study|Other Reasons|16|||
130443556|NCT02955277|469588474|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
130443557|NCT02955277|469588475|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
130443558|NCT02955277|469588474|FG000|Post to Follow-up|Lost to Follow-up|8|||
130443559|NCT02955277|469588475|FG001|Post to Follow-up|Lost to Follow-up|11|||
130443560|NCT01809210|469588486|FG000|Overall Study|Withdrawal by Subject|0|||
130443561|NCT01809210|469588487|FG001|Overall Study|Withdrawal by Subject|0|||
130688031|NCT01796171|470483168|FG005|Follow-up Period|Sponsor Decision|0|||
130688032|NCT01796171|470483169|FG006|Follow-up Period|Sponsor Decision|0|||
130443562|NCT01809210|469588488|FG002|Overall Study|Withdrawal by Subject|1|||
130443563|NCT01809210|469588489|FG003|Overall Study|Withdrawal by Subject|1|||
130443564|NCT01809210|469588490|FG004|Overall Study|Withdrawal by Subject|1|||
130443565|NCT01809210|469588491|FG005|Overall Study|Withdrawal by Subject|0|||
130443566|NCT01809210|469588492|FG006|Overall Study|Withdrawal by Subject|4|||
130443567|NCT01809210|469588486|FG000|Overall Study|Death|1|||
130443568|NCT01809210|469588487|FG001|Overall Study|Death|1|||
130443569|NCT01809210|469588488|FG002|Overall Study|Death|2|||
130443570|NCT01809210|469588489|FG003|Overall Study|Death|0|||
130443571|NCT01809210|469588490|FG004|Overall Study|Death|1|||
130443572|NCT01809210|469588491|FG005|Overall Study|Death|3|||
130443573|NCT01809210|469588492|FG006|Overall Study|Death|1|||
130443574|NCT01668147|469588493|FG000|Overall Study|Withdrawal by Subject|6|||
130443575|NCT00590980|469588494|FG000|Overall Study|Did not meet all inclusion criteria|10|||
130688033|NCT01796171|470483170|FG007|Follow-up Period|Sponsor Decision|0|||
130688034|NCT01796171|470483171|FG008|Follow-up Period|Sponsor Decision|0|||
130688035|NCT01796171|470483172|FG009|Follow-up Period|Sponsor Decision|0|||
130688036|NCT01796171|470483173|FG010|Follow-up Period|Sponsor Decision|40|||
130688037|NCT01796171|470483174|FG011|Follow-up Period|Sponsor Decision|15|||
130688038|NCT01796171|470483175|FG012|Follow-up Period|Sponsor Decision|7|||
130688039|NCT01796171|470483176|FG013|Follow-up Period|Sponsor Decision|0|||
130688040|NCT01796171|470483177|FG014|Follow-up Period|Sponsor Decision|0|||
130688041|NCT00418561|470483178|FG000|Overall Study|Participant's (guardian's) decision|0|||
130688042|NCT00418561|470483179|FG001|Overall Study|Participant's (guardian's) decision|1|||
130688043|NCT00418561|470483180|FG002|Overall Study|Participant's (guardian's) decision|0|||
130688044|NCT00829309|470483183|FG000|Washout: 7 Days|Protocol Violation|1|||
130688045|NCT00829309|470483184|FG001|Washout: 7 Days|Protocol Violation|0|||
130688046|NCT01558635|470483185|FG000|Overall Study|Death|1|||
130688047|NCT01558635|470483185|FG000|Overall Study|Withdrawal by Subject|2|||
130688048|NCT01558635|470483185|FG000|Overall Study|Physician Decision|1|||
130443576|NCT03699124|469588498|FG000|Overall Study|Adverse Event|6|||
130443577|NCT03699124|469588499|FG001|Overall Study|Adverse Event|5|||
130443578|NCT03699124|469588500|FG002|Overall Study|Adverse Event|2|||
130443579|NCT03699124|469588498|FG000|Overall Study|Death|0|||
130443580|NCT03699124|469588499|FG001|Overall Study|Death|2|||
130443581|NCT03699124|469588500|FG002|Overall Study|Death|0|||
130443582|NCT03699124|469588498|FG000|Overall Study|Lost to Follow-up|20|||
130443583|NCT03699124|469588499|FG001|Overall Study|Lost to Follow-up|16|||
130688049|NCT01558635|470483185|FG000|Overall Study|Subject received other treatment|1|||
130688050|NCT01558635|470483185|FG000|Overall Study|Reveal XT was explanted|1|||
130688051|NCT00455312|470483186|FG000|Overall Study|Death|0|||
130443584|NCT03699124|469588500|FG002|Overall Study|Lost to Follow-up|15|||
130443585|NCT03699124|469588498|FG000|Overall Study|Protocol Violation|1|||
130443586|NCT03699124|469588499|FG001|Overall Study|Protocol Violation|0|||
130443587|NCT03699124|469588500|FG002|Overall Study|Protocol Violation|0|||
130443588|NCT03699124|469588498|FG000|Overall Study|Withdrawal by Subject|13|||
130443589|NCT03699124|469588499|FG001|Overall Study|Withdrawal by Subject|14|||
130443590|NCT03699124|469588500|FG002|Overall Study|Withdrawal by Subject|13|||
130688052|NCT00455312|470483187|FG001|Overall Study|Death|1|||
130688053|NCT01693523|470483188|FG000|Overall Study|Adverse Event|2|||
130688054|NCT01693523|470483189|FG001|Overall Study|Adverse Event|1|||
130688055|NCT01693523|470483190|FG002|Overall Study|Adverse Event|0|||
130688056|NCT01693523|470483188|FG000|Overall Study|Death|0|||
130688057|NCT01693523|470483189|FG001|Overall Study|Death|1|||
130688058|NCT01693523|470483190|FG002|Overall Study|Death|1|||
130688059|NCT01693523|470483188|FG000|Overall Study|Lost to Follow-up|0|||
130688060|NCT01693523|470483189|FG001|Overall Study|Lost to Follow-up|0|||
130688061|NCT01693523|470483190|FG002|Overall Study|Lost to Follow-up|4|||
130688062|NCT01693523|470483188|FG000|Overall Study|Physician Decision|0|||
130688063|NCT01693523|470483189|FG001|Overall Study|Physician Decision|0|||
130688064|NCT01693523|470483190|FG002|Overall Study|Physician Decision|1|||
130688065|NCT01693523|470483188|FG000|Overall Study|Withdrawal by Subject|1|||
130688066|NCT01693523|470483189|FG001|Overall Study|Withdrawal by Subject|2|||
130688067|NCT01693523|470483190|FG002|Overall Study|Withdrawal by Subject|2|||
130688068|NCT01693523|470483188|FG000|Overall Study|Lack of compliance study medication|1|||
130688069|NCT01693523|470483189|FG001|Overall Study|Lack of compliance study medication|2|||
130688070|NCT01693523|470483190|FG002|Overall Study|Lack of compliance study medication|0|||
130688071|NCT01693523|470483188|FG000|Overall Study|Chemotherapy was held|1|||
130688072|NCT01693523|470483189|FG001|Overall Study|Chemotherapy was held|2|||
130688073|NCT01693523|470483190|FG002|Overall Study|Chemotherapy was held|0|||
130688074|NCT03343535|470483191|FG000|Overall Study|Lost to Follow-up|1|||
130688075|NCT03343535|470483191|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
130688076|NCT03343535|470483191|FG000|Overall Study|Death|12|||
130688077|NCT03699020|470483193|FG000|Overall Study|Withdrawal by Subject|3|||
130688078|NCT03699020|470483194|FG001|Overall Study|Withdrawal by Subject|2|||
130688079|NCT02246920|470483195|FG000|Overall Study|Adverse Event|3|||
130688080|NCT02246920|470483196|FG001|Overall Study|Adverse Event|1|||
130688081|NCT02246920|470483197|FG002|Overall Study|Adverse Event|1|||
130688082|NCT02246920|470483195|FG000|Overall Study|Lost to Follow-up|2|||
130688083|NCT02246920|470483196|FG001|Overall Study|Lost to Follow-up|1|||
130688084|NCT02246920|470483197|FG002|Overall Study|Lost to Follow-up|0|||
130688085|NCT02246920|470483195|FG000|Overall Study|Protocol Violation|2|||
130688086|NCT02246920|470483196|FG001|Overall Study|Protocol Violation|5|||
130688087|NCT02246920|470483197|FG002|Overall Study|Protocol Violation|1|||
130688088|NCT02246920|470483195|FG000|Overall Study|Withdrawal by Subject|0|||
130688089|NCT02246920|470483196|FG001|Overall Study|Withdrawal by Subject|0|||
130688090|NCT02246920|470483197|FG002|Overall Study|Withdrawal by Subject|1|||
130688091|NCT01037114|470483200|FG000|Year 20|Others|1|||
130688092|NCT03620747|470483202|FG000|Overall Study|Participant decision|7|||
130688093|NCT03620747|470483202|FG000|Overall Study|Adverse Event|6|||
130688094|NCT03620747|470483202|FG000|Overall Study|Lack of Efficacy|1|||
130688095|NCT03620747|470483202|FG000|Overall Study|Poor compliance to protocol|2|||
130688096|NCT03620747|470483202|FG000|Overall Study|Other-unspecified|3|||
130688097|NCT00640562|470483205|FG000|Overall Study|Adverse Event|8|||
130688098|NCT00640562|470483206|FG001|Overall Study|Adverse Event|5|||
130443591|NCT03699124|469588498|FG000|Overall Study|Other reasons|5|||
130688099|NCT00640562|470483205|FG000|Overall Study|Lack of Efficacy|1|||
130688100|NCT00640562|470483206|FG001|Overall Study|Lack of Efficacy|4|||
130688101|NCT00640562|470483205|FG000|Overall Study|Protocol Violation|2|||
130443592|NCT03699124|469588499|FG001|Overall Study|Other reasons|3|||
130443593|NCT03699124|469588500|FG002|Overall Study|Other reasons|10|||
130688102|NCT00640562|470483206|FG001|Overall Study|Protocol Violation|4|||
130688103|NCT00640562|470483205|FG000|Overall Study|Withdrawal by Subject|6|||
130688104|NCT00640562|470483206|FG001|Overall Study|Withdrawal by Subject|10|||
130688105|NCT00640562|470483205|FG000|Overall Study|Known risperidone intolerance|0|||
130688106|NCT00640562|470483206|FG001|Overall Study|Known risperidone intolerance|1|||
130688107|NCT00640562|470483205|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
130688108|NCT00640562|470483206|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
130688109|NCT00640562|470483205|FG000|Overall Study|Low study drug dose|0|||
130688110|NCT00640562|470483206|FG001|Overall Study|Low study drug dose|1|||
130688111|NCT00640562|470483205|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
130688112|NCT00640562|470483206|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
130688113|NCT02937870|470483207|FG000|Overall Study|Adverse Event|1|||
130688114|NCT02937870|470483207|FG000|Overall Study|Protocol Deviation|2|||
130688115|NCT00609674|470483208|FG000|Overall Study|Adverse Event|1|||
130688116|NCT00609674|470483209|FG001|Overall Study|Adverse Event|1|||
130688117|NCT00609674|470483208|FG000|Overall Study|Protocol Violation|3|||
130688118|NCT00609674|470483209|FG001|Overall Study|Protocol Violation|5|||
130688119|NCT00609674|470483208|FG000|Overall Study|Lost to Follow-up|1|||
130688120|NCT00609674|470483209|FG001|Overall Study|Lost to Follow-up|0|||
130688121|NCT00609674|470483208|FG000|Overall Study|Withdrew consent|2|||
130688122|NCT00609674|470483209|FG001|Overall Study|Withdrew consent|1|||
130688123|NCT03098394|470483210|FG000|Overall Study|Pregnancy|0|||
130688124|NCT03098394|470483211|FG001|Overall Study|Pregnancy|1|||
130688125|NCT00571064|470483213|FG000|Overall Study|Adverse Event|13|||
130688126|NCT00571064|470483213|FG000|Overall Study|Protocol Violation|4|||
130688127|NCT00571064|470483213|FG000|Overall Study|Withdrawal by Subject|2|||
130688128|NCT00571064|470483213|FG000|Overall Study|Other|2|||
130688129|NCT00244764|470483214|FG000|Overall Study|Adverse Event|37|||
130688130|NCT00244764|470483214|FG000|Overall Study|Lost to Follow-up|23|||
130688131|NCT00244764|470483214|FG000|Overall Study|Withdrawal by Subject|12|||
130688132|NCT00244764|470483214|FG000|Overall Study|Disease Progression|13|||
130688133|NCT00244764|470483214|FG000|Overall Study|Protocol Violation|2|||
130688134|NCT00244764|470483214|FG000|Overall Study|Death|1|||
130688135|NCT00244764|470483214|FG000|Overall Study|Off Study Medication for >21 Days|1|||
130688136|NCT00244764|470483214|FG000|Overall Study|Declining Performance Status|1|||
130688137|NCT00244764|470483214|FG000|Overall Study|Participant was Hospitalized until Death|1|||
130688138|NCT00244764|470483214|FG000|Overall Study|Primary Investigator Discretion|2|||
130688139|NCT00244764|470483214|FG000|Overall Study|Sponsor Terminated Study|2|||
130688140|NCT00244764|470483214|FG000|Overall Study|Developed Secondary Malignancy|1|||
130688141|NCT03872128|470483217|FG000|Overall Study|Dropped out before treatment|1|||
130688142|NCT03872128|470483218|FG001|Overall Study|Dropped out before treatment|0|||
130688143|NCT03872128|470483219|FG002|Overall Study|Dropped out before treatment|4|||
130688144|NCT03872128|470483217|FG000|Overall Study|Lost to Follow-up|2|||
130688145|NCT03872128|470483218|FG001|Overall Study|Lost to Follow-up|5|||
130688146|NCT03872128|470483219|FG002|Overall Study|Lost to Follow-up|8|||
130688147|NCT03285594|470483221|FG000|Overall Study|At the Participant's Own Request|10|||
130688148|NCT03285594|470483222|FG001|Overall Study|At the Participant's Own Request|5|||
130688149|NCT03285594|470483223|FG002|Overall Study|At the Participant's Own Request|21|||
130688150|NCT03285594|470483221|FG000|Overall Study|Adverse Event|2|||
130688151|NCT03285594|470483222|FG001|Overall Study|Adverse Event|2|||
130688152|NCT03285594|470483223|FG002|Overall Study|Adverse Event|6|||
130688153|NCT03285594|470483221|FG000|Overall Study|Poor Compliance to Protocol|0|||
130688154|NCT03285594|470483222|FG001|Overall Study|Poor Compliance to Protocol|0|||
130688155|NCT03285594|470483223|FG002|Overall Study|Poor Compliance to Protocol|1|||
130688156|NCT03285594|470483221|FG000|Overall Study|Lost to Follow-up|0|||
130688157|NCT03285594|470483222|FG001|Overall Study|Lost to Follow-up|0|||
130688158|NCT03285594|470483223|FG002|Overall Study|Lost to Follow-up|1|||
130688159|NCT03285594|470483221|FG000|Overall Study|Reason Not Specified|3|||
130688160|NCT03285594|470483222|FG001|Overall Study|Reason Not Specified|4|||
130688161|NCT03285594|470483223|FG002|Overall Study|Reason Not Specified|8|||
130688162|NCT03273153|470483227|FG000|Overall Study|Adverse Event|1|||
130688163|NCT03273153|470483228|FG001|Overall Study|Adverse Event|2|||
130688164|NCT03273153|470483227|FG000|Overall Study|Missing|0|||
130688165|NCT03273153|470483228|FG001|Overall Study|Missing|2|||
130688166|NCT03273153|470483227|FG000|Overall Study|Other|3|||
130688167|NCT03273153|470483228|FG001|Overall Study|Other|2|||
130688168|NCT03273153|470483227|FG000|Overall Study|Symptomatic Deterioration|0|||
130688169|NCT03273153|470483228|FG001|Overall Study|Symptomatic Deterioration|1|||
130443594|NCT01474512|469588501|FG000|Induction Period|Adverse Event|6|||
130443595|NCT01474512|469588502|FG001|Induction Period|Adverse Event|10|||
130688170|NCT03273153|470483227|FG000|Overall Study|Progressive Disease|6|||
130443596|NCT01474512|469588503|FG002|Induction Period|Adverse Event|10|||
130688171|NCT03273153|470483228|FG001|Overall Study|Progressive Disease|5|||
130688172|NCT03273153|470483227|FG000|Overall Study|Physician Decision|1|||
130688173|NCT03273153|470483228|FG001|Overall Study|Physician Decision|3|||
130688174|NCT03273153|470483227|FG000|Overall Study|Study Terminated by Sponsor|112|||
130688175|NCT03273153|470483228|FG001|Overall Study|Study Terminated by Sponsor|102|||
130688176|NCT03273153|470483227|FG000|Overall Study|Withdrawal by Subject|26|||
130688177|NCT03273153|470483228|FG001|Overall Study|Withdrawal by Subject|25|||
130688178|NCT03273153|470483227|FG000|Overall Study|Protocol Deviation|3|||
130688179|NCT03273153|470483228|FG001|Overall Study|Protocol Deviation|0|||
130688180|NCT03273153|470483227|FG000|Overall Study|Lost to Follow-up|6|||
130688181|NCT03273153|470483228|FG001|Overall Study|Lost to Follow-up|11|||
130688182|NCT03273153|470483227|FG000|Overall Study|Death|66|||
130688183|NCT03273153|470483228|FG001|Overall Study|Death|69|||
130688184|NCT05323396|470483229|FG000|Overall Study|Lost to Follow-up|1|||
130688185|NCT05323396|470483230|FG001|Overall Study|Lost to Follow-up|35|||
130688186|NCT05323396|470483229|FG000|Overall Study|Pregnancy|1|||
130688187|NCT05323396|470483230|FG001|Overall Study|Pregnancy|0|||
130688188|NCT04646213|470483231|FG000|Overall Study|Physician Decision|3|||
130688189|NCT04646213|470483231|FG000|Overall Study|Withdrawal by Subject|2|||
130688190|NCT00415363|470483236|FG000|Overall Study|Withdrawal by Subject|4|||
130443597|NCT01474512|469588504|FG003|Induction Period|Adverse Event|0|||
130443598|NCT01474512|469588505|FG004|Induction Period|Adverse Event|0|||
130443599|NCT01474512|469588506|FG005|Induction Period|Adverse Event|0|||
130443600|NCT01474512|469588507|FG006|Induction Period|Adverse Event|0|||
130443601|NCT01474512|469588508|FG007|Induction Period|Adverse Event|0|||
130443602|NCT01474512|469588509|FG008|Induction Period|Adverse Event|0|||
130443603|NCT01474512|469588510|FG009|Induction Period|Adverse Event|0|||
130443604|NCT01474512|469588511|FG010|Induction Period|Adverse Event|0|||
130443605|NCT01474512|469588512|FG011|Induction Period|Adverse Event|0|||
130443606|NCT01474512|469588513|FG012|Induction Period|Adverse Event|0|||
130443607|NCT01474512|469588514|FG013|Induction Period|Adverse Event|0|||
130443608|NCT01474512|469588515|FG014|Induction Period|Adverse Event|0|||
130443609|NCT01474512|469588516|FG015|Induction Period|Adverse Event|0|||
130443610|NCT01474512|469588517|FG016|Induction Period|Adverse Event|0|||
130443611|NCT01474512|469588518|FG017|Induction Period|Adverse Event|0|||
130443612|NCT01474512|469588501|FG000|Induction Period|Lack of Efficacy|7|||
130443613|NCT01474512|469588502|FG001|Induction Period|Lack of Efficacy|1|||
130443614|NCT01474512|469588503|FG002|Induction Period|Lack of Efficacy|0|||
130443615|NCT01474512|469588504|FG003|Induction Period|Lack of Efficacy|0|||
130443616|NCT01474512|469588505|FG004|Induction Period|Lack of Efficacy|0|||
130443617|NCT01474512|469588506|FG005|Induction Period|Lack of Efficacy|0|||
130443618|NCT01474512|469588507|FG006|Induction Period|Lack of Efficacy|0|||
130443619|NCT01474512|469588508|FG007|Induction Period|Lack of Efficacy|0|||
130443620|NCT01474512|469588509|FG008|Induction Period|Lack of Efficacy|0|||
130443621|NCT01474512|469588510|FG009|Induction Period|Lack of Efficacy|0|||
130443622|NCT01474512|469588511|FG010|Induction Period|Lack of Efficacy|0|||
130443623|NCT01474512|469588512|FG011|Induction Period|Lack of Efficacy|0|||
130443624|NCT01474512|469588513|FG012|Induction Period|Lack of Efficacy|0|||
130443625|NCT01474512|469588514|FG013|Induction Period|Lack of Efficacy|0|||
130443626|NCT01474512|469588515|FG014|Induction Period|Lack of Efficacy|0|||
130443627|NCT01474512|469588516|FG015|Induction Period|Lack of Efficacy|0|||
130443628|NCT01474512|469588517|FG016|Induction Period|Lack of Efficacy|0|||
130443629|NCT01474512|469588518|FG017|Induction Period|Lack of Efficacy|0|||
130443630|NCT01474512|469588501|FG000|Induction Period|Withdrawal by Subject|6|||
130443631|NCT01474512|469588502|FG001|Induction Period|Withdrawal by Subject|6|||
130443632|NCT01474512|469588503|FG002|Induction Period|Withdrawal by Subject|5|||
130443633|NCT01474512|469588504|FG003|Induction Period|Withdrawal by Subject|0|||
130443634|NCT01474512|469588505|FG004|Induction Period|Withdrawal by Subject|0|||
130443635|NCT01474512|469588506|FG005|Induction Period|Withdrawal by Subject|0|||
130443636|NCT01474512|469588507|FG006|Induction Period|Withdrawal by Subject|0|||
130443637|NCT01474512|469588508|FG007|Induction Period|Withdrawal by Subject|0|||
130443638|NCT01474512|469588509|FG008|Induction Period|Withdrawal by Subject|0|||
130443639|NCT01474512|469588510|FG009|Induction Period|Withdrawal by Subject|0|||
130443640|NCT01474512|469588511|FG010|Induction Period|Withdrawal by Subject|0|||
130443641|NCT01474512|469588512|FG011|Induction Period|Withdrawal by Subject|0|||
130443642|NCT01474512|469588513|FG012|Induction Period|Withdrawal by Subject|0|||
130443643|NCT01474512|469588514|FG013|Induction Period|Withdrawal by Subject|0|||
130443644|NCT01474512|469588515|FG014|Induction Period|Withdrawal by Subject|0|||
130443645|NCT01474512|469588516|FG015|Induction Period|Withdrawal by Subject|0|||
130443646|NCT01474512|469588517|FG016|Induction Period|Withdrawal by Subject|0|||
130443647|NCT01474512|469588518|FG017|Induction Period|Withdrawal by Subject|0|||
130443648|NCT01474512|469588501|FG000|Induction Period|Protocol Violation|3|||
130443649|NCT01474512|469588502|FG001|Induction Period|Protocol Violation|6|||
130443650|NCT01474512|469588503|FG002|Induction Period|Protocol Violation|0|||
130443651|NCT01474512|469588504|FG003|Induction Period|Protocol Violation|0|||
130443652|NCT01474512|469588505|FG004|Induction Period|Protocol Violation|0|||
130443653|NCT01474512|469588506|FG005|Induction Period|Protocol Violation|0|||
130443654|NCT01474512|469588507|FG006|Induction Period|Protocol Violation|0|||
130688191|NCT00415363|470483237|FG001|Overall Study|Withdrawal by Subject|4|||
130443655|NCT01474512|469588508|FG007|Induction Period|Protocol Violation|0|||
130443656|NCT01474512|469588509|FG008|Induction Period|Protocol Violation|0|||
130443657|NCT01474512|469588510|FG009|Induction Period|Protocol Violation|0|||
130443658|NCT01474512|469588511|FG010|Induction Period|Protocol Violation|0|||
130443659|NCT01474512|469588512|FG011|Induction Period|Protocol Violation|0|||
130443660|NCT01474512|469588513|FG012|Induction Period|Protocol Violation|0|||
130443661|NCT01474512|469588514|FG013|Induction Period|Protocol Violation|0|||
130443662|NCT01474512|469588515|FG014|Induction Period|Protocol Violation|0|||
130443663|NCT01474512|469588516|FG015|Induction Period|Protocol Violation|0|||
130443664|NCT01474512|469588517|FG016|Induction Period|Protocol Violation|0|||
130688192|NCT00415363|470483236|FG000|Overall Study|Adverse Event|4|||
130688193|NCT00415363|470483237|FG001|Overall Study|Adverse Event|4|||
130443665|NCT01474512|469588518|FG017|Induction Period|Protocol Violation|0|||
130443666|NCT01474512|469588501|FG000|Induction Period|Sponsor Decision|1|||
130443667|NCT01474512|469588502|FG001|Induction Period|Sponsor Decision|1|||
130443668|NCT01474512|469588503|FG002|Induction Period|Sponsor Decision|1|||
130443669|NCT01474512|469588504|FG003|Induction Period|Sponsor Decision|0|||
130443670|NCT01474512|469588505|FG004|Induction Period|Sponsor Decision|0|||
130443671|NCT01474512|469588506|FG005|Induction Period|Sponsor Decision|0|||
130443672|NCT01474512|469588507|FG006|Induction Period|Sponsor Decision|0|||
130443673|NCT01474512|469588508|FG007|Induction Period|Sponsor Decision|0|||
130443674|NCT01474512|469588509|FG008|Induction Period|Sponsor Decision|0|||
130443675|NCT01474512|469588510|FG009|Induction Period|Sponsor Decision|0|||
130443676|NCT01474512|469588511|FG010|Induction Period|Sponsor Decision|0|||
130443677|NCT01474512|469588512|FG011|Induction Period|Sponsor Decision|0|||
130443678|NCT01474512|469588513|FG012|Induction Period|Sponsor Decision|0|||
130443679|NCT01474512|469588514|FG013|Induction Period|Sponsor Decision|0|||
130443680|NCT01474512|469588515|FG014|Induction Period|Sponsor Decision|0|||
130443681|NCT01474512|469588516|FG015|Induction Period|Sponsor Decision|0|||
130443682|NCT01474512|469588517|FG016|Induction Period|Sponsor Decision|0|||
130443683|NCT01474512|469588518|FG017|Induction Period|Sponsor Decision|0|||
130443684|NCT01474512|469588501|FG000|Induction Period|Lost to Follow-up|1|||
130443685|NCT01474512|469588502|FG001|Induction Period|Lost to Follow-up|0|||
130443686|NCT01474512|469588503|FG002|Induction Period|Lost to Follow-up|2|||
130443687|NCT01474512|469588504|FG003|Induction Period|Lost to Follow-up|0|||
130443688|NCT01474512|469588505|FG004|Induction Period|Lost to Follow-up|0|||
130443689|NCT01474512|469588506|FG005|Induction Period|Lost to Follow-up|0|||
130443690|NCT01474512|469588507|FG006|Induction Period|Lost to Follow-up|0|||
130443691|NCT01474512|469588508|FG007|Induction Period|Lost to Follow-up|0|||
130443692|NCT01474512|469588509|FG008|Induction Period|Lost to Follow-up|0|||
130443693|NCT01474512|469588510|FG009|Induction Period|Lost to Follow-up|0|||
130443694|NCT01474512|469588511|FG010|Induction Period|Lost to Follow-up|0|||
130443695|NCT01474512|469588512|FG011|Induction Period|Lost to Follow-up|0|||
130443696|NCT01474512|469588513|FG012|Induction Period|Lost to Follow-up|0|||
130443697|NCT01474512|469588514|FG013|Induction Period|Lost to Follow-up|0|||
130443698|NCT01474512|469588515|FG014|Induction Period|Lost to Follow-up|0|||
130443699|NCT01474512|469588516|FG015|Induction Period|Lost to Follow-up|0|||
130443700|NCT01474512|469588517|FG016|Induction Period|Lost to Follow-up|0|||
130443701|NCT01474512|469588518|FG017|Induction Period|Lost to Follow-up|0|||
130443702|NCT01474512|469588501|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443703|NCT01474512|469588502|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443704|NCT01474512|469588503|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443705|NCT01474512|469588504|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
130443706|NCT01474512|469588505|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
130443707|NCT01474512|469588506|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
130443708|NCT01474512|469588507|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
130443709|NCT01474512|469588508|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443710|NCT01474512|469588509|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443711|NCT01474512|469588510|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443712|NCT01474512|469588511|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443713|NCT01474512|469588512|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443714|NCT01474512|469588513|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443715|NCT01474512|469588514|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443716|NCT01474512|469588515|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443717|NCT01474512|469588516|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443718|NCT01474512|469588517|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443719|NCT01474512|469588518|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
130443720|NCT01474512|469588501|FG000|Maintenance Period|Adverse Event|0|||
130443721|NCT01474512|469588502|FG001|Maintenance Period|Adverse Event|0|||
130443722|NCT01474512|469588503|FG002|Maintenance Period|Adverse Event|0|||
130443723|NCT01474512|469588504|FG003|Maintenance Period|Adverse Event|4|||
130443724|NCT01474512|469588505|FG004|Maintenance Period|Adverse Event|2|||
130443725|NCT01474512|469588506|FG005|Maintenance Period|Adverse Event|7|||
130443726|NCT01474512|469588507|FG006|Maintenance Period|Adverse Event|0|||
130443727|NCT01474512|469588508|FG007|Maintenance Period|Adverse Event|19|||
130443728|NCT01474512|469588509|FG008|Maintenance Period|Adverse Event|1|||
130443729|NCT01474512|469588510|FG009|Maintenance Period|Adverse Event|3|||
130443730|NCT01474512|469588511|FG010|Maintenance Period|Adverse Event|0|||
130443731|NCT01474512|469588512|FG011|Maintenance Period|Adverse Event|0|||
130443732|NCT01474512|469588513|FG012|Maintenance Period|Adverse Event|0|||
130443733|NCT01474512|469588514|FG013|Maintenance Period|Adverse Event|0|||
130443734|NCT01474512|469588515|FG014|Maintenance Period|Adverse Event|0|||
130443735|NCT01474512|469588516|FG015|Maintenance Period|Adverse Event|0|||
130443736|NCT01474512|469588517|FG016|Maintenance Period|Adverse Event|0|||
130443737|NCT01474512|469588518|FG017|Maintenance Period|Adverse Event|0|||
130443738|NCT01474512|469588501|FG000|Maintenance Period|Withdrawal by Subject|0|||
130443739|NCT01474512|469588502|FG001|Maintenance Period|Withdrawal by Subject|0|||
130443740|NCT01474512|469588503|FG002|Maintenance Period|Withdrawal by Subject|0|||
130443741|NCT01474512|469588504|FG003|Maintenance Period|Withdrawal by Subject|6|||
130443742|NCT01474512|469588505|FG004|Maintenance Period|Withdrawal by Subject|2|||
130443743|NCT01474512|469588506|FG005|Maintenance Period|Withdrawal by Subject|3|||
130688194|NCT00415363|470483236|FG000|Overall Study|Lost to Follow-up|2|||
130688195|NCT00415363|470483237|FG001|Overall Study|Lost to Follow-up|1|||
130688196|NCT00415363|470483236|FG000|Overall Study|Physician Decision|3|||
130688197|NCT00415363|470483237|FG001|Overall Study|Physician Decision|1|||
130688198|NCT00415363|470483236|FG000|Overall Study|Death|16|||
130688199|NCT00415363|470483237|FG001|Overall Study|Death|12|||
130688200|NCT00415363|470483236|FG000|Overall Study|Progressive disease|26|||
130688201|NCT00415363|470483237|FG001|Overall Study|Progressive disease|32|||
130688202|NCT00095212|470483238|FG000|Overall Study|Withdrawal by Subject|1|||
130688203|NCT00095212|470483239|FG001|Overall Study|Withdrawal by Subject|3|||
130688204|NCT05341622|470483240|FG000|Overall Study|Death|0|||
130688205|NCT05341622|470483241|FG001|Overall Study|Death|0|||
130688206|NCT05341622|470483242|FG002|Overall Study|Death|0|||
130688207|NCT05341622|470483243|FG003|Overall Study|Death|0|||
130688208|NCT05341622|470483244|FG004|Overall Study|Death|1|||
130688209|NCT05341622|470483245|FG005|Overall Study|Death|0|||
130688210|NCT05341622|470483246|FG006|Overall Study|Death|0|||
130688211|NCT05341622|470483247|FG007|Overall Study|Death|1|||
130688212|NCT05341622|470483240|FG000|Overall Study|Invalid Address|0|||
130688213|NCT05341622|470483241|FG001|Overall Study|Invalid Address|1|||
130688214|NCT05341622|470483242|FG002|Overall Study|Invalid Address|0|||
130688215|NCT05341622|470483243|FG003|Overall Study|Invalid Address|0|||
130688216|NCT05341622|470483244|FG004|Overall Study|Invalid Address|0|||
130688217|NCT05341622|470483245|FG005|Overall Study|Invalid Address|0|||
130688218|NCT05341622|470483246|FG006|Overall Study|Invalid Address|0|||
130688219|NCT05341622|470483247|FG007|Overall Study|Invalid Address|0|||
130688220|NCT05341622|470483240|FG000|Overall Study|Ineligible|26|||
130688221|NCT05341622|470483241|FG001|Overall Study|Ineligible|21|||
130688222|NCT05341622|470483242|FG002|Overall Study|Ineligible|28|||
130688223|NCT05341622|470483243|FG003|Overall Study|Ineligible|24|||
130688224|NCT05341622|470483244|FG004|Overall Study|Ineligible|29|||
130688225|NCT05341622|470483245|FG005|Overall Study|Ineligible|31|||
130688226|NCT05341622|470483246|FG006|Overall Study|Ineligible|28|||
130688227|NCT05341622|470483247|FG007|Overall Study|Ineligible|26|||
130688228|NCT02658084|470483248|FG000|Overall Study|Withdrawal by Subject|1|||
130688229|NCT02658084|470483249|FG001|Overall Study|Withdrawal by Subject|0|||
130688230|NCT02658084|470483248|FG000|Overall Study|Study Termination|1|||
130688231|NCT02658084|470483249|FG001|Overall Study|Study Termination|0|||
130688232|NCT02674152|470484537|FG000|Overall Study|Personal Reasons|1|||
130688233|NCT02674152|470484538|FG001|Overall Study|Personal Reasons|0|||
130688234|NCT02674152|470484539|FG002|Overall Study|Personal Reasons|0|||
130688235|NCT02674152|470484540|FG003|Overall Study|Personal Reasons|1|||
130688236|NCT02674152|470484541|FG004|Overall Study|Personal Reasons|1|||
130443744|NCT01474512|469588507|FG006|Maintenance Period|Withdrawal by Subject|1|||
130443745|NCT01474512|469588508|FG007|Maintenance Period|Withdrawal by Subject|6|||
130443746|NCT01474512|469588509|FG008|Maintenance Period|Withdrawal by Subject|3|||
130443747|NCT01474512|469588510|FG009|Maintenance Period|Withdrawal by Subject|1|||
130443748|NCT01474512|469588511|FG010|Maintenance Period|Withdrawal by Subject|0|||
130443749|NCT01474512|469588512|FG011|Maintenance Period|Withdrawal by Subject|0|||
130443750|NCT01474512|469588513|FG012|Maintenance Period|Withdrawal by Subject|0|||
130443751|NCT01474512|469588514|FG013|Maintenance Period|Withdrawal by Subject|0|||
130443752|NCT01474512|469588515|FG014|Maintenance Period|Withdrawal by Subject|0|||
130443753|NCT01474512|469588516|FG015|Maintenance Period|Withdrawal by Subject|0|||
130443754|NCT01474512|469588517|FG016|Maintenance Period|Withdrawal by Subject|0|||
130443755|NCT01474512|469588518|FG017|Maintenance Period|Withdrawal by Subject|0|||
130443756|NCT01474512|469588501|FG000|Maintenance Period|Lost to Follow-up|0|||
130443757|NCT01474512|469588502|FG001|Maintenance Period|Lost to Follow-up|0|||
130443758|NCT01474512|469588503|FG002|Maintenance Period|Lost to Follow-up|0|||
130443759|NCT01474512|469588504|FG003|Maintenance Period|Lost to Follow-up|3|||
130443760|NCT01474512|469588505|FG004|Maintenance Period|Lost to Follow-up|3|||
130443761|NCT01474512|469588506|FG005|Maintenance Period|Lost to Follow-up|0|||
130443762|NCT01474512|469588507|FG006|Maintenance Period|Lost to Follow-up|0|||
130443763|NCT01474512|469588508|FG007|Maintenance Period|Lost to Follow-up|2|||
130443764|NCT01474512|469588509|FG008|Maintenance Period|Lost to Follow-up|1|||
130443765|NCT01474512|469588510|FG009|Maintenance Period|Lost to Follow-up|1|||
130443766|NCT01474512|469588511|FG010|Maintenance Period|Lost to Follow-up|0|||
130443767|NCT01474512|469588512|FG011|Maintenance Period|Lost to Follow-up|0|||
130443768|NCT01474512|469588513|FG012|Maintenance Period|Lost to Follow-up|0|||
130443769|NCT01474512|469588514|FG013|Maintenance Period|Lost to Follow-up|0|||
130443770|NCT01474512|469588515|FG014|Maintenance Period|Lost to Follow-up|0|||
130443771|NCT01474512|469588516|FG015|Maintenance Period|Lost to Follow-up|0|||
130688237|NCT02674152|470484537|FG000|Overall Study|Other adverse event or clinical progression|0|||
130443772|NCT01474512|469588517|FG016|Maintenance Period|Lost to Follow-up|0|||
130688238|NCT02674152|470484538|FG001|Overall Study|Other adverse event or clinical progression|1|||
130688239|NCT02674152|470484539|FG002|Overall Study|Other adverse event or clinical progression|0|||
130688240|NCT02674152|470484540|FG003|Overall Study|Other adverse event or clinical progression|3|||
130688241|NCT02674152|470484541|FG004|Overall Study|Other adverse event or clinical progression|0|||
130688242|NCT02674152|470484537|FG000|Overall Study|Dose-limiting toxicity|0|||
130688243|NCT02674152|470484538|FG001|Overall Study|Dose-limiting toxicity|0|||
130688244|NCT02674152|470484539|FG002|Overall Study|Dose-limiting toxicity|0|||
130688245|NCT02674152|470484540|FG003|Overall Study|Dose-limiting toxicity|0|||
130688246|NCT02674152|470484541|FG004|Overall Study|Dose-limiting toxicity|1|||
130688247|NCT02674152|470484537|FG000|Overall Study|Progressive Disease|2|||
130688248|NCT02674152|470484538|FG001|Overall Study|Progressive Disease|1|||
130688249|NCT02674152|470484539|FG002|Overall Study|Progressive Disease|1|||
130688250|NCT02674152|470484540|FG003|Overall Study|Progressive Disease|13|||
130688251|NCT02674152|470484541|FG004|Overall Study|Progressive Disease|2|||
130688252|NCT02674152|470484537|FG000|Overall Study|Adverse Event|0|||
130688253|NCT02674152|470484538|FG001|Overall Study|Adverse Event|0|||
130688254|NCT02674152|470484539|FG002|Overall Study|Adverse Event|1|||
130688255|NCT02674152|470484540|FG003|Overall Study|Adverse Event|0|||
130688256|NCT02674152|470484541|FG004|Overall Study|Adverse Event|1|||
130688257|NCT04934722|470484542|FG000|Overall Study|Death|4|||
130688258|NCT04934722|470484543|FG001|Overall Study|Death|3|||
130688259|NCT04934722|470484542|FG000|Overall Study|Participants Ongoing|88|||
130688260|NCT04934722|470484543|FG001|Overall Study|Participants Ongoing|91|||
130688261|NCT05265624|470484544|FG000|Overall Study|Lost to Follow-up|3|||
130688262|NCT05265624|470484545|FG001|Overall Study|Lost to Follow-up|0|||
130688263|NCT05265624|470484544|FG000|Overall Study|Withdrawal by Subject|1|||
130688264|NCT05265624|470484545|FG001|Overall Study|Withdrawal by Subject|0|||
130688265|NCT03071575|470484546|FG000|Overall Study|Death|0|||
130688266|NCT03071575|470484547|FG001|Overall Study|Death|1|||
130688267|NCT03071575|470484546|FG000|Overall Study|Lost to Follow-up|5|||
130688268|NCT03071575|470484547|FG001|Overall Study|Lost to Follow-up|11|||
130688269|NCT03071575|470484546|FG000|Overall Study|Withdrawal by Subject|4|||
130688270|NCT03071575|470484547|FG001|Overall Study|Withdrawal by Subject|2|||
130688271|NCT00834795|470484548|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130688272|NCT00834795|470484549|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130688273|NCT00834795|470484548|FG000|Second Intervention|Adverse Event|1|||
130688274|NCT00834795|470484549|FG001|Second Intervention|Adverse Event|0|||
130688275|NCT00579345|470484550|FG000|Overall Study|Withdrawal by Subject|2|||
130688276|NCT00579345|470484551|FG001|Overall Study|Withdrawal by Subject|0|||
130688277|NCT00579345|470484552|FG002|Overall Study|Withdrawal by Subject|0|||
130688278|NCT00579345|470484553|FG003|Overall Study|Withdrawal by Subject|0|||
130688279|NCT00579345|470484554|FG004|Overall Study|Withdrawal by Subject|0|||
130688280|NCT00579345|470484555|FG005|Overall Study|Withdrawal by Subject|0|||
130688281|NCT00579345|470484556|FG006|Overall Study|Withdrawal by Subject|0|||
130688282|NCT00579345|470484557|FG007|Overall Study|Withdrawal by Subject|1|||
130688283|NCT00579345|470484550|FG000|Overall Study|Lost to Follow-up|1|||
130688284|NCT00579345|470484551|FG001|Overall Study|Lost to Follow-up|0|||
130688285|NCT00579345|470484552|FG002|Overall Study|Lost to Follow-up|0|||
130688286|NCT00579345|470484553|FG003|Overall Study|Lost to Follow-up|0|||
130688287|NCT00579345|470484554|FG004|Overall Study|Lost to Follow-up|0|||
130225059|NCT01211145|468788058|FG002|Overall Study|Severe noncompliance to protocol|0|||
130225060|NCT01211145|468788059|FG003|Overall Study|Severe noncompliance to protocol|0|||
130688288|NCT00579345|470484555|FG005|Overall Study|Lost to Follow-up|0|||
130688289|NCT00579345|470484556|FG006|Overall Study|Lost to Follow-up|0|||
130688290|NCT00579345|470484557|FG007|Overall Study|Lost to Follow-up|0|||
130688291|NCT00579345|470484550|FG000|Overall Study|Adverse Event|0|||
130688292|NCT00579345|470484551|FG001|Overall Study|Adverse Event|0|||
130688293|NCT00579345|470484552|FG002|Overall Study|Adverse Event|1|||
130688294|NCT00579345|470484553|FG003|Overall Study|Adverse Event|0|||
130688295|NCT00579345|470484554|FG004|Overall Study|Adverse Event|0|||
130688296|NCT00579345|470484555|FG005|Overall Study|Adverse Event|0|||
130688297|NCT00579345|470484556|FG006|Overall Study|Adverse Event|0|||
130688298|NCT00579345|470484557|FG007|Overall Study|Adverse Event|0|||
130688299|NCT00579345|470484550|FG000|Overall Study|Protocol Violation|1|||
130688300|NCT00579345|470484551|FG001|Overall Study|Protocol Violation|0|||
130688301|NCT00579345|470484552|FG002|Overall Study|Protocol Violation|0|||
130688302|NCT00579345|470484553|FG003|Overall Study|Protocol Violation|0|||
130688303|NCT00579345|470484554|FG004|Overall Study|Protocol Violation|0|||
130688304|NCT00579345|470484555|FG005|Overall Study|Protocol Violation|0|||
130688305|NCT00579345|470484556|FG006|Overall Study|Protocol Violation|0|||
130688306|NCT00579345|470484557|FG007|Overall Study|Protocol Violation|1|||
130688307|NCT00579345|470484550|FG000|Overall Study|Death|1|||
130688308|NCT00579345|470484551|FG001|Overall Study|Death|1|||
130688309|NCT00579345|470484552|FG002|Overall Study|Death|1|||
130688310|NCT00579345|470484553|FG003|Overall Study|Death|1|||
130688311|NCT00579345|470484554|FG004|Overall Study|Death|0|||
130688312|NCT00579345|470484555|FG005|Overall Study|Death|0|||
130688313|NCT00579345|470484556|FG006|Overall Study|Death|0|||
130688314|NCT00579345|470484557|FG007|Overall Study|Death|0|||
130688315|NCT05604170|470484561|FG000|Overall Study|Lack of Efficacy|5|||
130688316|NCT05604170|470484561|FG000|Overall Study|Adverse Event|6|||
130688317|NCT05604170|470484561|FG000|Overall Study|Physician Decision|6|||
130688318|NCT05604170|470484561|FG000|Overall Study|Lost to Follow-up|6|||
130688319|NCT05604170|470484561|FG000|Overall Study|Withdrawal by Subject|11|||
130688320|NCT05604170|470484561|FG000|Overall Study|Early study termination by sponsor|77|||
130688321|NCT05604170|470484561|FG000|Overall Study|Other|6|||
130688322|NCT00272779|470484564|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
130688323|NCT00272779|470484565|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
130688324|NCT00272779|470484564|FG000|Baseline Through Week 48|Death before Week 48|4|||
130688325|NCT00272779|470484565|FG001|Baseline Through Week 48|Death before Week 48|4|||
130688326|NCT00272779|470484564|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
130688327|NCT00272779|470484565|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
130688328|NCT00272779|470484564|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130688329|NCT00272779|470484565|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130688330|NCT00272779|470484564|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
130688331|NCT00272779|470484565|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
130688332|NCT00272779|470484564|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
130688333|NCT00272779|470484565|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
130688334|NCT00272779|470484564|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
130688335|NCT00272779|470484565|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
130688336|NCT00272779|470484564|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
130688337|NCT00272779|470484565|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
130688338|NCT00272779|470484564|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
130688339|NCT00272779|470484565|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
130688340|NCT00272779|470484564|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
130688341|NCT00272779|470484565|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
130688342|NCT00272779|470484564|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
130688343|NCT00272779|470484565|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
130688344|NCT00272779|470484564|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130688345|NCT00272779|470484565|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130688346|NCT00272779|470484564|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
130688347|NCT00272779|470484565|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
130688348|NCT00272779|470484564|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
130688349|NCT00272779|470484565|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
130688350|NCT00272779|470484564|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130688351|NCT00272779|470484565|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130688352|NCT00272779|470484564|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130688353|NCT00272779|470484565|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130688354|NCT00272779|470484564|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
130688355|NCT00272779|470484565|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
130688356|NCT00272779|470484564|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
130688357|NCT00272779|470484565|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
130688358|NCT00272779|470484564|FG000|Baseline Through Week 48|Continuing treatment|385|||
130688359|NCT00272779|470484565|FG001|Baseline Through Week 48|Continuing treatment|368|||
130688360|NCT00272779|470484564|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
130688361|NCT00272779|470484565|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
130688362|NCT00272779|470484564|FG000|Baseline Through Week 48|Never treated|2|||
130688363|NCT00272779|470484565|FG001|Baseline Through Week 48|Never treated|3|||
130688364|NCT00272779|470484564|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
130688365|NCT00272779|470484565|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
130688366|NCT00272779|470484564|FG000|Baseline Through Week 96|Death before Week 96|6|||
130688367|NCT00272779|470484565|FG001|Baseline Through Week 96|Death before Week 96|5|||
130688368|NCT00272779|470484564|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
130688369|NCT00272779|470484565|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
130688370|NCT00272779|470484564|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
130688371|NCT00272779|470484565|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
130688372|NCT00272779|470484564|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
130688373|NCT00272779|470484565|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
130688374|NCT00272779|470484564|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
130688375|NCT00272779|470484565|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
130688376|NCT00272779|470484564|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
130688377|NCT00272779|470484565|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
130688378|NCT00272779|470484564|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
130688379|NCT00272779|470484565|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
130688380|NCT00272779|470484564|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
130688381|NCT00272779|470484565|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
130688382|NCT00272779|470484564|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
130688383|NCT00272779|470484565|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
130688384|NCT00272779|470484564|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
130688385|NCT00272779|470484565|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
130688386|NCT00272779|470484564|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
130688387|NCT00272779|470484565|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
130688388|NCT00272779|470484564|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
130688389|NCT00272779|470484565|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
130688390|NCT00272779|470484564|FG000|Baseline Through Week 96|Never treated|2|||
130688391|NCT00272779|470484565|FG001|Baseline Through Week 96|Never treated|3|||
130688392|NCT00272779|470484564|FG000|Baseline Through Week 96|Continuing on treatment|61|||
130688393|NCT00272779|470484565|FG001|Baseline Through Week 96|Continuing on treatment|38|||
130688394|NCT00440518|470484567|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
130688395|NCT00440518|470484568|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
130688396|NCT00440518|470484569|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
130688397|NCT00440518|470484567|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
130688398|NCT00440518|470484568|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
130688399|NCT00440518|470484569|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
130688400|NCT00440518|470484567|FG000|Randomized /Titration Period|Protocol Deviation|1|||
130688401|NCT00440518|470484568|FG001|Randomized /Titration Period|Protocol Deviation|0|||
130688402|NCT00440518|470484569|FG002|Randomized /Titration Period|Protocol Deviation|0|||
130688403|NCT00440518|470484567|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130688404|NCT00440518|470484568|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
130688405|NCT00440518|470484569|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130688406|NCT00440518|470484567|FG000|Randomized /Titration Period|Other|1|||
130688407|NCT00440518|470484568|FG001|Randomized /Titration Period|Other|0|||
130688408|NCT00440518|470484569|FG002|Randomized /Titration Period|Other|0|||
130688409|NCT00440518|470484567|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
130688410|NCT00440518|470484568|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
130688411|NCT00440518|470484569|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
130688412|NCT00440518|470484567|FG000|Randomized /Titration Period|Adverse Event|2|||
130688413|NCT00440518|470484568|FG001|Randomized /Titration Period|Adverse Event|3|||
130688414|NCT00440518|470484569|FG002|Randomized /Titration Period|Adverse Event|0|||
130688415|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
130688416|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
130688417|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
130688418|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
130688419|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130688420|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130688421|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
130225061|NCT01211145|468788056|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
130225062|NCT01211145|468788057|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
130225063|NCT01211145|468788058|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
130688422|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
130688423|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
130688424|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
130688425|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
130688426|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
130688427|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
130443773|NCT01474512|469588518|FG017|Maintenance Period|Lost to Follow-up|0|||
130443774|NCT01474512|469588501|FG000|Maintenance Period|Death|0|||
130443775|NCT01474512|469588502|FG001|Maintenance Period|Death|0|||
130443776|NCT01474512|469588503|FG002|Maintenance Period|Death|0|||
130443777|NCT01474512|469588504|FG003|Maintenance Period|Death|0|||
130443778|NCT01474512|469588505|FG004|Maintenance Period|Death|0|||
130688428|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
130688429|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
130688430|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
130688431|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
130688432|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
130688433|NCT00561015|470484570|FG000|Overall Study|Adverse Event|0|||
130688434|NCT00561015|470484571|FG001|Overall Study|Adverse Event|0|||
130688435|NCT00561015|470484572|FG002|Overall Study|Adverse Event|0|||
130688436|NCT00561015|470484573|FG003|Overall Study|Adverse Event|0|||
130688437|NCT00561015|470484574|FG004|Overall Study|Adverse Event|1|||
130688438|NCT00561015|470484575|FG005|Overall Study|Adverse Event|0|||
130688439|NCT00561015|470484570|FG000|Overall Study|Lost to Follow-up|2|||
130688440|NCT00561015|470484571|FG001|Overall Study|Lost to Follow-up|0|||
130688441|NCT00561015|470484572|FG002|Overall Study|Lost to Follow-up|0|||
130688442|NCT00561015|470484573|FG003|Overall Study|Lost to Follow-up|1|||
130688443|NCT00561015|470484574|FG004|Overall Study|Lost to Follow-up|0|||
130688444|NCT00561015|470484575|FG005|Overall Study|Lost to Follow-up|3|||
130688445|NCT00561015|470484570|FG000|Overall Study|Participant non-compliance|2|||
130688446|NCT00561015|470484571|FG001|Overall Study|Participant non-compliance|0|||
130688447|NCT00561015|470484572|FG002|Overall Study|Participant non-compliance|0|||
130688448|NCT00561015|470484573|FG003|Overall Study|Participant non-compliance|0|||
130688449|NCT00561015|470484574|FG004|Overall Study|Participant non-compliance|0|||
130688450|NCT00561015|470484575|FG005|Overall Study|Participant non-compliance|0|||
130688451|NCT02440711|470484576|FG000|Second Intervention|Lost to Follow-up|1|||
130443779|NCT01474512|469588506|FG005|Maintenance Period|Death|2|||
130443780|NCT01474512|469588507|FG006|Maintenance Period|Death|0|||
130443781|NCT01474512|469588508|FG007|Maintenance Period|Death|0|||
130443782|NCT01474512|469588509|FG008|Maintenance Period|Death|0|||
130443783|NCT01474512|469588510|FG009|Maintenance Period|Death|0|||
130443784|NCT01474512|469588511|FG010|Maintenance Period|Death|0|||
130443785|NCT01474512|469588512|FG011|Maintenance Period|Death|0|||
130443786|NCT01474512|469588513|FG012|Maintenance Period|Death|0|||
130443787|NCT01474512|469588514|FG013|Maintenance Period|Death|0|||
130443788|NCT01474512|469588515|FG014|Maintenance Period|Death|0|||
130443789|NCT01474512|469588516|FG015|Maintenance Period|Death|0|||
130443790|NCT01474512|469588517|FG016|Maintenance Period|Death|0|||
130443791|NCT01474512|469588518|FG017|Maintenance Period|Death|0|||
130443792|NCT01474512|469588501|FG000|Maintenance Period|Physician Decision|0|||
130443793|NCT01474512|469588502|FG001|Maintenance Period|Physician Decision|0|||
130443794|NCT01474512|469588503|FG002|Maintenance Period|Physician Decision|0|||
130443795|NCT01474512|469588504|FG003|Maintenance Period|Physician Decision|0|||
130443796|NCT01474512|469588505|FG004|Maintenance Period|Physician Decision|0|||
130443797|NCT01474512|469588506|FG005|Maintenance Period|Physician Decision|1|||
130443798|NCT01474512|469588507|FG006|Maintenance Period|Physician Decision|0|||
130443799|NCT01474512|469588508|FG007|Maintenance Period|Physician Decision|2|||
130688452|NCT02440711|470484577|FG001|Second Intervention|Lost to Follow-up|0|||
130688453|NCT04247282|470484583|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
130688454|NCT04247282|470484584|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
130688455|NCT04247282|470484585|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
130688456|NCT04247282|470484586|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
130443800|NCT01474512|469588509|FG008|Maintenance Period|Physician Decision|0|||
130443801|NCT01474512|469588510|FG009|Maintenance Period|Physician Decision|0|||
130443802|NCT01474512|469588511|FG010|Maintenance Period|Physician Decision|0|||
130688457|NCT04247282|470484583|FG000|Overall Study|Refused further treatment|0|||
130443803|NCT01474512|469588512|FG011|Maintenance Period|Physician Decision|0|||
130443804|NCT01474512|469588513|FG012|Maintenance Period|Physician Decision|0|||
130688458|NCT04247282|470484584|FG001|Overall Study|Refused further treatment|1|||
130443805|NCT01474512|469588514|FG013|Maintenance Period|Physician Decision|0|||
130443806|NCT01474512|469588515|FG014|Maintenance Period|Physician Decision|0|||
130443807|NCT01474512|469588516|FG015|Maintenance Period|Physician Decision|0|||
130443808|NCT01474512|469588517|FG016|Maintenance Period|Physician Decision|0|||
130443809|NCT01474512|469588518|FG017|Maintenance Period|Physician Decision|0|||
130443810|NCT01474512|469588501|FG000|Maintenance Period|Clinical Relapse|0|||
130225064|NCT01211145|468788059|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
130443811|NCT01474512|469588502|FG001|Maintenance Period|Clinical Relapse|0|||
130443812|NCT01474512|469588503|FG002|Maintenance Period|Clinical Relapse|0|||
130443813|NCT01474512|469588504|FG003|Maintenance Period|Clinical Relapse|1|||
130443814|NCT01474512|469588505|FG004|Maintenance Period|Clinical Relapse|0|||
130443815|NCT01474512|469588506|FG005|Maintenance Period|Clinical Relapse|0|||
130443816|NCT01474512|469588507|FG006|Maintenance Period|Clinical Relapse|0|||
130443817|NCT01474512|469588508|FG007|Maintenance Period|Clinical Relapse|0|||
130443818|NCT01474512|469588509|FG008|Maintenance Period|Clinical Relapse|0|||
130443819|NCT01474512|469588510|FG009|Maintenance Period|Clinical Relapse|0|||
130443820|NCT01474512|469588511|FG010|Maintenance Period|Clinical Relapse|0|||
130443821|NCT01474512|469588512|FG011|Maintenance Period|Clinical Relapse|0|||
130443822|NCT01474512|469588513|FG012|Maintenance Period|Clinical Relapse|0|||
130443823|NCT01474512|469588514|FG013|Maintenance Period|Clinical Relapse|0|||
130443824|NCT01474512|469588515|FG014|Maintenance Period|Clinical Relapse|0|||
130443825|NCT01474512|469588516|FG015|Maintenance Period|Clinical Relapse|0|||
130443826|NCT01474512|469588517|FG016|Maintenance Period|Clinical Relapse|0|||
130443827|NCT01474512|469588518|FG017|Maintenance Period|Clinical Relapse|0|||
130443828|NCT01474512|469588501|FG000|Maintenance Period|Lack of Efficacy|0|||
130443829|NCT01474512|469588502|FG001|Maintenance Period|Lack of Efficacy|0|||
130443830|NCT01474512|469588503|FG002|Maintenance Period|Lack of Efficacy|0|||
130443831|NCT01474512|469588504|FG003|Maintenance Period|Lack of Efficacy|1|||
130443832|NCT01474512|469588505|FG004|Maintenance Period|Lack of Efficacy|0|||
130443833|NCT01474512|469588506|FG005|Maintenance Period|Lack of Efficacy|0|||
130443834|NCT01474512|469588507|FG006|Maintenance Period|Lack of Efficacy|0|||
130443835|NCT01474512|469588508|FG007|Maintenance Period|Lack of Efficacy|11|||
130443836|NCT01474512|469588509|FG008|Maintenance Period|Lack of Efficacy|11|||
130443837|NCT01474512|469588510|FG009|Maintenance Period|Lack of Efficacy|12|||
130443838|NCT01474512|469588511|FG010|Maintenance Period|Lack of Efficacy|0|||
130443839|NCT01474512|469588512|FG011|Maintenance Period|Lack of Efficacy|0|||
130443840|NCT01474512|469588513|FG012|Maintenance Period|Lack of Efficacy|0|||
130443841|NCT01474512|469588514|FG013|Maintenance Period|Lack of Efficacy|0|||
130443842|NCT01474512|469588515|FG014|Maintenance Period|Lack of Efficacy|0|||
130443843|NCT01474512|469588516|FG015|Maintenance Period|Lack of Efficacy|0|||
130443844|NCT01474512|469588517|FG016|Maintenance Period|Lack of Efficacy|0|||
130443845|NCT01474512|469588518|FG017|Maintenance Period|Lack of Efficacy|0|||
130443846|NCT01474512|469588501|FG000|Maintenance Period|Protocol Violation|0|||
130443847|NCT01474512|469588502|FG001|Maintenance Period|Protocol Violation|0|||
130443848|NCT01474512|469588503|FG002|Maintenance Period|Protocol Violation|0|||
130688459|NCT04247282|470484585|FG002|Overall Study|Refused further treatment|0|||
130688460|NCT04247282|470484586|FG003|Overall Study|Refused further treatment|0|||
130688461|NCT00968812|470484589|FG000|Overall Study|Adverse Event|30|||
130688462|NCT00968812|470484590|FG001|Overall Study|Adverse Event|46|||
130688463|NCT00968812|470484591|FG002|Overall Study|Adverse Event|33|||
130688464|NCT00968812|470484589|FG000|Overall Study|Death|2|||
130225065|NCT01211145|468788056|FG000|Overall Study|Patient decision|2|||
130225066|NCT01211145|468788057|FG001|Overall Study|Patient decision|1|||
130443849|NCT01474512|469588504|FG003|Maintenance Period|Protocol Violation|1|||
130443850|NCT01474512|469588505|FG004|Maintenance Period|Protocol Violation|0|||
130443851|NCT01474512|469588506|FG005|Maintenance Period|Protocol Violation|0|||
130443852|NCT01474512|469588507|FG006|Maintenance Period|Protocol Violation|0|||
130443853|NCT01474512|469588508|FG007|Maintenance Period|Protocol Violation|1|||
130443854|NCT01474512|469588509|FG008|Maintenance Period|Protocol Violation|0|||
130443855|NCT01474512|469588510|FG009|Maintenance Period|Protocol Violation|1|||
130443856|NCT01474512|469588511|FG010|Maintenance Period|Protocol Violation|0|||
130443857|NCT01474512|469588512|FG011|Maintenance Period|Protocol Violation|0|||
130443858|NCT01474512|469588513|FG012|Maintenance Period|Protocol Violation|0|||
130443859|NCT01474512|469588514|FG013|Maintenance Period|Protocol Violation|0|||
130688465|NCT00968812|470484590|FG001|Overall Study|Death|2|||
130688466|NCT00968812|470484591|FG002|Overall Study|Death|1|||
130688467|NCT00968812|470484589|FG000|Overall Study|Lack of Efficacy|9|||
130225067|NCT01211145|468788058|FG002|Overall Study|Patient decision|0|||
130443860|NCT01474512|469588515|FG014|Maintenance Period|Protocol Violation|0|||
130443861|NCT01474512|469588516|FG015|Maintenance Period|Protocol Violation|0|||
130688468|NCT00968812|470484590|FG001|Overall Study|Lack of Efficacy|7|||
130688469|NCT00968812|470484591|FG002|Overall Study|Lack of Efficacy|16|||
130225068|NCT01211145|468788059|FG003|Overall Study|Patient decision|2|||
130688470|NCT00968812|470484589|FG000|Overall Study|Lost to Follow-up|17|||
130225069|NCT00570401|468788060|FG000|Overall Study|Adverse Event|2|||
130443862|NCT01474512|469588517|FG016|Maintenance Period|Protocol Violation|0|||
130443863|NCT01474512|469588518|FG017|Maintenance Period|Protocol Violation|0|||
130443864|NCT01474512|469588501|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
130443865|NCT01474512|469588502|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
130443866|NCT01474512|469588503|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
130443867|NCT01474512|469588504|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
130443868|NCT01474512|469588505|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
130688471|NCT00968812|470484590|FG001|Overall Study|Lost to Follow-up|12|||
130688472|NCT00968812|470484591|FG002|Overall Study|Lost to Follow-up|11|||
130688473|NCT00968812|470484589|FG000|Overall Study|Physician Decision|8|||
130688474|NCT00968812|470484590|FG001|Overall Study|Physician Decision|5|||
130688475|NCT00968812|470484591|FG002|Overall Study|Physician Decision|9|||
130688476|NCT00968812|470484589|FG000|Overall Study|Protocol Violation|7|||
130688477|NCT00968812|470484590|FG001|Overall Study|Protocol Violation|4|||
130688478|NCT00968812|470484591|FG002|Overall Study|Protocol Violation|3|||
130688479|NCT00968812|470484589|FG000|Overall Study|Withdrawal by Subject|17|||
130688480|NCT00968812|470484590|FG001|Overall Study|Withdrawal by Subject|23|||
130688481|NCT00968812|470484591|FG002|Overall Study|Withdrawal by Subject|25|||
130688482|NCT00968812|470484589|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
130688483|NCT00968812|470484590|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
130688484|NCT00968812|470484591|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
130225070|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130225071|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130225072|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
130225073|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130225074|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130688485|NCT00968812|470484589|FG000|Overall Study|Noncompliance with study drug|4|||
130688486|NCT00968812|470484590|FG001|Overall Study|Noncompliance with study drug|1|||
130688487|NCT00968812|470484591|FG002|Overall Study|Noncompliance with study drug|6|||
130688488|NCT00968812|470484589|FG000|Overall Study|Unable to take rescue therapy|12|||
130688489|NCT00968812|470484590|FG001|Overall Study|Unable to take rescue therapy|12|||
130688490|NCT00968812|470484591|FG002|Overall Study|Unable to take rescue therapy|17|||
130688491|NCT00968812|470484589|FG000|Overall Study|Other|25|||
130688492|NCT00968812|470484590|FG001|Overall Study|Other|37|||
130688493|NCT00968812|470484591|FG002|Overall Study|Other|40|||
130688494|NCT00448591|470484592|FG000|Overall Study|Withdrawal by Subject|178|||
130688495|NCT00448591|470484592|FG000|Overall Study|Progressive Disease|1382|||
130688496|NCT00448591|470484592|FG000|Overall Study|Adverse Event|382|||
130688497|NCT00448591|470484592|FG000|Overall Study|Protocol Violation|41|||
130688498|NCT00448591|470484592|FG000|Overall Study|Lost to Follow-up|19|||
130688499|NCT00448591|470484592|FG000|Overall Study|Treatment Regimen Completed|70|||
130688500|NCT00448591|470484592|FG000|Overall Study|Other|154|||
130688501|NCT00448591|470484592|FG000|Overall Study|Termination of Study|70|||
130688502|NCT02648438|470484596|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130688503|NCT02648438|470484597|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130688504|NCT02648438|470484598|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130688505|NCT02648438|470484596|FG000|Overall Study|Protocol Violation|2|||
130688506|NCT02648438|470484597|FG001|Overall Study|Protocol Violation|0|||
130688507|NCT02648438|470484598|FG002|Overall Study|Protocol Violation|0|||
130688508|NCT02648438|470484596|FG000|Overall Study|Withdrawal by Subject|1|||
130688509|NCT02648438|470484597|FG001|Overall Study|Withdrawal by Subject|1|||
130688510|NCT02648438|470484598|FG002|Overall Study|Withdrawal by Subject|0|||
130688511|NCT04604275|470484599|FG000|Washout-1 Week|Withdrawal by Subject|1|||
130688512|NCT04604275|470484600|FG001|Washout-1 Week|Withdrawal by Subject|0|||
130688513|NCT05615935|470484601|FG000|Overall Study|Lost to Follow-up|1|||
130688514|NCT05615935|470484602|FG001|Overall Study|Lost to Follow-up|1|||
130688515|NCT02258074|470484603|FG000|Overall Study|Withdrawal by Subject|1|||
130688516|NCT02258074|470484604|FG001|Overall Study|Withdrawal by Subject|0|||
130688517|NCT02258074|470484605|FG002|Overall Study|Withdrawal by Subject|0|||
130688518|NCT02258074|470484606|FG003|Overall Study|Withdrawal by Subject|0|||
130688519|NCT05446870|470484607|FG000|Overall Study|Death|6|||
130688520|NCT05446870|470484608|FG001|Overall Study|Death|5|||
130688521|NCT05446870|470484607|FG000|Overall Study|Lost to Follow-up|0|||
130688522|NCT05446870|470484608|FG001|Overall Study|Lost to Follow-up|1|||
130688523|NCT05446870|470484607|FG000|Overall Study|Physician Decision|52|||
130688524|NCT05446870|470484608|FG001|Overall Study|Physician Decision|53|||
130688525|NCT05446870|470484607|FG000|Overall Study|Withdrawal by Subject|3|||
130688526|NCT05446870|470484608|FG001|Overall Study|Withdrawal by Subject|3|||
130688527|NCT02689505|470484610|FG000|Overall Study|Progressive disease|2|||
130688528|NCT02689505|470484611|FG001|Overall Study|Progressive disease|2|||
130688529|NCT02689505|470484612|FG002|Overall Study|Progressive disease|3|||
130688530|NCT02689505|470484613|FG003|Overall Study|Progressive disease|9|||
130688531|NCT02689505|470484614|FG004|Overall Study|Progressive disease|1|||
130688532|NCT02689505|470484610|FG000|Overall Study|Dose Limiting Toxicity|0|||
130688533|NCT02689505|470484611|FG001|Overall Study|Dose Limiting Toxicity|1|||
130688534|NCT02689505|470484612|FG002|Overall Study|Dose Limiting Toxicity|0|||
130688535|NCT02689505|470484613|FG003|Overall Study|Dose Limiting Toxicity|0|||
130688536|NCT02689505|470484614|FG004|Overall Study|Dose Limiting Toxicity|2|||
130688537|NCT02689505|470484610|FG000|Overall Study|Other AE or clinical progression|0|||
130688538|NCT02689505|470484611|FG001|Overall Study|Other AE or clinical progression|2|||
130688539|NCT02689505|470484612|FG002|Overall Study|Other AE or clinical progression|0|||
130688540|NCT02689505|470484613|FG003|Overall Study|Other AE or clinical progression|2|||
130688541|NCT02689505|470484614|FG004|Overall Study|Other AE or clinical progression|0|||
130688542|NCT02446600|470484615|FG000|Overall Study|Never treated|20|||
130688543|NCT02446600|470484616|FG001|Overall Study|Never treated|2|||
130688544|NCT02446600|470484617|FG002|Overall Study|Never treated|6|||
130688545|NCT02446600|470484618|FG003|Overall Study|Never treated|0|||
130688546|NCT02446600|470484615|FG000|Overall Study|Withdrawal by Subject|19|||
130688547|NCT02446600|470484616|FG001|Overall Study|Withdrawal by Subject|5|||
130688548|NCT02446600|470484617|FG002|Overall Study|Withdrawal by Subject|17|||
130688549|NCT02446600|470484618|FG003|Overall Study|Withdrawal by Subject|0|||
130688550|NCT02446600|470484615|FG000|Overall Study|Ineligible|1|||
130688551|NCT02446600|470484616|FG001|Overall Study|Ineligible|4|||
130688552|NCT02446600|470484617|FG002|Overall Study|Ineligible|4|||
130688553|NCT02446600|470484618|FG003|Overall Study|Ineligible|1|||
130688554|NCT02446600|470484615|FG000|Overall Study|Duplicate Enrollment|0|||
130688555|NCT02446600|470484616|FG001|Overall Study|Duplicate Enrollment|1|||
130688556|NCT02446600|470484617|FG002|Overall Study|Duplicate Enrollment|0|||
130688557|NCT02446600|470484618|FG003|Overall Study|Duplicate Enrollment|0|||
130688558|NCT04108858|470484619|FG000|Overall Study|Adverse Event|1|||
130688559|NCT02739997|470484620|FG000|Overall Study|Death|1|||
130688560|NCT02739997|470484620|FG000|Overall Study|Withdrawal by Subject|1|||
130688561|NCT03552393|470484624|FG000|Core Period|Kidney Transplant|1|||
130688562|NCT03552393|470484624|FG000|Core Period|Prohibited Medication|1|||
130688563|NCT03552393|470484624|FG000|Safety Extension Period|Kidney Transplant|4|||
130688564|NCT02601625|470484625|FG000|Overall Study|Lost to Follow-up|0|||
130688565|NCT02601625|470484626|FG001|Overall Study|Lost to Follow-up|0|||
130688566|NCT02601625|470484627|FG002|Overall Study|Lost to Follow-up|1|||
130688567|NCT02601625|470484628|FG003|Overall Study|Lost to Follow-up|1|||
130688568|NCT00359281|470484630|FG000|Overall Study|Adverse Event|1|||
130688569|NCT00359281|470484631|FG001|Overall Study|Adverse Event|0|||
130688570|NCT00359281|470484632|FG002|Overall Study|Adverse Event|0|||
130688571|NCT00359281|470484633|FG003|Overall Study|Adverse Event|0|||
130688572|NCT00359281|470484634|FG004|Overall Study|Adverse Event|0|||
130688573|NCT00359281|470484635|FG005|Overall Study|Adverse Event|0|||
130688574|NCT00359281|470484636|FG006|Overall Study|Adverse Event|1|||
130688575|NCT00359281|470484637|FG007|Overall Study|Adverse Event|0|||
130688576|NCT00359281|470484638|FG008|Overall Study|Adverse Event|0|||
130688577|NCT00359281|470484630|FG000|Overall Study|Withdrawal by Subject|0|||
130688578|NCT00359281|470484631|FG001|Overall Study|Withdrawal by Subject|0|||
130688579|NCT00359281|470484632|FG002|Overall Study|Withdrawal by Subject|0|||
130688580|NCT00359281|470484633|FG003|Overall Study|Withdrawal by Subject|0|||
130688581|NCT00359281|470484634|FG004|Overall Study|Withdrawal by Subject|0|||
130688582|NCT00359281|470484635|FG005|Overall Study|Withdrawal by Subject|0|||
130688583|NCT00359281|470484636|FG006|Overall Study|Withdrawal by Subject|1|||
130688584|NCT00359281|470484637|FG007|Overall Study|Withdrawal by Subject|0|||
130688585|NCT00359281|470484638|FG008|Overall Study|Withdrawal by Subject|0|||
130688586|NCT04887415|470484641|FG000|Overall Study|Lost to Follow-up|2|||
130688587|NCT04608188|470484642|FG000|Overall Study|Withdrawal by Subject|4|||
130688588|NCT04608188|470484643|FG001|Overall Study|Withdrawal by Subject|8|||
130688589|NCT01415986|470484647|FG000|Overall Study|Lost to Follow-up|1|||
130688590|NCT01250912|470484648|FG000|Overall Study|Lost to Follow-up|1|||
130688591|NCT05646251|470484649|FG000|Overall Study|Physician Decision|1|||
130688592|NCT05646251|470484650|FG001|Overall Study|Physician Decision|0|||
130688593|NCT05646251|470484651|FG002|Overall Study|Physician Decision|2|||
130688594|NCT03122457|470484653|FG000|Overall Study|Withdrawal by Subject|6|||
130688595|NCT04659603|470484654|FG000|Overall Study|Study terminated by sponsor|0|||
130688596|NCT04659603|470484655|FG001|Overall Study|Study terminated by sponsor|0|||
130688597|NCT04659603|470484656|FG002|Overall Study|Study terminated by sponsor|2|||
130688598|NCT04659603|470484654|FG000|Overall Study|Withdrawal by Subject|0|||
130688599|NCT04659603|470484655|FG001|Overall Study|Withdrawal by Subject|5|||
130688600|NCT04659603|470484656|FG002|Overall Study|Withdrawal by Subject|0|||
130688601|NCT04659603|470484654|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130688602|NCT04659603|470484655|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
130688603|NCT04659603|470484656|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
130688604|NCT01231906|470484659|FG000|Overall Study|Lack of Efficacy|75|||
130688605|NCT01231906|470484660|FG001|Overall Study|Lack of Efficacy|68|||
130688606|NCT01231906|470484659|FG000|Overall Study|Lost to Follow-up|1|||
130688607|NCT01231906|470484660|FG001|Overall Study|Lost to Follow-up|0|||
130688608|NCT01231906|470484659|FG000|Overall Study|Physician Decision|34|||
130688609|NCT01231906|470484660|FG001|Overall Study|Physician Decision|24|||
130688610|NCT01231906|470484659|FG000|Overall Study|Withdrawal by Subject|0|||
130688611|NCT01231906|470484660|FG001|Overall Study|Withdrawal by Subject|4|||
130688612|NCT01231906|470484659|FG000|Overall Study|Ineligible|10|||
130688613|NCT01231906|470484660|FG001|Overall Study|Ineligible|3|||
130688614|NCT01231906|470484659|FG000|Overall Study|No treatment|1|||
130688615|NCT01231906|470484660|FG001|Overall Study|No treatment|2|||
130688616|NCT01701674|470485595|FG000|Overall Study|Unable to safely complete treatment|1|||
130688617|NCT03032172|470485596|FG000|Treatment Period|Adverse Event|0|||
130688618|NCT03032172|470485597|FG001|Treatment Period|Adverse Event|1|||
130688619|NCT03032172|470485598|FG002|Treatment Period|Adverse Event|0|||
130688620|NCT03032172|470485599|FG003|Treatment Period|Adverse Event|0|||
130688621|NCT03032172|470485600|FG004|Treatment Period|Adverse Event|0|||
130688622|NCT03032172|470485601|FG005|Treatment Period|Adverse Event|0|||
130688623|NCT03032172|470485602|FG006|Treatment Period|Adverse Event|0|||
130688624|NCT03032172|470485603|FG007|Treatment Period|Adverse Event|0|||
130688625|NCT03032172|470485596|FG000|Treatment Period|Lack of Efficacy|0|||
130688626|NCT03032172|470485597|FG001|Treatment Period|Lack of Efficacy|1|||
130688627|NCT03032172|470485598|FG002|Treatment Period|Lack of Efficacy|0|||
130688628|NCT03032172|470485599|FG003|Treatment Period|Lack of Efficacy|0|||
130688629|NCT03032172|470485600|FG004|Treatment Period|Lack of Efficacy|0|||
130688630|NCT03032172|470485601|FG005|Treatment Period|Lack of Efficacy|0|||
130688631|NCT03032172|470485602|FG006|Treatment Period|Lack of Efficacy|0|||
130688632|NCT03032172|470485603|FG007|Treatment Period|Lack of Efficacy|0|||
130688633|NCT03032172|470485596|FG000|Treatment Period|Non-compliance With Study Drug|0|||
130688634|NCT03032172|470485597|FG001|Treatment Period|Non-compliance With Study Drug|1|||
130688635|NCT03032172|470485598|FG002|Treatment Period|Non-compliance With Study Drug|0|||
130688636|NCT03032172|470485599|FG003|Treatment Period|Non-compliance With Study Drug|0|||
130688637|NCT03032172|470485600|FG004|Treatment Period|Non-compliance With Study Drug|0|||
130688638|NCT03032172|470485601|FG005|Treatment Period|Non-compliance With Study Drug|0|||
130688639|NCT03032172|470485602|FG006|Treatment Period|Non-compliance With Study Drug|0|||
130688640|NCT03032172|470485603|FG007|Treatment Period|Non-compliance With Study Drug|0|||
130688641|NCT03032172|470485596|FG000|Treatment Period|Reason Not Specified|0|||
130688642|NCT03032172|470485597|FG001|Treatment Period|Reason Not Specified|4|||
130688643|NCT03032172|470485598|FG002|Treatment Period|Reason Not Specified|1|||
130688644|NCT03032172|470485599|FG003|Treatment Period|Reason Not Specified|0|||
130688645|NCT03032172|470485600|FG004|Treatment Period|Reason Not Specified|0|||
130688646|NCT03032172|470485601|FG005|Treatment Period|Reason Not Specified|0|||
130688647|NCT03032172|470485602|FG006|Treatment Period|Reason Not Specified|0|||
130688648|NCT03032172|470485603|FG007|Treatment Period|Reason Not Specified|0|||
130688649|NCT03032172|470485596|FG000|Treatment Period|Physician Decision|0|||
130688650|NCT03032172|470485597|FG001|Treatment Period|Physician Decision|2|||
130688651|NCT03032172|470485598|FG002|Treatment Period|Physician Decision|1|||
130688652|NCT03032172|470485599|FG003|Treatment Period|Physician Decision|0|||
130443869|NCT01474512|469588506|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
130443870|NCT01474512|469588507|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
130443871|NCT01474512|469588508|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
130443872|NCT01474512|469588509|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
130443873|NCT01474512|469588510|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
130443874|NCT01474512|469588511|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
130443875|NCT01474512|469588512|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
130443876|NCT01474512|469588513|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
130443877|NCT01474512|469588514|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
130443878|NCT01474512|469588515|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
130443879|NCT01474512|469588516|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
130443880|NCT01474512|469588517|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
130443881|NCT01474512|469588518|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
130443882|NCT01474512|469588501|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
130443883|NCT01474512|469588502|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
130443884|NCT01474512|469588503|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
130443885|NCT01474512|469588504|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
130443886|NCT01474512|469588505|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
130443887|NCT01474512|469588506|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
130443888|NCT01474512|469588507|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
130443889|NCT01474512|469588508|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
130443890|NCT01474512|469588509|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
130443891|NCT01474512|469588510|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
130443892|NCT01474512|469588511|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
130688653|NCT03032172|470485600|FG004|Treatment Period|Physician Decision|0|||
130688654|NCT03032172|470485601|FG005|Treatment Period|Physician Decision|0|||
130688655|NCT03032172|470485602|FG006|Treatment Period|Physician Decision|0|||
130225075|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
130225076|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130225077|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130443893|NCT01474512|469588512|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
130443894|NCT01474512|469588513|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
130688656|NCT03032172|470485603|FG007|Treatment Period|Physician Decision|0|||
130688657|NCT03032172|470485596|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688658|NCT03032172|470485597|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
130688659|NCT03032172|470485598|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
130225078|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
130225079|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
130225080|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130443895|NCT01474512|469588514|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
130443896|NCT01474512|469588515|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
130443897|NCT01474512|469588516|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
130443898|NCT01474512|469588517|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
130443899|NCT01474512|469588518|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
130443900|NCT01474512|469588501|FG000|Long-Term Extension Period|Adverse Event|0|||
130443901|NCT01474512|469588502|FG001|Long-Term Extension Period|Adverse Event|0|||
130443902|NCT01474512|469588503|FG002|Long-Term Extension Period|Adverse Event|0|||
130443903|NCT01474512|469588504|FG003|Long-Term Extension Period|Adverse Event|0|||
130443904|NCT01474512|469588505|FG004|Long-Term Extension Period|Adverse Event|0|||
130443905|NCT01474512|469588506|FG005|Long-Term Extension Period|Adverse Event|0|||
130443906|NCT01474512|469588507|FG006|Long-Term Extension Period|Adverse Event|0|||
130443907|NCT01474512|469588508|FG007|Long-Term Extension Period|Adverse Event|0|||
130443908|NCT01474512|469588509|FG008|Long-Term Extension Period|Adverse Event|0|||
130443909|NCT01474512|469588510|FG009|Long-Term Extension Period|Adverse Event|0|||
130443910|NCT01474512|469588511|FG010|Long-Term Extension Period|Adverse Event|0|||
130443911|NCT01474512|469588512|FG011|Long-Term Extension Period|Adverse Event|1|||
130443912|NCT01474512|469588513|FG012|Long-Term Extension Period|Adverse Event|57|||
130443913|NCT01474512|469588514|FG013|Long-Term Extension Period|Adverse Event|58|||
130443914|NCT01474512|469588515|FG014|Long-Term Extension Period|Adverse Event|0|||
130443915|NCT01474512|469588516|FG015|Long-Term Extension Period|Adverse Event|0|||
130443916|NCT01474512|469588517|FG016|Long-Term Extension Period|Adverse Event|0|||
130443917|NCT01474512|469588518|FG017|Long-Term Extension Period|Adverse Event|0|||
130443918|NCT01474512|469588501|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
130443919|NCT01474512|469588502|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
130443920|NCT01474512|469588503|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
130443921|NCT01474512|469588504|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
130443922|NCT01474512|469588505|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
130443923|NCT01474512|469588506|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
130443924|NCT01474512|469588507|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
130443925|NCT01474512|469588508|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
130443926|NCT01474512|469588509|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
130443927|NCT01474512|469588510|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
130443928|NCT01474512|469588511|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
130443929|NCT01474512|469588512|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
130443930|NCT01474512|469588513|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
130443931|NCT01474512|469588514|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
130443932|NCT01474512|469588515|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
130443933|NCT01474512|469588516|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
130443934|NCT01474512|469588517|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
130443935|NCT01474512|469588518|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
130443936|NCT01474512|469588501|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
130443937|NCT01474512|469588502|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
130443938|NCT01474512|469588503|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
130443939|NCT01474512|469588504|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
130443940|NCT01474512|469588505|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
130443941|NCT01474512|469588506|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
130443942|NCT01474512|469588507|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
130443943|NCT01474512|469588508|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
130443944|NCT01474512|469588509|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
130443945|NCT01474512|469588510|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
130443946|NCT01474512|469588511|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
130443947|NCT01474512|469588512|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
130443948|NCT01474512|469588513|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
130443949|NCT01474512|469588514|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
130443950|NCT01474512|469588515|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
130443951|NCT01474512|469588516|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
130443952|NCT01474512|469588517|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
130443953|NCT01474512|469588518|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
130443954|NCT01474512|469588501|FG000|Long-Term Extension Period|Physician Decision|0|||
130688660|NCT03032172|470485599|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
130443955|NCT01474512|469588502|FG001|Long-Term Extension Period|Physician Decision|0|||
130443956|NCT01474512|469588503|FG002|Long-Term Extension Period|Physician Decision|0|||
130443957|NCT01474512|469588504|FG003|Long-Term Extension Period|Physician Decision|0|||
130443958|NCT01474512|469588505|FG004|Long-Term Extension Period|Physician Decision|0|||
130443959|NCT01474512|469588506|FG005|Long-Term Extension Period|Physician Decision|0|||
130443960|NCT01474512|469588507|FG006|Long-Term Extension Period|Physician Decision|0|||
130443961|NCT01474512|469588508|FG007|Long-Term Extension Period|Physician Decision|0|||
130443962|NCT01474512|469588509|FG008|Long-Term Extension Period|Physician Decision|0|||
130443963|NCT01474512|469588510|FG009|Long-Term Extension Period|Physician Decision|0|||
130443964|NCT01474512|469588511|FG010|Long-Term Extension Period|Physician Decision|0|||
130443965|NCT01474512|469588512|FG011|Long-Term Extension Period|Physician Decision|0|||
130443966|NCT01474512|469588513|FG012|Long-Term Extension Period|Physician Decision|21|||
130443967|NCT01474512|469588514|FG013|Long-Term Extension Period|Physician Decision|21|||
130443968|NCT01474512|469588515|FG014|Long-Term Extension Period|Physician Decision|0|||
130443969|NCT01474512|469588516|FG015|Long-Term Extension Period|Physician Decision|0|||
130443970|NCT01474512|469588517|FG016|Long-Term Extension Period|Physician Decision|0|||
130443971|NCT01474512|469588518|FG017|Long-Term Extension Period|Physician Decision|0|||
130443972|NCT01474512|469588501|FG000|Long-Term Extension Period|Clinical Relapse|0|||
130443973|NCT01474512|469588502|FG001|Long-Term Extension Period|Clinical Relapse|0|||
130443974|NCT01474512|469588503|FG002|Long-Term Extension Period|Clinical Relapse|0|||
130443975|NCT01474512|469588504|FG003|Long-Term Extension Period|Clinical Relapse|0|||
130443976|NCT01474512|469588505|FG004|Long-Term Extension Period|Clinical Relapse|0|||
130688661|NCT03032172|470485600|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688662|NCT03032172|470485601|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688663|NCT03032172|470485602|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688664|NCT03032172|470485603|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688665|NCT03032172|470485596|FG000|Treatment Period|Withdrawal by Subject|2|||
130688666|NCT03032172|470485597|FG001|Treatment Period|Withdrawal by Subject|0|||
130688667|NCT03032172|470485598|FG002|Treatment Period|Withdrawal by Subject|3|||
130688668|NCT03032172|470485599|FG003|Treatment Period|Withdrawal by Subject|0|||
130688669|NCT03032172|470485600|FG004|Treatment Period|Withdrawal by Subject|0|||
130688670|NCT03032172|470485601|FG005|Treatment Period|Withdrawal by Subject|0|||
130688671|NCT03032172|470485602|FG006|Treatment Period|Withdrawal by Subject|0|||
130688672|NCT03032172|470485603|FG007|Treatment Period|Withdrawal by Subject|0|||
130688673|NCT03032172|470485596|FG000|Open-label Extension Period|Death|0|||
130688674|NCT03032172|470485597|FG001|Open-label Extension Period|Death|0|||
130688675|NCT03032172|470485598|FG002|Open-label Extension Period|Death|0|||
130688676|NCT03032172|470485599|FG003|Open-label Extension Period|Death|0|||
130688677|NCT03032172|470485600|FG004|Open-label Extension Period|Death|0|||
130688678|NCT03032172|470485601|FG005|Open-label Extension Period|Death|0|||
130688679|NCT03032172|470485602|FG006|Open-label Extension Period|Death|0|||
130688680|NCT03032172|470485603|FG007|Open-label Extension Period|Death|2|||
130688681|NCT03032172|470485596|FG000|Open-label Extension Period|Reason Not Specified|0|||
130688682|NCT03032172|470485597|FG001|Open-label Extension Period|Reason Not Specified|0|||
130688683|NCT03032172|470485598|FG002|Open-label Extension Period|Reason Not Specified|0|||
130688684|NCT03032172|470485599|FG003|Open-label Extension Period|Reason Not Specified|0|||
130688685|NCT03032172|470485600|FG004|Open-label Extension Period|Reason Not Specified|0|||
130688686|NCT03032172|470485601|FG005|Open-label Extension Period|Reason Not Specified|5|||
130688687|NCT03032172|470485602|FG006|Open-label Extension Period|Reason Not Specified|3|||
130688688|NCT03032172|470485603|FG007|Open-label Extension Period|Reason Not Specified|0|||
130688689|NCT03032172|470485596|FG000|Open-label Extension Period|Pregnancy|0|||
130688690|NCT03032172|470485597|FG001|Open-label Extension Period|Pregnancy|0|||
130688691|NCT03032172|470485598|FG002|Open-label Extension Period|Pregnancy|0|||
130688692|NCT03032172|470485599|FG003|Open-label Extension Period|Pregnancy|0|||
130688693|NCT03032172|470485600|FG004|Open-label Extension Period|Pregnancy|0|||
130688694|NCT03032172|470485601|FG005|Open-label Extension Period|Pregnancy|0|||
130688695|NCT03032172|470485602|FG006|Open-label Extension Period|Pregnancy|1|||
130688696|NCT03032172|470485603|FG007|Open-label Extension Period|Pregnancy|0|||
130688697|NCT03032172|470485596|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130688698|NCT03032172|470485597|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130688699|NCT03032172|470485598|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130688700|NCT03032172|470485599|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
130688701|NCT03032172|470485600|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
130688702|NCT03032172|470485601|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
130688703|NCT03032172|470485602|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
130688704|NCT03032172|470485603|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
130688705|NCT02869867|470485606|FG000|Overall Study|Protocol Violation|1|||
130225081|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130225082|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Physician Decision|1|||
130225083|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Physician Decision|0|||
130225084|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Physician Decision|0|||
130225085|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
130443977|NCT01474512|469588506|FG005|Long-Term Extension Period|Clinical Relapse|0|||
130443978|NCT01474512|469588507|FG006|Long-Term Extension Period|Clinical Relapse|0|||
130443979|NCT01474512|469588508|FG007|Long-Term Extension Period|Clinical Relapse|0|||
130688706|NCT02869867|470485607|FG001|Overall Study|Protocol Violation|0|||
130688707|NCT02869867|470485606|FG000|Overall Study|Lost to Follow-up|5|||
130688708|NCT02869867|470485607|FG001|Overall Study|Lost to Follow-up|5|||
130688709|NCT03570749|470485608|FG000|Overall Study|Ongoing|26|||
130688710|NCT03570749|470485609|FG001|Overall Study|Ongoing|25|||
130688711|NCT03570749|470485610|FG002|Overall Study|Ongoing|25|||
130688712|NCT03570749|470485611|FG003|Overall Study|Ongoing|26|||
130688713|NCT03570749|470485612|FG004|Overall Study|Ongoing|140|||
130688714|NCT03570749|470485613|FG005|Overall Study|Ongoing|142|||
130688715|NCT03570749|470485614|FG006|Overall Study|Ongoing|220|||
130688716|NCT03570749|470485608|FG000|Overall Study|Adverse Event|0|||
130688717|NCT03570749|470485609|FG001|Overall Study|Adverse Event|0|||
130688718|NCT03570749|470485610|FG002|Overall Study|Adverse Event|0|||
130688719|NCT03570749|470485611|FG003|Overall Study|Adverse Event|0|||
130688720|NCT03570749|470485612|FG004|Overall Study|Adverse Event|2|||
130225086|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
130225087|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
130225088|NCT01676701|468788068|FG000|Overall Study|Protocol Violation|1|||
130225089|NCT01676701|468788069|FG001|Overall Study|Protocol Violation|0|||
130225090|NCT01676701|468788068|FG000|Overall Study|Sponsor Decision|3|||
130225091|NCT01676701|468788069|FG001|Overall Study|Sponsor Decision|4|||
130225092|NCT00549549|468788079|FG000|Overall Study|Adverse Event|5|||
130225093|NCT00549549|468788080|FG001|Overall Study|Adverse Event|3|||
130225094|NCT00549549|468788081|FG002|Overall Study|Adverse Event|1|||
130225095|NCT00549549|468788082|FG003|Overall Study|Adverse Event|9|||
130688721|NCT03570749|470485613|FG005|Overall Study|Adverse Event|3|||
130225096|NCT00549549|468788079|FG000|Overall Study|Lack of Efficacy|9|||
130225097|NCT00549549|468788080|FG001|Overall Study|Lack of Efficacy|6|||
130225098|NCT00549549|468788081|FG002|Overall Study|Lack of Efficacy|4|||
130688722|NCT03570749|470485614|FG006|Overall Study|Adverse Event|6|||
130688723|NCT03570749|470485608|FG000|Overall Study|Lack of Efficacy|0|||
130688724|NCT03570749|470485609|FG001|Overall Study|Lack of Efficacy|0|||
130443980|NCT01474512|469588509|FG008|Long-Term Extension Period|Clinical Relapse|0|||
130443981|NCT01474512|469588510|FG009|Long-Term Extension Period|Clinical Relapse|0|||
130443982|NCT01474512|469588511|FG010|Long-Term Extension Period|Clinical Relapse|0|||
130443983|NCT01474512|469588512|FG011|Long-Term Extension Period|Clinical Relapse|0|||
130443984|NCT01474512|469588513|FG012|Long-Term Extension Period|Clinical Relapse|9|||
130443985|NCT01474512|469588514|FG013|Long-Term Extension Period|Clinical Relapse|9|||
130443986|NCT01474512|469588515|FG014|Long-Term Extension Period|Clinical Relapse|0|||
130443987|NCT01474512|469588516|FG015|Long-Term Extension Period|Clinical Relapse|0|||
130443988|NCT01474512|469588517|FG016|Long-Term Extension Period|Clinical Relapse|0|||
130443989|NCT01474512|469588518|FG017|Long-Term Extension Period|Clinical Relapse|0|||
130443990|NCT01474512|469588501|FG000|Long-Term Extension Period|Death|0|||
130443991|NCT01474512|469588502|FG001|Long-Term Extension Period|Death|0|||
130443992|NCT01474512|469588503|FG002|Long-Term Extension Period|Death|0|||
130688725|NCT03570749|470485610|FG002|Overall Study|Lack of Efficacy|0|||
130688726|NCT03570749|470485611|FG003|Overall Study|Lack of Efficacy|0|||
130688727|NCT03570749|470485612|FG004|Overall Study|Lack of Efficacy|8|||
130688728|NCT03570749|470485613|FG005|Overall Study|Lack of Efficacy|2|||
130688729|NCT03570749|470485614|FG006|Overall Study|Lack of Efficacy|7|||
130688730|NCT03570749|470485608|FG000|Overall Study|Lost to Follow-up|0|||
130225099|NCT00549549|468788082|FG003|Overall Study|Lack of Efficacy|2|||
130443993|NCT01474512|469588504|FG003|Long-Term Extension Period|Death|0|||
130443994|NCT01474512|469588505|FG004|Long-Term Extension Period|Death|0|||
130443995|NCT01474512|469588506|FG005|Long-Term Extension Period|Death|0|||
130443996|NCT01474512|469588507|FG006|Long-Term Extension Period|Death|0|||
130443997|NCT01474512|469588508|FG007|Long-Term Extension Period|Death|0|||
130443998|NCT01474512|469588509|FG008|Long-Term Extension Period|Death|0|||
130443999|NCT01474512|469588510|FG009|Long-Term Extension Period|Death|0|||
130444000|NCT01474512|469588511|FG010|Long-Term Extension Period|Death|0|||
130444001|NCT01474512|469588512|FG011|Long-Term Extension Period|Death|0|||
130444002|NCT01474512|469588513|FG012|Long-Term Extension Period|Death|9|||
130444003|NCT01474512|469588514|FG013|Long-Term Extension Period|Death|9|||
130444004|NCT01474512|469588515|FG014|Long-Term Extension Period|Death|0|||
130444005|NCT01474512|469588516|FG015|Long-Term Extension Period|Death|0|||
130444006|NCT01474512|469588517|FG016|Long-Term Extension Period|Death|0|||
130444007|NCT01474512|469588518|FG017|Long-Term Extension Period|Death|0|||
130444008|NCT01474512|469588501|FG000|Long-Term Extension Period|Sponsor Decision|0|||
130444009|NCT01474512|469588502|FG001|Long-Term Extension Period|Sponsor Decision|0|||
130444010|NCT01474512|469588503|FG002|Long-Term Extension Period|Sponsor Decision|0|||
130444011|NCT01474512|469588504|FG003|Long-Term Extension Period|Sponsor Decision|0|||
130444012|NCT01474512|469588505|FG004|Long-Term Extension Period|Sponsor Decision|0|||
130444013|NCT01474512|469588506|FG005|Long-Term Extension Period|Sponsor Decision|0|||
130444014|NCT01474512|469588507|FG006|Long-Term Extension Period|Sponsor Decision|0|||
130444015|NCT01474512|469588508|FG007|Long-Term Extension Period|Sponsor Decision|0|||
130444016|NCT01474512|469588509|FG008|Long-Term Extension Period|Sponsor Decision|0|||
130444017|NCT01474512|469588510|FG009|Long-Term Extension Period|Sponsor Decision|0|||
130444018|NCT01474512|469588511|FG010|Long-Term Extension Period|Sponsor Decision|0|||
130444019|NCT01474512|469588512|FG011|Long-Term Extension Period|Sponsor Decision|0|||
130444020|NCT01474512|469588513|FG012|Long-Term Extension Period|Sponsor Decision|6|||
130444021|NCT01474512|469588514|FG013|Long-Term Extension Period|Sponsor Decision|6|||
130444022|NCT01474512|469588515|FG014|Long-Term Extension Period|Sponsor Decision|0|||
130444023|NCT01474512|469588516|FG015|Long-Term Extension Period|Sponsor Decision|0|||
130444024|NCT01474512|469588517|FG016|Long-Term Extension Period|Sponsor Decision|0|||
130444025|NCT01474512|469588518|FG017|Long-Term Extension Period|Sponsor Decision|0|||
130444026|NCT01474512|469588501|FG000|Long-Term Extension Period|Protocol Violation|0|||
130444027|NCT01474512|469588502|FG001|Long-Term Extension Period|Protocol Violation|0|||
130444028|NCT01474512|469588503|FG002|Long-Term Extension Period|Protocol Violation|0|||
130444029|NCT01474512|469588504|FG003|Long-Term Extension Period|Protocol Violation|0|||
130444030|NCT01474512|469588505|FG004|Long-Term Extension Period|Protocol Violation|0|||
130444031|NCT01474512|469588506|FG005|Long-Term Extension Period|Protocol Violation|0|||
130444032|NCT01474512|469588507|FG006|Long-Term Extension Period|Protocol Violation|0|||
130444033|NCT01474512|469588508|FG007|Long-Term Extension Period|Protocol Violation|0|||
130444034|NCT01474512|469588509|FG008|Long-Term Extension Period|Protocol Violation|0|||
130444035|NCT01474512|469588510|FG009|Long-Term Extension Period|Protocol Violation|0|||
130444036|NCT01474512|469588511|FG010|Long-Term Extension Period|Protocol Violation|0|||
130444037|NCT01474512|469588512|FG011|Long-Term Extension Period|Protocol Violation|0|||
130688731|NCT03570749|470485609|FG001|Overall Study|Lost to Follow-up|0|||
130444038|NCT01474512|469588513|FG012|Long-Term Extension Period|Protocol Violation|5|||
130444039|NCT01474512|469588514|FG013|Long-Term Extension Period|Protocol Violation|5|||
130444040|NCT01474512|469588515|FG014|Long-Term Extension Period|Protocol Violation|0|||
130444041|NCT01474512|469588516|FG015|Long-Term Extension Period|Protocol Violation|0|||
130444042|NCT01474512|469588517|FG016|Long-Term Extension Period|Protocol Violation|0|||
130444043|NCT01474512|469588518|FG017|Long-Term Extension Period|Protocol Violation|0|||
130444044|NCT01474512|469588501|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130688732|NCT03570749|470485610|FG002|Overall Study|Lost to Follow-up|0|||
130225100|NCT00549549|468788079|FG000|Overall Study|Lost to Follow-up|1|||
130444045|NCT01474512|469588502|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444046|NCT01474512|469588503|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444047|NCT01474512|469588504|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444048|NCT01474512|469588505|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130688733|NCT03570749|470485611|FG003|Overall Study|Lost to Follow-up|0|||
130688734|NCT03570749|470485612|FG004|Overall Study|Lost to Follow-up|5|||
130688735|NCT03570749|470485613|FG005|Overall Study|Lost to Follow-up|10|||
130688736|NCT03570749|470485614|FG006|Overall Study|Lost to Follow-up|10|||
130688737|NCT03570749|470485608|FG000|Overall Study|Pregnancy|0|||
130688738|NCT03570749|470485609|FG001|Overall Study|Pregnancy|0|||
130688739|NCT03570749|470485610|FG002|Overall Study|Pregnancy|0|||
130688740|NCT03570749|470485611|FG003|Overall Study|Pregnancy|0|||
130688741|NCT03570749|470485612|FG004|Overall Study|Pregnancy|0|||
130688742|NCT03570749|470485613|FG005|Overall Study|Pregnancy|1|||
130688743|NCT03570749|470485614|FG006|Overall Study|Pregnancy|1|||
130688744|NCT03570749|470485608|FG000|Overall Study|Screen Fail|0|||
130688745|NCT03570749|470485609|FG001|Overall Study|Screen Fail|0|||
130688746|NCT03570749|470485610|FG002|Overall Study|Screen Fail|0|||
130688747|NCT03570749|470485611|FG003|Overall Study|Screen Fail|0|||
130688748|NCT03570749|470485612|FG004|Overall Study|Screen Fail|0|||
130688749|NCT03570749|470485613|FG005|Overall Study|Screen Fail|0|||
130688750|NCT03570749|470485614|FG006|Overall Study|Screen Fail|1|||
130688751|NCT03570749|470485608|FG000|Overall Study|Withdrawal by Subject|2|||
130688752|NCT03570749|470485609|FG001|Overall Study|Withdrawal by Subject|3|||
130688753|NCT03570749|470485610|FG002|Overall Study|Withdrawal by Subject|2|||
130688754|NCT03570749|470485611|FG003|Overall Study|Withdrawal by Subject|1|||
130688755|NCT03570749|470485612|FG004|Overall Study|Withdrawal by Subject|17|||
130688756|NCT03570749|470485613|FG005|Overall Study|Withdrawal by Subject|12|||
130688757|NCT03570749|470485614|FG006|Overall Study|Withdrawal by Subject|15|||
130688758|NCT03570749|470485608|FG000|Overall Study|Other|0|||
130688759|NCT03570749|470485609|FG001|Overall Study|Other|0|||
130688760|NCT03570749|470485610|FG002|Overall Study|Other|0|||
130444049|NCT01474512|469588506|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444050|NCT01474512|469588507|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444051|NCT01474512|469588508|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444052|NCT01474512|469588509|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444053|NCT01474512|469588510|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444054|NCT01474512|469588511|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444055|NCT01474512|469588512|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444056|NCT01474512|469588513|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
130444057|NCT01474512|469588514|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
130444058|NCT01474512|469588515|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444059|NCT01474512|469588516|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444060|NCT01474512|469588517|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444061|NCT01474512|469588518|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130444062|NCT01474512|469588501|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444063|NCT01474512|469588502|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444064|NCT01474512|469588503|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444065|NCT01474512|469588504|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444066|NCT01474512|469588505|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444067|NCT01474512|469588506|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444068|NCT01474512|469588507|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444069|NCT01474512|469588508|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444070|NCT01474512|469588509|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444071|NCT01474512|469588510|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130688761|NCT03570749|470485611|FG003|Overall Study|Other|0|||
130688762|NCT03570749|470485612|FG004|Overall Study|Other|17|||
130688763|NCT03570749|470485613|FG005|Overall Study|Other|14|||
130688764|NCT03570749|470485614|FG006|Overall Study|Other|21|||
130688765|NCT00163657|470485615|FG000|Overall Study|Death|12|||
130688766|NCT00163657|470485616|FG001|Overall Study|Death|14|||
130688767|NCT00163657|470485617|FG002|Overall Study|Death|19|||
130688768|NCT00163657|470485615|FG000|Overall Study|graft loss|4|||
130688769|NCT00163657|470485616|FG001|Overall Study|graft loss|1|||
130688770|NCT00163657|470485617|FG002|Overall Study|graft loss|2|||
130688771|NCT00163657|470485615|FG000|Overall Study|Withdrawal by Subject|2|||
130688772|NCT00163657|470485616|FG001|Overall Study|Withdrawal by Subject|3|||
130688773|NCT00163657|470485617|FG002|Overall Study|Withdrawal by Subject|2|||
130688774|NCT00163657|470485615|FG000|Overall Study|Physician Decision|0|||
130225101|NCT00549549|468788080|FG001|Overall Study|Lost to Follow-up|0|||
130444072|NCT01474512|469588511|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444073|NCT01474512|469588512|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
130688775|NCT00163657|470485616|FG001|Overall Study|Physician Decision|1|||
130688776|NCT00163657|470485617|FG002|Overall Study|Physician Decision|1|||
130688777|NCT00163657|470485615|FG000|Overall Study|Non Compliance|1|||
130688778|NCT00163657|470485616|FG001|Overall Study|Non Compliance|0|||
130688779|NCT00163657|470485617|FG002|Overall Study|Non Compliance|0|||
130688780|NCT00163657|470485615|FG000|Overall Study|Lost to Follow-up|1|||
130688781|NCT00163657|470485616|FG001|Overall Study|Lost to Follow-up|3|||
130688782|NCT00163657|470485617|FG002|Overall Study|Lost to Follow-up|10|||
130688783|NCT00163657|470485615|FG000|Overall Study|Other reason|0|||
130688784|NCT00163657|470485616|FG001|Overall Study|Other reason|1|||
130688785|NCT00163657|470485617|FG002|Overall Study|Other reason|3|||
130688786|NCT02436005|470485620|FG000|Second Intervention|Adverse Event|0|||
130688787|NCT02436005|470485621|FG001|Second Intervention|Adverse Event|1|||
130688788|NCT00583453|470485622|FG000|Overall Study|discontinued intervention|0|||
130688789|NCT00583453|470485623|FG001|Overall Study|discontinued intervention|2|||
130688790|NCT03868891|470485626|FG000|Overall Study|Adverse Event|1|||
130688791|NCT03868891|470485627|FG001|Overall Study|Adverse Event|0|||
130688792|NCT03868891|470485626|FG000|Overall Study|Lost to Follow-up|2|||
130688793|NCT03868891|470485627|FG001|Overall Study|Lost to Follow-up|1|||
130688794|NCT03868891|470485626|FG000|Overall Study|COVID-19 Restrictions|1|||
130225102|NCT00549549|468788081|FG002|Overall Study|Lost to Follow-up|1|||
130688795|NCT03868891|470485627|FG001|Overall Study|COVID-19 Restrictions|2|||
130688796|NCT03123094|470485629|FG000|Overall Study|Withdrawal by Subject|0|||
130688797|NCT03123094|470485630|FG001|Overall Study|Withdrawal by Subject|2|||
130688798|NCT03123094|470485631|FG002|Overall Study|Withdrawal by Subject|1|||
130688799|NCT03123094|470485632|FG003|Overall Study|Withdrawal by Subject|0|||
130688800|NCT03123094|470485633|FG004|Overall Study|Withdrawal by Subject|1|||
130688801|NCT00794963|470485640|FG000|Overall Study|Withdrawal by Subject|1|||
130688802|NCT00794963|470485641|FG001|Overall Study|Withdrawal by Subject|4|||
130688803|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
130688804|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
130688805|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
130688806|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Death|1|||
130688807|NCT03181594|470485647|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
130688808|NCT03181594|470485647|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
130688809|NCT03247972|470485649|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
130688810|NCT03247972|470485649|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
130688811|NCT01005745|470485654|FG000|Overall Study|No TIL growth|1|||
130688812|NCT01005745|470485654|FG000|Overall Study|Disease progressed during TIL growth|3|||
130688813|NCT01005745|470485654|FG000|Overall Study|Death prior to treatment|1|||
130688814|NCT01005745|470485654|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
130225103|NCT00549549|468788082|FG003|Overall Study|Lost to Follow-up|2|||
130356028|NCT01505647|469274633|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
130356029|NCT01505647|469274634|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
130356030|NCT01505647|469274633|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
130356031|NCT01505647|469274634|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
130356032|NCT01505647|469274633|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
130356033|NCT01505647|469274634|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
130356034|NCT01505647|469274633|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
130356035|NCT01505647|469274634|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
130356036|NCT02750943|469274635|FG000|Overall Study|Lost to Follow-up|1|||
130356037|NCT02750943|469274636|FG001|Overall Study|Lost to Follow-up|2|||
130356038|NCT02750943|469274635|FG000|Overall Study|Withdrawal by Subject|5|||
130356039|NCT02750943|469274636|FG001|Overall Study|Withdrawal by Subject|7|||
130356040|NCT00171054|469274637|FG000|Overall Study|Protocol Violation|1|||
130356041|NCT00171054|469274638|FG001|Overall Study|Protocol Violation|2|||
130356042|NCT00171054|469274637|FG000|Overall Study|Patient withdrew consent|1|||
130356043|NCT00171054|469274638|FG001|Overall Study|Patient withdrew consent|0|||
130356044|NCT00171054|469274637|FG000|Overall Study|Lost to Follow-up|0|||
130356045|NCT00171054|469274638|FG001|Overall Study|Lost to Follow-up|1|||
130356046|NCT00171054|469274637|FG000|Overall Study|Adverse Event|8|||
130356047|NCT00171054|469274638|FG001|Overall Study|Adverse Event|8|||
130356048|NCT00171054|469274637|FG000|Overall Study|Condition no longer required study drug|0|||
130356049|NCT00171054|469274638|FG001|Overall Study|Condition no longer required study drug|1|||
130356050|NCT03635788|469274642|FG000|Step 1|Death|1|||
130356051|NCT03635788|469274643|FG001|Step 1|Death|0|||
130356052|NCT03635788|469274644|FG002|Step 1|Death|0|||
130356053|NCT03635788|469274642|FG000|Step 1|Lost to Follow-up|31|||
130356054|NCT03635788|469274643|FG001|Step 1|Lost to Follow-up|0|||
130356055|NCT03635788|469274644|FG002|Step 1|Lost to Follow-up|0|||
130356056|NCT03635788|469274642|FG000|Step 1|Pregnancy|1|||
130356057|NCT03635788|469274643|FG001|Step 1|Pregnancy|0|||
130356058|NCT03635788|469274644|FG002|Step 1|Pregnancy|0|||
130356059|NCT03635788|469274642|FG000|Step 1|Protocol Violation|8|||
130356060|NCT03635788|469274643|FG001|Step 1|Protocol Violation|0|||
130356061|NCT03635788|469274644|FG002|Step 1|Protocol Violation|0|||
130356062|NCT03635788|469274642|FG000|Step 1|Withdrawal by Subject|13|||
130356063|NCT03635788|469274643|FG001|Step 1|Withdrawal by Subject|0|||
130356064|NCT03635788|469274644|FG002|Step 1|Withdrawal by Subject|0|||
130356065|NCT03635788|469274642|FG000|Step 1|Other reasons|12|||
130225104|NCT00549549|468788079|FG000|Overall Study|Withdrawal by Subject|0|||
130444074|NCT01474512|469588513|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130688815|NCT03769025|470485655|FG000|Overall Study|Withdrawal by Subject|1|||
130688816|NCT03769025|470485656|FG001|Overall Study|Withdrawal by Subject|1|||
130688817|NCT03769025|470485655|FG000|Overall Study|Lost to Follow-up|4|||
130688818|NCT03769025|470485656|FG001|Overall Study|Lost to Follow-up|3|||
130688819|NCT01908205|470485657|FG000|Overall Study|Lost to Follow-up|2|||
130688820|NCT01908205|470485658|FG001|Overall Study|Lost to Follow-up|0|||
130688821|NCT01908205|470485657|FG000|Overall Study|Withdrawal by Subject|3|||
130688822|NCT01908205|470485658|FG001|Overall Study|Withdrawal by Subject|1|||
130688823|NCT03482882|470485659|FG000|Overall Study|Adverse Event|3|||
130688824|NCT03482882|470485659|FG000|Overall Study|Lost to Follow-up|1|||
130688825|NCT03482882|470485659|FG000|Overall Study|Protocol Violation|2|||
130688826|NCT03482882|470485659|FG000|Overall Study|Not further specified|1|||
130688827|NCT02957942|470485667|FG000|Overall Study|Withdrawal by Subject|0|||
130688828|NCT02957942|470485668|FG001|Overall Study|Withdrawal by Subject|1|||
130688829|NCT02957942|470485667|FG000|Overall Study|Practicing experiment protocol|0|||
130688830|NCT02957942|470485668|FG001|Overall Study|Practicing experiment protocol|6|||
130688831|NCT01136174|470485669|FG000|Overall Study|Adverse Event|0|||
130688832|NCT01136174|470485670|FG001|Overall Study|Adverse Event|0|||
130688833|NCT01136174|470485671|FG002|Overall Study|Adverse Event|0|||
130688834|NCT01136174|470485672|FG003|Overall Study|Adverse Event|4|||
130688835|NCT01754597|470485673|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
130688836|NCT01754597|470485674|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
130688837|NCT01588236|470485675|FG000|Overall Study|Adverse Event|5|||
130688838|NCT01588236|470485676|FG001|Overall Study|Adverse Event|4|||
130688839|NCT01588236|470485677|FG002|Overall Study|Adverse Event|1|||
130688840|NCT01588236|470485675|FG000|Overall Study|Lost to Follow-up|8|||
130688841|NCT01588236|470485676|FG001|Overall Study|Lost to Follow-up|13|||
130688842|NCT01588236|470485677|FG002|Overall Study|Lost to Follow-up|6|||
130688843|NCT01588236|470485675|FG000|Overall Study|Physician Decision|1|||
130688844|NCT01588236|470485676|FG001|Overall Study|Physician Decision|2|||
130688845|NCT01588236|470485677|FG002|Overall Study|Physician Decision|0|||
130688846|NCT01588236|470485675|FG000|Overall Study|Protocol Violation|0|||
130688847|NCT01588236|470485676|FG001|Overall Study|Protocol Violation|1|||
130688848|NCT01588236|470485677|FG002|Overall Study|Protocol Violation|1|||
130688849|NCT01588236|470485675|FG000|Overall Study|Withdrawal by Subject|14|||
130688850|NCT01588236|470485676|FG001|Overall Study|Withdrawal by Subject|16|||
130688851|NCT01588236|470485677|FG002|Overall Study|Withdrawal by Subject|18|||
130688852|NCT01588236|470485675|FG000|Overall Study|Exclusion Criteria met during study|2|||
130688853|NCT01588236|470485676|FG001|Overall Study|Exclusion Criteria met during study|1|||
130688854|NCT01588236|470485677|FG002|Overall Study|Exclusion Criteria met during study|0|||
130688855|NCT01588236|470485675|FG000|Overall Study|sponsor decision|1|||
130688856|NCT01588236|470485676|FG001|Overall Study|sponsor decision|6|||
130688857|NCT01588236|470485677|FG002|Overall Study|sponsor decision|2|||
130688858|NCT04544410|470485678|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130688859|NCT04544410|470485679|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130688860|NCT04544410|470485678|FG000|Double-blind Treatment Period|Adverse Event|1|||
130688861|NCT04544410|470485679|FG001|Double-blind Treatment Period|Adverse Event|0|||
130688862|NCT04544410|470485678|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130688863|NCT04544410|470485679|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130688864|NCT04544410|470485678|FG000|Double-blind Treatment Period|Protocol Violation|1|||
130688865|NCT04544410|470485679|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130688866|NCT04544410|470485678|FG000|Open-Label Treatment Period|Study Terminated|15|||
130688867|NCT04544410|470485679|FG001|Open-Label Treatment Period|Study Terminated|19|||
130688868|NCT04544410|470485678|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
130688869|NCT04544410|470485679|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
130688870|NCT04544410|470485678|FG000|Open-Label Treatment Period|Adverse Event|0|||
130688871|NCT04544410|470485679|FG001|Open-Label Treatment Period|Adverse Event|1|||
130688872|NCT04544410|470485678|FG000|Open-Label Treatment Period|Physician Decision|1|||
130688873|NCT04544410|470485679|FG001|Open-Label Treatment Period|Physician Decision|0|||
130688874|NCT04544410|470485678|FG000|Open-Label Treatment Period|Other|0|||
130688875|NCT04544410|470485679|FG001|Open-Label Treatment Period|Other|1|||
130688876|NCT03761173|470485680|FG000|Overall Study|Lost to Follow-up|93|||
130688877|NCT03761173|470485680|FG000|Overall Study|Withdrawal by Subject|74|||
130688878|NCT03761173|470485680|FG000|Overall Study|Death|45|||
130688879|NCT03761173|470485680|FG000|Overall Study|Withdrawal for Other Reasons|29|||
130688880|NCT03761173|470485680|FG000|Overall Study|Protocol Violation|1|||
130688881|NCT06284525|470486954|FG000|Overall Study|Withdrawal by Subject|1|||
130688882|NCT01175018|470486959|FG000|Overall Study|Adverse Event|3|||
130688883|NCT01175018|470486960|FG001|Overall Study|Adverse Event|1|||
130688884|NCT02838420|470486964|FG000|Overall Study|Ongoing in Study|113|||
130688885|NCT02838420|470486965|FG001|Overall Study|Ongoing in Study|45|||
130688886|NCT02838420|470486964|FG000|Overall Study|Lost to Follow-up|1|||
130688887|NCT02838420|470486965|FG001|Overall Study|Lost to Follow-up|0|||
130688888|NCT02838420|470486964|FG000|Overall Study|Withdrawal by Subject|3|||
130688889|NCT02838420|470486965|FG001|Overall Study|Withdrawal by Subject|4|||
130688890|NCT02838420|470486964|FG000|Overall Study|Death|8|||
130688891|NCT02838420|470486965|FG001|Overall Study|Death|13|||
130688892|NCT02964039|470486966|FG000|Overall Study|Medical reason unrelated to study participation|1|||
130688893|NCT02964039|470486967|FG001|Overall Study|Medical reason unrelated to study participation|0|||
130688894|NCT02964039|470486968|FG002|Overall Study|Medical reason unrelated to study participation|3|||
130688895|NCT02964039|470486966|FG000|Overall Study|Research shutdown due to pandemic|2|||
130688896|NCT02964039|470486967|FG001|Overall Study|Research shutdown due to pandemic|0|||
130688897|NCT02964039|470486968|FG002|Overall Study|Research shutdown due to pandemic|1|||
130688898|NCT02964039|470486966|FG000|Overall Study|Withdrawal by Subject|0|||
130688899|NCT02964039|470486967|FG001|Overall Study|Withdrawal by Subject|1|||
130688900|NCT02964039|470486968|FG002|Overall Study|Withdrawal by Subject|0|||
130688901|NCT02964039|470486966|FG000|Overall Study|Lost to Follow-up|1|||
130688902|NCT02964039|470486967|FG001|Overall Study|Lost to Follow-up|0|||
130688903|NCT02964039|470486968|FG002|Overall Study|Lost to Follow-up|1|||
130688904|NCT00185458|470486971|FG000|Contraception Phase|Adverse Event|37|||
130688905|NCT00185458|470486971|FG000|Contraception Phase|Lost to Follow-up|10|||
130688906|NCT00185458|470486971|FG000|Contraception Phase|Protocol Violation|2|||
130688907|NCT00185458|470486971|FG000|Contraception Phase|Physician Decision|2|||
130688908|NCT00185458|470486971|FG000|Contraception Phase|Withdrawal by Subject|7|||
130688909|NCT00185458|470486971|FG000|HRT Phase|Adverse Event|18|||
130688910|NCT00185458|470486971|FG000|HRT Phase|Lost to Follow-up|4|||
130688911|NCT00185458|470486971|FG000|HRT Phase|Protocol Violation|2|||
130688912|NCT00185458|470486971|FG000|HRT Phase|Withdrawal by Subject|3|||
130688913|NCT00251979|470486972|FG000|Overall Study|Protocol Violation|3|||
130688914|NCT00251979|470486973|FG001|Overall Study|Protocol Violation|5|||
130688915|NCT00251979|470486972|FG000|Overall Study|Adverse Event|11|||
130688916|NCT00251979|470486973|FG001|Overall Study|Adverse Event|17|||
130688917|NCT00251979|470486972|FG000|Overall Study|Withdrawal by Subject|13|||
130688918|NCT00251979|470486973|FG001|Overall Study|Withdrawal by Subject|7|||
130688919|NCT00251979|470486972|FG000|Overall Study|Lost to Follow-up|8|||
130688920|NCT00251979|470486973|FG001|Overall Study|Lost to Follow-up|6|||
130688921|NCT00251979|470486972|FG000|Overall Study|Death|3|||
130688922|NCT00251979|470486973|FG001|Overall Study|Death|5|||
130688923|NCT01576042|470486974|FG000|Overall Study|Physician Decision|2|||
130688924|NCT01576042|470486975|FG001|Overall Study|Physician Decision|0|||
130688925|NCT00835536|470486979|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
130688926|NCT00835536|470486980|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
130688927|NCT03173547|470486984|FG000|Overall Study|Adverse Event|2|||
130688928|NCT03173547|470486985|FG001|Overall Study|Adverse Event|0|||
130688929|NCT03173547|470486984|FG000|Overall Study|Withdrawal by Subject|2|||
130688930|NCT03173547|470486985|FG001|Overall Study|Withdrawal by Subject|2|||
130688931|NCT00657553|470486986|FG000|Overall Study|low accrual, no analysis run|5|||
130688932|NCT00657553|470486987|FG001|Overall Study|low accrual, no analysis run|5|||
130688933|NCT00446563|470486988|FG000|Overall Study|Adverse Event|4|||
130688934|NCT00446563|470486989|FG001|Overall Study|Adverse Event|3|||
130688935|NCT00446563|470486988|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130688936|NCT00446563|470486989|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130688937|NCT00446563|470486988|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130688938|NCT00446563|470486989|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130688939|NCT00446563|470486988|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130688940|NCT00446563|470486989|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130688941|NCT00446563|470486988|FG000|Overall Study|Withdrawal by Subject|2|||
130688942|NCT00446563|470486989|FG001|Overall Study|Withdrawal by Subject|1|||
130688943|NCT00446563|470486988|FG000|Overall Study|Administrative problems|0|||
130688944|NCT00446563|470486989|FG001|Overall Study|Administrative problems|1|||
130688945|NCT01169558|470486990|FG000|Overall Study|Disease progression|98|||
130688946|NCT01169558|470486990|FG000|Overall Study|Adverse Event|25|||
130688947|NCT01169558|470486990|FG000|Overall Study|Withdrawal of Consent|8|||
130688948|NCT01169558|470486990|FG000|Overall Study|Medical Decision|7|||
130225105|NCT00549549|468788080|FG001|Overall Study|Withdrawal by Subject|4|||
130356066|NCT03635788|469274643|FG001|Step 1|Other reasons|0|||
130356067|NCT03635788|469274644|FG002|Step 1|Other reasons|0|||
130356068|NCT03635788|469274642|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
130356069|NCT03635788|469274643|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
130356070|NCT03635788|469274644|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
130356071|NCT03635788|469274642|FG000|Step 2|Lost to Follow-up|0|||
130356072|NCT03635788|469274643|FG001|Step 2|Lost to Follow-up|8|||
130356073|NCT03635788|469274644|FG002|Step 2|Lost to Follow-up|15|||
130356074|NCT03635788|469274642|FG000|Step 2|Withdrawal by Subject|0|||
130356075|NCT03635788|469274643|FG001|Step 2|Withdrawal by Subject|6|||
130356076|NCT03635788|469274644|FG002|Step 2|Withdrawal by Subject|6|||
130356077|NCT03635788|469274642|FG000|Step 2|Death|0|||
130356078|NCT03635788|469274643|FG001|Step 2|Death|2|||
130356079|NCT03635788|469274644|FG002|Step 2|Death|0|||
130356080|NCT03635788|469274642|FG000|Step 2|Incarceration|0|||
130356081|NCT03635788|469274643|FG001|Step 2|Incarceration|2|||
130356082|NCT03635788|469274644|FG002|Step 2|Incarceration|0|||
130688949|NCT01169558|470486990|FG000|Overall Study|Stable Disease|4|||
130688950|NCT01169558|470486990|FG000|Overall Study|Lost to Follow-up|4|||
130688951|NCT01169558|470486990|FG000|Overall Study|Need for Surgery|4|||
130688952|NCT01169558|470486990|FG000|Overall Study|Non-compliance|2|||
130688953|NCT01169558|470486990|FG000|Overall Study|Protocol Violation|2|||
130688954|NCT01169558|470486990|FG000|Overall Study|Partial response|2|||
130688955|NCT02409355|470486996|FG000|Overall Study|Withdrawal by Subject|1|||
130688956|NCT02409355|470486997|FG001|Overall Study|Withdrawal by Subject|0|||
130688957|NCT02409355|470486996|FG000|Overall Study|Death|1|||
130688958|NCT02409355|470486997|FG001|Overall Study|Death|1|||
130688959|NCT02409355|470486996|FG000|Overall Study|Study terminated by Sponsor|2|||
130688960|NCT02409355|470486997|FG001|Overall Study|Study terminated by Sponsor|3|||
130688961|NCT00838539|470486998|FG000|Overall Study|Disease Progression|2|||
130688962|NCT00838539|470486999|FG001|Overall Study|Disease Progression|4|||
130688963|NCT00838539|470487000|FG002|Overall Study|Disease Progression|3|||
130688964|NCT00838539|470487001|FG003|Overall Study|Disease Progression|2|||
130688965|NCT00838539|470487002|FG004|Overall Study|Disease Progression|4|||
130688966|NCT00838539|470487003|FG005|Overall Study|Disease Progression|2|||
130688967|NCT00838539|470487004|FG006|Overall Study|Disease Progression|3|||
130688968|NCT00838539|470487005|FG007|Overall Study|Disease Progression|4|||
130688969|NCT00838539|470487006|FG008|Overall Study|Disease Progression|4|||
130688970|NCT00838539|470487007|FG009|Overall Study|Disease Progression|5|||
130688971|NCT00838539|470487008|FG010|Overall Study|Disease Progression|1|||
130688972|NCT00838539|470487009|FG011|Overall Study|Disease Progression|4|||
130688973|NCT00838539|470486998|FG000|Overall Study|Adverse Event|1|||
130688974|NCT00838539|470486999|FG001|Overall Study|Adverse Event|1|||
130688975|NCT00838539|470487000|FG002|Overall Study|Adverse Event|1|||
130688976|NCT00838539|470487001|FG003|Overall Study|Adverse Event|1|||
130688977|NCT00838539|470487002|FG004|Overall Study|Adverse Event|2|||
130688978|NCT00838539|470487003|FG005|Overall Study|Adverse Event|1|||
130688979|NCT00838539|470487004|FG006|Overall Study|Adverse Event|0|||
130688980|NCT00838539|470487005|FG007|Overall Study|Adverse Event|2|||
130688981|NCT00838539|470487006|FG008|Overall Study|Adverse Event|0|||
130688982|NCT00838539|470487007|FG009|Overall Study|Adverse Event|1|||
130688983|NCT00838539|470487008|FG010|Overall Study|Adverse Event|2|||
130688984|NCT00838539|470487009|FG011|Overall Study|Adverse Event|0|||
130688985|NCT00838539|470486998|FG000|Overall Study|Withdrawal by Subject|0|||
130688986|NCT00838539|470486999|FG001|Overall Study|Withdrawal by Subject|1|||
130688987|NCT00838539|470487000|FG002|Overall Study|Withdrawal by Subject|0|||
130688988|NCT00838539|470487001|FG003|Overall Study|Withdrawal by Subject|0|||
130688989|NCT00838539|470487002|FG004|Overall Study|Withdrawal by Subject|0|||
130688990|NCT00838539|470487003|FG005|Overall Study|Withdrawal by Subject|0|||
130688991|NCT00838539|470487004|FG006|Overall Study|Withdrawal by Subject|0|||
130688992|NCT00838539|470487005|FG007|Overall Study|Withdrawal by Subject|0|||
130688993|NCT00838539|470487006|FG008|Overall Study|Withdrawal by Subject|0|||
130688994|NCT00838539|470487007|FG009|Overall Study|Withdrawal by Subject|1|||
130688995|NCT00838539|470487008|FG010|Overall Study|Withdrawal by Subject|2|||
130688996|NCT00838539|470487009|FG011|Overall Study|Withdrawal by Subject|0|||
130688997|NCT00838539|470486998|FG000|Overall Study|Death|0|||
130688998|NCT00838539|470486999|FG001|Overall Study|Death|0|||
130688999|NCT00838539|470487000|FG002|Overall Study|Death|0|||
130689000|NCT00838539|470487001|FG003|Overall Study|Death|0|||
130689001|NCT00838539|470487002|FG004|Overall Study|Death|0|||
130689002|NCT00838539|470487003|FG005|Overall Study|Death|0|||
130689003|NCT00838539|470487004|FG006|Overall Study|Death|1|||
130689004|NCT00838539|470487005|FG007|Overall Study|Death|0|||
130689005|NCT00838539|470487006|FG008|Overall Study|Death|0|||
130689006|NCT00838539|470487007|FG009|Overall Study|Death|0|||
130689007|NCT00838539|470487008|FG010|Overall Study|Death|0|||
130689008|NCT00838539|470487009|FG011|Overall Study|Death|0|||
130689009|NCT00838539|470486998|FG000|Overall Study|Physician Decision|0|||
130689010|NCT00838539|470486999|FG001|Overall Study|Physician Decision|0|||
130689011|NCT00838539|470487000|FG002|Overall Study|Physician Decision|0|||
130689012|NCT00838539|470487001|FG003|Overall Study|Physician Decision|0|||
130689013|NCT00838539|470487002|FG004|Overall Study|Physician Decision|0|||
130689014|NCT00838539|470487003|FG005|Overall Study|Physician Decision|0|||
130689015|NCT00838539|470487004|FG006|Overall Study|Physician Decision|0|||
130689016|NCT00838539|470487005|FG007|Overall Study|Physician Decision|0|||
130689017|NCT00838539|470487006|FG008|Overall Study|Physician Decision|1|||
130689018|NCT00838539|470487007|FG009|Overall Study|Physician Decision|0|||
130689019|NCT00838539|470487008|FG010|Overall Study|Physician Decision|0|||
130689020|NCT00838539|470487009|FG011|Overall Study|Physician Decision|0|||
130689021|NCT00838539|470486998|FG000|Overall Study|Clinical Progression|0|||
130689022|NCT00838539|470486999|FG001|Overall Study|Clinical Progression|0|||
130689023|NCT00838539|470487000|FG002|Overall Study|Clinical Progression|0|||
130689024|NCT00838539|470487001|FG003|Overall Study|Clinical Progression|0|||
130689025|NCT00838539|470487002|FG004|Overall Study|Clinical Progression|0|||
130689026|NCT00838539|470487003|FG005|Overall Study|Clinical Progression|0|||
130689027|NCT00838539|470487004|FG006|Overall Study|Clinical Progression|1|||
130689028|NCT00838539|470487005|FG007|Overall Study|Clinical Progression|0|||
130689029|NCT00838539|470487006|FG008|Overall Study|Clinical Progression|0|||
130689030|NCT00838539|470487007|FG009|Overall Study|Clinical Progression|0|||
130689031|NCT00838539|470487008|FG010|Overall Study|Clinical Progression|0|||
130689032|NCT00838539|470487009|FG011|Overall Study|Clinical Progression|0|||
130689033|NCT00838539|470486998|FG000|Overall Study|Symptomatic Deterioration|0|||
130689034|NCT00838539|470486999|FG001|Overall Study|Symptomatic Deterioration|0|||
130689035|NCT00838539|470487000|FG002|Overall Study|Symptomatic Deterioration|1|||
130689036|NCT00838539|470487001|FG003|Overall Study|Symptomatic Deterioration|1|||
130689037|NCT00838539|470487002|FG004|Overall Study|Symptomatic Deterioration|0|||
130689038|NCT00838539|470487003|FG005|Overall Study|Symptomatic Deterioration|1|||
130689039|NCT00838539|470487004|FG006|Overall Study|Symptomatic Deterioration|0|||
130689040|NCT00838539|470487005|FG007|Overall Study|Symptomatic Deterioration|0|||
130689041|NCT00838539|470487006|FG008|Overall Study|Symptomatic Deterioration|0|||
130689042|NCT00838539|470487007|FG009|Overall Study|Symptomatic Deterioration|1|||
130689043|NCT00838539|470487008|FG010|Overall Study|Symptomatic Deterioration|0|||
130689044|NCT00838539|470487009|FG011|Overall Study|Symptomatic Deterioration|0|||
130689045|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
130689046|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
130689047|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689048|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689049|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689050|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689051|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689052|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689053|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130689054|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130689055|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689056|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
130689057|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689058|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689059|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689060|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689061|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130689062|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130689063|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689064|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689065|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689066|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
130689067|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689068|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689069|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
130689070|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
130689071|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689072|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689073|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689074|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689075|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689076|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689077|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689078|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
130689079|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689080|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689081|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
130689082|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689083|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689084|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689085|NCT01110005|470487025|FG000|Overall Study|ineligible|1|||
130689086|NCT01110005|470487026|FG001|Overall Study|ineligible|2|||
130689087|NCT01110005|470487025|FG000|Overall Study|missing consent|3|||
130689088|NCT01110005|470487026|FG001|Overall Study|missing consent|2|||
130689089|NCT01110005|470487025|FG000|Overall Study|Withdrawal by Subject|0|||
130689090|NCT01110005|470487026|FG001|Overall Study|Withdrawal by Subject|1|||
130689091|NCT03123471|470487027|FG000|Placebo-controlled Phase|Adverse Event|3|||
130689092|NCT03123471|470487028|FG001|Placebo-controlled Phase|Adverse Event|8|||
130689093|NCT03123471|470487027|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
130689094|NCT03123471|470487028|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
130689095|NCT03123471|470487027|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
130689096|NCT03123471|470487028|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
130689097|NCT03123471|470487027|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
130689098|NCT03123471|470487028|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
130689099|NCT03123471|470487027|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
130689100|NCT03123471|470487028|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
130689101|NCT03123471|470487027|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
130689102|NCT03123471|470487028|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
130689103|NCT03123471|470487027|FG000|Placebo-controlled Phase|Miscellaneous|0|||
130689104|NCT03123471|470487028|FG001|Placebo-controlled Phase|Miscellaneous|1|||
130689105|NCT03123471|470487027|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
130689106|NCT03123471|470487028|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
130689107|NCT03123471|470487027|FG000|Apremilast Extension Phase|Adverse Event|1|||
130689108|NCT03123471|470487028|FG001|Apremilast Extension Phase|Adverse Event|5|||
130689109|NCT03123471|470487027|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
130689110|NCT03123471|470487028|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
130689111|NCT03123471|470487027|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
130689112|NCT03123471|470487028|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
130689113|NCT03681470|470487031|FG000|Overall Study|Lack of Efficacy|3|||
130689114|NCT03681470|470487031|FG000|Overall Study|Lost to Follow-up|1|||
130689115|NCT03681470|470487031|FG000|Overall Study|Protocol Violation|3|||
130689116|NCT03681470|470487031|FG000|Overall Study|Withdrawal by Subject|1|||
130689117|NCT01686477|470487032|FG000|Feeding Intervention|Death|1|||
130689118|NCT01686477|470487033|FG001|Feeding Intervention|Death|0|||
130689119|NCT01686477|470487034|FG002|Feeding Intervention|Death|1|||
130689120|NCT01686477|470487032|FG000|Feeding Intervention|Withdrawal by Subject|0|||
130689121|NCT01686477|470487033|FG001|Feeding Intervention|Withdrawal by Subject|6|||
130689122|NCT01686477|470487034|FG002|Feeding Intervention|Withdrawal by Subject|0|||
130689123|NCT01686477|470487032|FG000|Feeding Intervention|Physician Decision|1|||
130689124|NCT01686477|470487033|FG001|Feeding Intervention|Physician Decision|2|||
130689125|NCT01686477|470487034|FG002|Feeding Intervention|Physician Decision|0|||
130689126|NCT01686477|470487032|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
130689127|NCT01686477|470487033|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
130689128|NCT01686477|470487034|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
130689129|NCT01686477|470487032|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
130689130|NCT01686477|470487033|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
130689131|NCT01686477|470487034|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
130689132|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
130689133|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130689134|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130689135|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689136|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689137|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689138|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
130689139|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130689140|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130689141|NCT01686477|470487032|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
130689142|NCT01686477|470487033|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
130689143|NCT01686477|470487034|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
130689144|NCT01686477|470487032|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130689145|NCT01686477|470487033|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
130689146|NCT01686477|470487034|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130689147|NCT03290781|470487035|FG000|Overall Study|Adverse Event|5|||
130689148|NCT03290781|470487036|FG001|Overall Study|Adverse Event|7|||
130689149|NCT03290781|470487037|FG002|Overall Study|Adverse Event|4|||
130689150|NCT03290781|470487038|FG003|Overall Study|Adverse Event|1|||
130689151|NCT03290781|470487039|FG004|Overall Study|Adverse Event|0|||
130689152|NCT03290781|470487040|FG005|Overall Study|Adverse Event|0|||
130689153|NCT03290781|470487041|FG006|Overall Study|Adverse Event|0|||
130689154|NCT03290781|470487035|FG000|Overall Study|Death|0|||
130689155|NCT03290781|470487036|FG001|Overall Study|Death|0|||
130689156|NCT03290781|470487037|FG002|Overall Study|Death|1|||
130689157|NCT03290781|470487038|FG003|Overall Study|Death|0|||
130689158|NCT03290781|470487039|FG004|Overall Study|Death|1|||
130689159|NCT03290781|470487040|FG005|Overall Study|Death|0|||
130689160|NCT03290781|470487041|FG006|Overall Study|Death|0|||
130689161|NCT03290781|470487035|FG000|Overall Study|Withdrawal by Subject|6|||
130689162|NCT03290781|470487036|FG001|Overall Study|Withdrawal by Subject|5|||
130689163|NCT03290781|470487037|FG002|Overall Study|Withdrawal by Subject|9|||
130689164|NCT03290781|470487038|FG003|Overall Study|Withdrawal by Subject|10|||
130689165|NCT03290781|470487039|FG004|Overall Study|Withdrawal by Subject|1|||
130689166|NCT03290781|470487040|FG005|Overall Study|Withdrawal by Subject|2|||
130689167|NCT03290781|470487041|FG006|Overall Study|Withdrawal by Subject|0|||
130225106|NCT00549549|468788081|FG002|Overall Study|Withdrawal by Subject|1|||
130225107|NCT00549549|468788082|FG003|Overall Study|Withdrawal by Subject|0|||
130689168|NCT03290781|470487035|FG000|Overall Study|Physician Decision|0|||
130689169|NCT03290781|470487036|FG001|Overall Study|Physician Decision|1|||
130444075|NCT01474512|469588514|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444076|NCT01474512|469588515|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444077|NCT01474512|469588516|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444078|NCT01474512|469588517|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444079|NCT01474512|469588518|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130444080|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
130444081|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
130444082|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
130444083|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
130444084|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
130444085|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
130444086|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
130552880|NCT00752622|469991607|FG000|Observational Phase|Withdrawal by Subject|2|||
130689170|NCT03290781|470487037|FG002|Overall Study|Physician Decision|0|||
130689171|NCT03290781|470487038|FG003|Overall Study|Physician Decision|0|||
130689172|NCT03290781|470487039|FG004|Overall Study|Physician Decision|0|||
130689173|NCT03290781|470487040|FG005|Overall Study|Physician Decision|0|||
130689174|NCT03290781|470487041|FG006|Overall Study|Physician Decision|0|||
130689175|NCT03290781|470487035|FG000|Overall Study|Site Terminated by Sponsor|1|||
130689176|NCT03290781|470487036|FG001|Overall Study|Site Terminated by Sponsor|0|||
130689177|NCT03290781|470487037|FG002|Overall Study|Site Terminated by Sponsor|2|||
130689178|NCT03290781|470487038|FG003|Overall Study|Site Terminated by Sponsor|1|||
130689179|NCT03290781|470487039|FG004|Overall Study|Site Terminated by Sponsor|0|||
130689180|NCT03290781|470487040|FG005|Overall Study|Site Terminated by Sponsor|0|||
130689181|NCT03290781|470487041|FG006|Overall Study|Site Terminated by Sponsor|0|||
130689182|NCT03290781|470487035|FG000|Overall Study|Lost to Follow-up|0|||
130689183|NCT03290781|470487036|FG001|Overall Study|Lost to Follow-up|0|||
130689184|NCT03290781|470487037|FG002|Overall Study|Lost to Follow-up|0|||
130689185|NCT03290781|470487038|FG003|Overall Study|Lost to Follow-up|1|||
130689186|NCT03290781|470487039|FG004|Overall Study|Lost to Follow-up|0|||
130689187|NCT03290781|470487040|FG005|Overall Study|Lost to Follow-up|0|||
130689188|NCT03290781|470487041|FG006|Overall Study|Lost to Follow-up|0|||
130689189|NCT03290781|470487035|FG000|Overall Study|Protocol Deviation|2|||
130689190|NCT03290781|470487036|FG001|Overall Study|Protocol Deviation|0|||
130689191|NCT03290781|470487037|FG002|Overall Study|Protocol Deviation|0|||
130689192|NCT03290781|470487038|FG003|Overall Study|Protocol Deviation|1|||
130689193|NCT03290781|470487039|FG004|Overall Study|Protocol Deviation|0|||
130689194|NCT03290781|470487040|FG005|Overall Study|Protocol Deviation|0|||
130689195|NCT03290781|470487041|FG006|Overall Study|Protocol Deviation|0|||
130689196|NCT03290781|470487035|FG000|Overall Study|Disease Relapse|32|||
130689197|NCT03290781|470487036|FG001|Overall Study|Disease Relapse|5|||
130689198|NCT03290781|470487037|FG002|Overall Study|Disease Relapse|38|||
130689199|NCT03290781|470487038|FG003|Overall Study|Disease Relapse|7|||
130689200|NCT03290781|470487039|FG004|Overall Study|Disease Relapse|3|||
130689201|NCT03290781|470487040|FG005|Overall Study|Disease Relapse|1|||
130689202|NCT03290781|470487041|FG006|Overall Study|Disease Relapse|4|||
130689203|NCT03290781|470487035|FG000|Overall Study|Other|3|||
130689204|NCT03290781|470487036|FG001|Overall Study|Other|0|||
130689205|NCT03290781|470487037|FG002|Overall Study|Other|2|||
130689206|NCT03290781|470487038|FG003|Overall Study|Other|2|||
130689207|NCT03290781|470487039|FG004|Overall Study|Other|0|||
130689208|NCT03290781|470487040|FG005|Overall Study|Other|0|||
130689209|NCT03290781|470487041|FG006|Overall Study|Other|0|||
130689210|NCT03238781|470487042|FG000|Overall Study|Adverse Event|1|||
130689211|NCT03238781|470487043|FG001|Overall Study|Adverse Event|1|||
130689212|NCT03238781|470487044|FG002|Overall Study|Adverse Event|2|||
130689213|NCT03238781|470487042|FG000|Overall Study|Lost to Follow-up|2|||
130689214|NCT03238781|470487043|FG001|Overall Study|Lost to Follow-up|1|||
130689215|NCT03238781|470487044|FG002|Overall Study|Lost to Follow-up|2|||
130689216|NCT03238781|470487042|FG000|Overall Study|Withdrawal by Subject|23|||
130689217|NCT03238781|470487043|FG001|Overall Study|Withdrawal by Subject|14|||
130689218|NCT03238781|470487044|FG002|Overall Study|Withdrawal by Subject|16|||
130689219|NCT03238781|470487042|FG000|Overall Study|Decision by sponsor|0|||
130689220|NCT03238781|470487043|FG001|Overall Study|Decision by sponsor|1|||
130552881|NCT00752622|469991607|FG000|Observational Phase|Adverse Event|1|||
130689221|NCT03238781|470487044|FG002|Overall Study|Decision by sponsor|0|||
130689222|NCT00811655|470487057|FG000|Overall Study|Physician Decision|1|||
130689223|NCT00813592|470487058|FG000|Overall Study|Disease assessment was not completed per|2|||
130689224|NCT02820350|470487061|FG000|Overall Study|Withdrawal by Subject|3|||
130689225|NCT02820350|470487061|FG000|Overall Study|Death|4|||
130689226|NCT04852978|470487067|FG000|Overall Study|Physician Decision|0|||
130689227|NCT04852978|470487068|FG001|Overall Study|Physician Decision|1|||
130689228|NCT04852978|470487069|FG002|Overall Study|Physician Decision|0|||
130689229|NCT04852978|470487070|FG003|Overall Study|Physician Decision|0|||
130689230|NCT04852978|470487071|FG004|Overall Study|Physician Decision|0|||
130552882|NCT00752622|469991607|FG000|Observational Phase|Other|2|||
130689231|NCT04852978|470487072|FG005|Overall Study|Physician Decision|0|||
130689232|NCT04852978|470487073|FG006|Overall Study|Physician Decision|0|||
130689233|NCT04852978|470487074|FG007|Overall Study|Physician Decision|2|||
130689234|NCT04852978|470487075|FG008|Overall Study|Physician Decision|0|||
130689235|NCT04852978|470487067|FG000|Overall Study|Sponsor request|0|||
130689236|NCT04852978|470487068|FG001|Overall Study|Sponsor request|0|||
130689237|NCT04852978|470487069|FG002|Overall Study|Sponsor request|1|||
130689238|NCT04852978|470487070|FG003|Overall Study|Sponsor request|0|||
130689239|NCT04852978|470487071|FG004|Overall Study|Sponsor request|0|||
130689240|NCT04852978|470487072|FG005|Overall Study|Sponsor request|0|||
130689241|NCT04852978|470487073|FG006|Overall Study|Sponsor request|0|||
130689242|NCT04852978|470487074|FG007|Overall Study|Sponsor request|0|||
130689243|NCT04852978|470487075|FG008|Overall Study|Sponsor request|0|||
130689244|NCT04852978|470487067|FG000|Overall Study|Death|0|||
130689245|NCT04852978|470487068|FG001|Overall Study|Death|0|||
130689246|NCT04852978|470487069|FG002|Overall Study|Death|0|||
130689247|NCT04852978|470487070|FG003|Overall Study|Death|0|||
130689248|NCT04852978|470487071|FG004|Overall Study|Death|0|||
130689249|NCT04852978|470487072|FG005|Overall Study|Death|0|||
130689250|NCT04852978|470487073|FG006|Overall Study|Death|1|||
130689251|NCT04852978|470487074|FG007|Overall Study|Death|0|||
130689252|NCT04852978|470487075|FG008|Overall Study|Death|0|||
130689253|NCT04852978|470487067|FG000|Overall Study|Lost to Follow-up|3|||
130689254|NCT04852978|470487068|FG001|Overall Study|Lost to Follow-up|2|||
130689255|NCT04852978|470487069|FG002|Overall Study|Lost to Follow-up|2|||
130689256|NCT04852978|470487070|FG003|Overall Study|Lost to Follow-up|0|||
130689257|NCT04852978|470487071|FG004|Overall Study|Lost to Follow-up|2|||
130689258|NCT04852978|470487072|FG005|Overall Study|Lost to Follow-up|4|||
130689259|NCT04852978|470487073|FG006|Overall Study|Lost to Follow-up|1|||
130689260|NCT04852978|470487074|FG007|Overall Study|Lost to Follow-up|2|||
130689261|NCT04852978|470487075|FG008|Overall Study|Lost to Follow-up|2|||
130689262|NCT04852978|470487067|FG000|Overall Study|Withdrawal by Subject|4|||
130689263|NCT04852978|470487068|FG001|Overall Study|Withdrawal by Subject|2|||
130689264|NCT04852978|470487069|FG002|Overall Study|Withdrawal by Subject|2|||
130689265|NCT04852978|470487070|FG003|Overall Study|Withdrawal by Subject|1|||
130689266|NCT04852978|470487071|FG004|Overall Study|Withdrawal by Subject|5|||
130689267|NCT04852978|470487072|FG005|Overall Study|Withdrawal by Subject|3|||
130689268|NCT04852978|470487073|FG006|Overall Study|Withdrawal by Subject|2|||
130689269|NCT04852978|470487074|FG007|Overall Study|Withdrawal by Subject|2|||
130689270|NCT04852978|470487075|FG008|Overall Study|Withdrawal by Subject|1|||
130689271|NCT04299087|470488551|FG000|Overall Study|Lost to Follow-up|2|||
130689272|NCT04299087|470488552|FG001|Overall Study|Lost to Follow-up|1|||
130689273|NCT00594035|470488553|FG000|Overall Study|Lost to Follow-up|1|||
130689274|NCT00594035|470488554|FG001|Overall Study|Lost to Follow-up|1|||
130689275|NCT00594035|470488553|FG000|Overall Study|Withdrawal by Subject|1|||
130689276|NCT00594035|470488554|FG001|Overall Study|Withdrawal by Subject|0|||
130689277|NCT00594035|470488553|FG000|Overall Study|Subject transferred to nursing home|0|||
130689278|NCT00594035|470488554|FG001|Overall Study|Subject transferred to nursing home|1|||
130689279|NCT00594035|470488553|FG000|Overall Study|Subject couldn't return due to job|0|||
130689280|NCT00594035|470488554|FG001|Overall Study|Subject couldn't return due to job|1|||
130689281|NCT00795821|470488555|FG000|Acute Treatment Phase|Adverse Event|23|||
130689282|NCT00795821|470488556|FG001|Acute Treatment Phase|Adverse Event|4|||
130689283|NCT00795821|470488555|FG000|Acute Treatment Phase|Death|1|||
130689284|NCT00795821|470488556|FG001|Acute Treatment Phase|Death|0|||
130689285|NCT00795821|470488555|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
130689286|NCT00795821|470488556|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
130689287|NCT00795821|470488555|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
130689288|NCT00795821|470488556|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
130689289|NCT00795821|470488555|FG000|Acute Treatment Phase|Physician Decision|1|||
130689290|NCT00795821|470488556|FG001|Acute Treatment Phase|Physician Decision|1|||
130689291|NCT00795821|470488555|FG000|Acute Treatment Phase|Protocol Violation|1|||
130689292|NCT00795821|470488556|FG001|Acute Treatment Phase|Protocol Violation|2|||
130689293|NCT00795821|470488555|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
130689294|NCT00795821|470488556|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130689295|NCT00795821|470488555|FG000|Long-term Extension Phase|Adverse Event|25|||
130689296|NCT00795821|470488556|FG001|Long-term Extension Phase|Adverse Event|32|||
130689297|NCT00795821|470488555|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
130689298|NCT00795821|470488556|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
130689299|NCT00795821|470488555|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
130689300|NCT00795821|470488556|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
130689301|NCT00795821|470488555|FG000|Long-term Extension Phase|Physician Decision|1|||
130689302|NCT00795821|470488556|FG001|Long-term Extension Phase|Physician Decision|2|||
130689303|NCT00795821|470488555|FG000|Long-term Extension Phase|Protocol Violation|3|||
130689304|NCT00795821|470488556|FG001|Long-term Extension Phase|Protocol Violation|5|||
130689305|NCT00795821|470488555|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
130689306|NCT00795821|470488556|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
130689307|NCT00795821|470488555|FG000|Taper Phase|Adverse Event|2|||
130689308|NCT00795821|470488556|FG001|Taper Phase|Adverse Event|0|||
130689309|NCT00795821|470488555|FG000|Taper Phase|Lost to Follow-up|1|||
130689310|NCT00795821|470488556|FG001|Taper Phase|Lost to Follow-up|0|||
130689311|NCT00795821|470488555|FG000|Taper Phase|Physician Decision|2|||
130689312|NCT00795821|470488556|FG001|Taper Phase|Physician Decision|0|||
130689313|NCT00795821|470488555|FG000|Taper Phase|Withdrawal by Subject|4|||
130689314|NCT00795821|470488556|FG001|Taper Phase|Withdrawal by Subject|0|||
130689315|NCT03635320|470488567|FG000|Overall Study|not implanted the device|1|||
130689316|NCT03635320|470488568|FG001|Overall Study|not implanted the device|2|||
130689317|NCT03635320|470488567|FG000|Overall Study|Withdrawal by Subject|11|||
130689318|NCT03635320|470488568|FG001|Overall Study|Withdrawal by Subject|6|||
130689319|NCT03049748|470488575|FG000|Overall Study|Lost to Follow-up|1|||
130689320|NCT03049748|470488576|FG001|Overall Study|Lost to Follow-up|0|||
130689321|NCT03049748|470488575|FG000|Overall Study|Death|3|||
130689322|NCT03049748|470488576|FG001|Overall Study|Death|0|||
130689323|NCT03049748|470488575|FG000|Overall Study|Withdrawal by Subject|0|||
130689324|NCT03049748|470488576|FG001|Overall Study|Withdrawal by Subject|3|||
130689325|NCT03049748|470488575|FG000|Overall Study|Protocol Violation|0|||
130689326|NCT03049748|470488576|FG001|Overall Study|Protocol Violation|2|||
130689327|NCT03049748|470488575|FG000|Overall Study|Moved out of state (relocation)|0|||
130689328|NCT03049748|470488576|FG001|Overall Study|Moved out of state (relocation)|1|||
130689329|NCT03502811|470488579|FG000|Overall Study|Death|157|||
130689330|NCT03502811|470488579|FG000|Overall Study|Withdrawal by Subject|105|||
130689331|NCT03502811|470488579|FG000|Overall Study|Lost to Follow-up|26|||
130689332|NCT03502811|470488579|FG000|Overall Study|No Visits (Missed)|31|||
130689333|NCT01735994|470488580|FG000|Overall Study|Withdrawal by Subject|6|||
130689334|NCT01735994|470488581|FG001|Overall Study|Withdrawal by Subject|4|||
130689335|NCT01735994|470488580|FG000|Overall Study|Injury|2|||
130689336|NCT01735994|470488581|FG001|Overall Study|Injury|0|||
130689337|NCT01735994|470488580|FG000|Overall Study|Kicked off team|5|||
130689338|NCT01735994|470488581|FG001|Overall Study|Kicked off team|0|||
130689339|NCT01735994|470488580|FG000|Overall Study|Lost to Follow-up|50|||
130689340|NCT01735994|470488581|FG001|Overall Study|Lost to Follow-up|62|||
130689341|NCT00905840|470488584|FG000|Overall Study|Lost to Follow-up|11|||
130689342|NCT00905840|470488584|FG000|Overall Study|Death|3|||
130689343|NCT00905840|470488584|FG000|Overall Study|Withdrawal by Subject|1|||
130689344|NCT00905840|470488584|FG000|Overall Study|Adverse Event|1|||
130689345|NCT03496623|470488585|FG000|Run-In Period (2 Weeks)|Death|1|||
130689346|NCT03496623|470488586|FG001|Run-In Period (2 Weeks)|Death|0|||
130689347|NCT03496623|470488587|FG002|Run-In Period (2 Weeks)|Death|0|||
130689348|NCT03496623|470488588|FG003|Run-In Period (2 Weeks)|Death|0|||
130689349|NCT03496623|470488589|FG004|Run-In Period (2 Weeks)|Death|0|||
130689350|NCT03496623|470488585|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
130689351|NCT03496623|470488586|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689352|NCT03496623|470488587|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689353|NCT03496623|470488588|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689354|NCT03496623|470488589|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689355|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Death|0|||
130689356|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Death|3|||
130689357|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Death|0|||
130689358|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Death|0|||
130689359|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Death|0|||
130689360|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689361|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689362|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689363|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
130689364|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
130689365|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689366|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130689367|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130689368|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689369|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689370|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689371|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
130689372|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
130689373|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689374|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689375|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689376|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689377|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
130689378|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689379|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689380|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689381|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689382|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
130689383|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689384|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689385|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689386|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
130689387|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130689388|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689389|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689390|NCT01527006|470488593|FG000|Core Study|Adverse Event|0|||
130689391|NCT01527006|470488594|FG001|Core Study|Adverse Event|2|||
130689392|NCT01527006|470488593|FG000|Core Study|Lost to Follow-up|0|||
130225108|NCT00549549|468788079|FG000|Overall Study|Other|9|||
130225109|NCT00549549|468788080|FG001|Overall Study|Other|9|||
130689393|NCT01527006|470488594|FG001|Core Study|Lost to Follow-up|1|||
130689394|NCT01527006|470488593|FG000|Core Study|Subject Choice|1|||
130689395|NCT01527006|470488594|FG001|Core Study|Subject Choice|0|||
130689396|NCT01527006|470488593|FG000|Core Study|Inadequate Therapeutic Effect|1|||
130689397|NCT01527006|470488594|FG001|Core Study|Inadequate Therapeutic Effect|0|||
130689398|NCT01527006|470488593|FG000|Core Study|Withdrawal by Subject|0|||
130689399|NCT01527006|470488594|FG001|Core Study|Withdrawal by Subject|1|||
130689400|NCT01527006|470488593|FG000|Core Study|Other|0|||
130689401|NCT01527006|470488594|FG001|Core Study|Other|2|||
130689402|NCT01527006|470488593|FG000|Extension Phase|Adverse Event|4|||
130689403|NCT01527006|470488594|FG001|Extension Phase|Adverse Event|2|||
130689404|NCT01527006|470488593|FG000|Extension Phase|Lost to Follow-up|0|||
130689405|NCT01527006|470488594|FG001|Extension Phase|Lost to Follow-up|1|||
130689406|NCT01527006|470488593|FG000|Extension Phase|Subject Choice|1|||
130689407|NCT01527006|470488594|FG001|Extension Phase|Subject Choice|1|||
130689408|NCT01527006|470488593|FG000|Extension Phase|Inadequate therapeutic effect|1|||
130689409|NCT01527006|470488594|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130689410|NCT01527006|470488593|FG000|Extension Phase|Other|0|||
130689411|NCT01527006|470488594|FG001|Extension Phase|Other|3|||
130689412|NCT00123734|470488595|FG000|Overall Study|Death|3|||
130689413|NCT00123734|470488595|FG000|Overall Study|Lost to Follow-up|3|||
130689414|NCT00123734|470488595|FG000|Overall Study|Dropout|1|||
130689415|NCT00123734|470488595|FG000|Overall Study|Withdrawal by Subject|1|||
130689416|NCT00834340|470488596|FG000|Washout|Adverse Event|1|||
130689417|NCT00834340|470488597|FG001|Washout|Adverse Event|0|||
130689418|NCT00834340|470488596|FG000|Washout|Withdrawal by Subject|1|||
130689419|NCT00834340|470488597|FG001|Washout|Withdrawal by Subject|0|||
130689420|NCT04238754|470488603|FG000|Washout - 1 Week|Lost to Follow-up|1|||
130225110|NCT00549549|468788081|FG002|Overall Study|Other|9|||
130689421|NCT04238754|470488604|FG001|Washout - 1 Week|Lost to Follow-up|0|||
130689422|NCT00840073|470488608|FG000|Second Intervention|Missed 72 hour blood draw|1|||
130689423|NCT00840073|470488609|FG001|Second Intervention|Missed 72 hour blood draw|1|||
130689424|NCT01103713|470488613|FG000|Overall Study|Lost to Follow-up|2|||
130225111|NCT00549549|468788082|FG003|Overall Study|Other|11|||
130444087|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
130444088|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
130444089|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
130444090|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
130444091|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
130444092|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
130444093|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
130444094|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
130444095|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
130444096|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
130444097|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
130444098|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444099|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444100|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444101|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444102|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444103|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444104|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444105|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444106|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444107|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444108|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444109|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444110|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444111|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130444112|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
130444113|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
130444114|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
130444115|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
130444116|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444117|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444118|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444119|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444120|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444121|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444122|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444123|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444124|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444125|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444126|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444127|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444128|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444129|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
130444130|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
130444131|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
130444132|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
130444133|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
130444134|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130689425|NCT01103713|470488613|FG000|Overall Study|Withdrawal by Subject|8|||
130689426|NCT01103713|470488613|FG000|Overall Study|Study terminated by sponsor|2|||
130689427|NCT01103713|470488613|FG000|Overall Study|Other|1|||
130689428|NCT03084471|470488616|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
130689429|NCT03084471|470488616|FG000|Overall Study|Condition under investigation worsened|84|||
130689430|NCT03084471|470488616|FG000|Overall Study|Lack of therapeutic response|2|||
130689431|NCT03084471|470488616|FG000|Overall Study|Protocol Violation|1|||
130689432|NCT03084471|470488616|FG000|Overall Study|Adverse Event|73|||
130689433|NCT03084471|470488616|FG000|Overall Study|Withdrawal by Subject|12|||
130689434|NCT03084471|470488616|FG000|Overall Study|Disease relapse|181|||
130689435|NCT03084471|470488616|FG000|Overall Study|Subjective disease progression|359|||
130689436|NCT03084471|470488616|FG000|Overall Study|Other (as recorded)|33|||
130689437|NCT03084471|470488616|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
130225112|NCT00549549|468788079|FG000|Overall Study|Randomized but not treated|0|||
130444135|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444136|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444137|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130689438|NCT00505622|470488619|FG000|Overall Study|Adverse Event|5|||
130225113|NCT00549549|468788080|FG001|Overall Study|Randomized but not treated|0|||
130444138|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444139|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444140|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444141|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130689439|NCT00505622|470488620|FG001|Overall Study|Adverse Event|6|||
130689440|NCT00505622|470488621|FG002|Overall Study|Adverse Event|4|||
130689441|NCT00505622|470488619|FG000|Overall Study|Protocol Violation|1|||
130689442|NCT00505622|470488620|FG001|Overall Study|Protocol Violation|1|||
130689443|NCT00505622|470488621|FG002|Overall Study|Protocol Violation|0|||
130689444|NCT00505622|470488619|FG000|Overall Study|Withdrawal by Subject|0|||
130689445|NCT00505622|470488620|FG001|Overall Study|Withdrawal by Subject|3|||
130689446|NCT00505622|470488621|FG002|Overall Study|Withdrawal by Subject|2|||
130689447|NCT00505622|470488619|FG000|Overall Study|Study termination by sponsor|115|||
130689448|NCT00505622|470488620|FG001|Overall Study|Study termination by sponsor|98|||
130689449|NCT00505622|470488621|FG002|Overall Study|Study termination by sponsor|90|||
130689450|NCT00796653|470488622|FG000|Overall Study|Adverse Event|19|||
130689451|NCT00796653|470488623|FG001|Overall Study|Adverse Event|16|||
130689452|NCT00796653|470488624|FG002|Overall Study|Adverse Event|16|||
130689453|NCT00796653|470488625|FG003|Overall Study|Adverse Event|16|||
130689454|NCT00796653|470488622|FG000|Overall Study|Lost to Follow-up|2|||
130689455|NCT00796653|470488623|FG001|Overall Study|Lost to Follow-up|1|||
130689456|NCT00796653|470488624|FG002|Overall Study|Lost to Follow-up|2|||
130689457|NCT00796653|470488625|FG003|Overall Study|Lost to Follow-up|3|||
130689458|NCT00796653|470488622|FG000|Overall Study|Withdrawal by Subject|16|||
130689459|NCT00796653|470488623|FG001|Overall Study|Withdrawal by Subject|8|||
130689460|NCT00796653|470488624|FG002|Overall Study|Withdrawal by Subject|8|||
130689461|NCT00796653|470488625|FG003|Overall Study|Withdrawal by Subject|13|||
130689462|NCT00796653|470488622|FG000|Overall Study|Lack of Efficacy|8|||
130689463|NCT00796653|470488623|FG001|Overall Study|Lack of Efficacy|1|||
130689464|NCT00796653|470488624|FG002|Overall Study|Lack of Efficacy|3|||
130689465|NCT00796653|470488625|FG003|Overall Study|Lack of Efficacy|2|||
130689466|NCT00796653|470488622|FG000|Overall Study|Non compliance with protocol|2|||
130689467|NCT00796653|470488623|FG001|Overall Study|Non compliance with protocol|2|||
130689468|NCT00796653|470488624|FG002|Overall Study|Non compliance with protocol|0|||
130689469|NCT00796653|470488625|FG003|Overall Study|Non compliance with protocol|2|||
130689470|NCT00796653|470488622|FG000|Overall Study|Other reason not described above|4|||
130689471|NCT00796653|470488623|FG001|Overall Study|Other reason not described above|9|||
130689472|NCT00796653|470488624|FG002|Overall Study|Other reason not described above|7|||
130689473|NCT00796653|470488625|FG003|Overall Study|Other reason not described above|4|||
130689474|NCT01848938|470488636|FG000|Overall Study|Lost to Follow-up|1|||
130689475|NCT01848938|470488637|FG001|Overall Study|Lost to Follow-up|1|||
130689476|NCT01757392|470488638|FG000|Overall Study|Withdrawal by Subject|1|||
130689477|NCT01757392|470488638|FG000|Overall Study|Screen Fail|3|||
130689478|NCT00207090|470488643|FG000|Overall Study|Study drug toxicity|3|||
130689479|NCT00207090|470488643|FG000|Overall Study|Chest wall mass larger|1|||
130689480|NCT00207090|470488643|FG000|Overall Study|Disease progression/relapse|2|||
130689481|NCT00207090|470488643|FG000|Overall Study|Physician Decision|1|||
130689482|NCT00841698|470488646|FG000|First Intervention|Withdrawal by Subject|1|||
130689483|NCT00841698|470488647|FG001|First Intervention|Withdrawal by Subject|0|||
130689484|NCT00651820|470488658|FG000|Overall Study|Lost to Follow-up|2|||
130689485|NCT01878292|470488660|FG000|Randomized|Protocol Violation|1|||
130689486|NCT01878292|470488661|FG001|Randomized|Protocol Violation|0|||
130689487|NCT01878292|470488662|FG002|Randomized|Protocol Violation|0|||
130689488|NCT01878292|470488660|FG000|Randomized|Lost to Follow-up|1|||
130689489|NCT01878292|470488661|FG001|Randomized|Lost to Follow-up|0|||
130689490|NCT01878292|470488662|FG002|Randomized|Lost to Follow-up|0|||
130689491|NCT01878292|470488660|FG000|Randomized|Adverse Event|1|||
130689492|NCT01878292|470488661|FG001|Randomized|Adverse Event|0|||
130689493|NCT01878292|470488662|FG002|Randomized|Adverse Event|0|||
130689494|NCT01878292|470488660|FG000|Double-blind Treatment Period|Other Reasons|2|||
130689495|NCT01878292|470488661|FG001|Double-blind Treatment Period|Other Reasons|0|||
130689496|NCT01878292|470488662|FG002|Double-blind Treatment Period|Other Reasons|0|||
130689497|NCT01878292|470488660|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130689498|NCT01878292|470488661|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130689499|NCT01878292|470488662|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130689500|NCT01878292|470488660|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
130689501|NCT01878292|470488661|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
130689502|NCT01878292|470488662|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
130689503|NCT01878292|470488660|FG000|Double-blind Treatment Period|Protocol Violation|3|||
130689504|NCT01878292|470488661|FG001|Double-blind Treatment Period|Protocol Violation|4|||
130689505|NCT01878292|470488662|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130689506|NCT01878292|470488660|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130689507|NCT01878292|470488661|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
130689508|NCT01878292|470488662|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130689509|NCT01878292|470488660|FG000|Double-blind Treatment Period|Adverse Event|4|||
130689510|NCT01878292|470488661|FG001|Double-blind Treatment Period|Adverse Event|9|||
130689511|NCT01878292|470488662|FG002|Double-blind Treatment Period|Adverse Event|8|||
130689512|NCT01878292|470488660|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
130689513|NCT01878292|470488661|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
130689514|NCT01878292|470488662|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
130689515|NCT00773253|470488663|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
130689516|NCT00773253|470488664|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
130689517|NCT01302548|470488669|FG000|Overall Study|Lost to Follow-up|2|||
130689518|NCT01302548|470488670|FG001|Overall Study|Lost to Follow-up|1|||
130689519|NCT01249651|470488672|FG000|Overall Study|Withdrawal by Subject|4|||
130689520|NCT01249651|470488672|FG000|Overall Study|Adverse Event|1|||
130689521|NCT01249651|470488672|FG000|Overall Study|Protocol Violation|1|||
130689522|NCT01249651|470488672|FG000|Overall Study|Sponsor Decision|1|||
130689523|NCT03801707|470488677|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
130689524|NCT03873272|470488678|FG000|Overall Study|Withdrawal by Subject|2|||
130689525|NCT03873272|470488679|FG001|Overall Study|Withdrawal by Subject|0|||
130689526|NCT03873272|470488680|FG002|Overall Study|Withdrawal by Subject|1|||
130689527|NCT03873272|470488678|FG000|Overall Study|Death|0|||
130689528|NCT03873272|470488679|FG001|Overall Study|Death|2|||
130689529|NCT03873272|470488680|FG002|Overall Study|Death|1|||
130689530|NCT00787254|470488681|FG000|Overall Study|Adverse Event|24|||
130689531|NCT00787254|470488682|FG001|Overall Study|Adverse Event|23|||
130689532|NCT00787254|470488681|FG000|Overall Study|Protocol Violation|26|||
130689533|NCT00787254|470488682|FG001|Overall Study|Protocol Violation|23|||
130689534|NCT00787254|470488681|FG000|Overall Study|Withdrawal by Subject|16|||
130689535|NCT00787254|470488682|FG001|Overall Study|Withdrawal by Subject|11|||
130689536|NCT00787254|470488681|FG000|Overall Study|Lack of Efficacy|4|||
130689537|NCT00787254|470488682|FG001|Overall Study|Lack of Efficacy|15|||
130689538|NCT00787254|470488681|FG000|Overall Study|NSAIDs discontinuation|1|||
130689539|NCT00787254|470488682|FG001|Overall Study|NSAIDs discontinuation|2|||
130689540|NCT00787254|470488681|FG000|Overall Study|Institution closed|1|||
130689541|NCT00787254|470488682|FG001|Overall Study|Institution closed|0|||
130689542|NCT00787254|470488681|FG000|Overall Study|Physician Decision|4|||
130689543|NCT00787254|470488682|FG001|Overall Study|Physician Decision|8|||
130689544|NCT00859430|470488683|FG000|First Intervention|Withdrawal by Subject|0|||
130689545|NCT00859430|470488684|FG001|First Intervention|Withdrawal by Subject|1|||
130689546|NCT04115293|470491186|FG000|Overall Study|Adverse Event|0|||
130689547|NCT04115293|470491187|FG001|Overall Study|Adverse Event|2|||
130689548|NCT04115293|470491186|FG000|Overall Study|Withdrawal by Subject|2|||
130689549|NCT04115293|470491187|FG001|Overall Study|Withdrawal by Subject|1|||
130689550|NCT04115293|470491186|FG000|Overall Study|Physician Decision|1|||
130689551|NCT04115293|470491187|FG001|Overall Study|Physician Decision|0|||
130689552|NCT04115293|470491186|FG000|Overall Study|Death|1|||
130689553|NCT04115293|470491187|FG001|Overall Study|Death|1|||
130689554|NCT00001703|470491188|FG000|Overall Study|progressed disease|2|||
130689555|NCT00001703|470491188|FG000|Overall Study|No evidence of disease|1|||
130689556|NCT00001703|470491188|FG000|Overall Study|recurrent disease|2|||
130689557|NCT02057835|470491189|FG000|Overall Study|Withdrawal by Subject|0|||
130689558|NCT02057835|470491190|FG001|Overall Study|Withdrawal by Subject|2|||
130689559|NCT02057835|470491191|FG002|Overall Study|Withdrawal by Subject|0|||
130689560|NCT02057835|470491192|FG003|Overall Study|Withdrawal by Subject|0|||
130689561|NCT02057835|470491193|FG004|Overall Study|Withdrawal by Subject|0|||
130689562|NCT02057835|470491194|FG005|Overall Study|Withdrawal by Subject|0|||
130689563|NCT02057835|470491195|FG006|Overall Study|Withdrawal by Subject|0|||
130689564|NCT02057835|470491196|FG007|Overall Study|Withdrawal by Subject|0|||
130689565|NCT02057835|470491197|FG008|Overall Study|Withdrawal by Subject|0|||
130689566|NCT02057835|470491198|FG009|Overall Study|Withdrawal by Subject|0|||
130689567|NCT01660243|470491199|FG000|Overall Study|Adverse Event|1|||
130689568|NCT01660243|470491200|FG001|Overall Study|Adverse Event|0|||
130689569|NCT01660243|470491201|FG002|Overall Study|Adverse Event|1|||
130689570|NCT01660243|470491202|FG003|Overall Study|Adverse Event|0|||
130689571|NCT01660243|470491199|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
130689572|NCT01660243|470491200|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130689573|NCT01660243|470491201|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130689574|NCT01660243|470491202|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130356083|NCT03635788|469274642|FG000|Step 2|Non-Compliance With Study Requirements|0|||
130689575|NCT01660243|470491199|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689576|NCT01660243|470491200|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689577|NCT01660243|470491201|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
130689578|NCT01660243|470491202|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689579|NCT01660243|470491199|FG000|Overall Study|Randomization error|0|||
130689580|NCT01660243|470491200|FG001|Overall Study|Randomization error|0|||
130689581|NCT01660243|470491201|FG002|Overall Study|Randomization error|0|||
130689582|NCT01660243|470491202|FG003|Overall Study|Randomization error|1|||
130356084|NCT03635788|469274643|FG001|Step 2|Non-Compliance With Study Requirements|1|||
130689583|NCT00712959|470491203|FG000|Overall Study|Protocol Violation|3|||
130689584|NCT00712959|470491204|FG001|Overall Study|Protocol Violation|1|||
130689585|NCT00712959|470491203|FG000|Overall Study|Lost to Follow-up|13|||
130689586|NCT00712959|470491204|FG001|Overall Study|Lost to Follow-up|2|||
130689587|NCT00712959|470491203|FG000|Overall Study|Withdrawal by Subject|3|||
130689588|NCT00712959|470491204|FG001|Overall Study|Withdrawal by Subject|0|||
130689589|NCT00508651|470491205|FG000|Overall Study|Lost to Follow-up|3|||
130689590|NCT00508651|470491206|FG001|Overall Study|Lost to Follow-up|1|||
130689591|NCT00508651|470491205|FG000|Overall Study|Withdrawal by Subject|1|||
130689592|NCT00508651|470491206|FG001|Overall Study|Withdrawal by Subject|1|||
130689593|NCT02301975|470491213|FG000|Overall Study|Adverse Event|8|||
130689594|NCT02301975|470491214|FG001|Overall Study|Adverse Event|3|||
130689595|NCT02301975|470491215|FG002|Overall Study|Adverse Event|2|||
130689596|NCT02301975|470491213|FG000|Overall Study|Lack of Efficacy|1|||
130689597|NCT02301975|470491214|FG001|Overall Study|Lack of Efficacy|1|||
130689598|NCT02301975|470491215|FG002|Overall Study|Lack of Efficacy|1|||
130689599|NCT02301975|470491213|FG000|Overall Study|Protocol Violation|3|||
130689600|NCT02301975|470491214|FG001|Overall Study|Protocol Violation|5|||
130689601|NCT02301975|470491215|FG002|Overall Study|Protocol Violation|3|||
130689602|NCT02301975|470491213|FG000|Overall Study|Lost to Follow-up|0|||
130689603|NCT02301975|470491214|FG001|Overall Study|Lost to Follow-up|2|||
130689604|NCT02301975|470491215|FG002|Overall Study|Lost to Follow-up|2|||
130689605|NCT02301975|470491213|FG000|Overall Study|Physician Decision|4|||
130689606|NCT02301975|470491214|FG001|Overall Study|Physician Decision|2|||
130689607|NCT02301975|470491215|FG002|Overall Study|Physician Decision|3|||
130689608|NCT02301975|470491213|FG000|Overall Study|Withdrawal by Subject|15|||
130689609|NCT02301975|470491214|FG001|Overall Study|Withdrawal by Subject|12|||
130689610|NCT02301975|470491215|FG002|Overall Study|Withdrawal by Subject|11|||
130689611|NCT03733730|470491216|FG000|Overall Study|Lost to Follow-up|1|||
130689612|NCT03733730|470491217|FG001|Overall Study|Lost to Follow-up|32|||
130689613|NCT03733730|470491216|FG000|Overall Study|Other|1|||
130689614|NCT03733730|470491217|FG001|Overall Study|Other|0|||
130689615|NCT03733730|470491216|FG000|Overall Study|Adverse Event|0|||
130689616|NCT03733730|470491217|FG001|Overall Study|Adverse Event|4|||
130689617|NCT03733730|470491216|FG000|Overall Study|Death|0|||
130689618|NCT03733730|470491217|FG001|Overall Study|Death|5|||
130689619|NCT03733730|470491216|FG000|Overall Study|Withdrawal by Subject|0|||
130689620|NCT03733730|470491217|FG001|Overall Study|Withdrawal by Subject|8|||
130689621|NCT01531894|470491218|FG000|Overall Study|Physician Decision|8|||
130689622|NCT01531894|470491218|FG000|Overall Study|Death|1|||
130689623|NCT03086460|470491219|FG000|Study Participants|Lost to Follow-up|2|||
130689624|NCT03086460|470491219|FG000|Study Participants|Protocol Violation|1|||
130689625|NCT03086460|470491219|FG000|Study Participants|Withdrawal by Subject|6|||
130689626|NCT03086460|470491219|FG000|Treatment A|Lost to Follow-up|1|||
130689627|NCT03086460|470491219|FG000|Treatment A|Protocol Violation|1|||
130689628|NCT03086460|470491219|FG000|Treatment A|Withdrawal by Subject|2|||
130356085|NCT03635788|469274644|FG002|Step 2|Non-Compliance With Study Requirements|1|||
130356086|NCT03635788|469274642|FG000|Step 2|Confounding Medical Condition|0|||
130356087|NCT03635788|469274643|FG001|Step 2|Confounding Medical Condition|0|||
130356088|NCT03635788|469274644|FG002|Step 2|Confounding Medical Condition|1|||
130356089|NCT03635788|469274642|FG000|Step 2|Out Of State With No Plan To Return|0|||
130356090|NCT03635788|469274643|FG001|Step 2|Out Of State With No Plan To Return|1|||
130356091|NCT03635788|469274644|FG002|Step 2|Out Of State With No Plan To Return|0|||
130356092|NCT03635788|469274642|FG000|Step 2|Switched To Injectables|0|||
130356093|NCT03635788|469274643|FG001|Step 2|Switched To Injectables|0|||
130356094|NCT03635788|469274644|FG002|Step 2|Switched To Injectables|1|||
130356095|NCT03635788|469274642|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
130356096|NCT03635788|469274643|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
130356097|NCT03635788|469274644|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
130356098|NCT04669535|469274645|FG000|Overall Study|Death|1|||
130356099|NCT04669535|469274646|FG001|Overall Study|Death|1|||
130356100|NCT04669535|469274647|FG002|Overall Study|Death|0|||
130356101|NCT04669535|469274648|FG003|Overall Study|Death|0|||
130356102|NCT04382755|469274649|FG000|Overall Study|Withdrawal by Subject|1|||
130356103|NCT04382755|469274650|FG001|Overall Study|Withdrawal by Subject|0|||
130356104|NCT04382755|469274649|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
130356105|NCT04382755|469274650|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
130356106|NCT04382755|469274649|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
130689629|NCT03086460|470491219|FG000|Treatment C|Withdrawal by Subject|2|||
130689630|NCT03086460|470491219|FG000|Treatment E|Lost to Follow-up|1|||
130689631|NCT03086460|470491219|FG000|Treatment E|Withdrawal by Subject|3|||
130689632|NCT00835575|470491220|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
130689633|NCT00835575|470491221|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
130689634|NCT01440803|470491222|FG000|Overall Study|Met study stopping rule|2|||
130689635|NCT01440803|470491223|FG001|Overall Study|Met study stopping rule|1|||
130689636|NCT01440803|470491222|FG000|Overall Study|Lost to Follow-up|0|||
130689637|NCT01440803|470491223|FG001|Overall Study|Lost to Follow-up|2|||
130689638|NCT01440803|470491222|FG000|Overall Study|Withdrawal by Subject|0|||
130689639|NCT01440803|470491223|FG001|Overall Study|Withdrawal by Subject|1|||
130689640|NCT03606174|470491224|FG000|Overall Study|Death|37|||
130689641|NCT03606174|470491225|FG001|Overall Study|Death|15|||
130689642|NCT03606174|470491226|FG002|Overall Study|Death|15|||
130689643|NCT03606174|470491227|FG003|Overall Study|Death|7|||
130689644|NCT03606174|470491228|FG004|Overall Study|Death|35|||
130689645|NCT03606174|470491229|FG005|Overall Study|Death|12|||
130689646|NCT03606174|470491230|FG006|Overall Study|Death|35|||
130689647|NCT03606174|470491231|FG007|Overall Study|Death|8|||
130689648|NCT03606174|470491232|FG008|Overall Study|Death|5|||
130689649|NCT03606174|470491233|FG009|Overall Study|Death|3|||
130689650|NCT03606174|470491234|FG010|Overall Study|Death|0|||
130689651|NCT03606174|470491224|FG000|Overall Study|Lost to Follow-up|0|||
130689652|NCT03606174|470491225|FG001|Overall Study|Lost to Follow-up|0|||
130689653|NCT03606174|470491226|FG002|Overall Study|Lost to Follow-up|0|||
130689654|NCT03606174|470491227|FG003|Overall Study|Lost to Follow-up|0|||
130689655|NCT03606174|470491228|FG004|Overall Study|Lost to Follow-up|1|||
130689656|NCT03606174|470491229|FG005|Overall Study|Lost to Follow-up|1|||
130689657|NCT03606174|470491230|FG006|Overall Study|Lost to Follow-up|0|||
130689658|NCT03606174|470491231|FG007|Overall Study|Lost to Follow-up|0|||
130689659|NCT03606174|470491232|FG008|Overall Study|Lost to Follow-up|0|||
130689660|NCT03606174|470491233|FG009|Overall Study|Lost to Follow-up|0|||
130444142|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130689661|NCT03606174|470491234|FG010|Overall Study|Lost to Follow-up|0|||
130689662|NCT03606174|470491224|FG000|Overall Study|Withdrawal by Subject|6|||
130689663|NCT03606174|470491225|FG001|Overall Study|Withdrawal by Subject|0|||
130689664|NCT03606174|470491226|FG002|Overall Study|Withdrawal by Subject|0|||
130689665|NCT03606174|470491227|FG003|Overall Study|Withdrawal by Subject|1|||
130689666|NCT03606174|470491228|FG004|Overall Study|Withdrawal by Subject|2|||
130689667|NCT03606174|470491229|FG005|Overall Study|Withdrawal by Subject|1|||
130689668|NCT03606174|470491230|FG006|Overall Study|Withdrawal by Subject|4|||
130689669|NCT03606174|470491231|FG007|Overall Study|Withdrawal by Subject|0|||
130689670|NCT03606174|470491232|FG008|Overall Study|Withdrawal by Subject|0|||
130689671|NCT03606174|470491233|FG009|Overall Study|Withdrawal by Subject|0|||
130689672|NCT03606174|470491234|FG010|Overall Study|Withdrawal by Subject|1|||
130689673|NCT03606174|470491224|FG000|Overall Study|Study Terminated by Sponsor|5|||
130689674|NCT03606174|470491225|FG001|Overall Study|Study Terminated by Sponsor|7|||
130689675|NCT03606174|470491226|FG002|Overall Study|Study Terminated by Sponsor|3|||
130689676|NCT03606174|470491227|FG003|Overall Study|Study Terminated by Sponsor|0|||
130689677|NCT03606174|470491228|FG004|Overall Study|Study Terminated by Sponsor|11|||
130689678|NCT03606174|470491229|FG005|Overall Study|Study Terminated by Sponsor|6|||
130689679|NCT03606174|470491230|FG006|Overall Study|Study Terminated by Sponsor|12|||
130689680|NCT03606174|470491231|FG007|Overall Study|Study Terminated by Sponsor|1|||
130689681|NCT03606174|470491232|FG008|Overall Study|Study Terminated by Sponsor|3|||
130689682|NCT03606174|470491233|FG009|Overall Study|Study Terminated by Sponsor|1|||
130689683|NCT03606174|470491234|FG010|Overall Study|Study Terminated by Sponsor|2|||
130689684|NCT03606174|470491224|FG000|Overall Study|Miscellaneous|1|||
130689685|NCT03606174|470491225|FG001|Overall Study|Miscellaneous|1|||
130689686|NCT03606174|470491226|FG002|Overall Study|Miscellaneous|0|||
130689687|NCT03606174|470491227|FG003|Overall Study|Miscellaneous|1|||
130689688|NCT03606174|470491228|FG004|Overall Study|Miscellaneous|4|||
130689689|NCT03606174|470491229|FG005|Overall Study|Miscellaneous|7|||
130689690|NCT03606174|470491230|FG006|Overall Study|Miscellaneous|5|||
130689691|NCT03606174|470491231|FG007|Overall Study|Miscellaneous|0|||
130689692|NCT03606174|470491232|FG008|Overall Study|Miscellaneous|0|||
130689693|NCT03606174|470491233|FG009|Overall Study|Miscellaneous|0|||
130689694|NCT03606174|470491234|FG010|Overall Study|Miscellaneous|1|||
130689695|NCT01609257|470491235|FG000|Overall Study|Lost to Follow-up|2|||
130689696|NCT01609257|470491236|FG001|Overall Study|Lost to Follow-up|1|||
130689697|NCT01609257|470491235|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130689698|NCT01609257|470491236|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130689699|NCT01609257|470491235|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
130689700|NCT01609257|470491236|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
130689701|NCT02125461|470491237|FG000|Overall Study|Withdrawal by Subject|30|||
130689702|NCT02125461|470491238|FG001|Overall Study|Withdrawal by Subject|16|||
130689703|NCT02125461|470491237|FG000|Overall Study|Lost to Follow-up|8|||
130689704|NCT02125461|470491238|FG001|Overall Study|Lost to Follow-up|3|||
130689705|NCT02125461|470491237|FG000|Overall Study|Death|260|||
130689706|NCT02125461|470491238|FG001|Overall Study|Death|149|||
130689707|NCT02125461|470491237|FG000|Overall Study|Missing Termination Reason|0|||
130689708|NCT02125461|470491238|FG001|Overall Study|Missing Termination Reason|1|||
130689709|NCT01158118|470491240|FG000|Overall Study|Screen failure|1|||
130689710|NCT01158118|470491241|FG001|Overall Study|Screen failure|0|||
130689711|NCT01158118|470491240|FG000|Overall Study|Donor match was a screen failure|0|||
130689712|NCT01158118|470491241|FG001|Overall Study|Donor match was a screen failure|1|||
130689713|NCT01158118|470491240|FG000|Overall Study|Suffered stroke prior to transplant|0|||
130689714|NCT01158118|470491241|FG001|Overall Study|Suffered stroke prior to transplant|1|||
130689715|NCT01158118|470491240|FG000|Overall Study|Death|0|||
130689716|NCT01158118|470491241|FG001|Overall Study|Death|1|||
130689717|NCT04994535|470491242|FG000|Overall Study|Lost to Follow-up|7|||
130689718|NCT04994535|470491243|FG001|Overall Study|Lost to Follow-up|7|||
130689719|NCT04994535|470491242|FG000|Overall Study|Withdrawal by Subject|10|||
130689720|NCT04994535|470491243|FG001|Overall Study|Withdrawal by Subject|7|||
130689721|NCT04994535|470491242|FG000|Overall Study|Other|1|||
130689722|NCT04994535|470491243|FG001|Overall Study|Other|1|||
130689723|NCT00113386|470491246|FG000|Overall Study|Withdrawal by Subject|1|||
130689724|NCT00113386|470491247|FG001|Overall Study|Withdrawal by Subject|0|||
130689725|NCT00113386|470491246|FG000|Overall Study|Physician Decision|0|||
130689726|NCT00113386|470491247|FG001|Overall Study|Physician Decision|1|||
130689727|NCT00113386|470491246|FG000|Overall Study|Toxicity|3|||
130689728|NCT00113386|470491247|FG001|Overall Study|Toxicity|0|||
130689729|NCT00113386|470491246|FG000|Overall Study|Ineligible|1|||
130689730|NCT00113386|470491247|FG001|Overall Study|Ineligible|2|||
130689731|NCT00113386|470491246|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
130689732|NCT00113386|470491247|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
130689733|NCT00392665|470491248|FG000|Overall Study|Death|16|||
130689734|NCT00392665|470491249|FG001|Overall Study|Death|14|||
130689735|NCT00392665|470491248|FG000|Overall Study|Lost to Follow-up|1|||
130689736|NCT00392665|470491249|FG001|Overall Study|Lost to Follow-up|1|||
130689737|NCT04408794|470491252|FG000|Overall Study|Adverse Event|43|||
130689738|NCT04408794|470491252|FG000|Overall Study|Infrequent study drug usage|43|||
130689739|NCT04408794|470491252|FG000|Overall Study|Lack of Efficacy|61|||
130689740|NCT04408794|470491252|FG000|Overall Study|Lost to Follow-up|33|||
130689741|NCT04408794|470491252|FG000|Overall Study|Non-compliance|6|||
130689742|NCT04408794|470491252|FG000|Overall Study|Physician Decision|1|||
130689743|NCT04408794|470491252|FG000|Overall Study|Pregnancy|6|||
130689744|NCT04408794|470491252|FG000|Overall Study|Protocol Deviation|9|||
130689745|NCT04408794|470491252|FG000|Overall Study|Sheehan-STS Result|1|||
130689746|NCT04408794|470491252|FG000|Overall Study|Withdrawal by Subject|57|||
130689747|NCT04408794|470491252|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
130689748|NCT04408794|470491252|FG000|Overall Study|Never Treated Migraine|5|||
130689749|NCT02294786|470491257|FG000|Overall Study|Withdrawal by Subject|0|||
130689750|NCT02294786|470491258|FG001|Overall Study|Withdrawal by Subject|1|||
130689751|NCT02294786|470491257|FG000|Overall Study|Physician Decision|6|||
130689752|NCT02294786|470491258|FG001|Overall Study|Physician Decision|7|||
130689753|NCT02294786|470491257|FG000|Overall Study|Lost to Follow-up|1|||
130689754|NCT02294786|470491258|FG001|Overall Study|Lost to Follow-up|2|||
130689755|NCT02294786|470491257|FG000|Overall Study|Protocol Violation|1|||
130689756|NCT02294786|470491258|FG001|Overall Study|Protocol Violation|0|||
130689757|NCT02294786|470491257|FG000|Overall Study|Adverse Event|1|||
130689758|NCT02294786|470491258|FG001|Overall Study|Adverse Event|1|||
130689759|NCT02294786|470491257|FG000|Overall Study|Death|2|||
130689760|NCT02294786|470491258|FG001|Overall Study|Death|3|||
130689761|NCT01778010|470491259|FG000|Overall Study|Withdrawal by Subject|2|||
130689762|NCT01778010|470491259|FG000|Overall Study|abnormal ECG before meds|1|||
130689763|NCT01778010|470491259|FG000|Overall Study|Arrested|1|||
130689764|NCT01778010|470491259|FG000|Overall Study|rash while on placebo|1|||
130689765|NCT01518972|470491263|FG000|Overall Study|Lost to Follow-up|2|||
130689766|NCT01518972|470491264|FG001|Overall Study|Lost to Follow-up|1|||
130689767|NCT01518972|470491263|FG000|Overall Study|Withdrawal by Subject|1|||
130689768|NCT01518972|470491264|FG001|Overall Study|Withdrawal by Subject|0|||
130689769|NCT01518972|470491263|FG000|Overall Study|Moved from area|1|||
130689770|NCT01518972|470491264|FG001|Overall Study|Moved from area|0|||
130689771|NCT01518972|470491263|FG000|Overall Study|Transportation problems|1|||
130689772|NCT01518972|470491264|FG001|Overall Study|Transportation problems|0|||
130689773|NCT01518972|470491263|FG000|Overall Study|Exclusionary medical condition|1|||
130689774|NCT01518972|470491264|FG001|Overall Study|Exclusionary medical condition|0|||
130689775|NCT01518972|470491263|FG000|Overall Study|Missed safety visits|0|||
130689776|NCT01518972|470491264|FG001|Overall Study|Missed safety visits|1|||
130689777|NCT01518972|470491263|FG000|Overall Study|Exclusionary medication|0|||
130689778|NCT01518972|470491264|FG001|Overall Study|Exclusionary medication|1|||
130689779|NCT01518972|470491263|FG000|Overall Study|Declined medication starting on day 12|0|||
130689780|NCT01518972|470491264|FG001|Overall Study|Declined medication starting on day 12|1|||
130689781|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
130689782|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
130689783|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
130689784|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
130689785|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
130689786|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
130689787|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
130689788|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
130689789|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
130689790|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
130689791|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130689792|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130689793|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
130689794|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
130689795|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
130689796|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
130689797|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
130689798|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
130689799|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
130689800|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
130689801|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
130689802|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
130689803|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
130689804|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
130689805|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
130689806|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
130689807|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
130689808|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
130689809|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
130689810|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
130689811|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
130689812|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
130689813|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
130689814|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
130689815|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
130689816|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
130689817|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
130689818|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
130689819|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
130689820|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
130689821|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
130689822|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
130689823|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
130689824|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
130689825|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
130689826|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
130689827|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Death|0|||
130689828|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Death|1|||
130689829|NCT02159183|470491267|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
130689830|NCT02159183|470491268|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
130689831|NCT02159183|470491267|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
130689832|NCT02159183|470491268|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
130689833|NCT03733444|470491270|FG000|Overall Study|Adverse Event|8|||
130689834|NCT03733444|470491271|FG001|Overall Study|Adverse Event|10|||
130689835|NCT03733444|470491272|FG002|Overall Study|Adverse Event|5|||
130689836|NCT03733444|470491270|FG000|Overall Study|Death|20|||
130689837|NCT03733444|470491271|FG001|Overall Study|Death|19|||
130444143|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444144|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444145|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444146|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444147|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444148|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444149|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130444150|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
130444151|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
130444152|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
130444153|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
130444154|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
130444155|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
130444156|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
130444157|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
130444158|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
130444159|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
130444160|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
130444161|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
130444162|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
130444163|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
130689838|NCT03733444|470491272|FG002|Overall Study|Death|11|||
130689839|NCT03733444|470491270|FG000|Overall Study|Lost to Follow-up|3|||
130689840|NCT03733444|470491271|FG001|Overall Study|Lost to Follow-up|0|||
130689841|NCT03733444|470491272|FG002|Overall Study|Lost to Follow-up|1|||
130689842|NCT03733444|470491270|FG000|Overall Study|Lack of Efficacy|0|||
130689843|NCT03733444|470491271|FG001|Overall Study|Lack of Efficacy|1|||
130689844|NCT03733444|470491272|FG002|Overall Study|Lack of Efficacy|1|||
130689845|NCT03733444|470491270|FG000|Overall Study|Physician Decision|2|||
130689846|NCT03733444|470491271|FG001|Overall Study|Physician Decision|1|||
130689847|NCT03733444|470491272|FG002|Overall Study|Physician Decision|0|||
130689848|NCT03733444|470491270|FG000|Overall Study|Protocol Violation|2|||
130689849|NCT03733444|470491271|FG001|Overall Study|Protocol Violation|1|||
130689850|NCT03733444|470491272|FG002|Overall Study|Protocol Violation|0|||
130689851|NCT03733444|470491270|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130689852|NCT03733444|470491271|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130689853|NCT03733444|470491272|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
130689854|NCT03733444|470491270|FG000|Overall Study|Study Terminated by Sponsor|203|||
130689855|NCT03733444|470491271|FG001|Overall Study|Study Terminated by Sponsor|209|||
130689856|NCT03733444|470491272|FG002|Overall Study|Study Terminated by Sponsor|221|||
130689857|NCT03733444|470491270|FG000|Overall Study|Withdrawal by Subject|19|||
130689858|NCT03733444|470491271|FG001|Overall Study|Withdrawal by Subject|18|||
130689859|NCT03733444|470491272|FG002|Overall Study|Withdrawal by Subject|16|||
130689860|NCT03733444|470491270|FG000|Overall Study|Miscellaneous|1|||
130689861|NCT03733444|470491271|FG001|Overall Study|Miscellaneous|0|||
130689862|NCT03733444|470491272|FG002|Overall Study|Miscellaneous|1|||
130689863|NCT03733444|470491270|FG000|Overall Study|Not Treated|1|||
130689864|NCT03733444|470491271|FG001|Overall Study|Not Treated|2|||
130689865|NCT03733444|470491272|FG002|Overall Study|Not Treated|1|||
130689866|NCT00556322|470491273|FG000|Overall Study|Insufficient therapeutic response|158|||
130689867|NCT00556322|470491274|FG001|Overall Study|Insufficient therapeutic response|168|||
130689868|NCT00556322|470491273|FG000|Overall Study|Adverse Event|7|||
130689869|NCT00556322|470491274|FG001|Overall Study|Adverse Event|4|||
130689870|NCT00556322|470491273|FG000|Overall Study|Other|4|||
130689871|NCT00556322|470491274|FG001|Overall Study|Other|1|||
130689872|NCT00556322|470491273|FG000|Overall Study|Lost to Follow-up|5|||
130689873|NCT00556322|470491274|FG001|Overall Study|Lost to Follow-up|3|||
130689874|NCT00556322|470491273|FG000|Overall Study|Withdrawal by Subject|19|||
130689875|NCT00556322|470491274|FG001|Overall Study|Withdrawal by Subject|7|||
130689876|NCT00556322|470491273|FG000|Overall Study|Protocol Violation|5|||
130689877|NCT00556322|470491274|FG001|Overall Study|Protocol Violation|1|||
130689878|NCT00556322|470491273|FG000|Overall Study|Ongoing at data cutoff|3|||
130689879|NCT00556322|470491274|FG001|Overall Study|Ongoing at data cutoff|5|||
130689880|NCT00556322|470491273|FG000|Overall Study|Death|20|||
130689881|NCT00556322|470491274|FG001|Overall Study|Death|14|||
130689882|NCT01788423|470491275|FG000|Overall Study|See Comments in Completed (above)|0|||
130444164|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
130444165|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
130444166|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
130689883|NCT01788423|470491276|FG001|Overall Study|See Comments in Completed (above)|4|||
130689884|NCT01788423|470491277|FG002|Overall Study|See Comments in Completed (above)|5|||
130689885|NCT03637764|470491278|FG000|Overall Study|Adverse Event|2|||
130689886|NCT03637764|470491279|FG001|Overall Study|Adverse Event|0|||
130689887|NCT03637764|470491280|FG002|Overall Study|Adverse Event|0|||
130689888|NCT03637764|470491281|FG003|Overall Study|Adverse Event|1|||
130689889|NCT03637764|470491278|FG000|Overall Study|Progressive Disease|23|||
130689890|NCT03637764|470491279|FG001|Overall Study|Progressive Disease|23|||
130689891|NCT03637764|470491280|FG002|Overall Study|Progressive Disease|18|||
130689892|NCT03637764|470491281|FG003|Overall Study|Progressive Disease|31|||
130689893|NCT03637764|470491278|FG000|Overall Study|Withdrawal by Subject|1|||
130689894|NCT03637764|470491279|FG001|Overall Study|Withdrawal by Subject|3|||
130689895|NCT03637764|470491280|FG002|Overall Study|Withdrawal by Subject|0|||
130689896|NCT03637764|470491281|FG003|Overall Study|Withdrawal by Subject|1|||
130689897|NCT02760927|470491286|FG000|Overall Study|Tube Slippage from Device|1|||
130689898|NCT02105272|470491287|FG000|Overall Study|Adverse Event|1|||
130689899|NCT02105272|470491288|FG001|Overall Study|Adverse Event|2|||
130689900|NCT02105272|470491287|FG000|Overall Study|Physician Decision|0|||
130689901|NCT02105272|470491288|FG001|Overall Study|Physician Decision|1|||
130689902|NCT02105272|470491287|FG000|Overall Study|Protocol Violation|2|||
130689903|NCT02105272|470491288|FG001|Overall Study|Protocol Violation|0|||
130689904|NCT02105272|470491287|FG000|Overall Study|Withdrawal by Subject|2|||
130689905|NCT02105272|470491288|FG001|Overall Study|Withdrawal by Subject|0|||
130689906|NCT03190915|470491290|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
130689907|NCT03190915|470491290|FG000|Overall Study|Progressive Disease|3|||
130689908|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
130689909|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
130689910|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
130689911|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
130689912|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
130689913|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130689914|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130689915|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130689916|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
130689917|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
130689918|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130689919|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
130689920|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
130689921|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
130689922|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130689923|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130689924|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130689925|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130689926|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130689927|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130689928|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Death|0|||
130689929|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Death|1|||
130689930|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Death|0|||
130689931|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Death|0|||
130689932|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
130689933|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
130689934|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130689935|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130689936|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
130689937|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689938|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689939|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689940|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689941|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130689942|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689943|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689944|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130689945|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130689946|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
130689947|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
130689948|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130689949|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130689950|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
130689951|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
130444167|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
130444168|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
130444169|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
130444170|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444171|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444172|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444173|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444174|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444175|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444176|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444177|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444178|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444179|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444180|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444181|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444182|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444183|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444184|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444185|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
130444186|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
130444187|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
130444188|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
130444189|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
130444190|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
130444191|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
130444192|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
130444193|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
130444194|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
130444195|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
130444196|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
130444197|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
130444198|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
130444199|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
130444200|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
130444201|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
130444202|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
130444203|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
130444204|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
130444205|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
130444206|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444207|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444208|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444209|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444210|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444211|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444212|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444213|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444214|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444215|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444216|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444217|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
130552883|NCT00752622|469991607|FG000|Interventional Phase|Non-responder|2|||
130689952|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689953|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689954|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
130689955|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689956|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130689957|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130689958|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
130444218|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444219|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444220|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
130444221|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444222|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
130444223|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
130444224|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444225|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444226|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444227|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444228|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130689959|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
130689960|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689961|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689962|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
130689963|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689964|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689965|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689966|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
130689967|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689968|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689969|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689970|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130689971|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689972|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689973|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689974|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689975|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
130689976|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689977|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689978|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689979|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
130689980|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689981|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689982|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
130689983|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689984|NCT01911676|470491297|FG000|Period 1 of Study|Withdrawal by Subject|4|||
130689985|NCT01911676|470491298|FG001|Period 1 of Study|Withdrawal by Subject|2|||
130689986|NCT01911676|470491299|FG002|Period 1 of Study|Withdrawal by Subject|1|||
130689987|NCT01911676|470491300|FG003|Period 1 of Study|Withdrawal by Subject|2|||
130689988|NCT01911676|470491297|FG000|Period 1 of Study|Physician Decision|2|||
130689989|NCT01911676|470491298|FG001|Period 1 of Study|Physician Decision|0|||
130689990|NCT01911676|470491299|FG002|Period 1 of Study|Physician Decision|0|||
130689991|NCT01911676|470491300|FG003|Period 1 of Study|Physician Decision|1|||
130689992|NCT01911676|470491297|FG000|Period 2 of Study|Physician Decision|2|||
130689993|NCT01911676|470491298|FG001|Period 2 of Study|Physician Decision|0|||
130689994|NCT01911676|470491299|FG002|Period 2 of Study|Physician Decision|0|||
130689995|NCT01911676|470491300|FG003|Period 2 of Study|Physician Decision|1|||
130689996|NCT01911676|470491297|FG000|Period 2 of Study|Lost to Follow-up|0|||
130689997|NCT01911676|470491298|FG001|Period 2 of Study|Lost to Follow-up|0|||
130689998|NCT01911676|470491299|FG002|Period 2 of Study|Lost to Follow-up|0|||
130689999|NCT01911676|470491300|FG003|Period 2 of Study|Lost to Follow-up|1|||
130690000|NCT01566721|470491301|FG000|Treatment Period|Withdrawal by Subject|35|||
130690001|NCT01566721|470491302|FG001|Treatment Period|Withdrawal by Subject|9|||
130690002|NCT01566721|470491301|FG000|Treatment Period|Disease Progression/Recurrence|37|||
130690003|NCT01566721|470491302|FG001|Treatment Period|Disease Progression/Recurrence|13|||
130690004|NCT01566721|470491301|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
130690005|NCT01566721|470491302|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
130690006|NCT01566721|470491301|FG000|Treatment Period|Other|13|||
130690007|NCT01566721|470491302|FG001|Treatment Period|Other|2|||
130690008|NCT01566721|470491301|FG000|Treatment Period|Lack of Compliance|5|||
130690009|NCT01566721|470491302|FG001|Treatment Period|Lack of Compliance|1|||
130690010|NCT01566721|470491301|FG000|Treatment Period|Adverse Event|100|||
130690011|NCT01566721|470491302|FG001|Treatment Period|Adverse Event|30|||
130690012|NCT01566721|470491301|FG000|Treatment Period|Pregnancy|1|||
130690013|NCT01566721|470491302|FG001|Treatment Period|Pregnancy|0|||
130690014|NCT01566721|470491301|FG000|Safety Follow-up|Physician Decision|6|||
130690015|NCT01566721|470491302|FG001|Safety Follow-up|Physician Decision|4|||
130690016|NCT01566721|470491301|FG000|Safety Follow-up|Lost to Follow-up|101|||
130690017|NCT01566721|470491302|FG001|Safety Follow-up|Lost to Follow-up|48|||
130690018|NCT01566721|470491301|FG000|Safety Follow-up|Withdrawal by Subject|155|||
130690019|NCT01566721|470491302|FG001|Safety Follow-up|Withdrawal by Subject|49|||
130690020|NCT01566721|470491301|FG000|Safety Follow-up|Death|28|||
130690021|NCT01566721|470491302|FG001|Safety Follow-up|Death|4|||
130690022|NCT01566721|470491301|FG000|Safety Follow-up|Non-compliance|7|||
130690023|NCT01566721|470491302|FG001|Safety Follow-up|Non-compliance|3|||
130690024|NCT01566721|470491301|FG000|Safety Follow-up|Protocol Violation|7|||
130690025|NCT01566721|470491302|FG001|Safety Follow-up|Protocol Violation|0|||
130690026|NCT01566721|470491301|FG000|Safety Follow-up|Site closure|2|||
130690027|NCT01566721|470491302|FG001|Safety Follow-up|Site closure|3|||
130690028|NCT01566721|470491301|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
130690029|NCT01566721|470491302|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
130225114|NCT00549549|468788081|FG002|Overall Study|Randomized but not treated|1|||
130225115|NCT00549549|468788082|FG003|Overall Study|Randomized but not treated|1|||
130690030|NCT01566721|470491301|FG000|Safety Follow-up|Missing|7|||
130690031|NCT01566721|470491302|FG001|Safety Follow-up|Missing|2|||
130690032|NCT01566721|470491301|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
130690033|NCT01566721|470491302|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
130690034|NCT01566721|470491301|FG000|Safety Follow-up|Sponsor decision|1|||
130690035|NCT01566721|470491302|FG001|Safety Follow-up|Sponsor decision|0|||
130690036|NCT01566721|470491301|FG000|Safety Follow-up|Adverse Event|8|||
130690037|NCT01566721|470491302|FG001|Safety Follow-up|Adverse Event|4|||
130690038|NCT01237054|470491303|FG000|Overall Study|imaging 10C0096|1|||
130690039|NCT02619682|470491304|FG000|Overall Study|Withdrawal by Subject|3|||
130690040|NCT02619682|470491304|FG000|Overall Study|Lack of Efficacy|8|||
130690041|NCT02619682|470491304|FG000|Overall Study|new secondary cancer|1|||
130690042|NCT02619682|470491304|FG000|Overall Study|post surgery complications|2|||
130690043|NCT00268203|470491307|FG000|Overall Study|Lost to Follow-up|92|||
130690044|NCT00268203|470491307|FG000|Overall Study|Withdrawal by Subject|9|||
130690045|NCT00268203|470491307|FG000|Overall Study|Received Other NHL Therapy|7|||
130690046|NCT00268203|470491307|FG000|Overall Study|Progressive Disease|359|||
130690047|NCT00268203|470491307|FG000|Overall Study|Death|84|||
130690048|NCT00268203|470491307|FG000|Overall Study|Reason Not Specified|34|||
130690049|NCT00268203|470491307|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
130690050|NCT00730691|470491314|FG000|Overall Study|Adverse Event|4|||
130690051|NCT00730691|470491315|FG001|Overall Study|Adverse Event|8|||
130690052|NCT00730691|470491316|FG002|Overall Study|Adverse Event|11|||
130690053|NCT00730691|470491317|FG003|Overall Study|Adverse Event|11|||
130690054|NCT00730691|470491318|FG004|Overall Study|Adverse Event|23|||
130690055|NCT00730691|470491314|FG000|Overall Study|Lack of Efficacy|4|||
130690056|NCT00730691|470491315|FG001|Overall Study|Lack of Efficacy|4|||
130690057|NCT00730691|470491316|FG002|Overall Study|Lack of Efficacy|2|||
130690058|NCT00730691|470491317|FG003|Overall Study|Lack of Efficacy|1|||
130690059|NCT00730691|470491318|FG004|Overall Study|Lack of Efficacy|1|||
130690060|NCT00730691|470491314|FG000|Overall Study|Non-compliance with Study Drug|6|||
130690061|NCT00730691|470491315|FG001|Overall Study|Non-compliance with Study Drug|1|||
130690062|NCT00730691|470491316|FG002|Overall Study|Non-compliance with Study Drug|6|||
130690063|NCT00730691|470491317|FG003|Overall Study|Non-compliance with Study Drug|3|||
130690064|NCT00730691|470491318|FG004|Overall Study|Non-compliance with Study Drug|3|||
130690065|NCT00730691|470491314|FG000|Overall Study|Protocol Deviations|3|||
130690066|NCT00730691|470491315|FG001|Overall Study|Protocol Deviations|5|||
130690067|NCT00730691|470491316|FG002|Overall Study|Protocol Deviations|3|||
130690068|NCT00730691|470491317|FG003|Overall Study|Protocol Deviations|7|||
130690069|NCT00730691|470491318|FG004|Overall Study|Protocol Deviations|5|||
130690070|NCT00730691|470491314|FG000|Overall Study|Withdrawal of Consent|7|||
130690071|NCT00730691|470491315|FG001|Overall Study|Withdrawal of Consent|9|||
130690072|NCT00730691|470491316|FG002|Overall Study|Withdrawal of Consent|3|||
130690073|NCT00730691|470491317|FG003|Overall Study|Withdrawal of Consent|6|||
130690074|NCT00730691|470491318|FG004|Overall Study|Withdrawal of Consent|3|||
130690075|NCT00730691|470491314|FG000|Overall Study|Lost to Follow-up|11|||
130690076|NCT00730691|470491315|FG001|Overall Study|Lost to Follow-up|8|||
130690077|NCT00730691|470491316|FG002|Overall Study|Lost to Follow-up|13|||
130690078|NCT00730691|470491317|FG003|Overall Study|Lost to Follow-up|15|||
130690079|NCT00730691|470491318|FG004|Overall Study|Lost to Follow-up|13|||
130690080|NCT00730691|470491314|FG000|Overall Study|Other|1|||
130690081|NCT00730691|470491315|FG001|Overall Study|Other|1|||
130690082|NCT00730691|470491316|FG002|Overall Study|Other|1|||
130690083|NCT00730691|470491317|FG003|Overall Study|Other|2|||
130225116|NCT02155699|468788083|FG000|Overall Study|Withdrawal by Subject|0|||
130690084|NCT00730691|470491318|FG004|Overall Study|Other|2|||
130690085|NCT02178787|470491319|FG000|Overall Study|Lost to Follow-up|1|||
130690086|NCT02178787|470491320|FG001|Overall Study|Lost to Follow-up|0|||
130690087|NCT02178787|470491319|FG000|Overall Study|Withdrawal by Subject|0|||
130690088|NCT02178787|470491320|FG001|Overall Study|Withdrawal by Subject|2|||
130690089|NCT02178787|470491319|FG000|Overall Study|No TCD window|3|||
130690090|NCT02178787|470491320|FG001|Overall Study|No TCD window|7|||
130690091|NCT02178787|470491319|FG000|Overall Study|Physician Decision|1|||
130225117|NCT02155699|468788084|FG001|Overall Study|Withdrawal by Subject|3|||
130225118|NCT02155699|468788085|FG002|Overall Study|Withdrawal by Subject|6|||
130225119|NCT02155699|468788086|FG003|Overall Study|Withdrawal by Subject|1|||
130225120|NCT02155699|468788083|FG000|Overall Study|Lost to Follow-up|0|||
130225121|NCT02155699|468788084|FG001|Overall Study|Lost to Follow-up|0|||
130225122|NCT02155699|468788085|FG002|Overall Study|Lost to Follow-up|0|||
130225123|NCT02155699|468788086|FG003|Overall Study|Lost to Follow-up|3|||
130225124|NCT02155699|468788083|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130225125|NCT02155699|468788084|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130225126|NCT02155699|468788085|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
130225127|NCT02155699|468788086|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
130225128|NCT02227784|468788087|FG000|Double-Blind Phase|Adverse Event|3|||
130225129|NCT02227784|468788088|FG001|Double-Blind Phase|Adverse Event|2|||
130225130|NCT02227784|468788089|FG002|Double-Blind Phase|Adverse Event|1|||
130225131|NCT02227784|468788090|FG003|Double-Blind Phase|Adverse Event|3|||
130225132|NCT02227784|468788091|FG004|Double-Blind Phase|Adverse Event|0|||
130225133|NCT02227784|468788087|FG000|Double-Blind Phase|Physician Decision|1|||
130225134|NCT02227784|468788088|FG001|Double-Blind Phase|Physician Decision|0|||
130225135|NCT02227784|468788089|FG002|Double-Blind Phase|Physician Decision|0|||
130225136|NCT02227784|468788090|FG003|Double-Blind Phase|Physician Decision|1|||
130225137|NCT02227784|468788091|FG004|Double-Blind Phase|Physician Decision|0|||
130225138|NCT02227784|468788087|FG000|Double-Blind Phase|Protocol Violation|0|||
130225139|NCT02227784|468788088|FG001|Double-Blind Phase|Protocol Violation|0|||
130225140|NCT02227784|468788089|FG002|Double-Blind Phase|Protocol Violation|1|||
130225141|NCT02227784|468788090|FG003|Double-Blind Phase|Protocol Violation|1|||
130225142|NCT02227784|468788091|FG004|Double-Blind Phase|Protocol Violation|0|||
130690092|NCT02178787|470491320|FG001|Overall Study|Physician Decision|0|||
130690093|NCT02554890|470491321|FG000|Double-blind|Adverse Event|45|||
130690094|NCT02554890|470491322|FG001|Double-blind|Adverse Event|51|||
130690095|NCT02554890|470491321|FG000|Double-blind|Death|6|||
130690096|NCT02554890|470491322|FG001|Double-blind|Death|4|||
130225143|NCT02227784|468788087|FG000|Double-Blind Phase|Sponsor Decision|34|||
130225144|NCT02227784|468788088|FG001|Double-Blind Phase|Sponsor Decision|15|||
130225145|NCT02227784|468788089|FG002|Double-Blind Phase|Sponsor Decision|14|||
130225146|NCT02227784|468788090|FG003|Double-Blind Phase|Sponsor Decision|32|||
130225147|NCT02227784|468788091|FG004|Double-Blind Phase|Sponsor Decision|0|||
130225148|NCT02227784|468788087|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130225149|NCT02227784|468788088|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130225150|NCT02227784|468788089|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130225151|NCT02227784|468788090|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130225152|NCT02227784|468788091|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130225153|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225154|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130690097|NCT02554890|470491321|FG000|Double-blind|Protocol Violation|1|||
130690098|NCT02554890|470491322|FG001|Double-blind|Protocol Violation|1|||
130690099|NCT02554890|470491321|FG000|Double-blind|Physician Decision|4|||
130690100|NCT02554890|470491322|FG001|Double-blind|Physician Decision|3|||
130690101|NCT02554890|470491321|FG000|Double-blind|Subject/Guardian decision|21|||
130690102|NCT02554890|470491322|FG001|Double-blind|Subject/Guardian decision|16|||
130690103|NCT02554890|470491321|FG000|Double-blind|Lost to Follow-up|7|||
130690104|NCT02554890|470491322|FG001|Double-blind|Lost to Follow-up|5|||
130690105|NCT02554890|470491321|FG000|Double-blind|Technical problems|1|||
130690106|NCT02554890|470491322|FG001|Double-blind|Technical problems|0|||
130690107|NCT02554890|470491321|FG000|Double-blind|Withdrawal by Subject|5|||
130690108|NCT02554890|470491322|FG001|Double-blind|Withdrawal by Subject|6|||
130690109|NCT02554890|470491321|FG000|Double-blind|Noncompliance with study treatment|6|||
130690110|NCT02554890|470491322|FG001|Double-blind|Noncompliance with study treatment|5|||
130690111|NCT02554890|470491321|FG000|Open-label|Adverse Event|0|||
130690112|NCT02554890|470491322|FG001|Open-label|Adverse Event|30|||
130690113|NCT02554890|470491321|FG000|Open-label|Death|0|||
130690114|NCT02554890|470491322|FG001|Open-label|Death|1|||
130690115|NCT02554890|470491321|FG000|Open-label|Physician Decision|0|||
130690116|NCT02554890|470491322|FG001|Open-label|Physician Decision|1|||
130690117|NCT02554890|470491321|FG000|Open-label|Subject/Guardian decision|0|||
130690118|NCT02554890|470491322|FG001|Open-label|Subject/Guardian decision|11|||
130690119|NCT02554890|470491321|FG000|Open-label|Lost to Follow-up|0|||
130690120|NCT02554890|470491322|FG001|Open-label|Lost to Follow-up|7|||
130690121|NCT02554890|470491321|FG000|Open-label|Technical problems|0|||
130225155|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225156|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225157|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
130225158|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Death|0|||
130225159|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Death|0|||
130225160|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Death|0|||
130225161|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Death|0|||
130225162|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Death|1|||
130225163|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225164|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225165|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225166|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225167|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
130225168|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225169|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225170|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225171|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225172|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
130225173|NCT02688933|468788096|FG000|Overall Study|Adverse Event|3|||
130225174|NCT02688933|468788097|FG001|Overall Study|Adverse Event|1|||
130225175|NCT02688933|468788096|FG000|Overall Study|Lack of Efficacy|2|||
130225176|NCT02688933|468788097|FG001|Overall Study|Lack of Efficacy|2|||
130225177|NCT02688933|468788096|FG000|Overall Study|Poor compliance to protocol|7|||
130225178|NCT02688933|468788097|FG001|Overall Study|Poor compliance to protocol|4|||
130225179|NCT02688933|468788096|FG000|Overall Study|Hypoglycemia|2|||
130225180|NCT02688933|468788097|FG001|Overall Study|Hypoglycemia|0|||
130225181|NCT02688933|468788096|FG000|Overall Study|Other than Specified|14|||
130225182|NCT02688933|468788097|FG001|Overall Study|Other than Specified|25|||
130225183|NCT02688933|468788096|FG000|Overall Study|Lost to Follow-up|1|||
130225184|NCT02688933|468788097|FG001|Overall Study|Lost to Follow-up|5|||
130225185|NCT00248651|468788098|FG000|Overall Study|Withdrawal by Subject|28|||
130225186|NCT00248651|468788099|FG001|Overall Study|Withdrawal by Subject|40|||
130225187|NCT00248651|468788100|FG002|Overall Study|Withdrawal by Subject|32|||
130225188|NCT01275144|468788101|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
130225189|NCT01275144|468788102|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
130225190|NCT00828113|468788103|FG000|Overall Study|Withdrawal by Subject|27|||
130225191|NCT00828113|468788104|FG001|Overall Study|Withdrawal by Subject|26|||
130225192|NCT00828113|468788103|FG000|Overall Study|Lost to Follow-up|3|||
130225193|NCT00828113|468788104|FG001|Overall Study|Lost to Follow-up|5|||
130225194|NCT05607576|468788105|FG000|Overall Study|immediate sensor error|2|||
130225195|NCT05607576|468788105|FG000|Overall Study|Physician Decision|2|||
130225196|NCT01091246|468788106|FG000|Overall Study|Lost to Follow-up|23|||
130225197|NCT01091246|468788107|FG001|Overall Study|Lost to Follow-up|11|||
130356107|NCT04382755|469274650|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
130356108|NCT03552965|469274654|FG000|Overall Study|Death|1|||
130690122|NCT02554890|470491322|FG001|Open-label|Technical problems|1|||
130225198|NCT01091246|468788108|FG002|Overall Study|Lost to Follow-up|7|||
130225199|NCT01091246|468788106|FG000|Overall Study|Adverse Event|1|||
130225200|NCT01091246|468788107|FG001|Overall Study|Adverse Event|0|||
130225201|NCT01091246|468788108|FG002|Overall Study|Adverse Event|1|||
130225202|NCT01091246|468788106|FG000|Overall Study|Withdrawal by Subject|9|||
130225203|NCT01091246|468788107|FG001|Overall Study|Withdrawal by Subject|5|||
130225204|NCT01091246|468788108|FG002|Overall Study|Withdrawal by Subject|4|||
130225205|NCT01091246|468788106|FG000|Overall Study|Subject not dosed|2|||
130690123|NCT02554890|470491321|FG000|Open-label|Withdrawal by Subject|0|||
130690124|NCT02554890|470491322|FG001|Open-label|Withdrawal by Subject|1|||
130690125|NCT03649477|470491323|FG000|Overall Study|Adverse Event|2|||
130690126|NCT03649477|470491324|FG001|Overall Study|Adverse Event|0|||
130690127|NCT03649477|470491325|FG002|Overall Study|Adverse Event|0|||
130690128|NCT02430480|470491328|FG000|Overall Study|Death|1|||
130690129|NCT02430480|470491328|FG000|Overall Study|Anesthesia concerns|1|||
130690130|NCT02430480|470491328|FG000|Overall Study|Progressed on treatment|1|||
130690131|NCT01097577|470491336|FG000|Overall Study|Adverse Event|0|||
130690132|NCT01097577|470491337|FG001|Overall Study|Adverse Event|1|||
130690133|NCT00316186|470491338|FG000|Overall Study|Adverse Event|6|||
130690134|NCT00316186|470491338|FG000|Overall Study|Disease Progression|4|||
130690135|NCT00316186|470491338|FG000|Overall Study|Lost to Follow-up|1|||
130690136|NCT00316186|470491338|FG000|Overall Study|Other|1|||
130690137|NCT04493684|470491341|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690138|NCT04493684|470491342|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690139|NCT04493684|470491343|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690140|NCT04493684|470491344|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690141|NCT04493684|470491345|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690142|NCT04493684|470491346|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690143|NCT04493684|470491347|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690144|NCT04493684|470491348|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690145|NCT04493684|470491349|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690146|NCT04493684|470491350|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690147|NCT04493684|470491351|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690148|NCT04493684|470491352|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130356109|NCT03552965|469274655|FG001|Overall Study|Death|1|||
130225206|NCT01091246|468788107|FG001|Overall Study|Subject not dosed|0|||
130225207|NCT01091246|468788108|FG002|Overall Study|Subject not dosed|1|||
130225208|NCT02700048|468788111|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
130225209|NCT02700048|468788112|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
130225210|NCT02175225|468788113|FG000|Overall Study|Withdrawal by Subject|1|||
130225211|NCT02175225|468788114|FG001|Overall Study|Withdrawal by Subject|2|||
130225212|NCT02175225|468788113|FG000|Overall Study|Lost to Follow-up|6|||
130225213|NCT02175225|468788114|FG001|Overall Study|Lost to Follow-up|7|||
130225214|NCT02175225|468788113|FG000|Overall Study|Study drug not administered|1|||
130225215|NCT02175225|468788114|FG001|Overall Study|Study drug not administered|2|||
130225216|NCT02668640|468788115|FG000|Overall Study|Lost to Follow-up|13|||
130225217|NCT02668640|468788115|FG000|Overall Study|Other, not specified|1|||
130225218|NCT04877990|468788116|FG000|Treatment|Other reasons|3|||
130225219|NCT04877990|468788117|FG001|Treatment|Other reasons|1|||
130225220|NCT04877990|468788116|FG000|Treatment|Administrative reasons by sponsor|17|||
130225221|NCT04877990|468788117|FG001|Treatment|Administrative reasons by sponsor|33|||
130225222|NCT04877990|468788116|FG000|Treatment|Withdrawal by Subject|2|||
130225223|NCT04877990|468788117|FG001|Treatment|Withdrawal by Subject|6|||
130225224|NCT04877990|468788116|FG000|Treatment|Adverse Event|2|||
130225225|NCT04877990|468788117|FG001|Treatment|Adverse Event|1|||
130225226|NCT01121263|468788118|FG000|Overall Study|Death|3|||
130225227|NCT01121263|468788119|FG001|Overall Study|Death|2|||
130225228|NCT01121263|468788118|FG000|Overall Study|Lost to Follow-up|22|||
130225229|NCT01121263|468788119|FG001|Overall Study|Lost to Follow-up|12|||
130225230|NCT01121263|468788118|FG000|Overall Study|Withdrawal by Subject|0|||
130225231|NCT01121263|468788119|FG001|Overall Study|Withdrawal by Subject|1|||
130225232|NCT02007720|468788120|FG000|Overall Study|Withdrawal by Subject|9|||
130225233|NCT02007720|468788121|FG001|Overall Study|Withdrawal by Subject|11|||
130225234|NCT02007720|468788120|FG000|Overall Study|study terminated by sponsor|58|||
130225235|NCT02007720|468788121|FG001|Overall Study|study terminated by sponsor|54|||
130690149|NCT04493684|470491353|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690150|NCT04493684|470491354|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690151|NCT04493684|470491355|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690152|NCT04493684|470491356|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690153|NCT04493684|470491357|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690154|NCT04493684|470491341|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
130225236|NCT02007720|468788120|FG000|Overall Study|technical problem|4|||
130225237|NCT02007720|468788121|FG001|Overall Study|technical problem|2|||
130225238|NCT02007720|468788120|FG000|Overall Study|patient followd less than 165 days|11|||
130444229|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444230|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444231|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444232|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444233|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444234|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444235|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444236|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444237|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444238|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
130444239|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444240|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130444241|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
130444242|NCT01474512|469588501|FG000|Post-Treatment Follow-Up|Death|0|||
130444243|NCT01474512|469588502|FG001|Post-Treatment Follow-Up|Death|0|||
130444244|NCT01474512|469588503|FG002|Post-Treatment Follow-Up|Death|0|||
130444245|NCT01474512|469588504|FG003|Post-Treatment Follow-Up|Death|0|||
130444246|NCT01474512|469588505|FG004|Post-Treatment Follow-Up|Death|0|||
130444247|NCT01474512|469588506|FG005|Post-Treatment Follow-Up|Death|0|||
130690155|NCT04493684|470491342|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690156|NCT04493684|470491343|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690157|NCT04493684|470491344|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690158|NCT04493684|470491345|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690159|NCT04493684|470491346|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130225239|NCT02007720|468788121|FG001|Overall Study|patient followd less than 165 days|5|||
130225240|NCT01386606|468789891|FG000|Overall Study|Adverse Event|0|||
130225241|NCT01386606|468789892|FG001|Overall Study|Adverse Event|1|||
130225242|NCT01386606|468789893|FG002|Overall Study|Adverse Event|0|||
130225243|NCT01386606|468789894|FG003|Overall Study|Adverse Event|0|||
130225244|NCT01386606|468789891|FG000|Overall Study|Withdrawal by Subject|0|||
130225245|NCT01386606|468789892|FG001|Overall Study|Withdrawal by Subject|1|||
130444248|NCT01474512|469588507|FG006|Post-Treatment Follow-Up|Death|0|||
130444249|NCT01474512|469588508|FG007|Post-Treatment Follow-Up|Death|0|||
130225246|NCT01386606|468789893|FG002|Overall Study|Withdrawal by Subject|1|||
130225247|NCT01386606|468789894|FG003|Overall Study|Withdrawal by Subject|0|||
130225248|NCT01386606|468789891|FG000|Overall Study|Protocol Violation|1|||
130225249|NCT01386606|468789892|FG001|Overall Study|Protocol Violation|0|||
130225250|NCT01386606|468789893|FG002|Overall Study|Protocol Violation|1|||
130225251|NCT01386606|468789894|FG003|Overall Study|Protocol Violation|1|||
130225252|NCT01386606|468789891|FG000|Overall Study|Lost to Follow-up|2|||
130225253|NCT01386606|468789892|FG001|Overall Study|Lost to Follow-up|0|||
130225254|NCT01386606|468789893|FG002|Overall Study|Lost to Follow-up|0|||
130225255|NCT01386606|468789894|FG003|Overall Study|Lost to Follow-up|0|||
130225256|NCT01386606|468789891|FG000|Overall Study|Subject incarcerated|0|||
130225257|NCT01386606|468789892|FG001|Overall Study|Subject incarcerated|1|||
130225258|NCT01386606|468789893|FG002|Overall Study|Subject incarcerated|0|||
130225259|NCT01386606|468789894|FG003|Overall Study|Subject incarcerated|0|||
130225260|NCT01386606|468789891|FG000|Overall Study|Unable to draw PK|1|||
130225261|NCT01386606|468789892|FG001|Overall Study|Unable to draw PK|0|||
130225262|NCT01386606|468789893|FG002|Overall Study|Unable to draw PK|0|||
130225263|NCT01386606|468789894|FG003|Overall Study|Unable to draw PK|0|||
130225264|NCT01386606|468789891|FG000|Overall Study|T levels too high|0|||
130225265|NCT01386606|468789892|FG001|Overall Study|T levels too high|1|||
130225266|NCT01386606|468789893|FG002|Overall Study|T levels too high|1|||
130225267|NCT01386606|468789894|FG003|Overall Study|T levels too high|0|||
130225268|NCT04980014|468789895|FG000|Overall Study|Participants who are Duplicated|1|||
130225269|NCT04980014|468789895|FG000|Overall Study|Follow-up Failure|13|||
130225270|NCT04980014|468789895|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
130225271|NCT04980014|468789895|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
130225272|NCT04980014|468789895|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
130225273|NCT01965327|468789900|FG000|Overall Study|Physician Decision|2|||
130225274|NCT03964207|468789902|FG000|First Treatment|Withdrawal by Subject|1|||
130225275|NCT03964207|468789903|FG001|First Treatment|Withdrawal by Subject|2|||
130225276|NCT03964207|468789902|FG000|First Treatment|Protocol Violation|1|||
130225277|NCT03964207|468789903|FG001|First Treatment|Protocol Violation|0|||
130225278|NCT03964207|468789902|FG000|First Treatment|Lost to Follow-up|1|||
130225279|NCT03964207|468789903|FG001|First Treatment|Lost to Follow-up|0|||
130225280|NCT03964207|468789902|FG000|Second Treatment|Lost to Follow-up|0|||
130225281|NCT03964207|468789903|FG001|Second Treatment|Lost to Follow-up|1|||
130225282|NCT03964207|468789902|FG000|Second Treatment|Adverse Event|1|||
130225283|NCT03964207|468789903|FG001|Second Treatment|Adverse Event|2|||
130690160|NCT04493684|470491347|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690161|NCT04493684|470491348|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690162|NCT04493684|470491349|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690163|NCT04493684|470491350|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690164|NCT04493684|470491351|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690165|NCT04493684|470491352|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690166|NCT04493684|470491353|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690167|NCT04493684|470491354|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690168|NCT04493684|470491355|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130225284|NCT01294423|468789904|FG000|Overall Study|Adverse Event|1|||
130225285|NCT01294423|468789905|FG001|Overall Study|Adverse Event|2|||
130225286|NCT01294423|468789906|FG002|Overall Study|Adverse Event|3|||
130225287|NCT01294423|468789904|FG000|Overall Study|Withdrawal by Subject|1|||
130225288|NCT01294423|468789905|FG001|Overall Study|Withdrawal by Subject|2|||
130225289|NCT01294423|468789906|FG002|Overall Study|Withdrawal by Subject|2|||
130225290|NCT01294423|468789904|FG000|Overall Study|subject no longer meets study criteria|2|||
130225291|NCT01294423|468789905|FG001|Overall Study|subject no longer meets study criteria|5|||
130356110|NCT03552965|469274654|FG000|Overall Study|Lost to Follow-up|1|||
130690169|NCT04493684|470491356|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690170|NCT04493684|470491357|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690171|NCT04493684|470491341|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690172|NCT04493684|470491342|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690173|NCT04493684|470491343|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690174|NCT04493684|470491344|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690175|NCT04493684|470491345|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690176|NCT04493684|470491346|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690177|NCT04493684|470491347|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
130690178|NCT04493684|470491348|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690179|NCT04493684|470491349|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690180|NCT04493684|470491350|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690181|NCT04493684|470491351|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690182|NCT04493684|470491352|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690183|NCT04493684|470491353|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690184|NCT04493684|470491354|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690185|NCT04493684|470491355|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690186|NCT04493684|470491356|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690187|NCT04493684|470491357|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690188|NCT04493684|470491341|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
130690189|NCT04493684|470491342|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690190|NCT04493684|470491343|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690191|NCT04493684|470491344|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690192|NCT04493684|470491345|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690193|NCT04493684|470491346|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690194|NCT04493684|470491347|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690195|NCT04493684|470491348|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690196|NCT04493684|470491349|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690197|NCT04493684|470491350|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690198|NCT04493684|470491351|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690199|NCT04493684|470491352|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690200|NCT04493684|470491353|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690201|NCT04493684|470491354|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690202|NCT04493684|470491355|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690203|NCT04493684|470491356|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690204|NCT04493684|470491357|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690205|NCT04493684|470491341|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690206|NCT04493684|470491342|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690207|NCT04493684|470491343|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690208|NCT04493684|470491344|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690209|NCT04493684|470491345|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690210|NCT04493684|470491346|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
130690211|NCT04493684|470491347|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690212|NCT04493684|470491348|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690213|NCT04493684|470491349|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690214|NCT04493684|470491350|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690215|NCT04493684|470491351|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690216|NCT04493684|470491352|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690217|NCT04493684|470491353|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690218|NCT04493684|470491354|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690219|NCT04493684|470491355|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690220|NCT04493684|470491356|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690221|NCT04493684|470491357|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690222|NCT04493684|470491341|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690223|NCT04493684|470491342|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690224|NCT04493684|470491343|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690225|NCT04493684|470491344|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130356111|NCT03552965|469274655|FG001|Overall Study|Lost to Follow-up|1|||
130356112|NCT03552965|469274654|FG000|Overall Study|Physician Decision|1|||
130356113|NCT03552965|469274655|FG001|Overall Study|Physician Decision|1|||
130356114|NCT03552965|469274654|FG000|Overall Study|Withdrawal by Subject|0|||
130356115|NCT03552965|469274655|FG001|Overall Study|Withdrawal by Subject|2|||
130356116|NCT03552965|469274654|FG000|Overall Study|Continuation not in patient best interest|1|||
130444250|NCT01474512|469588509|FG008|Post-Treatment Follow-Up|Death|0|||
130225292|NCT01294423|468789906|FG002|Overall Study|subject no longer meets study criteria|2|||
130225293|NCT01294423|468789904|FG000|Overall Study|poor/non-compliance|1|||
130225294|NCT01294423|468789905|FG001|Overall Study|poor/non-compliance|0|||
130225295|NCT01294423|468789906|FG002|Overall Study|poor/non-compliance|1|||
130225296|NCT00301834|468789909|FG000|Overall Study|Death|1|||
130225297|NCT02026141|468789911|FG000|Overall Study|Protocol Violation|0|||
130225298|NCT02026141|468789912|FG001|Overall Study|Protocol Violation|1|||
130225299|NCT05081388|468789913|FG000|Overall Study|Adverse Event|1|||
130225300|NCT05081388|468789914|FG001|Overall Study|Adverse Event|0|||
130225301|NCT05081388|468789915|FG002|Overall Study|Adverse Event|0|||
130225302|NCT05081388|468789916|FG003|Overall Study|Adverse Event|0|||
130225303|NCT05081388|468789917|FG004|Overall Study|Adverse Event|0|||
130225304|NCT05081388|468789913|FG000|Overall Study|Lost to Follow-up|0|||
130225305|NCT05081388|468789914|FG001|Overall Study|Lost to Follow-up|1|||
130225306|NCT05081388|468789915|FG002|Overall Study|Lost to Follow-up|0|||
130225307|NCT05081388|468789916|FG003|Overall Study|Lost to Follow-up|0|||
130225308|NCT05081388|468789917|FG004|Overall Study|Lost to Follow-up|0|||
130225309|NCT05081388|468789913|FG000|Overall Study|Subject decision|0|||
130444251|NCT01474512|469588510|FG009|Post-Treatment Follow-Up|Death|0|||
130225310|NCT05081388|468789914|FG001|Overall Study|Subject decision|0|||
130225311|NCT05081388|468789915|FG002|Overall Study|Subject decision|0|||
130225312|NCT05081388|468789916|FG003|Overall Study|Subject decision|1|||
130225313|NCT05081388|468789917|FG004|Overall Study|Subject decision|0|||
130225314|NCT02059239|468789918|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
130225315|NCT02059239|468789919|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
130225316|NCT02059239|468789918|FG000|Overall Study|Physician Decision|1|||
130225317|NCT02059239|468789919|FG001|Overall Study|Physician Decision|0|||
130225318|NCT02219685|468789920|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
130225319|NCT02219685|468789921|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
130225320|NCT02219685|468789920|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
130225321|NCT02219685|468789921|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
130225322|NCT04202497|468789922|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
130225323|NCT04202497|468789923|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225324|NCT04202497|468789924|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225325|NCT04202497|468789925|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225326|NCT02115607|468789932|FG000|Overall Study|Withdrawal by Subject|1|||
130225327|NCT00102596|468789936|FG000|Part A|Screen failures|6|||
130225328|NCT00102596|468789937|FG001|Part A|Screen failures|0|||
130225329|NCT00102596|468789936|FG000|Part A|Adverse Event|1|||
130225330|NCT00102596|468789937|FG001|Part A|Adverse Event|0|||
130225331|NCT00069264|468789939|FG000|Overall Study|Adverse Event|3|||
130225332|NCT00069264|468789939|FG000|Overall Study|Progressive Disease|23|||
130225333|NCT00069264|468789939|FG000|Overall Study|Withdrawal by Subject|3|||
130225334|NCT00069264|468789939|FG000|Overall Study|Discon Therapy|3|||
130225335|NCT05547386|468789940|FG000|Overall Study|Withdrawal by Subject|7|||
130225336|NCT04622969|468789941|FG000|Overall Study|Withdrawal by Subject|2|||
130225337|NCT04622969|468789942|FG001|Overall Study|Withdrawal by Subject|3|||
130225338|NCT04467515|468789943|FG000|Overall Study|Lost to Follow-up|1|||
130225339|NCT04467515|468789944|FG001|Overall Study|Lost to Follow-up|0|||
130225340|NCT04467515|468789945|FG002|Overall Study|Lost to Follow-up|0|||
130225341|NCT04467515|468789943|FG000|Overall Study|Withdrawal by Subject|1|||
130225342|NCT04467515|468789944|FG001|Overall Study|Withdrawal by Subject|0|||
130225343|NCT04467515|468789945|FG002|Overall Study|Withdrawal by Subject|1|||
130444252|NCT01474512|469588511|FG010|Post-Treatment Follow-Up|Death|0|||
130444253|NCT01474512|469588512|FG011|Post-Treatment Follow-Up|Death|0|||
130444254|NCT01474512|469588513|FG012|Post-Treatment Follow-Up|Death|0|||
130444255|NCT01474512|469588514|FG013|Post-Treatment Follow-Up|Death|0|||
130444256|NCT01474512|469588515|FG014|Post-Treatment Follow-Up|Death|0|||
130444257|NCT01474512|469588516|FG015|Post-Treatment Follow-Up|Death|0|||
130444258|NCT01474512|469588517|FG016|Post-Treatment Follow-Up|Death|1|||
130444259|NCT01474512|469588518|FG017|Post-Treatment Follow-Up|Death|0|||
130444260|NCT01118962|469588521|FG000|Overall Study|Adverse Event|2|||
130444261|NCT01118962|469588521|FG000|Overall Study|Lack of Efficacy|1|||
130444262|NCT01118962|469588521|FG000|Overall Study|Protocol Violation|1|||
130444263|NCT01118962|469588521|FG000|Overall Study|Withdrawal by Subject|4|||
130444264|NCT01118962|469588521|FG000|Overall Study|Pregnancy|1|||
130444265|NCT01118962|469588521|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
130444266|NCT01023308|469588526|FG000|Overall Study|Abnormal test proceedure results|3|||
130444267|NCT01023308|469588527|FG001|Overall Study|Abnormal test proceedure results|8|||
130444268|NCT01023308|469588526|FG000|Overall Study|Administrative problems|2|||
130444269|NCT01023308|469588527|FG001|Overall Study|Administrative problems|1|||
130444270|NCT01023308|469588526|FG000|Overall Study|Adverse Event|130|||
130444271|NCT01023308|469588527|FG001|Overall Study|Adverse Event|66|||
130444272|NCT01023308|469588526|FG000|Overall Study|Death|21|||
130444273|NCT01023308|469588527|FG001|Overall Study|Death|17|||
130444274|NCT01023308|469588526|FG000|Overall Study|Disease progression|82|||
130444275|NCT01023308|469588527|FG001|Overall Study|Disease progression|153|||
130444276|NCT01023308|469588526|FG000|Overall Study|New Cancer therapy|4|||
130444277|NCT01023308|469588527|FG001|Overall Study|New Cancer therapy|7|||
130444278|NCT01023308|469588526|FG000|Overall Study|Protocol Violation|3|||
130444279|NCT01023308|469588527|FG001|Overall Study|Protocol Violation|4|||
130225344|NCT04467515|468789943|FG000|Overall Study|Progressive Disease|0|||
130444280|NCT01023308|469588526|FG000|Overall Study|Untreated|5|||
130444281|NCT01023308|469588527|FG001|Overall Study|Untreated|5|||
130444282|NCT01023308|469588526|FG000|Overall Study|Lost to Follow-up|1|||
130444283|NCT01023308|469588527|FG001|Overall Study|Lost to Follow-up|0|||
130444284|NCT01023308|469588526|FG000|Overall Study|Withdrawal by Subject|34|||
130225345|NCT04467515|468789944|FG001|Overall Study|Progressive Disease|1|||
130225346|NCT04467515|468789945|FG002|Overall Study|Progressive Disease|3|||
130225347|NCT04467515|468789943|FG000|Overall Study|Death|0|||
130225348|NCT04467515|468789944|FG001|Overall Study|Death|1|||
130225349|NCT04467515|468789945|FG002|Overall Study|Death|0|||
130444285|NCT01023308|469588527|FG001|Overall Study|Withdrawal by Subject|18|||
130444286|NCT01383993|469588528|FG000|Overall Study|Adverse Event|1|||
130225350|NCT05616013|468789948|FG000|Overall Study|Adverse Event|6|||
130444287|NCT01383993|469588529|FG001|Overall Study|Adverse Event|1|||
130444288|NCT01383993|469588530|FG002|Overall Study|Adverse Event|0|||
130444289|NCT01383993|469588528|FG000|Overall Study|Withdrawal by Subject|0|||
130225351|NCT05616013|468789949|FG001|Overall Study|Adverse Event|12|||
130225352|NCT05616013|468789950|FG002|Overall Study|Adverse Event|8|||
130225353|NCT05616013|468789951|FG003|Overall Study|Adverse Event|4|||
130225354|NCT05616013|468789952|FG004|Overall Study|Adverse Event|6|||
130690226|NCT04493684|470491345|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130225355|NCT05616013|468789953|FG005|Overall Study|Adverse Event|8|||
130225356|NCT05616013|468789954|FG006|Overall Study|Adverse Event|3|||
130225357|NCT05616013|468789955|FG007|Overall Study|Adverse Event|6|||
130225358|NCT05616013|468789956|FG008|Overall Study|Adverse Event|1|||
130225359|NCT05616013|468789948|FG000|Overall Study|Lost to Follow-up|5|||
130225360|NCT05616013|468789949|FG001|Overall Study|Lost to Follow-up|4|||
130225361|NCT05616013|468789950|FG002|Overall Study|Lost to Follow-up|3|||
130225362|NCT05616013|468789951|FG003|Overall Study|Lost to Follow-up|2|||
130225363|NCT05616013|468789952|FG004|Overall Study|Lost to Follow-up|0|||
130225364|NCT05616013|468789953|FG005|Overall Study|Lost to Follow-up|5|||
130225365|NCT05616013|468789954|FG006|Overall Study|Lost to Follow-up|2|||
130225366|NCT05616013|468789955|FG007|Overall Study|Lost to Follow-up|1|||
130225367|NCT05616013|468789956|FG008|Overall Study|Lost to Follow-up|2|||
130225368|NCT05616013|468789948|FG000|Overall Study|Non-compliance with study requirements|2|||
130225369|NCT05616013|468789949|FG001|Overall Study|Non-compliance with study requirements|2|||
130225370|NCT05616013|468789950|FG002|Overall Study|Non-compliance with study requirements|2|||
130225371|NCT05616013|468789951|FG003|Overall Study|Non-compliance with study requirements|3|||
130225372|NCT05616013|468789952|FG004|Overall Study|Non-compliance with study requirements|0|||
130225373|NCT05616013|468789953|FG005|Overall Study|Non-compliance with study requirements|2|||
130225374|NCT05616013|468789954|FG006|Overall Study|Non-compliance with study requirements|1|||
130225375|NCT05616013|468789955|FG007|Overall Study|Non-compliance with study requirements|1|||
130225376|NCT05616013|468789956|FG008|Overall Study|Non-compliance with study requirements|4|||
130225377|NCT05616013|468789948|FG000|Overall Study|Withdrawal by Subject|11|||
130225378|NCT05616013|468789949|FG001|Overall Study|Withdrawal by Subject|9|||
130225379|NCT05616013|468789950|FG002|Overall Study|Withdrawal by Subject|8|||
130225380|NCT05616013|468789951|FG003|Overall Study|Withdrawal by Subject|6|||
130225381|NCT05616013|468789952|FG004|Overall Study|Withdrawal by Subject|3|||
130225382|NCT05616013|468789953|FG005|Overall Study|Withdrawal by Subject|4|||
130444290|NCT01383993|469588529|FG001|Overall Study|Withdrawal by Subject|0|||
130690227|NCT04493684|470491346|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690228|NCT04493684|470491347|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690229|NCT04493684|470491348|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690230|NCT04493684|470491349|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690231|NCT04493684|470491350|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690232|NCT04493684|470491351|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690233|NCT04493684|470491352|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
130690234|NCT04493684|470491353|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690235|NCT04493684|470491354|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690236|NCT04493684|470491355|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690237|NCT04493684|470491356|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690238|NCT04493684|470491357|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690239|NCT04493684|470491341|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690240|NCT04493684|470491342|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690241|NCT04493684|470491343|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690242|NCT04493684|470491344|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690243|NCT04493684|470491345|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690244|NCT04493684|470491346|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690245|NCT04493684|470491347|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690246|NCT04493684|470491348|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690247|NCT04493684|470491349|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690248|NCT04493684|470491350|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690249|NCT04493684|470491351|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690250|NCT04493684|470491352|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690251|NCT04493684|470491353|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690252|NCT04493684|470491354|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690253|NCT04493684|470491355|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690254|NCT04493684|470491356|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
130225383|NCT05616013|468789954|FG006|Overall Study|Withdrawal by Subject|6|||
130225384|NCT05616013|468789955|FG007|Overall Study|Withdrawal by Subject|5|||
130225385|NCT05616013|468789956|FG008|Overall Study|Withdrawal by Subject|4|||
130225386|NCT05616013|468789948|FG000|Overall Study|Physician Decision|0|||
130225387|NCT05616013|468789949|FG001|Overall Study|Physician Decision|0|||
130444291|NCT01383993|469588530|FG002|Overall Study|Withdrawal by Subject|1|||
130444292|NCT01383993|469588528|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
130444293|NCT01383993|469588529|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
130444294|NCT01383993|469588530|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
130444295|NCT00262743|469588533|FG000|Overall Study|Adverse Event|0|||
130444296|NCT00262743|469588534|FG001|Overall Study|Adverse Event|9|||
130444297|NCT00262743|469588533|FG000|Overall Study|Disease progression|0|||
130444298|NCT00262743|469588534|FG001|Overall Study|Disease progression|3|||
130444299|NCT04430335|469588541|FG000|Overall Study|Withdrawal by Subject|1|||
130444300|NCT03249376|469588542|FG000|Overall Study|Adverse Event|11|||
130444301|NCT03249376|469588543|FG001|Overall Study|Adverse Event|5|||
130444302|NCT03249376|469588542|FG000|Overall Study|Lack of Efficacy|2|||
130444303|NCT03249376|469588543|FG001|Overall Study|Lack of Efficacy|4|||
130444304|NCT03249376|469588542|FG000|Overall Study|Protocol Violation|3|||
130444305|NCT03249376|469588543|FG001|Overall Study|Protocol Violation|2|||
130444306|NCT03249376|469588542|FG000|Overall Study|Physician Decision|0|||
130690255|NCT04493684|470491357|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690256|NCT04493684|470491341|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690257|NCT04493684|470491342|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690258|NCT04493684|470491343|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690259|NCT04493684|470491344|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690260|NCT04493684|470491345|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690261|NCT04493684|470491346|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690262|NCT04493684|470491347|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690263|NCT04493684|470491348|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690264|NCT04493684|470491349|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690265|NCT04493684|470491350|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690266|NCT04493684|470491351|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690267|NCT04493684|470491352|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690268|NCT04493684|470491353|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690269|NCT04493684|470491354|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690270|NCT04493684|470491355|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690271|NCT04493684|470491356|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
130690272|NCT04493684|470491357|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690273|NCT01963728|470491358|FG000|Overall Study|Study terminated early|0|||
130690274|NCT01963728|470491359|FG001|Overall Study|Study terminated early|1|||
130690275|NCT05152576|470491362|FG000|Overall Study|Lost to Follow-up|3|||
130690276|NCT05152576|470491363|FG001|Overall Study|Lost to Follow-up|0|||
130690277|NCT05152576|470491364|FG002|Overall Study|Lost to Follow-up|0|||
130690278|NCT05152576|470491365|FG003|Overall Study|Lost to Follow-up|1|||
130690279|NCT05152576|470491362|FG000|Overall Study|Withdrawal by Subject|0|||
130690280|NCT05152576|470491363|FG001|Overall Study|Withdrawal by Subject|1|||
130690281|NCT05152576|470491364|FG002|Overall Study|Withdrawal by Subject|0|||
130690282|NCT05152576|470491365|FG003|Overall Study|Withdrawal by Subject|1|||
130690283|NCT05152576|470491362|FG000|Overall Study|Other|2|||
130690284|NCT05152576|470491363|FG001|Overall Study|Other|0|||
130690285|NCT05152576|470491364|FG002|Overall Study|Other|0|||
130690286|NCT05152576|470491365|FG003|Overall Study|Other|0|||
130690287|NCT03447353|470493013|FG000|Overall Study|Failure at Screening Visit|2|||
130690288|NCT03447353|470493013|FG000|Overall Study|Lost to Follow-up|4|||
130690289|NCT03447353|470493013|FG000|Overall Study|Scheduling Conflicts|3|||
130690290|NCT03447353|470493013|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
130690291|NCT02642653|470493016|FG000|Overall Study|Adverse Event|2|||
130690292|NCT02642653|470493017|FG001|Overall Study|Adverse Event|0|||
130690293|NCT02267187|470493018|FG000|Overall Study|Physician Decision|2|||
130690294|NCT02267187|470493018|FG000|Overall Study|Screen fail|3|||
130690295|NCT02222818|470493024|FG000|Period 1|Eligibility criteria not met|0|||
130690296|NCT02222818|470493025|FG001|Period 1|Eligibility criteria not met|3|||
130690297|NCT03025087|470493026|FG000|Overall Study|Physician Decision|3|||
130690298|NCT03025087|470493027|FG001|Overall Study|Physician Decision|3|||
130690299|NCT03025087|470493028|FG002|Overall Study|Physician Decision|0|||
130690300|NCT03025087|470493029|FG003|Overall Study|Physician Decision|0|||
130690301|NCT03025087|470493030|FG004|Overall Study|Physician Decision|0|||
130690302|NCT03025087|470493026|FG000|Overall Study|Withdrawal by Subject|1|||
130690303|NCT03025087|470493027|FG001|Overall Study|Withdrawal by Subject|1|||
130444307|NCT03249376|469588543|FG001|Overall Study|Physician Decision|2|||
130690304|NCT03025087|470493028|FG002|Overall Study|Withdrawal by Subject|0|||
130690305|NCT03025087|470493029|FG003|Overall Study|Withdrawal by Subject|0|||
130690306|NCT03025087|470493030|FG004|Overall Study|Withdrawal by Subject|0|||
130690307|NCT03025087|470493026|FG000|Overall Study|Unable to complete MRI|2|||
130444308|NCT03249376|469588542|FG000|Overall Study|Withdrawal by Subject|3|||
130444309|NCT03249376|469588543|FG001|Overall Study|Withdrawal by Subject|9|||
130444310|NCT03249376|469588542|FG000|Overall Study|LTFU|2|||
130225388|NCT05616013|468789950|FG002|Overall Study|Physician Decision|1|||
130225389|NCT05616013|468789951|FG003|Overall Study|Physician Decision|0|||
130225390|NCT05616013|468789952|FG004|Overall Study|Physician Decision|0|||
130225391|NCT05616013|468789953|FG005|Overall Study|Physician Decision|1|||
130225392|NCT05616013|468789954|FG006|Overall Study|Physician Decision|3|||
130225393|NCT05616013|468789955|FG007|Overall Study|Physician Decision|0|||
130225394|NCT05616013|468789956|FG008|Overall Study|Physician Decision|0|||
130225395|NCT05616013|468789948|FG000|Overall Study|Protocol Violation|0|||
130225396|NCT05616013|468789949|FG001|Overall Study|Protocol Violation|0|||
130225397|NCT05616013|468789950|FG002|Overall Study|Protocol Violation|0|||
130225398|NCT05616013|468789951|FG003|Overall Study|Protocol Violation|0|||
130225399|NCT05616013|468789952|FG004|Overall Study|Protocol Violation|0|||
130225400|NCT05616013|468789953|FG005|Overall Study|Protocol Violation|0|||
130225401|NCT05616013|468789954|FG006|Overall Study|Protocol Violation|1|||
130225402|NCT05616013|468789955|FG007|Overall Study|Protocol Violation|0|||
130225403|NCT05616013|468789956|FG008|Overall Study|Protocol Violation|2|||
130225404|NCT05616013|468789948|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
130225405|NCT05616013|468789949|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
130444311|NCT03249376|469588543|FG001|Overall Study|LTFU|1|||
130444312|NCT01154036|469588544|FG000|Phase I|Physician Decision|0|||
130444313|NCT01154036|469588545|FG001|Phase I|Physician Decision|1|||
130444314|NCT01154036|469588546|FG002|Phase I|Physician Decision|0|||
130444315|NCT01154036|469588547|FG003|Phase I|Physician Decision|0|||
130444316|NCT01154036|469588548|FG004|Phase I|Physician Decision|0|||
130444317|NCT01154036|469588549|FG005|Phase I|Physician Decision|0|||
130444318|NCT01154036|469588550|FG006|Phase I|Physician Decision|0|||
130444319|NCT01154036|469588551|FG007|Phase I|Physician Decision|0|||
130444320|NCT01154036|469588544|FG000|Phase I|Lost to Follow-up|0|||
130444321|NCT01154036|469588545|FG001|Phase I|Lost to Follow-up|3|||
130444322|NCT01154036|469588546|FG002|Phase I|Lost to Follow-up|6|||
130444323|NCT01154036|469588547|FG003|Phase I|Lost to Follow-up|0|||
130444324|NCT01154036|469588548|FG004|Phase I|Lost to Follow-up|0|||
130444325|NCT01154036|469588549|FG005|Phase I|Lost to Follow-up|0|||
130444326|NCT01154036|469588550|FG006|Phase I|Lost to Follow-up|0|||
130444327|NCT01154036|469588551|FG007|Phase I|Lost to Follow-up|0|||
130444328|NCT01154036|469588544|FG000|Phase I|Protocol Violation|0|||
130444329|NCT01154036|469588545|FG001|Phase I|Protocol Violation|3|||
130444330|NCT01154036|469588546|FG002|Phase I|Protocol Violation|9|||
130444331|NCT01154036|469588547|FG003|Phase I|Protocol Violation|0|||
130444332|NCT01154036|469588548|FG004|Phase I|Protocol Violation|0|||
130444333|NCT01154036|469588549|FG005|Phase I|Protocol Violation|0|||
130444334|NCT01154036|469588550|FG006|Phase I|Protocol Violation|0|||
130225406|NCT05616013|468789950|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225407|NCT05616013|468789951|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225408|NCT05616013|468789952|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225409|NCT05616013|468789953|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
130444335|NCT01154036|469588551|FG007|Phase I|Protocol Violation|0|||
130444336|NCT01154036|469588544|FG000|Phase I|Withdrawal by Subject|2|||
130444337|NCT01154036|469588545|FG001|Phase I|Withdrawal by Subject|10|||
130225410|NCT05616013|468789954|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225411|NCT05616013|468789955|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225412|NCT05616013|468789956|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
130316109|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
130444338|NCT01154036|469588546|FG002|Phase I|Withdrawal by Subject|29|||
130444339|NCT01154036|469588547|FG003|Phase I|Withdrawal by Subject|0|||
130225413|NCT05616013|468789948|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
130225414|NCT05616013|468789949|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225415|NCT05616013|468789950|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225416|NCT05616013|468789951|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225417|NCT05616013|468789952|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225418|NCT05616013|468789953|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225419|NCT05616013|468789954|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225420|NCT05616013|468789955|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225421|NCT05616013|468789956|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225422|NCT05616013|468789948|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
130225423|NCT05616013|468789949|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225424|NCT05616013|468789950|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225425|NCT05616013|468789951|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225426|NCT05616013|468789952|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225427|NCT05616013|468789953|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225428|NCT05616013|468789954|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225429|NCT05616013|468789955|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225430|NCT05616013|468789956|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225431|NCT05616013|468789948|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225432|NCT05616013|468789949|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
130225433|NCT05616013|468789950|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225434|NCT05616013|468789951|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225435|NCT05616013|468789952|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225436|NCT05616013|468789953|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225437|NCT05616013|468789954|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225438|NCT05616013|468789955|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225439|NCT05616013|468789956|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225440|NCT05616013|468789948|FG000|Overall Study|Participant Decision, Time Constraints|0|||
130225441|NCT05616013|468789949|FG001|Overall Study|Participant Decision, Time Constraints|1|||
130225442|NCT05616013|468789950|FG002|Overall Study|Participant Decision, Time Constraints|0|||
130225443|NCT05616013|468789951|FG003|Overall Study|Participant Decision, Time Constraints|0|||
130225444|NCT05616013|468789952|FG004|Overall Study|Participant Decision, Time Constraints|0|||
130225445|NCT05616013|468789953|FG005|Overall Study|Participant Decision, Time Constraints|0|||
130225446|NCT05616013|468789954|FG006|Overall Study|Participant Decision, Time Constraints|0|||
130225447|NCT05616013|468789955|FG007|Overall Study|Participant Decision, Time Constraints|0|||
130225448|NCT05616013|468789956|FG008|Overall Study|Participant Decision, Time Constraints|0|||
130225449|NCT05616013|468789948|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130225450|NCT05616013|468789949|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130225451|NCT05616013|468789950|FG002|Overall Study|Prohibited Concomitant Medication|1|||
130225452|NCT05616013|468789951|FG003|Overall Study|Prohibited Concomitant Medication|0|||
130225453|NCT05616013|468789952|FG004|Overall Study|Prohibited Concomitant Medication|0|||
130225454|NCT05616013|468789953|FG005|Overall Study|Prohibited Concomitant Medication|0|||
130225455|NCT05616013|468789954|FG006|Overall Study|Prohibited Concomitant Medication|0|||
130225456|NCT05616013|468789955|FG007|Overall Study|Prohibited Concomitant Medication|0|||
130225457|NCT05616013|468789956|FG008|Overall Study|Prohibited Concomitant Medication|0|||
130444340|NCT01154036|469588548|FG004|Phase I|Withdrawal by Subject|0|||
130444341|NCT01154036|469588549|FG005|Phase I|Withdrawal by Subject|0|||
130444342|NCT01154036|469588550|FG006|Phase I|Withdrawal by Subject|0|||
130444343|NCT01154036|469588551|FG007|Phase I|Withdrawal by Subject|0|||
130444344|NCT01154036|469588544|FG000|Phase I|Adverse Event|1|||
130444345|NCT01154036|469588545|FG001|Phase I|Adverse Event|11|||
130444346|NCT01154036|469588546|FG002|Phase I|Adverse Event|12|||
130444347|NCT01154036|469588547|FG003|Phase I|Adverse Event|0|||
130444348|NCT01154036|469588548|FG004|Phase I|Adverse Event|0|||
130690308|NCT03025087|470493027|FG001|Overall Study|Unable to complete MRI|2|||
130690309|NCT03025087|470493028|FG002|Overall Study|Unable to complete MRI|0|||
130690310|NCT03025087|470493029|FG003|Overall Study|Unable to complete MRI|0|||
130690311|NCT03025087|470493030|FG004|Overall Study|Unable to complete MRI|0|||
130690312|NCT01376037|470493045|FG000|Overall Study|Lost to Follow-up|0|||
130690313|NCT01376037|470493046|FG001|Overall Study|Lost to Follow-up|2|||
130690314|NCT02328040|470493048|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
130690315|NCT02328040|470493049|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
130690316|NCT03121586|470493052|FG000|Overall Study|Study terminated by sponsor|0|||
130690317|NCT03121586|470493053|FG001|Overall Study|Study terminated by sponsor|0|||
130690318|NCT03121586|470493054|FG002|Overall Study|Study terminated by sponsor|99|||
130690319|NCT03121586|470493052|FG000|Overall Study|Withdrawal by Subject|37|||
130444349|NCT01154036|469588549|FG005|Phase I|Adverse Event|0|||
130444350|NCT01154036|469588550|FG006|Phase I|Adverse Event|0|||
130444351|NCT01154036|469588551|FG007|Phase I|Adverse Event|0|||
130444352|NCT01154036|469588544|FG000|Phase II|Adverse Event|0|||
130444353|NCT01154036|469588545|FG001|Phase II|Adverse Event|0|||
130444354|NCT01154036|469588546|FG002|Phase II|Adverse Event|0|||
130444355|NCT01154036|469588547|FG003|Phase II|Adverse Event|0|||
130444356|NCT01154036|469588548|FG004|Phase II|Adverse Event|1|||
130444357|NCT01154036|469588549|FG005|Phase II|Adverse Event|1|||
130444358|NCT01154036|469588550|FG006|Phase II|Adverse Event|1|||
130690320|NCT03121586|470493053|FG001|Overall Study|Withdrawal by Subject|14|||
130690321|NCT03121586|470493054|FG002|Overall Study|Withdrawal by Subject|9|||
130690322|NCT03121586|470493052|FG000|Overall Study|Not further specified|6|||
130690323|NCT03121586|470493053|FG001|Overall Study|Not further specified|11|||
130690324|NCT03121586|470493054|FG002|Overall Study|Not further specified|10|||
130690325|NCT03121586|470493052|FG000|Overall Study|Adverse Event|16|||
130690326|NCT03121586|470493053|FG001|Overall Study|Adverse Event|5|||
130690327|NCT03121586|470493054|FG002|Overall Study|Adverse Event|6|||
130690328|NCT03121586|470493052|FG000|Overall Study|Protocol Violation|0|||
130690329|NCT03121586|470493053|FG001|Overall Study|Protocol Violation|5|||
130690330|NCT03121586|470493054|FG002|Overall Study|Protocol Violation|0|||
130690331|NCT03121586|470493052|FG000|Overall Study|Lack of Efficacy|3|||
130690332|NCT03121586|470493053|FG001|Overall Study|Lack of Efficacy|3|||
130690333|NCT03121586|470493054|FG002|Overall Study|Lack of Efficacy|1|||
130690334|NCT03121586|470493052|FG000|Overall Study|Physician Decision|2|||
130690335|NCT03121586|470493053|FG001|Overall Study|Physician Decision|2|||
130690336|NCT03121586|470493054|FG002|Overall Study|Physician Decision|0|||
130690337|NCT03121586|470493052|FG000|Overall Study|Noncompliance with study drug|5|||
130690338|NCT03121586|470493053|FG001|Overall Study|Noncompliance with study drug|3|||
130690339|NCT03121586|470493054|FG002|Overall Study|Noncompliance with study drug|5|||
130690340|NCT03121586|470493052|FG000|Overall Study|Lost to Follow-up|4|||
130690341|NCT03121586|470493053|FG001|Overall Study|Lost to Follow-up|2|||
130690342|NCT03121586|470493054|FG002|Overall Study|Lost to Follow-up|0|||
130690343|NCT03121586|470493052|FG000|Overall Study|Death|2|||
130690344|NCT03121586|470493053|FG001|Overall Study|Death|0|||
130690345|NCT03121586|470493054|FG002|Overall Study|Death|0|||
130690346|NCT06381102|470493055|FG000|Washout 5 Days|Withdrawal by Subject|0|||
130690347|NCT06381102|470493056|FG001|Washout 5 Days|Withdrawal by Subject|2|||
130690348|NCT04278560|470493058|FG000|Overall Study|Adverse Event|1|||
130690349|NCT04278560|470493059|FG001|Overall Study|Adverse Event|2|||
130690350|NCT04278560|470493058|FG000|Overall Study|Withdrawal by Subject|0|||
130690351|NCT04278560|470493059|FG001|Overall Study|Withdrawal by Subject|1|||
130690352|NCT02832063|470493060|FG000|Overall Study|Adverse Event|2|||
130690353|NCT02832063|470493061|FG001|Overall Study|Adverse Event|1|||
130690354|NCT02832063|470493060|FG000|Overall Study|Physician Decision|5|||
130690355|NCT02832063|470493061|FG001|Overall Study|Physician Decision|7|||
130690356|NCT02832063|470493060|FG000|Overall Study|Lost to Follow-up|15|||
130690357|NCT02832063|470493061|FG001|Overall Study|Lost to Follow-up|8|||
130690358|NCT02832063|470493060|FG000|Overall Study|Withdrawal by Subject|10|||
130690359|NCT02832063|470493061|FG001|Overall Study|Withdrawal by Subject|21|||
130690360|NCT02832063|470493060|FG000|Overall Study|Other|2|||
130690361|NCT02832063|470493061|FG001|Overall Study|Other|1|||
130690362|NCT00604162|470493062|FG000|Overall Study|Physician Decision|3|||
130690363|NCT00604162|470493062|FG000|Overall Study|Withdrawal by Subject|1|||
130690364|NCT02241551|470493063|FG000|Overall Study|Adverse Event|1|||
130690365|NCT02241551|470493064|FG001|Overall Study|Adverse Event|0|||
130690366|NCT01015287|470493065|FG000|Overall Study|Death|21|||
130690367|NCT01015287|470493066|FG001|Overall Study|Death|16|||
130690368|NCT01015287|470493065|FG000|Overall Study|Adverse Event|1|||
130690369|NCT01015287|470493066|FG001|Overall Study|Adverse Event|0|||
130690370|NCT01015287|470493065|FG000|Overall Study|Sponsor Decision|3|||
130690371|NCT01015287|470493066|FG001|Overall Study|Sponsor Decision|7|||
130690372|NCT01015287|470493065|FG000|Overall Study|Physician Decision|19|||
130690373|NCT01015287|470493066|FG001|Overall Study|Physician Decision|21|||
130444359|NCT01154036|469588551|FG007|Phase II|Adverse Event|1|||
130444360|NCT01154036|469588544|FG000|Phase II|Physician Decision|0|||
130444361|NCT01154036|469588545|FG001|Phase II|Physician Decision|0|||
130690374|NCT01015287|470493065|FG000|Overall Study|Withdrawal by Subject|14|||
130690375|NCT01015287|470493066|FG001|Overall Study|Withdrawal by Subject|19|||
130690376|NCT01015287|470493065|FG000|Overall Study|Entry Criteria not Met|11|||
130690377|NCT01015287|470493066|FG001|Overall Study|Entry Criteria not Met|14|||
130690378|NCT01015287|470493065|FG000|Overall Study|Lost to Follow-up|2|||
130690379|NCT01015287|470493066|FG001|Overall Study|Lost to Follow-up|1|||
130690380|NCT01015287|470493065|FG000|Overall Study|Protocol Violation|1|||
130690381|NCT01015287|470493066|FG001|Overall Study|Protocol Violation|1|||
130690382|NCT00469898|470493067|FG000|Overall Study|Adverse Event|7|||
130690383|NCT00469898|470493067|FG000|Overall Study|Withdrawal by Subject|4|||
130690384|NCT00469898|470493067|FG000|Overall Study|Death|4|||
130444362|NCT01154036|469588546|FG002|Phase II|Physician Decision|0|||
130444363|NCT01154036|469588547|FG003|Phase II|Physician Decision|0|||
130690385|NCT00469898|470493067|FG000|Overall Study|Disease progression|9|||
130225458|NCT05616013|468789948|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225459|NCT05616013|468789949|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225460|NCT05616013|468789950|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
130225461|NCT05616013|468789951|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225462|NCT05616013|468789952|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225463|NCT05616013|468789953|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225464|NCT05616013|468789954|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225465|NCT05616013|468789955|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225466|NCT05616013|468789956|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225467|NCT05616013|468789948|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225468|NCT05616013|468789949|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225469|NCT05616013|468789950|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225470|NCT05616013|468789951|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
130225471|NCT05616013|468789952|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225472|NCT05616013|468789953|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225473|NCT05616013|468789954|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225474|NCT05616013|468789955|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225475|NCT05616013|468789956|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225476|NCT05616013|468789948|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225477|NCT05616013|468789949|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225478|NCT05616013|468789950|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225479|NCT05616013|468789951|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225480|NCT05616013|468789952|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225481|NCT05616013|468789953|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225482|NCT05616013|468789954|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
130225483|NCT05616013|468789955|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225484|NCT05616013|468789956|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225485|NCT05616013|468789948|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225486|NCT05616013|468789949|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225487|NCT05616013|468789950|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225488|NCT05616013|468789951|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225489|NCT05616013|468789952|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225490|NCT05616013|468789953|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225491|NCT05616013|468789954|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225492|NCT05616013|468789955|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225493|NCT05616013|468789956|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
130225494|NCT05616013|468789948|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225495|NCT05616013|468789949|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225496|NCT05616013|468789950|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225497|NCT05616013|468789951|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225498|NCT05616013|468789952|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225499|NCT05616013|468789953|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225500|NCT05616013|468789954|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225501|NCT05616013|468789955|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225502|NCT05616013|468789956|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
130225503|NCT05116202|468789957|FG000|Overall Study|Study Terminated by Sponsor|21|||
130225504|NCT05116202|468789958|FG001|Overall Study|Study Terminated by Sponsor|38|||
130225505|NCT05116202|468789959|FG002|Overall Study|Study Terminated by Sponsor|17|||
130225506|NCT05116202|468789960|FG003|Overall Study|Study Terminated by Sponsor|18|||
130225507|NCT05116202|468789961|FG004|Overall Study|Study Terminated by Sponsor|0|||
130225508|NCT05116202|468789957|FG000|Overall Study|Withdrawal by Subject|0|||
130225509|NCT05116202|468789958|FG001|Overall Study|Withdrawal by Subject|1|||
130225510|NCT05116202|468789959|FG002|Overall Study|Withdrawal by Subject|1|||
130225511|NCT05116202|468789960|FG003|Overall Study|Withdrawal by Subject|1|||
130225512|NCT05116202|468789961|FG004|Overall Study|Withdrawal by Subject|1|||
130225513|NCT05116202|468789957|FG000|Overall Study|Lost to Follow-up|0|||
130225514|NCT05116202|468789958|FG001|Overall Study|Lost to Follow-up|0|||
130225515|NCT05116202|468789959|FG002|Overall Study|Lost to Follow-up|0|||
130225516|NCT05116202|468789960|FG003|Overall Study|Lost to Follow-up|0|||
130444364|NCT01154036|469588548|FG004|Phase II|Physician Decision|0|||
130444365|NCT01154036|469588549|FG005|Phase II|Physician Decision|0|||
130690386|NCT00469898|470493067|FG000|Overall Study|Decreased performance status|1|||
130690387|NCT01370317|470493068|FG000|Overall Study|Participant withdrew consent|1|||
130690388|NCT01370317|470493069|FG001|Overall Study|Participant withdrew consent|0|||
130690389|NCT01370317|470493068|FG000|Overall Study|Protocol deviation|0|||
130690390|NCT01370317|470493069|FG001|Overall Study|Protocol deviation|1|||
130690391|NCT02849457|470493072|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690392|NCT02849457|470493073|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690393|NCT02849457|470493074|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
130690394|NCT02849457|470493075|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690395|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
130690396|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690397|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690398|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690399|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690400|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690401|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690402|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690403|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
130690404|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690405|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690406|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690407|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690408|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690409|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690410|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690411|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690412|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
130690413|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690414|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690415|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690416|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690417|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690418|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
130690419|NCT03673670|470493076|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690420|NCT03673670|470493077|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690421|NCT03673670|470493078|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
130690422|NCT03673670|470493079|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690423|NCT03673670|470493080|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
130690424|NCT03673670|470493081|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690425|NCT03673670|470493076|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690426|NCT03673670|470493077|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690427|NCT03673670|470493078|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690428|NCT03673670|470493079|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690429|NCT03673670|470493080|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
130690430|NCT03673670|470493081|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690431|NCT03673670|470493076|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690432|NCT03673670|470493077|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690433|NCT03673670|470493078|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690434|NCT03673670|470493079|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690435|NCT03673670|470493080|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
130690436|NCT03673670|470493081|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690437|NCT01294917|470493085|FG000|Overall Study|Relocation|5|||
130690438|NCT01294917|470493085|FG000|Overall Study|Inconvenience|1|||
130690439|NCT01444378|470493086|FG000|Overall Study|Lost to Follow-up|1|||
130444366|NCT01154036|469588550|FG006|Phase II|Physician Decision|1|||
130690440|NCT01444378|470493086|FG000|Overall Study|Withdrawal by Subject|1|||
130690441|NCT01444378|470493086|FG000|Overall Study|Death|3|||
130690442|NCT01444378|470493086|FG000|Overall Study|Administrative Closure Of The Study|2|||
130444367|NCT01154036|469588551|FG007|Phase II|Physician Decision|0|||
130225517|NCT05116202|468789961|FG004|Overall Study|Lost to Follow-up|2|||
130225518|NCT05116202|468789957|FG000|Overall Study|Death|1|||
130225519|NCT05116202|468789958|FG001|Overall Study|Death|1|||
130225520|NCT05116202|468789959|FG002|Overall Study|Death|2|||
130225521|NCT05116202|468789960|FG003|Overall Study|Death|1|||
130225522|NCT05116202|468789961|FG004|Overall Study|Death|5|||
130225523|NCT03834506|468789962|FG000|Overall Study|Death|336|||
130225524|NCT03834506|468789963|FG001|Overall Study|Death|326|||
130225525|NCT03834506|468789962|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130225526|NCT03834506|468789963|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130225527|NCT03834506|468789962|FG000|Overall Study|Withdrawal by Subject|10|||
130225528|NCT03834506|468789963|FG001|Overall Study|Withdrawal by Subject|8|||
130225529|NCT03834506|468789962|FG000|Overall Study|Sponsor decision|165|||
130225530|NCT03834506|468789963|FG001|Overall Study|Sponsor decision|178|||
130225531|NCT03834506|468789962|FG000|Overall Study|Physician Decision|3|||
130225532|NCT03834506|468789963|FG001|Overall Study|Physician Decision|1|||
130225533|NCT03834506|468789962|FG000|Overall Study|Lost to Follow-up|0|||
130225534|NCT03834506|468789963|FG001|Overall Study|Lost to Follow-up|1|||
130225535|NCT05067972|468789964|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225536|NCT05067972|468789965|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225537|NCT05067972|468789966|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225538|NCT05067972|468789967|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225539|NCT05067972|468789968|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225540|NCT05067972|468789969|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225541|NCT05067972|468789970|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225542|NCT05067972|468789964|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
130225543|NCT05067972|468789965|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
130225544|NCT05067972|468789966|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
130225545|NCT05067972|468789967|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
130225546|NCT05067972|468789968|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
130225547|NCT05067972|468789969|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
130225548|NCT05067972|468789970|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
130225549|NCT05067972|468789964|FG000|Part 1: Treatment|Progressive Disease|3|||
130225550|NCT05067972|468789965|FG001|Part 1: Treatment|Progressive Disease|3|||
130225551|NCT05067972|468789966|FG002|Part 1: Treatment|Progressive Disease|4|||
130225552|NCT05067972|468789967|FG003|Part 1: Treatment|Progressive Disease|2|||
130225553|NCT05067972|468789968|FG004|Part 1: Treatment|Progressive Disease|3|||
130225554|NCT05067972|468789969|FG005|Part 1: Treatment|Progressive Disease|0|||
130225555|NCT05067972|468789970|FG006|Part 1: Treatment|Progressive Disease|2|||
130225556|NCT05067972|468789964|FG000|Part 1: Treatment|Physician Decision|0|||
130225557|NCT05067972|468789965|FG001|Part 1: Treatment|Physician Decision|0|||
130225558|NCT05067972|468789966|FG002|Part 1: Treatment|Physician Decision|0|||
130225559|NCT05067972|468789967|FG003|Part 1: Treatment|Physician Decision|1|||
130225560|NCT05067972|468789968|FG004|Part 1: Treatment|Physician Decision|0|||
130225561|NCT05067972|468789969|FG005|Part 1: Treatment|Physician Decision|0|||
130225562|NCT05067972|468789970|FG006|Part 1: Treatment|Physician Decision|0|||
130225563|NCT05067972|468789964|FG000|Part 1: Treatment|Death|0|||
130225564|NCT05067972|468789965|FG001|Part 1: Treatment|Death|0|||
130225565|NCT05067972|468789966|FG002|Part 1: Treatment|Death|0|||
130225566|NCT05067972|468789967|FG003|Part 1: Treatment|Death|2|||
130225567|NCT05067972|468789968|FG004|Part 1: Treatment|Death|0|||
130225568|NCT05067972|468789969|FG005|Part 1: Treatment|Death|0|||
130225569|NCT05067972|468789970|FG006|Part 1: Treatment|Death|0|||
130225570|NCT05067972|468789964|FG000|Part 1: Treatment|Adverse Event|0|||
130225571|NCT05067972|468789965|FG001|Part 1: Treatment|Adverse Event|0|||
130225572|NCT05067972|468789966|FG002|Part 1: Treatment|Adverse Event|0|||
130225573|NCT05067972|468789967|FG003|Part 1: Treatment|Adverse Event|0|||
130225574|NCT05067972|468789968|FG004|Part 1: Treatment|Adverse Event|0|||
130225575|NCT05067972|468789969|FG005|Part 1: Treatment|Adverse Event|2|||
130225576|NCT05067972|468789970|FG006|Part 1: Treatment|Adverse Event|1|||
130225577|NCT05067972|468789964|FG000|Part 1: Follow-up|Adverse Event|0|||
130690443|NCT01444378|470493086|FG000|Overall Study|Missed Visits|10|||
130690444|NCT00927069|470493087|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
130690445|NCT00927069|470493088|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
130690446|NCT00927069|470493089|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
130690447|NCT00927069|470493090|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
130225578|NCT05067972|468789965|FG001|Part 1: Follow-up|Adverse Event|0|||
130225579|NCT05067972|468789966|FG002|Part 1: Follow-up|Adverse Event|0|||
130225580|NCT05067972|468789967|FG003|Part 1: Follow-up|Adverse Event|0|||
130225581|NCT05067972|468789968|FG004|Part 1: Follow-up|Adverse Event|0|||
130225582|NCT05067972|468789969|FG005|Part 1: Follow-up|Adverse Event|1|||
130225583|NCT05067972|468789970|FG006|Part 1: Follow-up|Adverse Event|0|||
130225584|NCT05067972|468789964|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
130225585|NCT05067972|468789965|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
130225586|NCT05067972|468789966|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
130225587|NCT05067972|468789967|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
130225588|NCT05067972|468789968|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
130690448|NCT00927069|470493087|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
130225589|NCT05067972|468789969|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
130225590|NCT05067972|468789970|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
130225591|NCT05067972|468789964|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225592|NCT05067972|468789965|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225593|NCT05067972|468789966|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225594|NCT05067972|468789967|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225595|NCT05067972|468789968|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225596|NCT05067972|468789969|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
130225597|NCT05067972|468789970|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225598|NCT05067972|468789964|FG000|Part 1: Follow-up|Physician Decision|0|||
130225599|NCT05067972|468789965|FG001|Part 1: Follow-up|Physician Decision|0|||
130225600|NCT05067972|468789966|FG002|Part 1: Follow-up|Physician Decision|0|||
130225601|NCT05067972|468789967|FG003|Part 1: Follow-up|Physician Decision|1|||
130225602|NCT05067972|468789968|FG004|Part 1: Follow-up|Physician Decision|0|||
130225603|NCT05067972|468789969|FG005|Part 1: Follow-up|Physician Decision|0|||
130225604|NCT05067972|468789970|FG006|Part 1: Follow-up|Physician Decision|0|||
130225605|NCT05067972|468789964|FG000|Part 1: Follow-up|Death|1|||
130225606|NCT05067972|468789965|FG001|Part 1: Follow-up|Death|2|||
130225607|NCT05067972|468789966|FG002|Part 1: Follow-up|Death|1|||
130225608|NCT05067972|468789967|FG003|Part 1: Follow-up|Death|0|||
130225609|NCT05067972|468789968|FG004|Part 1: Follow-up|Death|1|||
130225610|NCT05067972|468789969|FG005|Part 1: Follow-up|Death|0|||
130225611|NCT05067972|468789970|FG006|Part 1: Follow-up|Death|1|||
130225612|NCT04391842|468789971|FG000|Overall Study|Withdrawal by Subject|2|||
130225613|NCT02287038|468789972|FG000|Overall Study|Stopped attending appointments|3|||
130225614|NCT02287038|468789973|FG001|Overall Study|Stopped attending appointments|2|||
130225615|NCT02287038|468789972|FG000|Overall Study|Anxiety after starting medication|0|||
130690449|NCT00927069|470493088|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
130690450|NCT00927069|470493089|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
130690451|NCT00927069|470493090|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
130690452|NCT00927069|470493087|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
130690453|NCT00927069|470493088|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
130690454|NCT00927069|470493089|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
130690455|NCT00927069|470493090|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
130690456|NCT00927069|470493087|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
130690457|NCT00927069|470493088|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
130690458|NCT00927069|470493089|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
130690459|NCT00927069|470493090|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
130690460|NCT00927069|470493087|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
130690461|NCT00927069|470493088|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690462|NCT00927069|470493089|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690463|NCT00927069|470493090|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690464|NCT02911792|470493091|FG000|Overall Study|Lost to Follow-up|3|||
130690465|NCT02911792|470493092|FG001|Overall Study|Lost to Follow-up|3|||
130690466|NCT02911792|470493093|FG002|Overall Study|Lost to Follow-up|3|||
130690467|NCT02911792|470493094|FG003|Overall Study|Lost to Follow-up|3|||
130690468|NCT01244620|470493097|FG000|Overall Study|Study terminated|4|||
130690469|NCT01244620|470493098|FG001|Overall Study|Study terminated|4|||
130690470|NCT01244620|470493099|FG002|Overall Study|Study terminated|4|||
130690471|NCT01244620|470493100|FG003|Overall Study|Study terminated|4|||
130690472|NCT01663233|470493102|FG000|Overall Study|Withdrawal by Subject|3|||
130690473|NCT01663233|470493103|FG001|Overall Study|Withdrawal by Subject|2|||
130690474|NCT01663233|470493102|FG000|Overall Study|Protocol Deviation|1|||
130690475|NCT01663233|470493103|FG001|Overall Study|Protocol Deviation|4|||
130690476|NCT01663233|470493102|FG000|Overall Study|Lost to Follow-up|0|||
130690477|NCT01663233|470493103|FG001|Overall Study|Lost to Follow-up|1|||
130690478|NCT02321098|470493104|FG000|12 Weeks Treament|Lost to Follow-up|1|||
130690479|NCT02321098|470493105|FG001|12 Weeks Treament|Lost to Follow-up|1|||
130690480|NCT02321098|470493106|FG002|12 Weeks Treament|Lost to Follow-up|0|||
130225616|NCT02287038|468789973|FG001|Overall Study|Anxiety after starting medication|1|||
130225617|NCT02287038|468789972|FG000|Overall Study|Nausea after starting medication|1|||
130225618|NCT02287038|468789973|FG001|Overall Study|Nausea after starting medication|0|||
130225619|NCT02287038|468789972|FG000|Overall Study|Abnormal ECG after starting medication|1|||
130225620|NCT02287038|468789973|FG001|Overall Study|Abnormal ECG after starting medication|0|||
130444368|NCT01154036|469588544|FG000|Phase II|Lost to Follow-up|0|||
130444369|NCT01154036|469588545|FG001|Phase II|Lost to Follow-up|0|||
130444370|NCT01154036|469588546|FG002|Phase II|Lost to Follow-up|0|||
130444371|NCT01154036|469588547|FG003|Phase II|Lost to Follow-up|1|||
130444372|NCT01154036|469588548|FG004|Phase II|Lost to Follow-up|2|||
130225621|NCT01676012|468789979|FG000|Overall Study|Adverse Event|2|||
130444373|NCT01154036|469588549|FG005|Phase II|Lost to Follow-up|0|||
130690481|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
130690482|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
130690483|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
130690484|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
130225622|NCT01676012|468789979|FG000|Overall Study|incomplete set of videos|1|||
130225623|NCT02667301|468790000|FG000|Overall Study|Adverse Event|1|||
130225624|NCT02667301|468790000|FG000|Overall Study|Lack of Efficacy|1|||
130225625|NCT02283658|468790001|FG000|Overall Study|Withdrawal by Subject|1|||
130225626|NCT03528551|468790003|FG000|Overall Study|Lost to Follow-up|0|||
130225627|NCT03528551|468790004|FG001|Overall Study|Lost to Follow-up|1|||
130225628|NCT03528551|468790005|FG002|Overall Study|Lost to Follow-up|0|||
130225629|NCT03528551|468790003|FG000|Overall Study|Transferred to other arm/group|2|||
130225630|NCT03528551|468790004|FG001|Overall Study|Transferred to other arm/group|3|||
130225631|NCT03528551|468790005|FG002|Overall Study|Transferred to other arm/group|0|||
130225632|NCT03528551|468790003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130225633|NCT03528551|468790004|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130225634|NCT03528551|468790005|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130225635|NCT03528551|468790003|FG000|Overall Study|Protocol Violation|0|||
130225636|NCT03528551|468790004|FG001|Overall Study|Protocol Violation|3|||
130225637|NCT03528551|468790005|FG002|Overall Study|Protocol Violation|0|||
130225638|NCT03528551|468790003|FG000|Overall Study|Withdrawal by Subject|0|||
130225639|NCT03528551|468790004|FG001|Overall Study|Withdrawal by Subject|7|||
130225640|NCT03528551|468790005|FG002|Overall Study|Withdrawal by Subject|0|||
130225641|NCT00689338|468790006|FG000|Overall Study|Death|65|||
130225642|NCT00689338|468790006|FG000|Overall Study|Adverse Event|13|||
130225643|NCT00689338|468790006|FG000|Overall Study|Insufficient Clinical Response|1|||
130225644|NCT00689338|468790006|FG000|Overall Study|Lack of Efficacy|6|||
130225645|NCT00689338|468790006|FG000|Overall Study|Other|8|||
130225646|NCT00689338|468790006|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
130225647|NCT00689338|468790006|FG000|Overall Study|Lost to Follow-up|5|||
130225648|NCT00689338|468790006|FG000|Overall Study|Withdrawal by Subject|3|||
130225649|NCT00689338|468790006|FG000|Overall Study|Protocol Violation|15|||
130225650|NCT00846586|468790007|FG000|Overall Study|Adverse Event|20|||
130225651|NCT00846586|468790008|FG001|Overall Study|Adverse Event|10|||
130225652|NCT00846586|468790007|FG000|Overall Study|Subject withdrew consent|8|||
130225653|NCT00846586|468790008|FG001|Overall Study|Subject withdrew consent|10|||
130225654|NCT00846586|468790007|FG000|Overall Study|Administrative problems|5|||
130225655|NCT00846586|468790008|FG001|Overall Study|Administrative problems|4|||
130225656|NCT00846586|468790007|FG000|Overall Study|Death|2|||
130225657|NCT00846586|468790008|FG001|Overall Study|Death|0|||
130225658|NCT00846586|468790007|FG000|Overall Study|Protocol deviation|2|||
130225659|NCT00846586|468790008|FG001|Overall Study|Protocol deviation|6|||
130225660|NCT00846586|468790007|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130225661|NCT00846586|468790008|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130225662|NCT00846586|468790007|FG000|Overall Study|Lost to Follow-up|1|||
130225663|NCT00846586|468790008|FG001|Overall Study|Lost to Follow-up|4|||
130225664|NCT00846586|468790007|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130225665|NCT00846586|468790008|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130225666|NCT01061606|468790009|FG000|Overall Study|Adverse Event|1|||
130225667|NCT01061606|468790009|FG000|Overall Study|Death|1|||
130225668|NCT01061606|468790009|FG000|Overall Study|Disease Progression|4|||
130225669|NCT01061606|468790009|FG000|Overall Study|alternative therapy|2|||
130225670|NCT00735007|468790010|FG000|Overall Study|Adverse Event|4|||
130225671|NCT00735007|468790010|FG000|Overall Study|Protocol Violation|1|||
130225672|NCT00715403|468790011|FG000|Overall Study|Progressive disease|0|||
130225673|NCT00715403|468790012|FG001|Overall Study|Progressive disease|1|||
130225674|NCT00715403|468790013|FG002|Overall Study|Progressive disease|3|||
130225675|NCT00715403|468790014|FG003|Overall Study|Progressive disease|9|||
130225676|NCT00715403|468790015|FG004|Overall Study|Progressive disease|5|||
130225677|NCT00715403|468790016|FG005|Overall Study|Progressive disease|14|||
130225678|NCT00715403|468790017|FG006|Overall Study|Progressive disease|1|||
130225679|NCT00715403|468790011|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225680|NCT00715403|468790012|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225681|NCT00715403|468790013|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225682|NCT00715403|468790014|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225683|NCT00715403|468790015|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
130444374|NCT01154036|469588550|FG006|Phase II|Lost to Follow-up|2|||
130444375|NCT01154036|469588551|FG007|Phase II|Lost to Follow-up|1|||
130444376|NCT01154036|469588544|FG000|Phase II|Protocol Violation|0|||
130444377|NCT01154036|469588545|FG001|Phase II|Protocol Violation|0|||
130444378|NCT01154036|469588546|FG002|Phase II|Protocol Violation|0|||
130444379|NCT01154036|469588547|FG003|Phase II|Protocol Violation|0|||
130444380|NCT01154036|469588548|FG004|Phase II|Protocol Violation|1|||
130444381|NCT01154036|469588549|FG005|Phase II|Protocol Violation|2|||
130444382|NCT01154036|469588550|FG006|Phase II|Protocol Violation|0|||
130444383|NCT01154036|469588551|FG007|Phase II|Protocol Violation|0|||
130444384|NCT01154036|469588544|FG000|Phase II|Withdrawal by Subject|0|||
130444385|NCT01154036|469588545|FG001|Phase II|Withdrawal by Subject|0|||
130690485|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
130690486|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
130690487|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130690488|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130225684|NCT00715403|468790016|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
130225685|NCT00715403|468790017|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225686|NCT00715403|468790011|FG000|Overall Study|Other Adverse Event than DLT|1|||
130225687|NCT00715403|468790012|FG001|Overall Study|Other Adverse Event than DLT|0|||
130444386|NCT01154036|469588546|FG002|Phase II|Withdrawal by Subject|0|||
130690489|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
130690490|NCT02558491|470493107|FG000|First Invention|Withdrawal by Subject|3|||
130690491|NCT02558491|470493108|FG001|First Invention|Withdrawal by Subject|1|||
130225688|NCT00715403|468790013|FG002|Overall Study|Other Adverse Event than DLT|0|||
130225689|NCT00715403|468790014|FG003|Overall Study|Other Adverse Event than DLT|0|||
130225690|NCT00715403|468790015|FG004|Overall Study|Other Adverse Event than DLT|0|||
130444387|NCT01154036|469588547|FG003|Phase II|Withdrawal by Subject|0|||
130444388|NCT01154036|469588548|FG004|Phase II|Withdrawal by Subject|4|||
130444389|NCT01154036|469588549|FG005|Phase II|Withdrawal by Subject|2|||
130225691|NCT00715403|468790016|FG005|Overall Study|Other Adverse Event than DLT|2|||
130690492|NCT02558491|470493107|FG000|First Invention|Data collection issues|1|||
130690493|NCT02558491|470493108|FG001|First Invention|Data collection issues|0|||
130690494|NCT02558491|470493107|FG000|First Invention|Stopping criteria|0|||
130690495|NCT02558491|470493108|FG001|First Invention|Stopping criteria|1|||
130690496|NCT02558491|470493107|FG000|First Invention|Changed parameters during trial|1|||
130690497|NCT02558491|470493108|FG001|First Invention|Changed parameters during trial|0|||
130690498|NCT02558491|470493107|FG000|Second Intervention|Withdrawal by Subject|1|||
130690499|NCT02558491|470493108|FG001|Second Intervention|Withdrawal by Subject|0|||
130690500|NCT02558491|470493107|FG000|Second Intervention|Stopping Criteria|1|||
130690501|NCT02558491|470493108|FG001|Second Intervention|Stopping Criteria|0|||
130690502|NCT00834431|470493111|FG000|First Intervention|Adverse Event|0|||
130690503|NCT00834431|470493112|FG001|First Intervention|Adverse Event|1|||
130690504|NCT00834431|470493111|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130690505|NCT00834431|470493112|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130690506|NCT05630885|470493116|FG000|Study Completion|Took prohibited medications|2|||
130690507|NCT05630885|470493117|FG001|Study Completion|Took prohibited medications|0|||
130690508|NCT05630885|470493116|FG000|Study Completion|Non-compliance with study drug|1|||
130690509|NCT05630885|470493117|FG001|Study Completion|Non-compliance with study drug|0|||
130444390|NCT01154036|469588550|FG006|Phase II|Withdrawal by Subject|5|||
130444391|NCT01154036|469588551|FG007|Phase II|Withdrawal by Subject|4|||
130444392|NCT04011384|469588561|FG000|Overall Study|Withdrawal by Subject|2|||
130444393|NCT04011384|469588562|FG001|Overall Study|Withdrawal by Subject|0|||
130225692|NCT00715403|468790017|FG006|Overall Study|Other Adverse Event than DLT|0|||
130225693|NCT00715403|468790011|FG000|Overall Study|Protocol Violation|0|||
130225694|NCT00715403|468790012|FG001|Overall Study|Protocol Violation|0|||
130225695|NCT00715403|468790013|FG002|Overall Study|Protocol Violation|0|||
130225696|NCT00715403|468790014|FG003|Overall Study|Protocol Violation|0|||
130225697|NCT00715403|468790015|FG004|Overall Study|Protocol Violation|0|||
130225698|NCT00715403|468790016|FG005|Overall Study|Protocol Violation|1|||
130225699|NCT00715403|468790017|FG006|Overall Study|Protocol Violation|0|||
130225700|NCT00715403|468790011|FG000|Overall Study|Other reason not defined above|0|||
130225701|NCT00715403|468790012|FG001|Overall Study|Other reason not defined above|0|||
130225702|NCT00715403|468790013|FG002|Overall Study|Other reason not defined above|1|||
130225703|NCT00715403|468790014|FG003|Overall Study|Other reason not defined above|0|||
130225704|NCT00715403|468790015|FG004|Overall Study|Other reason not defined above|1|||
130225705|NCT00715403|468790016|FG005|Overall Study|Other reason not defined above|1|||
130225706|NCT00715403|468790017|FG006|Overall Study|Other reason not defined above|0|||
130225707|NCT01789047|468790018|FG000|Overall Study|Adverse Event|3|||
130225708|NCT01789047|468790019|FG001|Overall Study|Adverse Event|2|||
130225709|NCT01789047|468790018|FG000|Overall Study|Withdrawal by Subject|1|||
130225710|NCT01789047|468790019|FG001|Overall Study|Withdrawal by Subject|2|||
130225711|NCT03644017|468790020|FG000|Overall Study|Access Abandonment|5|||
130225712|NCT03644017|468790020|FG000|Overall Study|Kidney Transplant|2|||
130225713|NCT02340000|468790023|FG000|Time Period 1|Withdrawal by Subject|6|||
130225714|NCT02340000|468790024|FG001|Time Period 1|Withdrawal by Subject|8|||
130225715|NCT02340000|468790023|FG000|Time Period 1|Lost to Follow-up|6|||
130225716|NCT02340000|468790024|FG001|Time Period 1|Lost to Follow-up|7|||
130225717|NCT02340000|468790023|FG000|Time Period 2|Withdrawal by Subject|9|||
130225718|NCT02340000|468790024|FG001|Time Period 2|Withdrawal by Subject|7|||
130225719|NCT02340000|468790023|FG000|Time Period 2|Lost to Follow-up|10|||
130225720|NCT02340000|468790024|FG001|Time Period 2|Lost to Follow-up|8|||
130225721|NCT01883895|468790029|FG000|Overall Study|Lost to Follow-up|2|||
130225722|NCT00073918|468790030|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
130225723|NCT00073918|468790030|FG000|Overall Study|Rapid disease progression|2|||
130225724|NCT00073918|468790030|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
130225725|NCT00919633|468790033|FG000|Overall Study|Adverse Event|1|||
130225726|NCT00919633|468790034|FG001|Overall Study|Adverse Event|9|||
130225727|NCT00919633|468790035|FG002|Overall Study|Adverse Event|12|||
130225728|NCT00919633|468790036|FG003|Overall Study|Adverse Event|10|||
130225729|NCT00919633|468790033|FG000|Overall Study|Death|0|||
130225730|NCT00919633|468790034|FG001|Overall Study|Death|0|||
130225731|NCT00919633|468790035|FG002|Overall Study|Death|2|||
130225732|NCT00919633|468790036|FG003|Overall Study|Death|0|||
130225733|NCT00919633|468790033|FG000|Overall Study|Lack of Efficacy|17|||
130225734|NCT00919633|468790034|FG001|Overall Study|Lack of Efficacy|3|||
130225735|NCT00919633|468790035|FG002|Overall Study|Lack of Efficacy|2|||
130225736|NCT00919633|468790036|FG003|Overall Study|Lack of Efficacy|3|||
130225737|NCT00919633|468790033|FG000|Overall Study|Withdrawal by Subject|1|||
130225738|NCT00919633|468790034|FG001|Overall Study|Withdrawal by Subject|2|||
130225739|NCT00919633|468790035|FG002|Overall Study|Withdrawal by Subject|4|||
130225740|NCT00919633|468790036|FG003|Overall Study|Withdrawal by Subject|3|||
130225741|NCT00919633|468790033|FG000|Overall Study|Lost to Follow-up|3|||
130225742|NCT00919633|468790034|FG001|Overall Study|Lost to Follow-up|1|||
130225743|NCT00919633|468790035|FG002|Overall Study|Lost to Follow-up|0|||
130225744|NCT00919633|468790036|FG003|Overall Study|Lost to Follow-up|2|||
130225745|NCT00919633|468790033|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
130225746|NCT00919633|468790034|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
130444394|NCT01686932|469588563|FG000|Period 1|Adverse Event|1|||
130444395|NCT01686932|469588564|FG001|Period 1|Adverse Event|1|||
130690510|NCT05630885|470493116|FG000|Study Completion|Adverse Event|1|||
130690511|NCT05630885|470493117|FG001|Study Completion|Adverse Event|0|||
130225747|NCT00919633|468790035|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
130225748|NCT00919633|468790036|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
130225749|NCT00919633|468790033|FG000|Overall Study|Protocol Violation|0|||
130225750|NCT00919633|468790034|FG001|Overall Study|Protocol Violation|0|||
130225751|NCT00919633|468790035|FG002|Overall Study|Protocol Violation|0|||
130225752|NCT00919633|468790036|FG003|Overall Study|Protocol Violation|1|||
130225753|NCT00919633|468790033|FG000|Overall Study|Physician Decision|0|||
130225754|NCT00919633|468790034|FG001|Overall Study|Physician Decision|0|||
130444396|NCT01364727|469588567|FG000|Overall Study|Not Eligible|2|||
130444397|NCT04716881|469588568|FG000|Overall Study|Adverse Event|1|||
130225755|NCT00919633|468790035|FG002|Overall Study|Physician Decision|0|||
130225756|NCT00919633|468790036|FG003|Overall Study|Physician Decision|1|||
130225757|NCT00919633|468790033|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
130225758|NCT00919633|468790034|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
130225759|NCT00919633|468790035|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
130225760|NCT00919633|468790036|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
130225761|NCT00919633|468790033|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
130225762|NCT00919633|468790034|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
130225763|NCT00919633|468790035|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
130225764|NCT00919633|468790036|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
130225765|NCT02481050|468791699|FG000|Overall Study|Adverse Event|1|||
130225766|NCT02481050|468791699|FG000|Overall Study|Disease Progression|47|||
130225767|NCT02481050|468791699|FG000|Overall Study|Withdrawal by Subject|7|||
130225768|NCT02481050|468791699|FG000|Overall Study|Other|3|||
130225769|NCT03246347|468791702|FG000|Overall Study|On Study|23|||
130225770|NCT02188160|468791703|FG000|Overall Study|Adverse Event|1|||
130225771|NCT02188160|468791704|FG001|Overall Study|Adverse Event|0|||
130225772|NCT02188160|468791703|FG000|Overall Study|Use of an excluded medication|0|||
130225773|NCT02188160|468791704|FG001|Overall Study|Use of an excluded medication|1|||
130225774|NCT04113694|468791705|FG000|Overall Study|Adverse Event|2|||
130225775|NCT04113694|468791705|FG000|Overall Study|Lost to Follow-up|2|||
130225776|NCT04113694|468791705|FG000|Overall Study|Withdrawal by Subject|6|||
130225777|NCT04113694|468791705|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
130225778|NCT01022203|468791712|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
130225779|NCT01022203|468791713|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
130225780|NCT01022203|468791712|FG000|Post Treatment Assessment|Physician Decision|2|||
130225781|NCT01022203|468791713|FG001|Post Treatment Assessment|Physician Decision|0|||
130225782|NCT01022203|468791712|FG000|Post Treatment Assessment|Adverse Event|0|||
130225783|NCT01022203|468791713|FG001|Post Treatment Assessment|Adverse Event|2|||
130225784|NCT01022203|468791712|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
130225785|NCT01022203|468791713|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
130225786|NCT03638128|468791716|FG000|Overall Study|Withdrawal by Subject|1|||
130225787|NCT03638128|468791717|FG001|Overall Study|Withdrawal by Subject|7|||
130225788|NCT03638128|468791718|FG002|Overall Study|Withdrawal by Subject|6|||
130225789|NCT03638128|468791716|FG000|Overall Study|Sponsor Decision|15|||
130225790|NCT03638128|468791717|FG001|Overall Study|Sponsor Decision|12|||
130225791|NCT03638128|468791718|FG002|Overall Study|Sponsor Decision|19|||
130225792|NCT03638128|468791716|FG000|Overall Study|Lost to Follow-up|0|||
130225793|NCT03638128|468791717|FG001|Overall Study|Lost to Follow-up|0|||
130225794|NCT03638128|468791718|FG002|Overall Study|Lost to Follow-up|1|||
130225795|NCT00903201|468791720|FG000|Overall Study|Adverse Event|1|||
130225796|NCT00903201|468791721|FG001|Overall Study|Adverse Event|4|||
130225797|NCT00903201|468791722|FG002|Overall Study|Adverse Event|0|||
130225798|NCT00903201|468791720|FG000|Overall Study|Protocol Violation|2|||
130225799|NCT00903201|468791721|FG001|Overall Study|Protocol Violation|1|||
130225800|NCT00903201|468791722|FG002|Overall Study|Protocol Violation|0|||
130225801|NCT00903201|468791720|FG000|Overall Study|Lost to Follow-up|0|||
130225802|NCT00903201|468791721|FG001|Overall Study|Lost to Follow-up|1|||
130225803|NCT00903201|468791722|FG002|Overall Study|Lost to Follow-up|0|||
130225804|NCT00903201|468791720|FG000|Overall Study|Physician Decision|1|||
130225805|NCT00903201|468791721|FG001|Overall Study|Physician Decision|0|||
130225806|NCT00903201|468791722|FG002|Overall Study|Physician Decision|1|||
130225807|NCT00903201|468791720|FG000|Overall Study|Withdrawal by Subject|1|||
130225808|NCT00903201|468791721|FG001|Overall Study|Withdrawal by Subject|0|||
130225809|NCT00903201|468791722|FG002|Overall Study|Withdrawal by Subject|1|||
130225810|NCT00329108|468791723|FG000|Overall Study|Adverse Event|2|||
130225811|NCT00329108|468791724|FG001|Overall Study|Adverse Event|2|||
130225812|NCT00329108|468791723|FG000|Overall Study|Lack of Efficacy|3|||
130225813|NCT00329108|468791724|FG001|Overall Study|Lack of Efficacy|3|||
130225814|NCT00329108|468791723|FG000|Overall Study|Withdrawal by Subject|0|||
130225815|NCT00329108|468791724|FG001|Overall Study|Withdrawal by Subject|2|||
130225816|NCT00329108|468791723|FG000|Overall Study|symptomatic deterioration|1|||
130225817|NCT00329108|468791724|FG001|Overall Study|symptomatic deterioration|1|||
130225818|NCT00329108|468791723|FG000|Overall Study|Subject no longer willing to participate|2|||
130225819|NCT00329108|468791724|FG001|Overall Study|Subject no longer willing to participate|2|||
130225820|NCT00329108|468791723|FG000|Overall Study|study terminated by sponsor|1|||
130225821|NCT00329108|468791724|FG001|Overall Study|study terminated by sponsor|0|||
130225822|NCT00329108|468791723|FG000|Overall Study|withdrew patient after SAE resolved|1|||
130225823|NCT00329108|468791724|FG001|Overall Study|withdrew patient after SAE resolved|0|||
130225824|NCT00329108|468791723|FG000|Overall Study|Protocol Violation|0|||
130225825|NCT00329108|468791724|FG001|Overall Study|Protocol Violation|2|||
130225826|NCT01094288|468791727|FG000|Overall Study|Adverse Event|0|||
130225827|NCT01094288|468791728|FG001|Overall Study|Adverse Event|3|||
130225828|NCT01094288|468791729|FG002|Overall Study|Adverse Event|1|||
130225829|NCT01094288|468791730|FG003|Overall Study|Adverse Event|1|||
130225830|NCT01094288|468791731|FG004|Overall Study|Adverse Event|0|||
130225831|NCT01094288|468791732|FG005|Overall Study|Adverse Event|0|||
130225832|NCT01094288|468791733|FG006|Overall Study|Adverse Event|0|||
130225833|NCT01094288|468791734|FG007|Overall Study|Adverse Event|0|||
130225834|NCT01094288|468791727|FG000|Overall Study|Withdrawal by Subject|0|||
130225835|NCT01094288|468791728|FG001|Overall Study|Withdrawal by Subject|1|||
130225836|NCT01094288|468791729|FG002|Overall Study|Withdrawal by Subject|2|||
130225837|NCT01094288|468791730|FG003|Overall Study|Withdrawal by Subject|0|||
130225838|NCT01094288|468791731|FG004|Overall Study|Withdrawal by Subject|0|||
130225839|NCT01094288|468791732|FG005|Overall Study|Withdrawal by Subject|0|||
130225840|NCT01094288|468791733|FG006|Overall Study|Withdrawal by Subject|0|||
130225841|NCT01094288|468791734|FG007|Overall Study|Withdrawal by Subject|2|||
130225842|NCT01094288|468791727|FG000|Overall Study|Initiation of Alternative Therapy|0|||
130225843|NCT01094288|468791728|FG001|Overall Study|Initiation of Alternative Therapy|0|||
130225844|NCT01094288|468791729|FG002|Overall Study|Initiation of Alternative Therapy|1|||
130225845|NCT01094288|468791730|FG003|Overall Study|Initiation of Alternative Therapy|0|||
130225846|NCT01094288|468791731|FG004|Overall Study|Initiation of Alternative Therapy|0|||
130225847|NCT01094288|468791732|FG005|Overall Study|Initiation of Alternative Therapy|0|||
130225848|NCT01094288|468791733|FG006|Overall Study|Initiation of Alternative Therapy|0|||
130225849|NCT01094288|468791734|FG007|Overall Study|Initiation of Alternative Therapy|0|||
130225850|NCT01094288|468791727|FG000|Overall Study|Reason not Specified|2|||
130225851|NCT01094288|468791728|FG001|Overall Study|Reason not Specified|3|||
130225852|NCT01094288|468791729|FG002|Overall Study|Reason not Specified|0|||
130225853|NCT01094288|468791730|FG003|Overall Study|Reason not Specified|1|||
130225854|NCT01094288|468791731|FG004|Overall Study|Reason not Specified|0|||
130690512|NCT05630885|470493116|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
130690513|NCT05630885|470493117|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
130690514|NCT05630885|470493116|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
130690515|NCT05630885|470493117|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
130690516|NCT06539676|470493118|FG000|Overall Study|Early study termination|1|||
130690517|NCT06539676|470493119|FG001|Overall Study|Early study termination|0|||
130690518|NCT06539676|470493120|FG002|Overall Study|Early study termination|6|||
130690519|NCT02645409|470493121|FG000|Overall Study|Withdrawal by Subject|3|||
130690520|NCT02645409|470493122|FG001|Overall Study|Withdrawal by Subject|0|||
130690521|NCT02645409|470493121|FG000|Overall Study|Physician Decision|1|||
130690522|NCT02645409|470493122|FG001|Overall Study|Physician Decision|0|||
130690523|NCT03419403|470493123|FG000|Overall Study|Withdrawal by Subject|5|||
130690524|NCT03419403|470493124|FG001|Overall Study|Withdrawal by Subject|2|||
130690525|NCT03419403|470493125|FG002|Overall Study|Withdrawal by Subject|5|||
130690526|NCT03419403|470493126|FG003|Overall Study|Withdrawal by Subject|1|||
130690527|NCT03419403|470493123|FG000|Overall Study|Progressive disease (per protocol)|0|||
130690528|NCT03419403|470493124|FG001|Overall Study|Progressive disease (per protocol)|2|||
130690529|NCT03419403|470493125|FG002|Overall Study|Progressive disease (per protocol)|2|||
130690530|NCT03419403|470493126|FG003|Overall Study|Progressive disease (per protocol)|0|||
130690531|NCT03419403|470493123|FG000|Overall Study|Other, not specified|6|||
130690532|NCT03419403|470493124|FG001|Overall Study|Other, not specified|4|||
130690533|NCT03419403|470493125|FG002|Overall Study|Other, not specified|5|||
130690534|NCT03419403|470493126|FG003|Overall Study|Other, not specified|1|||
130690535|NCT03419403|470493123|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
130225855|NCT01094288|468791732|FG005|Overall Study|Reason not Specified|0|||
130225856|NCT01094288|468791733|FG006|Overall Study|Reason not Specified|0|||
130225857|NCT01094288|468791734|FG007|Overall Study|Reason not Specified|0|||
130225858|NCT01094288|468791727|FG000|Overall Study|Ongoing Participants|0|||
130225859|NCT01094288|468791728|FG001|Overall Study|Ongoing Participants|3|||
130225860|NCT01094288|468791729|FG002|Overall Study|Ongoing Participants|0|||
130225861|NCT01094288|468791730|FG003|Overall Study|Ongoing Participants|0|||
130225862|NCT01094288|468791731|FG004|Overall Study|Ongoing Participants|0|||
130225863|NCT01094288|468791732|FG005|Overall Study|Ongoing Participants|0|||
130225864|NCT01094288|468791733|FG006|Overall Study|Ongoing Participants|0|||
130225865|NCT01094288|468791734|FG007|Overall Study|Ongoing Participants|0|||
130225866|NCT02611882|468791735|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
130225867|NCT02611882|468791736|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130225868|NCT02611882|468791737|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130225869|NCT01389232|468791738|FG000|Overall Study|Had scaffold removed|15|||
130225870|NCT01389232|468791738|FG000|Overall Study|Personal reasons|2|||
130225871|NCT01389232|468791738|FG000|Overall Study|Adverse Event|1|||
130225872|NCT01389232|468791738|FG000|Overall Study|Death|1|||
130225873|NCT01317940|468791739|FG000|Overall Study|Death|1|||
130225874|NCT01317940|468791740|FG001|Overall Study|Death|0|||
130225875|NCT01317940|468791741|FG002|Overall Study|Death|1|||
130225876|NCT01317940|468791742|FG003|Overall Study|Death|0|||
130225877|NCT01317940|468791743|FG004|Overall Study|Death|0|||
130225878|NCT01317940|468791744|FG005|Overall Study|Death|0|||
130225879|NCT01317940|468791739|FG000|Overall Study|Lost to Follow-up|0|||
130225880|NCT01317940|468791740|FG001|Overall Study|Lost to Follow-up|0|||
130225881|NCT01317940|468791741|FG002|Overall Study|Lost to Follow-up|1|||
130225882|NCT01317940|468791742|FG003|Overall Study|Lost to Follow-up|1|||
130225883|NCT01317940|468791743|FG004|Overall Study|Lost to Follow-up|1|||
130225884|NCT01317940|468791744|FG005|Overall Study|Lost to Follow-up|0|||
130225885|NCT01317940|468791739|FG000|Overall Study|Change in therapy plan|0|||
130225886|NCT01317940|468791740|FG001|Overall Study|Change in therapy plan|0|||
130225887|NCT01317940|468791741|FG002|Overall Study|Change in therapy plan|3|||
130225888|NCT01317940|468791742|FG003|Overall Study|Change in therapy plan|0|||
130225889|NCT01317940|468791743|FG004|Overall Study|Change in therapy plan|0|||
130225890|NCT01317940|468791744|FG005|Overall Study|Change in therapy plan|0|||
130225891|NCT02371616|468791746|FG000|Overall Study|Protocol Violation|2|||
130225892|NCT02371616|468791747|FG001|Overall Study|Protocol Violation|1|||
130225893|NCT02371616|468791746|FG000|Overall Study|Adverse Event|0|||
130225894|NCT02371616|468791747|FG001|Overall Study|Adverse Event|1|||
130225895|NCT02371616|468791746|FG000|Overall Study|Withdrawal of Consent|1|||
130225896|NCT02371616|468791747|FG001|Overall Study|Withdrawal of Consent|0|||
130225897|NCT02371616|468791746|FG000|Overall Study|Other (Not specified)|1|||
130225898|NCT02371616|468791747|FG001|Overall Study|Other (Not specified)|5|||
130225899|NCT00754741|468791748|FG000|Overall Study|Died or disenrolled|57|||
130225900|NCT00754741|468791749|FG001|Overall Study|Died or disenrolled|69|||
130225901|NCT00754741|468791750|FG002|Overall Study|Died or disenrolled|54|||
130225902|NCT04152200|468791752|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
130225903|NCT04152200|468791753|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
130225904|NCT00593814|468791754|FG000|Overall Study|Death|7|||
130225905|NCT00593814|468791755|FG001|Overall Study|Death|0|||
130225906|NCT00593814|468791754|FG000|Overall Study|Withdrawal by Subject|7|||
130225907|NCT00593814|468791755|FG001|Overall Study|Withdrawal by Subject|0|||
130225908|NCT00593814|468791754|FG000|Overall Study|Lost to Follow-up|7|||
130225909|NCT00593814|468791755|FG001|Overall Study|Lost to Follow-up|0|||
130225910|NCT00593814|468791754|FG000|Overall Study|Physician Decision|3|||
130225911|NCT00593814|468791755|FG001|Overall Study|Physician Decision|0|||
130225912|NCT02699996|468791756|FG000|Overall Study|Withdrawal by Subject|5|||
130225913|NCT02699996|468791757|FG001|Overall Study|Withdrawal by Subject|2|||
130225914|NCT04069715|468791758|FG000|Overall Study|Lost to Follow-up|1|||
130225915|NCT04069715|468791759|FG001|Overall Study|Lost to Follow-up|1|||
130225916|NCT04069715|468791758|FG000|Overall Study|Physician Decision|1|||
130225917|NCT04069715|468791759|FG001|Overall Study|Physician Decision|1|||
130225918|NCT04069715|468791758|FG000|Overall Study|Withdrawal by Subject|3|||
130444398|NCT04716881|469588568|FG000|Overall Study|Lost to Follow-up|1|||
130444399|NCT01558674|469588569|FG000|Part 1|Study Terminated by Sponsor|10|||
130444400|NCT01558674|469588570|FG001|Part 1|Study Terminated by Sponsor|0|||
130690536|NCT03419403|470493124|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
130225919|NCT04069715|468791759|FG001|Overall Study|Withdrawal by Subject|3|||
130444401|NCT01558674|469588569|FG000|Part 1|Withdrawal by Subject|1|||
130225920|NCT03205150|468791760|FG000|Overall Study|Protocol deviation|1|||
130225921|NCT03205150|468791761|FG001|Overall Study|Protocol deviation|3|||
130225922|NCT03205150|468791762|FG002|Overall Study|Protocol deviation|0|||
130225923|NCT03205150|468791760|FG000|Overall Study|Patient/guardian decision|0|||
130690537|NCT03419403|470493125|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
130225924|NCT03205150|468791761|FG001|Overall Study|Patient/guardian decision|3|||
130225925|NCT03205150|468791762|FG002|Overall Study|Patient/guardian decision|0|||
130444402|NCT01558674|469588570|FG001|Part 1|Withdrawal by Subject|0|||
130225926|NCT03205150|468791760|FG000|Overall Study|Adverse Event|1|||
130225927|NCT03205150|468791761|FG001|Overall Study|Adverse Event|1|||
130225928|NCT03205150|468791762|FG002|Overall Study|Adverse Event|1|||
130225929|NCT03205150|468791760|FG000|Overall Study|Lost to Follow-up|0|||
130225930|NCT03205150|468791761|FG001|Overall Study|Lost to Follow-up|0|||
130225931|NCT03205150|468791762|FG002|Overall Study|Lost to Follow-up|1|||
130225932|NCT02723188|468791763|FG000|Overall Study|Withdrawal by Subject|1|||
130225933|NCT02723188|468791764|FG001|Overall Study|Withdrawal by Subject|0|||
130225934|NCT02723188|468791765|FG002|Overall Study|Withdrawal by Subject|0|||
130225935|NCT01095835|468791766|FG000|Overall Study|Adverse Event|8|||
130225936|NCT01095835|468791767|FG001|Overall Study|Adverse Event|6|||
130225937|NCT01095835|468791768|FG002|Overall Study|Adverse Event|6|||
130225938|NCT01095835|468791766|FG000|Overall Study|Lack of Efficacy|0|||
130225939|NCT01095835|468791767|FG001|Overall Study|Lack of Efficacy|1|||
130225940|NCT01095835|468791768|FG002|Overall Study|Lack of Efficacy|0|||
130225941|NCT01095835|468791766|FG000|Overall Study|Physician Decision|0|||
130225942|NCT01095835|468791767|FG001|Overall Study|Physician Decision|0|||
130225943|NCT01095835|468791768|FG002|Overall Study|Physician Decision|1|||
130225944|NCT01095835|468791766|FG000|Overall Study|Withdrawal by Subject|1|||
130225945|NCT01095835|468791767|FG001|Overall Study|Withdrawal by Subject|3|||
130225946|NCT01095835|468791768|FG002|Overall Study|Withdrawal by Subject|0|||
130225947|NCT01095835|468791766|FG000|Overall Study|Non study compliance|0|||
130225948|NCT01095835|468791767|FG001|Overall Study|Non study compliance|0|||
130225949|NCT01095835|468791768|FG002|Overall Study|Non study compliance|1|||
130225950|NCT01095835|468791766|FG000|Overall Study|Protocol Violation|1|||
130225951|NCT01095835|468791767|FG001|Overall Study|Protocol Violation|2|||
130225952|NCT01095835|468791768|FG002|Overall Study|Protocol Violation|0|||
130225953|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
130225954|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130225955|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130225956|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
130225957|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
130225958|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
130225959|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
130225960|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
130225961|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
130225962|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
130225963|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130225964|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130225965|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130225966|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
130225967|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130225968|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
130225969|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
130225970|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
130225971|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
130225972|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
130225973|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
130225974|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
130225975|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130225976|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130225977|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
130225978|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
130225979|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
130225980|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
130225981|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
130225982|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
130225983|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
130225984|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130225985|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130225986|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
130225987|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130225988|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130225989|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130225990|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
130225991|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130225992|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
130225993|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
130225994|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
130225995|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
130225996|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
130225997|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
130225998|NCT00789321|468791777|FG000|Overall Study|Adverse Event|0|||
130225999|NCT00789321|468791778|FG001|Overall Study|Adverse Event|1|||
130226000|NCT03652818|468791782|FG000|Overall Study|Adverse Event|1|||
130226001|NCT03652818|468791783|FG001|Overall Study|Adverse Event|0|||
130226002|NCT03652818|468791784|FG002|Overall Study|Adverse Event|0|||
130226003|NCT03652818|468791785|FG003|Overall Study|Adverse Event|0|||
130226004|NCT03652818|468791786|FG004|Overall Study|Adverse Event|0|||
130226005|NCT03652818|468791782|FG000|Overall Study|Physician Decision|1|||
130226006|NCT03652818|468791783|FG001|Overall Study|Physician Decision|0|||
130226007|NCT03652818|468791784|FG002|Overall Study|Physician Decision|0|||
130226008|NCT03652818|468791785|FG003|Overall Study|Physician Decision|0|||
130226009|NCT03652818|468791786|FG004|Overall Study|Physician Decision|0|||
130226010|NCT03652818|468791782|FG000|Overall Study|Lost to Follow-up|0|||
130226011|NCT03652818|468791783|FG001|Overall Study|Lost to Follow-up|1|||
130226012|NCT03652818|468791784|FG002|Overall Study|Lost to Follow-up|2|||
130226013|NCT03652818|468791785|FG003|Overall Study|Lost to Follow-up|1|||
130226014|NCT03652818|468791786|FG004|Overall Study|Lost to Follow-up|1|||
130226015|NCT01930539|468791791|FG000|Overall Study|Withdrawal by Subject|2|||
130226016|NCT01930539|468791792|FG001|Overall Study|Withdrawal by Subject|2|||
130226017|NCT00830219|468791793|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130226018|NCT00830219|468791794|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130226019|NCT01811732|468791795|FG000|Overall Study|Lost to Follow-up|24|||
130226020|NCT01811732|468791796|FG001|Overall Study|Lost to Follow-up|30|||
130226021|NCT01811732|468791795|FG000|Overall Study|Withdrawal by Subject|16|||
130226022|NCT01811732|468791796|FG001|Overall Study|Withdrawal by Subject|10|||
130226023|NCT01811732|468791795|FG000|Overall Study|Adverse Event|3|||
130226024|NCT01811732|468791796|FG001|Overall Study|Adverse Event|9|||
130226025|NCT01811732|468791795|FG000|Overall Study|Lack of Efficacy|3|||
130226026|NCT01811732|468791796|FG001|Overall Study|Lack of Efficacy|1|||
130226027|NCT01811732|468791795|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
130226028|NCT01811732|468791796|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
130226029|NCT01811732|468791795|FG000|Overall Study|Physician Decision|2|||
130226030|NCT01811732|468791796|FG001|Overall Study|Physician Decision|0|||
130226031|NCT01811732|468791795|FG000|Overall Study|Death|1|||
130226032|NCT01811732|468791796|FG001|Overall Study|Death|1|||
130226033|NCT01811732|468791795|FG000|Overall Study|Insufficient venous access|0|||
130226034|NCT01811732|468791796|FG001|Overall Study|Insufficient venous access|1|||
130226035|NCT01811732|468791795|FG000|Overall Study|Protocol Violation|0|||
130226036|NCT01811732|468791796|FG001|Overall Study|Protocol Violation|1|||
130226037|NCT01811732|468791795|FG000|Overall Study|Subject incarcerated|1|||
130226038|NCT01811732|468791796|FG001|Overall Study|Subject incarcerated|2|||
130226039|NCT01811732|468791795|FG000|Overall Study|Admitted to another facility|1|||
130226040|NCT01811732|468791796|FG001|Overall Study|Admitted to another facility|0|||
130226041|NCT01811732|468791795|FG000|Overall Study|Correct study drug not available on site|1|||
130226042|NCT01811732|468791796|FG001|Overall Study|Correct study drug not available on site|0|||
130226043|NCT00288912|468791799|FG000|Overall Study|Developed exclusion criterion|4|||
130226044|NCT00288912|468791800|FG001|Overall Study|Developed exclusion criterion|6|||
130226045|NCT00288912|468791801|FG002|Overall Study|Developed exclusion criterion|7|||
130226046|NCT00288912|468791799|FG000|Overall Study|Lost to Follow-up|9|||
130226047|NCT00288912|468791800|FG001|Overall Study|Lost to Follow-up|6|||
130226048|NCT00288912|468791801|FG002|Overall Study|Lost to Follow-up|9|||
130226049|NCT00288912|468791799|FG000|Overall Study|Withdrawal by Subject|4|||
130226050|NCT00288912|468791800|FG001|Overall Study|Withdrawal by Subject|5|||
130226051|NCT00288912|468791801|FG002|Overall Study|Withdrawal by Subject|12|||
130226052|NCT01868646|468791802|FG000|Overall Study|Do not meet inclusion criteria|3|||
130444403|NCT04147260|469588571|FG000|Overall Study|Adverse Event|1|||
130444404|NCT04147260|469588572|FG001|Overall Study|Adverse Event|0|||
130444405|NCT04147260|469588573|FG002|Overall Study|Adverse Event|1|||
130444406|NCT04147260|469588574|FG003|Overall Study|Adverse Event|2|||
130444407|NCT04147260|469588575|FG004|Overall Study|Adverse Event|0|||
130444408|NCT04147260|469588571|FG000|Overall Study|Withdrawal by Subject|0|||
130444409|NCT04147260|469588572|FG001|Overall Study|Withdrawal by Subject|0|||
130444410|NCT04147260|469588573|FG002|Overall Study|Withdrawal by Subject|1|||
130444411|NCT04147260|469588574|FG003|Overall Study|Withdrawal by Subject|1|||
130444412|NCT04147260|469588575|FG004|Overall Study|Withdrawal by Subject|0|||
130444413|NCT01734850|469588580|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
130444414|NCT01734850|469588581|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
130226053|NCT01868646|468791803|FG001|Overall Study|Do not meet inclusion criteria|5|||
130226054|NCT01783743|468791808|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
130226055|NCT01783743|468791809|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
130226056|NCT01783743|468791808|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
130444415|NCT01734850|469588582|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
130226057|NCT01783743|468791809|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
130226058|NCT01783743|468791808|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
130226059|NCT01783743|468791809|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
130226060|NCT01607593|468791810|FG000|Overall Study|Adverse Event|15|||
130226061|NCT01607593|468791810|FG000|Overall Study|Lack of Efficacy|16|||
130226062|NCT01607593|468791810|FG000|Overall Study|Lost to Follow-up|25|||
130226063|NCT01607593|468791810|FG000|Overall Study|Continuation|33|||
130226064|NCT01607593|468791810|FG000|Overall Study|Other|4|||
130226065|NCT02771275|468791811|FG000|Overall Study|Reoperation|3|||
130226066|NCT02771275|468791811|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
130226067|NCT00728494|468791824|FG000|Overall Study|Adverse Event|7|||
130226068|NCT00728494|468791825|FG001|Overall Study|Adverse Event|0|||
130226069|NCT00728494|468791824|FG000|Overall Study|Withdrawal by Subject|0|||
130226070|NCT00728494|468791825|FG001|Overall Study|Withdrawal by Subject|2|||
130226071|NCT00728494|468791824|FG000|Overall Study|Lack of Efficacy|2|||
130226072|NCT00728494|468791825|FG001|Overall Study|Lack of Efficacy|4|||
130226073|NCT00728494|468791824|FG000|Overall Study|No data available|0|||
130226074|NCT00728494|468791825|FG001|Overall Study|No data available|1|||
130226075|NCT03439137|468791826|FG000|Overall Study|Adverse Event|16|||
130226076|NCT03439137|468791827|FG001|Overall Study|Adverse Event|12|||
130226077|NCT03439137|468791826|FG000|Overall Study|Physician Decision|0|||
130226078|NCT03439137|468791827|FG001|Overall Study|Physician Decision|5|||
130226079|NCT03439137|468791826|FG000|Overall Study|Withdrawal by Subject|14|||
130226080|NCT03439137|468791827|FG001|Overall Study|Withdrawal by Subject|4|||
130226081|NCT03439137|468791826|FG000|Overall Study|Conducting rescue therapy|2|||
130226082|NCT03439137|468791827|FG001|Overall Study|Conducting rescue therapy|1|||
130226083|NCT03439137|468791826|FG000|Overall Study|Difficult to control Hb|10|||
130226084|NCT03439137|468791827|FG001|Overall Study|Difficult to control Hb|2|||
130226085|NCT03439137|468791826|FG000|Overall Study|Initiation of a renal transplant|0|||
130226086|NCT03439137|468791827|FG001|Overall Study|Initiation of a renal transplant|2|||
130226087|NCT01240382|468791829|FG000|Overall Study|Adverse Event|2|||
130226088|NCT01240382|468791830|FG001|Overall Study|Adverse Event|1|||
130226089|NCT01240382|468791829|FG000|Overall Study|Lack of Efficacy|0|||
130226090|NCT01240382|468791830|FG001|Overall Study|Lack of Efficacy|2|||
130226091|NCT01240382|468791829|FG000|Overall Study|Fear of adverse events|0|||
130226092|NCT01240382|468791830|FG001|Overall Study|Fear of adverse events|1|||
130226093|NCT02456727|468791831|FG000|Overall Study|Lost to Follow-up|63|||
130226094|NCT02456727|468791832|FG001|Overall Study|Lost to Follow-up|65|||
130226095|NCT02456727|468791831|FG000|Overall Study|Death|2|||
130226096|NCT02456727|468791832|FG001|Overall Study|Death|1|||
130226097|NCT02456727|468791831|FG000|Overall Study|Withdrawal by Subject|1|||
130226098|NCT02456727|468791832|FG001|Overall Study|Withdrawal by Subject|10|||
130226099|NCT02456727|468791831|FG000|Overall Study|Never Initiated Treatment|43|||
130226100|NCT02456727|468791832|FG001|Overall Study|Never Initiated Treatment|30|||
130226101|NCT02643693|468791833|FG000|Overall Study|Physician Decision|0|||
130226102|NCT02643693|468791834|FG001|Overall Study|Physician Decision|1|||
130226103|NCT02643693|468791835|FG002|Overall Study|Physician Decision|0|||
130226104|NCT02643693|468791836|FG003|Overall Study|Physician Decision|0|||
130226105|NCT02643693|468791837|FG004|Overall Study|Physician Decision|0|||
130226106|NCT02643693|468791838|FG005|Overall Study|Physician Decision|0|||
130226107|NCT02643693|468791833|FG000|Overall Study|Withdrawal by Subject|0|||
130226108|NCT02643693|468791834|FG001|Overall Study|Withdrawal by Subject|1|||
130226109|NCT02643693|468791835|FG002|Overall Study|Withdrawal by Subject|0|||
130226110|NCT02643693|468791836|FG003|Overall Study|Withdrawal by Subject|0|||
130226111|NCT02643693|468791837|FG004|Overall Study|Withdrawal by Subject|0|||
130226112|NCT02643693|468791838|FG005|Overall Study|Withdrawal by Subject|0|||
130226113|NCT02643693|468791833|FG000|Overall Study|Protocol Adherence Issues|2|||
130226114|NCT02643693|468791834|FG001|Overall Study|Protocol Adherence Issues|0|||
130226115|NCT02643693|468791835|FG002|Overall Study|Protocol Adherence Issues|1|||
130226116|NCT02643693|468791836|FG003|Overall Study|Protocol Adherence Issues|0|||
130226117|NCT02643693|468791837|FG004|Overall Study|Protocol Adherence Issues|0|||
130226118|NCT02643693|468791838|FG005|Overall Study|Protocol Adherence Issues|1|||
130226119|NCT00888654|468791839|FG000|Overall Study|Problems swallowing oral meds.|1|||
130226120|NCT00888654|468791839|FG000|Overall Study|Not enough oral meds before surgery|3|||
130226121|NCT00888654|468791839|FG000|Overall Study|Surgery aborted|2|||
130226122|NCT00888654|468791839|FG000|Overall Study|Withdrawal by Subject|1|||
130226123|NCT00888654|468791839|FG000|Overall Study|Inelig. due to contraindication of med|1|||
130226124|NCT00888654|468791839|FG000|Overall Study|Change in surg date|1|||
130226125|NCT00888654|468791839|FG000|Overall Study|Stopped meds due to headaches|1|||
130226126|NCT03829462|468791843|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
130226127|NCT03829462|468791844|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
130226128|NCT03829462|468791843|FG000|Overall Study|No treatment due to progression disease|0|||
130226129|NCT03829462|468791844|FG001|Overall Study|No treatment due to progression disease|1|||
130226130|NCT00791999|468791846|FG000|Overall Study|Protocol planed withdrawal|14|||
130226131|NCT00791999|468791847|FG001|Overall Study|Protocol planed withdrawal|11|||
130226132|NCT00791999|468791848|FG002|Overall Study|Protocol planed withdrawal|11|||
130226133|NCT00791999|468791849|FG003|Overall Study|Protocol planed withdrawal|45|||
130226134|NCT00791999|468791846|FG000|Overall Study|Withdrawal by Subject|0|||
130226135|NCT00791999|468791847|FG001|Overall Study|Withdrawal by Subject|1|||
130226136|NCT00791999|468791848|FG002|Overall Study|Withdrawal by Subject|0|||
130226137|NCT00791999|468791849|FG003|Overall Study|Withdrawal by Subject|2|||
130226138|NCT00791999|468791846|FG000|Overall Study|Protocol Violation|3|||
130226139|NCT00791999|468791847|FG001|Overall Study|Protocol Violation|0|||
130226140|NCT00791999|468791848|FG002|Overall Study|Protocol Violation|1|||
130226141|NCT00791999|468791849|FG003|Overall Study|Protocol Violation|0|||
130226142|NCT00791999|468791846|FG000|Overall Study|Adverse Event|3|||
130226143|NCT00791999|468791847|FG001|Overall Study|Adverse Event|3|||
130226144|NCT00791999|468791848|FG002|Overall Study|Adverse Event|7|||
130226145|NCT00791999|468791849|FG003|Overall Study|Adverse Event|3|||
130226146|NCT00791999|468791846|FG000|Overall Study|Lack of Efficacy|0|||
130226147|NCT00791999|468791847|FG001|Overall Study|Lack of Efficacy|1|||
130226148|NCT00791999|468791848|FG002|Overall Study|Lack of Efficacy|0|||
130226149|NCT00791999|468791849|FG003|Overall Study|Lack of Efficacy|2|||
130226150|NCT00791999|468791846|FG000|Overall Study|Reason other than those above|1|||
130226151|NCT00791999|468791847|FG001|Overall Study|Reason other than those above|0|||
130226152|NCT00791999|468791848|FG002|Overall Study|Reason other than those above|1|||
130226153|NCT00791999|468791849|FG003|Overall Study|Reason other than those above|0|||
130226154|NCT00427908|468791850|FG000|Primary Phase|Lost to Follow-up|4|||
130226155|NCT00427908|468791851|FG001|Primary Phase|Lost to Follow-up|0|||
130226156|NCT00427908|468791852|FG002|Primary Phase|Lost to Follow-up|2|||
130226157|NCT00427908|468791853|FG003|Primary Phase|Lost to Follow-up|0|||
130226158|NCT00427908|468791850|FG000|Primary Phase|Withdrawal by Subject|1|||
130226159|NCT00427908|468791851|FG001|Primary Phase|Withdrawal by Subject|2|||
130226160|NCT00427908|468791852|FG002|Primary Phase|Withdrawal by Subject|1|||
130226161|NCT00427908|468791853|FG003|Primary Phase|Withdrawal by Subject|0|||
130226162|NCT00427908|468791850|FG000|Primary Phase|Adverse Event|0|||
130226163|NCT00427908|468791851|FG001|Primary Phase|Adverse Event|1|||
130226164|NCT00427908|468791852|FG002|Primary Phase|Adverse Event|0|||
130226165|NCT00427908|468791853|FG003|Primary Phase|Adverse Event|0|||
130226166|NCT01710020|468791854|FG000|Period 1|Protocol Violation|1|||
130226167|NCT01190813|468791855|FG000|Overall Study|Lost to Follow-up|1|||
130226168|NCT01190813|468791856|FG001|Overall Study|Lost to Follow-up|2|||
130226169|NCT01190813|468791855|FG000|Overall Study|Withdrawal by Subject|2|||
130226170|NCT01190813|468791856|FG001|Overall Study|Withdrawal by Subject|1|||
130226171|NCT01190813|468791855|FG000|Overall Study|Refused study treatment after randomized|1|||
130226172|NCT01190813|468791856|FG001|Overall Study|Refused study treatment after randomized|0|||
130226173|NCT01190813|468791855|FG000|Overall Study|Adverse Event|0|||
130226174|NCT01190813|468791856|FG001|Overall Study|Adverse Event|1|||
130226175|NCT04194814|468791857|FG000|Overall Study|Physician Decision|3|||
130226176|NCT04194814|468791858|FG001|Overall Study|Physician Decision|0|||
130226177|NCT04194814|468791857|FG000|Overall Study|Withdrawal by Subject|0|||
130226178|NCT04194814|468791858|FG001|Overall Study|Withdrawal by Subject|2|||
130226179|NCT02737358|468793556|FG000|Overall Study|Withdrawal by Subject|7|||
130226180|NCT02737358|468793557|FG001|Overall Study|Withdrawal by Subject|12|||
130226181|NCT02737358|468793556|FG000|Overall Study|Lost to Follow-up|2|||
130226182|NCT02737358|468793557|FG001|Overall Study|Lost to Follow-up|3|||
130226183|NCT03191799|468793562|FG000|Overall Study|Withdrawal by Subject|4|||
130226184|NCT03191799|468793562|FG000|Overall Study|Physician Decision|2|||
130226185|NCT03191799|468793562|FG000|Overall Study|Lost to Follow-up|1|||
130226186|NCT03191799|468793562|FG000|Overall Study|Death|2|||
130690538|NCT03419403|470493126|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
130690539|NCT02089685|470493131|FG000|Overall Study|Adverse Event|1|||
130690540|NCT02089685|470493132|FG001|Overall Study|Adverse Event|0|||
130690541|NCT02089685|470493133|FG002|Overall Study|Adverse Event|0|||
130690542|NCT02089685|470493134|FG003|Overall Study|Adverse Event|0|||
130690543|NCT02089685|470493135|FG004|Overall Study|Adverse Event|1|||
130690544|NCT02089685|470493136|FG005|Overall Study|Adverse Event|0|||
130226187|NCT00748241|468793568|FG000|Overall Study|Implant failure|1|||
130226188|NCT00748241|468793568|FG000|Overall Study|Lost to Follow-up|5|||
130226189|NCT00748241|468793568|FG000|Overall Study|Death|2|||
130226190|NCT02974868|468793578|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130226191|NCT02974868|468793579|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130226192|NCT02974868|468793580|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
130226193|NCT02974868|468793581|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
130226194|NCT02974868|468793578|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
130226195|NCT02974868|468793579|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
130226196|NCT02974868|468793580|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
130226197|NCT02974868|468793581|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
130226198|NCT02974868|468793578|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
130226199|NCT02974868|468793579|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
130226200|NCT02974868|468793580|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
130690545|NCT02089685|470493131|FG000|Overall Study|Clinical Progression|4|||
130690546|NCT02089685|470493132|FG001|Overall Study|Clinical Progression|0|||
130226201|NCT02974868|468793581|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
130226202|NCT02974868|468793578|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
130226203|NCT02974868|468793579|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
130226204|NCT02974868|468793580|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
130226205|NCT02974868|468793581|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
130226206|NCT00706004|468793582|FG000|Overall Study|Did not meet eligibility criteria|2|||
130226207|NCT00297648|468793585|FG000|Overall Study|Adverse Event|13|||
130226208|NCT00297648|468793585|FG000|Overall Study|Lack of Efficacy|18|||
130226209|NCT00297648|468793585|FG000|Overall Study|Lost to Follow-up|1|||
130226210|NCT00297648|468793585|FG000|Overall Study|Withdrawal by Subject|3|||
130226211|NCT00297648|468793585|FG000|Overall Study|Other: Incompliance|1|||
130226212|NCT03575702|468793586|FG000|Overall Study|Withdrawal by Subject|1|||
130226213|NCT03575702|468793587|FG001|Overall Study|Withdrawal by Subject|1|||
130226214|NCT03575702|468793586|FG000|Overall Study|Lost to Follow-up|1|||
130226215|NCT03575702|468793587|FG001|Overall Study|Lost to Follow-up|2|||
130226216|NCT03575702|468793586|FG000|Overall Study|Protocol Violation|0|||
130226217|NCT03575702|468793587|FG001|Overall Study|Protocol Violation|1|||
130226218|NCT03575702|468793586|FG000|Overall Study|Patient non compliance|4|||
130226219|NCT03575702|468793587|FG001|Overall Study|Patient non compliance|0|||
130226220|NCT03903172|468793588|FG000|Overall Study|screen fail|4|||
130226221|NCT03903172|468793589|FG001|Overall Study|screen fail|1|||
130226222|NCT01545388|468793590|FG000|Overall Study|Adverse Event|2|||
130226223|NCT01545388|468793591|FG001|Overall Study|Adverse Event|4|||
130226224|NCT01545388|468793592|FG002|Overall Study|Adverse Event|1|||
130226225|NCT01545388|468793590|FG000|Overall Study|Lack of Efficacy|3|||
130226226|NCT01545388|468793591|FG001|Overall Study|Lack of Efficacy|2|||
130226227|NCT01545388|468793592|FG002|Overall Study|Lack of Efficacy|5|||
130226228|NCT01545388|468793590|FG000|Overall Study|Participant moved or relocated|1|||
130226229|NCT01545388|468793591|FG001|Overall Study|Participant moved or relocated|0|||
130226230|NCT01545388|468793592|FG002|Overall Study|Participant moved or relocated|0|||
130226231|NCT01545388|468793590|FG000|Overall Study|Withdrawal by Subject|1|||
130226232|NCT01545388|468793591|FG001|Overall Study|Withdrawal by Subject|4|||
130226233|NCT01545388|468793592|FG002|Overall Study|Withdrawal by Subject|2|||
130226234|NCT01545388|468793590|FG000|Overall Study|Other|1|||
130226235|NCT01545388|468793591|FG001|Overall Study|Other|1|||
130226236|NCT01545388|468793592|FG002|Overall Study|Other|0|||
130226237|NCT01255163|468793593|FG000|Overall Study|Withdrawal by Subject|1|||
130226238|NCT01255163|468793594|FG001|Overall Study|Withdrawal by Subject|0|||
130226239|NCT01255163|468793593|FG000|Overall Study|Lost to Follow-up|2|||
130226240|NCT01255163|468793594|FG001|Overall Study|Lost to Follow-up|0|||
130226241|NCT01255163|468793593|FG000|Overall Study|Adverse Event|0|||
130226242|NCT01255163|468793594|FG001|Overall Study|Adverse Event|2|||
130226243|NCT01255163|468793593|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
130226244|NCT01255163|468793594|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
130226245|NCT02495389|468793595|FG000|Overall Study|Withdrawal by Subject|40|||
130226246|NCT01802385|468793599|FG000|Overall Study|Death|106|||
130226247|NCT01802385|468793600|FG001|Overall Study|Death|120|||
130226248|NCT03834493|468793601|FG000|Overall Study|Participants Ongoing|311|||
130226249|NCT03834493|468793602|FG001|Overall Study|Participants Ongoing|324|||
130226250|NCT03834493|468793601|FG000|Overall Study|Withdrawal by Subject|20|||
130226251|NCT03834493|468793602|FG001|Overall Study|Withdrawal by Subject|17|||
130226252|NCT03834493|468793601|FG000|Overall Study|Physician Decision|1|||
130226253|NCT03834493|468793602|FG001|Overall Study|Physician Decision|0|||
130226254|NCT03834493|468793601|FG000|Overall Study|Death|289|||
130226255|NCT03834493|468793602|FG001|Overall Study|Death|282|||
130226256|NCT05559905|468793603|FG000|Overall Study|Withdrawal by Subject|1|||
130226257|NCT05559905|468793604|FG001|Overall Study|Withdrawal by Subject|0|||
130226258|NCT05559905|468793605|FG002|Overall Study|Withdrawal by Subject|0|||
130444416|NCT01734850|469588580|FG000|Overall Study|Not infused due to manufacturing failure|0|||
130226259|NCT05559905|468793603|FG000|Overall Study|Not Reported|1|||
130226260|NCT05559905|468793604|FG001|Overall Study|Not Reported|0|||
130226261|NCT05559905|468793605|FG002|Overall Study|Not Reported|0|||
130226262|NCT04003103|468793606|FG000|Overall Study|Death|1|||
130226263|NCT04003103|468793607|FG001|Overall Study|Death|0|||
130226264|NCT04003103|468793608|FG002|Overall Study|Death|0|||
130226265|NCT04003103|468793606|FG000|Overall Study|Lost to Follow-up|4|||
130226266|NCT04003103|468793607|FG001|Overall Study|Lost to Follow-up|3|||
130226267|NCT04003103|468793608|FG002|Overall Study|Lost to Follow-up|2|||
130226268|NCT04003103|468793606|FG000|Overall Study|Withdrawal by Subject|10|||
130226269|NCT04003103|468793607|FG001|Overall Study|Withdrawal by Subject|1|||
130226270|NCT04003103|468793608|FG002|Overall Study|Withdrawal by Subject|1|||
130226271|NCT04003103|468793606|FG000|Overall Study|Status not recorded|0|||
130226272|NCT04003103|468793607|FG001|Overall Study|Status not recorded|2|||
130226273|NCT04003103|468793608|FG002|Overall Study|Status not recorded|0|||
130226274|NCT02277028|468793610|FG000|Overall Study|Lost to Follow-up|1|||
130226275|NCT02277028|468793611|FG001|Overall Study|Lost to Follow-up|0|||
130690547|NCT02089685|470493133|FG002|Overall Study|Clinical Progression|0|||
130690548|NCT02089685|470493134|FG003|Overall Study|Clinical Progression|5|||
130690549|NCT02089685|470493135|FG004|Overall Study|Clinical Progression|1|||
130690550|NCT02089685|470493136|FG005|Overall Study|Clinical Progression|2|||
130690551|NCT02089685|470493131|FG000|Overall Study|Excluded Medication|1|||
130690552|NCT02089685|470493132|FG001|Overall Study|Excluded Medication|0|||
130690553|NCT02089685|470493133|FG002|Overall Study|Excluded Medication|0|||
130690554|NCT02089685|470493134|FG003|Overall Study|Excluded Medication|11|||
130690555|NCT02089685|470493135|FG004|Overall Study|Excluded Medication|2|||
130690556|NCT02089685|470493136|FG005|Overall Study|Excluded Medication|1|||
130690557|NCT02089685|470493131|FG000|Overall Study|Progressive disease|13|||
130226276|NCT02277028|468793610|FG000|Overall Study|Withdrawal by Subject|0|||
130226277|NCT02277028|468793611|FG001|Overall Study|Withdrawal by Subject|1|||
130226278|NCT02718911|468793612|FG000|Overall Study|Adverse Event|0|||
130226279|NCT02718911|468793613|FG001|Overall Study|Adverse Event|0|||
130226280|NCT02718911|468793614|FG002|Overall Study|Adverse Event|0|||
130226281|NCT02718911|468793615|FG003|Overall Study|Adverse Event|0|||
130226282|NCT02718911|468793616|FG004|Overall Study|Adverse Event|0|||
130226283|NCT02718911|468793617|FG005|Overall Study|Adverse Event|0|||
130226284|NCT02718911|468793618|FG006|Overall Study|Adverse Event|0|||
130226285|NCT02718911|468793619|FG007|Overall Study|Adverse Event|0|||
130226286|NCT02718911|468793620|FG008|Overall Study|Adverse Event|0|||
130226287|NCT02718911|468793621|FG009|Overall Study|Adverse Event|2|||
130226288|NCT02718911|468793612|FG000|Overall Study|Death|2|||
130226289|NCT02718911|468793613|FG001|Overall Study|Death|3|||
130226290|NCT02718911|468793614|FG002|Overall Study|Death|1|||
130226291|NCT02718911|468793615|FG003|Overall Study|Death|0|||
130226292|NCT02718911|468793616|FG004|Overall Study|Death|1|||
130226293|NCT02718911|468793617|FG005|Overall Study|Death|3|||
130226294|NCT02718911|468793618|FG006|Overall Study|Death|1|||
130226295|NCT02718911|468793619|FG007|Overall Study|Death|1|||
130226296|NCT02718911|468793620|FG008|Overall Study|Death|4|||
130226297|NCT02718911|468793621|FG009|Overall Study|Death|3|||
130226298|NCT02718911|468793612|FG000|Overall Study|Lost to Follow-up|0|||
130226299|NCT02718911|468793613|FG001|Overall Study|Lost to Follow-up|0|||
130226300|NCT02718911|468793614|FG002|Overall Study|Lost to Follow-up|0|||
130226301|NCT02718911|468793615|FG003|Overall Study|Lost to Follow-up|0|||
130226302|NCT02718911|468793616|FG004|Overall Study|Lost to Follow-up|0|||
130226303|NCT02718911|468793617|FG005|Overall Study|Lost to Follow-up|0|||
130226304|NCT02718911|468793618|FG006|Overall Study|Lost to Follow-up|0|||
130226305|NCT02718911|468793619|FG007|Overall Study|Lost to Follow-up|0|||
130226306|NCT02718911|468793620|FG008|Overall Study|Lost to Follow-up|1|||
130226307|NCT02718911|468793621|FG009|Overall Study|Lost to Follow-up|0|||
130226308|NCT02718911|468793612|FG000|Overall Study|Physician Decision|2|||
130226309|NCT02718911|468793613|FG001|Overall Study|Physician Decision|0|||
130226310|NCT02718911|468793614|FG002|Overall Study|Physician Decision|1|||
130226311|NCT02718911|468793615|FG003|Overall Study|Physician Decision|1|||
130226312|NCT02718911|468793616|FG004|Overall Study|Physician Decision|0|||
130226313|NCT02718911|468793617|FG005|Overall Study|Physician Decision|0|||
130226314|NCT02718911|468793618|FG006|Overall Study|Physician Decision|0|||
130226315|NCT02718911|468793619|FG007|Overall Study|Physician Decision|1|||
130226316|NCT02718911|468793620|FG008|Overall Study|Physician Decision|2|||
130226317|NCT02718911|468793621|FG009|Overall Study|Physician Decision|1|||
130226318|NCT02718911|468793612|FG000|Overall Study|Withdrawal by Subject|0|||
130226319|NCT02718911|468793613|FG001|Overall Study|Withdrawal by Subject|0|||
130226320|NCT02718911|468793614|FG002|Overall Study|Withdrawal by Subject|0|||
130226321|NCT02718911|468793615|FG003|Overall Study|Withdrawal by Subject|0|||
130226322|NCT02718911|468793616|FG004|Overall Study|Withdrawal by Subject|1|||
130226323|NCT02718911|468793617|FG005|Overall Study|Withdrawal by Subject|0|||
130226324|NCT02718911|468793618|FG006|Overall Study|Withdrawal by Subject|0|||
130226325|NCT02718911|468793619|FG007|Overall Study|Withdrawal by Subject|0|||
130690558|NCT02089685|470493132|FG001|Overall Study|Progressive disease|10|||
130690559|NCT02089685|470493133|FG002|Overall Study|Progressive disease|3|||
130226326|NCT02718911|468793620|FG008|Overall Study|Withdrawal by Subject|1|||
130226327|NCT02718911|468793621|FG009|Overall Study|Withdrawal by Subject|4|||
130356117|NCT03552965|469274655|FG001|Overall Study|Continuation not in patient best interest|0|||
130226328|NCT02718911|468793612|FG000|Overall Study|Reason Not Collected|0|||
130226329|NCT02718911|468793613|FG001|Overall Study|Reason Not Collected|0|||
130226330|NCT02718911|468793614|FG002|Overall Study|Reason Not Collected|1|||
130226331|NCT02718911|468793615|FG003|Overall Study|Reason Not Collected|0|||
130690560|NCT02089685|470493134|FG003|Overall Study|Progressive disease|51|||
130690561|NCT02089685|470493135|FG004|Overall Study|Progressive disease|17|||
130690562|NCT02089685|470493136|FG005|Overall Study|Progressive disease|12|||
130226332|NCT02718911|468793616|FG004|Overall Study|Reason Not Collected|0|||
130226333|NCT02718911|468793617|FG005|Overall Study|Reason Not Collected|0|||
130226334|NCT02718911|468793618|FG006|Overall Study|Reason Not Collected|2|||
130226335|NCT02718911|468793619|FG007|Overall Study|Reason Not Collected|1|||
130226336|NCT02718911|468793620|FG008|Overall Study|Reason Not Collected|4|||
130226337|NCT02718911|468793621|FG009|Overall Study|Reason Not Collected|9|||
130226338|NCT05002972|468793622|FG000|Overall Study|Withdrawal by Subject|2|||
130226339|NCT01172873|468793626|FG000|Overall Study|Withdrawal by Subject|3|||
130226340|NCT01172873|468793627|FG001|Overall Study|Withdrawal by Subject|2|||
130226341|NCT00983372|468793628|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130226342|NCT00983372|468793628|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
130226343|NCT00983372|468793628|FG000|Diltiazem ER Alone|Adverse Event|1|||
130226344|NCT05518539|468793631|FG000|Overall Study|Lost to Follow-up|6|||
130226345|NCT02053493|468793636|FG000|Overall Study|Withdrawal by Subject|1|||
130226346|NCT02053493|468793637|FG001|Overall Study|Withdrawal by Subject|1|||
130226347|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130226348|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130226349|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130226350|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130226351|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Adverse Event|0|||
130226352|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Adverse Event|1|||
130226353|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
130226354|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130226355|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130226356|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
130226357|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
130226358|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
130226359|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Other Reasons|2|||
130226360|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Other Reasons|0|||
130226361|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Other Reasons|0|||
130226362|NCT04613518|468793640|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130226363|NCT04613518|468793641|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
130226364|NCT04613518|468793642|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130226365|NCT04613518|468793640|FG000|Open-Label Treatment Period|Adverse Event|1|||
130226366|NCT04613518|468793641|FG001|Open-Label Treatment Period|Adverse Event|0|||
130226367|NCT04613518|468793642|FG002|Open-Label Treatment Period|Adverse Event|3|||
130226368|NCT04613518|468793640|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
130226369|NCT04613518|468793641|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130226370|NCT04613518|468793642|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130226371|NCT04613518|468793640|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
130226372|NCT04613518|468793641|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
130226373|NCT04613518|468793642|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
130226374|NCT04613518|468793640|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
130226375|NCT04613518|468793641|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130226376|NCT04613518|468793642|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130226377|NCT04613518|468793640|FG000|Open-Label Treatment Period|Other reasons|1|||
130226378|NCT04613518|468793641|FG001|Open-Label Treatment Period|Other reasons|0|||
130226379|NCT04613518|468793642|FG002|Open-Label Treatment Period|Other reasons|0|||
130226380|NCT01619865|468793643|FG000|Overall Study|Adverse Event|1|||
130226381|NCT01619865|468793643|FG000|Overall Study|Death|2|||
130226382|NCT01619865|468793643|FG000|Overall Study|subject not able to comply|1|||
130226383|NCT01494818|468793644|FG000|Overall Study|Relocation|1|||
130226384|NCT01494818|468793645|FG001|Overall Study|Relocation|2|||
130226385|NCT01494818|468793644|FG000|Overall Study|Lost to Follow-up|1|||
130226386|NCT01494818|468793645|FG001|Overall Study|Lost to Follow-up|0|||
130226387|NCT01077323|468793646|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
130226388|NCT01077323|468793647|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
130226389|NCT01077323|468793648|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
130226390|NCT01077323|468793646|FG000|Overall Study|Dispensing of drug in baseline period|0|||
130226391|NCT01077323|468793647|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
130226392|NCT01077323|468793648|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
130226393|NCT01077323|468793646|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
130690563|NCT02089685|470493131|FG000|Overall Study|Follow up ended by sponsor|2|||
130690564|NCT02089685|470493132|FG001|Overall Study|Follow up ended by sponsor|2|||
130690565|NCT02089685|470493133|FG002|Overall Study|Follow up ended by sponsor|0|||
130690566|NCT02089685|470493134|FG003|Overall Study|Follow up ended by sponsor|70|||
130690567|NCT02089685|470493135|FG004|Overall Study|Follow up ended by sponsor|26|||
130690568|NCT02089685|470493136|FG005|Overall Study|Follow up ended by sponsor|26|||
130690569|NCT02089685|470493131|FG000|Overall Study|Withdrawal by Subject|0|||
130690570|NCT02089685|470493132|FG001|Overall Study|Withdrawal by Subject|2|||
130690571|NCT02089685|470493133|FG002|Overall Study|Withdrawal by Subject|0|||
130226394|NCT01077323|468793647|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
130226395|NCT01077323|468793648|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
130226396|NCT00617357|468793649|FG000|Overall Study|Lost to Follow-up|7|||
130226397|NCT00617357|468793649|FG000|Overall Study|Death|5|||
130226398|NCT00617357|468793649|FG000|Overall Study|insurance concerns|2|||
130226399|NCT00617357|468793649|FG000|Overall Study|Withdrawal by Subject|1|||
130226400|NCT00617357|468793649|FG000|Overall Study|Physician Decision|1|||
130226401|NCT02153918|468793650|FG000|Overall Study|Refused further treatment|1|||
130226402|NCT01764841|468793651|FG000|Overall Study|Logistical Difficulties|0|||
130226403|NCT01764841|468793652|FG001|Overall Study|Logistical Difficulties|1|||
130226404|NCT01764841|468793653|FG002|Overall Study|Logistical Difficulties|0|||
130226405|NCT01764841|468793654|FG003|Overall Study|Logistical Difficulties|0|||
130226406|NCT01764841|468793651|FG000|Overall Study|Death|3|||
130226407|NCT01764841|468793652|FG001|Overall Study|Death|0|||
130226408|NCT01764841|468793653|FG002|Overall Study|Death|1|||
130226409|NCT01764841|468793654|FG003|Overall Study|Death|4|||
130226410|NCT01764841|468793651|FG000|Overall Study|No Follow Up|1|||
130226411|NCT01764841|468793652|FG001|Overall Study|No Follow Up|0|||
130226412|NCT01764841|468793653|FG002|Overall Study|No Follow Up|1|||
130226413|NCT01764841|468793654|FG003|Overall Study|No Follow Up|0|||
130226414|NCT01764841|468793651|FG000|Overall Study|Protocol Violation|0|||
130226415|NCT01764841|468793652|FG001|Overall Study|Protocol Violation|1|||
130226416|NCT01764841|468793653|FG002|Overall Study|Protocol Violation|0|||
130226417|NCT01764841|468793654|FG003|Overall Study|Protocol Violation|0|||
130226418|NCT01764841|468793651|FG000|Overall Study|Withdrawal by Subject|16|||
130226419|NCT01764841|468793652|FG001|Overall Study|Withdrawal by Subject|24|||
130226420|NCT01764841|468793653|FG002|Overall Study|Withdrawal by Subject|11|||
130226421|NCT01764841|468793654|FG003|Overall Study|Withdrawal by Subject|15|||
130226422|NCT01764841|468793651|FG000|Overall Study|Lost to Follow-up|3|||
130226423|NCT01764841|468793652|FG001|Overall Study|Lost to Follow-up|0|||
130226424|NCT01764841|468793653|FG002|Overall Study|Lost to Follow-up|1|||
130226425|NCT01764841|468793654|FG003|Overall Study|Lost to Follow-up|0|||
130226426|NCT02616783|468793655|FG000|Overall Study|Randomized but Not Treated|1|||
130226427|NCT02616783|468793656|FG001|Overall Study|Randomized but Not Treated|0|||
130226428|NCT02616783|468793655|FG000|Overall Study|Adverse Event|1|||
130226429|NCT02616783|468793656|FG001|Overall Study|Adverse Event|0|||
130226430|NCT02616783|468793655|FG000|Overall Study|Death|1|||
130226431|NCT02616783|468793656|FG001|Overall Study|Death|0|||
130226432|NCT02616783|468793655|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130226433|NCT02616783|468793656|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130226434|NCT02616783|468793655|FG000|Overall Study|Protocol Violation|1|||
130226435|NCT02616783|468793656|FG001|Overall Study|Protocol Violation|1|||
130226436|NCT02616783|468793655|FG000|Overall Study|Withdrew Consent|1|||
130226437|NCT02616783|468793656|FG001|Overall Study|Withdrew Consent|1|||
130226438|NCT04344301|468793657|FG000|Overall Study|Withdrawal by Subject|1|||
130226439|NCT04344301|468793658|FG001|Overall Study|Withdrawal by Subject|0|||
130226440|NCT04344301|468793657|FG000|Overall Study|Death|0|||
130226441|NCT04344301|468793658|FG001|Overall Study|Death|1|||
130226442|NCT05214118|468793661|FG000|Overall Study|Lost to Follow-up|0|||
130226443|NCT05214118|468793662|FG001|Overall Study|Lost to Follow-up|2|||
130226444|NCT05214118|468793661|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
130226445|NCT05214118|468793662|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
130226446|NCT05214118|468793661|FG000|Overall Study|moved|1|||
130226447|NCT05214118|468793662|FG001|Overall Study|moved|0|||
130226448|NCT04010461|468793663|FG000|Overall Study|COVID based withdrawal|5|||
130226449|NCT04010461|468793663|FG000|Overall Study|Withdrawal by Subject|5|||
130226450|NCT04010461|468793663|FG000|Overall Study|Adverse Event|1|||
130226451|NCT04010461|468793663|FG000|Overall Study|No Motor Threshold obtainable|1|||
130226452|NCT04010461|468793663|FG000|Overall Study|Physician Decision|1|||
130226453|NCT03797898|468793664|FG000|Overall Study|Lost to Follow-up|60|||
130226454|NCT03797898|468793665|FG001|Overall Study|Lost to Follow-up|69|||
130444417|NCT01734850|469588581|FG001|Overall Study|Not infused due to manufacturing failure|0|||
130444418|NCT01734850|469588582|FG002|Overall Study|Not infused due to manufacturing failure|1|||
130226455|NCT03797898|468793664|FG000|Overall Study|Withdrawal by Subject|9|||
130226456|NCT03797898|468793665|FG001|Overall Study|Withdrawal by Subject|7|||
130226457|NCT03797898|468793664|FG000|Overall Study|Became ineligible|5|||
130226458|NCT03797898|468793665|FG001|Overall Study|Became ineligible|2|||
130226459|NCT00086190|468793666|FG000|Overall Study|Adverse Event|6|||
130444419|NCT02204293|469588583|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
130444420|NCT02204293|469588584|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
130226460|NCT00086190|468793667|FG001|Overall Study|Adverse Event|2|||
130226461|NCT00086190|468793668|FG002|Overall Study|Adverse Event|2|||
130226462|NCT00086190|468793666|FG000|Overall Study|Withdrawal by Subject|0|||
130226463|NCT00086190|468793667|FG001|Overall Study|Withdrawal by Subject|2|||
130690572|NCT02089685|470493134|FG003|Overall Study|Withdrawal by Subject|8|||
130226464|NCT00086190|468793668|FG002|Overall Study|Withdrawal by Subject|2|||
130226465|NCT00086190|468793666|FG000|Overall Study|Protocol Violation|1|||
130226466|NCT00086190|468793667|FG001|Overall Study|Protocol Violation|0|||
130226467|NCT00086190|468793668|FG002|Overall Study|Protocol Violation|0|||
130226468|NCT00086190|468793666|FG000|Overall Study|Moved|1|||
130226469|NCT00086190|468793667|FG001|Overall Study|Moved|0|||
130226470|NCT00086190|468793668|FG002|Overall Study|Moved|0|||
130226471|NCT00086190|468793666|FG000|Overall Study|Worsening depression|0|||
130226472|NCT00086190|468793667|FG001|Overall Study|Worsening depression|0|||
130226473|NCT00086190|468793668|FG002|Overall Study|Worsening depression|2|||
130226474|NCT03902613|468793669|FG000|Overall Study|Physician Decision|1|||
130226475|NCT02027025|468793673|FG000|Overall Study|Adverse Event|0|||
130226476|NCT02027025|468793674|FG001|Overall Study|Adverse Event|1|||
130226477|NCT02027025|468793675|FG002|Overall Study|Adverse Event|1|||
130226478|NCT02027025|468793673|FG000|Overall Study|Protocol Violation|1|||
130226479|NCT02027025|468793674|FG001|Overall Study|Protocol Violation|0|||
130226480|NCT02027025|468793675|FG002|Overall Study|Protocol Violation|0|||
130226481|NCT02027025|468793673|FG000|Overall Study|Lost to Follow-up|0|||
130226482|NCT02027025|468793674|FG001|Overall Study|Lost to Follow-up|2|||
130226483|NCT02027025|468793675|FG002|Overall Study|Lost to Follow-up|0|||
130226484|NCT02027025|468793673|FG000|Overall Study|Withdrawal by Subject|0|||
130226485|NCT02027025|468793674|FG001|Overall Study|Withdrawal by Subject|1|||
130226486|NCT02027025|468793675|FG002|Overall Study|Withdrawal by Subject|0|||
130226487|NCT02027025|468793673|FG000|Overall Study|Sponsor's decision|0|||
130226488|NCT02027025|468793674|FG001|Overall Study|Sponsor's decision|1|||
130226489|NCT02027025|468793675|FG002|Overall Study|Sponsor's decision|0|||
130226490|NCT00732069|468793676|FG000|Washout After First Study Drug|Adverse Event|1|||
130226491|NCT00732069|468793677|FG001|Washout After First Study Drug|Adverse Event|0|||
130226492|NCT00732069|468793678|FG002|Washout After First Study Drug|Adverse Event|0|||
130226493|NCT00732069|468793679|FG003|Washout After First Study Drug|Adverse Event|0|||
130226494|NCT00732069|468793680|FG004|Washout After First Study Drug|Adverse Event|0|||
130226495|NCT00732069|468793681|FG005|Washout After First Study Drug|Adverse Event|0|||
130226496|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Early discharge|5|||
130226497|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Early discharge|5|||
130226498|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
130226499|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
130226500|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
130226501|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
130226502|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
130226503|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
130226504|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
130226505|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
130226506|NCT04460326|468793682|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
130226507|NCT04460326|468793683|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
130226508|NCT00577317|468793684|FG000|Overall Study|Study Terminated|0|||
130226509|NCT00577317|468793685|FG001|Overall Study|Study Terminated|2|||
130226510|NCT04794751|468793686|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
130226511|NCT04794751|468793687|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
130226512|NCT04794751|468793686|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
130226513|NCT04794751|468793687|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
130226514|NCT04794751|468793686|FG000|Period 1|Protocol Violation|0|||
130226515|NCT04794751|468793687|FG001|Period 1|Protocol Violation|2|||
130690573|NCT02089685|470493135|FG004|Overall Study|Withdrawal by Subject|1|||
130690574|NCT02089685|470493136|FG005|Overall Study|Withdrawal by Subject|1|||
130690575|NCT02089685|470493131|FG000|Overall Study|Status not recorded|1|||
130690576|NCT02089685|470493132|FG001|Overall Study|Status not recorded|0|||
130690577|NCT02089685|470493133|FG002|Overall Study|Status not recorded|0|||
130690578|NCT02089685|470493134|FG003|Overall Study|Status not recorded|0|||
130690579|NCT02089685|470493135|FG004|Overall Study|Status not recorded|1|||
130690580|NCT02089685|470493136|FG005|Overall Study|Status not recorded|0|||
130690581|NCT02089685|470493131|FG000|Overall Study|Death|0|||
130690582|NCT02089685|470493132|FG001|Overall Study|Death|0|||
130690583|NCT02089685|470493133|FG002|Overall Study|Death|0|||
130690584|NCT02089685|470493134|FG003|Overall Study|Death|7|||
130690585|NCT02089685|470493135|FG004|Overall Study|Death|2|||
130690586|NCT02089685|470493136|FG005|Overall Study|Death|5|||
130690587|NCT02089685|470493131|FG000|Overall Study|Lost to Follow-up|0|||
130690588|NCT02089685|470493132|FG001|Overall Study|Lost to Follow-up|0|||
130690589|NCT02089685|470493133|FG002|Overall Study|Lost to Follow-up|0|||
130690590|NCT02089685|470493134|FG003|Overall Study|Lost to Follow-up|1|||
130690591|NCT02089685|470493135|FG004|Overall Study|Lost to Follow-up|0|||
130690592|NCT02089685|470493136|FG005|Overall Study|Lost to Follow-up|0|||
130226516|NCT04794751|468793686|FG000|Period 1|Withdrawal by Subject|0|||
130226517|NCT04794751|468793687|FG001|Period 1|Withdrawal by Subject|1|||
130226518|NCT04794751|468793686|FG000|Period 2|Withdrawal by Subject|0|||
130226519|NCT04794751|468793687|FG001|Period 2|Withdrawal by Subject|1|||
130226520|NCT04794751|468793686|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
130690593|NCT02089685|470493131|FG000|Overall Study|Physician Decision|0|||
130690594|NCT02089685|470493132|FG001|Overall Study|Physician Decision|0|||
130226521|NCT04794751|468793687|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
130226522|NCT04794751|468793686|FG000|Period 2|Protocol Violation|1|||
130226523|NCT04794751|468793687|FG001|Period 2|Protocol Violation|0|||
130226524|NCT03669588|468793690|FG000|Overall Study|Adverse Event|1|||
130226525|NCT03669588|468793691|FG001|Overall Study|Adverse Event|0|||
130226526|NCT03669588|468793690|FG000|Overall Study|Physician Decision|0|||
130226527|NCT03669588|468793691|FG001|Overall Study|Physician Decision|1|||
130226528|NCT03669588|468793690|FG000|Overall Study|Protocol Violation|1|||
130226529|NCT03669588|468793691|FG001|Overall Study|Protocol Violation|0|||
130226530|NCT03669588|468793690|FG000|Overall Study|Sponsor Decision|1|||
130226531|NCT03669588|468793691|FG001|Overall Study|Sponsor Decision|1|||
130226532|NCT03669588|468793690|FG000|Overall Study|Withdrawal by Subject|1|||
130226533|NCT03669588|468793691|FG001|Overall Study|Withdrawal by Subject|4|||
130226534|NCT03669588|468793690|FG000|Overall Study|Rescue Therapy Needed|0|||
130226535|NCT03669588|468793691|FG001|Overall Study|Rescue Therapy Needed|1|||
130226536|NCT00369343|468793694|FG000|Double-blind Phase|Adverse Event|19|||
130226537|NCT00369343|468793695|FG001|Double-blind Phase|Adverse Event|4|||
130226538|NCT00369343|468793694|FG000|Double-blind Phase|Failed to return|2|||
130226539|NCT00369343|468793695|FG001|Double-blind Phase|Failed to return|0|||
130226540|NCT00369343|468793694|FG000|Double-blind Phase|Lost to Follow-up|9|||
130226541|NCT00369343|468793695|FG001|Double-blind Phase|Lost to Follow-up|2|||
130226542|NCT00369343|468793694|FG000|Double-blind Phase|Protocol Violation|2|||
130226543|NCT00369343|468793695|FG001|Double-blind Phase|Protocol Violation|0|||
130226544|NCT00369343|468793694|FG000|Double-blind Phase|Withdrawal by Subject|8|||
130226545|NCT00369343|468793695|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130444421|NCT02204293|469588585|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
130444422|NCT02204293|469588586|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
130444423|NCT02204293|469588587|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
130444424|NCT02204293|469588588|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
130444425|NCT02204293|469588583|FG000|Core Study Part I|Adverse Event|1|||
130444426|NCT02204293|469588584|FG001|Core Study Part I|Adverse Event|0|||
130444427|NCT02204293|469588585|FG002|Core Study Part I|Adverse Event|0|||
130444428|NCT02204293|469588586|FG003|Core Study Part I|Adverse Event|0|||
130444429|NCT02204293|469588587|FG004|Core Study Part I|Adverse Event|0|||
130444430|NCT02204293|469588588|FG005|Core Study Part I|Adverse Event|0|||
130444431|NCT02204293|469588583|FG000|Core Study Part I|Physician Decision|0|||
130444432|NCT02204293|469588584|FG001|Core Study Part I|Physician Decision|3|||
130444433|NCT02204293|469588585|FG002|Core Study Part I|Physician Decision|0|||
130444434|NCT02204293|469588586|FG003|Core Study Part I|Physician Decision|0|||
130444435|NCT02204293|469588587|FG004|Core Study Part I|Physician Decision|0|||
130444436|NCT02204293|469588588|FG005|Core Study Part I|Physician Decision|0|||
130444437|NCT02204293|469588583|FG000|LTE Phase|Study Suspended|0|||
130444438|NCT02204293|469588584|FG001|LTE Phase|Study Suspended|0|||
130444439|NCT02204293|469588585|FG002|LTE Phase|Study Suspended|0|||
130444440|NCT02204293|469588586|FG003|LTE Phase|Study Suspended|0|||
130444441|NCT02204293|469588587|FG004|LTE Phase|Study Suspended|0|||
130444442|NCT02204293|469588588|FG005|LTE Phase|Study Suspended|7|||
130444443|NCT02019602|469588589|FG000|Screening Period|Ineligibility|4|||
130444444|NCT02019602|469588590|FG001|Screening Period|Ineligibility|0|||
130444445|NCT02019602|469588589|FG000|Screening Period|Adverse Event|1|||
130444446|NCT02019602|469588590|FG001|Screening Period|Adverse Event|0|||
130444447|NCT01058863|469588591|FG000|Overall Study|Lost to Follow-up|1|||
130444448|NCT01058863|469588591|FG000|Overall Study|Withdrawal by Subject|1|||
130444449|NCT01058863|469588591|FG000|Overall Study|Sponsor requested withdrawal|1|||
130444450|NCT01058863|469588591|FG000|Overall Study|Randomized in error|1|||
130444451|NCT03653416|469588592|FG000|Overall Study|Protocol Violation|6|||
130444452|NCT03653416|469588593|FG001|Overall Study|Protocol Violation|1|||
130444453|NCT00598481|469588594|FG000|Treatment|Physician Decision|1|||
130444454|NCT02388074|469588595|FG000|Overall Study|Lost in Transit|2|||
130444455|NCT02388074|469588595|FG000|Overall Study|Sample Not Returned|1|||
130444456|NCT00003458|469588598|FG000|Overall Study|Not evaluable|4|||
130444457|NCT02133924|469588599|FG000|Overall Study|Death|38|||
130444458|NCT02133924|469588599|FG000|Overall Study|Physician Decision|1|||
130690595|NCT02089685|470493133|FG002|Overall Study|Physician Decision|0|||
130226546|NCT00369343|468793694|FG000|Double-blind Phase|Lack of Efficacy|0|||
130226547|NCT00369343|468793695|FG001|Double-blind Phase|Lack of Efficacy|4|||
130444459|NCT02133924|469588599|FG000|Overall Study|Withdrawal by Subject|3|||
130444460|NCT04157686|469588600|FG000|Overall Study|Adverse Event|1|||
130444461|NCT04157686|469588601|FG001|Overall Study|Adverse Event|0|||
130444462|NCT04157686|469588602|FG002|Overall Study|Adverse Event|1|||
130226548|NCT00369343|468793694|FG000|Double-blind Phase|Protocol deviation|4|||
130226549|NCT00369343|468793695|FG001|Double-blind Phase|Protocol deviation|0|||
130226550|NCT00369343|468793694|FG000|Open-label Phase|Adverse Event|19|||
130226551|NCT00369343|468793695|FG001|Open-label Phase|Adverse Event|7|||
130226552|NCT00369343|468793694|FG000|Open-label Phase|Failed to return|4|||
130444463|NCT04157686|469588603|FG003|Overall Study|Adverse Event|0|||
130444464|NCT04157686|469588604|FG004|Overall Study|Adverse Event|1|||
130444465|NCT04157686|469588605|FG005|Overall Study|Adverse Event|0|||
130226553|NCT00369343|468793695|FG001|Open-label Phase|Failed to return|0|||
130226554|NCT00369343|468793694|FG000|Open-label Phase|Physician Decision|2|||
130226555|NCT00369343|468793695|FG001|Open-label Phase|Physician Decision|0|||
130226556|NCT00369343|468793694|FG000|Open-label Phase|Lost to Follow-up|5|||
130226557|NCT00369343|468793695|FG001|Open-label Phase|Lost to Follow-up|3|||
130226558|NCT00369343|468793694|FG000|Open-label Phase|inadvertently reported study completers|3|||
130226559|NCT00369343|468793695|FG001|Open-label Phase|inadvertently reported study completers|2|||
130226560|NCT00369343|468793694|FG000|Open-label Phase|Protocol Violation|1|||
130226561|NCT00369343|468793695|FG001|Open-label Phase|Protocol Violation|3|||
130226562|NCT00369343|468793694|FG000|Open-label Phase|Withdrawal by Subject|15|||
130226563|NCT00369343|468793695|FG001|Open-label Phase|Withdrawal by Subject|6|||
130226564|NCT00369343|468793694|FG000|Open-label Phase|Lack of Efficacy|4|||
130226565|NCT00369343|468793695|FG001|Open-label Phase|Lack of Efficacy|3|||
130226566|NCT00369343|468793694|FG000|Open-label Phase|Lack of continuance tolerability|3|||
130226567|NCT00369343|468793695|FG001|Open-label Phase|Lack of continuance tolerability|4|||
130226568|NCT00369343|468793694|FG000|Open-label Phase|did not take study drug|1|||
130226569|NCT00369343|468793695|FG001|Open-label Phase|did not take study drug|2|||
130226570|NCT01100502|468793696|FG000|Overall Study|Withdrawal by Subject|18|||
130226571|NCT01100502|468793697|FG001|Overall Study|Withdrawal by Subject|25|||
130226572|NCT01100502|468793696|FG000|Overall Study|Lost to Follow-up|13|||
130226573|NCT01100502|468793697|FG001|Overall Study|Lost to Follow-up|28|||
130226574|NCT01100502|468793696|FG000|Overall Study|Site request to end participation in study|0|||
130226575|NCT01100502|468793697|FG001|Overall Study|Site request to end participation in study|1|||
130226576|NCT01100502|468793696|FG000|Overall Study|Death|45|||
130226577|NCT01100502|468793697|FG001|Overall Study|Death|40|||
130226578|NCT02322749|468793698|FG000|Period 2|Adverse Event|0|||
130226579|NCT02322749|468793699|FG001|Period 2|Adverse Event|0|||
130226580|NCT02322749|468793700|FG002|Period 2|Adverse Event|0|||
130226581|NCT02322749|468793701|FG003|Period 2|Adverse Event|1|||
130226582|NCT02322749|468793702|FG004|Period 2|Adverse Event|0|||
130226583|NCT02322749|468793703|FG005|Period 2|Adverse Event|0|||
130226584|NCT02322749|468793698|FG000|Period 2|Withdrawal by Subject|0|||
130226585|NCT02322749|468793699|FG001|Period 2|Withdrawal by Subject|0|||
130226586|NCT02322749|468793700|FG002|Period 2|Withdrawal by Subject|0|||
130226587|NCT02322749|468793701|FG003|Period 2|Withdrawal by Subject|1|||
130226588|NCT02322749|468793702|FG004|Period 2|Withdrawal by Subject|0|||
130226589|NCT02322749|468793703|FG005|Period 2|Withdrawal by Subject|0|||
130226590|NCT02322749|468793698|FG000|Period 3|Withdrawal by Subject|0|||
130226591|NCT02322749|468793699|FG001|Period 3|Withdrawal by Subject|0|||
130226592|NCT02322749|468793700|FG002|Period 3|Withdrawal by Subject|1|||
130226593|NCT02322749|468793701|FG003|Period 3|Withdrawal by Subject|0|||
130226594|NCT02322749|468793702|FG004|Period 3|Withdrawal by Subject|0|||
130226595|NCT02322749|468793703|FG005|Period 3|Withdrawal by Subject|0|||
130226596|NCT05158140|468793714|FG000|Overall Study|Death|0|||
130226597|NCT05158140|468793715|FG001|Overall Study|Death|0|||
130226598|NCT05158140|468793716|FG002|Overall Study|Death|0|||
130226599|NCT05158140|468793717|FG003|Overall Study|Death|1|||
130226600|NCT05158140|468793714|FG000|Overall Study|Lost to Follow-up|3|||
130226601|NCT05158140|468793715|FG001|Overall Study|Lost to Follow-up|6|||
130226602|NCT05158140|468793716|FG002|Overall Study|Lost to Follow-up|4|||
130226603|NCT05158140|468793717|FG003|Overall Study|Lost to Follow-up|3|||
130226604|NCT05158140|468793714|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130226605|NCT05158140|468793715|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130226606|NCT05158140|468793716|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
130226607|NCT05158140|468793717|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130226608|NCT05158140|468793714|FG000|Overall Study|Withdrawal by Subject|3|||
130226609|NCT05158140|468793715|FG001|Overall Study|Withdrawal by Subject|7|||
130226610|NCT05158140|468793716|FG002|Overall Study|Withdrawal by Subject|3|||
130226611|NCT05158140|468793717|FG003|Overall Study|Withdrawal by Subject|7|||
130226612|NCT04414787|468793722|FG000|Overall Study|Patient Death|18|||
130226613|NCT04414787|468793723|FG001|Overall Study|Patient Death|18|||
130226614|NCT04414787|468793724|FG002|Overall Study|Patient Death|15|||
130226615|NCT04414787|468793725|FG003|Overall Study|Patient Death|15|||
130226616|NCT04414787|468793722|FG000|Overall Study|Patient Hospitalization|1|||
130226617|NCT04414787|468793723|FG001|Overall Study|Patient Hospitalization|1|||
130226618|NCT04414787|468793724|FG002|Overall Study|Patient Hospitalization|2|||
130226619|NCT04414787|468793725|FG003|Overall Study|Patient Hospitalization|2|||
130226620|NCT04414787|468793722|FG000|Overall Study|Lost to Follow-up|7|||
130226621|NCT04414787|468793723|FG001|Overall Study|Lost to Follow-up|7|||
130226622|NCT04414787|468793724|FG002|Overall Study|Lost to Follow-up|5|||
130226623|NCT04414787|468793725|FG003|Overall Study|Lost to Follow-up|5|||
130226624|NCT04414787|468793722|FG000|Overall Study|Residence in post-acute care facility|3|||
130226625|NCT04414787|468793723|FG001|Overall Study|Residence in post-acute care facility|3|||
130226626|NCT04414787|468793724|FG002|Overall Study|Residence in post-acute care facility|5|||
130226627|NCT04414787|468793725|FG003|Overall Study|Residence in post-acute care facility|5|||
130226628|NCT00807365|468793726|FG000|Overall Study|Study Terminated|5|||
130226629|NCT01526785|468793727|FG000|Overall Study|Study Terminated by Sponsor|8|||
130690596|NCT02089685|470493134|FG003|Overall Study|Physician Decision|0|||
130690597|NCT02089685|470493135|FG004|Overall Study|Physician Decision|0|||
130690598|NCT02089685|470493136|FG005|Overall Study|Physician Decision|4|||
130690599|NCT02089685|470493131|FG000|Overall Study|Screen failure|1|||
130690600|NCT02089685|470493132|FG001|Overall Study|Screen failure|0|||
130690601|NCT02089685|470493133|FG002|Overall Study|Screen failure|0|||
130690602|NCT02089685|470493134|FG003|Overall Study|Screen failure|0|||
130690603|NCT02089685|470493135|FG004|Overall Study|Screen failure|0|||
130690604|NCT02089685|470493136|FG005|Overall Study|Screen failure|0|||
130690605|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Adverse Event|11|||
130690606|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Adverse Event|23|||
130690607|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Adverse Event|29|||
130690608|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Adverse Event|2|||
130690609|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Adverse Event|8|||
130690610|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
130690611|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
130690612|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
130690613|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
130690614|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
130690615|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
130690616|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
130690617|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
130690618|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
130690619|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
130690620|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
130690621|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
130690622|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
130690623|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
130690624|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
130690625|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690626|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
130690627|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690628|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690629|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690630|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
130690631|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
130690632|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
130690633|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
130690634|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
130690635|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130690636|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130690637|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
130690638|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130690639|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130690640|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Move|0|||
130690641|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Move|1|||
130690642|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Move|0|||
130690643|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Move|0|||
130690644|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Move|0|||
130690645|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690646|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690647|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690648|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690649|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
130690650|NCT00318461|470493137|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
130690651|NCT00318461|470493138|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690652|NCT00318461|470493139|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690653|NCT00318461|470493140|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
130690654|NCT00318461|470493141|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690655|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Work commitment|0|||
130690656|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Work commitment|0|||
130690657|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Work commitment|0|||
130690658|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Work commitment|0|||
130690659|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Work commitment|1|||
130690660|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Investigator decision|0|||
130690661|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Investigator decision|0|||
130690662|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Investigator decision|0|||
130690663|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Investigator decision|0|||
130690664|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Investigator decision|1|||
130690665|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lack of time|1|||
130690666|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lack of time|0|||
130690667|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lack of time|0|||
130690668|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lack of time|0|||
130690669|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lack of time|0|||
130690670|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690671|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690672|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690673|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690674|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
130690675|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690676|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690677|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690678|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
130690679|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690680|NCT00318461|470493137|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690681|NCT00318461|470493138|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690682|NCT00318461|470493139|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690683|NCT00318461|470493140|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690684|NCT00318461|470493141|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
130690685|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690686|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
130690687|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690688|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690689|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690690|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
130690691|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
130690692|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
130690693|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
130690694|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
130690695|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
130690696|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
130690697|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
130690698|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
130690699|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
130690700|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
130690701|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
130690702|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
130690703|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
130690704|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
130690705|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
130690706|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
130690707|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
130690708|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
130690709|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
130690710|NCT01929863|470493148|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
130690711|NCT01929863|470493149|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
130690712|NCT01929863|470493148|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
130690713|NCT01929863|470493149|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
130690714|NCT01929863|470493148|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
130690715|NCT01929863|470493149|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
130690716|NCT02911701|470493150|FG000|Overall Study|Withdrawal by Subject|2|||
130226630|NCT01526785|468793727|FG000|Overall Study|Death|2|||
130226631|NCT01526785|468793727|FG000|Overall Study|Physician Decision|1|||
130226632|NCT01526785|468793727|FG000|Overall Study|Withdrawal by Subject|2|||
130226633|NCT04350827|468793734|FG000|Overall Study|Lost to Follow-up|1|||
130444466|NCT04157686|469588606|FG006|Overall Study|Adverse Event|0|||
130690717|NCT02911701|470493151|FG001|Overall Study|Withdrawal by Subject|4|||
130690718|NCT02911701|470493150|FG000|Overall Study|Adverse Event|1|||
130690719|NCT02911701|470493151|FG001|Overall Study|Adverse Event|0|||
130690720|NCT00830024|470493152|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130690721|NCT00830024|470493153|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130690722|NCT00429416|470493154|FG000|Overall Study|Death|1|||
130690723|NCT01983969|470493155|FG000|Overall Study|Disease Progression|0|||
130690724|NCT01983969|470493156|FG001|Overall Study|Disease Progression|1|||
130690725|NCT01983969|470493157|FG002|Overall Study|Disease Progression|0|||
130226634|NCT04350827|468793735|FG001|Overall Study|Lost to Follow-up|2|||
130226635|NCT00916578|468795422|FG000|Overall Study|Physician Decision|2|||
130226636|NCT00916578|468795422|FG000|Overall Study|Withdrawal by Subject|3|||
130226637|NCT00916578|468795422|FG000|Overall Study|Insurance Denial|2|||
130226638|NCT00945243|468795427|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
130226639|NCT03256578|468795428|FG000|Overall Study|Excluded Post Randomization|66|||
130226640|NCT03256578|468795429|FG001|Overall Study|Excluded Post Randomization|56|||
130226641|NCT03028142|468795430|FG000|Overall Study|Adverse Event|1|||
130226642|NCT03028142|468795431|FG001|Overall Study|Adverse Event|1|||
130226643|NCT03028142|468795432|FG002|Overall Study|Adverse Event|0|||
130226644|NCT03028142|468795433|FG003|Overall Study|Adverse Event|0|||
130226645|NCT03028142|468795434|FG004|Overall Study|Adverse Event|0|||
130226646|NCT03028142|468795435|FG005|Overall Study|Adverse Event|1|||
130226647|NCT03028142|468795430|FG000|Overall Study|Withdrawal by Subject|0|||
130226648|NCT03028142|468795431|FG001|Overall Study|Withdrawal by Subject|0|||
130226649|NCT03028142|468795432|FG002|Overall Study|Withdrawal by Subject|0|||
130226650|NCT03028142|468795433|FG003|Overall Study|Withdrawal by Subject|0|||
130226651|NCT03028142|468795434|FG004|Overall Study|Withdrawal by Subject|1|||
130226652|NCT03028142|468795435|FG005|Overall Study|Withdrawal by Subject|0|||
130226653|NCT02810418|468795436|FG000|Arm A Dose Escalation|Adverse Event|2|||
130226654|NCT02810418|468795437|FG001|Arm A Dose Escalation|Adverse Event|1|||
130226655|NCT02810418|468795438|FG002|Arm A Dose Escalation|Adverse Event|0|||
130226656|NCT02810418|468795439|FG003|Arm A Dose Escalation|Adverse Event|0|||
130226657|NCT02810418|468795440|FG004|Arm A Dose Escalation|Adverse Event|0|||
130226658|NCT02810418|468795441|FG005|Arm A Dose Escalation|Adverse Event|0|||
130226659|NCT02810418|468795442|FG006|Arm A Dose Escalation|Adverse Event|0|||
130226660|NCT02810418|468795436|FG000|Dose Expansion|Adverse Event|0|||
130226661|NCT02810418|468795437|FG001|Dose Expansion|Adverse Event|1|||
130226662|NCT02810418|468795438|FG002|Dose Expansion|Adverse Event|1|||
130226663|NCT02810418|468795439|FG003|Dose Expansion|Adverse Event|0|||
130226664|NCT02810418|468795440|FG004|Dose Expansion|Adverse Event|0|||
130226665|NCT02810418|468795441|FG005|Dose Expansion|Adverse Event|0|||
130226666|NCT02810418|468795442|FG006|Dose Expansion|Adverse Event|0|||
130226667|NCT02810418|468795436|FG000|Dose Expansion|Physician Decision|0|||
130226668|NCT02810418|468795437|FG001|Dose Expansion|Physician Decision|0|||
130226669|NCT02810418|468795438|FG002|Dose Expansion|Physician Decision|2|||
130226670|NCT02810418|468795439|FG003|Dose Expansion|Physician Decision|0|||
130226671|NCT02810418|468795440|FG004|Dose Expansion|Physician Decision|0|||
130226672|NCT02810418|468795441|FG005|Dose Expansion|Physician Decision|0|||
130226673|NCT02810418|468795442|FG006|Dose Expansion|Physician Decision|0|||
130226674|NCT02810418|468795436|FG000|Arm B Dose Escalation|Adverse Event|0|||
130226675|NCT02810418|468795437|FG001|Arm B Dose Escalation|Adverse Event|0|||
130226676|NCT02810418|468795438|FG002|Arm B Dose Escalation|Adverse Event|0|||
130226677|NCT02810418|468795439|FG003|Arm B Dose Escalation|Adverse Event|0|||
130226678|NCT02810418|468795440|FG004|Arm B Dose Escalation|Adverse Event|1|||
130226679|NCT02810418|468795441|FG005|Arm B Dose Escalation|Adverse Event|2|||
130226680|NCT02810418|468795442|FG006|Arm B Dose Escalation|Adverse Event|0|||
130226681|NCT01162343|468795446|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
130226682|NCT01162343|468795446|FG000|Overall Study|Refused psychiatrist assessment|12|||
130226683|NCT04635839|468795460|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
130226684|NCT04635839|468795461|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
130226685|NCT02870868|468795462|FG000|Overall Study|Withdrawal by Subject|2|||
130226686|NCT02870868|468795463|FG001|Overall Study|Withdrawal by Subject|1|||
130226687|NCT00744939|468795464|FG000|Overall Study|Withdrawal by Subject|9|||
130226688|NCT00744939|468795464|FG000|Overall Study|Protocol Violation|13|||
130226689|NCT00744939|468795464|FG000|Overall Study|Death|24|||
130226690|NCT00744939|468795464|FG000|Overall Study|distance|4|||
130226691|NCT00744939|468795464|FG000|Overall Study|Lost to Follow-up|12|||
130226692|NCT00744939|468795464|FG000|Overall Study|Medical history exclusionary|1|||
130226693|NCT00744939|468795464|FG000|Overall Study|Did not receive Magnevist|7|||
130226694|NCT00744939|468795464|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
130226695|NCT00744939|468795464|FG000|Overall Study|coma|1|||
130226696|NCT00744939|468795464|FG000|Overall Study|incorrect race|1|||
130226697|NCT01674725|468795466|FG000|Overall Study|Adverse Event|1|||
130690726|NCT00436163|470493158|FG000|Overall Study|Lost to Follow-up|2|||
130226698|NCT01674725|468795467|FG001|Overall Study|Adverse Event|0|||
130226699|NCT01674725|468795466|FG000|Overall Study|Did not receive study drug|1|||
130226700|NCT01674725|468795467|FG001|Overall Study|Did not receive study drug|0|||
130226701|NCT01674725|468795466|FG000|Overall Study|Withdrawal by Subject|1|||
130226702|NCT01674725|468795467|FG001|Overall Study|Withdrawal by Subject|0|||
130226703|NCT01674725|468795466|FG000|Overall Study|Lost to Follow-up|0|||
130226704|NCT01674725|468795467|FG001|Overall Study|Lost to Follow-up|1|||
130226705|NCT02900352|468795468|FG000|Overall Study|Lost to Follow-up|28|||
130226706|NCT02900352|468795469|FG001|Overall Study|Lost to Follow-up|17|||
130226707|NCT03074695|468795470|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
130226708|NCT03074695|468795471|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
130226709|NCT03074695|468795470|FG000|Overall Study|Research staff not available|1|||
130690727|NCT00436163|470493158|FG000|Overall Study|Adverse Event|1|||
130226710|NCT03074695|468795471|FG001|Overall Study|Research staff not available|2|||
130226711|NCT03074695|468795470|FG000|Overall Study|Did not receive neuraxial block|2|||
130226712|NCT03074695|468795471|FG001|Overall Study|Did not receive neuraxial block|2|||
130226713|NCT01774981|468795472|FG000|Overall Study|Adverse Event|0|||
130226714|NCT01774981|468795473|FG001|Overall Study|Adverse Event|0|||
130226715|NCT01774981|468795474|FG002|Overall Study|Adverse Event|0|||
130226716|NCT01774981|468795475|FG003|Overall Study|Adverse Event|0|||
130226717|NCT01774981|468795476|FG004|Overall Study|Adverse Event|0|||
130226718|NCT01774981|468795477|FG005|Overall Study|Adverse Event|1|||
130226719|NCT01774981|468795478|FG006|Overall Study|Adverse Event|0|||
130226720|NCT01774981|468795479|FG007|Overall Study|Adverse Event|0|||
130226721|NCT01774981|468795472|FG000|Overall Study|Withdrawal by Subject|0|||
130226722|NCT01774981|468795473|FG001|Overall Study|Withdrawal by Subject|0|||
130226723|NCT01774981|468795474|FG002|Overall Study|Withdrawal by Subject|0|||
130226724|NCT01774981|468795475|FG003|Overall Study|Withdrawal by Subject|0|||
130226725|NCT01774981|468795476|FG004|Overall Study|Withdrawal by Subject|0|||
130226726|NCT01774981|468795477|FG005|Overall Study|Withdrawal by Subject|0|||
130226727|NCT01774981|468795478|FG006|Overall Study|Withdrawal by Subject|0|||
130226728|NCT01774981|468795479|FG007|Overall Study|Withdrawal by Subject|1|||
130226729|NCT01774981|468795472|FG000|Overall Study|Death|0|||
130226730|NCT01774981|468795473|FG001|Overall Study|Death|0|||
130226731|NCT01774981|468795474|FG002|Overall Study|Death|0|||
130226732|NCT01774981|468795475|FG003|Overall Study|Death|0|||
130226733|NCT01774981|468795476|FG004|Overall Study|Death|1|||
130226734|NCT01774981|468795477|FG005|Overall Study|Death|0|||
130226735|NCT01774981|468795478|FG006|Overall Study|Death|0|||
130226736|NCT01774981|468795479|FG007|Overall Study|Death|0|||
130226737|NCT00960193|468795480|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130226738|NCT01239797|468795481|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
130226739|NCT01239797|468795482|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
130226740|NCT01239797|468795481|FG000|Randomized Participants|Participant withdrew consent|1|||
130226741|NCT01239797|468795482|FG001|Randomized Participants|Participant withdrew consent|7|||
130226742|NCT01239797|468795481|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
130226743|NCT01239797|468795482|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
130226744|NCT01239797|468795481|FG000|Treated Participants|Disease progression|185|||
130226745|NCT01239797|468795482|FG001|Treated Participants|Disease progression|185|||
130226746|NCT01239797|468795481|FG000|Treated Participants|Study drug toxicity|39|||
130226747|NCT01239797|468795482|FG001|Treated Participants|Study drug toxicity|45|||
130226748|NCT01239797|468795481|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
130226749|NCT01239797|468795482|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
130226750|NCT01239797|468795481|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
130226751|NCT01239797|468795482|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
130226752|NCT01239797|468795481|FG000|Treated Participants|Administrative reason by sponsor|13|||
130226753|NCT01239797|468795482|FG001|Treated Participants|Administrative reason by sponsor|4|||
130226754|NCT01239797|468795481|FG000|Treated Participants|Other reasons|14|||
130226755|NCT01239797|468795482|FG001|Treated Participants|Other reasons|14|||
130226756|NCT01239797|468795481|FG000|Treated Participants|Participant withdrew consent|6|||
130226757|NCT01239797|468795482|FG001|Treated Participants|Participant withdrew consent|11|||
130226758|NCT01239797|468795481|FG000|Treated Participants|Death|1|||
130226759|NCT01239797|468795482|FG001|Treated Participants|Death|1|||
130226760|NCT01239797|468795481|FG000|Treated Participants|Participant no longer meets study criteria|1|||
130226761|NCT01239797|468795482|FG001|Treated Participants|Participant no longer meets study criteria|1|||
130226762|NCT01239797|468795481|FG000|Treated Participants|Poor/non-compliance|0|||
130226763|NCT01239797|468795482|FG001|Treated Participants|Poor/non-compliance|1|||
130226764|NCT02631941|468795487|FG000|Overall Study|Physician Decision|0|||
130226765|NCT02631941|468795488|FG001|Overall Study|Physician Decision|1|||
130226766|NCT02631941|468795489|FG002|Overall Study|Physician Decision|0|||
130226767|NCT02631941|468795490|FG003|Overall Study|Physician Decision|0|||
130226768|NCT02631941|468795491|FG004|Overall Study|Physician Decision|0|||
130226769|NCT02631941|468795492|FG005|Overall Study|Physician Decision|0|||
130226770|NCT02631941|468795493|FG006|Overall Study|Physician Decision|0|||
130226771|NCT02631941|468795494|FG007|Overall Study|Physician Decision|0|||
130226772|NCT02631941|468795495|FG008|Overall Study|Physician Decision|0|||
130226773|NCT02631941|468795496|FG009|Overall Study|Physician Decision|0|||
130226774|NCT02631941|468795487|FG000|Overall Study|Adverse Event|0|||
130226775|NCT02631941|468795488|FG001|Overall Study|Adverse Event|1|||
130226776|NCT02631941|468795489|FG002|Overall Study|Adverse Event|0|||
130226777|NCT02631941|468795490|FG003|Overall Study|Adverse Event|0|||
130226778|NCT02631941|468795491|FG004|Overall Study|Adverse Event|0|||
130226779|NCT02631941|468795492|FG005|Overall Study|Adverse Event|0|||
130226780|NCT02631941|468795493|FG006|Overall Study|Adverse Event|0|||
130226781|NCT02631941|468795494|FG007|Overall Study|Adverse Event|0|||
130226782|NCT02631941|468795495|FG008|Overall Study|Adverse Event|0|||
130226783|NCT02631941|468795496|FG009|Overall Study|Adverse Event|0|||
130226784|NCT02631941|468795487|FG000|Overall Study|Withdrawal by Subject|0|||
130226785|NCT02631941|468795488|FG001|Overall Study|Withdrawal by Subject|0|||
130226786|NCT02631941|468795489|FG002|Overall Study|Withdrawal by Subject|0|||
130444467|NCT04157686|469588607|FG007|Overall Study|Adverse Event|0|||
130444468|NCT04157686|469588600|FG000|Overall Study|Pregnancy|0|||
130444469|NCT04157686|469588601|FG001|Overall Study|Pregnancy|1|||
130444470|NCT04157686|469588602|FG002|Overall Study|Pregnancy|3|||
130444471|NCT04157686|469588603|FG003|Overall Study|Pregnancy|0|||
130444472|NCT04157686|469588604|FG004|Overall Study|Pregnancy|0|||
130444473|NCT04157686|469588605|FG005|Overall Study|Pregnancy|0|||
130444474|NCT04157686|469588606|FG006|Overall Study|Pregnancy|3|||
130444475|NCT04157686|469588607|FG007|Overall Study|Pregnancy|0|||
130444476|NCT04157686|469588600|FG000|Overall Study|Lost to Follow-up|1|||
130690728|NCT02530905|470493159|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130690729|NCT02530905|470493160|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130226787|NCT02631941|468795490|FG003|Overall Study|Withdrawal by Subject|0|||
130226788|NCT02631941|468795491|FG004|Overall Study|Withdrawal by Subject|1|||
130226789|NCT02631941|468795492|FG005|Overall Study|Withdrawal by Subject|0|||
130226790|NCT02631941|468795493|FG006|Overall Study|Withdrawal by Subject|0|||
130226791|NCT02631941|468795494|FG007|Overall Study|Withdrawal by Subject|1|||
130226792|NCT02631941|468795495|FG008|Overall Study|Withdrawal by Subject|0|||
130226793|NCT02631941|468795496|FG009|Overall Study|Withdrawal by Subject|0|||
130226794|NCT02631941|468795487|FG000|Overall Study|Lost to Follow-up|0|||
130226795|NCT02631941|468795488|FG001|Overall Study|Lost to Follow-up|0|||
130226796|NCT02631941|468795489|FG002|Overall Study|Lost to Follow-up|0|||
130226797|NCT02631941|468795490|FG003|Overall Study|Lost to Follow-up|0|||
130226798|NCT02631941|468795491|FG004|Overall Study|Lost to Follow-up|0|||
130226799|NCT02631941|468795492|FG005|Overall Study|Lost to Follow-up|0|||
130226800|NCT02631941|468795493|FG006|Overall Study|Lost to Follow-up|0|||
130226801|NCT02631941|468795494|FG007|Overall Study|Lost to Follow-up|0|||
130226802|NCT02631941|468795495|FG008|Overall Study|Lost to Follow-up|1|||
130226803|NCT02631941|468795496|FG009|Overall Study|Lost to Follow-up|0|||
130226804|NCT02915835|468795497|FG000|Overall Study|Physician Decision|1|||
130226805|NCT02915835|468795498|FG001|Overall Study|Physician Decision|0|||
130226806|NCT02915835|468795497|FG000|Overall Study|Withdrawal by Subject|0|||
130226807|NCT02915835|468795498|FG001|Overall Study|Withdrawal by Subject|1|||
130226808|NCT03722576|468795499|FG000|Overall Study|Withdrawal by Subject|3|||
130226809|NCT03722576|468795499|FG000|Overall Study|Adverse Event|2|||
130226810|NCT03722576|468795499|FG000|Overall Study|Physician Decision|1|||
130226811|NCT03722576|468795499|FG000|Overall Study|Lost to Follow-up|1|||
130226812|NCT02513550|468795502|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
130226813|NCT02513550|468795503|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
130226814|NCT02513550|468795504|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
130226815|NCT02513550|468795505|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226816|NCT02513550|468795506|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226817|NCT02513550|468795507|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226818|NCT02513550|468795502|FG000|Double Blind Treatment Period|Adverse Event|5|||
130226819|NCT02513550|468795503|FG001|Double Blind Treatment Period|Adverse Event|13|||
130226820|NCT02513550|468795504|FG002|Double Blind Treatment Period|Adverse Event|17|||
130226821|NCT02513550|468795505|FG003|Double Blind Treatment Period|Adverse Event|0|||
130226822|NCT02513550|468795506|FG004|Double Blind Treatment Period|Adverse Event|1|||
130226823|NCT02513550|468795507|FG005|Double Blind Treatment Period|Adverse Event|0|||
130226824|NCT02513550|468795502|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
130226825|NCT02513550|468795503|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
130226826|NCT02513550|468795504|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
130226827|NCT02513550|468795505|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
130226828|NCT02513550|468795506|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
130226829|NCT02513550|468795507|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
130226830|NCT02513550|468795502|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
130226831|NCT02513550|468795503|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
130226832|NCT02513550|468795504|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
130690730|NCT02530905|470493161|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
130690731|NCT00950989|470493163|FG000|Overall Study|Death|0|||
130226833|NCT02513550|468795505|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130226834|NCT02513550|468795506|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130226835|NCT02513550|468795507|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
130226836|NCT02513550|468795502|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130226837|NCT02513550|468795503|FG001|Double Blind Treatment Period|Protocol Violation|1|||
130226838|NCT02513550|468795504|FG002|Double Blind Treatment Period|Protocol Violation|4|||
130444477|NCT04157686|469588601|FG001|Overall Study|Lost to Follow-up|2|||
130444478|NCT04157686|469588602|FG002|Overall Study|Lost to Follow-up|8|||
130552884|NCT00752622|469991607|FG000|Interventional Phase|Physician Decision|1|||
130552885|NCT00752622|469991607|FG000|Interventional Phase|Premature Study Termination|5|||
130226839|NCT02513550|468795505|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130444479|NCT04157686|469588603|FG003|Overall Study|Lost to Follow-up|6|||
130444480|NCT04157686|469588604|FG004|Overall Study|Lost to Follow-up|6|||
130690732|NCT00950989|470493164|FG001|Overall Study|Death|0|||
130690733|NCT00950989|470493165|FG002|Overall Study|Death|1|||
130690734|NCT00950989|470493166|FG003|Overall Study|Death|0|||
130690735|NCT00950989|470493163|FG000|Overall Study|Administrative Decision|0|||
130690736|NCT00950989|470493164|FG001|Overall Study|Administrative Decision|1|||
130690737|NCT00950989|470493165|FG002|Overall Study|Administrative Decision|0|||
130690738|NCT00950989|470493166|FG003|Overall Study|Administrative Decision|0|||
130690739|NCT00950989|470493163|FG000|Overall Study|Disease Progression|0|||
130690740|NCT00950989|470493164|FG001|Overall Study|Disease Progression|0|||
130690741|NCT00950989|470493165|FG002|Overall Study|Disease Progression|1|||
130690742|NCT00950989|470493166|FG003|Overall Study|Disease Progression|0|||
130690743|NCT00950989|470493163|FG000|Overall Study|Withdrawal by Subject|2|||
130690744|NCT00950989|470493164|FG001|Overall Study|Withdrawal by Subject|1|||
130690745|NCT00950989|470493165|FG002|Overall Study|Withdrawal by Subject|0|||
130690746|NCT00950989|470493166|FG003|Overall Study|Withdrawal by Subject|0|||
130690747|NCT00950989|470493163|FG000|Overall Study|Adverse Event|2|||
130690748|NCT00950989|470493164|FG001|Overall Study|Adverse Event|1|||
130690749|NCT00950989|470493165|FG002|Overall Study|Adverse Event|1|||
130690750|NCT00950989|470493166|FG003|Overall Study|Adverse Event|0|||
130690751|NCT01841554|470493167|FG000|Overall Study|Death|7|||
130690752|NCT01841554|470493167|FG000|Overall Study|No Implantation|1|||
130690753|NCT01841554|470493167|FG000|Overall Study|Discontinued Follow Up|5|||
130690754|NCT01841554|470493167|FG000|Overall Study|Study exit due to secondary intervention|6|||
130690755|NCT03804983|470493171|FG000|Overall Study|Adverse Event|0|||
130690756|NCT03804983|470493172|FG001|Overall Study|Adverse Event|1|||
130690757|NCT03804983|470493171|FG000|Overall Study|Family Obligation|1|||
130690758|NCT03804983|470493172|FG001|Overall Study|Family Obligation|0|||
130690759|NCT03600376|470493173|FG000|Overall Study|Adverse Event|1|||
130690760|NCT03600376|470493174|FG001|Overall Study|Adverse Event|1|||
130690761|NCT03600376|470493173|FG000|Overall Study|Transferred to other facility|1|||
130690762|NCT03600376|470493174|FG001|Overall Study|Transferred to other facility|0|||
130690763|NCT03600376|470493173|FG000|Overall Study|Investigator Decision|0|||
130690764|NCT03600376|470493174|FG001|Overall Study|Investigator Decision|4|||
130690765|NCT03600376|470493173|FG000|Overall Study|Determined to be ineligible for study|0|||
130690766|NCT03600376|470493174|FG001|Overall Study|Determined to be ineligible for study|1|||
130690767|NCT02152163|470493175|FG000|Overall Study|Physician Decision|12|||
130690768|NCT02152163|470493176|FG001|Overall Study|Physician Decision|13|||
130690769|NCT00796562|470493177|FG000|Overall Study|Death|49|||
130690770|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
130690771|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
130690772|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
130690773|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
130690774|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
130690775|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
130690776|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
130690777|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
130690778|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
130690779|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
130690780|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
130690781|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
130690782|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Adverse Event|22|||
130690783|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Adverse Event|12|||
130690784|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Progression of disease|92|||
130690785|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Progression of disease|128|||
130690786|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
130690787|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
130690788|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
130690789|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
130690790|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Death|11|||
130690791|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Death|11|||
130690792|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Other|5|||
130690793|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Other|4|||
130690794|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
130690795|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
130690796|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
130690797|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
130690798|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
130690799|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
130690800|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
130690801|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
130690802|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
130690803|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
130226840|NCT02513550|468795506|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130226841|NCT02513550|468795507|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130226842|NCT02513550|468795502|FG000|Double Blind Treatment Period|Physician Decision|2|||
130226843|NCT02513550|468795503|FG001|Double Blind Treatment Period|Physician Decision|0|||
130226844|NCT02513550|468795504|FG002|Double Blind Treatment Period|Physician Decision|4|||
130226845|NCT02513550|468795505|FG003|Double Blind Treatment Period|Physician Decision|0|||
130226846|NCT02513550|468795506|FG004|Double Blind Treatment Period|Physician Decision|0|||
130226847|NCT02513550|468795507|FG005|Double Blind Treatment Period|Physician Decision|0|||
130226848|NCT02513550|468795502|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
130226849|NCT02513550|468795503|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
130226850|NCT02513550|468795504|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
130226851|NCT02513550|468795505|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226852|NCT02513550|468795506|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226853|NCT02513550|468795507|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226854|NCT02513550|468795502|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226855|NCT02513550|468795503|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226856|NCT02513550|468795504|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
130226857|NCT02513550|468795505|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226858|NCT02513550|468795506|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226859|NCT02513550|468795507|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226860|NCT02513550|468795502|FG000|Double Blind Treatment Period|Due to personal business|2|||
130226861|NCT02513550|468795503|FG001|Double Blind Treatment Period|Due to personal business|0|||
130226862|NCT02513550|468795504|FG002|Double Blind Treatment Period|Due to personal business|1|||
130226863|NCT02513550|468795505|FG003|Double Blind Treatment Period|Due to personal business|0|||
130226864|NCT02513550|468795506|FG004|Double Blind Treatment Period|Due to personal business|0|||
130226865|NCT02513550|468795507|FG005|Double Blind Treatment Period|Due to personal business|0|||
130226866|NCT02513550|468795502|FG000|Double Blind Treatment Period|Death|1|||
130226867|NCT02513550|468795503|FG001|Double Blind Treatment Period|Death|0|||
130226868|NCT02513550|468795504|FG002|Double Blind Treatment Period|Death|2|||
130226869|NCT02513550|468795505|FG003|Double Blind Treatment Period|Death|0|||
130226870|NCT02513550|468795506|FG004|Double Blind Treatment Period|Death|0|||
130226871|NCT02513550|468795507|FG005|Double Blind Treatment Period|Death|0|||
130226872|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
130226873|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
130226874|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
130226875|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226876|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226877|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226878|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
130226879|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
130444481|NCT04157686|469588605|FG005|Overall Study|Lost to Follow-up|3|||
130226880|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
130226881|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226882|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226883|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226884|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
130226885|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
130226886|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
130226887|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226888|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226889|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226890|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
130226891|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
130226892|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
130444482|NCT04157686|469588606|FG006|Overall Study|Lost to Follow-up|7|||
130444483|NCT04157686|469588607|FG007|Overall Study|Lost to Follow-up|9|||
130444484|NCT04157686|469588600|FG000|Overall Study|Lack of Efficacy|0|||
130444485|NCT04157686|469588601|FG001|Overall Study|Lack of Efficacy|0|||
130444486|NCT04157686|469588602|FG002|Overall Study|Lack of Efficacy|0|||
130226893|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
130226894|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
130226895|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
130226896|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
130226897|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
130444487|NCT04157686|469588603|FG003|Overall Study|Lack of Efficacy|0|||
130444488|NCT04157686|469588604|FG004|Overall Study|Lack of Efficacy|0|||
130226898|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
130226899|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
130226900|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
130226901|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
130226902|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Death|0|||
130226903|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Death|0|||
130226904|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Death|1|||
130226905|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Death|0|||
130444489|NCT04157686|469588605|FG005|Overall Study|Lack of Efficacy|2|||
130444490|NCT04157686|469588606|FG006|Overall Study|Lack of Efficacy|0|||
130444491|NCT04157686|469588607|FG007|Overall Study|Lack of Efficacy|1|||
130444492|NCT04157686|469588600|FG000|Overall Study|Withdrawal by Subject|10|||
130444493|NCT04157686|469588601|FG001|Overall Study|Withdrawal by Subject|10|||
130444494|NCT04157686|469588602|FG002|Overall Study|Withdrawal by Subject|12|||
130444495|NCT04157686|469588603|FG003|Overall Study|Withdrawal by Subject|20|||
130444496|NCT04157686|469588604|FG004|Overall Study|Withdrawal by Subject|12|||
130444497|NCT04157686|469588605|FG005|Overall Study|Withdrawal by Subject|11|||
130444498|NCT04157686|469588606|FG006|Overall Study|Withdrawal by Subject|18|||
130444499|NCT04157686|469588607|FG007|Overall Study|Withdrawal by Subject|24|||
130444500|NCT04157686|469588600|FG000|Overall Study|Physician Decision|0|||
130444501|NCT04157686|469588601|FG001|Overall Study|Physician Decision|0|||
130444502|NCT04157686|469588602|FG002|Overall Study|Physician Decision|1|||
130444503|NCT04157686|469588603|FG003|Overall Study|Physician Decision|0|||
130444504|NCT04157686|469588604|FG004|Overall Study|Physician Decision|1|||
130444505|NCT04157686|469588605|FG005|Overall Study|Physician Decision|0|||
130444506|NCT04157686|469588606|FG006|Overall Study|Physician Decision|3|||
130444507|NCT04157686|469588607|FG007|Overall Study|Physician Decision|0|||
130444508|NCT04157686|469588600|FG000|Overall Study|Death|0|||
130444509|NCT04157686|469588601|FG001|Overall Study|Death|0|||
130444510|NCT04157686|469588602|FG002|Overall Study|Death|0|||
130444511|NCT04157686|469588603|FG003|Overall Study|Death|2|||
130444512|NCT04157686|469588604|FG004|Overall Study|Death|0|||
130444513|NCT04157686|469588605|FG005|Overall Study|Death|0|||
130444514|NCT04157686|469588606|FG006|Overall Study|Death|0|||
130444515|NCT04157686|469588607|FG007|Overall Study|Death|0|||
130444516|NCT04157686|469588600|FG000|Overall Study|Protocol Violation|0|||
130444517|NCT04157686|469588601|FG001|Overall Study|Protocol Violation|0|||
130444518|NCT04157686|469588602|FG002|Overall Study|Protocol Violation|0|||
130444519|NCT04157686|469588603|FG003|Overall Study|Protocol Violation|0|||
130444520|NCT04157686|469588604|FG004|Overall Study|Protocol Violation|1|||
130444521|NCT04157686|469588605|FG005|Overall Study|Protocol Violation|0|||
130444522|NCT04157686|469588606|FG006|Overall Study|Protocol Violation|0|||
130444523|NCT04157686|469588607|FG007|Overall Study|Protocol Violation|0|||
130444524|NCT04157686|469588600|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
130444525|NCT04157686|469588601|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
130444526|NCT04157686|469588602|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
130444527|NCT04157686|469588603|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
130444528|NCT04157686|469588604|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
130444529|NCT04157686|469588605|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
130444530|NCT04157686|469588606|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
130444531|NCT04157686|469588607|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
130444532|NCT04212169|469590226|FG000|Overall Study|Adverse Event|0|||
130444533|NCT04212169|469590227|FG001|Overall Study|Adverse Event|0|||
130444534|NCT04212169|469590228|FG002|Overall Study|Adverse Event|0|||
130444535|NCT04212169|469590229|FG003|Overall Study|Adverse Event|2|||
130444536|NCT04212169|469590226|FG000|Overall Study|Lost to Follow-up|1|||
130444537|NCT04212169|469590227|FG001|Overall Study|Lost to Follow-up|0|||
130444538|NCT04212169|469590228|FG002|Overall Study|Lost to Follow-up|0|||
130444539|NCT04212169|469590229|FG003|Overall Study|Lost to Follow-up|2|||
130444540|NCT04212169|469590226|FG000|Overall Study|Withdrawal by Subject|10|||
130444541|NCT04212169|469590227|FG001|Overall Study|Withdrawal by Subject|2|||
130444542|NCT04212169|469590228|FG002|Overall Study|Withdrawal by Subject|5|||
130444543|NCT04212169|469590229|FG003|Overall Study|Withdrawal by Subject|7|||
130226906|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Death|0|||
130444544|NCT04212169|469590226|FG000|Overall Study|Other reason, unspecified|3|||
130444545|NCT04212169|469590227|FG001|Overall Study|Other reason, unspecified|1|||
130444546|NCT04212169|469590228|FG002|Overall Study|Other reason, unspecified|0|||
130444547|NCT04212169|469590229|FG003|Overall Study|Other reason, unspecified|2|||
130226907|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Death|0|||
130444548|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130444549|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
130444550|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
130444551|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
130444552|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
130444553|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
130444554|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130226908|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226909|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226910|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
130226911|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226912|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226913|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226914|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226915|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226916|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
130226917|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226918|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226919|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226920|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226921|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226922|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
130226923|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226924|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226925|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226926|NCT00192114|468795511|FG000|Overall Study|Objective Tumor Progression|19|||
130226927|NCT00192114|468795511|FG000|Overall Study|Adverse Event|2|||
130226928|NCT00192114|468795511|FG000|Overall Study|Clinical Progression|2|||
130226929|NCT00192114|468795511|FG000|Overall Study|Death|1|||
130226930|NCT00492297|468795512|FG000|Treatment|Death|2|||
130226931|NCT00492297|468795512|FG000|Treatment|Study terminated by sponsor|3|||
130226932|NCT00492297|468795512|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
130226933|NCT00492297|468795512|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
130226934|NCT00492297|468795512|FG000|Survival Only Follow-up|Death|46|||
130226935|NCT00492297|468795512|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
130226936|NCT00492297|468795512|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
130226937|NCT01408706|468795514|FG000|Overall Study|Physician Decision|1|||
130226938|NCT01408706|468795515|FG001|Overall Study|Physician Decision|0|||
130226939|NCT00113607|468795516|FG000|Overall Study|Adverse Event|40|||
130226940|NCT00113607|468795517|FG001|Overall Study|Adverse Event|71|||
130226941|NCT00113607|468795516|FG000|Overall Study|Death|8|||
130226942|NCT00113607|468795517|FG001|Overall Study|Death|8|||
130226943|NCT00113607|468795516|FG000|Overall Study|Withdrawal by Subject|50|||
130226944|NCT00113607|468795517|FG001|Overall Study|Withdrawal by Subject|58|||
130226945|NCT00113607|468795516|FG000|Overall Study|Lost to Follow-up|0|||
130226946|NCT00113607|468795517|FG001|Overall Study|Lost to Follow-up|2|||
130226947|NCT00113607|468795516|FG000|Overall Study|Disease Progression|180|||
130226948|NCT00113607|468795517|FG001|Overall Study|Disease Progression|142|||
130226949|NCT00113607|468795516|FG000|Overall Study|Complete Response (Confirmed)|14|||
130226950|NCT00113607|468795517|FG001|Overall Study|Complete Response (Confirmed)|24|||
130226951|NCT00113607|468795516|FG000|Overall Study|Other|43|||
130226952|NCT00113607|468795517|FG001|Overall Study|Other|32|||
130226953|NCT01222104|468795518|FG000|Overall Study|Lost to Follow-up|37|||
130226954|NCT01222104|468795518|FG000|Overall Study|Death|10|||
130226955|NCT01418339|468795520|FG000|Overall Study|Adverse Event|5|||
130226956|NCT01418339|468795521|FG001|Overall Study|Adverse Event|2|||
130226957|NCT01418339|468795520|FG000|Overall Study|Subject Withdrew Consent|1|||
130226958|NCT01418339|468795521|FG001|Overall Study|Subject Withdrew Consent|2|||
130226959|NCT01418339|468795520|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
130226960|NCT01418339|468795521|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
130226961|NCT03885908|468795522|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
130226962|NCT03885908|468795523|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
130226963|NCT03885908|468795522|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
130226964|NCT03885908|468795523|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
130226965|NCT03885908|468795522|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
130226966|NCT03885908|468795523|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
130226967|NCT03885908|468795522|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
130226968|NCT03885908|468795523|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
130226969|NCT02204917|468795524|FG000|Overall Study|Protocol Violation|1|||
130226970|NCT03669549|468795525|FG000|Overall Study|Adverse Event|4|||
130226971|NCT03669549|468795525|FG000|Overall Study|Withdrawal by Subject|1|||
130226972|NCT03669549|468795525|FG000|Overall Study|Study terminated by the Sponsor|1|||
130226973|NCT00909844|468795526|FG000|Overall Study|Adverse Event|1|||
130226974|NCT00909844|468795526|FG000|Overall Study|Withdrawal by Subject|1|||
130226975|NCT00909844|468795526|FG000|Overall Study|Lost to Follow-up|2|||
130226976|NCT00698815|468795527|FG000|Overall Study|Death|1|||
130226977|NCT00698815|468795528|FG001|Overall Study|Death|2|||
130226978|NCT00698815|468795529|FG002|Overall Study|Death|4|||
130226979|NCT00698815|468795527|FG000|Overall Study|Withdrawal by Subject|6|||
130226980|NCT00698815|468795528|FG001|Overall Study|Withdrawal by Subject|3|||
130226981|NCT00698815|468795529|FG002|Overall Study|Withdrawal by Subject|2|||
130226982|NCT00698815|468795527|FG000|Overall Study|MD discretion|2|||
130226983|NCT00698815|468795528|FG001|Overall Study|MD discretion|7|||
130226984|NCT00698815|468795529|FG002|Overall Study|MD discretion|2|||
130226985|NCT00698815|468795527|FG000|Overall Study|Did not receive protocol treatment|1|||
130226986|NCT00698815|468795528|FG001|Overall Study|Did not receive protocol treatment|2|||
130226987|NCT00698815|468795529|FG002|Overall Study|Did not receive protocol treatment|2|||
130226988|NCT01064479|468795530|FG000|Overall Study|Death|10|||
130226989|NCT01064479|468795531|FG001|Overall Study|Death|11|||
130226990|NCT01064479|468795530|FG000|Overall Study|Withdrawal by Subject|2|||
130226991|NCT01064479|468795531|FG001|Overall Study|Withdrawal by Subject|2|||
130226992|NCT01064479|468795530|FG000|Overall Study|Disease progression|1|||
130226993|NCT01064479|468795531|FG001|Overall Study|Disease progression|1|||
130226994|NCT01064479|468795530|FG000|Overall Study|Toxicity|1|||
130226995|NCT01064479|468795531|FG001|Overall Study|Toxicity|1|||
130226996|NCT01064479|468795530|FG000|Overall Study|Other|1|||
130226997|NCT01064479|468795531|FG001|Overall Study|Other|2|||
130226998|NCT01663402|468795536|FG000|Overall Study|Randomized but not treated|19|||
130226999|NCT01663402|468795537|FG001|Overall Study|Randomized but not treated|11|||
130227000|NCT01663402|468795536|FG000|Overall Study|Adverse Event|347|||
130227001|NCT01663402|468795537|FG001|Overall Study|Adverse Event|362|||
130227002|NCT01663402|468795536|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
130227003|NCT01663402|468795537|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
130227004|NCT01663402|468795536|FG000|Overall Study|Poor compliance to protocol|529|||
130227005|NCT01663402|468795537|FG001|Overall Study|Poor compliance to protocol|454|||
130227006|NCT01663402|468795536|FG000|Overall Study|Physician Decision|77|||
130227007|NCT01663402|468795537|FG001|Overall Study|Physician Decision|62|||
130227008|NCT01663402|468795536|FG000|Overall Study|Site terminated by sponsor|1|||
130227009|NCT01663402|468795537|FG001|Overall Study|Site terminated by sponsor|3|||
130227010|NCT01663402|468795536|FG000|Overall Study|Participant moved|139|||
130227011|NCT01663402|468795537|FG001|Overall Study|Participant moved|104|||
130227012|NCT01663402|468795536|FG000|Overall Study|Withdrawal by Subject|118|||
130227013|NCT01663402|468795537|FG001|Overall Study|Withdrawal by Subject|91|||
130227014|NCT01663402|468795536|FG000|Overall Study|Related to study drug administration|96|||
130227015|NCT01663402|468795537|FG001|Overall Study|Related to study drug administration|105|||
130227016|NCT01663402|468795536|FG000|Overall Study|Lost to Follow-up|17|||
130227017|NCT01663402|468795537|FG001|Overall Study|Lost to Follow-up|15|||
130227018|NCT01663402|468795536|FG000|Overall Study|Other than specified above|172|||
130227019|NCT01663402|468795537|FG001|Overall Study|Other than specified above|147|||
130227020|NCT02984982|468795551|FG000|Overall Study|Adverse Event|2|||
130227021|NCT02984982|468795552|FG001|Overall Study|Adverse Event|5|||
130227022|NCT02984982|468795551|FG000|Overall Study|Poor Compliance to Protocol|4|||
130227023|NCT02984982|468795552|FG001|Overall Study|Poor Compliance to Protocol|4|||
130227024|NCT02984982|468795551|FG000|Overall Study|Withdrawal by Subject|2|||
130227025|NCT02984982|468795552|FG001|Overall Study|Withdrawal by Subject|0|||
130227026|NCT02984982|468795551|FG000|Overall Study|Randomized but not treated|0|||
130227027|NCT02984982|468795552|FG001|Overall Study|Randomized but not treated|1|||
130227028|NCT01747499|468795554|FG000|Overall Study|Steroid refractory aGvHD|1|||
130227029|NCT01747499|468795555|FG001|Overall Study|Steroid refractory aGvHD|0|||
130444555|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130444556|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130690812|NCT02571907|470494382|FG000|Overall Study|Death|4|||
130690813|NCT02571907|470494382|FG000|Overall Study|Lost to Follow-up|3|||
130690814|NCT02571907|470494382|FG000|Overall Study|Withdrawal by Subject|3|||
130690815|NCT02286739|470494387|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
130690816|NCT02286739|470494388|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
130690817|NCT02286739|470494387|FG000|Overall Study|No Verasense type documented|0|||
130690818|NCT02286739|470494388|FG001|Overall Study|No Verasense type documented|23|||
130690819|NCT02286739|470494387|FG000|Overall Study|Adverse Event|1|||
130690820|NCT02286739|470494388|FG001|Overall Study|Adverse Event|2|||
130690821|NCT02286739|470494387|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
130690822|NCT02286739|470494388|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
130227030|NCT01747499|468795556|FG002|Overall Study|Steroid refractory aGvHD|0|||
130227031|NCT01747499|468795557|FG003|Overall Study|Steroid refractory aGvHD|1|||
130227032|NCT01747499|468795558|FG004|Overall Study|Steroid refractory aGvHD|4|||
130227033|NCT01747499|468795554|FG000|Overall Study|Physician Decision|0|||
130227034|NCT01747499|468795555|FG001|Overall Study|Physician Decision|1|||
130227035|NCT01747499|468795556|FG002|Overall Study|Physician Decision|0|||
130227036|NCT01747499|468795557|FG003|Overall Study|Physician Decision|0|||
130227037|NCT01747499|468795558|FG004|Overall Study|Physician Decision|2|||
130227038|NCT01747499|468795554|FG000|Overall Study|Death|0|||
130227039|NCT01747499|468795555|FG001|Overall Study|Death|0|||
130227040|NCT01747499|468795556|FG002|Overall Study|Death|0|||
130227041|NCT01747499|468795557|FG003|Overall Study|Death|1|||
130227042|NCT01747499|468795558|FG004|Overall Study|Death|1|||
130227043|NCT01747499|468795554|FG000|Overall Study|Withdrawal by Subject|0|||
130227044|NCT01747499|468795555|FG001|Overall Study|Withdrawal by Subject|0|||
130227045|NCT01747499|468795556|FG002|Overall Study|Withdrawal by Subject|0|||
130227046|NCT01747499|468795557|FG003|Overall Study|Withdrawal by Subject|0|||
130227047|NCT01747499|468795558|FG004|Overall Study|Withdrawal by Subject|6|||
130227048|NCT01747499|468795554|FG000|Overall Study|Developed AML and death|0|||
130227049|NCT01747499|468795555|FG001|Overall Study|Developed AML and death|0|||
130227050|NCT01747499|468795556|FG002|Overall Study|Developed AML and death|0|||
130227051|NCT01747499|468795557|FG003|Overall Study|Developed AML and death|0|||
130227052|NCT01747499|468795558|FG004|Overall Study|Developed AML and death|1|||
130227053|NCT01747499|468795554|FG000|Overall Study|Determined not to be eligible|0|||
130227054|NCT01747499|468795555|FG001|Overall Study|Determined not to be eligible|0|||
130227055|NCT01747499|468795556|FG002|Overall Study|Determined not to be eligible|0|||
130227056|NCT01747499|468795557|FG003|Overall Study|Determined not to be eligible|0|||
130227057|NCT01747499|468795558|FG004|Overall Study|Determined not to be eligible|1|||
130227058|NCT01103323|468795559|FG000|Without/Before Drug Switch|Adverse Event|50|||
130227059|NCT01103323|468795560|FG001|Without/Before Drug Switch|Adverse Event|7|||
130227060|NCT01103323|468795559|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
130227061|NCT01103323|468795560|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
130227062|NCT01103323|468795559|FG000|Without/Before Drug Switch|Protocol Violation|2|||
130227063|NCT01103323|468795560|FG001|Without/Before Drug Switch|Protocol Violation|0|||
130227064|NCT01103323|468795559|FG000|Without/Before Drug Switch|Physician Decision|2|||
130227065|NCT01103323|468795560|FG001|Without/Before Drug Switch|Physician Decision|0|||
130227066|NCT01103323|468795559|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
130227067|NCT01103323|468795560|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
130227068|NCT01103323|468795559|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
130227069|NCT01103323|468795560|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
130227070|NCT01103323|468795559|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
130227071|NCT01103323|468795560|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
130227072|NCT00372424|468795561|FG000|Overall Study|Adverse Event|2|||
130227073|NCT00372424|468795561|FG000|Overall Study|Withdrawal by Subject|1|||
130227074|NCT00372424|468795561|FG000|Overall Study|Death|1|||
130227075|NCT00372424|468795561|FG000|Overall Study|Objective Progression or Relapse|14|||
130227076|NCT00372424|468795561|FG000|Overall Study|Other|7|||
130227077|NCT00372424|468795561|FG000|Overall Study|Enrolled, Not Treated|1|||
130227078|NCT00072410|468795562|FG000|Overall Study|Progressive disease|0|||
130227079|NCT00072410|468795563|FG001|Overall Study|Progressive disease|3|||
130227080|NCT03160716|468795565|FG000|Overall Study|Lost to Follow-up|1|||
130227081|NCT00875810|468795569|FG000|Overall Study|Withdrawal by Subject|1|||
130227082|NCT00875810|468795569|FG000|Overall Study|Physician Decision|3|||
130227083|NCT00875810|468795569|FG000|Overall Study|Lost to Follow-up|39|||
130227084|NCT00875810|468795569|FG000|Overall Study|Patient enroled but not implanted|2|||
130227085|NCT00875810|468795569|FG000|Overall Study|Device explanted|1|||
130227086|NCT00780975|468795572|FG000|Overall Study|Progressive disease|3|||
130227087|NCT00780975|468795572|FG000|Overall Study|Toxicity|5|||
130227088|NCT01939314|468795573|FG000|Overall Study|Withdrawal by Subject|3|||
130227089|NCT01939314|468795574|FG001|Overall Study|Withdrawal by Subject|1|||
130227090|NCT01939314|468795573|FG000|Overall Study|Protocol Violation|1|||
130227091|NCT01939314|468795574|FG001|Overall Study|Protocol Violation|0|||
130227092|NCT01939314|468795573|FG000|Overall Study|Pregnancy|0|||
130227093|NCT01939314|468795574|FG001|Overall Study|Pregnancy|1|||
130227094|NCT01939314|468795573|FG000|Overall Study|Lost to Follow-up|5|||
130227095|NCT01939314|468795574|FG001|Overall Study|Lost to Follow-up|6|||
130227096|NCT00969228|468795578|FG000|Overall Study|Adverse Event|1|||
130227097|NCT00969228|468795579|FG001|Overall Study|Adverse Event|0|||
130227098|NCT00969228|468795578|FG000|Overall Study|Withdrawal by Subject|4|||
130690823|NCT00834717|470494389|FG000|First Intervention|Adverse Event|1|||
130690824|NCT00834717|470494390|FG001|First Intervention|Adverse Event|0|||
130227099|NCT00969228|468795579|FG001|Overall Study|Withdrawal by Subject|0|||
130690825|NCT00834717|470494389|FG000|First Intervention|Withdrawal by Subject|0|||
130227100|NCT00969228|468795578|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
130227101|NCT00969228|468795579|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
130227102|NCT02563899|468795580|FG000|Overall Study|Protocol Violation|1|||
130227103|NCT02563899|468795581|FG001|Overall Study|Protocol Violation|0|||
130227104|NCT02563899|468795582|FG002|Overall Study|Protocol Violation|0|||
130227105|NCT02563899|468795583|FG003|Overall Study|Protocol Violation|0|||
130227106|NCT02563899|468795580|FG000|Overall Study|Withdrawal by Subject|0|||
130227107|NCT02563899|468795581|FG001|Overall Study|Withdrawal by Subject|0|||
130690826|NCT00834717|470494390|FG001|First Intervention|Withdrawal by Subject|1|||
130690827|NCT02255149|470494393|FG000|Overall Study|Lost to Follow-up|2|||
130690828|NCT02255149|470494393|FG000|Overall Study|Withdrawal by Subject|1|||
130690829|NCT02255149|470494393|FG000|Overall Study|Withdrawal by PI|1|||
130690830|NCT02255149|470494393|FG000|Overall Study|Implant Failure|1|||
130690831|NCT05710718|470494399|FG000|Overall Study|Withdrawal by Subject|5|||
130690832|NCT05710718|470494400|FG001|Overall Study|Withdrawal by Subject|1|||
130690833|NCT05710718|470494399|FG000|Overall Study|Lost to Follow-up|0|||
130690834|NCT05710718|470494400|FG001|Overall Study|Lost to Follow-up|1|||
130690835|NCT05710718|470494399|FG000|Overall Study|Death|0|||
130227108|NCT02563899|468795582|FG002|Overall Study|Withdrawal by Subject|1|||
130227109|NCT02563899|468795583|FG003|Overall Study|Withdrawal by Subject|0|||
130227110|NCT00794664|468795584|FG000|Treatment Period|Withdrawal by Subject|0|||
130227111|NCT00794664|468795585|FG001|Treatment Period|Withdrawal by Subject|2|||
130227112|NCT00794664|468795584|FG000|Treatment Period|Protocol non-compliance|0|||
130227113|NCT00794664|468795585|FG001|Treatment Period|Protocol non-compliance|1|||
130227114|NCT00794664|468795584|FG000|Treatment Period|Other|0|||
130227115|NCT00794664|468795585|FG001|Treatment Period|Other|1|||
130227116|NCT00794664|468795584|FG000|Treatment Period|Adverse Event|1|||
130227117|NCT00794664|468795585|FG001|Treatment Period|Adverse Event|8|||
130227118|NCT00794664|468795584|FG000|Follow-up Period|Other|1|||
130227119|NCT00794664|468795585|FG001|Follow-up Period|Other|2|||
130227120|NCT00794664|468795584|FG000|Follow-up Period|Withdrawal by Subject|0|||
130227121|NCT00794664|468795585|FG001|Follow-up Period|Withdrawal by Subject|2|||
130690836|NCT05710718|470494400|FG001|Overall Study|Death|1|||
130690837|NCT01319383|470494401|FG000|Overall Study|No ex vivo or in vivo response|4|||
130690838|NCT01319383|470494402|FG001|Overall Study|No ex vivo or in vivo response|0|||
130227122|NCT00794664|468795584|FG000|Follow-up Period|Protocol non-compliance|0|||
130227123|NCT00794664|468795585|FG001|Follow-up Period|Protocol non-compliance|1|||
130227124|NCT01305564|468795590|FG000|Overall Study|Death|21|||
130227125|NCT01305564|468795590|FG000|Overall Study|Lost to Follow-up|12|||
130227126|NCT01305564|468795590|FG000|Overall Study|Withdrawal by Subject|1|||
130444557|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130444558|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130690839|NCT01319383|470494401|FG000|Overall Study|Physician Decision|3|||
130227127|NCT01305564|468795590|FG000|Overall Study|Physician Decision|3|||
130690840|NCT01319383|470494402|FG001|Overall Study|Physician Decision|0|||
130690841|NCT01319383|470494401|FG000|Overall Study|Lack of Efficacy|5|||
130227128|NCT01814007|468795595|FG000|Overall Study|Withdrawal by Subject|1|||
130690842|NCT01319383|470494402|FG001|Overall Study|Lack of Efficacy|9|||
130227129|NCT01655901|468798022|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227130|NCT01655901|468798023|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227131|NCT01655901|468798024|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227132|NCT01655901|468798025|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130227133|NCT01655901|468798026|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227134|NCT01655901|468798027|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130227135|NCT00922636|468798030|FG000|Overall Study|Adverse Event|3|||
130227136|NCT00922636|468798031|FG001|Overall Study|Adverse Event|3|||
130227137|NCT00922636|468798032|FG002|Overall Study|Adverse Event|2|||
130227138|NCT00922636|468798033|FG003|Overall Study|Adverse Event|3|||
130227139|NCT00922636|468798034|FG004|Overall Study|Adverse Event|2|||
130227140|NCT00922636|468798030|FG000|Overall Study|Lack of Efficacy|1|||
130227141|NCT00922636|468798031|FG001|Overall Study|Lack of Efficacy|7|||
130227142|NCT00922636|468798032|FG002|Overall Study|Lack of Efficacy|3|||
130227143|NCT00922636|468798033|FG003|Overall Study|Lack of Efficacy|2|||
130227144|NCT00922636|468798034|FG004|Overall Study|Lack of Efficacy|4|||
130227145|NCT00922636|468798030|FG000|Overall Study|Sponsor Decision|0|||
130227146|NCT00922636|468798031|FG001|Overall Study|Sponsor Decision|0|||
130227147|NCT00922636|468798032|FG002|Overall Study|Sponsor Decision|2|||
130690843|NCT01319383|470494401|FG000|Overall Study|No in vivo response to interval doses|0|||
130690844|NCT01319383|470494402|FG001|Overall Study|No in vivo response to interval doses|1|||
130227148|NCT00922636|468798033|FG003|Overall Study|Sponsor Decision|0|||
130227149|NCT00922636|468798034|FG004|Overall Study|Sponsor Decision|0|||
130227150|NCT00922636|468798030|FG000|Overall Study|Withdrawal by Subject|0|||
130227151|NCT00922636|468798031|FG001|Overall Study|Withdrawal by Subject|0|||
130227152|NCT00922636|468798032|FG002|Overall Study|Withdrawal by Subject|5|||
130227153|NCT00922636|468798033|FG003|Overall Study|Withdrawal by Subject|2|||
130227154|NCT00922636|468798034|FG004|Overall Study|Withdrawal by Subject|4|||
130227155|NCT00922636|468798030|FG000|Overall Study|Protocol Violation|0|||
130227156|NCT00922636|468798031|FG001|Overall Study|Protocol Violation|0|||
130227157|NCT00922636|468798032|FG002|Overall Study|Protocol Violation|2|||
130227158|NCT00922636|468798033|FG003|Overall Study|Protocol Violation|2|||
130227159|NCT00922636|468798034|FG004|Overall Study|Protocol Violation|0|||
130227160|NCT00922636|468798030|FG000|Overall Study|Entry Criteria Not Met|0|||
130227161|NCT00922636|468798031|FG001|Overall Study|Entry Criteria Not Met|0|||
130227162|NCT00922636|468798032|FG002|Overall Study|Entry Criteria Not Met|1|||
130227163|NCT00922636|468798033|FG003|Overall Study|Entry Criteria Not Met|1|||
130227164|NCT00922636|468798034|FG004|Overall Study|Entry Criteria Not Met|0|||
130227165|NCT00922636|468798030|FG000|Overall Study|Parent/Caregiver Decision|2|||
130227166|NCT00922636|468798031|FG001|Overall Study|Parent/Caregiver Decision|4|||
130227167|NCT00922636|468798032|FG002|Overall Study|Parent/Caregiver Decision|3|||
130227168|NCT00922636|468798033|FG003|Overall Study|Parent/Caregiver Decision|5|||
130227169|NCT00922636|468798034|FG004|Overall Study|Parent/Caregiver Decision|2|||
130227170|NCT00922636|468798030|FG000|Overall Study|Lost to Follow-up|1|||
130227171|NCT00922636|468798031|FG001|Overall Study|Lost to Follow-up|2|||
130227172|NCT00922636|468798032|FG002|Overall Study|Lost to Follow-up|2|||
130227173|NCT00922636|468798033|FG003|Overall Study|Lost to Follow-up|2|||
130227174|NCT00922636|468798034|FG004|Overall Study|Lost to Follow-up|4|||
130227175|NCT04969289|468798035|FG000|Overall Study|Lost to Follow-up|13|||
130227176|NCT04969289|468798036|FG001|Overall Study|Lost to Follow-up|9|||
130227177|NCT00557466|468798037|FG000|Overall Study|Adverse Event|3|||
130227178|NCT00557466|468798038|FG001|Overall Study|Adverse Event|1|||
130227179|NCT00557466|468798039|FG002|Overall Study|Adverse Event|4|||
130690845|NCT01987765|470494403|FG000|Overall Study|Protocol Violation|65|||
130690846|NCT01987765|470494403|FG000|Overall Study|Lost to Follow-up|37|||
130690847|NCT01528696|470494412|FG000|Overall Study|See detailed description|18|||
130690848|NCT01528696|470494413|FG001|Overall Study|See detailed description|19|||
130690849|NCT03600805|470494414|FG000|Overall Study|Adverse Event|2|||
130690850|NCT03600805|470494415|FG001|Overall Study|Adverse Event|1|||
130690851|NCT03600805|470494416|FG002|Overall Study|Adverse Event|1|||
130690852|NCT03600805|470494417|FG003|Overall Study|Adverse Event|7|||
130690853|NCT03600805|470494414|FG000|Overall Study|Lack of Efficacy|2|||
130690854|NCT03600805|470494415|FG001|Overall Study|Lack of Efficacy|1|||
130690855|NCT03600805|470494416|FG002|Overall Study|Lack of Efficacy|0|||
130690856|NCT03600805|470494417|FG003|Overall Study|Lack of Efficacy|0|||
130690857|NCT03600805|470494414|FG000|Overall Study|Withdrawal by Subject|1|||
130690858|NCT03600805|470494415|FG001|Overall Study|Withdrawal by Subject|0|||
130690859|NCT03600805|470494416|FG002|Overall Study|Withdrawal by Subject|0|||
130690860|NCT03600805|470494417|FG003|Overall Study|Withdrawal by Subject|1|||
130690861|NCT03600805|470494414|FG000|Overall Study|Other unspecified|14|||
130690862|NCT03600805|470494415|FG001|Overall Study|Other unspecified|6|||
130690863|NCT03600805|470494416|FG002|Overall Study|Other unspecified|7|||
130690864|NCT03600805|470494417|FG003|Overall Study|Other unspecified|11|||
130227180|NCT00557466|468798040|FG003|Overall Study|Adverse Event|1|||
130227181|NCT00557466|468798041|FG004|Overall Study|Adverse Event|2|||
130690865|NCT06195579|470494418|FG000|Overall Study|Withdrawal by Subject|1|||
130690866|NCT02545283|470494419|FG000|Overall Study|Lost to Follow-up|2|||
130690867|NCT02545283|470494420|FG001|Overall Study|Lost to Follow-up|4|||
130690868|NCT02545283|470494419|FG000|Overall Study|Withdrawal by Subject|5|||
130227182|NCT00557466|468798042|FG005|Overall Study|Adverse Event|4|||
130227183|NCT00557466|468798037|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130227184|NCT00557466|468798038|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130227185|NCT00557466|468798039|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130227186|NCT00557466|468798040|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130227187|NCT00557466|468798041|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130227188|NCT00557466|468798042|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130227189|NCT00557466|468798037|FG000|Overall Study|Protocol deviation|0|||
130227190|NCT00557466|468798038|FG001|Overall Study|Protocol deviation|1|||
130227191|NCT00557466|468798039|FG002|Overall Study|Protocol deviation|0|||
130227192|NCT00557466|468798040|FG003|Overall Study|Protocol deviation|2|||
130227193|NCT00557466|468798041|FG004|Overall Study|Protocol deviation|0|||
130227194|NCT00557466|468798042|FG005|Overall Study|Protocol deviation|0|||
130227195|NCT00557466|468798037|FG000|Overall Study|Subject withdrew consent|0|||
130227196|NCT00557466|468798038|FG001|Overall Study|Subject withdrew consent|0|||
130227197|NCT00557466|468798039|FG002|Overall Study|Subject withdrew consent|0|||
130227198|NCT00557466|468798040|FG003|Overall Study|Subject withdrew consent|0|||
130227199|NCT00557466|468798041|FG004|Overall Study|Subject withdrew consent|1|||
130227200|NCT00557466|468798042|FG005|Overall Study|Subject withdrew consent|2|||
130227201|NCT00557466|468798037|FG000|Overall Study|Administrative problems|0|||
130227202|NCT00557466|468798038|FG001|Overall Study|Administrative problems|1|||
130227203|NCT00557466|468798039|FG002|Overall Study|Administrative problems|1|||
130227204|NCT00557466|468798040|FG003|Overall Study|Administrative problems|0|||
130227205|NCT00557466|468798041|FG004|Overall Study|Administrative problems|0|||
130227206|NCT00557466|468798042|FG005|Overall Study|Administrative problems|0|||
130227207|NCT00557466|468798037|FG000|Overall Study|Abnormal test procedure results|0|||
130227208|NCT00557466|468798038|FG001|Overall Study|Abnormal test procedure results|0|||
130227209|NCT00557466|468798039|FG002|Overall Study|Abnormal test procedure results|1|||
130227210|NCT00557466|468798040|FG003|Overall Study|Abnormal test procedure results|0|||
130227211|NCT00557466|468798041|FG004|Overall Study|Abnormal test procedure results|0|||
130227212|NCT00557466|468798042|FG005|Overall Study|Abnormal test procedure results|0|||
130227213|NCT00557466|468798037|FG000|Overall Study|Lost to Follow-up|0|||
130227214|NCT00557466|468798038|FG001|Overall Study|Lost to Follow-up|0|||
130227215|NCT00557466|468798039|FG002|Overall Study|Lost to Follow-up|0|||
130227216|NCT00557466|468798040|FG003|Overall Study|Lost to Follow-up|1|||
130227217|NCT00557466|468798041|FG004|Overall Study|Lost to Follow-up|0|||
130227218|NCT00557466|468798042|FG005|Overall Study|Lost to Follow-up|0|||
130227219|NCT01251952|468798045|FG000|Overall Study|Adverse Event|1|||
130227220|NCT02486692|468798046|FG000|Overall Study|did not login for randomization|4|||
130227221|NCT02486692|468798047|FG001|Overall Study|did not login for randomization|7|||
130227222|NCT00496769|468798048|FG000|Double Blind|>=1 reason assigned per patient|558|||
130227223|NCT00496769|468798049|FG001|Double Blind|>=1 reason assigned per patient|649|||
130227224|NCT00496769|468798050|FG002|Double Blind|>=1 reason assigned per patient|0|||
130227225|NCT00496769|468798048|FG000|Open Label|>=1 reason assigned per patient|0|||
130227226|NCT00496769|468798049|FG001|Open Label|>=1 reason assigned per patient|0|||
130227227|NCT00496769|468798050|FG002|Open Label|>=1 reason assigned per patient|1011|||
130227228|NCT02224625|468798053|FG000|Irritation|Adverse Event|6|||
130227229|NCT02224625|468798053|FG000|Sensitization|Adverse Event|55|||
130227230|NCT02812186|468798054|FG000|Period 1|Post randomization screen failure|5|||
130227231|NCT02812186|468798055|FG001|Period 1|Post randomization screen failure|9|||
130227232|NCT02812186|468798054|FG000|Period 1|nonevaluable data sets|6|||
130227233|NCT02812186|468798055|FG001|Period 1|nonevaluable data sets|6|||
130227234|NCT01307787|468798058|FG000|Overall Study|Withdrawal by Subject|2|||
130227235|NCT01307787|468798059|FG001|Overall Study|Withdrawal by Subject|0|||
130227236|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
130227237|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
130227238|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
130227239|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130227240|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
130227241|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
130227242|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
130227243|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
130227244|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
130227245|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
130227246|NCT01573000|468798060|FG000|Crossover Phase|Lack of Efficacy|0|||
130227247|NCT01573000|468798061|FG001|Crossover Phase|Lack of Efficacy|13|||
130227248|NCT01573000|468798060|FG000|Crossover Phase|Lost to Follow-up|0|||
130227249|NCT01573000|468798061|FG001|Crossover Phase|Lost to Follow-up|2|||
130227250|NCT01573000|468798060|FG000|Crossover Phase|Death|0|||
130227251|NCT01573000|468798061|FG001|Crossover Phase|Death|3|||
130227252|NCT01573000|468798060|FG000|Long-Term Follow-Up|Death|3|||
130227253|NCT01573000|468798061|FG001|Long-Term Follow-Up|Death|0|||
130227254|NCT01573000|468798060|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
130227255|NCT01573000|468798061|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
130227256|NCT03353792|468798062|FG000|Overall Study|Lost to Follow-up|1|||
130227257|NCT03353792|468798063|FG001|Overall Study|Lost to Follow-up|0|||
130227258|NCT03353792|468798062|FG000|Overall Study|Participant Unable to Manage Device|1|||
130227259|NCT03353792|468798063|FG001|Overall Study|Participant Unable to Manage Device|0|||
130227260|NCT03342001|468798069|FG000|Overall Study|Adverse Event|1|||
130227261|NCT03342001|468798069|FG000|Overall Study|Lost to Follow-up|1|||
130227262|NCT01433159|468798071|FG000|Overall Study|Adverse Event|1|||
130227263|NCT01433159|468798072|FG001|Overall Study|Adverse Event|0|||
130227264|NCT01433159|468798071|FG000|Overall Study|Physician Decision|1|||
130227265|NCT01433159|468798072|FG001|Overall Study|Physician Decision|0|||
130227266|NCT01433159|468798071|FG000|Overall Study|Protocol Violation|0|||
130227267|NCT01433159|468798072|FG001|Overall Study|Protocol Violation|1|||
130227268|NCT01100853|468798073|FG000|Overall Study|Lost to Follow-up|11|||
130227269|NCT01100853|468798074|FG001|Overall Study|Lost to Follow-up|6|||
130227270|NCT01100853|468798073|FG000|Overall Study|Received <4 study injections|10|||
130227271|NCT01100853|468798074|FG001|Overall Study|Received <4 study injections|13|||
130227272|NCT01100853|468798073|FG000|Overall Study|Withdrawal by Subject|6|||
130227273|NCT01100853|468798074|FG001|Overall Study|Withdrawal by Subject|4|||
130227274|NCT04161391|468798079|FG000|Overall Study|Adverse Event|0|||
130227275|NCT04161391|468798080|FG001|Overall Study|Adverse Event|1|||
130227276|NCT04161391|468798081|FG002|Overall Study|Adverse Event|0|||
130227277|NCT04161391|468798082|FG003|Overall Study|Adverse Event|1|||
130227278|NCT04161391|468798083|FG004|Overall Study|Adverse Event|0|||
130227279|NCT04161391|468798084|FG005|Overall Study|Adverse Event|0|||
130227280|NCT04161391|468798085|FG006|Overall Study|Adverse Event|0|||
130227281|NCT04161391|468798086|FG007|Overall Study|Adverse Event|3|||
130227282|NCT04161391|468798087|FG008|Overall Study|Adverse Event|0|||
130227283|NCT04161391|468798079|FG000|Overall Study|Death|0|||
130227284|NCT04161391|468798080|FG001|Overall Study|Death|0|||
130227285|NCT04161391|468798081|FG002|Overall Study|Death|0|||
130227286|NCT04161391|468798082|FG003|Overall Study|Death|0|||
130227287|NCT04161391|468798083|FG004|Overall Study|Death|0|||
130227288|NCT04161391|468798084|FG005|Overall Study|Death|0|||
130227289|NCT04161391|468798085|FG006|Overall Study|Death|0|||
130227290|NCT04161391|468798086|FG007|Overall Study|Death|1|||
130227291|NCT04161391|468798087|FG008|Overall Study|Death|0|||
130227292|NCT04161391|468798079|FG000|Overall Study|Physician Decision|0|||
130227293|NCT04161391|468798080|FG001|Overall Study|Physician Decision|0|||
130227294|NCT04161391|468798081|FG002|Overall Study|Physician Decision|1|||
130227295|NCT04161391|468798082|FG003|Overall Study|Physician Decision|2|||
130227296|NCT04161391|468798083|FG004|Overall Study|Physician Decision|0|||
130227297|NCT04161391|468798084|FG005|Overall Study|Physician Decision|0|||
130227298|NCT04161391|468798085|FG006|Overall Study|Physician Decision|2|||
130227299|NCT04161391|468798086|FG007|Overall Study|Physician Decision|0|||
130227300|NCT04161391|468798087|FG008|Overall Study|Physician Decision|0|||
130227301|NCT04161391|468798079|FG000|Overall Study|Progressive Disease|4|||
130227302|NCT04161391|468798080|FG001|Overall Study|Progressive Disease|3|||
130227303|NCT04161391|468798081|FG002|Overall Study|Progressive Disease|3|||
130227304|NCT04161391|468798082|FG003|Overall Study|Progressive Disease|5|||
130227305|NCT04161391|468798083|FG004|Overall Study|Progressive Disease|3|||
130227306|NCT04161391|468798084|FG005|Overall Study|Progressive Disease|3|||
130227307|NCT04161391|468798085|FG006|Overall Study|Progressive Disease|5|||
130227308|NCT04161391|468798086|FG007|Overall Study|Progressive Disease|2|||
130227309|NCT04161391|468798087|FG008|Overall Study|Progressive Disease|2|||
130227310|NCT02579629|468798088|FG000|Overall Study|Withdrawal by Subject|0|||
130227311|NCT02579629|468798089|FG001|Overall Study|Withdrawal by Subject|1|||
130227312|NCT02579629|468798090|FG002|Overall Study|Withdrawal by Subject|0|||
130227313|NCT02579629|468798088|FG000|Overall Study|Screen Failure|2|||
130227314|NCT02579629|468798089|FG001|Overall Study|Screen Failure|0|||
130227315|NCT02579629|468798090|FG002|Overall Study|Screen Failure|2|||
130227316|NCT01190891|468798091|FG000|Overall Study|Protocol Violation|1|||
130227317|NCT01190891|468798092|FG001|Overall Study|Protocol Violation|0|||
130227318|NCT01190891|468798091|FG000|Overall Study|Withdrawal by Subject|5|||
130690869|NCT02545283|470494420|FG001|Overall Study|Withdrawal by Subject|9|||
130690870|NCT02545283|470494419|FG000|Overall Study|Death|109|||
130227319|NCT01190891|468798092|FG001|Overall Study|Withdrawal by Subject|0|||
130227320|NCT00266708|468798093|FG000|Overall Study|No renal function|1|||
130227321|NCT00266708|468798094|FG001|Overall Study|No renal function|1|||
130227322|NCT00266708|468798093|FG000|Overall Study|Refused biopsy|3|||
130227323|NCT00266708|468798094|FG001|Overall Study|Refused biopsy|6|||
130227324|NCT00266708|468798093|FG000|Overall Study|Asthma|0|||
130227325|NCT00266708|468798094|FG001|Overall Study|Asthma|2|||
130227326|NCT01926028|468798095|FG000|Overall Study|Lost to Follow-up|7|||
130227327|NCT01926028|468798096|FG001|Overall Study|Lost to Follow-up|6|||
130227328|NCT01926028|468798097|FG002|Overall Study|Lost to Follow-up|0|||
130690871|NCT02545283|470494420|FG001|Overall Study|Death|211|||
130444559|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130444560|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130444561|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
130444562|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
130444563|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130444564|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130690872|NCT02545283|470494419|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
130690873|NCT02545283|470494420|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
130690874|NCT02545283|470494419|FG000|Overall Study|Study Terminated By Sponsor|33|||
130690875|NCT02545283|470494420|FG001|Overall Study|Study Terminated By Sponsor|71|||
130690876|NCT01205035|470494433|FG000|Overall Study|Withdrawal by Subject|1|||
130690877|NCT01205035|470494434|FG001|Overall Study|Withdrawal by Subject|0|||
130690878|NCT01205035|470494433|FG000|Overall Study|Physician Decision|1|||
130690879|NCT01205035|470494434|FG001|Overall Study|Physician Decision|0|||
130690880|NCT02663349|470494435|FG000|Overall Study|Withdrawal by Subject|6|||
130690881|NCT03128723|470494438|FG000|Overall Study|Withdrawal by Subject|2|||
130690882|NCT00075478|470494439|FG000|Overall Study|not eligible|1|||
130690883|NCT00075478|470494440|FG001|Overall Study|not eligible|0|||
130690884|NCT00075478|470494439|FG000|Overall Study|Physician Decision|0|||
130690885|NCT00075478|470494440|FG001|Overall Study|Physician Decision|1|||
130690886|NCT00673660|470494441|FG000|Overall Study|Lost to Follow-up|107|||
130690887|NCT00245063|470494442|FG000|Overall Study|Adverse Event|6|||
130690888|NCT00245063|470494443|FG001|Overall Study|Adverse Event|5|||
130690889|NCT00245063|470494442|FG000|Overall Study|Death|1|||
130690890|NCT00245063|470494443|FG001|Overall Study|Death|0|||
130690891|NCT05099380|470494444|FG000|Overall Study|Subject enrolled in error|1|||
130690892|NCT05099380|470494445|FG001|Overall Study|Subject enrolled in error|0|||
130690893|NCT05099380|470494444|FG000|Overall Study|Study Procedure|1|||
130690894|NCT05099380|470494445|FG001|Overall Study|Study Procedure|0|||
130690895|NCT05099380|470494444|FG000|Overall Study|Protocol Violation|1|||
130690896|NCT05099380|470494445|FG001|Overall Study|Protocol Violation|0|||
130690897|NCT05099380|470494444|FG000|Overall Study|Adverse Event|1|||
130690898|NCT05099380|470494445|FG001|Overall Study|Adverse Event|1|||
130690899|NCT05099380|470494444|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
130690900|NCT05099380|470494445|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
130690901|NCT01020474|470494446|FG000|Overall Study|Adverse Event|4|||
130690902|NCT01020474|470494447|FG001|Overall Study|Adverse Event|4|||
130690903|NCT01020474|470494446|FG000|Overall Study|Protocol Violation|0|||
130690904|NCT01020474|470494447|FG001|Overall Study|Protocol Violation|2|||
130690905|NCT01020474|470494446|FG000|Overall Study|Withdrawal by Subject|5|||
130690906|NCT01020474|470494447|FG001|Overall Study|Withdrawal by Subject|7|||
130690907|NCT01020474|470494446|FG000|Overall Study|Other Reasons|1|||
130690908|NCT01020474|470494447|FG001|Overall Study|Other Reasons|1|||
130690909|NCT01020474|470494446|FG000|Overall Study|Insufficient Clinical Response|0|||
130690910|NCT01020474|470494447|FG001|Overall Study|Insufficient Clinical Response|3|||
130690911|NCT00466167|470494448|FG000|Overall Study|Adverse Event|8|||
130690912|NCT00466167|470494449|FG001|Overall Study|Adverse Event|8|||
130690913|NCT00466167|470494450|FG002|Overall Study|Adverse Event|7|||
130690914|NCT00466167|470494448|FG000|Overall Study|Lack of Efficacy|2|||
130690915|NCT00466167|470494449|FG001|Overall Study|Lack of Efficacy|0|||
130690916|NCT00466167|470494450|FG002|Overall Study|Lack of Efficacy|3|||
130690917|NCT00466167|470494448|FG000|Overall Study|Protocol Violation|1|||
130690918|NCT00466167|470494449|FG001|Overall Study|Protocol Violation|1|||
130690919|NCT00466167|470494450|FG002|Overall Study|Protocol Violation|2|||
130690920|NCT00466167|470494448|FG000|Overall Study|Lost to Follow-up|3|||
130690921|NCT00466167|470494449|FG001|Overall Study|Lost to Follow-up|2|||
130690922|NCT00466167|470494450|FG002|Overall Study|Lost to Follow-up|2|||
130690923|NCT00466167|470494448|FG000|Overall Study|Withdrawal by Subject|4|||
130690924|NCT00466167|470494449|FG001|Overall Study|Withdrawal by Subject|1|||
130690925|NCT00466167|470494450|FG002|Overall Study|Withdrawal by Subject|6|||
130690926|NCT00466167|470494448|FG000|Overall Study|patient did not meet inclusion criteria|1|||
130690927|NCT00466167|470494449|FG001|Overall Study|patient did not meet inclusion criteria|0|||
130690928|NCT00466167|470494450|FG002|Overall Study|patient did not meet inclusion criteria|1|||
130690929|NCT00466167|470494448|FG000|Overall Study|Not treated|1|||
130444565|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130690930|NCT00466167|470494449|FG001|Overall Study|Not treated|0|||
130690931|NCT00466167|470494450|FG002|Overall Study|Not treated|0|||
130690932|NCT03669861|470494451|FG000|Overall Study|Disease Flare|5|||
130690933|NCT03669861|470494451|FG000|Overall Study|Lack of Efficacy|2|||
130690934|NCT05479058|470494459|FG000|Overall Study|Withdrawal by Subject|1|||
130690935|NCT05479058|470494460|FG001|Overall Study|Withdrawal by Subject|1|||
130690936|NCT05479058|470494459|FG000|Overall Study|Study terminated by sponsor|10|||
130690937|NCT05479058|470494460|FG001|Overall Study|Study terminated by sponsor|10|||
130690938|NCT01370733|470494461|FG000|Overall Study|Withdrawal by Subject|8|||
130690939|NCT01370733|470494462|FG001|Overall Study|Withdrawal by Subject|8|||
130227329|NCT01926028|468798095|FG000|Overall Study|Physician Decision|1|||
130227330|NCT01926028|468798096|FG001|Overall Study|Physician Decision|5|||
130227331|NCT01926028|468798097|FG002|Overall Study|Physician Decision|0|||
130227332|NCT01926028|468798095|FG000|Overall Study|Withdrawal by Subject|9|||
130227333|NCT01926028|468798096|FG001|Overall Study|Withdrawal by Subject|9|||
130227334|NCT01926028|468798097|FG002|Overall Study|Withdrawal by Subject|2|||
130227335|NCT01926028|468798095|FG000|Overall Study|Non compliance or other reasons|4|||
130227336|NCT01926028|468798096|FG001|Overall Study|Non compliance or other reasons|2|||
130227337|NCT01926028|468798097|FG002|Overall Study|Non compliance or other reasons|0|||
130227338|NCT01130272|468798098|FG000|Overall Study|Adverse Event|2|||
130227339|NCT01130272|468798099|FG001|Overall Study|Adverse Event|5|||
130227340|NCT01130272|468798100|FG002|Overall Study|Adverse Event|6|||
130227341|NCT01130272|468798101|FG003|Overall Study|Adverse Event|22|||
130227342|NCT01130272|468798102|FG004|Overall Study|Adverse Event|7|||
130227343|NCT01130272|468798098|FG000|Overall Study|IVRS-confirmed constipation|0|||
130227344|NCT01130272|468798099|FG001|Overall Study|IVRS-confirmed constipation|1|||
130227345|NCT01130272|468798100|FG002|Overall Study|IVRS-confirmed constipation|1|||
130227346|NCT01130272|468798101|FG003|Overall Study|IVRS-confirmed constipation|2|||
130227347|NCT01130272|468798102|FG004|Overall Study|IVRS-confirmed constipation|0|||
130227348|NCT01130272|468798098|FG000|Overall Study|Rescue medications due to diarrhea|3|||
130227349|NCT01130272|468798099|FG001|Overall Study|Rescue medications due to diarrhea|5|||
130227350|NCT01130272|468798100|FG002|Overall Study|Rescue medications due to diarrhea|8|||
130227351|NCT01130272|468798101|FG003|Overall Study|Rescue medications due to diarrhea|8|||
130227352|NCT01130272|468798102|FG004|Overall Study|Rescue medications due to diarrhea|6|||
130227353|NCT01130272|468798098|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130227354|NCT01130272|468798099|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130227355|NCT01130272|468798100|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130227356|NCT01130272|468798101|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130227357|NCT01130272|468798102|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
130227358|NCT01130272|468798098|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227359|NCT01130272|468798099|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227360|NCT01130272|468798100|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227361|NCT01130272|468798101|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
130227362|NCT01130272|468798102|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227363|NCT01130272|468798098|FG000|Overall Study|Protocol Violation|0|||
130227364|NCT01130272|468798099|FG001|Overall Study|Protocol Violation|0|||
130227365|NCT01130272|468798100|FG002|Overall Study|Protocol Violation|3|||
130227366|NCT01130272|468798101|FG003|Overall Study|Protocol Violation|5|||
130227367|NCT01130272|468798102|FG004|Overall Study|Protocol Violation|5|||
130227368|NCT01130272|468798098|FG000|Overall Study|Lost to Follow-up|4|||
130227369|NCT01130272|468798099|FG001|Overall Study|Lost to Follow-up|3|||
130227370|NCT01130272|468798100|FG002|Overall Study|Lost to Follow-up|4|||
130227371|NCT01130272|468798101|FG003|Overall Study|Lost to Follow-up|7|||
130227372|NCT01130272|468798102|FG004|Overall Study|Lost to Follow-up|6|||
130227373|NCT01130272|468798098|FG000|Overall Study|Withdrawal by Subject|4|||
130227374|NCT01130272|468798099|FG001|Overall Study|Withdrawal by Subject|11|||
130227375|NCT01130272|468798100|FG002|Overall Study|Withdrawal by Subject|10|||
130227376|NCT01130272|468798101|FG003|Overall Study|Withdrawal by Subject|9|||
130227377|NCT01130272|468798102|FG004|Overall Study|Withdrawal by Subject|8|||
130227378|NCT01130272|468798098|FG000|Overall Study|Physician Decision|1|||
130227379|NCT01130272|468798099|FG001|Overall Study|Physician Decision|1|||
130227380|NCT01130272|468798100|FG002|Overall Study|Physician Decision|0|||
130227381|NCT01130272|468798101|FG003|Overall Study|Physician Decision|1|||
130227382|NCT01130272|468798102|FG004|Overall Study|Physician Decision|2|||
130227383|NCT01130272|468798098|FG000|Overall Study|Sponsor decision|6|||
130227384|NCT01130272|468798099|FG001|Overall Study|Sponsor decision|15|||
130444566|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130444567|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130444568|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130444569|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130444570|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130444571|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
130444572|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
130690940|NCT01370733|470494461|FG000|Overall Study|Lost to Follow-up|3|||
130227385|NCT01130272|468798100|FG002|Overall Study|Sponsor decision|16|||
130227386|NCT01130272|468798101|FG003|Overall Study|Sponsor decision|13|||
130227387|NCT01130272|468798102|FG004|Overall Study|Sponsor decision|16|||
130227388|NCT01130272|468798098|FG000|Overall Study|Study arm discontinued|38|||
130227389|NCT01130272|468798099|FG001|Overall Study|Study arm discontinued|0|||
130227390|NCT01130272|468798100|FG002|Overall Study|Study arm discontinued|0|||
130227391|NCT01130272|468798101|FG003|Overall Study|Study arm discontinued|0|||
130227392|NCT01130272|468798102|FG004|Overall Study|Study arm discontinued|0|||
130227393|NCT01548404|468798103|FG000|Overall Study|Adverse Event|3|||
130227394|NCT01548404|468798104|FG001|Overall Study|Adverse Event|1|||
130227395|NCT01548404|468798103|FG000|Overall Study|Physician Decision|2|||
130227396|NCT01548404|468798104|FG001|Overall Study|Physician Decision|1|||
130227397|NCT01548404|468798103|FG000|Overall Study|Inadequate response to study treatment|23|||
130227398|NCT01548404|468798104|FG001|Overall Study|Inadequate response to study treatment|7|||
130227399|NCT01548404|468798103|FG000|Overall Study|Lost to Follow-up|2|||
130227400|NCT01548404|468798104|FG001|Overall Study|Lost to Follow-up|0|||
130227401|NCT01548404|468798103|FG000|Overall Study|Withdrawal by Subject|0|||
130227402|NCT01548404|468798104|FG001|Overall Study|Withdrawal by Subject|3|||
130227403|NCT01548404|468798103|FG000|Overall Study|Other than specified above|0|||
130227404|NCT01548404|468798104|FG001|Overall Study|Other than specified above|2|||
130227405|NCT00641056|468798105|FG000|Overall Study|Adverse Event|12|||
130227406|NCT00641056|468798106|FG001|Overall Study|Adverse Event|2|||
130227407|NCT00641056|468798105|FG000|Overall Study|Lost to Follow-up|2|||
130227408|NCT00641056|468798106|FG001|Overall Study|Lost to Follow-up|1|||
130227409|NCT00641056|468798105|FG000|Overall Study|Physician Decision|3|||
130227410|NCT00641056|468798106|FG001|Overall Study|Physician Decision|1|||
130227411|NCT00641056|468798105|FG000|Overall Study|Protocol Violation|2|||
130227412|NCT00641056|468798106|FG001|Overall Study|Protocol Violation|0|||
130227413|NCT00641056|468798105|FG000|Overall Study|Entry Criteria Not Met|3|||
130227414|NCT00641056|468798106|FG001|Overall Study|Entry Criteria Not Met|0|||
130227415|NCT00641056|468798105|FG000|Overall Study|Subject Decision|6|||
130227416|NCT00641056|468798106|FG001|Overall Study|Subject Decision|19|||
130227417|NCT00641056|468798105|FG000|Overall Study|Sponsor Decision|1|||
130227418|NCT00641056|468798106|FG001|Overall Study|Sponsor Decision|2|||
130227419|NCT00737048|468798107|FG000|Overall Study|Physician Decision|0|||
130227420|NCT00737048|468798108|FG001|Overall Study|Physician Decision|0|||
130227421|NCT00737048|468798109|FG002|Overall Study|Physician Decision|1|||
130444573|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130444574|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130444575|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130444576|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130444577|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130444578|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
130444579|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444580|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444581|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
130444582|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
130444583|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444584|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444585|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444586|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444587|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130444588|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444589|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444590|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
130444591|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
130444592|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444593|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444594|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444595|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444596|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444597|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130444598|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444599|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444600|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444601|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444602|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
130444603|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444604|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444605|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444606|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130227422|NCT00737048|468798107|FG000|Overall Study|Adverse Event|0|||
130227423|NCT00737048|468798108|FG001|Overall Study|Adverse Event|1|||
130227424|NCT00737048|468798109|FG002|Overall Study|Adverse Event|0|||
130227425|NCT00737048|468798107|FG000|Overall Study|Worsening of the symptoms|3|||
130227426|NCT00737048|468798108|FG001|Overall Study|Worsening of the symptoms|5|||
130227427|NCT00737048|468798109|FG002|Overall Study|Worsening of the symptoms|3|||
130227428|NCT02351934|468798110|FG000|Allocation|POD weight<pre-op weight|3|||
130227429|NCT02351934|468798111|FG001|Allocation|POD weight<pre-op weight|0|||
130466711|NCT02544074|469676364|FG002|Overall Study|Withdrawal by Subject|0|||
130227430|NCT02351934|468798110|FG000|Allocation|Hypotension preventing administration|2|||
130227431|NCT02351934|468798111|FG001|Allocation|Hypotension preventing administration|0|||
130227432|NCT02351934|468798110|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
130227433|NCT02351934|468798111|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
130227434|NCT02351934|468798110|FG000|Follow-Up|POD weight<pre-op weight|3|||
130227435|NCT02351934|468798111|FG001|Follow-Up|POD weight<pre-op weight|0|||
130227436|NCT02351934|468798110|FG000|Follow-Up|Acute Kidney Injury|1|||
130227437|NCT02351934|468798111|FG001|Follow-Up|Acute Kidney Injury|0|||
130227438|NCT02351934|468798110|FG000|Follow-Up|Early dismissal|3|||
130227439|NCT02351934|468798111|FG001|Follow-Up|Early dismissal|0|||
130227440|NCT02351934|468798110|FG000|Follow-Up|Hypotension|3|||
130227441|NCT02351934|468798111|FG001|Follow-Up|Hypotension|0|||
130227442|NCT02351934|468798110|FG000|Follow-Up|No documentation|2|||
130227443|NCT02351934|468798111|FG001|Follow-Up|No documentation|0|||
130227444|NCT02351934|468798110|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
130227445|NCT02351934|468798111|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
130227446|NCT02351934|468798110|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
130227447|NCT02351934|468798111|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
130227448|NCT00896493|468798112|FG000|Overall Study|Early disease relapse|3|||
130227449|NCT01739335|468798114|FG000|Overall Study|Lost to Follow-up|7|||
130227450|NCT01739335|468798115|FG001|Overall Study|Lost to Follow-up|4|||
130227451|NCT01739335|468798114|FG000|Overall Study|Ineligible patient randomized|0|||
130227452|NCT01739335|468798115|FG001|Overall Study|Ineligible patient randomized|1|||
130227453|NCT04040439|468798121|FG000|Overall Study|Invalid registration|11|||
130227454|NCT04040439|468798121|FG000|Overall Study|No IC* on publication of study results|2|||
130227455|NCT01309386|468798122|FG000|Overall Study|Other|2|||
130227456|NCT01309386|468798123|FG001|Overall Study|Other|0|||
130227457|NCT01309386|468798122|FG000|Overall Study|Withdrawal by Subject|2|||
130227458|NCT01309386|468798123|FG001|Overall Study|Withdrawal by Subject|0|||
130227459|NCT01309386|468798122|FG000|Overall Study|Progressive disease|9|||
130227460|NCT01309386|468798123|FG001|Overall Study|Progressive disease|11|||
130227461|NCT01309386|468798122|FG000|Overall Study|Physician Decision|1|||
130227462|NCT01309386|468798123|FG001|Overall Study|Physician Decision|1|||
130227463|NCT01309386|468798122|FG000|Overall Study|Lack of Efficacy|3|||
130227464|NCT01309386|468798123|FG001|Overall Study|Lack of Efficacy|1|||
130227465|NCT01309386|468798122|FG000|Overall Study|Adverse Event|5|||
130227466|NCT01309386|468798123|FG001|Overall Study|Adverse Event|8|||
130227467|NCT02062437|468798124|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
130227468|NCT02062437|468798124|FG000|Overall Study|Patient not available for the 2y visit|18|||
130227469|NCT02062437|468798124|FG000|Overall Study|Death|2|||
130227470|NCT02062437|468798124|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
130227471|NCT00752089|468798125|FG000|Overall Study|Adverse Event|1|||
130227472|NCT00752089|468798125|FG000|Overall Study|Protocol Deviation|2|||
130227473|NCT00752089|468798125|FG000|Overall Study|Could not attend visit 9|1|||
130227474|NCT00752089|468798125|FG000|Overall Study|Not capable of wearing partial denture|1|||
130227475|NCT00752089|468798125|FG000|Overall Study|Cannot continue the study|1|||
130227476|NCT01324102|468798126|FG000|Overall Study|illness|1|||
130227477|NCT01324102|468798127|FG001|Overall Study|illness|6|||
130227478|NCT00386334|468798132|FG000|Double Blind Period|Adverse Event|9|||
130227479|NCT00386334|468798133|FG001|Double Blind Period|Adverse Event|14|||
130227480|NCT00386334|468798132|FG000|Double Blind Period|Protocol Violation|1|||
130227481|NCT00386334|468798133|FG001|Double Blind Period|Protocol Violation|1|||
130227482|NCT00386334|468798132|FG000|Double Blind Period|Withdrawal by Subject|9|||
130227483|NCT00386334|468798133|FG001|Double Blind Period|Withdrawal by Subject|13|||
130227484|NCT00386334|468798132|FG000|Double Blind Period|Lack of Efficacy|20|||
130227485|NCT00386334|468798133|FG001|Double Blind Period|Lack of Efficacy|11|||
130227486|NCT00386334|468798132|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
130227487|NCT00386334|468798133|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
130227488|NCT00386334|468798132|FG000|Double Blind Period|Other|3|||
130227489|NCT00386334|468798133|FG001|Double Blind Period|Other|3|||
130227490|NCT00386334|468798132|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
130227491|NCT00386334|468798133|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
130227492|NCT00902577|468798136|FG000|Overall Study|Withdrawal by Subject|6|||
130227493|NCT00902577|468798136|FG000|Overall Study|FMISO production failure|2|||
130227494|NCT00785356|468798139|FG000|Overall Study|Study prematurely terminated|8|||
130227495|NCT01232790|468798141|FG000|Randomization|Withdrawal by Subject|2|||
130227496|NCT01232790|468798142|FG001|Randomization|Withdrawal by Subject|0|||
130227497|NCT01232790|468798141|FG000|Randomization|Protocol Violation|0|||
130227498|NCT01232790|468798142|FG001|Randomization|Protocol Violation|1|||
130227499|NCT01232790|468798141|FG000|Randomization|Physician Decision|0|||
130227500|NCT01232790|468798142|FG001|Randomization|Physician Decision|1|||
130227501|NCT01232790|468798141|FG000|Initial Assessment|Withdrawal by Subject|0|||
130227502|NCT01232790|468798142|FG001|Initial Assessment|Withdrawal by Subject|1|||
130227503|NCT01232790|468798141|FG000|First Crossover|Withdrawal by Subject|1|||
130227504|NCT01232790|468798142|FG001|First Crossover|Withdrawal by Subject|0|||
130227505|NCT01232790|468798141|FG000|Second Crossover|Withdrawal by Subject|1|||
130227506|NCT01232790|468798142|FG001|Second Crossover|Withdrawal by Subject|2|||
130227507|NCT03238417|468798143|FG000|Overall|non-response|955|||
130227508|NCT03238417|468798144|FG001|Overall|non-response|1920|||
130227509|NCT03238417|468798143|FG000|Overall|partial completion|48|||
130227510|NCT03238417|468798144|FG001|Overall|partial completion|68|||
130227511|NCT03238417|468798143|FG000|Baseline|Partial completion|17|||
130227512|NCT03238417|468798144|FG001|Baseline|Partial completion|48|||
130227513|NCT03238417|468798143|FG000|Baseline|non-response|372|||
130227514|NCT03238417|468798144|FG001|Baseline|non-response|669|||
130227515|NCT03238417|468798143|FG000|12-month|non-response|296|||
130227516|NCT03238417|468798144|FG001|12-month|non-response|669|||
130227517|NCT03238417|468798143|FG000|12-month|partial completion|23|||
130227518|NCT03238417|468798144|FG001|12-month|partial completion|37|||
130227519|NCT03238417|468798143|FG000|24-month|non-response|287|||
130227520|NCT03238417|468798144|FG001|24-month|non-response|594|||
130227521|NCT03238417|468798143|FG000|24-month|partial completion|8|||
130227522|NCT03238417|468798144|FG001|24-month|partial completion|31|||
130227523|NCT00083915|468798145|FG000|Overall Study|Death|6|||
130227524|NCT00083915|468798146|FG001|Overall Study|Death|3|||
130227525|NCT00083915|468798145|FG000|Overall Study|Physician Decision|11|||
130227526|NCT00083915|468798146|FG001|Overall Study|Physician Decision|6|||
130227527|NCT00083915|468798145|FG000|Overall Study|Withdrawal by Subject|8|||
130227528|NCT00083915|468798146|FG001|Overall Study|Withdrawal by Subject|3|||
130227529|NCT00083915|468798145|FG000|Overall Study|disease progression|18|||
130227530|NCT00083915|468798146|FG001|Overall Study|disease progression|23|||
130227531|NCT00083915|468798145|FG000|Overall Study|Failure to collect|3|||
130227532|NCT00083915|468798146|FG001|Overall Study|Failure to collect|0|||
130227533|NCT00083915|468798145|FG000|Overall Study|No response|3|||
130227534|NCT00083915|468798146|FG001|Overall Study|No response|1|||
130227535|NCT00083915|468798145|FG000|Overall Study|Insurance issues|1|||
130227536|NCT00083915|468798146|FG001|Overall Study|Insurance issues|1|||
130227537|NCT00853762|468798150|FG000|Overall Study|Premature Termination|16|||
130227538|NCT00853762|468798151|FG001|Overall Study|Premature Termination|15|||
130227539|NCT00853762|468798152|FG002|Overall Study|Premature Termination|14|||
130227540|NCT00853762|468798153|FG003|Overall Study|Premature Termination|21|||
130227541|NCT00853762|468798150|FG000|Overall Study|Protocol Violation|0|||
130227542|NCT00853762|468798151|FG001|Overall Study|Protocol Violation|0|||
130227543|NCT00853762|468798152|FG002|Overall Study|Protocol Violation|0|||
130227544|NCT00853762|468798153|FG003|Overall Study|Protocol Violation|1|||
130227545|NCT00853762|468798150|FG000|Overall Study|Withdrawal by Subject|0|||
130227546|NCT00853762|468798151|FG001|Overall Study|Withdrawal by Subject|0|||
130227547|NCT00853762|468798152|FG002|Overall Study|Withdrawal by Subject|1|||
130227548|NCT00853762|468798153|FG003|Overall Study|Withdrawal by Subject|0|||
130227549|NCT00853762|468798150|FG000|Overall Study|Other|0|||
130227550|NCT00853762|468798151|FG001|Overall Study|Other|2|||
130227551|NCT00853762|468798152|FG002|Overall Study|Other|0|||
130227552|NCT00853762|468798153|FG003|Overall Study|Other|0|||
130227553|NCT00853762|468798150|FG000|Overall Study|Randomised but not Treated|0|||
130227554|NCT00853762|468798151|FG001|Overall Study|Randomised but not Treated|2|||
130227555|NCT00853762|468798152|FG002|Overall Study|Randomised but not Treated|2|||
130227556|NCT00853762|468798153|FG003|Overall Study|Randomised but not Treated|0|||
130227557|NCT02000921|468798156|FG000|Overall Study|Withdrawal by Subject|3|||
130227558|NCT02000921|468798157|FG001|Overall Study|Withdrawal by Subject|10|||
130227559|NCT02000921|468798158|FG002|Overall Study|Withdrawal by Subject|5|||
130227560|NCT02000921|468798156|FG000|Overall Study|Lost to Follow-up|2|||
130227561|NCT02000921|468798157|FG001|Overall Study|Lost to Follow-up|4|||
130227562|NCT02000921|468798158|FG002|Overall Study|Lost to Follow-up|5|||
130227563|NCT02000921|468798156|FG000|Overall Study|Physician Decision|0|||
130227564|NCT02000921|468798157|FG001|Overall Study|Physician Decision|2|||
130227565|NCT02000921|468798158|FG002|Overall Study|Physician Decision|0|||
130227566|NCT02051296|468798159|FG000|Overall Study|Lost to Follow-up|1|||
130227567|NCT02051296|468798160|FG001|Overall Study|Lost to Follow-up|2|||
130227568|NCT02051296|468798159|FG000|Overall Study|withdraw prior to treatment|7|||
130227569|NCT02051296|468798160|FG001|Overall Study|withdraw prior to treatment|7|||
130227570|NCT00106002|468798161|FG000|Overall Study|Did not take any study drug|1|||
130227571|NCT00106002|468798161|FG000|Overall Study|Ineligible after Registration|1|||
130227572|NCT01245101|468798164|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
130227573|NCT01245101|468798165|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
130227574|NCT01245101|468798164|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
130227575|NCT01245101|468798165|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
130227576|NCT01245101|468798164|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
130227577|NCT01245101|468798165|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
130227578|NCT01225549|468798168|FG000|Period 4 - Washout|Disallowed medication|0|||
130227579|NCT01225549|468798169|FG001|Period 4 - Washout|Disallowed medication|1|||
130227580|NCT01225549|468798170|FG002|Period 4 - Washout|Disallowed medication|0|||
130227581|NCT01225549|468798171|FG003|Period 4 - Washout|Disallowed medication|0|||
130227582|NCT01225549|468798172|FG004|Period 4 - Washout|Disallowed medication|0|||
130227583|NCT01225549|468798173|FG005|Period 4 - Washout|Disallowed medication|0|||
130227584|NCT01225549|468798174|FG006|Period 4 - Washout|Disallowed medication|0|||
130227585|NCT01225549|468798175|FG007|Period 4 - Washout|Disallowed medication|0|||
130227586|NCT01225549|468798176|FG008|Period 4 - Washout|Disallowed medication|0|||
130227587|NCT01225549|468798177|FG009|Period 4 - Washout|Disallowed medication|0|||
130227588|NCT01225549|468798168|FG000|Period 6 - Washout|Disallowed medication|0|||
130227589|NCT01225549|468798169|FG001|Period 6 - Washout|Disallowed medication|0|||
130227590|NCT01225549|468798170|FG002|Period 6 - Washout|Disallowed medication|0|||
130227591|NCT01225549|468798171|FG003|Period 6 - Washout|Disallowed medication|1|||
130227592|NCT01225549|468798172|FG004|Period 6 - Washout|Disallowed medication|0|||
130227593|NCT01225549|468798173|FG005|Period 6 - Washout|Disallowed medication|0|||
130227594|NCT01225549|468798174|FG006|Period 6 - Washout|Disallowed medication|0|||
130227595|NCT01225549|468798175|FG007|Period 6 - Washout|Disallowed medication|0|||
130227596|NCT01225549|468798176|FG008|Period 6 - Washout|Disallowed medication|0|||
130227597|NCT01225549|468798177|FG009|Period 6 - Washout|Disallowed medication|0|||
130227598|NCT04456686|468798178|FG000|Overall Study|Adverse Event|2|||
130227599|NCT04456686|468798179|FG001|Overall Study|Adverse Event|1|||
130227600|NCT04456686|468798178|FG000|Overall Study|Lack of Efficacy|3|||
130227601|NCT04456686|468798179|FG001|Overall Study|Lack of Efficacy|1|||
130227602|NCT04456686|468798178|FG000|Overall Study|Withdrew consent|3|||
130227603|NCT04456686|468798179|FG001|Overall Study|Withdrew consent|1|||
130227604|NCT04456686|468798178|FG000|Overall Study|Physician Decision|2|||
130227605|NCT04456686|468798179|FG001|Overall Study|Physician Decision|2|||
130227606|NCT04456686|468798178|FG000|Overall Study|Withdrawal by Subject|5|||
130227607|NCT04456686|468798179|FG001|Overall Study|Withdrawal by Subject|1|||
130227608|NCT04456686|468798178|FG000|Overall Study|Protocol Violation|0|||
130227609|NCT04456686|468798179|FG001|Overall Study|Protocol Violation|1|||
130227610|NCT00891813|468798181|FG000|Overall Study|Adverse Event|3|||
130227611|NCT00891813|468798181|FG000|Overall Study|Withdrawal by Subject|1|||
130227612|NCT00891813|468798181|FG000|Overall Study|Patient Noncompliance|6|||
130227613|NCT00891813|468798181|FG000|Overall Study|Protocol Violation|2|||
130227614|NCT00473083|468798186|FG000|Overall Study|Adverse Event|1|||
130227615|NCT00473083|468798187|FG001|Overall Study|Adverse Event|0|||
130227616|NCT00473083|468798188|FG002|Overall Study|Adverse Event|0|||
130227617|NCT02858401|468798189|FG000|Overall Study|Withdrew Consent|0|||
130227618|NCT02858401|468798190|FG001|Overall Study|Withdrew Consent|0|||
130227619|NCT02858401|468798191|FG002|Overall Study|Withdrew Consent|0|||
130227620|NCT02858401|468798192|FG003|Overall Study|Withdrew Consent|0|||
130227621|NCT02858401|468798193|FG004|Overall Study|Withdrew Consent|0|||
130227622|NCT02858401|468798194|FG005|Overall Study|Withdrew Consent|1|||
130227623|NCT02858401|468798195|FG006|Overall Study|Withdrew Consent|0|||
130227624|NCT02858401|468798189|FG000|Overall Study|Lost to Follow-up|0|||
130227625|NCT02858401|468798190|FG001|Overall Study|Lost to Follow-up|1|||
130227626|NCT02858401|468798191|FG002|Overall Study|Lost to Follow-up|0|||
130227627|NCT02858401|468798192|FG003|Overall Study|Lost to Follow-up|0|||
130690941|NCT01370733|470494462|FG001|Overall Study|Lost to Follow-up|0|||
130690942|NCT01370733|470494461|FG000|Overall Study|Adverse Event|2|||
130690943|NCT01370733|470494462|FG001|Overall Study|Adverse Event|4|||
130690944|NCT01370733|470494461|FG000|Overall Study|Lack of Efficacy|3|||
130227628|NCT02858401|468798193|FG004|Overall Study|Lost to Follow-up|0|||
130227629|NCT02858401|468798194|FG005|Overall Study|Lost to Follow-up|0|||
130227630|NCT02858401|468798195|FG006|Overall Study|Lost to Follow-up|0|||
130227631|NCT00749398|468798196|FG000|Overall Study|Lack of Efficacy|7|||
130227632|NCT00749398|468798196|FG000|Overall Study|Adverse Event|4|||
130227633|NCT00749398|468798196|FG000|Overall Study|Serious adverse event|11|||
130227634|NCT00749398|468798196|FG000|Overall Study|Withdrawal by Subject|17|||
130227635|NCT00749398|468798196|FG000|Overall Study|Lost to Follow-up|11|||
130227636|NCT00749398|468798196|FG000|Overall Study|Reason not specified|2|||
130690945|NCT01370733|470494462|FG001|Overall Study|Lack of Efficacy|5|||
130227637|NCT00749398|468798196|FG000|Overall Study|Unknown reason|1|||
130227638|NCT03093181|468798197|FG000|Overall Study|Withdrawal by Subject|2|||
130227639|NCT03093181|468798198|FG001|Overall Study|Withdrawal by Subject|1|||
130227640|NCT03093181|468798199|FG002|Overall Study|Withdrawal by Subject|2|||
130227641|NCT03093181|468798197|FG000|Overall Study|Other (Not specified)|1|||
130227642|NCT03093181|468798198|FG001|Overall Study|Other (Not specified)|0|||
130227643|NCT03093181|468798199|FG002|Overall Study|Other (Not specified)|0|||
130227644|NCT03093181|468798197|FG000|Overall Study|Adverse Event|0|||
130227645|NCT03093181|468798198|FG001|Overall Study|Adverse Event|1|||
130227646|NCT03093181|468798199|FG002|Overall Study|Adverse Event|0|||
130227647|NCT03093181|468798197|FG000|Overall Study|Other (Protocol violation)|0|||
130227648|NCT03093181|468798198|FG001|Overall Study|Other (Protocol violation)|0|||
130227649|NCT03093181|468798199|FG002|Overall Study|Other (Protocol violation)|1|||
130227650|NCT04210986|468798200|FG000|Overall Study|Lost to Follow-up|5|||
130227651|NCT04210986|468798201|FG001|Overall Study|Lost to Follow-up|2|||
130227652|NCT04210986|468798200|FG000|Overall Study|Withdrawal by Subject|3|||
130227653|NCT04210986|468798201|FG001|Overall Study|Withdrawal by Subject|1|||
130227654|NCT04210986|468798200|FG000|Overall Study|Protocol Violation|1|||
130227655|NCT04210986|468798201|FG001|Overall Study|Protocol Violation|1|||
130227656|NCT04210986|468798200|FG000|Overall Study|Physician Decision|0|||
130227657|NCT04210986|468798201|FG001|Overall Study|Physician Decision|1|||
130227658|NCT04233879|468798202|FG000|Overall Study|Death|2|||
130227659|NCT04233879|468798203|FG001|Overall Study|Death|0|||
130227660|NCT04233879|468798202|FG000|Overall Study|Lost to Follow-up|3|||
130227661|NCT04233879|468798203|FG001|Overall Study|Lost to Follow-up|8|||
130227662|NCT04233879|468798202|FG000|Overall Study|Physician Decision|4|||
130227663|NCT04233879|468798203|FG001|Overall Study|Physician Decision|4|||
130444607|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130444608|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444609|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444610|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444611|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
130444612|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
130444613|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
130444614|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444615|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444616|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444617|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130444618|NCT02018861|469590232|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444619|NCT02018861|469590233|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444620|NCT02018861|469590234|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444621|NCT02018861|469590235|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
130444622|NCT02018861|469590236|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
130444623|NCT02018861|469590237|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444624|NCT02018861|469590238|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444625|NCT02018861|469590239|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444626|NCT02018861|469590240|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444627|NCT02018861|469590241|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
130444628|NCT02018861|469590232|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444629|NCT02018861|469590233|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444630|NCT02018861|469590234|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444631|NCT02018861|469590235|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444632|NCT02018861|469590236|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444633|NCT02018861|469590237|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444634|NCT02018861|469590238|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
130444635|NCT02018861|469590239|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
130444636|NCT02018861|469590240|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130690946|NCT01370733|470494461|FG000|Overall Study|Physician Decision|0|||
130227664|NCT04233879|468798202|FG000|Overall Study|Withdrawal by Subject|7|||
130227665|NCT04233879|468798203|FG001|Overall Study|Withdrawal by Subject|10|||
130227666|NCT04233879|468798202|FG000|Overall Study|Other|281|||
130227667|NCT04233879|468798203|FG001|Overall Study|Other|279|||
130227668|NCT03585270|468798206|FG000|Overall Study|Withdrawal by Subject|2|||
130227669|NCT03585270|468798207|FG001|Overall Study|Withdrawal by Subject|6|||
130227670|NCT03585270|468798206|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
130444637|NCT02018861|469590241|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
130444638|NCT02018861|469590232|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130690947|NCT01370733|470494462|FG001|Overall Study|Physician Decision|2|||
130227671|NCT03585270|468798207|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
130690948|NCT01370733|470494461|FG000|Overall Study|Protocol Violation|1|||
130444639|NCT02018861|469590233|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444640|NCT02018861|469590234|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444641|NCT02018861|469590235|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444642|NCT02018861|469590236|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444643|NCT02018861|469590237|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444644|NCT02018861|469590238|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
130444645|NCT02018861|469590239|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
130444646|NCT02018861|469590240|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444647|NCT02018861|469590241|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130444648|NCT02018861|469590232|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444649|NCT02018861|469590233|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444650|NCT02018861|469590234|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444651|NCT02018861|469590235|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444652|NCT02018861|469590236|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444653|NCT02018861|469590237|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444654|NCT02018861|469590238|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444655|NCT02018861|469590239|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444656|NCT02018861|469590240|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
130444657|NCT02018861|469590241|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
130444658|NCT02018861|469590232|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444659|NCT02018861|469590233|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444660|NCT02018861|469590234|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444661|NCT02018861|469590235|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444662|NCT02018861|469590236|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444663|NCT02018861|469590237|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444664|NCT02018861|469590238|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444665|NCT02018861|469590239|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444666|NCT02018861|469590240|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
130444667|NCT02018861|469590241|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
130444668|NCT02018861|469590232|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444669|NCT02018861|469590233|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444670|NCT02018861|469590234|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444671|NCT02018861|469590235|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444672|NCT02018861|469590236|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444673|NCT02018861|469590237|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444674|NCT02018861|469590238|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444675|NCT02018861|469590239|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444676|NCT02018861|469590240|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
130444677|NCT02018861|469590241|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
130444678|NCT00504348|469590242|FG000|Overall Study|Adverse Event|3|||
130444679|NCT00504348|469590242|FG000|Overall Study|Lack of Efficacy|4|||
130444680|NCT00504348|469590242|FG000|Overall Study|Physician Decision|1|||
130444681|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
130444682|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
130444683|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
130444684|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
130444685|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
130444686|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
130444687|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
130444688|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
130444689|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
130444690|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
130444691|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
130444692|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
130444693|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
130444694|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
130444695|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
130444696|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
130444697|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
130444698|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
130444699|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
130444700|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
130444701|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
130444702|NCT02718417|469590244|FG000|Chemotherapy Phase (CP)|Other|2|||
130444703|NCT02718417|469590245|FG001|Chemotherapy Phase (CP)|Other|0|||
130444704|NCT02718417|469590246|FG002|Chemotherapy Phase (CP)|Other|1|||
130227672|NCT03585270|468798206|FG000|Overall Study|Adverse Event|5|||
130690949|NCT01370733|470494462|FG001|Overall Study|Protocol Violation|3|||
130690950|NCT00463684|470494465|FG000|Overall Study|Withdrawal by Subject|1|||
130690951|NCT00463684|470494465|FG000|Overall Study|Lost to Follow-up|3|||
130690952|NCT00191815|470494466|FG000|Overall Study|Adverse Event|2|||
130690953|NCT00191815|470494466|FG000|Overall Study|Disease progression or relapse|24|||
130690954|NCT00191815|470494466|FG000|Overall Study|Death|2|||
130690955|NCT00191815|470494466|FG000|Overall Study|Protocol Violation|3|||
130690956|NCT00191815|470494466|FG000|Overall Study|Physician Decision|2|||
130690957|NCT00191815|470494466|FG000|Overall Study|Withdrawal by Subject|7|||
130690958|NCT03808376|470494467|FG000|Overall Study|Withdrawal by Subject|10|||
130690959|NCT03644550|470494468|FG000|Overall Study|Withdrawal by Subject|3|||
130690960|NCT03644550|470494468|FG000|Overall Study|Progressive disease|15|||
130690961|NCT00323882|470494469|FG000|Overall Study|Adverse Event|2|||
130690962|NCT00323882|470494470|FG001|Overall Study|Adverse Event|1|||
130690963|NCT00323882|470494471|FG002|Overall Study|Adverse Event|1|||
130690964|NCT00323882|470494472|FG003|Overall Study|Adverse Event|1|||
130690965|NCT00323882|470494473|FG004|Overall Study|Adverse Event|3|||
130690966|NCT00323882|470494469|FG000|Overall Study|Disease Progression|6|||
130690967|NCT00323882|470494470|FG001|Overall Study|Disease Progression|4|||
130690968|NCT00323882|470494471|FG002|Overall Study|Disease Progression|10|||
130690969|NCT00323882|470494472|FG003|Overall Study|Disease Progression|5|||
130690970|NCT00323882|470494473|FG004|Overall Study|Disease Progression|22|||
130690971|NCT00323882|470494469|FG000|Overall Study|Death|0|||
130690972|NCT00323882|470494470|FG001|Overall Study|Death|1|||
130690973|NCT00323882|470494471|FG002|Overall Study|Death|1|||
130690974|NCT00323882|470494472|FG003|Overall Study|Death|0|||
130690975|NCT00323882|470494473|FG004|Overall Study|Death|5|||
130690976|NCT00323882|470494469|FG000|Overall Study|Lost to Follow-up|0|||
130690977|NCT00323882|470494470|FG001|Overall Study|Lost to Follow-up|0|||
130690978|NCT00323882|470494471|FG002|Overall Study|Lost to Follow-up|1|||
130690979|NCT00323882|470494472|FG003|Overall Study|Lost to Follow-up|0|||
130690980|NCT00323882|470494473|FG004|Overall Study|Lost to Follow-up|1|||
130690981|NCT00323882|470494469|FG000|Overall Study|Other|0|||
130690982|NCT00323882|470494470|FG001|Overall Study|Other|0|||
130690983|NCT00323882|470494471|FG002|Overall Study|Other|0|||
130690984|NCT00323882|470494472|FG003|Overall Study|Other|1|||
130690985|NCT00323882|470494473|FG004|Overall Study|Other|1|||
130690986|NCT01794845|470494474|FG000|Overall Study|Withdrawal by Subject|1|||
130690987|NCT01456221|470494475|FG000|Overall Study|Withdrawal by Subject|56|||
130690988|NCT01456221|470494476|FG001|Overall Study|Withdrawal by Subject|49|||
130690989|NCT01456221|470494475|FG000|Overall Study|Lost to Follow-up|1|||
130690990|NCT01456221|470494476|FG001|Overall Study|Lost to Follow-up|4|||
130690991|NCT01456221|470494475|FG000|Overall Study|Received medication|3|||
130690992|NCT01456221|470494476|FG001|Overall Study|Received medication|2|||
130690993|NCT01456221|470494475|FG000|Overall Study|Incomplete data|4|||
130690994|NCT01456221|470494476|FG001|Overall Study|Incomplete data|2|||
130690995|NCT06647173|470494477|FG000|Overall Study|Lost to Follow-up|24|||
130690996|NCT00312897|470494480|FG000|Overall Study|Adverse Event|1|||
130690997|NCT00312897|470494481|FG001|Overall Study|Adverse Event|0|||
130690998|NCT00312897|470494480|FG000|Overall Study|Lost to Follow-up|2|||
130690999|NCT00312897|470494481|FG001|Overall Study|Lost to Follow-up|0|||
130691000|NCT00312897|470494480|FG000|Overall Study|Physician Decision|1|||
130691001|NCT00312897|470494481|FG001|Overall Study|Physician Decision|0|||
130691002|NCT00312897|470494480|FG000|Overall Study|Withdrawal by Subject|1|||
130691003|NCT00312897|470494481|FG001|Overall Study|Withdrawal by Subject|3|||
130691004|NCT00312897|470494480|FG000|Overall Study|Pregnancy|1|||
130227673|NCT03585270|468798207|FG001|Overall Study|Adverse Event|2|||
130691005|NCT00312897|470494481|FG001|Overall Study|Pregnancy|0|||
130691006|NCT00312897|470494480|FG000|Overall Study|discontinued prior to getting treatment|0|||
130691007|NCT00312897|470494481|FG001|Overall Study|discontinued prior to getting treatment|3|||
130227674|NCT03585270|468798206|FG000|Overall Study|Lost to Follow-up|1|||
130691008|NCT03100344|470494482|FG000|Overall Study|Adverse Event|0|||
130691009|NCT03100344|470494483|FG001|Overall Study|Adverse Event|3|||
130691010|NCT03100344|470494484|FG002|Overall Study|Adverse Event|2|||
130691011|NCT03100344|470494485|FG003|Overall Study|Adverse Event|3|||
130691012|NCT03100344|470494482|FG000|Overall Study|Lack of Efficacy|2|||
130691013|NCT03100344|470494483|FG001|Overall Study|Lack of Efficacy|0|||
130691014|NCT03100344|470494484|FG002|Overall Study|Lack of Efficacy|0|||
130691015|NCT03100344|470494485|FG003|Overall Study|Lack of Efficacy|0|||
130227675|NCT03585270|468798207|FG001|Overall Study|Lost to Follow-up|4|||
130227676|NCT03585270|468798206|FG000|Overall Study|Death|5|||
130227677|NCT03585270|468798207|FG001|Overall Study|Death|3|||
130227678|NCT03585270|468798206|FG000|Overall Study|Other reasons|2|||
130227679|NCT03585270|468798207|FG001|Overall Study|Other reasons|2|||
130227680|NCT01076543|468798210|FG000|Overall Study|Withdrawal by Subject|2|||
130227681|NCT01076543|468798211|FG001|Overall Study|Withdrawal by Subject|0|||
130227682|NCT01076543|468798212|FG002|Overall Study|Withdrawal by Subject|0|||
130227683|NCT01076543|468798213|FG003|Overall Study|Withdrawal by Subject|0|||
130227684|NCT01076543|468798214|FG004|Overall Study|Withdrawal by Subject|0|||
130227685|NCT01076543|468798215|FG005|Overall Study|Withdrawal by Subject|0|||
130227686|NCT05222880|468798216|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130227687|NCT05222880|468798216|FG000|Overall Study|Withdrew Consent during Study|1|||
130227688|NCT05222880|468798216|FG000|Overall Study|COVID-19 Related|1|||
130227689|NCT01791985|468798217|FG000|Overall Study|Adverse Event|7|||
130227690|NCT01791985|468798217|FG000|Overall Study|Withdrawal by Subject|1|||
130227691|NCT03217591|468798233|FG000|Overall Study|Adverse Event|1|||
130227692|NCT03217591|468798234|FG001|Overall Study|Adverse Event|2|||
130227693|NCT03217591|468798235|FG002|Overall Study|Adverse Event|6|||
130227694|NCT03217591|468798233|FG000|Overall Study|Withdrawal by Subject|0|||
130227695|NCT03217591|468798234|FG001|Overall Study|Withdrawal by Subject|1|||
130227696|NCT03217591|468798235|FG002|Overall Study|Withdrawal by Subject|3|||
130227697|NCT03217591|468798233|FG000|Overall Study|Lost to Follow-up|1|||
130227698|NCT03217591|468798234|FG001|Overall Study|Lost to Follow-up|0|||
130227699|NCT03217591|468798235|FG002|Overall Study|Lost to Follow-up|0|||
130227700|NCT03217591|468798233|FG000|Overall Study|Protocol Violation|1|||
130227701|NCT03217591|468798234|FG001|Overall Study|Protocol Violation|0|||
130227702|NCT03217591|468798235|FG002|Overall Study|Protocol Violation|1|||
130227703|NCT02357459|468799902|FG000|Overall Study|Adverse Event|0|||
130227704|NCT02357459|468799903|FG001|Overall Study|Adverse Event|1|||
130227705|NCT02357459|468799904|FG002|Overall Study|Adverse Event|1|||
130227706|NCT02357459|468799902|FG000|Overall Study|Withdrawal by Subject|5|||
130227707|NCT02357459|468799903|FG001|Overall Study|Withdrawal by Subject|3|||
130227708|NCT02357459|468799904|FG002|Overall Study|Withdrawal by Subject|3|||
130227709|NCT02357459|468799902|FG000|Overall Study|Physician Decision|0|||
130227710|NCT02357459|468799903|FG001|Overall Study|Physician Decision|2|||
130227711|NCT02357459|468799904|FG002|Overall Study|Physician Decision|0|||
130227712|NCT02357459|468799902|FG000|Overall Study|Protocol Violation|1|||
130227713|NCT02357459|468799903|FG001|Overall Study|Protocol Violation|1|||
130227714|NCT02357459|468799904|FG002|Overall Study|Protocol Violation|0|||
130227715|NCT02357459|468799902|FG000|Overall Study|Lost to Follow-up|1|||
130227716|NCT02357459|468799903|FG001|Overall Study|Lost to Follow-up|3|||
130227717|NCT02357459|468799904|FG002|Overall Study|Lost to Follow-up|0|||
130227718|NCT02357459|468799902|FG000|Overall Study|Lack of Efficacy|7|||
130227719|NCT02357459|468799903|FG001|Overall Study|Lack of Efficacy|4|||
130227720|NCT02357459|468799904|FG002|Overall Study|Lack of Efficacy|4|||
130227721|NCT02357459|468799902|FG000|Overall Study|Patient Relocated|2|||
130227722|NCT02357459|468799903|FG001|Overall Study|Patient Relocated|0|||
130227723|NCT02357459|468799904|FG002|Overall Study|Patient Relocated|0|||
130227724|NCT02357459|468799902|FG000|Overall Study|Instruction from PCP|1|||
130227725|NCT02357459|468799903|FG001|Overall Study|Instruction from PCP|0|||
130227726|NCT02357459|468799904|FG002|Overall Study|Instruction from PCP|0|||
130227727|NCT02357459|468799902|FG000|Overall Study|Incarceration|0|||
130227728|NCT02357459|468799903|FG001|Overall Study|Incarceration|0|||
130227729|NCT02357459|468799904|FG002|Overall Study|Incarceration|1|||
130227730|NCT02357459|468799902|FG000|Overall Study|Pre-planned Knee surgery|0|||
130227731|NCT02357459|468799903|FG001|Overall Study|Pre-planned Knee surgery|0|||
130227732|NCT02357459|468799904|FG002|Overall Study|Pre-planned Knee surgery|2|||
130356118|NCT03552965|469274654|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
130356119|NCT03552965|469274655|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
130227733|NCT02357459|468799902|FG000|Overall Study|Job Commitments|0|||
130227734|NCT02357459|468799903|FG001|Overall Study|Job Commitments|0|||
130227735|NCT02357459|468799904|FG002|Overall Study|Job Commitments|1|||
130227736|NCT01548599|468799905|FG000|Overall Study|Lost to Follow-up|0|||
130227737|NCT01548599|468799906|FG001|Overall Study|Lost to Follow-up|1|||
130227738|NCT01548599|468799905|FG000|Overall Study|Withdrawal by Subject|4|||
130227739|NCT01548599|468799906|FG001|Overall Study|Withdrawal by Subject|0|||
130227740|NCT01548599|468799905|FG000|Overall Study|Death|2|||
130227741|NCT01548599|468799906|FG001|Overall Study|Death|1|||
130227742|NCT05630196|468799907|FG000|Overall Study|Adverse Event|2|||
130227743|NCT05630196|468799908|FG001|Overall Study|Adverse Event|1|||
130227744|NCT05630196|468799907|FG000|Overall Study|Lost to Follow-up|1|||
130227745|NCT05630196|468799908|FG001|Overall Study|Lost to Follow-up|1|||
130227746|NCT05630196|468799907|FG000|Overall Study|Protocol Violation|2|||
130227747|NCT05630196|468799908|FG001|Overall Study|Protocol Violation|3|||
130227748|NCT05630196|468799907|FG000|Overall Study|Physician Decision|1|||
130227749|NCT05630196|468799908|FG001|Overall Study|Physician Decision|0|||
130227750|NCT05630196|468799907|FG000|Overall Study|Withdrawal by Subject|3|||
130227751|NCT05630196|468799908|FG001|Overall Study|Withdrawal by Subject|4|||
130227752|NCT00352118|468799910|FG000|Overall Study|Physician Decision|4|||
130227753|NCT02990000|468799911|FG000|Overall Study|Failed to provide data beyond baseline|36|||
130227754|NCT02990000|468799912|FG001|Overall Study|Failed to provide data beyond baseline|34|||
130227755|NCT02308046|468799913|FG000|Overall Study|Negative yeast culture at Baseline|32|||
130227756|NCT02308046|468799914|FG001|Overall Study|Negative yeast culture at Baseline|33|||
130227757|NCT02308046|468799913|FG000|Overall Study|Positive for STD at Baseline|1|||
130227758|NCT02308046|468799914|FG001|Overall Study|Positive for STD at Baseline|2|||
130227759|NCT02308046|468799913|FG000|Overall Study|Lost to Follow-up|1|||
130227760|NCT02308046|468799914|FG001|Overall Study|Lost to Follow-up|3|||
130227761|NCT00883181|468799915|FG000|Overall Study|Hematological Adverse Event|26|||
130227762|NCT00883181|468799915|FG000|Overall Study|Non-hematological Adverse Event|55|||
130227763|NCT00883181|468799915|FG000|Overall Study|Disease Progression|94|||
130227764|NCT00883181|468799915|FG000|Overall Study|Administrative Reason|24|||
130227765|NCT00883181|468799915|FG000|Overall Study|Withdrawal by Subject|4|||
130227766|NCT00883181|468799915|FG000|Overall Study|Death|31|||
130227767|NCT00883181|468799915|FG000|Overall Study|Other|38|||
130227768|NCT00883181|468799915|FG000|Overall Study|Protocol Deviation|3|||
130227769|NCT00883181|468799915|FG000|Overall Study|Noncompliance|3|||
130227770|NCT01587885|468799918|FG000|Treatment Period 1|Failure to Return|0|||
130227771|NCT01587885|468799919|FG001|Treatment Period 1|Failure to Return|1|||
130227772|NCT01587885|468799918|FG000|Treatment Period 1|Protocol Violation|0|||
130227773|NCT01587885|468799919|FG001|Treatment Period 1|Protocol Violation|2|||
130227774|NCT00001566|468799924|FG000|Overall Study|patients' choice to discontinue protocol|3|||
130227775|NCT00001566|468799924|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
130227776|NCT00001566|468799924|FG000|Overall Study|Death|13|||
130227777|NCT00001566|468799924|FG000|Overall Study|Lost to Follow-up|1|||
130227778|NCT00001566|468799924|FG000|Overall Study|unable to complete initial apheresis|1|||
130227779|NCT02914834|468799925|FG000|Overall Study|Study halted due to COVID|1|||
130227780|NCT02914834|468799926|FG001|Overall Study|Study halted due to COVID|1|||
130227781|NCT02914834|468799925|FG000|Overall Study|1 subject withdrew|0|||
130227782|NCT02914834|468799926|FG001|Overall Study|1 subject withdrew|1|||
130227783|NCT00975416|468799929|FG000|Overall Study|early discharge from tx|3|||
130227784|NCT00975416|468799930|FG001|Overall Study|early discharge from tx|5|||
130227785|NCT01249131|468799935|FG000|Washout Period of 10 Days|Adverse Event|0|||
130227786|NCT01249131|468799936|FG001|Washout Period of 10 Days|Adverse Event|0|||
130227787|NCT01249131|468799937|FG002|Washout Period of 10 Days|Adverse Event|0|||
130227788|NCT01249131|468799938|FG003|Washout Period of 10 Days|Adverse Event|0|||
130227789|NCT01249131|468799939|FG004|Washout Period of 10 Days|Adverse Event|1|||
130227790|NCT01249131|468799940|FG005|Washout Period of 10 Days|Adverse Event|0|||
130227791|NCT02378662|468799941|FG000|Overall Study|Early Discontinuation|2|||
130227792|NCT02378662|468799942|FG001|Overall Study|Early Discontinuation|0|||
130227793|NCT01774591|468799943|FG000|Overall Study|Physician Decision|1|||
130227794|NCT01774591|468799944|FG001|Overall Study|Physician Decision|1|||
130227795|NCT01774591|468799943|FG000|Overall Study|Withdrawal by Subject|0|||
130227796|NCT01774591|468799944|FG001|Overall Study|Withdrawal by Subject|1|||
130227797|NCT01774591|468799943|FG000|Overall Study|Adverse Event|0|||
130227798|NCT01774591|468799944|FG001|Overall Study|Adverse Event|2|||
130227799|NCT01701245|468799945|FG000|Overall Study|Protocol Violation|1|||
130444705|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Adverse Event|21|||
130444706|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Adverse Event|26|||
130444707|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Adverse Event|0|||
130444708|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
130444709|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
130691016|NCT03100344|470494482|FG000|Overall Study|Protocol Violation|1|||
130691017|NCT03100344|470494483|FG001|Overall Study|Protocol Violation|0|||
130227800|NCT01701245|468799946|FG001|Overall Study|Protocol Violation|3|||
130227801|NCT01701245|468799945|FG000|Overall Study|Did not complete the open label period|11|||
130227802|NCT01701245|468799946|FG001|Overall Study|Did not complete the open label period|12|||
130227803|NCT01159574|468799947|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
130227804|NCT01159574|468799947|FG000|Treatment Phase|Adverse Event|3|||
130227805|NCT01159574|468799947|FG000|Treatment Phase|Death|6|||
130227806|NCT01159574|468799947|FG000|Treatment Phase|Physician Decision|2|||
130444710|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
130227807|NCT01159574|468799947|FG000|Treatment Phase|Withdrawal by Subject|7|||
130227808|NCT01159574|468799947|FG000|Treatment Phase|still on treatment|2|||
130227809|NCT01159574|468799947|FG000|Follow Up Phase|Lost to Follow-up|2|||
130691018|NCT03100344|470494484|FG002|Overall Study|Protocol Violation|0|||
130227810|NCT01159574|468799947|FG000|Follow Up Phase|still being followed for overall surviva|18|||
130227811|NCT03555149|468799952|FG000|Overall Study|Death|18|||
130227812|NCT03555149|468799953|FG001|Overall Study|Death|15|||
130227813|NCT03555149|468799954|FG002|Overall Study|Death|15|||
130227814|NCT03555149|468799955|FG003|Overall Study|Death|4|||
130227815|NCT03555149|468799956|FG004|Overall Study|Death|4|||
130227816|NCT03555149|468799957|FG005|Overall Study|Death|11|||
130227817|NCT03555149|468799958|FG006|Overall Study|Death|12|||
130227818|NCT03555149|468799959|FG007|Overall Study|Death|1|||
130227819|NCT03555149|468799952|FG000|Overall Study|Lost to Follow-up|1|||
130227820|NCT03555149|468799953|FG001|Overall Study|Lost to Follow-up|0|||
130227821|NCT03555149|468799954|FG002|Overall Study|Lost to Follow-up|0|||
130227822|NCT03555149|468799955|FG003|Overall Study|Lost to Follow-up|0|||
130227823|NCT03555149|468799956|FG004|Overall Study|Lost to Follow-up|0|||
130227824|NCT03555149|468799957|FG005|Overall Study|Lost to Follow-up|1|||
130227825|NCT03555149|468799958|FG006|Overall Study|Lost to Follow-up|0|||
130227826|NCT03555149|468799959|FG007|Overall Study|Lost to Follow-up|0|||
130227827|NCT03555149|468799952|FG000|Overall Study|Physician Decision|1|||
130227828|NCT03555149|468799953|FG001|Overall Study|Physician Decision|0|||
130227829|NCT03555149|468799954|FG002|Overall Study|Physician Decision|0|||
130227830|NCT03555149|468799955|FG003|Overall Study|Physician Decision|0|||
130227831|NCT03555149|468799956|FG004|Overall Study|Physician Decision|0|||
130227832|NCT03555149|468799957|FG005|Overall Study|Physician Decision|0|||
130227833|NCT03555149|468799958|FG006|Overall Study|Physician Decision|0|||
130227834|NCT03555149|468799959|FG007|Overall Study|Physician Decision|0|||
130227835|NCT03555149|468799952|FG000|Overall Study|Study Terminated By Sponsor|1|||
130227836|NCT03555149|468799953|FG001|Overall Study|Study Terminated By Sponsor|0|||
130227837|NCT03555149|468799954|FG002|Overall Study|Study Terminated By Sponsor|0|||
130227838|NCT03555149|468799955|FG003|Overall Study|Study Terminated By Sponsor|0|||
130227839|NCT03555149|468799956|FG004|Overall Study|Study Terminated By Sponsor|0|||
130227840|NCT03555149|468799957|FG005|Overall Study|Study Terminated By Sponsor|2|||
130227841|NCT03555149|468799958|FG006|Overall Study|Study Terminated By Sponsor|3|||
130227842|NCT03555149|468799959|FG007|Overall Study|Study Terminated By Sponsor|1|||
130227843|NCT03555149|468799952|FG000|Overall Study|Withdrawal by Subject|3|||
130227844|NCT03555149|468799953|FG001|Overall Study|Withdrawal by Subject|0|||
130227845|NCT03555149|468799954|FG002|Overall Study|Withdrawal by Subject|0|||
130227846|NCT03555149|468799955|FG003|Overall Study|Withdrawal by Subject|2|||
130227847|NCT03555149|468799956|FG004|Overall Study|Withdrawal by Subject|0|||
130227848|NCT03555149|468799957|FG005|Overall Study|Withdrawal by Subject|1|||
130227849|NCT03555149|468799958|FG006|Overall Study|Withdrawal by Subject|0|||
130227850|NCT03555149|468799959|FG007|Overall Study|Withdrawal by Subject|0|||
130227851|NCT02666222|468799961|FG000|Overall Study|Death|2|||
130227852|NCT01474486|468799963|FG000|Overall Study|Death|2|||
130227853|NCT01474486|468799963|FG000|Overall Study|Withdrawal by Subject|4|||
130227854|NCT01474486|468799963|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
130227855|NCT03504917|468799967|FG000|Blinded Treatment Period|Protocol Violation|1|||
130227856|NCT03504917|468799968|FG001|Blinded Treatment Period|Protocol Violation|0|||
130227857|NCT03504917|468799967|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
130227858|NCT03504917|468799968|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
130227859|NCT03504917|468799967|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130227860|NCT03504917|468799968|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
130227861|NCT03504917|468799967|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130227862|NCT03504917|468799968|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
130227863|NCT03504917|468799967|FG000|Blinded Treatment Period|Adverse Event|4|||
130227864|NCT03504917|468799968|FG001|Blinded Treatment Period|Adverse Event|4|||
130227865|NCT03504917|468799967|FG000|Blinded Treatment Period|Physician Decision|1|||
130227866|NCT03504917|468799968|FG001|Blinded Treatment Period|Physician Decision|0|||
130227867|NCT03504917|468799967|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
130227868|NCT03504917|468799968|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
130356120|NCT03120624|469274656|FG000|Overall Study|Withdrawal by Subject|0|||
130356121|NCT03120624|469274657|FG001|Overall Study|Withdrawal by Subject|1|||
130356122|NCT03120624|469274658|FG002|Overall Study|Withdrawal by Subject|0|||
130227869|NCT03504917|468799967|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
130227870|NCT03504917|468799968|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
130227871|NCT03504917|468799967|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
130227872|NCT03504917|468799968|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
130227873|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
130227874|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
130227875|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
130227876|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
130227877|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
130227878|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
130227879|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
130227880|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
130227881|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
130227882|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
130227883|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
130227884|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
130227885|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
130227886|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
130227887|NCT04219189|468799969|FG000|Overall Study|Withdrawal by Subject|1|||
130227888|NCT04219189|468799970|FG001|Overall Study|Withdrawal by Subject|2|||
130227889|NCT04219189|468799969|FG000|Overall Study|Protocol Violation|0|||
130227890|NCT04219189|468799970|FG001|Overall Study|Protocol Violation|1|||
130227891|NCT04219189|468799969|FG000|Overall Study|Lost to Follow-up|0|||
130227892|NCT04219189|468799970|FG001|Overall Study|Lost to Follow-up|1|||
130227893|NCT04219189|468799969|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
130227894|NCT04219189|468799970|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
130227895|NCT03101020|468799971|FG000|Overall Study|Lack of time to participate|1|||
130227896|NCT03101020|468799972|FG001|Overall Study|Lack of time to participate|0|||
130227897|NCT03101020|468799971|FG000|Overall Study|Ran over by a car|0|||
130227898|NCT03101020|468799972|FG001|Overall Study|Ran over by a car|1|||
130227899|NCT03101020|468799971|FG000|Overall Study|Withdrawal by Subject|0|||
130227900|NCT03101020|468799972|FG001|Overall Study|Withdrawal by Subject|2|||
130227901|NCT05817669|468799973|FG000|Overall Study|Prohibited medication used|1|||
130227902|NCT05817669|468799974|FG001|Overall Study|Prohibited medication used|2|||
130227903|NCT05817669|468799973|FG000|Overall Study|Adverse Event|1|||
130227904|NCT05817669|468799974|FG001|Overall Study|Adverse Event|0|||
130227905|NCT05817669|468799973|FG000|Overall Study|Withdrawal by Subject|1|||
130227906|NCT05817669|468799974|FG001|Overall Study|Withdrawal by Subject|2|||
130227907|NCT03292016|468799975|FG000|Second Washout|Adverse Event|0|||
130227908|NCT03292016|468799976|FG001|Second Washout|Adverse Event|1|||
130227909|NCT03292016|468799977|FG002|Second Washout|Adverse Event|0|||
130227910|NCT03292016|468799978|FG003|Second Washout|Adverse Event|0|||
130227911|NCT03292016|468799979|FG004|Second Washout|Adverse Event|0|||
130227912|NCT03292016|468799980|FG005|Second Washout|Adverse Event|0|||
130227913|NCT03786380|468799981|FG000|Overall Study|Adverse Event|1|||
130227914|NCT03786380|468799982|FG001|Overall Study|Adverse Event|0|||
130227915|NCT03786380|468799983|FG002|Overall Study|Adverse Event|0|||
130227916|NCT03786380|468799984|FG003|Overall Study|Adverse Event|3|||
130227917|NCT03786380|468799985|FG004|Overall Study|Adverse Event|1|||
130227918|NCT03786380|468799981|FG000|Overall Study|Lack of Efficacy|0|||
130227919|NCT03786380|468799982|FG001|Overall Study|Lack of Efficacy|0|||
130552886|NCT00894686|469991608|FG000|Overall Study|Withdrawal by Subject|50|||
130227920|NCT03786380|468799983|FG002|Overall Study|Lack of Efficacy|0|||
130227921|NCT03786380|468799984|FG003|Overall Study|Lack of Efficacy|0|||
130227922|NCT03786380|468799985|FG004|Overall Study|Lack of Efficacy|1|||
130227923|NCT03786380|468799981|FG000|Overall Study|Withdrawal by Subject|1|||
130227924|NCT03786380|468799982|FG001|Overall Study|Withdrawal by Subject|2|||
130227925|NCT03786380|468799983|FG002|Overall Study|Withdrawal by Subject|2|||
130227926|NCT03786380|468799984|FG003|Overall Study|Withdrawal by Subject|1|||
130227927|NCT03786380|468799985|FG004|Overall Study|Withdrawal by Subject|2|||
130552887|NCT00894686|469991608|FG000|Overall Study|Physician Decision|1|||
130552888|NCT00894686|469991608|FG000|Overall Study|Other|5|||
130227928|NCT03786380|468799981|FG000|Overall Study|Lost to Follow-up|3|||
130227929|NCT03786380|468799982|FG001|Overall Study|Lost to Follow-up|0|||
130227930|NCT03786380|468799983|FG002|Overall Study|Lost to Follow-up|1|||
130227931|NCT03786380|468799984|FG003|Overall Study|Lost to Follow-up|2|||
130227932|NCT03786380|468799985|FG004|Overall Study|Lost to Follow-up|0|||
130227933|NCT03786380|468799981|FG000|Overall Study|Physician Decision|0|||
130227934|NCT03786380|468799982|FG001|Overall Study|Physician Decision|0|||
130227935|NCT03786380|468799983|FG002|Overall Study|Physician Decision|1|||
130227936|NCT03786380|468799984|FG003|Overall Study|Physician Decision|0|||
130227937|NCT03786380|468799985|FG004|Overall Study|Physician Decision|0|||
130227938|NCT03786380|468799981|FG000|Overall Study|Study Terminated by the Sponsor|30|||
130227939|NCT03786380|468799982|FG001|Overall Study|Study Terminated by the Sponsor|20|||
130227940|NCT03786380|468799983|FG002|Overall Study|Study Terminated by the Sponsor|50|||
130227941|NCT03786380|468799984|FG003|Overall Study|Study Terminated by the Sponsor|57|||
130227942|NCT03786380|468799985|FG004|Overall Study|Study Terminated by the Sponsor|23|||
130227943|NCT03786380|468799981|FG000|Overall Study|Reason Not Specified|0|||
130227944|NCT03786380|468799982|FG001|Overall Study|Reason Not Specified|0|||
130227945|NCT03786380|468799983|FG002|Overall Study|Reason Not Specified|0|||
130227946|NCT03786380|468799984|FG003|Overall Study|Reason Not Specified|0|||
130227947|NCT03786380|468799985|FG004|Overall Study|Reason Not Specified|1|||
130227948|NCT01664091|468799988|FG000|Overall Study|Death|1|||
130227949|NCT01664091|468799988|FG000|Overall Study|Disease Progression|2|||
130227950|NCT01664091|468799988|FG000|Overall Study|Lost to Follow-up|2|||
130227951|NCT01664091|468799988|FG000|Overall Study|Withdrawal by Subject|1|||
130227952|NCT01909804|468799991|FG000|Overall Study|Randomized but Never Treated|0|||
130227953|NCT01909804|468799992|FG001|Overall Study|Randomized but Never Treated|0|||
130227954|NCT01909804|468799993|FG002|Overall Study|Randomized but Never Treated|0|||
130227955|NCT01909804|468799994|FG003|Overall Study|Randomized but Never Treated|0|||
130227956|NCT01909804|468799995|FG004|Overall Study|Randomized but Never Treated|0|||
130227957|NCT01909804|468799996|FG005|Overall Study|Randomized but Never Treated|0|||
130227958|NCT01909804|468799997|FG006|Overall Study|Randomized but Never Treated|1|||
130227959|NCT01909804|468799998|FG007|Overall Study|Randomized but Never Treated|0|||
130227960|NCT01909804|468799999|FG008|Overall Study|Randomized but Never Treated|0|||
130227961|NCT01909804|468800000|FG009|Overall Study|Randomized but Never Treated|0|||
130227962|NCT01909804|468800001|FG010|Overall Study|Randomized but Never Treated|0|||
130227963|NCT01909804|468800002|FG011|Overall Study|Randomized but Never Treated|1|||
130227964|NCT01909804|468799991|FG000|Overall Study|Death|0|||
130227965|NCT01909804|468799992|FG001|Overall Study|Death|0|||
130227966|NCT01909804|468799993|FG002|Overall Study|Death|0|||
130227967|NCT01909804|468799994|FG003|Overall Study|Death|0|||
130691019|NCT03100344|470494485|FG003|Overall Study|Protocol Violation|0|||
130691020|NCT03100344|470494482|FG000|Overall Study|Withdrawal by Subject|10|||
130691021|NCT03100344|470494483|FG001|Overall Study|Withdrawal by Subject|7|||
130691022|NCT03100344|470494484|FG002|Overall Study|Withdrawal by Subject|4|||
130691023|NCT03100344|470494485|FG003|Overall Study|Withdrawal by Subject|8|||
130691024|NCT03100344|470494482|FG000|Overall Study|Lost to Follow-up|1|||
130691025|NCT03100344|470494483|FG001|Overall Study|Lost to Follow-up|1|||
130691026|NCT03100344|470494484|FG002|Overall Study|Lost to Follow-up|1|||
130691027|NCT03100344|470494485|FG003|Overall Study|Lost to Follow-up|1|||
130691028|NCT04633564|470494486|FG000|Period 1|Adverse Event|28|||
130227968|NCT01909804|468799995|FG004|Overall Study|Death|0|||
130227969|NCT01909804|468799996|FG005|Overall Study|Death|0|||
130227970|NCT01909804|468799997|FG006|Overall Study|Death|0|||
130227971|NCT01909804|468799998|FG007|Overall Study|Death|0|||
130227972|NCT01909804|468799999|FG008|Overall Study|Death|0|||
130227973|NCT01909804|468800000|FG009|Overall Study|Death|0|||
130227974|NCT01909804|468800001|FG010|Overall Study|Death|1|||
130227975|NCT01909804|468800002|FG011|Overall Study|Death|0|||
130227976|NCT01909804|468799991|FG000|Overall Study|Lack of Efficacy|4|||
130227977|NCT01909804|468799992|FG001|Overall Study|Lack of Efficacy|1|||
130691029|NCT04633564|470494487|FG001|Period 1|Adverse Event|19|||
130691030|NCT04633564|470494486|FG000|Period 1|Death|8|||
130691031|NCT04633564|470494487|FG001|Period 1|Death|7|||
130227978|NCT01909804|468799993|FG002|Overall Study|Lack of Efficacy|0|||
130227979|NCT01909804|468799994|FG003|Overall Study|Lack of Efficacy|0|||
130227980|NCT01909804|468799995|FG004|Overall Study|Lack of Efficacy|7|||
130227981|NCT01909804|468799996|FG005|Overall Study|Lack of Efficacy|3|||
130227982|NCT01909804|468799997|FG006|Overall Study|Lack of Efficacy|1|||
130227983|NCT01909804|468799998|FG007|Overall Study|Lack of Efficacy|1|||
130227984|NCT01909804|468799999|FG008|Overall Study|Lack of Efficacy|0|||
130227985|NCT01909804|468800000|FG009|Overall Study|Lack of Efficacy|1|||
130227986|NCT01909804|468800001|FG010|Overall Study|Lack of Efficacy|0|||
130227987|NCT01909804|468800002|FG011|Overall Study|Lack of Efficacy|1|||
130227988|NCT01909804|468799991|FG000|Overall Study|Withdrew Consent|0|||
130227989|NCT01909804|468799992|FG001|Overall Study|Withdrew Consent|0|||
130227990|NCT01909804|468799993|FG002|Overall Study|Withdrew Consent|0|||
130227991|NCT01909804|468799994|FG003|Overall Study|Withdrew Consent|0|||
130227992|NCT01909804|468799995|FG004|Overall Study|Withdrew Consent|1|||
130227993|NCT01909804|468799996|FG005|Overall Study|Withdrew Consent|1|||
130227994|NCT01909804|468799997|FG006|Overall Study|Withdrew Consent|0|||
130227995|NCT01909804|468799998|FG007|Overall Study|Withdrew Consent|0|||
130227996|NCT01909804|468799999|FG008|Overall Study|Withdrew Consent|0|||
130227997|NCT01909804|468800000|FG009|Overall Study|Withdrew Consent|0|||
130227998|NCT01909804|468800001|FG010|Overall Study|Withdrew Consent|0|||
130227999|NCT01909804|468800002|FG011|Overall Study|Withdrew Consent|0|||
130228000|NCT01909804|468799991|FG000|Overall Study|Protocol Violation|0|||
130228001|NCT01909804|468799992|FG001|Overall Study|Protocol Violation|0|||
130228002|NCT01909804|468799993|FG002|Overall Study|Protocol Violation|0|||
130228003|NCT01909804|468799994|FG003|Overall Study|Protocol Violation|0|||
130228004|NCT01909804|468799995|FG004|Overall Study|Protocol Violation|0|||
130228005|NCT01909804|468799996|FG005|Overall Study|Protocol Violation|0|||
130228006|NCT01909804|468799997|FG006|Overall Study|Protocol Violation|0|||
130228007|NCT01909804|468799998|FG007|Overall Study|Protocol Violation|0|||
130228008|NCT01909804|468799999|FG008|Overall Study|Protocol Violation|0|||
130228009|NCT01909804|468800000|FG009|Overall Study|Protocol Violation|0|||
130228010|NCT01909804|468800001|FG010|Overall Study|Protocol Violation|0|||
130228011|NCT01909804|468800002|FG011|Overall Study|Protocol Violation|1|||
130228012|NCT01038687|468800003|FG000|Overall Study|Adverse Event|0|||
130228013|NCT01038687|468800004|FG001|Overall Study|Adverse Event|2|||
130228014|NCT01038687|468800005|FG002|Overall Study|Adverse Event|1|||
130228015|NCT00338741|468800007|FG000|Overall Study|Lost to Follow-up|2|||
130228016|NCT00338741|468800008|FG001|Overall Study|Lost to Follow-up|0|||
130228017|NCT02144701|468800009|FG000|Overall Study|development of relapse, GVHD or death|9|||
130228018|NCT02144701|468800010|FG001|Overall Study|development of relapse, GVHD or death|3|||
130228019|NCT01218802|468800012|FG000|Overall Study|Lost to Follow-up|5|||
130228020|NCT01218802|468800013|FG001|Overall Study|Lost to Follow-up|6|||
130228021|NCT01218802|468800012|FG000|Overall Study|Withdrawal by Subject|3|||
130228022|NCT01218802|468800013|FG001|Overall Study|Withdrawal by Subject|10|||
130228023|NCT01218802|468800012|FG000|Overall Study|Adverse Event|0|||
130228024|NCT01218802|468800013|FG001|Overall Study|Adverse Event|2|||
130228025|NCT01218802|468800012|FG000|Overall Study|Incarcerated|2|||
130228026|NCT01218802|468800013|FG001|Overall Study|Incarcerated|0|||
130228027|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228028|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228029|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130691032|NCT04633564|470494486|FG000|Period 1|Lost to Follow-up|3|||
130691033|NCT04633564|470494487|FG001|Period 1|Lost to Follow-up|5|||
130691034|NCT04633564|470494486|FG000|Period 1|Physician Decision|4|||
130691035|NCT04633564|470494487|FG001|Period 1|Physician Decision|12|||
130691036|NCT04633564|470494486|FG000|Period 1|Protocol Violation|0|||
130228030|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228031|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228032|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
130228033|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Refused|0|||
130228034|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Refused|0|||
130444711|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
130228035|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Refused|0|||
130444712|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
130444713|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
130228036|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Refused|0|||
130444714|NCT02718417|469590244|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
130228037|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Refused|1|||
130444715|NCT02718417|469590245|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
130228038|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Refused|0|||
130228039|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228040|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
130228041|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228042|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228043|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228044|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228045|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Death|0|||
130228046|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Death|0|||
130228047|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Death|0|||
130228048|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Death|0|||
130228049|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Death|1|||
130228050|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Death|0|||
130228051|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228052|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228053|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228054|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228055|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228056|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
130228057|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228058|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228059|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228060|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228061|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228062|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228063|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
130228064|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228065|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228066|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130228067|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228068|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130228069|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
130228070|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228071|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228072|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228073|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228074|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228075|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Death|1|||
130691037|NCT04633564|470494487|FG001|Period 1|Protocol Violation|1|||
130691038|NCT04633564|470494486|FG000|Period 1|Withdrawal by Subject|10|||
130691039|NCT04633564|470494487|FG001|Period 1|Withdrawal by Subject|8|||
130691040|NCT04633564|470494486|FG000|Period 1|Progressive disease|47|||
130691041|NCT04633564|470494487|FG001|Period 1|Progressive disease|51|||
130691042|NCT04633564|470494486|FG000|Period 1|Terminated by Sponsor|8|||
130691043|NCT04633564|470494487|FG001|Period 1|Terminated by Sponsor|6|||
130691044|NCT04633564|470494486|FG000|Period 2|Adverse Event|3|||
130691045|NCT04633564|470494487|FG001|Period 2|Adverse Event|4|||
130691046|NCT04633564|470494486|FG000|Period 2|Death|0|||
130691047|NCT04633564|470494487|FG001|Period 2|Death|2|||
130691048|NCT04633564|470494486|FG000|Period 2|Lost to Follow-up|0|||
130691049|NCT04633564|470494487|FG001|Period 2|Lost to Follow-up|1|||
130691050|NCT04633564|470494486|FG000|Period 2|Physician Decision|2|||
130691051|NCT04633564|470494487|FG001|Period 2|Physician Decision|4|||
130691052|NCT04633564|470494486|FG000|Period 2|Withdrawal by Subject|5|||
130691053|NCT04633564|470494487|FG001|Period 2|Withdrawal by Subject|1|||
130691054|NCT04633564|470494486|FG000|Period 2|Progressive Disease|74|||
130228076|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Death|0|||
130228077|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Death|1|||
130228078|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Death|1|||
130228079|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Death|1|||
130228080|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Death|0|||
130228081|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228082|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228083|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228084|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228085|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228086|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
130228087|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228088|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228089|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228090|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228091|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228092|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228093|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
130228094|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
130228095|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228096|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228097|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228098|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228099|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228100|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228101|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228102|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228103|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228104|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228105|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228106|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228107|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228108|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
130228109|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
130228110|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228111|NCT03327324|468800014|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
130228112|NCT03327324|468800015|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228113|NCT03327324|468800016|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228114|NCT03327324|468800017|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228115|NCT03327324|468800018|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228116|NCT03327324|468800019|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228117|NCT03327324|468800014|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
130228118|NCT03327324|468800015|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228119|NCT03327324|468800016|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228120|NCT03327324|468800017|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228121|NCT03327324|468800018|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228122|NCT03327324|468800019|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228123|NCT02314728|468800023|FG000|Overall Study|Protocol Violation|1|||
130228124|NCT02314728|468800024|FG001|Overall Study|Protocol Violation|0|||
130228125|NCT02314728|468800023|FG000|Overall Study|Lost to Follow-up|0|||
130228126|NCT02314728|468800024|FG001|Overall Study|Lost to Follow-up|1|||
130228127|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
130228128|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228129|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228130|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228131|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228132|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228133|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228134|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
130228135|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228136|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228137|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228138|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228139|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228140|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228141|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228142|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
130228143|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228144|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228145|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228146|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228147|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228148|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228149|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228150|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
130228151|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228152|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228153|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228154|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228155|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228156|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228157|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
130228158|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228159|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228160|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228161|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228162|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228163|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228164|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
130228165|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130444716|NCT02718417|469590246|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
130444717|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Physician's decision|6|||
130444718|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Physician's decision|7|||
130444719|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Physician's decision|0|||
130444720|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Progressive disease|100|||
130444721|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Progressive disease|88|||
130444722|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Progressive disease|0|||
130444723|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Other|2|||
130444724|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Other|1|||
130444725|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Other|0|||
130444726|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
130444727|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
130444728|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
130444729|NCT02718417|469590244|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
130444730|NCT02718417|469590245|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
130444731|NCT02718417|469590246|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
130444732|NCT02718417|469590244|FG000|Observation Phase (OP)|Adverse Event|0|||
130444733|NCT02718417|469590245|FG001|Observation Phase (OP)|Adverse Event|0|||
130444734|NCT02718417|469590246|FG002|Observation Phase (OP)|Adverse Event|1|||
130444735|NCT02718417|469590244|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
130444736|NCT02718417|469590245|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
130444737|NCT02718417|469590246|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
130444738|NCT02718417|469590244|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
130444739|NCT02718417|469590245|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
130444740|NCT02718417|469590246|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
130444741|NCT02718417|469590244|FG000|Observation Phase (OP)|Physician Decision|0|||
130444742|NCT02718417|469590245|FG001|Observation Phase (OP)|Physician Decision|0|||
130444743|NCT02718417|469590246|FG002|Observation Phase (OP)|Physician Decision|9|||
130228166|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228167|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228168|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228169|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228170|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228171|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228172|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
130228173|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228174|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228175|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228176|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228177|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228178|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228179|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
130228180|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228181|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228182|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228183|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228184|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228185|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228186|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228187|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
130228188|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228189|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228190|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228191|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228192|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228193|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228194|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
130228195|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228196|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228197|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228198|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228199|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228200|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228201|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
130228202|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228203|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228204|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228205|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228206|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228207|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228208|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
130228209|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228210|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228211|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228212|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228213|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228214|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228215|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228216|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
130228217|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228218|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228219|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228220|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228221|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228222|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228223|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
130228224|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130691055|NCT04633564|470494487|FG001|Period 2|Progressive Disease|82|||
130691056|NCT04633564|470494486|FG000|Period 2|Terminated by Sponsor|9|||
130691057|NCT04633564|470494487|FG001|Period 2|Terminated by Sponsor|3|||
130691058|NCT01010503|470494488|FG000|Overall Study|Adverse Event|1|||
130691059|NCT01010503|470494488|FG000|Overall Study|Death|1|||
130691060|NCT06999265|470494491|FG000|Overall Study|Lost to Follow-up|1|||
130691061|NCT06999265|470494492|FG001|Overall Study|Lost to Follow-up|1|||
130691062|NCT03043872|470494496|FG000|Overall Study|Withdrawal by Subject|6|||
130691063|NCT03043872|470494497|FG001|Overall Study|Withdrawal by Subject|6|||
130691064|NCT03043872|470494498|FG002|Overall Study|Withdrawal by Subject|15|||
130691065|NCT03043872|470494496|FG000|Overall Study|Lost to Follow-up|2|||
130691066|NCT03043872|470494497|FG001|Overall Study|Lost to Follow-up|1|||
130691067|NCT03043872|470494498|FG002|Overall Study|Lost to Follow-up|1|||
130691068|NCT03043872|470494496|FG000|Overall Study|Death|270|||
130691069|NCT03043872|470494497|FG001|Overall Study|Death|269|||
130691070|NCT03043872|470494498|FG002|Overall Study|Death|296|||
130691071|NCT01154231|470494499|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
130691072|NCT01154231|470494499|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
130691073|NCT03114891|470494505|FG000|First Treatment Round|Lost to Follow-up|0|||
130691074|NCT03114891|470494506|FG001|First Treatment Round|Lost to Follow-up|1|||
130691075|NCT03114891|470494507|FG002|First Treatment Round|Lost to Follow-up|1|||
130691076|NCT03114891|470494508|FG003|First Treatment Round|Lost to Follow-up|0|||
130691077|NCT03114891|470494505|FG000|First Treatment Round|Withdrawal by Subject|0|||
130691078|NCT03114891|470494506|FG001|First Treatment Round|Withdrawal by Subject|2|||
130691079|NCT03114891|470494507|FG002|First Treatment Round|Withdrawal by Subject|0|||
130691080|NCT03114891|470494508|FG003|First Treatment Round|Withdrawal by Subject|1|||
130691081|NCT03114891|470494505|FG000|3 Week Break|Lost to Follow-up|1|||
130691082|NCT03114891|470494506|FG001|3 Week Break|Lost to Follow-up|0|||
130691083|NCT03114891|470494507|FG002|3 Week Break|Lost to Follow-up|0|||
130691084|NCT03114891|470494508|FG003|3 Week Break|Lost to Follow-up|1|||
130691085|NCT03114891|470494505|FG000|3 Week Break|Withdrawal by Subject|0|||
130691086|NCT03114891|470494506|FG001|3 Week Break|Withdrawal by Subject|1|||
130691087|NCT03114891|470494507|FG002|3 Week Break|Withdrawal by Subject|0|||
130691088|NCT03114891|470494508|FG003|3 Week Break|Withdrawal by Subject|0|||
130691089|NCT03114891|470494505|FG000|Second Treatment Round|Lost to Follow-up|1|||
130691090|NCT03114891|470494506|FG001|Second Treatment Round|Lost to Follow-up|0|||
130691091|NCT03114891|470494507|FG002|Second Treatment Round|Lost to Follow-up|0|||
130691092|NCT03114891|470494508|FG003|Second Treatment Round|Lost to Follow-up|0|||
130691093|NCT03114891|470494505|FG000|Second Treatment Round|Physician Decision|1|||
130691094|NCT03114891|470494506|FG001|Second Treatment Round|Physician Decision|0|||
130691095|NCT03114891|470494507|FG002|Second Treatment Round|Physician Decision|0|||
130691096|NCT03114891|470494508|FG003|Second Treatment Round|Physician Decision|0|||
130444744|NCT02718417|469590244|FG000|Observation Phase (OP)|Progressive disease|0|||
130444745|NCT02718417|469590245|FG001|Observation Phase (OP)|Progressive disease|0|||
130691097|NCT00772603|470495816|FG000|Overall Study|Withdrawal by Subject|11|||
130444746|NCT02718417|469590246|FG002|Observation Phase (OP)|Progressive disease|92|||
130691098|NCT00772603|470495817|FG001|Overall Study|Withdrawal by Subject|10|||
130691099|NCT00772603|470495818|FG002|Overall Study|Withdrawal by Subject|6|||
130691100|NCT00772603|470495816|FG000|Overall Study|Adverse Event|37|||
130691101|NCT00772603|470495817|FG001|Overall Study|Adverse Event|18|||
130691102|NCT00772603|470495818|FG002|Overall Study|Adverse Event|10|||
130691103|NCT00772603|470495816|FG000|Overall Study|Subject Non-compliance|1|||
130691104|NCT00772603|470495817|FG001|Overall Study|Subject Non-compliance|6|||
130691105|NCT00772603|470495818|FG002|Overall Study|Subject Non-compliance|4|||
130691106|NCT00772603|470495816|FG000|Overall Study|Protocol Violation|0|||
130691107|NCT00772603|470495817|FG001|Overall Study|Protocol Violation|1|||
130691108|NCT00772603|470495818|FG002|Overall Study|Protocol Violation|1|||
130691109|NCT00772603|470495816|FG000|Overall Study|Lost to Follow-up|1|||
130691110|NCT00772603|470495817|FG001|Overall Study|Lost to Follow-up|5|||
130691111|NCT00772603|470495818|FG002|Overall Study|Lost to Follow-up|2|||
130691112|NCT00772603|470495816|FG000|Overall Study|Physician Decision|0|||
130691113|NCT00772603|470495817|FG001|Overall Study|Physician Decision|0|||
130691114|NCT00772603|470495818|FG002|Overall Study|Physician Decision|1|||
130691115|NCT00772603|470495816|FG000|Overall Study|Other|2|||
130691116|NCT00772603|470495817|FG001|Overall Study|Other|0|||
130691117|NCT00772603|470495818|FG002|Overall Study|Other|2|||
130691118|NCT01056484|470495821|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
130691119|NCT01056484|470495822|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
130691120|NCT01056484|470495821|FG000|Randomized Controlled Trial|Physician Decision|1|||
130691121|NCT01056484|470495822|FG001|Randomized Controlled Trial|Physician Decision|0|||
130691122|NCT01056484|470495821|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
130691123|NCT01056484|470495822|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
130691124|NCT00446966|470495825|FG000|Overall Study|Lost to Follow-up|10|||
130691125|NCT00446966|470495826|FG001|Overall Study|Lost to Follow-up|7|||
130691126|NCT01564394|470495827|FG000|Overall Study|Withdrawal by Subject|6|||
130691127|NCT01564394|470495828|FG001|Overall Study|Withdrawal by Subject|10|||
130691128|NCT00443651|470495829|FG000|Overall Study|Death|1|||
130691129|NCT00443651|470495830|FG001|Overall Study|Death|5|||
130691130|NCT00443651|470495829|FG000|Overall Study|Adverse Event|5|||
130691131|NCT00443651|470495830|FG001|Overall Study|Adverse Event|6|||
130691132|NCT00443651|470495829|FG000|Overall Study|Lost to Follow-up|18|||
130691133|NCT00443651|470495830|FG001|Overall Study|Lost to Follow-up|12|||
130228225|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228226|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228227|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228228|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228229|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228230|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228231|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
130228232|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228233|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228234|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228235|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228236|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228237|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228238|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
130228239|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228240|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228241|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228242|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228243|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228244|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228245|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
130228246|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228247|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228248|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228249|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228250|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228251|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228252|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
130228253|NCT03118934|468800032|FG000|Overall Study|Adverse Event|0|||
130228254|NCT03118934|468800033|FG001|Overall Study|Adverse Event|0|||
130228255|NCT03118934|468800034|FG002|Overall Study|Adverse Event|0|||
130228256|NCT03118934|468800035|FG003|Overall Study|Adverse Event|0|||
130228257|NCT03118934|468800036|FG004|Overall Study|Adverse Event|0|||
130228258|NCT03118934|468800037|FG005|Overall Study|Adverse Event|1|||
130228259|NCT03118934|468800032|FG000|Overall Study|Physician Decision|0|||
130228260|NCT03118934|468800033|FG001|Overall Study|Physician Decision|0|||
130228261|NCT03118934|468800034|FG002|Overall Study|Physician Decision|0|||
130228262|NCT03118934|468800035|FG003|Overall Study|Physician Decision|0|||
130228263|NCT03118934|468800036|FG004|Overall Study|Physician Decision|0|||
130228264|NCT03118934|468800037|FG005|Overall Study|Physician Decision|1|||
130228265|NCT03118934|468800032|FG000|Overall Study|Discontinued prior to exposure|0|||
130228266|NCT03118934|468800033|FG001|Overall Study|Discontinued prior to exposure|1|||
130228267|NCT03118934|468800034|FG002|Overall Study|Discontinued prior to exposure|1|||
130228268|NCT03118934|468800035|FG003|Overall Study|Discontinued prior to exposure|1|||
130228269|NCT03118934|468800036|FG004|Overall Study|Discontinued prior to exposure|2|||
130228270|NCT03118934|468800037|FG005|Overall Study|Discontinued prior to exposure|0|||
130228271|NCT01614470|468800038|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
130228272|NCT01614470|468800039|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130228273|NCT01614470|468800040|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130228274|NCT01614470|468800038|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130228275|NCT01614470|468800039|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130228276|NCT01614470|468800040|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
130228277|NCT00249834|468800041|FG000|Overall Study|Ovarian stimulation failed|1|||
130228278|NCT00249834|468800042|FG001|Overall Study|Ovarian stimulation failed|0|||
130228279|NCT00249834|468800043|FG002|Overall Study|Ovarian stimulation failed|0|||
130228280|NCT00249834|468800044|FG003|Overall Study|Ovarian stimulation failed|0|||
130228281|NCT00249834|468800045|FG004|Overall Study|Ovarian stimulation failed|0|||
130228282|NCT00249834|468800046|FG005|Overall Study|Ovarian stimulation failed|0|||
130228283|NCT00249834|468800047|FG006|Overall Study|Ovarian stimulation failed|0|||
130228284|NCT00249834|468800048|FG007|Overall Study|Ovarian stimulation failed|0|||
130228285|NCT00249834|468800041|FG000|Overall Study|Failure of down-regulation|0|||
130228286|NCT00249834|468800042|FG001|Overall Study|Failure of down-regulation|0|||
130228287|NCT00249834|468800043|FG002|Overall Study|Failure of down-regulation|0|||
130228288|NCT00249834|468800044|FG003|Overall Study|Failure of down-regulation|0|||
130228289|NCT00249834|468800045|FG004|Overall Study|Failure of down-regulation|0|||
130228290|NCT00249834|468800046|FG005|Overall Study|Failure of down-regulation|0|||
130228291|NCT00249834|468800047|FG006|Overall Study|Failure of down-regulation|1|||
130228292|NCT00249834|468800048|FG007|Overall Study|Failure of down-regulation|0|||
130228293|NCT00249834|468800041|FG000|Overall Study|Protocol Violation|0|||
130228294|NCT00249834|468800042|FG001|Overall Study|Protocol Violation|19|||
130228295|NCT00249834|468800043|FG002|Overall Study|Protocol Violation|14|||
130228296|NCT00249834|468800044|FG003|Overall Study|Protocol Violation|8|||
130228297|NCT00249834|468800045|FG004|Overall Study|Protocol Violation|5|||
130228298|NCT00249834|468800046|FG005|Overall Study|Protocol Violation|2|||
130228299|NCT00249834|468800047|FG006|Overall Study|Protocol Violation|0|||
130228300|NCT00249834|468800048|FG007|Overall Study|Protocol Violation|0|||
130228301|NCT02895347|468800049|FG000|Overall Study|Withdrawal by Subject|3|||
130228302|NCT02895347|468800050|FG001|Overall Study|Withdrawal by Subject|1|||
130228303|NCT03177148|468800054|FG000|Overall Study|Lost to Follow-up|50|||
130228304|NCT03177148|468800055|FG001|Overall Study|Lost to Follow-up|1|||
130228305|NCT03177148|468800054|FG000|Overall Study|Death|1|||
130228306|NCT03177148|468800055|FG001|Overall Study|Death|0|||
130228307|NCT02848664|468800058|FG000|Overall Study|Withdrawal by Subject|2|||
130228308|NCT02848664|468800058|FG000|Overall Study|Adverse Event|1|||
130228309|NCT02848664|468800058|FG000|Overall Study|no assistance for device training|1|||
130228310|NCT01204671|468800059|FG000|Overall Study|Adverse Event|4|||
130228311|NCT01204671|468800060|FG001|Overall Study|Adverse Event|3|||
130228312|NCT01204671|468800061|FG002|Overall Study|Adverse Event|3|||
130228313|NCT01204671|468800062|FG003|Overall Study|Adverse Event|3|||
130228314|NCT01204671|468800063|FG004|Overall Study|Adverse Event|1|||
130228315|NCT01204671|468800059|FG000|Overall Study|Withdrawal by Subject|2|||
130228316|NCT01204671|468800060|FG001|Overall Study|Withdrawal by Subject|3|||
130228317|NCT01204671|468800061|FG002|Overall Study|Withdrawal by Subject|4|||
130228318|NCT01204671|468800062|FG003|Overall Study|Withdrawal by Subject|5|||
130691134|NCT00443651|470495829|FG000|Overall Study|Patient's/Guardian's Decision|58|||
130691135|NCT00443651|470495830|FG001|Overall Study|Patient's/Guardian's Decision|30|||
130228319|NCT01204671|468800063|FG004|Overall Study|Withdrawal by Subject|3|||
130228320|NCT01204671|468800059|FG000|Overall Study|Lost to Follow-up|7|||
130228321|NCT01204671|468800060|FG001|Overall Study|Lost to Follow-up|8|||
130228322|NCT01204671|468800061|FG002|Overall Study|Lost to Follow-up|6|||
130228323|NCT01204671|468800062|FG003|Overall Study|Lost to Follow-up|4|||
130228324|NCT01204671|468800063|FG004|Overall Study|Lost to Follow-up|0|||
130228325|NCT01204671|468800059|FG000|Overall Study|Unknown Completion Status|1|||
130228326|NCT01204671|468800060|FG001|Overall Study|Unknown Completion Status|1|||
130228327|NCT01204671|468800061|FG002|Overall Study|Unknown Completion Status|0|||
130228328|NCT01204671|468800062|FG003|Overall Study|Unknown Completion Status|0|||
130228329|NCT01204671|468800063|FG004|Overall Study|Unknown Completion Status|0|||
130228330|NCT01204671|468800059|FG000|Overall Study|Physician Decision|0|||
130228331|NCT01204671|468800060|FG001|Overall Study|Physician Decision|0|||
130228332|NCT01204671|468800061|FG002|Overall Study|Physician Decision|0|||
130228333|NCT01204671|468800062|FG003|Overall Study|Physician Decision|1|||
130228334|NCT01204671|468800063|FG004|Overall Study|Physician Decision|0|||
130228335|NCT00492726|468800068|FG000|Overall Study|Adverse Event|10|||
130228336|NCT00492726|468800069|FG001|Overall Study|Adverse Event|6|||
130228337|NCT00492726|468800068|FG000|Overall Study|Death|7|||
130228338|NCT00492726|468800069|FG001|Overall Study|Death|2|||
130228339|NCT00492726|468800068|FG000|Overall Study|Lack of Efficacy|0|||
130228340|NCT00492726|468800069|FG001|Overall Study|Lack of Efficacy|2|||
130228341|NCT00492726|468800068|FG000|Overall Study|Lost to Follow-up|27|||
130228342|NCT00492726|468800069|FG001|Overall Study|Lost to Follow-up|19|||
130228343|NCT00492726|468800068|FG000|Overall Study|Physician Decision|0|||
130228344|NCT00492726|468800069|FG001|Overall Study|Physician Decision|1|||
130228345|NCT00492726|468800068|FG000|Overall Study|Withdrawal by Subject|6|||
130228346|NCT00492726|468800069|FG001|Overall Study|Withdrawal by Subject|3|||
130228347|NCT00492726|468800068|FG000|Overall Study|Non compliant with study medication|0|||
130228348|NCT00492726|468800069|FG001|Overall Study|Non compliant with study medication|3|||
130228349|NCT04386902|468800070|FG000|Overall Study|Withdrawal by Subject|5|||
130228350|NCT04386902|468800070|FG000|Overall Study|Technical problems in the recording|5|||
130228351|NCT02404545|468800071|FG000|Overall Study|Sponsor Termination|6|||
130228352|NCT02404545|468800072|FG001|Overall Study|Sponsor Termination|6|||
130228353|NCT01712516|468801556|FG000|Overall Study|Technical problems|0|||
130691136|NCT00443651|470495829|FG000|Overall Study|Physician Decision|13|||
130228354|NCT01712516|468801557|FG001|Overall Study|Technical problems|0|||
130228355|NCT01712516|468801558|FG002|Overall Study|Technical problems|0|||
130228356|NCT01712516|468801559|FG003|Overall Study|Technical problems|2|||
130228357|NCT01712516|468801556|FG000|Overall Study|Lost to Follow-up|0|||
130228358|NCT01712516|468801557|FG001|Overall Study|Lost to Follow-up|0|||
130228359|NCT01712516|468801558|FG002|Overall Study|Lost to Follow-up|2|||
130444747|NCT02718417|469590244|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
130691137|NCT00443651|470495830|FG001|Overall Study|Physician Decision|4|||
130228360|NCT01712516|468801559|FG003|Overall Study|Lost to Follow-up|1|||
130228361|NCT01712516|468801556|FG000|Overall Study|Death|0|||
130228362|NCT01712516|468801557|FG001|Overall Study|Death|1|||
130228363|NCT01712516|468801558|FG002|Overall Study|Death|0|||
130228364|NCT01712516|468801559|FG003|Overall Study|Death|0|||
130228365|NCT01712516|468801556|FG000|Overall Study|Protocol deviation|1|||
130228366|NCT01712516|468801557|FG001|Overall Study|Protocol deviation|0|||
130228367|NCT01712516|468801558|FG002|Overall Study|Protocol deviation|1|||
130228368|NCT01712516|468801559|FG003|Overall Study|Protocol deviation|0|||
130228369|NCT01712516|468801556|FG000|Overall Study|Physician Decision|2|||
130228370|NCT01712516|468801557|FG001|Overall Study|Physician Decision|0|||
130228371|NCT01712516|468801558|FG002|Overall Study|Physician Decision|0|||
130228372|NCT01712516|468801559|FG003|Overall Study|Physician Decision|1|||
130228373|NCT01712516|468801556|FG000|Overall Study|Withdrawal by Subject|3|||
130228374|NCT01712516|468801557|FG001|Overall Study|Withdrawal by Subject|9|||
130228375|NCT01712516|468801558|FG002|Overall Study|Withdrawal by Subject|3|||
130228376|NCT01712516|468801559|FG003|Overall Study|Withdrawal by Subject|9|||
130228377|NCT01181167|468801560|FG000|Overall Study|Adverse Event|11|||
130228378|NCT01181167|468801561|FG001|Overall Study|Adverse Event|21|||
130228379|NCT01181167|468801560|FG000|Overall Study|Lost to Follow-up|1|||
130228380|NCT01181167|468801561|FG001|Overall Study|Lost to Follow-up|0|||
130228381|NCT01181167|468801560|FG000|Overall Study|Physician Decision|2|||
130228382|NCT01181167|468801561|FG001|Overall Study|Physician Decision|3|||
130228383|NCT01181167|468801560|FG000|Overall Study|Protocol Violation|3|||
130228384|NCT01181167|468801561|FG001|Overall Study|Protocol Violation|0|||
130228385|NCT01181167|468801560|FG000|Overall Study|Withdrawal by Subject|6|||
130228386|NCT01181167|468801561|FG001|Overall Study|Withdrawal by Subject|8|||
130228387|NCT00161213|468801562|FG000|Overall Study|Withdrawal by Subject|1|||
130228388|NCT00161213|468801562|FG000|Overall Study|Evaluable for toxicity but not response|1|||
130228389|NCT03103503|468801563|FG000|Overall Study|Death|64|||
130228390|NCT03103503|468801563|FG000|Overall Study|Physician Decision|57|||
130228391|NCT03103503|468801563|FG000|Overall Study|Withdrawal by Subject|10|||
130228392|NCT03103503|468801563|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
130228393|NCT03103503|468801563|FG000|Overall Study|Lost to Follow-up|3|||
130228394|NCT03103503|468801563|FG000|Overall Study|Study Closure|757|||
130228395|NCT02683109|468801565|FG000|Overall Study|Adverse Event|1|||
130228396|NCT02683109|468801566|FG001|Overall Study|Adverse Event|0|||
130228397|NCT00183430|468801567|FG000|Overall Study|Adverse Event|1|||
130228398|NCT00183430|468801568|FG001|Overall Study|Adverse Event|0|||
130228399|NCT00183430|468801567|FG000|Overall Study|Lost to Follow-up|3|||
130228400|NCT00183430|468801568|FG001|Overall Study|Lost to Follow-up|0|||
130228401|NCT00183430|468801567|FG000|Overall Study|did not meet inclusion criteria|1|||
130228402|NCT00183430|468801568|FG001|Overall Study|did not meet inclusion criteria|0|||
130228403|NCT00183430|468801567|FG000|Overall Study|Withdrawal by Subject|1|||
130228404|NCT00183430|468801568|FG001|Overall Study|Withdrawal by Subject|0|||
130228405|NCT03322293|468801571|FG000|Overall Study|Lost to Follow-up|0|||
130228406|NCT03322293|468801572|FG001|Overall Study|Lost to Follow-up|0|||
130228407|NCT03322293|468801573|FG002|Overall Study|Lost to Follow-up|1|||
130228408|NCT01178294|468801574|FG000|Overall Study|Adverse Event|4|||
130228409|NCT01178294|468801574|FG000|Overall Study|Lost to Follow-up|2|||
130228410|NCT01178294|468801574|FG000|Overall Study|Lack of Efficacy|1|||
130228411|NCT01178294|468801574|FG000|Overall Study|Death|1|||
130228412|NCT01178294|468801574|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
130228413|NCT01178294|468801574|FG000|Overall Study|Subject status is terminal|1|||
130228414|NCT01178294|468801574|FG000|Overall Study|Completion status could not be verified|1|||
130228415|NCT02089347|468801575|FG000|Overall Study|Protocol Violation|1|||
130228416|NCT02089347|468801576|FG001|Overall Study|Protocol Violation|0|||
130228417|NCT00551369|468801577|FG000|Overall Study|Protocol Violation|5|||
130228418|NCT00551369|468801577|FG000|Overall Study|Withdrawal by Subject|1|||
130228419|NCT00551369|468801577|FG000|Overall Study|Not treated per protocol and re|1|||
130228420|NCT00719901|468801578|FG000|Overall Study|Adverse Event|5|||
130228421|NCT00719901|468801578|FG000|Overall Study|Withdrawal by Subject|1|||
130228422|NCT00719901|468801578|FG000|Overall Study|Alternate Treatment|1|||
130444748|NCT02718417|469590245|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
130691138|NCT00443651|470495829|FG000|Overall Study|Pregnancy|0|||
130691139|NCT00443651|470495830|FG001|Overall Study|Pregnancy|1|||
130691140|NCT00859521|470495833|FG000|Washout|Withdrawal by Subject|0|||
130691141|NCT00859521|470495834|FG001|Washout|Withdrawal by Subject|1|||
130691142|NCT02888756|470495835|FG000|Analytical Treatment Interruption|Physician Decision|10|||
130691143|NCT02888756|470495836|FG001|Analytical Treatment Interruption|Physician Decision|6|||
130228423|NCT00719901|468801578|FG000|Overall Study|Disease Progression|3|||
130228424|NCT00719901|468801578|FG000|Overall Study|Availability of Study Drug|1|||
130228425|NCT01122173|468801579|FG000|Overall Study|Lost to Follow-up|3|||
130228426|NCT01122173|468801579|FG000|Overall Study|Withdrawal by Subject|3|||
130228427|NCT01122173|468801579|FG000|Overall Study|Left study for other reasons|3|||
130228428|NCT01184872|468801580|FG000|Overall Study|Adverse Event|3|||
130228429|NCT01184872|468801581|FG001|Overall Study|Adverse Event|4|||
130228430|NCT01184872|468801580|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130228431|NCT01184872|468801581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130228432|NCT01184872|468801580|FG000|Overall Study|Withdrawal by Subject|2|||
130228433|NCT01184872|468801581|FG001|Overall Study|Withdrawal by Subject|0|||
130228434|NCT01184872|468801580|FG000|Overall Study|Lost to Follow-up|0|||
130444749|NCT02718417|469590246|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
130228435|NCT01184872|468801581|FG001|Overall Study|Lost to Follow-up|1|||
130691144|NCT02888756|470495837|FG002|Analytical Treatment Interruption|Physician Decision|5|||
130444750|NCT02718417|469590244|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
130444751|NCT02718417|469590245|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
130444752|NCT02718417|469590246|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
130444753|NCT02718417|469590244|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
130444754|NCT02718417|469590245|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
130444755|NCT02718417|469590246|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
130444756|NCT02718417|469590244|FG000|Observation Phase (OP)|Other|0|||
130444757|NCT02718417|469590245|FG001|Observation Phase (OP)|Other|0|||
130444758|NCT02718417|469590246|FG002|Observation Phase (OP)|Other|7|||
130444759|NCT02718417|469590244|FG000|Follow-up Phase|Adverse Event|3|||
130444760|NCT02718417|469590245|FG001|Follow-up Phase|Adverse Event|1|||
130444761|NCT02718417|469590246|FG002|Follow-up Phase|Adverse Event|1|||
130444762|NCT02718417|469590244|FG000|Follow-up Phase|Other|4|||
130444763|NCT02718417|469590245|FG001|Follow-up Phase|Other|6|||
130444764|NCT02718417|469590246|FG002|Follow-up Phase|Other|4|||
130444765|NCT02718417|469590244|FG000|Follow-up Phase|Withdrawal by Subject|19|||
130444766|NCT02718417|469590245|FG001|Follow-up Phase|Withdrawal by Subject|17|||
130444767|NCT02718417|469590246|FG002|Follow-up Phase|Withdrawal by Subject|5|||
130444768|NCT02718417|469590244|FG000|Follow-up Phase|Study terminated by sponsor|100|||
130444769|NCT02718417|469590245|FG001|Follow-up Phase|Study terminated by sponsor|138|||
130444770|NCT02718417|469590246|FG002|Follow-up Phase|Study terminated by sponsor|6|||
130444771|NCT02718417|469590244|FG000|Follow-up Phase|Lost to Follow-up|2|||
130444772|NCT02718417|469590245|FG001|Follow-up Phase|Lost to Follow-up|3|||
130444773|NCT02718417|469590246|FG002|Follow-up Phase|Lost to Follow-up|0|||
130444774|NCT02718417|469590244|FG000|Follow-up Phase|Death leading to discontinuation|7|||
130444775|NCT02718417|469590245|FG001|Follow-up Phase|Death leading to discontinuation|7|||
130444776|NCT02718417|469590246|FG002|Follow-up Phase|Death leading to discontinuation|3|||
130444777|NCT02718417|469590244|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
130444778|NCT02718417|469590245|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
130444779|NCT02718417|469590246|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
130444780|NCT02718417|469590244|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
130444781|NCT02718417|469590245|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
130444782|NCT02718417|469590246|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
130444783|NCT02718417|469590244|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
130444784|NCT02718417|469590245|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
130444785|NCT02718417|469590246|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
130444786|NCT02718417|469590244|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
130444787|NCT02718417|469590245|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
130444788|NCT02718417|469590246|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
130444789|NCT02718417|469590244|FG000|Long-term Follow-up Phase|Other|0|||
130444790|NCT02718417|469590245|FG001|Long-term Follow-up Phase|Other|2|||
130444791|NCT02718417|469590246|FG002|Long-term Follow-up Phase|Other|0|||
130444792|NCT00551213|469590249|FG000|Overall Study|Adverse Event|6|||
130444793|NCT00551213|469590250|FG001|Overall Study|Adverse Event|3|||
130444794|NCT00551213|469590249|FG000|Overall Study|Progressive Disease|41|||
130444795|NCT00551213|469590250|FG001|Overall Study|Progressive Disease|12|||
130444796|NCT00551213|469590249|FG000|Overall Study|Withdrawal by Subject|2|||
130444797|NCT00551213|469590250|FG001|Overall Study|Withdrawal by Subject|0|||
130444798|NCT00551213|469590249|FG000|Overall Study|Not Treated|1|||
130444799|NCT00551213|469590250|FG001|Overall Study|Not Treated|2|||
130444800|NCT01890967|469590251|FG000|Overall Study|Adverse Event|3|||
130444801|NCT01890967|469590252|FG001|Overall Study|Adverse Event|3|||
130444802|NCT01890967|469590253|FG002|Overall Study|Adverse Event|3|||
130444803|NCT01890967|469590254|FG003|Overall Study|Adverse Event|2|||
130444804|NCT01890967|469590255|FG004|Overall Study|Adverse Event|1|||
130444805|NCT01890967|469590256|FG005|Overall Study|Adverse Event|7|||
130444806|NCT01890967|469590251|FG000|Overall Study|Death|1|||
130444807|NCT01890967|469590252|FG001|Overall Study|Death|0|||
130444808|NCT01890967|469590253|FG002|Overall Study|Death|0|||
130444809|NCT01890967|469590254|FG003|Overall Study|Death|0|||
130444810|NCT01890967|469590255|FG004|Overall Study|Death|0|||
130444811|NCT01890967|469590256|FG005|Overall Study|Death|0|||
130444812|NCT01890967|469590251|FG000|Overall Study|Lost to Follow-up|1|||
130444813|NCT01890967|469590252|FG001|Overall Study|Lost to Follow-up|1|||
130444814|NCT01890967|469590253|FG002|Overall Study|Lost to Follow-up|1|||
130444815|NCT01890967|469590254|FG003|Overall Study|Lost to Follow-up|1|||
130444816|NCT01890967|469590255|FG004|Overall Study|Lost to Follow-up|0|||
130444817|NCT01890967|469590256|FG005|Overall Study|Lost to Follow-up|1|||
130444818|NCT01890967|469590251|FG000|Overall Study|Protocol Violation|0|||
130444819|NCT01890967|469590252|FG001|Overall Study|Protocol Violation|3|||
130444820|NCT01890967|469590253|FG002|Overall Study|Protocol Violation|3|||
130444821|NCT01890967|469590254|FG003|Overall Study|Protocol Violation|2|||
130444822|NCT01890967|469590255|FG004|Overall Study|Protocol Violation|4|||
130444823|NCT01890967|469590256|FG005|Overall Study|Protocol Violation|1|||
130444824|NCT01890967|469590251|FG000|Overall Study|Sponsor Decision|2|||
130444825|NCT01890967|469590252|FG001|Overall Study|Sponsor Decision|0|||
130228436|NCT01184872|468801580|FG000|Overall Study|Administrative problems|1|||
130228437|NCT01184872|468801581|FG001|Overall Study|Administrative problems|1|||
130228438|NCT01184872|468801580|FG000|Overall Study|Protocol deviation|1|||
130228439|NCT01184872|468801581|FG001|Overall Study|Protocol deviation|0|||
130228440|NCT02674516|468801582|FG000|Overall Study|Lost to Follow-up|3|||
130228441|NCT02674516|468801583|FG001|Overall Study|Lost to Follow-up|0|||
130228442|NCT02674516|468801582|FG000|Overall Study|Protocol Violation|0|||
130228443|NCT02674516|468801583|FG001|Overall Study|Protocol Violation|4|||
130228444|NCT02674516|468801582|FG000|Overall Study|Knowledge of study hypothesis|1|||
130228445|NCT02674516|468801583|FG001|Overall Study|Knowledge of study hypothesis|0|||
130228446|NCT02662569|468801585|FG000|Overall Study|Withdrawal by Subject|6|||
130228447|NCT02662569|468801586|FG001|Overall Study|Withdrawal by Subject|1|||
130228448|NCT02662569|468801587|FG002|Overall Study|Withdrawal by Subject|6|||
130228449|NCT02662569|468801588|FG003|Overall Study|Withdrawal by Subject|4|||
130228450|NCT02662569|468801585|FG000|Overall Study|Lost to Follow-up|1|||
130228451|NCT02662569|468801586|FG001|Overall Study|Lost to Follow-up|0|||
130228452|NCT02662569|468801587|FG002|Overall Study|Lost to Follow-up|0|||
130228453|NCT02662569|468801588|FG003|Overall Study|Lost to Follow-up|0|||
130228454|NCT04076917|468801589|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
130228455|NCT04076917|468801589|FG000|Overall Study|Study closure|13|||
130228456|NCT04076917|468801589|FG000|Overall Study|Physician Decision|3|||
130228457|NCT04076917|468801589|FG000|Overall Study|Death|1|||
130228458|NCT04076917|468801589|FG000|Overall Study|Lost to Follow-up|1|||
130228459|NCT04076917|468801589|FG000|Overall Study|Withdrawal by Subject|1|||
130228460|NCT04076917|468801589|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
130228461|NCT03863353|468801593|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
130228462|NCT03863353|468801594|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
130228463|NCT01299584|468801595|FG000|Overall Study|Protocol Violation|9|||
130228464|NCT02747927|468801596|FG000|Overall Study|Adverse Event|5|||
130228465|NCT02747927|468801597|FG001|Overall Study|Adverse Event|14|||
130228466|NCT02747927|468801596|FG000|Overall Study|Lost to Follow-up|22|||
130228467|NCT02747927|468801597|FG001|Overall Study|Lost to Follow-up|43|||
130228468|NCT02747927|468801596|FG000|Overall Study|Pregnancy|34|||
130228469|NCT02747927|468801597|FG001|Overall Study|Pregnancy|66|||
130228470|NCT02747927|468801596|FG000|Overall Study|Protocol Violation|2|||
130228471|NCT02747927|468801597|FG001|Overall Study|Protocol Violation|4|||
130228472|NCT02747927|468801596|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
130228473|NCT02747927|468801597|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
130228474|NCT02747927|468801596|FG000|Overall Study|Reason not Specified|11|||
130228475|NCT02747927|468801597|FG001|Overall Study|Reason not Specified|27|||
130228476|NCT03810183|468801601|FG000|Overall Study|Study terminated by Sponsor|2|||
130228477|NCT03810183|468801602|FG001|Overall Study|Study terminated by Sponsor|1|||
130228478|NCT00323063|468801603|FG000|Overall Study|Adverse Event|1|||
130228479|NCT00323063|468801604|FG001|Overall Study|Adverse Event|0|||
130228480|NCT00323063|468801603|FG000|Overall Study|brain mets discovered prior to treatment|1|||
130228481|NCT00323063|468801604|FG001|Overall Study|brain mets discovered prior to treatment|0|||
130228482|NCT00423046|468801605|FG000|Overall Study|Other|340|||
130228483|NCT00423046|468801606|FG001|Overall Study|Other|345|||
130228484|NCT00830128|468801607|FG000|Overall Study|Adverse Event|5|||
130228485|NCT00830128|468801607|FG000|Overall Study|Lack of Efficacy|7|||
130228486|NCT00830128|468801607|FG000|Overall Study|Protocol Violation|1|||
130228487|NCT00830128|468801607|FG000|Overall Study|Withdrawal by Subject|2|||
130228488|NCT00830128|468801607|FG000|Overall Study|Family obligation|1|||
130228489|NCT00830128|468801607|FG000|Overall Study|Relocation|1|||
130228490|NCT00830128|468801607|FG000|Overall Study|Work obligation|1|||
130228491|NCT00830128|468801607|FG000|Overall Study|Operating a vehicle|1|||
130228492|NCT04249427|468801612|FG000|Overall Study|Adverse Event|3|||
130228493|NCT04249427|468801613|FG001|Overall Study|Adverse Event|1|||
130228494|NCT04249427|468801612|FG000|Overall Study|Lack of Efficacy|0|||
130444826|NCT01890967|469590253|FG002|Overall Study|Sponsor Decision|1|||
130444827|NCT01890967|469590254|FG003|Overall Study|Sponsor Decision|3|||
130444828|NCT01890967|469590255|FG004|Overall Study|Sponsor Decision|2|||
130228495|NCT04249427|468801613|FG001|Overall Study|Lack of Efficacy|1|||
130228496|NCT04249427|468801612|FG000|Overall Study|Withdrawal by Subject|1|||
130444829|NCT01890967|469590256|FG005|Overall Study|Sponsor Decision|3|||
130228497|NCT04249427|468801613|FG001|Overall Study|Withdrawal by Subject|2|||
130228498|NCT01673178|468801614|FG000|Overall Study|Lost to Follow-up|0|||
130228499|NCT01673178|468801615|FG001|Overall Study|Lost to Follow-up|1|||
130228500|NCT01673178|468801616|FG002|Overall Study|Lost to Follow-up|0|||
130228501|NCT01673178|468801617|FG003|Overall Study|Lost to Follow-up|0|||
130228502|NCT01673178|468801618|FG004|Overall Study|Lost to Follow-up|0|||
130444830|NCT01890967|469590251|FG000|Overall Study|Withdrawal by Subject|3|||
130228503|NCT01673178|468801614|FG000|Overall Study|Withdrawal by Subject|0|||
130228504|NCT01673178|468801615|FG001|Overall Study|Withdrawal by Subject|0|||
130228505|NCT01673178|468801616|FG002|Overall Study|Withdrawal by Subject|1|||
130228506|NCT01673178|468801617|FG003|Overall Study|Withdrawal by Subject|4|||
130228507|NCT01673178|468801618|FG004|Overall Study|Withdrawal by Subject|2|||
130691145|NCT01547286|470495847|FG000|Overall Study|Did not meet all eligibility criteria|1|||
130691146|NCT01547286|470495847|FG000|Overall Study|Physician Decision|1|||
130691147|NCT03415308|470495850|FG000|Overall Study|Lost to Follow-up|0|||
130228508|NCT01673178|468801614|FG000|Overall Study|Protocol Violation|1|||
130228509|NCT01673178|468801615|FG001|Overall Study|Protocol Violation|1|||
130228510|NCT01673178|468801616|FG002|Overall Study|Protocol Violation|0|||
130691148|NCT03415308|470495851|FG001|Overall Study|Lost to Follow-up|0|||
130691149|NCT03415308|470495852|FG002|Overall Study|Lost to Follow-up|1|||
130691150|NCT03415308|470495850|FG000|Overall Study|Scheduling Conflicts|0|||
130691151|NCT03415308|470495851|FG001|Overall Study|Scheduling Conflicts|0|||
130691152|NCT03415308|470495852|FG002|Overall Study|Scheduling Conflicts|7|||
130691153|NCT01471353|470495853|FG000|Overall Study|remain on study|3|||
130691154|NCT00836472|470495854|FG000|Washout|Adverse Event|1|||
130691155|NCT00836472|470495855|FG001|Washout|Adverse Event|2|||
130691156|NCT00836472|470495854|FG000|Washout|Withdrawal by Subject|1|||
130691157|NCT00836472|470495855|FG001|Washout|Withdrawal by Subject|1|||
130691158|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130691159|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130691160|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
130691161|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
130691162|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691163|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691164|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691165|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691166|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691167|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691168|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691169|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691170|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691171|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691172|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691173|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691174|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691175|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
130691176|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691177|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691178|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691179|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691180|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691181|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691182|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691183|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691184|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691185|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691186|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
130691187|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691188|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
130691189|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691190|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691191|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691192|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691193|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691194|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691195|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691196|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691197|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691198|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691199|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691200|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
130691201|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130691202|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130691203|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691204|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691205|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691206|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691207|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691208|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691209|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130228511|NCT01673178|468801617|FG003|Overall Study|Protocol Violation|1|||
130228512|NCT01673178|468801618|FG004|Overall Study|Protocol Violation|0|||
130228513|NCT01673178|468801614|FG000|Overall Study|Adverse Event|1|||
130228514|NCT01673178|468801615|FG001|Overall Study|Adverse Event|0|||
130228515|NCT01673178|468801616|FG002|Overall Study|Adverse Event|0|||
130228516|NCT01673178|468801617|FG003|Overall Study|Adverse Event|2|||
130228517|NCT01673178|468801618|FG004|Overall Study|Adverse Event|0|||
130228518|NCT01673178|468801614|FG000|Overall Study|Other|1|||
130228519|NCT01673178|468801615|FG001|Overall Study|Other|0|||
130228520|NCT01673178|468801616|FG002|Overall Study|Other|2|||
130228521|NCT01673178|468801617|FG003|Overall Study|Other|1|||
130228522|NCT01673178|468801618|FG004|Overall Study|Other|0|||
130228523|NCT01419314|468801619|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
130228524|NCT01419314|468801620|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
130228525|NCT01419314|468801619|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
130228526|NCT01419314|468801620|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
130228527|NCT01419314|468801619|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
130228528|NCT01419314|468801620|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
130228529|NCT00402727|468801624|FG000|Overall Study|Adverse Event|10|||
130228530|NCT00402727|468801625|FG001|Overall Study|Adverse Event|6|||
130228531|NCT00402727|468801624|FG000|Overall Study|Death|1|||
130228532|NCT00402727|468801625|FG001|Overall Study|Death|0|||
130228533|NCT00402727|468801624|FG000|Overall Study|Lack of Efficacy|1|||
130228534|NCT00402727|468801625|FG001|Overall Study|Lack of Efficacy|3|||
130228535|NCT00402727|468801624|FG000|Overall Study|Lost to Follow-up|24|||
130228536|NCT00402727|468801625|FG001|Overall Study|Lost to Follow-up|11|||
130228537|NCT00402727|468801624|FG000|Overall Study|Physician Decision|1|||
130228538|NCT00402727|468801625|FG001|Overall Study|Physician Decision|1|||
130228539|NCT00402727|468801624|FG000|Overall Study|Protocol Violation|0|||
130228540|NCT00402727|468801625|FG001|Overall Study|Protocol Violation|4|||
130228541|NCT00402727|468801624|FG000|Overall Study|Withdrawal by Subject|3|||
130228542|NCT00402727|468801625|FG001|Overall Study|Withdrawal by Subject|7|||
130228543|NCT00402727|468801624|FG000|Overall Study|supply problems|2|||
130228544|NCT00402727|468801625|FG001|Overall Study|supply problems|1|||
130228545|NCT00402727|468801624|FG000|Overall Study|non-compliance|0|||
130228546|NCT00402727|468801625|FG001|Overall Study|non-compliance|1|||
130228547|NCT01405898|468801626|FG000|Overall Study|Withdrawal by Subject|2|||
130228548|NCT01405898|468801627|FG001|Overall Study|Withdrawal by Subject|2|||
130228549|NCT03188055|468801628|FG000|Overall Study|Unavailable for training|0|||
130228550|NCT03188055|468801629|FG001|Overall Study|Unavailable for training|0|||
130228551|NCT03188055|468801630|FG002|Overall Study|Unavailable for training|19|||
130228552|NCT03188055|468801631|FG003|Overall Study|Unavailable for training|0|||
130228553|NCT03188055|468801632|FG004|Overall Study|Unavailable for training|0|||
130228554|NCT03188055|468801633|FG005|Overall Study|Unavailable for training|0|||
130228555|NCT03188055|468801628|FG000|Overall Study|Lost to Follow-up|0|||
130228556|NCT03188055|468801629|FG001|Overall Study|Lost to Follow-up|18|||
130228557|NCT03188055|468801630|FG002|Overall Study|Lost to Follow-up|0|||
130228558|NCT03188055|468801631|FG003|Overall Study|Lost to Follow-up|11|||
130228559|NCT03188055|468801632|FG004|Overall Study|Lost to Follow-up|0|||
130228560|NCT03188055|468801633|FG005|Overall Study|Lost to Follow-up|0|||
130228561|NCT03188055|468801628|FG000|Overall Study|Withdrawal by Subject|0|||
130228562|NCT03188055|468801629|FG001|Overall Study|Withdrawal by Subject|1|||
130228563|NCT03188055|468801630|FG002|Overall Study|Withdrawal by Subject|0|||
130228564|NCT03188055|468801631|FG003|Overall Study|Withdrawal by Subject|1|||
130228565|NCT03188055|468801632|FG004|Overall Study|Withdrawal by Subject|0|||
130228566|NCT03188055|468801633|FG005|Overall Study|Withdrawal by Subject|0|||
130228567|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
130228568|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
130228569|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
130228570|NCT03044314|468801647|FG000|Overall Study|Physician Decision|2|||
130228571|NCT03044314|468801647|FG000|Overall Study|Withdrawal by Subject|1|||
130228572|NCT03044314|468801647|FG000|Overall Study|Connector tubing not available|1|||
130228573|NCT01316224|468801648|FG000|Overall Study|Protocol Violation|3|||
130228574|NCT01316224|468801648|FG000|Overall Study|Adverse Event|3|||
130228575|NCT01316224|468801648|FG000|Overall Study|Lack of Efficacy|1|||
130228576|NCT01316224|468801648|FG000|Overall Study|Withdrawal by Subject|1|||
130228577|NCT01316224|468801648|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
130228578|NCT01316224|468801648|FG000|Overall Study|Other|1|||
130228579|NCT00264147|468801649|FG000|Treatment I Period|Adverse Event|3|||
130228580|NCT00264147|468801650|FG001|Treatment I Period|Adverse Event|6|||
130228581|NCT00264147|468801651|FG002|Treatment I Period|Adverse Event|3|||
130691210|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691211|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691212|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691213|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691214|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
130691215|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130444831|NCT01890967|469590252|FG001|Overall Study|Withdrawal by Subject|4|||
130444832|NCT01890967|469590253|FG002|Overall Study|Withdrawal by Subject|2|||
130444833|NCT01890967|469590254|FG003|Overall Study|Withdrawal by Subject|3|||
130444834|NCT01890967|469590255|FG004|Overall Study|Withdrawal by Subject|3|||
130444835|NCT01890967|469590256|FG005|Overall Study|Withdrawal by Subject|1|||
130444836|NCT00795132|469590261|FG000|Overall Study|Death|1|||
130444837|NCT00795132|469590261|FG000|Overall Study|Relapse|2|||
130444838|NCT02561455|469590262|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
130444839|NCT02561455|469590263|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
130444840|NCT02561455|469590264|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
130444841|NCT02561455|469590265|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
130444842|NCT02561455|469590262|FG000|Overall Study|Withdrawal by Subject|1|||
130444843|NCT02561455|469590263|FG001|Overall Study|Withdrawal by Subject|0|||
130444844|NCT02561455|469590264|FG002|Overall Study|Withdrawal by Subject|1|||
130444845|NCT02561455|469590265|FG003|Overall Study|Withdrawal by Subject|0|||
130444846|NCT02561455|469590262|FG000|Overall Study|Disease Progression|0|||
130444847|NCT02561455|469590263|FG001|Overall Study|Disease Progression|1|||
130444848|NCT02561455|469590264|FG002|Overall Study|Disease Progression|0|||
130444849|NCT02561455|469590265|FG003|Overall Study|Disease Progression|0|||
130444850|NCT02451930|469590266|FG000|Overall Study|Death|0|||
130444851|NCT02451930|469590267|FG001|Overall Study|Death|15|||
130444852|NCT02451930|469590266|FG000|Overall Study|Lost to Follow-up|0|||
130444853|NCT02451930|469590267|FG001|Overall Study|Lost to Follow-up|3|||
130444854|NCT02451930|469590266|FG000|Overall Study|Sponsor Decision|2|||
130444855|NCT02451930|469590267|FG001|Overall Study|Sponsor Decision|10|||
130444856|NCT02451930|469590266|FG000|Overall Study|Withdrawal by Subject|0|||
130444857|NCT02451930|469590267|FG001|Overall Study|Withdrawal by Subject|1|||
130444858|NCT02451930|469590266|FG000|Overall Study|Other|0|||
130444859|NCT02451930|469590267|FG001|Overall Study|Other|1|||
130444860|NCT03685708|469590274|FG000|Overall Study|Withdrawal by Subject|0|||
130444861|NCT03685708|469590275|FG001|Overall Study|Withdrawal by Subject|0|||
130444862|NCT03685708|469590276|FG002|Overall Study|Withdrawal by Subject|1|||
130444863|NCT03685708|469590274|FG000|Overall Study|Screen Fail|0|||
130444864|NCT03685708|469590275|FG001|Overall Study|Screen Fail|1|||
130444865|NCT03685708|469590276|FG002|Overall Study|Screen Fail|1|||
130444866|NCT03685708|469590274|FG000|Overall Study|COVID 19 Pandemic|1|||
130444867|NCT03685708|469590275|FG001|Overall Study|COVID 19 Pandemic|1|||
130444868|NCT03685708|469590276|FG002|Overall Study|COVID 19 Pandemic|6|||
130444869|NCT03685708|469590274|FG000|Overall Study|Disease Progression|0|||
130444870|NCT03685708|469590275|FG001|Overall Study|Disease Progression|0|||
130444871|NCT03685708|469590276|FG002|Overall Study|Disease Progression|1|||
130444872|NCT04006366|469590277|FG000|Overall Study|Withdrawal by Subject|1|||
130444873|NCT00627042|469590284|FG000|Overall Study|Withdrawal by Subject|2|||
130444874|NCT02268552|469590285|FG000|Part 1|Death|1|||
130444875|NCT02268552|469590286|FG001|Part 1|Death|1|||
130444876|NCT02268552|469590287|FG002|Part 1|Death|1|||
130444877|NCT02268552|469590288|FG003|Part 1|Death|2|||
130444878|NCT02268552|469590289|FG004|Part 1|Death|0|||
130444879|NCT02268552|469590290|FG005|Part 1|Death|0|||
130444880|NCT02268552|469590291|FG006|Part 1|Death|0|||
130444881|NCT02268552|469590285|FG000|Part 1|Subject/guardian decision|0|||
130444882|NCT02268552|469590286|FG001|Part 1|Subject/guardian decision|0|||
130444883|NCT02268552|469590287|FG002|Part 1|Subject/guardian decision|0|||
130444884|NCT02268552|469590288|FG003|Part 1|Subject/guardian decision|1|||
130691216|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
130691217|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691218|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691219|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691220|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691221|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691222|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691223|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691224|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691225|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691226|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130444885|NCT02268552|469590289|FG004|Part 1|Subject/guardian decision|0|||
130444886|NCT02268552|469590290|FG005|Part 1|Subject/guardian decision|0|||
130444887|NCT02268552|469590291|FG006|Part 1|Subject/guardian decision|0|||
130444888|NCT02268552|469590285|FG000|Part 2|Death|0|||
130444889|NCT02268552|469590286|FG001|Part 2|Death|0|||
130444890|NCT02268552|469590287|FG002|Part 2|Death|0|||
130444891|NCT02268552|469590288|FG003|Part 2|Death|0|||
130444892|NCT02268552|469590289|FG004|Part 2|Death|0|||
130444893|NCT02268552|469590290|FG005|Part 2|Death|0|||
130444894|NCT02268552|469590291|FG006|Part 2|Death|2|||
130444895|NCT02268552|469590285|FG000|Part 2|Subject/guardian decision|0|||
130444896|NCT02268552|469590286|FG001|Part 2|Subject/guardian decision|0|||
130444897|NCT02268552|469590287|FG002|Part 2|Subject/guardian decision|0|||
130444898|NCT02268552|469590288|FG003|Part 2|Subject/guardian decision|0|||
130691227|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691228|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130691229|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691230|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130691231|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691232|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691233|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691234|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691235|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691236|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691237|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691238|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691239|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691240|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691241|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691242|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
130691243|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691244|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691245|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691246|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691247|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691248|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691249|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691250|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691251|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691252|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691253|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691254|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691255|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691256|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691257|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691258|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691259|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691260|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691261|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691262|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691263|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
130691264|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691265|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691266|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691267|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691268|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691269|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691270|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691271|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691272|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691273|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130552889|NCT00564018|469991611|FG000|Overall Study|Withdrawal by Subject|2|||
130228582|NCT00264147|468801652|FG003|Treatment I Period|Adverse Event|5|||
130228583|NCT00264147|468801653|FG004|Treatment I Period|Adverse Event|7|||
130228584|NCT00264147|468801654|FG005|Treatment I Period|Adverse Event|0|||
130228585|NCT00264147|468801649|FG000|Treatment I Period|Laboratory Adverse Event|0|||
130228586|NCT00264147|468801650|FG001|Treatment I Period|Laboratory Adverse Event|0|||
130228587|NCT00264147|468801651|FG002|Treatment I Period|Laboratory Adverse Event|0|||
130228588|NCT00264147|468801652|FG003|Treatment I Period|Laboratory Adverse Event|1|||
130228589|NCT00264147|468801653|FG004|Treatment I Period|Laboratory Adverse Event|0|||
130228590|NCT00264147|468801654|FG005|Treatment I Period|Laboratory Adverse Event|0|||
130228591|NCT00264147|468801649|FG000|Treatment I Period|Lack of Efficacy|6|||
130228592|NCT00264147|468801650|FG001|Treatment I Period|Lack of Efficacy|2|||
130228593|NCT00264147|468801651|FG002|Treatment I Period|Lack of Efficacy|8|||
130228594|NCT00264147|468801652|FG003|Treatment I Period|Lack of Efficacy|0|||
130228595|NCT00264147|468801653|FG004|Treatment I Period|Lack of Efficacy|1|||
130228596|NCT00264147|468801654|FG005|Treatment I Period|Lack of Efficacy|0|||
130228597|NCT00264147|468801649|FG000|Treatment I Period|Lost to Follow-up|1|||
130228598|NCT00264147|468801650|FG001|Treatment I Period|Lost to Follow-up|0|||
130228599|NCT00264147|468801651|FG002|Treatment I Period|Lost to Follow-up|0|||
130228600|NCT00264147|468801652|FG003|Treatment I Period|Lost to Follow-up|1|||
130228601|NCT00264147|468801653|FG004|Treatment I Period|Lost to Follow-up|1|||
130228602|NCT00264147|468801654|FG005|Treatment I Period|Lost to Follow-up|0|||
130228603|NCT00264147|468801649|FG000|Treatment I Period|Protocol Violation|2|||
130228604|NCT00264147|468801650|FG001|Treatment I Period|Protocol Violation|2|||
130228605|NCT00264147|468801651|FG002|Treatment I Period|Protocol Violation|0|||
130228606|NCT00264147|468801652|FG003|Treatment I Period|Protocol Violation|0|||
130228607|NCT00264147|468801653|FG004|Treatment I Period|Protocol Violation|0|||
130228608|NCT00264147|468801654|FG005|Treatment I Period|Protocol Violation|0|||
130444899|NCT02268552|469590289|FG004|Part 2|Subject/guardian decision|0|||
130691274|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691275|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691276|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691277|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
130691278|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691279|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691280|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691281|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691282|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691283|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691284|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691285|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691286|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691287|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691288|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691289|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691290|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691291|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
130691292|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691293|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691294|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691295|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691296|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691297|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691298|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691299|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691300|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691301|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691302|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691303|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691304|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691305|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691306|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
130228609|NCT00264147|468801649|FG000|Treatment I Period|Withdrawal by Subject|2|||
130228610|NCT00264147|468801650|FG001|Treatment I Period|Withdrawal by Subject|0|||
130228611|NCT00264147|468801651|FG002|Treatment I Period|Withdrawal by Subject|0|||
130228612|NCT00264147|468801652|FG003|Treatment I Period|Withdrawal by Subject|2|||
130444900|NCT02268552|469590290|FG005|Part 2|Subject/guardian decision|0|||
130228613|NCT00264147|468801653|FG004|Treatment I Period|Withdrawal by Subject|2|||
130228614|NCT00264147|468801654|FG005|Treatment I Period|Withdrawal by Subject|0|||
130228615|NCT00264147|468801649|FG000|Treatment I Period|Patient out of town for an extended time|0|||
130444901|NCT02268552|469590291|FG006|Part 2|Subject/guardian decision|1|||
130444902|NCT02268552|469590285|FG000|Part 3 Extension|Death|0|||
130444903|NCT02268552|469590286|FG001|Part 3 Extension|Death|1|||
130444904|NCT02268552|469590287|FG002|Part 3 Extension|Death|1|||
130444905|NCT02268552|469590288|FG003|Part 3 Extension|Death|1|||
130444906|NCT02268552|469590289|FG004|Part 3 Extension|Death|1|||
130444907|NCT02268552|469590290|FG005|Part 3 Extension|Death|1|||
130444908|NCT02268552|469590291|FG006|Part 3 Extension|Death|0|||
130444909|NCT02268552|469590285|FG000|Part 3 Extension|Early termination of trial|1|||
130444910|NCT02268552|469590286|FG001|Part 3 Extension|Early termination of trial|0|||
130444911|NCT02268552|469590287|FG002|Part 3 Extension|Early termination of trial|0|||
130444912|NCT02268552|469590288|FG003|Part 3 Extension|Early termination of trial|0|||
130444913|NCT02268552|469590289|FG004|Part 3 Extension|Early termination of trial|2|||
130444914|NCT02268552|469590290|FG005|Part 3 Extension|Early termination of trial|9|||
130444915|NCT02268552|469590291|FG006|Part 3 Extension|Early termination of trial|11|||
130444916|NCT02268552|469590285|FG000|Part 3 Extension|Subject/guardian decision|0|||
130444917|NCT02268552|469590286|FG001|Part 3 Extension|Subject/guardian decision|0|||
130444918|NCT02268552|469590287|FG002|Part 3 Extension|Subject/guardian decision|0|||
130444919|NCT02268552|469590288|FG003|Part 3 Extension|Subject/guardian decision|0|||
130444920|NCT02268552|469590289|FG004|Part 3 Extension|Subject/guardian decision|0|||
130444921|NCT02268552|469590290|FG005|Part 3 Extension|Subject/guardian decision|0|||
130444922|NCT02268552|469590291|FG006|Part 3 Extension|Subject/guardian decision|1|||
130444923|NCT00997243|469590292|FG000|Overall Study|Early termination of study by sponsor|7|||
130444924|NCT01349907|469590297|FG000|Overall Study|Adverse Event|37|||
130444925|NCT01349907|469590298|FG001|Overall Study|Adverse Event|11|||
130444926|NCT01349907|469590297|FG000|Overall Study|Treatment failure|13|||
130444927|NCT01349907|469590298|FG001|Overall Study|Treatment failure|4|||
130444928|NCT01349907|469590297|FG000|Overall Study|Lost to Follow-up|25|||
130444929|NCT01349907|469590298|FG001|Overall Study|Lost to Follow-up|6|||
130444930|NCT01349907|469590297|FG000|Overall Study|Withdrawal by Subject|30|||
130444931|NCT01349907|469590298|FG001|Overall Study|Withdrawal by Subject|8|||
130444932|NCT01349907|469590297|FG000|Overall Study|Protocol Violation|33|||
130444933|NCT01349907|469590298|FG001|Overall Study|Protocol Violation|13|||
130444934|NCT01349907|469590297|FG000|Overall Study|Administrative|1|||
130444935|NCT01349907|469590298|FG001|Overall Study|Administrative|1|||
130444936|NCT03583541|469590306|FG000|Overall Study|Lost to Follow-up|31|||
130444937|NCT03583541|469590307|FG001|Overall Study|Lost to Follow-up|65|||
130444938|NCT04102540|469590308|FG000|Overall Study|Withdrawn by PI|2|||
130444939|NCT04102540|469590308|FG000|Overall Study|Lost to Follow-up|6|||
130444940|NCT00280293|469590311|FG000|Overall Study|Protocol Violation|3|||
130444941|NCT00280293|469590312|FG001|Overall Study|Protocol Violation|0|||
130444942|NCT00280293|469590311|FG000|Overall Study|Physician Decision|5|||
130444943|NCT00280293|469590312|FG001|Overall Study|Physician Decision|4|||
130444944|NCT00280293|469590311|FG000|Overall Study|Lost to Follow-up|14|||
130444945|NCT00280293|469590312|FG001|Overall Study|Lost to Follow-up|12|||
130444946|NCT00280293|469590311|FG000|Overall Study|Withdrawal by Subject|3|||
130444947|NCT00280293|469590312|FG001|Overall Study|Withdrawal by Subject|5|||
130444948|NCT00280293|469590311|FG000|Overall Study|Incarceration/Legal Reasons|1|||
130444949|NCT00280293|469590312|FG001|Overall Study|Incarceration/Legal Reasons|1|||
130444950|NCT00280293|469590311|FG000|Overall Study|Adverse Event|0|||
130444951|NCT00280293|469590312|FG001|Overall Study|Adverse Event|1|||
130444952|NCT01458249|469590313|FG000|Overall Study|Not treated|1|||
130691307|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
130691308|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691309|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691310|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691311|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691312|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
130691313|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
130444953|NCT01458249|469590313|FG000|Overall Study|Adverse Event|4|||
130444954|NCT01458249|469590313|FG000|Overall Study|Other|2|||
130444955|NCT01458249|469590313|FG000|Overall Study|Ongoing|1|||
130444956|NCT01348854|469590314|FG000|Overall Study|Lost to Follow-up|2|||
130444957|NCT01348854|469590315|FG001|Overall Study|Lost to Follow-up|1|||
130444958|NCT01348854|469590314|FG000|Overall Study|Withdrawal by Subject|1|||
130444959|NCT01348854|469590315|FG001|Overall Study|Withdrawal by Subject|0|||
130444960|NCT00594932|469590318|FG000|First 3 Months|Withdrawal by Subject|1|||
130444961|NCT00594932|469590319|FG001|First 3 Months|Withdrawal by Subject|3|||
130444962|NCT00594932|469590318|FG000|Final 3 Months|Withdrawal by Subject|4|||
130444963|NCT00594932|469590319|FG001|Final 3 Months|Withdrawal by Subject|3|||
130444964|NCT01094171|469590320|FG000|Overall Study|Lost to Follow-up|2|||
130444965|NCT01094171|469590320|FG000|Overall Study|Informed consent withdrawal|4|||
130444966|NCT01094171|469590320|FG000|Overall Study|Migration from the study area|3|||
130444967|NCT01094171|469590320|FG000|Overall Study|Other|1|||
130444968|NCT01009047|469590322|FG000|Overall Study|Adverse Event|5|||
130444969|NCT01009047|469590323|FG001|Overall Study|Adverse Event|0|||
130444970|NCT01009047|469590322|FG000|Overall Study|Lost to Follow-up|0|||
130444971|NCT01009047|469590323|FG001|Overall Study|Lost to Follow-up|2|||
130444972|NCT01009047|469590322|FG000|Overall Study|Lack of Efficacy|4|||
130444973|NCT01009047|469590323|FG001|Overall Study|Lack of Efficacy|11|||
130444974|NCT01009047|469590322|FG000|Overall Study|Withdrawal by consent|16|||
130444975|NCT01009047|469590323|FG001|Overall Study|Withdrawal by consent|11|||
130444976|NCT01009047|469590322|FG000|Overall Study|Other|3|||
130444977|NCT01009047|469590323|FG001|Overall Study|Other|2|||
130444978|NCT01676220|469590324|FG000|Overall Study|Randomized But Not Treated|4|||
130444979|NCT01676220|469590325|FG001|Overall Study|Randomized But Not Treated|1|||
130444980|NCT01676220|469590324|FG000|Overall Study|Adverse Event|10|||
130444981|NCT01676220|469590325|FG001|Overall Study|Adverse Event|8|||
130444982|NCT01676220|469590324|FG000|Overall Study|Lack of Efficacy|2|||
130444983|NCT01676220|469590325|FG001|Overall Study|Lack of Efficacy|5|||
130444984|NCT01676220|469590324|FG000|Overall Study|Protocol Violation|11|||
130444985|NCT01676220|469590325|FG001|Overall Study|Protocol Violation|12|||
130444986|NCT01676220|469590324|FG000|Overall Study|Received Rescue Therapy|14|||
130444987|NCT01676220|469590325|FG001|Overall Study|Received Rescue Therapy|22|||
130444988|NCT01676220|469590324|FG000|Overall Study|Personal Reason|34|||
130444989|NCT01676220|469590325|FG001|Overall Study|Personal Reason|45|||
130444990|NCT01676220|469590324|FG000|Overall Study|Lost to Follow-up|11|||
130444991|NCT01676220|469590325|FG001|Overall Study|Lost to Follow-up|18|||
130444992|NCT01676220|469590324|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
130444993|NCT01676220|469590325|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
130444994|NCT01676220|469590324|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
130444995|NCT01676220|469590325|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
130444996|NCT01676220|469590324|FG000|Overall Study|Perceived Lack of Efficacy|3|||
130444997|NCT01676220|469590325|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130444998|NCT01676220|469590324|FG000|Overall Study|Non Serious Hypoglycemia|2|||
130444999|NCT01676220|469590325|FG001|Overall Study|Non Serious Hypoglycemia|0|||
130228616|NCT00264147|468801650|FG001|Treatment I Period|Patient out of town for an extended time|1|||
130445000|NCT01676220|469590324|FG000|Overall Study|No More Need of Insulin|1|||
130445001|NCT01676220|469590325|FG001|Overall Study|No More Need of Insulin|0|||
130445002|NCT03875911|469590328|FG000|Overall Study|Lost to Follow-up|3|||
130445003|NCT03875911|469590329|FG001|Overall Study|Lost to Follow-up|6|||
130445004|NCT03875911|469590330|FG002|Overall Study|Lost to Follow-up|2|||
130445005|NCT03875911|469590328|FG000|Overall Study|Surgery cancelled|1|||
130445006|NCT03875911|469590329|FG001|Overall Study|Surgery cancelled|0|||
130445007|NCT03875911|469590330|FG002|Overall Study|Surgery cancelled|1|||
130445008|NCT03875911|469590328|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
130445009|NCT03875911|469590329|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
130691314|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
130691315|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
130228617|NCT00264147|468801651|FG002|Treatment I Period|Patient out of town for an extended time|0|||
130228618|NCT00264147|468801652|FG003|Treatment I Period|Patient out of town for an extended time|0|||
130228619|NCT00264147|468801653|FG004|Treatment I Period|Patient out of town for an extended time|0|||
130228620|NCT00264147|468801654|FG005|Treatment I Period|Patient out of town for an extended time|0|||
130228621|NCT00264147|468801649|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130691316|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
130691317|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
130228622|NCT00264147|468801650|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228623|NCT00264147|468801651|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
130228624|NCT00264147|468801652|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228625|NCT00264147|468801653|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228626|NCT00264147|468801654|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228627|NCT00264147|468801649|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
130445010|NCT03875911|469590330|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
130445011|NCT03824938|469590331|FG000|Overall Study|Withdrawal by Subject|2|||
130445012|NCT03824938|469590332|FG001|Overall Study|Withdrawal by Subject|1|||
130691318|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
130691319|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
130691320|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
130691321|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
130445013|NCT03824938|469590333|FG002|Overall Study|Withdrawal by Subject|0|||
130445014|NCT03824938|469590334|FG003|Overall Study|Withdrawal by Subject|2|||
130445015|NCT03824938|469590335|FG004|Overall Study|Withdrawal by Subject|0|||
130445016|NCT03824938|469590336|FG005|Overall Study|Withdrawal by Subject|1|||
130445017|NCT03824938|469590331|FG000|Overall Study|Lost to Follow-up|0|||
130445018|NCT03824938|469590332|FG001|Overall Study|Lost to Follow-up|1|||
130445019|NCT03824938|469590333|FG002|Overall Study|Lost to Follow-up|0|||
130445020|NCT03824938|469590334|FG003|Overall Study|Lost to Follow-up|0|||
130445021|NCT03824938|469590335|FG004|Overall Study|Lost to Follow-up|1|||
130445022|NCT03824938|469590336|FG005|Overall Study|Lost to Follow-up|0|||
130691322|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
130691323|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
130691324|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
130691325|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
130691326|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691327|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691328|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691329|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691330|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691331|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691332|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691333|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691334|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
130691335|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
130691336|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691337|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691338|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691339|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691340|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
130691341|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
130691342|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
130691343|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
130691344|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
130691345|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
130691346|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
130691347|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
130691348|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
130691349|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
130691350|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
130691351|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
130691352|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
130691353|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
130691354|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691355|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691356|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130445023|NCT01990300|469590340|FG000|Overall Study|Case Report Forms Uncollected|89|||
130445024|NCT01990300|469590340|FG000|Overall Study|Protocol Deviation|53|||
130445025|NCT04496167|469590343|FG000|Overall Study|Adverse Event|6|||
130691357|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691358|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691359|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691360|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691361|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691362|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
130691363|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
130691364|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691365|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691366|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691367|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691368|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691369|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691370|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691371|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691372|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691373|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691374|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691375|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691376|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
130691377|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
130691378|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691379|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691380|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691381|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691382|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Death|0|||
130691383|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Death|0|||
130691384|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Death|0|||
130691385|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Death|0|||
130691386|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Death|0|||
130691387|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Death|0|||
130691388|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Death|0|||
130691389|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Death|0|||
130691390|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Death|1|||
130691391|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Death|0|||
130691392|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Death|0|||
130691393|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Death|0|||
130691394|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Death|0|||
130691395|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Death|0|||
130356123|NCT03120624|469274659|FG003|Overall Study|Withdrawal by Subject|0|||
130356124|NCT03120624|469274660|FG004|Overall Study|Withdrawal by Subject|0|||
130356125|NCT03120624|469274661|FG005|Overall Study|Withdrawal by Subject|0|||
130445026|NCT04496167|469590344|FG001|Overall Study|Adverse Event|2|||
130228628|NCT00264147|468801650|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
130228629|NCT00264147|468801651|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
130228630|NCT00264147|468801652|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
130228631|NCT00264147|468801653|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
130228632|NCT00264147|468801654|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
130228633|NCT00264147|468801649|FG000|Treatment II Period|Adverse Event|0|||
130228634|NCT00264147|468801650|FG001|Treatment II Period|Adverse Event|0|||
130228635|NCT00264147|468801651|FG002|Treatment II Period|Adverse Event|0|||
130228636|NCT00264147|468801652|FG003|Treatment II Period|Adverse Event|0|||
130228637|NCT00264147|468801653|FG004|Treatment II Period|Adverse Event|9|||
130228638|NCT00264147|468801654|FG005|Treatment II Period|Adverse Event|9|||
130228639|NCT00264147|468801649|FG000|Treatment II Period|Laboratory Adverse Event|0|||
130228640|NCT00264147|468801650|FG001|Treatment II Period|Laboratory Adverse Event|0|||
130228641|NCT00264147|468801651|FG002|Treatment II Period|Laboratory Adverse Event|0|||
130228642|NCT00264147|468801652|FG003|Treatment II Period|Laboratory Adverse Event|0|||
130228643|NCT00264147|468801653|FG004|Treatment II Period|Laboratory Adverse Event|0|||
130228644|NCT00264147|468801654|FG005|Treatment II Period|Laboratory Adverse Event|1|||
130228645|NCT00264147|468801649|FG000|Treatment II Period|Lack of Efficacy|0|||
130228646|NCT00264147|468801650|FG001|Treatment II Period|Lack of Efficacy|0|||
130228647|NCT00264147|468801651|FG002|Treatment II Period|Lack of Efficacy|0|||
130228648|NCT00264147|468801652|FG003|Treatment II Period|Lack of Efficacy|0|||
130228649|NCT00264147|468801653|FG004|Treatment II Period|Lack of Efficacy|20|||
130228650|NCT00264147|468801654|FG005|Treatment II Period|Lack of Efficacy|19|||
130228651|NCT00264147|468801649|FG000|Treatment II Period|Lost to Follow-up|0|||
130228652|NCT00264147|468801650|FG001|Treatment II Period|Lost to Follow-up|0|||
130228653|NCT00264147|468801651|FG002|Treatment II Period|Lost to Follow-up|0|||
130228654|NCT00264147|468801652|FG003|Treatment II Period|Lost to Follow-up|0|||
130228655|NCT00264147|468801653|FG004|Treatment II Period|Lost to Follow-up|1|||
130228656|NCT00264147|468801654|FG005|Treatment II Period|Lost to Follow-up|1|||
130228657|NCT00264147|468801649|FG000|Treatment II Period|Withdrawal by Subject|0|||
130228658|NCT00264147|468801650|FG001|Treatment II Period|Withdrawal by Subject|0|||
130228659|NCT00264147|468801651|FG002|Treatment II Period|Withdrawal by Subject|0|||
130228660|NCT00264147|468801652|FG003|Treatment II Period|Withdrawal by Subject|0|||
130228661|NCT00264147|468801653|FG004|Treatment II Period|Withdrawal by Subject|3|||
130228662|NCT00264147|468801654|FG005|Treatment II Period|Withdrawal by Subject|2|||
130228663|NCT00264147|468801649|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228664|NCT00264147|468801650|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228665|NCT00264147|468801651|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228666|NCT00264147|468801652|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228667|NCT00264147|468801653|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228668|NCT00264147|468801654|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
130228669|NCT03234465|468801655|FG000|Overall Study|Adverse Event|4|||
130228670|NCT03234465|468801656|FG001|Overall Study|Adverse Event|2|||
130228671|NCT03234465|468801655|FG000|Overall Study|Death|0|||
130228672|NCT03234465|468801656|FG001|Overall Study|Death|1|||
130228673|NCT03234465|468801655|FG000|Overall Study|Lost to Follow-up|1|||
130228674|NCT03234465|468801656|FG001|Overall Study|Lost to Follow-up|1|||
130228675|NCT03234465|468801655|FG000|Overall Study|Withdrawal by Subject|12|||
130228676|NCT03234465|468801656|FG001|Overall Study|Withdrawal by Subject|27|||
130228677|NCT03234465|468801655|FG000|Overall Study|Symptomatic deterioration|0|||
130228678|NCT03234465|468801656|FG001|Overall Study|Symptomatic deterioration|1|||
130228679|NCT03234465|468801655|FG000|Overall Study|Non-compliance|2|||
130228680|NCT03234465|468801656|FG001|Overall Study|Non-compliance|0|||
130228681|NCT03234465|468801655|FG000|Overall Study|Other|14|||
130228682|NCT03234465|468801656|FG001|Overall Study|Other|8|||
130228683|NCT00449163|468801657|FG000|Overall Study|Physician Decision|3|||
130228684|NCT03106077|468801658|FG000|Overall Study|Screen Failure|94|||
130228685|NCT03106077|468801659|FG001|Overall Study|Screen Failure|0|||
130228686|NCT00606307|468801662|FG000|Overall Study|Adverse Event|2|||
130228687|NCT00606307|468801662|FG000|Overall Study|Withdrawal by Subject|2|||
130228688|NCT00606307|468801662|FG000|Overall Study|Disease progression|6|||
130228689|NCT00606307|468801662|FG000|Overall Study|QTc prolongation|1|||
130228690|NCT01274533|468801663|FG000|Overall Study|Withdrawal by Subject|1|||
130228691|NCT01274533|468801663|FG000|Overall Study|Non-compliance|1|||
130228692|NCT01274533|468801663|FG000|Overall Study|Disease progression|2|||
130356126|NCT03120624|469274662|FG006|Overall Study|Withdrawal by Subject|0|||
130356127|NCT03120624|469274663|FG007|Overall Study|Withdrawal by Subject|0|||
130228693|NCT02008526|468801673|FG000|Overall Study|Death|0|||
130228694|NCT02008526|468801674|FG001|Overall Study|Death|2|||
130228695|NCT02008526|468801675|FG002|Overall Study|Death|1|||
130228696|NCT02008526|468801673|FG000|Overall Study|Withdrawal by Subject|3|||
130228697|NCT02008526|468801674|FG001|Overall Study|Withdrawal by Subject|3|||
130228698|NCT02008526|468801675|FG002|Overall Study|Withdrawal by Subject|2|||
130228699|NCT02008526|468801673|FG000|Overall Study|Lost to Follow-up|5|||
130228700|NCT02008526|468801674|FG001|Overall Study|Lost to Follow-up|9|||
130228701|NCT02008526|468801675|FG002|Overall Study|Lost to Follow-up|6|||
130228702|NCT01118052|468801676|FG000|Overall Study|Never treated|2|||
130228703|NCT02949947|468801677|FG000|Overall Study|Non Compliance|0|||
130228704|NCT02949947|468801678|FG001|Overall Study|Non Compliance|1|||
130228705|NCT02949947|468801677|FG000|Overall Study|Insurance change|1|||
130228706|NCT02949947|468801678|FG001|Overall Study|Insurance change|0|||
130228707|NCT00828711|468801680|FG000|Overall Study|Lost to Follow-up|1|||
130228708|NCT00828711|468801681|FG001|Overall Study|Lost to Follow-up|0|||
130228709|NCT00828711|468801682|FG002|Overall Study|Lost to Follow-up|0|||
130228710|NCT01618968|468801683|FG000|Overall Study|Adverse Event|1|||
130228711|NCT01618968|468801684|FG001|Overall Study|Adverse Event|0|||
130228712|NCT01618968|468801685|FG002|Overall Study|Adverse Event|0|||
130228713|NCT01618968|468801686|FG003|Overall Study|Adverse Event|0|||
130228714|NCT01618968|468801683|FG000|Overall Study|Death|0|||
130228715|NCT01618968|468801684|FG001|Overall Study|Death|0|||
130228716|NCT01618968|468801685|FG002|Overall Study|Death|0|||
130228717|NCT01618968|468801686|FG003|Overall Study|Death|1|||
130228718|NCT02230891|468801687|FG000|Baseline|Did not meet inclusion|0|||
130228719|NCT02230891|468801688|FG001|Baseline|Did not meet inclusion|1|||
130228720|NCT02230891|468801689|FG002|Baseline|Did not meet inclusion|1|||
130228721|NCT02230891|468801687|FG000|2 Week|Withdrawal by Subject|2|||
130228722|NCT02230891|468801688|FG001|2 Week|Withdrawal by Subject|2|||
130228723|NCT02230891|468801689|FG002|2 Week|Withdrawal by Subject|0|||
130228724|NCT02230891|468801687|FG000|2 Week|Consent withdrawn|1|||
130228725|NCT02230891|468801688|FG001|2 Week|Consent withdrawn|0|||
130228726|NCT02230891|468801689|FG002|2 Week|Consent withdrawn|0|||
130228727|NCT02230891|468801687|FG000|6 Month|Withdrawal by Subject|1|||
130228728|NCT02230891|468801688|FG001|6 Month|Withdrawal by Subject|1|||
130228729|NCT02230891|468801689|FG002|6 Month|Withdrawal by Subject|1|||
130228730|NCT02230891|468801687|FG000|6 Month|Physician Decision|0|||
130228731|NCT02230891|468801688|FG001|6 Month|Physician Decision|2|||
130228732|NCT02230891|468801689|FG002|6 Month|Physician Decision|0|||
130228733|NCT02230891|468801687|FG000|12 Month|Death|1|||
130228734|NCT02230891|468801688|FG001|12 Month|Death|0|||
130228735|NCT02230891|468801689|FG002|12 Month|Death|0|||
130228736|NCT02230891|468801687|FG000|12 Month|Lost to Follow-up|0|||
130228737|NCT02230891|468801688|FG001|12 Month|Lost to Follow-up|1|||
130228738|NCT02230891|468801689|FG002|12 Month|Lost to Follow-up|0|||
130228739|NCT02230891|468801687|FG000|12 Month|Withdrawal by Subject|0|||
130228740|NCT02230891|468801688|FG001|12 Month|Withdrawal by Subject|2|||
130228741|NCT02230891|468801689|FG002|12 Month|Withdrawal by Subject|0|||
130228742|NCT02230891|468801687|FG000|18 Month End of Study|Death|0|||
130228743|NCT02230891|468801688|FG001|18 Month End of Study|Death|0|||
130228744|NCT02230891|468801689|FG002|18 Month End of Study|Death|1|||
130228745|NCT02230891|468801687|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
130228746|NCT02230891|468801688|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
130228747|NCT02230891|468801689|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
130228748|NCT02370511|468801692|FG000|Overall Study|Death|10|||
130228749|NCT02370511|468801693|FG001|Overall Study|Death|7|||
130228750|NCT02370511|468801694|FG002|Overall Study|Death|1|||
130228751|NCT02370511|468801692|FG000|Overall Study|Withdrawal by Subject|2|||
130228752|NCT02370511|468801693|FG001|Overall Study|Withdrawal by Subject|0|||
130228753|NCT02370511|468801694|FG002|Overall Study|Withdrawal by Subject|0|||
130228754|NCT02370511|468801692|FG000|Overall Study|Lost to Follow-up|0|||
130228755|NCT02370511|468801693|FG001|Overall Study|Lost to Follow-up|4|||
130228756|NCT02370511|468801694|FG002|Overall Study|Lost to Follow-up|0|||
130228757|NCT03882918|468801702|FG000|Overall Study|Study terminated by sponsor|98|||
130228758|NCT03882918|468801702|FG000|Overall Study|Protocol Violation|1|||
130228759|NCT03882918|468801702|FG000|Overall Study|Other|9|||
130228760|NCT03882918|468801702|FG000|Overall Study|Lack of Efficacy|14|||
130228761|NCT03882918|468801702|FG000|Overall Study|Adverse Event|13|||
130228762|NCT03882918|468801702|FG000|Overall Study|Withdrawal by Subject|5|||
130228763|NCT02100124|468801708|FG000|Overall Study|Lost to Follow-up|5|||
130228764|NCT02100124|468801709|FG001|Overall Study|Lost to Follow-up|11|||
130228765|NCT02100124|468801710|FG002|Overall Study|Lost to Follow-up|3|||
130228766|NCT02100124|468801708|FG000|Overall Study|Withdrawal by Subject|1|||
130228767|NCT02100124|468801709|FG001|Overall Study|Withdrawal by Subject|0|||
130228768|NCT02100124|468801710|FG002|Overall Study|Withdrawal by Subject|0|||
130228769|NCT00870727|468803588|FG000|Overall Study|Lost to Follow-up|0|||
130228770|NCT00870727|468803589|FG001|Overall Study|Lost to Follow-up|1|||
130228771|NCT00870727|468803588|FG000|Overall Study|Lack of Efficacy|1|||
130228772|NCT00870727|468803589|FG001|Overall Study|Lack of Efficacy|3|||
130228773|NCT00870727|468803588|FG000|Overall Study|Adverse Event|0|||
130228774|NCT00870727|468803589|FG001|Overall Study|Adverse Event|1|||
130228775|NCT01384877|468803593|FG000|Treatment 2|Lost to Follow-up|2|||
130228776|NCT01384877|468803594|FG001|Treatment 2|Lost to Follow-up|2|||
130228777|NCT03630393|468803595|FG000|Overall Study|Death|1|||
130228778|NCT03630393|468803596|FG001|Overall Study|Death|0|||
130356128|NCT02477696|469274664|FG000|Overall Study|Death|89|||
130356129|NCT02477696|469274665|FG001|Overall Study|Death|106|||
130356130|NCT02477696|469274664|FG000|Overall Study|Lost to Follow-up|7|||
130228779|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228780|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228781|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
130228782|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228783|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228784|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130228785|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130228786|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228787|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228788|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228789|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130228790|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130228791|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228792|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228793|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228794|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Adverse Event|0|||
130228795|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Adverse Event|0|||
130228796|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Adverse Event|0|||
130228797|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Adverse Event|0|||
130228798|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Adverse Event|9|||
130228799|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Death|0|||
130228800|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Death|0|||
130228801|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Death|0|||
130228802|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Death|0|||
130228803|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Death|2|||
130228804|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Physician Decision|0|||
130228805|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Physician Decision|0|||
130228806|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Physician Decision|0|||
130228807|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Physician Decision|0|||
130228808|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Physician Decision|1|||
130228809|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228810|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228811|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228812|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228813|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
130228814|NCT00408499|468803597|FG000|Phase II- MTD Expansion|treatment delay|0|||
130228815|NCT00408499|468803598|FG001|Phase II- MTD Expansion|treatment delay|0|||
130228816|NCT00408499|468803599|FG002|Phase II- MTD Expansion|treatment delay|0|||
130228817|NCT00408499|468803600|FG003|Phase II- MTD Expansion|treatment delay|0|||
130228818|NCT00408499|468803601|FG004|Phase II- MTD Expansion|treatment delay|3|||
130228819|NCT01586195|468803602|FG000|Overall Study|Death|11|||
130228820|NCT01586195|468803602|FG000|Overall Study|Withdrawal of Consent|5|||
130228821|NCT01586195|468803602|FG000|Overall Study|Started new anti-melanoma therapy|1|||
130228822|NCT01586195|468803602|FG000|Overall Study|Reason not specified|9|||
130228823|NCT00997334|468803603|FG000|Overall Study|still on therapy|12|||
130228824|NCT00997334|468803603|FG000|Overall Study|Adverse Event|3|||
130356131|NCT02477696|469274665|FG001|Overall Study|Lost to Follow-up|5|||
130356132|NCT02477696|469274664|FG000|Overall Study|Withdrawal by Subject|37|||
130691396|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691397|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691398|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691399|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691400|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691401|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691402|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130228825|NCT00997334|468803603|FG000|Overall Study|Patient non-compliance|1|||
130356133|NCT02477696|469274665|FG001|Overall Study|Withdrawal by Subject|34|||
130356134|NCT02477696|469274664|FG000|Overall Study|Physician Decision|7|||
130356135|NCT02477696|469274665|FG001|Overall Study|Physician Decision|9|||
130356136|NCT02477696|469274664|FG000|Overall Study|Study terminated by sponsor|103|||
130356137|NCT02477696|469274665|FG001|Overall Study|Study terminated by sponsor|99|||
130356138|NCT02477696|469274664|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
130356139|NCT02477696|469274665|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
130356140|NCT02477696|469274664|FG000|Overall Study|Missing/Unknown|2|||
130356141|NCT02477696|469274665|FG001|Overall Study|Missing/Unknown|0|||
130356142|NCT02160782|469276236|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
130356143|NCT02160782|469276237|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
130356144|NCT02160782|469276238|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
130356145|NCT02160782|469276239|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
130228826|NCT00997334|468803603|FG000|Overall Study|Withdrawal by Subject|3|||
130228827|NCT00997334|468803603|FG000|Overall Study|Death|2|||
130228828|NCT00997334|468803603|FG000|Overall Study|Urgent Palliative Care|2|||
130691403|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130228829|NCT00997334|468803603|FG000|Overall Study|No lesion amenable|1|||
130228830|NCT00997334|468803603|FG000|Overall Study|Ineligible|1|||
130228831|NCT04745351|468803615|FG000|Overall Study|Death|51|||
130228832|NCT04745351|468803616|FG001|Overall Study|Death|25|||
130228833|NCT04745351|468803615|FG000|Overall Study|Lost to Follow-up|9|||
130228834|NCT04745351|468803616|FG001|Overall Study|Lost to Follow-up|3|||
130228835|NCT04745351|468803615|FG000|Overall Study|Randomized but Never Treated|3|||
130228836|NCT04745351|468803616|FG001|Overall Study|Randomized but Never Treated|3|||
130228837|NCT04745351|468803615|FG000|Overall Study|Adverse Event|4|||
130228838|NCT04745351|468803616|FG001|Overall Study|Adverse Event|0|||
130228839|NCT04745351|468803615|FG000|Overall Study|Withdrew Consent|1|||
130228840|NCT04745351|468803616|FG001|Overall Study|Withdrew Consent|2|||
130228841|NCT04745351|468803615|FG000|Overall Study|Investigator's Discretion|2|||
130228842|NCT04745351|468803616|FG001|Overall Study|Investigator's Discretion|0|||
130228843|NCT04745351|468803615|FG000|Overall Study|Protocol Violation|1|||
130228844|NCT04745351|468803616|FG001|Overall Study|Protocol Violation|0|||
130228845|NCT01863771|468803619|FG000|Induction Phase|Adverse Event|9|||
130228846|NCT01863771|468803620|FG001|Induction Phase|Adverse Event|0|||
130228847|NCT01863771|468803621|FG002|Induction Phase|Adverse Event|0|||
130228848|NCT01863771|468803622|FG003|Induction Phase|Adverse Event|0|||
130228849|NCT01863771|468803619|FG000|Induction Phase|Lack of Efficacy|10|||
130228850|NCT01863771|468803620|FG001|Induction Phase|Lack of Efficacy|0|||
130228851|NCT01863771|468803621|FG002|Induction Phase|Lack of Efficacy|0|||
130228852|NCT01863771|468803622|FG003|Induction Phase|Lack of Efficacy|0|||
130228853|NCT01863771|468803619|FG000|Induction Phase|Withdrawal by Subject|2|||
130228854|NCT01863771|468803620|FG001|Induction Phase|Withdrawal by Subject|0|||
130228855|NCT01863771|468803621|FG002|Induction Phase|Withdrawal by Subject|0|||
130228856|NCT01863771|468803622|FG003|Induction Phase|Withdrawal by Subject|0|||
130228857|NCT01863771|468803619|FG000|Maintenance Phase|Adverse Event|0|||
130228858|NCT01863771|468803620|FG001|Maintenance Phase|Adverse Event|0|||
130228859|NCT01863771|468803621|FG002|Maintenance Phase|Adverse Event|1|||
130228860|NCT01863771|468803622|FG003|Maintenance Phase|Adverse Event|1|||
130228861|NCT01863771|468803619|FG000|Maintenance Phase|Lack of Efficacy|0|||
130228862|NCT01863771|468803620|FG001|Maintenance Phase|Lack of Efficacy|3|||
130228863|NCT01863771|468803621|FG002|Maintenance Phase|Lack of Efficacy|7|||
130228864|NCT01863771|468803622|FG003|Maintenance Phase|Lack of Efficacy|38|||
130228865|NCT01863771|468803619|FG000|Maintenance Phase|Physician Decision|0|||
130228866|NCT01863771|468803620|FG001|Maintenance Phase|Physician Decision|0|||
130228867|NCT01863771|468803621|FG002|Maintenance Phase|Physician Decision|2|||
130228868|NCT01863771|468803622|FG003|Maintenance Phase|Physician Decision|1|||
130228869|NCT01863771|468803619|FG000|Maintenance Phase|Pregnancy|0|||
130228870|NCT01863771|468803620|FG001|Maintenance Phase|Pregnancy|1|||
130228871|NCT01863771|468803621|FG002|Maintenance Phase|Pregnancy|0|||
130228872|NCT01863771|468803622|FG003|Maintenance Phase|Pregnancy|0|||
130228873|NCT01863771|468803619|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130228874|NCT01863771|468803620|FG001|Maintenance Phase|Withdrawal by Subject|1|||
130228875|NCT01863771|468803621|FG002|Maintenance Phase|Withdrawal by Subject|2|||
130228876|NCT01863771|468803622|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130228877|NCT01248455|468803627|FG000|Overall Study|switched to alternate treatment|1|||
130228878|NCT00426270|468803628|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
130228879|NCT00426270|468803628|FG000|Overall Study|Adverse Event|5|||
130228880|NCT01117870|468803630|FG000|Overall Study|Inability to place needle|1|||
130228881|NCT01117870|468803631|FG001|Overall Study|Inability to place needle|0|||
130228882|NCT03102762|468803632|FG000|Overall Study|Lost to Follow-up|1|||
130228883|NCT03102762|468803633|FG001|Overall Study|Lost to Follow-up|0|||
130228884|NCT00958074|468803634|FG000|Overall Study|Withdrawal by Subject|0|||
130228885|NCT00958074|468803635|FG001|Overall Study|Withdrawal by Subject|1|||
130228886|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
130228887|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130356146|NCT02160782|469276240|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
130356147|NCT02160782|469276236|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130228888|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130228889|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130356148|NCT02160782|469276237|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130228890|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130228891|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
130228892|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228893|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228894|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228895|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228896|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
130228897|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228898|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228899|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228900|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228901|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
130228902|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228903|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228904|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228905|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228906|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
130228907|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228908|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228909|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228910|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228911|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
130228912|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228913|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228914|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228915|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228916|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
130228917|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228918|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228919|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228920|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228921|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
130228922|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228923|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228924|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228925|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228926|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
130228927|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228928|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228929|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228930|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228931|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228932|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
130228933|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228934|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228935|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
130228936|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
130228937|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
130228938|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
130228939|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
130228940|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
130228941|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130228942|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130228943|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
130228944|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130228945|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130228946|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130228947|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
130228948|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130228949|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
130228950|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
130691404|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130228951|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
130228952|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
130228953|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
130228954|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
130228955|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
130228956|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
130228957|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228958|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228959|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228960|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
130228961|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228962|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228963|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
130228964|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228965|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228966|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130228967|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
130228968|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130228969|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130228970|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130228971|NCT03426345|468803650|FG000|Overall Study|Adverse Event|4|||
130228972|NCT03426345|468803651|FG001|Overall Study|Adverse Event|4|||
130228973|NCT03426345|468803650|FG000|Overall Study|Lack of Efficacy|1|||
130228974|NCT03426345|468803651|FG001|Overall Study|Lack of Efficacy|0|||
130228975|NCT03426345|468803650|FG000|Overall Study|Withdrawal by Subject|5|||
130228976|NCT03426345|468803651|FG001|Overall Study|Withdrawal by Subject|6|||
130228977|NCT03426345|468803650|FG000|Overall Study|Lost to Follow-up|3|||
130228978|NCT03426345|468803651|FG001|Overall Study|Lost to Follow-up|1|||
130228979|NCT03426345|468803650|FG000|Overall Study|Protocol Deviation|3|||
130228980|NCT03426345|468803651|FG001|Overall Study|Protocol Deviation|4|||
130228981|NCT03426345|468803650|FG000|Overall Study|Reason Not Specified|1|||
130228982|NCT03426345|468803651|FG001|Overall Study|Reason Not Specified|2|||
130228983|NCT03426345|468803650|FG000|Overall Study|Missing Completion Status|1|||
130228984|NCT03426345|468803651|FG001|Overall Study|Missing Completion Status|0|||
130228985|NCT02446691|468803652|FG000|Overall Study|Withdrawal by Subject|2|||
130228986|NCT02446691|468803652|FG000|Overall Study|Lost to Follow-up|8|||
130228987|NCT02446691|468803652|FG000|Overall Study|Protocol Violation|1|||
130228988|NCT02497469|468803653|FG000|Overall Study|Randomized but not Treated|0|||
130228989|NCT02497469|468803654|FG001|Overall Study|Randomized but not Treated|2|||
130228990|NCT02497469|468803653|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
130228991|NCT02497469|468803654|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
130228992|NCT02497469|468803653|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
130228993|NCT02497469|468803654|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
130228994|NCT02497469|468803653|FG000|Overall Study|Significant Protocol Deviation|4|||
130228995|NCT02497469|468803654|FG001|Overall Study|Significant Protocol Deviation|5|||
130228996|NCT02497469|468803653|FG000|Overall Study|Lost to Follow-up|14|||
130228997|NCT02497469|468803654|FG001|Overall Study|Lost to Follow-up|4|||
130228998|NCT02497469|468803653|FG000|Overall Study|Voluntary Withdrawal|39|||
130228999|NCT02497469|468803654|FG001|Overall Study|Voluntary Withdrawal|41|||
130229000|NCT02497469|468803653|FG000|Overall Study|Pregnancy|1|||
130229001|NCT02497469|468803654|FG001|Overall Study|Pregnancy|1|||
130229002|NCT02497469|468803653|FG000|Overall Study|Lack of Efficacy|86|||
130229003|NCT02497469|468803654|FG001|Overall Study|Lack of Efficacy|40|||
130229004|NCT02497469|468803653|FG000|Overall Study|Reason not Specified|6|||
130229005|NCT02497469|468803654|FG001|Overall Study|Reason not Specified|6|||
130229006|NCT01026493|468803656|FG000|Overall Study|Protocol Violation|0|||
130229007|NCT01026493|468803657|FG001|Overall Study|Protocol Violation|1|||
130229008|NCT01026493|468803658|FG002|Overall Study|Protocol Violation|0|||
130229009|NCT01026493|468803659|FG003|Overall Study|Protocol Violation|0|||
130229010|NCT01026493|468803660|FG004|Overall Study|Protocol Violation|2|||
130229011|NCT01026493|468803661|FG005|Overall Study|Protocol Violation|3|||
130229012|NCT01026493|468803662|FG006|Overall Study|Protocol Violation|4|||
130229013|NCT01026493|468803663|FG007|Overall Study|Protocol Violation|1|||
130229014|NCT00630916|468803667|FG000|Overall Study|Death|110|||
130229015|NCT00630916|468803667|FG000|Overall Study|Explant|8|||
130229016|NCT00630916|468803667|FG000|Overall Study|Lost to Follow-up|5|||
130229017|NCT00630916|468803667|FG000|Overall Study|Withdrawal by Subject|30|||
130229018|NCT00630916|468803667|FG000|Overall Study|Protocol Violation|7|||
130229019|NCT00630916|468803667|FG000|Overall Study|Physician Decision|47|||
130229020|NCT00630916|468803667|FG000|Overall Study|Lack of Efficacy|3|||
130229021|NCT02295644|468803674|FG000|Overall Study|Did not meet inclusion criterion|0|||
130229022|NCT02295644|468803675|FG001|Overall Study|Did not meet inclusion criterion|0|||
130229023|NCT02295644|468803676|FG002|Overall Study|Did not meet inclusion criterion|1|||
130229024|NCT02295644|468803677|FG003|Overall Study|Did not meet inclusion criterion|2|||
130229025|NCT00324155|468803678|FG000|Enrolled and Randomized|No longer met study criteria|3|||
130229026|NCT00324155|468803679|FG001|Enrolled and Randomized|No longer met study criteria|0|||
130229027|NCT00324155|468803678|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
130229028|NCT00324155|468803679|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
130229029|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
130229030|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
130229031|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
130229032|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
130229033|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Death|8|||
130229034|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Death|15|||
130229035|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
130229036|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
130445027|NCT04496167|469590343|FG000|Overall Study|Withdrawal by Subject|7|||
130445028|NCT04496167|469590344|FG001|Overall Study|Withdrawal by Subject|6|||
130445029|NCT04496167|469590343|FG000|Overall Study|Lost to Follow-up|3|||
130445030|NCT04496167|469590344|FG001|Overall Study|Lost to Follow-up|5|||
130445031|NCT04496167|469590343|FG000|Overall Study|Not Treated|1|||
130445032|NCT04496167|469590344|FG001|Overall Study|Not Treated|2|||
130445033|NCT04496167|469590343|FG000|Overall Study|Other Than Specified|1|||
130445034|NCT04496167|469590344|FG001|Overall Study|Other Than Specified|1|||
130445035|NCT00681187|469590345|FG000|Overall Study|Withdrawal by Subject|1|||
130445036|NCT00681187|469590346|FG001|Overall Study|Withdrawal by Subject|0|||
130445037|NCT00681187|469590345|FG000|Overall Study|Death|0|||
130445038|NCT00681187|469590346|FG001|Overall Study|Death|1|||
130445039|NCT00681187|469590345|FG000|Overall Study|Adverse Event|0|||
130445040|NCT00681187|469590346|FG001|Overall Study|Adverse Event|1|||
130445041|NCT02788006|469590348|FG000|Overall Study|Patient not treated|1|||
130445042|NCT02269943|469590349|FG000|Treatment Period|Death|0|||
130445043|NCT02269943|469590350|FG001|Treatment Period|Death|1|||
130445044|NCT02269943|469590349|FG000|Treatment Period|Adverse Event|1|||
130445045|NCT02269943|469590350|FG001|Treatment Period|Adverse Event|10|||
130445046|NCT02269943|469590349|FG000|Treatment Period|Progressive Disease|5|||
130445047|NCT02269943|469590350|FG001|Treatment Period|Progressive Disease|17|||
130691405|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691406|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691407|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130691408|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130691409|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130691410|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691411|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691412|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691413|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691414|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691415|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691416|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691417|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691418|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691419|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691420|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691421|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691422|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130691423|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130691424|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691425|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691426|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691427|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691428|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691429|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691430|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691431|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691432|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691433|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691434|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
130229037|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
130445048|NCT02269943|469590349|FG000|Treatment Period|Symptomatic Deterioration|0|||
130691435|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691436|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
130445049|NCT02269943|469590350|FG001|Treatment Period|Symptomatic Deterioration|2|||
130445050|NCT02269943|469590349|FG000|Follow-Up Survival Period|Death|3|||
130691437|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
130229038|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
130229039|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
130229040|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
130229041|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
130229042|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
130229043|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
130229044|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
130229045|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
130229046|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
130229047|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
130229048|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
130229049|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
130229050|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
130229051|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
130229052|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
130229053|NCT00324155|468803678|FG000|Follow-up Phase|On-going participants still on drug|11|||
130229054|NCT00324155|468803679|FG001|Follow-up Phase|On-going participants still on drug|6|||
130229055|NCT05412134|468803680|FG000|Overall Study|Lost to Follow-up|2|||
130229056|NCT05412134|468803681|FG001|Overall Study|Lost to Follow-up|0|||
130229057|NCT03167242|468803682|FG000|Overall Study|Patient/Guardian Decision|0|||
130229058|NCT03167242|468803683|FG001|Overall Study|Patient/Guardian Decision|1|||
130229059|NCT03167242|468803684|FG002|Overall Study|Patient/Guardian Decision|2|||
130229060|NCT03167242|468803685|FG003|Overall Study|Patient/Guardian Decision|1|||
130229061|NCT03167242|468803686|FG004|Overall Study|Patient/Guardian Decision|1|||
130229062|NCT03167242|468803687|FG005|Overall Study|Patient/Guardian Decision|1|||
130229063|NCT03167242|468803688|FG006|Overall Study|Patient/Guardian Decision|0|||
130229064|NCT03167242|468803689|FG007|Overall Study|Patient/Guardian Decision|0|||
130229065|NCT03167242|468803690|FG008|Overall Study|Patient/Guardian Decision|0|||
130229066|NCT03167242|468803691|FG009|Overall Study|Patient/Guardian Decision|0|||
130229067|NCT03167242|468803692|FG010|Overall Study|Patient/Guardian Decision|1|||
130356149|NCT02160782|469276238|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130356150|NCT02160782|469276239|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
130356151|NCT02160782|469276240|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130356152|NCT02160782|469276236|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130356153|NCT02160782|469276237|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130356154|NCT02160782|469276238|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130356155|NCT02160782|469276239|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
130356156|NCT02160782|469276240|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130356157|NCT02160782|469276236|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130356158|NCT02160782|469276237|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130356159|NCT02160782|469276238|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130356160|NCT02160782|469276239|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130356161|NCT02160782|469276240|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
130356162|NCT02160782|469276236|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130356163|NCT02160782|469276237|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130356164|NCT02160782|469276238|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130356165|NCT02160782|469276239|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130356166|NCT02160782|469276240|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
130356167|NCT02160782|469276236|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130356168|NCT02160782|469276237|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130356169|NCT02160782|469276238|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130356170|NCT02160782|469276239|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130356171|NCT02160782|469276240|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
130356172|NCT02160782|469276236|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130356173|NCT02160782|469276237|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130356174|NCT02160782|469276238|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130356175|NCT02160782|469276239|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130356176|NCT02160782|469276240|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
130356177|NCT01104701|469276243|FG000|Overall Study|Withdrawal by Subject|0|||
130356178|NCT01104701|469276244|FG001|Overall Study|Withdrawal by Subject|1|||
130356179|NCT01104701|469276245|FG002|Overall Study|Withdrawal by Subject|2|||
130356180|NCT01104701|469276246|FG003|Overall Study|Withdrawal by Subject|1|||
130356181|NCT01104701|469276243|FG000|Overall Study|Adverse Event|0|||
130356182|NCT01104701|469276244|FG001|Overall Study|Adverse Event|0|||
130229068|NCT03167242|468803693|FG011|Overall Study|Patient/Guardian Decision|0|||
130229069|NCT03167242|468803682|FG000|Overall Study|Lost to Follow-up|0|||
130229070|NCT03167242|468803683|FG001|Overall Study|Lost to Follow-up|0|||
130229071|NCT03167242|468803684|FG002|Overall Study|Lost to Follow-up|1|||
130229072|NCT03167242|468803685|FG003|Overall Study|Lost to Follow-up|0|||
130229073|NCT03167242|468803686|FG004|Overall Study|Lost to Follow-up|0|||
130229074|NCT03167242|468803687|FG005|Overall Study|Lost to Follow-up|1|||
130229075|NCT03167242|468803688|FG006|Overall Study|Lost to Follow-up|2|||
130229076|NCT03167242|468803689|FG007|Overall Study|Lost to Follow-up|1|||
130229077|NCT03167242|468803690|FG008|Overall Study|Lost to Follow-up|0|||
130229078|NCT03167242|468803691|FG009|Overall Study|Lost to Follow-up|0|||
130229079|NCT03167242|468803692|FG010|Overall Study|Lost to Follow-up|1|||
130229080|NCT03167242|468803693|FG011|Overall Study|Lost to Follow-up|1|||
130229081|NCT03167242|468803682|FG000|Overall Study|Reason not provided|0|||
130229082|NCT03167242|468803683|FG001|Overall Study|Reason not provided|0|||
130229083|NCT03167242|468803684|FG002|Overall Study|Reason not provided|0|||
130229084|NCT03167242|468803685|FG003|Overall Study|Reason not provided|0|||
130229085|NCT03167242|468803686|FG004|Overall Study|Reason not provided|0|||
130229086|NCT03167242|468803687|FG005|Overall Study|Reason not provided|0|||
130229087|NCT03167242|468803688|FG006|Overall Study|Reason not provided|0|||
130229088|NCT03167242|468803689|FG007|Overall Study|Reason not provided|0|||
130229089|NCT03167242|468803690|FG008|Overall Study|Reason not provided|1|||
130229090|NCT03167242|468803691|FG009|Overall Study|Reason not provided|0|||
130229091|NCT03167242|468803692|FG010|Overall Study|Reason not provided|0|||
130229092|NCT03167242|468803693|FG011|Overall Study|Reason not provided|0|||
130229093|NCT05401565|468803698|FG000|Overall Study|Lost to Follow-up|1|||
130229094|NCT05401565|468803699|FG001|Overall Study|Lost to Follow-up|0|||
130229095|NCT05401565|468803698|FG000|Overall Study|Adverse Event|2|||
130229096|NCT05401565|468803699|FG001|Overall Study|Adverse Event|0|||
130229097|NCT00726609|468803702|FG000|Overall Study|Adverse Event|10|||
130229098|NCT00726609|468803702|FG000|Overall Study|Withdrawal by Subject|2|||
130229099|NCT00726609|468803702|FG000|Overall Study|Lack of Efficacy|25|||
130229100|NCT00726609|468803702|FG000|Overall Study|Other|16|||
130229101|NCT00726609|468803702|FG000|Overall Study|Missing|42|||
130229102|NCT00726609|468803702|FG000|Overall Study|Other|3|||
130229103|NCT03080935|468803712|FG000|Overall Study|Death|34|||
130229104|NCT03080935|468803713|FG001|Overall Study|Death|50|||
130229105|NCT03080935|468803712|FG000|Overall Study|Lost to Follow-up|5|||
130229106|NCT03080935|468803713|FG001|Overall Study|Lost to Follow-up|4|||
130229107|NCT03080935|468803712|FG000|Overall Study|Withdrawal by Subject|11|||
130229108|NCT03080935|468803713|FG001|Overall Study|Withdrawal by Subject|15|||
130229109|NCT02175121|468803714|FG000|Overall Study|Lack of Efficacy|1|||
130229110|NCT02175121|468803715|FG001|Overall Study|Lack of Efficacy|0|||
130229111|NCT02175121|468803716|FG002|Overall Study|Lack of Efficacy|0|||
130229112|NCT02175121|468803717|FG003|Overall Study|Lack of Efficacy|0|||
130229113|NCT02175121|468803718|FG004|Overall Study|Lack of Efficacy|0|||
130229114|NCT02175121|468803714|FG000|Overall Study|Lost to Follow-up|0|||
130229115|NCT02175121|468803715|FG001|Overall Study|Lost to Follow-up|1|||
130229116|NCT02175121|468803716|FG002|Overall Study|Lost to Follow-up|0|||
130229117|NCT02175121|468803717|FG003|Overall Study|Lost to Follow-up|1|||
130229118|NCT02175121|468803718|FG004|Overall Study|Lost to Follow-up|0|||
130229119|NCT02175121|468803714|FG000|Overall Study|Personal emergency|0|||
130229120|NCT02175121|468803715|FG001|Overall Study|Personal emergency|0|||
130229121|NCT02175121|468803716|FG002|Overall Study|Personal emergency|0|||
130229122|NCT02175121|468803717|FG003|Overall Study|Personal emergency|0|||
130229123|NCT02175121|468803718|FG004|Overall Study|Personal emergency|1|||
130229124|NCT02175121|468803714|FG000|Overall Study|Schedule conflict|0|||
130229125|NCT02175121|468803715|FG001|Overall Study|Schedule conflict|0|||
130229126|NCT02175121|468803716|FG002|Overall Study|Schedule conflict|1|||
130229127|NCT02175121|468803717|FG003|Overall Study|Schedule conflict|0|||
130229128|NCT02175121|468803718|FG004|Overall Study|Schedule conflict|0|||
130229129|NCT02175121|468803714|FG000|Overall Study|Time issues|0|||
130229130|NCT02175121|468803715|FG001|Overall Study|Time issues|0|||
130229131|NCT02175121|468803716|FG002|Overall Study|Time issues|1|||
130229132|NCT02175121|468803717|FG003|Overall Study|Time issues|0|||
130229133|NCT02175121|468803718|FG004|Overall Study|Time issues|0|||
130229134|NCT03329885|468803719|FG000|Overall Study|Sponsor discontinued the study early|0|||
130229135|NCT03329885|468803720|FG001|Overall Study|Sponsor discontinued the study early|0|||
130229136|NCT03329885|468803721|FG002|Overall Study|Sponsor discontinued the study early|0|||
130229137|NCT03329885|468803722|FG003|Overall Study|Sponsor discontinued the study early|0|||
130229138|NCT03329885|468803723|FG004|Overall Study|Sponsor discontinued the study early|0|||
130229139|NCT03329885|468803724|FG005|Overall Study|Sponsor discontinued the study early|0|||
130229140|NCT03329885|468803725|FG006|Overall Study|Sponsor discontinued the study early|1|||
130552890|NCT00564018|469991612|FG001|Overall Study|Withdrawal by Subject|3|||
130229141|NCT03329885|468803726|FG007|Overall Study|Sponsor discontinued the study early|1|||
130229142|NCT03329885|468803727|FG008|Overall Study|Sponsor discontinued the study early|0|||
130229143|NCT00269152|468803734|FG000|Overall Study|Adverse Event|9|||
130229144|NCT00269152|468803735|FG001|Overall Study|Adverse Event|3|||
130229145|NCT00269152|468803734|FG000|Overall Study|Withdrawal by Subject|7|||
130229146|NCT00269152|468803735|FG001|Overall Study|Withdrawal by Subject|3|||
130229147|NCT00269152|468803734|FG000|Overall Study|Physician Decision|2|||
130229148|NCT00269152|468803735|FG001|Overall Study|Physician Decision|3|||
130229149|NCT00269152|468803734|FG000|Overall Study|Protocol Violation|0|||
130229150|NCT00269152|468803735|FG001|Overall Study|Protocol Violation|1|||
130229151|NCT03886272|468803736|FG000|Period 1|Withdrawal by Subject|0|||
130229152|NCT03886272|468803737|FG001|Period 1|Withdrawal by Subject|0|||
130229153|NCT03886272|468803738|FG002|Period 1|Withdrawal by Subject|0|||
130229154|NCT03886272|468803739|FG003|Period 1|Withdrawal by Subject|0|||
130229155|NCT03886272|468803740|FG004|Period 1|Withdrawal by Subject|0|||
130229156|NCT03886272|468803741|FG005|Period 1|Withdrawal by Subject|1|||
130229157|NCT03886272|468803742|FG006|Period 1|Withdrawal by Subject|0|||
130229158|NCT02557399|468803743|FG000|Overall Study|Adverse Event|6|||
130229159|NCT02557399|468803744|FG001|Overall Study|Adverse Event|5|||
130229160|NCT02557399|468803743|FG000|Overall Study|Protocol Violation|0|||
130229161|NCT02557399|468803744|FG001|Overall Study|Protocol Violation|1|||
130229162|NCT02557399|468803743|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130229163|NCT02557399|468803744|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130229164|NCT02557399|468803743|FG000|Overall Study|Withdrawal by Subject|1|||
130229165|NCT02557399|468803744|FG001|Overall Study|Withdrawal by Subject|1|||
130229166|NCT00931632|468803745|FG000|Overall Study|Withdrawal by Subject|2|||
130229167|NCT00931632|468803746|FG001|Overall Study|Withdrawal by Subject|3|||
130229168|NCT00931632|468803745|FG000|Overall Study|Adverse Event|19|||
130229169|NCT00931632|468803746|FG001|Overall Study|Adverse Event|15|||
130229170|NCT01687218|468803749|FG000|Overall Study|Withdrawal by Subject|2|||
130229171|NCT01687218|468803750|FG001|Overall Study|Withdrawal by Subject|3|||
130229172|NCT01687218|468803751|FG002|Overall Study|Withdrawal by Subject|0|||
130229173|NCT01687218|468803752|FG003|Overall Study|Withdrawal by Subject|1|||
130229174|NCT01687218|468803753|FG004|Overall Study|Withdrawal by Subject|1|||
130229175|NCT01687218|468803754|FG005|Overall Study|Withdrawal by Subject|0|||
130229176|NCT01687218|468803749|FG000|Overall Study|Relocated, no follow-up planned|1|||
130229177|NCT01687218|468803750|FG001|Overall Study|Relocated, no follow-up planned|0|||
130229178|NCT01687218|468803751|FG002|Overall Study|Relocated, no follow-up planned|1|||
130229179|NCT01687218|468803752|FG003|Overall Study|Relocated, no follow-up planned|1|||
130229180|NCT01687218|468803753|FG004|Overall Study|Relocated, no follow-up planned|0|||
130229181|NCT01687218|468803754|FG005|Overall Study|Relocated, no follow-up planned|0|||
130229182|NCT03139552|468803760|FG000|Overall Study|unable to attend tasting due to schedule|3|||
130229183|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
130229184|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
130229185|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
130229186|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
130229187|NCT01973218|468803770|FG000|Overall Study|Adverse Event|1|||
130229188|NCT01973218|468803771|FG001|Overall Study|Adverse Event|0|||
130229189|NCT01973218|468803770|FG000|Overall Study|Withdrawal by Subject|1|||
130229190|NCT01973218|468803771|FG001|Overall Study|Withdrawal by Subject|0|||
130229191|NCT02247466|468803772|FG000|Overall Study|Procedure changed to open surgery|0|||
130229192|NCT02247466|468803773|FG001|Overall Study|Procedure changed to open surgery|3|||
130229193|NCT02033759|468803776|FG000|Overall Study|Withdrawal by Subject|2|||
130229194|NCT02033759|468803777|FG001|Overall Study|Withdrawal by Subject|1|||
130229195|NCT02033759|468803776|FG000|Overall Study|Protocol Violation|1|||
130229196|NCT02033759|468803777|FG001|Overall Study|Protocol Violation|1|||
130229197|NCT04356937|468803780|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
130229198|NCT04356937|468803781|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
130229199|NCT03533751|468803782|FG000|Overall Study|Withdrawal by Subject|12|||
130356183|NCT01104701|469276245|FG002|Overall Study|Adverse Event|0|||
130356184|NCT01104701|469276246|FG003|Overall Study|Adverse Event|1|||
130356185|NCT01104701|469276243|FG000|Overall Study|Physician Decision|0|||
130356186|NCT01104701|469276244|FG001|Overall Study|Physician Decision|2|||
130356187|NCT01104701|469276245|FG002|Overall Study|Physician Decision|0|||
130356188|NCT01104701|469276246|FG003|Overall Study|Physician Decision|0|||
130691438|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691439|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691440|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691441|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130229200|NCT03533751|468803783|FG001|Overall Study|Withdrawal by Subject|6|||
130229201|NCT03533751|468803784|FG002|Overall Study|Withdrawal by Subject|11|||
130229202|NCT03533751|468803785|FG003|Overall Study|Withdrawal by Subject|9|||
130229203|NCT03533751|468803786|FG004|Overall Study|Withdrawal by Subject|10|||
130229204|NCT03533751|468803782|FG000|Overall Study|Adverse Event|4|||
130229205|NCT03533751|468803783|FG001|Overall Study|Adverse Event|7|||
130229206|NCT03533751|468803784|FG002|Overall Study|Adverse Event|2|||
130229207|NCT03533751|468803785|FG003|Overall Study|Adverse Event|4|||
130229208|NCT03533751|468803786|FG004|Overall Study|Adverse Event|5|||
130229209|NCT03533751|468803782|FG000|Overall Study|Physician Decision|0|||
130229210|NCT03533751|468803783|FG001|Overall Study|Physician Decision|2|||
130229211|NCT03533751|468803784|FG002|Overall Study|Physician Decision|1|||
130229212|NCT03533751|468803785|FG003|Overall Study|Physician Decision|2|||
130229213|NCT03533751|468803786|FG004|Overall Study|Physician Decision|1|||
130229214|NCT03533751|468803782|FG000|Overall Study|Sponsor Decision|0|||
130229215|NCT03533751|468803783|FG001|Overall Study|Sponsor Decision|0|||
130229216|NCT03533751|468803784|FG002|Overall Study|Sponsor Decision|1|||
130229217|NCT03533751|468803785|FG003|Overall Study|Sponsor Decision|1|||
130229218|NCT03533751|468803786|FG004|Overall Study|Sponsor Decision|0|||
130229219|NCT03533751|468803782|FG000|Overall Study|Lost to Follow-up|3|||
130229220|NCT03533751|468803783|FG001|Overall Study|Lost to Follow-up|7|||
130229221|NCT03533751|468803784|FG002|Overall Study|Lost to Follow-up|6|||
130229222|NCT03533751|468803785|FG003|Overall Study|Lost to Follow-up|4|||
130229223|NCT03533751|468803786|FG004|Overall Study|Lost to Follow-up|3|||
130229224|NCT03533751|468803782|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
130229225|NCT03533751|468803783|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
130229226|NCT03533751|468803784|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
130229227|NCT03533751|468803785|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
130229228|NCT03533751|468803786|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
130229229|NCT03533751|468803782|FG000|Overall Study|Other|0|||
130229230|NCT03533751|468803783|FG001|Overall Study|Other|2|||
130229231|NCT03533751|468803784|FG002|Overall Study|Other|1|||
130229232|NCT03533751|468803785|FG003|Overall Study|Other|0|||
130229233|NCT03533751|468803786|FG004|Overall Study|Other|3|||
130229234|NCT05117060|468803787|FG000|Overall Study|Adverse Event|3|||
130229235|NCT05117060|468803788|FG001|Overall Study|Adverse Event|5|||
130229236|NCT05117060|468803789|FG002|Overall Study|Adverse Event|6|||
130229237|NCT05117060|468803790|FG003|Overall Study|Adverse Event|1|||
130229238|NCT05117060|468803787|FG000|Overall Study|Lost to Follow-up|0|||
130229239|NCT05117060|468803788|FG001|Overall Study|Lost to Follow-up|0|||
130229240|NCT05117060|468803789|FG002|Overall Study|Lost to Follow-up|0|||
130229241|NCT05117060|468803790|FG003|Overall Study|Lost to Follow-up|1|||
130229242|NCT05117060|468803787|FG000|Overall Study|Lack of Efficacy|4|||
130229243|NCT05117060|468803788|FG001|Overall Study|Lack of Efficacy|5|||
130229244|NCT05117060|468803789|FG002|Overall Study|Lack of Efficacy|2|||
130229245|NCT05117060|468803790|FG003|Overall Study|Lack of Efficacy|6|||
130229246|NCT05117060|468803787|FG000|Overall Study|Withdrawal by Subject|8|||
130229247|NCT05117060|468803788|FG001|Overall Study|Withdrawal by Subject|5|||
130229248|NCT05117060|468803789|FG002|Overall Study|Withdrawal by Subject|5|||
130229249|NCT05117060|468803790|FG003|Overall Study|Withdrawal by Subject|6|||
130229250|NCT05117060|468803787|FG000|Overall Study|Other|2|||
130356189|NCT03437512|469276247|FG000|Randomized|Withdrawal by Subject|0|||
130691442|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130356190|NCT03437512|469276248|FG001|Randomized|Withdrawal by Subject|2|||
130356191|NCT03437512|469276247|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
130356192|NCT03437512|469276248|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
130356193|NCT00674973|469276249|FG000|Overall Study|Insufficient Therapeutic Response|77|||
130356194|NCT00674973|469276250|FG001|Overall Study|Insufficient Therapeutic Response|72|||
130356195|NCT00674973|469276249|FG000|Overall Study|Refused Treatment|1|||
130356196|NCT00674973|469276250|FG001|Overall Study|Refused Treatment|5|||
130356197|NCT00674973|469276249|FG000|Overall Study|Failure to Return|1|||
130356198|NCT00674973|469276250|FG001|Overall Study|Failure to Return|0|||
130356199|NCT00674973|469276249|FG000|Overall Study|Adverse Event|2|||
130356200|NCT00674973|469276250|FG001|Overall Study|Adverse Event|9|||
130356201|NCT00674973|469276249|FG000|Overall Study|Death|19|||
130356202|NCT00674973|469276250|FG001|Overall Study|Death|15|||
130356203|NCT00674973|469276249|FG000|Overall Study|Protocol Violation|0|||
130356204|NCT00674973|469276250|FG001|Overall Study|Protocol Violation|1|||
130356205|NCT05036369|469276253|FG000|Overall Study|Run In non compliance|1|||
130356206|NCT05036369|469276254|FG001|Overall Study|Run In non compliance|2|||
130356207|NCT05036369|469276253|FG000|Overall Study|Change in eligibility criteria|0|||
130356208|NCT05036369|469276254|FG001|Overall Study|Change in eligibility criteria|1|||
130356209|NCT01397162|469276257|FG000|Overall Study|Adverse Event|4|||
130356210|NCT01397162|469276258|FG001|Overall Study|Adverse Event|0|||
130691443|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691444|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130229251|NCT05117060|468803788|FG001|Overall Study|Other|1|||
130229252|NCT05117060|468803789|FG002|Overall Study|Other|3|||
130229253|NCT05117060|468803790|FG003|Overall Study|Other|1|||
130229254|NCT01419535|468803791|FG000|Overall Study|could not maintain iv line|1|||
130229255|NCT01419535|468803792|FG001|Overall Study|could not maintain iv line|1|||
130229256|NCT01419535|468803791|FG000|Overall Study|Withdrawal by Subject|0|||
130229257|NCT01419535|468803792|FG001|Overall Study|Withdrawal by Subject|1|||
130229258|NCT02873689|468805844|FG000|Overall Study|Lack of Efficacy|1|||
130229259|NCT02873689|468805845|FG001|Overall Study|Lack of Efficacy|0|||
130356211|NCT01397162|469276259|FG002|Overall Study|Adverse Event|0|||
130356212|NCT01397162|469276260|FG003|Overall Study|Adverse Event|0|||
130356213|NCT01397162|469276261|FG004|Overall Study|Adverse Event|0|||
130356214|NCT01397162|469276257|FG000|Overall Study|Not yet defined|3|||
130691445|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691446|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691447|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691448|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691449|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691450|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691451|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
130691452|NCT05239195|470495871|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
130691453|NCT05239195|470495872|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
130691454|NCT03552484|470495873|FG000|Overall Study|Death|6|||
130691455|NCT03552484|470495874|FG001|Overall Study|Death|4|||
130691456|NCT03552484|470495873|FG000|Overall Study|Lost to Follow-up|0|||
130691457|NCT03552484|470495874|FG001|Overall Study|Lost to Follow-up|16|||
130691458|NCT03246503|470495879|FG000|Overall Study|Lost to Follow-up|23|||
130691459|NCT03246503|470495879|FG000|Overall Study|Withdrawal by Subject|20|||
130691460|NCT03246503|470495879|FG000|Overall Study|Physician Decision|5|||
130691461|NCT03246503|470495879|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
130691462|NCT00736190|470495880|FG000|Overall Study|Pregnancy|1|||
130691463|NCT00736190|470495880|FG000|Overall Study|Withdrawal by Subject|1|||
130691464|NCT00736190|470495880|FG000|Overall Study|Adverse Event|1|||
130691465|NCT00716625|470495882|FG000|Overall Study|Safety was not Assessable|1|||
130691466|NCT01492439|470495883|FG000|Overall Study|Withdrew from RTE|4|||
130691467|NCT01492439|470495884|FG001|Overall Study|Withdrew from RTE|9|||
130691468|NCT00488774|470495885|FG000|Overall Study|Withdrawal of consent|2|||
130691469|NCT00488774|470495886|FG001|Overall Study|Withdrawal of consent|2|||
130691470|NCT00488774|470495887|FG002|Overall Study|Withdrawal of consent|2|||
130691471|NCT00488774|470495888|FG003|Overall Study|Withdrawal of consent|0|||
130691472|NCT00488774|470495885|FG000|Overall Study|Other|6|||
130691473|NCT00488774|470495886|FG001|Overall Study|Other|3|||
130691474|NCT00488774|470495887|FG002|Overall Study|Other|2|||
130691475|NCT00488774|470495888|FG003|Overall Study|Other|2|||
130691476|NCT00488774|470495885|FG000|Overall Study|Lost to Follow-up|0|||
130691477|NCT00488774|470495886|FG001|Overall Study|Lost to Follow-up|0|||
130691478|NCT00488774|470495887|FG002|Overall Study|Lost to Follow-up|1|||
130691479|NCT00488774|470495888|FG003|Overall Study|Lost to Follow-up|1|||
130691480|NCT01204294|470495889|FG000|Overall Study|Adverse Event|2|||
130691481|NCT01204294|470495890|FG001|Overall Study|Adverse Event|6|||
130691482|NCT01204294|470495891|FG002|Overall Study|Adverse Event|0|||
130691483|NCT01204294|470495892|FG003|Overall Study|Adverse Event|7|||
130691484|NCT01204294|470495893|FG004|Overall Study|Adverse Event|1|||
130691485|NCT01204294|470495894|FG005|Overall Study|Adverse Event|4|||
130691486|NCT01204294|470495895|FG006|Overall Study|Adverse Event|0|||
130691487|NCT01204294|470495889|FG000|Overall Study|Protocol Violation|1|||
130691488|NCT01204294|470495890|FG001|Overall Study|Protocol Violation|0|||
130691489|NCT01204294|470495891|FG002|Overall Study|Protocol Violation|2|||
130691490|NCT01204294|470495892|FG003|Overall Study|Protocol Violation|1|||
130691491|NCT01204294|470495893|FG004|Overall Study|Protocol Violation|0|||
130691492|NCT01204294|470495894|FG005|Overall Study|Protocol Violation|0|||
130691493|NCT01204294|470495895|FG006|Overall Study|Protocol Violation|0|||
130691494|NCT01204294|470495889|FG000|Overall Study|Withdrawal by Subject|0|||
130691495|NCT01204294|470495890|FG001|Overall Study|Withdrawal by Subject|2|||
130691496|NCT01204294|470495891|FG002|Overall Study|Withdrawal by Subject|2|||
130691497|NCT01204294|470495892|FG003|Overall Study|Withdrawal by Subject|1|||
130691498|NCT01204294|470495893|FG004|Overall Study|Withdrawal by Subject|1|||
130691499|NCT01204294|470495894|FG005|Overall Study|Withdrawal by Subject|1|||
130691500|NCT01204294|470495895|FG006|Overall Study|Withdrawal by Subject|2|||
130691501|NCT01204294|470495889|FG000|Overall Study|Lack of Efficacy|0|||
130691502|NCT01204294|470495890|FG001|Overall Study|Lack of Efficacy|0|||
130691503|NCT01204294|470495891|FG002|Overall Study|Lack of Efficacy|0|||
130691504|NCT01204294|470495892|FG003|Overall Study|Lack of Efficacy|2|||
130229260|NCT02873689|468805844|FG000|Overall Study|Withdrawal by Subject|2|||
130229261|NCT02873689|468805845|FG001|Overall Study|Withdrawal by Subject|2|||
130229262|NCT02873689|468805844|FG000|Overall Study|Protocol Violation|1|||
130691505|NCT01204294|470495893|FG004|Overall Study|Lack of Efficacy|0|||
130445051|NCT02269943|469590350|FG001|Follow-Up Survival Period|Death|16|||
130691506|NCT01204294|470495894|FG005|Overall Study|Lack of Efficacy|0|||
130691507|NCT01204294|470495895|FG006|Overall Study|Lack of Efficacy|0|||
130445052|NCT02269943|469590349|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
130229263|NCT02873689|468805845|FG001|Overall Study|Protocol Violation|0|||
130691508|NCT01204294|470495889|FG000|Overall Study|Other (house moving)|0|||
130691509|NCT01204294|470495890|FG001|Overall Study|Other (house moving)|0|||
130691510|NCT01204294|470495891|FG002|Overall Study|Other (house moving)|1|||
130356215|NCT01397162|469276258|FG001|Overall Study|Not yet defined|4|||
130356216|NCT01397162|469276259|FG002|Overall Study|Not yet defined|3|||
130691511|NCT01204294|470495892|FG003|Overall Study|Other (house moving)|0|||
130691512|NCT01204294|470495893|FG004|Overall Study|Other (house moving)|0|||
130691513|NCT01204294|470495894|FG005|Overall Study|Other (house moving)|0|||
130691514|NCT01204294|470495895|FG006|Overall Study|Other (house moving)|0|||
130691515|NCT04590027|470495896|FG000|Overall Study|Lost to Follow-up|17|||
130691516|NCT04590027|470495897|FG001|Overall Study|Lost to Follow-up|14|||
130691517|NCT04590027|470495896|FG000|Overall Study|Protocol Violation|0|||
130691518|NCT04590027|470495897|FG001|Overall Study|Protocol Violation|3|||
130691519|NCT02682238|470495898|FG000|Overall Study|Lost to Follow-up|0|||
130691520|NCT02682238|470495899|FG001|Overall Study|Lost to Follow-up|2|||
130691521|NCT02682238|470495898|FG000|Overall Study|Withdrawal by Subject|1|||
130691522|NCT02682238|470495899|FG001|Overall Study|Withdrawal by Subject|0|||
130691523|NCT02682238|470495898|FG000|Overall Study|Adverse Event|1|||
130691524|NCT02682238|470495899|FG001|Overall Study|Adverse Event|0|||
130691525|NCT02682238|470495898|FG000|Overall Study|Non-compliance with Study Drug|1|||
130691526|NCT02682238|470495899|FG001|Overall Study|Non-compliance with Study Drug|0|||
130691527|NCT02682238|470495898|FG000|Overall Study|Non-compliance with Protocol|0|||
130691528|NCT02682238|470495899|FG001|Overall Study|Non-compliance with Protocol|2|||
130691529|NCT02909907|470495900|FG000|Overall Study|Withdrawal by Subject|0|||
130691530|NCT02909907|470495901|FG001|Overall Study|Withdrawal by Subject|1|||
130691531|NCT02075463|470495903|FG000|Overall Study|Adverse Event|3|||
130691532|NCT02075463|470495903|FG000|Overall Study|Par. reached stopping criteria|4|||
130691533|NCT02075463|470495903|FG000|Overall Study|Withdrawal by Subject|1|||
130691534|NCT00824291|470495905|FG000|Overall Study|Adverse Event|15|||
130691535|NCT00824291|470495906|FG001|Overall Study|Adverse Event|6|||
130691536|NCT00824291|470495905|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130691537|NCT00824291|470495906|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130691538|NCT00824291|470495905|FG000|Overall Study|Lost to Follow-up|11|||
130691539|NCT00824291|470495906|FG001|Overall Study|Lost to Follow-up|9|||
130691540|NCT00824291|470495905|FG000|Overall Study|Non-compliance|1|||
130691541|NCT00824291|470495906|FG001|Overall Study|Non-compliance|1|||
130691542|NCT00824291|470495905|FG000|Overall Study|Protocol Violation|4|||
130691543|NCT00824291|470495906|FG001|Overall Study|Protocol Violation|1|||
130691544|NCT00824291|470495905|FG000|Overall Study|Withdrawal by Subject|14|||
130691545|NCT00824291|470495906|FG001|Overall Study|Withdrawal by Subject|8|||
130691546|NCT00824291|470495905|FG000|Overall Study|Lack of Efficacy|7|||
130691547|NCT00824291|470495906|FG001|Overall Study|Lack of Efficacy|8|||
130691548|NCT00824291|470495905|FG000|Overall Study|Participant on prohibited medication|1|||
130691549|NCT00824291|470495906|FG001|Overall Study|Participant on prohibited medication|0|||
130691550|NCT00933686|470495907|FG000|Overall Study|Protocol Violation|0|||
130691551|NCT00933686|470495908|FG001|Overall Study|Protocol Violation|1|||
130691552|NCT00933686|470495907|FG000|Overall Study|Lost to Follow-up|2|||
130691553|NCT00933686|470495908|FG001|Overall Study|Lost to Follow-up|2|||
130691554|NCT00933686|470495907|FG000|Overall Study|Withdrawal by Subject|6|||
130691555|NCT00933686|470495908|FG001|Overall Study|Withdrawal by Subject|5|||
130691556|NCT00933686|470495907|FG000|Overall Study|Adverse Event|1|||
130691557|NCT00933686|470495908|FG001|Overall Study|Adverse Event|1|||
130691558|NCT00933686|470495907|FG000|Overall Study|Physician Decision|1|||
130691559|NCT00933686|470495908|FG001|Overall Study|Physician Decision|0|||
130691560|NCT00933686|470495907|FG000|Overall Study|Failure to show up at endpoint visits|0|||
130691561|NCT00933686|470495908|FG001|Overall Study|Failure to show up at endpoint visits|2|||
130691562|NCT01383486|470495909|FG000|Overall Study|Lost to Follow-up|10|||
130356217|NCT01397162|469276260|FG003|Overall Study|Not yet defined|5|||
130356218|NCT01397162|469276261|FG004|Overall Study|Not yet defined|3|||
130356219|NCT00401531|469276264|FG000|Overall Study|Adverse Event|2|||
130356220|NCT00401531|469276265|FG001|Overall Study|Adverse Event|0|||
130356221|NCT00401531|469276264|FG000|Overall Study|Protocol Violation|3|||
130356222|NCT00401531|469276265|FG001|Overall Study|Protocol Violation|7|||
130691563|NCT01383486|470495909|FG000|Overall Study|Incomplete information for analysis|2|||
130691564|NCT01383486|470495909|FG000|Overall Study|Did not take any product|6|||
130691565|NCT01839279|470495911|FG000|Overall Study|Adverse Event|4|||
130691566|NCT01839279|470495912|FG001|Overall Study|Adverse Event|1|||
130691567|NCT01839279|470495913|FG002|Overall Study|Adverse Event|1|||
130691568|NCT01839279|470495911|FG000|Overall Study|Withdrawal by Subject|4|||
130691569|NCT01839279|470495912|FG001|Overall Study|Withdrawal by Subject|1|||
130691570|NCT01839279|470495913|FG002|Overall Study|Withdrawal by Subject|1|||
130691571|NCT01839279|470495911|FG000|Overall Study|Classified as 'Other'|5|||
130691572|NCT01839279|470495912|FG001|Overall Study|Classified as 'Other'|0|||
130691573|NCT01839279|470495913|FG002|Overall Study|Classified as 'Other'|0|||
130691574|NCT01648582|470495916|FG000|Overall Study|Adverse Event|6|||
130691575|NCT01648582|470495917|FG001|Overall Study|Adverse Event|11|||
130691576|NCT01648582|470495918|FG002|Overall Study|Adverse Event|2|||
130691577|NCT01648582|470495916|FG000|Overall Study|Lost to Follow-up|9|||
130691578|NCT01648582|470495917|FG001|Overall Study|Lost to Follow-up|6|||
130356223|NCT00401531|469276264|FG000|Overall Study|Lost to Follow-up|1|||
130229264|NCT02873689|468805844|FG000|Overall Study|Adverse Event|2|||
130229265|NCT02873689|468805845|FG001|Overall Study|Adverse Event|2|||
130229266|NCT02873689|468805844|FG000|Overall Study|Randomized but not Treated|1|||
130229267|NCT02873689|468805845|FG001|Overall Study|Randomized but not Treated|1|||
130229268|NCT00350545|468805846|FG000|Overall Study|Withdrawal by Subject|2|||
130229269|NCT00720278|468805853|FG000|Overall Study|Adverse Event|5|||
130229270|NCT00720278|468805854|FG001|Overall Study|Adverse Event|3|||
130229271|NCT00720278|468805855|FG002|Overall Study|Adverse Event|4|||
130229272|NCT00720278|468805853|FG000|Overall Study|Withdrawal by Subject|0|||
130229273|NCT00720278|468805854|FG001|Overall Study|Withdrawal by Subject|1|||
130229274|NCT00720278|468805855|FG002|Overall Study|Withdrawal by Subject|0|||
130229275|NCT00720278|468805853|FG000|Overall Study|Lost to Follow-up|0|||
130229276|NCT00720278|468805854|FG001|Overall Study|Lost to Follow-up|0|||
130229277|NCT00720278|468805855|FG002|Overall Study|Lost to Follow-up|1|||
130229278|NCT00720278|468805853|FG000|Overall Study|Non-compliance|1|||
130229279|NCT00720278|468805854|FG001|Overall Study|Non-compliance|0|||
130229280|NCT00720278|468805855|FG002|Overall Study|Non-compliance|0|||
130229281|NCT00720278|468805853|FG000|Overall Study|eligibility criteria violation|1|||
130229282|NCT00720278|468805854|FG001|Overall Study|eligibility criteria violation|0|||
130229283|NCT00720278|468805855|FG002|Overall Study|eligibility criteria violation|1|||
130229284|NCT00368251|468805858|FG000|Overall Study|SAE, non-fatal|1|||
130229285|NCT00368251|468805859|FG001|Overall Study|SAE, non-fatal|0|||
130229286|NCT00368251|468805860|FG002|Overall Study|SAE, non-fatal|0|||
130229287|NCT00368251|468805858|FG000|Overall Study|AE, non-serious non-fatal|0|||
130229288|NCT00368251|468805859|FG001|Overall Study|AE, non-serious non-fatal|0|||
130552891|NCT00564018|469991613|FG002|Overall Study|Withdrawal by Subject|1|||
130552892|NCT03291587|469991622|FG000|Overall Study|Lost to Follow-up|62|||
130229289|NCT00368251|468805860|FG002|Overall Study|AE, non-serious non-fatal|1|||
130229290|NCT03312738|468805861|FG000|Overall Study|Progressive disease|58|||
130229291|NCT03312738|468805862|FG001|Overall Study|Progressive disease|67|||
130229292|NCT03312738|468805861|FG000|Overall Study|Patient/guardian decision|13|||
130229293|NCT03312738|468805862|FG001|Overall Study|Patient/guardian decision|5|||
130229294|NCT03312738|468805861|FG000|Overall Study|Adverse Event|5|||
130229295|NCT03312738|468805862|FG001|Overall Study|Adverse Event|3|||
130229296|NCT03312738|468805861|FG000|Overall Study|Protocol deviation|2|||
130229297|NCT03312738|468805862|FG001|Overall Study|Protocol deviation|0|||
130229298|NCT03312738|468805861|FG000|Overall Study|Technical problems|0|||
130229299|NCT03312738|468805862|FG001|Overall Study|Technical problems|1|||
130229300|NCT03312738|468805861|FG000|Overall Study|Physician Decision|2|||
130229301|NCT03312738|468805862|FG001|Overall Study|Physician Decision|3|||
130229302|NCT02466399|468805866|FG000|Overall Study|Adverse Event|1|||
130229303|NCT02466399|468805867|FG001|Overall Study|Adverse Event|0|||
130229304|NCT02466399|468805866|FG000|Overall Study|Early exit due to family emergency|1|||
130229305|NCT02466399|468805867|FG001|Overall Study|Early exit due to family emergency|0|||
130229306|NCT00607893|468805868|FG000|Overall Study|Lost to Follow-up|4|||
130229307|NCT00607893|468805869|FG001|Overall Study|Lost to Follow-up|0|||
130229308|NCT00607893|468805868|FG000|Overall Study|withdrew due to loss of interest|0|||
130229309|NCT00607893|468805869|FG001|Overall Study|withdrew due to loss of interest|1|||
130229310|NCT00607893|468805868|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
130229311|NCT00607893|468805869|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
130229312|NCT00607893|468805868|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
130229313|NCT00607893|468805869|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
130229314|NCT00607893|468805868|FG000|Overall Study|Declined to be treated|1|||
130229315|NCT00607893|468805869|FG001|Overall Study|Declined to be treated|0|||
130229316|NCT00607893|468805868|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
130229317|NCT00607893|468805869|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
130229318|NCT02669849|468805870|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130229319|NCT02669849|468805871|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130229320|NCT02669849|468805872|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130229321|NCT02669849|468805870|FG000|Overall Study|Lost to Follow-up|1|||
130229322|NCT02669849|468805871|FG001|Overall Study|Lost to Follow-up|0|||
130229323|NCT02669849|468805872|FG002|Overall Study|Lost to Follow-up|3|||
130229324|NCT02669849|468805870|FG000|Overall Study|Death|1|||
130229325|NCT02669849|468805871|FG001|Overall Study|Death|1|||
130229326|NCT02669849|468805872|FG002|Overall Study|Death|2|||
130229327|NCT02669849|468805870|FG000|Overall Study|Study terminated by sponsor|16|||
130229328|NCT02669849|468805871|FG001|Overall Study|Study terminated by sponsor|1|||
130229329|NCT02669849|468805872|FG002|Overall Study|Study terminated by sponsor|14|||
130229330|NCT02669849|468805870|FG000|Overall Study|Other|0|||
130691579|NCT01648582|470495918|FG002|Overall Study|Lost to Follow-up|8|||
130691580|NCT01648582|470495916|FG000|Overall Study|Protocol Violation|1|||
130691581|NCT01648582|470495917|FG001|Overall Study|Protocol Violation|2|||
130229331|NCT02669849|468805871|FG001|Overall Study|Other|0|||
130229332|NCT02669849|468805872|FG002|Overall Study|Other|2|||
130229333|NCT03408899|468805873|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
130229334|NCT00606008|468805874|FG000|Overall Study|Adverse Event|1|||
130229335|NCT00606008|468805874|FG000|Overall Study|Withdrawal by Subject|4|||
130356224|NCT00401531|469276265|FG001|Overall Study|Lost to Follow-up|1|||
130356225|NCT00401531|469276264|FG000|Overall Study|Withdrawal by Subject|3|||
130356226|NCT00401531|469276265|FG001|Overall Study|Withdrawal by Subject|2|||
130356227|NCT03875118|469276266|FG000|Overall Study|Withdrawal by Subject|4|||
130356228|NCT03875118|469276267|FG001|Overall Study|Withdrawal by Subject|4|||
130356229|NCT03956056|469276268|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
130691582|NCT01648582|470495918|FG002|Overall Study|Protocol Violation|1|||
130691583|NCT01648582|470495916|FG000|Overall Study|Withdrawal by Subject|15|||
130691584|NCT01648582|470495917|FG001|Overall Study|Withdrawal by Subject|17|||
130691585|NCT01648582|470495918|FG002|Overall Study|Withdrawal by Subject|17|||
130691586|NCT01648582|470495916|FG000|Overall Study|Physician Decision|0|||
130691587|NCT01648582|470495917|FG001|Overall Study|Physician Decision|1|||
130691588|NCT01648582|470495918|FG002|Overall Study|Physician Decision|3|||
130691589|NCT01648582|470495916|FG000|Overall Study|Death|1|||
130691590|NCT01648582|470495917|FG001|Overall Study|Death|0|||
130691591|NCT01648582|470495918|FG002|Overall Study|Death|0|||
130691592|NCT01648582|470495916|FG000|Overall Study|Sponsor Decision|0|||
130691593|NCT01648582|470495917|FG001|Overall Study|Sponsor Decision|1|||
130691594|NCT01648582|470495918|FG002|Overall Study|Sponsor Decision|1|||
130691595|NCT02699866|470495919|FG000|Overall Study|Withdrawal by Subject|3|||
130691596|NCT02699866|470495919|FG000|Overall Study|Physician Decision|2|||
130691597|NCT02699866|470495919|FG000|Overall Study|Adverse Event|3|||
130691598|NCT03276754|470495920|FG000|Overall Study|Withdrawal of informed consent|4|||
130691599|NCT03276754|470495920|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
130691600|NCT03276754|470495920|FG000|Overall Study|Lost to Follow-up|27|||
130691601|NCT03276754|470495920|FG000|Overall Study|No data reported at Month 24|31|||
130691602|NCT03276754|470495920|FG000|Overall Study|Death|39|||
130691603|NCT03437265|470495921|FG000|Overall Study|Protocol Violation|6|||
130691604|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
130691605|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
130691606|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
130691607|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
130691608|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
130691609|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
130691610|NCT00316277|470495923|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
130691611|NCT00316277|470495924|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
130691612|NCT00316277|470495923|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
130691613|NCT00316277|470495924|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
130691614|NCT00835263|470495933|FG000|Second Intervention|Adverse Event|1|||
130691615|NCT00835263|470495934|FG001|Second Intervention|Adverse Event|0|||
130691616|NCT00848536|470495935|FG000|Overall Study|Adverse Event|2|||
130691617|NCT00848536|470495936|FG001|Overall Study|Adverse Event|2|||
130691618|NCT00848536|470495935|FG000|Overall Study|Withdrawal by Subject|0|||
130691619|NCT00848536|470495936|FG001|Overall Study|Withdrawal by Subject|1|||
130691620|NCT00848536|470495935|FG000|Overall Study|Protocol Violation|0|||
130691621|NCT00848536|470495936|FG001|Overall Study|Protocol Violation|1|||
130691622|NCT00848536|470495935|FG000|Overall Study|Noncompliance|1|||
130691623|NCT00848536|470495936|FG001|Overall Study|Noncompliance|0|||
130691624|NCT00848536|470495935|FG000|Overall Study|Inadequate Control of IOP|1|||
130691625|NCT00848536|470495936|FG001|Overall Study|Inadequate Control of IOP|1|||
130691626|NCT00848536|470495935|FG000|Overall Study|Patient Moved|0|||
130691627|NCT00848536|470495936|FG001|Overall Study|Patient Moved|2|||
130691628|NCT03249454|470495937|FG000|Overall Study|Withdrawal by Subject|0|||
130691629|NCT03249454|470495938|FG001|Overall Study|Withdrawal by Subject|0|||
130691630|NCT03249454|470495939|FG002|Overall Study|Withdrawal by Subject|0|||
130691631|NCT03249454|470495940|FG003|Overall Study|Withdrawal by Subject|0|||
130691632|NCT03249454|470495941|FG004|Overall Study|Withdrawal by Subject|0|||
130691633|NCT03249454|470495942|FG005|Overall Study|Withdrawal by Subject|0|||
130691634|NCT03249454|470495943|FG006|Overall Study|Withdrawal by Subject|0|||
130691635|NCT03249454|470495944|FG007|Overall Study|Withdrawal by Subject|0|||
130691636|NCT03249454|470495945|FG008|Overall Study|Withdrawal by Subject|0|||
130691637|NCT03249454|470495946|FG009|Overall Study|Withdrawal by Subject|1|||
130691638|NCT03249454|470495947|FG010|Overall Study|Withdrawal by Subject|1|||
130356230|NCT03956056|469276268|FG000|Overall Study|Lack of Efficacy|1|||
130356231|NCT03403374|469276269|FG000|Overall Study|Lost to Follow-up|1|||
130356232|NCT01298531|469276270|FG000|Overall Study|Lack of Efficacy|0|||
130356233|NCT01298531|469276271|FG001|Overall Study|Lack of Efficacy|1|||
130691639|NCT01913405|470495948|FG000|Overall Study|Withdrawal by Subject|1|||
130691640|NCT01913405|470495948|FG000|Overall Study|Adverse Event|1|||
130691641|NCT03987191|470495951|FG000|Overall Study|COVID-19 related research disruption|0|||
130691642|NCT03987191|470495952|FG001|Overall Study|COVID-19 related research disruption|2|||
130691643|NCT03261167|470495953|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
130691644|NCT03261167|470495954|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
130356234|NCT01298531|469276270|FG000|Overall Study|Lost to Follow-up|2|||
130356235|NCT01298531|469276271|FG001|Overall Study|Lost to Follow-up|0|||
130356236|NCT01298531|469276270|FG000|Overall Study|Protocol Violation|1|||
130229336|NCT02014272|468805878|FG000|Intervention Period 1|Withdrawal by Subject|1|||
130229337|NCT02014272|468805879|FG001|Intervention Period 1|Withdrawal by Subject|0|||
130229338|NCT02014272|468805878|FG000|Intervention Period 1|Adverse Event|0|||
130229339|NCT02014272|468805879|FG001|Intervention Period 1|Adverse Event|1|||
130229340|NCT03499795|468805880|FG000|Overall Study|Adverse Event|1|||
130229341|NCT03499795|468805880|FG000|Overall Study|Lost to Follow-up|1|||
130229342|NCT03636256|468805881|FG000|Overall Study|Lost to Follow-up|3|||
130229343|NCT03636256|468805882|FG001|Overall Study|Lost to Follow-up|0|||
130229344|NCT03636256|468805883|FG002|Overall Study|Lost to Follow-up|2|||
130229345|NCT03636256|468805884|FG003|Overall Study|Lost to Follow-up|1|||
130229346|NCT03636256|468805885|FG004|Overall Study|Lost to Follow-up|0|||
130229347|NCT03636256|468805886|FG005|Overall Study|Lost to Follow-up|4|||
130229348|NCT03636256|468805887|FG006|Overall Study|Lost to Follow-up|2|||
130229349|NCT03636256|468805888|FG007|Overall Study|Lost to Follow-up|0|||
130229350|NCT03636256|468805889|FG008|Overall Study|Lost to Follow-up|4|||
130229351|NCT03636256|468805881|FG000|Overall Study|Withdrawal by Subject|0|||
130229352|NCT03636256|468805882|FG001|Overall Study|Withdrawal by Subject|0|||
130229353|NCT03636256|468805883|FG002|Overall Study|Withdrawal by Subject|0|||
130229354|NCT03636256|468805884|FG003|Overall Study|Withdrawal by Subject|0|||
130229355|NCT03636256|468805885|FG004|Overall Study|Withdrawal by Subject|0|||
130229356|NCT03636256|468805886|FG005|Overall Study|Withdrawal by Subject|0|||
130229357|NCT03636256|468805887|FG006|Overall Study|Withdrawal by Subject|0|||
130229358|NCT03636256|468805888|FG007|Overall Study|Withdrawal by Subject|0|||
130229359|NCT03636256|468805889|FG008|Overall Study|Withdrawal by Subject|1|||
130229360|NCT01218308|468805892|FG000|Overall Study|Adverse Event|1|||
130229361|NCT01218308|468805893|FG001|Overall Study|Adverse Event|2|||
130229362|NCT01218308|468805892|FG000|Overall Study|Protocol Violation|0|||
130229363|NCT01218308|468805893|FG001|Overall Study|Protocol Violation|2|||
130229364|NCT01218308|468805892|FG000|Overall Study|Withdrawal by Subject|61|||
130229365|NCT01218308|468805893|FG001|Overall Study|Withdrawal by Subject|64|||
130229366|NCT01218308|468805892|FG000|Overall Study|Lost to Follow-up|27|||
130229367|NCT01218308|468805893|FG001|Overall Study|Lost to Follow-up|31|||
130229368|NCT01218308|468805892|FG000|Overall Study|Other|14|||
130229369|NCT01218308|468805893|FG001|Overall Study|Other|21|||
130229370|NCT00547339|468805896|FG000|Overall Study|Physician Decision|0|||
130229371|NCT00547339|468805897|FG001|Overall Study|Physician Decision|0|||
130229372|NCT00547339|468805898|FG002|Overall Study|Physician Decision|1|||
130229373|NCT00547339|468805899|FG003|Overall Study|Physician Decision|0|||
130229374|NCT01516216|468805900|FG000|Overall Study|Adverse Event|2|||
130229375|NCT01516216|468805901|FG001|Overall Study|Adverse Event|4|||
130229376|NCT01516216|468805900|FG000|Overall Study|Disease Progression|38|||
130229377|NCT01516216|468805901|FG001|Overall Study|Disease Progression|34|||
130229378|NCT01516216|468805900|FG000|Overall Study|Withdrawal by Subject|9|||
130229379|NCT01516216|468805901|FG001|Overall Study|Withdrawal by Subject|11|||
130229380|NCT01516216|468805900|FG000|Overall Study|Potentially Curative Resection|6|||
130229381|NCT01516216|468805901|FG001|Overall Study|Potentially Curative Resection|12|||
130229382|NCT01516216|468805900|FG000|Overall Study|Nonadherence|2|||
130229383|NCT01516216|468805901|FG001|Overall Study|Nonadherence|3|||
130229384|NCT01516216|468805900|FG000|Overall Study|Physician Decision|6|||
130229385|NCT01516216|468805901|FG001|Overall Study|Physician Decision|3|||
130229386|NCT01516216|468805900|FG000|Overall Study|Prolonged Treatment Delay|5|||
130229387|NCT01516216|468805901|FG001|Overall Study|Prolonged Treatment Delay|1|||
130356237|NCT01298531|469276271|FG001|Overall Study|Protocol Violation|1|||
130356238|NCT01298531|469276270|FG000|Overall Study|Adverse Event|4|||
130356239|NCT01298531|469276271|FG001|Overall Study|Adverse Event|3|||
130356240|NCT01298531|469276270|FG000|Overall Study|Does not meet entrance criteria|0|||
130356241|NCT01298531|469276271|FG001|Overall Study|Does not meet entrance criteria|1|||
130356242|NCT01298531|469276270|FG000|Overall Study|Other|2|||
130356243|NCT01298531|469276271|FG001|Overall Study|Other|1|||
130356244|NCT02360995|469276272|FG000|Overall Study|Lost to Follow-up|2|||
130356245|NCT02360995|469276273|FG001|Overall Study|Lost to Follow-up|0|||
130356246|NCT02360995|469276274|FG002|Overall Study|Lost to Follow-up|2|||
130356247|NCT02360995|469276272|FG000|Overall Study|Withdrawal by Subject|0|||
130356248|NCT02360995|469276273|FG001|Overall Study|Withdrawal by Subject|1|||
130356249|NCT02360995|469276274|FG002|Overall Study|Withdrawal by Subject|0|||
130356250|NCT02611960|469276275|FG000|Overall Study|Adverse Event|7|||
130356251|NCT02611960|469276276|FG001|Overall Study|Adverse Event|8|||
130229388|NCT01516216|468805900|FG000|Overall Study|Intercurrent Illness|1|||
130356252|NCT02611960|469276275|FG000|Overall Study|Death|98|||
130356253|NCT02611960|469276276|FG001|Overall Study|Death|92|||
130356254|NCT02611960|469276275|FG000|Overall Study|Withdrawal by Subject|1|||
130229389|NCT01516216|468805901|FG001|Overall Study|Intercurrent Illness|0|||
130229390|NCT01516216|468805900|FG000|Overall Study|Death|1|||
130229391|NCT01516216|468805901|FG001|Overall Study|Death|1|||
130229392|NCT01458587|468805902|FG000|Overall Study|Withdrawal by Subject|1|||
130229393|NCT01458587|468805903|FG001|Overall Study|Withdrawal by Subject|0|||
130445053|NCT02269943|469590350|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
130229394|NCT01603602|468805904|FG000|Overall Study|Adverse Event|1|||
130229395|NCT01603602|468805905|FG001|Overall Study|Adverse Event|0|||
130229396|NCT01603602|468805906|FG002|Overall Study|Adverse Event|0|||
130229397|NCT01603602|468805904|FG000|Overall Study|Personal Reasons|1|||
130229398|NCT01603602|468805905|FG001|Overall Study|Personal Reasons|0|||
130229399|NCT01603602|468805906|FG002|Overall Study|Personal Reasons|1|||
130229400|NCT01079780|468805907|FG000|Overall Study|Disease progression|43|||
130229401|NCT01079780|468805908|FG001|Overall Study|Disease progression|7|||
130229402|NCT01079780|468805909|FG002|Overall Study|Disease progression|31|||
130229403|NCT01079780|468805907|FG000|Overall Study|Adverse Event|13|||
130229404|NCT01079780|468805908|FG001|Overall Study|Adverse Event|5|||
130229405|NCT01079780|468805909|FG002|Overall Study|Adverse Event|7|||
130229406|NCT01079780|468805907|FG000|Overall Study|Death|2|||
130229407|NCT01079780|468805908|FG001|Overall Study|Death|0|||
130229408|NCT01079780|468805909|FG002|Overall Study|Death|2|||
130229409|NCT01079780|468805907|FG000|Overall Study|Withdrawal by Subject|6|||
130229410|NCT01079780|468805908|FG001|Overall Study|Withdrawal by Subject|4|||
130229411|NCT01079780|468805909|FG002|Overall Study|Withdrawal by Subject|4|||
130229412|NCT01079780|468805907|FG000|Overall Study|Alternative therapy|2|||
130229413|NCT01079780|468805908|FG001|Overall Study|Alternative therapy|0|||
130229414|NCT01079780|468805909|FG002|Overall Study|Alternative therapy|2|||
130229415|NCT01079780|468805907|FG000|Overall Study|Physician Decision|1|||
130229416|NCT01079780|468805908|FG001|Overall Study|Physician Decision|0|||
130229417|NCT01079780|468805909|FG002|Overall Study|Physician Decision|1|||
130229418|NCT01079780|468805907|FG000|Overall Study|Error made in lesion measurement|1|||
130229419|NCT01079780|468805908|FG001|Overall Study|Error made in lesion measurement|0|||
130229420|NCT01079780|468805909|FG002|Overall Study|Error made in lesion measurement|0|||
130229421|NCT01079780|468805907|FG000|Overall Study|Patient had surgery|1|||
130229422|NCT01079780|468805908|FG001|Overall Study|Patient had surgery|0|||
130229423|NCT01079780|468805909|FG002|Overall Study|Patient had surgery|0|||
130229424|NCT01079780|468805907|FG000|Overall Study|Treatment cycle delay|0|||
130229425|NCT01079780|468805908|FG001|Overall Study|Treatment cycle delay|0|||
130229426|NCT01079780|468805909|FG002|Overall Study|Treatment cycle delay|1|||
130229427|NCT01079780|468805907|FG000|Overall Study|Never started treatment|1|||
130229428|NCT01079780|468805908|FG001|Overall Study|Never started treatment|0|||
130229429|NCT01079780|468805909|FG002|Overall Study|Never started treatment|2|||
130229430|NCT02783066|468805910|FG000|Overall Study|Withdrawal by Subject|13|||
130229431|NCT05379920|468805915|FG000|Overall Study|Lost to Follow-up|0|||
130229432|NCT05379920|468805916|FG001|Overall Study|Lost to Follow-up|5|||
130229433|NCT05379920|468805917|FG002|Overall Study|Lost to Follow-up|0|||
130229434|NCT05379920|468805918|FG003|Overall Study|Lost to Follow-up|0|||
130229435|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
130229436|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
130229437|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
130229438|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130229439|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130229440|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229441|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
130229442|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229443|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229444|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130356255|NCT02611960|469276276|FG001|Overall Study|Withdrawal by Subject|5|||
130356256|NCT02611960|469276275|FG000|Overall Study|Sponsor Decision|11|||
130356257|NCT02611960|469276276|FG001|Overall Study|Sponsor Decision|11|||
130356258|NCT02395666|469276277|FG000|Overall Study|Physician Decision|3|||
130356259|NCT02395666|469276278|FG001|Overall Study|Physician Decision|0|||
130356260|NCT02395666|469276277|FG000|Overall Study|Lost to Follow-up|1|||
130356261|NCT02395666|469276278|FG001|Overall Study|Lost to Follow-up|0|||
130356262|NCT02395666|469276277|FG000|Overall Study|Withdrawal by Subject|2|||
130356263|NCT02395666|469276278|FG001|Overall Study|Withdrawal by Subject|1|||
130356264|NCT01409434|469276279|FG000|Overall Study|Protocol Violation|4|||
130356265|NCT02213042|469276282|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
130356266|NCT02213042|469276283|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
130356267|NCT02213042|469276284|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
130356268|NCT02213042|469276282|FG000|Overall Study|Adverse Event|2|||
130356269|NCT02213042|469276283|FG001|Overall Study|Adverse Event|1|||
130356270|NCT02213042|469276284|FG002|Overall Study|Adverse Event|0|||
130356271|NCT02213042|469276282|FG000|Overall Study|Withdrawal by Subject|0|||
130356272|NCT02213042|469276283|FG001|Overall Study|Withdrawal by Subject|1|||
130229445|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
130229446|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
130229447|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
130229448|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130229449|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130229450|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130356273|NCT02213042|469276284|FG002|Overall Study|Withdrawal by Subject|1|||
130229451|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229452|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
130229453|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229454|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229455|NCT03176771|468805919|FG000|Double-Blind Extension Period|Adverse Event|0|||
130229456|NCT03176771|468805920|FG001|Double-Blind Extension Period|Adverse Event|0|||
130229457|NCT03176771|468805921|FG002|Double-Blind Extension Period|Adverse Event|0|||
130229458|NCT03176771|468805922|FG003|Double-Blind Extension Period|Adverse Event|15|||
130229459|NCT03176771|468805923|FG004|Double-Blind Extension Period|Adverse Event|18|||
130229460|NCT03176771|468805919|FG000|Double-Blind Extension Period|Death|0|||
130229461|NCT03176771|468805920|FG001|Double-Blind Extension Period|Death|0|||
130229462|NCT03176771|468805921|FG002|Double-Blind Extension Period|Death|0|||
130229463|NCT03176771|468805922|FG003|Double-Blind Extension Period|Death|3|||
130229464|NCT03176771|468805923|FG004|Double-Blind Extension Period|Death|4|||
130229465|NCT03176771|468805919|FG000|Double-Blind Extension Period|Physician Decision|0|||
130229466|NCT03176771|468805920|FG001|Double-Blind Extension Period|Physician Decision|0|||
130229467|NCT03176771|468805921|FG002|Double-Blind Extension Period|Physician Decision|0|||
130229468|NCT03176771|468805922|FG003|Double-Blind Extension Period|Physician Decision|3|||
130229469|NCT03176771|468805923|FG004|Double-Blind Extension Period|Physician Decision|1|||
130229470|NCT03176771|468805919|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229471|NCT03176771|468805920|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229472|NCT03176771|468805921|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229473|NCT03176771|468805922|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
130229474|NCT03176771|468805923|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
130229475|NCT03530293|468805924|FG000|Pre-randomization|Adverse Event|12|||
130229476|NCT03530293|468805925|FG001|Pre-randomization|Adverse Event|0|||
130229477|NCT03530293|468805926|FG002|Pre-randomization|Adverse Event|0|||
130229478|NCT03530293|468805924|FG000|Pre-randomization|Protocol Violation|2|||
130229479|NCT03530293|468805925|FG001|Pre-randomization|Protocol Violation|0|||
130229480|NCT03530293|468805926|FG002|Pre-randomization|Protocol Violation|0|||
130229481|NCT03530293|468805924|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
130229482|NCT03530293|468805925|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
130229483|NCT03530293|468805926|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
130229484|NCT03530293|468805924|FG000|Pre-randomization|Withdrawal by Subject|5|||
130229485|NCT03530293|468805925|FG001|Pre-randomization|Withdrawal by Subject|0|||
130229486|NCT03530293|468805926|FG002|Pre-randomization|Withdrawal by Subject|0|||
130229487|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
130229488|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
130229489|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
130229490|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130229491|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130229492|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
130229493|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
130229494|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
130229495|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
130229496|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130229497|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
130229498|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130229499|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
130229500|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130229501|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130229502|NCT02732639|468805928|FG000|Overall Study|Lost to Follow-up|1|||
130229503|NCT02265510|468805931|FG000|Overall Study|Withdrawal by Subject|1|||
130229504|NCT02265510|468805932|FG001|Overall Study|Withdrawal by Subject|1|||
130229505|NCT02265510|468805933|FG002|Overall Study|Withdrawal by Subject|2|||
130229506|NCT02265510|468805934|FG003|Overall Study|Withdrawal by Subject|1|||
130229507|NCT02265510|468805935|FG004|Overall Study|Withdrawal by Subject|0|||
130229508|NCT02265510|468805936|FG005|Overall Study|Withdrawal by Subject|2|||
130229509|NCT02265510|468805937|FG006|Overall Study|Withdrawal by Subject|0|||
130229510|NCT02265510|468805938|FG007|Overall Study|Withdrawal by Subject|2|||
130229511|NCT02265510|468805939|FG008|Overall Study|Withdrawal by Subject|0|||
130229512|NCT02265510|468805940|FG009|Overall Study|Withdrawal by Subject|0|||
130229513|NCT02265510|468805941|FG010|Overall Study|Withdrawal by Subject|0|||
130229514|NCT02265510|468805942|FG011|Overall Study|Withdrawal by Subject|0|||
130229515|NCT02265510|468805943|FG012|Overall Study|Withdrawal by Subject|1|||
130229516|NCT02265510|468805944|FG013|Overall Study|Withdrawal by Subject|0|||
130229517|NCT02265510|468805931|FG000|Overall Study|Disease Progression|0|||
130229518|NCT02265510|468805932|FG001|Overall Study|Disease Progression|1|||
130229519|NCT02265510|468805933|FG002|Overall Study|Disease Progression|2|||
130229520|NCT02265510|468805934|FG003|Overall Study|Disease Progression|1|||
130229521|NCT02265510|468805935|FG004|Overall Study|Disease Progression|1|||
130229522|NCT02265510|468805936|FG005|Overall Study|Disease Progression|0|||
130229523|NCT02265510|468805937|FG006|Overall Study|Disease Progression|0|||
130229524|NCT02265510|468805938|FG007|Overall Study|Disease Progression|0|||
130229525|NCT02265510|468805939|FG008|Overall Study|Disease Progression|0|||
130229526|NCT02265510|468805940|FG009|Overall Study|Disease Progression|0|||
130229527|NCT02265510|468805941|FG010|Overall Study|Disease Progression|0|||
130229528|NCT02265510|468805942|FG011|Overall Study|Disease Progression|0|||
130229529|NCT02265510|468805943|FG012|Overall Study|Disease Progression|0|||
130229530|NCT02265510|468805944|FG013|Overall Study|Disease Progression|0|||
130229531|NCT02265510|468805931|FG000|Overall Study|Death|2|||
130229532|NCT02265510|468805932|FG001|Overall Study|Death|0|||
130229533|NCT02265510|468805933|FG002|Overall Study|Death|2|||
130229534|NCT02265510|468805934|FG003|Overall Study|Death|2|||
130229535|NCT02265510|468805935|FG004|Overall Study|Death|1|||
130229536|NCT02265510|468805936|FG005|Overall Study|Death|3|||
130229537|NCT02265510|468805937|FG006|Overall Study|Death|2|||
130229538|NCT02265510|468805938|FG007|Overall Study|Death|1|||
130229539|NCT02265510|468805939|FG008|Overall Study|Death|3|||
130229540|NCT02265510|468805940|FG009|Overall Study|Death|3|||
130229541|NCT02265510|468805941|FG010|Overall Study|Death|4|||
130229542|NCT02265510|468805942|FG011|Overall Study|Death|12|||
130229543|NCT02265510|468805943|FG012|Overall Study|Death|7|||
130229544|NCT02265510|468805944|FG013|Overall Study|Death|6|||
130229545|NCT02265510|468805931|FG000|Overall Study|Lost to Follow-up|0|||
130229546|NCT02265510|468805932|FG001|Overall Study|Lost to Follow-up|0|||
130229547|NCT02265510|468805933|FG002|Overall Study|Lost to Follow-up|0|||
130229548|NCT02265510|468805934|FG003|Overall Study|Lost to Follow-up|0|||
130229549|NCT02265510|468805935|FG004|Overall Study|Lost to Follow-up|1|||
130229550|NCT02265510|468805936|FG005|Overall Study|Lost to Follow-up|0|||
130229551|NCT02265510|468805937|FG006|Overall Study|Lost to Follow-up|0|||
130229552|NCT02265510|468805938|FG007|Overall Study|Lost to Follow-up|0|||
130229553|NCT02265510|468805939|FG008|Overall Study|Lost to Follow-up|0|||
130229554|NCT02265510|468805940|FG009|Overall Study|Lost to Follow-up|2|||
130229555|NCT02265510|468805941|FG010|Overall Study|Lost to Follow-up|0|||
130229556|NCT02265510|468805942|FG011|Overall Study|Lost to Follow-up|0|||
130229557|NCT02265510|468805943|FG012|Overall Study|Lost to Follow-up|0|||
130229558|NCT02265510|468805944|FG013|Overall Study|Lost to Follow-up|2|||
130229559|NCT02265510|468805931|FG000|Overall Study|Other|0|||
130229560|NCT02265510|468805932|FG001|Overall Study|Other|1|||
130229561|NCT02265510|468805933|FG002|Overall Study|Other|0|||
130229562|NCT02265510|468805934|FG003|Overall Study|Other|0|||
130229563|NCT02265510|468805935|FG004|Overall Study|Other|0|||
130229564|NCT02265510|468805936|FG005|Overall Study|Other|0|||
130229565|NCT02265510|468805937|FG006|Overall Study|Other|0|||
130229566|NCT02265510|468805938|FG007|Overall Study|Other|0|||
130229567|NCT02265510|468805939|FG008|Overall Study|Other|0|||
130229568|NCT02265510|468805940|FG009|Overall Study|Other|0|||
130229569|NCT02265510|468805941|FG010|Overall Study|Other|0|||
130229570|NCT02265510|468805942|FG011|Overall Study|Other|0|||
130356274|NCT02213042|469276282|FG000|Overall Study|Protocol Violation|1|||
130356275|NCT02213042|469276283|FG001|Overall Study|Protocol Violation|0|||
130356276|NCT02213042|469276284|FG002|Overall Study|Protocol Violation|0|||
130356277|NCT02213042|469276282|FG000|Overall Study|Investigator discretion|0|||
130356278|NCT02213042|469276283|FG001|Overall Study|Investigator discretion|0|||
130356279|NCT02213042|469276284|FG002|Overall Study|Investigator discretion|1|||
130356280|NCT05314478|469276285|FG000|Overall Study|Physician Decision|1|||
130356281|NCT04629508|469276286|FG000|Overall Study|Adverse Event|1|||
130356282|NCT04629508|469276286|FG000|Overall Study|Death|2|||
130356283|NCT04629508|469276286|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
130356284|NCT02476422|469276287|FG000|Overall Study|Subject/guardian decision|0|||
130356285|NCT02476422|469276288|FG001|Overall Study|Subject/guardian decision|1|||
130356286|NCT00760214|469276290|FG000|Overall Study|Adverse Event|8|||
130356287|NCT00760214|469276291|FG001|Overall Study|Adverse Event|9|||
130356288|NCT00760214|469276292|FG002|Overall Study|Adverse Event|12|||
130356289|NCT00760214|469276290|FG000|Overall Study|Protocol Violation|3|||
130356290|NCT00760214|469276291|FG001|Overall Study|Protocol Violation|0|||
130229571|NCT02265510|468805943|FG012|Overall Study|Other|0|||
130229572|NCT02265510|468805944|FG013|Overall Study|Other|0|||
130229573|NCT02265510|468805931|FG000|Overall Study|Study Terminated by Sponsor|0|||
130229574|NCT02265510|468805932|FG001|Overall Study|Study Terminated by Sponsor|0|||
130229575|NCT02265510|468805933|FG002|Overall Study|Study Terminated by Sponsor|0|||
130229576|NCT02265510|468805934|FG003|Overall Study|Study Terminated by Sponsor|0|||
130229577|NCT02265510|468805935|FG004|Overall Study|Study Terminated by Sponsor|0|||
130229578|NCT02265510|468805936|FG005|Overall Study|Study Terminated by Sponsor|1|||
130229579|NCT02265510|468805937|FG006|Overall Study|Study Terminated by Sponsor|1|||
130229580|NCT02265510|468805938|FG007|Overall Study|Study Terminated by Sponsor|1|||
130356291|NCT00760214|469276292|FG002|Overall Study|Protocol Violation|3|||
130229581|NCT02265510|468805939|FG008|Overall Study|Study Terminated by Sponsor|1|||
130229582|NCT02265510|468805940|FG009|Overall Study|Study Terminated by Sponsor|2|||
130229583|NCT02265510|468805941|FG010|Overall Study|Study Terminated by Sponsor|1|||
130229584|NCT02265510|468805942|FG011|Overall Study|Study Terminated by Sponsor|4|||
130229585|NCT02265510|468805943|FG012|Overall Study|Study Terminated by Sponsor|1|||
130229586|NCT02265510|468805944|FG013|Overall Study|Study Terminated by Sponsor|2|||
130229587|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
130229588|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229589|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229590|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229591|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
130229592|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229593|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229594|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229595|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
130229596|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
130229597|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
130229598|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
130229599|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
130229600|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229601|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229602|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229603|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
130229604|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
130229605|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
130229606|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
130229607|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
130229608|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229609|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229610|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229611|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
130229612|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229613|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229614|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229615|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
130229616|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229617|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229618|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229619|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229620|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
130229621|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229622|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229623|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229624|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
130229625|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229626|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229627|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
130229628|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
130229629|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
130229630|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
130229631|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229632|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
130229633|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229634|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229635|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
130229636|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
130229637|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
130356292|NCT00760214|469276290|FG000|Overall Study|Lost to Follow-up|0|||
130356293|NCT00760214|469276291|FG001|Overall Study|Lost to Follow-up|0|||
130356294|NCT00760214|469276292|FG002|Overall Study|Lost to Follow-up|1|||
130356295|NCT00760214|469276290|FG000|Overall Study|Withdrawal by Subject|12|||
130356296|NCT00760214|469276291|FG001|Overall Study|Withdrawal by Subject|14|||
130356297|NCT00760214|469276292|FG002|Overall Study|Withdrawal by Subject|13|||
130356298|NCT00760214|469276290|FG000|Overall Study|Lack of Efficacy|3|||
130356299|NCT00760214|469276291|FG001|Overall Study|Lack of Efficacy|2|||
130356300|NCT00760214|469276292|FG002|Overall Study|Lack of Efficacy|4|||
130356301|NCT00760214|469276290|FG000|Overall Study|Pregnancy|0|||
130229638|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
130229639|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130229640|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
130356302|NCT00760214|469276291|FG001|Overall Study|Pregnancy|0|||
130356303|NCT00760214|469276292|FG002|Overall Study|Pregnancy|1|||
130229641|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130356304|NCT00760214|469276290|FG000|Overall Study|Physician Decision|1|||
130229642|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130229643|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229644|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
130229645|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229646|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229647|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229648|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
130229649|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229650|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229651|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130229652|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130229653|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
130229654|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
130229655|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130229656|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130229657|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130229658|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130229659|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130229660|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130229661|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
130229662|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
130229663|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130229664|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130229665|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
130229666|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
130229667|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229668|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229669|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
130229670|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229671|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130229672|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130229673|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
130229674|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
130229675|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130229676|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130229677|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
130229678|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
130229679|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130229680|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130229681|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
130229682|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
130445054|NCT02269943|469590349|FG000|Follow-Up Survival Period|Alive|2|||
130445055|NCT02269943|469590350|FG001|Follow-Up Survival Period|Alive|8|||
130445056|NCT03050398|469590353|FG000|Overall Study|Study terminated by sponsor|8|||
130445057|NCT03018106|469590354|FG000|Overall Study|Lost to Follow-up|0|||
130445058|NCT03018106|469590355|FG001|Overall Study|Lost to Follow-up|1|||
130445059|NCT03055832|469590356|FG000|Week 2|Withdrawal by Subject|1|||
130445060|NCT03055832|469590357|FG001|Week 2|Withdrawal by Subject|0|||
130445061|NCT03619174|469590358|FG000|Overall Study|Lost to Follow-up|3|||
130445062|NCT03619174|469590359|FG001|Overall Study|Lost to Follow-up|0|||
130445063|NCT03619174|469590358|FG000|Overall Study|Withdrawal by Subject|4|||
130445064|NCT03619174|469590359|FG001|Overall Study|Withdrawal by Subject|3|||
130445065|NCT03619174|469590358|FG000|Overall Study|Pregnancy|1|||
130445066|NCT03619174|469590359|FG001|Overall Study|Pregnancy|1|||
130445067|NCT03619174|469590358|FG000|Overall Study|Discomfort during treatment|1|||
130445068|NCT03619174|469590359|FG001|Overall Study|Discomfort during treatment|0|||
130445069|NCT01991197|469590360|FG000|Overall Study|Lost to Follow-up|1|||
130445070|NCT01991197|469590361|FG001|Overall Study|Lost to Follow-up|1|||
130445071|NCT01991197|469590360|FG000|Overall Study|Physician Decision|0|||
130445072|NCT01991197|469590361|FG001|Overall Study|Physician Decision|2|||
130445073|NCT01991197|469590360|FG000|Overall Study|Withdrawal by Subject|2|||
130445074|NCT01991197|469590361|FG001|Overall Study|Withdrawal by Subject|0|||
130445075|NCT01010217|469590362|FG000|Overall Study|Lost to Follow-up|4|||
130552893|NCT03291587|469991623|FG001|Overall Study|Lost to Follow-up|43|||
130445076|NCT01010217|469590363|FG001|Overall Study|Lost to Follow-up|5|||
130445077|NCT01010217|469590364|FG002|Overall Study|Lost to Follow-up|1|||
130445078|NCT01010217|469590365|FG003|Overall Study|Lost to Follow-up|0|||
130229683|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130229684|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130229685|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
130229686|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
130229687|NCT01004614|468805949|FG000|Washout|Withdrawal by Subject|0|||
130229688|NCT01004614|468805950|FG001|Washout|Withdrawal by Subject|1|||
130229689|NCT01004614|468805951|FG002|Washout|Withdrawal by Subject|0|||
130229690|NCT01004614|468805952|FG003|Washout|Withdrawal by Subject|0|||
130229691|NCT02530385|468805953|FG000|Overall Study|Withdrawal by Subject|0|||
130229692|NCT02530385|468805954|FG001|Overall Study|Withdrawal by Subject|1|||
130229693|NCT01569022|468805956|FG000|First Intervention|Lost to Follow-up|2|||
130229694|NCT01569022|468805957|FG001|First Intervention|Lost to Follow-up|1|||
130229695|NCT01569022|468805956|FG000|Second Intervention|Lost to Follow-up|2|||
130229696|NCT01569022|468805957|FG001|Second Intervention|Lost to Follow-up|2|||
130229697|NCT02111083|468805962|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130229698|NCT02111083|468805963|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130229699|NCT00116142|468805964|FG000|Overall Study|Adverse Event|8|||
130229700|NCT00116142|468805965|FG001|Overall Study|Adverse Event|7|||
130229701|NCT00116142|468805964|FG000|Overall Study|Protocol Violation|2|||
130229702|NCT00116142|468805965|FG001|Overall Study|Protocol Violation|1|||
130229703|NCT00116142|468805964|FG000|Overall Study|Withdrawal by Subject|5|||
130229704|NCT00116142|468805965|FG001|Overall Study|Withdrawal by Subject|5|||
130229705|NCT00116142|468805964|FG000|Overall Study|Physician Decision|3|||
130229706|NCT00116142|468805965|FG001|Overall Study|Physician Decision|1|||
130229707|NCT00116142|468805964|FG000|Overall Study|Delayed Radiation Therapy|1|||
130229708|NCT00116142|468805965|FG001|Overall Study|Delayed Radiation Therapy|0|||
130229709|NCT00116142|468805964|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
130229710|NCT00116142|468805965|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
130229711|NCT00116142|468805964|FG000|Overall Study|Patient stopped due to depression|0|||
130229712|NCT00116142|468805965|FG001|Overall Study|Patient stopped due to depression|1|||
130229713|NCT00116142|468805964|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
130229714|NCT00116142|468805965|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
130229715|NCT00116142|468805964|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
130229716|NCT00116142|468805965|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
130229717|NCT00116142|468805964|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
130229718|NCT00116142|468805965|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
130229719|NCT00433836|468805966|FG000|Overall Study|Adverse Event|7|||
130229720|NCT00433836|468805967|FG001|Overall Study|Adverse Event|0|||
130229721|NCT00433836|468805966|FG000|Overall Study|Lost to Follow-up|3|||
130229722|NCT00433836|468805967|FG001|Overall Study|Lost to Follow-up|0|||
130229723|NCT00433836|468805966|FG000|Overall Study|Withdrawal by Subject|2|||
130229724|NCT00433836|468805967|FG001|Overall Study|Withdrawal by Subject|1|||
130229725|NCT00433836|468805966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130229726|NCT00433836|468805967|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130229727|NCT00433836|468805966|FG000|Overall Study|Protocol Violation|0|||
130229728|NCT00433836|468805967|FG001|Overall Study|Protocol Violation|2|||
130229729|NCT00433836|468805966|FG000|Overall Study|Condition no longer requires study drug|0|||
130229730|NCT00433836|468805967|FG001|Overall Study|Condition no longer requires study drug|1|||
130229731|NCT00433836|468805966|FG000|Overall Study|Abnormal laboratory values|0|||
130229732|NCT00433836|468805967|FG001|Overall Study|Abnormal laboratory values|1|||
130229733|NCT00644059|468805968|FG000|Overall Study|Lost to Follow-up|37|||
130229734|NCT00644059|468805969|FG001|Overall Study|Lost to Follow-up|34|||
130229735|NCT00644059|468805970|FG002|Overall Study|Lost to Follow-up|16|||
130229736|NCT00644059|468805968|FG000|Overall Study|Withdrawal by Subject|52|||
130229737|NCT00644059|468805969|FG001|Overall Study|Withdrawal by Subject|60|||
130229738|NCT00644059|468805970|FG002|Overall Study|Withdrawal by Subject|30|||
130229739|NCT00644059|468805968|FG000|Overall Study|Adverse Event|8|||
130229740|NCT00644059|468805969|FG001|Overall Study|Adverse Event|5|||
130229741|NCT00644059|468805970|FG002|Overall Study|Adverse Event|1|||
130356305|NCT00760214|469276291|FG001|Overall Study|Physician Decision|1|||
130356306|NCT00760214|469276292|FG002|Overall Study|Physician Decision|1|||
130356307|NCT00760214|469276290|FG000|Overall Study|Other|3|||
130356308|NCT00760214|469276291|FG001|Overall Study|Other|4|||
130229742|NCT00644059|468805968|FG000|Overall Study|Inappropriate Enrollment|1|||
130229743|NCT00644059|468805969|FG001|Overall Study|Inappropriate Enrollment|3|||
130229744|NCT00644059|468805970|FG002|Overall Study|Inappropriate Enrollment|0|||
130229745|NCT00644059|468805968|FG000|Overall Study|Protocol Deviation/violation|20|||
130229746|NCT00644059|468805969|FG001|Overall Study|Protocol Deviation/violation|19|||
130229747|NCT00644059|468805970|FG002|Overall Study|Protocol Deviation/violation|15|||
130229748|NCT00644059|468805968|FG000|Overall Study|Unable to classify|6|||
130229749|NCT00644059|468805969|FG001|Overall Study|Unable to classify|2|||
130229750|NCT00644059|468805970|FG002|Overall Study|Unable to classify|3|||
130356309|NCT00760214|469276292|FG002|Overall Study|Other|6|||
130229751|NCT02133508|468805971|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
130229752|NCT02133508|468805971|FG000|Overall Study|Death|12|||
130229753|NCT02133508|468805971|FG000|Overall Study|Lost to Follow-up|2|||
130229754|NCT00472420|468805978|FG000|Induction Treatment Period|Physician Decision|9|||
130229755|NCT00472420|468805978|FG000|Induction Treatment Period|Adverse Event|3|||
130229756|NCT00472420|468805978|FG000|Induction Treatment Period|Non-compliance|1|||
130229757|NCT00472420|468805978|FG000|Induction Treatment Period|Death|3|||
130229758|NCT00472420|468805978|FG000|Follow-up Period|Death|5|||
130229759|NCT00472420|468805978|FG000|Follow-up Period|Physician Decision|9|||
130229760|NCT00472420|468805978|FG000|Follow-up Period|Lost to Follow-up|2|||
130229761|NCT00472420|468805978|FG000|Follow-up Period|Protocol Violation|1|||
130229762|NCT01787552|468805984|FG000|Overall Study|Withdrawal by Subject|2|||
130229763|NCT01787552|468805985|FG001|Overall Study|Withdrawal by Subject|0|||
130229764|NCT01787552|468805986|FG002|Overall Study|Withdrawal by Subject|0|||
130229765|NCT01787552|468805987|FG003|Overall Study|Withdrawal by Subject|4|||
130229766|NCT01787552|468805984|FG000|Overall Study|Physician Decision|2|||
130229767|NCT01787552|468805985|FG001|Overall Study|Physician Decision|2|||
130229768|NCT01787552|468805986|FG002|Overall Study|Physician Decision|1|||
130229769|NCT01787552|468805987|FG003|Overall Study|Physician Decision|2|||
130229770|NCT01787552|468805984|FG000|Overall Study|Death|0|||
130229771|NCT01787552|468805985|FG001|Overall Study|Death|0|||
130229772|NCT01787552|468805986|FG002|Overall Study|Death|0|||
130229773|NCT01787552|468805987|FG003|Overall Study|Death|1|||
130229774|NCT01787552|468805984|FG000|Overall Study|Adverse Event|2|||
130229775|NCT01787552|468805985|FG001|Overall Study|Adverse Event|5|||
130229776|NCT01787552|468805986|FG002|Overall Study|Adverse Event|2|||
130229777|NCT01787552|468805987|FG003|Overall Study|Adverse Event|16|||
130229778|NCT01787552|468805984|FG000|Overall Study|Study terminated by Sponsor|0|||
130229779|NCT01787552|468805985|FG001|Overall Study|Study terminated by Sponsor|0|||
130229780|NCT01787552|468805986|FG002|Overall Study|Study terminated by Sponsor|1|||
130229781|NCT01787552|468805987|FG003|Overall Study|Study terminated by Sponsor|3|||
130229782|NCT01787552|468805984|FG000|Overall Study|Progressive Disease|2|||
130229783|NCT01787552|468805985|FG001|Overall Study|Progressive Disease|2|||
130229784|NCT01787552|468805986|FG002|Overall Study|Progressive Disease|1|||
130229785|NCT01787552|468805987|FG003|Overall Study|Progressive Disease|1|||
130229786|NCT04079790|468805989|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
130229787|NCT04079790|468805990|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229788|NCT04079790|468805991|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229789|NCT04079790|468805992|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229790|NCT04079790|468805989|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229791|NCT04079790|468805990|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229792|NCT04079790|468805991|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
130229793|NCT04079790|468805992|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229794|NCT04079790|468805989|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229795|NCT04079790|468805990|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229796|NCT04079790|468805991|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
130229797|NCT04079790|468805992|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229798|NCT00390689|468805993|FG000|Overall Study|Adverse Event|2|||
130229799|NCT00390689|468805994|FG001|Overall Study|Adverse Event|5|||
130229800|NCT00390689|468805995|FG002|Overall Study|Adverse Event|2|||
130229801|NCT00390689|468805993|FG000|Overall Study|Lack of Efficacy|0|||
130229802|NCT00390689|468805994|FG001|Overall Study|Lack of Efficacy|0|||
130229803|NCT00390689|468805995|FG002|Overall Study|Lack of Efficacy|1|||
130229804|NCT00390689|468805993|FG000|Overall Study|Protocol Violation|1|||
130229805|NCT00390689|468805994|FG001|Overall Study|Protocol Violation|0|||
130229806|NCT00390689|468805995|FG002|Overall Study|Protocol Violation|0|||
130229807|NCT00390689|468805993|FG000|Overall Study|Investigator's judgement|2|||
130445079|NCT01010217|469590366|FG004|Overall Study|Lost to Follow-up|0|||
130691645|NCT03261167|470495953|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
130691646|NCT03261167|470495954|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
130691647|NCT03261167|470495953|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
130229808|NCT00390689|468805994|FG001|Overall Study|Investigator's judgement|0|||
130229809|NCT00390689|468805995|FG002|Overall Study|Investigator's judgement|0|||
130229810|NCT01253161|468805996|FG000|Overall Study|Adverse Event|1|||
130229811|NCT01924533|468805998|FG000|Overall Study|Death|181|||
130229812|NCT01924533|468805999|FG001|Overall Study|Death|200|||
130229813|NCT01924533|468805998|FG000|Overall Study|Lost to Follow-up|0|||
130229814|NCT01924533|468805999|FG001|Overall Study|Lost to Follow-up|1|||
130229815|NCT01924533|468805998|FG000|Overall Study|Withdrawal by Subject|7|||
130229816|NCT01924533|468805999|FG001|Overall Study|Withdrawal by Subject|3|||
130229817|NCT01924533|468805998|FG000|Overall Study|Other Eligibility criteria|1|||
130229818|NCT01924533|468805999|FG001|Overall Study|Other Eligibility criteria|1|||
130229819|NCT03307174|468806001|FG000|Overall Study|Unplanned ICU Administrion|5|||
130229820|NCT03307174|468806002|FG001|Overall Study|Unplanned ICU Administrion|3|||
130229821|NCT03307174|468806001|FG000|Overall Study|Aborted Surgery|1|||
130229822|NCT03307174|468806002|FG001|Overall Study|Aborted Surgery|2|||
130229823|NCT03307174|468806001|FG000|Overall Study|Hypotension|6|||
130229824|NCT03307174|468806002|FG001|Overall Study|Hypotension|0|||
130229825|NCT03307174|468806001|FG000|Overall Study|Nonfunctional epidural|1|||
130229826|NCT03307174|468806002|FG001|Overall Study|Nonfunctional epidural|1|||
130229827|NCT03307174|468806001|FG000|Overall Study|Planned epidural removal|1|||
130229828|NCT03307174|468806002|FG001|Overall Study|Planned epidural removal|0|||
130229829|NCT03307174|468806001|FG000|Overall Study|Intrathecal catheter placement|0|||
130229830|NCT03307174|468806002|FG001|Overall Study|Intrathecal catheter placement|1|||
130229831|NCT04275336|468806003|FG000|Overall Study|First venipuncture failed|4|||
130229832|NCT04275336|468806004|FG001|Overall Study|First venipuncture failed|6|||
130229833|NCT04275336|468806005|FG002|Overall Study|First venipuncture failed|5|||
130229834|NCT04275336|468806003|FG000|Overall Study|Unscheduled venipuncture|9|||
130229835|NCT04275336|468806004|FG001|Overall Study|Unscheduled venipuncture|13|||
130229836|NCT04275336|468806005|FG002|Overall Study|Unscheduled venipuncture|7|||
130229837|NCT04275336|468806003|FG000|Overall Study|Failed specimen of saliva|4|||
130229838|NCT04275336|468806004|FG001|Overall Study|Failed specimen of saliva|3|||
130229839|NCT04275336|468806005|FG002|Overall Study|Failed specimen of saliva|4|||
130229840|NCT03055936|468806006|FG000|Overall Study|Adverse Event|0|||
130229841|NCT03055936|468806007|FG001|Overall Study|Adverse Event|1|||
130229842|NCT03055936|468806008|FG002|Overall Study|Adverse Event|1|||
130229843|NCT03055936|468806009|FG003|Overall Study|Adverse Event|1|||
130229844|NCT03055936|468806006|FG000|Overall Study|Personal reason|2|||
130229845|NCT03055936|468806007|FG001|Overall Study|Personal reason|0|||
130229846|NCT03055936|468806008|FG002|Overall Study|Personal reason|1|||
130229847|NCT03055936|468806009|FG003|Overall Study|Personal reason|0|||
130229848|NCT03372798|468806018|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
130229849|NCT03372798|468806019|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
130229850|NCT03372798|468806018|FG000|Overall Study|Failure of imaging probe|0|||
130229851|NCT03372798|468806019|FG001|Overall Study|Failure of imaging probe|1|||
130229852|NCT00721799|468806038|FG000|Overall Study|Withdrawal by Subject|7|||
130229853|NCT00721799|468806038|FG000|Overall Study|withdraw by subject after scan 1|1|||
130229854|NCT03141359|468806039|FG000|Overall Study|Death|32|||
130229855|NCT03141359|468806039|FG000|Overall Study|Still On Study (in follow up)|29|||
130229856|NCT01081626|468806040|FG000|Overall Study|Dosing error|1|||
130229857|NCT01081626|468806041|FG001|Overall Study|Dosing error|1|||
130229858|NCT01081626|468806040|FG000|Overall Study|Missing Estradiol|25|||
130229859|NCT01081626|468806041|FG001|Overall Study|Missing Estradiol|28|||
130229860|NCT01081626|468806040|FG000|Overall Study|Low antral follicle count|1|||
130229861|NCT01081626|468806041|FG001|Overall Study|Low antral follicle count|0|||
130229862|NCT01081626|468806040|FG000|Overall Study|Overstimulation|0|||
130229863|NCT01081626|468806041|FG001|Overall Study|Overstimulation|1|||
130229864|NCT01081626|468806040|FG000|Overall Study|Lost to Follow-up|0|||
130229865|NCT01081626|468806041|FG001|Overall Study|Lost to Follow-up|1|||
130229866|NCT01081626|468806040|FG000|Overall Study|Other|33|||
130229867|NCT01081626|468806041|FG001|Overall Study|Other|30|||
130229868|NCT04158219|468806042|FG000|Overall Study|Lost to Follow-up|1|||
130229869|NCT02074514|468806043|FG000|Overall Study|Lack of Efficacy|3|||
130229870|NCT02074514|468806044|FG001|Overall Study|Lack of Efficacy|2|||
130229871|NCT02074514|468806043|FG000|Overall Study|Lost to Follow-up|0|||
130229872|NCT02074514|468806044|FG001|Overall Study|Lost to Follow-up|1|||
130229873|NCT02074514|468806043|FG000|Overall Study|Withdrew Consent|0|||
130229874|NCT02074514|468806044|FG001|Overall Study|Withdrew Consent|1|||
130229875|NCT02337764|468807349|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
130229876|NCT02337764|468807349|FG000|Overall Study|Voluntary Withdrawal|12|||
130229877|NCT02337764|468807349|FG000|Overall Study|Lack of Efficacy|2|||
130229878|NCT04748718|468807352|FG000|Overall Study|Lost to Follow-up|50|||
130356310|NCT01134315|469276294|FG000|Overall Study|Adverse Event|1|||
130356311|NCT01134315|469276295|FG001|Overall Study|Adverse Event|2|||
130356312|NCT01134315|469276294|FG000|Overall Study|Other Reason|8|||
130356313|NCT01134315|469276295|FG001|Overall Study|Other Reason|17|||
130356314|NCT01086423|469276296|FG000|Overall Study|Protocol Violation|0|||
130356315|NCT01086423|469276297|FG001|Overall Study|Protocol Violation|0|||
130229879|NCT01065818|468807353|FG000|Overall Study|Withdrawal by Subject|1|||
130356316|NCT01086423|469276298|FG002|Overall Study|Protocol Violation|1|||
130229880|NCT01065818|468807353|FG000|Overall Study|Not a candidate for surgery|1|||
130229881|NCT01450813|468807354|FG000|Overall Study|Physician Decision|1|||
130229882|NCT01450813|468807355|FG001|Overall Study|Physician Decision|1|||
130229883|NCT01450813|468807356|FG002|Overall Study|Physician Decision|0|||
130229884|NCT01450813|468807357|FG003|Overall Study|Physician Decision|3|||
130229885|NCT01935089|468807359|FG000|Overall Study|Adverse Event|2|||
130356317|NCT01086423|469276296|FG000|Overall Study|Migrated/moved from study area|2|||
130229886|NCT01935089|468807359|FG000|Overall Study|Withdrawal by Subject|1|||
130229887|NCT02337491|468807363|FG000|Overall Study|Death|1|||
130229888|NCT02337491|468807364|FG001|Overall Study|Death|1|||
130229889|NCT02337491|468807363|FG000|Overall Study|Adverse Event|0|||
130229890|NCT02337491|468807364|FG001|Overall Study|Adverse Event|1|||
130229891|NCT02337491|468807363|FG000|Overall Study|Withdrawal by Subject|3|||
130229892|NCT02337491|468807364|FG001|Overall Study|Withdrawal by Subject|0|||
130229893|NCT02337491|468807363|FG000|Overall Study|Progressive Disease|44|||
130229894|NCT02337491|468807364|FG001|Overall Study|Progressive Disease|28|||
130229895|NCT02337491|468807363|FG000|Overall Study|On Treatment|2|||
130229896|NCT02337491|468807364|FG001|Overall Study|On Treatment|0|||
130229897|NCT00723229|468807365|FG000|First Intervention|Lost to Follow-up|7|||
130229898|NCT00723229|468807366|FG001|First Intervention|Lost to Follow-up|3|||
130229899|NCT01483118|468807371|FG000|Overall Study|Lost to Follow-up|12|||
130229900|NCT01483118|468807372|FG001|Overall Study|Lost to Follow-up|16|||
130229901|NCT03435055|468807374|FG000|Screening|Physician Decision|2|||
130229902|NCT03435055|468807374|FG000|Received Intervention|Did not complete nitrous administration|3|||
130229903|NCT03712280|468807375|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130229904|NCT03712280|468807376|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130229905|NCT03712280|468807377|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130229906|NCT03712280|468807378|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130229907|NCT03712280|468807375|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
130229908|NCT03712280|468807376|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229909|NCT03712280|468807377|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229910|NCT03712280|468807378|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229911|NCT03712280|468807375|FG000|Overall Study|Adverse Event|0|||
130229912|NCT03712280|468807376|FG001|Overall Study|Adverse Event|0|||
130229913|NCT03712280|468807377|FG002|Overall Study|Adverse Event|1|||
130229914|NCT03712280|468807378|FG003|Overall Study|Adverse Event|0|||
130229915|NCT01302899|468807381|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
130229916|NCT01302899|468807382|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
130229917|NCT01302899|468807381|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
130229918|NCT01302899|468807382|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
130229919|NCT02834975|468807383|FG000|Overall Study|Physician Decision|2|||
130229920|NCT02834975|468807383|FG000|Overall Study|Adverse Event|1|||
130229921|NCT02834975|468807383|FG000|Overall Study|Withdrawal by Subject|1|||
130229922|NCT02834975|468807383|FG000|Overall Study|Lack of Efficacy|1|||
130229923|NCT03558516|468807384|FG000|Overall Study|Protocol Violation|2|||
130229924|NCT03558516|468807385|FG001|Overall Study|Protocol Violation|2|||
130229925|NCT00929669|468807386|FG000|Overall Study|elevated glucose levels|1|||
130229926|NCT04494646|468807391|FG000|Overall Study|Adverse Event|0|||
130229927|NCT04494646|468807392|FG001|Overall Study|Adverse Event|1|||
130229928|NCT04494646|468807391|FG000|Overall Study|Withdrawal by Subject|0|||
130229929|NCT04494646|468807392|FG001|Overall Study|Withdrawal by Subject|1|||
130229930|NCT02785939|468807395|FG000|Overall Study|Progression|25|||
130229931|NCT02785939|468807396|FG001|Overall Study|Progression|8|||
130229932|NCT02785939|468807395|FG000|Overall Study|Adverse Event|3|||
130229933|NCT02785939|468807396|FG001|Overall Study|Adverse Event|1|||
130229934|NCT02785939|468807395|FG000|Overall Study|Death|1|||
130229935|NCT02785939|468807396|FG001|Overall Study|Death|0|||
130229936|NCT02785939|468807395|FG000|Overall Study|Refusal|1|||
130229937|NCT02785939|468807396|FG001|Overall Study|Refusal|0|||
130229938|NCT02785939|468807395|FG000|Overall Study|Deteriorating health|1|||
130229939|NCT02785939|468807396|FG001|Overall Study|Deteriorating health|0|||
130229940|NCT02785939|468807395|FG000|Overall Study|Not protocol specified|0|||
130229941|NCT02785939|468807396|FG001|Overall Study|Not protocol specified|1|||
130229942|NCT02147626|468807399|FG000|Overall Study|Lost to Follow-up|4|||
130229943|NCT02147626|468807400|FG001|Overall Study|Lost to Follow-up|4|||
130229944|NCT02147626|468807399|FG000|Overall Study|Pregnancy|1|||
130229945|NCT02147626|468807400|FG001|Overall Study|Pregnancy|2|||
130229946|NCT02147626|468807399|FG000|Overall Study|Withdrawal by Subject|0|||
130229947|NCT02147626|468807400|FG001|Overall Study|Withdrawal by Subject|1|||
130229948|NCT00572832|468807401|FG000|Overall Study|Lost to Follow-up|0|||
130229949|NCT00572832|468807402|FG001|Overall Study|Lost to Follow-up|11|||
130229950|NCT00572832|468807401|FG000|Overall Study|Pregnancy|0|||
130229951|NCT00572832|468807402|FG001|Overall Study|Pregnancy|1|||
130229952|NCT01704261|468807406|FG000|Overall Study|Withdrawal by Subject|12|||
130229953|NCT01704261|468807407|FG001|Overall Study|Withdrawal by Subject|15|||
130552894|NCT03291587|469991622|FG000|Overall Study|Refused to Answer|5|||
130229954|NCT01704261|468807406|FG000|Overall Study|Lost to Follow-up|1|||
130229955|NCT01704261|468807407|FG001|Overall Study|Lost to Follow-up|0|||
130229956|NCT02722967|468807408|FG000|Overall Study|Adverse Event|1|||
130229957|NCT02722967|468807409|FG001|Overall Study|Adverse Event|0|||
130229958|NCT02722967|468807410|FG002|Overall Study|Adverse Event|0|||
130229959|NCT02722967|468807408|FG000|Overall Study|Lost to Follow-up|0|||
130229960|NCT02722967|468807409|FG001|Overall Study|Lost to Follow-up|1|||
130229961|NCT02722967|468807410|FG002|Overall Study|Lost to Follow-up|0|||
130229962|NCT02722967|468807408|FG000|Overall Study|Non-compliance with patch wearing|2|||
130229963|NCT02722967|468807409|FG001|Overall Study|Non-compliance with patch wearing|1|||
130229964|NCT02722967|468807410|FG002|Overall Study|Non-compliance with patch wearing|1|||
130229965|NCT02722967|468807408|FG000|Overall Study|Withdrawal by Subject|1|||
130229966|NCT02722967|468807409|FG001|Overall Study|Withdrawal by Subject|0|||
130229967|NCT02722967|468807410|FG002|Overall Study|Withdrawal by Subject|1|||
130229968|NCT02722967|468807408|FG000|Overall Study|Physician Decision|1|||
130229969|NCT02722967|468807409|FG001|Overall Study|Physician Decision|0|||
130229970|NCT02722967|468807410|FG002|Overall Study|Physician Decision|0|||
130229971|NCT02722967|468807408|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
130229972|NCT02722967|468807409|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
130229973|NCT02722967|468807410|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
130229974|NCT00846053|468807413|FG000|Overall Study|Physician Decision|3|||
130229975|NCT00846053|468807414|FG001|Overall Study|Physician Decision|0|||
130229976|NCT00111761|468807415|FG000|Part 1|Physician Decision|0|||
130229977|NCT00111761|468807416|FG001|Part 1|Physician Decision|1|||
130229978|NCT00111761|468807415|FG000|Part 1|Death|0|||
130229979|NCT00111761|468807416|FG001|Part 1|Death|2|||
130229980|NCT00111761|468807415|FG000|Part 1|Other|0|||
130229981|NCT00111761|468807416|FG001|Part 1|Other|1|||
130229982|NCT00111761|468807415|FG000|Part 1|Withdrawal by Subject|0|||
130229983|NCT00111761|468807416|FG001|Part 1|Withdrawal by Subject|1|||
130229984|NCT00111761|468807415|FG000|Part 2|Adverse Event|1|||
130229985|NCT00111761|468807416|FG001|Part 2|Adverse Event|0|||
130229986|NCT00111761|468807415|FG000|Part 2|Physician Decision|1|||
130229987|NCT00111761|468807416|FG001|Part 2|Physician Decision|0|||
130229988|NCT00111761|468807415|FG000|Part 2|Death|1|||
130229989|NCT00111761|468807416|FG001|Part 2|Death|0|||
130229990|NCT00111761|468807415|FG000|Part 2|Disease progression|3|||
130229991|NCT00111761|468807416|FG001|Part 2|Disease progression|0|||
130229992|NCT00111761|468807415|FG000|Part 2|Protocol-specified criteria|1|||
130229993|NCT00111761|468807416|FG001|Part 2|Protocol-specified criteria|0|||
130229994|NCT00111761|468807415|FG000|Part 2|Other|1|||
130229995|NCT00111761|468807416|FG001|Part 2|Other|0|||
130229996|NCT00467519|468807420|FG000|Overall Study|Protocol Violation|8|||
130229997|NCT00467519|468807421|FG001|Overall Study|Protocol Violation|4|||
130229998|NCT00467519|468807420|FG000|Overall Study|Lost to Follow-up|2|||
130229999|NCT00467519|468807421|FG001|Overall Study|Lost to Follow-up|9|||
130230000|NCT00467519|468807420|FG000|Overall Study|Withdrawal by Subject|4|||
130230001|NCT00467519|468807421|FG001|Overall Study|Withdrawal by Subject|10|||
130230002|NCT00843492|468807428|FG000|Overall Study|Adverse Event|0|||
130230003|NCT00843492|468807429|FG001|Overall Study|Adverse Event|3|||
130230004|NCT00843492|468807428|FG000|Overall Study|Lost to Follow-up|4|||
130230005|NCT00843492|468807429|FG001|Overall Study|Lost to Follow-up|4|||
130230006|NCT00843492|468807428|FG000|Overall Study|Withdrawal by Subject|0|||
130230007|NCT00843492|468807429|FG001|Overall Study|Withdrawal by Subject|4|||
130230008|NCT00843492|468807428|FG000|Overall Study|Immobilization Stopped|1|||
130230009|NCT00843492|468807429|FG001|Overall Study|Immobilization Stopped|0|||
130230010|NCT00843492|468807428|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130230011|NCT00843492|468807429|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130230012|NCT00843492|468807428|FG000|Overall Study|Orthopedic Surgery|0|||
130230013|NCT00843492|468807429|FG001|Overall Study|Orthopedic Surgery|2|||
130230014|NCT00843492|468807428|FG000|Overall Study|Visit Not Performed|1|||
130230015|NCT00843492|468807429|FG001|Overall Study|Visit Not Performed|0|||
130230016|NCT00843492|468807428|FG000|Overall Study|Deep-vein Thrombosis|1|||
130230017|NCT00843492|468807429|FG001|Overall Study|Deep-vein Thrombosis|0|||
130356318|NCT01086423|469276297|FG001|Overall Study|Migrated/moved from study area|0|||
130356319|NCT01086423|469276298|FG002|Overall Study|Migrated/moved from study area|4|||
130356320|NCT01086423|469276296|FG000|Overall Study|Adverse event, fatal|1|||
130356321|NCT01086423|469276297|FG001|Overall Study|Adverse event, fatal|1|||
130356322|NCT01086423|469276298|FG002|Overall Study|Adverse event, fatal|0|||
130356323|NCT01086423|469276296|FG000|Overall Study|Adverse event, non-fatal|2|||
130356324|NCT01086423|469276297|FG001|Overall Study|Adverse event, non-fatal|1|||
130356325|NCT01086423|469276298|FG002|Overall Study|Adverse event, non-fatal|0|||
130356326|NCT01086423|469276296|FG000|Overall Study|Withdrawal by Subject|5|||
130356327|NCT01086423|469276297|FG001|Overall Study|Withdrawal by Subject|1|||
130356328|NCT01086423|469276298|FG002|Overall Study|Withdrawal by Subject|3|||
130691648|NCT03261167|470495954|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
130230018|NCT01677741|468807430|FG000|Overall Study|Death|0|||
130230019|NCT01677741|468807431|FG001|Overall Study|Death|0|||
130230020|NCT01677741|468807432|FG002|Overall Study|Death|0|||
130230021|NCT01677741|468807433|FG003|Overall Study|Death|1|||
130230022|NCT01677741|468807434|FG004|Overall Study|Death|0|||
130230023|NCT01677741|468807435|FG005|Overall Study|Death|1|||
130230024|NCT01677741|468807436|FG006|Overall Study|Death|0|||
130230025|NCT01677741|468807437|FG007|Overall Study|Death|0|||
130230026|NCT01677741|468807430|FG000|Overall Study|Withdrawal by Subject|2|||
130230027|NCT01677741|468807431|FG001|Overall Study|Withdrawal by Subject|7|||
130230028|NCT01677741|468807432|FG002|Overall Study|Withdrawal by Subject|5|||
130230029|NCT01677741|468807433|FG003|Overall Study|Withdrawal by Subject|4|||
130356329|NCT01086423|469276296|FG000|Overall Study|Lost to Follow-up|0|||
130356330|NCT01086423|469276297|FG001|Overall Study|Lost to Follow-up|0|||
130230030|NCT01677741|468807434|FG004|Overall Study|Withdrawal by Subject|11|||
130230031|NCT01677741|468807435|FG005|Overall Study|Withdrawal by Subject|20|||
130230032|NCT01677741|468807436|FG006|Overall Study|Withdrawal by Subject|4|||
130230033|NCT01677741|468807437|FG007|Overall Study|Withdrawal by Subject|2|||
130230034|NCT01677741|468807430|FG000|Overall Study|Enrolled in a rollover study|0|||
130230035|NCT01677741|468807431|FG001|Overall Study|Enrolled in a rollover study|3|||
130230036|NCT01677741|468807432|FG002|Overall Study|Enrolled in a rollover study|2|||
130230037|NCT01677741|468807433|FG003|Overall Study|Enrolled in a rollover study|1|||
130230038|NCT01677741|468807434|FG004|Overall Study|Enrolled in a rollover study|6|||
130691649|NCT03261167|470495953|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
130691650|NCT03261167|470495954|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
130691651|NCT03261167|470495953|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130691652|NCT03261167|470495954|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130691653|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130691654|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130691655|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
130691656|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
130691657|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
130691658|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
130691659|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
130691660|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
130691661|NCT03199963|470495957|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
130691662|NCT03199963|470495958|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
130691663|NCT03199963|470495957|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
130691664|NCT03199963|470495958|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
130230039|NCT01677741|468807435|FG005|Overall Study|Enrolled in a rollover study|6|||
130230040|NCT01677741|468807436|FG006|Overall Study|Enrolled in a rollover study|7|||
130691665|NCT01572662|470495959|FG000|Overall Study|Withdrawal by Subject|1|||
130691666|NCT01572662|470495960|FG001|Overall Study|Withdrawal by Subject|0|||
130691667|NCT01572662|470495959|FG000|Overall Study|Physician Decision|0|||
130691668|NCT01572662|470495960|FG001|Overall Study|Physician Decision|1|||
130691669|NCT03364192|470495963|FG000|Overall Study|Ineligible|10|||
130691670|NCT03364192|470495963|FG000|Overall Study|Withdrawal by Subject|5|||
130691671|NCT03364192|470495963|FG000|Overall Study|Lost to Follow-up|1|||
130691672|NCT00918645|470495964|FG000|Overall Study|Withdrawal by Subject|1|||
130691673|NCT03446768|470495965|FG000|Overall Study|Withdrawal by Subject|0|||
130691674|NCT03446768|470495966|FG001|Overall Study|Withdrawal by Subject|1|||
130230041|NCT01677741|468807437|FG007|Overall Study|Enrolled in a rollover study|0|||
130230042|NCT01677741|468807430|FG000|Overall Study|Progressive disease|1|||
130230043|NCT01677741|468807431|FG001|Overall Study|Progressive disease|0|||
130230044|NCT01677741|468807432|FG002|Overall Study|Progressive disease|1|||
130230045|NCT01677741|468807433|FG003|Overall Study|Progressive disease|0|||
130230046|NCT01677741|468807434|FG004|Overall Study|Progressive disease|0|||
130691675|NCT05133180|470495967|FG000|Overall Study|Withdrawal of consent|1|||
130691676|NCT05133180|470495968|FG001|Overall Study|Withdrawal of consent|1|||
130230047|NCT01677741|468807435|FG005|Overall Study|Progressive disease|1|||
130230048|NCT01677741|468807436|FG006|Overall Study|Progressive disease|0|||
130230049|NCT01677741|468807437|FG007|Overall Study|Progressive disease|0|||
130230050|NCT00720499|468807438|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
130230051|NCT00720499|468807439|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130230052|NCT00720499|468807438|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
130691677|NCT05133180|470495967|FG000|Overall Study|Lost to Follow-up|1|||
130230053|NCT00720499|468807439|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
130230054|NCT00720499|468807438|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
130691678|NCT05133180|470495968|FG001|Overall Study|Lost to Follow-up|1|||
130691679|NCT05133180|470495967|FG000|Overall Study|Documented disease progression|0|||
130691680|NCT05133180|470495968|FG001|Overall Study|Documented disease progression|1|||
130230055|NCT00720499|468807439|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
130230056|NCT03641508|468807451|FG000|First Injection|Lost to Follow-up|2|||
130230057|NCT03641508|468807452|FG001|First Injection|Lost to Follow-up|0|||
130230058|NCT03642990|468807453|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
130230059|NCT03642990|468807453|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
130230060|NCT00855218|468807454|FG000|Overall Study|Adverse Event|43|||
130230061|NCT00855218|468807455|FG001|Overall Study|Adverse Event|27|||
130230062|NCT00855218|468807454|FG000|Overall Study|Withdrawal by Subject|10|||
130230063|NCT00855218|468807455|FG001|Overall Study|Withdrawal by Subject|6|||
130230064|NCT00855218|468807454|FG000|Overall Study|Physician Decision|18|||
130691681|NCT01535222|470495969|FG000|Overall Study|Inclusion/exclusion|0|||
130691682|NCT01535222|470495970|FG001|Overall Study|Inclusion/exclusion|0|||
130691683|NCT01535222|470495971|FG002|Overall Study|Inclusion/exclusion|1|||
130691684|NCT01535222|470495972|FG003|Overall Study|Inclusion/exclusion|0|||
130691685|NCT01535222|470495973|FG004|Overall Study|Inclusion/exclusion|0|||
130230065|NCT00855218|468807455|FG001|Overall Study|Physician Decision|11|||
130230066|NCT00855218|468807454|FG000|Overall Study|Lost to Follow-up|0|||
130230067|NCT00855218|468807455|FG001|Overall Study|Lost to Follow-up|1|||
130230068|NCT00855218|468807454|FG000|Overall Study|Protocol Violation|5|||
130230069|NCT00855218|468807455|FG001|Overall Study|Protocol Violation|9|||
130230070|NCT00855218|468807454|FG000|Overall Study|non-compliant with study drug|3|||
130230071|NCT00855218|468807455|FG001|Overall Study|non-compliant with study drug|1|||
130230072|NCT00855218|468807454|FG000|Overall Study|patient convenience|2|||
130230073|NCT00855218|468807455|FG001|Overall Study|patient convenience|0|||
130230074|NCT00855218|468807454|FG000|Overall Study|technical problems|2|||
130230075|NCT00855218|468807455|FG001|Overall Study|technical problems|1|||
130230076|NCT00855218|468807454|FG000|Overall Study|Still treated with study medication|0|||
130230077|NCT00855218|468807455|FG001|Overall Study|Still treated with study medication|1|||
130230078|NCT00855218|468807454|FG000|Overall Study|Untreatable disease progression|54|||
130230079|NCT00855218|468807455|FG001|Overall Study|Untreatable disease progression|67|||
130230080|NCT00855218|468807454|FG000|Overall Study|Second malignancy|0|||
130230081|NCT00855218|468807455|FG001|Overall Study|Second malignancy|1|||
130230082|NCT00855218|468807454|FG000|Overall Study|Progression measurement proven|7|||
130230083|NCT00855218|468807455|FG001|Overall Study|Progression measurement proven|15|||
130230084|NCT00855218|468807454|FG000|Overall Study|Clinical endpoint reached|10|||
130230085|NCT00855218|468807455|FG001|Overall Study|Clinical endpoint reached|13|||
130230086|NCT00764790|468807456|FG000|Overall Study|Protocol Violation|0|||
130230087|NCT00764790|468807457|FG001|Overall Study|Protocol Violation|0|||
130230088|NCT00764790|468807458|FG002|Overall Study|Protocol Violation|1|||
130230089|NCT00764790|468807456|FG000|Overall Study|Withdrawal by Subject|10|||
130230090|NCT00764790|468807457|FG001|Overall Study|Withdrawal by Subject|12|||
130230091|NCT00764790|468807458|FG002|Overall Study|Withdrawal by Subject|6|||
130230092|NCT00764790|468807456|FG000|Overall Study|Lost to Follow-up|28|||
130230093|NCT00764790|468807457|FG001|Overall Study|Lost to Follow-up|29|||
130230094|NCT00764790|468807458|FG002|Overall Study|Lost to Follow-up|23|||
130230095|NCT03191552|468807459|FG000|Overall Study|Lost to Follow-up|1|||
130230096|NCT03191552|468807460|FG001|Overall Study|Lost to Follow-up|0|||
130230097|NCT03191552|468807461|FG002|Overall Study|Lost to Follow-up|0|||
130230098|NCT03191552|468807459|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130230099|NCT03191552|468807460|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
130230100|NCT03191552|468807461|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130230101|NCT01441973|468807462|FG000|Overall Study|Disease progression|8|||
130230102|NCT01441973|468807463|FG001|Overall Study|Disease progression|6|||
130230103|NCT01441973|468807462|FG000|Overall Study|Adverse event unrelated to study drug|3|||
130230104|NCT01441973|468807463|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130230105|NCT01441973|468807462|FG000|Overall Study|Participant request to discontinue|1|||
130230106|NCT01441973|468807463|FG001|Overall Study|Participant request to discontinue|1|||
130230107|NCT01441973|468807462|FG000|Overall Study|Poor compliance/noncompliance|0|||
130230108|NCT01441973|468807463|FG001|Overall Study|Poor compliance/noncompliance|1|||
130230109|NCT01441973|468807462|FG000|Overall Study|Administrative reason by sponsor|3|||
130230110|NCT01441973|468807463|FG001|Overall Study|Administrative reason by sponsor|5|||
130230111|NCT01441973|468807462|FG000|Overall Study|Participant withdrew consent|0|||
130230112|NCT01441973|468807463|FG001|Overall Study|Participant withdrew consent|1|||
130230113|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
130230114|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230115|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230116|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230117|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
130230118|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130230119|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130230120|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130356331|NCT01086423|469276298|FG002|Overall Study|Lost to Follow-up|1|||
130356332|NCT01130103|469276303|FG000|Randomized Treatment|Adverse Event|1|||
130356333|NCT01130103|469276304|FG001|Randomized Treatment|Adverse Event|1|||
130356334|NCT01130103|469276303|FG000|Randomized Treatment|Lost to Follow-up|1|||
130356335|NCT01130103|469276304|FG001|Randomized Treatment|Lost to Follow-up|0|||
130356336|NCT01130103|469276303|FG000|Randomized Treatment|Protocol Violation|3|||
130356337|NCT01130103|469276304|FG001|Randomized Treatment|Protocol Violation|2|||
130356338|NCT01130103|469276303|FG000|Randomized Treatment|Withdrawal by Subject|1|||
130356339|NCT01130103|469276304|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130356340|NCT01130103|469276303|FG000|Maintenance Treatment|Lack of Efficacy|0|||
130356341|NCT01130103|469276304|FG001|Maintenance Treatment|Lack of Efficacy|1|||
130230121|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
130230122|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230123|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230124|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230125|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
130230126|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
130356342|NCT01130103|469276303|FG000|Maintenance Treatment|Lost to Follow-up|1|||
130356343|NCT01130103|469276304|FG001|Maintenance Treatment|Lost to Follow-up|1|||
130230127|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
130230128|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
130230129|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
130230130|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230131|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230132|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230133|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
130230134|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230135|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230136|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230137|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230138|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
130230139|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230140|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230141|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230142|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
130230143|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230144|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230145|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
130230146|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
130230147|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
130230148|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
130230149|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230150|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
130230151|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230152|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230153|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230154|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
130230155|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230156|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230157|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130230158|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130230159|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
130230160|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
130230161|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230162|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230163|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
130230164|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230165|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130230166|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130230167|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130230168|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130230169|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130230170|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130230171|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130230172|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130230173|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130230174|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130230175|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
130230176|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
130230177|NCT05079321|468807468|FG000|Overall Study|Withdrawal by Subject|2|||
130230178|NCT05079321|468807469|FG001|Overall Study|Withdrawal by Subject|2|||
130230179|NCT05079321|468807468|FG000|Overall Study|Lost to Follow-up|0|||
130230180|NCT05079321|468807469|FG001|Overall Study|Lost to Follow-up|1|||
130230181|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Other than specified|2|||
130356344|NCT01130103|469276303|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
130356345|NCT01130103|469276304|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
130356346|NCT01822678|469276305|FG000|Overall Study|Withdrawal by Subject|5|||
130356347|NCT01822678|469276306|FG001|Overall Study|Withdrawal by Subject|4|||
130356348|NCT01822678|469276307|FG002|Overall Study|Withdrawal by Subject|4|||
130356349|NCT01822678|469276305|FG000|Overall Study|Adverse Event|4|||
130356350|NCT01822678|469276306|FG001|Overall Study|Adverse Event|3|||
130356351|NCT01822678|469276307|FG002|Overall Study|Adverse Event|1|||
130356352|NCT01822678|469276305|FG000|Overall Study|Lack of Efficacy|3|||
130356353|NCT01822678|469276306|FG001|Overall Study|Lack of Efficacy|6|||
130356354|NCT01822678|469276307|FG002|Overall Study|Lack of Efficacy|5|||
130356355|NCT01822678|469276305|FG000|Overall Study|Lost to Follow-up|0|||
130356356|NCT01822678|469276306|FG001|Overall Study|Lost to Follow-up|2|||
130445080|NCT01010217|469590362|FG000|Overall Study|Withdrawal by Subject|1|||
130445081|NCT01010217|469590363|FG001|Overall Study|Withdrawal by Subject|0|||
130445082|NCT01010217|469590364|FG002|Overall Study|Withdrawal by Subject|0|||
130445083|NCT01010217|469590365|FG003|Overall Study|Withdrawal by Subject|0|||
130445084|NCT01010217|469590366|FG004|Overall Study|Withdrawal by Subject|0|||
130445085|NCT01010217|469590362|FG000|Overall Study|Physician Decision|0|||
130445086|NCT01010217|469590363|FG001|Overall Study|Physician Decision|0|||
130445087|NCT01010217|469590364|FG002|Overall Study|Physician Decision|0|||
130230182|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Other than specified|4|||
130230183|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
130230184|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
130230185|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Pregnancy|0|||
130230186|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Pregnancy|2|||
130230187|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Physician Decision|1|||
130230188|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Physician Decision|1|||
130230189|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
130230190|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
130230191|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Adverse Event|2|||
130230192|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Adverse Event|1|||
130230193|NCT05965752|468807472|FG000|Overall Study|Adverse Event|0|||
130230194|NCT05965752|468807473|FG001|Overall Study|Adverse Event|1|||
130230195|NCT05965752|468807474|FG002|Overall Study|Adverse Event|0|||
130230196|NCT05965752|468807475|FG003|Overall Study|Adverse Event|1|||
130230197|NCT05965752|468807476|FG004|Overall Study|Adverse Event|3|||
130230198|NCT05965752|468807472|FG000|Overall Study|Lost to Follow-up|2|||
130230199|NCT05965752|468807473|FG001|Overall Study|Lost to Follow-up|0|||
130230200|NCT05965752|468807474|FG002|Overall Study|Lost to Follow-up|1|||
130230201|NCT05965752|468807475|FG003|Overall Study|Lost to Follow-up|1|||
130230202|NCT05965752|468807476|FG004|Overall Study|Lost to Follow-up|1|||
130230203|NCT05965752|468807472|FG000|Overall Study|Withdrawal by Subject|2|||
130230204|NCT05965752|468807473|FG001|Overall Study|Withdrawal by Subject|2|||
130230205|NCT05965752|468807474|FG002|Overall Study|Withdrawal by Subject|1|||
130230206|NCT05965752|468807475|FG003|Overall Study|Withdrawal by Subject|5|||
130230207|NCT05965752|468807476|FG004|Overall Study|Withdrawal by Subject|0|||
130230208|NCT05965752|468807472|FG000|Overall Study|Disease Relapse|1|||
130230209|NCT05965752|468807473|FG001|Overall Study|Disease Relapse|0|||
130230210|NCT05965752|468807474|FG002|Overall Study|Disease Relapse|1|||
130230211|NCT05965752|468807475|FG003|Overall Study|Disease Relapse|0|||
130230212|NCT05965752|468807476|FG004|Overall Study|Disease Relapse|0|||
130230213|NCT05965752|468807472|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130230214|NCT05965752|468807473|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130230215|NCT05965752|468807474|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130230216|NCT05965752|468807475|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
130230217|NCT05965752|468807476|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130230218|NCT05965752|468807472|FG000|Overall Study|Unable to Return for Study Visits|0|||
130230219|NCT05965752|468807473|FG001|Overall Study|Unable to Return for Study Visits|1|||
130230220|NCT05965752|468807474|FG002|Overall Study|Unable to Return for Study Visits|0|||
130230221|NCT05965752|468807475|FG003|Overall Study|Unable to Return for Study Visits|3|||
130230222|NCT05965752|468807476|FG004|Overall Study|Unable to Return for Study Visits|1|||
130230223|NCT05965752|468807472|FG000|Overall Study|Early Termination|0|||
130230224|NCT05965752|468807473|FG001|Overall Study|Early Termination|0|||
130230225|NCT05965752|468807474|FG002|Overall Study|Early Termination|1|||
130356357|NCT01822678|469276307|FG002|Overall Study|Lost to Follow-up|1|||
130356358|NCT01465191|469276308|FG000|Overall Study|Protocol Violation|6|||
130356359|NCT01465191|469276309|FG001|Overall Study|Protocol Violation|3|||
130356360|NCT01465191|469276310|FG002|Overall Study|Protocol Violation|3|||
130356361|NCT01465191|469276308|FG000|Overall Study|Lost to Follow-up|3|||
130356362|NCT01465191|469276309|FG001|Overall Study|Lost to Follow-up|6|||
130356363|NCT01465191|469276310|FG002|Overall Study|Lost to Follow-up|4|||
130356364|NCT02992132|469276311|FG000|Overall Study|Adverse Event|4|||
130356365|NCT02992132|469276312|FG001|Overall Study|Adverse Event|1|||
130356366|NCT02992132|469276313|FG002|Overall Study|Adverse Event|3|||
130356367|NCT02992132|469276311|FG000|Overall Study|Lack of Efficacy|2|||
130445088|NCT01010217|469590365|FG003|Overall Study|Physician Decision|6|||
130445089|NCT01010217|469590366|FG004|Overall Study|Physician Decision|3|||
130230226|NCT05965752|468807475|FG003|Overall Study|Early Termination|0|||
130230227|NCT05965752|468807476|FG004|Overall Study|Early Termination|0|||
130356368|NCT02992132|469276312|FG001|Overall Study|Lack of Efficacy|0|||
130230228|NCT05965752|468807472|FG000|Overall Study|Reported Unwanted Symptoms|0|||
130230229|NCT05965752|468807473|FG001|Overall Study|Reported Unwanted Symptoms|0|||
130230230|NCT05965752|468807474|FG002|Overall Study|Reported Unwanted Symptoms|0|||
130230231|NCT05965752|468807475|FG003|Overall Study|Reported Unwanted Symptoms|0|||
130230232|NCT05965752|468807476|FG004|Overall Study|Reported Unwanted Symptoms|1|||
130356369|NCT02992132|469276313|FG002|Overall Study|Lack of Efficacy|0|||
130356370|NCT02992132|469276311|FG000|Overall Study|Non-compliance with study drug|2|||
130445090|NCT01439711|469590367|FG000|Overall Study|Ineligible|13|||
130445091|NCT01439711|469590367|FG000|Overall Study|Cancel|3|||
130230233|NCT05965752|468807472|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230234|NCT05965752|468807473|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230235|NCT05965752|468807474|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230236|NCT05965752|468807475|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230237|NCT05965752|468807476|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
130230238|NCT01324947|468807477|FG000|Overall Study|Adverse Event|7|||
130230239|NCT01324947|468807477|FG000|Overall Study|Death|10|||
130230240|NCT01324947|468807477|FG000|Overall Study|Other|3|||
130230241|NCT01324947|468807477|FG000|Overall Study|Progressive Disease|50|||
130230242|NCT01324947|468807477|FG000|Overall Study|Withdrawal by Subject|3|||
130230243|NCT01324947|468807477|FG000|Overall Study|1 discontinued before starting drug|1|||
130230244|NCT01274351|468807478|FG000|Overall Study|Lost to Follow-up|1|||
130230245|NCT01274351|468807478|FG000|Overall Study|patient not compliant with the protocol|1|||
130230246|NCT01274351|468807478|FG000|Overall Study|Pregnancy|1|||
130230247|NCT01274351|468807478|FG000|Overall Study|Death|2|||
130230248|NCT01274351|468807478|FG000|Overall Study|Withdrawal by Subject|3|||
130230249|NCT01274351|468807478|FG000|Overall Study|Adverse Event|8|||
130230250|NCT01274351|468807478|FG000|Overall Study|progression of disease|3|||
130230251|NCT01274351|468807478|FG000|Overall Study|hospitalization|1|||
130230252|NCT01296412|468807482|FG000|Overall Study|Adverse Event|8|||
130230253|NCT01296412|468807483|FG001|Overall Study|Adverse Event|29|||
130230254|NCT01296412|468807482|FG000|Overall Study|Lack of Efficacy|1|||
130230255|NCT01296412|468807483|FG001|Overall Study|Lack of Efficacy|0|||
130230256|NCT01296412|468807482|FG000|Overall Study|Lost to Follow-up|10|||
130230257|NCT01296412|468807483|FG001|Overall Study|Lost to Follow-up|7|||
130230258|NCT01296412|468807482|FG000|Overall Study|Non-compliance with study drug|1|||
130230259|NCT01296412|468807483|FG001|Overall Study|Non-compliance with study drug|2|||
130230260|NCT01296412|468807482|FG000|Overall Study|Other reason not specified|20|||
130230261|NCT01296412|468807483|FG001|Overall Study|Other reason not specified|15|||
130230262|NCT01296412|468807482|FG000|Overall Study|Physician Decision|1|||
130230263|NCT01296412|468807483|FG001|Overall Study|Physician Decision|3|||
130230264|NCT01296412|468807482|FG000|Overall Study|Pregnancy|0|||
130230265|NCT01296412|468807483|FG001|Overall Study|Pregnancy|1|||
130230266|NCT01296412|468807482|FG000|Overall Study|Withdrawal by Subject|10|||
130230267|NCT01296412|468807483|FG001|Overall Study|Withdrawal by Subject|13|||
130230268|NCT02160626|468807484|FG000|Overall Study|Adverse Event|1|||
130230269|NCT02160626|468807485|FG001|Overall Study|Adverse Event|0|||
130230270|NCT02160626|468807486|FG002|Overall Study|Adverse Event|0|||
130230271|NCT02160626|468807484|FG000|Overall Study|Schedule not conducive to study visits|0|||
130230272|NCT02160626|468807485|FG001|Overall Study|Schedule not conducive to study visits|0|||
130230273|NCT02160626|468807486|FG002|Overall Study|Schedule not conducive to study visits|1|||
130230274|NCT02160626|468807484|FG000|Overall Study|Withdrawal by Subject|0|||
130230275|NCT02160626|468807485|FG001|Overall Study|Withdrawal by Subject|1|||
130230276|NCT02160626|468807486|FG002|Overall Study|Withdrawal by Subject|0|||
130230277|NCT04239924|468807489|FG000|Overall Study|Lost to Follow-up|2|||
130230278|NCT00434252|468809599|FG000|Overall Study|Lack of Efficacy|50|||
130230279|NCT00434252|468809600|FG001|Overall Study|Lack of Efficacy|100|||
130230280|NCT00434252|468809599|FG000|Overall Study|Adverse Event|6|||
130230281|NCT00434252|468809600|FG001|Overall Study|Adverse Event|13|||
130230282|NCT00434252|468809599|FG000|Overall Study|Death|1|||
130230283|NCT00434252|468809600|FG001|Overall Study|Death|2|||
130230284|NCT00434252|468809599|FG000|Overall Study|Lost to Follow-up|0|||
130230285|NCT00434252|468809600|FG001|Overall Study|Lost to Follow-up|1|||
130230286|NCT00434252|468809599|FG000|Overall Study|Physician Decision|4|||
130230287|NCT00434252|468809600|FG001|Overall Study|Physician Decision|8|||
130230288|NCT00434252|468809599|FG000|Overall Study|Withdrawal by Subject|3|||
130230289|NCT00434252|468809600|FG001|Overall Study|Withdrawal by Subject|7|||
130230290|NCT02997163|468809602|FG000|Overall Study|Adverse Event|1|||
130230291|NCT02997163|468809603|FG001|Overall Study|Adverse Event|0|||
130230292|NCT02997163|468809604|FG002|Overall Study|Adverse Event|0|||
130230293|NCT02997163|468809605|FG003|Overall Study|Adverse Event|1|||
130230294|NCT01855958|468809620|FG000|Overall Study|Withdrawal by Subject|1|||
130230295|NCT01855958|468809621|FG001|Overall Study|Withdrawal by Subject|0|||
130230296|NCT00296244|468809622|FG000|Overall Study|Underwent retransplant|0|||
130230297|NCT00296244|468809623|FG001|Overall Study|Underwent retransplant|1|||
130230298|NCT00427934|468809624|FG000|Overall Study|Adverse Event|1|||
130230299|NCT00427934|468809625|FG001|Overall Study|Adverse Event|0|||
130230300|NCT00427934|468809626|FG002|Overall Study|Adverse Event|5|||
130230301|NCT00427934|468809627|FG003|Overall Study|Adverse Event|4|||
130230302|NCT00427934|468809624|FG000|Overall Study|Lack of Efficacy|0|||
130230303|NCT00427934|468809625|FG001|Overall Study|Lack of Efficacy|0|||
130230304|NCT00427934|468809626|FG002|Overall Study|Lack of Efficacy|5|||
130230305|NCT00427934|468809627|FG003|Overall Study|Lack of Efficacy|2|||
130230306|NCT00427934|468809624|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
130230307|NCT00427934|468809625|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
130230308|NCT00427934|468809626|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
130230309|NCT00427934|468809627|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
130230310|NCT00427934|468809624|FG000|Overall Study|Other|0|||
130230311|NCT00427934|468809625|FG001|Overall Study|Other|0|||
130230312|NCT00427934|468809626|FG002|Overall Study|Other|11|||
130230313|NCT00427934|468809627|FG003|Overall Study|Other|5|||
130230314|NCT00427934|468809624|FG000|Overall Study|Withdrawal by Subject|0|||
130230315|NCT00427934|468809625|FG001|Overall Study|Withdrawal by Subject|0|||
130230316|NCT00427934|468809626|FG002|Overall Study|Withdrawal by Subject|1|||
130230317|NCT00427934|468809627|FG003|Overall Study|Withdrawal by Subject|3|||
130230318|NCT00499122|468809628|FG000|Overall Study|Withdrawal by Subject|2|||
130230319|NCT00903968|468809631|FG000|Overall Study|Adverse Event|0|||
130230320|NCT00903968|468809632|FG001|Overall Study|Adverse Event|0|||
130230321|NCT00903968|468809633|FG002|Overall Study|Adverse Event|0|||
130230322|NCT00903968|468809634|FG003|Overall Study|Adverse Event|0|||
130230323|NCT00903968|468809635|FG004|Overall Study|Adverse Event|0|||
130230324|NCT00903968|468809636|FG005|Overall Study|Adverse Event|0|||
130230325|NCT00903968|468809637|FG006|Overall Study|Adverse Event|1|||
130230326|NCT00903968|468809638|FG007|Overall Study|Adverse Event|8|||
130230327|NCT00903968|468809631|FG000|Overall Study|DLT|0|||
130230328|NCT00903968|468809632|FG001|Overall Study|DLT|0|||
130230329|NCT00903968|468809633|FG002|Overall Study|DLT|0|||
130230330|NCT00903968|468809634|FG003|Overall Study|DLT|0|||
130230331|NCT00903968|468809635|FG004|Overall Study|DLT|0|||
130230332|NCT00903968|468809636|FG005|Overall Study|DLT|0|||
130230333|NCT00903968|468809637|FG006|Overall Study|DLT|2|||
130230334|NCT00903968|468809638|FG007|Overall Study|DLT|0|||
130230335|NCT00903968|468809631|FG000|Overall Study|Withdrawal by Subject|1|||
130230336|NCT00903968|468809632|FG001|Overall Study|Withdrawal by Subject|0|||
130230337|NCT00903968|468809633|FG002|Overall Study|Withdrawal by Subject|1|||
130230338|NCT00903968|468809634|FG003|Overall Study|Withdrawal by Subject|0|||
130230339|NCT00903968|468809635|FG004|Overall Study|Withdrawal by Subject|1|||
130230340|NCT00903968|468809636|FG005|Overall Study|Withdrawal by Subject|1|||
130230341|NCT00903968|468809637|FG006|Overall Study|Withdrawal by Subject|0|||
130230342|NCT00903968|468809638|FG007|Overall Study|Withdrawal by Subject|4|||
130230343|NCT00903968|468809631|FG000|Overall Study|Non-Compliance|0|||
130230344|NCT00903968|468809632|FG001|Overall Study|Non-Compliance|0|||
130230345|NCT00903968|468809633|FG002|Overall Study|Non-Compliance|0|||
130230346|NCT00903968|468809634|FG003|Overall Study|Non-Compliance|0|||
130230347|NCT00903968|468809635|FG004|Overall Study|Non-Compliance|0|||
130230348|NCT00903968|468809636|FG005|Overall Study|Non-Compliance|1|||
130230349|NCT00903968|468809637|FG006|Overall Study|Non-Compliance|0|||
130230350|NCT00903968|468809638|FG007|Overall Study|Non-Compliance|0|||
130230351|NCT00903968|468809631|FG000|Overall Study|Physician Decision|0|||
130230352|NCT00903968|468809632|FG001|Overall Study|Physician Decision|0|||
130230353|NCT00903968|468809633|FG002|Overall Study|Physician Decision|0|||
130230354|NCT00903968|468809634|FG003|Overall Study|Physician Decision|0|||
130230355|NCT00903968|468809635|FG004|Overall Study|Physician Decision|0|||
130230356|NCT00903968|468809636|FG005|Overall Study|Physician Decision|1|||
130356371|NCT02992132|469276312|FG001|Overall Study|Non-compliance with study drug|0|||
130356372|NCT02992132|469276313|FG002|Overall Study|Non-compliance with study drug|0|||
130356373|NCT02992132|469276311|FG000|Overall Study|Progressive disease|1|||
130356374|NCT02992132|469276312|FG001|Overall Study|Progressive disease|0|||
130356375|NCT02992132|469276313|FG002|Overall Study|Progressive disease|0|||
130356376|NCT02992132|469276311|FG000|Overall Study|Protocol Violation|2|||
130356377|NCT02992132|469276312|FG001|Overall Study|Protocol Violation|2|||
130356378|NCT02992132|469276313|FG002|Overall Study|Protocol Violation|0|||
130356379|NCT02992132|469276311|FG000|Overall Study|Caregiver withdrew consent|2|||
130356380|NCT02992132|469276312|FG001|Overall Study|Caregiver withdrew consent|3|||
130356381|NCT02992132|469276313|FG002|Overall Study|Caregiver withdrew consent|2|||
130356382|NCT02992132|469276311|FG000|Overall Study|Withdrawal by Subject|0|||
130230357|NCT00903968|468809637|FG006|Overall Study|Physician Decision|0|||
130230358|NCT00903968|468809638|FG007|Overall Study|Physician Decision|0|||
130230359|NCT00903968|468809631|FG000|Overall Study|Progressive Disease|2|||
130230360|NCT00903968|468809632|FG001|Overall Study|Progressive Disease|3|||
130230361|NCT00903968|468809633|FG002|Overall Study|Progressive Disease|2|||
130230362|NCT00903968|468809634|FG003|Overall Study|Progressive Disease|3|||
130230363|NCT00903968|468809635|FG004|Overall Study|Progressive Disease|3|||
130230364|NCT00903968|468809636|FG005|Overall Study|Progressive Disease|3|||
130230365|NCT00903968|468809637|FG006|Overall Study|Progressive Disease|0|||
130230366|NCT00903968|468809638|FG007|Overall Study|Progressive Disease|18|||
130230367|NCT00903968|468809631|FG000|Overall Study|Lack of Efficacy|0|||
130230368|NCT00903968|468809632|FG001|Overall Study|Lack of Efficacy|0|||
130230369|NCT00903968|468809633|FG002|Overall Study|Lack of Efficacy|0|||
130230370|NCT00903968|468809634|FG003|Overall Study|Lack of Efficacy|0|||
130230371|NCT00903968|468809635|FG004|Overall Study|Lack of Efficacy|0|||
130230372|NCT00903968|468809636|FG005|Overall Study|Lack of Efficacy|0|||
130356383|NCT02992132|469276312|FG001|Overall Study|Withdrawal by Subject|2|||
130356384|NCT02992132|469276313|FG002|Overall Study|Withdrawal by Subject|1|||
130230373|NCT00903968|468809637|FG006|Overall Study|Lack of Efficacy|0|||
130230374|NCT00903968|468809638|FG007|Overall Study|Lack of Efficacy|3|||
130230375|NCT04539275|468809639|FG000|Overall Study|Death|2|||
130356385|NCT02992132|469276311|FG000|Overall Study|Physician Decision|0|||
130230376|NCT04539275|468809640|FG001|Overall Study|Death|4|||
130230377|NCT04539275|468809639|FG000|Overall Study|Lost to Follow-up|1|||
130230378|NCT04539275|468809640|FG001|Overall Study|Lost to Follow-up|1|||
130230379|NCT04539275|468809639|FG000|Overall Study|Withdrawal by Subject|3|||
130230380|NCT04539275|468809640|FG001|Overall Study|Withdrawal by Subject|0|||
130230381|NCT01373164|468809641|FG000|Overall Study|Lost to Follow-up|0|||
130230382|NCT01373164|468809642|FG001|Overall Study|Lost to Follow-up|0|||
130230383|NCT01373164|468809643|FG002|Overall Study|Lost to Follow-up|1|||
130230384|NCT01373164|468809644|FG003|Overall Study|Lost to Follow-up|2|||
130230385|NCT01373164|468809645|FG004|Overall Study|Lost to Follow-up|0|||
130230386|NCT01373164|468809641|FG000|Overall Study|Withdrawal by Subject|0|||
130230387|NCT01373164|468809642|FG001|Overall Study|Withdrawal by Subject|1|||
130230388|NCT01373164|468809643|FG002|Overall Study|Withdrawal by Subject|0|||
130230389|NCT01373164|468809644|FG003|Overall Study|Withdrawal by Subject|10|||
130230390|NCT01373164|468809645|FG004|Overall Study|Withdrawal by Subject|2|||
130230391|NCT01799941|468809650|FG000|Overall Study|Adverse Event|34|||
130230392|NCT01799941|468809650|FG000|Overall Study|Withdrawal by Subject|21|||
130230393|NCT01799941|468809650|FG000|Overall Study|Death|2|||
130230394|NCT01799941|468809650|FG000|Overall Study|Investigator Decision|4|||
130230395|NCT01799941|468809650|FG000|Overall Study|Lack of Efficacy|3|||
130230396|NCT01799941|468809650|FG000|Overall Study|Lost to Follow-up|17|||
130230397|NCT01799941|468809650|FG000|Overall Study|Other|15|||
130230398|NCT03736967|468809666|FG000|Overall Study|Withdrawal by Subject|26|||
130230399|NCT03736967|468809667|FG001|Overall Study|Withdrawal by Subject|25|||
130356386|NCT02992132|469276312|FG001|Overall Study|Physician Decision|0|||
130356387|NCT02992132|469276313|FG002|Overall Study|Physician Decision|1|||
130356388|NCT00620464|469276314|FG000|Overall Study|Adverse Event|15|||
130356389|NCT00620464|469276315|FG001|Overall Study|Adverse Event|17|||
130356390|NCT00620464|469276314|FG000|Overall Study|Lost to Follow-up|1|||
130356391|NCT00620464|469276315|FG001|Overall Study|Lost to Follow-up|1|||
130356392|NCT00620464|469276314|FG000|Overall Study|Planning Pregnancy|1|||
130356393|NCT00620464|469276315|FG001|Overall Study|Planning Pregnancy|4|||
130356394|NCT00620464|469276314|FG000|Overall Study|Personal|2|||
130356395|NCT00620464|469276315|FG001|Overall Study|Personal|2|||
130356396|NCT00620464|469276314|FG000|Overall Study|Used prohibited medication|1|||
130356397|NCT00620464|469276315|FG001|Overall Study|Used prohibited medication|0|||
130356398|NCT00467610|469276316|FG000|Overall Study|Withdrawal by Subject|1|||
130356399|NCT01369615|469276317|FG000|Overall Study|Withdrawal by Subject|0|||
130356400|NCT01369615|469276318|FG001|Overall Study|Withdrawal by Subject|1|||
130356401|NCT01369615|469276317|FG000|Overall Study|Lost to Follow-up|0|||
130356402|NCT01369615|469276318|FG001|Overall Study|Lost to Follow-up|1|||
130356403|NCT04263454|469276319|FG000|Overall Study|Adverse Event|0|||
130356404|NCT04263454|469276320|FG001|Overall Study|Adverse Event|2|||
130356405|NCT04263454|469276319|FG000|Overall Study|Physician Decision|3|||
130356406|NCT04263454|469276320|FG001|Overall Study|Physician Decision|5|||
130356407|NCT04263454|469276319|FG000|Overall Study|Poor Data Quality|0|||
130356408|NCT04263454|469276320|FG001|Overall Study|Poor Data Quality|1|||
130356409|NCT00986479|469276321|FG000|Period 1|Improved mood|1|||
130356410|NCT00986479|469276322|FG001|Period 1|Improved mood|0|||
130356411|NCT00986479|469276321|FG000|Period 1|Administrative reasons|1|||
130356412|NCT00986479|469276322|FG001|Period 1|Administrative reasons|0|||
130356413|NCT00237185|469276323|FG000|Core|Adverse Event|3|||
130356414|NCT00237185|469276324|FG001|Core|Adverse Event|4|||
130356415|NCT00237185|469276323|FG000|Core|Abnormal laboratory value|0|||
130356416|NCT00237185|469276324|FG001|Core|Abnormal laboratory value|4|||
130356417|NCT00237185|469276323|FG000|Core|Abnormal test procedure results|1|||
130356418|NCT00237185|469276324|FG001|Core|Abnormal test procedure results|0|||
130356419|NCT00237185|469276323|FG000|Core|Lack of Efficacy|30|||
130356420|NCT00237185|469276324|FG001|Core|Lack of Efficacy|23|||
130356421|NCT00237185|469276323|FG000|Core|Protocol Violation|1|||
130356422|NCT00237185|469276324|FG001|Core|Protocol Violation|1|||
130356423|NCT00237185|469276323|FG000|Core|Withdrawal by Subject|4|||
130356424|NCT00237185|469276324|FG001|Core|Withdrawal by Subject|4|||
130356425|NCT00237185|469276323|FG000|Core|Administrative problems|0|||
130356426|NCT00237185|469276324|FG001|Core|Administrative problems|1|||
130230400|NCT03736967|468809668|FG002|Overall Study|Withdrawal by Subject|23|||
130230401|NCT03736967|468809669|FG003|Overall Study|Withdrawal by Subject|26|||
130230402|NCT03736967|468809666|FG000|Overall Study|Lost to Follow-up|3|||
130356427|NCT00237185|469276323|FG000|Core|Death|4|||
130356428|NCT00237185|469276324|FG001|Core|Death|0|||
130356429|NCT00237185|469276323|FG000|Core|Determined ineligible post randomization|1|||
130356430|NCT00237185|469276324|FG001|Core|Determined ineligible post randomization|0|||
130356431|NCT00237185|469276323|FG000|Extension|Adverse Event|1|||
130356432|NCT00237185|469276324|FG001|Extension|Adverse Event|0|||
130230403|NCT03736967|468809667|FG001|Overall Study|Lost to Follow-up|2|||
130230404|NCT03736967|468809668|FG002|Overall Study|Lost to Follow-up|1|||
130230405|NCT03736967|468809669|FG003|Overall Study|Lost to Follow-up|1|||
130230406|NCT03736967|468809666|FG000|Overall Study|Physician Decision|1|||
130356433|NCT00237185|469276323|FG000|Extension|Abnormal laboratory value|0|||
130356434|NCT00237185|469276324|FG001|Extension|Abnormal laboratory value|1|||
130356435|NCT00237185|469276323|FG000|Extension|Lack of Efficacy|9|||
130230407|NCT03736967|468809667|FG001|Overall Study|Physician Decision|0|||
130230408|NCT03736967|468809668|FG002|Overall Study|Physician Decision|0|||
130230409|NCT03736967|468809669|FG003|Overall Study|Physician Decision|1|||
130230410|NCT03736967|468809666|FG000|Overall Study|Adverse Event|0|||
130230411|NCT03736967|468809667|FG001|Overall Study|Adverse Event|1|||
130230412|NCT03736967|468809668|FG002|Overall Study|Adverse Event|0|||
130230413|NCT03736967|468809669|FG003|Overall Study|Adverse Event|1|||
130230414|NCT03736967|468809666|FG000|Overall Study|Death|0|||
130230415|NCT03736967|468809667|FG001|Overall Study|Death|0|||
130230416|NCT03736967|468809668|FG002|Overall Study|Death|0|||
130230417|NCT03736967|468809669|FG003|Overall Study|Death|1|||
130230418|NCT03736967|468809666|FG000|Overall Study|Randomized but never treated|1|||
130230419|NCT03736967|468809667|FG001|Overall Study|Randomized but never treated|0|||
130230420|NCT03736967|468809668|FG002|Overall Study|Randomized but never treated|0|||
130230421|NCT03736967|468809669|FG003|Overall Study|Randomized but never treated|0|||
130230422|NCT02419807|468809670|FG000|Overall Study|Withdrawal by Subject|4|||
130230423|NCT02419807|468809670|FG000|Overall Study|Physician Decision|1|||
130230424|NCT02419807|468809670|FG000|Overall Study|Protocol Violation|5|||
130230425|NCT01006629|468809671|FG000|Overall Study|Adverse Event|1|||
130230426|NCT01006629|468809671|FG000|Overall Study|Parent refused to continue participation|1|||
130230427|NCT01006629|468809671|FG000|Overall Study|Parent unable to perform site visit|4|||
130230428|NCT03157089|468809672|FG000|Overall Study|Treated only with pembrolizumab|1|||
130230429|NCT03157089|468809673|FG001|Overall Study|Treated only with pembrolizumab|0|||
130230430|NCT03157089|468809672|FG000|Overall Study|Adverse Event|5|||
130230431|NCT03157089|468809673|FG001|Overall Study|Adverse Event|4|||
130230432|NCT03157089|468809672|FG000|Overall Study|Progressive disease|6|||
130230433|NCT03157089|468809673|FG001|Overall Study|Progressive disease|8|||
130230434|NCT02932943|468809674|FG000|Overall Study|Lost to Follow-up|0|||
130230435|NCT02932943|468809675|FG001|Overall Study|Lost to Follow-up|2|||
130230436|NCT02932943|468809674|FG000|Overall Study|Adverse Event|2|||
130230437|NCT02932943|468809675|FG001|Overall Study|Adverse Event|2|||
130230438|NCT02932943|468809674|FG000|Overall Study|Withdrawal by Subject|3|||
130230439|NCT02932943|468809675|FG001|Overall Study|Withdrawal by Subject|3|||
130230440|NCT02300610|468809678|FG000|Overall Study|Withdrawal by Subject|1|||
130230441|NCT02300610|468809679|FG001|Overall Study|Withdrawal by Subject|0|||
130230442|NCT02300610|468809680|FG002|Overall Study|Withdrawal by Subject|1|||
130230443|NCT00095979|468809681|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
130230444|NCT01663623|468809684|FG000|Overall Study|Adverse Event|3|||
130230445|NCT01663623|468809685|FG001|Overall Study|Adverse Event|7|||
130230446|NCT01663623|468809684|FG000|Overall Study|Lack of Efficacy|5|||
130230447|NCT01663623|468809685|FG001|Overall Study|Lack of Efficacy|6|||
130230448|NCT01663623|468809684|FG000|Overall Study|Protocol Violation|0|||
130230449|NCT01663623|468809685|FG001|Overall Study|Protocol Violation|1|||
130230450|NCT01663623|468809684|FG000|Overall Study|Other-Study closed/terminated|1|||
130230451|NCT01663623|468809685|FG001|Overall Study|Other-Study closed/terminated|1|||
130230452|NCT01663623|468809684|FG000|Overall Study|Physician Decision|1|||
130230453|NCT01663623|468809685|FG001|Overall Study|Physician Decision|4|||
130230454|NCT01663623|468809684|FG000|Overall Study|Withdrawal by Subject|2|||
130230455|NCT01663623|468809685|FG001|Overall Study|Withdrawal by Subject|1|||
130230456|NCT02251275|468809686|FG000|Overall Study|Adverse Event|23|||
130230457|NCT02251275|468809687|FG001|Overall Study|Adverse Event|60|||
130230458|NCT02251275|468809688|FG002|Overall Study|Adverse Event|28|||
130230459|NCT02251275|468809689|FG003|Overall Study|Adverse Event|0|||
130230460|NCT02251275|468809690|FG004|Overall Study|Adverse Event|0|||
130230461|NCT02251275|468809686|FG000|Overall Study|Lost to Follow-up|5|||
130230462|NCT02251275|468809687|FG001|Overall Study|Lost to Follow-up|6|||
130230463|NCT02251275|468809688|FG002|Overall Study|Lost to Follow-up|4|||
130230464|NCT02251275|468809689|FG003|Overall Study|Lost to Follow-up|0|||
130230465|NCT02251275|468809690|FG004|Overall Study|Lost to Follow-up|0|||
130230466|NCT02251275|468809686|FG000|Overall Study|Physician Decision|19|||
130230467|NCT02251275|468809687|FG001|Overall Study|Physician Decision|30|||
130230468|NCT02251275|468809688|FG002|Overall Study|Physician Decision|26|||
130230469|NCT02251275|468809689|FG003|Overall Study|Physician Decision|0|||
130230470|NCT02251275|468809690|FG004|Overall Study|Physician Decision|1|||
130230471|NCT02251275|468809686|FG000|Overall Study|Protocol Deviation|0|||
130356436|NCT00237185|469276324|FG001|Extension|Lack of Efficacy|14|||
130356437|NCT00237185|469276323|FG000|Extension|Condition no longer required study drug|0|||
130230472|NCT02251275|468809687|FG001|Overall Study|Protocol Deviation|0|||
130230473|NCT02251275|468809688|FG002|Overall Study|Protocol Deviation|1|||
130230474|NCT02251275|468809689|FG003|Overall Study|Protocol Deviation|0|||
130230475|NCT02251275|468809690|FG004|Overall Study|Protocol Deviation|0|||
130356438|NCT00237185|469276324|FG001|Extension|Condition no longer required study drug|1|||
130230476|NCT02251275|468809686|FG000|Overall Study|Withdrawal by Subject|25|||
130230477|NCT02251275|468809687|FG001|Overall Study|Withdrawal by Subject|51|||
130230478|NCT02251275|468809688|FG002|Overall Study|Withdrawal by Subject|35|||
130230479|NCT02251275|468809689|FG003|Overall Study|Withdrawal by Subject|1|||
130230480|NCT02251275|468809690|FG004|Overall Study|Withdrawal by Subject|0|||
130230481|NCT00856180|468809694|FG000|Overall Study|Adverse Event|4|||
130691686|NCT01535222|470495974|FG005|Overall Study|Inclusion/exclusion|0|||
130691687|NCT01117623|470497826|FG000|Overall Study|Adverse Event|0|||
130691688|NCT01117623|470497827|FG001|Overall Study|Adverse Event|2|||
130691689|NCT01117623|470497828|FG002|Overall Study|Adverse Event|4|||
130691690|NCT01117623|470497829|FG003|Overall Study|Adverse Event|0|||
130691691|NCT01117623|470497830|FG004|Overall Study|Adverse Event|2|||
130691692|NCT01117623|470497831|FG005|Overall Study|Adverse Event|0|||
130691693|NCT01117623|470497832|FG006|Overall Study|Adverse Event|0|||
130691694|NCT01117623|470497833|FG007|Overall Study|Adverse Event|2|||
130691695|NCT01117623|470497826|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
130691696|NCT01117623|470497827|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
130691697|NCT01117623|470497828|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
130691698|NCT01117623|470497829|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
130691699|NCT01117623|470497830|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
130691700|NCT01117623|470497831|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
130691701|NCT01117623|470497832|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
130691702|NCT01117623|470497833|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
130691703|NCT01117623|470497826|FG000|Overall Study|Withdrawal by Subject|0|||
130691704|NCT01117623|470497827|FG001|Overall Study|Withdrawal by Subject|0|||
130691705|NCT01117623|470497828|FG002|Overall Study|Withdrawal by Subject|2|||
130691706|NCT01117623|470497829|FG003|Overall Study|Withdrawal by Subject|0|||
130691707|NCT01117623|470497830|FG004|Overall Study|Withdrawal by Subject|0|||
130691708|NCT01117623|470497831|FG005|Overall Study|Withdrawal by Subject|1|||
130691709|NCT01117623|470497832|FG006|Overall Study|Withdrawal by Subject|1|||
130691710|NCT01117623|470497833|FG007|Overall Study|Withdrawal by Subject|1|||
130691711|NCT01117623|470497826|FG000|Overall Study|Non-compliance with study medication|0|||
130691712|NCT01117623|470497827|FG001|Overall Study|Non-compliance with study medication|0|||
130691713|NCT01117623|470497828|FG002|Overall Study|Non-compliance with study medication|0|||
130691714|NCT01117623|470497829|FG003|Overall Study|Non-compliance with study medication|0|||
130691715|NCT01117623|470497830|FG004|Overall Study|Non-compliance with study medication|0|||
130691716|NCT01117623|470497831|FG005|Overall Study|Non-compliance with study medication|0|||
130691717|NCT01117623|470497832|FG006|Overall Study|Non-compliance with study medication|0|||
130691718|NCT01117623|470497833|FG007|Overall Study|Non-compliance with study medication|1|||
130691719|NCT01117623|470497826|FG000|Overall Study|Invest. text: completed all planned txs|0|||
130691720|NCT01117623|470497827|FG001|Overall Study|Invest. text: completed all planned txs|0|||
130691721|NCT01117623|470497828|FG002|Overall Study|Invest. text: completed all planned txs|0|||
130691722|NCT01117623|470497829|FG003|Overall Study|Invest. text: completed all planned txs|0|||
130691723|NCT01117623|470497830|FG004|Overall Study|Invest. text: completed all planned txs|0|||
130691724|NCT01117623|470497831|FG005|Overall Study|Invest. text: completed all planned txs|1|||
130691725|NCT01117623|470497832|FG006|Overall Study|Invest. text: completed all planned txs|0|||
130691726|NCT01117623|470497833|FG007|Overall Study|Invest. text: completed all planned txs|0|||
130691727|NCT00395694|470497839|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
130691728|NCT00395694|470497840|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
130691729|NCT00395694|470497839|FG000|Continuation Phase|Adverse Event|1|||
130691730|NCT00395694|470497840|FG001|Continuation Phase|Adverse Event|0|||
130691731|NCT00395694|470497839|FG000|Continuation Phase|Lack of Efficacy|12|||
130691732|NCT00395694|470497840|FG001|Continuation Phase|Lack of Efficacy|11|||
130691733|NCT00395694|470497839|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
130691734|NCT00395694|470497840|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
130691735|NCT00395694|470497839|FG000|Continuation Phase|Poor Compliance|1|||
130691736|NCT00395694|470497840|FG001|Continuation Phase|Poor Compliance|0|||
130691737|NCT00395694|470497839|FG000|Continuation Phase|Withdrawal by Subject|0|||
130691738|NCT00395694|470497840|FG001|Continuation Phase|Withdrawal by Subject|2|||
130691739|NCT00840216|470497841|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130691740|NCT00840216|470497842|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130691741|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Adverse Event|8|||
130691742|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Adverse Event|15|||
130691743|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Adverse Event|25|||
130691744|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
130691745|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
130691746|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
130691747|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
130691748|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
130691749|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
130691750|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
130691751|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
130691752|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
130691753|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130691754|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130691755|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
130230482|NCT00856180|468809694|FG000|Overall Study|Progressive Disease|16|||
130230483|NCT00686972|468809695|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
130230484|NCT01462942|468809698|FG000|Overall Study|Adverse Event|7|||
130230485|NCT01462942|468809699|FG001|Overall Study|Adverse Event|12|||
130230486|NCT01462942|468809700|FG002|Overall Study|Adverse Event|10|||
130230487|NCT01462942|468809701|FG003|Overall Study|Adverse Event|11|||
130230488|NCT01462942|468809702|FG004|Overall Study|Adverse Event|11|||
130230489|NCT01462942|468809698|FG000|Overall Study|Other, including COPD exacerbation|3|||
130230490|NCT01462942|468809699|FG001|Overall Study|Other, including COPD exacerbation|5|||
130230491|NCT01462942|468809700|FG002|Overall Study|Other, including COPD exacerbation|2|||
130230492|NCT01462942|468809701|FG003|Overall Study|Other, including COPD exacerbation|8|||
130230493|NCT01462942|468809702|FG004|Overall Study|Other, including COPD exacerbation|5|||
130230494|NCT01462942|468809698|FG000|Overall Study|Withdrawal by Subject|14|||
130230495|NCT01462942|468809699|FG001|Overall Study|Withdrawal by Subject|10|||
130230496|NCT01462942|468809700|FG002|Overall Study|Withdrawal by Subject|14|||
130230497|NCT01462942|468809701|FG003|Overall Study|Withdrawal by Subject|16|||
130230498|NCT01462942|468809702|FG004|Overall Study|Withdrawal by Subject|19|||
130230499|NCT01462942|468809698|FG000|Overall Study|Lack of Efficacy|6|||
130230500|NCT01462942|468809699|FG001|Overall Study|Lack of Efficacy|0|||
130230501|NCT01462942|468809700|FG002|Overall Study|Lack of Efficacy|4|||
130230502|NCT01462942|468809701|FG003|Overall Study|Lack of Efficacy|5|||
130230503|NCT01462942|468809702|FG004|Overall Study|Lack of Efficacy|3|||
130230504|NCT01462942|468809698|FG000|Overall Study|Lost to Follow-up|0|||
130230505|NCT01462942|468809699|FG001|Overall Study|Lost to Follow-up|1|||
130230506|NCT01462942|468809700|FG002|Overall Study|Lost to Follow-up|1|||
130230507|NCT01462942|468809701|FG003|Overall Study|Lost to Follow-up|1|||
130230508|NCT01462942|468809702|FG004|Overall Study|Lost to Follow-up|1|||
130230509|NCT01462942|468809698|FG000|Overall Study|Protocol Violation|4|||
130230510|NCT01462942|468809699|FG001|Overall Study|Protocol Violation|6|||
130230511|NCT01462942|468809700|FG002|Overall Study|Protocol Violation|9|||
130230512|NCT01462942|468809701|FG003|Overall Study|Protocol Violation|9|||
130230513|NCT01462942|468809702|FG004|Overall Study|Protocol Violation|6|||
130230514|NCT01027845|468809703|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
130230515|NCT01027845|468809704|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
130230516|NCT01027845|468809705|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
130230517|NCT01027845|468809706|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
130230518|NCT01027845|468809703|FG000|Primary Vaccination Phase|Adverse Event|1|||
130230519|NCT01027845|468809704|FG001|Primary Vaccination Phase|Adverse Event|0|||
130230520|NCT01027845|468809705|FG002|Primary Vaccination Phase|Adverse Event|0|||
130230521|NCT01027845|468809706|FG003|Primary Vaccination Phase|Adverse Event|0|||
130230522|NCT01027845|468809703|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130230523|NCT01027845|468809704|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130230524|NCT01027845|468809705|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130230525|NCT01027845|468809706|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130230526|NCT01027845|468809703|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230527|NCT01027845|468809704|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
130230528|NCT01027845|468809705|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230529|NCT01027845|468809706|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230530|NCT01027845|468809703|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130230531|NCT01027845|468809704|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230532|NCT01027845|468809705|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230533|NCT01027845|468809706|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230534|NCT01027845|468809703|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
130230535|NCT01027845|468809704|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230536|NCT01027845|468809705|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230537|NCT01027845|468809706|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230538|NCT00368550|468809707|FG000|Overall Study|Adverse Event|7|||
130230539|NCT00368550|468809708|FG001|Overall Study|Adverse Event|4|||
130356439|NCT00237185|469276323|FG000|Extension|Withdrawal by Subject|3|||
130356440|NCT00237185|469276324|FG001|Extension|Withdrawal by Subject|2|||
130691756|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
130691757|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
130230540|NCT00368550|468809707|FG000|Overall Study|Lack of Efficacy|4|||
130230541|NCT00368550|468809708|FG001|Overall Study|Lack of Efficacy|9|||
130230542|NCT00368550|468809707|FG000|Overall Study|Withdrawal by Subject|17|||
130230543|NCT00368550|468809708|FG001|Overall Study|Withdrawal by Subject|10|||
130230544|NCT00486044|468809709|FG000|Overall Study|Withdrawal by Subject|2|||
130356441|NCT00237185|469276323|FG000|Extension|Lost to Follow-up|1|||
130356442|NCT00237185|469276324|FG001|Extension|Lost to Follow-up|0|||
130230545|NCT00486044|468809710|FG001|Overall Study|Withdrawal by Subject|1|||
130230546|NCT00486044|468809709|FG000|Overall Study|Adverse Event|0|||
130356443|NCT00237185|469276323|FG000|Extension|Administrative problems|1|||
130356444|NCT00237185|469276324|FG001|Extension|Administrative problems|0|||
130356445|NCT00237185|469276323|FG000|Extension|Death|1|||
130691758|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
130230547|NCT00486044|468809710|FG001|Overall Study|Adverse Event|1|||
130230548|NCT00486044|468809709|FG000|Overall Study|Lost to Follow-up|0|||
130230549|NCT00486044|468809710|FG001|Overall Study|Lost to Follow-up|1|||
130230550|NCT01670292|468809714|FG000|Overall Study|Lost to Follow-up|14|||
130230551|NCT03154086|468809720|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230552|NCT03154086|468809721|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230553|NCT03154086|468809722|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230554|NCT03154086|468809723|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
130230555|NCT03154086|468809724|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230556|NCT03154086|468809725|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230557|NCT03154086|468809726|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230558|NCT03154086|468809727|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230559|NCT03154086|468809728|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230560|NCT03154086|468809729|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230561|NCT03154086|468809730|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230562|NCT03154086|468809731|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230563|NCT03154086|468809732|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230564|NCT03154086|468809733|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230565|NCT03154086|468809734|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230566|NCT03154086|468809720|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230567|NCT03154086|468809721|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
130230568|NCT03154086|468809722|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230569|NCT03154086|468809723|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230570|NCT03154086|468809724|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230571|NCT03154086|468809725|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230572|NCT03154086|468809726|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230573|NCT03154086|468809727|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230574|NCT03154086|468809728|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230575|NCT03154086|468809729|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230576|NCT03154086|468809730|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230577|NCT03154086|468809731|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230578|NCT03154086|468809732|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230579|NCT03154086|468809733|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230580|NCT03154086|468809734|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230581|NCT03154086|468809720|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230582|NCT03154086|468809721|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230583|NCT03154086|468809722|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
130230584|NCT03154086|468809723|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230585|NCT03154086|468809724|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230586|NCT03154086|468809725|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230587|NCT03154086|468809726|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230588|NCT03154086|468809727|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230589|NCT03154086|468809728|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230590|NCT03154086|468809729|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230591|NCT03154086|468809730|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230592|NCT03154086|468809731|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230593|NCT03154086|468809732|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230594|NCT03154086|468809733|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230595|NCT03154086|468809734|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230596|NCT03154086|468809720|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
130230597|NCT03154086|468809721|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230598|NCT03154086|468809722|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230599|NCT03154086|468809723|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230600|NCT03154086|468809724|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230601|NCT03154086|468809725|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230602|NCT03154086|468809726|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230603|NCT03154086|468809727|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230604|NCT03154086|468809728|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130356446|NCT00237185|469276324|FG001|Extension|Death|1|||
130691759|NCT00935012|470497850|FG000|Overall Study|Death|19|||
130356447|NCT02035475|469276325|FG000|Overall Study|Withdrawal by Subject|4|||
130356448|NCT02035475|469276325|FG000|Overall Study|Physician Decision|1|||
130356449|NCT02035475|469276325|FG000|Overall Study|Equipment Error|1|||
130356450|NCT01231347|469276326|FG000|Overall Study|Full Consent withdrawn|19|||
130356451|NCT01231347|469276327|FG001|Overall Study|Full Consent withdrawn|19|||
130691760|NCT00935012|470497850|FG000|Overall Study|Withdrawal by Subject|3|||
130691761|NCT00935012|470497850|FG000|Overall Study|Other|5|||
130445092|NCT01439711|469590367|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
130445093|NCT01439711|469590367|FG000|Overall Study|Adverse Event|5|||
130445094|NCT01439711|469590367|FG000|Overall Study|Withdrawal by Subject|3|||
130445095|NCT01439711|469590367|FG000|Overall Study|Progression During Active Tx|3|||
130445096|NCT01439711|469590367|FG000|Overall Study|Noncompliance|3|||
130445097|NCT01439711|469590367|FG000|Overall Study|No MRI|9|||
130445098|NCT04242875|469590368|FG000|Overall Study|Adverse Event|2|||
130445099|NCT02397460|469590369|FG000|Treatment Period 2|Adverse Event|0|||
130445100|NCT02397460|469590370|FG001|Treatment Period 2|Adverse Event|0|||
130445101|NCT02397460|469590371|FG002|Treatment Period 2|Adverse Event|0|||
130445102|NCT02397460|469590372|FG003|Treatment Period 2|Adverse Event|0|||
130445103|NCT02397460|469590373|FG004|Treatment Period 2|Adverse Event|0|||
130445104|NCT02397460|469590374|FG005|Treatment Period 2|Adverse Event|0|||
130445105|NCT02397460|469590375|FG006|Treatment Period 2|Adverse Event|0|||
130445106|NCT02397460|469590376|FG007|Treatment Period 2|Adverse Event|1|||
130445107|NCT02397460|469590369|FG000|Treatment Period 4|Adverse Event|0|||
130445108|NCT02397460|469590370|FG001|Treatment Period 4|Adverse Event|1|||
130691762|NCT00935012|470497850|FG000|Overall Study|Adverse Event|2|||
130691763|NCT01442155|470497851|FG000|Overall Study|Complete remission|35|||
130691764|NCT01442155|470497851|FG000|Overall Study|Recurrence|26|||
130691765|NCT01442155|470497851|FG000|Overall Study|Adverse Event|2|||
130691766|NCT01442155|470497851|FG000|Overall Study|Lost to Follow-up|2|||
130691767|NCT00705666|470497852|FG000|Overall Study|No post-treatment questionnaire|279|||
130691768|NCT00705666|470497852|FG000|Overall Study|Withdrawal by Subject|21|||
130691769|NCT00705666|470497852|FG000|Overall Study|Physician Decision|7|||
130691770|NCT00705666|470497852|FG000|Overall Study|Lost to Follow-up|5|||
130691771|NCT00705666|470497852|FG000|Overall Study|Death|1|||
130691772|NCT00705666|470497852|FG000|Overall Study|Adverse Event|4|||
130691773|NCT00705666|470497852|FG000|Overall Study|Other|12|||
130691774|NCT00705666|470497852|FG000|Overall Study|Other|2|||
130691775|NCT00705666|470497852|FG000|Overall Study|Lack of data|3|||
130691776|NCT00705666|470497852|FG000|Overall Study|Untreated|5|||
130691777|NCT01590563|470497863|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
130691778|NCT03256695|470497864|FG000|Overall Study|Adverse Event|8|||
130691779|NCT03256695|470497864|FG000|Overall Study|Death|2|||
130691780|NCT03256695|470497864|FG000|Overall Study|Withdrawal by Subject|14|||
130691781|NCT03256695|470497864|FG000|Overall Study|Non-compliance with study drug|1|||
130691782|NCT03256695|470497864|FG000|Overall Study|Lost to Follow-up|3|||
130691783|NCT03256695|470497864|FG000|Overall Study|Lack of Efficacy|3|||
130691784|NCT03256695|470497864|FG000|Overall Study|Protocol Violation|5|||
130691785|NCT03256695|470497864|FG000|Overall Study|Other than specified|3|||
130691786|NCT01604941|470497865|FG000|Overall Study|Adverse Event|1|||
130691787|NCT01604941|470497866|FG001|Overall Study|Adverse Event|2|||
130691788|NCT01604941|470497867|FG002|Overall Study|Adverse Event|0|||
130691789|NCT01604941|470497868|FG003|Overall Study|Adverse Event|0|||
130691790|NCT01604941|470497869|FG004|Overall Study|Adverse Event|1|||
130691791|NCT01604941|470497870|FG005|Overall Study|Adverse Event|5|||
130691792|NCT01604941|470497865|FG000|Overall Study|Non-compliance|1|||
130691793|NCT01604941|470497866|FG001|Overall Study|Non-compliance|0|||
130691794|NCT01604941|470497867|FG002|Overall Study|Non-compliance|0|||
130691795|NCT01604941|470497868|FG003|Overall Study|Non-compliance|0|||
130691796|NCT01604941|470497869|FG004|Overall Study|Non-compliance|0|||
130691797|NCT01604941|470497870|FG005|Overall Study|Non-compliance|0|||
130691798|NCT01604941|470497865|FG000|Overall Study|Participant Decision|0|||
130691799|NCT01604941|470497866|FG001|Overall Study|Participant Decision|0|||
130445109|NCT02397460|469590371|FG002|Treatment Period 4|Adverse Event|0|||
130445110|NCT02397460|469590372|FG003|Treatment Period 4|Adverse Event|0|||
130445111|NCT02397460|469590373|FG004|Treatment Period 4|Adverse Event|0|||
130445112|NCT02397460|469590374|FG005|Treatment Period 4|Adverse Event|0|||
130691800|NCT01604941|470497867|FG002|Overall Study|Participant Decision|0|||
130691801|NCT01604941|470497868|FG003|Overall Study|Participant Decision|0|||
130691802|NCT01604941|470497869|FG004|Overall Study|Participant Decision|0|||
130691803|NCT01604941|470497870|FG005|Overall Study|Participant Decision|2|||
130691804|NCT01604941|470497865|FG000|Overall Study|Early Study Termination|9|||
130691805|NCT01604941|470497866|FG001|Overall Study|Early Study Termination|2|||
130691806|NCT01604941|470497867|FG002|Overall Study|Early Study Termination|3|||
130691807|NCT01604941|470497868|FG003|Overall Study|Early Study Termination|3|||
130691808|NCT01604941|470497869|FG004|Overall Study|Early Study Termination|0|||
130691809|NCT01604941|470497870|FG005|Overall Study|Early Study Termination|0|||
130691810|NCT03930732|470497871|FG000|Overall Study|Adverse Event|9|||
130691811|NCT03930732|470497872|FG001|Overall Study|Adverse Event|7|||
130691812|NCT03930732|470497871|FG000|Overall Study|Poor compliance to protocol|0|||
130691813|NCT03930732|470497872|FG001|Overall Study|Poor compliance to protocol|1|||
130691814|NCT03930732|470497871|FG000|Overall Study|Withdrawal by Subject|23|||
130691815|NCT03930732|470497872|FG001|Overall Study|Withdrawal by Subject|11|||
130691816|NCT03930732|470497871|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
130691817|NCT03930732|470497872|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
130691818|NCT03930732|470497871|FG000|Overall Study|Other reason not related to COVID-19|5|||
130230605|NCT03154086|468809729|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230606|NCT03154086|468809730|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230607|NCT03154086|468809731|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230608|NCT03154086|468809732|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230609|NCT03154086|468809733|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230610|NCT03154086|468809734|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230611|NCT03154086|468809720|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230612|NCT03154086|468809721|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230613|NCT03154086|468809722|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230614|NCT03154086|468809723|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230615|NCT03154086|468809724|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230616|NCT03154086|468809725|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230617|NCT03154086|468809726|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230618|NCT03154086|468809727|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230619|NCT03154086|468809728|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
130230620|NCT03154086|468809729|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230621|NCT03154086|468809730|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230622|NCT03154086|468809731|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230623|NCT03154086|468809732|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230624|NCT03154086|468809733|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230625|NCT03154086|468809734|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230626|NCT03154086|468809720|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230627|NCT03154086|468809721|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230628|NCT03154086|468809722|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230629|NCT03154086|468809723|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230630|NCT03154086|468809724|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230631|NCT03154086|468809725|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230632|NCT03154086|468809726|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230633|NCT03154086|468809727|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
130230634|NCT03154086|468809728|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230635|NCT03154086|468809729|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230636|NCT03154086|468809730|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230637|NCT03154086|468809731|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230638|NCT03154086|468809732|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230639|NCT03154086|468809733|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230640|NCT03154086|468809734|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230641|NCT03154086|468809720|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
130230642|NCT03154086|468809721|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
130230643|NCT03154086|468809722|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
130230644|NCT03154086|468809723|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
130230645|NCT03154086|468809724|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
130230646|NCT03154086|468809725|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
130230647|NCT03154086|468809726|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
130356452|NCT01231347|469276328|FG002|Overall Study|Full Consent withdrawn|11|||
130356453|NCT01231347|469276326|FG000|Overall Study|Lost to Follow-up|4|||
130356454|NCT01231347|469276327|FG001|Overall Study|Lost to Follow-up|2|||
130356455|NCT01231347|469276328|FG002|Overall Study|Lost to Follow-up|2|||
130356456|NCT01231347|469276326|FG000|Overall Study|Death|202|||
130356457|NCT01231347|469276327|FG001|Overall Study|Death|210|||
130356458|NCT01231347|469276328|FG002|Overall Study|Death|101|||
130356459|NCT01231347|469276326|FG000|Overall Study|other event|7|||
130356460|NCT01231347|469276327|FG001|Overall Study|other event|9|||
130356461|NCT01231347|469276328|FG002|Overall Study|other event|3|||
130356462|NCT02322021|469276329|FG000|Core Phase|Adverse Event|1|||
130356463|NCT02322021|469276330|FG001|Core Phase|Adverse Event|3|||
130356464|NCT02322021|469276331|FG002|Core Phase|Adverse Event|4|||
130356465|NCT02322021|469276332|FG003|Core Phase|Adverse Event|2|||
130356466|NCT02322021|469276333|FG004|Core Phase|Adverse Event|0|||
130356467|NCT02322021|469276329|FG000|Core Phase|Participant Choice|4|||
130356468|NCT02322021|469276330|FG001|Core Phase|Participant Choice|5|||
130356469|NCT02322021|469276331|FG002|Core Phase|Participant Choice|4|||
130356470|NCT02322021|469276332|FG003|Core Phase|Participant Choice|2|||
130691819|NCT03930732|470497872|FG001|Overall Study|Other reason not related to COVID-19|8|||
130356471|NCT02322021|469276333|FG004|Core Phase|Participant Choice|0|||
130356472|NCT02322021|469276329|FG000|Core Phase|Lost to Follow-up|0|||
130356473|NCT02322021|469276330|FG001|Core Phase|Lost to Follow-up|0|||
130356474|NCT02322021|469276331|FG002|Core Phase|Lost to Follow-up|0|||
130356475|NCT02322021|469276332|FG003|Core Phase|Lost to Follow-up|1|||
130356476|NCT02322021|469276333|FG004|Core Phase|Lost to Follow-up|0|||
130356477|NCT02322021|469276329|FG000|Core Phase|Other|0|||
130552895|NCT03291587|469991623|FG001|Overall Study|Refused to Answer|2|||
130356478|NCT02322021|469276330|FG001|Core Phase|Other|0|||
130230648|NCT03154086|468809727|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
130230649|NCT03154086|468809728|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
130230650|NCT03154086|468809729|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
130230651|NCT03154086|468809730|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
130230652|NCT03154086|468809731|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
130230653|NCT03154086|468809732|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
130230654|NCT03154086|468809733|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
130230655|NCT03154086|468809734|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
130230656|NCT01603277|468809735|FG000|Overall Study|Adverse Event|1|||
130230657|NCT01603277|468809736|FG001|Overall Study|Adverse Event|2|||
130230658|NCT01603277|468809735|FG000|Overall Study|Physician Decision|0|||
130230659|NCT01603277|468809736|FG001|Overall Study|Physician Decision|1|||
130230660|NCT01603277|468809735|FG000|Overall Study|Protocol Violation|6|||
130230661|NCT01603277|468809736|FG001|Overall Study|Protocol Violation|10|||
130230662|NCT01603277|468809735|FG000|Overall Study|Withdrawal by Subject|5|||
130230663|NCT01603277|468809736|FG001|Overall Study|Withdrawal by Subject|4|||
130230664|NCT01603277|468809735|FG000|Overall Study|Non-Compliance|2|||
130230665|NCT01603277|468809736|FG001|Overall Study|Non-Compliance|1|||
130230666|NCT04465422|468809739|FG000|Overall Study|Lost to Follow-up|0|||
130230667|NCT04465422|468809740|FG001|Overall Study|Lost to Follow-up|2|||
130230668|NCT02391337|468809741|FG000|6 Months Follow-up|Death|5|||
130230669|NCT02391337|468809742|FG001|6 Months Follow-up|Death|4|||
130230670|NCT02391337|468809741|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
130230671|NCT02391337|468809742|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
130230672|NCT02391337|468809741|FG000|12 Months Follow-up|Death|2|||
130230673|NCT02391337|468809742|FG001|12 Months Follow-up|Death|0|||
130230674|NCT02391337|468809741|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
130230675|NCT02391337|468809742|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
130230676|NCT02391337|468809741|FG000|12 Months Follow-up|Lost to Follow-up|0|||
130230677|NCT02391337|468809742|FG001|12 Months Follow-up|Lost to Follow-up|2|||
130230678|NCT00746551|468809743|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
130230679|NCT00746551|468809744|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
130230680|NCT00746551|468809743|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
130230681|NCT00746551|468809744|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
130230682|NCT00746551|468809743|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
130230683|NCT00746551|468809744|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
130230684|NCT00062166|468809745|FG000|Overall Study|Withdrawal by Subject|6|||
130230685|NCT00833755|468809746|FG000|Overall Study|Physician Decision|4|||
130230686|NCT00833755|468809747|FG001|Overall Study|Physician Decision|4|||
130230687|NCT00833755|468809748|FG002|Overall Study|Physician Decision|2|||
130230688|NCT00833755|468809749|FG003|Overall Study|Physician Decision|6|||
130230689|NCT00833755|468809746|FG000|Overall Study|Subject had scheduling issues|0|||
130230690|NCT00833755|468809747|FG001|Overall Study|Subject had scheduling issues|1|||
130230691|NCT00833755|468809748|FG002|Overall Study|Subject had scheduling issues|0|||
130230692|NCT00833755|468809749|FG003|Overall Study|Subject had scheduling issues|0|||
130230693|NCT01776554|468809752|FG000|Overall Study|Adverse Event|1|||
130230694|NCT01776554|468809753|FG001|Overall Study|Adverse Event|0|||
130230695|NCT01776554|468809752|FG000|Overall Study|Withdrawal by Subject|3|||
130230696|NCT01776554|468809753|FG001|Overall Study|Withdrawal by Subject|8|||
130230697|NCT01776554|468809752|FG000|Overall Study|Lost to Follow-up|6|||
130230698|NCT01776554|468809753|FG001|Overall Study|Lost to Follow-up|9|||
130230699|NCT01776554|468809752|FG000|Overall Study|Administrative Reason|2|||
130230700|NCT01776554|468809753|FG001|Overall Study|Administrative Reason|5|||
130230701|NCT01776554|468809752|FG000|Overall Study|Protocol Violation|1|||
130230702|NCT01776554|468809753|FG001|Overall Study|Protocol Violation|0|||
130230703|NCT01776554|468809752|FG000|Overall Study|Unclassified|4|||
130230704|NCT01776554|468809753|FG001|Overall Study|Unclassified|1|||
130230705|NCT02475369|468809754|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
130230706|NCT02475369|468809755|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
130230707|NCT03608826|468809757|FG000|Overall Study|Death|3|||
130230708|NCT03608826|468809757|FG000|Overall Study|Heart Transplant|3|||
130230709|NCT03608826|468809757|FG000|Overall Study|Physician Decision|4|||
130230710|NCT03122171|468809758|FG000|Overall Study|Withdrawal by Subject|1|||
130230711|NCT00617279|468809770|FG000|Overall Study|Study terminated by Sponsor|10|||
130230712|NCT00617279|468809771|FG001|Overall Study|Study terminated by Sponsor|15|||
130230713|NCT00617279|468809770|FG000|Overall Study|Graft abandonment|2|||
130230714|NCT00617279|468809771|FG001|Overall Study|Graft abandonment|0|||
130230715|NCT00617279|468809770|FG000|Overall Study|Lost to Follow-up|1|||
130230716|NCT00617279|468809771|FG001|Overall Study|Lost to Follow-up|0|||
130230717|NCT00617279|468809770|FG000|Overall Study|Death|1|||
130230718|NCT00617279|468809771|FG001|Overall Study|Death|2|||
130230719|NCT00921024|468809774|FG000|Overall Study|Lost to Follow-up|2|||
130230720|NCT00921024|468809775|FG001|Overall Study|Lost to Follow-up|0|||
130230721|NCT00921024|468809774|FG000|Overall Study|Received concomittant therapy|2|||
130230722|NCT00921024|468809775|FG001|Overall Study|Received concomittant therapy|0|||
130356479|NCT02322021|469276331|FG002|Core Phase|Other|1|||
130230723|NCT00921024|468809774|FG000|Overall Study|Withdrawal by Subject|0|||
130230724|NCT00921024|468809775|FG001|Overall Study|Withdrawal by Subject|3|||
130230725|NCT03415178|468809777|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
130230726|NCT03415178|468809778|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
130230727|NCT03415178|468809777|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
130230728|NCT03415178|468809778|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
130230729|NCT00753519|468811472|FG000|Overall Study|Withdrawal by Subject|0|||
130230730|NCT00753519|468811473|FG001|Overall Study|Withdrawal by Subject|2|||
130230731|NCT02807259|468811474|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
130230732|NCT02807259|468811475|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
130230733|NCT02807259|468811474|FG000|Midline (3 Months)|migration, refusal, not available|30|||
130230734|NCT02807259|468811475|FG001|Midline (3 Months)|migration, refusal, not available|34|||
130230735|NCT02807259|468811474|FG000|Endline (3 Months)|migration, refusal, not available|35|||
130230736|NCT02807259|468811475|FG001|Endline (3 Months)|migration, refusal, not available|87|||
130230737|NCT03861039|468811476|FG000|Overall Study|Adverse Event|2|||
130230738|NCT03861039|468811477|FG001|Overall Study|Adverse Event|5|||
130230739|NCT03861039|468811478|FG002|Overall Study|Adverse Event|11|||
130230740|NCT03861039|468811476|FG000|Overall Study|Withdrawal by Subject|1|||
130230741|NCT03861039|468811477|FG001|Overall Study|Withdrawal by Subject|3|||
130230742|NCT03861039|468811478|FG002|Overall Study|Withdrawal by Subject|4|||
130230743|NCT02791269|468811494|FG000|Overall Study|Lost to Follow-up|0|||
130230744|NCT02791269|468811495|FG001|Overall Study|Lost to Follow-up|1|||
130230745|NCT00420745|468811496|FG000|Overall Study|Adverse Event|2|||
130230746|NCT00420745|468811497|FG001|Overall Study|Adverse Event|2|||
130230747|NCT00420745|468811496|FG000|Overall Study|Lost to Follow-up|10|||
130230748|NCT00420745|468811497|FG001|Overall Study|Lost to Follow-up|2|||
130230749|NCT00420745|468811496|FG000|Overall Study|Protocol Violation|1|||
130230750|NCT00420745|468811497|FG001|Overall Study|Protocol Violation|0|||
130230751|NCT00420745|468811496|FG000|Overall Study|Physician Decision|1|||
130230752|NCT00420745|468811497|FG001|Overall Study|Physician Decision|1|||
130230753|NCT00420745|468811496|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
130230754|NCT00420745|468811497|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
130230755|NCT00420745|468811496|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
130230756|NCT00420745|468811497|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
130230757|NCT01125930|468811498|FG000|Overall Study|Adverse Event|0|||
130230758|NCT01125930|468811499|FG001|Overall Study|Adverse Event|1|||
130230759|NCT01125930|468811498|FG000|Overall Study|Withdrawal by Subject|1|||
130230760|NCT01125930|468811499|FG001|Overall Study|Withdrawal by Subject|6|||
130230761|NCT01125930|468811498|FG000|Overall Study|Protocol Violation|0|||
130230762|NCT01125930|468811499|FG001|Overall Study|Protocol Violation|1|||
130230763|NCT01125930|468811498|FG000|Overall Study|Lost to Follow-up|0|||
130230764|NCT01125930|468811499|FG001|Overall Study|Lost to Follow-up|2|||
130691820|NCT03406156|470497873|FG000|Overall Study|Death|9|||
130691821|NCT03406156|470497874|FG001|Overall Study|Death|3|||
130691822|NCT03406156|470497873|FG000|Overall Study|Withdrawal by Subject|1|||
130691823|NCT03406156|470497874|FG001|Overall Study|Withdrawal by Subject|2|||
130691824|NCT03406156|470497873|FG000|Overall Study|COVID-19 infection|1|||
130691825|NCT03406156|470497874|FG001|Overall Study|COVID-19 infection|0|||
130691826|NCT03406156|470497873|FG000|Overall Study|Non-compliance with study procedures|1|||
130691827|NCT03406156|470497874|FG001|Overall Study|Non-compliance with study procedures|1|||
130691828|NCT03406156|470497873|FG000|Overall Study|Lost to Follow-up|0|||
130691829|NCT03406156|470497874|FG001|Overall Study|Lost to Follow-up|2|||
130691830|NCT03406156|470497873|FG000|Overall Study|Other, not specified|72|||
130691831|NCT03406156|470497874|FG001|Overall Study|Other, not specified|28|||
130230765|NCT03098979|468811500|FG000|Overall Study|Adverse Event|1|||
130230766|NCT03098979|468811501|FG001|Overall Study|Adverse Event|0|||
130230767|NCT03098979|468811502|FG002|Overall Study|Adverse Event|1|||
130230768|NCT03098979|468811503|FG003|Overall Study|Adverse Event|4|||
130230769|NCT03098979|468811504|FG004|Overall Study|Adverse Event|6|||
130230770|NCT03098979|468811505|FG005|Overall Study|Adverse Event|1|||
130230771|NCT03098979|468811500|FG000|Overall Study|Withdrawal by Subject|2|||
130230772|NCT03098979|468811501|FG001|Overall Study|Withdrawal by Subject|1|||
130230773|NCT03098979|468811502|FG002|Overall Study|Withdrawal by Subject|1|||
130230774|NCT03098979|468811503|FG003|Overall Study|Withdrawal by Subject|1|||
130230775|NCT03098979|468811504|FG004|Overall Study|Withdrawal by Subject|2|||
130230776|NCT03098979|468811505|FG005|Overall Study|Withdrawal by Subject|1|||
130230777|NCT03098979|468811500|FG000|Overall Study|Death|1|||
130230778|NCT03098979|468811501|FG001|Overall Study|Death|0|||
130230779|NCT03098979|468811502|FG002|Overall Study|Death|2|||
130691832|NCT03366792|470497877|FG000|Overall Study|Withdrawal by Subject|7|||
130691833|NCT03366792|470497877|FG000|Overall Study|Lost to Follow-up|2|||
130691834|NCT03366792|470497877|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
130230780|NCT03098979|468811503|FG003|Overall Study|Death|0|||
130230781|NCT03098979|468811504|FG004|Overall Study|Death|1|||
130230782|NCT03098979|468811505|FG005|Overall Study|Death|0|||
130230783|NCT03098979|468811500|FG000|Overall Study|Physician Decision|2|||
130230784|NCT03098979|468811501|FG001|Overall Study|Physician Decision|1|||
130230785|NCT03098979|468811502|FG002|Overall Study|Physician Decision|0|||
130230786|NCT03098979|468811503|FG003|Overall Study|Physician Decision|0|||
130230787|NCT03098979|468811504|FG004|Overall Study|Physician Decision|0|||
130230788|NCT03098979|468811505|FG005|Overall Study|Physician Decision|0|||
130230789|NCT03098979|468811500|FG000|Overall Study|Non-compliance|0|||
130230790|NCT03098979|468811501|FG001|Overall Study|Non-compliance|0|||
130230791|NCT03098979|468811502|FG002|Overall Study|Non-compliance|0|||
130230792|NCT03098979|468811503|FG003|Overall Study|Non-compliance|0|||
130230793|NCT03098979|468811504|FG004|Overall Study|Non-compliance|0|||
130230794|NCT03098979|468811505|FG005|Overall Study|Non-compliance|1|||
130230795|NCT03098979|468811500|FG000|Overall Study|Protocol Violation|0|||
130230796|NCT03098979|468811501|FG001|Overall Study|Protocol Violation|0|||
130230797|NCT03098979|468811502|FG002|Overall Study|Protocol Violation|0|||
130230798|NCT03098979|468811503|FG003|Overall Study|Protocol Violation|0|||
130230799|NCT03098979|468811504|FG004|Overall Study|Protocol Violation|0|||
130230800|NCT03098979|468811505|FG005|Overall Study|Protocol Violation|1|||
130230801|NCT02426684|468811506|FG000|Overall Study|Physician Decision|1|||
130230802|NCT02369653|468811507|FG000|Overall Study|Lost to Follow-up|0|||
130230803|NCT02369653|468811508|FG001|Overall Study|Lost to Follow-up|1|||
130230804|NCT02369653|468811507|FG000|Overall Study|Administrative reason by sponsor|0|||
130230805|NCT02369653|468811508|FG001|Overall Study|Administrative reason by sponsor|1|||
130230806|NCT02369653|468811507|FG000|Overall Study|Death|1|||
130230807|NCT02369653|468811508|FG001|Overall Study|Death|2|||
130230808|NCT02369653|468811507|FG000|Overall Study|Participant withdrew consent|13|||
130230809|NCT02369653|468811508|FG001|Overall Study|Participant withdrew consent|3|||
130230810|NCT03587636|468811509|FG000|Overall Study|Lost to Follow-up|2|||
130230811|NCT03587636|468811510|FG001|Overall Study|Lost to Follow-up|5|||
130230812|NCT03248037|468811511|FG000|Overall Study|Withdrawal by Subject|6|||
130230813|NCT03248037|468811512|FG001|Overall Study|Withdrawal by Subject|9|||
130230814|NCT03248037|468811511|FG000|Overall Study|Adverse Event|15|||
130230815|NCT03248037|468811512|FG001|Overall Study|Adverse Event|0|||
130230816|NCT02897349|468811513|FG000|Overall Study|Lost to Follow-up|2|||
130230817|NCT02897349|468811514|FG001|Overall Study|Lost to Follow-up|2|||
130230818|NCT02897349|468811513|FG000|Overall Study|Adverse Event|3|||
130230819|NCT02897349|468811514|FG001|Overall Study|Adverse Event|3|||
130230820|NCT02897349|468811513|FG000|Overall Study|Other than listed above|0|||
130230821|NCT02897349|468811514|FG001|Overall Study|Other than listed above|1|||
130230822|NCT00671749|468811521|FG000|Overall Study|Adverse Event|2|||
130230823|NCT00671749|468811521|FG000|Overall Study|Withdrawal by Subject|4|||
130230824|NCT00671749|468811521|FG000|Overall Study|Protocol Violation|1|||
130230825|NCT00671749|468811521|FG000|Overall Study|Lost to Follow-up|1|||
130230826|NCT02515227|468811522|FG000|Overall Study|Adverse Event|0|||
130230827|NCT02515227|468811523|FG001|Overall Study|Adverse Event|2|||
130230828|NCT02515227|468811522|FG000|Overall Study|Progressive disease|2|||
130230829|NCT02515227|468811523|FG001|Overall Study|Progressive disease|9|||
130230830|NCT01259245|468811524|FG000|Overall Study|Withdrawal by Subject|27|||
130230831|NCT01259245|468811525|FG001|Overall Study|Withdrawal by Subject|24|||
130230832|NCT01259245|468811524|FG000|Overall Study|Death|1|||
130230833|NCT01259245|468811525|FG001|Overall Study|Death|2|||
130230834|NCT03363906|468811535|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
130230835|NCT03363906|468811536|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
130230836|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
130230837|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
130230838|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130445113|NCT02397460|469590375|FG006|Treatment Period 4|Adverse Event|0|||
130445114|NCT02397460|469590376|FG007|Treatment Period 4|Adverse Event|0|||
130445115|NCT02397460|469590369|FG000|Treatment Period 4|Physician Decision|0|||
130445116|NCT02397460|469590370|FG001|Treatment Period 4|Physician Decision|0|||
130445117|NCT02397460|469590371|FG002|Treatment Period 4|Physician Decision|0|||
130445118|NCT02397460|469590372|FG003|Treatment Period 4|Physician Decision|0|||
130445119|NCT02397460|469590373|FG004|Treatment Period 4|Physician Decision|1|||
130445120|NCT02397460|469590374|FG005|Treatment Period 4|Physician Decision|0|||
130230839|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130230840|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
130230841|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
130230842|NCT02714153|468811538|FG000|Overall Study|Death|1|||
130230843|NCT00087178|468811541|FG000|Overall Study|No follow up data|5|||
130230844|NCT00087178|468811542|FG001|Overall Study|No follow up data|15|||
130445121|NCT02397460|469590375|FG006|Treatment Period 4|Physician Decision|0|||
130230845|NCT00087178|468811541|FG000|Overall Study|No clinical assessment|1|||
130230846|NCT00087178|468811542|FG001|Overall Study|No clinical assessment|2|||
130445122|NCT02397460|469590376|FG007|Treatment Period 4|Physician Decision|0|||
130445123|NCT01406717|469590377|FG000|Overall Study|Subject non-compliance|4|||
130230847|NCT00087178|468811541|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
130230848|NCT00087178|468811542|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
130230849|NCT01692119|468811557|FG000|Overall Study|Protocol Violation|3|||
130230850|NCT01692119|468811558|FG001|Overall Study|Protocol Violation|1|||
130230851|NCT01692119|468811557|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
130230852|NCT01692119|468811558|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
130230853|NCT00997893|468811559|FG000|Overall Study|Adverse Event|1|||
130230854|NCT00997893|468811560|FG001|Overall Study|Adverse Event|0|||
130230855|NCT00997893|468811561|FG002|Overall Study|Adverse Event|0|||
130230856|NCT00997893|468811559|FG000|Overall Study|Unable to meet study timelines|1|||
130230857|NCT00997893|468811560|FG001|Overall Study|Unable to meet study timelines|0|||
130230858|NCT00997893|468811561|FG002|Overall Study|Unable to meet study timelines|0|||
130230859|NCT00997893|468811559|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
130230860|NCT00997893|468811560|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
130230861|NCT00997893|468811561|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
130230862|NCT01142336|468811564|FG000|Overall Study|Adverse Event|1|||
130230863|NCT01142336|468811565|FG001|Overall Study|Adverse Event|1|||
130230864|NCT01142336|468811564|FG000|Overall Study|Lost to Follow-up|0|||
130230865|NCT01142336|468811565|FG001|Overall Study|Lost to Follow-up|1|||
130230866|NCT02029417|468811566|FG000|Overall Study|Death|1|||
130230867|NCT02029417|468811566|FG000|Overall Study|Adverse Event|1|||
130230868|NCT05219162|468811569|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
130230869|NCT05219162|468811569|FG000|Overall Study|Withdrawal by Subject|23|||
130230870|NCT00171249|468811572|FG000|Overall Study|Withdrawal by Subject|2|||
130230871|NCT00171249|468811573|FG001|Overall Study|Withdrawal by Subject|0|||
130230872|NCT00171249|468811574|FG002|Overall Study|Withdrawal by Subject|0|||
130230873|NCT00171249|468811575|FG003|Overall Study|Withdrawal by Subject|6|||
130230874|NCT00171249|468811576|FG004|Overall Study|Withdrawal by Subject|0|||
130230875|NCT00171249|468811577|FG005|Overall Study|Withdrawal by Subject|0|||
130230876|NCT00171249|468811578|FG006|Overall Study|Withdrawal by Subject|0|||
130230877|NCT00171249|468811572|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
130230878|NCT00171249|468811573|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130230879|NCT00171249|468811574|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
130230880|NCT00171249|468811575|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
130230881|NCT00171249|468811576|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130230882|NCT00171249|468811577|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
130230883|NCT00171249|468811578|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130230884|NCT00171249|468811572|FG000|Overall Study|Death|7|||
130230885|NCT00171249|468811573|FG001|Overall Study|Death|1|||
130230886|NCT00171249|468811574|FG002|Overall Study|Death|0|||
130230887|NCT00171249|468811575|FG003|Overall Study|Death|4|||
130230888|NCT00171249|468811576|FG004|Overall Study|Death|0|||
130230889|NCT00171249|468811577|FG005|Overall Study|Death|3|||
130230890|NCT00171249|468811578|FG006|Overall Study|Death|1|||
130230891|NCT00171249|468811572|FG000|Overall Study|Other|10|||
130230892|NCT00171249|468811573|FG001|Overall Study|Other|0|||
130230893|NCT00171249|468811574|FG002|Overall Study|Other|0|||
130691835|NCT03366792|470497877|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
130691836|NCT02450539|470497878|FG000|Overall Study|Withdrawal by Subject|12|||
130691837|NCT02450539|470497879|FG001|Overall Study|Withdrawal by Subject|6|||
130691838|NCT02450539|470497878|FG000|Overall Study|Lost to Follow-up|4|||
130691839|NCT02450539|470497879|FG001|Overall Study|Lost to Follow-up|1|||
130691840|NCT02699463|470497880|FG000|Overall Study|Lost to Follow-up|11|||
130691841|NCT02699463|470497881|FG001|Overall Study|Lost to Follow-up|8|||
130691842|NCT02699463|470497880|FG000|Overall Study|Withdrawal by Subject|4|||
130691843|NCT02699463|470497881|FG001|Overall Study|Withdrawal by Subject|1|||
130691844|NCT01808651|470497882|FG000|Study Period 1|Lost to Follow-up|1|||
130691845|NCT01808651|470497883|FG001|Study Period 1|Lost to Follow-up|3|||
130230894|NCT00171249|468811575|FG003|Overall Study|Other|43|||
130691846|NCT01808651|470497884|FG002|Study Period 1|Lost to Follow-up|0|||
130691847|NCT01808651|470497882|FG000|Study Period 1|Protocol Violation|1|||
130691848|NCT01808651|470497883|FG001|Study Period 1|Protocol Violation|0|||
130691849|NCT01808651|470497884|FG002|Study Period 1|Protocol Violation|1|||
130691850|NCT01808651|470497882|FG000|Study Period 1|Physician Decision|3|||
130230895|NCT00171249|468811576|FG004|Overall Study|Other|0|||
130230896|NCT00171249|468811577|FG005|Overall Study|Other|2|||
130230897|NCT00171249|468811578|FG006|Overall Study|Other|0|||
130230898|NCT00171249|468811572|FG000|Overall Study|No Longer Requires Study Drug|4|||
130691851|NCT01808651|470497883|FG001|Study Period 1|Physician Decision|2|||
130230899|NCT00171249|468811573|FG001|Overall Study|No Longer Requires Study Drug|0|||
130230900|NCT00171249|468811574|FG002|Overall Study|No Longer Requires Study Drug|0|||
130230901|NCT00171249|468811575|FG003|Overall Study|No Longer Requires Study Drug|3|||
130230902|NCT00171249|468811576|FG004|Overall Study|No Longer Requires Study Drug|0|||
130356480|NCT02322021|469276332|FG003|Core Phase|Other|0|||
130356481|NCT02322021|469276333|FG004|Core Phase|Other|0|||
130356482|NCT02322021|469276329|FG000|Extension Phase|Adverse Event|0|||
130356483|NCT02322021|469276330|FG001|Extension Phase|Adverse Event|0|||
130356484|NCT02322021|469276331|FG002|Extension Phase|Adverse Event|0|||
130356485|NCT02322021|469276332|FG003|Extension Phase|Adverse Event|0|||
130230903|NCT00171249|468811577|FG005|Overall Study|No Longer Requires Study Drug|5|||
130356486|NCT02322021|469276333|FG004|Extension Phase|Adverse Event|3|||
130691852|NCT01808651|470497884|FG002|Study Period 1|Physician Decision|0|||
130691853|NCT01808651|470497882|FG000|Study Period 1|Lack of Efficacy|2|||
130691854|NCT01808651|470497883|FG001|Study Period 1|Lack of Efficacy|1|||
130691855|NCT01808651|470497884|FG002|Study Period 1|Lack of Efficacy|0|||
130691856|NCT01808651|470497882|FG000|Study Period 1|Adverse Event|10|||
130691857|NCT01808651|470497883|FG001|Study Period 1|Adverse Event|4|||
130691858|NCT01808651|470497884|FG002|Study Period 1|Adverse Event|1|||
130691859|NCT01808651|470497882|FG000|Study Period 1|Participant Decision|9|||
130691860|NCT01808651|470497883|FG001|Study Period 1|Participant Decision|7|||
130691861|NCT01808651|470497884|FG002|Study Period 1|Participant Decision|3|||
130691862|NCT00585286|470497888|FG000|Overall Study|Lost to Follow-up|1|||
130691863|NCT03957551|470497889|FG000|Overall Study|Adverse Event|2|||
130691864|NCT03957551|470497890|FG001|Overall Study|Adverse Event|2|||
130691865|NCT03957551|470497891|FG002|Overall Study|Adverse Event|6|||
130691866|NCT03957551|470497889|FG000|Overall Study|Physician Decision|1|||
130230904|NCT00171249|468811578|FG006|Overall Study|No Longer Requires Study Drug|0|||
130230905|NCT00171249|468811572|FG000|Overall Study|Administrative Problems|1|||
130230906|NCT00171249|468811573|FG001|Overall Study|Administrative Problems|0|||
130230907|NCT00171249|468811574|FG002|Overall Study|Administrative Problems|0|||
130230908|NCT00171249|468811575|FG003|Overall Study|Administrative Problems|2|||
130230909|NCT00171249|468811576|FG004|Overall Study|Administrative Problems|0|||
130691867|NCT03957551|470497890|FG001|Overall Study|Physician Decision|0|||
130691868|NCT03957551|470497891|FG002|Overall Study|Physician Decision|2|||
130691869|NCT03957551|470497889|FG000|Overall Study|Withdrawal by Subject|1|||
130691870|NCT03957551|470497890|FG001|Overall Study|Withdrawal by Subject|0|||
130691871|NCT03957551|470497891|FG002|Overall Study|Withdrawal by Subject|2|||
130691872|NCT03957551|470497889|FG000|Overall Study|Disease progression|1|||
130691873|NCT03957551|470497890|FG001|Overall Study|Disease progression|0|||
130691874|NCT03957551|470497891|FG002|Overall Study|Disease progression|8|||
130691875|NCT02294981|470497899|FG000|Overall Study|Lost to Follow-up|1|||
130230910|NCT00171249|468811577|FG005|Overall Study|Administrative Problems|0|||
130230911|NCT00171249|468811578|FG006|Overall Study|Administrative Problems|0|||
130356487|NCT02322021|469276329|FG000|Extension Phase|Participant Choice|0|||
130356488|NCT02322021|469276330|FG001|Extension Phase|Participant Choice|0|||
130691876|NCT00829712|470497900|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130691877|NCT00829712|470497901|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130691878|NCT00606281|470497902|FG000|Overall Study|Adverse Event|11|||
130691879|NCT00606281|470497903|FG001|Overall Study|Adverse Event|12|||
130691880|NCT00606281|470497902|FG000|Overall Study|Death|1|||
130691881|NCT00606281|470497903|FG001|Overall Study|Death|0|||
130691882|NCT00606281|470497902|FG000|Overall Study|Lack of Efficacy|28|||
130691883|NCT00606281|470497903|FG001|Overall Study|Lack of Efficacy|35|||
130691884|NCT00606281|470497902|FG000|Overall Study|Physician Decision|0|||
130691885|NCT00606281|470497903|FG001|Overall Study|Physician Decision|1|||
130691886|NCT00606281|470497902|FG000|Overall Study|Protocol Violation|3|||
130691887|NCT00606281|470497903|FG001|Overall Study|Protocol Violation|3|||
130691888|NCT00606281|470497902|FG000|Overall Study|Withdrawal by Subject|11|||
130691889|NCT00606281|470497903|FG001|Overall Study|Withdrawal by Subject|13|||
130691890|NCT00606281|470497902|FG000|Overall Study|Progression to depressive phase|1|||
130691891|NCT00606281|470497903|FG001|Overall Study|Progression to depressive phase|1|||
130691892|NCT00606281|470497902|FG000|Overall Study|Change of residence or other commitments|1|||
130691893|NCT00606281|470497903|FG001|Overall Study|Change of residence or other commitments|1|||
130691894|NCT00263588|470497904|FG000|Overall Study|Death|54|||
130691895|NCT00263588|470497905|FG001|Overall Study|Death|90|||
130691896|NCT00263588|470497904|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
130691897|NCT00263588|470497905|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
130691898|NCT00263588|470497904|FG000|Overall Study|Lost to Follow-up|7|||
130356489|NCT02322021|469276331|FG002|Extension Phase|Participant Choice|0|||
130356490|NCT02322021|469276332|FG003|Extension Phase|Participant Choice|0|||
130356491|NCT02322021|469276333|FG004|Extension Phase|Participant Choice|6|||
130356492|NCT02322021|469276329|FG000|Extension Phase|Other|0|||
130691899|NCT00263588|470497905|FG001|Overall Study|Lost to Follow-up|10|||
130691900|NCT00263588|470497904|FG000|Overall Study|Withdrawal by Subject|3|||
130691901|NCT00263588|470497905|FG001|Overall Study|Withdrawal by Subject|4|||
130691902|NCT00263588|470497904|FG000|Overall Study|Protocol Violation|0|||
130691903|NCT00263588|470497905|FG001|Overall Study|Protocol Violation|1|||
130230912|NCT00171249|468811572|FG000|Overall Study|Adverse Event|3|||
130230913|NCT00171249|468811573|FG001|Overall Study|Adverse Event|1|||
130356493|NCT02322021|469276330|FG001|Extension Phase|Other|0|||
130356494|NCT02322021|469276331|FG002|Extension Phase|Other|0|||
130356495|NCT02322021|469276332|FG003|Extension Phase|Other|0|||
130356496|NCT02322021|469276333|FG004|Extension Phase|Other|3|||
130691904|NCT00263588|470497904|FG000|Overall Study|Investigator decision|7|||
130691905|NCT00263588|470497905|FG001|Overall Study|Investigator decision|15|||
130691906|NCT00263588|470497904|FG000|Overall Study|Sponsor terminated study|0|||
130691907|NCT00263588|470497905|FG001|Overall Study|Sponsor terminated study|1|||
130691908|NCT00918684|470497906|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
130230914|NCT00171249|468811574|FG002|Overall Study|Adverse Event|0|||
130691909|NCT00918684|470497906|FG000|Treatment Phase|Lack of Efficacy|6|||
130691910|NCT00918684|470497906|FG000|Treatment Phase|Lost to Follow-up|2|||
130691911|NCT00918684|470497906|FG000|Treatment Phase|Physician Decision|8|||
130691912|NCT00918684|470497906|FG000|Treatment Phase|Protocol Violation|1|||
130691913|NCT00918684|470497906|FG000|Treatment Phase|Withdrawal by Subject|8|||
130691914|NCT00909038|470497907|FG000|Overall Study|Protocol Violation|187|||
130691915|NCT00909038|470497907|FG000|Overall Study|Non-evaluable Subjects|230|||
130691916|NCT00484679|470497910|FG000|Overall Study|Withdrawal by Subject|3|||
130691917|NCT00402103|470497911|FG000|Overall Study|Adverse Event|60|||
130691918|NCT00402103|470497912|FG001|Overall Study|Adverse Event|7|||
130691919|NCT00402103|470497911|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130691920|NCT00402103|470497912|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130691921|NCT00402103|470497911|FG000|Overall Study|Condition no longer requires study drug|2|||
130691922|NCT00402103|470497912|FG001|Overall Study|Condition no longer requires study drug|0|||
130691923|NCT00402103|470497911|FG000|Overall Study|Protocol Deviation|8|||
130691924|NCT00402103|470497912|FG001|Overall Study|Protocol Deviation|0|||
130691925|NCT00402103|470497911|FG000|Overall Study|Patient withdrew consent|12|||
130691926|NCT00402103|470497912|FG001|Overall Study|Patient withdrew consent|1|||
130691927|NCT00402103|470497911|FG000|Overall Study|Lost to Follow-up|6|||
130691928|NCT00402103|470497912|FG001|Overall Study|Lost to Follow-up|3|||
130691929|NCT00402103|470497911|FG000|Overall Study|Administrative problems|2|||
130691930|NCT00402103|470497912|FG001|Overall Study|Administrative problems|0|||
130691931|NCT00835692|470497913|FG000|First Intervention|Withdrawal by Subject|1|||
130691932|NCT00835692|470497914|FG001|First Intervention|Withdrawal by Subject|0|||
130691933|NCT04345653|470497917|FG000|Overall Study|Withdrawal by Subject|2|||
130230915|NCT00171249|468811575|FG003|Overall Study|Adverse Event|15|||
130230916|NCT00171249|468811576|FG004|Overall Study|Adverse Event|0|||
130230917|NCT00171249|468811577|FG005|Overall Study|Adverse Event|2|||
130230918|NCT00171249|468811578|FG006|Overall Study|Adverse Event|0|||
130230919|NCT00171249|468811572|FG000|Overall Study|Lost to Follow-up|5|||
130230920|NCT00171249|468811573|FG001|Overall Study|Lost to Follow-up|0|||
130230921|NCT00171249|468811574|FG002|Overall Study|Lost to Follow-up|0|||
130230922|NCT00171249|468811575|FG003|Overall Study|Lost to Follow-up|9|||
130230923|NCT00171249|468811576|FG004|Overall Study|Lost to Follow-up|0|||
130230924|NCT00171249|468811577|FG005|Overall Study|Lost to Follow-up|0|||
130230925|NCT00171249|468811578|FG006|Overall Study|Lost to Follow-up|0|||
130230926|NCT01041859|468811579|FG000|Open-Label Titration|Adverse Event|69|||
130230927|NCT01041859|468811580|FG001|Open-Label Titration|Adverse Event|0|||
130230928|NCT01041859|468811581|FG002|Open-Label Titration|Adverse Event|0|||
130230929|NCT01041859|468811579|FG000|Open-Label Titration|Lack of Efficacy|3|||
130230930|NCT01041859|468811580|FG001|Open-Label Titration|Lack of Efficacy|0|||
130230931|NCT01041859|468811581|FG002|Open-Label Titration|Lack of Efficacy|0|||
130356497|NCT02322021|469276329|FG000|Extension Phase|Lost to Follow-up|0|||
130356498|NCT02322021|469276330|FG001|Extension Phase|Lost to Follow-up|0|||
130356499|NCT02322021|469276331|FG002|Extension Phase|Lost to Follow-up|0|||
130356500|NCT02322021|469276332|FG003|Extension Phase|Lost to Follow-up|0|||
130356501|NCT02322021|469276333|FG004|Extension Phase|Lost to Follow-up|1|||
130356502|NCT02322021|469276329|FG000|Extension Phase|Study terminated by sponsor|0|||
130356503|NCT02322021|469276330|FG001|Extension Phase|Study terminated by sponsor|0|||
130356504|NCT02322021|469276331|FG002|Extension Phase|Study terminated by sponsor|0|||
130356505|NCT02322021|469276332|FG003|Extension Phase|Study terminated by sponsor|0|||
130356506|NCT02322021|469276333|FG004|Extension Phase|Study terminated by sponsor|28|||
130356507|NCT01702571|469276334|FG000|Overall Study|Death|1067|||
130356508|NCT01702571|469276335|FG001|Overall Study|Death|76|||
130356509|NCT01702571|469276334|FG000|Overall Study|Lost to Follow-up|144|||
130356510|NCT01702571|469276335|FG001|Overall Study|Lost to Follow-up|10|||
130356511|NCT01702571|469276334|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
130356512|NCT01702571|469276335|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
130356513|NCT01702571|469276334|FG000|Overall Study|Investigator Decision|5|||
130356514|NCT01702571|469276335|FG001|Overall Study|Investigator Decision|0|||
130691934|NCT04078022|470497918|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
130691935|NCT04078022|470497919|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
130691936|NCT01895335|470497924|FG000|Overall Study|Adverse Event|106|||
130230932|NCT01041859|468811579|FG000|Open-Label Titration|Lost to Follow-up|1|||
130356515|NCT01702571|469276334|FG000|Overall Study|Not Classifiable|1|||
130356516|NCT01702571|469276335|FG001|Overall Study|Not Classifiable|0|||
130356517|NCT01702571|469276334|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
130356518|NCT01702571|469276335|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
130356519|NCT01702571|469276334|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
130691937|NCT01895335|470497924|FG000|Overall Study|Lack of Efficacy|53|||
130230933|NCT01041859|468811580|FG001|Open-Label Titration|Lost to Follow-up|0|||
130230934|NCT01041859|468811581|FG002|Open-Label Titration|Lost to Follow-up|0|||
130230935|NCT01041859|468811579|FG000|Open-Label Titration|Physician Decision|1|||
130230936|NCT01041859|468811580|FG001|Open-Label Titration|Physician Decision|0|||
130356520|NCT01702571|469276335|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
130691938|NCT01895335|470497924|FG000|Overall Study|Poor Compliance to Protocol|11|||
130230937|NCT01041859|468811581|FG002|Open-Label Titration|Physician Decision|0|||
130230938|NCT01041859|468811579|FG000|Open-Label Titration|Protocol Violation|1|||
130230939|NCT01041859|468811580|FG001|Open-Label Titration|Protocol Violation|0|||
130230940|NCT01041859|468811581|FG002|Open-Label Titration|Protocol Violation|0|||
130230941|NCT01041859|468811579|FG000|Open-Label Titration|Other|7|||
130230942|NCT01041859|468811580|FG001|Open-Label Titration|Other|0|||
130230943|NCT01041859|468811581|FG002|Open-Label Titration|Other|0|||
130230944|NCT01041859|468811579|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
130230945|NCT01041859|468811580|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
130230946|NCT01041859|468811581|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
130230947|NCT01041859|468811579|FG000|Open-Label Titration|Withdrawal by Subject|11|||
130230948|NCT01041859|468811580|FG001|Open-Label Titration|Withdrawal by Subject|0|||
130230949|NCT01041859|468811581|FG002|Open-Label Titration|Withdrawal by Subject|0|||
130230950|NCT01041859|468811579|FG000|Double-Blind Maintenance|Adverse Event|0|||
130230951|NCT01041859|468811580|FG001|Double-Blind Maintenance|Adverse Event|23|||
130230952|NCT01041859|468811581|FG002|Double-Blind Maintenance|Adverse Event|13|||
130230953|NCT01041859|468811579|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
130230954|NCT01041859|468811580|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
130230955|NCT01041859|468811581|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
130230956|NCT01041859|468811579|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
130230957|NCT01041859|468811580|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
130230958|NCT01041859|468811581|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
130230959|NCT01041859|468811579|FG000|Double-Blind Maintenance|Physician Decision|0|||
130230960|NCT01041859|468811580|FG001|Double-Blind Maintenance|Physician Decision|2|||
130230961|NCT01041859|468811581|FG002|Double-Blind Maintenance|Physician Decision|1|||
130356521|NCT01702571|469276334|FG000|Overall Study|Progressive Disease|3|||
130356522|NCT01702571|469276335|FG001|Overall Study|Progressive Disease|0|||
130356523|NCT01702571|469276334|FG000|Overall Study|Protocol Violation|2|||
130356524|NCT01702571|469276335|FG001|Overall Study|Protocol Violation|0|||
130356525|NCT01702571|469276334|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
130356526|NCT01702571|469276335|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
130356527|NCT01702571|469276334|FG000|Overall Study|Termination By Sponsor|4|||
130356528|NCT01702571|469276335|FG001|Overall Study|Termination By Sponsor|0|||
130356529|NCT01702571|469276334|FG000|Overall Study|Withdrawal by Subject|177|||
130356530|NCT01702571|469276335|FG001|Overall Study|Withdrawal by Subject|29|||
130356531|NCT02047227|469276336|FG000|Overall Study|Adverse Event|2|||
130356532|NCT02047227|469276337|FG001|Overall Study|Adverse Event|4|||
130356533|NCT02047227|469276336|FG000|Overall Study|Lost to Follow-up|0|||
130356534|NCT02047227|469276337|FG001|Overall Study|Lost to Follow-up|3|||
130356535|NCT02047227|469276336|FG000|Overall Study|Protocol Violation|1|||
130356536|NCT02047227|469276337|FG001|Overall Study|Protocol Violation|0|||
130356537|NCT02047227|469276336|FG000|Overall Study|Spontaneous pregnancy|1|||
130356538|NCT02047227|469276337|FG001|Overall Study|Spontaneous pregnancy|0|||
130356539|NCT02047227|469276336|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
130356540|NCT02047227|469276337|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
130356541|NCT02047227|469276336|FG000|Overall Study|No oocytes retrieved|21|||
130356542|NCT02047227|469276337|FG001|Overall Study|No oocytes retrieved|20|||
130356543|NCT02047227|469276336|FG000|Overall Study|No fertilization|61|||
130356544|NCT02047227|469276337|FG001|Overall Study|No fertilization|51|||
130356545|NCT02047227|469276336|FG000|Overall Study|Intention to freeze all embryos|1|||
130356546|NCT02047227|469276337|FG001|Overall Study|Intention to freeze all embryos|0|||
130356547|NCT02047227|469276336|FG000|Overall Study|All embryos discarded|12|||
130356548|NCT02047227|469276337|FG001|Overall Study|All embryos discarded|11|||
130356549|NCT02047227|469276336|FG000|Overall Study|Other|10|||
130356550|NCT02047227|469276337|FG001|Overall Study|Other|9|||
130356551|NCT01977937|469276346|FG000|Overall Study|Withdrawal by Subject|2|||
130356552|NCT01977937|469276347|FG001|Overall Study|Withdrawal by Subject|1|||
130356553|NCT01977937|469276346|FG000|Overall Study|Adverse Event|1|||
130356554|NCT01977937|469276347|FG001|Overall Study|Adverse Event|0|||
130356555|NCT01977937|469276346|FG000|Overall Study|Physician Decision|0|||
130356556|NCT01977937|469276347|FG001|Overall Study|Physician Decision|1|||
130356557|NCT00915356|469276348|FG000|Overall Study|Withdrawal by Subject|1|||
130356558|NCT00915356|469276349|FG001|Overall Study|Withdrawal by Subject|0|||
130356559|NCT00915356|469276350|FG002|Overall Study|Withdrawal by Subject|0|||
130356560|NCT00915356|469276351|FG003|Overall Study|Withdrawal by Subject|0|||
130356561|NCT00915356|469276352|FG004|Overall Study|Withdrawal by Subject|0|||
130356562|NCT02819518|469276358|FG000|Overall Study|Death|9|||
130356563|NCT02819518|469276359|FG001|Overall Study|Death|12|||
130356564|NCT02819518|469276360|FG002|Overall Study|Death|9|||
130356565|NCT02819518|469276361|FG003|Overall Study|Death|475|||
130356566|NCT02819518|469276362|FG004|Overall Study|Death|244|||
130230962|NCT01041859|468811579|FG000|Double-Blind Maintenance|Protocol Violation|0|||
130230963|NCT01041859|468811580|FG001|Double-Blind Maintenance|Protocol Violation|1|||
130230964|NCT01041859|468811581|FG002|Double-Blind Maintenance|Protocol Violation|3|||
130356567|NCT02819518|469276358|FG000|Overall Study|Withdrawal by Subject|0|||
130691939|NCT01895335|470497924|FG000|Overall Study|Included But Not treated|1|||
130691940|NCT01895335|470497924|FG000|Overall Study|Other than Specified Above|44|||
130691941|NCT00418938|470497925|FG000|Overall Study|Reimbursement|1|||
130691942|NCT00418938|470497926|FG001|Overall Study|Reimbursement|0|||
130691943|NCT00418938|470497925|FG000|Overall Study|Administrative decision|3|||
130691944|NCT00418938|470497926|FG001|Overall Study|Administrative decision|3|||
130691945|NCT00418938|470497925|FG000|Overall Study|Withdrawal by Subject|16|||
130691946|NCT00418938|470497926|FG001|Overall Study|Withdrawal by Subject|15|||
130445124|NCT01406717|469590378|FG001|Overall Study|Subject non-compliance|3|||
130445125|NCT01406717|469590377|FG000|Overall Study|Protocol Violation|5|||
130691947|NCT00418938|470497925|FG000|Overall Study|Lost to Follow-up|1|||
130691948|NCT00418938|470497926|FG001|Overall Study|Lost to Follow-up|3|||
130691949|NCT00418938|470497925|FG000|Overall Study|Adverse Event|1|||
130691950|NCT00418938|470497926|FG001|Overall Study|Adverse Event|1|||
130691951|NCT00418938|470497925|FG000|Overall Study|On-going|1|||
130691952|NCT00418938|470497926|FG001|Overall Study|On-going|1|||
130691953|NCT00418938|470497925|FG000|Overall Study|Ineligibility Determined|1|||
130691954|NCT00418938|470497926|FG001|Overall Study|Ineligibility Determined|0|||
130691955|NCT00115063|470497927|FG000|Overall Study|Lost to Follow-up|98|||
130691956|NCT00115063|470497928|FG001|Overall Study|Lost to Follow-up|104|||
130230965|NCT01041859|468811579|FG000|Double-Blind Maintenance|Other|0|||
130230966|NCT01041859|468811580|FG001|Double-Blind Maintenance|Other|6|||
130230967|NCT01041859|468811581|FG002|Double-Blind Maintenance|Other|2|||
130230968|NCT01041859|468811579|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
130230969|NCT01041859|468811580|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
130230970|NCT01041859|468811581|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
130230971|NCT01041859|468811579|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
130230972|NCT01041859|468811580|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
130230973|NCT01041859|468811581|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
130230974|NCT02908347|468811587|FG000|Overall Study|Adverse Event|0|||
130445126|NCT01406717|469590378|FG001|Overall Study|Protocol Violation|1|||
130445127|NCT01406717|469590377|FG000|Overall Study|Lost to Follow-up|14|||
130445128|NCT01406717|469590378|FG001|Overall Study|Lost to Follow-up|8|||
130445129|NCT01406717|469590377|FG000|Overall Study|Withdrawal by Subject|19|||
130445130|NCT01406717|469590378|FG001|Overall Study|Withdrawal by Subject|15|||
130445131|NCT01406717|469590377|FG000|Overall Study|Adverse Event|1|||
130691957|NCT00115063|470497927|FG000|Overall Study|Death|1|||
130691958|NCT00115063|470497928|FG001|Overall Study|Death|0|||
130691959|NCT01075282|470497929|FG000|Overall Study|Withdrawal by Subject|11|||
130691960|NCT01075282|470497930|FG001|Overall Study|Withdrawal by Subject|7|||
130691961|NCT01075282|470497931|FG002|Overall Study|Withdrawal by Subject|11|||
130691962|NCT01075282|470497929|FG000|Overall Study|Adverse Event|9|||
130691963|NCT01075282|470497930|FG001|Overall Study|Adverse Event|8|||
130691964|NCT01075282|470497931|FG002|Overall Study|Adverse Event|5|||
130691965|NCT01075282|470497929|FG000|Overall Study|Entry Criteria Not Met|3|||
130691966|NCT01075282|470497930|FG001|Overall Study|Entry Criteria Not Met|2|||
130691967|NCT01075282|470497931|FG002|Overall Study|Entry Criteria Not Met|0|||
130691968|NCT01075282|470497929|FG000|Overall Study|Lost to Follow-up|3|||
130691969|NCT01075282|470497930|FG001|Overall Study|Lost to Follow-up|3|||
130691970|NCT01075282|470497931|FG002|Overall Study|Lost to Follow-up|3|||
130691971|NCT01075282|470497929|FG000|Overall Study|Physician Decision|3|||
130691972|NCT01075282|470497930|FG001|Overall Study|Physician Decision|3|||
130691973|NCT01075282|470497931|FG002|Overall Study|Physician Decision|3|||
130691974|NCT01075282|470497929|FG000|Overall Study|Lack of Efficacy|1|||
130691975|NCT01075282|470497930|FG001|Overall Study|Lack of Efficacy|1|||
130445132|NCT01406717|469590378|FG001|Overall Study|Adverse Event|2|||
130445133|NCT01406717|469590377|FG000|Overall Study|Lack of Efficacy|0|||
130445134|NCT01406717|469590378|FG001|Overall Study|Lack of Efficacy|1|||
130445135|NCT01406717|469590377|FG000|Overall Study|Non-completion of visit activity|0|||
130445136|NCT01406717|469590378|FG001|Overall Study|Non-completion of visit activity|1|||
130445137|NCT02584855|469590382|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
130445138|NCT02584855|469590383|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130691976|NCT01075282|470497931|FG002|Overall Study|Lack of Efficacy|0|||
130691977|NCT01075282|470497929|FG000|Overall Study|Treatment Non-compliance|1|||
130691978|NCT01075282|470497930|FG001|Overall Study|Treatment Non-compliance|2|||
130691979|NCT01075282|470497931|FG002|Overall Study|Treatment Non-compliance|2|||
130691980|NCT01075282|470497929|FG000|Overall Study|Protocol Violation|0|||
130230975|NCT02908347|468811588|FG001|Overall Study|Adverse Event|1|||
130230976|NCT02908347|468811587|FG000|Overall Study|Lost to Follow-up|1|||
130230977|NCT02908347|468811588|FG001|Overall Study|Lost to Follow-up|0|||
130445139|NCT02584855|469590384|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130691981|NCT01075282|470497930|FG001|Overall Study|Protocol Violation|2|||
130691982|NCT01075282|470497931|FG002|Overall Study|Protocol Violation|1|||
130691983|NCT01075282|470497929|FG000|Overall Study|Death|0|||
130691984|NCT01075282|470497930|FG001|Overall Study|Death|1|||
130691985|NCT01075282|470497931|FG002|Overall Study|Death|2|||
130230978|NCT01326871|468811589|FG000|Overall Study|Major surgery|0|||
130230979|NCT01326871|468811590|FG001|Overall Study|Major surgery|1|||
130230980|NCT01326871|468811591|FG002|Overall Study|Major surgery|0|||
130230981|NCT01326871|468811589|FG000|Overall Study|SAE and death|0|||
130230982|NCT01326871|468811590|FG001|Overall Study|SAE and death|2|||
130230983|NCT01326871|468811591|FG002|Overall Study|SAE and death|0|||
130230984|NCT01326871|468811589|FG000|Overall Study|Physician decision and decreased performance status|0|||
130230985|NCT01326871|468811590|FG001|Overall Study|Physician decision and decreased performance status|1|||
130230986|NCT01326871|468811591|FG002|Overall Study|Physician decision and decreased performance status|0|||
130230987|NCT01326871|468811589|FG000|Overall Study|Disease progression|0|||
130230988|NCT01326871|468811590|FG001|Overall Study|Disease progression|11|||
130230989|NCT01326871|468811591|FG002|Overall Study|Disease progression|5|||
130230990|NCT01326871|468811589|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
130230991|NCT01326871|468811590|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
130230992|NCT01326871|468811591|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
130230993|NCT01326871|468811589|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
130230994|NCT01326871|468811590|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
130230995|NCT01326871|468811591|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
130230996|NCT01326871|468811589|FG000|Overall Study|Withdrawal by Subject|0|||
130445140|NCT02584855|469590385|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130445141|NCT02584855|469590386|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
130445142|NCT02584855|469590387|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
130445143|NCT02584855|469590382|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
130445144|NCT02584855|469590383|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130445145|NCT02584855|469590384|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130445146|NCT02584855|469590385|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130445147|NCT02584855|469590386|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
130445148|NCT02584855|469590387|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
130445149|NCT02584855|469590382|FG000|Open-Label Treatment Period|Adverse Event|14|||
130691986|NCT00700739|470497932|FG000|Overall Study|Lost to Follow-up|4|||
130445150|NCT02584855|469590383|FG001|Open-Label Treatment Period|Adverse Event|0|||
130445151|NCT02584855|469590384|FG002|Open-Label Treatment Period|Adverse Event|0|||
130445152|NCT02584855|469590385|FG003|Open-Label Treatment Period|Adverse Event|0|||
130445153|NCT02584855|469590386|FG004|Open-Label Treatment Period|Adverse Event|0|||
130445154|NCT02584855|469590387|FG005|Open-Label Treatment Period|Adverse Event|0|||
130445155|NCT02584855|469590382|FG000|Open-Label Treatment Period|Death|2|||
130445156|NCT02584855|469590383|FG001|Open-Label Treatment Period|Death|0|||
130445157|NCT02584855|469590384|FG002|Open-Label Treatment Period|Death|0|||
130445158|NCT02584855|469590385|FG003|Open-Label Treatment Period|Death|0|||
130445159|NCT02584855|469590386|FG004|Open-Label Treatment Period|Death|0|||
130445160|NCT02584855|469590387|FG005|Open-Label Treatment Period|Death|0|||
130445161|NCT02584855|469590382|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
130445162|NCT02584855|469590383|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130445163|NCT02584855|469590384|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130445164|NCT02584855|469590385|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130445165|NCT02584855|469590386|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
130445166|NCT02584855|469590387|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
130445167|NCT02584855|469590382|FG000|Open-Label Treatment Period|Protocol Violation|1|||
130445168|NCT02584855|469590383|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130445169|NCT02584855|469590384|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130445170|NCT02584855|469590385|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130445171|NCT02584855|469590386|FG004|Open-Label Treatment Period|Protocol Violation|0|||
130445172|NCT02584855|469590387|FG005|Open-Label Treatment Period|Protocol Violation|0|||
130445173|NCT02584855|469590382|FG000|Open-Label Treatment Period|No PI Available|2|||
130445174|NCT02584855|469590383|FG001|Open-Label Treatment Period|No PI Available|0|||
130691987|NCT00700739|470497933|FG001|Overall Study|Lost to Follow-up|4|||
130691988|NCT01316055|470497941|FG000|Overall Study|Lost to Follow-up|1|||
130691989|NCT01316055|470497942|FG001|Overall Study|Lost to Follow-up|0|||
130691990|NCT01316055|470497943|FG002|Overall Study|Lost to Follow-up|0|||
130230997|NCT01326871|468811590|FG001|Overall Study|Withdrawal by Subject|1|||
130230998|NCT01326871|468811591|FG002|Overall Study|Withdrawal by Subject|0|||
130230999|NCT01326871|468811589|FG000|Overall Study|DLT|0|||
130231000|NCT01326871|468811590|FG001|Overall Study|DLT|2|||
130231001|NCT01326871|468811591|FG002|Overall Study|DLT|0|||
130231002|NCT01326871|468811589|FG000|Overall Study|SAE, disease progression and subject decision|0|||
130231003|NCT01326871|468811590|FG001|Overall Study|SAE, disease progression and subject decision|1|||
130445175|NCT02584855|469590384|FG002|Open-Label Treatment Period|No PI Available|0|||
130445176|NCT02584855|469590385|FG003|Open-Label Treatment Period|No PI Available|0|||
130691991|NCT00003470|470497944|FG000|Overall Study|Not evaluable|6|||
130552896|NCT03291587|469991622|FG000|Overall Study|Death|2|||
130691992|NCT02679729|470497945|FG000|Overall Study|Lost to Follow-up|0|||
130231004|NCT01326871|468811591|FG002|Overall Study|SAE, disease progression and subject decision|0|||
130231005|NCT01326871|468811589|FG000|Overall Study|Death|0|||
130231006|NCT01326871|468811590|FG001|Overall Study|Death|1|||
130231007|NCT01326871|468811591|FG002|Overall Study|Death|0|||
130231008|NCT01326871|468811589|FG000|Overall Study|Other|0|||
130231009|NCT01326871|468811590|FG001|Overall Study|Other|3|||
130231010|NCT01326871|468811591|FG002|Overall Study|Other|0|||
130231011|NCT01326871|468811589|FG000|Overall Study|SAE and disease progression|0|||
130691993|NCT02679729|470497946|FG001|Overall Study|Lost to Follow-up|1|||
130691994|NCT02679729|470497947|FG002|Overall Study|Lost to Follow-up|0|||
130691995|NCT02679729|470497948|FG003|Overall Study|Lost to Follow-up|0|||
130691996|NCT02679729|470497949|FG004|Overall Study|Lost to Follow-up|1|||
130691997|NCT02679729|470497950|FG005|Overall Study|Lost to Follow-up|0|||
130691998|NCT02679729|470497951|FG006|Overall Study|Lost to Follow-up|0|||
130691999|NCT02679729|470497952|FG007|Overall Study|Lost to Follow-up|0|||
130692000|NCT02679729|470497953|FG008|Overall Study|Lost to Follow-up|0|||
130692001|NCT02679729|470497945|FG000|Overall Study|Participant decision|0|||
130231012|NCT01326871|468811590|FG001|Overall Study|SAE and disease progression|0|||
130231013|NCT01326871|468811591|FG002|Overall Study|SAE and disease progression|1|||
130231014|NCT01326871|468811589|FG000|Overall Study|SAE and physician decision|0|||
130231015|NCT01326871|468811590|FG001|Overall Study|SAE and physician decision|0|||
130445177|NCT02584855|469590386|FG004|Open-Label Treatment Period|No PI Available|0|||
130445178|NCT02584855|469590387|FG005|Open-Label Treatment Period|No PI Available|0|||
130445179|NCT02584855|469590382|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
130445180|NCT02584855|469590383|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
130445181|NCT02584855|469590384|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
130445182|NCT02584855|469590385|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
130445183|NCT02584855|469590386|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
130445184|NCT02584855|469590387|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
130445185|NCT02584855|469590382|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
130445186|NCT02584855|469590383|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
130445187|NCT02584855|469590384|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
130445188|NCT02584855|469590385|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
130445189|NCT02584855|469590386|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
130445190|NCT02584855|469590387|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
130445191|NCT02584855|469590382|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
130445192|NCT02584855|469590383|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
130445193|NCT02584855|469590384|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
130445194|NCT02584855|469590385|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
130445195|NCT02584855|469590386|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
130445196|NCT02584855|469590387|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
130445197|NCT02584855|469590382|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
130445198|NCT02584855|469590383|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
130445199|NCT02584855|469590384|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
130445200|NCT02584855|469590385|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
130445201|NCT02584855|469590386|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
130445202|NCT02584855|469590387|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
130445203|NCT02584855|469590382|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
130445204|NCT02584855|469590383|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
130445205|NCT02584855|469590384|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
130445206|NCT02584855|469590385|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
130445207|NCT02584855|469590386|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
130445208|NCT02584855|469590387|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
130445209|NCT02584855|469590382|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130445210|NCT02584855|469590383|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130445211|NCT02584855|469590384|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130445212|NCT02584855|469590385|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130445213|NCT02584855|469590386|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
130445214|NCT02584855|469590387|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130445215|NCT02584855|469590382|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
130445216|NCT02584855|469590383|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
130445217|NCT02584855|469590384|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
130445218|NCT02584855|469590385|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
130692002|NCT02679729|470497946|FG001|Overall Study|Participant decision|1|||
130692003|NCT02679729|470497947|FG002|Overall Study|Participant decision|0|||
130692004|NCT02679729|470497948|FG003|Overall Study|Participant decision|0|||
130231016|NCT01326871|468811591|FG002|Overall Study|SAE and physician decision|1|||
130231017|NCT01326871|468811589|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130231018|NCT01326871|468811590|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130231019|NCT01326871|468811591|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
130692005|NCT02679729|470497949|FG004|Overall Study|Participant decision|0|||
130231020|NCT01326871|468811589|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130231021|NCT01326871|468811590|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130231022|NCT01326871|468811591|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
130231023|NCT01326871|468811589|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
130231024|NCT01326871|468811590|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
130231025|NCT01326871|468811591|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
130231026|NCT01326871|468811589|FG000|Overall Study|Physician Decision|0|||
130231027|NCT01326871|468811590|FG001|Overall Study|Physician Decision|0|||
130231028|NCT01326871|468811591|FG002|Overall Study|Physician Decision|1|||
130231029|NCT01326871|468811589|FG000|Overall Study|SAE|0|||
130231030|NCT01326871|468811590|FG001|Overall Study|SAE|0|||
130231031|NCT01326871|468811591|FG002|Overall Study|SAE|1|||
130231032|NCT01326871|468811589|FG000|Overall Study|Disease progression and death|0|||
130231033|NCT01326871|468811590|FG001|Overall Study|Disease progression and death|0|||
130356568|NCT02819518|469276359|FG001|Overall Study|Withdrawal by Subject|0|||
130356569|NCT02819518|469276360|FG002|Overall Study|Withdrawal by Subject|0|||
130356570|NCT02819518|469276361|FG003|Overall Study|Withdrawal by Subject|25|||
130231034|NCT01326871|468811591|FG002|Overall Study|Disease progression and death|1|||
130231035|NCT01326871|468811589|FG000|Overall Study|Subject decision|0|||
130356571|NCT02819518|469276362|FG004|Overall Study|Withdrawal by Subject|8|||
130231036|NCT01326871|468811590|FG001|Overall Study|Subject decision|0|||
130692006|NCT02679729|470497950|FG005|Overall Study|Participant decision|0|||
130692007|NCT02679729|470497951|FG006|Overall Study|Participant decision|1|||
130692008|NCT02679729|470497952|FG007|Overall Study|Participant decision|0|||
130692009|NCT02679729|470497953|FG008|Overall Study|Participant decision|0|||
130692010|NCT03488108|470497960|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
130692011|NCT03488108|470497961|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130692012|NCT03488108|470497960|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130692013|NCT03488108|470497961|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
130692014|NCT01348789|470497963|FG000|Overall Study|Protocol Violation|2|||
130692015|NCT01348789|470497963|FG000|Overall Study|Withdrawal by Subject|2|||
130692016|NCT03503318|470497966|FG000|Overall Study|Death|1|||
130692017|NCT03503318|470497967|FG001|Overall Study|Death|0|||
130692018|NCT03503318|470497968|FG002|Overall Study|Death|4|||
130692019|NCT03503318|470497966|FG000|Overall Study|Adverse Event|3|||
130692020|NCT03503318|470497967|FG001|Overall Study|Adverse Event|4|||
130692021|NCT03503318|470497968|FG002|Overall Study|Adverse Event|2|||
130692022|NCT03503318|470497966|FG000|Overall Study|Withdrawal by Subject|12|||
130692023|NCT03503318|470497967|FG001|Overall Study|Withdrawal by Subject|17|||
130692024|NCT03503318|470497968|FG002|Overall Study|Withdrawal by Subject|16|||
130692025|NCT03503318|470497966|FG000|Overall Study|Protocol Violation|5|||
130692026|NCT03503318|470497967|FG001|Overall Study|Protocol Violation|0|||
130692027|NCT03503318|470497968|FG002|Overall Study|Protocol Violation|3|||
130692028|NCT03503318|470497966|FG000|Overall Study|Lost to Follow-up|17|||
130692029|NCT03503318|470497967|FG001|Overall Study|Lost to Follow-up|15|||
130231037|NCT01326871|468811591|FG002|Overall Study|Subject decision|1|||
130231038|NCT01200329|468811592|FG000|Overall Study|Lack of financial coverage|2|||
130231039|NCT01200329|468811592|FG000|Overall Study|Progressive disease|1|||
130231040|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
130231041|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
130231042|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231043|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231044|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231045|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
130231046|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
130692030|NCT03503318|470497968|FG002|Overall Study|Lost to Follow-up|12|||
130692031|NCT03503318|470497966|FG000|Overall Study|Other than specified|1|||
130692032|NCT03503318|470497967|FG001|Overall Study|Other than specified|3|||
130692033|NCT03503318|470497968|FG002|Overall Study|Other than specified|3|||
130692034|NCT02139826|470497975|FG000|Overall Study|Adverse Event|1|||
130231047|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231048|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231049|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231050|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
130231051|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
130231052|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231053|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231054|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231055|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
130231056|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
130231057|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130445219|NCT02584855|469590386|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
130445220|NCT02584855|469590387|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
130445221|NCT02337478|469590388|FG000|Overall Study|Lack of Efficacy|5|||
130445222|NCT01012973|469591925|FG000|Overall Study|Adverse Event|5|||
130692035|NCT01825798|470497976|FG000|Overall Study|Adverse Event|1|||
130692036|NCT01825798|470497977|FG001|Overall Study|Adverse Event|5|||
130692037|NCT01825798|470497976|FG000|Overall Study|Lost to Follow-up|1|||
130692038|NCT01825798|470497977|FG001|Overall Study|Lost to Follow-up|0|||
130692039|NCT00834873|470497980|FG000|First Intervention|Adverse Event|0|||
130692040|NCT00834873|470497981|FG001|First Intervention|Adverse Event|1|||
130692041|NCT05098743|470497982|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
130692042|NCT05098743|470497983|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
130692043|NCT05098743|470497982|FG000|Overall Study|Lost to Follow-up|1|||
130692044|NCT05098743|470497983|FG001|Overall Study|Lost to Follow-up|2|||
130692045|NCT02911025|470497988|FG000|Overall Study|Lost to Follow-up|3|||
130692046|NCT04063878|470497991|FG000|Overall Study|Withdrawal by Subject|2|||
130692047|NCT04063878|470497991|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
130692048|NCT01473953|470497994|FG000|Overall Study|Other|1|||
130692049|NCT01473953|470497995|FG001|Overall Study|Other|0|||
130692050|NCT01473953|470497996|FG002|Overall Study|Other|0|||
130692051|NCT01473953|470497997|FG003|Overall Study|Other|0|||
130692052|NCT01473953|470497998|FG004|Overall Study|Other|0|||
130692053|NCT02358538|470497999|FG000|Through Week 26|Adverse Event|0|||
130692054|NCT02358538|470498000|FG001|Through Week 26|Adverse Event|1|||
130692055|NCT02358538|470498001|FG002|Through Week 26|Adverse Event|1|||
130692056|NCT02358538|470498002|FG003|Through Week 26|Adverse Event|2|||
130692057|NCT02358538|470497999|FG000|Through Week 26|Lack of Efficacy|1|||
130692058|NCT02358538|470498000|FG001|Through Week 26|Lack of Efficacy|1|||
130692059|NCT02358538|470498001|FG002|Through Week 26|Lack of Efficacy|3|||
130692060|NCT02358538|470498002|FG003|Through Week 26|Lack of Efficacy|3|||
130692061|NCT02358538|470497999|FG000|Through Week 26|Withdrawal by Subject|1|||
130692062|NCT02358538|470498000|FG001|Through Week 26|Withdrawal by Subject|0|||
130692063|NCT02358538|470498001|FG002|Through Week 26|Withdrawal by Subject|0|||
130692064|NCT02358538|470498002|FG003|Through Week 26|Withdrawal by Subject|0|||
130692065|NCT02358538|470497999|FG000|Through Week 26|Non-Compliance|0|||
130692066|NCT02358538|470498000|FG001|Through Week 26|Non-Compliance|0|||
130692067|NCT02358538|470498001|FG002|Through Week 26|Non-Compliance|1|||
130692068|NCT02358538|470498002|FG003|Through Week 26|Non-Compliance|0|||
130692069|NCT02358538|470497999|FG000|Through Week 26|Family did not see benefit from IP|1|||
130692070|NCT02358538|470498000|FG001|Through Week 26|Family did not see benefit from IP|0|||
130692071|NCT02358538|470498001|FG002|Through Week 26|Family did not see benefit from IP|0|||
130692072|NCT02358538|470498002|FG003|Through Week 26|Family did not see benefit from IP|0|||
130692073|NCT02358538|470497999|FG000|52 Week Extension Period|Lack of Efficacy|0|||
130692074|NCT02358538|470498000|FG001|52 Week Extension Period|Lack of Efficacy|0|||
130692075|NCT02358538|470498001|FG002|52 Week Extension Period|Lack of Efficacy|2|||
130692076|NCT02358538|470498002|FG003|52 Week Extension Period|Lack of Efficacy|4|||
130692077|NCT01494532|470498003|FG000|Overall Study|Adverse Event|4|||
130692078|NCT01494532|470498004|FG001|Overall Study|Adverse Event|1|||
130692079|NCT01494532|470498005|FG002|Overall Study|Adverse Event|8|||
130692080|NCT01494532|470498006|FG003|Overall Study|Adverse Event|6|||
130692081|NCT01494532|470498007|FG004|Overall Study|Adverse Event|5|||
130692082|NCT01494532|470498008|FG005|Overall Study|Adverse Event|0|||
130692083|NCT01494532|470498003|FG000|Overall Study|Lack of Efficacy|0|||
130692084|NCT01494532|470498004|FG001|Overall Study|Lack of Efficacy|0|||
130692085|NCT01494532|470498005|FG002|Overall Study|Lack of Efficacy|0|||
130692086|NCT01494532|470498006|FG003|Overall Study|Lack of Efficacy|0|||
130692087|NCT01494532|470498007|FG004|Overall Study|Lack of Efficacy|2|||
130692088|NCT01494532|470498008|FG005|Overall Study|Lack of Efficacy|0|||
130692089|NCT01494532|470498003|FG000|Overall Study|Protocol deviation|2|||
130692090|NCT01494532|470498004|FG001|Overall Study|Protocol deviation|1|||
130692091|NCT01494532|470498005|FG002|Overall Study|Protocol deviation|3|||
130692092|NCT01494532|470498006|FG003|Overall Study|Protocol deviation|2|||
130692093|NCT01494532|470498007|FG004|Overall Study|Protocol deviation|3|||
130692094|NCT01494532|470498008|FG005|Overall Study|Protocol deviation|0|||
130692095|NCT01494532|470498003|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130692096|NCT01494532|470498004|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130692097|NCT01494532|470498005|FG002|Overall Study|Protocol-defined stopping criteria|1|||
130692098|NCT01494532|470498006|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130692099|NCT01494532|470498007|FG004|Overall Study|Protocol-defined stopping criteria|0|||
130692100|NCT01494532|470498008|FG005|Overall Study|Protocol-defined stopping criteria|0|||
130692101|NCT01494532|470498003|FG000|Overall Study|Lost to Follow-up|1|||
130692102|NCT01494532|470498004|FG001|Overall Study|Lost to Follow-up|0|||
130692103|NCT01494532|470498005|FG002|Overall Study|Lost to Follow-up|0|||
130692104|NCT01494532|470498006|FG003|Overall Study|Lost to Follow-up|2|||
130692105|NCT01494532|470498007|FG004|Overall Study|Lost to Follow-up|0|||
130692106|NCT01494532|470498008|FG005|Overall Study|Lost to Follow-up|0|||
130692107|NCT01494532|470498003|FG000|Overall Study|Physician Decision|0|||
130692108|NCT01494532|470498004|FG001|Overall Study|Physician Decision|1|||
130692109|NCT01494532|470498005|FG002|Overall Study|Physician Decision|1|||
130692110|NCT01494532|470498006|FG003|Overall Study|Physician Decision|2|||
130692111|NCT01494532|470498007|FG004|Overall Study|Physician Decision|0|||
130692112|NCT01494532|470498008|FG005|Overall Study|Physician Decision|0|||
130692113|NCT01494532|470498003|FG000|Overall Study|Withdrawal by Subject|3|||
130692114|NCT01494532|470498004|FG001|Overall Study|Withdrawal by Subject|1|||
130692115|NCT01494532|470498005|FG002|Overall Study|Withdrawal by Subject|4|||
130692116|NCT01494532|470498006|FG003|Overall Study|Withdrawal by Subject|3|||
130692117|NCT01494532|470498007|FG004|Overall Study|Withdrawal by Subject|2|||
130692118|NCT01494532|470498008|FG005|Overall Study|Withdrawal by Subject|0|||
130692119|NCT02068794|470500056|FG000|Overall Study|Withdrawal by Subject|0|||
130692120|NCT02068794|470500057|FG001|Overall Study|Withdrawal by Subject|1|||
130692121|NCT02068794|470500058|FG002|Overall Study|Withdrawal by Subject|2|||
130692122|NCT02068794|470500056|FG000|Overall Study|Early Progression|1|||
130692123|NCT02068794|470500057|FG001|Overall Study|Early Progression|0|||
130692124|NCT02068794|470500058|FG002|Overall Study|Early Progression|1|||
130692125|NCT02068794|470500056|FG000|Overall Study|Ineligible|0|||
130692126|NCT02068794|470500057|FG001|Overall Study|Ineligible|0|||
130692127|NCT02068794|470500058|FG002|Overall Study|Ineligible|1|||
130692128|NCT02316548|470500060|FG000|Overall Study|Protocol Violation|0|||
130692129|NCT02316548|470500061|FG001|Overall Study|Protocol Violation|1|||
130692130|NCT01958294|470500062|FG000|Overall Study|Clinical Circumstances|2|||
130692131|NCT02566850|470500064|FG000|Overall Study|Protocol Violation|1|||
130692132|NCT02635750|470500065|FG000|Part 1, Period 2|Adverse Event|1|||
130692133|NCT02635750|470500066|FG001|Part 1, Period 2|Adverse Event|0|||
130692134|NCT02635750|470500067|FG002|Part 1, Period 2|Adverse Event|0|||
130692135|NCT00830258|470500070|FG000|First Intervention|Adverse Event|1|||
130692136|NCT00830258|470500071|FG001|First Intervention|Adverse Event|0|||
130692137|NCT00830258|470500070|FG000|Washout: 7 Days|Protocol Violation|1|||
130692138|NCT00830258|470500071|FG001|Washout: 7 Days|Protocol Violation|0|||
130692139|NCT00682461|470500076|FG000|Overall Study|Adverse Event|5|||
130692140|NCT00682461|470500077|FG001|Overall Study|Adverse Event|7|||
130692141|NCT00682461|470500076|FG000|Overall Study|Lost to Follow-up|8|||
130692142|NCT00682461|470500077|FG001|Overall Study|Lost to Follow-up|5|||
130692143|NCT00682461|470500076|FG000|Overall Study|Withdrawal by Subject|12|||
130692144|NCT00682461|470500077|FG001|Overall Study|Withdrawal by Subject|19|||
130692145|NCT00665925|470500078|FG000|Overall Study|Lack of Efficacy|10|||
130692146|NCT00665925|470500079|FG001|Overall Study|Lack of Efficacy|8|||
130692147|NCT00665925|470500080|FG002|Overall Study|Lack of Efficacy|9|||
130692148|NCT00665925|470500081|FG003|Overall Study|Lack of Efficacy|8|||
130692149|NCT00665925|470500078|FG000|Overall Study|Lost to Follow-up|1|||
130692150|NCT00665925|470500079|FG001|Overall Study|Lost to Follow-up|2|||
130692151|NCT00665925|470500080|FG002|Overall Study|Lost to Follow-up|2|||
130692152|NCT00665925|470500081|FG003|Overall Study|Lost to Follow-up|2|||
130692153|NCT00665925|470500078|FG000|Overall Study|Withdrawal by Subject|2|||
130692154|NCT00665925|470500079|FG001|Overall Study|Withdrawal by Subject|2|||
130692155|NCT00665925|470500080|FG002|Overall Study|Withdrawal by Subject|3|||
130692156|NCT00665925|470500081|FG003|Overall Study|Withdrawal by Subject|2|||
130692157|NCT00665925|470500078|FG000|Overall Study|Physician Decision|0|||
130692158|NCT00665925|470500079|FG001|Overall Study|Physician Decision|0|||
130692159|NCT00665925|470500080|FG002|Overall Study|Physician Decision|1|||
130692160|NCT00665925|470500081|FG003|Overall Study|Physician Decision|2|||
130692161|NCT00665925|470500078|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130692162|NCT00665925|470500079|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130692163|NCT00665925|470500080|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130692164|NCT00665925|470500081|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
130692165|NCT00665925|470500078|FG000|Overall Study|Adverse Event|1|||
130692166|NCT00665925|470500079|FG001|Overall Study|Adverse Event|5|||
130692167|NCT00665925|470500080|FG002|Overall Study|Adverse Event|10|||
130692168|NCT00665925|470500081|FG003|Overall Study|Adverse Event|5|||
130692169|NCT00665925|470500078|FG000|Overall Study|Enrolled by mistake|0|||
130692170|NCT00665925|470500079|FG001|Overall Study|Enrolled by mistake|0|||
130692171|NCT00665925|470500080|FG002|Overall Study|Enrolled by mistake|0|||
130692172|NCT00665925|470500081|FG003|Overall Study|Enrolled by mistake|1|||
130692173|NCT00665925|470500078|FG000|Overall Study|Due to exclusion criteria|1|||
130692174|NCT00665925|470500079|FG001|Overall Study|Due to exclusion criteria|0|||
130692175|NCT00665925|470500080|FG002|Overall Study|Due to exclusion criteria|0|||
130692176|NCT00665925|470500081|FG003|Overall Study|Due to exclusion criteria|0|||
130692177|NCT04035187|470500084|FG000|Overall Study|Withdrawal by Subject|2|||
130692178|NCT04035187|470500085|FG001|Overall Study|Withdrawal by Subject|1|||
130692179|NCT04035187|470500086|FG002|Overall Study|Withdrawal by Subject|0|||
130692180|NCT04035187|470500087|FG003|Overall Study|Withdrawal by Subject|0|||
130692181|NCT04035187|470500084|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130692182|NCT04035187|470500085|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
130445223|NCT01012973|469591926|FG001|Overall Study|Adverse Event|5|||
130692183|NCT04035187|470500086|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130692184|NCT04035187|470500087|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
130692185|NCT01116739|470500088|FG000|Overall Study|Child had 2 years of HS|110|||
130692186|NCT01116739|470500089|FG001|Overall Study|Child had 2 years of HS|128|||
130692187|NCT01116739|470500088|FG000|Overall Study|Withdrawal by Subject|6|||
130692188|NCT01116739|470500089|FG001|Overall Study|Withdrawal by Subject|0|||
130692189|NCT01116739|470500088|FG000|Overall Study|child too young|2|||
130692190|NCT01116739|470500089|FG001|Overall Study|child too young|6|||
130692191|NCT01116739|470500088|FG000|Overall Study|child not enrolled in head start|10|||
130692192|NCT01116739|470500089|FG001|Overall Study|child not enrolled in head start|2|||
130692193|NCT01116739|470500088|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
130231058|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130231059|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130231060|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
130692194|NCT01116739|470500089|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
130692195|NCT05511935|470500090|FG000|Overall Study|Lost to Follow-up|9|||
130692196|NCT05511935|470500091|FG001|Overall Study|Lost to Follow-up|27|||
130692197|NCT05090839|470500094|FG000|Overall Study|Lost to Follow-up|2|||
130692198|NCT05090839|470500095|FG001|Overall Study|Lost to Follow-up|3|||
130692199|NCT05090839|470500096|FG002|Overall Study|Lost to Follow-up|1|||
130692200|NCT05090839|470500097|FG003|Overall Study|Lost to Follow-up|1|||
130692201|NCT00334815|470500098|FG000|Overall Study|Adverse Event|3|||
130692202|NCT00334815|470500099|FG001|Overall Study|Adverse Event|2|||
130692203|NCT00334815|470500098|FG000|Overall Study|Death|0|||
130692204|NCT00334815|470500099|FG001|Overall Study|Death|2|||
130692205|NCT00334815|470500098|FG000|Overall Study|Progression|1|||
130692206|NCT00334815|470500099|FG001|Overall Study|Progression|0|||
130692207|NCT00334815|470500098|FG000|Overall Study|ineligible|1|||
130692208|NCT00334815|470500099|FG001|Overall Study|ineligible|1|||
130692209|NCT00334815|470500098|FG000|Overall Study|patient refused treatment|0|||
130692210|NCT00334815|470500099|FG001|Overall Study|patient refused treatment|1|||
130231061|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
130231062|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130231063|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130356572|NCT02819518|469276358|FG000|Overall Study|Lost to Follow-up|0|||
130356573|NCT02819518|469276359|FG001|Overall Study|Lost to Follow-up|0|||
130356574|NCT02819518|469276360|FG002|Overall Study|Lost to Follow-up|0|||
130356575|NCT02819518|469276361|FG003|Overall Study|Lost to Follow-up|0|||
130356576|NCT02819518|469276362|FG004|Overall Study|Lost to Follow-up|1|||
130692211|NCT00334815|470500098|FG000|Overall Study|Physician Decision|2|||
130692212|NCT00334815|470500099|FG001|Overall Study|Physician Decision|4|||
130692213|NCT03913377|470500100|FG000|Period 1|Test Article no longer available|0|||
130692214|NCT03913377|470500101|FG001|Period 1|Test Article no longer available|1|||
130692215|NCT03913377|470500102|FG002|Period 1|Test Article no longer available|0|||
130692216|NCT03913377|470500100|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
130692217|NCT03913377|470500101|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130692218|NCT03913377|470500102|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
130692219|NCT03499353|470500103|FG000|Treatment|Adverse Event|3|||
130692220|NCT03499353|470500103|FG000|Treatment|Progressive Disease|10|||
130692221|NCT03499353|470500103|FG000|Treatment|Other|1|||
130692222|NCT03499353|470500103|FG000|Treatment|Withdrawal by Subject|2|||
130692223|NCT03499353|470500103|FG000|Long-Term Follow-up|Death|2|||
130692224|NCT03499353|470500103|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
130692225|NCT03499353|470500103|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130692226|NCT01592240|470500104|FG000|Overall Study|Adverse Event|1|||
130692227|NCT01592240|470500105|FG001|Overall Study|Adverse Event|0|||
130692228|NCT01592240|470500106|FG002|Overall Study|Adverse Event|0|||
130692229|NCT01592240|470500107|FG003|Overall Study|Adverse Event|1|||
130692230|NCT01592240|470500108|FG004|Overall Study|Adverse Event|1|||
130692231|NCT01592240|470500109|FG005|Overall Study|Adverse Event|0|||
130692232|NCT01592240|470500110|FG006|Overall Study|Adverse Event|0|||
130692233|NCT01592240|470500104|FG000|Overall Study|Death|0|||
130692234|NCT01592240|470500105|FG001|Overall Study|Death|1|||
130692235|NCT01592240|470500106|FG002|Overall Study|Death|0|||
130692236|NCT01592240|470500107|FG003|Overall Study|Death|0|||
130692237|NCT01592240|470500108|FG004|Overall Study|Death|0|||
130692238|NCT01592240|470500109|FG005|Overall Study|Death|0|||
130692239|NCT01592240|470500110|FG006|Overall Study|Death|0|||
130692240|NCT01592240|470500104|FG000|Overall Study|Lost to Follow-up|1|||
130692241|NCT01592240|470500105|FG001|Overall Study|Lost to Follow-up|3|||
130692242|NCT01592240|470500106|FG002|Overall Study|Lost to Follow-up|1|||
130692243|NCT01592240|470500107|FG003|Overall Study|Lost to Follow-up|0|||
130692244|NCT01592240|470500108|FG004|Overall Study|Lost to Follow-up|3|||
130692245|NCT01592240|470500109|FG005|Overall Study|Lost to Follow-up|2|||
130692246|NCT01592240|470500110|FG006|Overall Study|Lost to Follow-up|0|||
130692247|NCT01592240|470500104|FG000|Overall Study|Protocol Violation|0|||
130692248|NCT01592240|470500105|FG001|Overall Study|Protocol Violation|0|||
130692249|NCT01592240|470500106|FG002|Overall Study|Protocol Violation|0|||
130692250|NCT01592240|470500107|FG003|Overall Study|Protocol Violation|0|||
130692251|NCT01592240|470500108|FG004|Overall Study|Protocol Violation|0|||
130692252|NCT01592240|470500109|FG005|Overall Study|Protocol Violation|1|||
130692253|NCT01592240|470500110|FG006|Overall Study|Protocol Violation|0|||
130692254|NCT01592240|470500104|FG000|Overall Study|Withdrawal by Subject|0|||
130692255|NCT01592240|470500105|FG001|Overall Study|Withdrawal by Subject|4|||
130692256|NCT01592240|470500106|FG002|Overall Study|Withdrawal by Subject|4|||
130692257|NCT01592240|470500107|FG003|Overall Study|Withdrawal by Subject|1|||
130692258|NCT01592240|470500108|FG004|Overall Study|Withdrawal by Subject|3|||
130692259|NCT01592240|470500109|FG005|Overall Study|Withdrawal by Subject|0|||
130692260|NCT01592240|470500110|FG006|Overall Study|Withdrawal by Subject|2|||
130692261|NCT01592240|470500104|FG000|Overall Study|Other|0|||
130692262|NCT01592240|470500105|FG001|Overall Study|Other|3|||
130692263|NCT01592240|470500106|FG002|Overall Study|Other|1|||
130692264|NCT01592240|470500107|FG003|Overall Study|Other|1|||
130692265|NCT01592240|470500108|FG004|Overall Study|Other|0|||
130692266|NCT01592240|470500109|FG005|Overall Study|Other|0|||
130692267|NCT01592240|470500110|FG006|Overall Study|Other|1|||
130692268|NCT01592240|470500104|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130692269|NCT01592240|470500105|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130692270|NCT01592240|470500106|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
130692271|NCT01592240|470500107|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
130692272|NCT01592240|470500108|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
130231064|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130231065|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
130356577|NCT02819518|469276358|FG000|Overall Study|Sponsor Decision|1|||
130356578|NCT02819518|469276359|FG001|Overall Study|Sponsor Decision|1|||
130356579|NCT02819518|469276360|FG002|Overall Study|Sponsor Decision|0|||
130356580|NCT02819518|469276361|FG003|Overall Study|Sponsor Decision|34|||
130356581|NCT02819518|469276362|FG004|Overall Study|Sponsor Decision|17|||
130692273|NCT01592240|470500109|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
130692274|NCT01592240|470500110|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
130692275|NCT02751424|470500111|FG000|Part 2|Adverse Event|0|||
130692276|NCT02751424|470500112|FG001|Part 2|Adverse Event|0|||
130692277|NCT02751424|470500113|FG002|Part 2|Adverse Event|0|||
130692278|NCT02751424|470500114|FG003|Part 2|Adverse Event|0|||
130692279|NCT02751424|470500115|FG004|Part 2|Adverse Event|0|||
130692280|NCT02751424|470500116|FG005|Part 2|Adverse Event|0|||
130692281|NCT02751424|470500117|FG006|Part 2|Adverse Event|0|||
130231066|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
130231067|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130692282|NCT02751424|470500118|FG007|Part 2|Adverse Event|5|||
130692283|NCT02751424|470500119|FG008|Part 2|Adverse Event|0|||
130692284|NCT01896934|470500120|FG000|Overall Study|Adverse Event|1|||
130692285|NCT01896934|470500120|FG000|Overall Study|Withdrawal by Subject|1|||
130692286|NCT02197416|470500121|FG000|Overall Study|Other reasons|0|||
130692287|NCT02197416|470500122|FG001|Overall Study|Other reasons|2|||
130692288|NCT02197416|470500123|FG002|Overall Study|Other reasons|5|||
130692289|NCT02197416|470500121|FG000|Overall Study|Withdrawal by Subject|0|||
130692290|NCT02197416|470500122|FG001|Overall Study|Withdrawal by Subject|2|||
130692291|NCT02197416|470500123|FG002|Overall Study|Withdrawal by Subject|1|||
130692292|NCT02197416|470500121|FG000|Overall Study|Protocol Violation|1|||
130692293|NCT02197416|470500122|FG001|Overall Study|Protocol Violation|0|||
130692294|NCT02197416|470500123|FG002|Overall Study|Protocol Violation|1|||
130692295|NCT02197416|470500121|FG000|Overall Study|Adverse Event|0|||
130692296|NCT02197416|470500122|FG001|Overall Study|Adverse Event|0|||
130692297|NCT02197416|470500123|FG002|Overall Study|Adverse Event|1|||
130692298|NCT02451696|470500124|FG000|Overall Study|Surgery postponed|1|||
130692299|NCT02451696|470500125|FG001|Overall Study|Surgery postponed|0|||
130692300|NCT05014828|470500126|FG000|Overall Study|Study Completed by Sponsor|16|||
130692301|NCT05014828|470500127|FG001|Overall Study|Study Completed by Sponsor|16|||
130692302|NCT05014828|470500128|FG002|Overall Study|Study Completed by Sponsor|3|||
130692303|NCT05014828|470500129|FG003|Overall Study|Study Completed by Sponsor|3|||
130692304|NCT05014828|470500126|FG000|Overall Study|Death|11|||
130692305|NCT05014828|470500127|FG001|Overall Study|Death|6|||
130692306|NCT05014828|470500128|FG002|Overall Study|Death|0|||
130692307|NCT05014828|470500129|FG003|Overall Study|Death|0|||
130692308|NCT05014828|470500126|FG000|Overall Study|Lost to Follow-up|0|||
130692309|NCT05014828|470500127|FG001|Overall Study|Lost to Follow-up|0|||
130692310|NCT05014828|470500128|FG002|Overall Study|Lost to Follow-up|2|||
130692311|NCT05014828|470500129|FG003|Overall Study|Lost to Follow-up|0|||
130692312|NCT05014828|470500126|FG000|Overall Study|Miscellaneous.|0|||
130692313|NCT05014828|470500127|FG001|Overall Study|Miscellaneous.|1|||
130692314|NCT05014828|470500128|FG002|Overall Study|Miscellaneous.|0|||
130692315|NCT05014828|470500129|FG003|Overall Study|Miscellaneous.|0|||
130692316|NCT05523895|470500130|FG000|Overall Study|Adverse Event|2|||
130692317|NCT05523895|470500131|FG001|Overall Study|Adverse Event|1|||
130692318|NCT05523895|470500132|FG002|Overall Study|Adverse Event|1|||
130692319|NCT05523895|470500130|FG000|Overall Study|Lost to Follow-up|0|||
130692320|NCT05523895|470500131|FG001|Overall Study|Lost to Follow-up|1|||
130692321|NCT05523895|470500132|FG002|Overall Study|Lost to Follow-up|2|||
130692322|NCT05523895|470500130|FG000|Overall Study|Noncompliance with study drug|1|||
130692323|NCT05523895|470500131|FG001|Overall Study|Noncompliance with study drug|1|||
130692324|NCT05523895|470500132|FG002|Overall Study|Noncompliance with study drug|1|||
130692325|NCT05523895|470500130|FG000|Overall Study|Protocol Violation|0|||
130692326|NCT05523895|470500131|FG001|Overall Study|Protocol Violation|2|||
130692327|NCT05523895|470500132|FG002|Overall Study|Protocol Violation|0|||
130692328|NCT05523895|470500130|FG000|Overall Study|Withdrawal by Subject|1|||
130692329|NCT05523895|470500131|FG001|Overall Study|Withdrawal by Subject|3|||
130692330|NCT05523895|470500132|FG002|Overall Study|Withdrawal by Subject|1|||
130692331|NCT05523895|470500130|FG000|Overall Study|Not further specified|0|||
130692332|NCT05523895|470500131|FG001|Overall Study|Not further specified|3|||
130692333|NCT05523895|470500132|FG002|Overall Study|Not further specified|1|||
130692334|NCT03674892|470500133|FG000|Overall Study|Lack of Efficacy|5|||
130692335|NCT03674892|470500133|FG000|Overall Study|Lost to Follow-up|3|||
130692336|NCT03674892|470500133|FG000|Overall Study|Migraine|2|||
130692337|NCT03674892|470500133|FG000|Overall Study|Excessive Tearing|1|||
130692338|NCT03674892|470500133|FG000|Overall Study|Increased Eye Pain|1|||
130692339|NCT03674892|470500133|FG000|Overall Study|Increased Facial Pain|1|||
130692340|NCT03674892|470500133|FG000|Overall Study|Sinus Irritation|1|||
130692341|NCT03674892|470500133|FG000|Overall Study|Sinus Infection|1|||
130692342|NCT01959672|470500138|FG000|Overall Study|Death|1|||
130692343|NCT05041361|470500141|FG000|Overall Study|Lost to Follow-up|1|||
130692344|NCT05041361|470500142|FG001|Overall Study|Lost to Follow-up|3|||
130692345|NCT01642277|470500143|FG000|Overall Study|Adverse Event|10|||
130692346|NCT01642277|470500144|FG001|Overall Study|Adverse Event|0|||
130692347|NCT01642277|470500143|FG000|Overall Study|Physician Decision|2|||
130692348|NCT01642277|470500144|FG001|Overall Study|Physician Decision|0|||
130692349|NCT01642277|470500143|FG000|Overall Study|Protocol Violation|1|||
130692350|NCT01642277|470500144|FG001|Overall Study|Protocol Violation|0|||
130692351|NCT01642277|470500143|FG000|Overall Study|Withdrawal by Subject|11|||
130692352|NCT01642277|470500144|FG001|Overall Study|Withdrawal by Subject|0|||
130692353|NCT03605342|470500145|FG000|Overall Study|Withdrawal by Subject|9|||
130692354|NCT03605342|470500146|FG001|Overall Study|Withdrawal by Subject|7|||
130692355|NCT03605342|470500145|FG000|Overall Study|Lost to Follow-up|1|||
130692356|NCT03605342|470500146|FG001|Overall Study|Lost to Follow-up|1|||
130692357|NCT00796328|470500149|FG000|Overall Study|experienced hypotension requiring tx|6|||
130692358|NCT02842853|470500150|FG000|Overall Study|Non-compliance with the protocol|3|||
130692359|NCT02842853|470500151|FG001|Overall Study|Non-compliance with the protocol|7|||
130692360|NCT02842853|470500152|FG002|Overall Study|Non-compliance with the protocol|2|||
130692361|NCT02842853|470500153|FG003|Overall Study|Non-compliance with the protocol|5|||
130692362|NCT02842853|470500150|FG000|Overall Study|Subject met exclusion criteria|0|||
130692363|NCT02842853|470500151|FG001|Overall Study|Subject met exclusion criteria|1|||
130692364|NCT02842853|470500152|FG002|Overall Study|Subject met exclusion criteria|0|||
130692365|NCT02842853|470500153|FG003|Overall Study|Subject met exclusion criteria|0|||
130692366|NCT02842853|470500150|FG000|Overall Study|Withdrawal by Subject|11|||
130692367|NCT02842853|470500151|FG001|Overall Study|Withdrawal by Subject|13|||
130692368|NCT02842853|470500152|FG002|Overall Study|Withdrawal by Subject|9|||
130692369|NCT02842853|470500153|FG003|Overall Study|Withdrawal by Subject|8|||
130692370|NCT02842853|470500150|FG000|Overall Study|Lost to Follow-up|9|||
130692371|NCT02842853|470500151|FG001|Overall Study|Lost to Follow-up|13|||
130692372|NCT02842853|470500152|FG002|Overall Study|Lost to Follow-up|10|||
130692373|NCT02842853|470500153|FG003|Overall Study|Lost to Follow-up|11|||
130692374|NCT04089553|470500154|FG000|Overall Study|Death|1|||
130692375|NCT04089553|470500155|FG001|Overall Study|Death|1|||
130692376|NCT04089553|470500154|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
130692377|NCT04089553|470500155|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
130692378|NCT04089553|470500154|FG000|Overall Study|Withdrawal by Subject|3|||
130692379|NCT04089553|470500155|FG001|Overall Study|Withdrawal by Subject|3|||
130692380|NCT04089553|470500154|FG000|Overall Study|Physician Decision|1|||
130692381|NCT04089553|470500155|FG001|Overall Study|Physician Decision|0|||
130692382|NCT04089553|470500154|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
130692383|NCT04089553|470500155|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
130692384|NCT04089553|470500154|FG000|Overall Study|Other|1|||
130692385|NCT04089553|470500155|FG001|Overall Study|Other|0|||
130692386|NCT04089553|470500154|FG000|Overall Study|Adverse Event|1|||
130692387|NCT04089553|470500155|FG001|Overall Study|Adverse Event|1|||
130692388|NCT01403194|470500163|FG000|Overall Study|Screen Failure|2|||
130692389|NCT01403194|470500163|FG000|Overall Study|Lost to Follow-up|8|||
130692390|NCT00107991|470500168|FG000|Eligibility Assessment|Disease not severe enough|7|||
130692391|NCT00107991|470500168|FG000|Eligibility Assessment|Unwilling to participate|7|||
130692392|NCT00107991|470500168|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
130692393|NCT00107991|470500168|FG000|Eligibility Assessment|Abnormal labs|2|||
130692394|NCT00107991|470500168|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
130692395|NCT00107991|470500168|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
130692396|NCT00107991|470500168|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
130692397|NCT00107991|470500168|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
130692398|NCT00107991|470500168|FG000|12 Week Treatment Period|Adverse Event|1|||
130692399|NCT00107991|470500168|FG000|12 Week Treatment Period|Protocol Violation|1|||
130692400|NCT00107991|470500168|FG000|12 Week Treatment Period|Incarcerated|1|||
130692401|NCT00107991|470500168|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
130692402|NCT00506831|470500175|FG000|Overall Study|Death|1|||
130692403|NCT00506831|470500175|FG000|Overall Study|Withdrawal by Subject|1|||
130692404|NCT02488239|470500179|FG000|Overall Study|Death|3|||
130692405|NCT02488239|470500179|FG000|Overall Study|Withdrawal by Subject|3|||
130692406|NCT02488239|470500179|FG000|Overall Study|Physician Decision|2|||
130692407|NCT02488239|470500179|FG000|Overall Study|Consent ineligible|1|||
130692408|NCT02488239|470500179|FG000|Overall Study|Did not undergo implant procedure|1|||
130692409|NCT00608322|470500182|FG000|Overall Study|Death|2|||
130692410|NCT00608322|470500183|FG001|Overall Study|Death|1|||
130692411|NCT00834444|470500184|FG000|First Intervention|Adverse Event|1|||
130692412|NCT00834444|470500185|FG001|First Intervention|Adverse Event|0|||
130692413|NCT00834444|470500184|FG000|First Intervention|Intolerance to Venopuncture|0|||
130692414|NCT00834444|470500185|FG001|First Intervention|Intolerance to Venopuncture|1|||
130692415|NCT00834444|470500184|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130692416|NCT00834444|470500185|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130356582|NCT02819518|469276358|FG000|Overall Study|Transferred to extension study|1|||
130356583|NCT02819518|469276359|FG001|Overall Study|Transferred to extension study|1|||
130356584|NCT02819518|469276360|FG002|Overall Study|Transferred to extension study|1|||
130356585|NCT02819518|469276361|FG003|Overall Study|Transferred to extension study|32|||
130356586|NCT02819518|469276362|FG004|Overall Study|Transferred to extension study|11|||
130552897|NCT03291587|469991623|FG001|Overall Study|Death|4|||
130692417|NCT00834444|470500184|FG000|Second Intervention|Adverse Event|1|||
130692418|NCT00834444|470500185|FG001|Second Intervention|Adverse Event|0|||
130692419|NCT02213263|470500189|FG000|Overall Study|Insufficient clinical response|4|||
130692420|NCT02213263|470500190|FG001|Overall Study|Insufficient clinical response|3|||
130692421|NCT02213263|470500189|FG000|Overall Study|Lost to Follow-up|0|||
130692422|NCT02213263|470500190|FG001|Overall Study|Lost to Follow-up|1|||
130692423|NCT02213263|470500189|FG000|Overall Study|No longer willing to participate|3|||
130692424|NCT02213263|470500190|FG001|Overall Study|No longer willing to participate|4|||
130692425|NCT02213263|470500189|FG000|Overall Study|Progressive disease|20|||
130692426|NCT02213263|470500190|FG001|Overall Study|Progressive disease|14|||
130692427|NCT02213263|470500189|FG000|Overall Study|Protocol Violation|0|||
130356587|NCT00880165|469276363|FG000|Overall Study|Withdrawal by Subject|27|||
130356588|NCT00880165|469276364|FG001|Overall Study|Withdrawal by Subject|23|||
130356589|NCT00880165|469276363|FG000|Overall Study|Not diagnosed with OSA|14|||
130356590|NCT00880165|469276364|FG001|Overall Study|Not diagnosed with OSA|8|||
130356591|NCT00880165|469276363|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
130356592|NCT00880165|469276364|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
130356593|NCT00880165|469276363|FG000|Overall Study|Lost to follow|9|||
130356594|NCT00880165|469276364|FG001|Overall Study|Lost to follow|15|||
130356595|NCT00667602|469276365|FG000|Overall Study|Withdrawal by Subject|4|||
130356596|NCT00667602|469276366|FG001|Overall Study|Withdrawal by Subject|9|||
130692428|NCT02213263|470500190|FG001|Overall Study|Protocol Violation|1|||
130692429|NCT02213263|470500189|FG000|Overall Study|Adverse Event|1|||
130692430|NCT02213263|470500190|FG001|Overall Study|Adverse Event|3|||
130692431|NCT05752721|470500191|FG000|Overall Study|Lost to Follow-up|22|||
130692432|NCT05752721|470500192|FG001|Overall Study|Lost to Follow-up|20|||
130692433|NCT05752721|470500191|FG000|Overall Study|Withdrawal by Subject|15|||
130692434|NCT05752721|470500192|FG001|Overall Study|Withdrawal by Subject|12|||
130692435|NCT01188681|470500193|FG000|Overall Study|bladder cancer|0|||
130692436|NCT01188681|470500194|FG001|Overall Study|bladder cancer|0|||
130692437|NCT01188681|470500195|FG002|Overall Study|bladder cancer|1|||
130692438|NCT01188681|470500196|FG003|Overall Study|bladder cancer|0|||
130692439|NCT01188681|470500193|FG000|Overall Study|Withdrawal by Subject|0|||
130692440|NCT01188681|470500194|FG001|Overall Study|Withdrawal by Subject|0|||
130692441|NCT01188681|470500195|FG002|Overall Study|Withdrawal by Subject|0|||
130692442|NCT01188681|470500196|FG003|Overall Study|Withdrawal by Subject|1|||
130692443|NCT04827394|470500200|FG000|Overall Study|Physician Decision|0|||
130692444|NCT04827394|470500201|FG001|Overall Study|Physician Decision|2|||
130692445|NCT03500094|470500202|FG000|Overall Study|Withdrawal by Subject|1|||
130231068|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130231069|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130231070|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
130231071|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
130231072|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231073|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231074|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231075|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130231076|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130231077|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231078|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231079|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231080|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
130231081|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231082|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130316110|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316111|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
130692446|NCT03500094|470500202|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
130692447|NCT03500094|470500202|FG000|Overall Study|Lost to Follow-up|1|||
130692448|NCT01030133|470500205|FG000|Overall Study|failed to experience pain at level 7/10|2|||
130692449|NCT01030133|470500206|FG001|Overall Study|failed to experience pain at level 7/10|2|||
130692450|NCT00477594|470500207|FG000|Year 1 and Year 2|Adverse Event|4|||
130692451|NCT00477594|470500208|FG001|Year 1 and Year 2|Adverse Event|2|||
130692452|NCT00477594|470500207|FG000|Year 1 and Year 2|Physician Decision|2|||
130692453|NCT00477594|470500208|FG001|Year 1 and Year 2|Physician Decision|1|||
130692454|NCT00477594|470500207|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
130692455|NCT00477594|470500208|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
130692456|NCT00477594|470500207|FG000|Year 1 and Year 2|Other|1|||
130692457|NCT00477594|470500208|FG001|Year 1 and Year 2|Other|0|||
130692458|NCT00477594|470500207|FG000|Year 3|Adverse Event|1|||
130692459|NCT00477594|470500208|FG001|Year 3|Adverse Event|0|||
130692460|NCT00477594|470500207|FG000|Year 3|Withdrawal by Subject|1|||
130692461|NCT00477594|470500208|FG001|Year 3|Withdrawal by Subject|0|||
130692462|NCT00477594|470500207|FG000|Follow-up Period|Withdrawal by Subject|2|||
130692463|NCT00477594|470500208|FG001|Follow-up Period|Withdrawal by Subject|1|||
130692464|NCT00477594|470500207|FG000|Follow-up Period|Other|1|||
130692465|NCT00477594|470500208|FG001|Follow-up Period|Other|0|||
130692466|NCT02875392|470501893|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
130692467|NCT02875392|470501894|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
130692468|NCT03599193|470501895|FG000|Overall Study|Adverse Event|0|||
130692469|NCT03599193|470501896|FG001|Overall Study|Adverse Event|2|||
130692470|NCT03599193|470501895|FG000|Overall Study|Withdrawal by Subject|1|||
130692471|NCT03599193|470501896|FG001|Overall Study|Withdrawal by Subject|0|||
130692472|NCT03599193|470501895|FG000|Overall Study|Protocol Violation|1|||
130692473|NCT03599193|470501896|FG001|Overall Study|Protocol Violation|0|||
130692474|NCT03599193|470501895|FG000|Overall Study|Lost to Follow-up|0|||
130692475|NCT03599193|470501896|FG001|Overall Study|Lost to Follow-up|1|||
130692476|NCT00835705|470501897|FG000|First Intervention|Difficulty with vein|1|||
130316112|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
130692477|NCT00835705|470501898|FG001|First Intervention|Difficulty with vein|0|||
130692478|NCT00835705|470501897|FG000|Second Intervention|Difficulty with vein|1|||
130692479|NCT00835705|470501898|FG001|Second Intervention|Difficulty with vein|0|||
130692480|NCT01750294|470501899|FG000|Overall Study|Withdrawal by Subject|1|||
130692481|NCT01750294|470501899|FG000|Overall Study|Safety Endpoint|1|||
130692482|NCT04372238|470501902|FG000|Overall Study|Duplicate|3|||
130692483|NCT04372238|470501903|FG001|Overall Study|Duplicate|3|||
130692484|NCT04372238|470501902|FG000|Overall Study|Did not consent for data linkage|6|||
130692485|NCT04372238|470501903|FG001|Overall Study|Did not consent for data linkage|10|||
130692486|NCT03206749|470501913|FG000|Overall Study|Withdrawal of consent|5|||
130692487|NCT03206749|470501914|FG001|Overall Study|Withdrawal of consent|3|||
130692488|NCT03206749|470501915|FG002|Overall Study|Withdrawal of consent|6|||
130692489|NCT03206749|470501913|FG000|Overall Study|Lost to Follow-up|0|||
130692490|NCT03206749|470501914|FG001|Overall Study|Lost to Follow-up|0|||
130692491|NCT03206749|470501915|FG002|Overall Study|Lost to Follow-up|1|||
130692492|NCT03779334|470501919|FG000|Overall Study|Withdrawal by Subject|3|||
130692493|NCT03779334|470501920|FG001|Overall Study|Withdrawal by Subject|0|||
130692494|NCT03779334|470501921|FG002|Overall Study|Withdrawal by Subject|0|||
130692495|NCT03779334|470501919|FG000|Overall Study|Ongoing in Study|5|||
130692496|NCT03779334|470501920|FG001|Overall Study|Ongoing in Study|13|||
130692497|NCT03779334|470501921|FG002|Overall Study|Ongoing in Study|5|||
130692498|NCT01175135|470501922|FG000|Overall Study|Adverse Event|2|||
130692499|NCT01175135|470501923|FG001|Overall Study|Adverse Event|5|||
130692500|NCT01175135|470501924|FG002|Overall Study|Adverse Event|3|||
130692501|NCT01175135|470501925|FG003|Overall Study|Adverse Event|4|||
130692502|NCT01175135|470501922|FG000|Overall Study|Death|1|||
130692503|NCT01175135|470501923|FG001|Overall Study|Death|0|||
130692504|NCT01175135|470501924|FG002|Overall Study|Death|0|||
130692505|NCT01175135|470501925|FG003|Overall Study|Death|0|||
130692506|NCT01175135|470501922|FG000|Overall Study|Lack of Efficacy|4|||
130692507|NCT01175135|470501923|FG001|Overall Study|Lack of Efficacy|5|||
130692508|NCT01175135|470501924|FG002|Overall Study|Lack of Efficacy|0|||
130692509|NCT01175135|470501925|FG003|Overall Study|Lack of Efficacy|5|||
130692510|NCT01175135|470501922|FG000|Overall Study|Lost to Follow-up|1|||
130692511|NCT01175135|470501923|FG001|Overall Study|Lost to Follow-up|2|||
130692512|NCT01175135|470501924|FG002|Overall Study|Lost to Follow-up|0|||
130692513|NCT01175135|470501925|FG003|Overall Study|Lost to Follow-up|0|||
130692514|NCT01175135|470501922|FG000|Overall Study|Protocol Violation|1|||
130692515|NCT01175135|470501923|FG001|Overall Study|Protocol Violation|1|||
130692516|NCT01175135|470501924|FG002|Overall Study|Protocol Violation|0|||
130692517|NCT01175135|470501925|FG003|Overall Study|Protocol Violation|0|||
130692518|NCT01175135|470501922|FG000|Overall Study|Withdrawal by Subject|4|||
130692519|NCT01175135|470501923|FG001|Overall Study|Withdrawal by Subject|8|||
130692520|NCT01175135|470501924|FG002|Overall Study|Withdrawal by Subject|5|||
130692521|NCT01175135|470501925|FG003|Overall Study|Withdrawal by Subject|5|||
130692522|NCT01175135|470501922|FG000|Overall Study|Other|3|||
130692523|NCT01175135|470501923|FG001|Overall Study|Other|1|||
130692524|NCT01175135|470501924|FG002|Overall Study|Other|3|||
130692525|NCT01175135|470501925|FG003|Overall Study|Other|0|||
130692526|NCT01175135|470501922|FG000|Overall Study|Randomized But Not Treated|0|||
130692527|NCT01175135|470501923|FG001|Overall Study|Randomized But Not Treated|0|||
130692528|NCT01175135|470501924|FG002|Overall Study|Randomized But Not Treated|1|||
130692529|NCT01175135|470501925|FG003|Overall Study|Randomized But Not Treated|0|||
130692530|NCT04692155|470501929|FG000|Overall Study|Death|1|||
130692531|NCT03325881|470501933|FG000|Overall Study|Protocol Violation|0|||
130692532|NCT03325881|470501934|FG001|Overall Study|Protocol Violation|1|||
130692533|NCT03325881|470501933|FG000|Overall Study|Withdrawal by Subject|0|||
130692534|NCT03325881|470501934|FG001|Overall Study|Withdrawal by Subject|2|||
130692535|NCT03325881|470501933|FG000|Overall Study|Lack of Efficacy|2|||
130692536|NCT03325881|470501934|FG001|Overall Study|Lack of Efficacy|0|||
130692537|NCT03325881|470501933|FG000|Overall Study|Not treated|1|||
130692538|NCT03325881|470501934|FG001|Overall Study|Not treated|0|||
130692539|NCT03676634|470501939|FG000|Overall Study|Red blood cell loss|1|||
130692540|NCT03676634|470501939|FG000|Overall Study|Out-of-limit pulse|2|||
130692541|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
130692542|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
130692543|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
130692544|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
130692545|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130692546|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130692547|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
130692548|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130692549|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130692550|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
130692551|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130692552|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130692553|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Other|0|||
130692554|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Other|0|||
130692555|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Other|2|||
130692556|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Other|0|||
130692557|NCT03131895|470501943|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130692558|NCT03131895|470501944|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
130692559|NCT03131895|470501945|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130692560|NCT03131895|470501946|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130692561|NCT03131895|470501943|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
130692562|NCT03131895|470501944|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692563|NCT03131895|470501945|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692564|NCT03131895|470501946|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692565|NCT00540423|470501947|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130692566|NCT00540423|470501948|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130692567|NCT00540423|470501949|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130692568|NCT00540423|470501947|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130692569|NCT00540423|470501948|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130692570|NCT00540423|470501949|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
130692571|NCT02280863|470501953|FG000|Integrated Platform|Met stopping criteria|0|||
130692572|NCT02280863|470501954|FG001|Integrated Platform|Met stopping criteria|1|||
130692573|NCT00216736|470501960|FG000|Overall Study|Lost to Follow-up|1|||
130692574|NCT00216736|470501961|FG001|Overall Study|Lost to Follow-up|1|||
130692575|NCT02622386|470501962|FG000|First Assignment|Withdrawal by Subject|3|||
130692576|NCT02622386|470501963|FG001|First Assignment|Withdrawal by Subject|2|||
130231083|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231084|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231085|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
130231086|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
130231087|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
130231088|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
130231089|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
130231090|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
130231091|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
130231092|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
130231093|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
130231094|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
130231095|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
130231096|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231097|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231098|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231099|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231100|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
130231101|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231102|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231103|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231104|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231105|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231106|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
130231107|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231108|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231109|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231110|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
130231111|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
130231112|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
130231113|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
130356597|NCT00667602|469276367|FG002|Overall Study|Withdrawal by Subject|10|||
130692577|NCT02622386|470501962|FG000|Washout|Withdrawal by Subject|4|||
130692578|NCT02622386|470501963|FG001|Washout|Withdrawal by Subject|4|||
130692579|NCT02622386|470501962|FG000|Second Assignment|Withdrawal by Subject|0|||
130692580|NCT02622386|470501963|FG001|Second Assignment|Withdrawal by Subject|2|||
130692581|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692582|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
130692583|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692584|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692585|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692586|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692587|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692588|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692589|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692590|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692591|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692592|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692593|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692594|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692595|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130692596|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130692597|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692598|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
130692599|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692600|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692601|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692602|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692603|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692604|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692605|NCT03236311|470501972|FG000|Overall Study|Study terminated by sponsor|0|||
130692606|NCT03236311|470501973|FG001|Overall Study|Study terminated by sponsor|2|||
130692607|NCT03236311|470501972|FG000|Overall Study|Adverse Event|0|||
130692608|NCT03236311|470501973|FG001|Overall Study|Adverse Event|1|||
130692609|NCT00807495|470501975|FG000|Overall Study|Adverse Event|6|||
130692610|NCT00807495|470501976|FG001|Overall Study|Adverse Event|3|||
130692611|NCT00807495|470501977|FG002|Overall Study|Adverse Event|1|||
130692612|NCT00807495|470501978|FG003|Overall Study|Adverse Event|1|||
130692613|NCT00807495|470501979|FG004|Overall Study|Adverse Event|2|||
130692614|NCT00807495|470501975|FG000|Overall Study|Withdrawal by Patient|2|||
130692615|NCT00807495|470501976|FG001|Overall Study|Withdrawal by Patient|0|||
130692616|NCT00807495|470501977|FG002|Overall Study|Withdrawal by Patient|1|||
130692617|NCT00807495|470501978|FG003|Overall Study|Withdrawal by Patient|0|||
130692618|NCT00807495|470501979|FG004|Overall Study|Withdrawal by Patient|0|||
130692619|NCT00807495|470501975|FG000|Overall Study|Reason Not Specified|0|||
130692620|NCT00807495|470501976|FG001|Overall Study|Reason Not Specified|3|||
130692621|NCT00807495|470501977|FG002|Overall Study|Reason Not Specified|2|||
130692622|NCT00807495|470501978|FG003|Overall Study|Reason Not Specified|0|||
130692623|NCT00807495|470501979|FG004|Overall Study|Reason Not Specified|3|||
130692624|NCT01174186|470501982|FG000|Overall Study|Lost to Follow-up|0|||
130692625|NCT01174186|470501983|FG001|Overall Study|Lost to Follow-up|1|||
130692626|NCT01174186|470501982|FG000|Overall Study|Withdrawal by Subject|0|||
130692627|NCT01174186|470501983|FG001|Overall Study|Withdrawal by Subject|2|||
130692628|NCT05274763|470501984|FG000|Overall Study|Lost to Follow-up|1|||
130692629|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
130692630|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
130692631|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
130692632|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
130692633|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
130692634|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
130692635|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Death|9|||
130692636|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Death|7|||
130692637|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Death|14|||
130692638|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Death|7|||
130692639|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Death|0|||
130692640|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Death|0|||
130692641|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
130692642|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
130692643|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
130692644|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
130692645|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
130692646|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
130692647|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Other Event|49|||
130692648|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Other Event|52|||
130692649|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Other Event|41|||
130692650|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Other Event|58|||
130692651|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Other Event|0|||
130231114|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
130692652|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Other Event|0|||
130692653|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
130231115|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231116|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
130692654|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
130692655|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
130231117|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231118|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231119|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130692656|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
130692657|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130692658|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130692659|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
130692660|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
130692661|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
130692662|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
130692663|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
130692664|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
130692665|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130692666|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130692667|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
130692668|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
130692669|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130692670|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130692671|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
130692672|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
130692673|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
130692674|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
130692675|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130692676|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130692677|NCT00205777|470501990|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
130692678|NCT00205777|470501991|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
130692679|NCT00205777|470501992|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
130692680|NCT00205777|470501993|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
130692681|NCT00205777|470501994|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130692682|NCT00205777|470501995|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130692683|NCT00205777|470501990|FG000|Completed Core Study, Entered SE I|Other Event|52|||
130692684|NCT00205777|470501991|FG001|Completed Core Study, Entered SE I|Other Event|46|||
130692685|NCT00205777|470501992|FG002|Completed Core Study, Entered SE I|Other Event|47|||
130692686|NCT00205777|470501993|FG003|Completed Core Study, Entered SE I|Other Event|50|||
130692687|NCT00205777|470501994|FG004|Completed Core Study, Entered SE I|Other Event|0|||
130692688|NCT00205777|470501995|FG005|Completed Core Study, Entered SE I|Other Event|0|||
130692689|NCT00205777|470501990|FG000|Study Extension I|Adverse Event|57|||
130692690|NCT00205777|470501991|FG001|Study Extension I|Adverse Event|0|||
130692691|NCT00205777|470501992|FG002|Study Extension I|Adverse Event|0|||
130692692|NCT00205777|470501993|FG003|Study Extension I|Adverse Event|61|||
130692693|NCT00205777|470501994|FG004|Study Extension I|Adverse Event|58|||
130231120|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
130231121|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231122|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231123|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231124|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231125|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231126|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
130231127|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231128|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231129|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231130|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
130231131|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231132|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231133|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231134|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130692694|NCT00205777|470501995|FG005|Study Extension I|Adverse Event|0|||
130692695|NCT00205777|470501990|FG000|Study Extension I|Death|5|||
130356598|NCT00667602|469276365|FG000|Overall Study|Lost to Follow-up|4|||
130692696|NCT00205777|470501991|FG001|Study Extension I|Death|0|||
130356599|NCT00667602|469276366|FG001|Overall Study|Lost to Follow-up|5|||
130692697|NCT00205777|470501992|FG002|Study Extension I|Death|0|||
130692698|NCT00205777|470501993|FG003|Study Extension I|Death|1|||
130692699|NCT00205777|470501994|FG004|Study Extension I|Death|2|||
130692700|NCT00205777|470501995|FG005|Study Extension I|Death|0|||
130692701|NCT00205777|470501990|FG000|Study Extension I|Withdrawal by Subject|99|||
130692702|NCT00205777|470501991|FG001|Study Extension I|Withdrawal by Subject|0|||
130692703|NCT00205777|470501992|FG002|Study Extension I|Withdrawal by Subject|0|||
130692704|NCT00205777|470501993|FG003|Study Extension I|Withdrawal by Subject|106|||
130692705|NCT00205777|470501994|FG004|Study Extension I|Withdrawal by Subject|89|||
130692706|NCT00205777|470501995|FG005|Study Extension I|Withdrawal by Subject|0|||
130692707|NCT00205777|470501990|FG000|Study Extension I|Protocol Violation|4|||
130692708|NCT00205777|470501991|FG001|Study Extension I|Protocol Violation|0|||
130692709|NCT00205777|470501992|FG002|Study Extension I|Protocol Violation|0|||
130692710|NCT00205777|470501993|FG003|Study Extension I|Protocol Violation|8|||
130692711|NCT00205777|470501994|FG004|Study Extension I|Protocol Violation|8|||
130692712|NCT00205777|470501995|FG005|Study Extension I|Protocol Violation|0|||
130692713|NCT00205777|470501990|FG000|Study Extension I|Lack of Efficacy|0|||
130692714|NCT00205777|470501991|FG001|Study Extension I|Lack of Efficacy|0|||
130692715|NCT00205777|470501992|FG002|Study Extension I|Lack of Efficacy|0|||
130692716|NCT00205777|470501993|FG003|Study Extension I|Lack of Efficacy|1|||
130692717|NCT00205777|470501994|FG004|Study Extension I|Lack of Efficacy|2|||
130692718|NCT00205777|470501995|FG005|Study Extension I|Lack of Efficacy|0|||
130692719|NCT00205777|470501990|FG000|Study Extension I|Failed to return|15|||
130692720|NCT00205777|470501991|FG001|Study Extension I|Failed to return|0|||
130692721|NCT00205777|470501992|FG002|Study Extension I|Failed to return|0|||
130692722|NCT00205777|470501993|FG003|Study Extension I|Failed to return|17|||
130692723|NCT00205777|470501994|FG004|Study Extension I|Failed to return|13|||
130692724|NCT00205777|470501995|FG005|Study Extension I|Failed to return|0|||
130692725|NCT00205777|470501990|FG000|Study Extension I|Other Event|34|||
130692726|NCT00205777|470501991|FG001|Study Extension I|Other Event|0|||
130692727|NCT00205777|470501992|FG002|Study Extension I|Other Event|0|||
130692728|NCT00205777|470501993|FG003|Study Extension I|Other Event|34|||
130692729|NCT00205777|470501994|FG004|Study Extension I|Other Event|29|||
130692730|NCT00205777|470501995|FG005|Study Extension I|Other Event|0|||
130231135|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231136|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
130231137|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231138|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231139|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231140|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
130231141|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231142|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231143|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231144|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231145|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
130231146|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231147|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231148|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231149|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231150|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130231151|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130231152|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
130231153|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
130231154|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
130231155|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130231156|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130231157|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
130231158|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
130231159|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
130231160|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130231161|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130231162|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
130356600|NCT00667602|469276367|FG002|Overall Study|Lost to Follow-up|6|||
130692731|NCT00205777|470501990|FG000|Study Extension I|Withdrawn as per protocol|0|||
130692732|NCT00205777|470501991|FG001|Study Extension I|Withdrawn as per protocol|0|||
130692733|NCT00205777|470501992|FG002|Study Extension I|Withdrawn as per protocol|1070|||
130692734|NCT00205777|470501993|FG003|Study Extension I|Withdrawn as per protocol|0|||
130692735|NCT00205777|470501994|FG004|Study Extension I|Withdrawn as per protocol|0|||
130692736|NCT00205777|470501995|FG005|Study Extension I|Withdrawn as per protocol|0|||
130692737|NCT00205777|470501990|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
130692738|NCT00205777|470501991|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130692739|NCT00205777|470501992|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130231163|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
130231164|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
130231165|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231166|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231167|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130231168|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231169|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130231170|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130231171|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130231172|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
130231173|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
130445224|NCT01012973|469591925|FG000|Overall Study|Lack of Efficacy|0|||
130445225|NCT01012973|469591926|FG001|Overall Study|Lack of Efficacy|5|||
130445226|NCT01012973|469591925|FG000|Overall Study|Lost to Follow-up|1|||
130445227|NCT01012973|469591926|FG001|Overall Study|Lost to Follow-up|0|||
130692740|NCT00205777|470501993|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
130692741|NCT00205777|470501994|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
130692742|NCT00205777|470501995|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130692743|NCT00205777|470501990|FG000|Study Extension II|Adverse Event|0|||
130692744|NCT00205777|470501991|FG001|Study Extension II|Adverse Event|0|||
130692745|NCT00205777|470501992|FG002|Study Extension II|Adverse Event|0|||
130692746|NCT00205777|470501993|FG003|Study Extension II|Adverse Event|14|||
130692747|NCT00205777|470501994|FG004|Study Extension II|Adverse Event|0|||
130692748|NCT00205777|470501995|FG005|Study Extension II|Adverse Event|30|||
130692749|NCT00205777|470501990|FG000|Study Extension II|Death|0|||
130692750|NCT00205777|470501991|FG001|Study Extension II|Death|0|||
130692751|NCT00205777|470501992|FG002|Study Extension II|Death|0|||
130692752|NCT00205777|470501993|FG003|Study Extension II|Death|2|||
130445228|NCT01012973|469591925|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
130445229|NCT01012973|469591926|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
130445230|NCT01012973|469591925|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
130445231|NCT01012973|469591926|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
130445232|NCT01012973|469591925|FG000|Overall Study|Protocol Violation|5|||
130445233|NCT01012973|469591926|FG001|Overall Study|Protocol Violation|2|||
130445234|NCT01012973|469591925|FG000|Overall Study|Withdrawal by Subject|4|||
130692753|NCT00205777|470501994|FG004|Study Extension II|Death|0|||
130692754|NCT00205777|470501995|FG005|Study Extension II|Death|5|||
130692755|NCT00205777|470501990|FG000|Study Extension II|Withdrawal by Subject|0|||
130692756|NCT00205777|470501991|FG001|Study Extension II|Withdrawal by Subject|0|||
130692757|NCT00205777|470501992|FG002|Study Extension II|Withdrawal by Subject|0|||
130692758|NCT00205777|470501993|FG003|Study Extension II|Withdrawal by Subject|35|||
130692759|NCT00205777|470501994|FG004|Study Extension II|Withdrawal by Subject|0|||
130692760|NCT00205777|470501995|FG005|Study Extension II|Withdrawal by Subject|59|||
130692761|NCT00205777|470501990|FG000|Study Extension II|Protocol Violation|0|||
130692762|NCT00205777|470501991|FG001|Study Extension II|Protocol Violation|0|||
130692763|NCT00205777|470501992|FG002|Study Extension II|Protocol Violation|0|||
130445235|NCT01012973|469591926|FG001|Overall Study|Withdrawal by Subject|6|||
130445236|NCT02213055|469591928|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
130445237|NCT02213055|469591929|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
130445238|NCT02213055|469591928|FG000|Overall Study|Protocol was not Followed during Study|1|||
130445239|NCT02213055|469591929|FG001|Overall Study|Protocol was not Followed during Study|0|||
130692764|NCT00205777|470501993|FG003|Study Extension II|Protocol Violation|1|||
130692765|NCT00205777|470501994|FG004|Study Extension II|Protocol Violation|0|||
130692766|NCT00205777|470501995|FG005|Study Extension II|Protocol Violation|10|||
130692767|NCT00205777|470501990|FG000|Study Extension II|Lack of Efficacy|0|||
130692768|NCT00205777|470501991|FG001|Study Extension II|Lack of Efficacy|0|||
130692769|NCT00205777|470501992|FG002|Study Extension II|Lack of Efficacy|0|||
130692770|NCT00205777|470501993|FG003|Study Extension II|Lack of Efficacy|0|||
130231174|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
130231175|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130445240|NCT02213055|469591928|FG000|Overall Study|Documentation Issue at Enrollment|1|||
130445241|NCT02213055|469591929|FG001|Overall Study|Documentation Issue at Enrollment|0|||
130445242|NCT02213055|469591928|FG000|Overall Study|Documentation Issue during Study|10|||
130445243|NCT02213055|469591929|FG001|Overall Study|Documentation Issue during Study|0|||
130445244|NCT02213055|469591928|FG000|Overall Study|Did not have Live Lice|8|||
130692771|NCT00205777|470501994|FG004|Study Extension II|Lack of Efficacy|0|||
130445245|NCT02213055|469591929|FG001|Overall Study|Did not have Live Lice|0|||
130445246|NCT02213055|469591928|FG000|Overall Study|Had another Treatment during the Study|3|||
130445247|NCT02213055|469591929|FG001|Overall Study|Had another Treatment during the Study|0|||
130692772|NCT00205777|470501995|FG005|Study Extension II|Lack of Efficacy|1|||
130692773|NCT00205777|470501990|FG000|Study Extension II|Failed to return|0|||
130692774|NCT00205777|470501991|FG001|Study Extension II|Failed to return|0|||
130692775|NCT00205777|470501992|FG002|Study Extension II|Failed to return|0|||
130692776|NCT00205777|470501993|FG003|Study Extension II|Failed to return|14|||
130692777|NCT00205777|470501994|FG004|Study Extension II|Failed to return|0|||
130692778|NCT00205777|470501995|FG005|Study Extension II|Failed to return|26|||
130692779|NCT00205777|470501990|FG000|Study Extension II|Other Event|0|||
130692780|NCT00205777|470501991|FG001|Study Extension II|Other Event|0|||
130692781|NCT00205777|470501992|FG002|Study Extension II|Other Event|0|||
130692782|NCT00205777|470501993|FG003|Study Extension II|Other Event|12|||
130692783|NCT00205777|470501994|FG004|Study Extension II|Other Event|0|||
130692784|NCT00205777|470501995|FG005|Study Extension II|Other Event|20|||
130692785|NCT00205777|470501990|FG000|Study Extension II|Enrolled but not treated|0|||
130692786|NCT00205777|470501991|FG001|Study Extension II|Enrolled but not treated|0|||
130692787|NCT00205777|470501992|FG002|Study Extension II|Enrolled but not treated|0|||
130692788|NCT00205777|470501993|FG003|Study Extension II|Enrolled but not treated|71|||
130692789|NCT00205777|470501994|FG004|Study Extension II|Enrolled but not treated|0|||
130692790|NCT00205777|470501995|FG005|Study Extension II|Enrolled but not treated|131|||
130692791|NCT00367133|470501998|FG000|2 Years|Death|20|||
130692792|NCT00367133|470501999|FG001|2 Years|Death|12|||
130692793|NCT00367133|470502000|FG002|2 Years|Death|12|||
130692794|NCT00367133|470501998|FG000|2 Years|Dropped|34|||
130692795|NCT00367133|470501999|FG001|2 Years|Dropped|19|||
130692796|NCT00367133|470502000|FG002|2 Years|Dropped|33|||
130692797|NCT00367133|470501998|FG000|2 Years|Missed visit|4|||
130692798|NCT00367133|470501999|FG001|2 Years|Missed visit|5|||
130692799|NCT00367133|470502000|FG002|2 Years|Missed visit|4|||
130692800|NCT02336074|470502001|FG000|Overall Study|Adverse Event|0|||
130692801|NCT02336074|470502002|FG001|Overall Study|Adverse Event|2|||
130692802|NCT00906399|470502003|FG000|Year 1|Randomized But Not Treated|0|||
130692803|NCT00906399|470502004|FG001|Year 1|Randomized But Not Treated|1|||
130692804|NCT00906399|470502005|FG002|Year 1|Randomized But Not Treated|3|||
130692805|NCT00906399|470502006|FG003|Year 1|Randomized But Not Treated|0|||
130692806|NCT00906399|470502007|FG004|Year 1|Randomized But Not Treated|0|||
130692807|NCT00906399|470502008|FG005|Year 1|Randomized But Not Treated|0|||
130692808|NCT00906399|470502009|FG006|Year 1|Randomized But Not Treated|0|||
130692809|NCT00906399|470502003|FG000|Year 1|Adverse Event|4|||
130692810|NCT00906399|470502004|FG001|Year 1|Adverse Event|22|||
130692811|NCT00906399|470502005|FG002|Year 1|Adverse Event|24|||
130692812|NCT00906399|470502006|FG003|Year 1|Adverse Event|0|||
130692813|NCT00906399|470502007|FG004|Year 1|Adverse Event|0|||
130692814|NCT00906399|470502008|FG005|Year 1|Adverse Event|0|||
130692815|NCT00906399|470502009|FG006|Year 1|Adverse Event|0|||
130692816|NCT00906399|470502003|FG000|Year 1|Lost to Follow-up|4|||
130692817|NCT00906399|470502004|FG001|Year 1|Lost to Follow-up|4|||
130692818|NCT00906399|470502005|FG002|Year 1|Lost to Follow-up|2|||
130692819|NCT00906399|470502006|FG003|Year 1|Lost to Follow-up|0|||
130692820|NCT00906399|470502007|FG004|Year 1|Lost to Follow-up|0|||
130692821|NCT00906399|470502008|FG005|Year 1|Lost to Follow-up|0|||
130692822|NCT00906399|470502009|FG006|Year 1|Lost to Follow-up|0|||
130692823|NCT00906399|470502003|FG000|Year 1|Withdrawal by Subject|30|||
130692824|NCT00906399|470502004|FG001|Year 1|Withdrawal by Subject|32|||
130692825|NCT00906399|470502005|FG002|Year 1|Withdrawal by Subject|36|||
130692826|NCT00906399|470502006|FG003|Year 1|Withdrawal by Subject|0|||
130692827|NCT00906399|470502007|FG004|Year 1|Withdrawal by Subject|0|||
130692828|NCT00906399|470502008|FG005|Year 1|Withdrawal by Subject|0|||
130692829|NCT00906399|470502009|FG006|Year 1|Withdrawal by Subject|0|||
130692830|NCT00906399|470502003|FG000|Year 1|Physician Decision|0|||
130692831|NCT00906399|470502004|FG001|Year 1|Physician Decision|1|||
130692832|NCT00906399|470502005|FG002|Year 1|Physician Decision|3|||
130692833|NCT00906399|470502006|FG003|Year 1|Physician Decision|0|||
130692834|NCT00906399|470502007|FG004|Year 1|Physician Decision|0|||
130692835|NCT00906399|470502008|FG005|Year 1|Physician Decision|0|||
130692836|NCT00906399|470502009|FG006|Year 1|Physician Decision|0|||
130692837|NCT00906399|470502003|FG000|Year 1|Death|2|||
130692838|NCT00906399|470502004|FG001|Year 1|Death|1|||
130692839|NCT00906399|470502005|FG002|Year 1|Death|1|||
130692840|NCT00906399|470502006|FG003|Year 1|Death|0|||
130692841|NCT00906399|470502007|FG004|Year 1|Death|0|||
130692842|NCT00906399|470502008|FG005|Year 1|Death|0|||
130692843|NCT00906399|470502009|FG006|Year 1|Death|0|||
130692844|NCT00906399|470502003|FG000|Year 1|Other|4|||
130692845|NCT00906399|470502004|FG001|Year 1|Other|2|||
130692846|NCT00906399|470502005|FG002|Year 1|Other|7|||
130692847|NCT00906399|470502006|FG003|Year 1|Other|0|||
130692848|NCT00906399|470502007|FG004|Year 1|Other|0|||
130692849|NCT00906399|470502008|FG005|Year 1|Other|0|||
130692850|NCT00906399|470502009|FG006|Year 1|Other|0|||
130692851|NCT00906399|470502003|FG000|Year 2|Adverse Event|0|||
130692852|NCT00906399|470502004|FG001|Year 2|Adverse Event|0|||
130692853|NCT00906399|470502005|FG002|Year 2|Adverse Event|0|||
130692854|NCT00906399|470502006|FG003|Year 2|Adverse Event|9|||
130692855|NCT00906399|470502007|FG004|Year 2|Adverse Event|8|||
130692856|NCT00906399|470502008|FG005|Year 2|Adverse Event|11|||
130692857|NCT00906399|470502009|FG006|Year 2|Adverse Event|6|||
130692858|NCT00906399|470502003|FG000|Year 2|Lost to Follow-up|0|||
130692859|NCT00906399|470502004|FG001|Year 2|Lost to Follow-up|0|||
130692860|NCT00906399|470502005|FG002|Year 2|Lost to Follow-up|0|||
130692861|NCT00906399|470502006|FG003|Year 2|Lost to Follow-up|1|||
130692862|NCT00906399|470502007|FG004|Year 2|Lost to Follow-up|4|||
130692863|NCT00906399|470502008|FG005|Year 2|Lost to Follow-up|2|||
130692864|NCT00906399|470502009|FG006|Year 2|Lost to Follow-up|4|||
130692865|NCT00906399|470502003|FG000|Year 2|Withdrawal by Subject|0|||
130692866|NCT00906399|470502004|FG001|Year 2|Withdrawal by Subject|0|||
130692867|NCT00906399|470502005|FG002|Year 2|Withdrawal by Subject|0|||
130692868|NCT00906399|470502006|FG003|Year 2|Withdrawal by Subject|17|||
130692869|NCT00906399|470502007|FG004|Year 2|Withdrawal by Subject|18|||
130692870|NCT00906399|470502008|FG005|Year 2|Withdrawal by Subject|27|||
130692871|NCT00906399|470502009|FG006|Year 2|Withdrawal by Subject|13|||
130692872|NCT00906399|470502003|FG000|Year 2|Physician Decision|0|||
130692873|NCT00906399|470502004|FG001|Year 2|Physician Decision|0|||
130692874|NCT00906399|470502005|FG002|Year 2|Physician Decision|0|||
130692875|NCT00906399|470502006|FG003|Year 2|Physician Decision|0|||
130692876|NCT00906399|470502007|FG004|Year 2|Physician Decision|2|||
130692877|NCT00906399|470502008|FG005|Year 2|Physician Decision|6|||
130692878|NCT00906399|470502009|FG006|Year 2|Physician Decision|3|||
130692879|NCT00906399|470502003|FG000|Year 2|Death|0|||
130692880|NCT00906399|470502004|FG001|Year 2|Death|0|||
130692881|NCT00906399|470502005|FG002|Year 2|Death|0|||
130692882|NCT00906399|470502006|FG003|Year 2|Death|1|||
130692883|NCT00906399|470502007|FG004|Year 2|Death|0|||
130692884|NCT00906399|470502008|FG005|Year 2|Death|0|||
130692885|NCT00906399|470502009|FG006|Year 2|Death|3|||
130692886|NCT00906399|470502003|FG000|Year 2|Other|0|||
130692887|NCT00906399|470502004|FG001|Year 2|Other|0|||
130692888|NCT00906399|470502005|FG002|Year 2|Other|0|||
130692889|NCT00906399|470502006|FG003|Year 2|Other|2|||
130692890|NCT00906399|470502007|FG004|Year 2|Other|3|||
130692891|NCT00906399|470502008|FG005|Year 2|Other|1|||
130692892|NCT00906399|470502009|FG006|Year 2|Other|0|||
130692893|NCT00858780|470502024|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
130692894|NCT00858780|470502025|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692895|NCT00858780|470502026|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692896|NCT00858780|470502027|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692897|NCT00858780|470502028|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692898|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692899|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692900|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
130692901|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692902|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692903|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130692904|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692905|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692906|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692907|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130692908|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692909|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
130692910|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692911|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692912|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692913|NCT00858780|470502024|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692914|NCT00858780|470502025|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692915|NCT00858780|470502026|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692916|NCT00858780|470502027|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692917|NCT00858780|470502028|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
130692918|NCT00858780|470502024|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692919|NCT00858780|470502025|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692920|NCT00858780|470502026|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692921|NCT00858780|470502027|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
130356601|NCT00667602|469276365|FG000|Overall Study|Administrative reason|0|||
130692922|NCT00858780|470502028|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
130692923|NCT00863330|470502029|FG000|Overall Study|study terminated early due to administra|6|||
130692924|NCT03602339|470502030|FG000|Overall Study|Withdrawal by Subject|9|||
130692925|NCT03602339|470502030|FG000|Overall Study|Physician Decision|2|||
130692926|NCT03602339|470502030|FG000|Overall Study|Other reason|4|||
130692927|NCT01297504|470502031|FG000|Overall Study|Invalid Consent|1|||
130692928|NCT01297504|470502031|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
130692929|NCT01297504|470502031|FG000|Overall Study|No Study Visits|4|||
130692930|NCT01297504|470502031|FG000|Overall Study|Death|3|||
130692931|NCT01297504|470502031|FG000|Overall Study|Lost to Follow-up|43|||
130692932|NCT01297504|470502031|FG000|Overall Study|Withdrawal by Subject|9|||
130692933|NCT01297504|470502031|FG000|Overall Study|Site Closure|3|||
130692934|NCT01297504|470502031|FG000|Overall Study|Protocol Violation|3|||
130692935|NCT02615249|470502032|FG000|Overall Study|Withdrawal by Subject|1|||
130692936|NCT00574847|470502033|FG000|Overall Study|Adverse Event|2|||
130692937|NCT00574847|470502034|FG001|Overall Study|Adverse Event|0|||
130692938|NCT00574847|470502033|FG000|Overall Study|Death|1|||
130692939|NCT00574847|470502034|FG001|Overall Study|Death|0|||
130692940|NCT00574847|470502033|FG000|Overall Study|Withdrawal by Subject|2|||
130692941|NCT00574847|470502034|FG001|Overall Study|Withdrawal by Subject|2|||
130692942|NCT00574847|470502033|FG000|Overall Study|Physician Decision|1|||
130692943|NCT00574847|470502034|FG001|Overall Study|Physician Decision|0|||
130692944|NCT00574847|470502033|FG000|Overall Study|Did not receive medication (declined)|2|||
130692945|NCT00574847|470502034|FG001|Overall Study|Did not receive medication (declined)|5|||
130692946|NCT03719040|470502041|FG000|Overall Study|Withdrawal by Subject|177|||
130692947|NCT03719040|470502041|FG000|Overall Study|Lost to Follow-up|26|||
130692948|NCT02923349|470502042|FG000|Overall Study|Other|1|||
130692949|NCT02923349|470502043|FG001|Overall Study|Other|2|||
130692950|NCT02923349|470502044|FG002|Overall Study|Other|4|||
130692951|NCT02923349|470502045|FG003|Overall Study|Other|1|||
130692952|NCT02923349|470502046|FG004|Overall Study|Other|3|||
130692953|NCT02923349|470502047|FG005|Overall Study|Other|0|||
130692954|NCT02923349|470502048|FG006|Overall Study|Other|1|||
130692955|NCT02923349|470502042|FG000|Overall Study|Withdrawal by Subject|2|||
130692956|NCT02923349|470502043|FG001|Overall Study|Withdrawal by Subject|2|||
130692957|NCT02923349|470502044|FG002|Overall Study|Withdrawal by Subject|8|||
130692958|NCT02923349|470502045|FG003|Overall Study|Withdrawal by Subject|10|||
130692959|NCT02923349|470502046|FG004|Overall Study|Withdrawal by Subject|12|||
130692960|NCT02923349|470502047|FG005|Overall Study|Withdrawal by Subject|3|||
130692961|NCT02923349|470502048|FG006|Overall Study|Withdrawal by Subject|0|||
130692962|NCT02923349|470502042|FG000|Overall Study|Physician Decision|0|||
130692963|NCT02923349|470502043|FG001|Overall Study|Physician Decision|0|||
130692964|NCT02923349|470502044|FG002|Overall Study|Physician Decision|0|||
130692965|NCT02923349|470502045|FG003|Overall Study|Physician Decision|1|||
130692966|NCT02923349|470502046|FG004|Overall Study|Physician Decision|1|||
130692967|NCT02923349|470502047|FG005|Overall Study|Physician Decision|0|||
130692968|NCT02923349|470502048|FG006|Overall Study|Physician Decision|2|||
130692969|NCT02923349|470502042|FG000|Overall Study|Lost to Follow-up|0|||
130692970|NCT02923349|470502043|FG001|Overall Study|Lost to Follow-up|0|||
130692971|NCT02923349|470502044|FG002|Overall Study|Lost to Follow-up|3|||
130692972|NCT02923349|470502045|FG003|Overall Study|Lost to Follow-up|0|||
130692973|NCT02923349|470502046|FG004|Overall Study|Lost to Follow-up|1|||
130692974|NCT02923349|470502047|FG005|Overall Study|Lost to Follow-up|1|||
130692975|NCT02923349|470502048|FG006|Overall Study|Lost to Follow-up|0|||
130692976|NCT02923349|470502042|FG000|Overall Study|Death|1|||
130692977|NCT02923349|470502043|FG001|Overall Study|Death|0|||
130692978|NCT02923349|470502044|FG002|Overall Study|Death|2|||
130692979|NCT02923349|470502045|FG003|Overall Study|Death|4|||
130692980|NCT02923349|470502046|FG004|Overall Study|Death|2|||
130692981|NCT02923349|470502047|FG005|Overall Study|Death|3|||
130692982|NCT02923349|470502048|FG006|Overall Study|Death|0|||
130692983|NCT02751827|470502049|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130692984|NCT02751827|470502050|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130692985|NCT02751827|470502051|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
130692986|NCT03428750|470503529|FG000|Overall Study|Withdrawal by Subject|11|||
130692987|NCT03428750|470503530|FG001|Overall Study|Withdrawal by Subject|10|||
130692988|NCT03428750|470503529|FG000|Overall Study|Lost to Follow-up|3|||
130692989|NCT03428750|470503530|FG001|Overall Study|Lost to Follow-up|9|||
130231176|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130356602|NCT00667602|469276366|FG001|Overall Study|Administrative reason|0|||
130356603|NCT00667602|469276367|FG002|Overall Study|Administrative reason|2|||
130356604|NCT00667602|469276365|FG000|Overall Study|Protocol Violation|0|||
130692990|NCT03428750|470503529|FG000|Overall Study|Adverse Event|9|||
130692991|NCT03428750|470503530|FG001|Overall Study|Adverse Event|1|||
130692992|NCT03428750|470503529|FG000|Overall Study|Protocol Violation|1|||
130692993|NCT03428750|470503530|FG001|Overall Study|Protocol Violation|0|||
130692994|NCT03428750|470503529|FG000|Overall Study|Administrative|0|||
130692995|NCT03428750|470503530|FG001|Overall Study|Administrative|1|||
130692996|NCT04547192|470503531|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
130692997|NCT04547192|470503532|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
130692998|NCT04547192|470503533|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
130692999|NCT04547192|470503534|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
130231177|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130356605|NCT00667602|469276366|FG001|Overall Study|Protocol Violation|1|||
130356606|NCT00667602|469276367|FG002|Overall Study|Protocol Violation|0|||
130693000|NCT04547192|470503531|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
130693001|NCT04547192|470503532|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
130693002|NCT04547192|470503533|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
130693003|NCT04547192|470503534|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
130693004|NCT04547192|470503531|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
130693005|NCT04547192|470503532|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
130693006|NCT04547192|470503533|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
130693007|NCT04547192|470503534|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
130693008|NCT04547192|470503531|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
130693009|NCT04547192|470503532|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693010|NCT04547192|470503533|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693011|NCT04547192|470503534|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693012|NCT04547192|470503531|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693013|NCT04547192|470503532|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693014|NCT04547192|470503533|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
130693015|NCT04547192|470503534|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693016|NCT04723693|470503535|FG000|Overall Study|Withdrawal by Subject|2|||
130693017|NCT03497130|470503536|FG000|Overall Study|Lost to Follow-up|1|||
130693018|NCT03497130|470503537|FG001|Overall Study|Lost to Follow-up|1|||
130693019|NCT04002648|470503538|FG000|Overall Study|Lost to Follow-up|2|||
130693020|NCT04002648|470503539|FG001|Overall Study|Lost to Follow-up|0|||
130693021|NCT00669162|470503543|FG000|Overall Study|Withdrawal by Subject|1|||
130693022|NCT02412852|470503544|FG000|Overall Study|Withdrawal by Subject|0|||
130693023|NCT02412852|470503545|FG001|Overall Study|Withdrawal by Subject|1|||
130693024|NCT02412852|470503546|FG002|Overall Study|Withdrawal by Subject|0|||
130693025|NCT02412852|470503547|FG003|Overall Study|Withdrawal by Subject|0|||
130693026|NCT02412852|470503544|FG000|Overall Study|Physician Decision|0|||
130693027|NCT02412852|470503545|FG001|Overall Study|Physician Decision|0|||
130693028|NCT02412852|470503546|FG002|Overall Study|Physician Decision|0|||
130693029|NCT02412852|470503547|FG003|Overall Study|Physician Decision|1|||
130693030|NCT01051349|470503548|FG000|Overall Study|Adverse Event|88|||
130693031|NCT01051349|470503548|FG000|Overall Study|Consent Withdrawn|54|||
130693032|NCT01051349|470503548|FG000|Overall Study|Investigator Decision|6|||
130693033|NCT01051349|470503548|FG000|Overall Study|Lost to Follow-up|6|||
130693034|NCT01051349|470503548|FG000|Overall Study|Subject non-compliance|7|||
130693035|NCT01051349|470503548|FG000|Overall Study|Reason not Specified|12|||
130693036|NCT00909753|470503549|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
130693037|NCT00909753|470503550|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
130693038|NCT00909753|470503549|FG000|Period: Second Intervention|Protocol Violation|1|||
130693039|NCT00909753|470503550|FG001|Period: Second Intervention|Protocol Violation|0|||
130693040|NCT00841542|470503553|FG000|Period 1|Adverse Event|1|||
130693041|NCT00841542|470503554|FG001|Period 1|Adverse Event|0|||
130693042|NCT00418145|470503555|FG000|Overall Study|study terminated|6|||
130693043|NCT03214588|470503556|FG000|Overall Study|Adverse Event|1|||
130693044|NCT03214588|470503557|FG001|Overall Study|Adverse Event|0|||
130693045|NCT03214588|470503558|FG002|Overall Study|Adverse Event|2|||
130693046|NCT03214588|470503556|FG000|Overall Study|Reason Not Specified|0|||
130693047|NCT03214588|470503557|FG001|Overall Study|Reason Not Specified|1|||
130693048|NCT03214588|470503558|FG002|Overall Study|Reason Not Specified|0|||
130693049|NCT00472212|470503559|FG000|Overall Study|Lost to Follow-up|6|||
130693050|NCT00472212|470503560|FG001|Overall Study|Lost to Follow-up|4|||
130693051|NCT03480763|470503561|FG000|Overall Study|Withdrawal by Subject|18|||
130693052|NCT03480763|470503562|FG001|Overall Study|Withdrawal by Subject|10|||
130693053|NCT03480763|470503561|FG000|Overall Study|Lost to Follow-up|4|||
130693054|NCT03480763|470503562|FG001|Overall Study|Lost to Follow-up|7|||
130693055|NCT03480763|470503561|FG000|Overall Study|non-study pneumococcal vaccine|1|||
130693056|NCT03480763|470503562|FG001|Overall Study|non-study pneumococcal vaccine|0|||
130693057|NCT03480763|470503561|FG000|Overall Study|oncological treatment|0|||
130693058|NCT03480763|470503562|FG001|Overall Study|oncological treatment|2|||
130356607|NCT00973349|469276375|FG000|Overall Study|Adverse Event|0|||
130356608|NCT00973349|469276376|FG001|Overall Study|Adverse Event|0|||
130356609|NCT00973349|469276377|FG002|Overall Study|Adverse Event|0|||
130356610|NCT00973349|469276378|FG003|Overall Study|Adverse Event|0|||
130356611|NCT00973349|469276379|FG004|Overall Study|Adverse Event|1|||
130356612|NCT00973349|469276380|FG005|Overall Study|Adverse Event|0|||
130356613|NCT00973349|469276381|FG006|Overall Study|Adverse Event|0|||
130356614|NCT00973349|469276382|FG007|Overall Study|Adverse Event|0|||
130693059|NCT03480763|470503561|FG000|Overall Study|pain with vaccination|1|||
130356615|NCT00973349|469276383|FG008|Overall Study|Adverse Event|1|||
130356616|NCT00973349|469276384|FG009|Overall Study|Adverse Event|0|||
130356617|NCT00973349|469276385|FG010|Overall Study|Adverse Event|0|||
130693060|NCT03480763|470503562|FG001|Overall Study|pain with vaccination|0|||
130693061|NCT01647828|470503567|FG000|Overall Study|Death|3|||
130693062|NCT01647828|470503568|FG001|Overall Study|Death|4|||
130693063|NCT01647828|470503569|FG002|Overall Study|Death|4|||
130693064|NCT01647828|470503570|FG003|Overall Study|Death|5|||
130693065|NCT01647828|470503571|FG004|Overall Study|Death|6|||
130693066|NCT01647828|470503572|FG005|Overall Study|Death|3|||
130356618|NCT00973349|469276386|FG011|Overall Study|Adverse Event|0|||
130356619|NCT00973349|469276387|FG012|Overall Study|Adverse Event|0|||
130693067|NCT01647828|470503573|FG006|Overall Study|Death|10|||
130693068|NCT01647828|470503574|FG007|Overall Study|Death|60|||
130693069|NCT01647828|470503575|FG008|Overall Study|Death|71|||
130693070|NCT01647828|470503567|FG000|Overall Study|Withdrawal by Subject|2|||
130693071|NCT01647828|470503568|FG001|Overall Study|Withdrawal by Subject|0|||
130693072|NCT01647828|470503569|FG002|Overall Study|Withdrawal by Subject|0|||
130693073|NCT01647828|470503570|FG003|Overall Study|Withdrawal by Subject|1|||
130693074|NCT01647828|470503571|FG004|Overall Study|Withdrawal by Subject|0|||
130693075|NCT01647828|470503572|FG005|Overall Study|Withdrawal by Subject|0|||
130693076|NCT01647828|470503573|FG006|Overall Study|Withdrawal by Subject|1|||
130693077|NCT01647828|470503574|FG007|Overall Study|Withdrawal by Subject|0|||
130693078|NCT01647828|470503575|FG008|Overall Study|Withdrawal by Subject|2|||
130693079|NCT01647828|470503567|FG000|Overall Study|Study terminated by Sponsor|0|||
130693080|NCT01647828|470503568|FG001|Overall Study|Study terminated by Sponsor|0|||
130693081|NCT01647828|470503569|FG002|Overall Study|Study terminated by Sponsor|0|||
130693082|NCT01647828|470503570|FG003|Overall Study|Study terminated by Sponsor|0|||
130693083|NCT01647828|470503571|FG004|Overall Study|Study terminated by Sponsor|0|||
130693084|NCT01647828|470503572|FG005|Overall Study|Study terminated by Sponsor|0|||
130693085|NCT01647828|470503573|FG006|Overall Study|Study terminated by Sponsor|1|||
130693086|NCT01647828|470503574|FG007|Overall Study|Study terminated by Sponsor|26|||
130693087|NCT01647828|470503575|FG008|Overall Study|Study terminated by Sponsor|16|||
130693088|NCT01647828|470503567|FG000|Overall Study|Lost to Follow-up|0|||
130693089|NCT01647828|470503568|FG001|Overall Study|Lost to Follow-up|0|||
130693090|NCT01647828|470503569|FG002|Overall Study|Lost to Follow-up|0|||
130693091|NCT01647828|470503570|FG003|Overall Study|Lost to Follow-up|0|||
130693092|NCT01647828|470503571|FG004|Overall Study|Lost to Follow-up|0|||
130693093|NCT01647828|470503572|FG005|Overall Study|Lost to Follow-up|0|||
130693094|NCT01647828|470503573|FG006|Overall Study|Lost to Follow-up|0|||
130693095|NCT01647828|470503574|FG007|Overall Study|Lost to Follow-up|2|||
130693096|NCT01647828|470503575|FG008|Overall Study|Lost to Follow-up|0|||
130693097|NCT01906372|470503576|FG000|Overall Study|Withdrawal by Subject|2|||
130693098|NCT03629054|470503577|FG000|Period 2 (4 Days)|Not treated|0|||
130693099|NCT03629054|470503578|FG001|Period 2 (4 Days)|Not treated|1|||
130693100|NCT00624286|470503585|FG000|Overall Study|Protocol Deviation|7|||
130693101|NCT00624286|470503586|FG001|Overall Study|Protocol Deviation|9|||
130693102|NCT00624286|470503585|FG000|Overall Study|Adverse Event|6|||
130693103|NCT00624286|470503586|FG001|Overall Study|Adverse Event|3|||
130693104|NCT00624286|470503585|FG000|Overall Study|Withdrawal by Subject|5|||
130693105|NCT00624286|470503586|FG001|Overall Study|Withdrawal by Subject|4|||
130693106|NCT00624286|470503585|FG000|Overall Study|Lost to Follow-up|3|||
130693107|NCT00624286|470503586|FG001|Overall Study|Lost to Follow-up|2|||
130693108|NCT00624286|470503585|FG000|Overall Study|Administrative problems|3|||
130693109|NCT00624286|470503586|FG001|Overall Study|Administrative problems|0|||
130693110|NCT00624286|470503585|FG000|Overall Study|Lack of Efficacy|1|||
130693111|NCT00624286|470503586|FG001|Overall Study|Lack of Efficacy|6|||
130693112|NCT00624286|470503585|FG000|Overall Study|Not stated|0|||
130693113|NCT00624286|470503586|FG001|Overall Study|Not stated|1|||
130693114|NCT00624286|470503585|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130693115|NCT00624286|470503586|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130693116|NCT00624286|470503585|FG000|Overall Study|Death|0|||
130693117|NCT00624286|470503586|FG001|Overall Study|Death|1|||
130693118|NCT04404725|470503587|FG000|First Intervention|Withdrawal by Subject|0|||
130693119|NCT04404725|470503588|FG001|First Intervention|Withdrawal by Subject|2|||
130693120|NCT04404725|470503587|FG000|Second Intervention|Adverse Event|1|||
130693121|NCT04404725|470503588|FG001|Second Intervention|Adverse Event|1|||
130693122|NCT04404725|470503587|FG000|Second Intervention|Withdrawal by Subject|0|||
130693123|NCT04404725|470503588|FG001|Second Intervention|Withdrawal by Subject|1|||
130693124|NCT01075516|470503589|FG000|Overall Study|Death|5|||
130693125|NCT01075516|470503590|FG001|Overall Study|Death|9|||
130693126|NCT01075516|470503589|FG000|Overall Study|Lost to Follow-up|10|||
130693127|NCT01075516|470503590|FG001|Overall Study|Lost to Follow-up|2|||
130693128|NCT01075516|470503589|FG000|Overall Study|Withdrawal by Subject|3|||
130693129|NCT01075516|470503590|FG001|Overall Study|Withdrawal by Subject|5|||
130693130|NCT02252016|470503591|FG000|Overall Study|Lost to Follow-up|2|||
130693131|NCT02252016|470503592|FG001|Overall Study|Lost to Follow-up|1|||
130693132|NCT02252016|470503591|FG000|Overall Study|Physician Decision|1|||
130693133|NCT02252016|470503592|FG001|Overall Study|Physician Decision|0|||
130693134|NCT02252016|470503591|FG000|Overall Study|Withdrawal by Subject|0|||
130693135|NCT02252016|470503592|FG001|Overall Study|Withdrawal by Subject|2|||
130693136|NCT01190865|470503593|FG000|Overall Study|Withdrawal by Subject|1|||
130693137|NCT01190865|470503593|FG000|Overall Study|Non-compliance|2|||
130693138|NCT02055547|470503604|FG000|Overall Study|Protocol Violation|0|||
130693139|NCT02055547|470503605|FG001|Overall Study|Protocol Violation|0|||
130693140|NCT02055547|470503606|FG002|Overall Study|Protocol Violation|1|||
130693141|NCT02055547|470503607|FG003|Overall Study|Protocol Violation|0|||
130693142|NCT02055547|470503608|FG004|Overall Study|Protocol Violation|0|||
130693143|NCT02055547|470503609|FG005|Overall Study|Protocol Violation|0|||
130693144|NCT02055547|470503610|FG006|Overall Study|Protocol Violation|1|||
130693145|NCT02055547|470503611|FG007|Overall Study|Protocol Violation|0|||
130693146|NCT02055547|470503612|FG008|Overall Study|Protocol Violation|0|||
130693147|NCT02055547|470503613|FG009|Overall Study|Protocol Violation|0|||
130693148|NCT02055547|470503614|FG010|Overall Study|Protocol Violation|0|||
130693149|NCT02055547|470503615|FG011|Overall Study|Protocol Violation|0|||
130693150|NCT02055547|470503616|FG012|Overall Study|Protocol Violation|0|||
130693151|NCT02055547|470503617|FG013|Overall Study|Protocol Violation|0|||
130693152|NCT02055547|470503618|FG014|Overall Study|Protocol Violation|0|||
130693153|NCT02055547|470503619|FG015|Overall Study|Protocol Violation|0|||
130693154|NCT02055547|470503620|FG016|Overall Study|Protocol Violation|0|||
130693155|NCT02055547|470503621|FG017|Overall Study|Protocol Violation|0|||
130693156|NCT02055547|470503622|FG018|Overall Study|Protocol Violation|0|||
130693157|NCT02055547|470503604|FG000|Overall Study|Physician Decision|0|||
130693158|NCT02055547|470503605|FG001|Overall Study|Physician Decision|1|||
130693159|NCT02055547|470503606|FG002|Overall Study|Physician Decision|1|||
130693160|NCT02055547|470503607|FG003|Overall Study|Physician Decision|0|||
130693161|NCT02055547|470503608|FG004|Overall Study|Physician Decision|1|||
130693162|NCT02055547|470503609|FG005|Overall Study|Physician Decision|0|||
130693163|NCT02055547|470503610|FG006|Overall Study|Physician Decision|0|||
130693164|NCT02055547|470503611|FG007|Overall Study|Physician Decision|0|||
130693165|NCT02055547|470503612|FG008|Overall Study|Physician Decision|0|||
130693166|NCT02055547|470503613|FG009|Overall Study|Physician Decision|1|||
130693167|NCT02055547|470503614|FG010|Overall Study|Physician Decision|1|||
130693168|NCT02055547|470503615|FG011|Overall Study|Physician Decision|0|||
130693169|NCT02055547|470503616|FG012|Overall Study|Physician Decision|0|||
130693170|NCT02055547|470503617|FG013|Overall Study|Physician Decision|0|||
130693171|NCT02055547|470503618|FG014|Overall Study|Physician Decision|0|||
130693172|NCT02055547|470503619|FG015|Overall Study|Physician Decision|0|||
130693173|NCT02055547|470503620|FG016|Overall Study|Physician Decision|0|||
130693174|NCT02055547|470503621|FG017|Overall Study|Physician Decision|0|||
130693175|NCT02055547|470503622|FG018|Overall Study|Physician Decision|0|||
130693176|NCT02055547|470503604|FG000|Overall Study|Adverse Event|0|||
130693177|NCT02055547|470503605|FG001|Overall Study|Adverse Event|0|||
130693178|NCT02055547|470503606|FG002|Overall Study|Adverse Event|0|||
130693179|NCT02055547|470503607|FG003|Overall Study|Adverse Event|0|||
130693180|NCT02055547|470503608|FG004|Overall Study|Adverse Event|0|||
130693181|NCT02055547|470503609|FG005|Overall Study|Adverse Event|0|||
130693182|NCT02055547|470503610|FG006|Overall Study|Adverse Event|1|||
130693183|NCT02055547|470503611|FG007|Overall Study|Adverse Event|0|||
130693184|NCT02055547|470503612|FG008|Overall Study|Adverse Event|1|||
130231178|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
130693185|NCT02055547|470503613|FG009|Overall Study|Adverse Event|0|||
130693186|NCT02055547|470503614|FG010|Overall Study|Adverse Event|0|||
130693187|NCT02055547|470503615|FG011|Overall Study|Adverse Event|0|||
130693188|NCT02055547|470503616|FG012|Overall Study|Adverse Event|0|||
130693189|NCT02055547|470503617|FG013|Overall Study|Adverse Event|0|||
130693190|NCT02055547|470503618|FG014|Overall Study|Adverse Event|0|||
130693191|NCT02055547|470503619|FG015|Overall Study|Adverse Event|0|||
130693192|NCT02055547|470503620|FG016|Overall Study|Adverse Event|0|||
130693193|NCT02055547|470503621|FG017|Overall Study|Adverse Event|0|||
130693194|NCT02055547|470503622|FG018|Overall Study|Adverse Event|0|||
130693195|NCT02055547|470503604|FG000|Overall Study|Withdrawal by Subject|0|||
130693196|NCT02055547|470503605|FG001|Overall Study|Withdrawal by Subject|0|||
130693197|NCT02055547|470503606|FG002|Overall Study|Withdrawal by Subject|0|||
130231179|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
130231180|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231181|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231182|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
130231183|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130356620|NCT00973349|469276388|FG013|Overall Study|Adverse Event|0|||
130356621|NCT00973349|469276389|FG014|Overall Study|Adverse Event|1|||
130693198|NCT02055547|470503607|FG003|Overall Study|Withdrawal by Subject|0|||
130693199|NCT02055547|470503608|FG004|Overall Study|Withdrawal by Subject|0|||
130693200|NCT02055547|470503609|FG005|Overall Study|Withdrawal by Subject|1|||
130356622|NCT00973349|469276390|FG015|Overall Study|Adverse Event|0|||
130356623|NCT00973349|469276375|FG000|Overall Study|Withdrawal by Subject|1|||
130356624|NCT00973349|469276376|FG001|Overall Study|Withdrawal by Subject|2|||
130693201|NCT02055547|470503610|FG006|Overall Study|Withdrawal by Subject|0|||
130693202|NCT02055547|470503611|FG007|Overall Study|Withdrawal by Subject|0|||
130693203|NCT02055547|470503612|FG008|Overall Study|Withdrawal by Subject|1|||
130693204|NCT02055547|470503613|FG009|Overall Study|Withdrawal by Subject|0|||
130693205|NCT02055547|470503614|FG010|Overall Study|Withdrawal by Subject|0|||
130693206|NCT02055547|470503615|FG011|Overall Study|Withdrawal by Subject|0|||
130693207|NCT02055547|470503616|FG012|Overall Study|Withdrawal by Subject|0|||
130693208|NCT02055547|470503617|FG013|Overall Study|Withdrawal by Subject|1|||
130693209|NCT02055547|470503618|FG014|Overall Study|Withdrawal by Subject|0|||
130693210|NCT02055547|470503619|FG015|Overall Study|Withdrawal by Subject|1|||
130693211|NCT02055547|470503620|FG016|Overall Study|Withdrawal by Subject|0|||
130693212|NCT02055547|470503621|FG017|Overall Study|Withdrawal by Subject|0|||
130693213|NCT02055547|470503622|FG018|Overall Study|Withdrawal by Subject|0|||
130693214|NCT02055547|470503604|FG000|Overall Study|Lost to Follow-up|0|||
130693215|NCT02055547|470503605|FG001|Overall Study|Lost to Follow-up|0|||
130693216|NCT02055547|470503606|FG002|Overall Study|Lost to Follow-up|1|||
130693217|NCT02055547|470503607|FG003|Overall Study|Lost to Follow-up|0|||
130693218|NCT02055547|470503608|FG004|Overall Study|Lost to Follow-up|0|||
130693219|NCT02055547|470503609|FG005|Overall Study|Lost to Follow-up|0|||
130693220|NCT02055547|470503610|FG006|Overall Study|Lost to Follow-up|0|||
130693221|NCT02055547|470503611|FG007|Overall Study|Lost to Follow-up|0|||
130693222|NCT02055547|470503612|FG008|Overall Study|Lost to Follow-up|0|||
130693223|NCT02055547|470503613|FG009|Overall Study|Lost to Follow-up|0|||
130693224|NCT02055547|470503614|FG010|Overall Study|Lost to Follow-up|0|||
130693225|NCT02055547|470503615|FG011|Overall Study|Lost to Follow-up|0|||
130693226|NCT02055547|470503616|FG012|Overall Study|Lost to Follow-up|0|||
130693227|NCT02055547|470503617|FG013|Overall Study|Lost to Follow-up|0|||
130693228|NCT02055547|470503618|FG014|Overall Study|Lost to Follow-up|0|||
130693229|NCT02055547|470503619|FG015|Overall Study|Lost to Follow-up|0|||
130693230|NCT02055547|470503620|FG016|Overall Study|Lost to Follow-up|0|||
130693231|NCT02055547|470503621|FG017|Overall Study|Lost to Follow-up|0|||
130693232|NCT02055547|470503622|FG018|Overall Study|Lost to Follow-up|0|||
130693233|NCT00868998|470503630|FG000|Overall Study|Screen Failure|1|||
130693234|NCT00868998|470503630|FG000|Overall Study|Withdrawal by Subject|1|||
130693235|NCT00868998|470503630|FG000|Overall Study|Progression of disease|2|||
130693236|NCT00868998|470503630|FG000|Overall Study|Death|1|||
130693237|NCT01483820|470503632|FG000|Overall Study|Lack of Efficacy|6|||
130693238|NCT01483820|470503632|FG000|Overall Study|Adverse Event|1|||
130693239|NCT01483820|470503632|FG000|Overall Study|Death|1|||
130693240|NCT00867360|470503633|FG000|Overall Study|Withdrawal by Subject|1|||
130693241|NCT00867360|470503634|FG001|Overall Study|Withdrawal by Subject|0|||
130693242|NCT00867360|470503633|FG000|Overall Study|Physician Decision|0|||
130693243|NCT00867360|470503634|FG001|Overall Study|Physician Decision|1|||
130693244|NCT00842309|470503636|FG000|Overall Study|Withdrawal by Subject|3|||
130693245|NCT00842309|470503637|FG001|Overall Study|Withdrawal by Subject|1|||
130693246|NCT03218787|470503638|FG000|Overall Study|Lost to Follow-up|12|||
130693247|NCT03218787|470503638|FG000|Overall Study|Withdrawal by Subject|72|||
130693248|NCT03218787|470503638|FG000|Overall Study|Physician Decision|11|||
130693249|NCT03218787|470503638|FG000|Overall Study|Death|111|||
130693250|NCT02264977|470503639|FG000|Overall Study|Death|3|||
130693251|NCT02264977|470503639|FG000|Overall Study|Physician Decision|1|||
130693252|NCT02264977|470503639|FG000|Overall Study|Refuse to return|1|||
130693253|NCT03573544|470503640|FG000|Overall Study|Adverse Event|0|||
130693254|NCT03573544|470503641|FG001|Overall Study|Adverse Event|0|||
130693255|NCT03573544|470503642|FG002|Overall Study|Adverse Event|0|||
130693256|NCT03573544|470503643|FG003|Overall Study|Adverse Event|3|||
130693257|NCT03573544|470503644|FG004|Overall Study|Adverse Event|1|||
130693258|NCT03573544|470503645|FG005|Overall Study|Adverse Event|0|||
130693259|NCT03573544|470503646|FG006|Overall Study|Adverse Event|2|||
130356625|NCT00973349|469276377|FG002|Overall Study|Withdrawal by Subject|2|||
130356626|NCT00973349|469276378|FG003|Overall Study|Withdrawal by Subject|3|||
130356627|NCT00973349|469276379|FG004|Overall Study|Withdrawal by Subject|2|||
130356628|NCT00973349|469276380|FG005|Overall Study|Withdrawal by Subject|0|||
130356629|NCT00973349|469276381|FG006|Overall Study|Withdrawal by Subject|2|||
130356630|NCT00973349|469276382|FG007|Overall Study|Withdrawal by Subject|2|||
130693260|NCT03573544|470503647|FG007|Overall Study|Adverse Event|0|||
130693261|NCT03573544|470503640|FG000|Overall Study|Physician Decision|0|||
130693262|NCT03573544|470503641|FG001|Overall Study|Physician Decision|0|||
130693263|NCT03573544|470503642|FG002|Overall Study|Physician Decision|0|||
130693264|NCT03573544|470503643|FG003|Overall Study|Physician Decision|0|||
130693265|NCT03573544|470503644|FG004|Overall Study|Physician Decision|0|||
130693266|NCT03573544|470503645|FG005|Overall Study|Physician Decision|0|||
130693267|NCT03573544|470503646|FG006|Overall Study|Physician Decision|1|||
130693268|NCT03573544|470503647|FG007|Overall Study|Physician Decision|0|||
130693269|NCT03573544|470503640|FG000|Overall Study|Withdrawal by Subject|2|||
130693270|NCT03573544|470503641|FG001|Overall Study|Withdrawal by Subject|0|||
130693271|NCT03573544|470503642|FG002|Overall Study|Withdrawal by Subject|0|||
130693272|NCT03573544|470503643|FG003|Overall Study|Withdrawal by Subject|1|||
130693273|NCT03573544|470503644|FG004|Overall Study|Withdrawal by Subject|1|||
130693274|NCT03573544|470503645|FG005|Overall Study|Withdrawal by Subject|1|||
130356631|NCT00973349|469276383|FG008|Overall Study|Withdrawal by Subject|0|||
130356632|NCT00973349|469276384|FG009|Overall Study|Withdrawal by Subject|2|||
130693275|NCT03573544|470503646|FG006|Overall Study|Withdrawal by Subject|0|||
130693276|NCT03573544|470503647|FG007|Overall Study|Withdrawal by Subject|1|||
130693277|NCT03573544|470503640|FG000|Overall Study|Disease progression|3|||
130693278|NCT03573544|470503641|FG001|Overall Study|Disease progression|3|||
130693279|NCT03573544|470503642|FG002|Overall Study|Disease progression|6|||
130693280|NCT03573544|470503643|FG003|Overall Study|Disease progression|4|||
130693281|NCT03573544|470503644|FG004|Overall Study|Disease progression|5|||
130693282|NCT03573544|470503645|FG005|Overall Study|Disease progression|7|||
130693283|NCT03573544|470503646|FG006|Overall Study|Disease progression|6|||
130693284|NCT03573544|470503647|FG007|Overall Study|Disease progression|7|||
130693285|NCT01248728|470503651|FG000|Overall Study|Adverse Event|1|||
130693286|NCT01248728|470503652|FG001|Overall Study|Adverse Event|1|||
130693287|NCT01248728|470503651|FG000|Overall Study|Withdrawal by Subject|2|||
130693288|NCT01248728|470503652|FG001|Overall Study|Withdrawal by Subject|1|||
130693289|NCT01248728|470503651|FG000|Overall Study|Lack of Efficacy|1|||
130693290|NCT01248728|470503652|FG001|Overall Study|Lack of Efficacy|0|||
130693291|NCT00147498|470503653|FG000|Overall Study|Adverse Event|1|||
130693292|NCT00147498|470503654|FG001|Overall Study|Adverse Event|6|||
130693293|NCT00147498|470503655|FG002|Overall Study|Adverse Event|7|||
130231184|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231185|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231186|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231187|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231188|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
130231189|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
130231190|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231191|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231192|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231193|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130231194|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130231195|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231196|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231197|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231198|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231199|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
130231200|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231201|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231202|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231203|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
130231204|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
130231205|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231206|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231207|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130693294|NCT00147498|470503656|FG003|Overall Study|Adverse Event|3|||
130693295|NCT00147498|470503653|FG000|Overall Study|Lack of Efficacy|1|||
130693296|NCT00147498|470503654|FG001|Overall Study|Lack of Efficacy|1|||
130693297|NCT00147498|470503655|FG002|Overall Study|Lack of Efficacy|1|||
130693298|NCT00147498|470503656|FG003|Overall Study|Lack of Efficacy|8|||
130693299|NCT00147498|470503653|FG000|Overall Study|Laboratory abnormality|0|||
130693300|NCT00147498|470503654|FG001|Overall Study|Laboratory abnormality|0|||
130693301|NCT00147498|470503655|FG002|Overall Study|Laboratory abnormality|2|||
130693302|NCT00147498|470503656|FG003|Overall Study|Laboratory abnormality|0|||
130693303|NCT00147498|470503653|FG000|Overall Study|Participant defaulted|0|||
130693304|NCT00147498|470503654|FG001|Overall Study|Participant defaulted|1|||
130693305|NCT00147498|470503655|FG002|Overall Study|Participant defaulted|4|||
130693306|NCT00147498|470503656|FG003|Overall Study|Participant defaulted|3|||
130693307|NCT00147498|470503653|FG000|Overall Study|Other|1|||
130693308|NCT00147498|470503654|FG001|Overall Study|Other|1|||
130693309|NCT00147498|470503655|FG002|Overall Study|Other|3|||
130693310|NCT00147498|470503656|FG003|Overall Study|Other|3|||
130693311|NCT01838681|470503657|FG000|Period A|Adverse Event|39|||
130693312|NCT01838681|470503658|FG001|Period A|Adverse Event|0|||
130693313|NCT01838681|470503659|FG002|Period A|Adverse Event|0|||
130693314|NCT01838681|470503660|FG003|Period A|Adverse Event|0|||
130693315|NCT01838681|470503657|FG000|Period A|Lack of Efficacy|21|||
130693316|NCT01838681|470503658|FG001|Period A|Lack of Efficacy|0|||
130693317|NCT01838681|470503659|FG002|Period A|Lack of Efficacy|0|||
130693318|NCT01838681|470503660|FG003|Period A|Lack of Efficacy|0|||
130693319|NCT01838681|470503657|FG000|Period A|Early response|148|||
130693320|NCT01838681|470503658|FG001|Period A|Early response|0|||
130231208|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231209|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
130231210|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231211|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130693321|NCT01838681|470503659|FG002|Period A|Early response|0|||
130693322|NCT01838681|470503660|FG003|Period A|Early response|0|||
130693323|NCT01838681|470503657|FG000|Period A|Withdrawal by Subject|70|||
130693324|NCT01838681|470503658|FG001|Period A|Withdrawal by Subject|0|||
130693325|NCT01838681|470503659|FG002|Period A|Withdrawal by Subject|0|||
130693326|NCT01838681|470503660|FG003|Period A|Withdrawal by Subject|0|||
130693327|NCT01838681|470503657|FG000|Period A|Protocol Violation|16|||
130693328|NCT01838681|470503658|FG001|Period A|Protocol Violation|0|||
130231212|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
130231213|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231214|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231215|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231216|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231217|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231218|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130231219|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130231220|NCT03087058|468811600|FG000|Overall Study|Withdrawal by Subject|2|||
130231221|NCT03087058|468811601|FG001|Overall Study|Withdrawal by Subject|0|||
130231222|NCT03087058|468811602|FG002|Overall Study|Withdrawal by Subject|0|||
130231223|NCT02577029|468811603|FG000|Overall Study|Adverse Event|1|||
130231224|NCT02577029|468811604|FG001|Overall Study|Adverse Event|0|||
130231225|NCT02577029|468811605|FG002|Overall Study|Adverse Event|2|||
130231226|NCT02577029|468811606|FG003|Overall Study|Adverse Event|0|||
130231227|NCT02577029|468811607|FG004|Overall Study|Adverse Event|1|||
130231228|NCT02577029|468811608|FG005|Overall Study|Adverse Event|0|||
130231229|NCT02577029|468811609|FG006|Overall Study|Adverse Event|0|||
130231230|NCT02577029|468811610|FG007|Overall Study|Adverse Event|0|||
130231231|NCT02577029|468811603|FG000|Overall Study|Withdrawal by Subject|0|||
130231232|NCT02577029|468811604|FG001|Overall Study|Withdrawal by Subject|0|||
130231233|NCT02577029|468811605|FG002|Overall Study|Withdrawal by Subject|0|||
130231234|NCT02577029|468811606|FG003|Overall Study|Withdrawal by Subject|0|||
130231235|NCT02577029|468811607|FG004|Overall Study|Withdrawal by Subject|0|||
130231236|NCT02577029|468811608|FG005|Overall Study|Withdrawal by Subject|1|||
130231237|NCT02577029|468811609|FG006|Overall Study|Withdrawal by Subject|0|||
130231238|NCT02577029|468811610|FG007|Overall Study|Withdrawal by Subject|0|||
130231239|NCT02577029|468811603|FG000|Overall Study|Sponsor Termination of the Study|9|||
130231240|NCT02577029|468811604|FG001|Overall Study|Sponsor Termination of the Study|2|||
130231241|NCT02577029|468811605|FG002|Overall Study|Sponsor Termination of the Study|5|||
130231242|NCT02577029|468811606|FG003|Overall Study|Sponsor Termination of the Study|12|||
130231243|NCT02577029|468811607|FG004|Overall Study|Sponsor Termination of the Study|10|||
130231244|NCT02577029|468811608|FG005|Overall Study|Sponsor Termination of the Study|12|||
130231245|NCT02577029|468811609|FG006|Overall Study|Sponsor Termination of the Study|12|||
130231246|NCT02577029|468811610|FG007|Overall Study|Sponsor Termination of the Study|12|||
130231247|NCT02078817|468811611|FG000|Overall Study|Withdrawal by Subject|1|||
130231248|NCT01420536|468811612|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
130231249|NCT01420536|468811613|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
130231250|NCT01265498|468811618|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
130231251|NCT01265498|468811619|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
130231252|NCT01652690|468811621|FG000|Overall Study|Withdrawal by Subject|16|||
130231253|NCT01652690|468811622|FG001|Overall Study|Withdrawal by Subject|4|||
130231254|NCT01652690|468811621|FG000|Overall Study|Other|8|||
130231255|NCT01652690|468811622|FG001|Overall Study|Other|9|||
130231256|NCT01652690|468811621|FG000|Overall Study|Lost to Follow-up|6|||
130445248|NCT02213055|469591928|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
130445249|NCT02213055|469591929|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
130445250|NCT02213055|469591928|FG000|Overall Study|Did not Return to School|5|||
130445251|NCT02213055|469591929|FG001|Overall Study|Did not Return to School|0|||
130445252|NCT00231894|469591930|FG000|Overall Study|Withdrawal by Subject|1|||
130445253|NCT00231894|469591931|FG001|Overall Study|Withdrawal by Subject|1|||
130445254|NCT02025205|469591933|FG000|Overall Study|Withdrawal by Subject|1|||
130445255|NCT02025205|469591934|FG001|Overall Study|Withdrawal by Subject|1|||
130445256|NCT02025205|469591933|FG000|Overall Study|Protocol Violation|2|||
130445257|NCT02025205|469591934|FG001|Overall Study|Protocol Violation|1|||
130445258|NCT02025205|469591933|FG000|Overall Study|Death|0|||
130445259|NCT02025205|469591934|FG001|Overall Study|Death|1|||
130445260|NCT01782326|469591935|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
130445261|NCT01782326|469591936|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
130693329|NCT01838681|470503659|FG002|Period A|Protocol Violation|0|||
130445262|NCT01782326|469591935|FG000|Planned Treatment Epoch|Death|29|||
130445263|NCT01782326|469591936|FG001|Planned Treatment Epoch|Death|30|||
130445264|NCT01782326|469591935|FG000|Planned Treatment Epoch|Physician Decision|18|||
130445265|NCT01782326|469591936|FG001|Planned Treatment Epoch|Physician Decision|16|||
130693330|NCT01838681|470503660|FG003|Period A|Protocol Violation|0|||
130693331|NCT01838681|470503657|FG000|Period A|Non-compliance with IMP|6|||
130231257|NCT01652690|468811622|FG001|Overall Study|Lost to Follow-up|6|||
130231258|NCT01652690|468811621|FG000|Overall Study|Death|5|||
130231259|NCT01652690|468811622|FG001|Overall Study|Death|2|||
130231260|NCT03225287|468811623|FG000|Overall Study|Adverse Event|0|||
130231261|NCT03225287|468811624|FG001|Overall Study|Adverse Event|0|||
130445266|NCT01782326|469591935|FG000|Planned Treatment Epoch|Protocol deviation|2|||
130693332|NCT01838681|470503658|FG001|Period A|Non-compliance with IMP|0|||
130445267|NCT01782326|469591936|FG001|Planned Treatment Epoch|Protocol deviation|3|||
130231262|NCT03225287|468811625|FG002|Overall Study|Adverse Event|1|||
130231263|NCT03225287|468811623|FG000|Overall Study|Protocol non-compliance|0|||
130231264|NCT03225287|468811624|FG001|Overall Study|Protocol non-compliance|0|||
130231265|NCT03225287|468811625|FG002|Overall Study|Protocol non-compliance|1|||
130231266|NCT03225287|468811623|FG000|Overall Study|Subject withdraws consent|3|||
130231267|NCT03225287|468811624|FG001|Overall Study|Subject withdraws consent|0|||
130231268|NCT03225287|468811625|FG002|Overall Study|Subject withdraws consent|0|||
130231269|NCT03225287|468811623|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
130231270|NCT03225287|468811624|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
130231271|NCT03225287|468811625|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
130231272|NCT03225287|468811623|FG000|Overall Study|Trial drug not effective|0|||
130231273|NCT03225287|468811624|FG001|Overall Study|Trial drug not effective|1|||
130231274|NCT03225287|468811625|FG002|Overall Study|Trial drug not effective|0|||
130231275|NCT03225287|468811623|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
130231276|NCT03225287|468811624|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
130231277|NCT03225287|468811625|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
130231278|NCT03225287|468811623|FG000|Overall Study|Stem cell transplantation|0|||
130231279|NCT03225287|468811624|FG001|Overall Study|Stem cell transplantation|1|||
130231280|NCT03225287|468811625|FG002|Overall Study|Stem cell transplantation|0|||
130231281|NCT06996301|468811627|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130231282|NCT06996301|468811628|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130231283|NCT06996301|468811627|FG000|Overall Study|Patients with discordant diagnostic results|107|||
130231284|NCT06996301|468811628|FG001|Overall Study|Patients with discordant diagnostic results|90|||
130231285|NCT06996301|468811627|FG000|Overall Study|Lost to Follow-up|31|||
130231286|NCT06996301|468811628|FG001|Overall Study|Lost to Follow-up|56|||
130231287|NCT06996301|468811627|FG000|Overall Study|Withdrawal by Subject|12|||
130231288|NCT06996301|468811628|FG001|Overall Study|Withdrawal by Subject|7|||
130231289|NCT04030598|468811629|FG000|Overall Study|Voluntary Withdrawal|0|||
130231290|NCT04030598|468811630|FG001|Overall Study|Voluntary Withdrawal|1|||
130231291|NCT04030598|468811631|FG002|Overall Study|Voluntary Withdrawal|0|||
130231292|NCT02097823|468811634|FG000|Overall Study|Withdrawal by Subject|1|||
130693333|NCT01838681|470503659|FG002|Period A|Non-compliance with IMP|0|||
130693334|NCT01838681|470503660|FG003|Period A|Non-compliance with IMP|0|||
130693335|NCT01838681|470503657|FG000|Period A|Lost to Follow-up|4|||
130693336|NCT01838681|470503658|FG001|Period A|Lost to Follow-up|0|||
130693337|NCT01838681|470503659|FG002|Period A|Lost to Follow-up|0|||
130693338|NCT01838681|470503660|FG003|Period A|Lost to Follow-up|0|||
130693339|NCT01838681|470503657|FG000|Period A|Withdrawal before treatment|4|||
130693340|NCT01838681|470503658|FG001|Period A|Withdrawal before treatment|0|||
130693341|NCT01838681|470503659|FG002|Period A|Withdrawal before treatment|0|||
130693342|NCT01838681|470503660|FG003|Period A|Withdrawal before treatment|0|||
130693343|NCT01838681|470503657|FG000|Period A|Administrative or other reasons|17|||
130693344|NCT01838681|470503658|FG001|Period A|Administrative or other reasons|0|||
130693345|NCT01838681|470503659|FG002|Period A|Administrative or other reasons|0|||
130693346|NCT01838681|470503660|FG003|Period A|Administrative or other reasons|0|||
130693347|NCT01838681|470503657|FG000|Period B/A+|Adverse Event|0|||
130693348|NCT01838681|470503658|FG001|Period B/A+|Adverse Event|13|||
130693349|NCT01838681|470503659|FG002|Period B/A+|Adverse Event|27|||
130693350|NCT01838681|470503660|FG003|Period B/A+|Adverse Event|16|||
130693351|NCT01838681|470503657|FG000|Period B/A+|Lack of Efficacy|0|||
130693352|NCT01838681|470503658|FG001|Period B/A+|Lack of Efficacy|9|||
130693353|NCT01838681|470503659|FG002|Period B/A+|Lack of Efficacy|11|||
130693354|NCT01838681|470503660|FG003|Period B/A+|Lack of Efficacy|6|||
130693355|NCT01838681|470503657|FG000|Period B/A+|Withdrawal by Subject|0|||
130693356|NCT01838681|470503658|FG001|Period B/A+|Withdrawal by Subject|28|||
130693357|NCT01838681|470503659|FG002|Period B/A+|Withdrawal by Subject|35|||
130693358|NCT01838681|470503660|FG003|Period B/A+|Withdrawal by Subject|47|||
130693359|NCT01838681|470503657|FG000|Period B/A+|Protocol Violation|0|||
130693360|NCT01838681|470503658|FG001|Period B/A+|Protocol Violation|1|||
130693361|NCT01838681|470503659|FG002|Period B/A+|Protocol Violation|4|||
130231293|NCT02097823|468811635|FG001|Overall Study|Withdrawal by Subject|1|||
130356633|NCT00973349|469276385|FG010|Overall Study|Withdrawal by Subject|0|||
130356634|NCT00973349|469276386|FG011|Overall Study|Withdrawal by Subject|1|||
130356635|NCT00973349|469276387|FG012|Overall Study|Withdrawal by Subject|0|||
130356636|NCT00973349|469276388|FG013|Overall Study|Withdrawal by Subject|0|||
130356637|NCT00973349|469276389|FG014|Overall Study|Withdrawal by Subject|0|||
130356638|NCT00973349|469276390|FG015|Overall Study|Withdrawal by Subject|0|||
130231294|NCT00959751|468813466|FG000|Overall Study|Lost to Follow-up|2|||
130231295|NCT00959751|468813467|FG001|Overall Study|Lost to Follow-up|3|||
130231296|NCT00959751|468813466|FG000|Overall Study|Consent Withdrawn|0|||
130356639|NCT00973349|469276375|FG000|Overall Study|Lost to Follow-up|3|||
130693362|NCT01838681|470503660|FG003|Period B/A+|Protocol Violation|6|||
130693363|NCT01838681|470503657|FG000|Period B/A+|Non-compliance with IMP|0|||
130693364|NCT01838681|470503658|FG001|Period B/A+|Non-compliance with IMP|2|||
130693365|NCT01838681|470503659|FG002|Period B/A+|Non-compliance with IMP|3|||
130693366|NCT01838681|470503660|FG003|Period B/A+|Non-compliance with IMP|3|||
130231297|NCT00959751|468813467|FG001|Overall Study|Consent Withdrawn|1|||
130231298|NCT00959751|468813466|FG000|Overall Study|Non-compliance to Study Procedures|0|||
130231299|NCT00959751|468813467|FG001|Overall Study|Non-compliance to Study Procedures|1|||
130231300|NCT00959751|468813466|FG000|Overall Study|No migraine headache without aura|7|||
130231301|NCT00959751|468813467|FG001|Overall Study|No migraine headache without aura|7|||
130231302|NCT00900562|468813470|FG000|Overall Study|Progressive disease|9|||
130231303|NCT00900562|468813471|FG001|Overall Study|Progressive disease|5|||
130231304|NCT00900562|468813470|FG000|Overall Study|Toxicity|1|||
130231305|NCT00900562|468813471|FG001|Overall Study|Toxicity|0|||
130231306|NCT00900562|468813470|FG000|Overall Study|Death|1|||
130231307|NCT00900562|468813471|FG001|Overall Study|Death|1|||
130231308|NCT00900562|468813470|FG000|Overall Study|Withdrawal by Subject|0|||
130231309|NCT00900562|468813471|FG001|Overall Study|Withdrawal by Subject|1|||
130231310|NCT00900562|468813470|FG000|Overall Study|Unrelated adverse event|1|||
130231311|NCT00900562|468813471|FG001|Overall Study|Unrelated adverse event|0|||
130231312|NCT04459338|468813472|FG000|Overall Study|Loss of IV during study|1|||
130231313|NCT04459338|468813473|FG001|Overall Study|Loss of IV during study|0|||
130231314|NCT01454284|468813474|FG000|Overall Study|Adverse Event|20|||
130231315|NCT01454284|468813475|FG001|Overall Study|Adverse Event|7|||
130231316|NCT01454284|468813474|FG000|Overall Study|Death|0|||
130231317|NCT01454284|468813475|FG001|Overall Study|Death|3|||
130231318|NCT01454284|468813474|FG000|Overall Study|Lost to Follow-up|13|||
130231319|NCT01454284|468813475|FG001|Overall Study|Lost to Follow-up|8|||
130231320|NCT01454284|468813474|FG000|Overall Study|Protocol Violation|9|||
130231321|NCT01454284|468813475|FG001|Overall Study|Protocol Violation|6|||
130231322|NCT01454284|468813474|FG000|Overall Study|Withdrawal by Subject|58|||
130231323|NCT01454284|468813475|FG001|Overall Study|Withdrawal by Subject|36|||
130231324|NCT01454284|468813474|FG000|Overall Study|Physician Decision|16|||
130231325|NCT01454284|468813475|FG001|Overall Study|Physician Decision|11|||
130231326|NCT01454284|468813474|FG000|Overall Study|Sponsor Decision|0|||
130231327|NCT01454284|468813475|FG001|Overall Study|Sponsor Decision|2|||
130231328|NCT02665117|468813476|FG000|Overall Study|Physician Decision|1|||
130231329|NCT02665117|468813477|FG001|Overall Study|Physician Decision|0|||
130231330|NCT03817528|468813483|FG000|Overall Study|Withdrawal by Subject|1|||
130231331|NCT03817528|468813483|FG000|Overall Study|Adverse Event|2|||
130231332|NCT03451071|468813489|FG000|First Vaccine|Withdrawal by Subject|1|||
130231333|NCT03451071|468813489|FG000|Second Vaccine|Lost to Follow-up|19|||
130231334|NCT03451071|468813489|FG000|Third Vaccine|Lost to Follow-up|22|||
130231335|NCT03451071|468813489|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
130231336|NCT02065557|468813490|FG000|Induction Period|Withdrawal by Subject|2|||
130231337|NCT02065557|468813491|FG001|Induction Period|Withdrawal by Subject|1|||
130231338|NCT02065557|468813492|FG002|Induction Period|Withdrawal by Subject|0|||
130231339|NCT02065557|468813493|FG003|Induction Period|Withdrawal by Subject|0|||
130231340|NCT02065557|468813494|FG004|Induction Period|Withdrawal by Subject|0|||
130231341|NCT02065557|468813495|FG005|Induction Period|Withdrawal by Subject|0|||
130231342|NCT02065557|468813490|FG000|Induction Period|Lack of Efficacy|2|||
130231343|NCT02065557|468813491|FG001|Induction Period|Lack of Efficacy|1|||
130231344|NCT02065557|468813492|FG002|Induction Period|Lack of Efficacy|1|||
130231345|NCT02065557|468813493|FG003|Induction Period|Lack of Efficacy|0|||
130231346|NCT02065557|468813494|FG004|Induction Period|Lack of Efficacy|0|||
130231347|NCT02065557|468813495|FG005|Induction Period|Lack of Efficacy|0|||
130231348|NCT02065557|468813490|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231349|NCT02065557|468813491|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231350|NCT02065557|468813492|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231351|NCT02065557|468813493|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231352|NCT02065557|468813494|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231353|NCT02065557|468813495|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231354|NCT02065557|468813490|FG000|Induction Period|Non-Responder at Week 8|4|||
130231355|NCT02065557|468813491|FG001|Induction Period|Non-Responder at Week 8|4|||
130231356|NCT02065557|468813492|FG002|Induction Period|Non-Responder at Week 8|0|||
130231357|NCT02065557|468813493|FG003|Induction Period|Non-Responder at Week 8|0|||
130231358|NCT02065557|468813494|FG004|Induction Period|Non-Responder at Week 8|0|||
130231359|NCT02065557|468813495|FG005|Induction Period|Non-Responder at Week 8|0|||
130231360|NCT02065557|468813490|FG000|Induction Period|Adverse Event|1|||
130231361|NCT02065557|468813491|FG001|Induction Period|Adverse Event|1|||
130231362|NCT02065557|468813492|FG002|Induction Period|Adverse Event|0|||
130231363|NCT02065557|468813493|FG003|Induction Period|Adverse Event|0|||
130231364|NCT02065557|468813494|FG004|Induction Period|Adverse Event|0|||
130231365|NCT02065557|468813495|FG005|Induction Period|Adverse Event|0|||
130231366|NCT02065557|468813490|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231367|NCT02065557|468813491|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231368|NCT02065557|468813492|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231369|NCT02065557|468813493|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130231370|NCT02065557|468813494|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130231371|NCT02065557|468813495|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231372|NCT02065557|468813490|FG000|Maintenance Period|Withdrawal by Subject|0|||
130231373|NCT02065557|468813491|FG001|Maintenance Period|Withdrawal by Subject|0|||
130231374|NCT02065557|468813492|FG002|Maintenance Period|Withdrawal by Subject|0|||
130231375|NCT02065557|468813493|FG003|Maintenance Period|Withdrawal by Subject|0|||
130231376|NCT02065557|468813494|FG004|Maintenance Period|Withdrawal by Subject|2|||
130231377|NCT02065557|468813495|FG005|Maintenance Period|Withdrawal by Subject|1|||
130231378|NCT02065557|468813490|FG000|Maintenance Period|Lack of Efficacy|0|||
130231379|NCT02065557|468813491|FG001|Maintenance Period|Lack of Efficacy|0|||
130231380|NCT02065557|468813492|FG002|Maintenance Period|Lack of Efficacy|0|||
130231381|NCT02065557|468813493|FG003|Maintenance Period|Lack of Efficacy|0|||
130231382|NCT02065557|468813494|FG004|Maintenance Period|Lack of Efficacy|5|||
130231383|NCT02065557|468813495|FG005|Maintenance Period|Lack of Efficacy|2|||
130231384|NCT02065557|468813490|FG000|Maintenance Period|Subject Non-Compliance|0|||
130231385|NCT02065557|468813491|FG001|Maintenance Period|Subject Non-Compliance|0|||
130231386|NCT02065557|468813492|FG002|Maintenance Period|Subject Non-Compliance|0|||
130231387|NCT02065557|468813493|FG003|Maintenance Period|Subject Non-Compliance|0|||
130231388|NCT02065557|468813494|FG004|Maintenance Period|Subject Non-Compliance|0|||
130231389|NCT02065557|468813495|FG005|Maintenance Period|Subject Non-Compliance|1|||
130231390|NCT00250588|468813496|FG000|Overall Study|Withdrawal by Subject|3|||
130231391|NCT00250588|468813497|FG001|Overall Study|Withdrawal by Subject|6|||
130231392|NCT00250588|468813498|FG002|Overall Study|Withdrawal by Subject|0|||
130231393|NCT00250588|468813496|FG000|Overall Study|Lost to Follow-up|6|||
130231394|NCT00250588|468813497|FG001|Overall Study|Lost to Follow-up|13|||
130231395|NCT00250588|468813498|FG002|Overall Study|Lost to Follow-up|13|||
130231396|NCT03502798|468813499|FG000|Overall Study|equipment failure|0|||
130231397|NCT03502798|468813500|FG001|Overall Study|equipment failure|7|||
130231398|NCT00485303|468813501|FG000|Overall Study|Adverse Event|5|||
130231399|NCT00485303|468813501|FG000|Overall Study|Progressive Disease|44|||
130231400|NCT00485303|468813501|FG000|Overall Study|Other|3|||
130231401|NCT00485303|468813501|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
130231402|NCT00485303|468813501|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
130231403|NCT00296335|468813504|FG000|Overall Study|Recurrence|3|||
130231404|NCT00296335|468813505|FG001|Overall Study|Recurrence|51|||
130231405|NCT00296335|468813504|FG000|Overall Study|Adverse Event|17|||
130231406|NCT00296335|468813505|FG001|Overall Study|Adverse Event|27|||
130231407|NCT00296335|468813504|FG000|Overall Study|Lost to Follow-up|7|||
130231408|NCT00296335|468813505|FG001|Overall Study|Lost to Follow-up|33|||
130231409|NCT00296335|468813504|FG000|Overall Study|Physician Decision|3|||
130231410|NCT00296335|468813505|FG001|Overall Study|Physician Decision|11|||
130231411|NCT01401322|468813506|FG000|Overall Study|Withdrawal by Subject|1|||
130231412|NCT01401322|468813506|FG000|Overall Study|Physician Decision|1|||
130231413|NCT02737722|468813507|FG000|Overall Study|Physician Decision|0|||
130231414|NCT02737722|468813508|FG001|Overall Study|Physician Decision|0|||
130231415|NCT02737722|468813509|FG002|Overall Study|Physician Decision|1|||
130231416|NCT02737722|468813510|FG003|Overall Study|Physician Decision|0|||
130231417|NCT00112957|468813517|FG000|Overall Study|Progressive disease|18|||
130231418|NCT00112957|468813517|FG000|Overall Study|Physician Decision|1|||
130231419|NCT03444584|468813525|FG000|Overall Study|Withdrawal by Subject|0|||
130231420|NCT03444584|468813526|FG001|Overall Study|Withdrawal by Subject|1|||
130231421|NCT03444584|468813525|FG000|Overall Study|Other|0|||
130231422|NCT03444584|468813526|FG001|Overall Study|Other|1|||
130231423|NCT03451045|468813527|FG000|Overall Study|Lack of Efficacy|3|||
130231424|NCT03451045|468813528|FG001|Overall Study|Lack of Efficacy|2|||
130231425|NCT03451045|468813529|FG002|Overall Study|Lack of Efficacy|2|||
130231426|NCT03451045|468813527|FG000|Overall Study|Physician Decision|1|||
130231427|NCT03451045|468813528|FG001|Overall Study|Physician Decision|1|||
130231428|NCT03451045|468813529|FG002|Overall Study|Physician Decision|1|||
130231429|NCT03451045|468813527|FG000|Overall Study|Withdrawal by Subject|4|||
130231430|NCT03451045|468813528|FG001|Overall Study|Withdrawal by Subject|0|||
130231431|NCT03451045|468813529|FG002|Overall Study|Withdrawal by Subject|5|||
130231432|NCT03451045|468813527|FG000|Overall Study|Pregnancy|0|||
130693367|NCT01838681|470503657|FG000|Period B/A+|Lost to Follow-up|0|||
130693368|NCT01838681|470503658|FG001|Period B/A+|Lost to Follow-up|2|||
130231433|NCT03451045|468813528|FG001|Overall Study|Pregnancy|0|||
130231434|NCT03451045|468813529|FG002|Overall Study|Pregnancy|2|||
130231435|NCT03451045|468813527|FG000|Overall Study|Adverse Event|7|||
130356640|NCT00973349|469276376|FG001|Overall Study|Lost to Follow-up|1|||
130356641|NCT00973349|469276377|FG002|Overall Study|Lost to Follow-up|2|||
130356642|NCT00973349|469276378|FG003|Overall Study|Lost to Follow-up|2|||
130356643|NCT00973349|469276379|FG004|Overall Study|Lost to Follow-up|1|||
130693369|NCT01838681|470503659|FG002|Period B/A+|Lost to Follow-up|5|||
130693370|NCT01838681|470503660|FG003|Period B/A+|Lost to Follow-up|11|||
130693371|NCT01838681|470503657|FG000|Period B/A+|Withdrawal before treatment|0|||
130693372|NCT01838681|470503658|FG001|Period B/A+|Withdrawal before treatment|1|||
130231436|NCT03451045|468813528|FG001|Overall Study|Adverse Event|1|||
130231437|NCT03451045|468813529|FG002|Overall Study|Adverse Event|3|||
130231438|NCT03451045|468813527|FG000|Overall Study|Non-compliance with study|2|||
130231439|NCT03451045|468813528|FG001|Overall Study|Non-compliance with study|0|||
130231440|NCT03451045|468813529|FG002|Overall Study|Non-compliance with study|1|||
130231441|NCT03451045|468813527|FG000|Overall Study|any other reason|10|||
130231442|NCT03451045|468813528|FG001|Overall Study|any other reason|2|||
130231443|NCT03451045|468813529|FG002|Overall Study|any other reason|13|||
130231444|NCT00863707|468813530|FG000|Overall Study|Randomized, but drug not received|4|||
130231445|NCT00863707|468813531|FG001|Overall Study|Randomized, but drug not received|3|||
130231446|NCT03704064|468813532|FG000|Overall Study|Lost to Follow-up|8|||
130231447|NCT03704064|468813533|FG001|Overall Study|Lost to Follow-up|4|||
130231448|NCT03704064|468813532|FG000|Overall Study|Withdrawal by Subject|1|||
130231449|NCT03704064|468813533|FG001|Overall Study|Withdrawal by Subject|1|||
130231450|NCT03704064|468813532|FG000|Overall Study|No longer available for study visits|0|||
130231451|NCT03704064|468813533|FG001|Overall Study|No longer available for study visits|1|||
130231452|NCT03704064|468813532|FG000|Overall Study|Censoring event|1|||
130231453|NCT03704064|468813533|FG001|Overall Study|Censoring event|0|||
130231454|NCT04142242|468813534|FG000|Stage I|Non-compliance with the protocol|1|||
130231455|NCT04142242|468813535|FG001|Stage I|Non-compliance with the protocol|0|||
130231456|NCT04142242|468813536|FG002|Stage I|Non-compliance with the protocol|0|||
130231457|NCT04142242|468813537|FG003|Stage I|Non-compliance with the protocol|0|||
130231458|NCT04142242|468813538|FG004|Stage I|Non-compliance with the protocol|0|||
130231459|NCT04142242|468813539|FG005|Stage I|Non-compliance with the protocol|1|||
130231460|NCT04142242|468813534|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231461|NCT04142242|468813535|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
130231462|NCT04142242|468813536|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231463|NCT04142242|468813537|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231464|NCT04142242|468813538|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231465|NCT04142242|468813539|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231466|NCT04142242|468813534|FG000|Stage II|Non-compliance with the protocol|0|||
130231467|NCT04142242|468813535|FG001|Stage II|Non-compliance with the protocol|0|||
130231468|NCT04142242|468813536|FG002|Stage II|Non-compliance with the protocol|0|||
130231469|NCT04142242|468813537|FG003|Stage II|Non-compliance with the protocol|2|||
130231470|NCT04142242|468813538|FG004|Stage II|Non-compliance with the protocol|0|||
130231471|NCT04142242|468813539|FG005|Stage II|Non-compliance with the protocol|0|||
130231472|NCT04142242|468813534|FG000|Stage II|Lost to Follow-up|0|||
130231473|NCT04142242|468813535|FG001|Stage II|Lost to Follow-up|0|||
130231474|NCT04142242|468813536|FG002|Stage II|Lost to Follow-up|1|||
130231475|NCT04142242|468813537|FG003|Stage II|Lost to Follow-up|2|||
130231476|NCT04142242|468813538|FG004|Stage II|Lost to Follow-up|0|||
130231477|NCT04142242|468813539|FG005|Stage II|Lost to Follow-up|0|||
130231478|NCT04142242|468813534|FG000|Stage II|Withdrawal by Subject|0|||
130231479|NCT04142242|468813535|FG001|Stage II|Withdrawal by Subject|0|||
130231480|NCT04142242|468813536|FG002|Stage II|Withdrawal by Subject|5|||
130231481|NCT04142242|468813537|FG003|Stage II|Withdrawal by Subject|9|||
130231482|NCT04142242|468813538|FG004|Stage II|Withdrawal by Subject|0|||
130231483|NCT04142242|468813539|FG005|Stage II|Withdrawal by Subject|0|||
130231484|NCT00289276|468813542|FG000|Second Part of FAST Study (Expansion)|Death|0|||
130231485|NCT00289276|468813543|FG001|Second Part of FAST Study (Expansion)|Death|2|||
130231486|NCT00289276|468813542|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
130231487|NCT00289276|468813543|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
130231488|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
130231489|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
130445268|NCT01782326|469591935|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
130445269|NCT01782326|469591936|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
130445270|NCT01782326|469591935|FG000|Planned Treatment Epoch|Technical problems|0|||
130445271|NCT01782326|469591936|FG001|Planned Treatment Epoch|Technical problems|4|||
130231490|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130445272|NCT01782326|469591935|FG000|Double-blind Treatment|Adverse Event|129|||
130445273|NCT01782326|469591936|FG001|Double-blind Treatment|Adverse Event|145|||
130445274|NCT01782326|469591935|FG000|Double-blind Treatment|Subject/guardian decision|111|||
130445275|NCT01782326|469591936|FG001|Double-blind Treatment|Subject/guardian decision|125|||
130445276|NCT01782326|469591935|FG000|Double-blind Treatment|Lack of Efficacy|17|||
130445277|NCT01782326|469591936|FG001|Double-blind Treatment|Lack of Efficacy|22|||
130445278|NCT01782326|469591935|FG000|Double-blind Treatment|Physician Decision|13|||
130445279|NCT01782326|469591936|FG001|Double-blind Treatment|Physician Decision|16|||
130445280|NCT01782326|469591935|FG000|Double-blind Treatment|Protocol deviation|8|||
130445281|NCT01782326|469591936|FG001|Double-blind Treatment|Protocol deviation|7|||
130231491|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130445282|NCT01782326|469591935|FG000|Double-blind Treatment|Technical problems|0|||
130445283|NCT01782326|469591936|FG001|Double-blind Treatment|Technical problems|5|||
130445284|NCT01767129|469591937|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130231492|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
130231493|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
130231494|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
130445285|NCT01767129|469591938|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130231495|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
130231496|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
130231497|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
130231498|NCT02783911|468813546|FG000|Overall Study|Lost to Follow-up|3|||
130231499|NCT02783911|468813547|FG001|Overall Study|Lost to Follow-up|32|||
130231500|NCT00071981|468813548|FG000|Overall Study|Lack of Efficacy|37|||
130231501|NCT00071981|468813549|FG001|Overall Study|Lack of Efficacy|29|||
130231502|NCT00071981|468813550|FG002|Overall Study|Lack of Efficacy|30|||
130231503|NCT00071981|468813551|FG003|Overall Study|Lack of Efficacy|43|||
130231504|NCT00071981|468813548|FG000|Overall Study|Adverse Event|4|||
130231505|NCT00071981|468813549|FG001|Overall Study|Adverse Event|4|||
130231506|NCT00071981|468813550|FG002|Overall Study|Adverse Event|3|||
130231507|NCT00071981|468813551|FG003|Overall Study|Adverse Event|1|||
130231508|NCT00071981|468813548|FG000|Overall Study|Death|0|||
130231509|NCT00071981|468813549|FG001|Overall Study|Death|0|||
130231510|NCT00071981|468813550|FG002|Overall Study|Death|1|||
130231511|NCT00071981|468813551|FG003|Overall Study|Death|1|||
130231512|NCT00071981|468813548|FG000|Overall Study|Withdrawal by Subject|3|||
130231513|NCT00071981|468813549|FG001|Overall Study|Withdrawal by Subject|1|||
130231514|NCT00071981|468813550|FG002|Overall Study|Withdrawal by Subject|0|||
130231515|NCT00071981|468813551|FG003|Overall Study|Withdrawal by Subject|0|||
130231516|NCT00071981|468813548|FG000|Overall Study|No protocol therapy|2|||
130231517|NCT00071981|468813549|FG001|Overall Study|No protocol therapy|5|||
130231518|NCT00071981|468813550|FG002|Overall Study|No protocol therapy|1|||
130231519|NCT00071981|468813551|FG003|Overall Study|No protocol therapy|0|||
130231520|NCT00071981|468813548|FG000|Overall Study|others (not specified in the study)|0|||
130231521|NCT00071981|468813549|FG001|Overall Study|others (not specified in the study)|2|||
130231522|NCT00071981|468813550|FG002|Overall Study|others (not specified in the study)|2|||
130231523|NCT00071981|468813551|FG003|Overall Study|others (not specified in the study)|0|||
130231524|NCT01123655|468813552|FG000|Overall Study|Medication for RA had to be changed|1|||
130231525|NCT01123655|468813553|FG001|Overall Study|Medication for RA had to be changed|0|||
130231526|NCT01123655|468813554|FG002|Overall Study|Medication for RA had to be changed|0|||
130231527|NCT01123655|468813552|FG000|Overall Study|new illness|0|||
130231528|NCT01123655|468813553|FG001|Overall Study|new illness|1|||
130231529|NCT01123655|468813554|FG002|Overall Study|new illness|0|||
130231530|NCT01123655|468813552|FG000|Overall Study|began prohibitive drug|0|||
130231531|NCT01123655|468813553|FG001|Overall Study|began prohibitive drug|0|||
130231532|NCT01123655|468813554|FG002|Overall Study|began prohibitive drug|1|||
130231533|NCT00885118|468813557|FG000|Overall Study|Adverse Event|1|||
130231534|NCT00885118|468813558|FG001|Overall Study|Adverse Event|0|||
130231535|NCT00885118|468813559|FG002|Overall Study|Adverse Event|0|||
130231536|NCT00885118|468813560|FG003|Overall Study|Adverse Event|0|||
130231537|NCT00885118|468813561|FG004|Overall Study|Adverse Event|0|||
130231538|NCT00885118|468813557|FG000|Overall Study|Withdrawal by Subject|0|||
130231539|NCT00885118|468813558|FG001|Overall Study|Withdrawal by Subject|0|||
130231540|NCT00885118|468813559|FG002|Overall Study|Withdrawal by Subject|0|||
130231541|NCT00885118|468813560|FG003|Overall Study|Withdrawal by Subject|0|||
130231542|NCT00885118|468813561|FG004|Overall Study|Withdrawal by Subject|1|||
130231543|NCT00885118|468813557|FG000|Overall Study|Other reason not defined above|0|||
130231544|NCT00885118|468813558|FG001|Overall Study|Other reason not defined above|0|||
130231545|NCT00885118|468813559|FG002|Overall Study|Other reason not defined above|1|||
130231546|NCT00885118|468813560|FG003|Overall Study|Other reason not defined above|0|||
130231547|NCT00885118|468813561|FG004|Overall Study|Other reason not defined above|0|||
130231548|NCT02814526|468813566|FG000|Overall Study|Adverse Event|4|||
130231549|NCT02814526|468813567|FG001|Overall Study|Adverse Event|3|||
130231550|NCT02814526|468813566|FG000|Overall Study|Death|1|||
130445286|NCT03389893|469591939|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
130445287|NCT03389893|469591940|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
130445288|NCT03389893|469591941|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
130445289|NCT03389893|469591942|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
130445290|NCT03389893|469591939|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
130445291|NCT03389893|469591940|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
130231551|NCT02814526|468813567|FG001|Overall Study|Death|1|||
130445292|NCT03389893|469591941|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
130231552|NCT02814526|468813566|FG000|Overall Study|Lost to Follow-up|3|||
130231553|NCT02814526|468813567|FG001|Overall Study|Lost to Follow-up|4|||
130231554|NCT02814526|468813566|FG000|Overall Study|non site physician decision|1|||
130231555|NCT02814526|468813567|FG001|Overall Study|non site physician decision|0|||
130231556|NCT02814526|468813566|FG000|Overall Study|participant noncompliance|1|||
130231557|NCT02814526|468813567|FG001|Overall Study|participant noncompliance|1|||
130231558|NCT02814526|468813566|FG000|Overall Study|Withdrawal by Subject|20|||
130231559|NCT02814526|468813567|FG001|Overall Study|Withdrawal by Subject|14|||
130231560|NCT02814526|468813566|FG000|Overall Study|safety risk|2|||
130231561|NCT02814526|468813567|FG001|Overall Study|safety risk|1|||
130231562|NCT02814526|468813566|FG000|Overall Study|early termination-study terminated|1|||
130445293|NCT03389893|469591942|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
130445294|NCT03389893|469591939|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
130445295|NCT03389893|469591940|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
130445296|NCT03389893|469591941|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
130445297|NCT03389893|469591942|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
130445298|NCT03389893|469591939|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
130445299|NCT03389893|469591940|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
130445300|NCT03389893|469591941|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
130445301|NCT03389893|469591942|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
130445302|NCT02448719|469591946|FG000|Overall Study|Withdrawal by Subject|0|||
130445303|NCT02448719|469591947|FG001|Overall Study|Withdrawal by Subject|0|||
130445304|NCT02448719|469591948|FG002|Overall Study|Withdrawal by Subject|0|||
130445305|NCT02448719|469591949|FG003|Overall Study|Withdrawal by Subject|0|||
130445306|NCT02448719|469591950|FG004|Overall Study|Withdrawal by Subject|1|||
130445307|NCT02448719|469591951|FG005|Overall Study|Withdrawal by Subject|0|||
130445308|NCT02448719|469591952|FG006|Overall Study|Withdrawal by Subject|0|||
130231563|NCT02814526|468813567|FG001|Overall Study|early termination-study terminated|2|||
130445309|NCT02448719|469591953|FG007|Overall Study|Withdrawal by Subject|0|||
130445310|NCT02448719|469591954|FG008|Overall Study|Withdrawal by Subject|0|||
130445311|NCT02448719|469591955|FG009|Overall Study|Withdrawal by Subject|0|||
130445312|NCT02448719|469591956|FG010|Overall Study|Withdrawal by Subject|0|||
130445313|NCT01024751|469591957|FG000|Enrolled Participants|Ineligible at baseline|3|||
130445314|NCT01024751|469591958|FG001|Enrolled Participants|Ineligible at baseline|4|||
130445315|NCT01024751|469591957|FG000|Eligible Participants|Withdrawal by Subject|0|||
130445316|NCT01024751|469591958|FG001|Eligible Participants|Withdrawal by Subject|1|||
130445317|NCT01024751|469591957|FG000|Eligible Participants|Lost to Follow-up|0|||
130445318|NCT01024751|469591958|FG001|Eligible Participants|Lost to Follow-up|1|||
130445319|NCT01024751|469591957|FG000|Eligible Participants|Ineligible|0|||
130445320|NCT01024751|469591958|FG001|Eligible Participants|Ineligible|1|||
130445321|NCT01232556|469591959|FG000|Overall Study|Withdrawal by Subject|21|||
130445322|NCT01232556|469591960|FG001|Overall Study|Withdrawal by Subject|17|||
130445323|NCT01232556|469591959|FG000|Overall Study|Death|97|||
130445324|NCT01232556|469591960|FG001|Overall Study|Death|97|||
130445325|NCT01232556|469591959|FG000|Overall Study|Lost to Follow-up|0|||
130445326|NCT01232556|469591960|FG001|Overall Study|Lost to Follow-up|2|||
130445327|NCT01232556|469591959|FG000|Overall Study|Terminated by Sponsor|35|||
130445328|NCT01232556|469591960|FG001|Overall Study|Terminated by Sponsor|51|||
130445329|NCT01232556|469591959|FG000|Overall Study|Other|6|||
130445330|NCT01232556|469591960|FG001|Overall Study|Other|4|||
130445331|NCT01473420|469591962|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
130693373|NCT01838681|470503659|FG002|Period B/A+|Withdrawal before treatment|0|||
130231564|NCT02814526|468813566|FG000|Overall Study|Other|0|||
130231565|NCT02814526|468813567|FG001|Overall Study|Other|4|||
130231566|NCT03883386|468813568|FG000|First Assignment|Lost to Follow-up|1|||
130231567|NCT03883386|468813569|FG001|First Assignment|Lost to Follow-up|0|||
130231568|NCT03883386|468813568|FG000|First Assignment|Withdrawal by Subject|1|||
130231569|NCT03883386|468813569|FG001|First Assignment|Withdrawal by Subject|1|||
130231570|NCT00251758|468813570|FG000|Overall Study|Adverse Event|7|||
130231571|NCT00251758|468813571|FG001|Overall Study|Adverse Event|9|||
130231572|NCT00251758|468813572|FG002|Overall Study|Adverse Event|11|||
130231573|NCT00251758|468813570|FG000|Overall Study|Lost to Follow-up|4|||
130231574|NCT00251758|468813571|FG001|Overall Study|Lost to Follow-up|2|||
130231575|NCT00251758|468813572|FG002|Overall Study|Lost to Follow-up|5|||
130231576|NCT00251758|468813570|FG000|Overall Study|Withdrawal by Subject|13|||
130231577|NCT00251758|468813571|FG001|Overall Study|Withdrawal by Subject|7|||
130231578|NCT00251758|468813572|FG002|Overall Study|Withdrawal by Subject|3|||
130231579|NCT00251758|468813570|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130231580|NCT00251758|468813571|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
130231581|NCT00251758|468813572|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130231582|NCT00251758|468813570|FG000|Overall Study|Lack of Efficacy|3|||
130231583|NCT00251758|468813571|FG001|Overall Study|Lack of Efficacy|0|||
130231584|NCT00251758|468813572|FG002|Overall Study|Lack of Efficacy|0|||
130445332|NCT01473420|469591963|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
130445333|NCT01473420|469591962|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
130445334|NCT01473420|469591963|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
130445335|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
130693374|NCT01838681|470503660|FG003|Period B/A+|Withdrawal before treatment|0|||
130231585|NCT00251758|468813570|FG000|Overall Study|Noncompliant|0|||
130231586|NCT00251758|468813571|FG001|Overall Study|Noncompliant|2|||
130231587|NCT00251758|468813572|FG002|Overall Study|Noncompliant|2|||
130231588|NCT00251758|468813570|FG000|Overall Study|Pregnancy|0|||
130231589|NCT00251758|468813571|FG001|Overall Study|Pregnancy|1|||
130231590|NCT00251758|468813572|FG002|Overall Study|Pregnancy|0|||
130231591|NCT00251758|468813570|FG000|Overall Study|Per Subject Request|0|||
130231592|NCT00251758|468813571|FG001|Overall Study|Per Subject Request|0|||
130231593|NCT00251758|468813572|FG002|Overall Study|Per Subject Request|1|||
130231594|NCT00251758|468813570|FG000|Overall Study|Per Investigator Request|1|||
130231595|NCT00251758|468813571|FG001|Overall Study|Per Investigator Request|0|||
130231596|NCT00251758|468813572|FG002|Overall Study|Per Investigator Request|0|||
130231597|NCT01387269|468813573|FG000|Overall Study|Death|38|||
130231598|NCT01387269|468813574|FG001|Overall Study|Death|20|||
130231599|NCT01387269|468813573|FG000|Overall Study|Other|8|||
130231600|NCT01387269|468813574|FG001|Overall Study|Other|7|||
130231601|NCT01387269|468813573|FG000|Overall Study|Unrelated AE|12|||
130231602|NCT01387269|468813574|FG001|Overall Study|Unrelated AE|3|||
130231603|NCT01387269|468813573|FG000|Overall Study|Withdrawal by patient|32|||
130231604|NCT01387269|468813574|FG001|Overall Study|Withdrawal by patient|10|||
130231605|NCT01387269|468813573|FG000|Overall Study|Study drug-related AE|1|||
130231606|NCT01387269|468813574|FG001|Overall Study|Study drug-related AE|0|||
130231607|NCT01387269|468813573|FG000|Overall Study|Lost to Follow-up|1|||
130231608|NCT01387269|468813574|FG001|Overall Study|Lost to Follow-up|0|||
130231609|NCT03054428|468813577|FG000|Overall Study|Physician Decision|0|||
130231610|NCT03054428|468813578|FG001|Overall Study|Physician Decision|1|||
130231611|NCT03054428|468813579|FG002|Overall Study|Physician Decision|1|||
130231612|NCT03054428|468813577|FG000|Overall Study|Lack of Efficacy|3|||
130231613|NCT03054428|468813578|FG001|Overall Study|Lack of Efficacy|1|||
130231614|NCT03054428|468813579|FG002|Overall Study|Lack of Efficacy|0|||
130231615|NCT03054428|468813577|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130231616|NCT03054428|468813578|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130231617|NCT03054428|468813579|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
130231618|NCT03054428|468813577|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
130231619|NCT03054428|468813578|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130231620|NCT03054428|468813579|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130231621|NCT03054428|468813577|FG000|Overall Study|Transitioned to OLE study|76|||
130231622|NCT03054428|468813578|FG001|Overall Study|Transitioned to OLE study|76|||
130231623|NCT03054428|468813579|FG002|Overall Study|Transitioned to OLE study|73|||
130231624|NCT03054428|468813577|FG000|Overall Study|Withdrawal by Subject|3|||
130231625|NCT03054428|468813578|FG001|Overall Study|Withdrawal by Subject|2|||
130231626|NCT03054428|468813579|FG002|Overall Study|Withdrawal by Subject|3|||
130231627|NCT03054428|468813577|FG000|Overall Study|Lost to Follow-up|0|||
130231628|NCT03054428|468813578|FG001|Overall Study|Lost to Follow-up|0|||
130231629|NCT03054428|468813579|FG002|Overall Study|Lost to Follow-up|1|||
130356644|NCT00973349|469276380|FG005|Overall Study|Lost to Follow-up|3|||
130356645|NCT00973349|469276381|FG006|Overall Study|Lost to Follow-up|0|||
130356646|NCT00973349|469276382|FG007|Overall Study|Lost to Follow-up|1|||
130231630|NCT03092752|468813580|FG000|Overall Study|Aged <40 years|14209|||
130231631|NCT03092752|468813580|FG000|Overall Study|At least one claim with T2DM|61299|||
130231632|NCT03092752|468813580|FG000|Overall Study|Having no claim of study drugs|29282|||
130231633|NCT03092752|468813580|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
130356647|NCT00973349|469276383|FG008|Overall Study|Lost to Follow-up|2|||
130356648|NCT00973349|469276384|FG009|Overall Study|Lost to Follow-up|1|||
130356649|NCT00973349|469276385|FG010|Overall Study|Lost to Follow-up|0|||
130356650|NCT00973349|469276386|FG011|Overall Study|Lost to Follow-up|1|||
130356651|NCT00973349|469276387|FG012|Overall Study|Lost to Follow-up|0|||
130356652|NCT00973349|469276388|FG013|Overall Study|Lost to Follow-up|0|||
130356653|NCT00973349|469276389|FG014|Overall Study|Lost to Follow-up|0|||
130356654|NCT00973349|469276390|FG015|Overall Study|Lost to Follow-up|1|||
130356655|NCT00973349|469276375|FG000|Overall Study|Inappropriate enrolment|0|||
130356656|NCT00973349|469276376|FG001|Overall Study|Inappropriate enrolment|0|||
130356657|NCT00973349|469276377|FG002|Overall Study|Inappropriate enrolment|1|||
130356658|NCT00973349|469276378|FG003|Overall Study|Inappropriate enrolment|0|||
130356659|NCT00973349|469276379|FG004|Overall Study|Inappropriate enrolment|0|||
130356660|NCT00973349|469276380|FG005|Overall Study|Inappropriate enrolment|0|||
130356661|NCT00973349|469276381|FG006|Overall Study|Inappropriate enrolment|0|||
130356662|NCT00973349|469276382|FG007|Overall Study|Inappropriate enrolment|0|||
130356663|NCT00973349|469276383|FG008|Overall Study|Inappropriate enrolment|0|||
130356664|NCT00973349|469276384|FG009|Overall Study|Inappropriate enrolment|2|||
130356665|NCT00973349|469276385|FG010|Overall Study|Inappropriate enrolment|0|||
130356666|NCT00973349|469276386|FG011|Overall Study|Inappropriate enrolment|0|||
130445336|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
130445337|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
130445338|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
130231634|NCT03092752|468813580|FG000|Overall Study|<6 month history|245900|||
130231635|NCT01499810|468813588|FG000|Overall Study|Lost to Follow-up|10|||
130231636|NCT01499810|468813588|FG000|Overall Study|Protocol Violation|1|||
130231637|NCT01499810|468813588|FG000|Overall Study|Withdrawal by Subject|1|||
130231638|NCT01884597|468813589|FG000|Overall Study|Adverse Event|0|||
130231639|NCT01884597|468813590|FG001|Overall Study|Adverse Event|0|||
130356667|NCT00973349|469276387|FG012|Overall Study|Inappropriate enrolment|1|||
130356668|NCT00973349|469276388|FG013|Overall Study|Inappropriate enrolment|0|||
130356669|NCT00973349|469276389|FG014|Overall Study|Inappropriate enrolment|1|||
130693375|NCT01838681|470503657|FG000|Period B/A+|Administrative or other reasons|0|||
130693376|NCT01838681|470503658|FG001|Period B/A+|Administrative or other reasons|6|||
130693377|NCT01838681|470503659|FG002|Period B/A+|Administrative or other reasons|10|||
130693378|NCT01838681|470503660|FG003|Period B/A+|Administrative or other reasons|28|||
130693379|NCT01229150|470503661|FG000|Overall Study|Toxicity|2|||
130693380|NCT01229150|470503662|FG001|Overall Study|Toxicity|2|||
130693381|NCT01229150|470503663|FG002|Overall Study|Toxicity|0|||
130693382|NCT01229150|470503664|FG003|Overall Study|Toxicity|0|||
130693383|NCT02011945|470503665|FG000|Overall Study|Participant requested to Discontinue|0|||
130693384|NCT02011945|470503666|FG001|Overall Study|Participant requested to Discontinue|1|||
130693385|NCT02011945|470503667|FG002|Overall Study|Participant requested to Discontinue|1|||
130693386|NCT02011945|470503665|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
130693387|NCT02011945|470503666|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
130693388|NCT02011945|470503667|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
130693389|NCT02011945|470503665|FG000|Overall Study|Study Drug Toxicity|0|||
130693390|NCT02011945|470503666|FG001|Overall Study|Study Drug Toxicity|0|||
130693391|NCT02011945|470503667|FG002|Overall Study|Study Drug Toxicity|1|||
130693392|NCT02011945|470503665|FG000|Overall Study|Treatment Failure|0|||
130693393|NCT02011945|470503666|FG001|Overall Study|Treatment Failure|7|||
130693394|NCT02011945|470503667|FG002|Overall Study|Treatment Failure|6|||
130693395|NCT02011945|470503665|FG000|Overall Study|No Longer Meets Study Criteria|1|||
130693396|NCT02011945|470503666|FG001|Overall Study|No Longer Meets Study Criteria|0|||
130693397|NCT02011945|470503667|FG002|Overall Study|No Longer Meets Study Criteria|0|||
130693398|NCT02011945|470503665|FG000|Overall Study|Proceeded to stem cell transplant|0|||
130693399|NCT02011945|470503666|FG001|Overall Study|Proceeded to stem cell transplant|0|||
130693400|NCT02011945|470503667|FG002|Overall Study|Proceeded to stem cell transplant|1|||
130693401|NCT02011945|470503665|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
130693402|NCT02011945|470503666|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
130693403|NCT02011945|470503667|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
130693404|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
130693405|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693406|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693407|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693408|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693409|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693410|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
130693411|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693412|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693413|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693414|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693415|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693416|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
130693417|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693418|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693419|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693420|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693421|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693422|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
130693423|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693424|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693425|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693426|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693427|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693428|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
130693429|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693430|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693431|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693432|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693433|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693434|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
130693435|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
130356670|NCT00973349|469276390|FG015|Overall Study|Inappropriate enrolment|1|||
130356671|NCT00973349|469276375|FG000|Overall Study|Protocol Violation|0|||
130356672|NCT00973349|469276376|FG001|Overall Study|Protocol Violation|0|||
130356673|NCT00973349|469276377|FG002|Overall Study|Protocol Violation|0|||
130356674|NCT00973349|469276378|FG003|Overall Study|Protocol Violation|0|||
130356675|NCT00973349|469276379|FG004|Overall Study|Protocol Violation|0|||
130356676|NCT00973349|469276380|FG005|Overall Study|Protocol Violation|0|||
130231640|NCT01884597|468813591|FG002|Overall Study|Adverse Event|1|||
130231641|NCT01884597|468813589|FG000|Overall Study|Lack of Efficacy|1|||
130231642|NCT01884597|468813590|FG001|Overall Study|Lack of Efficacy|0|||
130231643|NCT01884597|468813591|FG002|Overall Study|Lack of Efficacy|0|||
130231644|NCT01884597|468813589|FG000|Overall Study|Death|0|||
130231645|NCT01884597|468813590|FG001|Overall Study|Death|1|||
130231646|NCT01884597|468813591|FG002|Overall Study|Death|0|||
130231647|NCT01093846|468813592|FG000|Overall Study|Adverse Event|0|||
130231648|NCT01093846|468813593|FG001|Overall Study|Adverse Event|0|||
130231649|NCT01093846|468813594|FG002|Overall Study|Adverse Event|1|||
130231650|NCT01093846|468813592|FG000|Overall Study|Lack of Efficacy|0|||
130231651|NCT01093846|468813593|FG001|Overall Study|Lack of Efficacy|0|||
130231652|NCT01093846|468813594|FG002|Overall Study|Lack of Efficacy|4|||
130231653|NCT01093846|468813592|FG000|Overall Study|Condition no longer required study drug|1|||
130231654|NCT01093846|468813593|FG001|Overall Study|Condition no longer required study drug|1|||
130231655|NCT01093846|468813594|FG002|Overall Study|Condition no longer required study drug|1|||
130231656|NCT01093846|468813592|FG000|Overall Study|Administrative Problems|18|||
130231657|NCT01093846|468813593|FG001|Overall Study|Administrative Problems|17|||
130231658|NCT01093846|468813594|FG002|Overall Study|Administrative Problems|15|||
130231659|NCT03082729|468813595|FG000|Overall Study|Lost to Follow-up|7|||
130231660|NCT03082729|468813595|FG000|Overall Study|Physician Decision|2|||
130231661|NCT03082729|468813595|FG000|Overall Study|Withdrawal by Subject|1|||
130231662|NCT03082729|468813595|FG000|Overall Study|Lack of Efficacy|9|||
130231663|NCT03082729|468813595|FG000|Overall Study|Adverse Event|4|||
130231664|NCT03082729|468813595|FG000|Overall Study|Protocol Violation|6|||
130231665|NCT03082729|468813595|FG000|Overall Study|Fear of study procedure|1|||
130231666|NCT03082729|468813595|FG000|Overall Study|Scheduling conflict|1|||
130231667|NCT03321721|468813598|FG000|Overall Study|Lost to Follow-up|4|||
130231668|NCT03321721|468813599|FG001|Overall Study|Lost to Follow-up|8|||
130231669|NCT03321721|468813600|FG002|Overall Study|Lost to Follow-up|11|||
130231670|NCT00666237|468813601|FG000|Overall Study|Death|5|||
130231671|NCT00666237|468813602|FG001|Overall Study|Death|5|||
130231672|NCT00666237|468813601|FG000|Overall Study|Lost to Follow-up|29|||
130231673|NCT00666237|468813602|FG001|Overall Study|Lost to Follow-up|25|||
130231674|NCT01416571|468813603|FG000|Overall Study|Lost to Follow-up|2|||
130231675|NCT03353220|468813604|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
130231676|NCT03353220|468813605|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
130231677|NCT01673386|468815429|FG000|Overall Study|Study terminated by sponsor|16|||
130231678|NCT01673386|468815430|FG001|Overall Study|Study terminated by sponsor|22|||
130231679|NCT01673386|468815429|FG000|Overall Study|Adverse Event|5|||
130231680|NCT01673386|468815430|FG001|Overall Study|Adverse Event|2|||
130231681|NCT01673386|468815429|FG000|Overall Study|Progressive disease|4|||
130231682|NCT01673386|468815430|FG001|Overall Study|Progressive disease|1|||
130231683|NCT01673386|468815429|FG000|Overall Study|Withdrawal by Subject|0|||
130231684|NCT01673386|468815430|FG001|Overall Study|Withdrawal by Subject|2|||
130231685|NCT00336544|468815434|FG000|Overall Study|Lack of Efficacy|8|||
130231686|NCT00336544|468815435|FG001|Overall Study|Lack of Efficacy|5|||
130231687|NCT00336544|468815434|FG000|Overall Study|Adverse Event|4|||
130231688|NCT00336544|468815435|FG001|Overall Study|Adverse Event|9|||
130231689|NCT00336544|468815434|FG000|Overall Study|Withdrawal by Subject|4|||
130231690|NCT00336544|468815435|FG001|Overall Study|Withdrawal by Subject|3|||
130231691|NCT00336544|468815434|FG000|Overall Study|Other|3|||
130231692|NCT00336544|468815435|FG001|Overall Study|Other|5|||
130231693|NCT01649765|468815436|FG000|Overall Study|Adverse Event|5|||
130231694|NCT01649765|468815437|FG001|Overall Study|Adverse Event|3|||
130231695|NCT01649765|468815436|FG000|Overall Study|Lack of Efficacy|1|||
130231696|NCT01649765|468815437|FG001|Overall Study|Lack of Efficacy|1|||
130231697|NCT01649765|468815436|FG000|Overall Study|Physician Decision|0|||
130231698|NCT01649765|468815437|FG001|Overall Study|Physician Decision|3|||
130231699|NCT01649765|468815436|FG000|Overall Study|Protocol Violation|1|||
130231700|NCT01649765|468815437|FG001|Overall Study|Protocol Violation|0|||
130231701|NCT01649765|468815436|FG000|Overall Study|Withdrawal by Subject|2|||
130231702|NCT01649765|468815437|FG001|Overall Study|Withdrawal by Subject|1|||
130231703|NCT01648764|468815438|FG000|Overall Study|Progressive Disease|0|||
130356677|NCT00973349|469276381|FG006|Overall Study|Protocol Violation|0|||
130356678|NCT00973349|469276382|FG007|Overall Study|Protocol Violation|0|||
130231704|NCT01648764|468815439|FG001|Overall Study|Progressive Disease|1|||
130231705|NCT01648764|468815440|FG002|Overall Study|Progressive Disease|0|||
130356679|NCT00973349|469276383|FG008|Overall Study|Protocol Violation|1|||
130356680|NCT00973349|469276384|FG009|Overall Study|Protocol Violation|0|||
130231706|NCT01648764|468815441|FG003|Overall Study|Progressive Disease|0|||
130231707|NCT01648764|468815442|FG004|Overall Study|Progressive Disease|0|||
130231708|NCT01648764|468815443|FG005|Overall Study|Progressive Disease|1|||
130231709|NCT01648764|468815444|FG006|Overall Study|Progressive Disease|1|||
130231710|NCT01648764|468815445|FG007|Overall Study|Progressive Disease|0|||
130231711|NCT01648764|468815446|FG008|Overall Study|Progressive Disease|0|||
130231712|NCT01648764|468815447|FG009|Overall Study|Progressive Disease|2|||
130231713|NCT01648764|468815448|FG010|Overall Study|Progressive Disease|0|||
130356681|NCT00973349|469276385|FG010|Overall Study|Protocol Violation|0|||
130231714|NCT01648764|468815449|FG011|Overall Study|Progressive Disease|1|||
130231715|NCT01648764|468815450|FG012|Overall Study|Progressive Disease|2|||
130231716|NCT01648764|468815451|FG013|Overall Study|Progressive Disease|1|||
130445339|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
130693436|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
130693437|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693438|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693439|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693440|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130693441|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
130693442|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130693443|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693444|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693445|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693446|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
130693447|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693448|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
130693449|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693450|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693451|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693452|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
130693453|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
130693454|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
130693455|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
130693456|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
130693457|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
130693458|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130693459|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130693460|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
130693461|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693462|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693463|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693464|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
130693465|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
130693466|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
130693467|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
130693468|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
130693469|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
130693470|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693471|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
130693472|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693473|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693474|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693475|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693476|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693477|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
130693478|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693479|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693480|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693481|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693482|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693483|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
130693484|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693485|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693486|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693487|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693488|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693489|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693490|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693491|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
130231717|NCT01648764|468815438|FG000|Overall Study|Adverse Event|0|||
130231718|NCT01648764|468815439|FG001|Overall Study|Adverse Event|0|||
130445340|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
130693492|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130693493|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130231719|NCT01648764|468815440|FG002|Overall Study|Adverse Event|0|||
130231720|NCT01648764|468815441|FG003|Overall Study|Adverse Event|0|||
130231721|NCT01648764|468815442|FG004|Overall Study|Adverse Event|0|||
130231722|NCT01648764|468815443|FG005|Overall Study|Adverse Event|1|||
130231723|NCT01648764|468815444|FG006|Overall Study|Adverse Event|0|||
130231724|NCT01648764|468815445|FG007|Overall Study|Adverse Event|0|||
130231725|NCT01648764|468815446|FG008|Overall Study|Adverse Event|0|||
130231726|NCT01648764|468815447|FG009|Overall Study|Adverse Event|1|||
130231727|NCT01648764|468815448|FG010|Overall Study|Adverse Event|0|||
130231728|NCT01648764|468815449|FG011|Overall Study|Adverse Event|3|||
130231729|NCT01648764|468815450|FG012|Overall Study|Adverse Event|1|||
130231730|NCT01648764|468815451|FG013|Overall Study|Adverse Event|1|||
130231731|NCT01648764|468815438|FG000|Overall Study|Death|0|||
130231732|NCT01648764|468815439|FG001|Overall Study|Death|0|||
130231733|NCT01648764|468815440|FG002|Overall Study|Death|0|||
130231734|NCT01648764|468815441|FG003|Overall Study|Death|0|||
130231735|NCT01648764|468815442|FG004|Overall Study|Death|0|||
130231736|NCT01648764|468815443|FG005|Overall Study|Death|0|||
130231737|NCT01648764|468815444|FG006|Overall Study|Death|1|||
130231738|NCT01648764|468815445|FG007|Overall Study|Death|0|||
130231739|NCT01648764|468815446|FG008|Overall Study|Death|0|||
130231740|NCT01648764|468815447|FG009|Overall Study|Death|0|||
130231741|NCT01648764|468815448|FG010|Overall Study|Death|0|||
130231742|NCT01648764|468815449|FG011|Overall Study|Death|0|||
130231743|NCT01648764|468815450|FG012|Overall Study|Death|0|||
130231744|NCT01648764|468815451|FG013|Overall Study|Death|1|||
130231745|NCT01648764|468815438|FG000|Overall Study|Withdrawal by Subject|0|||
130231746|NCT01648764|468815439|FG001|Overall Study|Withdrawal by Subject|0|||
130231747|NCT01648764|468815440|FG002|Overall Study|Withdrawal by Subject|0|||
130231748|NCT01648764|468815441|FG003|Overall Study|Withdrawal by Subject|0|||
130231749|NCT01648764|468815442|FG004|Overall Study|Withdrawal by Subject|0|||
130231750|NCT01648764|468815443|FG005|Overall Study|Withdrawal by Subject|0|||
130231751|NCT01648764|468815444|FG006|Overall Study|Withdrawal by Subject|2|||
130231752|NCT01648764|468815445|FG007|Overall Study|Withdrawal by Subject|0|||
130231753|NCT01648764|468815446|FG008|Overall Study|Withdrawal by Subject|0|||
130231754|NCT01648764|468815447|FG009|Overall Study|Withdrawal by Subject|0|||
130231755|NCT01648764|468815448|FG010|Overall Study|Withdrawal by Subject|0|||
130231756|NCT01648764|468815449|FG011|Overall Study|Withdrawal by Subject|0|||
130231757|NCT01648764|468815450|FG012|Overall Study|Withdrawal by Subject|1|||
130231758|NCT01648764|468815451|FG013|Overall Study|Withdrawal by Subject|0|||
130231759|NCT01648764|468815438|FG000|Overall Study|Investigator Decision|0|||
130231760|NCT01648764|468815439|FG001|Overall Study|Investigator Decision|0|||
130231761|NCT01648764|468815440|FG002|Overall Study|Investigator Decision|0|||
130231762|NCT01648764|468815441|FG003|Overall Study|Investigator Decision|0|||
130231763|NCT01648764|468815442|FG004|Overall Study|Investigator Decision|0|||
130231764|NCT01648764|468815443|FG005|Overall Study|Investigator Decision|0|||
130231765|NCT01648764|468815444|FG006|Overall Study|Investigator Decision|1|||
130231766|NCT01648764|468815445|FG007|Overall Study|Investigator Decision|0|||
130231767|NCT01648764|468815446|FG008|Overall Study|Investigator Decision|0|||
130231768|NCT01648764|468815447|FG009|Overall Study|Investigator Decision|0|||
130231769|NCT01648764|468815448|FG010|Overall Study|Investigator Decision|0|||
130231770|NCT01648764|468815449|FG011|Overall Study|Investigator Decision|1|||
130231771|NCT01648764|468815450|FG012|Overall Study|Investigator Decision|0|||
130231772|NCT01648764|468815451|FG013|Overall Study|Investigator Decision|0|||
130231773|NCT00715208|468815452|FG000|Overall Study|Withdrawal by Subject|1|||
130231774|NCT00715208|468815453|FG001|Overall Study|Withdrawal by Subject|1|||
130231775|NCT00715208|468815452|FG000|Overall Study|Adverse Event|0|||
130231776|NCT00715208|468815453|FG001|Overall Study|Adverse Event|6|||
130231777|NCT00715208|468815452|FG000|Overall Study|Lack of Efficacy|0|||
130231778|NCT00715208|468815453|FG001|Overall Study|Lack of Efficacy|2|||
130231779|NCT01715831|468815454|FG000|Overall Study|Adverse Event|1|||
130231780|NCT00316004|468815455|FG000|Overall Study|Subject was not given study fluid.|14|||
130231781|NCT00316004|468815456|FG001|Overall Study|Subject was not given study fluid.|14|||
130231782|NCT00316004|468815457|FG002|Overall Study|Subject was not given study fluid.|21|||
130231783|NCT01118299|468815460|FG000|Overall Study|Death|7|||
130231784|NCT01118299|468815461|FG001|Overall Study|Death|5|||
130231785|NCT01118299|468815460|FG000|Overall Study|Withdrawal by Subject|8|||
130231786|NCT01118299|468815461|FG001|Overall Study|Withdrawal by Subject|8|||
130231787|NCT01118299|468815460|FG000|Overall Study|Lost to Follow-up|2|||
130231788|NCT01118299|468815461|FG001|Overall Study|Lost to Follow-up|1|||
130231789|NCT01118299|468815460|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
130231790|NCT01118299|468815461|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
130231791|NCT00784875|468815462|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
130231792|NCT00784875|468815463|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
130231793|NCT00784875|468815464|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
130231794|NCT00784875|468815465|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
130231795|NCT00784875|468815462|FG000|Period A - Baseline|Adverse Event|0|||
130231796|NCT00784875|468815463|FG001|Period A - Baseline|Adverse Event|0|||
130231797|NCT00784875|468815464|FG002|Period A - Baseline|Adverse Event|0|||
130231798|NCT00784875|468815465|FG003|Period A - Baseline|Adverse Event|8|||
130693494|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130231799|NCT00784875|468815462|FG000|Period A - Baseline|Protocol Violation|0|||
130231800|NCT00784875|468815463|FG001|Period A - Baseline|Protocol Violation|0|||
130231801|NCT00784875|468815464|FG002|Period A - Baseline|Protocol Violation|0|||
130231802|NCT00784875|468815465|FG003|Period A - Baseline|Protocol Violation|25|||
130231803|NCT00784875|468815462|FG000|Period A - Baseline|Withdrawal by Subject|0|||
130231804|NCT00784875|468815463|FG001|Period A - Baseline|Withdrawal by Subject|0|||
130231805|NCT00784875|468815464|FG002|Period A - Baseline|Withdrawal by Subject|0|||
130231806|NCT00784875|468815465|FG003|Period A - Baseline|Withdrawal by Subject|27|||
130231807|NCT00784875|468815462|FG000|Period A - Baseline|Physician Decision|0|||
130231808|NCT00784875|468815463|FG001|Period A - Baseline|Physician Decision|0|||
130231809|NCT00784875|468815464|FG002|Period A - Baseline|Physician Decision|0|||
130231810|NCT00784875|468815465|FG003|Period A - Baseline|Physician Decision|2|||
130231811|NCT00784875|468815462|FG000|Period A - Baseline|Sponsor Decision|0|||
130231812|NCT00784875|468815463|FG001|Period A - Baseline|Sponsor Decision|0|||
130231813|NCT00784875|468815464|FG002|Period A - Baseline|Sponsor Decision|0|||
130231814|NCT00784875|468815465|FG003|Period A - Baseline|Sponsor Decision|113|||
130231815|NCT00784875|468815462|FG000|Period A - Baseline|Lost to Follow-up|0|||
130231816|NCT00784875|468815463|FG001|Period A - Baseline|Lost to Follow-up|0|||
130231817|NCT00784875|468815464|FG002|Period A - Baseline|Lost to Follow-up|0|||
130231818|NCT00784875|468815465|FG003|Period A - Baseline|Lost to Follow-up|2|||
130231819|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130231820|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130231821|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
130231822|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
130231823|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
130231824|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
130231825|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
130231826|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
130231827|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
130231828|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
130231829|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
130231830|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
130231831|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130231832|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
130231833|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130356682|NCT00973349|469276386|FG011|Overall Study|Protocol Violation|0|||
130356683|NCT00973349|469276387|FG012|Overall Study|Protocol Violation|0|||
130356684|NCT00973349|469276388|FG013|Overall Study|Protocol Violation|0|||
130356685|NCT00973349|469276389|FG014|Overall Study|Protocol Violation|0|||
130693495|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693496|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693497|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
130693498|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
130693499|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693500|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693501|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693502|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693503|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
130693504|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693505|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693506|NCT03531827|470503674|FG000|Overall Study|Adverse Event|2|||
130231834|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130231835|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
130231836|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130356686|NCT00973349|469276390|FG015|Overall Study|Protocol Violation|0|||
130356687|NCT00973349|469276375|FG000|Overall Study|Unable to classify|0|||
130356688|NCT00973349|469276376|FG001|Overall Study|Unable to classify|0|||
130356689|NCT00973349|469276377|FG002|Overall Study|Unable to classify|0|||
130445341|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
130445342|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
130693507|NCT03531827|470503675|FG001|Overall Study|Adverse Event|0|||
130693508|NCT03531827|470503674|FG000|Overall Study|Progressive disease|1|||
130231837|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130356690|NCT00973349|469276378|FG003|Overall Study|Unable to classify|0|||
130356691|NCT00973349|469276379|FG004|Overall Study|Unable to classify|1|||
130356692|NCT00973349|469276380|FG005|Overall Study|Unable to classify|1|||
130356693|NCT00973349|469276381|FG006|Overall Study|Unable to classify|0|||
130231838|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
130231839|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
130356694|NCT00973349|469276382|FG007|Overall Study|Unable to classify|0|||
130231840|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
130231841|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
130231842|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
130231843|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
130231844|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
130231845|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130231846|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130231847|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231848|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231849|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
130231850|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231851|NCT00784875|468815462|FG000|Period C|Adverse Event|1|||
130231852|NCT00784875|468815463|FG001|Period C|Adverse Event|0|||
130231853|NCT00784875|468815464|FG002|Period C|Adverse Event|4|||
130231854|NCT00784875|468815465|FG003|Period C|Adverse Event|2|||
130231855|NCT00784875|468815462|FG000|Period C|Protocol Violation|0|||
130231856|NCT00784875|468815463|FG001|Period C|Protocol Violation|0|||
130231857|NCT00784875|468815464|FG002|Period C|Protocol Violation|1|||
130231858|NCT00784875|468815465|FG003|Period C|Protocol Violation|2|||
130231859|NCT00784875|468815462|FG000|Period C|Lack of Efficacy|0|||
130231860|NCT00784875|468815463|FG001|Period C|Lack of Efficacy|0|||
130231861|NCT00784875|468815464|FG002|Period C|Lack of Efficacy|1|||
130231862|NCT00784875|468815465|FG003|Period C|Lack of Efficacy|0|||
130231863|NCT00784875|468815462|FG000|Period C|Withdrawal by Subject|1|||
130231864|NCT00784875|468815463|FG001|Period C|Withdrawal by Subject|1|||
130231865|NCT00784875|468815464|FG002|Period C|Withdrawal by Subject|2|||
130231866|NCT00784875|468815465|FG003|Period C|Withdrawal by Subject|0|||
130231867|NCT00784875|468815462|FG000|Period C|Physician Decision|0|||
130231868|NCT00784875|468815463|FG001|Period C|Physician Decision|0|||
130231869|NCT00784875|468815464|FG002|Period C|Physician Decision|1|||
130231870|NCT00784875|468815465|FG003|Period C|Physician Decision|1|||
130231871|NCT00784875|468815462|FG000|Period C|Sponsor Decision|5|||
130693509|NCT03531827|470503675|FG001|Overall Study|Progressive disease|0|||
130693510|NCT00849797|470503676|FG000|First Intervention|bad veins|1|||
130231872|NCT00784875|468815463|FG001|Period C|Sponsor Decision|5|||
130231873|NCT00784875|468815464|FG002|Period C|Sponsor Decision|4|||
130231874|NCT00784875|468815465|FG003|Period C|Sponsor Decision|2|||
130231875|NCT00784875|468815462|FG000|Period D|Adverse Event|0|||
130231876|NCT00784875|468815463|FG001|Period D|Adverse Event|2|||
130356695|NCT00973349|469276383|FG008|Overall Study|Unable to classify|0|||
130356696|NCT00973349|469276384|FG009|Overall Study|Unable to classify|1|||
130356697|NCT00973349|469276385|FG010|Overall Study|Unable to classify|0|||
130356698|NCT00973349|469276386|FG011|Overall Study|Unable to classify|0|||
130356699|NCT00973349|469276387|FG012|Overall Study|Unable to classify|0|||
130356700|NCT00973349|469276388|FG013|Overall Study|Unable to classify|0|||
130356701|NCT00973349|469276389|FG014|Overall Study|Unable to classify|0|||
130356702|NCT00973349|469276390|FG015|Overall Study|Unable to classify|0|||
130356703|NCT02301988|469276391|FG000|Overall Study|Withdrawal by Subject|2|||
130356704|NCT02301988|469276392|FG001|Overall Study|Withdrawal by Subject|1|||
130356705|NCT02301988|469276391|FG000|Overall Study|Physician Decision|2|||
130356706|NCT02301988|469276392|FG001|Overall Study|Physician Decision|2|||
130356707|NCT02301988|469276391|FG000|Overall Study|Unknown Reason|1|||
130356708|NCT02301988|469276392|FG001|Overall Study|Unknown Reason|3|||
130356709|NCT02301988|469276391|FG000|Overall Study|Lack of Efficacy|3|||
130356710|NCT02301988|469276392|FG001|Overall Study|Lack of Efficacy|2|||
130356711|NCT02301988|469276391|FG000|Overall Study|Death|1|||
130356712|NCT02301988|469276392|FG001|Overall Study|Death|0|||
130356713|NCT02301988|469276391|FG000|Overall Study|Adverse Event|1|||
130356714|NCT02301988|469276392|FG001|Overall Study|Adverse Event|1|||
130356715|NCT05169567|469276393|FG000|Overall Study|On study treatment|116|||
130356716|NCT05169567|469276394|FG001|Overall Study|On study treatment|128|||
130356717|NCT05169567|469276393|FG000|Overall Study|Lost to Follow-up|1|||
130356718|NCT05169567|469276394|FG001|Overall Study|Lost to Follow-up|0|||
130356719|NCT05169567|469276393|FG000|Overall Study|Withdrawal by Subject|25|||
130356720|NCT05169567|469276394|FG001|Overall Study|Withdrawal by Subject|21|||
130356721|NCT01015131|469276395|FG000|Overall Study|Physician Decision|1|||
130356722|NCT01015131|469276395|FG000|Overall Study|Protocol Violation|1|||
130356723|NCT01015131|469276395|FG000|Overall Study|Withdrawal by Subject|2|||
130356724|NCT01015131|469276395|FG000|Overall Study|Other Protocol Specified Criteria|4|||
130356725|NCT05430022|469276396|FG000|Overall Study|Withdrawal by Subject|4|||
130356726|NCT05430022|469276397|FG001|Overall Study|Withdrawal by Subject|4|||
130356727|NCT05069259|469276401|FG000|Overall Study|Withdrawal by Subject|1|||
130356728|NCT05069259|469276401|FG000|Overall Study|Sponsor decision|1|||
130356729|NCT03148275|469276402|FG000|Overall Study|Death|6|||
130356730|NCT03148275|469276402|FG000|Overall Study|Adverse Event|3|||
130356731|NCT03148275|469276402|FG000|Overall Study|Liver transplant|2|||
130356732|NCT03148275|469276402|FG000|Overall Study|Patient decision|5|||
130693511|NCT00849797|470503677|FG001|First Intervention|bad veins|0|||
130231877|NCT00784875|468815464|FG002|Period D|Adverse Event|2|||
130231878|NCT00784875|468815465|FG003|Period D|Adverse Event|0|||
130231879|NCT00784875|468815462|FG000|Period D|Protocol Violation|1|||
130231880|NCT00784875|468815463|FG001|Period D|Protocol Violation|0|||
130231881|NCT00784875|468815464|FG002|Period D|Protocol Violation|0|||
130231882|NCT00784875|468815465|FG003|Period D|Protocol Violation|0|||
130231883|NCT00784875|468815462|FG000|Period D|Withdrawal by Subject|2|||
130231884|NCT00784875|468815463|FG001|Period D|Withdrawal by Subject|0|||
130231885|NCT00784875|468815464|FG002|Period D|Withdrawal by Subject|2|||
130231886|NCT00784875|468815465|FG003|Period D|Withdrawal by Subject|0|||
130231887|NCT00784875|468815462|FG000|Period D|Physician Decision|0|||
130231888|NCT00784875|468815463|FG001|Period D|Physician Decision|1|||
130231889|NCT00784875|468815464|FG002|Period D|Physician Decision|0|||
130231890|NCT00784875|468815465|FG003|Period D|Physician Decision|0|||
130231891|NCT00784875|468815462|FG000|Period D|Sponsor Decision|1|||
130231892|NCT00784875|468815463|FG001|Period D|Sponsor Decision|1|||
130231893|NCT00784875|468815464|FG002|Period D|Sponsor Decision|1|||
130231894|NCT00784875|468815465|FG003|Period D|Sponsor Decision|0|||
130231895|NCT00784875|468815462|FG000|Period D|Lost to Follow-up|1|||
130231896|NCT00784875|468815463|FG001|Period D|Lost to Follow-up|0|||
130231897|NCT00784875|468815464|FG002|Period D|Lost to Follow-up|1|||
130231898|NCT00784875|468815465|FG003|Period D|Lost to Follow-up|1|||
130231899|NCT01829347|468815468|FG000|VTI-210|Death|5|||
130231900|NCT01829347|468815469|FG001|VTI-210|Death|3|||
130231901|NCT01829347|468815468|FG000|VTI-210|Withdrawal by Subject|1|||
130231902|NCT01829347|468815469|FG001|VTI-210|Withdrawal by Subject|0|||
130231903|NCT01829347|468815468|FG000|VTI-210E|Death|2|||
130231904|NCT01829347|468815469|FG001|VTI-210E|Death|1|||
130231905|NCT01829347|468815468|FG000|VTI-210E|Study terminated prematurely|1|||
130231906|NCT01829347|468815469|FG001|VTI-210E|Study terminated prematurely|5|||
130231907|NCT04018066|468815470|FG000|Overall Study|participants started taking medications during the study period|3|||
130231908|NCT04018066|468815470|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
130231909|NCT01027949|468815471|FG000|Overall Study|Death|174|||
130231910|NCT01027949|468815471|FG000|Overall Study|Progressive Disease|163|||
130231911|NCT01027949|468815471|FG000|Overall Study|Adverse Event|172|||
130231912|NCT01027949|468815471|FG000|Overall Study|Withdrawal by Subject|113|||
130231913|NCT01027949|468815471|FG000|Overall Study|Lost to Follow-up|17|||
130231914|NCT01027949|468815471|FG000|Overall Study|Protocol Violation|13|||
130231915|NCT01027949|468815471|FG000|Overall Study|PI Decision|8|||
130231916|NCT01027949|468815471|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
130231917|NCT01027949|468815471|FG000|Overall Study|Non-compliance with Study Procedures|7|||
130231918|NCT01027949|468815471|FG000|Overall Study|Lung Transplant|5|||
130231919|NCT01027949|468815471|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
130231920|NCT01027949|468815471|FG000|Overall Study|Use of Excluded Medication|2|||
130231921|NCT01027949|468815471|FG000|Overall Study|Patient Self-discontinuation|1|||
130231922|NCT01027949|468815471|FG000|Overall Study|Pregnancy|1|||
130231923|NCT01027949|468815471|FG000|Overall Study|Surgery|1|||
130231924|NCT02152007|468815483|FG000|Overall Study|Withdrawal by Subject|1|||
130231925|NCT00706797|468815486|FG000|Overall Study|Lack of Efficacy|3|||
130231926|NCT00706797|468815487|FG001|Overall Study|Lack of Efficacy|0|||
130231927|NCT00706797|468815486|FG000|Overall Study|Adverse Event|0|||
130231928|NCT00706797|468815487|FG001|Overall Study|Adverse Event|3|||
130231929|NCT00706797|468815486|FG000|Overall Study|Withdrawal by Subject|8|||
130231930|NCT00706797|468815487|FG001|Overall Study|Withdrawal by Subject|1|||
130231931|NCT00706797|468815486|FG000|Overall Study|Death|1|||
130231932|NCT00706797|468815487|FG001|Overall Study|Death|0|||
130231933|NCT00706797|468815486|FG000|Overall Study|Discontinuation of study by sponsor|52|||
130231934|NCT00706797|468815487|FG001|Overall Study|Discontinuation of study by sponsor|63|||
130231935|NCT00706797|468815486|FG000|Overall Study|Protocol Violation|3|||
130231936|NCT00706797|468815487|FG001|Overall Study|Protocol Violation|2|||
130231937|NCT00706797|468815486|FG000|Overall Study|Lost to Follow-up|1|||
130231938|NCT00706797|468815487|FG001|Overall Study|Lost to Follow-up|2|||
130356733|NCT03148275|469276402|FG000|Overall Study|transition to commercial drug|1|||
130356734|NCT03148275|469276402|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
130356735|NCT05098938|469276403|FG000|Overall Study|Adverse Event|4|||
130356736|NCT05098938|469276404|FG001|Overall Study|Adverse Event|3|||
130356737|NCT05098938|469276403|FG000|Overall Study|inclusion/exclusion criteria change|11|||
130356738|NCT05098938|469276404|FG001|Overall Study|inclusion/exclusion criteria change|5|||
130231939|NCT00706797|468815486|FG000|Overall Study|Other|1|||
130231940|NCT00706797|468815487|FG001|Overall Study|Other|0|||
130231941|NCT02309359|468815490|FG000|Overall Study|Adverse Event|4|||
130231942|NCT02309359|468815491|FG001|Overall Study|Adverse Event|5|||
130231943|NCT02309359|468815492|FG002|Overall Study|Adverse Event|5|||
130231944|NCT02309359|468815493|FG003|Overall Study|Adverse Event|4|||
130231945|NCT02309359|468815494|FG004|Overall Study|Adverse Event|4|||
130231946|NCT02309359|468815490|FG000|Overall Study|Death|1|||
130231947|NCT02309359|468815491|FG001|Overall Study|Death|0|||
130231948|NCT02309359|468815492|FG002|Overall Study|Death|0|||
130231949|NCT02309359|468815493|FG003|Overall Study|Death|0|||
130231950|NCT02309359|468815494|FG004|Overall Study|Death|0|||
130231951|NCT02309359|468815490|FG000|Overall Study|Withdrawal by Subject|2|||
130231952|NCT02309359|468815491|FG001|Overall Study|Withdrawal by Subject|2|||
130231953|NCT02309359|468815492|FG002|Overall Study|Withdrawal by Subject|4|||
130231954|NCT02309359|468815493|FG003|Overall Study|Withdrawal by Subject|4|||
130231955|NCT02309359|468815494|FG004|Overall Study|Withdrawal by Subject|0|||
130231956|NCT02309359|468815490|FG000|Overall Study|Lack of Efficacy|3|||
130231957|NCT02309359|468815491|FG001|Overall Study|Lack of Efficacy|1|||
130231958|NCT02309359|468815492|FG002|Overall Study|Lack of Efficacy|0|||
130231959|NCT02309359|468815493|FG003|Overall Study|Lack of Efficacy|0|||
130231960|NCT02309359|468815494|FG004|Overall Study|Lack of Efficacy|3|||
130231961|NCT02309359|468815490|FG000|Overall Study|Lost to Follow-up|0|||
130231962|NCT02309359|468815491|FG001|Overall Study|Lost to Follow-up|0|||
130231963|NCT02309359|468815492|FG002|Overall Study|Lost to Follow-up|0|||
130231964|NCT02309359|468815493|FG003|Overall Study|Lost to Follow-up|1|||
130231965|NCT02309359|468815494|FG004|Overall Study|Lost to Follow-up|0|||
130231966|NCT02309359|468815490|FG000|Overall Study|Other|2|||
130231967|NCT02309359|468815491|FG001|Overall Study|Other|0|||
130231968|NCT02309359|468815492|FG002|Overall Study|Other|2|||
130231969|NCT02309359|468815493|FG003|Overall Study|Other|3|||
130231970|NCT02309359|468815494|FG004|Overall Study|Other|2|||
130231971|NCT05144945|468815496|FG000|Overall Study|Withdrawal by Subject|1|||
130231972|NCT05144945|468815497|FG001|Overall Study|Withdrawal by Subject|0|||
130231973|NCT00284856|468815498|FG000|Overall Study|Adverse Event|3|||
130231974|NCT00284856|468815499|FG001|Overall Study|Adverse Event|3|||
130231975|NCT00284856|468815500|FG002|Overall Study|Adverse Event|3|||
130231976|NCT00284856|468815498|FG000|Overall Study|Lack of Efficacy|2|||
130231977|NCT00284856|468815499|FG001|Overall Study|Lack of Efficacy|1|||
130231978|NCT00284856|468815500|FG002|Overall Study|Lack of Efficacy|8|||
130231979|NCT00284856|468815498|FG000|Overall Study|Lost to Follow-up|25|||
130231980|NCT00284856|468815499|FG001|Overall Study|Lost to Follow-up|21|||
130231981|NCT00284856|468815500|FG002|Overall Study|Lost to Follow-up|22|||
130231982|NCT00284856|468815498|FG000|Overall Study|Protocol Violation|5|||
130231983|NCT00284856|468815499|FG001|Overall Study|Protocol Violation|4|||
130231984|NCT00284856|468815500|FG002|Overall Study|Protocol Violation|5|||
130231985|NCT00284856|468815498|FG000|Overall Study|Withdrawal by Subject|12|||
130231986|NCT00284856|468815499|FG001|Overall Study|Withdrawal by Subject|16|||
130231987|NCT00284856|468815500|FG002|Overall Study|Withdrawal by Subject|18|||
130231988|NCT00284856|468815498|FG000|Overall Study|Other|4|||
130231989|NCT00284856|468815499|FG001|Overall Study|Other|5|||
130231990|NCT00284856|468815500|FG002|Overall Study|Other|4|||
130231991|NCT01192815|468815501|FG000|Overall Study|Withdrawal by Subject|1|||
130231992|NCT01192815|468815501|FG000|Overall Study|Lack of Efficacy|1|||
130231993|NCT01394276|468815502|FG000|Overall Study|Related Adverse event (AEs)|15|||
130231994|NCT01394276|468815502|FG000|Overall Study|Not related AEs|9|||
130231995|NCT01394276|468815502|FG000|Overall Study|Remission of disease|2|||
130231996|NCT01394276|468815502|FG000|Overall Study|Insufficient therapeutic effect|17|||
130231997|NCT01394276|468815502|FG000|Overall Study|Insufficient compliance|9|||
130231998|NCT01394276|468815502|FG000|Overall Study|Lost to Follow-up|5|||
130231999|NCT01394276|468815502|FG000|Overall Study|Participant moved to another site|1|||
130232000|NCT01394276|468815502|FG000|Overall Study|Pregnancy|1|||
130232001|NCT01394276|468815502|FG000|Overall Study|unavailability of drug at the Hospital|2|||
130232002|NCT01394276|468815502|FG000|Overall Study|Symptoms of concurrent diseases|1|||
130232003|NCT00465179|468815503|FG000|Overall Study|Adverse Event|4|||
130232004|NCT00465179|468815503|FG000|Overall Study|Withdrawal by Subject|2|||
130232005|NCT00465179|468815503|FG000|Overall Study|Progression of Disease|47|||
130356739|NCT05098938|469276403|FG000|Overall Study|lack of compliance|26|||
130232006|NCT00262925|468815506|FG000|Overall Study|Lack of Efficacy|3|||
130232007|NCT00262925|468815506|FG000|Overall Study|Adverse Event|4|||
130232008|NCT00262925|468815506|FG000|Overall Study|Death|2|||
130232009|NCT00262925|468815506|FG000|Overall Study|alternative therapy|1|||
130232010|NCT00262925|468815506|FG000|Overall Study|Other|1|||
130232011|NCT04682301|468815507|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
130232012|NCT04682301|468815507|FG000|Overall Study|Death|2|||
130232013|NCT00560404|468815508|FG000|Overall Study|Adverse Event|2|||
130232014|NCT00560404|468815509|FG001|Overall Study|Adverse Event|3|||
130232015|NCT00560404|468815508|FG000|Overall Study|Death|3|||
130232016|NCT00560404|468815509|FG001|Overall Study|Death|3|||
130232017|NCT00560404|468815508|FG000|Overall Study|Protocol Violation|12|||
130232018|NCT00560404|468815509|FG001|Overall Study|Protocol Violation|7|||
130232019|NCT00560404|468815508|FG000|Overall Study|Administrative Reasons|1|||
130232020|NCT00560404|468815509|FG001|Overall Study|Administrative Reasons|1|||
130232021|NCT00560404|468815508|FG000|Overall Study|Withdrew Consent|4|||
130356740|NCT05098938|469276404|FG001|Overall Study|lack of compliance|19|||
130232022|NCT00560404|468815509|FG001|Overall Study|Withdrew Consent|0|||
130232023|NCT00560404|468815508|FG000|Overall Study|Failure to return|1|||
130232024|NCT00560404|468815509|FG001|Overall Study|Failure to return|2|||
130232025|NCT00560404|468815508|FG000|Overall Study|Other withdrawal reason|13|||
130232026|NCT00560404|468815509|FG001|Overall Study|Other withdrawal reason|5|||
130232027|NCT02187783|468815510|FG000|Overall Study|Adverse Event|8|||
130232028|NCT02187783|468815510|FG000|Overall Study|Death|3|||
130232029|NCT02187783|468815510|FG000|Overall Study|Progressive disease|80|||
130232030|NCT02187783|468815510|FG000|Overall Study|Protocol Violation|3|||
130232031|NCT02187783|468815510|FG000|Overall Study|Physician Decision|2|||
130232032|NCT02187783|468815510|FG000|Overall Study|Withdrawal by Subject|9|||
130232033|NCT02187783|468815510|FG000|Overall Study|Study terminated by sponsor|1|||
130232034|NCT00471497|468815511|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
130356741|NCT05098938|469276403|FG000|Overall Study|Lost to Follow-up|37|||
130693512|NCT00849797|470503676|FG000|First Intervention|Adverse Event|0|||
130693513|NCT00849797|470503677|FG001|First Intervention|Adverse Event|1|||
130693514|NCT00849797|470503676|FG000|Washout: One Week|Withdrawal by Subject|0|||
130693515|NCT00849797|470503677|FG001|Washout: One Week|Withdrawal by Subject|2|||
130693516|NCT00679081|470503678|FG000|Overall Study|Lost to Follow-up|1|||
130693517|NCT00725322|470503679|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
130693518|NCT00725322|470503680|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
130693519|NCT00725322|470503679|FG000|Washout (28 Days)|Protocol Violation|0|||
130693520|NCT00725322|470503680|FG001|Washout (28 Days)|Protocol Violation|1|||
130693521|NCT01279486|470503681|FG000|Overall Study|Lost to Follow-up|1|||
130693522|NCT04198363|470503685|FG000|Overall Study|Adverse Event|1|||
130693523|NCT04198363|470503686|FG001|Overall Study|Adverse Event|1|||
130693524|NCT04198363|470503685|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130693525|NCT04198363|470503686|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130693526|NCT04198363|470503685|FG000|Overall Study|Reason not Specified|1|||
130693527|NCT04198363|470503686|FG001|Overall Study|Reason not Specified|0|||
130693528|NCT03067987|470503688|FG000|Overall Study|Lost to Follow-up|7|||
130693529|NCT03067987|470503689|FG001|Overall Study|Lost to Follow-up|10|||
130693530|NCT03067987|470503688|FG000|Overall Study|Protocol Violation|1|||
130693531|NCT03067987|470503689|FG001|Overall Study|Protocol Violation|2|||
130693532|NCT03067987|470503688|FG000|Overall Study|Withdrawal by Subject|2|||
130693533|NCT03067987|470503689|FG001|Overall Study|Withdrawal by Subject|1|||
130693534|NCT01404988|470503692|FG000|Overall Study|Death|2|||
130693535|NCT01404988|470503693|FG001|Overall Study|Death|0|||
130693536|NCT01404988|470503694|FG002|Overall Study|Death|2|||
130693537|NCT01404988|470503692|FG000|Overall Study|Adverse Event|1|||
130693538|NCT01404988|470503693|FG001|Overall Study|Adverse Event|0|||
130693539|NCT01404988|470503694|FG002|Overall Study|Adverse Event|0|||
130693540|NCT01404988|470503692|FG000|Overall Study|Withdrawal by Subject|2|||
130693541|NCT01404988|470503693|FG001|Overall Study|Withdrawal by Subject|2|||
130693542|NCT01404988|470503694|FG002|Overall Study|Withdrawal by Subject|0|||
130693543|NCT01404988|470503692|FG000|Overall Study|Lost to Follow-up|1|||
130693544|NCT01404988|470503693|FG001|Overall Study|Lost to Follow-up|2|||
130693545|NCT01404988|470503694|FG002|Overall Study|Lost to Follow-up|1|||
130693546|NCT00829764|470503695|FG000|First Intervention|Adverse Event|1|||
130693547|NCT00829764|470503696|FG001|First Intervention|Adverse Event|0|||
130693548|NCT00829764|470503695|FG000|First Intervention|Withdrawal by Subject|1|||
130693549|NCT00829764|470503696|FG001|First Intervention|Withdrawal by Subject|1|||
130693550|NCT04594252|470503697|FG000|Overall Study|Adverse Event|0|||
130693551|NCT04594252|470503698|FG001|Overall Study|Adverse Event|2|||
130693552|NCT03578809|470505750|FG000|Overall Study|Death|0|||
130693553|NCT03578809|470505751|FG001|Overall Study|Death|2|||
130693554|NCT03578809|470505752|FG002|Overall Study|Death|0|||
130693555|NCT03578809|470505753|FG003|Overall Study|Death|1|||
130693556|NCT03578809|470505750|FG000|Overall Study|Lost to Follow-up|0|||
130693557|NCT03578809|470505751|FG001|Overall Study|Lost to Follow-up|1|||
130693558|NCT03578809|470505752|FG002|Overall Study|Lost to Follow-up|0|||
130693559|NCT03578809|470505753|FG003|Overall Study|Lost to Follow-up|0|||
130693560|NCT03578809|470505750|FG000|Overall Study|Withdrawal by Subject|3|||
130693561|NCT03578809|470505751|FG001|Overall Study|Withdrawal by Subject|5|||
130693562|NCT03578809|470505752|FG002|Overall Study|Withdrawal by Subject|2|||
130693563|NCT03578809|470505753|FG003|Overall Study|Withdrawal by Subject|0|||
130693564|NCT03578809|470505750|FG000|Overall Study|Other|3|||
130693565|NCT03578809|470505751|FG001|Overall Study|Other|6|||
130693566|NCT03578809|470505752|FG002|Overall Study|Other|2|||
130693567|NCT03578809|470505753|FG003|Overall Study|Other|8|||
130693568|NCT01952691|470505754|FG000|Overall Study|Lost to Follow-up|2|||
130693569|NCT00199901|470505755|FG000|Overall Study|Protocol Violation|2|||
130693570|NCT00199901|470505756|FG001|Overall Study|Protocol Violation|0|||
130693571|NCT00199901|470505755|FG000|Overall Study|Withdrawal by Subject|1|||
130693572|NCT00199901|470505756|FG001|Overall Study|Withdrawal by Subject|0|||
130693573|NCT00199901|470505755|FG000|Overall Study|Progressive Disease|24|||
130693574|NCT00199901|470505756|FG001|Overall Study|Progressive Disease|24|||
130693575|NCT05776901|470505759|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
130693576|NCT02997176|470505764|FG000|Overall Study|Adverse Event|0|||
130693577|NCT02997176|470505765|FG001|Overall Study|Adverse Event|0|||
130693578|NCT02997176|470505766|FG002|Overall Study|Adverse Event|0|||
130693579|NCT02997176|470505767|FG003|Overall Study|Adverse Event|8|||
130693580|NCT02997176|470505764|FG000|Overall Study|Progressive Disease|1|||
130693581|NCT02997176|470505765|FG001|Overall Study|Progressive Disease|0|||
130693582|NCT02997176|470505766|FG002|Overall Study|Progressive Disease|1|||
130693583|NCT02997176|470505767|FG003|Overall Study|Progressive Disease|1|||
130693584|NCT02997176|470505764|FG000|Overall Study|Death|0|||
130693585|NCT02997176|470505765|FG001|Overall Study|Death|0|||
130693586|NCT02997176|470505766|FG002|Overall Study|Death|1|||
130693587|NCT02997176|470505767|FG003|Overall Study|Death|1|||
130693588|NCT02997176|470505764|FG000|Overall Study|Withdrawal by Subject|0|||
130693589|NCT02997176|470505765|FG001|Overall Study|Withdrawal by Subject|2|||
130693590|NCT02997176|470505766|FG002|Overall Study|Withdrawal by Subject|0|||
130232035|NCT00471497|468815512|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
130232036|NCT00471497|468815513|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
130232037|NCT00471497|468815511|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
130232038|NCT00471497|468815512|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
130232039|NCT00471497|468815513|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
130232040|NCT00471497|468815511|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
130232041|NCT00471497|468815512|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
130232042|NCT00471497|468815513|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
130232043|NCT00471497|468815511|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
130232044|NCT00471497|468815512|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
130232045|NCT00471497|468815513|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
130232046|NCT00471497|468815511|FG000|Core Treatment Phase|Lost to Follow-up|6|||
130232047|NCT00471497|468815512|FG001|Core Treatment Phase|Lost to Follow-up|6|||
130232048|NCT00471497|468815513|FG002|Core Treatment Phase|Lost to Follow-up|3|||
130232049|NCT00471497|468815511|FG000|Core Treatment Phase|Death|3|||
130232050|NCT00471497|468815512|FG001|Core Treatment Phase|Death|9|||
130232051|NCT00471497|468815513|FG002|Core Treatment Phase|Death|3|||
130232052|NCT00471497|468815511|FG000|Core Treatment Phase|Disease Progression|10|||
130232053|NCT00471497|468815512|FG001|Core Treatment Phase|Disease Progression|2|||
130232054|NCT00471497|468815513|FG002|Core Treatment Phase|Disease Progression|4|||
130232055|NCT00471497|468815511|FG000|Core Treatment Phase|Protocol Violation|6|||
130232056|NCT00471497|468815512|FG001|Core Treatment Phase|Protocol Violation|15|||
130232057|NCT00471497|468815513|FG002|Core Treatment Phase|Protocol Violation|11|||
130232058|NCT00471497|468815511|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
130232059|NCT00471497|468815512|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
130232060|NCT00471497|468815513|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
130232061|NCT00471497|468815511|FG000|Core Treatment Phase|Administrative problems|14|||
130232062|NCT00471497|468815512|FG001|Core Treatment Phase|Administrative problems|14|||
130232063|NCT00471497|468815513|FG002|Core Treatment Phase|Administrative problems|12|||
130232064|NCT00471497|468815511|FG000|Core Treatment Phase|Adverse Event|43|||
130232065|NCT00471497|468815512|FG001|Core Treatment Phase|Adverse Event|53|||
130232066|NCT00471497|468815513|FG002|Core Treatment Phase|Adverse Event|89|||
130232067|NCT00471497|468815511|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
130232068|NCT00471497|468815512|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130232069|NCT00471497|468815513|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130232070|NCT00471497|468815511|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
130232071|NCT00471497|468815512|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
130232072|NCT00471497|468815513|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
130232073|NCT00471497|468815511|FG000|Extension Phase|Adverse Event|9|||
130232074|NCT00471497|468815512|FG001|Extension Phase|Adverse Event|5|||
130232075|NCT00471497|468815513|FG002|Extension Phase|Adverse Event|1|||
130232076|NCT00471497|468815511|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130232077|NCT00471497|468815512|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
130232078|NCT00471497|468815513|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130232079|NCT00471497|468815511|FG000|Extension Phase|Withdrawal by Subject|3|||
130232080|NCT00471497|468815512|FG001|Extension Phase|Withdrawal by Subject|1|||
130232081|NCT00471497|468815513|FG002|Extension Phase|Withdrawal by Subject|0|||
130232082|NCT00471497|468815511|FG000|Extension Phase|Lost to Follow-up|2|||
130232083|NCT00471497|468815512|FG001|Extension Phase|Lost to Follow-up|0|||
130232084|NCT00471497|468815513|FG002|Extension Phase|Lost to Follow-up|0|||
130232085|NCT00471497|468815511|FG000|Extension Phase|Death|1|||
130232086|NCT00471497|468815512|FG001|Extension Phase|Death|0|||
130232087|NCT00471497|468815513|FG002|Extension Phase|Death|0|||
130232088|NCT00471497|468815511|FG000|Extension Phase|Disease progression|2|||
130232089|NCT00471497|468815512|FG001|Extension Phase|Disease progression|0|||
130356742|NCT05098938|469276404|FG001|Overall Study|Lost to Follow-up|40|||
130356743|NCT05098938|469276403|FG000|Overall Study|Lost in treatment period|17|||
130356744|NCT05098938|469276404|FG001|Overall Study|Lost in treatment period|13|||
130693591|NCT02997176|470505767|FG003|Overall Study|Withdrawal by Subject|1|||
130693592|NCT01624233|470505768|FG000|Period 2 - Induction|Adverse Event|1|||
130232090|NCT00471497|468815513|FG002|Extension Phase|Disease progression|0|||
130232091|NCT00471497|468815511|FG000|Extension Phase|Protocol Violation|2|||
130232092|NCT00471497|468815512|FG001|Extension Phase|Protocol Violation|2|||
130232093|NCT00471497|468815513|FG002|Extension Phase|Protocol Violation|0|||
130232094|NCT00392223|468815514|FG000|Overall Study|Adverse Event|5|||
130356745|NCT05098938|469276403|FG000|Overall Study|Met an exclusion criterion|0|||
130693593|NCT01624233|470505768|FG000|Period 3 - Maintenance|Adverse Event|2|||
130232095|NCT00392223|468815515|FG001|Overall Study|Adverse Event|4|||
130232096|NCT00392223|468815514|FG000|Overall Study|Lost to Follow-up|1|||
130232097|NCT00392223|468815515|FG001|Overall Study|Lost to Follow-up|4|||
130232098|NCT00392223|468815514|FG000|Overall Study|Protocol Violation|0|||
130232099|NCT00392223|468815515|FG001|Overall Study|Protocol Violation|3|||
130693594|NCT01624233|470505768|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
130232100|NCT00392223|468815514|FG000|Overall Study|Withdrawal by Subject|3|||
130232101|NCT00392223|468815515|FG001|Overall Study|Withdrawal by Subject|2|||
130232102|NCT00402831|468815518|FG000|Overall Study|Lost to Follow-up|1|||
130232103|NCT00402831|468815519|FG001|Overall Study|Lost to Follow-up|2|||
130232104|NCT00402831|468815518|FG000|Overall Study|Non-compliance with protocol|0|||
130232105|NCT00402831|468815519|FG001|Overall Study|Non-compliance with protocol|1|||
130232106|NCT01114724|468815522|FG000|Overall Study|Death|8|||
130232107|NCT01114724|468815522|FG000|Overall Study|Lost to Follow-up|1|||
130232108|NCT01114724|468815522|FG000|Overall Study|Withdrawal by Subject|1|||
130232109|NCT01981616|468815531|FG000|Overall Study|Adverse Event|0|||
130232110|NCT01981616|468815532|FG001|Overall Study|Adverse Event|1|||
130232111|NCT01981616|468815531|FG000|Overall Study|Protocol Violation|1|||
130232112|NCT01981616|468815532|FG001|Overall Study|Protocol Violation|0|||
130232113|NCT01020123|468815533|FG000|Main Period|Withdrawal by Subject|6|||
130232114|NCT01020123|468815534|FG001|Main Period|Withdrawal by Subject|5|||
130232115|NCT01020123|468815535|FG002|Main Period|Withdrawal by Subject|3|||
130232116|NCT01020123|468815536|FG003|Main Period|Withdrawal by Subject|1|||
130232117|NCT01020123|468815537|FG004|Main Period|Withdrawal by Subject|6|||
130232118|NCT01020123|468815538|FG005|Main Period|Withdrawal by Subject|3|||
130232119|NCT01020123|468815539|FG006|Main Period|Withdrawal by Subject|2|||
130232120|NCT01020123|468815533|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
130232121|NCT01020123|468815534|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
130232122|NCT01020123|468815535|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
130232123|NCT01020123|468815536|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
130232124|NCT01020123|468815537|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
130232125|NCT01020123|468815538|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
130232126|NCT01020123|468815539|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
130232127|NCT01020123|468815533|FG000|Main Period|Adverse Event|5|||
130232128|NCT01020123|468815534|FG001|Main Period|Adverse Event|2|||
130232129|NCT01020123|468815535|FG002|Main Period|Adverse Event|2|||
130232130|NCT01020123|468815536|FG003|Main Period|Adverse Event|1|||
130232131|NCT01020123|468815537|FG004|Main Period|Adverse Event|1|||
130232132|NCT01020123|468815538|FG005|Main Period|Adverse Event|2|||
130232133|NCT01020123|468815539|FG006|Main Period|Adverse Event|1|||
130232134|NCT01020123|468815533|FG000|Main Period|Protocol Violation|4|||
130232135|NCT01020123|468815534|FG001|Main Period|Protocol Violation|4|||
130232136|NCT01020123|468815535|FG002|Main Period|Protocol Violation|2|||
130232137|NCT01020123|468815536|FG003|Main Period|Protocol Violation|5|||
130232138|NCT01020123|468815537|FG004|Main Period|Protocol Violation|2|||
130232139|NCT01020123|468815538|FG005|Main Period|Protocol Violation|3|||
130232140|NCT01020123|468815539|FG006|Main Period|Protocol Violation|2|||
130232141|NCT01020123|468815533|FG000|Main Period|Lost to Follow-up|0|||
130232142|NCT01020123|468815534|FG001|Main Period|Lost to Follow-up|2|||
130232143|NCT01020123|468815535|FG002|Main Period|Lost to Follow-up|0|||
130232144|NCT01020123|468815536|FG003|Main Period|Lost to Follow-up|0|||
130232145|NCT01020123|468815537|FG004|Main Period|Lost to Follow-up|0|||
130232146|NCT01020123|468815538|FG005|Main Period|Lost to Follow-up|0|||
130232147|NCT01020123|468815539|FG006|Main Period|Lost to Follow-up|0|||
130232148|NCT01020123|468815533|FG000|Main Period|Unclasified|2|||
130232149|NCT01020123|468815534|FG001|Main Period|Unclasified|0|||
130232150|NCT01020123|468815535|FG002|Main Period|Unclasified|1|||
130232151|NCT01020123|468815536|FG003|Main Period|Unclasified|0|||
130232152|NCT01020123|468815537|FG004|Main Period|Unclasified|1|||
130232153|NCT01020123|468815538|FG005|Main Period|Unclasified|3|||
130232154|NCT01020123|468815539|FG006|Main Period|Unclasified|6|||
130232155|NCT01020123|468815533|FG000|Extention Period|Withdrawal by Subject|2|||
130232156|NCT01020123|468815534|FG001|Extention Period|Withdrawal by Subject|1|||
130232157|NCT01020123|468815535|FG002|Extention Period|Withdrawal by Subject|1|||
130232158|NCT01020123|468815536|FG003|Extention Period|Withdrawal by Subject|0|||
130232159|NCT01020123|468815537|FG004|Extention Period|Withdrawal by Subject|0|||
130232160|NCT01020123|468815538|FG005|Extention Period|Withdrawal by Subject|0|||
130232161|NCT01020123|468815539|FG006|Extention Period|Withdrawal by Subject|0|||
130232162|NCT01020123|468815533|FG000|Extention Period|Adverse Event|0|||
130232163|NCT01020123|468815534|FG001|Extention Period|Adverse Event|0|||
130232164|NCT01020123|468815535|FG002|Extention Period|Adverse Event|0|||
130232165|NCT01020123|468815536|FG003|Extention Period|Adverse Event|1|||
130232166|NCT01020123|468815537|FG004|Extention Period|Adverse Event|0|||
130232167|NCT01020123|468815538|FG005|Extention Period|Adverse Event|0|||
130232168|NCT01020123|468815539|FG006|Extention Period|Adverse Event|0|||
130232169|NCT01020123|468815533|FG000|Extention Period|Protocol Violation|1|||
130232170|NCT01020123|468815534|FG001|Extention Period|Protocol Violation|1|||
130356746|NCT05098938|469276404|FG001|Overall Study|Met an exclusion criterion|3|||
130232171|NCT01020123|468815535|FG002|Extention Period|Protocol Violation|1|||
130232172|NCT01020123|468815536|FG003|Extention Period|Protocol Violation|0|||
130232173|NCT01020123|468815537|FG004|Extention Period|Protocol Violation|0|||
130232174|NCT01020123|468815538|FG005|Extention Period|Protocol Violation|0|||
130232175|NCT01020123|468815539|FG006|Extention Period|Protocol Violation|1|||
130232176|NCT01020123|468815533|FG000|Extention Period|Lost to Follow-up|0|||
130232177|NCT01020123|468815534|FG001|Extention Period|Lost to Follow-up|0|||
130232178|NCT01020123|468815535|FG002|Extention Period|Lost to Follow-up|0|||
130232179|NCT01020123|468815536|FG003|Extention Period|Lost to Follow-up|0|||
130232180|NCT01020123|468815537|FG004|Extention Period|Lost to Follow-up|0|||
130232181|NCT01020123|468815538|FG005|Extention Period|Lost to Follow-up|2|||
130232182|NCT01020123|468815539|FG006|Extention Period|Lost to Follow-up|0|||
130232183|NCT00094445|468815540|FG000|Overall Study|Withdrawal by Subject|3|||
130232184|NCT00094445|468815540|FG000|Overall Study|Lost to Follow-up|1|||
130232185|NCT00094445|468815540|FG000|Overall Study|Progressive Disease|2|||
130232186|NCT00769561|468815545|FG000|Overall Study|Withdrawal by Subject|2|||
130232187|NCT00769561|468815546|FG001|Overall Study|Withdrawal by Subject|2|||
130232188|NCT00769561|468815545|FG000|Overall Study|Lost to Follow-up|1|||
130232189|NCT00769561|468815546|FG001|Overall Study|Lost to Follow-up|3|||
130232190|NCT04711005|468815547|FG000|Overall Study|Withdrawal by Subject|0|||
130232191|NCT04711005|468815548|FG001|Overall Study|Withdrawal by Subject|0|||
130232192|NCT04711005|468815549|FG002|Overall Study|Withdrawal by Subject|0|||
130232193|NCT04711005|468815550|FG003|Overall Study|Withdrawal by Subject|0|||
130232194|NCT04711005|468815551|FG004|Overall Study|Withdrawal by Subject|0|||
130232195|NCT04711005|468815552|FG005|Overall Study|Withdrawal by Subject|0|||
130232196|NCT04711005|468815553|FG006|Overall Study|Withdrawal by Subject|0|||
130232197|NCT04711005|468815554|FG007|Overall Study|Withdrawal by Subject|1|||
130232198|NCT04711005|468815555|FG008|Overall Study|Withdrawal by Subject|0|||
130232199|NCT04711005|468815556|FG009|Overall Study|Withdrawal by Subject|0|||
130232200|NCT04711005|468815547|FG000|Overall Study|Physician Decision|0|||
130232201|NCT04711005|468815548|FG001|Overall Study|Physician Decision|0|||
130232202|NCT04711005|468815549|FG002|Overall Study|Physician Decision|0|||
130232203|NCT04711005|468815550|FG003|Overall Study|Physician Decision|0|||
130232204|NCT04711005|468815551|FG004|Overall Study|Physician Decision|0|||
130232205|NCT04711005|468815552|FG005|Overall Study|Physician Decision|0|||
130232206|NCT04711005|468815553|FG006|Overall Study|Physician Decision|0|||
130232207|NCT04711005|468815554|FG007|Overall Study|Physician Decision|2|||
130232208|NCT04711005|468815555|FG008|Overall Study|Physician Decision|1|||
130232209|NCT04711005|468815556|FG009|Overall Study|Physician Decision|0|||
130232210|NCT03824561|468815564|FG000|Overall Study|Protocol Violation|19|||
130232211|NCT01773928|468815565|FG000|Overall Study|Adverse Event|0|||
130232212|NCT01773928|468815566|FG001|Overall Study|Adverse Event|0|||
130232213|NCT01773928|468815567|FG002|Overall Study|Adverse Event|0|||
130232214|NCT01773928|468815568|FG003|Overall Study|Adverse Event|0|||
130232215|NCT01773928|468815569|FG004|Overall Study|Adverse Event|0|||
130232216|NCT01773928|468815570|FG005|Overall Study|Adverse Event|0|||
130232217|NCT01773928|468815571|FG006|Overall Study|Adverse Event|0|||
130232218|NCT01773928|468815572|FG007|Overall Study|Adverse Event|1|||
130232219|NCT01773928|468815573|FG008|Overall Study|Adverse Event|0|||
130232220|NCT01773928|468815565|FG000|Overall Study|Physician Decision|0|||
130232221|NCT01773928|468815566|FG001|Overall Study|Physician Decision|0|||
130232222|NCT01773928|468815567|FG002|Overall Study|Physician Decision|0|||
130232223|NCT01773928|468815568|FG003|Overall Study|Physician Decision|1|||
130232224|NCT01773928|468815569|FG004|Overall Study|Physician Decision|0|||
130232225|NCT01773928|468815570|FG005|Overall Study|Physician Decision|0|||
130232226|NCT01773928|468815571|FG006|Overall Study|Physician Decision|0|||
130232227|NCT01773928|468815572|FG007|Overall Study|Physician Decision|0|||
130232228|NCT01773928|468815573|FG008|Overall Study|Physician Decision|0|||
130232229|NCT01773928|468815565|FG000|Overall Study|Withdrawal by Subject|5|||
130232230|NCT01773928|468815566|FG001|Overall Study|Withdrawal by Subject|4|||
130232231|NCT01773928|468815567|FG002|Overall Study|Withdrawal by Subject|4|||
130232232|NCT01773928|468815568|FG003|Overall Study|Withdrawal by Subject|4|||
130232233|NCT01773928|468815569|FG004|Overall Study|Withdrawal by Subject|7|||
130232234|NCT01773928|468815570|FG005|Overall Study|Withdrawal by Subject|1|||
130232235|NCT01773928|468815571|FG006|Overall Study|Withdrawal by Subject|0|||
130232236|NCT01773928|468815572|FG007|Overall Study|Withdrawal by Subject|0|||
130232237|NCT01773928|468815573|FG008|Overall Study|Withdrawal by Subject|1|||
130232238|NCT01773928|468815565|FG000|Overall Study|Lost to Follow-up|0|||
130445343|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
130693595|NCT01624233|470505768|FG000|Period 3 - Maintenance|Physician Decision|2|||
130693596|NCT01624233|470505768|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
130693597|NCT01624233|470505768|FG000|Period 4 - Drug Free Period|Relapsed|61|||
130232239|NCT01773928|468815566|FG001|Overall Study|Lost to Follow-up|0|||
130232240|NCT01773928|468815567|FG002|Overall Study|Lost to Follow-up|0|||
130232241|NCT01773928|468815568|FG003|Overall Study|Lost to Follow-up|0|||
130232242|NCT01773928|468815569|FG004|Overall Study|Lost to Follow-up|0|||
130232243|NCT01773928|468815570|FG005|Overall Study|Lost to Follow-up|1|||
130232244|NCT01773928|468815571|FG006|Overall Study|Lost to Follow-up|0|||
130232245|NCT01773928|468815572|FG007|Overall Study|Lost to Follow-up|0|||
130232246|NCT01773928|468815573|FG008|Overall Study|Lost to Follow-up|0|||
130232247|NCT01773928|468815565|FG000|Overall Study|Subject misrepresented age|0|||
130232248|NCT01773928|468815566|FG001|Overall Study|Subject misrepresented age|1|||
130693598|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
130232249|NCT01773928|468815567|FG002|Overall Study|Subject misrepresented age|0|||
130232250|NCT01773928|468815568|FG003|Overall Study|Subject misrepresented age|0|||
130232251|NCT01773928|468815569|FG004|Overall Study|Subject misrepresented age|0|||
130232252|NCT01773928|468815570|FG005|Overall Study|Subject misrepresented age|0|||
130232253|NCT01773928|468815571|FG006|Overall Study|Subject misrepresented age|0|||
130232254|NCT01773928|468815572|FG007|Overall Study|Subject misrepresented age|0|||
130232255|NCT01773928|468815573|FG008|Overall Study|Subject misrepresented age|0|||
130232256|NCT01773928|468815565|FG000|Overall Study|Subject met exclusion criteria|0|||
130232257|NCT01773928|468815566|FG001|Overall Study|Subject met exclusion criteria|0|||
130232258|NCT01773928|468815567|FG002|Overall Study|Subject met exclusion criteria|0|||
130232259|NCT01773928|468815568|FG003|Overall Study|Subject met exclusion criteria|0|||
130232260|NCT01773928|468815569|FG004|Overall Study|Subject met exclusion criteria|0|||
130232261|NCT01773928|468815570|FG005|Overall Study|Subject met exclusion criteria|0|||
130232262|NCT01773928|468815571|FG006|Overall Study|Subject met exclusion criteria|0|||
130232263|NCT01773928|468815572|FG007|Overall Study|Subject met exclusion criteria|0|||
130232264|NCT01773928|468815573|FG008|Overall Study|Subject met exclusion criteria|1|||
130232265|NCT01773928|468815565|FG000|Overall Study|Randomized, had to leave, never returned|0|||
130232266|NCT01773928|468815566|FG001|Overall Study|Randomized, had to leave, never returned|0|||
130232267|NCT01773928|468815567|FG002|Overall Study|Randomized, had to leave, never returned|0|||
130232268|NCT01773928|468815568|FG003|Overall Study|Randomized, had to leave, never returned|1|||
130232269|NCT01773928|468815569|FG004|Overall Study|Randomized, had to leave, never returned|0|||
130232270|NCT01773928|468815570|FG005|Overall Study|Randomized, had to leave, never returned|0|||
130232271|NCT01773928|468815571|FG006|Overall Study|Randomized, had to leave, never returned|0|||
130232272|NCT01773928|468815572|FG007|Overall Study|Randomized, had to leave, never returned|0|||
130232273|NCT01773928|468815573|FG008|Overall Study|Randomized, had to leave, never returned|0|||
130232274|NCT01773928|468815565|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
130232275|NCT01773928|468815566|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
130232276|NCT01773928|468815567|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
130232277|NCT01773928|468815568|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
130232278|NCT01773928|468815569|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
130232279|NCT01773928|468815570|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
130232280|NCT01773928|468815571|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
130232281|NCT01773928|468815572|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
130232282|NCT01773928|468815573|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
130232283|NCT03573297|468815575|FG000|Open Label Treatment Period|Adverse Event|67|||
130232284|NCT03573297|468815576|FG001|Open Label Treatment Period|Adverse Event|0|||
130232285|NCT03573297|468815577|FG002|Open Label Treatment Period|Adverse Event|0|||
130232286|NCT03573297|468815578|FG003|Open Label Treatment Period|Adverse Event|0|||
130232287|NCT03573297|468815575|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
130232288|NCT03573297|468815576|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
130232289|NCT03573297|468815577|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130232290|NCT03573297|468815578|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130232291|NCT03573297|468815575|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
130232292|NCT03573297|468815576|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
130232293|NCT03573297|468815577|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130232294|NCT03573297|468815578|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130232295|NCT03573297|468815575|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
130232296|NCT03573297|468815576|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
130232297|NCT03573297|468815577|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130232298|NCT03573297|468815578|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130232299|NCT03573297|468815575|FG000|Open Label Treatment Period|Pregnancy|1|||
130232300|NCT03573297|468815576|FG001|Open Label Treatment Period|Pregnancy|0|||
130232301|NCT03573297|468815577|FG002|Open Label Treatment Period|Pregnancy|0|||
130232302|NCT03573297|468815578|FG003|Open Label Treatment Period|Pregnancy|0|||
130232303|NCT03573297|468815575|FG000|Open Label Treatment Period|Protocol Violation|17|||
130232304|NCT03573297|468815576|FG001|Open Label Treatment Period|Protocol Violation|0|||
130232305|NCT03573297|468815577|FG002|Open Label Treatment Period|Protocol Violation|0|||
130232306|NCT03573297|468815578|FG003|Open Label Treatment Period|Protocol Violation|0|||
130232307|NCT03573297|468815575|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
130232308|NCT03573297|468815576|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232309|NCT03573297|468815577|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232310|NCT03573297|468815578|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232311|NCT03573297|468815575|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
130232312|NCT03573297|468815576|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232313|NCT03573297|468815577|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232314|NCT03573297|468815578|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232315|NCT03573297|468815575|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
130445344|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
130445345|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
130445346|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
130693599|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
130232316|NCT03573297|468815576|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130232317|NCT03573297|468815577|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130232318|NCT03573297|468815578|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130693600|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
130693601|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
130232319|NCT03573297|468815575|FG000|Open Label Treatment Period|Other, Not Specified|7|||
130232320|NCT03573297|468815576|FG001|Open Label Treatment Period|Other, Not Specified|0|||
130693602|NCT01624233|470505768|FG000|Period 6: Follow-up|Adverse Event|3|||
130693603|NCT01624233|470505768|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
130693604|NCT01624233|470505768|FG000|Period 6: Follow-up|Physician Decision|1|||
130693605|NCT01624233|470505768|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
130693606|NCT00373256|470505769|FG000|Overall Study|Adverse Event (AE)|1|||
130693607|NCT00373256|470505770|FG001|Overall Study|Adverse Event (AE)|5|||
130693608|NCT00373256|470505769|FG000|Overall Study|Lost to Follow-up|2|||
130693609|NCT00373256|470505770|FG001|Overall Study|Lost to Follow-up|1|||
130693610|NCT00373256|470505769|FG000|Overall Study|Death|9|||
130693611|NCT00373256|470505770|FG001|Overall Study|Death|8|||
130693612|NCT00373256|470505769|FG000|Overall Study|Objective Progression or Relapse|111|||
130693613|NCT00373256|470505770|FG001|Overall Study|Objective Progression or Relapse|104|||
130693614|NCT00373256|470505769|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
130693615|NCT00373256|470505770|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
130693616|NCT00373256|470505769|FG000|Overall Study|Other|73|||
130693617|NCT00373256|470505770|FG001|Overall Study|Other|107|||
130693618|NCT00373256|470505769|FG000|Overall Study|Protocol Violation|0|||
130693619|NCT00373256|470505770|FG001|Overall Study|Protocol Violation|2|||
130693620|NCT00373256|470505769|FG000|Overall Study|Study Terminated by Sponsor|41|||
130693621|NCT00373256|470505770|FG001|Overall Study|Study Terminated by Sponsor|13|||
130693622|NCT04241458|470505771|FG000|Overall Study|Withdrawal by Subject|0|||
130693623|NCT04241458|470505772|FG001|Overall Study|Withdrawal by Subject|0|||
130232321|NCT03573297|468815577|FG002|Open Label Treatment Period|Other, Not Specified|0|||
130232322|NCT03573297|468815578|FG003|Open Label Treatment Period|Other, Not Specified|0|||
130232323|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
130232324|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
130232325|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
130693624|NCT04241458|470505773|FG002|Overall Study|Withdrawal by Subject|0|||
130693625|NCT04241458|470505774|FG003|Overall Study|Withdrawal by Subject|0|||
130232326|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
130232327|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130693626|NCT04241458|470505775|FG004|Overall Study|Withdrawal by Subject|1|||
130693627|NCT06144424|470505776|FG000|Overall Study|Withdrawal by Subject|2|||
130693628|NCT06144424|470505777|FG001|Overall Study|Withdrawal by Subject|0|||
130693629|NCT06144424|470505776|FG000|Overall Study|Incarceration|1|||
130693630|NCT06144424|470505777|FG001|Overall Study|Incarceration|0|||
130693631|NCT02727192|470505785|FG000|Overall Study|Lost to Follow-up|1|||
130232328|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130232329|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Adverse Event|5|||
130232330|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Adverse Event|1|||
130232331|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232332|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130232333|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232334|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232335|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130232336|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
130232337|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
130232338|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
130232339|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130232340|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
130232341|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
130232342|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
130356747|NCT05098938|469276403|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
130693632|NCT02727192|470505786|FG001|Overall Study|Lost to Follow-up|0|||
130693633|NCT02727192|470505787|FG002|Overall Study|Lost to Follow-up|0|||
130693634|NCT00928057|470505788|FG000|Overall Study|Adverse Event|1|||
130693635|NCT00928057|470505789|FG001|Overall Study|Adverse Event|2|||
130693636|NCT00928057|470505788|FG000|Overall Study|Withdrawal by Subject|1|||
130693637|NCT00928057|470505789|FG001|Overall Study|Withdrawal by Subject|0|||
130693638|NCT00928057|470505788|FG000|Overall Study|Lost to Follow-up|0|||
130693639|NCT00928057|470505789|FG001|Overall Study|Lost to Follow-up|1|||
130232343|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130232344|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
130232345|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
130232346|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
130232347|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130232348|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130232349|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130232350|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130232351|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130693640|NCT00928057|470505788|FG000|Overall Study|Protocol Violation|0|||
130693641|NCT00928057|470505789|FG001|Overall Study|Protocol Violation|1|||
130693642|NCT05497557|470505790|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130693643|NCT05497557|470505791|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
130693644|NCT05497557|470505792|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130693645|NCT02752074|470505795|FG000|Overall Study|Lost to Follow-up|1|||
130693646|NCT02752074|470505796|FG001|Overall Study|Lost to Follow-up|4|||
130232352|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
130232353|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
130232354|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
130232355|NCT02273167|468815581|FG000|Overall Study|Adverse Event|1|||
130232356|NCT02273167|468815582|FG001|Overall Study|Adverse Event|0|||
130232357|NCT02273167|468815583|FG002|Overall Study|Adverse Event|0|||
130232358|NCT02273167|468815581|FG000|Overall Study|Protocol Violation|3|||
130232359|NCT02273167|468815582|FG001|Overall Study|Protocol Violation|1|||
130232360|NCT02273167|468815583|FG002|Overall Study|Protocol Violation|1|||
130232361|NCT02273167|468815581|FG000|Overall Study|Lost to Follow-up|0|||
130232362|NCT02273167|468815582|FG001|Overall Study|Lost to Follow-up|1|||
130232363|NCT02273167|468815583|FG002|Overall Study|Lost to Follow-up|1|||
130232364|NCT02273167|468815581|FG000|Overall Study|Withdrawal by Subject|10|||
130232365|NCT02273167|468815582|FG001|Overall Study|Withdrawal by Subject|12|||
130232366|NCT02273167|468815583|FG002|Overall Study|Withdrawal by Subject|11|||
130232367|NCT02273167|468815581|FG000|Overall Study|Various|10|||
130232368|NCT02273167|468815582|FG001|Overall Study|Various|9|||
130693647|NCT02752074|470505795|FG000|Overall Study|Death|146|||
130693648|NCT02752074|470505796|FG001|Overall Study|Death|129|||
130693649|NCT02752074|470505795|FG000|Overall Study|Withdrawal by Subject|9|||
130693650|NCT02752074|470505796|FG001|Overall Study|Withdrawal by Subject|10|||
130693651|NCT02392195|470505799|FG000|Overall Study|Lost to Follow-up|4|||
130693652|NCT02392195|470505799|FG000|Overall Study|Withdrawal by Subject|4|||
130232369|NCT02273167|468815583|FG002|Overall Study|Various|8|||
130232370|NCT02781324|468815584|FG000|Overall Study|Withdrawal by Subject|1|||
130232371|NCT02781324|468815585|FG001|Overall Study|Withdrawal by Subject|0|||
130232372|NCT02781324|468815584|FG000|Overall Study|Physician Decision|1|||
130232373|NCT02781324|468815585|FG001|Overall Study|Physician Decision|2|||
130232374|NCT00661388|468815589|FG000|Overall Study|Adverse Event|14|||
130232375|NCT00661388|468815589|FG000|Overall Study|Protocol Violation|7|||
130356748|NCT05098938|469276404|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
130356749|NCT05098938|469276403|FG000|Overall Study|Physician Decision|25|||
130356750|NCT05098938|469276404|FG001|Overall Study|Physician Decision|32|||
130356751|NCT05098938|469276403|FG000|Overall Study|Run in failure in treatment phase|1|||
130356752|NCT05098938|469276404|FG001|Overall Study|Run in failure in treatment phase|1|||
130356753|NCT05098938|469276403|FG000|Overall Study|Withdrawal by Subject|0|||
130356754|NCT05098938|469276404|FG001|Overall Study|Withdrawal by Subject|3|||
130356755|NCT05098938|469276403|FG000|Overall Study|Run-in Failure in early study|505|||
130356756|NCT05098938|469276404|FG001|Overall Study|Run-in Failure in early study|514|||
130356757|NCT05098938|469276403|FG000|Overall Study|IMP delivery missed|1|||
130356758|NCT05098938|469276404|FG001|Overall Study|IMP delivery missed|5|||
130356759|NCT05098938|469276403|FG000|Overall Study|6 months visit was missed|2|||
130232376|NCT00661388|468815589|FG000|Overall Study|Renal transplantation|1|||
130232377|NCT00661388|468815589|FG000|Overall Study|Dialysis initiation|1|||
130232378|NCT00661388|468815589|FG000|Overall Study|Administrative reasons|1|||
130356760|NCT05098938|469276404|FG001|Overall Study|6 months visit was missed|0|||
130356761|NCT05098938|469276403|FG000|Overall Study|fit for use was not completed within window|3|||
130356762|NCT05098938|469276404|FG001|Overall Study|fit for use was not completed within window|0|||
130356763|NCT05098938|469276403|FG000|Overall Study|V2 visit was not completed within window|0|||
130693653|NCT00545792|470505802|FG000|Overall Study|Withdrawal by Subject|1|||
130232379|NCT03370172|468817739|FG000|Overall Study|Withdrawal by Subject|0|||
130693654|NCT01380782|470505807|FG000|Overall Study|Adverse Event|0|||
130693655|NCT01380782|470505808|FG001|Overall Study|Adverse Event|1|||
130693656|NCT01380782|470505809|FG002|Overall Study|Adverse Event|0|||
130693657|NCT01380782|470505810|FG003|Overall Study|Adverse Event|0|||
130693658|NCT01380782|470505807|FG000|Overall Study|Death|1|||
130693659|NCT01380782|470505808|FG001|Overall Study|Death|0|||
130693660|NCT01380782|470505809|FG002|Overall Study|Death|0|||
130693661|NCT01380782|470505810|FG003|Overall Study|Death|0|||
130232380|NCT03370172|468817740|FG001|Overall Study|Withdrawal by Subject|1|||
130232381|NCT01171534|468817747|FG000|Overall Study|Lost to Follow-up|0|||
130232382|NCT01171534|468817748|FG001|Overall Study|Lost to Follow-up|2|||
130232383|NCT01171534|468817747|FG000|Overall Study|screen failure|0|||
130232384|NCT01171534|468817748|FG001|Overall Study|screen failure|1|||
130232385|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
130232386|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130232387|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
130232388|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
130232389|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130232390|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130232391|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130232392|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
130232393|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
130232394|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
130232395|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130232396|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130232397|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
130232398|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
130232399|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
130232400|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
130232401|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130232402|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130232403|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130232404|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
130232405|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130232406|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130232407|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
130232408|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
130232409|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
130232410|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
130232411|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130232412|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130232413|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
130232414|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
130232415|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
130232416|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
130232417|NCT02934178|468817754|FG000|Received Vaccination 2|Death|0|||
130232418|NCT02934178|468817755|FG001|Received Vaccination 2|Death|1|||
130232419|NCT02934178|468817754|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
130232420|NCT02934178|468817755|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
130232421|NCT01898078|468817759|FG000|Overall Study|Progressive Disease|1|||
130356764|NCT05098938|469276404|FG001|Overall Study|V2 visit was not completed within window|1|||
130356765|NCT05098938|469276403|FG000|Overall Study|exclusionary medication use|1|||
130356766|NCT05098938|469276404|FG001|Overall Study|exclusionary medication use|2|||
130356767|NCT05098938|469276403|FG000|Overall Study|change in medication|1|||
130356768|NCT05098938|469276404|FG001|Overall Study|change in medication|0|||
130356769|NCT05098938|469276403|FG000|Overall Study|treatment failure|2|||
130356770|NCT05098938|469276404|FG001|Overall Study|treatment failure|1|||
130356771|NCT01828320|469276405|FG000|Overall Study|Lost to Follow-up|1|||
130693662|NCT01380782|470505807|FG000|Overall Study|Lack of Efficacy|10|||
130693663|NCT01380782|470505808|FG001|Overall Study|Lack of Efficacy|9|||
130693664|NCT01380782|470505809|FG002|Overall Study|Lack of Efficacy|10|||
130693665|NCT01380782|470505810|FG003|Overall Study|Lack of Efficacy|3|||
130693666|NCT01380782|470505807|FG000|Overall Study|Physician Decision|1|||
130693667|NCT01380782|470505808|FG001|Overall Study|Physician Decision|0|||
130693668|NCT01380782|470505809|FG002|Overall Study|Physician Decision|0|||
130232422|NCT01898078|468817760|FG001|Overall Study|Progressive Disease|5|||
130232423|NCT01898078|468817759|FG000|Overall Study|Adverse Event|2|||
130232424|NCT01898078|468817760|FG001|Overall Study|Adverse Event|1|||
130232425|NCT01898078|468817759|FG000|Overall Study|Withdrawal by Subject|1|||
130232426|NCT01898078|468817760|FG001|Overall Study|Withdrawal by Subject|1|||
130232427|NCT01898078|468817759|FG000|Overall Study|Symptomatic Deterioration|2|||
130232428|NCT01898078|468817760|FG001|Overall Study|Symptomatic Deterioration|0|||
130356772|NCT01828320|469276406|FG001|Overall Study|Lost to Follow-up|3|||
130356773|NCT01828320|469276405|FG000|Overall Study|Withdrawal by Subject|7|||
130693669|NCT01380782|470505810|FG003|Overall Study|Physician Decision|0|||
130693670|NCT01380782|470505807|FG000|Overall Study|Withdrawal by Subject|0|||
130693671|NCT01380782|470505808|FG001|Overall Study|Withdrawal by Subject|0|||
130693672|NCT01380782|470505809|FG002|Overall Study|Withdrawal by Subject|1|||
130693673|NCT01380782|470505810|FG003|Overall Study|Withdrawal by Subject|1|||
130232429|NCT01898078|468817759|FG000|Overall Study|Reason not Specified|0|||
130232430|NCT01898078|468817760|FG001|Overall Study|Reason not Specified|1|||
130232431|NCT01075048|468817761|FG000|Overall Study|Death|4|||
130232432|NCT01075048|468817762|FG001|Overall Study|Death|17|||
130232433|NCT01075048|468817763|FG002|Overall Study|Death|12|||
130232434|NCT01075048|468817761|FG000|Overall Study|Start of other or new therapy|4|||
130232435|NCT01075048|468817762|FG001|Overall Study|Start of other or new therapy|36|||
130232436|NCT01075048|468817763|FG002|Overall Study|Start of other or new therapy|46|||
130232437|NCT01075048|468817761|FG000|Overall Study|Withdrawal by Subject|1|||
130232438|NCT01075048|468817762|FG001|Overall Study|Withdrawal by Subject|6|||
130232439|NCT01075048|468817763|FG002|Overall Study|Withdrawal by Subject|3|||
130232440|NCT01075048|468817761|FG000|Overall Study|Lost to Follow-up|0|||
130232441|NCT01075048|468817762|FG001|Overall Study|Lost to Follow-up|1|||
130232442|NCT01075048|468817763|FG002|Overall Study|Lost to Follow-up|1|||
130232443|NCT01287936|468817764|FG000|Overall Study|Lost to Follow-up|0|||
130232444|NCT01287936|468817765|FG001|Overall Study|Lost to Follow-up|1|||
130232445|NCT01287936|468817766|FG002|Overall Study|Lost to Follow-up|1|||
130232446|NCT01140906|468817767|FG000|Overall Study|Adverse Event|7|||
130232447|NCT01140906|468817768|FG001|Overall Study|Adverse Event|10|||
130232448|NCT01140906|468817769|FG002|Overall Study|Adverse Event|17|||
130232449|NCT01140906|468817770|FG003|Overall Study|Adverse Event|7|||
130232450|NCT01140906|468817767|FG000|Overall Study|Lack of Efficacy|6|||
130232451|NCT01140906|468817768|FG001|Overall Study|Lack of Efficacy|8|||
130232452|NCT01140906|468817769|FG002|Overall Study|Lack of Efficacy|2|||
130232453|NCT01140906|468817770|FG003|Overall Study|Lack of Efficacy|1|||
130232454|NCT01140906|468817767|FG000|Overall Study|Non-compliance|0|||
130232455|NCT01140906|468817768|FG001|Overall Study|Non-compliance|1|||
130232456|NCT01140906|468817769|FG002|Overall Study|Non-compliance|0|||
130232457|NCT01140906|468817770|FG003|Overall Study|Non-compliance|1|||
130232458|NCT01140906|468817767|FG000|Overall Study|Protocol Violation|5|||
130232459|NCT01140906|468817768|FG001|Overall Study|Protocol Violation|3|||
130232460|NCT01140906|468817769|FG002|Overall Study|Protocol Violation|2|||
130232461|NCT01140906|468817770|FG003|Overall Study|Protocol Violation|1|||
130232462|NCT01140906|468817767|FG000|Overall Study|Withdrawal of consent|6|||
130232463|NCT01140906|468817768|FG001|Overall Study|Withdrawal of consent|6|||
130232464|NCT01140906|468817769|FG002|Overall Study|Withdrawal of consent|2|||
130232465|NCT01140906|468817770|FG003|Overall Study|Withdrawal of consent|2|||
130232466|NCT01140906|468817767|FG000|Overall Study|Lost to Follow-up|1|||
130232467|NCT01140906|468817768|FG001|Overall Study|Lost to Follow-up|1|||
130232468|NCT01140906|468817769|FG002|Overall Study|Lost to Follow-up|0|||
130232469|NCT01140906|468817770|FG003|Overall Study|Lost to Follow-up|2|||
130232470|NCT01140906|468817767|FG000|Overall Study|Administrative or other reason|0|||
130232471|NCT01140906|468817768|FG001|Overall Study|Administrative or other reason|5|||
130232472|NCT01140906|468817769|FG002|Overall Study|Administrative or other reason|3|||
130232473|NCT01140906|468817770|FG003|Overall Study|Administrative or other reason|2|||
130232474|NCT00703534|468817771|FG000|Overall Study|Adverse Event|14|||
130232475|NCT00703534|468817772|FG001|Overall Study|Adverse Event|3|||
130232476|NCT00703534|468817771|FG000|Overall Study|Withdrawal by Subject|8|||
130232477|NCT00703534|468817772|FG001|Overall Study|Withdrawal by Subject|7|||
130232478|NCT00703534|468817771|FG000|Overall Study|Incorrect Enrollment|6|||
130356774|NCT01828320|469276406|FG001|Overall Study|Withdrawal by Subject|2|||
130356775|NCT00426231|469277298|FG000|Overall Study|Withdrawal by Subject|9|||
130356776|NCT00426231|469277299|FG001|Overall Study|Withdrawal by Subject|12|||
130356777|NCT01795638|469277300|FG000|Overall Study|Death|0|||
130356778|NCT01795638|469277301|FG001|Overall Study|Death|3|||
130232479|NCT00703534|468817772|FG001|Overall Study|Incorrect Enrollment|6|||
130232480|NCT00703534|468817771|FG000|Overall Study|Lost to Follow-up|1|||
130356779|NCT01795638|469277300|FG000|Overall Study|transferred to quaternary hospital|2|||
130356780|NCT01795638|469277301|FG001|Overall Study|transferred to quaternary hospital|3|||
130552898|NCT03291587|469991622|FG000|Overall Study|Not interested in participating|8|||
130232481|NCT00703534|468817772|FG001|Overall Study|Lost to Follow-up|4|||
130232482|NCT00703534|468817771|FG000|Overall Study|Severe Non Compliance|1|||
130232483|NCT00703534|468817772|FG001|Overall Study|Severe Non Compliance|5|||
130232484|NCT01316614|468817773|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
130232485|NCT01316614|468817773|FG000|Overall Study|Cytology slides not available for review|4|||
130693674|NCT02554877|470505813|FG000|Overall Study|Adverse Event|2|||
130232486|NCT01316614|468817773|FG000|Overall Study|Cystic lesion|5|||
130232487|NCT01316614|468817773|FG000|Overall Study|Inadequate number of passes|2|||
130232488|NCT01316614|468817773|FG000|Overall Study|Medically unstable|1|||
130232489|NCT03427411|468817774|FG000|Overall Study|Screen failure - platelets too low|0|||
130693675|NCT02554877|470505814|FG001|Overall Study|Adverse Event|0|||
130693676|NCT02554877|470505815|FG002|Overall Study|Adverse Event|0|||
130693677|NCT02554877|470505816|FG003|Overall Study|Adverse Event|1|||
130693678|NCT02554877|470505813|FG000|Overall Study|Lost to Follow-up|1|||
130693679|NCT02554877|470505814|FG001|Overall Study|Lost to Follow-up|1|||
130693680|NCT02554877|470505815|FG002|Overall Study|Lost to Follow-up|1|||
130693681|NCT02554877|470505816|FG003|Overall Study|Lost to Follow-up|2|||
130232490|NCT03427411|468817775|FG001|Overall Study|Screen failure - platelets too low|1|||
130232491|NCT00076570|468817776|FG000|Overall Study|Drug intolerance|8|||
130232492|NCT00076570|468817777|FG001|Overall Study|Drug intolerance|8|||
130232493|NCT04889040|468817778|FG000|Overall Study|Withdrawal by Subject|3|||
130232494|NCT04889040|468817779|FG001|Overall Study|Withdrawal by Subject|3|||
130232495|NCT04889040|468817778|FG000|Overall Study|Lost to Follow-up|0|||
130232496|NCT04889040|468817779|FG001|Overall Study|Lost to Follow-up|1|||
130232497|NCT04889040|468817778|FG000|Overall Study|Adverse Event|2|||
130232498|NCT04889040|468817779|FG001|Overall Study|Adverse Event|1|||
130232499|NCT02058095|468817780|FG000|Overall Study|Adverse Event|1|||
130232500|NCT02058095|468817781|FG001|Overall Study|Adverse Event|0|||
130232501|NCT00998946|468817782|FG000|Overall Study|Lost to Follow-up|1|||
130232502|NCT00998946|468817782|FG000|Overall Study|Withdrawal by Subject|1|||
130232503|NCT00998946|468817782|FG000|Overall Study|Death|2|||
130232504|NCT00998946|468817782|FG000|Overall Study|Reason Unspecified|3|||
130232505|NCT00998946|468817782|FG000|Overall Study|Enrolled but not Dosed|2|||
130232506|NCT00977197|468817785|FG000|Overall Study|Withdrawal by Subject|3|||
130232507|NCT00977197|468817786|FG001|Overall Study|Withdrawal by Subject|4|||
130232508|NCT00977197|468817785|FG000|Overall Study|Adverse Event|3|||
130232509|NCT00977197|468817786|FG001|Overall Study|Adverse Event|1|||
130232510|NCT00977197|468817785|FG000|Overall Study|Lack of Efficacy|1|||
130232511|NCT00977197|468817786|FG001|Overall Study|Lack of Efficacy|0|||
130232512|NCT00977197|468817785|FG000|Overall Study|Lost to Follow-up|1|||
130232513|NCT00977197|468817786|FG001|Overall Study|Lost to Follow-up|3|||
130232514|NCT00977197|468817785|FG000|Overall Study|Nonadherence|1|||
130232515|NCT00977197|468817786|FG001|Overall Study|Nonadherence|1|||
130232516|NCT01432951|468817787|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
130232517|NCT00853385|468817788|FG000|Overall Study|Death|0|||
130232518|NCT00853385|468817789|FG001|Overall Study|Death|0|||
130232519|NCT00853385|468817790|FG002|Overall Study|Death|0|||
130232520|NCT00853385|468817791|FG003|Overall Study|Death|0|||
130232521|NCT00853385|468817792|FG004|Overall Study|Death|1|||
130232522|NCT00853385|468817788|FG000|Overall Study|Adverse Event|24|||
130232523|NCT00853385|468817789|FG001|Overall Study|Adverse Event|24|||
130232524|NCT00853385|468817790|FG002|Overall Study|Adverse Event|2|||
130232525|NCT00853385|468817791|FG003|Overall Study|Adverse Event|5|||
130232526|NCT00853385|468817792|FG004|Overall Study|Adverse Event|22|||
130232527|NCT00853385|468817788|FG000|Overall Study|Lack of Efficacy|6|||
130232528|NCT00853385|468817789|FG001|Overall Study|Lack of Efficacy|7|||
130232529|NCT00853385|468817790|FG002|Overall Study|Lack of Efficacy|3|||
130232530|NCT00853385|468817791|FG003|Overall Study|Lack of Efficacy|3|||
130232531|NCT00853385|468817792|FG004|Overall Study|Lack of Efficacy|6|||
130232532|NCT00853385|468817788|FG000|Overall Study|Lost to Follow-up|2|||
130232533|NCT00853385|468817789|FG001|Overall Study|Lost to Follow-up|1|||
130232534|NCT00853385|468817790|FG002|Overall Study|Lost to Follow-up|0|||
130232535|NCT00853385|468817791|FG003|Overall Study|Lost to Follow-up|0|||
130232536|NCT00853385|468817792|FG004|Overall Study|Lost to Follow-up|0|||
130232537|NCT00853385|468817788|FG000|Overall Study|Withdrawal by Subject|4|||
130232538|NCT00853385|468817789|FG001|Overall Study|Withdrawal by Subject|2|||
130232539|NCT00853385|468817790|FG002|Overall Study|Withdrawal by Subject|0|||
130232540|NCT00853385|468817791|FG003|Overall Study|Withdrawal by Subject|1|||
130232541|NCT00853385|468817792|FG004|Overall Study|Withdrawal by Subject|1|||
130232542|NCT00853385|468817788|FG000|Overall Study|Other|18|||
130232543|NCT00853385|468817789|FG001|Overall Study|Other|9|||
130232544|NCT00853385|468817790|FG002|Overall Study|Other|4|||
130232545|NCT00853385|468817791|FG003|Overall Study|Other|4|||
130232546|NCT00853385|468817792|FG004|Overall Study|Other|12|||
130232547|NCT02842866|468817795|FG000|Overall Study|Serious Adverse Event|0|||
130232548|NCT02842866|468817796|FG001|Overall Study|Serious Adverse Event|1|||
130232549|NCT02842866|468817795|FG000|Overall Study|Protocol Violation|4|||
130232550|NCT02842866|468817796|FG001|Overall Study|Protocol Violation|2|||
130232551|NCT02842866|468817795|FG000|Overall Study|Lost to Follow-up|2|||
130232552|NCT02842866|468817796|FG001|Overall Study|Lost to Follow-up|0|||
130232553|NCT02842866|468817795|FG000|Overall Study|Withdrawal by Subject|1|||
130232554|NCT02842866|468817796|FG001|Overall Study|Withdrawal by Subject|0|||
130232555|NCT00577408|468817797|FG000|Overall Study|Stopped attending study visits|9|||
130232556|NCT00577408|468817798|FG001|Overall Study|Stopped attending study visits|11|||
130232557|NCT00577408|468817797|FG000|Overall Study|Continued opioid use|3|||
130232558|NCT00577408|468817798|FG001|Overall Study|Continued opioid use|2|||
130232559|NCT00577408|468817797|FG000|Overall Study|Non-compliance with study meds|0|||
130232560|NCT00577408|468817798|FG001|Overall Study|Non-compliance with study meds|3|||
130232561|NCT00577408|468817797|FG000|Overall Study|Refused Oral Naltrexone|0|||
130232562|NCT00577408|468817798|FG001|Overall Study|Refused Oral Naltrexone|1|||
130232563|NCT00577408|468817797|FG000|Overall Study|Moved out of state|0|||
130232564|NCT00577408|468817798|FG001|Overall Study|Moved out of state|1|||
130232565|NCT00577408|468817797|FG000|Overall Study|Scheduling Issues|0|||
130232566|NCT00577408|468817798|FG001|Overall Study|Scheduling Issues|3|||
130232567|NCT00577408|468817797|FG000|Overall Study|Death|0|||
130232568|NCT00577408|468817798|FG001|Overall Study|Death|1|||
130232569|NCT00577408|468817797|FG000|Overall Study|Psychiatric hospitalization|0|||
130232570|NCT00577408|468817798|FG001|Overall Study|Psychiatric hospitalization|1|||
130232571|NCT00656617|468817799|FG000|Overall Study|Adverse Event|1|||
130232572|NCT00656617|468817799|FG000|Overall Study|Death|2|||
130232573|NCT00656617|468817799|FG000|Overall Study|Insurance Issues|2|||
130232574|NCT00656617|468817799|FG000|Overall Study|Move to different clinical trial|2|||
130232575|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
130232576|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
130232577|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
130232578|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
130232579|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130232580|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130232581|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
130232582|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
130232583|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232584|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232585|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
130232586|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232587|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232588|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232589|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
130232590|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232591|NCT02349386|468817808|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130232592|NCT02349386|468817809|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130232593|NCT02349386|468817810|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130232594|NCT02349386|468817811|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130232595|NCT02349386|468817808|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232596|NCT02349386|468817809|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232597|NCT02349386|468817810|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
130232598|NCT02349386|468817811|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232599|NCT00676143|468817812|FG000|Overall Study|Adverse Event|34|||
130232600|NCT00676143|468817813|FG001|Overall Study|Adverse Event|60|||
130232601|NCT00676143|468817812|FG000|Overall Study|Death|4|||
130232602|NCT00676143|468817813|FG001|Overall Study|Death|4|||
130232603|NCT00676143|468817812|FG000|Overall Study|Lack of Efficacy|0|||
130232604|NCT00676143|468817813|FG001|Overall Study|Lack of Efficacy|6|||
130232605|NCT00676143|468817812|FG000|Overall Study|Lost to Follow-up|0|||
130232606|NCT00676143|468817813|FG001|Overall Study|Lost to Follow-up|13|||
130232607|NCT00676143|468817812|FG000|Overall Study|Physician Decision|5|||
130232608|NCT00676143|468817813|FG001|Overall Study|Physician Decision|8|||
130232609|NCT00676143|468817812|FG000|Overall Study|Protocol Violation|4|||
130232610|NCT00676143|468817813|FG001|Overall Study|Protocol Violation|8|||
130232611|NCT00676143|468817812|FG000|Overall Study|Withdrawal by Subject|24|||
130232612|NCT00676143|468817813|FG001|Overall Study|Withdrawal by Subject|42|||
130232613|NCT00676143|468817812|FG000|Overall Study|Discontinuation of study by sponsor|65|||
130232614|NCT00676143|468817813|FG001|Overall Study|Discontinuation of study by sponsor|88|||
130232615|NCT00676143|468817812|FG000|Overall Study|Failed to return|2|||
130232616|NCT00676143|468817813|FG001|Overall Study|Failed to return|1|||
130232617|NCT00676143|468817812|FG000|Overall Study|Loss of caregiver|5|||
130232618|NCT00676143|468817813|FG001|Overall Study|Loss of caregiver|3|||
130232619|NCT00676143|468817812|FG000|Overall Study|Other|11|||
130232620|NCT00676143|468817813|FG001|Overall Study|Other|20|||
130232621|NCT00676143|468817812|FG000|Overall Study|Participant participation unknown|1|||
130232622|NCT00676143|468817813|FG001|Overall Study|Participant participation unknown|4|||
130232623|NCT00676143|468817812|FG000|Overall Study|Vasogenic edema recurrence|1|||
130232624|NCT00676143|468817813|FG001|Overall Study|Vasogenic edema recurrence|3|||
130232625|NCT01901185|468817814|FG000|Overall Study|Withdrawal by Subject|2|||
130232626|NCT00701363|468817817|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
130232627|NCT00701363|468817818|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130356781|NCT01795638|469277300|FG000|Overall Study|Protocol Violation|3|||
130356782|NCT01795638|469277301|FG001|Overall Study|Protocol Violation|0|||
130356783|NCT01795638|469277300|FG000|Overall Study|discharged from hospital|7|||
130356784|NCT01795638|469277301|FG001|Overall Study|discharged from hospital|5|||
130356785|NCT01795638|469277300|FG000|Overall Study|Withdrawal by Subject|1|||
130356786|NCT01795638|469277301|FG001|Overall Study|Withdrawal by Subject|0|||
130356787|NCT00293215|469277302|FG000|Overall Study|Progressive disease|3|||
130356788|NCT00293215|469277303|FG001|Overall Study|Progressive disease|1|||
130356789|NCT00293215|469277302|FG000|Overall Study|Adverse Event|2|||
130356790|NCT00293215|469277303|FG001|Overall Study|Adverse Event|2|||
130232628|NCT00701363|468817819|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130232629|NCT00701363|468817820|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130232630|NCT00701363|468817817|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
130693682|NCT02554877|470505813|FG000|Overall Study|Did not meet entrance criteria|0|||
130693683|NCT02554877|470505814|FG001|Overall Study|Did not meet entrance criteria|0|||
130693684|NCT02554877|470505815|FG002|Overall Study|Did not meet entrance criteria|1|||
130232631|NCT00701363|468817818|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
130232632|NCT00701363|468817819|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
130232633|NCT00701363|468817820|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
130232634|NCT00701363|468817817|FG000|Treatment Phase 1|Adverse Event|7|||
130232635|NCT00701363|468817818|FG001|Treatment Phase 1|Adverse Event|0|||
130232636|NCT00701363|468817819|FG002|Treatment Phase 1|Adverse Event|0|||
130232637|NCT00701363|468817820|FG003|Treatment Phase 1|Adverse Event|0|||
130232638|NCT00701363|468817817|FG000|Treatment Phase 1|Protocol Violation|1|||
130232639|NCT00701363|468817818|FG001|Treatment Phase 1|Protocol Violation|0|||
130232640|NCT00701363|468817819|FG002|Treatment Phase 1|Protocol Violation|0|||
130232641|NCT00701363|468817820|FG003|Treatment Phase 1|Protocol Violation|0|||
130232642|NCT00701363|468817817|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
130232643|NCT00701363|468817818|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130232644|NCT00701363|468817819|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
130232645|NCT00701363|468817820|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
130232646|NCT00701363|468817817|FG000|Treatment Phase 1|Lack of Efficacy|1|||
130232647|NCT00701363|468817818|FG001|Treatment Phase 1|Lack of Efficacy|0|||
130232648|NCT00701363|468817819|FG002|Treatment Phase 1|Lack of Efficacy|0|||
130232649|NCT00701363|468817820|FG003|Treatment Phase 1|Lack of Efficacy|0|||
130232650|NCT00701363|468817817|FG000|Treatment Phase 2|Adverse Event|0|||
130232651|NCT00701363|468817818|FG001|Treatment Phase 2|Adverse Event|0|||
130232652|NCT00701363|468817819|FG002|Treatment Phase 2|Adverse Event|1|||
130232653|NCT00701363|468817820|FG003|Treatment Phase 2|Adverse Event|0|||
130232654|NCT00701363|468817817|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
130232655|NCT00701363|468817818|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
130232656|NCT00701363|468817819|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
130445347|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
130445348|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
130445349|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
130356791|NCT01229371|469277304|FG000|Overall Study|Withdrawal by Subject|0|||
130356792|NCT01229371|469277305|FG001|Overall Study|Withdrawal by Subject|1|||
130356793|NCT01229371|469277306|FG002|Overall Study|Withdrawal by Subject|0|||
130356794|NCT01229371|469277307|FG003|Overall Study|Withdrawal by Subject|0|||
130356795|NCT01859143|469277308|FG000|Overall Study|Lost to Follow-up|2|||
130356796|NCT01859143|469277309|FG001|Overall Study|Lost to Follow-up|0|||
130356797|NCT01031381|469277311|FG000|Overall Study|Physician Decision|3|||
130356798|NCT01031381|469277311|FG000|Overall Study|Withdrawal by Subject|6|||
130356799|NCT00122109|469277313|FG000|Overall Study|Did not meet criteria|6|||
130356800|NCT00122109|469277314|FG001|Overall Study|Did not meet criteria|7|||
130356801|NCT00267189|469277319|FG000|Overall Study|Patient withdrew consent|1|||
130356802|NCT00267189|469277320|FG001|Overall Study|Patient withdrew consent|1|||
130356803|NCT00267189|469277319|FG000|Overall Study|Death|1|||
130356804|NCT00267189|469277320|FG001|Overall Study|Death|0|||
130356805|NCT00267189|469277319|FG000|Overall Study|Missing|3|||
130356806|NCT00267189|469277320|FG001|Overall Study|Missing|0|||
130356807|NCT01578330|469277325|FG000|Overall Study|Adverse Event|2|||
130356808|NCT01578330|469277325|FG000|Overall Study|Protocol Violation|5|||
130356809|NCT03114488|469277328|FG000|Time Period 2|Withdrawal by Subject|1|||
130356810|NCT03114488|469277329|FG001|Time Period 2|Withdrawal by Subject|3|||
130356811|NCT01225887|469277330|FG000|Overall Study|Ineligible:required test not done|2|||
130356812|NCT01225887|469277330|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
130356813|NCT01225887|469277330|FG000|Overall Study|Ineligible:inadequate pathology|2|||
130356814|NCT01669928|469277331|FG000|First Intervention|Withdrawal by Subject|3|||
130356815|NCT01669928|469277332|FG001|First Intervention|Withdrawal by Subject|5|||
130356816|NCT00925990|469277333|FG000|Overall Study|Adverse Event|1|||
130356817|NCT00925990|469277334|FG001|Overall Study|Adverse Event|3|||
130356818|NCT00925990|469277333|FG000|Overall Study|Withdrawal by Subject|2|||
130356819|NCT00925990|469277334|FG001|Overall Study|Withdrawal by Subject|2|||
130356820|NCT00925990|469277333|FG000|Overall Study|Lost to Follow-up|1|||
130445350|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
130356821|NCT00925990|469277334|FG001|Overall Study|Lost to Follow-up|3|||
130232657|NCT00701363|468817820|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
130232658|NCT04759131|468817821|FG000|Overall Study|Investigator's discretion|1|||
130232659|NCT04759131|468817822|FG001|Overall Study|Investigator's discretion|0|||
130356822|NCT00925990|469277333|FG000|Overall Study|Physician Decision|1|||
130356823|NCT00925990|469277334|FG001|Overall Study|Physician Decision|1|||
130356824|NCT00925990|469277333|FG000|Overall Study|moved out of state, missed medication|0|||
130356825|NCT00925990|469277334|FG001|Overall Study|moved out of state, missed medication|2|||
130356826|NCT00737438|469277337|FG000|Overall Study|Withdrawal by Subject|2|||
130693685|NCT02554877|470505816|FG003|Overall Study|Did not meet entrance criteria|0|||
130356827|NCT00737438|469277337|FG000|Overall Study|Patient ineligible|1|||
130356828|NCT04950166|469277344|FG000|Overall Study|Withdrawal by Subject|1|||
130356829|NCT00857415|469277347|FG000|Overall Study|Image acquisition failure|2|||
130232660|NCT04759131|468817821|FG000|Overall Study|Subject withdrawal|1|||
130232661|NCT04759131|468817822|FG001|Overall Study|Subject withdrawal|0|||
130232662|NCT03692949|468817823|FG000|Overall Study|Lost to Follow-up|0|||
130232663|NCT03692949|468817824|FG001|Overall Study|Lost to Follow-up|0|||
130232664|NCT03692949|468817825|FG002|Overall Study|Lost to Follow-up|0|||
130232665|NCT03692949|468817826|FG003|Overall Study|Lost to Follow-up|0|||
130232666|NCT03692949|468817827|FG004|Overall Study|Lost to Follow-up|0|||
130232667|NCT03692949|468817828|FG005|Overall Study|Lost to Follow-up|0|||
130232668|NCT03692949|468817829|FG006|Overall Study|Lost to Follow-up|0|||
130232669|NCT03692949|468817830|FG007|Overall Study|Lost to Follow-up|1|||
130232670|NCT02592824|468817838|FG000|Overall Study|Protocol Violation|5|||
130232671|NCT02592824|468817839|FG001|Overall Study|Protocol Violation|3|||
130232672|NCT02592824|468817838|FG000|Overall Study|Lost to Follow-up|2|||
130232673|NCT02592824|468817839|FG001|Overall Study|Lost to Follow-up|1|||
130232674|NCT03426878|468817840|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
130232675|NCT03426878|468817840|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
130232676|NCT03426878|468817840|FG000|Overall Study|Declined to receive results|3|||
130232677|NCT03426878|468817840|FG000|Overall Study|Received negative results by mailed letter|65|||
130232678|NCT03426878|468817840|FG000|Overall Study|Lost to Follow-up|177|||
130232679|NCT01286129|468817841|FG000|Overall Study|Withdrawal by Subject|4|||
130232680|NCT01286129|468817842|FG001|Overall Study|Withdrawal by Subject|1|||
130232681|NCT01286129|468817841|FG000|Overall Study|Could not comply with study requirements|4|||
130232682|NCT01286129|468817842|FG001|Overall Study|Could not comply with study requirements|4|||
130232683|NCT05233761|468817847|FG000|Treatment Period A|Withdrawal by Subject|12|||
130232684|NCT05233761|468817848|FG001|Treatment Period A|Withdrawal by Subject|10|||
130232685|NCT05233761|468817847|FG000|Treatment Period A|Lost to Follow-up|6|||
130232686|NCT05233761|468817848|FG001|Treatment Period A|Lost to Follow-up|12|||
130232687|NCT05233761|468817847|FG000|Treatment Period A|Protocol Violation|8|||
130232688|NCT05233761|468817848|FG001|Treatment Period A|Protocol Violation|15|||
130232689|NCT01604785|468817849|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
130232690|NCT01604785|468817850|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
130232691|NCT00869960|468817851|FG000|Overall Study|Lost to Follow-up|2|||
130232692|NCT01654276|468817861|FG000|Overall Study|Lack of Efficacy|1|||
130232693|NCT01654276|468817861|FG000|Overall Study|Lost to Follow-up|4|||
130232694|NCT01654276|468817861|FG000|Overall Study|Withdrawal by Subject|1|||
130232695|NCT01991795|468817862|FG000|Overall Study|Lost to Follow-up|6|||
130232696|NCT01991795|468817863|FG001|Overall Study|Lost to Follow-up|4|||
130232697|NCT01991795|468817862|FG000|Overall Study|Withdrawal by Subject|117|||
130232698|NCT01991795|468817863|FG001|Overall Study|Withdrawal by Subject|94|||
130232699|NCT01991795|468817862|FG000|Overall Study|Site prematurely closed by sponsor|26|||
130232700|NCT01991795|468817863|FG001|Overall Study|Site prematurely closed by sponsor|25|||
130232701|NCT03344757|468817864|FG000|Overall Study|Withdrawal by Subject|18|||
130232702|NCT03344757|468817865|FG001|Overall Study|Withdrawal by Subject|16|||
130232703|NCT03344757|468817864|FG000|Overall Study|Lost to Follow-up|0|||
130445351|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
130445352|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
130232704|NCT03344757|468817865|FG001|Overall Study|Lost to Follow-up|2|||
130232705|NCT04798027|468817871|FG000|Overall Study|Protocol Violation|0|||
130232706|NCT04798027|468817872|FG001|Overall Study|Protocol Violation|0|||
130232707|NCT04798027|468817873|FG002|Overall Study|Protocol Violation|0|||
130232708|NCT04798027|468817874|FG003|Overall Study|Protocol Violation|0|||
130232709|NCT04798027|468817875|FG004|Overall Study|Protocol Violation|1|||
130232710|NCT04798027|468817876|FG005|Overall Study|Protocol Violation|0|||
130232711|NCT04798027|468817877|FG006|Overall Study|Protocol Violation|0|||
130232712|NCT04798027|468817878|FG007|Overall Study|Protocol Violation|1|||
130232713|NCT04798027|468817879|FG008|Overall Study|Protocol Violation|0|||
130232714|NCT04798027|468817871|FG000|Overall Study|Withdrawal by Subject|1|||
130232715|NCT04798027|468817872|FG001|Overall Study|Withdrawal by Subject|0|||
130232716|NCT04798027|468817873|FG002|Overall Study|Withdrawal by Subject|1|||
130232717|NCT04798027|468817874|FG003|Overall Study|Withdrawal by Subject|1|||
130693686|NCT02554877|470505813|FG000|Overall Study|No longer met eligibility criteria|1|||
130693687|NCT02554877|470505814|FG001|Overall Study|No longer met eligibility criteria|0|||
130693688|NCT02554877|470505815|FG002|Overall Study|No longer met eligibility criteria|1|||
130693689|NCT02554877|470505816|FG003|Overall Study|No longer met eligibility criteria|1|||
130232718|NCT04798027|468817875|FG004|Overall Study|Withdrawal by Subject|1|||
130232719|NCT04798027|468817876|FG005|Overall Study|Withdrawal by Subject|1|||
130232720|NCT04798027|468817877|FG006|Overall Study|Withdrawal by Subject|3|||
130232721|NCT04798027|468817878|FG007|Overall Study|Withdrawal by Subject|2|||
130232722|NCT04798027|468817879|FG008|Overall Study|Withdrawal by Subject|2|||
130693690|NCT02554877|470505813|FG000|Overall Study|Protocol Violation|3|||
130232723|NCT04798027|468817871|FG000|Overall Study|Lost to Follow-up|1|||
130232724|NCT04798027|468817872|FG001|Overall Study|Lost to Follow-up|3|||
130232725|NCT04798027|468817873|FG002|Overall Study|Lost to Follow-up|0|||
130232726|NCT04798027|468817874|FG003|Overall Study|Lost to Follow-up|0|||
130232727|NCT04798027|468817875|FG004|Overall Study|Lost to Follow-up|0|||
130445353|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
130693691|NCT02554877|470505814|FG001|Overall Study|Protocol Violation|1|||
130693692|NCT02554877|470505815|FG002|Overall Study|Protocol Violation|1|||
130693693|NCT02554877|470505816|FG003|Overall Study|Protocol Violation|0|||
130693694|NCT02554877|470505813|FG000|Overall Study|Other|1|||
130693695|NCT02554877|470505814|FG001|Overall Study|Other|3|||
130693696|NCT02554877|470505815|FG002|Overall Study|Other|0|||
130693697|NCT02554877|470505816|FG003|Overall Study|Other|3|||
130693698|NCT02554877|470505813|FG000|Overall Study|Insufficient clinical response|4|||
130232728|NCT04798027|468817876|FG005|Overall Study|Lost to Follow-up|1|||
130232729|NCT04798027|468817877|FG006|Overall Study|Lost to Follow-up|0|||
130232730|NCT04798027|468817878|FG007|Overall Study|Lost to Follow-up|0|||
130232731|NCT04798027|468817879|FG008|Overall Study|Lost to Follow-up|1|||
130232732|NCT04798027|468817871|FG000|Overall Study|Withdrawal by Sponsor|8|||
130232733|NCT04798027|468817872|FG001|Overall Study|Withdrawal by Sponsor|22|||
130232734|NCT04798027|468817873|FG002|Overall Study|Withdrawal by Sponsor|9|||
130232735|NCT04798027|468817874|FG003|Overall Study|Withdrawal by Sponsor|26|||
130232736|NCT04798027|468817875|FG004|Overall Study|Withdrawal by Sponsor|24|||
130232737|NCT04798027|468817876|FG005|Overall Study|Withdrawal by Sponsor|11|||
130232738|NCT04798027|468817877|FG006|Overall Study|Withdrawal by Sponsor|25|||
130232739|NCT04798027|468817878|FG007|Overall Study|Withdrawal by Sponsor|26|||
130232740|NCT04798027|468817879|FG008|Overall Study|Withdrawal by Sponsor|11|||
130232741|NCT03104374|468817880|FG000|Period 1|Adverse Event|7|||
130232742|NCT03104374|468817881|FG001|Period 1|Adverse Event|7|||
130232743|NCT03104374|468817882|FG002|Period 1|Adverse Event|12|||
130232744|NCT03104374|468817883|FG003|Period 1|Adverse Event|14|||
130232745|NCT03104374|468817880|FG000|Period 1|Withdrawal by Subject|18|||
130232746|NCT03104374|468817881|FG001|Period 1|Withdrawal by Subject|9|||
130232747|NCT03104374|468817882|FG002|Period 1|Withdrawal by Subject|10|||
130232748|NCT03104374|468817883|FG003|Period 1|Withdrawal by Subject|17|||
130232749|NCT03104374|468817880|FG000|Period 1|Lost to Follow-up|4|||
130232750|NCT03104374|468817881|FG001|Period 1|Lost to Follow-up|4|||
130232751|NCT03104374|468817882|FG002|Period 1|Lost to Follow-up|6|||
130232752|NCT03104374|468817883|FG003|Period 1|Lost to Follow-up|8|||
130232753|NCT03104374|468817880|FG000|Period 1|Lack of Efficacy|6|||
130232754|NCT03104374|468817881|FG001|Period 1|Lack of Efficacy|7|||
130232755|NCT03104374|468817882|FG002|Period 1|Lack of Efficacy|12|||
130232756|NCT03104374|468817883|FG003|Period 1|Lack of Efficacy|6|||
130232757|NCT03104374|468817880|FG000|Period 1|Other|2|||
130232758|NCT03104374|468817881|FG001|Period 1|Other|2|||
130232759|NCT03104374|468817882|FG002|Period 1|Other|4|||
130232760|NCT03104374|468817883|FG003|Period 1|Other|7|||
130232761|NCT03104374|468817880|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232762|NCT03104374|468817881|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232763|NCT03104374|468817882|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232764|NCT03104374|468817883|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
130232765|NCT03104374|468817880|FG000|Period 2|Adverse Event|4|||
130232766|NCT03104374|468817881|FG001|Period 2|Adverse Event|7|||
130232767|NCT03104374|468817882|FG002|Period 2|Adverse Event|10|||
130232768|NCT03104374|468817883|FG003|Period 2|Adverse Event|10|||
130232769|NCT03104374|468817880|FG000|Period 2|Withdrawal by Subject|3|||
130232770|NCT03104374|468817881|FG001|Period 2|Withdrawal by Subject|7|||
130232771|NCT03104374|468817882|FG002|Period 2|Withdrawal by Subject|13|||
130232772|NCT03104374|468817883|FG003|Period 2|Withdrawal by Subject|16|||
130232773|NCT03104374|468817880|FG000|Period 2|Lost to Follow-up|2|||
130232774|NCT03104374|468817881|FG001|Period 2|Lost to Follow-up|2|||
130232775|NCT03104374|468817882|FG002|Period 2|Lost to Follow-up|3|||
130232776|NCT03104374|468817883|FG003|Period 2|Lost to Follow-up|5|||
130232777|NCT03104374|468817880|FG000|Period 2|Lack of Efficacy|2|||
130445354|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
130445355|NCT01473420|469591962|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
130232778|NCT03104374|468817881|FG001|Period 2|Lack of Efficacy|4|||
130232779|NCT03104374|468817882|FG002|Period 2|Lack of Efficacy|7|||
130232780|NCT03104374|468817883|FG003|Period 2|Lack of Efficacy|4|||
130232781|NCT03104374|468817880|FG000|Period 2|COVID-19 Infection|0|||
130232782|NCT03104374|468817881|FG001|Period 2|COVID-19 Infection|0|||
130232783|NCT03104374|468817882|FG002|Period 2|COVID-19 Infection|1|||
130232784|NCT03104374|468817883|FG003|Period 2|COVID-19 Infection|0|||
130232785|NCT03104374|468817880|FG000|Period 2|Other|3|||
130232786|NCT03104374|468817881|FG001|Period 2|Other|2|||
130693699|NCT02554877|470505814|FG001|Overall Study|Insufficient clinical response|0|||
130232787|NCT03104374|468817882|FG002|Period 2|Other|2|||
130232788|NCT03104374|468817883|FG003|Period 2|Other|4|||
130232789|NCT02121210|468817886|FG000|Overall Study|Adverse Event|5|||
130232790|NCT02121210|468817887|FG001|Overall Study|Adverse Event|7|||
130693700|NCT02554877|470505815|FG002|Overall Study|Insufficient clinical response|0|||
130232791|NCT02121210|468817886|FG000|Overall Study|Lack of Efficacy|2|||
130232792|NCT02121210|468817887|FG001|Overall Study|Lack of Efficacy|0|||
130693701|NCT02554877|470505816|FG003|Overall Study|Insufficient clinical response|0|||
130693702|NCT02554877|470505813|FG000|Overall Study|No longer willing to participate|0|||
130693703|NCT02554877|470505814|FG001|Overall Study|No longer willing to participate|2|||
130693704|NCT02554877|470505815|FG002|Overall Study|No longer willing to participate|2|||
130693705|NCT02554877|470505816|FG003|Overall Study|No longer willing to participate|0|||
130693706|NCT04474405|470505817|FG000|Overall Study|Withdrawal by Subject|0|||
130232793|NCT02121210|468817886|FG000|Overall Study|Other than specified above|0|||
130232794|NCT02121210|468817887|FG001|Overall Study|Other than specified above|2|||
130232795|NCT04609514|468817888|FG000|Overall Study|Lost to Follow-up|5|||
130232796|NCT04609514|468817889|FG001|Overall Study|Lost to Follow-up|4|||
130232797|NCT04609514|468817888|FG000|Overall Study|Withdrawal by PI|0|||
130232798|NCT04609514|468817889|FG001|Overall Study|Withdrawal by PI|2|||
130232799|NCT00909870|468817890|FG000|Overall Study|Adverse Event|13|||
130232800|NCT00909870|468817891|FG001|Overall Study|Adverse Event|7|||
130232801|NCT00909870|468817890|FG000|Overall Study|Protocol Violation|1|||
130232802|NCT00909870|468817891|FG001|Overall Study|Protocol Violation|2|||
130232803|NCT00909870|468817890|FG000|Overall Study|Withdrawal by Subject|5|||
130232804|NCT00909870|468817891|FG001|Overall Study|Withdrawal by Subject|8|||
130232805|NCT00909870|468817890|FG000|Overall Study|Lost to Follow-up|3|||
130232806|NCT00909870|468817891|FG001|Overall Study|Lost to Follow-up|3|||
130232807|NCT00909870|468817890|FG000|Overall Study|Physician Decision|0|||
130232808|NCT00909870|468817891|FG001|Overall Study|Physician Decision|2|||
130232809|NCT00909870|468817890|FG000|Overall Study|Other|1|||
130232810|NCT00909870|468817891|FG001|Overall Study|Other|5|||
130232811|NCT01316575|468817892|FG000|Overall Study|Withdrawal by Subject|2|||
130693707|NCT04474405|470505818|FG001|Overall Study|Withdrawal by Subject|0|||
130693708|NCT04474405|470505819|FG002|Overall Study|Withdrawal by Subject|1|||
130693709|NCT04474405|470505820|FG003|Overall Study|Withdrawal by Subject|0|||
130693710|NCT04474405|470505821|FG004|Overall Study|Withdrawal by Subject|1|||
130693711|NCT04474405|470505822|FG005|Overall Study|Withdrawal by Subject|0|||
130693712|NCT04474405|470505817|FG000|Overall Study|Other|0|||
130693713|NCT04474405|470505818|FG001|Overall Study|Other|0|||
130693714|NCT04474405|470505819|FG002|Overall Study|Other|0|||
130693715|NCT04474405|470505820|FG003|Overall Study|Other|0|||
130693716|NCT04474405|470505821|FG004|Overall Study|Other|3|||
130232812|NCT01316575|468817893|FG001|Overall Study|Withdrawal by Subject|0|||
130693717|NCT04474405|470505822|FG005|Overall Study|Other|0|||
130232813|NCT01316575|468817892|FG000|Overall Study|Required alternate treatment|0|||
130232814|NCT01316575|468817893|FG001|Overall Study|Required alternate treatment|1|||
130232815|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
130232816|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
130232817|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130356830|NCT00857415|469277348|FG001|Overall Study|Image acquisition failure|0|||
130356831|NCT00857415|469277347|FG000|Overall Study|Invalid image or not imaged|3|||
130356832|NCT00857415|469277348|FG001|Overall Study|Invalid image or not imaged|0|||
130356833|NCT00857415|469277347|FG000|Overall Study|Subject still living at end of study|110|||
130356834|NCT00857415|469277348|FG001|Overall Study|Subject still living at end of study|0|||
130693718|NCT00274651|470505823|FG000|Overall Study|Adverse Event|6|||
130693719|NCT00274651|470505824|FG001|Overall Study|Adverse Event|3|||
130693720|NCT00274651|470505823|FG000|Overall Study|Lack of Efficacy|13|||
130693721|NCT00274651|470505824|FG001|Overall Study|Lack of Efficacy|6|||
130693722|NCT00274651|470505823|FG000|Overall Study|Death|1|||
130693723|NCT00274651|470505824|FG001|Overall Study|Death|3|||
130693724|NCT00274651|470505823|FG000|Overall Study|Withdrawal by Subject|0|||
130693725|NCT00274651|470505824|FG001|Overall Study|Withdrawal by Subject|1|||
130693726|NCT00274651|470505823|FG000|Overall Study|Physician Decision|8|||
130693727|NCT00274651|470505824|FG001|Overall Study|Physician Decision|7|||
130693728|NCT02157974|470505825|FG000|Overall Study|Withdrawal by Subject|0|||
130693729|NCT02157974|470505826|FG001|Overall Study|Withdrawal by Subject|1|||
130693730|NCT02157974|470505827|FG002|Overall Study|Withdrawal by Subject|0|||
130693731|NCT02157974|470505828|FG003|Overall Study|Withdrawal by Subject|0|||
130693732|NCT02157974|470505829|FG004|Overall Study|Withdrawal by Subject|0|||
130693733|NCT02157974|470505825|FG000|Overall Study|Screen Failure|0|||
130232818|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232819|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232820|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232821|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130356835|NCT00857415|469277347|FG000|Overall Study|Deceased with no autopsy|2|||
130356836|NCT00857415|469277348|FG001|Overall Study|Deceased with no autopsy|0|||
130232822|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130356837|NCT00764504|469277351|FG000|Overall Study|Death|12|||
130445356|NCT01473420|469591963|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
130693734|NCT02157974|470505826|FG001|Overall Study|Screen Failure|1|||
130693735|NCT02157974|470505827|FG002|Overall Study|Screen Failure|0|||
130232823|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232824|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232825|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
130232826|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
130232827|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232828|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232829|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232830|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232831|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232832|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232833|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232834|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232835|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
130232836|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130693736|NCT02157974|470505828|FG003|Overall Study|Screen Failure|0|||
130693737|NCT02157974|470505829|FG004|Overall Study|Screen Failure|0|||
130232837|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232838|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232839|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232840|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130356838|NCT00764504|469277352|FG001|Overall Study|Death|6|||
130356839|NCT00764504|469277353|FG002|Overall Study|Death|13|||
130356840|NCT00764504|469277351|FG000|Overall Study|Revision of Device|12|||
130356841|NCT00764504|469277352|FG001|Overall Study|Revision of Device|23|||
130356842|NCT00764504|469277353|FG002|Overall Study|Revision of Device|14|||
130356843|NCT00764504|469277351|FG000|Overall Study|Physician Decision|1|||
130356844|NCT00764504|469277352|FG001|Overall Study|Physician Decision|0|||
130356845|NCT00764504|469277353|FG002|Overall Study|Physician Decision|0|||
130356846|NCT00764504|469277351|FG000|Overall Study|Withdrawal by Subject|1|||
130356847|NCT00764504|469277352|FG001|Overall Study|Withdrawal by Subject|7|||
130356848|NCT00764504|469277353|FG002|Overall Study|Withdrawal by Subject|4|||
130356849|NCT00764504|469277351|FG000|Overall Study|Lost to Follow-up|40|||
130356850|NCT00764504|469277352|FG001|Overall Study|Lost to Follow-up|34|||
130356851|NCT00764504|469277353|FG002|Overall Study|Lost to Follow-up|72|||
130356852|NCT01638819|469277364|FG000|Overall Study|Lost to Follow-up|1|||
130356853|NCT01638819|469277365|FG001|Overall Study|Lost to Follow-up|0|||
130356854|NCT03538431|469277366|FG000|Overall Study|Physician Decision|0|||
130356855|NCT03538431|469277367|FG001|Overall Study|Physician Decision|1|||
130356856|NCT03538431|469277366|FG000|Overall Study|Withdrawal by Subject|1|||
130356857|NCT03538431|469277367|FG001|Overall Study|Withdrawal by Subject|0|||
130356858|NCT03911154|469277368|FG000|Overall Study|Withdrawal by Subject|1|||
130356859|NCT01278160|469277372|FG000|Overall Study|Adverse Event|1|||
130356860|NCT01278160|469277373|FG001|Overall Study|Adverse Event|1|||
130356861|NCT01278160|469277372|FG000|Overall Study|Lost to Follow-up|0|||
130356862|NCT01278160|469277373|FG001|Overall Study|Lost to Follow-up|1|||
130356863|NCT01278160|469277372|FG000|Overall Study|Withdrawal by Subject|3|||
130356864|NCT01278160|469277373|FG001|Overall Study|Withdrawal by Subject|2|||
130356865|NCT01278160|469277372|FG000|Overall Study|Unclassified|1|||
130356866|NCT01278160|469277373|FG001|Overall Study|Unclassified|2|||
130356867|NCT02898116|469277381|FG000|Overall Study|Adverse Event|1|||
130356868|NCT02898116|469277381|FG000|Overall Study|Progressive disease|1|||
130356869|NCT02891161|469277384|FG000|Study Treatment|Disease Progression|2|||
130356870|NCT02891161|469277385|FG001|Study Treatment|Disease Progression|4|||
130356871|NCT02891161|469277384|FG000|Study Treatment|AE/Side Effects/Complications|1|||
130356872|NCT02891161|469277385|FG001|Study Treatment|AE/Side Effects/Complications|5|||
130356873|NCT02891161|469277384|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
130356874|NCT02891161|469277385|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
130356875|NCT02891161|469277384|FG000|Follow up|Death|4|||
130356876|NCT02891161|469277385|FG001|Follow up|Death|8|||
130356877|NCT02891161|469277384|FG000|Follow up|Refused to Follow up|0|||
130356878|NCT02891161|469277385|FG001|Follow up|Refused to Follow up|2|||
130356879|NCT02891161|469277384|FG000|Follow up|Symptomatic deterioration|0|||
130356880|NCT02891161|469277385|FG001|Follow up|Symptomatic deterioration|1|||
130356881|NCT02891161|469277384|FG000|Follow up|Study terminated|0|||
130356882|NCT02891161|469277385|FG001|Follow up|Study terminated|6|||
130693738|NCT02157974|470505825|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130356883|NCT04755283|469277386|FG000|Overall Study|Withdrawal by Subject|14|||
130356884|NCT04755283|469277387|FG001|Overall Study|Withdrawal by Subject|3|||
130356885|NCT04755283|469277388|FG002|Overall Study|Withdrawal by Subject|6|||
130356886|NCT04755283|469277386|FG000|Overall Study|Lost to Follow-up|0|||
130356887|NCT04755283|469277387|FG001|Overall Study|Lost to Follow-up|0|||
130356888|NCT04755283|469277388|FG002|Overall Study|Lost to Follow-up|1|||
130356889|NCT04755283|469277386|FG000|Overall Study|Death|31|||
130356890|NCT04755283|469277387|FG001|Overall Study|Death|36|||
130232841|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232842|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232843|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232844|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232845|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
130232846|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
130232847|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232848|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232849|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232850|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232851|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232852|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130356891|NCT04755283|469277388|FG002|Overall Study|Death|34|||
130693739|NCT02157974|470505826|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
130693740|NCT02157974|470505827|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693741|NCT02157974|470505828|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693742|NCT02157974|470505829|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693743|NCT01410227|470505830|FG000|Overall Study|Adverse Event|1|||
130693744|NCT01410227|470505831|FG001|Overall Study|Adverse Event|0|||
130693745|NCT01410227|470505832|FG002|Overall Study|Adverse Event|0|||
130693746|NCT01410227|470505833|FG003|Overall Study|Adverse Event|0|||
130693747|NCT01410227|470505830|FG000|Overall Study|Withdrawal by Subject|3|||
130693748|NCT01410227|470505831|FG001|Overall Study|Withdrawal by Subject|0|||
130693749|NCT01410227|470505832|FG002|Overall Study|Withdrawal by Subject|1|||
130693750|NCT01410227|470505833|FG003|Overall Study|Withdrawal by Subject|0|||
130693751|NCT01410227|470505830|FG000|Overall Study|Pregnancy|0|||
130693752|NCT01410227|470505831|FG001|Overall Study|Pregnancy|0|||
130693753|NCT01410227|470505832|FG002|Overall Study|Pregnancy|0|||
130693754|NCT01410227|470505833|FG003|Overall Study|Pregnancy|1|||
130693755|NCT01410227|470505830|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693756|NCT01410227|470505831|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693757|NCT01410227|470505832|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
130693758|NCT01410227|470505833|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693759|NCT01484912|470505834|FG000|Overall Study|Withdrawal by Subject|1|||
130693760|NCT01484912|470505835|FG001|Overall Study|Withdrawal by Subject|0|||
130693761|NCT01484912|470505834|FG000|Overall Study|Physician Decision|0|||
130693762|NCT01484912|470505835|FG001|Overall Study|Physician Decision|1|||
130693763|NCT03158727|470505836|FG000|Overall Study|Withdrawal by Subject|2|||
130693764|NCT03158727|470505837|FG001|Overall Study|Withdrawal by Subject|6|||
130693765|NCT03158727|470505836|FG000|Overall Study|Death|11|||
130693766|NCT03158727|470505837|FG001|Overall Study|Death|12|||
130693767|NCT03158727|470505836|FG000|Overall Study|Lost to Follow-up|1|||
130693768|NCT03158727|470505837|FG001|Overall Study|Lost to Follow-up|0|||
130693769|NCT03158727|470505836|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
130693770|NCT03158727|470505837|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
130693771|NCT03158727|470505836|FG000|Overall Study|Visit 11 not done by mistake|0|||
130693772|NCT03158727|470505837|FG001|Overall Study|Visit 11 not done by mistake|1|||
130693773|NCT03158727|470505836|FG000|Overall Study|Enrolled, not treated|1|||
130693774|NCT03158727|470505837|FG001|Overall Study|Enrolled, not treated|0|||
130693775|NCT00985439|470505838|FG000|Overall Study|Adverse Event|0|||
130693776|NCT00985439|470505839|FG001|Overall Study|Adverse Event|0|||
130693777|NCT00985439|470505840|FG002|Overall Study|Adverse Event|1|||
130356892|NCT05597020|469277396|FG000|Washout|Forbidden medication|2|||
130356893|NCT05597020|469277397|FG001|Washout|Forbidden medication|0|||
130356894|NCT05597020|469277396|FG000|Treatment Period II|Advice from primary care physician|1|||
130356895|NCT05597020|469277397|FG001|Treatment Period II|Advice from primary care physician|0|||
130356896|NCT05597020|469277396|FG000|Treatment Period II|Subject lost investigational product|1|||
130356897|NCT05597020|469277397|FG001|Treatment Period II|Subject lost investigational product|0|||
130356898|NCT05597020|469277396|FG000|Treatment Period II|Private reasons|0|||
130356899|NCT05597020|469277397|FG001|Treatment Period II|Private reasons|1|||
130356900|NCT02445391|469277408|FG000|Overall Study|No active protocol treatment|3|||
130356901|NCT02445391|469277409|FG001|Overall Study|No active protocol treatment|0|||
130356902|NCT02445391|469277410|FG002|Overall Study|No active protocol treatment|0|||
130356903|NCT02445391|469277408|FG000|Overall Study|Adverse Event|0|||
130356904|NCT02445391|469277409|FG001|Overall Study|Adverse Event|21|||
130356905|NCT02445391|469277410|FG002|Overall Study|Adverse Event|12|||
130356906|NCT02445391|469277408|FG000|Overall Study|Alternative therapy|0|||
130693778|NCT00985439|470505841|FG003|Overall Study|Adverse Event|0|||
130693779|NCT02462837|470505843|FG000|Overall Study|pt developed hives|1|||
130693780|NCT02462837|470505844|FG001|Overall Study|pt developed hives|0|||
130693781|NCT02462837|470505843|FG000|Overall Study|Withdrawal by Subject|1|||
130232853|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232854|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232855|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130232856|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130232857|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232858|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232859|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232860|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232861|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232862|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130693782|NCT02462837|470505844|FG001|Overall Study|Withdrawal by Subject|0|||
130693783|NCT05562011|470505852|FG000|Overall Study|Withdrawal by Subject|3|||
130693784|NCT05562011|470505852|FG000|Overall Study|Lost to Follow-up|1|||
130693785|NCT05562011|470505852|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
130693786|NCT05562011|470505852|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
130693787|NCT05562011|470505852|FG000|Overall Study|Device malfunction|13|||
130693788|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Refused|1|||
130693789|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Refused|3|||
130693790|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Medical|0|||
130693791|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Medical|1|||
130693792|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
130693793|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
130232863|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232864|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232865|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
130232866|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
130232867|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232868|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130356907|NCT02445391|469277409|FG001|Overall Study|Alternative therapy|0|||
130356908|NCT02445391|469277410|FG002|Overall Study|Alternative therapy|1|||
130356909|NCT02445391|469277408|FG000|Overall Study|Disease progression|0|||
130356910|NCT02445391|469277409|FG001|Overall Study|Disease progression|7|||
130356911|NCT02445391|469277410|FG002|Overall Study|Disease progression|22|||
130356912|NCT02445391|469277408|FG000|Overall Study|Complicating disease|0|||
130356913|NCT02445391|469277409|FG001|Overall Study|Complicating disease|2|||
130356914|NCT02445391|469277410|FG002|Overall Study|Complicating disease|1|||
130356915|NCT02445391|469277408|FG000|Overall Study|Withdrawal by Subject|0|||
130356916|NCT02445391|469277409|FG001|Overall Study|Withdrawal by Subject|4|||
130356917|NCT02445391|469277410|FG002|Overall Study|Withdrawal by Subject|9|||
130356918|NCT02445391|469277408|FG000|Overall Study|Financial issue|0|||
130356919|NCT02445391|469277409|FG001|Overall Study|Financial issue|0|||
130356920|NCT02445391|469277410|FG002|Overall Study|Financial issue|2|||
130356921|NCT02445391|469277408|FG000|Overall Study|Still on treatment|0|||
130356922|NCT02445391|469277409|FG001|Overall Study|Still on treatment|7|||
130356923|NCT02445391|469277410|FG002|Overall Study|Still on treatment|16|||
130356924|NCT02445391|469277408|FG000|Overall Study|Not start protocol therapy|0|||
130356925|NCT02445391|469277409|FG001|Overall Study|Not start protocol therapy|12|||
130356926|NCT02445391|469277410|FG002|Overall Study|Not start protocol therapy|9|||
130356927|NCT00560885|469277411|FG000|Overall Study|Death|7|||
130356928|NCT00560885|469277411|FG000|Overall Study|Withdrawal by Subject|1|||
130356929|NCT03803683|469277415|FG000|Overall Study|Lost to Follow-up|41|||
130356930|NCT03803683|469277416|FG001|Overall Study|Lost to Follow-up|18|||
130356931|NCT03803683|469277417|FG002|Overall Study|Lost to Follow-up|12|||
130356932|NCT03803683|469277415|FG000|Overall Study|Withdrawal by Subject|9|||
130356933|NCT03803683|469277416|FG001|Overall Study|Withdrawal by Subject|1|||
130356934|NCT03803683|469277417|FG002|Overall Study|Withdrawal by Subject|4|||
130356935|NCT00492050|469277418|FG000|Overall Study|Adverse Event|1|||
130356936|NCT00492050|469277418|FG000|Overall Study|Lack of Efficacy|1|||
130356937|NCT00492050|469277418|FG000|Overall Study|Withdrawal by Subject|3|||
130356938|NCT00492050|469277418|FG000|Overall Study|Unable to collect SCT|2|||
130356939|NCT00492050|469277418|FG000|Overall Study|Progressive Disease|2|||
130356940|NCT00518687|469279202|FG000|Overall Study|Adverse Event|201|||
130356941|NCT00518687|469279203|FG001|Overall Study|Adverse Event|177|||
130356942|NCT00518687|469279202|FG000|Overall Study|Lost to Follow-up|144|||
130356943|NCT00518687|469279203|FG001|Overall Study|Lost to Follow-up|155|||
130356944|NCT00518687|469279202|FG000|Overall Study|Physician Decision|42|||
130356945|NCT00518687|469279203|FG001|Overall Study|Physician Decision|48|||
130356946|NCT00518687|469279202|FG000|Overall Study|Progressive disease|2|||
130356947|NCT00518687|469279203|FG001|Overall Study|Progressive disease|2|||
130356948|NCT00518687|469279202|FG000|Overall Study|Protocol Violation|8|||
130356949|NCT00518687|469279203|FG001|Overall Study|Protocol Violation|10|||
130356950|NCT00518687|469279202|FG000|Overall Study|Study terminated by sponsor|930|||
130693794|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
130693795|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
130693796|NCT02054715|470505853|FG000|Baseline/Follow-up 1|No Reason|0|||
130693797|NCT02054715|470505854|FG001|Baseline/Follow-up 1|No Reason|1|||
130693798|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
130693799|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
130693800|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Ineligible|3|||
130693801|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Ineligible|0|||
130693802|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Hospitalization|1|||
130693803|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Hospitalization|0|||
130693804|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Changed Mind|1|||
130693805|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Changed Mind|0|||
130693806|NCT02054715|470505853|FG000|Follow-up 2|Lost to Followup|3|||
130693807|NCT02054715|470505854|FG001|Follow-up 2|Lost to Followup|1|||
130693808|NCT02054715|470505853|FG000|Follow-up 2|Refused|3|||
130693809|NCT02054715|470505854|FG001|Follow-up 2|Refused|2|||
130693810|NCT02054715|470505853|FG000|Follow-up 2|Followup Not Completed|3|||
130693811|NCT02054715|470505854|FG001|Follow-up 2|Followup Not Completed|4|||
130693812|NCT02054715|470505853|FG000|Follow-up 2|Ineligible|4|||
130693813|NCT02054715|470505854|FG001|Follow-up 2|Ineligible|5|||
130693814|NCT02054715|470505853|FG000|Follow-up 2|Death|3|||
130693815|NCT02054715|470505854|FG001|Follow-up 2|Death|3|||
130693816|NCT02054715|470505853|FG000|Follow-up 2|Hospitalization|0|||
130693817|NCT02054715|470505854|FG001|Follow-up 2|Hospitalization|2|||
130693818|NCT02054715|470505853|FG000|Follow-up 2|Changed MD/Facility|0|||
130693819|NCT02054715|470505854|FG001|Follow-up 2|Changed MD/Facility|1|||
130693820|NCT02054715|470505853|FG000|Follow-up 2|Changed Mind|0|||
130693821|NCT02054715|470505854|FG001|Follow-up 2|Changed Mind|1|||
130693822|NCT02054715|470505853|FG000|Follow-up 2|No Reason|2|||
130693823|NCT02054715|470505854|FG001|Follow-up 2|No Reason|0|||
130693824|NCT02054715|470505853|FG000|Follow-up 2|Treatment Change or Delay|1|||
130693825|NCT02054715|470505854|FG001|Follow-up 2|Treatment Change or Delay|0|||
130693826|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
130693827|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
130693828|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
130693829|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
130693830|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
130693831|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
130693832|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
130693833|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
130693834|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
130693835|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130693836|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130693837|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
130693838|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
130693839|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
130693840|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
130693841|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
130693842|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130693843|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130693844|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130693845|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
130693846|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130693847|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
130232869|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232870|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232871|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232872|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232873|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232874|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232875|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
130232876|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
130232877|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232878|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130356951|NCT00518687|469279203|FG001|Overall Study|Study terminated by sponsor|918|||
130693848|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
130693849|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
130693850|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130693851|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
130693852|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130693853|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
130693854|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
130232879|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232880|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232881|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232882|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232883|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232884|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232885|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232886|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232887|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
130232888|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
130232889|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232890|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232891|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130356952|NCT00518687|469279202|FG000|Overall Study|Withdrawal by Subject|110|||
130356953|NCT00518687|469279203|FG001|Overall Study|Withdrawal by Subject|110|||
130356954|NCT05108922|469279204|FG000|Overall Study|Adverse Event|2|||
130356955|NCT05108922|469279205|FG001|Overall Study|Adverse Event|3|||
130356956|NCT05108922|469279204|FG000|Overall Study|Lost to Follow-up|2|||
130356957|NCT05108922|469279205|FG001|Overall Study|Lost to Follow-up|1|||
130356958|NCT05108922|469279204|FG000|Overall Study|Inadvertent enrollment|0|||
130356959|NCT05108922|469279205|FG001|Overall Study|Inadvertent enrollment|1|||
130356960|NCT05108922|469279204|FG000|Overall Study|Physician Decision|2|||
130356961|NCT05108922|469279205|FG001|Overall Study|Physician Decision|3|||
130356962|NCT05108922|469279204|FG000|Overall Study|Protocol deviation|1|||
130356963|NCT05108922|469279205|FG001|Overall Study|Protocol deviation|0|||
130356964|NCT05108922|469279204|FG000|Overall Study|Screen failure|1|||
130356965|NCT05108922|469279205|FG001|Overall Study|Screen failure|0|||
130356966|NCT05108922|469279204|FG000|Overall Study|Withdrawal by Subject|11|||
130356967|NCT05108922|469279205|FG001|Overall Study|Withdrawal by Subject|8|||
130356968|NCT02095223|469279206|FG000|Overall Study|Withdrawal by Subject|1|||
130356969|NCT02095223|469279207|FG001|Overall Study|Withdrawal by Subject|0|||
130356970|NCT02339285|469279208|FG000|Overall Study|Withdrawal by Subject|0|||
130356971|NCT02339285|469279209|FG001|Overall Study|Withdrawal by Subject|1|||
130356972|NCT02339285|469279210|FG002|Overall Study|Withdrawal by Subject|1|||
130356973|NCT02339285|469279208|FG000|Overall Study|Lost to Follow-up|1|||
130356974|NCT02339285|469279209|FG001|Overall Study|Lost to Follow-up|1|||
130356975|NCT02339285|469279210|FG002|Overall Study|Lost to Follow-up|1|||
130356976|NCT02339285|469279208|FG000|Overall Study|Protocol Deviation|0|||
130356977|NCT02339285|469279209|FG001|Overall Study|Protocol Deviation|1|||
130356978|NCT02339285|469279210|FG002|Overall Study|Protocol Deviation|0|||
130356979|NCT00282412|469279211|FG000|Overall Study|Death|2|||
130356980|NCT01507298|469279212|FG000|Overall Study|Protocol Violation|0|||
130356981|NCT01507298|469279213|FG001|Overall Study|Protocol Violation|6|||
130356982|NCT00537238|469279214|FG000|Overall Study|Death|1|||
130356983|NCT00537238|469279215|FG001|Overall Study|Death|2|||
130356984|NCT00537238|469279214|FG000|Overall Study|Adverse Event|31|||
130356985|NCT00537238|469279215|FG001|Overall Study|Adverse Event|22|||
130356986|NCT00537238|469279214|FG000|Overall Study|Lack of Efficacy|20|||
130356987|NCT00537238|469279215|FG001|Overall Study|Lack of Efficacy|21|||
130356988|NCT00537238|469279214|FG000|Overall Study|Lost to Follow-up|12|||
130356989|NCT00537238|469279215|FG001|Overall Study|Lost to Follow-up|8|||
130356990|NCT00537238|469279214|FG000|Overall Study|Withdrawal by Subject|51|||
130356991|NCT00537238|469279215|FG001|Overall Study|Withdrawal by Subject|47|||
130356992|NCT00537238|469279214|FG000|Overall Study|Protocol Violation|15|||
130356993|NCT00537238|469279215|FG001|Overall Study|Protocol Violation|19|||
130356994|NCT00537238|469279214|FG000|Overall Study|Does not meet entrance criteria|0|||
130356995|NCT00537238|469279215|FG001|Overall Study|Does not meet entrance criteria|2|||
130356996|NCT00537238|469279214|FG000|Overall Study|Other|44|||
130356997|NCT00537238|469279215|FG001|Overall Study|Other|52|||
130356998|NCT02437513|469279218|FG000|Overall Study|Withdrawal by Subject|2|||
130356999|NCT00422097|469279219|FG000|Dose Level 2|Still on treatment|0|||
130357000|NCT00422097|469279220|FG001|Dose Level 2|Still on treatment|1|||
130357001|NCT00422097|469279221|FG002|Dose Level 2|Still on treatment|0|||
130552899|NCT03291587|469991623|FG001|Overall Study|Not interested in participating|6|||
130357002|NCT00422097|469279222|FG003|Dose Level 2|Still on treatment|0|||
130357003|NCT00422097|469279223|FG004|Dose Level 2|Still on treatment|0|||
130357004|NCT00422097|469279224|FG005|Dose Level 2|Still on treatment|0|||
130357005|NCT00422097|469279225|FG006|Dose Level 2|Still on treatment|0|||
130232892|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130357006|NCT00422097|469279226|FG007|Dose Level 2|Still on treatment|0|||
130357007|NCT00736957|469279227|FG000|Overall Study|Adverse Event|43|||
130357008|NCT00736957|469279227|FG000|Overall Study|Withdrawal by Subject|49|||
130357009|NCT00736957|469279227|FG000|Overall Study|violation of eligibility criteria|2|||
130357010|NCT00736957|469279227|FG000|Overall Study|did not attend hospital appointments|1|||
130693855|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
130693856|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130693857|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
130693858|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130693859|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
130693860|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
130693861|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
130693862|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
130693863|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
130693864|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
130693865|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130693866|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
130693867|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130693868|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130693869|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
130693870|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130232893|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232894|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232895|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232896|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130693871|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130693872|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130693873|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
130693874|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
130693875|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
130693876|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
130693877|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
130693878|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
130693879|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
130693880|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
130693881|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
130693882|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
130693883|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
130693884|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
130693885|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
130693886|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
130693887|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
130693888|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
130693889|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
130693890|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
130693891|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
130693892|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
130693893|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
130693894|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
130693895|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
130693896|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
130693897|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130693898|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130693899|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
130693900|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
130693901|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
130693902|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
130693903|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
130693904|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
130693905|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
130693906|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
130693907|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
130693908|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
130693909|NCT01438060|470505865|FG000|On Study Beyond Week 140|Adverse Event|0|||
130693910|NCT01438060|470505866|FG001|On Study Beyond Week 140|Adverse Event|2|||
130232897|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
130693911|NCT01438060|470505865|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
130693912|NCT01438060|470505866|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
130693913|NCT01438060|470505865|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
130232898|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
130232899|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232900|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232901|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232902|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232903|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130357011|NCT00736957|469279227|FG000|Overall Study|not eligible for Treatment Period I|22|||
130357012|NCT00736957|469279227|FG000|Overall Study|Physician Decision|5|||
130693914|NCT01438060|470505866|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
130693915|NCT01438060|470505865|FG000|On Study Beyond Week 140|Death|0|||
130693916|NCT01438060|470505866|FG001|On Study Beyond Week 140|Death|1|||
130693917|NCT01438060|470505865|FG000|On Study Beyond Week 140|Other Reason|0|||
130693918|NCT01438060|470505866|FG001|On Study Beyond Week 140|Other Reason|3|||
130693919|NCT01442376|470505867|FG000|Overall Study|Adverse Event|0|||
130693920|NCT01442376|470505868|FG001|Overall Study|Adverse Event|3|||
130693921|NCT01442376|470505869|FG002|Overall Study|Adverse Event|2|||
130693922|NCT01442376|470505867|FG000|Overall Study|Death|0|||
130693923|NCT01442376|470505868|FG001|Overall Study|Death|1|||
130693924|NCT01442376|470505869|FG002|Overall Study|Death|1|||
130693925|NCT01442376|470505867|FG000|Overall Study|Withdrawal of consent|0|||
130693926|NCT01442376|470505868|FG001|Overall Study|Withdrawal of consent|0|||
130693927|NCT01442376|470505869|FG002|Overall Study|Withdrawal of consent|1|||
130693928|NCT01442376|470505867|FG000|Overall Study|Patients not treated|2|||
130693929|NCT01442376|470505868|FG001|Overall Study|Patients not treated|3|||
130693930|NCT01442376|470505869|FG002|Overall Study|Patients not treated|1|||
130693931|NCT01442376|470505867|FG000|Overall Study|Not eligible for subsequent cycles|1|||
130693932|NCT01442376|470505868|FG001|Overall Study|Not eligible for subsequent cycles|2|||
130693933|NCT01442376|470505869|FG002|Overall Study|Not eligible for subsequent cycles|0|||
130693934|NCT03499873|470505870|FG000|Overall Study|Withdrawal by Subject|4|||
130693935|NCT03499873|470505871|FG001|Overall Study|Withdrawal by Subject|6|||
130693936|NCT03499873|470505872|FG002|Overall Study|Withdrawal by Subject|1|||
130693937|NCT03499873|470505870|FG000|Overall Study|Subjects condition worsened|0|||
130693938|NCT03499873|470505871|FG001|Overall Study|Subjects condition worsened|3|||
130357013|NCT00331864|469279228|FG000|Overall Study|Adverse Event|30|||
130357014|NCT00331864|469279229|FG001|Overall Study|Adverse Event|1|||
130357015|NCT00331864|469279228|FG000|Overall Study|Lack of Efficacy|4|||
130357016|NCT00331864|469279229|FG001|Overall Study|Lack of Efficacy|0|||
130357017|NCT00331864|469279228|FG000|Overall Study|Protocol Violation|3|||
130357018|NCT00331864|469279229|FG001|Overall Study|Protocol Violation|0|||
130357019|NCT00331864|469279228|FG000|Overall Study|Withdrawal by Subject|10|||
130357020|NCT00331864|469279229|FG001|Overall Study|Withdrawal by Subject|0|||
130357021|NCT00331864|469279228|FG000|Overall Study|Lost to Follow-up|4|||
130357022|NCT00331864|469279229|FG001|Overall Study|Lost to Follow-up|3|||
130357023|NCT00331864|469279228|FG000|Overall Study|Administrative Problems|1|||
130357024|NCT00331864|469279229|FG001|Overall Study|Administrative Problems|0|||
130357025|NCT00331864|469279228|FG000|Overall Study|Death|6|||
130357026|NCT00331864|469279229|FG001|Overall Study|Death|0|||
130357027|NCT01092507|469279230|FG000|Overall Study|Withdrawal by Subject|2|||
130357028|NCT01092507|469279231|FG001|Overall Study|Withdrawal by Subject|0|||
130357029|NCT05061966|469279242|FG000|Overall Study|Lost to Follow-up|13|||
130357030|NCT05061966|469279243|FG001|Overall Study|Lost to Follow-up|13|||
130357031|NCT02923427|469279250|FG000|Overall Study|convert to laparatomy|2|||
130357032|NCT02923427|469279251|FG001|Overall Study|convert to laparatomy|2|||
130357033|NCT02923427|469279250|FG000|Overall Study|destaturation|1|||
130357034|NCT02923427|469279251|FG001|Overall Study|destaturation|0|||
130357035|NCT02923427|469279250|FG000|Overall Study|can not replace LMA|1|||
130357036|NCT02923427|469279251|FG001|Overall Study|can not replace LMA|0|||
130357037|NCT01325623|469279252|FG000|Overall Study|Withdrawal by Subject|3|||
130357038|NCT00145600|469279253|FG000|Overall Study|Death|1|||
130357039|NCT00145600|469279254|FG001|Overall Study|Death|2|||
130445357|NCT04172987|469591964|FG000|Lead In Period|Adverse Event|1|||
130445358|NCT04172987|469591964|FG000|Lead In Period|Protocol Violation|1|||
130445359|NCT04172987|469591964|FG000|Period 1|Physician Decision|1|||
130693939|NCT03499873|470505872|FG002|Overall Study|Subjects condition worsened|11|||
130693940|NCT03499873|470505870|FG000|Overall Study|Adverse Event|8|||
130693941|NCT03499873|470505871|FG001|Overall Study|Adverse Event|3|||
130693942|NCT03499873|470505872|FG002|Overall Study|Adverse Event|6|||
130693943|NCT03499873|470505870|FG000|Overall Study|Physician Decision|1|||
130693944|NCT03499873|470505871|FG001|Overall Study|Physician Decision|0|||
130693945|NCT03499873|470505872|FG002|Overall Study|Physician Decision|0|||
130693946|NCT03499873|470505870|FG000|Overall Study|Administrative reasons|0|||
130693947|NCT03499873|470505871|FG001|Overall Study|Administrative reasons|1|||
130357040|NCT00145600|469279255|FG002|Overall Study|Death|2|||
130357041|NCT00145600|469279256|FG003|Overall Study|Death|6|||
130357042|NCT00145600|469279253|FG000|Overall Study|Ineligible|3|||
130357043|NCT00145600|469279254|FG001|Overall Study|Ineligible|0|||
130357044|NCT00145600|469279255|FG002|Overall Study|Ineligible|1|||
130357045|NCT00145600|469279256|FG003|Overall Study|Ineligible|5|||
130445360|NCT04172987|469591964|FG000|Period 2|Adverse Event|5|||
130445361|NCT04172987|469591964|FG000|Period 2|Dosing Termination by Sponsor|4|||
130445362|NCT00738530|469591974|FG000|Overall Study|Death|220|||
130445363|NCT00738530|469591975|FG001|Overall Study|Death|224|||
130445364|NCT00738530|469591974|FG000|Overall Study|Lost to Follow-up|8|||
130445365|NCT00738530|469591975|FG001|Overall Study|Lost to Follow-up|6|||
130445366|NCT00738530|469591974|FG000|Overall Study|Withdrawal by Subject|6|||
130445367|NCT00738530|469591975|FG001|Overall Study|Withdrawal by Subject|8|||
130445368|NCT01628510|469591976|FG000|Overall Study|Withdrawal by Subject|0|||
130445369|NCT01628510|469591977|FG001|Overall Study|Withdrawal by Subject|4|||
130445370|NCT01628510|469591976|FG000|Overall Study|Death|3|||
130445371|NCT01628510|469591977|FG001|Overall Study|Death|1|||
130445372|NCT04179461|469591978|FG000|Overall Study|Lost to Follow-up|4|||
130445373|NCT01653847|469591979|FG000|Overall Study|Withdrawal by Subject|1|||
130445374|NCT01653847|469591980|FG001|Overall Study|Withdrawal by Subject|0|||
130445375|NCT04707391|469591981|FG000|Overall Study|Adverse Event|5|||
130445376|NCT04707391|469591982|FG001|Overall Study|Adverse Event|8|||
130445377|NCT04707391|469591981|FG000|Overall Study|Lost to Follow-up|44|||
130445378|NCT04707391|469591982|FG001|Overall Study|Lost to Follow-up|31|||
130445379|NCT04707391|469591981|FG000|Overall Study|Protocol Violation|1|||
130445380|NCT04707391|469591982|FG001|Overall Study|Protocol Violation|5|||
130445381|NCT04707391|469591981|FG000|Overall Study|Withdrawal by Subject|27|||
130445382|NCT04707391|469591982|FG001|Overall Study|Withdrawal by Subject|25|||
130445383|NCT04707391|469591981|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
130445384|NCT04707391|469591982|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
130445385|NCT04707391|469591981|FG000|Overall Study|Other|0|||
130445386|NCT04707391|469591982|FG001|Overall Study|Other|2|||
130445387|NCT03246672|469591983|FG000|Overall Study|Lost to Follow-up|2|||
130445388|NCT01347645|469591984|FG000|Overall Study|Death|1|||
130445389|NCT01347645|469591985|FG001|Overall Study|Death|5|||
130445390|NCT01347645|469591986|FG002|Overall Study|Death|2|||
130445391|NCT01347645|469591987|FG003|Overall Study|Death|7|||
130445392|NCT01347645|469591988|FG004|Overall Study|Death|7|||
130445393|NCT01347645|469591984|FG000|Overall Study|Lost to Follow-up|1|||
130445394|NCT01347645|469591985|FG001|Overall Study|Lost to Follow-up|1|||
130445395|NCT01347645|469591986|FG002|Overall Study|Lost to Follow-up|0|||
130445396|NCT01347645|469591987|FG003|Overall Study|Lost to Follow-up|1|||
130445397|NCT01347645|469591988|FG004|Overall Study|Lost to Follow-up|1|||
130445398|NCT01347645|469591984|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
130445399|NCT01347645|469591985|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
130445400|NCT01347645|469591986|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
130445401|NCT01347645|469591987|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
130445402|NCT01347645|469591988|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
130357046|NCT00145600|469279253|FG000|Overall Study|Lost to Follow-up|2|||
130357047|NCT00145600|469279254|FG001|Overall Study|Lost to Follow-up|6|||
130357048|NCT00145600|469279255|FG002|Overall Study|Lost to Follow-up|2|||
130357049|NCT00145600|469279256|FG003|Overall Study|Lost to Follow-up|4|||
130357050|NCT00145600|469279253|FG000|Overall Study|Noncompliance|1|||
130357051|NCT00145600|469279254|FG001|Overall Study|Noncompliance|0|||
130357052|NCT00145600|469279255|FG002|Overall Study|Noncompliance|0|||
130357053|NCT00145600|469279256|FG003|Overall Study|Noncompliance|0|||
130357054|NCT00145600|469279253|FG000|Overall Study|Withdrawal by Subject|1|||
130357055|NCT00145600|469279254|FG001|Overall Study|Withdrawal by Subject|2|||
130357056|NCT00145600|469279255|FG002|Overall Study|Withdrawal by Subject|0|||
130357057|NCT00145600|469279256|FG003|Overall Study|Withdrawal by Subject|1|||
130357058|NCT01539642|469279258|FG000|Overall Study|Lack of Efficacy|20|||
130357059|NCT01539642|469279259|FG001|Overall Study|Lack of Efficacy|18|||
130357060|NCT01539642|469279258|FG000|Overall Study|Patient ready for early discharge|8|||
130357061|NCT01539642|469279259|FG001|Overall Study|Patient ready for early discharge|7|||
130357062|NCT01539642|469279258|FG000|Overall Study|Adverse Event|6|||
130357063|NCT01539642|469279259|FG001|Overall Study|Adverse Event|4|||
130357064|NCT01539642|469279258|FG000|Overall Study|Withdrawal by Subject|2|||
130445403|NCT01347645|469591984|FG000|Overall Study|Other|1|||
130445404|NCT01347645|469591985|FG001|Overall Study|Other|0|||
130445405|NCT01347645|469591986|FG002|Overall Study|Other|0|||
130445406|NCT01347645|469591987|FG003|Overall Study|Other|0|||
130445407|NCT01347645|469591988|FG004|Overall Study|Other|1|||
130445408|NCT01347645|469591984|FG000|Overall Study|Withdrawal by Subject|0|||
130445409|NCT01347645|469591985|FG001|Overall Study|Withdrawal by Subject|0|||
130445410|NCT01347645|469591986|FG002|Overall Study|Withdrawal by Subject|0|||
130445411|NCT01347645|469591987|FG003|Overall Study|Withdrawal by Subject|3|||
130445412|NCT01347645|469591988|FG004|Overall Study|Withdrawal by Subject|3|||
130445413|NCT01347645|469591984|FG000|Overall Study|Physician Decision|0|||
130357065|NCT01539642|469279259|FG001|Overall Study|Withdrawal by Subject|2|||
130357066|NCT00761579|469279260|FG000|Overall Study|Adverse Event|10|||
130445414|NCT01347645|469591985|FG001|Overall Study|Physician Decision|0|||
130232904|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232905|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232906|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232907|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
130357067|NCT00761579|469279260|FG000|Overall Study|Death|2|||
130357068|NCT00761579|469279260|FG000|Overall Study|Lack of Efficacy|21|||
130357069|NCT00761579|469279260|FG000|Overall Study|Lost to Follow-up|16|||
130357070|NCT00761579|469279260|FG000|Overall Study|Pregnancy|1|||
130357071|NCT00761579|469279260|FG000|Overall Study|Withdrawal by Subject|34|||
130357072|NCT00761579|469279260|FG000|Overall Study|Lack of compliance|2|||
130357073|NCT00761579|469279260|FG000|Overall Study|Protocol deviation|1|||
130357074|NCT00761579|469279260|FG000|Overall Study|Drug overdose|1|||
130357075|NCT00761579|469279260|FG000|Overall Study|Aggravation of depression|1|||
130357076|NCT00761579|469279260|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
130357077|NCT00761579|469279260|FG000|Overall Study|Lost survey form|1|||
130357078|NCT00761579|469279260|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
130357079|NCT03611010|469279261|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
130357080|NCT03611010|469279262|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130357081|NCT03611010|469279263|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130357082|NCT03611010|469279264|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130357083|NCT00950911|469279265|FG000|Overall Study|Adverse Event|0|||
130357084|NCT00950911|469279266|FG001|Overall Study|Adverse Event|2|||
130357085|NCT00950911|469279265|FG000|Overall Study|Death|4|||
130357086|NCT00950911|469279266|FG001|Overall Study|Death|6|||
130357087|NCT00950911|469279265|FG000|Overall Study|Disease progression|2|||
130357088|NCT00950911|469279266|FG001|Overall Study|Disease progression|2|||
130357089|NCT00950911|469279265|FG000|Overall Study|Consent withdrawn|1|||
130357090|NCT00950911|469279266|FG001|Overall Study|Consent withdrawn|3|||
130357091|NCT00950911|469279265|FG000|Overall Study|Administrative decision|3|||
130357092|NCT00950911|469279266|FG001|Overall Study|Administrative decision|1|||
130357093|NCT00950911|469279265|FG000|Overall Study|Ineligibility determined|1|||
130357094|NCT00950911|469279266|FG001|Overall Study|Ineligibility determined|0|||
130357095|NCT00950911|469279265|FG000|Overall Study|Noncompliance|1|||
130357096|NCT00950911|469279266|FG001|Overall Study|Noncompliance|0|||
130357097|NCT00950911|469279265|FG000|Overall Study|Poor performance status|0|||
130357098|NCT00950911|469279266|FG001|Overall Study|Poor performance status|1|||
130357099|NCT02600351|469279269|FG000|Overall Study|Lack of Efficacy|3|||
130357100|NCT02600351|469279270|FG001|Overall Study|Lack of Efficacy|0|||
130357101|NCT02600351|469279271|FG002|Overall Study|Lack of Efficacy|5|||
130357102|NCT02600351|469279272|FG003|Overall Study|Lack of Efficacy|2|||
130357103|NCT02600351|469279269|FG000|Overall Study|Lost to Follow-up|1|||
130357104|NCT02600351|469279270|FG001|Overall Study|Lost to Follow-up|0|||
130357105|NCT02600351|469279271|FG002|Overall Study|Lost to Follow-up|0|||
130357106|NCT02600351|469279272|FG003|Overall Study|Lost to Follow-up|0|||
130357107|NCT02600351|469279269|FG000|Overall Study|Randomized but Not Treated|1|||
130357108|NCT02600351|469279270|FG001|Overall Study|Randomized but Not Treated|0|||
130357109|NCT02600351|469279271|FG002|Overall Study|Randomized but Not Treated|1|||
130357110|NCT02600351|469279272|FG003|Overall Study|Randomized but Not Treated|3|||
130357111|NCT02063880|469279273|FG000|Overall Study|Death|21|||
130357112|NCT02063880|469279274|FG001|Overall Study|Death|18|||
130357113|NCT02063880|469279273|FG000|Overall Study|Lost to Follow-up|7|||
130357114|NCT02063880|469279274|FG001|Overall Study|Lost to Follow-up|7|||
130357115|NCT02063880|469279273|FG000|Overall Study|Ineligible|0|||
130357116|NCT02063880|469279274|FG001|Overall Study|Ineligible|2|||
130357117|NCT00567593|469279275|FG000|Overall Study|Adverse Event|1|||
130357118|NCT00567593|469279275|FG000|Overall Study|Physician Decision|1|||
130357119|NCT04087213|469279278|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
130357120|NCT04087213|469279278|FG000|In-Facility Introduction|Adverse Event|1|||
130357121|NCT04087213|469279278|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
130357122|NCT04087213|469279278|FG000|Assisted Evaluable Period|Personal reasons|3|||
130357123|NCT04087213|469279278|FG000|Transition Period B|Renal Transplantation|1|||
130357124|NCT02413372|469279282|FG000|Treatment|Lost to Follow-up|0|||
130357125|NCT02413372|469279283|FG001|Treatment|Lost to Follow-up|2|||
130357126|NCT02413372|469279284|FG002|Treatment|Lost to Follow-up|1|||
130357127|NCT02413372|469279282|FG000|Treatment|Withdrawal by Subject|1|||
130357128|NCT02413372|469279283|FG001|Treatment|Withdrawal by Subject|0|||
130357129|NCT02413372|469279284|FG002|Treatment|Withdrawal by Subject|0|||
130357130|NCT02413372|469279282|FG000|Follow-up|Lost to Follow-up|1|||
130357131|NCT02413372|469279283|FG001|Follow-up|Lost to Follow-up|1|||
130357132|NCT02413372|469279284|FG002|Follow-up|Lost to Follow-up|0|||
130357133|NCT02413372|469279282|FG000|Follow-up|Subject Withdrew Consent|1|||
130357134|NCT02413372|469279283|FG001|Follow-up|Subject Withdrew Consent|0|||
130357135|NCT02413372|469279284|FG002|Follow-up|Subject Withdrew Consent|1|||
130357136|NCT02413372|469279282|FG000|Follow-up|Subject unable to return for visit|0|||
130232908|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130357137|NCT02413372|469279283|FG001|Follow-up|Subject unable to return for visit|0|||
130693948|NCT03499873|470505872|FG002|Overall Study|Administrative reasons|0|||
130693949|NCT03499873|470505870|FG000|Overall Study|Concomitant therapy|5|||
130693950|NCT03499873|470505871|FG001|Overall Study|Concomitant therapy|4|||
130693951|NCT03499873|470505872|FG002|Overall Study|Concomitant therapy|7|||
130693952|NCT03499873|470505870|FG000|Overall Study|Miscellaneous|1|||
130357138|NCT02413372|469279284|FG002|Follow-up|Subject unable to return for visit|1|||
130357139|NCT02556203|469279291|FG000|Overall Study|Withdrawal by Subject|21|||
130357140|NCT02556203|469279292|FG001|Overall Study|Withdrawal by Subject|21|||
130357141|NCT02556203|469279291|FG000|Overall Study|Lost to Follow-up|5|||
130357142|NCT02556203|469279292|FG001|Overall Study|Lost to Follow-up|5|||
130357143|NCT02556203|469279291|FG000|Overall Study|Adverse Event|1|||
130357144|NCT02556203|469279292|FG001|Overall Study|Adverse Event|0|||
130357145|NCT04587271|469279293|FG000|Overall Study|Lost to Follow-up|2|||
130232909|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232910|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232911|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232912|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232913|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232914|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232915|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232916|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232917|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
130232918|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
130232919|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130357146|NCT04587271|469279294|FG001|Overall Study|Lost to Follow-up|2|||
130357147|NCT04587271|469279295|FG002|Overall Study|Lost to Follow-up|0|||
130357148|NCT04587271|469279296|FG003|Overall Study|Lost to Follow-up|2|||
130357149|NCT04587271|469279297|FG004|Overall Study|Lost to Follow-up|2|||
130357150|NCT04587271|469279298|FG005|Overall Study|Lost to Follow-up|0|||
130357151|NCT04587271|469279293|FG000|Overall Study|Caregiver brought child to visits|0|||
130357152|NCT04587271|469279294|FG001|Overall Study|Caregiver brought child to visits|0|||
130357153|NCT04587271|469279295|FG002|Overall Study|Caregiver brought child to visits|0|||
130357154|NCT04587271|469279296|FG003|Overall Study|Caregiver brought child to visits|1|||
130357155|NCT04587271|469279297|FG004|Overall Study|Caregiver brought child to visits|0|||
130357156|NCT04587271|469279298|FG005|Overall Study|Caregiver brought child to visits|0|||
130357157|NCT02180165|469279304|FG000|Overall Study|Not Treated|0|||
130357158|NCT02180165|469279305|FG001|Overall Study|Not Treated|0|||
130357159|NCT02180165|469279306|FG002|Overall Study|Not Treated|1|||
130357160|NCT02180165|469279307|FG003|Overall Study|Not Treated|0|||
130357161|NCT02180165|469279304|FG000|Overall Study|Adverse Event|7|||
130357162|NCT02180165|469279305|FG001|Overall Study|Adverse Event|0|||
130357163|NCT02180165|469279306|FG002|Overall Study|Adverse Event|18|||
130357164|NCT02180165|469279307|FG003|Overall Study|Adverse Event|3|||
130357165|NCT02180165|469279304|FG000|Overall Study|Lack of Efficacy|0|||
130357166|NCT02180165|469279305|FG001|Overall Study|Lack of Efficacy|1|||
130357167|NCT02180165|469279306|FG002|Overall Study|Lack of Efficacy|3|||
130357168|NCT02180165|469279307|FG003|Overall Study|Lack of Efficacy|2|||
130357169|NCT02180165|469279304|FG000|Overall Study|Physician Decision|1|||
130357170|NCT02180165|469279305|FG001|Overall Study|Physician Decision|0|||
130357171|NCT02180165|469279306|FG002|Overall Study|Physician Decision|5|||
130357172|NCT02180165|469279307|FG003|Overall Study|Physician Decision|0|||
130357173|NCT02180165|469279304|FG000|Overall Study|Withdrawal by Subject|3|||
130357174|NCT02180165|469279305|FG001|Overall Study|Withdrawal by Subject|0|||
130357175|NCT02180165|469279306|FG002|Overall Study|Withdrawal by Subject|2|||
130357176|NCT02180165|469279307|FG003|Overall Study|Withdrawal by Subject|1|||
130357177|NCT05246397|469279308|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
130357178|NCT02943460|469279309|FG000|Blinded Study Phase|Adverse Event|3|||
130357179|NCT02943460|469279310|FG001|Blinded Study Phase|Adverse Event|0|||
130357180|NCT02943460|469279311|FG002|Blinded Study Phase|Adverse Event|0|||
130357181|NCT02943460|469279309|FG000|Blinded Study Phase|Withdrew Consent|0|||
130693953|NCT03499873|470505871|FG001|Overall Study|Miscellaneous|2|||
130693954|NCT03499873|470505872|FG002|Overall Study|Miscellaneous|2|||
130693955|NCT03499873|470505870|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
130693956|NCT03499873|470505871|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
130357182|NCT02943460|469279310|FG001|Blinded Study Phase|Withdrew Consent|1|||
130357183|NCT02943460|469279311|FG002|Blinded Study Phase|Withdrew Consent|0|||
130445415|NCT01347645|469591986|FG002|Overall Study|Physician Decision|0|||
130357184|NCT02943460|469279309|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
130357185|NCT02943460|469279310|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
130357186|NCT02943460|469279311|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
130357187|NCT02943460|469279309|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
130357188|NCT02943460|469279310|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
130693957|NCT03499873|470505872|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
130693958|NCT04631562|470505883|FG000|Overall Study|Withdrawal by Subject|0|||
130693959|NCT04631562|470505884|FG001|Overall Study|Withdrawal by Subject|0|||
130693960|NCT04631562|470505885|FG002|Overall Study|Withdrawal by Subject|0|||
130693961|NCT04631562|470505886|FG003|Overall Study|Withdrawal by Subject|0|||
130693962|NCT04631562|470505887|FG004|Overall Study|Withdrawal by Subject|0|||
130693963|NCT04631562|470505888|FG005|Overall Study|Withdrawal by Subject|0|||
130693964|NCT04631562|470505889|FG006|Overall Study|Withdrawal by Subject|0|||
130693965|NCT04631562|470505890|FG007|Overall Study|Withdrawal by Subject|1|||
130693966|NCT04631562|470505891|FG008|Overall Study|Withdrawal by Subject|0|||
130232920|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232921|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232922|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232923|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232924|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232925|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232926|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232927|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
130232928|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
130357189|NCT02943460|469279311|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
130357190|NCT02943460|469279309|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
130357191|NCT02943460|469279310|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
130357192|NCT02943460|469279311|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
130357193|NCT03875768|469279312|FG000|Overall Study|Lost to Follow-up|16|||
130357194|NCT03875768|469279313|FG001|Overall Study|Lost to Follow-up|13|||
130357195|NCT03875768|469279312|FG000|Overall Study|Withdrawal by Subject|10|||
130357196|NCT03875768|469279313|FG001|Overall Study|Withdrawal by Subject|21|||
130357197|NCT03875768|469279312|FG000|Overall Study|Did not complete assessment|21|||
130357198|NCT03875768|469279313|FG001|Overall Study|Did not complete assessment|12|||
130357199|NCT03875768|469279312|FG000|Overall Study|Became ineligible|1|||
130357200|NCT03875768|469279313|FG001|Overall Study|Became ineligible|0|||
130357201|NCT01925274|469279316|FG000|Overall Study|Death|1|||
130357202|NCT01925274|469279317|FG001|Overall Study|Death|0|||
130357203|NCT01925274|469279318|FG002|Overall Study|Death|0|||
130357204|NCT01925274|469279316|FG000|Overall Study|Lost to Follow-up|0|||
130357205|NCT01925274|469279317|FG001|Overall Study|Lost to Follow-up|1|||
130357206|NCT01925274|469279318|FG002|Overall Study|Lost to Follow-up|0|||
130357207|NCT01925274|469279316|FG000|Overall Study|Withdrawal by Subject|1|||
130357208|NCT01925274|469279317|FG001|Overall Study|Withdrawal by Subject|2|||
130357209|NCT01925274|469279318|FG002|Overall Study|Withdrawal by Subject|0|||
130357210|NCT01925274|469279316|FG000|Overall Study|Study terminated by sponsor|4|||
130357211|NCT01925274|469279317|FG001|Overall Study|Study terminated by sponsor|0|||
130357212|NCT01925274|469279318|FG002|Overall Study|Study terminated by sponsor|0|||
130357213|NCT01925274|469279316|FG000|Overall Study|Protocol amendment|1|||
130357214|NCT01925274|469279317|FG001|Overall Study|Protocol amendment|3|||
130357215|NCT01925274|469279318|FG002|Overall Study|Protocol amendment|6|||
130357216|NCT00723398|469279319|FG000|Overall Study|Withdrawal by Subject|2|||
130357217|NCT00723398|469279320|FG001|Overall Study|Withdrawal by Subject|6|||
130357218|NCT00723398|469279321|FG002|Overall Study|Withdrawal by Subject|4|||
130357219|NCT00723398|469279322|FG003|Overall Study|Withdrawal by Subject|4|||
130357220|NCT00723398|469279323|FG004|Overall Study|Withdrawal by Subject|4|||
130357221|NCT00723398|469279319|FG000|Overall Study|Protocol Violation|2|||
130357222|NCT00723398|469279320|FG001|Overall Study|Protocol Violation|1|||
130357223|NCT00723398|469279321|FG002|Overall Study|Protocol Violation|5|||
130357224|NCT00723398|469279322|FG003|Overall Study|Protocol Violation|0|||
130357225|NCT00723398|469279323|FG004|Overall Study|Protocol Violation|0|||
130357226|NCT00723398|469279319|FG000|Overall Study|Physician Decision|2|||
130357227|NCT00723398|469279320|FG001|Overall Study|Physician Decision|2|||
130357228|NCT00723398|469279321|FG002|Overall Study|Physician Decision|5|||
130357229|NCT00723398|469279322|FG003|Overall Study|Physician Decision|0|||
130357230|NCT00723398|469279323|FG004|Overall Study|Physician Decision|1|||
130693967|NCT04631562|470505883|FG000|Overall Study|Other|0|||
130693968|NCT04631562|470505884|FG001|Overall Study|Other|0|||
130693969|NCT04631562|470505885|FG002|Overall Study|Other|0|||
130357231|NCT00723398|469279319|FG000|Overall Study|Adverse Event|0|||
130693970|NCT04631562|470505886|FG003|Overall Study|Other|0|||
130693971|NCT04631562|470505887|FG004|Overall Study|Other|0|||
130693972|NCT04631562|470505888|FG005|Overall Study|Other|0|||
130693973|NCT04631562|470505889|FG006|Overall Study|Other|0|||
130693974|NCT04631562|470505890|FG007|Overall Study|Other|0|||
130357232|NCT00723398|469279320|FG001|Overall Study|Adverse Event|5|||
130357233|NCT00723398|469279321|FG002|Overall Study|Adverse Event|3|||
130357234|NCT00723398|469279322|FG003|Overall Study|Adverse Event|1|||
130357235|NCT00723398|469279323|FG004|Overall Study|Adverse Event|4|||
130357236|NCT00723398|469279319|FG000|Overall Study|Lost to Follow-up|0|||
130357237|NCT00723398|469279320|FG001|Overall Study|Lost to Follow-up|1|||
130357238|NCT00723398|469279321|FG002|Overall Study|Lost to Follow-up|0|||
130232929|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232930|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232931|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232932|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232933|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232934|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232935|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
130232936|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
130232937|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
130232938|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
130232939|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
130232940|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
130232941|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
130232942|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
130232943|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
130232944|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
130232945|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232946|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232947|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232948|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232949|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
130232950|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130232951|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232952|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130232953|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232954|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232955|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232956|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232957|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232958|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232959|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
130232960|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232961|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
130232962|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
130232963|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232964|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232965|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232966|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130357239|NCT00723398|469279322|FG003|Overall Study|Lost to Follow-up|0|||
130357240|NCT00723398|469279323|FG004|Overall Study|Lost to Follow-up|0|||
130357241|NCT00777205|469279324|FG000|Overall Study|Lost to Follow-up|25|||
130357242|NCT00777205|469279325|FG001|Overall Study|Lost to Follow-up|9|||
130357243|NCT00777205|469279324|FG000|Overall Study|Withdrawal by Subject|6|||
130357244|NCT00777205|469279325|FG001|Overall Study|Withdrawal by Subject|4|||
130357245|NCT00777205|469279324|FG000|Overall Study|Death|0|||
130357246|NCT00777205|469279325|FG001|Overall Study|Death|2|||
130357247|NCT00777205|469279324|FG000|Overall Study|Protocol Violation|0|||
130357248|NCT00777205|469279325|FG001|Overall Study|Protocol Violation|56|||
130357249|NCT00100178|469279326|FG000|Overall Study|Lost to Follow-up|0|||
130357250|NCT00100178|469279327|FG001|Overall Study|Lost to Follow-up|6|||
130357251|NCT00100178|469279328|FG002|Overall Study|Lost to Follow-up|5|||
130357252|NCT00100178|469279326|FG000|Overall Study|Adverse Event|2|||
130357253|NCT00100178|469279327|FG001|Overall Study|Adverse Event|2|||
130357254|NCT00100178|469279328|FG002|Overall Study|Adverse Event|1|||
130357255|NCT00100178|469279326|FG000|Overall Study|Withdrawal by Subject|1|||
130357256|NCT00100178|469279327|FG001|Overall Study|Withdrawal by Subject|1|||
130357257|NCT00100178|469279328|FG002|Overall Study|Withdrawal by Subject|1|||
130357258|NCT00100178|469279326|FG000|Overall Study|Physician Decision|6|||
130357259|NCT00100178|469279327|FG001|Overall Study|Physician Decision|1|||
130357260|NCT00100178|469279328|FG002|Overall Study|Physician Decision|3|||
130445416|NCT01347645|469591987|FG003|Overall Study|Physician Decision|0|||
130693975|NCT04631562|470505891|FG008|Overall Study|Other|1|||
130693976|NCT04631562|470505883|FG000|Overall Study|Lost to Follow-up|0|||
130693977|NCT04631562|470505884|FG001|Overall Study|Lost to Follow-up|0|||
130693978|NCT04631562|470505885|FG002|Overall Study|Lost to Follow-up|0|||
130693979|NCT04631562|470505886|FG003|Overall Study|Lost to Follow-up|1|||
130693980|NCT04631562|470505887|FG004|Overall Study|Lost to Follow-up|0|||
130693981|NCT04631562|470505888|FG005|Overall Study|Lost to Follow-up|0|||
130693982|NCT04631562|470505889|FG006|Overall Study|Lost to Follow-up|0|||
130693983|NCT04631562|470505890|FG007|Overall Study|Lost to Follow-up|0|||
130693984|NCT04631562|470505891|FG008|Overall Study|Lost to Follow-up|0|||
130693985|NCT04631562|470505883|FG000|Overall Study|Adverse Event|0|||
130693986|NCT04631562|470505884|FG001|Overall Study|Adverse Event|0|||
130693987|NCT04631562|470505885|FG002|Overall Study|Adverse Event|0|||
130232967|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232968|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232969|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130232970|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130232971|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130445417|NCT01347645|469591988|FG004|Overall Study|Physician Decision|1|||
130445418|NCT01347645|469591984|FG000|Overall Study|Adverse Event|0|||
130445419|NCT01347645|469591985|FG001|Overall Study|Adverse Event|0|||
130445420|NCT01347645|469591986|FG002|Overall Study|Adverse Event|0|||
130445421|NCT01347645|469591987|FG003|Overall Study|Adverse Event|1|||
130445422|NCT01347645|469591988|FG004|Overall Study|Adverse Event|1|||
130445423|NCT00388362|469591989|FG000|Enrolled|Ineligible|1|||
130445424|NCT00388362|469591989|FG000|Enrolled|Adverse Event|9|||
130445425|NCT00388362|469591989|FG000|Enrolled|Death|1|||
130445426|NCT00388362|469591989|FG000|Enrolled|Loss insurance|1|||
130445427|NCT00388362|469591989|FG000|Enrolled|Withdrawal by Subject|1|||
130445428|NCT00388362|469591989|FG000|Remained on Study Median of 514 Days|Death|2|||
130445429|NCT01141660|469591990|FG000|Overall Study|Physician Decision|0|||
130445430|NCT01141660|469591991|FG001|Overall Study|Physician Decision|12|||
130445431|NCT00209027|469591993|FG000|Overall Study|study terminated|10|||
130445432|NCT00209027|469591994|FG001|Overall Study|study terminated|0|||
130445433|NCT01163149|469591995|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
130445434|NCT01163149|469591996|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130445435|NCT01163149|469591997|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
130445436|NCT01163149|469591995|FG000|Extension Treatment Period|Adverse Event|0|||
130445437|NCT01163149|469591996|FG001|Extension Treatment Period|Adverse Event|1|||
130445438|NCT01163149|469591997|FG002|Extension Treatment Period|Adverse Event|0|||
130445439|NCT01163149|469591995|FG000|Extension Treatment Period|Noncompliance|0|||
130445440|NCT01163149|469591996|FG001|Extension Treatment Period|Noncompliance|0|||
130445441|NCT01163149|469591997|FG002|Extension Treatment Period|Noncompliance|1|||
130445442|NCT01932996|469591998|FG000|Overall Study|Protocol Violation|2|||
130445443|NCT01932996|469591999|FG001|Overall Study|Protocol Violation|0|||
130445444|NCT02040090|469592005|FG000|Overall Study|Adverse Event|2|||
130445445|NCT02040090|469592006|FG001|Overall Study|Adverse Event|0|||
130445446|NCT02040090|469592005|FG000|Overall Study|Physician Decision|1|||
130445447|NCT02040090|469592006|FG001|Overall Study|Physician Decision|0|||
130693988|NCT04631562|470505886|FG003|Overall Study|Adverse Event|0|||
130693989|NCT04631562|470505887|FG004|Overall Study|Adverse Event|0|||
130693990|NCT04631562|470505888|FG005|Overall Study|Adverse Event|0|||
130693991|NCT04631562|470505889|FG006|Overall Study|Adverse Event|1|||
130693992|NCT04631562|470505890|FG007|Overall Study|Adverse Event|0|||
130693993|NCT04631562|470505891|FG008|Overall Study|Adverse Event|0|||
130693994|NCT02436200|470505898|FG000|Overall Study|Significant outlier|1|||
130693995|NCT02471807|470505899|FG000|Overall Study|Death|14|||
130693996|NCT02471807|470505899|FG000|Overall Study|Withdrawal by Subject|2|||
130693997|NCT02471807|470505899|FG000|Overall Study|Explant|5|||
130693998|NCT02471807|470505899|FG000|Overall Study|Lost to Follow-up|1|||
130693999|NCT00957021|470505900|FG000|Overall Study|Death|5|||
130694000|NCT00957021|470505900|FG000|Overall Study|Lost to Follow-up|8|||
130694001|NCT00957021|470505900|FG000|Overall Study|Withdrawal by Subject|34|||
130694002|NCT00957021|470505900|FG000|Overall Study|No 2 yr ROM data|35|||
130694003|NCT00957021|470505900|FG000|Overall Study|Revised study component by 2 yr visit|8|||
130694004|NCT00957021|470505900|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
130694005|NCT00957021|470505900|FG000|Overall Study|Surgery Cancelled|9|||
130694006|NCT00957021|470505900|FG000|Overall Study|Termination due to language issue|2|||
130694007|NCT04025021|470505903|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
130694008|NCT04025021|470505904|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
130694009|NCT01986647|470505905|FG000|Overall Study|Lost to Follow-up|4|||
130694010|NCT01986647|470505906|FG001|Overall Study|Lost to Follow-up|1|||
130694011|NCT01986647|470505907|FG002|Overall Study|Lost to Follow-up|4|||
130694012|NCT01986647|470505908|FG003|Overall Study|Lost to Follow-up|4|||
130694013|NCT01986647|470505905|FG000|Overall Study|Withdrawal by Subject|1|||
130694014|NCT01986647|470505906|FG001|Overall Study|Withdrawal by Subject|3|||
130694015|NCT01986647|470505907|FG002|Overall Study|Withdrawal by Subject|2|||
130694016|NCT01986647|470505908|FG003|Overall Study|Withdrawal by Subject|3|||
130694017|NCT01986647|470505905|FG000|Overall Study|Health|5|||
130694018|NCT01986647|470505906|FG001|Overall Study|Health|3|||
130232972|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
130445448|NCT02040090|469592005|FG000|Overall Study|Withdrawal by Subject|0|||
130445449|NCT02040090|469592006|FG001|Overall Study|Withdrawal by Subject|1|||
130445450|NCT02040090|469592005|FG000|Overall Study|Lost to Follow-up|0|||
130445451|NCT02040090|469592006|FG001|Overall Study|Lost to Follow-up|1|||
130445452|NCT04894903|469592015|FG000|Overall Study|Death|1|||
130445453|NCT04894903|469592016|FG001|Overall Study|Death|0|||
130445454|NCT04894903|469592015|FG000|Overall Study|Pregnancy|1|||
130445455|NCT04894903|469592016|FG001|Overall Study|Pregnancy|0|||
130445456|NCT04894903|469592015|FG000|Overall Study|Withdrawal by Subject|1|||
130445457|NCT04894903|469592016|FG001|Overall Study|Withdrawal by Subject|1|||
130445458|NCT04894903|469592015|FG000|Overall Study|moved or exited health system|1|||
130445459|NCT04894903|469592016|FG001|Overall Study|moved or exited health system|3|||
130445460|NCT01923428|469592018|FG000|Overall Study|Adverse Event|8|||
130445461|NCT01923428|469592019|FG001|Overall Study|Adverse Event|6|||
130445462|NCT01923428|469592020|FG002|Overall Study|Adverse Event|3|||
130445463|NCT01923428|469592021|FG003|Overall Study|Adverse Event|3|||
130445464|NCT01923428|469592018|FG000|Overall Study|Withdrawal by Subject|5|||
130445465|NCT01923428|469592019|FG001|Overall Study|Withdrawal by Subject|3|||
130445466|NCT01923428|469592020|FG002|Overall Study|Withdrawal by Subject|0|||
130445467|NCT01923428|469592021|FG003|Overall Study|Withdrawal by Subject|4|||
130445468|NCT01923428|469592018|FG000|Overall Study|Lost to Follow-up|2|||
130445469|NCT01923428|469592019|FG001|Overall Study|Lost to Follow-up|1|||
130445470|NCT01923428|469592020|FG002|Overall Study|Lost to Follow-up|5|||
130445471|NCT01923428|469592021|FG003|Overall Study|Lost to Follow-up|0|||
130445472|NCT01923428|469592018|FG000|Overall Study|Protocol Violation|3|||
130445473|NCT01923428|469592019|FG001|Overall Study|Protocol Violation|0|||
130445474|NCT01923428|469592020|FG002|Overall Study|Protocol Violation|2|||
130445475|NCT01923428|469592021|FG003|Overall Study|Protocol Violation|1|||
130445476|NCT01923428|469592018|FG000|Overall Study|Non Compliance to treatment|1|||
130445477|NCT01923428|469592019|FG001|Overall Study|Non Compliance to treatment|2|||
130445478|NCT01923428|469592020|FG002|Overall Study|Non Compliance to treatment|0|||
130445479|NCT01923428|469592021|FG003|Overall Study|Non Compliance to treatment|1|||
130445480|NCT01923428|469592018|FG000|Overall Study|Lack of Efficacy|0|||
130445481|NCT01923428|469592019|FG001|Overall Study|Lack of Efficacy|0|||
130445482|NCT01923428|469592020|FG002|Overall Study|Lack of Efficacy|1|||
130445483|NCT01923428|469592021|FG003|Overall Study|Lack of Efficacy|1|||
130445484|NCT02550873|469592022|FG000|Randomized Double Blind|Adverse Event|3|||
130445485|NCT02550873|469592023|FG001|Randomized Double Blind|Adverse Event|1|||
130445486|NCT02550873|469592024|FG002|Randomized Double Blind|Adverse Event|0|||
130445487|NCT02550873|469592022|FG000|Randomized Double Blind|Disease progression|1|||
130445488|NCT02550873|469592023|FG001|Randomized Double Blind|Disease progression|1|||
130445489|NCT02550873|469592024|FG002|Randomized Double Blind|Disease progression|0|||
130445490|NCT02550873|469592022|FG000|Open Label Extension|Study ongoing|0|||
130445491|NCT02550873|469592023|FG001|Open Label Extension|Study ongoing|0|||
130445492|NCT02550873|469592024|FG002|Open Label Extension|Study ongoing|111|||
130445493|NCT00895843|469592025|FG000|Overall Study|Protocol Violation|12|||
130445494|NCT00895843|469592026|FG001|Overall Study|Protocol Violation|12|||
130445495|NCT04963062|469592031|FG000|Overall Study|withdrew by the study team|4|||
130445496|NCT04963062|469592032|FG001|Overall Study|withdrew by the study team|2|||
130445497|NCT03873246|469592033|FG000|Overall Study|Adverse Event|1|||
130445498|NCT03873246|469592034|FG001|Overall Study|Adverse Event|3|||
130445499|NCT03873246|469592035|FG002|Overall Study|Adverse Event|3|||
130445500|NCT03873246|469592033|FG000|Overall Study|Lost to Follow-up|4|||
130445501|NCT03873246|469592034|FG001|Overall Study|Lost to Follow-up|4|||
130445502|NCT03873246|469592035|FG002|Overall Study|Lost to Follow-up|5|||
130694019|NCT01986647|470505907|FG002|Overall Study|Health|6|||
130694020|NCT01986647|470505908|FG003|Overall Study|Health|4|||
130694021|NCT02905435|470505909|FG000|Overall Study|Death|2|||
130694022|NCT02905435|470505909|FG000|Overall Study|Physician Decision|1|||
130232973|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232974|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232975|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232976|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232977|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130445503|NCT03873246|469592033|FG000|Overall Study|Protocol Violation|0|||
130445504|NCT03873246|469592034|FG001|Overall Study|Protocol Violation|1|||
130445505|NCT03873246|469592035|FG002|Overall Study|Protocol Violation|0|||
130445506|NCT03873246|469592033|FG000|Overall Study|Withdrawal by Subject|0|||
130445507|NCT03873246|469592034|FG001|Overall Study|Withdrawal by Subject|4|||
130445508|NCT03873246|469592035|FG002|Overall Study|Withdrawal by Subject|1|||
130694023|NCT02905435|470505909|FG000|Overall Study|Lost to Follow-up|4|||
130232978|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130445509|NCT01857323|469592036|FG000|Overall Study|Adverse Event|1|||
130445510|NCT01857323|469592036|FG000|Overall Study|Withdrawal by Subject|3|||
130445511|NCT01857323|469592036|FG000|Overall Study|Non-compliance|1|||
130445512|NCT01857323|469592036|FG000|Overall Study|Protocol Violation|6|||
130445513|NCT01857323|469592036|FG000|Overall Study|Lost to Follow-up|1|||
130445514|NCT01857323|469592036|FG000|Overall Study|Other|4|||
130445515|NCT01857323|469592036|FG000|Overall Study|Did not complete 180 doses|48|||
130445516|NCT00885495|469592041|FG000|Overall Study|Adverse Event|1|||
130445517|NCT00885495|469592042|FG001|Overall Study|Adverse Event|2|||
130445518|NCT00885495|469592041|FG000|Overall Study|Protocol Violation|0|||
130445519|NCT00885495|469592042|FG001|Overall Study|Protocol Violation|1|||
130445520|NCT00885495|469592041|FG000|Overall Study|Withdrawal by Subject|1|||
130445521|NCT00885495|469592042|FG001|Overall Study|Withdrawal by Subject|0|||
130445522|NCT01400893|469592043|FG000|Overall Study|Death|27|||
130694024|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
130694025|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
130694026|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
130694027|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
130694028|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
130694029|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694030|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694031|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694032|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694033|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694034|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694035|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694036|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694037|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694038|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694039|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694040|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694041|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694042|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694043|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694044|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694045|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
130232979|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
130232980|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232981|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130694046|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694047|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694048|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694049|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694050|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694051|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
130694052|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694053|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694054|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694055|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694056|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694057|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694058|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694059|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694060|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694061|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694062|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694063|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694064|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694065|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694066|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694067|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694068|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130357261|NCT02477839|469279331|FG000|Overall Study|Adverse Event|0|||
130357262|NCT02477839|469279332|FG001|Overall Study|Adverse Event|1|||
130357263|NCT02477839|469279331|FG000|Overall Study|Protocol Violation|0|||
130357264|NCT02477839|469279332|FG001|Overall Study|Protocol Violation|2|||
130357265|NCT02477839|469279331|FG000|Overall Study|Withdrawal by Subject|3|||
130357266|NCT02477839|469279332|FG001|Overall Study|Withdrawal by Subject|3|||
130357267|NCT02477839|469279331|FG000|Overall Study|Participant had PGS during V6|0|||
130357268|NCT02477839|469279332|FG001|Overall Study|Participant had PGS during V6|1|||
130357269|NCT02477839|469279331|FG000|Overall Study|Parents decided to stop medication|0|||
130357270|NCT02477839|469279332|FG001|Overall Study|Parents decided to stop medication|1|||
130357271|NCT02477839|469279331|FG000|Overall Study|Lack of tolerability|0|||
130357272|NCT02477839|469279332|FG001|Overall Study|Lack of tolerability|1|||
130357273|NCT02477839|469279331|FG000|Overall Study|Exclusion criterion|0|||
130357274|NCT02477839|469279332|FG001|Overall Study|Exclusion criterion|1|||
130357275|NCT01439568|469279333|FG000|Overall Study|Lost to Follow-up|1|||
130232982|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130357276|NCT01439568|469279334|FG001|Overall Study|Lost to Follow-up|0|||
130357277|NCT01439568|469279333|FG000|Overall Study|Withdrawal by Subject|2|||
130694069|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694070|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130357278|NCT01439568|469279334|FG001|Overall Study|Withdrawal by Subject|2|||
130357279|NCT01676727|469279335|FG000|Overall Study|Death|18|||
130357280|NCT01676727|469279335|FG000|Overall Study|Withdrawal by Subject|6|||
130357281|NCT01676727|469279335|FG000|Overall Study|Screening failure|5|||
130694071|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694072|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130445523|NCT01400893|469592044|FG001|Overall Study|Death|21|||
130445524|NCT01400893|469592043|FG000|Overall Study|Lost to Follow-up|0|||
130445525|NCT01400893|469592044|FG001|Overall Study|Lost to Follow-up|6|||
130445526|NCT01368211|469592048|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
130445527|NCT01368211|469592049|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
130445528|NCT01349660|469592050|FG000|Overall Study|Still Receiving Study Treatment|0|||
130445529|NCT01349660|469592051|FG001|Overall Study|Still Receiving Study Treatment|0|||
130445530|NCT01349660|469592052|FG002|Overall Study|Still Receiving Study Treatment|1|||
130445531|NCT01349660|469592050|FG000|Overall Study|Disease Progression|2|||
130445532|NCT01349660|469592051|FG001|Overall Study|Disease Progression|4|||
130445533|NCT01349660|469592052|FG002|Overall Study|Disease Progression|50|||
130445534|NCT01349660|469592050|FG000|Overall Study|Adverse Event|1|||
130445535|NCT01349660|469592051|FG001|Overall Study|Adverse Event|1|||
130445536|NCT01349660|469592052|FG002|Overall Study|Adverse Event|12|||
130445537|NCT01349660|469592050|FG000|Overall Study|Withdrawal by Subject|2|||
130445538|NCT01349660|469592051|FG001|Overall Study|Withdrawal by Subject|0|||
130445539|NCT01349660|469592052|FG002|Overall Study|Withdrawal by Subject|9|||
130445540|NCT01349660|469592050|FG000|Overall Study|Death|1|||
130445541|NCT01349660|469592051|FG001|Overall Study|Death|1|||
130445542|NCT01349660|469592052|FG002|Overall Study|Death|0|||
130445543|NCT01349660|469592050|FG000|Overall Study|Non-Permitted Interventions|0|||
130445544|NCT01349660|469592051|FG001|Overall Study|Non-Permitted Interventions|0|||
130445545|NCT01349660|469592052|FG002|Overall Study|Non-Permitted Interventions|2|||
130445546|NCT01349660|469592050|FG000|Overall Study|Study Compliance|0|||
130445547|NCT01349660|469592051|FG001|Overall Study|Study Compliance|0|||
130445548|NCT01349660|469592052|FG002|Overall Study|Study Compliance|1|||
130445549|NCT01349660|469592050|FG000|Overall Study|Declining Performance Status|0|||
130445550|NCT01349660|469592051|FG001|Overall Study|Declining Performance Status|0|||
130445551|NCT01349660|469592052|FG002|Overall Study|Declining Performance Status|1|||
130445552|NCT00519636|469592053|FG000|Treatment Period 1|Adverse Event|1|||
130445553|NCT00519636|469592054|FG001|Treatment Period 1|Adverse Event|0|||
130445554|NCT00519636|469592055|FG002|Treatment Period 1|Adverse Event|1|||
130445555|NCT00519636|469592056|FG003|Treatment Period 1|Adverse Event|0|||
130445556|NCT00519636|469592053|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
130445557|NCT00519636|469592054|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
130694073|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694074|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694075|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694076|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694077|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
130694078|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130357282|NCT01676727|469279335|FG000|Overall Study|Not willing to attend 1-year visit|2|||
130357283|NCT01676727|469279335|FG000|Overall Study|Valve explanted|1|||
130357284|NCT03053271|469279336|FG000|Overall Study|Did not meet randomization criteria|3|||
130357285|NCT03053271|469279336|FG000|Overall Study|Withdrawal by Subject|1|||
130357286|NCT00580970|469279337|FG000|Pre-treatment|Non-compliance|1|||
130357287|NCT00580970|469279337|FG000|Treatment (Lovastatin)|Non-compliance|6|||
130357288|NCT00580970|469279337|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
130357289|NCT00580970|469279337|FG000|Treatment (Lovastatin)|Physician Decision|4|||
130357290|NCT00580970|469279337|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
130357291|NCT00580970|469279337|FG000|Treatment (Lovastatin)|Death|1|||
130357292|NCT04137224|469279338|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
130357293|NCT04137224|469279339|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
130357294|NCT04137224|469279338|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
130357295|NCT04137224|469279339|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
130357296|NCT04137224|469279338|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
130357297|NCT04137224|469279339|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
130357298|NCT00566501|469279342|FG000|Overall Study|Adverse Event|68|||
130357299|NCT00566501|469279343|FG001|Overall Study|Adverse Event|59|||
130357300|NCT00566501|469279342|FG000|Overall Study|Medication Non-compliance|5|||
130357301|NCT00566501|469279343|FG001|Overall Study|Medication Non-compliance|0|||
130357302|NCT00566501|469279342|FG000|Overall Study|Protocol Violation|2|||
130445558|NCT00519636|469592055|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
130445559|NCT00519636|469592056|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
130445560|NCT00519636|469592053|FG000|Washout Period|Adverse Event|2|||
130445561|NCT00519636|469592054|FG001|Washout Period|Adverse Event|1|||
130445562|NCT00519636|469592055|FG002|Washout Period|Adverse Event|1|||
130445563|NCT00519636|469592056|FG003|Washout Period|Adverse Event|0|||
130445564|NCT00519636|469592053|FG000|Washout Period|Lost to Follow-up|1|||
130357303|NCT00566501|469279343|FG001|Overall Study|Protocol Violation|2|||
130357304|NCT00566501|469279342|FG000|Overall Study|Request of Investigator or Sponsor|6|||
130357305|NCT00566501|469279343|FG001|Overall Study|Request of Investigator or Sponsor|7|||
130694079|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694080|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694081|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694082|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694083|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694084|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694085|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694086|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694087|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694088|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694089|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694090|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694091|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694092|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694093|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694094|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130232983|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130694095|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694096|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694097|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694098|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694099|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694100|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130232984|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232985|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232986|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232987|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232988|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232989|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
130232990|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232991|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130232992|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130232993|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232994|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232995|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232996|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232997|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232998|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130357306|NCT00566501|469279342|FG000|Overall Study|Withdrawal by Subject|33|||
130357307|NCT00566501|469279343|FG001|Overall Study|Withdrawal by Subject|30|||
130357308|NCT00566501|469279342|FG000|Overall Study|Lack of Efficacy|8|||
130357309|NCT00566501|469279343|FG001|Overall Study|Lack of Efficacy|3|||
130357310|NCT00566501|469279342|FG000|Overall Study|Other|25|||
130357311|NCT00566501|469279343|FG001|Overall Study|Other|21|||
130357312|NCT00679055|469279346|FG000|Overall Study|Adverse Event|0|||
130357313|NCT00679055|469279347|FG001|Overall Study|Adverse Event|1|||
130357314|NCT00679055|469279346|FG000|Overall Study|Other|0|||
130357315|NCT00679055|469279347|FG001|Overall Study|Other|3|||
130357316|NCT00679055|469279346|FG000|Overall Study|Study Terminated|2|||
130357317|NCT00679055|469279347|FG001|Overall Study|Study Terminated|1|||
130357318|NCT01368432|469279348|FG000|Overall Study|Lost to Follow-up|0|||
130357319|NCT01368432|469279349|FG001|Overall Study|Lost to Follow-up|1|||
130357320|NCT01008150|469279350|FG000|Overall Study|did not receive study drug|1|||
130357321|NCT01008150|469279351|FG001|Overall Study|did not receive study drug|1|||
130357322|NCT01008150|469279352|FG002|Overall Study|did not receive study drug|1|||
130357323|NCT01008150|469279353|FG003|Overall Study|did not receive study drug|0|||
130357324|NCT03845543|469279355|FG000|Overall Study|Death|25|||
130357325|NCT03845543|469279355|FG000|Overall Study|Withdrawal by Subject|2|||
130357326|NCT03845543|469279355|FG000|Overall Study|Lost to Follow-up|12|||
130357327|NCT03845543|469279355|FG000|Overall Study|Adverse Event|17|||
130357328|NCT01400815|469279358|FG000|Overall Study|Adverse Event|3|||
130357329|NCT01400815|469279359|FG001|Overall Study|Adverse Event|0|||
130357330|NCT01400815|469279358|FG000|Overall Study|Death|0|||
130357331|NCT01400815|469279359|FG001|Overall Study|Death|1|||
130357332|NCT01400815|469279358|FG000|Overall Study|Lost to Follow-up|18|||
130357333|NCT01400815|469279359|FG001|Overall Study|Lost to Follow-up|11|||
130232999|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130357334|NCT01400815|469279358|FG000|Overall Study|Protocol Violation|0|||
130357335|NCT01400815|469279359|FG001|Overall Study|Protocol Violation|1|||
130357336|NCT01400815|469279358|FG000|Overall Study|Physician Decision|1|||
130357337|NCT01400815|469279359|FG001|Overall Study|Physician Decision|0|||
130357338|NCT01400815|469279358|FG000|Overall Study|Withdrawal by Subject|15|||
130233000|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130357339|NCT01400815|469279359|FG001|Overall Study|Withdrawal by Subject|8|||
130357340|NCT01400815|469279358|FG000|Overall Study|Subject in jail|1|||
130357341|NCT01400815|469279359|FG001|Overall Study|Subject in jail|0|||
130357342|NCT01123850|469279363|FG000|Overall Study|Slow enrollment|45|||
130357343|NCT00381381|469279370|FG000|Overall Study|Adverse Event|3|||
130445565|NCT00519636|469592054|FG001|Washout Period|Lost to Follow-up|0|||
130445566|NCT00519636|469592055|FG002|Washout Period|Lost to Follow-up|0|||
130445567|NCT00519636|469592056|FG003|Washout Period|Lost to Follow-up|0|||
130445568|NCT00519636|469592053|FG000|Washout Period|Protocol Violation|0|||
130445569|NCT00519636|469592054|FG001|Washout Period|Protocol Violation|0|||
130445570|NCT00519636|469592055|FG002|Washout Period|Protocol Violation|1|||
130445571|NCT00519636|469592056|FG003|Washout Period|Protocol Violation|2|||
130445572|NCT00519636|469592053|FG000|Washout Period|Withdrawal by Subject|1|||
130445573|NCT00519636|469592054|FG001|Washout Period|Withdrawal by Subject|0|||
130445574|NCT00519636|469592055|FG002|Washout Period|Withdrawal by Subject|1|||
130445575|NCT00519636|469592056|FG003|Washout Period|Withdrawal by Subject|0|||
130445576|NCT00519636|469592053|FG000|Washout Period|Failed to meet continuation criteria|14|||
130445577|NCT00519636|469592054|FG001|Washout Period|Failed to meet continuation criteria|11|||
130445578|NCT00519636|469592055|FG002|Washout Period|Failed to meet continuation criteria|9|||
130445579|NCT00519636|469592056|FG003|Washout Period|Failed to meet continuation criteria|3|||
130445580|NCT00519636|469592053|FG000|Washout Period|Out of pollen area > 48 hours|1|||
130445581|NCT00519636|469592054|FG001|Washout Period|Out of pollen area > 48 hours|0|||
130445582|NCT00519636|469592055|FG002|Washout Period|Out of pollen area > 48 hours|0|||
130445583|NCT00519636|469592056|FG003|Washout Period|Out of pollen area > 48 hours|0|||
130445584|NCT00519636|469592053|FG000|Washout Period|Participating in study at another site|1|||
130445585|NCT00519636|469592054|FG001|Washout Period|Participating in study at another site|0|||
130445586|NCT00519636|469592055|FG002|Washout Period|Participating in study at another site|0|||
130445587|NCT00519636|469592056|FG003|Washout Period|Participating in study at another site|0|||
130445588|NCT00519636|469592053|FG000|Washout Period|Non-compliant|0|||
130445589|NCT00519636|469592054|FG001|Washout Period|Non-compliant|1|||
130445590|NCT00519636|469592055|FG002|Washout Period|Non-compliant|0|||
130445591|NCT00519636|469592056|FG003|Washout Period|Non-compliant|0|||
130445592|NCT00519636|469592053|FG000|Washout Period|Per doctors request|0|||
130445593|NCT00519636|469592054|FG001|Washout Period|Per doctors request|1|||
130445594|NCT00519636|469592055|FG002|Washout Period|Per doctors request|0|||
130445595|NCT00519636|469592056|FG003|Washout Period|Per doctors request|0|||
130445596|NCT00519636|469592053|FG000|Washout Period|Subject randomized in error|0|||
130445597|NCT00519636|469592054|FG001|Washout Period|Subject randomized in error|0|||
130445598|NCT00519636|469592055|FG002|Washout Period|Subject randomized in error|1|||
130445599|NCT00519636|469592056|FG003|Washout Period|Subject randomized in error|0|||
130445600|NCT00519636|469592053|FG000|Washout Period|Prohibited medications|0|||
130694101|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694102|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694103|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694104|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
130694105|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694106|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694107|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694108|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694109|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694110|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694111|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694112|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694113|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694114|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694115|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130357344|NCT00381381|469279370|FG000|Overall Study|Lost to Follow-up|52|||
130357345|NCT00381381|469279370|FG000|Overall Study|Withdrawal by Subject|9|||
130357346|NCT01147172|469279373|FG000|Overall Study|Withdrawal by Subject|2|||
130357347|NCT01147172|469279373|FG000|Overall Study|Lost to Follow-up|2|||
130357348|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Adverse Event|10|||
130357349|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Adverse Event|0|||
130357350|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
130357351|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
130357352|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
130357353|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
130357354|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
130445601|NCT00519636|469592054|FG001|Washout Period|Prohibited medications|0|||
130445602|NCT00519636|469592055|FG002|Washout Period|Prohibited medications|1|||
130445603|NCT00519636|469592056|FG003|Washout Period|Prohibited medications|0|||
130445604|NCT00519636|469592053|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
130445605|NCT00519636|469592054|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
130233001|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233002|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
130233003|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233004|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233005|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233006|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233007|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233008|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233009|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233010|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
130694116|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694117|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694118|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694119|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694120|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694121|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694122|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694123|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694124|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694125|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694126|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694127|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694128|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130694129|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130694130|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
130694131|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
130694132|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
130694133|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694134|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694135|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694136|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694137|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130357355|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
130357356|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
130357357|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
130357358|NCT02787551|469279374|FG000|Core Period: 26 Weeks|Other than specified|3|||
130357359|NCT02787551|469279375|FG001|Core Period: 26 Weeks|Other than specified|1|||
130357360|NCT02787551|469279374|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
130357361|NCT02787551|469279375|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
130357362|NCT02787551|469279374|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
130357363|NCT02787551|469279375|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
130357364|NCT02787551|469279374|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
130357365|NCT02787551|469279375|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
130357366|NCT02001181|469279377|FG000|Overall Study|Adverse Event|0|||
130357367|NCT02001181|469279378|FG001|Overall Study|Adverse Event|2|||
130357368|NCT02001181|469279377|FG000|Overall Study|Lost to Follow-up|1|||
130357369|NCT02001181|469279378|FG001|Overall Study|Lost to Follow-up|0|||
130357370|NCT02001181|469279377|FG000|Overall Study|Withdrawal by Subject|0|||
130357371|NCT02001181|469279378|FG001|Overall Study|Withdrawal by Subject|1|||
130357372|NCT00292318|469279380|FG000|Overall Study|Study terminated by officials|2|||
130357373|NCT00292318|469279381|FG001|Overall Study|Study terminated by officials|1|||
130357374|NCT00771316|469279382|FG000|Overall Study|Adverse Event|0|||
130357375|NCT00771316|469279383|FG001|Overall Study|Adverse Event|1|||
130357376|NCT00771316|469279382|FG000|Overall Study|Patient withdrew consent|1|||
130357377|NCT00771316|469279383|FG001|Overall Study|Patient withdrew consent|0|||
130357378|NCT00771316|469279382|FG000|Overall Study|Discontinued due to early termination|1|||
130357379|NCT00771316|469279383|FG001|Overall Study|Discontinued due to early termination|0|||
130357380|NCT02027376|469279384|FG000|Overall Study|Death|1|||
130357381|NCT02027376|469279385|FG001|Overall Study|Death|0|||
130357382|NCT02027376|469279386|FG002|Overall Study|Death|0|||
130357383|NCT00843726|469279387|FG000|Overall Study|Death|1|||
130233011|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130357384|NCT00843726|469279388|FG001|Overall Study|Death|0|||
130445606|NCT00519636|469592055|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
130694138|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694139|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130357385|NCT00843726|469279387|FG000|Overall Study|Withdrawal by Subject|0|||
130357386|NCT00843726|469279388|FG001|Overall Study|Withdrawal by Subject|1|||
130357387|NCT00406718|469279389|FG000|Overall Study|Withdrawal by Subject|2|||
130357388|NCT00406718|469279390|FG001|Overall Study|Withdrawal by Subject|9|||
130357389|NCT00406718|469279391|FG002|Overall Study|Withdrawal by Subject|4|||
130357390|NCT00406718|469279389|FG000|Overall Study|Lost to Follow-up|2|||
130357391|NCT00406718|469279390|FG001|Overall Study|Lost to Follow-up|5|||
130357392|NCT00406718|469279391|FG002|Overall Study|Lost to Follow-up|4|||
130357393|NCT01897714|469281009|FG000|Phase I (Dose Escalation)|Disease progression|3|||
130357394|NCT01897714|469281010|FG001|Phase I (Dose Escalation)|Disease progression|5|||
130445607|NCT00519636|469592056|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
130445608|NCT00519636|469592053|FG000|Treatment Period 2|Subject randomized in error|0|||
130445609|NCT00519636|469592054|FG001|Treatment Period 2|Subject randomized in error|1|||
130445610|NCT00519636|469592055|FG002|Treatment Period 2|Subject randomized in error|0|||
130445611|NCT00519636|469592056|FG003|Treatment Period 2|Subject randomized in error|0|||
130445612|NCT00519636|469592053|FG000|Treatment Period 2|Per doctors request|0|||
130445613|NCT00519636|469592054|FG001|Treatment Period 2|Per doctors request|0|||
130445614|NCT00519636|469592055|FG002|Treatment Period 2|Per doctors request|1|||
130445615|NCT00519636|469592056|FG003|Treatment Period 2|Per doctors request|0|||
130445616|NCT00519636|469592053|FG000|Treatment Period 2|Subject misrandomized|0|||
130445617|NCT00519636|469592054|FG001|Treatment Period 2|Subject misrandomized|0|||
130445618|NCT00519636|469592055|FG002|Treatment Period 2|Subject misrandomized|0|||
130445619|NCT00519636|469592056|FG003|Treatment Period 2|Subject misrandomized|1|||
130445620|NCT00519636|469592053|FG000|Post Study Period|Subject randomized in error|0|||
130445621|NCT00519636|469592054|FG001|Post Study Period|Subject randomized in error|0|||
130445622|NCT00519636|469592055|FG002|Post Study Period|Subject randomized in error|0|||
130445623|NCT00519636|469592056|FG003|Post Study Period|Subject randomized in error|1|||
130445624|NCT02846558|469592061|FG000|Overall Study|Adverse Event|1|||
130445625|NCT02846558|469592062|FG001|Overall Study|Adverse Event|0|||
130445626|NCT02846558|469592063|FG002|Overall Study|Adverse Event|0|||
130357395|NCT01897714|469281011|FG002|Phase I (Dose Escalation)|Disease progression|1|||
130357396|NCT01897714|469281012|FG003|Phase I (Dose Escalation)|Disease progression|3|||
130357397|NCT01897714|469281013|FG004|Phase I (Dose Escalation)|Disease progression|0|||
130357398|NCT01897714|469281014|FG005|Phase I (Dose Escalation)|Disease progression|0|||
130357399|NCT01897714|469281009|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
130357400|NCT01897714|469281010|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
130445627|NCT02846558|469592064|FG003|Overall Study|Adverse Event|0|||
130445628|NCT02846558|469592061|FG000|Overall Study|Withdrawal by Subject|5|||
130445629|NCT02846558|469592062|FG001|Overall Study|Withdrawal by Subject|4|||
130445630|NCT02846558|469592063|FG002|Overall Study|Withdrawal by Subject|2|||
130445631|NCT02846558|469592064|FG003|Overall Study|Withdrawal by Subject|2|||
130445632|NCT02846558|469592061|FG000|Overall Study|Lost to Follow-up|2|||
130445633|NCT02846558|469592062|FG001|Overall Study|Lost to Follow-up|0|||
130445634|NCT02846558|469592063|FG002|Overall Study|Lost to Follow-up|0|||
130445635|NCT02846558|469592064|FG003|Overall Study|Lost to Follow-up|0|||
130694140|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694141|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694142|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694143|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130357401|NCT01897714|469281011|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
130357402|NCT01897714|469281012|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
130357403|NCT01897714|469281013|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
130357404|NCT01897714|469281014|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
130694144|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694145|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694146|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694147|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694148|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694149|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694150|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694151|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694152|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694153|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694154|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|moved|0|||
130694155|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|moved|1|||
130694156|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|moved|1|||
130694157|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|moved|0|||
130445636|NCT00904150|469592074|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
130445637|NCT00904150|469592075|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
130445638|NCT00904150|469592074|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
130445639|NCT00904150|469592075|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
130445640|NCT04129580|469593518|FG000|Overall Study|Lost to Follow-up|14|||
130445641|NCT04129580|469593519|FG001|Overall Study|Lost to Follow-up|25|||
130445642|NCT00322868|469593522|FG000|Overall Study|disease progression|1|||
130445643|NCT00224133|469593523|FG000|Overall Study|Adverse Event|93|||
130445644|NCT00224133|469593523|FG000|Overall Study|Protocol Violation|6|||
130445645|NCT00224133|469593523|FG000|Overall Study|Withdrawal by Subject|33|||
130445646|NCT00224133|469593523|FG000|Overall Study|Lack of Efficacy|58|||
130445647|NCT00224133|469593523|FG000|Overall Study|Lost to Follow-up|21|||
130445648|NCT00224133|469593523|FG000|Overall Study|Physician Decision|1|||
130445649|NCT00224133|469593523|FG000|Overall Study|Other|14|||
130445650|NCT02056119|469593528|FG000|Overall Study|Death|1|||
130445651|NCT02056119|469593529|FG001|Overall Study|Death|2|||
130445652|NCT02056119|469593528|FG000|Overall Study|Intubated for less than 24 hrs|2|||
130445653|NCT02056119|469593529|FG001|Overall Study|Intubated for less than 24 hrs|7|||
130445654|NCT02056119|469593528|FG000|Overall Study|No aerosol treatments were given.|3|||
130445655|NCT02056119|469593529|FG001|Overall Study|No aerosol treatments were given.|2|||
130445656|NCT02056119|469593528|FG000|Overall Study|Received Metaneb treatment|0|||
130445657|NCT02056119|469593529|FG001|Overall Study|Received Metaneb treatment|2|||
130445658|NCT02056119|469593528|FG000|Overall Study|Protocol Violation|4|||
130445659|NCT02056119|469593529|FG001|Overall Study|Protocol Violation|7|||
130445660|NCT03220737|469593530|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
130445661|NCT03220737|469593531|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
130445662|NCT03220737|469593532|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
130445663|NCT03220737|469593533|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
130445664|NCT03220737|469593534|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
130445665|NCT03220737|469593535|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
130445666|NCT03220737|469593536|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
130445667|NCT03220737|469593530|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
130445668|NCT03220737|469593531|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
130445669|NCT03220737|469593532|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
130445670|NCT03220737|469593533|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
130445671|NCT03220737|469593534|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
130445672|NCT03220737|469593535|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
130445673|NCT03220737|469593536|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
130445674|NCT03220737|469593530|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
130445675|NCT03220737|469593531|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
130445676|NCT03220737|469593532|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
130445677|NCT03220737|469593533|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
130445678|NCT03220737|469593534|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
130445679|NCT03220737|469593535|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
130445680|NCT03220737|469593536|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
130445681|NCT03220737|469593530|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445682|NCT03220737|469593531|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445683|NCT03220737|469593532|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
130445684|NCT03220737|469593533|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445685|NCT03220737|469593534|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445686|NCT03220737|469593535|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445687|NCT03220737|469593536|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
130445688|NCT03220737|469593530|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445689|NCT03220737|469593531|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445690|NCT03220737|469593532|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445691|NCT03220737|469593533|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445692|NCT03220737|469593534|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
130445693|NCT03220737|469593535|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445694|NCT03220737|469593536|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
130445695|NCT03220737|469593530|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
130445696|NCT03220737|469593531|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130445697|NCT03220737|469593532|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130445698|NCT03220737|469593533|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130445699|NCT03220737|469593534|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130694158|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|moved|0|||
130694159|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|moved|0|||
130445700|NCT03220737|469593535|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130445701|NCT03220737|469593536|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
130445702|NCT03220737|469593530|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
130694160|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|moved|0|||
130694161|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|moved|0|||
130445703|NCT03220737|469593531|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130445704|NCT03220737|469593532|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130445705|NCT03220737|469593533|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130445706|NCT03220737|469593534|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130694162|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|moved|0|||
130694163|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|moved|0|||
130694164|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|moved|0|||
130694165|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|moved|0|||
130233012|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233013|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130694166|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|moved|0|||
130694167|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|moved|0|||
130233014|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130357405|NCT01897714|469281009|FG000|Phase I (Dose Escalation)|Other|0|||
130357406|NCT01897714|469281010|FG001|Phase I (Dose Escalation)|Other|1|||
130357407|NCT01897714|469281011|FG002|Phase I (Dose Escalation)|Other|0|||
130357408|NCT01897714|469281012|FG003|Phase I (Dose Escalation)|Other|0|||
130357409|NCT01897714|469281013|FG004|Phase I (Dose Escalation)|Other|0|||
130357410|NCT01897714|469281014|FG005|Phase I (Dose Escalation)|Other|0|||
130357411|NCT01897714|469281009|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
130357412|NCT01897714|469281010|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
130357413|NCT01897714|469281011|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
130357414|NCT01897714|469281012|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
130357415|NCT01897714|469281013|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
130357416|NCT01897714|469281014|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
130357417|NCT01897714|469281009|FG000|Phase II (MTD)|Lost to Follow-up|0|||
130357418|NCT01897714|469281010|FG001|Phase II (MTD)|Lost to Follow-up|0|||
130357419|NCT01897714|469281011|FG002|Phase II (MTD)|Lost to Follow-up|0|||
130357420|NCT01897714|469281012|FG003|Phase II (MTD)|Lost to Follow-up|0|||
130357421|NCT01897714|469281013|FG004|Phase II (MTD)|Lost to Follow-up|1|||
130357422|NCT01897714|469281014|FG005|Phase II (MTD)|Lost to Follow-up|0|||
130357423|NCT01897714|469281009|FG000|Phase II (MTD)|Death|0|||
130357424|NCT01897714|469281010|FG001|Phase II (MTD)|Death|0|||
130357425|NCT01897714|469281011|FG002|Phase II (MTD)|Death|0|||
130357426|NCT01897714|469281012|FG003|Phase II (MTD)|Death|0|||
130357427|NCT01897714|469281013|FG004|Phase II (MTD)|Death|25|||
130357428|NCT01897714|469281014|FG005|Phase II (MTD)|Death|10|||
130357429|NCT01897714|469281009|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
130357430|NCT01897714|469281010|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
130357431|NCT01897714|469281011|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
130357432|NCT01897714|469281012|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
130357433|NCT01897714|469281013|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
130357434|NCT01897714|469281014|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
130357435|NCT01897714|469281009|FG000|Phase II (MTD)|Other|0|||
130357436|NCT01897714|469281010|FG001|Phase II (MTD)|Other|0|||
130357437|NCT01897714|469281011|FG002|Phase II (MTD)|Other|0|||
130357438|NCT01897714|469281012|FG003|Phase II (MTD)|Other|0|||
130357439|NCT01897714|469281013|FG004|Phase II (MTD)|Other|3|||
130357440|NCT01897714|469281014|FG005|Phase II (MTD)|Other|0|||
130357441|NCT00423722|469281015|FG000|Overall Study|Death|4|||
130357442|NCT00423722|469281016|FG001|Overall Study|Death|4|||
130357443|NCT00423722|469281015|FG000|Overall Study|Declined to participate|2|||
130357444|NCT00423722|469281016|FG001|Overall Study|Declined to participate|3|||
130357445|NCT00423722|469281015|FG000|Overall Study|Unable to complete questionnaires|4|||
130357446|NCT00423722|469281016|FG001|Overall Study|Unable to complete questionnaires|4|||
130357447|NCT00423722|469281015|FG000|Overall Study|Withdrawal by Subject|4|||
130357448|NCT00423722|469281016|FG001|Overall Study|Withdrawal by Subject|2|||
130357449|NCT01846104|469281021|FG000|Overall Study|Withdrawal by Subject|1|||
130357450|NCT00851630|469281025|FG000|Overall Study|Death|2|||
130357451|NCT00851630|469281026|FG001|Overall Study|Death|1|||
130357452|NCT00851630|469281025|FG000|Overall Study|Clinical failure|0|||
130357453|NCT00851630|469281026|FG001|Overall Study|Clinical failure|1|||
130357454|NCT02349061|469281028|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
130357455|NCT02349061|469281029|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
130357456|NCT02349061|469281030|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
130357457|NCT02349061|469281028|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
130357458|NCT02349061|469281029|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
130357459|NCT02349061|469281030|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
130357460|NCT02349061|469281028|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
130694168|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|moved|0|||
130357461|NCT02349061|469281029|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
130357462|NCT02349061|469281030|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
130357463|NCT02349061|469281028|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
130357464|NCT02349061|469281029|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
130357465|NCT02349061|469281030|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
130357466|NCT02349061|469281028|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
130357467|NCT02349061|469281029|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
130357468|NCT02349061|469281030|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
130357469|NCT02349061|469281028|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
130694169|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|moved|0|||
130694170|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|moved|0|||
130694171|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|moved|0|||
130694172|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|moved|0|||
130694173|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|moved|0|||
130694174|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|moved|0|||
130694175|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|moved|0|||
130694176|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|moved|0|||
130694177|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|moved|0|||
130694178|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|moved|0|||
130694179|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|moved|0|||
130694180|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694181|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694182|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130233015|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130445707|NCT03220737|469593535|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130445708|NCT03220737|469593536|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130445709|NCT03220737|469593530|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
130445710|NCT03220737|469593531|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445711|NCT03220737|469593532|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445712|NCT03220737|469593533|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445713|NCT03220737|469593534|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445714|NCT03220737|469593535|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445715|NCT03220737|469593536|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130445716|NCT01712789|469593537|FG000|Overall Study|Lack of Efficacy|2|||
130445717|NCT01712789|469593537|FG000|Overall Study|Lost to Follow-up|1|||
130445718|NCT01712789|469593537|FG000|Overall Study|Progressive Disease|504|||
130445719|NCT01712789|469593537|FG000|Overall Study|Death|57|||
130445720|NCT01712789|469593537|FG000|Overall Study|Adverse Event|52|||
130233016|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233017|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130445721|NCT01712789|469593537|FG000|Overall Study|Miscellaneous|31|||
130445722|NCT01712789|469593537|FG000|Overall Study|Withdrawal by Subject|21|||
130445723|NCT01712789|469593537|FG000|Overall Study|Transition to Commercial Treatment|8|||
130445724|NCT01712789|469593537|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
130445725|NCT03486899|469593538|FG000|Overall Study|Lost to Follow-up|4|||
130445726|NCT03486899|469593539|FG001|Overall Study|Lost to Follow-up|1|||
130445727|NCT03486899|469593540|FG002|Overall Study|Lost to Follow-up|4|||
130445728|NCT03486899|469593541|FG003|Overall Study|Lost to Follow-up|3|||
130445729|NCT03486899|469593538|FG000|Overall Study|Death|1|||
130445730|NCT03486899|469593539|FG001|Overall Study|Death|0|||
130445731|NCT03486899|469593540|FG002|Overall Study|Death|0|||
130445732|NCT03486899|469593541|FG003|Overall Study|Death|1|||
130445733|NCT03486899|469593538|FG000|Overall Study|Adverse Event|0|||
130445734|NCT03486899|469593539|FG001|Overall Study|Adverse Event|2|||
130445735|NCT03486899|469593540|FG002|Overall Study|Adverse Event|0|||
130445736|NCT03486899|469593541|FG003|Overall Study|Adverse Event|2|||
130445737|NCT03486899|469593538|FG000|Overall Study|Withdrawal by Subject|3|||
130445738|NCT03486899|469593539|FG001|Overall Study|Withdrawal by Subject|7|||
130445739|NCT03486899|469593540|FG002|Overall Study|Withdrawal by Subject|4|||
130445740|NCT03486899|469593541|FG003|Overall Study|Withdrawal by Subject|3|||
130445741|NCT03486899|469593538|FG000|Overall Study|Other Reasons|0|||
130445742|NCT03486899|469593539|FG001|Overall Study|Other Reasons|1|||
130445743|NCT03486899|469593540|FG002|Overall Study|Other Reasons|0|||
130445744|NCT03486899|469593541|FG003|Overall Study|Other Reasons|1|||
130445745|NCT01848834|469593547|FG000|Overall Study|Adverse Event|3|||
130445746|NCT01848834|469593548|FG001|Overall Study|Adverse Event|11|||
130445747|NCT01848834|469593549|FG002|Overall Study|Adverse Event|3|||
130445748|NCT01848834|469593550|FG003|Overall Study|Adverse Event|5|||
130445749|NCT01848834|469593551|FG004|Overall Study|Adverse Event|9|||
130445750|NCT01848834|469593547|FG000|Overall Study|Death|2|||
130445751|NCT01848834|469593548|FG001|Overall Study|Death|11|||
130445752|NCT01848834|469593549|FG002|Overall Study|Death|1|||
130445753|NCT01848834|469593550|FG003|Overall Study|Death|8|||
130445754|NCT01848834|469593551|FG004|Overall Study|Death|27|||
130445755|NCT01848834|469593547|FG000|Overall Study|Excluded Medication|5|||
130445756|NCT01848834|469593548|FG001|Overall Study|Excluded Medication|4|||
130445757|NCT01848834|469593549|FG002|Overall Study|Excluded Medication|3|||
130694183|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
130694184|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694185|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694186|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694187|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130445758|NCT01848834|469593550|FG003|Overall Study|Excluded Medication|6|||
130445759|NCT01848834|469593551|FG004|Overall Study|Excluded Medication|6|||
130694188|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694189|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130445760|NCT01848834|469593547|FG000|Overall Study|Lost to Follow-up|5|||
130445761|NCT01848834|469593548|FG001|Overall Study|Lost to Follow-up|5|||
130445762|NCT01848834|469593549|FG002|Overall Study|Lost to Follow-up|3|||
130445763|NCT01848834|469593550|FG003|Overall Study|Lost to Follow-up|0|||
130445764|NCT01848834|469593551|FG004|Overall Study|Lost to Follow-up|3|||
130445765|NCT01848834|469593547|FG000|Overall Study|Physician Decision|1|||
130445766|NCT01848834|469593548|FG001|Overall Study|Physician Decision|3|||
130445767|NCT01848834|469593549|FG002|Overall Study|Physician Decision|4|||
130445768|NCT01848834|469593550|FG003|Overall Study|Physician Decision|0|||
130445769|NCT01848834|469593551|FG004|Overall Study|Physician Decision|11|||
130445770|NCT01848834|469593547|FG000|Overall Study|Protocol Violation|0|||
130445771|NCT01848834|469593548|FG001|Overall Study|Protocol Violation|0|||
130445772|NCT01848834|469593549|FG002|Overall Study|Protocol Violation|0|||
130445773|NCT01848834|469593550|FG003|Overall Study|Protocol Violation|0|||
130445774|NCT01848834|469593551|FG004|Overall Study|Protocol Violation|1|||
130445775|NCT01848834|469593547|FG000|Overall Study|Sponsor Decision|1|||
130445776|NCT01848834|469593548|FG001|Overall Study|Sponsor Decision|1|||
130445777|NCT01848834|469593549|FG002|Overall Study|Sponsor Decision|0|||
130445778|NCT01848834|469593550|FG003|Overall Study|Sponsor Decision|1|||
130445779|NCT01848834|469593551|FG004|Overall Study|Sponsor Decision|1|||
130445780|NCT01848834|469593547|FG000|Overall Study|Withdrawal by Subject|2|||
130445781|NCT01848834|469593548|FG001|Overall Study|Withdrawal by Subject|13|||
130445782|NCT01848834|469593549|FG002|Overall Study|Withdrawal by Subject|10|||
130445783|NCT01848834|469593550|FG003|Overall Study|Withdrawal by Subject|6|||
130445784|NCT01848834|469593551|FG004|Overall Study|Withdrawal by Subject|36|||
130445785|NCT03259373|469593552|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
130445786|NCT03259373|469593553|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
130445787|NCT03259373|469593552|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
130445788|NCT03259373|469593553|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
130445789|NCT03259373|469593552|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
130445790|NCT03259373|469593553|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
130445791|NCT03259373|469593552|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
130445792|NCT03259373|469593553|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
130445793|NCT03259373|469593552|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
130445794|NCT03259373|469593553|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
130445795|NCT03259373|469593552|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
130445796|NCT03259373|469593553|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
130445797|NCT01822353|469593556|FG000|Overall Study|Adverse Event|1|||
130445798|NCT01822353|469593557|FG001|Overall Study|Adverse Event|3|||
130445799|NCT01822353|469593558|FG002|Overall Study|Adverse Event|1|||
130445800|NCT01822353|469593556|FG000|Overall Study|Pregnancy|0|||
130445801|NCT01822353|469593557|FG001|Overall Study|Pregnancy|1|||
130445802|NCT01822353|469593558|FG002|Overall Study|Pregnancy|0|||
130445803|NCT01822353|469593556|FG000|Overall Study|Withdrawal by Subject|3|||
130445804|NCT01822353|469593557|FG001|Overall Study|Withdrawal by Subject|1|||
130445805|NCT01822353|469593558|FG002|Overall Study|Withdrawal by Subject|0|||
130445806|NCT03658811|469593562|FG000|Overall Study|Lost to Follow-up|3|||
130445807|NCT00946647|469593563|FG000|Phase 1 Part|Adverse Event|2|||
130445808|NCT00946647|469593564|FG001|Phase 1 Part|Adverse Event|5|||
130445809|NCT00946647|469593565|FG002|Phase 1 Part|Adverse Event|3|||
130445810|NCT00946647|469593566|FG003|Phase 1 Part|Adverse Event|0|||
130445811|NCT00946647|469593567|FG004|Phase 1 Part|Adverse Event|0|||
130694190|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694191|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694192|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130445812|NCT00946647|469593563|FG000|Phase 1 Part|Disease progression|3|||
130445813|NCT00946647|469593564|FG001|Phase 1 Part|Disease progression|6|||
130445814|NCT00946647|469593565|FG002|Phase 1 Part|Disease progression|1|||
130445815|NCT00946647|469593566|FG003|Phase 1 Part|Disease progression|0|||
130445816|NCT00946647|469593567|FG004|Phase 1 Part|Disease progression|0|||
130445817|NCT00946647|469593563|FG000|Phase 1 Part|Withdrawal by Subject|1|||
130445818|NCT00946647|469593564|FG001|Phase 1 Part|Withdrawal by Subject|4|||
130445819|NCT00946647|469593565|FG002|Phase 1 Part|Withdrawal by Subject|3|||
130445820|NCT00946647|469593566|FG003|Phase 1 Part|Withdrawal by Subject|0|||
130445821|NCT00946647|469593567|FG004|Phase 1 Part|Withdrawal by Subject|0|||
130445822|NCT00946647|469593563|FG000|Phase 1 Part|Abnormal values|0|||
130445823|NCT00946647|469593564|FG001|Phase 1 Part|Abnormal values|2|||
130445824|NCT00946647|469593565|FG002|Phase 1 Part|Abnormal values|0|||
130445825|NCT00946647|469593566|FG003|Phase 1 Part|Abnormal values|0|||
130445826|NCT00946647|469593567|FG004|Phase 1 Part|Abnormal values|0|||
130445827|NCT00946647|469593563|FG000|Phase 1 Part|Reason missing|0|||
130445828|NCT00946647|469593564|FG001|Phase 1 Part|Reason missing|1|||
130445829|NCT00946647|469593565|FG002|Phase 1 Part|Reason missing|0|||
130445830|NCT00946647|469593566|FG003|Phase 1 Part|Reason missing|0|||
130445831|NCT00946647|469593567|FG004|Phase 1 Part|Reason missing|0|||
130445832|NCT00946647|469593563|FG000|Phase ll Part|Untreated|0|||
130445833|NCT00946647|469593564|FG001|Phase ll Part|Untreated|0|||
130445834|NCT00946647|469593565|FG002|Phase ll Part|Untreated|0|||
130445835|NCT00946647|469593566|FG003|Phase ll Part|Untreated|0|||
130445836|NCT00946647|469593567|FG004|Phase ll Part|Untreated|2|||
130445837|NCT00946647|469593563|FG000|Phase ll Part|Adverse Event|0|||
130445838|NCT00946647|469593564|FG001|Phase ll Part|Adverse Event|0|||
130445839|NCT00946647|469593565|FG002|Phase ll Part|Adverse Event|0|||
130445840|NCT00946647|469593566|FG003|Phase ll Part|Adverse Event|10|||
130445841|NCT00946647|469593567|FG004|Phase ll Part|Adverse Event|6|||
130445842|NCT00946647|469593563|FG000|Phase ll Part|Withdrawal by Subject|0|||
130445843|NCT00946647|469593564|FG001|Phase ll Part|Withdrawal by Subject|0|||
130445844|NCT00946647|469593565|FG002|Phase ll Part|Withdrawal by Subject|0|||
130445845|NCT00946647|469593566|FG003|Phase ll Part|Withdrawal by Subject|8|||
130445846|NCT00946647|469593567|FG004|Phase ll Part|Withdrawal by Subject|6|||
130445847|NCT00946647|469593563|FG000|Phase ll Part|Administrative problems|0|||
130445848|NCT00946647|469593564|FG001|Phase ll Part|Administrative problems|0|||
130445849|NCT00946647|469593565|FG002|Phase ll Part|Administrative problems|0|||
130445850|NCT00946647|469593566|FG003|Phase ll Part|Administrative problems|3|||
130445851|NCT00946647|469593567|FG004|Phase ll Part|Administrative problems|8|||
130445852|NCT00946647|469593563|FG000|Phase ll Part|Death|0|||
130445853|NCT00946647|469593564|FG001|Phase ll Part|Death|0|||
130445854|NCT00946647|469593565|FG002|Phase ll Part|Death|0|||
130445855|NCT00946647|469593566|FG003|Phase ll Part|Death|7|||
130445856|NCT00946647|469593567|FG004|Phase ll Part|Death|4|||
130445857|NCT00946647|469593563|FG000|Phase ll Part|Disease progression|0|||
130445858|NCT00946647|469593564|FG001|Phase ll Part|Disease progression|0|||
130445859|NCT00946647|469593565|FG002|Phase ll Part|Disease progression|0|||
130445860|NCT00946647|469593566|FG003|Phase ll Part|Disease progression|6|||
130445861|NCT00946647|469593567|FG004|Phase ll Part|Disease progression|14|||
130445862|NCT00946647|469593563|FG000|Phase ll Part|Protocol Violation|0|||
130445863|NCT00946647|469593564|FG001|Phase ll Part|Protocol Violation|0|||
130357470|NCT02349061|469281029|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
130357471|NCT02349061|469281030|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
130357472|NCT02349061|469281028|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
130357473|NCT02349061|469281029|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
130357474|NCT02349061|469281030|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
130357475|NCT02349061|469281028|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
130357476|NCT02349061|469281029|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
130357477|NCT02349061|469281030|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
130357478|NCT02349061|469281028|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
130445864|NCT00946647|469593565|FG002|Phase ll Part|Protocol Violation|0|||
130445865|NCT00946647|469593566|FG003|Phase ll Part|Protocol Violation|4|||
130445866|NCT00946647|469593567|FG004|Phase ll Part|Protocol Violation|2|||
130694193|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694194|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694195|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694196|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694197|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694198|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694199|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694200|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694201|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694202|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694203|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694204|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130357479|NCT02349061|469281029|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
130445867|NCT00946647|469593563|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
130445868|NCT00946647|469593564|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
130445869|NCT00946647|469593565|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
130445870|NCT00946647|469593566|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
130445871|NCT00946647|469593567|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
130445872|NCT01513967|469593578|FG000|Overall Study|Pregnancy|0|||
130445873|NCT01513967|469593579|FG001|Overall Study|Pregnancy|0|||
130445874|NCT01513967|469593580|FG002|Overall Study|Pregnancy|0|||
130445875|NCT01513967|469593581|FG003|Overall Study|Pregnancy|0|||
130445876|NCT01513967|469593582|FG004|Overall Study|Pregnancy|0|||
130445877|NCT01513967|469593583|FG005|Overall Study|Pregnancy|0|||
130694205|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694206|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694207|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694208|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130357480|NCT02349061|469281030|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
130357481|NCT02349061|469281028|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
130357482|NCT02349061|469281029|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
130357483|NCT02349061|469281030|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
130357484|NCT02349061|469281028|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
130357485|NCT02349061|469281029|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
130357486|NCT02349061|469281030|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
130357487|NCT02349061|469281028|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
130357488|NCT02349061|469281029|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
130357489|NCT02349061|469281030|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
130357490|NCT02349061|469281028|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
130357491|NCT02349061|469281029|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
130357492|NCT02349061|469281030|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
130357493|NCT00398411|469281031|FG000|Overall Study|Death|0|||
130357494|NCT00398411|469281032|FG001|Overall Study|Death|1|||
130357495|NCT03061097|469281033|FG000|Overall Study|Withdrawal by Subject|0|||
130357496|NCT03061097|469281034|FG001|Overall Study|Withdrawal by Subject|3|||
130357497|NCT03911713|469281035|FG000|Overall Study|Lost to Follow-up|0|||
130357498|NCT03911713|469281036|FG001|Overall Study|Lost to Follow-up|2|||
130357499|NCT03911713|469281037|FG002|Overall Study|Lost to Follow-up|0|||
130357500|NCT03911713|469281038|FG003|Overall Study|Lost to Follow-up|0|||
130357501|NCT03911713|469281039|FG004|Overall Study|Lost to Follow-up|0|||
130357502|NCT03911713|469281035|FG000|Overall Study|Other|0|||
130357503|NCT03911713|469281036|FG001|Overall Study|Other|0|||
130357504|NCT03911713|469281037|FG002|Overall Study|Other|0|||
130357505|NCT03911713|469281038|FG003|Overall Study|Other|1|||
130357506|NCT03911713|469281039|FG004|Overall Study|Other|0|||
130357507|NCT03911713|469281035|FG000|Overall Study|Randomized, Never Dosed|1|||
130357508|NCT03911713|469281036|FG001|Overall Study|Randomized, Never Dosed|0|||
130357509|NCT03911713|469281037|FG002|Overall Study|Randomized, Never Dosed|0|||
130357510|NCT03911713|469281038|FG003|Overall Study|Randomized, Never Dosed|1|||
130357511|NCT03911713|469281039|FG004|Overall Study|Randomized, Never Dosed|0|||
130357512|NCT01614600|469281040|FG000|Overall Study|Unacceptable fit|1|||
130357513|NCT01614600|469281040|FG000|Overall Study|Discomfort|1|||
130357514|NCT01614600|469281040|FG000|Overall Study|Unable to remove lens at the end of day|1|||
130357515|NCT01614600|469281040|FG000|Overall Study|Protocol deviation|1|||
130357516|NCT03347188|469281041|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
130357517|NCT03347188|469281042|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
130357518|NCT03347188|469281041|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
130357519|NCT03347188|469281042|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
130357520|NCT03347188|469281041|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
130357521|NCT03347188|469281042|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
130357522|NCT03347188|469281041|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
130357523|NCT03347188|469281042|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
130357524|NCT03347188|469281041|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
130357525|NCT03347188|469281042|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
130357526|NCT03347188|469281041|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
130357527|NCT03347188|469281042|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
130357528|NCT03347188|469281041|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
130357529|NCT03347188|469281042|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
130357530|NCT03347188|469281041|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
130357531|NCT03347188|469281042|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
130357532|NCT01845818|469281043|FG000|Overall Study|Withdrawal by Subject|0|||
130357533|NCT01845818|469281044|FG001|Overall Study|Withdrawal by Subject|1|||
130357534|NCT01845818|469281043|FG000|Overall Study|Lost to Follow-up|7|||
130357535|NCT01845818|469281044|FG001|Overall Study|Lost to Follow-up|5|||
130357536|NCT01845818|469281043|FG000|Overall Study|Administrative Reasons|3|||
130357537|NCT01845818|469281044|FG001|Overall Study|Administrative Reasons|1|||
130357538|NCT01845818|469281043|FG000|Overall Study|Serious Adverse Event|1|||
130357539|NCT01845818|469281044|FG001|Overall Study|Serious Adverse Event|1|||
130694209|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130357540|NCT01845818|469281043|FG000|Overall Study|Other|25|||
130357541|NCT01845818|469281044|FG001|Overall Study|Other|8|||
130357542|NCT01845818|469281043|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
130445878|NCT01513967|469593584|FG006|Overall Study|Pregnancy|1|||
130445879|NCT01513967|469593585|FG007|Overall Study|Pregnancy|0|||
130694210|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
130233018|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233019|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233020|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233021|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233022|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233023|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
130233024|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
130233025|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130445880|NCT01513967|469593578|FG000|Overall Study|missed a study visit|0|||
130445881|NCT01513967|469593579|FG001|Overall Study|missed a study visit|0|||
130445882|NCT01513967|469593580|FG002|Overall Study|missed a study visit|0|||
130445883|NCT01513967|469593581|FG003|Overall Study|missed a study visit|0|||
130445884|NCT01513967|469593582|FG004|Overall Study|missed a study visit|0|||
130445885|NCT01513967|469593583|FG005|Overall Study|missed a study visit|0|||
130445886|NCT01513967|469593584|FG006|Overall Study|missed a study visit|1|||
130445887|NCT01513967|469593585|FG007|Overall Study|missed a study visit|0|||
130445888|NCT01513967|469593578|FG000|Overall Study|excluded due to positive drug screen|0|||
130445889|NCT01513967|469593579|FG001|Overall Study|excluded due to positive drug screen|0|||
130445890|NCT01513967|469593580|FG002|Overall Study|excluded due to positive drug screen|0|||
130445891|NCT01513967|469593581|FG003|Overall Study|excluded due to positive drug screen|0|||
130445892|NCT01513967|469593582|FG004|Overall Study|excluded due to positive drug screen|0|||
130445893|NCT01513967|469593583|FG005|Overall Study|excluded due to positive drug screen|0|||
130445894|NCT01513967|469593584|FG006|Overall Study|excluded due to positive drug screen|0|||
130445895|NCT01513967|469593585|FG007|Overall Study|excluded due to positive drug screen|2|||
130445896|NCT01513967|469593578|FG000|Overall Study|Physician Decision|0|||
130445897|NCT01513967|469593579|FG001|Overall Study|Physician Decision|0|||
130445898|NCT01513967|469593580|FG002|Overall Study|Physician Decision|0|||
130445899|NCT01513967|469593581|FG003|Overall Study|Physician Decision|0|||
130445900|NCT01513967|469593582|FG004|Overall Study|Physician Decision|0|||
130445901|NCT01513967|469593583|FG005|Overall Study|Physician Decision|1|||
130445902|NCT01513967|469593584|FG006|Overall Study|Physician Decision|0|||
130445903|NCT01513967|469593585|FG007|Overall Study|Physician Decision|0|||
130445904|NCT02711826|469593586|FG000|Overall Study|Physician Decision|0|||
130445905|NCT02711826|469593587|FG001|Overall Study|Physician Decision|0|||
130445906|NCT02711826|469593588|FG002|Overall Study|Physician Decision|0|||
130445907|NCT02711826|469593589|FG003|Overall Study|Physician Decision|1|||
130445908|NCT02711826|469593590|FG004|Overall Study|Physician Decision|0|||
130445909|NCT02711826|469593586|FG000|Overall Study|Withdrawal by Subject|0|||
130445910|NCT02711826|469593587|FG001|Overall Study|Withdrawal by Subject|1|||
130445911|NCT02711826|469593588|FG002|Overall Study|Withdrawal by Subject|0|||
130445912|NCT02711826|469593589|FG003|Overall Study|Withdrawal by Subject|4|||
130445913|NCT02711826|469593590|FG004|Overall Study|Withdrawal by Subject|0|||
130445914|NCT02711826|469593586|FG000|Overall Study|Failure to manufacture cellular product|0|||
130445915|NCT02711826|469593587|FG001|Overall Study|Failure to manufacture cellular product|0|||
130445916|NCT02711826|469593588|FG002|Overall Study|Failure to manufacture cellular product|5|||
130445917|NCT02711826|469593589|FG003|Overall Study|Failure to manufacture cellular product|0|||
130445918|NCT02711826|469593590|FG004|Overall Study|Failure to manufacture cellular product|0|||
130445919|NCT02711826|469593586|FG000|Overall Study|Infusion canceled for active infection|0|||
130445920|NCT02711826|469593587|FG001|Overall Study|Infusion canceled for active infection|1|||
130445921|NCT02711826|469593588|FG002|Overall Study|Infusion canceled for active infection|0|||
130445922|NCT02711826|469593589|FG003|Overall Study|Infusion canceled for active infection|0|||
130445923|NCT02711826|469593590|FG004|Overall Study|Infusion canceled for active infection|0|||
130445924|NCT02711826|469593586|FG000|Overall Study|Screen failures|0|||
130445925|NCT02711826|469593587|FG001|Overall Study|Screen failures|0|||
130445926|NCT02711826|469593588|FG002|Overall Study|Screen failures|0|||
130694211|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694212|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130233026|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233027|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233028|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130445927|NCT02711826|469593589|FG003|Overall Study|Screen failures|4|||
130445928|NCT02711826|469593590|FG004|Overall Study|Screen failures|0|||
130445929|NCT02906202|469593591|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
130445930|NCT01960790|469593592|FG000|Overall Study|Survey forms could not be recovered|3|||
130445931|NCT01960790|469593592|FG000|Overall Study|Treat with Humira outside survey period|3|||
130445932|NCT01960790|469593592|FG000|Overall Study|Transferred to another hospital|4|||
130445933|NCT01960790|469593592|FG000|Overall Study|Unevaluable for safety|1|||
130445934|NCT01987830|469593593|FG000|Overall Study|Never received baseline scan|1|||
130445935|NCT03990363|469593594|FG000|Overall Study|Withdrawal by Subject|10|||
130694213|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694214|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694215|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130357543|NCT01845818|469281044|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
130357544|NCT01845818|469281043|FG000|Overall Study|No Follow-Up Data Available|4|||
130357545|NCT01845818|469281044|FG001|Overall Study|No Follow-Up Data Available|1|||
130357546|NCT02186873|469281045|FG000|Overall Study|Adverse Event|1|||
130357547|NCT02186873|469281046|FG001|Overall Study|Adverse Event|3|||
130357548|NCT02186873|469281045|FG000|Overall Study|Lack of Efficacy|0|||
130357549|NCT02186873|469281046|FG001|Overall Study|Lack of Efficacy|1|||
130357550|NCT02186873|469281045|FG000|Overall Study|Lost to Follow-up|1|||
130357551|NCT02186873|469281046|FG001|Overall Study|Lost to Follow-up|2|||
130357552|NCT02186873|469281045|FG000|Overall Study|Withdrawal by Subject|7|||
130357553|NCT02186873|469281046|FG001|Overall Study|Withdrawal by Subject|2|||
130357554|NCT01680965|469281047|FG000|Overall Study|Death|0|||
130357555|NCT01680965|469281048|FG001|Overall Study|Death|0|||
130357556|NCT01680965|469281049|FG002|Overall Study|Death|0|||
130357557|NCT01680965|469281050|FG003|Overall Study|Death|6|||
130357558|NCT00107783|469281051|FG000|Overall Study|Adverse Event|0|||
130357559|NCT00107783|469281052|FG001|Overall Study|Adverse Event|2|||
130357560|NCT00107783|469281051|FG000|Overall Study|Death|0|||
130357561|NCT00107783|469281052|FG001|Overall Study|Death|1|||
130357562|NCT00107783|469281051|FG000|Overall Study|Withdrawal by Subject|2|||
130357563|NCT00107783|469281052|FG001|Overall Study|Withdrawal by Subject|0|||
130357564|NCT00107783|469281051|FG000|Overall Study|Second hip replacement|1|||
130357565|NCT00107783|469281052|FG001|Overall Study|Second hip replacement|1|||
130357566|NCT02367131|469281053|FG000|Overall Study|Adverse Event|64|||
130357567|NCT02367131|469281053|FG000|Overall Study|No visit since the first visit|3|||
130357568|NCT02367131|469281053|FG000|Overall Study|Request by patient|53|||
130357569|NCT02367131|469281053|FG000|Overall Study|Improvement/remission|2|||
130357570|NCT02367131|469281053|FG000|Overall Study|No change/progressive disease|78|||
130357571|NCT02367131|469281053|FG000|Overall Study|Other than stated above|20|||
130357572|NCT02367131|469281053|FG000|Overall Study|Not treated|2|||
130357573|NCT01051466|469281055|FG000|Overall Study|Adverse Event|1|||
130357574|NCT01051466|469281056|FG001|Overall Study|Adverse Event|0|||
130357575|NCT01051466|469281055|FG000|Overall Study|Lost to Follow-up|1|||
130357576|NCT01051466|469281056|FG001|Overall Study|Lost to Follow-up|1|||
130357577|NCT01051466|469281055|FG000|Overall Study|Withdrawal by Subject|5|||
130357578|NCT01051466|469281056|FG001|Overall Study|Withdrawal by Subject|1|||
130357579|NCT01051466|469281055|FG000|Overall Study|Entry Criteria Not Met|0|||
130357580|NCT01051466|469281056|FG001|Overall Study|Entry Criteria Not Met|3|||
130357581|NCT01051466|469281055|FG000|Overall Study|Physician Decision|1|||
130357582|NCT01051466|469281056|FG001|Overall Study|Physician Decision|0|||
130357583|NCT02231918|469281057|FG000|Overall Study|Withdrawal by Subject|0|||
130357584|NCT02231918|469281058|FG001|Overall Study|Withdrawal by Subject|1|||
130357585|NCT02231918|469281059|FG002|Overall Study|Withdrawal by Subject|0|||
130357586|NCT02231918|469281057|FG000|Overall Study|Adverse Event|0|||
130357587|NCT02231918|469281058|FG001|Overall Study|Adverse Event|0|||
130357588|NCT02231918|469281059|FG002|Overall Study|Adverse Event|1|||
130552900|NCT03291587|469991622|FG000|Overall Study|Too busy to participate|4|||
130552901|NCT03291587|469991623|FG001|Overall Study|Too busy to participate|2|||
130552902|NCT00796120|469991625|FG000|Overall Study|Death|3|||
130552903|NCT00796120|469991626|FG001|Overall Study|Death|0|||
130552904|NCT00796120|469991625|FG000|Overall Study|Adverse Event|11|||
130552905|NCT00796120|469991626|FG001|Overall Study|Adverse Event|6|||
130552906|NCT00796120|469991625|FG000|Overall Study|Progressive disease|22|||
130552907|NCT00796120|469991626|FG001|Overall Study|Progressive disease|13|||
130552908|NCT00796120|469991625|FG000|Overall Study|Participant refusal|3|||
130552909|NCT00796120|469991626|FG001|Overall Study|Participant refusal|4|||
130552910|NCT00796120|469991625|FG000|Overall Study|Other|6|||
130552911|NCT00796120|469991626|FG001|Overall Study|Other|17|||
130552912|NCT00796120|469991625|FG000|Overall Study|Physician Decision|16|||
130552913|NCT00796120|469991626|FG001|Overall Study|Physician Decision|17|||
130552914|NCT00796120|469991625|FG000|Overall Study|Randomized but not treated|0|||
130552915|NCT00796120|469991626|FG001|Overall Study|Randomized but not treated|3|||
130694216|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130552916|NCT02520284|469991627|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
130552917|NCT02520284|469991628|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
130552918|NCT02520284|469991629|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
130552919|NCT02520284|469991627|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
130552920|NCT02520284|469991628|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
130552921|NCT02520284|469991629|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
130552922|NCT02520284|469991627|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
130552923|NCT02520284|469991628|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
130357589|NCT00137631|469281060|FG000|Overall Study|Lost to Follow-up|37|||
130357590|NCT00137631|469281061|FG001|Overall Study|Lost to Follow-up|41|||
130357591|NCT01871142|469281064|FG000|Overall Study|Adverse Event|1|||
130357592|NCT00598702|469281073|FG000|Overall Study|Other|0|||
130357593|NCT00598702|469281074|FG001|Overall Study|Other|2|||
130233029|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130445936|NCT03990363|469593595|FG001|Overall Study|Withdrawal by Subject|9|||
130445937|NCT03990363|469593596|FG002|Overall Study|Withdrawal by Subject|18|||
130445938|NCT03990363|469593597|FG003|Overall Study|Withdrawal by Subject|11|||
130445939|NCT03990363|469593598|FG004|Overall Study|Withdrawal by Subject|9|||
130445940|NCT03990363|469593594|FG000|Overall Study|Physician Decision|1|||
130445941|NCT03990363|469593595|FG001|Overall Study|Physician Decision|0|||
130445942|NCT03990363|469593596|FG002|Overall Study|Physician Decision|0|||
130445943|NCT03990363|469593597|FG003|Overall Study|Physician Decision|0|||
130445944|NCT03990363|469593598|FG004|Overall Study|Physician Decision|0|||
130445945|NCT03990363|469593594|FG000|Overall Study|Adverse Event|1|||
130445946|NCT03990363|469593595|FG001|Overall Study|Adverse Event|3|||
130445947|NCT03990363|469593596|FG002|Overall Study|Adverse Event|2|||
130445948|NCT03990363|469593597|FG003|Overall Study|Adverse Event|2|||
130445949|NCT03990363|469593598|FG004|Overall Study|Adverse Event|0|||
130445950|NCT03990363|469593594|FG000|Overall Study|Death|14|||
130445951|NCT03990363|469593595|FG001|Overall Study|Death|8|||
130694217|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694218|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694219|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130445952|NCT03990363|469593596|FG002|Overall Study|Death|14|||
130445953|NCT03990363|469593597|FG003|Overall Study|Death|10|||
130445954|NCT03990363|469593598|FG004|Overall Study|Death|11|||
130445955|NCT03990363|469593594|FG000|Overall Study|Failure to meet randomization criteria|0|||
130445956|NCT03990363|469593595|FG001|Overall Study|Failure to meet randomization criteria|1|||
130694220|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694221|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694222|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694223|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694224|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694225|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694226|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694227|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694228|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694229|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694230|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694231|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694232|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
130694233|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
130694234|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
130694235|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
130694236|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
130694237|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
130694238|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
130694239|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
130694240|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
130694241|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
130694242|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
130694243|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
130694244|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
130694245|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
130694246|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
130694247|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
130694248|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
130694249|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
130694250|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
130694251|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
130694252|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
130694253|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
130694254|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
130233030|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130445957|NCT03990363|469593596|FG002|Overall Study|Failure to meet randomization criteria|1|||
130445958|NCT03990363|469593597|FG003|Overall Study|Failure to meet randomization criteria|0|||
130445959|NCT03990363|469593598|FG004|Overall Study|Failure to meet randomization criteria|0|||
130694255|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
130694256|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
130694257|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
130694258|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694259|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694260|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130445960|NCT03990363|469593594|FG000|Overall Study|Lost to Follow-up|0|||
130445961|NCT03990363|469593595|FG001|Overall Study|Lost to Follow-up|0|||
130233031|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233032|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233033|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
130233034|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
130233035|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233036|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233037|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233038|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233039|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233040|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233041|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233042|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233043|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
130233044|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
130233045|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233046|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233047|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233048|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233049|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233050|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233051|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233052|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233053|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
130233054|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
130233055|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233056|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233057|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233058|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233059|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233060|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233061|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130445962|NCT03990363|469593596|FG002|Overall Study|Lost to Follow-up|0|||
130233062|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233063|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
130233064|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
130233065|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233066|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130694261|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694262|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694263|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
130694264|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
130694265|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694266|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694267|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
130694268|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694269|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694270|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694271|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694272|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694273|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694274|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130233067|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233068|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233069|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233070|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233071|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233072|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233073|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
130233074|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233075|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233076|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233077|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233078|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233079|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233080|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233081|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233082|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233083|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
130233084|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233085|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130694275|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694276|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694277|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694278|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694279|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694280|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694281|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694282|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694283|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694284|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694285|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694286|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694287|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694288|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694289|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694290|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694291|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130233086|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233087|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233088|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130357594|NCT00598702|469281075|FG002|Overall Study|Other|0|||
130357595|NCT00598702|469281076|FG003|Overall Study|Other|0|||
130357596|NCT00598702|469281077|FG004|Overall Study|Other|0|||
130357597|NCT00598702|469281078|FG005|Overall Study|Other|1|||
130357598|NCT00598702|469281079|FG006|Overall Study|Other|0|||
130357599|NCT00598702|469281080|FG007|Overall Study|Other|0|||
130357600|NCT00598702|469281073|FG000|Overall Study|Early discharge from hospital|0|||
130357601|NCT00598702|469281074|FG001|Overall Study|Early discharge from hospital|0|||
130357602|NCT00598702|469281075|FG002|Overall Study|Early discharge from hospital|2|||
130445963|NCT03990363|469593597|FG003|Overall Study|Lost to Follow-up|1|||
130445964|NCT03990363|469593598|FG004|Overall Study|Lost to Follow-up|2|||
130445965|NCT03990363|469593594|FG000|Overall Study|Non-compliance with study drug|2|||
130445966|NCT03990363|469593595|FG001|Overall Study|Non-compliance with study drug|1|||
130445967|NCT03990363|469593596|FG002|Overall Study|Non-compliance with study drug|2|||
130445968|NCT03990363|469593597|FG003|Overall Study|Non-compliance with study drug|0|||
130445969|NCT03990363|469593598|FG004|Overall Study|Non-compliance with study drug|0|||
130445970|NCT03990363|469593594|FG000|Overall Study|Study terminated by sponsor|0|||
130445971|NCT03990363|469593595|FG001|Overall Study|Study terminated by sponsor|1|||
130445972|NCT03990363|469593596|FG002|Overall Study|Study terminated by sponsor|0|||
130445973|NCT03990363|469593597|FG003|Overall Study|Study terminated by sponsor|0|||
130445974|NCT03990363|469593598|FG004|Overall Study|Study terminated by sponsor|0|||
130445975|NCT03990363|469593594|FG000|Overall Study|Site terminated by sponsor|2|||
130445976|NCT03990363|469593595|FG001|Overall Study|Site terminated by sponsor|1|||
130445977|NCT03990363|469593596|FG002|Overall Study|Site terminated by sponsor|2|||
130445978|NCT03990363|469593597|FG003|Overall Study|Site terminated by sponsor|0|||
130445979|NCT03990363|469593598|FG004|Overall Study|Site terminated by sponsor|2|||
130445980|NCT03990363|469593594|FG000|Overall Study|Not categorized|5|||
130445981|NCT03990363|469593595|FG001|Overall Study|Not categorized|5|||
130445982|NCT03990363|469593596|FG002|Overall Study|Not categorized|3|||
130445983|NCT03990363|469593597|FG003|Overall Study|Not categorized|2|||
130445984|NCT03990363|469593598|FG004|Overall Study|Not categorized|2|||
130445985|NCT00057811|469593608|FG000|Overall Study|Lack of Efficacy|1|||
130445986|NCT00057811|469593609|FG001|Overall Study|Lack of Efficacy|4|||
130445987|NCT00057811|469593608|FG000|Overall Study|Physician Decision|1|||
130445988|NCT00057811|469593609|FG001|Overall Study|Physician Decision|0|||
130445989|NCT00057811|469593608|FG000|Overall Study|Withdrawal by Subject|3|||
130445990|NCT00057811|469593609|FG001|Overall Study|Withdrawal by Subject|4|||
130445991|NCT00057811|469593608|FG000|Overall Study|Ineligible|4|||
130445992|NCT00057811|469593609|FG001|Overall Study|Ineligible|2|||
130445993|NCT00057811|469593608|FG000|Overall Study|Inevaluable|1|||
130445994|NCT00057811|469593609|FG001|Overall Study|Inevaluable|2|||
130445995|NCT00556374|469593610|FG000|Overall Study|Withdrawal by Subject|235|||
130445996|NCT00556374|469593611|FG001|Overall Study|Withdrawal by Subject|205|||
130445997|NCT00556374|469593610|FG000|Overall Study|Death|158|||
130445998|NCT00556374|469593611|FG001|Overall Study|Death|127|||
130445999|NCT00556374|469593610|FG000|Overall Study|Lost to Follow-up|24|||
130233089|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233090|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233091|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233092|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233093|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
130233094|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
130233095|NCT02792504|468817906|FG000|Overall Study|Lost to Follow-up|24|||
130233096|NCT02792504|468817906|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
130233097|NCT00848497|468817913|FG000|Overall Study|Screen failure|2|||
130233098|NCT00848497|468817914|FG001|Overall Study|Screen failure|0|||
130233099|NCT00848497|468817913|FG000|Overall Study|Withdrawal by Subject|0|||
130233100|NCT00848497|468817914|FG001|Overall Study|Withdrawal by Subject|1|||
130233101|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233102|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233103|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233104|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233105|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
130233106|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233107|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
130233108|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233109|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233110|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233111|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233112|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233113|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130233114|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130446000|NCT00556374|469593611|FG001|Overall Study|Lost to Follow-up|17|||
130446001|NCT00556374|469593610|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
130694292|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
130694293|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130446002|NCT00556374|469593611|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
130446003|NCT02169219|469593612|FG000|Overall Study|Lack of Efficacy|6|||
130446004|NCT00238420|469593613|FG000|Overall Study|Protocol Violation|1|||
130446005|NCT00238420|469593614|FG001|Overall Study|Protocol Violation|1|||
130446006|NCT00442286|469593615|FG000|Overall Study|Death|2|||
130446007|NCT00442286|469593616|FG001|Overall Study|Death|2|||
130446008|NCT00442286|469593615|FG000|Overall Study|Lost to Follow-up|1|||
130446009|NCT00442286|469593616|FG001|Overall Study|Lost to Follow-up|0|||
130446010|NCT00442286|469593615|FG000|Overall Study|Withdrawal by Subject|2|||
130446011|NCT00442286|469593616|FG001|Overall Study|Withdrawal by Subject|0|||
130446012|NCT00442286|469593615|FG000|Overall Study|System explanted|1|||
130446013|NCT00442286|469593616|FG001|Overall Study|System explanted|0|||
130446014|NCT00442286|469593615|FG000|Overall Study|Patient Injury|1|||
130446015|NCT00442286|469593616|FG001|Overall Study|Patient Injury|0|||
130446016|NCT00663962|469593619|FG000|Overall Study|somnolence|1|||
130446017|NCT00663962|469593620|FG001|Overall Study|somnolence|0|||
130446018|NCT01544582|469593621|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
130446019|NCT01544582|469593622|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
130446020|NCT01544582|469593623|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
130446021|NCT01544582|469593624|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
130446022|NCT01544582|469593621|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
130446023|NCT01544582|469593622|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
130446024|NCT01544582|469593623|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
130446025|NCT01544582|469593624|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
130446026|NCT01544582|469593621|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
130446027|NCT01544582|469593622|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
130446028|NCT01544582|469593623|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
130446029|NCT01544582|469593624|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
130446030|NCT01544582|469593621|FG000|Analysis Population|Physician Decision|0|||
130446031|NCT01544582|469593622|FG001|Analysis Population|Physician Decision|13|||
130446032|NCT01544582|469593623|FG002|Analysis Population|Physician Decision|10|||
130446033|NCT01544582|469593624|FG003|Analysis Population|Physician Decision|9|||
130446034|NCT01544582|469593621|FG000|Analysis Population|Safety Reason|0|||
130446035|NCT01544582|469593622|FG001|Analysis Population|Safety Reason|33|||
130446036|NCT01544582|469593623|FG002|Analysis Population|Safety Reason|31|||
130446037|NCT01544582|469593624|FG003|Analysis Population|Safety Reason|8|||
130446038|NCT01544582|469593621|FG000|Analysis Population|Effectiveness Reason|0|||
130446039|NCT01544582|469593622|FG001|Analysis Population|Effectiveness Reason|48|||
130446040|NCT01544582|469593623|FG002|Analysis Population|Effectiveness Reason|29|||
130446041|NCT01544582|469593624|FG003|Analysis Population|Effectiveness Reason|12|||
130446042|NCT01544582|469593621|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
130446043|NCT01544582|469593622|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
130446044|NCT01544582|469593623|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
130446045|NCT01544582|469593624|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
130446046|NCT01544582|469593621|FG000|Analysis Population|Lost to Follow-up|0|||
130446047|NCT01544582|469593622|FG001|Analysis Population|Lost to Follow-up|6|||
130446048|NCT01544582|469593623|FG002|Analysis Population|Lost to Follow-up|6|||
130446049|NCT01544582|469593624|FG003|Analysis Population|Lost to Follow-up|5|||
130446050|NCT01544582|469593621|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
130446051|NCT01544582|469593622|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
130446052|NCT01544582|469593623|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
130446053|NCT01544582|469593624|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
130694294|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694295|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694296|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694297|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694298|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694299|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130446054|NCT01544582|469593621|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
130446055|NCT01544582|469593622|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
130446056|NCT01544582|469593623|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
130446057|NCT01544582|469593624|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
130446058|NCT01544582|469593621|FG000|Analysis Population|Intolerance|0|||
130446059|NCT01544582|469593622|FG001|Analysis Population|Intolerance|1|||
130446060|NCT01544582|469593623|FG002|Analysis Population|Intolerance|0|||
130446061|NCT01544582|469593624|FG003|Analysis Population|Intolerance|0|||
130446062|NCT01544582|469593621|FG000|Analysis Population|Liver Transplantation|0|||
130446063|NCT01544582|469593622|FG001|Analysis Population|Liver Transplantation|0|||
130446064|NCT01544582|469593623|FG002|Analysis Population|Liver Transplantation|1|||
130446065|NCT01544582|469593624|FG003|Analysis Population|Liver Transplantation|0|||
130446066|NCT01544582|469593621|FG000|Analysis Population|No Social Insurance|0|||
130446067|NCT01544582|469593622|FG001|Analysis Population|No Social Insurance|0|||
130446068|NCT01544582|469593623|FG002|Analysis Population|No Social Insurance|1|||
130446069|NCT01544582|469593624|FG003|Analysis Population|No Social Insurance|0|||
130446070|NCT01544582|469593621|FG000|Analysis Population|Poor Adherence|0|||
130446071|NCT01544582|469593622|FG001|Analysis Population|Poor Adherence|0|||
130446072|NCT01544582|469593623|FG002|Analysis Population|Poor Adherence|1|||
130446073|NCT01544582|469593624|FG003|Analysis Population|Poor Adherence|0|||
130694300|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130446074|NCT01544582|469593621|FG000|Analysis Population|Poor Participant Compliance|0|||
130357603|NCT00598702|469281076|FG003|Overall Study|Early discharge from hospital|5|||
130694301|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130446075|NCT01544582|469593622|FG001|Analysis Population|Poor Participant Compliance|1|||
130446076|NCT01544582|469593623|FG002|Analysis Population|Poor Participant Compliance|0|||
130446077|NCT01544582|469593624|FG003|Analysis Population|Poor Participant Compliance|0|||
130446078|NCT01544582|469593621|FG000|Analysis Population|Programmed Surgery|0|||
130446079|NCT01544582|469593622|FG001|Analysis Population|Programmed Surgery|1|||
130446080|NCT01544582|469593623|FG002|Analysis Population|Programmed Surgery|0|||
130446081|NCT01544582|469593624|FG003|Analysis Population|Programmed Surgery|0|||
130446082|NCT01544582|469593621|FG000|Analysis Population|Participant in Jail|0|||
130446083|NCT01544582|469593622|FG001|Analysis Population|Participant in Jail|0|||
130446084|NCT01544582|469593623|FG002|Analysis Population|Participant in Jail|1|||
130446085|NCT01544582|469593624|FG003|Analysis Population|Participant in Jail|0|||
130446086|NCT03428815|469593625|FG000|Overall Study|Lost to Follow-up|2|||
130446087|NCT03428815|469593626|FG001|Overall Study|Lost to Follow-up|2|||
130446088|NCT03428815|469593625|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
130446089|NCT03428815|469593626|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
130446090|NCT03428815|469593625|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
130446091|NCT03428815|469593626|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
130446092|NCT02102464|469593627|FG000|Randomized Study|Withdrawal by Subject|0|||
130446093|NCT02102464|469593628|FG001|Randomized Study|Withdrawal by Subject|1|||
130446094|NCT02102464|469593629|FG002|Randomized Study|Withdrawal by Subject|0|||
130446095|NCT01700348|469593630|FG000|Overall Study|Withdrawal by Subject|22|||
130446096|NCT01700348|469593630|FG000|Overall Study|Lost to Follow-up|1|||
130446097|NCT04140890|469593631|FG000|Overall Study|Withdrawal by Subject|0|||
130446098|NCT04140890|469593632|FG001|Overall Study|Withdrawal by Subject|1|||
130357604|NCT00598702|469281077|FG004|Overall Study|Early discharge from hospital|0|||
130357605|NCT00598702|469281078|FG005|Overall Study|Early discharge from hospital|10|||
130694302|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694303|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694304|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130357606|NCT00598702|469281079|FG006|Overall Study|Early discharge from hospital|1|||
130357607|NCT00598702|469281080|FG007|Overall Study|Early discharge from hospital|0|||
130357608|NCT00598702|469281073|FG000|Overall Study|Adverse Event|0|||
130357609|NCT00598702|469281074|FG001|Overall Study|Adverse Event|0|||
130357610|NCT00598702|469281075|FG002|Overall Study|Adverse Event|0|||
130357611|NCT00598702|469281076|FG003|Overall Study|Adverse Event|1|||
130357612|NCT00598702|469281077|FG004|Overall Study|Adverse Event|0|||
130357613|NCT00598702|469281078|FG005|Overall Study|Adverse Event|0|||
130357614|NCT00598702|469281079|FG006|Overall Study|Adverse Event|0|||
130357615|NCT00598702|469281080|FG007|Overall Study|Adverse Event|0|||
130357616|NCT00598702|469281073|FG000|Overall Study|Withdrawal by Subject|0|||
130357617|NCT00598702|469281074|FG001|Overall Study|Withdrawal by Subject|0|||
130357618|NCT00598702|469281075|FG002|Overall Study|Withdrawal by Subject|0|||
130357619|NCT00598702|469281076|FG003|Overall Study|Withdrawal by Subject|1|||
130357620|NCT00598702|469281077|FG004|Overall Study|Withdrawal by Subject|1|||
130357621|NCT00598702|469281078|FG005|Overall Study|Withdrawal by Subject|0|||
130357622|NCT00598702|469281079|FG006|Overall Study|Withdrawal by Subject|0|||
130357623|NCT00598702|469281080|FG007|Overall Study|Withdrawal by Subject|0|||
130357624|NCT00598702|469281073|FG000|Overall Study|Physician Decision|0|||
130357625|NCT00598702|469281074|FG001|Overall Study|Physician Decision|0|||
130357626|NCT00598702|469281075|FG002|Overall Study|Physician Decision|0|||
130357627|NCT00598702|469281076|FG003|Overall Study|Physician Decision|0|||
130357628|NCT00598702|469281077|FG004|Overall Study|Physician Decision|1|||
130357629|NCT00598702|469281078|FG005|Overall Study|Physician Decision|0|||
130357630|NCT00598702|469281079|FG006|Overall Study|Physician Decision|0|||
130357631|NCT00598702|469281080|FG007|Overall Study|Physician Decision|0|||
130357632|NCT00598702|469281073|FG000|Overall Study|Dose limiting toxicity|0|||
130357633|NCT00598702|469281074|FG001|Overall Study|Dose limiting toxicity|0|||
130357634|NCT00598702|469281075|FG002|Overall Study|Dose limiting toxicity|0|||
130357635|NCT00598702|469281076|FG003|Overall Study|Dose limiting toxicity|1|||
130357636|NCT00598702|469281077|FG004|Overall Study|Dose limiting toxicity|1|||
130357637|NCT00598702|469281078|FG005|Overall Study|Dose limiting toxicity|1|||
130357638|NCT00598702|469281079|FG006|Overall Study|Dose limiting toxicity|0|||
130446099|NCT03958630|469593637|FG000|Overall Study|Withdrawal by Subject|0|||
130446100|NCT03958630|469593638|FG001|Overall Study|Withdrawal by Subject|0|||
130357639|NCT00598702|469281080|FG007|Overall Study|Dose limiting toxicity|0|||
130357640|NCT02106910|469281081|FG000|Overall Study|Lost to Follow-up|1|||
130446101|NCT03958630|469593639|FG002|Overall Study|Withdrawal by Subject|1|||
130446102|NCT03958630|469593637|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
130446103|NCT03958630|469593638|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
130446104|NCT03958630|469593639|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
130446105|NCT01824472|469593644|FG000|Overall Study|Lost to Follow-up|0|||
130357641|NCT02106910|469281082|FG001|Overall Study|Lost to Follow-up|1|||
130357642|NCT01675427|469281085|FG000|Overall Study|Withdrawal by Subject|7|||
130357643|NCT01675427|469281085|FG000|Overall Study|Participant Refused Sample Collection|18|||
130357644|NCT01675427|469281085|FG000|Overall Study|Sample not Collected by Mistake|2|||
130357645|NCT01675427|469281085|FG000|Overall Study|Lost to Follow-up|5|||
130357646|NCT01675427|469281085|FG000|Overall Study|Other|2|||
130357647|NCT00700570|469281086|FG000|Overall Study|Adverse Event|2|||
130357648|NCT00700570|469281087|FG001|Overall Study|Adverse Event|6|||
130357649|NCT00700570|469281086|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
130357650|NCT00700570|469281087|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
130357651|NCT00700570|469281086|FG000|Overall Study|Disease Progression|8|||
130357652|NCT00700570|469281087|FG001|Overall Study|Disease Progression|11|||
130357653|NCT00700570|469281086|FG000|Overall Study|Withdrawal by Subject|1|||
130357654|NCT00700570|469281087|FG001|Overall Study|Withdrawal by Subject|6|||
130357655|NCT00611533|469281088|FG000|First Intervention (6 Weeks)|Never started study|0|||
130357656|NCT00611533|469281089|FG001|First Intervention (6 Weeks)|Never started study|1|||
130357657|NCT00611533|469281088|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
130357658|NCT00611533|469281089|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130357659|NCT00611533|469281088|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130357660|NCT00611533|469281089|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
130357661|NCT04327674|469281096|FG000|Overall Study|Protocol Violation|19|||
130357662|NCT01461980|469281097|FG000|Overall Study|Other|9|||
130357663|NCT01461980|469281098|FG001|Overall Study|Other|8|||
130357664|NCT01461980|469281099|FG002|Overall Study|Other|6|||
130357665|NCT01461980|469281097|FG000|Overall Study|Medication error|7|||
130357666|NCT01461980|469281098|FG001|Overall Study|Medication error|5|||
130357667|NCT01461980|469281099|FG002|Overall Study|Medication error|6|||
130357668|NCT01461980|469281097|FG000|Overall Study|Adverse Event|12|||
130357669|NCT01461980|469281098|FG001|Overall Study|Adverse Event|5|||
130357670|NCT01461980|469281099|FG002|Overall Study|Adverse Event|6|||
130357671|NCT01461980|469281097|FG000|Overall Study|Protocol Violation|12|||
130357672|NCT01461980|469281098|FG001|Overall Study|Protocol Violation|19|||
130357673|NCT01461980|469281099|FG002|Overall Study|Protocol Violation|16|||
130357674|NCT01461980|469281097|FG000|Overall Study|No longer meets eligibility criteria|18|||
130357675|NCT01461980|469281098|FG001|Overall Study|No longer meets eligibility criteria|9|||
130357676|NCT01461980|469281099|FG002|Overall Study|No longer meets eligibility criteria|19|||
130357677|NCT01461980|469281097|FG000|Overall Study|Lost to Follow-up|52|||
130357678|NCT01461980|469281098|FG001|Overall Study|Lost to Follow-up|53|||
130357679|NCT01461980|469281099|FG002|Overall Study|Lost to Follow-up|51|||
130357680|NCT01461980|469281097|FG000|Overall Study|No longer willing to participate|52|||
130357681|NCT01461980|469281098|FG001|Overall Study|No longer willing to participate|38|||
130357682|NCT01461980|469281099|FG002|Overall Study|No longer willing to participate|54|||
130357683|NCT01461980|469281097|FG000|Overall Study|Randomized but not vaccinated|4|||
130357684|NCT01461980|469281098|FG001|Overall Study|Randomized but not vaccinated|8|||
130357685|NCT01461980|469281099|FG002|Overall Study|Randomized but not vaccinated|7|||
130357686|NCT00631696|469281104|FG000|Overall Study|Entered, not randomized to treatment|1|||
130357687|NCT00631696|469281105|FG001|Overall Study|Entered, not randomized to treatment|1|||
130357688|NCT00631696|469281104|FG000|Overall Study|Discontinued after database release date|1|||
130357689|NCT00631696|469281105|FG001|Overall Study|Discontinued after database release date|0|||
130357690|NCT00631696|469281104|FG000|Overall Study|Follow up after database release date|1|||
130357691|NCT00631696|469281105|FG001|Overall Study|Follow up after database release date|0|||
130357692|NCT00631696|469281104|FG000|Overall Study|Lost to Follow-up|7|||
130357693|NCT00631696|469281105|FG001|Overall Study|Lost to Follow-up|10|||
130357694|NCT00631696|469281104|FG000|Overall Study|Withdrawal by Subject|2|||
130357695|NCT00631696|469281105|FG001|Overall Study|Withdrawal by Subject|9|||
130357696|NCT00631696|469281104|FG000|Overall Study|Other|8|||
130357697|NCT00631696|469281105|FG001|Overall Study|Other|8|||
130357698|NCT00631696|469281104|FG000|Overall Study|Protocol Violation|9|||
130357699|NCT00631696|469281105|FG001|Overall Study|Protocol Violation|9|||
130357700|NCT00631696|469281104|FG000|Overall Study|Study terminated by sponsor|3|||
130357701|NCT00631696|469281105|FG001|Overall Study|Study terminated by sponsor|3|||
130357702|NCT00631696|469281104|FG000|Overall Study|Adverse Event|5|||
130357703|NCT00631696|469281105|FG001|Overall Study|Adverse Event|0|||
130357704|NCT01938573|469281107|FG000|Overall Study|Lack of Efficacy|1|||
130694305|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694306|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694307|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694308|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694309|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694310|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694311|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694312|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
130357705|NCT01938573|469281108|FG001|Overall Study|Lack of Efficacy|0|||
130357706|NCT01938573|469281107|FG000|Overall Study|Operation at other hospital|1|||
130357707|NCT01938573|469281108|FG001|Overall Study|Operation at other hospital|0|||
130233115|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
130316113|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
130357708|NCT01199731|469281112|FG000|Overall Study|Adverse Event|0|||
130357709|NCT01199731|469281113|FG001|Overall Study|Adverse Event|1|||
130357710|NCT01199731|469281114|FG002|Overall Study|Adverse Event|0|||
130357711|NCT01199731|469281112|FG000|Overall Study|Study closed/terminated|7|||
130357712|NCT01199731|469281113|FG001|Overall Study|Study closed/terminated|9|||
130357713|NCT01199731|469281114|FG002|Overall Study|Study closed/terminated|7|||
130357714|NCT01199731|469281112|FG000|Overall Study|Lost to Follow-up|0|||
130357715|NCT01199731|469281113|FG001|Overall Study|Lost to Follow-up|0|||
130357716|NCT01199731|469281114|FG002|Overall Study|Lost to Follow-up|2|||
130357717|NCT01199731|469281112|FG000|Overall Study|Physician Decision|0|||
130357718|NCT01199731|469281113|FG001|Overall Study|Physician Decision|1|||
130357719|NCT01199731|469281114|FG002|Overall Study|Physician Decision|1|||
130357720|NCT01199731|469281112|FG000|Overall Study|Withdrawal by Subject|2|||
130357721|NCT01199731|469281113|FG001|Overall Study|Withdrawal by Subject|0|||
130357722|NCT01199731|469281114|FG002|Overall Study|Withdrawal by Subject|0|||
130357723|NCT00943124|469281115|FG000|Period 1|Withdrawal by Subject|1|||
130357724|NCT00943124|469281116|FG001|Period 1|Withdrawal by Subject|1|||
130357725|NCT00943124|469281115|FG000|Period 1|Did Not Follow Study Procedures|1|||
130357726|NCT00943124|469281116|FG001|Period 1|Did Not Follow Study Procedures|0|||
130357727|NCT00943124|469281115|FG000|Period 1|Personal Reasons|0|||
130357728|NCT00943124|469281116|FG001|Period 1|Personal Reasons|1|||
130357729|NCT02448810|469281118|FG000|Overall Study|Adverse Event|0|||
130357730|NCT02448810|469281119|FG001|Overall Study|Adverse Event|0|||
130357731|NCT02448810|469281120|FG002|Overall Study|Adverse Event|1|||
130357732|NCT02448810|469281121|FG003|Overall Study|Adverse Event|0|||
130357733|NCT02448810|469281122|FG004|Overall Study|Adverse Event|0|||
130357734|NCT02448810|469281123|FG005|Overall Study|Adverse Event|0|||
130357735|NCT02448810|469281124|FG006|Overall Study|Adverse Event|0|||
130357736|NCT02448810|469281125|FG007|Overall Study|Adverse Event|0|||
130357737|NCT02448810|469281118|FG000|Overall Study|Withdrawal by Subject|0|||
130357738|NCT02448810|469281119|FG001|Overall Study|Withdrawal by Subject|0|||
130357739|NCT02448810|469281120|FG002|Overall Study|Withdrawal by Subject|1|||
130357740|NCT02448810|469281121|FG003|Overall Study|Withdrawal by Subject|0|||
130357741|NCT02448810|469281122|FG004|Overall Study|Withdrawal by Subject|3|||
130357742|NCT02448810|469281123|FG005|Overall Study|Withdrawal by Subject|5|||
130357743|NCT02448810|469281124|FG006|Overall Study|Withdrawal by Subject|0|||
130357744|NCT02448810|469281125|FG007|Overall Study|Withdrawal by Subject|2|||
130357745|NCT02448810|469281118|FG000|Overall Study|Other (study terminated by sponsor)|0|||
130357746|NCT02448810|469281119|FG001|Overall Study|Other (study terminated by sponsor)|0|||
130357747|NCT02448810|469281120|FG002|Overall Study|Other (study terminated by sponsor)|0|||
130357748|NCT02448810|469281121|FG003|Overall Study|Other (study terminated by sponsor)|0|||
130357749|NCT02448810|469281122|FG004|Overall Study|Other (study terminated by sponsor)|4|||
130357750|NCT02448810|469281123|FG005|Overall Study|Other (study terminated by sponsor)|2|||
130357751|NCT02448810|469281124|FG006|Overall Study|Other (study terminated by sponsor)|2|||
130357752|NCT02448810|469281125|FG007|Overall Study|Other (study terminated by sponsor)|1|||
130357753|NCT02448810|469281118|FG000|Overall Study|Death|1|||
130357754|NCT02448810|469281119|FG001|Overall Study|Death|0|||
130357755|NCT02448810|469281120|FG002|Overall Study|Death|1|||
130357756|NCT02448810|469281121|FG003|Overall Study|Death|0|||
130357757|NCT02448810|469281122|FG004|Overall Study|Death|1|||
130316114|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
130316115|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316116|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316117|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316118|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316119|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316120|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316121|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316122|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316123|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316124|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316125|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316126|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316127|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
130316128|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316129|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316130|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316131|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316132|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130694313|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694314|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694315|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694316|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694317|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694318|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
130694319|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694320|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
130233116|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
130233117|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130233118|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
130233119|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233120|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233121|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130357758|NCT02448810|469281123|FG005|Overall Study|Death|0|||
130357759|NCT02448810|469281124|FG006|Overall Study|Death|0|||
130357760|NCT02448810|469281125|FG007|Overall Study|Death|0|||
130357761|NCT02448810|469281118|FG000|Overall Study|Other (Progressive disease)|2|||
130357762|NCT02448810|469281119|FG001|Overall Study|Other (Progressive disease)|2|||
130357763|NCT02448810|469281120|FG002|Overall Study|Other (Progressive disease)|0|||
130357764|NCT02448810|469281121|FG003|Overall Study|Other (Progressive disease)|3|||
130357765|NCT02448810|469281122|FG004|Overall Study|Other (Progressive disease)|23|||
130357766|NCT02448810|469281123|FG005|Overall Study|Other (Progressive disease)|9|||
130357767|NCT02448810|469281124|FG006|Overall Study|Other (Progressive disease)|14|||
130357768|NCT02448810|469281125|FG007|Overall Study|Other (Progressive disease)|5|||
130357769|NCT02448810|469281118|FG000|Overall Study|Lost to Follow-up|0|||
130357770|NCT02448810|469281119|FG001|Overall Study|Lost to Follow-up|1|||
130357771|NCT02448810|469281120|FG002|Overall Study|Lost to Follow-up|0|||
130357772|NCT02448810|469281121|FG003|Overall Study|Lost to Follow-up|0|||
130357773|NCT02448810|469281122|FG004|Overall Study|Lost to Follow-up|0|||
130357774|NCT02448810|469281123|FG005|Overall Study|Lost to Follow-up|0|||
130357775|NCT02448810|469281124|FG006|Overall Study|Lost to Follow-up|0|||
130357776|NCT02448810|469281125|FG007|Overall Study|Lost to Follow-up|0|||
130357777|NCT02448810|469281118|FG000|Overall Study|Other (unspecified)|0|||
130357778|NCT02448810|469281119|FG001|Overall Study|Other (unspecified)|0|||
130357779|NCT02448810|469281120|FG002|Overall Study|Other (unspecified)|0|||
130357780|NCT02448810|469281121|FG003|Overall Study|Other (unspecified)|0|||
130357781|NCT02448810|469281122|FG004|Overall Study|Other (unspecified)|0|||
130357782|NCT02448810|469281123|FG005|Overall Study|Other (unspecified)|0|||
130357783|NCT02448810|469281124|FG006|Overall Study|Other (unspecified)|2|||
130357784|NCT02448810|469281125|FG007|Overall Study|Other (unspecified)|0|||
130357785|NCT00470847|469281128|FG000|Overall Study|Pt still receiving treatment|1|||
130357786|NCT01912963|469281135|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
130357787|NCT01912963|469281136|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
130357788|NCT01912963|469281137|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
130357789|NCT01912963|469281135|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
130357790|NCT01912963|469281136|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
130357791|NCT01912963|469281137|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
130357792|NCT01912963|469281135|FG000|Overall Study|Adverse Event|0|||
130357793|NCT01912963|469281136|FG001|Overall Study|Adverse Event|1|||
130357794|NCT01912963|469281137|FG002|Overall Study|Adverse Event|1|||
130357795|NCT01912963|469281135|FG000|Overall Study|Withdrawal by Subject|0|||
130357796|NCT01912963|469281136|FG001|Overall Study|Withdrawal by Subject|1|||
130357797|NCT01912963|469281137|FG002|Overall Study|Withdrawal by Subject|0|||
130357798|NCT01912963|469281135|FG000|Overall Study|Sought treatment locally|0|||
130357799|NCT01912963|469281136|FG001|Overall Study|Sought treatment locally|1|||
130357800|NCT01912963|469281137|FG002|Overall Study|Sought treatment locally|0|||
130357801|NCT03112590|469281142|FG000|Overall Study|Adverse Event|0|||
130357802|NCT03112590|469281143|FG001|Overall Study|Adverse Event|1|||
130357803|NCT03112590|469281144|FG002|Overall Study|Adverse Event|0|||
130357804|NCT05156073|469281145|FG000|Overall Study|Patient canceled appointment with PCP|1|||
130357805|NCT02734433|469281146|FG000|Overall Study|Disease progression|1|||
130357806|NCT02734433|469281147|FG001|Overall Study|Disease progression|5|||
130357807|NCT02734433|469281146|FG000|Overall Study|Clinical progression|0|||
130357808|NCT02734433|469281147|FG001|Overall Study|Clinical progression|1|||
130357809|NCT02734433|469281146|FG000|Overall Study|Withdrawal by Subject|1|||
130357810|NCT02734433|469281147|FG001|Overall Study|Withdrawal by Subject|2|||
130233122|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
130357811|NCT03805646|469281149|FG000|Overall Study|Death|40|||
130357812|NCT03805646|469281150|FG001|Overall Study|Death|49|||
130357813|NCT03805646|469281149|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
130694321|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
130357814|NCT03805646|469281150|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
130357815|NCT05521906|469281151|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
130357816|NCT05521906|469281152|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
130357817|NCT00891462|469283076|FG000|Overall Study|Withdrawal by Subject|9|||
130357818|NCT00891462|469283077|FG001|Overall Study|Withdrawal by Subject|6|||
130357819|NCT00891462|469283078|FG002|Overall Study|Withdrawal by Subject|7|||
130357820|NCT00891462|469283076|FG000|Overall Study|Adverse Event|7|||
130357821|NCT00891462|469283077|FG001|Overall Study|Adverse Event|8|||
130357822|NCT00891462|469283078|FG002|Overall Study|Adverse Event|7|||
130357823|NCT00891462|469283076|FG000|Overall Study|Lack of Efficacy|10|||
130357824|NCT00891462|469283077|FG001|Overall Study|Lack of Efficacy|5|||
130357825|NCT00891462|469283078|FG002|Overall Study|Lack of Efficacy|1|||
130357826|NCT00891462|469283076|FG000|Overall Study|COPD exacerbation|7|||
130357827|NCT00891462|469283077|FG001|Overall Study|COPD exacerbation|4|||
130357828|NCT00891462|469283078|FG002|Overall Study|COPD exacerbation|1|||
130357829|NCT00891462|469283076|FG000|Overall Study|Other Reason|2|||
130357830|NCT00891462|469283077|FG001|Overall Study|Other Reason|5|||
130357831|NCT00891462|469283078|FG002|Overall Study|Other Reason|3|||
130357832|NCT00891462|469283076|FG000|Overall Study|Protocol Violation|2|||
130357833|NCT00891462|469283077|FG001|Overall Study|Protocol Violation|1|||
130357834|NCT00891462|469283078|FG002|Overall Study|Protocol Violation|3|||
130357835|NCT00891462|469283076|FG000|Overall Study|Inclusion/exclusion criteria|0|||
130357836|NCT00891462|469283077|FG001|Overall Study|Inclusion/exclusion criteria|2|||
130357837|NCT00891462|469283078|FG002|Overall Study|Inclusion/exclusion criteria|2|||
130357838|NCT00891462|469283076|FG000|Overall Study|Lost to Follow-up|0|||
130357839|NCT00891462|469283077|FG001|Overall Study|Lost to Follow-up|2|||
130357840|NCT00891462|469283078|FG002|Overall Study|Lost to Follow-up|0|||
130357841|NCT00257608|469283084|FG000|Chemotherapy Phase|Adverse Event|138|||
130357842|NCT00257608|469283085|FG001|Chemotherapy Phase|Adverse Event|0|||
130357843|NCT00257608|469283086|FG002|Chemotherapy Phase|Adverse Event|0|||
130357844|NCT00257608|469283084|FG000|Chemotherapy Phase|Disease progression|139|||
130357845|NCT00257608|469283085|FG001|Chemotherapy Phase|Disease progression|0|||
130357846|NCT00257608|469283086|FG002|Chemotherapy Phase|Disease progression|0|||
130357847|NCT00257608|469283084|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
130357848|NCT00257608|469283085|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
130357849|NCT00257608|469283086|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
130357850|NCT00257608|469283084|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
130357851|NCT00257608|469283085|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130357852|NCT00257608|469283086|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130357853|NCT00257608|469283084|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
130357854|NCT00257608|469283085|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
130357855|NCT00257608|469283086|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
130357856|NCT00257608|469283084|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
130357857|NCT00257608|469283085|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
130357858|NCT00257608|469283086|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
130357859|NCT00257608|469283084|FG000|Chemotherapy Phase|Physician Decision|28|||
130357860|NCT00257608|469283085|FG001|Chemotherapy Phase|Physician Decision|0|||
130357861|NCT00257608|469283086|FG002|Chemotherapy Phase|Physician Decision|0|||
130357862|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Adverse Event|0|||
130357863|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Adverse Event|34|||
130357864|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Adverse Event|38|||
130357865|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Disease progression|0|||
130357866|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Disease progression|204|||
130357867|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Disease progression|168|||
130357868|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
130357869|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
130357870|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
130357871|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130357872|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
130357873|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
130357874|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
130357875|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
130357876|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
130233123|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233124|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130357877|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
130357878|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
130357879|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
130357880|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
130357881|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
130357882|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
130357883|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Physician Decision|0|||
130357884|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Physician Decision|8|||
130357885|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Physician Decision|11|||
130357886|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
130357887|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
130357888|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
130357889|NCT00257608|469283084|FG000|Post Chemotherapy Phase|Not treated|0|||
130357890|NCT00257608|469283085|FG001|Post Chemotherapy Phase|Not treated|4|||
130357891|NCT00257608|469283086|FG002|Post Chemotherapy Phase|Not treated|7|||
130357892|NCT02171065|469283087|FG000|Overall Study|Withdrawal by Subject|1|||
130357893|NCT02171065|469283088|FG001|Overall Study|Withdrawal by Subject|0|||
130357894|NCT02171065|469283089|FG002|Overall Study|Withdrawal by Subject|0|||
130357895|NCT02171065|469283087|FG000|Overall Study|Lost to Follow-up|0|||
130357896|NCT02171065|469283088|FG001|Overall Study|Lost to Follow-up|0|||
130357897|NCT02171065|469283089|FG002|Overall Study|Lost to Follow-up|1|||
130357898|NCT02598960|469283090|FG000|Treatment Period|Disease Progression|4|||
130357899|NCT02598960|469283091|FG001|Treatment Period|Disease Progression|4|||
130357900|NCT02598960|469283092|FG002|Treatment Period|Disease Progression|4|||
130357901|NCT02598960|469283093|FG003|Treatment Period|Disease Progression|6|||
130357902|NCT02598960|469283094|FG004|Treatment Period|Disease Progression|8|||
130357903|NCT02598960|469283095|FG005|Treatment Period|Disease Progression|2|||
130357904|NCT02598960|469283096|FG006|Treatment Period|Disease Progression|2|||
130357905|NCT02598960|469283097|FG007|Treatment Period|Disease Progression|3|||
130357906|NCT02598960|469283098|FG008|Treatment Period|Disease Progression|7|||
130357907|NCT02598960|469283099|FG009|Treatment Period|Disease Progression|9|||
130357908|NCT02598960|469283100|FG010|Treatment Period|Disease Progression|7|||
130357909|NCT02598960|469283101|FG011|Treatment Period|Disease Progression|143|||
130357910|NCT02598960|469283102|FG012|Treatment Period|Disease Progression|23|||
130357911|NCT02598960|469283090|FG000|Treatment Period|Study drug toxicity|0|||
130357912|NCT02598960|469283091|FG001|Treatment Period|Study drug toxicity|0|||
130357913|NCT02598960|469283092|FG002|Treatment Period|Study drug toxicity|0|||
130357914|NCT02598960|469283093|FG003|Treatment Period|Study drug toxicity|0|||
130357915|NCT02598960|469283094|FG004|Treatment Period|Study drug toxicity|0|||
130357916|NCT02598960|469283095|FG005|Treatment Period|Study drug toxicity|0|||
130357917|NCT02598960|469283096|FG006|Treatment Period|Study drug toxicity|0|||
130357918|NCT02598960|469283097|FG007|Treatment Period|Study drug toxicity|0|||
130357919|NCT02598960|469283098|FG008|Treatment Period|Study drug toxicity|0|||
130357920|NCT02598960|469283099|FG009|Treatment Period|Study drug toxicity|1|||
130357921|NCT02598960|469283100|FG010|Treatment Period|Study drug toxicity|0|||
130357922|NCT02598960|469283101|FG011|Treatment Period|Study drug toxicity|3|||
130357923|NCT02598960|469283102|FG012|Treatment Period|Study drug toxicity|0|||
130357924|NCT02598960|469283090|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
130357925|NCT02598960|469283091|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
130357926|NCT02598960|469283092|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
130357927|NCT02598960|469283093|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
130357928|NCT02598960|469283094|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
130357929|NCT02598960|469283095|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
130357930|NCT02598960|469283096|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
130357931|NCT02598960|469283097|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
130357932|NCT02598960|469283098|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
130357933|NCT02598960|469283099|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
130357934|NCT02598960|469283100|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
130357935|NCT02598960|469283101|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
130357936|NCT02598960|469283102|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
130357937|NCT02598960|469283090|FG000|Treatment Period|participant request to discontinue|0|||
130357938|NCT02598960|469283091|FG001|Treatment Period|participant request to discontinue|1|||
130357939|NCT02598960|469283092|FG002|Treatment Period|participant request to discontinue|0|||
130357940|NCT02598960|469283093|FG003|Treatment Period|participant request to discontinue|0|||
130446106|NCT01824472|469593645|FG001|Overall Study|Lost to Follow-up|0|||
130233125|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130357941|NCT02598960|469283094|FG004|Treatment Period|participant request to discontinue|1|||
130357942|NCT02598960|469283095|FG005|Treatment Period|participant request to discontinue|0|||
130357943|NCT02598960|469283096|FG006|Treatment Period|participant request to discontinue|0|||
130446107|NCT01824472|469593646|FG002|Overall Study|Lost to Follow-up|1|||
130446108|NCT01824472|469593644|FG000|Overall Study|Withdrawal by Subject|1|||
130446109|NCT01824472|469593645|FG001|Overall Study|Withdrawal by Subject|5|||
130446110|NCT01824472|469593646|FG002|Overall Study|Withdrawal by Subject|3|||
130446111|NCT01824472|469593644|FG000|Overall Study|Ineligible post randomization&screening|0|||
130446112|NCT01824472|469593645|FG001|Overall Study|Ineligible post randomization&screening|2|||
130446113|NCT01824472|469593646|FG002|Overall Study|Ineligible post randomization&screening|0|||
130446114|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
130446115|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
130446116|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
130446117|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
130446118|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
130446119|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
130446120|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
130446121|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
130446122|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
130446123|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
130446124|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
130446125|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
130446126|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
130446127|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
130446128|NCT01815736|469593647|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
130446129|NCT01815736|469593648|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
130446130|NCT01815736|469593647|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
130446131|NCT01815736|469593648|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
130446132|NCT01815736|469593647|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
130446133|NCT01815736|469593648|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
130446134|NCT01815736|469593647|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
130446135|NCT01815736|469593648|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
130446136|NCT01815736|469593647|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
130446137|NCT01815736|469593648|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
130446138|NCT01815736|469593647|FG000|Extension Treatment Phase- After Week 96|Death|1|||
130446139|NCT01815736|469593648|FG001|Extension Treatment Phase- After Week 96|Death|0|||
130446140|NCT03040687|469593650|FG000|Overall Study|Withdrawal by Subject|1|||
130446141|NCT03040687|469593651|FG001|Overall Study|Withdrawal by Subject|0|||
130446142|NCT03040687|469593652|FG002|Overall Study|Withdrawal by Subject|0|||
130446143|NCT03317379|469593653|FG000|Overall Study|Lost to Follow-up|0|||
130446144|NCT03317379|469593654|FG001|Overall Study|Lost to Follow-up|3|||
130446145|NCT03317379|469593655|FG002|Overall Study|Lost to Follow-up|2|||
130446146|NCT00550173|469593656|FG000|Overall Study|Death|45|||
130446147|NCT00550173|469593657|FG001|Overall Study|Death|38|||
130446148|NCT00550173|469593658|FG002|Overall Study|Death|50|||
130446149|NCT00550173|469593656|FG000|Overall Study|Physician Decision|1|||
130446150|NCT00550173|469593657|FG001|Overall Study|Physician Decision|2|||
130446151|NCT00550173|469593658|FG002|Overall Study|Physician Decision|2|||
130446152|NCT00550173|469593656|FG000|Overall Study|Withdrawal by Subject|9|||
130446153|NCT00550173|469593657|FG001|Overall Study|Withdrawal by Subject|12|||
130446154|NCT00550173|469593658|FG002|Overall Study|Withdrawal by Subject|17|||
130446155|NCT00550173|469593656|FG000|Overall Study|Sponsor Decision|13|||
130446156|NCT00550173|469593657|FG001|Overall Study|Sponsor Decision|7|||
130446157|NCT00550173|469593658|FG002|Overall Study|Sponsor Decision|1|||
130446158|NCT00550173|469593656|FG000|Overall Study|Lost to Follow-up|4|||
130446159|NCT00550173|469593657|FG001|Overall Study|Lost to Follow-up|4|||
130446160|NCT00550173|469593658|FG002|Overall Study|Lost to Follow-up|3|||
130446161|NCT00810641|469593660|FG000|Overall Study|Withdrawal by Subject|0|||
130446162|NCT00810641|469593661|FG001|Overall Study|Withdrawal by Subject|1|||
130446163|NCT00810641|469593662|FG002|Overall Study|Withdrawal by Subject|2|||
130446164|NCT01556243|469593663|FG000|Overall Study|Ineligible|34|||
130446165|NCT01556243|469593663|FG000|Overall Study|Converted to mastectomy|14|||
130446166|NCT01556243|469593663|FG000|Overall Study|Unable to achieve negative margins|2|||
130446167|NCT01556243|469593663|FG000|Overall Study|Withdrawal by Subject|16|||
130446168|NCT02325713|469593666|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446169|NCT02325713|469593667|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130694322|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
130446170|NCT02325713|469593668|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446171|NCT02325713|469593669|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446172|NCT02325713|469593670|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446173|NCT02325713|469593671|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446174|NCT02325713|469593672|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446175|NCT02325713|469593673|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446176|NCT02325713|469593674|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446177|NCT02325713|469593675|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446178|NCT02325713|469593676|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
130446179|NCT02325713|469593677|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446180|NCT02325713|469593678|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446181|NCT02325713|469593679|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446182|NCT02325713|469593680|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446183|NCT02325713|469593681|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130446184|NCT02325713|469593666|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
130446185|NCT02325713|469593667|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446186|NCT02325713|469593668|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446187|NCT02325713|469593669|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446188|NCT02325713|469593670|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446189|NCT02325713|469593671|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446190|NCT02325713|469593672|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446191|NCT02325713|469593673|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446192|NCT02325713|469593674|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446193|NCT02325713|469593675|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446194|NCT02325713|469593676|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446195|NCT02325713|469593677|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446196|NCT02325713|469593678|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446197|NCT02325713|469593679|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446198|NCT02325713|469593680|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446199|NCT02325713|469593681|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130446200|NCT02325713|469593666|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446201|NCT02325713|469593667|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446202|NCT02325713|469593668|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446203|NCT02325713|469593669|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446204|NCT02325713|469593670|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446205|NCT02325713|469593671|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446206|NCT02325713|469593672|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446207|NCT02325713|469593673|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446208|NCT02325713|469593674|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446209|NCT02325713|469593675|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
130446210|NCT02325713|469593676|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446211|NCT02325713|469593677|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446212|NCT02325713|469593678|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446213|NCT02325713|469593679|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446214|NCT02325713|469593680|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446215|NCT02325713|469593681|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130446216|NCT02684903|469593682|FG000|Overall Study|COVID-19 shutdown of lab|4|||
130446217|NCT02684903|469593683|FG001|Overall Study|COVID-19 shutdown of lab|6|||
130446218|NCT02684903|469593682|FG000|Overall Study|Lost to Follow-up|31|||
130446219|NCT02684903|469593683|FG001|Overall Study|Lost to Follow-up|41|||
130446220|NCT01354106|469593684|FG000|Overall Study|Withdrawal by Subject|2|||
130446221|NCT02176928|469595477|FG000|Overall Study|Lost to Follow-up|2|||
130446222|NCT02176928|469595478|FG001|Overall Study|Lost to Follow-up|4|||
130446223|NCT01440049|469595482|FG000|Overall Study|Adverse Event|5|||
130446224|NCT03415022|469595484|FG000|Overall Study|Withdrawal by Subject|1|||
130446225|NCT03415022|469595485|FG001|Overall Study|Withdrawal by Subject|2|||
130446226|NCT03415022|469595484|FG000|Overall Study|COVID-19 Suspension|2|||
130446227|NCT03415022|469595485|FG001|Overall Study|COVID-19 Suspension|3|||
130446228|NCT03415022|469595484|FG000|Overall Study|Lost to Follow-up|2|||
130446229|NCT03415022|469595485|FG001|Overall Study|Lost to Follow-up|0|||
130446230|NCT04466618|469595486|FG000|Overall Study|Withdrawal by Subject|0|||
130446231|NCT04466618|469595487|FG001|Overall Study|Withdrawal by Subject|1|||
130446232|NCT00884286|469595492|FG000|Overall Study|Progressive disease|21|||
130446233|NCT00884286|469595493|FG001|Overall Study|Progressive disease|28|||
130446234|NCT00884286|469595492|FG000|Overall Study|Toxicity|4|||
130233126|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233127|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233128|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
130233129|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233130|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130446235|NCT00884286|469595493|FG001|Overall Study|Toxicity|1|||
130446236|NCT00884286|469595492|FG000|Overall Study|Death|2|||
130446237|NCT00884286|469595493|FG001|Overall Study|Death|2|||
130446238|NCT00884286|469595492|FG000|Overall Study|Physician Decision|1|||
130446239|NCT00884286|469595493|FG001|Overall Study|Physician Decision|0|||
130446240|NCT00884286|469595492|FG000|Overall Study|Septic shock|1|||
130446241|NCT00884286|469595493|FG001|Overall Study|Septic shock|0|||
130446242|NCT00884286|469595492|FG000|Overall Study|Thrombus in right auricle|1|||
130446243|NCT00884286|469595493|FG001|Overall Study|Thrombus in right auricle|0|||
130446244|NCT00884286|469595492|FG000|Overall Study|Not treated|2|||
130446245|NCT00884286|469595493|FG001|Overall Study|Not treated|1|||
130446246|NCT00884286|469595492|FG000|Overall Study|Comprised lung carcinoma|0|||
130446247|NCT00884286|469595493|FG001|Overall Study|Comprised lung carcinoma|1|||
130446248|NCT01720797|469595494|FG000|Overall Study|Withdrawal by Subject|3|||
130446249|NCT01720797|469595495|FG001|Overall Study|Withdrawal by Subject|0|||
130446250|NCT00688259|469595506|FG000|Overall Study|Lost to Follow-up|2|||
130446251|NCT00688259|469595507|FG001|Overall Study|Lost to Follow-up|4|||
130446252|NCT00688259|469595506|FG000|Overall Study|Physician Decision|1|||
130446253|NCT00688259|469595507|FG001|Overall Study|Physician Decision|0|||
130446254|NCT00688259|469595506|FG000|Overall Study|Withdrawal by Subject|2|||
130446255|NCT00688259|469595507|FG001|Overall Study|Withdrawal by Subject|0|||
130446256|NCT00688259|469595506|FG000|Overall Study|Declined Interview|2|||
130446257|NCT00688259|469595507|FG001|Overall Study|Declined Interview|3|||
130446258|NCT00688259|469595506|FG000|Overall Study|Hospitalized at Follow-up|0|||
130446259|NCT00688259|469595507|FG001|Overall Study|Hospitalized at Follow-up|1|||
130446260|NCT01310868|469595509|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
130446261|NCT02411591|469595510|FG000|Overall Study|Adverse Event|0|||
130446262|NCT02411591|469595511|FG001|Overall Study|Adverse Event|4|||
130446263|NCT02411591|469595512|FG002|Overall Study|Adverse Event|2|||
130446264|NCT02411591|469595510|FG000|Overall Study|Withdrawal by Subject|0|||
130446265|NCT02411591|469595511|FG001|Overall Study|Withdrawal by Subject|3|||
130446266|NCT02411591|469595512|FG002|Overall Study|Withdrawal by Subject|0|||
130446267|NCT02411591|469595510|FG000|Overall Study|Physician Decision|0|||
130446268|NCT02411591|469595511|FG001|Overall Study|Physician Decision|3|||
130446269|NCT02411591|469595512|FG002|Overall Study|Physician Decision|1|||
130446270|NCT02491892|469595513|FG000|Overall Study|Adverse Event|1|||
130446271|NCT02491892|469595514|FG001|Overall Study|Adverse Event|1|||
130446272|NCT02491892|469595513|FG000|Overall Study|Death|1|||
130446273|NCT02491892|469595514|FG001|Overall Study|Death|1|||
130446274|NCT02491892|469595513|FG000|Overall Study|Lack of Efficacy|37|||
130446275|NCT02491892|469595514|FG001|Overall Study|Lack of Efficacy|36|||
130446276|NCT02491892|469595513|FG000|Overall Study|Refused Treatment|1|||
130446277|NCT02491892|469595514|FG001|Overall Study|Refused Treatment|0|||
130446278|NCT02491892|469595513|FG000|Overall Study|Lost to Follow-up|1|||
130446279|NCT02491892|469595514|FG001|Overall Study|Lost to Follow-up|0|||
130446280|NCT04227340|469595515|FG000|Overall Study|Withdrawal by Subject|3|||
130446281|NCT00661258|469595523|FG000|Overall Study|Death|1|||
130446282|NCT00661258|469595524|FG001|Overall Study|Death|0|||
130446283|NCT00661258|469595523|FG000|Overall Study|caught by police and in detox center|2|||
130446284|NCT00661258|469595524|FG001|Overall Study|caught by police and in detox center|1|||
130446285|NCT01628874|469595525|FG000|Overall Study|Physician Decision|1|||
130446286|NCT01628874|469595526|FG001|Overall Study|Physician Decision|1|||
130446287|NCT01628874|469595525|FG000|Overall Study|Age >4 months|4|||
130446288|NCT01628874|469595526|FG001|Overall Study|Age >4 months|2|||
130446289|NCT00683449|469595527|FG000|Overall Study|Lost to Follow-up|0|||
130446290|NCT00683449|469595528|FG001|Overall Study|Lost to Follow-up|1|||
130446291|NCT00683449|469595529|FG002|Overall Study|Lost to Follow-up|0|||
130446292|NCT00683449|469595530|FG003|Overall Study|Lost to Follow-up|0|||
130446293|NCT00683449|469595531|FG004|Overall Study|Lost to Follow-up|0|||
130446294|NCT03541642|469595534|FG000|Overall Study|Withdrawal by Subject|1|||
130446295|NCT03541642|469595535|FG001|Overall Study|Withdrawal by Subject|2|||
130446296|NCT03541642|469595534|FG000|Overall Study|Lost to Follow-up|16|||
130446297|NCT03541642|469595535|FG001|Overall Study|Lost to Follow-up|12|||
130446298|NCT03541642|469595534|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
130446299|NCT03541642|469595535|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
130446300|NCT01083160|469595540|FG000|Overall Study|Adverse Event|1|||
130446301|NCT00918749|469595543|FG000|Overall Study|Adverse Event|1|||
130446302|NCT00918749|469595544|FG001|Overall Study|Adverse Event|0|||
130446303|NCT00918749|469595545|FG002|Overall Study|Adverse Event|1|||
130446304|NCT00918749|469595543|FG000|Overall Study|Lost to Follow-up|0|||
130446305|NCT00918749|469595544|FG001|Overall Study|Lost to Follow-up|0|||
130446306|NCT00918749|469595545|FG002|Overall Study|Lost to Follow-up|1|||
130446307|NCT00918749|469595543|FG000|Overall Study|Withdrawal by Subject|5|||
130233131|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130446308|NCT00918749|469595544|FG001|Overall Study|Withdrawal by Subject|3|||
130446309|NCT00918749|469595545|FG002|Overall Study|Withdrawal by Subject|5|||
130446310|NCT00918749|469595543|FG000|Overall Study|No Study Medication Taken|1|||
130446311|NCT00918749|469595544|FG001|Overall Study|No Study Medication Taken|0|||
130446312|NCT00918749|469595545|FG002|Overall Study|No Study Medication Taken|0|||
130446313|NCT01951092|469595546|FG000|Overall Study|Lost to Follow-up|10|||
130446314|NCT01951092|469595546|FG000|Overall Study|Incarceration|1|||
130446315|NCT01951092|469595546|FG000|Overall Study|Transfer of Care|1|||
130446316|NCT00873093|469595547|FG000|Overall Study|Adverse Event|0|||
130357944|NCT02598960|469283097|FG007|Treatment Period|participant request to discontinue|0|||
130357945|NCT02598960|469283098|FG008|Treatment Period|participant request to discontinue|0|||
130357946|NCT02598960|469283099|FG009|Treatment Period|participant request to discontinue|0|||
130357947|NCT02598960|469283100|FG010|Treatment Period|participant request to discontinue|1|||
130357948|NCT02598960|469283101|FG011|Treatment Period|participant request to discontinue|4|||
130357949|NCT02598960|469283102|FG012|Treatment Period|participant request to discontinue|0|||
130357950|NCT02598960|469283090|FG000|Treatment Period|participant withdrew consent|0|||
130357951|NCT02598960|469283091|FG001|Treatment Period|participant withdrew consent|0|||
130357952|NCT02598960|469283092|FG002|Treatment Period|participant withdrew consent|0|||
130357953|NCT02598960|469283093|FG003|Treatment Period|participant withdrew consent|0|||
130357954|NCT02598960|469283094|FG004|Treatment Period|participant withdrew consent|0|||
130357955|NCT02598960|469283095|FG005|Treatment Period|participant withdrew consent|0|||
130357956|NCT02598960|469283096|FG006|Treatment Period|participant withdrew consent|0|||
130357957|NCT02598960|469283097|FG007|Treatment Period|participant withdrew consent|0|||
130357958|NCT02598960|469283098|FG008|Treatment Period|participant withdrew consent|0|||
130357959|NCT02598960|469283099|FG009|Treatment Period|participant withdrew consent|0|||
130357960|NCT02598960|469283100|FG010|Treatment Period|participant withdrew consent|0|||
130357961|NCT02598960|469283101|FG011|Treatment Period|participant withdrew consent|3|||
130357962|NCT02598960|469283102|FG012|Treatment Period|participant withdrew consent|0|||
130357963|NCT02598960|469283090|FG000|Treatment Period|No longer meets study criteria|0|||
130357964|NCT02598960|469283091|FG001|Treatment Period|No longer meets study criteria|0|||
130357965|NCT02598960|469283092|FG002|Treatment Period|No longer meets study criteria|0|||
130357966|NCT02598960|469283093|FG003|Treatment Period|No longer meets study criteria|0|||
130357967|NCT02598960|469283094|FG004|Treatment Period|No longer meets study criteria|0|||
130357968|NCT02598960|469283095|FG005|Treatment Period|No longer meets study criteria|0|||
130357969|NCT02598960|469283096|FG006|Treatment Period|No longer meets study criteria|0|||
130357970|NCT02598960|469283097|FG007|Treatment Period|No longer meets study criteria|0|||
130357971|NCT02598960|469283098|FG008|Treatment Period|No longer meets study criteria|0|||
130357972|NCT02598960|469283099|FG009|Treatment Period|No longer meets study criteria|0|||
130357973|NCT02598960|469283100|FG010|Treatment Period|No longer meets study criteria|0|||
130357974|NCT02598960|469283101|FG011|Treatment Period|No longer meets study criteria|1|||
130357975|NCT02598960|469283102|FG012|Treatment Period|No longer meets study criteria|0|||
130357976|NCT02598960|469283090|FG000|Treatment Period|Other Reasons|0|||
130357977|NCT02598960|469283091|FG001|Treatment Period|Other Reasons|0|||
130357978|NCT02598960|469283092|FG002|Treatment Period|Other Reasons|0|||
130357979|NCT02598960|469283093|FG003|Treatment Period|Other Reasons|0|||
130357980|NCT02598960|469283094|FG004|Treatment Period|Other Reasons|0|||
130357981|NCT02598960|469283095|FG005|Treatment Period|Other Reasons|0|||
130357982|NCT02598960|469283096|FG006|Treatment Period|Other Reasons|0|||
130357983|NCT02598960|469283097|FG007|Treatment Period|Other Reasons|0|||
130357984|NCT02598960|469283098|FG008|Treatment Period|Other Reasons|0|||
130357985|NCT02598960|469283099|FG009|Treatment Period|Other Reasons|0|||
130357986|NCT02598960|469283100|FG010|Treatment Period|Other Reasons|0|||
130357987|NCT02598960|469283101|FG011|Treatment Period|Other Reasons|0|||
130357988|NCT02598960|469283102|FG012|Treatment Period|Other Reasons|1|||
130357989|NCT02598960|469283090|FG000|Participants Entering Follow Up Period|Death|1|||
130357990|NCT02598960|469283091|FG001|Participants Entering Follow Up Period|Death|0|||
130357991|NCT02598960|469283092|FG002|Participants Entering Follow Up Period|Death|0|||
130357992|NCT02598960|469283093|FG003|Participants Entering Follow Up Period|Death|0|||
130357993|NCT02598960|469283094|FG004|Participants Entering Follow Up Period|Death|0|||
130357994|NCT02598960|469283095|FG005|Participants Entering Follow Up Period|Death|0|||
130357995|NCT02598960|469283096|FG006|Participants Entering Follow Up Period|Death|0|||
130357996|NCT02598960|469283097|FG007|Participants Entering Follow Up Period|Death|0|||
130357997|NCT02598960|469283098|FG008|Participants Entering Follow Up Period|Death|0|||
130357998|NCT02598960|469283099|FG009|Participants Entering Follow Up Period|Death|1|||
130357999|NCT02598960|469283100|FG010|Participants Entering Follow Up Period|Death|0|||
130358000|NCT02598960|469283101|FG011|Participants Entering Follow Up Period|Death|11|||
130358001|NCT02598960|469283102|FG012|Participants Entering Follow Up Period|Death|2|||
130358002|NCT02598960|469283090|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358003|NCT02598960|469283091|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358004|NCT02598960|469283092|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358005|NCT02598960|469283093|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358006|NCT02598960|469283094|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358007|NCT02598960|469283095|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358008|NCT02598960|469283096|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358009|NCT02598960|469283097|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358010|NCT02598960|469283098|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358011|NCT02598960|469283099|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358012|NCT02598960|469283100|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
130446317|NCT00873093|469595548|FG001|Overall Study|Adverse Event|2|||
130446318|NCT00873093|469595549|FG002|Overall Study|Adverse Event|0|||
130446319|NCT00873093|469595550|FG003|Overall Study|Adverse Event|0|||
130446320|NCT00873093|469595551|FG004|Overall Study|Adverse Event|0|||
130446321|NCT00873093|469595547|FG000|Overall Study|Death|0|||
130446322|NCT00873093|469595548|FG001|Overall Study|Death|3|||
130446323|NCT00873093|469595549|FG002|Overall Study|Death|2|||
130446324|NCT00873093|469595550|FG003|Overall Study|Death|0|||
130446325|NCT00873093|469595551|FG004|Overall Study|Death|0|||
130446326|NCT00873093|469595547|FG000|Overall Study|Physician Decision|0|||
130446327|NCT00873093|469595548|FG001|Overall Study|Physician Decision|17|||
130446328|NCT00873093|469595549|FG002|Overall Study|Physician Decision|10|||
130446329|NCT00873093|469595550|FG003|Overall Study|Physician Decision|10|||
130446330|NCT00873093|469595551|FG004|Overall Study|Physician Decision|2|||
130446331|NCT00873093|469595547|FG000|Overall Study|Withdrawal by Subject|1|||
130446332|NCT00873093|469595548|FG001|Overall Study|Withdrawal by Subject|4|||
130446333|NCT00873093|469595549|FG002|Overall Study|Withdrawal by Subject|4|||
130446334|NCT00873093|469595550|FG003|Overall Study|Withdrawal by Subject|0|||
130446335|NCT00873093|469595551|FG004|Overall Study|Withdrawal by Subject|0|||
130446336|NCT00873093|469595547|FG000|Overall Study|Ineligible|0|||
130446337|NCT00873093|469595548|FG001|Overall Study|Ineligible|1|||
130446338|NCT00873093|469595549|FG002|Overall Study|Ineligible|0|||
130446339|NCT00873093|469595550|FG003|Overall Study|Ineligible|1|||
130446340|NCT00873093|469595551|FG004|Overall Study|Ineligible|0|||
130446341|NCT01708187|469595552|FG000|Overall Study|Lost to Follow-up|0|||
130446342|NCT01708187|469595553|FG001|Overall Study|Lost to Follow-up|1|||
130446343|NCT00136916|469595555|FG000|Overall Study|Never received study treatment|3|||
130446344|NCT00136916|469595556|FG001|Overall Study|Never received study treatment|5|||
130446345|NCT00136916|469595555|FG000|Overall Study|Death|1|||
130446346|NCT00136916|469595556|FG001|Overall Study|Death|3|||
130446347|NCT00136916|469595555|FG000|Overall Study|Adverse Event|27|||
130446348|NCT00136916|469595556|FG001|Overall Study|Adverse Event|8|||
130446349|NCT00136916|469595555|FG000|Overall Study|Laboratory abnormality|0|||
130446350|NCT00136916|469595556|FG001|Overall Study|Laboratory abnormality|1|||
130446351|NCT00136916|469595555|FG000|Overall Study|Lack of Efficacy|13|||
130446352|NCT00136916|469595556|FG001|Overall Study|Lack of Efficacy|3|||
130446353|NCT00136916|469595555|FG000|Overall Study|Lost to Follow-up|12|||
130446354|NCT00136916|469595556|FG001|Overall Study|Lost to Follow-up|14|||
130446355|NCT00136916|469595555|FG000|Overall Study|Withdrawal by Subject|44|||
130446356|NCT00136916|469595556|FG001|Overall Study|Withdrawal by Subject|46|||
130446357|NCT00136916|469595555|FG000|Overall Study|Other|22|||
130446358|NCT00136916|469595556|FG001|Overall Study|Other|24|||
130446359|NCT00136916|469595555|FG000|Overall Study|Discontinued in follow up period|3|||
130446360|NCT00136916|469595556|FG001|Overall Study|Discontinued in follow up period|0|||
130446361|NCT01152554|469595557|FG000|Overall Study|Withdrawal by Subject|73|||
130446362|NCT01152554|469595558|FG001|Overall Study|Withdrawal by Subject|28|||
130446363|NCT01152554|469595557|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
130446364|NCT01152554|469595558|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
130446365|NCT01152554|469595557|FG000|Overall Study|Adverse Event|67|||
130446366|NCT01152554|469595558|FG001|Overall Study|Adverse Event|14|||
130446367|NCT01152554|469595557|FG000|Overall Study|Severe non-compliance to protocol|36|||
130446368|NCT01152554|469595558|FG001|Overall Study|Severe non-compliance to protocol|14|||
130446369|NCT01152554|469595557|FG000|Overall Study|Condition under investigation worsened|5|||
130446370|NCT01152554|469595558|FG001|Overall Study|Condition under investigation worsened|2|||
130446371|NCT01152554|469595557|FG000|Overall Study|Lack of Efficacy|20|||
130446372|NCT01152554|469595558|FG001|Overall Study|Lack of Efficacy|3|||
130446373|NCT01152554|469595557|FG000|Overall Study|Study-specific withdrawal criteria|17|||
130446374|NCT01152554|469595558|FG001|Overall Study|Study-specific withdrawal criteria|8|||
130446375|NCT01152554|469595557|FG000|Overall Study|Lost to Follow-up|87|||
130446376|NCT01152554|469595558|FG001|Overall Study|Lost to Follow-up|32|||
130446377|NCT01152554|469595557|FG000|Overall Study|Other|28|||
130446378|NCT01152554|469595558|FG001|Overall Study|Other|8|||
130446379|NCT01152554|469595557|FG000|Overall Study|Death|1|||
130446380|NCT01152554|469595558|FG001|Overall Study|Death|1|||
130446381|NCT02117544|469595559|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
130446382|NCT02117544|469595560|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
130446383|NCT02559817|469595561|FG000|Treatment Period|Adverse Event|1|||
130446384|NCT02559817|469595562|FG001|Treatment Period|Adverse Event|0|||
130446385|NCT02559817|469595563|FG002|Treatment Period|Adverse Event|1|||
130446386|NCT02559817|469595564|FG003|Treatment Period|Adverse Event|0|||
130446387|NCT02559817|469595565|FG004|Treatment Period|Adverse Event|0|||
130446388|NCT02559817|469595561|FG000|Treatment Period|Lack of Efficacy|0|||
130446389|NCT02559817|469595562|FG001|Treatment Period|Lack of Efficacy|1|||
130446390|NCT02559817|469595563|FG002|Treatment Period|Lack of Efficacy|0|||
130446391|NCT02559817|469595564|FG003|Treatment Period|Lack of Efficacy|0|||
130446392|NCT02559817|469595565|FG004|Treatment Period|Lack of Efficacy|0|||
130446393|NCT02559817|469595561|FG000|Treatment Period|Lost to Follow-up|0|||
130446394|NCT02559817|469595562|FG001|Treatment Period|Lost to Follow-up|1|||
130446395|NCT02559817|469595563|FG002|Treatment Period|Lost to Follow-up|0|||
130446396|NCT02559817|469595564|FG003|Treatment Period|Lost to Follow-up|1|||
130446397|NCT02559817|469595565|FG004|Treatment Period|Lost to Follow-up|0|||
130446398|NCT02559817|469595561|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
130446399|NCT02559817|469595562|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
130446400|NCT02559817|469595563|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
130446401|NCT02559817|469595564|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
130446402|NCT02559817|469595565|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
130446403|NCT02559817|469595561|FG000|Treatment Period|Protocol Violation|0|||
130446404|NCT02559817|469595562|FG001|Treatment Period|Protocol Violation|0|||
130446405|NCT02559817|469595563|FG002|Treatment Period|Protocol Violation|0|||
130446406|NCT02559817|469595564|FG003|Treatment Period|Protocol Violation|1|||
130446407|NCT02559817|469595565|FG004|Treatment Period|Protocol Violation|0|||
130446408|NCT00577720|469595576|FG000|Overall Study|Adverse Event|2|||
130446409|NCT00577720|469595577|FG001|Overall Study|Adverse Event|1|||
130446410|NCT00577720|469595578|FG002|Overall Study|Adverse Event|0|||
130446411|NCT00577720|469595579|FG003|Overall Study|Adverse Event|4|||
130446412|NCT00577720|469595576|FG000|Overall Study|Lost to Follow-up|0|||
130446413|NCT00577720|469595577|FG001|Overall Study|Lost to Follow-up|0|||
130446414|NCT00577720|469595578|FG002|Overall Study|Lost to Follow-up|1|||
130446415|NCT00577720|469595579|FG003|Overall Study|Lost to Follow-up|0|||
130446416|NCT00577720|469595576|FG000|Overall Study|Protocol Violation|0|||
130446417|NCT00577720|469595577|FG001|Overall Study|Protocol Violation|0|||
130446418|NCT00577720|469595578|FG002|Overall Study|Protocol Violation|0|||
130446419|NCT00577720|469595579|FG003|Overall Study|Protocol Violation|1|||
130446420|NCT00577720|469595576|FG000|Overall Study|Withdrawal by Subject|2|||
130446421|NCT00577720|469595577|FG001|Overall Study|Withdrawal by Subject|0|||
130446422|NCT00577720|469595578|FG002|Overall Study|Withdrawal by Subject|0|||
130446423|NCT00577720|469595579|FG003|Overall Study|Withdrawal by Subject|2|||
130446424|NCT03100838|469595580|FG000|Overall Study|Adverse Event|1|||
130446425|NCT03100838|469595581|FG001|Overall Study|Adverse Event|0|||
130446426|NCT03100838|469595582|FG002|Overall Study|Adverse Event|0|||
130446427|NCT03100838|469595583|FG003|Overall Study|Adverse Event|0|||
130446428|NCT03100838|469595580|FG000|Overall Study|Physician Decision|1|||
130446429|NCT03100838|469595581|FG001|Overall Study|Physician Decision|1|||
130446430|NCT03100838|469595582|FG002|Overall Study|Physician Decision|1|||
130446431|NCT03100838|469595583|FG003|Overall Study|Physician Decision|1|||
130446432|NCT03100838|469595580|FG000|Overall Study|Pregnancy|0|||
130446433|NCT03100838|469595581|FG001|Overall Study|Pregnancy|1|||
130446434|NCT03100838|469595582|FG002|Overall Study|Pregnancy|0|||
130446435|NCT03100838|469595583|FG003|Overall Study|Pregnancy|0|||
130446436|NCT03100838|469595580|FG000|Overall Study|Lost to Follow-up|0|||
130446437|NCT03100838|469595581|FG001|Overall Study|Lost to Follow-up|0|||
130446438|NCT03100838|469595582|FG002|Overall Study|Lost to Follow-up|1|||
130446439|NCT03100838|469595583|FG003|Overall Study|Lost to Follow-up|0|||
130446440|NCT02554513|469595584|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
130446441|NCT02554513|469595585|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
130446442|NCT00184028|469595586|FG000|Overall Study|Death|1|||
130446443|NCT00184028|469595586|FG000|Overall Study|Lack of Efficacy|4|||
130446444|NCT00184028|469595586|FG000|Overall Study|Adverse Event|2|||
130446445|NCT00184028|469595586|FG000|Overall Study|Withdrawal by Subject|1|||
130446446|NCT00184028|469595586|FG000|Overall Study|Non-compliance|2|||
130446447|NCT01354938|469595589|FG000|Overall Study|Lost to Follow-up|1|||
130446448|NCT02806336|469595590|FG000|Overall Study|Physician Decision|1|||
130446449|NCT02806336|469595591|FG001|Overall Study|Physician Decision|0|||
130446450|NCT02806336|469595590|FG000|Overall Study|Withdrawal by Subject|2|||
130446451|NCT02806336|469595591|FG001|Overall Study|Withdrawal by Subject|4|||
130446452|NCT02806336|469595590|FG000|Overall Study|COVID-19 research shut down|3|||
130446453|NCT02806336|469595591|FG001|Overall Study|COVID-19 research shut down|4|||
130446454|NCT02806336|469595590|FG000|Overall Study|Lack of Efficacy|0|||
130694323|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694324|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694325|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694326|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
130446455|NCT02806336|469595591|FG001|Overall Study|Lack of Efficacy|1|||
130446456|NCT00003509|469595594|FG000|Overall Study|Not evaluable|5|||
130446457|NCT01563978|469595595|FG000|Overall Study|Physician Decision|1|||
130446458|NCT01563978|469595596|FG001|Overall Study|Physician Decision|0|||
130446459|NCT01563978|469595595|FG000|Overall Study|Lost to Follow-up|1|||
130446460|NCT01563978|469595596|FG001|Overall Study|Lost to Follow-up|0|||
130694327|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694328|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694329|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694330|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
130446461|NCT01563978|469595595|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
130446462|NCT01563978|469595596|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130446463|NCT01563978|469595595|FG000|Overall Study|Adverse Event|1|||
130446464|NCT01563978|469595596|FG001|Overall Study|Adverse Event|2|||
130358013|NCT02598960|469283101|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
130358014|NCT02598960|469283102|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
130358015|NCT02598960|469283090|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
130358016|NCT02598960|469283091|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
130358017|NCT02598960|469283092|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
130358018|NCT02598960|469283093|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
130358019|NCT02598960|469283094|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
130358020|NCT02598960|469283095|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
130358021|NCT02598960|469283096|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
130358022|NCT02598960|469283097|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
130358023|NCT02598960|469283098|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
130358024|NCT02598960|469283099|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
130358025|NCT02598960|469283100|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
130358026|NCT02598960|469283101|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
130358027|NCT02598960|469283102|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
130358028|NCT02598960|469283090|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358029|NCT02598960|469283091|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358030|NCT02598960|469283092|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358031|NCT02598960|469283093|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358032|NCT02598960|469283094|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358033|NCT02598960|469283095|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358034|NCT02598960|469283096|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358035|NCT02598960|469283097|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358036|NCT02598960|469283098|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358037|NCT02598960|469283099|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358038|NCT02598960|469283100|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358039|NCT02598960|469283101|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
130358040|NCT02598960|469283102|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130358041|NCT02598960|469283090|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
130358042|NCT02598960|469283091|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
130358043|NCT02598960|469283092|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
130358044|NCT02598960|469283093|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
130358045|NCT02598960|469283094|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
130358046|NCT02598960|469283095|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
130358047|NCT02598960|469283096|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
130358048|NCT02598960|469283097|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
130358049|NCT02598960|469283098|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
130358050|NCT02598960|469283099|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
130358051|NCT02598960|469283100|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
130358052|NCT02598960|469283101|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
130358053|NCT02598960|469283102|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
130446465|NCT05764239|469595597|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
130446466|NCT05764239|469595597|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
130446467|NCT05764239|469595597|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
130446468|NCT05764239|469595597|FG000|DEP (Part 1)|Adverse Event|1|||
130446469|NCT05764239|469595597|FG000|DEP (Part 1)|Lost to Follow-up|1|||
130446470|NCT05764239|469595597|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
130446471|NCT05764239|469595597|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
130446472|NCT05764239|469595597|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
130446473|NCT05764239|469595597|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
130446474|NCT04562779|469595601|FG000|Overall Study|Lost to Follow-up|7|||
130446475|NCT04562779|469595602|FG001|Overall Study|Lost to Follow-up|5|||
130446476|NCT04562779|469595603|FG002|Overall Study|Lost to Follow-up|10|||
130446477|NCT04562779|469595601|FG000|Overall Study|Protocol Violation|2|||
130446478|NCT04562779|469595602|FG001|Overall Study|Protocol Violation|2|||
130446479|NCT04562779|469595603|FG002|Overall Study|Protocol Violation|0|||
130446480|NCT00333138|469595604|FG000|Core Study (6 Months)|Adverse Event|4|||
130446481|NCT00333138|469595605|FG001|Core Study (6 Months)|Adverse Event|5|||
130358054|NCT03265665|469283107|FG000|24-week Data Collection|Withdrawal by Subject|2|||
130358055|NCT03265665|469283108|FG001|24-week Data Collection|Withdrawal by Subject|2|||
130446482|NCT00333138|469595606|FG002|Core Study (6 Months)|Adverse Event|8|||
130358056|NCT03265665|469283107|FG000|24-week Data Collection|Lost to Follow-up|4|||
130358057|NCT03265665|469283108|FG001|24-week Data Collection|Lost to Follow-up|5|||
130446483|NCT00333138|469595604|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
130446484|NCT00333138|469595605|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
130233132|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233133|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233134|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
130233135|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233136|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233137|NCT03729362|468819666|FG000|Overall Study|Withdrawal by Subject|2|||
130233138|NCT03729362|468819667|FG001|Overall Study|Withdrawal by Subject|0|||
130233139|NCT03729362|468819666|FG000|Overall Study|Physician Decision|1|||
130233140|NCT03729362|468819667|FG001|Overall Study|Physician Decision|0|||
130233141|NCT03729362|468819666|FG000|Overall Study|COVID-19 Pandemic|1|||
130233142|NCT03729362|468819667|FG001|Overall Study|COVID-19 Pandemic|0|||
130358058|NCT03265665|469283107|FG000|36-week Data Collection|Lost to Follow-up|6|||
130358059|NCT03265665|469283108|FG001|36-week Data Collection|Lost to Follow-up|8|||
130358060|NCT01193660|469283109|FG000|Overall Study|Withdrawal by Subject|2|||
130358061|NCT01193660|469283110|FG001|Overall Study|Withdrawal by Subject|3|||
130358062|NCT01193660|469283111|FG002|Overall Study|Withdrawal by Subject|1|||
130694331|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694332|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
130233143|NCT03729362|468819666|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
130233144|NCT03729362|468819667|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
130233145|NCT03729362|468819666|FG000|Overall Study|Adverse Event|0|||
130358063|NCT01193660|469283109|FG000|Overall Study|Death|1|||
130358064|NCT01193660|469283110|FG001|Overall Study|Death|0|||
130358065|NCT01193660|469283111|FG002|Overall Study|Death|0|||
130694333|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694334|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694335|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694336|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694337|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130233146|NCT03729362|468819667|FG001|Overall Study|Adverse Event|1|||
130358066|NCT01193660|469283109|FG000|Overall Study|Physician Decision|1|||
130358067|NCT01193660|469283110|FG001|Overall Study|Physician Decision|0|||
130358068|NCT01193660|469283111|FG002|Overall Study|Physician Decision|1|||
130358069|NCT00195273|469283112|FG000|Overall Study|Adverse Event|9|||
130358070|NCT00195273|469283113|FG001|Overall Study|Adverse Event|9|||
130358071|NCT00195273|469283112|FG000|Overall Study|Protocol deviation|0|||
130358072|NCT00195273|469283113|FG001|Overall Study|Protocol deviation|1|||
130358073|NCT00195273|469283112|FG000|Overall Study|Lack of Efficacy|3|||
130358074|NCT00195273|469283113|FG001|Overall Study|Lack of Efficacy|1|||
130358075|NCT00195273|469283112|FG000|Overall Study|Procedural complications|9|||
130358076|NCT00195273|469283113|FG001|Overall Study|Procedural complications|3|||
130358077|NCT00595465|469283114|FG000|Overall Study|Adverse Event|4|||
130358078|NCT00595465|469283115|FG001|Overall Study|Adverse Event|3|||
130358079|NCT00595465|469283116|FG002|Overall Study|Adverse Event|3|||
130358080|NCT00595465|469283114|FG000|Overall Study|Pregnancy|0|||
130358081|NCT00595465|469283115|FG001|Overall Study|Pregnancy|0|||
130358082|NCT00595465|469283116|FG002|Overall Study|Pregnancy|1|||
130358083|NCT00595465|469283114|FG000|Overall Study|Protocol Violation|2|||
130358084|NCT00595465|469283115|FG001|Overall Study|Protocol Violation|1|||
130358085|NCT00595465|469283116|FG002|Overall Study|Protocol Violation|0|||
130358086|NCT00595465|469283114|FG000|Overall Study|Lost to Follow-up|0|||
130358087|NCT00595465|469283115|FG001|Overall Study|Lost to Follow-up|0|||
130358088|NCT00595465|469283116|FG002|Overall Study|Lost to Follow-up|2|||
130358089|NCT00595465|469283114|FG000|Overall Study|administrative reason|0|||
130358090|NCT00595465|469283115|FG001|Overall Study|administrative reason|0|||
130358091|NCT00595465|469283116|FG002|Overall Study|administrative reason|1|||
130358092|NCT02595970|469283117|FG000|Overall Study|Withdrawal by Subject|2|||
130358093|NCT02595970|469283117|FG000|Overall Study|Physician Decision|2|||
130358094|NCT02595970|469283117|FG000|Overall Study|Protocol Violation|4|||
130358095|NCT02595970|469283117|FG000|Overall Study|Adverse Event|5|||
130358096|NCT02595970|469283117|FG000|Overall Study|Lack of Efficacy|7|||
130358097|NCT04879225|469283118|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
130358098|NCT04879225|469283118|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
130358099|NCT02572388|469283121|FG000|Overall Study|Withdrawal by Subject|1|||
130358100|NCT02572388|469283122|FG001|Overall Study|Withdrawal by Subject|1|||
130358101|NCT02572388|469283123|FG002|Overall Study|Withdrawal by Subject|2|||
130358102|NCT02572388|469283124|FG003|Overall Study|Withdrawal by Subject|2|||
130358103|NCT01973569|469283125|FG000|Overall Study|Adverse Event|9|||
130358104|NCT01973569|469283126|FG001|Overall Study|Adverse Event|2|||
130358105|NCT01973569|469283127|FG002|Overall Study|Adverse Event|4|||
130358106|NCT01973569|469283125|FG000|Overall Study|Protocol Violation|2|||
130358107|NCT01973569|469283126|FG001|Overall Study|Protocol Violation|1|||
130358108|NCT01973569|469283127|FG002|Overall Study|Protocol Violation|3|||
130233147|NCT03729362|468819666|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
130358109|NCT01973569|469283125|FG000|Overall Study|Withdrawal by Subject|7|||
130358110|NCT01973569|469283126|FG001|Overall Study|Withdrawal by Subject|5|||
130358111|NCT01973569|469283127|FG002|Overall Study|Withdrawal by Subject|2|||
130694338|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694339|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694340|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694341|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694342|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694343|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
130694344|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
130694345|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694346|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694347|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694348|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694349|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694350|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694351|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694352|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130233148|NCT03729362|468819667|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
130694353|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694354|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694355|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130233149|NCT02711137|468819668|FG000|Overall Study|Death|1|||
130233150|NCT02711137|468819669|FG001|Overall Study|Death|4|||
130233151|NCT02711137|468819670|FG002|Overall Study|Death|5|||
130233152|NCT02711137|468819671|FG003|Overall Study|Death|5|||
130233153|NCT02711137|468819672|FG004|Overall Study|Death|3|||
130233154|NCT02711137|468819673|FG005|Overall Study|Death|1|||
130233155|NCT02711137|468819674|FG006|Overall Study|Death|61|||
130233156|NCT02711137|468819675|FG007|Overall Study|Death|3|||
130233157|NCT02711137|468819676|FG008|Overall Study|Death|0|||
130233158|NCT02711137|468819677|FG009|Overall Study|Death|1|||
130233159|NCT02711137|468819678|FG010|Overall Study|Death|1|||
130233160|NCT02711137|468819679|FG011|Overall Study|Death|1|||
130233161|NCT02711137|468819680|FG012|Overall Study|Death|0|||
130233162|NCT02711137|468819681|FG013|Overall Study|Death|0|||
130233163|NCT02711137|468819682|FG014|Overall Study|Death|0|||
130233164|NCT02711137|468819668|FG000|Overall Study|Study Terminated by Sponsor|0|||
130233165|NCT02711137|468819669|FG001|Overall Study|Study Terminated by Sponsor|0|||
130233166|NCT02711137|468819670|FG002|Overall Study|Study Terminated by Sponsor|1|||
130233167|NCT02711137|468819671|FG003|Overall Study|Study Terminated by Sponsor|0|||
130233168|NCT02711137|468819672|FG004|Overall Study|Study Terminated by Sponsor|0|||
130233169|NCT02711137|468819673|FG005|Overall Study|Study Terminated by Sponsor|0|||
130233170|NCT02711137|468819674|FG006|Overall Study|Study Terminated by Sponsor|1|||
130446485|NCT00333138|469595606|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
130446486|NCT00333138|469595604|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
130446487|NCT00333138|469595605|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
130446488|NCT00333138|469595606|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
130446489|NCT00333138|469595604|FG000|Core Study (6 Months)|Protocol Violation|1|||
130446490|NCT00333138|469595605|FG001|Core Study (6 Months)|Protocol Violation|0|||
130446491|NCT00333138|469595606|FG002|Core Study (6 Months)|Protocol Violation|1|||
130446492|NCT00333138|469595604|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
130446493|NCT00333138|469595605|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
130446494|NCT00333138|469595606|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
130446495|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
130446496|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
130446497|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
130446498|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
130446499|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
130446500|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
130446501|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
130446502|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
130446503|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
130446504|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
130446505|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
130446506|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
130446507|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
130446508|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
130446509|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
130446510|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
130446511|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
130446512|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
130446513|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
130446514|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
130446515|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
130446516|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
130446517|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
130446518|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
130446519|NCT00333138|469595604|FG000|Extension Study (Month6 to End of Study)|Death|0|||
130446520|NCT00333138|469595605|FG001|Extension Study (Month6 to End of Study)|Death|1|||
130446521|NCT00333138|469595606|FG002|Extension Study (Month6 to End of Study)|Death|0|||
130446522|NCT04630756|469595607|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
130446523|NCT04630756|469595608|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
130233171|NCT02711137|468819675|FG007|Overall Study|Study Terminated by Sponsor|0|||
130233172|NCT02711137|468819676|FG008|Overall Study|Study Terminated by Sponsor|0|||
130233173|NCT02711137|468819677|FG009|Overall Study|Study Terminated by Sponsor|0|||
130233174|NCT02711137|468819678|FG010|Overall Study|Study Terminated by Sponsor|0|||
130233175|NCT02711137|468819679|FG011|Overall Study|Study Terminated by Sponsor|0|||
130233176|NCT02711137|468819680|FG012|Overall Study|Study Terminated by Sponsor|0|||
130233177|NCT02711137|468819681|FG013|Overall Study|Study Terminated by Sponsor|0|||
130233178|NCT02711137|468819682|FG014|Overall Study|Study Terminated by Sponsor|0|||
130233179|NCT02711137|468819668|FG000|Overall Study|Physician Decision|1|||
130233180|NCT02711137|468819669|FG001|Overall Study|Physician Decision|0|||
130233181|NCT02711137|468819670|FG002|Overall Study|Physician Decision|2|||
130694356|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694357|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130233182|NCT02711137|468819671|FG003|Overall Study|Physician Decision|1|||
130233183|NCT02711137|468819672|FG004|Overall Study|Physician Decision|1|||
130233184|NCT02711137|468819673|FG005|Overall Study|Physician Decision|0|||
130233185|NCT02711137|468819674|FG006|Overall Study|Physician Decision|12|||
130233186|NCT02711137|468819675|FG007|Overall Study|Physician Decision|2|||
130233187|NCT02711137|468819676|FG008|Overall Study|Physician Decision|1|||
130233188|NCT02711137|468819677|FG009|Overall Study|Physician Decision|1|||
130233189|NCT02711137|468819678|FG010|Overall Study|Physician Decision|3|||
130233190|NCT02711137|468819679|FG011|Overall Study|Physician Decision|2|||
130233191|NCT02711137|468819680|FG012|Overall Study|Physician Decision|1|||
130233192|NCT02711137|468819681|FG013|Overall Study|Physician Decision|1|||
130233193|NCT02711137|468819682|FG014|Overall Study|Physician Decision|2|||
130694358|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694359|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694360|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694361|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694362|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694363|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694364|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694365|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694366|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694367|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694368|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694369|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694370|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694371|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
130694372|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694373|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694374|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694375|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694376|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694377|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694378|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694379|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694380|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694381|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694382|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694383|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694384|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694385|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694386|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694387|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694388|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694389|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
130233194|NCT02711137|468819668|FG000|Overall Study|Other|0|||
130233195|NCT02711137|468819669|FG001|Overall Study|Other|1|||
130233196|NCT02711137|468819670|FG002|Overall Study|Other|0|||
130233197|NCT02711137|468819671|FG003|Overall Study|Other|0|||
130233198|NCT02711137|468819672|FG004|Overall Study|Other|0|||
130233199|NCT02711137|468819673|FG005|Overall Study|Other|0|||
130233200|NCT02711137|468819674|FG006|Overall Study|Other|3|||
130233201|NCT02711137|468819675|FG007|Overall Study|Other|0|||
130233202|NCT02711137|468819676|FG008|Overall Study|Other|0|||
130694390|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694391|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694392|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
130233203|NCT02711137|468819677|FG009|Overall Study|Other|0|||
130233204|NCT02711137|468819678|FG010|Overall Study|Other|0|||
130233205|NCT02711137|468819679|FG011|Overall Study|Other|0|||
130233206|NCT02711137|468819680|FG012|Overall Study|Other|0|||
130233207|NCT02711137|468819681|FG013|Overall Study|Other|0|||
130233208|NCT02711137|468819682|FG014|Overall Study|Other|1|||
130233209|NCT02711137|468819668|FG000|Overall Study|Withdrawal by Subject|1|||
130233210|NCT02711137|468819669|FG001|Overall Study|Withdrawal by Subject|0|||
130694393|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694394|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694395|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
130233211|NCT02711137|468819670|FG002|Overall Study|Withdrawal by Subject|0|||
130233212|NCT02711137|468819671|FG003|Overall Study|Withdrawal by Subject|1|||
130233213|NCT02711137|468819672|FG004|Overall Study|Withdrawal by Subject|1|||
130233214|NCT02711137|468819673|FG005|Overall Study|Withdrawal by Subject|0|||
130233215|NCT02711137|468819674|FG006|Overall Study|Withdrawal by Subject|7|||
130694396|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694397|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
130233216|NCT02711137|468819675|FG007|Overall Study|Withdrawal by Subject|0|||
130233217|NCT02711137|468819676|FG008|Overall Study|Withdrawal by Subject|0|||
130233218|NCT02711137|468819677|FG009|Overall Study|Withdrawal by Subject|0|||
130233219|NCT02711137|468819678|FG010|Overall Study|Withdrawal by Subject|0|||
130233220|NCT02711137|468819679|FG011|Overall Study|Withdrawal by Subject|0|||
130233221|NCT02711137|468819680|FG012|Overall Study|Withdrawal by Subject|0|||
130233222|NCT02711137|468819681|FG013|Overall Study|Withdrawal by Subject|1|||
130233223|NCT02711137|468819682|FG014|Overall Study|Withdrawal by Subject|0|||
130233224|NCT02711137|468819668|FG000|Overall Study|Lost to Follow-up|1|||
130233225|NCT02711137|468819669|FG001|Overall Study|Lost to Follow-up|0|||
130233226|NCT02711137|468819670|FG002|Overall Study|Lost to Follow-up|0|||
130233227|NCT02711137|468819671|FG003|Overall Study|Lost to Follow-up|0|||
130694398|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694399|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694400|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694401|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694402|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694403|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694404|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694405|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
130233228|NCT02711137|468819672|FG004|Overall Study|Lost to Follow-up|0|||
130233229|NCT02711137|468819673|FG005|Overall Study|Lost to Follow-up|0|||
130233230|NCT02711137|468819674|FG006|Overall Study|Lost to Follow-up|2|||
130233231|NCT02711137|468819675|FG007|Overall Study|Lost to Follow-up|0|||
130233232|NCT02711137|468819676|FG008|Overall Study|Lost to Follow-up|0|||
130233233|NCT02711137|468819677|FG009|Overall Study|Lost to Follow-up|0|||
130233234|NCT02711137|468819678|FG010|Overall Study|Lost to Follow-up|0|||
130233235|NCT02711137|468819679|FG011|Overall Study|Lost to Follow-up|0|||
130233236|NCT02711137|468819680|FG012|Overall Study|Lost to Follow-up|0|||
130233237|NCT02711137|468819681|FG013|Overall Study|Lost to Follow-up|0|||
130233238|NCT02711137|468819682|FG014|Overall Study|Lost to Follow-up|0|||
130233239|NCT01113749|468819683|FG000|Overall Study|Lost to Follow-up|1|||
130233240|NCT01113749|468819684|FG001|Overall Study|Lost to Follow-up|2|||
130233241|NCT03427892|468819685|FG000|Overall Study|Lost to Follow-up|2|||
130233242|NCT00548327|468819686|FG000|Overall Study|Adverse Event|0|||
130233243|NCT00548327|468819687|FG001|Overall Study|Adverse Event|1|||
130233244|NCT00274456|468819691|FG000|Overall Study|Still on treatment|2|||
130233245|NCT00274456|468819692|FG001|Overall Study|Still on treatment|3|||
130233246|NCT00274456|468819693|FG002|Overall Study|Still on treatment|5|||
130233247|NCT00274456|468819694|FG003|Overall Study|Still on treatment|1|||
130233248|NCT00274456|468819691|FG000|Overall Study|Unacceptable toxicity|10|||
130233249|NCT00274456|468819692|FG001|Overall Study|Unacceptable toxicity|5|||
130233250|NCT00274456|468819693|FG002|Overall Study|Unacceptable toxicity|12|||
130233251|NCT00274456|468819694|FG003|Overall Study|Unacceptable toxicity|16|||
130233252|NCT00274456|468819691|FG000|Overall Study|Adverse Event|0|||
130233253|NCT00274456|468819692|FG001|Overall Study|Adverse Event|1|||
130233254|NCT00274456|468819693|FG002|Overall Study|Adverse Event|2|||
130233255|NCT00274456|468819694|FG003|Overall Study|Adverse Event|2|||
130233256|NCT00274456|468819691|FG000|Overall Study|Physician Decision|7|||
130233257|NCT00274456|468819692|FG001|Overall Study|Physician Decision|5|||
130233258|NCT00274456|468819693|FG002|Overall Study|Physician Decision|6|||
130233259|NCT00274456|468819694|FG003|Overall Study|Physician Decision|13|||
130233260|NCT00274456|468819691|FG000|Overall Study|Lost to Follow-up|0|||
130233261|NCT00274456|468819692|FG001|Overall Study|Lost to Follow-up|0|||
130233262|NCT00274456|468819693|FG002|Overall Study|Lost to Follow-up|1|||
130233263|NCT00274456|468819694|FG003|Overall Study|Lost to Follow-up|0|||
130233264|NCT00274456|468819691|FG000|Overall Study|Withdrawal by Subject|18|||
130233265|NCT00274456|468819692|FG001|Overall Study|Withdrawal by Subject|13|||
130233266|NCT00274456|468819693|FG002|Overall Study|Withdrawal by Subject|9|||
130233267|NCT00274456|468819694|FG003|Overall Study|Withdrawal by Subject|13|||
130233268|NCT03255187|468819695|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
130233269|NCT03255187|468819696|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
130233270|NCT03255187|468819695|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
130446524|NCT04630756|469595609|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
130446525|NCT00847301|469595610|FG000|Overall Study|Adverse Event|35|||
130446526|NCT00847301|469595610|FG000|Overall Study|Switch to other anticoagulants|16|||
130446527|NCT00847301|469595610|FG000|Overall Study|Lost to Follow-up|1|||
130446528|NCT00847301|469595610|FG000|Overall Study|No prescription after hospital discharge|1|||
130446529|NCT00847301|469595610|FG000|Overall Study|Other reason not defined above|1|||
130446530|NCT05593211|469595611|FG000|Overall Study|Withdrawal by Subject|1|||
130446531|NCT03077620|469595615|FG000|Overall Study|Unable to place lumbar catheter|1|||
130446532|NCT03077620|469595616|FG001|Overall Study|Unable to place lumbar catheter|0|||
130446533|NCT03077620|469595617|FG002|Overall Study|Unable to place lumbar catheter|1|||
130446534|NCT03077620|469595618|FG003|Overall Study|Unable to place lumbar catheter|0|||
130446535|NCT03077620|469595615|FG000|Overall Study|Withdrawal by Subject|0|||
130446536|NCT03077620|469595616|FG001|Overall Study|Withdrawal by Subject|1|||
130694406|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694407|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694408|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694409|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694410|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694411|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694412|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694413|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694414|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Moved|0|||
130694415|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Moved|0|||
130694416|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Moved|0|||
130694417|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Moved|0|||
130694418|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Moved|0|||
130694419|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Moved|0|||
130694420|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Moved|0|||
130694421|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Moved|0|||
130694422|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Moved|0|||
130694423|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Moved|1|||
130694424|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Moved|0|||
130694425|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Moved|0|||
130694426|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Moved|0|||
130694427|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Moved|0|||
130694428|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Moved|0|||
130694429|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Moved|0|||
130694430|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Moved|0|||
130694431|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Moved|0|||
130694432|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Moved|0|||
130694433|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Moved|0|||
130694434|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Moved|0|||
130694435|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Moved|0|||
130694436|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Moved|0|||
130694437|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Moved|0|||
130694438|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Moved|0|||
130694439|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Moved|0|||
130694440|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
130694441|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
130694442|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
130694443|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
130694444|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
130694445|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
130694446|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
130694447|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
130694448|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
130694449|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
130694450|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
130694451|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
130694452|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
130694453|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
130694454|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
130694455|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
130694456|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
130446537|NCT03077620|469595617|FG002|Overall Study|Withdrawal by Subject|0|||
130446538|NCT03077620|469595618|FG003|Overall Study|Withdrawal by Subject|0|||
130694457|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
130694458|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
130694459|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
130694460|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
130694461|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
130694462|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
130694463|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
130694464|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
130446539|NCT03077620|469595615|FG000|Overall Study|Physician Decision|0|||
130694465|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
130694466|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694467|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694468|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694469|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694470|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694471|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694472|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694473|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694474|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694475|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130233271|NCT03255187|468819696|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
130233272|NCT00375752|468819697|FG000|Overall Study|Lack of Efficacy|4|||
130233273|NCT00375752|468819698|FG001|Overall Study|Lack of Efficacy|4|||
130233274|NCT00375752|468819697|FG000|Overall Study|Adverse Event|1|||
130233275|NCT00375752|468819698|FG001|Overall Study|Adverse Event|6|||
130233276|NCT00375752|468819697|FG000|Overall Study|Withdrawal by Subject|6|||
130233277|NCT00375752|468819698|FG001|Overall Study|Withdrawal by Subject|1|||
130233278|NCT00375752|468819697|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130233279|NCT00375752|468819698|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130233280|NCT00375752|468819697|FG000|Overall Study|Protocol Violation|0|||
130233281|NCT00375752|468819698|FG001|Overall Study|Protocol Violation|2|||
130233282|NCT00375752|468819697|FG000|Overall Study|Administrative Problems|0|||
130233283|NCT00375752|468819698|FG001|Overall Study|Administrative Problems|1|||
130233284|NCT02034006|468819699|FG000|Overall Study|Withdrawal by Subject|7|||
130233285|NCT02034006|468819699|FG000|Overall Study|Lost to Follow-up|5|||
130233286|NCT02034006|468819699|FG000|Overall Study|Death|1|||
130233287|NCT02034006|468819699|FG000|Overall Study|Pregnancy|1|||
130233288|NCT00109343|468819700|FG000|Overall Study|Adverse Event|1|||
130233289|NCT00109343|468819701|FG001|Overall Study|Adverse Event|0|||
130233290|NCT00109343|468819702|FG002|Overall Study|Adverse Event|2|||
130233291|NCT00109343|468819700|FG000|Overall Study|Lack of Efficacy|1|||
130233292|NCT00109343|468819701|FG001|Overall Study|Lack of Efficacy|0|||
130233293|NCT00109343|468819702|FG002|Overall Study|Lack of Efficacy|0|||
130358112|NCT01973569|469283125|FG000|Overall Study|Invasive dental treatment|3|||
130358113|NCT01973569|469283126|FG001|Overall Study|Invasive dental treatment|5|||
130694476|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694477|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130694478|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694479|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130233294|NCT00109343|468819700|FG000|Overall Study|Lost to Follow-up|35|||
130233295|NCT00109343|468819701|FG001|Overall Study|Lost to Follow-up|20|||
130233296|NCT00109343|468819702|FG002|Overall Study|Lost to Follow-up|14|||
130233297|NCT00109343|468819700|FG000|Overall Study|Protocol Violation|1|||
130358114|NCT01973569|469283127|FG002|Overall Study|Invasive dental treatment|6|||
130358115|NCT01973569|469283125|FG000|Overall Study|Prohibited concomitant d|1|||
130358116|NCT01973569|469283126|FG001|Overall Study|Prohibited concomitant d|5|||
130694480|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694481|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130694482|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130233298|NCT00109343|468819701|FG001|Overall Study|Protocol Violation|2|||
130358117|NCT01973569|469283127|FG002|Overall Study|Prohibited concomitant d|0|||
130233299|NCT00109343|468819702|FG002|Overall Study|Protocol Violation|2|||
130233300|NCT00109343|468819700|FG000|Overall Study|Withdrawal by Subject|15|||
130358118|NCT01973569|469283125|FG000|Overall Study|Disease progression|0|||
130233301|NCT00109343|468819701|FG001|Overall Study|Withdrawal by Subject|11|||
130233302|NCT00109343|468819702|FG002|Overall Study|Withdrawal by Subject|10|||
130233303|NCT00109343|468819700|FG000|Overall Study|Subject Moved|6|||
130233304|NCT00109343|468819701|FG001|Overall Study|Subject Moved|2|||
130233305|NCT00109343|468819702|FG002|Overall Study|Subject Moved|1|||
130233306|NCT00109343|468819700|FG000|Overall Study|Other|5|||
130233307|NCT00109343|468819701|FG001|Overall Study|Other|2|||
130233308|NCT00109343|468819702|FG002|Overall Study|Other|1|||
130233309|NCT00750269|468819703|FG000|Overall Study|Protocol Violation|0|||
130233310|NCT00750269|468819704|FG001|Overall Study|Protocol Violation|1|||
130233311|NCT00750269|468819705|FG002|Overall Study|Protocol Violation|1|||
130233312|NCT00750269|468819706|FG003|Overall Study|Protocol Violation|2|||
130233313|NCT00750269|468819707|FG004|Overall Study|Protocol Violation|4|||
130233314|NCT00750269|468819703|FG000|Overall Study|Withdrawal by Subject|0|||
130233315|NCT00750269|468819704|FG001|Overall Study|Withdrawal by Subject|0|||
130233316|NCT00750269|468819705|FG002|Overall Study|Withdrawal by Subject|2|||
130233317|NCT00750269|468819706|FG003|Overall Study|Withdrawal by Subject|2|||
130233318|NCT00750269|468819707|FG004|Overall Study|Withdrawal by Subject|2|||
130233319|NCT00750269|468819703|FG000|Overall Study|Physician Decision|0|||
130233320|NCT00750269|468819704|FG001|Overall Study|Physician Decision|0|||
130233321|NCT00750269|468819705|FG002|Overall Study|Physician Decision|0|||
130233322|NCT00750269|468819706|FG003|Overall Study|Physician Decision|0|||
130233323|NCT00750269|468819707|FG004|Overall Study|Physician Decision|2|||
130233324|NCT00750269|468819703|FG000|Overall Study|Patient too large for positioning|0|||
130233325|NCT00750269|468819704|FG001|Overall Study|Patient too large for positioning|0|||
130233326|NCT00750269|468819705|FG002|Overall Study|Patient too large for positioning|1|||
130233327|NCT00750269|468819706|FG003|Overall Study|Patient too large for positioning|0|||
130233328|NCT00750269|468819707|FG004|Overall Study|Patient too large for positioning|0|||
130233329|NCT00750269|468819703|FG000|Overall Study|Site error|0|||
130233330|NCT00750269|468819704|FG001|Overall Study|Site error|0|||
130233331|NCT00750269|468819705|FG002|Overall Study|Site error|0|||
130233332|NCT00750269|468819706|FG003|Overall Study|Site error|1|||
130233333|NCT00750269|468819707|FG004|Overall Study|Site error|0|||
130233334|NCT00750269|468819703|FG000|Overall Study|SBRT plan could not be drawn|0|||
130233335|NCT00750269|468819704|FG001|Overall Study|SBRT plan could not be drawn|0|||
130233336|NCT00750269|468819705|FG002|Overall Study|SBRT plan could not be drawn|0|||
130233337|NCT00750269|468819706|FG003|Overall Study|SBRT plan could not be drawn|0|||
130233338|NCT00750269|468819707|FG004|Overall Study|SBRT plan could not be drawn|1|||
130233339|NCT00750269|468819703|FG000|Overall Study|Fiducials could not be placed|0|||
130233340|NCT00750269|468819704|FG001|Overall Study|Fiducials could not be placed|0|||
130233341|NCT00750269|468819705|FG002|Overall Study|Fiducials could not be placed|0|||
130233342|NCT00750269|468819706|FG003|Overall Study|Fiducials could not be placed|0|||
130233343|NCT00750269|468819707|FG004|Overall Study|Fiducials could not be placed|1|||
130233344|NCT02100631|468819709|FG000|Overall Study|Withdrawal by Subject|1|||
130233345|NCT02100631|468819710|FG001|Overall Study|Withdrawal by Subject|0|||
130233346|NCT02100631|468819711|FG002|Overall Study|Withdrawal by Subject|0|||
130233347|NCT02100631|468819709|FG000|Overall Study|Lost to Follow-up|3|||
130233348|NCT02100631|468819710|FG001|Overall Study|Lost to Follow-up|4|||
130233349|NCT02100631|468819711|FG002|Overall Study|Lost to Follow-up|0|||
130446540|NCT03077620|469595616|FG001|Overall Study|Physician Decision|0|||
130446541|NCT03077620|469595617|FG002|Overall Study|Physician Decision|1|||
130446542|NCT03077620|469595618|FG003|Overall Study|Physician Decision|0|||
130446543|NCT03225846|469595619|FG000|Overall Study|Adverse Event|0|||
130446544|NCT03225846|469595620|FG001|Overall Study|Adverse Event|0|||
130446545|NCT03225846|469595621|FG002|Overall Study|Adverse Event|0|||
130446546|NCT03225846|469595622|FG003|Overall Study|Adverse Event|0|||
130446547|NCT03225846|469595623|FG004|Overall Study|Adverse Event|0|||
130446548|NCT03225846|469595624|FG005|Overall Study|Adverse Event|0|||
130233350|NCT02100631|468819709|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
130233351|NCT02100631|468819710|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130233352|NCT02100631|468819711|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130233353|NCT03944616|468819713|FG000|Overall Study|Lost to Follow-up|0|||
130233354|NCT03944616|468819714|FG001|Overall Study|Lost to Follow-up|2|||
130233355|NCT01721798|468819715|FG000|Overall Study|Death|0|||
130446549|NCT03225846|469595625|FG006|Overall Study|Adverse Event|6|||
130446550|NCT03225846|469595619|FG000|Overall Study|Withdrawal by Subject|0|||
130694483|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694484|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
130694485|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694486|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694487|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694488|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694489|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130446551|NCT03225846|469595620|FG001|Overall Study|Withdrawal by Subject|1|||
130446552|NCT03225846|469595621|FG002|Overall Study|Withdrawal by Subject|0|||
130233356|NCT01721798|468819716|FG001|Overall Study|Death|0|||
130233357|NCT01721798|468819717|FG002|Overall Study|Death|1|||
130233358|NCT01721798|468819718|FG003|Overall Study|Death|1|||
130233359|NCT01721798|468819715|FG000|Overall Study|Lost to Follow-up|2|||
130233360|NCT01721798|468819716|FG001|Overall Study|Lost to Follow-up|2|||
130233361|NCT01721798|468819717|FG002|Overall Study|Lost to Follow-up|9|||
130233362|NCT01721798|468819718|FG003|Overall Study|Lost to Follow-up|9|||
130233363|NCT01721798|468819715|FG000|Overall Study|Pregnancy|0|||
130233364|NCT01721798|468819716|FG001|Overall Study|Pregnancy|0|||
130233365|NCT01721798|468819717|FG002|Overall Study|Pregnancy|1|||
130233366|NCT01721798|468819718|FG003|Overall Study|Pregnancy|1|||
130233367|NCT01721798|468819715|FG000|Overall Study|Withdrawal by Subject|1|||
130233368|NCT01721798|468819716|FG001|Overall Study|Withdrawal by Subject|0|||
130233369|NCT01721798|468819717|FG002|Overall Study|Withdrawal by Subject|2|||
130233370|NCT01721798|468819718|FG003|Overall Study|Withdrawal by Subject|1|||
130233371|NCT01721798|468819715|FG000|Overall Study|Not eligible for 24 month visit|1|||
130233372|NCT01721798|468819716|FG001|Overall Study|Not eligible for 24 month visit|0|||
130233373|NCT01721798|468819717|FG002|Overall Study|Not eligible for 24 month visit|8|||
130233374|NCT01721798|468819718|FG003|Overall Study|Not eligible for 24 month visit|7|||
130233375|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
130233376|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
130233377|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
130233378|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
130233379|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
130233380|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
130233381|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
130233382|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
130233383|NCT01294046|468819720|FG000|Overall Study|Infection and surgical explant|1|||
130233384|NCT01294046|468819720|FG000|Overall Study|Eligibility criteria expanded|1|||
130233385|NCT01294046|468819720|FG000|Overall Study|Stimulation response inadqequate|1|||
130233386|NCT00761319|468819721|FG000|Overall Study|Protocol Violation|21|||
130233387|NCT00761319|468819722|FG001|Overall Study|Protocol Violation|14|||
130233388|NCT00761319|468819721|FG000|Overall Study|Adverse Event|11|||
130233389|NCT00761319|468819722|FG001|Overall Study|Adverse Event|7|||
130233390|NCT00761319|468819721|FG000|Overall Study|Withdrawal by Subject|8|||
130233391|NCT00761319|468819722|FG001|Overall Study|Withdrawal by Subject|7|||
130233392|NCT00761319|468819721|FG000|Overall Study|Noncompliance|4|||
130233393|NCT00761319|468819722|FG001|Overall Study|Noncompliance|3|||
130233394|NCT00761319|468819721|FG000|Overall Study|Lost to Follow-up|1|||
130233395|NCT00761319|468819722|FG001|Overall Study|Lost to Follow-up|1|||
130233396|NCT00761319|468819721|FG000|Overall Study|Nonspecified|2|||
130233397|NCT00761319|468819722|FG001|Overall Study|Nonspecified|2|||
130233398|NCT00761319|468819721|FG000|Overall Study|Missing|1|||
130233399|NCT00761319|468819722|FG001|Overall Study|Missing|0|||
130233400|NCT03261401|468819723|FG000|Overall Study|Withdrawal by Subject|0|||
130233401|NCT03261401|468819724|FG001|Overall Study|Withdrawal by Subject|0|||
130233402|NCT03261401|468819725|FG002|Overall Study|Withdrawal by Subject|0|||
130233403|NCT03261401|468819726|FG003|Overall Study|Withdrawal by Subject|0|||
130233404|NCT03261401|468819727|FG004|Overall Study|Withdrawal by Subject|0|||
130233405|NCT03261401|468819728|FG005|Overall Study|Withdrawal by Subject|1|||
130233406|NCT03261401|468819729|FG006|Overall Study|Withdrawal by Subject|0|||
130233407|NCT03261401|468819730|FG007|Overall Study|Withdrawal by Subject|0|||
130233408|NCT03261401|468819731|FG008|Overall Study|Withdrawal by Subject|0|||
130233409|NCT03261401|468819732|FG009|Overall Study|Withdrawal by Subject|0|||
130233410|NCT03261401|468819733|FG010|Overall Study|Withdrawal by Subject|0|||
130233411|NCT03261401|468819734|FG011|Overall Study|Withdrawal by Subject|0|||
130358119|NCT01973569|469283126|FG001|Overall Study|Disease progression|3|||
130358120|NCT01973569|469283127|FG002|Overall Study|Disease progression|0|||
130358121|NCT01973569|469283125|FG000|Overall Study|Other|1|||
130358122|NCT01973569|469283126|FG001|Overall Study|Other|1|||
130358123|NCT01973569|469283127|FG002|Overall Study|Other|0|||
130358124|NCT01973569|469283125|FG000|Overall Study|Did not receive study drug|6|||
130358125|NCT01973569|469283126|FG001|Overall Study|Did not receive study drug|3|||
130233412|NCT03261401|468819735|FG012|Overall Study|Withdrawal by Subject|0|||
130233413|NCT03261401|468819723|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
130233414|NCT03261401|468819724|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
130358126|NCT01973569|469283127|FG002|Overall Study|Did not receive study drug|3|||
130358127|NCT00810108|469283130|FG000|Overall Study|Withdrawal by Subject|1|||
130233415|NCT03261401|468819725|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
130233416|NCT03261401|468819726|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
130233417|NCT03261401|468819727|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
130233418|NCT03261401|468819728|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
130233419|NCT03261401|468819729|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
130233420|NCT03261401|468819730|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
130233421|NCT03261401|468819731|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
130233422|NCT03261401|468819732|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
130233423|NCT03261401|468819733|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
130233424|NCT03261401|468819734|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
130233425|NCT03261401|468819735|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
130233426|NCT00915525|468819736|FG000|Overall Study|Protocol Violation|9|||
130233427|NCT00915525|468819737|FG001|Overall Study|Protocol Violation|4|||
130233428|NCT00915525|468819736|FG000|Overall Study|Withdrawal by Subject|59|||
130233429|NCT00915525|468819737|FG001|Overall Study|Withdrawal by Subject|21|||
130233430|NCT00915525|468819736|FG000|Overall Study|Lost to Follow-up|27|||
130233431|NCT00915525|468819737|FG001|Overall Study|Lost to Follow-up|16|||
130233432|NCT00915525|468819736|FG000|Overall Study|Pregnancy|2|||
130233433|NCT00915525|468819737|FG001|Overall Study|Pregnancy|0|||
130233434|NCT00915525|468819736|FG000|Overall Study|Lack of Efficacy|15|||
130233435|NCT00915525|468819737|FG001|Overall Study|Lack of Efficacy|32|||
130233436|NCT00915525|468819736|FG000|Overall Study|Adverse Event|29|||
130233437|NCT00915525|468819737|FG001|Overall Study|Adverse Event|13|||
130233438|NCT00915525|468819736|FG000|Overall Study|Missing|12|||
130233439|NCT00915525|468819737|FG001|Overall Study|Missing|1|||
130233440|NCT00915525|468819736|FG000|Overall Study|Other Reason|35|||
130233441|NCT00915525|468819737|FG001|Overall Study|Other Reason|12|||
130233442|NCT00915525|468819736|FG000|Overall Study|Site Closed|27|||
130233443|NCT00915525|468819737|FG001|Overall Study|Site Closed|9|||
130233444|NCT00915525|468819736|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
130233445|NCT00915525|468819737|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
130233446|NCT00915525|468819736|FG000|Overall Study|Study Burden|28|||
130233447|NCT00915525|468819737|FG001|Overall Study|Study Burden|12|||
130233448|NCT00915525|468819736|FG000|Overall Study|Non-Compliance|3|||
130233449|NCT00915525|468819737|FG001|Overall Study|Non-Compliance|1|||
130233450|NCT00915525|468819736|FG000|Overall Study|Patient Moved|15|||
130233451|NCT00915525|468819737|FG001|Overall Study|Patient Moved|9|||
130233452|NCT02765035|468819745|FG000|First Intervention (90 Days)|Adverse Event|1|||
130233453|NCT02765035|468819746|FG001|First Intervention (90 Days)|Adverse Event|1|||
130446553|NCT03225846|469595622|FG003|Overall Study|Withdrawal by Subject|0|||
130446554|NCT03225846|469595623|FG004|Overall Study|Withdrawal by Subject|0|||
130446555|NCT03225846|469595624|FG005|Overall Study|Withdrawal by Subject|0|||
130446556|NCT03225846|469595625|FG006|Overall Study|Withdrawal by Subject|0|||
130446557|NCT03225846|469595619|FG000|Overall Study|Death|0|||
130446558|NCT03225846|469595620|FG001|Overall Study|Death|1|||
130446559|NCT03225846|469595621|FG002|Overall Study|Death|0|||
130446560|NCT03225846|469595622|FG003|Overall Study|Death|0|||
130446561|NCT03225846|469595623|FG004|Overall Study|Death|0|||
130446562|NCT03225846|469595624|FG005|Overall Study|Death|0|||
130446563|NCT03225846|469595625|FG006|Overall Study|Death|0|||
130446564|NCT03225846|469595619|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446565|NCT03225846|469595620|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446566|NCT03225846|469595621|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
130446567|NCT03225846|469595622|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446568|NCT03225846|469595623|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446569|NCT03225846|469595624|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446570|NCT03225846|469595625|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
130446571|NCT03225846|469595619|FG000|Overall Study|Patient decision|0|||
130446572|NCT03225846|469595620|FG001|Overall Study|Patient decision|0|||
130446573|NCT03225846|469595621|FG002|Overall Study|Patient decision|0|||
130446574|NCT03225846|469595622|FG003|Overall Study|Patient decision|0|||
130446575|NCT03225846|469595623|FG004|Overall Study|Patient decision|0|||
130446576|NCT03225846|469595624|FG005|Overall Study|Patient decision|0|||
130233454|NCT02765035|468819745|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
130233455|NCT02765035|468819746|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
130233456|NCT01712178|468819748|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
130233457|NCT01712178|468819749|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
130233458|NCT01712178|468819748|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
130233459|NCT01712178|468819749|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
130233460|NCT01712178|468819748|FG000|Overall Study|Lost to Follow-up|0|||
130233461|NCT01712178|468819749|FG001|Overall Study|Lost to Follow-up|1|||
130233462|NCT00091819|468819750|FG000|Overall Study|Adverse Event|1|||
130233463|NCT00091819|468819751|FG001|Overall Study|Adverse Event|1|||
130233464|NCT00091819|468819750|FG000|Overall Study|Death|4|||
130233465|NCT00091819|468819751|FG001|Overall Study|Death|5|||
130233466|NCT00091819|468819750|FG000|Overall Study|Lost to Follow-up|26|||
130233467|NCT00091819|468819751|FG001|Overall Study|Lost to Follow-up|23|||
130233468|NCT00091819|468819750|FG000|Overall Study|Withdrawal by Subject|5|||
130233469|NCT00091819|468819751|FG001|Overall Study|Withdrawal by Subject|8|||
130233470|NCT00091819|468819750|FG000|Overall Study|Protocol Violation|1|||
130233471|NCT00091819|468819751|FG001|Overall Study|Protocol Violation|2|||
130446577|NCT03225846|469595625|FG006|Overall Study|Patient decision|1|||
130446578|NCT00996580|469595626|FG000|Overall Study|Adverse Event|466|||
130233472|NCT00091819|468819750|FG000|Overall Study|Other|2|||
130233473|NCT00091819|468819751|FG001|Overall Study|Other|3|||
130233474|NCT00091819|468819750|FG000|Overall Study|Never received study treatment|3|||
130233475|NCT00091819|468819751|FG001|Overall Study|Never received study treatment|4|||
130233476|NCT00984867|468819752|FG000|Overall Study|Adverse Event|3|||
130233477|NCT00984867|468819753|FG001|Overall Study|Adverse Event|7|||
130233478|NCT00984867|468819752|FG000|Overall Study|Death|1|||
130233479|NCT00984867|468819753|FG001|Overall Study|Death|0|||
130233480|NCT00984867|468819752|FG000|Overall Study|Withdrawal by Subject|13|||
130233481|NCT00984867|468819753|FG001|Overall Study|Withdrawal by Subject|4|||
130233482|NCT00984867|468819752|FG000|Overall Study|Lost to Follow-up|3|||
130233483|NCT00984867|468819753|FG001|Overall Study|Lost to Follow-up|4|||
130233484|NCT00984867|468819752|FG000|Overall Study|Poor/non-compliance|0|||
130233485|NCT00984867|468819753|FG001|Overall Study|Poor/non-compliance|1|||
130233486|NCT00984867|468819752|FG000|Overall Study|Subject no longer meets study criteria|1|||
130233487|NCT00984867|468819753|FG001|Overall Study|Subject no longer meets study criteria|1|||
130233488|NCT00984867|468819752|FG000|Overall Study|site closing|1|||
130233489|NCT00984867|468819753|FG001|Overall Study|site closing|0|||
130233490|NCT00984867|468819752|FG000|Overall Study|lack of efficacy and subject compliance|1|||
130233491|NCT00984867|468819753|FG001|Overall Study|lack of efficacy and subject compliance|0|||
130233492|NCT00634504|468819758|FG000|Overall Study|Protocol Violation|1|||
130233493|NCT00634504|468819759|FG001|Overall Study|Protocol Violation|0|||
130233494|NCT05001620|468819762|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
130233495|NCT05001620|468819763|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
130233496|NCT00481676|468819764|FG000|Overall Study|Adverse Event|0|||
130233497|NCT00481676|468819765|FG001|Overall Study|Adverse Event|1|||
130233498|NCT00481676|468819764|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130233499|NCT00481676|468819765|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130233500|NCT00481676|468819764|FG000|Overall Study|Administrative problem|1|||
130233501|NCT00481676|468819765|FG001|Overall Study|Administrative problem|0|||
130233502|NCT03937778|468819766|FG000|Overall Study|Withdrawal by Subject|1|||
130233503|NCT03937778|468819766|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
130233504|NCT00819039|468819767|FG000|Overall Study|Physician Decision|1|||
130233505|NCT00819039|468819768|FG001|Overall Study|Physician Decision|0|||
130233506|NCT00819039|468819769|FG002|Overall Study|Physician Decision|1|||
130233507|NCT00819039|468819767|FG000|Overall Study|Protocol Violation|1|||
130233508|NCT00819039|468819768|FG001|Overall Study|Protocol Violation|0|||
130233509|NCT00819039|468819769|FG002|Overall Study|Protocol Violation|0|||
130358128|NCT00810108|469283131|FG001|Overall Study|Withdrawal by Subject|0|||
130358129|NCT02486302|469283139|FG000|Overall Study|Discontinued prematurely|410|||
130358130|NCT02486302|469283139|FG000|Overall Study|Documentation not completed|255|||
130358131|NCT02486302|469283139|FG000|Overall Study|Excluded due to legal reasons|8|||
130358132|NCT02486302|469283139|FG000|Overall Study|Not treated|3|||
130358133|NCT04171765|469283141|FG000|Overall Study|Adverse Event|2|||
130358134|NCT04171765|469283142|FG001|Overall Study|Adverse Event|0|||
130358135|NCT04171765|469283143|FG002|Overall Study|Adverse Event|1|||
130358136|NCT04171765|469283144|FG003|Overall Study|Adverse Event|0|||
130358137|NCT04171765|469283141|FG000|Overall Study|Lost to Follow-up|0|||
130358138|NCT04171765|469283142|FG001|Overall Study|Lost to Follow-up|2|||
130358139|NCT04171765|469283143|FG002|Overall Study|Lost to Follow-up|2|||
130358140|NCT04171765|469283144|FG003|Overall Study|Lost to Follow-up|2|||
130358141|NCT04171765|469283141|FG000|Overall Study|Week 58 visit missed|0|||
130358142|NCT04171765|469283142|FG001|Overall Study|Week 58 visit missed|0|||
130358143|NCT04171765|469283143|FG002|Overall Study|Week 58 visit missed|1|||
130358144|NCT04171765|469283144|FG003|Overall Study|Week 58 visit missed|0|||
130358145|NCT04171765|469283141|FG000|Overall Study|Study terminated by sponsor|2|||
130358146|NCT04171765|469283142|FG001|Overall Study|Study terminated by sponsor|0|||
130358147|NCT04171765|469283143|FG002|Overall Study|Study terminated by sponsor|0|||
130233510|NCT01240694|468819770|FG000|Overall Study|Adverse Event|9|||
130233511|NCT01240694|468819770|FG000|Overall Study|Lack of Efficacy|6|||
130233512|NCT01240694|468819770|FG000|Overall Study|Withdrawal by Subject|6|||
130233513|NCT01240694|468819770|FG000|Overall Study|Protocol Violation|2|||
130233514|NCT01240694|468819770|FG000|Overall Study|Lost to Follow-up|2|||
130233515|NCT01240694|468819770|FG000|Overall Study|Other than specified|3|||
130233516|NCT01240694|468819770|FG000|Overall Study|Withdrawn due to early study termination|107|||
130233517|NCT01513590|468819771|FG000|Overall Study|Adverse Event|2|||
130358148|NCT04171765|469283144|FG003|Overall Study|Study terminated by sponsor|0|||
130358149|NCT04171765|469283141|FG000|Overall Study|Withdrawal by Subject|1|||
130358150|NCT04171765|469283142|FG001|Overall Study|Withdrawal by Subject|0|||
130358151|NCT04171765|469283143|FG002|Overall Study|Withdrawal by Subject|0|||
130358152|NCT04171765|469283144|FG003|Overall Study|Withdrawal by Subject|3|||
130358153|NCT00809354|469283145|FG000|Overall Study|Adverse Event|32|||
130358154|NCT00809354|469283146|FG001|Overall Study|Adverse Event|45|||
130358155|NCT00809354|469283147|FG002|Overall Study|Adverse Event|37|||
130358156|NCT00809354|469283148|FG003|Overall Study|Adverse Event|53|||
130358157|NCT00809354|469283149|FG004|Overall Study|Adverse Event|26|||
130233518|NCT01513590|468819772|FG001|Overall Study|Adverse Event|3|||
130233519|NCT01513590|468819771|FG000|Overall Study|Withdrawal Criteria|3|||
130233520|NCT01513590|468819772|FG001|Overall Study|Withdrawal Criteria|0|||
130233521|NCT01513590|468819771|FG000|Overall Study|Unclassified|5|||
130233522|NCT01513590|468819772|FG001|Overall Study|Unclassified|10|||
130233523|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
130233524|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
130233525|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
130233526|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
130233527|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
130233528|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
130233529|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
130233530|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
130233531|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
130233532|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
130233533|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Death|3|||
130233534|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Death|1|||
130233535|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
130233536|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
130233537|NCT01056276|468819773|FG000|Maintenance Therapy|Toxicity|0|||
130233538|NCT01056276|468819774|FG001|Maintenance Therapy|Toxicity|2|||
130233539|NCT01056276|468819773|FG000|Maintenance Therapy|Progressive Disease|0|||
130233540|NCT01056276|468819774|FG001|Maintenance Therapy|Progressive Disease|9|||
130233541|NCT01056276|468819773|FG000|Maintenance Therapy|Physician Decision|0|||
130233542|NCT01056276|468819774|FG001|Maintenance Therapy|Physician Decision|1|||
130233543|NCT01056276|468819773|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
130233544|NCT01056276|468819774|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
130233545|NCT01056276|468819773|FG000|Maintenance Therapy|Intercurrent Illness|0|||
130233546|NCT01056276|468819774|FG001|Maintenance Therapy|Intercurrent Illness|1|||
130233547|NCT01056276|468819773|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
130233548|NCT01056276|468819774|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
130233549|NCT01881425|468819775|FG000|Overall Study|Death|5|||
130233550|NCT01881425|468819776|FG001|Overall Study|Death|1|||
130233551|NCT01881425|468819775|FG000|Overall Study|Withdrawal by Subject|8|||
130233552|NCT01881425|468819776|FG001|Overall Study|Withdrawal by Subject|3|||
130233553|NCT01881425|468819775|FG000|Overall Study|Physician Decision|2|||
130233554|NCT01881425|468819776|FG001|Overall Study|Physician Decision|1|||
130233555|NCT01881425|468819775|FG000|Overall Study|Adverse Event|3|||
130233556|NCT01881425|468819776|FG001|Overall Study|Adverse Event|0|||
130233557|NCT01881425|468819775|FG000|Overall Study|General Anesthesia panic attack|0|||
130233558|NCT01881425|468819776|FG001|Overall Study|General Anesthesia panic attack|1|||
130233559|NCT01881425|468819775|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
130233560|NCT01881425|468819776|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
130233561|NCT01881425|468819775|FG000|Overall Study|Lost to Follow-up|7|||
130233562|NCT01881425|468819776|FG001|Overall Study|Lost to Follow-up|2|||
130358158|NCT00809354|469283150|FG005|Overall Study|Adverse Event|33|||
130358159|NCT00809354|469283151|FG006|Overall Study|Adverse Event|44|||
130358160|NCT00809354|469283152|FG007|Overall Study|Adverse Event|40|||
130358161|NCT00809354|469283153|FG008|Overall Study|Adverse Event|46|||
130358162|NCT00809354|469283154|FG009|Overall Study|Adverse Event|26|||
130358163|NCT00809354|469283145|FG000|Overall Study|Lack of Efficacy|23|||
130358164|NCT00809354|469283146|FG001|Overall Study|Lack of Efficacy|23|||
130358165|NCT00809354|469283147|FG002|Overall Study|Lack of Efficacy|22|||
130358166|NCT00809354|469283148|FG003|Overall Study|Lack of Efficacy|15|||
130358167|NCT00809354|469283149|FG004|Overall Study|Lack of Efficacy|40|||
130358168|NCT00809354|469283150|FG005|Overall Study|Lack of Efficacy|19|||
130358169|NCT00809354|469283151|FG006|Overall Study|Lack of Efficacy|21|||
130358170|NCT00809354|469283152|FG007|Overall Study|Lack of Efficacy|15|||
130358171|NCT00809354|469283153|FG008|Overall Study|Lack of Efficacy|18|||
130358172|NCT00809354|469283154|FG009|Overall Study|Lack of Efficacy|38|||
130233563|NCT01200355|468819777|FG000|Overall Study|Death|7|||
130233564|NCT01200355|468819778|FG001|Overall Study|Death|2|||
130233565|NCT04424901|468819779|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
130233566|NCT04424901|468819780|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
130233567|NCT01206764|468819781|FG000|Overall Study|Adverse Event|20|||
130358173|NCT00809354|469283145|FG000|Overall Study|Lost to Follow-up|10|||
130358174|NCT00809354|469283146|FG001|Overall Study|Lost to Follow-up|11|||
130358175|NCT00809354|469283147|FG002|Overall Study|Lost to Follow-up|8|||
130358176|NCT00809354|469283148|FG003|Overall Study|Lost to Follow-up|13|||
130358177|NCT00809354|469283149|FG004|Overall Study|Lost to Follow-up|6|||
130358178|NCT00809354|469283150|FG005|Overall Study|Lost to Follow-up|2|||
130358179|NCT00809354|469283151|FG006|Overall Study|Lost to Follow-up|0|||
130233568|NCT01206764|468819781|FG000|Overall Study|Abnormal laboratory value|2|||
130233569|NCT01206764|468819781|FG000|Overall Study|Abnormal test procedure result|1|||
130233570|NCT01206764|468819781|FG000|Overall Study|Patient withdrew consent|5|||
130358180|NCT00809354|469283152|FG007|Overall Study|Lost to Follow-up|5|||
130358181|NCT00809354|469283153|FG008|Overall Study|Lost to Follow-up|4|||
130233571|NCT01206764|468819781|FG000|Overall Study|Lost to Follow-up|6|||
130233572|NCT01206764|468819781|FG000|Overall Study|Death|11|||
130233573|NCT01206764|468819781|FG000|Overall Study|New cancer therapy|2|||
130233574|NCT01206764|468819781|FG000|Overall Study|Disease progression|88|||
130233575|NCT01206764|468819781|FG000|Overall Study|Protocol deviation|3|||
130233576|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
130233577|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
130233578|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
130233579|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
130233580|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
130233581|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
130233582|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
130233583|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
130233584|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
130233585|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
130233586|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
130233587|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
130233588|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130233589|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130233590|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
130233591|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
130233592|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
130233593|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
130233594|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
130233595|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
130233596|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130233597|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130233598|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
130233599|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
130233600|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
130233601|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
130233602|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
130233603|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
130233604|NCT00797563|468819786|FG000|Overall Study|Adverse Event|1|||
130233605|NCT00688597|468819787|FG000|Overall Study|Adverse Event|2|||
130233606|NCT00688597|468819788|FG001|Overall Study|Adverse Event|0|||
130233607|NCT00688597|468819789|FG002|Overall Study|Adverse Event|0|||
130233608|NCT00688597|468819787|FG000|Overall Study|Physician Decision|1|||
130233609|NCT00688597|468819788|FG001|Overall Study|Physician Decision|0|||
130233610|NCT00688597|468819789|FG002|Overall Study|Physician Decision|0|||
130233611|NCT05853120|468819790|FG000|Overall Study|Lost to Follow-up|4|||
130233612|NCT05853120|468819791|FG001|Overall Study|Lost to Follow-up|4|||
130233613|NCT05853120|468819790|FG000|Overall Study|Physician Decision|3|||
130233614|NCT05853120|468819791|FG001|Overall Study|Physician Decision|0|||
130233615|NCT05853120|468819790|FG000|Overall Study|Withdrawal by Subject|5|||
130233616|NCT05853120|468819791|FG001|Overall Study|Withdrawal by Subject|2|||
130233617|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130233618|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130233619|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
130233620|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
130233621|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
130233622|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
130233623|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
130233624|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
130233625|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130233626|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130233627|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
130233628|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
130233629|NCT00465517|468819794|FG000|Overall Study|Adverse Event|7|||
130233630|NCT00465517|468819795|FG001|Overall Study|Adverse Event|3|||
130233631|NCT00465517|468819794|FG000|Overall Study|Lost to Follow-up|1|||
130233632|NCT00465517|468819795|FG001|Overall Study|Lost to Follow-up|0|||
130358182|NCT00809354|469283154|FG009|Overall Study|Lost to Follow-up|0|||
130233633|NCT00465517|468819794|FG000|Overall Study|Withdrawal by Subject|4|||
130233634|NCT00465517|468819795|FG001|Overall Study|Withdrawal by Subject|1|||
130233635|NCT00834041|468819803|FG000|Overall Study|Withdrawal by Subject|1|||
130694490|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694491|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694492|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694493|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694494|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694495|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694496|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694497|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694498|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694499|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694500|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694501|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694502|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694503|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694504|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694505|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694506|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694507|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
130694508|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694509|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694510|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694511|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694512|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694513|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694514|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694515|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694516|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694517|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694518|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694519|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694520|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694521|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694522|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694523|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694524|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694525|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694526|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694527|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694528|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694529|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694530|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694531|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694532|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694533|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
130694534|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694535|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694536|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694537|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694538|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
130358183|NCT00809354|469283145|FG000|Overall Study|Protocol Violation|7|||
130358184|NCT00809354|469283146|FG001|Overall Study|Protocol Violation|14|||
130358185|NCT00809354|469283147|FG002|Overall Study|Protocol Violation|14|||
130358186|NCT00809354|469283148|FG003|Overall Study|Protocol Violation|12|||
130358187|NCT00809354|469283149|FG004|Overall Study|Protocol Violation|14|||
130358188|NCT00809354|469283150|FG005|Overall Study|Protocol Violation|6|||
130358189|NCT00809354|469283151|FG006|Overall Study|Protocol Violation|4|||
130358190|NCT00809354|469283152|FG007|Overall Study|Protocol Violation|6|||
130358191|NCT00809354|469283153|FG008|Overall Study|Protocol Violation|9|||
130358192|NCT00809354|469283154|FG009|Overall Study|Protocol Violation|3|||
130358193|NCT00809354|469283145|FG000|Overall Study|Withdrawal by Subject|32|||
130358194|NCT00809354|469283146|FG001|Overall Study|Withdrawal by Subject|27|||
130358195|NCT00809354|469283147|FG002|Overall Study|Withdrawal by Subject|31|||
130358196|NCT00809354|469283148|FG003|Overall Study|Withdrawal by Subject|33|||
130358197|NCT00809354|469283149|FG004|Overall Study|Withdrawal by Subject|34|||
130358198|NCT00809354|469283150|FG005|Overall Study|Withdrawal by Subject|29|||
130358199|NCT00809354|469283151|FG006|Overall Study|Withdrawal by Subject|27|||
130358200|NCT00809354|469283152|FG007|Overall Study|Withdrawal by Subject|19|||
130358201|NCT00809354|469283153|FG008|Overall Study|Withdrawal by Subject|18|||
130358202|NCT00809354|469283154|FG009|Overall Study|Withdrawal by Subject|20|||
130358203|NCT00809354|469283145|FG000|Overall Study|Other|10|||
130358204|NCT00809354|469283146|FG001|Overall Study|Other|2|||
130358205|NCT00809354|469283147|FG002|Overall Study|Other|7|||
130233636|NCT00834041|468819804|FG001|Overall Study|Withdrawal by Subject|0|||
130233637|NCT00834041|468819803|FG000|Overall Study|Lost to Follow-up|0|||
130233638|NCT00834041|468819804|FG001|Overall Study|Lost to Follow-up|1|||
130233639|NCT01799889|468821127|FG000|Overall Study|Adverse Event|4|||
130233640|NCT01799889|468821128|FG001|Overall Study|Adverse Event|4|||
130233641|NCT01799889|468821129|FG002|Overall Study|Adverse Event|5|||
130233642|NCT01799889|468821130|FG003|Overall Study|Adverse Event|1|||
130233643|NCT01799889|468821131|FG004|Overall Study|Adverse Event|11|||
130233644|NCT01799889|468821132|FG005|Overall Study|Adverse Event|1|||
130233645|NCT01799889|468821133|FG006|Overall Study|Adverse Event|5|||
130233646|NCT01799889|468821134|FG007|Overall Study|Adverse Event|2|||
130233647|NCT01799889|468821135|FG008|Overall Study|Adverse Event|3|||
130233648|NCT01799889|468821136|FG009|Overall Study|Adverse Event|1|||
130233649|NCT01799889|468821137|FG010|Overall Study|Adverse Event|1|||
130233650|NCT01799889|468821138|FG011|Overall Study|Adverse Event|0|||
130233651|NCT01799889|468821127|FG000|Overall Study|Death|1|||
130233652|NCT01799889|468821128|FG001|Overall Study|Death|0|||
130233653|NCT01799889|468821129|FG002|Overall Study|Death|5|||
130233654|NCT01799889|468821130|FG003|Overall Study|Death|3|||
130233655|NCT01799889|468821131|FG004|Overall Study|Death|1|||
130233656|NCT01799889|468821132|FG005|Overall Study|Death|0|||
130233657|NCT01799889|468821133|FG006|Overall Study|Death|0|||
130233658|NCT01799889|468821134|FG007|Overall Study|Death|0|||
130233659|NCT01799889|468821135|FG008|Overall Study|Death|1|||
130233660|NCT01799889|468821136|FG009|Overall Study|Death|0|||
130233661|NCT01799889|468821137|FG010|Overall Study|Death|1|||
130233662|NCT01799889|468821138|FG011|Overall Study|Death|0|||
130233663|NCT01799889|468821127|FG000|Overall Study|Lack of Efficacy|1|||
130233664|NCT01799889|468821128|FG001|Overall Study|Lack of Efficacy|1|||
130233665|NCT01799889|468821129|FG002|Overall Study|Lack of Efficacy|0|||
130233666|NCT01799889|468821130|FG003|Overall Study|Lack of Efficacy|1|||
130233667|NCT01799889|468821131|FG004|Overall Study|Lack of Efficacy|2|||
130233668|NCT01799889|468821132|FG005|Overall Study|Lack of Efficacy|2|||
130233669|NCT01799889|468821133|FG006|Overall Study|Lack of Efficacy|0|||
130233670|NCT01799889|468821134|FG007|Overall Study|Lack of Efficacy|0|||
130233671|NCT01799889|468821135|FG008|Overall Study|Lack of Efficacy|2|||
130233672|NCT01799889|468821136|FG009|Overall Study|Lack of Efficacy|0|||
130233673|NCT01799889|468821137|FG010|Overall Study|Lack of Efficacy|1|||
130233674|NCT01799889|468821138|FG011|Overall Study|Lack of Efficacy|0|||
130233675|NCT01799889|468821127|FG000|Overall Study|Lost to Follow-up|0|||
130233676|NCT01799889|468821128|FG001|Overall Study|Lost to Follow-up|1|||
130233677|NCT01799889|468821129|FG002|Overall Study|Lost to Follow-up|0|||
130233678|NCT01799889|468821130|FG003|Overall Study|Lost to Follow-up|0|||
130233679|NCT01799889|468821131|FG004|Overall Study|Lost to Follow-up|0|||
130233680|NCT01799889|468821132|FG005|Overall Study|Lost to Follow-up|0|||
130233681|NCT01799889|468821133|FG006|Overall Study|Lost to Follow-up|0|||
130233682|NCT01799889|468821134|FG007|Overall Study|Lost to Follow-up|0|||
130233683|NCT01799889|468821135|FG008|Overall Study|Lost to Follow-up|0|||
130233684|NCT01799889|468821136|FG009|Overall Study|Lost to Follow-up|0|||
130233685|NCT01799889|468821137|FG010|Overall Study|Lost to Follow-up|0|||
130233686|NCT01799889|468821138|FG011|Overall Study|Lost to Follow-up|0|||
130233687|NCT01799889|468821127|FG000|Overall Study|Physician Decision|3|||
130233688|NCT01799889|468821128|FG001|Overall Study|Physician Decision|2|||
130233689|NCT01799889|468821129|FG002|Overall Study|Physician Decision|4|||
130233690|NCT01799889|468821130|FG003|Overall Study|Physician Decision|4|||
130233691|NCT01799889|468821131|FG004|Overall Study|Physician Decision|5|||
130233692|NCT01799889|468821132|FG005|Overall Study|Physician Decision|5|||
130233693|NCT01799889|468821133|FG006|Overall Study|Physician Decision|5|||
130233694|NCT01799889|468821134|FG007|Overall Study|Physician Decision|2|||
130233695|NCT01799889|468821135|FG008|Overall Study|Physician Decision|6|||
130233696|NCT01799889|468821136|FG009|Overall Study|Physician Decision|0|||
130233697|NCT01799889|468821137|FG010|Overall Study|Physician Decision|0|||
130233698|NCT01799889|468821138|FG011|Overall Study|Physician Decision|1|||
130233699|NCT01799889|468821127|FG000|Overall Study|Progressive Disease|30|||
130233700|NCT01799889|468821128|FG001|Overall Study|Progressive Disease|26|||
130233701|NCT01799889|468821129|FG002|Overall Study|Progressive Disease|25|||
130233702|NCT01799889|468821130|FG003|Overall Study|Progressive Disease|30|||
130233703|NCT01799889|468821131|FG004|Overall Study|Progressive Disease|23|||
130233704|NCT01799889|468821132|FG005|Overall Study|Progressive Disease|9|||
130233705|NCT01799889|468821133|FG006|Overall Study|Progressive Disease|8|||
130233706|NCT01799889|468821134|FG007|Overall Study|Progressive Disease|13|||
130233707|NCT01799889|468821135|FG008|Overall Study|Progressive Disease|18|||
130233708|NCT01799889|468821136|FG009|Overall Study|Progressive Disease|5|||
130233709|NCT01799889|468821137|FG010|Overall Study|Progressive Disease|3|||
130233710|NCT01799889|468821138|FG011|Overall Study|Progressive Disease|1|||
130233711|NCT01799889|468821127|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
130233712|NCT01799889|468821128|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
130233713|NCT01799889|468821129|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
130233714|NCT01799889|468821130|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
130233715|NCT01799889|468821131|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
130233716|NCT01799889|468821132|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
130358206|NCT00809354|469283148|FG003|Overall Study|Other|10|||
130358207|NCT00809354|469283149|FG004|Overall Study|Other|5|||
130358208|NCT00809354|469283150|FG005|Overall Study|Other|3|||
130358209|NCT00809354|469283151|FG006|Overall Study|Other|2|||
130358210|NCT00809354|469283152|FG007|Overall Study|Other|3|||
130358211|NCT00809354|469283153|FG008|Overall Study|Other|4|||
130358212|NCT00809354|469283154|FG009|Overall Study|Other|3|||
130358213|NCT00809354|469283145|FG000|Overall Study|Study terminated by sponsor|138|||
130358214|NCT00809354|469283146|FG001|Overall Study|Study terminated by sponsor|134|||
130358215|NCT00809354|469283147|FG002|Overall Study|Study terminated by sponsor|129|||
130358216|NCT00809354|469283148|FG003|Overall Study|Study terminated by sponsor|120|||
130358217|NCT00809354|469283149|FG004|Overall Study|Study terminated by sponsor|126|||
130358218|NCT00809354|469283150|FG005|Overall Study|Study terminated by sponsor|133|||
130358219|NCT00809354|469283151|FG006|Overall Study|Study terminated by sponsor|124|||
130358220|NCT00809354|469283152|FG007|Overall Study|Study terminated by sponsor|148|||
130358221|NCT00809354|469283153|FG008|Overall Study|Study terminated by sponsor|127|||
130358222|NCT00809354|469283154|FG009|Overall Study|Study terminated by sponsor|135|||
130358223|NCT00809354|469283145|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130358224|NCT00809354|469283146|FG001|Overall Study|Withdrawn due to pregnancy|1|||
130358225|NCT00809354|469283147|FG002|Overall Study|Withdrawn due to pregnancy|0|||
130358226|NCT00809354|469283148|FG003|Overall Study|Withdrawn due to pregnancy|0|||
130358227|NCT00809354|469283149|FG004|Overall Study|Withdrawn due to pregnancy|0|||
130358228|NCT00809354|469283150|FG005|Overall Study|Withdrawn due to pregnancy|0|||
130358229|NCT00809354|469283151|FG006|Overall Study|Withdrawn due to pregnancy|0|||
130358230|NCT00809354|469283152|FG007|Overall Study|Withdrawn due to pregnancy|0|||
130358231|NCT00809354|469283153|FG008|Overall Study|Withdrawn due to pregnancy|0|||
130358232|NCT00809354|469283154|FG009|Overall Study|Withdrawn due to pregnancy|0|||
130358233|NCT00809354|469283145|FG000|Overall Study|Randomized but not Treated|3|||
130694539|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694540|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694541|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694542|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694543|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694544|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694545|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694546|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694547|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694548|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694549|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694550|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694551|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130233717|NCT01799889|468821133|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
130233718|NCT01799889|468821134|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
130233719|NCT01799889|468821135|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
130233720|NCT01799889|468821136|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
130233721|NCT01799889|468821137|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
130233722|NCT01799889|468821138|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
130233723|NCT01799889|468821127|FG000|Overall Study|Study Terminated By Sponsor|1|||
130233724|NCT01799889|468821128|FG001|Overall Study|Study Terminated By Sponsor|0|||
130233725|NCT01799889|468821129|FG002|Overall Study|Study Terminated By Sponsor|0|||
130233726|NCT01799889|468821130|FG003|Overall Study|Study Terminated By Sponsor|0|||
130233727|NCT01799889|468821131|FG004|Overall Study|Study Terminated By Sponsor|2|||
130233728|NCT01799889|468821132|FG005|Overall Study|Study Terminated By Sponsor|1|||
130233729|NCT01799889|468821133|FG006|Overall Study|Study Terminated By Sponsor|0|||
130233730|NCT01799889|468821134|FG007|Overall Study|Study Terminated By Sponsor|2|||
130233731|NCT01799889|468821135|FG008|Overall Study|Study Terminated By Sponsor|1|||
130233732|NCT01799889|468821136|FG009|Overall Study|Study Terminated By Sponsor|1|||
130233733|NCT01799889|468821137|FG010|Overall Study|Study Terminated By Sponsor|0|||
130233734|NCT01799889|468821138|FG011|Overall Study|Study Terminated By Sponsor|0|||
130233735|NCT01799889|468821127|FG000|Overall Study|Withdrawal by Subject|1|||
130233736|NCT01799889|468821128|FG001|Overall Study|Withdrawal by Subject|6|||
130233737|NCT01799889|468821129|FG002|Overall Study|Withdrawal by Subject|4|||
130233738|NCT01799889|468821130|FG003|Overall Study|Withdrawal by Subject|0|||
130233739|NCT01799889|468821131|FG004|Overall Study|Withdrawal by Subject|5|||
130233740|NCT01799889|468821132|FG005|Overall Study|Withdrawal by Subject|1|||
130233741|NCT01799889|468821133|FG006|Overall Study|Withdrawal by Subject|3|||
130233742|NCT01799889|468821134|FG007|Overall Study|Withdrawal by Subject|1|||
130358234|NCT00809354|469283146|FG001|Overall Study|Randomized but not Treated|1|||
130358235|NCT00809354|469283147|FG002|Overall Study|Randomized but not Treated|6|||
130358236|NCT00809354|469283148|FG003|Overall Study|Randomized but not Treated|0|||
130358237|NCT00809354|469283149|FG004|Overall Study|Randomized but not Treated|5|||
130358238|NCT00809354|469283150|FG005|Overall Study|Randomized but not Treated|0|||
130358239|NCT00809354|469283151|FG006|Overall Study|Randomized but not Treated|1|||
130358240|NCT00809354|469283152|FG007|Overall Study|Randomized but not Treated|1|||
130358241|NCT00809354|469283153|FG008|Overall Study|Randomized but not Treated|2|||
130233743|NCT01799889|468821135|FG008|Overall Study|Withdrawal by Subject|2|||
130233744|NCT01799889|468821136|FG009|Overall Study|Withdrawal by Subject|1|||
130233745|NCT01799889|468821137|FG010|Overall Study|Withdrawal by Subject|1|||
130233746|NCT01799889|468821138|FG011|Overall Study|Withdrawal by Subject|1|||
130233747|NCT01799889|468821127|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130233748|NCT01799889|468821128|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130233749|NCT01799889|468821129|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130233750|NCT01799889|468821130|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130233751|NCT01799889|468821131|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130233752|NCT01799889|468821132|FG005|Overall Study|Non-Compliance With Study Drug|1|||
130233753|NCT01799889|468821133|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130233754|NCT01799889|468821134|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130233755|NCT01799889|468821135|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130233756|NCT01799889|468821136|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130233757|NCT01799889|468821137|FG010|Overall Study|Non-Compliance With Study Drug|0|||
130233758|NCT01799889|468821138|FG011|Overall Study|Non-Compliance With Study Drug|0|||
130233759|NCT02194465|468821143|FG000|Overall Study|Adverse Event|6|||
130233760|NCT02194465|468821144|FG001|Overall Study|Adverse Event|1|||
130233761|NCT02194465|468821145|FG002|Overall Study|Adverse Event|4|||
130233762|NCT02194465|468821146|FG003|Overall Study|Adverse Event|4|||
130233763|NCT02194465|468821147|FG004|Overall Study|Adverse Event|4|||
130233764|NCT02194465|468821148|FG005|Overall Study|Adverse Event|2|||
130233765|NCT02194465|468821149|FG006|Overall Study|Adverse Event|0|||
130233766|NCT02194465|468821143|FG000|Overall Study|Lost to Follow-up|0|||
130233767|NCT02194465|468821144|FG001|Overall Study|Lost to Follow-up|0|||
130233768|NCT02194465|468821145|FG002|Overall Study|Lost to Follow-up|0|||
130233769|NCT02194465|468821146|FG003|Overall Study|Lost to Follow-up|1|||
130233770|NCT02194465|468821147|FG004|Overall Study|Lost to Follow-up|0|||
130233771|NCT02194465|468821148|FG005|Overall Study|Lost to Follow-up|1|||
130233772|NCT02194465|468821149|FG006|Overall Study|Lost to Follow-up|0|||
130233773|NCT02194465|468821143|FG000|Overall Study|Physician Decision|1|||
130233774|NCT02194465|468821144|FG001|Overall Study|Physician Decision|0|||
130233775|NCT02194465|468821145|FG002|Overall Study|Physician Decision|0|||
130233776|NCT02194465|468821146|FG003|Overall Study|Physician Decision|0|||
130233777|NCT02194465|468821147|FG004|Overall Study|Physician Decision|0|||
130233778|NCT02194465|468821148|FG005|Overall Study|Physician Decision|0|||
130233779|NCT02194465|468821149|FG006|Overall Study|Physician Decision|0|||
130233780|NCT02194465|468821143|FG000|Overall Study|Protocol Violation|1|||
130233781|NCT02194465|468821144|FG001|Overall Study|Protocol Violation|1|||
130233782|NCT02194465|468821145|FG002|Overall Study|Protocol Violation|2|||
130233783|NCT02194465|468821146|FG003|Overall Study|Protocol Violation|1|||
130233784|NCT02194465|468821147|FG004|Overall Study|Protocol Violation|1|||
130233785|NCT02194465|468821148|FG005|Overall Study|Protocol Violation|0|||
130233786|NCT02194465|468821149|FG006|Overall Study|Protocol Violation|0|||
130233787|NCT02194465|468821143|FG000|Overall Study|Withdrawal by Subject|1|||
130233788|NCT02194465|468821144|FG001|Overall Study|Withdrawal by Subject|3|||
130233789|NCT02194465|468821145|FG002|Overall Study|Withdrawal by Subject|1|||
130233790|NCT02194465|468821146|FG003|Overall Study|Withdrawal by Subject|2|||
130233791|NCT02194465|468821147|FG004|Overall Study|Withdrawal by Subject|2|||
130233792|NCT02194465|468821148|FG005|Overall Study|Withdrawal by Subject|1|||
130233793|NCT02194465|468821149|FG006|Overall Study|Withdrawal by Subject|2|||
130233794|NCT02194465|468821143|FG000|Overall Study|Discontinued follow-up period|0|||
130233795|NCT02194465|468821144|FG001|Overall Study|Discontinued follow-up period|2|||
130233796|NCT02194465|468821145|FG002|Overall Study|Discontinued follow-up period|1|||
130233797|NCT02194465|468821146|FG003|Overall Study|Discontinued follow-up period|0|||
130233798|NCT02194465|468821147|FG004|Overall Study|Discontinued follow-up period|2|||
130233799|NCT02194465|468821148|FG005|Overall Study|Discontinued follow-up period|0|||
130233800|NCT02194465|468821149|FG006|Overall Study|Discontinued follow-up period|0|||
130233801|NCT01408641|468821150|FG000|Overall Study|Physician Decision|1|||
130233802|NCT01408641|468821151|FG001|Overall Study|Physician Decision|0|||
130233803|NCT00576758|468821152|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130233804|NCT00576758|468821153|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130233805|NCT00576758|468821152|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
130233806|NCT00576758|468821153|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
130233807|NCT00576758|468821152|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
130233808|NCT00576758|468821153|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
130233809|NCT00576758|468821152|FG000|Induction Treatment Period|Death|1|||
130233810|NCT00576758|468821153|FG001|Induction Treatment Period|Death|0|||
130233811|NCT00576758|468821152|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
130233812|NCT00576758|468821153|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
130233813|NCT00576758|468821152|FG000|Induction Treatment Period|Withdrew consent|1|||
130233814|NCT00576758|468821153|FG001|Induction Treatment Period|Withdrew consent|0|||
130233815|NCT00576758|468821152|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
130233816|NCT00576758|468821153|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
130233817|NCT00576758|468821152|FG000|Extension Treatment Period|Death|1|||
130233818|NCT00576758|468821153|FG001|Extension Treatment Period|Death|1|||
130233819|NCT00576758|468821152|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
130233820|NCT00576758|468821153|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
130233821|NCT00576758|468821152|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
130233822|NCT00576758|468821153|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
130233823|NCT00576758|468821152|FG000|Extension Treatment Period|Administrative/Other|3|||
130233824|NCT00576758|468821153|FG001|Extension Treatment Period|Administrative/Other|1|||
130233825|NCT00576758|468821152|FG000|Follow-up Period|Administrative/Other|6|||
130233826|NCT00576758|468821153|FG001|Follow-up Period|Administrative/Other|8|||
130233827|NCT00576758|468821152|FG000|Follow-up Period|Death|3|||
130233828|NCT00576758|468821153|FG001|Follow-up Period|Death|3|||
130233829|NCT00576758|468821152|FG000|Follow-up Period|Insufficient therapeutic response|16|||
130233830|NCT00576758|468821153|FG001|Follow-up Period|Insufficient therapeutic response|5|||
130233831|NCT00576758|468821152|FG000|Follow-up Period|Withdrew consent|2|||
130233832|NCT00576758|468821153|FG001|Follow-up Period|Withdrew consent|1|||
130233833|NCT00089648|468821154|FG000|Overall Study|Adverse Event|7|||
130233834|NCT00089648|468821154|FG000|Overall Study|Withdrawal by Subject|1|||
130233835|NCT00089648|468821154|FG000|Overall Study|Lack of Efficacy|33|||
130233836|NCT00423605|468821155|FG000|Overall Study|Adverse Event|129|||
130233837|NCT00423605|468821155|FG000|Overall Study|Withdrawal by Subject|36|||
130233838|NCT00423605|468821155|FG000|Overall Study|Lost to Follow-up|15|||
130446579|NCT00996580|469595626|FG000|Overall Study|Lost to Follow-up|480|||
130446580|NCT00996580|469595626|FG000|Overall Study|Noncompliance with the protocol|137|||
130446581|NCT00996580|469595626|FG000|Overall Study|Physician Decision|5|||
130446582|NCT00996580|469595626|FG000|Overall Study|Pregnancy|68|||
130446583|NCT00996580|469595626|FG000|Overall Study|Protocol Violation|16|||
130446584|NCT00996580|469595626|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
130446585|NCT00996580|469595626|FG000|Overall Study|Withdrawal by Subject|217|||
130446586|NCT00996580|469595626|FG000|Overall Study|Other|29|||
130446587|NCT04248465|469595627|FG000|Randomized-Controlled Period|Death|12|||
130446588|NCT04248465|469595628|FG001|Randomized-Controlled Period|Death|5|||
130446589|NCT04248465|469595627|FG000|Randomized-Controlled Period|Adverse Event|2|||
130446590|NCT04248465|469595628|FG001|Randomized-Controlled Period|Adverse Event|0|||
130446591|NCT04248465|469595627|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
130446592|NCT04248465|469595628|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
130446593|NCT04248465|469595627|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
130446594|NCT04248465|469595628|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
130446595|NCT04248465|469595627|FG000|Randomized-Controlled Period|Physician Decision|1|||
130446596|NCT04248465|469595628|FG001|Randomized-Controlled Period|Physician Decision|1|||
130446597|NCT04248465|469595627|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
130446598|NCT04248465|469595628|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
130446599|NCT04248465|469595627|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
130446600|NCT04248465|469595628|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
130446601|NCT04248465|469595627|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130446602|NCT04248465|469595628|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
130446603|NCT05708846|469595629|FG000|Overall Study|Death|5|||
130446604|NCT05708846|469595629|FG000|Overall Study|Withdrawal by Subject|20|||
130446605|NCT03621982|469595630|FG000|Overall Study|Withdrawal by Subject|1|||
130446606|NCT03621982|469595631|FG001|Overall Study|Withdrawal by Subject|0|||
130446607|NCT03621982|469595632|FG002|Overall Study|Withdrawal by Subject|0|||
130446608|NCT03621982|469595633|FG003|Overall Study|Withdrawal by Subject|1|||
130446609|NCT03621982|469595634|FG004|Overall Study|Withdrawal by Subject|0|||
130446610|NCT03621982|469595635|FG005|Overall Study|Withdrawal by Subject|1|||
130446611|NCT03621982|469595636|FG006|Overall Study|Withdrawal by Subject|1|||
130446612|NCT03621982|469595637|FG007|Overall Study|Withdrawal by Subject|0|||
130446613|NCT03621982|469595638|FG008|Overall Study|Withdrawal by Subject|1|||
130446614|NCT03621982|469595639|FG009|Overall Study|Withdrawal by Subject|0|||
130446615|NCT03621982|469595640|FG010|Overall Study|Withdrawal by Subject|2|||
130446616|NCT03621982|469595641|FG011|Overall Study|Withdrawal by Subject|1|||
130446617|NCT03621982|469595642|FG012|Overall Study|Withdrawal by Subject|2|||
130446618|NCT03621982|469595643|FG013|Overall Study|Withdrawal by Subject|2|||
130446619|NCT03621982|469595630|FG000|Overall Study|Investigator/Sponsor decision|0|||
130446620|NCT03621982|469595631|FG001|Overall Study|Investigator/Sponsor decision|0|||
130446621|NCT03621982|469595632|FG002|Overall Study|Investigator/Sponsor decision|0|||
130446622|NCT03621982|469595633|FG003|Overall Study|Investigator/Sponsor decision|0|||
130446623|NCT03621982|469595634|FG004|Overall Study|Investigator/Sponsor decision|0|||
130233839|NCT00423605|468821155|FG000|Overall Study|Lack of Efficacy|38|||
130446624|NCT03621982|469595635|FG005|Overall Study|Investigator/Sponsor decision|0|||
130446625|NCT03621982|469595636|FG006|Overall Study|Investigator/Sponsor decision|0|||
130446626|NCT03621982|469595637|FG007|Overall Study|Investigator/Sponsor decision|0|||
130233840|NCT00423605|468821155|FG000|Overall Study|Sponsor Decision|3|||
130233841|NCT00423605|468821155|FG000|Overall Study|Physician Decision|8|||
130233842|NCT00423605|468821155|FG000|Overall Study|Protocol Violation|7|||
130233843|NCT00423605|468821155|FG000|Overall Study|Not one of the pre-specified options|5|||
130233844|NCT03183908|468821158|FG000|Overall Study|Missing Symptom Diary Data|0|||
130233845|NCT03183908|468821159|FG001|Overall Study|Missing Symptom Diary Data|2|||
130233846|NCT03738696|468821160|FG000|Overall Study|Withdrawal by Subject|0|||
130233847|NCT03738696|468821161|FG001|Overall Study|Withdrawal by Subject|1|||
130233848|NCT03738696|468821160|FG000|Overall Study|Lost to Follow-up|8|||
130233849|NCT03738696|468821161|FG001|Overall Study|Lost to Follow-up|14|||
130233850|NCT02566005|468821164|FG000|Overall Study|vaginal bleeding|0|||
130233851|NCT02566005|468821165|FG001|Overall Study|vaginal bleeding|1|||
130233852|NCT02566005|468821164|FG000|Overall Study|received foley|8|||
130233853|NCT02566005|468821165|FG001|Overall Study|received foley|0|||
130233854|NCT02566005|468821164|FG000|Overall Study|did not receive foley|0|||
130233855|NCT02566005|468821165|FG001|Overall Study|did not receive foley|1|||
130233856|NCT02566005|468821164|FG000|Overall Study|labor after randomization|0|||
130233857|NCT02566005|468821165|FG001|Overall Study|labor after randomization|4|||
130233858|NCT03617588|468821166|FG000|Overall Study|Withdrawal by Subject|1|||
130233859|NCT03617588|468821167|FG001|Overall Study|Withdrawal by Subject|0|||
130233860|NCT01294514|468821168|FG000|Overall Study|Excluded due to Arrhythmia|1|||
130233861|NCT01715298|468821169|FG000|Overall Study|Lost to Follow-up|0|||
130233862|NCT01715298|468821170|FG001|Overall Study|Lost to Follow-up|2|||
130233863|NCT01715298|468821169|FG000|Overall Study|Patient/guardian decision|7|||
130233864|NCT01715298|468821170|FG001|Overall Study|Patient/guardian decision|9|||
130233865|NCT01499511|468821175|FG000|Overall Study|Death|1|||
130233866|NCT01499511|468821176|FG001|Overall Study|Death|0|||
130233867|NCT00726453|468821178|FG000|Primary Enrollment Group|Death|18|||
130233868|NCT00726453|468821179|FG001|Primary Enrollment Group|Death|0|||
130233869|NCT00726453|468821178|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
130233870|NCT00726453|468821179|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
130233871|NCT00726453|468821178|FG000|38 mm Length Group|Death|0|||
130233872|NCT00726453|468821179|FG001|38 mm Length Group|Death|3|||
130233873|NCT00941928|468821181|FG000|Overall Study|Withdrawal by Subject|1|||
130233874|NCT00941928|468821181|FG000|Overall Study|Disease Progression|1|||
130233875|NCT03482024|468821188|FG000|Overall Study|Physician Decision|1|||
130233876|NCT03482024|468821189|FG001|Overall Study|Physician Decision|0|||
130233877|NCT03482024|468821190|FG002|Overall Study|Physician Decision|0|||
130233878|NCT03482024|468821191|FG003|Overall Study|Physician Decision|0|||
130233879|NCT03482024|468821192|FG004|Overall Study|Physician Decision|0|||
130233880|NCT04796415|468821193|FG000|Overall Study|not interested|12|||
130233881|NCT04796415|468821193|FG000|Overall Study|health issue|8|||
130233882|NCT04796415|468821193|FG000|Overall Study|Other|4|||
130233883|NCT04796415|468821193|FG000|Overall Study|discharged from home health service|3|||
130233884|NCT04796415|468821193|FG000|Overall Study|re-hospitalization|2|||
130233885|NCT04796415|468821193|FG000|Overall Study|moving to nursing home|1|||
130233886|NCT04796415|468821193|FG000|Overall Study|lost contact|1|||
130233887|NCT00147238|468821200|FG000|Overall Study|Inevaluable|8|||
130233888|NCT00297167|468821201|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130233889|NCT00297167|468821202|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130233890|NCT00297167|468821203|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
130233891|NCT00297167|468821201|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130233892|NCT00297167|468821202|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130233893|NCT00297167|468821203|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
130233894|NCT03185208|468821206|FG000|Overall Study|Did not start study medication|0|||
130233895|NCT03185208|468821207|FG001|Overall Study|Did not start study medication|3|||
130233896|NCT03834350|468821208|FG000|Overall Study|Withdrawal by Subject|1|||
130233897|NCT02410629|468821209|FG000|Overall Study|Family cannot commit to the study|2|||
130233898|NCT02410629|468821210|FG001|Overall Study|Family cannot commit to the study|1|||
130233899|NCT02410629|468821209|FG000|Overall Study|Subject returned to work|1|||
130233900|NCT02410629|468821210|FG001|Overall Study|Subject returned to work|0|||
130233901|NCT02410629|468821209|FG000|Overall Study|Subject moved back to home country|0|||
130233902|NCT02410629|468821210|FG001|Overall Study|Subject moved back to home country|1|||
130233903|NCT02410629|468821209|FG000|Overall Study|Subject underwent heart surgery|0|||
130233904|NCT02410629|468821210|FG001|Overall Study|Subject underwent heart surgery|1|||
130233905|NCT02765165|468821211|FG000|Treatment Period|Progressive disease|3|||
130233906|NCT02765165|468821212|FG001|Treatment Period|Progressive disease|2|||
130233907|NCT02765165|468821213|FG002|Treatment Period|Progressive disease|3|||
130233908|NCT02765165|468821214|FG003|Treatment Period|Progressive disease|3|||
130233909|NCT02765165|468821215|FG004|Treatment Period|Progressive disease|4|||
130233910|NCT02765165|468821216|FG005|Treatment Period|Progressive disease|2|||
130233911|NCT02765165|468821217|FG006|Treatment Period|Progressive disease|2|||
130233912|NCT02765165|468821211|FG000|Treatment Period|Physician Decision|0|||
130233913|NCT02765165|468821212|FG001|Treatment Period|Physician Decision|1|||
130233914|NCT02765165|468821213|FG002|Treatment Period|Physician Decision|0|||
130233915|NCT02765165|468821214|FG003|Treatment Period|Physician Decision|0|||
130233916|NCT02765165|468821215|FG004|Treatment Period|Physician Decision|0|||
130233917|NCT02765165|468821216|FG005|Treatment Period|Physician Decision|0|||
130233918|NCT02765165|468821217|FG006|Treatment Period|Physician Decision|0|||
130233919|NCT02765165|468821211|FG000|Treatment Period|Adverse Event|0|||
130233920|NCT02765165|468821212|FG001|Treatment Period|Adverse Event|1|||
130233921|NCT02765165|468821213|FG002|Treatment Period|Adverse Event|0|||
130233922|NCT02765165|468821214|FG003|Treatment Period|Adverse Event|0|||
130233923|NCT02765165|468821215|FG004|Treatment Period|Adverse Event|0|||
130233924|NCT02765165|468821216|FG005|Treatment Period|Adverse Event|0|||
130233925|NCT02765165|468821217|FG006|Treatment Period|Adverse Event|0|||
130233926|NCT02765165|468821211|FG000|Treatment Period|Withdrawal by Subject|0|||
130233927|NCT02765165|468821212|FG001|Treatment Period|Withdrawal by Subject|0|||
130233928|NCT02765165|468821213|FG002|Treatment Period|Withdrawal by Subject|0|||
130233929|NCT02765165|468821214|FG003|Treatment Period|Withdrawal by Subject|0|||
130233930|NCT02765165|468821215|FG004|Treatment Period|Withdrawal by Subject|2|||
130233931|NCT02765165|468821216|FG005|Treatment Period|Withdrawal by Subject|0|||
130233932|NCT02765165|468821217|FG006|Treatment Period|Withdrawal by Subject|0|||
130233933|NCT02765165|468821211|FG000|Treatment Period|Study terminated|0|||
130233934|NCT02765165|468821212|FG001|Treatment Period|Study terminated|0|||
130233935|NCT02765165|468821213|FG002|Treatment Period|Study terminated|0|||
130233936|NCT02765165|468821214|FG003|Treatment Period|Study terminated|0|||
130233937|NCT02765165|468821215|FG004|Treatment Period|Study terminated|0|||
130233938|NCT02765165|468821216|FG005|Treatment Period|Study terminated|1|||
130233939|NCT02765165|468821217|FG006|Treatment Period|Study terminated|2|||
130233940|NCT02765165|468821211|FG000|Post-treatment Follow-up|Death|1|||
130233941|NCT02765165|468821212|FG001|Post-treatment Follow-up|Death|2|||
130233942|NCT02765165|468821213|FG002|Post-treatment Follow-up|Death|1|||
130233943|NCT02765165|468821214|FG003|Post-treatment Follow-up|Death|1|||
130233944|NCT02765165|468821215|FG004|Post-treatment Follow-up|Death|1|||
130233945|NCT02765165|468821216|FG005|Post-treatment Follow-up|Death|1|||
130233946|NCT02765165|468821217|FG006|Post-treatment Follow-up|Death|0|||
130233947|NCT02765165|468821211|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
130233948|NCT02765165|468821212|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
130233949|NCT02765165|468821213|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
130233950|NCT02765165|468821214|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
130233951|NCT02765165|468821215|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
130233952|NCT02765165|468821216|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
130233953|NCT02765165|468821217|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
130233954|NCT02765165|468821211|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233955|NCT02765165|468821212|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233956|NCT02765165|468821213|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
130233957|NCT02765165|468821214|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233958|NCT02765165|468821215|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233959|NCT02765165|468821216|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233960|NCT02765165|468821217|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233961|NCT02765165|468821211|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233962|NCT02765165|468821212|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233963|NCT02765165|468821213|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130233964|NCT02765165|468821214|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130233965|NCT02765165|468821215|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233966|NCT02765165|468821216|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233967|NCT02765165|468821217|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233968|NCT02765165|468821211|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233969|NCT02765165|468821212|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
130233970|NCT02765165|468821213|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233971|NCT02765165|468821214|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233972|NCT02765165|468821215|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233973|NCT02765165|468821216|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233974|NCT02765165|468821217|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233975|NCT02765165|468821211|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233976|NCT02765165|468821212|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233977|NCT02765165|468821213|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233978|NCT02765165|468821214|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233979|NCT02765165|468821215|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130233980|NCT02765165|468821216|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130233981|NCT02765165|468821217|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
130233982|NCT01186770|468821218|FG000|Overall Study|Ineligibility|0|||
130233983|NCT01186770|468821219|FG001|Overall Study|Ineligibility|0|||
130233984|NCT01186770|468821220|FG002|Overall Study|Ineligibility|2|||
130233985|NCT01186770|468821221|FG003|Overall Study|Ineligibility|0|||
130233986|NCT01186770|468821218|FG000|Overall Study|Protocol Violation|7|||
130233987|NCT01186770|468821219|FG001|Overall Study|Protocol Violation|9|||
130233988|NCT01186770|468821220|FG002|Overall Study|Protocol Violation|12|||
130233989|NCT01186770|468821221|FG003|Overall Study|Protocol Violation|14|||
130233990|NCT01186770|468821218|FG000|Overall Study|Adverse Event|2|||
130233991|NCT01186770|468821219|FG001|Overall Study|Adverse Event|9|||
130233992|NCT01186770|468821220|FG002|Overall Study|Adverse Event|7|||
130233993|NCT01186770|468821221|FG003|Overall Study|Adverse Event|9|||
130233994|NCT01186770|468821218|FG000|Overall Study|Withdrawal by Subject|15|||
130233995|NCT01186770|468821219|FG001|Overall Study|Withdrawal by Subject|13|||
130233996|NCT01186770|468821220|FG002|Overall Study|Withdrawal by Subject|11|||
130233997|NCT01186770|468821221|FG003|Overall Study|Withdrawal by Subject|17|||
130233998|NCT01186770|468821218|FG000|Overall Study|Lost to Follow-up|10|||
130233999|NCT01186770|468821219|FG001|Overall Study|Lost to Follow-up|6|||
130234000|NCT01186770|468821220|FG002|Overall Study|Lost to Follow-up|14|||
130234001|NCT01186770|468821221|FG003|Overall Study|Lost to Follow-up|9|||
130234002|NCT01186770|468821218|FG000|Overall Study|Insufficient response to treatment|7|||
130234003|NCT01186770|468821219|FG001|Overall Study|Insufficient response to treatment|8|||
130234004|NCT01186770|468821220|FG002|Overall Study|Insufficient response to treatment|5|||
130234005|NCT01186770|468821221|FG003|Overall Study|Insufficient response to treatment|7|||
130234006|NCT01186770|468821218|FG000|Overall Study|Other than specified|0|||
130234007|NCT01186770|468821219|FG001|Overall Study|Other than specified|1|||
130234008|NCT01186770|468821220|FG002|Overall Study|Other than specified|1|||
130234009|NCT01186770|468821221|FG003|Overall Study|Other than specified|2|||
130234010|NCT02567188|468821222|FG000|Overall Study|Death|10|||
130234011|NCT02567188|468821222|FG000|Overall Study|Terminated Mircera Treatment|9|||
130234012|NCT02567188|468821222|FG000|Overall Study|Lost to Follow-up|5|||
130234013|NCT02567188|468821222|FG000|Overall Study|Adverse Event|1|||
130234014|NCT02567188|468821222|FG000|Overall Study|Withdrawal by Subject|1|||
130234015|NCT02567188|468821222|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
130234016|NCT02567188|468821222|FG000|Overall Study|Moved and Changed Clinic|1|||
130234017|NCT02567188|468821222|FG000|Overall Study|Started Hemodialysis|2|||
130234018|NCT02567188|468821222|FG000|Overall Study|Protocol Violation|5|||
130234019|NCT00321763|468821223|FG000|Overall Study|Adverse Event|1|||
130234020|NCT00321763|468821224|FG001|Overall Study|Adverse Event|1|||
130234021|NCT00321763|468821225|FG002|Overall Study|Adverse Event|0|||
130234022|NCT00321763|468821226|FG003|Overall Study|Adverse Event|1|||
130234023|NCT00321763|468821223|FG000|Overall Study|Withdrawal by Subject|2|||
130234024|NCT00321763|468821224|FG001|Overall Study|Withdrawal by Subject|0|||
130234025|NCT00321763|468821225|FG002|Overall Study|Withdrawal by Subject|1|||
130234026|NCT00321763|468821226|FG003|Overall Study|Withdrawal by Subject|0|||
130234027|NCT00321763|468821223|FG000|Overall Study|Lost to Follow-up|3|||
130234028|NCT00321763|468821224|FG001|Overall Study|Lost to Follow-up|1|||
130234029|NCT00321763|468821225|FG002|Overall Study|Lost to Follow-up|5|||
130234030|NCT00321763|468821226|FG003|Overall Study|Lost to Follow-up|4|||
130358242|NCT00809354|469283154|FG009|Overall Study|Randomized but not Treated|1|||
130358243|NCT00809354|469283145|FG000|Overall Study|Death|0|||
130358244|NCT00809354|469283146|FG001|Overall Study|Death|0|||
130358245|NCT00809354|469283147|FG002|Overall Study|Death|0|||
130694552|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694553|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694554|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694555|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
130694556|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130358246|NCT00809354|469283148|FG003|Overall Study|Death|0|||
130358247|NCT00809354|469283149|FG004|Overall Study|Death|0|||
130358248|NCT00809354|469283150|FG005|Overall Study|Death|0|||
130358249|NCT00809354|469283151|FG006|Overall Study|Death|0|||
130358250|NCT00809354|469283152|FG007|Overall Study|Death|1|||
130358251|NCT00809354|469283153|FG008|Overall Study|Death|0|||
130358252|NCT00809354|469283154|FG009|Overall Study|Death|0|||
130358253|NCT03257371|469283157|FG000|Overall Study|Lost to Follow-up|1|||
130358254|NCT03198078|469283163|FG000|Overall Study|Adverse Event|0|||
130358255|NCT03198078|469283164|FG001|Overall Study|Adverse Event|1|||
130358256|NCT03198078|469283165|FG002|Overall Study|Adverse Event|2|||
130358257|NCT03198078|469283163|FG000|Overall Study|Lack of Efficacy|0|||
130446627|NCT03621982|469595638|FG008|Overall Study|Investigator/Sponsor decision|0|||
130694557|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694558|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
130234031|NCT01572792|468821227|FG000|Lead-in Study|Lost to Follow-up|5|||
130234032|NCT01572792|468821228|FG001|Lead-in Study|Lost to Follow-up|9|||
130234033|NCT01572792|468821229|FG002|Lead-in Study|Lost to Follow-up|4|||
130234034|NCT01572792|468821230|FG003|Lead-in Study|Lost to Follow-up|2|||
130234035|NCT01572792|468821231|FG004|Lead-in Study|Lost to Follow-up|4|||
130234036|NCT01572792|468821227|FG000|Lead-in Study|Withdrawal by Subject|22|||
130234037|NCT01572792|468821228|FG001|Lead-in Study|Withdrawal by Subject|11|||
130358258|NCT03198078|469283164|FG001|Overall Study|Lack of Efficacy|0|||
130358259|NCT03198078|469283165|FG002|Overall Study|Lack of Efficacy|3|||
130358260|NCT03198078|469283163|FG000|Overall Study|Lost to Follow-up|1|||
130358261|NCT03198078|469283164|FG001|Overall Study|Lost to Follow-up|0|||
130358262|NCT03198078|469283165|FG002|Overall Study|Lost to Follow-up|0|||
130358263|NCT03198078|469283163|FG000|Overall Study|Pregnancy|0|||
130234038|NCT01572792|468821229|FG002|Lead-in Study|Withdrawal by Subject|12|||
130234039|NCT01572792|468821230|FG003|Lead-in Study|Withdrawal by Subject|24|||
130234040|NCT01572792|468821231|FG004|Lead-in Study|Withdrawal by Subject|11|||
130234041|NCT01572792|468821227|FG000|Lead-in Study|Protocol Violation|19|||
130234042|NCT01572792|468821228|FG001|Lead-in Study|Protocol Violation|10|||
130234043|NCT01572792|468821229|FG002|Lead-in Study|Protocol Violation|12|||
130234044|NCT01572792|468821230|FG003|Lead-in Study|Protocol Violation|13|||
130234045|NCT01572792|468821231|FG004|Lead-in Study|Protocol Violation|21|||
130234046|NCT01572792|468821227|FG000|Lead-in Study|Lack of Efficacy|20|||
130234047|NCT01572792|468821228|FG001|Lead-in Study|Lack of Efficacy|5|||
130446628|NCT03621982|469595639|FG009|Overall Study|Investigator/Sponsor decision|0|||
130446629|NCT03621982|469595640|FG010|Overall Study|Investigator/Sponsor decision|0|||
130446630|NCT03621982|469595641|FG011|Overall Study|Investigator/Sponsor decision|4|||
130446631|NCT03621982|469595642|FG012|Overall Study|Investigator/Sponsor decision|0|||
130446632|NCT03621982|469595643|FG013|Overall Study|Investigator/Sponsor decision|2|||
130446633|NCT03621982|469595630|FG000|Overall Study|Death|2|||
130446634|NCT03621982|469595631|FG001|Overall Study|Death|4|||
130446635|NCT03621982|469595632|FG002|Overall Study|Death|4|||
130446636|NCT03621982|469595633|FG003|Overall Study|Death|3|||
130446637|NCT03621982|469595634|FG004|Overall Study|Death|8|||
130446638|NCT03621982|469595635|FG005|Overall Study|Death|4|||
130446639|NCT03621982|469595636|FG006|Overall Study|Death|6|||
130446640|NCT03621982|469595637|FG007|Overall Study|Death|3|||
130446641|NCT03621982|469595638|FG008|Overall Study|Death|0|||
130446642|NCT03621982|469595639|FG009|Overall Study|Death|3|||
130446643|NCT03621982|469595640|FG010|Overall Study|Death|8|||
130446644|NCT03621982|469595641|FG011|Overall Study|Death|4|||
130446645|NCT03621982|469595642|FG012|Overall Study|Death|2|||
130446646|NCT03621982|469595643|FG013|Overall Study|Death|2|||
130446647|NCT03621982|469595630|FG000|Overall Study|Lost to Follow-up|0|||
130446648|NCT03621982|469595631|FG001|Overall Study|Lost to Follow-up|0|||
130446649|NCT03621982|469595632|FG002|Overall Study|Lost to Follow-up|1|||
130446650|NCT03621982|469595633|FG003|Overall Study|Lost to Follow-up|0|||
130446651|NCT03621982|469595634|FG004|Overall Study|Lost to Follow-up|0|||
130446652|NCT03621982|469595635|FG005|Overall Study|Lost to Follow-up|0|||
130446653|NCT03621982|469595636|FG006|Overall Study|Lost to Follow-up|1|||
130446654|NCT03621982|469595637|FG007|Overall Study|Lost to Follow-up|0|||
130446655|NCT03621982|469595638|FG008|Overall Study|Lost to Follow-up|0|||
130446656|NCT03621982|469595639|FG009|Overall Study|Lost to Follow-up|1|||
130446657|NCT03621982|469595640|FG010|Overall Study|Lost to Follow-up|0|||
130446658|NCT03621982|469595641|FG011|Overall Study|Lost to Follow-up|0|||
130446659|NCT03621982|469595642|FG012|Overall Study|Lost to Follow-up|0|||
130446660|NCT03621982|469595643|FG013|Overall Study|Lost to Follow-up|0|||
130446661|NCT02036515|469595644|FG000|Overall Study|Adverse Event|1|||
130446662|NCT02036515|469595645|FG001|Overall Study|Adverse Event|1|||
130446663|NCT02036515|469595646|FG002|Overall Study|Adverse Event|2|||
130446664|NCT02036515|469595644|FG000|Overall Study|Lost to Follow-up|0|||
130446665|NCT02036515|469595645|FG001|Overall Study|Lost to Follow-up|2|||
130446666|NCT02036515|469595646|FG002|Overall Study|Lost to Follow-up|0|||
130446667|NCT02036515|469595644|FG000|Overall Study|Non-compliance with study drug|0|||
130446668|NCT02036515|469595645|FG001|Overall Study|Non-compliance with study drug|0|||
130234048|NCT01572792|468821229|FG002|Lead-in Study|Lack of Efficacy|4|||
130234049|NCT01572792|468821230|FG003|Lead-in Study|Lack of Efficacy|8|||
130358264|NCT03198078|469283164|FG001|Overall Study|Pregnancy|1|||
130358265|NCT03198078|469283165|FG002|Overall Study|Pregnancy|0|||
130358266|NCT03198078|469283163|FG000|Overall Study|Withdrawal by Subject|1|||
130358267|NCT03198078|469283164|FG001|Overall Study|Withdrawal by Subject|0|||
130358268|NCT03198078|469283165|FG002|Overall Study|Withdrawal by Subject|2|||
130358269|NCT03198078|469283163|FG000|Overall Study|Withdrawal by Caregiver|1|||
130358270|NCT03198078|469283164|FG001|Overall Study|Withdrawal by Caregiver|3|||
130358271|NCT03198078|469283165|FG002|Overall Study|Withdrawal by Caregiver|5|||
130358272|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
130358273|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
130446669|NCT02036515|469595646|FG002|Overall Study|Non-compliance with study drug|2|||
130446670|NCT02036515|469595644|FG000|Overall Study|Screen failure|0|||
130446671|NCT02036515|469595645|FG001|Overall Study|Screen failure|2|||
130358274|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
130358275|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
130446672|NCT02036515|469595646|FG002|Overall Study|Screen failure|0|||
130446673|NCT02036515|469595644|FG000|Overall Study|Withdrawal by Subject|4|||
130446674|NCT02036515|469595645|FG001|Overall Study|Withdrawal by Subject|7|||
130446675|NCT02036515|469595646|FG002|Overall Study|Withdrawal by Subject|9|||
130446676|NCT02036515|469595644|FG000|Overall Study|Hyperglycemia|0|||
130446677|NCT02036515|469595645|FG001|Overall Study|Hyperglycemia|0|||
130446678|NCT02036515|469595646|FG002|Overall Study|Hyperglycemia|1|||
130234050|NCT01572792|468821231|FG004|Lead-in Study|Lack of Efficacy|10|||
130234051|NCT01572792|468821227|FG000|Lead-in Study|Adverse Event|21|||
130234052|NCT01572792|468821228|FG001|Lead-in Study|Adverse Event|21|||
130446679|NCT00394095|469597030|FG000|Screening|Withdrawal by Subject|1|||
130446680|NCT00394095|469597031|FG001|Screening|Withdrawal by Subject|0|||
130234053|NCT01572792|468821229|FG002|Lead-in Study|Adverse Event|22|||
130234054|NCT01572792|468821230|FG003|Lead-in Study|Adverse Event|16|||
130234055|NCT01572792|468821231|FG004|Lead-in Study|Adverse Event|14|||
130234056|NCT01572792|468821227|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
130234057|NCT01572792|468821228|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
130234058|NCT01572792|468821229|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
130234059|NCT01572792|468821230|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130234060|NCT01572792|468821231|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130234061|NCT01572792|468821227|FG000|Extension Study|Lost to Follow-up|6|||
130234062|NCT01572792|468821228|FG001|Extension Study|Lost to Follow-up|2|||
130234063|NCT01572792|468821229|FG002|Extension Study|Lost to Follow-up|0|||
130234064|NCT01572792|468821230|FG003|Extension Study|Lost to Follow-up|3|||
130234065|NCT01572792|468821231|FG004|Extension Study|Lost to Follow-up|3|||
130234066|NCT01572792|468821227|FG000|Extension Study|Withdrawal by Subject|7|||
130234067|NCT01572792|468821228|FG001|Extension Study|Withdrawal by Subject|6|||
130234068|NCT01572792|468821229|FG002|Extension Study|Withdrawal by Subject|11|||
130234069|NCT01572792|468821230|FG003|Extension Study|Withdrawal by Subject|8|||
130234070|NCT01572792|468821231|FG004|Extension Study|Withdrawal by Subject|14|||
130234071|NCT01572792|468821227|FG000|Extension Study|Protocol Violation|0|||
130234072|NCT01572792|468821228|FG001|Extension Study|Protocol Violation|4|||
130234073|NCT01572792|468821229|FG002|Extension Study|Protocol Violation|3|||
130234074|NCT01572792|468821230|FG003|Extension Study|Protocol Violation|4|||
130234075|NCT01572792|468821231|FG004|Extension Study|Protocol Violation|3|||
130234076|NCT01572792|468821227|FG000|Extension Study|Lack of Efficacy|2|||
130234077|NCT01572792|468821228|FG001|Extension Study|Lack of Efficacy|3|||
130234078|NCT01572792|468821229|FG002|Extension Study|Lack of Efficacy|3|||
130234079|NCT01572792|468821230|FG003|Extension Study|Lack of Efficacy|2|||
130234080|NCT01572792|468821231|FG004|Extension Study|Lack of Efficacy|2|||
130234081|NCT01572792|468821227|FG000|Extension Study|Adverse Event|7|||
130234082|NCT01572792|468821228|FG001|Extension Study|Adverse Event|6|||
130234083|NCT01572792|468821229|FG002|Extension Study|Adverse Event|5|||
130234084|NCT01572792|468821230|FG003|Extension Study|Adverse Event|6|||
130234085|NCT01572792|468821231|FG004|Extension Study|Adverse Event|4|||
130234086|NCT01572792|468821227|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
130234087|NCT01572792|468821228|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
130234088|NCT01572792|468821229|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
130234089|NCT01572792|468821230|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
130234090|NCT01572792|468821231|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
130234091|NCT01129128|468821232|FG000|Overall Study|Lost to Follow-up|2|||
130234092|NCT01129128|468821233|FG001|Overall Study|Lost to Follow-up|2|||
130234093|NCT01129128|468821234|FG002|Overall Study|Lost to Follow-up|1|||
130234094|NCT01129128|468821232|FG000|Overall Study|Protocol Violation|0|||
130234095|NCT01129128|468821233|FG001|Overall Study|Protocol Violation|1|||
130234096|NCT01129128|468821234|FG002|Overall Study|Protocol Violation|0|||
130234097|NCT01129128|468821232|FG000|Overall Study|Withdrawal by Subject|0|||
130234098|NCT01129128|468821233|FG001|Overall Study|Withdrawal by Subject|1|||
130234099|NCT01129128|468821234|FG002|Overall Study|Withdrawal by Subject|3|||
130234100|NCT01129128|468821232|FG000|Overall Study|Physician Decision|1|||
130234101|NCT01129128|468821233|FG001|Overall Study|Physician Decision|0|||
130234102|NCT01129128|468821234|FG002|Overall Study|Physician Decision|0|||
130234103|NCT00961415|468821235|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
130234104|NCT00961415|468821236|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130234105|NCT00961415|468821237|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
130234106|NCT00961415|468821235|FG000|Induction Treatment Phase|Death|77|||
130234107|NCT00961415|468821236|FG001|Induction Treatment Phase|Death|0|||
130234108|NCT00961415|468821237|FG002|Induction Treatment Phase|Death|0|||
130234109|NCT00961415|468821235|FG000|Induction Treatment Phase|Protocol Violation|1|||
130234110|NCT00961415|468821236|FG001|Induction Treatment Phase|Protocol Violation|0|||
130234111|NCT00961415|468821237|FG002|Induction Treatment Phase|Protocol Violation|0|||
130234112|NCT00961415|468821235|FG000|Induction Treatment Phase|Physician Decision|2|||
130234113|NCT00961415|468821236|FG001|Induction Treatment Phase|Physician Decision|0|||
130234114|NCT00961415|468821237|FG002|Induction Treatment Phase|Physician Decision|0|||
130234115|NCT00961415|468821235|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
130234116|NCT00961415|468821236|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130234117|NCT00961415|468821237|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130234118|NCT00961415|468821235|FG000|Induction Treatment Phase|Other Reason|5|||
130234119|NCT00961415|468821236|FG001|Induction Treatment Phase|Other Reason|0|||
130234120|NCT00961415|468821237|FG002|Induction Treatment Phase|Other Reason|0|||
130446681|NCT00394095|469597030|FG000|Randomized|Withdrawal by Subject|5|||
130234121|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Death|0|||
130234122|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Death|42|||
130234123|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Death|34|||
130234124|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Investigators decision|0|||
130234125|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Investigators decision|2|||
130234126|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Investigators decision|0|||
130234127|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130234128|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
130234129|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
130234130|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Other reason|0|||
130234131|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Other reason|1|||
130234132|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Other reason|3|||
130234133|NCT00639509|468821248|FG000|Overall Study|Death|1|||
130234134|NCT01933594|468821249|FG000|Overall Study|Lost to Follow-up|1|||
130234135|NCT01933594|468821250|FG001|Overall Study|Lost to Follow-up|0|||
130234136|NCT01933594|468821251|FG002|Overall Study|Lost to Follow-up|0|||
130234137|NCT01933594|468821252|FG003|Overall Study|Lost to Follow-up|0|||
130234138|NCT01933594|468821253|FG004|Overall Study|Lost to Follow-up|1|||
130234139|NCT01933594|468821254|FG005|Overall Study|Lost to Follow-up|0|||
130234140|NCT01933594|468821249|FG000|Overall Study|Ineligible for subsequent study step|0|||
130234141|NCT01933594|468821250|FG001|Overall Study|Ineligible for subsequent study step|0|||
130234142|NCT01933594|468821251|FG002|Overall Study|Ineligible for subsequent study step|0|||
130234143|NCT01933594|468821252|FG003|Overall Study|Ineligible for subsequent study step|0|||
130234144|NCT01933594|468821253|FG004|Overall Study|Ineligible for subsequent study step|1|||
130234145|NCT01933594|468821254|FG005|Overall Study|Ineligible for subsequent study step|0|||
130234146|NCT05049122|468821255|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
130234147|NCT05049122|468821255|FG000|Overall Study|Participant moved|1|||
130234148|NCT05049122|468821255|FG000|Overall Study|At the direction of the doctor|1|||
130234149|NCT05722015|468821256|FG000|Overall Study|Death|57|||
130234150|NCT05722015|468821257|FG001|Overall Study|Death|37|||
130234151|NCT05722015|468821256|FG000|Overall Study|Lost to Follow-up|1|||
130234152|NCT05722015|468821257|FG001|Overall Study|Lost to Follow-up|0|||
130234153|NCT05722015|468821256|FG000|Overall Study|Withdrawal by Subject|5|||
130234154|NCT05722015|468821257|FG001|Overall Study|Withdrawal by Subject|1|||
130234155|NCT05722015|468821256|FG000|Overall Study|Participants Ongoing|188|||
130234156|NCT05722015|468821257|FG001|Overall Study|Participants Ongoing|88|||
130234157|NCT04513366|468821258|FG000|Treatment Phase|Withdrawal by Subject|6|||
130234158|NCT04513366|468821259|FG001|Treatment Phase|Withdrawal by Subject|8|||
130234159|NCT04513366|468821260|FG002|Treatment Phase|Withdrawal by Subject|3|||
130234160|NCT04513366|468821258|FG000|Treatment Phase|Lost to Follow-up|1|||
130234161|NCT04513366|468821259|FG001|Treatment Phase|Lost to Follow-up|2|||
130234162|NCT04513366|468821260|FG002|Treatment Phase|Lost to Follow-up|5|||
130234163|NCT04513366|468821258|FG000|Treatment Phase|Other than Specified|1|||
130234164|NCT04513366|468821259|FG001|Treatment Phase|Other than Specified|0|||
130234165|NCT04513366|468821260|FG002|Treatment Phase|Other than Specified|2|||
130234166|NCT04513366|468821258|FG000|Treatment Phase|Physician Decision|2|||
130694559|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694560|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130234167|NCT04513366|468821259|FG001|Treatment Phase|Physician Decision|0|||
130358276|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
130358277|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
130358278|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
130358279|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
130358280|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
130358281|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
130358282|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
130358283|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
130358284|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
130358285|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
130358286|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
130358287|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
130358288|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
130358289|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
130358290|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
130358291|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
130358292|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
130358293|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
130358294|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
130358295|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
130358296|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Death|2|||
130234168|NCT04513366|468821260|FG002|Treatment Phase|Physician Decision|0|||
130358297|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Death|1|||
130358298|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Death|0|||
130234169|NCT04513366|468821258|FG000|Treatment Phase|Adverse Event|0|||
130234170|NCT04513366|468821259|FG001|Treatment Phase|Adverse Event|1|||
130234171|NCT04513366|468821260|FG002|Treatment Phase|Adverse Event|1|||
130234172|NCT04513366|468821258|FG000|Extension Phase|Withdrawal by Subject|3|||
130234173|NCT04513366|468821259|FG001|Extension Phase|Withdrawal by Subject|1|||
130234174|NCT04513366|468821260|FG002|Extension Phase|Withdrawal by Subject|1|||
130234175|NCT04513366|468821258|FG000|Extension Phase|Other than Specified|4|||
130234176|NCT04513366|468821259|FG001|Extension Phase|Other than Specified|0|||
130234177|NCT04513366|468821260|FG002|Extension Phase|Other than Specified|1|||
130234178|NCT04513366|468821258|FG000|Extension Phase|Lost to Follow-up|1|||
130234179|NCT04513366|468821259|FG001|Extension Phase|Lost to Follow-up|1|||
130234180|NCT04513366|468821260|FG002|Extension Phase|Lost to Follow-up|1|||
130234181|NCT04513366|468821258|FG000|Extension Phase|Sponsor Decision|0|||
130234182|NCT04513366|468821259|FG001|Extension Phase|Sponsor Decision|1|||
130234183|NCT04513366|468821260|FG002|Extension Phase|Sponsor Decision|0|||
130234184|NCT04513366|468821258|FG000|Extension Phase|Death|0|||
130234185|NCT04513366|468821259|FG001|Extension Phase|Death|1|||
130234186|NCT04513366|468821260|FG002|Extension Phase|Death|0|||
130234187|NCT04513366|468821258|FG000|Extension Phase|Adverse Event|0|||
130234188|NCT04513366|468821259|FG001|Extension Phase|Adverse Event|0|||
130234189|NCT04513366|468821260|FG002|Extension Phase|Adverse Event|1|||
130234190|NCT04478266|468821264|FG000|Overall Study|Adverse Event|20|||
130234191|NCT04478266|468821265|FG001|Overall Study|Adverse Event|21|||
130234192|NCT04478266|468821264|FG000|Overall Study|Progressive disease|146|||
130234193|NCT04478266|468821265|FG001|Overall Study|Progressive disease|168|||
130234194|NCT04478266|468821264|FG000|Overall Study|Poor compliance to protocol|1|||
130234195|NCT04478266|468821265|FG001|Overall Study|Poor compliance to protocol|0|||
130234196|NCT04478266|468821264|FG000|Overall Study|Withdrawal by Subject|19|||
130234197|NCT04478266|468821265|FG001|Overall Study|Withdrawal by Subject|16|||
130234198|NCT04478266|468821264|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
130234199|NCT04478266|468821265|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
130234200|NCT04478266|468821264|FG000|Overall Study|Study terminated by sponsor|33|||
130234201|NCT04478266|468821265|FG001|Overall Study|Study terminated by sponsor|35|||
130234202|NCT04478266|468821264|FG000|Overall Study|Other: unspecified|5|||
130234203|NCT04478266|468821265|FG001|Overall Study|Other: unspecified|7|||
130234204|NCT04478266|468821264|FG000|Overall Study|Randomized but not treated|1|||
130234205|NCT04478266|468821265|FG001|Overall Study|Randomized but not treated|1|||
130234206|NCT04058717|468821266|FG000|Randomization Period|Lost to Follow-up|2|||
130234207|NCT04058717|468821267|FG001|Randomization Period|Lost to Follow-up|3|||
130234208|NCT04058717|468821268|FG002|Randomization Period|Lost to Follow-up|4|||
130234209|NCT04058717|468821269|FG003|Randomization Period|Lost to Follow-up|4|||
130234210|NCT04058717|468821266|FG000|Randomization Period|Withdrawal by Subject|1|||
130234211|NCT04058717|468821267|FG001|Randomization Period|Withdrawal by Subject|3|||
130234212|NCT04058717|468821268|FG002|Randomization Period|Withdrawal by Subject|3|||
130234213|NCT04058717|468821269|FG003|Randomization Period|Withdrawal by Subject|3|||
130234214|NCT04058717|468821266|FG000|Randomization Period|PI decision|0|||
130234215|NCT04058717|468821267|FG001|Randomization Period|PI decision|1|||
130234216|NCT04058717|468821268|FG002|Randomization Period|PI decision|0|||
130234217|NCT04058717|468821269|FG003|Randomization Period|PI decision|0|||
130234218|NCT00671788|468821270|FG000|Overall Study|Adverse Event|8|||
130234219|NCT00671788|468821270|FG000|Overall Study|Refused further treatment|3|||
130234220|NCT00671788|468821270|FG000|Overall Study|Ineligible|1|||
130234221|NCT00671788|468821270|FG000|Overall Study|MD Decision|1|||
130234222|NCT00671788|468821270|FG000|Overall Study|Other|1|||
130234223|NCT01832766|468821271|FG000|Washout|Lost to Follow-up|0|||
130234224|NCT01832766|468821272|FG001|Washout|Lost to Follow-up|1|||
130234225|NCT03074500|468821277|FG000|Overall Study|Lost to Follow-up|1|||
130234226|NCT03074500|468821278|FG001|Overall Study|Lost to Follow-up|0|||
130234227|NCT03074500|468821279|FG002|Overall Study|Lost to Follow-up|0|||
130234228|NCT03074500|468821277|FG000|Overall Study|Lack of Efficacy|0|||
130234229|NCT03074500|468821278|FG001|Overall Study|Lack of Efficacy|1|||
130234230|NCT03074500|468821279|FG002|Overall Study|Lack of Efficacy|0|||
130358299|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Death|0|||
130358300|NCT02607930|469283168|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
130358301|NCT02607930|469283169|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130358302|NCT02607930|469283170|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130358303|NCT02607930|469283171|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130358304|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130234231|NCT03074500|468821277|FG000|Overall Study|Adverse Event|0|||
130358305|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130234232|NCT03074500|468821278|FG001|Overall Study|Adverse Event|0|||
130234233|NCT03074500|468821279|FG002|Overall Study|Adverse Event|1|||
130234234|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
130234235|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
130234236|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Death|1|||
130234237|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Death|3|||
130234238|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
130234239|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
130234240|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
130358306|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
130234241|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
130234242|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
130234243|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
130234244|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
130234245|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
130234246|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
130234247|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
130234248|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
130234249|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
130234250|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
130234251|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
130234252|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
130234253|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
130234254|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
130234255|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
130234256|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
130234257|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
130234258|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
130234259|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
130234260|NCT02233413|468822383|FG000|Overall Study|Lost to Follow-up|7|||
130234261|NCT02233413|468822384|FG001|Overall Study|Lost to Follow-up|9|||
130234262|NCT02233413|468822383|FG000|Overall Study|Withdrawal by Subject|4|||
130234263|NCT02233413|468822384|FG001|Overall Study|Withdrawal by Subject|5|||
130234264|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
130234265|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
130234266|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
130234267|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
130234268|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
130234269|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
130234270|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
130234271|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
130234272|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
130234273|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130234274|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130234275|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
130234276|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
130234277|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
130234278|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
130234279|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
130234280|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
130234281|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
130234282|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130234283|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130234284|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
130234285|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
130234286|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
130234287|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
130234288|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
130234289|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
130234290|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
130234291|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
130234292|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
130234293|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
130234294|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
130234295|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
130234296|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
130234297|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130358307|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
130694561|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694562|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694563|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130358308|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
130358309|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
130446682|NCT00394095|469597031|FG001|Randomized|Withdrawal by Subject|1|||
130694564|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130234298|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130234299|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
130234300|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
130234301|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130234302|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130234303|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
130234304|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130234305|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130234306|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
130234307|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130234308|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130234309|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
130234310|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130234311|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130234312|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
130234313|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
130234314|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
130234315|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
130234316|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130234317|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130234318|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
130234319|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130234320|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130234321|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130234322|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
130234323|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130234324|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130234325|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
130234326|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130234327|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
130234328|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130234329|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130234330|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130234331|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
130234332|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130234333|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130234334|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
130234335|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130234336|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130234337|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
130234338|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130234339|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130234340|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
130234341|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130234342|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130234343|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
130234344|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130234345|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
130234346|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
130234347|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
130358310|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
130358311|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
130358312|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
130358313|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
130358314|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
130358315|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
130358316|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
130358317|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
130358318|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
130358319|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
130358320|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
130358321|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
130358322|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
130234348|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130234349|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130234350|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
130234351|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130234352|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130234353|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
130234354|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130234355|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
130234356|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130234357|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
130234358|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
130234359|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
130234360|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
130234361|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
130234362|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
130234363|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
130234364|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
130234365|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
130234366|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
130234367|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
130234368|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
130234369|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
130234370|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
130234371|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
130234372|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
130234373|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
130234374|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
130234375|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
130234376|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
130234377|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
130234378|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
130234379|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130234380|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130234381|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
130234382|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
130234383|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
130234384|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130234385|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
130234386|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130234387|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
130234388|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
130234389|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
130234390|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130234391|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
130358323|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
130358324|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
130358325|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
130358326|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
130358327|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
130358328|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
130358329|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
130358330|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
130358331|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
130358332|NCT02607930|469283168|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130358333|NCT02607930|469283169|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130358334|NCT02607930|469283170|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
130358335|NCT02607930|469283171|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130358336|NCT01050543|469283172|FG000|Overall Study|Withdrawal by Subject|0|||
130358337|NCT01050543|469283173|FG001|Overall Study|Withdrawal by Subject|2|||
130358338|NCT01050543|469283172|FG000|Overall Study|Protocol Violation|0|||
130358339|NCT01050543|469283173|FG001|Overall Study|Protocol Violation|1|||
130358340|NCT01050543|469283172|FG000|Overall Study|Administrative|4|||
130358341|NCT01050543|469283173|FG001|Overall Study|Administrative|1|||
130358342|NCT00570765|469283174|FG000|DB Phase|Withdrawal by Subject|1|||
130358343|NCT00570765|469283175|FG001|DB Phase|Withdrawal by Subject|0|||
130358344|NCT00570765|469283176|FG002|DB Phase|Withdrawal by Subject|0|||
130446683|NCT00394095|469597030|FG000|Randomized|Adverse Event|1|||
130446684|NCT00394095|469597031|FG001|Randomized|Adverse Event|1|||
130234392|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130234393|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
130234394|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
130234395|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
130234396|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
130234397|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
130234398|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
130234399|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
130234400|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
130234401|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
130234402|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
130234403|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
130234404|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
130234405|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Death|1|||
130234406|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Death|0|||
130234407|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Death|1|||
130234408|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
130234409|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
130234410|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
130234411|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
130234412|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
130234413|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
130234414|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
130234415|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
130234416|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
130358345|NCT00570765|469283177|FG003|DB Phase|Withdrawal by Subject|0|||
130358346|NCT00570765|469283174|FG000|DB Phase|Protocol Violation|0|||
130358347|NCT00570765|469283175|FG001|DB Phase|Protocol Violation|1|||
130358348|NCT00570765|469283176|FG002|DB Phase|Protocol Violation|0|||
130358349|NCT00570765|469283177|FG003|DB Phase|Protocol Violation|0|||
130358350|NCT00570765|469283174|FG000|DB Phase|Adverse Event|3|||
130358351|NCT00570765|469283175|FG001|DB Phase|Adverse Event|6|||
130358352|NCT00570765|469283176|FG002|DB Phase|Adverse Event|0|||
130358353|NCT00570765|469283177|FG003|DB Phase|Adverse Event|0|||
130358354|NCT00570765|469283174|FG000|DB Phase|Did Not Receive Study Drug|0|||
130358355|NCT00570765|469283175|FG001|DB Phase|Did Not Receive Study Drug|0|||
130358356|NCT00570765|469283176|FG002|DB Phase|Did Not Receive Study Drug|1|||
130358357|NCT00570765|469283177|FG003|DB Phase|Did Not Receive Study Drug|0|||
130358358|NCT00570765|469283174|FG000|LTSE Phase|Withdrawal by Subject|0|||
130358359|NCT00570765|469283175|FG001|LTSE Phase|Withdrawal by Subject|0|||
130358360|NCT00570765|469283176|FG002|LTSE Phase|Withdrawal by Subject|0|||
130358361|NCT00570765|469283177|FG003|LTSE Phase|Withdrawal by Subject|1|||
130358362|NCT00570765|469283174|FG000|LTSE Phase|Adverse Event|0|||
130358363|NCT00570765|469283175|FG001|LTSE Phase|Adverse Event|0|||
130358364|NCT00570765|469283176|FG002|LTSE Phase|Adverse Event|0|||
130358365|NCT00570765|469283177|FG003|LTSE Phase|Adverse Event|7|||
130358366|NCT00570765|469283174|FG000|LTSE Phase|Physician Decision|0|||
130358367|NCT00570765|469283175|FG001|LTSE Phase|Physician Decision|0|||
130358368|NCT00570765|469283176|FG002|LTSE Phase|Physician Decision|0|||
130358369|NCT00570765|469283177|FG003|LTSE Phase|Physician Decision|4|||
130358370|NCT03711266|469283178|FG000|Overall Study|Lost to Follow-up|10|||
130358371|NCT00057876|469283179|FG000|Overall Study|Adverse Event|8|||
130358372|NCT00057876|469283180|FG001|Overall Study|Adverse Event|8|||
130358373|NCT00057876|469283179|FG000|Overall Study|Death|2|||
130358374|NCT00057876|469283180|FG001|Overall Study|Death|1|||
130358375|NCT00057876|469283179|FG000|Overall Study|Withdrawal by Subject|5|||
130358376|NCT00057876|469283180|FG001|Overall Study|Withdrawal by Subject|6|||
130358377|NCT00057876|469283179|FG000|Overall Study|Lack of Efficacy|10|||
130358378|NCT00057876|469283180|FG001|Overall Study|Lack of Efficacy|8|||
130358379|NCT00057876|469283179|FG000|Overall Study|Ineligible|1|||
130358380|NCT00057876|469283180|FG001|Overall Study|Ineligible|2|||
130358381|NCT00057876|469283179|FG000|Overall Study|other reason|2|||
130358382|NCT00057876|469283180|FG001|Overall Study|other reason|2|||
130358383|NCT00057876|469283179|FG000|Overall Study|other complicating disease|1|||
130358384|NCT00057876|469283180|FG001|Overall Study|other complicating disease|0|||
130358385|NCT00437320|469283183|FG000|Overall Study|Participant request|2|||
130358386|NCT00437320|469283184|FG001|Overall Study|Participant request|1|||
130358387|NCT00437320|469283185|FG002|Overall Study|Participant request|4|||
130234417|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130358388|NCT01649804|469283192|FG000|Overall Study|Administrative/Other|8|||
130358389|NCT02456103|469283193|FG000|Overall Study|Study Closure|207|||
130358390|NCT02456103|469283193|FG000|Overall Study|Physician Decision|1|||
130358391|NCT02456103|469283193|FG000|Overall Study|Required prohibited medications|5|||
130234418|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
130234419|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130234420|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
130234421|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
130234422|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
130234423|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
130234424|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
130234425|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
130234426|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
130234427|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
130234428|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
130234429|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Depression|0|||
130234430|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Depression|1|||
130234431|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Depression|0|||
130234432|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130234433|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
130234434|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130234435|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Jailed|0|||
130234436|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Jailed|1|||
130234437|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Jailed|0|||
130234438|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Other|0|||
130234439|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Other|1|||
130234440|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Other|0|||
130234441|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
130234442|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
130234443|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
130234444|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
130234445|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
130234446|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
130234447|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
130234448|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
130234449|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
130234450|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
130234451|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
130234452|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
130234453|NCT03979313|468822388|FG000|All Subjects|Any Other Reason|16|||
130234454|NCT03979313|468822389|FG001|All Subjects|Any Other Reason|23|||
130234455|NCT03979313|468822388|FG000|All Subjects|Covid-19|1|||
130234456|NCT03979313|468822389|FG001|All Subjects|Covid-19|3|||
130234457|NCT03979313|468822388|FG000|All Subjects|Withdrawal by Subject|35|||
130234458|NCT03979313|468822389|FG001|All Subjects|Withdrawal by Subject|44|||
130234459|NCT03979313|468822388|FG000|All Subjects|Death|0|||
130234460|NCT03979313|468822389|FG001|All Subjects|Death|5|||
130234461|NCT03979313|468822388|FG000|All Subjects|Lost to Follow-up|28|||
130234462|NCT03979313|468822389|FG001|All Subjects|Lost to Follow-up|61|||
130234463|NCT00300053|468822390|FG000|Overall Study|Patient/Caregiver Preference|2|||
130234464|NCT00300053|468822391|FG001|Overall Study|Patient/Caregiver Preference|2|||
130234465|NCT00300053|468822392|FG002|Overall Study|Patient/Caregiver Preference|3|||
130234466|NCT00300053|468822390|FG000|Overall Study|Death|0|||
130234467|NCT00300053|468822391|FG001|Overall Study|Death|0|||
130234468|NCT00300053|468822392|FG002|Overall Study|Death|3|||
130234469|NCT00300053|468822390|FG000|Overall Study|Lost to Follow-up|0|||
130234470|NCT00300053|468822391|FG001|Overall Study|Lost to Follow-up|1|||
130234471|NCT00300053|468822392|FG002|Overall Study|Lost to Follow-up|0|||
130234472|NCT02472405|468822396|FG000|Overall Study|Lost to Follow-up|9|||
130234473|NCT02472405|468822396|FG000|Overall Study|Adverse Event|1|||
130234474|NCT02736617|468822399|FG000|Treatment|Adverse Event|1|||
130234475|NCT02736617|468822399|FG000|Treatment|Lack of Efficacy|1|||
130234476|NCT02736617|468822399|FG000|Treatment|Withdrawal by Subject|1|||
130234477|NCT02736617|468822399|FG000|Maintenance|Lack of Efficacy|4|||
130234478|NCT02736617|468822399|FG000|Maintenance|Physician Decision|1|||
130234479|NCT02911116|468822404|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130234480|NCT02911116|468822405|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130234481|NCT02911116|468822404|FG000|Overall Study|Lost to Follow-up|0|||
130234482|NCT02911116|468822405|FG001|Overall Study|Lost to Follow-up|1|||
130234483|NCT02469857|468822406|FG000|Overall Study|Death|24|||
130234484|NCT02469857|468822407|FG001|Overall Study|Death|29|||
130234485|NCT02469857|468822406|FG000|Overall Study|Discontinuation|1|||
130234486|NCT02469857|468822407|FG001|Overall Study|Discontinuation|3|||
130234487|NCT02110693|468822408|FG000|Overall Study|Withdrawal by Subject|6|||
130234488|NCT02110693|468822409|FG001|Overall Study|Withdrawal by Subject|7|||
130234489|NCT02110693|468822408|FG000|Overall Study|skipped assessment|15|||
130234490|NCT02110693|468822409|FG001|Overall Study|skipped assessment|18|||
130234491|NCT02110693|468822408|FG000|Overall Study|technical difficulties|6|||
130234492|NCT02110693|468822409|FG001|Overall Study|technical difficulties|4|||
130234493|NCT02110693|468822408|FG000|Overall Study|Other|1|||
130234494|NCT02110693|468822409|FG001|Overall Study|Other|0|||
130234495|NCT04810962|468822410|FG000|Overall Study|Adverse Event|0|||
130234496|NCT04810962|468822411|FG001|Overall Study|Adverse Event|1|||
130234497|NCT04810962|468822410|FG000|Overall Study|Lost to Follow-up|2|||
130234498|NCT04810962|468822411|FG001|Overall Study|Lost to Follow-up|1|||
130234499|NCT04810962|468822410|FG000|Overall Study|Physician Decision|1|||
130234500|NCT04810962|468822411|FG001|Overall Study|Physician Decision|0|||
130234501|NCT04810962|468822410|FG000|Overall Study|Withdrawal by Subject|1|||
130234502|NCT04810962|468822411|FG001|Overall Study|Withdrawal by Subject|3|||
130234503|NCT04810962|468822410|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
130234504|NCT04810962|468822411|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
130234505|NCT00805532|468822412|FG000|Overall Study|invalid data|0|||
130234506|NCT00805532|468822413|FG001|Overall Study|invalid data|1|||
130234507|NCT02701634|468822415|FG000|Overall Study|Adverse Event|2|||
130234508|NCT02701634|468822416|FG001|Overall Study|Adverse Event|3|||
130234509|NCT02701634|468822415|FG000|Overall Study|Death|1|||
130234510|NCT02701634|468822416|FG001|Overall Study|Death|0|||
130234511|NCT02701634|468822415|FG000|Overall Study|Investigator's Discretion|7|||
130234512|NCT02701634|468822416|FG001|Overall Study|Investigator's Discretion|4|||
130234513|NCT02701634|468822415|FG000|Overall Study|Study terminated by Sponsor|15|||
130234514|NCT02701634|468822416|FG001|Overall Study|Study terminated by Sponsor|17|||
130234515|NCT02701634|468822415|FG000|Overall Study|Withdrew Consent|6|||
130234516|NCT02701634|468822416|FG001|Overall Study|Withdrew Consent|7|||
130234517|NCT02701634|468822415|FG000|Overall Study|Randomized but not treated|1|||
130234518|NCT02701634|468822416|FG001|Overall Study|Randomized but not treated|0|||
130234519|NCT01033136|468822419|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
130234520|NCT01033136|468822420|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
130234521|NCT00630292|468822421|FG000|Overall Study|Withdrawal by Subject|1|||
130234522|NCT00142415|468822422|FG000|Overall Study|Physician Decision|0|||
130234523|NCT00142415|468822423|FG001|Overall Study|Physician Decision|0|||
130234524|NCT00142415|468822424|FG002|Overall Study|Physician Decision|0|||
130234525|NCT00142415|468822425|FG003|Overall Study|Physician Decision|0|||
130234526|NCT00142415|468822426|FG004|Overall Study|Physician Decision|1|||
130234527|NCT00142415|468822427|FG005|Overall Study|Physician Decision|2|||
130234528|NCT01189266|468822432|FG000|Overall Study|Adverse Event|1|||
130234529|NCT01189266|468822433|FG001|Overall Study|Adverse Event|0|||
130234530|NCT01189266|468822434|FG002|Overall Study|Adverse Event|5|||
130234531|NCT01189266|468822432|FG000|Overall Study|Death|0|||
130234532|NCT01189266|468822433|FG001|Overall Study|Death|0|||
130234533|NCT01189266|468822434|FG002|Overall Study|Death|5|||
130234534|NCT01189266|468822432|FG000|Overall Study|Lack of Efficacy|4|||
130234535|NCT01189266|468822433|FG001|Overall Study|Lack of Efficacy|5|||
130234536|NCT01189266|468822434|FG002|Overall Study|Lack of Efficacy|44|||
130234537|NCT01189266|468822432|FG000|Overall Study|Physician Decision|0|||
130234538|NCT01189266|468822433|FG001|Overall Study|Physician Decision|0|||
130234539|NCT01189266|468822434|FG002|Overall Study|Physician Decision|1|||
130234540|NCT01189266|468822432|FG000|Overall Study|Protocol Violation|0|||
130234541|NCT01189266|468822433|FG001|Overall Study|Protocol Violation|1|||
130234542|NCT01189266|468822434|FG002|Overall Study|Protocol Violation|1|||
130234543|NCT01189266|468822432|FG000|Overall Study|Withdrawal by Subject|0|||
130234544|NCT01189266|468822433|FG001|Overall Study|Withdrawal by Subject|0|||
130234545|NCT01189266|468822434|FG002|Overall Study|Withdrawal by Subject|1|||
130234546|NCT01189266|468822432|FG000|Overall Study|Patient refuses further therapy|1|||
130234547|NCT01189266|468822433|FG001|Overall Study|Patient refuses further therapy|0|||
130234548|NCT01189266|468822434|FG002|Overall Study|Patient refuses further therapy|7|||
130234549|NCT01189266|468822432|FG000|Overall Study|No treatment|0|||
130234550|NCT01189266|468822433|FG001|Overall Study|No treatment|0|||
130234551|NCT01189266|468822434|FG002|Overall Study|No treatment|1|||
130234552|NCT04009837|468822435|FG000|Overall Study|Withdrawal by Subject|5|||
130234553|NCT04009837|468822436|FG001|Overall Study|Withdrawal by Subject|4|||
130234554|NCT04009837|468822435|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
130234555|NCT04009837|468822436|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
130234556|NCT03530696|468822439|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
130234557|NCT03530696|468822440|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
130234558|NCT02472353|468822441|FG000|Overall Study|Lost to Follow-up|1|||
130234559|NCT02472353|468822442|FG001|Overall Study|Lost to Follow-up|1|||
130446685|NCT00394095|469597030|FG000|Randomized|Overdose|1|||
130234560|NCT02472353|468822441|FG000|Overall Study|Withdrawal by Subject|2|||
130234561|NCT02472353|468822442|FG001|Overall Study|Withdrawal by Subject|1|||
130446686|NCT00394095|469597031|FG001|Randomized|Overdose|0|||
130446687|NCT00394095|469597030|FG000|Randomized|Lost to Follow-up|1|||
130234562|NCT02472353|468822441|FG000|Overall Study|Study Termination|1|||
130446688|NCT00394095|469597031|FG001|Randomized|Lost to Follow-up|2|||
130446689|NCT00107380|469597036|FG000|Overall Study|Adverse Event|7|||
130234563|NCT02472353|468822442|FG001|Overall Study|Study Termination|4|||
130234564|NCT03416179|468822443|FG000|Overall Study|Death|90|||
130694565|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130234565|NCT03416179|468822444|FG001|Overall Study|Death|87|||
130234566|NCT03416179|468822445|FG002|Overall Study|Death|117|||
130234567|NCT03416179|468822446|FG003|Overall Study|Death|113|||
130234568|NCT03416179|468822443|FG000|Overall Study|Withdrawal by Subject|15|||
130234569|NCT03416179|468822444|FG001|Overall Study|Withdrawal by Subject|20|||
130234570|NCT03416179|468822445|FG002|Overall Study|Withdrawal by Subject|6|||
130234571|NCT03416179|468822446|FG003|Overall Study|Withdrawal by Subject|9|||
130234572|NCT03416179|468822443|FG000|Overall Study|Lost to Follow-up|1|||
130234573|NCT03416179|468822444|FG001|Overall Study|Lost to Follow-up|1|||
130234574|NCT03416179|468822445|FG002|Overall Study|Lost to Follow-up|0|||
130234575|NCT03416179|468822446|FG003|Overall Study|Lost to Follow-up|3|||
130234576|NCT03416179|468822443|FG000|Overall Study|Study participation terminated by Sponsor|93|||
130234577|NCT03416179|468822444|FG001|Overall Study|Study participation terminated by Sponsor|91|||
130234578|NCT03416179|468822445|FG002|Overall Study|Study participation terminated by Sponsor|26|||
130234579|NCT03416179|468822446|FG003|Overall Study|Study participation terminated by Sponsor|31|||
130234580|NCT03416179|468822443|FG000|Overall Study|Other|2|||
130234581|NCT03416179|468822444|FG001|Overall Study|Other|3|||
130358392|NCT02456103|469283193|FG000|Overall Study|Protocol Violation|1|||
130358393|NCT02456103|469283193|FG000|Overall Study|Adverse Event|5|||
130358394|NCT02456103|469283193|FG000|Overall Study|Abnormal Laboratory Value|2|||
130358395|NCT02456103|469283193|FG000|Overall Study|Lost to Follow-up|1|||
130358396|NCT02456103|469283193|FG000|Overall Study|Withdrawal by Subject|24|||
130358397|NCT02028871|469283196|FG000|Overall Study|Positive urine drug screen|1|||
130234582|NCT03416179|468822445|FG002|Overall Study|Other|1|||
130234583|NCT03416179|468822446|FG003|Overall Study|Other|0|||
130234584|NCT02657551|468822466|FG000|Overall Study|Adverse Event|2|||
130234585|NCT02657551|468822466|FG000|Overall Study|Withdrawal by Subject|1|||
130234586|NCT02657551|468822466|FG000|Overall Study|Non-Compliance|1|||
130234587|NCT02657551|468822466|FG000|Overall Study|Progression / Relapse|4|||
130234588|NCT01035138|468822467|FG000|Overall Study|Adverse Event|4|||
130234589|NCT01035138|468822468|FG001|Overall Study|Adverse Event|0|||
130234590|NCT01035138|468822469|FG002|Overall Study|Adverse Event|2|||
130234591|NCT01035138|468822467|FG000|Overall Study|Caregiver Decision|2|||
130358398|NCT02028871|469283197|FG001|Overall Study|Positive urine drug screen|1|||
130358399|NCT02028871|469283196|FG000|Overall Study|Withdrawal by Subject|1|||
130358400|NCT02028871|469283197|FG001|Overall Study|Withdrawal by Subject|2|||
130358401|NCT02028871|469283196|FG000|Overall Study|IV placement difficulty|1|||
130358402|NCT02028871|469283197|FG001|Overall Study|IV placement difficulty|0|||
130358403|NCT02028871|469283196|FG000|Overall Study|Current Illness|1|||
130358404|NCT02028871|469283197|FG001|Overall Study|Current Illness|0|||
130358405|NCT01916967|469283203|FG000|Overall Study|Adverse Event|0|||
130358406|NCT01916967|469283204|FG001|Overall Study|Adverse Event|0|||
130358407|NCT01916967|469283205|FG002|Overall Study|Adverse Event|2|||
130358408|NCT01916967|469283203|FG000|Overall Study|Lack of Efficacy|0|||
130358409|NCT01916967|469283204|FG001|Overall Study|Lack of Efficacy|0|||
130358410|NCT01916967|469283205|FG002|Overall Study|Lack of Efficacy|6|||
130358411|NCT01916967|469283203|FG000|Overall Study|Physician Decision|0|||
130358412|NCT01916967|469283204|FG001|Overall Study|Physician Decision|0|||
130358413|NCT01916967|469283205|FG002|Overall Study|Physician Decision|1|||
130358414|NCT01916967|469283203|FG000|Overall Study|Protocol Violation|0|||
130358415|NCT01916967|469283204|FG001|Overall Study|Protocol Violation|1|||
130358416|NCT01916967|469283205|FG002|Overall Study|Protocol Violation|0|||
130358417|NCT00568685|469283206|FG000|Overall Study|Adverse Event|2|||
130358418|NCT00568685|469283207|FG001|Overall Study|Adverse Event|3|||
130358419|NCT00568685|469283208|FG002|Overall Study|Adverse Event|3|||
130358420|NCT00568685|469283206|FG000|Overall Study|Withdrawal by Subject|7|||
130358421|NCT00568685|469283207|FG001|Overall Study|Withdrawal by Subject|2|||
130358422|NCT00568685|469283208|FG002|Overall Study|Withdrawal by Subject|2|||
130358423|NCT00568685|469283206|FG000|Overall Study|Protocol Violation|1|||
130358424|NCT00568685|469283207|FG001|Overall Study|Protocol Violation|0|||
130358425|NCT00568685|469283208|FG002|Overall Study|Protocol Violation|0|||
130358426|NCT02038452|469283209|FG000|Overall Study|Withdrawal by Subject|7|||
130358427|NCT02038452|469283210|FG001|Overall Study|Withdrawal by Subject|9|||
130234592|NCT01035138|468822468|FG001|Overall Study|Caregiver Decision|0|||
130234593|NCT01035138|468822469|FG002|Overall Study|Caregiver Decision|1|||
130234594|NCT01035138|468822467|FG000|Overall Study|Withdrawal by Subject|1|||
130234595|NCT01035138|468822468|FG001|Overall Study|Withdrawal by Subject|0|||
130234596|NCT01035138|468822469|FG002|Overall Study|Withdrawal by Subject|0|||
130234597|NCT01035138|468822467|FG000|Overall Study|Physician Decision|0|||
130358428|NCT02038452|469283209|FG000|Overall Study|Lost to Follow-up|31|||
130358429|NCT02038452|469283210|FG001|Overall Study|Lost to Follow-up|28|||
130358430|NCT01090973|469283215|FG000|Overall Study|Disease progression|1|||
130358431|NCT01626495|469283217|FG000|Overall Study|Adverse Event|3|||
130234598|NCT01035138|468822468|FG001|Overall Study|Physician Decision|0|||
130358432|NCT01626495|469283217|FG000|Overall Study|Disease progression|27|||
130358433|NCT01626495|469283217|FG000|Overall Study|Withdrawal by Subject|1|||
130234599|NCT01035138|468822469|FG002|Overall Study|Physician Decision|1|||
130234600|NCT01035138|468822467|FG000|Overall Study|Sponsor Decision|66|||
130234601|NCT01035138|468822468|FG001|Overall Study|Sponsor Decision|60|||
130234602|NCT01035138|468822469|FG002|Overall Study|Sponsor Decision|42|||
130234603|NCT01035138|468822467|FG000|Overall Study|Lost to Follow-up|0|||
130234604|NCT01035138|468822468|FG001|Overall Study|Lost to Follow-up|0|||
130234605|NCT01035138|468822469|FG002|Overall Study|Lost to Follow-up|1|||
130234606|NCT02916927|468822470|FG000|Overall Study|Discharged prior to study drug receipt|0|||
130234607|NCT02916927|468822471|FG001|Overall Study|Discharged prior to study drug receipt|2|||
130234608|NCT02916927|468822470|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
130234609|NCT02916927|468822471|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
130234610|NCT02916927|468822470|FG000|Overall Study|Withdrawal before first time point|1|||
130234611|NCT02916927|468822471|FG001|Overall Study|Withdrawal before first time point|0|||
130234612|NCT00655889|468822472|FG000|Overall Study|Inadequate cell growth|1|||
130234613|NCT00655889|468822472|FG000|Overall Study|Protocol Violation|1|||
130234614|NCT04585893|468822475|FG000|Overall Study|Death|1|||
130234615|NCT04585893|468822476|FG001|Overall Study|Death|0|||
130234616|NCT01366092|468822477|FG000|Overall Study|Progressive cGVHD|2|||
130234617|NCT01366092|468822477|FG000|Overall Study|Physician Decision|1|||
130234618|NCT01366092|468822477|FG000|Overall Study|Withdrawal by Subject|1|||
130234619|NCT03608163|468822478|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
130234620|NCT03608163|468822479|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
130234621|NCT05399680|468823867|FG000|Overall Study|Lost to Follow-up|1|||
130234622|NCT05399680|468823868|FG001|Overall Study|Lost to Follow-up|0|||
130234623|NCT05399680|468823867|FG000|Overall Study|Death|0|||
130234624|NCT05399680|468823868|FG001|Overall Study|Death|1|||
130234625|NCT02659865|468823869|FG000|Period 1|Withdrawal by Subject|1|||
130234626|NCT02659865|468823870|FG001|Period 1|Withdrawal by Subject|0|||
130234627|NCT02659865|468823871|FG002|Period 1|Withdrawal by Subject|0|||
130234628|NCT02659865|468823872|FG003|Period 1|Withdrawal by Subject|0|||
130234629|NCT02659865|468823873|FG004|Period 1|Withdrawal by Subject|0|||
130234630|NCT02659865|468823869|FG000|Period 1|Adverse Event|0|||
130234631|NCT02659865|468823870|FG001|Period 1|Adverse Event|0|||
130234632|NCT02659865|468823871|FG002|Period 1|Adverse Event|0|||
130234633|NCT02659865|468823872|FG003|Period 1|Adverse Event|0|||
130234634|NCT02659865|468823873|FG004|Period 1|Adverse Event|1|||
130234635|NCT01288430|468823875|FG000|Part 1|Progressive disease|2|||
130234636|NCT01288430|468823876|FG001|Part 1|Progressive disease|1|||
130234637|NCT01288430|468823877|FG002|Part 1|Progressive disease|1|||
130234638|NCT01288430|468823878|FG003|Part 1|Progressive disease|6|||
130234639|NCT01288430|468823879|FG004|Part 1|Progressive disease|2|||
130234640|NCT01288430|468823880|FG005|Part 1|Progressive disease|4|||
130234641|NCT01288430|468823881|FG006|Part 1|Progressive disease|2|||
130234642|NCT01288430|468823882|FG007|Part 1|Progressive disease|0|||
130234643|NCT01288430|468823883|FG008|Part 1|Progressive disease|0|||
130234644|NCT01288430|468823884|FG009|Part 1|Progressive disease|0|||
130234645|NCT01288430|468823875|FG000|Part 1|Clinical disease progression|0|||
130234646|NCT01288430|468823876|FG001|Part 1|Clinical disease progression|0|||
130234647|NCT01288430|468823877|FG002|Part 1|Clinical disease progression|1|||
130234648|NCT01288430|468823878|FG003|Part 1|Clinical disease progression|0|||
130234649|NCT01288430|468823879|FG004|Part 1|Clinical disease progression|0|||
130234650|NCT01288430|468823880|FG005|Part 1|Clinical disease progression|2|||
130234651|NCT01288430|468823881|FG006|Part 1|Clinical disease progression|2|||
130234652|NCT01288430|468823882|FG007|Part 1|Clinical disease progression|0|||
130358434|NCT01626495|469283217|FG000|Overall Study|Administrative problem|1|||
130234653|NCT01288430|468823883|FG008|Part 1|Clinical disease progression|0|||
130234654|NCT01288430|468823884|FG009|Part 1|Clinical disease progression|0|||
130234655|NCT01288430|468823875|FG000|Part 1|Death due to disease progression|0|||
130234656|NCT01288430|468823876|FG001|Part 1|Death due to disease progression|0|||
130234657|NCT01288430|468823877|FG002|Part 1|Death due to disease progression|0|||
130234658|NCT01288430|468823878|FG003|Part 1|Death due to disease progression|0|||
130234659|NCT01288430|468823879|FG004|Part 1|Death due to disease progression|1|||
130234660|NCT01288430|468823880|FG005|Part 1|Death due to disease progression|0|||
130234661|NCT01288430|468823881|FG006|Part 1|Death due to disease progression|0|||
130234662|NCT01288430|468823882|FG007|Part 1|Death due to disease progression|0|||
130234663|NCT01288430|468823883|FG008|Part 1|Death due to disease progression|0|||
130234664|NCT01288430|468823884|FG009|Part 1|Death due to disease progression|0|||
130234665|NCT01288430|468823875|FG000|Part 1|Adverse Event|0|||
130234666|NCT01288430|468823876|FG001|Part 1|Adverse Event|0|||
130234667|NCT01288430|468823877|FG002|Part 1|Adverse Event|3|||
130234668|NCT01288430|468823878|FG003|Part 1|Adverse Event|1|||
130234669|NCT01288430|468823879|FG004|Part 1|Adverse Event|0|||
130234670|NCT01288430|468823880|FG005|Part 1|Adverse Event|0|||
130234671|NCT01288430|468823881|FG006|Part 1|Adverse Event|2|||
130234672|NCT01288430|468823882|FG007|Part 1|Adverse Event|0|||
130234673|NCT01288430|468823883|FG008|Part 1|Adverse Event|0|||
130358435|NCT01626495|469283217|FG000|Overall Study|Death|2|||
130234674|NCT01288430|468823884|FG009|Part 1|Adverse Event|0|||
130234675|NCT01288430|468823875|FG000|Part 1|Other|0|||
130234676|NCT01288430|468823876|FG001|Part 1|Other|2|||
130234677|NCT01288430|468823877|FG002|Part 1|Other|0|||
130234678|NCT01288430|468823878|FG003|Part 1|Other|0|||
130234679|NCT01288430|468823879|FG004|Part 1|Other|0|||
130234680|NCT01288430|468823880|FG005|Part 1|Other|0|||
130234681|NCT01288430|468823881|FG006|Part 1|Other|1|||
130234682|NCT01288430|468823882|FG007|Part 1|Other|0|||
130234683|NCT01288430|468823883|FG008|Part 1|Other|0|||
130234684|NCT01288430|468823884|FG009|Part 1|Other|0|||
130234685|NCT01288430|468823875|FG000|Part 2|Progressive disease|0|||
130234686|NCT01288430|468823876|FG001|Part 2|Progressive disease|0|||
130234687|NCT01288430|468823877|FG002|Part 2|Progressive disease|0|||
130234688|NCT01288430|468823878|FG003|Part 2|Progressive disease|0|||
130234689|NCT01288430|468823879|FG004|Part 2|Progressive disease|0|||
130234690|NCT01288430|468823880|FG005|Part 2|Progressive disease|0|||
130234691|NCT01288430|468823881|FG006|Part 2|Progressive disease|0|||
130234692|NCT01288430|468823882|FG007|Part 2|Progressive disease|8|||
130234693|NCT01288430|468823883|FG008|Part 2|Progressive disease|7|||
130234694|NCT01288430|468823884|FG009|Part 2|Progressive disease|2|||
130234695|NCT01288430|468823875|FG000|Part 2|Clinical disease progression|0|||
130234696|NCT01288430|468823876|FG001|Part 2|Clinical disease progression|0|||
130234697|NCT01288430|468823877|FG002|Part 2|Clinical disease progression|0|||
130234698|NCT01288430|468823878|FG003|Part 2|Clinical disease progression|0|||
130234699|NCT01288430|468823879|FG004|Part 2|Clinical disease progression|0|||
130234700|NCT01288430|468823880|FG005|Part 2|Clinical disease progression|0|||
130234701|NCT01288430|468823881|FG006|Part 2|Clinical disease progression|0|||
130234702|NCT01288430|468823882|FG007|Part 2|Clinical disease progression|2|||
130234703|NCT01288430|468823883|FG008|Part 2|Clinical disease progression|0|||
130234704|NCT01288430|468823884|FG009|Part 2|Clinical disease progression|0|||
130234705|NCT01288430|468823875|FG000|Part 2|Withdrawal by Subject|0|||
130234706|NCT01288430|468823876|FG001|Part 2|Withdrawal by Subject|0|||
130234707|NCT01288430|468823877|FG002|Part 2|Withdrawal by Subject|0|||
130234708|NCT01288430|468823878|FG003|Part 2|Withdrawal by Subject|0|||
130234709|NCT01288430|468823879|FG004|Part 2|Withdrawal by Subject|0|||
130234710|NCT01288430|468823880|FG005|Part 2|Withdrawal by Subject|0|||
130234711|NCT01288430|468823881|FG006|Part 2|Withdrawal by Subject|0|||
130234712|NCT01288430|468823882|FG007|Part 2|Withdrawal by Subject|1|||
130234713|NCT01288430|468823883|FG008|Part 2|Withdrawal by Subject|4|||
130234714|NCT01288430|468823884|FG009|Part 2|Withdrawal by Subject|0|||
130234715|NCT01288430|468823875|FG000|Part 2|Adverse Event|0|||
130234716|NCT01288430|468823876|FG001|Part 2|Adverse Event|0|||
130234717|NCT01288430|468823877|FG002|Part 2|Adverse Event|0|||
130234718|NCT01288430|468823878|FG003|Part 2|Adverse Event|0|||
130234719|NCT01288430|468823879|FG004|Part 2|Adverse Event|0|||
130234720|NCT01288430|468823880|FG005|Part 2|Adverse Event|0|||
130234721|NCT01288430|468823881|FG006|Part 2|Adverse Event|0|||
130234722|NCT01288430|468823882|FG007|Part 2|Adverse Event|1|||
130234723|NCT01288430|468823883|FG008|Part 2|Adverse Event|1|||
130234724|NCT01288430|468823884|FG009|Part 2|Adverse Event|0|||
130234725|NCT01288430|468823875|FG000|Part 2|Other|0|||
130234726|NCT01288430|468823876|FG001|Part 2|Other|0|||
130234727|NCT01288430|468823877|FG002|Part 2|Other|0|||
130234728|NCT01288430|468823878|FG003|Part 2|Other|0|||
130234729|NCT01288430|468823879|FG004|Part 2|Other|0|||
130234730|NCT01288430|468823880|FG005|Part 2|Other|0|||
130234731|NCT01288430|468823881|FG006|Part 2|Other|0|||
130234732|NCT01288430|468823882|FG007|Part 2|Other|0|||
130234733|NCT01288430|468823883|FG008|Part 2|Other|0|||
130234734|NCT01288430|468823884|FG009|Part 2|Other|1|||
130234735|NCT03836053|468823890|FG000|Overall Study|Protocol-specified criteria|0|||
130234736|NCT03836053|468823891|FG001|Overall Study|Protocol-specified criteria|2|||
130234737|NCT03836053|468823892|FG002|Overall Study|Protocol-specified criteria|1|||
130234738|NCT03836053|468823890|FG000|Overall Study|Death|1|||
130234739|NCT03836053|468823891|FG001|Overall Study|Death|6|||
130234740|NCT03836053|468823892|FG002|Overall Study|Death|4|||
130234741|NCT03836053|468823890|FG000|Overall Study|Withdrawal of consent from study|0|||
130234742|NCT03836053|468823891|FG001|Overall Study|Withdrawal of consent from study|0|||
130234743|NCT03836053|468823892|FG002|Overall Study|Withdrawal of consent from study|1|||
130234744|NCT03836053|468823890|FG000|Overall Study|Decision by sponsor|0|||
130234745|NCT03836053|468823891|FG001|Overall Study|Decision by sponsor|2|||
130234746|NCT03836053|468823892|FG002|Overall Study|Decision by sponsor|4|||
130234747|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
130234748|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
130234749|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
130234750|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Death|1|||
130234751|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Death|1|||
130234752|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Death|0|||
130234753|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
130234754|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
130234755|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
130234756|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
130234757|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
130234758|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
130234759|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
130234760|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
130234761|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
130234762|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
130234763|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
130234764|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
130234765|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
130234766|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
130234767|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
130234768|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
130234769|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
130234770|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
130234771|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
130234772|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
130234773|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
130234774|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
130234775|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
130234776|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
130234777|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Other|10|||
130234778|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Other|4|||
130234779|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Other|0|||
130234780|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130234781|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
130234782|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130234783|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
130234784|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
130234785|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
130234786|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
130234787|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130234788|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130234789|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
130446690|NCT00107380|469597036|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
130446691|NCT00107380|469597036|FG000|Overall Study|Progression/relapse|4|||
130446692|NCT00107380|469597036|FG000|Overall Study|Death|3|||
130446693|NCT00107380|469597036|FG000|Overall Study|Other - not protocol specified|7|||
130446694|NCT00107380|469597036|FG000|Overall Study|Ineligible|2|||
130446695|NCT03673098|469597037|FG000|Overall Study|Lost to Follow-up|2|||
130446696|NCT03673098|469597038|FG001|Overall Study|Lost to Follow-up|3|||
130446697|NCT03673098|469597037|FG000|Overall Study|Withdrawal by Subject|6|||
130446698|NCT03673098|469597038|FG001|Overall Study|Withdrawal by Subject|1|||
130446699|NCT03673098|469597037|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
130446700|NCT03673098|469597038|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
130446701|NCT01155726|469597044|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
130446702|NCT01155726|469597045|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
130446703|NCT01155726|469597046|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
130446704|NCT01155726|469597047|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
130446705|NCT03639675|469597048|FG000|Overall Study|Withdrawal by Subject|1|||
130446706|NCT02459587|469597049|FG000|3-Month Follow-up Assessment|Death|0|||
130446707|NCT02459587|469597050|FG001|3-Month Follow-up Assessment|Death|2|||
130446708|NCT02459587|469597049|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
130446709|NCT02459587|469597050|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
130446710|NCT02459587|469597049|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
130446711|NCT02459587|469597050|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
130446712|NCT02459587|469597049|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
130446713|NCT02459587|469597050|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
130446714|NCT02459587|469597049|FG000|6-month Follow-up Assessment|Death|2|||
130446715|NCT02459587|469597050|FG001|6-month Follow-up Assessment|Death|1|||
130446716|NCT02459587|469597049|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
130446717|NCT02459587|469597050|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
130446718|NCT02459587|469597049|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
130446719|NCT02459587|469597050|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
130446720|NCT02459587|469597049|FG000|12-month Follow-up Assessment|Death|2|||
130446721|NCT02459587|469597050|FG001|12-month Follow-up Assessment|Death|0|||
130446722|NCT02459587|469597049|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
130446723|NCT02459587|469597050|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
130234790|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
130446724|NCT02459587|469597049|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
130446725|NCT02459587|469597050|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
130234791|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
130234792|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
130234793|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
130234794|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
130234795|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
130234796|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
130234797|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
130234798|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Other|2|||
130234799|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Other|3|||
130234800|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Other|0|||
130234801|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
130234802|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
130234803|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
130234804|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Ongoing|86|||
130234805|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Ongoing|96|||
130234806|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Ongoing|0|||
130234807|NCT04006457|468823893|FG000|Main Study Observation Period|Adverse Event|1|||
130234808|NCT04006457|468823894|FG001|Main Study Observation Period|Adverse Event|1|||
130234809|NCT04006457|468823895|FG002|Main Study Observation Period|Adverse Event|0|||
130234810|NCT04006457|468823893|FG000|Main Study Observation Period|Lost to Follow-up|0|||
130234811|NCT04006457|468823894|FG001|Main Study Observation Period|Lost to Follow-up|1|||
130234812|NCT04006457|468823895|FG002|Main Study Observation Period|Lost to Follow-up|0|||
130234813|NCT04006457|468823893|FG000|Main Study Observation Period|Pregnancy|1|||
130234814|NCT04006457|468823894|FG001|Main Study Observation Period|Pregnancy|0|||
130234815|NCT04006457|468823895|FG002|Main Study Observation Period|Pregnancy|0|||
130234816|NCT04006457|468823893|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
130234817|NCT04006457|468823894|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
130234818|NCT04006457|468823895|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
130234819|NCT04006457|468823893|FG000|Main Study Observation Period|Other|8|||
130234820|NCT04006457|468823894|FG001|Main Study Observation Period|Other|16|||
130234821|NCT04006457|468823895|FG002|Main Study Observation Period|Other|0|||
130234822|NCT04006457|468823893|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
130234823|NCT04006457|468823894|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
130234824|NCT04006457|468823895|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
130234825|NCT04006457|468823893|FG000|Main Study Observation Period|Ongoing|2|||
130234826|NCT04006457|468823894|FG001|Main Study Observation Period|Ongoing|1|||
130234827|NCT04006457|468823895|FG002|Main Study Observation Period|Ongoing|0|||
130234828|NCT04006457|468823893|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
130234829|NCT04006457|468823894|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
130234830|NCT04006457|468823895|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
130234831|NCT04486716|468823896|FG000|Core Phase|Subject decision|6|||
130234832|NCT04486716|468823896|FG000|Core Phase|Adverse Event|5|||
130234833|NCT04486716|468823896|FG000|Core Phase|Lost to Follow-up|1|||
130234834|NCT04486716|468823896|FG000|Core Phase|Physician Decision|1|||
130234835|NCT04486716|468823896|FG000|Core Phase|Enrolled subjects not treated|9|||
130234836|NCT02332707|468823897|FG000|Overall Study|Adverse Event|0|||
130234837|NCT02332707|468823898|FG001|Overall Study|Adverse Event|0|||
130234838|NCT02332707|468823899|FG002|Overall Study|Adverse Event|0|||
130234839|NCT02332707|468823900|FG003|Overall Study|Adverse Event|0|||
130234840|NCT02332707|468823901|FG004|Overall Study|Adverse Event|0|||
130234841|NCT02332707|468823902|FG005|Overall Study|Adverse Event|0|||
130234842|NCT02332707|468823903|FG006|Overall Study|Adverse Event|0|||
130234843|NCT02332707|468823904|FG007|Overall Study|Adverse Event|0|||
130234844|NCT02332707|468823905|FG008|Overall Study|Adverse Event|0|||
130234845|NCT02332707|468823906|FG009|Overall Study|Adverse Event|0|||
130234846|NCT02332707|468823907|FG010|Overall Study|Adverse Event|0|||
130234847|NCT02332707|468823908|FG011|Overall Study|Adverse Event|0|||
130234848|NCT02332707|468823909|FG012|Overall Study|Adverse Event|1|||
130234849|NCT02332707|468823910|FG013|Overall Study|Adverse Event|0|||
130234850|NCT02332707|468823911|FG014|Overall Study|Adverse Event|0|||
130234851|NCT02332707|468823912|FG015|Overall Study|Adverse Event|0|||
130358436|NCT01626495|469283217|FG000|Overall Study|Physician Decision|1|||
130358437|NCT01626495|469283217|FG000|Overall Study|New cancer therapy|16|||
130358438|NCT01626495|469283217|FG000|Overall Study|Manufacturing failure|1|||
130358439|NCT03643159|469283218|FG000|Overall Study|Adverse Event|1|||
130358440|NCT03643159|469283218|FG000|Overall Study|Withdrawal by Subject|1|||
130234852|NCT02332707|468823913|FG016|Overall Study|Adverse Event|0|||
130234853|NCT02332707|468823914|FG017|Overall Study|Adverse Event|0|||
130234854|NCT02332707|468823897|FG000|Overall Study|Lost to Follow-up|0|||
130234855|NCT02332707|468823898|FG001|Overall Study|Lost to Follow-up|0|||
130358441|NCT02520661|469283219|FG000|Overall Study|Lost to Follow-up|7|||
130358442|NCT02520661|469283220|FG001|Overall Study|Lost to Follow-up|3|||
130358443|NCT02520661|469283219|FG000|Overall Study|Admitted from ED|49|||
130358444|NCT02520661|469283220|FG001|Overall Study|Admitted from ED|48|||
130694566|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694567|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694568|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130358445|NCT02520661|469283219|FG000|Overall Study|ED greater than 24 hours|29|||
130358446|NCT02520661|469283220|FG001|Overall Study|ED greater than 24 hours|38|||
130358447|NCT02520661|469283219|FG000|Overall Study|other ineligibility|14|||
130694569|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694570|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694571|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694572|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694573|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694574|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694575|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694576|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694577|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694578|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694579|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694580|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130694581|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130694582|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694583|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694584|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694585|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694586|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694587|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694588|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694589|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694590|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694591|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694592|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694593|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694594|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694595|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694596|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694597|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694598|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694599|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694600|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694601|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694602|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694603|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694604|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694605|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694606|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694607|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694608|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694609|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694610|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694611|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694612|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694613|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694614|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694615|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694616|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
130694617|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
130694618|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694619|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694620|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694621|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694622|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694623|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130358448|NCT02520661|469283220|FG001|Overall Study|other ineligibility|22|||
130358449|NCT02520661|469283219|FG000|Overall Study|Withdrawal by Subject|7|||
130358450|NCT02520661|469283220|FG001|Overall Study|Withdrawal by Subject|16|||
130358451|NCT00072176|469283223|FG000|Overall Study|Withdrawal by Subject|1|||
130694624|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694625|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694626|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694627|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694628|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694629|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694630|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694631|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694632|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694633|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694634|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694635|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694636|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694637|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694638|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694639|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694640|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130358452|NCT00072176|469283224|FG001|Overall Study|Withdrawal by Subject|0|||
130358453|NCT00072176|469283223|FG000|Overall Study|Protocol Violation|0|||
130358454|NCT00072176|469283224|FG001|Overall Study|Protocol Violation|1|||
130358455|NCT02887859|469283227|FG000|Overall Study|Ongoing|6|||
130358456|NCT02887859|469283227|FG000|Overall Study|Adverse Event|7|||
130358457|NCT02887859|469283227|FG000|Overall Study|Death|1|||
130358458|NCT02887859|469283227|FG000|Overall Study|Physician Decision|1|||
130358459|NCT01920555|469284737|FG000|Overall Study|Physician Decision|1|||
130358460|NCT01920555|469284738|FG001|Overall Study|Physician Decision|2|||
130358461|NCT01920555|469284739|FG002|Overall Study|Physician Decision|1|||
130358462|NCT01920555|469284740|FG003|Overall Study|Physician Decision|2|||
130358463|NCT01920555|469284741|FG004|Overall Study|Physician Decision|0|||
130358464|NCT01920555|469284737|FG000|Overall Study|Lack of Efficacy|2|||
130358465|NCT01920555|469284738|FG001|Overall Study|Lack of Efficacy|0|||
130358466|NCT01920555|469284739|FG002|Overall Study|Lack of Efficacy|0|||
130358467|NCT01920555|469284740|FG003|Overall Study|Lack of Efficacy|0|||
130358468|NCT01920555|469284741|FG004|Overall Study|Lack of Efficacy|0|||
130358469|NCT01920555|469284737|FG000|Overall Study|Travel Difficulties|1|||
130358470|NCT01920555|469284738|FG001|Overall Study|Travel Difficulties|1|||
130358471|NCT01920555|469284739|FG002|Overall Study|Travel Difficulties|0|||
130358472|NCT01920555|469284740|FG003|Overall Study|Travel Difficulties|0|||
130358473|NCT01920555|469284741|FG004|Overall Study|Travel Difficulties|1|||
130358474|NCT01920555|469284737|FG000|Overall Study|Lost to Follow-up|0|||
130358475|NCT01920555|469284738|FG001|Overall Study|Lost to Follow-up|1|||
130358476|NCT01920555|469284739|FG002|Overall Study|Lost to Follow-up|0|||
130358477|NCT01920555|469284740|FG003|Overall Study|Lost to Follow-up|1|||
130358478|NCT01920555|469284741|FG004|Overall Study|Lost to Follow-up|0|||
130358479|NCT01858376|469284742|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
130358480|NCT01886716|469284747|FG000|Week 1|Lost to Follow-up|0|||
130358481|NCT01886716|469284748|FG001|Week 1|Lost to Follow-up|0|||
130358482|NCT01886716|469284749|FG002|Week 1|Lost to Follow-up|2|||
130358483|NCT01886716|469284750|FG003|Week 1|Lost to Follow-up|2|||
130358484|NCT01886716|469284747|FG000|Week 2|Lost to Follow-up|3|||
130358485|NCT01886716|469284748|FG001|Week 2|Lost to Follow-up|2|||
130358486|NCT01886716|469284749|FG002|Week 2|Lost to Follow-up|1|||
130358487|NCT01886716|469284750|FG003|Week 2|Lost to Follow-up|3|||
130358488|NCT01886716|469284747|FG000|Week 3|Lost to Follow-up|1|||
130358489|NCT01886716|469284748|FG001|Week 3|Lost to Follow-up|1|||
130358490|NCT01886716|469284749|FG002|Week 3|Lost to Follow-up|0|||
130358491|NCT01886716|469284750|FG003|Week 3|Lost to Follow-up|1|||
130358492|NCT00785928|469284752|FG000|Treatment Phase|Adverse Event|1|||
130358493|NCT00785928|469284753|FG001|Treatment Phase|Adverse Event|1|||
130358494|NCT00785928|469284754|FG002|Treatment Phase|Adverse Event|2|||
130358495|NCT00785928|469284755|FG003|Treatment Phase|Adverse Event|0|||
130358496|NCT00785928|469284756|FG004|Treatment Phase|Adverse Event|0|||
130358497|NCT00785928|469284757|FG005|Treatment Phase|Adverse Event|0|||
130358498|NCT00785928|469284758|FG006|Treatment Phase|Adverse Event|2|||
130358499|NCT00785928|469284752|FG000|Treatment Phase|Inadequate Response|0|||
130358500|NCT00785928|469284753|FG001|Treatment Phase|Inadequate Response|1|||
130358501|NCT00785928|469284754|FG002|Treatment Phase|Inadequate Response|0|||
130358502|NCT00785928|469284755|FG003|Treatment Phase|Inadequate Response|0|||
130358503|NCT00785928|469284756|FG004|Treatment Phase|Inadequate Response|0|||
130358504|NCT00785928|469284757|FG005|Treatment Phase|Inadequate Response|0|||
130358505|NCT00785928|469284758|FG006|Treatment Phase|Inadequate Response|0|||
130358506|NCT00785928|469284752|FG000|Treatment Phase|Lack of Efficacy|0|||
130358507|NCT00785928|469284753|FG001|Treatment Phase|Lack of Efficacy|1|||
130358508|NCT00785928|469284754|FG002|Treatment Phase|Lack of Efficacy|1|||
130358509|NCT00785928|469284755|FG003|Treatment Phase|Lack of Efficacy|0|||
130234856|NCT02332707|468823899|FG002|Overall Study|Lost to Follow-up|0|||
130234857|NCT02332707|468823900|FG003|Overall Study|Lost to Follow-up|0|||
130234858|NCT02332707|468823901|FG004|Overall Study|Lost to Follow-up|0|||
130234859|NCT02332707|468823902|FG005|Overall Study|Lost to Follow-up|1|||
130234860|NCT02332707|468823903|FG006|Overall Study|Lost to Follow-up|0|||
130234861|NCT02332707|468823904|FG007|Overall Study|Lost to Follow-up|0|||
130234862|NCT02332707|468823905|FG008|Overall Study|Lost to Follow-up|0|||
130234863|NCT02332707|468823906|FG009|Overall Study|Lost to Follow-up|0|||
130234864|NCT02332707|468823907|FG010|Overall Study|Lost to Follow-up|2|||
130234865|NCT02332707|468823908|FG011|Overall Study|Lost to Follow-up|0|||
130234866|NCT02332707|468823909|FG012|Overall Study|Lost to Follow-up|3|||
130234867|NCT02332707|468823910|FG013|Overall Study|Lost to Follow-up|0|||
130234868|NCT02332707|468823911|FG014|Overall Study|Lost to Follow-up|0|||
130234869|NCT02332707|468823912|FG015|Overall Study|Lost to Follow-up|0|||
130234870|NCT02332707|468823913|FG016|Overall Study|Lost to Follow-up|0|||
130234871|NCT02332707|468823914|FG017|Overall Study|Lost to Follow-up|0|||
130234872|NCT02332707|468823897|FG000|Overall Study|Physician Decision|0|||
130234873|NCT02332707|468823898|FG001|Overall Study|Physician Decision|0|||
130234874|NCT02332707|468823899|FG002|Overall Study|Physician Decision|0|||
130234875|NCT02332707|468823900|FG003|Overall Study|Physician Decision|1|||
130234876|NCT02332707|468823901|FG004|Overall Study|Physician Decision|0|||
130234877|NCT02332707|468823902|FG005|Overall Study|Physician Decision|0|||
130234878|NCT02332707|468823903|FG006|Overall Study|Physician Decision|0|||
130234879|NCT02332707|468823904|FG007|Overall Study|Physician Decision|0|||
130234880|NCT02332707|468823905|FG008|Overall Study|Physician Decision|0|||
130234881|NCT02332707|468823906|FG009|Overall Study|Physician Decision|0|||
130234882|NCT02332707|468823907|FG010|Overall Study|Physician Decision|0|||
130234883|NCT02332707|468823908|FG011|Overall Study|Physician Decision|0|||
130234884|NCT02332707|468823909|FG012|Overall Study|Physician Decision|1|||
130234885|NCT02332707|468823910|FG013|Overall Study|Physician Decision|0|||
130234886|NCT02332707|468823911|FG014|Overall Study|Physician Decision|0|||
130234887|NCT02332707|468823912|FG015|Overall Study|Physician Decision|0|||
130234888|NCT02332707|468823913|FG016|Overall Study|Physician Decision|0|||
130234889|NCT02332707|468823914|FG017|Overall Study|Physician Decision|0|||
130234890|NCT02332707|468823897|FG000|Overall Study|Withdrawal by Subject|0|||
130234891|NCT02332707|468823898|FG001|Overall Study|Withdrawal by Subject|0|||
130234892|NCT02332707|468823899|FG002|Overall Study|Withdrawal by Subject|1|||
130234893|NCT02332707|468823900|FG003|Overall Study|Withdrawal by Subject|0|||
130234894|NCT02332707|468823901|FG004|Overall Study|Withdrawal by Subject|0|||
130234895|NCT02332707|468823902|FG005|Overall Study|Withdrawal by Subject|0|||
130234896|NCT02332707|468823903|FG006|Overall Study|Withdrawal by Subject|0|||
130234897|NCT02332707|468823904|FG007|Overall Study|Withdrawal by Subject|0|||
130234898|NCT02332707|468823905|FG008|Overall Study|Withdrawal by Subject|0|||
130234899|NCT02332707|468823906|FG009|Overall Study|Withdrawal by Subject|3|||
130358510|NCT00785928|469284756|FG004|Treatment Phase|Lack of Efficacy|0|||
130358511|NCT00785928|469284757|FG005|Treatment Phase|Lack of Efficacy|0|||
130358512|NCT00785928|469284758|FG006|Treatment Phase|Lack of Efficacy|0|||
130358513|NCT00785928|469284752|FG000|Treatment Phase|Physician Decision|0|||
130358514|NCT00785928|469284753|FG001|Treatment Phase|Physician Decision|0|||
130358515|NCT00785928|469284754|FG002|Treatment Phase|Physician Decision|0|||
130358516|NCT00785928|469284755|FG003|Treatment Phase|Physician Decision|0|||
130358517|NCT00785928|469284756|FG004|Treatment Phase|Physician Decision|1|||
130358518|NCT00785928|469284757|FG005|Treatment Phase|Physician Decision|0|||
130358519|NCT00785928|469284758|FG006|Treatment Phase|Physician Decision|0|||
130358520|NCT00785928|469284752|FG000|Treatment Phase|Sponsor Decision|1|||
130358521|NCT00785928|469284753|FG001|Treatment Phase|Sponsor Decision|0|||
130358522|NCT00785928|469284754|FG002|Treatment Phase|Sponsor Decision|0|||
130358523|NCT00785928|469284755|FG003|Treatment Phase|Sponsor Decision|0|||
130358524|NCT00785928|469284756|FG004|Treatment Phase|Sponsor Decision|0|||
130358525|NCT00785928|469284757|FG005|Treatment Phase|Sponsor Decision|0|||
130358526|NCT00785928|469284758|FG006|Treatment Phase|Sponsor Decision|1|||
130358527|NCT00785928|469284752|FG000|Treatment Phase|Withdrawal by Subject|1|||
130358528|NCT00785928|469284753|FG001|Treatment Phase|Withdrawal by Subject|2|||
130358529|NCT00785928|469284754|FG002|Treatment Phase|Withdrawal by Subject|0|||
130358530|NCT00785928|469284755|FG003|Treatment Phase|Withdrawal by Subject|0|||
130358531|NCT00785928|469284756|FG004|Treatment Phase|Withdrawal by Subject|1|||
130234900|NCT02332707|468823907|FG010|Overall Study|Withdrawal by Subject|0|||
130234901|NCT02332707|468823908|FG011|Overall Study|Withdrawal by Subject|0|||
130234902|NCT02332707|468823909|FG012|Overall Study|Withdrawal by Subject|0|||
130234903|NCT02332707|468823910|FG013|Overall Study|Withdrawal by Subject|0|||
130234904|NCT02332707|468823911|FG014|Overall Study|Withdrawal by Subject|0|||
130234905|NCT02332707|468823912|FG015|Overall Study|Withdrawal by Subject|0|||
130234906|NCT02332707|468823913|FG016|Overall Study|Withdrawal by Subject|0|||
130358532|NCT00785928|469284757|FG005|Treatment Phase|Withdrawal by Subject|0|||
130358533|NCT00785928|469284758|FG006|Treatment Phase|Withdrawal by Subject|0|||
130358534|NCT03387683|469284759|FG000|Overall Study|In receipt of disallowed medication|1|||
130358535|NCT03387683|469284760|FG001|Overall Study|In receipt of disallowed medication|0|||
130358536|NCT03387683|469284759|FG000|Overall Study|Did not receive treatment|1|||
130446726|NCT02459587|469597049|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
130234907|NCT02332707|468823914|FG017|Overall Study|Withdrawal by Subject|0|||
130234908|NCT04761822|468823915|FG000|Overall Study|Adverse Event|3|||
130234909|NCT04761822|468823916|FG001|Overall Study|Adverse Event|1|||
130234910|NCT04761822|468823917|FG002|Overall Study|Adverse Event|1|||
130234911|NCT04761822|468823918|FG003|Overall Study|Adverse Event|3|||
130234912|NCT04761822|468823915|FG000|Overall Study|Lost to Follow-up|1|||
130234913|NCT04761822|468823916|FG001|Overall Study|Lost to Follow-up|0|||
130234914|NCT04761822|468823917|FG002|Overall Study|Lost to Follow-up|2|||
130234915|NCT04761822|468823918|FG003|Overall Study|Lost to Follow-up|3|||
130234916|NCT04761822|468823915|FG000|Overall Study|Physician Decision|0|||
130234917|NCT04761822|468823916|FG001|Overall Study|Physician Decision|1|||
130234918|NCT04761822|468823917|FG002|Overall Study|Physician Decision|0|||
130234919|NCT04761822|468823918|FG003|Overall Study|Physician Decision|0|||
130234920|NCT04761822|468823915|FG000|Overall Study|Withdrawal by Subject|3|||
130234921|NCT04761822|468823916|FG001|Overall Study|Withdrawal by Subject|8|||
130234922|NCT04761822|468823917|FG002|Overall Study|Withdrawal by Subject|1|||
130234923|NCT04761822|468823918|FG003|Overall Study|Withdrawal by Subject|11|||
130234924|NCT04761822|468823915|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
130234925|NCT04761822|468823916|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234926|NCT04761822|468823917|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234927|NCT04761822|468823918|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234928|NCT04761822|468823915|FG000|Overall Study|Participant requested unblinding|0|||
130234929|NCT04761822|468823916|FG001|Overall Study|Participant requested unblinding|0|||
130234930|NCT04761822|468823917|FG002|Overall Study|Participant requested unblinding|0|||
130234931|NCT04761822|468823918|FG003|Overall Study|Participant requested unblinding|1|||
130234932|NCT00947544|468823923|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
130234933|NCT00947544|468823924|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
130234934|NCT01240746|468823925|FG000|Overall Study|Adverse Event|2|||
130234935|NCT01240746|468823926|FG001|Overall Study|Adverse Event|0|||
130234936|NCT01240746|468823927|FG002|Overall Study|Adverse Event|10|||
130234937|NCT01240746|468823925|FG000|Overall Study|Lost to Follow-up|23|||
130234938|NCT01240746|468823926|FG001|Overall Study|Lost to Follow-up|20|||
130234939|NCT01240746|468823927|FG002|Overall Study|Lost to Follow-up|102|||
130234940|NCT01240746|468823925|FG000|Overall Study|Protocol Violation|24|||
130234941|NCT01240746|468823926|FG001|Overall Study|Protocol Violation|15|||
130234942|NCT01240746|468823927|FG002|Overall Study|Protocol Violation|72|||
130234943|NCT01240746|468823925|FG000|Overall Study|Withdrawal by Subject|10|||
130234944|NCT01240746|468823926|FG001|Overall Study|Withdrawal by Subject|13|||
130234945|NCT01240746|468823927|FG002|Overall Study|Withdrawal by Subject|59|||
130234946|NCT02471183|468823931|FG000|Main Treatment Period|Adverse Event|1|||
130234947|NCT02471183|468823931|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130234948|NCT02471183|468823931|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130234949|NCT02690727|468823932|FG000|Overall Study|Adverse Event|2|||
130234950|NCT02690727|468823933|FG001|Overall Study|Adverse Event|2|||
130234951|NCT01461551|468823939|FG000|Overall Study|Physician Decision|2|||
130234952|NCT01461551|468823940|FG001|Overall Study|Physician Decision|1|||
130234953|NCT01461551|468823941|FG002|Overall Study|Physician Decision|2|||
130234954|NCT00827567|468823942|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
130234955|NCT01155141|468823943|FG000|Overall Study|Withdrawal by Subject|1|||
130234956|NCT01155141|468823943|FG000|Overall Study|Screen Failure|1|||
130234957|NCT03473197|468823944|FG000|Overall Study|Adverse Event|4|||
130234958|NCT03473197|468823944|FG000|Overall Study|Lost to Follow-up|1|||
130234959|NCT03473197|468823944|FG000|Overall Study|Withdrawal by Subject|5|||
130234960|NCT00785629|468823947|FG000|Overall Study|Adverse Event|2|||
130234961|NCT00785629|468823948|FG001|Overall Study|Adverse Event|1|||
130446727|NCT02459587|469597050|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
130446728|NCT02485353|469597051|FG000|Overall Study|Death|1|||
130446729|NCT02485353|469597051|FG000|Overall Study|Disease Progression|1|||
130446730|NCT01021332|469597052|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
130446731|NCT01021332|469597052|FG000|Overall Study|Adverse Event|43|||
130234962|NCT00785629|468823949|FG002|Overall Study|Adverse Event|1|||
130234963|NCT00785629|468823950|FG003|Overall Study|Adverse Event|5|||
130234964|NCT00785629|468823947|FG000|Overall Study|Protocol Violation|1|||
130234965|NCT00785629|468823948|FG001|Overall Study|Protocol Violation|2|||
130234966|NCT00785629|468823949|FG002|Overall Study|Protocol Violation|4|||
130234967|NCT00785629|468823950|FG003|Overall Study|Protocol Violation|5|||
130234968|NCT00785629|468823947|FG000|Overall Study|administrative decision|5|||
130234969|NCT00785629|468823948|FG001|Overall Study|administrative decision|1|||
130234970|NCT00785629|468823949|FG002|Overall Study|administrative decision|3|||
130234971|NCT00785629|468823950|FG003|Overall Study|administrative decision|4|||
130234972|NCT00785629|468823947|FG000|Overall Study|Withdrawal by Subject|0|||
130234973|NCT00785629|468823948|FG001|Overall Study|Withdrawal by Subject|1|||
130234974|NCT00785629|468823949|FG002|Overall Study|Withdrawal by Subject|2|||
130234975|NCT00785629|468823950|FG003|Overall Study|Withdrawal by Subject|2|||
130234976|NCT00851591|468823951|FG000|Overall Study|Withdrawal by Subject|2|||
130234977|NCT00851591|468823952|FG001|Overall Study|Withdrawal by Subject|0|||
130234978|NCT02326883|468823954|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
130234979|NCT02326883|468823955|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
130234980|NCT02326883|468823956|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
130234981|NCT04154956|468823957|FG000|Overall Study|Death|109|||
130234982|NCT04154956|468823958|FG001|Overall Study|Death|110|||
130234983|NCT04154956|468823957|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130234984|NCT04154956|468823958|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
130234985|NCT04154956|468823957|FG000|Overall Study|Withdrawal by Subject|1|||
130234986|NCT04154956|468823958|FG001|Overall Study|Withdrawal by Subject|7|||
130234987|NCT04154956|468823957|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
130234988|NCT04154956|468823958|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
130234989|NCT01859741|468823959|FG000|Overall Study|Death|3|||
130234990|NCT01859741|468823960|FG001|Overall Study|Death|2|||
130234991|NCT01859741|468823961|FG002|Overall Study|Death|4|||
130234992|NCT01859741|468823962|FG003|Overall Study|Death|3|||
130234993|NCT01859741|468823963|FG004|Overall Study|Death|5|||
130234994|NCT01859741|468823964|FG005|Overall Study|Death|4|||
130234995|NCT01859741|468823965|FG006|Overall Study|Death|51|||
130234996|NCT01859741|468823966|FG007|Overall Study|Death|51|||
130234997|NCT01859741|468823959|FG000|Overall Study|Lost to Follow-up|0|||
130234998|NCT01859741|468823960|FG001|Overall Study|Lost to Follow-up|0|||
130234999|NCT01859741|468823961|FG002|Overall Study|Lost to Follow-up|0|||
130235000|NCT01859741|468823962|FG003|Overall Study|Lost to Follow-up|0|||
130235001|NCT01859741|468823963|FG004|Overall Study|Lost to Follow-up|0|||
130235002|NCT01859741|468823964|FG005|Overall Study|Lost to Follow-up|1|||
130235003|NCT01859741|468823965|FG006|Overall Study|Lost to Follow-up|0|||
130235004|NCT01859741|468823966|FG007|Overall Study|Lost to Follow-up|4|||
130235005|NCT01859741|468823959|FG000|Overall Study|Withdrawal by Subject|0|||
130235006|NCT01859741|468823960|FG001|Overall Study|Withdrawal by Subject|1|||
130235007|NCT01859741|468823961|FG002|Overall Study|Withdrawal by Subject|2|||
130235008|NCT01859741|468823962|FG003|Overall Study|Withdrawal by Subject|0|||
130235009|NCT01859741|468823963|FG004|Overall Study|Withdrawal by Subject|0|||
130235010|NCT01859741|468823964|FG005|Overall Study|Withdrawal by Subject|1|||
130235011|NCT01859741|468823965|FG006|Overall Study|Withdrawal by Subject|1|||
130235012|NCT01859741|468823966|FG007|Overall Study|Withdrawal by Subject|1|||
130235013|NCT01859741|468823959|FG000|Overall Study|Study Terminated by Sponsor|0|||
130235014|NCT01859741|468823960|FG001|Overall Study|Study Terminated by Sponsor|0|||
130235015|NCT01859741|468823961|FG002|Overall Study|Study Terminated by Sponsor|0|||
130235016|NCT01859741|468823962|FG003|Overall Study|Study Terminated by Sponsor|0|||
130235017|NCT01859741|468823963|FG004|Overall Study|Study Terminated by Sponsor|1|||
130235018|NCT01859741|468823964|FG005|Overall Study|Study Terminated by Sponsor|0|||
130235019|NCT01859741|468823965|FG006|Overall Study|Study Terminated by Sponsor|16|||
130235020|NCT01859741|468823966|FG007|Overall Study|Study Terminated by Sponsor|14|||
130235021|NCT01859741|468823959|FG000|Overall Study|Other|0|||
130235022|NCT01859741|468823960|FG001|Overall Study|Other|0|||
130235023|NCT01859741|468823961|FG002|Overall Study|Other|0|||
130235024|NCT01859741|468823962|FG003|Overall Study|Other|0|||
130235025|NCT01859741|468823963|FG004|Overall Study|Other|0|||
130235026|NCT01859741|468823964|FG005|Overall Study|Other|0|||
130235027|NCT01859741|468823965|FG006|Overall Study|Other|2|||
130235028|NCT01859741|468823966|FG007|Overall Study|Other|0|||
130235029|NCT02412657|468823970|FG000|Overall Study|Lost to Follow-up|1|||
130446732|NCT01021332|469597052|FG000|Overall Study|Lack of Efficacy|19|||
130446733|NCT01021332|469597052|FG000|Overall Study|Withdrawal of Consent|23|||
130446734|NCT01021332|469597052|FG000|Overall Study|Lost to Follow-up|4|||
130446735|NCT01021332|469597052|FG000|Overall Study|Protocol Violation|9|||
130446736|NCT01021332|469597052|FG000|Overall Study|Miscellaneous|3|||
130235030|NCT02412657|468823971|FG001|Overall Study|Lost to Follow-up|0|||
130235031|NCT02412657|468823972|FG002|Overall Study|Lost to Follow-up|0|||
130235032|NCT02412657|468823970|FG000|Overall Study|Protocol Violation|0|||
130235033|NCT02412657|468823971|FG001|Overall Study|Protocol Violation|2|||
130235034|NCT02412657|468823972|FG002|Overall Study|Protocol Violation|3|||
130235035|NCT03620162|468823976|FG000|Overall Study|Physician Decision|4|||
130235036|NCT03620162|468823977|FG001|Overall Study|Physician Decision|0|||
130235037|NCT03620162|468823978|FG002|Overall Study|Physician Decision|1|||
130235038|NCT03620162|468823979|FG003|Overall Study|Physician Decision|0|||
130235039|NCT03620162|468823980|FG004|Overall Study|Physician Decision|2|||
130235040|NCT03620162|468823976|FG000|Overall Study|Lost to Follow-up|2|||
130235041|NCT03620162|468823977|FG001|Overall Study|Lost to Follow-up|6|||
130235042|NCT03620162|468823978|FG002|Overall Study|Lost to Follow-up|7|||
130235043|NCT03620162|468823979|FG003|Overall Study|Lost to Follow-up|3|||
130235044|NCT03620162|468823980|FG004|Overall Study|Lost to Follow-up|2|||
130235045|NCT03620162|468823976|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
130235046|NCT03620162|468823977|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
130235047|NCT03620162|468823978|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
130235048|NCT03620162|468823979|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
130358537|NCT03387683|469284760|FG001|Overall Study|Did not receive treatment|0|||
130358538|NCT01954342|469284761|FG000|Overall Study|Missing data from 13-16week study visit|0|||
130358539|NCT01954342|469284762|FG001|Overall Study|Missing data from 13-16week study visit|0|||
130358540|NCT01954342|469284763|FG002|Overall Study|Missing data from 13-16week study visit|0|||
130358541|NCT01954342|469284764|FG003|Overall Study|Missing data from 13-16week study visit|1|||
130235049|NCT03620162|468823980|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
130235050|NCT01682031|468823983|FG000|Overall Study|Withdrawal by Subject|0|||
130235051|NCT01682031|468823984|FG001|Overall Study|Withdrawal by Subject|1|||
130235052|NCT01682031|468823983|FG000|Overall Study|Adverse Event|0|||
130235053|NCT01682031|468823984|FG001|Overall Study|Adverse Event|2|||
130235054|NCT01682031|468823983|FG000|Overall Study|MRI results indicate increased nodul|0|||
130235055|NCT01682031|468823984|FG001|Overall Study|MRI results indicate increased nodul|1|||
130358542|NCT01954342|469284761|FG000|Overall Study|Miscarriage|0|||
130358543|NCT01954342|469284762|FG001|Overall Study|Miscarriage|0|||
130235056|NCT01682031|468823983|FG000|Overall Study|Patient could not swallow tablets|1|||
130235057|NCT01682031|468823984|FG001|Overall Study|Patient could not swallow tablets|0|||
130235058|NCT01682031|468823983|FG000|Overall Study|Patient stopped selenium on his own|0|||
130235059|NCT01682031|468823984|FG001|Overall Study|Patient stopped selenium on his own|1|||
130235060|NCT01056536|468823986|FG000|Overall Study|Lost to Follow-up|202|||
130235061|NCT01056536|468823987|FG001|Overall Study|Lost to Follow-up|116|||
130235062|NCT01056536|468823988|FG002|Overall Study|Lost to Follow-up|248|||
130235063|NCT02763566|468823989|FG000|Overall Study|Lost to Follow-up|1|||
130235064|NCT02763566|468823990|FG001|Overall Study|Lost to Follow-up|4|||
130235065|NCT02763566|468823991|FG002|Overall Study|Lost to Follow-up|0|||
130235066|NCT02763566|468823992|FG003|Overall Study|Lost to Follow-up|1|||
130235067|NCT02763566|468823989|FG000|Overall Study|On study treatment at study conclusion|114|||
130235068|NCT02763566|468823990|FG001|Overall Study|On study treatment at study conclusion|34|||
130235069|NCT02763566|468823991|FG002|Overall Study|On study treatment at study conclusion|54|||
130358544|NCT01954342|469284763|FG002|Overall Study|Miscarriage|0|||
130235070|NCT02763566|468823992|FG003|Overall Study|On study treatment at study conclusion|13|||
130235071|NCT02763566|468823989|FG000|Overall Study|Withdrawal by Subject|3|||
130235072|NCT02763566|468823990|FG001|Overall Study|Withdrawal by Subject|1|||
130235073|NCT02763566|468823991|FG002|Overall Study|Withdrawal by Subject|0|||
130235074|NCT02763566|468823992|FG003|Overall Study|Withdrawal by Subject|0|||
130358545|NCT01954342|469284764|FG003|Overall Study|Miscarriage|3|||
130358546|NCT01954342|469284761|FG000|Overall Study|Lost to Follow-up|0|||
130358547|NCT01954342|469284762|FG001|Overall Study|Lost to Follow-up|0|||
130358548|NCT01954342|469284763|FG002|Overall Study|Lost to Follow-up|0|||
130358549|NCT01954342|469284764|FG003|Overall Study|Lost to Follow-up|5|||
130358550|NCT01954342|469284761|FG000|Overall Study|Preterm delivery|0|||
130358551|NCT01954342|469284762|FG001|Overall Study|Preterm delivery|0|||
130358552|NCT01954342|469284763|FG002|Overall Study|Preterm delivery|0|||
130358553|NCT01954342|469284764|FG003|Overall Study|Preterm delivery|3|||
130358554|NCT01954342|469284761|FG000|Overall Study|Pre-eclampsia|0|||
130358555|NCT01954342|469284762|FG001|Overall Study|Pre-eclampsia|0|||
130358556|NCT01954342|469284763|FG002|Overall Study|Pre-eclampsia|0|||
130358557|NCT01954342|469284764|FG003|Overall Study|Pre-eclampsia|4|||
130358558|NCT01954342|469284761|FG000|Overall Study|Unreliable Data|0|||
130358559|NCT01954342|469284762|FG001|Overall Study|Unreliable Data|0|||
130358560|NCT01954342|469284763|FG002|Overall Study|Unreliable Data|0|||
130358561|NCT01954342|469284764|FG003|Overall Study|Unreliable Data|2|||
130358562|NCT01646073|469284765|FG000|Period A (12 Weeks)|Adverse Event|0|||
130358563|NCT01646073|469284766|FG001|Period A (12 Weeks)|Adverse Event|2|||
130358564|NCT01646073|469284765|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
130358565|NCT01646073|469284766|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
130358566|NCT01646073|469284765|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
130358567|NCT01646073|469284766|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
130358568|NCT01646073|469284765|FG000|Period A (12 Weeks)|Protocol Violation|0|||
130358569|NCT01646073|469284766|FG001|Period A (12 Weeks)|Protocol Violation|1|||
130358570|NCT01646073|469284765|FG000|Period A (12 Weeks)|Other|0|||
130358571|NCT01646073|469284766|FG001|Period A (12 Weeks)|Other|1|||
130358572|NCT01646073|469284765|FG000|Period B (12 Weeks)|Adverse Event|0|||
130358573|NCT01646073|469284766|FG001|Period B (12 Weeks)|Adverse Event|7|||
130358574|NCT01646073|469284765|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
130358575|NCT01646073|469284766|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
130358576|NCT01646073|469284765|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
130358577|NCT01646073|469284766|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
130358578|NCT02410551|469284770|FG000|Overall Study|Adverse Event|1|||
130358579|NCT02410551|469284770|FG000|Overall Study|Withdrawal by Subject|1|||
130358580|NCT02410551|469284770|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
130358581|NCT01739309|469284771|FG000|Overall Study|Adverse Event|1|||
130358582|NCT01739309|469284771|FG000|Overall Study|Withdrawal by Subject|1|||
130358583|NCT01495975|469284772|FG000|Overall Study|Lost to Follow-up|1|||
130358584|NCT01495975|469284773|FG001|Overall Study|Lost to Follow-up|0|||
130358585|NCT05447897|469284776|FG000|Overall Study|Did not participate in survey|2|||
130358586|NCT02083081|469284777|FG000|Overall Study|Lost to Follow-up|31|||
130235075|NCT00315445|468823993|FG000|Overall Study|Adverse Event|7|||
130235076|NCT00315445|468823994|FG001|Overall Study|Adverse Event|12|||
130235077|NCT00315445|468823995|FG002|Overall Study|Adverse Event|15|||
130235078|NCT00315445|468823993|FG000|Overall Study|Lack of Efficacy|16|||
130235079|NCT00315445|468823994|FG001|Overall Study|Lack of Efficacy|1|||
130235080|NCT00315445|468823995|FG002|Overall Study|Lack of Efficacy|7|||
130235081|NCT00315445|468823993|FG000|Overall Study|Lost to Follow-up|1|||
130235082|NCT00315445|468823994|FG001|Overall Study|Lost to Follow-up|0|||
130235083|NCT00315445|468823995|FG002|Overall Study|Lost to Follow-up|1|||
130235084|NCT00315445|468823993|FG000|Overall Study|Protocol Violation|2|||
130235085|NCT00315445|468823994|FG001|Overall Study|Protocol Violation|0|||
130235086|NCT00315445|468823995|FG002|Overall Study|Protocol Violation|1|||
130235087|NCT00315445|468823993|FG000|Overall Study|Other|1|||
130235088|NCT00315445|468823994|FG001|Overall Study|Other|3|||
130235089|NCT00315445|468823995|FG002|Overall Study|Other|0|||
130235090|NCT01101178|468823998|FG000|Period 1|Withdrawal by Subject|1|||
130235091|NCT01101178|468823999|FG001|Period 1|Withdrawal by Subject|2|||
130235092|NCT01101178|468823998|FG000|Period 1|Positive drug screen|1|||
130235093|NCT01101178|468823999|FG001|Period 1|Positive drug screen|1|||
130235094|NCT01101178|468823998|FG000|Period 1|Adverse Event|2|||
130235095|NCT01101178|468823999|FG001|Period 1|Adverse Event|1|||
130235096|NCT01101178|468823998|FG000|Period 2|Withdrawal by Subject|0|||
130235097|NCT01101178|468823999|FG001|Period 2|Withdrawal by Subject|1|||
130235098|NCT01850641|468824000|FG000|Overall Study|Physician Decision|1|||
130235099|NCT01850641|468824000|FG000|Overall Study|Decrease in serum phosphorus|1|||
130235100|NCT01850641|468824000|FG000|Overall Study|Decrease in serum calcium|2|||
130235101|NCT01850641|468824000|FG000|Overall Study|Increase in serum ferritin|1|||
130235102|NCT00141817|468824001|FG000|Overall Study|Protocol Violation|0|||
130235103|NCT00141817|468824002|FG001|Overall Study|Protocol Violation|0|||
130235104|NCT00141817|468824003|FG002|Overall Study|Protocol Violation|1|||
130235105|NCT00141817|468824004|FG003|Overall Study|Protocol Violation|0|||
130235106|NCT00141817|468824001|FG000|Overall Study|Parent request|1|||
130235107|NCT00141817|468824002|FG001|Overall Study|Parent request|0|||
130235108|NCT00141817|468824003|FG002|Overall Study|Parent request|0|||
130235109|NCT00141817|468824004|FG003|Overall Study|Parent request|0|||
130235110|NCT00846365|468824011|FG000|Overall Study|Adverse Event|20|||
130235111|NCT00846365|468824012|FG001|Overall Study|Adverse Event|30|||
130235112|NCT00846365|468824013|FG002|Overall Study|Adverse Event|11|||
130235113|NCT00846365|468824011|FG000|Overall Study|Protocol Violation|5|||
130235114|NCT00846365|468824012|FG001|Overall Study|Protocol Violation|4|||
130235115|NCT00846365|468824013|FG002|Overall Study|Protocol Violation|0|||
130235116|NCT00846365|468824011|FG000|Overall Study|Lost to Follow-up|8|||
130235117|NCT00846365|468824012|FG001|Overall Study|Lost to Follow-up|2|||
130235118|NCT00846365|468824013|FG002|Overall Study|Lost to Follow-up|5|||
130235119|NCT00846365|468824011|FG000|Overall Study|Withdrawal by Subject|11|||
130235120|NCT00846365|468824012|FG001|Overall Study|Withdrawal by Subject|11|||
130235121|NCT00846365|468824013|FG002|Overall Study|Withdrawal by Subject|9|||
130235122|NCT00846365|468824011|FG000|Overall Study|Pregnancy|1|||
130694641|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694642|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
130694643|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694644|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694645|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130235123|NCT00846365|468824012|FG001|Overall Study|Pregnancy|0|||
130235124|NCT00846365|468824013|FG002|Overall Study|Pregnancy|0|||
130235125|NCT00846365|468824011|FG000|Overall Study|Lack of Efficacy|1|||
130235126|NCT00846365|468824012|FG001|Overall Study|Lack of Efficacy|1|||
130235127|NCT00846365|468824013|FG002|Overall Study|Lack of Efficacy|2|||
130235128|NCT00846365|468824011|FG000|Overall Study|Other|9|||
130358587|NCT02083081|469284778|FG001|Overall Study|Lost to Follow-up|9|||
130358588|NCT01104155|469284779|FG000|Overall Study|Adverse Event|15|||
130358589|NCT01104155|469284780|FG001|Overall Study|Adverse Event|8|||
130358590|NCT01104155|469284779|FG000|Overall Study|Participant choice|6|||
130358591|NCT01104155|469284780|FG001|Overall Study|Participant choice|5|||
130358592|NCT01104155|469284779|FG000|Overall Study|Withdrawal of consent|1|||
130358593|NCT01104155|469284780|FG001|Overall Study|Withdrawal of consent|1|||
130235129|NCT00846365|468824012|FG001|Overall Study|Other|1|||
130235130|NCT00846365|468824013|FG002|Overall Study|Other|6|||
130235131|NCT03479905|468824014|FG000|Overall Study|Other airway method used|4|||
130235132|NCT03479905|468824015|FG001|Overall Study|Other airway method used|5|||
130235133|NCT03479905|468824016|FG002|Overall Study|Other airway method used|5|||
130235134|NCT00862992|468824017|FG000|Overall Study|Adverse Event|2|||
130235135|NCT00862992|468824018|FG001|Overall Study|Adverse Event|1|||
130358594|NCT01104155|469284779|FG000|Overall Study|Other|3|||
130694646|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130235136|NCT00862992|468824019|FG002|Overall Study|Adverse Event|1|||
130235137|NCT00862992|468824017|FG000|Overall Study|Physician Decision|1|||
130235138|NCT00862992|468824018|FG001|Overall Study|Physician Decision|0|||
130235139|NCT00862992|468824019|FG002|Overall Study|Physician Decision|0|||
130235140|NCT00862992|468824017|FG000|Overall Study|Withdrawal by Subject|0|||
130235141|NCT00862992|468824018|FG001|Overall Study|Withdrawal by Subject|0|||
130235142|NCT00862992|468824019|FG002|Overall Study|Withdrawal by Subject|2|||
130235143|NCT00720759|468824020|FG000|Overall Study|Lost to Follow-up|0|||
130235144|NCT00720759|468824021|FG001|Overall Study|Lost to Follow-up|1|||
130235145|NCT00720759|468824022|FG002|Overall Study|Lost to Follow-up|1|||
130235146|NCT00720759|468824023|FG003|Overall Study|Lost to Follow-up|0|||
130235147|NCT02318940|468824024|FG000|Overall Study|lost the record|1|||
130235148|NCT02318940|468824025|FG001|Overall Study|lost the record|0|||
130235149|NCT01047319|468824026|FG000|Overall Study|Teva requested participant withdrawal|3|||
130235150|NCT01047319|468824027|FG001|Overall Study|Teva requested participant withdrawal|0|||
130235151|NCT01047319|468824028|FG002|Overall Study|Teva requested participant withdrawal|1|||
130235152|NCT01047319|468824026|FG000|Overall Study|Protocol Violation|3|||
130235153|NCT01047319|468824027|FG001|Overall Study|Protocol Violation|2|||
130235154|NCT01047319|468824028|FG002|Overall Study|Protocol Violation|4|||
130235155|NCT01047319|468824026|FG000|Overall Study|Lack of Efficacy|4|||
130235156|NCT01047319|468824027|FG001|Overall Study|Lack of Efficacy|3|||
130235157|NCT01047319|468824028|FG002|Overall Study|Lack of Efficacy|3|||
130235158|NCT01047319|468824026|FG000|Overall Study|Death|5|||
130235159|NCT01047319|468824027|FG001|Overall Study|Death|1|||
130235160|NCT01047319|468824028|FG002|Overall Study|Death|5|||
130235161|NCT01047319|468824026|FG000|Overall Study|Pregnancy|13|||
130235162|NCT01047319|468824027|FG001|Overall Study|Pregnancy|8|||
130235163|NCT01047319|468824028|FG002|Overall Study|Pregnancy|8|||
130235164|NCT01047319|468824026|FG000|Overall Study|Physician Decision|12|||
130235165|NCT01047319|468824027|FG001|Overall Study|Physician Decision|9|||
130235166|NCT01047319|468824028|FG002|Overall Study|Physician Decision|10|||
130235167|NCT01047319|468824026|FG000|Overall Study|Lost to Follow-up|14|||
130235168|NCT01047319|468824027|FG001|Overall Study|Lost to Follow-up|10|||
130235169|NCT01047319|468824028|FG002|Overall Study|Lost to Follow-up|10|||
130235170|NCT01047319|468824026|FG000|Overall Study|Adverse Event|16|||
130235171|NCT01047319|468824027|FG001|Overall Study|Adverse Event|27|||
130235172|NCT01047319|468824028|FG002|Overall Study|Adverse Event|21|||
130235173|NCT01047319|468824026|FG000|Overall Study|Withdrawal by Subject|77|||
130235174|NCT01047319|468824027|FG001|Overall Study|Withdrawal by Subject|75|||
130446737|NCT03487666|469597055|FG000|Overall Study|Disease progression|4|||
130446738|NCT03487666|469597056|FG001|Overall Study|Disease progression|2|||
130446739|NCT03487666|469597057|FG002|Overall Study|Disease progression|0|||
130446740|NCT03487666|469597055|FG000|Overall Study|Adverse Event|0|||
130446741|NCT03487666|469597056|FG001|Overall Study|Adverse Event|0|||
130446742|NCT03487666|469597057|FG002|Overall Study|Adverse Event|1|||
130694647|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694648|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694649|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694650|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694651|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130446743|NCT05343455|469597060|FG000|Overall Study|Withdrawal by Subject|4|||
130446744|NCT05343455|469597061|FG001|Overall Study|Withdrawal by Subject|9|||
130446745|NCT05343455|469597062|FG002|Overall Study|Withdrawal by Subject|7|||
130446746|NCT05343455|469597060|FG000|Overall Study|Adverse Event|2|||
130446747|NCT05343455|469597061|FG001|Overall Study|Adverse Event|1|||
130446748|NCT05343455|469597062|FG002|Overall Study|Adverse Event|2|||
130446749|NCT05343455|469597060|FG000|Overall Study|Lost to Follow-up|1|||
130446750|NCT05343455|469597061|FG001|Overall Study|Lost to Follow-up|1|||
130446751|NCT05343455|469597062|FG002|Overall Study|Lost to Follow-up|3|||
130446752|NCT05343455|469597060|FG000|Overall Study|Pregnancy|1|||
130446753|NCT05343455|469597061|FG001|Overall Study|Pregnancy|0|||
130446754|NCT05343455|469597062|FG002|Overall Study|Pregnancy|0|||
130446755|NCT05343455|469597060|FG000|Overall Study|Physician Decision|0|||
130446756|NCT05343455|469597061|FG001|Overall Study|Physician Decision|0|||
130446757|NCT05343455|469597062|FG002|Overall Study|Physician Decision|1|||
130446758|NCT05343455|469597060|FG000|Overall Study|Protocol Violation|0|||
130694652|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130552924|NCT02520284|469991629|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
130235175|NCT01047319|468824028|FG002|Overall Study|Withdrawal by Subject|87|||
130235176|NCT01047319|468824026|FG000|Overall Study|Study terminated by Sponsor|198|||
130235177|NCT01047319|468824027|FG001|Overall Study|Study terminated by Sponsor|215|||
130235178|NCT01047319|468824028|FG002|Overall Study|Study terminated by Sponsor|203|||
130235179|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
130235180|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
130446759|NCT05343455|469597061|FG001|Overall Study|Protocol Violation|1|||
130446760|NCT05343455|469597062|FG002|Overall Study|Protocol Violation|1|||
130694653|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130235181|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
130235182|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Death|0|||
130235183|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Death|0|||
130235184|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Death|1|||
130235185|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
130235186|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130235187|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130235188|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130235189|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
130235190|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130235191|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
130235192|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
130235193|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
130235194|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
130235195|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
130235196|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
130235197|NCT02696798|468824031|FG000|Extended Treatment Period|Adverse Event|1|||
130235198|NCT02696798|468824032|FG001|Extended Treatment Period|Adverse Event|4|||
130235199|NCT02696798|468824033|FG002|Extended Treatment Period|Adverse Event|5|||
130235200|NCT02696798|468824031|FG000|Extended Treatment Period|Lack of Efficacy|7|||
130235201|NCT02696798|468824032|FG001|Extended Treatment Period|Lack of Efficacy|2|||
130235202|NCT02696798|468824033|FG002|Extended Treatment Period|Lack of Efficacy|2|||
130235203|NCT02696798|468824031|FG000|Extended Treatment Period|Lost to Follow-up|1|||
130235204|NCT02696798|468824032|FG001|Extended Treatment Period|Lost to Follow-up|0|||
130235205|NCT02696798|468824033|FG002|Extended Treatment Period|Lost to Follow-up|0|||
130235206|NCT02696798|468824031|FG000|Extended Treatment Period|Physician Decision|0|||
130235207|NCT02696798|468824032|FG001|Extended Treatment Period|Physician Decision|1|||
130235208|NCT02696798|468824033|FG002|Extended Treatment Period|Physician Decision|0|||
130235209|NCT02696798|468824031|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
130235210|NCT02696798|468824032|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
130235211|NCT02696798|468824033|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
130235212|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
130235213|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
130235214|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
130235215|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
130235216|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130235217|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130235218|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
130235219|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
130235220|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
130235221|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
130235222|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
130235223|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
130235224|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
130235225|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
130235226|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
130235227|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
130235228|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
130235229|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
130235230|NCT01277861|468824034|FG000|Overall Study|Physician Decision|2|||
130235231|NCT01277861|468824035|FG001|Overall Study|Physician Decision|2|||
130235232|NCT00857389|468824036|FG000|Overall Study|Did not proceed to transplant|2|||
130235233|NCT01157845|468824037|FG000|Overall Study|Lost to Follow-up|5|||
130358595|NCT01104155|469284780|FG001|Overall Study|Other|4|||
130358596|NCT01484132|469284786|FG000|Overall Study|Lost to Follow-up|8|||
130358597|NCT01484132|469284786|FG000|Overall Study|Difficulty with time commitment|2|||
130358598|NCT01484132|469284786|FG000|Overall Study|Ineligible|1|||
130358599|NCT01484132|469284786|FG000|Overall Study|No pre-treatment urine sample collected|1|||
130358600|NCT01484132|469284786|FG000|Overall Study|No post-treatment urine sample collected|10|||
130358601|NCT01934972|469284787|FG000|Overall Study|Withdrawal by Subject|9|||
130358602|NCT01934972|469284788|FG001|Overall Study|Withdrawal by Subject|6|||
130358603|NCT03131453|469284789|FG000|Overall Study|Study terminated by Sponsor|424|||
130358604|NCT03131453|469284790|FG001|Overall Study|Study terminated by Sponsor|222|||
130358605|NCT03131453|469284791|FG002|Overall Study|Study terminated by Sponsor|438|||
130358606|NCT03131453|469284789|FG000|Overall Study|Withdrawal by Subject|18|||
130358607|NCT03131453|469284790|FG001|Overall Study|Withdrawal by Subject|7|||
130235234|NCT01157845|468824037|FG000|Overall Study|Withdrawal by Subject|12|||
130235235|NCT01157845|468824037|FG000|Overall Study|Physician Decision|3|||
130235236|NCT01157845|468824037|FG000|Overall Study|Protocol Violation|13|||
130235237|NCT01157845|468824037|FG000|Overall Study|Study was ended|1|||
130235238|NCT01157845|468824037|FG000|Overall Study|Device malfunction|1|||
130358608|NCT03131453|469284791|FG002|Overall Study|Withdrawal by Subject|13|||
130358609|NCT03131453|469284789|FG000|Overall Study|Adverse Event|10|||
130235239|NCT03311555|468824038|FG000|Overall Study|Adverse Event|1|||
130235240|NCT04530630|468825679|FG000|Overall Study|Physician Decision|1|||
130235241|NCT03675308|468825682|FG000|Overall Study|Adverse Event|3|||
130235242|NCT03675308|468825683|FG001|Overall Study|Adverse Event|2|||
130235243|NCT03675308|468825682|FG000|Overall Study|Withdrawal by Subject|6|||
130235244|NCT03675308|468825683|FG001|Overall Study|Withdrawal by Subject|4|||
130235245|NCT03675308|468825682|FG000|Overall Study|Lost to Follow-up|3|||
130235246|NCT03675308|468825683|FG001|Overall Study|Lost to Follow-up|0|||
130235247|NCT03675308|468825682|FG000|Overall Study|Lack of Efficacy|1|||
130235248|NCT03675308|468825683|FG001|Overall Study|Lack of Efficacy|1|||
130235249|NCT03675308|468825682|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
130235250|NCT03675308|468825683|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
130235251|NCT03675308|468825682|FG000|Overall Study|Other|0|||
130235252|NCT03675308|468825683|FG001|Overall Study|Other|1|||
130235253|NCT00788671|468825687|FG000|Overall Study|Death|2|||
130235254|NCT00788671|468825687|FG000|Overall Study|Unable to biopsy|1|||
130235255|NCT00788671|468825687|FG000|Overall Study|Withdrawal by Subject|4|||
130235256|NCT00788671|468825687|FG000|Overall Study|IUD expulsed|1|||
130235257|NCT00788671|468825687|FG000|Overall Study|Lost to follow up|2|||
130235258|NCT05172609|468825688|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
130235259|NCT05172609|468825689|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
130235260|NCT05172609|468825688|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
130235261|NCT05172609|468825689|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
130235262|NCT05172609|468825688|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
130235263|NCT05172609|468825689|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
130235264|NCT04476043|468825692|FG000|Overall Study|Withdrawal by Subject|1|||
130235265|NCT04476043|468825693|FG001|Overall Study|Withdrawal by Subject|3|||
130235266|NCT04476043|468825694|FG002|Overall Study|Withdrawal by Subject|4|||
130235267|NCT04476043|468825695|FG003|Overall Study|Withdrawal by Subject|1|||
130235268|NCT04476043|468825692|FG000|Overall Study|Lost to Follow-up|1|||
130235269|NCT04476043|468825693|FG001|Overall Study|Lost to Follow-up|1|||
130235270|NCT04476043|468825694|FG002|Overall Study|Lost to Follow-up|2|||
130235271|NCT04476043|468825695|FG003|Overall Study|Lost to Follow-up|1|||
130235272|NCT04476043|468825692|FG000|Overall Study|Adverse Event|2|||
130235273|NCT04476043|468825693|FG001|Overall Study|Adverse Event|0|||
130235274|NCT04476043|468825694|FG002|Overall Study|Adverse Event|1|||
130235275|NCT04476043|468825695|FG003|Overall Study|Adverse Event|0|||
130235276|NCT04476043|468825692|FG000|Overall Study|Protocol Violation|0|||
130235277|NCT04476043|468825693|FG001|Overall Study|Protocol Violation|1|||
130235278|NCT04476043|468825694|FG002|Overall Study|Protocol Violation|0|||
130235279|NCT04476043|468825695|FG003|Overall Study|Protocol Violation|0|||
130235280|NCT06217380|468825696|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
130235281|NCT06217380|468825696|FG000|Overall Study|Physician Decision|1|||
130235282|NCT06217380|468825696|FG000|Overall Study|Withdrawal by Subject|2|||
130235283|NCT06633965|468825697|FG000|Overall Study|Withdrawal by Subject|0|||
130235284|NCT06633965|468825698|FG001|Overall Study|Withdrawal by Subject|1|||
130235285|NCT01963611|468825705|FG000|Overall Study|Adverse Event|1|||
130235286|NCT01963611|468825706|FG001|Overall Study|Adverse Event|1|||
130235287|NCT01963611|468825707|FG002|Overall Study|Adverse Event|3|||
130235288|NCT01963611|468825708|FG003|Overall Study|Adverse Event|4|||
130235289|NCT01963611|468825709|FG004|Overall Study|Adverse Event|3|||
130235290|NCT01963611|468825705|FG000|Overall Study|Protocol Violation|0|||
130235291|NCT01963611|468825706|FG001|Overall Study|Protocol Violation|0|||
130235292|NCT01963611|468825707|FG002|Overall Study|Protocol Violation|0|||
130235293|NCT01963611|468825708|FG003|Overall Study|Protocol Violation|1|||
130235294|NCT01963611|468825709|FG004|Overall Study|Protocol Violation|0|||
130235295|NCT01963611|468825705|FG000|Overall Study|Lack of Efficacy|0|||
130446761|NCT02748512|469597067|FG000|Overall Study|Lost to Follow-up|1|||
130446762|NCT02748512|469597068|FG001|Overall Study|Lost to Follow-up|1|||
130446763|NCT03930186|469597070|FG000|Weeks 0 to 16|Adverse Event|6|||
130446764|NCT03930186|469597070|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
130446765|NCT03930186|469597070|FG000|Weeks 16 to 32|Adverse Event|1|||
130446766|NCT03930186|469597070|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
130446767|NCT02264574|469597073|FG000|Overall Study|Death|21|||
130446768|NCT02264574|469597074|FG001|Overall Study|Death|21|||
130235296|NCT01963611|468825706|FG001|Overall Study|Lack of Efficacy|0|||
130235297|NCT01963611|468825707|FG002|Overall Study|Lack of Efficacy|0|||
130235298|NCT01963611|468825708|FG003|Overall Study|Lack of Efficacy|1|||
130235299|NCT01963611|468825709|FG004|Overall Study|Lack of Efficacy|0|||
130235300|NCT01963611|468825705|FG000|Overall Study|Withdrawal by Subject|3|||
130235301|NCT01963611|468825706|FG001|Overall Study|Withdrawal by Subject|2|||
130235302|NCT01963611|468825707|FG002|Overall Study|Withdrawal by Subject|1|||
130235303|NCT01963611|468825708|FG003|Overall Study|Withdrawal by Subject|1|||
130446769|NCT02264574|469597073|FG000|Overall Study|Withdrawal by Subject|8|||
130446770|NCT02264574|469597074|FG001|Overall Study|Withdrawal by Subject|6|||
130446771|NCT02264574|469597073|FG000|Overall Study|Other, Not Specified|0|||
130235304|NCT01963611|468825709|FG004|Overall Study|Withdrawal by Subject|3|||
130235305|NCT01963611|468825705|FG000|Overall Study|Other|47|||
130235306|NCT01963611|468825706|FG001|Overall Study|Other|46|||
130235307|NCT01963611|468825707|FG002|Overall Study|Other|48|||
130235308|NCT01963611|468825708|FG003|Overall Study|Other|45|||
130235309|NCT01963611|468825709|FG004|Overall Study|Other|45|||
130235310|NCT01126424|468825710|FG000|Overall Study|Adverse Event|0|||
130235311|NCT01126424|468825711|FG001|Overall Study|Adverse Event|0|||
130235312|NCT01126424|468825712|FG002|Overall Study|Adverse Event|0|||
130235313|NCT01126424|468825713|FG003|Overall Study|Adverse Event|0|||
130235314|NCT01126424|468825714|FG004|Overall Study|Adverse Event|1|||
130235315|NCT01126424|468825715|FG005|Overall Study|Adverse Event|0|||
130235316|NCT01126424|468825710|FG000|Overall Study|Withdrawal by Subject|0|||
130235317|NCT01126424|468825711|FG001|Overall Study|Withdrawal by Subject|0|||
130235318|NCT01126424|468825712|FG002|Overall Study|Withdrawal by Subject|1|||
130235319|NCT01126424|468825713|FG003|Overall Study|Withdrawal by Subject|3|||
130235320|NCT01126424|468825714|FG004|Overall Study|Withdrawal by Subject|1|||
130235321|NCT01126424|468825715|FG005|Overall Study|Withdrawal by Subject|0|||
130235322|NCT03801252|468825717|FG000|Overall Study|Protocol Violation|1|||
130235323|NCT03801252|468825718|FG001|Overall Study|Protocol Violation|2|||
130235324|NCT01134042|468825719|FG000|Overall Study|Adverse Event|3|||
130235325|NCT01134042|468825720|FG001|Overall Study|Adverse Event|7|||
130235326|NCT01134042|468825721|FG002|Overall Study|Adverse Event|2|||
130235327|NCT01134042|468825719|FG000|Overall Study|Lack of Efficacy|21|||
130235328|NCT01134042|468825720|FG001|Overall Study|Lack of Efficacy|6|||
130235329|NCT01134042|468825721|FG002|Overall Study|Lack of Efficacy|18|||
130235330|NCT01134042|468825719|FG000|Overall Study|Protocol Violation|5|||
130235331|NCT01134042|468825720|FG001|Overall Study|Protocol Violation|3|||
130235332|NCT01134042|468825721|FG002|Overall Study|Protocol Violation|5|||
130235333|NCT01134042|468825719|FG000|Overall Study|Lost to Follow-up|2|||
130235334|NCT01134042|468825720|FG001|Overall Study|Lost to Follow-up|0|||
130235335|NCT01134042|468825721|FG002|Overall Study|Lost to Follow-up|1|||
130235336|NCT01134042|468825719|FG000|Overall Study|Physician Decision|4|||
130235337|NCT01134042|468825720|FG001|Overall Study|Physician Decision|8|||
130235338|NCT01134042|468825721|FG002|Overall Study|Physician Decision|1|||
130235339|NCT01134042|468825719|FG000|Overall Study|Withdrawal by Subject|13|||
130235340|NCT01134042|468825720|FG001|Overall Study|Withdrawal by Subject|4|||
130235341|NCT01134042|468825721|FG002|Overall Study|Withdrawal by Subject|7|||
130235342|NCT02328105|468825722|FG000|Overall Study|Death|6|||
130235343|NCT02328105|468825722|FG000|Overall Study|Withdrawal by Subject|1|||
130235344|NCT02328105|468825722|FG000|Overall Study|Still On Study in Follow-Up|4|||
130235345|NCT01588509|468825726|FG000|Overall Study|Lost to Follow-up|1|||
130235346|NCT01588509|468825727|FG001|Overall Study|Lost to Follow-up|0|||
130235347|NCT01983930|468825728|FG000|Overall Study|Withdrawal by Subject|9|||
130235348|NCT01983930|468825729|FG001|Overall Study|Withdrawal by Subject|8|||
130235349|NCT01983930|468825728|FG000|Overall Study|Adverse Event|0|||
130235350|NCT01983930|468825729|FG001|Overall Study|Adverse Event|1|||
130235351|NCT00393367|468825730|FG000|Overall Study|Protocol Violation|2|||
130235352|NCT00393367|468825731|FG001|Overall Study|Protocol Violation|5|||
130235353|NCT00393367|468825730|FG000|Overall Study|Withdrawal by Subject|0|||
130235354|NCT00393367|468825731|FG001|Overall Study|Withdrawal by Subject|2|||
130235355|NCT03286504|468825732|FG000|Overall Study|Lost to Follow-up|19|||
130358610|NCT03131453|469284790|FG001|Overall Study|Adverse Event|3|||
130358611|NCT03131453|469284791|FG002|Overall Study|Adverse Event|3|||
130358612|NCT03131453|469284789|FG000|Overall Study|Lost to Follow-up|1|||
130358613|NCT03131453|469284790|FG001|Overall Study|Lost to Follow-up|0|||
130358614|NCT03131453|469284791|FG002|Overall Study|Lost to Follow-up|1|||
130358615|NCT03131453|469284789|FG000|Overall Study|Physician Decision|1|||
130358616|NCT03131453|469284790|FG001|Overall Study|Physician Decision|0|||
130358617|NCT03131453|469284791|FG002|Overall Study|Physician Decision|1|||
130358618|NCT03131453|469284789|FG000|Overall Study|Non-compliance with study treatment|1|||
130235356|NCT03286504|468825733|FG001|Overall Study|Lost to Follow-up|16|||
130235357|NCT01432327|468825734|FG000|Posttest 3 Months|depression|3|||
130235358|NCT01432327|468825735|FG001|Posttest 3 Months|depression|0|||
130235359|NCT01432327|468825736|FG002|Posttest 3 Months|depression|0|||
130235360|NCT01432327|468825737|FG003|Posttest 3 Months|depression|0|||
130235361|NCT01432327|468825734|FG000|Posttest 3 Months|Lost to Follow-up|1|||
130235362|NCT01432327|468825735|FG001|Posttest 3 Months|Lost to Follow-up|0|||
130235363|NCT01432327|468825736|FG002|Posttest 3 Months|Lost to Follow-up|2|||
130235364|NCT01432327|468825737|FG003|Posttest 3 Months|Lost to Follow-up|1|||
130235365|NCT01432327|468825734|FG000|Posttest 3 Months|Allergic reaction|0|||
130235366|NCT01432327|468825735|FG001|Posttest 3 Months|Allergic reaction|2|||
130235367|NCT01432327|468825736|FG002|Posttest 3 Months|Allergic reaction|0|||
130235368|NCT01432327|468825737|FG003|Posttest 3 Months|Allergic reaction|0|||
130235369|NCT01432327|468825734|FG000|Posttest 6 Months|Lost to Follow-up|0|||
130235370|NCT01432327|468825735|FG001|Posttest 6 Months|Lost to Follow-up|0|||
130235371|NCT01432327|468825736|FG002|Posttest 6 Months|Lost to Follow-up|3|||
130358619|NCT03131453|469284790|FG001|Overall Study|Non-compliance with study treatment|0|||
130358620|NCT03131453|469284791|FG002|Overall Study|Non-compliance with study treatment|0|||
130235372|NCT01432327|468825737|FG003|Posttest 6 Months|Lost to Follow-up|2|||
130235373|NCT01432327|468825734|FG000|Posttest 6 Months|Allergic reaction|0|||
130235374|NCT01432327|468825735|FG001|Posttest 6 Months|Allergic reaction|0|||
130235375|NCT01432327|468825736|FG002|Posttest 6 Months|Allergic reaction|1|||
130235376|NCT01432327|468825737|FG003|Posttest 6 Months|Allergic reaction|0|||
130235377|NCT01432327|468825734|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
130235378|NCT01432327|468825735|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
130235379|NCT01432327|468825736|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
130235380|NCT01432327|468825737|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
130235381|NCT01432327|468825734|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
130235382|NCT01432327|468825735|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
130235383|NCT01432327|468825736|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
130235384|NCT01432327|468825737|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
130235385|NCT01432327|468825734|FG000|Posttest 1 Year|Lost to Follow-up|0|||
130235386|NCT01432327|468825735|FG001|Posttest 1 Year|Lost to Follow-up|0|||
130235387|NCT01432327|468825736|FG002|Posttest 1 Year|Lost to Follow-up|4|||
130235388|NCT01432327|468825737|FG003|Posttest 1 Year|Lost to Follow-up|2|||
130235389|NCT01432327|468825734|FG000|Posttest 1 Year|Allergic reaction|0|||
130235390|NCT01432327|468825735|FG001|Posttest 1 Year|Allergic reaction|0|||
130235391|NCT01432327|468825736|FG002|Posttest 1 Year|Allergic reaction|1|||
130235392|NCT01432327|468825737|FG003|Posttest 1 Year|Allergic reaction|1|||
130235393|NCT00141921|468825740|FG000|Overall Study|Remain on Study|28|||
130235394|NCT00141921|468825740|FG000|Overall Study|Withdrawal by Subject|42|||
130235395|NCT00141921|468825740|FG000|Overall Study|Lost to Follow-up|19|||
130235396|NCT00141921|468825740|FG000|Overall Study|Noncompliance|17|||
130235397|NCT00141921|468825740|FG000|Overall Study|Disease Progression|7|||
130235398|NCT00141921|468825740|FG000|Overall Study|Protocol Deviation|7|||
130235399|NCT00141921|468825740|FG000|Overall Study|Adverse Event|5|||
130235400|NCT00141921|468825740|FG000|Overall Study|Administrative Decision|2|||
130235401|NCT00141921|468825740|FG000|Overall Study|Pregnancy|4|||
130235402|NCT00141921|468825740|FG000|Overall Study|Ineligibility Determined|2|||
130235403|NCT00141921|468825740|FG000|Overall Study|Other|8|||
130235404|NCT02030600|468825743|FG000|Treatment Period 1|Adverse Event|5|||
130235405|NCT02030600|468825744|FG001|Treatment Period 1|Adverse Event|7|||
130235406|NCT02030600|468825743|FG000|Treatment Period 1|Lack of Efficacy|0|||
130235407|NCT02030600|468825744|FG001|Treatment Period 1|Lack of Efficacy|1|||
130235408|NCT02030600|468825743|FG000|Treatment Period 1|Lost to Follow-up|11|||
130235409|NCT02030600|468825744|FG001|Treatment Period 1|Lost to Follow-up|3|||
130235410|NCT02030600|468825743|FG000|Treatment Period 1|Protocol Violation|22|||
130235411|NCT02030600|468825744|FG001|Treatment Period 1|Protocol Violation|17|||
130235412|NCT02030600|468825743|FG000|Treatment Period 1|Withdrawal by Subject|13|||
130235413|NCT02030600|468825744|FG001|Treatment Period 1|Withdrawal by Subject|17|||
130235414|NCT02030600|468825743|FG000|Treatment Period 1|Casebook Unsigned|1|||
130235415|NCT02030600|468825744|FG001|Treatment Period 1|Casebook Unsigned|0|||
130235416|NCT02030600|468825743|FG000|Treatment Period 1|Unclassified|1|||
130235417|NCT02030600|468825744|FG001|Treatment Period 1|Unclassified|0|||
130235418|NCT02030600|468825743|FG000|Treatment Period 2|Adverse Event|4|||
130235419|NCT02030600|468825744|FG001|Treatment Period 2|Adverse Event|4|||
130235420|NCT02030600|468825743|FG000|Treatment Period 2|Lack of Efficacy|2|||
130235421|NCT02030600|468825744|FG001|Treatment Period 2|Lack of Efficacy|1|||
130235422|NCT02030600|468825743|FG000|Treatment Period 2|Lost to Follow-up|4|||
130235423|NCT02030600|468825744|FG001|Treatment Period 2|Lost to Follow-up|2|||
130235424|NCT02030600|468825743|FG000|Treatment Period 2|Protocol Violation|1|||
130235425|NCT02030600|468825744|FG001|Treatment Period 2|Protocol Violation|2|||
130235426|NCT02030600|468825743|FG000|Treatment Period 2|Withdrawal by Subject|13|||
130235427|NCT02030600|468825744|FG001|Treatment Period 2|Withdrawal by Subject|9|||
130235428|NCT02030600|468825743|FG000|Treatment Period 2|Unclassified|1|||
130235429|NCT02030600|468825744|FG001|Treatment Period 2|Unclassified|0|||
130235430|NCT01155323|468825745|FG000|First Intervention|exclusion criteria|1|||
130235431|NCT01155323|468825746|FG001|First Intervention|exclusion criteria|1|||
130235432|NCT01155323|468825745|FG000|Second Intervention|Lost to Follow-up|1|||
130235433|NCT01155323|468825746|FG001|Second Intervention|Lost to Follow-up|1|||
130235434|NCT02471339|468825750|FG000|Overall Study|Did not provide follow-up data|2|||
130235435|NCT02471339|468825751|FG001|Overall Study|Did not provide follow-up data|0|||
130235436|NCT00626639|468825759|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130235437|NCT00626639|468825760|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130235438|NCT00303186|468825761|FG000|Overall Study|Other|52|||
130235439|NCT00937950|468825763|FG000|Overall Study|Withdrawal by Subject|23|||
130235440|NCT00937950|468825763|FG000|Overall Study|Migrated/moved from study area|27|||
130235441|NCT00937950|468825763|FG000|Overall Study|Lost to Follow-up|144|||
130235442|NCT00937950|468825763|FG000|Overall Study|Missing confirmed|4|||
130235443|NCT00937950|468825763|FG000|Overall Study|Other|18|||
130235444|NCT01137786|468825764|FG000|Overall Study|Lost to Follow-up|0|||
130235445|NCT01137786|468825765|FG001|Overall Study|Lost to Follow-up|2|||
130235446|NCT01137786|468825764|FG000|Overall Study|Withdrawal by Subject|1|||
130235447|NCT01137786|468825765|FG001|Overall Study|Withdrawal by Subject|1|||
130235448|NCT00460798|468825767|FG000|Overall Study|Death|59|||
130235449|NCT00460798|468825767|FG000|Overall Study|Adverse Event|27|||
130235450|NCT00460798|468825767|FG000|Overall Study|Lost to Follow-up|19|||
130235451|NCT00460798|468825767|FG000|Overall Study|Progressive Disease|99|||
130235452|NCT00460798|468825767|FG000|Overall Study|Other|27|||
130235453|NCT00460798|468825767|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
130235454|NCT00460798|468825767|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
130235455|NCT01898130|468825768|FG000|Treatment|Withdrawal by Subject|2|||
130235456|NCT01898130|468825768|FG000|Treatment|Progressive Disease|4|||
130235457|NCT01898130|468825768|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
130235458|NCT02320396|468825772|FG000|Overall Study|Adverse Event|2|||
130235459|NCT02320396|468825773|FG001|Overall Study|Adverse Event|2|||
130235460|NCT02320396|468825772|FG000|Overall Study|Pregnancy|0|||
130235461|NCT02320396|468825773|FG001|Overall Study|Pregnancy|1|||
130235462|NCT02320396|468825772|FG000|Overall Study|Protocol Violation|0|||
130235463|NCT02320396|468825773|FG001|Overall Study|Protocol Violation|1|||
130235464|NCT02320396|468825772|FG000|Overall Study|Withdrawal by Subject|2|||
130235465|NCT02320396|468825773|FG001|Overall Study|Withdrawal by Subject|0|||
130235466|NCT04666298|468825776|FG000|Overall Study|Subject decision|1|||
130235467|NCT04666298|468825777|FG001|Overall Study|Subject decision|0|||
130235468|NCT04666298|468825778|FG002|Overall Study|Subject decision|0|||
130235469|NCT04666298|468825779|FG003|Overall Study|Subject decision|2|||
130235470|NCT04666298|468825776|FG000|Overall Study|Death|1|||
130235471|NCT04666298|468825777|FG001|Overall Study|Death|0|||
130235472|NCT04666298|468825778|FG002|Overall Study|Death|0|||
130235473|NCT04666298|468825779|FG003|Overall Study|Death|0|||
130235474|NCT04666298|468825776|FG000|Overall Study|Lost to Follow-up|0|||
130235475|NCT04666298|468825777|FG001|Overall Study|Lost to Follow-up|0|||
130235476|NCT04666298|468825778|FG002|Overall Study|Lost to Follow-up|0|||
130235477|NCT04666298|468825779|FG003|Overall Study|Lost to Follow-up|1|||
130235478|NCT04666298|468825776|FG000|Overall Study|Physician Decision|0|||
130235479|NCT04666298|468825777|FG001|Overall Study|Physician Decision|0|||
130235480|NCT04666298|468825778|FG002|Overall Study|Physician Decision|0|||
130235481|NCT04666298|468825779|FG003|Overall Study|Physician Decision|1|||
130235482|NCT04666298|468825776|FG000|Overall Study|Protocol deviation|0|||
130235483|NCT04666298|468825777|FG001|Overall Study|Protocol deviation|0|||
130235484|NCT04666298|468825778|FG002|Overall Study|Protocol deviation|1|||
130235485|NCT04666298|468825779|FG003|Overall Study|Protocol deviation|0|||
130235486|NCT00844519|468825782|FG000|Overall Study|Withdrawal by Subject|1|||
130235487|NCT00844519|468825783|FG001|Overall Study|Withdrawal by Subject|1|||
130235488|NCT00844519|468825782|FG000|Overall Study|Adverse Event|1|||
130235489|NCT00844519|468825783|FG001|Overall Study|Adverse Event|0|||
130235490|NCT00226655|468825784|FG000|Overall Study|Death|13|||
130235491|NCT00226655|468825784|FG000|Overall Study|Withdrawal by Subject|15|||
130235492|NCT00226655|468825784|FG000|Overall Study|Adverse Event|35|||
130235493|NCT00226655|468825784|FG000|Overall Study|Physician Decision|6|||
130235494|NCT00226655|468825784|FG000|Overall Study|Clinical deterioration|10|||
130235495|NCT06438601|468825785|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
130235496|NCT06438601|468825786|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
130235497|NCT06438601|468825785|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
130235498|NCT06438601|468825786|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
130235499|NCT01311661|468825789|FG000|Overall Study|Adverse Event|2|||
130235500|NCT01311661|468825789|FG000|Overall Study|Protocol Violation|3|||
130235501|NCT01311661|468825789|FG000|Overall Study|Withdrawal by Subject|2|||
130235502|NCT03188822|468825790|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
130235503|NCT03188822|468825790|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
130446772|NCT02264574|469597074|FG001|Overall Study|Other, Not Specified|3|||
130446773|NCT02886728|469597080|FG000|Overall Study|Withdrew Consent|31|||
130446774|NCT02886728|469597081|FG001|Overall Study|Withdrew Consent|13|||
130446775|NCT02886728|469597082|FG002|Overall Study|Withdrew Consent|11|||
130694654|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694655|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694656|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694657|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130235504|NCT01285518|468825791|FG000|Overall Study|Lost to Follow-up|0|||
130235505|NCT01285518|468825792|FG001|Overall Study|Lost to Follow-up|0|||
130235506|NCT01285518|468825793|FG002|Overall Study|Lost to Follow-up|0|||
130446776|NCT02886728|469597083|FG003|Overall Study|Withdrew Consent|47|||
130694658|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694659|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130235507|NCT01285518|468825794|FG003|Overall Study|Lost to Follow-up|0|||
130235508|NCT01285518|468825795|FG004|Overall Study|Lost to Follow-up|0|||
130235509|NCT01285518|468825796|FG005|Overall Study|Lost to Follow-up|1|||
130235510|NCT01285518|468825797|FG006|Overall Study|Lost to Follow-up|0|||
130235511|NCT01285518|468825798|FG007|Overall Study|Lost to Follow-up|0|||
130235512|NCT03805841|468825799|FG000|Overall Study|Clinical Progression|2|||
130235513|NCT03805841|468825800|FG001|Overall Study|Clinical Progression|0|||
130446777|NCT02886728|469597080|FG000|Overall Study|Lost to Follow-up|12|||
130235514|NCT03805841|468825801|FG002|Overall Study|Clinical Progression|0|||
130235515|NCT03805841|468825799|FG000|Overall Study|Death|0|||
130235516|NCT03805841|468825800|FG001|Overall Study|Death|3|||
130235517|NCT03805841|468825801|FG002|Overall Study|Death|1|||
130235518|NCT03805841|468825799|FG000|Overall Study|Lost to Follow-up|0|||
130235519|NCT03805841|468825800|FG001|Overall Study|Lost to Follow-up|0|||
130235520|NCT03805841|468825801|FG002|Overall Study|Lost to Follow-up|1|||
130235521|NCT03805841|468825799|FG000|Overall Study|Withdrawal by Subject|2|||
130235522|NCT03805841|468825800|FG001|Overall Study|Withdrawal by Subject|3|||
130235523|NCT03805841|468825801|FG002|Overall Study|Withdrawal by Subject|0|||
130235524|NCT03805841|468825799|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130235525|NCT03805841|468825800|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
130235526|NCT03805841|468825801|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130235527|NCT02460289|468825809|FG000|Overall Study|Adverse Event|1|||
130235528|NCT02460289|468825809|FG000|Overall Study|Withdrawal by Subject|8|||
130235529|NCT02460289|468825809|FG000|Overall Study|Lost to Follow-up|1|||
130235530|NCT01977846|468825810|FG000|Total Study - Prospective|Death|0|||
130235531|NCT01977846|468825811|FG001|Total Study - Prospective|Death|1|||
130235532|NCT01977846|468825810|FG000|Total Study - Prospective|Lost to Follow-up|0|||
130235533|NCT01977846|468825811|FG001|Total Study - Prospective|Lost to Follow-up|8|||
130235534|NCT01977846|468825810|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
130235535|NCT01977846|468825811|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
130235536|NCT01977846|468825810|FG000|Total Study - Prospective|Not available at time of visit|0|||
130235537|NCT01977846|468825811|FG001|Total Study - Prospective|Not available at time of visit|5|||
130235538|NCT01977846|468825810|FG000|Total Study - Prospective|No show|0|||
130235539|NCT01977846|468825811|FG001|Total Study - Prospective|No show|1|||
130235540|NCT01977846|468825810|FG000|Total Study - Prospective|Protocol Violation|0|||
130235541|NCT01977846|468825811|FG001|Total Study - Prospective|Protocol Violation|1|||
130235542|NCT02164916|468825812|FG000|Overall Study|Adverse Event|3|||
130235543|NCT02164916|468825813|FG001|Overall Study|Adverse Event|8|||
130235544|NCT02164916|468825812|FG000|Overall Study|Death|1|||
130235545|NCT02164916|468825813|FG001|Overall Study|Death|1|||
130235546|NCT02164916|468825812|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130235547|NCT02164916|468825813|FG001|Overall Study|Refusal unrelated to adverse event|7|||
130235548|NCT02164916|468825812|FG000|Overall Study|Progression|37|||
130235549|NCT02164916|468825813|FG001|Overall Study|Progression|26|||
130235550|NCT02164916|468825812|FG000|Overall Study|Not protocol specified|5|||
130235551|NCT02164916|468825813|FG001|Overall Study|Not protocol specified|1|||
130235552|NCT02164916|468825812|FG000|Overall Study|Reason under review|1|||
130235553|NCT02164916|468825813|FG001|Overall Study|Reason under review|6|||
130235554|NCT02164916|468825812|FG000|Overall Study|Not eligible|2|||
130235555|NCT02164916|468825813|FG001|Overall Study|Not eligible|5|||
130235556|NCT00596635|468825816|FG000|Overall Study|Lost to Follow-up|0|||
130235557|NCT00596635|468825817|FG001|Overall Study|Lost to Follow-up|2|||
130235558|NCT00596635|468825818|FG002|Overall Study|Lost to Follow-up|0|||
130235559|NCT00596635|468825816|FG000|Overall Study|Treatment for symptomatic UTI|4|||
130235560|NCT00596635|468825817|FG001|Overall Study|Treatment for symptomatic UTI|6|||
130235561|NCT00596635|468825818|FG002|Overall Study|Treatment for symptomatic UTI|3|||
130235562|NCT00596635|468825816|FG000|Overall Study|Hip fracture|2|||
130235563|NCT00596635|468825817|FG001|Overall Study|Hip fracture|3|||
130235564|NCT00596635|468825818|FG002|Overall Study|Hip fracture|3|||
130235565|NCT00596635|468825816|FG000|Overall Study|Could not provide urine specimen|1|||
130235566|NCT00596635|468825817|FG001|Overall Study|Could not provide urine specimen|2|||
130235567|NCT00596635|468825818|FG002|Overall Study|Could not provide urine specimen|2|||
130235568|NCT00127803|468825822|FG000|Overall Study|Adverse Event|2|||
130235569|NCT00127803|468825823|FG001|Overall Study|Adverse Event|0|||
130235570|NCT00127803|468825824|FG002|Overall Study|Adverse Event|0|||
130235571|NCT00127803|468825825|FG003|Overall Study|Adverse Event|0|||
130235572|NCT00127803|468825822|FG000|Overall Study|Withdrawal by Subject|1|||
130235573|NCT00127803|468825823|FG001|Overall Study|Withdrawal by Subject|0|||
130235574|NCT00127803|468825824|FG002|Overall Study|Withdrawal by Subject|0|||
130235575|NCT00127803|468825825|FG003|Overall Study|Withdrawal by Subject|0|||
130235576|NCT00127803|468825822|FG000|Overall Study|Lost to Follow-up|0|||
130235577|NCT00127803|468825823|FG001|Overall Study|Lost to Follow-up|0|||
130235578|NCT00127803|468825824|FG002|Overall Study|Lost to Follow-up|0|||
130235579|NCT00127803|468825825|FG003|Overall Study|Lost to Follow-up|1|||
130235580|NCT01925417|468825830|FG000|Overall Study|Withdrawal by Subject|2|||
130235581|NCT01925417|468825830|FG000|Overall Study|Death|1|||
130235582|NCT03454555|468827876|FG000|Overall Study|Death|6|||
130235583|NCT03454555|468827877|FG001|Overall Study|Death|6|||
130235584|NCT03454555|468827876|FG000|Overall Study|Lost to Follow-up|31|||
130235585|NCT03454555|468827877|FG001|Overall Study|Lost to Follow-up|12|||
130235586|NCT03454555|468827876|FG000|Overall Study|Physician Decision|2|||
130235587|NCT03454555|468827877|FG001|Overall Study|Physician Decision|6|||
130235588|NCT03454555|468827876|FG000|Overall Study|Withdrawal by Subject|34|||
130235589|NCT03454555|468827877|FG001|Overall Study|Withdrawal by Subject|5|||
130235590|NCT03454555|468827876|FG000|Overall Study|Ineligible|1|||
130235591|NCT03454555|468827877|FG001|Overall Study|Ineligible|5|||
130235592|NCT01386385|468827878|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
130235593|NCT01386385|468827879|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235594|NCT01386385|468827880|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235595|NCT01386385|468827881|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235596|NCT01386385|468827882|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235597|NCT01386385|468827883|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235598|NCT01386385|468827884|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235599|NCT01386385|468827885|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235600|NCT01386385|468827878|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
130235601|NCT01386385|468827879|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235602|NCT01386385|468827880|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235603|NCT01386385|468827881|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235604|NCT01386385|468827882|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235605|NCT01386385|468827883|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235606|NCT01386385|468827884|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235607|NCT01386385|468827885|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235608|NCT01386385|468827878|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235609|NCT01386385|468827879|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235610|NCT01386385|468827880|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
130235611|NCT01386385|468827881|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235612|NCT01386385|468827882|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235613|NCT01386385|468827883|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235614|NCT01386385|468827884|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235615|NCT01386385|468827885|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235616|NCT01386385|468827878|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235617|NCT01386385|468827879|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235618|NCT01386385|468827880|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235619|NCT01386385|468827881|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235620|NCT01386385|468827882|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
130235621|NCT01386385|468827883|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235622|NCT01386385|468827884|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235623|NCT01386385|468827885|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235624|NCT01386385|468827878|FG000|Phase II Concurrent CRT|Adverse Event|0|||
130235625|NCT01386385|468827879|FG001|Phase II Concurrent CRT|Adverse Event|0|||
130235626|NCT01386385|468827880|FG002|Phase II Concurrent CRT|Adverse Event|0|||
130235627|NCT01386385|468827881|FG003|Phase II Concurrent CRT|Adverse Event|0|||
130235628|NCT01386385|468827882|FG004|Phase II Concurrent CRT|Adverse Event|0|||
130235629|NCT01386385|468827883|FG005|Phase II Concurrent CRT|Adverse Event|0|||
130235630|NCT01386385|468827884|FG006|Phase II Concurrent CRT|Adverse Event|3|||
130235631|NCT01386385|468827885|FG007|Phase II Concurrent CRT|Adverse Event|3|||
130235632|NCT01386385|468827878|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235633|NCT01386385|468827879|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235634|NCT01386385|468827880|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235635|NCT01386385|468827881|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235636|NCT01386385|468827882|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235637|NCT01386385|468827883|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235638|NCT01386385|468827884|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
130235639|NCT01386385|468827885|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235640|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
130235641|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
130235642|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
130235643|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
130235644|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
130235645|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
130235646|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
130235647|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
130235648|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235649|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235650|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235651|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235652|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130358621|NCT03131453|469284789|FG000|Overall Study|Technical problems|1|||
130358622|NCT03131453|469284790|FG001|Overall Study|Technical problems|0|||
130358623|NCT03131453|469284791|FG002|Overall Study|Technical problems|0|||
130358624|NCT03131453|469284789|FG000|Overall Study|Protocol deviation|0|||
130358625|NCT03131453|469284790|FG001|Overall Study|Protocol deviation|1|||
130358626|NCT03131453|469284791|FG002|Overall Study|Protocol deviation|0|||
130358627|NCT02770170|469284794|FG000|Overall Study|Withdrawal by Subject|0|||
130446778|NCT02886728|469597081|FG001|Overall Study|Lost to Follow-up|6|||
130235653|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235654|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
130235655|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235656|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235657|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235658|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235659|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235660|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235661|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235662|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
130235663|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
130235664|NCT05399485|468827886|FG000|DBT Phase|Other|6|||
130235665|NCT05399485|468827887|FG001|DBT Phase|Other|5|||
130235666|NCT05399485|468827886|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130235667|NCT05399485|468827887|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130235668|NCT05399485|468827886|FG000|DBT Phase|Withdrawal by Subject|3|||
130235669|NCT05399485|468827887|FG001|DBT Phase|Withdrawal by Subject|2|||
130235670|NCT05399485|468827886|FG000|DBT Phase|Protocol Violation|2|||
130235671|NCT05399485|468827887|FG001|DBT Phase|Protocol Violation|1|||
130235672|NCT05399485|468827886|FG000|DBT Phase|Physician Decision|0|||
130235673|NCT05399485|468827887|FG001|DBT Phase|Physician Decision|1|||
130235674|NCT05399485|468827886|FG000|DBT Phase|Adverse Event|2|||
130235675|NCT05399485|468827887|FG001|DBT Phase|Adverse Event|1|||
130235676|NCT05399485|468827886|FG000|OLE Phase|Not reported|0|||
130235677|NCT05399485|468827887|FG001|OLE Phase|Not reported|1|||
130235678|NCT05399485|468827886|FG000|OLE Phase|Other|3|||
130235679|NCT05399485|468827887|FG001|OLE Phase|Other|3|||
130235680|NCT05399485|468827886|FG000|OLE Phase|Withdrawal by Subject|8|||
130235681|NCT05399485|468827887|FG001|OLE Phase|Withdrawal by Subject|5|||
130235682|NCT05399485|468827886|FG000|OLE Phase|Pregnancy|0|||
130235683|NCT05399485|468827887|FG001|OLE Phase|Pregnancy|1|||
130235684|NCT05399485|468827886|FG000|OLE Phase|Physician Decision|2|||
130235685|NCT05399485|468827887|FG001|OLE Phase|Physician Decision|0|||
130235686|NCT05399485|468827886|FG000|OLE Phase|Adverse Event|0|||
130235687|NCT05399485|468827887|FG001|OLE Phase|Adverse Event|1|||
130235688|NCT05399485|468827886|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
130235689|NCT05399485|468827887|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
130235690|NCT03405870|468827890|FG000|Overall Study|Withdrawal|1|||
130235691|NCT03405870|468827891|FG001|Overall Study|Withdrawal|0|||
130235692|NCT03405870|468827892|FG002|Overall Study|Withdrawal|1|||
130235693|NCT03405870|468827893|FG003|Overall Study|Withdrawal|0|||
130235694|NCT03405870|468827894|FG004|Overall Study|Withdrawal|0|||
130235695|NCT03405870|468827895|FG005|Overall Study|Withdrawal|0|||
130235696|NCT03405870|468827896|FG006|Overall Study|Withdrawal|1|||
130235697|NCT03405870|468827897|FG007|Overall Study|Withdrawal|0|||
130235698|NCT03737994|468827898|FG000|Overall Study|Withdrawal by Subject|0|||
130235699|NCT03737994|468827899|FG001|Overall Study|Withdrawal by Subject|0|||
130235700|NCT03737994|468827900|FG002|Overall Study|Withdrawal by Subject|0|||
130235701|NCT03737994|468827901|FG003|Overall Study|Withdrawal by Subject|0|||
130235702|NCT03737994|468827902|FG004|Overall Study|Withdrawal by Subject|0|||
130235703|NCT03737994|468827903|FG005|Overall Study|Withdrawal by Subject|0|||
130235704|NCT03737994|468827904|FG006|Overall Study|Withdrawal by Subject|1|||
130235705|NCT03846479|468827905|FG000|Overall Study|Death|8|||
130235706|NCT03846479|468827905|FG000|Overall Study|Lost to Follow-up|1|||
130235707|NCT01473134|468827906|FG000|Overall Study|Lost to Follow-up|21|||
130235708|NCT01473134|468827907|FG001|Overall Study|Lost to Follow-up|13|||
130235709|NCT01473134|468827906|FG000|Overall Study|Protocol Violation|32|||
130235710|NCT01473134|468827907|FG001|Overall Study|Protocol Violation|19|||
130235711|NCT01473134|468827906|FG000|Overall Study|Withdrawal by Subject|1|||
130358628|NCT02770170|469284795|FG001|Overall Study|Withdrawal by Subject|0|||
130358629|NCT02770170|469284796|FG002|Overall Study|Withdrawal by Subject|0|||
130694660|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694661|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694662|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130235712|NCT01473134|468827907|FG001|Overall Study|Withdrawal by Subject|2|||
130235713|NCT01473134|468827906|FG000|Overall Study|Death|0|||
130235714|NCT01473134|468827907|FG001|Overall Study|Death|1|||
130235715|NCT01473134|468827906|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
130235716|NCT01473134|468827907|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
130235717|NCT05020015|468827914|FG000|Overall Study|Ongoing on study|1|||
130235718|NCT05020015|468827915|FG001|Overall Study|Ongoing on study|3|||
130235719|NCT05020015|468827916|FG002|Overall Study|Ongoing on study|4|||
130235720|NCT05020015|468827917|FG003|Overall Study|Ongoing on study|7|||
130235721|NCT05020015|468827914|FG000|Overall Study|Death|2|||
130235722|NCT05020015|468827915|FG001|Overall Study|Death|3|||
130235723|NCT05020015|468827916|FG002|Overall Study|Death|4|||
130235724|NCT05020015|468827917|FG003|Overall Study|Death|0|||
130235725|NCT05020015|468827914|FG000|Overall Study|Withdrawal by Subject|0|||
130235726|NCT05020015|468827915|FG001|Overall Study|Withdrawal by Subject|0|||
130235727|NCT05020015|468827916|FG002|Overall Study|Withdrawal by Subject|1|||
130235728|NCT05020015|468827917|FG003|Overall Study|Withdrawal by Subject|0|||
130235729|NCT05020015|468827914|FG000|Overall Study|Reason Not Specified|0|||
130235730|NCT05020015|468827915|FG001|Overall Study|Reason Not Specified|0|||
130235731|NCT05020015|468827916|FG002|Overall Study|Reason Not Specified|2|||
130235732|NCT05020015|468827917|FG003|Overall Study|Reason Not Specified|0|||
130235733|NCT00614393|468827924|FG000|Overall Study|Adverse Event|20|||
130235734|NCT00614393|468827925|FG001|Overall Study|Adverse Event|2|||
130235735|NCT00614393|468827926|FG002|Overall Study|Adverse Event|3|||
130235736|NCT00614393|468827927|FG003|Overall Study|Adverse Event|13|||
130235737|NCT00614393|468827928|FG004|Overall Study|Adverse Event|21|||
130235738|NCT00614393|468827924|FG000|Overall Study|Lost to Follow-up|0|||
130235739|NCT00614393|468827925|FG001|Overall Study|Lost to Follow-up|0|||
130235740|NCT00614393|468827926|FG002|Overall Study|Lost to Follow-up|0|||
130235741|NCT00614393|468827927|FG003|Overall Study|Lost to Follow-up|1|||
130235742|NCT00614393|468827928|FG004|Overall Study|Lost to Follow-up|2|||
130235743|NCT00614393|468827924|FG000|Overall Study|Physician Decision|17|||
130235744|NCT00614393|468827925|FG001|Overall Study|Physician Decision|0|||
130235745|NCT00614393|468827926|FG002|Overall Study|Physician Decision|1|||
130235746|NCT00614393|468827927|FG003|Overall Study|Physician Decision|8|||
130235747|NCT00614393|468827928|FG004|Overall Study|Physician Decision|9|||
130235748|NCT00614393|468827924|FG000|Overall Study|Progressive Disease|118|||
130235749|NCT00614393|468827925|FG001|Overall Study|Progressive Disease|5|||
130235750|NCT00614393|468827926|FG002|Overall Study|Progressive Disease|5|||
130235751|NCT00614393|468827927|FG003|Overall Study|Progressive Disease|138|||
130235752|NCT00614393|468827928|FG004|Overall Study|Progressive Disease|130|||
130235753|NCT00614393|468827924|FG000|Overall Study|Protocol Violation|1|||
130235754|NCT00614393|468827925|FG001|Overall Study|Protocol Violation|0|||
130235755|NCT00614393|468827926|FG002|Overall Study|Protocol Violation|0|||
130235756|NCT00614393|468827927|FG003|Overall Study|Protocol Violation|0|||
130235757|NCT00614393|468827928|FG004|Overall Study|Protocol Violation|0|||
130235758|NCT00614393|468827924|FG000|Overall Study|Terminated by Sponsor|0|||
130446779|NCT02886728|469597082|FG002|Overall Study|Lost to Follow-up|13|||
130446780|NCT02886728|469597083|FG003|Overall Study|Lost to Follow-up|12|||
130446781|NCT02886728|469597080|FG000|Overall Study|Adverse Event|13|||
130446782|NCT02886728|469597081|FG001|Overall Study|Adverse Event|5|||
130446783|NCT02886728|469597082|FG002|Overall Study|Adverse Event|5|||
130235759|NCT00614393|468827925|FG001|Overall Study|Terminated by Sponsor|0|||
130446784|NCT02886728|469597083|FG003|Overall Study|Adverse Event|11|||
130446785|NCT02886728|469597080|FG000|Overall Study|Investigator's Discretion|11|||
130446786|NCT02886728|469597081|FG001|Overall Study|Investigator's Discretion|7|||
130446787|NCT02886728|469597082|FG002|Overall Study|Investigator's Discretion|5|||
130446788|NCT02886728|469597083|FG003|Overall Study|Investigator's Discretion|11|||
130446789|NCT02886728|469597080|FG000|Overall Study|Death|3|||
130446790|NCT02886728|469597081|FG001|Overall Study|Death|1|||
130446791|NCT02886728|469597082|FG002|Overall Study|Death|0|||
130446792|NCT02886728|469597083|FG003|Overall Study|Death|0|||
130446793|NCT02886728|469597080|FG000|Overall Study|Protocol Violation|0|||
130446794|NCT02886728|469597081|FG001|Overall Study|Protocol Violation|0|||
130446795|NCT02886728|469597082|FG002|Overall Study|Protocol Violation|0|||
130446796|NCT02886728|469597083|FG003|Overall Study|Protocol Violation|4|||
130446797|NCT02886728|469597080|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130446798|NCT02886728|469597081|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130446799|NCT02886728|469597082|FG002|Overall Study|Non-Compliance with Study Drug|1|||
130446800|NCT02886728|469597083|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130446801|NCT02886728|469597080|FG000|Overall Study|Pregnancy|0|||
130446802|NCT02886728|469597081|FG001|Overall Study|Pregnancy|0|||
130694663|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694664|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130235760|NCT00614393|468827926|FG002|Overall Study|Terminated by Sponsor|0|||
130235761|NCT00614393|468827927|FG003|Overall Study|Terminated by Sponsor|0|||
130446803|NCT02886728|469597082|FG002|Overall Study|Pregnancy|1|||
130235762|NCT00614393|468827928|FG004|Overall Study|Terminated by Sponsor|1|||
130235763|NCT00614393|468827924|FG000|Overall Study|Withdrawal by Subject|20|||
130446804|NCT02886728|469597083|FG003|Overall Study|Pregnancy|0|||
130446805|NCT02886728|469597080|FG000|Overall Study|Randomized but Not Dosed|1|||
130446806|NCT02886728|469597081|FG001|Overall Study|Randomized but Not Dosed|0|||
130446807|NCT02886728|469597082|FG002|Overall Study|Randomized but Not Dosed|0|||
130446808|NCT02886728|469597083|FG003|Overall Study|Randomized but Not Dosed|2|||
130446809|NCT04990440|469597088|FG000|Overall Study|Sponsor's Decision|0|||
130235764|NCT00614393|468827925|FG001|Overall Study|Withdrawal by Subject|1|||
130235765|NCT00614393|468827926|FG002|Overall Study|Withdrawal by Subject|1|||
130235766|NCT00614393|468827927|FG003|Overall Study|Withdrawal by Subject|16|||
130235767|NCT00614393|468827928|FG004|Overall Study|Withdrawal by Subject|13|||
130235768|NCT00614393|468827924|FG000|Overall Study|Other|4|||
130235769|NCT00614393|468827925|FG001|Overall Study|Other|0|||
130235770|NCT00614393|468827926|FG002|Overall Study|Other|0|||
130446810|NCT04990440|469597089|FG001|Overall Study|Sponsor's Decision|0|||
130235771|NCT00614393|468827927|FG003|Overall Study|Other|4|||
130235772|NCT00614393|468827928|FG004|Overall Study|Other|2|||
130235773|NCT00614393|468827924|FG000|Overall Study|Not Treated|0|||
130235774|NCT00614393|468827925|FG001|Overall Study|Not Treated|0|||
130235775|NCT00614393|468827926|FG002|Overall Study|Not Treated|0|||
130235776|NCT00614393|468827927|FG003|Overall Study|Not Treated|0|||
130235777|NCT00614393|468827928|FG004|Overall Study|Not Treated|2|||
130235778|NCT00855582|468827929|FG000|Overall Study|Adverse Event|2|||
130235779|NCT00855582|468827930|FG001|Overall Study|Adverse Event|6|||
130235780|NCT00855582|468827931|FG002|Overall Study|Adverse Event|3|||
130235781|NCT00855582|468827929|FG000|Overall Study|Death|1|||
130235782|NCT00855582|468827930|FG001|Overall Study|Death|0|||
130235783|NCT00855582|468827931|FG002|Overall Study|Death|0|||
130235784|NCT00855582|468827929|FG000|Overall Study|Lack of Efficacy|1|||
130235785|NCT00855582|468827930|FG001|Overall Study|Lack of Efficacy|3|||
130235786|NCT00855582|468827931|FG002|Overall Study|Lack of Efficacy|8|||
130235787|NCT00855582|468827929|FG000|Overall Study|Lost to Follow-up|1|||
130235788|NCT00855582|468827930|FG001|Overall Study|Lost to Follow-up|3|||
130235789|NCT00855582|468827931|FG002|Overall Study|Lost to Follow-up|1|||
130235790|NCT00855582|468827929|FG000|Overall Study|Physician Decision|0|||
130235791|NCT00855582|468827930|FG001|Overall Study|Physician Decision|0|||
130235792|NCT00855582|468827931|FG002|Overall Study|Physician Decision|1|||
130235793|NCT00855582|468827929|FG000|Overall Study|Protocol Violation|6|||
130235794|NCT00855582|468827930|FG001|Overall Study|Protocol Violation|2|||
130235795|NCT00855582|468827931|FG002|Overall Study|Protocol Violation|6|||
130235796|NCT00855582|468827929|FG000|Overall Study|Entry Criteria Not Met|8|||
130235797|NCT00855582|468827930|FG001|Overall Study|Entry Criteria Not Met|6|||
130235798|NCT00855582|468827931|FG002|Overall Study|Entry Criteria Not Met|3|||
130235799|NCT00855582|468827929|FG000|Overall Study|Withdrawal by Subject|7|||
130235800|NCT00855582|468827930|FG001|Overall Study|Withdrawal by Subject|4|||
130235801|NCT00855582|468827931|FG002|Overall Study|Withdrawal by Subject|8|||
130235802|NCT03345004|468827932|FG000|Overall Study|Physician Decision|1|||
130235803|NCT03345004|468827933|FG001|Overall Study|Physician Decision|0|||
130235804|NCT03345004|468827932|FG000|Overall Study|Withdrawal by Subject|0|||
130235805|NCT03345004|468827933|FG001|Overall Study|Withdrawal by Subject|1|||
130235806|NCT01013753|468827934|FG000|Overall Study|Adverse Event|8|||
130235807|NCT01013753|468827934|FG000|Overall Study|Protocol Violation|3|||
130235808|NCT01013753|468827934|FG000|Overall Study|Lost to Follow-up|1|||
130235809|NCT01013753|468827934|FG000|Overall Study|Withdrawal by Subject|2|||
130235810|NCT01013753|468827934|FG000|Overall Study|Other|2|||
130235811|NCT03320369|468827937|FG000|Overall Study|Adverse Event|1|||
130235812|NCT03320369|468827937|FG000|Overall Study|Withdrawal by Subject|2|||
130235813|NCT01732692|468827938|FG000|Overall Study|Adverse Event|0|||
130235814|NCT01732692|468827939|FG001|Overall Study|Adverse Event|1|||
130235815|NCT01281306|468827940|FG000|Overall Study|Lack of Efficacy|0|||
130235816|NCT01281306|468827941|FG001|Overall Study|Lack of Efficacy|1|||
130235817|NCT01281306|468827942|FG002|Overall Study|Lack of Efficacy|3|||
130235818|NCT01281306|468827943|FG003|Overall Study|Lack of Efficacy|0|||
130235819|NCT01281306|468827944|FG004|Overall Study|Lack of Efficacy|2|||
130235820|NCT01281306|468827945|FG005|Overall Study|Lack of Efficacy|0|||
130235821|NCT01281306|468827946|FG006|Overall Study|Lack of Efficacy|1|||
130235822|NCT01281306|468827940|FG000|Overall Study|Withdrawal by Subject|1|||
130235823|NCT01281306|468827941|FG001|Overall Study|Withdrawal by Subject|0|||
130235824|NCT01281306|468827942|FG002|Overall Study|Withdrawal by Subject|2|||
130235825|NCT01281306|468827943|FG003|Overall Study|Withdrawal by Subject|4|||
130235826|NCT01281306|468827944|FG004|Overall Study|Withdrawal by Subject|1|||
130235827|NCT01281306|468827945|FG005|Overall Study|Withdrawal by Subject|3|||
130235828|NCT01281306|468827946|FG006|Overall Study|Withdrawal by Subject|1|||
130358630|NCT02770170|469284797|FG003|Overall Study|Withdrawal by Subject|2|||
130358631|NCT02770170|469284794|FG000|Overall Study|due to pregnancy|1|||
130358632|NCT02770170|469284795|FG001|Overall Study|due to pregnancy|0|||
130358633|NCT02770170|469284796|FG002|Overall Study|due to pregnancy|0|||
130358634|NCT02770170|469284797|FG003|Overall Study|due to pregnancy|0|||
130358635|NCT02770170|469284794|FG000|Overall Study|Lack of Efficacy|2|||
130358636|NCT02770170|469284795|FG001|Overall Study|Lack of Efficacy|0|||
130358637|NCT02770170|469284796|FG002|Overall Study|Lack of Efficacy|0|||
130358638|NCT02770170|469284797|FG003|Overall Study|Lack of Efficacy|1|||
130358639|NCT02770170|469284794|FG000|Overall Study|Adverse Event|4|||
130358640|NCT02770170|469284795|FG001|Overall Study|Adverse Event|3|||
130358641|NCT02770170|469284796|FG002|Overall Study|Adverse Event|5|||
130358642|NCT02770170|469284797|FG003|Overall Study|Adverse Event|3|||
130235829|NCT01281306|468827940|FG000|Overall Study|Protocol deviation|0|||
130235830|NCT01281306|468827941|FG001|Overall Study|Protocol deviation|1|||
130235831|NCT01281306|468827942|FG002|Overall Study|Protocol deviation|1|||
130235832|NCT01281306|468827943|FG003|Overall Study|Protocol deviation|1|||
130235833|NCT01281306|468827944|FG004|Overall Study|Protocol deviation|1|||
130235834|NCT01281306|468827945|FG005|Overall Study|Protocol deviation|0|||
130235835|NCT01281306|468827946|FG006|Overall Study|Protocol deviation|0|||
130358643|NCT02770170|469284794|FG000|Overall Study|due to disease worsening|0|||
130358644|NCT02770170|469284795|FG001|Overall Study|due to disease worsening|0|||
130235836|NCT01281306|468827940|FG000|Overall Study|Condition no longer requires study drug|1|||
130235837|NCT01281306|468827941|FG001|Overall Study|Condition no longer requires study drug|0|||
130235838|NCT01281306|468827942|FG002|Overall Study|Condition no longer requires study drug|0|||
130235839|NCT01281306|468827943|FG003|Overall Study|Condition no longer requires study drug|0|||
130235840|NCT01281306|468827944|FG004|Overall Study|Condition no longer requires study drug|0|||
130235841|NCT01281306|468827945|FG005|Overall Study|Condition no longer requires study drug|1|||
130235842|NCT01281306|468827946|FG006|Overall Study|Condition no longer requires study drug|1|||
130235843|NCT01281306|468827940|FG000|Overall Study|Lost to Follow-up|1|||
130235844|NCT01281306|468827941|FG001|Overall Study|Lost to Follow-up|0|||
130235845|NCT01281306|468827942|FG002|Overall Study|Lost to Follow-up|0|||
130235846|NCT01281306|468827943|FG003|Overall Study|Lost to Follow-up|2|||
130235847|NCT01281306|468827944|FG004|Overall Study|Lost to Follow-up|0|||
130235848|NCT01281306|468827945|FG005|Overall Study|Lost to Follow-up|0|||
130235849|NCT01281306|468827946|FG006|Overall Study|Lost to Follow-up|1|||
130235850|NCT01281306|468827940|FG000|Overall Study|Death|1|||
130235851|NCT01281306|468827941|FG001|Overall Study|Death|0|||
130235852|NCT01281306|468827942|FG002|Overall Study|Death|0|||
130235853|NCT01281306|468827943|FG003|Overall Study|Death|0|||
130235854|NCT01281306|468827944|FG004|Overall Study|Death|0|||
130235855|NCT01281306|468827945|FG005|Overall Study|Death|0|||
130235856|NCT01281306|468827946|FG006|Overall Study|Death|0|||
130235857|NCT01281306|468827940|FG000|Overall Study|Adverse Event|3|||
130235858|NCT01281306|468827941|FG001|Overall Study|Adverse Event|2|||
130235859|NCT01281306|468827942|FG002|Overall Study|Adverse Event|2|||
130235860|NCT01281306|468827943|FG003|Overall Study|Adverse Event|3|||
130235861|NCT01281306|468827944|FG004|Overall Study|Adverse Event|5|||
130235862|NCT01281306|468827945|FG005|Overall Study|Adverse Event|3|||
130235863|NCT01281306|468827946|FG006|Overall Study|Adverse Event|3|||
130235864|NCT01281306|468827940|FG000|Overall Study|Randomized in error|1|||
130235865|NCT01281306|468827941|FG001|Overall Study|Randomized in error|0|||
130235866|NCT01281306|468827942|FG002|Overall Study|Randomized in error|0|||
130235867|NCT01281306|468827943|FG003|Overall Study|Randomized in error|1|||
130235868|NCT01281306|468827944|FG004|Overall Study|Randomized in error|0|||
130235869|NCT01281306|468827945|FG005|Overall Study|Randomized in error|0|||
130235870|NCT01281306|468827946|FG006|Overall Study|Randomized in error|0|||
130235871|NCT02606253|468827947|FG000|Overall Study|Adverse Event|2|||
130235872|NCT02606253|468827948|FG001|Overall Study|Adverse Event|0|||
130235873|NCT02606253|468827949|FG002|Overall Study|Adverse Event|0|||
130235874|NCT02606253|468827947|FG000|Overall Study|Protocol Violation|2|||
130235875|NCT02606253|468827948|FG001|Overall Study|Protocol Violation|1|||
130235876|NCT02606253|468827949|FG002|Overall Study|Protocol Violation|0|||
130235877|NCT02606253|468827947|FG000|Overall Study|Physician Decision|1|||
130235878|NCT02606253|468827948|FG001|Overall Study|Physician Decision|1|||
130235879|NCT02606253|468827949|FG002|Overall Study|Physician Decision|0|||
130235880|NCT03331562|468827952|FG000|Overall Study|Adverse Event|2|||
130235881|NCT03331562|468827953|FG001|Overall Study|Adverse Event|0|||
130235882|NCT03331562|468827952|FG000|Overall Study|Death|1|||
130235883|NCT03331562|468827953|FG001|Overall Study|Death|0|||
130235884|NCT03718000|468827954|FG000|Overall Study|Relocation|2|||
130235885|NCT03718000|468827955|FG001|Overall Study|Relocation|4|||
130235886|NCT03718000|468827954|FG000|Overall Study|Pregnancy|0|||
130235887|NCT03718000|468827955|FG001|Overall Study|Pregnancy|1|||
130235888|NCT05522751|468827958|FG000|Overall Study|Adverse Event|1|||
130235889|NCT02475213|468827959|FG000|Overall Study|Adverse Event|2|||
130235890|NCT02475213|468827960|FG001|Overall Study|Adverse Event|0|||
130235891|NCT02475213|468827961|FG002|Overall Study|Adverse Event|0|||
130235892|NCT02475213|468827962|FG003|Overall Study|Adverse Event|1|||
130235893|NCT02475213|468827963|FG004|Overall Study|Adverse Event|1|||
130235894|NCT02475213|468827964|FG005|Overall Study|Adverse Event|4|||
130235895|NCT02475213|468827965|FG006|Overall Study|Adverse Event|6|||
130235896|NCT02475213|468827966|FG007|Overall Study|Adverse Event|2|||
130235897|NCT02475213|468827959|FG000|Overall Study|Physician Decision|1|||
130235898|NCT02475213|468827960|FG001|Overall Study|Physician Decision|1|||
130235899|NCT02475213|468827961|FG002|Overall Study|Physician Decision|1|||
130235900|NCT02475213|468827962|FG003|Overall Study|Physician Decision|0|||
130235901|NCT02475213|468827963|FG004|Overall Study|Physician Decision|0|||
130235902|NCT02475213|468827964|FG005|Overall Study|Physician Decision|1|||
130235903|NCT02475213|468827965|FG006|Overall Study|Physician Decision|4|||
130235904|NCT02475213|468827966|FG007|Overall Study|Physician Decision|0|||
130235905|NCT02475213|468827959|FG000|Overall Study|Progressive Disease|3|||
130235906|NCT02475213|468827960|FG001|Overall Study|Progressive Disease|2|||
130235907|NCT02475213|468827961|FG002|Overall Study|Progressive Disease|2|||
130235908|NCT02475213|468827962|FG003|Overall Study|Progressive Disease|13|||
130235909|NCT02475213|468827963|FG004|Overall Study|Progressive Disease|15|||
130235910|NCT02475213|468827964|FG005|Overall Study|Progressive Disease|25|||
130235911|NCT02475213|468827965|FG006|Overall Study|Progressive Disease|30|||
130235912|NCT02475213|468827966|FG007|Overall Study|Progressive Disease|10|||
130235913|NCT02475213|468827959|FG000|Overall Study|Death|0|||
130235914|NCT02475213|468827960|FG001|Overall Study|Death|0|||
130235915|NCT02475213|468827961|FG002|Overall Study|Death|0|||
130235916|NCT02475213|468827962|FG003|Overall Study|Death|0|||
130235917|NCT02475213|468827963|FG004|Overall Study|Death|0|||
130235918|NCT02475213|468827964|FG005|Overall Study|Death|4|||
130235919|NCT02475213|468827965|FG006|Overall Study|Death|1|||
130235920|NCT02475213|468827966|FG007|Overall Study|Death|0|||
130235921|NCT02475213|468827959|FG000|Overall Study|Protocol Violation|0|||
130235922|NCT02475213|468827960|FG001|Overall Study|Protocol Violation|0|||
130235923|NCT02475213|468827961|FG002|Overall Study|Protocol Violation|0|||
130235924|NCT02475213|468827962|FG003|Overall Study|Protocol Violation|0|||
130235925|NCT02475213|468827963|FG004|Overall Study|Protocol Violation|1|||
130235926|NCT02475213|468827964|FG005|Overall Study|Protocol Violation|0|||
130235927|NCT02475213|468827965|FG006|Overall Study|Protocol Violation|0|||
130235928|NCT02475213|468827966|FG007|Overall Study|Protocol Violation|0|||
130235929|NCT02475213|468827959|FG000|Overall Study|Withdrawal by Subject|0|||
130235930|NCT02475213|468827960|FG001|Overall Study|Withdrawal by Subject|0|||
130235931|NCT02475213|468827961|FG002|Overall Study|Withdrawal by Subject|0|||
130235932|NCT02475213|468827962|FG003|Overall Study|Withdrawal by Subject|1|||
130235933|NCT02475213|468827963|FG004|Overall Study|Withdrawal by Subject|0|||
130235934|NCT02475213|468827964|FG005|Overall Study|Withdrawal by Subject|2|||
130235935|NCT02475213|468827965|FG006|Overall Study|Withdrawal by Subject|2|||
130235936|NCT02475213|468827966|FG007|Overall Study|Withdrawal by Subject|0|||
130235937|NCT02475213|468827959|FG000|Overall Study|Other|0|||
130235938|NCT02475213|468827960|FG001|Overall Study|Other|0|||
130235939|NCT02475213|468827961|FG002|Overall Study|Other|0|||
130235940|NCT02475213|468827962|FG003|Overall Study|Other|1|||
130235941|NCT02475213|468827963|FG004|Overall Study|Other|3|||
130235942|NCT02475213|468827964|FG005|Overall Study|Other|1|||
130235943|NCT02475213|468827965|FG006|Overall Study|Other|0|||
130235944|NCT02475213|468827966|FG007|Overall Study|Other|0|||
130235945|NCT00505921|468827967|FG000|Overall Study|Ineligible|1|||
130235946|NCT00505921|468827967|FG000|Overall Study|Failed to Mobilize|8|||
130235947|NCT02441283|468827968|FG000|Overall Study|Withdrew consent|15|||
130235948|NCT02441283|468827968|FG000|Overall Study|Lost to Follow-up|42|||
130235949|NCT02441283|468827968|FG000|Overall Study|Death|1|||
130235950|NCT02441283|468827968|FG000|Overall Study|Other, not specified|32|||
130235951|NCT02382939|468827974|FG000|Overall Study|Adverse Event|1|||
130235952|NCT02382939|468827975|FG001|Overall Study|Adverse Event|1|||
130235953|NCT02382939|468827974|FG000|Overall Study|Withdrawal by Subject|2|||
130235954|NCT02382939|468827975|FG001|Overall Study|Withdrawal by Subject|2|||
130235955|NCT00537277|468827978|FG000|Overall Study|Adverse Event|1|||
130235956|NCT00537277|468827978|FG000|Overall Study|Lack of Efficacy|2|||
130235957|NCT00537277|468827978|FG000|Overall Study|Lost to Follow-up|12|||
130235958|NCT00537277|468827978|FG000|Overall Study|Protocol Violation|11|||
130235959|NCT00537277|468827978|FG000|Overall Study|Unclassified|4|||
130235960|NCT00537277|468827978|FG000|Overall Study|Inability to tolerate trial medication|4|||
130235961|NCT00537277|468827978|FG000|Overall Study|Non-compliance with trial procedures|15|||
130235962|NCT05383209|468827979|FG000|Overall Study|Adverse Event: Non-ocular|0|||
130235963|NCT05383209|468827980|FG001|Overall Study|Adverse Event: Non-ocular|1|||
130235964|NCT05383209|468827981|FG002|Overall Study|Adverse Event: Non-ocular|0|||
130235965|NCT05383209|468827979|FG000|Overall Study|Lost to Follow-up|2|||
130235966|NCT05383209|468827980|FG001|Overall Study|Lost to Follow-up|1|||
130235967|NCT05383209|468827981|FG002|Overall Study|Lost to Follow-up|4|||
130358645|NCT02770170|469284796|FG002|Overall Study|due to disease worsening|0|||
130358646|NCT02770170|469284797|FG003|Overall Study|due to disease worsening|1|||
130358647|NCT00445978|469284798|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
130358648|NCT00445978|469284798|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
130358649|NCT00445978|469284798|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
130358650|NCT00445978|469284798|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
130358651|NCT00445978|469284798|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
130358652|NCT00445978|469284798|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
130235968|NCT05383209|468827979|FG000|Overall Study|Withdrawal by Subject|2|||
130235969|NCT05383209|468827980|FG001|Overall Study|Withdrawal by Subject|0|||
130446811|NCT04990440|469597090|FG002|Overall Study|Sponsor's Decision|1|||
130235970|NCT05383209|468827981|FG002|Overall Study|Withdrawal by Subject|1|||
130235971|NCT05383209|468827979|FG000|Overall Study|Death|1|||
130235972|NCT05383209|468827980|FG001|Overall Study|Death|0|||
130235973|NCT05383209|468827981|FG002|Overall Study|Death|0|||
130235974|NCT05383209|468827979|FG000|Overall Study|Other|0|||
130235975|NCT05383209|468827980|FG001|Overall Study|Other|1|||
130235976|NCT05383209|468827981|FG002|Overall Study|Other|0|||
130235977|NCT00717886|468827982|FG000|Overall Study|Withdrawal by Subject|3|||
130235978|NCT00717886|468827982|FG000|Overall Study|Treatment Failure|1|||
130235979|NCT00716417|468827983|FG000|Overall Study|Adverse Event|0|||
130235980|NCT00716417|468827984|FG001|Overall Study|Adverse Event|0|||
130235981|NCT00716417|468827985|FG002|Overall Study|Adverse Event|2|||
130235982|NCT00716417|468827986|FG003|Overall Study|Adverse Event|1|||
130235983|NCT00716417|468827987|FG004|Overall Study|Adverse Event|0|||
130235984|NCT00716417|468827988|FG005|Overall Study|Adverse Event|0|||
130235985|NCT00716417|468827989|FG006|Overall Study|Adverse Event|3|||
130235986|NCT00716417|468827990|FG007|Overall Study|Adverse Event|1|||
130235987|NCT00716417|468827991|FG008|Overall Study|Adverse Event|0|||
130235988|NCT00716417|468827992|FG009|Overall Study|Adverse Event|3|||
130235989|NCT00716417|468827983|FG000|Overall Study|Withdrawal by Subject|0|||
130235990|NCT00716417|468827984|FG001|Overall Study|Withdrawal by Subject|1|||
130235991|NCT00716417|468827985|FG002|Overall Study|Withdrawal by Subject|0|||
130235992|NCT00716417|468827986|FG003|Overall Study|Withdrawal by Subject|2|||
130235993|NCT00716417|468827987|FG004|Overall Study|Withdrawal by Subject|0|||
130235994|NCT00716417|468827988|FG005|Overall Study|Withdrawal by Subject|0|||
130235995|NCT00716417|468827989|FG006|Overall Study|Withdrawal by Subject|1|||
130235996|NCT00716417|468827990|FG007|Overall Study|Withdrawal by Subject|0|||
130235997|NCT00716417|468827991|FG008|Overall Study|Withdrawal by Subject|0|||
130235998|NCT00716417|468827992|FG009|Overall Study|Withdrawal by Subject|0|||
130235999|NCT00716417|468827983|FG000|Overall Study|Progressive disease|3|||
130236000|NCT00716417|468827984|FG001|Overall Study|Progressive disease|5|||
130236001|NCT00716417|468827985|FG002|Overall Study|Progressive disease|3|||
130236002|NCT00716417|468827986|FG003|Overall Study|Progressive disease|8|||
130236003|NCT00716417|468827987|FG004|Overall Study|Progressive disease|0|||
130236004|NCT00716417|468827988|FG005|Overall Study|Progressive disease|3|||
130236005|NCT00716417|468827989|FG006|Overall Study|Progressive disease|3|||
130236006|NCT00716417|468827990|FG007|Overall Study|Progressive disease|1|||
130236007|NCT00716417|468827991|FG008|Overall Study|Progressive disease|5|||
130236008|NCT00716417|468827992|FG009|Overall Study|Progressive disease|0|||
130236009|NCT00716417|468827983|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130236010|NCT00716417|468827984|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130236011|NCT00716417|468827985|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130236012|NCT00716417|468827986|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
130236013|NCT00716417|468827987|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
130236014|NCT00716417|468827988|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
130236015|NCT00716417|468827989|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130236016|NCT00716417|468827990|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130236017|NCT00716417|468827991|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
130236018|NCT00716417|468827992|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
130236019|NCT00716417|468827983|FG000|Overall Study|On patient request due to toxicities|0|||
130236020|NCT00716417|468827984|FG001|Overall Study|On patient request due to toxicities|0|||
130236021|NCT00716417|468827985|FG002|Overall Study|On patient request due to toxicities|0|||
130236022|NCT00716417|468827986|FG003|Overall Study|On patient request due to toxicities|0|||
130236023|NCT00716417|468827987|FG004|Overall Study|On patient request due to toxicities|0|||
130236024|NCT00716417|468827988|FG005|Overall Study|On patient request due to toxicities|0|||
130236025|NCT00716417|468827989|FG006|Overall Study|On patient request due to toxicities|0|||
130236026|NCT00716417|468827990|FG007|Overall Study|On patient request due to toxicities|1|||
130236027|NCT00716417|468827991|FG008|Overall Study|On patient request due to toxicities|0|||
130358653|NCT00445978|469284798|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
130446812|NCT03712098|469597091|FG000|Overall Study|Lost to Follow-up|3|||
130236028|NCT00716417|468827992|FG009|Overall Study|On patient request due to toxicities|0|||
130236029|NCT01369433|468827993|FG000|Overall Study|Adverse Event|31|||
130236030|NCT01369433|468827994|FG001|Overall Study|Adverse Event|1|||
130236031|NCT01369433|468827993|FG000|Overall Study|Required significant surgical procedure|1|||
130358654|NCT00445978|469284798|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
130358655|NCT00445978|469284798|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
130358656|NCT01822496|469284801|FG000|Overall Study|Protocol Violation|2|||
130358657|NCT01822496|469284802|FG001|Overall Study|Protocol Violation|2|||
130358658|NCT01822496|469284803|FG002|Overall Study|Protocol Violation|0|||
130358659|NCT01822496|469284804|FG003|Overall Study|Protocol Violation|1|||
130236032|NCT01369433|468827994|FG001|Overall Study|Required significant surgical procedure|0|||
130236033|NCT01369433|468827993|FG000|Overall Study|Non-compliance|1|||
130236034|NCT01369433|468827994|FG001|Overall Study|Non-compliance|0|||
130358660|NCT01822496|469284801|FG000|Overall Study|Withdrawal by Subject|0|||
130358661|NCT01822496|469284802|FG001|Overall Study|Withdrawal by Subject|0|||
130446813|NCT03712098|469597092|FG001|Overall Study|Lost to Follow-up|7|||
130236035|NCT01369433|468827993|FG000|Overall Study|Withdrawal by Subject|5|||
130236036|NCT01369433|468827994|FG001|Overall Study|Withdrawal by Subject|2|||
130236037|NCT01369433|468827993|FG000|Overall Study|Study terminated by Sponsor|67|||
130236038|NCT01369433|468827994|FG001|Overall Study|Study terminated by Sponsor|0|||
130236039|NCT01369433|468827993|FG000|Overall Study|Lost to Follow-up|1|||
130236040|NCT01369433|468827994|FG001|Overall Study|Lost to Follow-up|0|||
130236041|NCT01369433|468827993|FG000|Overall Study|Death|5|||
130236042|NCT01369433|468827994|FG001|Overall Study|Death|0|||
130236043|NCT01369433|468827993|FG000|Overall Study|Investigator discretion|6|||
130236044|NCT01369433|468827994|FG001|Overall Study|Investigator discretion|1|||
130236045|NCT01369433|468827993|FG000|Overall Study|Progressive Disease|92|||
130236046|NCT01369433|468827994|FG001|Overall Study|Progressive Disease|12|||
130236047|NCT01553851|468827995|FG000|Overall Study|Adverse Event|2|||
130236048|NCT01553851|468827995|FG000|Overall Study|constipation|1|||
130236049|NCT01838876|468827997|FG000|Overall Study|Adverse Event|49|||
130236050|NCT01838876|468827997|FG000|Overall Study|Insufficient Therapeutic Response|10|||
130236051|NCT01838876|468827997|FG000|Overall Study|Protocol Violation|34|||
130236052|NCT01838876|468827997|FG000|Overall Study|Withdrawal of Consent|33|||
130236053|NCT01838876|468827997|FG000|Overall Study|Lost to Follow-up|21|||
130236054|NCT01838876|468827997|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
130236055|NCT01838876|468827997|FG000|Overall Study|Reason not Specified|7|||
130236056|NCT01838876|468827997|FG000|Overall Study|Did not meet eligibility criteria|78|||
130236057|NCT02101294|468827998|FG000|Overall Study|Withdrawal by Subject|5|||
130236058|NCT02101294|468827998|FG000|Overall Study|Lost to Follow-up|6|||
130236059|NCT02755090|468828004|FG000|Overall Study|equipment malfunction|1|||
130236060|NCT02755090|468828005|FG001|Overall Study|equipment malfunction|0|||
130236061|NCT00207740|468828009|FG000|Overall Study|Adverse Event|4|||
130236062|NCT00207740|468828010|FG001|Overall Study|Adverse Event|14|||
130236063|NCT00207740|468828011|FG002|Overall Study|Adverse Event|14|||
130236064|NCT00207740|468828012|FG003|Overall Study|Adverse Event|11|||
130236065|NCT00207740|468828009|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130236066|NCT00207740|468828010|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130236067|NCT00207740|468828011|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130236068|NCT00207740|468828012|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
130236069|NCT00207740|468828009|FG000|Overall Study|Lost to Follow-up|0|||
130236070|NCT00207740|468828010|FG001|Overall Study|Lost to Follow-up|2|||
130236071|NCT00207740|468828011|FG002|Overall Study|Lost to Follow-up|1|||
130236072|NCT00207740|468828012|FG003|Overall Study|Lost to Follow-up|1|||
130236073|NCT00207740|468828009|FG000|Overall Study|Death|0|||
130236074|NCT00207740|468828010|FG001|Overall Study|Death|0|||
130236075|NCT00207740|468828011|FG002|Overall Study|Death|0|||
130236076|NCT00207740|468828012|FG003|Overall Study|Death|1|||
130236077|NCT00207740|468828009|FG000|Overall Study|Sponsor Directive|22|||
130236078|NCT00207740|468828010|FG001|Overall Study|Sponsor Directive|15|||
130236079|NCT00207740|468828011|FG002|Overall Study|Sponsor Directive|16|||
130236080|NCT00207740|468828012|FG003|Overall Study|Sponsor Directive|21|||
130236081|NCT00207740|468828009|FG000|Overall Study|Other|2|||
130236082|NCT00207740|468828010|FG001|Overall Study|Other|10|||
130236083|NCT00207740|468828011|FG002|Overall Study|Other|7|||
130236084|NCT00207740|468828012|FG003|Overall Study|Other|5|||
130236085|NCT00390013|468828013|FG000|Phase 1|tired|0|||
130236086|NCT00390013|468828014|FG001|Phase 1|tired|0|||
130236087|NCT00390013|468828015|FG002|Phase 1|tired|0|||
130236088|NCT00390013|468828016|FG003|Phase 1|tired|1|||
130236089|NCT00390013|468828013|FG000|Phase 2 First Treatment|tired|1|||
130236090|NCT00390013|468828014|FG001|Phase 2 First Treatment|tired|0|||
130236091|NCT00390013|468828015|FG002|Phase 2 First Treatment|tired|0|||
130236092|NCT00390013|468828016|FG003|Phase 2 First Treatment|tired|0|||
130236093|NCT00390013|468828013|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236094|NCT00390013|468828014|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
130236095|NCT00390013|468828015|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236096|NCT00390013|468828016|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236097|NCT00924898|468828022|FG000|Overall Study|Withdrawal by Subject|2|||
130236098|NCT00294658|468828023|FG000|Overall Study|Death|0|||
130236099|NCT00294658|468828024|FG001|Overall Study|Death|1|||
130236100|NCT00294658|468828023|FG000|Overall Study|Lost to Follow-up|4|||
130236101|NCT00294658|468828024|FG001|Overall Study|Lost to Follow-up|0|||
130236102|NCT00294658|468828023|FG000|Overall Study|Physician Decision|1|||
130236103|NCT00294658|468828024|FG001|Overall Study|Physician Decision|2|||
130236104|NCT00294658|468828023|FG000|Overall Study|Pregnancy|0|||
130236105|NCT00294658|468828024|FG001|Overall Study|Pregnancy|1|||
130236106|NCT00294658|468828023|FG000|Overall Study|Withdrawal by Subject|0|||
130236107|NCT00294658|468828024|FG001|Overall Study|Withdrawal by Subject|4|||
130236108|NCT00294658|468828023|FG000|Overall Study|Found to have invasive thymoma|1|||
130236109|NCT00294658|468828024|FG001|Overall Study|Found to have invasive thymoma|0|||
130236110|NCT00294658|468828023|FG000|Overall Study|Patient and family were not satisfied|0|||
130236111|NCT00294658|468828024|FG001|Overall Study|Patient and family were not satisfied|1|||
130236112|NCT01910441|468828025|FG000|Overall Study|Sponsor decision|0|||
130236113|NCT01910441|468828026|FG001|Overall Study|Sponsor decision|2|||
130236114|NCT01910441|468828025|FG000|Overall Study|Lost to Follow-up|6|||
130236115|NCT01910441|468828026|FG001|Overall Study|Lost to Follow-up|5|||
130236116|NCT01910441|468828025|FG000|Overall Study|Withdrawal by Subject|0|||
130236117|NCT01910441|468828026|FG001|Overall Study|Withdrawal by Subject|1|||
130236118|NCT01910441|468828025|FG000|Overall Study|Non-compliance|0|||
130236119|NCT01910441|468828026|FG001|Overall Study|Non-compliance|1|||
130236120|NCT01910441|468828025|FG000|Overall Study|Adverse Event|1|||
130236121|NCT01910441|468828026|FG001|Overall Study|Adverse Event|0|||
130236122|NCT01910441|468828025|FG000|Overall Study|Physician Decision|0|||
130236123|NCT01910441|468828026|FG001|Overall Study|Physician Decision|1|||
130236124|NCT01811238|468828027|FG000|Overall Study|Withdrawal by Subject|42|||
130236125|NCT01811238|468828027|FG000|Overall Study|Adverse Event|25|||
130236126|NCT01811238|468828027|FG000|Overall Study|Protocol Violation|4|||
130236127|NCT01811238|468828027|FG000|Overall Study|Lack of Efficacy|4|||
130236128|NCT01811238|468828027|FG000|Overall Study|subject refused study medication|6|||
130236129|NCT02340949|468828028|FG000|Overall Study|Adverse Event|4|||
130236130|NCT02340949|468828029|FG001|Overall Study|Adverse Event|2|||
130236131|NCT02340949|468828028|FG000|Overall Study|Withdrawal by Subject|2|||
130236132|NCT02340949|468828029|FG001|Overall Study|Withdrawal by Subject|0|||
130236133|NCT02340949|468828028|FG000|Overall Study|Progression disease|6|||
130236134|NCT02340949|468828029|FG001|Overall Study|Progression disease|2|||
130236135|NCT02340949|468828028|FG000|Overall Study|Death|3|||
130236136|NCT02340949|468828029|FG001|Overall Study|Death|0|||
130236137|NCT02340949|468828028|FG000|Overall Study|Physician Decision|1|||
130236138|NCT02340949|468828029|FG001|Overall Study|Physician Decision|0|||
130236139|NCT01192178|468828030|FG000|Overall Study|Withdrawal by Subject|6|||
130236140|NCT01192178|468828031|FG001|Overall Study|Withdrawal by Subject|10|||
130236141|NCT01192178|468828030|FG000|Overall Study|Protocol Violation|10|||
130236142|NCT01192178|468828031|FG001|Overall Study|Protocol Violation|3|||
130236143|NCT01192178|468828030|FG000|Overall Study|Physician Decision|2|||
130236144|NCT01192178|468828031|FG001|Overall Study|Physician Decision|4|||
130236145|NCT01192178|468828030|FG000|Overall Study|Lost to Follow-up|3|||
130236146|NCT01192178|468828031|FG001|Overall Study|Lost to Follow-up|3|||
130236147|NCT01192178|468828030|FG000|Overall Study|Adverse Event|2|||
130236148|NCT01192178|468828031|FG001|Overall Study|Adverse Event|1|||
130236149|NCT01192178|468828030|FG000|Overall Study|Lack of Efficacy|1|||
130236150|NCT01192178|468828031|FG001|Overall Study|Lack of Efficacy|2|||
130446814|NCT03712098|469597091|FG000|Overall Study|Withdrawal by Subject|9|||
130446815|NCT03712098|469597092|FG001|Overall Study|Withdrawal by Subject|4|||
130446816|NCT03712098|469597091|FG000|Overall Study|Protocol Violation|2|||
130446817|NCT03712098|469597092|FG001|Overall Study|Protocol Violation|1|||
130446818|NCT02724020|469597095|FG000|Overall Study|Death|16|||
130446819|NCT02724020|469597096|FG001|Overall Study|Death|18|||
130446820|NCT02724020|469597097|FG002|Overall Study|Death|19|||
130446821|NCT02724020|469597095|FG000|Overall Study|Lost to Follow-up|0|||
130446822|NCT02724020|469597096|FG001|Overall Study|Lost to Follow-up|3|||
130236151|NCT01155570|468828032|FG000|Overall Study|Adverse Event|39|||
130236152|NCT01155570|468828032|FG000|Overall Study|Lack of Efficacy|46|||
130236153|NCT01155570|468828032|FG000|Overall Study|Participant's Economic Reasons|17|||
130446823|NCT02724020|469597097|FG002|Overall Study|Lost to Follow-up|0|||
130446824|NCT02724020|469597095|FG000|Overall Study|Site Terminated by Sponsor|15|||
130446825|NCT02724020|469597096|FG001|Overall Study|Site Terminated by Sponsor|8|||
130446826|NCT02724020|469597097|FG002|Overall Study|Site Terminated by Sponsor|8|||
130236154|NCT01155570|468828032|FG000|Overall Study|No Hospital Visits|7|||
130236155|NCT01155570|468828032|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
130236156|NCT01155570|468828032|FG000|Overall Study|Adverse Event + Other Reasons|7|||
130236157|NCT01155570|468828032|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
130236158|NCT01155570|468828032|FG000|Overall Study|Other Reasons|23|||
130236159|NCT00296517|468828033|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
130446827|NCT02724020|469597095|FG000|Overall Study|Withdrawal by Subject|1|||
130446828|NCT02724020|469597096|FG001|Overall Study|Withdrawal by Subject|3|||
130446829|NCT02724020|469597097|FG002|Overall Study|Withdrawal by Subject|5|||
130446830|NCT01066156|469597098|FG000|Overall Study|ineligible|2|||
130446831|NCT01066156|469597098|FG000|Overall Study|Lost to Follow-up|7|||
130236160|NCT00296517|468828034|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
130236161|NCT00296517|468828033|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
130236162|NCT00296517|468828034|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
130236163|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
130236164|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
130236165|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
130236166|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
130236167|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
130236168|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
130236169|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
130236170|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
130446832|NCT01066156|469597098|FG000|Overall Study|Withdrawal by Subject|1|||
130446833|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
130236171|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
130236172|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
130236173|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
130236174|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
130236175|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
130236176|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
130236177|NCT04584788|468828053|FG000|Overall Study|Physician Decision|8|||
130236178|NCT04584788|468828053|FG000|Overall Study|Withdrawal by Subject|1|||
130236179|NCT04584788|468828053|FG000|Overall Study|Adverse Event|3|||
130316133|NCT02079740|469124298|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316134|NCT02079740|469124299|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316135|NCT02079740|469124300|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316136|NCT02079740|469124301|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316137|NCT02079740|469124302|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316138|NCT02079740|469124303|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316139|NCT02079740|469124304|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316140|NCT02079740|469124305|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316141|NCT02079740|469124306|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316142|NCT02079740|469124307|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130316143|NCT02079740|469124308|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316144|NCT02079740|469124309|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
130316145|NCT02079740|469124310|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130316146|NCT03493945|469124311|FG000|Phase I Dose Escalation|Ineligible|0|||
130316147|NCT03493945|469124312|FG001|Phase I Dose Escalation|Ineligible|0|||
130316148|NCT03493945|469124313|FG002|Phase I Dose Escalation|Ineligible|1|||
130316149|NCT03493945|469124314|FG003|Phase I Dose Escalation|Ineligible|0|||
130316150|NCT03493945|469124315|FG004|Phase I Dose Escalation|Ineligible|0|||
130316151|NCT03493945|469124316|FG005|Phase I Dose Escalation|Ineligible|0|||
130316152|NCT03493945|469124317|FG006|Phase I Dose Escalation|Ineligible|0|||
130316153|NCT03493945|469124311|FG000|Phase I Dose Escalation|New therapy|0|||
130316154|NCT03493945|469124312|FG001|Phase I Dose Escalation|New therapy|1|||
130316155|NCT03493945|469124313|FG002|Phase I Dose Escalation|New therapy|0|||
130316156|NCT03493945|469124314|FG003|Phase I Dose Escalation|New therapy|0|||
130316157|NCT03493945|469124315|FG004|Phase I Dose Escalation|New therapy|0|||
130316158|NCT03493945|469124316|FG005|Phase I Dose Escalation|New therapy|0|||
130316159|NCT03493945|469124317|FG006|Phase I Dose Escalation|New therapy|0|||
130316160|NCT03493945|469124311|FG000|Phase II Dose Expansion|Refused further treatment|0|||
130316161|NCT03493945|469124312|FG001|Phase II Dose Expansion|Refused further treatment|0|||
130316162|NCT03493945|469124313|FG002|Phase II Dose Expansion|Refused further treatment|0|||
130316163|NCT03493945|469124314|FG003|Phase II Dose Expansion|Refused further treatment|0|||
130316164|NCT03493945|469124315|FG004|Phase II Dose Expansion|Refused further treatment|1|||
130316165|NCT03493945|469124316|FG005|Phase II Dose Expansion|Refused further treatment|1|||
130316166|NCT03493945|469124317|FG006|Phase II Dose Expansion|Refused further treatment|0|||
130316167|NCT03493945|469124311|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316168|NCT03493945|469124312|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316169|NCT03493945|469124313|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316170|NCT03493945|469124314|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
130316171|NCT03493945|469124315|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316172|NCT03493945|469124316|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316173|NCT03493945|469124317|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316174|NCT01690052|469124322|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
130316175|NCT01690052|469124323|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
130316176|NCT02421172|469124324|FG000|Period 1|Adverse Event|1|||
130316177|NCT02421172|469124325|FG001|Period 1|Adverse Event|0|||
130316178|NCT02421172|469124326|FG002|Period 1|Adverse Event|0|||
130316179|NCT02421172|469124327|FG003|Period 1|Adverse Event|0|||
130316180|NCT02421172|469124328|FG004|Period 1|Adverse Event|0|||
130316181|NCT02421172|469124324|FG000|Period 1|Lost to Follow-up|3|||
130316182|NCT02421172|469124325|FG001|Period 1|Lost to Follow-up|1|||
130316183|NCT02421172|469124326|FG002|Period 1|Lost to Follow-up|0|||
130316184|NCT02421172|469124327|FG003|Period 1|Lost to Follow-up|0|||
130316185|NCT02421172|469124328|FG004|Period 1|Lost to Follow-up|0|||
130316186|NCT02421172|469124324|FG000|Period 1|Patient/guardian decision|0|||
130316187|NCT02421172|469124325|FG001|Period 1|Patient/guardian decision|1|||
130316188|NCT02421172|469124326|FG002|Period 1|Patient/guardian decision|0|||
130316189|NCT02421172|469124327|FG003|Period 1|Patient/guardian decision|0|||
130316190|NCT02421172|469124328|FG004|Period 1|Patient/guardian decision|0|||
130316191|NCT02421172|469124324|FG000|Period 2|Adverse Event|0|||
130316192|NCT02421172|469124325|FG001|Period 2|Adverse Event|0|||
130316193|NCT02421172|469124326|FG002|Period 2|Adverse Event|4|||
130316194|NCT02421172|469124327|FG003|Period 2|Adverse Event|0|||
130316195|NCT02421172|469124328|FG004|Period 2|Adverse Event|0|||
130316196|NCT02421172|469124324|FG000|Period 2|Lost to Follow-up|0|||
130316197|NCT02421172|469124325|FG001|Period 2|Lost to Follow-up|0|||
130236180|NCT03095287|468829731|FG000|Overall Study|Treatment Failure|1|||
130236181|NCT03095287|468829731|FG000|Overall Study|Adverse Event|1|||
130236182|NCT02394275|468829734|FG000|Overall Study|Adverse Event|22|||
130236183|NCT02394275|468829734|FG000|Overall Study|Lost to Follow-up|7|||
130236184|NCT04757636|468829740|FG000|Overall Study|Adverse Event|25|||
130236185|NCT04757636|468829741|FG001|Overall Study|Adverse Event|8|||
130236186|NCT04757636|468829742|FG002|Overall Study|Adverse Event|11|||
130236187|NCT04757636|468829740|FG000|Overall Study|Death|9|||
130236188|NCT04757636|468829741|FG001|Overall Study|Death|12|||
130236189|NCT04757636|468829742|FG002|Overall Study|Death|6|||
130236190|NCT04757636|468829740|FG000|Overall Study|Lack of Efficacy|2|||
130236191|NCT04757636|468829741|FG001|Overall Study|Lack of Efficacy|0|||
130236192|NCT04757636|468829742|FG002|Overall Study|Lack of Efficacy|0|||
130236193|NCT04757636|468829740|FG000|Overall Study|Lost to Follow-up|1|||
130236194|NCT04757636|468829741|FG001|Overall Study|Lost to Follow-up|6|||
130236195|NCT04757636|468829742|FG002|Overall Study|Lost to Follow-up|7|||
130236196|NCT04757636|468829740|FG000|Overall Study|Physician Decision|1|||
130236197|NCT04757636|468829741|FG001|Overall Study|Physician Decision|3|||
130236198|NCT04757636|468829742|FG002|Overall Study|Physician Decision|4|||
130236199|NCT04757636|468829740|FG000|Overall Study|Withdrawal by Subject|20|||
130236200|NCT04757636|468829741|FG001|Overall Study|Withdrawal by Subject|23|||
130236201|NCT04757636|468829742|FG002|Overall Study|Withdrawal by Subject|18|||
130236202|NCT04757636|468829740|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130236203|NCT04757636|468829741|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
130236204|NCT04757636|468829742|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130236205|NCT04757636|468829740|FG000|Overall Study|Study Terminated by Sponsor|103|||
130236206|NCT04757636|468829741|FG001|Overall Study|Study Terminated by Sponsor|104|||
130236207|NCT04757636|468829742|FG002|Overall Study|Study Terminated by Sponsor|114|||
130236208|NCT04757636|468829740|FG000|Overall Study|Sponsor Decision|0|||
130236209|NCT04757636|468829741|FG001|Overall Study|Sponsor Decision|0|||
130236210|NCT04757636|468829742|FG002|Overall Study|Sponsor Decision|1|||
130236211|NCT04757636|468829740|FG000|Overall Study|Randomized in Error|0|||
130236212|NCT04757636|468829741|FG001|Overall Study|Randomized in Error|0|||
130236213|NCT04757636|468829742|FG002|Overall Study|Randomized in Error|2|||
130236214|NCT05350423|468829748|FG000|Overall Study|Lost to Follow-up|3|||
130446834|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
130446835|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
130446836|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
130446837|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
130446838|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
130446839|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
130446840|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
130446841|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
130446842|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
130446843|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
130446844|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
130446845|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
130446846|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
130446847|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
130446848|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
130446849|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
130446850|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
130446851|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
130446852|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
130694665|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694666|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694667|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694668|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694669|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
130236215|NCT05350423|468829749|FG001|Overall Study|Lost to Follow-up|3|||
130236216|NCT05350423|468829748|FG000|Overall Study|screen failure|5|||
130236217|NCT05350423|468829749|FG001|Overall Study|screen failure|6|||
130236218|NCT02097277|468829750|FG000|Overall Study|Subject no longer meets study criteria|0|||
130236219|NCT02097277|468829751|FG001|Overall Study|Subject no longer meets study criteria|1|||
130236220|NCT02097277|468829752|FG002|Overall Study|Subject no longer meets study criteria|0|||
130236221|NCT02097277|468829753|FG003|Overall Study|Subject no longer meets study criteria|1|||
130446853|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
130694670|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130236222|NCT02097277|468829754|FG004|Overall Study|Subject no longer meets study criteria|0|||
130236223|NCT02097277|468829750|FG000|Overall Study|Subject request to discontinue treatment|0|||
130236224|NCT02097277|468829751|FG001|Overall Study|Subject request to discontinue treatment|0|||
130694671|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130236225|NCT02097277|468829752|FG002|Overall Study|Subject request to discontinue treatment|0|||
130236226|NCT02097277|468829753|FG003|Overall Study|Subject request to discontinue treatment|0|||
130236227|NCT02097277|468829754|FG004|Overall Study|Subject request to discontinue treatment|1|||
130236228|NCT02097277|468829750|FG000|Overall Study|Lost to Follow-up|0|||
130236229|NCT02097277|468829751|FG001|Overall Study|Lost to Follow-up|1|||
130236230|NCT02097277|468829752|FG002|Overall Study|Lost to Follow-up|1|||
130236231|NCT02097277|468829753|FG003|Overall Study|Lost to Follow-up|0|||
130236232|NCT02097277|468829754|FG004|Overall Study|Lost to Follow-up|0|||
130236233|NCT02097277|468829750|FG000|Overall Study|Withdrawal by Subject|2|||
130236234|NCT02097277|468829751|FG001|Overall Study|Withdrawal by Subject|1|||
130236235|NCT02097277|468829752|FG002|Overall Study|Withdrawal by Subject|0|||
130236236|NCT02097277|468829753|FG003|Overall Study|Withdrawal by Subject|1|||
130236237|NCT02097277|468829754|FG004|Overall Study|Withdrawal by Subject|0|||
130236238|NCT02097277|468829750|FG000|Overall Study|Adverse Event|0|||
130236239|NCT02097277|468829751|FG001|Overall Study|Adverse Event|0|||
130236240|NCT02097277|468829752|FG002|Overall Study|Adverse Event|1|||
130236241|NCT02097277|468829753|FG003|Overall Study|Adverse Event|2|||
130236242|NCT02097277|468829754|FG004|Overall Study|Adverse Event|0|||
130236243|NCT01091259|468829757|FG000|Overall Study|Adverse Event|3|||
130236244|NCT01091259|468829757|FG000|Overall Study|Lack of Efficacy|2|||
130236245|NCT00671060|468829760|FG000|Overall Study|Protocol Violation|1|||
130236246|NCT00671060|468829761|FG001|Overall Study|Protocol Violation|0|||
130358662|NCT01822496|469284803|FG002|Overall Study|Withdrawal by Subject|0|||
130358663|NCT01822496|469284804|FG003|Overall Study|Withdrawal by Subject|3|||
130358664|NCT00304239|469284805|FG000|Overall Study|Protocol Deviations/Violations|15|||
130358665|NCT00304239|469284806|FG001|Overall Study|Protocol Deviations/Violations|0|||
130358666|NCT00304239|469284805|FG000|Overall Study|Adverse Event|2|||
130358667|NCT00304239|469284806|FG001|Overall Study|Adverse Event|0|||
130358668|NCT02979197|469284807|FG000|Overall Study|Adverse Event|4|||
130358669|NCT02979197|469284808|FG001|Overall Study|Adverse Event|2|||
130358670|NCT02979197|469284809|FG002|Overall Study|Adverse Event|0|||
130236247|NCT00671060|468829760|FG000|Overall Study|Physician Decision|0|||
130236248|NCT00671060|468829761|FG001|Overall Study|Physician Decision|1|||
130236249|NCT06057064|468829762|FG000|Overall Study|Death|2|||
130236250|NCT06057064|468829763|FG001|Overall Study|Death|0|||
130236251|NCT06057064|468829762|FG000|Overall Study|Physician Decision|1|||
130236252|NCT06057064|468829763|FG001|Overall Study|Physician Decision|0|||
130236253|NCT06057064|468829762|FG000|Overall Study|Withdrawal by Subject|1|||
130236254|NCT06057064|468829763|FG001|Overall Study|Withdrawal by Subject|1|||
130236255|NCT01541748|468829764|FG000|Overall Study|Lost to Follow-up|17|||
130236256|NCT01541748|468829764|FG000|Overall Study|Moved out of state|1|||
130236257|NCT01541748|468829764|FG000|Overall Study|Withdrawal by Subject|7|||
130236258|NCT01541748|468829764|FG000|Overall Study|Screen failure|5|||
130236259|NCT01541748|468829764|FG000|Overall Study|Did not receive study device|1|||
130236260|NCT02832037|468829765|FG000|Overall Study|Administrative reasons|0|||
130236261|NCT02832037|468829766|FG001|Overall Study|Administrative reasons|0|||
130236262|NCT02832037|468829767|FG002|Overall Study|Administrative reasons|1|||
130236263|NCT02832037|468829768|FG003|Overall Study|Administrative reasons|0|||
130236264|NCT02832037|468829769|FG004|Overall Study|Administrative reasons|0|||
130236265|NCT02832037|468829765|FG000|Overall Study|Protocol Violation|3|||
130236266|NCT02832037|468829766|FG001|Overall Study|Protocol Violation|0|||
130236267|NCT02832037|468829767|FG002|Overall Study|Protocol Violation|4|||
130236268|NCT02832037|468829768|FG003|Overall Study|Protocol Violation|1|||
130236269|NCT02832037|468829769|FG004|Overall Study|Protocol Violation|2|||
130236270|NCT02832037|468829765|FG000|Overall Study|Lost to Follow-up|2|||
130236271|NCT02832037|468829766|FG001|Overall Study|Lost to Follow-up|0|||
130358671|NCT02979197|469284807|FG000|Overall Study|Protocol Violation|0|||
130358672|NCT02979197|469284808|FG001|Overall Study|Protocol Violation|1|||
130358673|NCT02979197|469284809|FG002|Overall Study|Protocol Violation|0|||
130358674|NCT02979197|469284807|FG000|Overall Study|Subject unable to commit to study dates|0|||
130358675|NCT02979197|469284808|FG001|Overall Study|Subject unable to commit to study dates|1|||
130358676|NCT02979197|469284809|FG002|Overall Study|Subject unable to commit to study dates|0|||
130358677|NCT03438383|469284810|FG000|Overall Study|Protocol Violation|9|||
130358678|NCT03438383|469284811|FG001|Overall Study|Protocol Violation|3|||
130358679|NCT02766465|469284812|FG000|Overall Study|Withdrawal by Subject|0|||
130358680|NCT02766465|469284813|FG001|Overall Study|Withdrawal by Subject|10|||
130236272|NCT02832037|468829767|FG002|Overall Study|Lost to Follow-up|3|||
130358681|NCT01631812|469284814|FG000|Overall Study|Adverse Event|25|||
130236273|NCT02832037|468829768|FG003|Overall Study|Lost to Follow-up|0|||
130236274|NCT02832037|468829769|FG004|Overall Study|Lost to Follow-up|5|||
130236275|NCT02832037|468829765|FG000|Overall Study|Withdrawal by Subject|9|||
130236276|NCT02832037|468829766|FG001|Overall Study|Withdrawal by Subject|8|||
130236277|NCT02832037|468829767|FG002|Overall Study|Withdrawal by Subject|0|||
130358682|NCT01631812|469284814|FG000|Overall Study|Lack of Efficacy|5|||
130236278|NCT02832037|468829768|FG003|Overall Study|Withdrawal by Subject|4|||
130236279|NCT02832037|468829769|FG004|Overall Study|Withdrawal by Subject|8|||
130236280|NCT02832037|468829765|FG000|Overall Study|Adverse Event|5|||
130236281|NCT02832037|468829766|FG001|Overall Study|Adverse Event|4|||
130236282|NCT02832037|468829767|FG002|Overall Study|Adverse Event|0|||
130236283|NCT02832037|468829768|FG003|Overall Study|Adverse Event|2|||
130236284|NCT02832037|468829769|FG004|Overall Study|Adverse Event|4|||
130236285|NCT03329989|468829770|FG000|Overall Study|Withdrawal by Subject|9|||
130236286|NCT03329989|468829770|FG000|Overall Study|Lost to Follow-up|8|||
130236287|NCT03329989|468829770|FG000|Overall Study|Adverse Event|5|||
130236288|NCT03329989|468829770|FG000|Overall Study|Protocol Violation|1|||
130236289|NCT00435942|468829773|FG000|Overall Study|Death|17|||
130236290|NCT00435942|468829774|FG001|Overall Study|Death|10|||
130236291|NCT00435942|468829773|FG000|Overall Study|Withdrawal by Subject|2|||
130236292|NCT00435942|468829774|FG001|Overall Study|Withdrawal by Subject|0|||
130236293|NCT00435942|468829773|FG000|Overall Study|Lost to Follow-up|0|||
130236294|NCT00435942|468829774|FG001|Overall Study|Lost to Follow-up|16|||
130236295|NCT00435942|468829773|FG000|Overall Study|Conversion to Open Repair|1|||
130236296|NCT00435942|468829774|FG001|Overall Study|Conversion to Open Repair|0|||
130236297|NCT00435942|468829773|FG000|Overall Study|Technical Failure|3|||
130236298|NCT00435942|468829774|FG001|Overall Study|Technical Failure|0|||
130236299|NCT00435942|468829773|FG000|Overall Study|Other|0|||
130236300|NCT00435942|468829774|FG001|Overall Study|Other|1|||
130236301|NCT04491994|468829775|FG000|Overall Study|Withdrawal by Subject|10|||
130236302|NCT04491994|468829776|FG001|Overall Study|Withdrawal by Subject|5|||
130236303|NCT04491994|468829775|FG000|Overall Study|developed fever > 3 days|4|||
130236304|NCT04491994|468829776|FG001|Overall Study|developed fever > 3 days|1|||
130236305|NCT04491994|468829775|FG000|Overall Study|Protocol Violation|11|||
130236306|NCT04491994|468829776|FG001|Overall Study|Protocol Violation|2|||
130236307|NCT04491994|468829775|FG000|Overall Study|Lost to Follow-up|4|||
130236308|NCT04491994|468829776|FG001|Overall Study|Lost to Follow-up|3|||
130236309|NCT04167462|468829784|FG000|Overall Study|Other reasons|3|||
130236310|NCT04167462|468829785|FG001|Overall Study|Other reasons|2|||
130236311|NCT04167462|468829784|FG000|Overall Study|Withdrawal by Subject|6|||
130236312|NCT04167462|468829785|FG001|Overall Study|Withdrawal by Subject|7|||
130236313|NCT04167462|468829784|FG000|Overall Study|Adverse Event|4|||
130236314|NCT04167462|468829785|FG001|Overall Study|Adverse Event|0|||
130236315|NCT04167462|468829784|FG000|Overall Study|Pregnancy|1|||
130236316|NCT04167462|468829785|FG001|Overall Study|Pregnancy|0|||
130236317|NCT04167462|468829784|FG000|Overall Study|Lack of Efficacy|0|||
130236318|NCT04167462|468829785|FG001|Overall Study|Lack of Efficacy|1|||
130236319|NCT03881371|468829790|FG000|Overall Study|Adverse Event|8|||
130236320|NCT03881371|468829791|FG001|Overall Study|Adverse Event|9|||
130236321|NCT03881371|468829790|FG000|Overall Study|Death|1|||
130236322|NCT03881371|468829791|FG001|Overall Study|Death|0|||
130236323|NCT03881371|468829790|FG000|Overall Study|Lost to Follow-up|1|||
130236324|NCT03881371|468829791|FG001|Overall Study|Lost to Follow-up|0|||
130236325|NCT03881371|468829790|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130236326|NCT03881371|468829791|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130236327|NCT03881371|468829790|FG000|Overall Study|Physician Decision|3|||
130236328|NCT03881371|468829791|FG001|Overall Study|Physician Decision|3|||
130236329|NCT03881371|468829790|FG000|Overall Study|Withdrawal by Subject|2|||
130236330|NCT03881371|468829791|FG001|Overall Study|Withdrawal by Subject|10|||
130236331|NCT03881371|468829790|FG000|Overall Study|Discontinuation from Study|1|||
130236332|NCT03881371|468829791|FG001|Overall Study|Discontinuation from Study|0|||
130236333|NCT00933933|468829795|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130236334|NCT00933933|468829796|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
130236335|NCT00933933|468829797|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130236336|NCT00933933|468829795|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130236337|NCT00933933|468829796|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
130236338|NCT00933933|468829797|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130236339|NCT01138046|468829798|FG000|Overall Study|Withdrawal due to death|6|||
130236340|NCT02178956|468829799|FG000|Overall Study|Lost to Follow-up|4|||
130236341|NCT02178956|468829800|FG001|Overall Study|Lost to Follow-up|4|||
130236342|NCT02178956|468829799|FG000|Overall Study|Sponsor terminated study|49|||
130236343|NCT02178956|468829800|FG001|Overall Study|Sponsor terminated study|58|||
130236344|NCT02178956|468829799|FG000|Overall Study|Withdrawal by Subject|15|||
130236345|NCT02178956|468829800|FG001|Overall Study|Withdrawal by Subject|11|||
130236346|NCT02178956|468829799|FG000|Overall Study|Various Reasons|3|||
130236347|NCT02178956|468829800|FG001|Overall Study|Various Reasons|5|||
130236348|NCT01900314|468829801|FG000|Overall Study|Lost to Follow-up|1|||
130236349|NCT01900314|468829802|FG001|Overall Study|Lost to Follow-up|0|||
130236350|NCT01900314|468829801|FG000|Overall Study|Protocol Violation|0|||
130236351|NCT01900314|468829802|FG001|Overall Study|Protocol Violation|1|||
130236352|NCT01900314|468829801|FG000|Overall Study|Withdrawal by Subject|3|||
130236353|NCT01900314|468829802|FG001|Overall Study|Withdrawal by Subject|3|||
130236354|NCT04225832|468829803|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
130236355|NCT04225832|468829804|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
130236356|NCT04225832|468829803|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
130236357|NCT04225832|468829804|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
130236358|NCT03282097|468829805|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
130236359|NCT03282097|468829806|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
130236360|NCT03282097|468829805|FG000|Intervention Visit Complete|Patient Death|13|||
130236361|NCT03282097|468829806|FG001|Intervention Visit Complete|Patient Death|15|||
130236362|NCT03282097|468829805|FG000|Intervention Visit Complete|Caregiver Death|0|||
130236363|NCT03282097|468829806|FG001|Intervention Visit Complete|Caregiver Death|3|||
130236364|NCT03282097|468829805|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
130236365|NCT03282097|468829806|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
130236366|NCT03282097|468829805|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
130236367|NCT03282097|468829806|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
130236368|NCT03282097|468829805|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
130236369|NCT03282097|468829806|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
130236370|NCT03282097|468829805|FG000|Primary Outcome Data Collection Complete|Missing|2|||
130236371|NCT03282097|468829806|FG001|Primary Outcome Data Collection Complete|Missing|3|||
130236372|NCT03282097|468829805|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
130236373|NCT03282097|468829806|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
130236374|NCT03282097|468829805|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
130236375|NCT03282097|468829806|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
130236376|NCT03282097|468829805|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
130236377|NCT03282097|468829806|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
130236378|NCT06001021|468829810|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130236379|NCT06001021|468829811|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236380|NCT06001021|468829812|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236381|NCT06001021|468829813|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
130236382|NCT06001021|468829814|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
130236383|NCT06001021|468829815|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130236384|NCT06001021|468829816|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236385|NCT06001021|468829810|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
130236386|NCT06001021|468829811|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236387|NCT06001021|468829812|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236388|NCT06001021|468829813|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
130236389|NCT06001021|468829814|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
130236390|NCT06001021|468829815|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236391|NCT06001021|468829816|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236392|NCT04797169|468829817|FG000|Overall Study|Lost to Follow-up|84|||
130236393|NCT04797169|468829818|FG001|Overall Study|Lost to Follow-up|67|||
130236394|NCT04797169|468829817|FG000|Overall Study|Pregnancy|1|||
130236395|NCT04797169|468829818|FG001|Overall Study|Pregnancy|3|||
130236396|NCT04797169|468829817|FG000|Overall Study|Withdrawal by Subject|27|||
130236397|NCT04797169|468829818|FG001|Overall Study|Withdrawal by Subject|35|||
130236398|NCT03839641|468829827|FG000|Overall Study|Withdrawal by Subject|1|||
130236399|NCT03839641|468829828|FG001|Overall Study|Withdrawal by Subject|1|||
130236400|NCT02550795|468829835|FG000|Overall Study|Physician Decision|0|||
130236401|NCT02550795|468829836|FG001|Overall Study|Physician Decision|1|||
130236402|NCT02550795|468829837|FG002|Overall Study|Physician Decision|0|||
130236403|NCT00879658|468829838|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130236404|NCT00879658|468829839|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130236405|NCT00879658|468829840|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130236406|NCT00879658|468829841|FG003|Overall Study|Abnormal laboratory value(s)|1|||
130236407|NCT00879658|468829842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130236408|NCT00879658|468829843|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130236409|NCT00879658|468829844|FG006|Overall Study|Abnormal laboratory value(s)|0|||
130236410|NCT00879658|468829838|FG000|Overall Study|Administrative problems|2|||
130358683|NCT01631812|469284814|FG000|Overall Study|Withdrawal by Subject|4|||
130358684|NCT01631812|469284814|FG000|Overall Study|Physician Decision|3|||
130358685|NCT02435069|469284815|FG000|Dose Response - First Intervention|Adverse Event|0|||
130694672|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694673|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130236411|NCT00879658|468829839|FG001|Overall Study|Administrative problems|1|||
130236412|NCT00879658|468829840|FG002|Overall Study|Administrative problems|0|||
130236413|NCT00879658|468829841|FG003|Overall Study|Administrative problems|1|||
130236414|NCT00879658|468829842|FG004|Overall Study|Administrative problems|0|||
130236415|NCT00879658|468829843|FG005|Overall Study|Administrative problems|0|||
130236416|NCT00879658|468829844|FG006|Overall Study|Administrative problems|0|||
130236417|NCT00879658|468829838|FG000|Overall Study|Adverse Event|6|||
130694674|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694675|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694676|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
130236418|NCT00879658|468829839|FG001|Overall Study|Adverse Event|4|||
130236419|NCT00879658|468829840|FG002|Overall Study|Adverse Event|3|||
130236420|NCT00879658|468829841|FG003|Overall Study|Adverse Event|1|||
130236421|NCT00879658|468829842|FG004|Overall Study|Adverse Event|2|||
130236422|NCT00879658|468829843|FG005|Overall Study|Adverse Event|0|||
130236423|NCT00879658|468829844|FG006|Overall Study|Adverse Event|0|||
130236424|NCT00879658|468829838|FG000|Overall Study|Protocol Violation|1|||
130236425|NCT00879658|468829839|FG001|Overall Study|Protocol Violation|0|||
130236426|NCT00879658|468829840|FG002|Overall Study|Protocol Violation|0|||
130236427|NCT00879658|468829841|FG003|Overall Study|Protocol Violation|0|||
130236428|NCT00879658|468829842|FG004|Overall Study|Protocol Violation|0|||
130236429|NCT00879658|468829843|FG005|Overall Study|Protocol Violation|0|||
130236430|NCT00879658|468829844|FG006|Overall Study|Protocol Violation|0|||
130236431|NCT00879658|468829838|FG000|Overall Study|Withdrawal by Subject|3|||
130236432|NCT00879658|468829839|FG001|Overall Study|Withdrawal by Subject|0|||
130236433|NCT00879658|468829840|FG002|Overall Study|Withdrawal by Subject|2|||
130236434|NCT00879658|468829841|FG003|Overall Study|Withdrawal by Subject|0|||
130236435|NCT00879658|468829842|FG004|Overall Study|Withdrawal by Subject|0|||
130236436|NCT00879658|468829843|FG005|Overall Study|Withdrawal by Subject|1|||
130236437|NCT00879658|468829844|FG006|Overall Study|Withdrawal by Subject|0|||
130236438|NCT00879658|468829838|FG000|Overall Study|Lack of Efficacy|0|||
130236439|NCT00879658|468829839|FG001|Overall Study|Lack of Efficacy|0|||
130236440|NCT00879658|468829840|FG002|Overall Study|Lack of Efficacy|2|||
130236441|NCT00879658|468829841|FG003|Overall Study|Lack of Efficacy|0|||
130236442|NCT00879658|468829842|FG004|Overall Study|Lack of Efficacy|0|||
130236443|NCT00879658|468829843|FG005|Overall Study|Lack of Efficacy|0|||
130236444|NCT00879658|468829844|FG006|Overall Study|Lack of Efficacy|0|||
130236445|NCT00879658|468829838|FG000|Overall Study|misrandomized (never received study med)|0|||
130236446|NCT00879658|468829839|FG001|Overall Study|misrandomized (never received study med)|0|||
130236447|NCT00879658|468829840|FG002|Overall Study|misrandomized (never received study med)|0|||
130236448|NCT00879658|468829841|FG003|Overall Study|misrandomized (never received study med)|1|||
130236449|NCT00879658|468829842|FG004|Overall Study|misrandomized (never received study med)|0|||
130236450|NCT00879658|468829843|FG005|Overall Study|misrandomized (never received study med)|0|||
130236451|NCT00879658|468829844|FG006|Overall Study|misrandomized (never received study med)|0|||
130236452|NCT00580840|468829845|FG000|Run-in|Adverse Event|17|||
130236453|NCT00580840|468829846|FG001|Run-in|Adverse Event|0|||
130236454|NCT00580840|468829847|FG002|Run-in|Adverse Event|0|||
130236455|NCT00580840|468829848|FG003|Run-in|Adverse Event|0|||
130236456|NCT00580840|468829845|FG000|Run-in|Lack of Efficacy|93|||
130236457|NCT00580840|468829846|FG001|Run-in|Lack of Efficacy|0|||
130236458|NCT00580840|468829847|FG002|Run-in|Lack of Efficacy|0|||
130236459|NCT00580840|468829848|FG003|Run-in|Lack of Efficacy|0|||
130236460|NCT00580840|468829845|FG000|Run-in|Loss of Efficacy|1|||
130236461|NCT00580840|468829846|FG001|Run-in|Loss of Efficacy|0|||
130236462|NCT00580840|468829847|FG002|Run-in|Loss of Efficacy|0|||
130236463|NCT00580840|468829848|FG003|Run-in|Loss of Efficacy|0|||
130236464|NCT00580840|468829845|FG000|Run-in|Lost to Follow-up|4|||
130236465|NCT00580840|468829846|FG001|Run-in|Lost to Follow-up|0|||
130236466|NCT00580840|468829847|FG002|Run-in|Lost to Follow-up|0|||
130236467|NCT00580840|468829848|FG003|Run-in|Lost to Follow-up|0|||
130236468|NCT00580840|468829845|FG000|Run-in|Withdrawal by Subject|5|||
130236469|NCT00580840|468829846|FG001|Run-in|Withdrawal by Subject|0|||
130236470|NCT00580840|468829847|FG002|Run-in|Withdrawal by Subject|0|||
130358686|NCT02435069|469284816|FG001|Dose Response - First Intervention|Adverse Event|1|||
130358687|NCT02435069|469284817|FG002|Dose Response - First Intervention|Adverse Event|1|||
130358688|NCT02435069|469284818|FG003|Dose Response - First Intervention|Adverse Event|0|||
130358689|NCT02435069|469284819|FG004|Dose Response - First Intervention|Adverse Event|0|||
130358690|NCT02435069|469284815|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130358691|NCT02435069|469284816|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130358692|NCT02435069|469284817|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130358693|NCT02435069|469284818|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130358694|NCT02435069|469284819|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
130358695|NCT01528033|469284820|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
130358696|NCT01528033|469284821|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
130236471|NCT00580840|468829848|FG003|Run-in|Withdrawal by Subject|0|||
130358697|NCT01528033|469284820|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
130236472|NCT00580840|468829845|FG000|Run-in|Other: Per Sponsor Request|2|||
130236473|NCT00580840|468829846|FG001|Run-in|Other: Per Sponsor Request|0|||
130236474|NCT00580840|468829847|FG002|Run-in|Other: Per Sponsor Request|0|||
130236475|NCT00580840|468829848|FG003|Run-in|Other: Per Sponsor Request|0|||
130236476|NCT00580840|468829845|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
130236477|NCT00580840|468829846|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236478|NCT00580840|468829847|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236479|NCT00580840|468829848|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236480|NCT00580840|468829845|FG000|Run-in|Other: Exclusionary Lab Value|1|||
130236481|NCT00580840|468829846|FG001|Run-in|Other: Exclusionary Lab Value|0|||
130236482|NCT00580840|468829847|FG002|Run-in|Other: Exclusionary Lab Value|0|||
130236483|NCT00580840|468829848|FG003|Run-in|Other: Exclusionary Lab Value|0|||
130236484|NCT00580840|468829845|FG000|Double-Blind|Adverse Event|0|||
130236485|NCT00580840|468829846|FG001|Double-Blind|Adverse Event|3|||
130236486|NCT00580840|468829847|FG002|Double-Blind|Adverse Event|4|||
130236487|NCT00580840|468829848|FG003|Double-Blind|Adverse Event|1|||
130236488|NCT00580840|468829845|FG000|Double-Blind|Loss of Efficacy|0|||
130236489|NCT00580840|468829846|FG001|Double-Blind|Loss of Efficacy|1|||
130236490|NCT00580840|468829847|FG002|Double-Blind|Loss of Efficacy|2|||
130236491|NCT00580840|468829848|FG003|Double-Blind|Loss of Efficacy|10|||
130236492|NCT00580840|468829845|FG000|Double-Blind|Lost to Follow-up|0|||
130236493|NCT00580840|468829846|FG001|Double-Blind|Lost to Follow-up|1|||
130236494|NCT00580840|468829847|FG002|Double-Blind|Lost to Follow-up|0|||
130236495|NCT00580840|468829848|FG003|Double-Blind|Lost to Follow-up|2|||
130236496|NCT00580840|468829845|FG000|Double-Blind|Withdrawal by Subject|0|||
130236497|NCT00580840|468829846|FG001|Double-Blind|Withdrawal by Subject|1|||
130236498|NCT00580840|468829847|FG002|Double-Blind|Withdrawal by Subject|2|||
130236499|NCT00580840|468829848|FG003|Double-Blind|Withdrawal by Subject|2|||
130236500|NCT00580840|468829845|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
130236501|NCT00580840|468829846|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
130236502|NCT00580840|468829847|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
130236503|NCT00580840|468829848|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
130236504|NCT00580840|468829845|FG000|Double-Blind|Other: Forbidden Medication|0|||
130236505|NCT00580840|468829846|FG001|Double-Blind|Other: Forbidden Medication|0|||
130236506|NCT00580840|468829847|FG002|Double-Blind|Other: Forbidden Medication|1|||
130236507|NCT00580840|468829848|FG003|Double-Blind|Other: Forbidden Medication|0|||
130236508|NCT01551173|468829849|FG000|Overall Study|Withdrawal by Subject|11|||
130236509|NCT01551173|468829850|FG001|Overall Study|Withdrawal by Subject|16|||
130236510|NCT01551173|468829849|FG000|Overall Study|Adverse Event|7|||
130236511|NCT01551173|468829850|FG001|Overall Study|Adverse Event|6|||
130236512|NCT01551173|468829849|FG000|Overall Study|Lost to Follow-up|5|||
130236513|NCT01551173|468829850|FG001|Overall Study|Lost to Follow-up|7|||
130236514|NCT01551173|468829849|FG000|Overall Study|Other|5|||
130236515|NCT01551173|468829850|FG001|Overall Study|Other|3|||
130236516|NCT04530344|468829851|FG000|Overall Study|Lost to Follow-up|3|||
130236517|NCT04530344|468829852|FG001|Overall Study|Lost to Follow-up|3|||
130236518|NCT04530344|468829853|FG002|Overall Study|Lost to Follow-up|3|||
130236519|NCT04530344|468829854|FG003|Overall Study|Lost to Follow-up|10|||
130236520|NCT04530344|468829851|FG000|Overall Study|Withdrawal by Subject|14|||
130236521|NCT04530344|468829852|FG001|Overall Study|Withdrawal by Subject|5|||
130236522|NCT04530344|468829853|FG002|Overall Study|Withdrawal by Subject|18|||
130236523|NCT04530344|468829854|FG003|Overall Study|Withdrawal by Subject|33|||
130236524|NCT04530344|468829851|FG000|Overall Study|Adverse Event|0|||
130236525|NCT04530344|468829852|FG001|Overall Study|Adverse Event|0|||
130236526|NCT04530344|468829853|FG002|Overall Study|Adverse Event|0|||
130236527|NCT04530344|468829854|FG003|Overall Study|Adverse Event|1|||
130236528|NCT04530344|468829851|FG000|Overall Study|Lack of Efficacy|0|||
130236529|NCT04530344|468829852|FG001|Overall Study|Lack of Efficacy|0|||
130236530|NCT04530344|468829853|FG002|Overall Study|Lack of Efficacy|0|||
130236531|NCT04530344|468829854|FG003|Overall Study|Lack of Efficacy|1|||
130236532|NCT04530344|468829851|FG000|Overall Study|Physician Decision|0|||
130236533|NCT04530344|468829852|FG001|Overall Study|Physician Decision|0|||
130236534|NCT04530344|468829853|FG002|Overall Study|Physician Decision|1|||
130236535|NCT04530344|468829854|FG003|Overall Study|Physician Decision|1|||
130236536|NCT04530344|468829851|FG000|Overall Study|Pregnancy|0|||
130236537|NCT04530344|468829852|FG001|Overall Study|Pregnancy|0|||
130236538|NCT04530344|468829853|FG002|Overall Study|Pregnancy|2|||
130236539|NCT04530344|468829854|FG003|Overall Study|Pregnancy|1|||
130236540|NCT04530344|468829851|FG000|Overall Study|Protocol Violation|0|||
130236541|NCT04530344|468829852|FG001|Overall Study|Protocol Violation|0|||
130236542|NCT04530344|468829853|FG002|Overall Study|Protocol Violation|0|||
130236543|NCT04530344|468829854|FG003|Overall Study|Protocol Violation|1|||
130236544|NCT04530344|468829851|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
130236545|NCT04530344|468829852|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
130236546|NCT04530344|468829853|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
130236547|NCT04530344|468829854|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
130236548|NCT04530344|468829851|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236549|NCT04530344|468829852|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236550|NCT04530344|468829853|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
130236551|NCT04530344|468829854|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236552|NCT04530344|468829851|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
130236553|NCT04530344|468829852|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
130236554|NCT04530344|468829853|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
130236555|NCT04530344|468829854|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
130236556|NCT04530344|468829851|FG000|Overall Study|Personal Reasons|0|||
130236557|NCT04530344|468829852|FG001|Overall Study|Personal Reasons|0|||
130236558|NCT04530344|468829853|FG002|Overall Study|Personal Reasons|0|||
130236559|NCT04530344|468829854|FG003|Overall Study|Personal Reasons|1|||
130316198|NCT02421172|469124326|FG002|Period 2|Lost to Follow-up|0|||
130236560|NCT04530344|468829851|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236561|NCT04530344|468829852|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236562|NCT04530344|468829853|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236563|NCT04530344|468829854|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
130236564|NCT01402700|468829855|FG000|Overall Study|Death|3|||
130236565|NCT01402700|468829855|FG000|Overall Study|Withdrawal by Subject|3|||
130236566|NCT01402700|468829855|FG000|Overall Study|Missed Visit|1|||
130236567|NCT02401230|468829859|FG000|Overall Study|Adverse Event|3|||
130236568|NCT02401230|468829860|FG001|Overall Study|Adverse Event|2|||
130236569|NCT02401230|468829861|FG002|Overall Study|Adverse Event|0|||
130236570|NCT02401230|468829859|FG000|Overall Study|Withdrawal by Subject|2|||
130236571|NCT02401230|468829860|FG001|Overall Study|Withdrawal by Subject|1|||
130236572|NCT02401230|468829861|FG002|Overall Study|Withdrawal by Subject|1|||
130236573|NCT02401230|468829859|FG000|Overall Study|Lost to Follow-up|1|||
130236574|NCT02401230|468829860|FG001|Overall Study|Lost to Follow-up|3|||
130236575|NCT02401230|468829861|FG002|Overall Study|Lost to Follow-up|3|||
130236576|NCT00830765|468829862|FG000|Overall Study|Protocol Violation|3|||
130236577|NCT00830765|468829863|FG001|Overall Study|Protocol Violation|2|||
130236578|NCT01299909|468829864|FG000|Overall Study|Lost to Follow-up|22|||
130236579|NCT01299909|468829865|FG001|Overall Study|Lost to Follow-up|18|||
130236580|NCT01299909|468829866|FG002|Overall Study|Lost to Follow-up|17|||
130236581|NCT00964782|468829867|FG000|Overall Study|Lost to Follow-up|1|||
130236582|NCT00964782|468829868|FG001|Overall Study|Lost to Follow-up|0|||
130236583|NCT01143324|468829874|FG000|Overall Study|Lost to Follow-up|11|||
130236584|NCT01143324|468829874|FG000|Overall Study|Withdrawal by Subject|4|||
130236585|NCT01143324|468829874|FG000|Overall Study|Explant of the device|4|||
130236586|NCT02774889|468829884|FG000|Overall Study|Lost to Follow-up|2|||
130236587|NCT02774889|468829885|FG001|Overall Study|Lost to Follow-up|1|||
130236588|NCT00858988|468829886|FG000|Analysis|Lactulose unable to be detected in urine|2|||
130236589|NCT00858988|468829887|FG001|Analysis|Lactulose unable to be detected in urine|1|||
130236590|NCT01349595|468829888|FG000|Overall Study|Lack of funding|2|||
130236591|NCT01349595|468829889|FG001|Overall Study|Lack of funding|2|||
130236592|NCT00549055|468831775|FG000|Overall Study|Adverse Event|4|||
130236593|NCT00549055|468831775|FG000|Overall Study|Lack of Efficacy|18|||
130236594|NCT00549055|468831775|FG000|Overall Study|Stabilization|5|||
130236595|NCT00549055|468831775|FG000|Overall Study|Progression to fibrosis|2|||
130236596|NCT00549055|468831775|FG000|Overall Study|Decrease of size|1|||
130236597|NCT00549055|468831775|FG000|Overall Study|Active choroidal neovascula increased|1|||
130236598|NCT00549055|468831775|FG000|Overall Study|Vitreous hemorrhage|1|||
130236599|NCT00549055|468831775|FG000|Overall Study|Growth choroidal neovascularisation|1|||
130236600|NCT00549055|468831775|FG000|Overall Study|Choroidal neovascularization|1|||
130236601|NCT00549055|468831775|FG000|Overall Study|Very low visual acuity (VA)|1|||
130236602|NCT00770809|468831780|FG000|Overall Study|Adverse Event|9|||
130236603|NCT00770809|468831781|FG001|Overall Study|Adverse Event|1|||
130236604|NCT00770809|468831782|FG002|Overall Study|Adverse Event|12|||
130236605|NCT00770809|468831780|FG000|Overall Study|Death|1|||
130236606|NCT00770809|468831781|FG001|Overall Study|Death|0|||
130236607|NCT00770809|468831782|FG002|Overall Study|Death|0|||
130236608|NCT00770809|468831780|FG000|Overall Study|Withdrawal by Subject|3|||
130236609|NCT00770809|468831781|FG001|Overall Study|Withdrawal by Subject|3|||
130236610|NCT00770809|468831782|FG002|Overall Study|Withdrawal by Subject|7|||
130236611|NCT00770809|468831780|FG000|Overall Study|Progression|2|||
130236612|NCT00770809|468831781|FG001|Overall Study|Progression|2|||
130236613|NCT00770809|468831782|FG002|Overall Study|Progression|0|||
130236614|NCT00770809|468831780|FG000|Overall Study|Complicating illness|0|||
130236615|NCT00770809|468831781|FG001|Overall Study|Complicating illness|0|||
130236616|NCT00770809|468831782|FG002|Overall Study|Complicating illness|1|||
130236617|NCT00770809|468831780|FG000|Overall Study|Other Medical Reasons|2|||
130236618|NCT00770809|468831781|FG001|Overall Study|Other Medical Reasons|4|||
130236619|NCT00770809|468831782|FG002|Overall Study|Other Medical Reasons|3|||
130236620|NCT02469233|468831783|FG000|Overall Study|Death|1|||
130236621|NCT02469233|468831784|FG001|Overall Study|Death|1|||
130236622|NCT02469233|468831783|FG000|Overall Study|Lost to post or 6 month follow up|7|||
130236623|NCT02469233|468831784|FG001|Overall Study|Lost to post or 6 month follow up|2|||
130236624|NCT03474107|468831785|FG000|Overall Study|Adverse Event|42|||
130236625|NCT03474107|468831786|FG001|Overall Study|Adverse Event|46|||
130236626|NCT03474107|468831785|FG000|Overall Study|Death|2|||
130236627|NCT03474107|468831786|FG001|Overall Study|Death|2|||
130236628|NCT03474107|468831785|FG000|Overall Study|Lost to Follow-up|0|||
130236629|NCT03474107|468831786|FG001|Overall Study|Lost to Follow-up|1|||
130236630|NCT03474107|468831785|FG000|Overall Study|Progressive Disease|177|||
130236631|NCT03474107|468831786|FG001|Overall Study|Progressive Disease|180|||
130236632|NCT03474107|468831785|FG000|Overall Study|Protocol Violation|1|||
130236633|NCT03474107|468831786|FG001|Overall Study|Protocol Violation|1|||
130236634|NCT03474107|468831785|FG000|Overall Study|Withdrawal by Subject|15|||
130236635|NCT03474107|468831786|FG001|Overall Study|Withdrawal by Subject|27|||
130236636|NCT03474107|468831785|FG000|Overall Study|Physician Decision|7|||
130236637|NCT03474107|468831786|FG001|Overall Study|Physician Decision|22|||
130236638|NCT03474107|468831785|FG000|Overall Study|Miscellaneous|1|||
130236639|NCT03474107|468831786|FG001|Overall Study|Miscellaneous|6|||
130236640|NCT02127671|468831787|FG000|Overall Study|Death|2|||
130236641|NCT02127671|468831788|FG001|Overall Study|Death|2|||
130236642|NCT02127671|468831787|FG000|Overall Study|Lost to Follow-up|4|||
130236643|NCT02127671|468831788|FG001|Overall Study|Lost to Follow-up|2|||
130236644|NCT02127671|468831787|FG000|Overall Study|Physician Decision|1|||
130236645|NCT02127671|468831788|FG001|Overall Study|Physician Decision|0|||
130236646|NCT02127671|468831787|FG000|Overall Study|incarceration|0|||
130236647|NCT02127671|468831788|FG001|Overall Study|incarceration|1|||
130236648|NCT02127671|468831787|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
130236649|NCT02127671|468831788|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
130236650|NCT00764517|468831789|FG000|Overall Study|Adverse Event|9|||
130236651|NCT00764517|468831790|FG001|Overall Study|Adverse Event|3|||
130236652|NCT00764517|468831789|FG000|Overall Study|Death|3|||
130236653|NCT00764517|468831790|FG001|Overall Study|Death|11|||
130236654|NCT00764517|468831789|FG000|Overall Study|Physician Decision|3|||
130236655|NCT00764517|468831790|FG001|Overall Study|Physician Decision|0|||
130236656|NCT03813654|468831795|FG000|Overall Study|Protocol Violation|0|||
130236657|NCT03813654|468831796|FG001|Overall Study|Protocol Violation|1|||
130236658|NCT03813654|468831797|FG002|Overall Study|Protocol Violation|2|||
130236659|NCT03813654|468831795|FG000|Overall Study|Withdrawal by Subject|1|||
130236660|NCT03813654|468831796|FG001|Overall Study|Withdrawal by Subject|0|||
130236661|NCT03813654|468831797|FG002|Overall Study|Withdrawal by Subject|0|||
130236662|NCT01208051|468831798|FG000|Total Enrollment|Withdrawal by Subject|0|||
130236663|NCT01208051|468831799|FG001|Total Enrollment|Withdrawal by Subject|1|||
130236664|NCT01208051|468831800|FG002|Total Enrollment|Withdrawal by Subject|0|||
130236665|NCT01208051|468831801|FG003|Total Enrollment|Withdrawal by Subject|0|||
130236666|NCT01208051|468831802|FG004|Total Enrollment|Withdrawal by Subject|2|||
130236667|NCT01208051|468831798|FG000|Total Enrollment|Brain metastases|0|||
130236668|NCT01208051|468831799|FG001|Total Enrollment|Brain metastases|0|||
130236669|NCT01208051|468831800|FG002|Total Enrollment|Brain metastases|1|||
130236670|NCT01208051|468831801|FG003|Total Enrollment|Brain metastases|0|||
130236671|NCT01208051|468831802|FG004|Total Enrollment|Brain metastases|0|||
130236672|NCT02107898|468831805|FG000|Overall Study|Adverse Event|4|||
130236673|NCT02107898|468831806|FG001|Overall Study|Adverse Event|7|||
130236674|NCT02107898|468831805|FG000|Overall Study|Poor compliance to protocol|0|||
130236675|NCT02107898|468831806|FG001|Overall Study|Poor compliance to protocol|1|||
130236676|NCT02107898|468831805|FG000|Overall Study|Participant moved|0|||
130236677|NCT02107898|468831806|FG001|Overall Study|Participant moved|2|||
130236678|NCT02107898|468831805|FG000|Overall Study|Consent withdrawn by participant|2|||
130236679|NCT02107898|468831806|FG001|Overall Study|Consent withdrawn by participant|1|||
130236680|NCT02107898|468831805|FG000|Overall Study|Randomized but not treated|0|||
130236681|NCT02107898|468831806|FG001|Overall Study|Randomized but not treated|1|||
130236682|NCT01283386|468831807|FG000|Overall Study|Death|2|||
130236683|NCT01283386|468831808|FG001|Overall Study|Death|0|||
130236684|NCT01283386|468831807|FG000|Overall Study|Withdrawal by Subject|2|||
130236685|NCT01283386|468831808|FG001|Overall Study|Withdrawal by Subject|1|||
130236686|NCT01283386|468831807|FG000|Overall Study|Relapse of underlying disease|1|||
130236687|NCT01283386|468831808|FG001|Overall Study|Relapse of underlying disease|3|||
130236688|NCT01283386|468831807|FG000|Overall Study|Progression of underlying disease|2|||
130236689|NCT01283386|468831808|FG001|Overall Study|Progression of underlying disease|7|||
130236690|NCT01283386|468831807|FG000|Overall Study|Reason not specified|1|||
130236691|NCT01283386|468831808|FG001|Overall Study|Reason not specified|0|||
130236692|NCT01283386|468831807|FG000|Overall Study|Protocol Violation|0|||
130236693|NCT01283386|468831808|FG001|Overall Study|Protocol Violation|1|||
130236694|NCT01531153|468831809|FG000|Overall Study|Withdrawal by Subject|10|||
130236695|NCT01531153|468831810|FG001|Overall Study|Withdrawal by Subject|9|||
130236696|NCT01531153|468831811|FG002|Overall Study|Withdrawal by Subject|15|||
130236697|NCT00770367|468831812|FG000|First Intervention|Withdrawal by Subject|0|||
130236698|NCT00770367|468831813|FG001|First Intervention|Withdrawal by Subject|2|||
130236699|NCT00770367|468831812|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
130236700|NCT00770367|468831813|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
130236701|NCT00770367|468831812|FG000|Second Intervention|Lost to Follow-up|2|||
130236702|NCT00770367|468831813|FG001|Second Intervention|Lost to Follow-up|0|||
130236703|NCT00920816|468831815|FG000|Overall Study|Death|116|||
130236704|NCT00920816|468831816|FG001|Overall Study|Death|63|||
130236705|NCT00920816|468831817|FG002|Overall Study|Death|8|||
130236706|NCT00920816|468831818|FG003|Overall Study|Death|3|||
130236707|NCT00920816|468831815|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
130236708|NCT00920816|468831816|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
130236709|NCT00920816|468831817|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
130236710|NCT00920816|468831818|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
130236711|NCT00920816|468831815|FG000|Overall Study|Global deterioration of health status|2|||
130236712|NCT00920816|468831816|FG001|Overall Study|Global deterioration of health status|0|||
130236713|NCT00920816|468831817|FG002|Overall Study|Global deterioration of health status|0|||
130236714|NCT00920816|468831818|FG003|Overall Study|Global deterioration of health status|0|||
130236715|NCT00920816|468831815|FG000|Overall Study|Objective progression or relapse|6|||
130236716|NCT00920816|468831816|FG001|Overall Study|Objective progression or relapse|2|||
130236717|NCT00920816|468831817|FG002|Overall Study|Objective progression or relapse|0|||
130236718|NCT00920816|468831818|FG003|Overall Study|Objective progression or relapse|0|||
130236719|NCT00920816|468831815|FG000|Overall Study|Other|26|||
130236720|NCT00920816|468831816|FG001|Overall Study|Other|15|||
130236721|NCT00920816|468831817|FG002|Overall Study|Other|1|||
130236722|NCT00920816|468831818|FG003|Overall Study|Other|2|||
130358698|NCT01528033|469284821|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
130358699|NCT01528033|469284820|FG000|Primary Endpoint Assessment ITT|Death|2|||
130358700|NCT01528033|469284821|FG001|Primary Endpoint Assessment ITT|Death|2|||
130358701|NCT01528033|469284820|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
130358702|NCT01528033|469284821|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
130236723|NCT00920816|468831815|FG000|Overall Study|Lost to Follow-up|11|||
130236724|NCT00920816|468831816|FG001|Overall Study|Lost to Follow-up|2|||
130236725|NCT00920816|468831817|FG002|Overall Study|Lost to Follow-up|0|||
130236726|NCT00920816|468831818|FG003|Overall Study|Lost to Follow-up|0|||
130236727|NCT00920816|468831815|FG000|Overall Study|Adverse Event|1|||
130236728|NCT00920816|468831816|FG001|Overall Study|Adverse Event|1|||
130236729|NCT00920816|468831817|FG002|Overall Study|Adverse Event|1|||
130236730|NCT00920816|468831818|FG003|Overall Study|Adverse Event|0|||
130236731|NCT00920816|468831815|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
130236732|NCT00920816|468831816|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
130236733|NCT00920816|468831817|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
130236734|NCT00920816|468831818|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
130358703|NCT01528033|469284820|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
130358704|NCT01528033|469284821|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
130358705|NCT01528033|469284820|FG000|Follow Up|No data available|46|||
130236735|NCT00920816|468831815|FG000|Overall Study|Randomized but not treated|3|||
130236736|NCT00920816|468831816|FG001|Overall Study|Randomized but not treated|0|||
130236737|NCT00920816|468831817|FG002|Overall Study|Randomized but not treated|0|||
130236738|NCT00920816|468831818|FG003|Overall Study|Randomized but not treated|0|||
130236739|NCT01180777|468831819|FG000|Overall Study|Protocol Violation|6|||
130236740|NCT01180777|468831819|FG000|Overall Study|Poor lens fit|4|||
130236741|NCT01180777|468831819|FG000|Overall Study|Lost to Follow-up|1|||
130236742|NCT01180777|468831819|FG000|Overall Study|Adverse Event|1|||
130236743|NCT03517137|468831822|FG000|Overall Study|Lack of Efficacy|1|||
130236744|NCT03517137|468831822|FG000|Overall Study|Adverse Event|2|||
130236745|NCT03517137|468831822|FG000|Overall Study|Withdrawal by Subject|2|||
130236746|NCT03517137|468831822|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
130236747|NCT01582451|468831823|FG000|Overall Study|Adverse Event|1|||
130236748|NCT01582451|468831824|FG001|Overall Study|Adverse Event|3|||
130236749|NCT01582451|468831823|FG000|Overall Study|Death|3|||
130236750|NCT01582451|468831824|FG001|Overall Study|Death|3|||
130236751|NCT01582451|468831823|FG000|Overall Study|Lost to Follow-up|0|||
130236752|NCT01582451|468831824|FG001|Overall Study|Lost to Follow-up|2|||
130236753|NCT01582451|468831823|FG000|Overall Study|Protocol Violation|11|||
130236754|NCT01582451|468831824|FG001|Overall Study|Protocol Violation|3|||
130236755|NCT01582451|468831823|FG000|Overall Study|Withdrawal by Subject|13|||
130236756|NCT01582451|468831824|FG001|Overall Study|Withdrawal by Subject|9|||
130236757|NCT01582451|468831823|FG000|Overall Study|Physician Decision|3|||
130236758|NCT01582451|468831824|FG001|Overall Study|Physician Decision|0|||
130236759|NCT01582451|468831823|FG000|Overall Study|Sponsor Decision|1|||
130358706|NCT01528033|469284821|FG001|Follow Up|No data available|44|||
130358707|NCT02436681|469284824|FG000|Overall Study|Lost to Follow-up|10|||
130694677|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694678|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694679|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694680|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694681|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694682|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694683|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
130236760|NCT01582451|468831824|FG001|Overall Study|Sponsor Decision|0|||
130236761|NCT00487188|468831828|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
130236762|NCT00487188|468831829|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
130236763|NCT00487188|468831830|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
130358708|NCT02436681|469284824|FG000|Overall Study|Withdrawal by Subject|2|||
130358709|NCT02436681|469284824|FG000|Overall Study|Death|2|||
130358710|NCT02030938|469284827|FG000|Overall Study|Lost to Follow-up|4|||
130358711|NCT02030938|469284827|FG000|Overall Study|Withdrawal by Subject|1|||
130358712|NCT03954132|469284829|FG000|Overall Study|Adverse Event|2|||
130694684|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
130236764|NCT00487188|468831828|FG000|Induction Phase|Adverse Event|5|||
130236765|NCT00487188|468831829|FG001|Induction Phase|Adverse Event|0|||
130236766|NCT00487188|468831830|FG002|Induction Phase|Adverse Event|0|||
130236767|NCT00487188|468831828|FG000|Induction Phase|Lack of Efficacy|0|||
130236768|NCT00487188|468831829|FG001|Induction Phase|Lack of Efficacy|1|||
130236769|NCT00487188|468831830|FG002|Induction Phase|Lack of Efficacy|0|||
130236770|NCT00487188|468831828|FG000|Induction Phase|Protocol Violation|1|||
130236771|NCT00487188|468831829|FG001|Induction Phase|Protocol Violation|0|||
130236772|NCT00487188|468831830|FG002|Induction Phase|Protocol Violation|0|||
130236773|NCT00487188|468831828|FG000|Induction Phase|Refused Treatment|1|||
130236774|NCT00487188|468831829|FG001|Induction Phase|Refused Treatment|2|||
130236775|NCT00487188|468831830|FG002|Induction Phase|Refused Treatment|0|||
130236776|NCT00487188|468831828|FG000|Induction Phase|Lost to Follow-up|2|||
130236777|NCT00487188|468831829|FG001|Induction Phase|Lost to Follow-up|2|||
130236778|NCT00487188|468831830|FG002|Induction Phase|Lost to Follow-up|0|||
130236779|NCT00487188|468831828|FG000|Induction Phase|Administrative|0|||
130236780|NCT00487188|468831829|FG001|Induction Phase|Administrative|1|||
130236781|NCT00487188|468831830|FG002|Induction Phase|Administrative|0|||
130236782|NCT00487188|468831828|FG000|Maintenance Phase|Adverse Event|1|||
130236783|NCT00487188|468831829|FG001|Maintenance Phase|Adverse Event|0|||
130236784|NCT00487188|468831830|FG002|Maintenance Phase|Adverse Event|0|||
130236785|NCT00487188|468831828|FG000|Maintenance Phase|Death|1|||
130236786|NCT00487188|468831829|FG001|Maintenance Phase|Death|0|||
130236787|NCT00487188|468831830|FG002|Maintenance Phase|Death|0|||
130236788|NCT00487188|468831828|FG000|Maintenance Phase|Lost to Follow-up|1|||
130236789|NCT00487188|468831829|FG001|Maintenance Phase|Lost to Follow-up|0|||
130236790|NCT00487188|468831830|FG002|Maintenance Phase|Lost to Follow-up|0|||
130236791|NCT00487188|468831828|FG000|Maintenance Phase|Administrative|0|||
130236792|NCT00487188|468831829|FG001|Maintenance Phase|Administrative|0|||
130236793|NCT00487188|468831830|FG002|Maintenance Phase|Administrative|1|||
130236794|NCT03822416|468831833|FG000|Overall Study|Lost to Follow-up|1|||
130236795|NCT03822416|468831834|FG001|Overall Study|Lost to Follow-up|0|||
130236796|NCT03822416|468831833|FG000|Overall Study|Withdrawal by Subject|0|||
130236797|NCT03822416|468831834|FG001|Overall Study|Withdrawal by Subject|1|||
130236798|NCT01995201|468831837|FG000|From Baseline Until Week 24|Adverse Event|4|||
130236799|NCT01995201|468831838|FG001|From Baseline Until Week 24|Adverse Event|15|||
130236800|NCT01995201|468831839|FG002|From Baseline Until Week 24|Adverse Event|0|||
130236801|NCT01995201|468831840|FG003|From Baseline Until Week 24|Adverse Event|0|||
130236802|NCT01995201|468831841|FG004|From Baseline Until Week 24|Adverse Event|0|||
130236803|NCT01995201|468831842|FG005|From Baseline Until Week 24|Adverse Event|0|||
130236804|NCT01995201|468831843|FG006|From Baseline Until Week 24|Adverse Event|0|||
130236805|NCT01995201|468831837|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236806|NCT01995201|468831838|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
130236807|NCT01995201|468831839|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236808|NCT01995201|468831840|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236809|NCT01995201|468831841|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236810|NCT01995201|468831842|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236811|NCT01995201|468831843|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236812|NCT01995201|468831837|FG000|From Baseline Until Week 24|Death|0|||
130236813|NCT01995201|468831838|FG001|From Baseline Until Week 24|Death|1|||
130236814|NCT01995201|468831839|FG002|From Baseline Until Week 24|Death|0|||
130236815|NCT01995201|468831840|FG003|From Baseline Until Week 24|Death|0|||
130236816|NCT01995201|468831841|FG004|From Baseline Until Week 24|Death|0|||
130236817|NCT01995201|468831842|FG005|From Baseline Until Week 24|Death|0|||
130236818|NCT01995201|468831843|FG006|From Baseline Until Week 24|Death|0|||
130236819|NCT01995201|468831837|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
130236820|NCT01995201|468831838|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
130236821|NCT01995201|468831839|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
130236822|NCT01995201|468831840|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
130236823|NCT01995201|468831841|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
130236824|NCT01995201|468831842|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
130236825|NCT01995201|468831843|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
130236826|NCT01995201|468831837|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
130236827|NCT01995201|468831838|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
130236828|NCT01995201|468831839|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
130236829|NCT01995201|468831840|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
130236830|NCT01995201|468831841|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
130236831|NCT01995201|468831842|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
130236832|NCT01995201|468831843|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
130236833|NCT01995201|468831837|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
130236834|NCT01995201|468831838|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
130236835|NCT01995201|468831839|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236836|NCT01995201|468831840|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236837|NCT01995201|468831841|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236838|NCT01995201|468831842|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236839|NCT01995201|468831843|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236840|NCT01995201|468831837|FG000|From Baseline Until Week 24|Physician Decision|0|||
130236841|NCT01995201|468831838|FG001|From Baseline Until Week 24|Physician Decision|2|||
130236842|NCT01995201|468831839|FG002|From Baseline Until Week 24|Physician Decision|0|||
130236843|NCT01995201|468831840|FG003|From Baseline Until Week 24|Physician Decision|0|||
130236844|NCT01995201|468831841|FG004|From Baseline Until Week 24|Physician Decision|0|||
130236845|NCT01995201|468831842|FG005|From Baseline Until Week 24|Physician Decision|0|||
130236846|NCT01995201|468831843|FG006|From Baseline Until Week 24|Physician Decision|0|||
130236847|NCT01995201|468831837|FG000|From Baseline Until Week 24|Protocol Violation|0|||
130236848|NCT01995201|468831838|FG001|From Baseline Until Week 24|Protocol Violation|9|||
130236849|NCT01995201|468831839|FG002|From Baseline Until Week 24|Protocol Violation|0|||
130236850|NCT01995201|468831840|FG003|From Baseline Until Week 24|Protocol Violation|0|||
130236851|NCT01995201|468831841|FG004|From Baseline Until Week 24|Protocol Violation|0|||
130236852|NCT01995201|468831842|FG005|From Baseline Until Week 24|Protocol Violation|0|||
130236853|NCT01995201|468831843|FG006|From Baseline Until Week 24|Protocol Violation|0|||
130236854|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Adverse Event|0|||
130236855|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Adverse Event|0|||
130236856|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Adverse Event|2|||
130236857|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Adverse Event|1|||
130236858|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Adverse Event|1|||
130236859|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Adverse Event|3|||
130236860|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Adverse Event|1|||
130236861|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Death|0|||
130236862|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Death|0|||
130236863|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Death|0|||
130236864|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Death|0|||
130236865|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Death|0|||
130236866|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Death|2|||
130236867|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Death|0|||
130236868|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236869|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236870|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
130236871|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236872|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236873|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
130236874|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
130236875|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236876|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236877|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236878|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236879|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
130236880|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
130236881|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236882|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236883|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236884|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130236885|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236886|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130236887|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236888|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236889|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Physician Decision|0|||
130236890|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Physician Decision|0|||
130236891|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Physician Decision|0|||
130236892|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Physician Decision|0|||
130236893|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Physician Decision|1|||
130236894|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Physician Decision|0|||
130236895|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Physician Decision|0|||
130236896|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
130236897|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
130236898|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
130236899|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
130236900|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
130236901|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
130236902|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
130236903|NCT03329001|468831844|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130316199|NCT02421172|469124327|FG003|Period 2|Lost to Follow-up|1|||
130316200|NCT02421172|469124328|FG004|Period 2|Lost to Follow-up|0|||
130316201|NCT02421172|469124324|FG000|Period 2|Patient/guardian decision|0|||
130316202|NCT02421172|469124325|FG001|Period 2|Patient/guardian decision|0|||
130316203|NCT02421172|469124326|FG002|Period 2|Patient/guardian decision|3|||
130316204|NCT02421172|469124327|FG003|Period 2|Patient/guardian decision|2|||
130236904|NCT03329001|468831845|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236905|NCT03329001|468831846|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
130236906|NCT03329001|468831847|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
130236907|NCT03329001|468831848|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236908|NCT03329001|468831849|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236909|NCT03329001|468831850|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236910|NCT03329001|468831851|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236911|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236912|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236913|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236914|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
130236915|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236916|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236917|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236918|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236919|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236920|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236921|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236922|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
130236923|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236924|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236925|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236926|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236927|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236928|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236929|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236930|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
130236931|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236932|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236933|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236934|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236935|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236936|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236937|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
130236938|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236939|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236940|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236941|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236942|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236943|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236944|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236945|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
130236946|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236947|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236948|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236949|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236950|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236951|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236952|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236953|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
130236954|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236955|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130358713|NCT03954132|469284830|FG001|Overall Study|Adverse Event|0|||
130552925|NCT02520284|469991627|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
130236956|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236957|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236958|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236959|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236960|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236961|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
130236962|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236963|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236964|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236965|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130358714|NCT03954132|469284829|FG000|Overall Study|Patient's wish|5|||
130358715|NCT03954132|469284830|FG001|Overall Study|Patient's wish|0|||
130358716|NCT03954132|469284829|FG000|Overall Study|Lost to Follow-up|10|||
130358717|NCT03954132|469284830|FG001|Overall Study|Lost to Follow-up|0|||
130358718|NCT03954132|469284829|FG000|Overall Study|Screening failure|0|||
130358719|NCT03954132|469284830|FG001|Overall Study|Screening failure|1|||
130358720|NCT03954132|469284829|FG000|Overall Study|No registration after Visit 1|5|||
130358721|NCT03954132|469284830|FG001|Overall Study|No registration after Visit 1|2|||
130358722|NCT03954132|469284829|FG000|Overall Study|Other reason than listed|2|||
130358723|NCT03954132|469284830|FG001|Overall Study|Other reason than listed|2|||
130236966|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236967|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236968|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130358724|NCT03954132|469284829|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
130358725|NCT03954132|469284830|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
130358726|NCT03954132|469284829|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
130358727|NCT03954132|469284830|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
130236969|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130236970|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130236971|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236972|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236973|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236974|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236975|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236976|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236977|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
130236978|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236979|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236980|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236981|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236982|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236983|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130358728|NCT04502979|469284836|FG000|Overall Study|Lost to Follow-up|1|||
130358729|NCT04502979|469284837|FG001|Overall Study|Lost to Follow-up|3|||
130358730|NCT04502979|469284836|FG000|Overall Study|Withdrawal by Subject|2|||
130358731|NCT04502979|469284837|FG001|Overall Study|Withdrawal by Subject|1|||
130358732|NCT00932737|469284845|FG000|Overall Study|Not treated in second episode|1|||
130358733|NCT00932737|469284846|FG001|Overall Study|Not treated in second episode|0|||
130358734|NCT00932737|469284845|FG000|Overall Study|Adverse Event|0|||
130358735|NCT00932737|469284846|FG001|Overall Study|Adverse Event|1|||
130358736|NCT02906332|469284851|FG000|Overall Study|Withdrawal by Subject|1|||
130358737|NCT02949700|469284852|FG000|Phase I|Withdrawal by Subject|1|||
130358738|NCT02949700|469284853|FG001|Phase I|Withdrawal by Subject|1|||
130358739|NCT02949700|469284854|FG002|Phase I|Withdrawal by Subject|0|||
130358740|NCT02949700|469284855|FG003|Phase I|Withdrawal by Subject|0|||
130446854|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
130446855|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
130446856|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
130694685|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694686|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694687|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694688|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694689|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
130358741|NCT02949700|469284852|FG000|Phase I|Protocol Violation|1|||
130236984|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236985|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130236986|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130236987|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236988|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236989|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236990|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236991|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236992|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236993|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
130236994|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
130236995|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236996|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236997|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236998|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236999|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237000|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237001|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
130237002|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
130237003|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237004|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237005|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237006|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237007|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237008|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237009|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237010|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
130237011|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237012|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237013|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237014|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237015|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237016|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237017|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237018|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
130237019|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237020|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237021|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237022|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237023|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237024|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237025|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
130237026|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237027|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237028|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237029|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237030|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237031|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237032|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237033|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130237034|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130237035|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237036|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237037|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237038|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130358742|NCT02949700|469284853|FG001|Phase I|Protocol Violation|0|||
130358743|NCT02949700|469284854|FG002|Phase I|Protocol Violation|0|||
130358744|NCT02949700|469284855|FG003|Phase I|Protocol Violation|0|||
130358745|NCT02949700|469284852|FG000|Phase II|Withdrawal by Subject|0|||
130358746|NCT02949700|469284853|FG001|Phase II|Withdrawal by Subject|0|||
130358747|NCT02949700|469284854|FG002|Phase II|Withdrawal by Subject|0|||
130358748|NCT02949700|469284855|FG003|Phase II|Withdrawal by Subject|2|||
130358749|NCT02949700|469284852|FG000|Phase II|Protocol Violation|0|||
130358750|NCT02949700|469284853|FG001|Phase II|Protocol Violation|0|||
130358751|NCT02949700|469284854|FG002|Phase II|Protocol Violation|1|||
130237039|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237040|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237041|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
130237042|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237043|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237044|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237045|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237046|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237047|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237048|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237049|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
130237050|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237051|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237052|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237053|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237054|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237055|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237056|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237057|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237058|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
130237059|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237060|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237061|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237062|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237063|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237064|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237065|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237066|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237067|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237068|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
130237069|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130358752|NCT02949700|469284855|FG003|Phase II|Protocol Violation|3|||
130358753|NCT04399837|469284859|FG000|Overall Study|Other than listed|0|||
130358754|NCT04399837|469284860|FG001|Overall Study|Other than listed|2|||
130358755|NCT04399837|469284861|FG002|Overall Study|Other than listed|2|||
130358756|NCT04399837|469284862|FG003|Overall Study|Other than listed|3|||
130358757|NCT04399837|469284859|FG000|Overall Study|Withdrawal by Subject|1|||
130358758|NCT04399837|469284860|FG001|Overall Study|Withdrawal by Subject|2|||
130358759|NCT04399837|469284861|FG002|Overall Study|Withdrawal by Subject|1|||
130358760|NCT04399837|469284862|FG003|Overall Study|Withdrawal by Subject|1|||
130358761|NCT02628769|469284874|FG000|First Intervention|Adverse Event|1|||
130358762|NCT02628769|469284875|FG001|First Intervention|Adverse Event|0|||
130358763|NCT02628769|469284874|FG000|First Intervention|Withdrawal by Subject|0|||
130358764|NCT02628769|469284875|FG001|First Intervention|Withdrawal by Subject|1|||
130358765|NCT02628769|469284874|FG000|Second Intervention|Adverse Event|2|||
130358766|NCT02628769|469284875|FG001|Second Intervention|Adverse Event|0|||
130358767|NCT02628769|469284874|FG000|Second Intervention|Physician Decision|0|||
130358768|NCT02628769|469284875|FG001|Second Intervention|Physician Decision|1|||
130358769|NCT02024555|469284876|FG000|Overall Study|Lost to Follow-up|1|||
130358770|NCT02024555|469284877|FG001|Overall Study|Lost to Follow-up|1|||
130358771|NCT02024555|469284876|FG000|Overall Study|Withdrawal by Subject|5|||
130358772|NCT02024555|469284877|FG001|Overall Study|Withdrawal by Subject|1|||
130358773|NCT02719327|469284880|FG000|Overall Study|Withdrawal by Subject|11|||
130358774|NCT02719327|469284881|FG001|Overall Study|Withdrawal by Subject|8|||
130358775|NCT03350620|469284882|FG000|Stage 2|Adverse Event|0|||
130358776|NCT03350620|469284883|FG001|Stage 2|Adverse Event|1|||
130358777|NCT03350620|469284884|FG002|Stage 2|Adverse Event|1|||
130358778|NCT03350620|469284882|FG000|Stage 2|Lack of Efficacy|0|||
130358779|NCT03350620|469284883|FG001|Stage 2|Lack of Efficacy|2|||
130358780|NCT03350620|469284884|FG002|Stage 2|Lack of Efficacy|0|||
130358781|NCT03350620|469284882|FG000|Stage 2|Lost to Follow-up|1|||
130358782|NCT03350620|469284883|FG001|Stage 2|Lost to Follow-up|2|||
130358783|NCT03350620|469284884|FG002|Stage 2|Lost to Follow-up|2|||
130358784|NCT03350620|469284882|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
130358785|NCT03350620|469284883|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
130376534|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130237070|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237071|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237072|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237073|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237074|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237075|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
130446857|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
130237076|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237077|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130446858|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
130446859|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
130446860|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
130446861|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
130446862|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
130446863|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
130446864|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
130446865|NCT03890120|469597102|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
130446866|NCT03890120|469597103|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
130446867|NCT03890120|469597104|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
130446868|NCT03890120|469597105|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
130446869|NCT03890120|469597102|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
130446870|NCT03890120|469597103|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
130446871|NCT03890120|469597104|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
130446872|NCT03890120|469597105|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
130446873|NCT03890120|469597102|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
130446874|NCT03890120|469597103|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
130446875|NCT03890120|469597104|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
130446876|NCT03890120|469597105|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
130446877|NCT03890120|469597102|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
130446878|NCT03890120|469597103|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
130446879|NCT03890120|469597104|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
130446880|NCT03890120|469597105|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
130446881|NCT03890120|469597102|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
130446882|NCT03890120|469597103|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
130446883|NCT03890120|469597104|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
130446884|NCT03890120|469597105|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
130446885|NCT02335268|469597106|FG000|Overall Study|Physician Decision|5|||
130446886|NCT02335268|469597107|FG001|Overall Study|Physician Decision|1|||
130446887|NCT02335268|469597106|FG000|Overall Study|Lack of Efficacy|2|||
130446888|NCT02335268|469597107|FG001|Overall Study|Lack of Efficacy|1|||
130446889|NCT02335268|469597106|FG000|Overall Study|Adverse Event|5|||
130446890|NCT02335268|469597107|FG001|Overall Study|Adverse Event|2|||
130446891|NCT02335268|469597106|FG000|Overall Study|increase blasts|2|||
130446892|NCT02335268|469597107|FG001|Overall Study|increase blasts|0|||
130446893|NCT02335268|469597106|FG000|Overall Study|Withdrawal by Subject|3|||
130446894|NCT02335268|469597107|FG001|Overall Study|Withdrawal by Subject|2|||
130446895|NCT01192295|469597111|FG000|Overall Study|Adverse Event|3|||
130446896|NCT01192295|469597112|FG001|Overall Study|Adverse Event|7|||
130446897|NCT01192295|469597111|FG000|Overall Study|Withdrawal by Subject|3|||
130446898|NCT01192295|469597112|FG001|Overall Study|Withdrawal by Subject|4|||
130446899|NCT01192295|469597111|FG000|Overall Study|Lost to Follow-up|0|||
130446900|NCT01192295|469597112|FG001|Overall Study|Lost to Follow-up|1|||
130446901|NCT01192295|469597111|FG000|Overall Study|Lack of Efficacy|0|||
130446902|NCT01192295|469597112|FG001|Overall Study|Lack of Efficacy|5|||
130446903|NCT01192295|469597111|FG000|Overall Study|Administrative|4|||
130446904|NCT01192295|469597112|FG001|Overall Study|Administrative|6|||
130446905|NCT03785340|469597113|FG000|Overall Study|Lost to Follow-up|2|||
130237078|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237079|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237080|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130446906|NCT03785340|469597114|FG001|Overall Study|Lost to Follow-up|0|||
130446907|NCT03785340|469597113|FG000|Overall Study|Adverse Event|1|||
130446908|NCT03785340|469597114|FG001|Overall Study|Adverse Event|0|||
130446909|NCT01670500|469597122|FG000|Overall Study|Withdrawal by Subject|1|||
130446910|NCT01670500|469597123|FG001|Overall Study|Withdrawal by Subject|0|||
130446911|NCT04320615|469597124|FG000|Overall Study|Withdrawal by Subject|4|||
130446912|NCT04320615|469597125|FG001|Overall Study|Withdrawal by Subject|10|||
130446913|NCT04320615|469597124|FG000|Overall Study|Physician Decision|2|||
130446914|NCT04320615|469597125|FG001|Overall Study|Physician Decision|0|||
130446915|NCT04320615|469597124|FG000|Overall Study|Other|2|||
130237081|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237082|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237083|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130237084|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130237085|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237086|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237087|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237088|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237089|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237090|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237091|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
130237092|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237093|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130358786|NCT03350620|469284884|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
130358787|NCT01066000|469284887|FG000|Overall Study|Protocol Violation|4|||
130358788|NCT01066000|469284887|FG000|Overall Study|Death|3|||
130358789|NCT01066000|469284887|FG000|Overall Study|Withdrawal by Subject|1|||
130358790|NCT01066000|469284887|FG000|Overall Study|Adverse Event|1|||
130358791|NCT05268055|469284888|FG000|Overall Study|Lost to Follow-up|68|||
130358792|NCT05268055|469284889|FG001|Overall Study|Lost to Follow-up|68|||
130237094|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237095|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237096|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237097|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237098|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237099|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130237100|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130358793|NCT05268055|469284888|FG000|Overall Study|Withdrawal by Subject|12|||
130358794|NCT05268055|469284889|FG001|Overall Study|Withdrawal by Subject|8|||
130358795|NCT01854658|469286385|FG000|Overall Study|Protocol Violation|6|||
130358796|NCT01854658|469286386|FG001|Overall Study|Protocol Violation|2|||
130358797|NCT01854658|469286387|FG002|Overall Study|Protocol Violation|2|||
130358798|NCT01854658|469286388|FG003|Overall Study|Protocol Violation|1|||
130358799|NCT01854658|469286385|FG000|Overall Study|Physician Decision|7|||
130358800|NCT01854658|469286386|FG001|Overall Study|Physician Decision|5|||
130358801|NCT01854658|469286387|FG002|Overall Study|Physician Decision|2|||
130358802|NCT01854658|469286388|FG003|Overall Study|Physician Decision|4|||
130358803|NCT01854658|469286385|FG000|Overall Study|Lost to Follow-up|8|||
130358804|NCT01854658|469286386|FG001|Overall Study|Lost to Follow-up|9|||
130358805|NCT01854658|469286387|FG002|Overall Study|Lost to Follow-up|8|||
130358806|NCT01854658|469286388|FG003|Overall Study|Lost to Follow-up|4|||
130358807|NCT01854658|469286385|FG000|Overall Study|Withdrawal by Subject|28|||
130358808|NCT01854658|469286386|FG001|Overall Study|Withdrawal by Subject|21|||
130358809|NCT01854658|469286387|FG002|Overall Study|Withdrawal by Subject|29|||
130358810|NCT01854658|469286388|FG003|Overall Study|Withdrawal by Subject|15|||
130358811|NCT01854658|469286385|FG000|Overall Study|Protocol-specified criteria|15|||
130358812|NCT01854658|469286386|FG001|Overall Study|Protocol-specified criteria|15|||
130358813|NCT01854658|469286387|FG002|Overall Study|Protocol-specified criteria|10|||
130358814|NCT01854658|469286388|FG003|Overall Study|Protocol-specified criteria|7|||
130358815|NCT01854658|469286385|FG000|Overall Study|Lack of Efficacy|3|||
130358816|NCT01854658|469286386|FG001|Overall Study|Lack of Efficacy|8|||
130358817|NCT01854658|469286387|FG002|Overall Study|Lack of Efficacy|4|||
130358818|NCT01854658|469286388|FG003|Overall Study|Lack of Efficacy|7|||
130358819|NCT01854658|469286385|FG000|Overall Study|Adverse Event|21|||
130358820|NCT01854658|469286386|FG001|Overall Study|Adverse Event|14|||
130358821|NCT01854658|469286387|FG002|Overall Study|Adverse Event|23|||
130446916|NCT04320615|469597125|FG001|Overall Study|Other|0|||
130446917|NCT04320615|469597124|FG000|Overall Study|Lost to Follow-up|5|||
130446918|NCT04320615|469597125|FG001|Overall Study|Lost to Follow-up|23|||
130446919|NCT04320615|469597124|FG000|Overall Study|Death|35|||
130446920|NCT04320615|469597125|FG001|Overall Study|Death|71|||
130446921|NCT01449721|469597126|FG000|Overall Study|Physician Decision|0|||
130446922|NCT01449721|469597127|FG001|Overall Study|Physician Decision|1|||
130358822|NCT01854658|469286388|FG003|Overall Study|Adverse Event|19|||
130358823|NCT01854658|469286385|FG000|Overall Study|Administrative reasons|5|||
130358824|NCT01854658|469286386|FG001|Overall Study|Administrative reasons|1|||
130358825|NCT01854658|469286387|FG002|Overall Study|Administrative reasons|2|||
130358826|NCT01854658|469286388|FG003|Overall Study|Administrative reasons|2|||
130358827|NCT00697073|469286389|FG000|Overall Study|Withdrawal by Subject|2|||
130446923|NCT01449721|469597126|FG000|Overall Study|Physician Decision|0|||
130446924|NCT01449721|469597127|FG001|Overall Study|Physician Decision|1|||
130358828|NCT00697073|469286389|FG000|Overall Study|Pregnancy|1|||
130446925|NCT03285711|469597128|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
130694690|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694691|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694692|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694693|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694694|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
130237101|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237102|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237103|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237104|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237105|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237106|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237107|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237108|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237109|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
130237110|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
130237111|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237112|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237113|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237114|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237115|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237116|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237117|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
130237118|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237119|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237120|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237121|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237122|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237123|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237124|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237125|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
130237126|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
130237127|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237128|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237129|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237130|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237131|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237132|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237133|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
130237134|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
130237135|NCT02709369|468831855|FG000|Overall Study|Lost to Follow-up|15|||
130237136|NCT02709369|468831855|FG000|Overall Study|Withdrawal by Subject|10|||
130237137|NCT02709369|468831855|FG000|Overall Study|Did not received intervention|2|||
130237138|NCT00963235|468831856|FG000|Overall Study|Withdrawal by Subject|22|||
130237139|NCT00963235|468831856|FG000|Overall Study|Lost to Follow-up|14|||
130237140|NCT00963235|468831856|FG000|Overall Study|Failed to return|9|||
130237141|NCT00963235|468831856|FG000|Overall Study|Protocol Violation|7|||
130237142|NCT00963235|468831856|FG000|Overall Study|Adverse Event|5|||
130237143|NCT00963235|468831856|FG000|Overall Study|Physician Decision|2|||
130237144|NCT00963235|468831856|FG000|Overall Study|Other|1|||
130237145|NCT01104766|468831858|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130237146|NCT01104766|468831859|FG001|Overall Study|Did not meet inc/exc criteria|0|||
130237147|NCT01104766|468831860|FG002|Overall Study|Did not meet inc/exc criteria|0|||
130237148|NCT01104766|468831861|FG003|Overall Study|Did not meet inc/exc criteria|0|||
130237149|NCT01104766|468831858|FG000|Overall Study|Adverse Event|17|||
130237150|NCT01104766|468831859|FG001|Overall Study|Adverse Event|15|||
130237151|NCT01104766|468831860|FG002|Overall Study|Adverse Event|20|||
130237152|NCT01104766|468831861|FG003|Overall Study|Adverse Event|14|||
130237153|NCT01104766|468831858|FG000|Overall Study|Lack of Efficacy|20|||
130237154|NCT01104766|468831859|FG001|Overall Study|Lack of Efficacy|15|||
130358829|NCT00697073|469286389|FG000|Overall Study|non compliance and other|6|||
130358830|NCT02203071|469286390|FG000|Overall Study|Lost to Follow-up|3|||
130358831|NCT02203071|469286391|FG001|Overall Study|Lost to Follow-up|1|||
130358832|NCT03894046|469286392|FG000|Overall Study|Protocol Violation|1|||
130358833|NCT03894046|469286393|FG001|Overall Study|Protocol Violation|0|||
130358834|NCT03894046|469286394|FG002|Overall Study|Protocol Violation|0|||
130694695|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
130237155|NCT01104766|468831860|FG002|Overall Study|Lack of Efficacy|14|||
130237156|NCT01104766|468831861|FG003|Overall Study|Lack of Efficacy|8|||
130694696|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
130237157|NCT01104766|468831858|FG000|Overall Study|Protocol Violation|2|||
130237158|NCT01104766|468831859|FG001|Overall Study|Protocol Violation|0|||
130237159|NCT01104766|468831860|FG002|Overall Study|Protocol Violation|0|||
130237160|NCT01104766|468831861|FG003|Overall Study|Protocol Violation|0|||
130237161|NCT01104766|468831858|FG000|Overall Study|Withdrawal by Subject|17|||
130237162|NCT01104766|468831859|FG001|Overall Study|Withdrawal by Subject|19|||
130237163|NCT01104766|468831860|FG002|Overall Study|Withdrawal by Subject|25|||
130237164|NCT01104766|468831861|FG003|Overall Study|Withdrawal by Subject|15|||
130237165|NCT01104766|468831858|FG000|Overall Study|Lost to Follow-up|1|||
130237166|NCT01104766|468831859|FG001|Overall Study|Lost to Follow-up|2|||
130237167|NCT01104766|468831860|FG002|Overall Study|Lost to Follow-up|1|||
130237168|NCT01104766|468831861|FG003|Overall Study|Lost to Follow-up|1|||
130237169|NCT01341470|468831863|FG000|Overall Study|Sponsor decision|0|||
130237170|NCT01341470|468831864|FG001|Overall Study|Sponsor decision|0|||
130237171|NCT01341470|468831865|FG002|Overall Study|Sponsor decision|1|||
130237172|NCT01341470|468831866|FG003|Overall Study|Sponsor decision|1|||
130237173|NCT01341470|468831867|FG004|Overall Study|Sponsor decision|0|||
130237174|NCT01341470|468831868|FG005|Overall Study|Sponsor decision|1|||
130237175|NCT01136915|468831870|FG000|Overall Study|Lost to Follow-up|2|||
130237176|NCT01136915|468831871|FG001|Overall Study|Lost to Follow-up|0|||
130237177|NCT01136915|468831870|FG000|Overall Study|Exclusion criterion met|0|||
130237178|NCT01136915|468831871|FG001|Overall Study|Exclusion criterion met|1|||
130446926|NCT03285711|469597129|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
130446927|NCT03285711|469597130|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
130446928|NCT03285711|469597131|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
130446929|NCT03285711|469597128|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
130446930|NCT03285711|469597129|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
130446931|NCT03285711|469597130|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
130446932|NCT03285711|469597131|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
130446933|NCT03285711|469597128|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
130446934|NCT03285711|469597129|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
130446935|NCT03285711|469597130|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
130446936|NCT03285711|469597131|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
130446937|NCT03285711|469597128|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
130446938|NCT03285711|469597129|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
130446939|NCT03285711|469597130|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
130446940|NCT03285711|469597131|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
130446941|NCT02431533|469597132|FG000|Overall Study|Withdrawal by Subject|1|||
130446942|NCT02431533|469597133|FG001|Overall Study|Withdrawal by Subject|3|||
130446943|NCT02431533|469597132|FG000|Overall Study|Developed Exclusionary criteria|1|||
130446944|NCT02431533|469597133|FG001|Overall Study|Developed Exclusionary criteria|0|||
130446945|NCT02107443|469597134|FG000|Overall Study|Death|42|||
130446946|NCT02107443|469597135|FG001|Overall Study|Death|30|||
130446947|NCT02107443|469597134|FG000|Overall Study|Study Protocol Violation|3|||
130446948|NCT02107443|469597135|FG001|Overall Study|Study Protocol Violation|1|||
130446949|NCT02107443|469597134|FG000|Overall Study|Registered but Not Eligible|0|||
130446950|NCT02107443|469597135|FG001|Overall Study|Registered but Not Eligible|1|||
130446951|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
130446952|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
130446953|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
130446954|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
130446955|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Changed Mind|2|||
130446956|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Changed Mind|0|||
130446957|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
130446958|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
130446959|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
130446960|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
130446961|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
130446962|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
130237179|NCT01756235|468831872|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130237180|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130446963|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
130237181|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
130446964|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
130237182|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130237183|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130237184|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
130446965|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Other Medical|9|||
130446966|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Other Medical|5|||
130694697|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694698|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694699|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694700|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694701|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694702|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694703|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694704|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694705|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694706|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694707|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694708|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694709|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694710|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694711|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694712|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694713|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694714|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694715|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694716|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694717|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694718|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694719|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694720|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
130694721|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
130694722|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694723|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694724|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694725|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694726|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694727|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694728|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694729|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694730|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694731|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694732|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694733|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694734|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694735|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694736|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694737|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694738|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694739|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694740|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694741|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694742|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694743|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694744|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130358835|NCT03894046|469286392|FG000|Overall Study|Adverse Event|0|||
130358836|NCT03894046|469286393|FG001|Overall Study|Adverse Event|1|||
130694745|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694746|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694747|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694748|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130694749|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
130694750|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694751|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130694752|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Death|0|||
130694753|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Death|0|||
130694754|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Death|0|||
130694755|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Death|0|||
130694756|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Death|0|||
130694757|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Death|0|||
130694758|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Death|0|||
130694759|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Death|0|||
130694760|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Death|0|||
130694761|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Death|0|||
130694762|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Death|0|||
130358837|NCT03894046|469286394|FG002|Overall Study|Adverse Event|0|||
130237185|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
130237186|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
130237187|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130237188|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
130446967|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Disease Progression|4|||
130446968|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Disease Progression|2|||
130446969|NCT02107443|469597134|FG000|Overall Study|Withdrawal: Personal Issues|0|||
130446970|NCT02107443|469597135|FG001|Overall Study|Withdrawal: Personal Issues|3|||
130446971|NCT00333788|469597136|FG000|Overall Study|Adverse Event|44|||
130446972|NCT00333788|469597136|FG000|Overall Study|Lack of Efficacy|80|||
130446973|NCT00333788|469597136|FG000|Overall Study|Lost to Follow-up|2|||
130446974|NCT00333788|469597136|FG000|Overall Study|Withdrawal by Subject|24|||
130446975|NCT00333788|469597136|FG000|Overall Study|Other: Non-compliance|2|||
130446976|NCT00333788|469597136|FG000|Overall Study|Other: Moved|2|||
130446977|NCT00333788|469597136|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
130446978|NCT00333788|469597136|FG000|Overall Study|Other: Investigator decision|1|||
130446979|NCT00333788|469597136|FG000|Overall Study|Other: Quality of life concern|1|||
130446980|NCT00333788|469597136|FG000|Overall Study|Other: Sponsor decision|1|||
130446981|NCT00333788|469597136|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
130446982|NCT00333788|469597136|FG000|Overall Study|Other: Medical monitor decision|1|||
130446983|NCT00333788|469597136|FG000|Overall Study|Other: Physician decision|1|||
130446984|NCT00333788|469597136|FG000|Overall Study|Other: Signed consent for another study|1|||
130446985|NCT00729690|469597137|FG000|Overall Study|IT Catheter Malfunction|0|||
130446986|NCT00729690|469597138|FG001|Overall Study|IT Catheter Malfunction|2|||
130446987|NCT00729690|469597139|FG002|Overall Study|IT Catheter Malfunction|2|||
130446988|NCT02886936|469597145|FG000|Overall Study|Lost to Follow-up|4|||
130446989|NCT02886936|469597146|FG001|Overall Study|Lost to Follow-up|3|||
130446990|NCT02886936|469597147|FG002|Overall Study|Lost to Follow-up|0|||
130446991|NCT02320721|469597148|FG000|Overall Study|Adverse Event|6|||
130446992|NCT02320721|469597149|FG001|Overall Study|Adverse Event|6|||
130446993|NCT02320721|469597148|FG000|Overall Study|Lack of Efficacy|2|||
130446994|NCT02320721|469597149|FG001|Overall Study|Lack of Efficacy|0|||
130446995|NCT02320721|469597148|FG000|Overall Study|Poor compliance to protocol|3|||
130446996|NCT02320721|469597149|FG001|Overall Study|Poor compliance to protocol|7|||
130446997|NCT02320721|469597148|FG000|Overall Study|Randomized but not treated|0|||
130446998|NCT02320721|469597149|FG001|Overall Study|Randomized but not treated|1|||
130446999|NCT02320721|469597148|FG000|Overall Study|Hypoglycemia|1|||
130447000|NCT02320721|469597149|FG001|Overall Study|Hypoglycemia|0|||
130447001|NCT02320721|469597148|FG000|Overall Study|Other than specified above|15|||
130447002|NCT02320721|469597149|FG001|Overall Study|Other than specified above|20|||
130447003|NCT04131907|469597150|FG000|Overall Study|Adverse Event|2|||
130447004|NCT04131907|469597151|FG001|Overall Study|Adverse Event|0|||
130447005|NCT04131907|469597152|FG002|Overall Study|Adverse Event|0|||
130447006|NCT04131907|469597150|FG000|Overall Study|Physician Decision|4|||
130447007|NCT04131907|469597151|FG001|Overall Study|Physician Decision|22|||
130447008|NCT04131907|469597152|FG002|Overall Study|Physician Decision|0|||
130447009|NCT04131907|469597150|FG000|Overall Study|Withdrawal by Subject|2|||
130447010|NCT04131907|469597151|FG001|Overall Study|Withdrawal by Subject|0|||
130447011|NCT04131907|469597152|FG002|Overall Study|Withdrawal by Subject|1|||
130447012|NCT04131907|469597150|FG000|Overall Study|Treatment failure|2|||
130447013|NCT04131907|469597151|FG001|Overall Study|Treatment failure|0|||
130447014|NCT04131907|469597152|FG002|Overall Study|Treatment failure|1|||
130447015|NCT01778062|469597153|FG000|Overall Study|Adverse Event|1|||
130447016|NCT01778062|469597154|FG001|Overall Study|Adverse Event|3|||
130447017|NCT01778062|469597153|FG000|Overall Study|Consent Withdrawal|1|||
130447018|NCT01778062|469597154|FG001|Overall Study|Consent Withdrawal|5|||
130447019|NCT01778062|469597153|FG000|Overall Study|major protocol deviation|4|||
130447020|NCT01778062|469597154|FG001|Overall Study|major protocol deviation|3|||
130447021|NCT03387514|469597155|FG000|Overall Study|Withdrawal by Subject|2|||
130447022|NCT03387514|469597155|FG000|Overall Study|Physician Decision|1|||
130447023|NCT03387514|469597155|FG000|Overall Study|Lost to Follow-up|2|||
130447024|NCT00245011|469597166|FG000|Overall Study|Lack of Efficacy|1|||
130694763|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Death|0|||
130694764|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Death|0|||
130694765|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Death|0|||
130694766|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Death|0|||
130447025|NCT04445155|469597169|FG000|Overall Study|Lost to Follow-up|11|||
130447026|NCT04445155|469597170|FG001|Overall Study|Lost to Follow-up|2|||
130447027|NCT04445155|469597171|FG002|Overall Study|Lost to Follow-up|3|||
130447028|NCT04445155|469597172|FG003|Overall Study|Lost to Follow-up|0|||
130447029|NCT04445155|469597169|FG000|Overall Study|Withdrawal by Subject|8|||
130694767|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Death|0|||
130694768|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Death|0|||
130552926|NCT02520284|469991628|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
130694769|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Death|0|||
130694770|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Death|0|||
130694771|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Death|0|||
130694772|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Death|0|||
130694773|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Death|0|||
130694774|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Death|0|||
130694775|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Death|2|||
130694776|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Death|0|||
130694777|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Death|0|||
130694778|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694779|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694780|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694781|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694782|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694783|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694784|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694785|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694786|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694787|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694788|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694789|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694790|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694791|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694792|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694793|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694794|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694795|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694796|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694797|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694798|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694799|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694800|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694801|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694802|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694803|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
130694804|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Other|0|||
130694805|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Other|0|||
130694806|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Other|0|||
130694807|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Other|0|||
130694808|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Other|0|||
130694809|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Other|0|||
130694810|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Other|0|||
130694811|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Other|0|||
130694812|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Other|0|||
130694813|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Other|0|||
130694814|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Other|0|||
130694815|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Other|0|||
130694816|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Other|0|||
130694817|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Other|0|||
130694818|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Other|0|||
130694819|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Other|0|||
130694820|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Other|0|||
130694821|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Other|0|||
130694822|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Other|0|||
130694823|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Other|0|||
130694824|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Other|0|||
130694825|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Other|0|||
130694826|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Other|0|||
130694827|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Other|0|||
130694828|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Other|1|||
130694829|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Other|0|||
130694830|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694831|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694832|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694833|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694834|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694835|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694836|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694837|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694838|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694839|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694840|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694841|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694842|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694843|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694844|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694845|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694846|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694847|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694848|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694849|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694850|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694851|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694852|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694853|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
130694854|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694855|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694856|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694857|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694858|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694859|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694860|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694861|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694862|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694863|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694864|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694865|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694866|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694867|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694868|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694869|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694870|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694871|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694872|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694873|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694874|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694875|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694876|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694877|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694878|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
130694879|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
130694880|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694881|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
130694882|NCT03541252|470505942|FG000|Overall Study|Withdrawal by Subject|1|||
130694883|NCT00227370|470505943|FG000|Overall Study|Withdrawal by Subject|1|||
130694884|NCT00227370|470505944|FG001|Overall Study|Withdrawal by Subject|2|||
130694885|NCT00227370|470505943|FG000|Overall Study|Death|3|||
130694886|NCT00227370|470505944|FG001|Overall Study|Death|4|||
130694887|NCT00227370|470505943|FG000|Overall Study|Adverse Event|6|||
130694888|NCT00227370|470505944|FG001|Overall Study|Adverse Event|11|||
130694889|NCT00227370|470505943|FG000|Overall Study|Physician Decision|9|||
130694890|NCT00227370|470505944|FG001|Overall Study|Physician Decision|6|||
130694891|NCT00227370|470505943|FG000|Overall Study|Other reasons|2|||
130694892|NCT00227370|470505944|FG001|Overall Study|Other reasons|1|||
130694893|NCT03846193|470505945|FG000|Overall Study|Physician Decision|0|||
130694894|NCT03846193|470505946|FG001|Overall Study|Physician Decision|0|||
130694895|NCT03846193|470505947|FG002|Overall Study|Physician Decision|1|||
130694896|NCT03846193|470505948|FG003|Overall Study|Physician Decision|0|||
130237189|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
130237190|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
130237191|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
130237192|NCT03965923|468831875|FG000|Overall Study|Withdrawal by Subject|1|||
130237193|NCT03965923|468831876|FG001|Overall Study|Withdrawal by Subject|2|||
130447030|NCT04445155|469597170|FG001|Overall Study|Withdrawal by Subject|0|||
130694897|NCT03846193|470505949|FG004|Overall Study|Physician Decision|0|||
130237194|NCT03965923|468831877|FG002|Overall Study|Withdrawal by Subject|3|||
130358838|NCT03894046|469286392|FG000|Overall Study|Withdrawal by Subject|2|||
130358839|NCT03894046|469286393|FG001|Overall Study|Withdrawal by Subject|3|||
130358840|NCT03894046|469286394|FG002|Overall Study|Withdrawal by Subject|1|||
130358841|NCT03894046|469286392|FG000|Overall Study|Death|15|||
130358842|NCT03894046|469286393|FG001|Overall Study|Death|21|||
130447031|NCT04445155|469597171|FG002|Overall Study|Withdrawal by Subject|0|||
130447032|NCT04445155|469597172|FG003|Overall Study|Withdrawal by Subject|0|||
130447033|NCT04445155|469597169|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
130447034|NCT04445155|469597170|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
130447035|NCT04445155|469597171|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
130447036|NCT04445155|469597172|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
130447037|NCT04445155|469597169|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
130447038|NCT04445155|469597170|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
130447039|NCT04445155|469597171|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
130447040|NCT04445155|469597172|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
130447041|NCT01388543|469597178|FG000|Day 14|Adverse Event|1|||
130447042|NCT01388543|469597179|FG001|Day 14|Adverse Event|4|||
130447043|NCT00731042|469598683|FG000|Second Intervention|Did not meet inclusion criteria|0|||
130447044|NCT00731042|469598684|FG001|Second Intervention|Did not meet inclusion criteria|2|||
130447045|NCT04213846|469598685|FG000|Overall Study|Withdrawal by Subject|7|||
130447046|NCT04213846|469598686|FG001|Overall Study|Withdrawal by Subject|6|||
130447047|NCT04213846|469598685|FG000|Overall Study|Lost to Follow-up|15|||
130447048|NCT04213846|469598686|FG001|Overall Study|Lost to Follow-up|21|||
130447049|NCT04423393|469598687|FG000|Overall Study|Withdrawal by Subject|0|||
130447050|NCT04423393|469598688|FG001|Overall Study|Withdrawal by Subject|0|||
130447051|NCT04423393|469598689|FG002|Overall Study|Withdrawal by Subject|0|||
130447052|NCT04423393|469598690|FG003|Overall Study|Withdrawal by Subject|0|||
130447053|NCT04423393|469598691|FG004|Overall Study|Withdrawal by Subject|0|||
130447054|NCT04423393|469598692|FG005|Overall Study|Withdrawal by Subject|1|||
130694898|NCT03846193|470505945|FG000|Overall Study|Lost to Follow-up|0|||
130237195|NCT03965923|468831878|FG003|Overall Study|Withdrawal by Subject|1|||
130237196|NCT03965923|468831879|FG004|Overall Study|Withdrawal by Subject|2|||
130237197|NCT03965923|468831880|FG005|Overall Study|Withdrawal by Subject|0|||
130237198|NCT03965923|468831881|FG006|Overall Study|Withdrawal by Subject|4|||
130237199|NCT03965923|468831882|FG007|Overall Study|Withdrawal by Subject|3|||
130237200|NCT03965923|468831883|FG008|Overall Study|Withdrawal by Subject|4|||
130237201|NCT03965923|468831884|FG009|Overall Study|Withdrawal by Subject|0|||
130237202|NCT03965923|468831885|FG010|Overall Study|Withdrawal by Subject|2|||
130237203|NCT03965923|468831886|FG011|Overall Study|Withdrawal by Subject|0|||
130237204|NCT03965923|468831875|FG000|Overall Study|Lost to Follow-up|2|||
130237205|NCT03965923|468831876|FG001|Overall Study|Lost to Follow-up|1|||
130237206|NCT03965923|468831877|FG002|Overall Study|Lost to Follow-up|1|||
130237207|NCT03965923|468831878|FG003|Overall Study|Lost to Follow-up|0|||
130237208|NCT03965923|468831879|FG004|Overall Study|Lost to Follow-up|2|||
130237209|NCT03965923|468831880|FG005|Overall Study|Lost to Follow-up|1|||
130358843|NCT03894046|469286394|FG002|Overall Study|Death|4|||
130358844|NCT03894046|469286392|FG000|Overall Study|No growth of ABC|2|||
130358845|NCT03894046|469286393|FG001|Overall Study|No growth of ABC|1|||
130358846|NCT03894046|469286394|FG002|Overall Study|No growth of ABC|0|||
130358847|NCT03894046|469286392|FG000|Overall Study|Physician Decision|1|||
130358848|NCT03894046|469286393|FG001|Overall Study|Physician Decision|1|||
130358849|NCT03894046|469286394|FG002|Overall Study|Physician Decision|1|||
130358850|NCT03894046|469286392|FG000|Overall Study|Prohibited concomitant medication|1|||
130358851|NCT03894046|469286393|FG001|Overall Study|Prohibited concomitant medication|0|||
130358852|NCT03894046|469286394|FG002|Overall Study|Prohibited concomitant medication|0|||
130358853|NCT03894046|469286392|FG000|Overall Study|Transferred to other arm/group|1|||
130358854|NCT03894046|469286393|FG001|Overall Study|Transferred to other arm/group|1|||
130358855|NCT03894046|469286394|FG002|Overall Study|Transferred to other arm/group|0|||
130358856|NCT02436304|469286404|FG000|Overall Study|Lost to Follow-up|0|||
130358857|NCT02436304|469286405|FG001|Overall Study|Lost to Follow-up|1|||
130358858|NCT02436304|469286406|FG002|Overall Study|Lost to Follow-up|0|||
130358859|NCT02436304|469286404|FG000|Overall Study|Withdrawal by Subject|0|||
130358860|NCT02436304|469286405|FG001|Overall Study|Withdrawal by Subject|1|||
130447055|NCT04423393|469598693|FG006|Overall Study|Withdrawal by Subject|0|||
130694899|NCT03846193|470505946|FG001|Overall Study|Lost to Follow-up|0|||
130237210|NCT03965923|468831881|FG006|Overall Study|Lost to Follow-up|2|||
130237211|NCT03965923|468831882|FG007|Overall Study|Lost to Follow-up|1|||
130237212|NCT03965923|468831883|FG008|Overall Study|Lost to Follow-up|0|||
130237213|NCT03965923|468831884|FG009|Overall Study|Lost to Follow-up|2|||
130358861|NCT02436304|469286406|FG002|Overall Study|Withdrawal by Subject|0|||
130358862|NCT02436304|469286404|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
130358863|NCT02436304|469286405|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
130358864|NCT02436304|469286406|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
130447056|NCT04423393|469598694|FG007|Overall Study|Withdrawal by Subject|0|||
130447057|NCT04423393|469598695|FG008|Overall Study|Withdrawal by Subject|0|||
130447058|NCT04423393|469598696|FG009|Overall Study|Withdrawal by Subject|0|||
130447059|NCT04423393|469598697|FG010|Overall Study|Withdrawal by Subject|0|||
130447060|NCT04423393|469598698|FG011|Overall Study|Withdrawal by Subject|0|||
130447061|NCT04423393|469598699|FG012|Overall Study|Withdrawal by Subject|0|||
130447062|NCT04423393|469598700|FG013|Overall Study|Withdrawal by Subject|1|||
130447063|NCT04423393|469598701|FG014|Overall Study|Withdrawal by Subject|0|||
130447064|NCT04423393|469598702|FG015|Overall Study|Withdrawal by Subject|0|||
130447065|NCT04423393|469598703|FG016|Overall Study|Withdrawal by Subject|0|||
130447066|NCT04423393|469598704|FG017|Overall Study|Withdrawal by Subject|0|||
130447067|NCT04423393|469598687|FG000|Overall Study|Sponsor Decision|0|||
130447068|NCT04423393|469598688|FG001|Overall Study|Sponsor Decision|0|||
130447069|NCT04423393|469598689|FG002|Overall Study|Sponsor Decision|0|||
130447070|NCT04423393|469598690|FG003|Overall Study|Sponsor Decision|0|||
130447071|NCT04423393|469598691|FG004|Overall Study|Sponsor Decision|0|||
130447072|NCT04423393|469598692|FG005|Overall Study|Sponsor Decision|0|||
130447073|NCT04423393|469598693|FG006|Overall Study|Sponsor Decision|0|||
130447074|NCT04423393|469598694|FG007|Overall Study|Sponsor Decision|0|||
130447075|NCT04423393|469598695|FG008|Overall Study|Sponsor Decision|0|||
130447076|NCT04423393|469598696|FG009|Overall Study|Sponsor Decision|0|||
130447077|NCT04423393|469598697|FG010|Overall Study|Sponsor Decision|0|||
130447078|NCT04423393|469598698|FG011|Overall Study|Sponsor Decision|0|||
130447079|NCT04423393|469598699|FG012|Overall Study|Sponsor Decision|0|||
130447080|NCT04423393|469598700|FG013|Overall Study|Sponsor Decision|1|||
130447081|NCT04423393|469598701|FG014|Overall Study|Sponsor Decision|0|||
130447082|NCT04423393|469598702|FG015|Overall Study|Sponsor Decision|0|||
130447083|NCT04423393|469598703|FG016|Overall Study|Sponsor Decision|0|||
130447084|NCT04423393|469598704|FG017|Overall Study|Sponsor Decision|0|||
130447085|NCT02692235|469598707|FG000|Overall Study|Withdrawal by Subject|2|||
130447086|NCT02692235|469598708|FG001|Overall Study|Withdrawal by Subject|1|||
130447087|NCT02692235|469598707|FG000|Overall Study|Adverse Event|1|||
130447088|NCT02692235|469598708|FG001|Overall Study|Adverse Event|2|||
130447089|NCT00802841|469598709|FG000|Overall Study|Administrative problems|1|||
130447090|NCT00802841|469598710|FG001|Overall Study|Administrative problems|0|||
130447091|NCT00802841|469598709|FG000|Overall Study|Lost to Follow-up|2|||
130447092|NCT00802841|469598710|FG001|Overall Study|Lost to Follow-up|1|||
130447093|NCT00802841|469598709|FG000|Overall Study|Death|1|||
130447094|NCT00802841|469598710|FG001|Overall Study|Death|2|||
130447095|NCT00802841|469598709|FG000|Overall Study|Adverse Event|8|||
130447096|NCT00802841|469598710|FG001|Overall Study|Adverse Event|2|||
130447097|NCT00802841|469598709|FG000|Overall Study|Disease progression|7|||
130447098|NCT00802841|469598710|FG001|Overall Study|Disease progression|3|||
130447099|NCT00802841|469598709|FG000|Overall Study|Withdrawal by Subject|9|||
130447100|NCT00802841|469598710|FG001|Overall Study|Withdrawal by Subject|5|||
130447101|NCT00802841|469598709|FG000|Overall Study|Protocol deviation|2|||
130447102|NCT00802841|469598710|FG001|Overall Study|Protocol deviation|6|||
130447103|NCT00802841|469598709|FG000|Overall Study|Treatment duration completed|66|||
130447104|NCT00802841|469598710|FG001|Overall Study|Treatment duration completed|76|||
130447105|NCT02711995|469598711|FG000|Washout (90 Days)|Conflicting medication|1|||
130447106|NCT01115998|469598716|FG000|Overall Study|Lost to Follow-up|6|||
130447107|NCT01115998|469598717|FG001|Overall Study|Lost to Follow-up|6|||
130447108|NCT02819479|469598718|FG000|Overall Study|Adverse Event|2|||
130447109|NCT03531905|469598719|FG000|Overall Study|Withdrawal by Subject|3|||
130447110|NCT03531905|469598720|FG001|Overall Study|Withdrawal by Subject|3|||
130447111|NCT03531905|469598721|FG002|Overall Study|Withdrawal by Subject|2|||
130447112|NCT03531905|469598719|FG000|Overall Study|Lost to Follow-up|2|||
130447113|NCT03531905|469598720|FG001|Overall Study|Lost to Follow-up|2|||
130447114|NCT03531905|469598721|FG002|Overall Study|Lost to Follow-up|1|||
130447115|NCT03531905|469598719|FG000|Overall Study|Participant was out of town|1|||
130447116|NCT03531905|469598720|FG001|Overall Study|Participant was out of town|0|||
130237214|NCT03965923|468831885|FG010|Overall Study|Lost to Follow-up|0|||
130237215|NCT03965923|468831886|FG011|Overall Study|Lost to Follow-up|0|||
130447117|NCT03531905|469598721|FG002|Overall Study|Participant was out of town|0|||
130237216|NCT03965923|468831875|FG000|Overall Study|Death|0|||
130447118|NCT03531905|469598719|FG000|Overall Study|Could not speak with the participant|1|||
130447119|NCT03531905|469598720|FG001|Overall Study|Could not speak with the participant|0|||
130447120|NCT03531905|469598721|FG002|Overall Study|Could not speak with the participant|0|||
130447121|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
130447122|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
130237217|NCT03965923|468831876|FG001|Overall Study|Death|0|||
130237218|NCT03965923|468831877|FG002|Overall Study|Death|0|||
130447123|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
130447124|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
130447125|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
130447126|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
130694900|NCT03846193|470505947|FG002|Overall Study|Lost to Follow-up|0|||
130694901|NCT03846193|470505948|FG003|Overall Study|Lost to Follow-up|0|||
130694902|NCT03846193|470505949|FG004|Overall Study|Lost to Follow-up|1|||
130694903|NCT03846193|470505945|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694904|NCT03846193|470505946|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694905|NCT03846193|470505947|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694906|NCT03846193|470505948|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
130694907|NCT03846193|470505949|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694908|NCT02588339|470505951|FG000|Overall Study|Withdrawal by Subject|1|||
130694909|NCT02588339|470505951|FG000|Overall Study|GVHD Progression prior to treatment|2|||
130694910|NCT03679598|470507566|FG000|Overall Study|Adverse Event|2|||
130694911|NCT03679598|470507567|FG001|Overall Study|Adverse Event|0|||
130694912|NCT01701063|470507568|FG000|Overall Study|Lost to Follow-up|0|||
130694913|NCT01701063|470507569|FG001|Overall Study|Lost to Follow-up|1|||
130694914|NCT01701063|470507570|FG002|Overall Study|Lost to Follow-up|0|||
130694915|NCT01701063|470507568|FG000|Overall Study|Withdrawal by Subject|0|||
130694916|NCT01701063|470507569|FG001|Overall Study|Withdrawal by Subject|0|||
130694917|NCT01701063|470507570|FG002|Overall Study|Withdrawal by Subject|1|||
130694918|NCT01701063|470507568|FG000|Overall Study|Other|0|||
130237219|NCT03965923|468831878|FG003|Overall Study|Death|0|||
130237220|NCT03965923|468831879|FG004|Overall Study|Death|0|||
130237221|NCT03965923|468831880|FG005|Overall Study|Death|0|||
130237222|NCT03965923|468831881|FG006|Overall Study|Death|0|||
130237223|NCT03965923|468831882|FG007|Overall Study|Death|1|||
130694919|NCT01701063|470507569|FG001|Overall Study|Other|0|||
130694920|NCT01701063|470507570|FG002|Overall Study|Other|1|||
130694921|NCT05387408|470507571|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
130694922|NCT01919112|470507572|FG000|Secondary Analysis-day 30|Death|1|||
130694923|NCT01919112|470507573|FG001|Secondary Analysis-day 30|Death|1|||
130694924|NCT01919112|470507574|FG002|Secondary Analysis-day 30|Death|1|||
130694925|NCT01919112|470507572|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
130694926|NCT01919112|470507573|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
130694927|NCT01919112|470507574|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
130694928|NCT02043132|470507575|FG000|Overall Study|Lost to Follow-up|1|||
130694929|NCT02043132|470507576|FG001|Overall Study|Lost to Follow-up|1|||
130694930|NCT02043132|470507575|FG000|Overall Study|screen failures|4|||
130694931|NCT02043132|470507576|FG001|Overall Study|screen failures|8|||
130694932|NCT00635648|470507577|FG000|Overall Study|Adverse Event|12|||
130694933|NCT00635648|470507577|FG000|Overall Study|Withdrawal by Subject|9|||
130694934|NCT00635648|470507577|FG000|Overall Study|Physician Decision|4|||
130694935|NCT00635648|470507577|FG000|Overall Study|Rapid progression of baseline disease|4|||
130694936|NCT00635648|470507577|FG000|Overall Study|Use of other antifungal agent needed|1|||
130694937|NCT00635648|470507577|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
130694938|NCT00635648|470507577|FG000|Overall Study|Noncompliance with protocol|1|||
130694939|NCT00635648|470507577|FG000|Overall Study|Other reason|2|||
130694940|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
130694941|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
130694942|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
130694943|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
130694944|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
130694945|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
130694946|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
130694947|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130694948|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130694949|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
130694950|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
130694951|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
130694952|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130694953|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
130694954|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130694955|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
130237224|NCT03965923|468831883|FG008|Overall Study|Death|4|||
130237225|NCT03965923|468831884|FG009|Overall Study|Death|0|||
130237226|NCT03965923|468831885|FG010|Overall Study|Death|4|||
130237227|NCT03965923|468831886|FG011|Overall Study|Death|0|||
130237228|NCT03965923|468831875|FG000|Overall Study|Other reason|0|||
130237229|NCT03965923|468831876|FG001|Overall Study|Other reason|0|||
130694956|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
130694957|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
130694958|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130237230|NCT03965923|468831877|FG002|Overall Study|Other reason|0|||
130237231|NCT03965923|468831878|FG003|Overall Study|Other reason|1|||
130237232|NCT03965923|468831879|FG004|Overall Study|Other reason|0|||
130237233|NCT03965923|468831880|FG005|Overall Study|Other reason|0|||
130237234|NCT03965923|468831881|FG006|Overall Study|Other reason|0|||
130447127|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
130447128|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
130237235|NCT03965923|468831882|FG007|Overall Study|Other reason|0|||
130358865|NCT03793556|469286407|FG000|Overall Study|Withdrawal by Subject|12|||
130358866|NCT03793556|469286408|FG001|Overall Study|Withdrawal by Subject|1|||
130358867|NCT03793556|469286407|FG000|Overall Study|Lost to Follow-up|1|||
130358868|NCT03793556|469286408|FG001|Overall Study|Lost to Follow-up|1|||
130358869|NCT04416633|469286409|FG000|Overall Study|Death|1|||
130358870|NCT04416633|469286409|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
130358871|NCT04416633|469286409|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
130358872|NCT04416633|469286409|FG000|Overall Study|Adverse Event|6|||
130358873|NCT04416633|469286409|FG000|Overall Study|Withdrawal by Subject|6|||
130358874|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Death|1|||
130358875|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Death|1|||
130358876|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Death|0|||
130358877|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Death|0|||
130358878|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
130358879|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130358880|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130358881|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130358882|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
130358883|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
130358884|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
130358885|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
130358886|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
130358887|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
130358888|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
130358889|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
130358890|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
130358891|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
130358892|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
130358893|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
130358894|NCT04612790|469286410|FG000|DB Period (Up to 36 Weeks)|Other|1|||
130358895|NCT04612790|469286411|FG001|DB Period (Up to 36 Weeks)|Other|0|||
130358896|NCT04612790|469286412|FG002|DB Period (Up to 36 Weeks)|Other|0|||
130358897|NCT04612790|469286413|FG003|DB Period (Up to 36 Weeks)|Other|0|||
130358898|NCT04612790|469286410|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130358899|NCT04612790|469286411|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130358900|NCT04612790|469286412|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130358901|NCT04612790|469286413|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
130358902|NCT04612790|469286410|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
130358903|NCT04612790|469286411|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
130358904|NCT04612790|469286412|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
130358905|NCT04612790|469286413|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
130358906|NCT04612790|469286410|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
130358907|NCT04612790|469286411|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
130358908|NCT04612790|469286412|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
130358909|NCT04612790|469286413|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
130358910|NCT04612790|469286410|FG000|OLE Period (Up to 1 Year)|Other|0|||
130358911|NCT04612790|469286411|FG001|OLE Period (Up to 1 Year)|Other|0|||
130358912|NCT04612790|469286412|FG002|OLE Period (Up to 1 Year)|Other|0|||
130358913|NCT04612790|469286413|FG003|OLE Period (Up to 1 Year)|Other|1|||
130358914|NCT05021081|469286418|FG000|Phase 2|Subject enrolled in error|1|||
130358915|NCT05021081|469286419|FG001|Phase 2|Subject enrolled in error|1|||
130358916|NCT05021081|469286420|FG002|Phase 2|Subject enrolled in error|0|||
130358917|NCT00369122|469286421|FG000|Overall Study|Ineligible|10|||
130358918|NCT00369122|469286421|FG000|Overall Study|No protocol treatment|1|||
130358919|NCT00408629|469286422|FG000|Overall Study|Adverse Event|13|||
130358920|NCT00408629|469286423|FG001|Overall Study|Adverse Event|27|||
130358921|NCT00408629|469286422|FG000|Overall Study|Withdrawal by Subject|8|||
130358922|NCT00408629|469286423|FG001|Overall Study|Withdrawal by Subject|4|||
130358923|NCT00408629|469286422|FG000|Overall Study|Lost to Follow-up|1|||
130358924|NCT00408629|469286423|FG001|Overall Study|Lost to Follow-up|1|||
130358925|NCT00408629|469286422|FG000|Overall Study|Lack of Efficacy|63|||
130358926|NCT00408629|469286423|FG001|Overall Study|Lack of Efficacy|73|||
130358927|NCT00408629|469286422|FG000|Overall Study|Protocol Violation|1|||
130358928|NCT00408629|469286423|FG001|Overall Study|Protocol Violation|5|||
130237236|NCT03965923|468831883|FG008|Overall Study|Other reason|0|||
130358929|NCT00408629|469286422|FG000|Overall Study|Miscellaneous|11|||
130358930|NCT00408629|469286423|FG001|Overall Study|Miscellaneous|15|||
130358931|NCT00191906|469286424|FG000|Study Period II|Adverse Event|0|||
130237237|NCT03965923|468831884|FG009|Overall Study|Other reason|0|||
130447129|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130447130|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130447131|NCT01646320|469598729|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
130447132|NCT01646320|469598730|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
130447133|NCT01646320|469598729|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
130447134|NCT01646320|469598730|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
130447135|NCT01646320|469598729|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
130447136|NCT01646320|469598730|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
130447137|NCT01646320|469598729|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
130447138|NCT01646320|469598730|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
130447139|NCT01646320|469598729|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
130447140|NCT01646320|469598730|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
130447141|NCT01646320|469598729|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
130447142|NCT01646320|469598730|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
130447143|NCT01489020|469598731|FG000|Overall Study|Withdrawal by Subject|1|||
130447144|NCT01489020|469598732|FG001|Overall Study|Withdrawal by Subject|0|||
130447145|NCT01489020|469598733|FG002|Overall Study|Withdrawal by Subject|0|||
130447146|NCT01489020|469598734|FG003|Overall Study|Withdrawal by Subject|0|||
130447147|NCT01489020|469598735|FG004|Overall Study|Withdrawal by Subject|0|||
130447148|NCT01489020|469598736|FG005|Overall Study|Withdrawal by Subject|0|||
130447149|NCT01489020|469598731|FG000|Overall Study|Adverse Event|0|||
130447150|NCT01489020|469598732|FG001|Overall Study|Adverse Event|0|||
130447151|NCT01489020|469598733|FG002|Overall Study|Adverse Event|3|||
130447152|NCT01489020|469598734|FG003|Overall Study|Adverse Event|0|||
130447153|NCT01489020|469598735|FG004|Overall Study|Adverse Event|3|||
130447154|NCT01489020|469598736|FG005|Overall Study|Adverse Event|0|||
130447155|NCT01489020|469598731|FG000|Overall Study|Concomitant disease|0|||
130447156|NCT01489020|469598732|FG001|Overall Study|Concomitant disease|0|||
130447157|NCT01489020|469598733|FG002|Overall Study|Concomitant disease|0|||
130447158|NCT01489020|469598734|FG003|Overall Study|Concomitant disease|0|||
130447159|NCT01489020|469598735|FG004|Overall Study|Concomitant disease|3|||
130447160|NCT01489020|469598736|FG005|Overall Study|Concomitant disease|0|||
130447161|NCT01174550|469598737|FG000|Overall Study|Death|75|||
130447162|NCT01174550|469598738|FG001|Overall Study|Death|74|||
130447163|NCT01174550|469598737|FG000|Overall Study|Lost to Follow-up|652|||
130447164|NCT01174550|469598738|FG001|Overall Study|Lost to Follow-up|510|||
130447165|NCT01174550|469598737|FG000|Overall Study|Withdrawal by Subject|543|||
130447166|NCT01174550|469598738|FG001|Overall Study|Withdrawal by Subject|289|||
130447167|NCT01536262|469598739|FG000|Overall Study|Adverse Event|6|||
130447168|NCT01536262|469598740|FG001|Overall Study|Adverse Event|1|||
130447169|NCT01536262|469598741|FG002|Overall Study|Adverse Event|2|||
130447170|NCT01536262|469598739|FG000|Overall Study|Withdrawal by Subject|1|||
130447171|NCT01536262|469598740|FG001|Overall Study|Withdrawal by Subject|1|||
130447172|NCT01536262|469598741|FG002|Overall Study|Withdrawal by Subject|0|||
130447173|NCT01536262|469598739|FG000|Overall Study|Other than stated above|1|||
130447174|NCT01536262|469598740|FG001|Overall Study|Other than stated above|0|||
130447175|NCT01536262|469598741|FG002|Overall Study|Other than stated above|0|||
130447176|NCT05257837|469598745|FG000|Overall Study|Excluded (did not find the guns)|4|||
130447177|NCT05257837|469598746|FG001|Overall Study|Excluded (did not find the guns)|2|||
130447178|NCT05257837|469598747|FG002|Overall Study|Excluded (did not find the guns)|4|||
130447179|NCT05257837|469598748|FG003|Overall Study|Excluded (did not find the guns)|0|||
130447180|NCT01781611|469598749|FG000|Overall Study|Adverse Event|4|||
130447181|NCT01781611|469598750|FG001|Overall Study|Adverse Event|0|||
130447182|NCT01625338|469598751|FG000|Overall Study|Enrolled but not Treated|0|||
130447183|NCT01625338|469598752|FG001|Overall Study|Enrolled but not Treated|0|||
130447184|NCT01625338|469598753|FG002|Overall Study|Enrolled but not Treated|1|||
130447185|NCT01625338|469598751|FG000|Overall Study|Efficacy Failure|27|||
130447186|NCT01625338|469598752|FG001|Overall Study|Efficacy Failure|39|||
130447187|NCT01625338|469598753|FG002|Overall Study|Efficacy Failure|31|||
130447188|NCT01625338|469598751|FG000|Overall Study|Lost to Follow-up|3|||
130447189|NCT01625338|469598752|FG001|Overall Study|Lost to Follow-up|3|||
130447190|NCT01625338|469598753|FG002|Overall Study|Lost to Follow-up|2|||
130447191|NCT01625338|469598751|FG000|Overall Study|Investigator Decision|0|||
130447192|NCT01625338|469598752|FG001|Overall Study|Investigator Decision|2|||
130447193|NCT01625338|469598753|FG002|Overall Study|Investigator Decision|1|||
130447194|NCT01625338|469598751|FG000|Overall Study|Subject Withdrew Consent|1|||
130447195|NCT01625338|469598752|FG001|Overall Study|Subject Withdrew Consent|0|||
130447196|NCT01625338|469598753|FG002|Overall Study|Subject Withdrew Consent|2|||
130447197|NCT01625338|469598751|FG000|Overall Study|Adverse Event|1|||
130447198|NCT01625338|469598752|FG001|Overall Study|Adverse Event|0|||
130447199|NCT01625338|469598753|FG002|Overall Study|Adverse Event|1|||
130447200|NCT01625338|469598751|FG000|Overall Study|Study Discontinued by Sponsor|0|||
130447201|NCT01625338|469598752|FG001|Overall Study|Study Discontinued by Sponsor|0|||
130447202|NCT01625338|469598753|FG002|Overall Study|Study Discontinued by Sponsor|1|||
130447203|NCT00031447|469598754|FG000|Overall Study|Lost to Follow-up|0|||
130694959|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130694960|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
130694961|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
130694962|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
130694963|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
130694964|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
130694965|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
130694966|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
130694967|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
130694968|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
130694969|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
130694970|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130694971|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
130694972|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130694973|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
130694974|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
130694975|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
130694976|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130694977|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130694978|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
130694979|NCT04194801|470507578|FG000|Part Ib/II End of Study|Death|2|||
130694980|NCT04194801|470507579|FG001|Part Ib/II End of Study|Death|3|||
130694981|NCT04194801|470507580|FG002|Part Ib/II End of Study|Death|3|||
130694982|NCT04194801|470507578|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
130694983|NCT04194801|470507579|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
130694984|NCT04194801|470507580|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
130694985|NCT04194801|470507578|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
130694986|NCT04194801|470507579|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
130694987|NCT04194801|470507580|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
130694988|NCT04194801|470507578|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
130694989|NCT04194801|470507579|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
130694990|NCT04194801|470507580|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
130694991|NCT04194801|470507578|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
130694992|NCT04194801|470507579|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
130237238|NCT03965923|468831885|FG010|Overall Study|Other reason|2|||
130237239|NCT03965923|468831886|FG011|Overall Study|Other reason|0|||
130237240|NCT04221490|468831887|FG000|At 30 Days Follow-up|Death|7|||
130237241|NCT04221490|468831887|FG000|At 30 Days Follow-up|Missed Visit|4|||
130237242|NCT04221490|468831887|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
130237243|NCT04221490|468831887|FG000|At 6 Months Follow-up|Death|9|||
130237244|NCT04221490|468831887|FG000|At 6 Months Follow-up|Physician Decision|1|||
130237245|NCT04221490|468831887|FG000|At 6 Months Follow-up|Missed Visit|8|||
130237246|NCT04221490|468831887|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
130237247|NCT03034967|468831888|FG000|Overall Study|Withdrawal by Subject|9|||
130237248|NCT03034967|468831889|FG001|Overall Study|Withdrawal by Subject|2|||
130237249|NCT03034967|468831890|FG002|Overall Study|Withdrawal by Subject|6|||
130237250|NCT03034967|468831891|FG003|Overall Study|Withdrawal by Subject|6|||
130237251|NCT03034967|468831892|FG004|Overall Study|Withdrawal by Subject|9|||
130237252|NCT03034967|468831893|FG005|Overall Study|Withdrawal by Subject|2|||
130237253|NCT03034967|468831888|FG000|Overall Study|Physician Decision|1|||
130237254|NCT03034967|468831889|FG001|Overall Study|Physician Decision|0|||
130237255|NCT03034967|468831890|FG002|Overall Study|Physician Decision|1|||
130237256|NCT03034967|468831891|FG003|Overall Study|Physician Decision|1|||
130237257|NCT03034967|468831892|FG004|Overall Study|Physician Decision|1|||
130237258|NCT03034967|468831893|FG005|Overall Study|Physician Decision|0|||
130237259|NCT03034967|468831888|FG000|Overall Study|Lost to Follow-up|0|||
130237260|NCT03034967|468831889|FG001|Overall Study|Lost to Follow-up|0|||
130237261|NCT03034967|468831890|FG002|Overall Study|Lost to Follow-up|0|||
130237262|NCT03034967|468831891|FG003|Overall Study|Lost to Follow-up|1|||
130237263|NCT03034967|468831892|FG004|Overall Study|Lost to Follow-up|0|||
130237264|NCT03034967|468831893|FG005|Overall Study|Lost to Follow-up|2|||
130237265|NCT03034967|468831888|FG000|Overall Study|Liver function test abnormality|0|||
130694993|NCT04194801|470507580|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
130237266|NCT03034967|468831889|FG001|Overall Study|Liver function test abnormality|0|||
130237267|NCT03034967|468831890|FG002|Overall Study|Liver function test abnormality|1|||
130237268|NCT03034967|468831891|FG003|Overall Study|Liver function test abnormality|0|||
130447204|NCT00031447|469598755|FG001|Overall Study|Lost to Follow-up|1|||
130447205|NCT00031447|469598754|FG000|Overall Study|Non-compliant|1|||
130447206|NCT00031447|469598755|FG001|Overall Study|Non-compliant|1|||
130694994|NCT03827395|470507581|FG000|Overall Study|Lost to Follow-up|1|||
130694995|NCT03827395|470507582|FG001|Overall Study|Lost to Follow-up|0|||
130694996|NCT03827395|470507581|FG000|Overall Study|Protocol Violation|1|||
130694997|NCT03827395|470507582|FG001|Overall Study|Protocol Violation|0|||
130694998|NCT03827395|470507581|FG000|Overall Study|Became ineligible after enrollment|1|||
130694999|NCT03827395|470507582|FG001|Overall Study|Became ineligible after enrollment|2|||
130695000|NCT01923740|470507583|FG000|Overall Study|Lost to Follow-up|4|||
130695001|NCT01923740|470507584|FG001|Overall Study|Lost to Follow-up|9|||
130695002|NCT01923740|470507583|FG000|Overall Study|Withdrawal by Subject|2|||
130695003|NCT01923740|470507584|FG001|Overall Study|Withdrawal by Subject|0|||
130695004|NCT00294047|470507585|FG000|Month 48|Adverse Event|28|||
130695005|NCT00294047|470507586|FG001|Month 48|Adverse Event|13|||
130695006|NCT00294047|470507585|FG000|Month 48|Protocol Violation|4|||
130695007|NCT00294047|470507586|FG001|Month 48|Protocol Violation|4|||
130695008|NCT00294047|470507585|FG000|Month 48|Withdrawal by Subject|111|||
130695009|NCT00294047|470507586|FG001|Month 48|Withdrawal by Subject|115|||
130695010|NCT00294047|470507585|FG000|Month 48|Lost to Follow-up|272|||
130695011|NCT00294047|470507586|FG001|Month 48|Lost to Follow-up|287|||
130695012|NCT00294047|470507585|FG000|Month 48|Other|10|||
130695013|NCT00294047|470507586|FG001|Month 48|Other|14|||
130695014|NCT00294047|470507585|FG000|Month 84|Adverse Event|4|||
130695015|NCT00294047|470507586|FG001|Month 84|Adverse Event|2|||
130695016|NCT00294047|470507585|FG000|Month 84|Protocol Violation|1|||
130695017|NCT00294047|470507586|FG001|Month 84|Protocol Violation|1|||
130695018|NCT00294047|470507585|FG000|Month 84|Withdrawal by Subject|33|||
130695019|NCT00294047|470507586|FG001|Month 84|Withdrawal by Subject|31|||
130695020|NCT00294047|470507585|FG000|Month 84|Lost to Follow-up|187|||
130695021|NCT00294047|470507586|FG001|Month 84|Lost to Follow-up|190|||
130695022|NCT00294047|470507585|FG000|Month 84|Absent Cervix|2|||
130695023|NCT00294047|470507586|FG001|Month 84|Absent Cervix|0|||
130695024|NCT00294047|470507585|FG000|Month 84|Work related reasons|4|||
130695025|NCT00294047|470507586|FG001|Month 84|Work related reasons|2|||
130695026|NCT00294047|470507585|FG000|Month 84|Center closed, subject did not transfer|1|||
130695027|NCT00294047|470507586|FG001|Month 84|Center closed, subject did not transfer|0|||
130695028|NCT00294047|470507585|FG000|Month 84|Family problems|2|||
130695029|NCT00294047|470507586|FG001|Month 84|Family problems|2|||
130695030|NCT00294047|470507585|FG000|Month 84|Lack of time|3|||
130695031|NCT00294047|470507586|FG001|Month 84|Lack of time|1|||
130695032|NCT00294047|470507585|FG000|Month 84|Personal reason|2|||
130695033|NCT00294047|470507586|FG001|Month 84|Personal reason|4|||
130695034|NCT00294047|470507585|FG000|Month 84|Subject does not want male physician|1|||
130695035|NCT00294047|470507586|FG001|Month 84|Subject does not want male physician|0|||
130695036|NCT00294047|470507585|FG000|Month 84|Transport reimbursement delayed|0|||
130695037|NCT00294047|470507586|FG001|Month 84|Transport reimbursement delayed|1|||
130695038|NCT00294047|470507585|FG000|Month 84|Unable to reach study site|1|||
130695039|NCT00294047|470507586|FG001|Month 84|Unable to reach study site|0|||
130695040|NCT00294047|470507585|FG000|Month 84|Under investigation locally|1|||
130695041|NCT00294047|470507586|FG001|Month 84|Under investigation locally|0|||
130695042|NCT00294047|470507585|FG000|Month 84|Visit missed|0|||
130695043|NCT00294047|470507586|FG001|Month 84|Visit missed|1|||
130695044|NCT00294047|470507585|FG000|Month 84|No consent for Month 84 Follow-up|731|||
130695045|NCT00294047|470507586|FG001|Month 84|No consent for Month 84 Follow-up|754|||
130695046|NCT00924638|470507592|FG000|Overall Study|Death|3|||
130695047|NCT00924638|470507593|FG001|Overall Study|Death|2|||
130695048|NCT00924638|470507592|FG000|Overall Study|Lost to Follow-up|1|||
130695049|NCT00924638|470507593|FG001|Overall Study|Lost to Follow-up|1|||
130695050|NCT00924638|470507592|FG000|Overall Study|Withdrawal by Subject|5|||
130695051|NCT00924638|470507593|FG001|Overall Study|Withdrawal by Subject|7|||
130695052|NCT00924638|470507592|FG000|Overall Study|Physician Decision|3|||
130695053|NCT00924638|470507593|FG001|Overall Study|Physician Decision|3|||
130695054|NCT00847535|470507594|FG000|Overall Study|Withdrawal by Subject|2|||
130695055|NCT00847535|470507595|FG001|Overall Study|Withdrawal by Subject|1|||
130695056|NCT00847535|470507596|FG002|Overall Study|Withdrawal by Subject|1|||
130695057|NCT00847535|470507594|FG000|Overall Study|Lost to Follow-up|0|||
130695058|NCT00847535|470507595|FG001|Overall Study|Lost to Follow-up|1|||
130447207|NCT00031447|469598754|FG000|Overall Study|Re-activation of Disease|2|||
130447208|NCT00031447|469598755|FG001|Overall Study|Re-activation of Disease|1|||
130447209|NCT00031447|469598754|FG000|Overall Study|Disruption of blinded study drug supply|7|||
130447210|NCT00031447|469598755|FG001|Overall Study|Disruption of blinded study drug supply|4|||
130695059|NCT00847535|470507596|FG002|Overall Study|Lost to Follow-up|0|||
130447211|NCT01636362|469598756|FG000|Overall Study|Physician Decision|6|||
130695060|NCT01252953|470507597|FG000|Overall Study|Withdrawal by Subject|16|||
130695061|NCT01252953|470507598|FG001|Overall Study|Withdrawal by Subject|17|||
130695062|NCT01252953|470507597|FG000|Overall Study|Lost to Follow-up|22|||
130695063|NCT01252953|470507598|FG001|Overall Study|Lost to Follow-up|21|||
130695064|NCT00958724|470507602|FG000|Overall Study|Disease Progression|6|||
130695065|NCT05604014|470507620|FG000|Overall Study|Lost to Follow-up|13|||
130695066|NCT00840203|470507621|FG000|First Intervention|Protocol Violation|1|||
130695067|NCT00840203|470507622|FG001|First Intervention|Protocol Violation|1|||
130695068|NCT00840203|470507621|FG000|Washout|Protocol Violation|1|||
130695069|NCT00840203|470507622|FG001|Washout|Protocol Violation|0|||
130695070|NCT02121184|470507623|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
130720849|NCT04126213|470601546|FG001|Overall Study|Withdrawal by Subject|2|||
130695071|NCT02121184|470507624|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
130695072|NCT02121184|470507623|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
130695073|NCT02121184|470507624|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
130695074|NCT02121184|470507623|FG000|Overall Study|Emergency cesarean section required|0|||
130695075|NCT02121184|470507624|FG001|Overall Study|Emergency cesarean section required|2|||
130695076|NCT02121184|470507623|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
130695077|NCT02121184|470507624|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
130695078|NCT04411680|470507629|FG000|Treatment Period|Adverse Event|3|||
130695079|NCT04411680|470507630|FG001|Treatment Period|Adverse Event|0|||
130695080|NCT04411680|470507629|FG000|Treatment Period|Discharged from hospital|18|||
130695081|NCT04411680|470507630|FG001|Treatment Period|Discharged from hospital|7|||
130695082|NCT04411680|470507629|FG000|Treatment Period|Missed 1 or more doses|8|||
130695083|NCT04411680|470507630|FG001|Treatment Period|Missed 1 or more doses|0|||
130695084|NCT04411680|470507629|FG000|Treatment Period|Transferred to another hospital|0|||
130695085|NCT04411680|470507630|FG001|Treatment Period|Transferred to another hospital|1|||
130695086|NCT04411680|470507629|FG000|Follow up Period|Withdrawal by Subject|2|||
130695087|NCT04411680|470507630|FG001|Follow up Period|Withdrawal by Subject|0|||
130695088|NCT04411680|470507629|FG000|Follow up Period|Lost to Follow-up|5|||
130695089|NCT04411680|470507630|FG001|Follow up Period|Lost to Follow-up|6|||
130695090|NCT04411680|470507629|FG000|Follow up Period|Death|11|||
130695091|NCT04411680|470507630|FG001|Follow up Period|Death|8|||
130695092|NCT00748566|470507631|FG000|Overall Study|Adverse Event|49|||
130695093|NCT00748566|470507631|FG000|Overall Study|Death|1|||
130695094|NCT00748566|470507631|FG000|Overall Study|Lack of Efficacy|12|||
130695095|NCT00748566|470507631|FG000|Overall Study|Lost to Follow-up|1|||
130695096|NCT00748566|470507631|FG000|Overall Study|Protocol Violation|13|||
130695097|NCT00748566|470507631|FG000|Overall Study|Withdrawal by Subject|22|||
130695098|NCT00748566|470507631|FG000|Overall Study|Study terminated by sponsor|5|||
130695099|NCT00748566|470507631|FG000|Overall Study|Other|9|||
130695100|NCT00841659|470507632|FG000|Washout: 2 Weeks|Protocol Violation|1|||
130695101|NCT00841659|470507633|FG001|Washout: 2 Weeks|Protocol Violation|0|||
130695102|NCT01964950|470507635|FG000|Overall Study|Protocol Violation|25|||
130695103|NCT00674128|470507638|FG000|Overall Study|Withdrawal by Subject|25|||
130695104|NCT00674128|470507639|FG001|Overall Study|Withdrawal by Subject|23|||
130695105|NCT00829452|470507640|FG000|First Intervention|Withdrawal by Subject|0|||
130695106|NCT00829452|470507641|FG001|First Intervention|Withdrawal by Subject|1|||
130695107|NCT00829452|470507640|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
130695108|NCT00829452|470507641|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
130695109|NCT00829452|470507640|FG000|Second Intervention|Physician Decision|0|||
130695110|NCT00829452|470507641|FG001|Second Intervention|Physician Decision|1|||
130695111|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130695112|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
130695113|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130695114|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
130695115|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
130695116|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
130695117|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
130695118|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
130237269|NCT03034967|468831892|FG004|Overall Study|Liver function test abnormality|0|||
130237270|NCT03034967|468831893|FG005|Overall Study|Liver function test abnormality|0|||
130237271|NCT03034967|468831888|FG000|Overall Study|Protocol Violation|1|||
130237272|NCT03034967|468831889|FG001|Overall Study|Protocol Violation|0|||
130447212|NCT01636362|469598756|FG000|Overall Study|Subject healed, not returning|1|||
130447213|NCT01636362|469598756|FG000|Overall Study|Withdrawal by Subject|1|||
130447214|NCT03302910|469598758|FG000|Overall Study|Protocol Violation|1|||
130447215|NCT03302910|469598759|FG001|Overall Study|Protocol Violation|0|||
130447216|NCT01477749|469598760|FG000|Overall Study|Physician Decision|4|||
130237273|NCT03034967|468831890|FG002|Overall Study|Protocol Violation|0|||
130447217|NCT00724061|469598767|FG000|Dose Escalation Phase|Adverse Event|2|||
130695119|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
130695120|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
130695121|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
130695122|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
130695123|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
130695124|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
130695125|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
130695126|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130695127|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
130237274|NCT03034967|468831891|FG003|Overall Study|Protocol Violation|0|||
130447218|NCT00724061|469598767|FG000|Dose Escalation Phase|Disease Progression|3|||
130447219|NCT00953160|469598770|FG000|Overall Study|Lost to Follow-up|23|||
130237275|NCT03034967|468831892|FG004|Overall Study|Protocol Violation|0|||
130237276|NCT03034967|468831893|FG005|Overall Study|Protocol Violation|2|||
130237277|NCT03034967|468831888|FG000|Overall Study|Lack of Efficacy|0|||
130237278|NCT03034967|468831889|FG001|Overall Study|Lack of Efficacy|1|||
130237279|NCT03034967|468831890|FG002|Overall Study|Lack of Efficacy|2|||
130237280|NCT03034967|468831891|FG003|Overall Study|Lack of Efficacy|1|||
130237281|NCT03034967|468831892|FG004|Overall Study|Lack of Efficacy|1|||
130237282|NCT03034967|468831893|FG005|Overall Study|Lack of Efficacy|0|||
130237283|NCT03034967|468831888|FG000|Overall Study|Adverse Event, non-fatal|3|||
130237284|NCT03034967|468831889|FG001|Overall Study|Adverse Event, non-fatal|1|||
130237285|NCT03034967|468831890|FG002|Overall Study|Adverse Event, non-fatal|2|||
130237286|NCT03034967|468831891|FG003|Overall Study|Adverse Event, non-fatal|0|||
130237287|NCT03034967|468831892|FG004|Overall Study|Adverse Event, non-fatal|2|||
130237288|NCT03034967|468831893|FG005|Overall Study|Adverse Event, non-fatal|8|||
130237289|NCT03034967|468831888|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130237290|NCT03034967|468831889|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
130237291|NCT03034967|468831890|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
130237292|NCT03034967|468831891|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
130237293|NCT03034967|468831892|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
130237294|NCT03034967|468831893|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
130237295|NCT04225039|468831900|FG000|Overall Study|Withdrawal by Subject|1|||
130237296|NCT04225039|468831901|FG001|Overall Study|Withdrawal by Subject|0|||
130237297|NCT04225039|468831902|FG002|Overall Study|Withdrawal by Subject|0|||
130237298|NCT04225039|468831903|FG003|Overall Study|Withdrawal by Subject|1|||
130237299|NCT04225039|468831900|FG000|Overall Study|Currently active on study treatment|0|||
130237300|NCT04225039|468831901|FG001|Overall Study|Currently active on study treatment|1|||
130237301|NCT04225039|468831902|FG002|Overall Study|Currently active on study treatment|0|||
130237302|NCT04225039|468831903|FG003|Overall Study|Currently active on study treatment|0|||
130237303|NCT04225039|468831900|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
130447220|NCT00953160|469598770|FG000|Overall Study|Withdrawal by Subject|4|||
130447221|NCT00425503|469598771|FG000|Overall Study|Adverse Event|2|||
130237304|NCT04225039|468831901|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237305|NCT04225039|468831902|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237306|NCT04225039|468831903|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237307|NCT04225039|468831900|FG000|Overall Study|Ineligible for treatment|0|||
130237308|NCT04225039|468831901|FG001|Overall Study|Ineligible for treatment|0|||
130447222|NCT00425503|469598771|FG000|Overall Study|Protocol Violation|1|||
130237309|NCT04225039|468831902|FG002|Overall Study|Ineligible for treatment|0|||
130237310|NCT04225039|468831903|FG003|Overall Study|Ineligible for treatment|4|||
130237311|NCT02802228|468831905|FG000|Overall Study|Withdrawal by Subject|2|||
130237312|NCT02802228|468831906|FG001|Overall Study|Withdrawal by Subject|0|||
130237313|NCT02802228|468831905|FG000|Overall Study|Lost to Follow-up|1|||
130237314|NCT02802228|468831906|FG001|Overall Study|Lost to Follow-up|0|||
130237315|NCT02802228|468831905|FG000|Overall Study|Adverse Event|1|||
130237316|NCT02802228|468831906|FG001|Overall Study|Adverse Event|0|||
130237317|NCT02802228|468831905|FG000|Overall Study|Physician Decision|1|||
130237318|NCT02802228|468831906|FG001|Overall Study|Physician Decision|0|||
130237319|NCT02225587|468831907|FG000|Overall Study|Adverse Event|5|||
130237320|NCT02225587|468831908|FG001|Overall Study|Adverse Event|5|||
130237321|NCT02225587|468831907|FG000|Overall Study|Lost to Follow-up|5|||
130237322|NCT02225587|468831908|FG001|Overall Study|Lost to Follow-up|5|||
130237323|NCT02225587|468831907|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130237324|NCT02225587|468831908|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130237325|NCT02225587|468831907|FG000|Overall Study|Physician Decision|2|||
130237326|NCT02225587|468831908|FG001|Overall Study|Physician Decision|0|||
130237327|NCT02225587|468831907|FG000|Overall Study|Protocol Violation|1|||
130237328|NCT02225587|468831908|FG001|Overall Study|Protocol Violation|0|||
130237329|NCT02225587|468831907|FG000|Overall Study|Participant Moved|1|||
130237330|NCT02225587|468831908|FG001|Overall Study|Participant Moved|0|||
130237331|NCT02225587|468831907|FG000|Overall Study|Withdrawal by Subject|13|||
130237332|NCT02225587|468831908|FG001|Overall Study|Withdrawal by Subject|28|||
130237333|NCT02879695|468831911|FG000|Overall Study|Did not start study treatment|2|||
130237334|NCT02879695|468831912|FG001|Overall Study|Did not start study treatment|0|||
130237335|NCT02879695|468831913|FG002|Overall Study|Did not start study treatment|3|||
130237336|NCT02879695|468831914|FG003|Overall Study|Did not start study treatment|0|||
130237337|NCT00157755|468831917|FG000|Overall Study|Death|2|||
130237338|NCT00157755|468831918|FG001|Overall Study|Death|3|||
130237339|NCT00157755|468831919|FG002|Overall Study|Death|3|||
130237340|NCT00157755|468831920|FG003|Overall Study|Death|2|||
130447223|NCT02118714|469598772|FG000|Overall Study|Lost to Follow-up|2|||
130447224|NCT02118714|469598772|FG000|Overall Study|Protocol Violation|1|||
130447225|NCT02954575|469598773|FG000|Overall Study|Withdrawal by Subject|2|||
130237341|NCT00157755|468831921|FG004|Overall Study|Death|0|||
130237342|NCT00157755|468831922|FG005|Overall Study|Death|0|||
130447226|NCT02954575|469598773|FG000|Overall Study|Adverse Event|1|||
130447227|NCT02400307|469598775|FG000|Overall Study|Enrolled and Never Dosed|1|||
130237343|NCT00157755|468831917|FG000|Overall Study|Lost to Follow-up|0|||
130237344|NCT00157755|468831918|FG001|Overall Study|Lost to Follow-up|0|||
130237345|NCT00157755|468831919|FG002|Overall Study|Lost to Follow-up|1|||
130237346|NCT00157755|468831920|FG003|Overall Study|Lost to Follow-up|0|||
130237347|NCT00157755|468831921|FG004|Overall Study|Lost to Follow-up|0|||
130237348|NCT00157755|468831922|FG005|Overall Study|Lost to Follow-up|0|||
130237349|NCT00157755|468831917|FG000|Overall Study|Withdrawal by Subject|0|||
130237350|NCT00157755|468831918|FG001|Overall Study|Withdrawal by Subject|0|||
130237351|NCT00157755|468831919|FG002|Overall Study|Withdrawal by Subject|1|||
130237352|NCT00157755|468831920|FG003|Overall Study|Withdrawal by Subject|1|||
130237353|NCT00157755|468831921|FG004|Overall Study|Withdrawal by Subject|1|||
130237354|NCT00157755|468831922|FG005|Overall Study|Withdrawal by Subject|2|||
130237355|NCT00157755|468831917|FG000|Overall Study|Explant due to infection|0|||
130237356|NCT00157755|468831918|FG001|Overall Study|Explant due to infection|0|||
130237357|NCT00157755|468831919|FG002|Overall Study|Explant due to infection|1|||
130237358|NCT00157755|468831920|FG003|Overall Study|Explant due to infection|0|||
130237359|NCT00157755|468831921|FG004|Overall Study|Explant due to infection|0|||
130237360|NCT00157755|468831922|FG005|Overall Study|Explant due to infection|0|||
130237361|NCT00157755|468831917|FG000|Overall Study|Medical reason|0|||
130237362|NCT00157755|468831918|FG001|Overall Study|Medical reason|0|||
130237363|NCT00157755|468831919|FG002|Overall Study|Medical reason|1|||
130237364|NCT00157755|468831920|FG003|Overall Study|Medical reason|1|||
130237365|NCT00157755|468831921|FG004|Overall Study|Medical reason|0|||
130237366|NCT00157755|468831922|FG005|Overall Study|Medical reason|0|||
130237367|NCT00157755|468831917|FG000|Overall Study|Study site closure|0|||
130237368|NCT00157755|468831918|FG001|Overall Study|Study site closure|1|||
130237369|NCT00157755|468831919|FG002|Overall Study|Study site closure|0|||
130237370|NCT00157755|468831920|FG003|Overall Study|Study site closure|0|||
130237371|NCT00157755|468831921|FG004|Overall Study|Study site closure|0|||
130237372|NCT00157755|468831922|FG005|Overall Study|Study site closure|0|||
130237373|NCT00157755|468831917|FG000|Overall Study|Subject non-compliance|0|||
130237374|NCT00157755|468831918|FG001|Overall Study|Subject non-compliance|0|||
130237375|NCT00157755|468831919|FG002|Overall Study|Subject non-compliance|0|||
130237376|NCT00157755|468831920|FG003|Overall Study|Subject non-compliance|0|||
130237377|NCT00157755|468831921|FG004|Overall Study|Subject non-compliance|0|||
130237378|NCT00157755|468831922|FG005|Overall Study|Subject non-compliance|1|||
130237379|NCT00157755|468831917|FG000|Overall Study|Study completion|0|||
130237380|NCT00157755|468831918|FG001|Overall Study|Study completion|0|||
130237381|NCT00157755|468831919|FG002|Overall Study|Study completion|0|||
130237382|NCT00157755|468831920|FG003|Overall Study|Study completion|0|||
130237383|NCT00157755|468831921|FG004|Overall Study|Study completion|1|||
130237384|NCT00157755|468831922|FG005|Overall Study|Study completion|2|||
130237385|NCT05523297|468831927|FG000|Overall Study|Death|7|||
130237386|NCT05523297|468831928|FG001|Overall Study|Death|8|||
130237387|NCT05523297|468831927|FG000|Overall Study|Lost to Follow-up|2|||
130237388|NCT05523297|468831928|FG001|Overall Study|Lost to Follow-up|1|||
130237389|NCT03462680|468831929|FG000|Overall Study|Withdrawal by Subject|3|||
130237390|NCT03462680|468831930|FG001|Overall Study|Withdrawal by Subject|5|||
130237391|NCT02246777|468831931|FG000|Overall Study|Adverse Event|2|||
130237392|NCT02246777|468831931|FG000|Overall Study|Change of residence|1|||
130237393|NCT04133909|468831932|FG000|Overall Study|Death|11|||
130237394|NCT04133909|468831933|FG001|Overall Study|Death|11|||
130237395|NCT04133909|468831932|FG000|Overall Study|Adverse Event|4|||
130237396|NCT04133909|468831933|FG001|Overall Study|Adverse Event|5|||
130237397|NCT04133909|468831932|FG000|Overall Study|Lost to Follow-up|3|||
130237398|NCT04133909|468831933|FG001|Overall Study|Lost to Follow-up|5|||
130237399|NCT04133909|468831932|FG000|Overall Study|Physician Decision|4|||
130237400|NCT04133909|468831933|FG001|Overall Study|Physician Decision|7|||
130237401|NCT04133909|468831932|FG000|Overall Study|Withdrawal by Subject|40|||
130358932|NCT00191906|469286425|FG001|Study Period II|Adverse Event|1|||
130358933|NCT00191906|469286426|FG002|Study Period II|Adverse Event|0|||
130358934|NCT00191906|469286427|FG003|Study Period II|Adverse Event|0|||
130237402|NCT04133909|468831933|FG001|Overall Study|Withdrawal by Subject|35|||
130237403|NCT04133909|468831932|FG000|Overall Study|Lack of Efficacy|2|||
130237404|NCT04133909|468831933|FG001|Overall Study|Lack of Efficacy|7|||
130237405|NCT04133909|468831932|FG000|Overall Study|Randomized in error|1|||
130237406|NCT04133909|468831933|FG001|Overall Study|Randomized in error|1|||
130358935|NCT00191906|469286424|FG000|Study Period II|Withdrawal by Subject|0|||
130237407|NCT04817410|468833957|FG000|Overall Study|Withdrawal by Subject|5|||
130358936|NCT00191906|469286425|FG001|Study Period II|Withdrawal by Subject|3|||
130358937|NCT00191906|469286426|FG002|Study Period II|Withdrawal by Subject|0|||
130358938|NCT00191906|469286427|FG003|Study Period II|Withdrawal by Subject|0|||
130237408|NCT04817410|468833957|FG000|Overall Study|Physician Decision|3|||
130237409|NCT03595748|468833958|FG000|Overall Study|Death|11|||
130237410|NCT03595748|468833959|FG001|Overall Study|Death|12|||
130358939|NCT00191906|469286424|FG000|Study Period II|Parent/Caregiver Decision|0|||
130237411|NCT03595748|468833958|FG000|Overall Study|Withdrawal by Subject|28|||
130237412|NCT03595748|468833959|FG001|Overall Study|Withdrawal by Subject|29|||
130358940|NCT00191906|469286425|FG001|Study Period II|Parent/Caregiver Decision|1|||
130237413|NCT03595748|468833958|FG000|Overall Study|Protocol Violation|0|||
130237414|NCT03595748|468833959|FG001|Overall Study|Protocol Violation|1|||
130237415|NCT04809974|468833961|FG000|Lead-in Phase|Withdrawal by Subject|3|||
130237416|NCT04809974|468833962|FG001|Lead-in Phase|Withdrawal by Subject|0|||
130237417|NCT04809974|468833963|FG002|Lead-in Phase|Withdrawal by Subject|0|||
130237418|NCT04809974|468833961|FG000|Lead-in Phase|No longer eligible|11|||
130237419|NCT04809974|468833962|FG001|Lead-in Phase|No longer eligible|0|||
130237420|NCT04809974|468833963|FG002|Lead-in Phase|No longer eligible|0|||
130237421|NCT04809974|468833961|FG000|Randomized Phase|Lost to Follow-up|0|||
130237422|NCT04809974|468833962|FG001|Randomized Phase|Lost to Follow-up|1|||
130237423|NCT04809974|468833963|FG002|Randomized Phase|Lost to Follow-up|5|||
130358941|NCT00191906|469286426|FG002|Study Period II|Parent/Caregiver Decision|0|||
130358942|NCT00191906|469286427|FG003|Study Period II|Parent/Caregiver Decision|0|||
130358943|NCT00191906|469286424|FG000|Study Period II|Entry Criteria Exclusion|0|||
130358944|NCT00191906|469286425|FG001|Study Period II|Entry Criteria Exclusion|0|||
130358945|NCT00191906|469286426|FG002|Study Period II|Entry Criteria Exclusion|1|||
130358946|NCT00191906|469286427|FG003|Study Period II|Entry Criteria Exclusion|0|||
130358947|NCT00191906|469286424|FG000|Study Period III|Adverse Event|1|||
130358948|NCT00191906|469286425|FG001|Study Period III|Adverse Event|0|||
130358949|NCT00191906|469286426|FG002|Study Period III|Adverse Event|0|||
130358950|NCT00191906|469286427|FG003|Study Period III|Adverse Event|0|||
130358951|NCT00191906|469286424|FG000|Study Period III|Lost to Follow-up|0|||
130358952|NCT00191906|469286425|FG001|Study Period III|Lost to Follow-up|1|||
130358953|NCT00191906|469286426|FG002|Study Period III|Lost to Follow-up|0|||
130358954|NCT00191906|469286427|FG003|Study Period III|Lost to Follow-up|0|||
130358955|NCT00191906|469286424|FG000|Study Period III|Parent/Caregiver Decision|1|||
130358956|NCT00191906|469286425|FG001|Study Period III|Parent/Caregiver Decision|0|||
130358957|NCT00191906|469286426|FG002|Study Period III|Parent/Caregiver Decision|0|||
130358958|NCT00191906|469286427|FG003|Study Period III|Parent/Caregiver Decision|0|||
130358959|NCT00191906|469286424|FG000|Study Period III|Lack of Efficacy|3|||
130358960|NCT00191906|469286425|FG001|Study Period III|Lack of Efficacy|3|||
130358961|NCT00191906|469286426|FG002|Study Period III|Lack of Efficacy|0|||
130358962|NCT00191906|469286427|FG003|Study Period III|Lack of Efficacy|0|||
130358963|NCT00573937|469286428|FG000|Overall Study|Study Terminated|0|||
130358964|NCT00573937|469286429|FG001|Overall Study|Study Terminated|1|||
130358965|NCT00333801|469286430|FG000|Overall Study|Moved to another state|5|||
130358966|NCT00333801|469286431|FG001|Overall Study|Moved to another state|3|||
130358967|NCT00333801|469286430|FG000|Overall Study|Lost to Follow-up|2|||
130358968|NCT00333801|469286431|FG001|Overall Study|Lost to Follow-up|0|||
130358969|NCT00333801|469286430|FG000|Overall Study|Incarcerated|1|||
130358970|NCT00333801|469286431|FG001|Overall Study|Incarcerated|2|||
130358971|NCT00333801|469286430|FG000|Overall Study|Withdrawal by Subject|0|||
130358972|NCT00333801|469286431|FG001|Overall Study|Withdrawal by Subject|1|||
130358973|NCT01999114|469286434|FG000|Overall Study|Adverse Event|8|||
130358974|NCT01999114|469286435|FG001|Overall Study|Adverse Event|7|||
130358975|NCT01999114|469286436|FG002|Overall Study|Adverse Event|2|||
130358976|NCT01999114|469286437|FG003|Overall Study|Adverse Event|2|||
130358977|NCT01999114|469286438|FG004|Overall Study|Adverse Event|1|||
130358978|NCT01999114|469286434|FG000|Overall Study|Withdrawal by Subject|0|||
130358979|NCT01999114|469286435|FG001|Overall Study|Withdrawal by Subject|0|||
130358980|NCT01999114|469286436|FG002|Overall Study|Withdrawal by Subject|1|||
130358981|NCT01999114|469286437|FG003|Overall Study|Withdrawal by Subject|0|||
130358982|NCT01999114|469286438|FG004|Overall Study|Withdrawal by Subject|1|||
130358983|NCT01999114|469286434|FG000|Overall Study|Lost to Follow-up|0|||
130358984|NCT01999114|469286435|FG001|Overall Study|Lost to Follow-up|0|||
130358985|NCT01999114|469286436|FG002|Overall Study|Lost to Follow-up|1|||
130358986|NCT01999114|469286437|FG003|Overall Study|Lost to Follow-up|0|||
130358987|NCT01999114|469286438|FG004|Overall Study|Lost to Follow-up|0|||
130358988|NCT01999114|469286434|FG000|Overall Study|Administrative|0|||
130358989|NCT01999114|469286435|FG001|Overall Study|Administrative|0|||
130358990|NCT01999114|469286436|FG002|Overall Study|Administrative|1|||
130358991|NCT01999114|469286437|FG003|Overall Study|Administrative|1|||
130237424|NCT04809974|468833961|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
130237425|NCT04809974|468833962|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
130358992|NCT01999114|469286438|FG004|Overall Study|Administrative|2|||
130358993|NCT01497275|469286439|FG000|Overall Study|Death|1|||
130358994|NCT01497275|469286439|FG000|Overall Study|Adverse Event|1|||
130358995|NCT01950169|469286440|FG000|Overall Study|Withdrawal by Subject|2|||
130695128|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130695129|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
130695130|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
130695131|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
130695132|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130695133|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
130695134|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130695135|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
130695136|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
130695137|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
130695138|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130695139|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130695140|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
130695141|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
130695142|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
130695143|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
130695144|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130695145|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130695146|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
130695147|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130695148|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130695149|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
130695150|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130695151|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130695152|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
130695153|NCT03966911|470507651|FG000|Overall Study|Adverse Event|1|||
130695154|NCT03966911|470507652|FG001|Overall Study|Adverse Event|1|||
130695155|NCT03966911|470507651|FG000|Overall Study|Withdrawal by Subject|8|||
130695156|NCT03966911|470507652|FG001|Overall Study|Withdrawal by Subject|2|||
130695157|NCT03966911|470507651|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
130695158|NCT03966911|470507652|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
130695159|NCT03498560|470507653|FG000|Overall Study|Found Ineligible|2|||
130695160|NCT03498560|470507653|FG000|Overall Study|Withdrawal by Subject|14|||
130695161|NCT03498560|470507653|FG000|Overall Study|Lost to Follow-up|4|||
130695162|NCT03498560|470507653|FG000|Overall Study|Death|1|||
130695163|NCT01507662|470507654|FG000|Overall Study|Death|26|||
130695164|NCT01507662|470507655|FG001|Overall Study|Death|18|||
130695165|NCT01507662|470507654|FG000|Overall Study|Withdrawal by Subject|290|||
130237426|NCT04809974|468833963|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
130237427|NCT04809974|468833961|FG000|Randomized Phase|Adverse Event|0|||
130237428|NCT04809974|468833962|FG001|Randomized Phase|Adverse Event|1|||
130237429|NCT04809974|468833963|FG002|Randomized Phase|Adverse Event|4|||
130237430|NCT04809974|468833961|FG000|Randomized Phase|Withdrawal by Subject|0|||
130237431|NCT04809974|468833962|FG001|Randomized Phase|Withdrawal by Subject|0|||
130237432|NCT04809974|468833963|FG002|Randomized Phase|Withdrawal by Subject|5|||
130237433|NCT05493111|468833964|FG000|Overall Study|Adverse Event|3|||
130237434|NCT05493111|468833965|FG001|Overall Study|Adverse Event|4|||
130695166|NCT01507662|470507655|FG001|Overall Study|Withdrawal by Subject|287|||
130695167|NCT01507662|470507654|FG000|Overall Study|Lost to Follow-up|498|||
130695168|NCT01507662|470507655|FG001|Overall Study|Lost to Follow-up|523|||
130695169|NCT01507662|470507654|FG000|Overall Study|Proxy interview done|2|||
130695170|NCT01507662|470507655|FG001|Overall Study|Proxy interview done|3|||
130695171|NCT01395017|470507660|FG000|Overall Study|Lost to Follow-up|1|||
130695172|NCT01395017|470507661|FG001|Overall Study|Lost to Follow-up|0|||
130695173|NCT01395017|470507660|FG000|Overall Study|Adverse Event|26|||
130695174|NCT01395017|470507661|FG001|Overall Study|Adverse Event|12|||
130695175|NCT01395017|470507660|FG000|Overall Study|Physician Decision|11|||
130695176|NCT01395017|470507661|FG001|Overall Study|Physician Decision|15|||
130695177|NCT01395017|470507660|FG000|Overall Study|Withdrawal by Subject|14|||
130447228|NCT02400307|469598776|FG001|Overall Study|Enrolled and Never Dosed|0|||
130447229|NCT02015663|469598778|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
130695178|NCT01395017|470507661|FG001|Overall Study|Withdrawal by Subject|8|||
130695179|NCT01395017|470507660|FG000|Overall Study|Protocol deviation|1|||
130695180|NCT01395017|470507661|FG001|Overall Study|Protocol deviation|2|||
130695181|NCT01395017|470507660|FG000|Overall Study|Death|4|||
130695182|NCT01395017|470507661|FG001|Overall Study|Death|3|||
130695183|NCT01395017|470507660|FG000|Overall Study|Disease progression|42|||
130695184|NCT01395017|470507661|FG001|Overall Study|Disease progression|58|||
130237435|NCT05493111|468833964|FG000|Overall Study|Withdrawal of Consent|19|||
130237436|NCT05493111|468833965|FG001|Overall Study|Withdrawal of Consent|10|||
130237437|NCT05493111|468833964|FG000|Overall Study|Non-compliance|1|||
130695185|NCT01395017|470507660|FG000|Overall Study|Sponsor discontinued study|1|||
130695186|NCT01395017|470507661|FG001|Overall Study|Sponsor discontinued study|4|||
130695187|NCT01004510|470507662|FG000|Overall Study|Adverse Event|1|||
130695188|NCT01960296|470507665|FG000|Overall Study|Postponed surgery|1|||
130695189|NCT01960296|470507666|FG001|Overall Study|Postponed surgery|0|||
130695190|NCT01960296|470507665|FG000|Overall Study|Received different procedure|1|||
130695191|NCT01960296|470507666|FG001|Overall Study|Received different procedure|3|||
130695192|NCT02003391|470507667|FG000|Overall Study|Withdrawal by Subject|2|||
130695193|NCT02003391|470507668|FG001|Overall Study|Withdrawal by Subject|1|||
130695194|NCT02003391|470507667|FG000|Overall Study|Protocol Violation|0|||
130695195|NCT02003391|470507668|FG001|Overall Study|Protocol Violation|1|||
130695196|NCT02003391|470507667|FG000|Overall Study|Adverse Event|1|||
130695197|NCT02003391|470507668|FG001|Overall Study|Adverse Event|0|||
130695198|NCT02272803|470507669|FG000|Overall Study|Disease progression|16|||
130695199|NCT02272803|470507670|FG001|Overall Study|Disease progression|8|||
130695200|NCT02272803|470507669|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
130695201|NCT02272803|470507670|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
130237438|NCT05493111|468833965|FG001|Overall Study|Non-compliance|1|||
130237439|NCT05493111|468833964|FG000|Overall Study|Lost to Follow-up|8|||
130237440|NCT05493111|468833965|FG001|Overall Study|Lost to Follow-up|1|||
130237441|NCT05493111|468833964|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
130237442|NCT05493111|468833965|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
130237443|NCT05493111|468833964|FG000|Overall Study|Withdrawal by Subject|1|||
130237444|NCT05493111|468833965|FG001|Overall Study|Withdrawal by Subject|1|||
130237445|NCT06125964|468833966|FG000|Overall Study|Lost to Follow-up|0|||
130237446|NCT06125964|468833967|FG001|Overall Study|Lost to Follow-up|1|||
130237447|NCT06125964|468833968|FG002|Overall Study|Lost to Follow-up|0|||
130237448|NCT06125964|468833969|FG003|Overall Study|Lost to Follow-up|0|||
130237449|NCT01787838|468833970|FG000|Overall Study|refused|1413|||
130237450|NCT01431976|468833971|FG000|Overall Study|Adverse Event|6|||
130237451|NCT01431976|468833971|FG000|Overall Study|Lack of Efficacy|2|||
130237452|NCT01431976|468833971|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130237453|NCT01431976|468833971|FG000|Overall Study|Physician Decision|1|||
130237454|NCT01431976|468833971|FG000|Overall Study|Withdrawal by Subject|1|||
130237455|NCT01136954|468833973|FG000|Overall Study|Adverse Event|3|||
130237456|NCT01136954|468833974|FG001|Overall Study|Adverse Event|2|||
130237457|NCT01136954|468833973|FG000|Overall Study|Withdrawal by Subject|6|||
130237458|NCT01136954|468833974|FG001|Overall Study|Withdrawal by Subject|2|||
130237459|NCT01136954|468833973|FG000|Overall Study|Lack of Efficacy|14|||
130237460|NCT01136954|468833974|FG001|Overall Study|Lack of Efficacy|13|||
130358996|NCT01950169|469286441|FG001|Overall Study|Withdrawal by Subject|8|||
130358997|NCT01950169|469286442|FG002|Overall Study|Withdrawal by Subject|1|||
130358998|NCT01950169|469286440|FG000|Overall Study|Death|1|||
130358999|NCT01950169|469286441|FG001|Overall Study|Death|0|||
130359000|NCT01950169|469286442|FG002|Overall Study|Death|0|||
130359001|NCT01254292|469286448|FG000|Comparative Phase|Adverse Event|25|||
130359002|NCT01254292|469286449|FG001|Comparative Phase|Adverse Event|25|||
130359003|NCT01254292|469286448|FG000|Comparative Phase|Lost to Follow-up|3|||
130359004|NCT01254292|469286449|FG001|Comparative Phase|Lost to Follow-up|21|||
130359005|NCT01254292|469286448|FG000|Comparative Phase|Pregnancy|2|||
130359006|NCT01254292|469286449|FG001|Comparative Phase|Pregnancy|6|||
130359007|NCT01254292|469286448|FG000|Comparative Phase|Withdrawal by Subject|20|||
130359008|NCT01254292|469286449|FG001|Comparative Phase|Withdrawal by Subject|21|||
130359009|NCT01254292|469286448|FG000|Comparative Phase|Protocol Violation|1|||
130359010|NCT01254292|469286449|FG001|Comparative Phase|Protocol Violation|2|||
130359011|NCT01254292|469286448|FG000|Comparative Phase|Wish for pregnancy|4|||
130359012|NCT01254292|469286449|FG001|Comparative Phase|Wish for pregnancy|6|||
130359013|NCT01254292|469286448|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
130359014|NCT01254292|469286449|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
130359015|NCT01254292|469286448|FG000|LCS12 Extension Phase|Adverse Event|9|||
130359016|NCT01254292|469286449|FG001|LCS12 Extension Phase|Adverse Event|0|||
130359017|NCT01254292|469286448|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
130359018|NCT01254292|469286449|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
130359019|NCT01254292|469286448|FG000|LCS12 Extension Phase|Other unknown|4|||
130359020|NCT01254292|469286449|FG001|LCS12 Extension Phase|Other unknown|0|||
130359021|NCT01254292|469286448|FG000|LCS12 Extension Phase|Pregnancy|2|||
130359022|NCT01254292|469286449|FG001|LCS12 Extension Phase|Pregnancy|0|||
130359023|NCT01254292|469286448|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
130359024|NCT01254292|469286449|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
130359025|NCT03799211|469286450|FG000|Overall Study|Lost to Follow-up|2|||
130359026|NCT03799211|469286451|FG001|Overall Study|Lost to Follow-up|13|||
130695202|NCT02272803|470507669|FG000|Overall Study|Study drug toxicity|4|||
130695203|NCT02272803|470507670|FG001|Overall Study|Study drug toxicity|9|||
130237461|NCT01136954|468833973|FG000|Overall Study|Physician Decision|0|||
130237462|NCT01136954|468833974|FG001|Overall Study|Physician Decision|1|||
130237463|NCT01136954|468833973|FG000|Overall Study|Other|1|||
130359027|NCT03799211|469286450|FG000|Overall Study|Withdrawal by Subject|2|||
130695204|NCT02272803|470507669|FG000|Overall Study|Participant request to discontinue study treatment|3|||
130695205|NCT02272803|470507670|FG001|Overall Study|Participant request to discontinue study treatment|7|||
130695206|NCT02272803|470507669|FG000|Overall Study|Maximum clinical benefit|4|||
130695207|NCT02272803|470507670|FG001|Overall Study|Maximum clinical benefit|2|||
130695208|NCT02272803|470507669|FG000|Overall Study|Poor/non-compliance|2|||
130695209|NCT02272803|470507670|FG001|Overall Study|Poor/non-compliance|2|||
130695210|NCT02272803|470507669|FG000|Overall Study|Withdrawal by Subject|2|||
130695211|NCT02272803|470507670|FG001|Overall Study|Withdrawal by Subject|1|||
130695212|NCT02272803|470507669|FG000|Overall Study|Death|0|||
130695213|NCT02272803|470507670|FG001|Overall Study|Death|1|||
130695214|NCT02272803|470507669|FG000|Overall Study|Other reasons|1|||
130695215|NCT02272803|470507670|FG001|Overall Study|Other reasons|3|||
130695216|NCT02272803|470507669|FG000|Overall Study|Administrative reason by sponsor|5|||
130695217|NCT02272803|470507670|FG001|Overall Study|Administrative reason by sponsor|4|||
130359028|NCT03799211|469286451|FG001|Overall Study|Withdrawal by Subject|0|||
130359029|NCT00764491|469286452|FG000|Overall Study|Lost to Follow-up|35|||
130359030|NCT00764491|469286453|FG001|Overall Study|Lost to Follow-up|17|||
130359031|NCT03139279|469286456|FG000|Overall Study|Physician Decision|2|||
130359032|NCT03139279|469286457|FG001|Overall Study|Physician Decision|0|||
130359033|NCT03139279|469286456|FG000|Overall Study|Protocol Violation|5|||
130359034|NCT03139279|469286457|FG001|Overall Study|Protocol Violation|4|||
130359035|NCT03139279|469286456|FG000|Overall Study|Withdrawal by Subject|0|||
130359036|NCT03139279|469286457|FG001|Overall Study|Withdrawal by Subject|2|||
130359037|NCT01336569|469286458|FG000|Overall Study|Lost to Follow-up|4|||
130359038|NCT02337738|469286459|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130359039|NCT02337738|469286460|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
130359040|NCT02337738|469286461|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130359041|NCT02337738|469286459|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130359042|NCT02337738|469286460|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
130359043|NCT02337738|469286461|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
130359044|NCT02337738|469286459|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
130359045|NCT02337738|469286460|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
130359046|NCT02337738|469286461|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
130359047|NCT02337738|469286459|FG000|Overall Study|Voluntary Withdrawal|10|||
130359048|NCT02337738|469286460|FG001|Overall Study|Voluntary Withdrawal|5|||
130359049|NCT02337738|469286461|FG002|Overall Study|Voluntary Withdrawal|2|||
130359050|NCT02337738|469286459|FG000|Overall Study|Lack of Efficacy|2|||
130359051|NCT02337738|469286460|FG001|Overall Study|Lack of Efficacy|4|||
130695218|NCT01566435|470507674|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
130359052|NCT02337738|469286461|FG002|Overall Study|Lack of Efficacy|0|||
130359053|NCT02337738|469286459|FG000|Overall Study|Investigator's Judgment|1|||
130359054|NCT02337738|469286460|FG001|Overall Study|Investigator's Judgment|1|||
130695219|NCT03684928|470507675|FG000|First Intervention|Lost to Follow-up|0|||
130695220|NCT03684928|470507676|FG001|First Intervention|Lost to Follow-up|1|||
130237464|NCT01136954|468833974|FG001|Overall Study|Other|3|||
130237465|NCT00782067|468833975|FG000|Overall Study|Adverse Event|35|||
130237466|NCT00782067|468833975|FG000|Overall Study|Subject withdrew consent|11|||
130237467|NCT00782067|468833975|FG000|Overall Study|Lost to Follow-up|2|||
130237468|NCT00782067|468833975|FG000|Overall Study|Administrative problems|14|||
130237469|NCT00782067|468833975|FG000|Overall Study|Death|9|||
130237470|NCT00782067|468833975|FG000|Overall Study|Disease progression|43|||
130237471|NCT00782067|468833975|FG000|Overall Study|Protocol deviation|2|||
130237472|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
130237473|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
130237474|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
130237475|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
130237476|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
130237477|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
130237478|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
130237479|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
130237480|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130237481|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130237482|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130237483|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130237484|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
130237485|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
130237486|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
130237487|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
130237488|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
130237489|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
130237490|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
130237491|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
130237492|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
130237493|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
130237494|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
130237495|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
130237496|NCT02020941|468833983|FG000|Overall Study|Adverse Event|1|||
130237497|NCT02020941|468833983|FG000|Overall Study|Physician Decision|2|||
130237498|NCT02020941|468833983|FG000|Overall Study|Withdrawal by Subject|1|||
130237499|NCT02020941|468833983|FG000|Overall Study|Disease Progression|4|||
130237500|NCT02239328|468833991|FG000|Overall Study|Benign disease noted at time of surgery|6|||
130237501|NCT02239328|468833991|FG000|Overall Study|Equipment or website malfunction|2|||
130237502|NCT03483103|468833992|FG000|Pre-Treatment Phase|Other reasons|1|||
130237503|NCT03483103|468833992|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
130237504|NCT03483103|468833992|FG000|Pre-Treatment Phase|Disease-related complications|1|||
130237505|NCT03483103|468833992|FG000|Pre-Treatment Phase|Death|5|||
130237506|NCT03483103|468833992|FG000|Treatment Phase|Withdrawal by Subject|7|||
130237507|NCT03483103|468833992|FG000|Treatment Phase|Other reasons|1|||
130237508|NCT03483103|468833992|FG000|Treatment Phase|Death|23|||
130237509|NCT03483103|468833992|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
130237510|NCT03483103|468833992|FG000|Treatment Phase|Received nonconforming product|1|||
130237511|NCT01481779|468833993|FG000|Overall Study|Adverse Event|23|||
130237512|NCT01481779|468833994|FG001|Overall Study|Adverse Event|5|||
130237513|NCT01481779|468833993|FG000|Overall Study|Lost to Follow-up|3|||
130237514|NCT01481779|468833994|FG001|Overall Study|Lost to Follow-up|2|||
130447230|NCT02015663|469598779|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
130447231|NCT02015663|469598778|FG000|Overall Study|Withdrawal by Subject|1|||
130447232|NCT02015663|469598779|FG001|Overall Study|Withdrawal by Subject|0|||
130447233|NCT02015663|469598778|FG000|Overall Study|Protocol Violation|0|||
130447234|NCT02015663|469598779|FG001|Overall Study|Protocol Violation|1|||
130447235|NCT02015663|469598778|FG000|Overall Study|Adverse Event|3|||
130447236|NCT02015663|469598779|FG001|Overall Study|Adverse Event|0|||
130447237|NCT02015663|469598778|FG000|Overall Study|Administrative problems|10|||
130447238|NCT02015663|469598779|FG001|Overall Study|Administrative problems|11|||
130559412|NCT01621542|470016490|FG000|Overall Study|Withdrawal by Subject|2|||
130695221|NCT03684928|470507675|FG000|First Intervention|Withdrawal by Subject|0|||
130237515|NCT01481779|468833993|FG000|Overall Study|Protocol Violation|2|||
130237516|NCT01481779|468833994|FG001|Overall Study|Protocol Violation|3|||
130237517|NCT01481779|468833993|FG000|Overall Study|Withdrawal by Subject|26|||
130237518|NCT01481779|468833994|FG001|Overall Study|Withdrawal by Subject|13|||
130237519|NCT01481779|468833993|FG000|Overall Study|Physician Decision|13|||
130237520|NCT01481779|468833994|FG001|Overall Study|Physician Decision|4|||
130237521|NCT01481779|468833993|FG000|Overall Study|Sponsor Decision|3|||
130237522|NCT01481779|468833994|FG001|Overall Study|Sponsor Decision|1|||
130237523|NCT02378181|468833995|FG000|Overall Study|Lost to Follow-up|2|||
130237524|NCT02378181|468833996|FG001|Overall Study|Lost to Follow-up|5|||
130237525|NCT02378181|468833995|FG000|Overall Study|Withdrawal by Subject|1|||
130237526|NCT02378181|468833996|FG001|Overall Study|Withdrawal by Subject|1|||
130237527|NCT02378181|468833995|FG000|Overall Study|Incarcerated|0|||
130237528|NCT02378181|468833996|FG001|Overall Study|Incarcerated|1|||
130237529|NCT04115059|468833997|FG000|Overall Study|Withdrawal by Subject|1|||
130237530|NCT04115059|468833997|FG000|Overall Study|Lack of Efficacy|2|||
130447239|NCT00479674|469598780|FG000|Overall Study|Adverse Event|18|||
130447240|NCT00479674|469598780|FG000|Overall Study|Withdrawal by Subject|6|||
130447241|NCT00479674|469598780|FG000|Overall Study|Physician Decision|14|||
130447242|NCT00479674|469598780|FG000|Overall Study|none provided|3|||
130447243|NCT00146640|469598786|FG000|Overall Study|Adverse Event|12|||
130447244|NCT00146640|469598787|FG001|Overall Study|Adverse Event|10|||
130447245|NCT00146640|469598786|FG000|Overall Study|Medical Reasons|3|||
130447246|NCT00146640|469598787|FG001|Overall Study|Medical Reasons|0|||
130447247|NCT00146640|469598786|FG000|Overall Study|Non-Medical Reasons|8|||
130447248|NCT00146640|469598787|FG001|Overall Study|Non-Medical Reasons|4|||
130447249|NCT02839681|469598788|FG000|Overall Study|Death|2|||
130447250|NCT01656759|469598789|FG000|Overall Study|Protocol Violation|2|||
130447251|NCT01656759|469598790|FG001|Overall Study|Protocol Violation|3|||
130447252|NCT02687919|469598791|FG000|Overall Study|Withdrawal by Subject|6|||
130447253|NCT02687919|469598792|FG001|Overall Study|Withdrawal by Subject|6|||
130447254|NCT02687919|469598791|FG000|Overall Study|Protocol Violation|2|||
130447255|NCT02687919|469598792|FG001|Overall Study|Protocol Violation|0|||
130447256|NCT00131911|469598800|FG000|Overall Study|Withdrawal by Subject|1|||
130447257|NCT00131911|469598801|FG001|Overall Study|Withdrawal by Subject|0|||
130447258|NCT00329303|469598802|FG000|Overall Study|Lack of Efficacy|1|||
130447259|NCT00329303|469598803|FG001|Overall Study|Lack of Efficacy|0|||
130447260|NCT00329303|469598802|FG000|Overall Study|Decision of the sponsor|0|||
130447261|NCT00329303|469598803|FG001|Overall Study|Decision of the sponsor|1|||
130447262|NCT00329303|469598802|FG000|Overall Study|Patient no longer available|1|||
130447263|NCT00329303|469598803|FG001|Overall Study|Patient no longer available|0|||
130447264|NCT00329303|469598802|FG000|Overall Study|Patient relocated|0|||
130447265|NCT00329303|469598803|FG001|Overall Study|Patient relocated|1|||
130447266|NCT03473756|469598810|FG000|Overall Study|Withdrawal by Subject|1|||
130447267|NCT03473756|469598811|FG001|Overall Study|Withdrawal by Subject|4|||
130447268|NCT03473756|469598810|FG000|Overall Study|Adverse Event|6|||
130447269|NCT03473756|469598811|FG001|Overall Study|Adverse Event|7|||
130447270|NCT03473756|469598810|FG000|Overall Study|Lack of Efficacy|3|||
130447271|NCT03473756|469598811|FG001|Overall Study|Lack of Efficacy|10|||
130447272|NCT03473756|469598810|FG000|Overall Study|Physician Decision|0|||
130447273|NCT03473756|469598811|FG001|Overall Study|Physician Decision|2|||
130447274|NCT03473756|469598810|FG000|Overall Study|End of study treatment|0|||
130447275|NCT03473756|469598811|FG001|Overall Study|End of study treatment|2|||
130447276|NCT03473756|469598810|FG000|Overall Study|Lost to Follow-up|0|||
130447277|NCT03473756|469598811|FG001|Overall Study|Lost to Follow-up|1|||
130447278|NCT02148718|469598812|FG000|Overall Study|Protocol Violation|26|||
130447279|NCT02148718|469598812|FG000|Overall Study|Discontinued Study Prematurely|5|||
130447280|NCT02192359|469598816|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
130447281|NCT02192359|469598817|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
130447282|NCT02192359|469598818|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
130447283|NCT02192359|469598819|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
130447284|NCT02192359|469598816|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
130447285|NCT02192359|469598817|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
130447286|NCT02192359|469598818|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
130447287|NCT02192359|469598819|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
130447288|NCT02192359|469598816|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
130447289|NCT02192359|469598817|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
130447290|NCT02192359|469598818|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
130447291|NCT02192359|469598819|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
130695222|NCT03684928|470507676|FG001|First Intervention|Withdrawal by Subject|2|||
130695223|NCT03684928|470507675|FG000|Second Intervention|Soft Tissue Injury|1|||
130237531|NCT06420232|468834006|FG000|Overall Study|Withdrawal by Subject|3|||
130237532|NCT00689936|468834007|FG000|Active Treatment Phase|Adverse Event|68|||
130237533|NCT00689936|468834008|FG001|Active Treatment Phase|Adverse Event|71|||
130447292|NCT04951479|469598820|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
130447293|NCT01213173|469598822|FG000|Overall Study|Protocol Violation|2|||
130447294|NCT01213173|469598823|FG001|Overall Study|Protocol Violation|0|||
130447295|NCT01213173|469598822|FG000|Overall Study|Adverse Event|4|||
130447296|NCT01213173|469598823|FG001|Overall Study|Adverse Event|8|||
130447297|NCT01213173|469598822|FG000|Overall Study|Withdrawal by Subject|5|||
130447298|NCT01213173|469598823|FG001|Overall Study|Withdrawal by Subject|5|||
130447299|NCT01213173|469598822|FG000|Overall Study|Incorrect Enrollment|1|||
130447300|NCT01213173|469598823|FG001|Overall Study|Incorrect Enrollment|3|||
130447301|NCT02353832|469598826|FG000|Overall Study|Ineligible after enrollment|1|||
130447302|NCT02353832|469598826|FG000|Overall Study|Lost to Follow-up|1|||
130447303|NCT04880161|469598827|FG000|Overall Study|Withdrawal by Subject|1|||
130447304|NCT04880161|469598828|FG001|Overall Study|Withdrawal by Subject|0|||
130447305|NCT04880161|469598827|FG000|Overall Study|Lack of Compliance|1|||
130447306|NCT04880161|469598828|FG001|Overall Study|Lack of Compliance|1|||
130447307|NCT04880161|469598827|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
130447308|NCT04880161|469598828|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
130237534|NCT00689936|468834009|FG002|Active Treatment Phase|Adverse Event|76|||
130237535|NCT00689936|468834007|FG000|Active Treatment Phase|Disease Progression|273|||
130237536|NCT00689936|468834008|FG001|Active Treatment Phase|Disease Progression|362|||
130237537|NCT00689936|468834009|FG002|Active Treatment Phase|Disease Progression|339|||
130237538|NCT00689936|468834007|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
130237539|NCT00689936|468834008|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
130237540|NCT00689936|468834009|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
130237541|NCT00689936|468834007|FG000|Active Treatment Phase|Death|60|||
130447309|NCT04880161|469598827|FG000|Overall Study|Screen Failure|0|||
130447310|NCT04880161|469598828|FG001|Overall Study|Screen Failure|1|||
130447311|NCT00777803|469600446|FG000|Overall Study|Lost to Follow-up|12|||
130447312|NCT00777803|469600447|FG001|Overall Study|Lost to Follow-up|5|||
130447313|NCT00777803|469600446|FG000|Overall Study|Adverse Event|1|||
130447314|NCT00777803|469600447|FG001|Overall Study|Adverse Event|0|||
130447315|NCT00777803|469600446|FG000|Overall Study|Non-compliance|2|||
130447316|NCT00777803|469600447|FG001|Overall Study|Non-compliance|2|||
130447317|NCT01268059|469600448|FG000|Overall Study|Lost to Follow-up|0|||
130447318|NCT01268059|469600449|FG001|Overall Study|Lost to Follow-up|1|||
130447319|NCT01268059|469600450|FG002|Overall Study|Lost to Follow-up|0|||
130447320|NCT01268059|469600451|FG003|Overall Study|Lost to Follow-up|0|||
130447321|NCT01268059|469600448|FG000|Overall Study|Withdrawal by Subject|7|||
130447322|NCT01268059|469600449|FG001|Overall Study|Withdrawal by Subject|4|||
130447323|NCT01268059|469600450|FG002|Overall Study|Withdrawal by Subject|0|||
130447324|NCT01268059|469600451|FG003|Overall Study|Withdrawal by Subject|0|||
130447325|NCT01268059|469600448|FG000|Overall Study|Death|20|||
130447326|NCT01268059|469600449|FG001|Overall Study|Death|30|||
130447327|NCT01268059|469600450|FG002|Overall Study|Death|3|||
130447328|NCT01268059|469600451|FG003|Overall Study|Death|5|||
130447329|NCT01268059|469600448|FG000|Overall Study|Progression of disease|1|||
130447330|NCT01268059|469600449|FG001|Overall Study|Progression of disease|0|||
130447331|NCT01268059|469600450|FG002|Overall Study|Progression of disease|0|||
130447332|NCT01268059|469600451|FG003|Overall Study|Progression of disease|0|||
130447333|NCT03850444|469600452|FG000|Overall Study|Adverse Event|16|||
130447334|NCT03850444|469600453|FG001|Overall Study|Adverse Event|10|||
130447335|NCT03850444|469600452|FG000|Overall Study|Death|87|||
130447336|NCT03850444|469600453|FG001|Overall Study|Death|107|||
130447337|NCT03850444|469600452|FG000|Overall Study|Lost to Follow-up|1|||
130447338|NCT03850444|469600453|FG001|Overall Study|Lost to Follow-up|1|||
130447339|NCT03850444|469600452|FG000|Overall Study|Withdrawal by Subject|1|||
130447340|NCT03850444|469600453|FG001|Overall Study|Withdrawal by Subject|5|||
130447341|NCT03850444|469600452|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
130447342|NCT03850444|469600453|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
130447343|NCT01598987|469600454|FG000|Baseline to Month 12|Administrative problems|2|||
130447344|NCT01598987|469600454|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
130447345|NCT01598987|469600454|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
130447346|NCT01598987|469600454|FG000|Baseline to 24 Month|Administrative problems|2|||
130447347|NCT01598987|469600454|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
130447348|NCT02107274|469600455|FG000|Treatment vs. Placebo|Adverse Event|3|||
130447349|NCT02107274|469600456|FG001|Treatment vs. Placebo|Adverse Event|0|||
130447350|NCT02107274|469600455|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
130695224|NCT03684928|470507676|FG001|Second Intervention|Soft Tissue Injury|0|||
130695225|NCT03733145|470507680|FG000|Overall Study|screenfail|3|||
130447351|NCT02107274|469600456|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
130695226|NCT03733145|470507681|FG001|Overall Study|screenfail|3|||
130237542|NCT00689936|468834008|FG001|Active Treatment Phase|Death|28|||
130237543|NCT00689936|468834009|FG002|Active Treatment Phase|Death|37|||
130237544|NCT00689936|468834007|FG000|Active Treatment Phase|Lost to Follow-up|0|||
130447352|NCT02107274|469600455|FG000|Control Phase|Lost to Follow-up|1|||
130447353|NCT02107274|469600456|FG001|Control Phase|Lost to Follow-up|1|||
130447354|NCT02107274|469600455|FG000|Control Phase|Death|2|||
130447355|NCT02107274|469600456|FG001|Control Phase|Death|0|||
130447356|NCT02107274|469600455|FG000|Control Phase|Adverse Event|0|||
130447357|NCT02107274|469600456|FG001|Control Phase|Adverse Event|1|||
130447358|NCT01036087|469600458|FG000|Overall Study|Adverse Event|2|||
130447359|NCT01036087|469600458|FG000|Overall Study|Lack of Efficacy|1|||
130447360|NCT01021878|469600462|FG000|Overall Study|Lost to Follow-up|4|||
130695227|NCT03733145|470507682|FG002|Overall Study|screenfail|2|||
130695228|NCT02302716|470508952|FG000|Overall Study|Adverse Event|1|||
130695229|NCT02302716|470508953|FG001|Overall Study|Adverse Event|1|||
130695230|NCT02302716|470508952|FG000|Overall Study|Death|0|||
130695231|NCT02302716|470508953|FG001|Overall Study|Death|1|||
130695232|NCT02302716|470508952|FG000|Overall Study|Lack of Efficacy|0|||
130695233|NCT02302716|470508953|FG001|Overall Study|Lack of Efficacy|1|||
130695234|NCT02302716|470508952|FG000|Overall Study|Lost to Follow-up|2|||
130695235|NCT02302716|470508953|FG001|Overall Study|Lost to Follow-up|4|||
130695236|NCT02302716|470508952|FG000|Overall Study|Physician Decision|3|||
130695237|NCT02302716|470508953|FG001|Overall Study|Physician Decision|4|||
130695238|NCT02302716|470508952|FG000|Overall Study|Withdrawal by Subject|13|||
130695239|NCT02302716|470508953|FG001|Overall Study|Withdrawal by Subject|7|||
130695240|NCT02302716|470508952|FG000|Overall Study|Protocol Violation|0|||
130695241|NCT02302716|470508953|FG001|Overall Study|Protocol Violation|1|||
130695242|NCT00557245|470508957|FG000|Overall Study|Lost to Follow-up|7|||
130695243|NCT00557245|470508958|FG001|Overall Study|Lost to Follow-up|8|||
130695244|NCT00557245|470508959|FG002|Overall Study|Lost to Follow-up|10|||
130695245|NCT00557245|470508957|FG000|Overall Study|Ineligible|5|||
130695246|NCT00557245|470508958|FG001|Overall Study|Ineligible|4|||
130695247|NCT00557245|470508959|FG002|Overall Study|Ineligible|2|||
130695248|NCT00798603|470508961|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
130695249|NCT00798603|470508961|FG000|Overall Study|Withdrawal by Subject|10|||
130695250|NCT00798603|470508961|FG000|Overall Study|Adverse Event|22|||
130695251|NCT00798603|470508961|FG000|Overall Study|Physician Decision|1|||
130695252|NCT00798603|470508961|FG000|Overall Study|Lack of insurance coverage|1|||
130695253|NCT02316223|470508964|FG000|Overall Study|Lack of Efficacy|0|||
130695254|NCT02316223|470508965|FG001|Overall Study|Lack of Efficacy|1|||
130695255|NCT02316223|470508966|FG002|Overall Study|Lack of Efficacy|1|||
130695256|NCT02316223|470508964|FG000|Overall Study|Lost to Follow-up|27|||
130695257|NCT02316223|470508965|FG001|Overall Study|Lost to Follow-up|34|||
130695258|NCT02316223|470508966|FG002|Overall Study|Lost to Follow-up|36|||
130695259|NCT02316223|470508964|FG000|Overall Study|COPD Diagnosis|3|||
130695260|NCT02316223|470508965|FG001|Overall Study|COPD Diagnosis|2|||
130695261|NCT02316223|470508966|FG002|Overall Study|COPD Diagnosis|3|||
130695262|NCT02316223|470508964|FG000|Overall Study|Reside outside study area|1|||
130695263|NCT02316223|470508965|FG001|Overall Study|Reside outside study area|1|||
130695264|NCT02316223|470508966|FG002|Overall Study|Reside outside study area|1|||
130695265|NCT02316223|470508964|FG000|Overall Study|No asthma|2|||
130695266|NCT02316223|470508965|FG001|Overall Study|No asthma|0|||
130695267|NCT02316223|470508966|FG002|Overall Study|No asthma|0|||
130695268|NCT02316223|470508964|FG000|Overall Study|Discontinued by PI|11|||
130695269|NCT02316223|470508965|FG001|Overall Study|Discontinued by PI|19|||
130695270|NCT02316223|470508966|FG002|Overall Study|Discontinued by PI|3|||
130695271|NCT00529763|470508968|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130695272|NCT00529763|470508969|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
130695273|NCT00529763|470508970|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130695274|NCT00529763|470508968|FG000|Overall Study|Death|1|||
130695275|NCT00529763|470508969|FG001|Overall Study|Death|1|||
130695276|NCT00529763|470508970|FG002|Overall Study|Death|1|||
130695277|NCT00529763|470508968|FG000|Overall Study|Disease Progression|10|||
130695278|NCT00529763|470508969|FG001|Overall Study|Disease Progression|16|||
130695279|NCT00529763|470508970|FG002|Overall Study|Disease Progression|11|||
130695280|NCT00529763|470508968|FG000|Overall Study|Lost to Follow-up|1|||
130237545|NCT00689936|468834008|FG001|Active Treatment Phase|Lost to Follow-up|2|||
130695281|NCT00529763|470508969|FG001|Overall Study|Lost to Follow-up|2|||
130695282|NCT00529763|470508970|FG002|Overall Study|Lost to Follow-up|3|||
130695283|NCT00529763|470508968|FG000|Overall Study|Stem Cell Transplant|0|||
130695284|NCT00529763|470508969|FG001|Overall Study|Stem Cell Transplant|3|||
130695285|NCT00529763|470508970|FG002|Overall Study|Stem Cell Transplant|1|||
130695286|NCT00529763|470508968|FG000|Overall Study|Study Drug Toxicity|3|||
130695287|NCT00529763|470508969|FG001|Overall Study|Study Drug Toxicity|6|||
130695288|NCT00529763|470508970|FG002|Overall Study|Study Drug Toxicity|4|||
130695289|NCT00529763|470508968|FG000|Overall Study|Participant Withdrew Consent|2|||
130695290|NCT00529763|470508969|FG001|Overall Study|Participant Withdrew Consent|3|||
130237546|NCT00689936|468834009|FG002|Active Treatment Phase|Lost to Follow-up|2|||
130695291|NCT00529763|470508970|FG002|Overall Study|Participant Withdrew Consent|4|||
130695292|NCT00529763|470508968|FG000|Overall Study|Other reasons|2|||
130695293|NCT00529763|470508969|FG001|Overall Study|Other reasons|0|||
130695294|NCT00529763|470508970|FG002|Overall Study|Other reasons|2|||
130447361|NCT01021878|469600463|FG001|Overall Study|Lost to Follow-up|3|||
130447362|NCT01021878|469600462|FG000|Overall Study|Death|0|||
130447363|NCT01021878|469600463|FG001|Overall Study|Death|1|||
130447364|NCT01021878|469600462|FG000|Overall Study|Adverse Event|6|||
130447365|NCT01021878|469600463|FG001|Overall Study|Adverse Event|5|||
130447366|NCT01021878|469600462|FG000|Overall Study|Transplantation|6|||
130447367|NCT01021878|469600463|FG001|Overall Study|Transplantation|1|||
130447368|NCT02424344|469600464|FG000|Overall Study|Lack of Efficacy|0|||
130447369|NCT02424344|469600465|FG001|Overall Study|Lack of Efficacy|1|||
130447370|NCT02424344|469600464|FG000|Overall Study|Withdrawal by Subject|2|||
130447371|NCT02424344|469600465|FG001|Overall Study|Withdrawal by Subject|1|||
130447372|NCT02424344|469600464|FG000|Overall Study|Lost to Follow-up|1|||
130447373|NCT02424344|469600465|FG001|Overall Study|Lost to Follow-up|0|||
130447374|NCT02424344|469600464|FG000|Overall Study|Adverse Event|4|||
130447375|NCT02424344|469600465|FG001|Overall Study|Adverse Event|8|||
130447376|NCT01460381|469600466|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
130447377|NCT01460381|469600467|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
130447378|NCT01333943|469600472|FG000|Overall Study|Known neuropathy|1|||
130447379|NCT01333943|469600473|FG001|Overall Study|Known neuropathy|0|||
130447380|NCT01511536|469600480|FG000|Phase 1|Other|0|||
130447381|NCT01511536|469600481|FG001|Phase 1|Other|1|||
130447382|NCT01511536|469600482|FG002|Phase 1|Other|0|||
130447383|NCT01511536|469600480|FG000|Phase 2|Other|0|||
130447384|NCT01511536|469600481|FG001|Phase 2|Other|0|||
130447385|NCT01511536|469600482|FG002|Phase 2|Other|9|||
130447386|NCT00765362|469600486|FG000|Overall Study|Death|9|||
130447387|NCT00765362|469600486|FG000|Overall Study|Adverse Event|2|||
130447388|NCT00765362|469600486|FG000|Overall Study|Protocol Violation|18|||
130447389|NCT00765362|469600486|FG000|Overall Study|Withdrawal by Subject|13|||
130447390|NCT00765362|469600486|FG000|Overall Study|Lost to Follow-up|95|||
130447391|NCT00557505|469600487|FG000|Overall Study|Death|0|||
130447392|NCT00557505|469600488|FG001|Overall Study|Death|0|||
130447393|NCT00557505|469600489|FG002|Overall Study|Death|0|||
130447394|NCT00557505|469600490|FG003|Overall Study|Death|0|||
130447395|NCT00557505|469600491|FG004|Overall Study|Death|0|||
130447396|NCT00557505|469600492|FG005|Overall Study|Death|0|||
130447397|NCT00557505|469600493|FG006|Overall Study|Death|0|||
130447398|NCT00557505|469600494|FG007|Overall Study|Death|0|||
130447399|NCT00557505|469600495|FG008|Overall Study|Death|1|||
130447400|NCT00557505|469600487|FG000|Overall Study|Adverse Event|0|||
130447401|NCT00557505|469600488|FG001|Overall Study|Adverse Event|0|||
130447402|NCT00557505|469600489|FG002|Overall Study|Adverse Event|1|||
130447403|NCT00557505|469600490|FG003|Overall Study|Adverse Event|0|||
130447404|NCT00557505|469600491|FG004|Overall Study|Adverse Event|0|||
130447405|NCT00557505|469600492|FG005|Overall Study|Adverse Event|0|||
130447406|NCT00557505|469600493|FG006|Overall Study|Adverse Event|1|||
130447407|NCT00557505|469600494|FG007|Overall Study|Adverse Event|0|||
130447408|NCT00557505|469600495|FG008|Overall Study|Adverse Event|0|||
130447409|NCT00557505|469600487|FG000|Overall Study|Global deterioration of health|1|||
130447410|NCT00557505|469600488|FG001|Overall Study|Global deterioration of health|0|||
130447411|NCT00557505|469600489|FG002|Overall Study|Global deterioration of health|0|||
130447412|NCT00557505|469600490|FG003|Overall Study|Global deterioration of health|0|||
130447413|NCT00557505|469600491|FG004|Overall Study|Global deterioration of health|0|||
130447414|NCT00557505|469600492|FG005|Overall Study|Global deterioration of health|0|||
130447415|NCT00557505|469600493|FG006|Overall Study|Global deterioration of health|0|||
130447416|NCT00557505|469600494|FG007|Overall Study|Global deterioration of health|0|||
130447417|NCT00557505|469600495|FG008|Overall Study|Global deterioration of health|0|||
130447418|NCT00557505|469600487|FG000|Overall Study|Objective progression or relapse|2|||
130447419|NCT00557505|469600488|FG001|Overall Study|Objective progression or relapse|3|||
130447420|NCT00557505|469600489|FG002|Overall Study|Objective progression or relapse|3|||
130447421|NCT00557505|469600490|FG003|Overall Study|Objective progression or relapse|2|||
130447422|NCT00557505|469600491|FG004|Overall Study|Objective progression or relapse|2|||
130447423|NCT00557505|469600492|FG005|Overall Study|Objective progression or relapse|3|||
130447424|NCT00557505|469600493|FG006|Overall Study|Objective progression or relapse|2|||
130447425|NCT00557505|469600494|FG007|Overall Study|Objective progression or relapse|5|||
130447426|NCT00557505|469600495|FG008|Overall Study|Objective progression or relapse|15|||
130447427|NCT00557505|469600487|FG000|Overall Study|Withdrawal by Subject|0|||
130447428|NCT00557505|469600488|FG001|Overall Study|Withdrawal by Subject|0|||
130447429|NCT00557505|469600489|FG002|Overall Study|Withdrawal by Subject|0|||
130447430|NCT00557505|469600490|FG003|Overall Study|Withdrawal by Subject|1|||
130447431|NCT00557505|469600491|FG004|Overall Study|Withdrawal by Subject|0|||
130447432|NCT00557505|469600492|FG005|Overall Study|Withdrawal by Subject|0|||
130447433|NCT00557505|469600493|FG006|Overall Study|Withdrawal by Subject|0|||
130447434|NCT00557505|469600494|FG007|Overall Study|Withdrawal by Subject|0|||
130447435|NCT00557505|469600495|FG008|Overall Study|Withdrawal by Subject|1|||
130447436|NCT01244763|469600496|FG000|Overall Study|Adverse Event|1|||
130447437|NCT01244763|469600497|FG001|Overall Study|Adverse Event|0|||
130447438|NCT01244763|469600498|FG002|Overall Study|Adverse Event|0|||
130447439|NCT01244763|469600499|FG003|Overall Study|Adverse Event|0|||
130237547|NCT00689936|468834007|FG000|Active Treatment Phase|Protocol Violation|2|||
130237548|NCT00689936|468834008|FG001|Active Treatment Phase|Protocol Violation|2|||
130237549|NCT00689936|468834009|FG002|Active Treatment Phase|Protocol Violation|4|||
130237550|NCT00689936|468834007|FG000|Active Treatment Phase|Study Close Out|64|||
130237551|NCT00689936|468834008|FG001|Active Treatment Phase|Study Close Out|26|||
130237552|NCT00689936|468834009|FG002|Active Treatment Phase|Study Close Out|21|||
130237553|NCT00689936|468834007|FG000|Active Treatment Phase|Miscellaneous|52|||
130237554|NCT00689936|468834008|FG001|Active Treatment Phase|Miscellaneous|34|||
130237555|NCT00689936|468834009|FG002|Active Treatment Phase|Miscellaneous|47|||
130237556|NCT00689936|468834007|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
130237557|NCT00689936|468834008|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
130237558|NCT00689936|468834009|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
130237559|NCT01303419|468834010|FG000|Overall Study|Discontinuation of study|60|||
130237560|NCT01303419|468834010|FG000|Overall Study|Did not complete both imaging methods|5|||
130237561|NCT01303419|468834010|FG000|Overall Study|Did not meet all I/E after screening|31|||
130237562|NCT00311168|468834013|FG000|First Intervention|Withdrawal by Subject|2|||
130237563|NCT00311168|468834014|FG001|First Intervention|Withdrawal by Subject|2|||
130237564|NCT00311168|468834013|FG000|First Intervention|Lost to Follow-up|1|||
130359055|NCT02337738|469286461|FG002|Overall Study|Investigator's Judgment|3|||
130359056|NCT00406354|469286462|FG000|All Randomized Patients|Protocol Violation|0|||
130359057|NCT00406354|469286463|FG001|All Randomized Patients|Protocol Violation|0|||
130359058|NCT00406354|469286464|FG002|All Randomized Patients|Protocol Violation|1|||
130359059|NCT00406354|469286462|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
130359060|NCT00406354|469286463|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
130695295|NCT00529763|470508968|FG000|Overall Study|Participant request to discontinue treatment|1|||
130695296|NCT00529763|470508969|FG001|Overall Study|Participant request to discontinue treatment|1|||
130695297|NCT00529763|470508970|FG002|Overall Study|Participant request to discontinue treatment|3|||
130359061|NCT00406354|469286464|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
130359062|NCT00406354|469286462|FG000|All Randomized and Treated Patients|Adverse Event|6|||
130359063|NCT00406354|469286463|FG001|All Randomized and Treated Patients|Adverse Event|2|||
130359064|NCT00406354|469286464|FG002|All Randomized and Treated Patients|Adverse Event|1|||
130359065|NCT00406354|469286462|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
130359066|NCT00406354|469286463|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
130359067|NCT00406354|469286464|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
130359068|NCT00406354|469286462|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
130359069|NCT00406354|469286463|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
130359070|NCT00406354|469286464|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
130359071|NCT00406354|469286462|FG000|All Randomized and Treated Patients|Physician Decision|0|||
130359072|NCT00406354|469286463|FG001|All Randomized and Treated Patients|Physician Decision|0|||
130359073|NCT00406354|469286464|FG002|All Randomized and Treated Patients|Physician Decision|1|||
130359074|NCT01460368|469286465|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130695298|NCT03669250|470508971|FG000|Overall Study|Adverse Event|0|||
130237565|NCT00311168|468834014|FG001|First Intervention|Lost to Follow-up|1|||
130237566|NCT00311168|468834013|FG000|First Intervention|Protocol Violation|1|||
130237567|NCT00311168|468834014|FG001|First Intervention|Protocol Violation|1|||
130237568|NCT00311168|468834013|FG000|First Intervention|Adverse Event|1|||
130237569|NCT00311168|468834014|FG001|First Intervention|Adverse Event|0|||
130237570|NCT00311168|468834013|FG000|First Intervention|Other|2|||
130237571|NCT00311168|468834014|FG001|First Intervention|Other|2|||
130237572|NCT00311168|468834013|FG000|Second Intervention|Lost to Follow-up|9|||
130237573|NCT00311168|468834014|FG001|Second Intervention|Lost to Follow-up|2|||
130237574|NCT00311168|468834013|FG000|Second Intervention|Withdrawal by Subject|0|||
130237575|NCT00311168|468834014|FG001|Second Intervention|Withdrawal by Subject|1|||
130237576|NCT00311168|468834013|FG000|Second Intervention|Other|1|||
130237577|NCT00311168|468834014|FG001|Second Intervention|Other|1|||
130237578|NCT05513950|468834021|FG000|Overall Study|Not treated due to technical reasons|0|||
130237579|NCT05513950|468834022|FG001|Overall Study|Not treated due to technical reasons|0|||
130237580|NCT05513950|468834023|FG002|Overall Study|Not treated due to technical reasons|1|||
130237581|NCT05513950|468834024|FG003|Overall Study|Not treated due to technical reasons|0|||
130237582|NCT06001866|468834025|FG000|Overall Study|Withdrawal by Subject|0|||
130237583|NCT06001866|468834026|FG001|Overall Study|Withdrawal by Subject|2|||
130237584|NCT06001866|468834025|FG000|Overall Study|Protocol Violation|0|||
130237585|NCT06001866|468834026|FG001|Overall Study|Protocol Violation|2|||
130237586|NCT02903914|468834027|FG000|Overall Study|Adverse Event|0|||
130237587|NCT02903914|468834028|FG001|Overall Study|Adverse Event|0|||
130237588|NCT02903914|468834029|FG002|Overall Study|Adverse Event|1|||
130237589|NCT02903914|468834030|FG003|Overall Study|Adverse Event|0|||
130237590|NCT02903914|468834031|FG004|Overall Study|Adverse Event|0|||
130237591|NCT02903914|468834032|FG005|Overall Study|Adverse Event|0|||
130237592|NCT02903914|468834033|FG006|Overall Study|Adverse Event|2|||
130237593|NCT02903914|468834034|FG007|Overall Study|Adverse Event|0|||
130237594|NCT02903914|468834027|FG000|Overall Study|Withdrawal by Subject|3|||
130237595|NCT02903914|468834028|FG001|Overall Study|Withdrawal by Subject|1|||
130237596|NCT02903914|468834029|FG002|Overall Study|Withdrawal by Subject|28|||
130237597|NCT02903914|468834030|FG003|Overall Study|Withdrawal by Subject|0|||
130237598|NCT02903914|468834031|FG004|Overall Study|Withdrawal by Subject|1|||
130237599|NCT02903914|468834032|FG005|Overall Study|Withdrawal by Subject|2|||
130237600|NCT02903914|468834033|FG006|Overall Study|Withdrawal by Subject|12|||
130237601|NCT02903914|468834034|FG007|Overall Study|Withdrawal by Subject|0|||
130237602|NCT02903914|468834027|FG000|Overall Study|Progressive Disease|1|||
130237603|NCT02903914|468834028|FG001|Overall Study|Progressive Disease|0|||
130237604|NCT02903914|468834029|FG002|Overall Study|Progressive Disease|4|||
130237605|NCT02903914|468834030|FG003|Overall Study|Progressive Disease|0|||
130237606|NCT02903914|468834031|FG004|Overall Study|Progressive Disease|0|||
130237607|NCT02903914|468834032|FG005|Overall Study|Progressive Disease|0|||
130237608|NCT02903914|468834033|FG006|Overall Study|Progressive Disease|2|||
130237609|NCT02903914|468834034|FG007|Overall Study|Progressive Disease|0|||
130237610|NCT02903914|468834027|FG000|Overall Study|Death|0|||
130237611|NCT02903914|468834028|FG001|Overall Study|Death|0|||
130237612|NCT02903914|468834029|FG002|Overall Study|Death|9|||
130237613|NCT02903914|468834030|FG003|Overall Study|Death|0|||
130237614|NCT02903914|468834031|FG004|Overall Study|Death|1|||
130237615|NCT02903914|468834032|FG005|Overall Study|Death|3|||
130237616|NCT02903914|468834033|FG006|Overall Study|Death|24|||
130237617|NCT02903914|468834034|FG007|Overall Study|Death|2|||
130237618|NCT02903914|468834027|FG000|Overall Study|Lost to Follow-up|0|||
130237619|NCT02903914|468834028|FG001|Overall Study|Lost to Follow-up|1|||
130237620|NCT02903914|468834029|FG002|Overall Study|Lost to Follow-up|0|||
130237621|NCT02903914|468834030|FG003|Overall Study|Lost to Follow-up|0|||
130237622|NCT02903914|468834031|FG004|Overall Study|Lost to Follow-up|2|||
130237623|NCT02903914|468834032|FG005|Overall Study|Lost to Follow-up|0|||
130237624|NCT02903914|468834033|FG006|Overall Study|Lost to Follow-up|1|||
130237625|NCT02903914|468834034|FG007|Overall Study|Lost to Follow-up|0|||
130237626|NCT02903914|468834027|FG000|Overall Study|Physician Decision|0|||
130237627|NCT02903914|468834028|FG001|Overall Study|Physician Decision|0|||
130237628|NCT02903914|468834029|FG002|Overall Study|Physician Decision|1|||
130237629|NCT02903914|468834030|FG003|Overall Study|Physician Decision|0|||
130237630|NCT02903914|468834031|FG004|Overall Study|Physician Decision|0|||
130237631|NCT02903914|468834032|FG005|Overall Study|Physician Decision|0|||
130237632|NCT02903914|468834033|FG006|Overall Study|Physician Decision|1|||
130237633|NCT02903914|468834034|FG007|Overall Study|Physician Decision|0|||
130447440|NCT01244763|469600500|FG004|Overall Study|Adverse Event|0|||
130447441|NCT01244763|469600501|FG005|Overall Study|Adverse Event|1|||
130237634|NCT02903914|468834027|FG000|Overall Study|Symptomatic Deterioration|0|||
130237635|NCT02903914|468834028|FG001|Overall Study|Symptomatic Deterioration|0|||
130237636|NCT02903914|468834029|FG002|Overall Study|Symptomatic Deterioration|1|||
130237637|NCT02903914|468834030|FG003|Overall Study|Symptomatic Deterioration|0|||
130237638|NCT02903914|468834031|FG004|Overall Study|Symptomatic Deterioration|0|||
130237639|NCT02903914|468834032|FG005|Overall Study|Symptomatic Deterioration|0|||
130237640|NCT02903914|468834033|FG006|Overall Study|Symptomatic Deterioration|0|||
130237641|NCT02903914|468834034|FG007|Overall Study|Symptomatic Deterioration|0|||
130237642|NCT02903914|468834027|FG000|Overall Study|New Cancer Therapy|2|||
130237643|NCT02903914|468834028|FG001|Overall Study|New Cancer Therapy|2|||
130359075|NCT01460368|469286466|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130359076|NCT01460368|469286467|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130359077|NCT01460368|469286468|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130359078|NCT01460368|469286469|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
130359079|NCT01460368|469286470|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130359080|NCT01460368|469286471|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130359081|NCT01460368|469286465|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130359082|NCT01460368|469286466|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
130359083|NCT01460368|469286467|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130359084|NCT01460368|469286468|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130359085|NCT01460368|469286469|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130447442|NCT01244763|469600496|FG000|Overall Study|Death|1|||
130447443|NCT01244763|469600497|FG001|Overall Study|Death|0|||
130695299|NCT03669250|470508972|FG001|Overall Study|Adverse Event|0|||
130695300|NCT03669250|470508973|FG002|Overall Study|Adverse Event|0|||
130695301|NCT03669250|470508974|FG003|Overall Study|Adverse Event|0|||
130237644|NCT02903914|468834029|FG002|Overall Study|New Cancer Therapy|21|||
130237645|NCT02903914|468834030|FG003|Overall Study|New Cancer Therapy|4|||
130237646|NCT02903914|468834031|FG004|Overall Study|New Cancer Therapy|3|||
130237647|NCT02903914|468834032|FG005|Overall Study|New Cancer Therapy|6|||
130237648|NCT02903914|468834033|FG006|Overall Study|New Cancer Therapy|56|||
130237649|NCT02903914|468834034|FG007|Overall Study|New Cancer Therapy|3|||
130237650|NCT02903914|468834027|FG000|Overall Study|Didn't Return to Site|1|||
130237651|NCT02903914|468834028|FG001|Overall Study|Didn't Return to Site|0|||
130237652|NCT02903914|468834029|FG002|Overall Study|Didn't Return to Site|1|||
130237653|NCT02903914|468834030|FG003|Overall Study|Didn't Return to Site|1|||
130695302|NCT03669250|470508975|FG004|Overall Study|Adverse Event|1|||
130695303|NCT03669250|470508976|FG005|Overall Study|Adverse Event|0|||
130695304|NCT03669250|470508971|FG000|Overall Study|Withdrawal by Subject|0|||
130695305|NCT03669250|470508972|FG001|Overall Study|Withdrawal by Subject|1|||
130237654|NCT02903914|468834031|FG004|Overall Study|Didn't Return to Site|0|||
130237655|NCT02903914|468834032|FG005|Overall Study|Didn't Return to Site|0|||
130237656|NCT02903914|468834033|FG006|Overall Study|Didn't Return to Site|2|||
130237657|NCT02903914|468834034|FG007|Overall Study|Didn't Return to Site|0|||
130237658|NCT02903914|468834027|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
130237659|NCT02903914|468834028|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
130237660|NCT02903914|468834029|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
130237661|NCT02903914|468834030|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
130237662|NCT02903914|468834031|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
130237663|NCT02903914|468834032|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
130237664|NCT02903914|468834033|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
130237665|NCT02903914|468834034|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
130237666|NCT02903914|468834027|FG000|Overall Study|Follow-up Did Not Occur|0|||
130237667|NCT02903914|468834028|FG001|Overall Study|Follow-up Did Not Occur|1|||
130237668|NCT02903914|468834029|FG002|Overall Study|Follow-up Did Not Occur|1|||
130237669|NCT02903914|468834030|FG003|Overall Study|Follow-up Did Not Occur|0|||
130237670|NCT02903914|468834031|FG004|Overall Study|Follow-up Did Not Occur|2|||
130237671|NCT02903914|468834032|FG005|Overall Study|Follow-up Did Not Occur|0|||
130237672|NCT02903914|468834033|FG006|Overall Study|Follow-up Did Not Occur|8|||
130237673|NCT02903914|468834034|FG007|Overall Study|Follow-up Did Not Occur|0|||
130237674|NCT02903914|468834027|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
130237675|NCT02903914|468834028|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
130237676|NCT02903914|468834029|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
130237677|NCT02903914|468834030|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
130237678|NCT02903914|468834031|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
130237679|NCT02903914|468834032|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
130237680|NCT02903914|468834033|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
130237681|NCT02903914|468834034|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
130237682|NCT02903914|468834027|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237683|NCT02903914|468834028|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237684|NCT02903914|468834029|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
130237685|NCT02903914|468834030|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237686|NCT02903914|468834031|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237687|NCT02903914|468834032|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
130237688|NCT02903914|468834033|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237689|NCT02903914|468834034|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237690|NCT02903914|468834027|FG000|Overall Study|Clinical Disease Progression|0|||
130237691|NCT02903914|468834028|FG001|Overall Study|Clinical Disease Progression|0|||
130237692|NCT02903914|468834029|FG002|Overall Study|Clinical Disease Progression|2|||
130237693|NCT02903914|468834030|FG003|Overall Study|Clinical Disease Progression|0|||
130237694|NCT02903914|468834031|FG004|Overall Study|Clinical Disease Progression|0|||
130237695|NCT02903914|468834032|FG005|Overall Study|Clinical Disease Progression|0|||
130237696|NCT02903914|468834033|FG006|Overall Study|Clinical Disease Progression|0|||
130237697|NCT02903914|468834034|FG007|Overall Study|Clinical Disease Progression|0|||
130237698|NCT02903914|468834027|FG000|Overall Study|Completed Follow-up Period|0|||
130237699|NCT02903914|468834028|FG001|Overall Study|Completed Follow-up Period|0|||
130237700|NCT02903914|468834029|FG002|Overall Study|Completed Follow-up Period|6|||
130237701|NCT02903914|468834030|FG003|Overall Study|Completed Follow-up Period|2|||
130237702|NCT02903914|468834031|FG004|Overall Study|Completed Follow-up Period|1|||
130237703|NCT02903914|468834032|FG005|Overall Study|Completed Follow-up Period|0|||
130237704|NCT02903914|468834033|FG006|Overall Study|Completed Follow-up Period|9|||
130237705|NCT02903914|468834034|FG007|Overall Study|Completed Follow-up Period|1|||
130237706|NCT02903914|468834027|FG000|Overall Study|Taken off Treatment per Protocol|0|||
130237707|NCT02903914|468834028|FG001|Overall Study|Taken off Treatment per Protocol|0|||
130237708|NCT02903914|468834029|FG002|Overall Study|Taken off Treatment per Protocol|0|||
130237709|NCT02903914|468834030|FG003|Overall Study|Taken off Treatment per Protocol|0|||
130237710|NCT02903914|468834031|FG004|Overall Study|Taken off Treatment per Protocol|0|||
130237711|NCT02903914|468834032|FG005|Overall Study|Taken off Treatment per Protocol|1|||
130237712|NCT02903914|468834033|FG006|Overall Study|Taken off Treatment per Protocol|0|||
130237713|NCT02903914|468834034|FG007|Overall Study|Taken off Treatment per Protocol|0|||
130237714|NCT02903914|468834027|FG000|Overall Study|Refused Further Treatment/Contact|0|||
130237715|NCT02903914|468834028|FG001|Overall Study|Refused Further Treatment/Contact|0|||
130237716|NCT02903914|468834029|FG002|Overall Study|Refused Further Treatment/Contact|0|||
130695306|NCT03669250|470508973|FG002|Overall Study|Withdrawal by Subject|0|||
130695307|NCT03669250|470508974|FG003|Overall Study|Withdrawal by Subject|1|||
130695308|NCT03669250|470508975|FG004|Overall Study|Withdrawal by Subject|0|||
130237717|NCT02903914|468834030|FG003|Overall Study|Refused Further Treatment/Contact|0|||
130237718|NCT02903914|468834031|FG004|Overall Study|Refused Further Treatment/Contact|0|||
130237719|NCT02903914|468834032|FG005|Overall Study|Refused Further Treatment/Contact|0|||
130237720|NCT02903914|468834033|FG006|Overall Study|Refused Further Treatment/Contact|1|||
130237721|NCT02903914|468834034|FG007|Overall Study|Refused Further Treatment/Contact|0|||
130237722|NCT02903914|468834027|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237723|NCT02903914|468834028|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237724|NCT02903914|468834029|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130447444|NCT01244763|469600498|FG002|Overall Study|Death|1|||
130447445|NCT01244763|469600499|FG003|Overall Study|Death|0|||
130447446|NCT01244763|469600500|FG004|Overall Study|Death|2|||
130447447|NCT01244763|469600501|FG005|Overall Study|Death|0|||
130447448|NCT01244763|469600496|FG000|Overall Study|Physician Decision|0|||
130447449|NCT01244763|469600497|FG001|Overall Study|Physician Decision|0|||
130447450|NCT01244763|469600498|FG002|Overall Study|Physician Decision|1|||
130447451|NCT01244763|469600499|FG003|Overall Study|Physician Decision|0|||
130447452|NCT01244763|469600500|FG004|Overall Study|Physician Decision|0|||
130447453|NCT01244763|469600501|FG005|Overall Study|Physician Decision|0|||
130447454|NCT01244763|469600496|FG000|Overall Study|Withdrawal by Subject|1|||
130447455|NCT01244763|469600497|FG001|Overall Study|Withdrawal by Subject|2|||
130237725|NCT02903914|468834030|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130447456|NCT01244763|469600498|FG002|Overall Study|Withdrawal by Subject|0|||
130447457|NCT01244763|469600499|FG003|Overall Study|Withdrawal by Subject|1|||
130447458|NCT01244763|469600500|FG004|Overall Study|Withdrawal by Subject|1|||
130447459|NCT01244763|469600501|FG005|Overall Study|Withdrawal by Subject|2|||
130447460|NCT01244763|469600496|FG000|Overall Study|Lost to Follow-up|0|||
130447461|NCT01244763|469600497|FG001|Overall Study|Lost to Follow-up|1|||
130447462|NCT01244763|469600498|FG002|Overall Study|Lost to Follow-up|0|||
130447463|NCT01244763|469600499|FG003|Overall Study|Lost to Follow-up|0|||
130447464|NCT01244763|469600500|FG004|Overall Study|Lost to Follow-up|0|||
130447465|NCT01244763|469600501|FG005|Overall Study|Lost to Follow-up|0|||
130447466|NCT01244763|469600496|FG000|Overall Study|Enrolled into the Extension Study|0|||
130447467|NCT01244763|469600497|FG001|Overall Study|Enrolled into the Extension Study|0|||
130447468|NCT01244763|469600498|FG002|Overall Study|Enrolled into the Extension Study|0|||
130447469|NCT01244763|469600499|FG003|Overall Study|Enrolled into the Extension Study|0|||
130447470|NCT01244763|469600500|FG004|Overall Study|Enrolled into the Extension Study|0|||
130447471|NCT01244763|469600501|FG005|Overall Study|Enrolled into the Extension Study|1|||
130447472|NCT00519779|469600502|FG000|Overall Study|Withdrawal by Subject|0|||
130447473|NCT00519779|469600503|FG001|Overall Study|Withdrawal by Subject|1|||
130447474|NCT03330119|469600504|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
130447475|NCT03330119|469600505|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
130447476|NCT02059161|469600514|FG000|Overall Study|Pregnancy|0|||
130447477|NCT02059161|469600515|FG001|Overall Study|Pregnancy|2|||
130447478|NCT02059161|469600514|FG000|Overall Study|Adverse Event|2|||
130447479|NCT02059161|469600515|FG001|Overall Study|Adverse Event|6|||
130447480|NCT02059161|469600514|FG000|Overall Study|Lost to Follow-up|20|||
130447481|NCT02059161|469600515|FG001|Overall Study|Lost to Follow-up|12|||
130447482|NCT02059161|469600514|FG000|Overall Study|Physician Decision|4|||
130447483|NCT02059161|469600515|FG001|Overall Study|Physician Decision|4|||
130447484|NCT02059161|469600514|FG000|Overall Study|Protocol Violation|1|||
130447485|NCT02059161|469600515|FG001|Overall Study|Protocol Violation|1|||
130447486|NCT02059161|469600514|FG000|Overall Study|Withdrawal by Subject|16|||
130447487|NCT02059161|469600515|FG001|Overall Study|Withdrawal by Subject|13|||
130447488|NCT02059161|469600514|FG000|Overall Study|Randomized in error, no study drug|0|||
130447489|NCT02059161|469600515|FG001|Overall Study|Randomized in error, no study drug|1|||
130447490|NCT02059161|469600514|FG000|Overall Study|Non-compliance with study drug|6|||
130447491|NCT02059161|469600515|FG001|Overall Study|Non-compliance with study drug|2|||
130447492|NCT03293485|469600517|FG000|Overall Study|Death|1|||
130447493|NCT03293485|469600517|FG000|Overall Study|Screen Failure|2|||
130447494|NCT03293485|469600517|FG000|Overall Study|Withdrawal by Subject|2|||
130447495|NCT01723826|469600521|FG000|Overall Study|Adverse Event|4|||
130237726|NCT02903914|468834031|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130447496|NCT01723826|469600522|FG001|Overall Study|Adverse Event|1|||
130447497|NCT01723826|469600523|FG002|Overall Study|Adverse Event|4|||
130447498|NCT01723826|469600524|FG003|Overall Study|Adverse Event|5|||
130447499|NCT01723826|469600521|FG000|Overall Study|Death according to AE eCRF|2|||
130447500|NCT01723826|469600522|FG001|Overall Study|Death according to AE eCRF|3|||
130447501|NCT01723826|469600523|FG002|Overall Study|Death according to AE eCRF|3|||
130447502|NCT01723826|469600524|FG003|Overall Study|Death according to AE eCRF|7|||
130447503|NCT01723826|469600521|FG000|Overall Study|Lost to Follow-up|1|||
130447504|NCT01723826|469600522|FG001|Overall Study|Lost to Follow-up|3|||
130447505|NCT01723826|469600523|FG002|Overall Study|Lost to Follow-up|1|||
130447506|NCT01723826|469600524|FG003|Overall Study|Lost to Follow-up|1|||
130447507|NCT01723826|469600521|FG000|Overall Study|Non-compliance|0|||
130447508|NCT01723826|469600522|FG001|Overall Study|Non-compliance|1|||
130447509|NCT01723826|469600523|FG002|Overall Study|Non-compliance|3|||
130447510|NCT01723826|469600524|FG003|Overall Study|Non-compliance|3|||
130447511|NCT01723826|469600521|FG000|Overall Study|Non-compliance With Study Drug|0|||
130447512|NCT01723826|469600522|FG001|Overall Study|Non-compliance With Study Drug|1|||
130447513|NCT01723826|469600523|FG002|Overall Study|Non-compliance With Study Drug|0|||
130447514|NCT01723826|469600524|FG003|Overall Study|Non-compliance With Study Drug|0|||
130447515|NCT01723826|469600521|FG000|Overall Study|Other Reason|8|||
130447516|NCT01723826|469600522|FG001|Overall Study|Other Reason|6|||
130447517|NCT01723826|469600523|FG002|Overall Study|Other Reason|12|||
130447518|NCT01723826|469600524|FG003|Overall Study|Other Reason|14|||
130447519|NCT01723826|469600521|FG000|Overall Study|Physician Decision|1|||
130447520|NCT01723826|469600522|FG001|Overall Study|Physician Decision|3|||
130447521|NCT01723826|469600523|FG002|Overall Study|Physician Decision|4|||
130447522|NCT01723826|469600524|FG003|Overall Study|Physician Decision|11|||
130447523|NCT01723826|469600521|FG000|Overall Study|Protocol Violation|1|||
130447524|NCT01723826|469600522|FG001|Overall Study|Protocol Violation|1|||
130447525|NCT01723826|469600523|FG002|Overall Study|Protocol Violation|3|||
130237727|NCT02903914|468834032|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237728|NCT02903914|468834033|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
130237729|NCT02903914|468834034|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237730|NCT03112603|468834038|FG000|End of Randomization Period|Lost to Follow-up|3|||
130237731|NCT03112603|468834039|FG001|End of Randomization Period|Lost to Follow-up|0|||
130359086|NCT01460368|469286470|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130359087|NCT01460368|469286471|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
130359088|NCT01460368|469286465|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359089|NCT01460368|469286466|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
130359090|NCT01460368|469286467|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359091|NCT01460368|469286468|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359092|NCT01460368|469286469|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359093|NCT01460368|469286470|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359094|NCT01460368|469286471|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130359095|NCT01460368|469286465|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359096|NCT01460368|469286466|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359097|NCT01460368|469286467|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
130359098|NCT01460368|469286468|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359099|NCT01460368|469286469|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359100|NCT01460368|469286470|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359101|NCT01460368|469286471|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130359102|NCT01460368|469286465|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130359103|NCT01460368|469286466|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130359104|NCT01460368|469286467|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130359105|NCT01460368|469286468|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130359106|NCT01460368|469286469|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130359107|NCT01460368|469286470|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130359108|NCT01460368|469286471|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130359109|NCT00747461|469286478|FG000|Overall Study|study terminated by sponsor|5|||
130359110|NCT00299182|469286494|FG000|Overall Study|Withdrawal by Subject|0|||
130359111|NCT00299182|469286495|FG001|Overall Study|Withdrawal by Subject|0|||
130359112|NCT00299182|469286496|FG002|Overall Study|Withdrawal by Subject|1|||
130359113|NCT00299182|469286497|FG003|Overall Study|Withdrawal by Subject|0|||
130359114|NCT00299182|469286498|FG004|Overall Study|Withdrawal by Subject|1|||
130359115|NCT00299182|469286499|FG005|Overall Study|Withdrawal by Subject|2|||
130359116|NCT00299182|469286500|FG006|Overall Study|Withdrawal by Subject|0|||
130359117|NCT00299182|469286494|FG000|Overall Study|Chemotherapy Changed|0|||
130359118|NCT00299182|469286495|FG001|Overall Study|Chemotherapy Changed|0|||
130359119|NCT00299182|469286496|FG002|Overall Study|Chemotherapy Changed|1|||
130359120|NCT00299182|469286497|FG003|Overall Study|Chemotherapy Changed|0|||
130359121|NCT00299182|469286498|FG004|Overall Study|Chemotherapy Changed|1|||
130359122|NCT00299182|469286499|FG005|Overall Study|Chemotherapy Changed|0|||
130359123|NCT00299182|469286500|FG006|Overall Study|Chemotherapy Changed|1|||
130447526|NCT01723826|469600524|FG003|Overall Study|Protocol Violation|1|||
130447527|NCT01723826|469600521|FG000|Overall Study|Withdrawal by Subject|10|||
130447528|NCT01723826|469600522|FG001|Overall Study|Withdrawal by Subject|17|||
130359124|NCT00299182|469286494|FG000|Overall Study|Adverse Event|0|||
130359125|NCT00299182|469286495|FG001|Overall Study|Adverse Event|0|||
130359126|NCT00299182|469286496|FG002|Overall Study|Adverse Event|0|||
130359127|NCT00299182|469286497|FG003|Overall Study|Adverse Event|0|||
130447529|NCT01723826|469600523|FG002|Overall Study|Withdrawal by Subject|27|||
130447530|NCT01723826|469600524|FG003|Overall Study|Withdrawal by Subject|48|||
130447531|NCT02408549|469600527|FG000|Overall Study|Adverse Event|15|||
130447532|NCT02408549|469600527|FG000|Overall Study|Death|4|||
130237732|NCT03112603|468834040|FG002|End of Randomization Period|Lost to Follow-up|0|||
130237733|NCT03112603|468834038|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
130237734|NCT03112603|468834039|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
130237735|NCT03112603|468834040|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
130237736|NCT03112603|468834038|FG000|End of Randomization Period|Physician Decision|43|||
130237737|NCT03112603|468834039|FG001|End of Randomization Period|Physician Decision|18|||
130237738|NCT03112603|468834040|FG002|End of Randomization Period|Physician Decision|0|||
130237739|NCT03112603|468834038|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
130237740|NCT03112603|468834039|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
130237741|NCT03112603|468834040|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
130237742|NCT03112603|468834038|FG000|End of Randomization Period|Death|10|||
130237743|NCT03112603|468834039|FG001|End of Randomization Period|Death|7|||
130237744|NCT03112603|468834040|FG002|End of Randomization Period|Death|0|||
130237745|NCT03112603|468834038|FG000|End of Randomization Period|Disease Relapse|12|||
130237746|NCT03112603|468834039|FG001|End of Randomization Period|Disease Relapse|7|||
130237747|NCT03112603|468834040|FG002|End of Randomization Period|Disease Relapse|0|||
130237748|NCT03112603|468834038|FG000|End of Randomization Period|Lack of Efficacy|25|||
130237749|NCT03112603|468834039|FG001|End of Randomization Period|Lack of Efficacy|77|||
130237750|NCT03112603|468834040|FG002|End of Randomization Period|Lack of Efficacy|0|||
130237751|NCT03112603|468834038|FG000|End of Randomization Period|Adverse Event|32|||
130237752|NCT03112603|468834039|FG001|End of Randomization Period|Adverse Event|12|||
130237753|NCT03112603|468834040|FG002|End of Randomization Period|Adverse Event|0|||
130237754|NCT03112603|468834038|FG000|End of Cross Over Period|Death|0|||
130237755|NCT03112603|468834039|FG001|End of Cross Over Period|Death|0|||
130237756|NCT03112603|468834040|FG002|End of Cross Over Period|Death|2|||
130237757|NCT03112603|468834038|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
130237758|NCT03112603|468834039|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
130237759|NCT03112603|468834040|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
130237760|NCT03112603|468834038|FG000|End of Cross Over Period|Physician Decision|0|||
130237761|NCT03112603|468834039|FG001|End of Cross Over Period|Physician Decision|0|||
130237762|NCT03112603|468834040|FG002|End of Cross Over Period|Physician Decision|29|||
130237763|NCT03112603|468834038|FG000|End of Cross Over Period|Lack of Efficacy|0|||
130237764|NCT03112603|468834039|FG001|End of Cross Over Period|Lack of Efficacy|0|||
130237765|NCT03112603|468834040|FG002|End of Cross Over Period|Lack of Efficacy|8|||
130237766|NCT03112603|468834038|FG000|End of Cross Over Period|Adverse Event|0|||
130237767|NCT03112603|468834039|FG001|End of Cross Over Period|Adverse Event|0|||
130237768|NCT03112603|468834040|FG002|End of Cross Over Period|Adverse Event|6|||
130359128|NCT00299182|469286498|FG004|Overall Study|Adverse Event|0|||
130447533|NCT02408549|469600527|FG000|Overall Study|Lack of Efficacy|17|||
130447534|NCT02408549|469600527|FG000|Overall Study|Protocol Violation|4|||
130359129|NCT00299182|469286499|FG005|Overall Study|Adverse Event|1|||
130359130|NCT00299182|469286500|FG006|Overall Study|Adverse Event|0|||
130359131|NCT00299182|469286494|FG000|Overall Study|Not Eligible|0|||
130359132|NCT00299182|469286495|FG001|Overall Study|Not Eligible|0|||
130359133|NCT00299182|469286496|FG002|Overall Study|Not Eligible|0|||
130359134|NCT00299182|469286497|FG003|Overall Study|Not Eligible|0|||
130359135|NCT00299182|469286498|FG004|Overall Study|Not Eligible|1|||
130359136|NCT00299182|469286499|FG005|Overall Study|Not Eligible|0|||
130359137|NCT00299182|469286500|FG006|Overall Study|Not Eligible|0|||
130359138|NCT01565642|469286507|FG000|Overall Study|Withdrawal by Subject|2|||
130359139|NCT01565642|469286508|FG001|Overall Study|Withdrawal by Subject|1|||
130359140|NCT01898208|469286511|FG000|Overall Study|Positive blood culture|17|||
130359141|NCT01898208|469286512|FG001|Overall Study|Positive blood culture|23|||
130359142|NCT01898208|469286513|FG002|Overall Study|Positive blood culture|15|||
130359143|NCT01898208|469286511|FG000|Overall Study|Death/comfort care within 24 hours|10|||
130359144|NCT01898208|469286512|FG001|Overall Study|Death/comfort care within 24 hours|9|||
130359145|NCT01898208|469286513|FG002|Overall Study|Death/comfort care within 24 hours|8|||
130359146|NCT01898208|469286511|FG000|Overall Study|Negative Gram Stain|6|||
130359147|NCT01898208|469286512|FG001|Overall Study|Negative Gram Stain|9|||
130359148|NCT01898208|469286513|FG002|Overall Study|Negative Gram Stain|6|||
130359149|NCT01898208|469286511|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
130359150|NCT01898208|469286512|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
130359151|NCT01898208|469286513|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
130359152|NCT01898208|469286511|FG000|Overall Study|System/Technical Error|1|||
130237769|NCT03112603|468834038|FG000|End of Cross Over Period|Disease Relapse|0|||
130237770|NCT03112603|468834039|FG001|End of Cross Over Period|Disease Relapse|0|||
130237771|NCT03112603|468834040|FG002|End of Cross Over Period|Disease Relapse|2|||
130237772|NCT04725188|468834041|FG000|Overall Study|Death|72|||
130237773|NCT04725188|468834042|FG001|Overall Study|Death|69|||
130359153|NCT01898208|469286512|FG001|Overall Study|System/Technical Error|2|||
130359154|NCT01898208|469286513|FG002|Overall Study|System/Technical Error|3|||
130359155|NCT01898208|469286511|FG000|Overall Study|Lost to Follow-up|3|||
130359156|NCT01898208|469286512|FG001|Overall Study|Lost to Follow-up|1|||
130447535|NCT02408549|469600527|FG000|Overall Study|Lost to Follow-up|6|||
130695309|NCT03669250|470508976|FG005|Overall Study|Withdrawal by Subject|0|||
130695310|NCT00828321|470508977|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
130695311|NCT00828321|470508978|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
130695312|NCT00828321|470508977|FG000|Second Intervention|Protocol Violation|0|||
130695313|NCT00828321|470508978|FG001|Second Intervention|Protocol Violation|1|||
130237774|NCT04725188|468834043|FG002|Overall Study|Death|76|||
130237775|NCT04725188|468834041|FG000|Overall Study|Lost to Follow-up|1|||
130237776|NCT04725188|468834042|FG001|Overall Study|Lost to Follow-up|0|||
130237777|NCT04725188|468834043|FG002|Overall Study|Lost to Follow-up|1|||
130237778|NCT04725188|468834041|FG000|Overall Study|Withdrawal by Subject|2|||
130237779|NCT04725188|468834042|FG001|Overall Study|Withdrawal by Subject|2|||
130237780|NCT04725188|468834043|FG002|Overall Study|Withdrawal by Subject|1|||
130237781|NCT04725188|468834041|FG000|Overall Study|Sponsor Decision|12|||
130237782|NCT04725188|468834042|FG001|Overall Study|Sponsor Decision|12|||
130237783|NCT04725188|468834043|FG002|Overall Study|Sponsor Decision|7|||
130695314|NCT02034513|470508979|FG000|Overall Study|Adverse Event|11|||
130695315|NCT02034513|470508980|FG001|Overall Study|Adverse Event|10|||
130695316|NCT02034513|470508979|FG000|Overall Study|Lack of Efficacy|0|||
130695317|NCT02034513|470508980|FG001|Overall Study|Lack of Efficacy|1|||
130695318|NCT02034513|470508979|FG000|Overall Study|Lost to Follow-up|6|||
130695319|NCT02034513|470508980|FG001|Overall Study|Lost to Follow-up|7|||
130695320|NCT02034513|470508979|FG000|Overall Study|Pregnancy|0|||
130695321|NCT02034513|470508980|FG001|Overall Study|Pregnancy|3|||
130695322|NCT02034513|470508979|FG000|Overall Study|Protocol Violation|7|||
130695323|NCT02034513|470508980|FG001|Overall Study|Protocol Violation|10|||
130695324|NCT02034513|470508979|FG000|Overall Study|Withdrawal by Subject|25|||
130695325|NCT02034513|470508980|FG001|Overall Study|Withdrawal by Subject|25|||
130695326|NCT02034513|470508979|FG000|Overall Study|Unclassified|0|||
130695327|NCT02034513|470508980|FG001|Overall Study|Unclassified|1|||
130695328|NCT03119662|470508983|FG000|Overall Study|Withdrawal by Subject|0|||
130695329|NCT03119662|470508984|FG001|Overall Study|Withdrawal by Subject|1|||
130695330|NCT00660660|470508985|FG000|Overall Study|Adverse Event|1|||
130695331|NCT00660660|470508986|FG001|Overall Study|Adverse Event|0|||
130695332|NCT00660660|470508985|FG000|Overall Study|Lost to Follow-up|0|||
130695333|NCT00660660|470508986|FG001|Overall Study|Lost to Follow-up|6|||
130695334|NCT00660660|470508985|FG000|Overall Study|Lack of Efficacy|0|||
130695335|NCT00660660|470508986|FG001|Overall Study|Lack of Efficacy|2|||
130695336|NCT00660660|470508985|FG000|Overall Study|Withdrawal by Subject|3|||
130695337|NCT00660660|470508986|FG001|Overall Study|Withdrawal by Subject|0|||
130695338|NCT00660660|470508985|FG000|Overall Study|Incorrect enrollment and other|0|||
130695339|NCT00660660|470508986|FG001|Overall Study|Incorrect enrollment and other|1|||
130695340|NCT00660660|470508985|FG000|Overall Study|New medication after randomization|1|||
130695341|NCT00660660|470508986|FG001|Overall Study|New medication after randomization|0|||
130695342|NCT04158687|470508990|FG000|Overall Study|Adverse Event|2|||
130695343|NCT04158687|470508991|FG001|Overall Study|Adverse Event|3|||
130695344|NCT04158687|470508992|FG002|Overall Study|Adverse Event|0|||
130695345|NCT04158687|470508993|FG003|Overall Study|Adverse Event|3|||
130695346|NCT04158687|470508990|FG000|Overall Study|Lost to Follow-up|5|||
130695347|NCT04158687|470508991|FG001|Overall Study|Lost to Follow-up|12|||
130695348|NCT04158687|470508992|FG002|Overall Study|Lost to Follow-up|4|||
130237784|NCT02337829|468834044|FG000|Overall Study|Death|0|||
130237785|NCT02337829|468834045|FG001|Overall Study|Death|1|||
130359157|NCT01898208|469286513|FG002|Overall Study|Lost to Follow-up|1|||
130359158|NCT03001882|469286516|FG000|Overall Study|Death|1|||
130359159|NCT03001882|469286517|FG001|Overall Study|Death|0|||
130695349|NCT04158687|470508993|FG003|Overall Study|Lost to Follow-up|5|||
130695350|NCT04158687|470508990|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130695351|NCT04158687|470508991|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
130695352|NCT04158687|470508992|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130695353|NCT04158687|470508993|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
130695354|NCT04158687|470508990|FG000|Overall Study|Non-Compliance with Study Medication|2|||
130695355|NCT04158687|470508991|FG001|Overall Study|Non-Compliance with Study Medication|2|||
130695356|NCT04158687|470508992|FG002|Overall Study|Non-Compliance with Study Medication|3|||
130695357|NCT04158687|470508993|FG003|Overall Study|Non-Compliance with Study Medication|0|||
130695358|NCT04158687|470508990|FG000|Overall Study|Investigator Decision|0|||
130695359|NCT04158687|470508991|FG001|Overall Study|Investigator Decision|0|||
130695360|NCT04158687|470508992|FG002|Overall Study|Investigator Decision|2|||
130695361|NCT04158687|470508993|FG003|Overall Study|Investigator Decision|0|||
130695362|NCT04158687|470508990|FG000|Overall Study|Protocol Violation|0|||
130695363|NCT04158687|470508991|FG001|Overall Study|Protocol Violation|2|||
130695364|NCT04158687|470508992|FG002|Overall Study|Protocol Violation|1|||
130695365|NCT04158687|470508993|FG003|Overall Study|Protocol Violation|0|||
130695366|NCT04158687|470508990|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
130695367|NCT04158687|470508991|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
130695368|NCT04158687|470508992|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
130237786|NCT02337829|468834046|FG002|Overall Study|Death|0|||
130237787|NCT02337829|468834047|FG003|Overall Study|Death|0|||
130447536|NCT02408549|469600527|FG000|Overall Study|Consent withdrawn|30|||
130447537|NCT02408549|469600527|FG000|Overall Study|Neurology research program closing at site|1|||
130695369|NCT04158687|470508993|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
130237788|NCT02337829|468834044|FG000|Overall Study|Study terminated by sponsor|12|||
130237789|NCT02337829|468834045|FG001|Overall Study|Study terminated by sponsor|10|||
130237790|NCT02337829|468834046|FG002|Overall Study|Study terminated by sponsor|5|||
130237791|NCT02337829|468834047|FG003|Overall Study|Study terminated by sponsor|6|||
130237792|NCT02337829|468834044|FG000|Overall Study|discontinued for other reasons|6|||
130237793|NCT02337829|468834045|FG001|Overall Study|discontinued for other reasons|3|||
130237794|NCT02337829|468834046|FG002|Overall Study|discontinued for other reasons|1|||
130237795|NCT02337829|468834047|FG003|Overall Study|discontinued for other reasons|4|||
130237796|NCT03330197|468834048|FG000|Overall Study|Adverse Event|0|||
130237797|NCT03330197|468834049|FG001|Overall Study|Adverse Event|1|||
130237798|NCT03330197|468834048|FG000|Overall Study|Withdrawal by Subject|0|||
130237799|NCT03330197|468834049|FG001|Overall Study|Withdrawal by Subject|1|||
130237800|NCT00695019|468834060|FG000|Overall Study|Withdrawal by Subject|8|||
130237801|NCT00695019|468834061|FG001|Overall Study|Withdrawal by Subject|6|||
130237802|NCT00695019|468834062|FG002|Overall Study|Withdrawal by Subject|4|||
130237803|NCT00695019|468834060|FG000|Overall Study|Protocol Violation|1|||
130237804|NCT00695019|468834061|FG001|Overall Study|Protocol Violation|3|||
130237805|NCT00695019|468834062|FG002|Overall Study|Protocol Violation|1|||
130237806|NCT00695019|468834060|FG000|Overall Study|Lack of Efficacy|0|||
130237807|NCT00695019|468834061|FG001|Overall Study|Lack of Efficacy|0|||
130237808|NCT00695019|468834062|FG002|Overall Study|Lack of Efficacy|1|||
130237809|NCT00695019|468834060|FG000|Overall Study|Various|4|||
130237810|NCT00695019|468834061|FG001|Overall Study|Various|5|||
130237811|NCT00695019|468834062|FG002|Overall Study|Various|4|||
130237812|NCT03197129|468834065|FG000|Overall Study|did not answer the VPT: shyness|4|||
130237813|NCT03197129|468834066|FG001|Overall Study|did not answer the VPT: shyness|5|||
130237814|NCT01564407|468834067|FG000|Overall Study|Lost to Follow-up|0|||
130237815|NCT01564407|468834068|FG001|Overall Study|Lost to Follow-up|1|||
130237816|NCT01564407|468834069|FG002|Overall Study|Lost to Follow-up|0|||
130237817|NCT01564407|468834070|FG003|Overall Study|Lost to Follow-up|0|||
130695370|NCT04158687|470508990|FG000|Overall Study|Reason not Specified|3|||
130695371|NCT04158687|470508991|FG001|Overall Study|Reason not Specified|2|||
130695372|NCT04158687|470508992|FG002|Overall Study|Reason not Specified|4|||
130237818|NCT01564407|468834071|FG004|Overall Study|Lost to Follow-up|0|||
130237819|NCT01564407|468834067|FG000|Overall Study|Withdrawal by Subject|0|||
130359160|NCT03001882|469286518|FG002|Overall Study|Death|0|||
130359161|NCT03001882|469286519|FG003|Overall Study|Death|3|||
130359162|NCT03001882|469286516|FG000|Overall Study|Participant withdrew consent|0|||
130359163|NCT03001882|469286517|FG001|Overall Study|Participant withdrew consent|1|||
130359164|NCT03001882|469286518|FG002|Overall Study|Participant withdrew consent|0|||
130359165|NCT03001882|469286519|FG003|Overall Study|Participant withdrew consent|5|||
130359166|NCT03001882|469286516|FG000|Overall Study|Other reasons|1|||
130359167|NCT03001882|469286517|FG001|Overall Study|Other reasons|2|||
130359168|NCT03001882|469286518|FG002|Overall Study|Other reasons|0|||
130359169|NCT03001882|469286519|FG003|Overall Study|Other reasons|5|||
130359170|NCT03001882|469286516|FG000|Overall Study|Administrative reason by sponsor|0|||
130359171|NCT03001882|469286517|FG001|Overall Study|Administrative reason by sponsor|0|||
130359172|NCT03001882|469286518|FG002|Overall Study|Administrative reason by sponsor|0|||
130359173|NCT03001882|469286519|FG003|Overall Study|Administrative reason by sponsor|1|||
130359174|NCT03001882|469286516|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130359175|NCT03001882|469286517|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
130359176|NCT03001882|469286518|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130359177|NCT03001882|469286519|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
130359178|NCT03001882|469286516|FG000|Overall Study|Not reported|0|||
130359179|NCT03001882|469286517|FG001|Overall Study|Not reported|0|||
130359180|NCT03001882|469286518|FG002|Overall Study|Not reported|0|||
130359181|NCT03001882|469286519|FG003|Overall Study|Not reported|6|||
130359182|NCT03001882|469286516|FG000|Overall Study|Maximum clinical benefit|2|||
130359183|NCT03001882|469286517|FG001|Overall Study|Maximum clinical benefit|3|||
130359184|NCT03001882|469286518|FG002|Overall Study|Maximum clinical benefit|0|||
130359185|NCT03001882|469286519|FG003|Overall Study|Maximum clinical benefit|10|||
130237820|NCT01564407|468834068|FG001|Overall Study|Withdrawal by Subject|1|||
130237821|NCT01564407|468834069|FG002|Overall Study|Withdrawal by Subject|0|||
130359186|NCT03001882|469286516|FG000|Overall Study|AE unrelated to study drug|3|||
130359187|NCT03001882|469286517|FG001|Overall Study|AE unrelated to study drug|3|||
130359188|NCT03001882|469286518|FG002|Overall Study|AE unrelated to study drug|0|||
130359189|NCT03001882|469286519|FG003|Overall Study|AE unrelated to study drug|11|||
130359190|NCT03001882|469286516|FG000|Overall Study|Study Drug Toxicity|8|||
130695373|NCT04158687|470508993|FG003|Overall Study|Reason not Specified|4|||
130237822|NCT01564407|468834070|FG003|Overall Study|Withdrawal by Subject|0|||
130237823|NCT01564407|468834071|FG004|Overall Study|Withdrawal by Subject|0|||
130237824|NCT01564407|468834067|FG000|Overall Study|funding lost, study ended|0|||
130695374|NCT04523480|470508996|FG000|Overall Study|Lost to Follow-up|30|||
130695375|NCT04523480|470508997|FG001|Overall Study|Lost to Follow-up|35|||
130695376|NCT04523480|470508998|FG002|Overall Study|Lost to Follow-up|0|||
130237825|NCT01564407|468834068|FG001|Overall Study|funding lost, study ended|0|||
130237826|NCT01564407|468834069|FG002|Overall Study|funding lost, study ended|0|||
130237827|NCT01564407|468834070|FG003|Overall Study|funding lost, study ended|1|||
130237828|NCT01564407|468834071|FG004|Overall Study|funding lost, study ended|0|||
130237829|NCT02442349|468834072|FG000|Overall Study|Death|95|||
130237830|NCT02442349|468834072|FG000|Overall Study|Withdrawal by Subject|27|||
130237831|NCT02442349|468834072|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
130237832|NCT02442349|468834072|FG000|Overall Study|Lost to Follow-up|1|||
130237833|NCT00314145|468834073|FG000|Overall Study|Withdrawal by Subject|8|||
130237834|NCT00314145|468834074|FG001|Overall Study|Withdrawal by Subject|10|||
130237835|NCT00314145|468834073|FG000|Overall Study|Lost to Follow-up|5|||
130237836|NCT00314145|468834074|FG001|Overall Study|Lost to Follow-up|12|||
130237837|NCT00314145|468834073|FG000|Overall Study|Physician Decision|3|||
130237838|NCT00314145|468834074|FG001|Overall Study|Physician Decision|4|||
130237839|NCT00314145|468834073|FG000|Overall Study|Adverse Event|0|||
130237840|NCT00314145|468834074|FG001|Overall Study|Adverse Event|3|||
130237841|NCT00314145|468834073|FG000|Overall Study|Protocol Violation|3|||
130237842|NCT00314145|468834074|FG001|Overall Study|Protocol Violation|0|||
130237843|NCT00314145|468834073|FG000|Overall Study|Sponsor Decision|2|||
130237844|NCT00314145|468834074|FG001|Overall Study|Sponsor Decision|0|||
130237845|NCT03507790|468834077|FG000|Overall Study|Adverse Event|0|||
130237846|NCT03507790|468834078|FG001|Overall Study|Adverse Event|11|||
130237847|NCT03507790|468834079|FG002|Overall Study|Adverse Event|3|||
130237848|NCT03507790|468834077|FG000|Overall Study|Withdrawal by Subject|2|||
130237849|NCT03507790|468834078|FG001|Overall Study|Withdrawal by Subject|0|||
130237850|NCT03507790|468834079|FG002|Overall Study|Withdrawal by Subject|0|||
130237851|NCT03507790|468834077|FG000|Overall Study|Subject moved to another location|1|||
130237852|NCT03507790|468834078|FG001|Overall Study|Subject moved to another location|2|||
130237853|NCT03507790|468834079|FG002|Overall Study|Subject moved to another location|0|||
130237854|NCT03507790|468834077|FG000|Overall Study|Non-compliance with study drug|0|||
130237855|NCT03507790|468834078|FG001|Overall Study|Non-compliance with study drug|0|||
130237856|NCT03507790|468834079|FG002|Overall Study|Non-compliance with study drug|1|||
130237857|NCT03507790|468834077|FG000|Overall Study|COVID 19 Pandemic|0|||
130237858|NCT03507790|468834078|FG001|Overall Study|COVID 19 Pandemic|1|||
130237859|NCT03507790|468834079|FG002|Overall Study|COVID 19 Pandemic|0|||
130237860|NCT03507790|468834077|FG000|Overall Study|Lost to Follow-up|0|||
130237861|NCT03507790|468834078|FG001|Overall Study|Lost to Follow-up|1|||
130237862|NCT03507790|468834079|FG002|Overall Study|Lost to Follow-up|0|||
130237863|NCT03507790|468834077|FG000|Overall Study|Discontinuation of the trial at the site|1|||
130237864|NCT03507790|468834078|FG001|Overall Study|Discontinuation of the trial at the site|1|||
130237865|NCT03507790|468834079|FG002|Overall Study|Discontinuation of the trial at the site|0|||
130237866|NCT03507790|468834077|FG000|Overall Study|Randomized in error|0|||
130237867|NCT03507790|468834078|FG001|Overall Study|Randomized in error|0|||
130237868|NCT03507790|468834079|FG002|Overall Study|Randomized in error|1|||
130237869|NCT02296125|468834082|FG000|Overall Study|Withdrawal by Subject|18|||
130237870|NCT02296125|468834083|FG001|Overall Study|Withdrawal by Subject|8|||
130237871|NCT02296125|468834084|FG002|Overall Study|Withdrawal by Subject|6|||
130237872|NCT02296125|468834085|FG003|Overall Study|Withdrawal by Subject|2|||
130237873|NCT02296125|468834082|FG000|Overall Study|Adverse Event|41|||
130237874|NCT02296125|468834083|FG001|Overall Study|Adverse Event|52|||
130237875|NCT02296125|468834084|FG002|Overall Study|Adverse Event|9|||
130237876|NCT02296125|468834085|FG003|Overall Study|Adverse Event|4|||
130237877|NCT02296125|468834082|FG000|Overall Study|Severe non-compliance to protocol|0|||
130237878|NCT02296125|468834083|FG001|Overall Study|Severe non-compliance to protocol|1|||
130237879|NCT02296125|468834084|FG002|Overall Study|Severe non-compliance to protocol|0|||
130237880|NCT02296125|468834085|FG003|Overall Study|Severe non-compliance to protocol|0|||
130237881|NCT02296125|468834082|FG000|Overall Study|Condition under investigation worsened|153|||
130237882|NCT02296125|468834083|FG001|Overall Study|Condition under investigation worsened|199|||
130237883|NCT02296125|468834084|FG002|Overall Study|Condition under investigation worsened|39|||
130237884|NCT02296125|468834085|FG003|Overall Study|Condition under investigation worsened|56|||
130237885|NCT02296125|468834082|FG000|Overall Study|Any reason not specifically recorded|6|||
130237886|NCT02296125|468834083|FG001|Overall Study|Any reason not specifically recorded|4|||
130237887|NCT02296125|468834084|FG002|Overall Study|Any reason not specifically recorded|2|||
130237888|NCT02296125|468834085|FG003|Overall Study|Any reason not specifically recorded|0|||
130237889|NCT01160614|468834086|FG000|Overall Study|Withdrawal by Subject|0|||
130237890|NCT01160614|468834087|FG001|Overall Study|Withdrawal by Subject|2|||
130237891|NCT03314935|468834088|FG000|Phase 1|Death|4|||
130237892|NCT03314935|468834089|FG001|Phase 1|Death|2|||
130237893|NCT03314935|468834090|FG002|Phase 1|Death|5|||
130237894|NCT03314935|468834091|FG003|Phase 1|Death|4|||
130237895|NCT03314935|468834092|FG004|Phase 1|Death|3|||
130237896|NCT03314935|468834093|FG005|Phase 1|Death|4|||
130237897|NCT03314935|468834094|FG006|Phase 1|Death|5|||
130237898|NCT03314935|468834095|FG007|Phase 1|Death|4|||
130695377|NCT00081653|470509004|FG000|Overall Study|Adverse Event|23|||
130695378|NCT00081653|470509005|FG001|Overall Study|Adverse Event|17|||
130695379|NCT00081653|470509004|FG000|Overall Study|Lost to Follow-up|2|||
130695380|NCT00081653|470509005|FG001|Overall Study|Lost to Follow-up|4|||
130695381|NCT00081653|470509004|FG000|Overall Study|Refused Treatment|18|||
130695382|NCT00081653|470509005|FG001|Overall Study|Refused Treatment|14|||
130695383|NCT00081653|470509004|FG000|Overall Study|Low bone mineral density|1|||
130695384|NCT00081653|470509005|FG001|Overall Study|Low bone mineral density|0|||
130695385|NCT00081653|470509004|FG000|Overall Study|Bone loss|2|||
130695386|NCT00081653|470509005|FG001|Overall Study|Bone loss|0|||
130695387|NCT00081653|470509004|FG000|Overall Study|Participant leaving country|1|||
130695388|NCT00081653|470509005|FG001|Overall Study|Participant leaving country|0|||
130695389|NCT00081653|470509004|FG000|Overall Study|Loss of bone mass|0|||
130695390|NCT00081653|470509005|FG001|Overall Study|Loss of bone mass|2|||
130695391|NCT02694536|470509008|FG000|Overall Study|Progressive Disease|40|||
130695392|NCT02694536|470509008|FG000|Overall Study|Lost to Follow-up|1|||
130695393|NCT02694536|470509008|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
130695394|NCT02694536|470509008|FG000|Overall Study|Withdrawal by Subject|8|||
130695395|NCT02694536|470509008|FG000|Overall Study|Death|8|||
130695396|NCT02694536|470509008|FG000|Overall Study|Other|22|||
130695397|NCT01911429|470509013|FG000|Overall Study|Adverse Event|5|||
130695398|NCT01911429|470509014|FG001|Overall Study|Adverse Event|3|||
130695399|NCT01911429|470509015|FG002|Overall Study|Adverse Event|9|||
130695400|NCT01911429|470509013|FG000|Overall Study|Lack of Efficacy|1|||
130695401|NCT01911429|470509014|FG001|Overall Study|Lack of Efficacy|2|||
130695402|NCT01911429|470509015|FG002|Overall Study|Lack of Efficacy|4|||
130695403|NCT01911429|470509013|FG000|Overall Study|Lost to Follow-up|0|||
130695404|NCT01911429|470509014|FG001|Overall Study|Lost to Follow-up|0|||
130695405|NCT01911429|470509015|FG002|Overall Study|Lost to Follow-up|1|||
130695406|NCT01911429|470509013|FG000|Overall Study|Protocol Violation|0|||
130695407|NCT01911429|470509014|FG001|Overall Study|Protocol Violation|0|||
130695408|NCT01911429|470509015|FG002|Overall Study|Protocol Violation|1|||
130695409|NCT01911429|470509013|FG000|Overall Study|Withdrawal by Subject|5|||
130447538|NCT02408549|469600527|FG000|Overall Study|Site closure|1|||
130447539|NCT02408549|469600527|FG000|Overall Study|Pregnancy|1|||
130447540|NCT02408549|469600527|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
130447541|NCT02408549|469600527|FG000|Overall Study|Subject moved to another place, far from site|1|||
130447542|NCT02408549|469600527|FG000|Overall Study|Study terminated at site|1|||
130447543|NCT02013687|469600528|FG000|Overall Study|Lost to Follow-up|0|||
130447544|NCT02013687|469600529|FG001|Overall Study|Lost to Follow-up|0|||
130447545|NCT02013687|469600530|FG002|Overall Study|Lost to Follow-up|1|||
130447546|NCT02013687|469600531|FG003|Overall Study|Lost to Follow-up|0|||
130447547|NCT02013687|469600528|FG000|Overall Study|Protocol Violation|0|||
130447548|NCT02013687|469600529|FG001|Overall Study|Protocol Violation|0|||
130447549|NCT02013687|469600530|FG002|Overall Study|Protocol Violation|0|||
130447550|NCT02013687|469600531|FG003|Overall Study|Protocol Violation|1|||
130447551|NCT02013687|469600528|FG000|Overall Study|Withdrawal by Subject|0|||
130447552|NCT02013687|469600529|FG001|Overall Study|Withdrawal by Subject|0|||
130447553|NCT02013687|469600530|FG002|Overall Study|Withdrawal by Subject|0|||
130447554|NCT02013687|469600531|FG003|Overall Study|Withdrawal by Subject|1|||
130447555|NCT02013687|469600528|FG000|Overall Study|Missed visits due to patient travel|0|||
130447556|NCT02013687|469600529|FG001|Overall Study|Missed visits due to patient travel|0|||
130447557|NCT02013687|469600530|FG002|Overall Study|Missed visits due to patient travel|1|||
130447558|NCT02013687|469600531|FG003|Overall Study|Missed visits due to patient travel|0|||
130447559|NCT01272011|469600532|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
130447560|NCT01272011|469600533|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
130447561|NCT01272011|469600534|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
130447562|NCT01627340|469600535|FG000|Overall Study|Adverse Event|1|||
130447563|NCT01627340|469600536|FG001|Overall Study|Adverse Event|0|||
130447564|NCT01627340|469600535|FG000|Overall Study|Lost to Follow-up|8|||
130447565|NCT01627340|469600536|FG001|Overall Study|Lost to Follow-up|4|||
130447566|NCT01627340|469600535|FG000|Overall Study|Pregnancy|1|||
130447567|NCT01627340|469600536|FG001|Overall Study|Pregnancy|0|||
130695410|NCT01911429|470509014|FG001|Overall Study|Withdrawal by Subject|5|||
130695411|NCT01911429|470509015|FG002|Overall Study|Withdrawal by Subject|4|||
130695412|NCT01911429|470509013|FG000|Overall Study|Accidental randomization|0|||
130695413|NCT01911429|470509014|FG001|Overall Study|Accidental randomization|0|||
130447568|NCT01627340|469600535|FG000|Overall Study|Withdrawal by Subject|2|||
130447569|NCT01627340|469600536|FG001|Overall Study|Withdrawal by Subject|0|||
130447570|NCT01657032|469600537|FG000|Overall Study|Lost to Follow-up|0|||
130447571|NCT01657032|469600538|FG001|Overall Study|Lost to Follow-up|7|||
130447572|NCT03633903|469600539|FG000|Overall Study|Withdrawal by Subject|1|||
130695414|NCT01911429|470509015|FG002|Overall Study|Accidental randomization|1|||
130695415|NCT01911429|470509013|FG000|Overall Study|subject left study|1|||
130695416|NCT01911429|470509014|FG001|Overall Study|subject left study|0|||
130695417|NCT01911429|470509015|FG002|Overall Study|subject left study|0|||
130447573|NCT03633903|469600540|FG001|Overall Study|Withdrawal by Subject|2|||
130695418|NCT01557751|470509021|FG000|Overall Study|Physician Decision|3|||
130695419|NCT01168856|470509028|FG000|Overall Study|Lost to Follow-up|4|||
130695420|NCT01168856|470509029|FG001|Overall Study|Lost to Follow-up|34|||
130695421|NCT01168856|470509028|FG000|Overall Study|Withdrawal by Subject|6|||
130695422|NCT01168856|470509029|FG001|Overall Study|Withdrawal by Subject|8|||
130695423|NCT01168856|470509028|FG000|Overall Study|Physician Decision|2|||
130695424|NCT01168856|470509029|FG001|Overall Study|Physician Decision|1|||
130695425|NCT01168856|470509028|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
130695426|NCT01168856|470509029|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
130695427|NCT01168856|470509028|FG000|Overall Study|Participant received anti-HCV treatment|1|||
130695428|NCT01168856|470509029|FG001|Overall Study|Participant received anti-HCV treatment|0|||
130695429|NCT01168856|470509028|FG000|Overall Study|Death|0|||
130695430|NCT01168856|470509029|FG001|Overall Study|Death|2|||
130695431|NCT01168856|470509028|FG000|Overall Study|Other|1|||
130695432|NCT01168856|470509029|FG001|Overall Study|Other|291|||
130695433|NCT01168856|470509028|FG000|Overall Study|Protocol Violation|4|||
130695434|NCT01168856|470509029|FG001|Overall Study|Protocol Violation|6|||
130695435|NCT04567329|470509034|FG000|Overall Study|Withdrawal by Subject|5|||
130695436|NCT04567329|470509035|FG001|Overall Study|Withdrawal by Subject|6|||
130695437|NCT04567329|470509034|FG000|Overall Study|Protocol Violation|2|||
130695438|NCT04567329|470509035|FG001|Overall Study|Protocol Violation|3|||
130695439|NCT04567329|470509034|FG000|Overall Study|Discontinued|2|||
130695440|NCT04567329|470509035|FG001|Overall Study|Discontinued|2|||
130695441|NCT04567329|470509034|FG000|Overall Study|Lost to Follow-up|0|||
130695442|NCT04567329|470509035|FG001|Overall Study|Lost to Follow-up|1|||
130695443|NCT04567329|470509034|FG000|Overall Study|Lack of Efficacy|0|||
130695444|NCT04567329|470509035|FG001|Overall Study|Lack of Efficacy|1|||
130695449|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
130695450|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130695451|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130695452|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695453|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695454|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695455|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
130695456|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695457|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695458|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695459|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695460|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695461|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130695462|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130695463|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695464|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130237899|NCT03314935|468834096|FG008|Phase 1|Death|3|||
130237900|NCT03314935|468834097|FG009|Phase 1|Death|0|||
130237901|NCT03314935|468834098|FG010|Phase 1|Death|0|||
130237902|NCT03314935|468834099|FG011|Phase 1|Death|0|||
130237903|NCT03314935|468834100|FG012|Phase 1|Death|0|||
130237904|NCT03314935|468834101|FG013|Phase 1|Death|0|||
130237905|NCT03314935|468834102|FG014|Phase 1|Death|0|||
130237906|NCT03314935|468834088|FG000|Phase 1|Withdrawal by Subject|2|||
130237907|NCT03314935|468834089|FG001|Phase 1|Withdrawal by Subject|1|||
130237908|NCT03314935|468834090|FG002|Phase 1|Withdrawal by Subject|1|||
130237909|NCT03314935|468834091|FG003|Phase 1|Withdrawal by Subject|2|||
130237910|NCT03314935|468834092|FG004|Phase 1|Withdrawal by Subject|1|||
130237911|NCT03314935|468834093|FG005|Phase 1|Withdrawal by Subject|0|||
130237912|NCT03314935|468834094|FG006|Phase 1|Withdrawal by Subject|1|||
130237913|NCT03314935|468834095|FG007|Phase 1|Withdrawal by Subject|0|||
130237914|NCT03314935|468834096|FG008|Phase 1|Withdrawal by Subject|1|||
130359191|NCT03001882|469286517|FG001|Overall Study|Study Drug Toxicity|5|||
130359192|NCT03001882|469286518|FG002|Overall Study|Study Drug Toxicity|0|||
130359193|NCT03001882|469286519|FG003|Overall Study|Study Drug Toxicity|37|||
130695465|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695466|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695467|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
130237915|NCT03314935|468834097|FG009|Phase 1|Withdrawal by Subject|0|||
130237916|NCT03314935|468834098|FG010|Phase 1|Withdrawal by Subject|0|||
130237917|NCT03314935|468834099|FG011|Phase 1|Withdrawal by Subject|0|||
130237918|NCT03314935|468834100|FG012|Phase 1|Withdrawal by Subject|0|||
130359194|NCT03001882|469286516|FG000|Overall Study|Disease progression|16|||
130359195|NCT03001882|469286517|FG001|Overall Study|Disease progression|14|||
130695468|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695469|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
130695470|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695471|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695472|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695473|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695474|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
130695475|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695476|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695477|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695478|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695479|NCT01559363|470509057|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695480|NCT01559363|470509058|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695481|NCT01559363|470509059|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695482|NCT01559363|470509060|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130695483|NCT01559363|470509061|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130695484|NCT01559363|470509062|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695485|NCT01559363|470509057|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695486|NCT01559363|470509058|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695487|NCT01559363|470509059|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695488|NCT01559363|470509060|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
130695489|NCT01559363|470509061|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695490|NCT01559363|470509062|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695491|NCT00672984|470509063|FG000|First Intervention|Adverse Event|5|||
130695492|NCT00672984|470509064|FG001|First Intervention|Adverse Event|0|||
130695493|NCT00672984|470509065|FG002|First Intervention|Adverse Event|0|||
130695494|NCT00672984|470509063|FG000|First Intervention|Withdrawal by Subject|1|||
130237919|NCT03314935|468834101|FG013|Phase 1|Withdrawal by Subject|0|||
130237920|NCT03314935|468834102|FG014|Phase 1|Withdrawal by Subject|0|||
130237921|NCT03314935|468834088|FG000|Phase 1|Progressive Disease|2|||
130237922|NCT03314935|468834089|FG001|Phase 1|Progressive Disease|0|||
130237923|NCT03314935|468834090|FG002|Phase 1|Progressive Disease|0|||
130237924|NCT03314935|468834091|FG003|Phase 1|Progressive Disease|1|||
130237925|NCT03314935|468834092|FG004|Phase 1|Progressive Disease|0|||
130237926|NCT03314935|468834093|FG005|Phase 1|Progressive Disease|0|||
130237927|NCT03314935|468834094|FG006|Phase 1|Progressive Disease|0|||
130237928|NCT03314935|468834095|FG007|Phase 1|Progressive Disease|0|||
130237929|NCT03314935|468834096|FG008|Phase 1|Progressive Disease|0|||
130237930|NCT03314935|468834097|FG009|Phase 1|Progressive Disease|0|||
130237931|NCT03314935|468834098|FG010|Phase 1|Progressive Disease|0|||
130695495|NCT00672984|470509064|FG001|First Intervention|Withdrawal by Subject|2|||
130237932|NCT03314935|468834099|FG011|Phase 1|Progressive Disease|0|||
130237933|NCT03314935|468834100|FG012|Phase 1|Progressive Disease|0|||
130359196|NCT03001882|469286518|FG002|Overall Study|Disease progression|1|||
130359197|NCT03001882|469286519|FG003|Overall Study|Disease progression|90|||
130359198|NCT00589290|469286520|FG000|Overall Study|Withdrawal by Subject|1|||
130359199|NCT01067976|469286521|FG000|Overall Study|Study drug never administered|20|||
130359200|NCT01067976|469286521|FG000|Overall Study|Study prematurely discontinued|2|||
130359201|NCT00566111|469286522|FG000|Overall Study|Adverse Event|0|||
130359202|NCT00566111|469286523|FG001|Overall Study|Adverse Event|2|||
130359203|NCT01554397|469286526|FG000|Overall Study|Withdrawal by Subject|1|||
130359204|NCT01554397|469286527|FG001|Overall Study|Withdrawal by Subject|0|||
130359205|NCT01554397|469286526|FG000|Overall Study|Ineligible|7|||
130359206|NCT01554397|469286527|FG001|Overall Study|Ineligible|0|||
130359207|NCT02570074|469288564|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
130359208|NCT02570074|469288565|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
130359209|NCT00004635|469288566|FG000|Period One|refused|2|||
130359210|NCT00004635|469288567|FG001|Period One|refused|1|||
130359211|NCT00004635|469288566|FG000|Period One|Withdrawal by Subject|1|||
130359212|NCT00004635|469288567|FG001|Period One|Withdrawal by Subject|1|||
130359213|NCT00004635|469288566|FG000|Period One|Protocol Violation|1|||
130359214|NCT00004635|469288567|FG001|Period One|Protocol Violation|0|||
130359215|NCT00004635|469288566|FG000|Period One|PSA did not go <5 ng/mL|1|||
130359216|NCT00004635|469288567|FG001|Period One|PSA did not go <5 ng/mL|0|||
130359217|NCT00004635|469288566|FG000|Period One|second malignancy|1|||
130359218|NCT00004635|469288567|FG001|Period One|second malignancy|0|||
130359219|NCT00004635|469288566|FG000|Period One|progressed|0|||
130359220|NCT00004635|469288567|FG001|Period One|progressed|2|||
130237934|NCT03314935|468834101|FG013|Phase 1|Progressive Disease|0|||
130359221|NCT00004635|469288566|FG000|Period One|health problem|0|||
130359222|NCT00004635|469288567|FG001|Period One|health problem|1|||
130359223|NCT00004635|469288566|FG000|Period One|discrepancy in data entry|0|||
130359224|NCT00004635|469288567|FG001|Period One|discrepancy in data entry|1|||
130359225|NCT00004635|469288566|FG000|Period Two|progression|2|||
130237935|NCT03314935|468834102|FG014|Phase 1|Progressive Disease|0|||
130237936|NCT03314935|468834088|FG000|Phase 1|Study Terminated by Sponsor|0|||
130237937|NCT03314935|468834089|FG001|Phase 1|Study Terminated by Sponsor|1|||
130237938|NCT03314935|468834090|FG002|Phase 1|Study Terminated by Sponsor|0|||
130237939|NCT03314935|468834091|FG003|Phase 1|Study Terminated by Sponsor|0|||
130237940|NCT03314935|468834092|FG004|Phase 1|Study Terminated by Sponsor|0|||
130237941|NCT03314935|468834093|FG005|Phase 1|Study Terminated by Sponsor|0|||
130237942|NCT03314935|468834094|FG006|Phase 1|Study Terminated by Sponsor|0|||
130237943|NCT03314935|468834095|FG007|Phase 1|Study Terminated by Sponsor|0|||
130237944|NCT03314935|468834096|FG008|Phase 1|Study Terminated by Sponsor|1|||
130237945|NCT03314935|468834097|FG009|Phase 1|Study Terminated by Sponsor|0|||
130237946|NCT03314935|468834098|FG010|Phase 1|Study Terminated by Sponsor|0|||
130237947|NCT03314935|468834099|FG011|Phase 1|Study Terminated by Sponsor|0|||
130237948|NCT03314935|468834100|FG012|Phase 1|Study Terminated by Sponsor|0|||
130237949|NCT03314935|468834101|FG013|Phase 1|Study Terminated by Sponsor|0|||
130237950|NCT03314935|468834102|FG014|Phase 1|Study Terminated by Sponsor|0|||
130237951|NCT03314935|468834088|FG000|Phase 1|"Captured as Other in Database"|0|||
130237952|NCT03314935|468834089|FG001|Phase 1|"Captured as Other in Database"|2|||
130237953|NCT03314935|468834090|FG002|Phase 1|"Captured as Other in Database"|0|||
130237954|NCT03314935|468834091|FG003|Phase 1|"Captured as Other in Database"|0|||
130237955|NCT03314935|468834092|FG004|Phase 1|"Captured as Other in Database"|0|||
130237956|NCT03314935|468834093|FG005|Phase 1|"Captured as Other in Database"|0|||
130237957|NCT03314935|468834094|FG006|Phase 1|"Captured as Other in Database"|1|||
130237958|NCT03314935|468834095|FG007|Phase 1|"Captured as Other in Database"|1|||
130237959|NCT03314935|468834096|FG008|Phase 1|"Captured as Other in Database"|1|||
130237960|NCT03314935|468834097|FG009|Phase 1|"Captured as Other in Database"|0|||
130237961|NCT03314935|468834098|FG010|Phase 1|"Captured as Other in Database"|0|||
130359226|NCT00004635|469288567|FG001|Period Two|progression|3|||
130359227|NCT00004635|469288566|FG000|Period Two|Adverse Event|1|||
130359228|NCT00004635|469288567|FG001|Period Two|Adverse Event|0|||
130359229|NCT00004635|469288566|FG000|Period Two|refused|0|||
130359230|NCT00004635|469288567|FG001|Period Two|refused|2|||
130359231|NCT00004635|469288566|FG000|Period Two|health problem|1|||
130359232|NCT00004635|469288567|FG001|Period Two|health problem|1|||
130359233|NCT00004635|469288566|FG000|Period Two|travel issues|0|||
130359234|NCT00004635|469288567|FG001|Period Two|travel issues|1|||
130359235|NCT00004635|469288566|FG000|Period Two|secondary malignancy|1|||
130359236|NCT00004635|469288567|FG001|Period Two|secondary malignancy|1|||
130359237|NCT00004635|469288566|FG000|Period Two|Lost to Follow-up|1|||
130359238|NCT00004635|469288567|FG001|Period Two|Lost to Follow-up|0|||
130359239|NCT00004635|469288566|FG000|Period Two|discrepancy in data entry|0|||
130359240|NCT00004635|469288567|FG001|Period Two|discrepancy in data entry|1|||
130359241|NCT03633617|469288568|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
130359242|NCT03633617|469288569|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
130359243|NCT03633617|469288570|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359244|NCT03633617|469288571|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359245|NCT03633617|469288572|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359246|NCT03633617|469288573|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359247|NCT03633617|469288574|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359248|NCT03633617|469288575|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359249|NCT03633617|469288576|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359250|NCT03633617|469288577|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359251|NCT03633617|469288578|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130359252|NCT03633617|469288568|FG000|Part A|Unconfirmed early termination visit|1|||
130359253|NCT03633617|469288569|FG001|Part A|Unconfirmed early termination visit|0|||
130359254|NCT03633617|469288570|FG002|Part A|Unconfirmed early termination visit|0|||
130359255|NCT03633617|469288571|FG003|Part A|Unconfirmed early termination visit|0|||
130359256|NCT03633617|469288572|FG004|Part A|Unconfirmed early termination visit|0|||
130359257|NCT03633617|469288573|FG005|Part A|Unconfirmed early termination visit|0|||
130359258|NCT03633617|469288574|FG006|Part A|Unconfirmed early termination visit|0|||
130359259|NCT03633617|469288575|FG007|Part A|Unconfirmed early termination visit|0|||
130359260|NCT03633617|469288576|FG008|Part A|Unconfirmed early termination visit|0|||
130359261|NCT03633617|469288577|FG009|Part A|Unconfirmed early termination visit|0|||
130359262|NCT03633617|469288578|FG010|Part A|Unconfirmed early termination visit|0|||
130359263|NCT03633617|469288568|FG000|Part A|Adverse Event|0|||
130359264|NCT03633617|469288569|FG001|Part A|Adverse Event|1|||
130359265|NCT03633617|469288570|FG002|Part A|Adverse Event|0|||
130359266|NCT03633617|469288571|FG003|Part A|Adverse Event|0|||
130237962|NCT03314935|468834099|FG011|Phase 1|"Captured as Other in Database"|0|||
130237963|NCT03314935|468834100|FG012|Phase 1|"Captured as Other in Database"|0|||
130237964|NCT03314935|468834101|FG013|Phase 1|"Captured as Other in Database"|0|||
130237965|NCT03314935|468834102|FG014|Phase 1|"Captured as Other in Database"|0|||
130237966|NCT03314935|468834088|FG000|Phase 1|Lost to Follow-up|0|||
130237967|NCT03314935|468834089|FG001|Phase 1|Lost to Follow-up|0|||
130695496|NCT00672984|470509065|FG002|First Intervention|Withdrawal by Subject|2|||
130695497|NCT00672984|470509063|FG000|First Intervention|Sponsor decision|3|||
130695498|NCT00672984|470509064|FG001|First Intervention|Sponsor decision|0|||
130695499|NCT00672984|470509065|FG002|First Intervention|Sponsor decision|0|||
130695500|NCT00672984|470509063|FG000|Second Intervention|Non-compliance with facility policies|0|||
130695501|NCT00672984|470509064|FG001|Second Intervention|Non-compliance with facility policies|2|||
130695502|NCT00672984|470509065|FG002|Second Intervention|Non-compliance with facility policies|0|||
130695503|NCT00672984|470509063|FG000|Second Intervention|Withdrawal by Subject|0|||
130237968|NCT03314935|468834090|FG002|Phase 1|Lost to Follow-up|0|||
130237969|NCT03314935|468834091|FG003|Phase 1|Lost to Follow-up|0|||
130237970|NCT03314935|468834092|FG004|Phase 1|Lost to Follow-up|0|||
130237971|NCT03314935|468834093|FG005|Phase 1|Lost to Follow-up|0|||
130237972|NCT03314935|468834094|FG006|Phase 1|Lost to Follow-up|0|||
130237973|NCT03314935|468834095|FG007|Phase 1|Lost to Follow-up|0|||
130237974|NCT03314935|468834096|FG008|Phase 1|Lost to Follow-up|1|||
130237975|NCT03314935|468834097|FG009|Phase 1|Lost to Follow-up|0|||
130237976|NCT03314935|468834098|FG010|Phase 1|Lost to Follow-up|0|||
130237977|NCT03314935|468834099|FG011|Phase 1|Lost to Follow-up|0|||
130237978|NCT03314935|468834100|FG012|Phase 1|Lost to Follow-up|0|||
130237979|NCT03314935|468834101|FG013|Phase 1|Lost to Follow-up|0|||
130237980|NCT03314935|468834102|FG014|Phase 1|Lost to Follow-up|0|||
130237981|NCT03314935|468834088|FG000|Phase 2|Death|0|||
130237982|NCT03314935|468834089|FG001|Phase 2|Death|0|||
130237983|NCT03314935|468834090|FG002|Phase 2|Death|0|||
130237984|NCT03314935|468834091|FG003|Phase 2|Death|0|||
130237985|NCT03314935|468834092|FG004|Phase 2|Death|0|||
130237986|NCT03314935|468834093|FG005|Phase 2|Death|0|||
130237987|NCT03314935|468834094|FG006|Phase 2|Death|0|||
130237988|NCT03314935|468834095|FG007|Phase 2|Death|0|||
130237989|NCT03314935|468834096|FG008|Phase 2|Death|0|||
130237990|NCT03314935|468834097|FG009|Phase 2|Death|5|||
130237991|NCT03314935|468834098|FG010|Phase 2|Death|20|||
130237992|NCT03314935|468834099|FG011|Phase 2|Death|6|||
130237993|NCT03314935|468834100|FG012|Phase 2|Death|7|||
130237994|NCT03314935|468834101|FG013|Phase 2|Death|6|||
130237995|NCT03314935|468834102|FG014|Phase 2|Death|17|||
130237996|NCT03314935|468834088|FG000|Phase 2|Withdrawal by Subject|0|||
130237997|NCT03314935|468834089|FG001|Phase 2|Withdrawal by Subject|0|||
130237998|NCT03314935|468834090|FG002|Phase 2|Withdrawal by Subject|0|||
130237999|NCT03314935|468834091|FG003|Phase 2|Withdrawal by Subject|0|||
130238000|NCT03314935|468834092|FG004|Phase 2|Withdrawal by Subject|0|||
130238001|NCT03314935|468834093|FG005|Phase 2|Withdrawal by Subject|0|||
130238002|NCT03314935|468834094|FG006|Phase 2|Withdrawal by Subject|0|||
130238003|NCT03314935|468834095|FG007|Phase 2|Withdrawal by Subject|0|||
130238004|NCT03314935|468834096|FG008|Phase 2|Withdrawal by Subject|0|||
130238005|NCT03314935|468834097|FG009|Phase 2|Withdrawal by Subject|1|||
130238006|NCT03314935|468834098|FG010|Phase 2|Withdrawal by Subject|4|||
130238007|NCT03314935|468834099|FG011|Phase 2|Withdrawal by Subject|0|||
130238008|NCT03314935|468834100|FG012|Phase 2|Withdrawal by Subject|1|||
130238009|NCT03314935|468834101|FG013|Phase 2|Withdrawal by Subject|0|||
130238010|NCT03314935|468834102|FG014|Phase 2|Withdrawal by Subject|1|||
130238011|NCT03314935|468834088|FG000|Phase 2|Progressive Disease|0|||
130238012|NCT03314935|468834089|FG001|Phase 2|Progressive Disease|0|||
130238013|NCT03314935|468834090|FG002|Phase 2|Progressive Disease|0|||
130238014|NCT03314935|468834091|FG003|Phase 2|Progressive Disease|0|||
130238015|NCT03314935|468834092|FG004|Phase 2|Progressive Disease|0|||
130238016|NCT03314935|468834093|FG005|Phase 2|Progressive Disease|0|||
130238017|NCT03314935|468834094|FG006|Phase 2|Progressive Disease|0|||
130238018|NCT03314935|468834095|FG007|Phase 2|Progressive Disease|0|||
130695504|NCT00672984|470509064|FG001|Second Intervention|Withdrawal by Subject|3|||
130238019|NCT03314935|468834096|FG008|Phase 2|Progressive Disease|0|||
130238020|NCT03314935|468834097|FG009|Phase 2|Progressive Disease|1|||
130238021|NCT03314935|468834098|FG010|Phase 2|Progressive Disease|1|||
130238022|NCT03314935|468834099|FG011|Phase 2|Progressive Disease|1|||
130238023|NCT03314935|468834100|FG012|Phase 2|Progressive Disease|2|||
130238024|NCT03314935|468834101|FG013|Phase 2|Progressive Disease|0|||
130238025|NCT03314935|468834102|FG014|Phase 2|Progressive Disease|1|||
130238026|NCT03314935|468834088|FG000|Phase 2|Study Terminated by Sponsor|0|||
130238027|NCT03314935|468834089|FG001|Phase 2|Study Terminated by Sponsor|0|||
130238028|NCT03314935|468834090|FG002|Phase 2|Study Terminated by Sponsor|0|||
130238029|NCT03314935|468834091|FG003|Phase 2|Study Terminated by Sponsor|0|||
130238030|NCT03314935|468834092|FG004|Phase 2|Study Terminated by Sponsor|0|||
130238031|NCT03314935|468834093|FG005|Phase 2|Study Terminated by Sponsor|0|||
130238032|NCT03314935|468834094|FG006|Phase 2|Study Terminated by Sponsor|0|||
130238033|NCT03314935|468834095|FG007|Phase 2|Study Terminated by Sponsor|0|||
130238034|NCT03314935|468834096|FG008|Phase 2|Study Terminated by Sponsor|0|||
130238035|NCT03314935|468834097|FG009|Phase 2|Study Terminated by Sponsor|0|||
130695505|NCT00672984|470509065|FG002|Second Intervention|Withdrawal by Subject|0|||
130238036|NCT03314935|468834098|FG010|Phase 2|Study Terminated by Sponsor|7|||
130238037|NCT03314935|468834099|FG011|Phase 2|Study Terminated by Sponsor|2|||
130238038|NCT03314935|468834100|FG012|Phase 2|Study Terminated by Sponsor|1|||
130238039|NCT03314935|468834101|FG013|Phase 2|Study Terminated by Sponsor|4|||
130238040|NCT03314935|468834102|FG014|Phase 2|Study Terminated by Sponsor|4|||
130238041|NCT03314935|468834088|FG000|Phase 2|Lost to Follow-up|0|||
130238042|NCT03314935|468834089|FG001|Phase 2|Lost to Follow-up|0|||
130238043|NCT03314935|468834090|FG002|Phase 2|Lost to Follow-up|0|||
130238044|NCT03314935|468834091|FG003|Phase 2|Lost to Follow-up|0|||
130238045|NCT03314935|468834092|FG004|Phase 2|Lost to Follow-up|0|||
130238046|NCT03314935|468834093|FG005|Phase 2|Lost to Follow-up|0|||
130238047|NCT03314935|468834094|FG006|Phase 2|Lost to Follow-up|0|||
130238048|NCT03314935|468834095|FG007|Phase 2|Lost to Follow-up|0|||
130238049|NCT03314935|468834096|FG008|Phase 2|Lost to Follow-up|0|||
130238050|NCT03314935|468834097|FG009|Phase 2|Lost to Follow-up|1|||
130238051|NCT03314935|468834098|FG010|Phase 2|Lost to Follow-up|0|||
130238052|NCT03314935|468834099|FG011|Phase 2|Lost to Follow-up|0|||
130238053|NCT03314935|468834100|FG012|Phase 2|Lost to Follow-up|0|||
130238054|NCT03314935|468834101|FG013|Phase 2|Lost to Follow-up|0|||
130238055|NCT03314935|468834102|FG014|Phase 2|Lost to Follow-up|1|||
130238056|NCT03314935|468834088|FG000|Phase 2|Physician Decision|0|||
130238057|NCT03314935|468834089|FG001|Phase 2|Physician Decision|0|||
130238058|NCT03314935|468834090|FG002|Phase 2|Physician Decision|0|||
130238059|NCT03314935|468834091|FG003|Phase 2|Physician Decision|0|||
130238060|NCT03314935|468834092|FG004|Phase 2|Physician Decision|0|||
130238061|NCT03314935|468834093|FG005|Phase 2|Physician Decision|0|||
130238062|NCT03314935|468834094|FG006|Phase 2|Physician Decision|0|||
130238063|NCT03314935|468834095|FG007|Phase 2|Physician Decision|0|||
130238064|NCT03314935|468834096|FG008|Phase 2|Physician Decision|0|||
130238065|NCT03314935|468834097|FG009|Phase 2|Physician Decision|0|||
130238066|NCT03314935|468834098|FG010|Phase 2|Physician Decision|1|||
130238067|NCT03314935|468834099|FG011|Phase 2|Physician Decision|0|||
130238068|NCT03314935|468834100|FG012|Phase 2|Physician Decision|0|||
130238069|NCT03314935|468834101|FG013|Phase 2|Physician Decision|0|||
130238070|NCT03314935|468834102|FG014|Phase 2|Physician Decision|0|||
130238071|NCT05845619|468834103|FG000|Overall Study|duplicate enrollment|2|||
130238072|NCT05845619|468834104|FG001|Overall Study|duplicate enrollment|2|||
130238073|NCT05845619|468834105|FG002|Overall Study|duplicate enrollment|1|||
130238074|NCT03636477|468834109|FG000|Overall Study|Adverse Event|0|||
130238075|NCT03636477|468834110|FG001|Overall Study|Adverse Event|0|||
130238076|NCT03636477|468834111|FG002|Overall Study|Adverse Event|1|||
130238077|NCT03621592|468834112|FG000|Overall Study|Lost to Follow-up|1|||
130238078|NCT03621592|468834113|FG001|Overall Study|Lost to Follow-up|0|||
130238079|NCT03621592|468834112|FG000|Overall Study|Lack of Improvement|1|||
130238080|NCT03621592|468834113|FG001|Overall Study|Lack of Improvement|0|||
130238081|NCT03621592|468834112|FG000|Overall Study|Preference to receive wound care closer to home|1|||
130238082|NCT03621592|468834113|FG001|Overall Study|Preference to receive wound care closer to home|0|||
130238083|NCT03621592|468834112|FG000|Overall Study|Lack of healing|0|||
130238084|NCT03621592|468834113|FG001|Overall Study|Lack of healing|2|||
130238085|NCT02382380|468834115|FG000|Overall Study|Withdrawal by Subject|2|||
130238086|NCT02382380|468834116|FG001|Overall Study|Withdrawal by Subject|2|||
130238087|NCT02382380|468834115|FG000|Overall Study|Lost to Follow-up|0|||
130238088|NCT02382380|468834116|FG001|Overall Study|Lost to Follow-up|1|||
130238089|NCT05168800|468834117|FG000|Time 1 Survey|Did not start T1 survey|182|||
130238090|NCT05168800|468834118|FG001|Time 1 Survey|Did not start T1 survey|150|||
130238091|NCT05168800|468834119|FG002|Time 1 Survey|Did not start T1 survey|140|||
130238092|NCT05168800|468834117|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
130238093|NCT05168800|468834118|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
130359267|NCT03633617|469288572|FG004|Part A|Adverse Event|0|||
130359268|NCT03633617|469288573|FG005|Part A|Adverse Event|0|||
130359269|NCT03633617|469288574|FG006|Part A|Adverse Event|0|||
130359270|NCT03633617|469288575|FG007|Part A|Adverse Event|0|||
130359271|NCT03633617|469288576|FG008|Part A|Adverse Event|0|||
130359272|NCT03633617|469288577|FG009|Part A|Adverse Event|0|||
130359273|NCT03633617|469288578|FG010|Part A|Adverse Event|0|||
130559413|NCT01621542|470016491|FG001|Overall Study|Withdrawal by Subject|0|||
130238094|NCT05168800|468834119|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
130238095|NCT05168800|468834117|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130238096|NCT05168800|468834118|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
130238097|NCT05168800|468834119|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130238098|NCT05168800|468834117|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
130238099|NCT05168800|468834118|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
130238100|NCT05168800|468834119|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
130238101|NCT05168800|468834117|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
130238102|NCT05168800|468834118|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
130238103|NCT05168800|468834119|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
130238104|NCT05168800|468834117|FG000|Time 1 Survey|Withdrawal by Subject|6|||
130238105|NCT05168800|468834118|FG001|Time 1 Survey|Withdrawal by Subject|3|||
130238106|NCT05168800|468834119|FG002|Time 1 Survey|Withdrawal by Subject|2|||
130359274|NCT03633617|469288568|FG000|Part A|Pregnancy|1|||
130359275|NCT03633617|469288569|FG001|Part A|Pregnancy|0|||
130238107|NCT05168800|468834117|FG000|Time 2 Survey|Already excluded at Time 1|228|||
130238108|NCT05168800|468834118|FG001|Time 2 Survey|Already excluded at Time 1|202|||
130238109|NCT05168800|468834119|FG002|Time 2 Survey|Already excluded at Time 1|173|||
130238110|NCT05168800|468834117|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
130238111|NCT05168800|468834118|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
130238112|NCT05168800|468834119|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
130238113|NCT05168800|468834117|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
130238114|NCT05168800|468834118|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
130238115|NCT05168800|468834119|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
130238116|NCT05168800|468834117|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
130447574|NCT03633903|469600539|FG000|Overall Study|Lost to Follow-up|5|||
130447575|NCT03633903|469600540|FG001|Overall Study|Lost to Follow-up|5|||
130447576|NCT05968482|469600541|FG000|First Crossover Period|Withdrawal by Subject|0|||
130447577|NCT05968482|469600542|FG001|First Crossover Period|Withdrawal by Subject|0|||
130447578|NCT05968482|469600543|FG002|First Crossover Period|Withdrawal by Subject|1|||
130447579|NCT05968482|469600544|FG003|First Crossover Period|Withdrawal by Subject|0|||
130695506|NCT00672984|470509063|FG000|Second Intervention|Protocol Violation|0|||
130447580|NCT05968482|469600545|FG004|First Crossover Period|Withdrawal by Subject|0|||
130447581|NCT05968482|469600546|FG005|First Crossover Period|Withdrawal by Subject|0|||
130447582|NCT05968482|469600541|FG000|First Crossover Period|Adverse Event|0|||
130447583|NCT05968482|469600542|FG001|First Crossover Period|Adverse Event|0|||
130447584|NCT05968482|469600543|FG002|First Crossover Period|Adverse Event|0|||
130447585|NCT05968482|469600544|FG003|First Crossover Period|Adverse Event|0|||
130447586|NCT05968482|469600545|FG004|First Crossover Period|Adverse Event|0|||
130447587|NCT05968482|469600546|FG005|First Crossover Period|Adverse Event|1|||
130447588|NCT05968482|469600541|FG000|Second Crossover Period|Withdrawal by Subject|0|||
130447589|NCT05968482|469600542|FG001|Second Crossover Period|Withdrawal by Subject|0|||
130447590|NCT05968482|469600543|FG002|Second Crossover Period|Withdrawal by Subject|0|||
130447591|NCT05968482|469600544|FG003|Second Crossover Period|Withdrawal by Subject|0|||
130447592|NCT05968482|469600545|FG004|Second Crossover Period|Withdrawal by Subject|1|||
130447593|NCT05968482|469600546|FG005|Second Crossover Period|Withdrawal by Subject|0|||
130447594|NCT05968482|469600541|FG000|Third Crossover Period|Adverse Event|0|||
130447595|NCT05968482|469600542|FG001|Third Crossover Period|Adverse Event|0|||
130447596|NCT05968482|469600543|FG002|Third Crossover Period|Adverse Event|0|||
130447597|NCT05968482|469600544|FG003|Third Crossover Period|Adverse Event|0|||
130447598|NCT05968482|469600545|FG004|Third Crossover Period|Adverse Event|1|||
130447599|NCT05968482|469600546|FG005|Third Crossover Period|Adverse Event|0|||
130447600|NCT05968482|469600541|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
130447601|NCT05968482|469600542|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
130447602|NCT05968482|469600543|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
130447603|NCT05968482|469600544|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
130447604|NCT05968482|469600545|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
130447605|NCT05968482|469600546|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
130447606|NCT00761774|469600548|FG000|Overall Study|Adverse Event|17|||
130695507|NCT00672984|470509064|FG001|Second Intervention|Protocol Violation|1|||
130695508|NCT00672984|470509065|FG002|Second Intervention|Protocol Violation|1|||
130695509|NCT00672984|470509063|FG000|Third Intervention|Adverse Event|1|||
130695510|NCT00672984|470509064|FG001|Third Intervention|Adverse Event|0|||
130695511|NCT00672984|470509065|FG002|Third Intervention|Adverse Event|1|||
130695512|NCT04060251|470509066|FG000|Overall Study|Study terminated due to low enrollment.|7|||
130695513|NCT04060251|470509067|FG001|Overall Study|Study terminated due to low enrollment.|5|||
130695514|NCT04060251|470509068|FG002|Overall Study|Study terminated due to low enrollment.|7|||
130695515|NCT04060251|470509066|FG000|Overall Study|Adverse Event|1|||
130695516|NCT04060251|470509067|FG001|Overall Study|Adverse Event|1|||
130695517|NCT04060251|470509068|FG002|Overall Study|Adverse Event|0|||
130695518|NCT00487435|470509069|FG000|Overall Study|Adverse Event|146|||
130695519|NCT00487435|470509069|FG000|Overall Study|Death|2|||
130695520|NCT00487435|470509069|FG000|Overall Study|Lack of Efficacy|33|||
130695521|NCT00487435|470509069|FG000|Overall Study|Lost to Follow-up|54|||
130695522|NCT00487435|470509069|FG000|Overall Study|Pregnancy|2|||
130447607|NCT00761774|469600548|FG000|Overall Study|Lack of Efficacy|37|||
130695523|NCT00487435|470509069|FG000|Overall Study|Withdrawal by Subject|132|||
130695524|NCT00487435|470509069|FG000|Overall Study|Resolution Of Pain|1|||
130447608|NCT00761774|469600548|FG000|Overall Study|Lost to Follow-up|2|||
130447609|NCT00761774|469600548|FG000|Overall Study|Withdrawal by Subject|9|||
130447610|NCT00761774|469600548|FG000|Overall Study|Non-compliance|4|||
130695525|NCT00487435|470509069|FG000|Overall Study|Study Medication Non-Compliant|32|||
130238117|NCT05168800|468834118|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130238118|NCT05168800|468834119|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130238119|NCT05168800|468834117|FG000|Time 2 Survey|Withdrawal by Subject|1|||
130447611|NCT00761774|469600548|FG000|Overall Study|End of study|2|||
130447612|NCT00761774|469600548|FG000|Overall Study|Reclassification of seizures|1|||
130695526|NCT00487435|470509069|FG000|Overall Study|Other|83|||
130238120|NCT05168800|468834118|FG001|Time 2 Survey|Withdrawal by Subject|0|||
130238121|NCT05168800|468834119|FG002|Time 2 Survey|Withdrawal by Subject|1|||
130238122|NCT05168800|468834117|FG000|Time 3 Survey|Already excluded at Time 1|228|||
130238123|NCT05168800|468834118|FG001|Time 3 Survey|Already excluded at Time 1|200|||
130238124|NCT05168800|468834119|FG002|Time 3 Survey|Already excluded at Time 1|173|||
130238125|NCT05168800|468834117|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
130238126|NCT05168800|468834118|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
130238127|NCT05168800|468834119|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
130238128|NCT05168800|468834117|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
130238129|NCT05168800|468834118|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
130238130|NCT05168800|468834119|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
130238131|NCT05168800|468834117|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130238132|NCT05168800|468834118|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
130238133|NCT05168800|468834119|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130238134|NCT04556097|468834120|FG000|Overall Study|Death|0|||
130238135|NCT04556097|468834121|FG001|Overall Study|Death|5|||
130238136|NCT04556097|468834122|FG002|Overall Study|Death|0|||
130238137|NCT04556097|468834123|FG003|Overall Study|Death|0|||
130238138|NCT04556097|468834120|FG000|Overall Study|No caregiver|43|||
130238139|NCT04556097|468834121|FG001|Overall Study|No caregiver|53|||
130238140|NCT04556097|468834122|FG002|Overall Study|No caregiver|0|||
130238141|NCT04556097|468834123|FG003|Overall Study|No caregiver|0|||
130238142|NCT04556097|468834120|FG000|Overall Study|Ineligible, SNF|2|||
130238143|NCT04556097|468834121|FG001|Overall Study|Ineligible, SNF|2|||
130238144|NCT04556097|468834122|FG002|Overall Study|Ineligible, SNF|0|||
130238145|NCT04556097|468834123|FG003|Overall Study|Ineligible, SNF|0|||
130238146|NCT04556097|468834120|FG000|Overall Study|Ineligible, health|3|||
130238147|NCT04556097|468834121|FG001|Overall Study|Ineligible, health|4|||
130238148|NCT04556097|468834122|FG002|Overall Study|Ineligible, health|0|||
130238149|NCT04556097|468834123|FG003|Overall Study|Ineligible, health|0|||
130238150|NCT04556097|468834120|FG000|Overall Study|Ineligible, language|0|||
130238151|NCT04556097|468834121|FG001|Overall Study|Ineligible, language|1|||
130238152|NCT04556097|468834122|FG002|Overall Study|Ineligible, language|0|||
130238153|NCT04556097|468834123|FG003|Overall Study|Ineligible, language|0|||
130238154|NCT04556097|468834120|FG000|Overall Study|Ineligible, no longer in care management|0|||
130238155|NCT04556097|468834121|FG001|Overall Study|Ineligible, no longer in care management|2|||
130238156|NCT04556097|468834122|FG002|Overall Study|Ineligible, no longer in care management|1|||
130238157|NCT04556097|468834123|FG003|Overall Study|Ineligible, no longer in care management|0|||
130238158|NCT04556097|468834120|FG000|Overall Study|No dementia|13|||
130238159|NCT04556097|468834121|FG001|Overall Study|No dementia|3|||
130238160|NCT04556097|468834122|FG002|Overall Study|No dementia|0|||
130238161|NCT04556097|468834123|FG003|Overall Study|No dementia|0|||
130238162|NCT04556097|468834120|FG000|Overall Study|Missing identifier|2|||
130238163|NCT04556097|468834121|FG001|Overall Study|Missing identifier|4|||
130238164|NCT04556097|468834122|FG002|Overall Study|Missing identifier|0|||
130238165|NCT04556097|468834123|FG003|Overall Study|Missing identifier|0|||
130238166|NCT04556097|468834120|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
130238167|NCT04556097|468834121|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
130238168|NCT04556097|468834122|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130238169|NCT04556097|468834123|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130238170|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
130238171|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
130238172|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130238173|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130238174|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
130238175|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
130238176|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238177|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130359276|NCT03633617|469288570|FG002|Part A|Pregnancy|0|||
130359277|NCT03633617|469288571|FG003|Part A|Pregnancy|0|||
130359278|NCT03633617|469288572|FG004|Part A|Pregnancy|0|||
130359279|NCT03633617|469288573|FG005|Part A|Pregnancy|0|||
130238178|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
130238179|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
130238180|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130359280|NCT03633617|469288574|FG006|Part A|Pregnancy|0|||
130359281|NCT03633617|469288575|FG007|Part A|Pregnancy|0|||
130359282|NCT03633617|469288576|FG008|Part A|Pregnancy|0|||
130359283|NCT03633617|469288577|FG009|Part A|Pregnancy|0|||
130238181|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130238182|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
130238183|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
130238184|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130359284|NCT03633617|469288578|FG010|Part A|Pregnancy|0|||
130359285|NCT03633617|469288568|FG000|Part A|Withdrawal by Subject|0|||
130359286|NCT03633617|469288569|FG001|Part A|Withdrawal by Subject|1|||
130238185|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130238186|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238187|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
130238188|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238189|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238190|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238191|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
130238192|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238193|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238194|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130238195|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130238196|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130238197|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130238198|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
130238199|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
130238200|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
130238201|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
130447613|NCT00761774|469600548|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
130447614|NCT00761774|469600548|FG000|Overall Study|Sponsor decision|1|||
130447615|NCT00761774|469600548|FG000|Overall Study|Investigator clinical judgement|1|||
130447616|NCT00761774|469600548|FG000|Overall Study|Patient moved out of study area|1|||
130447617|NCT00761774|469600548|FG000|Overall Study|Coordinator leaving site|1|||
130447618|NCT00761774|469600548|FG000|Overall Study|Subject IP non-compliance|1|||
130447619|NCT00761774|469600548|FG000|Overall Study|IP stopped by hospital physician|1|||
130447620|NCT01925170|469600549|FG000|Overall Study|Unverified cancer status|53|||
130447621|NCT01077024|469600552|FG000|Overall Study|Lost to Follow-up|20|||
130447622|NCT01077024|469600553|FG001|Overall Study|Lost to Follow-up|14|||
130447623|NCT01077024|469600552|FG000|Overall Study|Withdrawal by Subject|0|||
130447624|NCT01077024|469600553|FG001|Overall Study|Withdrawal by Subject|2|||
130447625|NCT01077024|469600552|FG000|Overall Study|Incarcerated|7|||
130447626|NCT01077024|469600553|FG001|Overall Study|Incarcerated|8|||
130447627|NCT01077024|469600552|FG000|Overall Study|Other|4|||
130447628|NCT01077024|469600553|FG001|Overall Study|Other|4|||
130447629|NCT03379233|469600554|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
130447630|NCT03379233|469600555|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
130447631|NCT01603121|469600556|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
130447632|NCT01603121|469600557|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
130447633|NCT02300311|469600560|FG000|Overall Study|Other than the reason specified|1|||
130447634|NCT02300311|469600561|FG001|Overall Study|Other than the reason specified|0|||
130447635|NCT02300311|469600560|FG000|Overall Study|Refused to continue taking medication|18|||
130447636|NCT02300311|469600561|FG001|Overall Study|Refused to continue taking medication|0|||
130447637|NCT00419003|469600562|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
130447638|NCT00419003|469600563|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
130447639|NCT00419003|469600562|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
130447640|NCT00419003|469600563|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
130447641|NCT02531438|469600564|FG000|Overall Study|Adverse Event|7|||
130447642|NCT02531438|469600565|FG001|Overall Study|Adverse Event|9|||
130447643|NCT02531438|469600564|FG000|Overall Study|Lost to Follow-up|0|||
130447644|NCT02531438|469600565|FG001|Overall Study|Lost to Follow-up|3|||
130447645|NCT02531438|469600564|FG000|Overall Study|Withdrawal by Subject|7|||
130447646|NCT02531438|469600565|FG001|Overall Study|Withdrawal by Subject|8|||
130447647|NCT02531438|469600564|FG000|Overall Study|Physician Decision|0|||
130447648|NCT02531438|469600565|FG001|Overall Study|Physician Decision|1|||
130447649|NCT02531438|469600564|FG000|Overall Study|Death|6|||
130447650|NCT02531438|469600565|FG001|Overall Study|Death|3|||
130447651|NCT02531438|469600564|FG000|Overall Study|Randomized, but Not Treated|4|||
130447652|NCT02531438|469600565|FG001|Overall Study|Randomized, but Not Treated|0|||
130447653|NCT02531438|469600564|FG000|Overall Study|Missed EOT/PTE Visit|5|||
130447654|NCT02531438|469600565|FG001|Overall Study|Missed EOT/PTE Visit|2|||
130447655|NCT02531438|469600564|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
130238202|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130238203|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130238204|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
130238205|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
130238206|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130447656|NCT02531438|469600565|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
130447657|NCT00772928|469600566|FG000|Overall Study|Lost to Follow-up|9|||
130447658|NCT00772928|469600567|FG001|Overall Study|Lost to Follow-up|6|||
130447659|NCT00772928|469600566|FG000|Overall Study|Protocol Violation|10|||
130447660|NCT00772928|469600567|FG001|Overall Study|Protocol Violation|12|||
130447661|NCT00772928|469600566|FG000|Overall Study|Withdrawal by Subject|25|||
130447662|NCT00772928|469600567|FG001|Overall Study|Withdrawal by Subject|22|||
130447663|NCT00772928|469600566|FG000|Overall Study|Did not receive vaccine|0|||
130447664|NCT00772928|469600567|FG001|Overall Study|Did not receive vaccine|1|||
130447665|NCT00801242|469600568|FG000|Overall Study|Adverse Event|10|||
130447666|NCT00801242|469600568|FG000|Overall Study|Withdrawal by Subject|13|||
130447667|NCT00801242|469600568|FG000|Overall Study|Protocol Violation|5|||
130447668|NCT00801242|469600568|FG000|Overall Study|Physician Decision|3|||
130447669|NCT00801242|469600568|FG000|Overall Study|Lost to Follow-up|1|||
130447670|NCT00801242|469600568|FG000|Overall Study|Miscellaneous reasons|20|||
130447671|NCT02015195|469600569|FG000|Overall Study|Adverse Event|0|||
130447672|NCT02015195|469600570|FG001|Overall Study|Adverse Event|0|||
130447673|NCT02015195|469600571|FG002|Overall Study|Adverse Event|0|||
130447674|NCT02015195|469600572|FG003|Overall Study|Adverse Event|1|||
130447675|NCT02015195|469600573|FG004|Overall Study|Adverse Event|0|||
130447676|NCT02015195|469600574|FG005|Overall Study|Adverse Event|0|||
130447677|NCT02015195|469600575|FG006|Overall Study|Adverse Event|0|||
130238207|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130238208|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
130238209|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
130238210|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130238211|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130238212|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
130238213|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
130238214|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130238215|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130238216|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
130238217|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
130238218|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
130238219|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
130238220|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
130238221|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
130238222|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130238223|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130238224|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130238225|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130238226|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
130238227|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
130238228|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
130238229|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
130238230|NCT01970371|468836187|FG000|Overall Study|Death|8|||
130238231|NCT01970371|468836188|FG001|Overall Study|Death|13|||
130238232|NCT01970371|468836189|FG002|Overall Study|Death|12|||
130238233|NCT01970371|468836187|FG000|Overall Study|Lost to Follow-up|0|||
130238234|NCT01970371|468836188|FG001|Overall Study|Lost to Follow-up|0|||
130238235|NCT01970371|468836189|FG002|Overall Study|Lost to Follow-up|1|||
130238236|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
130238237|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
130238238|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
130238239|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
130238240|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
130238241|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
130238242|NCT04727749|468836192|FG000|Overall Study|Lost to Follow-up|10|||
130238243|NCT04727749|468836193|FG001|Overall Study|Lost to Follow-up|3|||
130238244|NCT03575364|468836197|FG000|Overall Study|Death|45|||
130238245|NCT03575364|468836197|FG000|Overall Study|Lost to Follow-up|114|||
130238246|NCT03575364|468836197|FG000|Overall Study|Withdrawal by Subject|21|||
130238247|NCT03575364|468836197|FG000|Overall Study|Physician Decision|11|||
130238248|NCT03575364|468836197|FG000|Overall Study|Subject Refused Follow-up|13|||
130238249|NCT03575364|468836197|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
130238250|NCT03575364|468836197|FG000|Overall Study|Patient moved out of the state|1|||
130238251|NCT03575364|468836197|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
130238252|NCT03575364|468836197|FG000|Overall Study|Patient is lost to follow up|1|||
130238253|NCT03575364|468836197|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
130447678|NCT01318811|469600576|FG000|Overall Study|Physician Decision|1|||
130447679|NCT01318811|469600577|FG001|Overall Study|Physician Decision|1|||
130238254|NCT02313155|468836198|FG000|Overall Study|Lost to Follow-up|0|||
130238255|NCT02313155|468836199|FG001|Overall Study|Lost to Follow-up|1|||
130238256|NCT02213926|468836200|FG000|Overall Study|Death|59|||
130238257|NCT02213926|468836200|FG000|Overall Study|Withdrawal by Subject|10|||
130238258|NCT02213926|468836200|FG000|Overall Study|study terminated by sponsor|51|||
130238259|NCT02213926|468836200|FG000|Overall Study|Lost to Follow-up|3|||
130238260|NCT02213926|468836200|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
130447680|NCT01318811|469600576|FG000|Overall Study|CRRT stopped for head CT|0|||
130447681|NCT01318811|469600577|FG001|Overall Study|CRRT stopped for head CT|1|||
130447682|NCT01318811|469600576|FG000|Overall Study|Death|0|||
130447683|NCT01318811|469600577|FG001|Overall Study|Death|1|||
130238261|NCT01697579|468836201|FG000|Base Study-Cycle 1|Adverse Event|1|||
130238262|NCT01697579|468836202|FG001|Base Study-Cycle 1|Adverse Event|0|||
130238263|NCT01697579|468836203|FG002|Base Study-Cycle 1|Adverse Event|0|||
130238264|NCT01697579|468836204|FG003|Base Study-Cycle 1|Adverse Event|0|||
130238265|NCT01697579|468836205|FG004|Base Study-Cycle 1|Adverse Event|0|||
130238266|NCT01697579|468836206|FG005|Base Study-Cycle 1|Adverse Event|0|||
130238267|NCT01697579|468836207|FG006|Base Study-Cycle 1|Adverse Event|0|||
130238268|NCT01697579|468836201|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
130238269|NCT01697579|468836202|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238270|NCT01697579|468836203|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238271|NCT01697579|468836204|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238272|NCT01697579|468836205|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130447684|NCT01318811|469600576|FG000|Overall Study|CRRT stopped for head MRI|0|||
130447685|NCT01318811|469600577|FG001|Overall Study|CRRT stopped for head MRI|1|||
130447686|NCT00811187|469600578|FG000|Overall Study|Unable to place device / procedure abort|3|||
130447687|NCT00811187|469600579|FG001|Overall Study|Unable to place device / procedure abort|3|||
130447688|NCT00994279|469600582|FG000|Overall Study|Withdrawal by Subject|2|||
130447689|NCT00994279|469600583|FG001|Overall Study|Withdrawal by Subject|2|||
130447690|NCT00994279|469600582|FG000|Overall Study|Toxicity|1|||
130447691|NCT00994279|469600583|FG001|Overall Study|Toxicity|0|||
130447692|NCT00994279|469600582|FG000|Overall Study|Multiple reasons|1|||
130447693|NCT00994279|469600583|FG001|Overall Study|Multiple reasons|3|||
130447694|NCT01606189|469600584|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
130447695|NCT01606189|469600585|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
130447696|NCT01606189|469600586|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
130447697|NCT01606189|469600587|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
130447698|NCT01606189|469600588|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
130447699|NCT01606189|469600589|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
130447700|NCT01606189|469600584|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130447701|NCT01606189|469600585|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130447702|NCT01606189|469600586|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130447703|NCT01606189|469600587|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130447704|NCT01606189|469600588|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130447705|NCT01606189|469600589|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
130447706|NCT00162942|469600590|FG000|Overall Study|Adverse Event|10|||
130447707|NCT00162942|469600591|FG001|Overall Study|Adverse Event|6|||
130447708|NCT00162942|469600590|FG000|Overall Study|Death|1|||
130447709|NCT00162942|469600591|FG001|Overall Study|Death|0|||
130447710|NCT00162942|469600590|FG000|Overall Study|Withdrawal by Subject|3|||
130447711|NCT00162942|469600591|FG001|Overall Study|Withdrawal by Subject|6|||
130447712|NCT00162942|469600590|FG000|Overall Study|Physician Decision|1|||
130447713|NCT00162942|469600591|FG001|Overall Study|Physician Decision|0|||
130447714|NCT00162942|469600590|FG000|Overall Study|Enter Open-Label Study|76|||
130447715|NCT00162942|469600591|FG001|Overall Study|Enter Open-Label Study|35|||
130447716|NCT00162942|469600590|FG000|Overall Study|Alternate Therapy|6|||
130447717|NCT00162942|469600591|FG001|Overall Study|Alternate Therapy|2|||
130447718|NCT00162942|469600590|FG000|Overall Study|Lack of Efficacy|1|||
130447719|NCT00162942|469600591|FG001|Overall Study|Lack of Efficacy|0|||
130447720|NCT00162942|469600590|FG000|Overall Study|Flare During Active Treatment|7|||
130447721|NCT00162942|469600591|FG001|Overall Study|Flare During Active Treatment|3|||
130447722|NCT00162942|469600590|FG000|Overall Study|2 or more consecutive treatments missed|1|||
130447723|NCT00162942|469600591|FG001|Overall Study|2 or more consecutive treatments missed|0|||
130447724|NCT02162732|469600592|FG000|Overall Study|Biopsy not performed.|18|||
130447725|NCT00410384|469600593|FG000|Overall Study|Withdrawal by Subject|28|||
130447726|NCT00410384|469600594|FG001|Overall Study|Withdrawal by Subject|17|||
130447727|NCT00410384|469600595|FG002|Overall Study|Withdrawal by Subject|20|||
130447728|NCT00410384|469600593|FG000|Overall Study|Adverse Event|23|||
130447729|NCT00410384|469600594|FG001|Overall Study|Adverse Event|18|||
130447730|NCT00410384|469600595|FG002|Overall Study|Adverse Event|23|||
130238273|NCT01697579|468836206|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238274|NCT01697579|468836207|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238275|NCT01697579|468836201|FG000|Base Study-Cycle 1|Protocol Violation|0|||
130238276|NCT01697579|468836202|FG001|Base Study-Cycle 1|Protocol Violation|0|||
130238277|NCT01697579|468836203|FG002|Base Study-Cycle 1|Protocol Violation|0|||
130447731|NCT00410384|469600593|FG000|Overall Study|Lack of Efficacy|20|||
130447732|NCT00410384|469600594|FG001|Overall Study|Lack of Efficacy|12|||
130447733|NCT00410384|469600595|FG002|Overall Study|Lack of Efficacy|17|||
130447734|NCT00410384|469600593|FG000|Overall Study|Lack of Compliance|2|||
130447735|NCT00410384|469600594|FG001|Overall Study|Lack of Compliance|2|||
130447736|NCT00410384|469600595|FG002|Overall Study|Lack of Compliance|2|||
130447737|NCT00410384|469600593|FG000|Overall Study|Lost to Follow-up|4|||
130447738|NCT00410384|469600594|FG001|Overall Study|Lost to Follow-up|6|||
130238278|NCT01697579|468836204|FG003|Base Study-Cycle 1|Protocol Violation|0|||
130447739|NCT00410384|469600595|FG002|Overall Study|Lost to Follow-up|6|||
130447740|NCT00410384|469600593|FG000|Overall Study|Protocol Violation|6|||
130238279|NCT01697579|468836205|FG004|Base Study-Cycle 1|Protocol Violation|3|||
130238280|NCT01697579|468836206|FG005|Base Study-Cycle 1|Protocol Violation|0|||
130238281|NCT01697579|468836207|FG006|Base Study-Cycle 1|Protocol Violation|0|||
130238282|NCT01697579|468836201|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238283|NCT01697579|468836202|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
130238284|NCT01697579|468836203|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238285|NCT01697579|468836204|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238286|NCT01697579|468836205|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238287|NCT01697579|468836206|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238288|NCT01697579|468836207|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238289|NCT01697579|468836201|FG000|Base Study-Cycle 1|Technical Problems|0|||
130238290|NCT01697579|468836202|FG001|Base Study-Cycle 1|Technical Problems|0|||
130238291|NCT01697579|468836203|FG002|Base Study-Cycle 1|Technical Problems|1|||
130238292|NCT01697579|468836204|FG003|Base Study-Cycle 1|Technical Problems|1|||
130238293|NCT01697579|468836205|FG004|Base Study-Cycle 1|Technical Problems|0|||
130238294|NCT01697579|468836206|FG005|Base Study-Cycle 1|Technical Problems|0|||
130238295|NCT01697579|468836207|FG006|Base Study-Cycle 1|Technical Problems|0|||
130238296|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Death|0|||
130238297|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Death|0|||
130238298|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Death|0|||
130238299|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Death|0|||
130238300|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Death|0|||
130238301|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Death|0|||
130238302|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Death|2|||
130238303|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238304|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238305|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238306|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238307|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238308|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
130238309|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
130238310|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238311|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238312|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238313|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238314|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238315|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
130238316|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
130238317|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238318|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238319|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238320|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238321|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238322|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238323|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
130238324|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238325|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238326|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238327|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238328|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238329|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
130238330|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
130238331|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238332|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238333|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130359287|NCT03633617|469288570|FG002|Part A|Withdrawal by Subject|0|||
130359288|NCT03633617|469288571|FG003|Part A|Withdrawal by Subject|0|||
130359289|NCT03633617|469288572|FG004|Part A|Withdrawal by Subject|0|||
130238334|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238335|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238336|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
130238337|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130359290|NCT03633617|469288573|FG005|Part A|Withdrawal by Subject|0|||
130359291|NCT03633617|469288574|FG006|Part A|Withdrawal by Subject|0|||
130359292|NCT03633617|469288575|FG007|Part A|Withdrawal by Subject|0|||
130359293|NCT03633617|469288576|FG008|Part A|Withdrawal by Subject|0|||
130359294|NCT03633617|469288577|FG009|Part A|Withdrawal by Subject|0|||
130359295|NCT03633617|469288578|FG010|Part A|Withdrawal by Subject|0|||
130359296|NCT03633617|469288568|FG000|Part B|Adverse Event|0|||
130359297|NCT03633617|469288569|FG001|Part B|Adverse Event|0|||
130238338|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238339|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238340|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238341|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238342|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238343|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
130238344|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
130238345|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238346|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238347|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238348|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238349|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238350|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
130695527|NCT02705716|470509070|FG000|Overall Study|Adverse Event|0|||
130238351|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
130238352|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238353|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238354|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238355|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238356|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238357|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238358|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
130238359|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
130359298|NCT03633617|469288570|FG002|Part B|Adverse Event|2|||
130359299|NCT03633617|469288571|FG003|Part B|Adverse Event|2|||
130359300|NCT03633617|469288572|FG004|Part B|Adverse Event|1|||
130359301|NCT03633617|469288573|FG005|Part B|Adverse Event|0|||
130359302|NCT03633617|469288574|FG006|Part B|Adverse Event|0|||
130359303|NCT03633617|469288575|FG007|Part B|Adverse Event|0|||
130359304|NCT03633617|469288576|FG008|Part B|Adverse Event|0|||
130359305|NCT03633617|469288577|FG009|Part B|Adverse Event|0|||
130359306|NCT03633617|469288578|FG010|Part B|Adverse Event|0|||
130359307|NCT03633617|469288568|FG000|Part B|Withdrawal by Subject|0|||
130359308|NCT03633617|469288569|FG001|Part B|Withdrawal by Subject|0|||
130359309|NCT03633617|469288570|FG002|Part B|Withdrawal by Subject|1|||
130359310|NCT03633617|469288571|FG003|Part B|Withdrawal by Subject|0|||
130359311|NCT03633617|469288572|FG004|Part B|Withdrawal by Subject|2|||
130359312|NCT03633617|469288573|FG005|Part B|Withdrawal by Subject|0|||
130359313|NCT03633617|469288574|FG006|Part B|Withdrawal by Subject|0|||
130359314|NCT03633617|469288575|FG007|Part B|Withdrawal by Subject|0|||
130359315|NCT03633617|469288576|FG008|Part B|Withdrawal by Subject|0|||
130359316|NCT03633617|469288577|FG009|Part B|Withdrawal by Subject|0|||
130359317|NCT03633617|469288578|FG010|Part B|Withdrawal by Subject|0|||
130359318|NCT03633617|469288568|FG000|Part B|Lost to Follow-up|0|||
130359319|NCT03633617|469288569|FG001|Part B|Lost to Follow-up|0|||
130359320|NCT03633617|469288570|FG002|Part B|Lost to Follow-up|0|||
130359321|NCT03633617|469288571|FG003|Part B|Lost to Follow-up|0|||
130359322|NCT03633617|469288572|FG004|Part B|Lost to Follow-up|1|||
130359323|NCT03633617|469288573|FG005|Part B|Lost to Follow-up|0|||
130359324|NCT03633617|469288574|FG006|Part B|Lost to Follow-up|0|||
130359325|NCT03633617|469288575|FG007|Part B|Lost to Follow-up|0|||
130359326|NCT03633617|469288576|FG008|Part B|Lost to Follow-up|0|||
130359327|NCT03633617|469288577|FG009|Part B|Lost to Follow-up|0|||
130359328|NCT03633617|469288578|FG010|Part B|Lost to Follow-up|0|||
130359329|NCT03633617|469288568|FG000|Part B|Physician Decision|0|||
130359330|NCT03633617|469288569|FG001|Part B|Physician Decision|0|||
130359331|NCT03633617|469288570|FG002|Part B|Physician Decision|0|||
130359332|NCT03633617|469288571|FG003|Part B|Physician Decision|0|||
130359333|NCT03633617|469288572|FG004|Part B|Physician Decision|1|||
130359334|NCT03633617|469288573|FG005|Part B|Physician Decision|0|||
130359335|NCT03633617|469288574|FG006|Part B|Physician Decision|0|||
130359336|NCT03633617|469288575|FG007|Part B|Physician Decision|0|||
130359337|NCT03633617|469288576|FG008|Part B|Physician Decision|0|||
130359338|NCT03633617|469288577|FG009|Part B|Physician Decision|0|||
130359339|NCT03633617|469288578|FG010|Part B|Physician Decision|0|||
130359340|NCT03633617|469288568|FG000|Part B|COVID-19 Restrictions|0|||
130359341|NCT03633617|469288569|FG001|Part B|COVID-19 Restrictions|0|||
130359342|NCT03633617|469288570|FG002|Part B|COVID-19 Restrictions|1|||
130359343|NCT03633617|469288571|FG003|Part B|COVID-19 Restrictions|0|||
130359344|NCT03633617|469288572|FG004|Part B|COVID-19 Restrictions|0|||
130359345|NCT03633617|469288573|FG005|Part B|COVID-19 Restrictions|0|||
130359346|NCT03633617|469288574|FG006|Part B|COVID-19 Restrictions|0|||
130359347|NCT03633617|469288575|FG007|Part B|COVID-19 Restrictions|0|||
130359348|NCT03633617|469288576|FG008|Part B|COVID-19 Restrictions|0|||
130359349|NCT03633617|469288577|FG009|Part B|COVID-19 Restrictions|0|||
130359350|NCT03633617|469288578|FG010|Part B|COVID-19 Restrictions|0|||
130238360|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238361|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238362|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238363|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238364|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238365|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
130238366|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238367|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238368|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238369|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238370|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238371|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238372|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
130238373|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238374|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238375|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238376|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238377|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238378|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
130238379|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
130238380|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238381|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238382|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238383|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238384|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238385|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238386|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
130238387|NCT02452190|468836208|FG000|Overall Study|Withdrawal by Sponsor|1|||
130238388|NCT02452190|468836209|FG001|Overall Study|Withdrawal by Sponsor|3|||
130238389|NCT02452190|468836208|FG000|Overall Study|Pregnancy|1|||
130238390|NCT02452190|468836209|FG001|Overall Study|Pregnancy|0|||
130238391|NCT02452190|468836208|FG000|Overall Study|Investigator's Decision|2|||
130238392|NCT02452190|468836209|FG001|Overall Study|Investigator's Decision|0|||
130238393|NCT02452190|468836208|FG000|Overall Study|Lack of Efficacy|3|||
130238394|NCT02452190|468836209|FG001|Overall Study|Lack of Efficacy|1|||
130238395|NCT02452190|468836208|FG000|Overall Study|Lost to Follow-up|4|||
130238396|NCT02452190|468836209|FG001|Overall Study|Lost to Follow-up|3|||
130238397|NCT02452190|468836208|FG000|Overall Study|Adverse Event|2|||
130238398|NCT02452190|468836209|FG001|Overall Study|Adverse Event|5|||
130238399|NCT02452190|468836208|FG000|Overall Study|Withdrawal by Subject|20|||
130238400|NCT02452190|468836209|FG001|Overall Study|Withdrawal by Subject|11|||
130238401|NCT02452190|468836208|FG000|Overall Study|Noncompliance with study drug|1|||
130238402|NCT02452190|468836209|FG001|Overall Study|Noncompliance with study drug|0|||
130238403|NCT02452190|468836208|FG000|Overall Study|Participant traveled abroad|1|||
130238404|NCT02452190|468836209|FG001|Overall Study|Participant traveled abroad|0|||
130238405|NCT02452190|468836208|FG000|Overall Study|Death|0|||
130238406|NCT02452190|468836209|FG001|Overall Study|Death|1|||
130238407|NCT01044498|468836210|FG000|Overall Study|Withdrew consent|1|||
130238408|NCT01044498|468836211|FG001|Overall Study|Withdrew consent|1|||
130238409|NCT01044498|468836210|FG000|Overall Study|Adverse Event|1|||
130238410|NCT01044498|468836211|FG001|Overall Study|Adverse Event|1|||
130238411|NCT01044498|468836210|FG000|Overall Study|Other|1|||
130238412|NCT01044498|468836211|FG001|Overall Study|Other|0|||
130238413|NCT02327078|468836216|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130238414|NCT02327078|468836217|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130238415|NCT02327078|468836218|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
130238416|NCT02327078|468836219|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130238417|NCT02327078|468836220|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130359351|NCT03633617|469288568|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359352|NCT03633617|469288569|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359353|NCT03633617|469288570|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
130359354|NCT03633617|469288571|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359355|NCT03633617|469288572|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359356|NCT03633617|469288573|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130238418|NCT02327078|468836221|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130238419|NCT02327078|468836222|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130376535|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130238420|NCT02327078|468836223|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
130238421|NCT02327078|468836224|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
130238422|NCT02327078|468836216|FG000|Overall Study|Death|2|||
130238423|NCT02327078|468836217|FG001|Overall Study|Death|4|||
130238424|NCT02327078|468836218|FG002|Overall Study|Death|10|||
130238425|NCT02327078|468836219|FG003|Overall Study|Death|6|||
130238426|NCT02327078|468836220|FG004|Overall Study|Death|4|||
130238427|NCT02327078|468836221|FG005|Overall Study|Death|3|||
130238428|NCT02327078|468836222|FG006|Overall Study|Death|2|||
130238429|NCT02327078|468836223|FG007|Overall Study|Death|51|||
130238430|NCT02327078|468836224|FG008|Overall Study|Death|97|||
130238431|NCT02327078|468836216|FG000|Overall Study|Lost to Follow-up|0|||
130238432|NCT02327078|468836217|FG001|Overall Study|Lost to Follow-up|1|||
130238433|NCT02327078|468836218|FG002|Overall Study|Lost to Follow-up|1|||
130238434|NCT02327078|468836219|FG003|Overall Study|Lost to Follow-up|0|||
130238435|NCT02327078|468836220|FG004|Overall Study|Lost to Follow-up|0|||
130238436|NCT02327078|468836221|FG005|Overall Study|Lost to Follow-up|0|||
130238437|NCT02327078|468836222|FG006|Overall Study|Lost to Follow-up|0|||
130238438|NCT02327078|468836223|FG007|Overall Study|Lost to Follow-up|2|||
130238439|NCT02327078|468836224|FG008|Overall Study|Lost to Follow-up|5|||
130238440|NCT02327078|468836216|FG000|Overall Study|Site Terminated by Sponsor|1|||
130238441|NCT02327078|468836217|FG001|Overall Study|Site Terminated by Sponsor|0|||
130238442|NCT02327078|468836218|FG002|Overall Study|Site Terminated by Sponsor|1|||
130238443|NCT02327078|468836219|FG003|Overall Study|Site Terminated by Sponsor|4|||
130238444|NCT02327078|468836220|FG004|Overall Study|Site Terminated by Sponsor|0|||
130238445|NCT02327078|468836221|FG005|Overall Study|Site Terminated by Sponsor|0|||
130238446|NCT02327078|468836222|FG006|Overall Study|Site Terminated by Sponsor|0|||
130238447|NCT02327078|468836223|FG007|Overall Study|Site Terminated by Sponsor|11|||
130238448|NCT02327078|468836224|FG008|Overall Study|Site Terminated by Sponsor|25|||
130238449|NCT02327078|468836216|FG000|Overall Study|Physician Decision|0|||
130238450|NCT02327078|468836217|FG001|Overall Study|Physician Decision|0|||
130238451|NCT02327078|468836218|FG002|Overall Study|Physician Decision|0|||
130238452|NCT02327078|468836219|FG003|Overall Study|Physician Decision|1|||
130238453|NCT02327078|468836220|FG004|Overall Study|Physician Decision|0|||
130238454|NCT02327078|468836221|FG005|Overall Study|Physician Decision|0|||
130238455|NCT02327078|468836222|FG006|Overall Study|Physician Decision|0|||
130238456|NCT02327078|468836223|FG007|Overall Study|Physician Decision|0|||
130695528|NCT02705716|470509071|FG001|Overall Study|Adverse Event|1|||
130695529|NCT02705716|470509070|FG000|Overall Study|Protocol Violation|3|||
130695530|NCT02705716|470509071|FG001|Overall Study|Protocol Violation|0|||
130695531|NCT02705716|470509070|FG000|Overall Study|Withdrawal of Consent|1|||
130695532|NCT02705716|470509071|FG001|Overall Study|Withdrawal of Consent|1|||
130238457|NCT02327078|468836224|FG008|Overall Study|Physician Decision|1|||
130238458|NCT02327078|468836216|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238459|NCT02327078|468836217|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238460|NCT02327078|468836218|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130359357|NCT03633617|469288574|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359358|NCT03633617|469288575|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359359|NCT03633617|469288576|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359360|NCT03633617|469288577|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359361|NCT03633617|469288578|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130359362|NCT03633617|469288568|FG000|Part C (& Follow-up)|Adverse Event|0|||
130359363|NCT03633617|469288569|FG001|Part C (& Follow-up)|Adverse Event|0|||
130359364|NCT03633617|469288570|FG002|Part C (& Follow-up)|Adverse Event|0|||
130359365|NCT03633617|469288571|FG003|Part C (& Follow-up)|Adverse Event|0|||
130359366|NCT03633617|469288572|FG004|Part C (& Follow-up)|Adverse Event|0|||
130359367|NCT03633617|469288573|FG005|Part C (& Follow-up)|Adverse Event|1|||
130359368|NCT03633617|469288574|FG006|Part C (& Follow-up)|Adverse Event|0|||
130359369|NCT03633617|469288575|FG007|Part C (& Follow-up)|Adverse Event|1|||
130359370|NCT03633617|469288576|FG008|Part C (& Follow-up)|Adverse Event|0|||
130359371|NCT03633617|469288577|FG009|Part C (& Follow-up)|Adverse Event|0|||
130359372|NCT03633617|469288578|FG010|Part C (& Follow-up)|Adverse Event|0|||
130359373|NCT03633617|469288568|FG000|Part C (& Follow-up)|Pregnancy|0|||
130359374|NCT03633617|469288569|FG001|Part C (& Follow-up)|Pregnancy|0|||
130359375|NCT03633617|469288570|FG002|Part C (& Follow-up)|Pregnancy|0|||
130238461|NCT02327078|468836219|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130238462|NCT02327078|468836220|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130238463|NCT02327078|468836221|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238464|NCT02327078|468836222|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130359376|NCT03633617|469288571|FG003|Part C (& Follow-up)|Pregnancy|0|||
130238465|NCT02327078|468836223|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
130238466|NCT02327078|468836224|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
130238467|NCT02327078|468836216|FG000|Overall Study|Reason not Specified|0|||
130695533|NCT00562718|470509072|FG000|Overall Study|Death|1|||
130447741|NCT00410384|469600594|FG001|Overall Study|Protocol Violation|6|||
130447742|NCT00410384|469600595|FG002|Overall Study|Protocol Violation|6|||
130447743|NCT00410384|469600593|FG000|Overall Study|Physician Decision|3|||
130447744|NCT00410384|469600594|FG001|Overall Study|Physician Decision|3|||
130447745|NCT00410384|469600595|FG002|Overall Study|Physician Decision|4|||
130447746|NCT00410384|469600593|FG000|Overall Study|Other|3|||
130447747|NCT00410384|469600594|FG001|Overall Study|Other|8|||
130447748|NCT00410384|469600595|FG002|Overall Study|Other|4|||
130447749|NCT01167023|469600596|FG000|Overall Study|Lost to Follow-up|0|||
130447750|NCT01167023|469600597|FG001|Overall Study|Lost to Follow-up|1|||
130447751|NCT01167023|469600598|FG002|Overall Study|Lost to Follow-up|1|||
130447752|NCT01167023|469600596|FG000|Overall Study|Screen Failure|0|||
130447753|NCT01167023|469600597|FG001|Overall Study|Screen Failure|1|||
130447754|NCT01167023|469600598|FG002|Overall Study|Screen Failure|0|||
130447755|NCT01167023|469600596|FG000|Overall Study|Sponsor Decision|0|||
130447756|NCT01167023|469600597|FG001|Overall Study|Sponsor Decision|1|||
130447757|NCT01167023|469600598|FG002|Overall Study|Sponsor Decision|0|||
130447758|NCT01167023|469600596|FG000|Overall Study|Withdrawal by Subject|0|||
130447759|NCT01167023|469600597|FG001|Overall Study|Withdrawal by Subject|0|||
130447760|NCT01167023|469600598|FG002|Overall Study|Withdrawal by Subject|1|||
130447761|NCT01253200|469600601|FG000|Overall Study|Death|1|||
130447762|NCT01253200|469600602|FG001|Overall Study|Death|0|||
130447763|NCT01253200|469600603|FG002|Overall Study|Death|0|||
130447764|NCT01253200|469600604|FG003|Overall Study|Death|0|||
130447765|NCT01253200|469600605|FG004|Overall Study|Death|0|||
130447766|NCT01253200|469600601|FG000|Overall Study|Lost to Follow-up|1|||
130447767|NCT01253200|469600602|FG001|Overall Study|Lost to Follow-up|1|||
130695534|NCT00562718|470509072|FG000|Overall Study|Withdrawal by Subject|3|||
130695535|NCT00562718|470509072|FG000|Overall Study|Adverse Event|4|||
130695536|NCT00562718|470509072|FG000|Overall Study|Lack of Efficacy|2|||
130695537|NCT00562718|470509072|FG000|Overall Study|not stated|1|||
130238468|NCT02327078|468836217|FG001|Overall Study|Reason not Specified|0|||
130359377|NCT03633617|469288572|FG004|Part C (& Follow-up)|Pregnancy|0|||
130359378|NCT03633617|469288573|FG005|Part C (& Follow-up)|Pregnancy|0|||
130359379|NCT03633617|469288574|FG006|Part C (& Follow-up)|Pregnancy|0|||
130359380|NCT03633617|469288575|FG007|Part C (& Follow-up)|Pregnancy|0|||
130359381|NCT03633617|469288576|FG008|Part C (& Follow-up)|Pregnancy|0|||
130359382|NCT03633617|469288577|FG009|Part C (& Follow-up)|Pregnancy|1|||
130359383|NCT03633617|469288578|FG010|Part C (& Follow-up)|Pregnancy|0|||
130359384|NCT03633617|469288568|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359385|NCT03633617|469288569|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359386|NCT03633617|469288570|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359387|NCT03633617|469288571|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359388|NCT03633617|469288572|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359389|NCT03633617|469288573|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
130359390|NCT03633617|469288574|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
130359391|NCT03633617|469288575|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
130359392|NCT03633617|469288576|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
130359393|NCT03633617|469288577|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
130359394|NCT03633617|469288578|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
130359395|NCT03633617|469288568|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
130359396|NCT03633617|469288569|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
130359397|NCT03633617|469288570|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
130359398|NCT03633617|469288571|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
130359399|NCT03633617|469288572|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
130359400|NCT03633617|469288573|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
130359401|NCT03633617|469288574|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
130359402|NCT03633617|469288575|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
130359403|NCT03633617|469288576|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
130359404|NCT03633617|469288577|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
130359405|NCT03633617|469288578|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
130359406|NCT03633617|469288568|FG000|Part C (& Follow-up)|Physician Decision|0|||
130359407|NCT03633617|469288569|FG001|Part C (& Follow-up)|Physician Decision|0|||
130359408|NCT03633617|469288570|FG002|Part C (& Follow-up)|Physician Decision|0|||
130359409|NCT03633617|469288571|FG003|Part C (& Follow-up)|Physician Decision|0|||
130447768|NCT01253200|469600603|FG002|Overall Study|Lost to Follow-up|0|||
130447769|NCT01253200|469600604|FG003|Overall Study|Lost to Follow-up|0|||
130359410|NCT03633617|469288572|FG004|Part C (& Follow-up)|Physician Decision|0|||
130447770|NCT01253200|469600605|FG004|Overall Study|Lost to Follow-up|0|||
130447771|NCT01253200|469600601|FG000|Overall Study|Withdrawal by Subject|2|||
130359411|NCT03633617|469288573|FG005|Part C (& Follow-up)|Physician Decision|0|||
130359412|NCT03633617|469288574|FG006|Part C (& Follow-up)|Physician Decision|0|||
130447772|NCT01253200|469600602|FG001|Overall Study|Withdrawal by Subject|0|||
130695538|NCT01868243|470509073|FG000|Overall Study|Death|0|||
130359413|NCT03633617|469288575|FG007|Part C (& Follow-up)|Physician Decision|1|||
130447773|NCT01253200|469600603|FG002|Overall Study|Withdrawal by Subject|0|||
130447774|NCT01253200|469600604|FG003|Overall Study|Withdrawal by Subject|0|||
130695539|NCT01868243|470509074|FG001|Overall Study|Death|1|||
130238469|NCT02327078|468836218|FG002|Overall Study|Reason not Specified|0|||
130238470|NCT02327078|468836219|FG003|Overall Study|Reason not Specified|0|||
130238471|NCT02327078|468836220|FG004|Overall Study|Reason not Specified|0|||
130238472|NCT02327078|468836221|FG005|Overall Study|Reason not Specified|0|||
130238473|NCT02327078|468836222|FG006|Overall Study|Reason not Specified|0|||
130238474|NCT02327078|468836223|FG007|Overall Study|Reason not Specified|5|||
130238475|NCT02327078|468836224|FG008|Overall Study|Reason not Specified|12|||
130238476|NCT03916926|468836228|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
130238477|NCT03916926|468836229|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
130238478|NCT03916926|468836228|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
130359414|NCT03633617|469288576|FG008|Part C (& Follow-up)|Physician Decision|0|||
130359415|NCT03633617|469288577|FG009|Part C (& Follow-up)|Physician Decision|0|||
130359416|NCT03633617|469288578|FG010|Part C (& Follow-up)|Physician Decision|1|||
130359417|NCT03633617|469288568|FG000|Part C (& Follow-up)|COVID-19 related|0|||
130359418|NCT03633617|469288569|FG001|Part C (& Follow-up)|COVID-19 related|0|||
130359419|NCT03633617|469288570|FG002|Part C (& Follow-up)|COVID-19 related|0|||
130359420|NCT03633617|469288571|FG003|Part C (& Follow-up)|COVID-19 related|0|||
130359421|NCT03633617|469288572|FG004|Part C (& Follow-up)|COVID-19 related|0|||
130359422|NCT03633617|469288573|FG005|Part C (& Follow-up)|COVID-19 related|1|||
130359423|NCT03633617|469288574|FG006|Part C (& Follow-up)|COVID-19 related|0|||
130359424|NCT03633617|469288575|FG007|Part C (& Follow-up)|COVID-19 related|0|||
130359425|NCT03633617|469288576|FG008|Part C (& Follow-up)|COVID-19 related|0|||
130359426|NCT03633617|469288577|FG009|Part C (& Follow-up)|COVID-19 related|0|||
130359427|NCT03633617|469288578|FG010|Part C (& Follow-up)|COVID-19 related|0|||
130359428|NCT03633617|469288568|FG000|Part C (& Follow-up)|Protocol Violation|0|||
130359429|NCT03633617|469288569|FG001|Part C (& Follow-up)|Protocol Violation|0|||
130359430|NCT03633617|469288570|FG002|Part C (& Follow-up)|Protocol Violation|0|||
130359431|NCT03633617|469288571|FG003|Part C (& Follow-up)|Protocol Violation|0|||
130359432|NCT03633617|469288572|FG004|Part C (& Follow-up)|Protocol Violation|0|||
130359433|NCT03633617|469288573|FG005|Part C (& Follow-up)|Protocol Violation|0|||
130359434|NCT03633617|469288574|FG006|Part C (& Follow-up)|Protocol Violation|0|||
130359435|NCT03633617|469288575|FG007|Part C (& Follow-up)|Protocol Violation|0|||
130359436|NCT03633617|469288576|FG008|Part C (& Follow-up)|Protocol Violation|0|||
130359437|NCT03633617|469288577|FG009|Part C (& Follow-up)|Protocol Violation|3|||
130359438|NCT03633617|469288578|FG010|Part C (& Follow-up)|Protocol Violation|1|||
130359439|NCT03633617|469288568|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
130359440|NCT03633617|469288569|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
130359441|NCT03633617|469288570|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
130359442|NCT03633617|469288571|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
130359443|NCT03633617|469288572|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
130359444|NCT03633617|469288573|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
130359445|NCT03633617|469288574|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
130359446|NCT03633617|469288575|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
130359447|NCT03633617|469288576|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
130359448|NCT03633617|469288577|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
130359449|NCT03633617|469288578|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
130359450|NCT00629772|469288583|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
130359451|NCT00629772|469288584|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
130359452|NCT00629772|469288583|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
130359453|NCT00629772|469288584|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
130359454|NCT01393301|469288585|FG000|Overall Study|Lost to Follow-up|5|||
130359455|NCT01393301|469288586|FG001|Overall Study|Lost to Follow-up|3|||
130359456|NCT01393301|469288585|FG000|Overall Study|Withdrawal by Subject|2|||
130359457|NCT01393301|469288586|FG001|Overall Study|Withdrawal by Subject|0|||
130359458|NCT01393301|469288585|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
130359459|NCT01393301|469288586|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
130359460|NCT00853073|469288587|FG000|Overall Study|Withdrawal by Subject|3|||
130359461|NCT00853073|469288588|FG001|Overall Study|Withdrawal by Subject|2|||
130359462|NCT02758171|469288589|FG000|Wash-out|Withdrawal by Subject|1|||
130359463|NCT02758171|469288590|FG001|Wash-out|Withdrawal by Subject|0|||
130359464|NCT02758171|469288589|FG000|Wash-out|Other reason|1|||
130359465|NCT02758171|469288590|FG001|Wash-out|Other reason|0|||
130359466|NCT00722423|469288591|FG000|Overall Study|Protocol Violation|0|||
130359467|NCT00722423|469288592|FG001|Overall Study|Protocol Violation|1|||
130359468|NCT01309165|469288593|FG000|Overall Study|Lost to Follow-up|4|||
130359469|NCT01309165|469288594|FG001|Overall Study|Lost to Follow-up|3|||
130359470|NCT01309165|469288593|FG000|Overall Study|Return to work|1|||
130359471|NCT01309165|469288594|FG001|Overall Study|Return to work|2|||
130359472|NCT01309165|469288593|FG000|Overall Study|Left country|0|||
130359473|NCT01309165|469288594|FG001|Overall Study|Left country|1|||
130359474|NCT01309165|469288593|FG000|Overall Study|No transportation|0|||
130359475|NCT01309165|469288594|FG001|Overall Study|No transportation|1|||
130359476|NCT01309165|469288593|FG000|Overall Study|Admitted to hospital for second stroke|1|||
130359477|NCT01309165|469288594|FG001|Overall Study|Admitted to hospital for second stroke|0|||
130359478|NCT05085730|469288596|FG000|Overall Study|Withdrawal by Subject|4|||
130695540|NCT00985751|470509075|FG000|Overall Study|Adverse Event|0|||
130695541|NCT00985751|470509076|FG001|Overall Study|Adverse Event|0|||
130695542|NCT00985751|470509077|FG002|Overall Study|Adverse Event|0|||
130695543|NCT00985751|470509078|FG003|Overall Study|Adverse Event|0|||
130695544|NCT00985751|470509079|FG004|Overall Study|Adverse Event|1|||
130695545|NCT00999687|470509088|FG000|First Intervention|Withdrawal by Subject|1|||
130695546|NCT00999687|470509088|FG000|Second Intervention|Withdrawal by Subject|2|||
130695547|NCT00999687|470509088|FG000|Second Intervention|Lack of Efficacy|1|||
130695548|NCT00474188|470509089|FG000|Overall Study|Withdrawal by Subject|1|||
130695549|NCT00474188|470509089|FG000|Overall Study|Study discontinued by sponsor|5|||
130695550|NCT00858403|470509091|FG000|Overall Study|Withdrawal by Subject|1|||
130695551|NCT00858403|470509091|FG000|Overall Study|Death|3|||
130695552|NCT00858403|470509091|FG000|Overall Study|Disease Progression|1|||
130695553|NCT03961204|470509096|FG000|Overall Study|Withdrawal by Subject|2|||
130695554|NCT03961204|470509096|FG000|Overall Study|Lost to Follow-up|3|||
130695555|NCT03961204|470509096|FG000|Overall Study|Other|1|||
130695556|NCT03961204|470509096|FG000|Overall Study|Missing|1|||
130695557|NCT03867760|470509097|FG000|Overall Study|Lost to Follow-up|2|||
130695558|NCT03867760|470509098|FG001|Overall Study|Lost to Follow-up|3|||
130359479|NCT05085730|469288596|FG000|Overall Study|Physician Decision|1|||
130359480|NCT02038881|469288597|FG000|Overall Study|Withdrawal by Subject|0|||
130359481|NCT02038881|469288598|FG001|Overall Study|Withdrawal by Subject|0|||
130359482|NCT02038881|469288599|FG002|Overall Study|Withdrawal by Subject|1|||
130359483|NCT02038881|469288597|FG000|Overall Study|Lost to Follow-up|2|||
130359484|NCT02038881|469288598|FG001|Overall Study|Lost to Follow-up|0|||
130359485|NCT02038881|469288599|FG002|Overall Study|Lost to Follow-up|0|||
130359486|NCT02038881|469288597|FG000|Overall Study|incarcerated|1|||
130359487|NCT02038881|469288598|FG001|Overall Study|incarcerated|0|||
130359488|NCT02038881|469288599|FG002|Overall Study|incarcerated|0|||
130359489|NCT00333840|469288600|FG000|First-line Treatment Period|Adverse Event|38|||
130359490|NCT00333840|469288601|FG001|First-line Treatment Period|Adverse Event|37|||
130359491|NCT00333840|469288602|FG002|First-line Treatment Period|Adverse Event|0|||
130359492|NCT00333840|469288603|FG003|First-line Treatment Period|Adverse Event|0|||
130359493|NCT00333840|469288600|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
130359494|NCT00333840|469288601|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
130359495|NCT00333840|469288602|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
130359496|NCT00333840|469288603|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
130359497|NCT00333840|469288600|FG000|First-line Treatment Period|Abnormal procedure|2|||
130359498|NCT00333840|469288601|FG001|First-line Treatment Period|Abnormal procedure|0|||
130359499|NCT00333840|469288602|FG002|First-line Treatment Period|Abnormal procedure|0|||
130359500|NCT00333840|469288603|FG003|First-line Treatment Period|Abnormal procedure|0|||
130359501|NCT00333840|469288600|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
130359502|NCT00333840|469288601|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
130359503|NCT00333840|469288602|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130359504|NCT00333840|469288603|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130359505|NCT00333840|469288600|FG000|First-line Treatment Period|No longer required study drug|21|||
130359506|NCT00333840|469288601|FG001|First-line Treatment Period|No longer required study drug|8|||
130359507|NCT00333840|469288602|FG002|First-line Treatment Period|No longer required study drug|0|||
130359508|NCT00333840|469288603|FG003|First-line Treatment Period|No longer required study drug|0|||
130359509|NCT00333840|469288600|FG000|First-line Treatment Period|Protocol Violation|17|||
130359510|NCT00333840|469288601|FG001|First-line Treatment Period|Protocol Violation|17|||
130359511|NCT00333840|469288602|FG002|First-line Treatment Period|Protocol Violation|0|||
130359512|NCT00333840|469288603|FG003|First-line Treatment Period|Protocol Violation|0|||
130359513|NCT00333840|469288600|FG000|First-line Treatment Period|Subject withdrew consent|57|||
130359514|NCT00333840|469288601|FG001|First-line Treatment Period|Subject withdrew consent|77|||
130359515|NCT00333840|469288602|FG002|First-line Treatment Period|Subject withdrew consent|0|||
130359516|NCT00333840|469288603|FG003|First-line Treatment Period|Subject withdrew consent|0|||
130359517|NCT00333840|469288600|FG000|First-line Treatment Period|Lost to Follow-up|15|||
130359518|NCT00333840|469288601|FG001|First-line Treatment Period|Lost to Follow-up|6|||
130359519|NCT00333840|469288602|FG002|First-line Treatment Period|Lost to Follow-up|0|||
130359520|NCT00333840|469288603|FG003|First-line Treatment Period|Lost to Follow-up|0|||
130359521|NCT00333840|469288600|FG000|First-line Treatment Period|Administrative problems|12|||
130359522|NCT00333840|469288601|FG001|First-line Treatment Period|Administrative problems|6|||
130359523|NCT00333840|469288602|FG002|First-line Treatment Period|Administrative problems|0|||
130695559|NCT03867760|470509097|FG000|Overall Study|Withdrawal by Subject|1|||
130359524|NCT00333840|469288603|FG003|First-line Treatment Period|Administrative problems|0|||
130359525|NCT00333840|469288600|FG000|First-line Treatment Period|Death|19|||
130359526|NCT00333840|469288601|FG001|First-line Treatment Period|Death|2|||
130359527|NCT00333840|469288602|FG002|First-line Treatment Period|Death|0|||
130695560|NCT03867760|470509098|FG001|Overall Study|Withdrawal by Subject|2|||
130695561|NCT03867760|470509097|FG000|Overall Study|subject could not meet study logistics|3|||
130695562|NCT03867760|470509098|FG001|Overall Study|subject could not meet study logistics|3|||
130447775|NCT01253200|469600605|FG004|Overall Study|Withdrawal by Subject|0|||
130447776|NCT01253200|469600601|FG000|Overall Study|Protocol Violation|1|||
130447777|NCT01253200|469600602|FG001|Overall Study|Protocol Violation|4|||
130447778|NCT01253200|469600603|FG002|Overall Study|Protocol Violation|0|||
130447779|NCT01253200|469600604|FG003|Overall Study|Protocol Violation|0|||
130447780|NCT01253200|469600605|FG004|Overall Study|Protocol Violation|5|||
130447781|NCT01253200|469600601|FG000|Overall Study|intents|10|||
130447782|NCT01253200|469600602|FG001|Overall Study|intents|10|||
130447783|NCT01253200|469600603|FG002|Overall Study|intents|1|||
130447784|NCT01253200|469600604|FG003|Overall Study|intents|3|||
130447785|NCT01253200|469600605|FG004|Overall Study|intents|0|||
130447786|NCT01253200|469600601|FG000|Overall Study|Attempts|6|||
130447787|NCT01253200|469600602|FG001|Overall Study|Attempts|4|||
130447788|NCT01253200|469600603|FG002|Overall Study|Attempts|1|||
130447789|NCT01253200|469600604|FG003|Overall Study|Attempts|2|||
130447790|NCT01253200|469600605|FG004|Overall Study|Attempts|0|||
130447791|NCT02049437|469600606|FG000|Period 1|Adverse Event|1|||
130447792|NCT02049437|469600607|FG001|Period 1|Adverse Event|1|||
130447793|NCT02049437|469600606|FG000|Period 1|Adverse Event|1|||
130238479|NCT03916926|468836229|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
130238480|NCT03916926|468836228|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
130238481|NCT03916926|468836229|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
130238482|NCT03916926|468836228|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
130238483|NCT03916926|468836229|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
130238484|NCT01081951|468836230|FG000|Overall Study|Death|54|||
130238485|NCT01081951|468836231|FG001|Overall Study|Death|47|||
130238486|NCT01081951|468836230|FG000|Overall Study|Withdrawal by Subject|2|||
130238487|NCT01081951|468836231|FG001|Overall Study|Withdrawal by Subject|6|||
130238488|NCT01081951|468836230|FG000|Overall Study|Allocated treatment but did not take it|0|||
130238489|NCT01081951|468836231|FG001|Overall Study|Allocated treatment but did not take it|1|||
130238490|NCT01081951|468836230|FG000|Overall Study|Lost to Follow-up|0|||
130238491|NCT01081951|468836231|FG001|Overall Study|Lost to Follow-up|1|||
130238492|NCT03765073|468836233|FG000|Stage 1|Lost to Follow-up|1|||
130238493|NCT03765073|468836234|FG001|Stage 1|Lost to Follow-up|0|||
130238494|NCT03765073|468836235|FG002|Stage 1|Lost to Follow-up|0|||
130238495|NCT03765073|468836236|FG003|Stage 1|Lost to Follow-up|0|||
130238496|NCT03765073|468836237|FG004|Stage 1|Lost to Follow-up|0|||
130238497|NCT03765073|468836238|FG005|Stage 1|Lost to Follow-up|0|||
130238498|NCT03765073|468836239|FG006|Stage 1|Lost to Follow-up|0|||
130238499|NCT03765073|468836240|FG007|Stage 1|Lost to Follow-up|0|||
130359528|NCT00333840|469288603|FG003|First-line Treatment Period|Death|0|||
130359529|NCT00333840|469288600|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
130359530|NCT00333840|469288601|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
130359531|NCT00333840|469288602|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
130359532|NCT00333840|469288603|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
130359533|NCT00333840|469288600|FG000|Second-line Treatment Period|Adverse Event|0|||
130359534|NCT00333840|469288601|FG001|Second-line Treatment Period|Adverse Event|0|||
130359535|NCT00333840|469288602|FG002|Second-line Treatment Period|Adverse Event|3|||
130359536|NCT00333840|469288603|FG003|Second-line Treatment Period|Adverse Event|34|||
130359537|NCT00333840|469288600|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130359538|NCT00333840|469288601|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130359539|NCT00333840|469288602|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130359540|NCT00333840|469288603|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
130359541|NCT00333840|469288600|FG000|Second-line Treatment Period|Abnormal procedure|0|||
130359542|NCT00333840|469288601|FG001|Second-line Treatment Period|Abnormal procedure|0|||
130359543|NCT00333840|469288602|FG002|Second-line Treatment Period|Abnormal procedure|0|||
130359544|NCT00333840|469288603|FG003|Second-line Treatment Period|Abnormal procedure|1|||
130359545|NCT00333840|469288600|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130359546|NCT00333840|469288601|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130359547|NCT00333840|469288602|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
130359548|NCT00333840|469288603|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
130359549|NCT00333840|469288600|FG000|Second-line Treatment Period|No longer required study drug|0|||
130359550|NCT00333840|469288601|FG001|Second-line Treatment Period|No longer required study drug|0|||
130359551|NCT00333840|469288602|FG002|Second-line Treatment Period|No longer required study drug|1|||
130359552|NCT00333840|469288603|FG003|Second-line Treatment Period|No longer required study drug|14|||
130359553|NCT00333840|469288600|FG000|Second-line Treatment Period|Protocol Violation|0|||
130359554|NCT00333840|469288601|FG001|Second-line Treatment Period|Protocol Violation|0|||
130359555|NCT00333840|469288602|FG002|Second-line Treatment Period|Protocol Violation|1|||
130447794|NCT02049437|469600607|FG001|Period 1|Adverse Event|0|||
130447795|NCT04529538|469600608|FG000|Overall Study|Lost to Follow-up|3|||
130447796|NCT04529538|469600609|FG001|Overall Study|Lost to Follow-up|2|||
130359556|NCT00333840|469288603|FG003|Second-line Treatment Period|Protocol Violation|10|||
130447797|NCT04529538|469600610|FG002|Overall Study|Lost to Follow-up|1|||
130447798|NCT04529538|469600611|FG003|Overall Study|Lost to Follow-up|0|||
130447799|NCT04529538|469600612|FG004|Overall Study|Lost to Follow-up|1|||
130447800|NCT04529538|469600613|FG005|Overall Study|Lost to Follow-up|1|||
130447801|NCT04529538|469600614|FG006|Overall Study|Lost to Follow-up|2|||
130447802|NCT04529538|469600615|FG007|Overall Study|Lost to Follow-up|0|||
130447803|NCT04529538|469600608|FG000|Overall Study|Not eligible at enrollment|0|||
130447804|NCT04529538|469600609|FG001|Overall Study|Not eligible at enrollment|1|||
130447805|NCT04529538|469600610|FG002|Overall Study|Not eligible at enrollment|2|||
130447806|NCT04529538|469600611|FG003|Overall Study|Not eligible at enrollment|1|||
130447807|NCT04529538|469600612|FG004|Overall Study|Not eligible at enrollment|0|||
130447808|NCT04529538|469600613|FG005|Overall Study|Not eligible at enrollment|0|||
130447809|NCT04529538|469600614|FG006|Overall Study|Not eligible at enrollment|0|||
130447810|NCT04529538|469600615|FG007|Overall Study|Not eligible at enrollment|1|||
130447811|NCT04529538|469600608|FG000|Overall Study|Withdrawal by Subject|0|||
130447812|NCT04529538|469600609|FG001|Overall Study|Withdrawal by Subject|1|||
130447813|NCT04529538|469600610|FG002|Overall Study|Withdrawal by Subject|1|||
130447814|NCT04529538|469600611|FG003|Overall Study|Withdrawal by Subject|2|||
130447815|NCT04529538|469600612|FG004|Overall Study|Withdrawal by Subject|0|||
130447816|NCT04529538|469600613|FG005|Overall Study|Withdrawal by Subject|2|||
130447817|NCT04529538|469600614|FG006|Overall Study|Withdrawal by Subject|3|||
130447818|NCT04529538|469600615|FG007|Overall Study|Withdrawal by Subject|0|||
130447819|NCT04529538|469600608|FG000|Overall Study|Other|0|||
130447820|NCT04529538|469600609|FG001|Overall Study|Other|1|||
130447821|NCT04529538|469600610|FG002|Overall Study|Other|0|||
130447822|NCT04529538|469600611|FG003|Overall Study|Other|0|||
130447823|NCT04529538|469600612|FG004|Overall Study|Other|0|||
130447824|NCT04529538|469600613|FG005|Overall Study|Other|0|||
130447825|NCT04529538|469600614|FG006|Overall Study|Other|0|||
130447826|NCT04529538|469600615|FG007|Overall Study|Other|0|||
130447827|NCT04529538|469600608|FG000|Overall Study|Adverse Event|0|||
130447828|NCT04529538|469600609|FG001|Overall Study|Adverse Event|0|||
130447829|NCT04529538|469600610|FG002|Overall Study|Adverse Event|0|||
130447830|NCT04529538|469600611|FG003|Overall Study|Adverse Event|1|||
130447831|NCT04529538|469600612|FG004|Overall Study|Adverse Event|0|||
130447832|NCT04529538|469600613|FG005|Overall Study|Adverse Event|0|||
130447833|NCT04529538|469600614|FG006|Overall Study|Adverse Event|0|||
130447834|NCT04529538|469600615|FG007|Overall Study|Adverse Event|0|||
130447835|NCT04529538|469600608|FG000|Overall Study|Protocol Deviation|0|||
130447836|NCT04529538|469600609|FG001|Overall Study|Protocol Deviation|0|||
130447837|NCT04529538|469600610|FG002|Overall Study|Protocol Deviation|0|||
130447838|NCT04529538|469600611|FG003|Overall Study|Protocol Deviation|1|||
130447839|NCT04529538|469600612|FG004|Overall Study|Protocol Deviation|0|||
130447840|NCT04529538|469600613|FG005|Overall Study|Protocol Deviation|0|||
130447841|NCT04529538|469600614|FG006|Overall Study|Protocol Deviation|0|||
130447842|NCT04529538|469600615|FG007|Overall Study|Protocol Deviation|0|||
130447843|NCT04529538|469600608|FG000|Overall Study|Physician Decision|0|||
130447844|NCT04529538|469600609|FG001|Overall Study|Physician Decision|0|||
130447845|NCT04529538|469600610|FG002|Overall Study|Physician Decision|0|||
130447846|NCT04529538|469600611|FG003|Overall Study|Physician Decision|0|||
130695563|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Subject request|8|||
130238500|NCT03765073|468836241|FG008|Stage 1|Lost to Follow-up|0|||
130238501|NCT03765073|468836242|FG009|Stage 1|Lost to Follow-up|0|||
130238502|NCT03765073|468836243|FG010|Stage 1|Lost to Follow-up|0|||
130238503|NCT03765073|468836244|FG011|Stage 1|Lost to Follow-up|0|||
130238504|NCT03765073|468836245|FG012|Stage 1|Lost to Follow-up|0|||
130238505|NCT03765073|468836246|FG013|Stage 1|Lost to Follow-up|0|||
130238506|NCT03765073|468836247|FG014|Stage 1|Lost to Follow-up|0|||
130238507|NCT03765073|468836248|FG015|Stage 1|Lost to Follow-up|0|||
130238508|NCT03765073|468836249|FG016|Stage 1|Lost to Follow-up|0|||
130238509|NCT03765073|468836250|FG017|Stage 1|Lost to Follow-up|0|||
130238510|NCT03765073|468836251|FG018|Stage 1|Lost to Follow-up|0|||
130695564|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Subject request|11|||
130695565|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
130238511|NCT03765073|468836252|FG019|Stage 1|Lost to Follow-up|0|||
130447847|NCT04529538|469600612|FG004|Overall Study|Physician Decision|0|||
130447848|NCT04529538|469600613|FG005|Overall Study|Physician Decision|1|||
130447849|NCT04529538|469600614|FG006|Overall Study|Physician Decision|0|||
130447850|NCT04529538|469600615|FG007|Overall Study|Physician Decision|1|||
130447851|NCT00235495|469600618|FG000|Overall Study|Death|52|||
130447852|NCT00235495|469600619|FG001|Overall Study|Death|42|||
130447853|NCT00235495|469600618|FG000|Overall Study|Withdrawal by Subject|5|||
130695566|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
130695567|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
130238512|NCT03765073|468836253|FG020|Stage 1|Lost to Follow-up|0|||
130447854|NCT00235495|469600619|FG001|Overall Study|Withdrawal by Subject|3|||
130447855|NCT00235495|469600618|FG000|Overall Study|Lost to Follow-up|11|||
130447856|NCT00235495|469600619|FG001|Overall Study|Lost to Follow-up|13|||
130447857|NCT00235495|469600618|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
130447858|NCT00235495|469600619|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
130447859|NCT05567952|469602013|FG000|Overall Study|Lost to Follow-up|3|||
130238513|NCT03765073|468836233|FG000|Stage 1|Withdrawal by participant|0|||
130238514|NCT03765073|468836234|FG001|Stage 1|Withdrawal by participant|1|||
130238515|NCT03765073|468836235|FG002|Stage 1|Withdrawal by participant|0|||
130238516|NCT03765073|468836236|FG003|Stage 1|Withdrawal by participant|0|||
130359557|NCT00333840|469288600|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
130359558|NCT00333840|469288601|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
130359559|NCT00333840|469288602|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
130359560|NCT00333840|469288603|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
130359561|NCT00333840|469288600|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
130359562|NCT00333840|469288601|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
130359563|NCT00333840|469288602|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
130359564|NCT00333840|469288603|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
130359565|NCT00333840|469288600|FG000|Second-line Treatment Period|Administrative problems|0|||
130359566|NCT00333840|469288601|FG001|Second-line Treatment Period|Administrative problems|0|||
130359567|NCT00333840|469288602|FG002|Second-line Treatment Period|Administrative problems|0|||
130359568|NCT00333840|469288603|FG003|Second-line Treatment Period|Administrative problems|7|||
130359569|NCT00333840|469288600|FG000|Second-line Treatment Period|Death|0|||
130359570|NCT00333840|469288601|FG001|Second-line Treatment Period|Death|0|||
130359571|NCT00333840|469288602|FG002|Second-line Treatment Period|Death|0|||
130359572|NCT00333840|469288603|FG003|Second-line Treatment Period|Death|9|||
130359573|NCT01453725|469288604|FG000|Overall Study|Adverse Event|3|||
130359574|NCT01453725|469288605|FG001|Overall Study|Adverse Event|3|||
130359575|NCT01453725|469288604|FG000|Overall Study|Lost to Follow-up|4|||
130359576|NCT01453725|469288605|FG001|Overall Study|Lost to Follow-up|0|||
130359577|NCT01453725|469288604|FG000|Overall Study|Non-compliance With Protocol|1|||
130359578|NCT01453725|469288605|FG001|Overall Study|Non-compliance With Protocol|2|||
130359579|NCT01453725|469288604|FG000|Overall Study|Protocol Violation|1|||
130359580|NCT01453725|469288605|FG001|Overall Study|Protocol Violation|0|||
130359581|NCT01453725|469288604|FG000|Overall Study|Withdrawal by Subject|2|||
130359582|NCT01453725|469288605|FG001|Overall Study|Withdrawal by Subject|3|||
130359583|NCT01453725|469288604|FG000|Overall Study|Pregnancy Wish|0|||
130359584|NCT01453725|469288605|FG001|Overall Study|Pregnancy Wish|2|||
130359585|NCT01453725|469288604|FG000|Overall Study|Pregnancy|1|||
130359586|NCT01453725|469288605|FG001|Overall Study|Pregnancy|0|||
130359587|NCT01453725|469288604|FG000|Overall Study|Physician Decision|1|||
130359588|NCT01453725|469288605|FG001|Overall Study|Physician Decision|1|||
130359589|NCT00875979|469288614|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
130359590|NCT00875979|469288615|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
130359591|NCT00875979|469288614|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
130359592|NCT00875979|469288615|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
130359593|NCT00875979|469288614|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
130359594|NCT00875979|469288615|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
130359595|NCT00875979|469288614|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
130359596|NCT00875979|469288615|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
130359597|NCT00875979|469288614|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
130359598|NCT00875979|469288615|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
130359599|NCT00875979|469288614|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
130359600|NCT00875979|469288615|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
130359601|NCT00875979|469288614|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
130359602|NCT00875979|469288615|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
130359603|NCT00875979|469288614|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
130359604|NCT00875979|469288615|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
130359605|NCT00875979|469288614|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
130359606|NCT00875979|469288615|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
130359607|NCT03719586|469288616|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
130359608|NCT03719586|469288617|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
130359609|NCT03719586|469288618|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
130359610|NCT03719586|469288619|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
130359611|NCT00178633|469288620|FG000|Overall Study|Lost to Follow-up|6|||
130359612|NCT04810481|469288622|FG000|Overall Study|Disqualified data sets|10|||
130359613|NCT04810481|469288623|FG001|Overall Study|Disqualified data sets|28|||
130359614|NCT00369707|469288626|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
130359615|NCT00369707|469288626|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
130359616|NCT00369707|469288626|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
130238517|NCT03765073|468836237|FG004|Stage 1|Withdrawal by participant|0|||
130359617|NCT00369707|469288626|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
130359618|NCT00369707|469288626|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
130359619|NCT00369707|469288626|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
130359620|NCT00369707|469288626|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
130695568|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
130238518|NCT03765073|468836238|FG005|Stage 1|Withdrawal by participant|0|||
130238519|NCT03765073|468836239|FG006|Stage 1|Withdrawal by participant|0|||
130238520|NCT03765073|468836240|FG007|Stage 1|Withdrawal by participant|0|||
130238521|NCT03765073|468836241|FG008|Stage 1|Withdrawal by participant|0|||
130238522|NCT03765073|468836242|FG009|Stage 1|Withdrawal by participant|0|||
130238523|NCT03765073|468836243|FG010|Stage 1|Withdrawal by participant|0|||
130238524|NCT03765073|468836244|FG011|Stage 1|Withdrawal by participant|0|||
130238525|NCT03765073|468836245|FG012|Stage 1|Withdrawal by participant|0|||
130238526|NCT03765073|468836246|FG013|Stage 1|Withdrawal by participant|0|||
130238527|NCT03765073|468836247|FG014|Stage 1|Withdrawal by participant|0|||
130238528|NCT03765073|468836248|FG015|Stage 1|Withdrawal by participant|0|||
130238529|NCT03765073|468836249|FG016|Stage 1|Withdrawal by participant|0|||
130238530|NCT03765073|468836250|FG017|Stage 1|Withdrawal by participant|0|||
130238531|NCT03765073|468836251|FG018|Stage 1|Withdrawal by participant|0|||
130238532|NCT03765073|468836252|FG019|Stage 1|Withdrawal by participant|0|||
130238533|NCT03765073|468836253|FG020|Stage 1|Withdrawal by participant|0|||
130238534|NCT03765073|468836233|FG000|Stage 2|Death|0|||
130238535|NCT03765073|468836234|FG001|Stage 2|Death|0|||
130238536|NCT03765073|468836235|FG002|Stage 2|Death|0|||
130238537|NCT03765073|468836236|FG003|Stage 2|Death|0|||
130238538|NCT03765073|468836237|FG004|Stage 2|Death|0|||
130238539|NCT03765073|468836238|FG005|Stage 2|Death|0|||
130238540|NCT03765073|468836239|FG006|Stage 2|Death|0|||
130238541|NCT03765073|468836240|FG007|Stage 2|Death|0|||
130238542|NCT03765073|468836241|FG008|Stage 2|Death|0|||
130238543|NCT03765073|468836242|FG009|Stage 2|Death|1|||
130238544|NCT03765073|468836243|FG010|Stage 2|Death|0|||
130238545|NCT03765073|468836244|FG011|Stage 2|Death|1|||
130238546|NCT03765073|468836245|FG012|Stage 2|Death|0|||
130238547|NCT03765073|468836246|FG013|Stage 2|Death|0|||
130238548|NCT03765073|468836247|FG014|Stage 2|Death|0|||
130238549|NCT03765073|468836248|FG015|Stage 2|Death|0|||
130238550|NCT03765073|468836249|FG016|Stage 2|Death|2|||
130238551|NCT03765073|468836250|FG017|Stage 2|Death|0|||
130238552|NCT03765073|468836251|FG018|Stage 2|Death|0|||
130238553|NCT03765073|468836252|FG019|Stage 2|Death|0|||
130238554|NCT03765073|468836253|FG020|Stage 2|Death|0|||
130238555|NCT03765073|468836233|FG000|Stage 2|Lost to Follow-up|0|||
130238556|NCT03765073|468836234|FG001|Stage 2|Lost to Follow-up|0|||
130238557|NCT03765073|468836235|FG002|Stage 2|Lost to Follow-up|0|||
130238558|NCT03765073|468836236|FG003|Stage 2|Lost to Follow-up|5|||
130238559|NCT03765073|468836237|FG004|Stage 2|Lost to Follow-up|1|||
130238560|NCT03765073|468836238|FG005|Stage 2|Lost to Follow-up|0|||
130238561|NCT03765073|468836239|FG006|Stage 2|Lost to Follow-up|3|||
130238562|NCT03765073|468836240|FG007|Stage 2|Lost to Follow-up|3|||
130238563|NCT03765073|468836241|FG008|Stage 2|Lost to Follow-up|1|||
130238564|NCT03765073|468836242|FG009|Stage 2|Lost to Follow-up|6|||
130238565|NCT03765073|468836243|FG010|Stage 2|Lost to Follow-up|5|||
130238566|NCT03765073|468836244|FG011|Stage 2|Lost to Follow-up|1|||
130238567|NCT03765073|468836245|FG012|Stage 2|Lost to Follow-up|1|||
130238568|NCT03765073|468836246|FG013|Stage 2|Lost to Follow-up|3|||
130238569|NCT03765073|468836247|FG014|Stage 2|Lost to Follow-up|3|||
130238570|NCT03765073|468836248|FG015|Stage 2|Lost to Follow-up|1|||
130238571|NCT03765073|468836249|FG016|Stage 2|Lost to Follow-up|6|||
130238572|NCT03765073|468836250|FG017|Stage 2|Lost to Follow-up|0|||
130238573|NCT03765073|468836251|FG018|Stage 2|Lost to Follow-up|0|||
130238574|NCT03765073|468836252|FG019|Stage 2|Lost to Follow-up|0|||
130238575|NCT03765073|468836253|FG020|Stage 2|Lost to Follow-up|0|||
130695569|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
130695570|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
130238576|NCT03765073|468836233|FG000|Stage 2|Other|0|||
130238577|NCT03765073|468836234|FG001|Stage 2|Other|0|||
130238578|NCT03765073|468836235|FG002|Stage 2|Other|0|||
130238579|NCT03765073|468836236|FG003|Stage 2|Other|0|||
130238580|NCT03765073|468836237|FG004|Stage 2|Other|0|||
130238581|NCT03765073|468836238|FG005|Stage 2|Other|0|||
130695571|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
130238582|NCT03765073|468836239|FG006|Stage 2|Other|0|||
130238583|NCT03765073|468836240|FG007|Stage 2|Other|1|||
130238584|NCT03765073|468836241|FG008|Stage 2|Other|1|||
130238585|NCT03765073|468836242|FG009|Stage 2|Other|3|||
130238586|NCT03765073|468836243|FG010|Stage 2|Other|0|||
130238587|NCT03765073|468836244|FG011|Stage 2|Other|0|||
130238588|NCT03765073|468836245|FG012|Stage 2|Other|0|||
130238589|NCT03765073|468836246|FG013|Stage 2|Other|0|||
130238590|NCT03765073|468836247|FG014|Stage 2|Other|0|||
130238591|NCT03765073|468836248|FG015|Stage 2|Other|1|||
130695572|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
130238592|NCT03765073|468836249|FG016|Stage 2|Other|2|||
130238593|NCT03765073|468836250|FG017|Stage 2|Other|0|||
130238594|NCT03765073|468836251|FG018|Stage 2|Other|0|||
130238595|NCT03765073|468836252|FG019|Stage 2|Other|0|||
130238596|NCT03765073|468836253|FG020|Stage 2|Other|0|||
130238597|NCT03765073|468836233|FG000|Stage 2|Withdrawal by parent/guardian|0|||
130238598|NCT03765073|468836234|FG001|Stage 2|Withdrawal by parent/guardian|0|||
130238599|NCT03765073|468836235|FG002|Stage 2|Withdrawal by parent/guardian|0|||
130238600|NCT03765073|468836236|FG003|Stage 2|Withdrawal by parent/guardian|0|||
130695573|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
130695574|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
130695575|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Death|1|||
130695576|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Death|0|||
130695577|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
130695578|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
130695579|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
130695580|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
130695581|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
130695582|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
130695583|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
130695584|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
130695585|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130695586|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130238601|NCT03765073|468836237|FG004|Stage 2|Withdrawal by parent/guardian|0|||
130238602|NCT03765073|468836238|FG005|Stage 2|Withdrawal by parent/guardian|0|||
130695587|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
130695588|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
130695589|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
130695590|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
130695591|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
130695592|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
130695593|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
130695594|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
130695595|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
130238603|NCT03765073|468836239|FG006|Stage 2|Withdrawal by parent/guardian|0|||
130238604|NCT03765073|468836240|FG007|Stage 2|Withdrawal by parent/guardian|0|||
130238605|NCT03765073|468836241|FG008|Stage 2|Withdrawal by parent/guardian|0|||
130238606|NCT03765073|468836242|FG009|Stage 2|Withdrawal by parent/guardian|0|||
130238607|NCT03765073|468836243|FG010|Stage 2|Withdrawal by parent/guardian|3|||
130238608|NCT03765073|468836244|FG011|Stage 2|Withdrawal by parent/guardian|3|||
130238609|NCT03765073|468836245|FG012|Stage 2|Withdrawal by parent/guardian|3|||
130238610|NCT03765073|468836246|FG013|Stage 2|Withdrawal by parent/guardian|1|||
130238611|NCT03765073|468836247|FG014|Stage 2|Withdrawal by parent/guardian|1|||
130238612|NCT03765073|468836248|FG015|Stage 2|Withdrawal by parent/guardian|0|||
130238613|NCT03765073|468836249|FG016|Stage 2|Withdrawal by parent/guardian|3|||
130238614|NCT03765073|468836250|FG017|Stage 2|Withdrawal by parent/guardian|0|||
130238615|NCT03765073|468836251|FG018|Stage 2|Withdrawal by parent/guardian|0|||
130238616|NCT03765073|468836252|FG019|Stage 2|Withdrawal by parent/guardian|0|||
130238617|NCT03765073|468836253|FG020|Stage 2|Withdrawal by parent/guardian|0|||
130238618|NCT03765073|468836233|FG000|Stage 2|Withdrawal by Subject|0|||
130238619|NCT03765073|468836234|FG001|Stage 2|Withdrawal by Subject|0|||
130238620|NCT03765073|468836235|FG002|Stage 2|Withdrawal by Subject|0|||
130238621|NCT03765073|468836236|FG003|Stage 2|Withdrawal by Subject|3|||
130238622|NCT03765073|468836237|FG004|Stage 2|Withdrawal by Subject|3|||
130238623|NCT03765073|468836238|FG005|Stage 2|Withdrawal by Subject|3|||
130238624|NCT03765073|468836239|FG006|Stage 2|Withdrawal by Subject|0|||
130238625|NCT03765073|468836240|FG007|Stage 2|Withdrawal by Subject|1|||
130238626|NCT03765073|468836241|FG008|Stage 2|Withdrawal by Subject|0|||
130238627|NCT03765073|468836242|FG009|Stage 2|Withdrawal by Subject|5|||
130238628|NCT03765073|468836243|FG010|Stage 2|Withdrawal by Subject|0|||
130238629|NCT03765073|468836244|FG011|Stage 2|Withdrawal by Subject|0|||
130238630|NCT03765073|468836245|FG012|Stage 2|Withdrawal by Subject|0|||
130238631|NCT03765073|468836246|FG013|Stage 2|Withdrawal by Subject|0|||
130238632|NCT03765073|468836247|FG014|Stage 2|Withdrawal by Subject|0|||
130238633|NCT03765073|468836248|FG015|Stage 2|Withdrawal by Subject|0|||
130238634|NCT03765073|468836249|FG016|Stage 2|Withdrawal by Subject|0|||
130238635|NCT03765073|468836250|FG017|Stage 2|Withdrawal by Subject|0|||
130238636|NCT03765073|468836251|FG018|Stage 2|Withdrawal by Subject|0|||
130238637|NCT03765073|468836252|FG019|Stage 2|Withdrawal by Subject|0|||
130238638|NCT03765073|468836253|FG020|Stage 2|Withdrawal by Subject|0|||
130238639|NCT03765073|468836233|FG000|Stage 3|Adverse Event|0|||
130238640|NCT03765073|468836234|FG001|Stage 3|Adverse Event|0|||
130238641|NCT03765073|468836235|FG002|Stage 3|Adverse Event|0|||
130238642|NCT03765073|468836236|FG003|Stage 3|Adverse Event|0|||
130238643|NCT03765073|468836237|FG004|Stage 3|Adverse Event|0|||
130238644|NCT03765073|468836238|FG005|Stage 3|Adverse Event|0|||
130447860|NCT05567952|469602014|FG001|Overall Study|Lost to Follow-up|2|||
130238645|NCT03765073|468836239|FG006|Stage 3|Adverse Event|0|||
130238646|NCT03765073|468836240|FG007|Stage 3|Adverse Event|0|||
130238647|NCT03765073|468836241|FG008|Stage 3|Adverse Event|0|||
130238648|NCT03765073|468836242|FG009|Stage 3|Adverse Event|0|||
130238649|NCT03765073|468836243|FG010|Stage 3|Adverse Event|0|||
130238650|NCT03765073|468836244|FG011|Stage 3|Adverse Event|0|||
130238651|NCT03765073|468836245|FG012|Stage 3|Adverse Event|0|||
130238652|NCT03765073|468836246|FG013|Stage 3|Adverse Event|0|||
130238653|NCT03765073|468836247|FG014|Stage 3|Adverse Event|0|||
130238654|NCT03765073|468836248|FG015|Stage 3|Adverse Event|0|||
130238655|NCT03765073|468836249|FG016|Stage 3|Adverse Event|0|||
130238656|NCT03765073|468836250|FG017|Stage 3|Adverse Event|0|||
130238657|NCT03765073|468836251|FG018|Stage 3|Adverse Event|1|||
130238658|NCT03765073|468836252|FG019|Stage 3|Adverse Event|0|||
130238659|NCT03765073|468836253|FG020|Stage 3|Adverse Event|0|||
130238660|NCT03765073|468836233|FG000|Stage 3|Death|0|||
130238661|NCT03765073|468836234|FG001|Stage 3|Death|0|||
130238662|NCT03765073|468836235|FG002|Stage 3|Death|0|||
130238663|NCT03765073|468836236|FG003|Stage 3|Death|0|||
130238664|NCT03765073|468836237|FG004|Stage 3|Death|0|||
130238665|NCT03765073|468836238|FG005|Stage 3|Death|0|||
130238666|NCT03765073|468836239|FG006|Stage 3|Death|0|||
130238667|NCT03765073|468836240|FG007|Stage 3|Death|0|||
130238668|NCT03765073|468836241|FG008|Stage 3|Death|0|||
130238669|NCT03765073|468836242|FG009|Stage 3|Death|0|||
130238670|NCT03765073|468836243|FG010|Stage 3|Death|0|||
130238671|NCT03765073|468836244|FG011|Stage 3|Death|0|||
130238672|NCT03765073|468836245|FG012|Stage 3|Death|0|||
130238673|NCT03765073|468836246|FG013|Stage 3|Death|0|||
130238674|NCT03765073|468836247|FG014|Stage 3|Death|0|||
130238675|NCT03765073|468836248|FG015|Stage 3|Death|0|||
130238676|NCT03765073|468836249|FG016|Stage 3|Death|0|||
130238677|NCT03765073|468836250|FG017|Stage 3|Death|0|||
130238678|NCT03765073|468836251|FG018|Stage 3|Death|0|||
130238679|NCT03765073|468836252|FG019|Stage 3|Death|3|||
130238680|NCT03765073|468836253|FG020|Stage 3|Death|2|||
130238681|NCT03765073|468836233|FG000|Stage 3|Lost to Follow-up|0|||
130238682|NCT03765073|468836234|FG001|Stage 3|Lost to Follow-up|0|||
130238683|NCT03765073|468836235|FG002|Stage 3|Lost to Follow-up|0|||
130238684|NCT03765073|468836236|FG003|Stage 3|Lost to Follow-up|0|||
130238685|NCT03765073|468836237|FG004|Stage 3|Lost to Follow-up|0|||
130238686|NCT03765073|468836238|FG005|Stage 3|Lost to Follow-up|0|||
130238687|NCT03765073|468836239|FG006|Stage 3|Lost to Follow-up|0|||
130238688|NCT03765073|468836240|FG007|Stage 3|Lost to Follow-up|0|||
130238689|NCT03765073|468836241|FG008|Stage 3|Lost to Follow-up|0|||
130238690|NCT03765073|468836242|FG009|Stage 3|Lost to Follow-up|0|||
130238691|NCT03765073|468836243|FG010|Stage 3|Lost to Follow-up|0|||
130238692|NCT03765073|468836244|FG011|Stage 3|Lost to Follow-up|0|||
130238693|NCT03765073|468836245|FG012|Stage 3|Lost to Follow-up|0|||
130238694|NCT03765073|468836246|FG013|Stage 3|Lost to Follow-up|0|||
130238695|NCT03765073|468836247|FG014|Stage 3|Lost to Follow-up|0|||
130238696|NCT03765073|468836248|FG015|Stage 3|Lost to Follow-up|0|||
130238697|NCT03765073|468836249|FG016|Stage 3|Lost to Follow-up|0|||
130359621|NCT00369707|469288626|FG000|Follow up for 2 Years After Treatment|Death|1|||
130359622|NCT00369707|469288626|FG000|Follow up for 2 Years After Treatment|Other|2|||
130359623|NCT04674644|469288636|FG000|Overall Study|with missing data|37|||
130695596|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
130695597|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
130695598|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
130359624|NCT01230710|469288642|FG000|Overall Study|Disease Progression|41|||
130359625|NCT01230710|469288642|FG000|Overall Study|Lost to Follow-up|3|||
130359626|NCT01230710|469288642|FG000|Overall Study|Death|4|||
130359627|NCT01230710|469288642|FG000|Overall Study|Withdrawal of Consent|1|||
130695599|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
130695600|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
130695601|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130695602|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130695603|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695604|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130238698|NCT03765073|468836250|FG017|Stage 3|Lost to Follow-up|8|||
130238699|NCT03765073|468836251|FG018|Stage 3|Lost to Follow-up|5|||
130238700|NCT03765073|468836252|FG019|Stage 3|Lost to Follow-up|7|||
130238701|NCT03765073|468836253|FG020|Stage 3|Lost to Follow-up|4|||
130238702|NCT03765073|468836233|FG000|Stage 3|No longer meets eligibility criteria|0|||
130238703|NCT03765073|468836234|FG001|Stage 3|No longer meets eligibility criteria|0|||
130359628|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
130238704|NCT03765073|468836235|FG002|Stage 3|No longer meets eligibility criteria|0|||
130238705|NCT03765073|468836236|FG003|Stage 3|No longer meets eligibility criteria|0|||
130238706|NCT03765073|468836237|FG004|Stage 3|No longer meets eligibility criteria|0|||
130238707|NCT03765073|468836238|FG005|Stage 3|No longer meets eligibility criteria|0|||
130238708|NCT03765073|468836239|FG006|Stage 3|No longer meets eligibility criteria|0|||
130238709|NCT03765073|468836240|FG007|Stage 3|No longer meets eligibility criteria|0|||
130238710|NCT03765073|468836241|FG008|Stage 3|No longer meets eligibility criteria|0|||
130238711|NCT03765073|468836242|FG009|Stage 3|No longer meets eligibility criteria|0|||
130695605|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695606|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695607|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
130695608|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
130695609|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695610|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695611|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695612|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695613|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
130695614|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695615|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695616|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695617|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695618|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695619|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130695620|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130695621|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695622|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695623|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695624|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695625|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695626|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695627|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695628|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
130695629|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
130695630|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
130695631|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130695632|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130695633|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
130695634|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130695635|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130695636|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
130695637|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695638|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695639|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695640|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130695641|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130695642|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
130695643|NCT00642993|470510577|FG000|Overall Study|Adverse Event|85|||
130695644|NCT00642993|470510578|FG001|Overall Study|Adverse Event|4|||
130695645|NCT00642993|470510577|FG000|Overall Study|Lost to Follow-up|8|||
130695646|NCT00642993|470510578|FG001|Overall Study|Lost to Follow-up|4|||
130695647|NCT00642993|470510577|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
130695648|NCT00642993|470510578|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
130695649|NCT00642993|470510577|FG000|Overall Study|Protocol Violation|1|||
130695650|NCT00642993|470510578|FG001|Overall Study|Protocol Violation|4|||
130695651|NCT00642993|470510577|FG000|Overall Study|Did not meet protocol eligibility|0|||
130695652|NCT00642993|470510578|FG001|Overall Study|Did not meet protocol eligibility|1|||
130695653|NCT00642993|470510577|FG000|Overall Study|Administrative|1|||
130695654|NCT00642993|470510578|FG001|Overall Study|Administrative|0|||
130695655|NCT02664415|470510579|FG000|Overall Study|Adverse Event|1|||
130695656|NCT02664415|470510580|FG001|Overall Study|Adverse Event|0|||
130695657|NCT02986139|470510584|FG000|Overall Study|Sponsor Decision|1|||
130695658|NCT02986139|470510585|FG001|Overall Study|Sponsor Decision|2|||
130695659|NCT02986139|470510584|FG000|Overall Study|Withdrawal by Subject|0|||
130695660|NCT02986139|470510585|FG001|Overall Study|Withdrawal by Subject|1|||
130695661|NCT02986139|470510584|FG000|Overall Study|Lost to Follow-up|0|||
130695662|NCT02986139|470510585|FG001|Overall Study|Lost to Follow-up|1|||
130238712|NCT03765073|468836243|FG010|Stage 3|No longer meets eligibility criteria|0|||
130238713|NCT03765073|468836244|FG011|Stage 3|No longer meets eligibility criteria|0|||
130238714|NCT03765073|468836245|FG012|Stage 3|No longer meets eligibility criteria|0|||
130238715|NCT03765073|468836246|FG013|Stage 3|No longer meets eligibility criteria|0|||
130238716|NCT03765073|468836247|FG014|Stage 3|No longer meets eligibility criteria|0|||
130238717|NCT03765073|468836248|FG015|Stage 3|No longer meets eligibility criteria|0|||
130359629|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
130559414|NCT01621542|470016492|FG002|Overall Study|Withdrawal by Subject|1|||
130238718|NCT03765073|468836249|FG016|Stage 3|No longer meets eligibility criteria|0|||
130238719|NCT03765073|468836250|FG017|Stage 3|No longer meets eligibility criteria|0|||
130238720|NCT03765073|468836251|FG018|Stage 3|No longer meets eligibility criteria|1|||
130238721|NCT03765073|468836252|FG019|Stage 3|No longer meets eligibility criteria|0|||
130238722|NCT03765073|468836253|FG020|Stage 3|No longer meets eligibility criteria|1|||
130447861|NCT05567952|469602013|FG000|Overall Study|Withdrawal by Subject|6|||
130447862|NCT05567952|469602014|FG001|Overall Study|Withdrawal by Subject|3|||
130447863|NCT05567952|469602013|FG000|Overall Study|Other|3|||
130447864|NCT05567952|469602014|FG001|Overall Study|Other|1|||
130447865|NCT01929993|469602024|FG000|Overall Study|Protocol Violation|4|||
130447866|NCT01929993|469602025|FG001|Overall Study|Protocol Violation|6|||
130447867|NCT01929993|469602024|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
130447868|NCT01929993|469602025|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
130447869|NCT01852162|469602026|FG000|Overall Study|Adverse Event|1|||
130447870|NCT01852162|469602027|FG001|Overall Study|Adverse Event|0|||
130447871|NCT01852162|469602026|FG000|Overall Study|Withdrawal by Subject|3|||
130447872|NCT01852162|469602027|FG001|Overall Study|Withdrawal by Subject|1|||
130447873|NCT03660943|469602034|FG000|Overall Study|Adverse Event|5|||
130447874|NCT03660943|469602035|FG001|Overall Study|Adverse Event|3|||
130447875|NCT03660943|469602034|FG000|Overall Study|Death|0|||
130447876|NCT03660943|469602035|FG001|Overall Study|Death|2|||
130447877|NCT03660943|469602034|FG000|Overall Study|Lost to Follow-up|7|||
130447878|NCT03660943|469602035|FG001|Overall Study|Lost to Follow-up|3|||
130447879|NCT03660943|469602034|FG000|Overall Study|Protocol Violation|3|||
130447880|NCT03660943|469602035|FG001|Overall Study|Protocol Violation|5|||
130447881|NCT03660943|469602034|FG000|Overall Study|Withdrawal by Subject|8|||
130447882|NCT03660943|469602035|FG001|Overall Study|Withdrawal by Subject|15|||
130447883|NCT03660943|469602034|FG000|Overall Study|Lack of Efficacy|9|||
130447884|NCT03660943|469602035|FG001|Overall Study|Lack of Efficacy|12|||
130447885|NCT03660943|469602034|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
130447886|NCT03660943|469602035|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
130447887|NCT04096365|469602036|FG000|Overall Study|Adverse Event|1|||
130447888|NCT05310084|469602037|FG000|Overall Study|Withdrawal by Subject|2|||
130447889|NCT05310084|469602038|FG001|Overall Study|Withdrawal by Subject|3|||
130447890|NCT05310084|469602037|FG000|Overall Study|Participant availability|0|||
130447891|NCT05310084|469602038|FG001|Overall Study|Participant availability|4|||
130447892|NCT05310084|469602037|FG000|Overall Study|Lost to Follow-up|1|||
130447893|NCT05310084|469602038|FG001|Overall Study|Lost to Follow-up|1|||
130447894|NCT05310084|469602037|FG000|Overall Study|Adverse Event|1|||
130447895|NCT05310084|469602038|FG001|Overall Study|Adverse Event|1|||
130447896|NCT05310084|469602037|FG000|Overall Study|Randomized but not vaccinated|4|||
130447897|NCT05310084|469602038|FG001|Overall Study|Randomized but not vaccinated|2|||
130447898|NCT02892409|469602042|FG000|Overall Study|Adverse Event|1|||
130447899|NCT02892409|469602043|FG001|Overall Study|Adverse Event|0|||
130447900|NCT02892409|469602042|FG000|Overall Study|Withdrawal by Subject|2|||
130447901|NCT02892409|469602043|FG001|Overall Study|Withdrawal by Subject|1|||
130447902|NCT02123966|469602046|FG000|Overall Study|Intercurrent Illness|1|||
130447903|NCT03019458|469602050|FG000|Overall Study|Death|0|||
130447904|NCT03019458|469602051|FG001|Overall Study|Death|1|||
130447905|NCT01561079|469602052|FG000|Overall Study|Physician Decision|17|||
130447906|NCT01561079|469602052|FG000|Overall Study|Withdrawal by Subject|59|||
130447907|NCT01561079|469602052|FG000|Overall Study|Protocol Violation|2|||
130447908|NCT00664521|469602061|FG000|Overall Study|Adverse Event|4|||
130447909|NCT00664521|469602062|FG001|Overall Study|Adverse Event|1|||
130447910|NCT00664521|469602061|FG000|Overall Study|Lost to Follow-up|1|||
130447911|NCT00664521|469602062|FG001|Overall Study|Lost to Follow-up|0|||
130447912|NCT00664521|469602061|FG000|Overall Study|Other|1|||
130447913|NCT00664521|469602062|FG001|Overall Study|Other|0|||
130447914|NCT02459964|469602063|FG000|Overall Study|Withdrawal by Subject|0|||
130447915|NCT02459964|469602064|FG001|Overall Study|Withdrawal by Subject|0|||
130447916|NCT02459964|469602065|FG002|Overall Study|Withdrawal by Subject|1|||
130238723|NCT03765073|468836233|FG000|Stage 3|Other|0|||
130238724|NCT03765073|468836234|FG001|Stage 3|Other|0|||
130238725|NCT03765073|468836235|FG002|Stage 3|Other|0|||
130447917|NCT02459964|469602063|FG000|Overall Study|Abnormal EKG changes|0|||
130447918|NCT02459964|469602064|FG001|Overall Study|Abnormal EKG changes|0|||
130447919|NCT02459964|469602065|FG002|Overall Study|Abnormal EKG changes|1|||
130238726|NCT03765073|468836236|FG003|Stage 3|Other|0|||
130238727|NCT03765073|468836237|FG004|Stage 3|Other|0|||
130238728|NCT03765073|468836238|FG005|Stage 3|Other|0|||
130447920|NCT00367237|469602066|FG000|Overall Study|Adverse Event|7|||
130447921|NCT00367237|469602067|FG001|Overall Study|Adverse Event|2|||
130447922|NCT00367237|469602066|FG000|Overall Study|Lost to Follow-up|1|||
130447923|NCT00367237|469602067|FG001|Overall Study|Lost to Follow-up|0|||
130238729|NCT03765073|468836239|FG006|Stage 3|Other|0|||
130238730|NCT03765073|468836240|FG007|Stage 3|Other|0|||
130238731|NCT03765073|468836241|FG008|Stage 3|Other|0|||
130238732|NCT03765073|468836242|FG009|Stage 3|Other|0|||
130238733|NCT03765073|468836243|FG010|Stage 3|Other|0|||
130238734|NCT03765073|468836244|FG011|Stage 3|Other|0|||
130238735|NCT03765073|468836245|FG012|Stage 3|Other|0|||
130238736|NCT03765073|468836246|FG013|Stage 3|Other|0|||
130238737|NCT03765073|468836247|FG014|Stage 3|Other|0|||
130238738|NCT03765073|468836248|FG015|Stage 3|Other|0|||
130238739|NCT03765073|468836249|FG016|Stage 3|Other|0|||
130238740|NCT03765073|468836250|FG017|Stage 3|Other|1|||
130238741|NCT03765073|468836251|FG018|Stage 3|Other|2|||
130238742|NCT03765073|468836252|FG019|Stage 3|Other|2|||
130238743|NCT03765073|468836253|FG020|Stage 3|Other|2|||
130238744|NCT03765073|468836233|FG000|Stage 3|Withdrawal by parent/guardian|0|||
130238745|NCT03765073|468836234|FG001|Stage 3|Withdrawal by parent/guardian|0|||
130238746|NCT03765073|468836235|FG002|Stage 3|Withdrawal by parent/guardian|0|||
130238747|NCT03765073|468836236|FG003|Stage 3|Withdrawal by parent/guardian|0|||
130238748|NCT03765073|468836237|FG004|Stage 3|Withdrawal by parent/guardian|0|||
130238749|NCT03765073|468836238|FG005|Stage 3|Withdrawal by parent/guardian|0|||
130238750|NCT03765073|468836239|FG006|Stage 3|Withdrawal by parent/guardian|0|||
130238751|NCT03765073|468836240|FG007|Stage 3|Withdrawal by parent/guardian|0|||
130238752|NCT03765073|468836241|FG008|Stage 3|Withdrawal by parent/guardian|0|||
130238753|NCT03765073|468836242|FG009|Stage 3|Withdrawal by parent/guardian|0|||
130238754|NCT03765073|468836243|FG010|Stage 3|Withdrawal by parent/guardian|0|||
130238755|NCT03765073|468836244|FG011|Stage 3|Withdrawal by parent/guardian|0|||
130238756|NCT03765073|468836245|FG012|Stage 3|Withdrawal by parent/guardian|0|||
130238757|NCT03765073|468836246|FG013|Stage 3|Withdrawal by parent/guardian|0|||
130238758|NCT03765073|468836247|FG014|Stage 3|Withdrawal by parent/guardian|0|||
130238759|NCT03765073|468836248|FG015|Stage 3|Withdrawal by parent/guardian|0|||
130238760|NCT03765073|468836249|FG016|Stage 3|Withdrawal by parent/guardian|0|||
130238761|NCT03765073|468836250|FG017|Stage 3|Withdrawal by parent/guardian|0|||
130238762|NCT03765073|468836251|FG018|Stage 3|Withdrawal by parent/guardian|0|||
130238763|NCT03765073|468836252|FG019|Stage 3|Withdrawal by parent/guardian|6|||
130238764|NCT03765073|468836253|FG020|Stage 3|Withdrawal by parent/guardian|9|||
130238765|NCT03765073|468836233|FG000|Stage 3|Withdrawal by Subject|0|||
130238766|NCT03765073|468836234|FG001|Stage 3|Withdrawal by Subject|0|||
130238767|NCT03765073|468836235|FG002|Stage 3|Withdrawal by Subject|0|||
130238768|NCT03765073|468836236|FG003|Stage 3|Withdrawal by Subject|0|||
130238769|NCT03765073|468836237|FG004|Stage 3|Withdrawal by Subject|0|||
130238770|NCT03765073|468836238|FG005|Stage 3|Withdrawal by Subject|0|||
130238771|NCT03765073|468836239|FG006|Stage 3|Withdrawal by Subject|0|||
130238772|NCT03765073|468836240|FG007|Stage 3|Withdrawal by Subject|0|||
130238773|NCT03765073|468836241|FG008|Stage 3|Withdrawal by Subject|0|||
130238774|NCT03765073|468836242|FG009|Stage 3|Withdrawal by Subject|0|||
130238775|NCT03765073|468836243|FG010|Stage 3|Withdrawal by Subject|0|||
130238776|NCT03765073|468836244|FG011|Stage 3|Withdrawal by Subject|0|||
130359630|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Physician Decision|1|||
130359631|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Physician Decision|0|||
130359632|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
130359633|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
130359634|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
130359635|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
130359636|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Adverse Event|15|||
130359637|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Adverse Event|0|||
130359638|NCT03277690|469288643|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
130359639|NCT03277690|469288644|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
130359640|NCT03277690|469288643|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
130359641|NCT03277690|469288644|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
130359642|NCT01691898|469288645|FG000|Overall Study|Death|34|||
130359643|NCT01691898|469288646|FG001|Overall Study|Death|32|||
130359644|NCT01691898|469288647|FG002|Overall Study|Death|6|||
130359645|NCT01691898|469288648|FG003|Overall Study|Death|3|||
130359646|NCT01691898|469288649|FG004|Overall Study|Death|8|||
130359647|NCT01691898|469288650|FG005|Overall Study|Death|31|||
130359648|NCT01691898|469288645|FG000|Overall Study|Adverse Event|0|||
130238777|NCT03765073|468836245|FG012|Stage 3|Withdrawal by Subject|0|||
130238778|NCT03765073|468836246|FG013|Stage 3|Withdrawal by Subject|0|||
130238779|NCT03765073|468836247|FG014|Stage 3|Withdrawal by Subject|0|||
130359649|NCT01691898|469288646|FG001|Overall Study|Adverse Event|1|||
130359650|NCT01691898|469288647|FG002|Overall Study|Adverse Event|0|||
130238780|NCT03765073|468836248|FG015|Stage 3|Withdrawal by Subject|0|||
130238781|NCT03765073|468836249|FG016|Stage 3|Withdrawal by Subject|0|||
130238782|NCT03765073|468836250|FG017|Stage 3|Withdrawal by Subject|8|||
130238783|NCT03765073|468836251|FG018|Stage 3|Withdrawal by Subject|11|||
130238784|NCT03765073|468836252|FG019|Stage 3|Withdrawal by Subject|0|||
130359651|NCT01691898|469288648|FG003|Overall Study|Adverse Event|1|||
130359652|NCT01691898|469288649|FG004|Overall Study|Adverse Event|1|||
130359653|NCT01691898|469288650|FG005|Overall Study|Adverse Event|0|||
130238785|NCT03765073|468836253|FG020|Stage 3|Withdrawal by Subject|0|||
130238786|NCT04537299|468836254|FG000|Overall Study|Withdrawal by Subject|2|||
130238787|NCT04537299|468836255|FG001|Overall Study|Withdrawal by Subject|0|||
130238788|NCT04537299|468836254|FG000|Overall Study|Protocol Violation|1|||
130238789|NCT04537299|468836255|FG001|Overall Study|Protocol Violation|1|||
130238790|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
130238791|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
130238792|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
130238793|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
130238794|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130238795|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130238796|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
130238797|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130238798|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130238799|NCT00876343|468836267|FG000|Overall Study|Adverse Event|7|||
130238800|NCT00876343|468836268|FG001|Overall Study|Adverse Event|8|||
130238801|NCT00876343|468836269|FG002|Overall Study|Adverse Event|2|||
130238802|NCT00876343|468836267|FG000|Overall Study|Withdrawal by Subject|4|||
130238803|NCT00876343|468836268|FG001|Overall Study|Withdrawal by Subject|4|||
130238804|NCT00876343|468836269|FG002|Overall Study|Withdrawal by Subject|3|||
130238805|NCT00876343|468836267|FG000|Overall Study|Lack of Efficacy|0|||
130238806|NCT00876343|468836268|FG001|Overall Study|Lack of Efficacy|0|||
130238807|NCT00876343|468836269|FG002|Overall Study|Lack of Efficacy|1|||
130238808|NCT00876343|468836267|FG000|Overall Study|Protocol Violation|4|||
130238809|NCT00876343|468836268|FG001|Overall Study|Protocol Violation|1|||
130238810|NCT00876343|468836269|FG002|Overall Study|Protocol Violation|1|||
130238811|NCT00876343|468836267|FG000|Overall Study|Physician Decision|0|||
130238812|NCT00876343|468836268|FG001|Overall Study|Physician Decision|1|||
130238813|NCT00876343|468836269|FG002|Overall Study|Physician Decision|1|||
130238814|NCT00876343|468836267|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
130238815|NCT00876343|468836268|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130238816|NCT00876343|468836269|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130238817|NCT00876343|468836267|FG000|Overall Study|Change of residence or other commitments|2|||
130238818|NCT00876343|468836268|FG001|Overall Study|Change of residence or other commitments|2|||
130238819|NCT00876343|468836269|FG002|Overall Study|Change of residence or other commitments|3|||
130238820|NCT01933932|468836272|FG000|Overall Study|Death|173|||
130238821|NCT01933932|468836273|FG001|Overall Study|Death|163|||
130238822|NCT01933932|468836272|FG000|Overall Study|Withdrawal by Subject|11|||
130238823|NCT01933932|468836273|FG001|Overall Study|Withdrawal by Subject|14|||
130238824|NCT01933932|468836272|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130238825|NCT01933932|468836273|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130238826|NCT01925794|468836281|FG000|180 Days|Death|2|||
130238827|NCT01925794|468836281|FG000|180 Days|Withdrawal by Subject|2|||
130238828|NCT01925794|468836281|FG000|270 Days|Death|2|||
130359654|NCT01691898|469288645|FG000|Overall Study|Progression of Disease|1|||
130359655|NCT01691898|469288646|FG001|Overall Study|Progression of Disease|2|||
130359656|NCT01691898|469288647|FG002|Overall Study|Progression of Disease|1|||
130359657|NCT01691898|469288648|FG003|Overall Study|Progression of Disease|0|||
130359658|NCT01691898|469288649|FG004|Overall Study|Progression of Disease|0|||
130359659|NCT01691898|469288650|FG005|Overall Study|Progression of Disease|1|||
130359660|NCT01691898|469288645|FG000|Overall Study|Lost to Follow-up|3|||
130359661|NCT01691898|469288646|FG001|Overall Study|Lost to Follow-up|1|||
130359662|NCT01691898|469288647|FG002|Overall Study|Lost to Follow-up|0|||
130359663|NCT01691898|469288648|FG003|Overall Study|Lost to Follow-up|0|||
130359664|NCT01691898|469288649|FG004|Overall Study|Lost to Follow-up|1|||
130359665|NCT01691898|469288650|FG005|Overall Study|Lost to Follow-up|0|||
130359666|NCT01691898|469288645|FG000|Overall Study|Withdrawal by Subject|9|||
130359667|NCT01691898|469288646|FG001|Overall Study|Withdrawal by Subject|8|||
130359668|NCT01691898|469288647|FG002|Overall Study|Withdrawal by Subject|2|||
130695663|NCT00414726|470510586|FG000|Overall Study|Withdrawal by Subject|0|||
130695664|NCT00414726|470510587|FG001|Overall Study|Withdrawal by Subject|1|||
130695665|NCT02107196|470510588|FG000|12-week Treatment Period|Adverse Event|6|||
130238829|NCT01925794|468836281|FG000|270 Days|Protocol Violation|3|||
130238830|NCT00790036|468836282|FG000|Overall Study|Abnormal lab values|3|||
130238831|NCT00790036|468836283|FG001|Overall Study|Abnormal lab values|2|||
130238832|NCT00790036|468836282|FG000|Overall Study|Administrative problems|5|||
130238833|NCT00790036|468836283|FG001|Overall Study|Administrative problems|9|||
130238834|NCT00790036|468836282|FG000|Overall Study|Adverse Event|113|||
130238835|NCT00790036|468836283|FG001|Overall Study|Adverse Event|44|||
130238836|NCT00790036|468836282|FG000|Overall Study|Death|1|||
130238837|NCT00790036|468836283|FG001|Overall Study|Death|0|||
130238838|NCT00790036|468836282|FG000|Overall Study|Disease progression|24|||
130238839|NCT00790036|468836283|FG001|Overall Study|Disease progression|48|||
130238840|NCT00790036|468836282|FG000|Overall Study|Lost to Follow-up|1|||
130238841|NCT00790036|468836283|FG001|Overall Study|Lost to Follow-up|2|||
130359669|NCT01691898|469288648|FG003|Overall Study|Withdrawal by Subject|1|||
130359670|NCT01691898|469288649|FG004|Overall Study|Withdrawal by Subject|3|||
130359671|NCT01691898|469288650|FG005|Overall Study|Withdrawal by Subject|3|||
130695666|NCT02107196|470510589|FG001|12-week Treatment Period|Adverse Event|3|||
130695667|NCT02107196|470510588|FG000|12-week Treatment Period|Lack of Efficacy|2|||
130695668|NCT02107196|470510589|FG001|12-week Treatment Period|Lack of Efficacy|1|||
130695669|NCT02107196|470510588|FG000|12-week Treatment Period|Lost to Follow-up|3|||
130695670|NCT02107196|470510589|FG001|12-week Treatment Period|Lost to Follow-up|6|||
130695671|NCT02107196|470510588|FG000|12-week Treatment Period|Physician Decision|0|||
130695672|NCT02107196|470510589|FG001|12-week Treatment Period|Physician Decision|1|||
130695673|NCT02107196|470510588|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
130695674|NCT02107196|470510589|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
130695675|NCT02107196|470510588|FG000|12-week Treatment Period|Protocol Violation|7|||
130695676|NCT02107196|470510589|FG001|12-week Treatment Period|Protocol Violation|8|||
130695677|NCT02107196|470510588|FG000|12-week Treatment Period|Reason Missing|11|||
130695678|NCT02107196|470510589|FG001|12-week Treatment Period|Reason Missing|8|||
130695679|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
130695680|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
130695681|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
130695682|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130695683|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
130695684|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
130695685|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
130695686|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
130695687|NCT00516295|470510590|FG000|Overall Study|Lack of Efficacy|2|||
130695688|NCT00516295|470510591|FG001|Overall Study|Lack of Efficacy|0|||
130695689|NCT00516295|470510592|FG002|Overall Study|Lack of Efficacy|0|||
130695690|NCT00516295|470510590|FG000|Overall Study|Ineligible|1|||
130695691|NCT00516295|470510591|FG001|Overall Study|Ineligible|0|||
130695692|NCT00516295|470510592|FG002|Overall Study|Ineligible|0|||
130695693|NCT01630616|470510597|FG000|Overall Study|Adverse Event|0|||
130238842|NCT00790036|468836282|FG000|Overall Study|Protocol Violation|10|||
130238843|NCT00790036|468836283|FG001|Overall Study|Protocol Violation|2|||
130238844|NCT00790036|468836282|FG000|Overall Study|Withdrawal by Subject|18|||
130238845|NCT00790036|468836283|FG001|Overall Study|Withdrawal by Subject|7|||
130238846|NCT00790036|468836282|FG000|Overall Study|Subject/guardian decision|20|||
130238847|NCT00790036|468836283|FG001|Overall Study|Subject/guardian decision|7|||
130238848|NCT03126110|468836292|FG000|Phase 1|Death|2|||
130238849|NCT03126110|468836293|FG001|Phase 1|Death|2|||
130238850|NCT03126110|468836294|FG002|Phase 1|Death|4|||
130695694|NCT01630616|470510598|FG001|Overall Study|Adverse Event|0|||
130695695|NCT01630616|470510599|FG002|Overall Study|Adverse Event|0|||
130695696|NCT01630616|470510600|FG003|Overall Study|Adverse Event|1|||
130695697|NCT01630616|470510601|FG004|Overall Study|Adverse Event|0|||
130238851|NCT03126110|468836295|FG003|Phase 1|Death|3|||
130238852|NCT03126110|468836296|FG004|Phase 1|Death|4|||
130238853|NCT03126110|468836297|FG005|Phase 1|Death|4|||
130238854|NCT03126110|468836298|FG006|Phase 1|Death|3|||
130238855|NCT03126110|468836299|FG007|Phase 1|Death|4|||
130238856|NCT03126110|468836300|FG008|Phase 1|Death|5|||
130238857|NCT03126110|468836301|FG009|Phase 1|Death|2|||
130238858|NCT03126110|468836302|FG010|Phase 1|Death|6|||
130359672|NCT01691898|469288645|FG000|Overall Study|Non-Compliance|0|||
130359673|NCT01691898|469288646|FG001|Overall Study|Non-Compliance|0|||
130359674|NCT01691898|469288647|FG002|Overall Study|Non-Compliance|0|||
130359675|NCT01691898|469288648|FG003|Overall Study|Non-Compliance|0|||
130359676|NCT01691898|469288649|FG004|Overall Study|Non-Compliance|1|||
130359677|NCT01691898|469288650|FG005|Overall Study|Non-Compliance|0|||
130359678|NCT00747812|469288651|FG000|Overall Study|Research Site Staff Relocation|5|||
130359679|NCT00747812|469288652|FG001|Overall Study|Research Site Staff Relocation|3|||
130359680|NCT01708161|469288653|FG000|Overall Study|Adverse Event|1|||
130359681|NCT01708161|469288654|FG001|Overall Study|Adverse Event|3|||
130359682|NCT01708161|469288655|FG002|Overall Study|Adverse Event|4|||
130359683|NCT01708161|469288656|FG003|Overall Study|Adverse Event|2|||
130695698|NCT01630616|470510602|FG005|Overall Study|Adverse Event|0|||
130695699|NCT01630616|470510597|FG000|Overall Study|Withdrawal by Subject|0|||
130238859|NCT03126110|468836303|FG011|Phase 1|Death|0|||
130238860|NCT03126110|468836304|FG012|Phase 1|Death|0|||
130238861|NCT03126110|468836305|FG013|Phase 1|Death|0|||
130238862|NCT03126110|468836306|FG014|Phase 1|Death|0|||
130238863|NCT03126110|468836307|FG015|Phase 1|Death|0|||
130238864|NCT03126110|468836308|FG016|Phase 1|Death|0|||
130238865|NCT03126110|468836292|FG000|Phase 1|Lost to Follow-up|0|||
130238866|NCT03126110|468836293|FG001|Phase 1|Lost to Follow-up|1|||
130359684|NCT01708161|469288657|FG004|Overall Study|Adverse Event|3|||
130359685|NCT01708161|469288658|FG005|Overall Study|Adverse Event|0|||
130359686|NCT01708161|469288653|FG000|Overall Study|Death|0|||
130359687|NCT01708161|469288654|FG001|Overall Study|Death|0|||
130359688|NCT01708161|469288655|FG002|Overall Study|Death|0|||
130695700|NCT01630616|470510598|FG001|Overall Study|Withdrawal by Subject|0|||
130695701|NCT01630616|470510599|FG002|Overall Study|Withdrawal by Subject|0|||
130695702|NCT01630616|470510600|FG003|Overall Study|Withdrawal by Subject|2|||
130695703|NCT01630616|470510601|FG004|Overall Study|Withdrawal by Subject|0|||
130238867|NCT03126110|468836294|FG002|Phase 1|Lost to Follow-up|0|||
130238868|NCT03126110|468836295|FG003|Phase 1|Lost to Follow-up|0|||
130238869|NCT03126110|468836296|FG004|Phase 1|Lost to Follow-up|0|||
130238870|NCT03126110|468836297|FG005|Phase 1|Lost to Follow-up|0|||
130238871|NCT03126110|468836298|FG006|Phase 1|Lost to Follow-up|0|||
130238872|NCT03126110|468836299|FG007|Phase 1|Lost to Follow-up|0|||
130238873|NCT03126110|468836300|FG008|Phase 1|Lost to Follow-up|1|||
130238874|NCT03126110|468836301|FG009|Phase 1|Lost to Follow-up|0|||
130238875|NCT03126110|468836302|FG010|Phase 1|Lost to Follow-up|0|||
130238876|NCT03126110|468836303|FG011|Phase 1|Lost to Follow-up|0|||
130238877|NCT03126110|468836304|FG012|Phase 1|Lost to Follow-up|0|||
130238878|NCT03126110|468836305|FG013|Phase 1|Lost to Follow-up|0|||
130238879|NCT03126110|468836306|FG014|Phase 1|Lost to Follow-up|0|||
130238880|NCT03126110|468836307|FG015|Phase 1|Lost to Follow-up|0|||
130238881|NCT03126110|468836308|FG016|Phase 1|Lost to Follow-up|0|||
130238882|NCT03126110|468836292|FG000|Phase 1|Withdrawal by Subject|1|||
130238883|NCT03126110|468836293|FG001|Phase 1|Withdrawal by Subject|0|||
130238884|NCT03126110|468836294|FG002|Phase 1|Withdrawal by Subject|0|||
130238885|NCT03126110|468836295|FG003|Phase 1|Withdrawal by Subject|1|||
130238886|NCT03126110|468836296|FG004|Phase 1|Withdrawal by Subject|1|||
130238887|NCT03126110|468836297|FG005|Phase 1|Withdrawal by Subject|0|||
130238888|NCT03126110|468836298|FG006|Phase 1|Withdrawal by Subject|0|||
130238889|NCT03126110|468836299|FG007|Phase 1|Withdrawal by Subject|0|||
130238890|NCT03126110|468836300|FG008|Phase 1|Withdrawal by Subject|2|||
130238891|NCT03126110|468836301|FG009|Phase 1|Withdrawal by Subject|1|||
130238892|NCT03126110|468836302|FG010|Phase 1|Withdrawal by Subject|0|||
130238893|NCT03126110|468836303|FG011|Phase 1|Withdrawal by Subject|0|||
130238894|NCT03126110|468836304|FG012|Phase 1|Withdrawal by Subject|0|||
130238895|NCT03126110|468836305|FG013|Phase 1|Withdrawal by Subject|0|||
130238896|NCT03126110|468836306|FG014|Phase 1|Withdrawal by Subject|0|||
130238897|NCT03126110|468836307|FG015|Phase 1|Withdrawal by Subject|0|||
130238898|NCT03126110|468836308|FG016|Phase 1|Withdrawal by Subject|0|||
130238899|NCT03126110|468836292|FG000|Phase 1|Safety follow-up no longer necessary|1|||
130238900|NCT03126110|468836293|FG001|Phase 1|Safety follow-up no longer necessary|0|||
130238901|NCT03126110|468836294|FG002|Phase 1|Safety follow-up no longer necessary|0|||
130238902|NCT03126110|468836295|FG003|Phase 1|Safety follow-up no longer necessary|0|||
130238903|NCT03126110|468836296|FG004|Phase 1|Safety follow-up no longer necessary|0|||
130238904|NCT03126110|468836297|FG005|Phase 1|Safety follow-up no longer necessary|0|||
130238905|NCT03126110|468836298|FG006|Phase 1|Safety follow-up no longer necessary|0|||
130238906|NCT03126110|468836299|FG007|Phase 1|Safety follow-up no longer necessary|0|||
130238907|NCT03126110|468836300|FG008|Phase 1|Safety follow-up no longer necessary|0|||
130238908|NCT03126110|468836301|FG009|Phase 1|Safety follow-up no longer necessary|0|||
130238909|NCT03126110|468836302|FG010|Phase 1|Safety follow-up no longer necessary|0|||
130238910|NCT03126110|468836303|FG011|Phase 1|Safety follow-up no longer necessary|0|||
130238911|NCT03126110|468836304|FG012|Phase 1|Safety follow-up no longer necessary|0|||
130238912|NCT03126110|468836305|FG013|Phase 1|Safety follow-up no longer necessary|0|||
130238913|NCT03126110|468836306|FG014|Phase 1|Safety follow-up no longer necessary|0|||
130238914|NCT03126110|468836307|FG015|Phase 1|Safety follow-up no longer necessary|0|||
130238915|NCT03126110|468836308|FG016|Phase 1|Safety follow-up no longer necessary|0|||
130238916|NCT03126110|468836292|FG000|Phase 1|Survival follow-up no longer necessary|0|||
130238917|NCT03126110|468836293|FG001|Phase 1|Survival follow-up no longer necessary|0|||
130238918|NCT03126110|468836294|FG002|Phase 1|Survival follow-up no longer necessary|1|||
130238919|NCT03126110|468836295|FG003|Phase 1|Survival follow-up no longer necessary|0|||
130238920|NCT03126110|468836296|FG004|Phase 1|Survival follow-up no longer necessary|0|||
130238921|NCT03126110|468836297|FG005|Phase 1|Survival follow-up no longer necessary|0|||
130238922|NCT03126110|468836298|FG006|Phase 1|Survival follow-up no longer necessary|0|||
130238923|NCT03126110|468836299|FG007|Phase 1|Survival follow-up no longer necessary|0|||
130238924|NCT03126110|468836300|FG008|Phase 1|Survival follow-up no longer necessary|0|||
130238925|NCT03126110|468836301|FG009|Phase 1|Survival follow-up no longer necessary|0|||
130238926|NCT03126110|468836302|FG010|Phase 1|Survival follow-up no longer necessary|0|||
130238927|NCT03126110|468836303|FG011|Phase 1|Survival follow-up no longer necessary|0|||
130238928|NCT03126110|468836304|FG012|Phase 1|Survival follow-up no longer necessary|0|||
130359689|NCT01708161|469288656|FG003|Overall Study|Death|1|||
130238929|NCT03126110|468836305|FG013|Phase 1|Survival follow-up no longer necessary|0|||
130238930|NCT03126110|468836306|FG014|Phase 1|Survival follow-up no longer necessary|0|||
130238931|NCT03126110|468836307|FG015|Phase 1|Survival follow-up no longer necessary|0|||
130359690|NCT01708161|469288657|FG004|Overall Study|Death|0|||
130238932|NCT03126110|468836308|FG016|Phase 1|Survival follow-up no longer necessary|0|||
130238933|NCT03126110|468836292|FG000|Phase 2|Study terminated by the sponsor|0|||
130238934|NCT03126110|468836293|FG001|Phase 2|Study terminated by the sponsor|0|||
130359691|NCT01708161|469288658|FG005|Overall Study|Death|1|||
130238935|NCT03126110|468836294|FG002|Phase 2|Study terminated by the sponsor|0|||
130238936|NCT03126110|468836295|FG003|Phase 2|Study terminated by the sponsor|0|||
130238937|NCT03126110|468836296|FG004|Phase 2|Study terminated by the sponsor|0|||
130238938|NCT03126110|468836297|FG005|Phase 2|Study terminated by the sponsor|0|||
130238939|NCT03126110|468836298|FG006|Phase 2|Study terminated by the sponsor|0|||
130359692|NCT01708161|469288653|FG000|Overall Study|Withdrawal by Subject|0|||
130238940|NCT03126110|468836299|FG007|Phase 2|Study terminated by the sponsor|0|||
130238941|NCT03126110|468836300|FG008|Phase 2|Study terminated by the sponsor|0|||
130238942|NCT03126110|468836301|FG009|Phase 2|Study terminated by the sponsor|0|||
130238943|NCT03126110|468836302|FG010|Phase 2|Study terminated by the sponsor|0|||
130238944|NCT03126110|468836303|FG011|Phase 2|Study terminated by the sponsor|0|||
130238945|NCT03126110|468836304|FG012|Phase 2|Study terminated by the sponsor|0|||
130238946|NCT03126110|468836305|FG013|Phase 2|Study terminated by the sponsor|4|||
130238947|NCT03126110|468836306|FG014|Phase 2|Study terminated by the sponsor|0|||
130238948|NCT03126110|468836307|FG015|Phase 2|Study terminated by the sponsor|0|||
130238949|NCT03126110|468836308|FG016|Phase 2|Study terminated by the sponsor|0|||
130238950|NCT03126110|468836292|FG000|Phase 2|Withdrawal by Subject|0|||
130238951|NCT03126110|468836293|FG001|Phase 2|Withdrawal by Subject|0|||
130238952|NCT03126110|468836294|FG002|Phase 2|Withdrawal by Subject|0|||
130238953|NCT03126110|468836295|FG003|Phase 2|Withdrawal by Subject|0|||
130238954|NCT03126110|468836296|FG004|Phase 2|Withdrawal by Subject|0|||
130238955|NCT03126110|468836297|FG005|Phase 2|Withdrawal by Subject|0|||
130238956|NCT03126110|468836298|FG006|Phase 2|Withdrawal by Subject|0|||
130238957|NCT03126110|468836299|FG007|Phase 2|Withdrawal by Subject|0|||
130238958|NCT03126110|468836300|FG008|Phase 2|Withdrawal by Subject|0|||
130238959|NCT03126110|468836301|FG009|Phase 2|Withdrawal by Subject|0|||
130238960|NCT03126110|468836302|FG010|Phase 2|Withdrawal by Subject|0|||
130238961|NCT03126110|468836303|FG011|Phase 2|Withdrawal by Subject|1|||
130238962|NCT03126110|468836304|FG012|Phase 2|Withdrawal by Subject|3|||
130238963|NCT03126110|468836305|FG013|Phase 2|Withdrawal by Subject|3|||
130238964|NCT03126110|468836306|FG014|Phase 2|Withdrawal by Subject|2|||
130238965|NCT03126110|468836307|FG015|Phase 2|Withdrawal by Subject|1|||
130238966|NCT03126110|468836308|FG016|Phase 2|Withdrawal by Subject|0|||
130238967|NCT03126110|468836292|FG000|Phase 2|Lost to Follow-up|0|||
130238968|NCT03126110|468836293|FG001|Phase 2|Lost to Follow-up|0|||
130238969|NCT03126110|468836294|FG002|Phase 2|Lost to Follow-up|0|||
130238970|NCT03126110|468836295|FG003|Phase 2|Lost to Follow-up|0|||
130238971|NCT03126110|468836296|FG004|Phase 2|Lost to Follow-up|0|||
130238972|NCT03126110|468836297|FG005|Phase 2|Lost to Follow-up|0|||
130238973|NCT03126110|468836298|FG006|Phase 2|Lost to Follow-up|0|||
130238974|NCT03126110|468836299|FG007|Phase 2|Lost to Follow-up|0|||
130238975|NCT03126110|468836300|FG008|Phase 2|Lost to Follow-up|0|||
130238976|NCT03126110|468836301|FG009|Phase 2|Lost to Follow-up|0|||
130238977|NCT03126110|468836302|FG010|Phase 2|Lost to Follow-up|0|||
130238978|NCT03126110|468836303|FG011|Phase 2|Lost to Follow-up|1|||
130238979|NCT03126110|468836304|FG012|Phase 2|Lost to Follow-up|1|||
130238980|NCT03126110|468836305|FG013|Phase 2|Lost to Follow-up|1|||
130238981|NCT03126110|468836306|FG014|Phase 2|Lost to Follow-up|2|||
130238982|NCT03126110|468836307|FG015|Phase 2|Lost to Follow-up|0|||
130238983|NCT03126110|468836308|FG016|Phase 2|Lost to Follow-up|0|||
130238984|NCT03126110|468836292|FG000|Phase 2|Death|0|||
130238985|NCT03126110|468836293|FG001|Phase 2|Death|0|||
130238986|NCT03126110|468836294|FG002|Phase 2|Death|0|||
130238987|NCT03126110|468836295|FG003|Phase 2|Death|0|||
130238988|NCT03126110|468836296|FG004|Phase 2|Death|0|||
130238989|NCT03126110|468836297|FG005|Phase 2|Death|0|||
130238990|NCT03126110|468836298|FG006|Phase 2|Death|0|||
130238991|NCT03126110|468836299|FG007|Phase 2|Death|0|||
130238992|NCT03126110|468836300|FG008|Phase 2|Death|0|||
130238993|NCT03126110|468836301|FG009|Phase 2|Death|0|||
130238994|NCT03126110|468836302|FG010|Phase 2|Death|0|||
130238995|NCT03126110|468836303|FG011|Phase 2|Death|6|||
130238996|NCT03126110|468836304|FG012|Phase 2|Death|12|||
130238997|NCT03126110|468836305|FG013|Phase 2|Death|25|||
130238998|NCT03126110|468836306|FG014|Phase 2|Death|11|||
130238999|NCT03126110|468836307|FG015|Phase 2|Death|3|||
130239000|NCT03126110|468836308|FG016|Phase 2|Death|2|||
130239001|NCT03126110|468836292|FG000|Phase 2|Progressive Disease|0|||
130239002|NCT03126110|468836293|FG001|Phase 2|Progressive Disease|0|||
130239003|NCT03126110|468836294|FG002|Phase 2|Progressive Disease|0|||
130239004|NCT03126110|468836295|FG003|Phase 2|Progressive Disease|0|||
130239005|NCT03126110|468836296|FG004|Phase 2|Progressive Disease|0|||
130239006|NCT03126110|468836297|FG005|Phase 2|Progressive Disease|0|||
130239007|NCT03126110|468836298|FG006|Phase 2|Progressive Disease|0|||
130239008|NCT03126110|468836299|FG007|Phase 2|Progressive Disease|0|||
130239009|NCT03126110|468836300|FG008|Phase 2|Progressive Disease|0|||
130239010|NCT03126110|468836301|FG009|Phase 2|Progressive Disease|0|||
130239011|NCT03126110|468836302|FG010|Phase 2|Progressive Disease|0|||
130239012|NCT03126110|468836303|FG011|Phase 2|Progressive Disease|0|||
130239013|NCT03126110|468836304|FG012|Phase 2|Progressive Disease|0|||
130239014|NCT03126110|468836305|FG013|Phase 2|Progressive Disease|1|||
130239015|NCT03126110|468836306|FG014|Phase 2|Progressive Disease|0|||
130239016|NCT03126110|468836307|FG015|Phase 2|Progressive Disease|0|||
130239017|NCT03126110|468836308|FG016|Phase 2|Progressive Disease|0|||
130239018|NCT03126110|468836292|FG000|Phase 2|Started new treatment|0|||
130239019|NCT03126110|468836293|FG001|Phase 2|Started new treatment|0|||
130239020|NCT03126110|468836294|FG002|Phase 2|Started new treatment|0|||
130239021|NCT03126110|468836295|FG003|Phase 2|Started new treatment|0|||
130239022|NCT03126110|468836296|FG004|Phase 2|Started new treatment|0|||
130239023|NCT03126110|468836297|FG005|Phase 2|Started new treatment|0|||
130695704|NCT01630616|470510602|FG005|Overall Study|Withdrawal by Subject|0|||
130695705|NCT02218541|470510603|FG000|Overall Study|Lost to Follow-up|2|||
130695706|NCT02218541|470510604|FG001|Overall Study|Lost to Follow-up|1|||
130695707|NCT02218541|470510603|FG000|Overall Study|Implant Failure|4|||
130239024|NCT03126110|468836298|FG006|Phase 2|Started new treatment|0|||
130239025|NCT03126110|468836299|FG007|Phase 2|Started new treatment|0|||
130239026|NCT03126110|468836300|FG008|Phase 2|Started new treatment|0|||
130239027|NCT03126110|468836301|FG009|Phase 2|Started new treatment|0|||
130239028|NCT03126110|468836302|FG010|Phase 2|Started new treatment|0|||
130239029|NCT03126110|468836303|FG011|Phase 2|Started new treatment|0|||
130239030|NCT03126110|468836304|FG012|Phase 2|Started new treatment|0|||
130239031|NCT03126110|468836305|FG013|Phase 2|Started new treatment|0|||
130239032|NCT03126110|468836306|FG014|Phase 2|Started new treatment|1|||
130239033|NCT03126110|468836307|FG015|Phase 2|Started new treatment|0|||
130239034|NCT03126110|468836308|FG016|Phase 2|Started new treatment|0|||
130239035|NCT04235374|468836309|FG000|Overall Study|Death|91|||
130239036|NCT04235374|468836310|FG001|Overall Study|Death|91|||
130447924|NCT00367237|469602066|FG000|Overall Study|Withdrawal by Subject|0|||
130447925|NCT00367237|469602067|FG001|Overall Study|Withdrawal by Subject|4|||
130447926|NCT00367237|469602066|FG000|Overall Study|Protocol Violation|2|||
130447927|NCT00367237|469602067|FG001|Overall Study|Protocol Violation|5|||
130447928|NCT00550732|469602068|FG000|Overall Study|Death|4|||
130447929|NCT00550732|469602068|FG000|Overall Study|Withdrawal by Subject|2|||
130447930|NCT00550732|469602068|FG000|Overall Study|Physician Decision|2|||
130447931|NCT00550732|469602068|FG000|Overall Study|Lost to Follow-up|1|||
130447932|NCT00550732|469602068|FG000|Overall Study|Palliative care|1|||
130447933|NCT00550732|469602068|FG000|Overall Study|Adverse Event|1|||
130447934|NCT02800928|469602075|FG000|Overall Study|Withdrawal by Subject|1|||
130447935|NCT02800928|469602076|FG001|Overall Study|Withdrawal by Subject|1|||
130239037|NCT04235374|468836309|FG000|Overall Study|Refused|2|||
130239038|NCT04235374|468836310|FG001|Overall Study|Refused|2|||
130239039|NCT04235374|468836309|FG000|Overall Study|Unavailable|12|||
130239040|NCT04235374|468836310|FG001|Overall Study|Unavailable|3|||
130239041|NCT04235374|468836309|FG000|Overall Study|Withdrawal by Subject|0|||
130239042|NCT04235374|468836310|FG001|Overall Study|Withdrawal by Subject|1|||
130239043|NCT04235374|468836309|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
130239044|NCT04235374|468836310|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
130239045|NCT04967222|468836318|FG000|Randomized|Lost to Follow-up|0|||
130239046|NCT04967222|468836319|FG001|Randomized|Lost to Follow-up|1|||
130239047|NCT04967222|468836320|FG002|Randomized|Lost to Follow-up|1|||
130447936|NCT02800928|469602075|FG000|Overall Study|Protocol Violation|1|||
130447937|NCT02800928|469602076|FG001|Overall Study|Protocol Violation|1|||
130447938|NCT04004208|469602082|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130447939|NCT04004208|469602083|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130447940|NCT04004208|469602082|FG000|Overall Study|Death|3|||
130447941|NCT04004208|469602083|FG001|Overall Study|Death|0|||
130447942|NCT04004208|469602082|FG000|Overall Study|COVID-19 pandemic|1|||
130447943|NCT04004208|469602083|FG001|Overall Study|COVID-19 pandemic|0|||
130447944|NCT04004208|469602082|FG000|Overall Study|Physician Decision|1|||
130447945|NCT04004208|469602083|FG001|Overall Study|Physician Decision|0|||
130695708|NCT02218541|470510604|FG001|Overall Study|Implant Failure|1|||
130695709|NCT01993186|470510605|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
130695710|NCT01993186|470510606|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130695711|NCT01993186|470510605|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
130695712|NCT01993186|470510606|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130695713|NCT01993186|470510605|FG000|Open-Label Extension Period|Other, Not Specified|0|||
130695714|NCT01993186|470510606|FG001|Open-Label Extension Period|Other, Not Specified|1|||
130695715|NCT01993186|470510605|FG000|Open-Label Extension Period|Adverse Event|1|||
130695716|NCT01993186|470510606|FG001|Open-Label Extension Period|Adverse Event|0|||
130695717|NCT01993186|470510605|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
130695718|NCT01993186|470510606|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
130695719|NCT01993186|470510605|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
130695720|NCT01993186|470510606|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
130695721|NCT01993186|470510605|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
130447946|NCT04004208|469602082|FG000|Overall Study|Adverse Event|1|||
130447947|NCT04004208|469602083|FG001|Overall Study|Adverse Event|1|||
130239048|NCT04967222|468836318|FG000|Randomized|Physician Decision|0|||
130239049|NCT04967222|468836319|FG001|Randomized|Physician Decision|0|||
130239050|NCT04967222|468836320|FG002|Randomized|Physician Decision|1|||
130239051|NCT04967222|468836318|FG000|Randomized|Withdrawal by Subject|0|||
130239052|NCT04967222|468836319|FG001|Randomized|Withdrawal by Subject|0|||
130239053|NCT04967222|468836320|FG002|Randomized|Withdrawal by Subject|2|||
130239054|NCT04967222|468836318|FG000|Randomized|abnormal finding in MRI|0|||
130239055|NCT04967222|468836319|FG001|Randomized|abnormal finding in MRI|2|||
130239056|NCT04967222|468836320|FG002|Randomized|abnormal finding in MRI|0|||
130447948|NCT00570661|469602090|FG000|Overall Study|Disease worsening|5|||
130695722|NCT01993186|470510606|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
130239057|NCT01295944|468836321|FG000|Overall Study|Switched to alternative treatment|1|||
130239058|NCT01295944|468836321|FG000|Overall Study|Ineligible|9|||
130239059|NCT01295944|468836321|FG000|Overall Study|Withdrawal by Subject|1|||
130239060|NCT01295944|468836321|FG000|Overall Study|Participant chose to be treated in Peru|1|||
130239061|NCT01295944|468836321|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
130239062|NCT01295944|468836321|FG000|Overall Study|Physician Decision|1|||
130239063|NCT01295944|468836321|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
130239064|NCT01295944|468836321|FG000|Overall Study|Disease progression|4|||
130239065|NCT01295944|468836321|FG000|Overall Study|Transferred care before starting new treatment|1|||
130239066|NCT02783274|468836329|FG000|Overall Study|Withdrawal by Subject|16|||
130447949|NCT00570661|469602090|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
130447950|NCT00570661|469602090|FG000|Overall Study|Adverse Event|1|||
130239067|NCT02783274|468836329|FG000|Overall Study|Physician Decision|6|||
130239068|NCT02783274|468836329|FG000|Overall Study|Death|9|||
130239069|NCT02783274|468836329|FG000|Overall Study|Lost to Follow-up|22|||
130239070|NCT02783274|468836329|FG000|Overall Study|Other|22|||
130239071|NCT04717557|468836330|FG000|Overall Study|Withdrawal by Subject|2|||
130239072|NCT04717557|468836331|FG001|Overall Study|Withdrawal by Subject|0|||
130447951|NCT01734382|469602091|FG000|Part 1|Adverse Event|2|||
130447952|NCT01734382|469602092|FG001|Part 1|Adverse Event|0|||
130447953|NCT01734382|469602093|FG002|Part 1|Adverse Event|0|||
130447954|NCT01734382|469602091|FG000|Part 2|Adverse Event|0|||
130447955|NCT01734382|469602092|FG001|Part 2|Adverse Event|0|||
130447956|NCT01734382|469602093|FG002|Part 2|Adverse Event|1|||
130447957|NCT01734382|469602091|FG000|Part 2|Lack of Efficacy|0|||
130447958|NCT01734382|469602092|FG001|Part 2|Lack of Efficacy|1|||
130447959|NCT01734382|469602093|FG002|Part 2|Lack of Efficacy|1|||
130447960|NCT01734382|469602091|FG000|Part 2|Other|0|||
130447961|NCT01734382|469602092|FG001|Part 2|Other|0|||
130447962|NCT01734382|469602093|FG002|Part 2|Other|1|||
130447963|NCT01734382|469602091|FG000|Part 2|Physician Decision|0|||
130447964|NCT01734382|469602092|FG001|Part 2|Physician Decision|0|||
130447965|NCT01734382|469602093|FG002|Part 2|Physician Decision|3|||
130447966|NCT01734382|469602091|FG000|Part 2|Protocol Violation|0|||
130447967|NCT01734382|469602092|FG001|Part 2|Protocol Violation|1|||
130447968|NCT01734382|469602093|FG002|Part 2|Protocol Violation|0|||
130447969|NCT01734382|469602091|FG000|Part 2|Withdrawal by Subject|0|||
130447970|NCT01734382|469602092|FG001|Part 2|Withdrawal by Subject|0|||
130447971|NCT01734382|469602093|FG002|Part 2|Withdrawal by Subject|1|||
130447972|NCT01052662|469602096|FG000|Overall Study|Lost to Follow-up|15|||
130447973|NCT01052662|469602097|FG001|Overall Study|Lost to Follow-up|13|||
130447974|NCT01052662|469602098|FG002|Overall Study|Lost to Follow-up|18|||
130447975|NCT01052662|469602096|FG000|Overall Study|Withdrawal by Subject|3|||
130447976|NCT01052662|469602097|FG001|Overall Study|Withdrawal by Subject|2|||
130447977|NCT01052662|469602098|FG002|Overall Study|Withdrawal by Subject|1|||
130447978|NCT01052662|469602096|FG000|Overall Study|Pharmacy issue|1|||
130447979|NCT01052662|469602097|FG001|Overall Study|Pharmacy issue|3|||
130447980|NCT01052662|469602098|FG002|Overall Study|Pharmacy issue|3|||
130447981|NCT01052662|469602096|FG000|Overall Study|Adverse Event|1|||
130447982|NCT01052662|469602097|FG001|Overall Study|Adverse Event|1|||
130447983|NCT01052662|469602098|FG002|Overall Study|Adverse Event|0|||
130447984|NCT01052662|469602096|FG000|Overall Study|Legal Problem|2|||
130695723|NCT00691704|470510607|FG000|Induction Therapy|Disease Progression|1|||
130695724|NCT00691704|470510607|FG000|Induction Therapy|Active Hepatitis|1|||
130695725|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
130695726|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
130695727|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
130695728|NCT04661202|470510609|FG000|Overall Study|Withdrawal by Subject|1|||
130695729|NCT04661202|470510610|FG001|Overall Study|Withdrawal by Subject|1|||
130695730|NCT04661202|470510609|FG000|Overall Study|Lack of Efficacy|2|||
130695731|NCT04661202|470510610|FG001|Overall Study|Lack of Efficacy|0|||
130695732|NCT02313558|470510611|FG000|Overall Study|Withdrawal by Subject|2|||
130695733|NCT02313558|470510612|FG001|Overall Study|Withdrawal by Subject|0|||
130239073|NCT04717557|468836330|FG000|Overall Study|Death|1|||
130239074|NCT04717557|468836331|FG001|Overall Study|Death|0|||
130239075|NCT02516241|468836335|FG000|Overall Study|Death|255|||
130239076|NCT02516241|468836336|FG001|Overall Study|Death|262|||
130239077|NCT02516241|468836337|FG002|Overall Study|Death|270|||
130239078|NCT02516241|468836335|FG000|Overall Study|Lost to Follow-up|1|||
130447985|NCT01052662|469602097|FG001|Overall Study|Legal Problem|0|||
130447986|NCT01052662|469602098|FG002|Overall Study|Legal Problem|0|||
130447987|NCT01052662|469602096|FG000|Overall Study|Administrative|0|||
130447988|NCT01052662|469602097|FG001|Overall Study|Administrative|3|||
130447989|NCT01052662|469602098|FG002|Overall Study|Administrative|0|||
130447990|NCT00087490|469602099|FG000|Overall Study|Death|6|||
130447991|NCT00087490|469602100|FG001|Overall Study|Death|4|||
130447992|NCT00087490|469602099|FG000|Overall Study|Adverse Event|3|||
130447993|NCT00087490|469602100|FG001|Overall Study|Adverse Event|8|||
130695734|NCT02313558|470510611|FG000|Overall Study|Lost to Follow-up|4|||
130695735|NCT02313558|470510612|FG001|Overall Study|Lost to Follow-up|4|||
130447994|NCT00087490|469602099|FG000|Overall Study|Lack of Efficacy|0|||
130447995|NCT00087490|469602100|FG001|Overall Study|Lack of Efficacy|2|||
130447996|NCT00087490|469602099|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
130447997|NCT00087490|469602100|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
130447998|NCT00087490|469602099|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
130447999|NCT00087490|469602100|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
130448000|NCT00087490|469602099|FG000|Overall Study|Randomized but not treated|7|||
130448001|NCT00087490|469602100|FG001|Overall Study|Randomized but not treated|18|||
130448002|NCT02034435|469602101|FG000|Overall Study|Withdrawal by Subject|1|||
130448003|NCT02034435|469602102|FG001|Overall Study|Withdrawal by Subject|0|||
130448004|NCT02034435|469602103|FG002|Overall Study|Withdrawal by Subject|0|||
130448005|NCT02034435|469602104|FG003|Overall Study|Withdrawal by Subject|0|||
130448006|NCT02034435|469602101|FG000|Overall Study|Illness|0|||
130448007|NCT02034435|469602102|FG001|Overall Study|Illness|2|||
130448008|NCT02034435|469602103|FG002|Overall Study|Illness|0|||
130239079|NCT02516241|468836336|FG001|Overall Study|Lost to Follow-up|1|||
130239080|NCT02516241|468836337|FG002|Overall Study|Lost to Follow-up|3|||
130239081|NCT02516241|468836335|FG000|Overall Study|Withdrawal by Subject|2|||
130239082|NCT02516241|468836336|FG001|Overall Study|Withdrawal by Subject|7|||
130239083|NCT02516241|468836337|FG002|Overall Study|Withdrawal by Subject|12|||
130239084|NCT02516241|468836335|FG000|Overall Study|participants ongoing at data cut-off|84|||
130239085|NCT02516241|468836336|FG001|Overall Study|participants ongoing at data cut-off|76|||
130239086|NCT02516241|468836337|FG002|Overall Study|participants ongoing at data cut-off|59|||
130239087|NCT00724945|468836338|FG000|Period 1|non-compliance|1|||
130239088|NCT00724945|468836339|FG001|Period 1|non-compliance|0|||
130239089|NCT00724945|468836338|FG000|Period 1|Adverse Event|1|||
130239090|NCT00724945|468836339|FG001|Period 1|Adverse Event|1|||
130239091|NCT00724945|468836338|FG000|Period 1|Lost to Follow-up|1|||
130239092|NCT00724945|468836339|FG001|Period 1|Lost to Follow-up|0|||
130239093|NCT00724945|468836338|FG000|Period 2|lens comfort issue|3|||
130239094|NCT00724945|468836339|FG001|Period 2|lens comfort issue|0|||
130239095|NCT00724945|468836338|FG000|Period 2|lens physiology issue|1|||
130239096|NCT00724945|468836339|FG001|Period 2|lens physiology issue|0|||
130239097|NCT04835441|468836340|FG000|Overall Study|Physician Decision|4|||
130239098|NCT04835441|468836341|FG001|Overall Study|Physician Decision|4|||
130239099|NCT04835441|468836340|FG000|Overall Study|Other|1|||
130239100|NCT04835441|468836341|FG001|Overall Study|Other|1|||
130239101|NCT04835441|468836340|FG000|Overall Study|Lost to Follow-up|0|||
130239102|NCT04835441|468836341|FG001|Overall Study|Lost to Follow-up|1|||
130239103|NCT03069989|468836345|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
130239104|NCT03069989|468836346|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
130239105|NCT01901562|468837498|FG000|Overall Study|Protocol Violation|5|||
130239106|NCT01901562|468837498|FG000|Overall Study|Excluded intraoperatively|4|||
130239107|NCT00088153|468837499|FG000|Overall Study|Physician Decision|3|||
130239108|NCT00088153|468837500|FG001|Overall Study|Physician Decision|3|||
130239109|NCT00088153|468837499|FG000|Overall Study|Withdrawal by Subject|10|||
130239110|NCT00088153|468837500|FG001|Overall Study|Withdrawal by Subject|10|||
130239111|NCT00088153|468837499|FG000|Overall Study|Lost to Follow-up|11|||
130239112|NCT00088153|468837500|FG001|Overall Study|Lost to Follow-up|12|||
130239113|NCT00976027|468837502|FG000|Overall Study|Serious Adverse Event|36|||
130239114|NCT00976027|468837503|FG001|Overall Study|Serious Adverse Event|17|||
130239115|NCT00976027|468837502|FG000|Overall Study|Adverse Event|0|||
130239116|NCT00976027|468837503|FG001|Overall Study|Adverse Event|2|||
130239117|NCT00976027|468837502|FG000|Overall Study|Protocol Violation|60|||
130239118|NCT00976027|468837503|FG001|Overall Study|Protocol Violation|27|||
130239119|NCT00976027|468837502|FG000|Overall Study|Lost to Follow-up|208|||
130239120|NCT00976027|468837503|FG001|Overall Study|Lost to Follow-up|103|||
130239121|NCT00976027|468837502|FG000|Overall Study|Withdrawal by Subject|107|||
130448009|NCT02034435|469602104|FG003|Overall Study|Illness|0|||
130448010|NCT02034435|469602101|FG000|Overall Study|Inadequate IV access|1|||
130552927|NCT02520284|469991629|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
130239122|NCT00976027|468837503|FG001|Overall Study|Withdrawal by Subject|66|||
130239123|NCT04435626|468837508|FG000|Overall Study|Lost to Follow-up|1|||
130239124|NCT04435626|468837509|FG001|Overall Study|Lost to Follow-up|5|||
130239125|NCT04435626|468837508|FG000|Overall Study|Withdrawal by Subject|6|||
130239126|NCT04435626|468837509|FG001|Overall Study|Withdrawal by Subject|7|||
130239127|NCT04435626|468837508|FG000|Overall Study|major GCP violations|8|||
130239128|NCT04435626|468837509|FG001|Overall Study|major GCP violations|7|||
130239129|NCT01771107|468837517|FG000|Overall Study|Adverse Event|1|||
130239130|NCT01771107|468837518|FG001|Overall Study|Adverse Event|3|||
130239131|NCT01771107|468837517|FG000|Overall Study|Withdrawal by Subject|0|||
130448011|NCT02034435|469602102|FG001|Overall Study|Inadequate IV access|0|||
130448012|NCT02034435|469602103|FG002|Overall Study|Inadequate IV access|0|||
130448013|NCT02034435|469602104|FG003|Overall Study|Inadequate IV access|1|||
130448014|NCT00630539|469602105|FG000|Overall Study|Adverse Event|1|||
130552928|NCT02520284|469991627|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
130695736|NCT04102345|470510613|FG000|Overall Study|Withdrawal by Subject|1|||
130695737|NCT04102345|470510614|FG001|Overall Study|Withdrawal by Subject|0|||
130695738|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
130695739|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
130695740|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
130695741|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
130695742|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
130695743|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
130695744|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130695745|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
130695746|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130695747|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
130695748|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
130695749|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
130695750|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130695751|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130695752|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
130695753|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Other|0|||
130695754|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Other|0|||
130695755|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Other|1|||
130695756|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130695757|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
130695758|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130695759|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130695760|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130695761|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
130239132|NCT01771107|468837518|FG001|Overall Study|Withdrawal by Subject|2|||
130239133|NCT01771107|468837517|FG000|Overall Study|Lost to Follow-up|0|||
130239134|NCT01771107|468837518|FG001|Overall Study|Lost to Follow-up|1|||
130239135|NCT01771107|468837517|FG000|Overall Study|participant moved|0|||
130239136|NCT01771107|468837518|FG001|Overall Study|participant moved|1|||
130239137|NCT01771107|468837517|FG000|Overall Study|Other|0|||
130239138|NCT01771107|468837518|FG001|Overall Study|Other|1|||
130239139|NCT05248386|468837520|FG000|Overall Study|Technical problems|0|||
130239140|NCT05248386|468837521|FG001|Overall Study|Technical problems|1|||
130239141|NCT05248386|468837520|FG000|Overall Study|Withdrawal by Subject|15|||
130239142|NCT05248386|468837521|FG001|Overall Study|Withdrawal by Subject|10|||
130359693|NCT01708161|469288654|FG001|Overall Study|Withdrawal by Subject|1|||
130359694|NCT01708161|469288655|FG002|Overall Study|Withdrawal by Subject|1|||
130359695|NCT01708161|469288656|FG003|Overall Study|Withdrawal by Subject|0|||
130359696|NCT01708161|469288657|FG004|Overall Study|Withdrawal by Subject|0|||
130359697|NCT01708161|469288658|FG005|Overall Study|Withdrawal by Subject|0|||
130359698|NCT01708161|469288653|FG000|Overall Study|Administrative problems|0|||
130359699|NCT01708161|469288654|FG001|Overall Study|Administrative problems|1|||
130359700|NCT01708161|469288655|FG002|Overall Study|Administrative problems|0|||
130359701|NCT01708161|469288656|FG003|Overall Study|Administrative problems|0|||
130359702|NCT01708161|469288657|FG004|Overall Study|Administrative problems|0|||
130359703|NCT01708161|469288658|FG005|Overall Study|Administrative problems|0|||
130359704|NCT01708161|469288653|FG000|Overall Study|Disease progression|3|||
130359705|NCT01708161|469288654|FG001|Overall Study|Disease progression|5|||
130359706|NCT01708161|469288655|FG002|Overall Study|Disease progression|5|||
130359707|NCT01708161|469288656|FG003|Overall Study|Disease progression|13|||
130359708|NCT01708161|469288657|FG004|Overall Study|Disease progression|3|||
130359709|NCT01708161|469288658|FG005|Overall Study|Disease progression|0|||
130359710|NCT02019277|469288659|FG000|Overall Study|Withdrawal by Subject|3|||
130359711|NCT02019277|469288659|FG000|Overall Study|Death|7|||
130359712|NCT02019277|469288659|FG000|Overall Study|Did no Cooperate|1|||
130359713|NCT02019277|469288659|FG000|Overall Study|Adverse Event|1|||
130359714|NCT02633501|469288661|FG000|Overall Study|Adverse Event|0|||
130359715|NCT02633501|469288662|FG001|Overall Study|Adverse Event|0|||
130359716|NCT02633501|469288663|FG002|Overall Study|Adverse Event|1|||
130695762|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
130695763|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130695764|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130695765|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
130359717|NCT02633501|469288664|FG003|Overall Study|Adverse Event|0|||
130359718|NCT02633501|469288665|FG004|Overall Study|Adverse Event|1|||
130239143|NCT05248386|468837520|FG000|Overall Study|Physician Decision|0|||
130239144|NCT05248386|468837521|FG001|Overall Study|Physician Decision|1|||
130239145|NCT05248386|468837520|FG000|Overall Study|Adverse Event|2|||
130359719|NCT02633501|469288666|FG005|Overall Study|Adverse Event|1|||
130359720|NCT02633501|469288661|FG000|Overall Study|Withdrawal by Subject|2|||
130359721|NCT02633501|469288662|FG001|Overall Study|Withdrawal by Subject|1|||
130448015|NCT00630539|469602106|FG001|Overall Study|Adverse Event|3|||
130695766|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
130695767|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
130695768|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
130695769|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
130695770|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
130695771|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
130695772|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
130695773|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
130695774|NCT00385736|470510615|FG000|Safety Analysis Set|Adverse Event|23|||
130695775|NCT00385736|470510616|FG001|Safety Analysis Set|Adverse Event|15|||
130695776|NCT00385736|470510617|FG002|Safety Analysis Set|Adverse Event|23|||
130695777|NCT00385736|470510615|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
130695778|NCT00385736|470510616|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
130695779|NCT00385736|470510617|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
130695780|NCT00385736|470510615|FG000|Safety Analysis Set|Lost to Follow-up|0|||
130695781|NCT00385736|470510616|FG001|Safety Analysis Set|Lost to Follow-up|2|||
130695782|NCT00385736|470510617|FG002|Safety Analysis Set|Lost to Follow-up|2|||
130695783|NCT00385736|470510615|FG000|Safety Analysis Set|Lack of Efficacy|38|||
130695784|NCT00385736|470510616|FG001|Safety Analysis Set|Lack of Efficacy|16|||
130695785|NCT00385736|470510617|FG002|Safety Analysis Set|Lack of Efficacy|31|||
130695786|NCT00385736|470510615|FG000|Safety Analysis Set|Protocol Violation|2|||
130695787|NCT00385736|470510616|FG001|Safety Analysis Set|Protocol Violation|1|||
130695788|NCT00385736|470510617|FG002|Safety Analysis Set|Protocol Violation|6|||
130695789|NCT00385736|470510615|FG000|Safety Analysis Set|Other|1|||
130695790|NCT00385736|470510616|FG001|Safety Analysis Set|Other|4|||
130695791|NCT00385736|470510617|FG002|Safety Analysis Set|Other|4|||
130695792|NCT00198133|470510618|FG000|Overall Study|Disease progression|2|||
130695793|NCT00198133|470510619|FG001|Overall Study|Disease progression|5|||
130695794|NCT00198133|470510618|FG000|Overall Study|Adverse Event|1|||
130695795|NCT00198133|470510619|FG001|Overall Study|Adverse Event|3|||
130695796|NCT00198133|470510618|FG000|Overall Study|Withdrawal by Subject|1|||
130695797|NCT00198133|470510619|FG001|Overall Study|Withdrawal by Subject|0|||
130695798|NCT00198133|470510618|FG000|Overall Study|Physician Decision|1|||
130695799|NCT00198133|470510619|FG001|Overall Study|Physician Decision|0|||
130695800|NCT00835666|470510623|FG000|Washout|Protocol Violation|1|||
130695801|NCT00835666|470510624|FG001|Washout|Protocol Violation|0|||
130695802|NCT00835666|470510623|FG000|Washout|Withdrawal by Subject|1|||
130695803|NCT00835666|470510624|FG001|Washout|Withdrawal by Subject|0|||
130695804|NCT03599362|470510625|FG000|Overall Study|Screen Failure|3|||
130695805|NCT03707587|470510626|FG000|Overall Study|Death|0|||
130695806|NCT03707587|470510627|FG001|Overall Study|Death|1|||
130695807|NCT01537887|470510628|FG000|Period 1|Physician Decision|0|||
130695808|NCT01537887|470510629|FG001|Period 1|Physician Decision|0|||
130695809|NCT01537887|470510630|FG002|Period 1|Physician Decision|0|||
130695810|NCT01537887|470510631|FG003|Period 1|Physician Decision|0|||
130695811|NCT01537887|470510632|FG004|Period 1|Physician Decision|1|||
130695812|NCT01537887|470510633|FG005|Period 1|Physician Decision|1|||
130695813|NCT01537887|470510628|FG000|Period 1|Did not receive treatment|0|||
130695814|NCT01537887|470510629|FG001|Period 1|Did not receive treatment|0|||
130695815|NCT01537887|470510630|FG002|Period 1|Did not receive treatment|1|||
130695816|NCT01537887|470510631|FG003|Period 1|Did not receive treatment|0|||
130695817|NCT01537887|470510632|FG004|Period 1|Did not receive treatment|0|||
130695818|NCT01537887|470510633|FG005|Period 1|Did not receive treatment|0|||
130695819|NCT01537887|470510628|FG000|Period 2|Withdrawal by Subject|0|||
130695820|NCT01537887|470510629|FG001|Period 2|Withdrawal by Subject|1|||
130695821|NCT01537887|470510630|FG002|Period 2|Withdrawal by Subject|0|||
130448016|NCT00630539|469602107|FG002|Overall Study|Adverse Event|1|||
130695822|NCT01537887|470510631|FG003|Period 2|Withdrawal by Subject|0|||
130695823|NCT01537887|470510632|FG004|Period 2|Withdrawal by Subject|0|||
130695824|NCT01537887|470510633|FG005|Period 2|Withdrawal by Subject|0|||
130695825|NCT01537887|470510628|FG000|Period 3|Adverse Event|0|||
130695826|NCT01537887|470510629|FG001|Period 3|Adverse Event|0|||
130695827|NCT01537887|470510630|FG002|Period 3|Adverse Event|1|||
130695828|NCT01537887|470510631|FG003|Period 3|Adverse Event|0|||
130695829|NCT01537887|470510632|FG004|Period 3|Adverse Event|0|||
130695830|NCT01537887|470510633|FG005|Period 3|Adverse Event|0|||
130695831|NCT01537887|470510628|FG000|Period 3|Withdrawal by Subject|0|||
130695832|NCT01537887|470510629|FG001|Period 3|Withdrawal by Subject|1|||
130695833|NCT01537887|470510630|FG002|Period 3|Withdrawal by Subject|0|||
130695834|NCT01537887|470510631|FG003|Period 3|Withdrawal by Subject|0|||
130695835|NCT01537887|470510632|FG004|Period 3|Withdrawal by Subject|0|||
130695836|NCT01537887|470510633|FG005|Period 3|Withdrawal by Subject|0|||
130695837|NCT01634139|470510635|FG000|Overall Study|Non compliant with protocol|1|||
130695838|NCT01634139|470510636|FG001|Overall Study|Non compliant with protocol|0|||
130695839|NCT01634139|470510637|FG002|Overall Study|Non compliant with protocol|0|||
130695840|NCT01634139|470510635|FG000|Overall Study|Consent withdrawn not due to AE|4|||
130695841|NCT01634139|470510636|FG001|Overall Study|Consent withdrawn not due to AE|3|||
130695842|NCT01634139|470510637|FG002|Overall Study|Consent withdrawn not due to AE|2|||
130695843|NCT01634139|470510635|FG000|Overall Study|Other|4|||
130695844|NCT01634139|470510636|FG001|Overall Study|Other|0|||
130695845|NCT01634139|470510637|FG002|Overall Study|Other|3|||
130695846|NCT01634139|470510635|FG000|Overall Study|Lost to Follow-up|0|||
130695847|NCT01634139|470510636|FG001|Overall Study|Lost to Follow-up|2|||
130695848|NCT01634139|470510637|FG002|Overall Study|Lost to Follow-up|0|||
130695849|NCT01634139|470510635|FG000|Overall Study|Not treated|1|||
130695850|NCT01634139|470510636|FG001|Overall Study|Not treated|1|||
130695851|NCT01634139|470510637|FG002|Overall Study|Not treated|0|||
130695852|NCT00425308|470510645|FG000|Overall Study|Adverse Event|2|||
130695853|NCT00425308|470510646|FG001|Overall Study|Adverse Event|1|||
130695854|NCT00425308|470510645|FG000|Overall Study|Withdrawal by Subject|1|||
130695855|NCT00425308|470510646|FG001|Overall Study|Withdrawal by Subject|0|||
130695856|NCT00425308|470510645|FG000|Overall Study|Death|1|||
130695857|NCT00425308|470510646|FG001|Overall Study|Death|0|||
130695858|NCT04442503|470510649|FG000|Overall Study|Adverse Event|1|||
130695859|NCT04442503|470510650|FG001|Overall Study|Adverse Event|1|||
130695860|NCT04442503|470510649|FG000|Overall Study|Lost to Follow-up|8|||
130695861|NCT04442503|470510650|FG001|Overall Study|Lost to Follow-up|6|||
130695862|NCT04442503|470510649|FG000|Overall Study|Physician Decision|0|||
130695863|NCT04442503|470510650|FG001|Overall Study|Physician Decision|2|||
130695864|NCT04442503|470510649|FG000|Overall Study|Withdrawal by Subject|3|||
130695865|NCT04442503|470510650|FG001|Overall Study|Withdrawal by Subject|4|||
130239146|NCT05248386|468837521|FG001|Overall Study|Adverse Event|4|||
130239147|NCT05248386|468837520|FG000|Overall Study|Other|1|||
130239148|NCT05248386|468837521|FG001|Overall Study|Other|0|||
130239149|NCT05248386|468837520|FG000|Overall Study|Lack of Efficacy|14|||
130239150|NCT05248386|468837521|FG001|Overall Study|Lack of Efficacy|12|||
130239151|NCT02864992|468837522|FG000|Overall Study|still on treatment|15|||
130239152|NCT02864992|468837523|FG001|Overall Study|still on treatment|1|||
130695866|NCT04442503|470510649|FG000|Overall Study|Reason not Specified|0|||
130695867|NCT04442503|470510650|FG001|Overall Study|Reason not Specified|1|||
130695868|NCT04442503|470510649|FG000|Overall Study|Randomized but not Treated|3|||
130695869|NCT04442503|470510650|FG001|Overall Study|Randomized but not Treated|1|||
130695870|NCT02933060|470510651|FG000|Overall Study|Withdrawal by Subject|0|||
130695871|NCT02933060|470510652|FG001|Overall Study|Withdrawal by Subject|1|||
130359722|NCT02633501|469288663|FG002|Overall Study|Withdrawal by Subject|2|||
130359723|NCT02633501|469288664|FG003|Overall Study|Withdrawal by Subject|2|||
130359724|NCT02633501|469288665|FG004|Overall Study|Withdrawal by Subject|1|||
130359725|NCT02633501|469288666|FG005|Overall Study|Withdrawal by Subject|3|||
130359726|NCT02633501|469288661|FG000|Overall Study|Various other reasons|0|||
130359727|NCT02633501|469288662|FG001|Overall Study|Various other reasons|2|||
130359728|NCT02633501|469288663|FG002|Overall Study|Various other reasons|4|||
130359729|NCT02633501|469288664|FG003|Overall Study|Various other reasons|1|||
130359730|NCT02633501|469288665|FG004|Overall Study|Various other reasons|7|||
130359731|NCT02633501|469288666|FG005|Overall Study|Various other reasons|11|||
130359732|NCT02633501|469288661|FG000|Overall Study|Lost to Follow-up|0|||
130359733|NCT02633501|469288662|FG001|Overall Study|Lost to Follow-up|0|||
130359734|NCT02633501|469288663|FG002|Overall Study|Lost to Follow-up|0|||
130359735|NCT02633501|469288664|FG003|Overall Study|Lost to Follow-up|1|||
130359736|NCT02633501|469288665|FG004|Overall Study|Lost to Follow-up|2|||
130359737|NCT02633501|469288666|FG005|Overall Study|Lost to Follow-up|0|||
130359738|NCT01986140|469288668|FG000|Overall Study|Withdrawal by Subject|31|||
130359739|NCT01986140|469288669|FG001|Overall Study|Withdrawal by Subject|25|||
130359740|NCT01986140|469288668|FG000|Overall Study|alternative treatment|1|||
130359741|NCT01986140|469288669|FG001|Overall Study|alternative treatment|1|||
130359742|NCT01986140|469288668|FG000|Overall Study|found not eligible|3|||
130359743|NCT01986140|469288669|FG001|Overall Study|found not eligible|0|||
130359744|NCT01986140|469288668|FG000|Overall Study|Adverse Event|0|||
130695872|NCT00989950|470510653|FG000|Randomized Phase|Protocol Violation|1|||
130359745|NCT01986140|469288669|FG001|Overall Study|Adverse Event|1|||
130359746|NCT01986140|469288668|FG000|Overall Study|progression disease|0|||
130359747|NCT01986140|469288669|FG001|Overall Study|progression disease|1|||
130239153|NCT02864992|468837524|FG002|Overall Study|still on treatment|33|||
130359748|NCT02808650|469288675|FG000|Overall Study|Death|0|||
130359749|NCT02808650|469288676|FG001|Overall Study|Death|0|||
130359750|NCT02808650|469288677|FG002|Overall Study|Death|0|||
130359751|NCT02808650|469288678|FG003|Overall Study|Death|0|||
130359752|NCT02808650|469288679|FG004|Overall Study|Death|1|||
130695873|NCT00989950|470510654|FG001|Randomized Phase|Protocol Violation|0|||
130695874|NCT00989950|470510655|FG002|Randomized Phase|Protocol Violation|0|||
130695875|NCT00989950|470510656|FG003|Randomized Phase|Protocol Violation|0|||
130695876|NCT00989950|470510653|FG000|Randomized Phase|Adverse Event|0|||
130695877|NCT00989950|470510654|FG001|Randomized Phase|Adverse Event|1|||
130695878|NCT00989950|470510655|FG002|Randomized Phase|Adverse Event|0|||
130695879|NCT00989950|470510656|FG003|Randomized Phase|Adverse Event|0|||
130239154|NCT03785366|468837525|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
130239155|NCT03785366|468837526|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
130239156|NCT03785366|468837525|FG000|Overall Study|Lost to Follow-up|1|||
130239157|NCT03785366|468837526|FG001|Overall Study|Lost to Follow-up|0|||
130239158|NCT03785366|468837525|FG000|Overall Study|Partial IUD Expulsion|0|||
130239159|NCT03785366|468837526|FG001|Overall Study|Partial IUD Expulsion|2|||
130239160|NCT03785366|468837525|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
130239161|NCT03785366|468837526|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
130239162|NCT03240874|468837527|FG000|Overall Study|Lost to Follow-up|0|||
130239163|NCT03240874|468837528|FG001|Overall Study|Lost to Follow-up|2|||
130239164|NCT03240874|468837529|FG002|Overall Study|Lost to Follow-up|4|||
130239165|NCT03240874|468837530|FG003|Overall Study|Lost to Follow-up|1|||
130239166|NCT05252702|468837531|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
130239167|NCT05252702|468837531|FG000|Overall Study|Death|16|||
130239168|NCT05252702|468837531|FG000|Overall Study|System explant|5|||
130239169|NCT05252702|468837531|FG000|Overall Study|Lost to Follow-up|1|||
130239170|NCT05252702|468837531|FG000|Overall Study|Withdrawn by investigator|1|||
130239171|NCT05252702|468837531|FG000|Overall Study|Visit not due|306|||
130239172|NCT05252702|468837531|FG000|Overall Study|Visit within window but not completed|92|||
130239173|NCT05252702|468837531|FG000|Overall Study|Unsuccessful implant|1|||
130239174|NCT04153864|468837532|FG000|Overall Study|Withdrawal by Subject|21|||
130239175|NCT04153864|468837533|FG001|Overall Study|Withdrawal by Subject|7|||
130239176|NCT04153864|468837534|FG002|Overall Study|Withdrawal by Subject|23|||
130239177|NCT04153864|468837535|FG003|Overall Study|Withdrawal by Subject|2|||
130239178|NCT04153864|468837532|FG000|Overall Study|Lost to Follow-up|4|||
130239179|NCT04153864|468837533|FG001|Overall Study|Lost to Follow-up|0|||
130239180|NCT04153864|468837534|FG002|Overall Study|Lost to Follow-up|3|||
130239181|NCT04153864|468837535|FG003|Overall Study|Lost to Follow-up|0|||
130239182|NCT04153864|468837532|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
130239183|NCT04153864|468837533|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
130239184|NCT04153864|468837534|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
130239185|NCT04153864|468837535|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
130239186|NCT04958707|468837536|FG000|Post Intervention|Withdrawal by Subject|1|||
130239187|NCT04958707|468837537|FG001|Post Intervention|Withdrawal by Subject|0|||
130239188|NCT04958707|468837538|FG002|Post Intervention|Withdrawal by Subject|0|||
130239189|NCT04958707|468837536|FG000|3 Months Follow- up|Lost to Follow-up|0|||
130239190|NCT04958707|468837537|FG001|3 Months Follow- up|Lost to Follow-up|3|||
130239191|NCT04958707|468837538|FG002|3 Months Follow- up|Lost to Follow-up|0|||
130239192|NCT04958707|468837536|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
130239193|NCT04958707|468837537|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
130239194|NCT04958707|468837538|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
130239195|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
130239196|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
130239197|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
130359753|NCT02808650|469288675|FG000|Overall Study|Lack of Efficacy|5|||
130359754|NCT02808650|469288676|FG001|Overall Study|Lack of Efficacy|5|||
130359755|NCT02808650|469288677|FG002|Overall Study|Lack of Efficacy|6|||
130359756|NCT02808650|469288678|FG003|Overall Study|Lack of Efficacy|5|||
130359757|NCT02808650|469288679|FG004|Overall Study|Lack of Efficacy|4|||
130359758|NCT02808650|469288675|FG000|Overall Study|Physician Decision|1|||
130359759|NCT02808650|469288676|FG001|Overall Study|Physician Decision|1|||
130359760|NCT02808650|469288677|FG002|Overall Study|Physician Decision|0|||
130359761|NCT02808650|469288678|FG003|Overall Study|Physician Decision|0|||
130359762|NCT02808650|469288679|FG004|Overall Study|Physician Decision|0|||
130359763|NCT02808650|469288675|FG000|Overall Study|Withdrawal by Subject|0|||
130359764|NCT02808650|469288676|FG001|Overall Study|Withdrawal by Subject|0|||
130359765|NCT02808650|469288677|FG002|Overall Study|Withdrawal by Subject|0|||
130359766|NCT02808650|469288678|FG003|Overall Study|Withdrawal by Subject|1|||
130359767|NCT02808650|469288679|FG004|Overall Study|Withdrawal by Subject|1|||
130359768|NCT01069627|469288682|FG000|Overall Study|Disease progression|7|||
130359769|NCT01069627|469288682|FG000|Overall Study|Adverse Event|12|||
130359770|NCT01069627|469288682|FG000|Overall Study|Protocol Violation|1|||
130359771|NCT02939079|469288686|FG000|Overall Study|Adverse Event|2|||
130359772|NCT02939079|469288687|FG001|Overall Study|Adverse Event|1|||
130359773|NCT02939079|469288686|FG000|Overall Study|Lost to Follow-up|0|||
130359774|NCT02939079|469288687|FG001|Overall Study|Lost to Follow-up|2|||
130359775|NCT02939079|469288686|FG000|Overall Study|Protocol Violation|1|||
130239198|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
130239199|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
130239200|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
130239201|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
130359776|NCT02939079|469288687|FG001|Overall Study|Protocol Violation|0|||
130359777|NCT02939079|469288686|FG000|Overall Study|Withdrawal by Subject|0|||
130695880|NCT00101439|470510657|FG000|Period 2|Withdrawal by Subject|0|||
130695881|NCT00101439|470510658|FG001|Period 2|Withdrawal by Subject|2|||
130695882|NCT03101358|470510659|FG000|Overall Study|Non-compliance with study schedule|1|||
130359778|NCT02939079|469288687|FG001|Overall Study|Withdrawal by Subject|1|||
130359779|NCT02939079|469288686|FG000|Overall Study|relapse during the study|1|||
130359780|NCT02939079|469288687|FG001|Overall Study|relapse during the study|1|||
130359781|NCT04093414|469288688|FG000|3 Month Follow up|Physician Decision|0|||
130359782|NCT04093414|469288689|FG001|3 Month Follow up|Physician Decision|1|||
130359783|NCT04093414|469288688|FG000|6month Follow up|Physician Decision|1|||
130359784|NCT04093414|469288689|FG001|6month Follow up|Physician Decision|3|||
130359785|NCT04209348|469288690|FG000|Overall Study|Lost to Follow-up|1|||
130359786|NCT04209348|469288691|FG001|Overall Study|Lost to Follow-up|0|||
130359787|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
130359788|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
130359789|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Death|1|||
130359790|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Death|0|||
130359791|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
130359792|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
130359793|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
130359794|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
130359795|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
130359796|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
130359797|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
130376536|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130376537|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|Other|1|||
130376538|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|Other|1|||
130376539|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|Other|0|||
130376540|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|Other|0|||
130376541|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|Other|0|||
130376542|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130376543|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130376544|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130376545|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
130376546|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
130376547|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130376548|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130376549|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130376550|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
130376551|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130376552|NCT02310568|469345857|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130376553|NCT02310568|469345858|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130376554|NCT02310568|469345859|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130376555|NCT02310568|469345860|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
130376556|NCT02310568|469345861|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130376557|NCT02310568|469345857|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
130376558|NCT02310568|469345858|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130376559|NCT02310568|469345859|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130376560|NCT02310568|469345860|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
130376561|NCT02310568|469345861|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130376562|NCT02310568|469345857|FG000|Stage 2 (4 Weeks)|Other|0|||
130376563|NCT02310568|469345858|FG001|Stage 2 (4 Weeks)|Other|1|||
130376564|NCT02310568|469345859|FG002|Stage 2 (4 Weeks)|Other|1|||
130376565|NCT02310568|469345860|FG003|Stage 2 (4 Weeks)|Other|0|||
130376566|NCT02310568|469345861|FG004|Stage 2 (4 Weeks)|Other|0|||
130376567|NCT02310568|469345857|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
130376568|NCT02310568|469345858|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
130376569|NCT02310568|469345859|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
130376570|NCT02310568|469345860|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
130376571|NCT02310568|469345861|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
130376572|NCT02310568|469345857|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
130376573|NCT02310568|469345858|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
130376574|NCT02310568|469345859|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
130376575|NCT02310568|469345860|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
130376576|NCT02310568|469345861|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
130376577|NCT02310568|469345857|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130376578|NCT02310568|469345858|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130376579|NCT02310568|469345859|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130376580|NCT02310568|469345860|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
130376581|NCT02310568|469345861|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130376582|NCT01384760|469345862|FG000|Overall Study|Lost to Follow-up|0|||
130376583|NCT01384760|469345863|FG001|Overall Study|Lost to Follow-up|6|||
130376584|NCT01384760|469345862|FG000|Overall Study|Protocol Violation|16|||
130448017|NCT00630539|469602108|FG003|Overall Study|Adverse Event|2|||
130359798|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
130359799|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
130359800|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
130359801|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
130359802|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
130359803|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
130359804|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
130359805|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
130359806|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
130359807|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
130359808|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
130359809|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
130359810|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
130359811|NCT02927262|469288694|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
130359812|NCT02927262|469288695|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
130359813|NCT02927262|469288694|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
130359814|NCT02927262|469288695|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
130359815|NCT02927262|469288694|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
130359816|NCT02927262|469288695|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
130359817|NCT02927262|469288694|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
130359818|NCT02927262|469288695|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
130359819|NCT00923936|469288696|FG000|Overall Study|progressive disease on study|2|||
130359820|NCT00923936|469288697|FG001|Overall Study|progressive disease on study|1|||
130359821|NCT00923936|469288696|FG000|Overall Study|Adverse Event|2|||
130359822|NCT00923936|469288697|FG001|Overall Study|Adverse Event|1|||
130359823|NCT00923936|469288696|FG000|Overall Study|Lost to follow up|2|||
130359824|NCT00923936|469288697|FG001|Overall Study|Lost to follow up|0|||
130359825|NCT00923936|469288696|FG000|Overall Study|Continuing in follow up period|2|||
130359826|NCT00923936|469288697|FG001|Overall Study|Continuing in follow up period|1|||
130359827|NCT01697358|469288698|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
130359828|NCT01697358|469288699|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
130359829|NCT01697358|469288698|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
130359830|NCT01697358|469288699|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
130359831|NCT01697358|469288698|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
130359832|NCT01697358|469288699|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
130359833|NCT01697358|469288698|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
130359834|NCT01697358|469288699|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
130359835|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
130359836|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
130359837|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
130359838|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
130359839|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
130359840|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
130359841|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
130359842|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
130359843|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
130359844|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
130359845|NCT01697358|469288698|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
130359846|NCT01697358|469288699|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
130359847|NCT00471146|469288700|FG000|Overall Study|Adverse Event|32|||
130359848|NCT00471146|469288701|FG001|Overall Study|Adverse Event|33|||
130359849|NCT00471146|469288700|FG000|Overall Study|Withdrawal by Subject|14|||
130359850|NCT00471146|469288701|FG001|Overall Study|Withdrawal by Subject|11|||
130359851|NCT00471146|469288700|FG000|Overall Study|Death|11|||
130359852|NCT00471146|469288701|FG001|Overall Study|Death|12|||
130359853|NCT00471146|469288700|FG000|Overall Study|Lost to Follow-up|4|||
130359854|NCT00471146|469288701|FG001|Overall Study|Lost to Follow-up|2|||
130359855|NCT00471146|469288700|FG000|Overall Study|Protocol Violation|2|||
130359856|NCT00471146|469288701|FG001|Overall Study|Protocol Violation|2|||
130359857|NCT00471146|469288700|FG000|Overall Study|Objective progression or relapse|84|||
130376585|NCT01384760|469345863|FG001|Overall Study|Protocol Violation|0|||
130376586|NCT00963547|469345864|FG000|Overall Study|Adverse Event|0|||
130376587|NCT00963547|469345865|FG001|Overall Study|Adverse Event|1|||
130376588|NCT00963547|469345866|FG002|Overall Study|Adverse Event|0|||
130376589|NCT00963547|469345867|FG003|Overall Study|Adverse Event|1|||
130376590|NCT00963547|469345868|FG004|Overall Study|Adverse Event|0|||
130695883|NCT03101358|470510660|FG001|Overall Study|Non-compliance with study schedule|0|||
130695884|NCT03101358|470510661|FG002|Overall Study|Non-compliance with study schedule|0|||
130695885|NCT03101358|470510662|FG003|Overall Study|Non-compliance with study schedule|1|||
130695886|NCT03101358|470510659|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695887|NCT03101358|470510660|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695888|NCT03101358|470510661|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
130695889|NCT03101358|470510662|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695890|NCT03101358|470510659|FG000|Overall Study|Physician Decision|1|||
130695891|NCT03101358|470510660|FG001|Overall Study|Physician Decision|0|||
130695892|NCT03101358|470510661|FG002|Overall Study|Physician Decision|0|||
130695893|NCT03101358|470510662|FG003|Overall Study|Physician Decision|3|||
130695894|NCT03101358|470510659|FG000|Overall Study|Adverse Event|0|||
130695895|NCT03101358|470510660|FG001|Overall Study|Adverse Event|0|||
130695896|NCT03101358|470510661|FG002|Overall Study|Adverse Event|1|||
130695897|NCT03101358|470510662|FG003|Overall Study|Adverse Event|0|||
130695898|NCT03101358|470510659|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695899|NCT03101358|470510660|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695900|NCT03101358|470510661|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695901|NCT03101358|470510662|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
130695902|NCT03101358|470510659|FG000|Overall Study|Lost to Follow-up|1|||
130695903|NCT03101358|470510660|FG001|Overall Study|Lost to Follow-up|0|||
130695904|NCT03101358|470510661|FG002|Overall Study|Lost to Follow-up|0|||
130695905|NCT03101358|470510662|FG003|Overall Study|Lost to Follow-up|1|||
130695906|NCT00474058|470510663|FG000|Overall Study|Adverse Event|11|||
130695907|NCT00474058|470510664|FG001|Overall Study|Adverse Event|6|||
130695908|NCT00474058|470510663|FG000|Overall Study|Lack of Efficacy|0|||
130695909|NCT00474058|470510664|FG001|Overall Study|Lack of Efficacy|4|||
130695910|NCT00474058|470510663|FG000|Overall Study|Withdrawal by Subject|11|||
130695911|NCT00474058|470510664|FG001|Overall Study|Withdrawal by Subject|7|||
130695912|NCT00474058|470510663|FG000|Overall Study|Other|2|||
130695913|NCT00474058|470510664|FG001|Overall Study|Other|0|||
130695914|NCT02426918|470510665|FG000|Overall Study|Adverse Event|2|||
130695915|NCT02426918|470510666|FG001|Overall Study|Adverse Event|2|||
130695916|NCT02426918|470510667|FG002|Overall Study|Adverse Event|0|||
130695917|NCT02426918|470510665|FG000|Overall Study|Physician Decision|1|||
130695918|NCT02426918|470510666|FG001|Overall Study|Physician Decision|1|||
130239202|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
130239203|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130448018|NCT00630539|469602105|FG000|Overall Study|Withdrawal by Subject|0|||
130448019|NCT00630539|469602106|FG001|Overall Study|Withdrawal by Subject|1|||
130448020|NCT00630539|469602107|FG002|Overall Study|Withdrawal by Subject|0|||
130695919|NCT02426918|470510667|FG002|Overall Study|Physician Decision|1|||
130695920|NCT02426918|470510665|FG000|Overall Study|Withdrawal by Subject|5|||
130695921|NCT02426918|470510666|FG001|Overall Study|Withdrawal by Subject|5|||
130695922|NCT02426918|470510667|FG002|Overall Study|Withdrawal by Subject|4|||
130239204|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130359858|NCT00471146|469288701|FG001|Overall Study|Objective progression or relapse|87|||
130359859|NCT00471146|469288700|FG000|Overall Study|Global deterioration of health status|12|||
130359860|NCT00471146|469288701|FG001|Overall Study|Global deterioration of health status|14|||
130359861|NCT00471146|469288700|FG000|Overall Study|Randomized but not treated|9|||
130359862|NCT00471146|469288701|FG001|Overall Study|Randomized but not treated|8|||
130359863|NCT00471146|469288700|FG000|Overall Study|Other|4|||
130359864|NCT00471146|469288701|FG001|Overall Study|Other|5|||
130359865|NCT05394350|469288702|FG000|Overall Study|Death|2|||
130359866|NCT05394350|469288703|FG001|Overall Study|Death|2|||
130359867|NCT05394350|469288704|FG002|Overall Study|Death|4|||
130359868|NCT05394350|469288705|FG003|Overall Study|Death|0|||
130359869|NCT05394350|469288706|FG004|Overall Study|Death|1|||
130359870|NCT05394350|469288707|FG005|Overall Study|Death|0|||
130359871|NCT05394350|469288702|FG000|Overall Study|Study terminated by sponsor|1|||
130359872|NCT05394350|469288703|FG001|Overall Study|Study terminated by sponsor|1|||
130359873|NCT05394350|469288704|FG002|Overall Study|Study terminated by sponsor|7|||
130695923|NCT02426918|470510665|FG000|Overall Study|Other|9|||
130695924|NCT02426918|470510666|FG001|Overall Study|Other|11|||
130239205|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Physician Decision|0|||
130359874|NCT05394350|469288705|FG003|Overall Study|Study terminated by sponsor|3|||
130359875|NCT05394350|469288706|FG004|Overall Study|Study terminated by sponsor|2|||
130359876|NCT05394350|469288707|FG005|Overall Study|Study terminated by sponsor|4|||
130359877|NCT02963935|469288710|FG000|Overall Study|Adverse Event|12|||
130359878|NCT02963935|469288711|FG001|Overall Study|Adverse Event|6|||
130695925|NCT02426918|470510667|FG002|Overall Study|Other|9|||
130239206|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Physician Decision|3|||
130448021|NCT00630539|469602108|FG003|Overall Study|Withdrawal by Subject|1|||
130448022|NCT01700530|469602109|FG000|Overall Study|Withdrawal by Subject|0|||
130695926|NCT01496118|470510668|FG000|Overall Study|Disease progression|3|||
130695927|NCT01496118|470510669|FG001|Overall Study|Disease progression|2|||
130695928|NCT01496118|470510670|FG002|Overall Study|Disease progression|3|||
130695929|NCT01496118|470510671|FG003|Overall Study|Disease progression|1|||
130695930|NCT01496118|470510672|FG004|Overall Study|Disease progression|2|||
130695931|NCT01496118|470510673|FG005|Overall Study|Disease progression|2|||
130695932|NCT01496118|470510674|FG006|Overall Study|Disease progression|14|||
130695933|NCT01496118|470510675|FG007|Overall Study|Disease progression|10|||
130695934|NCT01496118|470510668|FG000|Overall Study|Physician Decision|0|||
130695935|NCT01496118|470510669|FG001|Overall Study|Physician Decision|0|||
130695936|NCT01496118|470510670|FG002|Overall Study|Physician Decision|0|||
130695937|NCT01496118|470510671|FG003|Overall Study|Physician Decision|0|||
130695938|NCT01496118|470510672|FG004|Overall Study|Physician Decision|1|||
130695939|NCT01496118|470510673|FG005|Overall Study|Physician Decision|0|||
130695940|NCT01496118|470510674|FG006|Overall Study|Physician Decision|3|||
130695941|NCT01496118|470510675|FG007|Overall Study|Physician Decision|6|||
130695942|NCT01496118|470510668|FG000|Overall Study|Adverse Event|1|||
130695943|NCT01496118|470510669|FG001|Overall Study|Adverse Event|1|||
130695944|NCT01496118|470510670|FG002|Overall Study|Adverse Event|0|||
130695945|NCT01496118|470510671|FG003|Overall Study|Adverse Event|0|||
130695946|NCT01496118|470510672|FG004|Overall Study|Adverse Event|0|||
130695947|NCT01496118|470510673|FG005|Overall Study|Adverse Event|0|||
130695948|NCT01496118|470510674|FG006|Overall Study|Adverse Event|6|||
130695949|NCT01496118|470510675|FG007|Overall Study|Adverse Event|10|||
130695950|NCT01496118|470510668|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695951|NCT01496118|470510669|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695952|NCT01496118|470510670|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695953|NCT01496118|470510671|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695954|NCT01496118|470510672|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695955|NCT01496118|470510673|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695956|NCT01496118|470510674|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
130695957|NCT01496118|470510675|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695958|NCT01496118|470510668|FG000|Overall Study|Death|0|||
130695959|NCT01496118|470510669|FG001|Overall Study|Death|0|||
130695960|NCT01496118|470510670|FG002|Overall Study|Death|0|||
130695961|NCT01496118|470510671|FG003|Overall Study|Death|0|||
130695962|NCT01496118|470510672|FG004|Overall Study|Death|0|||
130695963|NCT01496118|470510673|FG005|Overall Study|Death|0|||
130695964|NCT01496118|470510674|FG006|Overall Study|Death|1|||
130695965|NCT01496118|470510675|FG007|Overall Study|Death|1|||
130695966|NCT01496118|470510668|FG000|Overall Study|Withdrawal by Subject|0|||
130695967|NCT01496118|470510669|FG001|Overall Study|Withdrawal by Subject|0|||
130695968|NCT01496118|470510670|FG002|Overall Study|Withdrawal by Subject|0|||
130695969|NCT01496118|470510671|FG003|Overall Study|Withdrawal by Subject|2|||
130695970|NCT01496118|470510672|FG004|Overall Study|Withdrawal by Subject|0|||
130695971|NCT01496118|470510673|FG005|Overall Study|Withdrawal by Subject|1|||
130695972|NCT01496118|470510674|FG006|Overall Study|Withdrawal by Subject|6|||
130695973|NCT01496118|470510675|FG007|Overall Study|Withdrawal by Subject|3|||
130695974|NCT05616728|470510676|FG000|Overall Study|Lost to Follow-up|0|||
130695975|NCT05616728|470510677|FG001|Overall Study|Lost to Follow-up|0|||
130695976|NCT05616728|470510678|FG002|Overall Study|Lost to Follow-up|1|||
130695977|NCT05616728|470510676|FG000|Overall Study|Withdrawal by Subject|1|||
130695978|NCT05616728|470510677|FG001|Overall Study|Withdrawal by Subject|1|||
130695979|NCT05616728|470510678|FG002|Overall Study|Withdrawal by Subject|0|||
130695980|NCT05616728|470510676|FG000|Overall Study|Physician Decision|1|||
130695981|NCT05616728|470510677|FG001|Overall Study|Physician Decision|1|||
130695982|NCT05616728|470510678|FG002|Overall Study|Physician Decision|1|||
130695983|NCT05616728|470510676|FG000|Overall Study|Other|0|||
130695984|NCT05616728|470510677|FG001|Overall Study|Other|2|||
130695985|NCT05616728|470510678|FG002|Overall Study|Other|0|||
130695986|NCT01024855|470510681|FG000|Overall Study|Inclusion/exclusion criteria|1|||
130695987|NCT03306277|470510686|FG000|Overall Study|Death|1|||
130695988|NCT03306277|470510686|FG000|Overall Study|Adverse Event|1|||
130695989|NCT03306277|470510686|FG000|Overall Study|Withdrawal by Subject|1|||
130695990|NCT00881751|470510687|FG000|Overall Study|Physician Decision|0|||
130695991|NCT00881751|470510688|FG001|Overall Study|Physician Decision|1|||
130695992|NCT00881751|470510687|FG000|Overall Study|Adverse Event|0|||
130695993|NCT00881751|470510688|FG001|Overall Study|Adverse Event|2|||
130695994|NCT00881751|470510687|FG000|Overall Study|Withdrawal by Subject|0|||
130695995|NCT00881751|470510688|FG001|Overall Study|Withdrawal by Subject|2|||
130695996|NCT02385708|470510689|FG000|Overall Study|Withdrawal by Subject|0|||
130695997|NCT02385708|470510690|FG001|Overall Study|Withdrawal by Subject|2|||
130695998|NCT02385708|470510689|FG000|Overall Study|Withdrawn - surgery canceled|2|||
130695999|NCT02385708|470510690|FG001|Overall Study|Withdrawn - surgery canceled|5|||
130696000|NCT02385708|470510689|FG000|Overall Study|Investigator decision|5|||
130696001|NCT02385708|470510690|FG001|Overall Study|Investigator decision|7|||
130239207|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Adverse Event|0|||
130239208|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Adverse Event|1|||
130239209|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
130239210|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
130239211|NCT02629159|468837543|FG000|Overall Study|Adverse Event|17|||
130239212|NCT02629159|468837544|FG001|Overall Study|Adverse Event|20|||
130239213|NCT02629159|468837545|FG002|Overall Study|Adverse Event|22|||
130239214|NCT02629159|468837543|FG000|Overall Study|Withdrawal by Subject|22|||
130239215|NCT02629159|468837544|FG001|Overall Study|Withdrawal by Subject|11|||
130239216|NCT02629159|468837545|FG002|Overall Study|Withdrawal by Subject|15|||
130239217|NCT02629159|468837543|FG000|Overall Study|Lost to Follow-up|7|||
130239218|NCT02629159|468837544|FG001|Overall Study|Lost to Follow-up|4|||
130239219|NCT02629159|468837545|FG002|Overall Study|Lost to Follow-up|5|||
130239220|NCT02629159|468837543|FG000|Overall Study|Lack of Efficacy|4|||
130239221|NCT02629159|468837544|FG001|Overall Study|Lack of Efficacy|0|||
130239222|NCT02629159|468837545|FG002|Overall Study|Lack of Efficacy|1|||
130239223|NCT02629159|468837543|FG000|Overall Study|Other|6|||
130239224|NCT02629159|468837544|FG001|Overall Study|Other|4|||
130239225|NCT02629159|468837545|FG002|Overall Study|Other|8|||
130239226|NCT05352399|468837558|FG000|Overall Study|Discontinued intervention|6|||
130239227|NCT01802281|468837559|FG000|Overall Study|Death|1|||
130239228|NCT01802281|468837560|FG001|Overall Study|Death|2|||
130239229|NCT01802281|468837559|FG000|Overall Study|Withdrawal by Subject|2|||
130239230|NCT01802281|468837560|FG001|Overall Study|Withdrawal by Subject|1|||
130239231|NCT01802281|468837559|FG000|Overall Study|Ineligible|5|||
130239232|NCT01802281|468837560|FG001|Overall Study|Ineligible|3|||
130239233|NCT02685735|468837561|FG000|Overall Study|Surgery Cancelled|4|||
130239234|NCT02685735|468837562|FG001|Overall Study|Surgery Cancelled|9|||
130239235|NCT02685735|468837561|FG000|Overall Study|Adverse Event|10|||
130239236|NCT02685735|468837562|FG001|Overall Study|Adverse Event|3|||
130239237|NCT02685735|468837561|FG000|Overall Study|Preop testing found to be incomplete|2|||
130239238|NCT02685735|468837562|FG001|Overall Study|Preop testing found to be incomplete|2|||
130239239|NCT02685735|468837561|FG000|Overall Study|Withdrawal by Subject|1|||
130239240|NCT02685735|468837562|FG001|Overall Study|Withdrawal by Subject|2|||
130239241|NCT02685735|468837561|FG000|Overall Study|Death|1|||
130239242|NCT02685735|468837562|FG001|Overall Study|Death|0|||
130239243|NCT00927472|468837572|FG000|Overall Study|Withdrawal by Subject|10|||
130239244|NCT00927472|468837573|FG001|Overall Study|Withdrawal by Subject|11|||
130239245|NCT00927472|468837572|FG000|Overall Study|Lost to Follow-up|1|||
130239246|NCT00927472|468837573|FG001|Overall Study|Lost to Follow-up|6|||
130239247|NCT00927472|468837572|FG000|Overall Study|Protocol Violation|0|||
130359879|NCT02963935|469288710|FG000|Overall Study|Protocol Violation|2|||
130359880|NCT02963935|469288711|FG001|Overall Study|Protocol Violation|1|||
130359881|NCT02963935|469288710|FG000|Overall Study|Lack of Efficacy|0|||
130359882|NCT02963935|469288711|FG001|Overall Study|Lack of Efficacy|2|||
130359883|NCT02963935|469288710|FG000|Overall Study|Lost to Follow-up|1|||
130359884|NCT02963935|469288711|FG001|Overall Study|Lost to Follow-up|6|||
130359885|NCT02963935|469288710|FG000|Overall Study|Unclassified|13|||
130359886|NCT02963935|469288711|FG001|Overall Study|Unclassified|22|||
130359887|NCT00464269|469288712|FG000|Overall Study|Lack of Efficacy|1|||
130359888|NCT00464269|469288713|FG001|Overall Study|Lack of Efficacy|0|||
130359889|NCT00464269|469288714|FG002|Overall Study|Lack of Efficacy|0|||
130359890|NCT00464269|469288715|FG003|Overall Study|Lack of Efficacy|0|||
130359891|NCT00464269|469288712|FG000|Overall Study|Lost to Follow-up|0|||
130359892|NCT00464269|469288713|FG001|Overall Study|Lost to Follow-up|4|||
130359893|NCT00464269|469288714|FG002|Overall Study|Lost to Follow-up|0|||
130359894|NCT00464269|469288715|FG003|Overall Study|Lost to Follow-up|1|||
130359895|NCT00464269|469288712|FG000|Overall Study|Withdrawal by Subject|0|||
130359896|NCT00464269|469288713|FG001|Overall Study|Withdrawal by Subject|2|||
130359897|NCT00464269|469288714|FG002|Overall Study|Withdrawal by Subject|1|||
130359898|NCT00464269|469288715|FG003|Overall Study|Withdrawal by Subject|1|||
130359899|NCT00464269|469288712|FG000|Overall Study|Other reason|3|||
130359900|NCT00464269|469288713|FG001|Overall Study|Other reason|3|||
130359901|NCT00464269|469288714|FG002|Overall Study|Other reason|1|||
130359902|NCT00464269|469288715|FG003|Overall Study|Other reason|1|||
130359903|NCT00464269|469288712|FG000|Overall Study|AE, serious fatal|0|||
130696002|NCT02385708|470510689|FG000|Overall Study|Protocol Violation|1|||
130696003|NCT02385708|470510690|FG001|Overall Study|Protocol Violation|1|||
130696004|NCT02761915|470510691|FG000|Overall Study|Death|3|||
130239248|NCT00927472|468837573|FG001|Overall Study|Protocol Violation|1|||
130239249|NCT00927472|468837572|FG000|Overall Study|Post treatment Assessment out of window|0|||
130239250|NCT00927472|468837573|FG001|Overall Study|Post treatment Assessment out of window|4|||
130239251|NCT05436613|468837581|FG000|Overall Study|Lost to Follow-up|9|||
130239252|NCT05436613|468837581|FG000|Overall Study|Withdrawal by Subject|3|||
130239253|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
130239254|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
130239255|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
130359904|NCT00464269|469288713|FG001|Overall Study|AE, serious fatal|0|||
130696005|NCT02761915|470510692|FG001|Overall Study|Death|1|||
130239256|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
130239257|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130239258|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130239259|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
130239260|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
130239261|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
130239262|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
130239263|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
130239264|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
130239265|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
130239266|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
130239267|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
130239268|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
130239269|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
130239270|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
130239271|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Removal|1|||
130359905|NCT00464269|469288714|FG002|Overall Study|AE, serious fatal|1|||
130359906|NCT00464269|469288715|FG003|Overall Study|AE, serious fatal|1|||
130359907|NCT00464269|469288712|FG000|Overall Study|SAE, non-fatal|0|||
130696006|NCT02761915|470510693|FG002|Overall Study|Death|1|||
130696007|NCT02761915|470510694|FG003|Overall Study|Death|1|||
130696008|NCT02761915|470510695|FG004|Overall Study|Death|0|||
130696009|NCT02761915|470510696|FG005|Overall Study|Death|1|||
130696010|NCT02761915|470510691|FG000|Overall Study|Withdrawal by Subject|1|||
130696011|NCT02761915|470510692|FG001|Overall Study|Withdrawal by Subject|0|||
130696012|NCT02761915|470510693|FG002|Overall Study|Withdrawal by Subject|0|||
130696013|NCT02761915|470510694|FG003|Overall Study|Withdrawal by Subject|0|||
130696014|NCT02761915|470510695|FG004|Overall Study|Withdrawal by Subject|1|||
130696015|NCT02761915|470510696|FG005|Overall Study|Withdrawal by Subject|2|||
130696016|NCT02761915|470510691|FG000|Overall Study|Disease Progression|0|||
130696017|NCT02761915|470510692|FG001|Overall Study|Disease Progression|0|||
130359908|NCT00464269|469288713|FG001|Overall Study|SAE, non-fatal|0|||
130359909|NCT00464269|469288714|FG002|Overall Study|SAE, non-fatal|0|||
130359910|NCT00464269|469288715|FG003|Overall Study|SAE, non-fatal|1|||
130359911|NCT00464269|469288712|FG000|Overall Study|AE, non-serious non-fatal|2|||
130359912|NCT00464269|469288713|FG001|Overall Study|AE, non-serious non-fatal|8|||
130359913|NCT00464269|469288714|FG002|Overall Study|AE, non-serious non-fatal|3|||
130359914|NCT00464269|469288715|FG003|Overall Study|AE, non-serious non-fatal|4|||
130359915|NCT00464269|469288712|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130359916|NCT00464269|469288713|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130359917|NCT00464269|469288714|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130359918|NCT00464269|469288715|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130359919|NCT05055128|469288716|FG000|Overall Study|Adverse Event|0|||
130359920|NCT05055128|469288717|FG001|Overall Study|Adverse Event|0|||
130359921|NCT05055128|469288718|FG002|Overall Study|Adverse Event|0|||
130359922|NCT05055128|469288719|FG003|Overall Study|Adverse Event|1|||
130359923|NCT05055128|469288720|FG004|Overall Study|Adverse Event|1|||
130359924|NCT05055128|469288716|FG000|Overall Study|Protocol Violation|0|||
130359925|NCT05055128|469288717|FG001|Overall Study|Protocol Violation|0|||
130359926|NCT05055128|469288718|FG002|Overall Study|Protocol Violation|0|||
130359927|NCT05055128|469288719|FG003|Overall Study|Protocol Violation|1|||
130359928|NCT05055128|469288720|FG004|Overall Study|Protocol Violation|0|||
130359929|NCT05055128|469288716|FG000|Overall Study|Withdrawal by Subject|5|||
130359930|NCT05055128|469288717|FG001|Overall Study|Withdrawal by Subject|2|||
130359931|NCT05055128|469288718|FG002|Overall Study|Withdrawal by Subject|2|||
130359932|NCT05055128|469288719|FG003|Overall Study|Withdrawal by Subject|4|||
130359933|NCT05055128|469288720|FG004|Overall Study|Withdrawal by Subject|2|||
130359934|NCT05055128|469288716|FG000|Overall Study|Randomized By Mistake|0|||
130359935|NCT05055128|469288717|FG001|Overall Study|Randomized By Mistake|1|||
130359936|NCT05055128|469288718|FG002|Overall Study|Randomized By Mistake|0|||
130359937|NCT05055128|469288719|FG003|Overall Study|Randomized By Mistake|0|||
130359938|NCT05055128|469288720|FG004|Overall Study|Randomized By Mistake|0|||
130359939|NCT05055128|469288716|FG000|Overall Study|Other|1|||
130359940|NCT05055128|469288717|FG001|Overall Study|Other|0|||
130359941|NCT05055128|469288718|FG002|Overall Study|Other|0|||
130359942|NCT05055128|469288719|FG003|Overall Study|Other|0|||
130359943|NCT05055128|469288720|FG004|Overall Study|Other|0|||
130359944|NCT02149875|469288721|FG000|Overall Study|Lost to Follow-up|3|||
130359945|NCT02149875|469288722|FG001|Overall Study|Lost to Follow-up|4|||
130359946|NCT02149875|469288723|FG002|Overall Study|Lost to Follow-up|5|||
130359947|NCT02149875|469288721|FG000|Overall Study|Withdrawal by Subject|3|||
130359948|NCT02149875|469288722|FG001|Overall Study|Withdrawal by Subject|2|||
130696018|NCT02761915|470510693|FG002|Overall Study|Disease Progression|0|||
130696019|NCT02761915|470510694|FG003|Overall Study|Disease Progression|2|||
130696020|NCT02761915|470510695|FG004|Overall Study|Disease Progression|2|||
130696021|NCT02761915|470510696|FG005|Overall Study|Disease Progression|2|||
130696022|NCT00645853|470510701|FG000|Overall Study|Adverse Event|18|||
130696023|NCT00645853|470510702|FG001|Overall Study|Adverse Event|7|||
130696024|NCT00645853|470510701|FG000|Overall Study|AZ study closure in Hungary|60|||
130696025|NCT00645853|470510702|FG001|Overall Study|AZ study closure in Hungary|40|||
130696026|NCT00645853|470510701|FG000|Overall Study|Withdrawal by Subject|5|||
130696027|NCT00645853|470510702|FG001|Overall Study|Withdrawal by Subject|2|||
130696028|NCT00645853|470510701|FG000|Overall Study|Protocol Violation|0|||
130696029|NCT00645853|470510702|FG001|Overall Study|Protocol Violation|2|||
130696030|NCT00645853|470510701|FG000|Overall Study|Discontinuation criteria|2|||
130696031|NCT00645853|470510702|FG001|Overall Study|Discontinuation criteria|2|||
130696032|NCT00645853|470510701|FG000|Overall Study|recall of ICF, planned operation, death|7|||
130696033|NCT00645853|470510702|FG001|Overall Study|recall of ICF, planned operation, death|4|||
130696034|NCT00380588|470510703|FG000|Overall Study|Unequivocal Disease Progression|25|||
130696035|NCT00380588|470510704|FG001|Overall Study|Unequivocal Disease Progression|34|||
130696036|NCT00380588|470510703|FG000|Overall Study|Next Cycle Not Started|4|||
130696037|NCT00380588|470510704|FG001|Overall Study|Next Cycle Not Started|0|||
130696038|NCT00380588|470510703|FG000|Overall Study|Adverse Event|7|||
130696039|NCT00380588|470510704|FG001|Overall Study|Adverse Event|3|||
130696040|NCT00380588|470510703|FG000|Overall Study|Withdrawal by Subject|1|||
130696041|NCT00380588|470510704|FG001|Overall Study|Withdrawal by Subject|3|||
130696042|NCT00380588|470510703|FG000|Overall Study|Physician Decision|2|||
130696043|NCT00380588|470510704|FG001|Overall Study|Physician Decision|0|||
130696044|NCT01120028|470510708|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696045|NCT01120028|470510709|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
130696046|NCT01120028|470510710|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696047|NCT01120028|470510711|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696048|NCT01120028|470510708|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
130696049|NCT01120028|470510709|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
130696050|NCT01120028|470510710|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
130696051|NCT01120028|470510711|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
130359949|NCT02149875|469288723|FG002|Overall Study|Withdrawal by Subject|2|||
130359950|NCT02149875|469288721|FG000|Overall Study|Physician Decision|1|||
130359951|NCT02149875|469288722|FG001|Overall Study|Physician Decision|2|||
130359952|NCT02149875|469288723|FG002|Overall Study|Physician Decision|2|||
130359953|NCT01385371|469288724|FG000|Overall Study|Adverse Event|54|||
130359954|NCT01385371|469288725|FG001|Overall Study|Adverse Event|19|||
130359955|NCT01385371|469288724|FG000|Overall Study|Lost to Follow-up|16|||
130359956|NCT01385371|469288725|FG001|Overall Study|Lost to Follow-up|16|||
130359957|NCT01385371|469288724|FG000|Overall Study|Withdrawal by Subject|52|||
130359958|NCT01385371|469288725|FG001|Overall Study|Withdrawal by Subject|39|||
130359959|NCT01385371|469288724|FG000|Overall Study|Protocol Violation|25|||
130359960|NCT01385371|469288725|FG001|Overall Study|Protocol Violation|21|||
130359961|NCT01385371|469288724|FG000|Overall Study|Administrative|2|||
130359962|NCT01385371|469288725|FG001|Overall Study|Administrative|2|||
130359963|NCT02478372|469288726|FG000|Overall Study|Protocol Violation|12|||
130359964|NCT02478372|469288727|FG001|Overall Study|Protocol Violation|8|||
130359965|NCT02478372|469288726|FG000|Overall Study|Lost to Follow-up|1|||
130359966|NCT02478372|469288727|FG001|Overall Study|Lost to Follow-up|4|||
130359967|NCT02478372|469288726|FG000|Overall Study|Death|0|||
130359968|NCT02478372|469288727|FG001|Overall Study|Death|2|||
130359969|NCT02955797|469288728|FG000|Overall Study|Protocol Violation|1|||
130359970|NCT02955797|469288729|FG001|Overall Study|Protocol Violation|0|||
130359971|NCT02955797|469288730|FG002|Overall Study|Protocol Violation|0|||
130359972|NCT02955797|469288731|FG003|Overall Study|Protocol Violation|1|||
130359973|NCT02955797|469288728|FG000|Overall Study|Withdrawal by Subject|2|||
130359974|NCT02955797|469288729|FG001|Overall Study|Withdrawal by Subject|2|||
130359975|NCT02955797|469288730|FG002|Overall Study|Withdrawal by Subject|0|||
130359976|NCT02955797|469288731|FG003|Overall Study|Withdrawal by Subject|1|||
130696052|NCT01401062|470510712|FG000|Overall Study|Death|9|||
130696053|NCT01401062|470510713|FG001|Overall Study|Death|7|||
130696054|NCT01401062|470510712|FG000|Overall Study|Physician Decision|1|||
130696055|NCT01401062|470510713|FG001|Overall Study|Physician Decision|0|||
130696056|NCT01401062|470510712|FG000|Overall Study|Withdrawal by Subject|1|||
130359977|NCT02955797|469288728|FG000|Overall Study|Lost to Follow-up|0|||
130359978|NCT02955797|469288729|FG001|Overall Study|Lost to Follow-up|1|||
130359979|NCT02955797|469288730|FG002|Overall Study|Lost to Follow-up|0|||
130359980|NCT02955797|469288731|FG003|Overall Study|Lost to Follow-up|0|||
130359981|NCT00961649|469288733|FG000|Overall Study|Adverse Event|4|||
130359982|NCT00961649|469288734|FG001|Overall Study|Adverse Event|0|||
130696057|NCT01401062|470510713|FG001|Overall Study|Withdrawal by Subject|1|||
130696058|NCT01131260|470510716|FG000|Overall Study|Randomization error|5|||
130359983|NCT00961649|469288735|FG002|Overall Study|Adverse Event|0|||
130359984|NCT00961649|469288736|FG003|Overall Study|Adverse Event|2|||
130359985|NCT00961649|469288733|FG000|Overall Study|Inadequate control of IOP|0|||
130359986|NCT00961649|469288734|FG001|Overall Study|Inadequate control of IOP|0|||
130696059|NCT01131260|470510717|FG001|Overall Study|Randomization error|1|||
130696060|NCT01131260|470510716|FG000|Overall Study|Declined to continue participation|8|||
130696061|NCT01131260|470510717|FG001|Overall Study|Declined to continue participation|13|||
130696062|NCT01131260|470510716|FG000|Overall Study|Physician Decision|22|||
130696063|NCT01131260|470510717|FG001|Overall Study|Physician Decision|24|||
130696064|NCT01131260|470510716|FG000|Overall Study|Technical problems|7|||
130696065|NCT01131260|470510717|FG001|Overall Study|Technical problems|6|||
130359987|NCT00961649|469288735|FG002|Overall Study|Inadequate control of IOP|0|||
130359988|NCT00961649|469288736|FG003|Overall Study|Inadequate control of IOP|1|||
130359989|NCT00961649|469288733|FG000|Overall Study|Patient has travel plans during holidays|0|||
130359990|NCT00961649|469288734|FG001|Overall Study|Patient has travel plans during holidays|0|||
130359991|NCT00961649|469288735|FG002|Overall Study|Patient has travel plans during holidays|1|||
130359992|NCT00961649|469288736|FG003|Overall Study|Patient has travel plans during holidays|0|||
130359993|NCT00961649|469288733|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
130359994|NCT00961649|469288734|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
130359995|NCT00961649|469288735|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
130359996|NCT00961649|469288736|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
130359997|NCT00961649|469288733|FG000|Overall Study|Study terminated by sponsor|4|||
130359998|NCT00961649|469288734|FG001|Overall Study|Study terminated by sponsor|4|||
130359999|NCT00961649|469288735|FG002|Overall Study|Study terminated by sponsor|4|||
130360000|NCT00961649|469288736|FG003|Overall Study|Study terminated by sponsor|1|||
130360001|NCT02711345|469288737|FG000|Overall Study|Adverse Event|0|||
130360002|NCT02711345|469288738|FG001|Overall Study|Adverse Event|0|||
130360003|NCT02711345|469288739|FG002|Overall Study|Adverse Event|0|||
130360004|NCT02711345|469288740|FG003|Overall Study|Adverse Event|1|||
130360005|NCT02711345|469288741|FG004|Overall Study|Adverse Event|1|||
130360006|NCT02711345|469288742|FG005|Overall Study|Adverse Event|2|||
130360007|NCT02711345|469288743|FG006|Overall Study|Adverse Event|1|||
130360008|NCT02711345|469288744|FG007|Overall Study|Adverse Event|0|||
130360009|NCT02711345|469288745|FG008|Overall Study|Adverse Event|0|||
130360010|NCT02711345|469288746|FG009|Overall Study|Adverse Event|2|||
130360011|NCT02711345|469288737|FG000|Overall Study|Physician Decision|0|||
130360012|NCT02711345|469288738|FG001|Overall Study|Physician Decision|0|||
130360013|NCT02711345|469288739|FG002|Overall Study|Physician Decision|1|||
130360014|NCT02711345|469288740|FG003|Overall Study|Physician Decision|0|||
130360015|NCT02711345|469288741|FG004|Overall Study|Physician Decision|0|||
130360016|NCT02711345|469288742|FG005|Overall Study|Physician Decision|0|||
130360017|NCT02711345|469288743|FG006|Overall Study|Physician Decision|0|||
130360018|NCT02711345|469288744|FG007|Overall Study|Physician Decision|0|||
130360019|NCT02711345|469288745|FG008|Overall Study|Physician Decision|1|||
130360020|NCT02711345|469288746|FG009|Overall Study|Physician Decision|0|||
130360021|NCT02711345|469288737|FG000|Overall Study|Progressive disease|1|||
130360022|NCT02711345|469288738|FG001|Overall Study|Progressive disease|3|||
130360023|NCT02711345|469288739|FG002|Overall Study|Progressive disease|5|||
130360024|NCT02711345|469288740|FG003|Overall Study|Progressive disease|3|||
130360025|NCT02711345|469288741|FG004|Overall Study|Progressive disease|7|||
130360026|NCT02711345|469288742|FG005|Overall Study|Progressive disease|2|||
130360027|NCT02711345|469288743|FG006|Overall Study|Progressive disease|8|||
130360028|NCT02711345|469288744|FG007|Overall Study|Progressive disease|4|||
130360029|NCT02711345|469288745|FG008|Overall Study|Progressive disease|5|||
130360030|NCT02711345|469288746|FG009|Overall Study|Progressive disease|6|||
130360031|NCT02711345|469288737|FG000|Overall Study|Subject/guardian decision|0|||
130360032|NCT02711345|469288738|FG001|Overall Study|Subject/guardian decision|0|||
130360033|NCT02711345|469288739|FG002|Overall Study|Subject/guardian decision|0|||
130360034|NCT02711345|469288740|FG003|Overall Study|Subject/guardian decision|0|||
130360035|NCT02711345|469288741|FG004|Overall Study|Subject/guardian decision|0|||
130360036|NCT02711345|469288742|FG005|Overall Study|Subject/guardian decision|2|||
130360037|NCT02711345|469288743|FG006|Overall Study|Subject/guardian decision|3|||
130360038|NCT02711345|469288744|FG007|Overall Study|Subject/guardian decision|1|||
130360039|NCT02711345|469288745|FG008|Overall Study|Subject/guardian decision|0|||
130360040|NCT02711345|469288746|FG009|Overall Study|Subject/guardian decision|4|||
130360041|NCT02711345|469288737|FG000|Overall Study|Death|1|||
130360042|NCT02711345|469288738|FG001|Overall Study|Death|0|||
130360043|NCT02711345|469288739|FG002|Overall Study|Death|0|||
130360044|NCT02711345|469288740|FG003|Overall Study|Death|0|||
130360045|NCT02711345|469288741|FG004|Overall Study|Death|0|||
130360046|NCT02711345|469288742|FG005|Overall Study|Death|0|||
130360047|NCT02711345|469288743|FG006|Overall Study|Death|0|||
130360048|NCT02711345|469288744|FG007|Overall Study|Death|1|||
130360049|NCT02711345|469288745|FG008|Overall Study|Death|0|||
130360050|NCT02711345|469288746|FG009|Overall Study|Death|0|||
130360051|NCT01558739|469288749|FG000|Overall Study|Adverse Event|7|||
130360052|NCT01558739|469288749|FG000|Overall Study|Withdrawal by Subject|2|||
130360053|NCT01558739|469288749|FG000|Overall Study|Death|3|||
130360054|NCT01558739|469288749|FG000|Overall Study|Disease Progression|4|||
130696066|NCT01131260|470510716|FG000|Overall Study|Staff error|2|||
130360055|NCT01558739|469288749|FG000|Overall Study|Protocol Violation|1|||
130360056|NCT00108433|469290867|FG000|Overall Study|Lack of Efficacy|1|||
130696067|NCT01131260|470510717|FG001|Overall Study|Staff error|1|||
130239272|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Removal|0|||
130239273|NCT00191100|468837594|FG000|Overall Study|Adverse Event|18|||
130239274|NCT00191100|468837595|FG001|Overall Study|Adverse Event|1|||
130239275|NCT00191100|468837594|FG000|Overall Study|Lost to Follow-up|2|||
130239276|NCT00191100|468837595|FG001|Overall Study|Lost to Follow-up|0|||
130239277|NCT00191100|468837594|FG000|Overall Study|Patient Moved|0|||
130239278|NCT00191100|468837595|FG001|Overall Study|Patient Moved|1|||
130239279|NCT00191100|468837594|FG000|Overall Study|Withdrawal by Subject|9|||
130239280|NCT00191100|468837595|FG001|Overall Study|Withdrawal by Subject|3|||
130239281|NCT00191100|468837594|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130239282|NCT00191100|468837595|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
130239283|NCT00191100|468837594|FG000|Overall Study|Clinical Relapse|2|||
130239284|NCT00191100|468837595|FG001|Overall Study|Clinical Relapse|1|||
130239285|NCT00191100|468837594|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
130239286|NCT00191100|468837595|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
130239287|NCT00191100|468837594|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
130239288|NCT00191100|468837595|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
130239289|NCT00191100|468837594|FG000|Overall Study|Physician Decision|3|||
130239290|NCT00191100|468837595|FG001|Overall Study|Physician Decision|1|||
130239291|NCT00191100|468837594|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130239292|NCT00191100|468837595|FG001|Overall Study|Death from Study Drug Toxicity|0|||
130239293|NCT00191100|468837594|FG000|Overall Study|Protocol Violation|1|||
130239294|NCT00191100|468837595|FG001|Overall Study|Protocol Violation|1|||
130239295|NCT00191100|468837594|FG000|Overall Study|Death from Other Cause|1|||
130239296|NCT00191100|468837595|FG001|Overall Study|Death from Other Cause|0|||
130239297|NCT00191100|468837594|FG000|Overall Study|Reason Not Specified|0|||
130239298|NCT00191100|468837595|FG001|Overall Study|Reason Not Specified|1|||
130239299|NCT01525589|468837598|FG000|Overall Study|Non-treatment-related AE|1|||
130239300|NCT01525589|468837599|FG001|Overall Study|Non-treatment-related AE|0|||
130239301|NCT01525589|468837600|FG002|Overall Study|Non-treatment-related AE|0|||
130239302|NCT01525589|468837598|FG000|Overall Study|Progressive disease|48|||
130239303|NCT01525589|468837599|FG001|Overall Study|Progressive disease|15|||
130239304|NCT01525589|468837600|FG002|Overall Study|Progressive disease|29|||
130239305|NCT01525589|468837598|FG000|Overall Study|Never treated|2|||
130239306|NCT01525589|468837599|FG001|Overall Study|Never treated|0|||
130239307|NCT01525589|468837600|FG002|Overall Study|Never treated|0|||
130239308|NCT01525589|468837598|FG000|Overall Study|Physician Decision|4|||
130239309|NCT01525589|468837599|FG001|Overall Study|Physician Decision|2|||
130239310|NCT01525589|468837600|FG002|Overall Study|Physician Decision|2|||
130239311|NCT01525589|468837598|FG000|Overall Study|Death|0|||
130239312|NCT01525589|468837599|FG001|Overall Study|Death|0|||
130239313|NCT01525589|468837600|FG002|Overall Study|Death|2|||
130239314|NCT01525589|468837598|FG000|Overall Study|Treatment-related AE|1|||
130239315|NCT01525589|468837599|FG001|Overall Study|Treatment-related AE|1|||
130360057|NCT00108433|469290868|FG001|Overall Study|Lack of Efficacy|2|||
130360058|NCT00108433|469290867|FG000|Overall Study|Death|3|||
130360059|NCT00108433|469290868|FG001|Overall Study|Death|0|||
130360060|NCT00108433|469290867|FG000|Overall Study|Adverse Event|3|||
130360061|NCT00108433|469290868|FG001|Overall Study|Adverse Event|1|||
130360062|NCT00108433|469290867|FG000|Overall Study|Other|14|||
130360063|NCT00108433|469290868|FG001|Overall Study|Other|14|||
130360064|NCT00734474|469290876|FG000|Overall Study|Entry Criteria Not Met|0|||
130360065|NCT00734474|469290877|FG001|Overall Study|Entry Criteria Not Met|0|||
130360066|NCT00734474|469290878|FG002|Overall Study|Entry Criteria Not Met|5|||
130360067|NCT00734474|469290879|FG003|Overall Study|Entry Criteria Not Met|0|||
130360068|NCT00734474|469290880|FG004|Overall Study|Entry Criteria Not Met|3|||
130360069|NCT00734474|469290881|FG005|Overall Study|Entry Criteria Not Met|1|||
130360070|NCT00734474|469290882|FG006|Overall Study|Entry Criteria Not Met|0|||
130360071|NCT00734474|469290883|FG007|Overall Study|Entry Criteria Not Met|1|||
130360072|NCT00734474|469290884|FG008|Overall Study|Entry Criteria Not Met|1|||
130360073|NCT00734474|469290876|FG000|Overall Study|Lost to Follow-up|1|||
130360074|NCT00734474|469290877|FG001|Overall Study|Lost to Follow-up|0|||
130360075|NCT00734474|469290878|FG002|Overall Study|Lost to Follow-up|13|||
130360076|NCT00734474|469290879|FG003|Overall Study|Lost to Follow-up|0|||
130239316|NCT01525589|468837600|FG002|Overall Study|Treatment-related AE|2|||
130239317|NCT01525589|468837598|FG000|Overall Study|Other reasons|0|||
130239318|NCT01525589|468837599|FG001|Overall Study|Other reasons|1|||
130360077|NCT00734474|469290880|FG004|Overall Study|Lost to Follow-up|11|||
130448023|NCT01700530|469602110|FG001|Overall Study|Withdrawal by Subject|3|||
130239319|NCT01525589|468837600|FG002|Overall Study|Other reasons|0|||
130360078|NCT00734474|469290881|FG005|Overall Study|Lost to Follow-up|1|||
130360079|NCT00734474|469290882|FG006|Overall Study|Lost to Follow-up|0|||
130360080|NCT00734474|469290883|FG007|Overall Study|Lost to Follow-up|9|||
130448024|NCT01700530|469602111|FG002|Overall Study|Withdrawal by Subject|1|||
130239320|NCT01525589|468837598|FG000|Overall Study|Withdrawal by Subject|0|||
130239321|NCT01525589|468837599|FG001|Overall Study|Withdrawal by Subject|1|||
130239322|NCT01525589|468837600|FG002|Overall Study|Withdrawal by Subject|0|||
130360081|NCT00734474|469290884|FG008|Overall Study|Lost to Follow-up|4|||
130696068|NCT01131260|470510716|FG000|Overall Study|Ineligible|0|||
130696069|NCT01131260|470510717|FG001|Overall Study|Ineligible|2|||
130696070|NCT01018862|470510729|FG000|Overall Study|Adverse Event|2|||
130696071|NCT01018862|470510730|FG001|Overall Study|Adverse Event|0|||
130696072|NCT01018862|470510731|FG002|Overall Study|Adverse Event|6|||
130696073|NCT01018862|470510729|FG000|Overall Study|Lack of Efficacy|1|||
130696074|NCT01018862|470510730|FG001|Overall Study|Lack of Efficacy|0|||
130696075|NCT01018862|470510731|FG002|Overall Study|Lack of Efficacy|2|||
130696076|NCT01018862|470510729|FG000|Overall Study|Lost to Follow-up|3|||
130696077|NCT01018862|470510730|FG001|Overall Study|Lost to Follow-up|1|||
130696078|NCT01018862|470510731|FG002|Overall Study|Lost to Follow-up|0|||
130696079|NCT01018862|470510729|FG000|Overall Study|Protocol Violation|1|||
130696080|NCT01018862|470510730|FG001|Overall Study|Protocol Violation|3|||
130696081|NCT01018862|470510731|FG002|Overall Study|Protocol Violation|3|||
130696082|NCT01018862|470510729|FG000|Overall Study|Withdrawal by Subject|1|||
130696083|NCT01018862|470510730|FG001|Overall Study|Withdrawal by Subject|2|||
130696084|NCT01018862|470510731|FG002|Overall Study|Withdrawal by Subject|1|||
130696085|NCT01018862|470510729|FG000|Overall Study|administrative problems|5|||
130696086|NCT01018862|470510730|FG001|Overall Study|administrative problems|4|||
130696087|NCT01018862|470510731|FG002|Overall Study|administrative problems|4|||
130696088|NCT01968031|470510732|FG000|Overall Study|Adverse Event|13|||
130696089|NCT01968031|470510733|FG001|Overall Study|Adverse Event|10|||
130696090|NCT01968031|470510734|FG002|Overall Study|Adverse Event|22|||
130696091|NCT01968031|470510732|FG000|Overall Study|Withdrawal by Subject|3|||
130696092|NCT01968031|470510733|FG001|Overall Study|Withdrawal by Subject|7|||
130696093|NCT01968031|470510734|FG002|Overall Study|Withdrawal by Subject|3|||
130696094|NCT01968031|470510732|FG000|Overall Study|Did not meet entry criteria|1|||
130696095|NCT01968031|470510733|FG001|Overall Study|Did not meet entry criteria|1|||
130696096|NCT01968031|470510734|FG002|Overall Study|Did not meet entry criteria|1|||
130696097|NCT01968031|470510732|FG000|Overall Study|Noncompliance|0|||
130696098|NCT01968031|470510733|FG001|Overall Study|Noncompliance|0|||
130696099|NCT01968031|470510734|FG002|Overall Study|Noncompliance|2|||
130696100|NCT01968031|470510732|FG000|Overall Study|Failed inclusion criteria|0|||
130696101|NCT01968031|470510733|FG001|Overall Study|Failed inclusion criteria|2|||
130696102|NCT01968031|470510734|FG002|Overall Study|Failed inclusion criteria|0|||
130696103|NCT01968031|470510732|FG000|Overall Study|Death|0|||
130696104|NCT01968031|470510733|FG001|Overall Study|Death|0|||
130696105|NCT01968031|470510734|FG002|Overall Study|Death|1|||
130696106|NCT01968031|470510732|FG000|Overall Study|Prohibited concomitant medication|1|||
130696107|NCT01968031|470510733|FG001|Overall Study|Prohibited concomitant medication|0|||
130696108|NCT01968031|470510734|FG002|Overall Study|Prohibited concomitant medication|0|||
130696109|NCT02583048|470512477|FG000|Overall Study|Withdrawal by Subject|0|||
130696110|NCT02583048|470512478|FG001|Overall Study|Withdrawal by Subject|1|||
130696111|NCT02583048|470512479|FG002|Overall Study|Withdrawal by Subject|0|||
130696112|NCT02583048|470512477|FG000|Overall Study|Failed to meet eligibility criterion|0|||
130696113|NCT02583048|470512478|FG001|Overall Study|Failed to meet eligibility criterion|0|||
130696114|NCT02583048|470512479|FG002|Overall Study|Failed to meet eligibility criterion|1|||
130316205|NCT02421172|469124328|FG004|Period 2|Patient/guardian decision|1|||
130696115|NCT01151280|470512485|FG000|Overall Study|Adverse Event|1|||
130552929|NCT02520284|469991628|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
130696116|NCT01151280|470512485|FG000|Overall Study|Lack of Efficacy|3|||
130696117|NCT01243151|470512486|FG000|Overall Study|Adverse Event|0|||
130696118|NCT01243151|470512487|FG001|Overall Study|Adverse Event|1|||
130239461|NCT04409002|468837608|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
130239462|NCT06481579|468837609|FG000|Overall Study|Death|1|||
130239463|NCT06481579|468837610|FG001|Overall Study|Death|0|||
130239464|NCT06481579|468837609|FG000|Overall Study|Withdrawal by Subject|3|||
130239465|NCT06481579|468837610|FG001|Overall Study|Withdrawal by Subject|0|||
130239466|NCT06481579|468837609|FG000|Overall Study|Other|1|||
130239467|NCT06481579|468837610|FG001|Overall Study|Other|1|||
130239468|NCT05032196|468837611|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239469|NCT05032196|468837612|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
130239470|NCT05032196|468837613|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239471|NCT05032196|468837614|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239472|NCT05032196|468837615|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239473|NCT05032196|468837616|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239474|NCT05032196|468837611|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239475|NCT05032196|468837612|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239476|NCT05032196|468837613|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239477|NCT05032196|468837614|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
130239478|NCT05032196|468837615|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239479|NCT05032196|468837616|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239480|NCT05032196|468837611|FG000|Period 2 (Multidose)|Physician Decision|0|||
130239481|NCT05032196|468837612|FG001|Period 2 (Multidose)|Physician Decision|0|||
130239482|NCT05032196|468837613|FG002|Period 2 (Multidose)|Physician Decision|0|||
130239483|NCT05032196|468837614|FG003|Period 2 (Multidose)|Physician Decision|0|||
130239484|NCT05032196|468837615|FG004|Period 2 (Multidose)|Physician Decision|1|||
130239485|NCT05032196|468837616|FG005|Period 2 (Multidose)|Physician Decision|0|||
130239486|NCT05260008|468837617|FG000|Overall Study|Physician Decision|0|||
130239487|NCT05260008|468837618|FG001|Overall Study|Physician Decision|1|||
130239488|NCT05260008|468837619|FG002|Overall Study|Physician Decision|0|||
130239489|NCT05260008|468837620|FG003|Overall Study|Physician Decision|0|||
130239490|NCT05977868|468838676|FG000|Overall Study|Withdrawal by Subject|1|||
130239491|NCT05977868|468838677|FG001|Overall Study|Withdrawal by Subject|2|||
130239492|NCT05977868|468838676|FG000|Overall Study|Transitioned to comfort care|1|||
130239493|NCT05977868|468838677|FG001|Overall Study|Transitioned to comfort care|0|||
130239494|NCT05696847|468838686|FG000|Overall Study|Withdrawal by Subject|1|||
130239495|NCT05696847|468838687|FG001|Overall Study|Withdrawal by Subject|0|||
130239496|NCT05696847|468838688|FG002|Overall Study|Withdrawal by Subject|0|||
130239497|NCT05696847|468838689|FG003|Overall Study|Withdrawal by Subject|0|||
130239498|NCT05696847|468838690|FG004|Overall Study|Withdrawal by Subject|0|||
130239499|NCT05696847|468838691|FG005|Overall Study|Withdrawal by Subject|0|||
130239500|NCT05696847|468838686|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130239501|NCT05696847|468838687|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130239502|NCT05696847|468838688|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130239503|NCT05696847|468838689|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130239504|NCT05696847|468838690|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130239505|NCT05696847|468838691|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130239506|NCT05696847|468838686|FG000|Overall Study|Adverse Event|0|||
130239507|NCT05696847|468838687|FG001|Overall Study|Adverse Event|0|||
130239508|NCT05696847|468838688|FG002|Overall Study|Adverse Event|0|||
130239509|NCT05696847|468838689|FG003|Overall Study|Adverse Event|0|||
130239510|NCT05696847|468838690|FG004|Overall Study|Adverse Event|0|||
130239511|NCT05696847|468838691|FG005|Overall Study|Adverse Event|1|||
130239512|NCT05696847|468838686|FG000|Overall Study|Sponsor Decision|0|||
130239513|NCT05696847|468838687|FG001|Overall Study|Sponsor Decision|0|||
130239514|NCT05696847|468838688|FG002|Overall Study|Sponsor Decision|0|||
130239515|NCT05696847|468838689|FG003|Overall Study|Sponsor Decision|1|||
130239516|NCT05696847|468838690|FG004|Overall Study|Sponsor Decision|0|||
130239517|NCT05696847|468838691|FG005|Overall Study|Sponsor Decision|0|||
130239518|NCT03323502|468838692|FG000|Overall Study|Resident could not be linked to CMS data|594|||
130239519|NCT03323502|468838693|FG001|Overall Study|Resident could not be linked to CMS data|435|||
130239520|NCT03323502|468838692|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
130239521|NCT03323502|468838693|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
130239522|NCT03323502|468838692|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
130239523|NCT03323502|468838693|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
130239524|NCT03323502|468838692|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
130239525|NCT03323502|468838693|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
130239526|NCT03323502|468838692|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
130239527|NCT03323502|468838693|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
130239528|NCT04092777|468838694|FG000|Overall Study|Lost to Follow-up|28|||
130239529|NCT04092777|468838695|FG001|Overall Study|Lost to Follow-up|46|||
130239530|NCT04092777|468838694|FG000|Overall Study|Withdrawal by Subject|8|||
130239531|NCT04092777|468838695|FG001|Overall Study|Withdrawal by Subject|5|||
130239532|NCT00975923|468838700|FG000|Overall Study|Withdrawal by Subject|0|||
130239533|NCT00975923|468838701|FG001|Overall Study|Withdrawal by Subject|1|||
130239534|NCT04896385|468838702|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
130239535|NCT04896385|468838703|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
130239536|NCT04896385|468838704|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
130239537|NCT04896385|468838705|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130239538|NCT04896385|468838702|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130239539|NCT04896385|468838703|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130239540|NCT04896385|468838704|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130239541|NCT04896385|468838705|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130239542|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130316206|NCT00683878|469124329|FG000|Overall Study|Lack of Efficacy|3|||
130316207|NCT00683878|469124330|FG001|Overall Study|Lack of Efficacy|0|||
130316208|NCT00683878|469124331|FG002|Overall Study|Lack of Efficacy|1|||
130316209|NCT00683878|469124329|FG000|Overall Study|Adverse Event|4|||
130316210|NCT00683878|469124330|FG001|Overall Study|Adverse Event|3|||
130316211|NCT00683878|469124331|FG002|Overall Study|Adverse Event|3|||
130696119|NCT01243151|470512488|FG002|Overall Study|Adverse Event|0|||
130696120|NCT01243151|470512489|FG003|Overall Study|Adverse Event|0|||
130696121|NCT01243151|470512490|FG004|Overall Study|Adverse Event|0|||
130696122|NCT01243151|470512486|FG000|Overall Study|Protocol Violation|0|||
130696123|NCT01243151|470512487|FG001|Overall Study|Protocol Violation|0|||
130696124|NCT01243151|470512488|FG002|Overall Study|Protocol Violation|1|||
130696125|NCT01243151|470512489|FG003|Overall Study|Protocol Violation|0|||
130696126|NCT01243151|470512490|FG004|Overall Study|Protocol Violation|0|||
130696127|NCT01243151|470512486|FG000|Overall Study|Other|0|||
130696128|NCT01243151|470512487|FG001|Overall Study|Other|0|||
130696129|NCT01243151|470512488|FG002|Overall Study|Other|0|||
130696130|NCT01243151|470512489|FG003|Overall Study|Other|1|||
130696131|NCT01243151|470512490|FG004|Overall Study|Other|0|||
130696132|NCT01243151|470512486|FG000|Overall Study|Randomized but not treated|0|||
130696133|NCT01243151|470512487|FG001|Overall Study|Randomized but not treated|0|||
130696134|NCT01243151|470512488|FG002|Overall Study|Randomized but not treated|0|||
130696135|NCT01243151|470512489|FG003|Overall Study|Randomized but not treated|1|||
130696136|NCT01243151|470512490|FG004|Overall Study|Randomized but not treated|0|||
130696137|NCT02308241|470512493|FG000|Overall Study|Withdrawal by Subject|3|||
130696138|NCT04408924|470512494|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
130239543|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130239544|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
130239545|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
130239546|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130239547|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130239548|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130239549|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130239550|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130239551|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130239552|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
130239553|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
130239554|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
130239555|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
130239556|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
130239557|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
130239558|NCT05291689|468838708|FG000|Overall Study|Adverse Event|3|||
130239559|NCT05291689|468838708|FG000|Overall Study|Lack of Efficacy|10|||
130239560|NCT05291689|468838708|FG000|Overall Study|Withdrawal by Subject|4|||
130239561|NCT01931098|468838709|FG000|Overall Study|Withdrawal by Subject|0|||
130239562|NCT01931098|468838710|FG001|Overall Study|Withdrawal by Subject|1|||
130239563|NCT01931098|468838709|FG000|Overall Study|Enrolled in different protocol|0|||
130239564|NCT01931098|468838710|FG001|Overall Study|Enrolled in different protocol|1|||
130239565|NCT01931098|468838709|FG000|Overall Study|Unable to begin trmt:active infection|0|||
130239566|NCT01931098|468838710|FG001|Overall Study|Unable to begin trmt:active infection|1|||
130239567|NCT01931098|468838709|FG000|Overall Study|Refused further treatment|0|||
130696139|NCT04408924|470512494|FG000|Overall Study|Lost to Follow-up|3|||
130696140|NCT04408924|470512494|FG000|Overall Study|Withdrawal by Subject|5|||
130696141|NCT04408924|470512494|FG000|Overall Study|Sponsor Decision|2|||
130696142|NCT02578641|470512495|FG000|Overall Study|Adverse Event|5|||
130696143|NCT02578641|470512496|FG001|Overall Study|Adverse Event|15|||
130239568|NCT01931098|468838710|FG001|Overall Study|Refused further treatment|1|||
130239569|NCT02278354|468838711|FG000|Overall Study|Lost to Follow-up|2|||
130239570|NCT02278354|468838712|FG001|Overall Study|Lost to Follow-up|2|||
130239571|NCT02278354|468838711|FG000|Overall Study|Withdrawal by Subject|0|||
130360082|NCT00734474|469290876|FG000|Overall Study|Withdrawal by Subject|2|||
130360083|NCT00734474|469290877|FG001|Overall Study|Withdrawal by Subject|1|||
130360084|NCT00734474|469290878|FG002|Overall Study|Withdrawal by Subject|18|||
130360085|NCT00734474|469290879|FG003|Overall Study|Withdrawal by Subject|0|||
130360086|NCT00734474|469290880|FG004|Overall Study|Withdrawal by Subject|24|||
130360087|NCT00734474|469290881|FG005|Overall Study|Withdrawal by Subject|2|||
130360088|NCT00734474|469290882|FG006|Overall Study|Withdrawal by Subject|0|||
130360089|NCT00734474|469290883|FG007|Overall Study|Withdrawal by Subject|36|||
130696144|NCT02578641|470512495|FG000|Overall Study|Death|16|||
130696145|NCT02578641|470512496|FG001|Overall Study|Death|8|||
130696146|NCT02578641|470512495|FG000|Overall Study|Lost to Follow-up|0|||
130239572|NCT02278354|468838712|FG001|Overall Study|Withdrawal by Subject|1|||
130239573|NCT02278354|468838711|FG000|Overall Study|<10 professional fights|2|||
130696147|NCT02578641|470512496|FG001|Overall Study|Lost to Follow-up|1|||
130696148|NCT02578641|470512495|FG000|Overall Study|Withdrawal by Subject|14|||
130696149|NCT02578641|470512496|FG001|Overall Study|Withdrawal by Subject|7|||
130239574|NCT02278354|468838712|FG001|Overall Study|<10 professional fights|0|||
130239575|NCT02612155|468838714|FG000|Overall Study|Death|1|||
130239576|NCT02612155|468838715|FG001|Overall Study|Death|1|||
130239577|NCT02612155|468838714|FG000|Overall Study|Lost to Follow-up|2|||
130239578|NCT02612155|468838715|FG001|Overall Study|Lost to Follow-up|2|||
130239579|NCT02572167|468838718|FG000|Overall Study|Withdrawal by Subject|0|||
130239580|NCT02572167|468838719|FG001|Overall Study|Withdrawal by Subject|3|||
130239581|NCT02572167|468838720|FG002|Overall Study|Withdrawal by Subject|0|||
130239582|NCT02572167|468838718|FG000|Overall Study|Lost to Follow-up|2|||
130239583|NCT02572167|468838719|FG001|Overall Study|Lost to Follow-up|5|||
130239584|NCT02572167|468838720|FG002|Overall Study|Lost to Follow-up|3|||
130239585|NCT02572167|468838718|FG000|Overall Study|Death|0|||
130239586|NCT02572167|468838719|FG001|Overall Study|Death|8|||
130239587|NCT02572167|468838720|FG002|Overall Study|Death|3|||
130239588|NCT02572167|468838718|FG000|Overall Study|Did not meet inclusion criteria|0|||
130448025|NCT02223182|469602118|FG000|Double-Blind Period|Adverse Event|0|||
130448026|NCT02223182|469602119|FG001|Double-Blind Period|Adverse Event|2|||
130448027|NCT02223182|469602120|FG002|Double-Blind Period|Adverse Event|1|||
130448028|NCT02223182|469602121|FG003|Double-Blind Period|Adverse Event|0|||
130448029|NCT02223182|469602118|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130448030|NCT02223182|469602119|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130448031|NCT02223182|469602120|FG002|Double-Blind Period|Withdrawal by Subject|1|||
130448032|NCT02223182|469602121|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130448033|NCT02223182|469602118|FG000|Double-Blind Period|Lost to Follow-up|0|||
130448034|NCT02223182|469602119|FG001|Double-Blind Period|Lost to Follow-up|1|||
130448035|NCT02223182|469602120|FG002|Double-Blind Period|Lost to Follow-up|0|||
130448036|NCT02223182|469602121|FG003|Double-Blind Period|Lost to Follow-up|0|||
130448037|NCT02223182|469602118|FG000|Double-Blind Period|Non Compliance|0|||
130448038|NCT02223182|469602119|FG001|Double-Blind Period|Non Compliance|0|||
130239589|NCT02572167|468838719|FG001|Overall Study|Did not meet inclusion criteria|0|||
130239590|NCT02572167|468838720|FG002|Overall Study|Did not meet inclusion criteria|1|||
130239591|NCT02572167|468838718|FG000|Overall Study|Study closure by Sponsor|4|||
130239592|NCT02572167|468838719|FG001|Overall Study|Study closure by Sponsor|40|||
130239593|NCT02572167|468838720|FG002|Overall Study|Study closure by Sponsor|24|||
130239594|NCT00569127|468838721|FG000|Overall Study|Adverse Event|57|||
130239595|NCT00569127|468838722|FG001|Overall Study|Adverse Event|47|||
130239596|NCT00569127|468838721|FG000|Overall Study|Withdrawal by Subject|13|||
130239597|NCT00569127|468838722|FG001|Overall Study|Withdrawal by Subject|27|||
130239598|NCT00569127|468838721|FG000|Overall Study|Progression|99|||
130239599|NCT00569127|468838722|FG001|Overall Study|Progression|100|||
130239600|NCT00569127|468838721|FG000|Overall Study|Death|4|||
130239601|NCT00569127|468838722|FG001|Overall Study|Death|3|||
130239602|NCT00569127|468838721|FG000|Overall Study|Other|20|||
130239603|NCT00569127|468838722|FG001|Overall Study|Other|19|||
130239604|NCT00569127|468838721|FG000|Overall Study|Lost to Follow-up|0|||
130239605|NCT00569127|468838722|FG001|Overall Study|Lost to Follow-up|3|||
130239606|NCT00569127|468838721|FG000|Overall Study|Not Eligible|14|||
130239607|NCT00569127|468838722|FG001|Overall Study|Not Eligible|11|||
130239608|NCT00569127|468838721|FG000|Overall Study|Still on Treatment|7|||
130239609|NCT00569127|468838722|FG001|Overall Study|Still on Treatment|3|||
130239610|NCT03036254|468838725|FG000|Overall Study|Adverse Event|6|||
130239611|NCT03036254|468838726|FG001|Overall Study|Adverse Event|4|||
130239612|NCT03036254|468838725|FG000|Overall Study|Death|3|||
130239613|NCT03036254|468838726|FG001|Overall Study|Death|1|||
130239614|NCT03036254|468838725|FG000|Overall Study|Lack of Efficacy|5|||
130239615|NCT03036254|468838726|FG001|Overall Study|Lack of Efficacy|1|||
130239616|NCT03036254|468838725|FG000|Overall Study|Withdrawal by Subject|3|||
130239617|NCT03036254|468838726|FG001|Overall Study|Withdrawal by Subject|5|||
130239618|NCT06354257|468838727|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130239619|NCT06354257|468838727|FG000|Treatment Period 2|Adverse Event|1|||
130360090|NCT00734474|469290884|FG008|Overall Study|Withdrawal by Subject|21|||
130360091|NCT00734474|469290876|FG000|Overall Study|Physician Decision|0|||
130360092|NCT00734474|469290877|FG001|Overall Study|Physician Decision|0|||
130360093|NCT00734474|469290878|FG002|Overall Study|Physician Decision|4|||
130360094|NCT00734474|469290879|FG003|Overall Study|Physician Decision|1|||
130360095|NCT00734474|469290880|FG004|Overall Study|Physician Decision|11|||
130360096|NCT00734474|469290881|FG005|Overall Study|Physician Decision|0|||
130360097|NCT00734474|469290882|FG006|Overall Study|Physician Decision|0|||
130360098|NCT00734474|469290883|FG007|Overall Study|Physician Decision|9|||
130360099|NCT00734474|469290884|FG008|Overall Study|Physician Decision|9|||
130360100|NCT00734474|469290876|FG000|Overall Study|Adverse Event|4|||
130239620|NCT03168672|468838728|FG000|Overall Study|Withdrawal by Subject|13|||
130360101|NCT00734474|469290877|FG001|Overall Study|Adverse Event|4|||
130448039|NCT02223182|469602120|FG002|Double-Blind Period|Non Compliance|0|||
130448040|NCT02223182|469602121|FG003|Double-Blind Period|Non Compliance|1|||
130239621|NCT03168672|468838728|FG000|Overall Study|Death|3|||
130239622|NCT03168672|468838728|FG000|Overall Study|Investigator's Decision|137|||
130360102|NCT00734474|469290878|FG002|Overall Study|Adverse Event|63|||
130448041|NCT02223182|469602118|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
130696150|NCT02578641|470512495|FG000|Overall Study|Progressive Disease|69|||
130696151|NCT02578641|470512496|FG001|Overall Study|Progressive Disease|21|||
130696152|NCT02578641|470512495|FG000|Overall Study|No Study Drug|2|||
130239623|NCT03168672|468838728|FG000|Overall Study|Adverse Event|1|||
130239624|NCT03168672|468838728|FG000|Overall Study|Other|2|||
130239625|NCT03168672|468838728|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
130239626|NCT01757847|468838729|FG000|Overall Study|Withdrawal by Subject|3|||
130239627|NCT01757847|468838730|FG001|Overall Study|Withdrawal by Subject|4|||
130239628|NCT00831844|468838731|FG000|Overall Study|Adverse Event|2|||
130239629|NCT00831844|468838732|FG001|Overall Study|Adverse Event|0|||
130239630|NCT00831844|468838733|FG002|Overall Study|Adverse Event|0|||
130239631|NCT00831844|468838734|FG003|Overall Study|Adverse Event|0|||
130239632|NCT00831844|468838735|FG004|Overall Study|Adverse Event|1|||
130239633|NCT00831844|468838736|FG005|Overall Study|Adverse Event|1|||
130239634|NCT00831844|468838737|FG006|Overall Study|Adverse Event|2|||
130239635|NCT00831844|468838738|FG007|Overall Study|Adverse Event|0|||
130239636|NCT00831844|468838739|FG008|Overall Study|Adverse Event|0|||
130239637|NCT00831844|468838740|FG009|Overall Study|Adverse Event|0|||
130239638|NCT00831844|468838731|FG000|Overall Study|Death|0|||
130239639|NCT00831844|468838732|FG001|Overall Study|Death|0|||
130360103|NCT00734474|469290879|FG003|Overall Study|Adverse Event|1|||
130360104|NCT00734474|469290880|FG004|Overall Study|Adverse Event|64|||
130360105|NCT00734474|469290881|FG005|Overall Study|Adverse Event|0|||
130360106|NCT00734474|469290882|FG006|Overall Study|Adverse Event|1|||
130360107|NCT00734474|469290883|FG007|Overall Study|Adverse Event|65|||
130360108|NCT00734474|469290884|FG008|Overall Study|Adverse Event|39|||
130360109|NCT00734474|469290876|FG000|Overall Study|Protocol Violation|0|||
130360110|NCT00734474|469290877|FG001|Overall Study|Protocol Violation|0|||
130360111|NCT00734474|469290878|FG002|Overall Study|Protocol Violation|4|||
130360112|NCT00734474|469290879|FG003|Overall Study|Protocol Violation|0|||
130360113|NCT00734474|469290880|FG004|Overall Study|Protocol Violation|3|||
130360114|NCT00734474|469290881|FG005|Overall Study|Protocol Violation|0|||
130360115|NCT00734474|469290882|FG006|Overall Study|Protocol Violation|0|||
130360116|NCT00734474|469290883|FG007|Overall Study|Protocol Violation|3|||
130360117|NCT00734474|469290884|FG008|Overall Study|Protocol Violation|1|||
130360118|NCT00734474|469290876|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
130360119|NCT00734474|469290877|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
130360120|NCT00734474|469290878|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130360121|NCT00734474|469290879|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
130360122|NCT00734474|469290880|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130360123|NCT00734474|469290881|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
130360124|NCT00734474|469290882|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
130360125|NCT00734474|469290883|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130360126|NCT00734474|469290884|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130360127|NCT00734474|469290876|FG000|Overall Study|Sponsor Decision|0|||
130360128|NCT00734474|469290877|FG001|Overall Study|Sponsor Decision|0|||
130360129|NCT00734474|469290878|FG002|Overall Study|Sponsor Decision|0|||
130360130|NCT00734474|469290879|FG003|Overall Study|Sponsor Decision|0|||
130360131|NCT00734474|469290880|FG004|Overall Study|Sponsor Decision|2|||
130360132|NCT00734474|469290881|FG005|Overall Study|Sponsor Decision|0|||
130360133|NCT00734474|469290882|FG006|Overall Study|Sponsor Decision|0|||
130360134|NCT00734474|469290883|FG007|Overall Study|Sponsor Decision|0|||
130360135|NCT00734474|469290884|FG008|Overall Study|Sponsor Decision|0|||
130360136|NCT00734474|469290876|FG000|Overall Study|Death|0|||
130360137|NCT00734474|469290877|FG001|Overall Study|Death|0|||
130360138|NCT00734474|469290878|FG002|Overall Study|Death|1|||
130360139|NCT00734474|469290879|FG003|Overall Study|Death|0|||
130360140|NCT00734474|469290880|FG004|Overall Study|Death|0|||
130360141|NCT00734474|469290881|FG005|Overall Study|Death|0|||
130360142|NCT00734474|469290882|FG006|Overall Study|Death|0|||
130360143|NCT00734474|469290883|FG007|Overall Study|Death|2|||
130360144|NCT00734474|469290884|FG008|Overall Study|Death|1|||
130360145|NCT00734474|469290876|FG000|Overall Study|Lack of Efficacy|0|||
130360146|NCT00734474|469290877|FG001|Overall Study|Lack of Efficacy|0|||
130360147|NCT00734474|469290878|FG002|Overall Study|Lack of Efficacy|4|||
130360148|NCT00734474|469290879|FG003|Overall Study|Lack of Efficacy|0|||
130360149|NCT00734474|469290880|FG004|Overall Study|Lack of Efficacy|0|||
130360150|NCT00734474|469290881|FG005|Overall Study|Lack of Efficacy|0|||
130360151|NCT00734474|469290882|FG006|Overall Study|Lack of Efficacy|0|||
130360152|NCT00734474|469290883|FG007|Overall Study|Lack of Efficacy|4|||
130360153|NCT00734474|469290884|FG008|Overall Study|Lack of Efficacy|6|||
130360154|NCT02497612|469290895|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
130360155|NCT02497612|469290896|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
130360156|NCT02497612|469290897|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
130360157|NCT02497612|469290898|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
130360158|NCT02497612|469290895|FG000|Overall Study|Participant's request|2|||
130360159|NCT02497612|469290896|FG001|Overall Study|Participant's request|3|||
130360160|NCT02497612|469290897|FG002|Overall Study|Participant's request|4|||
130360161|NCT02497612|469290898|FG003|Overall Study|Participant's request|1|||
130239640|NCT00831844|468838733|FG002|Overall Study|Death|0|||
130239641|NCT00831844|468838734|FG003|Overall Study|Death|1|||
130448042|NCT02223182|469602119|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
130448043|NCT02223182|469602120|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
130448044|NCT02223182|469602121|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
130448045|NCT02223182|469602118|FG000|Open-Label 500 Period|Adverse Event|1|||
130239642|NCT00831844|468838735|FG004|Overall Study|Death|0|||
130239643|NCT00831844|468838736|FG005|Overall Study|Death|0|||
130239644|NCT00831844|468838737|FG006|Overall Study|Death|0|||
130239645|NCT00831844|468838738|FG007|Overall Study|Death|0|||
130239646|NCT00831844|468838739|FG008|Overall Study|Death|0|||
130239647|NCT00831844|468838740|FG009|Overall Study|Death|0|||
130239648|NCT00831844|468838731|FG000|Overall Study|Lack of Efficacy|8|||
130239649|NCT00831844|468838732|FG001|Overall Study|Lack of Efficacy|10|||
130239650|NCT00831844|468838733|FG002|Overall Study|Lack of Efficacy|15|||
130448046|NCT02223182|469602119|FG001|Open-Label 500 Period|Adverse Event|0|||
130448047|NCT02223182|469602120|FG002|Open-Label 500 Period|Adverse Event|2|||
130239651|NCT00831844|468838734|FG003|Overall Study|Lack of Efficacy|8|||
130239652|NCT00831844|468838735|FG004|Overall Study|Lack of Efficacy|11|||
130239653|NCT00831844|468838736|FG005|Overall Study|Lack of Efficacy|17|||
130239654|NCT00831844|468838737|FG006|Overall Study|Lack of Efficacy|8|||
130239655|NCT00831844|468838738|FG007|Overall Study|Lack of Efficacy|9|||
130239656|NCT00831844|468838739|FG008|Overall Study|Lack of Efficacy|7|||
130239657|NCT00831844|468838740|FG009|Overall Study|Lack of Efficacy|0|||
130239658|NCT00831844|468838731|FG000|Overall Study|Physician Decision|0|||
130360162|NCT02497612|469290895|FG000|Overall Study|Investigator's judgement|1|||
130360163|NCT02497612|469290896|FG001|Overall Study|Investigator's judgement|0|||
130360164|NCT02497612|469290897|FG002|Overall Study|Investigator's judgement|0|||
130360165|NCT02497612|469290898|FG003|Overall Study|Investigator's judgement|2|||
130360166|NCT02497612|469290895|FG000|Overall Study|Adverse Event|3|||
130360167|NCT02497612|469290896|FG001|Overall Study|Adverse Event|1|||
130360168|NCT02497612|469290897|FG002|Overall Study|Adverse Event|4|||
130360169|NCT02497612|469290898|FG003|Overall Study|Adverse Event|1|||
130360170|NCT02497612|469290895|FG000|Overall Study|Lost to Follow-up|1|||
130360171|NCT02497612|469290896|FG001|Overall Study|Lost to Follow-up|1|||
130360172|NCT02497612|469290897|FG002|Overall Study|Lost to Follow-up|0|||
130360173|NCT02497612|469290898|FG003|Overall Study|Lost to Follow-up|1|||
130360174|NCT02497612|469290895|FG000|Overall Study|Other unspecified|1|||
130360175|NCT02497612|469290896|FG001|Overall Study|Other unspecified|1|||
130360176|NCT02497612|469290897|FG002|Overall Study|Other unspecified|2|||
130360177|NCT02497612|469290898|FG003|Overall Study|Other unspecified|0|||
130360178|NCT02497612|469290895|FG000|Overall Study|Not eligible|1|||
130360179|NCT02497612|469290896|FG001|Overall Study|Not eligible|0|||
130360180|NCT02497612|469290897|FG002|Overall Study|Not eligible|0|||
130360181|NCT02497612|469290898|FG003|Overall Study|Not eligible|1|||
130360182|NCT02651467|469290899|FG000|Overall Study|Withdrawal by Subject|0|||
130360183|NCT02651467|469290900|FG001|Overall Study|Withdrawal by Subject|0|||
130360184|NCT02651467|469290901|FG002|Overall Study|Withdrawal by Subject|2|||
130360185|NCT02651467|469290899|FG000|Overall Study|Other (Not specified)|1|||
130360186|NCT02651467|469290900|FG001|Overall Study|Other (Not specified)|0|||
130360187|NCT02651467|469290901|FG002|Overall Study|Other (Not specified)|2|||
130360188|NCT02024529|469290902|FG000|Overall Study|Withdrawal by Subject|11|||
130360189|NCT02024529|469290903|FG001|Overall Study|Withdrawal by Subject|21|||
130360190|NCT02024529|469290902|FG000|Overall Study|Lost to Follow-up|2|||
130360191|NCT02024529|469290903|FG001|Overall Study|Lost to Follow-up|4|||
130360192|NCT00354614|469290904|FG000|Overall Study|Lack of Efficacy|28|||
130360193|NCT01890746|469290905|FG000|Overall Study|Death|39|||
130360194|NCT01890746|469290906|FG001|Overall Study|Death|30|||
130360195|NCT01890746|469290905|FG000|Overall Study|Adverse Event|1|||
130360196|NCT01890746|469290906|FG001|Overall Study|Adverse Event|0|||
130360197|NCT01890746|469290905|FG000|Overall Study|Lost to Follow-up|4|||
130360198|NCT01890746|469290906|FG001|Overall Study|Lost to Follow-up|1|||
130360199|NCT01890746|469290905|FG000|Overall Study|Physician Decision|3|||
130448048|NCT02223182|469602121|FG003|Open-Label 500 Period|Adverse Event|1|||
130239659|NCT00831844|468838732|FG001|Overall Study|Physician Decision|1|||
130239660|NCT00831844|468838733|FG002|Overall Study|Physician Decision|3|||
130239661|NCT00831844|468838734|FG003|Overall Study|Physician Decision|1|||
130239662|NCT00831844|468838735|FG004|Overall Study|Physician Decision|1|||
130239663|NCT00831844|468838736|FG005|Overall Study|Physician Decision|1|||
130360200|NCT01890746|469290906|FG001|Overall Study|Physician Decision|2|||
130360201|NCT01890746|469290905|FG000|Overall Study|Withdrawal by Subject|5|||
130360202|NCT01890746|469290906|FG001|Overall Study|Withdrawal by Subject|8|||
130360203|NCT02642029|469290907|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
130239664|NCT00831844|468838737|FG006|Overall Study|Physician Decision|0|||
130360204|NCT02642029|469290908|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130239665|NCT00831844|468838738|FG007|Overall Study|Physician Decision|0|||
130239666|NCT00831844|468838739|FG008|Overall Study|Physician Decision|1|||
130239667|NCT00831844|468838740|FG009|Overall Study|Physician Decision|0|||
130360205|NCT02642029|469290909|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130239668|NCT00831844|468838731|FG000|Overall Study|Withdrawal by Subject|0|||
130239669|NCT00831844|468838732|FG001|Overall Study|Withdrawal by Subject|0|||
130360206|NCT02642029|469290910|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130360207|NCT02642029|469290911|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130360208|NCT02642029|469290912|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130360209|NCT02642029|469290907|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130360210|NCT02642029|469290908|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
130360211|NCT02642029|469290909|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130360212|NCT02642029|469290910|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130360213|NCT02642029|469290911|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130360214|NCT02642029|469290912|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130360215|NCT02642029|469290907|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130360216|NCT02642029|469290908|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130360217|NCT02642029|469290909|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130360218|NCT02642029|469290910|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130360219|NCT02642029|469290911|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
130360220|NCT02642029|469290912|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130360221|NCT02642029|469290907|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
130360222|NCT02642029|469290908|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
130360223|NCT02642029|469290909|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
130360224|NCT02642029|469290910|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
130360225|NCT02642029|469290911|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
130360226|NCT02642029|469290912|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
130360227|NCT02642029|469290907|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
130360228|NCT02642029|469290908|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130360229|NCT02642029|469290909|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130360230|NCT02642029|469290910|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130360231|NCT02642029|469290911|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130360232|NCT02642029|469290912|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130360233|NCT02642029|469290907|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
130360234|NCT02642029|469290908|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130360235|NCT02642029|469290909|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130360236|NCT02642029|469290910|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130360237|NCT02642029|469290911|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130360238|NCT02642029|469290912|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130360239|NCT01134731|469290914|FG000|Overall Study|Adverse Event|3|||
130360240|NCT01134731|469290915|FG001|Overall Study|Adverse Event|2|||
130360241|NCT01134731|469290916|FG002|Overall Study|Adverse Event|1|||
130360242|NCT01134731|469290914|FG000|Overall Study|Physician Decision|2|||
130360243|NCT01134731|469290915|FG001|Overall Study|Physician Decision|2|||
130360244|NCT01134731|469290916|FG002|Overall Study|Physician Decision|2|||
130360245|NCT01134731|469290914|FG000|Overall Study|Lack of Efficacy|0|||
130360246|NCT01134731|469290915|FG001|Overall Study|Lack of Efficacy|0|||
130360247|NCT01134731|469290916|FG002|Overall Study|Lack of Efficacy|1|||
130360248|NCT01134731|469290914|FG000|Overall Study|Withdrawal by Subject|3|||
130360249|NCT01134731|469290915|FG001|Overall Study|Withdrawal by Subject|3|||
130360250|NCT01134731|469290916|FG002|Overall Study|Withdrawal by Subject|1|||
130360251|NCT01134731|469290914|FG000|Overall Study|Lost to Follow-up|5|||
130360252|NCT01134731|469290915|FG001|Overall Study|Lost to Follow-up|4|||
130360253|NCT01134731|469290916|FG002|Overall Study|Lost to Follow-up|3|||
130360254|NCT00676338|469290917|FG000|Overall Study|Adverse Event|6|||
130360255|NCT00676338|469290918|FG001|Overall Study|Adverse Event|6|||
130360256|NCT00676338|469290919|FG002|Overall Study|Adverse Event|5|||
130360257|NCT00676338|469290920|FG003|Overall Study|Adverse Event|1|||
130360258|NCT00676338|469290917|FG000|Overall Study|Lost to Follow-up|4|||
130360259|NCT00676338|469290918|FG001|Overall Study|Lost to Follow-up|1|||
130360260|NCT00676338|469290919|FG002|Overall Study|Lost to Follow-up|3|||
130360261|NCT00676338|469290920|FG003|Overall Study|Lost to Follow-up|4|||
130360262|NCT00676338|469290917|FG000|Overall Study|Physician Decision|3|||
130360263|NCT00676338|469290918|FG001|Overall Study|Physician Decision|3|||
130360264|NCT00676338|469290919|FG002|Overall Study|Physician Decision|2|||
130360265|NCT00676338|469290920|FG003|Overall Study|Physician Decision|3|||
130360266|NCT00676338|469290917|FG000|Overall Study|Protocol Violation|5|||
130360267|NCT00676338|469290918|FG001|Overall Study|Protocol Violation|9|||
130360268|NCT00676338|469290919|FG002|Overall Study|Protocol Violation|2|||
130360269|NCT00676338|469290920|FG003|Overall Study|Protocol Violation|5|||
130360270|NCT00676338|469290917|FG000|Overall Study|Withdrawal by Subject|17|||
130360271|NCT00676338|469290918|FG001|Overall Study|Withdrawal by Subject|9|||
130360272|NCT00676338|469290919|FG002|Overall Study|Withdrawal by Subject|12|||
130360273|NCT00676338|469290920|FG003|Overall Study|Withdrawal by Subject|6|||
130360274|NCT00676338|469290917|FG000|Overall Study|Entry Criteria Not Met|0|||
130376591|NCT00963547|469345869|FG005|Overall Study|Adverse Event|0|||
130448049|NCT02223182|469602118|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
130448050|NCT02223182|469602119|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
130448051|NCT02223182|469602120|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
130448052|NCT02223182|469602121|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
130448053|NCT02223182|469602118|FG000|Open-Label 500 Period|Physician Decision|0|||
130448054|NCT02223182|469602119|FG001|Open-Label 500 Period|Physician Decision|0|||
130448055|NCT02223182|469602120|FG002|Open-Label 500 Period|Physician Decision|0|||
130448056|NCT02223182|469602121|FG003|Open-Label 500 Period|Physician Decision|1|||
130448057|NCT02223182|469602118|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
130448058|NCT02223182|469602119|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
130448059|NCT02223182|469602120|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
130448060|NCT02223182|469602121|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
130448061|NCT02223182|469602118|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
130448062|NCT02223182|469602119|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
130448063|NCT02223182|469602120|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
130448064|NCT02223182|469602121|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
130448065|NCT02223182|469602118|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
130696153|NCT02578641|470512496|FG001|Overall Study|No Study Drug|0|||
130696154|NCT02578641|470512495|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
130696155|NCT02578641|470512496|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
130239670|NCT00831844|468838733|FG002|Overall Study|Withdrawal by Subject|1|||
130239671|NCT00831844|468838734|FG003|Overall Study|Withdrawal by Subject|0|||
130239672|NCT00831844|468838735|FG004|Overall Study|Withdrawal by Subject|0|||
130239673|NCT00831844|468838736|FG005|Overall Study|Withdrawal by Subject|0|||
130239674|NCT00831844|468838737|FG006|Overall Study|Withdrawal by Subject|0|||
130239675|NCT00831844|468838738|FG007|Overall Study|Withdrawal by Subject|1|||
130239676|NCT00831844|468838739|FG008|Overall Study|Withdrawal by Subject|1|||
130239677|NCT00831844|468838740|FG009|Overall Study|Withdrawal by Subject|0|||
130239678|NCT00831844|468838731|FG000|Overall Study|Ineligible|0|||
130239679|NCT00831844|468838732|FG001|Overall Study|Ineligible|1|||
130448066|NCT02223182|469602119|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
130448067|NCT02223182|469602120|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
130448068|NCT02223182|469602121|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
130448069|NCT02223182|469602118|FG000|Open-Label 300 Period|Non Compliance|0|||
130448070|NCT02223182|469602119|FG001|Open-Label 300 Period|Non Compliance|2|||
130448071|NCT02223182|469602120|FG002|Open-Label 300 Period|Non Compliance|1|||
130448072|NCT02223182|469602121|FG003|Open-Label 300 Period|Non Compliance|0|||
130448073|NCT03714022|469602122|FG000|Overall Study|Adverse Event|1|||
130448074|NCT03714022|469602123|FG001|Overall Study|Adverse Event|0|||
130448075|NCT03714022|469602122|FG000|Overall Study|Consent withdrawal|0|||
130696156|NCT02578641|470512495|FG000|Overall Study|Non-compliance with Study Schedule|1|||
130696157|NCT02578641|470512496|FG001|Overall Study|Non-compliance with Study Schedule|0|||
130696158|NCT02578641|470512495|FG000|Overall Study|Other|1|||
130696159|NCT02578641|470512496|FG001|Overall Study|Other|10|||
130696160|NCT02578641|470512495|FG000|Overall Study|Not treated|1|||
130696161|NCT02578641|470512496|FG001|Overall Study|Not treated|4|||
130696162|NCT00084864|470512499|FG000|Overall Study|Adverse Event|1|||
130696163|NCT00084864|470512500|FG001|Overall Study|Adverse Event|0|||
130696164|NCT00084864|470512501|FG002|Overall Study|Adverse Event|0|||
130696165|NCT00084864|470512502|FG003|Overall Study|Adverse Event|0|||
130696166|NCT01741545|470512503|FG000|Treatment Period|Lack of Efficacy|0|||
130696167|NCT01741545|470512504|FG001|Treatment Period|Lack of Efficacy|1|||
130696168|NCT01741545|470512503|FG000|Treatment Period|Adverse event, non-fatal|1|||
130696169|NCT01741545|470512504|FG001|Treatment Period|Adverse event, non-fatal|3|||
130696170|NCT01741545|470512503|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
130696171|NCT01741545|470512504|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
130696172|NCT01741545|470512503|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130448076|NCT03714022|469602123|FG001|Overall Study|Consent withdrawal|1|||
130448077|NCT03714022|469602122|FG000|Overall Study|Lost to Follow-up|3|||
130448078|NCT03714022|469602123|FG001|Overall Study|Lost to Follow-up|2|||
130448079|NCT03289455|469602132|FG000|Overall Study|Death|1|||
130448080|NCT03289455|469602133|FG001|Overall Study|Death|0|||
130448081|NCT03289455|469602134|FG002|Overall Study|Death|0|||
130448082|NCT03289455|469602132|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
130448083|NCT03289455|469602133|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
130696173|NCT01741545|470512504|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130696174|NCT01456962|470512505|FG000|Overall Study|Lost to Follow-up|2|||
130696175|NCT01456962|470512506|FG001|Overall Study|Lost to Follow-up|1|||
130239680|NCT00831844|468838733|FG002|Overall Study|Ineligible|1|||
130696176|NCT01853176|470512507|FG000|Overall Study|Study terminated|4|||
130696177|NCT01853176|470512508|FG001|Overall Study|Study terminated|0|||
130696178|NCT01370083|470512511|FG000|Overall Study|Lost to Follow-up|2|||
130239681|NCT00831844|468838734|FG003|Overall Study|Ineligible|0|||
130239682|NCT00831844|468838735|FG004|Overall Study|Ineligible|1|||
130448084|NCT03289455|469602134|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
130696179|NCT01370083|470512512|FG001|Overall Study|Lost to Follow-up|0|||
130696180|NCT01370083|470512511|FG000|Overall Study|Adverse Event|0|||
130696181|NCT01370083|470512512|FG001|Overall Study|Adverse Event|1|||
130696182|NCT00731939|470512514|FG000|Overall Study|Adverse Event|6|||
130696183|NCT00731939|470512514|FG000|Overall Study|Lost to Follow-up|15|||
130696184|NCT00731939|470512514|FG000|Overall Study|Not implanted with study device|9|||
130696185|NCT00731939|470512514|FG000|Overall Study|Withdrawal by Subject|2|||
130696186|NCT00731939|470512514|FG000|Overall Study|Did not meet enrollment criteria|2|||
130696187|NCT02072096|470512515|FG000|Overall Study|Lack of Efficacy|18|||
130696188|NCT02072096|470512516|FG001|Overall Study|Lack of Efficacy|29|||
130696189|NCT02072096|470512515|FG000|Overall Study|Protocol Violation|7|||
130696190|NCT02072096|470512516|FG001|Overall Study|Protocol Violation|7|||
130696191|NCT02072096|470512515|FG000|Overall Study|Withdrawal by Subject|5|||
130696192|NCT02072096|470512516|FG001|Overall Study|Withdrawal by Subject|7|||
130696193|NCT02072096|470512515|FG000|Overall Study|Adverse Event|5|||
130696194|NCT02072096|470512516|FG001|Overall Study|Adverse Event|2|||
130696195|NCT02072096|470512515|FG000|Overall Study|No Reason Provided|4|||
130696196|NCT02072096|470512516|FG001|Overall Study|No Reason Provided|2|||
130696197|NCT02072096|470512515|FG000|Overall Study|Death|2|||
130696198|NCT02072096|470512516|FG001|Overall Study|Death|0|||
130696199|NCT02072096|470512515|FG000|Overall Study|Physician Decision|0|||
130696200|NCT02072096|470512516|FG001|Overall Study|Physician Decision|1|||
130696201|NCT02072096|470512515|FG000|Overall Study|Study Terminated by Sponsor|43|||
130696202|NCT02072096|470512516|FG001|Overall Study|Study Terminated by Sponsor|30|||
130696203|NCT02072096|470512515|FG000|Overall Study|Lost to Follow-up|1|||
130696204|NCT02072096|470512516|FG001|Overall Study|Lost to Follow-up|0|||
130696205|NCT01266902|470512518|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
130696206|NCT01266902|470512519|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
130696207|NCT01266902|470512520|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
130696208|NCT01266902|470512518|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
130696209|NCT01266902|470512519|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
130696210|NCT01266902|470512520|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
130696211|NCT01266902|470512518|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
130696212|NCT01266902|470512519|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
130696213|NCT01266902|470512520|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
130696214|NCT01266902|470512518|FG000|Period 1 (Main Study)|Adverse Event|3|||
130696215|NCT01266902|470512519|FG001|Period 1 (Main Study)|Adverse Event|11|||
130696216|NCT01266902|470512520|FG002|Period 1 (Main Study)|Adverse Event|0|||
130696217|NCT01266902|470512518|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
130448085|NCT03289455|469602132|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
130448086|NCT03289455|469602133|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
130448087|NCT03289455|469602134|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
130448088|NCT03289455|469602132|FG000|Overall Study|Progressive disease|3|||
130448089|NCT03289455|469602133|FG001|Overall Study|Progressive disease|4|||
130448090|NCT03289455|469602134|FG002|Overall Study|Progressive disease|5|||
130448091|NCT00114959|469602135|FG000|Overall Study|Lack of Efficacy|6|||
130448092|NCT00114959|469602135|FG000|Overall Study|Physician Decision|1|||
130448093|NCT00114959|469602135|FG000|Overall Study|Death|1|||
130448094|NCT01007552|469602141|FG000|Overall Study|Withdrawal by Subject|1|||
130448095|NCT00429793|469602149|FG000|Overall Study|Improper pre-protocol treatment|3|||
130448096|NCT00429793|469602149|FG000|Overall Study|Required test not done|1|||
130448097|NCT00429793|469602149|FG000|Overall Study|Never treated|1|||
130448098|NCT00429793|469602149|FG000|Overall Study|Non-measurable|1|||
130448099|NCT00097370|469602150|FG000|Stage 1|Adverse Event|3|||
130448100|NCT00097370|469602150|FG000|Stage 1|Withdrawal by Subject|1|||
130448101|NCT00097370|469602150|FG000|Stage 1|Lack of Efficacy|2|||
130448102|NCT00097370|469602150|FG000|Stage 2|Adverse Event|5|||
130448103|NCT00097370|469602150|FG000|Stage 2|Withdrawal by Subject|1|||
130448104|NCT00097370|469602150|FG000|Stage 2|Lack of Efficacy|3|||
130448105|NCT00097370|469602150|FG000|Stage 2|Pregnancy|1|||
130448106|NCT00097370|469602150|FG000|Stage 2|Sponsor Terminated Study|2|||
130448107|NCT00097370|469602150|FG000|Stage 2|Lost to Follow-up|1|||
130448108|NCT00097370|469602150|FG000|Stage 3|Adverse Event|2|||
130448109|NCT00097370|469602150|FG000|Stage 3|Withdrawal by Subject|3|||
130448110|NCT00097370|469602150|FG000|Stage 3|Lack of Efficacy|1|||
130448111|NCT00097370|469602150|FG000|Stage 3|Sponsor Terminated Study|52|||
130696218|NCT01266902|470512519|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
130696219|NCT01266902|470512520|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
130696220|NCT01266902|470512518|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
130696221|NCT01266902|470512519|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
130696222|NCT01266902|470512520|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
130696223|NCT01266902|470512518|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
130696224|NCT01266902|470512519|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
130448112|NCT00097370|469602150|FG000|Stage 3|Lost to Follow-up|1|||
130696225|NCT01266902|470512520|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
130448113|NCT02419755|469602151|FG000|Overall Study|Death|1|||
130239683|NCT00831844|468838736|FG005|Overall Study|Ineligible|0|||
130239684|NCT00831844|468838737|FG006|Overall Study|Ineligible|0|||
130239685|NCT00831844|468838738|FG007|Overall Study|Ineligible|0|||
130239686|NCT00831844|468838739|FG008|Overall Study|Ineligible|0|||
130239687|NCT00831844|468838740|FG009|Overall Study|Ineligible|0|||
130239688|NCT04738487|468838743|FG000|Overall Study|Participant Ongoing in Study|298|||
130239689|NCT04738487|468838744|FG001|Overall Study|Participant Ongoing in Study|297|||
130239690|NCT04738487|468838743|FG000|Overall Study|Withdrawal by Subject|7|||
130239691|NCT04738487|468838744|FG001|Overall Study|Withdrawal by Subject|9|||
130239692|NCT04738487|468838743|FG000|Overall Study|Lost to Follow-up|2|||
130239693|NCT04738487|468838744|FG001|Overall Study|Lost to Follow-up|0|||
130448114|NCT02419755|469602152|FG001|Overall Study|Death|3|||
130448115|NCT02419755|469602151|FG000|Overall Study|Relapse|0|||
130448116|NCT02419755|469602152|FG001|Overall Study|Relapse|1|||
130448117|NCT02419755|469602151|FG000|Overall Study|Ineligible|1|||
130448118|NCT02419755|469602152|FG001|Overall Study|Ineligible|0|||
130696226|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
130448119|NCT02419755|469602151|FG000|Overall Study|Withdrawal by Subject|1|||
130448120|NCT02419755|469602152|FG001|Overall Study|Withdrawal by Subject|0|||
130448121|NCT02337361|469602153|FG000|3-month Follow-up|Lost to Follow-up|19|||
130448122|NCT02337361|469602154|FG001|3-month Follow-up|Lost to Follow-up|14|||
130448123|NCT02337361|469602153|FG000|6-month Follow-up|Lost to Follow-up|2|||
130448124|NCT02337361|469602154|FG001|6-month Follow-up|Lost to Follow-up|4|||
130448125|NCT02427646|469602156|FG000|Overall Study|Lack of Efficacy|2|||
130448126|NCT02427646|469602157|FG001|Overall Study|Lack of Efficacy|3|||
130448127|NCT02427646|469602156|FG000|Overall Study|Physician Decision|1|||
130448128|NCT02427646|469602157|FG001|Overall Study|Physician Decision|4|||
130448129|NCT02427646|469602156|FG000|Overall Study|Protocol Violation|3|||
130448130|NCT02427646|469602157|FG001|Overall Study|Protocol Violation|3|||
130448131|NCT02427646|469602156|FG000|Overall Study|Bothersome hand weakness|2|||
130448132|NCT02427646|469602157|FG001|Overall Study|Bothersome hand weakness|4|||
130448133|NCT01641861|469602158|FG000|Overall Study|Lost to Follow-up|21|||
130448134|NCT01641861|469602159|FG001|Overall Study|Lost to Follow-up|16|||
130448135|NCT01641861|469602158|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
130448136|NCT01641861|469602159|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
130448137|NCT01641861|469602158|FG000|Overall Study|Died due to drowning|0|||
130448138|NCT01641861|469602159|FG001|Overall Study|Died due to drowning|1|||
130448139|NCT01101542|469602160|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
130448140|NCT01101542|469602160|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
130448141|NCT01101542|469602160|FG000|Year 4 Surveillance Period|Other|287|||
130448142|NCT01101542|469602160|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
130448143|NCT01101542|469602160|FG000|Year 5 Surveillance Period|Pregnancy|1|||
130448144|NCT01101542|469602160|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
130448145|NCT01101542|469602160|FG000|Year 6 Surveillance Period|Pregnancy|1|||
130448146|NCT01101542|469602160|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
130448147|NCT00901485|469602161|FG000|Overall Study|Lack of Efficacy|0|||
130448148|NCT00901485|469602162|FG001|Overall Study|Lack of Efficacy|2|||
130448149|NCT00901485|469602161|FG000|Overall Study|Withdrawal by Subject|1|||
130448150|NCT00901485|469602162|FG001|Overall Study|Withdrawal by Subject|2|||
130448151|NCT00432159|469604640|FG000|Overall Study|Death|0|||
130448152|NCT00432159|469604641|FG001|Overall Study|Death|1|||
130448153|NCT00432159|469604642|FG002|Overall Study|Death|0|||
130448154|NCT00432159|469604643|FG003|Overall Study|Death|0|||
130448155|NCT00432159|469604644|FG004|Overall Study|Death|0|||
130448156|NCT00432159|469604640|FG000|Overall Study|Failure|9|||
130448157|NCT00432159|469604641|FG001|Overall Study|Failure|5|||
130696227|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
130696228|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
130239694|NCT04738487|468838743|FG000|Overall Study|Death|287|||
130239695|NCT04738487|468838744|FG001|Overall Study|Death|306|||
130239696|NCT05350202|468838745|FG000|Visit 1 - Baseline|Not-treated|18|||
130448158|NCT00432159|469604642|FG002|Overall Study|Failure|3|||
130448159|NCT00432159|469604643|FG003|Overall Study|Failure|2|||
130448160|NCT00432159|469604644|FG004|Overall Study|Failure|3|||
130448161|NCT00432159|469604640|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
130448162|NCT00432159|469604641|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
130448163|NCT00432159|469604642|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
130448164|NCT00432159|469604643|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
130448165|NCT00432159|469604644|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
130448166|NCT01256476|469604645|FG000|Overall Study|Adverse Event|2|||
130239697|NCT05350202|468838746|FG001|Visit 1 - Baseline|Not-treated|0|||
130448167|NCT01256476|469604646|FG001|Overall Study|Adverse Event|1|||
130448168|NCT01256476|469604645|FG000|Overall Study|Withdrawal by Subject|2|||
130448169|NCT01256476|469604646|FG001|Overall Study|Withdrawal by Subject|1|||
130448170|NCT01256476|469604645|FG000|Overall Study|Lost to Follow-up|1|||
130448171|NCT01256476|469604646|FG001|Overall Study|Lost to Follow-up|2|||
130239698|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
130448172|NCT01256476|469604645|FG000|Overall Study|Persistent ALT or AST elevation|1|||
130448173|NCT01256476|469604646|FG001|Overall Study|Persistent ALT or AST elevation|0|||
130448174|NCT01256476|469604645|FG000|Overall Study|Physician Decision|0|||
130448175|NCT01256476|469604646|FG001|Overall Study|Physician Decision|1|||
130448176|NCT01256476|469604645|FG000|Overall Study|Subject non-compliance|0|||
130448177|NCT01256476|469604646|FG001|Overall Study|Subject non-compliance|1|||
130448178|NCT01256476|469604645|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
130448179|NCT01256476|469604646|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
130448180|NCT00163215|469604647|FG000|Overall Study|Lack of Efficacy|3|||
130448181|NCT00163215|469604647|FG000|Overall Study|Withdrawal by Subject|5|||
130448182|NCT00163215|469604647|FG000|Overall Study|Other|7|||
130448183|NCT05305040|469604649|FG000|Overall Study|Not Dosed|37|||
130448184|NCT05305040|469604650|FG001|Overall Study|Not Dosed|37|||
130448185|NCT05305040|469604649|FG000|Overall Study|Study Closure|34|||
130448186|NCT05305040|469604650|FG001|Overall Study|Study Closure|46|||
130448187|NCT05305040|469604649|FG000|Overall Study|Death|14|||
130448188|NCT05305040|469604650|FG001|Overall Study|Death|13|||
130448189|NCT05305040|469604649|FG000|Overall Study|Withdrawal by Subject|15|||
130448190|NCT05305040|469604650|FG001|Overall Study|Withdrawal by Subject|10|||
130448191|NCT05305040|469604649|FG000|Overall Study|Other|13|||
130448192|NCT05305040|469604650|FG001|Overall Study|Other|10|||
130448193|NCT05305040|469604649|FG000|Overall Study|Primary Malignancy Relapse|3|||
130448194|NCT05305040|469604650|FG001|Overall Study|Primary Malignancy Relapse|4|||
130448195|NCT05305040|469604649|FG000|Overall Study|Adverse Event|3|||
130448196|NCT05305040|469604650|FG001|Overall Study|Adverse Event|3|||
130448197|NCT05305040|469604649|FG000|Overall Study|Lost to Follow-up|2|||
130448198|NCT05305040|469604650|FG001|Overall Study|Lost to Follow-up|1|||
130448199|NCT05305040|469604649|FG000|Overall Study|Graft versus host disease|2|||
130448200|NCT05305040|469604650|FG001|Overall Study|Graft versus host disease|0|||
130448201|NCT05305040|469604649|FG000|Overall Study|Investigator's Decision|1|||
130448202|NCT05305040|469604650|FG001|Overall Study|Investigator's Decision|1|||
130448203|NCT05305040|469604649|FG000|Overall Study|COVID-19 Reasons|1|||
130448204|NCT05305040|469604650|FG001|Overall Study|COVID-19 Reasons|0|||
130448205|NCT01033643|469604651|FG000|Overall Study|Withdrew Consent|0|||
130448206|NCT01033643|469604652|FG001|Overall Study|Withdrew Consent|3|||
130448207|NCT01033643|469604653|FG002|Overall Study|Withdrew Consent|0|||
130448208|NCT01033643|469604654|FG003|Overall Study|Withdrew Consent|0|||
130448209|NCT01033643|469604655|FG004|Overall Study|Withdrew Consent|0|||
130448210|NCT01033643|469604656|FG005|Overall Study|Withdrew Consent|1|||
130448211|NCT00465361|469604657|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
130448212|NCT02652130|469604658|FG000|Overall Study|Death|1|||
130448213|NCT00751790|469604665|FG000|Overall Study|Lost to Follow-up|1|||
130448214|NCT00751790|469604665|FG000|Overall Study|Death|3|||
130448215|NCT00751790|469604665|FG000|Overall Study|Withdrawal by Subject|1|||
130448216|NCT01106976|469604666|FG000|Overall Study|Lost to Follow-up|8|||
130448217|NCT03836664|469604669|FG000|Overall Study|Didn't complete forms and lost drug|3|||
130448218|NCT03836664|469604670|FG001|Overall Study|Didn't complete forms and lost drug|3|||
130448219|NCT01427907|469604671|FG000|Overall Study|Withdrawal by Subject|3|||
130448220|NCT01427907|469604672|FG001|Overall Study|Withdrawal by Subject|4|||
130448221|NCT02179918|469604673|FG000|Overall Study|Death|0|||
130448222|NCT02179918|469604674|FG001|Overall Study|Death|0|||
130448223|NCT02179918|469604675|FG002|Overall Study|Death|0|||
130448224|NCT02179918|469604676|FG003|Overall Study|Death|1|||
130448225|NCT02179918|469604677|FG004|Overall Study|Death|0|||
130448226|NCT02179918|469604673|FG000|Overall Study|Lost to Follow-up|0|||
130448227|NCT02179918|469604674|FG001|Overall Study|Lost to Follow-up|0|||
130448228|NCT02179918|469604675|FG002|Overall Study|Lost to Follow-up|1|||
130448229|NCT02179918|469604676|FG003|Overall Study|Lost to Follow-up|0|||
130448230|NCT02179918|469604677|FG004|Overall Study|Lost to Follow-up|0|||
130448231|NCT02179918|469604673|FG000|Overall Study|Progressive Disease|4|||
130448232|NCT02179918|469604674|FG001|Overall Study|Progressive Disease|1|||
130448233|NCT02179918|469604675|FG002|Overall Study|Progressive Disease|1|||
130448234|NCT02179918|469604676|FG003|Overall Study|Progressive Disease|2|||
130448235|NCT02179918|469604677|FG004|Overall Study|Progressive Disease|6|||
130448236|NCT02179918|469604673|FG000|Overall Study|Other|0|||
130448237|NCT02179918|469604674|FG001|Overall Study|Other|1|||
130448238|NCT02179918|469604675|FG002|Overall Study|Other|0|||
130448239|NCT02179918|469604676|FG003|Overall Study|Other|0|||
130448240|NCT02179918|469604677|FG004|Overall Study|Other|1|||
130448241|NCT02179918|469604673|FG000|Overall Study|Subject refused further follow-up|0|||
130448242|NCT02179918|469604674|FG001|Overall Study|Subject refused further follow-up|1|||
130448243|NCT02179918|469604675|FG002|Overall Study|Subject refused further follow-up|0|||
130448244|NCT02179918|469604676|FG003|Overall Study|Subject refused further follow-up|0|||
130448245|NCT02179918|469604677|FG004|Overall Study|Subject refused further follow-up|1|||
130448246|NCT04337489|469604682|FG000|Overall Study|Withdrawal by Subject|1|||
130448247|NCT00972543|469604683|FG000|Overall Study|Adverse Event|1|||
130448248|NCT00972543|469604684|FG001|Overall Study|Adverse Event|0|||
130448249|NCT00972543|469604683|FG000|Overall Study|Early study termination by sponsor|4|||
130448250|NCT00972543|469604684|FG001|Overall Study|Early study termination by sponsor|1|||
130239699|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
130239700|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
130239701|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
130239702|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
130239703|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
130239704|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
130239705|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
130239706|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
130239707|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
130239708|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
130239709|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
130239710|NCT04635423|468838747|FG000|Overall Study|Ongoing|493|||
130239711|NCT04635423|468838748|FG001|Overall Study|Ongoing|501|||
130239712|NCT04635423|468838747|FG000|Overall Study|Withdrawal by Subject|36|||
130239713|NCT04635423|468838748|FG001|Overall Study|Withdrawal by Subject|29|||
130239714|NCT05119569|468838763|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130239715|NCT05119569|468838764|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130239716|NCT05119569|468838765|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130239717|NCT05119569|468838766|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130239718|NCT05119569|468838763|FG000|Double Blind Treatment Phase|Adverse Event|6|||
130239719|NCT05119569|468838764|FG001|Double Blind Treatment Phase|Adverse Event|0|||
130239720|NCT05119569|468838765|FG002|Double Blind Treatment Phase|Adverse Event|0|||
130239721|NCT05119569|468838766|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130239722|NCT05119569|468838763|FG000|Open Label Extension Phase|Ongoing in the study|0|||
130239723|NCT05119569|468838764|FG001|Open Label Extension Phase|Ongoing in the study|0|||
130239724|NCT05119569|468838765|FG002|Open Label Extension Phase|Ongoing in the study|65|||
130239725|NCT05119569|468838766|FG003|Open Label Extension Phase|Ongoing in the study|34|||
130239726|NCT03683030|468838767|FG000|Overall Study|Enrolled but screen failures|12|||
130239727|NCT03683030|468838768|FG001|Overall Study|Enrolled but screen failures|7|||
130239728|NCT03683030|468838767|FG000|Overall Study|Enrolled but no catheter inserted|11|||
130239729|NCT03683030|468838768|FG001|Overall Study|Enrolled but no catheter inserted|13|||
130239730|NCT03683030|468838767|FG000|Overall Study|Withdrawal by Subject|0|||
130239731|NCT03683030|468838768|FG001|Overall Study|Withdrawal by Subject|2|||
130239732|NCT03683030|468838767|FG000|Overall Study|Early termination by subject|1|||
130239733|NCT03683030|468838768|FG001|Overall Study|Early termination by subject|0|||
130239734|NCT03683030|468838767|FG000|Overall Study|Lost to Follow-up|0|||
130239735|NCT03683030|468838768|FG001|Overall Study|Lost to Follow-up|6|||
130239736|NCT03683030|468838767|FG000|Overall Study|Death|0|||
130239737|NCT03683030|468838768|FG001|Overall Study|Death|2|||
130239738|NCT03683030|468838767|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
130239739|NCT03683030|468838768|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
130239740|NCT03488524|468838769|FG000|Overall Study|Withdrawal by Subject|51|||
130239741|NCT03488524|468838769|FG000|Overall Study|Death|19|||
130239742|NCT03488524|468838769|FG000|Overall Study|Study Sponsor|11|||
130239743|NCT03488524|468838769|FG000|Overall Study|Physician Decision|4|||
130239744|NCT03488524|468838769|FG000|Overall Study|Lost to Follow-up|3|||
130239745|NCT02390284|468838770|FG000|Overall Study|Physician Decision|0|||
130239746|NCT02390284|468838771|FG001|Overall Study|Physician Decision|0|||
130239747|NCT02390284|468838772|FG002|Overall Study|Physician Decision|9|||
130239748|NCT03980223|468838773|FG000|Overall Study|Lost to Follow-up|3|||
130239749|NCT03980223|468838774|FG001|Overall Study|Lost to Follow-up|7|||
130239750|NCT03980223|468838775|FG002|Overall Study|Lost to Follow-up|10|||
130239751|NCT03980223|468838776|FG003|Overall Study|Lost to Follow-up|8|||
130239752|NCT03980223|468838773|FG000|Overall Study|Withdrawal by Subject|0|||
130239753|NCT03980223|468838774|FG001|Overall Study|Withdrawal by Subject|0|||
130239754|NCT03980223|468838775|FG002|Overall Study|Withdrawal by Subject|1|||
130239755|NCT03980223|468838776|FG003|Overall Study|Withdrawal by Subject|2|||
130239756|NCT03980223|468838773|FG000|Overall Study|Physician Decision|0|||
130239757|NCT03980223|468838774|FG001|Overall Study|Physician Decision|0|||
130239758|NCT03980223|468838775|FG002|Overall Study|Physician Decision|1|||
130239759|NCT03980223|468838776|FG003|Overall Study|Physician Decision|0|||
130239760|NCT03980223|468838773|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
130239761|NCT03980223|468838774|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
130239762|NCT03980223|468838775|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
130360275|NCT00676338|469290918|FG001|Overall Study|Entry Criteria Not Met|2|||
130360276|NCT00676338|469290919|FG002|Overall Study|Entry Criteria Not Met|1|||
130360277|NCT00676338|469290920|FG003|Overall Study|Entry Criteria Not Met|1|||
130360278|NCT00676338|469290917|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130360279|NCT00676338|469290918|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130360280|NCT00676338|469290919|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
130360281|NCT00676338|469290920|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130239763|NCT03980223|468838776|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
130239764|NCT06239610|468838777|FG000|Overall Study|no usable migration data for minimum of one day|11|||
130239765|NCT01922934|468838781|FG000|Eligible Patients|Death|0|||
130239766|NCT01922934|468838782|FG001|Eligible Patients|Death|7|||
130239767|NCT01922934|468838781|FG000|Eligible Patients|Physician Decision|17|||
130239768|NCT01922934|468838782|FG001|Eligible Patients|Physician Decision|0|||
130239769|NCT01922934|468838781|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
130239770|NCT01922934|468838782|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
130239771|NCT01922934|468838781|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
130239772|NCT01922934|468838782|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
130239773|NCT01922934|468838781|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
130239774|NCT01922934|468838782|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
130239775|NCT01922934|468838781|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
130239776|NCT01922934|468838782|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
130239777|NCT05166876|468838785|FG000|Overall Study|Withdrawal by Subject|1|||
130239778|NCT05166876|468838786|FG001|Overall Study|Withdrawal by Subject|0|||
130239779|NCT05166876|468838787|FG002|Overall Study|Withdrawal by Subject|0|||
130239780|NCT00658528|468838788|FG000|Overall Study|Adverse Event|5|||
130239781|NCT00658528|468838789|FG001|Overall Study|Adverse Event|7|||
130239782|NCT00658528|468838788|FG000|Overall Study|Lost to Follow-up|14|||
130239783|NCT00658528|468838789|FG001|Overall Study|Lost to Follow-up|22|||
130239784|NCT00658528|468838788|FG000|Overall Study|Withdrawal by Subject|8|||
130239785|NCT00658528|468838789|FG001|Overall Study|Withdrawal by Subject|6|||
130239786|NCT00658528|468838788|FG000|Overall Study|Withdrawal of consent|5|||
130239787|NCT00658528|468838789|FG001|Overall Study|Withdrawal of consent|6|||
130239788|NCT00658528|468838788|FG000|Overall Study|Other|8|||
130239789|NCT00658528|468838789|FG001|Overall Study|Other|4|||
130239790|NCT01937299|468838790|FG000|Overall Study|Adverse Event|13|||
130239791|NCT01937299|468838791|FG001|Overall Study|Adverse Event|0|||
130239792|NCT01937299|468838790|FG000|Overall Study|Lack of Efficacy|0|||
130239793|NCT01937299|468838791|FG001|Overall Study|Lack of Efficacy|4|||
130239794|NCT01937299|468838790|FG000|Overall Study|Withdrawal by Subject|1|||
130696229|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130239795|NCT01937299|468838791|FG001|Overall Study|Withdrawal by Subject|0|||
130239796|NCT00385840|468838792|FG000|Overall Study|Adverse Event|1|||
130239797|NCT00385840|468838793|FG001|Overall Study|Adverse Event|1|||
130239798|NCT00385840|468838792|FG000|Overall Study|Lost to Follow-up|3|||
130239799|NCT00385840|468838793|FG001|Overall Study|Lost to Follow-up|13|||
130239800|NCT01706328|468838801|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
130239801|NCT01706328|468838802|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130239802|NCT01706328|468838803|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130239803|NCT01706328|468838801|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
130239804|NCT01706328|468838802|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130239805|NCT01706328|468838803|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130239806|NCT01706328|468838801|FG000|2-week Run-in Period|Physician Decision|4|||
130239807|NCT01706328|468838802|FG001|2-week Run-in Period|Physician Decision|0|||
130360282|NCT02122458|469290921|FG000|Overall Study|Withdrawal by Subject|0|||
130360283|NCT02122458|469290922|FG001|Overall Study|Withdrawal by Subject|0|||
130696230|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130696231|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
130696232|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
130360284|NCT02122458|469290923|FG002|Overall Study|Withdrawal by Subject|0|||
130696233|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
130696234|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
130239808|NCT01706328|468838803|FG002|2-week Run-in Period|Physician Decision|0|||
130360285|NCT02122458|469290924|FG003|Overall Study|Withdrawal by Subject|4|||
130360286|NCT02122458|469290925|FG004|Overall Study|Withdrawal by Subject|4|||
130360287|NCT02122458|469290926|FG005|Overall Study|Withdrawal by Subject|4|||
130360288|NCT02122458|469290927|FG006|Overall Study|Withdrawal by Subject|0|||
130360289|NCT02122458|469290921|FG000|Overall Study|Lost to Follow-up|1|||
130360290|NCT02122458|469290922|FG001|Overall Study|Lost to Follow-up|3|||
130360291|NCT02122458|469290923|FG002|Overall Study|Lost to Follow-up|0|||
130360292|NCT02122458|469290924|FG003|Overall Study|Lost to Follow-up|7|||
130360293|NCT02122458|469290925|FG004|Overall Study|Lost to Follow-up|5|||
130360294|NCT02122458|469290926|FG005|Overall Study|Lost to Follow-up|15|||
130360295|NCT02122458|469290927|FG006|Overall Study|Lost to Follow-up|1|||
130696235|NCT00387153|470512521|FG000|Overall Study|Adverse Event|1|||
130239809|NCT01706328|468838801|FG000|2-week Run-in Period|Adverse Event|4|||
130239810|NCT01706328|468838802|FG001|2-week Run-in Period|Adverse Event|0|||
130239811|NCT01706328|468838803|FG002|2-week Run-in Period|Adverse Event|0|||
130239812|NCT01706328|468838801|FG000|2-week Run-in Period|Lost to Follow-up|2|||
130239813|NCT01706328|468838802|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130360296|NCT02122458|469290921|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
130239814|NCT01706328|468838803|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130239815|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
130239816|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
130239817|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
130239818|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
130239819|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130239820|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130239821|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
130239822|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
130239823|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
130239824|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
130239825|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
130239826|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
130239827|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
130239828|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
130239829|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
130239830|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
130239831|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
130239832|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
130239833|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130239834|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
130239835|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
130239836|NCT03018938|468838806|FG000|Overall Study|Death|0|||
130239837|NCT03018938|468838807|FG001|Overall Study|Death|1|||
130239838|NCT03018938|468838806|FG000|Overall Study|Lost to Follow-up|21|||
130239839|NCT03018938|468838807|FG001|Overall Study|Lost to Follow-up|32|||
130239840|NCT03018938|468838806|FG000|Overall Study|Withdrawal by Subject|38|||
130239841|NCT03018938|468838807|FG001|Overall Study|Withdrawal by Subject|45|||
130239842|NCT03018938|468838806|FG000|Overall Study|Physician Decision|3|||
130239843|NCT03018938|468838807|FG001|Overall Study|Physician Decision|2|||
130239844|NCT03018938|468838806|FG000|Overall Study|Sponsor Decision|0|||
130239845|NCT03018938|468838807|FG001|Overall Study|Sponsor Decision|1|||
130239846|NCT03018938|468838806|FG000|Overall Study|Screen failure-After randomization|4|||
130239847|NCT03018938|468838807|FG001|Overall Study|Screen failure-After randomization|2|||
130239848|NCT03018938|468838806|FG000|Overall Study|Not recorded|0|||
130239849|NCT03018938|468838807|FG001|Overall Study|Not recorded|2|||
130239850|NCT02916771|468838814|FG000|Overall Study|Withdrawal by Subject|9|||
130239851|NCT02916771|468838814|FG000|Overall Study|Physician Decision|1|||
130239852|NCT02916771|468838814|FG000|Overall Study|Began treatment for another active malignancy|1|||
130239853|NCT05759338|468838815|FG000|Overall Study|Withdrawal by Subject|3|||
130239854|NCT02924376|468838816|FG000|Overall Study|Progressive Disease|4|||
130239855|NCT02924376|468838817|FG001|Overall Study|Progressive Disease|0|||
130239856|NCT02924376|468838818|FG002|Overall Study|Progressive Disease|1|||
130239857|NCT02924376|468838819|FG003|Overall Study|Progressive Disease|0|||
130239858|NCT02924376|468838816|FG000|Overall Study|Death|73|||
130239859|NCT02924376|468838817|FG001|Overall Study|Death|18|||
130239860|NCT02924376|468838818|FG002|Overall Study|Death|15|||
130239861|NCT02924376|468838819|FG003|Overall Study|Death|2|||
130239862|NCT02924376|468838816|FG000|Overall Study|Lost to Follow-up|3|||
130239863|NCT02924376|468838817|FG001|Overall Study|Lost to Follow-up|0|||
130239864|NCT02924376|468838818|FG002|Overall Study|Lost to Follow-up|0|||
130239865|NCT02924376|468838819|FG003|Overall Study|Lost to Follow-up|0|||
130239866|NCT02924376|468838816|FG000|Overall Study|Study Terminated by Sponsor|19|||
130239867|NCT02924376|468838817|FG001|Overall Study|Study Terminated by Sponsor|0|||
130239868|NCT02924376|468838818|FG002|Overall Study|Study Terminated by Sponsor|0|||
130239869|NCT02924376|468838819|FG003|Overall Study|Study Terminated by Sponsor|0|||
130239870|NCT02924376|468838816|FG000|Overall Study|Physician Decision|1|||
130239871|NCT02924376|468838817|FG001|Overall Study|Physician Decision|0|||
130448251|NCT04537949|469604687|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
130448252|NCT04537949|469604688|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
130448253|NCT04537949|469604689|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
130448254|NCT04537949|469604690|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
130448255|NCT04537949|469604691|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
130448256|NCT04537949|469604692|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
130448257|NCT04537949|469604693|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
130448258|NCT04537949|469604694|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
130448259|NCT04537949|469604687|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
130239872|NCT02924376|468838818|FG002|Overall Study|Physician Decision|0|||
130239873|NCT02924376|468838819|FG003|Overall Study|Physician Decision|0|||
130239874|NCT02924376|468838816|FG000|Overall Study|Withdrawal by Subject|7|||
130552930|NCT02520284|469991629|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
130239875|NCT02924376|468838817|FG001|Overall Study|Withdrawal by Subject|2|||
130696236|NCT00387153|470512521|FG000|Overall Study|Disease Progression|3|||
130696237|NCT00387153|470512521|FG000|Overall Study|Lack of Response|4|||
130696238|NCT01945580|470512524|FG000|Overall Study|Withdrawal by Subject|13|||
130696239|NCT01945580|470512525|FG001|Overall Study|Withdrawal by Subject|35|||
130239876|NCT02924376|468838818|FG002|Overall Study|Withdrawal by Subject|1|||
130239877|NCT02924376|468838819|FG003|Overall Study|Withdrawal by Subject|0|||
130239878|NCT02924376|468838816|FG000|Overall Study|Rolled Over to Another Study|1|||
130239879|NCT02924376|468838817|FG001|Overall Study|Rolled Over to Another Study|0|||
130239880|NCT02924376|468838818|FG002|Overall Study|Rolled Over to Another Study|0|||
130239881|NCT02924376|468838819|FG003|Overall Study|Rolled Over to Another Study|0|||
130239882|NCT06455111|468838821|FG000|Overall Study|Withdrawal by Subject|11|||
130239883|NCT06455111|468838822|FG001|Overall Study|Withdrawal by Subject|4|||
130239884|NCT00005047|468840110|FG000|Overall Study|Withdrawal by Subject|12|||
130239885|NCT00005047|468840111|FG001|Overall Study|Withdrawal by Subject|0|||
130239886|NCT00005047|468840112|FG002|Overall Study|Withdrawal by Subject|0|||
130239887|NCT00005047|468840113|FG003|Overall Study|Withdrawal by Subject|0|||
130239888|NCT00005047|468840110|FG000|Overall Study|Adverse Event|5|||
130239889|NCT00005047|468840111|FG001|Overall Study|Adverse Event|0|||
130239890|NCT00005047|468840112|FG002|Overall Study|Adverse Event|0|||
130239891|NCT00005047|468840113|FG003|Overall Study|Adverse Event|0|||
130239892|NCT00005047|468840110|FG000|Overall Study|Lost to Follow-up|1|||
130239893|NCT00005047|468840111|FG001|Overall Study|Lost to Follow-up|0|||
130239894|NCT00005047|468840112|FG002|Overall Study|Lost to Follow-up|0|||
130239895|NCT00005047|468840113|FG003|Overall Study|Lost to Follow-up|0|||
130239896|NCT00005047|468840110|FG000|Overall Study|Lack of Efficacy|1|||
130239897|NCT00005047|468840111|FG001|Overall Study|Lack of Efficacy|0|||
130239898|NCT00005047|468840112|FG002|Overall Study|Lack of Efficacy|0|||
130239899|NCT00005047|468840113|FG003|Overall Study|Lack of Efficacy|0|||
130239900|NCT00098475|468840121|FG000|Step 1|Progressive disease|33|||
130239901|NCT00098475|468840122|FG001|Step 1|Progressive disease|35|||
130239902|NCT00098475|468840123|FG002|Step 1|Progressive disease|2|||
130360297|NCT02122458|469290922|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360298|NCT02122458|469290923|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360299|NCT02122458|469290924|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360300|NCT02122458|469290925|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360301|NCT02122458|469290926|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360302|NCT02122458|469290927|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
130360303|NCT02122458|469290921|FG000|Overall Study|Adverse Event|1|||
130360304|NCT02122458|469290922|FG001|Overall Study|Adverse Event|0|||
130360305|NCT02122458|469290923|FG002|Overall Study|Adverse Event|0|||
130360306|NCT02122458|469290924|FG003|Overall Study|Adverse Event|0|||
130360307|NCT02122458|469290925|FG004|Overall Study|Adverse Event|0|||
130360308|NCT02122458|469290926|FG005|Overall Study|Adverse Event|0|||
130360309|NCT02122458|469290927|FG006|Overall Study|Adverse Event|0|||
130360310|NCT02122458|469290921|FG000|Overall Study|Experimental Error|0|||
130360311|NCT02122458|469290922|FG001|Overall Study|Experimental Error|0|||
130360312|NCT02122458|469290923|FG002|Overall Study|Experimental Error|0|||
130360313|NCT02122458|469290924|FG003|Overall Study|Experimental Error|0|||
130360314|NCT02122458|469290925|FG004|Overall Study|Experimental Error|3|||
130360315|NCT02122458|469290926|FG005|Overall Study|Experimental Error|0|||
130360316|NCT02122458|469290927|FG006|Overall Study|Experimental Error|0|||
130360317|NCT02122458|469290921|FG000|Overall Study|Deployed or Moved|0|||
130360318|NCT02122458|469290922|FG001|Overall Study|Deployed or Moved|0|||
130360319|NCT02122458|469290923|FG002|Overall Study|Deployed or Moved|0|||
130360320|NCT02122458|469290924|FG003|Overall Study|Deployed or Moved|0|||
130360321|NCT02122458|469290925|FG004|Overall Study|Deployed or Moved|1|||
130360322|NCT02122458|469290926|FG005|Overall Study|Deployed or Moved|0|||
130360323|NCT02122458|469290927|FG006|Overall Study|Deployed or Moved|0|||
130360324|NCT02122458|469290921|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
130360325|NCT02122458|469290922|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
130360326|NCT02122458|469290923|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
130360327|NCT02122458|469290924|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
130360328|NCT02122458|469290925|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
130360329|NCT02122458|469290926|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
130360330|NCT02122458|469290927|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
130360331|NCT02122458|469290921|FG000|Overall Study|Noncompliance|0|||
130360332|NCT02122458|469290922|FG001|Overall Study|Noncompliance|1|||
130360333|NCT02122458|469290923|FG002|Overall Study|Noncompliance|0|||
130360334|NCT02122458|469290924|FG003|Overall Study|Noncompliance|0|||
130360335|NCT02122458|469290925|FG004|Overall Study|Noncompliance|0|||
130696240|NCT01945580|470512524|FG000|Overall Study|Physician Decision|3|||
130239903|NCT00098475|468840124|FG003|Step 1|Progressive disease|1|||
130239904|NCT00098475|468840121|FG000|Step 1|Adverse Event|56|||
130239905|NCT00098475|468840122|FG001|Step 1|Adverse Event|37|||
130239906|NCT00098475|468840123|FG002|Step 1|Adverse Event|0|||
130360336|NCT02122458|469290926|FG005|Overall Study|Noncompliance|0|||
130239907|NCT00098475|468840124|FG003|Step 1|Adverse Event|1|||
130239908|NCT00098475|468840121|FG000|Step 1|Death|8|||
130239909|NCT00098475|468840122|FG001|Step 1|Death|5|||
130239910|NCT00098475|468840123|FG002|Step 1|Death|0|||
130239911|NCT00098475|468840124|FG003|Step 1|Death|1|||
130239912|NCT00098475|468840121|FG000|Step 1|Withdrawal by Subject|14|||
130239913|NCT00098475|468840122|FG001|Step 1|Withdrawal by Subject|11|||
130239914|NCT00098475|468840123|FG002|Step 1|Withdrawal by Subject|0|||
130448260|NCT04537949|469604688|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
130239915|NCT00098475|468840124|FG003|Step 1|Withdrawal by Subject|0|||
130239916|NCT00098475|468840121|FG000|Step 1|Physician Decision|5|||
130239917|NCT00098475|468840122|FG001|Step 1|Physician Decision|2|||
130239918|NCT00098475|468840123|FG002|Step 1|Physician Decision|0|||
130239919|NCT00098475|468840124|FG003|Step 1|Physician Decision|0|||
130239920|NCT00098475|468840121|FG000|Step 1|Alternative therapy|31|||
130239921|NCT00098475|468840122|FG001|Step 1|Alternative therapy|43|||
130239922|NCT00098475|468840123|FG002|Step 1|Alternative therapy|1|||
130239923|NCT00098475|468840124|FG003|Step 1|Alternative therapy|0|||
130239924|NCT00098475|468840121|FG000|Step 1|Other disease|2|||
130239925|NCT00098475|468840122|FG001|Step 1|Other disease|1|||
130239926|NCT00098475|468840123|FG002|Step 1|Other disease|1|||
130239927|NCT00098475|468840124|FG003|Step 1|Other disease|0|||
130239928|NCT00098475|468840121|FG000|Step 1|Never started treatment|0|||
130239929|NCT00098475|468840122|FG001|Step 1|Never started treatment|2|||
130239930|NCT00098475|468840123|FG002|Step 1|Never started treatment|0|||
130239931|NCT00098475|468840124|FG003|Step 1|Never started treatment|0|||
130239932|NCT00098475|468840121|FG000|Step 1|Still on treatment as of this analysis|14|||
130239933|NCT00098475|468840122|FG001|Step 1|Still on treatment as of this analysis|27|||
130239934|NCT00098475|468840123|FG002|Step 1|Still on treatment as of this analysis|0|||
130239935|NCT00098475|468840124|FG003|Step 1|Still on treatment as of this analysis|0|||
130239936|NCT00098475|468840121|FG000|Step 1|Knee surgery|1|||
130239937|NCT00098475|468840122|FG001|Step 1|Knee surgery|0|||
130239938|NCT00098475|468840123|FG002|Step 1|Knee surgery|0|||
130239939|NCT00098475|468840124|FG003|Step 1|Knee surgery|0|||
130239940|NCT00098475|468840121|FG000|Step 1|Complications|1|||
130239941|NCT00098475|468840122|FG001|Step 1|Complications|0|||
130239942|NCT00098475|468840123|FG002|Step 1|Complications|0|||
130239943|NCT00098475|468840124|FG003|Step 1|Complications|0|||
130239944|NCT00098475|468840121|FG000|Step 1|Cannot comply due to other tx|0|||
130448261|NCT04537949|469604689|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
130448262|NCT04537949|469604690|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
130448263|NCT04537949|469604691|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
130448264|NCT04537949|469604692|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
130448265|NCT04537949|469604693|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
130448266|NCT04537949|469604694|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
130448267|NCT04537949|469604687|FG000|Follow-up Phase|Lost to Follow-up|0|||
130448268|NCT04537949|469604688|FG001|Follow-up Phase|Lost to Follow-up|3|||
130448269|NCT04537949|469604689|FG002|Follow-up Phase|Lost to Follow-up|0|||
130448270|NCT04537949|469604690|FG003|Follow-up Phase|Lost to Follow-up|0|||
130448271|NCT04537949|469604691|FG004|Follow-up Phase|Lost to Follow-up|0|||
130448272|NCT04537949|469604692|FG005|Follow-up Phase|Lost to Follow-up|0|||
130448273|NCT04537949|469604693|FG006|Follow-up Phase|Lost to Follow-up|0|||
130448274|NCT04537949|469604694|FG007|Follow-up Phase|Lost to Follow-up|0|||
130448275|NCT04537949|469604687|FG000|Follow-up Phase|personal reasons|0|||
130448276|NCT04537949|469604688|FG001|Follow-up Phase|personal reasons|0|||
130448277|NCT04537949|469604689|FG002|Follow-up Phase|personal reasons|0|||
130448278|NCT04537949|469604690|FG003|Follow-up Phase|personal reasons|1|||
130448279|NCT04537949|469604691|FG004|Follow-up Phase|personal reasons|1|||
130239945|NCT00098475|468840122|FG001|Step 1|Cannot comply due to other tx|1|||
130239946|NCT00098475|468840123|FG002|Step 1|Cannot comply due to other tx|0|||
130239947|NCT00098475|468840124|FG003|Step 1|Cannot comply due to other tx|0|||
130448280|NCT04537949|469604692|FG005|Follow-up Phase|personal reasons|0|||
130448281|NCT04537949|469604693|FG006|Follow-up Phase|personal reasons|0|||
130448282|NCT04537949|469604694|FG007|Follow-up Phase|personal reasons|0|||
130448283|NCT04537949|469604687|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130448284|NCT04537949|469604688|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130448285|NCT04537949|469604689|FG002|Follow-up Phase|Withdrawal by Subject|0|||
130448286|NCT04537949|469604690|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130448287|NCT04537949|469604691|FG004|Follow-up Phase|Withdrawal by Subject|1|||
130448288|NCT04537949|469604692|FG005|Follow-up Phase|Withdrawal by Subject|0|||
130239948|NCT00098475|468840121|FG000|Step 1|Both patient and physician's decision|2|||
130239949|NCT00098475|468840122|FG001|Step 1|Both patient and physician's decision|1|||
130239950|NCT00098475|468840123|FG002|Step 1|Both patient and physician's decision|0|||
130239951|NCT00098475|468840124|FG003|Step 1|Both patient and physician's decision|0|||
130239952|NCT00098475|468840121|FG000|Step 1|Incorrect disease assessment|2|||
130448289|NCT04537949|469604693|FG006|Follow-up Phase|Withdrawal by Subject|0|||
130239953|NCT00098475|468840122|FG001|Step 1|Incorrect disease assessment|0|||
130239954|NCT00098475|468840123|FG002|Step 1|Incorrect disease assessment|0|||
130239955|NCT00098475|468840124|FG003|Step 1|Incorrect disease assessment|0|||
130448290|NCT04537949|469604694|FG007|Follow-up Phase|Withdrawal by Subject|0|||
130239956|NCT00098475|468840121|FG000|Step 1|Off treatment for > specified timeframe|1|||
130239957|NCT00098475|468840122|FG001|Step 1|Off treatment for > specified timeframe|1|||
130239958|NCT00098475|468840123|FG002|Step 1|Off treatment for > specified timeframe|0|||
130239959|NCT00098475|468840124|FG003|Step 1|Off treatment for > specified timeframe|0|||
130239960|NCT00098475|468840121|FG000|Step 1|Declining performance status|0|||
130239961|NCT00098475|468840122|FG001|Step 1|Declining performance status|1|||
130448291|NCT04003974|469604696|FG000|Overall Study|Missing|1|||
130448292|NCT04003974|469604697|FG001|Overall Study|Missing|0|||
130448293|NCT04003974|469604696|FG000|Overall Study|Withdrawal by Subject|0|||
130239962|NCT00098475|468840123|FG002|Step 1|Declining performance status|0|||
130239963|NCT00098475|468840124|FG003|Step 1|Declining performance status|0|||
130239964|NCT00098475|468840121|FG000|Step 1|Insurance issue|0|||
130239965|NCT00098475|468840122|FG001|Step 1|Insurance issue|1|||
130239966|NCT00098475|468840123|FG002|Step 1|Insurance issue|0|||
130239967|NCT00098475|468840124|FG003|Step 1|Insurance issue|0|||
130239968|NCT00098475|468840121|FG000|Step 1|Rising paraprotein|0|||
130239969|NCT00098475|468840122|FG001|Step 1|Rising paraprotein|1|||
130239970|NCT00098475|468840123|FG002|Step 1|Rising paraprotein|0|||
130239971|NCT00098475|468840124|FG003|Step 1|Rising paraprotein|0|||
130239972|NCT00098475|468840121|FG000|Step 1|Referred to other physicians|0|||
130239973|NCT00098475|468840122|FG001|Step 1|Referred to other physicians|1|||
130239974|NCT00098475|468840123|FG002|Step 1|Referred to other physicians|0|||
130239975|NCT00098475|468840124|FG003|Step 1|Referred to other physicians|0|||
130239976|NCT00098475|468840121|FG000|Step 1|Criteria to continue treatment not met|0|||
130239977|NCT00098475|468840122|FG001|Step 1|Criteria to continue treatment not met|1|||
130448294|NCT04003974|469604697|FG001|Overall Study|Withdrawal by Subject|2|||
130448295|NCT04296942|469604698|FG000|Overall Study|Study closure by sponsor|1|||
130239978|NCT00098475|468840123|FG002|Step 1|Criteria to continue treatment not met|0|||
130239979|NCT00098475|468840124|FG003|Step 1|Criteria to continue treatment not met|0|||
130239980|NCT00098475|468840121|FG000|Step 1|Misinterpretation of lab data|0|||
130239981|NCT00098475|468840122|FG001|Step 1|Misinterpretation of lab data|1|||
130239982|NCT00098475|468840123|FG002|Step 1|Misinterpretation of lab data|0|||
130239983|NCT00098475|468840124|FG003|Step 1|Misinterpretation of lab data|0|||
130239984|NCT00098475|468840121|FG000|Step 1|Patient fell with fracture|1|||
130239985|NCT00098475|468840122|FG001|Step 1|Patient fell with fracture|0|||
130239986|NCT00098475|468840123|FG002|Step 1|Patient fell with fracture|0|||
130239987|NCT00098475|468840124|FG003|Step 1|Patient fell with fracture|0|||
130239988|NCT00098475|468840121|FG000|Step 1|Not documented|0|||
130239989|NCT00098475|468840122|FG001|Step 1|Not documented|1|||
130239990|NCT00098475|468840123|FG002|Step 1|Not documented|0|||
130239991|NCT00098475|468840124|FG003|Step 1|Not documented|0|||
130448296|NCT04296942|469604699|FG001|Overall Study|Study closure by sponsor|0|||
130448297|NCT04296942|469604700|FG002|Overall Study|Study closure by sponsor|0|||
130448298|NCT00335153|469604701|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
130448299|NCT00335153|469604701|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
130448300|NCT00335153|469604701|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
130239992|NCT00098475|468840121|FG000|Step 2|Disease progression|1|||
130239993|NCT00098475|468840122|FG001|Step 2|Disease progression|4|||
130239994|NCT00098475|468840123|FG002|Step 2|Disease progression|0|||
130239995|NCT00098475|468840124|FG003|Step 2|Disease progression|0|||
130239996|NCT00098475|468840121|FG000|Step 2|Adverse Event|2|||
130239997|NCT00098475|468840122|FG001|Step 2|Adverse Event|0|||
130239998|NCT00098475|468840123|FG002|Step 2|Adverse Event|0|||
130239999|NCT00098475|468840124|FG003|Step 2|Adverse Event|0|||
130240000|NCT00098475|468840121|FG000|Step 2|Withdrawal by Subject|0|||
130240001|NCT00098475|468840122|FG001|Step 2|Withdrawal by Subject|2|||
130240002|NCT00098475|468840123|FG002|Step 2|Withdrawal by Subject|0|||
130240003|NCT00098475|468840124|FG003|Step 2|Withdrawal by Subject|0|||
130448301|NCT00335153|469604701|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
130448302|NCT00335153|469604701|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
130240004|NCT00098475|468840121|FG000|Step 2|Physician Decision|0|||
130240005|NCT00098475|468840122|FG001|Step 2|Physician Decision|1|||
130240006|NCT00098475|468840123|FG002|Step 2|Physician Decision|0|||
130240007|NCT00098475|468840124|FG003|Step 2|Physician Decision|0|||
130240008|NCT00098475|468840121|FG000|Step 2|Alternative therapy|1|||
130240009|NCT00098475|468840122|FG001|Step 2|Alternative therapy|2|||
130240010|NCT00098475|468840123|FG002|Step 2|Alternative therapy|0|||
130240011|NCT00098475|468840124|FG003|Step 2|Alternative therapy|0|||
130240012|NCT00098475|468840121|FG000|Step 2|Never started treatment|1|||
130240013|NCT00098475|468840122|FG001|Step 2|Never started treatment|1|||
130696241|NCT01945580|470512525|FG001|Overall Study|Physician Decision|2|||
130240014|NCT00098475|468840123|FG002|Step 2|Never started treatment|0|||
130240015|NCT00098475|468840124|FG003|Step 2|Never started treatment|0|||
130240016|NCT04132050|468840125|FG000|Period I (Double-blind Period)|Adverse Event|3|||
130240017|NCT04132050|468840126|FG001|Period I (Double-blind Period)|Adverse Event|0|||
130240018|NCT04132050|468840125|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
130240019|NCT04132050|468840126|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
130240020|NCT04132050|468840125|FG000|R788 Treatment Period|Adverse Event|5|||
130240021|NCT04132050|468840126|FG001|R788 Treatment Period|Adverse Event|0|||
130240022|NCT04132050|468840125|FG000|R788 Treatment Period|Lack of Efficacy|5|||
130240023|NCT04132050|468840126|FG001|R788 Treatment Period|Lack of Efficacy|0|||
130240024|NCT04132050|468840125|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
130240025|NCT04132050|468840126|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
130240026|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130240027|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
130240028|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130240029|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130240030|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130240031|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
130240032|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130240033|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130240034|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
130240035|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130240036|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130240037|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
130240038|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
130240039|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130240040|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130240041|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
130240042|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130240043|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130240044|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
130240045|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130240046|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130240047|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
130240048|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130240049|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130696242|NCT01945580|470512524|FG000|Overall Study|Lost to Follow-up|26|||
130240050|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
130240051|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130240052|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130240053|NCT00843882|468840130|FG000|Step 1|Lack of Efficacy|14|||
130240054|NCT00843882|468840131|FG001|Step 1|Lack of Efficacy|10|||
130240055|NCT00843882|468840132|FG002|Step 1|Lack of Efficacy|21|||
130240056|NCT00843882|468840130|FG000|Step 1|Adverse Event|8|||
130240057|NCT00843882|468840131|FG001|Step 1|Adverse Event|17|||
130240058|NCT00843882|468840132|FG002|Step 1|Adverse Event|20|||
130240059|NCT00843882|468840130|FG000|Step 1|Death|1|||
130240060|NCT00843882|468840131|FG001|Step 1|Death|2|||
130240061|NCT00843882|468840132|FG002|Step 1|Death|4|||
130240062|NCT00843882|468840130|FG000|Step 1|Withdrawal by Subject|6|||
130240063|NCT00843882|468840131|FG001|Step 1|Withdrawal by Subject|12|||
130240064|NCT00843882|468840132|FG002|Step 1|Withdrawal by Subject|9|||
130240065|NCT00843882|468840130|FG000|Step 1|Physician Decision|0|||
130240066|NCT00843882|468840131|FG001|Step 1|Physician Decision|5|||
130240067|NCT00843882|468840132|FG002|Step 1|Physician Decision|1|||
130360337|NCT02122458|469290927|FG006|Overall Study|Noncompliance|0|||
130360338|NCT00412542|469290928|FG000|Overall Study|Withdrawal by Subject|0|||
130360339|NCT00412542|469290929|FG001|Overall Study|Withdrawal by Subject|2|||
130360340|NCT00412542|469290928|FG000|Overall Study|Not Eligible|0|||
130360341|NCT00412542|469290929|FG001|Overall Study|Not Eligible|1|||
130360342|NCT03161093|469290930|FG000|Overall Study|Protocol Violation|11|||
130360343|NCT03161093|469290931|FG001|Overall Study|Protocol Violation|14|||
130360344|NCT03161093|469290932|FG002|Overall Study|Protocol Violation|6|||
130360345|NCT03161093|469290933|FG003|Overall Study|Protocol Violation|13|||
130360346|NCT03161093|469290934|FG004|Overall Study|Protocol Violation|1|||
130360347|NCT03161093|469290935|FG005|Overall Study|Protocol Violation|0|||
130360348|NCT03161093|469290930|FG000|Overall Study|Adverse Event|5|||
130360349|NCT03161093|469290931|FG001|Overall Study|Adverse Event|21|||
130360350|NCT03161093|469290932|FG002|Overall Study|Adverse Event|16|||
130360351|NCT03161093|469290933|FG003|Overall Study|Adverse Event|35|||
130696243|NCT01945580|470512525|FG001|Overall Study|Lost to Follow-up|39|||
130696244|NCT01945580|470512524|FG000|Overall Study|Death|7|||
130240068|NCT00843882|468840130|FG000|Step 1|Patient and physician's decision|0|||
130360352|NCT03161093|469290934|FG004|Overall Study|Adverse Event|2|||
130240069|NCT00843882|468840131|FG001|Step 1|Patient and physician's decision|0|||
130360353|NCT03161093|469290935|FG005|Overall Study|Adverse Event|1|||
130240070|NCT00843882|468840132|FG002|Step 1|Patient and physician's decision|1|||
130240071|NCT00843882|468840130|FG000|Step 1|Other complicating disease|1|||
130240072|NCT00843882|468840131|FG001|Step 1|Other complicating disease|3|||
130240073|NCT00843882|468840132|FG002|Step 1|Other complicating disease|4|||
130360354|NCT03161093|469290930|FG000|Overall Study|Lack of Efficacy|9|||
130360355|NCT03161093|469290931|FG001|Overall Study|Lack of Efficacy|13|||
130360356|NCT03161093|469290932|FG002|Overall Study|Lack of Efficacy|9|||
130448303|NCT00335153|469604701|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
130448304|NCT00335153|469604701|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
130448305|NCT00335153|469604701|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
130448306|NCT00335153|469604701|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
130448307|NCT00335153|469604701|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
130448308|NCT01113463|469604706|FG000|Overall Study|Physician Decision|5|||
130448309|NCT02478359|469604707|FG000|Overall Study|Disenrolled from health plan|106|||
130448310|NCT02478359|469604708|FG001|Overall Study|Disenrolled from health plan|65|||
130448311|NCT01237678|469604709|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
130448312|NCT01237678|469604710|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
130448313|NCT01237678|469604711|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
130448314|NCT01237678|469604709|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
130448315|NCT01237678|469604710|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
130448316|NCT01237678|469604711|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
130448317|NCT01237678|469604709|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
130448318|NCT01237678|469604710|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
130448319|NCT01237678|469604711|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
130448320|NCT01237678|469604709|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
130448321|NCT01237678|469604710|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
130448322|NCT01237678|469604711|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
130448323|NCT01237678|469604709|FG000|Phase II|Adverse Event|0|||
130448324|NCT01237678|469604710|FG001|Phase II|Adverse Event|39|||
130448325|NCT01237678|469604711|FG002|Phase II|Adverse Event|9|||
130448326|NCT01237678|469604709|FG000|Phase II|Death|0|||
130448327|NCT01237678|469604710|FG001|Phase II|Death|0|||
130448328|NCT01237678|469604711|FG002|Phase II|Death|2|||
130448329|NCT01237678|469604709|FG000|Phase II|Lack of Efficacy|0|||
130448330|NCT01237678|469604710|FG001|Phase II|Lack of Efficacy|25|||
130448331|NCT01237678|469604711|FG002|Phase II|Lack of Efficacy|3|||
130448332|NCT01237678|469604709|FG000|Phase II|Withdrawal by Subject|0|||
130448333|NCT01237678|469604710|FG001|Phase II|Withdrawal by Subject|1|||
130448334|NCT01237678|469604711|FG002|Phase II|Withdrawal by Subject|5|||
130448335|NCT01237678|469604709|FG000|Phase II|Completed Cycles 4-6|0|||
130448336|NCT01237678|469604710|FG001|Phase II|Completed Cycles 4-6|11|||
130448337|NCT01237678|469604711|FG002|Phase II|Completed Cycles 4-6|21|||
130448338|NCT01237678|469604709|FG000|Phase II|Sponsor Decision/Study Closed|0|||
130448339|NCT01237678|469604710|FG001|Phase II|Sponsor Decision/Study Closed|18|||
130448340|NCT01237678|469604711|FG002|Phase II|Sponsor Decision/Study Closed|7|||
130448341|NCT01237678|469604709|FG000|Phase II|Randomized but were not treated|0|||
130448342|NCT01237678|469604710|FG001|Phase II|Randomized but were not treated|4|||
130448343|NCT01237678|469604711|FG002|Phase II|Randomized but were not treated|3|||
130448344|NCT03023332|469604712|FG000|Overall Study|Withdrawal by Subject|10|||
130448345|NCT03023332|469604713|FG001|Overall Study|Withdrawal by Subject|5|||
130448346|NCT03023332|469604714|FG002|Overall Study|Withdrawal by Subject|4|||
130448347|NCT03023332|469604715|FG003|Overall Study|Withdrawal by Subject|7|||
130448348|NCT03023332|469604712|FG000|Overall Study|Lost to Follow-up|13|||
130448349|NCT03023332|469604713|FG001|Overall Study|Lost to Follow-up|16|||
130448350|NCT03023332|469604714|FG002|Overall Study|Lost to Follow-up|8|||
130448351|NCT03023332|469604715|FG003|Overall Study|Lost to Follow-up|13|||
130448352|NCT03023332|469604712|FG000|Overall Study|Death|1|||
130448353|NCT03023332|469604713|FG001|Overall Study|Death|0|||
130448354|NCT03023332|469604714|FG002|Overall Study|Death|0|||
130448355|NCT03023332|469604715|FG003|Overall Study|Death|0|||
130448356|NCT01818700|469604716|FG000|Overall Study|Adverse Event|67|||
130448357|NCT01818700|469604716|FG000|Overall Study|Lack of Efficacy|2|||
130448358|NCT01818700|469604716|FG000|Overall Study|Lost to Follow-up|5|||
130448359|NCT01818700|469604716|FG000|Overall Study|Withdrawal by Subject|27|||
130448360|NCT01818700|469604716|FG000|Overall Study|Protocol Violation|2|||
130448361|NCT01818700|469604716|FG000|Overall Study|Other|1|||
130448362|NCT02412761|469604717|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130448363|NCT02412761|469604718|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130448364|NCT02412761|469604719|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130448365|NCT02412761|469604720|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130448366|NCT02412761|469604721|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130448367|NCT02412761|469604722|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130448368|NCT01657682|469604723|FG000|Overall Study|Lost to Follow-up|1|||
130448369|NCT01657682|469604724|FG001|Overall Study|Lost to Follow-up|0|||
130448370|NCT01657682|469604725|FG002|Overall Study|Lost to Follow-up|0|||
130448371|NCT01657682|469604723|FG000|Overall Study|Withdrawal by Subject|0|||
130448372|NCT01657682|469604724|FG001|Overall Study|Withdrawal by Subject|1|||
130448373|NCT01657682|469604725|FG002|Overall Study|Withdrawal by Subject|1|||
130448374|NCT01657682|469604723|FG000|Overall Study|Adverse Event|0|||
130448375|NCT01657682|469604724|FG001|Overall Study|Adverse Event|1|||
130448376|NCT01657682|469604725|FG002|Overall Study|Adverse Event|0|||
130448377|NCT01719861|469604726|FG000|Cycle 1|Death|4|||
130240074|NCT00843882|468840130|FG000|Step 1|Alternative therapy|0|||
130448378|NCT01719861|469604726|FG000|Cycle 2|Death|1|||
130448379|NCT04833855|469604732|FG000|Overall Study|Decision by sponsor|0|||
130448380|NCT04833855|469604733|FG001|Overall Study|Decision by sponsor|1|||
130448381|NCT04833855|469604734|FG002|Overall Study|Decision by sponsor|0|||
130448382|NCT04833855|469604735|FG003|Overall Study|Decision by sponsor|0|||
130448383|NCT04833855|469604732|FG000|Overall Study|Withdrawal by Subject|4|||
130448384|NCT04833855|469604733|FG001|Overall Study|Withdrawal by Subject|1|||
130448385|NCT04833855|469604734|FG002|Overall Study|Withdrawal by Subject|3|||
130448386|NCT04833855|469604735|FG003|Overall Study|Withdrawal by Subject|1|||
130448387|NCT04833855|469604732|FG000|Overall Study|Lost to Follow-up|1|||
130448388|NCT04833855|469604733|FG001|Overall Study|Lost to Follow-up|0|||
130448389|NCT04833855|469604734|FG002|Overall Study|Lost to Follow-up|2|||
130448390|NCT04833855|469604735|FG003|Overall Study|Lost to Follow-up|2|||
130240075|NCT00843882|468840131|FG001|Step 1|Alternative therapy|1|||
130240076|NCT00843882|468840132|FG002|Step 1|Alternative therapy|1|||
130240077|NCT00843882|468840130|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
130240078|NCT00843882|468840131|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
130240079|NCT00843882|468840132|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
130240080|NCT00843882|468840130|FG000|Step 1|Off treatment reason unknown|0|||
130240081|NCT00843882|468840131|FG001|Step 1|Off treatment reason unknown|1|||
130240082|NCT00843882|468840132|FG002|Step 1|Off treatment reason unknown|4|||
130240083|NCT00843882|468840130|FG000|Step 1|Never started treatment|2|||
130240084|NCT00843882|468840131|FG001|Step 1|Never started treatment|0|||
130240085|NCT00843882|468840132|FG002|Step 1|Never started treatment|0|||
130240086|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
130240087|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
130240088|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
130240089|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
130240090|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
130240091|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
130240092|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
130240093|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
130240094|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
130240095|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
130240096|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
130240097|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
130240098|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
130240099|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
130240100|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
130240101|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
130240102|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
130240103|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
130240104|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
130240105|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
130240106|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
130240107|NCT05317546|468840133|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
130240108|NCT05317546|468840134|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
130240109|NCT03331250|468840135|FG000|Overall Study|Withdrawal by Subject|1|||
130240110|NCT04590963|468840136|FG000|Overall Study|Death|118|||
130240111|NCT04590963|468840137|FG001|Overall Study|Death|59|||
130240112|NCT04590963|468840136|FG000|Overall Study|Lost to Follow-up|1|||
130240113|NCT04590963|468840137|FG001|Overall Study|Lost to Follow-up|1|||
130240114|NCT04590963|468840136|FG000|Overall Study|Progressive disease|0|||
130240115|NCT04590963|468840137|FG001|Overall Study|Progressive disease|1|||
130240116|NCT04590963|468840136|FG000|Overall Study|Study terminated by sponsor|103|||
130240117|NCT04590963|468840137|FG001|Overall Study|Study terminated by sponsor|50|||
130240118|NCT04590963|468840136|FG000|Overall Study|Withdrawal by Subject|15|||
130240119|NCT04590963|468840137|FG001|Overall Study|Withdrawal by Subject|8|||
130240120|NCT04590963|468840136|FG000|Overall Study|Ongoing at data cut-off|9|||
130240121|NCT04590963|468840137|FG001|Overall Study|Ongoing at data cut-off|4|||
130240122|NCT04590963|468840136|FG000|Overall Study|Screen failure|1|||
130448391|NCT04833855|469604732|FG000|Overall Study|Protocol specified criteria|0|||
130448392|NCT04833855|469604733|FG001|Overall Study|Protocol specified criteria|0|||
130240123|NCT04590963|468840137|FG001|Overall Study|Screen failure|0|||
130240124|NCT04057365|468840138|FG000|Overall Study|Withdrawal by Subject|2|||
130240125|NCT04057365|468840139|FG001|Overall Study|Withdrawal by Subject|0|||
130448393|NCT04833855|469604734|FG002|Overall Study|Protocol specified criteria|2|||
130240126|NCT03976375|468840140|FG000|Overall Study|Death|158|||
130240127|NCT03976375|468840141|FG001|Overall Study|Death|160|||
130240128|NCT03976375|468840142|FG002|Overall Study|Death|42|||
130448394|NCT04833855|469604735|FG003|Overall Study|Protocol specified criteria|1|||
130448395|NCT03682536|469604737|FG000|Randomization|Withdrawal by Subject|0|||
130448396|NCT03682536|469604738|FG001|Randomization|Withdrawal by Subject|2|||
130448397|NCT03682536|469604737|FG000|Treatment|Other Reasons|8|||
130696245|NCT01945580|470512525|FG001|Overall Study|Death|2|||
130240129|NCT03976375|468840140|FG000|Overall Study|Lost to Follow-up|2|||
130240130|NCT03976375|468840141|FG001|Overall Study|Lost to Follow-up|1|||
130240131|NCT03976375|468840142|FG002|Overall Study|Lost to Follow-up|1|||
130240132|NCT03976375|468840140|FG000|Overall Study|Withdrawal by Subject|5|||
130240133|NCT03976375|468840141|FG001|Overall Study|Withdrawal by Subject|9|||
130240134|NCT03976375|468840142|FG002|Overall Study|Withdrawal by Subject|4|||
130240135|NCT03976375|468840140|FG000|Overall Study|Sponsor decision|20|||
130240136|NCT03976375|468840141|FG001|Overall Study|Sponsor decision|19|||
130240137|NCT03976375|468840142|FG002|Overall Study|Sponsor decision|1|||
130240138|NCT01063114|468840143|FG000|Overall Study|Lost to Follow-up|1|||
130240139|NCT05556057|468840156|FG000|Overall Study|Lost to Follow-up|5|||
130240140|NCT05556057|468840157|FG001|Overall Study|Lost to Follow-up|4|||
130240141|NCT05556057|468840156|FG000|Overall Study|Withdrawal by Subject|0|||
130240142|NCT05556057|468840157|FG001|Overall Study|Withdrawal by Subject|2|||
130240143|NCT02466971|468840161|FG000|Overall Study|eligible and never treated|14|||
130240144|NCT02466971|468840162|FG001|Overall Study|eligible and never treated|20|||
130240145|NCT02466971|468840161|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
130240146|NCT02466971|468840162|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
130240147|NCT02466971|468840161|FG000|Overall Study|ineligible and treated|1|||
130240148|NCT02466971|468840162|FG001|Overall Study|ineligible and treated|0|||
130240149|NCT02466971|468840161|FG000|Overall Study|ineligible and never treated|0|||
130240150|NCT02466971|468840162|FG001|Overall Study|ineligible and never treated|1|||
130240151|NCT04818112|468840167|FG000|Overall Study|Withdrawal by Subject|54|||
130240152|NCT04818112|468840168|FG001|Overall Study|Withdrawal by Subject|12|||
130240153|NCT04818112|468840167|FG000|Overall Study|Lost to Follow-up|38|||
130240154|NCT04818112|468840168|FG001|Overall Study|Lost to Follow-up|10|||
130240155|NCT06187909|468840169|FG000|Overall Study|Withdrawal by Subject|2|||
130240156|NCT06187909|468840170|FG001|Overall Study|Withdrawal by Subject|2|||
130240157|NCT05020743|468840171|FG000|Overall Study|Enrollment in Interventional Study|2|||
130240158|NCT05020743|468840172|FG001|Overall Study|Enrollment in Interventional Study|9|||
130240159|NCT05020743|468840173|FG002|Overall Study|Enrollment in Interventional Study|0|||
130240160|NCT05020743|468840171|FG000|Overall Study|Withdrawal by Subject|0|||
130360357|NCT03161093|469290933|FG003|Overall Study|Lack of Efficacy|24|||
130360358|NCT03161093|469290934|FG004|Overall Study|Lack of Efficacy|4|||
130360359|NCT03161093|469290935|FG005|Overall Study|Lack of Efficacy|1|||
130360360|NCT03161093|469290930|FG000|Overall Study|Physician Decision|0|||
130360361|NCT03161093|469290931|FG001|Overall Study|Physician Decision|1|||
130360362|NCT03161093|469290932|FG002|Overall Study|Physician Decision|0|||
130696246|NCT01945580|470512524|FG000|Overall Study|Patient moved out of state|0|||
130240161|NCT05020743|468840172|FG001|Overall Study|Withdrawal by Subject|3|||
130240162|NCT05020743|468840173|FG002|Overall Study|Withdrawal by Subject|1|||
130360363|NCT03161093|469290933|FG003|Overall Study|Physician Decision|2|||
130360364|NCT03161093|469290934|FG004|Overall Study|Physician Decision|17|||
130360365|NCT03161093|469290935|FG005|Overall Study|Physician Decision|15|||
130360366|NCT03161093|469290930|FG000|Overall Study|Withdrawal by Subject|24|||
130360367|NCT03161093|469290931|FG001|Overall Study|Withdrawal by Subject|73|||
130360368|NCT03161093|469290932|FG002|Overall Study|Withdrawal by Subject|44|||
130360369|NCT03161093|469290933|FG003|Overall Study|Withdrawal by Subject|97|||
130360370|NCT03161093|469290934|FG004|Overall Study|Withdrawal by Subject|11|||
130360371|NCT03161093|469290935|FG005|Overall Study|Withdrawal by Subject|10|||
130360372|NCT03161093|469290930|FG000|Overall Study|Lost to Follow-up|3|||
130360373|NCT03161093|469290931|FG001|Overall Study|Lost to Follow-up|12|||
130360374|NCT03161093|469290932|FG002|Overall Study|Lost to Follow-up|4|||
130360375|NCT03161093|469290933|FG003|Overall Study|Lost to Follow-up|7|||
130360376|NCT03161093|469290934|FG004|Overall Study|Lost to Follow-up|8|||
130360377|NCT03161093|469290935|FG005|Overall Study|Lost to Follow-up|13|||
130360378|NCT03161093|469290930|FG000|Overall Study|Death|3|||
130360379|NCT03161093|469290931|FG001|Overall Study|Death|9|||
130240163|NCT05020743|468840171|FG000|Overall Study|Lost to Follow-up|1|||
130240164|NCT05020743|468840172|FG001|Overall Study|Lost to Follow-up|0|||
130240165|NCT05020743|468840173|FG002|Overall Study|Lost to Follow-up|0|||
130240166|NCT05020743|468840171|FG000|Overall Study|Study Termination by Sponsor|10|||
130240167|NCT05020743|468840172|FG001|Overall Study|Study Termination by Sponsor|11|||
130240168|NCT05020743|468840173|FG002|Overall Study|Study Termination by Sponsor|10|||
130240169|NCT01913353|468840176|FG000|Overall Study|Adverse Event|2|||
130240170|NCT01913353|468840177|FG001|Overall Study|Adverse Event|0|||
130240171|NCT01913353|468840176|FG000|Overall Study|Physician Decision|0|||
130240172|NCT01913353|468840177|FG001|Overall Study|Physician Decision|2|||
130240173|NCT01913353|468840176|FG000|Overall Study|Withdrawal by Subject|20|||
130240174|NCT01913353|468840177|FG001|Overall Study|Withdrawal by Subject|6|||
130360380|NCT03161093|469290932|FG002|Overall Study|Death|7|||
130360381|NCT03161093|469290933|FG003|Overall Study|Death|9|||
130360382|NCT03161093|469290934|FG004|Overall Study|Death|0|||
130360383|NCT03161093|469290935|FG005|Overall Study|Death|0|||
130376592|NCT00963547|469345870|FG006|Overall Study|Adverse Event|0|||
130376593|NCT00963547|469345864|FG000|Overall Study|Physician Decision|1|||
130376594|NCT00963547|469345865|FG001|Overall Study|Physician Decision|1|||
130240175|NCT01913353|468840176|FG000|Overall Study|multiple reasons|10|||
130240176|NCT01913353|468840177|FG001|Overall Study|multiple reasons|7|||
130240177|NCT04017962|468840178|FG000|Overall Study|Death|2|||
130240178|NCT04017962|468840179|FG001|Overall Study|Death|0|||
130240179|NCT04017962|468840178|FG000|Overall Study|Lost to Follow-up|2|||
130240180|NCT04017962|468840179|FG001|Overall Study|Lost to Follow-up|0|||
130240181|NCT04017962|468840178|FG000|Overall Study|Physician Decision|1|||
130240182|NCT04017962|468840179|FG001|Overall Study|Physician Decision|0|||
130240183|NCT04017962|468840178|FG000|Overall Study|Discontinued LTV|5|||
130240184|NCT04017962|468840179|FG001|Overall Study|Discontinued LTV|0|||
130240185|NCT01260948|468840181|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130240186|NCT01260948|468840182|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
130240187|NCT01260948|468840181|FG000|Second Intervention|Emesis|0|||
130240188|NCT01260948|468840182|FG001|Second Intervention|Emesis|1|||
130240189|NCT00462462|468840183|FG000|Overall Study|Physician Decision|0|||
130240190|NCT00462462|468840184|FG001|Overall Study|Physician Decision|1|||
130240191|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240192|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
130240193|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240194|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240195|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240196|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130448398|NCT03682536|469604738|FG001|Treatment|Other Reasons|7|||
130448399|NCT03682536|469604737|FG000|Treatment|Physician Decision|5|||
130448400|NCT03682536|469604738|FG001|Treatment|Physician Decision|5|||
130448401|NCT03682536|469604737|FG000|Treatment|Protocol Violation|1|||
130448402|NCT03682536|469604738|FG001|Treatment|Protocol Violation|0|||
130448403|NCT03682536|469604737|FG000|Treatment|Study Terminated by Sponsor|1|||
130448404|NCT03682536|469604738|FG001|Treatment|Study Terminated by Sponsor|2|||
130448405|NCT03682536|469604737|FG000|Treatment|Lost to Follow-up|0|||
130448406|NCT03682536|469604738|FG001|Treatment|Lost to Follow-up|1|||
130448407|NCT03682536|469604737|FG000|Treatment|Withdrawal by Subject|16|||
130448408|NCT03682536|469604738|FG001|Treatment|Withdrawal by Subject|18|||
130448409|NCT03682536|469604737|FG000|Treatment|Lack of Efficacy|41|||
130448410|NCT03682536|469604738|FG001|Treatment|Lack of Efficacy|68|||
130448411|NCT03682536|469604737|FG000|Treatment|Disease Progression|9|||
130448412|NCT03682536|469604738|FG001|Treatment|Disease Progression|7|||
130696247|NCT01945580|470512525|FG001|Overall Study|Patient moved out of state|1|||
130696248|NCT01945580|470512524|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
130696249|NCT01945580|470512525|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
130696250|NCT01945580|470512524|FG000|Overall Study|Family illness - unable to return|0|||
130448413|NCT03682536|469604737|FG000|Treatment|Adverse Event|9|||
130448414|NCT03682536|469604738|FG001|Treatment|Adverse Event|5|||
130448415|NCT03682536|469604737|FG000|Treatment|Death|14|||
130448416|NCT03682536|469604738|FG001|Treatment|Death|13|||
130696251|NCT01945580|470512525|FG001|Overall Study|Family illness - unable to return|1|||
130448417|NCT03008122|469604739|FG000|Overall Study|Physician Decision|3|||
130448418|NCT03008122|469604740|FG001|Overall Study|Physician Decision|2|||
130448419|NCT03008122|469604741|FG002|Overall Study|Physician Decision|0|||
130448420|NCT03008122|469604739|FG000|Overall Study|Withdrawal by Subject|1|||
130448421|NCT03008122|469604740|FG001|Overall Study|Withdrawal by Subject|3|||
130448422|NCT03008122|469604741|FG002|Overall Study|Withdrawal by Subject|0|||
130448423|NCT03008122|469604739|FG000|Overall Study|Lost to Follow-up|4|||
130448424|NCT03008122|469604740|FG001|Overall Study|Lost to Follow-up|8|||
130448425|NCT03008122|469604741|FG002|Overall Study|Lost to Follow-up|3|||
130448426|NCT03008122|469604739|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130448427|NCT03008122|469604740|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130448428|NCT03008122|469604741|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130448429|NCT03008122|469604739|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
130448430|NCT03008122|469604740|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
130448431|NCT03008122|469604741|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
130448432|NCT03008122|469604739|FG000|Overall Study|Death|0|||
130448433|NCT03008122|469604740|FG001|Overall Study|Death|0|||
130240197|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240198|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240199|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240200|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
130696252|NCT01945580|470512524|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
130696253|NCT01945580|470512525|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
130448434|NCT03008122|469604741|FG002|Overall Study|Death|1|||
130448435|NCT02338609|469604742|FG000|Overall Study|Physician Decision|1|||
130448436|NCT02338609|469604742|FG000|Overall Study|Death|1|||
130448437|NCT02234310|469604745|FG000|Overall Study|Physician Decision|1|||
130448438|NCT02234310|469604745|FG000|Overall Study|Adverse Event|1|||
130696254|NCT01945580|470512524|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
130696255|NCT01945580|470512525|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
130696256|NCT01945580|470512524|FG000|Overall Study|Noncompliance with 36 month visit|1|||
130696257|NCT01945580|470512525|FG001|Overall Study|Noncompliance with 36 month visit|0|||
130696258|NCT01945580|470512524|FG000|Overall Study|The patient moved.|1|||
130696259|NCT01945580|470512525|FG001|Overall Study|The patient moved.|0|||
130696260|NCT01945580|470512524|FG000|Overall Study|No data available|0|||
130696261|NCT01945580|470512525|FG001|Overall Study|No data available|2|||
130696262|NCT05034874|470512528|FG000|Overall Study|Withdrawal by Subject|6|||
130240201|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240202|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130360384|NCT03161093|469290930|FG000|Overall Study|Unknown - Not reported|0|||
130360385|NCT03161093|469290931|FG001|Overall Study|Unknown - Not reported|1|||
130360386|NCT03161093|469290932|FG002|Overall Study|Unknown - Not reported|0|||
130360387|NCT03161093|469290933|FG003|Overall Study|Unknown - Not reported|0|||
130360388|NCT03161093|469290934|FG004|Overall Study|Unknown - Not reported|0|||
130360389|NCT03161093|469290935|FG005|Overall Study|Unknown - Not reported|1|||
130360390|NCT01031706|469290936|FG000|Overall Study|Adverse Event|1|||
130360391|NCT01031706|469290937|FG001|Overall Study|Adverse Event|0|||
130360392|NCT01031706|469290936|FG000|Overall Study|Withdrawal by Subject|1|||
130360393|NCT01031706|469290937|FG001|Overall Study|Withdrawal by Subject|1|||
130360394|NCT02124161|469290938|FG000|Overall Study|Other unspecified|0|||
130360395|NCT02124161|469290939|FG001|Overall Study|Other unspecified|1|||
130360396|NCT02124161|469290938|FG000|Overall Study|Death|1|||
130360397|NCT02124161|469290939|FG001|Overall Study|Death|0|||
130360398|NCT02124161|469290938|FG000|Overall Study|Protocol Violation|2|||
130360399|NCT02124161|469290939|FG001|Overall Study|Protocol Violation|1|||
130360400|NCT02124161|469290938|FG000|Overall Study|Withdrawal by Subject|1|||
130360401|NCT02124161|469290939|FG001|Overall Study|Withdrawal by Subject|2|||
130360402|NCT02124161|469290938|FG000|Overall Study|Adverse Event|2|||
130360403|NCT02124161|469290939|FG001|Overall Study|Adverse Event|0|||
130360404|NCT02124161|469290938|FG000|Overall Study|Does not meet entrance criteria|2|||
130360405|NCT02124161|469290939|FG001|Overall Study|Does not meet entrance criteria|3|||
130360406|NCT02124161|469290938|FG000|Overall Study|No longer meets eligibility criteria|5|||
130360407|NCT02124161|469290939|FG001|Overall Study|No longer meets eligibility criteria|4|||
130360408|NCT02124161|469290938|FG000|Overall Study|Lost to Follow-up|3|||
130360409|NCT02124161|469290939|FG001|Overall Study|Lost to Follow-up|4|||
130360410|NCT02517866|469290940|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130360411|NCT02517866|469290941|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130360412|NCT02517866|469290942|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130360413|NCT02517866|469290940|FG000|Overall Study|Significant Protocol Deviation|4|||
130360414|NCT02517866|469290941|FG001|Overall Study|Significant Protocol Deviation|1|||
130360415|NCT02517866|469290942|FG002|Overall Study|Significant Protocol Deviation|0|||
130360416|NCT02517866|469290940|FG000|Overall Study|Lost to Follow-up|1|||
130360417|NCT02517866|469290941|FG001|Overall Study|Lost to Follow-up|0|||
130360418|NCT02517866|469290942|FG002|Overall Study|Lost to Follow-up|0|||
130360419|NCT02517866|469290940|FG000|Overall Study|Voluntary Withdrawal|2|||
130360420|NCT02517866|469290941|FG001|Overall Study|Voluntary Withdrawal|2|||
130360421|NCT02517866|469290942|FG002|Overall Study|Voluntary Withdrawal|0|||
130360422|NCT02517866|469290940|FG000|Overall Study|Investigator Decision|2|||
130360423|NCT02517866|469290941|FG001|Overall Study|Investigator Decision|1|||
130360424|NCT02517866|469290942|FG002|Overall Study|Investigator Decision|0|||
130360425|NCT02517866|469290940|FG000|Overall Study|Reason not specified|2|||
130360426|NCT02517866|469290941|FG001|Overall Study|Reason not specified|0|||
130360427|NCT02517866|469290942|FG002|Overall Study|Reason not specified|0|||
130360428|NCT01147640|469290944|FG000|Overall Study|Adverse Event|2|||
130360429|NCT01147640|469290945|FG001|Overall Study|Adverse Event|0|||
130360430|NCT01147640|469290944|FG000|Overall Study|Physician Decision|1|||
130360431|NCT01147640|469290945|FG001|Overall Study|Physician Decision|0|||
130360432|NCT01147640|469290944|FG000|Overall Study|Withdrawal by Subject|1|||
130360433|NCT01147640|469290945|FG001|Overall Study|Withdrawal by Subject|0|||
130360434|NCT01147640|469290944|FG000|Overall Study|Lost to Follow-up|0|||
130360435|NCT01147640|469290945|FG001|Overall Study|Lost to Follow-up|1|||
130360436|NCT01147640|469290944|FG000|Overall Study|Didn't meet eligibility criteria|1|||
130360437|NCT01147640|469290945|FG001|Overall Study|Didn't meet eligibility criteria|0|||
130360438|NCT01797731|469290947|FG000|Overall Study|Didn't have proper radiographs required|3|||
130360439|NCT01797731|469290948|FG001|Overall Study|Didn't have proper radiographs required|3|||
130360440|NCT00091442|469290950|FG000|Overall Study|Progressive Disease|220|||
130360441|NCT00091442|469290951|FG001|Overall Study|Progressive Disease|189|||
130360442|NCT00091442|469290950|FG000|Overall Study|Physician Decision|61|||
130360443|NCT00091442|469290951|FG001|Overall Study|Physician Decision|58|||
130696263|NCT05034874|470512529|FG001|Overall Study|Withdrawal by Subject|6|||
130360444|NCT00091442|469290950|FG000|Overall Study|Withdrawal by Subject|38|||
130360445|NCT00091442|469290951|FG001|Overall Study|Withdrawal by Subject|46|||
130696264|NCT05034874|470512528|FG000|Overall Study|Lost to Follow-up|18|||
130696265|NCT05034874|470512529|FG001|Overall Study|Lost to Follow-up|8|||
130696266|NCT05034874|470512528|FG000|Overall Study|Physician Decision|0|||
130696267|NCT05034874|470512529|FG001|Overall Study|Physician Decision|1|||
130696268|NCT05034874|470512528|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
130240203|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130360446|NCT00091442|469290950|FG000|Overall Study|Adverse Event|29|||
130360447|NCT00091442|469290951|FG001|Overall Study|Adverse Event|48|||
130360448|NCT00091442|469290950|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
130360449|NCT00091442|469290951|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
130360450|NCT00091442|469290950|FG000|Overall Study|Death|9|||
130360451|NCT00091442|469290951|FG001|Overall Study|Death|7|||
130360452|NCT00091442|469290950|FG000|Overall Study|Lost to Follow-up|1|||
130360453|NCT00091442|469290951|FG001|Overall Study|Lost to Follow-up|3|||
130360454|NCT00091442|469290950|FG000|Overall Study|Other|2|||
130360455|NCT00091442|469290951|FG001|Overall Study|Other|6|||
130360456|NCT05095454|469290956|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
130360457|NCT05095454|469290957|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
130360458|NCT03342963|469290958|FG000|Overall Study|Adverse Event|1|||
130360459|NCT03342963|469290959|FG001|Overall Study|Adverse Event|2|||
130360460|NCT03342963|469290960|FG002|Overall Study|Adverse Event|0|||
130360461|NCT03342963|469290961|FG003|Overall Study|Adverse Event|0|||
130360462|NCT03342963|469290958|FG000|Overall Study|Withdrawal by Subject|1|||
130360463|NCT03342963|469290959|FG001|Overall Study|Withdrawal by Subject|0|||
130360464|NCT03342963|469290960|FG002|Overall Study|Withdrawal by Subject|0|||
130360465|NCT03342963|469290961|FG003|Overall Study|Withdrawal by Subject|0|||
130360466|NCT03605212|469290962|FG000|Treatment Period|Adverse Event|1|||
130360467|NCT03605212|469290963|FG001|Treatment Period|Adverse Event|0|||
130360468|NCT03605212|469290964|FG002|Treatment Period|Adverse Event|0|||
130360469|NCT03605212|469290965|FG003|Treatment Period|Adverse Event|0|||
130360470|NCT03605212|469290966|FG004|Treatment Period|Adverse Event|0|||
130360471|NCT03605212|469290962|FG000|Treatment Period|Physician Decision|0|||
130360472|NCT03605212|469290963|FG001|Treatment Period|Physician Decision|0|||
130360473|NCT03605212|469290964|FG002|Treatment Period|Physician Decision|0|||
130360474|NCT03605212|469290965|FG003|Treatment Period|Physician Decision|0|||
130360475|NCT03605212|469290966|FG004|Treatment Period|Physician Decision|1|||
130360476|NCT01756053|469290967|FG000|Period 1 (10 Days)|Protocol Violation|1|||
130360477|NCT01756053|469290968|FG001|Period 1 (10 Days)|Protocol Violation|1|||
130360478|NCT01756053|469290967|FG000|Period 2 (10 Days)|Protocol Violation|0|||
130360479|NCT01756053|469290968|FG001|Period 2 (10 Days)|Protocol Violation|2|||
130360480|NCT00285818|469290969|FG000|Overall Study|Withdrawal by Subject|3|||
130360481|NCT00285818|469290970|FG001|Overall Study|Withdrawal by Subject|2|||
130360482|NCT00285818|469290969|FG000|Overall Study|Lost to Follow-up|1|||
130360483|NCT00285818|469290970|FG001|Overall Study|Lost to Follow-up|0|||
130360484|NCT04041375|469290971|FG000|Intervention Phase|Withdrawal by Subject|2|||
130360485|NCT04041375|469290972|FG001|Intervention Phase|Withdrawal by Subject|2|||
130360486|NCT04041375|469290971|FG000|Follow-up Phase|Death|2|||
130360487|NCT04041375|469290972|FG001|Follow-up Phase|Death|0|||
130360488|NCT04041375|469290971|FG000|Follow-up Phase|Lost to Follow-up|2|||
130360489|NCT04041375|469290972|FG001|Follow-up Phase|Lost to Follow-up|1|||
130360490|NCT04041375|469290971|FG000|Follow-up Phase|Too ill|3|||
130360491|NCT04041375|469290972|FG001|Follow-up Phase|Too ill|0|||
130360492|NCT04043728|469290977|FG000|Overall Study|Lost to Follow-up|1|||
130360493|NCT04043728|469290978|FG001|Overall Study|Lost to Follow-up|2|||
130360494|NCT04043728|469290979|FG002|Overall Study|Lost to Follow-up|0|||
130360495|NCT01033851|469290980|FG000|Overall Study|Withdrawal by Subject|3|||
130360496|NCT01033851|469290981|FG001|Overall Study|Withdrawal by Subject|7|||
130360497|NCT02349542|469290982|FG000|Overall Study|Withdrawal by Subject|5|||
130360498|NCT00543543|469290985|FG000|Base Study|Adverse Event|1|||
130360499|NCT00543543|469290986|FG001|Base Study|Adverse Event|11|||
130360500|NCT00543543|469290987|FG002|Base Study|Adverse Event|0|||
130360501|NCT00543543|469290988|FG003|Base Study|Adverse Event|5|||
130360502|NCT00543543|469290985|FG000|Base Study|Lost to Follow-up|12|||
130360503|NCT00543543|469290986|FG001|Base Study|Lost to Follow-up|749|||
130360504|NCT00543543|469290987|FG002|Base Study|Lost to Follow-up|9|||
130360505|NCT00543543|469290988|FG003|Base Study|Lost to Follow-up|701|||
130360506|NCT00543543|469290985|FG000|Base Study|Physician Decision|0|||
130360507|NCT00543543|469290986|FG001|Base Study|Physician Decision|4|||
130360508|NCT00543543|469290987|FG002|Base Study|Physician Decision|0|||
130360509|NCT00543543|469290988|FG003|Base Study|Physician Decision|7|||
130360510|NCT00543543|469290985|FG000|Base Study|Protocol Violation|0|||
130360511|NCT00543543|469290986|FG001|Base Study|Protocol Violation|6|||
130360512|NCT00543543|469290987|FG002|Base Study|Protocol Violation|0|||
130360513|NCT00543543|469290988|FG003|Base Study|Protocol Violation|6|||
130360514|NCT00543543|469290985|FG000|Base Study|Withdrawal by Subject|7|||
130360515|NCT00543543|469290986|FG001|Base Study|Withdrawal by Subject|482|||
130360516|NCT00543543|469290987|FG002|Base Study|Withdrawal by Subject|5|||
130360517|NCT00543543|469290988|FG003|Base Study|Withdrawal by Subject|503|||
130448439|NCT02234310|469604745|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
130448440|NCT02234310|469604745|FG000|Overall Study|Withdrawal by Subject|2|||
130448441|NCT03251378|469604748|FG000|Overall Study|Death|3|||
130448442|NCT03251378|469604749|FG001|Overall Study|Death|2|||
130448443|NCT03251378|469604750|FG002|Overall Study|Death|3|||
130448444|NCT03251378|469604751|FG003|Overall Study|Death|30|||
130448445|NCT03251378|469604752|FG004|Overall Study|Death|24|||
130448446|NCT03251378|469604753|FG005|Overall Study|Death|12|||
130448447|NCT03251378|469604754|FG006|Overall Study|Death|12|||
130448448|NCT03251378|469604748|FG000|Overall Study|Lost to Follow-up|0|||
130448449|NCT03251378|469604749|FG001|Overall Study|Lost to Follow-up|0|||
130448450|NCT03251378|469604750|FG002|Overall Study|Lost to Follow-up|1|||
130448451|NCT03251378|469604751|FG003|Overall Study|Lost to Follow-up|3|||
130448452|NCT03251378|469604752|FG004|Overall Study|Lost to Follow-up|0|||
130448453|NCT03251378|469604753|FG005|Overall Study|Lost to Follow-up|0|||
130448454|NCT03251378|469604754|FG006|Overall Study|Lost to Follow-up|0|||
130448455|NCT03251378|469604748|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
130448456|NCT03251378|469604749|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
130448457|NCT03251378|469604750|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
130448458|NCT03251378|469604751|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
130448459|NCT03251378|469604752|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
130448460|NCT03251378|469604753|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
130448461|NCT03251378|469604754|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
130448462|NCT03251378|469604748|FG000|Overall Study|Progressive disease|2|||
130448463|NCT03251378|469604749|FG001|Overall Study|Progressive disease|0|||
130448464|NCT03251378|469604750|FG002|Overall Study|Progressive disease|0|||
130448465|NCT03251378|469604751|FG003|Overall Study|Progressive disease|1|||
130448466|NCT03251378|469604752|FG004|Overall Study|Progressive disease|0|||
130448467|NCT03251378|469604753|FG005|Overall Study|Progressive disease|0|||
130448468|NCT03251378|469604754|FG006|Overall Study|Progressive disease|0|||
130448469|NCT03251378|469604748|FG000|Overall Study|Physician Decision|0|||
130448470|NCT03251378|469604749|FG001|Overall Study|Physician Decision|2|||
130448471|NCT03251378|469604750|FG002|Overall Study|Physician Decision|0|||
130448472|NCT03251378|469604751|FG003|Overall Study|Physician Decision|0|||
130448473|NCT03251378|469604752|FG004|Overall Study|Physician Decision|0|||
130448474|NCT03251378|469604753|FG005|Overall Study|Physician Decision|0|||
130448475|NCT03251378|469604754|FG006|Overall Study|Physician Decision|0|||
130448476|NCT03251378|469604748|FG000|Overall Study|Other|2|||
130448477|NCT03251378|469604749|FG001|Overall Study|Other|3|||
130448478|NCT03251378|469604750|FG002|Overall Study|Other|2|||
130448479|NCT03251378|469604751|FG003|Overall Study|Other|0|||
130448480|NCT03251378|469604752|FG004|Overall Study|Other|1|||
130696269|NCT05034874|470512529|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
130696270|NCT01867658|470512531|FG000|Overall Study|Withdrawal by Subject|6|||
130696271|NCT01867658|470512531|FG000|Overall Study|Death|2|||
130240204|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130448481|NCT03251378|469604753|FG005|Overall Study|Other|1|||
130448482|NCT03251378|469604754|FG006|Overall Study|Other|1|||
130448483|NCT03251378|469604748|FG000|Overall Study|Other|0|||
130448484|NCT03251378|469604749|FG001|Overall Study|Other|0|||
130448485|NCT03251378|469604750|FG002|Overall Study|Other|0|||
130448486|NCT03251378|469604751|FG003|Overall Study|Other|4|||
130448487|NCT03251378|469604752|FG004|Overall Study|Other|13|||
130448488|NCT03251378|469604753|FG005|Overall Study|Other|0|||
130448489|NCT03251378|469604754|FG006|Overall Study|Other|0|||
130448490|NCT04060680|469604755|FG000|Overall Study|Unsuccessful implant|17|||
130448491|NCT04060680|469604756|FG001|Overall Study|Unsuccessful implant|2|||
130448492|NCT04060680|469604755|FG000|Overall Study|Adverse Event|3|||
130448493|NCT04060680|469604756|FG001|Overall Study|Adverse Event|0|||
130448494|NCT04060680|469604755|FG000|Overall Study|Death|2|||
130448495|NCT04060680|469604756|FG001|Overall Study|Death|0|||
130448496|NCT04060680|469604755|FG000|Overall Study|Study product no longer in use|1|||
130448497|NCT04060680|469604756|FG001|Overall Study|Study product no longer in use|0|||
130448498|NCT04060680|469604755|FG000|Overall Study|Withdrawal by Subject|1|||
130448499|NCT04060680|469604756|FG001|Overall Study|Withdrawal by Subject|0|||
130448500|NCT02322775|469604760|FG000|Overall Study|Adverse Event|1|||
130448501|NCT02322775|469604761|FG001|Overall Study|Adverse Event|0|||
130448502|NCT02322775|469604760|FG000|Overall Study|Lost to Follow-up|0|||
130448503|NCT02322775|469604761|FG001|Overall Study|Lost to Follow-up|1|||
130696272|NCT01867658|470512531|FG000|Overall Study|Subject could not be contacted|1|||
130696273|NCT00840658|470512532|FG000|Overall Study|Death|2|||
130696274|NCT00840658|470512533|FG001|Overall Study|Death|2|||
130448504|NCT02322775|469604760|FG000|Overall Study|Protocol Violation|1|||
130448505|NCT02322775|469604761|FG001|Overall Study|Protocol Violation|0|||
130448506|NCT02322775|469604760|FG000|Overall Study|Withdrawal by Subject|3|||
130448507|NCT02322775|469604761|FG001|Overall Study|Withdrawal by Subject|4|||
130448508|NCT02322775|469604760|FG000|Overall Study|Not willing to perform all FU visits|0|||
130448509|NCT02322775|469604761|FG001|Overall Study|Not willing to perform all FU visits|1|||
130448510|NCT02956967|469604762|FG000|Overall Study|Adverse Event|3|||
130448511|NCT02956967|469604762|FG000|Overall Study|Reason non-related to neutropenia|10|||
130448512|NCT02956967|469604762|FG000|Overall Study|Lost to Follow-up|5|||
130448513|NCT02956967|469604762|FG000|Overall Study|Missing|1|||
130448514|NCT02956967|469604762|FG000|Overall Study|Termination of Nivestim administration|29|||
130448515|NCT04739423|469604763|FG000|Overall Study|Protocol Violation|0|||
130448516|NCT04739423|469604764|FG001|Overall Study|Protocol Violation|1|||
130448517|NCT04739423|469604765|FG002|Overall Study|Protocol Violation|0|||
130448518|NCT04739423|469604766|FG003|Overall Study|Protocol Violation|0|||
130448519|NCT04739423|469604767|FG004|Overall Study|Protocol Violation|0|||
130448520|NCT04739423|469604768|FG005|Overall Study|Protocol Violation|0|||
130448521|NCT04739423|469604763|FG000|Overall Study|Adverse Event|0|||
130448522|NCT04739423|469604764|FG001|Overall Study|Adverse Event|0|||
130448523|NCT04739423|469604765|FG002|Overall Study|Adverse Event|1|||
130448524|NCT04739423|469604766|FG003|Overall Study|Adverse Event|0|||
130448525|NCT04739423|469604767|FG004|Overall Study|Adverse Event|1|||
130448526|NCT04739423|469604768|FG005|Overall Study|Adverse Event|0|||
130448527|NCT04739423|469604763|FG000|Overall Study|Withdrawal by Subject|0|||
130448528|NCT04739423|469604764|FG001|Overall Study|Withdrawal by Subject|0|||
130448529|NCT04739423|469604765|FG002|Overall Study|Withdrawal by Subject|0|||
130448530|NCT04739423|469604766|FG003|Overall Study|Withdrawal by Subject|0|||
130448531|NCT04739423|469604767|FG004|Overall Study|Withdrawal by Subject|0|||
130448532|NCT04739423|469604768|FG005|Overall Study|Withdrawal by Subject|1|||
130448533|NCT04482855|469604772|FG000|Overall Study|Lost to Follow-up|1|||
130448534|NCT04482855|469604773|FG001|Overall Study|Lost to Follow-up|0|||
130448535|NCT04482855|469604772|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
130448536|NCT04482855|469604773|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
130448537|NCT04482855|469604772|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
130448538|NCT04482855|469604773|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
130448539|NCT03212365|469604779|FG000|Overall Study|Discharged prior to Xa level|12|||
130448540|NCT03212365|469604780|FG001|Overall Study|Discharged prior to Xa level|8|||
130448541|NCT03212365|469604779|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
130448542|NCT03212365|469604780|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
130448543|NCT03212365|469604779|FG000|Overall Study|Refused study medication|3|||
130448544|NCT03212365|469604780|FG001|Overall Study|Refused study medication|0|||
130448545|NCT03212365|469604779|FG000|Overall Study|Initiated heparin infusion on floor|1|||
130448546|NCT03212365|469604780|FG001|Overall Study|Initiated heparin infusion on floor|1|||
130448547|NCT03212365|469604779|FG000|Overall Study|Unexpected return to OR|1|||
130448548|NCT03212365|469604780|FG001|Overall Study|Unexpected return to OR|1|||
130448549|NCT03212365|469604779|FG000|Overall Study|Medication distribution error|1|||
130448550|NCT03212365|469604780|FG001|Overall Study|Medication distribution error|0|||
130448551|NCT03212365|469604779|FG000|Overall Study|Required epidural placement|1|||
130448552|NCT03212365|469604780|FG001|Overall Study|Required epidural placement|0|||
130448553|NCT03212365|469604779|FG000|Overall Study|Withdrawal by Subject|0|||
130448554|NCT03212365|469604780|FG001|Overall Study|Withdrawal by Subject|1|||
130448555|NCT03212365|469604779|FG000|Overall Study|developed acute renal failure|0|||
130696275|NCT00840658|470512534|FG002|Overall Study|Death|3|||
130696276|NCT00840658|470512535|FG003|Overall Study|Death|3|||
130696277|NCT00840658|470512532|FG000|Overall Study|Lost to Follow-up|3|||
130696278|NCT00840658|470512533|FG001|Overall Study|Lost to Follow-up|1|||
130696279|NCT00840658|470512534|FG002|Overall Study|Lost to Follow-up|2|||
130696280|NCT00840658|470512535|FG003|Overall Study|Lost to Follow-up|1|||
130696281|NCT02845336|470512540|FG000|Overall Study|Lost to Follow-up|3|||
130696282|NCT02845336|470512541|FG001|Overall Study|Lost to Follow-up|1|||
130696283|NCT02845336|470512540|FG000|Overall Study|Inability to get medication|2|||
130696284|NCT02845336|470512541|FG001|Overall Study|Inability to get medication|0|||
130696285|NCT02420353|470512548|FG000|Overall Study|Withdrawal by Subject|0|||
130696286|NCT02420353|470512549|FG001|Overall Study|Withdrawal by Subject|1|||
130696287|NCT01149057|470512550|FG000|Overall Study|Lack of Efficacy|16|||
130696288|NCT01149057|470512550|FG000|Overall Study|Adverse Event|13|||
130696289|NCT01149057|470512550|FG000|Overall Study|Withdrawal by Subject|9|||
130448556|NCT03212365|469604780|FG001|Overall Study|developed acute renal failure|1|||
130696290|NCT01149057|470512550|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
130696291|NCT01149057|470512550|FG000|Overall Study|B Cell Depletion|4|||
130696292|NCT01149057|470512550|FG000|Overall Study|Participant Non-Compliance|2|||
130448557|NCT02507219|469604781|FG000|Overall Study|Physician Decision|1|||
130448558|NCT02507219|469604782|FG001|Overall Study|Physician Decision|0|||
130448559|NCT02507219|469604783|FG002|Overall Study|Physician Decision|0|||
130448560|NCT02507219|469604784|FG003|Overall Study|Physician Decision|0|||
130696293|NCT01149057|470512550|FG000|Overall Study|Lost to Follow-up|1|||
130696294|NCT01149057|470512550|FG000|Overall Study|High Parathyroid Hormone Value|1|||
130696295|NCT01149057|470512550|FG000|Overall Study|Other|6|||
130696296|NCT04608448|470512551|FG000|Overall Study|Withdrawal by Subject|1|||
130240205|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130448561|NCT02507219|469604785|FG004|Overall Study|Physician Decision|0|||
130448562|NCT02507219|469604786|FG005|Overall Study|Physician Decision|0|||
130448563|NCT02507219|469604781|FG000|Overall Study|Withdrawal by Subject|0|||
130448564|NCT02507219|469604782|FG001|Overall Study|Withdrawal by Subject|0|||
130448565|NCT02507219|469604783|FG002|Overall Study|Withdrawal by Subject|0|||
130448566|NCT02507219|469604784|FG003|Overall Study|Withdrawal by Subject|0|||
130448567|NCT02507219|469604785|FG004|Overall Study|Withdrawal by Subject|1|||
130448568|NCT02507219|469604786|FG005|Overall Study|Withdrawal by Subject|0|||
130448569|NCT00819234|469604791|FG000|Overall Study|Withdrawal by Subject|8|||
130448570|NCT00819234|469604792|FG001|Overall Study|Withdrawal by Subject|13|||
130448571|NCT00819234|469604793|FG002|Overall Study|Withdrawal by Subject|6|||
130448572|NCT00819234|469604794|FG003|Overall Study|Withdrawal by Subject|3|||
130448573|NCT00819234|469604795|FG004|Overall Study|Withdrawal by Subject|0|||
130240206|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240207|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240208|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240209|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
130240210|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240211|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240212|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240213|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240214|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240215|NCT02394756|468840193|FG000|Period 1|Lens Discomfort|0|||
130240216|NCT02394756|468840194|FG001|Period 1|Lens Discomfort|0|||
130448574|NCT00819234|469604796|FG005|Overall Study|Withdrawal by Subject|4|||
130448575|NCT00819234|469604797|FG006|Overall Study|Withdrawal by Subject|4|||
130448576|NCT00819234|469604798|FG007|Overall Study|Withdrawal by Subject|8|||
130448577|NCT00819234|469604799|FG008|Overall Study|Withdrawal by Subject|5|||
130448578|NCT00819234|469604800|FG009|Overall Study|Withdrawal by Subject|3|||
130448579|NCT00819234|469604791|FG000|Overall Study|Adverse Event|0|||
130448580|NCT00819234|469604792|FG001|Overall Study|Adverse Event|0|||
130448581|NCT00819234|469604793|FG002|Overall Study|Adverse Event|1|||
130448582|NCT00819234|469604794|FG003|Overall Study|Adverse Event|0|||
130448583|NCT00819234|469604795|FG004|Overall Study|Adverse Event|0|||
130448584|NCT00819234|469604796|FG005|Overall Study|Adverse Event|2|||
130448585|NCT00819234|469604797|FG006|Overall Study|Adverse Event|0|||
130448586|NCT00819234|469604798|FG007|Overall Study|Adverse Event|0|||
130448587|NCT00819234|469604799|FG008|Overall Study|Adverse Event|0|||
130448588|NCT00819234|469604800|FG009|Overall Study|Adverse Event|0|||
130448589|NCT00819234|469604791|FG000|Overall Study|Physician Decision|0|||
130448590|NCT00819234|469604792|FG001|Overall Study|Physician Decision|0|||
130448591|NCT00819234|469604793|FG002|Overall Study|Physician Decision|0|||
130448592|NCT00819234|469604794|FG003|Overall Study|Physician Decision|1|||
130448593|NCT00819234|469604795|FG004|Overall Study|Physician Decision|0|||
130448594|NCT00819234|469604796|FG005|Overall Study|Physician Decision|0|||
130448595|NCT00819234|469604797|FG006|Overall Study|Physician Decision|0|||
130448596|NCT00819234|469604798|FG007|Overall Study|Physician Decision|0|||
130448597|NCT00819234|469604799|FG008|Overall Study|Physician Decision|0|||
130448598|NCT00819234|469604800|FG009|Overall Study|Physician Decision|2|||
130448599|NCT00819234|469604791|FG000|Overall Study|Protocol Violation|0|||
130448600|NCT00819234|469604792|FG001|Overall Study|Protocol Violation|0|||
130448601|NCT00819234|469604793|FG002|Overall Study|Protocol Violation|1|||
130448602|NCT00819234|469604794|FG003|Overall Study|Protocol Violation|0|||
130448603|NCT00819234|469604795|FG004|Overall Study|Protocol Violation|0|||
130448604|NCT00819234|469604796|FG005|Overall Study|Protocol Violation|0|||
130448605|NCT00819234|469604797|FG006|Overall Study|Protocol Violation|0|||
130448606|NCT00819234|469604798|FG007|Overall Study|Protocol Violation|0|||
130448607|NCT00819234|469604799|FG008|Overall Study|Protocol Violation|0|||
130448608|NCT00819234|469604800|FG009|Overall Study|Protocol Violation|0|||
130448609|NCT00819234|469604791|FG000|Overall Study|Lost to Follow-up|2|||
130448610|NCT00819234|469604792|FG001|Overall Study|Lost to Follow-up|2|||
130448611|NCT00819234|469604793|FG002|Overall Study|Lost to Follow-up|0|||
130696297|NCT04608448|470512551|FG000|Overall Study|Adverse Event|1|||
130448612|NCT00819234|469604794|FG003|Overall Study|Lost to Follow-up|2|||
130448613|NCT00819234|469604795|FG004|Overall Study|Lost to Follow-up|1|||
130448614|NCT00819234|469604796|FG005|Overall Study|Lost to Follow-up|1|||
130448615|NCT00819234|469604797|FG006|Overall Study|Lost to Follow-up|1|||
130448616|NCT00819234|469604798|FG007|Overall Study|Lost to Follow-up|1|||
130448617|NCT00819234|469604799|FG008|Overall Study|Lost to Follow-up|1|||
130448618|NCT00819234|469604800|FG009|Overall Study|Lost to Follow-up|2|||
130448619|NCT05174065|469604801|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
130448620|NCT05174065|469604802|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
130448621|NCT05174065|469604803|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
130448622|NCT05174065|469604801|FG000|Placebo-controlled Period|Other|0|||
130240217|NCT02394756|468840195|FG002|Period 1|Lens Discomfort|0|||
130448623|NCT05174065|469604802|FG001|Placebo-controlled Period|Other|1|||
130448624|NCT05174065|469604803|FG002|Placebo-controlled Period|Other|0|||
130448625|NCT05174065|469604801|FG000|Placebo-controlled Period|Adverse Event|1|||
130448626|NCT05174065|469604802|FG001|Placebo-controlled Period|Adverse Event|1|||
130448627|NCT05174065|469604803|FG002|Placebo-controlled Period|Adverse Event|0|||
130448628|NCT05174065|469604801|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
130448629|NCT05174065|469604802|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
130448630|NCT05174065|469604803|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
130448631|NCT05174065|469604801|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
130448632|NCT05174065|469604802|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
130448633|NCT05174065|469604803|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
130448634|NCT05174065|469604801|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
130448635|NCT05174065|469604802|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
130448636|NCT05174065|469604803|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
130448637|NCT01342887|469604809|FG000|Overall Study|Death|2|||
130448638|NCT00209274|469604810|FG000|Overall Study|Missed visit|3|||
130448639|NCT00209274|469604811|FG001|Overall Study|Missed visit|2|||
130448640|NCT00209274|469604810|FG000|Overall Study|Death|32|||
130448641|NCT00209274|469604811|FG001|Overall Study|Death|15|||
130448642|NCT00209274|469604810|FG000|Overall Study|Withdrawal by Subject|30|||
130448643|NCT00209274|469604811|FG001|Overall Study|Withdrawal by Subject|15|||
130448644|NCT00209274|469604810|FG000|Overall Study|Randomized not treated (RNT)|6|||
130448645|NCT00209274|469604811|FG001|Overall Study|Randomized not treated (RNT)|15|||
130448646|NCT02753530|469604812|FG000|Overall Study|Adverse Event|7|||
130448647|NCT02753530|469604813|FG001|Overall Study|Adverse Event|1|||
130448648|NCT02753530|469604812|FG000|Overall Study|Death|0|||
130448649|NCT02753530|469604813|FG001|Overall Study|Death|1|||
130448650|NCT02753530|469604812|FG000|Overall Study|Physician Decision|0|||
130448651|NCT02753530|469604813|FG001|Overall Study|Physician Decision|1|||
130448652|NCT02753530|469604812|FG000|Overall Study|Protocol Violation|1|||
130448653|NCT02753530|469604813|FG001|Overall Study|Protocol Violation|0|||
130448654|NCT02753530|469604812|FG000|Overall Study|Withdrawal by Subject|4|||
130448655|NCT02753530|469604813|FG001|Overall Study|Withdrawal by Subject|3|||
130448656|NCT00231179|469606551|FG000|Overall Study|Lost to Follow-up|21|||
130448657|NCT00231179|469606552|FG001|Overall Study|Lost to Follow-up|21|||
130448658|NCT00231179|469606551|FG000|Overall Study|Withdrawal by Subject|3|||
130448659|NCT00231179|469606552|FG001|Overall Study|Withdrawal by Subject|3|||
130448660|NCT02401529|469606555|FG000|Overall Study|Lost to Follow-up|2|||
130448661|NCT02401529|469606556|FG001|Overall Study|Lost to Follow-up|1|||
130448662|NCT02401529|469606555|FG000|Overall Study|Physician Decision|2|||
130448663|NCT02401529|469606556|FG001|Overall Study|Physician Decision|6|||
130448664|NCT02401529|469606555|FG000|Overall Study|Protocol Violation|5|||
130448665|NCT02401529|469606556|FG001|Overall Study|Protocol Violation|0|||
130448666|NCT02491411|469606559|FG000|Overall Study|Physician Decision|4|||
130448667|NCT04034238|469606560|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
130448668|NCT04034238|469606561|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130448669|NCT04034238|469606562|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130448670|NCT04034238|469606563|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130448671|NCT04034238|469606560|FG000|Dose Escalation Phase|Screen failures|0|||
130448672|NCT04034238|469606561|FG001|Dose Escalation Phase|Screen failures|0|||
130448673|NCT04034238|469606562|FG002|Dose Escalation Phase|Screen failures|0|||
130448674|NCT04034238|469606563|FG003|Dose Escalation Phase|Screen failures|2|||
130448675|NCT04034238|469606560|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
130448676|NCT04034238|469606561|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
130448677|NCT04034238|469606562|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
130240218|NCT02394756|468840196|FG003|Period 1|Lens Discomfort|0|||
130240219|NCT02394756|468840197|FG004|Period 1|Lens Discomfort|0|||
130240220|NCT02394756|468840198|FG005|Period 1|Lens Discomfort|1|||
130240221|NCT02394756|468840193|FG000|Period 1|Withdrawal by Subject|0|||
130240222|NCT02394756|468840194|FG001|Period 1|Withdrawal by Subject|1|||
130240223|NCT02394756|468840195|FG002|Period 1|Withdrawal by Subject|1|||
130448678|NCT04034238|469606563|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
130448679|NCT04034238|469606560|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
130448680|NCT04034238|469606561|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
130240224|NCT02394756|468840196|FG003|Period 1|Withdrawal by Subject|1|||
130240225|NCT02394756|468840197|FG004|Period 1|Withdrawal by Subject|0|||
130240226|NCT02394756|468840198|FG005|Period 1|Withdrawal by Subject|0|||
130448681|NCT04034238|469606562|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
130448682|NCT04034238|469606563|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
130448683|NCT02065245|469606566|FG000|Infusion 1|Lost to Follow-up|0|||
130448684|NCT02065245|469606567|FG001|Infusion 1|Lost to Follow-up|0|||
130448685|NCT02065245|469606568|FG002|Infusion 1|Lost to Follow-up|0|||
130240227|NCT02394756|468840193|FG000|Period 2|Unsatisfactory Visual Response|0|||
130448686|NCT02065245|469606569|FG003|Infusion 1|Lost to Follow-up|0|||
130448687|NCT02065245|469606570|FG004|Infusion 1|Lost to Follow-up|0|||
130448688|NCT02065245|469606571|FG005|Infusion 1|Lost to Follow-up|0|||
130448689|NCT02065245|469606572|FG006|Infusion 1|Lost to Follow-up|1|||
130448690|NCT02065245|469606566|FG000|Infusion 1|Death|0|||
130448691|NCT02065245|469606567|FG001|Infusion 1|Death|0|||
130448692|NCT02065245|469606568|FG002|Infusion 1|Death|1|||
130448693|NCT02065245|469606569|FG003|Infusion 1|Death|0|||
130448694|NCT02065245|469606570|FG004|Infusion 1|Death|1|||
130448695|NCT02065245|469606571|FG005|Infusion 1|Death|0|||
130448696|NCT02065245|469606572|FG006|Infusion 1|Death|0|||
130448697|NCT02065245|469606566|FG000|Infusion 2|Death|0|||
130448698|NCT02065245|469606567|FG001|Infusion 2|Death|0|||
130448699|NCT02065245|469606568|FG002|Infusion 2|Death|0|||
130448700|NCT02065245|469606569|FG003|Infusion 2|Death|0|||
130448701|NCT02065245|469606570|FG004|Infusion 2|Death|0|||
130448702|NCT02065245|469606571|FG005|Infusion 2|Death|0|||
130448703|NCT02065245|469606572|FG006|Infusion 2|Death|1|||
130448704|NCT02065245|469606566|FG000|Infusion 3|Lost to Follow-up|1|||
130448705|NCT02065245|469606567|FG001|Infusion 3|Lost to Follow-up|1|||
130448706|NCT02065245|469606568|FG002|Infusion 3|Lost to Follow-up|0|||
130448707|NCT02065245|469606569|FG003|Infusion 3|Lost to Follow-up|0|||
130448708|NCT02065245|469606570|FG004|Infusion 3|Lost to Follow-up|0|||
130448709|NCT02065245|469606571|FG005|Infusion 3|Lost to Follow-up|0|||
130448710|NCT02065245|469606572|FG006|Infusion 3|Lost to Follow-up|0|||
130448711|NCT01518257|469606573|FG000|Overall Study|Lost to Follow-up|1|||
130448712|NCT01518257|469606574|FG001|Overall Study|Lost to Follow-up|0|||
130448713|NCT01518257|469606573|FG000|Overall Study|Other Miscellaneous Reason|1|||
130448714|NCT01518257|469606574|FG001|Overall Study|Other Miscellaneous Reason|0|||
130448715|NCT00924664|469606575|FG000|Overall Study|Adverse Event|23|||
130448716|NCT00924664|469606576|FG001|Overall Study|Adverse Event|39|||
130448717|NCT00924664|469606575|FG000|Overall Study|Lack of Efficacy|10|||
130448718|NCT00924664|469606576|FG001|Overall Study|Lack of Efficacy|15|||
130448719|NCT00924664|469606575|FG000|Overall Study|Lost to Follow-up|10|||
130448720|NCT00924664|469606576|FG001|Overall Study|Lost to Follow-up|12|||
130448721|NCT00924664|469606575|FG000|Overall Study|Withdrawal by Subject|47|||
130448722|NCT00924664|469606576|FG001|Overall Study|Withdrawal by Subject|71|||
130448723|NCT00924664|469606575|FG000|Overall Study|Protocol Violation|2|||
130448724|NCT00924664|469606576|FG001|Overall Study|Protocol Violation|5|||
130448725|NCT00924664|469606575|FG000|Overall Study|Pregnancy|1|||
130448726|NCT00924664|469606576|FG001|Overall Study|Pregnancy|1|||
130448727|NCT00924664|469606575|FG000|Overall Study|Death|0|||
130448728|NCT00924664|469606576|FG001|Overall Study|Death|2|||
130448729|NCT00924664|469606575|FG000|Overall Study|Study terminated by sponsor|199|||
130448730|NCT00924664|469606576|FG001|Overall Study|Study terminated by sponsor|330|||
130448731|NCT00924664|469606575|FG000|Overall Study|Other|29|||
130448732|NCT00924664|469606576|FG001|Overall Study|Other|52|||
130448733|NCT00924664|469606575|FG000|Overall Study|Randomized but not Treated|1|||
130448734|NCT00924664|469606576|FG001|Overall Study|Randomized but not Treated|0|||
130448735|NCT01304706|469606577|FG000|Overall Study|Adverse Event|2|||
130448736|NCT01304706|469606577|FG000|Overall Study|Lack of Efficacy|1|||
130448737|NCT01304706|469606577|FG000|Overall Study|Death|3|||
130448738|NCT01304706|469606577|FG000|Overall Study|Withdrawal by Subject|3|||
130448739|NCT01304706|469606577|FG000|Overall Study|Lost to Follow-up|7|||
130448740|NCT01304706|469606577|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
130448741|NCT03158948|469606578|FG000|Overall Study|Death|1|||
130448742|NCT03158948|469606579|FG001|Overall Study|Death|1|||
130448743|NCT03158948|469606580|FG002|Overall Study|Death|3|||
130448744|NCT03158948|469606581|FG003|Overall Study|Death|2|||
130448745|NCT03158948|469606578|FG000|Overall Study|Physician Decision|0|||
130448746|NCT03158948|469606579|FG001|Overall Study|Physician Decision|0|||
130448747|NCT03158948|469606580|FG002|Overall Study|Physician Decision|0|||
130448748|NCT03158948|469606581|FG003|Overall Study|Physician Decision|1|||
130448749|NCT01876043|469606582|FG000|Overall Study|Death|1|||
130448750|NCT01876043|469606582|FG000|Overall Study|Withdrawal by Subject|1|||
130448751|NCT00079937|469606583|FG000|Overall Study|Adverse Event|2|||
130448752|NCT00079937|469606584|FG001|Overall Study|Adverse Event|1|||
130448753|NCT00079937|469606583|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130448754|NCT00079937|469606584|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130448755|NCT00079937|469606583|FG000|Overall Study|Subject no longer requires study drug|3|||
130448756|NCT00079937|469606584|FG001|Overall Study|Subject no longer requires study drug|0|||
130448757|NCT00079937|469606583|FG000|Overall Study|Protocol Violation|8|||
130448758|NCT00079937|469606584|FG001|Overall Study|Protocol Violation|6|||
130448759|NCT00079937|469606583|FG000|Overall Study|Withdrawal by Subject|21|||
130448760|NCT00079937|469606584|FG001|Overall Study|Withdrawal by Subject|7|||
130448761|NCT00079937|469606583|FG000|Overall Study|Lost to Follow-up|12|||
130448762|NCT00079937|469606584|FG001|Overall Study|Lost to Follow-up|5|||
130448763|NCT00079937|469606583|FG000|Overall Study|Administrative problems|22|||
130448764|NCT00079937|469606584|FG001|Overall Study|Administrative problems|11|||
130448765|NCT01616563|469606585|FG000|Overall Study|Lost to Follow-up|40|||
130448766|NCT02206685|469606586|FG000|Overall Study|Surgery cancelled/changed|2|||
130448767|NCT02206685|469606587|FG001|Overall Study|Surgery cancelled/changed|3|||
130448768|NCT02206685|469606586|FG000|Overall Study|Withdrawal by Subject|1|||
130448769|NCT02206685|469606587|FG001|Overall Study|Withdrawal by Subject|2|||
130448770|NCT02206685|469606586|FG000|Overall Study|Protocol Violation|2|||
130448771|NCT02206685|469606587|FG001|Overall Study|Protocol Violation|2|||
130448772|NCT01195675|469606591|FG000|Overall Study|Adverse Event|1|||
130448773|NCT01195675|469606591|FG000|Overall Study|Withdrawal by Subject|2|||
130448774|NCT01106287|469606592|FG000|Overall Study|Adverse Event|1|||
130448775|NCT01106287|469606593|FG001|Overall Study|Adverse Event|0|||
130448776|NCT01106287|469606594|FG002|Overall Study|Adverse Event|0|||
130448777|NCT01106287|469606595|FG003|Overall Study|Adverse Event|0|||
130448778|NCT00072475|469606596|FG000|Overall Study|Adverse Event|44|||
130448779|NCT00072475|469606596|FG000|Overall Study|Death|3|||
130448780|NCT00072475|469606596|FG000|Overall Study|Withdrawal by Subject|46|||
130448781|NCT00072475|469606596|FG000|Overall Study|Patient/Investigator Decision|4|||
130448782|NCT04730947|469606597|FG000|Overall Study|Withdrawal by Subject|0|||
130448783|NCT04730947|469606598|FG001|Overall Study|Withdrawal by Subject|1|||
130448784|NCT00940017|469606599|FG000|Overall Study|did not meet entrance criteria|3|||
130448785|NCT00940017|469606599|FG000|Overall Study|Adverse Event|1|||
130448786|NCT01450943|469606600|FG000|Overall Study|Screen failure, loss to follow-up|2|||
130448787|NCT01450943|469606601|FG001|Overall Study|Screen failure, loss to follow-up|7|||
130448788|NCT01450943|469606602|FG002|Overall Study|Screen failure, loss to follow-up|6|||
130448789|NCT05406791|469606607|FG000|Overall Study|Lost to Follow-up|13|||
130448790|NCT05406791|469606608|FG001|Overall Study|Lost to Follow-up|10|||
130448791|NCT01789203|469606609|FG000|Overall Study|Adverse Event|2|||
130448792|NCT01789203|469606610|FG001|Overall Study|Adverse Event|2|||
130448793|NCT01789203|469606609|FG000|Overall Study|Withdrawal by Subject|1|||
130448794|NCT01789203|469606610|FG001|Overall Study|Withdrawal by Subject|0|||
130448795|NCT01789203|469606609|FG000|Overall Study|Death|1|||
130448796|NCT01789203|469606610|FG001|Overall Study|Death|0|||
130448797|NCT01789203|469606609|FG000|Overall Study|Protocol Violation|2|||
130448798|NCT01789203|469606610|FG001|Overall Study|Protocol Violation|1|||
130448799|NCT01789203|469606609|FG000|Overall Study|Other|1|||
130448800|NCT01789203|469606610|FG001|Overall Study|Other|1|||
130448801|NCT01789203|469606609|FG000|Overall Study|patient non-adherent|2|||
130448802|NCT01789203|469606610|FG001|Overall Study|patient non-adherent|0|||
130448803|NCT00354029|469606613|FG000|Overall Study|Protocol Violation|4|||
130448804|NCT00354029|469606614|FG001|Overall Study|Protocol Violation|2|||
130448805|NCT00826280|469606615|FG000|Overall Study|Randomized but drug not received|1|||
130448806|NCT00826280|469606616|FG001|Overall Study|Randomized but drug not received|0|||
130448807|NCT00826280|469606617|FG002|Overall Study|Randomized but drug not received|1|||
130448808|NCT00826280|469606615|FG000|Overall Study|Adverse Event|1|||
130448809|NCT00826280|469606616|FG001|Overall Study|Adverse Event|3|||
130448810|NCT00826280|469606617|FG002|Overall Study|Adverse Event|0|||
130448811|NCT00826280|469606615|FG000|Overall Study|Lost to Follow-up|0|||
130448812|NCT00826280|469606616|FG001|Overall Study|Lost to Follow-up|1|||
130448813|NCT00826280|469606617|FG002|Overall Study|Lost to Follow-up|0|||
130448814|NCT00826280|469606615|FG000|Overall Study|Sponsor discontinued subject or study|1|||
130448815|NCT00826280|469606616|FG001|Overall Study|Sponsor discontinued subject or study|0|||
130448816|NCT00826280|469606617|FG002|Overall Study|Sponsor discontinued subject or study|0|||
130448817|NCT00826280|469606615|FG000|Overall Study|Reversible ischemic defect not present|43|||
130448818|NCT00826280|469606616|FG001|Overall Study|Reversible ischemic defect not present|40|||
130448819|NCT00826280|469606617|FG002|Overall Study|Reversible ischemic defect not present|44|||
130448820|NCT00826280|469606615|FG000|Overall Study|Interpretation Failure|1|||
130448821|NCT00826280|469606616|FG001|Overall Study|Interpretation Failure|0|||
130448822|NCT00826280|469606617|FG002|Overall Study|Interpretation Failure|0|||
130448823|NCT00826280|469606615|FG000|Overall Study|Machine Failure|1|||
130448824|NCT00826280|469606616|FG001|Overall Study|Machine Failure|1|||
130448825|NCT00826280|469606617|FG002|Overall Study|Machine Failure|0|||
130448826|NCT00826280|469606615|FG000|Overall Study|One or more non-interpretable scan|0|||
130448827|NCT00826280|469606616|FG001|Overall Study|One or more non-interpretable scan|1|||
130448828|NCT00826280|469606617|FG002|Overall Study|One or more non-interpretable scan|1|||
130448829|NCT03201757|469606618|FG000|Overall Study|Withdrawal by Subject|133|||
130448830|NCT03201757|469606618|FG000|Overall Study|Adverse Event|44|||
130448831|NCT03201757|469606618|FG000|Overall Study|Lost to Follow-up|37|||
130448832|NCT03201757|469606618|FG000|Overall Study|Pregnancy|2|||
130696298|NCT00654186|470512552|FG000|Overall Study|Withdrawal by Subject|5|||
130360518|NCT00543543|469290985|FG000|Extension Study|Adverse Event|0|||
130360519|NCT00543543|469290986|FG001|Extension Study|Adverse Event|0|||
130360520|NCT00543543|469290987|FG002|Extension Study|Adverse Event|0|||
130360521|NCT00543543|469290988|FG003|Extension Study|Adverse Event|5|||
130360522|NCT00543543|469290985|FG000|Extension Study|Lost to Follow-up|0|||
130360523|NCT00543543|469290986|FG001|Extension Study|Lost to Follow-up|0|||
130360524|NCT00543543|469290987|FG002|Extension Study|Lost to Follow-up|0|||
130360525|NCT00543543|469290988|FG003|Extension Study|Lost to Follow-up|77|||
130448833|NCT03201757|469606618|FG000|Overall Study|Lack of Efficacy|1|||
130448834|NCT03201757|469606618|FG000|Overall Study|Protocol Violation|20|||
130448835|NCT03201757|469606618|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
130240228|NCT02394756|468840194|FG001|Period 2|Unsatisfactory Visual Response|0|||
130240229|NCT02394756|468840195|FG002|Period 2|Unsatisfactory Visual Response|0|||
130360526|NCT00543543|469290985|FG000|Extension Study|Physician Decision|0|||
130360527|NCT00543543|469290986|FG001|Extension Study|Physician Decision|0|||
130360528|NCT00543543|469290987|FG002|Extension Study|Physician Decision|0|||
130360529|NCT00543543|469290988|FG003|Extension Study|Physician Decision|7|||
130360530|NCT00543543|469290985|FG000|Extension Study|Pregnancy|0|||
130360531|NCT00543543|469290986|FG001|Extension Study|Pregnancy|0|||
130360532|NCT00543543|469290987|FG002|Extension Study|Pregnancy|0|||
130360533|NCT00543543|469290988|FG003|Extension Study|Pregnancy|6|||
130360534|NCT00543543|469290985|FG000|Extension Study|Protocol Violation|0|||
130360535|NCT00543543|469290986|FG001|Extension Study|Protocol Violation|0|||
130360536|NCT00543543|469290987|FG002|Extension Study|Protocol Violation|0|||
130360537|NCT00543543|469290988|FG003|Extension Study|Protocol Violation|11|||
130360538|NCT00543543|469290985|FG000|Extension Study|Withdrawal by Subject|0|||
130360539|NCT00543543|469290986|FG001|Extension Study|Withdrawal by Subject|0|||
130360540|NCT00543543|469290987|FG002|Extension Study|Withdrawal by Subject|0|||
130360541|NCT00543543|469290988|FG003|Extension Study|Withdrawal by Subject|120|||
130360542|NCT02919696|469290989|FG000|Overall Study|Adverse Event|1|||
130360543|NCT02919696|469290990|FG001|Overall Study|Adverse Event|2|||
130360544|NCT02919696|469290989|FG000|Overall Study|Withdrawal by Subject|2|||
130360545|NCT02919696|469290990|FG001|Overall Study|Withdrawal by Subject|1|||
130360546|NCT02919696|469290989|FG000|Overall Study|Sponsor Decision|1|||
130360547|NCT02919696|469290990|FG001|Overall Study|Sponsor Decision|1|||
130360548|NCT02919696|469290989|FG000|Overall Study|Never Treated|0|||
130360549|NCT02919696|469290990|FG001|Overall Study|Never Treated|1|||
130360550|NCT04308304|469290991|FG000|Overall Study|Withdrawal by Subject|4|||
130360551|NCT04308304|469290992|FG001|Overall Study|Withdrawal by Subject|0|||
130360552|NCT04308304|469290991|FG000|Overall Study|Protocol Violation|1|||
130360553|NCT04308304|469290992|FG001|Overall Study|Protocol Violation|0|||
130360554|NCT00945555|469290993|FG000|Overall Study|Referred to another hospital|5|||
130360555|NCT00945555|469290993|FG000|Overall Study|Worsening condition, intensive care unit|1|||
130360556|NCT00945555|469290993|FG000|Overall Study|Withdrawal by Subject|2|||
130360557|NCT00945555|469290993|FG000|Overall Study|Participant continued treatment at home|1|||
130360558|NCT00945555|469290993|FG000|Overall Study|Death|18|||
130360559|NCT00945555|469290993|FG000|Overall Study|Other|1|||
130360560|NCT00484094|469290994|FG000|Overall Study|Discontinued|39|||
130360561|NCT00484094|469290994|FG000|Overall Study|Other|3|||
130360562|NCT01414608|469290995|FG000|Overall Study|Ineligible|5|||
130360563|NCT01414608|469290996|FG001|Overall Study|Ineligible|2|||
130360564|NCT01686828|469290997|FG000|Overall Study|Physician Decision|1|||
130360565|NCT01686828|469290998|FG001|Overall Study|Physician Decision|0|||
130360566|NCT01686828|469290999|FG002|Overall Study|Physician Decision|0|||
130360567|NCT01686828|469291000|FG003|Overall Study|Physician Decision|0|||
130360568|NCT01686828|469290997|FG000|Overall Study|New Job|0|||
130360569|NCT01686828|469290998|FG001|Overall Study|New Job|1|||
130360570|NCT01686828|469290999|FG002|Overall Study|New Job|0|||
130360571|NCT01686828|469291000|FG003|Overall Study|New Job|0|||
130360572|NCT01686828|469290997|FG000|Overall Study|Weight Loss|0|||
130360573|NCT01686828|469290998|FG001|Overall Study|Weight Loss|0|||
130360574|NCT01686828|469290999|FG002|Overall Study|Weight Loss|1|||
130360575|NCT01686828|469291000|FG003|Overall Study|Weight Loss|0|||
130360576|NCT04176705|469291003|FG000|Overall Study|Withdrawal by Subject|4|||
130360577|NCT04176705|469291004|FG001|Overall Study|Withdrawal by Subject|4|||
130360578|NCT04176705|469291003|FG000|Overall Study|Death|1|||
130360579|NCT04176705|469291004|FG001|Overall Study|Death|1|||
130360580|NCT04176705|469291003|FG000|Overall Study|Lost to Follow-up|3|||
130360581|NCT04176705|469291004|FG001|Overall Study|Lost to Follow-up|3|||
130360582|NCT01193842|469291006|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130360583|NCT01193842|469291007|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
130360584|NCT01193842|469291008|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130360585|NCT01193842|469291009|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130360586|NCT01193842|469291010|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130360587|NCT01193842|469291006|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
130360588|NCT01193842|469291007|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130240230|NCT02394756|468840196|FG003|Period 2|Unsatisfactory Visual Response|0|||
130360589|NCT01193842|469291008|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130360590|NCT01193842|469291009|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130360591|NCT01193842|469291010|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130360592|NCT01193842|469291006|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130360593|NCT01193842|469291007|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130360594|NCT01193842|469291008|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
130360595|NCT01193842|469291009|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130360596|NCT01193842|469291010|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130360597|NCT01193842|469291006|FG000|Phase II: Randomized Groups|Death|0|||
130360598|NCT01193842|469291007|FG001|Phase II: Randomized Groups|Death|0|||
130360599|NCT01193842|469291008|FG002|Phase II: Randomized Groups|Death|0|||
130448836|NCT03201757|469606618|FG000|Overall Study|Not Yet Determined|5|||
130448837|NCT03201757|469606618|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
130448838|NCT03201757|469606618|FG000|Overall Study|Other|20|||
130448839|NCT02297503|469606619|FG000|Overall Study|Withdrawal by Subject|1|||
130448840|NCT02297503|469606620|FG001|Overall Study|Withdrawal by Subject|1|||
130448841|NCT02297503|469606619|FG000|Overall Study|Protocol Violation|1|||
130448842|NCT02297503|469606620|FG001|Overall Study|Protocol Violation|0|||
130448843|NCT02297503|469606619|FG000|Overall Study|Pregnancy|0|||
130448844|NCT02297503|469606620|FG001|Overall Study|Pregnancy|1|||
130448845|NCT02297503|469606619|FG000|Overall Study|Lost to Follow-up|0|||
130448846|NCT02297503|469606620|FG001|Overall Study|Lost to Follow-up|1|||
130448847|NCT02297503|469606619|FG000|Overall Study|Medical reason|0|||
130448848|NCT02297503|469606620|FG001|Overall Study|Medical reason|1|||
130448849|NCT02788656|469606622|FG000|Overall Study|Withdrawal by Subject|1|||
130448850|NCT02788656|469606623|FG001|Overall Study|Withdrawal by Subject|0|||
130448851|NCT02263885|469606624|FG000|Overall Study|Withdrawal by Subject|7|||
130448852|NCT02263885|469606624|FG000|Overall Study|Alternative Treatment|3|||
130448853|NCT01403987|469606632|FG000|Overall Study|Residents forgot their secret PIN|18|||
130448854|NCT01403987|469606633|FG001|Overall Study|Residents forgot their secret PIN|17|||
130448855|NCT01403987|469606634|FG002|Overall Study|Residents forgot their secret PIN|18|||
130448856|NCT00180674|469606636|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
130448857|NCT00180674|469606636|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
130448858|NCT00372528|469606638|FG000|Overall Study|Lack of Efficacy|1|||
130448859|NCT00372528|469606638|FG000|Overall Study|Adverse Event|1|||
130448860|NCT00372528|469606638|FG000|Overall Study|Study Terminated by Sponsor|18|||
130448861|NCT00372528|469606638|FG000|Overall Study|Other|1|||
130448862|NCT02240680|469606639|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
130448863|NCT02240680|469606640|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
130448864|NCT02240680|469606641|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
130448865|NCT02240680|469606642|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
130448866|NCT02240680|469606639|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
130448867|NCT02240680|469606640|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
130448868|NCT02240680|469606641|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
130448869|NCT02240680|469606642|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
130448870|NCT02240680|469606639|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
130448871|NCT02240680|469606640|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
130448872|NCT02240680|469606641|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
130448873|NCT02240680|469606642|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
130448874|NCT02240680|469606639|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
130448875|NCT02240680|469606640|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
130448876|NCT02240680|469606641|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
130448877|NCT02240680|469606642|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
130448878|NCT02240680|469606639|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
130448879|NCT02240680|469606640|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
130448880|NCT02240680|469606641|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
130448881|NCT02240680|469606642|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
130448882|NCT02240680|469606639|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
130448883|NCT02240680|469606640|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
130448884|NCT02240680|469606641|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
130448885|NCT02240680|469606642|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
130448886|NCT02240680|469606639|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
130448887|NCT02240680|469606640|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
130448888|NCT02240680|469606641|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
130448889|NCT02240680|469606642|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
130448890|NCT02240680|469606639|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
130448891|NCT02240680|469606640|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
130448892|NCT02240680|469606641|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
130448893|NCT02240680|469606642|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
130448894|NCT00562965|469606643|FG000|Overall Study|Withdrawal by Subject|0|||
130448895|NCT00562965|469606644|FG001|Overall Study|Withdrawal by Subject|1|||
130448896|NCT00562965|469606643|FG000|Overall Study|Death|2|||
130448897|NCT00562965|469606644|FG001|Overall Study|Death|4|||
130448898|NCT00562965|469606643|FG000|Overall Study|Lost to Follow-up|1|||
130448899|NCT00562965|469606644|FG001|Overall Study|Lost to Follow-up|0|||
130448900|NCT00562965|469606643|FG000|Overall Study|Other|0|||
130448901|NCT00562965|469606644|FG001|Overall Study|Other|1|||
130448902|NCT00965484|469606648|FG000|Overall Study|Protocol Violation|1|||
130448903|NCT00965484|469606648|FG000|Overall Study|Withdrawal by Subject|1|||
130448904|NCT00848211|469606649|FG000|Overall Study|Protocol Violation|0|||
130448905|NCT00848211|469606650|FG001|Overall Study|Protocol Violation|1|||
130448906|NCT00848211|469606651|FG002|Overall Study|Protocol Violation|1|||
130448907|NCT00848211|469606652|FG003|Overall Study|Protocol Violation|0|||
130448908|NCT00848211|469606649|FG000|Overall Study|Adverse Event|0|||
130696299|NCT00577655|470512553|FG000|Overall Study|Patient Request|0|||
130696300|NCT00577655|470512554|FG001|Overall Study|Patient Request|2|||
130696301|NCT00577655|470512553|FG000|Overall Study|Protocol Violation|0|||
130696302|NCT00577655|470512554|FG001|Overall Study|Protocol Violation|1|||
130696303|NCT00577655|470512553|FG000|Overall Study|Lost to Follow-up|1|||
130696304|NCT00577655|470512554|FG001|Overall Study|Lost to Follow-up|1|||
130696305|NCT00875524|470512556|FG000|Overall Study|Serious adverse event|0|||
130696306|NCT00875524|470512557|FG001|Overall Study|Serious adverse event|1|||
130696307|NCT00875524|470512556|FG000|Overall Study|Protocol Violation|4|||
130696308|NCT00875524|470512557|FG001|Overall Study|Protocol Violation|0|||
130696309|NCT00875524|470512556|FG000|Overall Study|Lost to Follow-up|1|||
130696310|NCT00875524|470512557|FG001|Overall Study|Lost to Follow-up|0|||
130696311|NCT00875524|470512556|FG000|Overall Study|Withdrawal by Subject|3|||
130696312|NCT00875524|470512557|FG001|Overall Study|Withdrawal by Subject|5|||
130696313|NCT01370863|470512558|FG000|Overall Study|Adverse Event|1|||
130696314|NCT01370863|470512559|FG001|Overall Study|Adverse Event|1|||
130696315|NCT01370863|470512558|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
130696316|NCT01370863|470512559|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
130696317|NCT01370863|470512558|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130696318|NCT01370863|470512559|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130696319|NCT01143337|470512560|FG000|Overall Study|Adverse Event|3|||
130696320|NCT01143337|470512561|FG001|Overall Study|Adverse Event|9|||
130696321|NCT01143337|470512562|FG002|Overall Study|Adverse Event|5|||
130696322|NCT01143337|470512560|FG000|Overall Study|Lack of Efficacy|6|||
130696323|NCT01143337|470512561|FG001|Overall Study|Lack of Efficacy|2|||
130696324|NCT01143337|470512562|FG002|Overall Study|Lack of Efficacy|1|||
130696325|NCT01143337|470512560|FG000|Overall Study|Protocol Violation|1|||
130696326|NCT01143337|470512561|FG001|Overall Study|Protocol Violation|0|||
130696327|NCT01143337|470512562|FG002|Overall Study|Protocol Violation|0|||
130696328|NCT01143337|470512560|FG000|Overall Study|Withdrawal by Subject|0|||
130696329|NCT01143337|470512561|FG001|Overall Study|Withdrawal by Subject|0|||
130696330|NCT01143337|470512562|FG002|Overall Study|Withdrawal by Subject|1|||
130696331|NCT01143337|470512560|FG000|Overall Study|Other reason|0|||
130240231|NCT02394756|468840197|FG004|Period 2|Unsatisfactory Visual Response|1|||
130696332|NCT01143337|470512561|FG001|Overall Study|Other reason|0|||
130696333|NCT01143337|470512562|FG002|Overall Study|Other reason|5|||
130696334|NCT00406393|470512572|FG000|Overall Study|Did not undergo transplantation|2|||
130696335|NCT00406393|470512573|FG001|Overall Study|Did not undergo transplantation|1|||
130696336|NCT01597791|470512574|FG000|Overall Study|Physician Decision|2|||
130696337|NCT01597791|470512575|FG001|Overall Study|Physician Decision|1|||
130696338|NCT01597791|470512574|FG000|Overall Study|Cesarean Section|6|||
130240232|NCT02394756|468840198|FG005|Period 2|Unsatisfactory Visual Response|0|||
130240233|NCT02335944|468840199|FG000|Treatment Phase|Progressive Disease|2|||
130240234|NCT02335944|468840200|FG001|Treatment Phase|Progressive Disease|5|||
130240235|NCT02335944|468840201|FG002|Treatment Phase|Progressive Disease|2|||
130240236|NCT02335944|468840202|FG003|Treatment Phase|Progressive Disease|11|||
130552931|NCT02520284|469991627|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
130360600|NCT01193842|469291009|FG003|Phase II: Randomized Groups|Death|1|||
130696339|NCT01597791|470512575|FG001|Overall Study|Cesarean Section|7|||
130696340|NCT01597791|470512574|FG000|Overall Study|Subject withdrawal|0|||
130552932|NCT02520284|469991628|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
130360601|NCT01193842|469291010|FG004|Phase II: Randomized Groups|Death|1|||
130360602|NCT01193842|469291006|FG000|Phase II: Randomized Groups|Adverse Event|0|||
130360603|NCT01193842|469291007|FG001|Phase II: Randomized Groups|Adverse Event|0|||
130360604|NCT01193842|469291008|FG002|Phase II: Randomized Groups|Adverse Event|0|||
130360605|NCT01193842|469291009|FG003|Phase II: Randomized Groups|Adverse Event|5|||
130360606|NCT01193842|469291010|FG004|Phase II: Randomized Groups|Adverse Event|3|||
130360607|NCT01193842|469291006|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130360608|NCT01193842|469291007|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130360609|NCT01193842|469291008|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130360610|NCT01193842|469291009|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
130360611|NCT01193842|469291010|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
130360612|NCT01193842|469291006|FG000|Phase II: Randomized Groups|Ineligible|0|||
130360613|NCT01193842|469291007|FG001|Phase II: Randomized Groups|Ineligible|0|||
130360614|NCT01193842|469291008|FG002|Phase II: Randomized Groups|Ineligible|0|||
130360615|NCT01193842|469291009|FG003|Phase II: Randomized Groups|Ineligible|0|||
130360616|NCT01193842|469291010|FG004|Phase II: Randomized Groups|Ineligible|1|||
130552933|NCT02520284|469991629|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
130696341|NCT01597791|470512575|FG001|Overall Study|Subject withdrawal|1|||
130696342|NCT01597791|470512574|FG000|Overall Study|Protocol Violation|0|||
130696343|NCT01597791|470512575|FG001|Overall Study|Protocol Violation|1|||
130360617|NCT01193842|469291006|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130376595|NCT00963547|469345866|FG002|Overall Study|Physician Decision|0|||
130696344|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
130696345|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
130696346|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130696347|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130696348|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130696349|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130696350|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
130696351|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
130696352|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
130696353|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
130696354|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
130696355|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
130696356|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
130696357|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
130696358|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
130696359|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
130696360|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
130696361|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
130696362|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
130696363|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
130696364|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
130696365|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
130696366|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
130696367|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
130696368|NCT01151618|470512578|FG000|Overall Study|Adverse Event|2|||
130696369|NCT01151618|470512578|FG000|Overall Study|Withdrawal by Subject|7|||
130696370|NCT01632306|470512579|FG000|Overall Study|Protocol Violation|1|||
130696371|NCT01632306|470512580|FG001|Overall Study|Protocol Violation|0|||
130696372|NCT01632306|470512581|FG002|Overall Study|Protocol Violation|0|||
130696373|NCT01663896|470512584|FG000|Overall Study|Various reasons|43|||
130696374|NCT01451541|470512585|FG000|Overall Study|Adverse Event|4|||
130696375|NCT01451541|470512586|FG001|Overall Study|Adverse Event|3|||
130696376|NCT01451541|470512587|FG002|Overall Study|Adverse Event|6|||
130696377|NCT01451541|470512585|FG000|Overall Study|Lack of Efficacy|2|||
130696378|NCT01451541|470512586|FG001|Overall Study|Lack of Efficacy|0|||
130696379|NCT01451541|470512587|FG002|Overall Study|Lack of Efficacy|0|||
130696380|NCT01451541|470512585|FG000|Overall Study|Lost to Follow-up|4|||
130696381|NCT01451541|470512586|FG001|Overall Study|Lost to Follow-up|4|||
130696382|NCT01451541|470512587|FG002|Overall Study|Lost to Follow-up|7|||
130696383|NCT01451541|470512585|FG000|Overall Study|Withdrawal by Subject|15|||
130696384|NCT01451541|470512586|FG001|Overall Study|Withdrawal by Subject|8|||
130696385|NCT01451541|470512587|FG002|Overall Study|Withdrawal by Subject|6|||
130696386|NCT01451541|470512585|FG000|Overall Study|randomization error, noncompliance|11|||
130448909|NCT00848211|469606650|FG001|Overall Study|Adverse Event|0|||
130448910|NCT00848211|469606651|FG002|Overall Study|Adverse Event|0|||
130448911|NCT00848211|469606652|FG003|Overall Study|Adverse Event|0|||
130448912|NCT01124617|469606653|FG000|Overall Study|Adverse Event|5|||
130448913|NCT01124617|469606654|FG001|Overall Study|Adverse Event|2|||
130448914|NCT01124617|469606653|FG000|Overall Study|Lack of Efficacy|2|||
130448915|NCT01124617|469606654|FG001|Overall Study|Lack of Efficacy|1|||
130448916|NCT01124617|469606653|FG000|Overall Study|Protocol Violation|1|||
130448917|NCT01124617|469606654|FG001|Overall Study|Protocol Violation|1|||
130448918|NCT01124617|469606653|FG000|Overall Study|Withdrawal by Subject|9|||
130448919|NCT01124617|469606654|FG001|Overall Study|Withdrawal by Subject|1|||
130696387|NCT01451541|470512586|FG001|Overall Study|randomization error, noncompliance|10|||
130696388|NCT01451541|470512587|FG002|Overall Study|randomization error, noncompliance|8|||
130696389|NCT03366428|470512588|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
130696390|NCT03366428|470512588|FG000|Overall Study|Adverse Event|12|||
130696391|NCT03366428|470512588|FG000|Overall Study|Clinical progression|2|||
130696392|NCT03366428|470512588|FG000|Overall Study|Withdrawal by Subject|4|||
130696393|NCT01046084|470512592|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
130696394|NCT01046084|470512593|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
130696395|NCT00379353|470512594|FG000|Overall Study|Hospitalization|3|||
130696396|NCT00379353|470512595|FG001|Overall Study|Hospitalization|3|||
130696397|NCT00379353|470512594|FG000|Overall Study|Withdrawal by Subject|5|||
130448920|NCT01124617|469606653|FG000|Overall Study|Other|2|||
130696398|NCT00379353|470512595|FG001|Overall Study|Withdrawal by Subject|2|||
130696399|NCT00379353|470512594|FG000|Overall Study|Death|1|||
130696400|NCT00379353|470512595|FG001|Overall Study|Death|0|||
130696401|NCT00379353|470512594|FG000|Overall Study|Cardiac Tamponade|1|||
130696402|NCT00379353|470512595|FG001|Overall Study|Cardiac Tamponade|0|||
130696403|NCT00379353|470512594|FG000|Overall Study|Non-compliance|1|||
130696404|NCT00379353|470512595|FG001|Overall Study|Non-compliance|0|||
130696405|NCT00379353|470512594|FG000|Overall Study|Conflicting drug treatment|0|||
130696406|NCT00379353|470512595|FG001|Overall Study|Conflicting drug treatment|1|||
130448921|NCT01124617|469606654|FG001|Overall Study|Other|1|||
130448922|NCT00945477|469606655|FG000|Overall Study|Adverse Event|3|||
130696407|NCT03614728|470512596|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
130552934|NCT02520284|469991627|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
130552935|NCT02520284|469991628|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
130552936|NCT02520284|469991629|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
130552937|NCT02520284|469991627|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
130552938|NCT02520284|469991628|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
130552939|NCT02520284|469991629|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
130552940|NCT02520284|469991627|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
130552941|NCT02520284|469991628|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
130552942|NCT02520284|469991629|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
130552943|NCT02520284|469991627|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
130552944|NCT02520284|469991628|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
130552945|NCT02520284|469991629|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
130552946|NCT02520284|469991627|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
130552947|NCT02520284|469991628|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
130552948|NCT02520284|469991629|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
130552949|NCT01898923|469991630|FG000|Overall Study|Lack of Efficacy|5|||
130552950|NCT01898923|469991631|FG001|Overall Study|Lack of Efficacy|6|||
130552951|NCT01898923|469991630|FG000|Overall Study|Adverse Event|3|||
130552952|NCT01898923|469991631|FG001|Overall Study|Adverse Event|1|||
130552953|NCT01898923|469991630|FG000|Overall Study|Lost to Follow-up|0|||
130552954|NCT01898923|469991631|FG001|Overall Study|Lost to Follow-up|1|||
130552955|NCT01898923|469991630|FG000|Overall Study|Withdrawal by Subject|4|||
130552956|NCT01898923|469991631|FG001|Overall Study|Withdrawal by Subject|7|||
130552957|NCT01898923|469991630|FG000|Overall Study|Physician Decision|3|||
130552958|NCT01898923|469991631|FG001|Overall Study|Physician Decision|4|||
130552959|NCT01898923|469991630|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
130552960|NCT01898923|469991631|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
130552961|NCT00547365|469991636|FG000|Overall Study|Physician Decision|1|||
130552962|NCT00547365|469991636|FG000|Overall Study|Lost to Follow-up|1|||
130552963|NCT00547365|469991636|FG000|Overall Study|Protocol Violation|2|||
130552964|NCT00547365|469991636|FG000|Overall Study|death (not related to study)|4|||
130552965|NCT00504881|469991637|FG000|Overall Study|Lack of Efficacy|1|||
130552966|NCT00504881|469991638|FG001|Overall Study|Lack of Efficacy|5|||
130240237|NCT02335944|468840203|FG004|Treatment Phase|Progressive Disease|4|||
130240238|NCT02335944|468840204|FG005|Treatment Phase|Progressive Disease|25|||
130360618|NCT01193842|469291007|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130360619|NCT01193842|469291008|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130360620|NCT01193842|469291009|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
130360621|NCT01193842|469291010|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
130360622|NCT03698331|469291011|FG000|Overall Study|Adverse Event|2|||
130360623|NCT03698331|469291012|FG001|Overall Study|Adverse Event|3|||
130360624|NCT03698331|469291011|FG000|Overall Study|Withdrawal by Subject|1|||
130360625|NCT03698331|469291012|FG001|Overall Study|Withdrawal by Subject|1|||
130360626|NCT03698331|469291011|FG000|Overall Study|Lost to Follow-up|0|||
130360627|NCT03698331|469291012|FG001|Overall Study|Lost to Follow-up|2|||
130360628|NCT03698331|469291011|FG000|Overall Study|Non-compliance with study drug|1|||
130360629|NCT03698331|469291012|FG001|Overall Study|Non-compliance with study drug|0|||
130360630|NCT01467583|469291013|FG000|Overall Study|Death|1|||
130360631|NCT01467583|469291014|FG001|Overall Study|Death|1|||
130360632|NCT01467583|469291015|FG002|Overall Study|Death|0|||
130360633|NCT01467583|469291013|FG000|Overall Study|Withdrawal by Subject|1|||
130360634|NCT01467583|469291014|FG001|Overall Study|Withdrawal by Subject|0|||
130448923|NCT00945477|469606655|FG000|Overall Study|Lack of Efficacy|2|||
130448924|NCT00945477|469606655|FG000|Overall Study|Withdrawal by Subject|1|||
130448925|NCT00619151|469606656|FG000|Overall Study|Study terminated prior to followup|1|||
130448926|NCT00619151|469606657|FG001|Overall Study|Study terminated prior to followup|0|||
130448927|NCT02825043|469606658|FG000|Overall Study|Lost to Follow-up|4|||
130448928|NCT03582137|469606661|FG000|Overall Study|Adverse Event|1|||
130448929|NCT03582137|469606662|FG001|Overall Study|Adverse Event|0|||
130448930|NCT01982760|469606664|FG000|Overall Study|Physician Decision|1|||
130448931|NCT01982760|469606665|FG001|Overall Study|Physician Decision|0|||
130448932|NCT03704298|469606668|FG000|Overall Study|Death|3|||
130448933|NCT03704298|469606669|FG001|Overall Study|Death|1|||
130448934|NCT03704298|469606670|FG002|Overall Study|Death|1|||
130448935|NCT03704298|469606671|FG003|Overall Study|Death|0|||
130448936|NCT03704298|469606668|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
130448937|NCT03704298|469606669|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
130448938|NCT03704298|469606670|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
130448939|NCT03704298|469606671|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
130448940|NCT03704298|469606668|FG000|Overall Study|Withdrawal by Subject|1|||
130448941|NCT03704298|469606669|FG001|Overall Study|Withdrawal by Subject|0|||
130240239|NCT02335944|468840205|FG006|Treatment Phase|Progressive Disease|2|||
130240240|NCT02335944|468840206|FG007|Treatment Phase|Progressive Disease|30|||
130240241|NCT02335944|468840207|FG008|Treatment Phase|Progressive Disease|27|||
130240242|NCT02335944|468840208|FG009|Treatment Phase|Progressive Disease|0|||
130240243|NCT02335944|468840199|FG000|Treatment Phase|Adverse Event|2|||
130240244|NCT02335944|468840200|FG001|Treatment Phase|Adverse Event|0|||
130240245|NCT02335944|468840201|FG002|Treatment Phase|Adverse Event|0|||
130240246|NCT02335944|468840202|FG003|Treatment Phase|Adverse Event|2|||
130240247|NCT02335944|468840203|FG004|Treatment Phase|Adverse Event|1|||
130240248|NCT02335944|468840204|FG005|Treatment Phase|Adverse Event|15|||
130240249|NCT02335944|468840205|FG006|Treatment Phase|Adverse Event|0|||
130240250|NCT02335944|468840206|FG007|Treatment Phase|Adverse Event|5|||
130240251|NCT02335944|468840207|FG008|Treatment Phase|Adverse Event|7|||
130240252|NCT02335944|468840208|FG009|Treatment Phase|Adverse Event|0|||
130240253|NCT02335944|468840199|FG000|Treatment Phase|Physician Decision|0|||
130240254|NCT02335944|468840200|FG001|Treatment Phase|Physician Decision|0|||
130240255|NCT02335944|468840201|FG002|Treatment Phase|Physician Decision|0|||
130240256|NCT02335944|468840202|FG003|Treatment Phase|Physician Decision|1|||
130240257|NCT02335944|468840203|FG004|Treatment Phase|Physician Decision|0|||
130240258|NCT02335944|468840204|FG005|Treatment Phase|Physician Decision|6|||
130240259|NCT02335944|468840205|FG006|Treatment Phase|Physician Decision|1|||
130240260|NCT02335944|468840206|FG007|Treatment Phase|Physician Decision|2|||
130240261|NCT02335944|468840207|FG008|Treatment Phase|Physician Decision|1|||
130240262|NCT02335944|468840208|FG009|Treatment Phase|Physician Decision|0|||
130240263|NCT02335944|468840199|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
130240264|NCT02335944|468840200|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
130360635|NCT01467583|469291015|FG002|Overall Study|Withdrawal by Subject|0|||
130360636|NCT01467583|469291013|FG000|Overall Study|Protocol Violation|0|||
130360637|NCT01467583|469291014|FG001|Overall Study|Protocol Violation|0|||
130360638|NCT01467583|469291015|FG002|Overall Study|Protocol Violation|2|||
130360639|NCT02130024|469291016|FG000|Overall Study|Adverse Event|10|||
130360640|NCT02130024|469291017|FG001|Overall Study|Adverse Event|11|||
130360641|NCT02130024|469291016|FG000|Overall Study|Death|2|||
130360642|NCT02130024|469291017|FG001|Overall Study|Death|2|||
130360643|NCT02130024|469291016|FG000|Overall Study|Lost to Follow-up|1|||
130360644|NCT02130024|469291017|FG001|Overall Study|Lost to Follow-up|1|||
130360645|NCT02130024|469291016|FG000|Overall Study|Physician Decision|1|||
130360646|NCT02130024|469291017|FG001|Overall Study|Physician Decision|3|||
130360647|NCT02130024|469291016|FG000|Overall Study|Protocol Deviation|4|||
130360648|NCT02130024|469291017|FG001|Overall Study|Protocol Deviation|0|||
130360649|NCT02130024|469291016|FG000|Overall Study|Site Administration Problems|1|||
130360650|NCT02130024|469291017|FG001|Overall Study|Site Administration Problems|0|||
130360651|NCT02130024|469291016|FG000|Overall Study|Subject Withdrew Consent|6|||
130360652|NCT02130024|469291017|FG001|Overall Study|Subject Withdrew Consent|14|||
130360653|NCT05274165|469291018|FG000|Overall Study|Withdrawal by Subject|3|||
130360654|NCT05274165|469291019|FG001|Overall Study|Withdrawal by Subject|3|||
130360655|NCT02484690|469291020|FG000|Overall Study|Adverse Event|1|||
130360656|NCT02484690|469291021|FG001|Overall Study|Adverse Event|3|||
130360657|NCT02484690|469291022|FG002|Overall Study|Adverse Event|0|||
130360658|NCT02484690|469291023|FG003|Overall Study|Adverse Event|0|||
130360659|NCT02484690|469291024|FG004|Overall Study|Adverse Event|5|||
130360660|NCT02484690|469291020|FG000|Overall Study|Death|0|||
130360661|NCT02484690|469291021|FG001|Overall Study|Death|0|||
130360662|NCT02484690|469291022|FG002|Overall Study|Death|0|||
130360663|NCT02484690|469291023|FG003|Overall Study|Death|0|||
130360664|NCT02484690|469291024|FG004|Overall Study|Death|1|||
130360665|NCT02484690|469291020|FG000|Overall Study|Withdrawal by Subject|1|||
130360666|NCT02484690|469291021|FG001|Overall Study|Withdrawal by Subject|3|||
130360667|NCT02484690|469291022|FG002|Overall Study|Withdrawal by Subject|1|||
130360668|NCT02484690|469291023|FG003|Overall Study|Withdrawal by Subject|2|||
130360669|NCT02484690|469291024|FG004|Overall Study|Withdrawal by Subject|0|||
130360670|NCT02484690|469291020|FG000|Overall Study|Physician Decision|2|||
130360671|NCT02484690|469291021|FG001|Overall Study|Physician Decision|0|||
130360672|NCT02484690|469291022|FG002|Overall Study|Physician Decision|1|||
130360673|NCT02484690|469291023|FG003|Overall Study|Physician Decision|0|||
130240265|NCT02335944|468840201|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
130240266|NCT02335944|468840202|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
130240267|NCT02335944|468840203|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
130240268|NCT02335944|468840204|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
130240269|NCT02335944|468840205|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
130240270|NCT02335944|468840206|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
130240271|NCT02335944|468840207|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
130360674|NCT02484690|469291024|FG004|Overall Study|Physician Decision|0|||
130360675|NCT02484690|469291020|FG000|Overall Study|Lost to Follow-up|0|||
130360676|NCT02484690|469291021|FG001|Overall Study|Lost to Follow-up|0|||
130360677|NCT02484690|469291022|FG002|Overall Study|Lost to Follow-up|1|||
130360678|NCT02484690|469291023|FG003|Overall Study|Lost to Follow-up|0|||
130240272|NCT02335944|468840208|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
130240273|NCT02335944|468840199|FG000|Treatment Phase|Subject/Guardian Decision|0|||
130240274|NCT02335944|468840200|FG001|Treatment Phase|Subject/Guardian Decision|0|||
130240275|NCT02335944|468840201|FG002|Treatment Phase|Subject/Guardian Decision|1|||
130240276|NCT02335944|468840202|FG003|Treatment Phase|Subject/Guardian Decision|0|||
130240277|NCT02335944|468840203|FG004|Treatment Phase|Subject/Guardian Decision|0|||
130240278|NCT02335944|468840204|FG005|Treatment Phase|Subject/Guardian Decision|1|||
130240279|NCT02335944|468840205|FG006|Treatment Phase|Subject/Guardian Decision|0|||
130240280|NCT02335944|468840206|FG007|Treatment Phase|Subject/Guardian Decision|4|||
130240281|NCT02335944|468840207|FG008|Treatment Phase|Subject/Guardian Decision|0|||
130240282|NCT02335944|468840208|FG009|Treatment Phase|Subject/Guardian Decision|0|||
130240283|NCT02335944|468840199|FG000|Post-treatment Follow-up|Progressive Disease|0|||
130240284|NCT02335944|468840200|FG001|Post-treatment Follow-up|Progressive Disease|0|||
130240285|NCT02335944|468840201|FG002|Post-treatment Follow-up|Progressive Disease|0|||
130240286|NCT02335944|468840202|FG003|Post-treatment Follow-up|Progressive Disease|1|||
130240287|NCT02335944|468840203|FG004|Post-treatment Follow-up|Progressive Disease|0|||
130240288|NCT02335944|468840204|FG005|Post-treatment Follow-up|Progressive Disease|9|||
130240289|NCT02335944|468840205|FG006|Post-treatment Follow-up|Progressive Disease|0|||
130240290|NCT02335944|468840206|FG007|Post-treatment Follow-up|Progressive Disease|2|||
130240291|NCT02335944|468840207|FG008|Post-treatment Follow-up|Progressive Disease|3|||
130240292|NCT02335944|468840208|FG009|Post-treatment Follow-up|Progressive Disease|0|||
130240293|NCT02335944|468840199|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130360679|NCT02484690|469291024|FG004|Overall Study|Lost to Follow-up|0|||
130360680|NCT04916769|469291028|FG000|Period 1|Physician Decision|0|||
130360681|NCT04916769|469291029|FG001|Period 1|Physician Decision|0|||
130360682|NCT04916769|469291030|FG002|Period 1|Physician Decision|0|||
130360683|NCT04916769|469291031|FG003|Period 1|Physician Decision|0|||
130360684|NCT04916769|469291032|FG004|Period 1|Physician Decision|0|||
130360685|NCT04916769|469291033|FG005|Period 1|Physician Decision|1|||
130360686|NCT04916769|469291028|FG000|Period 2|Physician Decision|0|||
130360687|NCT04916769|469291029|FG001|Period 2|Physician Decision|1|||
130360688|NCT04916769|469291030|FG002|Period 2|Physician Decision|0|||
130360689|NCT04916769|469291031|FG003|Period 2|Physician Decision|0|||
130360690|NCT04916769|469291032|FG004|Period 2|Physician Decision|0|||
130360691|NCT04916769|469291033|FG005|Period 2|Physician Decision|0|||
130360692|NCT03672643|469291046|FG000|Overall Study|Adverse Event|3|||
130360693|NCT03672643|469291046|FG000|Overall Study|Death|2|||
130360694|NCT03672643|469291046|FG000|Overall Study|Withdrawal by Subject|1|||
130360695|NCT03672643|469291046|FG000|Overall Study|Progressive disease|11|||
130360696|NCT03672643|469291046|FG000|Overall Study|Global deterioration of health status|1|||
130360697|NCT03672643|469291046|FG000|Overall Study|Refused further treatment|7|||
130360698|NCT03672643|469291046|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
130360699|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
130360700|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360701|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360702|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360703|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360704|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360705|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130360706|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
130360707|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360708|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360709|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360710|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360711|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360712|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130360713|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
130240294|NCT02335944|468840200|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240295|NCT02335944|468840201|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240296|NCT02335944|468840202|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240297|NCT02335944|468840203|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240298|NCT02335944|468840204|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
130240299|NCT02335944|468840205|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240300|NCT02335944|468840206|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240301|NCT02335944|468840207|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240302|NCT02335944|468840208|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240303|NCT02335944|468840199|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240304|NCT02335944|468840200|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240305|NCT02335944|468840201|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240306|NCT02335944|468840202|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240307|NCT02335944|468840203|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240308|NCT02335944|468840204|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240309|NCT02335944|468840205|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240310|NCT02335944|468840206|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
130240311|NCT02335944|468840207|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240312|NCT02335944|468840208|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240313|NCT02335944|468840199|FG000|Post-treatment Follow-up|Adverse Event|0|||
130240314|NCT02335944|468840200|FG001|Post-treatment Follow-up|Adverse Event|0|||
130240315|NCT02335944|468840201|FG002|Post-treatment Follow-up|Adverse Event|0|||
130240316|NCT02335944|468840202|FG003|Post-treatment Follow-up|Adverse Event|0|||
130240317|NCT02335944|468840203|FG004|Post-treatment Follow-up|Adverse Event|0|||
130240318|NCT02335944|468840204|FG005|Post-treatment Follow-up|Adverse Event|1|||
130240319|NCT02335944|468840205|FG006|Post-treatment Follow-up|Adverse Event|0|||
130240320|NCT02335944|468840206|FG007|Post-treatment Follow-up|Adverse Event|0|||
130240321|NCT02335944|468840207|FG008|Post-treatment Follow-up|Adverse Event|0|||
130240322|NCT02335944|468840208|FG009|Post-treatment Follow-up|Adverse Event|0|||
130240323|NCT02335944|468840199|FG000|Post-treatment Follow-up|Death|0|||
130240324|NCT02335944|468840200|FG001|Post-treatment Follow-up|Death|0|||
130240325|NCT02335944|468840201|FG002|Post-treatment Follow-up|Death|0|||
130240326|NCT02335944|468840202|FG003|Post-treatment Follow-up|Death|1|||
130240327|NCT02335944|468840203|FG004|Post-treatment Follow-up|Death|0|||
130240328|NCT02335944|468840204|FG005|Post-treatment Follow-up|Death|1|||
130240329|NCT02335944|468840205|FG006|Post-treatment Follow-up|Death|0|||
130240330|NCT02335944|468840206|FG007|Post-treatment Follow-up|Death|0|||
130240331|NCT02335944|468840207|FG008|Post-treatment Follow-up|Death|0|||
130240332|NCT02335944|468840208|FG009|Post-treatment Follow-up|Death|0|||
130696408|NCT03614728|470512597|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130696409|NCT03614728|470512598|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130696410|NCT03614728|470512599|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130240333|NCT02335944|468840199|FG000|Post-treatment Follow-up|Physician Decision|1|||
130240334|NCT02335944|468840200|FG001|Post-treatment Follow-up|Physician Decision|0|||
130240335|NCT02335944|468840201|FG002|Post-treatment Follow-up|Physician Decision|0|||
130240336|NCT02335944|468840202|FG003|Post-treatment Follow-up|Physician Decision|0|||
130360714|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360715|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360716|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360717|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360718|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360719|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130360720|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
130360721|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360722|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360723|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360724|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360725|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360726|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130360727|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
130360728|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130360729|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130360730|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130696411|NCT03614728|470512596|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696412|NCT03614728|470512597|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
130696413|NCT03614728|470512598|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696414|NCT03614728|470512599|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696415|NCT01958476|470512600|FG000|Overall Study|Parent requested exclusion from analysis|1|||
130696416|NCT01958476|470512601|FG001|Overall Study|Parent requested exclusion from analysis|0|||
130696417|NCT01824576|470512602|FG000|Overall Study|Device deficiency|2|||
130696418|NCT05412121|470512603|FG000|Overall Study|Withdrawal by Subject|4|||
130696419|NCT05412121|470512603|FG000|Overall Study|Physician Decision|1|||
130696420|NCT05412121|470512603|FG000|Overall Study|Lost to Follow-up|5|||
130696421|NCT03727139|470512604|FG000|Overall Study|Protocol Violation|60|||
130696422|NCT00757172|470512605|FG000|Overall Study|Withdrawal by Subject|4|||
130696423|NCT00757172|470512605|FG000|Overall Study|Physician Decision|3|||
130696424|NCT00757172|470512605|FG000|Overall Study|Progression|4|||
130696425|NCT00840879|470512606|FG000|Second Intervention|Withdrawal by Subject|1|||
130696426|NCT00840879|470512607|FG001|Second Intervention|Withdrawal by Subject|0|||
130696427|NCT04236596|470512608|FG000|Overall Study|Withdrawal by Subject|1|||
130696428|NCT04236596|470512608|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
130240337|NCT02335944|468840203|FG004|Post-treatment Follow-up|Physician Decision|0|||
130240338|NCT02335944|468840204|FG005|Post-treatment Follow-up|Physician Decision|0|||
130240339|NCT02335944|468840205|FG006|Post-treatment Follow-up|Physician Decision|0|||
130360731|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130696429|NCT04236596|470512608|FG000|Overall Study|Participants did not receive implant at all|4|||
130696430|NCT02957331|470512613|FG000|Overall Study|Protocol Violation|1|||
130696431|NCT02957331|470512614|FG001|Overall Study|Protocol Violation|0|||
130696432|NCT03247686|470514386|FG000|Overall Study|Withdrawal by Subject|1|||
130696433|NCT03247686|470514387|FG001|Overall Study|Withdrawal by Subject|2|||
130696434|NCT00754052|470514399|FG000|Overall Study|Study terminated by Sponsor|5|||
130696435|NCT00754052|470514400|FG001|Overall Study|Study terminated by Sponsor|3|||
130696436|NCT02658019|470514402|FG000|Overall Study|Adverse Event|1|||
130696437|NCT04364854|470514406|FG000|Overall Study|Withdrawal by Subject|1|||
130696438|NCT04364854|470514407|FG001|Overall Study|Withdrawal by Subject|0|||
130696439|NCT04364854|470514408|FG002|Overall Study|Withdrawal by Subject|1|||
130696440|NCT04364854|470514409|FG003|Overall Study|Withdrawal by Subject|3|||
130696441|NCT04364854|470514406|FG000|Overall Study|Death|1|||
130696442|NCT04364854|470514407|FG001|Overall Study|Death|0|||
130240340|NCT02335944|468840206|FG007|Post-treatment Follow-up|Physician Decision|1|||
130360732|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130360733|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130360734|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
130360735|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360736|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360737|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360738|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360739|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360740|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130360741|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
130360742|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360743|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360744|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360745|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360746|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360747|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130360748|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
130696443|NCT04364854|470514408|FG002|Overall Study|Death|0|||
130696444|NCT04364854|470514409|FG003|Overall Study|Death|0|||
130696445|NCT04364854|470514406|FG000|Overall Study|Lost to Follow-up|0|||
130696446|NCT04364854|470514407|FG001|Overall Study|Lost to Follow-up|0|||
130696447|NCT04364854|470514408|FG002|Overall Study|Lost to Follow-up|0|||
130696448|NCT04364854|470514409|FG003|Overall Study|Lost to Follow-up|1|||
130696449|NCT02435433|470514410|FG000|Overall Study|Withdrawal by Subject|2|||
130696450|NCT02435433|470514411|FG001|Overall Study|Withdrawal by Subject|3|||
130696451|NCT02435433|470514412|FG002|Overall Study|Withdrawal by Subject|1|||
130240341|NCT02335944|468840207|FG008|Post-treatment Follow-up|Physician Decision|0|||
130240342|NCT02335944|468840208|FG009|Post-treatment Follow-up|Physician Decision|0|||
130240343|NCT00832975|468840209|FG000|Overall Study|Lost to Follow-up|7|||
130240344|NCT00832975|468840209|FG000|Overall Study|Protocol Violation|6|||
130240345|NCT00832975|468840209|FG000|Overall Study|Death|5|||
130240346|NCT00832975|468840209|FG000|Overall Study|Physician Decision|4|||
130240347|NCT00832975|468840209|FG000|Overall Study|Withdrawal by Subject|3|||
130240348|NCT00832975|468840209|FG000|Overall Study|Other reasons|14|||
130240349|NCT02811159|468840210|FG000|Treatment Course 1|Lost to Follow-up|1|||
130240350|NCT04603066|468840211|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
130240351|NCT04603066|468840212|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
130240352|NCT02406612|468840213|FG000|Overall Study|Screening Failure|3|||
130240353|NCT02406612|468840214|FG001|Overall Study|Screening Failure|0|||
130240354|NCT02406612|468840213|FG000|Overall Study|Intra-procedural Exclusion|1|||
130240355|NCT02406612|468840214|FG001|Overall Study|Intra-procedural Exclusion|3|||
130240356|NCT02406612|468840213|FG000|Overall Study|Guidewire Failure|0|||
130240357|NCT02406612|468840214|FG001|Overall Study|Guidewire Failure|1|||
130240358|NCT01371981|468840215|FG000|Overall Study|Adverse Event|12|||
130360749|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360750|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360751|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360752|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360753|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360754|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130360755|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
130360756|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360757|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360758|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360759|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360760|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360761|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130360762|NCT04526509|469291047|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
130360763|NCT04526509|469291048|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360764|NCT04526509|469291049|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360765|NCT04526509|469291050|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360766|NCT04526509|469291051|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360767|NCT04526509|469291052|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360768|NCT04526509|469291053|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130360769|NCT04526509|469291047|FG000|Enrolled|Study Terminated by Sponsor|0|||
130360770|NCT04526509|469291048|FG001|Enrolled|Study Terminated by Sponsor|0|||
130360771|NCT04526509|469291049|FG002|Enrolled|Study Terminated by Sponsor|0|||
130360772|NCT04526509|469291050|FG003|Enrolled|Study Terminated by Sponsor|0|||
130360773|NCT04526509|469291051|FG004|Enrolled|Study Terminated by Sponsor|0|||
130360774|NCT04526509|469291052|FG005|Enrolled|Study Terminated by Sponsor|0|||
130360775|NCT04526509|469291053|FG006|Enrolled|Study Terminated by Sponsor|1|||
130360776|NCT04526509|469291047|FG000|Enrolled|Death prior to lymphodepletion|0|||
130360777|NCT04526509|469291048|FG001|Enrolled|Death prior to lymphodepletion|0|||
130360778|NCT04526509|469291049|FG002|Enrolled|Death prior to lymphodepletion|0|||
130360779|NCT04526509|469291050|FG003|Enrolled|Death prior to lymphodepletion|1|||
130360780|NCT04526509|469291051|FG004|Enrolled|Death prior to lymphodepletion|0|||
130360781|NCT04526509|469291052|FG005|Enrolled|Death prior to lymphodepletion|0|||
130360782|NCT04526509|469291053|FG006|Enrolled|Death prior to lymphodepletion|0|||
130360783|NCT04526509|469291047|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130448942|NCT03704298|469606670|FG002|Overall Study|Withdrawal by Subject|0|||
130448943|NCT03704298|469606671|FG003|Overall Study|Withdrawal by Subject|0|||
130240359|NCT01371981|468840216|FG001|Overall Study|Adverse Event|17|||
130240360|NCT01371981|468840217|FG002|Overall Study|Adverse Event|0|||
130240361|NCT01371981|468840218|FG003|Overall Study|Adverse Event|4|||
130240362|NCT01371981|468840219|FG004|Overall Study|Adverse Event|1|||
130240363|NCT01371981|468840220|FG005|Overall Study|Adverse Event|0|||
130696452|NCT02435433|470514413|FG003|Overall Study|Withdrawal by Subject|0|||
130696453|NCT02435433|470514414|FG004|Overall Study|Withdrawal by Subject|0|||
130696454|NCT02435433|470514410|FG000|Overall Study|Lost to Follow-up|2|||
130696455|NCT02435433|470514411|FG001|Overall Study|Lost to Follow-up|2|||
130696456|NCT02435433|470514412|FG002|Overall Study|Lost to Follow-up|4|||
130696457|NCT02435433|470514413|FG003|Overall Study|Lost to Follow-up|1|||
130696458|NCT02435433|470514414|FG004|Overall Study|Lost to Follow-up|0|||
130696459|NCT00757705|470514415|FG000|Overall Study|Adverse Event|19|||
130696460|NCT00757705|470514415|FG000|Overall Study|Lost to Follow-up|16|||
130696461|NCT00757705|470514415|FG000|Overall Study|Withdrawal by Subject|25|||
130696462|NCT00757705|470514415|FG000|Overall Study|Insufficient Response|26|||
130696463|NCT00757705|470514415|FG000|Overall Study|Ineligible to continue|8|||
130696464|NCT00757705|470514415|FG000|Overall Study|Non-compliant|9|||
130696465|NCT00757705|470514415|FG000|Overall Study|Other|18|||
130696466|NCT00659815|470514416|FG000|Overall Study|Study related symptoms and complaints|2|||
130696467|NCT00659815|470514417|FG001|Overall Study|Study related symptoms and complaints|1|||
130696468|NCT00659815|470514416|FG000|Overall Study|Inability to maintain wearing schedule|1|||
130696469|NCT00659815|470514417|FG001|Overall Study|Inability to maintain wearing schedule|2|||
130696470|NCT00659815|470514416|FG000|Overall Study|Withdrawal by Subject|1|||
130696471|NCT00659815|470514417|FG001|Overall Study|Withdrawal by Subject|1|||
130696472|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
130696473|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
130696474|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
130696475|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130696476|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
130696477|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130696478|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
130696479|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130696480|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130696481|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
130696482|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
130696483|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
130696484|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130696485|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
130696486|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130696487|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
130696488|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130696489|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130696490|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
130696491|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130696492|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130696493|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
130696494|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
130696495|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130696496|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130696497|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130696498|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
130696499|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
130696500|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
130696501|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
130696502|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130696503|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
130696504|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130696505|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130696506|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130696507|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
130696508|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130696509|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130696510|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
130696511|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130696512|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
130696513|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130696514|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
130696515|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
130696516|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
130696517|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
130696518|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
130696519|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
130696520|NCT01710358|470514418|FG000|Rescue Period|Adverse Event|0|||
130696521|NCT01710358|470514419|FG001|Rescue Period|Adverse Event|15|||
130696522|NCT01710358|470514420|FG002|Rescue Period|Adverse Event|0|||
130696523|NCT01710358|470514418|FG000|Rescue Period|Death|0|||
130696524|NCT01710358|470514419|FG001|Rescue Period|Death|1|||
130696525|NCT01710358|470514420|FG002|Rescue Period|Death|0|||
130696526|NCT01710358|470514418|FG000|Rescue Period|Lack of Efficacy|0|||
130696527|NCT01710358|470514419|FG001|Rescue Period|Lack of Efficacy|7|||
130696528|NCT01710358|470514420|FG002|Rescue Period|Lack of Efficacy|0|||
130696529|NCT01710358|470514418|FG000|Rescue Period|Withdrawal by Subject|0|||
130696530|NCT01710358|470514419|FG001|Rescue Period|Withdrawal by Subject|8|||
130696531|NCT01710358|470514420|FG002|Rescue Period|Withdrawal by Subject|0|||
130696532|NCT00640393|470514428|FG000|Part 1|Lost to Follow-up|2|||
130696533|NCT00640393|470514429|FG001|Part 1|Lost to Follow-up|0|||
130448944|NCT03704298|469606668|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
130448945|NCT03704298|469606669|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
130448946|NCT03704298|469606670|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
130448947|NCT03704298|469606671|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
130448948|NCT02303574|469606672|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448949|NCT02303574|469606673|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448950|NCT02303574|469606674|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
130448951|NCT02303574|469606675|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448952|NCT02303574|469606676|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448953|NCT02303574|469606677|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448954|NCT02303574|469606678|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448955|NCT02303574|469606679|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448956|NCT02303574|469606680|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448957|NCT02303574|469606681|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130448958|NCT02303574|469606672|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448959|NCT02303574|469606673|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448960|NCT02303574|469606674|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448961|NCT02303574|469606675|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448962|NCT02303574|469606676|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448963|NCT02303574|469606677|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448964|NCT02303574|469606678|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448965|NCT02303574|469606679|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
130696534|NCT00640393|470514430|FG002|Part 1|Lost to Follow-up|0|||
130696535|NCT00640393|470514428|FG000|Part 1|Withdrawal by Subject|3|||
130696536|NCT00640393|470514429|FG001|Part 1|Withdrawal by Subject|0|||
130696537|NCT00640393|470514430|FG002|Part 1|Withdrawal by Subject|0|||
130696538|NCT00640393|470514428|FG000|Randomization|Withdrawn per protocol|17|||
130696539|NCT00640393|470514429|FG001|Randomization|Withdrawn per protocol|0|||
130696540|NCT00640393|470514430|FG002|Randomization|Withdrawn per protocol|0|||
130696541|NCT00640393|470514428|FG000|Randomization|Never randomized by site|2|||
130696542|NCT00640393|470514429|FG001|Randomization|Never randomized by site|0|||
130696543|NCT00640393|470514430|FG002|Randomization|Never randomized by site|0|||
130696544|NCT00640393|470514428|FG000|Part 2|Lost to Follow-up|0|||
130696545|NCT00640393|470514429|FG001|Part 2|Lost to Follow-up|2|||
130696546|NCT00640393|470514430|FG002|Part 2|Lost to Follow-up|2|||
130696547|NCT00640393|470514428|FG000|Part 2|Withdrawal by Subject|0|||
130696548|NCT00640393|470514429|FG001|Part 2|Withdrawal by Subject|6|||
130696549|NCT00640393|470514430|FG002|Part 2|Withdrawal by Subject|1|||
130696550|NCT00640393|470514428|FG000|Part 2|Non-adherence|0|||
130696551|NCT00640393|470514429|FG001|Part 2|Non-adherence|1|||
130696552|NCT00640393|470514430|FG002|Part 2|Non-adherence|0|||
130696553|NCT00640393|470514428|FG000|Part 2|Adverse Event|0|||
130696554|NCT00640393|470514429|FG001|Part 2|Adverse Event|1|||
130696555|NCT00640393|470514430|FG002|Part 2|Adverse Event|0|||
130696556|NCT04406194|470514431|FG000|Period 1|Withdrawal by Subject|0|||
130696557|NCT04406194|470514432|FG001|Period 1|Withdrawal by Subject|1|||
130696558|NCT00396162|470514433|FG000|Overall Study|Withdrawal by Subject|2|||
130696559|NCT00396162|470514434|FG001|Overall Study|Withdrawal by Subject|3|||
130696560|NCT03540160|470514436|FG000|Overall Study|Protocol Violation|1|||
130696561|NCT03540160|470514436|FG000|Overall Study|Physician Decision|8|||
130696562|NCT03540160|470514436|FG000|Overall Study|Lack of Efficacy|60|||
130696563|NCT03540160|470514436|FG000|Overall Study|Pregnancy|1|||
130696564|NCT03540160|470514436|FG000|Overall Study|Adverse Event|20|||
130696565|NCT03540160|470514436|FG000|Overall Study|Withdrawal by Subject|68|||
130696566|NCT03540160|470514436|FG000|Overall Study|COVID-19|2|||
130696567|NCT03540160|470514436|FG000|Overall Study|Study Closure|10|||
130696568|NCT03540160|470514436|FG000|Overall Study|Lost to Follow-up|18|||
130696569|NCT03540160|470514436|FG000|Overall Study|Sponsor decision|191|||
130696570|NCT01664039|470514439|FG000|Overall Study|Adverse Event|3|||
130696571|NCT01664039|470514440|FG001|Overall Study|Adverse Event|4|||
130696572|NCT01664039|470514439|FG000|Overall Study|Lost to Follow-up|1|||
130240364|NCT01371981|468840215|FG000|Overall Study|Death|22|||
130240365|NCT01371981|468840216|FG001|Overall Study|Death|16|||
130240366|NCT01371981|468840217|FG002|Overall Study|Death|0|||
130240367|NCT01371981|468840218|FG003|Overall Study|Death|0|||
130240368|NCT01371981|468840219|FG004|Overall Study|Death|2|||
130240369|NCT01371981|468840220|FG005|Overall Study|Death|2|||
130240370|NCT01371981|468840215|FG000|Overall Study|Lack of Efficacy|69|||
130240371|NCT01371981|468840216|FG001|Overall Study|Lack of Efficacy|61|||
130240372|NCT01371981|468840217|FG002|Overall Study|Lack of Efficacy|4|||
130240373|NCT01371981|468840218|FG003|Overall Study|Lack of Efficacy|8|||
130240374|NCT01371981|468840219|FG004|Overall Study|Lack of Efficacy|5|||
130240375|NCT01371981|468840220|FG005|Overall Study|Lack of Efficacy|0|||
130240376|NCT01371981|468840215|FG000|Overall Study|Physician Decision|48|||
130240377|NCT01371981|468840216|FG001|Overall Study|Physician Decision|63|||
130240378|NCT01371981|468840217|FG002|Overall Study|Physician Decision|1|||
130240379|NCT01371981|468840218|FG003|Overall Study|Physician Decision|7|||
130240380|NCT01371981|468840219|FG004|Overall Study|Physician Decision|14|||
130240381|NCT01371981|468840220|FG005|Overall Study|Physician Decision|3|||
130240382|NCT01371981|468840215|FG000|Overall Study|Withdrawal by Subject|12|||
130240383|NCT01371981|468840216|FG001|Overall Study|Withdrawal by Subject|19|||
130240384|NCT01371981|468840217|FG002|Overall Study|Withdrawal by Subject|1|||
130240385|NCT01371981|468840218|FG003|Overall Study|Withdrawal by Subject|2|||
130240386|NCT01371981|468840219|FG004|Overall Study|Withdrawal by Subject|10|||
130240387|NCT01371981|468840220|FG005|Overall Study|Withdrawal by Subject|3|||
130240388|NCT01371981|468840215|FG000|Overall Study|Ineligible|19|||
130240389|NCT01371981|468840216|FG001|Overall Study|Ineligible|13|||
130240390|NCT01371981|468840217|FG002|Overall Study|Ineligible|0|||
130240391|NCT01371981|468840218|FG003|Overall Study|Ineligible|0|||
130240392|NCT01371981|468840219|FG004|Overall Study|Ineligible|0|||
130240393|NCT01371981|468840220|FG005|Overall Study|Ineligible|4|||
130240394|NCT01371981|468840215|FG000|Overall Study|Did not start treatment|2|||
130240395|NCT01371981|468840216|FG001|Overall Study|Did not start treatment|3|||
130240396|NCT01371981|468840217|FG002|Overall Study|Did not start treatment|0|||
130240397|NCT01371981|468840218|FG003|Overall Study|Did not start treatment|0|||
130240398|NCT01371981|468840219|FG004|Overall Study|Did not start treatment|0|||
130240399|NCT01371981|468840220|FG005|Overall Study|Did not start treatment|2|||
130240400|NCT05253807|468840221|FG000|Overall Study|Death|1|||
130240401|NCT05253807|468840222|FG001|Overall Study|Death|4|||
130240402|NCT05253807|468840221|FG000|Overall Study|Withdrawal by Subject|1|||
130448966|NCT02303574|469606680|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448967|NCT02303574|469606681|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130448968|NCT00859014|469606682|FG000|Overall Study|Death|4|||
130448969|NCT00859014|469606682|FG000|Overall Study|Lost to Follow-up|1|||
130448970|NCT04796935|469606683|FG000|Overall Study|Withdrawal by Subject|0|||
130448971|NCT04796935|469606684|FG001|Overall Study|Withdrawal by Subject|1|||
130448972|NCT04796935|469606683|FG000|Overall Study|Physician Decision|0|||
130552967|NCT00504881|469991637|FG000|Overall Study|Lost to Follow-up|0|||
130552968|NCT00504881|469991638|FG001|Overall Study|Lost to Follow-up|2|||
130552969|NCT00504881|469991637|FG000|Overall Study|Withdrawal by Subject|1|||
130552970|NCT00504881|469991638|FG001|Overall Study|Withdrawal by Subject|4|||
130552971|NCT00504881|469991637|FG000|Overall Study|Non-Compliance|1|||
130552972|NCT00504881|469991638|FG001|Overall Study|Non-Compliance|0|||
130552973|NCT00504881|469991637|FG000|Overall Study|No Birth Control|0|||
130552974|NCT00504881|469991638|FG001|Overall Study|No Birth Control|1|||
130552975|NCT00504881|469991637|FG000|Overall Study|Safety Visit not performed|0|||
130552976|NCT00504881|469991638|FG001|Overall Study|Safety Visit not performed|1|||
130552977|NCT00504881|469991637|FG000|Overall Study|AE, serious fatal|0|||
130696573|NCT01664039|470514440|FG001|Overall Study|Lost to Follow-up|1|||
130448973|NCT04796935|469606684|FG001|Overall Study|Physician Decision|1|||
130448974|NCT04796935|469606683|FG000|Overall Study|Device not available|1|||
130240403|NCT05253807|468840222|FG001|Overall Study|Withdrawal by Subject|0|||
130240404|NCT05253807|468840221|FG000|Overall Study|Study Terminated by Sponsor|1|||
130240405|NCT05253807|468840222|FG001|Overall Study|Study Terminated by Sponsor|1|||
130448975|NCT04796935|469606684|FG001|Overall Study|Device not available|0|||
130448976|NCT04796935|469606683|FG000|Overall Study|Trained provider not available|1|||
130448977|NCT04796935|469606684|FG001|Overall Study|Trained provider not available|0|||
130448978|NCT00783718|469606685|FG000|Induction Phase|Adverse Event|4|||
130448979|NCT00783718|469606686|FG001|Induction Phase|Adverse Event|0|||
130696574|NCT01664039|470514439|FG000|Overall Study|Withdrawal by Subject|1|||
130240406|NCT04611126|468840223|FG000|Overall Study|TIL expansion unsuccessful|1|||
130240407|NCT04611126|468840224|FG001|Overall Study|TIL expansion unsuccessful|0|||
130448980|NCT00783718|469606687|FG002|Induction Phase|Adverse Event|7|||
130240408|NCT03459846|468840229|FG000|Overall Study|Death|52|||
130240409|NCT03459846|468840230|FG001|Overall Study|Death|46|||
130240410|NCT03459846|468840229|FG000|Overall Study|Study terminated by sponsor|24|||
130240411|NCT03459846|468840230|FG001|Overall Study|Study terminated by sponsor|28|||
130240412|NCT03459846|468840229|FG000|Overall Study|Withdrawal by Subject|2|||
130240413|NCT03459846|468840230|FG001|Overall Study|Withdrawal by Subject|2|||
130240414|NCT05578872|468840238|FG000|Overall Study|Withdrawal by Subject|2|||
130240415|NCT05578872|468840239|FG001|Overall Study|Withdrawal by Subject|1|||
130240416|NCT05578872|468840238|FG000|Overall Study|Adverse Event|1|||
130240417|NCT05578872|468840239|FG001|Overall Study|Adverse Event|1|||
130240418|NCT05578872|468840238|FG000|Overall Study|Physician Decision|1|||
130240419|NCT05578872|468840239|FG001|Overall Study|Physician Decision|2|||
130240420|NCT05578872|468840238|FG000|Overall Study|Progressive disease|10|||
130240421|NCT05578872|468840239|FG001|Overall Study|Progressive disease|9|||
130240422|NCT05578872|468840238|FG000|Overall Study|Sponsor decision|0|||
130240423|NCT05578872|468840239|FG001|Overall Study|Sponsor decision|1|||
130240424|NCT05578872|468840238|FG000|Overall Study|Toxicity and Patient's decision|0|||
130240425|NCT05578872|468840239|FG001|Overall Study|Toxicity and Patient's decision|1|||
130240426|NCT03506477|468840527|FG000|Overall Study|Withdrawal by Subject|1|||
130240427|NCT03506477|468840528|FG001|Overall Study|Withdrawal by Subject|0|||
130240428|NCT00632359|468840533|FG000|Overall Study|Withdrawal by Subject|2|||
130240429|NCT06717399|468840534|FG000|Overall Study|Death|1|||
130240430|NCT05763875|468840539|FG000|Overall Study|Subject decision|5|||
130240431|NCT05763875|468840540|FG001|Overall Study|Subject decision|2|||
130240432|NCT05763875|468840541|FG002|Overall Study|Subject decision|1|||
130240433|NCT05763875|468840539|FG000|Overall Study|Lost to Follow-up|4|||
130240434|NCT05763875|468840540|FG001|Overall Study|Lost to Follow-up|1|||
130240435|NCT05763875|468840541|FG002|Overall Study|Lost to Follow-up|2|||
130240436|NCT05763875|468840539|FG000|Overall Study|Adverse Event|1|||
130240437|NCT05763875|468840540|FG001|Overall Study|Adverse Event|0|||
130240438|NCT05763875|468840541|FG002|Overall Study|Adverse Event|0|||
130240439|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130448981|NCT00783718|469606688|FG003|Induction Phase|Adverse Event|0|||
130448982|NCT00783718|469606689|FG004|Induction Phase|Adverse Event|0|||
130448983|NCT00783718|469606690|FG005|Induction Phase|Adverse Event|0|||
130448984|NCT00783718|469606691|FG006|Induction Phase|Adverse Event|0|||
130448985|NCT00783718|469606685|FG000|Induction Phase|Protocol Violation|1|||
130448986|NCT00783718|469606686|FG001|Induction Phase|Protocol Violation|1|||
130448987|NCT00783718|469606687|FG002|Induction Phase|Protocol Violation|6|||
130448988|NCT00783718|469606688|FG003|Induction Phase|Protocol Violation|0|||
130448989|NCT00783718|469606689|FG004|Induction Phase|Protocol Violation|0|||
130448990|NCT00783718|469606690|FG005|Induction Phase|Protocol Violation|0|||
130448991|NCT00783718|469606691|FG006|Induction Phase|Protocol Violation|0|||
130448992|NCT00783718|469606685|FG000|Induction Phase|Lack of Efficacy|5|||
130448993|NCT00783718|469606686|FG001|Induction Phase|Lack of Efficacy|2|||
130448994|NCT00783718|469606687|FG002|Induction Phase|Lack of Efficacy|14|||
130448995|NCT00783718|469606688|FG003|Induction Phase|Lack of Efficacy|0|||
130448996|NCT00783718|469606689|FG004|Induction Phase|Lack of Efficacy|0|||
130448997|NCT00783718|469606690|FG005|Induction Phase|Lack of Efficacy|0|||
130448998|NCT00783718|469606691|FG006|Induction Phase|Lack of Efficacy|0|||
130448999|NCT00783718|469606685|FG000|Induction Phase|Withdrawal by Subject|3|||
130449000|NCT00783718|469606686|FG001|Induction Phase|Withdrawal by Subject|4|||
130240440|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130449001|NCT00783718|469606687|FG002|Induction Phase|Withdrawal by Subject|8|||
130449002|NCT00783718|469606688|FG003|Induction Phase|Withdrawal by Subject|0|||
130449003|NCT00783718|469606689|FG004|Induction Phase|Withdrawal by Subject|0|||
130449004|NCT00783718|469606690|FG005|Induction Phase|Withdrawal by Subject|0|||
130449005|NCT00783718|469606691|FG006|Induction Phase|Withdrawal by Subject|0|||
130449006|NCT00783718|469606685|FG000|Induction Phase|Lost to Follow-up|1|||
130449007|NCT00783718|469606686|FG001|Induction Phase|Lost to Follow-up|0|||
130449008|NCT00783718|469606687|FG002|Induction Phase|Lost to Follow-up|1|||
130449009|NCT00783718|469606688|FG003|Induction Phase|Lost to Follow-up|0|||
130449010|NCT00783718|469606689|FG004|Induction Phase|Lost to Follow-up|0|||
130449011|NCT00783718|469606690|FG005|Induction Phase|Lost to Follow-up|0|||
130449012|NCT00783718|469606691|FG006|Induction Phase|Lost to Follow-up|0|||
130449013|NCT00783718|469606685|FG000|Maintenance Phase|Adverse Event|12|||
130449014|NCT00783718|469606686|FG001|Maintenance Phase|Adverse Event|0|||
130449015|NCT00783718|469606687|FG002|Maintenance Phase|Adverse Event|0|||
130449016|NCT00783718|469606688|FG003|Maintenance Phase|Adverse Event|15|||
130240441|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130240442|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
130449017|NCT00783718|469606689|FG004|Maintenance Phase|Adverse Event|7|||
130240443|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130240444|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130449018|NCT00783718|469606690|FG005|Maintenance Phase|Adverse Event|6|||
130449019|NCT00783718|469606691|FG006|Maintenance Phase|Adverse Event|16|||
130240445|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130240446|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
130449020|NCT00783718|469606685|FG000|Maintenance Phase|Protocol Violation|1|||
130449021|NCT00783718|469606686|FG001|Maintenance Phase|Protocol Violation|0|||
130449022|NCT00783718|469606687|FG002|Maintenance Phase|Protocol Violation|0|||
130449023|NCT00783718|469606688|FG003|Maintenance Phase|Protocol Violation|0|||
130449024|NCT00783718|469606689|FG004|Maintenance Phase|Protocol Violation|0|||
130552978|NCT00504881|469991638|FG001|Overall Study|AE, serious fatal|1|||
130240447|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130240448|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130449025|NCT00783718|469606690|FG005|Maintenance Phase|Protocol Violation|0|||
130449026|NCT00783718|469606691|FG006|Maintenance Phase|Protocol Violation|2|||
130449027|NCT00783718|469606685|FG000|Maintenance Phase|Lack of Efficacy|83|||
130449028|NCT00783718|469606686|FG001|Maintenance Phase|Lack of Efficacy|0|||
130449029|NCT00783718|469606687|FG002|Maintenance Phase|Lack of Efficacy|0|||
130449030|NCT00783718|469606688|FG003|Maintenance Phase|Lack of Efficacy|61|||
130449031|NCT00783718|469606689|FG004|Maintenance Phase|Lack of Efficacy|31|||
130449032|NCT00783718|469606690|FG005|Maintenance Phase|Lack of Efficacy|33|||
130449033|NCT00783718|469606691|FG006|Maintenance Phase|Lack of Efficacy|155|||
130449034|NCT00783718|469606685|FG000|Maintenance Phase|Withdrawal by Subject|6|||
130449035|NCT00783718|469606686|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130449036|NCT00783718|469606687|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130449037|NCT00783718|469606688|FG003|Maintenance Phase|Withdrawal by Subject|2|||
130449038|NCT00783718|469606689|FG004|Maintenance Phase|Withdrawal by Subject|5|||
130449039|NCT00783718|469606690|FG005|Maintenance Phase|Withdrawal by Subject|2|||
130449040|NCT00783718|469606691|FG006|Maintenance Phase|Withdrawal by Subject|20|||
130449041|NCT00783718|469606685|FG000|Maintenance Phase|Lost to Follow-up|3|||
130449042|NCT00783718|469606686|FG001|Maintenance Phase|Lost to Follow-up|0|||
130449043|NCT00783718|469606687|FG002|Maintenance Phase|Lost to Follow-up|0|||
130449044|NCT00783718|469606688|FG003|Maintenance Phase|Lost to Follow-up|0|||
130449045|NCT00783718|469606689|FG004|Maintenance Phase|Lost to Follow-up|2|||
130449046|NCT00783718|469606690|FG005|Maintenance Phase|Lost to Follow-up|0|||
130449047|NCT00783718|469606691|FG006|Maintenance Phase|Lost to Follow-up|2|||
130240449|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130240450|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
130449048|NCT01027871|469606693|FG000|Overall Study|Physician Decision|1|||
130449049|NCT01027871|469606694|FG001|Overall Study|Physician Decision|5|||
130449050|NCT01027871|469606695|FG002|Overall Study|Physician Decision|0|||
130449051|NCT01027871|469606693|FG000|Overall Study|Protocol Violation|0|||
130449052|NCT01027871|469606694|FG001|Overall Study|Protocol Violation|2|||
130449053|NCT01027871|469606695|FG002|Overall Study|Protocol Violation|2|||
130449054|NCT01027871|469606693|FG000|Overall Study|Withdrawal by Subject|1|||
130449055|NCT01027871|469606694|FG001|Overall Study|Withdrawal by Subject|2|||
130449056|NCT01027871|469606695|FG002|Overall Study|Withdrawal by Subject|2|||
130449057|NCT01027871|469606693|FG000|Overall Study|Adverse Event|0|||
130449058|NCT01027871|469606694|FG001|Overall Study|Adverse Event|2|||
130449059|NCT01027871|469606695|FG002|Overall Study|Adverse Event|2|||
130449060|NCT01027871|469606693|FG000|Overall Study|Sponsor Decision|0|||
130449061|NCT01027871|469606694|FG001|Overall Study|Sponsor Decision|2|||
130449062|NCT01027871|469606695|FG002|Overall Study|Sponsor Decision|0|||
130449063|NCT01027871|469606693|FG000|Overall Study|Discontinued Prior to Treatment|0|||
130449064|NCT01027871|469606694|FG001|Overall Study|Discontinued Prior to Treatment|0|||
130449065|NCT01027871|469606695|FG002|Overall Study|Discontinued Prior to Treatment|1|||
130449066|NCT04159896|469606701|FG000|Overall Study|Lack of Efficacy|7|||
130449067|NCT04159896|469606701|FG000|Overall Study|Withdrawal by Subject|1|||
130449068|NCT04159896|469606701|FG000|Overall Study|Adverse Event|1|||
130449069|NCT04159896|469606701|FG000|Overall Study|A transient ischaemic attack|1|||
130449070|NCT02084082|469606702|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
130449071|NCT02084082|469606703|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
130449072|NCT02084082|469606704|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
130449073|NCT02084082|469606705|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
130449074|NCT02084082|469606702|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130449075|NCT02084082|469606703|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130449076|NCT02084082|469606704|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
130449077|NCT02084082|469606705|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
130449078|NCT05705167|469606706|FG000|Overall Study|Randomised but not Treated|0|||
130449079|NCT05705167|469606707|FG001|Overall Study|Randomised but not Treated|2|||
130449080|NCT05705167|469606708|FG002|Overall Study|Randomised but not Treated|0|||
130449081|NCT05705167|469606709|FG003|Overall Study|Randomised but not Treated|7|||
130449082|NCT05705167|469606710|FG004|Overall Study|Randomised but not Treated|0|||
130449083|NCT05705167|469606711|FG005|Overall Study|Randomised but not Treated|0|||
130449084|NCT05705167|469606712|FG006|Overall Study|Randomised but not Treated|0|||
130449085|NCT05705167|469606706|FG000|Overall Study|Death|0|||
130449086|NCT05705167|469606707|FG001|Overall Study|Death|0|||
130449087|NCT05705167|469606708|FG002|Overall Study|Death|3|||
130449088|NCT05705167|469606709|FG003|Overall Study|Death|0|||
130449089|NCT05705167|469606710|FG004|Overall Study|Death|1|||
130449090|NCT05705167|469606711|FG005|Overall Study|Death|1|||
130449091|NCT05705167|469606712|FG006|Overall Study|Death|1|||
130449092|NCT05705167|469606706|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
130449093|NCT05705167|469606707|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
130449094|NCT05705167|469606708|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
130449095|NCT05705167|469606709|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
130449096|NCT05705167|469606710|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
130449097|NCT05705167|469606711|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
130449098|NCT05705167|469606712|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
130240451|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240452|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240453|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240454|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
130240455|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240456|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240457|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240458|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
130240459|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240460|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240461|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240462|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
130240463|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240464|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240465|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240466|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
130240467|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240468|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240469|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240470|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
130240471|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240472|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240473|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240474|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
130240475|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240476|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240477|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240478|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
130240479|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240480|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240481|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240482|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
130240483|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
130240484|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
130240485|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
130240486|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
130240487|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130240488|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130360784|NCT04526509|469291048|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130360785|NCT04526509|469291049|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130360786|NCT04526509|469291050|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
130360787|NCT04526509|469291051|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130360788|NCT04526509|469291052|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130360789|NCT04526509|469291053|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130360790|NCT04526509|469291047|FG000|Enrolled|Physician Decision|0|||
130360791|NCT04526509|469291048|FG001|Enrolled|Physician Decision|1|||
130360792|NCT04526509|469291049|FG002|Enrolled|Physician Decision|0|||
130360793|NCT04526509|469291050|FG003|Enrolled|Physician Decision|0|||
130360794|NCT04526509|469291051|FG004|Enrolled|Physician Decision|0|||
130360795|NCT04526509|469291052|FG005|Enrolled|Physician Decision|0|||
130360796|NCT04526509|469291053|FG006|Enrolled|Physician Decision|0|||
130360797|NCT04340193|469291055|FG000|Overall Study|Other reason|0|||
130360798|NCT04340193|469291056|FG001|Overall Study|Other reason|0|||
130360799|NCT04340193|469291057|FG002|Overall Study|Other reason|1|||
130360800|NCT04340193|469291055|FG000|Overall Study|Disease recurrence|0|||
130360801|NCT04340193|469291056|FG001|Overall Study|Disease recurrence|1|||
130360802|NCT04340193|469291057|FG002|Overall Study|Disease recurrence|0|||
130360803|NCT04340193|469291055|FG000|Overall Study|Study drug toxicity|1|||
130360804|NCT04340193|469291056|FG001|Overall Study|Study drug toxicity|0|||
130360805|NCT04340193|469291057|FG002|Overall Study|Study drug toxicity|0|||
130360806|NCT04340193|469291055|FG000|Overall Study|Disease progression|1|||
130360807|NCT04340193|469291056|FG001|Overall Study|Disease progression|2|||
130360808|NCT04340193|469291057|FG002|Overall Study|Disease progression|3|||
130449099|NCT04736056|469606713|FG000|Overall Study|Death|0|||
130449100|NCT04736056|469606714|FG001|Overall Study|Death|0|||
130696575|NCT01664039|470514440|FG001|Overall Study|Withdrawal by Subject|3|||
130696576|NCT01664039|470514439|FG000|Overall Study|Noncompliance|1|||
130240489|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130240490|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
130240491|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240492|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240493|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240494|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
130240495|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130240496|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130240497|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130360809|NCT04340193|469291055|FG000|Overall Study|Administrative reasons by sponsor|0|||
130360810|NCT04340193|469291056|FG001|Overall Study|Administrative reasons by sponsor|1|||
130360811|NCT04340193|469291057|FG002|Overall Study|Administrative reasons by sponsor|0|||
130360812|NCT04340193|469291055|FG000|Overall Study|Adverse Event|1|||
130360813|NCT04340193|469291056|FG001|Overall Study|Adverse Event|1|||
130360814|NCT04340193|469291057|FG002|Overall Study|Adverse Event|0|||
130360815|NCT01386008|469291058|FG000|Overall Study|exited w/o incident /study discontinued|17|||
130360816|NCT01386008|469291058|FG000|Overall Study|Adverse Event|3|||
130360817|NCT04449861|469291059|FG000|Overall Study|Withdrawal by Subject|4|||
130360818|NCT04449861|469291059|FG000|Overall Study|Lost to Follow-up|5|||
130360819|NCT04449861|469291059|FG000|Overall Study|Death|112|||
130360820|NCT00976677|469291060|FG000|Overall Study|Adverse Event|1|||
130360821|NCT00976677|469291061|FG001|Overall Study|Adverse Event|0|||
130360822|NCT00976677|469291060|FG000|Overall Study|Withdrawal by Subject|0|||
130360823|NCT00976677|469291061|FG001|Overall Study|Withdrawal by Subject|2|||
130360824|NCT00976677|469291060|FG000|Overall Study|Disease progression|1|||
130360825|NCT00976677|469291061|FG001|Overall Study|Disease progression|1|||
130360826|NCT00976677|469291060|FG000|Overall Study|Trial unblinded|2|||
130360827|NCT00976677|469291061|FG001|Overall Study|Trial unblinded|2|||
130360828|NCT00976677|469291060|FG000|Overall Study|Unknown/Missing|1|||
130360829|NCT00976677|469291061|FG001|Overall Study|Unknown/Missing|0|||
130360830|NCT03507400|469291062|FG000|Overall Study|discontinued|5|||
130360831|NCT03507400|469291063|FG001|Overall Study|discontinued|1|||
130360832|NCT03507400|469291062|FG000|Overall Study|Lost to Follow-up|8|||
130360833|NCT03507400|469291063|FG001|Overall Study|Lost to Follow-up|6|||
130360834|NCT03507400|469291062|FG000|Overall Study|Protocol Violation|0|||
130360835|NCT03507400|469291063|FG001|Overall Study|Protocol Violation|1|||
130360836|NCT01555983|469291068|FG000|Overall Study|Withdrawal by Subject|1|||
130360837|NCT01555983|469291069|FG001|Overall Study|Withdrawal by Subject|0|||
130360838|NCT01555983|469291070|FG002|Overall Study|Withdrawal by Subject|0|||
130360839|NCT01555983|469291071|FG003|Overall Study|Withdrawal by Subject|0|||
130360840|NCT01555983|469291072|FG004|Overall Study|Withdrawal by Subject|1|||
130360841|NCT01555983|469291073|FG005|Overall Study|Withdrawal by Subject|1|||
130360842|NCT04806503|469292538|FG000|Overall Study|Lost to Follow-up|0|||
130360843|NCT04806503|469292539|FG001|Overall Study|Lost to Follow-up|0|||
130360844|NCT04806503|469292540|FG002|Overall Study|Lost to Follow-up|1|||
130360845|NCT04806503|469292541|FG003|Overall Study|Lost to Follow-up|0|||
130360846|NCT04806503|469292542|FG004|Overall Study|Lost to Follow-up|0|||
130360847|NCT04806503|469292538|FG000|Overall Study|Withdrawal by Subject|1|||
130360848|NCT04806503|469292539|FG001|Overall Study|Withdrawal by Subject|0|||
130360849|NCT04806503|469292540|FG002|Overall Study|Withdrawal by Subject|1|||
130360850|NCT04806503|469292541|FG003|Overall Study|Withdrawal by Subject|1|||
130360851|NCT04806503|469292542|FG004|Overall Study|Withdrawal by Subject|1|||
130360852|NCT04806503|469292538|FG000|Overall Study|Adverse Event|1|||
130360853|NCT04806503|469292539|FG001|Overall Study|Adverse Event|1|||
130360854|NCT04806503|469292540|FG002|Overall Study|Adverse Event|0|||
130360855|NCT04806503|469292541|FG003|Overall Study|Adverse Event|1|||
130360856|NCT04806503|469292542|FG004|Overall Study|Adverse Event|0|||
130360857|NCT03589469|469292543|FG000|Overall Study|Withdrawal by Subject|8|||
130360858|NCT03589469|469292543|FG000|Overall Study|Physician Decision|20|||
130360859|NCT03589469|469292543|FG000|Overall Study|Death|97|||
130360860|NCT03589469|469292543|FG000|Overall Study|Lost to Follow-up|8|||
130360861|NCT03589469|469292543|FG000|Overall Study|Miscellaneous|1|||
130360862|NCT02008318|469292545|FG000|Overall Study|Adverse Event|4|||
130360863|NCT02008318|469292546|FG001|Overall Study|Adverse Event|0|||
130360864|NCT02008318|469292545|FG000|Overall Study|Physician Decision|2|||
130360865|NCT02008318|469292546|FG001|Overall Study|Physician Decision|0|||
130360866|NCT02008318|469292545|FG000|Overall Study|Progressive Disease|2|||
130360867|NCT02008318|469292546|FG001|Overall Study|Progressive Disease|0|||
130360868|NCT02008318|469292545|FG000|Overall Study|Protocol Violation|1|||
130360869|NCT02008318|469292546|FG001|Overall Study|Protocol Violation|1|||
130360870|NCT02008318|469292545|FG000|Overall Study|Withdrawal by Subject|3|||
130360871|NCT02008318|469292546|FG001|Overall Study|Withdrawal by Subject|0|||
130360872|NCT00371826|469292553|FG000|Core Phase (12 Months)|Adverse Event|15|||
130360873|NCT00371826|469292554|FG001|Core Phase (12 Months)|Adverse Event|4|||
130360874|NCT00371826|469292555|FG002|Core Phase (12 Months)|Adverse Event|9|||
130360875|NCT00371826|469292553|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
130240498|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
130240499|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
130240500|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
130240501|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
130240502|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
130240503|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240504|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240505|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240506|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
130240507|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
130240508|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
130240509|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
130240510|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
130240511|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
130240512|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
130240513|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130240514|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130240515|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Study suspension|0|||
130240516|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Study suspension|45|||
130240517|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Study suspension|0|||
130240518|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Study suspension|0|||
130240519|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
130240520|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
130240521|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
130240522|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
130240523|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Death|2|||
130240524|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Death|3|||
130240525|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Death|0|||
130240526|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Death|0|||
130360876|NCT00371826|469292554|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
130360877|NCT00371826|469292555|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
130360878|NCT00371826|469292553|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
130360879|NCT00371826|469292554|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
130360880|NCT00371826|469292555|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
130360881|NCT00371826|469292553|FG000|Core Phase (12 Months)|Protocol Violation|1|||
130360882|NCT00371826|469292554|FG001|Core Phase (12 Months)|Protocol Violation|0|||
130360883|NCT00371826|469292555|FG002|Core Phase (12 Months)|Protocol Violation|1|||
130360884|NCT00371826|469292553|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
130360885|NCT00371826|469292554|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
130360886|NCT00371826|469292555|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
130360887|NCT00371826|469292553|FG000|Core Phase (12 Months)|Administrative problems|1|||
130360888|NCT00371826|469292554|FG001|Core Phase (12 Months)|Administrative problems|0|||
130360889|NCT00371826|469292555|FG002|Core Phase (12 Months)|Administrative problems|8|||
130360890|NCT00371826|469292553|FG000|Core Phase (12 Months)|Graft Loss|0|||
130360891|NCT00371826|469292554|FG001|Core Phase (12 Months)|Graft Loss|1|||
130360892|NCT00371826|469292555|FG002|Core Phase (12 Months)|Graft Loss|0|||
130360893|NCT00371826|469292553|FG000|Extension Phase (24 Months)|Adverse Event|4|||
130360894|NCT00371826|469292554|FG001|Extension Phase (24 Months)|Adverse Event|5|||
130360895|NCT00371826|469292555|FG002|Extension Phase (24 Months)|Adverse Event|0|||
130360896|NCT00371826|469292553|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
130360897|NCT00371826|469292554|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
130360898|NCT00371826|469292555|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
130360899|NCT00371826|469292553|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
130360900|NCT00371826|469292554|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
130360901|NCT00371826|469292555|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
130360902|NCT00371826|469292553|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
130360903|NCT00371826|469292554|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
130360904|NCT00371826|469292555|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
130360905|NCT00371826|469292553|FG000|Extension Phase (24 Months)|Administrative problems|0|||
130360906|NCT00371826|469292554|FG001|Extension Phase (24 Months)|Administrative problems|0|||
130360907|NCT00371826|469292555|FG002|Extension Phase (24 Months)|Administrative problems|2|||
130360908|NCT00385762|469292556|FG000|Overall Study|Adverse Event|1|||
130360909|NCT00385762|469292556|FG000|Overall Study|Lost to Follow-up|1|||
130360910|NCT00573183|469292557|FG000|Overall Study|Lost to Follow-up|52|||
130360911|NCT00573183|469292558|FG001|Overall Study|Lost to Follow-up|50|||
130240527|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
130360912|NCT00573183|469292557|FG000|Overall Study|Withdrawal by Subject|8|||
130360913|NCT00573183|469292558|FG001|Overall Study|Withdrawal by Subject|2|||
130696577|NCT01664039|470514440|FG001|Overall Study|Noncompliance|1|||
130240528|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
130240529|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
130240530|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
130240531|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
130240532|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
130240533|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
130240534|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
130240535|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
130240536|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
130240537|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
130240538|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
130240539|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240540|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
130240541|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240542|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240543|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240544|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
130240545|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240546|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240547|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
130240548|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240549|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240550|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240551|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
130240552|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
130240553|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130240554|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130240555|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Other|1|||
130240556|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Other|2|||
130240557|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Other|0|||
130240558|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Other|0|||
130240559|NCT02145390|468840546|FG000|Overall Study|Withdrawal by Subject|1|||
130240560|NCT01732783|468841438|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
130240561|NCT01732783|468841439|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
130240562|NCT01732783|468841440|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
130240563|NCT01732783|468841438|FG000|Overall Study|Death|13|||
130240564|NCT01732783|468841439|FG001|Overall Study|Death|4|||
130240565|NCT01732783|468841440|FG002|Overall Study|Death|1|||
130240566|NCT01732783|468841438|FG000|Overall Study|Lost to Follow-up|7|||
130240567|NCT01732783|468841439|FG001|Overall Study|Lost to Follow-up|1|||
130240568|NCT01732783|468841440|FG002|Overall Study|Lost to Follow-up|1|||
130240569|NCT01732783|468841438|FG000|Overall Study|Administrative Decision|8|||
130240570|NCT01732783|468841439|FG001|Overall Study|Administrative Decision|2|||
130240571|NCT01732783|468841440|FG002|Overall Study|Administrative Decision|1|||
130240572|NCT01732783|468841438|FG000|Overall Study|Withdrawal by Subject|1|||
130240573|NCT01732783|468841439|FG001|Overall Study|Withdrawal by Subject|0|||
130240574|NCT01732783|468841440|FG002|Overall Study|Withdrawal by Subject|0|||
130240575|NCT02717611|468841441|FG000|Overall Study|Death|13|||
130240576|NCT02717611|468841441|FG000|Overall Study|Withdrawal by Subject|6|||
130360914|NCT00573183|469292557|FG000|Overall Study|Death|0|||
130360915|NCT00573183|469292558|FG001|Overall Study|Death|1|||
130360916|NCT00573183|469292557|FG000|Overall Study|Adverse Event|2|||
130360917|NCT00573183|469292558|FG001|Overall Study|Adverse Event|0|||
130360918|NCT00573183|469292557|FG000|Overall Study|Incarceration|5|||
130240577|NCT02717611|468841441|FG000|Overall Study|Active, not recruiting|40|||
130240578|NCT02717611|468841441|FG000|Overall Study|Complicating disease|1|||
130240579|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
130240580|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
130240581|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
130240582|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
130240583|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
130360919|NCT00573183|469292558|FG001|Overall Study|Incarceration|8|||
130360920|NCT00573183|469292557|FG000|Overall Study|Other|5|||
130449101|NCT04736056|469606715|FG002|Overall Study|Death|0|||
130449102|NCT04736056|469606716|FG003|Overall Study|Death|1|||
130449103|NCT04736056|469606713|FG000|Overall Study|Lost to Follow-up|1|||
130449104|NCT04736056|469606714|FG001|Overall Study|Lost to Follow-up|0|||
130449105|NCT04736056|469606715|FG002|Overall Study|Lost to Follow-up|1|||
130449106|NCT04736056|469606716|FG003|Overall Study|Lost to Follow-up|1|||
130449107|NCT04736056|469606713|FG000|Overall Study|Withdrawal by Subject|2|||
130449108|NCT04736056|469606714|FG001|Overall Study|Withdrawal by Subject|0|||
130449109|NCT04736056|469606715|FG002|Overall Study|Withdrawal by Subject|0|||
130449110|NCT04736056|469606716|FG003|Overall Study|Withdrawal by Subject|0|||
130449111|NCT04736056|469606713|FG000|Overall Study|Physician Decision|1|||
130449112|NCT04736056|469606714|FG001|Overall Study|Physician Decision|0|||
130449113|NCT04736056|469606715|FG002|Overall Study|Physician Decision|1|||
130449114|NCT04736056|469606716|FG003|Overall Study|Physician Decision|0|||
130449115|NCT02099539|469606721|FG000|Overall Study|Progressive Disease|3|||
130449116|NCT02099539|469606722|FG001|Overall Study|Progressive Disease|2|||
130449117|NCT02099539|469606723|FG002|Overall Study|Progressive Disease|2|||
130449118|NCT02099539|469606724|FG003|Overall Study|Progressive Disease|1|||
130449119|NCT02099539|469606725|FG004|Overall Study|Progressive Disease|4|||
130449120|NCT02099539|469606726|FG005|Overall Study|Progressive Disease|2|||
130449121|NCT02099539|469606727|FG006|Overall Study|Progressive Disease|0|||
130449122|NCT02099539|469606721|FG000|Overall Study|Adverse Event|0|||
130449123|NCT02099539|469606722|FG001|Overall Study|Adverse Event|0|||
130449124|NCT02099539|469606723|FG002|Overall Study|Adverse Event|1|||
130449125|NCT02099539|469606724|FG003|Overall Study|Adverse Event|1|||
130449126|NCT02099539|469606725|FG004|Overall Study|Adverse Event|0|||
130449127|NCT02099539|469606726|FG005|Overall Study|Adverse Event|0|||
130449128|NCT02099539|469606727|FG006|Overall Study|Adverse Event|0|||
130449129|NCT02099539|469606721|FG000|Overall Study|Physician Decision|0|||
130449130|NCT02099539|469606722|FG001|Overall Study|Physician Decision|0|||
130449131|NCT02099539|469606723|FG002|Overall Study|Physician Decision|0|||
130449132|NCT02099539|469606724|FG003|Overall Study|Physician Decision|0|||
130449133|NCT02099539|469606725|FG004|Overall Study|Physician Decision|0|||
130449134|NCT02099539|469606726|FG005|Overall Study|Physician Decision|1|||
130449135|NCT02099539|469606727|FG006|Overall Study|Physician Decision|0|||
130449136|NCT04091672|469608852|FG000|Overall Study|Death|6|||
130449137|NCT04091672|469608853|FG001|Overall Study|Death|6|||
130449138|NCT04091672|469608852|FG000|Overall Study|Lost to Follow-up|7|||
130449139|NCT04091672|469608853|FG001|Overall Study|Lost to Follow-up|7|||
130449140|NCT04091672|469608852|FG000|Overall Study|Withdrawal by Subject|3|||
130449141|NCT04091672|469608853|FG001|Overall Study|Withdrawal by Subject|3|||
130449142|NCT04091672|469608852|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
130449143|NCT04091672|469608853|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
130449144|NCT05296629|469608854|FG000|Overall Study|Withdrawal by Subject|3|||
130449145|NCT05296629|469608855|FG001|Overall Study|Withdrawal by Subject|10|||
130449146|NCT05296629|469608856|FG002|Overall Study|Withdrawal by Subject|4|||
130449147|NCT05296629|469608854|FG000|Overall Study|Lost to Follow-up|2|||
130449148|NCT05296629|469608855|FG001|Overall Study|Lost to Follow-up|7|||
130449149|NCT05296629|469608856|FG002|Overall Study|Lost to Follow-up|1|||
130449150|NCT05296629|469608854|FG000|Overall Study|Adverse Event|0|||
130449151|NCT05296629|469608855|FG001|Overall Study|Adverse Event|4|||
130449152|NCT05296629|469608856|FG002|Overall Study|Adverse Event|2|||
130449153|NCT05296629|469608854|FG000|Overall Study|Protocol Violation|0|||
130449154|NCT05296629|469608855|FG001|Overall Study|Protocol Violation|2|||
130240584|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
130449155|NCT05296629|469608856|FG002|Overall Study|Protocol Violation|0|||
130449156|NCT02268396|469608860|FG000|Overall Study|Adverse Event|3|||
130449157|NCT02268396|469608860|FG000|Overall Study|Administrative|2|||
130449158|NCT02268396|469608860|FG000|Overall Study|Withdrawal by Subject|1|||
130449159|NCT02268396|469608860|FG000|Overall Study|Lost to Follow-up|2|||
130696578|NCT03358147|470514446|FG000|Overall Study|Withdrawal by Subject|13|||
130696579|NCT03358147|470514447|FG001|Overall Study|Withdrawal by Subject|19|||
130696580|NCT03358147|470514448|FG002|Overall Study|Withdrawal by Subject|16|||
130696581|NCT03358147|470514449|FG003|Overall Study|Withdrawal by Subject|10|||
130449160|NCT02268396|469608860|FG000|Overall Study|Protocol-Specified Criteria|2|||
130449161|NCT02268396|469608860|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
130449162|NCT01939158|469608861|FG000|Overall Study|Adverse Event|1|||
130449163|NCT01939158|469608862|FG001|Overall Study|Adverse Event|0|||
130240585|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
130240586|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
130449164|NCT01939158|469608863|FG002|Overall Study|Adverse Event|0|||
130449165|NCT01939158|469608864|FG003|Overall Study|Adverse Event|0|||
130449166|NCT01939158|469608861|FG000|Overall Study|Withdrawal by Subject|22|||
130449167|NCT01939158|469608862|FG001|Overall Study|Withdrawal by Subject|25|||
130449168|NCT01939158|469608863|FG002|Overall Study|Withdrawal by Subject|15|||
130449169|NCT01939158|469608864|FG003|Overall Study|Withdrawal by Subject|17|||
130449170|NCT01939158|469608861|FG000|Overall Study|Migrated/moved from study area|5|||
130449171|NCT01939158|469608862|FG001|Overall Study|Migrated/moved from study area|7|||
130240587|NCT00325416|468841442|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
130240588|NCT00325416|468841443|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
130240589|NCT00325416|468841442|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
130240590|NCT00325416|468841443|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
130240591|NCT04589650|468841444|FG000|Overall Study|Subject decision|6|||
130240592|NCT04589650|468841445|FG001|Overall Study|Subject decision|2|||
130240593|NCT04589650|468841446|FG002|Overall Study|Subject decision|2|||
130240594|NCT04589650|468841447|FG003|Overall Study|Subject decision|0|||
130240595|NCT04589650|468841448|FG004|Overall Study|Subject decision|0|||
130240596|NCT04589650|468841449|FG005|Overall Study|Subject decision|0|||
130240597|NCT04589650|468841444|FG000|Overall Study|Adverse Event|3|||
130240598|NCT04589650|468841445|FG001|Overall Study|Adverse Event|1|||
130240599|NCT04589650|468841446|FG002|Overall Study|Adverse Event|1|||
130240600|NCT04589650|468841447|FG003|Overall Study|Adverse Event|1|||
130240601|NCT04589650|468841448|FG004|Overall Study|Adverse Event|0|||
130240602|NCT04589650|468841449|FG005|Overall Study|Adverse Event|1|||
130240603|NCT04589650|468841444|FG000|Overall Study|Physician Decision|1|||
130240604|NCT04589650|468841445|FG001|Overall Study|Physician Decision|1|||
130240605|NCT04589650|468841446|FG002|Overall Study|Physician Decision|0|||
130240606|NCT04589650|468841447|FG003|Overall Study|Physician Decision|0|||
130240607|NCT04589650|468841448|FG004|Overall Study|Physician Decision|0|||
130240608|NCT04589650|468841449|FG005|Overall Study|Physician Decision|0|||
130240609|NCT04589650|468841444|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130240610|NCT04589650|468841445|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130240611|NCT04589650|468841446|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130240612|NCT04589650|468841447|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130240613|NCT04589650|468841448|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130240614|NCT04589650|468841449|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130240615|NCT04589650|468841444|FG000|Overall Study|Death|0|||
130240616|NCT04589650|468841445|FG001|Overall Study|Death|0|||
130240617|NCT04589650|468841446|FG002|Overall Study|Death|0|||
130240618|NCT04589650|468841447|FG003|Overall Study|Death|1|||
130240619|NCT04589650|468841448|FG004|Overall Study|Death|0|||
130240620|NCT04589650|468841449|FG005|Overall Study|Death|0|||
130240621|NCT04589650|468841444|FG000|Overall Study|Guardian Decision|0|||
130240622|NCT04589650|468841445|FG001|Overall Study|Guardian Decision|0|||
130240623|NCT04589650|468841446|FG002|Overall Study|Guardian Decision|0|||
130240624|NCT04589650|468841447|FG003|Overall Study|Guardian Decision|1|||
130240625|NCT04589650|468841448|FG004|Overall Study|Guardian Decision|0|||
130240626|NCT04589650|468841449|FG005|Overall Study|Guardian Decision|0|||
130240627|NCT02324153|468841450|FG000|Overall Study|Withdrawal by Subject|4|||
130240628|NCT02324153|468841451|FG001|Overall Study|Withdrawal by Subject|1|||
130240629|NCT02324153|468841450|FG000|Overall Study|Surgery postponed after randomization|3|||
130240630|NCT02324153|468841451|FG001|Overall Study|Surgery postponed after randomization|0|||
130240631|NCT02324153|468841450|FG000|Overall Study|Developed delirium preoperatively|1|||
130240632|NCT02324153|468841451|FG001|Overall Study|Developed delirium preoperatively|0|||
130240633|NCT03122106|468841454|FG000|Overall Study|Not enough tissue|1|||
130240634|NCT03122106|468841454|FG000|Overall Study|Disease progression during screening|2|||
130240635|NCT03122106|468841454|FG000|Overall Study|Poor RNA quality for vaccine|1|||
130696582|NCT03358147|470514450|FG004|Overall Study|Withdrawal by Subject|5|||
130696583|NCT03358147|470514446|FG000|Overall Study|Adverse Event|3|||
130696584|NCT03358147|470514447|FG001|Overall Study|Adverse Event|9|||
130696585|NCT03358147|470514448|FG002|Overall Study|Adverse Event|7|||
130240636|NCT01147458|468841456|FG000|First Intervention|Study terminated by sponsor|8|||
130240637|NCT01147458|468841457|FG001|First Intervention|Study terminated by sponsor|8|||
130240638|NCT01147458|468841458|FG002|First Intervention|Study terminated by sponsor|7|||
130240639|NCT01147458|468841459|FG003|First Intervention|Study terminated by sponsor|8|||
130240640|NCT01147458|468841456|FG000|First Intervention|Protocol Violation|2|||
130240641|NCT01147458|468841457|FG001|First Intervention|Protocol Violation|3|||
130240642|NCT01147458|468841458|FG002|First Intervention|Protocol Violation|2|||
130240643|NCT01147458|468841459|FG003|First Intervention|Protocol Violation|3|||
130360921|NCT00573183|469292558|FG001|Overall Study|Other|2|||
130360922|NCT00231842|469292559|FG000|Overall Study|Withdrawal by Subject|3|||
130360923|NCT00231842|469292559|FG000|Overall Study|Did not complete the last 3 cycle|8|||
130360924|NCT02422303|469292560|FG000|Overall Study|Lost to Follow-up|1|||
130360925|NCT02422303|469292561|FG001|Overall Study|Lost to Follow-up|1|||
130360926|NCT03270644|469292569|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
130360927|NCT03270644|469292569|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
130360928|NCT00902668|469292570|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
130360929|NCT03643575|469292573|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
130360930|NCT03643575|469292574|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
130360931|NCT03643575|469292575|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
130696586|NCT03358147|470514449|FG003|Overall Study|Adverse Event|5|||
130696587|NCT03358147|470514450|FG004|Overall Study|Adverse Event|2|||
130240644|NCT01147458|468841456|FG000|First Intervention|Withdrawal by Subject|3|||
130360932|NCT03643575|469292576|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
130240645|NCT01147458|468841457|FG001|First Intervention|Withdrawal by Subject|0|||
130240646|NCT01147458|468841458|FG002|First Intervention|Withdrawal by Subject|1|||
130240647|NCT01147458|468841459|FG003|First Intervention|Withdrawal by Subject|0|||
130240648|NCT01147458|468841456|FG000|First Intervention|Adverse Event|0|||
130449172|NCT01939158|469608863|FG002|Overall Study|Migrated/moved from study area|3|||
130449173|NCT01939158|469608864|FG003|Overall Study|Migrated/moved from study area|6|||
130449174|NCT01939158|469608861|FG000|Overall Study|Lost to Follow-up|18|||
130449175|NCT01939158|469608862|FG001|Overall Study|Lost to Follow-up|17|||
130449176|NCT01939158|469608863|FG002|Overall Study|Lost to Follow-up|17|||
130449177|NCT01939158|469608864|FG003|Overall Study|Lost to Follow-up|17|||
130449178|NCT01939158|469608861|FG000|Overall Study|Death|0|||
130449179|NCT01939158|469608862|FG001|Overall Study|Death|0|||
130449180|NCT01939158|469608863|FG002|Overall Study|Death|1|||
130449181|NCT01939158|469608864|FG003|Overall Study|Death|1|||
130449182|NCT01939158|469608861|FG000|Overall Study|No longer meets eligibility criteria|0|||
130449183|NCT01939158|469608862|FG001|Overall Study|No longer meets eligibility criteria|0|||
130449184|NCT01939158|469608863|FG002|Overall Study|No longer meets eligibility criteria|1|||
130449185|NCT01939158|469608864|FG003|Overall Study|No longer meets eligibility criteria|0|||
130449186|NCT01939158|469608861|FG000|Overall Study|Other|1|||
130449187|NCT01939158|469608862|FG001|Overall Study|Other|3|||
130449188|NCT01939158|469608863|FG002|Overall Study|Other|4|||
130449189|NCT01939158|469608864|FG003|Overall Study|Other|3|||
130449190|NCT01097655|469608865|FG000|Overall Study|Withdrawal by Subject|1|||
130449191|NCT01097655|469608865|FG000|Overall Study|Subject Documented Twice|1|||
130449192|NCT01097655|469608865|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
130449193|NCT01345292|469608866|FG000|Overall Study|Withdrawal by Subject|2|||
130449194|NCT01345292|469608867|FG001|Overall Study|Withdrawal by Subject|0|||
130449195|NCT01345292|469608868|FG002|Overall Study|Withdrawal by Subject|1|||
130449196|NCT03303105|469608870|FG000|Overall Study|Adverse Event|0|||
130240649|NCT01147458|468841457|FG001|First Intervention|Adverse Event|3|||
130240650|NCT01147458|468841458|FG002|First Intervention|Adverse Event|2|||
130240651|NCT01147458|468841459|FG003|First Intervention|Adverse Event|3|||
130240652|NCT01147458|468841456|FG000|First Intervention|Other|1|||
130240653|NCT01147458|468841457|FG001|First Intervention|Other|2|||
130240654|NCT01147458|468841458|FG002|First Intervention|Other|0|||
130240655|NCT01147458|468841459|FG003|First Intervention|Other|0|||
130240656|NCT01147458|468841456|FG000|Second Intervention|Study terminated by sponsor|7|||
130240657|NCT01147458|468841457|FG001|Second Intervention|Study terminated by sponsor|5|||
130240658|NCT01147458|468841458|FG002|Second Intervention|Study terminated by sponsor|5|||
130449197|NCT03303105|469608871|FG001|Overall Study|Adverse Event|2|||
130449198|NCT03303105|469608870|FG000|Overall Study|Lack of Efficacy|1|||
130449199|NCT03303105|469608871|FG001|Overall Study|Lack of Efficacy|0|||
130449200|NCT03303105|469608870|FG000|Overall Study|Protocol Violation|1|||
130449201|NCT03303105|469608871|FG001|Overall Study|Protocol Violation|0|||
130449202|NCT03303105|469608870|FG000|Overall Study|Withdrawal by Subject|0|||
130449203|NCT03303105|469608871|FG001|Overall Study|Withdrawal by Subject|2|||
130449204|NCT04822298|469608872|FG000|Overall Study|Death|3|||
130449205|NCT00852475|469608881|FG000|Overall Study|Lost to Follow-up|3|||
130449206|NCT00852475|469608882|FG001|Overall Study|Lost to Follow-up|4|||
130449207|NCT00515086|469608883|FG000|Overall Study|Adverse Event|1|||
130696588|NCT03358147|470514446|FG000|Overall Study|Lost to Follow-up|4|||
130240659|NCT01147458|468841459|FG003|Second Intervention|Study terminated by sponsor|3|||
130240660|NCT01147458|468841456|FG000|Second Intervention|Protocol Violation|0|||
130240661|NCT01147458|468841457|FG001|Second Intervention|Protocol Violation|1|||
130240662|NCT01147458|468841458|FG002|Second Intervention|Protocol Violation|1|||
130240663|NCT01147458|468841459|FG003|Second Intervention|Protocol Violation|0|||
130240664|NCT01147458|468841456|FG000|Second Intervention|Withdrawal by Subject|0|||
130240665|NCT01147458|468841457|FG001|Second Intervention|Withdrawal by Subject|1|||
130240666|NCT01147458|468841458|FG002|Second Intervention|Withdrawal by Subject|0|||
130240667|NCT01147458|468841459|FG003|Second Intervention|Withdrawal by Subject|0|||
130240668|NCT01147458|468841456|FG000|Second Intervention|Adverse Event|2|||
130449208|NCT00515086|469608884|FG001|Overall Study|Adverse Event|1|||
130240669|NCT01147458|468841457|FG001|Second Intervention|Adverse Event|0|||
130240670|NCT01147458|468841458|FG002|Second Intervention|Adverse Event|1|||
130240671|NCT01147458|468841459|FG003|Second Intervention|Adverse Event|1|||
130449209|NCT00515086|469608885|FG002|Overall Study|Adverse Event|2|||
130449210|NCT00515086|469608886|FG003|Overall Study|Adverse Event|3|||
130240672|NCT01147458|468841456|FG000|Second Intervention|Other|0|||
130240673|NCT01147458|468841457|FG001|Second Intervention|Other|0|||
130240674|NCT01147458|468841458|FG002|Second Intervention|Other|1|||
130240675|NCT01147458|468841459|FG003|Second Intervention|Other|0|||
130240676|NCT03550209|468841460|FG000|Overall Study|Lost to Follow-up|1|||
130240677|NCT03550209|468841461|FG001|Overall Study|Lost to Follow-up|0|||
130449211|NCT00515086|469608883|FG000|Overall Study|Administrative|1|||
130449212|NCT00515086|469608884|FG001|Overall Study|Administrative|1|||
130449213|NCT00515086|469608885|FG002|Overall Study|Administrative|0|||
130449214|NCT00515086|469608886|FG003|Overall Study|Administrative|0|||
130449215|NCT00515086|469608883|FG000|Overall Study|Withdrawal by Subject|1|||
130696589|NCT03358147|470514447|FG001|Overall Study|Lost to Follow-up|3|||
130240678|NCT03550209|468841462|FG002|Overall Study|Lost to Follow-up|1|||
130240679|NCT03550209|468841463|FG003|Overall Study|Lost to Follow-up|0|||
130240680|NCT03550209|468841460|FG000|Overall Study|Withdrawal by Subject|0|||
130240681|NCT03550209|468841461|FG001|Overall Study|Withdrawal by Subject|3|||
130240682|NCT03550209|468841462|FG002|Overall Study|Withdrawal by Subject|1|||
130240683|NCT03550209|468841463|FG003|Overall Study|Withdrawal by Subject|2|||
130240684|NCT03550209|468841460|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
130240685|NCT03550209|468841461|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
130240686|NCT03550209|468841462|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
130240687|NCT03550209|468841463|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
130240688|NCT02555878|468841464|FG000|Overall Study|Lost to Follow-up|2|||
130240689|NCT02555878|468841465|FG001|Overall Study|Lost to Follow-up|3|||
130240690|NCT02555878|468841464|FG000|Overall Study|Withdrawal by Subject|48|||
130240691|NCT02555878|468841465|FG001|Overall Study|Withdrawal by Subject|48|||
130240692|NCT02555878|468841464|FG000|Overall Study|Adverse Event|12|||
130240693|NCT02555878|468841465|FG001|Overall Study|Adverse Event|8|||
130240694|NCT02555878|468841464|FG000|Overall Study|Death|74|||
130240695|NCT02555878|468841465|FG001|Overall Study|Death|59|||
130240696|NCT02555878|468841464|FG000|Overall Study|Protocol Violation|1|||
130240697|NCT02555878|468841465|FG001|Overall Study|Protocol Violation|2|||
130240698|NCT02555878|468841464|FG000|Overall Study|Physician Decision|12|||
130240699|NCT02555878|468841465|FG001|Overall Study|Physician Decision|13|||
130240700|NCT02555878|468841464|FG000|Overall Study|Other|17|||
130240701|NCT02555878|468841465|FG001|Overall Study|Other|17|||
130240702|NCT00765076|468841466|FG000|Overall Study|Adverse Event|1|||
130240703|NCT00765076|468841467|FG001|Overall Study|Adverse Event|0|||
130449216|NCT00515086|469608884|FG001|Overall Study|Withdrawal by Subject|0|||
130449217|NCT00515086|469608885|FG002|Overall Study|Withdrawal by Subject|0|||
130449218|NCT00515086|469608886|FG003|Overall Study|Withdrawal by Subject|1|||
130449219|NCT00515086|469608883|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130240704|NCT00765076|468841468|FG002|Overall Study|Adverse Event|0|||
130240705|NCT00765076|468841466|FG000|Overall Study|Withdrawal by Subject|0|||
130240706|NCT00765076|468841467|FG001|Overall Study|Withdrawal by Subject|0|||
130240707|NCT00765076|468841468|FG002|Overall Study|Withdrawal by Subject|1|||
130240708|NCT02875080|468841469|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
130240709|NCT02875080|468841470|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130240710|NCT02875080|468841471|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130240711|NCT00768053|468841472|FG000|Overall Study|Adverse Event|10|||
130240712|NCT00768053|468841472|FG000|Overall Study|Lost to Follow-up|1|||
130240713|NCT01164475|468841473|FG000|Overall Study|Lack of Efficacy|1|||
130240714|NCT01164475|468841474|FG001|Overall Study|Lack of Efficacy|0|||
130240715|NCT01164475|468841473|FG000|Overall Study|Other|0|||
130240716|NCT01164475|468841474|FG001|Overall Study|Other|1|||
130240717|NCT01164475|468841473|FG000|Overall Study|Progressive disease|0|||
130240718|NCT01164475|468841474|FG001|Overall Study|Progressive disease|1|||
130240719|NCT01164475|468841473|FG000|Overall Study|Protocol Violation|1|||
130449220|NCT00515086|469608884|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130449221|NCT00515086|469608885|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130449222|NCT00515086|469608886|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
130449223|NCT00515086|469608883|FG000|Overall Study|Lost to Follow-up|1|||
130240720|NCT01164475|468841474|FG001|Overall Study|Protocol Violation|0|||
130240721|NCT03244189|468841476|FG000|Overall Study|Death|0|||
130240722|NCT03244189|468841477|FG001|Overall Study|Death|2|||
130240723|NCT03244189|468841476|FG000|Overall Study|Lost to Follow-up|92|||
130240724|NCT03244189|468841477|FG001|Overall Study|Lost to Follow-up|107|||
130240725|NCT03244189|468841476|FG000|Overall Study|Physician Decision|4|||
130240726|NCT03244189|468841477|FG001|Overall Study|Physician Decision|2|||
130449224|NCT00515086|469608884|FG001|Overall Study|Lost to Follow-up|0|||
130449225|NCT00515086|469608885|FG002|Overall Study|Lost to Follow-up|0|||
130449226|NCT00515086|469608886|FG003|Overall Study|Lost to Follow-up|0|||
130240727|NCT03244189|468841476|FG000|Overall Study|Pregnancy|7|||
130240728|NCT03244189|468841477|FG001|Overall Study|Pregnancy|5|||
130240729|NCT03244189|468841476|FG000|Overall Study|Protocol Violation|0|||
130240730|NCT03244189|468841477|FG001|Overall Study|Protocol Violation|2|||
130240731|NCT03244189|468841476|FG000|Overall Study|Withdrawal by Subject|45|||
130240732|NCT03244189|468841477|FG001|Overall Study|Withdrawal by Subject|23|||
130449227|NCT00515086|469608883|FG000|Overall Study|Study drug no longer required|0|||
130449228|NCT00515086|469608884|FG001|Overall Study|Study drug no longer required|1|||
130449229|NCT00515086|469608885|FG002|Overall Study|Study drug no longer required|0|||
130240733|NCT03244189|468841476|FG000|Overall Study|Technical Problems|2|||
130449230|NCT00515086|469608886|FG003|Overall Study|Study drug no longer required|0|||
130240734|NCT03244189|468841477|FG001|Overall Study|Technical Problems|0|||
130240735|NCT06170827|468841478|FG000|Overall Study|Withdrawal by Subject|1|||
130240736|NCT06170827|468841479|FG001|Overall Study|Withdrawal by Subject|1|||
130240737|NCT03421808|468841484|FG000|Overall Study|COVID related problems|2|||
130240738|NCT03421808|468841485|FG001|Overall Study|COVID related problems|0|||
130240739|NCT03421808|468841484|FG000|Overall Study|Withdrawal by Subject|1|||
130240740|NCT03421808|468841485|FG001|Overall Study|Withdrawal by Subject|0|||
130240741|NCT03421808|468841484|FG000|Overall Study|Protocol Violation|0|||
130240742|NCT03421808|468841485|FG001|Overall Study|Protocol Violation|1|||
130240743|NCT02180867|468841488|FG000|Overall Study|Adverse Event|3|||
130240744|NCT02180867|468841489|FG001|Overall Study|Adverse Event|4|||
130240745|NCT02180867|468841490|FG002|Overall Study|Adverse Event|1|||
130240746|NCT02180867|468841491|FG003|Overall Study|Adverse Event|5|||
130240747|NCT02180867|468841492|FG004|Overall Study|Adverse Event|0|||
130240748|NCT02180867|468841493|FG005|Overall Study|Adverse Event|0|||
130240749|NCT02180867|468841494|FG006|Overall Study|Adverse Event|0|||
130240750|NCT02180867|468841488|FG000|Overall Study|Death|0|||
130240751|NCT02180867|468841489|FG001|Overall Study|Death|0|||
130240752|NCT02180867|468841490|FG002|Overall Study|Death|0|||
130240753|NCT02180867|468841491|FG003|Overall Study|Death|0|||
130240754|NCT02180867|468841492|FG004|Overall Study|Death|1|||
130240755|NCT02180867|468841493|FG005|Overall Study|Death|0|||
130240756|NCT02180867|468841494|FG006|Overall Study|Death|0|||
130240757|NCT02180867|468841488|FG000|Overall Study|Lack of Efficacy|0|||
130240758|NCT02180867|468841489|FG001|Overall Study|Lack of Efficacy|2|||
130240759|NCT02180867|468841490|FG002|Overall Study|Lack of Efficacy|0|||
130240760|NCT02180867|468841491|FG003|Overall Study|Lack of Efficacy|1|||
130240761|NCT02180867|468841492|FG004|Overall Study|Lack of Efficacy|6|||
130240762|NCT02180867|468841493|FG005|Overall Study|Lack of Efficacy|0|||
130240763|NCT02180867|468841494|FG006|Overall Study|Lack of Efficacy|1|||
130240764|NCT02180867|468841488|FG000|Overall Study|Physician Decision|1|||
130240765|NCT02180867|468841489|FG001|Overall Study|Physician Decision|3|||
130240766|NCT02180867|468841490|FG002|Overall Study|Physician Decision|1|||
130240767|NCT02180867|468841491|FG003|Overall Study|Physician Decision|10|||
130240768|NCT02180867|468841492|FG004|Overall Study|Physician Decision|9|||
130240769|NCT02180867|468841493|FG005|Overall Study|Physician Decision|3|||
130240770|NCT02180867|468841494|FG006|Overall Study|Physician Decision|4|||
130240771|NCT02180867|468841488|FG000|Overall Study|Withdrawal by Subject|0|||
130240772|NCT02180867|468841489|FG001|Overall Study|Withdrawal by Subject|0|||
130240773|NCT02180867|468841490|FG002|Overall Study|Withdrawal by Subject|0|||
130240774|NCT02180867|468841491|FG003|Overall Study|Withdrawal by Subject|1|||
130240775|NCT02180867|468841492|FG004|Overall Study|Withdrawal by Subject|1|||
130240776|NCT02180867|468841493|FG005|Overall Study|Withdrawal by Subject|0|||
130240777|NCT02180867|468841494|FG006|Overall Study|Withdrawal by Subject|0|||
130240778|NCT02180867|468841488|FG000|Overall Study|Ineligible|1|||
130240779|NCT02180867|468841489|FG001|Overall Study|Ineligible|2|||
130240780|NCT02180867|468841490|FG002|Overall Study|Ineligible|0|||
130240781|NCT02180867|468841491|FG003|Overall Study|Ineligible|3|||
130240782|NCT02180867|468841492|FG004|Overall Study|Ineligible|5|||
130240783|NCT02180867|468841493|FG005|Overall Study|Ineligible|0|||
130240784|NCT02180867|468841494|FG006|Overall Study|Ineligible|0|||
130240785|NCT02180867|468841488|FG000|Overall Study|Repeat Eligibility Studies|0|||
130240786|NCT02180867|468841489|FG001|Overall Study|Repeat Eligibility Studies|0|||
130240787|NCT02180867|468841490|FG002|Overall Study|Repeat Eligibility Studies|0|||
130240788|NCT02180867|468841491|FG003|Overall Study|Repeat Eligibility Studies|0|||
130240789|NCT02180867|468841492|FG004|Overall Study|Repeat Eligibility Studies|1|||
130240790|NCT02180867|468841493|FG005|Overall Study|Repeat Eligibility Studies|0|||
130240791|NCT02180867|468841494|FG006|Overall Study|Repeat Eligibility Studies|0|||
130240792|NCT02180867|468841488|FG000|Overall Study|Refusal of further protocol therapy|1|||
130240793|NCT02180867|468841489|FG001|Overall Study|Refusal of further protocol therapy|0|||
130240794|NCT02180867|468841490|FG002|Overall Study|Refusal of further protocol therapy|2|||
130240795|NCT02180867|468841491|FG003|Overall Study|Refusal of further protocol therapy|6|||
130449231|NCT00515086|469608883|FG000|Overall Study|Death|2|||
130449232|NCT00515086|469608884|FG001|Overall Study|Death|0|||
130240796|NCT02180867|468841492|FG004|Overall Study|Refusal of further protocol therapy|4|||
130240797|NCT02180867|468841493|FG005|Overall Study|Refusal of further protocol therapy|0|||
130240798|NCT02180867|468841494|FG006|Overall Study|Refusal of further protocol therapy|0|||
130240799|NCT02337686|468841495|FG000|Overall Study|Adverse Event|1|||
130240800|NCT00177671|468842460|FG000|Overall Study|Withdrawal by Subject|5|||
130240801|NCT00177671|468842461|FG001|Overall Study|Withdrawal by Subject|6|||
130449233|NCT00515086|469608885|FG002|Overall Study|Death|0|||
130240802|NCT00177671|468842460|FG000|Overall Study|medical complications|2|||
130240803|NCT00177671|468842461|FG001|Overall Study|medical complications|0|||
130240804|NCT00177671|468842460|FG000|Overall Study|Adverse Event|6|||
130240805|NCT00177671|468842461|FG001|Overall Study|Adverse Event|0|||
130240806|NCT00177671|468842460|FG000|Overall Study|Physician Decision|12|||
130240807|NCT00177671|468842461|FG001|Overall Study|Physician Decision|8|||
130240808|NCT02293499|468842462|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130240809|NCT02293499|468842463|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130316212|NCT00683878|469124329|FG000|Overall Study|Withdrawal by Subject|9|||
130449234|NCT00515086|469608886|FG003|Overall Study|Death|0|||
130449235|NCT02028884|469608887|FG000|Double-blind Period|Adverse Event|5|||
130449236|NCT02028884|469608888|FG001|Double-blind Period|Adverse Event|3|||
130449237|NCT02028884|469608889|FG002|Double-blind Period|Adverse Event|0|||
130449238|NCT02028884|469608887|FG000|Double-blind Period|Eligibility Violation|1|||
130449239|NCT02028884|469608888|FG001|Double-blind Period|Eligibility Violation|0|||
130449240|NCT02028884|469608889|FG002|Double-blind Period|Eligibility Violation|0|||
130449241|NCT02028884|469608887|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
130449242|NCT02028884|469608888|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
130449243|NCT02028884|469608889|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
130449244|NCT02028884|469608887|FG000|Double-blind Period|Withdrawal by Subject|2|||
130449245|NCT02028884|469608888|FG001|Double-blind Period|Withdrawal by Subject|0|||
130449246|NCT02028884|469608889|FG002|Double-blind Period|Withdrawal by Subject|0|||
130449247|NCT02028884|469608887|FG000|Open-label Extension Period|Adverse Event|3|||
130449248|NCT02028884|469608888|FG001|Open-label Extension Period|Adverse Event|1|||
130552979|NCT00504881|469991637|FG000|Overall Study|SAE, non-fatal|2|||
130552980|NCT00504881|469991638|FG001|Overall Study|SAE, non-fatal|6|||
130449249|NCT02028884|469608889|FG002|Open-label Extension Period|Adverse Event|0|||
130449250|NCT02028884|469608887|FG000|Open-label Extension Period|Lack of Efficacy|3|||
130449251|NCT02028884|469608888|FG001|Open-label Extension Period|Lack of Efficacy|0|||
130449252|NCT02028884|469608889|FG002|Open-label Extension Period|Lack of Efficacy|0|||
130449253|NCT02028884|469608887|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
130449254|NCT02028884|469608888|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
130449255|NCT02028884|469608889|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
130449256|NCT02028884|469608887|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130449257|NCT02028884|469608888|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
130449258|NCT02028884|469608889|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130449259|NCT02028884|469608887|FG000|Open-label Extension Period|Switched to another treatment option|3|||
130449260|NCT02028884|469608888|FG001|Open-label Extension Period|Switched to another treatment option|0|||
130449261|NCT02028884|469608889|FG002|Open-label Extension Period|Switched to another treatment option|0|||
130449262|NCT02373813|469608890|FG000|Run-In Period|Other, Not Specified|5|||
130449263|NCT02373813|469608891|FG001|Run-In Period|Other, Not Specified|0|||
130449264|NCT02373813|469608892|FG002|Run-In Period|Other, Not Specified|0|||
130449265|NCT02373813|469608893|FG003|Run-In Period|Other, Not Specified|0|||
130449266|NCT02373813|469608890|FG000|Run-In Period|Withdrawal by Subject|16|||
130449267|NCT02373813|469608891|FG001|Run-In Period|Withdrawal by Subject|0|||
130449268|NCT02373813|469608892|FG002|Run-In Period|Withdrawal by Subject|0|||
130449269|NCT02373813|469608893|FG003|Run-In Period|Withdrawal by Subject|0|||
130449270|NCT02373813|469608890|FG000|Run-In Period|Decision by Sponsor|11|||
130449271|NCT02373813|469608891|FG001|Run-In Period|Decision by Sponsor|0|||
130449272|NCT02373813|469608892|FG002|Run-In Period|Decision by Sponsor|0|||
130240810|NCT02293499|468842464|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
130240811|NCT02293499|468842462|FG000|Intervention - Camp|Withdrawal by Subject|3|||
130240812|NCT02293499|468842463|FG001|Intervention - Camp|Withdrawal by Subject|6|||
130240813|NCT02293499|468842464|FG002|Intervention - Camp|Withdrawal by Subject|2|||
130240814|NCT02293499|468842462|FG000|Intervention - Camp|these are those not showing up at camp|24|||
130449273|NCT02373813|469608893|FG003|Run-In Period|Decision by Sponsor|0|||
130449274|NCT02373813|469608890|FG000|Run-In Period|Protocol Violation|75|||
130449275|NCT02373813|469608891|FG001|Run-In Period|Protocol Violation|0|||
130449276|NCT02373813|469608892|FG002|Run-In Period|Protocol Violation|0|||
130449277|NCT02373813|469608893|FG003|Run-In Period|Protocol Violation|0|||
130449278|NCT02373813|469608890|FG000|Run-In Period|Lost to Follow-up|2|||
130449279|NCT02373813|469608891|FG001|Run-In Period|Lost to Follow-up|0|||
130449280|NCT02373813|469608892|FG002|Run-In Period|Lost to Follow-up|0|||
130449281|NCT02373813|469608893|FG003|Run-In Period|Lost to Follow-up|0|||
130449282|NCT02373813|469608890|FG000|Run-In Period|Adverse Event|3|||
130449283|NCT02373813|469608891|FG001|Run-In Period|Adverse Event|0|||
130449284|NCT02373813|469608892|FG002|Run-In Period|Adverse Event|0|||
130449285|NCT02373813|469608893|FG003|Run-In Period|Adverse Event|0|||
130449286|NCT02373813|469608890|FG000|Run-In Period|Noncompliance|1|||
130449287|NCT02373813|469608891|FG001|Run-In Period|Noncompliance|0|||
130449288|NCT02373813|469608892|FG002|Run-In Period|Noncompliance|0|||
130449289|NCT02373813|469608893|FG003|Run-In Period|Noncompliance|0|||
130449290|NCT02373813|469608890|FG000|Run-In Period|Ineligibility Determined|3|||
130449291|NCT02373813|469608891|FG001|Run-In Period|Ineligibility Determined|0|||
130449292|NCT02373813|469608892|FG002|Run-In Period|Ineligibility Determined|0|||
130449293|NCT02373813|469608893|FG003|Run-In Period|Ineligibility Determined|0|||
130449294|NCT02373813|469608890|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
130449295|NCT02373813|469608891|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
130449296|NCT02373813|469608892|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
130449297|NCT02373813|469608893|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
130240815|NCT02293499|468842463|FG001|Intervention - Camp|these are those not showing up at camp|28|||
130240816|NCT02293499|468842464|FG002|Intervention - Camp|these are those not showing up at camp|4|||
130240817|NCT02293499|468842462|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
130240818|NCT02293499|468842463|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130240819|NCT02293499|468842464|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
130449298|NCT02373813|469608890|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130449299|NCT02373813|469608891|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
130449300|NCT02373813|469608892|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
130449301|NCT02373813|469608893|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
130449302|NCT02373813|469608890|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130449303|NCT02373813|469608891|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130449304|NCT02373813|469608892|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
130449305|NCT02373813|469608893|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130449306|NCT02373813|469608890|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130449307|NCT02373813|469608891|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
130449308|NCT02373813|469608892|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
130449309|NCT02373813|469608893|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
130449310|NCT02403674|469608896|FG000|Base Study|Death|1|||
130449311|NCT02403674|469608897|FG001|Base Study|Death|4|||
130449312|NCT02403674|469608896|FG000|Base Study|Adverse Event|11|||
130449313|NCT02403674|469608897|FG001|Base Study|Adverse Event|26|||
130449314|NCT02403674|469608896|FG000|Base Study|Lack of Efficacy|31|||
130449315|NCT02403674|469608897|FG001|Base Study|Lack of Efficacy|23|||
130449316|NCT02403674|469608896|FG000|Base Study|Lost to Follow-up|6|||
130449317|NCT02403674|469608897|FG001|Base Study|Lost to Follow-up|8|||
130240820|NCT02293499|468842462|FG000|3 Month Follow Up|Lost to Follow-up|14|||
130240821|NCT02293499|468842463|FG001|3 Month Follow Up|Lost to Follow-up|15|||
130240822|NCT02293499|468842464|FG002|3 Month Follow Up|Lost to Follow-up|6|||
130240823|NCT02293499|468842462|FG000|6 Month Follow Up|Lost to Follow-up|17|||
130240824|NCT02293499|468842463|FG001|6 Month Follow Up|Lost to Follow-up|27|||
130240825|NCT02293499|468842464|FG002|6 Month Follow Up|Lost to Follow-up|6|||
130240826|NCT02293499|468842462|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130240827|NCT02293499|468842463|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
130240828|NCT02293499|468842464|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
130240829|NCT02293499|468842462|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
130360933|NCT03643575|469292577|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
130360934|NCT03643575|469292578|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
130360935|NCT03643575|469292573|FG000|Washout: 7 Days|Adverse Event|1|||
130360936|NCT03643575|469292574|FG001|Washout: 7 Days|Adverse Event|0|||
130360937|NCT03643575|469292575|FG002|Washout: 7 Days|Adverse Event|0|||
130360938|NCT03643575|469292576|FG003|Washout: 7 Days|Adverse Event|0|||
130360939|NCT03643575|469292577|FG004|Washout: 7 Days|Adverse Event|0|||
130360940|NCT03643575|469292578|FG005|Washout: 7 Days|Adverse Event|0|||
130360941|NCT03643575|469292573|FG000|Washout: 7 Days|Non compliance check in|0|||
130360942|NCT03643575|469292574|FG001|Washout: 7 Days|Non compliance check in|1|||
130360943|NCT03643575|469292575|FG002|Washout: 7 Days|Non compliance check in|0|||
130360944|NCT03643575|469292576|FG003|Washout: 7 Days|Non compliance check in|0|||
130360945|NCT03643575|469292577|FG004|Washout: 7 Days|Non compliance check in|0|||
130360946|NCT03643575|469292578|FG005|Washout: 7 Days|Non compliance check in|0|||
130360947|NCT01189604|469292579|FG000|Overall Study|Impossible to visit|0|||
130360948|NCT01189604|469292580|FG001|Overall Study|Impossible to visit|0|||
130360949|NCT01189604|469292581|FG002|Overall Study|Impossible to visit|0|||
130360950|NCT01189604|469292582|FG003|Overall Study|Impossible to visit|0|||
130360951|NCT01189604|469292583|FG004|Overall Study|Impossible to visit|0|||
130360952|NCT01189604|469292584|FG005|Overall Study|Impossible to visit|1|||
130360953|NCT01189604|469292585|FG006|Overall Study|Impossible to visit|0|||
130360954|NCT01189604|469292579|FG000|Overall Study|Adverse Event|0|||
130360955|NCT01189604|469292580|FG001|Overall Study|Adverse Event|1|||
130360956|NCT01189604|469292581|FG002|Overall Study|Adverse Event|0|||
130360957|NCT01189604|469292582|FG003|Overall Study|Adverse Event|0|||
130360958|NCT01189604|469292583|FG004|Overall Study|Adverse Event|2|||
130360959|NCT01189604|469292584|FG005|Overall Study|Adverse Event|0|||
130360960|NCT01189604|469292585|FG006|Overall Study|Adverse Event|1|||
130360961|NCT01189604|469292579|FG000|Overall Study|Withdrawal by Subject|1|||
130360962|NCT01189604|469292580|FG001|Overall Study|Withdrawal by Subject|0|||
130360963|NCT01189604|469292581|FG002|Overall Study|Withdrawal by Subject|0|||
130360964|NCT01189604|469292582|FG003|Overall Study|Withdrawal by Subject|0|||
130360965|NCT01189604|469292583|FG004|Overall Study|Withdrawal by Subject|0|||
130360966|NCT01189604|469292584|FG005|Overall Study|Withdrawal by Subject|0|||
130360967|NCT01189604|469292585|FG006|Overall Study|Withdrawal by Subject|0|||
130360968|NCT00986830|469292588|FG000|Overall Study|Death|1|||
130360969|NCT00986830|469292588|FG000|Overall Study|Lost to Follow-up|1|||
130360970|NCT00986830|469292588|FG000|Overall Study|Lack of Efficacy|1|||
130360971|NCT00986830|469292588|FG000|Overall Study|Unable to access sinus with device|5|||
130360972|NCT01332331|469292590|FG000|Overall Study|Lost to Follow-up|0|||
130360973|NCT01332331|469292591|FG001|Overall Study|Lost to Follow-up|1|||
130360974|NCT01332331|469292590|FG000|Overall Study|Adverse Event|1|||
130360975|NCT01332331|469292591|FG001|Overall Study|Adverse Event|1|||
130360976|NCT01332331|469292590|FG000|Overall Study|Physician Decision|1|||
130449318|NCT02403674|469608896|FG000|Base Study|Withdrawal by Subject|10|||
130240830|NCT02293499|468842463|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
130240831|NCT02293499|468842464|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
130360977|NCT01332331|469292591|FG001|Overall Study|Physician Decision|0|||
130360978|NCT00538291|469292592|FG000|Overall Study|Adverse Event|2|||
130360979|NCT00538291|469292592|FG000|Overall Study|Withdrawal by Subject|1|||
130360980|NCT00591344|469292593|FG000|Overall Study|Transportation issues|1|||
130360981|NCT00591344|469292594|FG001|Overall Study|Transportation issues|0|||
130360982|NCT00591344|469292593|FG000|Overall Study|Moved out of state|1|||
130360983|NCT00591344|469292594|FG001|Overall Study|Moved out of state|0|||
130360984|NCT00591344|469292593|FG000|Overall Study|Medical complications|1|||
130449319|NCT02403674|469608897|FG001|Base Study|Withdrawal by Subject|17|||
130449320|NCT02403674|469608896|FG000|Base Study|Physician Decision|2|||
130240832|NCT02293499|468842462|FG000|9 Month Follow Up|Lost to Follow-up|24|||
130360985|NCT00591344|469292594|FG001|Overall Study|Medical complications|3|||
130360986|NCT00591344|469292593|FG000|Overall Study|Underwent DBS|2|||
130360987|NCT00591344|469292594|FG001|Overall Study|Underwent DBS|2|||
130449321|NCT02403674|469608897|FG001|Base Study|Physician Decision|2|||
130240833|NCT02293499|468842463|FG001|9 Month Follow Up|Lost to Follow-up|28|||
130240834|NCT02293499|468842464|FG002|9 Month Follow Up|Lost to Follow-up|4|||
130240835|NCT02293499|468842462|FG000|12 Month Follow Up|Lost to Follow-up|26|||
130240836|NCT02293499|468842463|FG001|12 Month Follow Up|Lost to Follow-up|25|||
130240837|NCT02293499|468842464|FG002|12 Month Follow Up|Lost to Follow-up|6|||
130240838|NCT02293499|468842462|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130240839|NCT02293499|468842463|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130240840|NCT02293499|468842464|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
130240841|NCT02293499|468842462|FG000|15 Month Follow Up|Lost to Follow-up|22|||
130240842|NCT02293499|468842463|FG001|15 Month Follow Up|Lost to Follow-up|22|||
130240843|NCT02293499|468842464|FG002|15 Month Follow Up|Lost to Follow-up|7|||
130240844|NCT00690898|468842465|FG000|SCREENING|Screen failure|18|||
130240845|NCT00690898|468842465|FG000|TREATMENT|Adverse Event|3|||
130240846|NCT00690898|468842465|FG000|TREATMENT|Lack of Efficacy|18|||
130240847|NCT00690898|468842465|FG000|TREATMENT|Withdrawal by Subject|4|||
130240848|NCT00690898|468842465|FG000|TREATMENT|Other (not otherwise specified)|1|||
130240849|NCT01847209|468842468|FG000|Overall Study|Withdrawal by Subject|1|||
130240850|NCT01847209|468842468|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
130240851|NCT02008370|468842489|FG000|Overall Study|Lost to Follow-up|7|||
130240852|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
130240853|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
130240854|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130240855|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130240856|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
130240857|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240858|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
130240859|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240860|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240861|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240862|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Death|0|||
130240863|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Death|0|||
130240864|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Death|1|||
130240865|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Death|0|||
130240866|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Death|0|||
130240867|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
130240868|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
130240869|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
130240870|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
130240871|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
130240872|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Other|2|||
130240873|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Other|1|||
130240874|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Other|0|||
130240875|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Other|0|||
130240876|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Other|0|||
130240877|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240878|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240879|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
130240880|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240881|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240882|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240883|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130240884|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240885|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130240886|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240887|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
130240888|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
130240889|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
130240890|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
130240891|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
130240892|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
130240893|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240894|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130449322|NCT02403674|469608896|FG000|Base Study|Pregnancy|2|||
130696590|NCT03358147|470514448|FG002|Overall Study|Lost to Follow-up|7|||
130240895|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240896|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240897|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240898|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240899|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
130240900|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240901|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240902|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
130449323|NCT02403674|469608897|FG001|Base Study|Pregnancy|2|||
130696591|NCT03358147|470514449|FG003|Overall Study|Lost to Follow-up|6|||
130240903|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
130240904|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
130240905|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
130240906|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
130240907|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
130240908|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
130240909|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130240910|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
130240911|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130240912|NCT03317496|468842493|FG000|Phase 2: Treatment|Adverse Event|0|||
130240913|NCT03317496|468842494|FG001|Phase 2: Treatment|Adverse Event|0|||
130240914|NCT03317496|468842495|FG002|Phase 2: Treatment|Adverse Event|0|||
130240915|NCT03317496|468842496|FG003|Phase 2: Treatment|Adverse Event|0|||
130240916|NCT03317496|468842497|FG004|Phase 2: Treatment|Adverse Event|6|||
130240917|NCT03317496|468842493|FG000|Phase 2: Treatment|Progressive disease|0|||
130240918|NCT03317496|468842494|FG001|Phase 2: Treatment|Progressive disease|0|||
130240919|NCT03317496|468842495|FG002|Phase 2: Treatment|Progressive disease|0|||
130240920|NCT03317496|468842496|FG003|Phase 2: Treatment|Progressive disease|0|||
130240921|NCT03317496|468842497|FG004|Phase 2: Treatment|Progressive disease|22|||
130240922|NCT03317496|468842493|FG000|Phase 2: Treatment|Other|0|||
130240923|NCT03317496|468842494|FG001|Phase 2: Treatment|Other|0|||
130240924|NCT03317496|468842495|FG002|Phase 2: Treatment|Other|0|||
130240925|NCT03317496|468842496|FG003|Phase 2: Treatment|Other|0|||
130240926|NCT03317496|468842497|FG004|Phase 2: Treatment|Other|4|||
130240927|NCT03317496|468842493|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
130240928|NCT03317496|468842494|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
130240929|NCT03317496|468842495|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
130240930|NCT03317496|468842496|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
130240931|NCT03317496|468842497|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
130240932|NCT03317496|468842493|FG000|Phase 2: Treatment|Physician Decision|0|||
130240933|NCT03317496|468842494|FG001|Phase 2: Treatment|Physician Decision|0|||
130240934|NCT03317496|468842495|FG002|Phase 2: Treatment|Physician Decision|0|||
130240935|NCT03317496|468842496|FG003|Phase 2: Treatment|Physician Decision|0|||
130240936|NCT03317496|468842497|FG004|Phase 2: Treatment|Physician Decision|1|||
130240937|NCT03317496|468842493|FG000|Phase 2: Treatment|Death|0|||
130240938|NCT03317496|468842494|FG001|Phase 2: Treatment|Death|0|||
130240939|NCT03317496|468842495|FG002|Phase 2: Treatment|Death|0|||
130240940|NCT03317496|468842496|FG003|Phase 2: Treatment|Death|0|||
130240941|NCT03317496|468842497|FG004|Phase 2: Treatment|Death|1|||
130240942|NCT03317496|468842493|FG000|Phase 2: Follow-up|Death|0|||
130360988|NCT00591344|469292593|FG000|Overall Study|Death|0|||
130360989|NCT00591344|469292594|FG001|Overall Study|Death|1|||
130360990|NCT00591344|469292593|FG000|Overall Study|Lost to Follow-up|0|||
130360991|NCT00591344|469292594|FG001|Overall Study|Lost to Follow-up|1|||
130360992|NCT00591344|469292593|FG000|Overall Study|Did not want to come off medication|0|||
130360993|NCT00591344|469292594|FG001|Overall Study|Did not want to come off medication|1|||
130360994|NCT01672736|469292601|FG000|Overall Study|Available drug expired on 31 May 16|3|||
130360995|NCT01262573|469292602|FG000|Overall Study|Withdrawal by Subject|0|||
130360996|NCT01262573|469292603|FG001|Overall Study|Withdrawal by Subject|1|||
130360997|NCT03800173|469292610|FG000|Overall Study|Lost to Follow-up|0|||
130360998|NCT03800173|469292611|FG001|Overall Study|Lost to Follow-up|0|||
130360999|NCT03800173|469292612|FG002|Overall Study|Lost to Follow-up|0|||
130361000|NCT03800173|469292613|FG003|Overall Study|Lost to Follow-up|0|||
130361001|NCT03800173|469292614|FG004|Overall Study|Lost to Follow-up|1|||
130361002|NCT00936611|469292615|FG000|Overall Study|Progressive Disease|3|||
130361003|NCT00936611|469292615|FG000|Overall Study|New Systemic Therapy|22|||
130361004|NCT00936611|469292615|FG000|Overall Study|Lost to Follow-up|1|||
130361005|NCT00936611|469292615|FG000|Overall Study|Withdrawal by Subject|2|||
130361006|NCT00936611|469292615|FG000|Overall Study|Still on Follow-up|1|||
130361007|NCT00936611|469292615|FG000|Overall Study|Still on Active Therapy|7|||
130361008|NCT00936611|469292615|FG000|Overall Study|Ineligible for Study Drug|3|||
130240943|NCT03317496|468842494|FG001|Phase 2: Follow-up|Death|0|||
130240944|NCT03317496|468842495|FG002|Phase 2: Follow-up|Death|0|||
130240945|NCT03317496|468842496|FG003|Phase 2: Follow-up|Death|0|||
130240946|NCT03317496|468842497|FG004|Phase 2: Follow-up|Death|24|||
130240947|NCT03317496|468842493|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
130361009|NCT02507973|469292616|FG000|Overall Study|Adverse Event|1|||
130361010|NCT02081183|469292618|FG000|Overall Study|Lost to Follow-up|0|||
130361011|NCT02081183|469292619|FG001|Overall Study|Lost to Follow-up|1|||
130361012|NCT02081183|469292618|FG000|Overall Study|Protocol Violation|1|||
130361013|NCT02081183|469292619|FG001|Overall Study|Protocol Violation|0|||
130361014|NCT02081183|469292618|FG000|Overall Study|Other|3|||
130361015|NCT02081183|469292619|FG001|Overall Study|Other|3|||
130361016|NCT00910273|469292624|FG000|Overall Study|Lack of Efficacy|6|||
130361017|NCT00910273|469292625|FG001|Overall Study|Lack of Efficacy|9|||
130361018|NCT00910273|469292624|FG000|Overall Study|Adverse Event|1|||
130361019|NCT00910273|469292625|FG001|Overall Study|Adverse Event|1|||
130361020|NCT00910273|469292624|FG000|Overall Study|Withdrawal by Subject|1|||
130361021|NCT00910273|469292625|FG001|Overall Study|Withdrawal by Subject|0|||
130240948|NCT03317496|468842494|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
130240949|NCT03317496|468842495|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
130240950|NCT03317496|468842496|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
130240951|NCT03317496|468842497|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
130240952|NCT03317496|468842493|FG000|Phase 2: Follow-up|Other|0|||
130696592|NCT03358147|470514450|FG004|Overall Study|Lost to Follow-up|4|||
130696593|NCT03358147|470514446|FG000|Overall Study|Major Protocol Deviation|11|||
130240953|NCT03317496|468842494|FG001|Phase 2: Follow-up|Other|0|||
130240954|NCT03317496|468842495|FG002|Phase 2: Follow-up|Other|0|||
130240955|NCT03317496|468842496|FG003|Phase 2: Follow-up|Other|0|||
130240956|NCT03317496|468842497|FG004|Phase 2: Follow-up|Other|1|||
130240957|NCT03317496|468842493|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240958|NCT03317496|468842494|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240959|NCT03317496|468842495|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240960|NCT03317496|468842496|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240961|NCT03317496|468842497|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
130240962|NCT02737618|468842498|FG000|Overall Study|Withdrawal by Subject|9|||
130240963|NCT01879852|468842502|FG000|Overall Study|Withdrawal by Subject|2|||
130240964|NCT01879852|468842503|FG001|Overall Study|Withdrawal by Subject|0|||
130240965|NCT02696616|468842504|FG000|Overall Study|Adverse Event|0|||
130240966|NCT02696616|468842505|FG001|Overall Study|Adverse Event|1|||
130240967|NCT02696616|468842506|FG002|Overall Study|Adverse Event|0|||
130240968|NCT02696616|468842507|FG003|Overall Study|Adverse Event|0|||
130240969|NCT02696616|468842508|FG004|Overall Study|Adverse Event|0|||
130696594|NCT03358147|470514447|FG001|Overall Study|Major Protocol Deviation|3|||
130240970|NCT02696616|468842509|FG005|Overall Study|Adverse Event|0|||
130240971|NCT02696616|468842510|FG006|Overall Study|Adverse Event|0|||
130240972|NCT01500083|468842513|FG000|Overall Study|Adverse Event|4|||
130240973|NCT01500083|468842514|FG001|Overall Study|Adverse Event|17|||
130240974|NCT01500083|468842513|FG000|Overall Study|Death|0|||
130240975|NCT01500083|468842514|FG001|Overall Study|Death|2|||
130240976|NCT01500083|468842513|FG000|Overall Study|Lost to Follow-up|1|||
130240977|NCT01500083|468842514|FG001|Overall Study|Lost to Follow-up|0|||
130240978|NCT01500083|468842513|FG000|Overall Study|Withdrawal of Consent|0|||
130240979|NCT01500083|468842514|FG001|Overall Study|Withdrawal of Consent|1|||
130240980|NCT01500083|468842513|FG000|Overall Study|Disease Progression|2|||
130240981|NCT01500083|468842514|FG001|Overall Study|Disease Progression|10|||
130240982|NCT01500083|468842513|FG000|Overall Study|Investigator Discretion|3|||
130240983|NCT01500083|468842514|FG001|Overall Study|Investigator Discretion|8|||
130240984|NCT01500083|468842513|FG000|Overall Study|Other Reasons|2|||
130240985|NCT01500083|468842514|FG001|Overall Study|Other Reasons|5|||
130240986|NCT01555931|468842515|FG000|Overall Study|Lost to Follow-up|2|||
130240987|NCT01555931|468842516|FG001|Overall Study|Lost to Follow-up|5|||
130240988|NCT02299167|468842519|FG000|Overall Study|patients were excluded from the study|11|||
130240989|NCT04615507|468842520|FG000|Period 1|Covid-19 exposure|2|||
130240990|NCT04615507|468842521|FG001|Period 1|Covid-19 exposure|1|||
130240991|NCT04615507|468842520|FG000|Period 2|Covid-19 exposure|0|||
130240992|NCT04615507|468842521|FG001|Period 2|Covid-19 exposure|1|||
130240993|NCT04615507|468842520|FG000|Period 2|Protocol Violation|1|||
130240994|NCT04615507|468842521|FG001|Period 2|Protocol Violation|0|||
130240995|NCT04615507|468842520|FG000|Period 2|Withdrawal by Subject|1|||
130240996|NCT04615507|468842521|FG001|Period 2|Withdrawal by Subject|0|||
130361022|NCT00910273|469292624|FG000|Overall Study|Discontinuation of study by sponsor|8|||
130361023|NCT00910273|469292625|FG001|Overall Study|Discontinuation of study by sponsor|2|||
130361024|NCT00910273|469292624|FG000|Overall Study|Protocol Violation|1|||
130361025|NCT00910273|469292625|FG001|Overall Study|Protocol Violation|0|||
130361026|NCT00910273|469292624|FG000|Overall Study|Lost to Follow-up|1|||
130696595|NCT03358147|470514448|FG002|Overall Study|Major Protocol Deviation|2|||
130240997|NCT04615507|468842520|FG000|Period 2|Adverse Event|0|||
130240998|NCT04615507|468842521|FG001|Period 2|Adverse Event|1|||
130361027|NCT00910273|469292625|FG001|Overall Study|Lost to Follow-up|1|||
130696596|NCT03358147|470514449|FG003|Overall Study|Major Protocol Deviation|3|||
130240999|NCT04615507|468842520|FG000|Period 3|Covid-19 exposure|0|||
130241000|NCT04615507|468842521|FG001|Period 3|Covid-19 exposure|1|||
130241001|NCT04598828|468842522|FG000|Overall Study|Physician Decision|1|||
130241002|NCT04598828|468842523|FG001|Overall Study|Physician Decision|0|||
130241003|NCT04598828|468842522|FG000|Overall Study|Withdrawal by Subject|0|||
130241004|NCT04598828|468842523|FG001|Overall Study|Withdrawal by Subject|1|||
130241005|NCT04598828|468842522|FG000|Overall Study|Withdrawal by Subject|0|||
130241006|NCT04598828|468842523|FG001|Overall Study|Withdrawal by Subject|1|||
130241007|NCT02676973|468842524|FG000|Overall Study|Withdrawal by Subject|9|||
130241008|NCT02676973|468842525|FG001|Overall Study|Withdrawal by Subject|8|||
130241009|NCT02676973|468842526|FG002|Overall Study|Withdrawal by Subject|11|||
130241010|NCT02676973|468842524|FG000|Overall Study|Lost to Follow-up|8|||
130241011|NCT02676973|468842525|FG001|Overall Study|Lost to Follow-up|12|||
130361028|NCT01011738|469292626|FG000|Overall Study|Death|12|||
130361029|NCT01011738|469292627|FG001|Overall Study|Death|3|||
130361030|NCT01011738|469292628|FG002|Overall Study|Death|0|||
130361031|NCT01011738|469292626|FG000|Overall Study|Unknown reasons|312|||
130241012|NCT02676973|468842526|FG002|Overall Study|Lost to Follow-up|8|||
130241013|NCT02676973|468842524|FG000|Overall Study|Death|2|||
130241014|NCT02676973|468842525|FG001|Overall Study|Death|1|||
130241015|NCT02676973|468842526|FG002|Overall Study|Death|5|||
130241016|NCT01078662|468842528|FG000|Overall Study|Death|41|||
130241017|NCT01078662|468842529|FG001|Overall Study|Death|103|||
130241018|NCT01078662|468842530|FG002|Overall Study|Death|18|||
130241019|NCT01078662|468842531|FG003|Overall Study|Death|5|||
130241020|NCT01078662|468842532|FG004|Overall Study|Death|8|||
130241021|NCT01078662|468842528|FG000|Overall Study|Patients reached data cut-off|12|||
130241022|NCT01078662|468842529|FG001|Overall Study|Patients reached data cut-off|53|||
130241023|NCT01078662|468842530|FG002|Overall Study|Patients reached data cut-off|2|||
130241024|NCT01078662|468842531|FG003|Overall Study|Patients reached data cut-off|2|||
130241025|NCT01078662|468842532|FG004|Overall Study|Patients reached data cut-off|3|||
130241026|NCT01078662|468842528|FG000|Overall Study|Withdrawal by Subject|4|||
130241027|NCT01078662|468842529|FG001|Overall Study|Withdrawal by Subject|11|||
130241028|NCT01078662|468842530|FG002|Overall Study|Withdrawal by Subject|1|||
130241029|NCT01078662|468842531|FG003|Overall Study|Withdrawal by Subject|0|||
130241030|NCT01078662|468842532|FG004|Overall Study|Withdrawal by Subject|0|||
130241031|NCT01078662|468842528|FG000|Overall Study|Protocol Violation|0|||
130241032|NCT01078662|468842529|FG001|Overall Study|Protocol Violation|1|||
130241033|NCT01078662|468842530|FG002|Overall Study|Protocol Violation|0|||
130241034|NCT01078662|468842531|FG003|Overall Study|Protocol Violation|0|||
130241035|NCT01078662|468842532|FG004|Overall Study|Protocol Violation|0|||
130241036|NCT01078662|468842528|FG000|Overall Study|Lost to Follow-up|1|||
130241037|NCT01078662|468842529|FG001|Overall Study|Lost to Follow-up|0|||
130241038|NCT01078662|468842530|FG002|Overall Study|Lost to Follow-up|0|||
130241039|NCT01078662|468842531|FG003|Overall Study|Lost to Follow-up|0|||
130241040|NCT01078662|468842532|FG004|Overall Study|Lost to Follow-up|0|||
130241041|NCT00700635|468842534|FG000|Overall Study|Adverse Event|1|||
130241042|NCT00700635|468842535|FG001|Overall Study|Adverse Event|0|||
130241043|NCT00700635|468842536|FG002|Overall Study|Adverse Event|0|||
130241044|NCT00700635|468842534|FG000|Overall Study|Lost to Follow-up|1|||
130241045|NCT00700635|468842535|FG001|Overall Study|Lost to Follow-up|3|||
130241046|NCT00700635|468842536|FG002|Overall Study|Lost to Follow-up|0|||
130241047|NCT00700635|468842534|FG000|Overall Study|Protocol Violation|2|||
130241048|NCT00700635|468842535|FG001|Overall Study|Protocol Violation|2|||
130361032|NCT01011738|469292627|FG001|Overall Study|Unknown reasons|291|||
130361033|NCT01011738|469292628|FG002|Overall Study|Unknown reasons|17|||
130361034|NCT03841448|469292629|FG000|Double-blind Treatment (DBT) Period|Death|1|||
130361035|NCT03841448|469292630|FG001|Double-blind Treatment (DBT) Period|Death|1|||
130361036|NCT03841448|469292631|FG002|Double-blind Treatment (DBT) Period|Death|0|||
130361037|NCT03841448|469292632|FG003|Double-blind Treatment (DBT) Period|Death|0|||
130361038|NCT03841448|469292629|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
130361039|NCT03841448|469292630|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
130361040|NCT03841448|469292631|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
130361041|NCT03841448|469292632|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
130361042|NCT03841448|469292629|FG000|Open-Label Extension (OLE) Period|Death|0|||
130361043|NCT03841448|469292630|FG001|Open-Label Extension (OLE) Period|Death|0|||
130361044|NCT03841448|469292631|FG002|Open-Label Extension (OLE) Period|Death|0|||
130361045|NCT03841448|469292632|FG003|Open-Label Extension (OLE) Period|Death|1|||
130361046|NCT03841448|469292629|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130361047|NCT03841448|469292630|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130361048|NCT03841448|469292631|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
130361049|NCT03841448|469292632|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
130361050|NCT03841448|469292629|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
130361051|NCT03841448|469292630|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
130361052|NCT03841448|469292631|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
130361053|NCT03841448|469292632|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
130361054|NCT03841448|469292629|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
130241049|NCT00700635|468842536|FG002|Overall Study|Protocol Violation|0|||
130361055|NCT03841448|469292630|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
130361056|NCT03841448|469292631|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
130376596|NCT00963547|469345867|FG003|Overall Study|Physician Decision|0|||
130376597|NCT00963547|469345868|FG004|Overall Study|Physician Decision|0|||
130241050|NCT00700635|468842534|FG000|Overall Study|Withdrawal by Subject|7|||
130241051|NCT00700635|468842535|FG001|Overall Study|Withdrawal by Subject|3|||
130241052|NCT00700635|468842536|FG002|Overall Study|Withdrawal by Subject|1|||
130241053|NCT05172570|468842537|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130241054|NCT05172570|468842538|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
130241055|NCT05172570|468842539|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130241056|NCT05172570|468842537|FG000|Overall Study|PI Decision due to equipment shortages|0|||
130241057|NCT05172570|468842538|FG001|Overall Study|PI Decision due to equipment shortages|0|||
130449324|NCT02403674|469608896|FG000|Base Study|Protocol Violation|8|||
130449325|NCT02403674|469608897|FG001|Base Study|Protocol Violation|4|||
130449326|NCT02403674|469608896|FG000|Base Study|Non-Compliance with study drug|1|||
130449327|NCT02403674|469608897|FG001|Base Study|Non-Compliance with study drug|4|||
130449328|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
130449329|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
130449330|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
130449331|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
130449332|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
130449333|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
130449334|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
130449335|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
130449336|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
130449337|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
130449338|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
130449339|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
130449340|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Death|1|||
130449341|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Death|0|||
130449342|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
130449343|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
130449344|NCT02403674|469608896|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
130449345|NCT02403674|469608897|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
130449346|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
130449347|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
130449348|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
130449349|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
130449350|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
130449351|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
130449352|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
130449353|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
130449354|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
130449355|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
130449356|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Death|2|||
130449357|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Death|2|||
130449358|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
130449359|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
130449360|NCT02403674|469608896|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
130449361|NCT02403674|469608897|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
130449362|NCT02403674|469608896|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
130449363|NCT02403674|469608897|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
130449364|NCT02403674|469608896|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
130449365|NCT02403674|469608897|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
130449366|NCT02403674|469608896|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
130449367|NCT02403674|469608897|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
130449368|NCT02403674|469608896|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
130449369|NCT02403674|469608897|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
130449370|NCT02403674|469608896|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
130449371|NCT02403674|469608897|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
130449372|NCT01254305|469608899|FG000|Overall Study|Adverse Event|6|||
130449373|NCT01254305|469608900|FG001|Overall Study|Adverse Event|3|||
130449374|NCT01254305|469608901|FG002|Overall Study|Adverse Event|2|||
130449375|NCT01254305|469608899|FG000|Overall Study|Lack of Efficacy|1|||
130449376|NCT01254305|469608900|FG001|Overall Study|Lack of Efficacy|0|||
130449377|NCT01254305|469608901|FG002|Overall Study|Lack of Efficacy|1|||
130449378|NCT01254305|469608899|FG000|Overall Study|Protocol Violation|1|||
130449379|NCT01254305|469608900|FG001|Overall Study|Protocol Violation|7|||
130449380|NCT01254305|469608901|FG002|Overall Study|Protocol Violation|3|||
130449381|NCT01254305|469608899|FG000|Overall Study|Withdrawal by Subject|4|||
130449382|NCT01254305|469608900|FG001|Overall Study|Withdrawal by Subject|2|||
130449383|NCT01254305|469608901|FG002|Overall Study|Withdrawal by Subject|4|||
130449384|NCT01254305|469608899|FG000|Overall Study|Lost to Follow-up|10|||
130449385|NCT01254305|469608900|FG001|Overall Study|Lost to Follow-up|6|||
130449386|NCT01254305|469608901|FG002|Overall Study|Lost to Follow-up|5|||
130449387|NCT01254305|469608899|FG000|Overall Study|Other Reasons|0|||
130449388|NCT01254305|469608900|FG001|Overall Study|Other Reasons|0|||
130449389|NCT01254305|469608901|FG002|Overall Study|Other Reasons|2|||
130449390|NCT03738241|469608905|FG000|Overall Study|Withdrawal by Subject|0|||
130449391|NCT03738241|469608906|FG001|Overall Study|Withdrawal by Subject|0|||
130449392|NCT03738241|469608907|FG002|Overall Study|Withdrawal by Subject|0|||
130449393|NCT03738241|469608908|FG003|Overall Study|Withdrawal by Subject|0|||
130449394|NCT03738241|469608909|FG004|Overall Study|Withdrawal by Subject|0|||
130449395|NCT03738241|469608910|FG005|Overall Study|Withdrawal by Subject|0|||
130449396|NCT03738241|469608911|FG006|Overall Study|Withdrawal by Subject|0|||
130449397|NCT03738241|469608912|FG007|Overall Study|Withdrawal by Subject|0|||
130449398|NCT03738241|469608913|FG008|Overall Study|Withdrawal by Subject|0|||
130449399|NCT03738241|469608914|FG009|Overall Study|Withdrawal by Subject|1|||
130449400|NCT03738241|469608905|FG000|Overall Study|Physician Decision|0|||
130449401|NCT03738241|469608906|FG001|Overall Study|Physician Decision|0|||
130696597|NCT03358147|470514450|FG004|Overall Study|Major Protocol Deviation|1|||
130696598|NCT03358147|470514446|FG000|Overall Study|Protocol specified criteria|2|||
130241058|NCT05172570|468842539|FG002|Overall Study|PI Decision due to equipment shortages|1|||
130241059|NCT04937387|468842542|FG000|Overall Study|Adverse Event|1|||
130241060|NCT04937387|468842543|FG001|Overall Study|Adverse Event|0|||
130241061|NCT04937387|468842544|FG002|Overall Study|Adverse Event|2|||
130241062|NCT04937387|468842545|FG003|Overall Study|Adverse Event|0|||
130241063|NCT04937387|468842542|FG000|Overall Study|Lack of Efficacy|1|||
130241064|NCT04937387|468842543|FG001|Overall Study|Lack of Efficacy|0|||
130241065|NCT04937387|468842544|FG002|Overall Study|Lack of Efficacy|0|||
130241066|NCT04937387|468842545|FG003|Overall Study|Lack of Efficacy|1|||
130241067|NCT04937387|468842542|FG000|Overall Study|Withdrawal by Subject|1|||
130241068|NCT04937387|468842543|FG001|Overall Study|Withdrawal by Subject|0|||
130241069|NCT04937387|468842544|FG002|Overall Study|Withdrawal by Subject|1|||
130241070|NCT04937387|468842545|FG003|Overall Study|Withdrawal by Subject|1|||
130241071|NCT04937387|468842542|FG000|Overall Study|Randomized in error|0|||
130241072|NCT04937387|468842543|FG001|Overall Study|Randomized in error|0|||
130241073|NCT04937387|468842544|FG002|Overall Study|Randomized in error|0|||
130241074|NCT04937387|468842545|FG003|Overall Study|Randomized in error|1|||
130241075|NCT02872714|468842554|FG000|Overall Study|Progressive Disease|1|||
130241076|NCT02872714|468842555|FG001|Overall Study|Progressive Disease|2|||
130241077|NCT02872714|468842556|FG002|Overall Study|Progressive Disease|0|||
130241078|NCT02872714|468842557|FG003|Overall Study|Progressive Disease|0|||
130241079|NCT02872714|468842558|FG004|Overall Study|Progressive Disease|0|||
130241080|NCT02872714|468842554|FG000|Overall Study|Death|87|||
130241081|NCT02872714|468842555|FG001|Overall Study|Death|36|||
130241082|NCT02872714|468842556|FG002|Overall Study|Death|8|||
130241083|NCT02872714|468842557|FG003|Overall Study|Death|81|||
130241084|NCT02872714|468842558|FG004|Overall Study|Death|2|||
130361057|NCT03841448|469292632|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
130361058|NCT01163266|469292633|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
130361059|NCT01163266|469292634|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
130361060|NCT01163266|469292635|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
130361061|NCT01163266|469292633|FG000|Overall Study|Lack of Efficacy|1|||
130361062|NCT01163266|469292634|FG001|Overall Study|Lack of Efficacy|3|||
130361063|NCT01163266|469292635|FG002|Overall Study|Lack of Efficacy|1|||
130361064|NCT01163266|469292633|FG000|Overall Study|Noncompliance with Study Drug|0|||
130361065|NCT01163266|469292634|FG001|Overall Study|Noncompliance with Study Drug|2|||
130361066|NCT01163266|469292635|FG002|Overall Study|Noncompliance with Study Drug|0|||
130361067|NCT01163266|469292633|FG000|Overall Study|Protocol Deviations|2|||
130361068|NCT01163266|469292634|FG001|Overall Study|Protocol Deviations|2|||
130361069|NCT01163266|469292635|FG002|Overall Study|Protocol Deviations|5|||
130361070|NCT01163266|469292633|FG000|Overall Study|Withdrawal of Consent|5|||
130361071|NCT01163266|469292634|FG001|Overall Study|Withdrawal of Consent|7|||
130361072|NCT01163266|469292635|FG002|Overall Study|Withdrawal of Consent|3|||
130361073|NCT01163266|469292633|FG000|Overall Study|Lost to Follow-up|7|||
130361074|NCT01163266|469292634|FG001|Overall Study|Lost to Follow-up|7|||
130361075|NCT01163266|469292635|FG002|Overall Study|Lost to Follow-up|10|||
130361076|NCT01163266|469292633|FG000|Overall Study|Other|1|||
130361077|NCT01163266|469292634|FG001|Overall Study|Other|1|||
130361078|NCT01163266|469292635|FG002|Overall Study|Other|2|||
130361079|NCT02586064|469292636|FG000|Overall Study|Other Obligations|6|||
130361080|NCT02586064|469292637|FG001|Overall Study|Other Obligations|6|||
130361081|NCT02586064|469292636|FG000|Overall Study|Other|3|||
130361082|NCT02586064|469292637|FG001|Overall Study|Other|7|||
130449402|NCT03738241|469608907|FG002|Overall Study|Physician Decision|0|||
130696599|NCT03358147|470514447|FG001|Overall Study|Protocol specified criteria|3|||
130696600|NCT03358147|470514448|FG002|Overall Study|Protocol specified criteria|0|||
130696601|NCT03358147|470514449|FG003|Overall Study|Protocol specified criteria|3|||
130241085|NCT02872714|468842554|FG000|Overall Study|Lost to Follow-up|2|||
130361083|NCT02586064|469292636|FG000|Overall Study|Never Started|3|||
130361084|NCT02586064|469292637|FG001|Overall Study|Never Started|3|||
130449403|NCT03738241|469608908|FG003|Overall Study|Physician Decision|0|||
130241086|NCT02872714|468842555|FG001|Overall Study|Lost to Follow-up|1|||
130241087|NCT02872714|468842556|FG002|Overall Study|Lost to Follow-up|0|||
130241088|NCT02872714|468842557|FG003|Overall Study|Lost to Follow-up|3|||
130361085|NCT02586064|469292636|FG000|Overall Study|Lost Interest|1|||
130361086|NCT02586064|469292637|FG001|Overall Study|Lost Interest|4|||
130361087|NCT02586064|469292636|FG000|Overall Study|Miscellaneous Life Issues|0|||
130696602|NCT03358147|470514450|FG004|Overall Study|Protocol specified criteria|1|||
130241089|NCT02872714|468842558|FG004|Overall Study|Lost to Follow-up|0|||
130241090|NCT02872714|468842554|FG000|Overall Study|Physician Decision|0|||
130241091|NCT02872714|468842555|FG001|Overall Study|Physician Decision|0|||
130241092|NCT02872714|468842556|FG002|Overall Study|Physician Decision|0|||
130241093|NCT02872714|468842557|FG003|Overall Study|Physician Decision|1|||
130241094|NCT02872714|468842558|FG004|Overall Study|Physician Decision|0|||
130241095|NCT02872714|468842554|FG000|Overall Study|Withdrawal by Subject|1|||
130241096|NCT02872714|468842555|FG001|Overall Study|Withdrawal by Subject|3|||
130241097|NCT02872714|468842556|FG002|Overall Study|Withdrawal by Subject|0|||
130241098|NCT02872714|468842557|FG003|Overall Study|Withdrawal by Subject|2|||
130241099|NCT02872714|468842558|FG004|Overall Study|Withdrawal by Subject|0|||
130241100|NCT02872714|468842554|FG000|Overall Study|Captured as Other|2|||
130241101|NCT02872714|468842555|FG001|Overall Study|Captured as Other|0|||
130241102|NCT02872714|468842556|FG002|Overall Study|Captured as Other|0|||
130241103|NCT02872714|468842557|FG003|Overall Study|Captured as Other|1|||
130241104|NCT02872714|468842558|FG004|Overall Study|Captured as Other|0|||
130241105|NCT01001104|468843448|FG000|Overall Study|Adverse Event|2|||
130241106|NCT01001104|468843449|FG001|Overall Study|Adverse Event|1|||
130241107|NCT01001104|468843450|FG002|Overall Study|Adverse Event|0|||
130241108|NCT01001104|468843451|FG003|Overall Study|Adverse Event|0|||
130241109|NCT01001104|468843448|FG000|Overall Study|Lost to Follow-up|0|||
130241110|NCT01001104|468843449|FG001|Overall Study|Lost to Follow-up|0|||
130241111|NCT01001104|468843450|FG002|Overall Study|Lost to Follow-up|1|||
130241112|NCT01001104|468843451|FG003|Overall Study|Lost to Follow-up|0|||
130241113|NCT01001104|468843448|FG000|Overall Study|Entry Criteria Not Met|0|||
130241114|NCT01001104|468843449|FG001|Overall Study|Entry Criteria Not Met|0|||
130241115|NCT01001104|468843450|FG002|Overall Study|Entry Criteria Not Met|0|||
130241116|NCT01001104|468843451|FG003|Overall Study|Entry Criteria Not Met|1|||
130241117|NCT01001104|468843448|FG000|Overall Study|Withdrawal by Subject|0|||
130241118|NCT01001104|468843449|FG001|Overall Study|Withdrawal by Subject|0|||
130241119|NCT01001104|468843450|FG002|Overall Study|Withdrawal by Subject|0|||
130241120|NCT01001104|468843451|FG003|Overall Study|Withdrawal by Subject|2|||
130241121|NCT02397837|468843452|FG000|Overall Study|Withdrawal by Subject|6|||
130241122|NCT02397837|468843453|FG001|Overall Study|Withdrawal by Subject|5|||
130241123|NCT02397837|468843452|FG000|Overall Study|Physician Decision|1|||
130241124|NCT02397837|468843453|FG001|Overall Study|Physician Decision|1|||
130241125|NCT00599313|468843455|FG000|Overall Study|Adverse Event|19|||
130241126|NCT00599313|468843455|FG000|Overall Study|Disease Progression|12|||
130241127|NCT00599313|468843455|FG000|Overall Study|Patient Request|4|||
130241128|NCT00599313|468843455|FG000|Overall Study|Ineligible|1|||
130241129|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Adverse Event|2|||
130241130|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
130241131|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
130241132|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
130241133|NCT02536794|468843456|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
130241134|NCT02536794|468843456|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
130241135|NCT00898807|468843469|FG000|Overall Study|Withdrawal by Subject|5|||
130241136|NCT00898807|468843470|FG001|Overall Study|Withdrawal by Subject|3|||
130449404|NCT03738241|469608909|FG004|Overall Study|Physician Decision|0|||
130449405|NCT03738241|469608910|FG005|Overall Study|Physician Decision|0|||
130449406|NCT03738241|469608911|FG006|Overall Study|Physician Decision|0|||
130449407|NCT03738241|469608912|FG007|Overall Study|Physician Decision|0|||
130449408|NCT03738241|469608913|FG008|Overall Study|Physician Decision|1|||
130449409|NCT03738241|469608914|FG009|Overall Study|Physician Decision|0|||
130449410|NCT03738241|469608905|FG000|Overall Study|Adverse Event|1|||
130449411|NCT03738241|469608906|FG001|Overall Study|Adverse Event|0|||
130449412|NCT03738241|469608907|FG002|Overall Study|Adverse Event|0|||
130449413|NCT03738241|469608908|FG003|Overall Study|Adverse Event|0|||
130449414|NCT03738241|469608909|FG004|Overall Study|Adverse Event|0|||
130449415|NCT03738241|469608910|FG005|Overall Study|Adverse Event|0|||
130241137|NCT00898807|468843469|FG000|Overall Study|Family pressure to discontinue|2|||
130449416|NCT03738241|469608911|FG006|Overall Study|Adverse Event|0|||
130696603|NCT03358147|470514446|FG000|Overall Study|Physician Decision|1|||
130696604|NCT03358147|470514447|FG001|Overall Study|Physician Decision|0|||
130696605|NCT03358147|470514448|FG002|Overall Study|Physician Decision|1|||
130696606|NCT03358147|470514449|FG003|Overall Study|Physician Decision|6|||
130696607|NCT03358147|470514450|FG004|Overall Study|Physician Decision|1|||
130696608|NCT03358147|470514446|FG000|Overall Study|Administrative reasons|0|||
130696609|NCT03358147|470514447|FG001|Overall Study|Administrative reasons|1|||
130241138|NCT00898807|468843470|FG001|Overall Study|Family pressure to discontinue|2|||
130241139|NCT00898807|468843469|FG000|Overall Study|Lost to Follow-up|1|||
130241140|NCT00898807|468843470|FG001|Overall Study|Lost to Follow-up|3|||
130241141|NCT00898807|468843469|FG000|Overall Study|Death|0|||
130241142|NCT00898807|468843470|FG001|Overall Study|Death|1|||
130241143|NCT00817063|468843471|FG000|Overall Study|Adverse Event|32|||
130241144|NCT00817063|468843472|FG001|Overall Study|Adverse Event|13|||
130241145|NCT00817063|468843471|FG000|Overall Study|Death|1|||
130241146|NCT00817063|468843472|FG001|Overall Study|Death|1|||
130449417|NCT03738241|469608912|FG007|Overall Study|Adverse Event|0|||
130241147|NCT00817063|468843471|FG000|Overall Study|Lack of Efficacy|33|||
130241148|NCT00817063|468843472|FG001|Overall Study|Lack of Efficacy|86|||
130449418|NCT03738241|469608913|FG008|Overall Study|Adverse Event|0|||
130449419|NCT03738241|469608914|FG009|Overall Study|Adverse Event|0|||
130449420|NCT03169361|469608915|FG000|Overall Study|Protocol Violation|32|||
130241149|NCT00817063|468843471|FG000|Overall Study|Failure to Return|13|||
130241150|NCT00817063|468843472|FG001|Overall Study|Failure to Return|12|||
130241151|NCT00817063|468843471|FG000|Overall Study|Violation of Selection at Entry|7|||
130241152|NCT00817063|468843472|FG001|Overall Study|Violation of Selection at Entry|4|||
130241153|NCT00817063|468843471|FG000|Overall Study|Protocol Violation|3|||
130241154|NCT00817063|468843472|FG001|Overall Study|Protocol Violation|8|||
130241155|NCT00817063|468843471|FG000|Overall Study|Withdrawal by Subject|17|||
130241156|NCT00817063|468843472|FG001|Overall Study|Withdrawal by Subject|37|||
130241157|NCT00817063|468843471|FG000|Overall Study|Early Improvement|19|||
130241158|NCT00817063|468843472|FG001|Overall Study|Early Improvement|4|||
130241159|NCT00817063|468843471|FG000|Overall Study|Administrative|10|||
130241160|NCT00817063|468843472|FG001|Overall Study|Administrative|4|||
130241161|NCT00817063|468843471|FG000|Overall Study|Abnormality of Laboratory Test|2|||
130241162|NCT00817063|468843472|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130241163|NCT01496456|468843473|FG000|Overall Study|Protocol Violation|1|||
130241164|NCT01496456|468843473|FG000|Overall Study|Lost to Follow-up|7|||
130241165|NCT04919161|468843474|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
130241166|NCT04919161|468843475|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
130241167|NCT04919161|468843474|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
130241168|NCT04919161|468843475|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
130241169|NCT04919161|468843474|FG000|Overall Study|Acute ankle sprain after session 1|0|||
130241170|NCT04919161|468843475|FG001|Overall Study|Acute ankle sprain after session 1|1|||
130241171|NCT02489773|468843476|FG000|Overall Study|Lost to Follow-up|4|||
130241172|NCT02489773|468843477|FG001|Overall Study|Lost to Follow-up|1|||
130241173|NCT02489773|468843476|FG000|Overall Study|Physician Decision|1|||
130241174|NCT02489773|468843477|FG001|Overall Study|Physician Decision|0|||
130241175|NCT02489773|468843476|FG000|Overall Study|Withdrawal by Subject|1|||
130241176|NCT02489773|468843477|FG001|Overall Study|Withdrawal by Subject|0|||
130241177|NCT02489773|468843476|FG000|Overall Study|Leave the country or the state|1|||
130241178|NCT02489773|468843477|FG001|Overall Study|Leave the country or the state|1|||
130241179|NCT00712920|468843478|FG000|Overall Study|Adverse Event|3|||
130241180|NCT00712920|468843479|FG001|Overall Study|Adverse Event|4|||
130241181|NCT00712920|468843480|FG002|Overall Study|Adverse Event|7|||
130241182|NCT00712920|468843478|FG000|Overall Study|Withdrawal by Subject|4|||
130241183|NCT00712920|468843479|FG001|Overall Study|Withdrawal by Subject|2|||
130241184|NCT00712920|468843480|FG002|Overall Study|Withdrawal by Subject|1|||
130241185|NCT00712920|468843478|FG000|Overall Study|Lost to Follow-up|1|||
130241186|NCT00712920|468843479|FG001|Overall Study|Lost to Follow-up|4|||
130241187|NCT00712920|468843480|FG002|Overall Study|Lost to Follow-up|0|||
130241188|NCT00712920|468843478|FG000|Overall Study|Lack of Efficacy|1|||
130241189|NCT00712920|468843479|FG001|Overall Study|Lack of Efficacy|0|||
130241190|NCT00712920|468843480|FG002|Overall Study|Lack of Efficacy|1|||
130241191|NCT00712920|468843478|FG000|Overall Study|Other|5|||
130241192|NCT00712920|468843479|FG001|Overall Study|Other|7|||
130241193|NCT00712920|468843480|FG002|Overall Study|Other|3|||
130241194|NCT00712920|468843478|FG000|Overall Study|Non-compliance|3|||
130241195|NCT00712920|468843479|FG001|Overall Study|Non-compliance|0|||
130241196|NCT00712920|468843480|FG002|Overall Study|Non-compliance|0|||
130241197|NCT02362451|468843483|FG000|Overall Study|Withdrawal by Subject|0|||
130241198|NCT02362451|468843484|FG001|Overall Study|Withdrawal by Subject|1|||
130241199|NCT02362451|468843483|FG000|Overall Study|Lack of Efficacy|2|||
130241200|NCT02362451|468843484|FG001|Overall Study|Lack of Efficacy|0|||
130241201|NCT02362451|468843483|FG000|Overall Study|Progression|1|||
130241202|NCT02362451|468843484|FG001|Overall Study|Progression|0|||
130241203|NCT02362451|468843483|FG000|Overall Study|Participant chose other therapy.|1|||
130241204|NCT02362451|468843484|FG001|Overall Study|Participant chose other therapy.|0|||
130449421|NCT00088465|469608916|FG000|Overall Study|Withdrawal by Subject|290|||
130449422|NCT00088465|469608916|FG000|Overall Study|Adverse Event|77|||
130449423|NCT00088465|469608916|FG000|Overall Study|Lost to Follow-up|57|||
130241205|NCT02115386|468843485|FG000|Overall Study|Protocol Violation|1|||
130449424|NCT00088465|469608916|FG000|Overall Study|Physician Decision|45|||
130696610|NCT03358147|470514448|FG002|Overall Study|Administrative reasons|0|||
130696611|NCT03358147|470514449|FG003|Overall Study|Administrative reasons|3|||
130241206|NCT02115386|468843485|FG000|Overall Study|Administrative - trial was terminated|6|||
130241207|NCT02493855|468843486|FG000|Overall Study|Non-compliance|1|||
130241208|NCT02493855|468843487|FG001|Overall Study|Non-compliance|0|||
130241209|NCT02493855|468843488|FG002|Overall Study|Non-compliance|0|||
130241210|NCT02493855|468843486|FG000|Overall Study|Adverse Event|0|||
130241211|NCT02493855|468843487|FG001|Overall Study|Adverse Event|1|||
130241212|NCT02493855|468843488|FG002|Overall Study|Adverse Event|0|||
130241213|NCT02493855|468843486|FG000|Overall Study|Withdrawal by Subject|1|||
130241214|NCT02493855|468843487|FG001|Overall Study|Withdrawal by Subject|0|||
130449425|NCT00088465|469608916|FG000|Overall Study|Sponsor Decision|37|||
130449426|NCT00088465|469608916|FG000|Overall Study|Lack of Efficacy|27|||
130696612|NCT03358147|470514450|FG004|Overall Study|Administrative reasons|0|||
130696613|NCT03358147|470514446|FG000|Overall Study|Lack of Efficacy|0|||
130696614|NCT03358147|470514447|FG001|Overall Study|Lack of Efficacy|1|||
130696615|NCT03358147|470514448|FG002|Overall Study|Lack of Efficacy|1|||
130696616|NCT03358147|470514449|FG003|Overall Study|Lack of Efficacy|0|||
130696617|NCT03358147|470514450|FG004|Overall Study|Lack of Efficacy|0|||
130696618|NCT02704091|470514451|FG000|Overall Study|Adverse Event|4|||
130696619|NCT02704091|470514452|FG001|Overall Study|Adverse Event|3|||
130696620|NCT02704091|470514451|FG000|Overall Study|Protocol Violation|5|||
130696621|NCT02704091|470514452|FG001|Overall Study|Protocol Violation|3|||
130696622|NCT02704091|470514451|FG000|Overall Study|Consent withdrawn|4|||
130696623|NCT02704091|470514452|FG001|Overall Study|Consent withdrawn|4|||
130696624|NCT02704091|470514451|FG000|Overall Study|Lost to Follow-up|13|||
130696625|NCT02704091|470514452|FG001|Overall Study|Lost to Follow-up|5|||
130696626|NCT02704091|470514451|FG000|Overall Study|Other|2|||
130696627|NCT02704091|470514452|FG001|Overall Study|Other|8|||
130696628|NCT03073798|470514455|FG000|Overall Study|Adverse Event|1|||
130696629|NCT03073798|470514455|FG000|Overall Study|Withdrawal by Subject|1|||
130696630|NCT01186458|470514459|FG000|Overall Study|Adverse Event|1|||
130696631|NCT02640235|470514460|FG000|Overall Study|Withdrawal by Subject|7|||
130696632|NCT02640235|470514461|FG001|Overall Study|Withdrawal by Subject|6|||
130696633|NCT02640235|470514460|FG000|Overall Study|Lost to Follow-up|4|||
130696634|NCT02640235|470514461|FG001|Overall Study|Lost to Follow-up|3|||
130696635|NCT02640235|470514460|FG000|Overall Study|Death|2|||
130696636|NCT02640235|470514461|FG001|Overall Study|Death|3|||
130696637|NCT02640235|470514460|FG000|Overall Study|Other|1|||
130696638|NCT02640235|470514461|FG001|Overall Study|Other|2|||
130696639|NCT00301964|470514462|FG000|Overall Study|Second primary|2|||
130696640|NCT00301964|470514462|FG000|Overall Study|Wrong primary|1|||
130696641|NCT00301964|470514462|FG000|Overall Study|Inadequate pathology|1|||
130696642|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130696643|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130696644|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
130696645|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130696646|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
130696647|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130696648|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130696649|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130696650|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
130696651|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130696652|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130696653|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
130696654|NCT01968551|470514467|FG000|Extension Phase|Adverse Event|0|||
130696655|NCT01968551|470514468|FG001|Extension Phase|Adverse Event|0|||
130696656|NCT01968551|470514469|FG002|Extension Phase|Adverse Event|2|||
130696657|NCT01968551|470514467|FG000|Extension Phase|Death|0|||
130696658|NCT01968551|470514468|FG001|Extension Phase|Death|1|||
130361088|NCT02586064|469292637|FG001|Overall Study|Miscellaneous Life Issues|5|||
130361089|NCT02586064|469292636|FG000|Overall Study|Infrequent Attendance|2|||
130361090|NCT02586064|469292637|FG001|Overall Study|Infrequent Attendance|1|||
130361091|NCT02586064|469292636|FG000|Overall Study|Timed Out|2|||
130361092|NCT02586064|469292637|FG001|Overall Study|Timed Out|0|||
130696659|NCT01968551|470514469|FG002|Extension Phase|Death|0|||
130696660|NCT01968551|470514467|FG000|Extension Phase|Withdrew Consent|0|||
130696661|NCT01968551|470514468|FG001|Extension Phase|Withdrew Consent|0|||
130696662|NCT01968551|470514469|FG002|Extension Phase|Withdrew Consent|1|||
130696663|NCT01968551|470514467|FG000|Extension Phase|Lost to Follow-up|1|||
130696664|NCT01968551|470514468|FG001|Extension Phase|Lost to Follow-up|0|||
130696665|NCT01968551|470514469|FG002|Extension Phase|Lost to Follow-up|1|||
130696666|NCT00819169|470514470|FG000|Overall Study|Withdrawal by Subject|2|||
130361093|NCT02586064|469292636|FG000|Overall Study|AUD relapse|0|||
130361094|NCT02586064|469292637|FG001|Overall Study|AUD relapse|2|||
130361095|NCT02586064|469292636|FG000|Overall Study|Legal Issue|1|||
130696667|NCT00819169|470514471|FG001|Overall Study|Withdrawal by Subject|0|||
130696668|NCT00819169|470514472|FG002|Overall Study|Withdrawal by Subject|0|||
130361096|NCT02586064|469292637|FG001|Overall Study|Legal Issue|0|||
130696669|NCT00819169|470514473|FG003|Overall Study|Withdrawal by Subject|1|||
130696670|NCT00819169|470514474|FG004|Overall Study|Withdrawal by Subject|1|||
130696671|NCT00819169|470514475|FG005|Overall Study|Withdrawal by Subject|1|||
130696672|NCT00819169|470514476|FG006|Overall Study|Withdrawal by Subject|5|||
130696673|NCT00819169|470514477|FG007|Overall Study|Withdrawal by Subject|1|||
130696674|NCT00819169|470514478|FG008|Overall Study|Withdrawal by Subject|4|||
130696675|NCT00819169|470514470|FG000|Overall Study|Lost to Follow-up|0|||
130376598|NCT00963547|469345869|FG005|Overall Study|Physician Decision|0|||
130376599|NCT00963547|469345870|FG006|Overall Study|Physician Decision|0|||
130376600|NCT00963547|469345864|FG000|Overall Study|Progressive Disease|3|||
130696676|NCT00819169|470514471|FG001|Overall Study|Lost to Follow-up|2|||
130696677|NCT00819169|470514472|FG002|Overall Study|Lost to Follow-up|0|||
130696678|NCT00819169|470514473|FG003|Overall Study|Lost to Follow-up|1|||
130241215|NCT02493855|468843488|FG002|Overall Study|Withdrawal by Subject|0|||
130241216|NCT02453048|468843489|FG000|Overall Study|Only part of initial 6 mo. study|0|||
130241217|NCT02453048|468843490|FG001|Overall Study|Only part of initial 6 mo. study|0|||
130241218|NCT02453048|468843491|FG002|Overall Study|Only part of initial 6 mo. study|0|||
130241219|NCT02453048|468843492|FG003|Overall Study|Only part of initial 6 mo. study|0|||
130241220|NCT02453048|468843493|FG004|Overall Study|Only part of initial 6 mo. study|6|||
130241221|NCT02453048|468843489|FG000|Overall Study|Lost to Follow-up|0|||
130241222|NCT02453048|468843490|FG001|Overall Study|Lost to Follow-up|1|||
130241223|NCT02453048|468843491|FG002|Overall Study|Lost to Follow-up|2|||
130241224|NCT02453048|468843492|FG003|Overall Study|Lost to Follow-up|0|||
130241225|NCT02453048|468843493|FG004|Overall Study|Lost to Follow-up|0|||
130241226|NCT03600428|468843495|FG000|Overall Study|Not eligible|0|||
130241227|NCT03600428|468843496|FG001|Overall Study|Not eligible|1|||
130241228|NCT03600428|468843495|FG000|Overall Study|Lost to Follow-up|5|||
130241229|NCT03600428|468843496|FG001|Overall Study|Lost to Follow-up|4|||
130241230|NCT01695746|468843500|FG000|Overall Study|Adverse Event|1|||
130241231|NCT01695746|468843500|FG000|Overall Study|Non-compliance by the participant|3|||
130241232|NCT01695746|468843500|FG000|Overall Study|Protocol Violation|5|||
130241233|NCT01695746|468843500|FG000|Overall Study|Participant not willing to participate|3|||
130241234|NCT01202591|468843501|FG000|Overall Study|Adverse Event|2|||
130241235|NCT01202591|468843502|FG001|Overall Study|Adverse Event|1|||
130241236|NCT01202591|468843503|FG002|Overall Study|Adverse Event|4|||
130241237|NCT01202591|468843504|FG003|Overall Study|Adverse Event|4|||
130241238|NCT01202591|468843505|FG004|Overall Study|Adverse Event|0|||
130241239|NCT01202591|468843506|FG005|Overall Study|Adverse Event|0|||
130449427|NCT00088465|469608916|FG000|Overall Study|Protocol Violation|17|||
130449428|NCT00088465|469608916|FG000|Overall Study|Death|11|||
130241240|NCT01202591|468843501|FG000|Overall Study|Other reason as per investigator|3|||
130241241|NCT01202591|468843502|FG001|Overall Study|Other reason as per investigator|4|||
130241242|NCT01202591|468843503|FG002|Overall Study|Other reason as per investigator|7|||
130241243|NCT01202591|468843504|FG003|Overall Study|Other reason as per investigator|3|||
130241244|NCT01202591|468843505|FG004|Overall Study|Other reason as per investigator|1|||
130449429|NCT00495469|469608917|FG000|Overall Study|Adverse Event|0|||
130449430|NCT00495469|469608918|FG001|Overall Study|Adverse Event|1|||
130449431|NCT00495469|469608919|FG002|Overall Study|Adverse Event|3|||
130449432|NCT00495469|469608920|FG003|Overall Study|Adverse Event|0|||
130449433|NCT00495469|469608921|FG004|Overall Study|Adverse Event|1|||
130449434|NCT00495469|469608922|FG005|Overall Study|Adverse Event|1|||
130449435|NCT00495469|469608923|FG006|Overall Study|Adverse Event|1|||
130449436|NCT00495469|469608917|FG000|Overall Study|Lost to Follow-up|1|||
130449437|NCT00495469|469608918|FG001|Overall Study|Lost to Follow-up|1|||
130241245|NCT01202591|468843506|FG005|Overall Study|Other reason as per investigator|3|||
130241246|NCT01202591|468843501|FG000|Overall Study|Withdrawal by Subject|0|||
130241247|NCT01202591|468843502|FG001|Overall Study|Withdrawal by Subject|0|||
130241248|NCT01202591|468843503|FG002|Overall Study|Withdrawal by Subject|0|||
130241249|NCT01202591|468843504|FG003|Overall Study|Withdrawal by Subject|0|||
130449438|NCT00495469|469608919|FG002|Overall Study|Lost to Follow-up|3|||
130449439|NCT00495469|469608920|FG003|Overall Study|Lost to Follow-up|1|||
130449440|NCT00495469|469608921|FG004|Overall Study|Lost to Follow-up|0|||
130449441|NCT00495469|469608922|FG005|Overall Study|Lost to Follow-up|0|||
130449442|NCT00495469|469608923|FG006|Overall Study|Lost to Follow-up|0|||
130449443|NCT00495469|469608917|FG000|Overall Study|Protocol Violation|0|||
130449444|NCT00495469|469608918|FG001|Overall Study|Protocol Violation|0|||
130361097|NCT03181893|469292638|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361098|NCT03181893|469292639|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
130361099|NCT03181893|469292640|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361100|NCT03181893|469292641|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361101|NCT03181893|469292642|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361102|NCT03181893|469292643|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361103|NCT03181893|469292644|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130449445|NCT00495469|469608919|FG002|Overall Study|Protocol Violation|0|||
130449446|NCT00495469|469608920|FG003|Overall Study|Protocol Violation|0|||
130449447|NCT00495469|469608921|FG004|Overall Study|Protocol Violation|1|||
130449448|NCT00495469|469608922|FG005|Overall Study|Protocol Violation|2|||
130449449|NCT00495469|469608923|FG006|Overall Study|Protocol Violation|0|||
130449450|NCT00495469|469608917|FG000|Overall Study|Withdrawal by Subject|5|||
130696679|NCT00819169|470514474|FG004|Overall Study|Lost to Follow-up|0|||
130696680|NCT00819169|470514475|FG005|Overall Study|Lost to Follow-up|6|||
130696681|NCT00819169|470514476|FG006|Overall Study|Lost to Follow-up|2|||
130241250|NCT01202591|468843505|FG004|Overall Study|Withdrawal by Subject|2|||
130241251|NCT01202591|468843506|FG005|Overall Study|Withdrawal by Subject|1|||
130241252|NCT01202591|468843501|FG000|Overall Study|Objective Disease Progression|0|||
130241253|NCT01202591|468843502|FG001|Overall Study|Objective Disease Progression|0|||
130241254|NCT01202591|468843503|FG002|Overall Study|Objective Disease Progression|0|||
130241255|NCT01202591|468843504|FG003|Overall Study|Objective Disease Progression|0|||
130241256|NCT01202591|468843505|FG004|Overall Study|Objective Disease Progression|2|||
130449451|NCT00495469|469608918|FG001|Overall Study|Withdrawal by Subject|3|||
130449452|NCT00495469|469608919|FG002|Overall Study|Withdrawal by Subject|1|||
130449453|NCT00495469|469608920|FG003|Overall Study|Withdrawal by Subject|3|||
130449454|NCT00495469|469608921|FG004|Overall Study|Withdrawal by Subject|3|||
130449455|NCT00495469|469608922|FG005|Overall Study|Withdrawal by Subject|2|||
130696682|NCT00819169|470514477|FG007|Overall Study|Lost to Follow-up|2|||
130696683|NCT00819169|470514478|FG008|Overall Study|Lost to Follow-up|1|||
130696684|NCT00819169|470514470|FG000|Overall Study|Death|1|||
130696685|NCT00819169|470514471|FG001|Overall Study|Death|1|||
130696686|NCT00819169|470514472|FG002|Overall Study|Death|3|||
130696687|NCT00819169|470514473|FG003|Overall Study|Death|8|||
130696688|NCT00819169|470514474|FG004|Overall Study|Death|5|||
130696689|NCT00819169|470514475|FG005|Overall Study|Death|7|||
130696690|NCT00819169|470514476|FG006|Overall Study|Death|9|||
130696691|NCT00819169|470514477|FG007|Overall Study|Death|4|||
130696692|NCT00819169|470514478|FG008|Overall Study|Death|7|||
130696693|NCT00819169|470514470|FG000|Overall Study|Ineligibility determined|0|||
130241257|NCT01202591|468843506|FG005|Overall Study|Objective Disease Progression|0|||
130241258|NCT02830087|468843509|FG000|Overall Study|No study staff to follow-up patients|4|||
130241259|NCT02830087|468843510|FG001|Overall Study|No study staff to follow-up patients|4|||
130241260|NCT02830087|468843511|FG002|Overall Study|No study staff to follow-up patients|4|||
130241261|NCT02830087|468843512|FG003|Overall Study|No study staff to follow-up patients|3|||
130241262|NCT02830087|468843513|FG004|Overall Study|No study staff to follow-up patients|3|||
130241263|NCT02830087|468843514|FG005|Overall Study|No study staff to follow-up patients|3|||
130241264|NCT02583269|468843515|FG000|Overall Study|Patient hospitalized prior to start|1|||
130241265|NCT02583269|468843516|FG001|Overall Study|Patient hospitalized prior to start|0|||
130241266|NCT02583269|468843517|FG002|Overall Study|Patient hospitalized prior to start|0|||
130241267|NCT02583269|468843518|FG003|Overall Study|Patient hospitalized prior to start|0|||
130241268|NCT02583269|468843519|FG004|Overall Study|Patient hospitalized prior to start|0|||
130241269|NCT03611946|468843520|FG000|Overall Study|Withdrawal by Subject|0|||
130241270|NCT03611946|468843521|FG001|Overall Study|Withdrawal by Subject|0|||
130241271|NCT03611946|468843522|FG002|Overall Study|Withdrawal by Subject|1|||
130241272|NCT03611946|468843523|FG003|Overall Study|Withdrawal by Subject|0|||
130241273|NCT02207608|468843524|FG000|Overall Study|Adverse Event|1|||
130241274|NCT02207608|468843525|FG001|Overall Study|Adverse Event|0|||
130241275|NCT00980460|468843526|FG000|Overall Study|Death|0|||
130449456|NCT00495469|469608923|FG006|Overall Study|Withdrawal by Subject|3|||
130449457|NCT00495469|469608917|FG000|Overall Study|Lack of Efficacy|0|||
130449458|NCT00495469|469608918|FG001|Overall Study|Lack of Efficacy|0|||
130449459|NCT00495469|469608919|FG002|Overall Study|Lack of Efficacy|0|||
130449460|NCT00495469|469608920|FG003|Overall Study|Lack of Efficacy|0|||
130449461|NCT00495469|469608921|FG004|Overall Study|Lack of Efficacy|0|||
130449462|NCT00495469|469608922|FG005|Overall Study|Lack of Efficacy|0|||
130449463|NCT00495469|469608923|FG006|Overall Study|Lack of Efficacy|1|||
130696694|NCT00819169|470514471|FG001|Overall Study|Ineligibility determined|0|||
130696695|NCT00819169|470514472|FG002|Overall Study|Ineligibility determined|0|||
130696696|NCT00819169|470514473|FG003|Overall Study|Ineligibility determined|2|||
130696697|NCT00819169|470514474|FG004|Overall Study|Ineligibility determined|0|||
130696698|NCT00819169|470514475|FG005|Overall Study|Ineligibility determined|0|||
130696699|NCT00819169|470514476|FG006|Overall Study|Ineligibility determined|0|||
130696700|NCT00819169|470514477|FG007|Overall Study|Ineligibility determined|0|||
130241276|NCT00980460|468843527|FG001|Overall Study|Death|0|||
130241277|NCT00980460|468843528|FG002|Overall Study|Death|1|||
130361104|NCT03181893|469292645|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361105|NCT03181893|469292646|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361106|NCT03181893|469292647|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361107|NCT03181893|469292648|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130361108|NCT03181893|469292638|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
130361109|NCT03181893|469292639|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
130361110|NCT03181893|469292640|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361111|NCT03181893|469292641|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130696701|NCT00819169|470514478|FG008|Overall Study|Ineligibility determined|1|||
130696702|NCT00819169|470514470|FG000|Overall Study|Adverse Event|0|||
130241278|NCT00980460|468843529|FG003|Overall Study|Death|2|||
130696703|NCT00819169|470514471|FG001|Overall Study|Adverse Event|0|||
130696704|NCT00819169|470514472|FG002|Overall Study|Adverse Event|0|||
130696705|NCT00819169|470514473|FG003|Overall Study|Adverse Event|0|||
130696706|NCT00819169|470514474|FG004|Overall Study|Adverse Event|1|||
130696707|NCT00819169|470514475|FG005|Overall Study|Adverse Event|0|||
130361112|NCT03181893|469292642|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361113|NCT03181893|469292643|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130449464|NCT00495469|469608917|FG000|Overall Study|Liver function test abnormality|0|||
130696708|NCT00819169|470514476|FG006|Overall Study|Adverse Event|0|||
130696709|NCT00819169|470514477|FG007|Overall Study|Adverse Event|0|||
130241279|NCT00980460|468843530|FG004|Overall Study|Death|1|||
130241280|NCT00980460|468843526|FG000|Overall Study|Lack of Efficacy|0|||
130696710|NCT00819169|470514478|FG008|Overall Study|Adverse Event|0|||
130696711|NCT00819169|470514470|FG000|Overall Study|Administrative Decision|0|||
130696712|NCT00819169|470514471|FG001|Overall Study|Administrative Decision|0|||
130696713|NCT00819169|470514472|FG002|Overall Study|Administrative Decision|0|||
130696714|NCT00819169|470514473|FG003|Overall Study|Administrative Decision|0|||
130696715|NCT00819169|470514474|FG004|Overall Study|Administrative Decision|1|||
130696716|NCT00819169|470514475|FG005|Overall Study|Administrative Decision|2|||
130361114|NCT03181893|469292644|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361115|NCT03181893|469292645|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361116|NCT03181893|469292646|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361117|NCT03181893|469292647|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361118|NCT03181893|469292648|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130361119|NCT03181893|469292638|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361120|NCT03181893|469292639|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361121|NCT03181893|469292640|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361122|NCT03181893|469292641|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361123|NCT03181893|469292642|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361124|NCT03181893|469292643|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361125|NCT03181893|469292644|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361126|NCT03181893|469292645|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
130361127|NCT03181893|469292646|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
130361128|NCT03181893|469292647|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361129|NCT03181893|469292648|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130361130|NCT03181893|469292638|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361131|NCT03181893|469292639|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361132|NCT03181893|469292640|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361133|NCT03181893|469292641|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361134|NCT03181893|469292642|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361135|NCT03181893|469292643|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361136|NCT03181893|469292644|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361137|NCT03181893|469292645|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361138|NCT03181893|469292646|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361139|NCT03181893|469292647|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
130361140|NCT03181893|469292648|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130361141|NCT03181893|469292638|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361142|NCT03181893|469292639|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361143|NCT03181893|469292640|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361144|NCT03181893|469292641|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361145|NCT03181893|469292642|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361146|NCT03181893|469292643|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361147|NCT03181893|469292644|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361148|NCT03181893|469292645|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361149|NCT03181893|469292646|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361150|NCT03181893|469292647|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130361151|NCT03181893|469292648|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
130361152|NCT00968864|469292650|FG000|Overall Study|Protocol exception/ not evaluable|1|||
130361153|NCT04815031|469292651|FG000|Overall Study|No adverse event information (missing information)|33|||
130361154|NCT00586625|469292652|FG000|Overall Study|Adverse Event|6|||
130361155|NCT00586625|469292653|FG001|Overall Study|Adverse Event|6|||
130361156|NCT00586625|469292652|FG000|Overall Study|Protocol Violation|3|||
130361157|NCT00586625|469292653|FG001|Overall Study|Protocol Violation|0|||
130361158|NCT00586625|469292652|FG000|Overall Study|Withdrawal by Subject|32|||
130361159|NCT00586625|469292653|FG001|Overall Study|Withdrawal by Subject|10|||
130361160|NCT00586625|469292652|FG000|Overall Study|Subject non-compliance|0|||
130361161|NCT00586625|469292653|FG001|Overall Study|Subject non-compliance|1|||
130361162|NCT00586625|469292652|FG000|Overall Study|Subject unable to return for visit|2|||
130361163|NCT00586625|469292653|FG001|Overall Study|Subject unable to return for visit|0|||
130361164|NCT02728596|469292654|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130361165|NCT02728596|469292655|FG001|Overall Study|Refusal unrelated to adverse event|6|||
130361166|NCT02728596|469292656|FG002|Overall Study|Refusal unrelated to adverse event|7|||
130696717|NCT00819169|470514476|FG006|Overall Study|Administrative Decision|0|||
130361167|NCT02728596|469292657|FG003|Overall Study|Refusal unrelated to adverse event|7|||
130361168|NCT02728596|469292654|FG000|Overall Study|Death|44|||
130361169|NCT02728596|469292655|FG001|Overall Study|Death|42|||
130361170|NCT02728596|469292656|FG002|Overall Study|Death|123|||
130361171|NCT02728596|469292657|FG003|Overall Study|Death|68|||
130361172|NCT04032652|469292664|FG000|Overall Study|The study was terminated and the PI has|1|||
130376601|NCT00963547|469345865|FG001|Overall Study|Progressive Disease|8|||
130376602|NCT00963547|469345866|FG002|Overall Study|Progressive Disease|9|||
130376603|NCT00963547|469345867|FG003|Overall Study|Progressive Disease|5|||
130696718|NCT00819169|470514477|FG007|Overall Study|Administrative Decision|2|||
130696719|NCT00819169|470514478|FG008|Overall Study|Administrative Decision|0|||
130696720|NCT00573313|470514481|FG000|Overall Study|Protocol Violation|5|||
130696721|NCT00573313|470514482|FG001|Overall Study|Protocol Violation|0|||
130696722|NCT00573313|470514483|FG002|Overall Study|Protocol Violation|6|||
130449465|NCT00495469|469608918|FG001|Overall Study|Liver function test abnormality|1|||
130449466|NCT00495469|469608919|FG002|Overall Study|Liver function test abnormality|0|||
130449467|NCT00495469|469608920|FG003|Overall Study|Liver function test abnormality|0|||
130449468|NCT00495469|469608921|FG004|Overall Study|Liver function test abnormality|0|||
130449469|NCT00495469|469608922|FG005|Overall Study|Liver function test abnormality|0|||
130449470|NCT00495469|469608923|FG006|Overall Study|Liver function test abnormality|0|||
130449471|NCT00495469|469608917|FG000|Overall Study|ST depression at randomisation in ECG|0|||
130449472|NCT00495469|469608918|FG001|Overall Study|ST depression at randomisation in ECG|1|||
130449473|NCT00495469|469608919|FG002|Overall Study|ST depression at randomisation in ECG|0|||
130449474|NCT00495469|469608920|FG003|Overall Study|ST depression at randomisation in ECG|0|||
130449475|NCT00495469|469608921|FG004|Overall Study|ST depression at randomisation in ECG|0|||
130449476|NCT00495469|469608922|FG005|Overall Study|ST depression at randomisation in ECG|0|||
130449477|NCT00495469|469608923|FG006|Overall Study|ST depression at randomisation in ECG|0|||
130449478|NCT00448864|469608926|FG000|Overall Study|Death|1|||
130449479|NCT00448864|469608927|FG001|Overall Study|Death|0|||
130449480|NCT00448864|469608928|FG002|Overall Study|Death|0|||
130449481|NCT00448864|469608926|FG000|Overall Study|Lost to Follow-up|3|||
130449482|NCT00448864|469608927|FG001|Overall Study|Lost to Follow-up|1|||
130449483|NCT00448864|469608928|FG002|Overall Study|Lost to Follow-up|0|||
130449484|NCT00448864|469608926|FG000|Overall Study|Physician Decision|1|||
130696723|NCT00573313|470514484|FG003|Overall Study|Protocol Violation|0|||
130696724|NCT00467597|470514493|FG000|Overall Study|Withdrawal by Subject|2|||
130696725|NCT00467597|470514494|FG001|Overall Study|Withdrawal by Subject|0|||
130449485|NCT00448864|469608927|FG001|Overall Study|Physician Decision|0|||
130449486|NCT00448864|469608928|FG002|Overall Study|Physician Decision|1|||
130449487|NCT00448864|469608926|FG000|Overall Study|Withdrawal by Subject|0|||
130449488|NCT00448864|469608927|FG001|Overall Study|Withdrawal by Subject|2|||
130449489|NCT00448864|469608928|FG002|Overall Study|Withdrawal by Subject|0|||
130449490|NCT00448864|469608926|FG000|Overall Study|Protocol Violation|0|||
130449491|NCT00448864|469608927|FG001|Overall Study|Protocol Violation|2|||
130449492|NCT00448864|469608928|FG002|Overall Study|Protocol Violation|0|||
130449493|NCT04454567|469608929|FG000|Overall Study|Study Terminated by Sponsor|1|||
130449494|NCT04454567|469608930|FG001|Overall Study|Study Terminated by Sponsor|1|||
130449495|NCT01175707|469608934|FG000|Overall Study|Adverse Event|4|||
130449496|NCT01175707|469608935|FG001|Overall Study|Adverse Event|6|||
130449497|NCT03606460|469608938|FG000|Overall Study|Lost to Follow-up|1|||
130449498|NCT03606460|469608939|FG001|Overall Study|Lost to Follow-up|8|||
130449499|NCT04170023|469608940|FG000|LTE Period|Withdrawal by Subject|1|||
130449500|NCT04170023|469608941|FG001|LTE Period|Withdrawal by Subject|0|||
130449501|NCT04170023|469608942|FG002|LTE Period|Withdrawal by Subject|0|||
130449502|NCT04170023|469608940|FG000|LTE Period|Study Termination|11|||
130449503|NCT04170023|469608941|FG001|LTE Period|Study Termination|11|||
130449504|NCT04170023|469608942|FG002|LTE Period|Study Termination|5|||
130449505|NCT00578227|469608953|FG000|Overall Study|Lost to Follow-up|0|||
130449506|NCT00578227|469608954|FG001|Overall Study|Lost to Follow-up|1|||
130449507|NCT00578227|469608955|FG002|Overall Study|Lost to Follow-up|1|||
130449508|NCT00578227|469608953|FG000|Overall Study|Withdrawal by Subject|5|||
130449509|NCT00578227|469608954|FG001|Overall Study|Withdrawal by Subject|1|||
130449510|NCT00578227|469608955|FG002|Overall Study|Withdrawal by Subject|3|||
130449511|NCT00577629|469608956|FG000|Treatment Period|Death|1|||
130449512|NCT00577629|469608956|FG000|Long Term Follow-Up|Death|15|||
130449513|NCT00577629|469608956|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
130449514|NCT00577629|469608956|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
130449515|NCT00577629|469608956|FG000|Long Term Follow-Up|Physician Decision|1|||
130449516|NCT01414166|469608957|FG000|Overall Study|Adverse Event|10|||
130449517|NCT01414166|469608958|FG001|Overall Study|Adverse Event|2|||
130449518|NCT01414166|469608957|FG000|Overall Study|Lost to Follow-up|4|||
130696726|NCT02096705|470514495|FG000|Treatment|Adverse Event|6|||
130449519|NCT01414166|469608958|FG001|Overall Study|Lost to Follow-up|1|||
130449520|NCT01414166|469608957|FG000|Overall Study|Non-compliance with study drug|2|||
130696727|NCT02096705|470514496|FG001|Treatment|Adverse Event|3|||
130449521|NCT01414166|469608958|FG001|Overall Study|Non-compliance with study drug|0|||
130449522|NCT01414166|469608957|FG000|Overall Study|Physician Decision|2|||
130449523|NCT01414166|469608958|FG001|Overall Study|Physician Decision|0|||
130449524|NCT01414166|469608957|FG000|Overall Study|Protocol Violation|2|||
130696728|NCT02096705|470514495|FG000|Treatment|Subject request to discontinue treatment|1|||
130696729|NCT02096705|470514496|FG001|Treatment|Subject request to discontinue treatment|1|||
130696730|NCT02096705|470514495|FG000|Treatment|Withdrawal by Subject|1|||
130696731|NCT02096705|470514496|FG001|Treatment|Withdrawal by Subject|0|||
130696732|NCT02096705|470514495|FG000|Treatment|Other|1|||
130696733|NCT02096705|470514496|FG001|Treatment|Other|1|||
130449525|NCT01414166|469608958|FG001|Overall Study|Protocol Violation|0|||
130449526|NCT01414166|469608957|FG000|Overall Study|Study terminated by Sponsor|68|||
130449527|NCT01414166|469608958|FG001|Overall Study|Study terminated by Sponsor|75|||
130449528|NCT01414166|469608957|FG000|Overall Study|Withdrawal by Subject|3|||
130449529|NCT01414166|469608958|FG001|Overall Study|Withdrawal by Subject|5|||
130449530|NCT03782727|469608959|FG000|Overall Study|Lost to Follow-up|32|||
130449531|NCT05489224|469608960|FG000|Treatment Period I|Withdrawal by Subject|6|||
130449532|NCT05489224|469608961|FG001|Treatment Period I|Withdrawal by Subject|5|||
130449533|NCT05489224|469608962|FG002|Treatment Period I|Withdrawal by Subject|0|||
130449534|NCT05489224|469608960|FG000|Treatment Period I|Adverse Event|3|||
130449535|NCT05489224|469608961|FG001|Treatment Period I|Adverse Event|11|||
130449536|NCT05489224|469608962|FG002|Treatment Period I|Adverse Event|0|||
130449537|NCT05489224|469608960|FG000|Treatment Period I|Lost to Follow-up|0|||
130449538|NCT05489224|469608961|FG001|Treatment Period I|Lost to Follow-up|1|||
130449539|NCT05489224|469608962|FG002|Treatment Period I|Lost to Follow-up|0|||
130449540|NCT05489224|469608960|FG000|Treatment Period I|Physician Decision|0|||
130449541|NCT05489224|469608961|FG001|Treatment Period I|Physician Decision|1|||
130449542|NCT05489224|469608962|FG002|Treatment Period I|Physician Decision|0|||
130449543|NCT05489224|469608960|FG000|Treatment Period II up to Week 32|Ongoing|222|||
130449544|NCT05489224|469608961|FG001|Treatment Period II up to Week 32|Ongoing|107|||
130449545|NCT05489224|469608962|FG002|Treatment Period II up to Week 32|Ongoing|107|||
130449546|NCT05489224|469608960|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
130449547|NCT05489224|469608961|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
130449548|NCT05489224|469608962|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
130449549|NCT05489224|469608960|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
130449550|NCT05489224|469608961|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
130449551|NCT05489224|469608962|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
130449552|NCT00764868|469608968|FG000|Overall Study|Adverse Event|18|||
130449553|NCT00764868|469608968|FG000|Overall Study|Withdrawal by Subject|31|||
130449554|NCT00764868|469608968|FG000|Overall Study|Non-compliance|16|||
130449555|NCT00764868|469608968|FG000|Overall Study|Lost to Follow-up|25|||
130449556|NCT00764868|469608968|FG000|Overall Study|Lack of Efficacy|5|||
130449557|NCT00764868|469608968|FG000|Overall Study|Subject moved|7|||
130449558|NCT00764868|469608968|FG000|Overall Study|Pregnancy|3|||
130449559|NCT00764868|469608968|FG000|Overall Study|Prohibited medication|1|||
130449560|NCT00764868|469608968|FG000|Overall Study|Out of town|1|||
130449561|NCT00764868|469608968|FG000|Overall Study|Misuse and compliance of study drug|1|||
130449562|NCT00764868|469608968|FG000|Overall Study|Subject sent to boarding school|1|||
130449563|NCT00764868|469608968|FG000|Overall Study|Met an exclusion criteria|1|||
130449564|NCT00764868|469608968|FG000|Overall Study|Positive drug screen|2|||
130449565|NCT00764868|469608968|FG000|Overall Study|Sponsor requested withdrawal|1|||
130449566|NCT04438785|469608973|FG000|Overall Study|change of weight, give up intervention|2|||
130449567|NCT04438785|469608974|FG001|Overall Study|change of weight, give up intervention|10|||
130449568|NCT04011033|469608975|FG000|Overall Study|Physician Decision|2|||
130449569|NCT04011033|469608976|FG001|Overall Study|Physician Decision|3|||
130449570|NCT04011033|469608975|FG000|Overall Study|Withdrawal by Subject|1|||
130449571|NCT04011033|469608976|FG001|Overall Study|Withdrawal by Subject|0|||
130449572|NCT01823341|469608977|FG000|Overall Study|Failed run-in|7|||
130449573|NCT01823341|469608977|FG000|Overall Study|Withdrawal by Subject|7|||
130449574|NCT01823341|469608977|FG000|Overall Study|Adverse Event|1|||
130449575|NCT02027935|469608978|FG000|Overall Study|Death|1|||
130449576|NCT02027935|469608978|FG000|Overall Study|Lack of Efficacy|5|||
130449577|NCT02027935|469608978|FG000|Overall Study|Study Closure|1|||
130449578|NCT00689104|469608979|FG000|Overall Study|Eligibility criterion not met|5|||
130449579|NCT00689104|469608980|FG001|Overall Study|Eligibility criterion not met|8|||
130449580|NCT00689104|469608981|FG002|Overall Study|Eligibility criterion not met|0|||
130449581|NCT00689104|469608982|FG003|Overall Study|Eligibility criterion not met|4|||
130449582|NCT00689104|469608979|FG000|Overall Study|Adverse Event|13|||
130449583|NCT00689104|469608980|FG001|Overall Study|Adverse Event|25|||
130449584|NCT00689104|469608981|FG002|Overall Study|Adverse Event|16|||
130449585|NCT00689104|469608982|FG003|Overall Study|Adverse Event|24|||
130449586|NCT00689104|469608979|FG000|Overall Study|Lack of Efficacy|5|||
130449587|NCT00689104|469608980|FG001|Overall Study|Lack of Efficacy|6|||
130696734|NCT02096705|470514495|FG000|Follow-up|Withdrawal by Subject|1|||
130696735|NCT02096705|470514496|FG001|Follow-up|Withdrawal by Subject|0|||
130696736|NCT02096705|470514495|FG000|Follow-up|Adverse Event|2|||
130696737|NCT02096705|470514496|FG001|Follow-up|Adverse Event|2|||
130696738|NCT02096705|470514495|FG000|Follow-up|Subjects not reporting status|1|||
130449588|NCT00689104|469608981|FG002|Overall Study|Lack of Efficacy|2|||
130449589|NCT00689104|469608982|FG003|Overall Study|Lack of Efficacy|3|||
130449590|NCT00689104|469608979|FG000|Overall Study|Withdrawal by Subject|12|||
130449591|NCT00689104|469608980|FG001|Overall Study|Withdrawal by Subject|11|||
130449592|NCT00689104|469608981|FG002|Overall Study|Withdrawal by Subject|18|||
130449593|NCT00689104|469608982|FG003|Overall Study|Withdrawal by Subject|11|||
130449594|NCT00689104|469608979|FG000|Overall Study|Lost to Follow-up|4|||
130449595|NCT00689104|469608980|FG001|Overall Study|Lost to Follow-up|3|||
130449596|NCT00689104|469608981|FG002|Overall Study|Lost to Follow-up|2|||
130241281|NCT00980460|468843527|FG001|Overall Study|Lack of Efficacy|0|||
130241282|NCT00980460|468843528|FG002|Overall Study|Lack of Efficacy|10|||
130241283|NCT00980460|468843529|FG003|Overall Study|Lack of Efficacy|6|||
130241284|NCT00980460|468843530|FG004|Overall Study|Lack of Efficacy|8|||
130241285|NCT00980460|468843526|FG000|Overall Study|Lost to Follow-up|0|||
130241286|NCT00980460|468843527|FG001|Overall Study|Lost to Follow-up|0|||
130241287|NCT00980460|468843528|FG002|Overall Study|Lost to Follow-up|0|||
130241288|NCT00980460|468843529|FG003|Overall Study|Lost to Follow-up|1|||
130241289|NCT00980460|468843530|FG004|Overall Study|Lost to Follow-up|0|||
130241290|NCT00980460|468843526|FG000|Overall Study|Physician Decision|0|||
130241291|NCT00980460|468843527|FG001|Overall Study|Physician Decision|0|||
130241292|NCT00980460|468843528|FG002|Overall Study|Physician Decision|11|||
130241293|NCT00980460|468843529|FG003|Overall Study|Physician Decision|5|||
130241294|NCT00980460|468843530|FG004|Overall Study|Physician Decision|3|||
130241295|NCT00980460|468843526|FG000|Overall Study|Withdrawal by Subject|0|||
130241296|NCT00980460|468843527|FG001|Overall Study|Withdrawal by Subject|0|||
130241297|NCT00980460|468843528|FG002|Overall Study|Withdrawal by Subject|1|||
130241298|NCT00980460|468843529|FG003|Overall Study|Withdrawal by Subject|0|||
130241299|NCT00980460|468843530|FG004|Overall Study|Withdrawal by Subject|0|||
130241300|NCT00980460|468843526|FG000|Overall Study|Ineligible|0|||
130241301|NCT00980460|468843527|FG001|Overall Study|Ineligible|2|||
130241302|NCT00980460|468843528|FG002|Overall Study|Ineligible|3|||
130241303|NCT00980460|468843529|FG003|Overall Study|Ineligible|1|||
130241304|NCT00980460|468843530|FG004|Overall Study|Ineligible|4|||
130241305|NCT00980460|468843526|FG000|Overall Study|Refusal of further therapy|0|||
130241306|NCT00980460|468843527|FG001|Overall Study|Refusal of further therapy|2|||
130241307|NCT00980460|468843528|FG002|Overall Study|Refusal of further therapy|3|||
130241308|NCT00980460|468843529|FG003|Overall Study|Refusal of further therapy|2|||
130241309|NCT00980460|468843530|FG004|Overall Study|Refusal of further therapy|0|||
130241310|NCT00980460|468843526|FG000|Overall Study|No therapy within 42 days of resection|0|||
130241311|NCT00980460|468843527|FG001|Overall Study|No therapy within 42 days of resection|0|||
130241312|NCT00980460|468843528|FG002|Overall Study|No therapy within 42 days of resection|3|||
130241313|NCT00980460|468843529|FG003|Overall Study|No therapy within 42 days of resection|1|||
130361173|NCT04032652|469292665|FG001|Overall Study|The study was terminated and the PI has|1|||
130361174|NCT00165984|469292666|FG000|Overall Study|Death|15|||
130361175|NCT03945266|469292667|FG000|Overall Study|Withdrawal by Subject|1|||
130361176|NCT03945266|469292668|FG001|Overall Study|Withdrawal by Subject|0|||
130361177|NCT03945266|469292667|FG000|Overall Study|Miscarriage|0|||
130361178|NCT03945266|469292668|FG001|Overall Study|Miscarriage|2|||
130361179|NCT03945266|469292667|FG000|Overall Study|Lost to Follow-up|1|||
130361180|NCT03945266|469292668|FG001|Overall Study|Lost to Follow-up|0|||
130361181|NCT01736124|469292669|FG000|Post-intervention Assessment|Death|2|||
130361182|NCT01736124|469292670|FG001|Post-intervention Assessment|Death|2|||
130361183|NCT01736124|469292669|FG000|Post-intervention Assessment|lost computer access|1|||
130361184|NCT01736124|469292670|FG001|Post-intervention Assessment|lost computer access|1|||
130361185|NCT01736124|469292669|FG000|Post-intervention Assessment|Moved away|3|||
130361186|NCT01736124|469292670|FG001|Post-intervention Assessment|Moved away|1|||
130361187|NCT01736124|469292669|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
130361188|NCT01736124|469292670|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
130361189|NCT01736124|469292669|FG000|Post-intervention Assessment|Illness|3|||
130361190|NCT01736124|469292670|FG001|Post-intervention Assessment|Illness|2|||
130361191|NCT01736124|469292669|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
130361192|NCT01736124|469292670|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
130361193|NCT01736124|469292669|FG000|Post-intervention Assessment|Temporarily away|3|||
130361194|NCT01736124|469292670|FG001|Post-intervention Assessment|Temporarily away|1|||
130361195|NCT01736124|469292669|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
130361196|NCT01736124|469292670|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
130361197|NCT01736124|469292669|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
130361198|NCT01736124|469292670|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
130361199|NCT01736124|469292669|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
130361200|NCT01736124|469292670|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
130361201|NCT01736124|469292669|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
130361202|NCT01736124|469292670|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
130361203|NCT01736124|469292669|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
130361204|NCT01736124|469292670|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
130361205|NCT01736124|469292669|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
130361206|NCT01736124|469292670|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
130241314|NCT00980460|468843530|FG004|Overall Study|No therapy within 42 days of resection|0|||
130361207|NCT01736124|469292669|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
130361208|NCT01736124|469292670|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
130361209|NCT01736124|469292669|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
130241315|NCT00980460|468843526|FG000|Overall Study|No transplant by protocol timepoints|0|||
130241316|NCT00980460|468843527|FG001|Overall Study|No transplant by protocol timepoints|0|||
130241317|NCT00980460|468843528|FG002|Overall Study|No transplant by protocol timepoints|3|||
130241318|NCT00980460|468843529|FG003|Overall Study|No transplant by protocol timepoints|0|||
130241319|NCT00980460|468843530|FG004|Overall Study|No transplant by protocol timepoints|0|||
130241320|NCT03599713|468843534|FG000|Overall Study|Death|38|||
130241321|NCT03599713|468843535|FG001|Overall Study|Death|3|||
130241322|NCT03599713|468843534|FG000|Overall Study|Withdrawal by Subject|17|||
130361210|NCT01736124|469292670|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
130361211|NCT01736124|469292669|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
130361212|NCT01736124|469292670|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
130361213|NCT03553927|469292671|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
130361214|NCT03553927|469292672|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
130361215|NCT03553927|469292671|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
130361216|NCT03553927|469292672|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
130361217|NCT02423772|469292673|FG000|Overall Study|Lost to Follow-up|3|||
130361218|NCT02423772|469292674|FG001|Overall Study|Lost to Follow-up|3|||
130361219|NCT02423772|469292673|FG000|Overall Study|Did not begin intervention|2|||
130361220|NCT02423772|469292674|FG001|Overall Study|Did not begin intervention|5|||
130361221|NCT03360747|469292681|FG000|Overall Study|Voluntary Withdrawal|1|||
130361222|NCT01759511|469292682|FG000|Overall Study|Adverse Event|4|||
130361223|NCT01759511|469292682|FG000|Overall Study|Death|2|||
130361224|NCT01759511|469292682|FG000|Overall Study|Lack of Efficacy|2|||
130361225|NCT01759511|469292682|FG000|Overall Study|Physician Decision|1|||
130361226|NCT01759511|469292682|FG000|Overall Study|Progressive Disease|5|||
130361227|NCT01759511|469292682|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
130361228|NCT01759511|469292682|FG000|Overall Study|Study Terminated by Sponsor|13|||
130361229|NCT01759511|469292682|FG000|Overall Study|Withdrawal by Subject|3|||
130361230|NCT03693300|469294127|FG000|Overall Study|Withdrawal by Subject|6|||
130361231|NCT03693300|469294128|FG001|Overall Study|Withdrawal by Subject|0|||
130361232|NCT03693300|469294127|FG000|Overall Study|Death|50|||
130361233|NCT03693300|469294128|FG001|Overall Study|Death|2|||
130361234|NCT03693300|469294127|FG000|Overall Study|Lost to Follow-up|2|||
130361235|NCT03693300|469294128|FG001|Overall Study|Lost to Follow-up|0|||
130361236|NCT02206048|469294129|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
130361237|NCT04195906|469294132|FG000|Part 1|Adverse Event|3|||
130361238|NCT04195906|469294133|FG001|Part 1|Adverse Event|7|||
130361239|NCT04195906|469294132|FG000|Part 1|Withdrawal by Subject|0|||
130361240|NCT04195906|469294133|FG001|Part 1|Withdrawal by Subject|1|||
130361241|NCT04195906|469294132|FG000|Part 2|Adverse Event|1|||
130361242|NCT04195906|469294133|FG001|Part 2|Adverse Event|1|||
130361243|NCT04195906|469294132|FG000|Part 2|Withdrawal by Subject|0|||
130361244|NCT04195906|469294133|FG001|Part 2|Withdrawal by Subject|3|||
130361245|NCT04195906|469294132|FG000|Part 2|Other|1|||
130361246|NCT04195906|469294133|FG001|Part 2|Other|3|||
130361247|NCT00428792|469294134|FG000|Overall Study|Lack of Efficacy|1|||
130361248|NCT00428792|469294135|FG001|Overall Study|Lack of Efficacy|3|||
130361249|NCT00428792|469294134|FG000|Overall Study|Lost to Follow-up|0|||
130361250|NCT00428792|469294135|FG001|Overall Study|Lost to Follow-up|1|||
130361251|NCT01926015|469294136|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130361252|NCT01926015|469294137|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130361253|NCT01926015|469294136|FG000|Overall Study|Randomized not treated|2|||
130361254|NCT01926015|469294137|FG001|Overall Study|Randomized not treated|0|||
130361255|NCT00639678|469294138|FG000|Overall Study|Withdrawal by Subject|3|||
130361256|NCT00639678|469294139|FG001|Overall Study|Withdrawal by Subject|0|||
130361257|NCT00639678|469294140|FG002|Overall Study|Withdrawal by Subject|4|||
130361258|NCT00639678|469294141|FG003|Overall Study|Withdrawal by Subject|0|||
130361259|NCT00639678|469294138|FG000|Overall Study|Lost to Follow-up|1|||
130361260|NCT00639678|469294139|FG001|Overall Study|Lost to Follow-up|0|||
130361261|NCT00639678|469294140|FG002|Overall Study|Lost to Follow-up|6|||
130361262|NCT00639678|469294141|FG003|Overall Study|Lost to Follow-up|0|||
130361263|NCT00639678|469294138|FG000|Overall Study|Adverse Event|0|||
130361264|NCT00639678|469294139|FG001|Overall Study|Adverse Event|1|||
130361265|NCT00639678|469294140|FG002|Overall Study|Adverse Event|0|||
130361266|NCT00639678|469294141|FG003|Overall Study|Adverse Event|0|||
130361267|NCT00639678|469294138|FG000|Overall Study|Lack of Compliance|0|||
130361268|NCT00639678|469294139|FG001|Overall Study|Lack of Compliance|0|||
130361269|NCT00639678|469294140|FG002|Overall Study|Lack of Compliance|1|||
130361270|NCT00639678|469294141|FG003|Overall Study|Lack of Compliance|0|||
130361271|NCT01364649|469294142|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
130361272|NCT01364649|469294143|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
130361273|NCT01364649|469294142|FG000|Overall Study|Lack of Efficacy|6|||
130361274|NCT01364649|469294143|FG001|Overall Study|Lack of Efficacy|0|||
130361275|NCT01364649|469294142|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
130361276|NCT01364649|469294143|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
130361277|NCT01364649|469294142|FG000|Overall Study|Protocol Deviations|4|||
130361278|NCT01364649|469294143|FG001|Overall Study|Protocol Deviations|8|||
130361279|NCT01364649|469294142|FG000|Overall Study|Withdrawal of Consent|9|||
130361280|NCT01364649|469294143|FG001|Overall Study|Withdrawal of Consent|7|||
130361281|NCT01364649|469294142|FG000|Overall Study|Lost to Follow-up|12|||
130241323|NCT03599713|468843535|FG001|Overall Study|Withdrawal by Subject|0|||
130241324|NCT03599713|468843534|FG000|Overall Study|Lost to Follow-up|4|||
130361282|NCT01364649|469294143|FG001|Overall Study|Lost to Follow-up|13|||
130361283|NCT01364649|469294142|FG000|Overall Study|Other|4|||
130361284|NCT01364649|469294143|FG001|Overall Study|Other|1|||
130361285|NCT01914757|469294160|FG000|Overall Study|Severe non-compliance to protocol|3|||
130361286|NCT01914757|469294161|FG001|Overall Study|Severe non-compliance to protocol|1|||
130361287|NCT01914757|469294162|FG002|Overall Study|Severe non-compliance to protocol|2|||
130361288|NCT01914757|469294160|FG000|Overall Study|Lost to Follow-up|5|||
130361289|NCT01914757|469294161|FG001|Overall Study|Lost to Follow-up|8|||
130361290|NCT01914757|469294162|FG002|Overall Study|Lost to Follow-up|6|||
130361291|NCT01914757|469294160|FG000|Overall Study|Withdrawal by Subject|15|||
130361292|NCT01914757|469294161|FG001|Overall Study|Withdrawal by Subject|27|||
130361293|NCT01914757|469294162|FG002|Overall Study|Withdrawal by Subject|19|||
130361294|NCT01914757|469294160|FG000|Overall Study|Death|2|||
130361295|NCT01914757|469294161|FG001|Overall Study|Death|2|||
130361296|NCT01914757|469294162|FG002|Overall Study|Death|1|||
130361297|NCT01914757|469294160|FG000|Overall Study|Adverse Event|4|||
130361298|NCT01914757|469294161|FG001|Overall Study|Adverse Event|3|||
130361299|NCT01914757|469294162|FG002|Overall Study|Adverse Event|4|||
130361300|NCT01914757|469294160|FG000|Overall Study|Study specific withdrawal criteria|0|||
130361301|NCT01914757|469294161|FG001|Overall Study|Study specific withdrawal criteria|1|||
130361302|NCT01914757|469294162|FG002|Overall Study|Study specific withdrawal criteria|0|||
130361303|NCT01914757|469294160|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130361304|NCT01914757|469294161|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130361305|NCT01914757|469294162|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130361306|NCT01914757|469294160|FG000|Overall Study|Other reasons|5|||
130361307|NCT01914757|469294161|FG001|Overall Study|Other reasons|9|||
130361308|NCT01914757|469294162|FG002|Overall Study|Other reasons|4|||
130361309|NCT00615108|469294163|FG000|Overall Study|Adverse Event|122|||
130361310|NCT00615108|469294163|FG000|Overall Study|Other|370|||
130361311|NCT00615108|469294163|FG000|Overall Study|Lost to Follow-up|15|||
130361312|NCT01426438|469294170|FG000|Overall Study|Lost to Follow-up|1|||
130361313|NCT01426438|469294171|FG001|Overall Study|Lost to Follow-up|3|||
130361314|NCT01426438|469294170|FG000|Overall Study|Off study Treatment|9|||
130361315|NCT01426438|469294171|FG001|Overall Study|Off study Treatment|3|||
130361316|NCT01426438|469294170|FG000|Overall Study|Poor scan quality|3|||
130361317|NCT01426438|469294171|FG001|Overall Study|Poor scan quality|2|||
130361318|NCT01426438|469294170|FG000|Overall Study|Missed Scan|2|||
130361319|NCT01426438|469294171|FG001|Overall Study|Missed Scan|2|||
130361320|NCT02833350|469294172|FG000|Overall Study|Adverse Event|0|||
130361321|NCT02833350|469294173|FG001|Overall Study|Adverse Event|3|||
130361322|NCT02833350|469294174|FG002|Overall Study|Adverse Event|4|||
130361323|NCT02833350|469294175|FG003|Overall Study|Adverse Event|4|||
130361324|NCT02833350|469294176|FG004|Overall Study|Adverse Event|1|||
130361325|NCT02833350|469294177|FG005|Overall Study|Adverse Event|0|||
130361326|NCT02833350|469294178|FG006|Overall Study|Adverse Event|1|||
130361327|NCT02833350|469294172|FG000|Overall Study|Death|0|||
130361328|NCT02833350|469294173|FG001|Overall Study|Death|0|||
130361329|NCT02833350|469294174|FG002|Overall Study|Death|1|||
130361330|NCT02833350|469294175|FG003|Overall Study|Death|0|||
130361331|NCT02833350|469294176|FG004|Overall Study|Death|0|||
130361332|NCT02833350|469294177|FG005|Overall Study|Death|0|||
130361333|NCT02833350|469294178|FG006|Overall Study|Death|0|||
130361334|NCT02833350|469294172|FG000|Overall Study|Lack of Efficacy|0|||
130361335|NCT02833350|469294173|FG001|Overall Study|Lack of Efficacy|2|||
130361336|NCT02833350|469294174|FG002|Overall Study|Lack of Efficacy|1|||
130361337|NCT02833350|469294175|FG003|Overall Study|Lack of Efficacy|4|||
130696739|NCT02096705|470514496|FG001|Follow-up|Subjects not reporting status|2|||
130696740|NCT02166606|470514499|FG000|Overall Study|Adverse Event|3|||
130696741|NCT02166606|470514499|FG000|Overall Study|Death|31|||
130696742|NCT02166606|470514499|FG000|Overall Study|Protocol Violation|7|||
130696743|NCT02166606|470514499|FG000|Overall Study|Lost to Follow-up|30|||
130241325|NCT03599713|468843535|FG001|Overall Study|Lost to Follow-up|0|||
130361338|NCT02833350|469294176|FG004|Overall Study|Lack of Efficacy|0|||
130361339|NCT02833350|469294177|FG005|Overall Study|Lack of Efficacy|1|||
130361340|NCT02833350|469294178|FG006|Overall Study|Lack of Efficacy|1|||
130361341|NCT02833350|469294172|FG000|Overall Study|Lost to Follow-up|0|||
130361342|NCT02833350|469294173|FG001|Overall Study|Lost to Follow-up|1|||
130361343|NCT02833350|469294174|FG002|Overall Study|Lost to Follow-up|0|||
130361344|NCT02833350|469294175|FG003|Overall Study|Lost to Follow-up|0|||
130361345|NCT02833350|469294176|FG004|Overall Study|Lost to Follow-up|0|||
130696744|NCT02166606|470514499|FG000|Overall Study|Withdrawal by Subject|1|||
130696745|NCT02166606|470514499|FG000|Overall Study|Physician Decision|1|||
130696746|NCT02166606|470514499|FG000|Overall Study|Device upgrade|1|||
130361346|NCT02833350|469294177|FG005|Overall Study|Lost to Follow-up|0|||
130361347|NCT02833350|469294178|FG006|Overall Study|Lost to Follow-up|1|||
130361348|NCT02833350|469294172|FG000|Overall Study|Withdrawal by Subject|3|||
130361349|NCT02833350|469294173|FG001|Overall Study|Withdrawal by Subject|3|||
130361350|NCT02833350|469294174|FG002|Overall Study|Withdrawal by Subject|2|||
130449597|NCT00689104|469608982|FG003|Overall Study|Lost to Follow-up|5|||
130449598|NCT00689104|469608979|FG000|Overall Study|Protocol Violation|2|||
130449599|NCT00689104|469608980|FG001|Overall Study|Protocol Violation|3|||
130449600|NCT00689104|469608981|FG002|Overall Study|Protocol Violation|5|||
130449601|NCT00689104|469608982|FG003|Overall Study|Protocol Violation|3|||
130449602|NCT00689104|469608979|FG000|Overall Study|Randomized but never received study drug|2|||
130449603|NCT00689104|469608980|FG001|Overall Study|Randomized but never received study drug|1|||
130449604|NCT00689104|469608981|FG002|Overall Study|Randomized but never received study drug|1|||
130449605|NCT00689104|469608982|FG003|Overall Study|Randomized but never received study drug|0|||
130449606|NCT00689104|469608979|FG000|Overall Study|Physician Decision|1|||
130449607|NCT00689104|469608980|FG001|Overall Study|Physician Decision|0|||
130449608|NCT00689104|469608981|FG002|Overall Study|Physician Decision|0|||
130449609|NCT00689104|469608982|FG003|Overall Study|Physician Decision|0|||
130449610|NCT00689104|469608979|FG000|Overall Study|Non-compliance with study procedures|0|||
130449611|NCT00689104|469608980|FG001|Overall Study|Non-compliance with study procedures|0|||
130449612|NCT00689104|469608981|FG002|Overall Study|Non-compliance with study procedures|1|||
130449613|NCT00689104|469608982|FG003|Overall Study|Non-compliance with study procedures|0|||
130449614|NCT04873817|469608983|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
130449615|NCT04873817|469608983|FG000|Overall Study|Lost to Follow-up|4|||
130449616|NCT04873817|469608983|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
130449617|NCT04873817|469608983|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
130449618|NCT04873817|469608983|FG000|Overall Study|Other Reasons|3|||
130449619|NCT00924560|469608984|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
130449620|NCT00924560|469608985|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
130449621|NCT00924560|469608986|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
130449622|NCT00924560|469608984|FG000|Overall Study|Non Compliance with the Protocol|20|||
130449623|NCT00924560|469608985|FG001|Overall Study|Non Compliance with the Protocol|15|||
130449624|NCT00924560|469608986|FG002|Overall Study|Non Compliance with the Protocol|4|||
130449625|NCT00924560|469608984|FG000|Overall Study|Physician Decision|2|||
130449626|NCT00924560|469608985|FG001|Overall Study|Physician Decision|3|||
130449627|NCT00924560|469608986|FG002|Overall Study|Physician Decision|4|||
130449628|NCT00924560|469608984|FG000|Overall Study|Withdrawal by Subject|50|||
130449629|NCT00924560|469608985|FG001|Overall Study|Withdrawal by Subject|44|||
130449630|NCT00924560|469608986|FG002|Overall Study|Withdrawal by Subject|18|||
130449631|NCT00924560|469608984|FG000|Overall Study|Adverse Event|39|||
130449632|NCT00924560|469608985|FG001|Overall Study|Adverse Event|33|||
130449633|NCT00924560|469608986|FG002|Overall Study|Adverse Event|0|||
130449634|NCT00924560|469608984|FG000|Overall Study|Pregnancy|5|||
130449635|NCT00924560|469608985|FG001|Overall Study|Pregnancy|7|||
130449636|NCT00924560|469608986|FG002|Overall Study|Pregnancy|1|||
130449637|NCT00924560|469608984|FG000|Overall Study|Lost to Follow-up|78|||
130449638|NCT00924560|469608985|FG001|Overall Study|Lost to Follow-up|94|||
130449639|NCT00924560|469608986|FG002|Overall Study|Lost to Follow-up|45|||
130449640|NCT00924560|469608984|FG000|Overall Study|Miscellaneous Reasons|13|||
130449641|NCT00924560|469608985|FG001|Overall Study|Miscellaneous Reasons|10|||
130449642|NCT00924560|469608986|FG002|Overall Study|Miscellaneous Reasons|10|||
130449643|NCT02696226|469608990|FG000|Overall Study|Study terminated - lack of enrollment|1|||
130449644|NCT02696226|469608991|FG001|Overall Study|Study terminated - lack of enrollment|0|||
130449645|NCT02696226|469608992|FG002|Overall Study|Study terminated - lack of enrollment|2|||
130449646|NCT02696226|469608993|FG003|Overall Study|Study terminated - lack of enrollment|0|||
130449647|NCT02909101|469609001|FG000|Overall Study|Lost to Follow-up|1|||
130449648|NCT02909101|469609002|FG001|Overall Study|Lost to Follow-up|1|||
130449649|NCT03073005|469609003|FG000|Overall Study|Death|6|||
130449650|NCT03073005|469609004|FG001|Overall Study|Death|0|||
130449651|NCT03073005|469609005|FG002|Overall Study|Death|7|||
130449652|NCT03073005|469609006|FG003|Overall Study|Death|0|||
130449653|NCT03073005|469609003|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
130449654|NCT03073005|469609004|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
130449655|NCT03073005|469609005|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
130449656|NCT03073005|469609006|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
130449657|NCT03073005|469609003|FG000|Overall Study|Lost to Follow-up|2|||
130449658|NCT03073005|469609004|FG001|Overall Study|Lost to Follow-up|2|||
130449659|NCT03073005|469609005|FG002|Overall Study|Lost to Follow-up|1|||
130449660|NCT03073005|469609006|FG003|Overall Study|Lost to Follow-up|2|||
130449661|NCT03073005|469609003|FG000|Overall Study|Withdrawal by Subject|0|||
130449662|NCT03073005|469609004|FG001|Overall Study|Withdrawal by Subject|4|||
130449663|NCT03073005|469609005|FG002|Overall Study|Withdrawal by Subject|4|||
130449664|NCT03073005|469609006|FG003|Overall Study|Withdrawal by Subject|4|||
130449665|NCT01290094|469609007|FG000|Overall Study|Withdrawal by Subject|1|||
130449666|NCT01290094|469609007|FG000|Overall Study|Lost to Follow-up|5|||
130449667|NCT04949399|469609010|FG000|Overall Study|Lost to Follow-up|11|||
130449668|NCT04949399|469609011|FG001|Overall Study|Lost to Follow-up|6|||
130449669|NCT04949399|469609010|FG000|Overall Study|Withdrawal by Subject|2|||
130449670|NCT04949399|469609011|FG001|Overall Study|Withdrawal by Subject|3|||
130449671|NCT00814489|469609012|FG000|Overall Study|Other|2|||
130449672|NCT00814489|469609013|FG001|Overall Study|Other|0|||
130241326|NCT03599713|468843534|FG000|Overall Study|Discontinued Due to End of Study|42|||
130241327|NCT03599713|468843535|FG001|Overall Study|Discontinued Due to End of Study|3|||
130241328|NCT05800145|468843536|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
130241329|NCT05800145|468843537|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241330|NCT05800145|468843538|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241331|NCT05800145|468843539|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
130241332|NCT05800145|468843540|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241333|NCT05800145|468843541|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241334|NCT05800145|468843536|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
130241335|NCT05800145|468843537|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241336|NCT05800145|468843538|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130376604|NCT00963547|469345868|FG004|Overall Study|Progressive Disease|0|||
130376605|NCT00963547|469345869|FG005|Overall Study|Progressive Disease|0|||
130376606|NCT00963547|469345870|FG006|Overall Study|Progressive Disease|0|||
130376607|NCT00963547|469345864|FG000|Overall Study|Withdrawal by Subject|0|||
130376608|NCT00963547|469345865|FG001|Overall Study|Withdrawal by Subject|0|||
130376609|NCT00963547|469345866|FG002|Overall Study|Withdrawal by Subject|3|||
130376610|NCT00963547|469345867|FG003|Overall Study|Withdrawal by Subject|0|||
130376611|NCT00963547|469345868|FG004|Overall Study|Withdrawal by Subject|0|||
130376612|NCT00963547|469345869|FG005|Overall Study|Withdrawal by Subject|0|||
130376613|NCT00963547|469345870|FG006|Overall Study|Withdrawal by Subject|0|||
130376614|NCT00963547|469345864|FG000|Overall Study|Reason Unknown|0|||
130376615|NCT00963547|469345865|FG001|Overall Study|Reason Unknown|1|||
130376616|NCT00963547|469345866|FG002|Overall Study|Reason Unknown|0|||
130376617|NCT00963547|469345867|FG003|Overall Study|Reason Unknown|0|||
130376618|NCT00963547|469345868|FG004|Overall Study|Reason Unknown|0|||
130376619|NCT00963547|469345869|FG005|Overall Study|Reason Unknown|0|||
130376620|NCT00963547|469345870|FG006|Overall Study|Reason Unknown|0|||
130376621|NCT02989194|469345880|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
130376622|NCT02989194|469345881|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
130376623|NCT02989194|469345882|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
130376624|NCT02989194|469345880|FG000|Overall Study|Lost to Follow-up|0|||
130376625|NCT02989194|469345881|FG001|Overall Study|Lost to Follow-up|1|||
130376626|NCT02989194|469345882|FG002|Overall Study|Lost to Follow-up|0|||
130376627|NCT02989194|469345880|FG000|Overall Study|Withdrawal by Subject|0|||
130376628|NCT02989194|469345881|FG001|Overall Study|Withdrawal by Subject|1|||
130376629|NCT02989194|469345882|FG002|Overall Study|Withdrawal by Subject|0|||
130376630|NCT00660023|469345883|FG000|Overall Study|Adverse Event|2|||
130376631|NCT00660023|469345883|FG000|Overall Study|Death|8|||
130376632|NCT00660023|469345883|FG000|Overall Study|Blood Transfusion|5|||
130376633|NCT00660023|469345883|FG000|Overall Study|Renal Transplantation|3|||
130376634|NCT00660023|469345883|FG000|Overall Study|Withdrawal by Subject|1|||
130376635|NCT00660023|469345883|FG000|Overall Study|Missed Pregnancy Test|1|||
130376636|NCT00660023|469345883|FG000|Overall Study|Other Screening Failure|9|||
130376637|NCT04180488|469345884|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130376638|NCT04180488|469345885|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
130376639|NCT04180488|469345886|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
130376640|NCT04180488|469345887|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
130376641|NCT04180488|469345888|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130376642|NCT04180488|469345889|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130376643|NCT04180488|469345884|FG000|Overall Study|Withdrawal by Subject|8|||
130376644|NCT04180488|469345885|FG001|Overall Study|Withdrawal by Subject|4|||
130376645|NCT04180488|469345886|FG002|Overall Study|Withdrawal by Subject|5|||
130376646|NCT04180488|469345887|FG003|Overall Study|Withdrawal by Subject|2|||
130376647|NCT04180488|469345888|FG004|Overall Study|Withdrawal by Subject|8|||
130376648|NCT04180488|469345889|FG005|Overall Study|Withdrawal by Subject|6|||
130376649|NCT04180488|469345884|FG000|Overall Study|Adverse Event|3|||
130376650|NCT04180488|469345885|FG001|Overall Study|Adverse Event|2|||
130376651|NCT04180488|469345886|FG002|Overall Study|Adverse Event|0|||
130376652|NCT04180488|469345887|FG003|Overall Study|Adverse Event|0|||
130376653|NCT04180488|469345888|FG004|Overall Study|Adverse Event|0|||
130376654|NCT04180488|469345889|FG005|Overall Study|Adverse Event|0|||
130376655|NCT04180488|469345884|FG000|Overall Study|Poor compliance to protocol|0|||
130376656|NCT04180488|469345885|FG001|Overall Study|Poor compliance to protocol|0|||
130376657|NCT04180488|469345886|FG002|Overall Study|Poor compliance to protocol|1|||
130376658|NCT04180488|469345887|FG003|Overall Study|Poor compliance to protocol|0|||
130376659|NCT04180488|469345888|FG004|Overall Study|Poor compliance to protocol|0|||
130376660|NCT04180488|469345889|FG005|Overall Study|Poor compliance to protocol|0|||
130376661|NCT01327885|469345895|FG000|Overall Study|Disease progression-according to RECIST|173|||
130376662|NCT01327885|469345896|FG001|Overall Study|Disease progression-according to RECIST|165|||
130376663|NCT01327885|469345895|FG000|Overall Study|Clinical progression|24|||
130241337|NCT05800145|468843539|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
130241338|NCT05800145|468843540|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241339|NCT05800145|468843541|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241340|NCT05800145|468843536|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130241341|NCT05800145|468843537|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
130241342|NCT05800145|468843538|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
130241343|NCT05800145|468843539|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
130241344|NCT05800145|468843540|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130241345|NCT05800145|468843541|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130241346|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241347|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241348|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241349|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
130241350|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241351|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241352|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241353|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241354|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241355|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241356|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
130241357|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
130241358|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241359|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241360|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241361|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241362|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241363|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241364|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
130241365|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241366|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241367|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241368|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241369|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241370|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
130241371|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
130241372|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
130241373|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
130241374|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
130241375|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
130241376|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
130241377|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
130241378|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241379|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241380|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241381|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241382|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
130241383|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
130241384|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241385|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241386|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241387|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241388|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241389|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241390|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
130241391|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
130241392|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241393|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241394|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241395|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241396|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241397|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241398|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
130241399|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241400|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241401|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241402|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Other|0|||
130241403|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Other|0|||
130241404|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Other|0|||
130241405|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Other|0|||
130241406|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Other|1|||
130241407|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Other|3|||
130241408|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Other|0|||
130241409|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Other|0|||
130241410|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241411|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241412|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241413|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241414|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241415|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241416|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
130241417|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241418|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241419|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241420|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241421|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241422|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241423|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241424|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241425|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
130241426|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241427|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241428|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241429|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241430|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241431|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241432|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
130241433|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
130241434|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Other|0|||
130241435|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Other|0|||
130241436|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Other|0|||
130241437|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Other|0|||
130241438|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Other|0|||
130241439|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Other|0|||
130241440|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Other|0|||
130241441|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Other|1|||
130241442|NCT00876395|468844870|FG000|Overall Study|Untreated|8|||
130241443|NCT00876395|468844871|FG001|Overall Study|Untreated|1|||
130241444|NCT00876395|468844870|FG000|Overall Study|Adverse Event|63|||
130241445|NCT00876395|468844871|FG001|Overall Study|Adverse Event|11|||
130241446|NCT00876395|468844870|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130241447|NCT00876395|468844871|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130241448|NCT00876395|468844870|FG000|Overall Study|Disease progression|259|||
130241449|NCT00876395|468844871|FG001|Overall Study|Disease progression|162|||
130241450|NCT00876395|468844870|FG000|Overall Study|New cancer therapy|25|||
130241451|NCT00876395|468844871|FG001|Overall Study|New cancer therapy|7|||
130241452|NCT00876395|468844870|FG000|Overall Study|Protocol Violation|5|||
130241453|NCT00876395|468844871|FG001|Overall Study|Protocol Violation|2|||
130241454|NCT00876395|468844870|FG000|Overall Study|Withdrawal by Subject|66|||
130241455|NCT00876395|468844871|FG001|Overall Study|Withdrawal by Subject|33|||
130241456|NCT00876395|468844870|FG000|Overall Study|Lost to Follow-up|2|||
130241457|NCT00876395|468844871|FG001|Overall Study|Lost to Follow-up|0|||
130241458|NCT00876395|468844870|FG000|Overall Study|Administrative problems|39|||
130241459|NCT00876395|468844871|FG001|Overall Study|Administrative problems|23|||
130241460|NCT00876395|468844870|FG000|Overall Study|Death|12|||
130241461|NCT00876395|468844871|FG001|Overall Study|Death|0|||
130241462|NCT03807843|468844872|FG000|Overall Study|Lost to Follow-up|1|||
130241463|NCT03807843|468844873|FG001|Overall Study|Lost to Follow-up|0|||
130241464|NCT01312129|468844874|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
130241465|NCT01312129|468844875|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
130241466|NCT00924651|468844878|FG000|Overall Study|Chemo started too soon|2|||
130241467|NCT00924651|468844879|FG001|Overall Study|Chemo started too soon|3|||
130241468|NCT00924651|468844878|FG000|Overall Study|No Reason|3|||
130241469|NCT00924651|468844879|FG001|Overall Study|No Reason|7|||
130241470|NCT00924651|468844878|FG000|Overall Study|Overwhelmed|6|||
130241471|NCT00924651|468844879|FG001|Overall Study|Overwhelmed|6|||
130241472|NCT00924651|468844878|FG000|Overall Study|Noncompliant|1|||
130241473|NCT00924651|468844879|FG001|Overall Study|Noncompliant|4|||
130241474|NCT00924651|468844878|FG000|Overall Study|Medical|1|||
130241475|NCT00924651|468844879|FG001|Overall Study|Medical|3|||
130241476|NCT00924651|468844878|FG000|Overall Study|Changed Mind|10|||
130241477|NCT00924651|468844879|FG001|Overall Study|Changed Mind|1|||
130241478|NCT00924651|468844878|FG000|Overall Study|Incomplete Form|2|||
130241479|NCT00924651|468844879|FG001|Overall Study|Incomplete Form|1|||
130241480|NCT01991314|468844880|FG000|Overall Study|Adverse Event|5|||
130241481|NCT01991314|468844881|FG001|Overall Study|Adverse Event|1|||
130241482|NCT01991314|468844880|FG000|Overall Study|Lost to Follow-up|6|||
130241483|NCT01991314|468844881|FG001|Overall Study|Lost to Follow-up|10|||
130241484|NCT00970944|468844882|FG000|Overall Study|Death|1|||
130241485|NCT00970944|468844883|FG001|Overall Study|Death|0|||
130241486|NCT00970944|468844882|FG000|Overall Study|Physician Decision|0|||
130241487|NCT00970944|468844883|FG001|Overall Study|Physician Decision|2|||
130241488|NCT00662259|468844884|FG000|Overall Study|Adverse Event|2|||
130241489|NCT00662259|468844885|FG001|Overall Study|Adverse Event|0|||
130241490|NCT01033942|468844886|FG000|Overall Study|Withdrawal by Subject|1|||
130241491|NCT01033942|468844887|FG001|Overall Study|Withdrawal by Subject|1|||
130241492|NCT01033942|468844888|FG002|Overall Study|Withdrawal by Subject|1|||
130241493|NCT01033942|468844886|FG000|Overall Study|Lost to Follow-up|1|||
130241494|NCT01033942|468844887|FG001|Overall Study|Lost to Follow-up|0|||
130241495|NCT01033942|468844888|FG002|Overall Study|Lost to Follow-up|0|||
130241496|NCT01033942|468844886|FG000|Overall Study|Enrolled in Extension Study|0|||
130696747|NCT02166606|470514499|FG000|Overall Study|Enrolled after End of Enrollment|4|||
130696748|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
130696749|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
130696750|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
130696751|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
130696752|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Death|3|||
130696753|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Death|1|||
130696754|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130696755|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130696756|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
130696757|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
130696758|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
130696759|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
130696760|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Adverse Event|2|||
130696761|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Adverse Event|11|||
130696762|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
130696763|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
130696764|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Death|2|||
130696765|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Death|2|||
130696766|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
130696767|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
130696768|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
130696769|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
130696770|NCT00566722|470514506|FG000|Overall Study|Adverse Event|0|||
130696771|NCT00566722|470514507|FG001|Overall Study|Adverse Event|1|||
130696772|NCT00566722|470514508|FG002|Overall Study|Adverse Event|0|||
130696773|NCT00566722|470514506|FG000|Overall Study|Withdrawal by Subject|0|||
130696774|NCT00566722|470514507|FG001|Overall Study|Withdrawal by Subject|0|||
130696775|NCT00566722|470514508|FG002|Overall Study|Withdrawal by Subject|1|||
130696776|NCT00566722|470514506|FG000|Overall Study|Lost to Follow-up|1|||
130696777|NCT00566722|470514507|FG001|Overall Study|Lost to Follow-up|1|||
130696778|NCT00566722|470514508|FG002|Overall Study|Lost to Follow-up|1|||
130696779|NCT00566722|470514506|FG000|Overall Study|Lack of Efficacy|1|||
130696780|NCT00566722|470514507|FG001|Overall Study|Lack of Efficacy|2|||
130696781|NCT00566722|470514508|FG002|Overall Study|Lack of Efficacy|4|||
130696782|NCT00566722|470514506|FG000|Overall Study|Did not meet exclusion criteria|0|||
130696783|NCT00566722|470514507|FG001|Overall Study|Did not meet exclusion criteria|0|||
130696784|NCT00566722|470514508|FG002|Overall Study|Did not meet exclusion criteria|2|||
130696785|NCT00566722|470514506|FG000|Overall Study|Serious adverse event|0|||
130696786|NCT00566722|470514507|FG001|Overall Study|Serious adverse event|1|||
130696787|NCT00566722|470514508|FG002|Overall Study|Serious adverse event|0|||
130696788|NCT00566722|470514506|FG000|Overall Study|Noncompliant with drug administration|0|||
130696789|NCT00566722|470514507|FG001|Overall Study|Noncompliant with drug administration|0|||
130241497|NCT01033942|468844887|FG001|Overall Study|Enrolled in Extension Study|3|||
130241498|NCT01033942|468844888|FG002|Overall Study|Enrolled in Extension Study|0|||
130241499|NCT02693418|468844889|FG000|Overall Study|Lost to Follow-up|1|||
130241500|NCT02693418|468844890|FG001|Overall Study|Lost to Follow-up|2|||
130241501|NCT02693418|468844891|FG002|Overall Study|Lost to Follow-up|0|||
130241502|NCT02693418|468844892|FG003|Overall Study|Lost to Follow-up|0|||
130241503|NCT02693418|468844893|FG004|Overall Study|Lost to Follow-up|0|||
130241504|NCT02693418|468844889|FG000|Overall Study|Menses during study period|0|||
130241505|NCT02693418|468844890|FG001|Overall Study|Menses during study period|0|||
130449673|NCT00814489|469609014|FG002|Overall Study|Other|1|||
130696790|NCT00566722|470514508|FG002|Overall Study|Noncompliant with drug administration|1|||
130696791|NCT02611323|470514509|FG000|Overall Study|Death|3|||
130696792|NCT02611323|470514510|FG001|Overall Study|Death|1|||
130696793|NCT02611323|470514511|FG002|Overall Study|Death|0|||
130241506|NCT02693418|468844891|FG002|Overall Study|Menses during study period|2|||
130241507|NCT02693418|468844892|FG003|Overall Study|Menses during study period|0|||
130241508|NCT02693418|468844893|FG004|Overall Study|Menses during study period|0|||
130241509|NCT01750346|468844895|FG000|Overall Study|Adverse Event|1|||
130241510|NCT01750346|468844896|FG001|Overall Study|Adverse Event|0|||
130241511|NCT01750346|468844897|FG002|Overall Study|Adverse Event|0|||
130241512|NCT02260986|468844898|FG000|Overall Study|Adverse Event|24|||
130241513|NCT02260986|468844899|FG001|Overall Study|Adverse Event|0|||
130241514|NCT02260986|468844900|FG002|Overall Study|Adverse Event|11|||
130241515|NCT02260986|468844898|FG000|Overall Study|Lack of Efficacy|27|||
130241516|NCT02260986|468844899|FG001|Overall Study|Lack of Efficacy|3|||
130241517|NCT02260986|468844900|FG002|Overall Study|Lack of Efficacy|0|||
130241518|NCT02260986|468844898|FG000|Overall Study|Protocol Violation|14|||
130241519|NCT02260986|468844899|FG001|Overall Study|Protocol Violation|5|||
130241520|NCT02260986|468844900|FG002|Overall Study|Protocol Violation|16|||
130241521|NCT02260986|468844898|FG000|Overall Study|Car accident|0|||
130241522|NCT02260986|468844899|FG001|Overall Study|Car accident|0|||
130241523|NCT02260986|468844900|FG002|Overall Study|Car accident|1|||
130241524|NCT02260986|468844898|FG000|Overall Study|Withdrawal by Subject|17|||
130241525|NCT02260986|468844899|FG001|Overall Study|Withdrawal by Subject|4|||
130241526|NCT02260986|468844900|FG002|Overall Study|Withdrawal by Subject|9|||
130241527|NCT02260986|468844898|FG000|Overall Study|Incorrect randomization|0|||
130241528|NCT02260986|468844899|FG001|Overall Study|Incorrect randomization|1|||
130241529|NCT02260986|468844900|FG002|Overall Study|Incorrect randomization|0|||
130241530|NCT02260986|468844898|FG000|Overall Study|Lack of investigation product supply|2|||
130241531|NCT02260986|468844899|FG001|Overall Study|Lack of investigation product supply|0|||
130241532|NCT02260986|468844900|FG002|Overall Study|Lack of investigation product supply|1|||
130241533|NCT02260986|468844898|FG000|Overall Study|Lost to Follow-up|4|||
130241534|NCT02260986|468844899|FG001|Overall Study|Lost to Follow-up|0|||
130241535|NCT02260986|468844900|FG002|Overall Study|Lost to Follow-up|3|||
130241536|NCT02260986|468844898|FG000|Overall Study|Pregnancy|2|||
130241537|NCT02260986|468844899|FG001|Overall Study|Pregnancy|0|||
130241538|NCT02260986|468844900|FG002|Overall Study|Pregnancy|0|||
130241539|NCT02782468|468844903|FG000|Overall Study|Progressive Disease|2|||
130241540|NCT02782468|468844904|FG001|Overall Study|Progressive Disease|5|||
130241541|NCT02782468|468844905|FG002|Overall Study|Progressive Disease|0|||
130241542|NCT02782468|468844906|FG003|Overall Study|Progressive Disease|4|||
130241543|NCT02782468|468844903|FG000|Overall Study|Adverse Event|0|||
130241544|NCT02782468|468844904|FG001|Overall Study|Adverse Event|2|||
130241545|NCT02782468|468844905|FG002|Overall Study|Adverse Event|2|||
130241546|NCT02782468|468844906|FG003|Overall Study|Adverse Event|3|||
130241547|NCT02782468|468844903|FG000|Overall Study|Other|0|||
130241548|NCT02782468|468844904|FG001|Overall Study|Other|0|||
130241549|NCT02782468|468844905|FG002|Overall Study|Other|1|||
130241550|NCT02782468|468844906|FG003|Overall Study|Other|1|||
130241551|NCT02782468|468844903|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241552|NCT02782468|468844904|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241553|NCT02782468|468844905|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241554|NCT02782468|468844906|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
130241555|NCT02782468|468844903|FG000|Overall Study|Symptomatic Deterioration|0|||
130241556|NCT02782468|468844904|FG001|Overall Study|Symptomatic Deterioration|0|||
130241557|NCT02782468|468844905|FG002|Overall Study|Symptomatic Deterioration|0|||
130241558|NCT02782468|468844906|FG003|Overall Study|Symptomatic Deterioration|1|||
130241559|NCT02782468|468844903|FG000|Overall Study|Withdrawal by Subject|1|||
130241560|NCT02782468|468844904|FG001|Overall Study|Withdrawal by Subject|0|||
130241561|NCT02782468|468844905|FG002|Overall Study|Withdrawal by Subject|0|||
130241562|NCT02782468|468844906|FG003|Overall Study|Withdrawal by Subject|0|||
130361351|NCT02833350|469294175|FG003|Overall Study|Withdrawal by Subject|0|||
130361352|NCT02833350|469294176|FG004|Overall Study|Withdrawal by Subject|2|||
130361353|NCT02833350|469294177|FG005|Overall Study|Withdrawal by Subject|0|||
130241563|NCT00356590|468844907|FG000|Overall Study|Adverse Event|54|||
130241564|NCT00356590|468844907|FG000|Overall Study|Death|10|||
130241565|NCT00356590|468844907|FG000|Overall Study|Lost to Follow-up|35|||
130241566|NCT00356590|468844907|FG000|Overall Study|Physician Decision|46|||
130241567|NCT00356590|468844907|FG000|Overall Study|Withdrawal by Subject|41|||
130241568|NCT00356590|468844907|FG000|Overall Study|Completed month 12 only|2|||
130241569|NCT00356590|468844907|FG000|Overall Study|Protocol issues|6|||
130241570|NCT00356590|468844907|FG000|Overall Study|Response status|28|||
130241571|NCT00356590|468844907|FG000|Overall Study|Other|52|||
130241572|NCT01482221|468844912|FG000|Overall Study|Lack of Efficacy|1|||
130361354|NCT02833350|469294178|FG006|Overall Study|Withdrawal by Subject|2|||
130361355|NCT01500031|469294181|FG000|Overall Study|Death|1|||
130361356|NCT01500031|469294181|FG000|Overall Study|Withdrawal by Subject|4|||
130361357|NCT01604408|469294182|FG000|Treatment Period 1|Protocol Violation|0|||
130241573|NCT01482221|468844913|FG001|Overall Study|Lack of Efficacy|0|||
130241574|NCT01482221|468844914|FG002|Overall Study|Lack of Efficacy|1|||
130241575|NCT01482221|468844912|FG000|Overall Study|Lost to Follow-up|3|||
130241576|NCT01482221|468844913|FG001|Overall Study|Lost to Follow-up|2|||
130361358|NCT01604408|469294183|FG001|Treatment Period 1|Protocol Violation|1|||
130241577|NCT01482221|468844914|FG002|Overall Study|Lost to Follow-up|1|||
130241578|NCT01482221|468844912|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
130241579|NCT01482221|468844913|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
130241580|NCT01482221|468844914|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130241581|NCT01482221|468844912|FG000|Overall Study|Condition under Investigation Worsened|3|||
130241582|NCT01482221|468844913|FG001|Overall Study|Condition under Investigation Worsened|2|||
130241583|NCT01482221|468844914|FG002|Overall Study|Condition under Investigation Worsened|4|||
130241584|NCT01482221|468844912|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130241585|NCT01482221|468844913|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130241586|NCT01482221|468844914|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130241587|NCT01482221|468844912|FG000|Overall Study|Adverse Event|1|||
130241588|NCT01482221|468844913|FG001|Overall Study|Adverse Event|7|||
130241589|NCT01482221|468844914|FG002|Overall Study|Adverse Event|3|||
130241590|NCT01482221|468844912|FG000|Overall Study|Withdrawal by Subject|10|||
130241591|NCT01482221|468844913|FG001|Overall Study|Withdrawal by Subject|7|||
130241592|NCT01482221|468844914|FG002|Overall Study|Withdrawal by Subject|12|||
130241593|NCT01482221|468844912|FG000|Overall Study|Incorrect randomization|0|||
130241594|NCT01482221|468844913|FG001|Overall Study|Incorrect randomization|1|||
130241595|NCT01482221|468844914|FG002|Overall Study|Incorrect randomization|0|||
130241596|NCT01482221|468844912|FG000|Overall Study|Physician Decision|0|||
130241597|NCT01482221|468844913|FG001|Overall Study|Physician Decision|1|||
130241598|NCT01482221|468844914|FG002|Overall Study|Physician Decision|0|||
130241599|NCT03086343|468844915|FG000|Period 1|Adverse Event|7|||
130241600|NCT03086343|468844916|FG001|Period 1|Adverse Event|7|||
130241601|NCT03086343|468844917|FG002|Period 1|Adverse Event|0|||
130241602|NCT03086343|468844918|FG003|Period 1|Adverse Event|1|||
130241603|NCT03086343|468844915|FG000|Period 1|Withdrawal by Subject|6|||
130241604|NCT03086343|468844916|FG001|Period 1|Withdrawal by Subject|10|||
130241605|NCT03086343|468844917|FG002|Period 1|Withdrawal by Subject|0|||
130241606|NCT03086343|468844918|FG003|Period 1|Withdrawal by Subject|0|||
130241607|NCT03086343|468844915|FG000|Period 1|Lost to Follow-up|1|||
130241608|NCT03086343|468844916|FG001|Period 1|Lost to Follow-up|3|||
130241609|NCT03086343|468844917|FG002|Period 1|Lost to Follow-up|1|||
130241610|NCT03086343|468844918|FG003|Period 1|Lost to Follow-up|0|||
130241611|NCT03086343|468844915|FG000|Period 1|Other, Not Specified|10|||
130241612|NCT03086343|468844916|FG001|Period 1|Other, Not Specified|12|||
130241613|NCT03086343|468844917|FG002|Period 1|Other, Not Specified|2|||
130241614|NCT03086343|468844918|FG003|Period 1|Other, Not Specified|1|||
130241615|NCT03086343|468844915|FG000|Period 1|Missing|1|||
130241616|NCT03086343|468844916|FG001|Period 1|Missing|0|||
130241617|NCT03086343|468844917|FG002|Period 1|Missing|0|||
130241618|NCT03086343|468844918|FG003|Period 1|Missing|0|||
130241619|NCT03086343|468844915|FG000|Period 2|Adverse Event|20|||
130241620|NCT03086343|468844916|FG001|Period 2|Adverse Event|11|||
130241621|NCT03086343|468844917|FG002|Period 2|Adverse Event|1|||
130241622|NCT03086343|468844918|FG003|Period 2|Adverse Event|2|||
130241623|NCT03086343|468844915|FG000|Period 2|Withdrawal by Subject|15|||
130241624|NCT03086343|468844916|FG001|Period 2|Withdrawal by Subject|25|||
130241625|NCT03086343|468844917|FG002|Period 2|Withdrawal by Subject|2|||
130241626|NCT03086343|468844918|FG003|Period 2|Withdrawal by Subject|2|||
130241627|NCT03086343|468844915|FG000|Period 2|Lost to Follow-up|6|||
130241628|NCT03086343|468844916|FG001|Period 2|Lost to Follow-up|11|||
130241629|NCT03086343|468844917|FG002|Period 2|Lost to Follow-up|1|||
130241630|NCT03086343|468844918|FG003|Period 2|Lost to Follow-up|0|||
130241631|NCT03086343|468844915|FG000|Period 2|COVID-19 Infection|5|||
130241632|NCT03086343|468844916|FG001|Period 2|COVID-19 Infection|0|||
130241633|NCT03086343|468844917|FG002|Period 2|COVID-19 Infection|0|||
130241634|NCT03086343|468844918|FG003|Period 2|COVID-19 Infection|0|||
130241635|NCT03086343|468844915|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
130241636|NCT03086343|468844916|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
130241637|NCT03086343|468844917|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
130241638|NCT03086343|468844918|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
130241639|NCT03086343|468844915|FG000|Period 2|Other, Not Specified|23|||
130241640|NCT03086343|468844916|FG001|Period 2|Other, Not Specified|22|||
130241641|NCT03086343|468844917|FG002|Period 2|Other, Not Specified|2|||
130241642|NCT03086343|468844918|FG003|Period 2|Other, Not Specified|4|||
130241643|NCT05607043|468844920|FG000|Overall Study|Lost to Follow-up|2|||
130241644|NCT00741611|468844921|FG000|Overall Study|Death|0|||
130241645|NCT00741611|468844922|FG001|Overall Study|Death|0|||
130241646|NCT00741611|468844923|FG002|Overall Study|Death|1|||
130241647|NCT00741611|468844921|FG000|Overall Study|Withdrawal by Subject|0|||
130241648|NCT00741611|468844922|FG001|Overall Study|Withdrawal by Subject|2|||
130241649|NCT00741611|468844923|FG002|Overall Study|Withdrawal by Subject|2|||
130241650|NCT00800540|468844931|FG000|Period One: 6 Weeks|Noncompliance|1|||
130241651|NCT00800540|468844932|FG001|Period One: 6 Weeks|Noncompliance|0|||
130241652|NCT00800540|468844931|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
130241653|NCT00800540|468844932|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
130241654|NCT00800540|468844931|FG000|Period 2: 6 Weeks|Adverse Event|0|||
130241655|NCT00800540|468844932|FG001|Period 2: 6 Weeks|Adverse Event|1|||
130241656|NCT01922011|468844933|FG000|Overall Study|Protocol Violation|0|||
130241657|NCT01922011|468844934|FG001|Overall Study|Protocol Violation|1|||
130241658|NCT01922011|468844933|FG000|Overall Study|Physician Decision|0|||
130241659|NCT01922011|468844934|FG001|Overall Study|Physician Decision|1|||
130241660|NCT01922011|468844933|FG000|Overall Study|Parent/Guardian Decision|3|||
130241661|NCT01922011|468844934|FG001|Overall Study|Parent/Guardian Decision|0|||
130241662|NCT01922011|468844933|FG000|Overall Study|Lost to Follow-up|0|||
130241663|NCT01922011|468844934|FG001|Overall Study|Lost to Follow-up|1|||
130241664|NCT01922011|468844933|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
130241665|NCT01922011|468844934|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
130241666|NCT01922011|468844933|FG000|Overall Study|Not Treated|1|||
130241667|NCT01922011|468844934|FG001|Overall Study|Not Treated|0|||
130241668|NCT01922011|468844933|FG000|Overall Study|Lack of willing home health agency|1|||
130241669|NCT01922011|468844934|FG001|Overall Study|Lack of willing home health agency|0|||
130241670|NCT01922011|468844933|FG000|Overall Study|Randomized in error|1|||
130241671|NCT01922011|468844934|FG001|Overall Study|Randomized in error|0|||
130241672|NCT04398134|468844935|FG000|Overall Study|Adverse Event|0|||
130241673|NCT04398134|468844936|FG001|Overall Study|Adverse Event|0|||
130241674|NCT04398134|468844937|FG002|Overall Study|Adverse Event|1|||
130241675|NCT04398134|468844938|FG003|Overall Study|Adverse Event|0|||
130241676|NCT04398134|468844935|FG000|Overall Study|Withdrawal by Subject|2|||
130241677|NCT04398134|468844936|FG001|Overall Study|Withdrawal by Subject|0|||
130241678|NCT04398134|468844937|FG002|Overall Study|Withdrawal by Subject|0|||
130241679|NCT04398134|468844938|FG003|Overall Study|Withdrawal by Subject|1|||
130241680|NCT04398134|468844935|FG000|Overall Study|Study Terminated by Sponsor|30|||
130241681|NCT04398134|468844936|FG001|Overall Study|Study Terminated by Sponsor|11|||
130241682|NCT04398134|468844937|FG002|Overall Study|Study Terminated by Sponsor|32|||
130241683|NCT04398134|468844938|FG003|Overall Study|Study Terminated by Sponsor|11|||
130241684|NCT00153920|468844940|FG000|Overall Study|Adverse Event|9|||
130241685|NCT00153920|468844940|FG000|Overall Study|Progressive Disease|9|||
130241686|NCT00153920|468844940|FG000|Overall Study|Physician Decision|3|||
130241687|NCT00153920|468844940|FG000|Overall Study|Lack of Response|3|||
130241688|NCT00153920|468844940|FG000|Overall Study|Death|2|||
130241689|NCT00153920|468844940|FG000|Overall Study|Withdrawal by Subject|1|||
130241690|NCT00153920|468844940|FG000|Overall Study|Non-Protocol Therapy|1|||
130241691|NCT00153920|468844940|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
130241692|NCT00153920|468844940|FG000|Overall Study|Progressive Disease before Trt|1|||
130241693|NCT02202616|468844941|FG000|Overall Study|Screen failed|24|||
130241694|NCT02202616|468844941|FG000|Overall Study|Adverse Event|32|||
130241695|NCT02202616|468844941|FG000|Overall Study|Protocol deviation|18|||
130241696|NCT02202616|468844941|FG000|Overall Study|Patient withdrew consent|12|||
130241697|NCT02202616|468844941|FG000|Overall Study|Lost to Follow-up|6|||
130241698|NCT02202616|468844941|FG000|Overall Study|Administrative problems|6|||
130241699|NCT02202616|468844941|FG000|Overall Study|Abnormal test procedure result|1|||
130241700|NCT02202616|468844941|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130241701|NCT01334515|468844944|FG000|Overall Study|Adverse Event|1|||
130241702|NCT01334515|468844945|FG001|Overall Study|Adverse Event|6|||
130241703|NCT01334515|468844944|FG000|Overall Study|Death|1|||
130241704|NCT01334515|468844945|FG001|Overall Study|Death|0|||
130241705|NCT01334515|468844944|FG000|Overall Study|Lack of Efficacy|8|||
130241706|NCT01334515|468844945|FG001|Overall Study|Lack of Efficacy|21|||
130241707|NCT01334515|468844944|FG000|Overall Study|Physician Decision|1|||
130241708|NCT01334515|468844945|FG001|Overall Study|Physician Decision|1|||
130241709|NCT01334515|468844944|FG000|Overall Study|Withdrawal by Subject|1|||
130241710|NCT01334515|468844945|FG001|Overall Study|Withdrawal by Subject|1|||
130241711|NCT04327271|468844946|FG000|Overall Study|Death|1|||
130241712|NCT04327271|468844947|FG001|Overall Study|Death|0|||
130241713|NCT04327271|468844946|FG000|Overall Study|Withdrawal by Subject|1|||
130241714|NCT04327271|468844947|FG001|Overall Study|Withdrawal by Subject|0|||
130241715|NCT04327271|468844946|FG000|Overall Study|randomization error (data capture)|4|||
130241716|NCT04327271|468844947|FG001|Overall Study|randomization error (data capture)|3|||
130241717|NCT01479530|468844949|FG000|Overall Study|Adverse Event|5|||
130241718|NCT01479530|468844950|FG001|Overall Study|Adverse Event|6|||
130241719|NCT01479530|468844949|FG000|Overall Study|Lack of Efficacy|0|||
130241720|NCT01479530|468844950|FG001|Overall Study|Lack of Efficacy|1|||
130241721|NCT01479530|468844949|FG000|Overall Study|Protocol Violation|2|||
130241722|NCT01479530|468844950|FG001|Overall Study|Protocol Violation|3|||
130241723|NCT01479530|468844949|FG000|Overall Study|Withdrawal of Consent|3|||
130241724|NCT01479530|468844950|FG001|Overall Study|Withdrawal of Consent|2|||
130241725|NCT00303628|468844951|FG000|Overall Study|Disease progression|0|||
130241726|NCT00303628|468844952|FG001|Overall Study|Disease progression|1|||
130241727|NCT00303628|468844951|FG000|Overall Study|Adverse Event|26|||
130241728|NCT00303628|468844952|FG001|Overall Study|Adverse Event|36|||
130241729|NCT00303628|468844951|FG000|Overall Study|Death|0|||
130241730|NCT00303628|468844952|FG001|Overall Study|Death|1|||
130241731|NCT00303628|468844951|FG000|Overall Study|Withdrawal by Subject|11|||
130241732|NCT00303628|468844952|FG001|Overall Study|Withdrawal by Subject|20|||
130241733|NCT00303628|468844951|FG000|Overall Study|Alternative therapy|2|||
130241734|NCT00303628|468844952|FG001|Overall Study|Alternative therapy|0|||
130241735|NCT00303628|468844951|FG000|Overall Study|Other complicating disease|0|||
130241736|NCT00303628|468844952|FG001|Overall Study|Other complicating disease|1|||
130241737|NCT00303628|468844951|FG000|Overall Study|Not start protocol therapy|3|||
130241738|NCT00303628|468844952|FG001|Overall Study|Not start protocol therapy|5|||
130241739|NCT00303628|468844951|FG000|Overall Study|Other|8|||
130241740|NCT00303628|468844952|FG001|Overall Study|Other|9|||
130241741|NCT01666652|468844953|FG000|Overall Study|Serious Adverse Event|0|||
130241742|NCT01666652|468844954|FG001|Overall Study|Serious Adverse Event|0|||
130241743|NCT01666652|468844955|FG002|Overall Study|Serious Adverse Event|0|||
130241744|NCT01666652|468844956|FG003|Overall Study|Serious Adverse Event|1|||
130241745|NCT01666652|468844957|FG004|Overall Study|Serious Adverse Event|0|||
130241746|NCT01666652|468844953|FG000|Overall Study|Withdrawal by Subject|0|||
130241747|NCT01666652|468844954|FG001|Overall Study|Withdrawal by Subject|0|||
130241748|NCT01666652|468844955|FG002|Overall Study|Withdrawal by Subject|0|||
130241749|NCT01666652|468844956|FG003|Overall Study|Withdrawal by Subject|0|||
130241750|NCT01666652|468844957|FG004|Overall Study|Withdrawal by Subject|1|||
130241751|NCT01666652|468844953|FG000|Overall Study|Moved from study area|1|||
130241752|NCT01666652|468844954|FG001|Overall Study|Moved from study area|0|||
130241753|NCT01666652|468844955|FG002|Overall Study|Moved from study area|0|||
130241754|NCT01666652|468844956|FG003|Overall Study|Moved from study area|2|||
130241755|NCT01666652|468844957|FG004|Overall Study|Moved from study area|0|||
130241756|NCT01666652|468844953|FG000|Overall Study|Lost to Follow-up|1|||
130241757|NCT01666652|468844954|FG001|Overall Study|Lost to Follow-up|1|||
130241758|NCT01666652|468844955|FG002|Overall Study|Lost to Follow-up|1|||
130241759|NCT01666652|468844956|FG003|Overall Study|Lost to Follow-up|1|||
130241760|NCT01666652|468844957|FG004|Overall Study|Lost to Follow-up|0|||
130241761|NCT01018979|468844958|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
130241762|NCT01018979|468844959|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
130241763|NCT01018979|468844958|FG000|Overall Study|Not received at least one dose|0|||
130241764|NCT01018979|468844959|FG001|Overall Study|Not received at least one dose|1|||
130241765|NCT03010501|468844962|FG000|Study Week 1|Withdrawal by Subject|2|||
130241766|NCT03010501|468844963|FG001|Study Week 1|Withdrawal by Subject|1|||
130241767|NCT03010501|468844964|FG002|Study Week 1|Withdrawal by Subject|0|||
130241768|NCT03010501|468844965|FG003|Study Week 1|Withdrawal by Subject|2|||
130241769|NCT03010501|468844966|FG004|Study Week 1|Withdrawal by Subject|0|||
130241770|NCT03010501|468844967|FG005|Study Week 1|Withdrawal by Subject|0|||
130241771|NCT03010501|468844962|FG000|Study Week 3|Withdrawal by Subject|0|||
130241772|NCT03010501|468844963|FG001|Study Week 3|Withdrawal by Subject|0|||
130241773|NCT03010501|468844964|FG002|Study Week 3|Withdrawal by Subject|0|||
130241774|NCT03010501|468844965|FG003|Study Week 3|Withdrawal by Subject|1|||
130241775|NCT03010501|468844966|FG004|Study Week 3|Withdrawal by Subject|0|||
130241776|NCT03010501|468844967|FG005|Study Week 3|Withdrawal by Subject|0|||
130241777|NCT00640289|468844968|FG000|Overall Study|Death|3|||
130241778|NCT00640289|468844968|FG000|Overall Study|Withdrawal by Subject|1|||
130241779|NCT00640289|468844968|FG000|Overall Study|Lost to Follow-up|1|||
130241780|NCT00640289|468844968|FG000|Overall Study|Data collected under different amendment|2|||
130241781|NCT00640289|468844968|FG000|Overall Study|Transferred to another center|1|||
130241782|NCT00640289|468844968|FG000|Overall Study|Missing status|5|||
130241783|NCT00544882|468844971|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
130241784|NCT00544882|468844972|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130241785|NCT00544882|468844973|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130241786|NCT00544882|468844971|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
130241787|NCT00544882|468844972|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
130241788|NCT00544882|468844973|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
130241789|NCT00544882|468844971|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130241790|NCT00544882|468844972|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
130241791|NCT00544882|468844973|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130241792|NCT00544882|468844971|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130241793|NCT00544882|468844972|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130241794|NCT00544882|468844973|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
130241795|NCT00544882|468844971|FG000|Cycle 3: Follow-up|Noncompliance|0|||
130241796|NCT00544882|468844972|FG001|Cycle 3: Follow-up|Noncompliance|1|||
130241797|NCT00544882|468844973|FG002|Cycle 3: Follow-up|Noncompliance|0|||
130241798|NCT00544882|468844971|FG000|Cycle 3: Follow-up|Pregnancy|0|||
130241799|NCT00544882|468844972|FG001|Cycle 3: Follow-up|Pregnancy|1|||
130241800|NCT00544882|468844973|FG002|Cycle 3: Follow-up|Pregnancy|0|||
130241801|NCT03043573|468844974|FG000|Overall Study|Lost to Follow-up|3|||
130361359|NCT01604408|469294182|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130361360|NCT01604408|469294183|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130241802|NCT03043573|468844975|FG001|Overall Study|Lost to Follow-up|3|||
130241803|NCT03043573|468844974|FG000|Overall Study|Physician Decision|0|||
130241804|NCT03043573|468844975|FG001|Overall Study|Physician Decision|5|||
130241805|NCT03043573|468844974|FG000|Overall Study|Withdrawal by Subject|0|||
130241806|NCT03043573|468844975|FG001|Overall Study|Withdrawal by Subject|4|||
130361361|NCT01604408|469294182|FG000|Treatment Period 2|Protocol Violation|1|||
130241807|NCT01373229|468846030|FG000|Overall Study|Death|3|||
130241808|NCT01373229|468846030|FG000|Overall Study|Physician Decision|3|||
130241809|NCT00143507|468846031|FG000|Overall Study|Death|572|||
130241810|NCT00143507|468846032|FG001|Overall Study|Death|547|||
130241811|NCT00143507|468846031|FG000|Overall Study|Withdrawal by Subject|114|||
130241812|NCT00143507|468846032|FG001|Overall Study|Withdrawal by Subject|102|||
130241813|NCT00143507|468846031|FG000|Overall Study|Lost to Follow-up|1|||
130241814|NCT00143507|468846032|FG001|Overall Study|Lost to Follow-up|0|||
130241815|NCT00143507|468846031|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
130241816|NCT00143507|468846032|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
130241817|NCT00587457|468846033|FG000|Overall Study|Adverse Event|1|||
130241818|NCT00587457|468846034|FG001|Overall Study|Adverse Event|2|||
130241819|NCT00587457|468846035|FG002|Overall Study|Adverse Event|1|||
130241820|NCT00587457|468846033|FG000|Overall Study|Disease progression|2|||
130241821|NCT00587457|468846034|FG001|Overall Study|Disease progression|0|||
130241822|NCT00587457|468846035|FG002|Overall Study|Disease progression|2|||
130241823|NCT00587457|468846033|FG000|Overall Study|Initiation of alternative therapy|0|||
130241824|NCT00587457|468846034|FG001|Overall Study|Initiation of alternative therapy|1|||
130241825|NCT00587457|468846035|FG002|Overall Study|Initiation of alternative therapy|0|||
130241826|NCT00587457|468846033|FG000|Overall Study|Undefined|0|||
130241827|NCT00587457|468846034|FG001|Overall Study|Undefined|0|||
130241828|NCT00587457|468846035|FG002|Overall Study|Undefined|1|||
130241829|NCT00587457|468846033|FG000|Overall Study|Development of neutralizing Abs|0|||
130241830|NCT00587457|468846034|FG001|Overall Study|Development of neutralizing Abs|0|||
130241831|NCT00587457|468846035|FG002|Overall Study|Development of neutralizing Abs|1|||
130241832|NCT03234881|468846036|FG000|Overall Study|Lost to Follow-up|9|||
130241833|NCT03234881|468846037|FG001|Overall Study|Lost to Follow-up|3|||
130241834|NCT00729586|468846038|FG000|Overall Study|Ineligible|0|||
130241835|NCT00729586|468846039|FG001|Overall Study|Ineligible|1|||
130241836|NCT00729586|468846038|FG000|Overall Study|never treated|1|||
130241837|NCT00729586|468846039|FG001|Overall Study|never treated|0|||
130241838|NCT00972738|468846041|FG000|Overall Study|Adverse Event|7|||
130241839|NCT00972738|468846042|FG001|Overall Study|Adverse Event|1|||
130241840|NCT00972738|468846043|FG002|Overall Study|Adverse Event|8|||
130241841|NCT00972738|468846041|FG000|Overall Study|Protocol Violation|2|||
130241842|NCT00972738|468846042|FG001|Overall Study|Protocol Violation|1|||
130241843|NCT00972738|468846043|FG002|Overall Study|Protocol Violation|3|||
130241844|NCT00972738|468846041|FG000|Overall Study|Lost to Follow-up|1|||
130241845|NCT00972738|468846042|FG001|Overall Study|Lost to Follow-up|0|||
130241846|NCT00972738|468846043|FG002|Overall Study|Lost to Follow-up|1|||
130241847|NCT00972738|468846041|FG000|Overall Study|Lack of Efficacy|5|||
130241848|NCT00972738|468846042|FG001|Overall Study|Lack of Efficacy|1|||
130241849|NCT00972738|468846043|FG002|Overall Study|Lack of Efficacy|11|||
130241850|NCT00972738|468846041|FG000|Overall Study|Withdrawal by Subject|5|||
130241851|NCT00972738|468846042|FG001|Overall Study|Withdrawal by Subject|1|||
130241852|NCT00972738|468846043|FG002|Overall Study|Withdrawal by Subject|4|||
130241853|NCT00972738|468846041|FG000|Overall Study|Moved|0|||
130241854|NCT00972738|468846042|FG001|Overall Study|Moved|0|||
130241855|NCT00972738|468846043|FG002|Overall Study|Moved|1|||
130241856|NCT00972738|468846041|FG000|Overall Study|Other|1|||
130241857|NCT00972738|468846042|FG001|Overall Study|Other|2|||
130241858|NCT00972738|468846043|FG002|Overall Study|Other|1|||
130241859|NCT03915067|468846044|FG000|Overall Study|Adverse Event|0|||
130241860|NCT03915067|468846045|FG001|Overall Study|Adverse Event|0|||
130241861|NCT03915067|468846046|FG002|Overall Study|Adverse Event|1|||
130241862|NCT03915067|468846044|FG000|Overall Study|Withdrawal by Subject|4|||
130241863|NCT03915067|468846045|FG001|Overall Study|Withdrawal by Subject|3|||
130241864|NCT03915067|468846046|FG002|Overall Study|Withdrawal by Subject|0|||
130241865|NCT03915067|468846044|FG000|Overall Study|Lost to Follow-up|3|||
130241866|NCT03915067|468846045|FG001|Overall Study|Lost to Follow-up|2|||
130241867|NCT03915067|468846046|FG002|Overall Study|Lost to Follow-up|0|||
130241868|NCT03915067|468846044|FG000|Overall Study|Protocol Deviation|0|||
130241869|NCT03915067|468846045|FG001|Overall Study|Protocol Deviation|0|||
130241870|NCT03915067|468846046|FG002|Overall Study|Protocol Deviation|1|||
130241871|NCT03915067|468846044|FG000|Overall Study|Covid-19 Related Issues|2|||
130241872|NCT03915067|468846045|FG001|Overall Study|Covid-19 Related Issues|4|||
130241873|NCT03915067|468846046|FG002|Overall Study|Covid-19 Related Issues|4|||
130241874|NCT03915067|468846044|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
130241875|NCT03915067|468846045|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
130241876|NCT03915067|468846046|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
130241877|NCT02034591|468846054|FG000|Overall Study|Withdrawal by Subject|0|||
130241878|NCT02034591|468846055|FG001|Overall Study|Withdrawal by Subject|0|||
130241879|NCT02034591|468846056|FG002|Overall Study|Withdrawal by Subject|0|||
130241880|NCT02034591|468846057|FG003|Overall Study|Withdrawal by Subject|0|||
130241881|NCT02034591|468846058|FG004|Overall Study|Withdrawal by Subject|1|||
130241882|NCT02034591|468846059|FG005|Overall Study|Withdrawal by Subject|0|||
130241883|NCT01793935|468846062|FG000|Overall Study|Pregnancy|1|||
130241884|NCT01793935|468846063|FG001|Overall Study|Pregnancy|0|||
130241885|NCT01793935|468846062|FG000|Overall Study|Protocol Violation|2|||
130241886|NCT01793935|468846063|FG001|Overall Study|Protocol Violation|1|||
130241887|NCT01793935|468846062|FG000|Overall Study|Adverse Event|2|||
130241888|NCT01793935|468846063|FG001|Overall Study|Adverse Event|0|||
130241889|NCT01793935|468846062|FG000|Overall Study|Patient did not take study medication|1|||
130241890|NCT01793935|468846063|FG001|Overall Study|Patient did not take study medication|1|||
130241891|NCT01793935|468846062|FG000|Overall Study|Lost to Follow-up|0|||
130241892|NCT01793935|468846063|FG001|Overall Study|Lost to Follow-up|1|||
130241893|NCT01121926|468846064|FG000|First Intervention Period|Adverse Event|1|||
130241894|NCT01121926|468846065|FG001|First Intervention Period|Adverse Event|0|||
130241895|NCT01121926|468846064|FG000|Washout Period|Adverse Event|0|||
130241896|NCT01121926|468846065|FG001|Washout Period|Adverse Event|1|||
130241897|NCT01121926|468846064|FG000|Washout Period|Positive pregnancy test|0|||
130241898|NCT01121926|468846065|FG001|Washout Period|Positive pregnancy test|1|||
130241899|NCT00416949|468846067|FG000|Overall Study|Patients refused to participate|5|||
130241900|NCT00313170|468846068|FG000|Overall Study|Death|2|||
130241901|NCT00313170|468846069|FG001|Overall Study|Death|4|||
130241902|NCT00313170|468846070|FG002|Overall Study|Death|2|||
130241903|NCT00313170|468846068|FG000|Overall Study|Adverse Event|1|||
130241904|NCT00313170|468846069|FG001|Overall Study|Adverse Event|2|||
130241905|NCT00313170|468846070|FG002|Overall Study|Adverse Event|0|||
130241906|NCT00313170|468846068|FG000|Overall Study|Disease progression|31|||
130241907|NCT00313170|468846069|FG001|Overall Study|Disease progression|26|||
130241908|NCT00313170|468846070|FG002|Overall Study|Disease progression|27|||
130241909|NCT00313170|468846068|FG000|Overall Study|Withdrawal by Subject|1|||
130241910|NCT00313170|468846069|FG001|Overall Study|Withdrawal by Subject|0|||
130241911|NCT00313170|468846070|FG002|Overall Study|Withdrawal by Subject|1|||
130241912|NCT00313170|468846068|FG000|Overall Study|Incorrect enrollment|0|||
130241913|NCT00313170|468846069|FG001|Overall Study|Incorrect enrollment|2|||
130241914|NCT00313170|468846070|FG002|Overall Study|Incorrect enrollment|1|||
130241915|NCT00313170|468846068|FG000|Overall Study|Lost to Follow-up|0|||
130241916|NCT00313170|468846069|FG001|Overall Study|Lost to Follow-up|0|||
130241917|NCT00313170|468846070|FG002|Overall Study|Lost to Follow-up|1|||
130241918|NCT00313170|468846068|FG000|Overall Study|Progression (investigators opinion)|1|||
130241919|NCT00313170|468846069|FG001|Overall Study|Progression (investigators opinion)|0|||
130241920|NCT00313170|468846070|FG002|Overall Study|Progression (investigators opinion)|0|||
130241921|NCT01410604|468846072|FG000|Overall Study|Adverse Event|2|||
130241922|NCT01410604|468846073|FG001|Overall Study|Adverse Event|1|||
130241923|NCT01410604|468846072|FG000|Overall Study|Lost to Follow-up|1|||
130241924|NCT01410604|468846073|FG001|Overall Study|Lost to Follow-up|0|||
130241925|NCT01410604|468846072|FG000|Overall Study|Physician Decision|0|||
130241926|NCT01410604|468846073|FG001|Overall Study|Physician Decision|1|||
130241927|NCT00529035|468846075|FG000|Overall Study|Withdrawal by Subject|1|||
130241928|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Other|4|||
130241929|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Other|1|||
130241930|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
130241931|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130241932|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
130241933|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
130241934|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
130241935|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130241936|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Death|1|||
130241937|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Death|2|||
130241938|NCT02175758|468846078|FG000|Treatment Phase|Lost to Follow-up|0|||
130241939|NCT02175758|468846079|FG001|Treatment Phase|Lost to Follow-up|1|||
130241940|NCT02175758|468846080|FG002|Treatment Phase|Lost to Follow-up|0|||
130241941|NCT02175758|468846081|FG003|Treatment Phase|Lost to Follow-up|0|||
130241942|NCT02175758|468846082|FG004|Treatment Phase|Lost to Follow-up|0|||
130241943|NCT02175758|468846083|FG005|Treatment Phase|Lost to Follow-up|0|||
130241944|NCT02175758|468846078|FG000|Treatment Phase|Adverse Event|0|||
130241945|NCT02175758|468846079|FG001|Treatment Phase|Adverse Event|0|||
130241946|NCT02175758|468846080|FG002|Treatment Phase|Adverse Event|0|||
130241947|NCT02175758|468846081|FG003|Treatment Phase|Adverse Event|0|||
130241948|NCT02175758|468846082|FG004|Treatment Phase|Adverse Event|1|||
130241949|NCT02175758|468846083|FG005|Treatment Phase|Adverse Event|0|||
130241950|NCT01047501|468846084|FG000|Overall Study|Adverse Event|7|||
130449674|NCT00093795|469611010|FG000|Overall Study|No follow up data|20|||
130241951|NCT01047501|468846085|FG001|Overall Study|Adverse Event|8|||
130449675|NCT00093795|469611011|FG001|Overall Study|No follow up data|16|||
130241952|NCT01047501|468846086|FG002|Overall Study|Adverse Event|5|||
130241953|NCT01047501|468846084|FG000|Overall Study|Withdrew Consent|6|||
130241954|NCT01047501|468846085|FG001|Overall Study|Withdrew Consent|2|||
130241955|NCT01047501|468846086|FG002|Overall Study|Withdrew Consent|4|||
130241956|NCT01047501|468846084|FG000|Overall Study|Lost to Follow-up|0|||
130241957|NCT01047501|468846085|FG001|Overall Study|Lost to Follow-up|1|||
130241958|NCT01047501|468846086|FG002|Overall Study|Lost to Follow-up|1|||
130241959|NCT01047501|468846084|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
130241960|NCT01047501|468846085|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
130241961|NCT01047501|468846086|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
130241962|NCT01047501|468846084|FG000|Overall Study|Death|1|||
130241963|NCT01047501|468846085|FG001|Overall Study|Death|0|||
130241964|NCT01047501|468846086|FG002|Overall Study|Death|0|||
130241965|NCT01047501|468846084|FG000|Overall Study|Other discontinuation|1|||
130241966|NCT01047501|468846085|FG001|Overall Study|Other discontinuation|0|||
130241967|NCT01047501|468846086|FG002|Overall Study|Other discontinuation|1|||
130241968|NCT01047501|468846084|FG000|Overall Study|Investigator judgement|0|||
130241969|NCT01047501|468846085|FG001|Overall Study|Investigator judgement|0|||
130241970|NCT01047501|468846086|FG002|Overall Study|Investigator judgement|1|||
130241971|NCT00429299|468846089|FG000|Overall Study|Disease Progression|1|||
130241972|NCT00429299|468846090|FG001|Overall Study|Disease Progression|1|||
130241973|NCT00429299|468846091|FG002|Overall Study|Disease Progression|0|||
130241974|NCT00429299|468846089|FG000|Overall Study|Adverse Event|2|||
130241975|NCT00429299|468846090|FG001|Overall Study|Adverse Event|5|||
130241976|NCT00429299|468846091|FG002|Overall Study|Adverse Event|1|||
130241977|NCT00429299|468846089|FG000|Overall Study|Protocol Violation|1|||
130241978|NCT00429299|468846090|FG001|Overall Study|Protocol Violation|0|||
130241979|NCT00429299|468846091|FG002|Overall Study|Protocol Violation|0|||
130241980|NCT00429299|468846089|FG000|Overall Study|Withdrawal by Subject|0|||
130241981|NCT00429299|468846090|FG001|Overall Study|Withdrawal by Subject|1|||
130241982|NCT00429299|468846091|FG002|Overall Study|Withdrawal by Subject|3|||
130241983|NCT01510756|468846092|FG000|Overall Study|Death|1|||
130241984|NCT01510756|468846092|FG000|Overall Study|Lack of Efficacy|2|||
130241985|NCT01510756|468846092|FG000|Overall Study|Physician Decision|1|||
130241986|NCT03927157|468846093|FG000|Overall Study|Adverse Event|1|||
130241987|NCT03927157|468846094|FG001|Overall Study|Adverse Event|3|||
130241988|NCT03927157|468846093|FG000|Overall Study|Protocol Violation|1|||
130241989|NCT03927157|468846094|FG001|Overall Study|Protocol Violation|2|||
130241990|NCT03927157|468846093|FG000|Overall Study|Withdrawal by Subject|8|||
130241991|NCT03927157|468846094|FG001|Overall Study|Withdrawal by Subject|21|||
130241992|NCT03927157|468846093|FG000|Overall Study|Due to COVID-19 pandemic|5|||
130241993|NCT03927157|468846094|FG001|Overall Study|Due to COVID-19 pandemic|2|||
130241994|NCT03927157|468846093|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
130241995|NCT03927157|468846094|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
130241996|NCT03927157|468846093|FG000|Overall Study|Other than above|0|||
130241997|NCT03927157|468846094|FG001|Overall Study|Other than above|1|||
130241998|NCT04871113|468846095|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130241999|NCT04871113|468846096|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242000|NCT04871113|468846097|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242001|NCT04871113|468846098|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242002|NCT04871113|468846099|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242003|NCT04871113|468846100|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
130242004|NCT04871113|468846101|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242005|NCT04871113|468846102|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242006|NCT04871113|468846103|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242007|NCT04871113|468846104|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242008|NCT04871113|468846095|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242009|NCT04871113|468846096|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242010|NCT04871113|468846097|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242011|NCT04871113|468846098|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242012|NCT04871113|468846099|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242013|NCT04871113|468846100|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242014|NCT04871113|468846101|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
130242015|NCT04871113|468846102|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
130242016|NCT04871113|468846103|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242017|NCT04871113|468846104|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242018|NCT02447029|468846105|FG000|Overall Study|Withdrawal by Subject|3|||
130242019|NCT02447029|468846106|FG001|Overall Study|Withdrawal by Subject|2|||
130242020|NCT01239745|468846107|FG000|Overall Study|Study terminated by sponsor|45|||
130242021|NCT01239745|468846107|FG000|Overall Study|Adverse Event|1|||
130696794|NCT02611323|470514512|FG003|Overall Study|Death|0|||
130696795|NCT02611323|470514513|FG004|Overall Study|Death|1|||
130242022|NCT00726557|468846108|FG000|Overall Study|Screening failure|4|||
130242023|NCT00726557|468846108|FG000|Overall Study|No end of treatment documentation|37|||
130242024|NCT00726557|468846108|FG000|Overall Study|No follow-up documentation available|55|||
130242025|NCT00726557|468846108|FG000|Overall Study|Treatment less than 3 months|17|||
130242026|NCT00726557|468846108|FG000|Overall Study|Inclusion criteria not met|15|||
130242027|NCT01257542|468846111|FG000|Overall Study|Protocol Violation|3|||
130242028|NCT01257542|468846112|FG001|Overall Study|Protocol Violation|5|||
130242029|NCT01257542|468846111|FG000|Overall Study|Withdrawal by Subject|0|||
130242030|NCT01257542|468846112|FG001|Overall Study|Withdrawal by Subject|2|||
130449676|NCT00093795|469611012|FG002|Overall Study|No follow up data|17|||
130696796|NCT02611323|470514514|FG005|Overall Study|Death|1|||
130449677|NCT02949271|469611017|FG000|Overall Study|Lack of Efficacy|5|||
130449678|NCT02949271|469611018|FG001|Overall Study|Lack of Efficacy|4|||
130449679|NCT02949271|469611017|FG000|Overall Study|Lost to Follow-up|3|||
130449680|NCT02949271|469611018|FG001|Overall Study|Lost to Follow-up|6|||
130449681|NCT02949271|469611017|FG000|Overall Study|Physician Decision|5|||
130449682|NCT02949271|469611018|FG001|Overall Study|Physician Decision|5|||
130449683|NCT02949271|469611017|FG000|Overall Study|Protocol Violation|6|||
130449684|NCT02949271|469611018|FG001|Overall Study|Protocol Violation|3|||
130449685|NCT02949271|469611017|FG000|Overall Study|Withdrawal by Subject|1|||
130449686|NCT02949271|469611018|FG001|Overall Study|Withdrawal by Subject|0|||
130449687|NCT02949271|469611017|FG000|Overall Study|Delivered prior to intervention|7|||
130449688|NCT02949271|469611018|FG001|Overall Study|Delivered prior to intervention|9|||
130449689|NCT02949271|469611017|FG000|Overall Study|Outside the window for cervical dilation|2|||
130449690|NCT02949271|469611018|FG001|Overall Study|Outside the window for cervical dilation|3|||
130449691|NCT05458102|469611019|FG000|Overall Study|Withdrew consent|2|||
130242047|NCT00776997|468846122|FG000|Overall Study|Adverse Event|2|||
130242048|NCT03487445|468846123|FG000|Randomization|Not treated for administrative reasons|1|||
130242049|NCT03487445|468846124|FG001|Randomization|Not treated for administrative reasons|0|||
130242050|NCT03301714|468846125|FG000|Overall Study|Lost to Follow-up|10|||
130242051|NCT03301714|468846126|FG001|Overall Study|Lost to Follow-up|4|||
130242052|NCT03301714|468846127|FG002|Overall Study|Lost to Follow-up|4|||
130242053|NCT03301714|468846125|FG000|Overall Study|Did not receive allocated intervention|0|||
130242054|NCT03301714|468846126|FG001|Overall Study|Did not receive allocated intervention|2|||
130242055|NCT03301714|468846127|FG002|Overall Study|Did not receive allocated intervention|3|||
130242056|NCT01251861|468846130|FG000|Overall Study|Disease progression|6|||
130242057|NCT01251861|468846131|FG001|Overall Study|Disease progression|6|||
130242058|NCT01251861|468846130|FG000|Overall Study|Adverse Event|2|||
130242059|NCT01251861|468846131|FG001|Overall Study|Adverse Event|17|||
130242060|NCT01251861|468846130|FG000|Overall Study|Withdrawal by Subject|2|||
130242061|NCT01251861|468846131|FG001|Overall Study|Withdrawal by Subject|2|||
130242062|NCT01251861|468846130|FG000|Overall Study|Alternative therapy|1|||
130242063|NCT01251861|468846131|FG001|Overall Study|Alternative therapy|0|||
130242064|NCT01251861|468846130|FG000|Overall Study|Other complicating disease|0|||
130242065|NCT01251861|468846131|FG001|Overall Study|Other complicating disease|1|||
130242066|NCT01251861|468846130|FG000|Overall Study|Physician Decision|1|||
130242067|NCT01251861|468846131|FG001|Overall Study|Physician Decision|0|||
130242068|NCT01251861|468846130|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
130242069|NCT01251861|468846131|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
130242070|NCT01251861|468846130|FG000|Overall Study|Other|1|||
130242071|NCT01251861|468846131|FG001|Overall Study|Other|0|||
130242072|NCT01251861|468846130|FG000|Overall Study|Never started therapy|4|||
130242073|NCT01251861|468846131|FG001|Overall Study|Never started therapy|1|||
130242074|NCT01251861|468846130|FG000|Overall Study|Potential interaction of drugs|0|||
130242075|NCT01251861|468846131|FG001|Overall Study|Potential interaction of drugs|1|||
130242076|NCT03580928|468846134|FG000|Overall Study|Death|0|||
130242077|NCT03580928|468846135|FG001|Overall Study|Death|3|||
130242078|NCT03580928|468846134|FG000|Overall Study|Withdrawal by Subject|2|||
130242079|NCT03580928|468846135|FG001|Overall Study|Withdrawal by Subject|1|||
130242080|NCT03580928|468846134|FG000|Overall Study|Lost to Follow-up|2|||
130242081|NCT03580928|468846135|FG001|Overall Study|Lost to Follow-up|0|||
130242082|NCT03580928|468846134|FG000|Overall Study|Progressive Disease|0|||
130242083|NCT03580928|468846135|FG001|Overall Study|Progressive Disease|1|||
130242084|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130242085|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130242086|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130242087|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130242088|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130242089|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130361362|NCT01604408|469294183|FG001|Treatment Period 2|Protocol Violation|0|||
130361363|NCT01604408|469294182|FG000|Treatment Period 2|Adverse Event|0|||
130361364|NCT01604408|469294183|FG001|Treatment Period 2|Adverse Event|1|||
130361365|NCT01604408|469294182|FG000|Treatment Period 3|Protocol Violation|1|||
130361366|NCT01604408|469294183|FG001|Treatment Period 3|Protocol Violation|1|||
130361367|NCT01604408|469294182|FG000|Treatment Period 3|Adverse Event|0|||
130361368|NCT01604408|469294183|FG001|Treatment Period 3|Adverse Event|3|||
130449692|NCT05458102|469611020|FG001|Overall Study|Withdrew consent|0|||
130449693|NCT05458102|469611019|FG000|Overall Study|Adverse Event|1|||
130242090|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242091|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130242092|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242093|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130242094|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130361369|NCT01604408|469294182|FG000|Treatment Period 3|Withdrawal by Subject|3|||
130361370|NCT01604408|469294183|FG001|Treatment Period 3|Withdrawal by Subject|1|||
130361371|NCT01604408|469294182|FG000|Treatment Period 3|Sponsor Decision|1|||
130361372|NCT01604408|469294183|FG001|Treatment Period 3|Sponsor Decision|0|||
130361373|NCT01604408|469294182|FG000|Treatment Period 4|Death|1|||
130361374|NCT01604408|469294183|FG001|Treatment Period 4|Death|0|||
130361375|NCT01604408|469294182|FG000|Treatment Period 4|Withdrawal by Subject|2|||
130361376|NCT01604408|469294183|FG001|Treatment Period 4|Withdrawal by Subject|1|||
130361377|NCT01604408|469294182|FG000|Treatment Period 4|Adverse Event|0|||
130361378|NCT01604408|469294183|FG001|Treatment Period 4|Adverse Event|1|||
130361379|NCT01604408|469294182|FG000|Treatment Period 5|Adverse Event|4|||
130361380|NCT01604408|469294183|FG001|Treatment Period 5|Adverse Event|0|||
130361381|NCT01604408|469294182|FG000|Treatment Period 6|Lost to Follow-up|0|||
130361382|NCT01604408|469294183|FG001|Treatment Period 6|Lost to Follow-up|1|||
130361383|NCT01604408|469294182|FG000|Treatment Period 6|Adverse Event|2|||
130361384|NCT01604408|469294183|FG001|Treatment Period 6|Adverse Event|0|||
130361385|NCT01604408|469294182|FG000|Treatment Period 6|Sponsor decision|0|||
130361386|NCT01604408|469294183|FG001|Treatment Period 6|Sponsor decision|1|||
130361387|NCT01604408|469294182|FG000|Observation Period|Adverse Event|1|||
130361388|NCT01604408|469294183|FG001|Observation Period|Adverse Event|1|||
130361389|NCT01604408|469294182|FG000|Observation Period|Withdrawal by Subject|0|||
130361390|NCT01604408|469294183|FG001|Observation Period|Withdrawal by Subject|2|||
130361391|NCT00917501|469294184|FG000|Overall Study|Lost to Follow-up|4|||
130361392|NCT00917501|469294185|FG001|Overall Study|Lost to Follow-up|1|||
130361393|NCT00917501|469294184|FG000|Overall Study|Withdrawal by Subject|3|||
130242095|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130242096|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130361394|NCT00917501|469294185|FG001|Overall Study|Withdrawal by Subject|1|||
130361395|NCT00917501|469294184|FG000|Overall Study|Lack of Efficacy|1|||
130361396|NCT00917501|469294185|FG001|Overall Study|Lack of Efficacy|2|||
130361397|NCT00917501|469294184|FG000|Overall Study|trouble swollowing capsules|0|||
130361398|NCT00917501|469294185|FG001|Overall Study|trouble swollowing capsules|1|||
130361399|NCT00808483|469294186|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
130361400|NCT00808483|469294187|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
130361401|NCT00808483|469294186|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
130242097|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242098|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242099|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
130242100|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130242101|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130242102|NCT04167670|468847230|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
130242103|NCT04167670|468847231|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
130242104|NCT04167670|468847232|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
130242105|NCT04167670|468847230|FG000|Overall Study|Significant protocol deviation|3|||
130242106|NCT04167670|468847231|FG001|Overall Study|Significant protocol deviation|1|||
130242107|NCT04167670|468847232|FG002|Overall Study|Significant protocol deviation|0|||
130242108|NCT04167670|468847230|FG000|Overall Study|Lost to Follow-up|0|||
130242109|NCT04167670|468847231|FG001|Overall Study|Lost to Follow-up|3|||
130242110|NCT04167670|468847232|FG002|Overall Study|Lost to Follow-up|3|||
130242111|NCT04167670|468847230|FG000|Overall Study|Voluntary Withdrawal|0|||
130242112|NCT04167670|468847231|FG001|Overall Study|Voluntary Withdrawal|1|||
130361402|NCT00808483|469294187|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
130361403|NCT00808483|469294186|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
130361404|NCT00808483|469294187|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
130361405|NCT04553679|469294188|FG000|Overall Study|Withdrawal by Subject|2|||
130242113|NCT04167670|468847232|FG002|Overall Study|Voluntary Withdrawal|1|||
130361406|NCT04553679|469294189|FG001|Overall Study|Withdrawal by Subject|0|||
130361407|NCT04553679|469294188|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
130361408|NCT04553679|469294189|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
130696797|NCT02611323|470514515|FG006|Overall Study|Death|8|||
130696798|NCT02611323|470514516|FG007|Overall Study|Death|0|||
130696799|NCT02611323|470514517|FG008|Overall Study|Death|4|||
130696800|NCT02611323|470514518|FG009|Overall Study|Death|6|||
130696801|NCT02611323|470514519|FG010|Overall Study|Death|26|||
130696802|NCT02611323|470514509|FG000|Overall Study|Lost to Follow-up|1|||
130696803|NCT02611323|470514510|FG001|Overall Study|Lost to Follow-up|0|||
130696804|NCT02611323|470514511|FG002|Overall Study|Lost to Follow-up|0|||
130696805|NCT02611323|470514512|FG003|Overall Study|Lost to Follow-up|0|||
130696806|NCT02611323|470514513|FG004|Overall Study|Lost to Follow-up|0|||
130696807|NCT02611323|470514514|FG005|Overall Study|Lost to Follow-up|0|||
130696808|NCT02611323|470514515|FG006|Overall Study|Lost to Follow-up|3|||
130696809|NCT02611323|470514516|FG007|Overall Study|Lost to Follow-up|0|||
130696810|NCT02611323|470514517|FG008|Overall Study|Lost to Follow-up|0|||
130696811|NCT02611323|470514518|FG009|Overall Study|Lost to Follow-up|0|||
130696812|NCT02611323|470514519|FG010|Overall Study|Lost to Follow-up|2|||
130242114|NCT04167670|468847230|FG000|Overall Study|Withdrawal of Consent|4|||
130242115|NCT04167670|468847231|FG001|Overall Study|Withdrawal of Consent|1|||
130242116|NCT04167670|468847232|FG002|Overall Study|Withdrawal of Consent|3|||
130242117|NCT04167670|468847230|FG000|Overall Study|Miscellaneous|7|||
130242118|NCT04167670|468847231|FG001|Overall Study|Miscellaneous|5|||
130242119|NCT04167670|468847232|FG002|Overall Study|Miscellaneous|3|||
130242120|NCT01127061|468847233|FG000|Overall Study|Lost to Follow-up|7|||
130242121|NCT01127061|468847234|FG001|Overall Study|Lost to Follow-up|10|||
130242122|NCT01127061|468847233|FG000|Overall Study|Physician Decision|3|||
130242123|NCT01127061|468847234|FG001|Overall Study|Physician Decision|3|||
130242124|NCT04827446|468847237|FG000|Overall Study|Lost to Follow-up|1|||
130242125|NCT04827446|468847238|FG001|Overall Study|Lost to Follow-up|1|||
130696813|NCT02611323|470514509|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
130242126|NCT04827446|468847237|FG000|Overall Study|Death|2|||
130361409|NCT02357979|469294190|FG000|Overall Study|Lost to Follow-up|5|||
130361410|NCT02357979|469294191|FG001|Overall Study|Lost to Follow-up|5|||
130696814|NCT02611323|470514510|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696815|NCT02611323|470514511|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696816|NCT02611323|470514512|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696817|NCT02611323|470514513|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696818|NCT02611323|470514514|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696819|NCT02611323|470514515|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696820|NCT02611323|470514516|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696821|NCT02611323|470514517|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696822|NCT02611323|470514518|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
130696823|NCT02611323|470514519|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696824|NCT02611323|470514509|FG000|Overall Study|Progressive Disease|0|||
130696825|NCT02611323|470514510|FG001|Overall Study|Progressive Disease|0|||
130696826|NCT02611323|470514511|FG002|Overall Study|Progressive Disease|0|||
130696827|NCT02611323|470514512|FG003|Overall Study|Progressive Disease|0|||
130696828|NCT02611323|470514513|FG004|Overall Study|Progressive Disease|0|||
130361411|NCT03945214|469294192|FG000|Overall Study|Lost to Follow-up|3|||
130242127|NCT04827446|468847238|FG001|Overall Study|Death|0|||
130242128|NCT04827446|468847237|FG000|Overall Study|Withdrawal by Subject|2|||
130242129|NCT04827446|468847238|FG001|Overall Study|Withdrawal by Subject|2|||
130242130|NCT00003456|468847241|FG000|Overall Study|Not evaluable|8|||
130361412|NCT03945214|469294193|FG001|Overall Study|Lost to Follow-up|4|||
130361413|NCT03945214|469294194|FG002|Overall Study|Lost to Follow-up|7|||
130361414|NCT03945214|469294195|FG003|Overall Study|Lost to Follow-up|4|||
130242131|NCT00479232|468847242|FG000|Overall Study|Adverse Event|0|||
130242132|NCT00479232|468847243|FG001|Overall Study|Adverse Event|0|||
130242133|NCT00479232|468847244|FG002|Overall Study|Adverse Event|5|||
130242134|NCT00479232|468847245|FG003|Overall Study|Adverse Event|0|||
130242135|NCT00479232|468847246|FG004|Overall Study|Adverse Event|0|||
130242136|NCT00479232|468847247|FG005|Overall Study|Adverse Event|10|||
130242137|NCT00479232|468847242|FG000|Overall Study|Deviation from Protocol|0|||
130242138|NCT00479232|468847243|FG001|Overall Study|Deviation from Protocol|0|||
130242139|NCT00479232|468847244|FG002|Overall Study|Deviation from Protocol|1|||
130242140|NCT00479232|468847245|FG003|Overall Study|Deviation from Protocol|0|||
130242141|NCT00479232|468847246|FG004|Overall Study|Deviation from Protocol|0|||
130242142|NCT00479232|468847247|FG005|Overall Study|Deviation from Protocol|0|||
130242143|NCT00479232|468847242|FG000|Overall Study|Lack of Efficacy|0|||
130696829|NCT02611323|470514514|FG005|Overall Study|Progressive Disease|0|||
130242144|NCT00479232|468847243|FG001|Overall Study|Lack of Efficacy|0|||
130242145|NCT00479232|468847244|FG002|Overall Study|Lack of Efficacy|2|||
130242146|NCT00479232|468847245|FG003|Overall Study|Lack of Efficacy|0|||
130242147|NCT00479232|468847246|FG004|Overall Study|Lack of Efficacy|0|||
130242148|NCT00479232|468847247|FG005|Overall Study|Lack of Efficacy|4|||
130242149|NCT00479232|468847242|FG000|Overall Study|Physician Decision|0|||
130242150|NCT00479232|468847243|FG001|Overall Study|Physician Decision|0|||
130242151|NCT00479232|468847244|FG002|Overall Study|Physician Decision|2|||
130242152|NCT00479232|468847245|FG003|Overall Study|Physician Decision|0|||
130242153|NCT00479232|468847246|FG004|Overall Study|Physician Decision|0|||
130242154|NCT00479232|468847247|FG005|Overall Study|Physician Decision|1|||
130242155|NCT00479232|468847242|FG000|Overall Study|Progressive Disease|3|||
130242156|NCT00479232|468847243|FG001|Overall Study|Progressive Disease|1|||
130242157|NCT00479232|468847244|FG002|Overall Study|Progressive Disease|12|||
130242158|NCT00479232|468847245|FG003|Overall Study|Progressive Disease|3|||
130242159|NCT00479232|468847246|FG004|Overall Study|Progressive Disease|3|||
130242160|NCT00479232|468847247|FG005|Overall Study|Progressive Disease|12|||
130242161|NCT00479232|468847242|FG000|Overall Study|Withdrew Consent|0|||
130242162|NCT00479232|468847243|FG001|Overall Study|Withdrew Consent|2|||
130242163|NCT00479232|468847244|FG002|Overall Study|Withdrew Consent|6|||
130242164|NCT00479232|468847245|FG003|Overall Study|Withdrew Consent|0|||
130242165|NCT00479232|468847246|FG004|Overall Study|Withdrew Consent|1|||
130242166|NCT00479232|468847247|FG005|Overall Study|Withdrew Consent|3|||
130242167|NCT05399771|468847248|FG000|Overall Study|Physician Decision|3|||
130242168|NCT05399771|468847248|FG000|Overall Study|Adverse Event|1|||
130242169|NCT00484159|468847249|FG000|Overall Study|Lost to Follow-up|1|||
130242170|NCT00484159|468847250|FG001|Overall Study|Lost to Follow-up|1|||
130242171|NCT00484159|468847251|FG002|Overall Study|Lost to Follow-up|0|||
130242172|NCT03720847|468847252|FG000|Washout|Physician Decision|1|||
130242173|NCT03720847|468847253|FG001|Washout|Physician Decision|2|||
130242174|NCT01239680|468847254|FG000|Overall Study|Withdrawal by Subject|2|||
130242175|NCT01239680|468847255|FG001|Overall Study|Withdrawal by Subject|0|||
130242176|NCT03033901|468847256|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
130242177|NCT03033901|468847256|FG000|Overall Study|Refused PSG|23|||
130242178|NCT03033901|468847256|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
130242179|NCT03033901|468847256|FG000|Overall Study|Missing Oximetry Data|3|||
130242180|NCT02513199|468847259|FG000|Treatment|Death|1|||
130242181|NCT02513199|468847259|FG000|Treatment|Lost to Follow-up|1|||
130242182|NCT02513199|468847259|FG000|Follow-Up|Death|11|||
130242183|NCT04307394|468847265|FG000|Overall Study|Lost to Follow-up|3|||
130242184|NCT04307394|468847265|FG000|Overall Study|Withdrawal by Subject|2|||
130361415|NCT00074984|469294199|FG000|Overall Study|Death|1|||
130242185|NCT01521364|468847273|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
130242186|NCT01521364|468847273|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
130242187|NCT04900272|468847274|FG000|Overall Study|Lost to Follow-up|2|||
130242188|NCT04900272|468847274|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
130361416|NCT00074984|469294200|FG001|Overall Study|Death|2|||
130361417|NCT00074984|469294199|FG000|Overall Study|Withdrawal by Subject|2|||
130361418|NCT00074984|469294200|FG001|Overall Study|Withdrawal by Subject|3|||
130361419|NCT00074984|469294199|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
130361420|NCT00074984|469294200|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
130696830|NCT02611323|470514515|FG006|Overall Study|Progressive Disease|0|||
130696831|NCT02611323|470514516|FG007|Overall Study|Progressive Disease|0|||
130242189|NCT04900272|468847274|FG000|Overall Study|Withdrawal by Subject|1|||
130242190|NCT05059080|468847275|FG000|Overall Study|Withdrawal by Subject|3|||
130242191|NCT05059080|468847275|FG000|Overall Study|Study Terminated by Sponsor|64|||
130242192|NCT00081458|468847277|FG000|Overall Study|Adverse Event|1|||
130242193|NCT00081458|468847278|FG001|Overall Study|Adverse Event|5|||
130242194|NCT00081458|468847279|FG002|Overall Study|Adverse Event|2|||
130242195|NCT00081458|468847277|FG000|Overall Study|Withdrawal by Subject|0|||
130242196|NCT00081458|468847278|FG001|Overall Study|Withdrawal by Subject|3|||
130242197|NCT00081458|468847279|FG002|Overall Study|Withdrawal by Subject|1|||
130242198|NCT00081458|468847277|FG000|Overall Study|Randomized but not dosed|0|||
130361421|NCT01772160|469294204|FG000|Overall Study|Death|3|||
130696832|NCT02611323|470514517|FG008|Overall Study|Progressive Disease|0|||
130242199|NCT00081458|468847278|FG001|Overall Study|Randomized but not dosed|0|||
130242200|NCT00081458|468847279|FG002|Overall Study|Randomized but not dosed|1|||
130242201|NCT00549328|468847280|FG000|Overall Study|Adverse Event|2|||
130242202|NCT00549328|468847280|FG000|Overall Study|Disease Progression|10|||
130242203|NCT00549328|468847280|FG000|Overall Study|Death|1|||
130242204|NCT00549328|468847280|FG000|Overall Study|Use of Prohibited Medication|1|||
130242205|NCT00770484|468847281|FG000|Overall Study|Withdrawal by Subject|1|||
130242206|NCT00770484|468847282|FG001|Overall Study|Withdrawal by Subject|0|||
130242207|NCT01946802|468847287|FG000|Overall Study|Death|1|||
130242208|NCT01946802|468847287|FG000|Overall Study|Withdrawal by Subject|2|||
130696833|NCT02611323|470514518|FG009|Overall Study|Progressive Disease|0|||
130696834|NCT02611323|470514519|FG010|Overall Study|Progressive Disease|1|||
130242209|NCT01946802|468847287|FG000|Overall Study|Combined septic shock|1|||
130242210|NCT01946802|468847287|FG000|Overall Study|Protocol Violation|1|||
130242211|NCT03097315|468847288|FG000|Overall Study|Withdrawal by Subject|1|||
130242212|NCT03384966|468847289|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
130242213|NCT03384966|468847290|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130242214|NCT03384966|468847291|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130242215|NCT03384966|468847289|FG000|Follow-up Period|Adverse Event|1|||
130242216|NCT03384966|468847290|FG001|Follow-up Period|Adverse Event|0|||
130242217|NCT03384966|468847291|FG002|Follow-up Period|Adverse Event|0|||
130242218|NCT03637374|468847292|FG000|Overall Study|Death|2|||
130242219|NCT03637374|468847293|FG001|Overall Study|Death|0|||
130242220|NCT02836769|468847295|FG000|Overall Study|Lost to Follow-up|10|||
130242221|NCT02836769|468847295|FG000|Overall Study|Medical withdrawal|2|||
130242222|NCT02836769|468847295|FG000|Overall Study|Withdrawal by Subject|3|||
130242223|NCT00376506|468847304|FG000|Overall Study|Death|0|||
130242224|NCT00376506|468847305|FG001|Overall Study|Death|2|||
130242225|NCT02948400|468847308|FG000|Overall Study|Withdrawal by Subject|17|||
130242226|NCT02948400|468847309|FG001|Overall Study|Withdrawal by Subject|10|||
130242227|NCT02948400|468847308|FG000|Overall Study|failed to attend appointments|47|||
130242228|NCT02948400|468847309|FG001|Overall Study|failed to attend appointments|34|||
130242229|NCT02948400|468847308|FG000|Overall Study|COVID-related closure|6|||
130242230|NCT02948400|468847309|FG001|Overall Study|COVID-related closure|2|||
130242231|NCT02948400|468847308|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
130242232|NCT02948400|468847309|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
130242233|NCT02948400|468847308|FG000|Overall Study|motion sickness in virtual reality|2|||
130242234|NCT02948400|468847309|FG001|Overall Study|motion sickness in virtual reality|0|||
130242235|NCT02403271|468847310|FG000|Period 1|Other varied reasons|1|||
130242236|NCT02403271|468847311|FG001|Period 1|Other varied reasons|0|||
130242237|NCT02403271|468847310|FG000|Period 2|Withdrawal by Subject|0|||
130242238|NCT02403271|468847311|FG001|Period 2|Withdrawal by Subject|14|||
130242239|NCT02403271|468847310|FG000|Period 2|Death|0|||
130242240|NCT02403271|468847311|FG001|Period 2|Death|84|||
130242241|NCT02403271|468847310|FG000|Period 2|Lost to Follow-up|0|||
130242242|NCT02403271|468847311|FG001|Period 2|Lost to Follow-up|2|||
130242243|NCT02403271|468847310|FG000|Period 2|Study Terminated by Sponsor|0|||
130242244|NCT02403271|468847311|FG001|Period 2|Study Terminated by Sponsor|14|||
130242245|NCT02403271|468847310|FG000|Period 2|Other varied reasons|0|||
130242246|NCT02403271|468847311|FG001|Period 2|Other varied reasons|10|||
130242247|NCT00221104|468847316|FG000|Overall Study|Adverse Event|1|||
130242248|NCT00221104|468847317|FG001|Overall Study|Adverse Event|0|||
130242249|NCT00221104|468847316|FG000|Overall Study|Physician Decision|1|||
130242250|NCT00221104|468847317|FG001|Overall Study|Physician Decision|0|||
130242251|NCT00221104|468847316|FG000|Overall Study|Protocol Violation|2|||
130242252|NCT00221104|468847317|FG001|Overall Study|Protocol Violation|0|||
130242253|NCT00221104|468847316|FG000|Overall Study|Withdrawal by Subject|42|||
130242254|NCT00221104|468847317|FG001|Overall Study|Withdrawal by Subject|29|||
130242255|NCT00221104|468847316|FG000|Overall Study|Others|37|||
130242256|NCT00221104|468847317|FG001|Overall Study|Others|47|||
130242257|NCT02989389|468847318|FG000|Period 1|Lost to Follow-up|0|||
130242258|NCT02989389|468847319|FG001|Period 1|Lost to Follow-up|1|||
130242259|NCT02989389|468847320|FG002|Period 1|Lost to Follow-up|0|||
130242260|NCT02989389|468847321|FG003|Period 1|Lost to Follow-up|0|||
130242261|NCT02989389|468847322|FG004|Period 1|Lost to Follow-up|0|||
130242262|NCT02989389|468847323|FG005|Period 1|Lost to Follow-up|0|||
130242263|NCT02989389|468847324|FG006|Period 1|Lost to Follow-up|0|||
130242264|NCT02989389|468847325|FG007|Period 1|Lost to Follow-up|0|||
130242265|NCT02989389|468847326|FG008|Period 1|Lost to Follow-up|0|||
130242266|NCT02989389|468847327|FG009|Period 1|Lost to Follow-up|0|||
130242267|NCT02989389|468847318|FG000|Period 1|Physician Decision|0|||
130242268|NCT02989389|468847319|FG001|Period 1|Physician Decision|0|||
130242269|NCT02989389|468847320|FG002|Period 1|Physician Decision|0|||
130242270|NCT02989389|468847321|FG003|Period 1|Physician Decision|0|||
130242271|NCT02989389|468847322|FG004|Period 1|Physician Decision|0|||
130242272|NCT02989389|468847323|FG005|Period 1|Physician Decision|0|||
130242273|NCT02989389|468847324|FG006|Period 1|Physician Decision|0|||
130696835|NCT02611323|470514509|FG000|Overall Study|Withdrawal by Subject|1|||
130242274|NCT02989389|468847325|FG007|Period 1|Physician Decision|0|||
130242275|NCT02989389|468847326|FG008|Period 1|Physician Decision|1|||
130242276|NCT02989389|468847327|FG009|Period 1|Physician Decision|0|||
130242277|NCT04470427|468847328|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
130242278|NCT04470427|468847329|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
130242279|NCT04470427|468847330|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
130242280|NCT04470427|468847331|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
130242281|NCT04470427|468847332|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
130242282|NCT04470427|468847333|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
130242283|NCT04470427|468847328|FG000|Part B :Open-label|Other than specified|0|||
130242284|NCT04470427|468847329|FG001|Part B :Open-label|Other than specified|0|||
130242285|NCT04470427|468847330|FG002|Part B :Open-label|Other than specified|788|||
130242286|NCT04470427|468847331|FG003|Part B :Open-label|Other than specified|0|||
130242287|NCT04470427|468847332|FG004|Part B :Open-label|Other than specified|523|||
130242288|NCT04470427|468847333|FG005|Part B :Open-label|Other than specified|0|||
130242289|NCT04470427|468847328|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
130242290|NCT04470427|468847329|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
130242291|NCT04470427|468847330|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
130242292|NCT04470427|468847331|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
130242293|NCT04470427|468847332|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
130242294|NCT04470427|468847333|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
130242295|NCT04470427|468847328|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
130242296|NCT04470427|468847329|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
130242297|NCT04470427|468847330|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
130242298|NCT04470427|468847331|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
130242299|NCT04470427|468847332|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
130242300|NCT04470427|468847333|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
130242301|NCT03412890|468847340|FG000|Overall Study|Adverse Event|5|||
130242302|NCT03412890|468847341|FG001|Overall Study|Adverse Event|5|||
130242303|NCT03412890|468847342|FG002|Overall Study|Adverse Event|9|||
130242304|NCT03412890|468847340|FG000|Overall Study|Protocol deviation|2|||
130242305|NCT03412890|468847341|FG001|Overall Study|Protocol deviation|1|||
130242306|NCT03412890|468847342|FG002|Overall Study|Protocol deviation|2|||
130242307|NCT03412890|468847340|FG000|Overall Study|Lost to Follow-up|7|||
130242308|NCT03412890|468847341|FG001|Overall Study|Lost to Follow-up|10|||
130242309|NCT03412890|468847342|FG002|Overall Study|Lost to Follow-up|10|||
130242310|NCT03412890|468847340|FG000|Overall Study|Withdrawal by Subject|9|||
130242311|NCT03412890|468847341|FG001|Overall Study|Withdrawal by Subject|12|||
130242312|NCT03412890|468847342|FG002|Overall Study|Withdrawal by Subject|11|||
130242313|NCT03412890|468847340|FG000|Overall Study|Lack of Efficacy|2|||
130242314|NCT03412890|468847341|FG001|Overall Study|Lack of Efficacy|7|||
130242315|NCT03412890|468847342|FG002|Overall Study|Lack of Efficacy|5|||
130242316|NCT03412890|468847340|FG000|Overall Study|Other|5|||
130242317|NCT03412890|468847341|FG001|Overall Study|Other|6|||
130242318|NCT03412890|468847342|FG002|Overall Study|Other|5|||
130242319|NCT03412890|468847340|FG000|Overall Study|Participants who did not receive any study drug|0|||
130242320|NCT03412890|468847341|FG001|Overall Study|Participants who did not receive any study drug|1|||
130242321|NCT03412890|468847342|FG002|Overall Study|Participants who did not receive any study drug|0|||
130242322|NCT00021255|468847343|FG000|Overall Study|Death|1|||
130242323|NCT00021255|468847344|FG001|Overall Study|Death|0|||
130242324|NCT00021255|468847345|FG002|Overall Study|Death|2|||
130242325|NCT00021255|468847343|FG000|Overall Study|Breast cancer relapse|5|||
130242326|NCT00021255|468847344|FG001|Overall Study|Breast cancer relapse|18|||
130242327|NCT00021255|468847345|FG002|Overall Study|Breast cancer relapse|11|||
130242328|NCT00021255|468847343|FG000|Overall Study|Second primary malignancy|0|||
130242329|NCT00021255|468847344|FG001|Overall Study|Second primary malignancy|4|||
130242330|NCT00021255|468847345|FG002|Overall Study|Second primary malignancy|1|||
130361422|NCT01772160|469294204|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
130361423|NCT01772160|469294204|FG000|Overall Study|Consent withdrawal|3|||
130361424|NCT01772160|469294204|FG000|Overall Study|Migrated / moved from the study area|4|||
130361425|NCT01772160|469294204|FG000|Overall Study|Lost to Follow-up|30|||
130361426|NCT01772160|469294204|FG000|Overall Study|Other|5|||
130361427|NCT01522248|469294205|FG000|Overall Study|Lost to Follow-up|1|||
130361428|NCT01522248|469294206|FG001|Overall Study|Lost to Follow-up|0|||
130361429|NCT00694707|469294211|FG000|Overall Study|Did Not Receive Treatment|0|||
130361430|NCT00694707|469294212|FG001|Overall Study|Did Not Receive Treatment|0|||
130242331|NCT00021255|468847343|FG000|Overall Study|Withdrawal by Subject|41|||
130242332|NCT00021255|468847344|FG001|Overall Study|Withdrawal by Subject|64|||
130242333|NCT00021255|468847345|FG002|Overall Study|Withdrawal by Subject|26|||
130242334|NCT00021255|468847343|FG000|Overall Study|Lost to Follow-up|0|||
130242335|NCT00021255|468847344|FG001|Overall Study|Lost to Follow-up|2|||
130242336|NCT00021255|468847345|FG002|Overall Study|Lost to Follow-up|3|||
130242337|NCT00021255|468847343|FG000|Overall Study|Cardiac toxicity|0|||
130242338|NCT00021255|468847344|FG001|Overall Study|Cardiac toxicity|61|||
130361431|NCT00694707|469294213|FG002|Overall Study|Did Not Receive Treatment|1|||
130242339|NCT00021255|468847345|FG002|Overall Study|Cardiac toxicity|32|||
130242340|NCT00021255|468847343|FG000|Overall Study|Herceptin toxicity|0|||
130242341|NCT00021255|468847344|FG001|Overall Study|Herceptin toxicity|22|||
130242342|NCT00021255|468847345|FG002|Overall Study|Herceptin toxicity|6|||
130242343|NCT00021255|468847343|FG000|Overall Study|Adverse Event|46|||
130242344|NCT00021255|468847344|FG001|Overall Study|Adverse Event|30|||
130242345|NCT00021255|468847345|FG002|Overall Study|Adverse Event|18|||
130242346|NCT00021255|468847343|FG000|Overall Study|Protocol Violation|0|||
130242347|NCT00021255|468847344|FG001|Overall Study|Protocol Violation|2|||
130242348|NCT00021255|468847345|FG002|Overall Study|Protocol Violation|0|||
130242349|NCT00021255|468847343|FG000|Overall Study|Other than specified above|0|||
130242350|NCT00021255|468847344|FG001|Overall Study|Other than specified above|38|||
130242351|NCT00021255|468847345|FG002|Overall Study|Other than specified above|19|||
130242352|NCT00021255|468847343|FG000|Overall Study|Missing|0|||
130242353|NCT00021255|468847344|FG001|Overall Study|Missing|27|||
130242354|NCT00021255|468847345|FG002|Overall Study|Missing|13|||
130242355|NCT00021255|468847343|FG000|Overall Study|Randomized but not treated|28|||
130242356|NCT00021255|468847344|FG001|Overall Study|Randomized but not treated|2|||
130242357|NCT00021255|468847345|FG002|Overall Study|Randomized but not treated|18|||
130242358|NCT01132755|468847348|FG000|Overall Study|Procedure not done due to medical reason|23|||
130361432|NCT00694707|469294214|FG003|Overall Study|Did Not Receive Treatment|1|||
130361433|NCT00694707|469294215|FG004|Overall Study|Did Not Receive Treatment|1|||
130361434|NCT00694707|469294211|FG000|Overall Study|Adverse Event|22|||
130361435|NCT00694707|469294212|FG001|Overall Study|Adverse Event|14|||
130361436|NCT00694707|469294213|FG002|Overall Study|Adverse Event|8|||
130361437|NCT00694707|469294214|FG003|Overall Study|Adverse Event|12|||
130361438|NCT00694707|469294215|FG004|Overall Study|Adverse Event|13|||
130361439|NCT00694707|469294211|FG000|Overall Study|Insufficient Therapeutic Response|33|||
130361440|NCT00694707|469294212|FG001|Overall Study|Insufficient Therapeutic Response|18|||
130361441|NCT00694707|469294213|FG002|Overall Study|Insufficient Therapeutic Response|17|||
130361442|NCT00694707|469294214|FG003|Overall Study|Insufficient Therapeutic Response|15|||
130361443|NCT00694707|469294215|FG004|Overall Study|Insufficient Therapeutic Response|10|||
130361444|NCT00694707|469294211|FG000|Overall Study|Protocol Violation|1|||
130361445|NCT00694707|469294212|FG001|Overall Study|Protocol Violation|2|||
130361446|NCT00694707|469294213|FG002|Overall Study|Protocol Violation|1|||
130361447|NCT00694707|469294214|FG003|Overall Study|Protocol Violation|3|||
130361448|NCT00694707|469294215|FG004|Overall Study|Protocol Violation|1|||
130361449|NCT00694707|469294211|FG000|Overall Study|Withdrawal of Consent|14|||
130361450|NCT00694707|469294212|FG001|Overall Study|Withdrawal of Consent|18|||
130361451|NCT00694707|469294213|FG002|Overall Study|Withdrawal of Consent|22|||
130361452|NCT00694707|469294214|FG003|Overall Study|Withdrawal of Consent|16|||
130361453|NCT00694707|469294215|FG004|Overall Study|Withdrawal of Consent|15|||
130361454|NCT00694707|469294211|FG000|Overall Study|Lost to Follow-up|0|||
130361455|NCT00694707|469294212|FG001|Overall Study|Lost to Follow-up|1|||
130361456|NCT00694707|469294213|FG002|Overall Study|Lost to Follow-up|2|||
130361457|NCT00694707|469294214|FG003|Overall Study|Lost to Follow-up|0|||
130361458|NCT00694707|469294215|FG004|Overall Study|Lost to Follow-up|0|||
130361459|NCT00694707|469294211|FG000|Overall Study|Jeopardizing Parole Status|1|||
130361460|NCT00694707|469294212|FG001|Overall Study|Jeopardizing Parole Status|0|||
130361461|NCT00694707|469294213|FG002|Overall Study|Jeopardizing Parole Status|0|||
130361462|NCT00694707|469294214|FG003|Overall Study|Jeopardizing Parole Status|0|||
130361463|NCT00694707|469294215|FG004|Overall Study|Jeopardizing Parole Status|0|||
130361464|NCT00694707|469294211|FG000|Overall Study|Death in the Family|1|||
130361465|NCT00694707|469294212|FG001|Overall Study|Death in the Family|0|||
130361466|NCT00694707|469294213|FG002|Overall Study|Death in the Family|0|||
130361467|NCT00694707|469294214|FG003|Overall Study|Death in the Family|0|||
130361468|NCT00694707|469294215|FG004|Overall Study|Death in the Family|0|||
130361469|NCT00694707|469294211|FG000|Overall Study|Arrest by Police|0|||
130361470|NCT00694707|469294212|FG001|Overall Study|Arrest by Police|1|||
130361471|NCT00694707|469294213|FG002|Overall Study|Arrest by Police|0|||
130361472|NCT00694707|469294214|FG003|Overall Study|Arrest by Police|0|||
130361473|NCT00694707|469294215|FG004|Overall Study|Arrest by Police|0|||
130361474|NCT00694707|469294211|FG000|Overall Study|Administrative Reasons|0|||
130361475|NCT00694707|469294212|FG001|Overall Study|Administrative Reasons|1|||
130361476|NCT00694707|469294213|FG002|Overall Study|Administrative Reasons|0|||
130361477|NCT00694707|469294214|FG003|Overall Study|Administrative Reasons|2|||
130361478|NCT00694707|469294215|FG004|Overall Study|Administrative Reasons|0|||
130361479|NCT00694707|469294211|FG000|Overall Study|Notification of Past Head Injury|0|||
130361480|NCT00694707|469294212|FG001|Overall Study|Notification of Past Head Injury|0|||
130361481|NCT00694707|469294213|FG002|Overall Study|Notification of Past Head Injury|0|||
130242359|NCT01132755|468847348|FG000|Overall Study|Protocol Violation|15|||
130242360|NCT01132755|468847348|FG000|Overall Study|Withdrawal by Subject|4|||
130242361|NCT02232698|468847349|FG000|Overall Study|Pregnancy|1|||
130242362|NCT02232698|468847350|FG001|Overall Study|Pregnancy|1|||
130242363|NCT02232698|468847349|FG000|Overall Study|Met exclusion criteria|1|||
130361482|NCT00694707|469294214|FG003|Overall Study|Notification of Past Head Injury|1|||
130361483|NCT00694707|469294215|FG004|Overall Study|Notification of Past Head Injury|0|||
130361484|NCT01904058|469294220|FG000|Overall Study|Adverse Event|2|||
130242364|NCT02232698|468847350|FG001|Overall Study|Met exclusion criteria|1|||
130242365|NCT02232698|468847349|FG000|Overall Study|Had device-associated symptoms|7|||
130242366|NCT02232698|468847350|FG001|Overall Study|Had device-associated symptoms|0|||
130242367|NCT02232698|468847349|FG000|Overall Study|Non-compliance with study device|1|||
130242368|NCT02232698|468847350|FG001|Overall Study|Non-compliance with study device|4|||
130242369|NCT02232698|468847349|FG000|Overall Study|Allocated to control group|0|||
130242370|NCT02232698|468847350|FG001|Overall Study|Allocated to control group|3|||
130242371|NCT02232698|468847349|FG000|Overall Study|Withdrawal by Subject|0|||
130242372|NCT02232698|468847350|FG001|Overall Study|Withdrawal by Subject|11|||
130242373|NCT02393755|468847351|FG000|Overall Study|Withdrawal by Subject|0|||
130242374|NCT02393755|468847352|FG001|Overall Study|Withdrawal by Subject|3|||
130242375|NCT02393755|468847351|FG000|Overall Study|Adverse Event|0|||
130242376|NCT02393755|468847352|FG001|Overall Study|Adverse Event|2|||
130242377|NCT02393755|468847351|FG000|Overall Study|Physician Decision|0|||
130242378|NCT02393755|468847352|FG001|Overall Study|Physician Decision|2|||
130242379|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
130242380|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
130242381|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
130242382|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
130242383|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130242384|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130242385|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
130242386|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130242387|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130242388|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
130242389|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130242390|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130242391|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
130242392|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130242393|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130242394|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
130242395|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130242396|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130242397|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
130242398|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130242399|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130242400|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
130242401|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
130242402|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
130242403|NCT02337946|468847353|FG000|In-between Period|Without Informed Consent|1|||
130242404|NCT02337946|468847354|FG001|In-between Period|Without Informed Consent|0|||
130242405|NCT02337946|468847355|FG002|In-between Period|Without Informed Consent|0|||
130242406|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
130242407|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
130242408|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
130242409|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
130242410|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
130242411|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
130242412|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
130242413|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130242414|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130242415|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130449694|NCT05458102|469611020|FG001|Overall Study|Adverse Event|0|||
130449695|NCT05458102|469611019|FG000|Overall Study|Enrolled but never treated|1|||
130449696|NCT05458102|469611020|FG001|Overall Study|Enrolled but never treated|0|||
130449697|NCT05458102|469611019|FG000|Overall Study|Protocol Violation|1|||
130449698|NCT05458102|469611020|FG001|Overall Study|Protocol Violation|0|||
130449699|NCT00723294|469611021|FG000|Overall Study|Lobular histology|2|||
130449700|NCT00723294|469611021|FG000|Overall Study|>25% intraductal component|1|||
130449701|NCT00723294|469611021|FG000|Overall Study|No MRI tumor enhancement|1|||
130449702|NCT00723294|469611021|FG000|Overall Study|1.0-Tesla MRI|1|||
130449703|NCT00723294|469611021|FG000|Overall Study|No cryoabalation|2|||
130242416|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
130242417|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130242418|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
130242419|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
130242420|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
130449704|NCT00723294|469611021|FG000|Overall Study|Did not undergo surgery|1|||
130449705|NCT00723294|469611021|FG000|Overall Study|Treated prior to registration|1|||
130449706|NCT00723294|469611021|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
130242421|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
130242422|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
130242423|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
130242424|NCT05324371|468847357|FG000|Overall Study|Withdrawal by Subject|1|||
130242425|NCT05324371|468847357|FG000|Overall Study|Death|1|||
130242426|NCT02949934|468847359|FG000|Natural Drinking Period|Adverse Event|1|||
130242427|NCT02949934|468847360|FG001|Natural Drinking Period|Adverse Event|0|||
130242428|NCT02949934|468847361|FG002|Natural Drinking Period|Adverse Event|0|||
130242429|NCT02949934|468847362|FG003|Natural Drinking Period|Adverse Event|1|||
130242430|NCT02949934|468847363|FG004|Natural Drinking Period|Adverse Event|0|||
130242431|NCT02949934|468847364|FG005|Natural Drinking Period|Adverse Event|0|||
130242432|NCT02949934|468847359|FG000|Natural Drinking Period|Lost to Follow-up|0|||
130242433|NCT02949934|468847360|FG001|Natural Drinking Period|Lost to Follow-up|0|||
130242434|NCT02949934|468847361|FG002|Natural Drinking Period|Lost to Follow-up|0|||
130242435|NCT02949934|468847362|FG003|Natural Drinking Period|Lost to Follow-up|0|||
130242436|NCT02949934|468847363|FG004|Natural Drinking Period|Lost to Follow-up|1|||
130242437|NCT02949934|468847364|FG005|Natural Drinking Period|Lost to Follow-up|0|||
130242438|NCT02949934|468847359|FG000|Neuroimaging|Protocol Violation|2|||
130242439|NCT02949934|468847360|FG001|Neuroimaging|Protocol Violation|0|||
130242440|NCT02949934|468847361|FG002|Neuroimaging|Protocol Violation|0|||
130242441|NCT02949934|468847362|FG003|Neuroimaging|Protocol Violation|0|||
130242442|NCT02949934|468847363|FG004|Neuroimaging|Protocol Violation|1|||
130242443|NCT02949934|468847364|FG005|Neuroimaging|Protocol Violation|0|||
130242444|NCT02949934|468847359|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
130242445|NCT02949934|468847360|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
130242446|NCT02949934|468847361|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
130242447|NCT02949934|468847362|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
130242448|NCT02949934|468847363|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
130242449|NCT02949934|468847364|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
130242450|NCT02949934|468847359|FG000|Neuroimaging|Not scanned|0|||
130242451|NCT02949934|468847360|FG001|Neuroimaging|Not scanned|0|||
130242452|NCT02949934|468847361|FG002|Neuroimaging|Not scanned|1|||
130242453|NCT02949934|468847362|FG003|Neuroimaging|Not scanned|0|||
130242454|NCT02949934|468847363|FG004|Neuroimaging|Not scanned|0|||
130242455|NCT02949934|468847364|FG005|Neuroimaging|Not scanned|2|||
130242456|NCT02949934|468847359|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
130242457|NCT02949934|468847360|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242458|NCT02949934|468847361|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242459|NCT02949934|468847362|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
130242460|NCT02949934|468847363|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242461|NCT02949934|468847364|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
130242462|NCT02949934|468847359|FG000|Bar Laboratory|Adverse Event|1|||
130242463|NCT02949934|468847360|FG001|Bar Laboratory|Adverse Event|0|||
130242464|NCT02949934|468847361|FG002|Bar Laboratory|Adverse Event|2|||
130242465|NCT02949934|468847362|FG003|Bar Laboratory|Adverse Event|0|||
130242466|NCT02949934|468847363|FG004|Bar Laboratory|Adverse Event|1|||
130242467|NCT02949934|468847364|FG005|Bar Laboratory|Adverse Event|0|||
130242468|NCT02949934|468847359|FG000|Bar Laboratory|Protocol Violation|0|||
130242469|NCT02949934|468847360|FG001|Bar Laboratory|Protocol Violation|0|||
130242470|NCT02949934|468847361|FG002|Bar Laboratory|Protocol Violation|0|||
130242471|NCT02949934|468847362|FG003|Bar Laboratory|Protocol Violation|1|||
130242472|NCT02949934|468847363|FG004|Bar Laboratory|Protocol Violation|0|||
130242473|NCT02949934|468847364|FG005|Bar Laboratory|Protocol Violation|0|||
130242474|NCT01363076|468848007|FG000|Overall Study|Withdrawal by Subject|0|||
130242475|NCT01363076|468848008|FG001|Overall Study|Withdrawal by Subject|1|||
130242476|NCT04706403|468848009|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130242477|NCT04706403|468848010|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130242478|NCT04706403|468848011|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130242479|NCT04706403|468848012|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130242480|NCT04706403|468848013|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
130242481|NCT00182637|468848014|FG000|Overall Study|Adverse Event|2|||
130242482|NCT00182637|468848014|FG000|Overall Study|Disease Progression|1|||
130242483|NCT04766333|468848017|FG000|Overall Study|Lost to Follow-up|40|||
130242484|NCT04766333|468848018|FG001|Overall Study|Lost to Follow-up|826|||
130242485|NCT00639379|468848019|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
130242486|NCT00639379|468848020|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
130242487|NCT00639379|468848019|FG000|Period 1 - 2 Weeks|lens issue|3|||
130449707|NCT00723294|469611021|FG000|Overall Study|Benign lesion|1|||
130449708|NCT00723294|469611021|FG000|Overall Study|Withdrawal by Subject|1|||
130242488|NCT00639379|468848020|FG001|Period 1 - 2 Weeks|lens issue|0|||
130242489|NCT01771913|468848028|FG000|Overall Study|Withdrawal by Subject|1|||
130242490|NCT01771913|468848029|FG001|Overall Study|Withdrawal by Subject|0|||
130242491|NCT00407511|468848030|FG000|Overall Study|Adverse Event|9|||
130242492|NCT00407511|468848030|FG000|Overall Study|Lost to Follow-up|4|||
130242493|NCT00407511|468848030|FG000|Overall Study|Other|5|||
130242494|NCT00407511|468848030|FG000|Overall Study|Withdrawal by Subject|4|||
130242495|NCT02636283|468848031|FG000|Overall Study|Adverse Event|2|||
130242496|NCT02636283|468848032|FG001|Overall Study|Adverse Event|0|||
130242497|NCT02636283|468848031|FG000|Overall Study|Trial Terminated Prematurely|0|||
130242498|NCT02636283|468848032|FG001|Overall Study|Trial Terminated Prematurely|3|||
130242499|NCT00195429|468848035|FG000|Overall Study|Adverse Event|2|||
130242500|NCT00195429|468848036|FG001|Overall Study|Adverse Event|4|||
130242501|NCT00195429|468848035|FG000|Overall Study|Lack of Efficacy|2|||
130242502|NCT00195429|468848036|FG001|Overall Study|Lack of Efficacy|1|||
130242503|NCT00195429|468848035|FG000|Overall Study|Lost to Follow-up|1|||
130242504|NCT00195429|468848036|FG001|Overall Study|Lost to Follow-up|0|||
130242505|NCT02541903|468848037|FG000|Overall Study|Death|1|||
130242506|NCT04795323|468848040|FG000|Overall Study|Did not interact with TARA|1|||
130242507|NCT04795323|468848041|FG001|Overall Study|Did not interact with TARA|0|||
130242508|NCT03142750|468848043|FG000|Overall Study|Lost to Follow-up|4|||
130242509|NCT03142750|468848044|FG001|Overall Study|Lost to Follow-up|1|||
130242510|NCT04925934|468848045|FG000|Overall Study|Adverse Event|1|||
130242511|NCT04925934|468848046|FG001|Overall Study|Adverse Event|0|||
130242512|NCT04925934|468848047|FG002|Overall Study|Adverse Event|0|||
130242513|NCT04925934|468848045|FG000|Overall Study|Lost to Follow-up|2|||
130242514|NCT04925934|468848046|FG001|Overall Study|Lost to Follow-up|0|||
130242515|NCT04925934|468848047|FG002|Overall Study|Lost to Follow-up|1|||
130242516|NCT04925934|468848045|FG000|Overall Study|Death|0|||
130242517|NCT04925934|468848046|FG001|Overall Study|Death|1|||
130242518|NCT04925934|468848047|FG002|Overall Study|Death|0|||
130242519|NCT04925934|468848045|FG000|Overall Study|Withdrawal by Subject|8|||
130242520|NCT04925934|468848046|FG001|Overall Study|Withdrawal by Subject|5|||
130242521|NCT04925934|468848047|FG002|Overall Study|Withdrawal by Subject|9|||
130242522|NCT04925934|468848045|FG000|Overall Study|Other|2|||
130242523|NCT04925934|468848046|FG001|Overall Study|Other|2|||
130242524|NCT04925934|468848047|FG002|Overall Study|Other|2|||
130242525|NCT04925934|468848045|FG000|Overall Study|Eastern European Conflict|7|||
130242526|NCT04925934|468848046|FG001|Overall Study|Eastern European Conflict|3|||
130242527|NCT04925934|468848047|FG002|Overall Study|Eastern European Conflict|2|||
130242528|NCT03158688|468848048|FG000|Overall Study|Withdrawal by Subject|14|||
130242529|NCT03158688|468848049|FG001|Overall Study|Withdrawal by Subject|28|||
130242530|NCT03158688|468848048|FG000|Overall Study|Decision by sponsor|13|||
130242531|NCT03158688|468848049|FG001|Overall Study|Decision by sponsor|37|||
130242532|NCT03158688|468848048|FG000|Overall Study|Lost to Follow-up|4|||
130242533|NCT03158688|468848049|FG001|Overall Study|Lost to Follow-up|3|||
130242534|NCT03158688|468848048|FG000|Overall Study|Death|74|||
130242535|NCT03158688|468848049|FG001|Overall Study|Death|142|||
130242536|NCT00374868|468848053|FG000|Overall Study|Adverse Event|12|||
130242537|NCT00374868|468848053|FG000|Overall Study|Progressive Disease|7|||
130242538|NCT00374868|468848053|FG000|Overall Study|Physician Decision|13|||
130242539|NCT00374868|468848053|FG000|Overall Study|Lost to Follow-up|1|||
130242540|NCT00374868|468848053|FG000|Overall Study|Death|2|||
130242541|NCT00374868|468848053|FG000|Overall Study|Other - Not Specified|1|||
130242542|NCT03188185|468848054|FG000|Stage 1|Adverse Event|4|||
130242543|NCT03188185|468848055|FG001|Stage 1|Adverse Event|12|||
130242544|NCT03188185|468848056|FG002|Stage 1|Adverse Event|0|||
130242545|NCT03188185|468848057|FG003|Stage 1|Adverse Event|0|||
130242546|NCT03188185|468848054|FG000|Stage 1|Lack of Efficacy|0|||
130242547|NCT03188185|468848055|FG001|Stage 1|Lack of Efficacy|2|||
130242548|NCT03188185|468848056|FG002|Stage 1|Lack of Efficacy|0|||
130242549|NCT03188185|468848057|FG003|Stage 1|Lack of Efficacy|0|||
130242550|NCT03188185|468848054|FG000|Stage 1|Lost to Follow-up|6|||
130242551|NCT03188185|468848055|FG001|Stage 1|Lost to Follow-up|1|||
130696836|NCT02611323|470514510|FG001|Overall Study|Withdrawal by Subject|0|||
130242552|NCT03188185|468848056|FG002|Stage 1|Lost to Follow-up|0|||
130242553|NCT03188185|468848057|FG003|Stage 1|Lost to Follow-up|0|||
130696837|NCT02611323|470514511|FG002|Overall Study|Withdrawal by Subject|0|||
130242554|NCT03188185|468848054|FG000|Stage 1|Withdrawal by Subject|9|||
130242555|NCT03188185|468848055|FG001|Stage 1|Withdrawal by Subject|0|||
130242556|NCT03188185|468848056|FG002|Stage 1|Withdrawal by Subject|0|||
130242557|NCT03188185|468848057|FG003|Stage 1|Withdrawal by Subject|0|||
130696838|NCT02611323|470514512|FG003|Overall Study|Withdrawal by Subject|0|||
130242558|NCT03188185|468848054|FG000|Stage 1|Identified as a professional patient|0|||
130242559|NCT03188185|468848055|FG001|Stage 1|Identified as a professional patient|1|||
130242560|NCT03188185|468848056|FG002|Stage 1|Identified as a professional patient|0|||
130242561|NCT03188185|468848057|FG003|Stage 1|Identified as a professional patient|0|||
130242562|NCT03188185|468848054|FG000|Stage 2|Adverse Event|0|||
130242563|NCT03188185|468848055|FG001|Stage 2|Adverse Event|0|||
130242564|NCT03188185|468848056|FG002|Stage 2|Adverse Event|2|||
130242565|NCT03188185|468848057|FG003|Stage 2|Adverse Event|4|||
130242566|NCT03188185|468848054|FG000|Stage 2|Lack of Efficacy|0|||
130242567|NCT03188185|468848055|FG001|Stage 2|Lack of Efficacy|0|||
130242568|NCT03188185|468848056|FG002|Stage 2|Lack of Efficacy|3|||
130242569|NCT03188185|468848057|FG003|Stage 2|Lack of Efficacy|0|||
130242570|NCT03188185|468848054|FG000|Stage 2|Lost to Follow-up|0|||
130242571|NCT03188185|468848055|FG001|Stage 2|Lost to Follow-up|0|||
130242572|NCT03188185|468848056|FG002|Stage 2|Lost to Follow-up|1|||
130242573|NCT03188185|468848057|FG003|Stage 2|Lost to Follow-up|0|||
130242574|NCT03188185|468848054|FG000|Stage 2|Physician Decision|0|||
130242575|NCT03188185|468848055|FG001|Stage 2|Physician Decision|0|||
130242576|NCT03188185|468848056|FG002|Stage 2|Physician Decision|0|||
130242577|NCT03188185|468848057|FG003|Stage 2|Physician Decision|1|||
130242578|NCT03188185|468848054|FG000|Stage 2|Withdrawal by Subject|0|||
130242579|NCT03188185|468848055|FG001|Stage 2|Withdrawal by Subject|0|||
130242580|NCT03188185|468848056|FG002|Stage 2|Withdrawal by Subject|3|||
130242581|NCT03188185|468848057|FG003|Stage 2|Withdrawal by Subject|1|||
130242582|NCT02315625|468848061|FG000|First Intervention|Disease Progression|1|||
130242583|NCT02315625|468848062|FG001|First Intervention|Disease Progression|0|||
130242584|NCT02315625|468848061|FG000|Second Intervention|Physician Decision|2|||
130242585|NCT02315625|468848062|FG001|Second Intervention|Physician Decision|1|||
130242586|NCT02315625|468848061|FG000|Second Intervention|Study closure|1|||
130242587|NCT02315625|468848062|FG001|Second Intervention|Study closure|0|||
130242588|NCT02315625|468848061|FG000|Second Intervention|Disease Progression|1|||
130242589|NCT02315625|468848062|FG001|Second Intervention|Disease Progression|0|||
130242590|NCT04822194|468848065|FG000|Overall Study|Withdrawal by Subject|5|||
130242591|NCT04822194|468848066|FG001|Overall Study|Withdrawal by Subject|4|||
130242592|NCT04822194|468848065|FG000|Overall Study|Technical issues with MR scanner|1|||
130242593|NCT04822194|468848066|FG001|Overall Study|Technical issues with MR scanner|0|||
130242594|NCT04822194|468848065|FG000|Overall Study|Lost to Follow-up|5|||
130242595|NCT04822194|468848066|FG001|Overall Study|Lost to Follow-up|7|||
130242596|NCT01947933|468848068|FG000|Overall Study|Withdrawal by Subject|0|||
130242597|NCT01947933|468848069|FG001|Overall Study|Withdrawal by Subject|0|||
130242598|NCT01947933|468848070|FG002|Overall Study|Withdrawal by Subject|1|||
130242599|NCT01947933|468848071|FG003|Overall Study|Withdrawal by Subject|0|||
130242600|NCT01947933|468848072|FG004|Overall Study|Withdrawal by Subject|0|||
130242601|NCT01947933|468848073|FG005|Overall Study|Withdrawal by Subject|0|||
130242602|NCT01947933|468848074|FG006|Overall Study|Withdrawal by Subject|0|||
130242603|NCT01947933|468848075|FG007|Overall Study|Withdrawal by Subject|0|||
130242604|NCT01947933|468848076|FG008|Overall Study|Withdrawal by Subject|0|||
130242605|NCT01947933|468848068|FG000|Overall Study|Lost to Follow-up|0|||
130242606|NCT01947933|468848069|FG001|Overall Study|Lost to Follow-up|0|||
130242607|NCT01947933|468848070|FG002|Overall Study|Lost to Follow-up|0|||
130242608|NCT01947933|468848071|FG003|Overall Study|Lost to Follow-up|0|||
130242609|NCT01947933|468848072|FG004|Overall Study|Lost to Follow-up|0|||
130242610|NCT01947933|468848073|FG005|Overall Study|Lost to Follow-up|0|||
130242611|NCT01947933|468848074|FG006|Overall Study|Lost to Follow-up|0|||
130242612|NCT01947933|468848075|FG007|Overall Study|Lost to Follow-up|0|||
130242613|NCT01947933|468848076|FG008|Overall Study|Lost to Follow-up|1|||
130242614|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
130242615|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
130242616|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130242617|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130242618|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
130242619|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
130242620|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
130242621|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
130242622|NCT02965833|468848079|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
130242623|NCT02965833|468848080|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
130242624|NCT03442569|468848081|FG000|Overall Study|Subject was ineligible after enrollment|1|||
130242625|NCT03770455|468848082|FG000|Overall Study|Screen failures|3|||
130242626|NCT02582632|468849465|FG000|Overall Study|Other|1|||
130242627|NCT03298061|468849466|FG000|Overall Study|Adverse Event|3|||
130242628|NCT03298061|468849466|FG000|Overall Study|Lack of Efficacy|6|||
130242629|NCT03298061|468849466|FG000|Overall Study|Protocol Violation|1|||
130242630|NCT03298061|468849466|FG000|Overall Study|Physician Decision|7|||
130242631|NCT03298061|468849466|FG000|Overall Study|Withdrawal by Subject|10|||
130242632|NCT01617967|468849467|FG000|Overall Study|Protocol Violation|0|||
130242633|NCT01617967|468849468|FG001|Overall Study|Protocol Violation|0|||
130242634|NCT01617967|468849469|FG002|Overall Study|Protocol Violation|0|||
130242635|NCT01617967|468849470|FG003|Overall Study|Protocol Violation|1|||
130242636|NCT01617967|468849471|FG004|Overall Study|Protocol Violation|0|||
130242637|NCT01617967|468849472|FG005|Overall Study|Protocol Violation|0|||
130242638|NCT01617967|468849467|FG000|Overall Study|Withdrawal by Subject|0|||
130242639|NCT01617967|468849468|FG001|Overall Study|Withdrawal by Subject|0|||
130242640|NCT01617967|468849469|FG002|Overall Study|Withdrawal by Subject|0|||
130242641|NCT01617967|468849470|FG003|Overall Study|Withdrawal by Subject|0|||
130242642|NCT01617967|468849471|FG004|Overall Study|Withdrawal by Subject|0|||
130242643|NCT01617967|468849472|FG005|Overall Study|Withdrawal by Subject|1|||
130361485|NCT01904058|469294221|FG001|Overall Study|Adverse Event|0|||
130361486|NCT01904058|469294222|FG002|Overall Study|Adverse Event|0|||
130361487|NCT01904058|469294223|FG003|Overall Study|Adverse Event|0|||
130242644|NCT01617967|468849467|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
130242645|NCT01617967|468849468|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
130242646|NCT01617967|468849469|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
130242647|NCT01617967|468849470|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
130242648|NCT01617967|468849471|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
130242649|NCT01617967|468849472|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
130242650|NCT05276804|468849479|FG000|Overall Study|screen failure|23|||
130242651|NCT05276804|468849480|FG001|Overall Study|screen failure|0|||
130242652|NCT02827708|468849481|FG000|Overall Study|Lost to Follow-up|3|||
130242653|NCT02827708|468849482|FG001|Overall Study|Lost to Follow-up|1|||
130242654|NCT02827708|468849481|FG000|Overall Study|Withdrawal by Subject|1|||
130242655|NCT02827708|468849482|FG001|Overall Study|Withdrawal by Subject|2|||
130242656|NCT02827708|468849481|FG000|Overall Study|Death|1|||
130242657|NCT02827708|468849482|FG001|Overall Study|Death|2|||
130242658|NCT02383173|468849486|FG000|Overall Study|Palliative Care Team withdrew|0|||
130242659|NCT02383173|468849487|FG001|Overall Study|Palliative Care Team withdrew|2|||
130242660|NCT01297244|468849488|FG000|Overall Study|Progressive disease|22|||
130242661|NCT01297244|468849489|FG001|Overall Study|Progressive disease|3|||
130242662|NCT01297244|468849488|FG000|Overall Study|Adverse Event|9|||
130242663|NCT01297244|468849489|FG001|Overall Study|Adverse Event|1|||
130242664|NCT01297244|468849488|FG000|Overall Study|Death|1|||
130242665|NCT01297244|468849489|FG001|Overall Study|Death|1|||
130242666|NCT01297244|468849488|FG000|Overall Study|Clinical progression|1|||
130242667|NCT01297244|468849489|FG001|Overall Study|Clinical progression|1|||
130242668|NCT01297244|468849488|FG000|Overall Study|Withdrawal by Subject|2|||
130242669|NCT01297244|468849489|FG001|Overall Study|Withdrawal by Subject|0|||
130242670|NCT03677401|468849490|FG000|Overall Study|Adverse Event|4|||
130242671|NCT03677401|468849491|FG001|Overall Study|Adverse Event|14|||
130242672|NCT03677401|468849490|FG000|Overall Study|Lack of Efficacy|3|||
130242673|NCT03677401|468849491|FG001|Overall Study|Lack of Efficacy|1|||
130242674|NCT03677401|468849490|FG000|Overall Study|Withdrawal by Subject|2|||
130242675|NCT03677401|468849491|FG001|Overall Study|Withdrawal by Subject|2|||
130242676|NCT03677401|468849490|FG000|Overall Study|Sponsor decision|0|||
130242677|NCT03677401|468849491|FG001|Overall Study|Sponsor decision|1|||
130242678|NCT03677401|468849490|FG000|Overall Study|Reason Unspecified|1|||
130242679|NCT03677401|468849491|FG001|Overall Study|Reason Unspecified|0|||
130242680|NCT01177410|468849492|FG000|Overall Study|Adverse Event|0|||
130242681|NCT01177410|468849493|FG001|Overall Study|Adverse Event|2|||
130242682|NCT01177410|468849494|FG002|Overall Study|Adverse Event|2|||
130242683|NCT01177410|468849492|FG000|Overall Study|Withdrawal by Subject|1|||
130242684|NCT01177410|468849493|FG001|Overall Study|Withdrawal by Subject|4|||
130242685|NCT01177410|468849494|FG002|Overall Study|Withdrawal by Subject|3|||
130242686|NCT01177410|468849492|FG000|Overall Study|Lost to Follow-up|0|||
130242687|NCT01177410|468849493|FG001|Overall Study|Lost to Follow-up|1|||
130242688|NCT01177410|468849494|FG002|Overall Study|Lost to Follow-up|0|||
130242689|NCT00875667|468849498|FG000|Overall Study|Adverse Event|29|||
130242690|NCT00875667|468849499|FG001|Overall Study|Adverse Event|10|||
130242691|NCT00875667|468849498|FG000|Overall Study|Withdrawal by Subject|17|||
130242692|NCT00875667|468849499|FG001|Overall Study|Withdrawal by Subject|5|||
130242693|NCT00875667|468849498|FG000|Overall Study|Death|7|||
130242694|NCT00875667|468849499|FG001|Overall Study|Death|2|||
130242695|NCT00875667|468849498|FG000|Overall Study|Protocol Violation|2|||
130242696|NCT00875667|468849499|FG001|Overall Study|Protocol Violation|0|||
130696839|NCT02611323|470514513|FG004|Overall Study|Withdrawal by Subject|0|||
130696840|NCT02611323|470514514|FG005|Overall Study|Withdrawal by Subject|0|||
130696841|NCT02611323|470514515|FG006|Overall Study|Withdrawal by Subject|0|||
130696842|NCT02611323|470514516|FG007|Overall Study|Withdrawal by Subject|1|||
130696843|NCT02611323|470514517|FG008|Overall Study|Withdrawal by Subject|0|||
130696844|NCT02611323|470514518|FG009|Overall Study|Withdrawal by Subject|1|||
130696845|NCT02611323|470514519|FG010|Overall Study|Withdrawal by Subject|0|||
130696846|NCT02597049|470514520|FG000|Overall Study|Lost to Follow-up|0|||
130242697|NCT00875667|468849498|FG000|Overall Study|Disease Progression|100|||
130242698|NCT00875667|468849499|FG001|Overall Study|Disease Progression|49|||
130242699|NCT00875667|468849498|FG000|Overall Study|Miscellaneous|12|||
130242700|NCT00875667|468849499|FG001|Overall Study|Miscellaneous|6|||
130242701|NCT00875667|468849498|FG000|Overall Study|Randomized but no Study Drug Given|3|||
130242702|NCT00875667|468849499|FG001|Overall Study|Randomized but no Study Drug Given|1|||
130242703|NCT00894647|468849500|FG000|Overall Study|Adverse Event|5|||
130242704|NCT00894647|468849501|FG001|Overall Study|Adverse Event|4|||
130242705|NCT00894647|468849500|FG000|Overall Study|Withdrawal by Subject|4|||
130242706|NCT00894647|468849501|FG001|Overall Study|Withdrawal by Subject|4|||
130242707|NCT00894647|468849500|FG000|Overall Study|Lost to Follow-up|0|||
130242708|NCT00894647|468849501|FG001|Overall Study|Lost to Follow-up|2|||
130242709|NCT00894647|468849500|FG000|Overall Study|Non-compliance with study procedures|0|||
130242710|NCT00894647|468849501|FG001|Overall Study|Non-compliance with study procedures|2|||
130696847|NCT02597049|470514521|FG001|Overall Study|Lost to Follow-up|3|||
130696848|NCT02597049|470514522|FG002|Overall Study|Lost to Follow-up|2|||
130242711|NCT00894647|468849500|FG000|Overall Study|Other, not due to AE|1|||
130242712|NCT00894647|468849501|FG001|Overall Study|Other, not due to AE|2|||
130242713|NCT01913470|468849502|FG000|Overall Study|Lost to Follow-up|0|||
130242714|NCT01913470|468849503|FG001|Overall Study|Lost to Follow-up|1|||
130242715|NCT01913470|468849502|FG000|Overall Study|Physician Decision|0|||
130242716|NCT01913470|468849503|FG001|Overall Study|Physician Decision|1|||
130242717|NCT01913470|468849502|FG000|Overall Study|Withdrawal by Subject|0|||
130242718|NCT01913470|468849503|FG001|Overall Study|Withdrawal by Subject|1|||
130242719|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242720|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242721|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
130242722|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242723|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
130242724|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
130242725|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
130242726|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
130242727|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
130242728|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130242729|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130242730|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
130242731|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
130242732|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
130242733|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
130242734|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
130242735|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Death|1|||
130242736|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Death|1|||
130242737|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Death|0|||
130242738|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Death|1|||
130242739|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
130242740|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
130242741|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
130242742|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
130242743|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
130242744|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
130242745|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
130242746|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
130242747|NCT00923702|468849513|FG000|Overall Study|Ongoing enrollment|0|||
130242748|NCT00923702|468849514|FG001|Overall Study|Ongoing enrollment|0|||
130242749|NCT00923702|468849515|FG002|Overall Study|Ongoing enrollment|0|||
130449709|NCT00723294|469611021|FG000|Overall Study|No treatment due to probe failure|1|||
130449710|NCT02703532|469611025|FG000|Overall Study|Withdrawal by Subject|0|||
130449711|NCT02703532|469611026|FG001|Overall Study|Withdrawal by Subject|1|||
130449712|NCT02703532|469611027|FG002|Overall Study|Withdrawal by Subject|0|||
130449713|NCT02703532|469611028|FG003|Overall Study|Withdrawal by Subject|1|||
130449714|NCT02703532|469611025|FG000|Overall Study|Lost to Follow-up|2|||
130449715|NCT02703532|469611026|FG001|Overall Study|Lost to Follow-up|0|||
130449716|NCT02703532|469611027|FG002|Overall Study|Lost to Follow-up|2|||
130449717|NCT02703532|469611028|FG003|Overall Study|Lost to Follow-up|0|||
130449718|NCT02271594|469611031|FG000|Overall Study|Study closed; recruiting failure|19|||
130449719|NCT02271594|469611032|FG001|Overall Study|Study closed; recruiting failure|12|||
130449720|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
130449721|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130449722|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130449723|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130449724|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130449725|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
130449726|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130449727|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
130449728|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
130449729|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
130449730|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130449731|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
130242750|NCT00923702|468849516|FG003|Overall Study|Ongoing enrollment|0|||
130449732|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130242751|NCT00923702|468849517|FG004|Overall Study|Ongoing enrollment|354|||
130242752|NCT00367458|468849518|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
130242753|NCT00367458|468849519|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
130242754|NCT04339972|468849525|FG000|Overall Study|Scheduling Issues|3|||
130242755|NCT04339972|468849526|FG001|Overall Study|Scheduling Issues|3|||
130242756|NCT04339972|468849525|FG000|Overall Study|dropout|1|||
130242757|NCT04339972|468849526|FG001|Overall Study|dropout|1|||
130449733|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130242758|NCT04339972|468849525|FG000|Overall Study|Technical issues|1|||
130242759|NCT04339972|468849526|FG001|Overall Study|Technical issues|0|||
130242760|NCT04339972|468849525|FG000|Overall Study|Claustraphobia|0|||
130242761|NCT04339972|468849526|FG001|Overall Study|Claustraphobia|1|||
130242762|NCT02691663|468849527|FG000|Overall Study|Screen failure after baseline|2|||
130242763|NCT02691663|468849528|FG001|Overall Study|Screen failure after baseline|2|||
130242764|NCT02691663|468849527|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
130242765|NCT02691663|468849528|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
130242766|NCT02691663|468849527|FG000|Overall Study|Withdrawn after Follow up 2|1|||
130242767|NCT02691663|468849528|FG001|Overall Study|Withdrawn after Follow up 2|1|||
130242768|NCT02691663|468849527|FG000|Overall Study|Lost to Follow-up|3|||
130242769|NCT02691663|468849528|FG001|Overall Study|Lost to Follow-up|2|||
130242770|NCT02942407|468849532|FG000|Overall Study|Lost to Follow-up|3|||
130242771|NCT02942407|468849533|FG001|Overall Study|Lost to Follow-up|2|||
130242772|NCT02942407|468849532|FG000|Overall Study|Withdrawal by Subject|7|||
130242773|NCT02942407|468849533|FG001|Overall Study|Withdrawal by Subject|9|||
130242774|NCT02942407|468849532|FG000|Overall Study|Death|16|||
130242775|NCT02942407|468849533|FG001|Overall Study|Death|13|||
130242776|NCT01716156|468849535|FG000|Overall Study|Protocol Violation|1|||
130242777|NCT01716156|468849536|FG001|Overall Study|Protocol Violation|0|||
130242778|NCT01716156|468849537|FG002|Overall Study|Protocol Violation|0|||
130242779|NCT01716156|468849535|FG000|Overall Study|Withdrawal by Subject|0|||
130242780|NCT01716156|468849536|FG001|Overall Study|Withdrawal by Subject|1|||
130242781|NCT01716156|468849537|FG002|Overall Study|Withdrawal by Subject|2|||
130242782|NCT01716156|468849535|FG000|Overall Study|Lost to Follow-up|1|||
130242783|NCT01716156|468849536|FG001|Overall Study|Lost to Follow-up|0|||
130242784|NCT01716156|468849537|FG002|Overall Study|Lost to Follow-up|0|||
130242785|NCT03925220|468849538|FG000|Overall Study|Withdrawal by Subject|4|||
130242786|NCT03925220|468849539|FG001|Overall Study|Withdrawal by Subject|4|||
130242787|NCT03925220|468849540|FG002|Overall Study|Withdrawal by Subject|4|||
130242788|NCT03925220|468849541|FG003|Overall Study|Withdrawal by Subject|4|||
130242789|NCT03925220|468849538|FG000|Overall Study|Lost to Follow-up|40|||
130242790|NCT03925220|468849539|FG001|Overall Study|Lost to Follow-up|46|||
130242791|NCT03925220|468849540|FG002|Overall Study|Lost to Follow-up|37|||
130242792|NCT03925220|468849541|FG003|Overall Study|Lost to Follow-up|38|||
130242793|NCT05221866|468849542|FG000|Overall Study|Withdrawal by Subject|5|||
130242794|NCT05221866|468849543|FG001|Overall Study|Withdrawal by Subject|7|||
130242795|NCT05221866|468849544|FG002|Overall Study|Withdrawal by Subject|6|||
130242796|NCT05221866|468849545|FG003|Overall Study|Withdrawal by Subject|4|||
130242797|NCT05221866|468849542|FG000|Overall Study|Physician Decision|3|||
130242798|NCT05221866|468849543|FG001|Overall Study|Physician Decision|2|||
130242799|NCT05221866|468849544|FG002|Overall Study|Physician Decision|1|||
130242800|NCT05221866|468849545|FG003|Overall Study|Physician Decision|4|||
130242801|NCT05221866|468849542|FG000|Overall Study|Lost to Follow-up|12|||
130242802|NCT05221866|468849543|FG001|Overall Study|Lost to Follow-up|17|||
130242803|NCT05221866|468849544|FG002|Overall Study|Lost to Follow-up|14|||
130242804|NCT05221866|468849545|FG003|Overall Study|Lost to Follow-up|14|||
130242805|NCT05221866|468849542|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
130242806|NCT05221866|468849543|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
130242807|NCT05221866|468849544|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
130242808|NCT05221866|468849545|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
130242809|NCT05561140|468849546|FG000|Randomized Treatment Period|Adverse Event|1|||
130449734|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130449735|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130449736|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130449737|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130449738|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130449739|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130449740|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130449741|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130449742|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
130552981|NCT00504881|469991637|FG000|Overall Study|AE, non-serious non-fatal|4|||
130552982|NCT00504881|469991638|FG001|Overall Study|AE, non-serious non-fatal|14|||
130242810|NCT05561140|468849547|FG001|Randomized Treatment Period|Adverse Event|0|||
130242811|NCT05561140|468849546|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130552983|NCT00504881|469991637|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130242812|NCT05561140|468849547|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130242813|NCT05561140|468849546|FG000|Open Label Treatment Period|Adverse Event|6|||
130242814|NCT05561140|468849547|FG001|Open Label Treatment Period|Adverse Event|4|||
130242815|NCT05561140|468849546|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
130242816|NCT05561140|468849547|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
130242817|NCT05561140|468849546|FG000|Open Label Treatment Period|Physician Decision|0|||
130242818|NCT05561140|468849547|FG001|Open Label Treatment Period|Physician Decision|1|||
130242819|NCT05561140|468849546|FG000|Open Label Treatment Period|Pregnancy|1|||
130242820|NCT05561140|468849547|FG001|Open Label Treatment Period|Pregnancy|0|||
130242821|NCT05561140|468849546|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
130242822|NCT05561140|468849547|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
130242823|NCT05561140|468849546|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
130242824|NCT05561140|468849547|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
130242825|NCT05561140|468849546|FG000|Open Label Treatment Period|Other|1|||
130242826|NCT05561140|468849547|FG001|Open Label Treatment Period|Other|0|||
130242827|NCT01944774|468849548|FG000|Overall Study|Withdrawal by Subject|2|||
130242828|NCT01944774|468849549|FG001|Overall Study|Withdrawal by Subject|3|||
130242829|NCT01944774|468849550|FG002|Overall Study|Withdrawal by Subject|3|||
130242830|NCT01944774|468849548|FG000|Overall Study|Adverse Event|3|||
130242831|NCT01944774|468849549|FG001|Overall Study|Adverse Event|2|||
130242832|NCT01944774|468849550|FG002|Overall Study|Adverse Event|3|||
130242833|NCT01944774|468849548|FG000|Overall Study|Lack of Efficacy|1|||
130242834|NCT01944774|468849549|FG001|Overall Study|Lack of Efficacy|2|||
130242835|NCT01944774|468849550|FG002|Overall Study|Lack of Efficacy|2|||
130242836|NCT01944774|468849548|FG000|Overall Study|Lost to Follow-up|0|||
130242837|NCT01944774|468849549|FG001|Overall Study|Lost to Follow-up|1|||
130242838|NCT01944774|468849550|FG002|Overall Study|Lost to Follow-up|0|||
130242839|NCT03325439|468849556|FG000|Overall Study|Ineligibility|3|||
130242840|NCT00774748|468849557|FG000|Overall Study|Lost to Follow-up|3|||
130242841|NCT00866320|468849558|FG000|Overall Study|Withdrawal by Subject|4|||
130242842|NCT00866320|468849558|FG000|Overall Study|Death|2|||
130242843|NCT03349515|468849559|FG000|Overall Study|Lack of Efficacy|2|||
130242844|NCT03349515|468849560|FG001|Overall Study|Lack of Efficacy|0|||
130242845|NCT03349515|468849559|FG000|Overall Study|Physician Decision|3|||
130242846|NCT03349515|468849560|FG001|Overall Study|Physician Decision|1|||
130242847|NCT02503865|468849561|FG000|Overall Study|Moved out of area|1|||
130242848|NCT02503865|468849562|FG001|Overall Study|Moved out of area|8|||
130242849|NCT02503865|468849563|FG002|Overall Study|Moved out of area|0|||
130242850|NCT02503865|468849561|FG000|Overall Study|Refused treatment|4|||
130242851|NCT02503865|468849562|FG001|Overall Study|Refused treatment|39|||
130696849|NCT02597049|470514520|FG000|Overall Study|Withdrawal by Subject|2|||
130242852|NCT02503865|468849563|FG002|Overall Study|Refused treatment|2|||
130242853|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
130242854|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
130242855|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
130242856|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Death|1|||
130242857|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Death|0|||
130242858|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Death|0|||
130242859|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
130242860|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130242861|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130242862|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
130242863|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130242864|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130242865|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
130242866|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
130242867|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
130242868|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
130242869|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130361488|NCT01904058|469294220|FG000|Overall Study|Withdrawal by Subject|1|||
130361489|NCT01904058|469294221|FG001|Overall Study|Withdrawal by Subject|0|||
130361490|NCT01904058|469294222|FG002|Overall Study|Withdrawal by Subject|1|||
130361491|NCT01904058|469294223|FG003|Overall Study|Withdrawal by Subject|0|||
130361492|NCT01904058|469294220|FG000|Overall Study|Pregnancy|0|||
130361493|NCT01904058|469294221|FG001|Overall Study|Pregnancy|0|||
130361494|NCT01904058|469294222|FG002|Overall Study|Pregnancy|0|||
130361495|NCT01904058|469294223|FG003|Overall Study|Pregnancy|1|||
130361496|NCT03096483|469294225|FG000|Overall Study|Withdrawal by site|1|||
130696850|NCT02597049|470514521|FG001|Overall Study|Withdrawal by Subject|2|||
130696851|NCT02597049|470514522|FG002|Overall Study|Withdrawal by Subject|1|||
130242870|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130242871|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
130242872|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130242873|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130242874|NCT05073315|468849564|FG000|Period 2|Adverse Event|0|||
130242875|NCT05073315|468849565|FG001|Period 2|Adverse Event|3|||
130242876|NCT05073315|468849566|FG002|Period 2|Adverse Event|6|||
130242877|NCT05073315|468849564|FG000|Period 2|Lost to Follow-up|0|||
130242878|NCT05073315|468849565|FG001|Period 2|Lost to Follow-up|5|||
130242879|NCT05073315|468849566|FG002|Period 2|Lost to Follow-up|5|||
130242880|NCT05073315|468849564|FG000|Period 2|Withdrawal by Subject|0|||
130242881|NCT05073315|468849565|FG001|Period 2|Withdrawal by Subject|4|||
130696852|NCT02597049|470514520|FG000|Overall Study|Adverse Event|2|||
130242882|NCT05073315|468849566|FG002|Period 2|Withdrawal by Subject|9|||
130242883|NCT05073315|468849564|FG000|Period 2|Protocol Violation|0|||
130242884|NCT05073315|468849565|FG001|Period 2|Protocol Violation|0|||
130242885|NCT05073315|468849566|FG002|Period 2|Protocol Violation|1|||
130242886|NCT01529268|468849567|FG000|Overall Study|Lost to Follow-up|9|||
130242887|NCT01529268|468849568|FG001|Overall Study|Lost to Follow-up|3|||
130242888|NCT01529268|468849567|FG000|Overall Study|Moved|3|||
130242889|NCT01529268|468849568|FG001|Overall Study|Moved|0|||
130242890|NCT04069520|468849574|FG000|Overall Study|Lost to Follow-up|0|||
130242891|NCT04069520|468849575|FG001|Overall Study|Lost to Follow-up|2|||
130242892|NCT04069520|468849574|FG000|Overall Study|Withdrawal by Subject|0|||
130242893|NCT04069520|468849575|FG001|Overall Study|Withdrawal by Subject|1|||
130242894|NCT04069520|468849574|FG000|Overall Study|Prior Injury|1|||
130242895|NCT04069520|468849575|FG001|Overall Study|Prior Injury|0|||
130242896|NCT04069520|468849574|FG000|Overall Study|Orthodontia|1|||
130242897|NCT04069520|468849575|FG001|Overall Study|Orthodontia|0|||
130242898|NCT04069520|468849574|FG000|Overall Study|Cut from team|0|||
130242899|NCT04069520|468849575|FG001|Overall Study|Cut from team|2|||
130449743|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130242900|NCT01068912|468849576|FG000|Overall Study|Adverse Event|2|||
130242901|NCT01068912|468849577|FG001|Overall Study|Adverse Event|3|||
130242902|NCT01068912|468849578|FG002|Overall Study|Adverse Event|2|||
130242903|NCT01068912|468849576|FG000|Overall Study|Withdrawal by Subject|5|||
130449744|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130449745|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130449746|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130449747|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130449748|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130449749|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130449750|NCT01323660|469611036|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
130449751|NCT01323660|469611037|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130696853|NCT02597049|470514521|FG001|Overall Study|Adverse Event|0|||
130242904|NCT01068912|468849577|FG001|Overall Study|Withdrawal by Subject|6|||
130242905|NCT01068912|468849578|FG002|Overall Study|Withdrawal by Subject|6|||
130242906|NCT01068912|468849576|FG000|Overall Study|Lost to Follow-up|3|||
130242907|NCT01068912|468849577|FG001|Overall Study|Lost to Follow-up|7|||
130242908|NCT01068912|468849578|FG002|Overall Study|Lost to Follow-up|3|||
130242909|NCT01068912|468849576|FG000|Overall Study|Protocol Violation|0|||
130242910|NCT01068912|468849577|FG001|Overall Study|Protocol Violation|2|||
130242911|NCT01068912|468849578|FG002|Overall Study|Protocol Violation|0|||
130242912|NCT01068912|468849576|FG000|Overall Study|aggravation influenza|1|||
130242913|NCT01068912|468849577|FG001|Overall Study|aggravation influenza|1|||
130242914|NCT01068912|468849578|FG002|Overall Study|aggravation influenza|1|||
130242915|NCT01068912|468849576|FG000|Overall Study|other underlying illness|0|||
130242916|NCT01068912|468849577|FG001|Overall Study|other underlying illness|3|||
130242917|NCT01068912|468849578|FG002|Overall Study|other underlying illness|3|||
130242918|NCT00294398|468849579|FG000|Overall Study|Lost to Follow-up|21|||
130242919|NCT00294398|468849580|FG001|Overall Study|Lost to Follow-up|26|||
130242920|NCT00118287|468849584|FG000|Overall Study|Intracranial haemorrhage|1|||
130242921|NCT00118287|468849584|FG000|Overall Study|Muscle pain|1|||
130242922|NCT03407482|468849585|FG000|Overall Study|Adverse Event|12|||
130242923|NCT03407482|468849585|FG000|Overall Study|Disease Relapse|1|||
130242924|NCT03407482|468849585|FG000|Overall Study|Lost to Follow-up|1|||
130242925|NCT03407482|468849585|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130242926|NCT03407482|468849585|FG000|Overall Study|Pregnancy|2|||
130242927|NCT03407482|468849585|FG000|Overall Study|Protocol Violation|1|||
130242928|NCT03407482|468849585|FG000|Overall Study|Study Terminated By Sponsor|106|||
130242929|NCT03407482|468849585|FG000|Overall Study|Withdrawal by Subject|6|||
130242930|NCT03407482|468849585|FG000|Overall Study|Data Entry Error|1|||
130242931|NCT05089357|468849588|FG000|Overall Study|Withdrawal by Subject|23|||
130242932|NCT05089357|468849588|FG000|Overall Study|Lost to Follow-up|6|||
130242933|NCT05089357|468849588|FG000|Overall Study|Medical reason|1|||
130449752|NCT01323660|469611038|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130449753|NCT01323660|469611039|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130696854|NCT02597049|470514522|FG002|Overall Study|Adverse Event|0|||
130242934|NCT05089357|468849588|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
130242935|NCT05089357|468849588|FG000|Overall Study|Pregnancy|2|||
130242936|NCT05537571|468849589|FG000|Overall Study|Withdrawal by Subject|1|||
130242937|NCT05537571|468849590|FG001|Overall Study|Withdrawal by Subject|1|||
130242938|NCT05537571|468849591|FG002|Overall Study|Withdrawal by Subject|0|||
130242939|NCT05537571|468849592|FG003|Overall Study|Withdrawal by Subject|0|||
130242940|NCT05537571|468849593|FG004|Overall Study|Withdrawal by Subject|0|||
130242941|NCT05537571|468849589|FG000|Overall Study|Adverse Event|2|||
130242942|NCT05537571|468849590|FG001|Overall Study|Adverse Event|0|||
130242943|NCT05537571|468849591|FG002|Overall Study|Adverse Event|0|||
130242944|NCT05537571|468849592|FG003|Overall Study|Adverse Event|0|||
130242945|NCT05537571|468849593|FG004|Overall Study|Adverse Event|0|||
130242946|NCT05537571|468849589|FG000|Overall Study|Hepatitis A screening result|2|||
130242947|NCT05537571|468849590|FG001|Overall Study|Hepatitis A screening result|0|||
130242948|NCT05537571|468849591|FG002|Overall Study|Hepatitis A screening result|0|||
130242949|NCT05537571|468849592|FG003|Overall Study|Hepatitis A screening result|0|||
130242950|NCT05537571|468849593|FG004|Overall Study|Hepatitis A screening result|0|||
130242951|NCT05537571|468849589|FG000|Overall Study|Lost to Follow-up|0|||
130242952|NCT05537571|468849590|FG001|Overall Study|Lost to Follow-up|0|||
130242953|NCT05537571|468849591|FG002|Overall Study|Lost to Follow-up|1|||
130242954|NCT05537571|468849592|FG003|Overall Study|Lost to Follow-up|0|||
130242955|NCT05537571|468849593|FG004|Overall Study|Lost to Follow-up|1|||
130242956|NCT05752487|468849598|FG000|Overall Study|Enrolled, not treated|9|||
130242957|NCT05752487|468849598|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
130242958|NCT05752487|468849598|FG000|Overall Study|Withdrawal by Subject|2|||
130242959|NCT03091439|468849599|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130242960|NCT03091439|468849600|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130242961|NCT01860989|468849601|FG000|Overall Study|Unsatisfactory therapeutic|5|||
130242962|NCT01685437|468849604|FG000|Overall Study|Withdrawal by Subject|22|||
130242963|NCT01685437|468849604|FG000|Overall Study|Lost to Follow-up|3|||
130242964|NCT01685437|468849604|FG000|Overall Study|Adverse Event|1|||
130242965|NCT01685437|468849604|FG000|Overall Study|Protocol Violation|4|||
130242966|NCT01685437|468849604|FG000|Overall Study|Unable to make visits due to work|1|||
130242967|NCT01214720|468849607|FG000|Overall Study|Alive and still on treatment|34|||
130242968|NCT01214720|468849608|FG001|Overall Study|Alive and still on treatment|18|||
130242969|NCT01214720|468849607|FG000|Overall Study|Alive and in follow-up|45|||
130242970|NCT01214720|468849608|FG001|Overall Study|Alive and in follow-up|48|||
130242971|NCT01214720|468849607|FG000|Overall Study|Lost to Follow-up|6|||
130242972|NCT01214720|468849608|FG001|Overall Study|Lost to Follow-up|2|||
130242973|NCT02347787|468849609|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
130242974|NCT02347787|468849610|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
130242975|NCT02347787|468849609|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
130242976|NCT02347787|468849610|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
130242977|NCT02347787|468849609|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
130242978|NCT02347787|468849610|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
130242979|NCT02347787|468849609|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
130242980|NCT02347787|468849610|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
130242981|NCT01039675|468849619|FG000|Overall Study|Adverse Event|0|||
130242982|NCT01039675|468849620|FG001|Overall Study|Adverse Event|2|||
130242983|NCT01039675|468849619|FG000|Overall Study|Lack of Efficacy|0|||
130242984|NCT01039675|468849620|FG001|Overall Study|Lack of Efficacy|2|||
130242985|NCT01039675|468849619|FG000|Overall Study|Withdrawal by Subject|0|||
130242986|NCT01039675|468849620|FG001|Overall Study|Withdrawal by Subject|1|||
130242987|NCT01039675|468849619|FG000|Overall Study|Lost to Follow-up|0|||
130242988|NCT01039675|468849620|FG001|Overall Study|Lost to Follow-up|1|||
130242989|NCT01039675|468849619|FG000|Overall Study|Physician Decision|0|||
130242990|NCT01039675|468849620|FG001|Overall Study|Physician Decision|1|||
130242991|NCT00992836|468851404|FG000|Overall Study|Lost to Follow-up|1|||
130242992|NCT00992836|468851404|FG000|Overall Study|Withdrawal by Subject|2|||
130242993|NCT00992836|468851404|FG000|Overall Study|Protocol Violation|2|||
130242994|NCT01137812|468851405|FG000|Overall Study|Adverse Event|21|||
130242995|NCT01137812|468851406|FG001|Overall Study|Adverse Event|14|||
130242996|NCT01137812|468851405|FG000|Overall Study|Lost to Follow-up|6|||
130242997|NCT01137812|468851406|FG001|Overall Study|Lost to Follow-up|8|||
130242998|NCT01137812|468851405|FG000|Overall Study|Physician Decision|25|||
130242999|NCT01137812|468851406|FG001|Overall Study|Physician Decision|17|||
130243000|NCT01137812|468851405|FG000|Overall Study|Protocol Violation|5|||
130243001|NCT01137812|468851406|FG001|Overall Study|Protocol Violation|4|||
130243002|NCT01137812|468851405|FG000|Overall Study|Withdrawal by Subject|5|||
130243003|NCT01137812|468851406|FG001|Overall Study|Withdrawal by Subject|13|||
130243004|NCT01137812|468851405|FG000|Overall Study|Death|2|||
130243005|NCT01137812|468851406|FG001|Overall Study|Death|0|||
130243006|NCT01137812|468851405|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
130449754|NCT01323660|469611040|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130449755|NCT01323660|469611041|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130243007|NCT01137812|468851406|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
130243008|NCT01137812|468851405|FG000|Overall Study|Other|19|||
130243009|NCT01137812|468851406|FG001|Overall Study|Other|27|||
130243010|NCT04621760|468851407|FG000|Overall Study|Lost to Follow-up|2|||
130243011|NCT04621760|468851408|FG001|Overall Study|Lost to Follow-up|4|||
130243012|NCT04621760|468851407|FG000|Overall Study|Withdrawal by Subject|1|||
130243013|NCT04621760|468851408|FG001|Overall Study|Withdrawal by Subject|0|||
130243014|NCT04602000|468851411|FG000|Overall Study|Withdrawal by Subject|3|||
130243015|NCT04602000|468851412|FG001|Overall Study|Withdrawal by Subject|6|||
130243016|NCT04602000|468851413|FG002|Overall Study|Withdrawal by Subject|3|||
130243017|NCT04602000|468851414|FG003|Overall Study|Withdrawal by Subject|27|||
130243018|NCT04602000|468851415|FG004|Overall Study|Withdrawal by Subject|39|||
130243019|NCT04602000|468851411|FG000|Overall Study|Physician Decision|1|||
130243020|NCT04602000|468851412|FG001|Overall Study|Physician Decision|0|||
130243021|NCT04602000|468851413|FG002|Overall Study|Physician Decision|0|||
130243022|NCT04602000|468851414|FG003|Overall Study|Physician Decision|2|||
130243023|NCT04602000|468851415|FG004|Overall Study|Physician Decision|2|||
130243024|NCT04602000|468851411|FG000|Overall Study|Death|0|||
130243025|NCT04602000|468851412|FG001|Overall Study|Death|1|||
130243026|NCT04602000|468851413|FG002|Overall Study|Death|0|||
130243027|NCT04602000|468851414|FG003|Overall Study|Death|1|||
130243028|NCT04602000|468851415|FG004|Overall Study|Death|2|||
130243029|NCT04602000|468851411|FG000|Overall Study|Lost to Follow-up|0|||
130243030|NCT04602000|468851412|FG001|Overall Study|Lost to Follow-up|0|||
130243031|NCT04602000|468851413|FG002|Overall Study|Lost to Follow-up|0|||
130243032|NCT04602000|468851414|FG003|Overall Study|Lost to Follow-up|3|||
130243033|NCT04602000|468851415|FG004|Overall Study|Lost to Follow-up|4|||
130243034|NCT04602000|468851411|FG000|Overall Study|Other|4|||
130243035|NCT04602000|468851412|FG001|Overall Study|Other|1|||
130243036|NCT04602000|468851413|FG002|Overall Study|Other|2|||
130243037|NCT04602000|468851414|FG003|Overall Study|Other|5|||
130243038|NCT04602000|468851415|FG004|Overall Study|Other|4|||
130243039|NCT04602000|468851411|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243040|NCT04602000|468851412|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243041|NCT04602000|468851413|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
130243042|NCT04602000|468851414|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243043|NCT04602000|468851415|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243044|NCT00471354|468851416|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130243045|NCT00471354|468851416|FG000|Overall Study|Adverse Event|13|||
130243046|NCT00471354|468851416|FG000|Overall Study|Protocol Violation|12|||
130243047|NCT00471354|468851416|FG000|Overall Study|Withdrawal by Subject|1|||
130243048|NCT00471354|468851416|FG000|Overall Study|Physician Decision|4|||
130243049|NCT00471354|468851416|FG000|Overall Study|Sponsor Decision|1|||
130243050|NCT00471354|468851416|FG000|Overall Study|Lost to Follow-up|3|||
130243051|NCT00471354|468851416|FG000|Overall Study|Lack of Efficacy|5|||
130243052|NCT00471354|468851416|FG000|Overall Study|Patient/Caregiver Decision|12|||
130243053|NCT02153827|468851420|FG000|Overall Study|Lost to Follow-up|3|||
130243054|NCT02153827|468851421|FG001|Overall Study|Lost to Follow-up|9|||
130243055|NCT01158404|468851422|FG000|Overall Study|Withdrawal by Subject|0|||
130243056|NCT01158404|468851423|FG001|Overall Study|Withdrawal by Subject|1|||
130243057|NCT01158404|468851424|FG002|Overall Study|Withdrawal by Subject|0|||
130243058|NCT01158404|468851425|FG003|Overall Study|Withdrawal by Subject|0|||
130243059|NCT01158404|468851426|FG004|Overall Study|Withdrawal by Subject|3|||
130243060|NCT01158404|468851427|FG005|Overall Study|Withdrawal by Subject|1|||
130243061|NCT01158404|468851428|FG006|Overall Study|Withdrawal by Subject|0|||
130243062|NCT01158404|468851429|FG007|Overall Study|Withdrawal by Subject|1|||
130243063|NCT01158404|468851422|FG000|Overall Study|Physician Decision|0|||
130243064|NCT01158404|468851423|FG001|Overall Study|Physician Decision|0|||
130243065|NCT01158404|468851424|FG002|Overall Study|Physician Decision|0|||
130243066|NCT01158404|468851425|FG003|Overall Study|Physician Decision|0|||
130243067|NCT01158404|468851426|FG004|Overall Study|Physician Decision|0|||
130243068|NCT01158404|468851427|FG005|Overall Study|Physician Decision|0|||
130243069|NCT01158404|468851428|FG006|Overall Study|Physician Decision|0|||
130243070|NCT01158404|468851429|FG007|Overall Study|Physician Decision|1|||
130243071|NCT01158404|468851422|FG000|Overall Study|Progressive Disease|0|||
130243072|NCT01158404|468851423|FG001|Overall Study|Progressive Disease|0|||
130243073|NCT01158404|468851424|FG002|Overall Study|Progressive Disease|0|||
130243074|NCT01158404|468851425|FG003|Overall Study|Progressive Disease|0|||
130243075|NCT01158404|468851426|FG004|Overall Study|Progressive Disease|0|||
130243076|NCT01158404|468851427|FG005|Overall Study|Progressive Disease|0|||
130243077|NCT01158404|468851428|FG006|Overall Study|Progressive Disease|1|||
130243078|NCT01158404|468851429|FG007|Overall Study|Progressive Disease|0|||
130361497|NCT02046733|469294226|FG000|Overall Study|never initiated 'treatment visits'|6|||
130361498|NCT02046733|469294227|FG001|Overall Study|never initiated 'treatment visits'|0|||
130361499|NCT00199875|469294232|FG000|Overall Study|Withdrawal by Subject|0|||
130361500|NCT00199875|469294233|FG001|Overall Study|Withdrawal by Subject|0|||
130361501|NCT00199875|469294234|FG002|Overall Study|Withdrawal by Subject|0|||
130361502|NCT00199875|469294235|FG003|Overall Study|Withdrawal by Subject|0|||
130243079|NCT02143778|468851431|FG000|Overall Study|Withdrawal by Subject|2|||
130243080|NCT02143778|468851431|FG000|Overall Study|Device malfunction|1|||
130243081|NCT00625378|468851433|FG000|Overall Study|Adverse Event|22|||
130243082|NCT00625378|468851434|FG001|Overall Study|Adverse Event|0|||
130243083|NCT00625378|468851433|FG000|Overall Study|Withdrawal by Subject|16|||
130243084|NCT00625378|468851434|FG001|Overall Study|Withdrawal by Subject|0|||
130243085|NCT00625378|468851433|FG000|Overall Study|Death|38|||
130243086|NCT00625378|468851434|FG001|Overall Study|Death|0|||
130243087|NCT00625378|468851433|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
130243088|NCT00625378|468851434|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
130243089|NCT00625378|468851433|FG000|Overall Study|Lost to Follow-up|17|||
130243090|NCT00625378|468851434|FG001|Overall Study|Lost to Follow-up|0|||
130243091|NCT00625378|468851433|FG000|Overall Study|Non-compliant with study medication|3|||
130243092|NCT00625378|468851434|FG001|Overall Study|Non-compliant with study medication|0|||
130243093|NCT00625378|468851433|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
130243094|NCT00625378|468851434|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
130243095|NCT00625378|468851433|FG000|Overall Study|Medical decision|1|||
130243096|NCT00625378|468851434|FG001|Overall Study|Medical decision|0|||
130243097|NCT00625378|468851433|FG000|Overall Study|Multiple toxicities|1|||
130243098|NCT00625378|468851434|FG001|Overall Study|Multiple toxicities|0|||
130243099|NCT00625378|468851433|FG000|Overall Study|New cancer|1|||
130243100|NCT00625378|468851434|FG001|Overall Study|New cancer|0|||
130243101|NCT00625378|468851433|FG000|Overall Study|PTA program|2|||
130243102|NCT00625378|468851434|FG001|Overall Study|PTA program|0|||
130243103|NCT00625378|468851433|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
130243104|NCT00625378|468851434|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
130243105|NCT00625378|468851433|FG000|Overall Study|Sponsor decision|1|||
130243106|NCT00625378|468851434|FG001|Overall Study|Sponsor decision|0|||
130243107|NCT00625378|468851433|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
130243108|NCT00625378|468851434|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
130243109|NCT00625378|468851433|FG000|Overall Study|Switch to commercial drug|6|||
130243110|NCT00625378|468851434|FG001|Overall Study|Switch to commercial drug|1|||
130243111|NCT00625378|468851433|FG000|Overall Study|Missing|2|||
130243112|NCT00625378|468851434|FG001|Overall Study|Missing|0|||
130243113|NCT00625378|468851433|FG000|Overall Study|End of treatment not available|2|||
130243114|NCT00625378|468851434|FG001|Overall Study|End of treatment not available|0|||
130243115|NCT00625378|468851433|FG000|Overall Study|Never treated|2|||
130243116|NCT00625378|468851434|FG001|Overall Study|Never treated|0|||
130243117|NCT02639559|468851436|FG000|Overall Study|Mobilization failure|0|||
130243118|NCT02639559|468851437|FG001|Overall Study|Mobilization failure|3|||
130243119|NCT02639559|468851436|FG000|Overall Study|Issues with vascular acess|1|||
130243120|NCT02639559|468851437|FG001|Overall Study|Issues with vascular acess|0|||
130243121|NCT03880565|468851438|FG000|Overall Study|Withdrawal by Subject|1|||
130243122|NCT03880565|468851439|FG001|Overall Study|Withdrawal by Subject|0|||
130361503|NCT00199875|469294236|FG004|Overall Study|Withdrawal by Subject|1|||
130361504|NCT01024231|469294237|FG000|Overall Study|Other Reasons|1|||
130361505|NCT01024231|469294238|FG001|Overall Study|Other Reasons|2|||
130696855|NCT02597049|470514520|FG000|Overall Study|Death|2|||
130696856|NCT02597049|470514521|FG001|Overall Study|Death|0|||
130696857|NCT02597049|470514522|FG002|Overall Study|Death|0|||
130696858|NCT02597049|470514520|FG000|Overall Study|Noncompliant with Study Visits|1|||
130696859|NCT02597049|470514521|FG001|Overall Study|Noncompliant with Study Visits|0|||
130696860|NCT02597049|470514522|FG002|Overall Study|Noncompliant with Study Visits|0|||
130696861|NCT00243347|470514525|FG000|Overall Study|Lack of Efficacy|4|||
130696862|NCT00243347|470514525|FG000|Overall Study|Adverse Event|2|||
130696863|NCT00243347|470514525|FG000|Overall Study|Death|1|||
130696864|NCT00243347|470514525|FG000|Overall Study|Withdrawal by Subject|5|||
130361506|NCT01024231|469294239|FG002|Overall Study|Other Reasons|0|||
130361507|NCT01024231|469294240|FG003|Overall Study|Other Reasons|0|||
130361508|NCT01024231|469294241|FG004|Overall Study|Other Reasons|2|||
130361509|NCT01024231|469294242|FG005|Overall Study|Other Reasons|0|||
130361510|NCT01024231|469294243|FG006|Overall Study|Other Reasons|1|||
130361511|NCT01024231|469294237|FG000|Overall Study|Maximum Clinical Benefit|1|||
130361512|NCT01024231|469294238|FG001|Overall Study|Maximum Clinical Benefit|2|||
130361513|NCT01024231|469294239|FG002|Overall Study|Maximum Clinical Benefit|0|||
130361514|NCT01024231|469294240|FG003|Overall Study|Maximum Clinical Benefit|1|||
130361515|NCT01024231|469294241|FG004|Overall Study|Maximum Clinical Benefit|1|||
130361516|NCT01024231|469294242|FG005|Overall Study|Maximum Clinical Benefit|0|||
130361517|NCT01024231|469294243|FG006|Overall Study|Maximum Clinical Benefit|0|||
130361518|NCT01024231|469294237|FG000|Overall Study|Disease Progression|3|||
130361519|NCT01024231|469294238|FG001|Overall Study|Disease Progression|1|||
130361520|NCT01024231|469294239|FG002|Overall Study|Disease Progression|3|||
130361521|NCT01024231|469294240|FG003|Overall Study|Disease Progression|0|||
130361522|NCT01024231|469294241|FG004|Overall Study|Disease Progression|4|||
130361523|NCT01024231|469294242|FG005|Overall Study|Disease Progression|11|||
130361524|NCT01024231|469294243|FG006|Overall Study|Disease Progression|6|||
130361525|NCT01024231|469294237|FG000|Overall Study|AE unrelated to Study Drug|0|||
130243123|NCT02969018|468851444|FG000|Overall Study|Adverse Event|2|||
130361526|NCT01024231|469294238|FG001|Overall Study|AE unrelated to Study Drug|1|||
130361527|NCT01024231|469294239|FG002|Overall Study|AE unrelated to Study Drug|0|||
130243124|NCT02969018|468851445|FG001|Overall Study|Adverse Event|4|||
130361528|NCT01024231|469294240|FG003|Overall Study|AE unrelated to Study Drug|0|||
130243125|NCT02969018|468851446|FG002|Overall Study|Adverse Event|1|||
130243126|NCT02969018|468851447|FG003|Overall Study|Adverse Event|2|||
130243127|NCT02969018|468851448|FG004|Overall Study|Adverse Event|0|||
130243128|NCT02969018|468851449|FG005|Overall Study|Adverse Event|1|||
130696865|NCT00243347|470514525|FG000|Overall Study|Condition worsened|7|||
130696866|NCT01899053|470514528|FG000|Overall Study|Progressive Disease|4|||
130243129|NCT02969018|468851450|FG006|Overall Study|Adverse Event|2|||
130243130|NCT02969018|468851451|FG007|Overall Study|Adverse Event|0|||
130243131|NCT02969018|468851444|FG000|Overall Study|Lack of Efficacy|0|||
130243132|NCT02969018|468851445|FG001|Overall Study|Lack of Efficacy|1|||
130243133|NCT02969018|468851446|FG002|Overall Study|Lack of Efficacy|0|||
130243134|NCT02969018|468851447|FG003|Overall Study|Lack of Efficacy|0|||
130243135|NCT02969018|468851448|FG004|Overall Study|Lack of Efficacy|1|||
130243136|NCT02969018|468851449|FG005|Overall Study|Lack of Efficacy|1|||
130243137|NCT02969018|468851450|FG006|Overall Study|Lack of Efficacy|1|||
130243138|NCT02969018|468851451|FG007|Overall Study|Lack of Efficacy|1|||
130243139|NCT02969018|468851444|FG000|Overall Study|Lost to Follow-up|1|||
130243140|NCT02969018|468851445|FG001|Overall Study|Lost to Follow-up|2|||
130243141|NCT02969018|468851446|FG002|Overall Study|Lost to Follow-up|2|||
130243142|NCT02969018|468851447|FG003|Overall Study|Lost to Follow-up|0|||
130243143|NCT02969018|468851448|FG004|Overall Study|Lost to Follow-up|1|||
130243144|NCT02969018|468851449|FG005|Overall Study|Lost to Follow-up|1|||
130243145|NCT02969018|468851450|FG006|Overall Study|Lost to Follow-up|0|||
130243146|NCT02969018|468851451|FG007|Overall Study|Lost to Follow-up|1|||
130243147|NCT02969018|468851444|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243148|NCT02969018|468851445|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243149|NCT02969018|468851446|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243150|NCT02969018|468851447|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243151|NCT02969018|468851448|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243152|NCT02969018|468851449|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243153|NCT02969018|468851450|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
130243154|NCT02969018|468851451|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243155|NCT02969018|468851444|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130243156|NCT02969018|468851445|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130243157|NCT02969018|468851446|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130243158|NCT02969018|468851447|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130243159|NCT02969018|468851448|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130361529|NCT01024231|469294241|FG004|Overall Study|AE unrelated to Study Drug|0|||
130361530|NCT01024231|469294242|FG005|Overall Study|AE unrelated to Study Drug|0|||
130361531|NCT01024231|469294243|FG006|Overall Study|AE unrelated to Study Drug|0|||
130361532|NCT01024231|469294237|FG000|Overall Study|No longer meets criteria|0|||
130361533|NCT01024231|469294238|FG001|Overall Study|No longer meets criteria|0|||
130361534|NCT01024231|469294239|FG002|Overall Study|No longer meets criteria|0|||
130361535|NCT01024231|469294240|FG003|Overall Study|No longer meets criteria|0|||
130361536|NCT01024231|469294241|FG004|Overall Study|No longer meets criteria|1|||
130361537|NCT01024231|469294242|FG005|Overall Study|No longer meets criteria|0|||
130361538|NCT01024231|469294243|FG006|Overall Study|No longer meets criteria|1|||
130361539|NCT01024231|469294237|FG000|Overall Study|Study Drug Toxicity|1|||
130361540|NCT01024231|469294238|FG001|Overall Study|Study Drug Toxicity|6|||
130361541|NCT01024231|469294239|FG002|Overall Study|Study Drug Toxicity|6|||
130361542|NCT01024231|469294240|FG003|Overall Study|Study Drug Toxicity|4|||
130361543|NCT01024231|469294241|FG004|Overall Study|Study Drug Toxicity|2|||
130361544|NCT01024231|469294242|FG005|Overall Study|Study Drug Toxicity|0|||
130361545|NCT01024231|469294243|FG006|Overall Study|Study Drug Toxicity|7|||
130361546|NCT01024231|469294237|FG000|Overall Study|Death|6|||
130361547|NCT01024231|469294238|FG001|Overall Study|Death|2|||
130361548|NCT01024231|469294239|FG002|Overall Study|Death|1|||
130361549|NCT01024231|469294240|FG003|Overall Study|Death|0|||
130361550|NCT01024231|469294241|FG004|Overall Study|Death|4|||
130361551|NCT01024231|469294242|FG005|Overall Study|Death|3|||
130361552|NCT01024231|469294243|FG006|Overall Study|Death|5|||
130361553|NCT01024231|469294237|FG000|Overall Study|Lost to Follow-up|0|||
130361554|NCT01024231|469294238|FG001|Overall Study|Lost to Follow-up|0|||
130361555|NCT01024231|469294239|FG002|Overall Study|Lost to Follow-up|0|||
130361556|NCT01024231|469294240|FG003|Overall Study|Lost to Follow-up|0|||
130361557|NCT01024231|469294241|FG004|Overall Study|Lost to Follow-up|0|||
130243160|NCT02969018|468851449|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130243161|NCT02969018|468851450|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130361558|NCT01024231|469294242|FG005|Overall Study|Lost to Follow-up|0|||
130361559|NCT01024231|469294243|FG006|Overall Study|Lost to Follow-up|1|||
130361560|NCT01024231|469294237|FG000|Overall Study|Withdrew Consent|0|||
130361561|NCT01024231|469294238|FG001|Overall Study|Withdrew Consent|1|||
130361562|NCT01024231|469294239|FG002|Overall Study|Withdrew Consent|0|||
130361563|NCT01024231|469294240|FG003|Overall Study|Withdrew Consent|0|||
130361564|NCT01024231|469294241|FG004|Overall Study|Withdrew Consent|0|||
130361565|NCT01024231|469294242|FG005|Overall Study|Withdrew Consent|0|||
130243162|NCT02969018|468851451|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130243163|NCT02969018|468851444|FG000|Overall Study|Other|0|||
130243164|NCT02969018|468851445|FG001|Overall Study|Other|0|||
130243165|NCT02969018|468851446|FG002|Overall Study|Other|0|||
130243166|NCT02969018|468851447|FG003|Overall Study|Other|1|||
130361566|NCT01024231|469294243|FG006|Overall Study|Withdrew Consent|0|||
130361567|NCT01024231|469294237|FG000|Overall Study|Continuing on Treatment|0|||
130361568|NCT01024231|469294238|FG001|Overall Study|Continuing on Treatment|0|||
130243167|NCT02969018|468851448|FG004|Overall Study|Other|0|||
130243168|NCT02969018|468851449|FG005|Overall Study|Other|0|||
130243169|NCT02969018|468851450|FG006|Overall Study|Other|0|||
130243170|NCT02969018|468851451|FG007|Overall Study|Other|2|||
130243171|NCT02969018|468851444|FG000|Overall Study|Pregnancy|0|||
130243172|NCT02969018|468851445|FG001|Overall Study|Pregnancy|0|||
130243173|NCT02969018|468851446|FG002|Overall Study|Pregnancy|0|||
130243174|NCT02969018|468851447|FG003|Overall Study|Pregnancy|0|||
130243175|NCT02969018|468851448|FG004|Overall Study|Pregnancy|0|||
130243176|NCT02969018|468851449|FG005|Overall Study|Pregnancy|1|||
130243177|NCT02969018|468851450|FG006|Overall Study|Pregnancy|0|||
130243178|NCT02969018|468851451|FG007|Overall Study|Pregnancy|0|||
130243179|NCT02969018|468851444|FG000|Overall Study|Protocol Violation|0|||
130243180|NCT02969018|468851445|FG001|Overall Study|Protocol Violation|0|||
130243181|NCT02969018|468851446|FG002|Overall Study|Protocol Violation|1|||
130243182|NCT02969018|468851447|FG003|Overall Study|Protocol Violation|1|||
130243183|NCT02969018|468851448|FG004|Overall Study|Protocol Violation|0|||
130243184|NCT02969018|468851449|FG005|Overall Study|Protocol Violation|0|||
130243185|NCT02969018|468851450|FG006|Overall Study|Protocol Violation|0|||
130243186|NCT02969018|468851451|FG007|Overall Study|Protocol Violation|0|||
130243187|NCT02969018|468851444|FG000|Overall Study|Withdrawal by Subject|0|||
130243188|NCT02969018|468851445|FG001|Overall Study|Withdrawal by Subject|1|||
130243189|NCT02969018|468851446|FG002|Overall Study|Withdrawal by Subject|2|||
130243190|NCT02969018|468851447|FG003|Overall Study|Withdrawal by Subject|1|||
130243191|NCT02969018|468851448|FG004|Overall Study|Withdrawal by Subject|0|||
130243192|NCT02969018|468851449|FG005|Overall Study|Withdrawal by Subject|4|||
130243193|NCT02969018|468851450|FG006|Overall Study|Withdrawal by Subject|4|||
130243194|NCT02969018|468851451|FG007|Overall Study|Withdrawal by Subject|3|||
130243195|NCT04790201|468851455|FG000|Overall Study|Lost to Follow-up|0|||
130243196|NCT04790201|468851456|FG001|Overall Study|Lost to Follow-up|0|||
130243197|NCT04790201|468851457|FG002|Overall Study|Lost to Follow-up|2|||
130243198|NCT04790201|468851455|FG000|Overall Study|Death|0|||
130243199|NCT04790201|468851456|FG001|Overall Study|Death|1|||
130243200|NCT04790201|468851457|FG002|Overall Study|Death|0|||
130243201|NCT04790201|468851455|FG000|Overall Study|Protocol Violation|1|||
130243202|NCT04790201|468851456|FG001|Overall Study|Protocol Violation|0|||
130243203|NCT04790201|468851457|FG002|Overall Study|Protocol Violation|1|||
130243204|NCT05762679|468851460|FG000|Overall Study|Withdrawal by Subject|1|||
130243205|NCT05762679|468851460|FG000|Overall Study|No analyzable imaging data|1|||
130243206|NCT03670628|468851461|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
130243207|NCT03670628|468851462|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
130243208|NCT03670628|468851461|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
130243209|NCT03670628|468851462|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
130243210|NCT06377488|468851463|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
130243211|NCT06377488|468851463|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
130243212|NCT06377488|468851463|FG000|Overall Study|Protocol Violation|1|||
130243213|NCT06377488|468851463|FG000|Overall Study|Lost to Follow-up|1|||
130243214|NCT06377488|468851463|FG000|Overall Study|Incorrect Lens Dispensed|2|||
130243215|NCT01179516|468851464|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130243216|NCT01179516|468851465|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
130243217|NCT01179516|468851466|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
130243218|NCT01179516|468851464|FG000|Overall Study|Lack of Efficacy|4|||
130243219|NCT01179516|468851465|FG001|Overall Study|Lack of Efficacy|2|||
130243220|NCT01179516|468851466|FG002|Overall Study|Lack of Efficacy|0|||
130361569|NCT01024231|469294239|FG002|Overall Study|Continuing on Treatment|0|||
130361570|NCT01024231|469294240|FG003|Overall Study|Continuing on Treatment|0|||
130361571|NCT01024231|469294241|FG004|Overall Study|Continuing on Treatment|3|||
130361572|NCT01024231|469294242|FG005|Overall Study|Continuing on Treatment|2|||
130361573|NCT01024231|469294243|FG006|Overall Study|Continuing on Treatment|0|||
130361574|NCT01013350|469294244|FG000|Overall Study|Lost to Follow-up|15|||
130361575|NCT01013350|469294245|FG001|Overall Study|Lost to Follow-up|95|||
130361576|NCT01013350|469294244|FG000|Overall Study|Adverse Event|0|||
130361577|NCT01013350|469294245|FG001|Overall Study|Adverse Event|1|||
130361578|NCT01013350|469294244|FG000|Overall Study|Physician Decision|4|||
130361579|NCT01013350|469294245|FG001|Overall Study|Physician Decision|20|||
130243221|NCT01179516|468851464|FG000|Overall Study|Noncompliance with Study Drug|2|||
130243222|NCT01179516|468851465|FG001|Overall Study|Noncompliance with Study Drug|0|||
130243223|NCT01179516|468851466|FG002|Overall Study|Noncompliance with Study Drug|1|||
130243224|NCT01179516|468851464|FG000|Overall Study|Protocol Deviations|4|||
130243225|NCT01179516|468851465|FG001|Overall Study|Protocol Deviations|3|||
130243226|NCT01179516|468851466|FG002|Overall Study|Protocol Deviations|3|||
130243227|NCT01179516|468851464|FG000|Overall Study|Withdrawal of Consent|2|||
130243228|NCT01179516|468851465|FG001|Overall Study|Withdrawal of Consent|6|||
130243229|NCT01179516|468851466|FG002|Overall Study|Withdrawal of Consent|10|||
130243230|NCT01179516|468851464|FG000|Overall Study|Lost to Follow-up|7|||
130361580|NCT01013350|469294244|FG000|Overall Study|Withdrawal by Subject|15|||
130449756|NCT01323660|469611036|FG000|Washout Period (14 Days)|Adverse Event|0|||
130449757|NCT01323660|469611037|FG001|Washout Period (14 Days)|Adverse Event|0|||
130449758|NCT01323660|469611038|FG002|Washout Period (14 Days)|Adverse Event|0|||
130449759|NCT01323660|469611039|FG003|Washout Period (14 Days)|Adverse Event|0|||
130449760|NCT01323660|469611040|FG004|Washout Period (14 Days)|Adverse Event|1|||
130449761|NCT01323660|469611041|FG005|Washout Period (14 Days)|Adverse Event|0|||
130449762|NCT01323660|469611036|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
130449763|NCT01323660|469611037|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
130449764|NCT01323660|469611038|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
130449765|NCT01323660|469611039|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
130449766|NCT01323660|469611040|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
130449767|NCT01323660|469611041|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
130449768|NCT01323660|469611036|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130449769|NCT01323660|469611037|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130449770|NCT01323660|469611038|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130449771|NCT01323660|469611039|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130449772|NCT01323660|469611040|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130449773|NCT01323660|469611041|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
130449774|NCT01323660|469611036|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
130449775|NCT01323660|469611037|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130449776|NCT01323660|469611038|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
130449777|NCT01323660|469611039|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
130449778|NCT01323660|469611040|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130449779|NCT01323660|469611041|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
130449780|NCT01323660|469611036|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130449781|NCT01323660|469611037|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130449782|NCT01323660|469611038|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130449783|NCT01323660|469611039|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130449784|NCT01323660|469611040|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130449785|NCT01323660|469611041|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
130449786|NCT01323660|469611036|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130449787|NCT01323660|469611037|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130449788|NCT01323660|469611038|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130449789|NCT01323660|469611039|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130449790|NCT01323660|469611040|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130449791|NCT01323660|469611041|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130449792|NCT01323660|469611036|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130449793|NCT01323660|469611037|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130449794|NCT01323660|469611038|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130449795|NCT01323660|469611039|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130449796|NCT01323660|469611040|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
130449797|NCT01323660|469611041|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130449798|NCT00278564|469611046|FG000|Overall Study|Lack of Efficacy|4|||
130449799|NCT00051311|469611047|FG000|Overall Study|Starting new study|0|||
130449800|NCT00051311|469611048|FG001|Overall Study|Starting new study|1|||
130361581|NCT01013350|469294245|FG001|Overall Study|Withdrawal by Subject|38|||
130361582|NCT01013350|469294244|FG000|Overall Study|Death|3|||
130361583|NCT01013350|469294245|FG001|Overall Study|Death|5|||
130361584|NCT01013350|469294244|FG000|Overall Study|Participant entered interventional study|0|||
130361585|NCT01013350|469294245|FG001|Overall Study|Participant entered interventional study|8|||
130361586|NCT01013350|469294244|FG000|Overall Study|Other|1|||
130361587|NCT01013350|469294245|FG001|Overall Study|Other|25|||
130361588|NCT04738734|469294246|FG000|Overall Study|Withdrawal by Subject|2|||
130361589|NCT04738734|469294247|FG001|Overall Study|Withdrawal by Subject|4|||
130361590|NCT04738734|469294246|FG000|Overall Study|Lost to Follow-up|5|||
130361591|NCT04738734|469294247|FG001|Overall Study|Lost to Follow-up|2|||
130361592|NCT04738734|469294246|FG000|Overall Study|Physician Decision|0|||
130361593|NCT04738734|469294247|FG001|Overall Study|Physician Decision|1|||
130361594|NCT04738734|469294246|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
130361595|NCT04738734|469294247|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
130361596|NCT02435147|469294249|FG000|Overall Study|non-evaluable DXA scan|11|||
130361597|NCT00331422|469294252|FG000|Overall Study|Did not receive entire study regimen|5|||
130361598|NCT01710046|469294253|FG000|Overall Study|Lost to Follow-up|1|||
130361599|NCT01710046|469294254|FG001|Overall Study|Lost to Follow-up|0|||
130361600|NCT04128371|469294255|FG000|Overall Study|Lack of Efficacy|1|||
130361601|NCT01346969|469294256|FG000|Overall Study|Withdrawal by Subject|0|||
130696867|NCT01899053|470514529|FG001|Overall Study|Progressive Disease|0|||
130696868|NCT01899053|470514530|FG002|Overall Study|Progressive Disease|3|||
130361602|NCT01346969|469294257|FG001|Overall Study|Withdrawal by Subject|0|||
130361603|NCT01346969|469294258|FG002|Overall Study|Withdrawal by Subject|1|||
130361604|NCT01346969|469294259|FG003|Overall Study|Withdrawal by Subject|0|||
130361605|NCT01346969|469294256|FG000|Overall Study|Lost to Follow-up|1|||
130361606|NCT01346969|469294257|FG001|Overall Study|Lost to Follow-up|0|||
130243231|NCT01179516|468851465|FG001|Overall Study|Lost to Follow-up|7|||
130243232|NCT01179516|468851466|FG002|Overall Study|Lost to Follow-up|3|||
130243233|NCT01179516|468851464|FG000|Overall Study|Other|2|||
130243234|NCT01179516|468851465|FG001|Overall Study|Other|0|||
130243235|NCT01179516|468851466|FG002|Overall Study|Other|2|||
130243236|NCT02112552|468851469|FG000|Overall Study|Withdrawal by Subject|1|||
130243237|NCT02112552|468851469|FG000|Overall Study|Adverse Event|1|||
130243238|NCT02965456|468851470|FG000|Overall Study|Lost to Follow-up|40|||
130243239|NCT02965456|468851471|FG001|Overall Study|Lost to Follow-up|18|||
130243240|NCT02965456|468851470|FG000|Overall Study|Subject Request|22|||
130243241|NCT02965456|468851471|FG001|Overall Study|Subject Request|13|||
130243242|NCT02965456|468851470|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
130243243|NCT02965456|468851471|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
130243244|NCT02965456|468851470|FG000|Overall Study|Adverse Event|3|||
130243245|NCT02965456|468851471|FG001|Overall Study|Adverse Event|0|||
130243246|NCT02965456|468851470|FG000|Overall Study|Noncompliance with Study Drug|1|||
130243247|NCT02965456|468851471|FG001|Overall Study|Noncompliance with Study Drug|1|||
130243248|NCT02965456|468851470|FG000|Overall Study|Worsening Condition|0|||
130243249|NCT02965456|468851471|FG001|Overall Study|Worsening Condition|2|||
130243250|NCT02965456|468851470|FG000|Overall Study|Lack of Efficacy|1|||
130243251|NCT02965456|468851471|FG001|Overall Study|Lack of Efficacy|0|||
130243252|NCT02965456|468851470|FG000|Overall Study|Physician Decision|0|||
130243253|NCT02965456|468851471|FG001|Overall Study|Physician Decision|1|||
130243254|NCT02965456|468851470|FG000|Overall Study|Pregnancy|1|||
130243255|NCT02965456|468851471|FG001|Overall Study|Pregnancy|0|||
130243256|NCT02965456|468851470|FG000|Overall Study|Protocol Violation|0|||
130243257|NCT02965456|468851471|FG001|Overall Study|Protocol Violation|1|||
130243258|NCT02965456|468851470|FG000|Overall Study|Participant ran out of study drug|0|||
130243259|NCT02965456|468851471|FG001|Overall Study|Participant ran out of study drug|1|||
130243260|NCT00303953|468851472|FG000|Overall Study|Ineligible|1|||
130243261|NCT00303953|468851472|FG000|Overall Study|Death|1|||
130243262|NCT00303953|468851472|FG000|Overall Study|Adverse Event|4|||
130243263|NCT00303953|468851472|FG000|Overall Study|Lack of Efficacy|12|||
130243264|NCT00303953|468851472|FG000|Overall Study|Physician Decision|1|||
130243265|NCT04465955|468851473|FG000|Overall Study|Withdrew consent|6|||
130243266|NCT04465955|468851474|FG001|Overall Study|Withdrew consent|10|||
130243267|NCT04465955|468851475|FG002|Overall Study|Withdrew consent|7|||
130243268|NCT04465955|468851473|FG000|Overall Study|Adverse Event|6|||
130243269|NCT04465955|468851474|FG001|Overall Study|Adverse Event|5|||
130243270|NCT04465955|468851475|FG002|Overall Study|Adverse Event|1|||
130243271|NCT04465955|468851473|FG000|Overall Study|Lost to Follow-up|2|||
130243272|NCT04465955|468851474|FG001|Overall Study|Lost to Follow-up|0|||
130243273|NCT04465955|468851475|FG002|Overall Study|Lost to Follow-up|3|||
130243274|NCT04465955|468851473|FG000|Overall Study|Other|1|||
130243275|NCT04465955|468851474|FG001|Overall Study|Other|1|||
130243276|NCT04465955|468851475|FG002|Overall Study|Other|3|||
130243277|NCT00387127|468851478|FG000|Overall Study|Lost to Follow-up|0|||
130243278|NCT00387127|468851479|FG001|Overall Study|Lost to Follow-up|4|||
130243279|NCT00387127|468851478|FG000|Overall Study|Death|16|||
130243280|NCT00387127|468851479|FG001|Overall Study|Death|16|||
130243281|NCT00387127|468851478|FG000|Overall Study|Physician Decision|0|||
130243282|NCT00387127|468851479|FG001|Overall Study|Physician Decision|1|||
130243283|NCT00387127|468851478|FG000|Overall Study|Withdrawal by Subject|3|||
130243284|NCT00387127|468851479|FG001|Overall Study|Withdrawal by Subject|2|||
130243285|NCT00387127|468851478|FG000|Overall Study|Required by Protocol Amendment #4|12|||
130243286|NCT00387127|468851479|FG001|Overall Study|Required by Protocol Amendment #4|10|||
130243287|NCT00387127|468851478|FG000|Overall Study|Serious Adverse Event|1|||
130243288|NCT00387127|468851479|FG001|Overall Study|Serious Adverse Event|1|||
130361607|NCT01346969|469294258|FG002|Overall Study|Lost to Follow-up|2|||
130361608|NCT01346969|469294259|FG003|Overall Study|Lost to Follow-up|0|||
130361609|NCT01346969|469294256|FG000|Overall Study|Physician Decision|0|||
130361610|NCT01346969|469294257|FG001|Overall Study|Physician Decision|0|||
130361611|NCT01346969|469294258|FG002|Overall Study|Physician Decision|0|||
130361612|NCT01346969|469294259|FG003|Overall Study|Physician Decision|1|||
130243289|NCT00387127|468851478|FG000|Overall Study|Sponsor Unblinded|1|||
130243290|NCT00387127|468851479|FG001|Overall Study|Sponsor Unblinded|0|||
130243291|NCT00812097|468851480|FG000|Overall Study|Death|3|||
130243292|NCT00812097|468851481|FG001|Overall Study|Death|10|||
130243293|NCT00812097|468851482|FG002|Overall Study|Death|3|||
130243294|NCT00812097|468851483|FG003|Overall Study|Death|3|||
130243295|NCT00812097|468851480|FG000|Overall Study|Withdrawal by Subject|14|||
130243296|NCT00812097|468851481|FG001|Overall Study|Withdrawal by Subject|12|||
130243297|NCT00812097|468851482|FG002|Overall Study|Withdrawal by Subject|8|||
130243298|NCT00812097|468851483|FG003|Overall Study|Withdrawal by Subject|2|||
130243299|NCT00812097|468851480|FG000|Overall Study|Lost to Follow-up|90|||
130243300|NCT00812097|468851481|FG001|Overall Study|Lost to Follow-up|14|||
130243301|NCT00812097|468851482|FG002|Overall Study|Lost to Follow-up|17|||
130243302|NCT00812097|468851483|FG003|Overall Study|Lost to Follow-up|5|||
130243303|NCT00812097|468851480|FG000|Overall Study|Explantation of study device(s)|27|||
130243304|NCT00812097|468851481|FG001|Overall Study|Explantation of study device(s)|29|||
130243305|NCT00812097|468851482|FG002|Overall Study|Explantation of study device(s)|14|||
130243306|NCT00812097|468851483|FG003|Overall Study|Explantation of study device(s)|20|||
130243307|NCT00812097|468851480|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
130243308|NCT00812097|468851481|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
130243309|NCT00812097|468851482|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
130243310|NCT00812097|468851483|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
130243311|NCT01786109|468851484|FG000|Overall Study|fail manometry barostat tube placement|1|||
130243312|NCT01786109|468851485|FG001|Overall Study|fail manometry barostat tube placement|0|||
130243313|NCT01786109|468851486|FG002|Overall Study|fail manometry barostat tube placement|0|||
130243314|NCT01786109|468851484|FG000|Overall Study|unrelated illness|0|||
130243315|NCT01786109|468851485|FG001|Overall Study|unrelated illness|0|||
130243316|NCT01786109|468851486|FG002|Overall Study|unrelated illness|1|||
130243317|NCT01786109|468851484|FG000|Overall Study|adverse effects colon preparation|0|||
130243318|NCT01786109|468851485|FG001|Overall Study|adverse effects colon preparation|0|||
130243319|NCT01786109|468851486|FG002|Overall Study|adverse effects colon preparation|1|||
130243320|NCT00317369|468851487|FG000|Overall Study|Adverse Event|2|||
130243321|NCT00317369|468851488|FG001|Overall Study|Adverse Event|1|||
130243322|NCT00317369|468851489|FG002|Overall Study|Adverse Event|0|||
130243323|NCT00317369|468851487|FG000|Overall Study|Lack of Efficacy|0|||
130243324|NCT00317369|468851488|FG001|Overall Study|Lack of Efficacy|1|||
130243325|NCT00317369|468851489|FG002|Overall Study|Lack of Efficacy|1|||
130243326|NCT00317369|468851487|FG000|Overall Study|Withdrawal by Subject|0|||
130243327|NCT00317369|468851488|FG001|Overall Study|Withdrawal by Subject|0|||
130243328|NCT00317369|468851489|FG002|Overall Study|Withdrawal by Subject|1|||
130243329|NCT00825175|468851492|FG000|Overall Study|Withdrawal by Subject|0|||
130243330|NCT00825175|468851493|FG001|Overall Study|Withdrawal by Subject|5|||
130243331|NCT02762604|468851494|FG000|Overall Study|Lost to Follow-up|2|||
130243332|NCT02762604|468851495|FG001|Overall Study|Lost to Follow-up|7|||
130243333|NCT02762604|468851494|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
130243334|NCT02762604|468851495|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
130243335|NCT02691572|468851501|FG000|Overall Study|Withdrawal by Subject|1|||
130243336|NCT02691572|468851502|FG001|Overall Study|Withdrawal by Subject|0|||
130243337|NCT02691572|468851501|FG000|Overall Study|Protocol Violation|0|||
130243338|NCT02691572|468851502|FG001|Overall Study|Protocol Violation|1|||
130243339|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130243340|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130243341|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Death|28|||
130243342|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Death|29|||
130361613|NCT01346969|469294256|FG000|Overall Study|Randomized but not treated|1|||
130361614|NCT01346969|469294257|FG001|Overall Study|Randomized but not treated|0|||
130361615|NCT01346969|469294258|FG002|Overall Study|Randomized but not treated|0|||
130361616|NCT01346969|469294259|FG003|Overall Study|Randomized but not treated|0|||
130361617|NCT05736224|469294263|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
130361618|NCT02557295|469294264|FG000|Overall Study|Withdrawal by Subject|9|||
130361619|NCT02557295|469294265|FG001|Overall Study|Withdrawal by Subject|2|||
130361620|NCT02557295|469294266|FG002|Overall Study|Withdrawal by Subject|4|||
130361621|NCT02557295|469294267|FG003|Overall Study|Withdrawal by Subject|0|||
130361622|NCT02557295|469294268|FG004|Overall Study|Withdrawal by Subject|0|||
130361623|NCT02557295|469294269|FG005|Overall Study|Withdrawal by Subject|0|||
130361624|NCT02557295|469294270|FG006|Overall Study|Withdrawal by Subject|15|||
130361625|NCT02557295|469294271|FG007|Overall Study|Withdrawal by Subject|1|||
130361626|NCT02557295|469294272|FG008|Overall Study|Withdrawal by Subject|3|||
130361627|NCT02557295|469294264|FG000|Overall Study|Disease Progression|0|||
130361628|NCT02557295|469294265|FG001|Overall Study|Disease Progression|0|||
130361629|NCT02557295|469294266|FG002|Overall Study|Disease Progression|0|||
130361630|NCT02557295|469294267|FG003|Overall Study|Disease Progression|0|||
130361631|NCT02557295|469294268|FG004|Overall Study|Disease Progression|0|||
130361632|NCT02557295|469294269|FG005|Overall Study|Disease Progression|0|||
130361633|NCT02557295|469294270|FG006|Overall Study|Disease Progression|1|||
130361634|NCT02557295|469294271|FG007|Overall Study|Disease Progression|0|||
130361635|NCT02557295|469294272|FG008|Overall Study|Disease Progression|0|||
130361636|NCT02557295|469294264|FG000|Overall Study|Lack of Efficacy|24|||
130361637|NCT02557295|469294265|FG001|Overall Study|Lack of Efficacy|1|||
130361638|NCT02557295|469294266|FG002|Overall Study|Lack of Efficacy|3|||
130361639|NCT02557295|469294267|FG003|Overall Study|Lack of Efficacy|0|||
130361640|NCT02557295|469294268|FG004|Overall Study|Lack of Efficacy|0|||
130361641|NCT02557295|469294269|FG005|Overall Study|Lack of Efficacy|0|||
130361642|NCT02557295|469294270|FG006|Overall Study|Lack of Efficacy|12|||
130361643|NCT02557295|469294271|FG007|Overall Study|Lack of Efficacy|1|||
130243343|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
130243344|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
130243345|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Other|30|||
130243346|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Other|20|||
130243347|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
130243348|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
130243349|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
130243350|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
130243351|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
130243352|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
130243353|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
130243354|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
130243355|NCT03370302|468851507|FG000|Dose Escalation Phase|Other|0|||
130243356|NCT03370302|468851508|FG001|Dose Escalation Phase|Other|1|||
130243357|NCT03370302|468851509|FG002|Dose Escalation Phase|Other|1|||
130243358|NCT03370302|468851510|FG003|Dose Escalation Phase|Other|0|||
130243359|NCT03370302|468851511|FG004|Dose Escalation Phase|Other|0|||
130243360|NCT03370302|468851512|FG005|Dose Escalation Phase|Other|0|||
130243361|NCT03370302|468851507|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130243362|NCT03370302|468851508|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
130243363|NCT03370302|468851509|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
130243364|NCT03370302|468851510|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130243365|NCT03370302|468851511|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130243366|NCT03370302|468851512|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
130243367|NCT03370302|468851507|FG000|Dose Escalation Phase|Adverse Event|1|||
130243368|NCT03370302|468851508|FG001|Dose Escalation Phase|Adverse Event|0|||
130243369|NCT03370302|468851509|FG002|Dose Escalation Phase|Adverse Event|2|||
130243370|NCT03370302|468851510|FG003|Dose Escalation Phase|Adverse Event|0|||
130243371|NCT03370302|468851511|FG004|Dose Escalation Phase|Adverse Event|0|||
130243372|NCT03370302|468851512|FG005|Dose Escalation Phase|Adverse Event|0|||
130243373|NCT03370302|468851507|FG000|Dose Escalation Phase|Progressive Disease|2|||
130243374|NCT03370302|468851508|FG001|Dose Escalation Phase|Progressive Disease|4|||
130243375|NCT03370302|468851509|FG002|Dose Escalation Phase|Progressive Disease|2|||
130243376|NCT03370302|468851510|FG003|Dose Escalation Phase|Progressive Disease|0|||
130243377|NCT03370302|468851511|FG004|Dose Escalation Phase|Progressive Disease|3|||
130243378|NCT03370302|468851512|FG005|Dose Escalation Phase|Progressive Disease|1|||
130243379|NCT03370302|468851507|FG000|Dose Expansion Phase|Progressive Disease|0|||
130243380|NCT03370302|468851508|FG001|Dose Expansion Phase|Progressive Disease|0|||
130243381|NCT03370302|468851509|FG002|Dose Expansion Phase|Progressive Disease|0|||
130243382|NCT03370302|468851510|FG003|Dose Expansion Phase|Progressive Disease|6|||
130243383|NCT03370302|468851511|FG004|Dose Expansion Phase|Progressive Disease|0|||
130243384|NCT03370302|468851512|FG005|Dose Expansion Phase|Progressive Disease|0|||
130243385|NCT01428128|468851513|FG000|Overall Study|Withdrawal by Subject|4|||
130243386|NCT01428128|468851513|FG000|Overall Study|Screen failure by p53|10|||
130243387|NCT01428128|468851513|FG000|Overall Study|Received Neulasta in one cycle|2|||
130243388|NCT01428128|468851513|FG000|Overall Study|Adverse Event|1|||
130243389|NCT00985790|468851516|FG000|Overall Study|Withdrawal by Subject|1|||
130243390|NCT00985790|468851517|FG001|Overall Study|Withdrawal by Subject|1|||
130243391|NCT00985790|468851516|FG000|Overall Study|Lost to Follow-up|6|||
130243392|NCT00985790|468851517|FG001|Overall Study|Lost to Follow-up|7|||
130243393|NCT04124965|468851521|FG000|Overall Study|Adverse event, non-fatal|3|||
130243394|NCT04124965|468851522|FG001|Overall Study|Adverse event, non-fatal|1|||
130243395|NCT04124965|468851521|FG000|Overall Study|Withdrawal by Subject|1|||
130696869|NCT01899053|470514531|FG003|Overall Study|Progressive Disease|0|||
130696870|NCT01899053|470514532|FG004|Overall Study|Progressive Disease|3|||
130696871|NCT01899053|470514533|FG005|Overall Study|Progressive Disease|1|||
130696872|NCT01899053|470514534|FG006|Overall Study|Progressive Disease|1|||
130696873|NCT01899053|470514535|FG007|Overall Study|Progressive Disease|1|||
130696874|NCT01899053|470514536|FG008|Overall Study|Progressive Disease|4|||
130243396|NCT04124965|468851522|FG001|Overall Study|Withdrawal by Subject|1|||
130243397|NCT04124965|468851521|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
130243398|NCT04124965|468851522|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
130243399|NCT04124965|468851521|FG000|Overall Study|Pregnancy|1|||
130449801|NCT00051311|469611047|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
130243400|NCT04124965|468851522|FG001|Overall Study|Pregnancy|0|||
130243401|NCT04124965|468851521|FG000|Overall Study|Sponsor and participant decision|0|||
130243402|NCT04124965|468851522|FG001|Overall Study|Sponsor and participant decision|1|||
130243403|NCT04124965|468851521|FG000|Overall Study|Personal surgery|0|||
130243404|NCT04124965|468851522|FG001|Overall Study|Personal surgery|1|||
130243405|NCT04124965|468851521|FG000|Overall Study|Physician Decision|0|||
130243406|NCT04124965|468851522|FG001|Overall Study|Physician Decision|1|||
130243407|NCT02184156|468851523|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
130696875|NCT01899053|470514537|FG009|Overall Study|Progressive Disease|3|||
130696876|NCT01899053|470514538|FG010|Overall Study|Progressive Disease|12|||
130696877|NCT01899053|470514539|FG011|Overall Study|Progressive Disease|5|||
130696878|NCT01899053|470514540|FG012|Overall Study|Progressive Disease|8|||
130696879|NCT01899053|470514541|FG013|Overall Study|Progressive Disease|17|||
130696880|NCT01899053|470514528|FG000|Overall Study|Adverse Event|1|||
130696881|NCT01899053|470514529|FG001|Overall Study|Adverse Event|1|||
130696882|NCT01899053|470514530|FG002|Overall Study|Adverse Event|1|||
130696883|NCT01899053|470514531|FG003|Overall Study|Adverse Event|3|||
130696884|NCT01899053|470514532|FG004|Overall Study|Adverse Event|1|||
130696885|NCT01899053|470514533|FG005|Overall Study|Adverse Event|1|||
130696886|NCT01899053|470514534|FG006|Overall Study|Adverse Event|1|||
130696887|NCT01899053|470514535|FG007|Overall Study|Adverse Event|0|||
130696888|NCT01899053|470514536|FG008|Overall Study|Adverse Event|2|||
130696889|NCT01899053|470514537|FG009|Overall Study|Adverse Event|0|||
130696890|NCT01899053|470514538|FG010|Overall Study|Adverse Event|3|||
130696891|NCT01899053|470514539|FG011|Overall Study|Adverse Event|1|||
130243408|NCT02184156|468851524|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
130243409|NCT02184156|468851523|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
130243410|NCT02184156|468851524|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
130243411|NCT00002874|468851525|FG000|Overall Study|Withdrawal by Subject|1|||
130243412|NCT00002874|468851526|FG001|Overall Study|Withdrawal by Subject|1|||
130243413|NCT00002874|468851525|FG000|Overall Study|Protocol Violation|44|||
130243414|NCT00002874|468851526|FG001|Overall Study|Protocol Violation|34|||
130243415|NCT01397747|468851529|FG000|Overall Study|Multitarget DNA test excluded|689|||
130243416|NCT01397747|468851529|FG000|Overall Study|Colonoscopy excluded|304|||
130243417|NCT01397747|468851529|FG000|Overall Study|FIT excluded|34|||
130243418|NCT03828383|468851530|FG000|Overall Study|Lost to Follow-up|3|||
130243419|NCT03828383|468851531|FG001|Overall Study|Lost to Follow-up|2|||
130243420|NCT03828383|468851530|FG000|Overall Study|Withdrawal by Subject|4|||
130243421|NCT03828383|468851531|FG001|Overall Study|Withdrawal by Subject|5|||
130243422|NCT00308685|468851533|FG000|Overall Study|Lost to Follow-up|1|||
130243423|NCT00308685|468851534|FG001|Overall Study|Lost to Follow-up|0|||
130243424|NCT00308685|468851533|FG000|Overall Study|Need to administer prohibited medication|1|||
130243425|NCT00308685|468851534|FG001|Overall Study|Need to administer prohibited medication|2|||
130243426|NCT00308685|468851533|FG000|Overall Study|Other than specified|1|||
130243427|NCT00308685|468851534|FG001|Overall Study|Other than specified|3|||
130243428|NCT03158311|468851537|FG000|Overall Study|Subject/Guardian Decision|10|||
130696892|NCT01899053|470514540|FG012|Overall Study|Adverse Event|2|||
130696893|NCT01899053|470514541|FG013|Overall Study|Adverse Event|2|||
130696894|NCT01899053|470514528|FG000|Overall Study|Reason Not Specified|0|||
130696895|NCT01899053|470514529|FG001|Overall Study|Reason Not Specified|0|||
130696896|NCT01899053|470514530|FG002|Overall Study|Reason Not Specified|0|||
130696897|NCT01899053|470514531|FG003|Overall Study|Reason Not Specified|0|||
130243429|NCT03158311|468851538|FG001|Overall Study|Subject/Guardian Decision|6|||
130243430|NCT03158311|468851539|FG002|Overall Study|Subject/Guardian Decision|11|||
130243431|NCT03158311|468851537|FG000|Overall Study|Adverse Event|5|||
130243432|NCT03158311|468851538|FG001|Overall Study|Adverse Event|3|||
130243433|NCT03158311|468851539|FG002|Overall Study|Adverse Event|3|||
130243434|NCT03158311|468851537|FG000|Overall Study|Techinical Problems|3|||
130243435|NCT03158311|468851538|FG001|Overall Study|Techinical Problems|1|||
130243436|NCT03158311|468851539|FG002|Overall Study|Techinical Problems|5|||
130243437|NCT03158311|468851537|FG000|Overall Study|Physician Decision|2|||
130243438|NCT03158311|468851538|FG001|Overall Study|Physician Decision|3|||
130361644|NCT02557295|469294272|FG008|Overall Study|Lack of Efficacy|0|||
130361645|NCT02557295|469294264|FG000|Overall Study|Adverse Event|16|||
130361646|NCT02557295|469294265|FG001|Overall Study|Adverse Event|2|||
130361647|NCT02557295|469294266|FG002|Overall Study|Adverse Event|3|||
130361648|NCT02557295|469294267|FG003|Overall Study|Adverse Event|0|||
130361649|NCT02557295|469294268|FG004|Overall Study|Adverse Event|0|||
130361650|NCT02557295|469294269|FG005|Overall Study|Adverse Event|0|||
130361651|NCT02557295|469294270|FG006|Overall Study|Adverse Event|2|||
130361652|NCT02557295|469294271|FG007|Overall Study|Adverse Event|1|||
130361653|NCT02557295|469294272|FG008|Overall Study|Adverse Event|1|||
130361654|NCT02557295|469294264|FG000|Overall Study|Lost to Follow-up|4|||
130361655|NCT02557295|469294265|FG001|Overall Study|Lost to Follow-up|0|||
130361656|NCT02557295|469294266|FG002|Overall Study|Lost to Follow-up|0|||
130361657|NCT02557295|469294267|FG003|Overall Study|Lost to Follow-up|0|||
130361658|NCT02557295|469294268|FG004|Overall Study|Lost to Follow-up|0|||
130361659|NCT02557295|469294269|FG005|Overall Study|Lost to Follow-up|0|||
130361660|NCT02557295|469294270|FG006|Overall Study|Lost to Follow-up|9|||
130361661|NCT02557295|469294271|FG007|Overall Study|Lost to Follow-up|0|||
130361662|NCT02557295|469294272|FG008|Overall Study|Lost to Follow-up|0|||
130361663|NCT02557295|469294264|FG000|Overall Study|Study Close|54|||
130243439|NCT03158311|468851539|FG002|Overall Study|Physician Decision|7|||
130696898|NCT01899053|470514532|FG004|Overall Study|Reason Not Specified|0|||
130696899|NCT01899053|470514533|FG005|Overall Study|Reason Not Specified|0|||
130696900|NCT01899053|470514534|FG006|Overall Study|Reason Not Specified|1|||
130696901|NCT01899053|470514535|FG007|Overall Study|Reason Not Specified|0|||
130696902|NCT01899053|470514536|FG008|Overall Study|Reason Not Specified|0|||
130696903|NCT01899053|470514537|FG009|Overall Study|Reason Not Specified|0|||
130243440|NCT03158311|468851537|FG000|Overall Study|Lost to Follow-up|1|||
130243441|NCT03158311|468851538|FG001|Overall Study|Lost to Follow-up|1|||
130243442|NCT03158311|468851539|FG002|Overall Study|Lost to Follow-up|1|||
130243443|NCT03158311|468851537|FG000|Overall Study|Sponsor decision|1|||
130243444|NCT03158311|468851538|FG001|Overall Study|Sponsor decision|0|||
130243445|NCT03158311|468851539|FG002|Overall Study|Sponsor decision|0|||
130243446|NCT03158311|468851537|FG000|Overall Study|Pregnancy|0|||
130243447|NCT03158311|468851538|FG001|Overall Study|Pregnancy|2|||
130243448|NCT03158311|468851539|FG002|Overall Study|Pregnancy|0|||
130243449|NCT03158311|468851537|FG000|Overall Study|Randomized in error|0|||
130243450|NCT03158311|468851538|FG001|Overall Study|Randomized in error|0|||
130243451|NCT03158311|468851539|FG002|Overall Study|Randomized in error|1|||
130243452|NCT01018953|468851540|FG000|Overall Study|Adverse Event|2|||
130243453|NCT01018953|468851540|FG000|Overall Study|Withdrawal by Subject|1|||
130243454|NCT01018953|468851540|FG000|Overall Study|Study termination by sponsor|5|||
130243455|NCT02665455|468851541|FG000|Overall Study|Withdrawal by Subject|6|||
130243456|NCT02665455|468851541|FG000|Overall Study|Lost to Follow-up|1|||
130243457|NCT02665455|468851541|FG000|Overall Study|Adverse Event|1|||
130243458|NCT02665455|468851541|FG000|Overall Study|Protocol Violation|1|||
130243459|NCT01928771|468851543|FG000|Overall Study|Adverse Event|6|||
130243460|NCT01928771|468851544|FG001|Overall Study|Adverse Event|5|||
130243461|NCT01928771|468851545|FG002|Overall Study|Adverse Event|1|||
130243462|NCT01928771|468851543|FG000|Overall Study|Death|2|||
130243463|NCT01928771|468851544|FG001|Overall Study|Death|2|||
130243464|NCT01928771|468851545|FG002|Overall Study|Death|2|||
130243465|NCT01928771|468851543|FG000|Overall Study|Lost to Follow-up|5|||
130361664|NCT02557295|469294265|FG001|Overall Study|Study Close|3|||
130361665|NCT02557295|469294266|FG002|Overall Study|Study Close|5|||
130361666|NCT02557295|469294267|FG003|Overall Study|Study Close|3|||
130361667|NCT02557295|469294268|FG004|Overall Study|Study Close|0|||
130361668|NCT02557295|469294269|FG005|Overall Study|Study Close|0|||
130361669|NCT02557295|469294270|FG006|Overall Study|Study Close|37|||
130361670|NCT02557295|469294271|FG007|Overall Study|Study Close|3|||
130361671|NCT02557295|469294272|FG008|Overall Study|Study Close|19|||
130361672|NCT02557295|469294264|FG000|Overall Study|except for study close|4|||
130361673|NCT02557295|469294265|FG001|Overall Study|except for study close|0|||
130361674|NCT02557295|469294266|FG002|Overall Study|except for study close|0|||
130361675|NCT02557295|469294267|FG003|Overall Study|except for study close|0|||
130361676|NCT02557295|469294268|FG004|Overall Study|except for study close|0|||
130361677|NCT02557295|469294269|FG005|Overall Study|except for study close|0|||
130361678|NCT02557295|469294270|FG006|Overall Study|except for study close|5|||
130361679|NCT02557295|469294271|FG007|Overall Study|except for study close|1|||
130361680|NCT02557295|469294272|FG008|Overall Study|except for study close|0|||
130361681|NCT03673046|469296136|FG000|Overall Study|Adverse Event|1|||
130361682|NCT03673046|469296137|FG001|Overall Study|Adverse Event|1|||
130361683|NCT03673046|469296136|FG000|Overall Study|Withdrawal by Subject|8|||
130361684|NCT03673046|469296137|FG001|Overall Study|Withdrawal by Subject|2|||
130361685|NCT03817879|469296138|FG000|Overall Study|Drop out|5|||
130361686|NCT03817879|469296139|FG001|Overall Study|Drop out|12|||
130361687|NCT03817879|469296138|FG000|Overall Study|Withdrawal by Subject|0|||
130361688|NCT03817879|469296139|FG001|Overall Study|Withdrawal by Subject|1|||
130361689|NCT01896050|469296140|FG000|Overall Study|Adverse Event|37|||
130361690|NCT01896050|469296141|FG001|Overall Study|Adverse Event|2|||
130361691|NCT01896050|469296140|FG000|Overall Study|Death|1|||
130361692|NCT01896050|469296141|FG001|Overall Study|Death|0|||
130361693|NCT00392015|469296142|FG000|Overall Study|Lost to Follow-up|2|||
130361694|NCT00392015|469296143|FG001|Overall Study|Lost to Follow-up|0|||
130361695|NCT00392015|469296144|FG002|Overall Study|Lost to Follow-up|2|||
130361696|NCT00392015|469296145|FG003|Overall Study|Lost to Follow-up|1|||
130361697|NCT00392015|469296146|FG004|Overall Study|Lost to Follow-up|1|||
130361698|NCT00392015|469296147|FG005|Overall Study|Lost to Follow-up|0|||
130361699|NCT00392015|469296142|FG000|Overall Study|Withdrawal by Subject|0|||
130361700|NCT00392015|469296143|FG001|Overall Study|Withdrawal by Subject|0|||
130361701|NCT00392015|469296144|FG002|Overall Study|Withdrawal by Subject|2|||
130361702|NCT00392015|469296145|FG003|Overall Study|Withdrawal by Subject|0|||
130361703|NCT00392015|469296146|FG004|Overall Study|Withdrawal by Subject|0|||
130361704|NCT00392015|469296147|FG005|Overall Study|Withdrawal by Subject|0|||
130361705|NCT00392015|469296142|FG000|Overall Study|Adverse Event|0|||
130361706|NCT00392015|469296143|FG001|Overall Study|Adverse Event|0|||
130361707|NCT00392015|469296144|FG002|Overall Study|Adverse Event|0|||
130361708|NCT00392015|469296145|FG003|Overall Study|Adverse Event|0|||
130361709|NCT00392015|469296146|FG004|Overall Study|Adverse Event|1|||
130361710|NCT00392015|469296147|FG005|Overall Study|Adverse Event|0|||
130361711|NCT00392015|469296142|FG000|Overall Study|Previous trial recipient|0|||
130361712|NCT00392015|469296143|FG001|Overall Study|Previous trial recipient|0|||
130361713|NCT00392015|469296144|FG002|Overall Study|Previous trial recipient|0|||
130243466|NCT01928771|468851544|FG001|Overall Study|Lost to Follow-up|6|||
130243467|NCT01928771|468851545|FG002|Overall Study|Lost to Follow-up|3|||
130361714|NCT00392015|469296145|FG003|Overall Study|Previous trial recipient|0|||
130361715|NCT00392015|469296146|FG004|Overall Study|Previous trial recipient|1|||
130243468|NCT01928771|468851543|FG000|Overall Study|Withdrawal by Subject|20|||
130243469|NCT01928771|468851544|FG001|Overall Study|Withdrawal by Subject|15|||
130243470|NCT01928771|468851545|FG002|Overall Study|Withdrawal by Subject|17|||
130243471|NCT01928771|468851543|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
130243472|NCT01928771|468851544|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130243473|NCT01928771|468851545|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130243474|NCT01928771|468851543|FG000|Overall Study|Other Reasons|9|||
130243475|NCT01928771|468851544|FG001|Overall Study|Other Reasons|9|||
130243476|NCT01928771|468851545|FG002|Overall Study|Other Reasons|14|||
130243477|NCT01928771|468851543|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130243478|NCT01928771|468851544|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130243479|NCT01928771|468851545|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
130243480|NCT03921541|468853290|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
130449802|NCT00051311|469611048|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
130449803|NCT00051311|469611047|FG000|Overall Study|Death of recipient|8|||
130449804|NCT00051311|469611048|FG001|Overall Study|Death of recipient|8|||
130449805|NCT00051311|469611047|FG000|Overall Study|Recipient taken off study|4|||
130449806|NCT00051311|469611048|FG001|Overall Study|Recipient taken off study|4|||
130449807|NCT02256969|469611055|FG000|Overall Study|Screenfailed or withdrew|2|||
130449808|NCT02256969|469611056|FG001|Overall Study|Screenfailed or withdrew|1|||
130449809|NCT02256969|469611057|FG002|Overall Study|Screenfailed or withdrew|1|||
130449810|NCT00372567|469611060|FG000|Phase 3 Study|Adverse Event|5|||
130449811|NCT00372567|469611061|FG001|Phase 3 Study|Adverse Event|1|||
130449812|NCT00372567|469611062|FG002|Phase 3 Study|Adverse Event|1|||
130449813|NCT00372567|469611060|FG000|Phase 3 Study|Death|1|||
130449814|NCT00372567|469611061|FG001|Phase 3 Study|Death|1|||
130449815|NCT00372567|469611062|FG002|Phase 3 Study|Death|0|||
130449816|NCT00372567|469611060|FG000|Phase 3 Study|Protocol Violation|0|||
130449817|NCT00372567|469611061|FG001|Phase 3 Study|Protocol Violation|0|||
130449818|NCT00372567|469611062|FG002|Phase 3 Study|Protocol Violation|1|||
130449819|NCT00372567|469611060|FG000|Phase 3 Study|Objective progression or relapse|10|||
130449820|NCT00372567|469611061|FG001|Phase 3 Study|Objective progression or relapse|13|||
130449821|NCT00372567|469611062|FG002|Phase 3 Study|Objective progression or relapse|4|||
130449822|NCT00372567|469611060|FG000|Phase 3 Study|Global deterioration of health status|0|||
130449823|NCT00372567|469611061|FG001|Phase 3 Study|Global deterioration of health status|1|||
130449824|NCT00372567|469611062|FG002|Phase 3 Study|Global deterioration of health status|0|||
130449825|NCT00372567|469611060|FG000|Phase 3 Study|Other|2|||
130449826|NCT00372567|469611061|FG001|Phase 3 Study|Other|2|||
130449827|NCT00372567|469611062|FG002|Phase 3 Study|Other|1|||
130449828|NCT00372567|469611060|FG000|Phase 3 Study|study terminated by sponsor|13|||
130449829|NCT00372567|469611061|FG001|Phase 3 Study|study terminated by sponsor|8|||
130449830|NCT00372567|469611062|FG002|Phase 3 Study|study terminated by sponsor|5|||
130449831|NCT02347943|469611064|FG000|Overall Study|Study was cancelled|140|||
130449832|NCT02347943|469611065|FG001|Overall Study|Study was cancelled|67|||
130449833|NCT02347943|469611066|FG002|Overall Study|Study was cancelled|45|||
130449834|NCT00303303|469611067|FG000|Overall Study|Withdrawal by Subject|0|||
130449835|NCT00303303|469611068|FG001|Overall Study|Withdrawal by Subject|0|||
130449836|NCT00303303|469611069|FG002|Overall Study|Withdrawal by Subject|1|||
130449837|NCT03566680|469611073|FG000|Overall Study|Pregnancy|1|||
130449838|NCT03566680|469611073|FG000|Overall Study|Lost to Follow-up|13|||
130449839|NCT03566680|469611073|FG000|Overall Study|Withdrawal by Subject|3|||
130449840|NCT00582790|469611076|FG000|Overall Study|Rapid progression of disease|1|||
130449841|NCT00480441|469611077|FG000|Screening|Not Eligible|37|||
130449842|NCT00480441|469611078|FG001|Screening|Not Eligible|0|||
130449843|NCT00480441|469611079|FG002|Screening|Not Eligible|0|||
130449844|NCT00480441|469611077|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
130449845|NCT00480441|469611078|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
130449846|NCT00480441|469611079|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
130449847|NCT00480441|469611077|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
130449848|NCT00480441|469611078|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
130449849|NCT00480441|469611079|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
130449850|NCT00480441|469611077|FG000|Baseline Functional MRI|physical contraindication|4|||
130243481|NCT03921541|468853291|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130243482|NCT02642679|468853292|FG000|Overall Study|Withdrawal by Subject|1|||
130361716|NCT00392015|469296147|FG005|Overall Study|Previous trial recipient|0|||
130361717|NCT02925923|469296151|FG000|Overall Study|blood samples hemolyzed|0|||
130361718|NCT02925923|469296152|FG001|Overall Study|blood samples hemolyzed|2|||
130361719|NCT00866788|469296153|FG000|Overall Study|Adverse Event|0|||
130361720|NCT00866788|469296154|FG001|Overall Study|Adverse Event|2|||
130361721|NCT00866788|469296155|FG002|Overall Study|Adverse Event|0|||
130361722|NCT00866788|469296156|FG003|Overall Study|Adverse Event|1|||
130361723|NCT00866788|469296153|FG000|Overall Study|Lost to Follow-up|1|||
130361724|NCT00866788|469296154|FG001|Overall Study|Lost to Follow-up|1|||
130361725|NCT00866788|469296155|FG002|Overall Study|Lost to Follow-up|0|||
130361726|NCT00866788|469296156|FG003|Overall Study|Lost to Follow-up|2|||
130361727|NCT00866788|469296153|FG000|Overall Study|Withdrawal by Subject|2|||
130361728|NCT00866788|469296154|FG001|Overall Study|Withdrawal by Subject|1|||
130361729|NCT00866788|469296155|FG002|Overall Study|Withdrawal by Subject|0|||
130361730|NCT00866788|469296156|FG003|Overall Study|Withdrawal by Subject|1|||
130361731|NCT00866788|469296153|FG000|Overall Study|Pregnancy|0|||
130361732|NCT00866788|469296154|FG001|Overall Study|Pregnancy|1|||
130361733|NCT00866788|469296155|FG002|Overall Study|Pregnancy|0|||
130361734|NCT00866788|469296156|FG003|Overall Study|Pregnancy|0|||
130361735|NCT00866788|469296153|FG000|Overall Study|Disease progression|3|||
130361736|NCT00866788|469296154|FG001|Overall Study|Disease progression|1|||
130361737|NCT00866788|469296155|FG002|Overall Study|Disease progression|1|||
130361738|NCT00866788|469296156|FG003|Overall Study|Disease progression|0|||
130361739|NCT00866788|469296153|FG000|Overall Study|Physician Decision|0|||
130361740|NCT00866788|469296154|FG001|Overall Study|Physician Decision|0|||
130361741|NCT00866788|469296155|FG002|Overall Study|Physician Decision|1|||
130361742|NCT00866788|469296156|FG003|Overall Study|Physician Decision|1|||
130361743|NCT02742441|469296157|FG000|Overall Study|Lost to Follow-up|4|||
130361744|NCT02742441|469296158|FG001|Overall Study|Lost to Follow-up|4|||
130361745|NCT02742441|469296157|FG000|Overall Study|Withdrawal by Subject|2|||
130361746|NCT02742441|469296158|FG001|Overall Study|Withdrawal by Subject|2|||
130361747|NCT02742441|469296157|FG000|Overall Study|Adverse Event|0|||
130361748|NCT02742441|469296158|FG001|Overall Study|Adverse Event|2|||
130361749|NCT02202837|469296159|FG000|Overall Study|Enbrel treatment discontinued|36|||
130361750|NCT02202837|469296160|FG001|Overall Study|Enbrel treatment discontinued|4|||
130361751|NCT02202837|469296159|FG000|Overall Study|Other|10|||
130361752|NCT02202837|469296160|FG001|Overall Study|Other|0|||
130361753|NCT02202837|469296159|FG000|Overall Study|Lost to Follow-up|7|||
130361754|NCT02202837|469296160|FG001|Overall Study|Lost to Follow-up|1|||
130361755|NCT02281773|469296161|FG000|Overall Study|Adverse Event|6|||
130361756|NCT02281773|469296162|FG001|Overall Study|Adverse Event|1|||
130361757|NCT02281773|469296163|FG002|Overall Study|Adverse Event|4|||
130361758|NCT02281773|469296164|FG003|Overall Study|Adverse Event|8|||
130361759|NCT02281773|469296165|FG004|Overall Study|Adverse Event|9|||
130361760|NCT02281773|469296161|FG000|Overall Study|Protocol Violation|1|||
130361761|NCT02281773|469296162|FG001|Overall Study|Protocol Violation|0|||
130361762|NCT02281773|469296163|FG002|Overall Study|Protocol Violation|0|||
130361763|NCT02281773|469296164|FG003|Overall Study|Protocol Violation|2|||
130361764|NCT02281773|469296165|FG004|Overall Study|Protocol Violation|2|||
130361765|NCT02281773|469296161|FG000|Overall Study|Lost to Follow-up|2|||
130361766|NCT02281773|469296162|FG001|Overall Study|Lost to Follow-up|2|||
130361767|NCT02281773|469296163|FG002|Overall Study|Lost to Follow-up|6|||
130361768|NCT02281773|469296164|FG003|Overall Study|Lost to Follow-up|2|||
130361769|NCT02281773|469296165|FG004|Overall Study|Lost to Follow-up|10|||
130361770|NCT02281773|469296161|FG000|Overall Study|Withdrawal by Subject|2|||
130361771|NCT02281773|469296162|FG001|Overall Study|Withdrawal by Subject|8|||
130361772|NCT02281773|469296163|FG002|Overall Study|Withdrawal by Subject|6|||
130361773|NCT02281773|469296164|FG003|Overall Study|Withdrawal by Subject|6|||
130361774|NCT02281773|469296165|FG004|Overall Study|Withdrawal by Subject|8|||
130361775|NCT02281773|469296161|FG000|Overall Study|Other Reason|0|||
130361776|NCT02281773|469296162|FG001|Overall Study|Other Reason|4|||
130361777|NCT02281773|469296163|FG002|Overall Study|Other Reason|2|||
130361778|NCT02281773|469296164|FG003|Overall Study|Other Reason|3|||
130361779|NCT02281773|469296165|FG004|Overall Study|Other Reason|1|||
130361780|NCT02104752|469296166|FG000|Overall Study|Withdrawal by Subject|1|||
130449851|NCT00480441|469611078|FG001|Baseline Functional MRI|physical contraindication|0|||
130449852|NCT00480441|469611079|FG002|Baseline Functional MRI|physical contraindication|0|||
130449853|NCT00480441|469611077|FG000|Randomization|Lost to Follow-up|0|||
130449854|NCT00480441|469611078|FG001|Randomization|Lost to Follow-up|7|||
130449855|NCT00480441|469611079|FG002|Randomization|Lost to Follow-up|2|||
130449856|NCT02374957|469611080|FG000|Overall Study|Patient did not complete forms correctly|1|||
130449857|NCT02374957|469611081|FG001|Overall Study|Patient did not complete forms correctly|0|||
130449858|NCT01687270|469611082|FG000|Overall Study|Lack of Efficacy|11|||
130449859|NCT01687270|469611082|FG000|Overall Study|Lost to Follow-up|1|||
130449860|NCT05349084|469611083|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
130449861|NCT01004263|469611095|FG000|Overall Study|Adverse Event|15|||
130449862|NCT01004263|469611095|FG000|Overall Study|Withdrawal by Subject|58|||
130449863|NCT01004263|469611095|FG000|Overall Study|Protocol Violation|10|||
130449864|NCT01004263|469611095|FG000|Overall Study|Lost to Follow-up|64|||
130449865|NCT01004263|469611095|FG000|Overall Study|Lack of Efficacy|13|||
130449866|NCT01004263|469611095|FG000|Overall Study|Pregnancy|2|||
130449867|NCT01004263|469611095|FG000|Overall Study|Physician Decision|15|||
130449868|NCT01004263|469611095|FG000|Overall Study|Lack of Qualifying Event|2|||
130449869|NCT00958009|469611097|FG000|Overall Study|Adverse Event|1|||
130449870|NCT00958009|469611097|FG000|Overall Study|Subject found device difficult to use|1|||
130449871|NCT00558753|469611098|FG000|Overall Study|Lost to Follow-up|5|||
130449872|NCT00558753|469611099|FG001|Overall Study|Lost to Follow-up|7|||
130449873|NCT01605136|469611100|FG000|Study Period|Withdrawal by Subject|2|||
130449874|NCT01605136|469611101|FG001|Study Period|Withdrawal by Subject|0|||
130449875|NCT01605136|469611100|FG000|Study Period|Physician Decision|1|||
130449876|NCT01605136|469611101|FG001|Study Period|Physician Decision|1|||
130449877|NCT01605136|469611100|FG000|Study Period|Lost to Follow-up|0|||
130449878|NCT01605136|469611101|FG001|Study Period|Lost to Follow-up|2|||
130449879|NCT01605136|469611100|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
130449880|NCT01605136|469611101|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
130449881|NCT01072929|469611102|FG000|Overall Study|Adverse Event|8|||
130449882|NCT01072929|469611103|FG001|Overall Study|Adverse Event|11|||
130449883|NCT01072929|469611104|FG002|Overall Study|Adverse Event|2|||
130449884|NCT01072929|469611102|FG000|Overall Study|Lack of Efficacy|7|||
130243483|NCT02642679|468853292|FG000|Overall Study|Physician Decision|1|||
130243484|NCT02642679|468853292|FG000|Overall Study|Physician Decision|1|||
130243485|NCT01653262|468853293|FG000|Overall Study|Lack of Efficacy|1|||
130361781|NCT02104752|469296167|FG001|Overall Study|Withdrawal by Subject|0|||
130361782|NCT02104752|469296166|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
130361783|NCT02104752|469296167|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
130361784|NCT05439941|469296168|FG000|Overall Study|Lack of Efficacy|8|||
130361785|NCT05439941|469296169|FG001|Overall Study|Lack of Efficacy|5|||
130361786|NCT05439941|469296170|FG002|Overall Study|Lack of Efficacy|3|||
130361787|NCT05439941|469296168|FG000|Overall Study|Treatment Failure|0|||
130361788|NCT05439941|469296169|FG001|Overall Study|Treatment Failure|1|||
130361789|NCT05439941|469296170|FG002|Overall Study|Treatment Failure|0|||
130361790|NCT05439941|469296168|FG000|Overall Study|Adverse Event|1|||
130361791|NCT05439941|469296169|FG001|Overall Study|Adverse Event|3|||
130361792|NCT05439941|469296170|FG002|Overall Study|Adverse Event|0|||
130361793|NCT05439941|469296168|FG000|Overall Study|Adverse Event - Parent Study|1|||
130361794|NCT05439941|469296169|FG001|Overall Study|Adverse Event - Parent Study|0|||
130361795|NCT05439941|469296170|FG002|Overall Study|Adverse Event - Parent Study|0|||
130361796|NCT05439941|469296168|FG000|Overall Study|Pregnancy|1|||
130361797|NCT05439941|469296169|FG001|Overall Study|Pregnancy|0|||
130361798|NCT05439941|469296170|FG002|Overall Study|Pregnancy|0|||
130361799|NCT05439941|469296168|FG000|Overall Study|Withdrawal by Subject|9|||
130361800|NCT05439941|469296169|FG001|Overall Study|Withdrawal by Subject|6|||
130361801|NCT05439941|469296170|FG002|Overall Study|Withdrawal by Subject|10|||
130361802|NCT05439941|469296168|FG000|Overall Study|Non-Compliance|1|||
130361803|NCT05439941|469296169|FG001|Overall Study|Non-Compliance|1|||
130361804|NCT05439941|469296170|FG002|Overall Study|Non-Compliance|1|||
130361805|NCT05439941|469296168|FG000|Overall Study|Lost to Follow-up|2|||
130361806|NCT05439941|469296169|FG001|Overall Study|Lost to Follow-up|2|||
130361807|NCT05439941|469296170|FG002|Overall Study|Lost to Follow-up|0|||
130361808|NCT05439941|469296168|FG000|Overall Study|Physician Decision|1|||
130361809|NCT05439941|469296169|FG001|Overall Study|Physician Decision|0|||
130361810|NCT05439941|469296170|FG002|Overall Study|Physician Decision|0|||
130361811|NCT05439941|469296168|FG000|Overall Study|Trial Termination by Sponsor|78|||
130361812|NCT05439941|469296169|FG001|Overall Study|Trial Termination by Sponsor|83|||
130361813|NCT05439941|469296170|FG002|Overall Study|Trial Termination by Sponsor|65|||
130361814|NCT05439941|469296168|FG000|Overall Study|Other than Reasons Listed|2|||
130361815|NCT05439941|469296169|FG001|Overall Study|Other than Reasons Listed|1|||
130361816|NCT05439941|469296170|FG002|Overall Study|Other than Reasons Listed|0|||
130361817|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
130449885|NCT01072929|469611103|FG001|Overall Study|Lack of Efficacy|4|||
130361818|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
130361819|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
130361820|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
130361821|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
130361822|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
130361823|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
130361824|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
130361825|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
130361826|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
130361827|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
130361828|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
130361829|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
130361830|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
130361831|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
130361832|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
130361833|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
130361834|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
130361835|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
130361836|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
130361837|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
130361838|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
130361839|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
130361840|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
130361841|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
130361842|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
130361843|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
130361844|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
130361845|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
130361846|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
130361847|NCT00313300|469296171|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
130361848|NCT00313300|469296172|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130361849|NCT00313300|469296173|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130243486|NCT01653262|468853293|FG000|Overall Study|SAE, non-fatal|1|||
130449886|NCT01072929|469611104|FG002|Overall Study|Lack of Efficacy|0|||
130449887|NCT01072929|469611102|FG000|Overall Study|Withdrawal by Subject|7|||
130449888|NCT01072929|469611103|FG001|Overall Study|Withdrawal by Subject|15|||
130449889|NCT01072929|469611104|FG002|Overall Study|Withdrawal by Subject|3|||
130449890|NCT01072929|469611102|FG000|Overall Study|Protocol Violation|13|||
130449891|NCT01072929|469611103|FG001|Overall Study|Protocol Violation|11|||
130449892|NCT01072929|469611104|FG002|Overall Study|Protocol Violation|2|||
130449893|NCT01072929|469611102|FG000|Overall Study|Lost to Follow-up|8|||
130449894|NCT01072929|469611103|FG001|Overall Study|Lost to Follow-up|4|||
130449895|NCT01072929|469611104|FG002|Overall Study|Lost to Follow-up|1|||
130449896|NCT01072929|469611102|FG000|Overall Study|Noncompliance with study medication|0|||
130449897|NCT01072929|469611103|FG001|Overall Study|Noncompliance with study medication|3|||
130449898|NCT01072929|469611104|FG002|Overall Study|Noncompliance with study medication|0|||
130449899|NCT01072929|469611102|FG000|Overall Study|Noncompliance with study procedures|1|||
130449900|NCT01072929|469611103|FG001|Overall Study|Noncompliance with study procedures|0|||
130449901|NCT01072929|469611104|FG002|Overall Study|Noncompliance with study procedures|1|||
130449902|NCT01072929|469611102|FG000|Overall Study|Other|0|||
130449903|NCT01072929|469611103|FG001|Overall Study|Other|3|||
130449904|NCT01072929|469611104|FG002|Overall Study|Other|0|||
130449905|NCT04824131|469611105|FG000|CAB LA Oral Phase|Adverse Event|1|||
130449906|NCT04824131|469611105|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
130449907|NCT04824131|469611105|FG000|Step 3|Withdrawal by Subject|2|||
130449908|NCT04887285|469611106|FG000|Overall Study|Lost to Follow-up|0|||
130449909|NCT04887285|469611107|FG001|Overall Study|Lost to Follow-up|2|||
130449910|NCT04887285|469611108|FG002|Overall Study|Lost to Follow-up|3|||
130449911|NCT04640571|469611109|FG000|Overall Study|Withdrawal by Subject|0|||
130449912|NCT04640571|469611110|FG001|Overall Study|Withdrawal by Subject|0|||
130449913|NCT04640571|469611111|FG002|Overall Study|Withdrawal by Subject|0|||
130449914|NCT04640571|469611112|FG003|Overall Study|Withdrawal by Subject|0|||
130449915|NCT04640571|469611113|FG004|Overall Study|Withdrawal by Subject|0|||
130449916|NCT04640571|469611114|FG005|Overall Study|Withdrawal by Subject|2|||
130449917|NCT01723774|469611120|FG000|Neoadjuvant|Ki67 > 10%|4|||
130449918|NCT01723774|469611121|FG001|Neoadjuvant|Ki67 > 10%|0|||
130449919|NCT01723774|469611122|FG002|Neoadjuvant|Ki67 > 10%|10|||
130449920|NCT01723774|469611123|FG003|Neoadjuvant|Ki67 > 10%|0|||
130449921|NCT01723774|469611120|FG000|Neoadjuvant|Withdrawal by Subject|3|||
130449922|NCT01723774|469611121|FG001|Neoadjuvant|Withdrawal by Subject|1|||
130449923|NCT01723774|469611122|FG002|Neoadjuvant|Withdrawal by Subject|0|||
130449924|NCT01723774|469611123|FG003|Neoadjuvant|Withdrawal by Subject|0|||
130449925|NCT01723774|469611120|FG000|Neoadjuvant|Disease progression|0|||
130449926|NCT01723774|469611121|FG001|Neoadjuvant|Disease progression|1|||
130449927|NCT01723774|469611122|FG002|Neoadjuvant|Disease progression|1|||
130449928|NCT01723774|469611123|FG003|Neoadjuvant|Disease progression|0|||
130449929|NCT01723774|469611120|FG000|Neoadjuvant|Adverse Event|0|||
130449930|NCT01723774|469611121|FG001|Neoadjuvant|Adverse Event|1|||
130449931|NCT01723774|469611122|FG002|Neoadjuvant|Adverse Event|2|||
130449932|NCT01723774|469611123|FG003|Neoadjuvant|Adverse Event|0|||
130449933|NCT01723774|469611120|FG000|Neoadjuvant|High estradiol|0|||
130449934|NCT01723774|469611121|FG001|Neoadjuvant|High estradiol|1|||
130449935|NCT01723774|469611122|FG002|Neoadjuvant|High estradiol|0|||
130449936|NCT01723774|469611123|FG003|Neoadjuvant|High estradiol|0|||
130449937|NCT04319094|469611127|FG000|Baseline|Lost to Follow-up|4|||
130449938|NCT04319094|469611128|FG001|Baseline|Lost to Follow-up|5|||
130449939|NCT04319094|469611127|FG000|Baseline|Protocol Violation|0|||
130449940|NCT04319094|469611128|FG001|Baseline|Protocol Violation|3|||
130449941|NCT04319094|469611127|FG000|Baseline|Withdrawal by Subject|2|||
130449942|NCT04319094|469611128|FG001|Baseline|Withdrawal by Subject|1|||
130449943|NCT04319094|469611127|FG000|Post-Intervention|Death|0|||
130449944|NCT04319094|469611128|FG001|Post-Intervention|Death|1|||
130449945|NCT04319094|469611127|FG000|Post-Intervention|Lost to Follow-up|4|||
130449946|NCT04319094|469611128|FG001|Post-Intervention|Lost to Follow-up|4|||
130449947|NCT04319094|469611127|FG000|Post-Intervention|Withdrawal by Subject|8|||
130449948|NCT04319094|469611128|FG001|Post-Intervention|Withdrawal by Subject|5|||
130449949|NCT04319094|469611127|FG000|Post-Intervention|Incomplete Data Collection|1|||
130449950|NCT04319094|469611128|FG001|Post-Intervention|Incomplete Data Collection|3|||
130449951|NCT04319094|469611127|FG000|3-month|Death|1|||
130449952|NCT04319094|469611128|FG001|3-month|Death|0|||
130449953|NCT04319094|469611127|FG000|3-month|Lost to Follow-up|2|||
130449954|NCT04319094|469611128|FG001|3-month|Lost to Follow-up|2|||
130449955|NCT04319094|469611127|FG000|3-month|Withdrawal by Subject|0|||
130449956|NCT04319094|469611128|FG001|3-month|Withdrawal by Subject|3|||
130449957|NCT04319094|469611127|FG000|3-month|Incomplete data collection|9|||
130449958|NCT04319094|469611128|FG001|3-month|Incomplete data collection|7|||
130449959|NCT04319094|469611127|FG000|6-month|Lost to Follow-up|1|||
130449960|NCT04319094|469611128|FG001|6-month|Lost to Follow-up|1|||
130449961|NCT04319094|469611127|FG000|6-month|Withdrawal by Subject|0|||
130449962|NCT04319094|469611128|FG001|6-month|Withdrawal by Subject|3|||
130449963|NCT04319094|469611127|FG000|6-month|Incomplete data collection|14|||
130449964|NCT04319094|469611128|FG001|6-month|Incomplete data collection|9|||
130449965|NCT04319094|469611127|FG000|9-month|Lost to Follow-up|8|||
130696904|NCT01899053|470514538|FG010|Overall Study|Reason Not Specified|0|||
130696905|NCT01899053|470514539|FG011|Overall Study|Reason Not Specified|0|||
130696906|NCT01899053|470514540|FG012|Overall Study|Reason Not Specified|1|||
130696907|NCT01899053|470514541|FG013|Overall Study|Reason Not Specified|0|||
130696908|NCT01899053|470514528|FG000|Overall Study|Withdrawal by Subject|1|||
130696909|NCT01899053|470514529|FG001|Overall Study|Withdrawal by Subject|1|||
130696910|NCT01899053|470514530|FG002|Overall Study|Withdrawal by Subject|2|||
130696911|NCT01899053|470514531|FG003|Overall Study|Withdrawal by Subject|0|||
130696912|NCT01899053|470514532|FG004|Overall Study|Withdrawal by Subject|2|||
130696913|NCT01899053|470514533|FG005|Overall Study|Withdrawal by Subject|0|||
130696914|NCT01899053|470514534|FG006|Overall Study|Withdrawal by Subject|0|||
130696915|NCT01899053|470514535|FG007|Overall Study|Withdrawal by Subject|1|||
130696916|NCT01899053|470514536|FG008|Overall Study|Withdrawal by Subject|0|||
130696917|NCT01899053|470514537|FG009|Overall Study|Withdrawal by Subject|0|||
130696918|NCT01899053|470514538|FG010|Overall Study|Withdrawal by Subject|0|||
130696919|NCT01899053|470514539|FG011|Overall Study|Withdrawal by Subject|0|||
130696920|NCT01899053|470514540|FG012|Overall Study|Withdrawal by Subject|1|||
130696921|NCT01899053|470514541|FG013|Overall Study|Withdrawal by Subject|1|||
130696922|NCT01899053|470514528|FG000|Overall Study|Protocol Violation|0|||
130696923|NCT01899053|470514529|FG001|Overall Study|Protocol Violation|0|||
130696924|NCT01899053|470514530|FG002|Overall Study|Protocol Violation|1|||
130696925|NCT01899053|470514531|FG003|Overall Study|Protocol Violation|0|||
130696926|NCT01899053|470514532|FG004|Overall Study|Protocol Violation|0|||
130696927|NCT01899053|470514533|FG005|Overall Study|Protocol Violation|0|||
130696928|NCT01899053|470514534|FG006|Overall Study|Protocol Violation|0|||
130696929|NCT01899053|470514535|FG007|Overall Study|Protocol Violation|0|||
130696930|NCT01899053|470514536|FG008|Overall Study|Protocol Violation|0|||
130696931|NCT01899053|470514537|FG009|Overall Study|Protocol Violation|0|||
130696932|NCT01899053|470514538|FG010|Overall Study|Protocol Violation|0|||
130696933|NCT01899053|470514539|FG011|Overall Study|Protocol Violation|0|||
130696934|NCT01899053|470514540|FG012|Overall Study|Protocol Violation|0|||
130696935|NCT01899053|470514541|FG013|Overall Study|Protocol Violation|0|||
130696936|NCT01899053|470514528|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130696937|NCT01899053|470514529|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
130696938|NCT01899053|470514530|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696939|NCT01899053|470514531|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696940|NCT01899053|470514532|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696941|NCT01899053|470514533|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696942|NCT01899053|470514534|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696943|NCT01899053|470514535|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696944|NCT01899053|470514536|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696945|NCT01899053|470514537|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696946|NCT01899053|470514538|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
130361850|NCT00313300|469296174|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130361851|NCT00313300|469296175|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130361852|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
130361853|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
130361854|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
130361855|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
130361856|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
130361857|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
130361858|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
130361859|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
130361860|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
130361861|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
130361862|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
130361863|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
130361864|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
130361865|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
130361866|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
130361867|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
130361868|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
130361869|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
130361870|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
130696947|NCT01899053|470514539|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696948|NCT01899053|470514540|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696949|NCT01899053|470514541|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696950|NCT01899053|470514528|FG000|Overall Study|Symptomatic Deterioration|0|||
130696951|NCT01899053|470514529|FG001|Overall Study|Symptomatic Deterioration|0|||
130696952|NCT01899053|470514530|FG002|Overall Study|Symptomatic Deterioration|0|||
130696953|NCT01899053|470514531|FG003|Overall Study|Symptomatic Deterioration|0|||
130696954|NCT01899053|470514532|FG004|Overall Study|Symptomatic Deterioration|0|||
130552984|NCT00504881|469991638|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
130696955|NCT01899053|470514533|FG005|Overall Study|Symptomatic Deterioration|1|||
130696956|NCT01899053|470514534|FG006|Overall Study|Symptomatic Deterioration|0|||
130696957|NCT01899053|470514535|FG007|Overall Study|Symptomatic Deterioration|1|||
130696958|NCT01899053|470514536|FG008|Overall Study|Symptomatic Deterioration|0|||
130696959|NCT01899053|470514537|FG009|Overall Study|Symptomatic Deterioration|0|||
130696960|NCT01899053|470514538|FG010|Overall Study|Symptomatic Deterioration|0|||
130361871|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
130361872|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
130361873|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
130361874|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
130361875|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
130361876|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
130361877|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
130361878|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
130361879|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
130361880|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
130361881|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
130361882|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
130361883|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
130361884|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
130361885|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
130361886|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
130361887|NCT00313300|469296171|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
130361888|NCT00313300|469296172|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
130361889|NCT00313300|469296173|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
130361890|NCT00313300|469296174|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
130361891|NCT00313300|469296175|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
130361892|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
130361893|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
130361894|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
130361895|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
130361896|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
130361897|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
130361898|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
130361899|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
130361900|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
130361901|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
130361902|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130361903|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
130361904|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
130361905|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130361906|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130361907|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
130361908|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
130361909|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
130361910|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
130361911|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
130361912|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130361913|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130361914|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130361915|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
130361916|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
130361917|NCT00313300|469296171|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
130361918|NCT00313300|469296172|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130361919|NCT00313300|469296173|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130361920|NCT00313300|469296174|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
130361921|NCT00313300|469296175|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130361922|NCT02336373|469296176|FG000|Overall Study|Protocol closed early|4|||
130361923|NCT02336373|469296176|FG000|Overall Study|Physician Decision|14|||
130361924|NCT00850343|469296177|FG000|Overall Study|Withdrawal by Subject|11|||
130361925|NCT00850343|469296178|FG001|Overall Study|Withdrawal by Subject|0|||
130361926|NCT00850343|469296179|FG002|Overall Study|Withdrawal by Subject|3|||
130361927|NCT00850343|469296180|FG003|Overall Study|Withdrawal by Subject|2|||
130361928|NCT00850343|469296177|FG000|Overall Study|Adverse Event|15|||
130552985|NCT00504881|469991637|FG000|Overall Study|AE of unknown type|1|||
130696961|NCT01899053|470514539|FG011|Overall Study|Symptomatic Deterioration|1|||
130361929|NCT00850343|469296178|FG001|Overall Study|Adverse Event|2|||
130361930|NCT00850343|469296179|FG002|Overall Study|Adverse Event|6|||
130361931|NCT00850343|469296180|FG003|Overall Study|Adverse Event|6|||
130361932|NCT00850343|469296177|FG000|Overall Study|Pregnancy|0|||
130361933|NCT00850343|469296178|FG001|Overall Study|Pregnancy|0|||
130361934|NCT00850343|469296179|FG002|Overall Study|Pregnancy|0|||
130361935|NCT00850343|469296180|FG003|Overall Study|Pregnancy|1|||
130361936|NCT00850343|469296177|FG000|Overall Study|Lack of Efficacy|17|||
130361937|NCT00850343|469296178|FG001|Overall Study|Lack of Efficacy|0|||
130361938|NCT00850343|469296179|FG002|Overall Study|Lack of Efficacy|3|||
130361939|NCT00850343|469296180|FG003|Overall Study|Lack of Efficacy|2|||
130361940|NCT00850343|469296177|FG000|Overall Study|Non-compliance with Study Procedures|1|||
130361941|NCT00850343|469296178|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130361942|NCT00850343|469296179|FG002|Overall Study|Non-compliance with Study Procedures|1|||
130361943|NCT00850343|469296180|FG003|Overall Study|Non-compliance with Study Procedures|1|||
130361944|NCT00850343|469296177|FG000|Overall Study|Physician Decision|2|||
130361945|NCT00850343|469296178|FG001|Overall Study|Physician Decision|1|||
130361946|NCT00850343|469296179|FG002|Overall Study|Physician Decision|1|||
130361947|NCT00850343|469296180|FG003|Overall Study|Physician Decision|1|||
130361948|NCT02764333|469296183|FG000|Overall Study|Ineligible|1|||
130361949|NCT01788046|469296197|FG000|Overall Study|Withdrawal by Subject|12|||
130361950|NCT01788046|469296198|FG001|Overall Study|Withdrawal by Subject|12|||
130361951|NCT01788046|469296197|FG000|Overall Study|Lost to Follow-up|12|||
130361952|NCT01788046|469296198|FG001|Overall Study|Lost to Follow-up|19|||
130361953|NCT01788046|469296197|FG000|Overall Study|Death|7|||
130361954|NCT01788046|469296198|FG001|Overall Study|Death|5|||
130361955|NCT01788046|469296197|FG000|Overall Study|Protocol Specified Criteria|25|||
130361956|NCT01788046|469296198|FG001|Overall Study|Protocol Specified Criteria|1|||
130361957|NCT01856907|469296199|FG000|Overall Study|Pregnancy|0|||
130361958|NCT01856907|469296200|FG001|Overall Study|Pregnancy|1|||
130361959|NCT01856907|469296201|FG002|Overall Study|Pregnancy|0|||
130361960|NCT01856907|469296199|FG000|Overall Study|Pregnancy|0|||
130361961|NCT01856907|469296200|FG001|Overall Study|Pregnancy|1|||
130361962|NCT01856907|469296201|FG002|Overall Study|Pregnancy|0|||
130361963|NCT01856907|469296199|FG000|Overall Study|Withdrawal by Subject|0|||
130361964|NCT01856907|469296200|FG001|Overall Study|Withdrawal by Subject|1|||
130361965|NCT01856907|469296201|FG002|Overall Study|Withdrawal by Subject|0|||
130361966|NCT03626168|469296206|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130361967|NCT03626168|469296207|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130361968|NCT03626168|469296206|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
130361969|NCT03626168|469296207|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
130361970|NCT03626168|469296206|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130361971|NCT03626168|469296207|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
130361972|NCT00850070|469296208|FG000|Overall Study|Lack of Efficacy|1|||
130361973|NCT00850070|469296209|FG001|Overall Study|Lack of Efficacy|1|||
130361974|NCT00850070|469296208|FG000|Overall Study|Adverse Event|2|||
130361975|NCT00850070|469296209|FG001|Overall Study|Adverse Event|0|||
130361976|NCT05047770|469296210|FG000|Overall Study|Withdrawal by Subject|15|||
130361977|NCT05047770|469296211|FG001|Overall Study|Withdrawal by Subject|10|||
130361978|NCT05047770|469296212|FG002|Overall Study|Withdrawal by Subject|6|||
130361979|NCT05047770|469296213|FG003|Overall Study|Withdrawal by Subject|12|||
130361980|NCT05047770|469296210|FG000|Overall Study|Lost to Follow-up|7|||
130361981|NCT05047770|469296211|FG001|Overall Study|Lost to Follow-up|5|||
130361982|NCT05047770|469296212|FG002|Overall Study|Lost to Follow-up|12|||
130361983|NCT05047770|469296213|FG003|Overall Study|Lost to Follow-up|13|||
130361984|NCT05047770|469296210|FG000|Overall Study|Other|1|||
130361985|NCT05047770|469296211|FG001|Overall Study|Other|0|||
130361986|NCT05047770|469296212|FG002|Overall Study|Other|1|||
130361987|NCT05047770|469296213|FG003|Overall Study|Other|0|||
130361988|NCT01268150|469296223|FG000|Treatment Phase|Progression of disease|18|||
130361989|NCT01268150|469296223|FG000|Treatment Phase|Adverse Event|3|||
130361990|NCT01268150|469296223|FG000|Treatment Phase|Withdrawal by Subject|3|||
130361991|NCT01268150|469296223|FG000|Treatment Phase|Other|4|||
130361992|NCT01268150|469296223|FG000|Extension Phase|Adverse Event|3|||
130361993|NCT01268150|469296223|FG000|Extension Phase|Disease progression|18|||
130361994|NCT01268150|469296223|FG000|Extension Phase|Other|6|||
130361995|NCT00395733|469296224|FG000|Period 2|Withdrawal by Subject|1|||
130361996|NCT00395733|469296225|FG001|Period 2|Withdrawal by Subject|2|||
130361997|NCT00395733|469296224|FG000|Period 2|Protocol Violation|0|||
130361998|NCT00395733|469296225|FG001|Period 2|Protocol Violation|1|||
130361999|NCT00395733|469296224|FG000|Period 2|Adverse Event|0|||
130362000|NCT00395733|469296225|FG001|Period 2|Adverse Event|2|||
130362001|NCT00395733|469296224|FG000|Period 2|Technical problems|1|||
130362002|NCT00395733|469296225|FG001|Period 2|Technical problems|0|||
130362003|NCT03725852|469296226|FG000|Overall Study|Death|1|||
130362004|NCT03725852|469296227|FG001|Overall Study|Death|0|||
130362005|NCT03725852|469296226|FG000|Overall Study|Withdrawal by Subject|1|||
130362006|NCT03725852|469296227|FG001|Overall Study|Withdrawal by Subject|0|||
130362007|NCT03725852|469296226|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
130696962|NCT01899053|470514540|FG012|Overall Study|Symptomatic Deterioration|2|||
130696963|NCT01899053|470514541|FG013|Overall Study|Symptomatic Deterioration|0|||
130362008|NCT03725852|469296227|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
130362009|NCT03452228|469296232|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130362010|NCT03452228|469296233|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130362011|NCT03452228|469296234|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130362012|NCT03452228|469296232|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130362013|NCT03452228|469296233|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130362014|NCT03452228|469296234|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130362015|NCT03452228|469296232|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
130362016|NCT03452228|469296233|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
130362017|NCT03452228|469296234|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
130362018|NCT03452228|469296232|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130362019|NCT03452228|469296233|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130362020|NCT03452228|469296234|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130362021|NCT04251273|469296235|FG000|Overall Study|Lost to Follow-up|331|||
130362022|NCT04251273|469296236|FG001|Overall Study|Lost to Follow-up|290|||
130362023|NCT00810693|469296237|FG000|Treatment Period|Adverse Event|8|||
130362024|NCT00810693|469296238|FG001|Treatment Period|Adverse Event|1|||
130362025|NCT00810693|469296239|FG002|Treatment Period|Adverse Event|7|||
130362026|NCT00810693|469296237|FG000|Treatment Period|Death|0|||
130362027|NCT00810693|469296238|FG001|Treatment Period|Death|1|||
130362028|NCT00810693|469296239|FG002|Treatment Period|Death|2|||
130362029|NCT00810693|469296237|FG000|Treatment Period|Lack of Efficacy|0|||
130362030|NCT00810693|469296238|FG001|Treatment Period|Lack of Efficacy|0|||
130362031|NCT00810693|469296239|FG002|Treatment Period|Lack of Efficacy|1|||
130362032|NCT00810693|469296237|FG000|Treatment Period|Lost to Follow-up|1|||
130362033|NCT00810693|469296238|FG001|Treatment Period|Lost to Follow-up|0|||
130362034|NCT00810693|469296239|FG002|Treatment Period|Lost to Follow-up|0|||
130362035|NCT00810693|469296237|FG000|Treatment Period|Non-compliance|1|||
130362036|NCT00810693|469296238|FG001|Treatment Period|Non-compliance|0|||
130362037|NCT00810693|469296239|FG002|Treatment Period|Non-compliance|0|||
130362038|NCT00810693|469296237|FG000|Treatment Period|Protocol Violation|1|||
130362039|NCT00810693|469296238|FG001|Treatment Period|Protocol Violation|2|||
130362040|NCT00810693|469296239|FG002|Treatment Period|Protocol Violation|2|||
130362041|NCT00810693|469296237|FG000|Treatment Period|Withdrawal by Subject|6|||
130362042|NCT00810693|469296238|FG001|Treatment Period|Withdrawal by Subject|2|||
130362043|NCT00810693|469296239|FG002|Treatment Period|Withdrawal by Subject|3|||
130362044|NCT00810693|469296237|FG000|Treatment Period|Not treated|0|||
130362045|NCT00810693|469296238|FG001|Treatment Period|Not treated|1|||
130362046|NCT00810693|469296239|FG002|Treatment Period|Not treated|1|||
130362047|NCT00810693|469296237|FG000|Follow-up Period (FUP)|Adverse Event|3|||
130362048|NCT00810693|469296238|FG001|Follow-up Period (FUP)|Adverse Event|1|||
130362049|NCT00810693|469296239|FG002|Follow-up Period (FUP)|Adverse Event|1|||
130362050|NCT00810693|469296237|FG000|Follow-up Period (FUP)|Death|2|||
130362051|NCT00810693|469296238|FG001|Follow-up Period (FUP)|Death|0|||
130362052|NCT00810693|469296239|FG002|Follow-up Period (FUP)|Death|1|||
130362053|NCT00810693|469296237|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
130362054|NCT00810693|469296238|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
130362055|NCT00810693|469296239|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
130362056|NCT00810693|469296237|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
130362057|NCT00810693|469296238|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
130362058|NCT00810693|469296239|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
130362059|NCT00810693|469296237|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
130362060|NCT00810693|469296238|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
130362061|NCT00810693|469296239|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
130362062|NCT01297920|469296240|FG000|Overall Study|Adverse Event|42|||
130362063|NCT01297920|469296241|FG001|Overall Study|Adverse Event|10|||
130362064|NCT01297920|469296242|FG002|Overall Study|Adverse Event|38|||
130362065|NCT01297920|469296240|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
130362066|NCT01297920|469296241|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
130362067|NCT01297920|469296242|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
130362068|NCT01297920|469296240|FG000|Overall Study|Noncompliance|1|||
130362069|NCT01297920|469296241|FG001|Overall Study|Noncompliance|0|||
130362070|NCT01297920|469296242|FG002|Overall Study|Noncompliance|0|||
130362071|NCT01297920|469296240|FG000|Overall Study|Protocol Violation|1|||
130362072|NCT01297920|469296241|FG001|Overall Study|Protocol Violation|3|||
130362073|NCT01297920|469296242|FG002|Overall Study|Protocol Violation|0|||
130362074|NCT01297920|469296240|FG000|Overall Study|Inadequate Control of IOP|7|||
130362075|NCT01297920|469296241|FG001|Overall Study|Inadequate Control of IOP|9|||
130362076|NCT01297920|469296242|FG002|Overall Study|Inadequate Control of IOP|17|||
130362077|NCT01297920|469296240|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
130449966|NCT04319094|469611128|FG001|9-month|Lost to Follow-up|4|||
130449967|NCT04319094|469611127|FG000|9-month|Withdrawal by Subject|0|||
130362078|NCT01297920|469296241|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
130362079|NCT01297920|469296242|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
130362080|NCT03212690|469296243|FG000|Overall Study|Protocol Violation|1|||
130362081|NCT00474760|469296244|FG000|Overall Study|Death|0|||
130362082|NCT00474760|469296245|FG001|Overall Study|Death|0|||
130362083|NCT00474760|469296246|FG002|Overall Study|Death|0|||
130362084|NCT00474760|469296247|FG003|Overall Study|Death|0|||
130362085|NCT00474760|469296248|FG004|Overall Study|Death|2|||
130362086|NCT00474760|469296249|FG005|Overall Study|Death|0|||
130362087|NCT00474760|469296250|FG006|Overall Study|Death|0|||
130362088|NCT00474760|469296244|FG000|Overall Study|Adverse Event|0|||
130362089|NCT00474760|469296245|FG001|Overall Study|Adverse Event|0|||
130362090|NCT00474760|469296246|FG002|Overall Study|Adverse Event|0|||
130362091|NCT00474760|469296247|FG003|Overall Study|Adverse Event|0|||
130362092|NCT00474760|469296248|FG004|Overall Study|Adverse Event|1|||
130362093|NCT00474760|469296249|FG005|Overall Study|Adverse Event|7|||
130362094|NCT00474760|469296250|FG006|Overall Study|Adverse Event|0|||
130362095|NCT00474760|469296244|FG000|Overall Study|Laboratory abnormality|0|||
130362096|NCT00474760|469296245|FG001|Overall Study|Laboratory abnormality|0|||
130362097|NCT00474760|469296246|FG002|Overall Study|Laboratory abnormality|0|||
130362098|NCT00474760|469296247|FG003|Overall Study|Laboratory abnormality|0|||
130362099|NCT00474760|469296248|FG004|Overall Study|Laboratory abnormality|0|||
130362100|NCT00474760|469296249|FG005|Overall Study|Laboratory abnormality|1|||
130362101|NCT00474760|469296250|FG006|Overall Study|Laboratory abnormality|0|||
130362102|NCT00474760|469296244|FG000|Overall Study|Withdrawal by Subject|0|||
130362103|NCT00474760|469296245|FG001|Overall Study|Withdrawal by Subject|0|||
130362104|NCT00474760|469296246|FG002|Overall Study|Withdrawal by Subject|0|||
130362105|NCT00474760|469296247|FG003|Overall Study|Withdrawal by Subject|1|||
130362106|NCT00474760|469296248|FG004|Overall Study|Withdrawal by Subject|0|||
130362107|NCT00474760|469296249|FG005|Overall Study|Withdrawal by Subject|1|||
130362108|NCT00474760|469296250|FG006|Overall Study|Withdrawal by Subject|1|||
130362109|NCT00474760|469296244|FG000|Overall Study|Other|0|||
130362110|NCT00474760|469296245|FG001|Overall Study|Other|1|||
130362111|NCT00474760|469296246|FG002|Overall Study|Other|0|||
130362112|NCT00474760|469296247|FG003|Overall Study|Other|0|||
130362113|NCT00474760|469296248|FG004|Overall Study|Other|1|||
130362114|NCT00474760|469296249|FG005|Overall Study|Other|0|||
130362115|NCT00474760|469296250|FG006|Overall Study|Other|0|||
130362116|NCT00474760|469296244|FG000|Overall Study|Progressive disease|3|||
130362117|NCT00474760|469296245|FG001|Overall Study|Progressive disease|2|||
130362118|NCT00474760|469296246|FG002|Overall Study|Progressive disease|3|||
130362119|NCT00474760|469296247|FG003|Overall Study|Progressive disease|2|||
130362120|NCT00474760|469296248|FG004|Overall Study|Progressive disease|8|||
130362121|NCT00474760|469296249|FG005|Overall Study|Progressive disease|20|||
130362122|NCT00474760|469296250|FG006|Overall Study|Progressive disease|7|||
130362123|NCT00474760|469296244|FG000|Overall Study|Terminated by sponsor|0|||
130362124|NCT00474760|469296245|FG001|Overall Study|Terminated by sponsor|0|||
130362125|NCT00474760|469296246|FG002|Overall Study|Terminated by sponsor|0|||
130362126|NCT00474760|469296247|FG003|Overall Study|Terminated by sponsor|0|||
130362127|NCT00474760|469296248|FG004|Overall Study|Terminated by sponsor|0|||
130362128|NCT00474760|469296249|FG005|Overall Study|Terminated by sponsor|0|||
130362129|NCT00474760|469296250|FG006|Overall Study|Terminated by sponsor|2|||
130362130|NCT02345226|469296251|FG000|Double-Blind Phase|Adverse Event|5|||
130362131|NCT02345226|469296252|FG001|Double-Blind Phase|Adverse Event|6|||
130362132|NCT02345226|469296251|FG000|Double-Blind Phase|Death|3|||
130362133|NCT02345226|469296252|FG001|Double-Blind Phase|Death|0|||
130362134|NCT02345226|469296251|FG000|Double-Blind Phase|Pregnancy|0|||
130362135|NCT02345226|469296252|FG001|Double-Blind Phase|Pregnancy|1|||
130362136|NCT02345226|469296251|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130362137|NCT02345226|469296252|FG001|Double-Blind Phase|Lack of Efficacy|0|||
130362138|NCT02345226|469296251|FG000|Double-Blind Phase|Investigator's Discretion|4|||
130362139|NCT02345226|469296252|FG001|Double-Blind Phase|Investigator's Discretion|3|||
130362140|NCT02345226|469296251|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130362141|NCT02345226|469296252|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
130362142|NCT02345226|469296251|FG000|Double-Blind Phase|Withdrew Consent|41|||
130362143|NCT02345226|469296252|FG001|Double-Blind Phase|Withdrew Consent|39|||
130362144|NCT02345226|469296251|FG000|Double-Blind Phase|Lost to Follow-up|12|||
130362145|NCT02345226|469296252|FG001|Double-Blind Phase|Lost to Follow-up|16|||
130362146|NCT02345226|469296251|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
130362147|NCT02345226|469296252|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
130362148|NCT02345226|469296251|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130362149|NCT02345226|469296252|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130362150|NCT02282358|469296257|FG000|Overall Study|Nonevaluable|1|||
130362151|NCT01786148|469296258|FG000|Overall Study|Lost to Follow-up|21|||
130362152|NCT01786148|469296259|FG001|Overall Study|Lost to Follow-up|13|||
130362153|NCT01786148|469296258|FG000|Overall Study|Death|0|||
130362154|NCT01786148|469296259|FG001|Overall Study|Death|1|||
130362155|NCT01786148|469296258|FG000|Overall Study|Withdrawal by Subject|0|||
130362156|NCT01786148|469296259|FG001|Overall Study|Withdrawal by Subject|7|||
130449968|NCT04319094|469611128|FG001|9-month|Withdrawal by Subject|1|||
130449969|NCT04319094|469611127|FG000|9-month|Incomplete data collection|8|||
130449970|NCT04319094|469611128|FG001|9-month|Incomplete data collection|5|||
130449971|NCT04319094|469611127|FG000|12-month|Lost to Follow-up|11|||
130449972|NCT04319094|469611128|FG001|12-month|Lost to Follow-up|8|||
130449973|NCT02487446|469611132|FG000|Period 1|Physician Decision|0|||
130449974|NCT02487446|469611133|FG001|Period 1|Physician Decision|1|||
130449975|NCT02487446|469611132|FG000|Period 1|Lack of Efficacy|1|||
130449976|NCT02487446|469611133|FG001|Period 1|Lack of Efficacy|0|||
130449977|NCT02487446|469611132|FG000|Period 1|Protocol deviation|3|||
130449978|NCT02487446|469611133|FG001|Period 1|Protocol deviation|2|||
130449979|NCT02487446|469611132|FG000|Period 1|Lost to Follow-up|2|||
130449980|NCT02487446|469611133|FG001|Period 1|Lost to Follow-up|0|||
130449981|NCT02487446|469611132|FG000|Period 1|Withdrawal by Subject|2|||
130449982|NCT02487446|469611133|FG001|Period 1|Withdrawal by Subject|0|||
130449983|NCT02487446|469611132|FG000|Period 1|Adverse Event|5|||
130449984|NCT02487446|469611133|FG001|Period 1|Adverse Event|5|||
130449985|NCT02487446|469611132|FG000|Washout|Lost to Follow-up|0|||
130449986|NCT02487446|469611133|FG001|Washout|Lost to Follow-up|2|||
130449987|NCT02487446|469611132|FG000|Washout|Withdrawal by Subject|1|||
130449988|NCT02487446|469611133|FG001|Washout|Withdrawal by Subject|4|||
130449989|NCT02487446|469611132|FG000|Washout|Adverse Event|2|||
130449990|NCT02487446|469611133|FG001|Washout|Adverse Event|2|||
130449991|NCT02487446|469611132|FG000|Period 2|Protocol deviation|0|||
130449992|NCT02487446|469611133|FG001|Period 2|Protocol deviation|1|||
130449993|NCT02487446|469611132|FG000|Period 2|Lost to Follow-up|1|||
130449994|NCT02487446|469611133|FG001|Period 2|Lost to Follow-up|1|||
130449995|NCT02487446|469611132|FG000|Period 2|Withdrawal by Subject|1|||
130449996|NCT02487446|469611133|FG001|Period 2|Withdrawal by Subject|1|||
130449997|NCT02487446|469611132|FG000|Period 2|Adverse Event|6|||
130449998|NCT02487446|469611133|FG001|Period 2|Adverse Event|2|||
130449999|NCT01822821|469611134|FG000|Overall Study|Eligible surgery cancelled|1|||
130450000|NCT01822821|469611135|FG001|Overall Study|Eligible surgery cancelled|1|||
130450001|NCT01822821|469611134|FG000|Overall Study|Other reasons|1|||
130450002|NCT01822821|469611135|FG001|Overall Study|Other reasons|0|||
130450003|NCT05780047|469611136|FG000|Overall Study|Did not submit baseline urine test kit|226|||
130450004|NCT05780047|469611136|FG000|Overall Study|Lost to Follow-up|34|||
130450005|NCT05780047|469611136|FG000|Overall Study|Did not submit second urine test kit|124|||
130450006|NCT03590743|469611137|FG000|Overall Study|Withdrawal by Subject|0|||
130450007|NCT03590743|469611138|FG001|Overall Study|Withdrawal by Subject|1|||
130450008|NCT00604786|469611139|FG000|Overall Study|Lost to Follow-up|2|||
130450009|NCT00604786|469611140|FG001|Overall Study|Lost to Follow-up|0|||
130450010|NCT01221181|469611141|FG000|Overall Study|Lost to Follow-up|1|||
130450011|NCT02698436|469611142|FG000|Overall Study|Adverse Event|1|||
130450012|NCT02698436|469611143|FG001|Overall Study|Adverse Event|0|||
130450013|NCT02698436|469611142|FG000|Overall Study|Withdrawal by Subject|3|||
130450014|NCT02698436|469611143|FG001|Overall Study|Withdrawal by Subject|3|||
130450015|NCT02698436|469611142|FG000|Overall Study|Lost to Follow-up|2|||
130450016|NCT02698436|469611143|FG001|Overall Study|Lost to Follow-up|4|||
130450017|NCT02698436|469611142|FG000|Overall Study|Non-compliance with study regimen|1|||
130450018|NCT02698436|469611143|FG001|Overall Study|Non-compliance with study regimen|0|||
130450019|NCT01394991|469611146|FG000|Overall Study|Adverse Event|0|||
130450020|NCT01394991|469611147|FG001|Overall Study|Adverse Event|4|||
130450021|NCT01394991|469611146|FG000|Overall Study|Lack of Efficacy|5|||
130450022|NCT01394991|469611147|FG001|Overall Study|Lack of Efficacy|7|||
130450023|NCT01394991|469611146|FG000|Overall Study|Lost to Follow-up|6|||
130450024|NCT01394991|469611147|FG001|Overall Study|Lost to Follow-up|8|||
130450025|NCT01394991|469611146|FG000|Overall Study|Physician Decision|1|||
130450026|NCT01394991|469611147|FG001|Overall Study|Physician Decision|3|||
130450027|NCT01394991|469611146|FG000|Overall Study|Protocol Violation|1|||
130696964|NCT03105297|470514542|FG000|Baseline Phase (Day 1)|Other|21|||
130696965|NCT03105297|470514542|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
130450028|NCT01394991|469611147|FG001|Overall Study|Protocol Violation|1|||
130696966|NCT03105297|470514542|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
130450029|NCT01394991|469611146|FG000|Overall Study|Withdrawal by Subject|20|||
130696967|NCT01390948|470514543|FG000|Overall Study|End of Study|1|||
130696968|NCT01390948|470514544|FG001|Overall Study|End of Study|0|||
130696969|NCT01390948|470514545|FG002|Overall Study|End of Study|0|||
130450030|NCT01394991|469611147|FG001|Overall Study|Withdrawal by Subject|17|||
130450031|NCT01394991|469611146|FG000|Overall Study|Chemotherapy Termination|10|||
130450032|NCT01394991|469611147|FG001|Overall Study|Chemotherapy Termination|15|||
130450033|NCT01394991|469611146|FG000|Overall Study|Disease Progression|7|||
130450034|NCT01394991|469611147|FG001|Overall Study|Disease Progression|7|||
130450035|NCT01394991|469611146|FG000|Overall Study|Prematurely Termination of Trial|9|||
130450036|NCT01394991|469611147|FG001|Overall Study|Prematurely Termination of Trial|10|||
130450037|NCT00062868|469611155|FG000|Dose Level 1|Death|2|||
130450038|NCT00062868|469611156|FG001|Dose Level 1|Death|0|||
130450039|NCT00062868|469611157|FG002|Dose Level 1|Death|0|||
130696970|NCT01390948|470514543|FG000|Overall Study|Withdrew consent|2|||
130696971|NCT01390948|470514544|FG001|Overall Study|Withdrew consent|2|||
130450040|NCT00062868|469611158|FG003|Dose Level 1|Death|2|||
130450041|NCT00062868|469611159|FG004|Dose Level 1|Death|0|||
130450042|NCT00062868|469611160|FG005|Dose Level 1|Death|0|||
130450043|NCT00062868|469611161|FG006|Dose Level 1|Death|3|||
130450044|NCT00062868|469611162|FG007|Dose Level 1|Death|0|||
130450045|NCT00062868|469611163|FG008|Dose Level 1|Death|0|||
130450046|NCT00062868|469611164|FG009|Dose Level 1|Death|0|||
130450047|NCT00062868|469611165|FG010|Dose Level 1|Death|0|||
130450048|NCT00062868|469611166|FG011|Dose Level 1|Death|0|||
130450049|NCT00062868|469611167|FG012|Dose Level 1|Death|0|||
130450050|NCT00062868|469611168|FG013|Dose Level 1|Death|0|||
130450051|NCT00062868|469611169|FG014|Dose Level 1|Death|0|||
130450052|NCT00062868|469611170|FG015|Dose Level 1|Death|0|||
130450053|NCT00062868|469611171|FG016|Dose Level 1|Death|0|||
130450054|NCT00062868|469611172|FG017|Dose Level 1|Death|0|||
130450055|NCT00062868|469611173|FG018|Dose Level 1|Death|7|||
130450056|NCT00062868|469611174|FG019|Dose Level 1|Death|0|||
130450057|NCT00062868|469611175|FG020|Dose Level 1|Death|1|||
130450058|NCT00062868|469611155|FG000|Dose Level 1|Lost to Follow-up|0|||
130450059|NCT00062868|469611156|FG001|Dose Level 1|Lost to Follow-up|0|||
130450060|NCT00062868|469611157|FG002|Dose Level 1|Lost to Follow-up|0|||
130450061|NCT00062868|469611158|FG003|Dose Level 1|Lost to Follow-up|0|||
130450062|NCT00062868|469611159|FG004|Dose Level 1|Lost to Follow-up|0|||
130450063|NCT00062868|469611160|FG005|Dose Level 1|Lost to Follow-up|0|||
130450064|NCT00062868|469611161|FG006|Dose Level 1|Lost to Follow-up|0|||
130450065|NCT00062868|469611162|FG007|Dose Level 1|Lost to Follow-up|0|||
130243487|NCT01653262|468853293|FG000|Overall Study|AE, non-serious non-fatal|1|||
130243488|NCT01112267|468853295|FG000|Overall Study|Adverse Event|24|||
130243489|NCT01112267|468853296|FG001|Overall Study|Adverse Event|6|||
130450066|NCT00062868|469611163|FG008|Dose Level 1|Lost to Follow-up|0|||
130450067|NCT00062868|469611164|FG009|Dose Level 1|Lost to Follow-up|0|||
130450068|NCT00062868|469611165|FG010|Dose Level 1|Lost to Follow-up|0|||
130450069|NCT00062868|469611166|FG011|Dose Level 1|Lost to Follow-up|0|||
130450070|NCT00062868|469611167|FG012|Dose Level 1|Lost to Follow-up|1|||
130450071|NCT00062868|469611168|FG013|Dose Level 1|Lost to Follow-up|0|||
130450072|NCT00062868|469611169|FG014|Dose Level 1|Lost to Follow-up|0|||
130450073|NCT00062868|469611170|FG015|Dose Level 1|Lost to Follow-up|0|||
130450074|NCT00062868|469611171|FG016|Dose Level 1|Lost to Follow-up|0|||
130450075|NCT00062868|469611172|FG017|Dose Level 1|Lost to Follow-up|0|||
130450076|NCT00062868|469611173|FG018|Dose Level 1|Lost to Follow-up|2|||
130450077|NCT00062868|469611174|FG019|Dose Level 1|Lost to Follow-up|0|||
130450078|NCT00062868|469611175|FG020|Dose Level 1|Lost to Follow-up|1|||
130450079|NCT00062868|469611155|FG000|Dose Level 2|Death|0|||
130450080|NCT00062868|469611156|FG001|Dose Level 2|Death|3|||
130450081|NCT00062868|469611157|FG002|Dose Level 2|Death|0|||
130450082|NCT00062868|469611158|FG003|Dose Level 2|Death|0|||
130450083|NCT00062868|469611159|FG004|Dose Level 2|Death|2|||
130450084|NCT00062868|469611160|FG005|Dose Level 2|Death|0|||
130450085|NCT00062868|469611161|FG006|Dose Level 2|Death|0|||
130450086|NCT00062868|469611162|FG007|Dose Level 2|Death|0|||
130450087|NCT00062868|469611163|FG008|Dose Level 2|Death|0|||
130450088|NCT00062868|469611164|FG009|Dose Level 2|Death|0|||
130450089|NCT00062868|469611165|FG010|Dose Level 2|Death|1|||
130450090|NCT00062868|469611166|FG011|Dose Level 2|Death|0|||
130450091|NCT00062868|469611167|FG012|Dose Level 2|Death|0|||
130450092|NCT00062868|469611168|FG013|Dose Level 2|Death|0|||
130450093|NCT00062868|469611169|FG014|Dose Level 2|Death|0|||
130450094|NCT00062868|469611170|FG015|Dose Level 2|Death|0|||
130450095|NCT00062868|469611171|FG016|Dose Level 2|Death|2|||
130450096|NCT00062868|469611172|FG017|Dose Level 2|Death|0|||
130243490|NCT01112267|468853295|FG000|Overall Study|Withdrawal by Subject|3|||
130450097|NCT00062868|469611173|FG018|Dose Level 2|Death|0|||
130450098|NCT00062868|469611174|FG019|Dose Level 2|Death|0|||
130450099|NCT00062868|469611175|FG020|Dose Level 2|Death|0|||
130450100|NCT00062868|469611155|FG000|Dose Level 2|Lost to Follow-up|0|||
130450101|NCT00062868|469611156|FG001|Dose Level 2|Lost to Follow-up|0|||
130243491|NCT01112267|468853296|FG001|Overall Study|Withdrawal by Subject|5|||
130450102|NCT00062868|469611157|FG002|Dose Level 2|Lost to Follow-up|0|||
130450103|NCT00062868|469611158|FG003|Dose Level 2|Lost to Follow-up|0|||
130450104|NCT00062868|469611159|FG004|Dose Level 2|Lost to Follow-up|0|||
130450105|NCT00062868|469611160|FG005|Dose Level 2|Lost to Follow-up|0|||
130450106|NCT00062868|469611161|FG006|Dose Level 2|Lost to Follow-up|0|||
130552986|NCT00504881|469991638|FG001|Overall Study|AE of unknown type|0|||
130450107|NCT00062868|469611162|FG007|Dose Level 2|Lost to Follow-up|0|||
130243492|NCT01112267|468853295|FG000|Overall Study|Protocol Violation|5|||
130243493|NCT01112267|468853296|FG001|Overall Study|Protocol Violation|3|||
130450108|NCT00062868|469611163|FG008|Dose Level 2|Lost to Follow-up|0|||
130450109|NCT00062868|469611164|FG009|Dose Level 2|Lost to Follow-up|0|||
130450110|NCT00062868|469611165|FG010|Dose Level 2|Lost to Follow-up|0|||
130450111|NCT00062868|469611166|FG011|Dose Level 2|Lost to Follow-up|0|||
130450112|NCT00062868|469611167|FG012|Dose Level 2|Lost to Follow-up|0|||
130450113|NCT00062868|469611168|FG013|Dose Level 2|Lost to Follow-up|1|||
130450114|NCT00062868|469611169|FG014|Dose Level 2|Lost to Follow-up|0|||
130450115|NCT00062868|469611170|FG015|Dose Level 2|Lost to Follow-up|0|||
130450116|NCT00062868|469611171|FG016|Dose Level 2|Lost to Follow-up|1|||
130450117|NCT00062868|469611172|FG017|Dose Level 2|Lost to Follow-up|0|||
130362157|NCT01786148|469296258|FG000|Overall Study|Incarceration|1|||
130362158|NCT01786148|469296259|FG001|Overall Study|Incarceration|1|||
130362159|NCT03896165|469296268|FG000|Overall Study|Withdrawal by Subject|2|||
130362160|NCT01811225|469296269|FG000|Treatment Period 1|Adverse Event|2|||
130362161|NCT01811225|469296270|FG001|Treatment Period 1|Adverse Event|3|||
130362162|NCT01811225|469296269|FG000|Treatment Period 1|Lost to Follow-up|12|||
130362163|NCT01811225|469296270|FG001|Treatment Period 1|Lost to Follow-up|8|||
130362164|NCT01811225|469296269|FG000|Treatment Period 1|transporation|1|||
130362165|NCT01811225|469296270|FG001|Treatment Period 1|transporation|0|||
130362166|NCT01811225|469296269|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
130362167|NCT01811225|469296270|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
130362168|NCT01811225|469296269|FG000|Treatment Period 2|Lost to Follow-up|1|||
130362169|NCT01811225|469296270|FG001|Treatment Period 2|Lost to Follow-up|2|||
130362170|NCT01811225|469296269|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
130362171|NCT01811225|469296270|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
130362172|NCT02158975|469296271|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
130362173|NCT03000569|469296272|FG000|Overall Study|Withdrawal by Subject|1|||
130362174|NCT03000569|469296273|FG001|Overall Study|Withdrawal by Subject|0|||
130362175|NCT04122534|469296279|FG000|Overall Study|Lost to Follow-up|4|||
130362176|NCT00397215|469296287|FG000|Month 0 (Day 0)|Adverse Event|0|||
130362177|NCT00397215|469296288|FG001|Month 0 (Day 0)|Adverse Event|1|||
130362178|NCT00397215|469296289|FG002|Month 0 (Day 0)|Adverse Event|0|||
130362179|NCT00397215|469296290|FG003|Month 0 (Day 0)|Adverse Event|0|||
130362180|NCT00397215|469296287|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
130362181|NCT00397215|469296288|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
130362182|NCT00397215|469296289|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
130362183|NCT00397215|469296290|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
130362184|NCT00397215|469296287|FG000|Month 0 (Day 0)|Other|4|||
130362185|NCT00397215|469296288|FG001|Month 0 (Day 0)|Other|1|||
130362186|NCT00397215|469296289|FG002|Month 0 (Day 0)|Other|3|||
130362187|NCT00397215|469296290|FG003|Month 0 (Day 0)|Other|3|||
130362188|NCT00397215|469296287|FG000|Month 6 (Day 180)|Adverse Event|0|||
130362189|NCT00397215|469296288|FG001|Month 6 (Day 180)|Adverse Event|3|||
130362190|NCT00397215|469296289|FG002|Month 6 (Day 180)|Adverse Event|2|||
130362191|NCT00397215|469296290|FG003|Month 6 (Day 180)|Adverse Event|0|||
130362192|NCT00397215|469296287|FG000|Month 6 (Day 180)|Other|2|||
130362193|NCT00397215|469296288|FG001|Month 6 (Day 180)|Other|0|||
130362194|NCT00397215|469296289|FG002|Month 6 (Day 180)|Other|3|||
130362195|NCT00397215|469296290|FG003|Month 6 (Day 180)|Other|0|||
130362196|NCT02128932|469296291|FG000|Overall Study|Withdrawal by Subject|11|||
130362197|NCT02128932|469296292|FG001|Overall Study|Withdrawal by Subject|7|||
130362198|NCT02128932|469296293|FG002|Overall Study|Withdrawal by Subject|8|||
130362199|NCT02128932|469296291|FG000|Overall Study|Death|2|||
130362200|NCT02128932|469296292|FG001|Overall Study|Death|0|||
130362201|NCT02128932|469296293|FG002|Overall Study|Death|2|||
130362202|NCT02128932|469296291|FG000|Overall Study|Lost to Follow-up|2|||
130362203|NCT02128932|469296292|FG001|Overall Study|Lost to Follow-up|1|||
130362204|NCT02128932|469296293|FG002|Overall Study|Lost to Follow-up|1|||
130362205|NCT02128932|469296291|FG000|Overall Study|No reason for withdrawal|12|||
130362206|NCT02128932|469296292|FG001|Overall Study|No reason for withdrawal|11|||
130362207|NCT02128932|469296293|FG002|Overall Study|No reason for withdrawal|7|||
130362208|NCT01361568|469296294|FG000|Overall Study|Adverse Event|0|||
130362209|NCT01361568|469296295|FG001|Overall Study|Adverse Event|0|||
130362210|NCT01361568|469296296|FG002|Overall Study|Adverse Event|0|||
130362211|NCT01361568|469296297|FG003|Overall Study|Adverse Event|0|||
130362212|NCT01361568|469296298|FG004|Overall Study|Adverse Event|1|||
130362213|NCT01361568|469296299|FG005|Overall Study|Adverse Event|0|||
130362214|NCT01361568|469296294|FG000|Overall Study|Physician Decision|0|||
130362215|NCT01361568|469296295|FG001|Overall Study|Physician Decision|0|||
130362216|NCT01361568|469296296|FG002|Overall Study|Physician Decision|0|||
130362217|NCT01361568|469296297|FG003|Overall Study|Physician Decision|0|||
130450118|NCT00062868|469611173|FG018|Dose Level 2|Lost to Follow-up|0|||
130362218|NCT01361568|469296298|FG004|Overall Study|Physician Decision|0|||
130450119|NCT00062868|469611174|FG019|Dose Level 2|Lost to Follow-up|0|||
130362219|NCT01361568|469296299|FG005|Overall Study|Physician Decision|1|||
130362220|NCT01361568|469296294|FG000|Overall Study|Withdrawal by Subject|2|||
130450120|NCT00062868|469611175|FG020|Dose Level 2|Lost to Follow-up|0|||
130362221|NCT01361568|469296295|FG001|Overall Study|Withdrawal by Subject|1|||
130362222|NCT01361568|469296296|FG002|Overall Study|Withdrawal by Subject|0|||
130362223|NCT01361568|469296297|FG003|Overall Study|Withdrawal by Subject|0|||
130362224|NCT01361568|469296298|FG004|Overall Study|Withdrawal by Subject|0|||
130362225|NCT01361568|469296299|FG005|Overall Study|Withdrawal by Subject|1|||
130362226|NCT00657358|469296304|FG000|Overall Study|Lack of Efficacy|6|||
130362227|NCT01254630|469296305|FG000|Overall Study|Adverse Event|36|||
130362228|NCT01254630|469296306|FG001|Overall Study|Adverse Event|15|||
130450121|NCT00062868|469611155|FG000|Dose Level 3|Death|0|||
130450122|NCT00062868|469611156|FG001|Dose Level 3|Death|0|||
130450123|NCT00062868|469611157|FG002|Dose Level 3|Death|0|||
130450124|NCT00062868|469611158|FG003|Dose Level 3|Death|0|||
130450125|NCT00062868|469611159|FG004|Dose Level 3|Death|0|||
130450126|NCT00062868|469611160|FG005|Dose Level 3|Death|0|||
130450127|NCT00062868|469611161|FG006|Dose Level 3|Death|0|||
130450128|NCT00062868|469611162|FG007|Dose Level 3|Death|0|||
130450129|NCT00062868|469611163|FG008|Dose Level 3|Death|0|||
130450130|NCT00062868|469611164|FG009|Dose Level 3|Death|0|||
130362229|NCT01254630|469296307|FG002|Overall Study|Adverse Event|40|||
130362230|NCT01254630|469296308|FG003|Overall Study|Adverse Event|8|||
130362231|NCT01254630|469296305|FG000|Overall Study|Death|461|||
130362232|NCT01254630|469296306|FG001|Overall Study|Death|151|||
130362233|NCT01254630|469296307|FG002|Overall Study|Death|478|||
130362234|NCT01254630|469296308|FG003|Overall Study|Death|139|||
130362235|NCT01254630|469296305|FG000|Overall Study|Lost to Follow-up|80|||
130362236|NCT01254630|469296306|FG001|Overall Study|Lost to Follow-up|26|||
130362237|NCT01254630|469296307|FG002|Overall Study|Lost to Follow-up|89|||
130362238|NCT01254630|469296308|FG003|Overall Study|Lost to Follow-up|32|||
130362239|NCT01254630|469296305|FG000|Overall Study|Physician Decision|24|||
130362240|NCT01254630|469296306|FG001|Overall Study|Physician Decision|8|||
130362241|NCT01254630|469296307|FG002|Overall Study|Physician Decision|16|||
130362242|NCT01254630|469296308|FG003|Overall Study|Physician Decision|7|||
130362243|NCT01254630|469296305|FG000|Overall Study|Withdrawal by Subject|201|||
130362244|NCT01254630|469296306|FG001|Overall Study|Withdrawal by Subject|94|||
130362245|NCT01254630|469296307|FG002|Overall Study|Withdrawal by Subject|188|||
130362246|NCT01254630|469296308|FG003|Overall Study|Withdrawal by Subject|89|||
130362247|NCT01254630|469296305|FG000|Overall Study|Study terminated by sponsor|0|||
130362248|NCT01254630|469296306|FG001|Overall Study|Study terminated by sponsor|994|||
130362249|NCT01254630|469296307|FG002|Overall Study|Study terminated by sponsor|0|||
130362250|NCT01254630|469296308|FG003|Overall Study|Study terminated by sponsor|1010|||
130362251|NCT01254630|469296305|FG000|Overall Study|Status not recorded|0|||
130362252|NCT01254630|469296306|FG001|Overall Study|Status not recorded|0|||
130362253|NCT01254630|469296307|FG002|Overall Study|Status not recorded|1|||
130362254|NCT01254630|469296308|FG003|Overall Study|Status not recorded|0|||
130362255|NCT02959983|469296309|FG000|Overall Study|Protocol Violation|0|||
130362256|NCT02959983|469296310|FG001|Overall Study|Protocol Violation|1|||
130362257|NCT02959983|469296309|FG000|Overall Study|Lack of Efficacy|0|||
130362258|NCT02959983|469296310|FG001|Overall Study|Lack of Efficacy|1|||
130362259|NCT02959983|469296309|FG000|Overall Study|Lost to Follow-up|12|||
130362260|NCT02959983|469296310|FG001|Overall Study|Lost to Follow-up|9|||
130362261|NCT02959983|469296309|FG000|Overall Study|Other|1|||
130362262|NCT02959983|469296310|FG001|Overall Study|Other|1|||
130362263|NCT02959983|469296309|FG000|Overall Study|Physician Decision|1|||
130362264|NCT02959983|469296310|FG001|Overall Study|Physician Decision|0|||
130362265|NCT02959983|469296309|FG000|Overall Study|Adverse Event|5|||
130362266|NCT02959983|469296310|FG001|Overall Study|Adverse Event|1|||
130362267|NCT02959983|469296309|FG000|Overall Study|Withdrawal by Subject|7|||
130362268|NCT02959983|469296310|FG001|Overall Study|Withdrawal by Subject|12|||
130362269|NCT00241358|469296311|FG000|Overall Study|Determined to be not ineligible|0|||
130362270|NCT00241358|469296312|FG001|Overall Study|Determined to be not ineligible|1|||
130362271|NCT00241358|469296313|FG002|Overall Study|Determined to be not ineligible|1|||
130362272|NCT02180724|469297851|FG000|Overall Study|Death|26|||
130362273|NCT02180724|469297852|FG001|Overall Study|Death|1|||
130362274|NCT02180724|469297851|FG000|Overall Study|Lost to Follow-up|3|||
130362275|NCT02180724|469297852|FG001|Overall Study|Lost to Follow-up|1|||
130362276|NCT02180724|469297851|FG000|Overall Study|Withdrawal by Subject|4|||
130362277|NCT02180724|469297852|FG001|Overall Study|Withdrawal by Subject|2|||
130362278|NCT02180724|469297851|FG000|Overall Study|PI Decision|5|||
130362279|NCT02180724|469297852|FG001|Overall Study|PI Decision|2|||
130362280|NCT02180724|469297851|FG000|Overall Study|Study terminated by sponsor|54|||
130362281|NCT02180724|469297852|FG001|Overall Study|Study terminated by sponsor|8|||
130362282|NCT01863953|469297857|FG000|Overall Study|Adverse Event|0|||
130362283|NCT01863953|469297858|FG001|Overall Study|Adverse Event|0|||
130362284|NCT01863953|469297859|FG002|Overall Study|Adverse Event|1|||
130450131|NCT00062868|469611165|FG010|Dose Level 3|Death|0|||
130450132|NCT00062868|469611166|FG011|Dose Level 3|Death|1|||
130362285|NCT01824342|469297861|FG000|Overall Study|Withdrawal by Subject|0|||
130362286|NCT01824342|469297862|FG001|Overall Study|Withdrawal by Subject|3|||
130362287|NCT01824342|469297861|FG000|Overall Study|Adverse Event|1|||
130362288|NCT01824342|469297862|FG001|Overall Study|Adverse Event|1|||
130362289|NCT01824342|469297861|FG000|Overall Study|Disease Progression|1|||
130362290|NCT01824342|469297862|FG001|Overall Study|Disease Progression|1|||
130362291|NCT01824342|469297861|FG000|Overall Study|Physician Decision|5|||
130362292|NCT01824342|469297862|FG001|Overall Study|Physician Decision|0|||
130362293|NCT01824342|469297861|FG000|Overall Study|Death|2|||
130362294|NCT01824342|469297862|FG001|Overall Study|Death|0|||
130362295|NCT01313858|469297868|FG000|Overall Study|Premature Treatment Termination|251|||
130362296|NCT01313858|469297869|FG001|Overall Study|Premature Treatment Termination|219|||
130450133|NCT00062868|469611167|FG012|Dose Level 3|Death|0|||
130450134|NCT00062868|469611168|FG013|Dose Level 3|Death|0|||
130450135|NCT00062868|469611169|FG014|Dose Level 3|Death|0|||
130450136|NCT00062868|469611170|FG015|Dose Level 3|Death|0|||
130450137|NCT00062868|469611171|FG016|Dose Level 3|Death|0|||
130450138|NCT00062868|469611172|FG017|Dose Level 3|Death|1|||
130450139|NCT00062868|469611173|FG018|Dose Level 3|Death|0|||
130450140|NCT00062868|469611174|FG019|Dose Level 3|Death|0|||
130450141|NCT00062868|469611175|FG020|Dose Level 3|Death|0|||
130450142|NCT00062868|469611155|FG000|Dose Level 3|Lost to Follow-up|0|||
130450143|NCT00062868|469611156|FG001|Dose Level 3|Lost to Follow-up|0|||
130696972|NCT01390948|470514545|FG002|Overall Study|Withdrew consent|0|||
130696973|NCT01390948|470514543|FG000|Overall Study|Progressive Disease|2|||
130696974|NCT01390948|470514544|FG001|Overall Study|Progressive Disease|5|||
130696975|NCT01390948|470514545|FG002|Overall Study|Progressive Disease|0|||
130450144|NCT00062868|469611157|FG002|Dose Level 3|Lost to Follow-up|0|||
130450145|NCT00062868|469611158|FG003|Dose Level 3|Lost to Follow-up|0|||
130450146|NCT00062868|469611159|FG004|Dose Level 3|Lost to Follow-up|0|||
130450147|NCT00062868|469611160|FG005|Dose Level 3|Lost to Follow-up|0|||
130450148|NCT00062868|469611161|FG006|Dose Level 3|Lost to Follow-up|0|||
130450149|NCT00062868|469611162|FG007|Dose Level 3|Lost to Follow-up|0|||
130450150|NCT00062868|469611163|FG008|Dose Level 3|Lost to Follow-up|0|||
130450151|NCT00062868|469611164|FG009|Dose Level 3|Lost to Follow-up|0|||
130450152|NCT00062868|469611165|FG010|Dose Level 3|Lost to Follow-up|0|||
130450153|NCT00062868|469611166|FG011|Dose Level 3|Lost to Follow-up|0|||
130450154|NCT00062868|469611167|FG012|Dose Level 3|Lost to Follow-up|0|||
130450155|NCT00062868|469611168|FG013|Dose Level 3|Lost to Follow-up|0|||
130450156|NCT00062868|469611169|FG014|Dose Level 3|Lost to Follow-up|1|||
130450157|NCT00062868|469611170|FG015|Dose Level 3|Lost to Follow-up|0|||
130450158|NCT00062868|469611171|FG016|Dose Level 3|Lost to Follow-up|0|||
130450159|NCT00062868|469611172|FG017|Dose Level 3|Lost to Follow-up|0|||
130450160|NCT00062868|469611173|FG018|Dose Level 3|Lost to Follow-up|0|||
130450161|NCT00062868|469611174|FG019|Dose Level 3|Lost to Follow-up|0|||
130450162|NCT00062868|469611175|FG020|Dose Level 3|Lost to Follow-up|0|||
130450163|NCT00062868|469611155|FG000|Dose Level 3|Withdrew|0|||
130450164|NCT00062868|469611156|FG001|Dose Level 3|Withdrew|0|||
130450165|NCT00062868|469611157|FG002|Dose Level 3|Withdrew|2|||
130450166|NCT00062868|469611158|FG003|Dose Level 3|Withdrew|0|||
130450167|NCT00062868|469611159|FG004|Dose Level 3|Withdrew|0|||
130450168|NCT00062868|469611160|FG005|Dose Level 3|Withdrew|0|||
130450169|NCT00062868|469611161|FG006|Dose Level 3|Withdrew|0|||
130450170|NCT00062868|469611162|FG007|Dose Level 3|Withdrew|0|||
130450171|NCT00062868|469611163|FG008|Dose Level 3|Withdrew|0|||
130450172|NCT00062868|469611164|FG009|Dose Level 3|Withdrew|0|||
130450173|NCT00062868|469611165|FG010|Dose Level 3|Withdrew|0|||
130450174|NCT00062868|469611166|FG011|Dose Level 3|Withdrew|0|||
130450175|NCT00062868|469611167|FG012|Dose Level 3|Withdrew|0|||
130450176|NCT00062868|469611168|FG013|Dose Level 3|Withdrew|0|||
130450177|NCT00062868|469611169|FG014|Dose Level 3|Withdrew|0|||
130450178|NCT00062868|469611170|FG015|Dose Level 3|Withdrew|0|||
130450179|NCT00062868|469611171|FG016|Dose Level 3|Withdrew|0|||
130450180|NCT00062868|469611172|FG017|Dose Level 3|Withdrew|0|||
130450181|NCT00062868|469611173|FG018|Dose Level 3|Withdrew|0|||
130450182|NCT00062868|469611174|FG019|Dose Level 3|Withdrew|0|||
130450183|NCT00062868|469611175|FG020|Dose Level 3|Withdrew|0|||
130450184|NCT01734811|469611176|FG000|Overall Study|Lost to Follow-up|2|||
130450185|NCT01734811|469611177|FG001|Overall Study|Lost to Follow-up|3|||
130450186|NCT01734811|469611176|FG000|Overall Study|Withdrawal by Subject|2|||
130450187|NCT01734811|469611177|FG001|Overall Study|Withdrawal by Subject|0|||
130450188|NCT00725010|469611180|FG000|Overall Study|Toxicity|9|||
130450189|NCT00725010|469611180|FG000|Overall Study|Tumor Progression|7|||
130450190|NCT00725010|469611180|FG000|Overall Study|Withdrawal by Subject|2|||
130450191|NCT00725010|469611180|FG000|Overall Study|Death|1|||
130450192|NCT00725010|469611180|FG000|Overall Study|Lost to Follow-up|1|||
130450193|NCT00725010|469611180|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
130450194|NCT00725010|469611180|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
130696976|NCT01390948|470514543|FG000|Overall Study|Death during follow-up|10|||
130450195|NCT00725010|469611180|FG000|Overall Study|No further documentation|1|||
130450196|NCT00725010|469611180|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
130450197|NCT02414828|469611181|FG000|Overall Study|Lost to Follow-up|0|||
130696977|NCT01390948|470514544|FG001|Overall Study|Death during follow-up|11|||
130696978|NCT01390948|470514545|FG002|Overall Study|Death during follow-up|1|||
130450198|NCT02414828|469611182|FG001|Overall Study|Lost to Follow-up|1|||
130450199|NCT02414828|469611183|FG002|Overall Study|Lost to Follow-up|1|||
130450200|NCT02414828|469611184|FG003|Overall Study|Lost to Follow-up|2|||
130450201|NCT01712685|469611216|FG000|Overall Study|pt declined to participate before trmt|1|||
130450202|NCT01866917|469611217|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
130450203|NCT01866917|469611218|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
130450204|NCT03253653|469611219|FG000|Overall Study|Withdrawal by Subject|4|||
130450205|NCT03253653|469611220|FG001|Overall Study|Withdrawal by Subject|1|||
130450206|NCT03253653|469611219|FG000|Overall Study|Protocol Violation|0|||
130450207|NCT03253653|469611220|FG001|Overall Study|Protocol Violation|5|||
130696979|NCT05315713|470514547|FG000|Overall Study|Death|5|||
130696980|NCT05315713|470514547|FG000|Overall Study|Progressive disease|1|||
130450208|NCT04610684|469612757|FG000|Study Treatment|Withdrawal by Subject|1|||
130450209|NCT04610684|469612757|FG000|Study Treatment|Disease Progression|2|||
130450210|NCT04610684|469612757|FG000|Follow up|Death|2|||
130450211|NCT04610684|469612757|FG000|Follow up|Withdrawal by Subject|1|||
130450212|NCT01251614|469612761|FG000|Overall Study|Adverse Event|1|||
130450213|NCT01251614|469612762|FG001|Overall Study|Adverse Event|0|||
130450214|NCT01251614|469612763|FG002|Overall Study|Adverse Event|1|||
130450215|NCT01251614|469612761|FG000|Overall Study|Lack of Efficacy|1|||
130450216|NCT01251614|469612762|FG001|Overall Study|Lack of Efficacy|9|||
130450217|NCT01251614|469612763|FG002|Overall Study|Lack of Efficacy|4|||
130696981|NCT05315713|470514547|FG000|Overall Study|Withdrawal by Subject|1|||
130696982|NCT05315713|470514547|FG000|Overall Study|Study terminated by sponsor|1|||
130696983|NCT03250117|470514550|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
130696984|NCT03250117|470514551|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130696985|NCT03250117|470514552|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130696986|NCT03250117|470514553|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130362297|NCT01313858|469297870|FG002|Overall Study|Premature Treatment Termination|191|||
130362298|NCT01313858|469297868|FG000|Overall Study|Lost to Follow-up|35|||
130362299|NCT01313858|469297869|FG001|Overall Study|Lost to Follow-up|51|||
130362300|NCT01313858|469297870|FG002|Overall Study|Lost to Follow-up|47|||
130362301|NCT02899299|469297872|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
130362302|NCT02899299|469297873|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
130362303|NCT02899299|469297872|FG000|Pre-treatment|Participant withdrew consent|1|||
130362304|NCT02899299|469297873|FG001|Pre-treatment|Participant withdrew consent|11|||
130362305|NCT02899299|469297872|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
130362306|NCT02899299|469297873|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
130362307|NCT02899299|469297872|FG000|Pre-treatment|Not reported|0|||
130362308|NCT02899299|469297873|FG001|Pre-treatment|Not reported|1|||
130362309|NCT02899299|469297872|FG000|Treatment|Disease Progression|182|||
130362310|NCT02899299|469297873|FG001|Treatment|Disease Progression|43|||
130362311|NCT02899299|469297872|FG000|Treatment|Study Drug Toxicity|60|||
130362312|NCT02899299|469297873|FG001|Treatment|Study Drug Toxicity|24|||
130362313|NCT02899299|469297872|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
130362314|NCT02899299|469297873|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
130362315|NCT02899299|469297872|FG000|Treatment|Participant request to discontinue Study treatment|4|||
130362316|NCT02899299|469297873|FG001|Treatment|Participant request to discontinue Study treatment|10|||
130362317|NCT02899299|469297872|FG000|Treatment|Participant withdrew consent|6|||
130362318|NCT02899299|469297873|FG001|Treatment|Participant withdrew consent|3|||
130362319|NCT02899299|469297872|FG000|Treatment|Lost to Follow-up|0|||
130362320|NCT02899299|469297873|FG001|Treatment|Lost to Follow-up|2|||
130362321|NCT02899299|469297872|FG000|Treatment|Maximum Clinical Benefit|11|||
130362322|NCT02899299|469297873|FG001|Treatment|Maximum Clinical Benefit|2|||
130362323|NCT02899299|469297872|FG000|Treatment|Poor/Non-compliance|1|||
130362324|NCT02899299|469297873|FG001|Treatment|Poor/Non-compliance|0|||
130362325|NCT02899299|469297872|FG000|Treatment|Participant no longer meets Study criteria|4|||
130362326|NCT02899299|469297873|FG001|Treatment|Participant no longer meets Study criteria|0|||
130362327|NCT02899299|469297872|FG000|Treatment|Administrative reason by Sponsor|2|||
130362328|NCT02899299|469297873|FG001|Treatment|Administrative reason by Sponsor|0|||
130362329|NCT02899299|469297872|FG000|Treatment|Other reasons|12|||
130362330|NCT02899299|469297873|FG001|Treatment|Other reasons|2|||
130362331|NCT02899299|469297872|FG000|Treatment|Not reported|7|||
130362332|NCT02899299|469297873|FG001|Treatment|Not reported|0|||
130362333|NCT02468232|469297883|FG000|Core Part of Study|Adverse Event|0|||
130362334|NCT02468232|469297884|FG001|Core Part of Study|Adverse Event|1|||
130362335|NCT02468232|469297885|FG002|Core Part of Study|Adverse Event|0|||
130362336|NCT02468232|469297886|FG003|Core Part of Study|Adverse Event|0|||
130362337|NCT02468232|469297883|FG000|Core Part of Study|Death|20|||
130362338|NCT02468232|469297884|FG001|Core Part of Study|Death|17|||
130362339|NCT02468232|469297885|FG002|Core Part of Study|Death|0|||
130362340|NCT02468232|469297886|FG003|Core Part of Study|Death|0|||
130362341|NCT02468232|469297883|FG000|Core Part of Study|Technical Problems|1|||
130362342|NCT02468232|469297884|FG001|Core Part of Study|Technical Problems|1|||
130362343|NCT02468232|469297885|FG002|Core Part of Study|Technical Problems|0|||
130362344|NCT02468232|469297886|FG003|Core Part of Study|Technical Problems|0|||
130362345|NCT02468232|469297883|FG000|OLE Part of Study|Adverse Event|0|||
130362346|NCT02468232|469297884|FG001|OLE Part of Study|Adverse Event|0|||
130362347|NCT02468232|469297885|FG002|OLE Part of Study|Adverse Event|4|||
130362348|NCT02468232|469297886|FG003|OLE Part of Study|Adverse Event|5|||
130450218|NCT01251614|469612761|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
130450219|NCT01251614|469612762|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
130362349|NCT02468232|469297883|FG000|OLE Part of Study|Death|0|||
130362350|NCT02468232|469297884|FG001|OLE Part of Study|Death|0|||
130362351|NCT02468232|469297885|FG002|OLE Part of Study|Death|4|||
130362352|NCT02468232|469297886|FG003|OLE Part of Study|Death|2|||
130450220|NCT01251614|469612763|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
130362353|NCT02468232|469297883|FG000|OLE Part of Study|Physician Decision|0|||
130362354|NCT02468232|469297884|FG001|OLE Part of Study|Physician Decision|0|||
130362355|NCT02468232|469297885|FG002|OLE Part of Study|Physician Decision|4|||
130362356|NCT02468232|469297886|FG003|OLE Part of Study|Physician Decision|0|||
130362357|NCT02468232|469297883|FG000|OLE Part of Study|Subject/Guardian decision|0|||
130362358|NCT02468232|469297884|FG001|OLE Part of Study|Subject/Guardian decision|0|||
130362359|NCT02468232|469297885|FG002|OLE Part of Study|Subject/Guardian decision|2|||
130362360|NCT02468232|469297886|FG003|OLE Part of Study|Subject/Guardian decision|5|||
130362361|NCT00506662|469297887|FG000|Overall Study|Adverse Event|0|||
130362362|NCT00506662|469297888|FG001|Overall Study|Adverse Event|2|||
130362363|NCT00506662|469297887|FG000|Overall Study|Lack of Efficacy|1|||
130362364|NCT00506662|469297888|FG001|Overall Study|Lack of Efficacy|0|||
130362365|NCT00506662|469297887|FG000|Overall Study|Protocol Violation|2|||
130362366|NCT00506662|469297888|FG001|Overall Study|Protocol Violation|4|||
130362367|NCT00506662|469297887|FG000|Overall Study|Trial terminated|10|||
130362368|NCT00506662|469297888|FG001|Overall Study|Trial terminated|16|||
130362369|NCT00506662|469297887|FG000|Overall Study|Not recorded|4|||
130362370|NCT00506662|469297888|FG001|Overall Study|Not recorded|6|||
130362371|NCT00246753|469297889|FG000|Overall Study|Withdrawal by Subject|2|||
130362372|NCT00246753|469297889|FG000|Overall Study|Physician Decision|2|||
130362373|NCT00246753|469297889|FG000|Overall Study|Adverse Event|2|||
130362374|NCT00246753|469297889|FG000|Overall Study|Unacceptable toxicity|2|||
130362375|NCT00617851|469297893|FG000|Overall Study|Death|0|||
130362376|NCT00617851|469297894|FG001|Overall Study|Death|0|||
130362377|NCT00617851|469297895|FG002|Overall Study|Death|0|||
130362378|NCT00617851|469297896|FG003|Overall Study|Death|1|||
130362379|NCT00617851|469297893|FG000|Overall Study|Withdrawal by Subject|14|||
130362380|NCT00617851|469297894|FG001|Overall Study|Withdrawal by Subject|7|||
130362381|NCT00617851|469297895|FG002|Overall Study|Withdrawal by Subject|12|||
130362382|NCT00617851|469297896|FG003|Overall Study|Withdrawal by Subject|4|||
130362383|NCT00617851|469297893|FG000|Overall Study|Lost to Follow-up|27|||
130362384|NCT00617851|469297894|FG001|Overall Study|Lost to Follow-up|29|||
130362385|NCT00617851|469297895|FG002|Overall Study|Lost to Follow-up|31|||
130362386|NCT00617851|469297896|FG003|Overall Study|Lost to Follow-up|19|||
130362387|NCT00617851|469297893|FG000|Overall Study|Inappropriate Enrollment|5|||
130362388|NCT00617851|469297894|FG001|Overall Study|Inappropriate Enrollment|4|||
130362389|NCT00617851|469297895|FG002|Overall Study|Inappropriate Enrollment|1|||
130362390|NCT00617851|469297896|FG003|Overall Study|Inappropriate Enrollment|1|||
130362391|NCT00617851|469297893|FG000|Overall Study|Unable to classify|1|||
130362392|NCT00617851|469297894|FG001|Overall Study|Unable to classify|0|||
130362393|NCT00617851|469297895|FG002|Overall Study|Unable to classify|1|||
130362394|NCT00617851|469297896|FG003|Overall Study|Unable to classify|0|||
130362395|NCT01200524|469297897|FG000|Overall Study|Withdrawal by Subject|1|||
130362396|NCT01200524|469297898|FG001|Overall Study|Withdrawal by Subject|1|||
130362397|NCT01200524|469297899|FG002|Overall Study|Withdrawal by Subject|3|||
130362398|NCT01200524|469297897|FG000|Overall Study|Adverse Event|1|||
130362399|NCT01200524|469297898|FG001|Overall Study|Adverse Event|0|||
130362400|NCT01200524|469297899|FG002|Overall Study|Adverse Event|0|||
130362401|NCT01200524|469297897|FG000|Overall Study|Non availability of study nurse|0|||
130362402|NCT01200524|469297898|FG001|Overall Study|Non availability of study nurse|0|||
130362403|NCT01200524|469297899|FG002|Overall Study|Non availability of study nurse|1|||
130362404|NCT01303861|469297900|FG000|Overall Study|Lost to Follow-up|34|||
130362405|NCT01303861|469297901|FG001|Overall Study|Lost to Follow-up|14|||
130362406|NCT01303861|469297902|FG002|Overall Study|Lost to Follow-up|27|||
130362407|NCT01303861|469297903|FG003|Overall Study|Lost to Follow-up|31|||
130362408|NCT01303861|469297900|FG000|Overall Study|Lack of Efficacy|3|||
130362409|NCT01303861|469297901|FG001|Overall Study|Lack of Efficacy|2|||
130362410|NCT01303861|469297902|FG002|Overall Study|Lack of Efficacy|1|||
130362411|NCT01303861|469297903|FG003|Overall Study|Lack of Efficacy|0|||
130362412|NCT01303861|469297900|FG000|Overall Study|Withdrawal by Subject|16|||
130362413|NCT01303861|469297901|FG001|Overall Study|Withdrawal by Subject|8|||
130362414|NCT01303861|469297902|FG002|Overall Study|Withdrawal by Subject|8|||
130362415|NCT01303861|469297903|FG003|Overall Study|Withdrawal by Subject|23|||
130362416|NCT01303861|469297900|FG000|Overall Study|Adverse Event|4|||
130362417|NCT01303861|469297901|FG001|Overall Study|Adverse Event|1|||
130362418|NCT01303861|469297902|FG002|Overall Study|Adverse Event|0|||
130362419|NCT01303861|469297903|FG003|Overall Study|Adverse Event|5|||
130362420|NCT01303861|469297900|FG000|Overall Study|Pregnancy|1|||
130362421|NCT01303861|469297901|FG001|Overall Study|Pregnancy|0|||
130696987|NCT00556673|470514555|FG000|Overall Study|Protocol deviation|3|||
130362422|NCT01303861|469297902|FG002|Overall Study|Pregnancy|0|||
130362423|NCT01303861|469297903|FG003|Overall Study|Pregnancy|0|||
130362424|NCT02476201|469297906|FG000|Overall Study|Unable to program MPP|9|||
130362425|NCT02476201|469297906|FG000|Overall Study|Study echo not performed|5|||
130362426|NCT02476201|469297906|FG000|Overall Study|Adverse Event|4|||
130362427|NCT02476201|469297906|FG000|Overall Study|Death|2|||
130362428|NCT02476201|469297906|FG000|Overall Study|Lost to Follow-up|2|||
130362429|NCT02476201|469297906|FG000|Overall Study|MPP programmed to OFF|2|||
130362430|NCT02476201|469297906|FG000|Overall Study|Withdrawal by Subject|1|||
130450221|NCT01251614|469612761|FG000|Overall Study|Pregnancy|0|||
130450222|NCT01251614|469612762|FG001|Overall Study|Pregnancy|0|||
130450223|NCT01251614|469612763|FG002|Overall Study|Pregnancy|2|||
130243494|NCT01112267|468853295|FG000|Overall Study|Participants not compliant|1|||
130243495|NCT01112267|468853296|FG001|Overall Study|Participants not compliant|2|||
130243496|NCT01112267|468853295|FG000|Overall Study|Participants not receive any study drug|1|||
130243497|NCT01112267|468853296|FG001|Overall Study|Participants not receive any study drug|2|||
130243498|NCT00420407|468853298|FG000|Overall Study|Lost to Follow-up|0|||
130243499|NCT00420407|468853299|FG001|Overall Study|Lost to Follow-up|3|||
130243500|NCT00420407|468853298|FG000|Overall Study|Physician Decision|2|||
130243501|NCT00420407|468853299|FG001|Overall Study|Physician Decision|1|||
130243502|NCT00420407|468853298|FG000|Overall Study|subject identified as detainee|1|||
130243503|NCT00420407|468853299|FG001|Overall Study|subject identified as detainee|0|||
130243504|NCT00420407|468853298|FG000|Overall Study|subject identified as Jehovah's witness|1|||
130243505|NCT00420407|468853299|FG001|Overall Study|subject identified as Jehovah's witness|0|||
130243506|NCT00420407|468853298|FG000|Overall Study|Withdrawal by Subject|0|||
130243507|NCT00420407|468853299|FG001|Overall Study|Withdrawal by Subject|2|||
130243508|NCT05638737|468853302|FG000|Overall Study|Withdrawal by Subject|4|||
130243509|NCT05638737|468853303|FG001|Overall Study|Withdrawal by Subject|7|||
130243510|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
130243511|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
130243512|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130243513|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130243514|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
130243515|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
130243516|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
130243517|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
130243518|NCT04633447|468853306|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
130243519|NCT04633447|468853307|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
130243520|NCT04633447|468853306|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130243521|NCT04633447|468853307|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130243522|NCT03641924|468853308|FG000|Overall Study|Withdrawal by Subject|26|||
130243523|NCT03641924|468853308|FG000|Overall Study|Lost to Follow-up|16|||
130243524|NCT03641924|468853308|FG000|Overall Study|Protocol Violation|10|||
130243525|NCT04333498|468853309|FG000|Overall Study|Lost to Follow-up|1|||
130243526|NCT04333498|468853310|FG001|Overall Study|Lost to Follow-up|0|||
130243527|NCT04333498|468853309|FG000|Overall Study|Lost to Follow-up|0|||
130243528|NCT04333498|468853310|FG001|Overall Study|Lost to Follow-up|1|||
130243529|NCT01565694|468853311|FG000|Dose-Titration Period|Adverse Event|4|||
130243530|NCT01565694|468853311|FG000|Dose-Titration Period|Protocol Violation|10|||
130243531|NCT01565694|468853311|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
130243532|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
130243533|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
130243534|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
130243535|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
130243536|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
130243537|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
130243538|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243539|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243540|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243541|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130362431|NCT02476201|469297906|FG000|Overall Study|Unsuccessful implant|1|||
130362432|NCT02248701|469297912|FG000|Overall Study|Withdrawal by Subject|2|||
130362433|NCT02248701|469297913|FG001|Overall Study|Withdrawal by Subject|1|||
130362434|NCT02248701|469297912|FG000|Overall Study|Physician Decision|0|||
130362435|NCT02248701|469297913|FG001|Overall Study|Physician Decision|1|||
130362436|NCT02248701|469297912|FG000|Overall Study|Adverse Event|1|||
130362437|NCT02248701|469297913|FG001|Overall Study|Adverse Event|0|||
130362438|NCT02248701|469297912|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
130450224|NCT01251614|469612761|FG000|Overall Study|Loss of Disease Control|0|||
130450225|NCT01251614|469612762|FG001|Overall Study|Loss of Disease Control|1|||
130243542|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243543|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
130243544|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243545|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243546|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243547|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243548|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130450226|NCT01251614|469612763|FG002|Overall Study|Loss of Disease Control|0|||
130450227|NCT01251614|469612761|FG000|Overall Study|Withdrawal by Subject|0|||
130243549|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
130243550|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243551|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130243552|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
130243553|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130243554|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243555|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243556|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
130243557|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
130243558|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
130243559|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
130243560|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
130243561|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
130243562|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
130243563|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
130243564|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
130243565|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
130243566|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
130243567|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
130243568|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243569|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243570|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243571|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243572|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243573|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
130243574|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243575|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
130243576|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243577|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243578|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
130243579|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
130243580|NCT00541229|468853318|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
130243581|NCT00541229|468853319|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
130243582|NCT00541229|468853320|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
130243583|NCT00541229|468853321|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
130243584|NCT00541229|468853322|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
130243585|NCT00541229|468853323|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
130243586|NCT00541229|468853318|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130362439|NCT02248701|469297913|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
130362440|NCT00845858|469297914|FG000|Overall Study|Withdrawal by Subject|5|||
130362441|NCT00845858|469297915|FG001|Overall Study|Withdrawal by Subject|1|||
130362442|NCT00845858|469297916|FG002|Overall Study|Withdrawal by Subject|1|||
130362443|NCT00845858|469297914|FG000|Overall Study|Adverse Event|3|||
130362444|NCT00845858|469297915|FG001|Overall Study|Adverse Event|8|||
130362445|NCT00845858|469297916|FG002|Overall Study|Adverse Event|4|||
130362446|NCT00845858|469297914|FG000|Overall Study|Protocol Violation|0|||
130362447|NCT00845858|469297915|FG001|Overall Study|Protocol Violation|0|||
130362448|NCT00845858|469297916|FG002|Overall Study|Protocol Violation|1|||
130362449|NCT00845858|469297914|FG000|Overall Study|not eligible|0|||
130362450|NCT00845858|469297915|FG001|Overall Study|not eligible|3|||
130362451|NCT00845858|469297916|FG002|Overall Study|not eligible|2|||
130362452|NCT00880542|469297917|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
130362453|NCT00880542|469297917|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
130362454|NCT00880542|469297917|FG000|REP: Surgical Resection|progressive disease|1|||
130362455|NCT04289623|469297918|FG000|Wave 1 Emails|Email was not delivered|268|||
130362456|NCT04289623|469297919|FG001|Wave 1 Emails|Email was not delivered|257|||
130362457|NCT04289623|469297920|FG002|Wave 1 Emails|Email was not delivered|0|||
130362458|NCT04289623|469297921|FG003|Wave 1 Emails|Email was not delivered|0|||
130362459|NCT04289623|469297922|FG004|Wave 1 Emails|Email was not delivered|0|||
130362460|NCT04289623|469297923|FG005|Wave 1 Emails|Email was not delivered|0|||
130362461|NCT03758443|469297924|FG000|Induction Period|Adverse Event|2|||
130243587|NCT00541229|468853319|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243588|NCT00541229|468853320|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243589|NCT00541229|468853321|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130362462|NCT03758443|469297925|FG001|Induction Period|Adverse Event|4|||
130362463|NCT03758443|469297926|FG002|Induction Period|Adverse Event|2|||
130362464|NCT03758443|469297927|FG003|Induction Period|Adverse Event|3|||
130362465|NCT03758443|469297924|FG000|Induction Period|Physician Decision|1|||
130362466|NCT03758443|469297925|FG001|Induction Period|Physician Decision|1|||
130243590|NCT00541229|468853322|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243591|NCT00541229|468853323|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130243592|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
130243593|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243594|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243595|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243596|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243597|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243598|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243599|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243600|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243601|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243602|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
130243603|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243604|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130243605|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130243606|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
130243607|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130243608|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130243609|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130362467|NCT03758443|469297926|FG002|Induction Period|Physician Decision|3|||
130362468|NCT03758443|469297927|FG003|Induction Period|Physician Decision|0|||
130362469|NCT03758443|469297924|FG000|Induction Period|Protocol Violation|0|||
130362470|NCT03758443|469297925|FG001|Induction Period|Protocol Violation|0|||
130362471|NCT03758443|469297926|FG002|Induction Period|Protocol Violation|0|||
130362472|NCT03758443|469297927|FG003|Induction Period|Protocol Violation|1|||
130362473|NCT03758443|469297924|FG000|Induction Period|Withdrawal by Subject|3|||
130362474|NCT03758443|469297925|FG001|Induction Period|Withdrawal by Subject|2|||
130362475|NCT03758443|469297926|FG002|Induction Period|Withdrawal by Subject|2|||
130362476|NCT03758443|469297927|FG003|Induction Period|Withdrawal by Subject|4|||
130362477|NCT03758443|469297924|FG000|Extended Induction Period|Adverse Event|1|||
130362478|NCT03758443|469297925|FG001|Extended Induction Period|Adverse Event|1|||
130362479|NCT03758443|469297926|FG002|Extended Induction Period|Adverse Event|0|||
130362480|NCT03758443|469297927|FG003|Extended Induction Period|Adverse Event|1|||
130362481|NCT03758443|469297924|FG000|Extended Induction Period|Lost to Follow-up|1|||
130362482|NCT03758443|469297925|FG001|Extended Induction Period|Lost to Follow-up|0|||
130362483|NCT03758443|469297926|FG002|Extended Induction Period|Lost to Follow-up|0|||
130362484|NCT03758443|469297927|FG003|Extended Induction Period|Lost to Follow-up|0|||
130362485|NCT03758443|469297924|FG000|Extended Induction Period|Physician Decision|2|||
130362486|NCT03758443|469297925|FG001|Extended Induction Period|Physician Decision|1|||
130362487|NCT03758443|469297926|FG002|Extended Induction Period|Physician Decision|2|||
130362488|NCT03758443|469297927|FG003|Extended Induction Period|Physician Decision|2|||
130362489|NCT03758443|469297924|FG000|Extended Induction Period|Protocol Violation|0|||
130362490|NCT03758443|469297925|FG001|Extended Induction Period|Protocol Violation|0|||
130362491|NCT03758443|469297926|FG002|Extended Induction Period|Protocol Violation|0|||
130362492|NCT03758443|469297927|FG003|Extended Induction Period|Protocol Violation|1|||
130362493|NCT03758443|469297924|FG000|Extended Induction Period|Withdrawal by Subject|8|||
130362494|NCT03758443|469297925|FG001|Extended Induction Period|Withdrawal by Subject|1|||
130362495|NCT03758443|469297926|FG002|Extended Induction Period|Withdrawal by Subject|7|||
130362496|NCT03758443|469297927|FG003|Extended Induction Period|Withdrawal by Subject|3|||
130362497|NCT03758443|469297924|FG000|Extended Induction Period|Miscellaneous|1|||
130362498|NCT03758443|469297925|FG001|Extended Induction Period|Miscellaneous|0|||
130362499|NCT03758443|469297926|FG002|Extended Induction Period|Miscellaneous|0|||
130362500|NCT03758443|469297927|FG003|Extended Induction Period|Miscellaneous|0|||
130362501|NCT03758443|469297924|FG000|Maintenance Period|Adverse Event|1|||
130362502|NCT03758443|469297925|FG001|Maintenance Period|Adverse Event|2|||
130362503|NCT03758443|469297926|FG002|Maintenance Period|Adverse Event|0|||
130362504|NCT03758443|469297927|FG003|Maintenance Period|Adverse Event|0|||
130362505|NCT03758443|469297924|FG000|Maintenance Period|Lost to Follow-up|0|||
130362506|NCT03758443|469297925|FG001|Maintenance Period|Lost to Follow-up|0|||
130362507|NCT03758443|469297926|FG002|Maintenance Period|Lost to Follow-up|0|||
130362508|NCT03758443|469297927|FG003|Maintenance Period|Lost to Follow-up|1|||
130362509|NCT03758443|469297924|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
130362510|NCT03758443|469297925|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
130362511|NCT03758443|469297926|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
130362512|NCT03758443|469297927|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
130362513|NCT03758443|469297924|FG000|Maintenance Period|Protocol Violation|0|||
130362514|NCT03758443|469297925|FG001|Maintenance Period|Protocol Violation|1|||
130362515|NCT03758443|469297926|FG002|Maintenance Period|Protocol Violation|0|||
130362516|NCT03758443|469297927|FG003|Maintenance Period|Protocol Violation|0|||
130362517|NCT03758443|469297924|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
130450228|NCT01251614|469612762|FG001|Overall Study|Withdrawal by Subject|2|||
130450229|NCT01251614|469612763|FG002|Overall Study|Withdrawal by Subject|1|||
130450230|NCT01251614|469612761|FG000|Overall Study|Lost to Follow-up|0|||
130450231|NCT01251614|469612762|FG001|Overall Study|Lost to Follow-up|1|||
130450232|NCT01251614|469612763|FG002|Overall Study|Lost to Follow-up|0|||
130450233|NCT02153788|469612764|FG000|Overall Study|Physician Decision|2|||
130450234|NCT02153788|469612765|FG001|Overall Study|Physician Decision|1|||
130450235|NCT01684046|469612767|FG000|Period 1, First 30 Days|Adverse Event|0|||
130450236|NCT01684046|469612768|FG001|Period 1, First 30 Days|Adverse Event|2|||
130450237|NCT04531540|469612771|FG000|Overall Study|Adverse Event|1|||
130450238|NCT04531540|469612771|FG000|Overall Study|Protocol Violation|3|||
130450239|NCT04531540|469612771|FG000|Overall Study|Withdrawal by Subject|4|||
130450240|NCT04531540|469612771|FG000|Overall Study|Found to be Ineligible|1|||
130450241|NCT02688621|469612772|FG000|Overall Study|Pregnancy|1|||
130450242|NCT02688621|469612773|FG001|Overall Study|Pregnancy|3|||
130450243|NCT02688621|469612772|FG000|Overall Study|Lost to Follow-up|38|||
130450244|NCT02688621|469612773|FG001|Overall Study|Lost to Follow-up|15|||
130450245|NCT02688621|469612772|FG000|Overall Study|Withdrawal by Subject|1|||
130450246|NCT02688621|469612773|FG001|Overall Study|Withdrawal by Subject|0|||
130450247|NCT03239210|469612774|FG000|Overall Study|Lost to Follow-up|2|||
130450248|NCT03239210|469612775|FG001|Overall Study|Lost to Follow-up|2|||
130450249|NCT03239210|469612774|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
130450250|NCT03239210|469612775|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
130450251|NCT03239210|469612774|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
130450252|NCT03239210|469612775|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
130450253|NCT01575860|469612776|FG000|Overall Study|Withdrawal by Subject|1|||
130450254|NCT01575860|469612776|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
130450255|NCT01094743|469612778|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
130450256|NCT02851511|469612779|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
130450257|NCT02851511|469612780|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
130450258|NCT02851511|469612781|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
130450259|NCT02851511|469612782|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
130450260|NCT02851511|469612779|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
130450261|NCT02851511|469612780|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
130450262|NCT02851511|469612781|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
130450263|NCT02851511|469612782|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
130450264|NCT02851511|469612779|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
130450265|NCT02851511|469612780|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
130450266|NCT02851511|469612781|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
130243610|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
130243611|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
130243612|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
130243613|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
130243614|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
130243615|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
130243616|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130362518|NCT03758443|469297925|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
130362519|NCT03758443|469297926|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
130362520|NCT03758443|469297927|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
130362521|NCT03758443|469297924|FG000|Maintenance Period|Withdrawal by Subject|1|||
130362522|NCT03758443|469297925|FG001|Maintenance Period|Withdrawal by Subject|0|||
130362523|NCT03758443|469297926|FG002|Maintenance Period|Withdrawal by Subject|1|||
130362524|NCT03758443|469297927|FG003|Maintenance Period|Withdrawal by Subject|1|||
130362525|NCT03758443|469297924|FG000|Maintenance Period|Miscellaneous|0|||
130362526|NCT03758443|469297925|FG001|Maintenance Period|Miscellaneous|0|||
130362527|NCT03758443|469297926|FG002|Maintenance Period|Miscellaneous|1|||
130362528|NCT03758443|469297927|FG003|Maintenance Period|Miscellaneous|0|||
130362529|NCT03080454|469297928|FG000|Baseline|Adverse Event|2|||
130362530|NCT03080454|469297928|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
130362531|NCT03080454|469297928|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
130362532|NCT01436396|469297929|FG000|Overall Study|Protocol Violation|7|||
130362533|NCT01436396|469297930|FG001|Overall Study|Protocol Violation|5|||
130362534|NCT01436396|469297929|FG000|Overall Study|Adverse Event|1|||
130362535|NCT01436396|469297930|FG001|Overall Study|Adverse Event|2|||
130450267|NCT02851511|469612782|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
130450268|NCT02851511|469612779|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
130450269|NCT02851511|469612780|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
130450270|NCT02851511|469612781|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
130696988|NCT00556673|470514556|FG001|Overall Study|Protocol deviation|2|||
130696989|NCT03555695|470514557|FG000|Overall Study|Withdrawal by Subject|1|||
130362536|NCT01436396|469297929|FG000|Overall Study|Withdrawal by Subject|19|||
130362537|NCT01436396|469297930|FG001|Overall Study|Withdrawal by Subject|29|||
130362538|NCT01436396|469297929|FG000|Overall Study|Serious adverse event|2|||
130243617|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243618|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243619|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243620|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243621|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
130243622|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243623|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243624|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
130243625|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243626|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243627|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243628|NCT00134719|468853324|FG000|Primary Vaccination Phase|Adverse Event|4|||
130243629|NCT00134719|468853325|FG001|Primary Vaccination Phase|Adverse Event|0|||
130243630|NCT00134719|468853326|FG002|Primary Vaccination Phase|Adverse Event|0|||
130243631|NCT00134719|468853324|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130243632|NCT00134719|468853325|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130243633|NCT00134719|468853326|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130243634|NCT00134719|468853324|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
130243635|NCT00134719|468853325|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
130243636|NCT00134719|468853326|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
130243637|NCT00134719|468853324|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
130243638|NCT00134719|468853325|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
130243639|NCT00134719|468853326|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
130243640|NCT00134719|468853324|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130243641|NCT00134719|468853325|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
130243642|NCT00134719|468853326|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130243643|NCT00134719|468853324|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
130243644|NCT00134719|468853325|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130243645|NCT00134719|468853326|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130243646|NCT03439839|468853327|FG000|Overall Study|Death|3|||
130243647|NCT03439839|468853328|FG001|Overall Study|Death|0|||
130243648|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243649|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
130243650|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
130243651|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243652|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243653|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243654|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243655|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130243656|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243657|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130243658|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243659|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243660|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243661|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243662|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243663|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243664|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
130243665|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243666|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130696990|NCT03555695|470514557|FG000|Overall Study|Lost to Follow-up|1|||
130696991|NCT03555695|470514557|FG000|Overall Study|appendicitis (unrelated)|1|||
130243667|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243668|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243669|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
130243670|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243671|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243672|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243673|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243674|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243675|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243676|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243677|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243678|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
130243679|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243680|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130696992|NCT03555695|470514557|FG000|Overall Study|pre-existing sciatica|1|||
130696993|NCT04194151|470514558|FG000|Overall Study|Physician Decision|1|||
130362539|NCT01436396|469297930|FG001|Overall Study|Serious adverse event|3|||
130362540|NCT01436396|469297929|FG000|Overall Study|Lost to Follow-up|3|||
130362541|NCT01436396|469297930|FG001|Overall Study|Lost to Follow-up|3|||
130362542|NCT00216476|469297931|FG000|Overall Study|Withdrawal by Subject|59|||
130362543|NCT00216476|469297932|FG001|Overall Study|Withdrawal by Subject|72|||
130362544|NCT00216476|469297933|FG002|Overall Study|Withdrawal by Subject|9|||
130362545|NCT00216476|469297931|FG000|Overall Study|Lost to Follow-up|10|||
130362546|NCT00216476|469297932|FG001|Overall Study|Lost to Follow-up|9|||
130362547|NCT00216476|469297933|FG002|Overall Study|Lost to Follow-up|1|||
130362548|NCT00216476|469297931|FG000|Overall Study|Adverse Event|6|||
130362549|NCT00216476|469297932|FG001|Overall Study|Adverse Event|10|||
130362550|NCT00216476|469297933|FG002|Overall Study|Adverse Event|1|||
130362551|NCT00216476|469297931|FG000|Overall Study|Lack of Efficacy|4|||
130362552|NCT00216476|469297932|FG001|Overall Study|Lack of Efficacy|3|||
130362553|NCT00216476|469297933|FG002|Overall Study|Lack of Efficacy|0|||
130362554|NCT00216476|469297931|FG000|Overall Study|Death|2|||
130362555|NCT00216476|469297932|FG001|Overall Study|Death|0|||
130362556|NCT00216476|469297933|FG002|Overall Study|Death|0|||
130362557|NCT00216476|469297931|FG000|Overall Study|Pregnancy|0|||
130362558|NCT00216476|469297932|FG001|Overall Study|Pregnancy|1|||
130362559|NCT00216476|469297933|FG002|Overall Study|Pregnancy|1|||
130362560|NCT00216476|469297931|FG000|Overall Study|Other|0|||
130362561|NCT00216476|469297932|FG001|Overall Study|Other|0|||
130362562|NCT00216476|469297933|FG002|Overall Study|Other|1|||
130362563|NCT00216476|469297931|FG000|Overall Study|Refuses Injection|11|||
130362564|NCT00216476|469297932|FG001|Overall Study|Refuses Injection|0|||
130362565|NCT00216476|469297933|FG002|Overall Study|Refuses Injection|0|||
130362566|NCT00216476|469297931|FG000|Overall Study|No Further Need for Treatment|3|||
130362567|NCT00216476|469297932|FG001|Overall Study|No Further Need for Treatment|4|||
130362568|NCT00216476|469297933|FG002|Overall Study|No Further Need for Treatment|1|||
130362569|NCT00216476|469297931|FG000|Overall Study|Non-compliance|0|||
130362570|NCT00216476|469297932|FG001|Overall Study|Non-compliance|4|||
130362571|NCT00216476|469297933|FG002|Overall Study|Non-compliance|1|||
130362572|NCT00216476|469297931|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
130362573|NCT00216476|469297932|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
130362574|NCT00216476|469297933|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
130362575|NCT00216476|469297931|FG000|Overall Study|Administrative Reasons|1|||
130362576|NCT00216476|469297932|FG001|Overall Study|Administrative Reasons|1|||
130362577|NCT00216476|469297933|FG002|Overall Study|Administrative Reasons|0|||
130362578|NCT00216476|469297931|FG000|Overall Study|Protocol Deviation|5|||
130362579|NCT00216476|469297932|FG001|Overall Study|Protocol Deviation|1|||
130362580|NCT00216476|469297933|FG002|Overall Study|Protocol Deviation|0|||
130362581|NCT00216476|469297931|FG000|Overall Study|Patient Moved|2|||
130362582|NCT00216476|469297932|FG001|Overall Study|Patient Moved|2|||
130362583|NCT00216476|469297933|FG002|Overall Study|Patient Moved|0|||
130362584|NCT02191137|469297934|FG000|Treatment|Death|4|||
130362585|NCT02191137|469297934|FG000|Treatment|Withdrawal by Subject|3|||
130362586|NCT02191137|469297934|FG000|Treatment|Adverse Event|2|||
130362587|NCT02191137|469297934|FG000|Treatment|Other|1|||
130362588|NCT02191137|469297934|FG000|Follow-up|Lost to Follow-up|2|||
130362589|NCT02191137|469297934|FG000|Follow-up|Ongoing/unknown|2|||
130362590|NCT02191137|469297934|FG000|Follow-up|Adverse Event|1|||
130362591|NCT00696800|469297935|FG000|Overall Study|Adverse Event|16|||
130362592|NCT00696800|469297936|FG001|Overall Study|Adverse Event|3|||
130362593|NCT00696800|469297935|FG000|Overall Study|Insufficient compliance with medication|2|||
130362594|NCT00696800|469297936|FG001|Overall Study|Insufficient compliance with medication|1|||
130362595|NCT00696800|469297935|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
130362596|NCT00696800|469297936|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
130362597|NCT00696800|469297935|FG000|Overall Study|Insufficient ovarian response|4|||
130362598|NCT00696800|469297936|FG001|Overall Study|Insufficient ovarian response|1|||
130362599|NCT00696800|469297935|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
130696994|NCT04194151|470514559|FG001|Overall Study|Physician Decision|1|||
130696995|NCT04194151|470514560|FG002|Overall Study|Physician Decision|1|||
130696996|NCT04194151|470514561|FG003|Overall Study|Physician Decision|1|||
130696997|NCT04194151|470514562|FG004|Overall Study|Physician Decision|0|||
130696998|NCT04194151|470514563|FG005|Overall Study|Physician Decision|1|||
130362600|NCT00696800|469297936|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
130362601|NCT00696800|469297935|FG000|Overall Study|Too high ovarian response|6|||
130362602|NCT00696800|469297936|FG001|Overall Study|Too high ovarian response|1|||
130362603|NCT00696800|469297935|FG000|Overall Study|No/too few/bad quality oocytes|4|||
130362604|NCT00696800|469297936|FG001|Overall Study|No/too few/bad quality oocytes|3|||
130362605|NCT00696800|469297935|FG000|Overall Study|No/abnormal fertilization|11|||
130362606|NCT00696800|469297936|FG001|Overall Study|No/abnormal fertilization|13|||
130362607|NCT00696800|469297935|FG000|Overall Study|No/too few/bad quality embryos|24|||
130362608|NCT00696800|469297936|FG001|Overall Study|No/too few/bad quality embryos|18|||
130362609|NCT00696800|469297935|FG000|Overall Study|Other Reasons|5|||
130696999|NCT04194151|470514558|FG000|Overall Study|Monitorization problem|0|||
130697000|NCT04194151|470514559|FG001|Overall Study|Monitorization problem|1|||
130243681|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243682|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243683|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
130243684|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243685|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243686|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243687|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243688|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243689|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243690|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
130243691|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
130243692|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243693|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243694|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
130243695|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243696|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243697|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243698|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243699|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243700|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
130243701|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243702|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243703|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243704|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
130243705|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243706|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130362610|NCT00696800|469297936|FG001|Overall Study|Other Reasons|3|||
130362611|NCT00696800|469297935|FG000|Overall Study|Not treated|1|||
130362612|NCT00696800|469297936|FG001|Overall Study|Not treated|2|||
130362613|NCT02853344|469297941|FG000|Overall Study|Lost to Follow-up|1|||
130362614|NCT02853344|469297942|FG001|Overall Study|Lost to Follow-up|1|||
130243707|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243708|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243709|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243710|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243711|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243712|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
130243713|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243714|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243715|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243716|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243717|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243718|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
130243719|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243720|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243721|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
130243722|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243723|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243724|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243725|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
130243726|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
130243727|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243728|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243729|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
130243730|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243731|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243732|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243733|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243734|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243735|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243736|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243737|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243738|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243739|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
130243740|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
130362615|NCT02853344|469297941|FG000|Overall Study|Withdrawal by Subject|2|||
130243741|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243742|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130243743|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130243744|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243745|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243746|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243747|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243748|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243749|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243750|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243751|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
130243752|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243753|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243754|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243755|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243756|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243757|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243758|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
130243759|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243760|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243761|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243762|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243763|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243764|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243765|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
130243766|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
130243767|NCT01797185|468853341|FG000|Overall Study|Adverse Event|5|||
130243768|NCT01797185|468853342|FG001|Overall Study|Adverse Event|15|||
130243769|NCT01797185|468853343|FG002|Overall Study|Adverse Event|6|||
130243770|NCT01797185|468853341|FG000|Overall Study|Withdrawal by Subject|6|||
130243771|NCT01797185|468853342|FG001|Overall Study|Withdrawal by Subject|9|||
130243772|NCT01797185|468853343|FG002|Overall Study|Withdrawal by Subject|5|||
130243773|NCT01797185|468853341|FG000|Overall Study|Site terminated|8|||
130243774|NCT01797185|468853342|FG001|Overall Study|Site terminated|4|||
130243775|NCT01797185|468853343|FG002|Overall Study|Site terminated|0|||
130243776|NCT01797185|468853341|FG000|Overall Study|Lost to Follow-up|2|||
130243777|NCT01797185|468853342|FG001|Overall Study|Lost to Follow-up|6|||
130243778|NCT01797185|468853343|FG002|Overall Study|Lost to Follow-up|1|||
130243779|NCT01797185|468853341|FG000|Overall Study|Withdrawn per sponsor|5|||
130243780|NCT01797185|468853342|FG001|Overall Study|Withdrawn per sponsor|0|||
130243781|NCT01797185|468853343|FG002|Overall Study|Withdrawn per sponsor|0|||
130243782|NCT01797185|468853341|FG000|Overall Study|Physician Decision|1|||
130243783|NCT01797185|468853342|FG001|Overall Study|Physician Decision|3|||
130243784|NCT01797185|468853343|FG002|Overall Study|Physician Decision|0|||
130243785|NCT01797185|468853341|FG000|Overall Study|Protocol Violation|1|||
130243786|NCT01797185|468853342|FG001|Overall Study|Protocol Violation|1|||
130243787|NCT01797185|468853343|FG002|Overall Study|Protocol Violation|0|||
130243788|NCT00723944|468853344|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130243789|NCT00723944|468853345|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
130243790|NCT00723944|468853344|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130243791|NCT00723944|468853345|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130243792|NCT00723944|468853344|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
130243793|NCT00723944|468853345|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
130243794|NCT05177094|468853346|FG000|Overall Study|Adverse Event|5|||
130243795|NCT05177094|468853347|FG001|Overall Study|Adverse Event|5|||
130243796|NCT05177094|468853346|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
130243797|NCT05177094|468853347|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
130243798|NCT05177094|468853346|FG000|Overall Study|Protocol Deviation|3|||
130243799|NCT05177094|468853347|FG001|Overall Study|Protocol Deviation|0|||
130243800|NCT05177094|468853346|FG000|Overall Study|Withdrawal by Subject|6|||
130243801|NCT05177094|468853347|FG001|Overall Study|Withdrawal by Subject|3|||
130243802|NCT05177094|468853346|FG000|Overall Study|Participant could not tolerate long study visits|1|||
130243803|NCT05177094|468853347|FG001|Overall Study|Participant could not tolerate long study visits|0|||
130243804|NCT02400736|468853348|FG000|Overall Study|Lost to Follow-up|6|||
130243805|NCT02400736|468853349|FG001|Overall Study|Lost to Follow-up|6|||
130243806|NCT02400736|468853348|FG000|Overall Study|Withdrawal by Subject|2|||
130243807|NCT02400736|468853349|FG001|Overall Study|Withdrawal by Subject|1|||
130243808|NCT02400736|468853348|FG000|Overall Study|Moved from the area|3|||
130243809|NCT02400736|468853349|FG001|Overall Study|Moved from the area|1|||
130243810|NCT03520569|468853350|FG000|Overall Study|Withdrawal by Subject|1|||
130243811|NCT03418675|468853351|FG000|Overall Study|Lost to Follow-up|13|||
130243812|NCT03418675|468853352|FG001|Overall Study|Lost to Follow-up|10|||
130243813|NCT03418675|468853351|FG000|Overall Study|Adverse Event|2|||
130243814|NCT03418675|468853352|FG001|Overall Study|Adverse Event|0|||
130243815|NCT01178411|468853353|FG000|Overall Study|Adverse Event|5|||
130243816|NCT01178411|468853353|FG000|Overall Study|Withdrawal by Subject|4|||
130243817|NCT01178411|468853353|FG000|Overall Study|Protocol Violation|1|||
130243818|NCT01178411|468853353|FG000|Overall Study|Progressive disease per RECIST|32|||
130243819|NCT01178411|468853353|FG000|Overall Study|Progressive disease per clinician|9|||
130243820|NCT01178411|468853353|FG000|Overall Study|Physician Decision|6|||
130243821|NCT01178411|468853353|FG000|Overall Study|Death|1|||
130243822|NCT01178411|468853353|FG000|Overall Study|No reason provided|1|||
130243823|NCT01178411|468853353|FG000|Overall Study|Drug manufacturing ended|1|||
130243824|NCT01875237|468853354|FG000|Overall Study|GVDH before DLI|1|||
130243825|NCT01875237|468853355|FG001|Overall Study|GVDH before DLI|0|||
130243826|NCT01875237|468853354|FG000|Overall Study|DLI cells could not be produced|1|||
130243827|NCT01875237|468853355|FG001|Overall Study|DLI cells could not be produced|0|||
130243828|NCT03558672|468853356|FG000|Overall Study|Study Early Termination|10|||
130243829|NCT00421733|468853358|FG000|Overall Study|Adverse Event|4|||
130243830|NCT00421733|468853359|FG001|Overall Study|Adverse Event|9|||
130243831|NCT00421733|468853360|FG002|Overall Study|Adverse Event|2|||
130243832|NCT00421733|468853358|FG000|Overall Study|Lost to Follow-up|1|||
130243833|NCT00421733|468853359|FG001|Overall Study|Lost to Follow-up|2|||
130243834|NCT00421733|468853360|FG002|Overall Study|Lost to Follow-up|4|||
130243835|NCT00421733|468853358|FG000|Overall Study|Withdrawal by Subject|1|||
130243836|NCT00421733|468853359|FG001|Overall Study|Withdrawal by Subject|2|||
130243837|NCT00421733|468853360|FG002|Overall Study|Withdrawal by Subject|7|||
130243838|NCT00421733|468853358|FG000|Overall Study|Death|0|||
130243839|NCT00421733|468853359|FG001|Overall Study|Death|3|||
130243840|NCT00421733|468853360|FG002|Overall Study|Death|0|||
130243841|NCT00421733|468853358|FG000|Overall Study|Required dialysis|1|||
130243842|NCT00421733|468853359|FG001|Overall Study|Required dialysis|0|||
130243843|NCT00421733|468853360|FG002|Overall Study|Required dialysis|0|||
130243844|NCT00421733|468853358|FG000|Overall Study|Administrative|2|||
130243845|NCT00421733|468853359|FG001|Overall Study|Administrative|0|||
130243846|NCT00421733|468853360|FG002|Overall Study|Administrative|0|||
130243847|NCT00421733|468853358|FG000|Overall Study|Did not satisfy entry criteria|1|||
130243848|NCT00421733|468853359|FG001|Overall Study|Did not satisfy entry criteria|3|||
130243849|NCT00421733|468853360|FG002|Overall Study|Did not satisfy entry criteria|2|||
130243850|NCT00421733|468853358|FG000|Overall Study|Sponsor request|1|||
130243851|NCT00421733|468853359|FG001|Overall Study|Sponsor request|0|||
130243852|NCT00421733|468853360|FG002|Overall Study|Sponsor request|3|||
130243853|NCT00421733|468853358|FG000|Overall Study|Protocol deviation|4|||
130243854|NCT00421733|468853359|FG001|Overall Study|Protocol deviation|7|||
130243855|NCT00421733|468853360|FG002|Overall Study|Protocol deviation|2|||
130243856|NCT02265744|468853365|FG000|Overall Study|Poor/Non-compliance|1|||
130243857|NCT02265744|468853366|FG001|Overall Study|Poor/Non-compliance|1|||
130243858|NCT02265744|468853367|FG002|Overall Study|Poor/Non-compliance|0|||
130243859|NCT02265744|468853368|FG003|Overall Study|Poor/Non-compliance|0|||
130243860|NCT02265744|468853369|FG004|Overall Study|Poor/Non-compliance|2|||
130243861|NCT02265744|468853365|FG000|Overall Study|Lost to Follow-up|0|||
130243862|NCT02265744|468853366|FG001|Overall Study|Lost to Follow-up|0|||
130243863|NCT02265744|468853367|FG002|Overall Study|Lost to Follow-up|0|||
130243864|NCT02265744|468853368|FG003|Overall Study|Lost to Follow-up|1|||
130450271|NCT02851511|469612782|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
130243865|NCT02265744|468853369|FG004|Overall Study|Lost to Follow-up|0|||
130243866|NCT02265744|468853365|FG000|Overall Study|Death|0|||
130362616|NCT02853344|469297942|FG001|Overall Study|Withdrawal by Subject|4|||
130362617|NCT02853344|469297941|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
130362618|NCT02853344|469297942|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
130362619|NCT02853344|469297941|FG000|Overall Study|Death|70|||
130362620|NCT02853344|469297942|FG001|Overall Study|Death|112|||
130362621|NCT02913612|469297943|FG000|Overall Study|Lost to Follow-up|6|||
130362622|NCT02913612|469297944|FG001|Overall Study|Lost to Follow-up|5|||
130362623|NCT02913612|469297945|FG002|Overall Study|Lost to Follow-up|2|||
130362624|NCT02913612|469297946|FG003|Overall Study|Lost to Follow-up|0|||
130362625|NCT02913612|469297943|FG000|Overall Study|Physician Decision|1|||
130362626|NCT02913612|469297944|FG001|Overall Study|Physician Decision|4|||
130362627|NCT02913612|469297945|FG002|Overall Study|Physician Decision|1|||
130362628|NCT02913612|469297946|FG003|Overall Study|Physician Decision|0|||
130362629|NCT02913612|469297943|FG000|Overall Study|Withdrawal by Subject|2|||
130362630|NCT02913612|469297944|FG001|Overall Study|Withdrawal by Subject|4|||
130450272|NCT02851511|469612779|FG000|Phase I|Physician Decision|0|||
130243867|NCT02265744|468853366|FG001|Overall Study|Death|0|||
130243868|NCT02265744|468853367|FG002|Overall Study|Death|0|||
130243869|NCT02265744|468853368|FG003|Overall Study|Death|2|||
130243870|NCT02265744|468853369|FG004|Overall Study|Death|0|||
130362631|NCT02913612|469297945|FG002|Overall Study|Withdrawal by Subject|0|||
130243871|NCT02265744|468853365|FG000|Overall Study|Withdrawal by Subject|2|||
130243872|NCT02265744|468853366|FG001|Overall Study|Withdrawal by Subject|0|||
130243873|NCT02265744|468853367|FG002|Overall Study|Withdrawal by Subject|0|||
130362632|NCT02913612|469297946|FG003|Overall Study|Withdrawal by Subject|0|||
130362633|NCT02913612|469297943|FG000|Overall Study|Hemangioma resolved|1|||
130243874|NCT02265744|468853368|FG003|Overall Study|Withdrawal by Subject|2|||
130243875|NCT02265744|468853369|FG004|Overall Study|Withdrawal by Subject|0|||
130243876|NCT02265744|468853365|FG000|Overall Study|Participant request to discontinue|2|||
130243877|NCT02265744|468853366|FG001|Overall Study|Participant request to discontinue|2|||
130243878|NCT02265744|468853367|FG002|Overall Study|Participant request to discontinue|2|||
130243879|NCT02265744|468853368|FG003|Overall Study|Participant request to discontinue|0|||
130243880|NCT02265744|468853369|FG004|Overall Study|Participant request to discontinue|0|||
130243881|NCT02265744|468853365|FG000|Overall Study|Adverse Event|8|||
130243882|NCT02265744|468853366|FG001|Overall Study|Adverse Event|4|||
130243883|NCT02265744|468853367|FG002|Overall Study|Adverse Event|9|||
130243884|NCT02265744|468853368|FG003|Overall Study|Adverse Event|8|||
130243885|NCT02265744|468853369|FG004|Overall Study|Adverse Event|2|||
130243886|NCT02265744|468853365|FG000|Overall Study|Lack of Efficacy|2|||
130243887|NCT02265744|468853366|FG001|Overall Study|Lack of Efficacy|4|||
130243888|NCT02265744|468853367|FG002|Overall Study|Lack of Efficacy|3|||
130243889|NCT02265744|468853368|FG003|Overall Study|Lack of Efficacy|4|||
130243890|NCT02265744|468853369|FG004|Overall Study|Lack of Efficacy|5|||
130243891|NCT02265744|468853365|FG000|Overall Study|Reason not provided by Investigator|1|||
130243892|NCT02265744|468853366|FG001|Overall Study|Reason not provided by Investigator|0|||
130243893|NCT02265744|468853367|FG002|Overall Study|Reason not provided by Investigator|0|||
130243894|NCT02265744|468853368|FG003|Overall Study|Reason not provided by Investigator|2|||
130243895|NCT02265744|468853369|FG004|Overall Study|Reason not provided by Investigator|0|||
130243896|NCT02265744|468853365|FG000|Overall Study|Administrative reason by sponsor|3|||
130243897|NCT02265744|468853366|FG001|Overall Study|Administrative reason by sponsor|2|||
130243898|NCT02265744|468853367|FG002|Overall Study|Administrative reason by sponsor|2|||
130243899|NCT02265744|468853368|FG003|Overall Study|Administrative reason by sponsor|3|||
130243900|NCT02265744|468853369|FG004|Overall Study|Administrative reason by sponsor|3|||
130450273|NCT02851511|469612780|FG001|Phase I|Physician Decision|0|||
130697001|NCT04194151|470514560|FG002|Overall Study|Monitorization problem|0|||
130697002|NCT04194151|470514561|FG003|Overall Study|Monitorization problem|0|||
130697003|NCT04194151|470514562|FG004|Overall Study|Monitorization problem|0|||
130697004|NCT04194151|470514563|FG005|Overall Study|Monitorization problem|0|||
130697005|NCT00874276|470514564|FG000|Overall Study|Withdrawal by Subject|1|||
130697006|NCT00874276|470514565|FG001|Overall Study|Withdrawal by Subject|1|||
130697007|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
130697008|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
130697009|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130450274|NCT02851511|469612781|FG002|Phase I|Physician Decision|0|||
130450275|NCT02851511|469612782|FG003|Phase I|Physician Decision|1|||
130450276|NCT02851511|469612779|FG000|Phase I|Withdrawal by Subject|2|||
130450277|NCT02851511|469612780|FG001|Phase I|Withdrawal by Subject|1|||
130450278|NCT02851511|469612781|FG002|Phase I|Withdrawal by Subject|0|||
130450279|NCT02851511|469612782|FG003|Phase I|Withdrawal by Subject|3|||
130450280|NCT02851511|469612779|FG000|Phase II|Physician Decision|18|||
130450281|NCT02851511|469612780|FG001|Phase II|Physician Decision|16|||
130450282|NCT02851511|469612781|FG002|Phase II|Physician Decision|0|||
130450283|NCT02851511|469612782|FG003|Phase II|Physician Decision|0|||
130450284|NCT02851511|469612779|FG000|Phase II|Withdrawal by Subject|18|||
130450285|NCT02851511|469612780|FG001|Phase II|Withdrawal by Subject|16|||
130450286|NCT02851511|469612781|FG002|Phase II|Withdrawal by Subject|0|||
130697010|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130697011|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130697012|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
130697013|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697014|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697015|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697016|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697017|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
130697018|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
130697019|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697020|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697021|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697022|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|move away|2|||
130697023|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|move away|7|||
130450287|NCT02851511|469612782|FG003|Phase II|Withdrawal by Subject|0|||
130450288|NCT02851511|469612779|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
130243901|NCT02265744|468853365|FG000|Overall Study|Subject no longer meets study criteria|0|||
130243902|NCT02265744|468853366|FG001|Overall Study|Subject no longer meets study criteria|0|||
130243903|NCT02265744|468853367|FG002|Overall Study|Subject no longer meets study criteria|0|||
130243904|NCT02265744|468853368|FG003|Overall Study|Subject no longer meets study criteria|0|||
130450289|NCT02851511|469612780|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
130450290|NCT02851511|469612781|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
130697024|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|move away|0|||
130697025|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|move away|0|||
130697026|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|move away|0|||
130697027|NCT01109849|470516024|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130697028|NCT01109849|470516025|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130697029|NCT01109849|470516026|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697030|NCT01109849|470516027|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697031|NCT01109849|470516028|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697032|NCT01109849|470516024|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
130697033|NCT01109849|470516025|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
130697034|NCT01109849|470516026|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
130697035|NCT01109849|470516027|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
130697036|NCT01109849|470516028|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
130697037|NCT03969641|470516029|FG000|Overall Study|Lost to Follow-up|5|||
130697038|NCT03969641|470516030|FG001|Overall Study|Lost to Follow-up|3|||
130697039|NCT03969641|470516029|FG000|Overall Study|Withdrawal by Subject|1|||
130697040|NCT03969641|470516030|FG001|Overall Study|Withdrawal by Subject|2|||
130697041|NCT03969641|470516029|FG000|Overall Study|Found to be ineligible|1|||
130697042|NCT03969641|470516030|FG001|Overall Study|Found to be ineligible|1|||
130697043|NCT03969641|470516029|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
130697044|NCT03969641|470516030|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
130697045|NCT03969641|470516029|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
130697046|NCT03969641|470516030|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
130697047|NCT03969641|470516029|FG000|Overall Study|Elective termination|0|||
130697048|NCT03969641|470516030|FG001|Overall Study|Elective termination|1|||
130450291|NCT02851511|469612782|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
130450292|NCT02851511|469612779|FG000|Phase II|Lost to Follow-up|0|||
130450293|NCT02851511|469612780|FG001|Phase II|Lost to Follow-up|1|||
130450294|NCT02851511|469612781|FG002|Phase II|Lost to Follow-up|0|||
130450295|NCT02851511|469612782|FG003|Phase II|Lost to Follow-up|0|||
130450296|NCT00003377|469612783|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
130450297|NCT00003377|469612784|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
130450298|NCT00003377|469612785|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
130450299|NCT00003377|469612786|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
130450300|NCT00003377|469612787|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
130450301|NCT00003377|469612783|FG000|Period II|Ureteral stent complications|0|||
130450302|NCT00003377|469612784|FG001|Period II|Ureteral stent complications|0|||
130450303|NCT00003377|469612785|FG002|Period II|Ureteral stent complications|0|||
130450304|NCT00003377|469612786|FG003|Period II|Ureteral stent complications|0|||
130450305|NCT00003377|469612787|FG004|Period II|Ureteral stent complications|1|||
130450306|NCT01417000|469612791|FG000|Overall Study|Death|59|||
130450307|NCT01417000|469612792|FG001|Overall Study|Death|28|||
130450308|NCT01417000|469612791|FG000|Overall Study|Lost to Follow-up|1|||
130450309|NCT01417000|469612792|FG001|Overall Study|Lost to Follow-up|0|||
130450310|NCT01417000|469612791|FG000|Overall Study|Study Terminated by Sponsor|1|||
130450311|NCT01417000|469612792|FG001|Overall Study|Study Terminated by Sponsor|1|||
130697049|NCT00354835|470516031|FG000|Overall Study|Death|1|||
130697050|NCT00354835|470516032|FG001|Overall Study|Death|1|||
130697051|NCT00354835|470516031|FG000|Overall Study|Physician Decision|8|||
130697052|NCT00354835|470516032|FG001|Overall Study|Physician Decision|13|||
130697053|NCT00354835|470516031|FG000|Overall Study|Withdrawal by Subject|2|||
130697054|NCT00354835|470516032|FG001|Overall Study|Withdrawal by Subject|1|||
130697055|NCT00354835|470516031|FG000|Overall Study|Ineligible|17|||
130697056|NCT00354835|470516032|FG001|Overall Study|Ineligible|16|||
130697057|NCT00354835|470516031|FG000|Overall Study|Disease progression or relapse|15|||
130697058|NCT00354835|470516032|FG001|Overall Study|Disease progression or relapse|22|||
130697059|NCT00354835|470516031|FG000|Overall Study|Adverse Event|6|||
130697060|NCT00354835|470516032|FG001|Overall Study|Adverse Event|0|||
130697061|NCT00354835|470516031|FG000|Overall Study|Refusal of further therapy|3|||
130697062|NCT00354835|470516032|FG001|Overall Study|Refusal of further therapy|8|||
130697063|NCT03141151|470516033|FG000|Overall Study|Lost to Follow-up|3|||
130697064|NCT03141151|470516034|FG001|Overall Study|Lost to Follow-up|2|||
130243905|NCT02265744|468853369|FG004|Overall Study|Subject no longer meets study criteria|1|||
130450312|NCT00821236|469612794|FG000|Overall Study|Lost to Follow-up|3|||
130450313|NCT01928940|469612795|FG000|Overall Study|Adverse Event|0|||
130450314|NCT01928940|469612796|FG001|Overall Study|Adverse Event|1|||
130450315|NCT02954055|469612797|FG000|Overall Study|Did not initiate therapy|6|||
130450316|NCT02954055|469612798|FG001|Overall Study|Did not initiate therapy|1|||
130450317|NCT02096003|469612801|FG000|Overall Study|Protocol Violation|0|||
130697065|NCT03141151|470516033|FG000|Overall Study|Withdrawal by Subject|3|||
130697066|NCT03141151|470516034|FG001|Overall Study|Withdrawal by Subject|2|||
130697067|NCT00884390|470516035|FG000|Overall Study|Adverse Event|0|||
130697068|NCT00884390|470516036|FG001|Overall Study|Adverse Event|1|||
130697069|NCT00884390|470516035|FG000|Overall Study|Lost to Follow-up|0|||
130697070|NCT00884390|470516036|FG001|Overall Study|Lost to Follow-up|1|||
130697071|NCT00884390|470516035|FG000|Overall Study|Physician Decision|2|||
130697072|NCT00884390|470516036|FG001|Overall Study|Physician Decision|1|||
130697073|NCT00884390|470516035|FG000|Overall Study|Protocol Violation|4|||
130697074|NCT00884390|470516036|FG001|Overall Study|Protocol Violation|1|||
130697075|NCT00884390|470516035|FG000|Overall Study|Withdrawal by Subject|4|||
130697076|NCT00884390|470516036|FG001|Overall Study|Withdrawal by Subject|1|||
130697077|NCT00884390|470516035|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
130697078|NCT00884390|470516036|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130697079|NCT00884390|470516035|FG000|Overall Study|Other|11|||
130697080|NCT00884390|470516036|FG001|Overall Study|Other|1|||
130697081|NCT02670551|470516037|FG000|Overall Study|Adverse Event|4|||
130697082|NCT02670551|470516038|FG001|Overall Study|Adverse Event|7|||
130697083|NCT02670551|470516039|FG002|Overall Study|Adverse Event|9|||
130697084|NCT02670551|470516037|FG000|Overall Study|Lack of Efficacy|2|||
130697085|NCT02670551|470516038|FG001|Overall Study|Lack of Efficacy|0|||
130697086|NCT02670551|470516039|FG002|Overall Study|Lack of Efficacy|3|||
130697087|NCT02670551|470516037|FG000|Overall Study|Withdrawal of Consent|6|||
130697088|NCT02670551|470516038|FG001|Overall Study|Withdrawal of Consent|3|||
130697089|NCT02670551|470516039|FG002|Overall Study|Withdrawal of Consent|8|||
130697090|NCT02670551|470516037|FG000|Overall Study|Lost to Follow-up|5|||
130697091|NCT02670551|470516038|FG001|Overall Study|Lost to Follow-up|7|||
130697092|NCT02670551|470516039|FG002|Overall Study|Lost to Follow-up|6|||
130697093|NCT02670551|470516037|FG000|Overall Study|Protocol Violation|1|||
130697094|NCT02670551|470516038|FG001|Overall Study|Protocol Violation|0|||
130697095|NCT02670551|470516039|FG002|Overall Study|Protocol Violation|0|||
130697096|NCT02670551|470516037|FG000|Overall Study|Noncompliance with study drug|3|||
130697097|NCT02670551|470516038|FG001|Overall Study|Noncompliance with study drug|3|||
130697098|NCT02670551|470516039|FG002|Overall Study|Noncompliance with study drug|2|||
130697099|NCT02670551|470516037|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130697100|NCT02670551|470516038|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130697101|NCT02670551|470516039|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130697102|NCT02670551|470516037|FG000|Overall Study|Did Not Receive Treatment|5|||
130697103|NCT02670551|470516038|FG001|Overall Study|Did Not Receive Treatment|3|||
130697104|NCT02670551|470516039|FG002|Overall Study|Did Not Receive Treatment|0|||
130697105|NCT01971645|470516041|FG000|Overall Study|Adverse Event|1|||
130697106|NCT01971645|470516042|FG001|Overall Study|Adverse Event|0|||
130697107|NCT01971645|470516043|FG002|Overall Study|Adverse Event|0|||
130243906|NCT02265744|468853365|FG000|Overall Study|Pregnancy|1|||
130243907|NCT02265744|468853366|FG001|Overall Study|Pregnancy|2|||
130243908|NCT02265744|468853367|FG002|Overall Study|Pregnancy|1|||
130243909|NCT02265744|468853368|FG003|Overall Study|Pregnancy|1|||
130243910|NCT02265744|468853369|FG004|Overall Study|Pregnancy|0|||
130243911|NCT05161936|468853372|FG000|Overall Study|Study terminated by Sponsor|1|||
130243912|NCT05161936|468853373|FG001|Overall Study|Study terminated by Sponsor|0|||
130243913|NCT05161936|468853374|FG002|Overall Study|Study terminated by Sponsor|0|||
130243914|NCT05161936|468853372|FG000|Overall Study|Withdrawal by Subject|0|||
130243915|NCT05161936|468853373|FG001|Overall Study|Withdrawal by Subject|0|||
130243916|NCT05161936|468853374|FG002|Overall Study|Withdrawal by Subject|1|||
130243917|NCT02384460|468853379|FG000|Overall Study|Protocol Violation|0|||
130362634|NCT02913612|469297944|FG001|Overall Study|Hemangioma resolved|0|||
130362635|NCT02913612|469297945|FG002|Overall Study|Hemangioma resolved|0|||
130362636|NCT02913612|469297946|FG003|Overall Study|Hemangioma resolved|0|||
130362637|NCT02913612|469297943|FG000|Overall Study|Local IRB decision|1|||
130362638|NCT02913612|469297944|FG001|Overall Study|Local IRB decision|0|||
130362639|NCT02913612|469297945|FG002|Overall Study|Local IRB decision|0|||
130362640|NCT02913612|469297946|FG003|Overall Study|Local IRB decision|0|||
130362641|NCT02913612|469297943|FG000|Overall Study|Study drug non-compliance|1|||
130362642|NCT02913612|469297944|FG001|Overall Study|Study drug non-compliance|1|||
130362643|NCT02913612|469297945|FG002|Overall Study|Study drug non-compliance|0|||
130697108|NCT01971645|470516041|FG000|Overall Study|Lost to Follow-up|1|||
130697109|NCT01971645|470516042|FG001|Overall Study|Lost to Follow-up|0|||
130697110|NCT01971645|470516043|FG002|Overall Study|Lost to Follow-up|1|||
130697111|NCT01971645|470516041|FG000|Overall Study|Protocol Violation|0|||
130697112|NCT01971645|470516042|FG001|Overall Study|Protocol Violation|0|||
130697113|NCT01971645|470516043|FG002|Overall Study|Protocol Violation|1|||
130697114|NCT04476277|470516044|FG000|Overall Study|Withdrawal by Subject|0|||
130697115|NCT04476277|470516045|FG001|Overall Study|Withdrawal by Subject|0|||
130697116|NCT04476277|470516046|FG002|Overall Study|Withdrawal by Subject|1|||
130697117|NCT04476277|470516047|FG003|Overall Study|Withdrawal by Subject|0|||
130697118|NCT01962298|470516048|FG000|Overall Study|Protocol Violation|1|||
130697119|NCT01962298|470516049|FG001|Overall Study|Protocol Violation|0|||
130697120|NCT01962298|470516050|FG002|Overall Study|Protocol Violation|1|||
130243918|NCT02384460|468853380|FG001|Overall Study|Protocol Violation|1|||
130362644|NCT02913612|469297946|FG003|Overall Study|Study drug non-compliance|0|||
130362645|NCT02913612|469297943|FG000|Overall Study|Insurance issues|0|||
130697121|NCT01962298|470516051|FG003|Overall Study|Protocol Violation|1|||
130697122|NCT01962298|470516052|FG004|Overall Study|Protocol Violation|0|||
130697123|NCT01962298|470516048|FG000|Overall Study|Data quality insufficient|2|||
130697124|NCT01962298|470516049|FG001|Overall Study|Data quality insufficient|0|||
130697125|NCT01962298|470516050|FG002|Overall Study|Data quality insufficient|3|||
130243919|NCT02384460|468853379|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
130243920|NCT02384460|468853380|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
130243921|NCT02384460|468853379|FG000|Overall Study|Adverse Event|5|||
130243922|NCT02384460|468853380|FG001|Overall Study|Adverse Event|2|||
130243923|NCT02384460|468853379|FG000|Overall Study|Withdrawal by Subject|0|||
130243924|NCT02384460|468853380|FG001|Overall Study|Withdrawal by Subject|3|||
130243925|NCT02384460|468853379|FG000|Overall Study|Elective medical treatment|1|||
130243926|NCT02384460|468853380|FG001|Overall Study|Elective medical treatment|0|||
130243927|NCT02384460|468853379|FG000|Overall Study|Non-compliance|1|||
130243928|NCT02384460|468853380|FG001|Overall Study|Non-compliance|0|||
130243929|NCT01060111|468853381|FG000|Overall Study|Adverse Event|9|||
130243930|NCT01060111|468853382|FG001|Overall Study|Adverse Event|5|||
130243931|NCT01060111|468853383|FG002|Overall Study|Adverse Event|18|||
130243932|NCT01060111|468853381|FG000|Overall Study|Lack of Efficacy|2|||
130243933|NCT01060111|468853382|FG001|Overall Study|Lack of Efficacy|1|||
130243934|NCT01060111|468853383|FG002|Overall Study|Lack of Efficacy|0|||
130243935|NCT01060111|468853381|FG000|Overall Study|Inappropriate participant|5|||
130243936|NCT01060111|468853382|FG001|Overall Study|Inappropriate participant|4|||
130243937|NCT01060111|468853383|FG002|Overall Study|Inappropriate participant|5|||
130243938|NCT01060111|468853381|FG000|Overall Study|Participants' evasion for hospital visit|0|||
130243939|NCT01060111|468853382|FG001|Overall Study|Participants' evasion for hospital visit|3|||
130243940|NCT01060111|468853383|FG002|Overall Study|Participants' evasion for hospital visit|2|||
130243941|NCT01060111|468853381|FG000|Overall Study|Participants' non-cooperation|8|||
130243942|NCT01060111|468853382|FG001|Overall Study|Participants' non-cooperation|6|||
130243943|NCT01060111|468853383|FG002|Overall Study|Participants' non-cooperation|6|||
130243944|NCT01060111|468853381|FG000|Overall Study|Adverse event and insufficient effect|0|||
130243945|NCT01060111|468853382|FG001|Overall Study|Adverse event and insufficient effect|1|||
130243946|NCT01060111|468853383|FG002|Overall Study|Adverse event and insufficient effect|0|||
130243947|NCT01060111|468853381|FG000|Overall Study|Participants' non-cooperation|1|||
130243948|NCT01060111|468853382|FG001|Overall Study|Participants' non-cooperation|0|||
130243949|NCT01060111|468853383|FG002|Overall Study|Participants' non-cooperation|0|||
130243950|NCT01060111|468853381|FG000|Overall Study|Other|2|||
130450318|NCT02096003|469612802|FG001|Overall Study|Protocol Violation|2|||
130697126|NCT01962298|470516051|FG003|Overall Study|Data quality insufficient|1|||
130697127|NCT01962298|470516052|FG004|Overall Study|Data quality insufficient|4|||
130697128|NCT01962298|470516048|FG000|Overall Study|Insufficient data|0|||
130697129|NCT01962298|470516049|FG001|Overall Study|Insufficient data|2|||
130697130|NCT01962298|470516050|FG002|Overall Study|Insufficient data|1|||
130697131|NCT01962298|470516051|FG003|Overall Study|Insufficient data|0|||
130697132|NCT01962298|470516052|FG004|Overall Study|Insufficient data|1|||
130697133|NCT01962298|470516048|FG000|Overall Study|Incorrect data recorded|0|||
130697134|NCT01962298|470516049|FG001|Overall Study|Incorrect data recorded|1|||
130450319|NCT02096003|469612801|FG000|Overall Study|additional surgery|2|||
130450320|NCT02096003|469612802|FG001|Overall Study|additional surgery|1|||
130697135|NCT01962298|470516050|FG002|Overall Study|Incorrect data recorded|0|||
130697136|NCT01962298|470516051|FG003|Overall Study|Incorrect data recorded|0|||
130697137|NCT01962298|470516052|FG004|Overall Study|Incorrect data recorded|0|||
130697138|NCT01962298|470516048|FG000|Overall Study|Physician Decision|0|||
130450321|NCT01511250|469612803|FG000|Overall Study|Withdrawal of Consent|1|||
130450322|NCT01511250|469612804|FG001|Overall Study|Withdrawal of Consent|0|||
130450323|NCT01511250|469612805|FG002|Overall Study|Withdrawal of Consent|0|||
130450324|NCT01511250|469612806|FG003|Overall Study|Withdrawal of Consent|0|||
130450325|NCT01511250|469612807|FG004|Overall Study|Withdrawal of Consent|0|||
130450326|NCT01511250|469612808|FG005|Overall Study|Withdrawal of Consent|0|||
130450327|NCT01511250|469612809|FG006|Overall Study|Withdrawal of Consent|0|||
130450328|NCT01511250|469612810|FG007|Overall Study|Withdrawal of Consent|1|||
130697139|NCT01962298|470516049|FG001|Overall Study|Physician Decision|1|||
130697140|NCT01962298|470516050|FG002|Overall Study|Physician Decision|0|||
130243951|NCT01060111|468853382|FG001|Overall Study|Other|3|||
130243952|NCT01060111|468853383|FG002|Overall Study|Other|4|||
130243953|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
130243954|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
130243955|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130243956|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130697141|NCT01962298|470516051|FG003|Overall Study|Physician Decision|0|||
130697142|NCT01962298|470516052|FG004|Overall Study|Physician Decision|1|||
130697143|NCT00533507|470516053|FG000|Overall Study|Withdrawal by Subject|1|||
130697144|NCT01576705|470516054|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
130697145|NCT01576705|470516055|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
130697146|NCT01576705|470516056|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
130697147|NCT01576705|470516057|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
130697148|NCT01576705|470516054|FG000|Overall Study|invalid ICF|0|||
130697149|NCT01576705|470516055|FG001|Overall Study|invalid ICF|1|||
130697150|NCT01576705|470516056|FG002|Overall Study|invalid ICF|0|||
130697151|NCT01576705|470516057|FG003|Overall Study|invalid ICF|0|||
130697152|NCT02896296|470516058|FG000|Overall Study|Adverse Event|1|||
130697153|NCT02896296|470516058|FG000|Overall Study|Lost to Follow-up|19|||
130697154|NCT02896296|470516058|FG000|Overall Study|Pregnancy|1|||
130697155|NCT02896296|470516058|FG000|Overall Study|Physician Decision|2|||
130697156|NCT02896296|470516058|FG000|Overall Study|Withdrawal by Subject|10|||
130697157|NCT02896296|470516058|FG000|Overall Study|Site closing|7|||
130697158|NCT02896296|470516058|FG000|Overall Study|Incarceration|1|||
130697159|NCT02896296|470516058|FG000|Overall Study|Relocation|1|||
130697160|NCT01874535|470516059|FG000|Overall Study|Lost to Follow-up|10|||
130697161|NCT01874535|470516060|FG001|Overall Study|Lost to Follow-up|9|||
130697162|NCT01874535|470516059|FG000|Overall Study|incomplete symptom resolution|45|||
130697163|NCT01874535|470516060|FG001|Overall Study|incomplete symptom resolution|35|||
130697164|NCT01215721|470516061|FG000|Overall Study|Adverse Event|2|||
130450329|NCT01511250|469612811|FG008|Overall Study|Withdrawal of Consent|1|||
130450330|NCT01511250|469612812|FG009|Overall Study|Withdrawal of Consent|0|||
130450331|NCT01511250|469612803|FG000|Overall Study|Sponsor/Investigator Decision|1|||
130450332|NCT01511250|469612804|FG001|Overall Study|Sponsor/Investigator Decision|0|||
130450333|NCT01511250|469612805|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130450334|NCT01511250|469612806|FG003|Overall Study|Sponsor/Investigator Decision|0|||
130450335|NCT01511250|469612807|FG004|Overall Study|Sponsor/Investigator Decision|0|||
130450336|NCT01511250|469612808|FG005|Overall Study|Sponsor/Investigator Decision|0|||
130450337|NCT01511250|469612809|FG006|Overall Study|Sponsor/Investigator Decision|0|||
130450338|NCT01511250|469612810|FG007|Overall Study|Sponsor/Investigator Decision|0|||
130450339|NCT01511250|469612811|FG008|Overall Study|Sponsor/Investigator Decision|0|||
130697165|NCT00045162|470516062|FG000|Overall Study|Ineligible|12|||
130697166|NCT00045162|470516063|FG001|Overall Study|Ineligible|8|||
130697167|NCT00045162|470516062|FG000|Overall Study|Not treated|7|||
130697168|NCT00045162|470516063|FG001|Overall Study|Not treated|2|||
130697169|NCT00045162|470516062|FG000|Overall Study|Adverse Event|55|||
130697170|NCT00045162|470516063|FG001|Overall Study|Adverse Event|50|||
130697171|NCT00045162|470516062|FG000|Overall Study|Lack of Efficacy|32|||
130697172|NCT00045162|470516063|FG001|Overall Study|Lack of Efficacy|29|||
130697173|NCT00045162|470516062|FG000|Overall Study|Death|10|||
130697174|NCT00045162|470516063|FG001|Overall Study|Death|10|||
130697175|NCT00045162|470516062|FG000|Overall Study|Withdrawal by Subject|5|||
130697176|NCT00045162|470516063|FG001|Overall Study|Withdrawal by Subject|3|||
130697177|NCT00045162|470516062|FG000|Overall Study|Other|21|||
130697178|NCT00045162|470516063|FG001|Overall Study|Other|16|||
130697179|NCT01044433|470516064|FG000|Overall Study|Lost to Follow-up|3|||
130697180|NCT01044433|470516064|FG000|Overall Study|Withdrawal by Subject|3|||
130697181|NCT02943096|470516065|FG000|Overall Study|Lack of Efficacy|0|||
130697182|NCT02943096|470516066|FG001|Overall Study|Lack of Efficacy|1|||
130697183|NCT05065619|470516067|FG000|Up to Day 42|Lost to Follow-up|1|||
130697184|NCT05065619|470516068|FG001|Up to Day 42|Lost to Follow-up|0|||
130697185|NCT05065619|470516067|FG000|Up to Day 42|Withdrawal by Subject|1|||
130697186|NCT05065619|470516068|FG001|Up to Day 42|Withdrawal by Subject|0|||
130450340|NCT01511250|469612812|FG009|Overall Study|Sponsor/Investigator Decision|0|||
130450341|NCT01511250|469612803|FG000|Overall Study|Lost to Follow-up|7|||
130450342|NCT01511250|469612804|FG001|Overall Study|Lost to Follow-up|3|||
130450343|NCT01511250|469612805|FG002|Overall Study|Lost to Follow-up|3|||
130450344|NCT01511250|469612806|FG003|Overall Study|Lost to Follow-up|3|||
130450345|NCT01511250|469612807|FG004|Overall Study|Lost to Follow-up|0|||
130697187|NCT05065619|470516067|FG000|After Day 43|Lost to Follow-up|1|||
130697188|NCT05065619|470516068|FG001|After Day 43|Lost to Follow-up|0|||
130697189|NCT05065619|470516067|FG000|After Day 43|Physician Decision|3|||
130697190|NCT05065619|470516068|FG001|After Day 43|Physician Decision|0|||
130697191|NCT05065619|470516067|FG000|After Day 43|Withdrawal by Subject|1|||
130697192|NCT05065619|470516068|FG001|After Day 43|Withdrawal by Subject|2|||
130697193|NCT05065619|470516067|FG000|After Day 43|Public vaccination|6|||
130697194|NCT05065619|470516068|FG001|After Day 43|Public vaccination|8|||
130697195|NCT05065619|470516067|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
130697196|NCT05065619|470516068|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
130697197|NCT05065619|470516067|FG000|After Day 43|Study Terminated by Sponsor|88|||
130697198|NCT05065619|470516068|FG001|After Day 43|Study Terminated by Sponsor|16|||
130697199|NCT00714051|470516074|FG000|Overall Study|Withdrawal by Subject|1|||
130697200|NCT00714051|470516075|FG001|Overall Study|Withdrawal by Subject|0|||
130697201|NCT00714051|470516074|FG000|Overall Study|Death|0|||
130697202|NCT00714051|470516075|FG001|Overall Study|Death|1|||
130697203|NCT02119936|470516084|FG000|Overall Study|Lost to Follow-up|10|||
130697204|NCT00570128|470516085|FG000|Overall Study|Adverse Event|1|||
130697205|NCT00570128|470516086|FG001|Overall Study|Adverse Event|0|||
130697206|NCT00570128|470516085|FG000|Overall Study|Lost to Follow-up|1|||
130697207|NCT00570128|470516086|FG001|Overall Study|Lost to Follow-up|0|||
130697208|NCT00570128|470516085|FG000|Overall Study|Withdrawal by Subject|2|||
130243957|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
130243958|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
130697209|NCT00570128|470516086|FG001|Overall Study|Withdrawal by Subject|0|||
130243959|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
130362646|NCT02913612|469297944|FG001|Overall Study|Insurance issues|1|||
130362647|NCT02913612|469297945|FG002|Overall Study|Insurance issues|0|||
130362648|NCT02913612|469297946|FG003|Overall Study|Insurance issues|0|||
130362649|NCT02913612|469297943|FG000|Overall Study|Needed to treat second hemangioma|0|||
130362650|NCT02913612|469297944|FG001|Overall Study|Needed to treat second hemangioma|1|||
130362651|NCT02913612|469297945|FG002|Overall Study|Needed to treat second hemangioma|0|||
130362652|NCT02913612|469297946|FG003|Overall Study|Needed to treat second hemangioma|0|||
130362653|NCT02913612|469297943|FG000|Overall Study|Study completion criteria not met|0|||
130362654|NCT02913612|469297944|FG001|Overall Study|Study completion criteria not met|1|||
130362655|NCT02913612|469297945|FG002|Overall Study|Study completion criteria not met|0|||
130362656|NCT02913612|469297946|FG003|Overall Study|Study completion criteria not met|0|||
130362657|NCT02913612|469297943|FG000|Overall Study|Ineligible|0|||
130362658|NCT02913612|469297944|FG001|Overall Study|Ineligible|1|||
130362659|NCT02913612|469297945|FG002|Overall Study|Ineligible|0|||
130362660|NCT02913612|469297946|FG003|Overall Study|Ineligible|0|||
130362661|NCT00973674|469297949|FG000|Overall Study|Protocol Violation|2|||
130362662|NCT00973674|469297950|FG001|Overall Study|Protocol Violation|0|||
130362663|NCT00071396|469297951|FG000|Overall Study|Withdrawal by Subject|1|||
130362664|NCT00071396|469297951|FG000|Overall Study|Physician Decision|2|||
130362665|NCT00116428|469297952|FG000|Overall Study|Withdrawal by Subject|2|||
130362666|NCT00116428|469297953|FG001|Overall Study|Withdrawal by Subject|5|||
130362667|NCT00116428|469297952|FG000|Overall Study|Did not meet inclusion criteria|1|||
130362668|NCT00116428|469297953|FG001|Overall Study|Did not meet inclusion criteria|0|||
130362669|NCT02713204|469297954|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
130362670|NCT02713204|469297955|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362671|NCT02713204|469297956|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
130362672|NCT02713204|469297957|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362673|NCT02713204|469297958|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362674|NCT02713204|469297959|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362675|NCT02713204|469297960|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362676|NCT02713204|469297961|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130362677|NCT02713204|469297954|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362678|NCT02713204|469297955|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362679|NCT02713204|469297956|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
130362680|NCT02713204|469297957|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362681|NCT02713204|469297958|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362682|NCT02713204|469297959|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362683|NCT02713204|469297960|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362684|NCT02713204|469297961|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130362685|NCT02713204|469297954|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362686|NCT02713204|469297955|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
130362687|NCT02713204|469297956|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362688|NCT02713204|469297957|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362689|NCT02713204|469297958|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362690|NCT02713204|469297959|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362691|NCT02713204|469297960|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362692|NCT02713204|469297961|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130362693|NCT02713204|469297954|FG000|From Week 12 up to Week 36|Adverse Event|1|||
130362694|NCT02713204|469297955|FG001|From Week 12 up to Week 36|Adverse Event|0|||
130362695|NCT02713204|469297956|FG002|From Week 12 up to Week 36|Adverse Event|0|||
130362696|NCT02713204|469297957|FG003|From Week 12 up to Week 36|Adverse Event|1|||
130362697|NCT02713204|469297958|FG004|From Week 12 up to Week 36|Adverse Event|1|||
130362698|NCT02713204|469297959|FG005|From Week 12 up to Week 36|Adverse Event|0|||
130362699|NCT02713204|469297960|FG006|From Week 12 up to Week 36|Adverse Event|2|||
130362700|NCT02713204|469297961|FG007|From Week 12 up to Week 36|Adverse Event|1|||
130362701|NCT02713204|469297954|FG000|From Week 12 up to Week 36|Death|0|||
130697210|NCT03868631|470516087|FG000|Baseline to Week 6|Adverse Event|0|||
130697211|NCT03868631|470516088|FG001|Baseline to Week 6|Adverse Event|3|||
130697212|NCT03868631|470516087|FG000|Baseline to Week 6|Protocol Violation|1|||
130450346|NCT01511250|469612808|FG005|Overall Study|Lost to Follow-up|0|||
130450347|NCT01511250|469612809|FG006|Overall Study|Lost to Follow-up|2|||
130450348|NCT01511250|469612810|FG007|Overall Study|Lost to Follow-up|3|||
130450349|NCT01511250|469612811|FG008|Overall Study|Lost to Follow-up|13|||
130450350|NCT01511250|469612812|FG009|Overall Study|Lost to Follow-up|5|||
130450351|NCT01511250|469612803|FG000|Overall Study|Protocol Violation|0|||
130450352|NCT01511250|469612804|FG001|Overall Study|Protocol Violation|2|||
130450353|NCT01511250|469612805|FG002|Overall Study|Protocol Violation|1|||
130450354|NCT01511250|469612806|FG003|Overall Study|Protocol Violation|0|||
130697213|NCT03868631|470516088|FG001|Baseline to Week 6|Protocol Violation|1|||
130697214|NCT03868631|470516087|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
130697215|NCT03868631|470516088|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
130697216|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
130697217|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
130697218|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
130697219|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
130697220|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130697221|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130697222|NCT01929681|470516090|FG000|Overall Study|Withdrawal by Subject|1|||
130697223|NCT01929681|470516091|FG001|Overall Study|Withdrawal by Subject|0|||
130697224|NCT01929681|470516090|FG000|Overall Study|Physician Decision|1|||
130697225|NCT01929681|470516091|FG001|Overall Study|Physician Decision|1|||
130697226|NCT02218216|470516092|FG000|Overall Study|Study terminated before completed|6|||
130697227|NCT02218216|470516093|FG001|Overall Study|Study terminated before completed|0|||
130697228|NCT02218216|470516094|FG002|Overall Study|Study terminated before completed|0|||
130697229|NCT02452463|470516099|FG000|Overall Study|Death|1|||
130697230|NCT02452463|470516100|FG001|Overall Study|Death|0|||
130697231|NCT02452463|470516101|FG002|Overall Study|Death|0|||
130697232|NCT02452463|470516099|FG000|Overall Study|Study Suspended|1|||
130697233|NCT02452463|470516100|FG001|Overall Study|Study Suspended|0|||
130697234|NCT02452463|470516101|FG002|Overall Study|Study Suspended|0|||
130697235|NCT02452463|470516099|FG000|Overall Study|Recommended by DSMB|0|||
130697236|NCT02452463|470516100|FG001|Overall Study|Recommended by DSMB|1|||
130697237|NCT02452463|470516101|FG002|Overall Study|Recommended by DSMB|0|||
130697238|NCT02452463|470516099|FG000|Overall Study|Withdrawal by Subject|0|||
130697239|NCT02452463|470516100|FG001|Overall Study|Withdrawal by Subject|1|||
130697240|NCT02452463|470516101|FG002|Overall Study|Withdrawal by Subject|0|||
130697241|NCT05740098|470516102|FG000|Overall Study|Lost to Follow-up|26|||
130697242|NCT05740098|470516103|FG001|Overall Study|Lost to Follow-up|17|||
130697243|NCT05740098|470516104|FG002|Overall Study|Lost to Follow-up|21|||
130697244|NCT01073631|470516105|FG000|Overall Study|Death|82|||
130697245|NCT01073631|470516105|FG000|Overall Study|Adverse Event|24|||
130697246|NCT01073631|470516105|FG000|Overall Study|Other|63|||
130697247|NCT01528735|470516106|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130697248|NCT01528735|470516107|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130697249|NCT01528735|470516106|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
130697250|NCT01528735|470516107|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
130697251|NCT01426854|470516110|FG000|Overall Study|Adverse Event|1|||
130697252|NCT01426854|470516111|FG001|Overall Study|Adverse Event|5|||
130697253|NCT01426854|470516110|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
130243960|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
130450355|NCT01511250|469612807|FG004|Overall Study|Protocol Violation|0|||
130450356|NCT01511250|469612808|FG005|Overall Study|Protocol Violation|0|||
130450357|NCT01511250|469612809|FG006|Overall Study|Protocol Violation|0|||
130450358|NCT01511250|469612810|FG007|Overall Study|Protocol Violation|0|||
130450359|NCT01511250|469612811|FG008|Overall Study|Protocol Violation|0|||
130450360|NCT01511250|469612812|FG009|Overall Study|Protocol Violation|0|||
130450361|NCT04668144|469612817|FG000|Overall Study|Protocol Violation|0|||
130450362|NCT04668144|469612818|FG001|Overall Study|Protocol Violation|1|||
130450363|NCT04668144|469612819|FG002|Overall Study|Protocol Violation|2|||
130450364|NCT00916006|469612821|FG000|Overall Study|Adverse Event|1|||
130450365|NCT00916006|469612822|FG001|Overall Study|Adverse Event|1|||
130450366|NCT00916006|469612821|FG000|Overall Study|Withdrawal by Subject|2|||
130450367|NCT00916006|469612822|FG001|Overall Study|Withdrawal by Subject|5|||
130697254|NCT01426854|470516111|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
130697255|NCT01426854|470516110|FG000|Overall Study|Lost to Follow-up|3|||
130697256|NCT01426854|470516111|FG001|Overall Study|Lost to Follow-up|0|||
130450368|NCT00916006|469612821|FG000|Overall Study|Protocol Violation|0|||
130697257|NCT01426854|470516110|FG000|Overall Study|Noncompliance|0|||
130243961|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
130450369|NCT00916006|469612822|FG001|Overall Study|Protocol Violation|1|||
130450370|NCT02929108|469612827|FG000|Overall Study|Hospice patient death|100|||
130450371|NCT02929108|469612828|FG001|Overall Study|Hospice patient death|64|||
130697258|NCT01426854|470516111|FG001|Overall Study|Noncompliance|1|||
130697259|NCT01426854|470516110|FG000|Overall Study|Treatment Failure|0|||
130697260|NCT01426854|470516111|FG001|Overall Study|Treatment Failure|16|||
130697261|NCT01426854|470516110|FG000|Overall Study|Protocol Deviation|0|||
130697262|NCT01426854|470516111|FG001|Overall Study|Protocol Deviation|1|||
130697263|NCT01426854|470516110|FG000|Overall Study|Other|3|||
130697264|NCT01426854|470516111|FG001|Overall Study|Other|2|||
130697265|NCT01971554|470516112|FG000|Overall Study|Lost to Follow-up|1|||
130697266|NCT01971554|470516113|FG001|Overall Study|Lost to Follow-up|0|||
130450372|NCT02929108|469612829|FG002|Overall Study|Hospice patient death|28|||
130450373|NCT02929108|469612830|FG003|Overall Study|Hospice patient death|46|||
130450374|NCT02929108|469612831|FG004|Overall Study|Hospice patient death|55|||
130450375|NCT02929108|469612832|FG005|Overall Study|Hospice patient death|28|||
130450376|NCT02929108|469612833|FG006|Overall Study|Hospice patient death|78|||
130450377|NCT00052962|469612834|FG000|Overall Study|Not evaluable|0|||
130450378|NCT00052962|469612835|FG001|Overall Study|Not evaluable|2|||
130450379|NCT00052962|469612834|FG000|Overall Study|Not randomized/not evaluable|1|||
130450380|NCT00052962|469612835|FG001|Overall Study|Not randomized/not evaluable|0|||
130450381|NCT05487703|469612836|FG000|Overall Study|Other|19|||
130450382|NCT05487703|469612836|FG000|Overall Study|Participant not well|5|||
130450383|NCT05487703|469612836|FG000|Overall Study|Insurance Reasons|6|||
130450384|NCT05487703|469612836|FG000|Overall Study|Physician Decision|19|||
130450385|NCT05487703|469612836|FG000|Overall Study|Lack of Efficacy|60|||
130450386|NCT00832780|469612842|FG000|Overall Study|Death|16|||
130450387|NCT00832780|469612842|FG000|Overall Study|Lost to Follow-up|4|||
130450388|NCT00832780|469612842|FG000|Overall Study|no reason given|2|||
130450389|NCT00832780|469612842|FG000|Overall Study|other complicating condition|2|||
130450390|NCT00832780|469612842|FG000|Overall Study|Physician Decision|1|||
130450391|NCT01767909|469612845|FG000|Overall Study|Withdrawal by Subject|4|||
130450392|NCT01767909|469612846|FG001|Overall Study|Withdrawal by Subject|7|||
130450393|NCT01767909|469612845|FG000|Overall Study|Adverse Event|3|||
130450394|NCT01767909|469612846|FG001|Overall Study|Adverse Event|1|||
130450395|NCT01767909|469612845|FG000|Overall Study|Withdrawal by Study Partner|3|||
130450396|NCT01767909|469612846|FG001|Overall Study|Withdrawal by Study Partner|1|||
130450397|NCT01767909|469612845|FG000|Overall Study|Non-Compliance|2|||
130450398|NCT01767909|469612846|FG001|Overall Study|Non-Compliance|0|||
130450399|NCT01767909|469612845|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130450400|NCT01767909|469612846|FG001|Overall Study|Perceived Lack of Efficacy|0|||
130450401|NCT01767909|469612845|FG000|Overall Study|Investigator Recommendation|0|||
130450402|NCT01767909|469612846|FG001|Overall Study|Investigator Recommendation|1|||
130450403|NCT01767909|469612845|FG000|Overall Study|Lost to Follow-up|0|||
130450404|NCT01767909|469612846|FG001|Overall Study|Lost to Follow-up|1|||
130450405|NCT01767909|469612845|FG000|Overall Study|LP uncessessful|0|||
130450406|NCT01767909|469612846|FG001|Overall Study|LP uncessessful|1|||
130450407|NCT04956692|469612848|FG000|Overall Study|Death|115|||
130450408|NCT04956692|469612849|FG001|Overall Study|Death|47|||
130450409|NCT04956692|469612848|FG000|Overall Study|Lost to Follow-up|0|||
130450410|NCT04956692|469612849|FG001|Overall Study|Lost to Follow-up|1|||
130450411|NCT04956692|469612848|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130450412|NCT04956692|469612849|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130450413|NCT04956692|469612848|FG000|Overall Study|Withdrawal by Subject|5|||
130450414|NCT04956692|469612849|FG001|Overall Study|Withdrawal by Subject|2|||
130450415|NCT04956692|469612848|FG000|Overall Study|Ongoing in Study|236|||
130450416|NCT04956692|469612849|FG001|Overall Study|Ongoing in Study|123|||
130450417|NCT04639947|469612850|FG000|Overall Study|Screen fail|1|||
130450418|NCT04863898|469612853|FG000|Overall Study|Away from study clinic during intervention training period|2|||
130450419|NCT04863898|469612853|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
130450420|NCT04863898|469612853|FG000|Overall Study|Lost to Follow-up|3|||
130450421|NCT04863898|469612853|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
130450422|NCT04863898|469612853|FG000|Overall Study|No longer employed at clinic|3|||
130450423|NCT00614744|469612854|FG000|Overall Study|Lost to Follow-up|5|||
130450424|NCT00614744|469612855|FG001|Overall Study|Lost to Follow-up|4|||
130697267|NCT01971554|470516114|FG002|Overall Study|Lost to Follow-up|0|||
130697268|NCT01971554|470516115|FG003|Overall Study|Lost to Follow-up|0|||
130243962|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
130450425|NCT00614744|469612854|FG000|Overall Study|Incomplete for Behavior Issues|0|||
130450426|NCT00614744|469612855|FG001|Overall Study|Incomplete for Behavior Issues|2|||
130450427|NCT00877851|469612856|FG000|Overall Study|Lost to Follow-up|5|||
130450428|NCT00877851|469612857|FG001|Overall Study|Lost to Follow-up|5|||
130450429|NCT00877851|469612856|FG000|Overall Study|computer problem|3|||
130450430|NCT00877851|469612857|FG001|Overall Study|computer problem|0|||
130450431|NCT00877851|469612856|FG000|Overall Study|no longer interested in participating|1|||
130450432|NCT00877851|469612857|FG001|Overall Study|no longer interested in participating|0|||
130450433|NCT00770211|469612865|FG000|Overall Study|Lost to Follow-up|1|||
130450434|NCT00770211|469612866|FG001|Overall Study|Lost to Follow-up|0|||
130450435|NCT00770211|469612865|FG000|Overall Study|Withdrawal by Subject|0|||
130450436|NCT00770211|469612866|FG001|Overall Study|Withdrawal by Subject|2|||
130450437|NCT03005288|469612868|FG000|Overall Study|Withdrawal by Subject|7|||
130450438|NCT03005288|469612869|FG001|Overall Study|Withdrawal by Subject|5|||
130697269|NCT01942135|470516119|FG000|Overall Study|Adverse Event|21|||
130697270|NCT01942135|470516120|FG001|Overall Study|Adverse Event|7|||
130697271|NCT01942135|470516119|FG000|Overall Study|Global Deterioration of Health Status|9|||
130697272|NCT01942135|470516120|FG001|Overall Study|Global Deterioration of Health Status|6|||
130697273|NCT01942135|470516119|FG000|Overall Study|Randomized Not Treated|2|||
130697274|NCT01942135|470516120|FG001|Overall Study|Randomized Not Treated|2|||
130697275|NCT01942135|470516119|FG000|Overall Study|Death|2|||
130697276|NCT01942135|470516120|FG001|Overall Study|Death|1|||
130697277|NCT01942135|470516119|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
130697278|NCT01942135|470516120|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
130697279|NCT01942135|470516119|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
130697280|NCT01942135|470516120|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
130697281|NCT01942135|470516119|FG000|Overall Study|Withdrawal by Subject|4|||
130697282|NCT01942135|470516120|FG001|Overall Study|Withdrawal by Subject|3|||
130697283|NCT01942135|470516119|FG000|Overall Study|Protocol Violation|1|||
130697284|NCT01942135|470516120|FG001|Overall Study|Protocol Violation|0|||
130697285|NCT01942135|470516119|FG000|Overall Study|Other|19|||
130697286|NCT01942135|470516120|FG001|Overall Study|Other|4|||
130697287|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
130697288|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
130243963|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
130243964|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
130243965|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130243966|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130243967|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130243968|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130243969|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130243970|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130243971|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
130243972|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
130243973|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243974|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243975|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
130243976|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243977|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243978|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243979|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
130243980|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243981|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243982|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243983|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243984|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
130243985|NCT02448043|468853390|FG000|Overall Study|Withdrawal by Subject|2|||
130243986|NCT02448043|468853391|FG001|Overall Study|Withdrawal by Subject|2|||
130243987|NCT02448043|468853390|FG000|Overall Study|Protocol Violation|1|||
130243988|NCT02448043|468853391|FG001|Overall Study|Protocol Violation|2|||
130243989|NCT00997126|468853392|FG000|Overall Study|Physician Decision|7|||
130243990|NCT00997126|468853393|FG001|Overall Study|Physician Decision|11|||
130243991|NCT02583477|468853398|FG000|Overall Study|Adverse Event|0|||
130243992|NCT02583477|468853399|FG001|Overall Study|Adverse Event|2|||
130243993|NCT02583477|468853398|FG000|Overall Study|Death|1|||
130243994|NCT02583477|468853399|FG001|Overall Study|Death|16|||
130243995|NCT02583477|468853398|FG000|Overall Study|Study terminated|2|||
130243996|NCT02583477|468853399|FG001|Overall Study|Study terminated|2|||
130243997|NCT01327703|468853402|FG000|Second Treatment Period|Adverse Event|1|||
130243998|NCT01327703|468853403|FG001|Second Treatment Period|Adverse Event|1|||
130243999|NCT01327703|468853402|FG000|Second Treatment Period|Protocol Violation|0|||
130244000|NCT01327703|468853403|FG001|Second Treatment Period|Protocol Violation|1|||
130244001|NCT01131585|468853404|FG000|Overall Study|Adverse Event|0|||
130244002|NCT01131585|468853405|FG001|Overall Study|Adverse Event|2|||
130244003|NCT01131585|468853404|FG000|Overall Study|Abnormal laboratory value|1|||
130244004|NCT01131585|468853405|FG001|Overall Study|Abnormal laboratory value|0|||
130244005|NCT01131585|468853404|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130244006|NCT01131585|468853405|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130244007|NCT01131585|468853404|FG000|Overall Study|Protocol Violation|2|||
130244008|NCT01131585|468853405|FG001|Overall Study|Protocol Violation|1|||
130244009|NCT01131585|468853404|FG000|Overall Study|Withdrawal by Subject|3|||
130244010|NCT01131585|468853405|FG001|Overall Study|Withdrawal by Subject|3|||
130244011|NCT01131585|468853404|FG000|Overall Study|Lost to Follow-up|0|||
130244012|NCT01131585|468853405|FG001|Overall Study|Lost to Follow-up|1|||
130244013|NCT01131585|468853404|FG000|Overall Study|Administrative problems|1|||
130697289|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
130697290|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
130697291|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
130697292|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
130697293|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
130697294|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
130697295|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
130697296|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
130697297|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
130697298|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
130697299|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
130697300|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
130697301|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
130697302|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
130697303|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
130697304|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
130697305|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130697306|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130697307|NCT00950300|470516121|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
130244014|NCT01131585|468853405|FG001|Overall Study|Administrative problems|1|||
130450439|NCT03005288|469612868|FG000|Overall Study|Lost to Follow-up|0|||
130450440|NCT03005288|469612869|FG001|Overall Study|Lost to Follow-up|1|||
130450441|NCT03005288|469612868|FG000|Overall Study|Adverse Event|5|||
130450442|NCT03005288|469612869|FG001|Overall Study|Adverse Event|0|||
130450443|NCT03005288|469612868|FG000|Overall Study|Protocol deviation|0|||
130450444|NCT03005288|469612869|FG001|Overall Study|Protocol deviation|1|||
130450445|NCT03005288|469612868|FG000|Overall Study|Physician Decision|0|||
130450446|NCT03005288|469612869|FG001|Overall Study|Physician Decision|1|||
130450447|NCT00665561|469612870|FG000|Overall Study|Death recorded on subject summary pages|75|||
130450448|NCT00665561|469612871|FG001|Overall Study|Death recorded on subject summary pages|75|||
130450449|NCT00665561|469612870|FG000|Overall Study|Does not meet entrance criteria|19|||
130450450|NCT00665561|469612871|FG001|Overall Study|Does not meet entrance criteria|21|||
130450451|NCT00665561|469612870|FG000|Overall Study|Lost to Follow-up|203|||
130450452|NCT00665561|469612871|FG001|Overall Study|Lost to Follow-up|264|||
130450453|NCT00665561|469612870|FG000|Overall Study|Withdrawal by Subject|74|||
130450454|NCT00665561|469612871|FG001|Overall Study|Withdrawal by Subject|65|||
130450455|NCT00665561|469612870|FG000|Overall Study|Other|123|||
130450456|NCT00665561|469612871|FG001|Overall Study|Other|108|||
130450457|NCT00665561|469612870|FG000|Overall Study|Site closed|8|||
130450458|NCT00665561|469612871|FG001|Overall Study|Site closed|0|||
130450459|NCT00665561|469612870|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130450460|NCT00665561|469612871|FG001|Overall Study|Withdrawn due to pregnancy|1|||
130450461|NCT03824236|469612872|FG000|Overall Study|Lost to Follow-up|0|||
130450462|NCT03824236|469612873|FG001|Overall Study|Lost to Follow-up|0|||
130450463|NCT03824236|469612874|FG002|Overall Study|Lost to Follow-up|1|||
130450464|NCT00701311|469612877|FG000|Overall Study|Lack of Efficacy|3|||
130450465|NCT00701311|469612877|FG000|Overall Study|Adverse Event|3|||
130450466|NCT00701311|469612877|FG000|Overall Study|Withdrawal by Subject|2|||
130450467|NCT00670540|469612878|FG000|Overall Study|ineligible|17|||
130450468|NCT00670540|469612878|FG000|Overall Study|not living in France|348|||
130450469|NCT00670540|469612878|FG000|Overall Study|refused to participate|189|||
130450470|NCT00670540|469612878|FG000|Overall Study|controls randomised for no follow up|2770|||
130450471|NCT00670540|469612878|FG000|Overall Study|missing information inclusion criteria|1|||
130450472|NCT01140347|469612879|FG000|Overall Study|Lost to Follow-up|5|||
130450473|NCT01140347|469612880|FG001|Overall Study|Lost to Follow-up|6|||
130450474|NCT01140347|469612879|FG000|Overall Study|Withdrawal by Subject|13|||
130450475|NCT01140347|469612880|FG001|Overall Study|Withdrawal by Subject|8|||
130450476|NCT01515319|469612881|FG000|Overall Study|Withdrawal by Subject|0|||
130697308|NCT00950300|470516122|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
130697309|NCT00950300|470516121|FG000|TFFU Period|Death|4|||
130697310|NCT00950300|470516122|FG001|TFFU Period|Death|1|||
130697311|NCT00950300|470516121|FG000|TFFU Period|Refused Treatment|10|||
130697312|NCT00950300|470516122|FG001|TFFU Period|Refused Treatment|11|||
130697313|NCT00950300|470516121|FG000|TFFU Period|Failure to Return|16|||
130244015|NCT01131585|468853404|FG000|Overall Study|Study termination|78|||
130450477|NCT01515319|469612882|FG001|Overall Study|Withdrawal by Subject|0|||
130450478|NCT01515319|469612883|FG002|Overall Study|Withdrawal by Subject|0|||
130450479|NCT01515319|469612884|FG003|Overall Study|Withdrawal by Subject|0|||
130450480|NCT01515319|469612885|FG004|Overall Study|Withdrawal by Subject|0|||
130450481|NCT01515319|469612886|FG005|Overall Study|Withdrawal by Subject|0|||
130450482|NCT01515319|469612887|FG006|Overall Study|Withdrawal by Subject|1|||
130450483|NCT01515319|469612888|FG007|Overall Study|Withdrawal by Subject|0|||
130450484|NCT01515319|469612889|FG008|Overall Study|Withdrawal by Subject|0|||
130697314|NCT00950300|470516122|FG001|TFFU Period|Failure to Return|16|||
130697315|NCT00950300|470516121|FG000|TFFU Period|Recurrence of Disease|63|||
130697316|NCT00950300|470516122|FG001|TFFU Period|Recurrence of Disease|72|||
130697317|NCT00950300|470516121|FG000|TFFU Period|Other|4|||
130697318|NCT00950300|470516122|FG001|TFFU Period|Other|3|||
130697319|NCT00950300|470516121|FG000|SFU Period|Death|44|||
130697320|NCT00950300|470516122|FG001|SFU Period|Death|42|||
130244016|NCT01131585|468853405|FG001|Overall Study|Study termination|32|||
130244017|NCT00927082|468853406|FG000|Overall Study|Lost to Follow-up|9|||
130244018|NCT00927082|468853407|FG001|Overall Study|Lost to Follow-up|8|||
130244019|NCT00927082|468853408|FG002|Overall Study|Lost to Follow-up|12|||
130244020|NCT00927082|468853409|FG003|Overall Study|Lost to Follow-up|16|||
130244021|NCT00927082|468853406|FG000|Overall Study|Withdrawal by Subject|3|||
130244022|NCT00927082|468853407|FG001|Overall Study|Withdrawal by Subject|2|||
130244023|NCT00927082|468853408|FG002|Overall Study|Withdrawal by Subject|7|||
130697321|NCT00950300|470516121|FG000|SFU Period|Lost to Follow-up|30|||
130697322|NCT00950300|470516122|FG001|SFU Period|Lost to Follow-up|28|||
130697323|NCT00950300|470516121|FG000|SFU Period|Withdrawal by Subject|4|||
130697324|NCT00950300|470516122|FG001|SFU Period|Withdrawal by Subject|8|||
130697325|NCT01717040|470516123|FG000|Overall Study|Lost to Follow-up|2|||
130697326|NCT01717040|470516124|FG001|Overall Study|Lost to Follow-up|3|||
130697327|NCT01717040|470516123|FG000|Overall Study|Lack of Efficacy|1|||
130697328|NCT01717040|470516124|FG001|Overall Study|Lack of Efficacy|1|||
130697329|NCT01717040|470516123|FG000|Overall Study|Adverse Event|1|||
130697330|NCT01717040|470516124|FG001|Overall Study|Adverse Event|0|||
130697331|NCT01717040|470516123|FG000|Overall Study|Required Medication Change|0|||
130697332|NCT01717040|470516124|FG001|Overall Study|Required Medication Change|1|||
130697333|NCT01717040|470516123|FG000|Overall Study|New Substance Use Disorder|1|||
130697334|NCT01717040|470516124|FG001|Overall Study|New Substance Use Disorder|0|||
130697335|NCT00494013|470516125|FG000|Overall Study|Adverse Event|0|||
130697336|NCT00494013|470516126|FG001|Overall Study|Adverse Event|1|||
130244024|NCT00927082|468853409|FG003|Overall Study|Withdrawal by Subject|2|||
130244025|NCT00927082|468853406|FG000|Overall Study|Death|0|||
130244026|NCT00927082|468853407|FG001|Overall Study|Death|0|||
130244027|NCT00927082|468853408|FG002|Overall Study|Death|1|||
130244028|NCT00927082|468853409|FG003|Overall Study|Death|0|||
130244029|NCT00927082|468853406|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130244030|NCT00927082|468853407|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130244031|NCT00927082|468853408|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
130244032|NCT00927082|468853409|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
130244033|NCT01860404|468853411|FG000|Overall Study|Lost to Follow-up|3|||
130244034|NCT01860404|468853412|FG001|Overall Study|Lost to Follow-up|4|||
130244035|NCT01860404|468853413|FG002|Overall Study|Lost to Follow-up|1|||
130244036|NCT01860404|468853414|FG003|Overall Study|Lost to Follow-up|6|||
130244037|NCT01860404|468853415|FG004|Overall Study|Lost to Follow-up|4|||
130244038|NCT01860404|468853411|FG000|Overall Study|Withdrawal by Subject|0|||
130244039|NCT01860404|468853412|FG001|Overall Study|Withdrawal by Subject|0|||
130244040|NCT01860404|468853413|FG002|Overall Study|Withdrawal by Subject|4|||
130244041|NCT01860404|468853414|FG003|Overall Study|Withdrawal by Subject|0|||
130244042|NCT01860404|468853415|FG004|Overall Study|Withdrawal by Subject|0|||
130244043|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
130244044|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
130362702|NCT02713204|469297955|FG001|From Week 12 up to Week 36|Death|0|||
130362703|NCT02713204|469297956|FG002|From Week 12 up to Week 36|Death|0|||
130450485|NCT01515319|469612890|FG009|Overall Study|Withdrawal by Subject|0|||
130450486|NCT01515319|469612881|FG000|Overall Study|Adverse Event|0|||
130244045|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
130362704|NCT02713204|469297957|FG003|From Week 12 up to Week 36|Death|1|||
130362705|NCT02713204|469297958|FG004|From Week 12 up to Week 36|Death|0|||
130362706|NCT02713204|469297959|FG005|From Week 12 up to Week 36|Death|1|||
130362707|NCT02713204|469297960|FG006|From Week 12 up to Week 36|Death|0|||
130362708|NCT02713204|469297961|FG007|From Week 12 up to Week 36|Death|3|||
130362709|NCT02713204|469297954|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
130450487|NCT01515319|469612882|FG001|Overall Study|Adverse Event|0|||
130697337|NCT00494013|470516125|FG000|Overall Study|Entry Criteria Not Met|1|||
130362710|NCT02713204|469297955|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362711|NCT02713204|469297956|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362712|NCT02713204|469297957|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
130450488|NCT01515319|469612883|FG002|Overall Study|Adverse Event|0|||
130697338|NCT00494013|470516126|FG001|Overall Study|Entry Criteria Not Met|4|||
130697339|NCT00494013|470516125|FG000|Overall Study|Lost to Follow-up|5|||
130450489|NCT01515319|469612884|FG003|Overall Study|Adverse Event|0|||
130697340|NCT00494013|470516126|FG001|Overall Study|Lost to Follow-up|6|||
130697341|NCT00494013|470516125|FG000|Overall Study|Physician Decision|3|||
130697342|NCT00494013|470516126|FG001|Overall Study|Physician Decision|5|||
130697343|NCT00494013|470516125|FG000|Overall Study|Protocol Violation|8|||
130697344|NCT00494013|470516126|FG001|Overall Study|Protocol Violation|5|||
130697345|NCT00494013|470516125|FG000|Overall Study|Withdrawal by Subject|13|||
130244046|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
130244047|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
130244048|NCT00849472|468853416|FG000|Weekly Paclitaxel|Disease Progression|1|||
130697346|NCT00494013|470516126|FG001|Overall Study|Withdrawal by Subject|14|||
130697347|NCT00494013|470516125|FG000|Overall Study|Sponsor Decision|0|||
130697348|NCT00494013|470516126|FG001|Overall Study|Sponsor Decision|1|||
130697349|NCT04203823|470516127|FG000|Overall Study|Withdrawal by Subject|2|||
130697350|NCT04203823|470516128|FG001|Overall Study|Withdrawal by Subject|2|||
130697351|NCT04203823|470516127|FG000|Overall Study|Adverse Event|1|||
130697352|NCT04203823|470516128|FG001|Overall Study|Adverse Event|1|||
130697353|NCT04203823|470516127|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130697354|NCT04203823|470516128|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130697355|NCT01499043|470516129|FG000|Overall Study|Progressive disease (radiographic)|2|||
130244049|NCT00849472|468853416|FG000|Weekly Paclitaxel|Adverse Event|11|||
130244050|NCT00849472|468853416|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
130244051|NCT00849472|468853416|FG000|Weekly Paclitaxel|Physician Decision|3|||
130244052|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
130244053|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
130244054|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
130244055|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
130244056|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
130244057|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
130244058|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
130697356|NCT01499043|470516129|FG000|Overall Study|Progressive disease (clinical)|1|||
130697357|NCT01499043|470516129|FG000|Overall Study|Withdrawal by Subject|2|||
130697358|NCT01499043|470516129|FG000|Overall Study|Adverse Event|1|||
130697359|NCT00438633|470516131|FG000|Overall Study|Withdrawal by Subject|1|||
130697360|NCT00438633|470516132|FG001|Overall Study|Withdrawal by Subject|0|||
130697361|NCT00438633|470516131|FG000|Overall Study|Lost to Follow-up|15|||
130244059|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
130244060|NCT05259033|468853421|FG000|Overall Study|Withdrawal by Subject|10|||
130244061|NCT05259033|468853422|FG001|Overall Study|Withdrawal by Subject|5|||
130362713|NCT02713204|469297958|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362714|NCT02713204|469297959|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362715|NCT02713204|469297960|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362716|NCT02713204|469297961|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
130362717|NCT02713204|469297954|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
130362718|NCT02713204|469297955|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
130362719|NCT02713204|469297956|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
130362720|NCT02713204|469297957|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
130362721|NCT02713204|469297958|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
130362722|NCT02713204|469297959|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
130362723|NCT02713204|469297960|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
130362724|NCT02713204|469297961|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
130362725|NCT00669396|469297962|FG000|Overall Study|Lost to Follow-up|10|||
130697362|NCT00438633|470516132|FG001|Overall Study|Lost to Follow-up|17|||
130697363|NCT03193021|470516133|FG000|Overall Study|Lost to Follow-up|1|||
130697364|NCT03193021|470516134|FG001|Overall Study|Lost to Follow-up|1|||
130244062|NCT05259033|468853421|FG000|Overall Study|Lost to Follow-up|1|||
130362726|NCT00669396|469297963|FG001|Overall Study|Lost to Follow-up|12|||
130362727|NCT04402060|469297964|FG000|Overall Study|Death|1|||
130362728|NCT04402060|469297965|FG001|Overall Study|Death|12|||
130697365|NCT02286466|470516135|FG000|Overall Study|Death|1|||
130697366|NCT02286466|470516136|FG001|Overall Study|Death|3|||
130697367|NCT02286466|470516135|FG000|Overall Study|Withdrawal by Subject|5|||
130697368|NCT02286466|470516136|FG001|Overall Study|Withdrawal by Subject|2|||
130697369|NCT02286466|470516135|FG000|Overall Study|Lost to Follow-up|1|||
130697370|NCT02286466|470516136|FG001|Overall Study|Lost to Follow-up|4|||
130244063|NCT05259033|468853422|FG001|Overall Study|Lost to Follow-up|0|||
130244064|NCT05259033|468853421|FG000|Overall Study|Death|2|||
130244065|NCT05259033|468853422|FG001|Overall Study|Death|0|||
130244066|NCT04180696|468853423|FG000|Overall Study|Death|5|||
130244067|NCT04180696|468853424|FG001|Overall Study|Death|6|||
130244068|NCT04180696|468853423|FG000|Overall Study|Lost to Follow-up|1|||
130244069|NCT04180696|468853424|FG001|Overall Study|Lost to Follow-up|0|||
130244070|NCT04180696|468853423|FG000|Overall Study|Withdrawal by Subject|0|||
130244071|NCT04180696|468853424|FG001|Overall Study|Withdrawal by Subject|1|||
130244072|NCT04210375|468853425|FG000|Overall Study|Death|0|||
130244073|NCT04210375|468853426|FG001|Overall Study|Death|1|||
130244074|NCT04210375|468853427|FG002|Overall Study|Death|0|||
130244075|NCT04210375|468853428|FG003|Overall Study|Death|0|||
130362729|NCT04402060|469297966|FG002|Overall Study|Death|7|||
130362730|NCT04402060|469297964|FG000|Overall Study|Adverse Event|0|||
130362731|NCT04402060|469297965|FG001|Overall Study|Adverse Event|0|||
130697371|NCT02286466|470516135|FG000|Overall Study|Declined Clinician Assessment|0|||
130697372|NCT02286466|470516136|FG001|Overall Study|Declined Clinician Assessment|1|||
130697373|NCT00835081|470516137|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130697374|NCT00835081|470516138|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130697375|NCT00421304|470516139|FG000|Overall Study|Lost to Follow-up|5|||
130697376|NCT00421304|470516140|FG001|Overall Study|Lost to Follow-up|2|||
130697377|NCT00421304|470516141|FG002|Overall Study|Lost to Follow-up|5|||
130697378|NCT00421304|470516139|FG000|Overall Study|Withdrawal by Subject|2|||
130697379|NCT00421304|470516140|FG001|Overall Study|Withdrawal by Subject|2|||
130697380|NCT00421304|470516141|FG002|Overall Study|Withdrawal by Subject|2|||
130697381|NCT00421304|470516139|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
130697382|NCT00421304|470516140|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130697383|NCT00421304|470516141|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130697384|NCT00421304|470516139|FG000|Overall Study|Did not attend Day 360 visit|0|||
130697385|NCT00421304|470516140|FG001|Overall Study|Did not attend Day 360 visit|0|||
130697386|NCT00421304|470516141|FG002|Overall Study|Did not attend Day 360 visit|1|||
130362732|NCT04402060|469297966|FG002|Overall Study|Adverse Event|1|||
130362733|NCT04402060|469297964|FG000|Overall Study|Withdrawal by Subject|0|||
130362734|NCT04402060|469297965|FG001|Overall Study|Withdrawal by Subject|1|||
130362735|NCT04402060|469297966|FG002|Overall Study|Withdrawal by Subject|2|||
130362736|NCT04402060|469297964|FG000|Overall Study|Sponsor Request|0|||
130362737|NCT04402060|469297965|FG001|Overall Study|Sponsor Request|2|||
130362738|NCT04402060|469297966|FG002|Overall Study|Sponsor Request|0|||
130362739|NCT04402060|469297964|FG000|Overall Study|Physician Decision|0|||
130362740|NCT04402060|469297965|FG001|Overall Study|Physician Decision|0|||
130362741|NCT04402060|469297966|FG002|Overall Study|Physician Decision|1|||
130362742|NCT04402060|469297964|FG000|Overall Study|Other|0|||
130362743|NCT04402060|469297965|FG001|Overall Study|Other|1|||
130362744|NCT04402060|469297966|FG002|Overall Study|Other|0|||
130362745|NCT03386474|469297978|FG000|Overall Study|Death|1|||
130362746|NCT03386474|469297979|FG001|Overall Study|Death|0|||
130362747|NCT03386474|469297978|FG000|Overall Study|Adverse Event|0|||
130362748|NCT03386474|469297979|FG001|Overall Study|Adverse Event|1|||
130362749|NCT02155881|469297980|FG000|Overall Study|Withdrawal by Subject|0|||
130362750|NCT02155881|469297981|FG001|Overall Study|Withdrawal by Subject|2|||
130362751|NCT02155881|469297980|FG000|Overall Study|Inappropriately randomized|2|||
130362752|NCT02155881|469297981|FG001|Overall Study|Inappropriately randomized|2|||
130362753|NCT04357782|469297982|FG000|Overall Study|Discharged from hospital|1|||
130362754|NCT04357782|469297983|FG001|Overall Study|Discharged from hospital|0|||
130697387|NCT03196284|470516142|FG000|Main Part|Withdrawal by Subject|0|||
130697388|NCT03196284|470516143|FG001|Main Part|Withdrawal by Subject|1|||
130697389|NCT03196284|470516144|FG002|Main Part|Withdrawal by Subject|0|||
130697390|NCT03196284|470516142|FG000|Extension Part|Lack of Efficacy|0|||
130244076|NCT00424008|468853429|FG000|Overall Study|Adverse Event|8|||
130362755|NCT04357782|469297982|FG000|Overall Study|Death|0|||
130362756|NCT04357782|469297983|FG001|Overall Study|Death|2|||
130362757|NCT03780543|469297984|FG000|Overall Study|Adverse Event|1|||
130244077|NCT00424008|468853430|FG001|Overall Study|Adverse Event|6|||
130244078|NCT00424008|468853429|FG000|Overall Study|Lack of Efficacy|40|||
130244079|NCT00424008|468853430|FG001|Overall Study|Lack of Efficacy|34|||
130362758|NCT03780543|469297985|FG001|Overall Study|Adverse Event|0|||
130362759|NCT03780543|469297986|FG002|Overall Study|Adverse Event|2|||
130362760|NCT03780543|469297984|FG000|Overall Study|Lost to Follow-up|2|||
130362761|NCT03780543|469297985|FG001|Overall Study|Lost to Follow-up|0|||
130697391|NCT03196284|470516143|FG001|Extension Part|Lack of Efficacy|0|||
130697392|NCT03196284|470516144|FG002|Extension Part|Lack of Efficacy|1|||
130697393|NCT03196284|470516142|FG000|Extension Part|Withdrawal by Subject|0|||
130697394|NCT03196284|470516143|FG001|Extension Part|Withdrawal by Subject|0|||
130697395|NCT03196284|470516144|FG002|Extension Part|Withdrawal by Subject|1|||
130697396|NCT03196284|470516142|FG000|Extension Part|Physician Decision|0|||
130697397|NCT03196284|470516143|FG001|Extension Part|Physician Decision|0|||
130697398|NCT03196284|470516144|FG002|Extension Part|Physician Decision|1|||
130697399|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
130697400|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130697401|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130697402|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
130697403|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
130697404|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
130697405|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
130450490|NCT01515319|469612885|FG004|Overall Study|Adverse Event|0|||
130450491|NCT01515319|469612886|FG005|Overall Study|Adverse Event|0|||
130450492|NCT01515319|469612887|FG006|Overall Study|Adverse Event|0|||
130450493|NCT01515319|469612888|FG007|Overall Study|Adverse Event|0|||
130450494|NCT01515319|469612889|FG008|Overall Study|Adverse Event|3|||
130450495|NCT01515319|469612890|FG009|Overall Study|Adverse Event|0|||
130450496|NCT01515319|469612881|FG000|Overall Study|Protocol Violation|0|||
130450497|NCT01515319|469612882|FG001|Overall Study|Protocol Violation|0|||
130450498|NCT01515319|469612883|FG002|Overall Study|Protocol Violation|0|||
130450499|NCT01515319|469612884|FG003|Overall Study|Protocol Violation|0|||
130450500|NCT01515319|469612885|FG004|Overall Study|Protocol Violation|0|||
130450501|NCT01515319|469612886|FG005|Overall Study|Protocol Violation|0|||
130450502|NCT01515319|469612887|FG006|Overall Study|Protocol Violation|0|||
130450503|NCT01515319|469612888|FG007|Overall Study|Protocol Violation|0|||
130450504|NCT01515319|469612889|FG008|Overall Study|Protocol Violation|2|||
130450505|NCT01515319|469612890|FG009|Overall Study|Protocol Violation|0|||
130450506|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Adverse Event|5|||
130450507|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Adverse Event|13|||
130450508|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Adverse Event|0|||
130450509|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
130450510|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
130450511|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
130450512|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
130450513|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
130450514|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
130450515|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
130450516|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
130450517|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
130450518|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
130450519|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
130450520|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
130450521|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
130450522|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
130450523|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
130450524|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Physician Decision|2|||
130450525|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Physician Decision|3|||
130450526|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Physician Decision|0|||
130450527|NCT01449929|469612891|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
130450528|NCT01449929|469612892|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
130450529|NCT01449929|469612893|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
130450530|NCT01449929|469612891|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
130450531|NCT01449929|469612892|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
130450532|NCT01449929|469612893|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
130450533|NCT01449929|469612891|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
130697406|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130697407|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130697408|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
130697409|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
130697410|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
130450534|NCT01449929|469612892|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
130450535|NCT01449929|469612893|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
130450536|NCT01449929|469612891|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
130450537|NCT01449929|469612892|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
130450538|NCT01449929|469612893|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
130450539|NCT01871285|469612894|FG000|First Intervention (1 Day)|Adverse Event|1|||
130450540|NCT01871285|469612895|FG001|First Intervention (1 Day)|Adverse Event|0|||
130450541|NCT01871285|469612896|FG002|First Intervention (1 Day)|Adverse Event|0|||
130697411|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
130697412|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
130697413|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
130697414|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
130697415|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130697416|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130697417|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
130697418|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
130697419|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
130362762|NCT03780543|469297986|FG002|Overall Study|Lost to Follow-up|1|||
130362763|NCT03780543|469297984|FG000|Overall Study|Study terminated by Sponsor|8|||
130362764|NCT03780543|469297985|FG001|Overall Study|Study terminated by Sponsor|7|||
130362765|NCT03780543|469297986|FG002|Overall Study|Study terminated by Sponsor|13|||
130362766|NCT03780543|469297984|FG000|Overall Study|Withdrawal by Subject|1|||
130362767|NCT03780543|469297985|FG001|Overall Study|Withdrawal by Subject|8|||
130362768|NCT03780543|469297986|FG002|Overall Study|Withdrawal by Subject|1|||
130362769|NCT03780543|469297984|FG000|Overall Study|Noncompliance with study drug|1|||
130362770|NCT03780543|469297985|FG001|Overall Study|Noncompliance with study drug|0|||
130362771|NCT03780543|469297986|FG002|Overall Study|Noncompliance with study drug|0|||
130362772|NCT00066729|469297987|FG000|Overall Study|Lost to Follow-up|1|||
130362773|NCT00066729|469297987|FG000|Overall Study|Disease progression|1|||
130362774|NCT00287365|469297990|FG000|Overall Study|sample not acquired|13|||
130362775|NCT02298023|469297993|FG000|Overall Study|Withdrawal by Subject|1|||
130362776|NCT02298023|469297994|FG001|Overall Study|Withdrawal by Subject|0|||
130362777|NCT02298023|469297995|FG002|Overall Study|Withdrawal by Subject|0|||
130362778|NCT01967173|469297996|FG000|Overall Study|Lost to Follow-up|5|||
130362779|NCT01967173|469297997|FG001|Overall Study|Lost to Follow-up|3|||
130362780|NCT01967173|469297998|FG002|Overall Study|Lost to Follow-up|2|||
130362781|NCT01967173|469297999|FG003|Overall Study|Lost to Follow-up|4|||
130362782|NCT01967173|469298000|FG004|Overall Study|Lost to Follow-up|8|||
130362783|NCT01967173|469298001|FG005|Overall Study|Lost to Follow-up|12|||
130362784|NCT01967173|469298002|FG006|Overall Study|Lost to Follow-up|6|||
130362785|NCT01967173|469298003|FG007|Overall Study|Lost to Follow-up|8|||
130362786|NCT01967173|469297996|FG000|Overall Study|Physician Decision|2|||
130362787|NCT01967173|469297997|FG001|Overall Study|Physician Decision|0|||
130362788|NCT01967173|469297998|FG002|Overall Study|Physician Decision|2|||
130362789|NCT01967173|469297999|FG003|Overall Study|Physician Decision|1|||
130362790|NCT01967173|469298000|FG004|Overall Study|Physician Decision|1|||
130362791|NCT01967173|469298001|FG005|Overall Study|Physician Decision|1|||
130362792|NCT01967173|469298002|FG006|Overall Study|Physician Decision|1|||
130362793|NCT01967173|469298003|FG007|Overall Study|Physician Decision|0|||
130362794|NCT01967173|469297996|FG000|Overall Study|Lack of Efficacy|2|||
130362795|NCT01967173|469297997|FG001|Overall Study|Lack of Efficacy|0|||
130362796|NCT01967173|469297998|FG002|Overall Study|Lack of Efficacy|2|||
130362797|NCT01967173|469297999|FG003|Overall Study|Lack of Efficacy|2|||
130362798|NCT01967173|469298000|FG004|Overall Study|Lack of Efficacy|0|||
130362799|NCT01967173|469298001|FG005|Overall Study|Lack of Efficacy|1|||
130362800|NCT01967173|469298002|FG006|Overall Study|Lack of Efficacy|0|||
130362801|NCT01967173|469298003|FG007|Overall Study|Lack of Efficacy|2|||
130362802|NCT01967173|469297996|FG000|Overall Study|Pregnancy|0|||
130362803|NCT01967173|469297997|FG001|Overall Study|Pregnancy|0|||
130362804|NCT01967173|469297998|FG002|Overall Study|Pregnancy|0|||
130362805|NCT01967173|469297999|FG003|Overall Study|Pregnancy|0|||
130362806|NCT01967173|469298000|FG004|Overall Study|Pregnancy|0|||
130362807|NCT01967173|469298001|FG005|Overall Study|Pregnancy|0|||
130362808|NCT01967173|469298002|FG006|Overall Study|Pregnancy|1|||
130362809|NCT01967173|469298003|FG007|Overall Study|Pregnancy|1|||
130362810|NCT01967173|469297996|FG000|Overall Study|Adverse Event|0|||
130697420|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Death|0|||
130697421|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Death|1|||
130697422|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Death|1|||
130697423|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
130697424|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
130244080|NCT00424008|468853429|FG000|Overall Study|Lost to Follow-up|1|||
130362811|NCT01967173|469297997|FG001|Overall Study|Adverse Event|0|||
130450542|NCT01871285|469612897|FG003|First Intervention (1 Day)|Adverse Event|0|||
130697425|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
130362812|NCT01967173|469297998|FG002|Overall Study|Adverse Event|0|||
130362813|NCT01967173|469297999|FG003|Overall Study|Adverse Event|0|||
130362814|NCT01967173|469298000|FG004|Overall Study|Adverse Event|0|||
130362815|NCT01967173|469298001|FG005|Overall Study|Adverse Event|0|||
130362816|NCT01967173|469298002|FG006|Overall Study|Adverse Event|0|||
130362817|NCT01967173|469298003|FG007|Overall Study|Adverse Event|1|||
130362818|NCT01967173|469297996|FG000|Overall Study|Withdrawal by Subject|15|||
130362819|NCT01967173|469297997|FG001|Overall Study|Withdrawal by Subject|14|||
130362820|NCT01967173|469297998|FG002|Overall Study|Withdrawal by Subject|10|||
130362821|NCT01967173|469297999|FG003|Overall Study|Withdrawal by Subject|7|||
130362822|NCT01967173|469298000|FG004|Overall Study|Withdrawal by Subject|8|||
130362823|NCT01967173|469298001|FG005|Overall Study|Withdrawal by Subject|9|||
130450543|NCT01871285|469612894|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
130450544|NCT01871285|469612895|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
130450545|NCT01871285|469612896|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
130450546|NCT01871285|469612897|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
130450547|NCT01959880|469612898|FG000|Overall Study|Withdrawal by Subject|11|||
130450548|NCT01959880|469612899|FG001|Overall Study|Withdrawal by Subject|13|||
130450549|NCT01959880|469612900|FG002|Overall Study|Withdrawal by Subject|8|||
130450550|NCT01959880|469612901|FG003|Overall Study|Withdrawal by Subject|7|||
130450551|NCT01959880|469612898|FG000|Overall Study|Death|1|||
130450552|NCT01959880|469612899|FG001|Overall Study|Death|10|||
130450553|NCT01959880|469612900|FG002|Overall Study|Death|1|||
130450554|NCT01959880|469612901|FG003|Overall Study|Death|2|||
130450555|NCT01959880|469612898|FG000|Overall Study|Lost to Follow-up|95|||
130450556|NCT01959880|469612899|FG001|Overall Study|Lost to Follow-up|18|||
130450557|NCT01959880|469612900|FG002|Overall Study|Lost to Follow-up|15|||
130450558|NCT01959880|469612901|FG003|Overall Study|Lost to Follow-up|8|||
130450559|NCT01959880|469612898|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
130450560|NCT01959880|469612899|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
130450561|NCT01959880|469612900|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
130450562|NCT01959880|469612901|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
130450563|NCT01959880|469612898|FG000|Overall Study|Study completed early-FDA approved|1003|||
130450564|NCT01959880|469612899|FG001|Overall Study|Study completed early-FDA approved|311|||
130450565|NCT01959880|469612900|FG002|Overall Study|Study completed early-FDA approved|179|||
130450566|NCT01959880|469612901|FG003|Overall Study|Study completed early-FDA approved|152|||
130450567|NCT01919619|469612902|FG000|Overall Study|Physician Decision|1|||
130450568|NCT01919619|469612903|FG001|Overall Study|Physician Decision|1|||
130450569|NCT00662909|469612909|FG000|Overall Study|Adverse Event|17|||
130450570|NCT00662909|469612910|FG001|Overall Study|Adverse Event|18|||
130450571|NCT00662909|469612911|FG002|Overall Study|Adverse Event|19|||
130450572|NCT00662909|469612909|FG000|Overall Study|Lack of Efficacy|9|||
130450573|NCT00662909|469612910|FG001|Overall Study|Lack of Efficacy|1|||
130450574|NCT00662909|469612911|FG002|Overall Study|Lack of Efficacy|5|||
130450575|NCT00662909|469612909|FG000|Overall Study|Withdrawal by Subject|29|||
130450576|NCT00662909|469612910|FG001|Overall Study|Withdrawal by Subject|22|||
130450577|NCT00662909|469612911|FG002|Overall Study|Withdrawal by Subject|16|||
130450578|NCT00662909|469612909|FG000|Overall Study|Lost to Follow-up|2|||
130450579|NCT00662909|469612910|FG001|Overall Study|Lost to Follow-up|9|||
130450580|NCT00662909|469612911|FG002|Overall Study|Lost to Follow-up|3|||
130450581|NCT00662909|469612909|FG000|Overall Study|Protocol Violation|7|||
130450582|NCT00662909|469612910|FG001|Overall Study|Protocol Violation|4|||
130450583|NCT00662909|469612911|FG002|Overall Study|Protocol Violation|5|||
130450584|NCT00662909|469612909|FG000|Overall Study|Randomized- never received study drug|1|||
130450585|NCT00662909|469612910|FG001|Overall Study|Randomized- never received study drug|0|||
130450586|NCT00662909|469612911|FG002|Overall Study|Randomized- never received study drug|0|||
130450587|NCT00662909|469612909|FG000|Overall Study|Non-compliance with study procedures|3|||
130450588|NCT00662909|469612910|FG001|Overall Study|Non-compliance with study procedures|3|||
130450589|NCT00662909|469612911|FG002|Overall Study|Non-compliance with study procedures|2|||
130450590|NCT00662909|469612909|FG000|Overall Study|Physician Decision|1|||
130450591|NCT00662909|469612910|FG001|Overall Study|Physician Decision|1|||
130450592|NCT00662909|469612911|FG002|Overall Study|Physician Decision|2|||
130450593|NCT00662909|469612909|FG000|Overall Study|Eligibility criterion not met|0|||
130244081|NCT00424008|468853430|FG001|Overall Study|Lost to Follow-up|2|||
130450594|NCT00662909|469612910|FG001|Overall Study|Eligibility criterion not met|1|||
130450595|NCT00662909|469612911|FG002|Overall Study|Eligibility criterion not met|1|||
130450596|NCT04978363|469614479|FG000|Overall Study|Other medical issues unrelated to the study|0|||
130450597|NCT04978363|469614480|FG001|Overall Study|Other medical issues unrelated to the study|0|||
130450598|NCT04978363|469614481|FG002|Overall Study|Other medical issues unrelated to the study|0|||
130450599|NCT04978363|469614482|FG003|Overall Study|Other medical issues unrelated to the study|0|||
130450600|NCT04978363|469614483|FG004|Overall Study|Other medical issues unrelated to the study|1|||
130450601|NCT04978363|469614484|FG005|Overall Study|Other medical issues unrelated to the study|0|||
130697426|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
130697427|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
130697428|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
130697429|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
130697430|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
130697431|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
130697432|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130697433|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
130697434|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130697435|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
130697436|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
130697437|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
130697438|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
130697439|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
130697440|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
130697441|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
130697442|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
130697443|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
130697444|NCT01912807|470516148|FG000|Overall Study|Did not meet elegibility criteria|6|||
130697445|NCT01912807|470516149|FG001|Overall Study|Did not meet elegibility criteria|4|||
130697446|NCT01912807|470516148|FG000|Overall Study|Lost to Follow-up|36|||
130697447|NCT01912807|470516149|FG001|Overall Study|Lost to Follow-up|37|||
130697448|NCT04750239|470516150|FG000|Overall Study|Withdrawal by Subject|2|||
130697449|NCT04750239|470516150|FG000|Overall Study|Trial terminated by sponsor|1|||
130697450|NCT00919711|470516151|FG000|Overall Study|Withdrawal by Subject|15|||
130697451|NCT00919711|470516152|FG001|Overall Study|Withdrawal by Subject|7|||
130697452|NCT00919711|470516151|FG000|Overall Study|Adverse Event|13|||
130697453|NCT00919711|470516152|FG001|Overall Study|Adverse Event|3|||
130697454|NCT00919711|470516151|FG000|Overall Study|Other|1|||
130697455|NCT00919711|470516152|FG001|Overall Study|Other|2|||
130697456|NCT00919711|470516151|FG000|Overall Study|Administrative Decision|0|||
130697457|NCT00919711|470516152|FG001|Overall Study|Administrative Decision|1|||
130697458|NCT00919711|470516151|FG000|Overall Study|Lost to Follow-up|2|||
130697459|NCT00919711|470516152|FG001|Overall Study|Lost to Follow-up|0|||
130697460|NCT00919711|470516151|FG000|Overall Study|Death|1|||
130697461|NCT00919711|470516152|FG001|Overall Study|Death|0|||
130697462|NCT00919711|470516151|FG000|Overall Study|Noncompliance|1|||
130697463|NCT00919711|470516152|FG001|Overall Study|Noncompliance|0|||
130697464|NCT00903877|470516153|FG000|Overall Study|Did not meet study criteria|33|||
130697465|NCT00903877|470516153|FG000|Overall Study|Withdrawal by Subject|3|||
130697466|NCT00903877|470516153|FG000|Overall Study|Adverse Event|2|||
130697467|NCT00903877|470516153|FG000|Overall Study|Lost to Follow-up|1|||
130697468|NCT00903877|470516153|FG000|Overall Study|Participation put on hold|4|||
130697469|NCT00087529|470516155|FG000|Overall Study|Death|1|||
130697470|NCT00087529|470516156|FG001|Overall Study|Death|0|||
130697471|NCT00087529|470516155|FG000|Overall Study|Adverse Event|0|||
130697472|NCT00087529|470516156|FG001|Overall Study|Adverse Event|8|||
130697473|NCT00087529|470516155|FG000|Overall Study|Pregnancy|0|||
130697474|NCT00087529|470516156|FG001|Overall Study|Pregnancy|1|||
130697475|NCT00087529|470516155|FG000|Overall Study|Lost to Follow-up|2|||
130697476|NCT00087529|470516156|FG001|Overall Study|Lost to Follow-up|3|||
130697477|NCT00087529|470516155|FG000|Overall Study|Participant Decision|14|||
130697478|NCT00087529|470516156|FG001|Overall Study|Participant Decision|37|||
130697479|NCT00087529|470516155|FG000|Overall Study|Physician Decision|4|||
130697480|NCT00087529|470516156|FG001|Overall Study|Physician Decision|8|||
130697481|NCT00087529|470516155|FG000|Overall Study|Initiation of Excluded Therapy|0|||
130697482|NCT00087529|470516156|FG001|Overall Study|Initiation of Excluded Therapy|1|||
130697483|NCT00087529|470516155|FG000|Overall Study|Participant Noncompliance|0|||
130697484|NCT00087529|470516156|FG001|Overall Study|Participant Noncompliance|1|||
130697485|NCT00087529|470516155|FG000|Overall Study|Disease Progression|5|||
130244082|NCT00424008|468853429|FG000|Overall Study|Withdrawal by Subject|5|||
130244083|NCT00424008|468853430|FG001|Overall Study|Withdrawal by Subject|8|||
130244084|NCT00424008|468853429|FG000|Overall Study|Noncompliance with protocol|13|||
130244085|NCT00424008|468853430|FG001|Overall Study|Noncompliance with protocol|7|||
130697486|NCT00087529|470516156|FG001|Overall Study|Disease Progression|4|||
130697487|NCT00087529|470516155|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130244086|NCT00424008|468853429|FG000|Overall Study|Did not meet protocol eligibility|16|||
130697488|NCT00087529|470516156|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130697489|NCT02535923|470516157|FG000|Overall Study|Lost to Follow-up|5|||
130697490|NCT02535923|470516158|FG001|Overall Study|Lost to Follow-up|5|||
130697491|NCT02535923|470516157|FG000|Overall Study|Withdrawal by Subject|4|||
130697492|NCT02535923|470516158|FG001|Overall Study|Withdrawal by Subject|3|||
130697493|NCT00685334|470516166|FG000|Overall Study|Withdrawal by Subject|5|||
130697494|NCT00685334|470516167|FG001|Overall Study|Withdrawal by Subject|6|||
130697495|NCT00685334|470516166|FG000|Overall Study|Lost to Follow-up|4|||
130697496|NCT00685334|470516167|FG001|Overall Study|Lost to Follow-up|0|||
130697497|NCT00685334|470516166|FG000|Overall Study|Chose to enter hospital|1|||
130697498|NCT00685334|470516167|FG001|Overall Study|Chose to enter hospital|1|||
130697499|NCT01891357|470516168|FG000|Overall Study|Protocol Violation|3|||
130697500|NCT01253564|470516169|FG000|Overall Study|Disease Progression|22|||
130697501|NCT01253564|470516169|FG000|Overall Study|Withdrawal by Subject|1|||
130697502|NCT01253564|470516169|FG000|Overall Study|Serious Adverse Event|1|||
130697503|NCT03694197|470516172|FG000|Overall Study|Adverse Event|9|||
130697504|NCT03694197|470516172|FG000|Overall Study|Protocol became inconvenient to participate|1|||
130697505|NCT03694197|470516172|FG000|Overall Study|Physician Decision|4|||
130697506|NCT03694197|470516172|FG000|Overall Study|Study terminated by sponsor|1350|||
130697507|NCT03694197|470516172|FG000|Overall Study|Participant moved|5|||
130697508|NCT03694197|470516172|FG000|Overall Study|Participant withdrew consent|10|||
130697509|NCT03694197|470516172|FG000|Overall Study|Related to IMP administration|1|||
130697510|NCT03694197|470516172|FG000|Overall Study|Not disclosed|5|||
130697511|NCT03506633|470517855|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
130697512|NCT03506633|470517856|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
130697513|NCT04573309|470517858|FG000|Overall Study|Protocol Violation|1|||
130697514|NCT04573309|470517859|FG001|Overall Study|Protocol Violation|0|||
130697515|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
130697516|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
130697517|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
130244087|NCT00424008|468853430|FG001|Overall Study|Did not meet protocol eligibility|21|||
130244088|NCT00424008|468853429|FG000|Overall Study|Administrative|266|||
130244089|NCT00424008|468853430|FG001|Overall Study|Administrative|257|||
130244090|NCT02593864|468853433|FG000|Overall Study|Withdrawal by Subject|3|||
130244091|NCT02593864|468853433|FG000|Overall Study|Lost to Follow-up|3|||
130244092|NCT01405911|468853434|FG000|Overall Study|Pre-treatment lab AE|0|||
130244093|NCT01405911|468853435|FG001|Overall Study|Pre-treatment lab AE|1|||
130244094|NCT01405911|468853436|FG002|Overall Study|Pre-treatment lab AE|0|||
130244095|NCT01405911|468853434|FG000|Overall Study|Lost to Follow-up|0|||
130244096|NCT01405911|468853435|FG001|Overall Study|Lost to Follow-up|1|||
130244097|NCT01405911|468853436|FG002|Overall Study|Lost to Follow-up|0|||
130244098|NCT01405911|468853434|FG000|Overall Study|Protocol Violation|1|||
130244099|NCT01405911|468853435|FG001|Overall Study|Protocol Violation|0|||
130244100|NCT01405911|468853436|FG002|Overall Study|Protocol Violation|0|||
130244101|NCT01405911|468853434|FG000|Overall Study|Withdrawal by Subject|3|||
130244102|NCT01405911|468853435|FG001|Overall Study|Withdrawal by Subject|1|||
130244103|NCT01405911|468853436|FG002|Overall Study|Withdrawal by Subject|1|||
130244104|NCT03932331|468853441|FG000|Overall Study|Death|0|||
130244105|NCT03932331|468853442|FG001|Overall Study|Death|7|||
130244106|NCT03932331|468853443|FG002|Overall Study|Death|2|||
130244107|NCT03932331|468853441|FG000|Overall Study|Withdrawal by Subject|0|||
130244108|NCT03932331|468853442|FG001|Overall Study|Withdrawal by Subject|3|||
130244109|NCT03932331|468853443|FG002|Overall Study|Withdrawal by Subject|0|||
130244110|NCT03932331|468853441|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
130244111|NCT03932331|468853442|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
130244112|NCT03932331|468853443|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
130244113|NCT03932331|468853441|FG000|Overall Study|Progressive disease|3|||
130244114|NCT03932331|468853442|FG001|Overall Study|Progressive disease|0|||
130244115|NCT03932331|468853443|FG002|Overall Study|Progressive disease|0|||
130244116|NCT03932331|468853441|FG000|Overall Study|Lung infection|1|||
130244117|NCT03932331|468853442|FG001|Overall Study|Lung infection|0|||
130244118|NCT03932331|468853443|FG002|Overall Study|Lung infection|0|||
130244119|NCT03932331|468853441|FG000|Overall Study|Other|0|||
130244120|NCT03932331|468853442|FG001|Overall Study|Other|0|||
130244121|NCT03932331|468853443|FG002|Overall Study|Other|58|||
130244122|NCT01937117|468853444|FG000|Overall Study|Disease Progression|7|||
130244123|NCT01937117|468853444|FG000|Overall Study|Physician Decision|4|||
130244124|NCT01937117|468853444|FG000|Overall Study|Adverse Event|2|||
130362824|NCT01967173|469298002|FG006|Overall Study|Withdrawal by Subject|10|||
130362825|NCT01967173|469298003|FG007|Overall Study|Withdrawal by Subject|12|||
130362826|NCT02020577|469298004|FG000|Overall Study|Progressive disease|3|||
130244125|NCT01407367|468853447|FG000|Overall Study|Death|24|||
130244126|NCT01407367|468853448|FG001|Overall Study|Death|32|||
130244127|NCT01407367|468853447|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
130244128|NCT01407367|468853448|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
130244129|NCT01407367|468853447|FG000|Overall Study|Withdrawal by Subject|4|||
130244130|NCT01407367|468853448|FG001|Overall Study|Withdrawal by Subject|15|||
130697518|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
130697519|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
130697520|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
130697521|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
130697522|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
130244131|NCT01407367|468853447|FG000|Overall Study|Lost to Follow-up|0|||
130244132|NCT01407367|468853448|FG001|Overall Study|Lost to Follow-up|2|||
130244133|NCT01452347|468853451|FG000|Overall Study|Adverse Event|2|||
130244134|NCT01452347|468853452|FG001|Overall Study|Adverse Event|1|||
130244135|NCT01452347|468853451|FG000|Overall Study|Non compliance protocol|2|||
130244136|NCT01452347|468853452|FG001|Overall Study|Non compliance protocol|0|||
130244137|NCT01452347|468853451|FG000|Overall Study|Lost to Follow-up|2|||
130244138|NCT01452347|468853452|FG001|Overall Study|Lost to Follow-up|0|||
130244139|NCT01452347|468853451|FG000|Overall Study|Withdrawal by Subject|3|||
130244140|NCT01452347|468853452|FG001|Overall Study|Withdrawal by Subject|3|||
130244141|NCT01452347|468853451|FG000|Overall Study|Not treated|6|||
130244142|NCT01452347|468853452|FG001|Overall Study|Not treated|3|||
130244143|NCT01452347|468853451|FG000|Overall Study|Other reason not defined above|2|||
130244144|NCT01452347|468853452|FG001|Overall Study|Other reason not defined above|0|||
130244145|NCT05417113|468855103|FG000|Overall Study|Lost to Follow-up|2|||
130244146|NCT05417113|468855104|FG001|Overall Study|Lost to Follow-up|2|||
130244147|NCT01022580|468855105|FG000|Overall Study|Death|18|||
130244148|NCT01022580|468855106|FG001|Overall Study|Death|22|||
130244149|NCT01500096|468855109|FG000|Overall Study|Lost to Follow-up|1|||
130244150|NCT01500096|468855110|FG001|Overall Study|Lost to Follow-up|0|||
130244151|NCT01500096|468855111|FG002|Overall Study|Lost to Follow-up|0|||
130244152|NCT01500096|468855112|FG003|Overall Study|Lost to Follow-up|2|||
130244153|NCT01734928|468855113|FG000|Randomization|Physician Decision|0|||
130244154|NCT01734928|468855114|FG001|Randomization|Physician Decision|1|||
130244155|NCT01734928|468855113|FG000|Randomization|clinical progression|0|||
130244156|NCT01734928|468855114|FG001|Randomization|clinical progression|1|||
130244157|NCT01734928|468855113|FG000|Randomization|progressive disease|0|||
130244158|NCT01734928|468855114|FG001|Randomization|progressive disease|2|||
130244159|NCT01734928|468855113|FG000|Randomization|Withdrew informed consent|0|||
130244160|NCT01734928|468855114|FG001|Randomization|Withdrew informed consent|4|||
130244161|NCT01734928|468855113|FG000|Randomization|Death|1|||
130244162|NCT01734928|468855114|FG001|Randomization|Death|0|||
130244163|NCT01734928|468855113|FG000|Randomization|Randomization error|1|||
130244164|NCT01734928|468855114|FG001|Randomization|Randomization error|0|||
130244165|NCT01734928|468855113|FG000|Randomization|Lost to Follow-up|1|||
130244166|NCT01734928|468855114|FG001|Randomization|Lost to Follow-up|0|||
130244167|NCT01734928|468855113|FG000|Treatment Period|Lost to Follow-up|0|||
130244168|NCT01734928|468855114|FG001|Treatment Period|Lost to Follow-up|2|||
130244169|NCT01734928|468855113|FG000|Treatment Period|Progressive Disease|167|||
130244170|NCT01734928|468855114|FG001|Treatment Period|Progressive Disease|165|||
130244171|NCT01734928|468855113|FG000|Treatment Period|Adverse Event|39|||
130244172|NCT01734928|468855114|FG001|Treatment Period|Adverse Event|52|||
130244173|NCT01734928|468855113|FG000|Treatment Period|Withdrawal of Consent|25|||
130244174|NCT01734928|468855114|FG001|Treatment Period|Withdrawal of Consent|22|||
130244175|NCT01734928|468855113|FG000|Treatment Period|Death|20|||
130244176|NCT01734928|468855114|FG001|Treatment Period|Death|9|||
130362827|NCT02020577|469298005|FG001|Overall Study|Progressive disease|38|||
130362828|NCT02020577|469298004|FG000|Overall Study|Other AE or clinical progression|0|||
130362829|NCT02020577|469298005|FG001|Overall Study|Other AE or clinical progression|15|||
130362830|NCT02020577|469298004|FG000|Overall Study|Withdrawal by Subject|0|||
130362831|NCT02020577|469298005|FG001|Overall Study|Withdrawal by Subject|1|||
130362832|NCT02020577|469298004|FG000|Overall Study|Other than stated above|0|||
130362833|NCT02020577|469298005|FG001|Overall Study|Other than stated above|1|||
130244177|NCT01734928|468855113|FG000|Treatment Period|Other Reasons|27|||
130244178|NCT01734928|468855114|FG001|Treatment Period|Other Reasons|19|||
130244179|NCT01734928|468855113|FG000|Treatment Period|Pregnancy|0|||
130244180|NCT01734928|468855114|FG001|Treatment Period|Pregnancy|1|||
130244181|NCT01778985|468855115|FG000|Overall Study|Lost to Follow-up|1|||
130244182|NCT01778985|468855116|FG001|Overall Study|Lost to Follow-up|0|||
130244183|NCT01778985|468855115|FG000|Overall Study|Physician Decision|2|||
130244184|NCT01778985|468855116|FG001|Overall Study|Physician Decision|2|||
130244185|NCT01778985|468855115|FG000|Overall Study|Protocol Violation|4|||
130244186|NCT01778985|468855116|FG001|Overall Study|Protocol Violation|1|||
130244187|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
130362834|NCT02663908|469298006|FG000|Overall Study|Withdrawal by Subject|8|||
130244188|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Adverse Event|1|||
130362835|NCT02663908|469298007|FG001|Overall Study|Withdrawal by Subject|5|||
130362836|NCT02663908|469298006|FG000|Overall Study|Lost to Follow-up|1|||
130362837|NCT02663908|469298007|FG001|Overall Study|Lost to Follow-up|5|||
130362838|NCT02663908|469298006|FG000|Overall Study|Adverse Event|13|||
130362839|NCT02663908|469298007|FG001|Overall Study|Adverse Event|11|||
130362840|NCT02663908|469298006|FG000|Overall Study|Protocol Violation|1|||
130362841|NCT02663908|469298007|FG001|Overall Study|Protocol Violation|2|||
130362842|NCT02663908|469298006|FG000|Overall Study|Lack of therapeutic response|2|||
130362843|NCT02663908|469298007|FG001|Overall Study|Lack of therapeutic response|0|||
130362844|NCT02663908|469298006|FG000|Overall Study|COVID-19|1|||
130362845|NCT02663908|469298007|FG001|Overall Study|COVID-19|0|||
130362846|NCT02663908|469298006|FG000|Overall Study|Site closed|1|||
130362847|NCT02663908|469298007|FG001|Overall Study|Site closed|0|||
130244189|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
130244190|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Physician Decision|1|||
130244191|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
130244192|NCT00088881|468855117|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
130244193|NCT00088881|468855117|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
130244194|NCT01631188|468855123|FG000|Overall Study|Physician Decision|75|||
130244195|NCT03600350|468855124|FG000|Overall Study|Death|1|||
130244196|NCT03600350|468855124|FG000|Overall Study|On Follow Up|18|||
130244197|NCT00835978|468855125|FG000|Overall Study|Death|33|||
130244198|NCT00835978|468855126|FG001|Overall Study|Death|40|||
130244199|NCT00835978|468855127|FG002|Overall Study|Death|49|||
130450602|NCT04978363|469614485|FG006|Overall Study|Other medical issues unrelated to the study|0|||
130450603|NCT04978363|469614486|FG007|Overall Study|Other medical issues unrelated to the study|0|||
130450604|NCT04978363|469614487|FG008|Overall Study|Other medical issues unrelated to the study|0|||
130450605|NCT04978363|469614488|FG009|Overall Study|Other medical issues unrelated to the study|0|||
130450606|NCT04978363|469614489|FG010|Overall Study|Other medical issues unrelated to the study|0|||
130450607|NCT04978363|469614479|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
130450608|NCT04978363|469614480|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
130450609|NCT04978363|469614481|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
130450610|NCT04978363|469614482|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
130450611|NCT04978363|469614483|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
130450612|NCT04978363|469614484|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
130450613|NCT04978363|469614485|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
130450614|NCT04978363|469614486|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
130450615|NCT04978363|469614487|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
130450616|NCT04978363|469614488|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
130450617|NCT04978363|469614489|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
130450618|NCT04978363|469614479|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450619|NCT04978363|469614480|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
130450620|NCT04978363|469614481|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450621|NCT04978363|469614482|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450622|NCT04978363|469614483|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450623|NCT04978363|469614484|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450624|NCT04978363|469614485|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450625|NCT04978363|469614486|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130466712|NCT02544074|469676365|FG003|Overall Study|Withdrawal by Subject|0|||
130697523|NCT01541215|470517862|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
130244200|NCT00835978|468855128|FG003|Overall Study|Death|4|||
130244201|NCT00835978|468855125|FG000|Overall Study|Lost to Follow-up|3|||
130244202|NCT00835978|468855126|FG001|Overall Study|Lost to Follow-up|4|||
130244203|NCT00835978|468855127|FG002|Overall Study|Lost to Follow-up|2|||
130244204|NCT00835978|468855128|FG003|Overall Study|Lost to Follow-up|1|||
130244205|NCT00835978|468855125|FG000|Overall Study|Other|5|||
130244206|NCT00835978|468855126|FG001|Overall Study|Other|1|||
130362848|NCT02663908|469298006|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
130362849|NCT02663908|469298007|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
130362850|NCT02663908|469298006|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
130362851|NCT02663908|469298007|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
130362852|NCT02663908|469298006|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
130362853|NCT02663908|469298007|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
130362854|NCT02663908|469298006|FG000|Overall Study|Death|1|||
130362855|NCT02663908|469298007|FG001|Overall Study|Death|0|||
130362856|NCT02663908|469298006|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
130362857|NCT02663908|469298007|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
130362858|NCT02663908|469298006|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
130362859|NCT02663908|469298007|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
130362860|NCT03308786|469298008|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
130362861|NCT06238362|469298012|FG000|Overall Study|Insufficient total sleep time|1|||
130362862|NCT06238362|469298013|FG001|Overall Study|Insufficient total sleep time|0|||
130362863|NCT06238362|469298012|FG000|Overall Study|Inadequate signal quality|1|||
130362864|NCT06238362|469298013|FG001|Overall Study|Inadequate signal quality|0|||
130362865|NCT05136690|469298014|FG000|Period 1|Withdrawal by Subject|0|||
130362866|NCT05136690|469298015|FG001|Period 1|Withdrawal by Subject|1|||
130244207|NCT00835978|468855127|FG002|Overall Study|Other|8|||
130244208|NCT00835978|468855128|FG003|Overall Study|Other|0|||
130244209|NCT00835978|468855125|FG000|Overall Study|Objective progression or relapse|2|||
130244210|NCT00835978|468855126|FG001|Overall Study|Objective progression or relapse|0|||
130244211|NCT00835978|468855127|FG002|Overall Study|Objective progression or relapse|1|||
130244212|NCT00835978|468855128|FG003|Overall Study|Objective progression or relapse|0|||
130244213|NCT00835978|468855125|FG000|Overall Study|Adverse Event|1|||
130244214|NCT00835978|468855126|FG001|Overall Study|Adverse Event|0|||
130244215|NCT00835978|468855127|FG002|Overall Study|Adverse Event|1|||
130244216|NCT00835978|468855128|FG003|Overall Study|Adverse Event|0|||
130244217|NCT00835978|468855125|FG000|Overall Study|Withdrawal by Subject|0|||
130244218|NCT00835978|468855126|FG001|Overall Study|Withdrawal by Subject|3|||
130244219|NCT00835978|468855127|FG002|Overall Study|Withdrawal by Subject|0|||
130244220|NCT00835978|468855128|FG003|Overall Study|Withdrawal by Subject|5|||
130244221|NCT00835978|468855125|FG000|Overall Study|Study terminated by sponsor|12|||
130697524|NCT01541215|470517863|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
130697525|NCT01541215|470517862|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
130697526|NCT01541215|470517863|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
130697527|NCT02817828|470517869|FG000|Overall Study|Lost to Follow-up|41|||
130697528|NCT02817828|470517869|FG000|Overall Study|Adverse event not related to bleeding|104|||
130697529|NCT02817828|470517869|FG000|Overall Study|Adverse event related to bleeding|53|||
130697530|NCT02817828|470517869|FG000|Overall Study|Protocol Violation|11|||
130697531|NCT02817828|470517869|FG000|Overall Study|Pregnancy|7|||
130697532|NCT02817828|470517869|FG000|Overall Study|Pregnancy wish|15|||
130697533|NCT02817828|470517869|FG000|Overall Study|Withdrawal by Subject|78|||
130697534|NCT02817828|470517869|FG000|Overall Study|Other|26|||
130697535|NCT02651987|470517870|FG000|Overall Study|Adverse Event|2|||
130697536|NCT02651987|470517871|FG001|Overall Study|Adverse Event|2|||
130697537|NCT02651987|470517870|FG000|Overall Study|Consent Withdrawn|2|||
130697538|NCT02651987|470517871|FG001|Overall Study|Consent Withdrawn|0|||
130697539|NCT02651987|470517870|FG000|Overall Study|Local PD|0|||
130244222|NCT00835978|468855126|FG001|Overall Study|Study terminated by sponsor|8|||
130244223|NCT00835978|468855127|FG002|Overall Study|Study terminated by sponsor|30|||
130244224|NCT00835978|468855128|FG003|Overall Study|Study terminated by sponsor|0|||
130244225|NCT03684057|468855129|FG000|Overall Study|Withdrawal by Subject|4|||
130244226|NCT03684057|468855130|FG001|Overall Study|Withdrawal by Subject|5|||
130244227|NCT01105130|468855131|FG000|Overall Study|Withdrawal by Subject|4|||
130450626|NCT04978363|469614487|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450627|NCT04978363|469614488|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130697540|NCT02651987|470517871|FG001|Overall Study|Local PD|2|||
130697541|NCT02651987|470517870|FG000|Overall Study|Investigator Decision|1|||
130697542|NCT02651987|470517871|FG001|Overall Study|Investigator Decision|1|||
130697543|NCT00486434|470517872|FG000|Overall Study|Withdrawal by Subject|34|||
130697544|NCT00486434|470517873|FG001|Overall Study|Withdrawal by Subject|39|||
130697545|NCT00486434|470517872|FG000|Overall Study|Adverse Event|118|||
130697546|NCT00486434|470517873|FG001|Overall Study|Adverse Event|44|||
130697547|NCT00486434|470517872|FG000|Overall Study|Protocol Violation|22|||
130697548|NCT00486434|470517873|FG001|Overall Study|Protocol Violation|21|||
130697549|NCT00486434|470517872|FG000|Overall Study|Lack of Efficacy|12|||
130697550|NCT00486434|470517873|FG001|Overall Study|Lack of Efficacy|19|||
130697551|NCT00486434|470517872|FG000|Overall Study|Lost to Follow-up|2|||
130697552|NCT00486434|470517873|FG001|Overall Study|Lost to Follow-up|3|||
130697553|NCT00486434|470517872|FG000|Overall Study|Death|1|||
130697554|NCT00486434|470517873|FG001|Overall Study|Death|2|||
130697555|NCT00486434|470517872|FG000|Overall Study|Personal reasons|5|||
130697556|NCT00486434|470517873|FG001|Overall Study|Personal reasons|6|||
130697557|NCT00522041|470517874|FG000|Overall Study|Adverse Event|9|||
130697558|NCT00522041|470517875|FG001|Overall Study|Adverse Event|3|||
130697559|NCT00522041|470517874|FG000|Overall Study|Protocol Violation|2|||
130697560|NCT00522041|470517875|FG001|Overall Study|Protocol Violation|0|||
130697561|NCT00522041|470517874|FG000|Overall Study|Lost to Follow-up|1|||
130697562|NCT00522041|470517875|FG001|Overall Study|Lost to Follow-up|4|||
130697563|NCT00522041|470517874|FG000|Overall Study|Voluntary withdrawal|5|||
130450628|NCT04978363|469614489|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
130450629|NCT02790606|469614497|FG000|Overall Study|Death|27|||
130450630|NCT02790606|469614497|FG000|Overall Study|Lost to Follow-up|4|||
130697564|NCT00522041|470517875|FG001|Overall Study|Voluntary withdrawal|4|||
130244228|NCT01105130|468855132|FG001|Overall Study|Withdrawal by Subject|6|||
130244229|NCT01105130|468855133|FG002|Overall Study|Withdrawal by Subject|2|||
130697565|NCT00522041|470517874|FG000|Overall Study|Did not receive treatment|0|||
130697566|NCT00522041|470517875|FG001|Overall Study|Did not receive treatment|1|||
130697567|NCT00735696|470517877|FG000|Overall Study|Withdrawal by Subject|1|||
130244230|NCT01105130|468855131|FG000|Overall Study|Never Started|2|||
130244231|NCT01105130|468855132|FG001|Overall Study|Never Started|2|||
130244232|NCT01105130|468855133|FG002|Overall Study|Never Started|4|||
130697568|NCT00735696|470517877|FG000|Overall Study|Enrolled but never Treated|1|||
130697569|NCT02998541|470517881|FG000|Overall Study|Adverse Event|4|||
130697570|NCT02998541|470517882|FG001|Overall Study|Adverse Event|5|||
130697571|NCT02998541|470517883|FG002|Overall Study|Adverse Event|1|||
130697572|NCT02998541|470517881|FG000|Overall Study|Protocol Violation|1|||
130697573|NCT02998541|470517882|FG001|Overall Study|Protocol Violation|0|||
130697574|NCT02998541|470517883|FG002|Overall Study|Protocol Violation|0|||
130697575|NCT02998541|470517881|FG000|Overall Study|Withdrawal by Subject|3|||
130697576|NCT02998541|470517882|FG001|Overall Study|Withdrawal by Subject|1|||
130697577|NCT02998541|470517883|FG002|Overall Study|Withdrawal by Subject|0|||
130697578|NCT02998541|470517881|FG000|Overall Study|Lost to Follow-up|0|||
130697579|NCT02998541|470517882|FG001|Overall Study|Lost to Follow-up|3|||
130697580|NCT02998541|470517883|FG002|Overall Study|Lost to Follow-up|1|||
130697581|NCT02998541|470517881|FG000|Overall Study|Physician Decision|0|||
130697582|NCT02998541|470517882|FG001|Overall Study|Physician Decision|0|||
130697583|NCT02998541|470517883|FG002|Overall Study|Physician Decision|3|||
130697584|NCT02998541|470517881|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130697585|NCT02998541|470517882|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130697586|NCT02998541|470517883|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130697587|NCT03387462|470517889|FG000|Overall Study|Lost to Follow-up|1|||
130244233|NCT01105130|468855131|FG000|Overall Study|Toxicity|1|||
130244234|NCT01105130|468855132|FG001|Overall Study|Toxicity|3|||
130244235|NCT01105130|468855133|FG002|Overall Study|Toxicity|2|||
130362867|NCT05136690|469298014|FG000|Period 2|Lost to Follow-up|0|||
130362868|NCT05136690|469298015|FG001|Period 2|Lost to Follow-up|3|||
130697588|NCT01944722|470517894|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
130697589|NCT01944722|470517894|FG000|Overall Study|Specimen Shipping Issues|34|||
130697590|NCT01944722|470517894|FG000|Overall Study|Improper Storage/Transport|5|||
130697591|NCT01944722|470517894|FG000|Overall Study|Insufficient Volume for Test|1|||
130697592|NCT01944722|470517894|FG000|Overall Study|Missing Specimens|3|||
130697593|NCT01944722|470517894|FG000|Overall Study|Specimens Mislabeled|2|||
130697594|NCT01944722|470517894|FG000|Overall Study|Withdrawal by Subject|8|||
130697595|NCT01944722|470517894|FG000|Overall Study|NILM Subjects <30 years old|8106|||
130697596|NCT01944722|470517894|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
130697597|NCT01944722|470517894|FG000|Overall Study|>ASCUS Cytology|1122|||
130697598|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
130697599|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
130697600|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
130697601|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
130697602|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
130697603|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
130697604|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
130697605|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
130697606|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
130697607|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
130697608|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
130697609|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
130697610|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
130697611|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
130697612|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
130697613|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
130697614|NCT00210639|470517898|FG000|Overall Study|Lost to Follow-up|37|||
130244236|NCT01105130|468855131|FG000|Overall Study|Multiple Reasons|3|||
130362869|NCT05136690|469298014|FG000|Period 2|Withdrawal by Subject|0|||
130362870|NCT05136690|469298015|FG001|Period 2|Withdrawal by Subject|1|||
130362871|NCT01626456|469299534|FG000|Overall Study|Withdrawal by Subject|21|||
130362872|NCT01626456|469299535|FG001|Overall Study|Withdrawal by Subject|46|||
130362873|NCT01626456|469299534|FG000|Overall Study|Adverse Event|2|||
130362874|NCT01626456|469299535|FG001|Overall Study|Adverse Event|27|||
130362875|NCT01626456|469299534|FG000|Overall Study|Lost to Follow-up|2|||
130362876|NCT01626456|469299535|FG001|Overall Study|Lost to Follow-up|27|||
130362877|NCT01626456|469299534|FG000|Overall Study|Lack of Efficacy|6|||
130362878|NCT01626456|469299535|FG001|Overall Study|Lack of Efficacy|7|||
130362879|NCT01626456|469299534|FG000|Overall Study|Physician Decision|1|||
130362880|NCT01626456|469299535|FG001|Overall Study|Physician Decision|4|||
130362881|NCT01626456|469299534|FG000|Overall Study|Protocol Violation|1|||
130362882|NCT01626456|469299535|FG001|Overall Study|Protocol Violation|1|||
130362883|NCT01626456|469299534|FG000|Overall Study|Site Closure|2|||
130362884|NCT01626456|469299535|FG001|Overall Study|Site Closure|3|||
130697615|NCT00210639|470517899|FG001|Overall Study|Lost to Follow-up|29|||
130244237|NCT01105130|468855132|FG001|Overall Study|Multiple Reasons|0|||
130362885|NCT01626456|469299534|FG000|Overall Study|Incarceration|0|||
130362886|NCT01626456|469299535|FG001|Overall Study|Incarceration|2|||
130362887|NCT04015336|469299536|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
130362888|NCT01868503|469299540|FG000|Overall Study|Withdrawal by Subject|1|||
130697616|NCT00210639|470517898|FG000|Overall Study|Withdrawal by Subject|8|||
130697617|NCT00210639|470517899|FG001|Overall Study|Withdrawal by Subject|1|||
130697618|NCT00210639|470517898|FG000|Overall Study|Other|18|||
130697619|NCT00210639|470517899|FG001|Overall Study|Other|12|||
130697620|NCT00874822|470517903|FG000|Overall Study|excluded by criteria|8|||
130244238|NCT01105130|468855133|FG002|Overall Study|Multiple Reasons|2|||
130697621|NCT02854800|470517904|FG000|Overall Study|Protocol Violation|16|||
130697622|NCT02854800|470517905|FG001|Overall Study|Protocol Violation|11|||
130697623|NCT02854800|470517906|FG002|Overall Study|Protocol Violation|3|||
130697624|NCT02854800|470517904|FG000|Overall Study|Withdrawal by Subject|4|||
130697625|NCT02854800|470517905|FG001|Overall Study|Withdrawal by Subject|2|||
130697626|NCT02854800|470517906|FG002|Overall Study|Withdrawal by Subject|3|||
130697627|NCT02627963|470517913|FG000|Overall Study|Randomized but not treated|2|||
130697628|NCT02627963|470517914|FG001|Overall Study|Randomized but not treated|6|||
130697633|NCT05278858|470517916|FG000|Overall Study|Withdrawal by Subject|1|||
130697634|NCT00503867|470517921|FG000|Overall Study|Lost to Follow-up|1|||
130697635|NCT00503867|470517921|FG000|Overall Study|Adverse Event|1|||
130697636|NCT04697173|470517925|FG000|Overall Study|Withdrawal by Subject|34|||
130697637|NCT04697173|470517926|FG001|Overall Study|Withdrawal by Subject|38|||
130697638|NCT03807440|470517927|FG000|Overall Study|No documentation of index date 2|320|||
130697639|NCT03807440|470517927|FG000|Overall Study|No informed consent for index date 2|117|||
130697640|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
130697641|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
130697642|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
130697643|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
130697644|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
130697645|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
130697646|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
130697647|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
130697648|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
130697649|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
130697650|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
130697651|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
130697652|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
130697653|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
130697654|NCT02372006|470517939|FG000|Overall Study|Progressive disease|8|||
130697655|NCT02372006|470517940|FG001|Overall Study|Progressive disease|7|||
130697656|NCT02372006|470517941|FG002|Overall Study|Progressive disease|34|||
130697657|NCT02372006|470517939|FG000|Overall Study|Dose limiting toxicity|0|||
130697658|NCT02372006|470517940|FG001|Overall Study|Dose limiting toxicity|1|||
130697659|NCT02372006|470517941|FG002|Overall Study|Dose limiting toxicity|0|||
130697660|NCT02372006|470517939|FG000|Overall Study|Adverse Event|0|||
130697661|NCT02372006|470517940|FG001|Overall Study|Adverse Event|0|||
130697662|NCT02372006|470517941|FG002|Overall Study|Adverse Event|3|||
130697663|NCT02372006|470517939|FG000|Overall Study|Withdrawal by Subject|0|||
130697664|NCT02372006|470517940|FG001|Overall Study|Withdrawal by Subject|1|||
130697665|NCT02372006|470517941|FG002|Overall Study|Withdrawal by Subject|1|||
130697666|NCT02372006|470517939|FG000|Overall Study|Other reason for not completing|0|||
130697667|NCT02372006|470517940|FG001|Overall Study|Other reason for not completing|0|||
130697668|NCT02372006|470517941|FG002|Overall Study|Other reason for not completing|1|||
130697669|NCT03504085|470517944|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
130697670|NCT03504085|470517945|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
130697671|NCT03504085|470517944|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
130362889|NCT01868503|469299540|FG000|Overall Study|Protocol Violation|1|||
130362890|NCT03650556|469299541|FG000|Overall Study|Death|2|||
130362891|NCT03650556|469299541|FG000|Overall Study|Withdrawal by Subject|20|||
130362892|NCT03650556|469299541|FG000|Overall Study|Physician Decision|2|||
130362893|NCT03650556|469299541|FG000|Overall Study|Lost to Follow-up|8|||
130362894|NCT03650556|469299541|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
130362895|NCT03650556|469299541|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
130362896|NCT00691301|469299542|FG000|Overall Study|Adverse Event|10|||
130362897|NCT00691301|469299542|FG000|Overall Study|Death|2|||
130362898|NCT00691301|469299542|FG000|Overall Study|Lack of Efficacy|32|||
130362899|NCT00691301|469299542|FG000|Overall Study|Withdrawal by Subject|4|||
130362900|NCT00691301|469299542|FG000|Overall Study|Concurrent illness|2|||
130362901|NCT00691301|469299542|FG000|Overall Study|other reason|3|||
130362902|NCT00691301|469299542|FG000|Overall Study|Did not initiate study treatment|1|||
130362903|NCT01823146|469299543|FG000|Overall Study|Withdrawal by Subject|0|||
130362904|NCT01823146|469299544|FG001|Overall Study|Withdrawal by Subject|1|||
130362905|NCT01823146|469299543|FG000|Overall Study|Lost to Follow-up|2|||
130362906|NCT01823146|469299544|FG001|Overall Study|Lost to Follow-up|1|||
130362907|NCT00463580|469299545|FG000|Overall Study|Lost to Follow-up|1|||
130362908|NCT00463580|469299546|FG001|Overall Study|Lost to Follow-up|0|||
130697672|NCT03504085|470517945|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
130697673|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Death|1|||
130697674|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Death|0|||
130697675|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Death|0|||
130697676|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Death|0|||
130697677|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130697678|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130697679|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130697680|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130697681|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130697682|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130697683|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130697684|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130697685|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697686|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
130697687|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697688|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697689|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697690|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697691|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697692|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
130697693|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130697694|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130697695|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130697696|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130697697|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697698|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697699|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
130697700|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697701|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
130697702|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
130697703|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
130697704|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
130697705|NCT01926119|470517952|FG000|Overall Study|Withdrawal by Subject|1|||
130697706|NCT01859598|470517953|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
130362909|NCT00463580|469299545|FG000|Overall Study|Schedule conflict|2|||
130362910|NCT00463580|469299546|FG001|Overall Study|Schedule conflict|0|||
130362911|NCT00463580|469299545|FG000|Overall Study|Medical/psychiatric complications|0|||
130362912|NCT00463580|469299546|FG001|Overall Study|Medical/psychiatric complications|2|||
130362913|NCT03917459|469299547|FG000|Overall Study|Adverse Event|1|||
130362914|NCT03917459|469299548|FG001|Overall Study|Adverse Event|0|||
130362915|NCT03917459|469299547|FG000|Overall Study|Withdrawal by Subject|0|||
130362916|NCT03917459|469299548|FG001|Overall Study|Withdrawal by Subject|1|||
130362917|NCT00491764|469299549|FG000|Overall Study|Adverse Event|1|||
130362918|NCT00491764|469299550|FG001|Overall Study|Adverse Event|2|||
130362919|NCT00491764|469299551|FG002|Overall Study|Adverse Event|4|||
130362920|NCT00491764|469299552|FG003|Overall Study|Adverse Event|4|||
130362921|NCT00491764|469299553|FG004|Overall Study|Adverse Event|0|||
130362922|NCT00491764|469299554|FG005|Overall Study|Adverse Event|1|||
130362923|NCT00491764|469299549|FG000|Overall Study|Lost to Follow-up|0|||
130362924|NCT00491764|469299550|FG001|Overall Study|Lost to Follow-up|1|||
130362925|NCT00491764|469299551|FG002|Overall Study|Lost to Follow-up|0|||
130362926|NCT00491764|469299552|FG003|Overall Study|Lost to Follow-up|1|||
130362927|NCT00491764|469299553|FG004|Overall Study|Lost to Follow-up|0|||
130362928|NCT00491764|469299554|FG005|Overall Study|Lost to Follow-up|3|||
130362929|NCT00491764|469299549|FG000|Overall Study|Withdrawal by Subject|2|||
130362930|NCT00491764|469299550|FG001|Overall Study|Withdrawal by Subject|3|||
130362931|NCT00491764|469299551|FG002|Overall Study|Withdrawal by Subject|1|||
130362932|NCT00491764|469299552|FG003|Overall Study|Withdrawal by Subject|2|||
130362933|NCT00491764|469299553|FG004|Overall Study|Withdrawal by Subject|2|||
130362934|NCT00491764|469299554|FG005|Overall Study|Withdrawal by Subject|4|||
130362935|NCT00491764|469299549|FG000|Overall Study|Non Compliance with the Protocol|1|||
130362936|NCT00491764|469299550|FG001|Overall Study|Non Compliance with the Protocol|0|||
130362937|NCT00491764|469299551|FG002|Overall Study|Non Compliance with the Protocol|0|||
130362938|NCT00491764|469299552|FG003|Overall Study|Non Compliance with the Protocol|0|||
130362939|NCT00491764|469299553|FG004|Overall Study|Non Compliance with the Protocol|0|||
130362940|NCT00491764|469299554|FG005|Overall Study|Non Compliance with the Protocol|0|||
130450631|NCT02790606|469614497|FG000|Overall Study|Physician Decision|3|||
130450632|NCT02790606|469614497|FG000|Overall Study|Withdrawal by Subject|1|||
130362941|NCT00491764|469299549|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
130697707|NCT03255980|470517958|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
130697708|NCT03255980|470517959|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
130697709|NCT03255980|470517960|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
130697710|NCT03255980|470517961|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
130697711|NCT03255980|470517958|FG000|Overall Study|Adverse Event|1|||
130697712|NCT03255980|470517959|FG001|Overall Study|Adverse Event|1|||
130697713|NCT03255980|470517960|FG002|Overall Study|Adverse Event|0|||
130697714|NCT03255980|470517961|FG003|Overall Study|Adverse Event|1|||
130697715|NCT03255980|470517958|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
130697716|NCT03255980|470517959|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
130697717|NCT03255980|470517960|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
130697718|NCT03255980|470517961|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
130697719|NCT03255980|470517958|FG000|Overall Study|Lost to Follow-up|1|||
130697720|NCT03255980|470517959|FG001|Overall Study|Lost to Follow-up|1|||
130697721|NCT03255980|470517960|FG002|Overall Study|Lost to Follow-up|0|||
130697722|NCT03255980|470517961|FG003|Overall Study|Lost to Follow-up|3|||
130697723|NCT03255980|470517958|FG000|Overall Study|Withdrawal by Subject|0|||
130697724|NCT03255980|470517959|FG001|Overall Study|Withdrawal by Subject|1|||
130697725|NCT03255980|470517960|FG002|Overall Study|Withdrawal by Subject|0|||
130697726|NCT03255980|470517961|FG003|Overall Study|Withdrawal by Subject|3|||
130697727|NCT02611362|470517962|FG000|Overall Study|Withdrawal by Subject|7|||
130697728|NCT02611362|470517963|FG001|Overall Study|Withdrawal by Subject|2|||
130697729|NCT02611362|470517962|FG000|Overall Study|Lost to Follow-up|2|||
130697730|NCT02611362|470517963|FG001|Overall Study|Lost to Follow-up|4|||
130697731|NCT01155531|470517964|FG000|Overall Study|Adverse Event|0|||
130697732|NCT01155531|470517965|FG001|Overall Study|Adverse Event|0|||
130697733|NCT01155531|470517966|FG002|Overall Study|Adverse Event|1|||
130697734|NCT01155531|470517967|FG003|Overall Study|Adverse Event|0|||
130697735|NCT01155531|470517964|FG000|Overall Study|Lost to Follow-up|0|||
130697736|NCT01155531|470517965|FG001|Overall Study|Lost to Follow-up|0|||
130697737|NCT01155531|470517966|FG002|Overall Study|Lost to Follow-up|0|||
130697738|NCT01155531|470517967|FG003|Overall Study|Lost to Follow-up|1|||
130697739|NCT01155531|470517964|FG000|Overall Study|Withdrawal by Subject|1|||
130697740|NCT01155531|470517965|FG001|Overall Study|Withdrawal by Subject|0|||
130697741|NCT01155531|470517966|FG002|Overall Study|Withdrawal by Subject|1|||
130697742|NCT01155531|470517967|FG003|Overall Study|Withdrawal by Subject|0|||
130697743|NCT00354159|470517968|FG000|Randomized Study Period|Withdrawal by Subject|5|||
130697744|NCT00354159|470517969|FG001|Randomized Study Period|Withdrawal by Subject|3|||
130697745|NCT00354159|470517968|FG000|Randomized Study Period|Physician Decision|6|||
130697746|NCT00354159|470517969|FG001|Randomized Study Period|Physician Decision|10|||
130697747|NCT00354159|470517968|FG000|Randomized Study Period|Lost to Follow-up|4|||
130697748|NCT00354159|470517969|FG001|Randomized Study Period|Lost to Follow-up|0|||
130697749|NCT00354159|470517968|FG000|Randomized Study Period|Death|7|||
130697750|NCT00354159|470517969|FG001|Randomized Study Period|Death|9|||
130697751|NCT00354159|470517968|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
130697752|NCT00354159|470517969|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
130697753|NCT00354159|470517968|FG000|Long-term Follow-up|Physician Decision|127|||
130697754|NCT00354159|470517969|FG001|Long-term Follow-up|Physician Decision|122|||
130697755|NCT00354159|470517968|FG000|Long-term Follow-up|Lost to Follow-up|1|||
130244239|NCT02927145|468855135|FG000|Initial Recruitment|Withdrawal by Subject|0|||
130244240|NCT02927145|468855136|FG001|Initial Recruitment|Withdrawal by Subject|1|||
130244241|NCT02927145|468855137|FG002|Initial Recruitment|Withdrawal by Subject|1|||
130244242|NCT02927145|468855138|FG003|Initial Recruitment|Withdrawal by Subject|4|||
130244243|NCT02927145|468855139|FG004|Initial Recruitment|Withdrawal by Subject|1|||
130244244|NCT02927145|468855140|FG005|Initial Recruitment|Withdrawal by Subject|1|||
130244245|NCT02927145|468855141|FG006|Initial Recruitment|Withdrawal by Subject|0|||
130244246|NCT02927145|468855142|FG007|Initial Recruitment|Withdrawal by Subject|0|||
130244247|NCT02927145|468855143|FG008|Initial Recruitment|Withdrawal by Subject|2|||
130244248|NCT02927145|468855135|FG000|Initial Recruitment|Adverse Event|0|||
130697756|NCT00354159|470517969|FG001|Long-term Follow-up|Lost to Follow-up|0|||
130697757|NCT00354159|470517968|FG000|Long-term Follow-up|Death|14|||
130697758|NCT00354159|470517969|FG001|Long-term Follow-up|Death|11|||
130697759|NCT00354159|470517968|FG000|Long-term Follow-up|Study Closed|29|||
130697760|NCT00354159|470517969|FG001|Long-term Follow-up|Study Closed|34|||
130697761|NCT01653704|470517971|FG000|Overall Study|Technical failure during recording|1|||
130244249|NCT02927145|468855136|FG001|Initial Recruitment|Adverse Event|0|||
130697762|NCT01653704|470517972|FG001|Overall Study|Technical failure during recording|1|||
130697763|NCT01653704|470517971|FG000|Overall Study|Performance not reflective of training|1|||
130697764|NCT01653704|470517972|FG001|Overall Study|Performance not reflective of training|0|||
130244250|NCT02927145|468855137|FG002|Initial Recruitment|Adverse Event|0|||
130244251|NCT02927145|468855138|FG003|Initial Recruitment|Adverse Event|0|||
130244252|NCT02927145|468855139|FG004|Initial Recruitment|Adverse Event|2|||
130697765|NCT01728116|470517973|FG000|Overall Study|Sponsor Terminated Study|106|||
130697766|NCT01728116|470517974|FG001|Overall Study|Sponsor Terminated Study|35|||
130697767|NCT01728116|470517973|FG000|Overall Study|Withdrawal by Subject|16|||
130697768|NCT01728116|470517974|FG001|Overall Study|Withdrawal by Subject|9|||
130697769|NCT01728116|470517973|FG000|Overall Study|Adverse Event|13|||
130697770|NCT01728116|470517974|FG001|Overall Study|Adverse Event|0|||
130697771|NCT01728116|470517973|FG000|Overall Study|Procedure/device failure|7|||
130697772|NCT01728116|470517974|FG001|Overall Study|Procedure/device failure|0|||
130697773|NCT01728116|470517973|FG000|Overall Study|Lost to Follow-up|9|||
130697774|NCT01728116|470517974|FG001|Overall Study|Lost to Follow-up|2|||
130697775|NCT01728116|470517973|FG000|Overall Study|Physician Decision|2|||
130697776|NCT01728116|470517974|FG001|Overall Study|Physician Decision|0|||
130697777|NCT01728116|470517973|FG000|Overall Study|Subject Non-Compliance|2|||
130697778|NCT01728116|470517974|FG001|Overall Study|Subject Non-Compliance|0|||
130697779|NCT01728116|470517973|FG000|Overall Study|Inter-current finding at procedure|1|||
130697780|NCT01728116|470517974|FG001|Overall Study|Inter-current finding at procedure|0|||
130697781|NCT01728116|470517973|FG000|Overall Study|Incorrectly enrolled in Study|0|||
130697782|NCT01728116|470517974|FG001|Overall Study|Incorrectly enrolled in Study|1|||
130697783|NCT01728116|470517973|FG000|Overall Study|various not noted previously|5|||
130697784|NCT01728116|470517974|FG001|Overall Study|various not noted previously|0|||
130697785|NCT03277248|470517987|FG000|Overall Study|Adverse Event|3|||
130697786|NCT03277248|470517988|FG001|Overall Study|Adverse Event|1|||
130697787|NCT03277248|470517987|FG000|Overall Study|Subject Withdrawal of Consent|6|||
130697788|NCT03277248|470517988|FG001|Overall Study|Subject Withdrawal of Consent|23|||
130697789|NCT03277248|470517987|FG000|Overall Study|Investigator/Sponsor Decision|2|||
130697790|NCT03277248|470517988|FG001|Overall Study|Investigator/Sponsor Decision|2|||
130697791|NCT03277248|470517987|FG000|Overall Study|Pregnancy|4|||
130697792|NCT03277248|470517988|FG001|Overall Study|Pregnancy|1|||
130697793|NCT03277248|470517987|FG000|Overall Study|Lost to Follow-up|0|||
130697794|NCT03277248|470517988|FG001|Overall Study|Lost to Follow-up|2|||
130697795|NCT03277248|470517987|FG000|Overall Study|Lack of Efficacy|0|||
130697796|NCT03277248|470517988|FG001|Overall Study|Lack of Efficacy|2|||
130697797|NCT03277248|470517987|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130697798|NCT03277248|470517988|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130697799|NCT01691612|470517993|FG000|Overall Study|deemed ineligible after 1st visit|6|||
130697800|NCT01691612|470517993|FG000|Overall Study|Adverse Event|1|||
130697801|NCT00640341|470519059|FG000|Overall Study|Adverse Event|0|||
130244253|NCT02927145|468855140|FG005|Initial Recruitment|Adverse Event|0|||
130244254|NCT02927145|468855141|FG006|Initial Recruitment|Adverse Event|0|||
130244255|NCT02927145|468855142|FG007|Initial Recruitment|Adverse Event|0|||
130362942|NCT00491764|469299550|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
130362943|NCT00491764|469299551|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
130697802|NCT00640341|470519060|FG001|Overall Study|Adverse Event|0|||
130697803|NCT00640341|470519061|FG002|Overall Study|Adverse Event|1|||
130697804|NCT00640341|470519059|FG000|Overall Study|Positive Slit Lamp Findings|0|||
130697805|NCT00640341|470519060|FG001|Overall Study|Positive Slit Lamp Findings|0|||
130697806|NCT00640341|470519061|FG002|Overall Study|Positive Slit Lamp Findings|1|||
130697807|NCT00640341|470519059|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
130697808|NCT00640341|470519060|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
130697809|NCT00640341|470519061|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
130697810|NCT00640341|470519059|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
130697811|NCT00640341|470519060|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
130697812|NCT00640341|470519061|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
130697813|NCT00640341|470519059|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
130697814|NCT00640341|470519060|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
130697815|NCT00640341|470519061|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
130362944|NCT00491764|469299552|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
130362945|NCT00491764|469299553|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
130362946|NCT00491764|469299554|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
130362947|NCT00491764|469299549|FG000|Overall Study|Administrative|1|||
130362948|NCT00491764|469299550|FG001|Overall Study|Administrative|0|||
130362949|NCT00491764|469299551|FG002|Overall Study|Administrative|2|||
130362950|NCT00491764|469299552|FG003|Overall Study|Administrative|1|||
130362951|NCT00491764|469299553|FG004|Overall Study|Administrative|0|||
130362952|NCT00491764|469299554|FG005|Overall Study|Administrative|0|||
130697816|NCT00640341|470519059|FG000|Overall Study|Lost to Follow-up|2|||
130697817|NCT00640341|470519060|FG001|Overall Study|Lost to Follow-up|0|||
130697818|NCT00640341|470519061|FG002|Overall Study|Lost to Follow-up|0|||
130362953|NCT00697788|469299557|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362954|NCT00697788|469299558|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
130362955|NCT00697788|469299559|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362956|NCT00697788|469299560|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130697819|NCT00640341|470519059|FG000|Overall Study|Withdrawal by Subject|4|||
130697820|NCT00640341|470519060|FG001|Overall Study|Withdrawal by Subject|0|||
130697821|NCT00640341|470519061|FG002|Overall Study|Withdrawal by Subject|1|||
130697822|NCT00640341|470519059|FG000|Overall Study|Unacceptable Lens Movement|1|||
130697823|NCT00640341|470519060|FG001|Overall Study|Unacceptable Lens Movement|0|||
130697824|NCT00640341|470519061|FG002|Overall Study|Unacceptable Lens Movement|0|||
130697825|NCT00640341|470519059|FG000|Overall Study|Poor fit/Uncomfortable|4|||
130697826|NCT00640341|470519060|FG001|Overall Study|Poor fit/Uncomfortable|0|||
130244256|NCT02927145|468855143|FG008|Initial Recruitment|Adverse Event|0|||
130244257|NCT02927145|468855135|FG000|Invitation for Additional Challenge|Pregnancy|0|||
130244258|NCT02927145|468855136|FG001|Invitation for Additional Challenge|Pregnancy|0|||
130244259|NCT02927145|468855137|FG002|Invitation for Additional Challenge|Pregnancy|0|||
130244260|NCT02927145|468855138|FG003|Invitation for Additional Challenge|Pregnancy|0|||
130244261|NCT02927145|468855139|FG004|Invitation for Additional Challenge|Pregnancy|0|||
130244262|NCT02927145|468855140|FG005|Invitation for Additional Challenge|Pregnancy|0|||
130244263|NCT02927145|468855141|FG006|Invitation for Additional Challenge|Pregnancy|1|||
130244264|NCT02927145|468855142|FG007|Invitation for Additional Challenge|Pregnancy|0|||
130244265|NCT02927145|468855143|FG008|Invitation for Additional Challenge|Pregnancy|0|||
130244266|NCT01363440|468855144|FG000|Overall Study|Adverse Event|5|||
130244267|NCT01363440|468855145|FG001|Overall Study|Adverse Event|4|||
130244268|NCT01363440|468855146|FG002|Overall Study|Adverse Event|4|||
130244269|NCT01363440|468855144|FG000|Overall Study|Death|3|||
130244270|NCT01363440|468855145|FG001|Overall Study|Death|7|||
130244271|NCT01363440|468855146|FG002|Overall Study|Death|5|||
130244272|NCT01363440|468855144|FG000|Overall Study|Withdrawal by Subject|9|||
130244273|NCT01363440|468855145|FG001|Overall Study|Withdrawal by Subject|11|||
130244274|NCT01363440|468855146|FG002|Overall Study|Withdrawal by Subject|11|||
130244275|NCT01363440|468855144|FG000|Overall Study|Lost to Follow-up|2|||
130244276|NCT01363440|468855145|FG001|Overall Study|Lost to Follow-up|4|||
130244277|NCT01363440|468855146|FG002|Overall Study|Lost to Follow-up|5|||
130244278|NCT01363440|468855144|FG000|Overall Study|Other|4|||
130244279|NCT01363440|468855145|FG001|Overall Study|Other|5|||
130697827|NCT00640341|470519061|FG002|Overall Study|Poor fit/Uncomfortable|0|||
130697828|NCT00640341|470519059|FG000|Overall Study|Ineligable at Baseline|5|||
130697829|NCT00640341|470519060|FG001|Overall Study|Ineligable at Baseline|3|||
130697830|NCT00640341|470519061|FG002|Overall Study|Ineligable at Baseline|2|||
130697831|NCT00640341|470519059|FG000|Overall Study|Adverse event and positive slit lamp|1|||
130697832|NCT00640341|470519060|FG001|Overall Study|Adverse event and positive slit lamp|0|||
130697833|NCT00640341|470519061|FG002|Overall Study|Adverse event and positive slit lamp|0|||
130697834|NCT01894230|470519062|FG000|Overall Study|Lost to Follow-up|2|||
130697835|NCT01894230|470519063|FG001|Overall Study|Lost to Follow-up|2|||
130697836|NCT01894230|470519062|FG000|Overall Study|Withdrawal by Subject|4|||
130697837|NCT01894230|470519063|FG001|Overall Study|Withdrawal by Subject|4|||
130697838|NCT01894230|470519062|FG000|Overall Study|Non-adherent|0|||
130697839|NCT01894230|470519063|FG001|Overall Study|Non-adherent|1|||
130697840|NCT01894230|470519062|FG000|Overall Study|Death|1|||
130697841|NCT01894230|470519063|FG001|Overall Study|Death|0|||
130697842|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
130697843|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
130697844|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
130244280|NCT01363440|468855146|FG002|Overall Study|Other|2|||
130244281|NCT02323334|468855149|FG000|Period 3|Lost to Follow-up|0|||
130244282|NCT02323334|468855150|FG001|Period 3|Lost to Follow-up|0|||
130244283|NCT02323334|468855151|FG002|Period 3|Lost to Follow-up|1|||
130244284|NCT02323334|468855152|FG003|Period 3|Lost to Follow-up|0|||
130244285|NCT02323334|468855153|FG004|Period 3|Lost to Follow-up|0|||
130244286|NCT02323334|468855154|FG005|Period 3|Lost to Follow-up|0|||
130244287|NCT02323334|468855155|FG006|Period 3|Lost to Follow-up|0|||
130244288|NCT02323334|468855156|FG007|Period 3|Lost to Follow-up|0|||
130244289|NCT02323334|468855157|FG008|Period 3|Lost to Follow-up|0|||
130244290|NCT02323334|468855158|FG009|Period 3|Lost to Follow-up|0|||
130244291|NCT02323334|468855159|FG010|Period 3|Lost to Follow-up|0|||
130244292|NCT02323334|468855160|FG011|Period 3|Lost to Follow-up|0|||
130244293|NCT02323334|468855161|FG012|Period 3|Lost to Follow-up|0|||
130244294|NCT02323334|468855162|FG013|Period 3|Lost to Follow-up|0|||
130244295|NCT02323334|468855163|FG014|Period 3|Lost to Follow-up|0|||
130244296|NCT02323334|468855164|FG015|Period 3|Lost to Follow-up|0|||
130244297|NCT02323334|468855165|FG016|Period 3|Lost to Follow-up|0|||
130244298|NCT02323334|468855149|FG000|Period 3|Withdrawal by Subject|1|||
130697845|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
130244299|NCT02323334|468855150|FG001|Period 3|Withdrawal by Subject|0|||
130244300|NCT02323334|468855151|FG002|Period 3|Withdrawal by Subject|0|||
130244301|NCT02323334|468855152|FG003|Period 3|Withdrawal by Subject|0|||
130244302|NCT02323334|468855153|FG004|Period 3|Withdrawal by Subject|0|||
130450633|NCT02735915|469614498|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
130697846|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
130697847|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
130697848|NCT02300987|470519064|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
130244303|NCT02323334|468855154|FG005|Period 3|Withdrawal by Subject|0|||
130362957|NCT00697788|469299561|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362958|NCT00697788|469299562|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362959|NCT00697788|469299563|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362960|NCT00697788|469299564|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130362961|NCT00697788|469299557|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362962|NCT00697788|469299558|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362963|NCT00697788|469299559|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362964|NCT00697788|469299560|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362965|NCT00697788|469299561|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
130244304|NCT02323334|468855155|FG006|Period 3|Withdrawal by Subject|0|||
130244305|NCT02323334|468855156|FG007|Period 3|Withdrawal by Subject|0|||
130244306|NCT02323334|468855157|FG008|Period 3|Withdrawal by Subject|0|||
130244307|NCT02323334|468855158|FG009|Period 3|Withdrawal by Subject|0|||
130244308|NCT02323334|468855159|FG010|Period 3|Withdrawal by Subject|0|||
130244309|NCT02323334|468855160|FG011|Period 3|Withdrawal by Subject|0|||
130450634|NCT02735915|469614498|FG000|Overall Study|Withdrawal following SAE|2|||
130450635|NCT02735915|469614498|FG000|Overall Study|Withdrawal by Subject|1|||
130450636|NCT05328973|469614499|FG000|Overall Study|Withdrawal by Subject|0|||
130450637|NCT05328973|469614500|FG001|Overall Study|Withdrawal by Subject|1|||
130450638|NCT00946114|469614501|FG000|Overall Study|Death|5|||
130450639|NCT00946114|469614502|FG001|Overall Study|Death|2|||
130450640|NCT00946114|469614501|FG000|Overall Study|Other|1|||
130450641|NCT00946114|469614502|FG001|Overall Study|Other|0|||
130450642|NCT00946114|469614501|FG000|Overall Study|Withdrawal by Subject|2|||
130450643|NCT00946114|469614502|FG001|Overall Study|Withdrawal by Subject|0|||
130450644|NCT01764386|469614504|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
130450645|NCT01764386|469614505|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
130450646|NCT01764386|469614504|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
130450647|NCT01764386|469614505|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
130450648|NCT01764386|469614504|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
130450649|NCT01764386|469614505|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
130450650|NCT01764386|469614504|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
130450651|NCT01764386|469614505|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
130450652|NCT01764386|469614504|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
130450653|NCT01764386|469614505|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
130450654|NCT01764386|469614504|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
130450655|NCT01764386|469614505|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
130450656|NCT01764386|469614504|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
130450657|NCT01764386|469614505|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
130450658|NCT01764386|469614504|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
130450659|NCT01764386|469614505|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
130450660|NCT00498186|469614506|FG000|Overall Study|Protocol Violation|10|||
130450661|NCT00498186|469614506|FG000|Overall Study|Lack of Efficacy|31|||
130450662|NCT00498186|469614506|FG000|Overall Study|Adverse Event|89|||
130450663|NCT00498186|469614506|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
130450664|NCT00498186|469614506|FG000|Overall Study|Withdrawal by Subject|18|||
130697849|NCT02300987|470519065|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
130697850|NCT02300987|470519064|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
130697851|NCT02300987|470519065|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
130697852|NCT02488109|470519069|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
130697853|NCT02488109|470519070|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
130697854|NCT02488109|470519069|FG000|12-month Follow-Up|Lost to Follow-up|4|||
130697855|NCT02488109|470519070|FG001|12-month Follow-Up|Lost to Follow-up|7|||
130697856|NCT00660387|470519071|FG000|Overall Study|Adverse Event|1|||
130697857|NCT00660387|470519072|FG001|Overall Study|Adverse Event|2|||
130697858|NCT00660387|470519071|FG000|Overall Study|Lack of Efficacy|0|||
130697859|NCT00660387|470519072|FG001|Overall Study|Lack of Efficacy|1|||
130697860|NCT00660387|470519071|FG000|Overall Study|Protocol Violation|1|||
130697861|NCT00660387|470519072|FG001|Overall Study|Protocol Violation|0|||
130697862|NCT03086135|470519077|FG000|Overall Study|Adverse Event|1|||
130697863|NCT03086135|470519077|FG000|Overall Study|Lost to Follow-up|2|||
130697864|NCT01023061|470519080|FG000|Overall Study|Withdrawal prior to treatment|2|||
130697865|NCT02966340|470519081|FG000|Overall Study|Adverse Event|0|||
130697866|NCT02966340|470519082|FG001|Overall Study|Adverse Event|1|||
130697867|NCT02966340|470519081|FG000|Overall Study|Lost to Follow-up|0|||
130697868|NCT02966340|470519082|FG001|Overall Study|Lost to Follow-up|1|||
130697869|NCT02966340|470519081|FG000|Overall Study|Withdrawal by Subject|1|||
130697870|NCT02966340|470519082|FG001|Overall Study|Withdrawal by Subject|0|||
130697871|NCT02966340|470519081|FG000|Overall Study|data acquisition error|1|||
130244310|NCT02323334|468855161|FG012|Period 3|Withdrawal by Subject|0|||
130450665|NCT00498186|469614506|FG000|Overall Study|Lost to Follow-up|3|||
130450666|NCT00498186|469614506|FG000|Overall Study|Other|10|||
130450667|NCT03929302|469614507|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
130450668|NCT03929302|469614508|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
130697872|NCT02966340|470519082|FG001|Overall Study|data acquisition error|0|||
130697873|NCT02966340|470519081|FG000|Overall Study|startle non-responder|1|||
130697874|NCT02966340|470519082|FG001|Overall Study|startle non-responder|1|||
130697875|NCT01622660|470519083|FG000|Overall Study|Adverse Event|1|||
130697876|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
130697877|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130697878|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130244311|NCT02323334|468855162|FG013|Period 3|Withdrawal by Subject|0|||
130697879|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697880|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697881|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697882|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697883|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697884|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130697885|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697886|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697887|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697888|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697889|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697890|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697891|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697892|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130244312|NCT02323334|468855163|FG014|Period 3|Withdrawal by Subject|0|||
130697893|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130244313|NCT02323334|468855164|FG015|Period 3|Withdrawal by Subject|0|||
130450669|NCT03929302|469614509|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
130450670|NCT03929302|469614507|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
130450671|NCT03929302|469614508|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
130450672|NCT03929302|469614509|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
130450673|NCT03929302|469614507|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
130450674|NCT03929302|469614508|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
130450675|NCT03929302|469614509|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
130450676|NCT02757885|469614510|FG000|Overall Study|Screen Failures|4|||
130450677|NCT00886613|469614511|FG000|Overall Study|Protocol deviation (Part B)|1|||
130450678|NCT00886613|469614512|FG001|Overall Study|Protocol deviation (Part B)|0|||
130450679|NCT00886613|469614513|FG002|Overall Study|Protocol deviation (Part B)|0|||
130450680|NCT00886613|469614511|FG000|Overall Study|Lost to follow-up (Part B)|1|||
130450681|NCT00886613|469614512|FG001|Overall Study|Lost to follow-up (Part B)|0|||
130450682|NCT00886613|469614513|FG002|Overall Study|Lost to follow-up (Part B)|1|||
130450683|NCT00886613|469614511|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
130450684|NCT00886613|469614512|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
130450685|NCT00886613|469614513|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
130450686|NCT03681691|469614521|FG000|Overall Study|COVID|1|||
130450687|NCT03681691|469614522|FG001|Overall Study|COVID|0|||
130450688|NCT03681691|469614521|FG000|Overall Study|prolonged bleeding|1|||
130450689|NCT03681691|469614522|FG001|Overall Study|prolonged bleeding|0|||
130450690|NCT03681691|469614521|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
130450691|NCT03681691|469614522|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
130450692|NCT00748969|469614523|FG000|Overall Study|Withdrawal by Subject|1|||
130450693|NCT00748969|469614524|FG001|Overall Study|Withdrawal by Subject|0|||
130450694|NCT00748969|469614523|FG000|Overall Study|Withdrawal by Subject|0|||
130450695|NCT00748969|469614524|FG001|Overall Study|Withdrawal by Subject|1|||
130450696|NCT03613129|469614525|FG000|Pre-treatment Assessment|Protocol Violation|2|||
130450697|NCT03613129|469614526|FG001|Pre-treatment Assessment|Protocol Violation|0|||
130450698|NCT03613129|469614527|FG002|Pre-treatment Assessment|Protocol Violation|0|||
130450699|NCT03613129|469614528|FG003|Pre-treatment Assessment|Protocol Violation|0|||
130450700|NCT03613129|469614529|FG004|Pre-treatment Assessment|Protocol Violation|0|||
130450701|NCT03613129|469614525|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
130450702|NCT03613129|469614526|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
130450703|NCT03613129|469614527|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
130450704|NCT03613129|469614528|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
130697894|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130697895|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697896|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697897|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697898|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697899|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130244314|NCT02323334|468855165|FG016|Period 3|Withdrawal by Subject|0|||
130244315|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Death|1|||
130244316|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Death|0|||
130450705|NCT03613129|469614529|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
130450706|NCT02334306|469614530|FG000|Double-blind Period|Adverse Event|0|||
130450707|NCT02334306|469614531|FG001|Double-blind Period|Adverse Event|1|||
130244317|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
130450708|NCT02334306|469614530|FG000|Double-blind Period|Withdrawal by Subject|1|||
130450709|NCT02334306|469614531|FG001|Double-blind Period|Withdrawal by Subject|1|||
130450710|NCT00465985|469614532|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
130244318|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
130450711|NCT00465985|469614533|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
130450712|NCT00465985|469614532|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
130450713|NCT00465985|469614533|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
130450714|NCT00465985|469614532|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
130450715|NCT00465985|469614533|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
130450716|NCT00465985|469614532|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
130450717|NCT00465985|469614533|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
130450718|NCT03302156|469614534|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
130450719|NCT03302156|469614535|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
130450720|NCT03302156|469614536|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
130450721|NCT03532178|469614537|FG000|First Period|Withdrawal by Subject|1|||
130450722|NCT03532178|469614538|FG001|First Period|Withdrawal by Subject|3|||
130450723|NCT03532178|469614537|FG000|First Period|technical issues in data collection Technical issues|0|||
130450724|NCT03532178|469614538|FG001|First Period|technical issues in data collection Technical issues|1|||
130450725|NCT03532178|469614537|FG000|Second Period|Withdrawal by Subject|1|||
130450726|NCT03532178|469614538|FG001|Second Period|Withdrawal by Subject|1|||
130450727|NCT03532178|469614537|FG000|Second Period|Technical issues|0|||
130450728|NCT03532178|469614538|FG001|Second Period|Technical issues|1|||
130450729|NCT02390557|469614539|FG000|Wave 2|Survey non-respondent|72|||
130450730|NCT02390557|469614540|FG001|Wave 2|Survey non-respondent|41|||
130450731|NCT02390557|469614541|FG002|Wave 2|Survey non-respondent|23|||
130450732|NCT03278028|469614544|FG000|Overall Study|Lost to Follow-up|1|||
130244319|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
130244320|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
130244321|NCT00552058|468855168|FG000|Overall Study|Adverse Event|8|||
130244322|NCT00552058|468855169|FG001|Overall Study|Adverse Event|7|||
130244323|NCT00552058|468855168|FG000|Overall Study|Lack of Efficacy|1|||
130244324|NCT00552058|468855169|FG001|Overall Study|Lack of Efficacy|5|||
130244325|NCT00552058|468855168|FG000|Overall Study|Lost to Follow-up|1|||
130244326|NCT00552058|468855169|FG001|Overall Study|Lost to Follow-up|0|||
130244327|NCT00552058|468855168|FG000|Overall Study|Withdrawal by Subject|4|||
130244328|NCT00552058|468855169|FG001|Overall Study|Withdrawal by Subject|4|||
130244329|NCT00552058|468855168|FG000|Overall Study|Other: Protocol Violation|0|||
130450733|NCT03278028|469614545|FG001|Overall Study|Lost to Follow-up|0|||
130450734|NCT03278028|469614544|FG000|Overall Study|Withdrawal by Subject|3|||
130450735|NCT03278028|469614545|FG001|Overall Study|Withdrawal by Subject|1|||
130697900|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
130697901|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697902|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697903|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697904|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697905|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697906|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697907|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697908|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697909|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697910|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
130697911|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697912|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697913|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697914|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697915|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697916|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Not reported|0|||
130697917|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Not reported|0|||
130697918|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Not reported|0|||
130697919|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Not reported|0|||
130697920|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Not reported|0|||
130697921|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Not reported|1|||
130697922|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Not reported|0|||
130697923|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Not reported|0|||
130244330|NCT00552058|468855169|FG001|Overall Study|Other: Protocol Violation|1|||
130244331|NCT00552058|468855168|FG000|Overall Study|Other: Non Compliance|1|||
130450736|NCT03278028|469614544|FG000|Overall Study|Pregnancy|0|||
130450737|NCT03278028|469614545|FG001|Overall Study|Pregnancy|1|||
130450738|NCT00463151|469614547|FG000|Overall Study|Adverse Event|0|||
130450739|NCT00463151|469614548|FG001|Overall Study|Adverse Event|0|||
130450740|NCT00463151|469614549|FG002|Overall Study|Adverse Event|1|||
130697924|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697925|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697926|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697927|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697928|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697929|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697930|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697931|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
130697932|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
130697933|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
130697934|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
130697935|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
130697936|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
130697937|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
130697938|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
130697939|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
130697940|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697941|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697942|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697943|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130697944|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
130697945|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
130697946|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130697947|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697948|NCT01120899|470519094|FG000|Overall Study|Withdrawal by Subject|3|||
130697949|NCT00820599|470519095|FG000|Overall Study|Death|129|||
130697950|NCT00820599|470519095|FG000|Overall Study|Withdrawal by Subject|2|||
130697951|NCT00202839|470519096|FG000|Overall Study|Adverse Event|1|||
130697952|NCT00202839|470519097|FG001|Overall Study|Adverse Event|5|||
130244332|NCT00552058|468855169|FG001|Overall Study|Other: Non Compliance|2|||
130362966|NCT00697788|469299562|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362967|NCT00697788|469299563|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362968|NCT00697788|469299564|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130362969|NCT00075218|469299573|FG000|Double-Blind Treatment|Adverse Event|23|||
130362970|NCT00075218|469299574|FG001|Double-Blind Treatment|Adverse Event|4|||
130362971|NCT00075218|469299575|FG002|Double-Blind Treatment|Adverse Event|0|||
130362972|NCT00075218|469299573|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
130362973|NCT00075218|469299574|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
130362974|NCT00075218|469299575|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
130362975|NCT00075218|469299573|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
130362976|NCT00075218|469299574|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
130362977|NCT00075218|469299575|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
130362978|NCT00075218|469299573|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
130362979|NCT00075218|469299574|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
130362980|NCT00075218|469299575|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
130362981|NCT00075218|469299573|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
130362982|NCT00075218|469299574|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
130362983|NCT00075218|469299575|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
130362984|NCT00075218|469299573|FG000|Double-Blind Treatment|No study medication taken|2|||
130362985|NCT00075218|469299574|FG001|Double-Blind Treatment|No study medication taken|0|||
130362986|NCT00075218|469299575|FG002|Double-Blind Treatment|No study medication taken|0|||
130362987|NCT00075218|469299573|FG000|Open-Label Treatment|Lack of Efficacy|0|||
130362988|NCT00075218|469299574|FG001|Open-Label Treatment|Lack of Efficacy|0|||
130362989|NCT00075218|469299575|FG002|Open-Label Treatment|Lack of Efficacy|174|||
130362990|NCT00075218|469299573|FG000|Open-Label Treatment|Adverse Event|0|||
130362991|NCT00075218|469299574|FG001|Open-Label Treatment|Adverse Event|0|||
130362992|NCT00075218|469299575|FG002|Open-Label Treatment|Adverse Event|51|||
130362993|NCT00075218|469299573|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
130362994|NCT00075218|469299574|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130362995|NCT00075218|469299575|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
130362996|NCT00075218|469299573|FG000|Open-Label Treatment|Decision of Sponsor|0|||
130362997|NCT00075218|469299574|FG001|Open-Label Treatment|Decision of Sponsor|0|||
130362998|NCT00075218|469299575|FG002|Open-Label Treatment|Decision of Sponsor|8|||
130362999|NCT00075218|469299573|FG000|Open-Label Treatment|Protocol Violation|0|||
130363000|NCT00075218|469299574|FG001|Open-Label Treatment|Protocol Violation|0|||
130363001|NCT00075218|469299575|FG002|Open-Label Treatment|Protocol Violation|1|||
130363002|NCT00075218|469299573|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
130363003|NCT00075218|469299574|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
130363004|NCT00075218|469299575|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
130363005|NCT03840174|469299576|FG000|Overall Study|Withdrawal by Subject|1|||
130363006|NCT03840174|469299577|FG001|Overall Study|Withdrawal by Subject|0|||
130363007|NCT03840174|469299578|FG002|Overall Study|Withdrawal by Subject|0|||
130450741|NCT00463151|469614550|FG003|Overall Study|Adverse Event|0|||
130363008|NCT03840174|469299579|FG003|Overall Study|Withdrawal by Subject|0|||
130450742|NCT00463151|469614547|FG000|Overall Study|Lack of Efficacy|2|||
130450743|NCT00463151|469614548|FG001|Overall Study|Lack of Efficacy|5|||
130363009|NCT00131508|469299580|FG000|Overall Study|Disease progression|0|||
130363010|NCT00131508|469299581|FG001|Overall Study|Disease progression|2|||
130450744|NCT00463151|469614549|FG002|Overall Study|Lack of Efficacy|2|||
130450745|NCT00463151|469614550|FG003|Overall Study|Lack of Efficacy|5|||
130450746|NCT00463151|469614547|FG000|Overall Study|Protocol Violation|0|||
130450747|NCT00463151|469614548|FG001|Overall Study|Protocol Violation|0|||
130450748|NCT00463151|469614549|FG002|Overall Study|Protocol Violation|0|||
130450749|NCT00463151|469614550|FG003|Overall Study|Protocol Violation|1|||
130450750|NCT00463151|469614547|FG000|Overall Study|Withdrawal by Subject|0|||
130450751|NCT00463151|469614548|FG001|Overall Study|Withdrawal by Subject|0|||
130450752|NCT00463151|469614549|FG002|Overall Study|Withdrawal by Subject|0|||
130450753|NCT00463151|469614550|FG003|Overall Study|Withdrawal by Subject|1|||
130450754|NCT00293462|469614551|FG000|Overall Study|Withdrawal by Subject|4|||
130450755|NCT00293462|469614552|FG001|Overall Study|Withdrawal by Subject|3|||
130450756|NCT00293462|469614553|FG002|Overall Study|Withdrawal by Subject|8|||
130450757|NCT00293462|469614551|FG000|Overall Study|Death|1|||
130450758|NCT00293462|469614552|FG001|Overall Study|Death|0|||
130450759|NCT00293462|469614553|FG002|Overall Study|Death|0|||
130450760|NCT00293462|469614551|FG000|Overall Study|Lost to Follow-up|0|||
130450761|NCT00293462|469614552|FG001|Overall Study|Lost to Follow-up|1|||
130450762|NCT00293462|469614553|FG002|Overall Study|Lost to Follow-up|0|||
130450763|NCT00293462|469614551|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
130450764|NCT00293462|469614552|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
130450765|NCT00293462|469614553|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
130450766|NCT00293462|469614551|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
130450767|NCT00293462|469614552|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
130450768|NCT00293462|469614553|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
130450769|NCT00293462|469614551|FG000|Overall Study|Refuse Radiation Treatment|1|||
130697953|NCT00202839|470519096|FG000|Overall Study|Physician Decision|12|||
130697954|NCT00202839|470519097|FG001|Overall Study|Physician Decision|0|||
130697955|NCT00202839|470519096|FG000|Overall Study|Withdrawal by Subject|6|||
130450770|NCT00293462|469614552|FG001|Overall Study|Refuse Radiation Treatment|0|||
130450771|NCT00293462|469614553|FG002|Overall Study|Refuse Radiation Treatment|0|||
130450772|NCT00293462|469614551|FG000|Overall Study|No Show|0|||
130450773|NCT00293462|469614552|FG001|Overall Study|No Show|0|||
130450774|NCT00293462|469614553|FG002|Overall Study|No Show|1|||
130450775|NCT00293462|469614551|FG000|Overall Study|Went back to his home country|0|||
130450776|NCT00293462|469614552|FG001|Overall Study|Went back to his home country|0|||
130450777|NCT00293462|469614553|FG002|Overall Study|Went back to his home country|1|||
130697956|NCT00202839|470519097|FG001|Overall Study|Withdrawal by Subject|2|||
130697957|NCT00202839|470519096|FG000|Overall Study|Protocol Violation|2|||
130697958|NCT00202839|470519097|FG001|Overall Study|Protocol Violation|1|||
130697959|NCT00202839|470519096|FG000|Overall Study|Lost to Follow-up|3|||
130697960|NCT00202839|470519097|FG001|Overall Study|Lost to Follow-up|2|||
130697961|NCT00442351|470519098|FG000|Overall Study|Administrative|6|||
130697962|NCT00442351|470519099|FG001|Overall Study|Administrative|5|||
130697963|NCT00442351|470519098|FG000|Overall Study|Did not meet protocol eligibility|1|||
130697964|NCT00442351|470519099|FG001|Overall Study|Did not meet protocol eligibility|0|||
130697965|NCT00442351|470519098|FG000|Overall Study|Other|0|||
130697966|NCT00442351|470519099|FG001|Overall Study|Other|1|||
130697967|NCT00544167|470519103|FG000|Overall Study|Adverse Event|21|||
130697968|NCT00544167|470519103|FG000|Overall Study|Physician Decision|8|||
130697969|NCT04281472|470519108|FG000|Stage A|Lack of Efficacy|8|||
130697970|NCT04281472|470519109|FG001|Stage A|Lack of Efficacy|0|||
130697971|NCT04281472|470519110|FG002|Stage A|Lack of Efficacy|0|||
130697972|NCT04281472|470519108|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
130697973|NCT04281472|470519109|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130697974|NCT04281472|470519110|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130697975|NCT04281472|470519108|FG000|Stage A|Adverse Event|20|||
130697976|NCT04281472|470519109|FG001|Stage A|Adverse Event|0|||
130697977|NCT04281472|470519110|FG002|Stage A|Adverse Event|0|||
130697978|NCT04281472|470519108|FG000|Stage A|Death|1|||
130697979|NCT04281472|470519109|FG001|Stage A|Death|0|||
130697980|NCT04281472|470519110|FG002|Stage A|Death|0|||
130697981|NCT04281472|470519108|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
130697982|NCT04281472|470519109|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
130697983|NCT04281472|470519110|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
130697984|NCT04281472|470519108|FG000|Stage A|Lost to Follow-up|2|||
130697985|NCT04281472|470519109|FG001|Stage A|Lost to Follow-up|0|||
130697986|NCT04281472|470519110|FG002|Stage A|Lost to Follow-up|0|||
130697987|NCT04281472|470519108|FG000|Stage A|Non-compliance with study drug|1|||
130450778|NCT00293462|469614551|FG000|Overall Study|Blood clot after chemotherapy|0|||
130450779|NCT00293462|469614552|FG001|Overall Study|Blood clot after chemotherapy|0|||
130450780|NCT00293462|469614553|FG002|Overall Study|Blood clot after chemotherapy|1|||
130450781|NCT00293462|469614551|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
130450782|NCT00293462|469614552|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
130450783|NCT00293462|469614553|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
130450784|NCT00293462|469614551|FG000|Overall Study|Possible Tracheostomy leakage|0|||
130450785|NCT00293462|469614552|FG001|Overall Study|Possible Tracheostomy leakage|1|||
130450786|NCT00293462|469614553|FG002|Overall Study|Possible Tracheostomy leakage|0|||
130450787|NCT00293462|469614551|FG000|Overall Study|Low radiation dose in oral cavity|0|||
130450788|NCT00293462|469614552|FG001|Overall Study|Low radiation dose in oral cavity|1|||
130450789|NCT00293462|469614553|FG002|Overall Study|Low radiation dose in oral cavity|0|||
130450790|NCT00293462|469614551|FG000|Overall Study|Physician Decision|0|||
130450791|NCT00293462|469614552|FG001|Overall Study|Physician Decision|1|||
130697988|NCT04281472|470519109|FG001|Stage A|Non-compliance with study drug|0|||
130450792|NCT00293462|469614553|FG002|Overall Study|Physician Decision|0|||
130450793|NCT00688688|469614554|FG000|Overall Study|Eligibility criterion not met|7|||
130450794|NCT00688688|469614555|FG001|Overall Study|Eligibility criterion not met|7|||
130450795|NCT00688688|469614556|FG002|Overall Study|Eligibility criterion not met|10|||
130697989|NCT04281472|470519110|FG002|Stage A|Non-compliance with study drug|0|||
130697990|NCT04281472|470519108|FG000|Stage A|Physician Decision|1|||
130697991|NCT04281472|470519109|FG001|Stage A|Physician Decision|0|||
130697992|NCT04281472|470519110|FG002|Stage A|Physician Decision|0|||
130697993|NCT04281472|470519108|FG000|Stage A|Prohibited medications|2|||
130697994|NCT04281472|470519109|FG001|Stage A|Prohibited medications|0|||
130697995|NCT04281472|470519110|FG002|Stage A|Prohibited medications|0|||
130697996|NCT04281472|470519108|FG000|Stage A|Withdrawal by Subject|11|||
130697997|NCT04281472|470519109|FG001|Stage A|Withdrawal by Subject|0|||
130697998|NCT04281472|470519110|FG002|Stage A|Withdrawal by Subject|0|||
130697999|NCT04281472|470519108|FG000|Stage A|Other|5|||
130698000|NCT04281472|470519109|FG001|Stage A|Other|0|||
130698001|NCT04281472|470519110|FG002|Stage A|Other|0|||
130698002|NCT04281472|470519108|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130698003|NCT04281472|470519109|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
130698004|NCT04281472|470519110|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
130698005|NCT04281472|470519108|FG000|Stage B|Adverse Event|0|||
130698006|NCT04281472|470519109|FG001|Stage B|Adverse Event|3|||
130698007|NCT04281472|470519110|FG002|Stage B|Adverse Event|0|||
130698008|NCT04281472|470519108|FG000|Stage B|Death|0|||
130698009|NCT04281472|470519109|FG001|Stage B|Death|0|||
130698010|NCT04281472|470519110|FG002|Stage B|Death|1|||
130698011|NCT04281472|470519108|FG000|Stage B|Lack of Efficacy|0|||
130698012|NCT04281472|470519109|FG001|Stage B|Lack of Efficacy|0|||
130698013|NCT04281472|470519110|FG002|Stage B|Lack of Efficacy|1|||
130698014|NCT04281472|470519108|FG000|Stage B|Lost to Follow-up|0|||
130698015|NCT04281472|470519109|FG001|Stage B|Lost to Follow-up|0|||
130698016|NCT04281472|470519110|FG002|Stage B|Lost to Follow-up|2|||
130698017|NCT04281472|470519108|FG000|Stage B|Prohibited medications|0|||
130698018|NCT04281472|470519109|FG001|Stage B|Prohibited medications|2|||
130698019|NCT04281472|470519110|FG002|Stage B|Prohibited medications|1|||
130698020|NCT04281472|470519108|FG000|Stage B|Protocol Violation|0|||
130698021|NCT04281472|470519109|FG001|Stage B|Protocol Violation|1|||
130698022|NCT04281472|470519110|FG002|Stage B|Protocol Violation|1|||
130698023|NCT04281472|470519108|FG000|Stage B|Sponsor decision|0|||
130698024|NCT04281472|470519109|FG001|Stage B|Sponsor decision|0|||
130698025|NCT04281472|470519110|FG002|Stage B|Sponsor decision|1|||
130698026|NCT04281472|470519108|FG000|Stage B|Withdrawal by Subject|0|||
130698027|NCT04281472|470519109|FG001|Stage B|Withdrawal by Subject|3|||
130698028|NCT04281472|470519110|FG002|Stage B|Withdrawal by Subject|3|||
130698029|NCT04281472|470519108|FG000|Stage B|Other|0|||
130698030|NCT04281472|470519109|FG001|Stage B|Other|3|||
130698031|NCT04281472|470519110|FG002|Stage B|Other|0|||
130698032|NCT00152451|470519111|FG000|Overall Study|Adverse Event|4|||
130698033|NCT01055834|470519118|FG000|Treatment Period I|Adverse Event|1|||
130698034|NCT01055834|470519119|FG001|Treatment Period I|Adverse Event|0|||
130698035|NCT05004649|470519120|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
130698036|NCT05004649|470519120|FG000|Overall Study|Lost to Follow-up|1|||
130698037|NCT05004649|470519120|FG000|Overall Study|Withdrawal by Subject|2|||
130698038|NCT05004649|470519120|FG000|Overall Study|COVID-19|1|||
130450796|NCT00688688|469614554|FG000|Overall Study|Adverse Event|52|||
130450797|NCT00688688|469614555|FG001|Overall Study|Adverse Event|51|||
130450798|NCT00688688|469614556|FG002|Overall Study|Adverse Event|50|||
130698039|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Death|0|||
130698040|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Death|1|||
130698041|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
130698042|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
130698043|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130698044|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
130450799|NCT00688688|469614554|FG000|Overall Study|Lack of Efficacy|34|||
130450800|NCT00688688|469614555|FG001|Overall Study|Lack of Efficacy|25|||
130450801|NCT00688688|469614556|FG002|Overall Study|Lack of Efficacy|45|||
130698045|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
130698046|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
130698047|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130698048|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130698049|NCT01717313|470519121|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
130450802|NCT00688688|469614554|FG000|Overall Study|Withdrawal by Subject|66|||
130450803|NCT00688688|469614555|FG001|Overall Study|Withdrawal by Subject|75|||
130450804|NCT00688688|469614556|FG002|Overall Study|Withdrawal by Subject|65|||
130450805|NCT00688688|469614554|FG000|Overall Study|Lost to Follow-up|14|||
130450806|NCT00688688|469614555|FG001|Overall Study|Lost to Follow-up|7|||
130450807|NCT00688688|469614556|FG002|Overall Study|Lost to Follow-up|7|||
130450808|NCT00688688|469614554|FG000|Overall Study|Protocol Violation|6|||
130450809|NCT00688688|469614555|FG001|Overall Study|Protocol Violation|9|||
130698050|NCT01717313|470519122|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
130698051|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130698052|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130698053|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
130698054|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
130698055|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
130698056|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
130698057|NCT00728754|470519123|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130698058|NCT00728754|470519124|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
130698059|NCT00728754|470519123|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130698060|NCT00728754|470519124|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130698061|NCT00728754|470519123|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
130698062|NCT00728754|470519124|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
130698063|NCT00009945|470519125|FG000|Overall Study|no follow up data|7|||
130698064|NCT00009945|470519126|FG001|Overall Study|no follow up data|5|||
130698065|NCT02654145|470519127|FG000|Overall Study|Lack of Efficacy|1|||
130698066|NCT02654145|470519127|FG000|Overall Study|Protocol Violation|1|||
130698067|NCT02654145|470519127|FG000|Overall Study|Withdrawal by Subject|5|||
130698068|NCT01943435|470519135|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
130698069|NCT01943435|470519136|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
130698070|NCT01943435|470519137|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
130698071|NCT01943435|470519135|FG000|Intervention Period|Withdrawal by Subject|3|||
130698072|NCT01943435|470519136|FG001|Intervention Period|Withdrawal by Subject|3|||
130698073|NCT01943435|470519137|FG002|Intervention Period|Withdrawal by Subject|4|||
130698074|NCT01943435|470519135|FG000|2 Month Follow up|Lost to Follow-up|2|||
130698075|NCT01943435|470519136|FG001|2 Month Follow up|Lost to Follow-up|3|||
130698076|NCT01943435|470519137|FG002|2 Month Follow up|Lost to Follow-up|0|||
130698077|NCT01943435|470519135|FG000|6 Month Follow up|Lost to Follow-up|12|||
130698078|NCT01943435|470519136|FG001|6 Month Follow up|Lost to Follow-up|7|||
130698079|NCT01943435|470519137|FG002|6 Month Follow up|Lost to Follow-up|15|||
130698080|NCT00295490|470519138|FG000|Overall Study|Protocol Violation|0|||
130698081|NCT00295490|470519139|FG001|Overall Study|Protocol Violation|0|||
130698082|NCT00295490|470519140|FG002|Overall Study|Protocol Violation|3|||
130698083|NCT00295490|470519141|FG003|Overall Study|Protocol Violation|3|||
130698084|NCT00295490|470519138|FG000|Overall Study|Withdrawal by Subject|0|||
130698085|NCT00295490|470519139|FG001|Overall Study|Withdrawal by Subject|2|||
130698086|NCT00295490|470519140|FG002|Overall Study|Withdrawal by Subject|0|||
130698087|NCT00295490|470519141|FG003|Overall Study|Withdrawal by Subject|1|||
130698088|NCT00295490|470519138|FG000|Overall Study|Lost to Follow-up|0|||
130698089|NCT00295490|470519139|FG001|Overall Study|Lost to Follow-up|0|||
130698090|NCT00295490|470519140|FG002|Overall Study|Lost to Follow-up|1|||
130698091|NCT00295490|470519141|FG003|Overall Study|Lost to Follow-up|0|||
130698092|NCT00295490|470519138|FG000|Overall Study|Adverse Event|1|||
130698093|NCT00295490|470519139|FG001|Overall Study|Adverse Event|0|||
130698094|NCT00295490|470519140|FG002|Overall Study|Adverse Event|0|||
130698095|NCT00295490|470519141|FG003|Overall Study|Adverse Event|0|||
130698096|NCT00295490|470519138|FG000|Overall Study|Other|0|||
130698097|NCT00295490|470519139|FG001|Overall Study|Other|2|||
130698098|NCT00295490|470519140|FG002|Overall Study|Other|0|||
130698099|NCT00295490|470519141|FG003|Overall Study|Other|1|||
130698100|NCT01617096|470519142|FG000|Overall Study|Withdrawal by Subject|96|||
130698101|NCT01617096|470519143|FG001|Overall Study|Withdrawal by Subject|81|||
130698102|NCT01617096|470519142|FG000|Overall Study|Lost to Follow-up|37|||
130698103|NCT01617096|470519143|FG001|Overall Study|Lost to Follow-up|32|||
130698104|NCT01617096|470519142|FG000|Overall Study|Physician Decision|10|||
130698105|NCT01617096|470519143|FG001|Overall Study|Physician Decision|18|||
130698106|NCT01617096|470519142|FG000|Overall Study|Death|4|||
130698107|NCT01617096|470519143|FG001|Overall Study|Death|3|||
130698108|NCT01617096|470519142|FG000|Overall Study|Other|1|||
130698109|NCT01617096|470519143|FG001|Overall Study|Other|3|||
130698110|NCT01196390|470519146|FG000|Overall Study|Protocol Violation|4|||
130698111|NCT01196390|470519147|FG001|Overall Study|Protocol Violation|5|||
130698112|NCT04610580|470519148|FG000|Two-way Crossover Period|Adverse Event|1|||
130450810|NCT00688688|469614556|FG002|Overall Study|Protocol Violation|11|||
130698113|NCT04610580|470519149|FG001|Two-way Crossover Period|Adverse Event|0|||
130698114|NCT04610580|470519150|FG002|Two-way Crossover Period|Adverse Event|0|||
130698115|NCT04610580|470519151|FG003|Two-way Crossover Period|Adverse Event|0|||
130698116|NCT04610580|470519152|FG004|Two-way Crossover Period|Adverse Event|0|||
130698117|NCT04610580|470519153|FG005|Two-way Crossover Period|Adverse Event|0|||
130450811|NCT00688688|469614554|FG000|Overall Study|Randomized but never received study drug|1|||
130450812|NCT00688688|469614555|FG001|Overall Study|Randomized but never received study drug|0|||
130450813|NCT00688688|469614556|FG002|Overall Study|Randomized but never received study drug|0|||
130450814|NCT00688688|469614554|FG000|Overall Study|Non-compliance with study procedures|5|||
130450815|NCT00688688|469614555|FG001|Overall Study|Non-compliance with study procedures|3|||
130450816|NCT00688688|469614556|FG002|Overall Study|Non-compliance with study procedures|4|||
130450817|NCT00688688|469614554|FG000|Overall Study|Taking exclusionary medications|1|||
130450818|NCT00688688|469614555|FG001|Overall Study|Taking exclusionary medications|0|||
130450819|NCT00688688|469614556|FG002|Overall Study|Taking exclusionary medications|0|||
130450820|NCT00688688|469614554|FG000|Overall Study|Site closure|0|||
130450821|NCT00688688|469614555|FG001|Overall Study|Site closure|1|||
130450822|NCT00688688|469614556|FG002|Overall Study|Site closure|0|||
130450823|NCT00688688|469614554|FG000|Overall Study|Violation of exclusion criterion|0|||
130450824|NCT00688688|469614555|FG001|Overall Study|Violation of exclusion criterion|1|||
130450825|NCT00688688|469614556|FG002|Overall Study|Violation of exclusion criterion|0|||
130450826|NCT03283553|469614559|FG000|Patient Participant Flow|Death|5|||
130450827|NCT03283553|469614560|FG001|Patient Participant Flow|Death|10|||
130450828|NCT03283553|469614559|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
130450829|NCT03283553|469614560|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
130450830|NCT03283553|469614559|FG000|Patient Participant Flow|Lost to Follow-up|1|||
130450831|NCT03283553|469614560|FG001|Patient Participant Flow|Lost to Follow-up|1|||
130450832|NCT03283553|469614559|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
130450833|NCT03283553|469614560|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
130450834|NCT03283553|469614559|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
130450835|NCT03283553|469614560|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
130450836|NCT03283553|469614559|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
130450837|NCT03283553|469614560|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
130450838|NCT03686683|469614561|FG000|Overall Study|Withdrawal by Subject|52|||
130450839|NCT03686683|469614562|FG001|Overall Study|Withdrawal by Subject|32|||
130450840|NCT03686683|469614561|FG000|Overall Study|Lost to Follow-up|23|||
130450841|NCT03686683|469614562|FG001|Overall Study|Lost to Follow-up|19|||
130450842|NCT03686683|469614561|FG000|Overall Study|Adverse Event|1|||
130698118|NCT04610580|470519148|FG000|Two-way Crossover Period|Physician Decision|1|||
130698119|NCT04610580|470519149|FG001|Two-way Crossover Period|Physician Decision|0|||
130698120|NCT04610580|470519150|FG002|Two-way Crossover Period|Physician Decision|0|||
130698121|NCT04610580|470519151|FG003|Two-way Crossover Period|Physician Decision|0|||
130698122|NCT04610580|470519152|FG004|Two-way Crossover Period|Physician Decision|0|||
130698123|NCT04610580|470519153|FG005|Two-way Crossover Period|Physician Decision|0|||
130698124|NCT04610580|470519148|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
130698125|NCT04610580|470519149|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
130698126|NCT04610580|470519150|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
130698127|NCT04610580|470519151|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
130698128|NCT04610580|470519152|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
130698129|NCT04610580|470519153|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
130698130|NCT04610580|470519148|FG000|Two-way Crossover Period|Other than specified|0|||
130698131|NCT04610580|470519149|FG001|Two-way Crossover Period|Other than specified|1|||
130698132|NCT04610580|470519150|FG002|Two-way Crossover Period|Other than specified|0|||
130698133|NCT04610580|470519151|FG003|Two-way Crossover Period|Other than specified|0|||
130698134|NCT04610580|470519152|FG004|Two-way Crossover Period|Other than specified|0|||
130698135|NCT04610580|470519153|FG005|Two-way Crossover Period|Other than specified|0|||
130698136|NCT04610580|470519148|FG000|Washout Before Extension Period|Other than specified|0|||
130698137|NCT04610580|470519149|FG001|Washout Before Extension Period|Other than specified|1|||
130698138|NCT04610580|470519150|FG002|Washout Before Extension Period|Other than specified|0|||
130698139|NCT04610580|470519151|FG003|Washout Before Extension Period|Other than specified|0|||
130698140|NCT04610580|470519152|FG004|Washout Before Extension Period|Other than specified|0|||
130698141|NCT04610580|470519153|FG005|Washout Before Extension Period|Other than specified|0|||
130698142|NCT04610580|470519148|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
130698143|NCT04610580|470519149|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
130450843|NCT03686683|469614562|FG001|Overall Study|Adverse Event|0|||
130450844|NCT03686683|469614561|FG000|Overall Study|Death|10|||
130450845|NCT03686683|469614562|FG001|Overall Study|Death|5|||
130450846|NCT03686683|469614561|FG000|Overall Study|Progressive Disease|1|||
130450847|NCT03686683|469614562|FG001|Overall Study|Progressive Disease|1|||
130450848|NCT03686683|469614561|FG000|Overall Study|Noncompliance|1|||
130450849|NCT03686683|469614562|FG001|Overall Study|Noncompliance|0|||
130450850|NCT03686683|469614561|FG000|Overall Study|Physician Decision|1|||
130698144|NCT04610580|470519150|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
130698145|NCT04610580|470519151|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
130698146|NCT04610580|470519152|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
130698147|NCT04610580|470519153|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
130698148|NCT04610580|470519148|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130450851|NCT03686683|469614562|FG001|Overall Study|Physician Decision|1|||
130450852|NCT03686683|469614561|FG000|Overall Study|Screen fail post-randomization|1|||
130450853|NCT03686683|469614562|FG001|Overall Study|Screen fail post-randomization|0|||
130698149|NCT04610580|470519149|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698150|NCT04610580|470519150|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698151|NCT04610580|470519151|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698152|NCT04610580|470519152|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
130698153|NCT04610580|470519153|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698154|NCT01097694|470519154|FG000|Overall Study|Adverse Event|5|||
130698155|NCT01097694|470519155|FG001|Overall Study|Adverse Event|0|||
130698156|NCT01097694|470519154|FG000|Overall Study|Lost to Follow-up|0|||
130698157|NCT01097694|470519155|FG001|Overall Study|Lost to Follow-up|3|||
130698158|NCT01097694|470519154|FG000|Overall Study|Withdrawal by Subject|3|||
130698159|NCT01097694|470519155|FG001|Overall Study|Withdrawal by Subject|1|||
130698160|NCT02179190|470519156|FG000|Enrollment|Exit Prior to Device Attempt|11|||
130698161|NCT02179190|470519156|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
130698162|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
130698163|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
130698164|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
130698165|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
130698166|NCT02377349|470519157|FG000|Overall Study|Serious Adverse Event|1|||
130698167|NCT02377349|470519158|FG001|Overall Study|Serious Adverse Event|0|||
130698168|NCT02377349|470519157|FG000|Overall Study|Protocol Violation|3|||
130698169|NCT02377349|470519158|FG001|Overall Study|Protocol Violation|2|||
130698170|NCT02377349|470519157|FG000|Overall Study|Withdrawal by Subject|5|||
130698171|NCT02377349|470519158|FG001|Overall Study|Withdrawal by Subject|3|||
130698172|NCT02377349|470519157|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
130698173|NCT02377349|470519158|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
130698174|NCT02377349|470519157|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
130698175|NCT02377349|470519158|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
130698176|NCT02377349|470519157|FG000|Overall Study|Other|0|||
130698177|NCT02377349|470519158|FG001|Overall Study|Other|1|||
130698178|NCT01993940|470519161|FG000|Overall Study|Adverse Event|16|||
130698179|NCT01993940|470519162|FG001|Overall Study|Adverse Event|11|||
130698180|NCT01993940|470519161|FG000|Overall Study|Withdrawal by Subject|15|||
130698181|NCT01993940|470519162|FG001|Overall Study|Withdrawal by Subject|19|||
130698182|NCT01993940|470519161|FG000|Overall Study|Lost to Follow-up|2|||
130698183|NCT01993940|470519162|FG001|Overall Study|Lost to Follow-up|5|||
130698184|NCT01993940|470519161|FG000|Overall Study|Protocol Violation|5|||
130450854|NCT03686683|469614561|FG000|Overall Study|Protocol Violation|3|||
130450855|NCT03686683|469614562|FG001|Overall Study|Protocol Violation|0|||
130698185|NCT01993940|470519162|FG001|Overall Study|Protocol Violation|8|||
130698186|NCT01993940|470519161|FG000|Overall Study|Death|1|||
130698187|NCT01993940|470519162|FG001|Overall Study|Death|0|||
130698188|NCT01993940|470519161|FG000|Overall Study|Other - Miscellaneous|1|||
130698189|NCT01993940|470519162|FG001|Overall Study|Other - Miscellaneous|1|||
130698190|NCT03259165|470519163|FG000|Overall Study|COVID 19 pandemic|1|||
130698191|NCT03259165|470519164|FG001|Overall Study|COVID 19 pandemic|1|||
130698192|NCT01949532|470519165|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
130698193|NCT01949532|470519166|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
130698194|NCT00939523|470519171|FG000|Overall Study|Lack of Efficacy|1|||
130698195|NCT00939523|470519171|FG000|Overall Study|Physician Decision|2|||
130698196|NCT00024258|470519172|FG000|Overall Study|Withdrawal by Subject|1|||
130698197|NCT00024258|470519172|FG000|Overall Study|Disease Progression|8|||
130698198|NCT01050764|470519173|FG000|Overall Study|Death, before HSCT|1|||
130698199|NCT01050764|470519173|FG000|Overall Study|Donor mobilization failure, death|1|||
130698200|NCT01050764|470519173|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
130698201|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Adverse Event|8|||
130698202|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Adverse Event|5|||
130698203|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Adverse Event|9|||
130698204|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130698205|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Adverse Event|0|||
130698206|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Adverse Event|0|||
130698207|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
130698208|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
130698209|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
130698210|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698211|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698212|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698213|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
130698214|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
130698215|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
130698216|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698217|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698218|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698219|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Physician Decision|4|||
130698220|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Physician Decision|0|||
130698221|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Physician Decision|2|||
130698222|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Physician Decision|0|||
130698223|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Physician Decision|0|||
130698224|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Physician Decision|0|||
130698225|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Pregnancy|1|||
130698226|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Pregnancy|2|||
130698227|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Pregnancy|0|||
130698228|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Pregnancy|0|||
130698229|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Pregnancy|0|||
130698230|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Pregnancy|0|||
130698231|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
130698232|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
130698233|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
130698234|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
130698235|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
130698236|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
130698237|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
130698238|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698239|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698240|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698241|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698242|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698243|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
130698244|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
130698245|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
130698246|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
130698247|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130698248|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130698249|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
130698250|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
130698251|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
130698252|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
130698253|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
130363011|NCT00131508|469299580|FG000|Overall Study|Non-Compliance|2|||
130363012|NCT00131508|469299581|FG001|Overall Study|Non-Compliance|4|||
130363013|NCT00131508|469299580|FG000|Overall Study|Withdrawal by Subject|1|||
130363014|NCT00131508|469299581|FG001|Overall Study|Withdrawal by Subject|2|||
130698254|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
130698255|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
130698256|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130698257|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130698258|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130363015|NCT05224141|469299583|FG000|Overall Study|Ongoing|75|||
130363016|NCT05224141|469299584|FG001|Overall Study|Ongoing|88|||
130363017|NCT05224141|469299583|FG000|Overall Study|Withdrawal by Subject|2|||
130363018|NCT05224141|469299584|FG001|Overall Study|Withdrawal by Subject|4|||
130363019|NCT05224141|469299583|FG000|Overall Study|Death|153|||
130363020|NCT05224141|469299584|FG001|Overall Study|Death|138|||
130363021|NCT03469934|469299589|FG000|Overall Study|Withdrawal by Subject|0|||
130363022|NCT03469934|469299590|FG001|Overall Study|Withdrawal by Subject|1|||
130363023|NCT04889222|469299592|FG000|Overall Study|Did not meet eligibility criteria|8|||
130363024|NCT04889222|469299592|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
130363025|NCT04889222|469299592|FG000|Overall Study|Did not proceed due to time constraints|5|||
130363026|NCT02639546|469299597|FG000|Overall Study|Death|2|||
130363027|NCT02639546|469299598|FG001|Overall Study|Death|2|||
130363028|NCT02639546|469299599|FG002|Overall Study|Death|1|||
130363029|NCT02639546|469299600|FG003|Overall Study|Death|2|||
130363030|NCT02639546|469299601|FG004|Overall Study|Death|2|||
130363031|NCT02639546|469299602|FG005|Overall Study|Death|2|||
130363032|NCT02639546|469299603|FG006|Overall Study|Death|0|||
130363033|NCT02639546|469299604|FG007|Overall Study|Death|0|||
130363034|NCT02639546|469299597|FG000|Overall Study|Lost to Follow-up|0|||
130363035|NCT02639546|469299598|FG001|Overall Study|Lost to Follow-up|0|||
130363036|NCT02639546|469299599|FG002|Overall Study|Lost to Follow-up|1|||
130363037|NCT02639546|469299600|FG003|Overall Study|Lost to Follow-up|0|||
130363038|NCT02639546|469299601|FG004|Overall Study|Lost to Follow-up|1|||
130363039|NCT02639546|469299602|FG005|Overall Study|Lost to Follow-up|1|||
130363040|NCT02639546|469299603|FG006|Overall Study|Lost to Follow-up|0|||
130698259|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
130698260|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130698261|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
130698262|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
130698263|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
130698264|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
130363041|NCT02639546|469299604|FG007|Overall Study|Lost to Follow-up|1|||
130363042|NCT02639546|469299597|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
130363043|NCT02639546|469299598|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
130363044|NCT02639546|469299599|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
130363045|NCT02639546|469299600|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
130363046|NCT02639546|469299601|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
130363047|NCT02639546|469299602|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
130363048|NCT02639546|469299603|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
130363049|NCT02639546|469299604|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
130698265|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
130698266|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
130698267|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698268|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
130698269|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698270|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698271|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
130698272|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698273|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
130698274|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130698275|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
130698276|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130698277|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130698278|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130698279|NCT00258856|470520780|FG000|Overall Study|Lost to Follow-up|1|||
130698280|NCT00258856|470520781|FG001|Overall Study|Lost to Follow-up|0|||
130698281|NCT00258856|470520782|FG002|Overall Study|Lost to Follow-up|2|||
130698282|NCT00258856|470520783|FG003|Overall Study|Lost to Follow-up|0|||
130698283|NCT00258856|470520780|FG000|Overall Study|Non-compliance|2|||
130698284|NCT00258856|470520781|FG001|Overall Study|Non-compliance|0|||
130698285|NCT00258856|470520782|FG002|Overall Study|Non-compliance|0|||
130698286|NCT00258856|470520783|FG003|Overall Study|Non-compliance|1|||
130698287|NCT01691430|470520784|FG000|Overall Study|Death|17|||
130698288|NCT01691430|470520785|FG001|Overall Study|Death|16|||
130698289|NCT01691430|470520784|FG000|Overall Study|Withdrawal by Subject|5|||
130698290|NCT01691430|470520785|FG001|Overall Study|Withdrawal by Subject|1|||
130363050|NCT02639546|469299597|FG000|Overall Study|Study Terminated By Sponsor|0|||
130450856|NCT03686683|469614561|FG000|Overall Study|No data available|1|||
130363051|NCT02639546|469299598|FG001|Overall Study|Study Terminated By Sponsor|2|||
130363052|NCT02639546|469299599|FG002|Overall Study|Study Terminated By Sponsor|3|||
130363053|NCT02639546|469299600|FG003|Overall Study|Study Terminated By Sponsor|4|||
130363054|NCT02639546|469299601|FG004|Overall Study|Study Terminated By Sponsor|4|||
130363055|NCT02639546|469299602|FG005|Overall Study|Study Terminated By Sponsor|3|||
130698291|NCT01691430|470520784|FG000|Overall Study|Lost to Follow-up|0|||
130698292|NCT01691430|470520785|FG001|Overall Study|Lost to Follow-up|3|||
130450857|NCT03686683|469614562|FG001|Overall Study|No data available|0|||
130450858|NCT03255941|469614563|FG000|Overall Study|Not eligible or refused injection|37|||
130450859|NCT03255941|469614564|FG001|Overall Study|Not eligible or refused injection|44|||
130450860|NCT03255941|469614565|FG002|Overall Study|Not eligible or refused injection|5|||
130450861|NCT03255941|469614566|FG003|Overall Study|Not eligible or refused injection|6|||
130450862|NCT03255941|469614563|FG000|Overall Study|Did not complete exit interview|1|||
130450863|NCT03255941|469614564|FG001|Overall Study|Did not complete exit interview|2|||
130450864|NCT03255941|469614565|FG002|Overall Study|Did not complete exit interview|0|||
130450865|NCT03255941|469614566|FG003|Overall Study|Did not complete exit interview|0|||
130450866|NCT00372060|469614567|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
130450867|NCT00372060|469614568|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
130450868|NCT00372060|469614567|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
130450869|NCT00372060|469614568|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
130450870|NCT00372060|469614567|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
130450871|NCT00372060|469614568|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
130450872|NCT00372060|469614567|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
130698293|NCT02219009|470520788|FG000|Overall Study|Withdrawal by Subject|5|||
130698294|NCT02219009|470520789|FG001|Overall Study|Withdrawal by Subject|1|||
130698295|NCT02219009|470520788|FG000|Overall Study|Adverse Event|2|||
130698296|NCT02219009|470520789|FG001|Overall Study|Adverse Event|4|||
130698297|NCT02219009|470520788|FG000|Overall Study|Lost to Follow-up|2|||
130698298|NCT02219009|470520789|FG001|Overall Study|Lost to Follow-up|2|||
130698299|NCT02219009|470520788|FG000|Overall Study|Protocol deviation|1|||
130698300|NCT02219009|470520789|FG001|Overall Study|Protocol deviation|0|||
130698301|NCT02219009|470520788|FG000|Overall Study|Physician Decision|0|||
130698302|NCT02219009|470520789|FG001|Overall Study|Physician Decision|1|||
130698303|NCT00762411|470520790|FG000|Initial Treatment|Death|7|||
130698304|NCT00762411|470520791|FG001|Initial Treatment|Death|6|||
130698305|NCT00762411|470520790|FG000|Initial Treatment|Adverse Event|132|||
130698306|NCT00762411|470520791|FG001|Initial Treatment|Adverse Event|40|||
130698307|NCT00762411|470520790|FG000|Initial Treatment|Protocol Violation|4|||
130698308|NCT00762411|470520791|FG001|Initial Treatment|Protocol Violation|1|||
130698309|NCT00762411|470520790|FG000|Initial Treatment|Withdrawal by Subject|65|||
130698310|NCT00762411|470520791|FG001|Initial Treatment|Withdrawal by Subject|52|||
130698311|NCT00762411|470520790|FG000|Initial Treatment|Physician Decision|1|||
130698312|NCT00762411|470520791|FG001|Initial Treatment|Physician Decision|0|||
130698313|NCT00762411|470520790|FG000|Initial Treatment|Sponsor Decision|293|||
130698314|NCT00762411|470520791|FG001|Initial Treatment|Sponsor Decision|401|||
130698315|NCT00762411|470520790|FG000|Initial Treatment|Lost to Follow-up|5|||
130698316|NCT00762411|470520791|FG001|Initial Treatment|Lost to Follow-up|0|||
130698317|NCT00762411|470520790|FG000|Initial Treatment|Caregiver Decision|21|||
130698318|NCT00762411|470520791|FG001|Initial Treatment|Caregiver Decision|16|||
130698319|NCT00762411|470520790|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
130698320|NCT00762411|470520791|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
130698321|NCT00762411|470520790|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
130698322|NCT00762411|470520791|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
130698323|NCT00762411|470520790|FG000|Delayed Start|Adverse Event|0|||
130698324|NCT00762411|470520791|FG001|Delayed Start|Adverse Event|4|||
130698325|NCT00762411|470520790|FG000|Delayed Start|Protocol Violation|0|||
130698326|NCT00762411|470520791|FG001|Delayed Start|Protocol Violation|1|||
130698327|NCT00762411|470520790|FG000|Delayed Start|Sponsor Decision|16|||
130698328|NCT00762411|470520791|FG001|Delayed Start|Sponsor Decision|20|||
130698329|NCT00762411|470520790|FG000|Delayed Start|Caregiver Decision|1|||
130698330|NCT00762411|470520791|FG001|Delayed Start|Caregiver Decision|1|||
130698331|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
130698332|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
130244333|NCT00552058|468855168|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
130244334|NCT00552058|468855169|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
130244335|NCT00552058|468855168|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
130244336|NCT00552058|468855169|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
130244337|NCT00552058|468855168|FG000|Overall Study|Other: Positive Stool Result|0|||
130244338|NCT00552058|468855169|FG001|Overall Study|Other: Positive Stool Result|1|||
130244339|NCT00552058|468855168|FG000|Overall Study|Other: Randomized in error|0|||
130244340|NCT00552058|468855169|FG001|Overall Study|Other: Randomized in error|1|||
130450873|NCT00372060|469614568|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
130450874|NCT00372060|469614567|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
130450875|NCT00372060|469614568|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
130450876|NCT00372060|469614567|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
130450877|NCT00372060|469614568|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
130450878|NCT01579578|469614569|FG000|Overall Study|Death|4|||
130698333|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130698334|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
130698335|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
130244341|NCT00552058|468855168|FG000|Overall Study|Other: Sponsors Decision|0|||
130244342|NCT00552058|468855169|FG001|Overall Study|Other: Sponsors Decision|1|||
130244343|NCT00552058|468855168|FG000|Overall Study|Other: Early Roll Over|1|||
130244344|NCT00552058|468855169|FG001|Overall Study|Other: Early Roll Over|0|||
130363056|NCT02639546|469299603|FG006|Overall Study|Study Terminated By Sponsor|3|||
130363057|NCT02639546|469299604|FG007|Overall Study|Study Terminated By Sponsor|9|||
130363058|NCT02639546|469299597|FG000|Overall Study|Withdrawal by Subject|2|||
130363059|NCT02639546|469299598|FG001|Overall Study|Withdrawal by Subject|2|||
130363060|NCT02639546|469299599|FG002|Overall Study|Withdrawal by Subject|1|||
130363061|NCT02639546|469299600|FG003|Overall Study|Withdrawal by Subject|0|||
130363062|NCT02639546|469299601|FG004|Overall Study|Withdrawal by Subject|0|||
130363063|NCT02639546|469299602|FG005|Overall Study|Withdrawal by Subject|1|||
130363064|NCT02639546|469299603|FG006|Overall Study|Withdrawal by Subject|2|||
130363065|NCT02639546|469299604|FG007|Overall Study|Withdrawal by Subject|1|||
130363066|NCT00113087|469299605|FG000|Overall Study|Death or Transplant|14|||
130363067|NCT00113087|469299606|FG001|Overall Study|Death or Transplant|16|||
130363068|NCT00113087|469299605|FG000|Overall Study|Family or MD withdrew subject|10|||
130363069|NCT00113087|469299606|FG001|Overall Study|Family or MD withdrew subject|5|||
130363070|NCT02215096|469299607|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
130363071|NCT02215096|469299608|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
130363072|NCT02215096|469299609|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
130363073|NCT02215096|469299610|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
130363074|NCT02215096|469299611|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
130363075|NCT02215096|469299607|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130363076|NCT02215096|469299608|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130363077|NCT02215096|469299609|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130363078|NCT02215096|469299610|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130363079|NCT02215096|469299611|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
130363080|NCT02215096|469299607|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130363081|NCT02215096|469299608|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130363082|NCT02215096|469299609|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130363083|NCT02215096|469299610|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
130363084|NCT02215096|469299611|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130363085|NCT02215096|469299607|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
130363086|NCT02215096|469299608|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
130363087|NCT02215096|469299609|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
130363088|NCT02215096|469299610|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
130363089|NCT02215096|469299611|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
130363090|NCT02840721|469299612|FG000|Treatment Period|Adverse Event|1|||
130363091|NCT02840721|469299612|FG000|Follow-Up|Lack of Efficacy|1|||
130363092|NCT02840721|469299612|FG000|Follow-Up|Withdrawal by Subject|4|||
130363093|NCT02840721|469299612|FG000|Follow-Up|Withdrawal of Consent|2|||
130363094|NCT00423514|469299614|FG000|Overall Study|Ineligible|1|||
130363095|NCT00423514|469299615|FG001|Overall Study|Ineligible|0|||
130363096|NCT03685123|469299616|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
130698336|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
130698337|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
130698338|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
130698339|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130698340|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130698341|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
130698342|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
130698343|NCT02259348|470520794|FG000|Overall Study|Donors|6|||
130698344|NCT02259348|470520794|FG000|Overall Study|Death|4|||
130698345|NCT04211766|470520795|FG000|Overall Study|Withdrawal by Subject|5|||
130698346|NCT04211766|470520796|FG001|Overall Study|Withdrawal by Subject|1|||
130698347|NCT04590781|470520798|FG000|Overall Study|Death|0|||
130698348|NCT04590781|470520799|FG001|Overall Study|Death|2|||
130698349|NCT04590781|470520798|FG000|Overall Study|Withdrawal by Subject|2|||
130698350|NCT04590781|470520799|FG001|Overall Study|Withdrawal by Subject|0|||
130698351|NCT01680016|470520802|FG000|Overall Study|Adverse Event|0|||
130698352|NCT01680016|470520803|FG001|Overall Study|Adverse Event|0|||
130698353|NCT01680016|470520804|FG002|Overall Study|Adverse Event|1|||
130698354|NCT01680016|470520805|FG003|Overall Study|Adverse Event|4|||
130698355|NCT01680016|470520802|FG000|Overall Study|The Subject went out of The Trial|1|||
130363097|NCT03685123|469299617|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
130698356|NCT01680016|470520803|FG001|Overall Study|The Subject went out of The Trial|0|||
130363098|NCT03685123|469299618|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
130450879|NCT01579578|469614570|FG001|Overall Study|Death|1|||
130450880|NCT01579578|469614569|FG000|Overall Study|Lost to Follow-up|1|||
130698357|NCT01680016|470520804|FG002|Overall Study|The Subject went out of The Trial|3|||
130698358|NCT01680016|470520805|FG003|Overall Study|The Subject went out of The Trial|0|||
130244345|NCT03422718|468855172|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
130244346|NCT03422718|468855173|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
130244347|NCT03422718|468855174|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
130244348|NCT03422718|468855175|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
130244349|NCT03422718|468855176|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
130244350|NCT03422718|468855177|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
130244351|NCT03422718|468855178|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
130244352|NCT03422718|468855179|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
130244353|NCT03422718|468855172|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130244354|NCT03422718|468855173|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
130244355|NCT03422718|468855174|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
130244356|NCT03422718|468855175|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
130698359|NCT01680016|470520802|FG000|Overall Study|Protocol Violation|0|||
130698360|NCT01680016|470520803|FG001|Overall Study|Protocol Violation|1|||
130698361|NCT01680016|470520804|FG002|Overall Study|Protocol Violation|0|||
130698362|NCT01680016|470520805|FG003|Overall Study|Protocol Violation|0|||
130698363|NCT01680016|470520802|FG000|Overall Study|Withdrawal by Subject|5|||
130698364|NCT01680016|470520803|FG001|Overall Study|Withdrawal by Subject|7|||
130698365|NCT01680016|470520804|FG002|Overall Study|Withdrawal by Subject|1|||
130698366|NCT01680016|470520805|FG003|Overall Study|Withdrawal by Subject|1|||
130698367|NCT03686215|470520806|FG000|Overall Study|Adverse Event|0|||
130698368|NCT03686215|470520807|FG001|Overall Study|Adverse Event|0|||
130698369|NCT03686215|470520808|FG002|Overall Study|Adverse Event|7|||
130698370|NCT03686215|470520806|FG000|Overall Study|Physician Decision|0|||
130698371|NCT03686215|470520807|FG001|Overall Study|Physician Decision|0|||
130698372|NCT03686215|470520808|FG002|Overall Study|Physician Decision|1|||
130698373|NCT03686215|470520806|FG000|Overall Study|Protocol Violation|0|||
130698374|NCT03686215|470520807|FG001|Overall Study|Protocol Violation|0|||
130698375|NCT03686215|470520808|FG002|Overall Study|Protocol Violation|4|||
130698376|NCT03686215|470520806|FG000|Overall Study|Device issue|1|||
130698377|NCT03686215|470520807|FG001|Overall Study|Device issue|0|||
130698378|NCT03686215|470520808|FG002|Overall Study|Device issue|2|||
130698379|NCT02485158|470520811|FG000|Overall Study|Withdrawal by Subject|3|||
130698380|NCT02485158|470520811|FG000|Overall Study|expected drug side effect|1|||
130698381|NCT02846883|470520812|FG000|Overall Study|Death|0|||
130698382|NCT02846883|470520813|FG001|Overall Study|Death|1|||
130698383|NCT02846883|470520814|FG002|Overall Study|Death|1|||
130698384|NCT02846883|470520812|FG000|Overall Study|Lost to Follow-up|0|||
130698385|NCT02846883|470520813|FG001|Overall Study|Lost to Follow-up|0|||
130698386|NCT02846883|470520814|FG002|Overall Study|Lost to Follow-up|1|||
130698387|NCT02846883|470520812|FG000|Overall Study|Withdrawal by Subject|1|||
130698388|NCT02846883|470520813|FG001|Overall Study|Withdrawal by Subject|0|||
130698389|NCT02846883|470520814|FG002|Overall Study|Withdrawal by Subject|0|||
130698390|NCT02846883|470520812|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
130698391|NCT02846883|470520813|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130698392|NCT02846883|470520814|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130698393|NCT02846883|470520812|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130698394|NCT02846883|470520813|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130698395|NCT02846883|470520814|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
130698396|NCT01098851|470520817|FG000|Overall Study|Equipment failure|1|||
130698397|NCT01098851|470520818|FG001|Overall Study|Equipment failure|0|||
130698398|NCT00927251|470520819|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
130698399|NCT01813435|470520827|FG000|Overall Study|did not finish experimental regimen|1902|||
130698400|NCT01813435|470520828|FG001|Overall Study|did not finish experimental regimen|770|||
130698401|NCT01813435|470520827|FG000|Overall Study|Lost to Follow-up|268|||
130698402|NCT01813435|470520828|FG001|Overall Study|Lost to Follow-up|237|||
130698403|NCT03035890|470520829|FG000|Overall Study|Death|1|||
130698404|NCT00452348|470520831|FG000|Overall Study|Adverse Event|6|||
130698405|NCT00452348|470520832|FG001|Overall Study|Adverse Event|9|||
130698406|NCT00452348|470520831|FG000|Overall Study|Lack of Efficacy|10|||
130698407|NCT00452348|470520832|FG001|Overall Study|Lack of Efficacy|9|||
130698408|NCT00452348|470520831|FG000|Overall Study|Lost to Follow-up|14|||
130698409|NCT00452348|470520832|FG001|Overall Study|Lost to Follow-up|8|||
130698410|NCT00452348|470520831|FG000|Overall Study|Protocol Violation|22|||
130698411|NCT00452348|470520832|FG001|Overall Study|Protocol Violation|28|||
130698412|NCT00452348|470520831|FG000|Overall Study|Withdrawal by Subject|18|||
130698413|NCT00452348|470520832|FG001|Overall Study|Withdrawal by Subject|21|||
130244357|NCT03422718|468855176|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
130698414|NCT00452348|470520831|FG000|Overall Study|Other|9|||
130698415|NCT00452348|470520832|FG001|Overall Study|Other|9|||
130698416|NCT01490190|470520833|FG000|Overall Study|Withdrawal by Subject|9|||
130698417|NCT01490190|470520833|FG000|Overall Study|Adverse Event|17|||
130698418|NCT01490190|470520833|FG000|Overall Study|Protocol Violation|5|||
130698419|NCT01490190|470520833|FG000|Overall Study|Lost to Follow-up|13|||
130450881|NCT01579578|469614570|FG001|Overall Study|Lost to Follow-up|1|||
130450882|NCT01579578|469614569|FG000|Overall Study|Withdrawal by Subject|2|||
130450883|NCT01579578|469614570|FG001|Overall Study|Withdrawal by Subject|1|||
130450884|NCT01579578|469614569|FG000|Overall Study|Eligibility criteria|3|||
130450885|NCT01579578|469614570|FG001|Overall Study|Eligibility criteria|9|||
130450886|NCT01579578|469614569|FG000|Overall Study|Ongoing|3|||
130450887|NCT01579578|469614570|FG001|Overall Study|Ongoing|0|||
130450888|NCT01528709|469614571|FG000|Overall Study|Death|2|||
130450889|NCT01528709|469614572|FG001|Overall Study|Death|0|||
130450890|NCT01528709|469614571|FG000|Overall Study|Withdrawal by Subject|10|||
130450891|NCT01528709|469614572|FG001|Overall Study|Withdrawal by Subject|15|||
130450892|NCT01528709|469614571|FG000|Overall Study|allergy|1|||
130450893|NCT01528709|469614572|FG001|Overall Study|allergy|0|||
130450894|NCT05124899|469614576|FG000|Overall Study|Lost to Follow-up|3|||
130450895|NCT00647348|469614584|FG000|Overall Study|Lost to Follow-up|3|||
130450896|NCT00647348|469614585|FG001|Overall Study|Lost to Follow-up|6|||
130450897|NCT01653743|469614593|FG000|Overall Study|Withdrawal by Subject|1|||
130450898|NCT01653743|469614594|FG001|Overall Study|Withdrawal by Subject|0|||
130450899|NCT01653743|469614593|FG000|Overall Study|Investigator discretion|3|||
130450900|NCT01653743|469614594|FG001|Overall Study|Investigator discretion|0|||
130450901|NCT04889118|469614595|FG000|Overall Study|Death|33|||
130450902|NCT04889118|469614596|FG001|Overall Study|Death|37|||
130450903|NCT04889118|469614595|FG000|Overall Study|Ongoing in Study|31|||
130450904|NCT04889118|469614596|FG001|Overall Study|Ongoing in Study|30|||
130450905|NCT01582243|469614603|FG000|Overall Study|Withdrawal by Subject|1|||
130450906|NCT01582243|469614603|FG000|Overall Study|Adverse Event|1|||
130450907|NCT01582243|469614603|FG000|Overall Study|Lost to Follow-up|1|||
130450908|NCT02397889|469614605|FG000|Overall Study|Physician Decision|1|||
130450909|NCT02397889|469614606|FG001|Overall Study|Physician Decision|0|||
130450910|NCT00797225|469614618|FG000|Weeks 1 to 12|Adverse Event|0|||
130450911|NCT00797225|469614619|FG001|Weeks 1 to 12|Adverse Event|0|||
130698420|NCT01490190|470520833|FG000|Overall Study|Relocation|1|||
130698421|NCT01490190|470520833|FG000|Overall Study|Inconvenience|1|||
130698422|NCT01490190|470520833|FG000|Overall Study|Ring expulsion|2|||
130450912|NCT00797225|469614620|FG002|Weeks 1 to 12|Adverse Event|1|||
130450913|NCT00797225|469614621|FG003|Weeks 1 to 12|Adverse Event|0|||
130450914|NCT00797225|469614622|FG004|Weeks 1 to 12|Adverse Event|0|||
130450915|NCT00797225|469614623|FG005|Weeks 1 to 12|Adverse Event|0|||
130450916|NCT00797225|469614624|FG006|Weeks 1 to 12|Adverse Event|0|||
130450917|NCT00797225|469614625|FG007|Weeks 1 to 12|Adverse Event|0|||
130450918|NCT00797225|469614618|FG000|Weeks 1 to 12|Non-compliance|0|||
130450919|NCT00797225|469614619|FG001|Weeks 1 to 12|Non-compliance|1|||
130450920|NCT00797225|469614620|FG002|Weeks 1 to 12|Non-compliance|0|||
130450921|NCT00797225|469614621|FG003|Weeks 1 to 12|Non-compliance|0|||
130450922|NCT00797225|469614622|FG004|Weeks 1 to 12|Non-compliance|0|||
130450923|NCT00797225|469614623|FG005|Weeks 1 to 12|Non-compliance|0|||
130450924|NCT00797225|469614624|FG006|Weeks 1 to 12|Non-compliance|0|||
130450925|NCT00797225|469614625|FG007|Weeks 1 to 12|Non-compliance|0|||
130450926|NCT00797225|469614618|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
130450927|NCT00797225|469614619|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
130450928|NCT00797225|469614620|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
130450929|NCT00797225|469614621|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
130450930|NCT00797225|469614622|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
130450931|NCT00797225|469614623|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
130450932|NCT00797225|469614624|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
130450933|NCT00797225|469614625|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
130450934|NCT00797225|469614618|FG000|Weeks 1 to 12|Sponsor Decision|1|||
130698423|NCT00960154|470520839|FG000|Overall Study|Study termination|25|||
130698424|NCT00960154|470520840|FG001|Overall Study|Study termination|25|||
130450935|NCT00797225|469614619|FG001|Weeks 1 to 12|Sponsor Decision|0|||
130450936|NCT00797225|469614620|FG002|Weeks 1 to 12|Sponsor Decision|0|||
130698425|NCT00377156|470520841|FG000|Overall Study|Death|23|||
130698426|NCT00377156|470520842|FG001|Overall Study|Death|19|||
130698427|NCT00377156|470520841|FG000|Overall Study|Withdrawal by Subject|16|||
130450937|NCT00797225|469614621|FG003|Weeks 1 to 12|Sponsor Decision|0|||
130450938|NCT00797225|469614622|FG004|Weeks 1 to 12|Sponsor Decision|0|||
130450939|NCT00797225|469614623|FG005|Weeks 1 to 12|Sponsor Decision|0|||
130698428|NCT00377156|470520842|FG001|Overall Study|Withdrawal by Subject|24|||
130450940|NCT00797225|469614624|FG006|Weeks 1 to 12|Sponsor Decision|0|||
130450941|NCT00797225|469614625|FG007|Weeks 1 to 12|Sponsor Decision|0|||
130450942|NCT00797225|469614618|FG000|Weeks 13 to 24|Non-compliance|0|||
130450943|NCT00797225|469614619|FG001|Weeks 13 to 24|Non-compliance|2|||
130450944|NCT00797225|469614620|FG002|Weeks 13 to 24|Non-compliance|0|||
130450945|NCT00797225|469614621|FG003|Weeks 13 to 24|Non-compliance|0|||
130450946|NCT00797225|469614622|FG004|Weeks 13 to 24|Non-compliance|0|||
130450947|NCT00797225|469614623|FG005|Weeks 13 to 24|Non-compliance|0|||
130450948|NCT00797225|469614624|FG006|Weeks 13 to 24|Non-compliance|0|||
130450949|NCT00797225|469614625|FG007|Weeks 13 to 24|Non-compliance|0|||
130450950|NCT00797225|469614618|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
130450951|NCT00797225|469614619|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
130698429|NCT00377156|470520841|FG000|Overall Study|Had follow-up <90 d|3|||
130698430|NCT00377156|470520842|FG001|Overall Study|Had follow-up <90 d|6|||
130698431|NCT00377156|470520841|FG000|Overall Study|Cancellation|1|||
130698432|NCT00377156|470520842|FG001|Overall Study|Cancellation|0|||
130698433|NCT00377156|470520841|FG000|Overall Study|Refused testing|0|||
130698434|NCT00377156|470520842|FG001|Overall Study|Refused testing|1|||
130698435|NCT00377156|470520841|FG000|Overall Study|Ineligible|0|||
130698436|NCT00377156|470520842|FG001|Overall Study|Ineligible|1|||
130698437|NCT00377156|470520841|FG000|Overall Study|Disability or language problem|0|||
130698438|NCT00377156|470520842|FG001|Overall Study|Disability or language problem|1|||
130698439|NCT00377156|470520841|FG000|Overall Study|Other|5|||
130698440|NCT00377156|470520842|FG001|Overall Study|Other|2|||
130698441|NCT00856349|470520843|FG000|Overall Study|Death|418|||
130698442|NCT00856349|470520843|FG000|Overall Study|Withdrawal by Subject|116|||
130698443|NCT00856349|470520843|FG000|Overall Study|Lost to Follow-up|91|||
130698444|NCT00856349|470520843|FG000|Overall Study|Protocol Violation|38|||
130698445|NCT00856349|470520843|FG000|Overall Study|Physician Decision|13|||
130698446|NCT00856349|470520843|FG000|Overall Study|Subject relocation|104|||
130698447|NCT00856349|470520843|FG000|Overall Study|Device explant|33|||
130698448|NCT00856349|470520843|FG000|Overall Study|Site closure|78|||
130698449|NCT00856349|470520843|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
130698450|NCT02725515|470520844|FG000|Overall Study|Refused infusion (no study treatment)|1|||
130698451|NCT02725515|470520845|FG001|Overall Study|Refused infusion (no study treatment)|0|||
130698452|NCT02725515|470520844|FG000|Overall Study|Loss of Improvement per Protocol|14|||
130698453|NCT02725515|470520845|FG001|Overall Study|Loss of Improvement per Protocol|25|||
130698454|NCT02725515|470520844|FG000|Overall Study|Withdrawal by Subject|2|||
130698455|NCT02725515|470520845|FG001|Overall Study|Withdrawal by Subject|1|||
130698456|NCT02725515|470520844|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130698457|NCT02725515|470520845|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130698458|NCT02725515|470520844|FG000|Overall Study|Lost to Follow-up|1|||
130698459|NCT02725515|470520845|FG001|Overall Study|Lost to Follow-up|1|||
130698460|NCT02725515|470520844|FG000|Overall Study|Adverse Event|7|||
130698461|NCT02725515|470520845|FG001|Overall Study|Adverse Event|2|||
130698462|NCT02725515|470520844|FG000|Overall Study|No Documented Disease Improvement|0|||
130698463|NCT02725515|470520845|FG001|Overall Study|No Documented Disease Improvement|1|||
130698464|NCT02725515|470520844|FG000|Overall Study|Completed Study Under Original Protocol|0|||
130698465|NCT02725515|470520845|FG001|Overall Study|Completed Study Under Original Protocol|1|||
130698466|NCT02725515|470520844|FG000|Overall Study|Lack of Response|0|||
130698467|NCT02725515|470520845|FG001|Overall Study|Lack of Response|1|||
130698468|NCT00874549|470520846|FG000|Overall Study|Adverse Event|0|||
130698469|NCT00874549|470520847|FG001|Overall Study|Adverse Event|0|||
130698470|NCT00874549|470520848|FG002|Overall Study|Adverse Event|1|||
130698471|NCT00874549|470520849|FG003|Overall Study|Adverse Event|0|||
130698472|NCT00874549|470520846|FG000|Overall Study|Protocol Violation|1|||
130698473|NCT00874549|470520847|FG001|Overall Study|Protocol Violation|0|||
130698474|NCT00874549|470520848|FG002|Overall Study|Protocol Violation|2|||
130698475|NCT00874549|470520849|FG003|Overall Study|Protocol Violation|1|||
130698476|NCT00874549|470520846|FG000|Overall Study|Lost to Follow-up|0|||
130698477|NCT00874549|470520847|FG001|Overall Study|Lost to Follow-up|0|||
130698478|NCT00874549|470520848|FG002|Overall Study|Lost to Follow-up|1|||
130698479|NCT00874549|470520849|FG003|Overall Study|Lost to Follow-up|0|||
130698480|NCT00874549|470520846|FG000|Overall Study|Withdrawal by Subject|0|||
130363099|NCT03685123|469299616|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
130363100|NCT03685123|469299617|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
130363101|NCT03685123|469299618|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
130363102|NCT03685123|469299616|FG000|Weight Loss Phase|Lost to Follow-up|1|||
130363103|NCT03685123|469299617|FG001|Weight Loss Phase|Lost to Follow-up|0|||
130363104|NCT03685123|469299618|FG002|Weight Loss Phase|Lost to Follow-up|0|||
130363105|NCT03685123|469299616|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
130363106|NCT03685123|469299617|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
130363107|NCT03685123|469299618|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
130363108|NCT03685123|469299616|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
130363109|NCT03685123|469299617|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
130363110|NCT03685123|469299618|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
130363111|NCT03685123|469299616|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
130363112|NCT03685123|469299617|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
130363113|NCT03685123|469299618|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
130363114|NCT00400764|469299619|FG000|Phase Ib|Adverse Event|1|||
130698481|NCT00874549|470520847|FG001|Overall Study|Withdrawal by Subject|1|||
130363115|NCT00400764|469299620|FG001|Phase Ib|Adverse Event|0|||
130363116|NCT00400764|469299621|FG002|Phase Ib|Adverse Event|0|||
130363117|NCT00400764|469299622|FG003|Phase Ib|Adverse Event|0|||
130698482|NCT00874549|470520848|FG002|Overall Study|Withdrawal by Subject|0|||
130698483|NCT00874549|470520849|FG003|Overall Study|Withdrawal by Subject|1|||
130698484|NCT00517192|470520856|FG000|Overall Study|Adverse Event|1|||
130698485|NCT00517192|470520857|FG001|Overall Study|Adverse Event|1|||
130698486|NCT00517192|470520856|FG000|Overall Study|Lost to Follow-up|1|||
130450952|NCT00797225|469614620|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
130698487|NCT00517192|470520857|FG001|Overall Study|Lost to Follow-up|1|||
130698488|NCT00517192|470520856|FG000|Overall Study|Withdrawal by Subject|1|||
130698489|NCT00517192|470520857|FG001|Overall Study|Withdrawal by Subject|0|||
130698490|NCT00517192|470520856|FG000|Overall Study|Early termination of the trial|16|||
130698491|NCT00517192|470520857|FG001|Overall Study|Early termination of the trial|18|||
130698492|NCT02733627|470520859|FG000|Overall Study|Adverse Event|0|||
130698493|NCT02733627|470520860|FG001|Overall Study|Adverse Event|1|||
130698494|NCT02733627|470520861|FG002|Overall Study|Adverse Event|1|||
130698495|NCT02733627|470520862|FG003|Overall Study|Adverse Event|0|||
130698496|NCT02733627|470520859|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698497|NCT02733627|470520860|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698498|NCT02733627|470520861|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
130698499|NCT02733627|470520862|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698500|NCT00183196|470520863|FG000|Overall Study|Withdrawal by Subject|18|||
130698501|NCT00183196|470520864|FG001|Overall Study|Withdrawal by Subject|11|||
130698502|NCT00183196|470520865|FG002|Overall Study|Withdrawal by Subject|13|||
130698503|NCT00183196|470520863|FG000|Overall Study|Adverse Event|1|||
130698504|NCT00183196|470520864|FG001|Overall Study|Adverse Event|2|||
130698505|NCT00183196|470520865|FG002|Overall Study|Adverse Event|2|||
130698506|NCT00183196|470520863|FG000|Overall Study|Legal event|1|||
130698507|NCT00183196|470520864|FG001|Overall Study|Legal event|1|||
130698508|NCT00183196|470520865|FG002|Overall Study|Legal event|1|||
130698509|NCT00183196|470520863|FG000|Overall Study|Required more intensive care|0|||
130698510|NCT00183196|470520864|FG001|Overall Study|Required more intensive care|1|||
130698511|NCT00183196|470520865|FG002|Overall Study|Required more intensive care|2|||
130698512|NCT01513239|470520866|FG000|Period 1: Main Phase|Adverse Event|1|||
130698513|NCT01513239|470520867|FG001|Period 1: Main Phase|Adverse Event|1|||
130698514|NCT01513239|470520868|FG002|Period 1: Main Phase|Adverse Event|2|||
130698515|NCT01513239|470520869|FG003|Period 1: Main Phase|Adverse Event|0|||
130698516|NCT01513239|470520870|FG004|Period 1: Main Phase|Adverse Event|0|||
130698517|NCT01513239|470520871|FG005|Period 1: Main Phase|Adverse Event|0|||
130698518|NCT01513239|470520866|FG000|Period 1: Main Phase|Death|29|||
130698519|NCT01513239|470520867|FG001|Period 1: Main Phase|Death|22|||
130698520|NCT01513239|470520868|FG002|Period 1: Main Phase|Death|32|||
130698521|NCT01513239|470520869|FG003|Period 1: Main Phase|Death|0|||
130698522|NCT01513239|470520870|FG004|Period 1: Main Phase|Death|0|||
130698523|NCT01513239|470520871|FG005|Period 1: Main Phase|Death|0|||
130698524|NCT01513239|470520866|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
130698525|NCT01513239|470520867|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
130698526|NCT01513239|470520868|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
130698527|NCT01513239|470520869|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
130698528|NCT01513239|470520870|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
130698529|NCT01513239|470520871|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
130698530|NCT01513239|470520866|FG000|Period 1: Main Phase|Physician Decision|4|||
130698531|NCT01513239|470520867|FG001|Period 1: Main Phase|Physician Decision|4|||
130698532|NCT01513239|470520868|FG002|Period 1: Main Phase|Physician Decision|4|||
130698533|NCT01513239|470520869|FG003|Period 1: Main Phase|Physician Decision|0|||
130698534|NCT01513239|470520870|FG004|Period 1: Main Phase|Physician Decision|0|||
130698535|NCT01513239|470520871|FG005|Period 1: Main Phase|Physician Decision|0|||
130698536|NCT01513239|470520866|FG000|Period 1: Main Phase|Protocol Violation|2|||
130698537|NCT01513239|470520867|FG001|Period 1: Main Phase|Protocol Violation|2|||
130698538|NCT01513239|470520868|FG002|Period 1: Main Phase|Protocol Violation|2|||
130698539|NCT01513239|470520869|FG003|Period 1: Main Phase|Protocol Violation|0|||
130698540|NCT01513239|470520870|FG004|Period 1: Main Phase|Protocol Violation|0|||
130698541|NCT01513239|470520871|FG005|Period 1: Main Phase|Protocol Violation|0|||
130698542|NCT01513239|470520866|FG000|Period 1: Main Phase|Technical Problems|1|||
130698543|NCT01513239|470520867|FG001|Period 1: Main Phase|Technical Problems|2|||
130698544|NCT01513239|470520868|FG002|Period 1: Main Phase|Technical Problems|0|||
130698545|NCT01513239|470520869|FG003|Period 1: Main Phase|Technical Problems|0|||
130698546|NCT01513239|470520870|FG004|Period 1: Main Phase|Technical Problems|0|||
130698547|NCT01513239|470520871|FG005|Period 1: Main Phase|Technical Problems|0|||
130698548|NCT01513239|470520866|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
130450953|NCT00797225|469614621|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
130450954|NCT00797225|469614622|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
130450955|NCT00797225|469614623|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
130698549|NCT01513239|470520867|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
130698550|NCT01513239|470520868|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
130698551|NCT01513239|470520869|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
130698552|NCT01513239|470520870|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
130450956|NCT00797225|469614624|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
130450957|NCT00797225|469614625|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
130698553|NCT01513239|470520871|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
130698554|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698555|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698556|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698557|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
130698558|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
130698559|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
130698560|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Death|0|||
130698561|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Death|0|||
130698562|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Death|0|||
130698563|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Death|2|||
130698564|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Death|5|||
130698565|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Death|2|||
130698566|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698567|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698568|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698569|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
130698570|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
130698571|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698572|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698573|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698574|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698575|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
130698576|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698577|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698578|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698579|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698580|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698581|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698582|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130698583|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130698584|NCT03167606|470520874|FG000|Overall Study|Lost to Follow-up|73|||
130698585|NCT03167606|470520875|FG001|Overall Study|Lost to Follow-up|64|||
130698586|NCT03167606|470520874|FG000|Overall Study|Withdrawal by Subject|6|||
130698587|NCT03167606|470520875|FG001|Overall Study|Withdrawal by Subject|5|||
130698588|NCT03167606|470520874|FG000|Overall Study|Withdrawal by Investigator|0|||
130698589|NCT03167606|470520875|FG001|Overall Study|Withdrawal by Investigator|2|||
130698590|NCT00059332|470520876|FG000|Overall Study|Withdrawal by Subject|2|||
130698591|NCT00059332|470520877|FG001|Overall Study|Withdrawal by Subject|1|||
130698592|NCT00059332|470520876|FG000|Overall Study|Lost to Follow-up|1|||
130698593|NCT00059332|470520877|FG001|Overall Study|Lost to Follow-up|1|||
130698594|NCT00413049|470520879|FG000|Overall Study|Adverse Event|10|||
130698595|NCT00413049|470520880|FG001|Overall Study|Adverse Event|8|||
130698596|NCT00413049|470520879|FG000|Overall Study|Withdrawal by Subject|7|||
130698597|NCT00413049|470520880|FG001|Overall Study|Withdrawal by Subject|5|||
130698598|NCT00413049|470520879|FG000|Overall Study|Lost to Follow-up|2|||
130698599|NCT00413049|470520880|FG001|Overall Study|Lost to Follow-up|3|||
130698600|NCT00413049|470520879|FG000|Overall Study|Protocol Violation|3|||
130698601|NCT00413049|470520880|FG001|Overall Study|Protocol Violation|1|||
130698602|NCT00413049|470520879|FG000|Overall Study|Subject no longer requires study drug|0|||
130698603|NCT00413049|470520880|FG001|Overall Study|Subject no longer requires study drug|1|||
130698604|NCT00413049|470520879|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130698605|NCT00413049|470520880|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130698606|NCT00413049|470520879|FG000|Overall Study|Lack of Efficacy|1|||
130698607|NCT00413049|470520880|FG001|Overall Study|Lack of Efficacy|0|||
130698608|NCT01460628|470520881|FG000|Overall Study|Adverse Event|3|||
130698609|NCT01460628|470520881|FG000|Overall Study|Withdrawal by Subject|2|||
130698610|NCT02587143|470520882|FG000|Overall Study|Adverse Event|1|||
130698611|NCT02587143|470520883|FG001|Overall Study|Adverse Event|0|||
130698612|NCT03314857|470520886|FG000|Overall Study|Death|4|||
130698613|NCT03314857|470520886|FG000|Overall Study|Physician Decision|1|||
130698614|NCT01119625|470520887|FG000|Overall Study|Lost to Follow-up|1|||
130698615|NCT01119625|470520888|FG001|Overall Study|Lost to Follow-up|2|||
130698616|NCT01119625|470520887|FG000|Overall Study|Withdrawal by Subject|2|||
130698617|NCT01119625|470520888|FG001|Overall Study|Withdrawal by Subject|1|||
130698618|NCT01119625|470520887|FG000|Overall Study|Other|0|||
130698619|NCT01119625|470520888|FG001|Overall Study|Other|1|||
130698620|NCT01721772|470520895|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
130698621|NCT01721772|470520896|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
130698622|NCT01721772|470520895|FG000|Pre-Treatment|Poor/non-compliance|0|||
130698623|NCT01721772|470520896|FG001|Pre-Treatment|Poor/non-compliance|1|||
130698624|NCT01721772|470520895|FG000|Pre-Treatment|Participant withdrew consent|0|||
130698625|NCT01721772|470520896|FG001|Pre-Treatment|Participant withdrew consent|1|||
130698626|NCT01721772|470520895|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130698627|NCT01721772|470520896|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130698628|NCT01721772|470520895|FG000|Treatment|Disease progression|119|||
130698629|NCT01721772|470520896|FG001|Treatment|Disease progression|168|||
130698630|NCT01721772|470520895|FG000|Treatment|Study drug toxicity|19|||
130698631|NCT01721772|470520896|FG001|Treatment|Study drug toxicity|10|||
130698632|NCT01721772|470520895|FG000|Treatment|Adverse event unrelated to study drug|7|||
130698633|NCT01721772|470520896|FG001|Treatment|Adverse event unrelated to study drug|7|||
130698634|NCT01721772|470520895|FG000|Treatment|Maximum clinical benefit|16|||
130698635|NCT01721772|470520896|FG001|Treatment|Maximum clinical benefit|4|||
130698636|NCT01721772|470520895|FG000|Treatment|Other|19|||
130698637|NCT01721772|470520896|FG001|Treatment|Other|2|||
130698638|NCT01721772|470520895|FG000|Treatment|Participant withdrew consent|2|||
130698639|NCT01721772|470520896|FG001|Treatment|Participant withdrew consent|5|||
130698640|NCT01721772|470520895|FG000|Treatment|Participant request to discontinue study treatment|21|||
130698641|NCT01721772|470520896|FG001|Treatment|Participant request to discontinue study treatment|8|||
130698642|NCT01721772|470520895|FG000|Treatment|Death|1|||
130698643|NCT01721772|470520896|FG001|Treatment|Death|0|||
130698644|NCT01721772|470520895|FG000|Treatment|Not reported|1|||
130698645|NCT01721772|470520896|FG001|Treatment|Not reported|0|||
130698646|NCT01721772|470520895|FG000|Treatment|Poor/non-compliance|1|||
130698647|NCT01721772|470520896|FG001|Treatment|Poor/non-compliance|0|||
130698648|NCT01721772|470520895|FG000|Treatment|Lost to Follow-up|0|||
130698649|NCT01721772|470520896|FG001|Treatment|Lost to Follow-up|1|||
130698650|NCT00397254|470520904|FG000|Overall Study|Lost to Follow-up|2|||
130698651|NCT00397254|470520905|FG001|Overall Study|Lost to Follow-up|2|||
130698652|NCT02340780|470520906|FG000|Overall Study|Ineligible|1|||
130698653|NCT02637141|470520908|FG000|Overall Study|Adverse Event|1|||
130698654|NCT02637141|470520909|FG001|Overall Study|Adverse Event|1|||
130698655|NCT02637141|470520910|FG002|Overall Study|Adverse Event|0|||
130698656|NCT02637141|470520908|FG000|Overall Study|Withdrawal by Subject|1|||
130698657|NCT02637141|470520909|FG001|Overall Study|Withdrawal by Subject|1|||
130698658|NCT02637141|470520910|FG002|Overall Study|Withdrawal by Subject|1|||
130698659|NCT03885934|470520915|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130698660|NCT03885934|470520916|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
130698661|NCT03885934|470520917|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130698662|NCT03885934|470520918|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
130698663|NCT03885934|470520919|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
130698664|NCT03885934|470520920|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
130698665|NCT04473326|470520925|FG000|Overall Study|Death|0|||
130698666|NCT04473326|470520926|FG001|Overall Study|Death|1|||
130698667|NCT04473326|470520925|FG000|Overall Study|Withdrawal by Subject|1|||
130698668|NCT04473326|470520926|FG001|Overall Study|Withdrawal by Subject|2|||
130698669|NCT02046122|470520927|FG000|Overall Study|Physician Decision|8|||
130698670|NCT02046122|470520927|FG000|Overall Study|Withdrawal by Subject|1|||
130698671|NCT01559116|470520928|FG000|Overall Study|Adverse Event|10|||
130698672|NCT01559116|470520928|FG000|Overall Study|Lack of Efficacy|1|||
130698673|NCT01559116|470520928|FG000|Overall Study|Lost to Follow-up|1|||
130698674|NCT01559116|470520928|FG000|Overall Study|Protocol Violation|1|||
130698675|NCT01559116|470520928|FG000|Overall Study|Withdrawal by Subject|4|||
130698676|NCT01559116|470520928|FG000|Overall Study|other than stated above|9|||
130698677|NCT01532908|470520929|FG000|Overall Study|Not Transplanted|1|||
130698678|NCT01532908|470520930|FG001|Overall Study|Not Transplanted|0|||
130698679|NCT00021541|470520931|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
130698680|NCT00021541|470520932|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
130698681|NCT00021541|470520931|FG000|Period 1-First Treatment|Adverse Event|2|||
130698682|NCT00021541|470520932|FG001|Period 1-First Treatment|Adverse Event|1|||
130698683|NCT00021541|470520931|FG000|Period 1-First Treatment|non-adherence|3|||
130363118|NCT00400764|469299623|FG004|Phase Ib|Adverse Event|0|||
130363119|NCT00400764|469299619|FG000|Phase Ib|Death|1|||
130363120|NCT00400764|469299620|FG001|Phase Ib|Death|0|||
130363121|NCT00400764|469299621|FG002|Phase Ib|Death|0|||
130363122|NCT00400764|469299622|FG003|Phase Ib|Death|0|||
130363123|NCT00400764|469299623|FG004|Phase Ib|Death|0|||
130698684|NCT00021541|470520932|FG001|Period 1-First Treatment|non-adherence|0|||
130698685|NCT00021541|470520931|FG000|Period 1-First Treatment|Death|1|||
130698686|NCT00021541|470520932|FG001|Period 1-First Treatment|Death|0|||
130698687|NCT00021541|470520931|FG000|Period 1-First Treatment|Pts that did not progress|2|||
130698688|NCT00021541|470520932|FG001|Period 1-First Treatment|Pts that did not progress|2|||
130698689|NCT00021541|470520931|FG000|Period 1-First Treatment|Ineligible|0|||
130698690|NCT00021541|470520932|FG001|Period 1-First Treatment|Ineligible|2|||
130698691|NCT00021541|470520931|FG000|Period 2-crossover|refused phase B|2|||
130698692|NCT00021541|470520932|FG001|Period 2-crossover|refused phase B|2|||
130698693|NCT00021541|470520931|FG000|Period 2-crossover|Withdrawal by Subject|3|||
130698694|NCT00021541|470520932|FG001|Period 2-crossover|Withdrawal by Subject|4|||
130698695|NCT00021541|470520931|FG000|Period 2-crossover|Adverse Event|2|||
130698696|NCT00021541|470520932|FG001|Period 2-crossover|Adverse Event|2|||
130450958|NCT00797225|469614618|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
130450959|NCT00797225|469614619|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
130450960|NCT00797225|469614620|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
130450961|NCT00797225|469614621|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
130450962|NCT00797225|469614622|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
130450963|NCT00797225|469614623|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
130450964|NCT00797225|469614624|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
130450965|NCT00797225|469614625|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
130450966|NCT00797225|469614618|FG000|Weeks 13 to 24|Adverse Event|0|||
130450967|NCT00797225|469614619|FG001|Weeks 13 to 24|Adverse Event|1|||
130450968|NCT00797225|469614620|FG002|Weeks 13 to 24|Adverse Event|0|||
130450969|NCT00797225|469614621|FG003|Weeks 13 to 24|Adverse Event|0|||
130450970|NCT00797225|469614622|FG004|Weeks 13 to 24|Adverse Event|0|||
130450971|NCT00797225|469614623|FG005|Weeks 13 to 24|Adverse Event|0|||
130450972|NCT00797225|469614624|FG006|Weeks 13 to 24|Adverse Event|1|||
130450973|NCT00797225|469614625|FG007|Weeks 13 to 24|Adverse Event|0|||
130450974|NCT00797225|469614618|FG000|Weeks 13 to 24|Sponsor Decision|0|||
130698697|NCT00021541|470520931|FG000|Period 2-crossover|non-adherence|1|||
130698698|NCT00021541|470520932|FG001|Period 2-crossover|non-adherence|0|||
130698699|NCT00021541|470520931|FG000|Period 2-crossover|Pts that did not progress|2|||
130698700|NCT00021541|470520932|FG001|Period 2-crossover|Pts that did not progress|3|||
130450975|NCT00797225|469614619|FG001|Weeks 13 to 24|Sponsor Decision|0|||
130450976|NCT00797225|469614620|FG002|Weeks 13 to 24|Sponsor Decision|0|||
130450977|NCT00797225|469614621|FG003|Weeks 13 to 24|Sponsor Decision|0|||
130450978|NCT00797225|469614622|FG004|Weeks 13 to 24|Sponsor Decision|0|||
130450979|NCT00797225|469614623|FG005|Weeks 13 to 24|Sponsor Decision|0|||
130698701|NCT00826241|470520933|FG000|Overall Study|Withdrawal from Follow-up|1|||
130698702|NCT00826241|470520933|FG000|Overall Study|Withdrew consent|2|||
130698703|NCT00826241|470520933|FG000|Overall Study|Death|4|||
130698704|NCT00826241|470520933|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
130698705|NCT00826241|470520933|FG000|Overall Study|Non-compliance|1|||
130698706|NCT00826241|470520933|FG000|Overall Study|Progression of disease|1|||
130698707|NCT00826241|470520933|FG000|Overall Study|Patient refused follow-up|3|||
130698708|NCT00826241|470520933|FG000|Overall Study|Lost to Follow-up|9|||
130698709|NCT00826241|470520933|FG000|Overall Study|Could not obtain records|1|||
130698710|NCT00826241|470520933|FG000|Overall Study|Screen failure|2|||
130698711|NCT00826241|470520933|FG000|Overall Study|Pt unable to proceed to registration|1|||
130698712|NCT00826241|470520933|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
130698713|NCT01675596|470520936|FG000|Overall Study|Death|6|||
130698714|NCT01675596|470520936|FG000|Overall Study|Exit with other reason|1|||
130698715|NCT01675596|470520936|FG000|Overall Study|Missed Visit|1|||
130698716|NCT01539239|470520937|FG000|Overall Study|Death|5|||
130698717|NCT01539239|470520938|FG001|Overall Study|Death|5|||
130698718|NCT01539239|470520937|FG000|Overall Study|Lost to Follow-up|7|||
130698719|NCT01539239|470520938|FG001|Overall Study|Lost to Follow-up|12|||
130698720|NCT03201003|470520940|FG000|Overall Study|Adverse Event|14|||
130698721|NCT03201003|470520941|FG001|Overall Study|Adverse Event|1|||
130698722|NCT03201003|470520940|FG000|Overall Study|Other reasons|5|||
130698723|NCT03201003|470520941|FG001|Overall Study|Other reasons|1|||
130698724|NCT03201003|470520940|FG000|Overall Study|Withdrawal by Subject|4|||
130698725|NCT03201003|470520941|FG001|Overall Study|Withdrawal by Subject|1|||
130698726|NCT03201003|470520940|FG000|Overall Study|Lost to Follow-up|2|||
130698727|NCT03201003|470520941|FG001|Overall Study|Lost to Follow-up|0|||
130698728|NCT03201003|470520940|FG000|Overall Study|Protocol Violation|1|||
130698729|NCT03201003|470520941|FG001|Overall Study|Protocol Violation|0|||
130698730|NCT00834613|470520942|FG000|First Intervention|Protocol Violation|1|||
130698731|NCT00834613|470520943|FG001|First Intervention|Protocol Violation|0|||
130698732|NCT01751087|470520944|FG000|Overall Study|Withdrawal by Subject|1|||
130698733|NCT01751087|470520945|FG001|Overall Study|Withdrawal by Subject|0|||
130698734|NCT01751087|470520946|FG002|Overall Study|Withdrawal by Subject|0|||
130698735|NCT01751087|470520944|FG000|Overall Study|Physician Decision|0|||
130450980|NCT00797225|469614624|FG006|Weeks 13 to 24|Sponsor Decision|1|||
130450981|NCT00797225|469614625|FG007|Weeks 13 to 24|Sponsor Decision|0|||
130450982|NCT01352507|469614628|FG000|Treatment Period 1|Adverse Event|3|||
130450983|NCT01352507|469614629|FG001|Treatment Period 1|Adverse Event|0|||
130450984|NCT01352507|469614628|FG000|Treatment Period 1|Lost to Follow-up|3|||
130450985|NCT01352507|469614629|FG001|Treatment Period 1|Lost to Follow-up|4|||
130450986|NCT01352507|469614628|FG000|Treatment Period 1|Withdrawal by Subject|7|||
130450987|NCT01352507|469614629|FG001|Treatment Period 1|Withdrawal by Subject|5|||
130450988|NCT01352507|469614628|FG000|Treatment Period 1|Physician Decision|1|||
130450989|NCT01352507|469614629|FG001|Treatment Period 1|Physician Decision|0|||
130698736|NCT01751087|470520945|FG001|Overall Study|Physician Decision|0|||
130698737|NCT01751087|470520946|FG002|Overall Study|Physician Decision|1|||
130698738|NCT00697619|470520947|FG000|Overall Study|Lack of Efficacy|2|||
130698739|NCT00697619|470520948|FG001|Overall Study|Lack of Efficacy|2|||
130698740|NCT00697619|470520947|FG000|Overall Study|Adverse Event|4|||
130698741|NCT00697619|470520948|FG001|Overall Study|Adverse Event|6|||
130698742|NCT02005562|470522688|FG000|Overall Study|Death|2|||
130698743|NCT02005562|470522689|FG001|Overall Study|Death|2|||
130450990|NCT01352507|469614628|FG000|Washout Period|Withdrawal by Subject|0|||
130450991|NCT01352507|469614629|FG001|Washout Period|Withdrawal by Subject|1|||
130450992|NCT01352507|469614628|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
130450993|NCT01352507|469614629|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
130450994|NCT01352507|469614628|FG000|Treatment Period 2|Withdrawal by Subject|4|||
130450995|NCT01352507|469614629|FG001|Treatment Period 2|Withdrawal by Subject|3|||
130450996|NCT01352507|469614628|FG000|Treatment Period 2|Lack of Efficacy|1|||
130450997|NCT01352507|469614629|FG001|Treatment Period 2|Lack of Efficacy|0|||
130450998|NCT01119703|469614630|FG000|Overall Study|Adverse Event|0|||
130450999|NCT01119703|469614631|FG001|Overall Study|Adverse Event|1|||
130451000|NCT03178201|469614632|FG000|Overall Study|Off study|5|||
130451001|NCT03686384|469614633|FG000|Overall Study|Lack of Efficacy|4|||
130451002|NCT03686384|469614634|FG001|Overall Study|Lack of Efficacy|13|||
130451003|NCT03686384|469614633|FG000|Overall Study|Lost to Follow-up|3|||
130451004|NCT03686384|469614634|FG001|Overall Study|Lost to Follow-up|0|||
130451005|NCT03686384|469614633|FG000|Overall Study|Physician Decision|0|||
130451006|NCT03686384|469614634|FG001|Overall Study|Physician Decision|1|||
130451007|NCT03686384|469614633|FG000|Overall Study|Took prohibited medication|0|||
130451008|NCT03686384|469614634|FG001|Overall Study|Took prohibited medication|1|||
130451009|NCT02820051|469614635|FG000|Overall Study|Lost to Follow-up|7|||
130451010|NCT02820051|469614636|FG001|Overall Study|Lost to Follow-up|4|||
130451011|NCT01222247|469614637|FG000|Overall Study|Lost to Follow-up|2|||
130451012|NCT01222247|469614638|FG001|Overall Study|Lost to Follow-up|2|||
130451013|NCT04939428|469614639|FG000|Overall Study|Death|0|||
130451014|NCT04939428|469614640|FG001|Overall Study|Death|1|||
130451015|NCT04939428|469614641|FG002|Overall Study|Death|0|||
130451016|NCT04939428|469614639|FG000|Overall Study|Lost to Follow-up|0|||
130451017|NCT04939428|469614640|FG001|Overall Study|Lost to Follow-up|5|||
130451018|NCT04939428|469614641|FG002|Overall Study|Lost to Follow-up|0|||
130451019|NCT04939428|469614639|FG000|Overall Study|Physician Decision|1|||
130451020|NCT04939428|469614640|FG001|Overall Study|Physician Decision|0|||
130451021|NCT04939428|469614641|FG002|Overall Study|Physician Decision|0|||
130451022|NCT04939428|469614639|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130451023|NCT04939428|469614640|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130451024|NCT04939428|469614641|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130451025|NCT04939428|469614639|FG000|Overall Study|Withdrawal by Subject|10|||
130451026|NCT04939428|469614640|FG001|Overall Study|Withdrawal by Subject|11|||
130451027|NCT04939428|469614641|FG002|Overall Study|Withdrawal by Subject|0|||
130451028|NCT04939428|469614639|FG000|Overall Study|Unkown|6|||
130451029|NCT04939428|469614640|FG001|Overall Study|Unkown|3|||
130451030|NCT04939428|469614641|FG002|Overall Study|Unkown|0|||
130451031|NCT04939428|469614639|FG000|Overall Study|Discotinued per protocol|0|||
130451032|NCT04939428|469614640|FG001|Overall Study|Discotinued per protocol|0|||
130451033|NCT04939428|469614641|FG002|Overall Study|Discotinued per protocol|902|||
130451034|NCT02696785|469614643|FG000|Blinded Treatment Period|Adverse Event|0|||
130451035|NCT02696785|469614644|FG001|Blinded Treatment Period|Adverse Event|1|||
130451036|NCT02696785|469614645|FG002|Blinded Treatment Period|Adverse Event|3|||
130451037|NCT02696785|469614646|FG003|Blinded Treatment Period|Adverse Event|0|||
130244358|NCT03422718|468855177|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
130244359|NCT03422718|468855178|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
130451038|NCT02696785|469614643|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
130451039|NCT02696785|469614644|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
130451040|NCT02696785|469614645|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
130451041|NCT02696785|469614646|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
130451042|NCT02696785|469614643|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
130451043|NCT02696785|469614644|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
130451044|NCT02696785|469614645|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
130451045|NCT02696785|469614646|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
130451046|NCT02696785|469614643|FG000|Blinded Treatment Period|Screen Failure|1|||
130451047|NCT02696785|469614644|FG001|Blinded Treatment Period|Screen Failure|0|||
130451048|NCT02696785|469614645|FG002|Blinded Treatment Period|Screen Failure|0|||
130363124|NCT00400764|469299619|FG000|Phase Ib|Disease Progression|4|||
130363125|NCT00400764|469299620|FG001|Phase Ib|Disease Progression|4|||
130363126|NCT00400764|469299621|FG002|Phase Ib|Disease Progression|0|||
130363127|NCT00400764|469299622|FG003|Phase Ib|Disease Progression|0|||
130363128|NCT00400764|469299623|FG004|Phase Ib|Disease Progression|0|||
130363129|NCT00400764|469299619|FG000|Phase II|Death|0|||
130363130|NCT00400764|469299620|FG001|Phase II|Death|0|||
130451049|NCT02696785|469614646|FG003|Blinded Treatment Period|Screen Failure|0|||
130451050|NCT02696785|469614643|FG000|Washout Period|Withdrawal by Subject|0|||
130451051|NCT02696785|469614644|FG001|Washout Period|Withdrawal by Subject|1|||
130451052|NCT02696785|469614645|FG002|Washout Period|Withdrawal by Subject|0|||
130451053|NCT02696785|469614646|FG003|Washout Period|Withdrawal by Subject|0|||
130451054|NCT02696785|469614643|FG000|Washout Period|Lack of Efficacy|0|||
130451055|NCT02696785|469614644|FG001|Washout Period|Lack of Efficacy|1|||
130451056|NCT02696785|469614645|FG002|Washout Period|Lack of Efficacy|0|||
130698744|NCT02005562|470522688|FG000|Overall Study|Graft loss|7|||
130698745|NCT02005562|470522689|FG001|Overall Study|Graft loss|6|||
130698746|NCT02005562|470522688|FG000|Overall Study|Withdrawal by Subject|2|||
130698747|NCT02005562|470522689|FG001|Overall Study|Withdrawal by Subject|2|||
130698748|NCT02005562|470522688|FG000|Overall Study|No transplant|1|||
130698749|NCT02005562|470522689|FG001|Overall Study|No transplant|4|||
130698750|NCT02005562|470522688|FG000|Overall Study|Physician Decision|0|||
130698751|NCT02005562|470522689|FG001|Overall Study|Physician Decision|1|||
130698752|NCT00288704|470522692|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130698753|NCT00288704|470522693|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
130698754|NCT00288704|470522694|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130698755|NCT00288704|470522692|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130698756|NCT00288704|470522693|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
130698757|NCT00288704|470522694|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130698758|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130698759|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130698760|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
130698761|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130698762|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130451057|NCT02696785|469614646|FG003|Washout Period|Lack of Efficacy|0|||
130451058|NCT02696785|469614643|FG000|Extended Treatment Period|Adverse Event|2|||
130698763|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
130698764|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130698765|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130698766|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
130698767|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130698768|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130698769|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
130698770|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130698771|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130698772|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
130698773|NCT01579006|470522695|FG000|Overall Study|Lack of Efficacy|10|||
130698774|NCT01579006|470522695|FG000|Overall Study|Adverse Event|13|||
130698775|NCT01579006|470522695|FG000|Overall Study|Withdrawal by Subject|5|||
130698776|NCT01579006|470522695|FG000|Overall Study|Non-compliance|3|||
130698777|NCT01579006|470522695|FG000|Overall Study|Due to participant's health fund|1|||
130698778|NCT01579006|470522695|FG000|Overall Study|Scheduled surgery|1|||
130698779|NCT00799708|470522698|FG000|Overall Study|non-compliance|1|||
130698780|NCT00799708|470522699|FG001|Overall Study|non-compliance|0|||
130698781|NCT00799708|470522700|FG002|Overall Study|non-compliance|0|||
130244360|NCT03422718|468855179|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130363131|NCT00400764|469299621|FG002|Phase II|Death|1|||
130363132|NCT00400764|469299622|FG003|Phase II|Death|2|||
130363133|NCT00400764|469299623|FG004|Phase II|Death|0|||
130363134|NCT00400764|469299619|FG000|Phase II|Lost to Follow-up|0|||
130363135|NCT00400764|469299620|FG001|Phase II|Lost to Follow-up|0|||
130363136|NCT00400764|469299621|FG002|Phase II|Lost to Follow-up|1|||
130363137|NCT00400764|469299622|FG003|Phase II|Lost to Follow-up|0|||
130363138|NCT00400764|469299623|FG004|Phase II|Lost to Follow-up|0|||
130363139|NCT00400764|469299619|FG000|Phase II|Physician Decision|0|||
130363140|NCT00400764|469299620|FG001|Phase II|Physician Decision|0|||
130363141|NCT00400764|469299621|FG002|Phase II|Physician Decision|1|||
130363142|NCT00400764|469299622|FG003|Phase II|Physician Decision|1|||
130451059|NCT02696785|469614644|FG001|Extended Treatment Period|Adverse Event|3|||
130451060|NCT02696785|469614645|FG002|Extended Treatment Period|Adverse Event|2|||
130698782|NCT03343639|470522701|FG000|Overall Study|Withdrawal by Subject|10|||
130698783|NCT03343639|470522702|FG001|Overall Study|Withdrawal by Subject|6|||
130698784|NCT03343639|470522701|FG000|Overall Study|Lost to Follow-up|4|||
130698785|NCT03343639|470522702|FG001|Overall Study|Lost to Follow-up|5|||
130698786|NCT03343639|470522701|FG000|Overall Study|Protocol Violation|0|||
130698787|NCT03343639|470522702|FG001|Overall Study|Protocol Violation|1|||
130363143|NCT00400764|469299623|FG004|Phase II|Physician Decision|0|||
130363144|NCT00400764|469299619|FG000|Phase II|Sponsor's decision to terminate|0|||
130363145|NCT00400764|469299620|FG001|Phase II|Sponsor's decision to terminate|0|||
130363146|NCT00400764|469299621|FG002|Phase II|Sponsor's decision to terminate|18|||
130363147|NCT00400764|469299622|FG003|Phase II|Sponsor's decision to terminate|22|||
130363148|NCT00400764|469299623|FG004|Phase II|Sponsor's decision to terminate|11|||
130363149|NCT00400764|469299619|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
130363150|NCT00400764|469299620|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
130363151|NCT00400764|469299621|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
130451061|NCT02696785|469614646|FG003|Extended Treatment Period|Adverse Event|1|||
130451062|NCT02696785|469614643|FG000|Extended Treatment Period|Lack of Efficacy|0|||
130451063|NCT02696785|469614644|FG001|Extended Treatment Period|Lack of Efficacy|1|||
130451064|NCT02696785|469614645|FG002|Extended Treatment Period|Lack of Efficacy|0|||
130451065|NCT02696785|469614646|FG003|Extended Treatment Period|Lack of Efficacy|0|||
130451066|NCT02696785|469614643|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
130451067|NCT02696785|469614644|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
130451068|NCT02696785|469614645|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
130451069|NCT02696785|469614646|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
130451070|NCT02696785|469614643|FG000|Follow-up Period|Adverse Event|0|||
130698788|NCT02697617|470522706|FG000|Overall Study|Withdrawal by Subject|0|||
130698789|NCT02697617|470522707|FG001|Overall Study|Withdrawal by Subject|2|||
130698790|NCT02697617|470522706|FG000|Overall Study|Pregnancy|1|||
130698791|NCT02697617|470522707|FG001|Overall Study|Pregnancy|0|||
130698792|NCT02460835|470522710|FG000|Overall Study|Disease progression prior to treatment|3|||
130698793|NCT02460835|470522710|FG000|Overall Study|Unable to complete planning scans|2|||
130698794|NCT02460835|470522710|FG000|Overall Study|Decrease in performance status|1|||
130698795|NCT02460835|470522710|FG000|Overall Study|Withdrawal by Subject|3|||
130698796|NCT02460835|470522710|FG000|Overall Study|Underwent fractionated RT|10|||
130698797|NCT02460835|470522710|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
130698798|NCT01157234|470522711|FG000|Overall Study|Withdrawal by Subject|1|||
130698799|NCT01157234|470522712|FG001|Overall Study|Withdrawal by Subject|0|||
130698800|NCT00876265|470522719|FG000|Overall Study|Miscellaneous reasons|4|||
130698801|NCT00876265|470522719|FG000|Overall Study|Lost to Follow-up|6|||
130698802|NCT00876265|470522719|FG000|Overall Study|Withdrawal by Subject|2|||
130698803|NCT03433703|470522722|FG000|Overall Study|Study terminated by Sponsor|2|||
130698804|NCT02786953|470522725|FG000|Overall Study|Withdrawal by Subject|3|||
130698805|NCT02786953|470522726|FG001|Overall Study|Withdrawal by Subject|0|||
130698806|NCT02786953|470522725|FG000|Overall Study|Physician Decision|0|||
130698807|NCT02786953|470522726|FG001|Overall Study|Physician Decision|1|||
130698808|NCT01698554|470522730|FG000|Overall Study|Adverse Event|2|||
130698809|NCT01698554|470522731|FG001|Overall Study|Adverse Event|5|||
130698810|NCT01698554|470522732|FG002|Overall Study|Adverse Event|0|||
130698811|NCT01698554|470522733|FG003|Overall Study|Adverse Event|1|||
130698812|NCT01698554|470522730|FG000|Overall Study|Lost to Follow-up|1|||
130698813|NCT01698554|470522731|FG001|Overall Study|Lost to Follow-up|0|||
130698814|NCT01698554|470522732|FG002|Overall Study|Lost to Follow-up|0|||
130698815|NCT01698554|470522733|FG003|Overall Study|Lost to Follow-up|0|||
130698816|NCT01698554|470522730|FG000|Overall Study|Personal Reasons|0|||
130698817|NCT01698554|470522731|FG001|Overall Study|Personal Reasons|5|||
130698818|NCT01698554|470522732|FG002|Overall Study|Personal Reasons|1|||
130698819|NCT01698554|470522733|FG003|Overall Study|Personal Reasons|1|||
130698820|NCT01698554|470522730|FG000|Overall Study|Protocol Violation|2|||
130698821|NCT01698554|470522731|FG001|Overall Study|Protocol Violation|0|||
130698822|NCT01698554|470522732|FG002|Overall Study|Protocol Violation|1|||
130698823|NCT01698554|470522733|FG003|Overall Study|Protocol Violation|0|||
130698824|NCT01698554|470522730|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130698825|NCT01698554|470522731|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130698826|NCT01698554|470522732|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130698827|NCT01698554|470522733|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130698828|NCT02229084|470522734|FG000|Overall Study|Adverse Event|1|||
130363152|NCT00400764|469299622|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
130451071|NCT02696785|469614644|FG001|Follow-up Period|Adverse Event|0|||
130698829|NCT02229084|470522735|FG001|Overall Study|Adverse Event|0|||
130698830|NCT02229084|470522736|FG002|Overall Study|Adverse Event|0|||
130451072|NCT02696785|469614645|FG002|Follow-up Period|Adverse Event|8|||
130698831|NCT02229084|470522737|FG003|Overall Study|Adverse Event|0|||
130698832|NCT02229084|470522738|FG004|Overall Study|Adverse Event|0|||
130698833|NCT02229084|470522739|FG005|Overall Study|Adverse Event|0|||
130698834|NCT02229084|470522740|FG006|Overall Study|Adverse Event|0|||
130698835|NCT02229084|470522734|FG000|Overall Study|Lost to Follow-up|0|||
130698836|NCT02229084|470522735|FG001|Overall Study|Lost to Follow-up|0|||
130698837|NCT02229084|470522736|FG002|Overall Study|Lost to Follow-up|1|||
130698838|NCT02229084|470522737|FG003|Overall Study|Lost to Follow-up|1|||
130698839|NCT02229084|470522738|FG004|Overall Study|Lost to Follow-up|0|||
130698840|NCT02229084|470522739|FG005|Overall Study|Lost to Follow-up|0|||
130451073|NCT02696785|469614646|FG003|Follow-up Period|Adverse Event|2|||
130451074|NCT02696785|469614643|FG000|Follow-up Period|Lost to Follow-up|0|||
130451075|NCT02696785|469614644|FG001|Follow-up Period|Lost to Follow-up|0|||
130451076|NCT02696785|469614645|FG002|Follow-up Period|Lost to Follow-up|0|||
130451077|NCT02696785|469614646|FG003|Follow-up Period|Lost to Follow-up|1|||
130451078|NCT02696785|469614643|FG000|Follow-up Period|Lack of Efficacy|0|||
130451079|NCT02696785|469614644|FG001|Follow-up Period|Lack of Efficacy|0|||
130451080|NCT02696785|469614645|FG002|Follow-up Period|Lack of Efficacy|0|||
130451081|NCT02696785|469614646|FG003|Follow-up Period|Lack of Efficacy|1|||
130451082|NCT02696785|469614643|FG000|Follow-up Period|Withdrawal by Subject|1|||
130451083|NCT02696785|469614644|FG001|Follow-up Period|Withdrawal by Subject|0|||
130451084|NCT02696785|469614645|FG002|Follow-up Period|Withdrawal by Subject|5|||
130451085|NCT02696785|469614646|FG003|Follow-up Period|Withdrawal by Subject|4|||
130451086|NCT02320253|469614647|FG000|Overall Study|Withdrawal by Subject|3|||
130451087|NCT02320253|469614648|FG001|Overall Study|Withdrawal by Subject|0|||
130451088|NCT02320253|469614649|FG002|Overall Study|Withdrawal by Subject|0|||
130451089|NCT02320253|469614647|FG000|Overall Study|Lost to Follow-up|2|||
130451090|NCT02320253|469614648|FG001|Overall Study|Lost to Follow-up|2|||
130451091|NCT02320253|469614649|FG002|Overall Study|Lost to Follow-up|1|||
130451092|NCT02320253|469614647|FG000|Overall Study|Death|1|||
130451093|NCT02320253|469614648|FG001|Overall Study|Death|0|||
130451094|NCT02320253|469614649|FG002|Overall Study|Death|1|||
130451095|NCT00603538|469614650|FG000|Overall Study|Adverse Event|0|||
130451096|NCT00603538|469614651|FG001|Overall Study|Adverse Event|4|||
130451097|NCT00603538|469614652|FG002|Overall Study|Adverse Event|2|||
130451098|NCT00603538|469614650|FG000|Overall Study|Objective progression or relapse|3|||
130451099|NCT00603538|469614651|FG001|Overall Study|Objective progression or relapse|0|||
130698841|NCT02229084|470522740|FG006|Overall Study|Lost to Follow-up|1|||
130698842|NCT02229084|470522734|FG000|Overall Study|Physician Decision|0|||
130698843|NCT02229084|470522735|FG001|Overall Study|Physician Decision|0|||
130698844|NCT02229084|470522736|FG002|Overall Study|Physician Decision|0|||
130698845|NCT02229084|470522737|FG003|Overall Study|Physician Decision|1|||
130698846|NCT02229084|470522738|FG004|Overall Study|Physician Decision|3|||
130698847|NCT02229084|470522739|FG005|Overall Study|Physician Decision|0|||
130698848|NCT02229084|470522740|FG006|Overall Study|Physician Decision|1|||
130698849|NCT02229084|470522734|FG000|Overall Study|Withdrawal by Subject|0|||
130698850|NCT02229084|470522735|FG001|Overall Study|Withdrawal by Subject|0|||
130698851|NCT02229084|470522736|FG002|Overall Study|Withdrawal by Subject|1|||
130698852|NCT02229084|470522737|FG003|Overall Study|Withdrawal by Subject|0|||
130698853|NCT02229084|470522738|FG004|Overall Study|Withdrawal by Subject|1|||
130698854|NCT02229084|470522739|FG005|Overall Study|Withdrawal by Subject|1|||
130698855|NCT02229084|470522740|FG006|Overall Study|Withdrawal by Subject|1|||
130698856|NCT02229084|470522734|FG000|Overall Study|Death|0|||
130698857|NCT02229084|470522735|FG001|Overall Study|Death|0|||
130698858|NCT02229084|470522736|FG002|Overall Study|Death|0|||
130698859|NCT02229084|470522737|FG003|Overall Study|Death|0|||
130698860|NCT02229084|470522738|FG004|Overall Study|Death|0|||
130698861|NCT02229084|470522739|FG005|Overall Study|Death|0|||
130698862|NCT02229084|470522740|FG006|Overall Study|Death|1|||
130698863|NCT04535986|470522749|FG000|Overall Study|Death|4|||
130698864|NCT04535986|470522750|FG001|Overall Study|Death|5|||
130698865|NCT04535986|470522749|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
130698866|NCT04535986|470522750|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
130698867|NCT04535986|470522749|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
130698868|NCT04535986|470522750|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
130698869|NCT04535986|470522749|FG000|Overall Study|Adverse Event|10|||
130698870|NCT04535986|470522750|FG001|Overall Study|Adverse Event|1|||
130698871|NCT04535986|470522749|FG000|Overall Study|Lack of Efficacy|3|||
130698872|NCT04535986|470522750|FG001|Overall Study|Lack of Efficacy|2|||
130698873|NCT04535986|470522749|FG000|Overall Study|Investigator discretion|3|||
130451100|NCT00603538|469614652|FG002|Overall Study|Objective progression or relapse|0|||
130451101|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
130451102|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
130451103|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
130698874|NCT04535986|470522750|FG001|Overall Study|Investigator discretion|0|||
130451104|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
130451105|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
130451106|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
130698875|NCT04535986|470522749|FG000|Overall Study|Withdrawal by Subject|32|||
130698876|NCT04535986|470522750|FG001|Overall Study|Withdrawal by Subject|14|||
130698877|NCT04535986|470522749|FG000|Overall Study|Lost to Follow-up|5|||
130698878|NCT04535986|470522750|FG001|Overall Study|Lost to Follow-up|3|||
130698879|NCT04535986|470522749|FG000|Overall Study|Other|7|||
130698880|NCT04535986|470522750|FG001|Overall Study|Other|3|||
130698881|NCT04561115|470522753|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
130698882|NCT04561115|470522754|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
130698883|NCT04561115|470522753|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130698884|NCT04561115|470522754|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130698885|NCT04561115|470522753|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130698886|NCT04561115|470522754|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130698887|NCT00743145|470522755|FG000|Overall Study|Withdrawal by Subject|1|||
130698888|NCT00743145|470522755|FG000|Overall Study|Adverse Event|2|||
130698889|NCT00743145|470522755|FG000|Overall Study|Pregnancy|1|||
130698890|NCT01745094|470522756|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
130698891|NCT01745094|470522757|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
130698892|NCT01745094|470522758|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
130698893|NCT01745094|470522759|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
130698894|NCT01745094|470522756|FG000|Overall Study|Adverse Event|0|||
130698895|NCT01745094|470522757|FG001|Overall Study|Adverse Event|0|||
130698896|NCT01745094|470522758|FG002|Overall Study|Adverse Event|3|||
130698897|NCT01745094|470522759|FG003|Overall Study|Adverse Event|0|||
130698898|NCT01745094|470522756|FG000|Overall Study|Withdrawal by Subject|2|||
130698899|NCT01745094|470522757|FG001|Overall Study|Withdrawal by Subject|0|||
130698900|NCT01745094|470522758|FG002|Overall Study|Withdrawal by Subject|1|||
130698901|NCT01745094|470522759|FG003|Overall Study|Withdrawal by Subject|2|||
130698902|NCT01745094|470522756|FG000|Overall Study|Protocol Violation|1|||
130698903|NCT01745094|470522757|FG001|Overall Study|Protocol Violation|0|||
130698904|NCT01745094|470522758|FG002|Overall Study|Protocol Violation|3|||
130698905|NCT01745094|470522759|FG003|Overall Study|Protocol Violation|1|||
130698906|NCT01745094|470522756|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698907|NCT01745094|470522757|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698908|NCT01745094|470522758|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
130698909|NCT01745094|470522759|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698910|NCT01745094|470522756|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
130698911|NCT01745094|470522757|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
130698912|NCT01745094|470522758|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
130698913|NCT01745094|470522759|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
130698914|NCT01745094|470522756|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
130698915|NCT01745094|470522757|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698916|NCT01745094|470522758|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698917|NCT01745094|470522759|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698918|NCT02416180|470522760|FG000|Overall Study|Withdrawal by Subject|1|||
130698919|NCT00881569|470522764|FG000|Overall Study|Disease progression|1|||
130698920|NCT00881569|470522765|FG001|Overall Study|Disease progression|1|||
130698921|NCT01567527|470522776|FG000|Conversion Phase.|Protocol deviation|3|||
130698922|NCT01567527|470522777|FG001|Conversion Phase.|Protocol deviation|0|||
130698923|NCT01567527|470522778|FG002|Conversion Phase.|Protocol deviation|0|||
130698924|NCT01567527|470522779|FG003|Conversion Phase.|Protocol deviation|0|||
130698925|NCT01567527|470522780|FG004|Conversion Phase.|Protocol deviation|0|||
130698926|NCT01567527|470522776|FG000|Conversion Phase.|Met withdrawal criteria|10|||
130698927|NCT01567527|470522777|FG001|Conversion Phase.|Met withdrawal criteria|0|||
130698928|NCT01567527|470522778|FG002|Conversion Phase.|Met withdrawal criteria|0|||
130698929|NCT01567527|470522779|FG003|Conversion Phase.|Met withdrawal criteria|0|||
130698930|NCT01567527|470522780|FG004|Conversion Phase.|Met withdrawal criteria|0|||
130698931|NCT01567527|470522776|FG000|Conversion Phase.|Withdrawal by Subject|32|||
130698932|NCT01567527|470522777|FG001|Conversion Phase.|Withdrawal by Subject|0|||
130698933|NCT01567527|470522778|FG002|Conversion Phase.|Withdrawal by Subject|0|||
130698934|NCT01567527|470522779|FG003|Conversion Phase.|Withdrawal by Subject|0|||
130698935|NCT01567527|470522780|FG004|Conversion Phase.|Withdrawal by Subject|0|||
130698936|NCT01567527|470522776|FG000|Conversion Phase.|Lost to Follow-up|16|||
130698937|NCT01567527|470522777|FG001|Conversion Phase.|Lost to Follow-up|0|||
130698938|NCT01567527|470522778|FG002|Conversion Phase.|Lost to Follow-up|0|||
130698939|NCT01567527|470522779|FG003|Conversion Phase.|Lost to Follow-up|0|||
130698940|NCT01567527|470522780|FG004|Conversion Phase.|Lost to Follow-up|0|||
130698941|NCT01567527|470522776|FG000|Conversion Phase.|Lack of Efficacy|2|||
130698942|NCT01567527|470522777|FG001|Conversion Phase.|Lack of Efficacy|0|||
130698943|NCT01567527|470522778|FG002|Conversion Phase.|Lack of Efficacy|0|||
130698944|NCT01567527|470522779|FG003|Conversion Phase.|Lack of Efficacy|0|||
130698945|NCT01567527|470522780|FG004|Conversion Phase.|Lack of Efficacy|0|||
130698946|NCT01567527|470522776|FG000|Conversion Phase.|Adverse Event|33|||
130698947|NCT01567527|470522777|FG001|Conversion Phase.|Adverse Event|0|||
130698948|NCT01567527|470522778|FG002|Conversion Phase.|Adverse Event|0|||
130698949|NCT01567527|470522779|FG003|Conversion Phase.|Adverse Event|0|||
130698950|NCT01567527|470522780|FG004|Conversion Phase.|Adverse Event|0|||
130698951|NCT01567527|470522776|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
130698952|NCT01567527|470522777|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
130698953|NCT01567527|470522778|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
130698954|NCT01567527|470522779|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
130698955|NCT01567527|470522780|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
130698956|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698957|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
130698958|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698959|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698960|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698961|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698962|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
130698963|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698964|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698965|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698966|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698967|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
130698968|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698969|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698970|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698971|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130698972|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
130698973|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130698974|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130363153|NCT00400764|469299623|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
130363154|NCT00400764|469299619|FG000|Phase II|Withdrawal by Subject|0|||
130363155|NCT00400764|469299620|FG001|Phase II|Withdrawal by Subject|0|||
130363156|NCT00400764|469299621|FG002|Phase II|Withdrawal by Subject|1|||
130363157|NCT00400764|469299622|FG003|Phase II|Withdrawal by Subject|1|||
130363158|NCT00400764|469299623|FG004|Phase II|Withdrawal by Subject|0|||
130363159|NCT02628938|469299624|FG000|Overall Study|Did not attend the follow up recall|2|||
130363160|NCT02628938|469299625|FG001|Overall Study|Did not attend the follow up recall|2|||
130363161|NCT02628938|469299626|FG002|Overall Study|Did not attend the follow up recall|1|||
130363162|NCT02628938|469299624|FG000|Overall Study|Failure to comply with the instructions|3|||
130363163|NCT02628938|469299625|FG001|Overall Study|Failure to comply with the instructions|0|||
130363164|NCT02628938|469299626|FG002|Overall Study|Failure to comply with the instructions|3|||
130363165|NCT03113916|469299627|FG000|Overall Study|Withdrawal by Subject|9|||
130363166|NCT03113916|469299628|FG001|Overall Study|Withdrawal by Subject|7|||
130363167|NCT03113916|469299627|FG000|Overall Study|Pregnancy|1|||
130363168|NCT03113916|469299628|FG001|Overall Study|Pregnancy|3|||
130363169|NCT03113916|469299627|FG000|Overall Study|Lost to Follow-up|1|||
130363170|NCT03113916|469299628|FG001|Overall Study|Lost to Follow-up|2|||
130363171|NCT00370071|469299629|FG000|Overall Study|Withdrawal by Subject|2|||
130363172|NCT01999868|469299631|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
130363173|NCT01999868|469299632|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
130363174|NCT01999868|469299633|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
130363175|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
130363176|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
130363177|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
130363178|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
130363179|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
130363180|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
130363181|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
130363182|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
130363183|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
130363184|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
130363185|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
130363186|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
130363187|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
130363188|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
130363189|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
130363190|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
130363191|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
130363192|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
130698975|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130363193|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
130363194|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
130698976|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698977|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
130363195|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
130698978|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130363196|NCT01999868|469299631|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
130698979|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698980|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698981|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698982|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
130698983|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698984|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698985|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130363197|NCT01999868|469299632|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
130363198|NCT01999868|469299633|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
130363199|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
130363200|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
130363201|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
130363202|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
130363203|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
130363204|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
130363205|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
130363206|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
130363207|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
130363208|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
130363209|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
130363210|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
130363211|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
130363212|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
130363213|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
130363214|NCT01999868|469299631|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
130363215|NCT01999868|469299632|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
130363216|NCT01999868|469299633|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
130363217|NCT00761631|469299634|FG000|Overall Study|Parent/legal guardian request|8|||
130363218|NCT00761631|469299635|FG001|Overall Study|Parent/legal guardian request|3|||
130363219|NCT00761631|469299636|FG002|Overall Study|Parent/legal guardian request|8|||
130698986|NCT01567527|470522776|FG000|IM Depot Stabilization.|Protocol deviation|0|||
130698987|NCT01567527|470522777|FG001|IM Depot Stabilization.|Protocol deviation|0|||
130363220|NCT00761631|469299637|FG003|Overall Study|Parent/legal guardian request|0|||
130698988|NCT01567527|470522778|FG002|IM Depot Stabilization.|Protocol deviation|5|||
130698989|NCT01567527|470522779|FG003|IM Depot Stabilization.|Protocol deviation|0|||
130698990|NCT01567527|470522780|FG004|IM Depot Stabilization.|Protocol deviation|0|||
130698991|NCT01567527|470522776|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698992|NCT01567527|470522777|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698993|NCT01567527|470522778|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
130698994|NCT01567527|470522779|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698995|NCT01567527|470522780|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698996|NCT01567527|470522776|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
130698997|NCT01567527|470522777|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
130698998|NCT01567527|470522778|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
130698999|NCT01567527|470522779|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
130699000|NCT01567527|470522780|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
130699001|NCT01567527|470522776|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699002|NCT01567527|470522777|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
130244361|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
130244362|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
130244363|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
130244364|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130699003|NCT01567527|470522778|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
130699004|NCT01567527|470522779|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699005|NCT01567527|470522780|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699006|NCT01567527|470522776|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
130699007|NCT01567527|470522777|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
130699008|NCT01567527|470522778|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
130699009|NCT01567527|470522779|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
130699010|NCT01567527|470522780|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
130244365|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
130244366|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130244367|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130244368|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
130244369|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244370|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
130244371|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244372|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130363221|NCT00761631|469299638|FG004|Overall Study|Parent/legal guardian request|5|||
130363222|NCT00761631|469299639|FG005|Overall Study|Parent/legal guardian request|0|||
130363223|NCT00761631|469299634|FG000|Overall Study|Lost to Follow-up|2|||
130363224|NCT00761631|469299635|FG001|Overall Study|Lost to Follow-up|4|||
130363225|NCT00761631|469299636|FG002|Overall Study|Lost to Follow-up|7|||
130363226|NCT00761631|469299637|FG003|Overall Study|Lost to Follow-up|1|||
130363227|NCT00761631|469299638|FG004|Overall Study|Lost to Follow-up|6|||
130363228|NCT00761631|469299639|FG005|Overall Study|Lost to Follow-up|1|||
130363229|NCT00761631|469299634|FG000|Overall Study|Protocol Violation|2|||
130363230|NCT00761631|469299635|FG001|Overall Study|Protocol Violation|0|||
130363231|NCT00761631|469299636|FG002|Overall Study|Protocol Violation|0|||
130363232|NCT00761631|469299637|FG003|Overall Study|Protocol Violation|1|||
130363233|NCT00761631|469299638|FG004|Overall Study|Protocol Violation|5|||
130363234|NCT00761631|469299639|FG005|Overall Study|Protocol Violation|1|||
130363235|NCT00761631|469299634|FG000|Overall Study|Randomized, not treated|1|||
130363236|NCT00761631|469299635|FG001|Overall Study|Randomized, not treated|0|||
130363237|NCT00761631|469299636|FG002|Overall Study|Randomized, not treated|0|||
130363238|NCT00761631|469299637|FG003|Overall Study|Randomized, not treated|0|||
130363239|NCT00761631|469299638|FG004|Overall Study|Randomized, not treated|0|||
130363240|NCT00761631|469299639|FG005|Overall Study|Randomized, not treated|0|||
130363241|NCT00761631|469299634|FG000|Overall Study|Failed to return|1|||
130363242|NCT00761631|469299635|FG001|Overall Study|Failed to return|0|||
130363243|NCT00761631|469299636|FG002|Overall Study|Failed to return|1|||
130363244|NCT00761631|469299637|FG003|Overall Study|Failed to return|1|||
130363245|NCT00761631|469299638|FG004|Overall Study|Failed to return|5|||
130363246|NCT00761631|469299639|FG005|Overall Study|Failed to return|2|||
130363247|NCT00761631|469299634|FG000|Overall Study|Physician Decision|1|||
130363248|NCT00761631|469299635|FG001|Overall Study|Physician Decision|0|||
130363249|NCT00761631|469299636|FG002|Overall Study|Physician Decision|0|||
130363250|NCT00761631|469299637|FG003|Overall Study|Physician Decision|0|||
130363251|NCT00761631|469299638|FG004|Overall Study|Physician Decision|0|||
130363252|NCT00761631|469299639|FG005|Overall Study|Physician Decision|0|||
130363253|NCT00761631|469299634|FG000|Overall Study|Other|0|||
130363254|NCT00761631|469299635|FG001|Overall Study|Other|0|||
130699011|NCT01567527|470522776|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
130699012|NCT01567527|470522777|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
130699013|NCT01567527|470522778|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
130451107|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
130451108|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
130451109|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
130451110|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
130451111|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
130451112|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
130451113|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
130451114|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
130451115|NCT04672460|469616167|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
130451116|NCT04672460|469616168|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
130451117|NCT04672460|469616167|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
130451118|NCT04672460|469616168|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
130451119|NCT04672460|469616167|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
130244373|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
130244374|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
130244375|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244376|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244377|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
130244378|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
130244379|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
130244380|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
130244381|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
130244382|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
130244383|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
130244384|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
130244385|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130244386|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
130244387|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130244388|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
130244389|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
130244390|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130244391|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
130244392|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130244393|NCT01129284|468855180|FG000|Overall Study|Adverse Event|2|||
130244394|NCT01129284|468855181|FG001|Overall Study|Adverse Event|0|||
130244395|NCT01129284|468855182|FG002|Overall Study|Adverse Event|1|||
130244396|NCT00845182|468855190|FG000|Overall Study|Lost to Follow-up|3|||
130244397|NCT00845182|468855191|FG001|Overall Study|Lost to Follow-up|3|||
130244398|NCT00845182|468855192|FG002|Overall Study|Lost to Follow-up|4|||
130244399|NCT00845182|468855190|FG000|Overall Study|Adverse Event|0|||
130244400|NCT00845182|468855191|FG001|Overall Study|Adverse Event|1|||
130244401|NCT00845182|468855192|FG002|Overall Study|Adverse Event|1|||
130244402|NCT00845182|468855190|FG000|Overall Study|Physician Decision|0|||
130244403|NCT00845182|468855191|FG001|Overall Study|Physician Decision|0|||
130244404|NCT00845182|468855192|FG002|Overall Study|Physician Decision|1|||
130244405|NCT01625182|468855195|FG000|Overall Study|Administrative problems|1|||
130244406|NCT01625182|468855196|FG001|Overall Study|Administrative problems|0|||
130244407|NCT01625182|468855195|FG000|Overall Study|Protocol deviation|0|||
130244408|NCT01625182|468855196|FG001|Overall Study|Protocol deviation|2|||
130244409|NCT01625182|468855195|FG000|Overall Study|Adverse Event|2|||
130244410|NCT01625182|468855196|FG001|Overall Study|Adverse Event|0|||
130244411|NCT01625182|468855195|FG000|Overall Study|Withdrawal by Subject|5|||
130244412|NCT01625182|468855196|FG001|Overall Study|Withdrawal by Subject|1|||
130244413|NCT01625182|468855195|FG000|Overall Study|Lack of Efficacy|12|||
130244414|NCT01625182|468855196|FG001|Overall Study|Lack of Efficacy|8|||
130244415|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
130244416|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
130244417|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
130244418|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
130244419|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
130244420|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
130244421|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
130244422|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
130244423|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
130244424|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
130244425|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
130244426|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
130244427|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
130244428|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
130244429|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130244430|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130244431|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130244432|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130244433|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
130244434|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
130244435|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
130244436|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
130244437|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130244438|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130244439|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
130244440|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
130244441|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
130244442|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
130244443|NCT01348698|468855199|FG000|Overall Study|Does not meet lesion size criteria|1|||
130244444|NCT01348698|468855199|FG000|Overall Study|Death|3|||
130244445|NCT01348698|468855199|FG000|Overall Study|PI decision to close study|68|||
130244446|NCT02595749|468855200|FG000|Overall Study|Withdrawal by Subject|12|||
130244447|NCT02595749|468855201|FG001|Overall Study|Withdrawal by Subject|7|||
130244448|NCT00263562|468855202|FG000|Overall Study|Protocol Violation|3|||
130244449|NCT00263562|468855203|FG001|Overall Study|Protocol Violation|0|||
130244450|NCT05427916|468855209|FG000|Overall Study|Adverse Event|3|||
130244451|NCT05427916|468855210|FG001|Overall Study|Adverse Event|0|||
130244452|NCT05427916|468855209|FG000|Overall Study|Lack of Efficacy|6|||
130244453|NCT05427916|468855210|FG001|Overall Study|Lack of Efficacy|0|||
130244454|NCT05427916|468855209|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
130244455|NCT05427916|468855210|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
130244456|NCT05558410|468855211|FG000|Overall Study|Adverse Event|1|||
130244457|NCT05558410|468855212|FG001|Overall Study|Adverse Event|2|||
130244458|NCT05558410|468855213|FG002|Overall Study|Adverse Event|0|||
130244459|NCT05558410|468855211|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130244460|NCT05558410|468855212|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130244461|NCT05558410|468855213|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
130244462|NCT05558410|468855211|FG000|Overall Study|Lost to Follow-up|10|||
130244463|NCT05558410|468855212|FG001|Overall Study|Lost to Follow-up|17|||
130244464|NCT05558410|468855213|FG002|Overall Study|Lost to Follow-up|19|||
130244465|NCT05558410|468855211|FG000|Overall Study|Death|1|||
130244466|NCT05558410|468855212|FG001|Overall Study|Death|0|||
130244467|NCT05558410|468855213|FG002|Overall Study|Death|0|||
130244468|NCT05558410|468855211|FG000|Overall Study|Other non-compliance|0|||
130244469|NCT05558410|468855212|FG001|Overall Study|Other non-compliance|1|||
130244470|NCT05558410|468855213|FG002|Overall Study|Other non-compliance|2|||
130244471|NCT05558410|468855211|FG000|Overall Study|Sponsor Decision|1|||
130244472|NCT05558410|468855212|FG001|Overall Study|Sponsor Decision|0|||
130244473|NCT05558410|468855213|FG002|Overall Study|Sponsor Decision|0|||
130244474|NCT05558410|468855211|FG000|Overall Study|Other|1|||
130244475|NCT05558410|468855212|FG001|Overall Study|Other|0|||
130244476|NCT05558410|468855213|FG002|Overall Study|Other|1|||
130244477|NCT00933166|468855218|FG000|Overall Study|Lost to Follow-up|4|||
130244478|NCT00933166|468855218|FG000|Overall Study|Lack of Efficacy|9|||
130244479|NCT00933166|468855218|FG000|Overall Study|Unavailable|4|||
130244480|NCT00933166|468855218|FG000|Overall Study|Withdrawal by Subject|1|||
130451120|NCT04672460|469616168|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
130451121|NCT04672460|469616167|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
130451122|NCT04672460|469616168|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
130451123|NCT04672460|469616167|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
130451124|NCT04672460|469616168|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
130451125|NCT04672460|469616167|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
130451126|NCT04672460|469616168|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
130451127|NCT04672460|469616167|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
130244481|NCT03501277|468855222|FG000|Intervention Period 1 (4 Days)|Other|0|||
130451128|NCT04672460|469616168|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
130451129|NCT04672460|469616167|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
130451130|NCT04672460|469616168|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
130451131|NCT04672460|469616167|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
130451132|NCT04672460|469616168|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
130451133|NCT04672460|469616167|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
130451134|NCT04672460|469616168|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
130451135|NCT00049517|469616171|FG000|Induction|Disease progression|0|||
130451136|NCT00049517|469616172|FG001|Induction|Disease progression|0|||
130451137|NCT00049517|469616173|FG002|Induction|Disease progression|0|||
130451138|NCT00049517|469616174|FG003|Induction|Disease progression|0|||
130451139|NCT00049517|469616175|FG004|Induction|Disease progression|18|||
130244482|NCT03501277|468855223|FG001|Intervention Period 1 (4 Days)|Other|0|||
130451140|NCT00049517|469616176|FG005|Induction|Disease progression|11|||
130451141|NCT00049517|469616171|FG000|Induction|Adverse Event|0|||
130244483|NCT03501277|468855224|FG002|Intervention Period 1 (4 Days)|Other|1|||
130244484|NCT03501277|468855225|FG003|Intervention Period 1 (4 Days)|Other|0|||
130451142|NCT00049517|469616172|FG001|Induction|Adverse Event|0|||
130244485|NCT03501277|468855222|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
130244486|NCT03501277|468855223|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
130451143|NCT00049517|469616173|FG002|Induction|Adverse Event|0|||
130451144|NCT00049517|469616174|FG003|Induction|Adverse Event|0|||
130451145|NCT00049517|469616175|FG004|Induction|Adverse Event|5|||
130451146|NCT00049517|469616176|FG005|Induction|Adverse Event|7|||
130244487|NCT03501277|468855224|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
130244488|NCT03501277|468855225|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
130244489|NCT03501277|468855222|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
130244490|NCT03501277|468855223|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
130699014|NCT01567527|470522779|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
130451147|NCT00049517|469616171|FG000|Induction|Death|0|||
130451148|NCT00049517|469616172|FG001|Induction|Death|0|||
130451149|NCT00049517|469616173|FG002|Induction|Death|0|||
130699015|NCT01567527|470522780|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
130699016|NCT01567527|470522776|FG000|IM Depot Stabilization.|Adverse Event|0|||
130699017|NCT01567527|470522777|FG001|IM Depot Stabilization.|Adverse Event|0|||
130699018|NCT01567527|470522778|FG002|IM Depot Stabilization.|Adverse Event|37|||
130699019|NCT01567527|470522779|FG003|IM Depot Stabilization.|Adverse Event|0|||
130699020|NCT01567527|470522780|FG004|IM Depot Stabilization.|Adverse Event|0|||
130699021|NCT01567527|470522776|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699022|NCT01567527|470522777|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699023|NCT01567527|470522778|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
130699024|NCT01567527|470522779|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699025|NCT01567527|470522780|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699026|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699027|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699028|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699029|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130699030|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130699031|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699032|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699033|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699034|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
130699035|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
130699036|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699037|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699038|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699039|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
130699040|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
130699041|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699042|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699043|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699044|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
130699045|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
130699046|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699047|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699048|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699049|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
130699050|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
130699051|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699052|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699053|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699054|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
130699055|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
130699056|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699057|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699058|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699059|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
130699060|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
130699061|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699062|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699063|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699064|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
130699065|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
130699066|NCT02004691|470522781|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
130699067|NCT02004691|470522782|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
130699068|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
130699069|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
130699070|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
130451150|NCT00049517|469616174|FG003|Induction|Death|0|||
130451151|NCT00049517|469616175|FG004|Induction|Death|9|||
130451152|NCT00049517|469616176|FG005|Induction|Death|6|||
130451153|NCT00049517|469616171|FG000|Induction|Withdrawal by Subject|0|||
130451154|NCT00049517|469616172|FG001|Induction|Withdrawal by Subject|0|||
130244491|NCT03501277|468855224|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
130244492|NCT03501277|468855225|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
130244493|NCT03501277|468855222|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244494|NCT03501277|468855223|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244495|NCT03501277|468855224|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244496|NCT03501277|468855225|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
130244497|NCT06038643|468855229|FG000|Overall Study|Withdrawal by Subject|9|||
130244498|NCT06038643|468855230|FG001|Overall Study|Withdrawal by Subject|4|||
130244499|NCT06038643|468855229|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
130244500|NCT06038643|468855230|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
130244501|NCT04739709|468855238|FG000|Overall Study|Physician Decision|1|||
130244502|NCT04739709|468855239|FG001|Overall Study|Physician Decision|0|||
130244503|NCT02530242|468855248|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
130244504|NCT02530242|468855249|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
130244505|NCT00283959|468855250|FG000|Extension Period|Low Compliance|1|||
130244506|NCT05591755|468855251|FG000|Overall Study|Screen Failure|1|||
130244507|NCT05591755|468855252|FG001|Overall Study|Screen Failure|0|||
130244508|NCT05591755|468855253|FG002|Overall Study|Screen Failure|0|||
130244509|NCT05591755|468855254|FG003|Overall Study|Screen Failure|0|||
130244510|NCT05591755|468855251|FG000|Overall Study|Protocol Violation|0|||
130244511|NCT05591755|468855252|FG001|Overall Study|Protocol Violation|0|||
130244512|NCT05591755|468855253|FG002|Overall Study|Protocol Violation|2|||
130244513|NCT05591755|468855254|FG003|Overall Study|Protocol Violation|0|||
130244514|NCT05591755|468855251|FG000|Overall Study|Withdrawal by Subject|0|||
130244515|NCT05591755|468855252|FG001|Overall Study|Withdrawal by Subject|1|||
130244516|NCT05591755|468855253|FG002|Overall Study|Withdrawal by Subject|0|||
130244517|NCT05591755|468855254|FG003|Overall Study|Withdrawal by Subject|0|||
130244518|NCT00433290|468855255|FG000|Overall Study|Adverse Event|24|||
130244519|NCT00433290|468855256|FG001|Overall Study|Adverse Event|7|||
130244520|NCT00433290|468855255|FG000|Overall Study|Lack of Efficacy|1|||
130244521|NCT00433290|468855256|FG001|Overall Study|Lack of Efficacy|5|||
130244522|NCT00433290|468855255|FG000|Overall Study|Withdrawal by Subject|4|||
130244523|NCT00433290|468855256|FG001|Overall Study|Withdrawal by Subject|2|||
130244524|NCT00433290|468855255|FG000|Overall Study|Protocol Violation|3|||
130244525|NCT00433290|468855256|FG001|Overall Study|Protocol Violation|2|||
130244526|NCT00433290|468855255|FG000|Overall Study|Physician Decision|2|||
130244527|NCT00433290|468855256|FG001|Overall Study|Physician Decision|0|||
130244528|NCT00433290|468855255|FG000|Overall Study|Entry Criteria Not Met|0|||
130244529|NCT00433290|468855256|FG001|Overall Study|Entry Criteria Not Met|1|||
130244530|NCT00433290|468855255|FG000|Overall Study|Lost to Follow-up|1|||
130244531|NCT00433290|468855256|FG001|Overall Study|Lost to Follow-up|0|||
130244532|NCT01483651|468855257|FG000|Overall Study|Withdrawal by Subject|0|||
130244533|NCT01483651|468855258|FG001|Overall Study|Withdrawal by Subject|1|||
130244534|NCT01483651|468855259|FG002|Overall Study|Withdrawal by Subject|1|||
130244535|NCT01483651|468855260|FG003|Overall Study|Withdrawal by Subject|0|||
130244536|NCT01483651|468855261|FG004|Overall Study|Withdrawal by Subject|0|||
130244537|NCT01483651|468855262|FG005|Overall Study|Withdrawal by Subject|1|||
130244538|NCT00504309|468855272|FG000|Overall Study|Death|0|||
130244539|NCT00504309|468855273|FG001|Overall Study|Death|0|||
130244540|NCT00504309|468855274|FG002|Overall Study|Death|0|||
130244541|NCT00504309|468855275|FG003|Overall Study|Death|0|||
130244542|NCT00504309|468855276|FG004|Overall Study|Death|1|||
130244543|NCT00504309|468855277|FG005|Overall Study|Death|0|||
130244544|NCT00504309|468855272|FG000|Overall Study|Withdrawal by Subject|0|||
130244545|NCT00504309|468855273|FG001|Overall Study|Withdrawal by Subject|0|||
130244546|NCT00504309|468855274|FG002|Overall Study|Withdrawal by Subject|1|||
130244547|NCT00504309|468855275|FG003|Overall Study|Withdrawal by Subject|0|||
130244548|NCT00504309|468855276|FG004|Overall Study|Withdrawal by Subject|0|||
130244549|NCT00504309|468855277|FG005|Overall Study|Withdrawal by Subject|0|||
130244550|NCT03345095|468855278|FG000|Overall Study|Lack of Efficacy|184|||
130244551|NCT03345095|468855279|FG001|Overall Study|Lack of Efficacy|156|||
130244552|NCT03345095|468855278|FG000|Overall Study|Adverse Event|36|||
130244553|NCT03345095|468855279|FG001|Overall Study|Adverse Event|118|||
130244554|NCT03345095|468855278|FG000|Overall Study|Withdrawal by Subject|22|||
130244555|NCT03345095|468855279|FG001|Overall Study|Withdrawal by Subject|59|||
130244556|NCT03345095|468855278|FG000|Overall Study|Physician Decision|3|||
130244557|NCT03345095|468855279|FG001|Overall Study|Physician Decision|18|||
130244558|NCT03345095|468855278|FG000|Overall Study|Death|2|||
130244559|NCT03345095|468855279|FG001|Overall Study|Death|4|||
130244560|NCT03345095|468855278|FG000|Overall Study|Other reasons|2|||
130244561|NCT03345095|468855279|FG001|Overall Study|Other reasons|11|||
130244562|NCT03345095|468855278|FG000|Overall Study|Protocol Violation|0|||
130244563|NCT03345095|468855279|FG001|Overall Study|Protocol Violation|1|||
130244564|NCT01121575|468855280|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
130244565|NCT01121575|468855281|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130244566|NCT01121575|468855282|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
130244567|NCT01121575|468855283|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
130244568|NCT01121575|468855284|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
130244569|NCT01121575|468855285|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
130244570|NCT01121575|468855280|FG000|Overall Study|Unspecified Reasons|8|||
130244571|NCT01121575|468855281|FG001|Overall Study|Unspecified Reasons|6|||
130244572|NCT01121575|468855282|FG002|Overall Study|Unspecified Reasons|7|||
130244573|NCT01121575|468855283|FG003|Overall Study|Unspecified Reasons|5|||
130244574|NCT01121575|468855284|FG004|Overall Study|Unspecified Reasons|13|||
130244575|NCT01121575|468855285|FG005|Overall Study|Unspecified Reasons|10|||
130244576|NCT01121575|468855280|FG000|Overall Study|Death|6|||
130244577|NCT01121575|468855281|FG001|Overall Study|Death|0|||
130244578|NCT01121575|468855282|FG002|Overall Study|Death|0|||
130244579|NCT01121575|468855283|FG003|Overall Study|Death|1|||
130244580|NCT01121575|468855284|FG004|Overall Study|Death|7|||
130244581|NCT01121575|468855285|FG005|Overall Study|Death|1|||
130244582|NCT00724503|468855287|FG000|Overall Study|Lost to Follow-up|4|||
130244583|NCT00724503|468855288|FG001|Overall Study|Lost to Follow-up|8|||
130244584|NCT00724503|468855287|FG000|Overall Study|Withdrawal by Subject|11|||
130244585|NCT00724503|468855288|FG001|Overall Study|Withdrawal by Subject|23|||
130244586|NCT00724503|468855287|FG000|Overall Study|Death|190|||
130244587|NCT00724503|468855288|FG001|Overall Study|Death|182|||
130244588|NCT00724503|468855287|FG000|Overall Study|Adverse Event|1|||
130244589|NCT00724503|468855288|FG001|Overall Study|Adverse Event|0|||
130244590|NCT00724503|468855287|FG000|Overall Study|Not otherwise specified|4|||
130244591|NCT00724503|468855288|FG001|Overall Study|Not otherwise specified|7|||
130244592|NCT01186419|468855291|FG000|Overall Study|Withdrawal by Subject|5|||
130244593|NCT01186419|468855292|FG001|Overall Study|Withdrawal by Subject|3|||
130244594|NCT01186419|468855291|FG000|Overall Study|Adverse Event|1|||
130244595|NCT01186419|468855292|FG001|Overall Study|Adverse Event|2|||
130244596|NCT01186419|468855291|FG000|Overall Study|Physician Decision|0|||
130244597|NCT01186419|468855292|FG001|Overall Study|Physician Decision|3|||
130244598|NCT01186419|468855291|FG000|Overall Study|Other|1|||
130244599|NCT01186419|468855292|FG001|Overall Study|Other|1|||
130244600|NCT01560416|468855296|FG000|Randomized Phase|Crossover Participants|7|||
130244601|NCT01560416|468855297|FG001|Randomized Phase|Crossover Participants|0|||
130244602|NCT00853047|468855298|FG000|Core Phase|Participant Request|0|||
130244603|NCT00853047|468855299|FG001|Core Phase|Participant Request|0|||
130244604|NCT00853047|468855300|FG002|Core Phase|Participant Request|0|||
130244605|NCT00853047|468855301|FG003|Core Phase|Participant Request|1|||
130244606|NCT00853047|468855302|FG004|Core Phase|Participant Request|0|||
130244607|NCT00853047|468855303|FG005|Core Phase|Participant Request|0|||
130244608|NCT00853047|468855298|FG000|Open-Label Extension Phase|Participant Request|0|||
130244609|NCT00853047|468855299|FG001|Open-Label Extension Phase|Participant Request|0|||
130244610|NCT00853047|468855300|FG002|Open-Label Extension Phase|Participant Request|0|||
130244611|NCT00853047|468855301|FG003|Open-Label Extension Phase|Participant Request|0|||
130244612|NCT00853047|468855302|FG004|Open-Label Extension Phase|Participant Request|0|||
130244613|NCT00853047|468855303|FG005|Open-Label Extension Phase|Participant Request|7|||
130244614|NCT00853047|468855298|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130244615|NCT00853047|468855299|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130244616|NCT00853047|468855300|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130244617|NCT00853047|468855301|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
130244618|NCT00853047|468855302|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
130244619|NCT00853047|468855303|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
130244620|NCT00853047|468855298|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130363255|NCT00761631|469299636|FG002|Overall Study|Other|0|||
130363256|NCT00761631|469299637|FG003|Overall Study|Other|0|||
130363257|NCT00761631|469299638|FG004|Overall Study|Other|1|||
130363258|NCT00761631|469299639|FG005|Overall Study|Other|1|||
130363259|NCT00289016|469299642|FG000|Overall Study|Disease Progression|29|||
130363260|NCT00289016|469299642|FG000|Overall Study|Death|2|||
130363261|NCT00289016|469299642|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
130363262|NCT00289016|469299642|FG000|Overall Study|Withdrawal by Subject|2|||
130363263|NCT00289016|469299642|FG000|Overall Study|Adverse Event|1|||
130363264|NCT00289016|469299642|FG000|Overall Study|Other|1|||
130244621|NCT00853047|468855299|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244622|NCT00853047|468855300|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244623|NCT00853047|468855301|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130363265|NCT01441180|469299648|FG000|Overall Study|Lost to Follow-up|1|||
130699071|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
130244624|NCT00853047|468855302|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244625|NCT00853047|468855303|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
130244626|NCT00853047|468855298|FG000|Open-Label Extension Phase|Investigator Decision|0|||
130244627|NCT00853047|468855299|FG001|Open-Label Extension Phase|Investigator Decision|0|||
130244628|NCT00853047|468855300|FG002|Open-Label Extension Phase|Investigator Decision|0|||
130244629|NCT00853047|468855301|FG003|Open-Label Extension Phase|Investigator Decision|0|||
130363266|NCT01441180|469299649|FG001|Overall Study|Lost to Follow-up|1|||
130363267|NCT01441180|469299650|FG002|Overall Study|Lost to Follow-up|1|||
130699072|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
130244630|NCT00853047|468855302|FG004|Open-Label Extension Phase|Investigator Decision|0|||
130244631|NCT00853047|468855303|FG005|Open-Label Extension Phase|Investigator Decision|1|||
130244632|NCT00853047|468855298|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
130244633|NCT00853047|468855299|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
130244634|NCT00853047|468855300|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
130244635|NCT00853047|468855301|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
130244636|NCT00853047|468855302|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
130244637|NCT00853047|468855303|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
130244638|NCT00004859|468855304|FG000|Overall Study|Lack of Efficacy|43|||
130244639|NCT00004859|468855305|FG001|Overall Study|Lack of Efficacy|113|||
130244640|NCT00004859|468855304|FG000|Overall Study|Adverse Event|31|||
130244641|NCT00004859|468855305|FG001|Overall Study|Adverse Event|93|||
130244642|NCT00004859|468855304|FG000|Overall Study|Death|5|||
130244643|NCT00004859|468855305|FG001|Overall Study|Death|5|||
130244644|NCT00004859|468855304|FG000|Overall Study|Withdrawal by Subject|7|||
130244645|NCT00004859|468855305|FG001|Overall Study|Withdrawal by Subject|33|||
130244646|NCT00004859|468855304|FG000|Overall Study|Protocol Violation|2|||
130244647|NCT00004859|468855305|FG001|Overall Study|Protocol Violation|2|||
130244648|NCT00004859|468855304|FG000|Overall Study|other disease|0|||
130244649|NCT00004859|468855305|FG001|Overall Study|other disease|3|||
130244650|NCT00004859|468855304|FG000|Overall Study|error|3|||
130244651|NCT00004859|468855305|FG001|Overall Study|error|1|||
130244652|NCT00004859|468855304|FG000|Overall Study|missing data|14|||
130244653|NCT00004859|468855305|FG001|Overall Study|missing data|11|||
130244654|NCT00004859|468855304|FG000|Overall Study|Other|13|||
130244655|NCT00004859|468855305|FG001|Overall Study|Other|21|||
130244656|NCT00504231|468856961|FG000|Overall Study|Discrepant chart documentation re route|0|||
130244657|NCT00504231|468856962|FG001|Overall Study|Discrepant chart documentation re route|0|||
130244658|NCT00504231|468856963|FG002|Overall Study|Discrepant chart documentation re route|1|||
130244659|NCT00504231|468856964|FG003|Overall Study|Discrepant chart documentation re route|0|||
130244660|NCT00456612|468856967|FG000|Overall Study|Withdrawal by Subject|3|||
130244661|NCT00266812|468856968|FG000|Overall Study|Disease Progression|9|||
130244662|NCT00266812|468856969|FG001|Overall Study|Disease Progression|3|||
130244663|NCT00266812|468856968|FG000|Overall Study|Death|5|||
130244664|NCT00266812|468856969|FG001|Overall Study|Death|4|||
130244665|NCT00266812|468856968|FG000|Overall Study|Adverse Event|3|||
130244666|NCT00266812|468856969|FG001|Overall Study|Adverse Event|1|||
130244667|NCT00266812|468856968|FG000|Overall Study|Protocol Violation|0|||
130244668|NCT00266812|468856969|FG001|Overall Study|Protocol Violation|1|||
130244669|NCT00266812|468856968|FG000|Overall Study|Withdrawal by Subject|0|||
130244670|NCT00266812|468856969|FG001|Overall Study|Withdrawal by Subject|2|||
130244671|NCT00266812|468856968|FG000|Overall Study|Discontinued before starting study drug|4|||
130244672|NCT00266812|468856969|FG001|Overall Study|Discontinued before starting study drug|0|||
130244673|NCT03695094|468856970|FG000|Overall Study|Adverse Event|1|||
130244674|NCT03695094|468856971|FG001|Overall Study|Adverse Event|1|||
130244675|NCT03695094|468856970|FG000|Overall Study|Withdrawal by Subject|1|||
130244676|NCT03695094|468856971|FG001|Overall Study|Withdrawal by Subject|0|||
130244677|NCT00530075|468856974|FG000|Overall Study|Adverse Event|1|||
130244678|NCT00530075|468856974|FG000|Overall Study|Death|1|||
130244679|NCT00530075|468856974|FG000|Overall Study|Lack of Efficacy|3|||
130244680|NCT00530075|468856974|FG000|Overall Study|Protocol Violation|1|||
130244681|NCT00530075|468856974|FG000|Overall Study|Withdrawal by Subject|1|||
130244682|NCT02316613|468856975|FG000|Overall Study|Death|63|||
130244683|NCT02316613|468856975|FG000|Overall Study|Lost to Follow-up|9|||
130244684|NCT02316613|468856975|FG000|Overall Study|Lymphoma transformation|2|||
130244685|NCT02316613|468856975|FG000|Overall Study|Participant moved/changed medical team|11|||
130244686|NCT02316613|468856975|FG000|Overall Study|No data and duplicate cases|5|||
130244687|NCT02316613|468856975|FG000|Overall Study|Did not met selection criteria|14|||
130244688|NCT00758043|468856979|FG000|Overall Study|Adverse Event|1|||
130244689|NCT00758043|468856980|FG001|Overall Study|Adverse Event|20|||
130244690|NCT00758043|468856981|FG002|Overall Study|Adverse Event|12|||
130244691|NCT00758043|468856982|FG003|Overall Study|Adverse Event|62|||
130363268|NCT01441180|469299648|FG000|Overall Study|Discontinued|0|||
130363269|NCT01441180|469299649|FG001|Overall Study|Discontinued|0|||
130363270|NCT01441180|469299650|FG002|Overall Study|Discontinued|2|||
130363271|NCT01402011|469299653|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
130244692|NCT00758043|468856979|FG000|Overall Study|Lack of Efficacy|0|||
130244693|NCT00758043|468856980|FG001|Overall Study|Lack of Efficacy|6|||
130244694|NCT00758043|468856981|FG002|Overall Study|Lack of Efficacy|18|||
130244695|NCT00758043|468856982|FG003|Overall Study|Lack of Efficacy|12|||
130244696|NCT00758043|468856979|FG000|Overall Study|Refused Further Treatment|0|||
130244697|NCT00758043|468856980|FG001|Overall Study|Refused Further Treatment|11|||
130244698|NCT00758043|468856981|FG002|Overall Study|Refused Further Treatment|5|||
130244699|NCT00758043|468856982|FG003|Overall Study|Refused Further Treatment|8|||
130244700|NCT00758043|468856979|FG000|Overall Study|Lost to Follow-up|0|||
130244701|NCT00758043|468856980|FG001|Overall Study|Lost to Follow-up|2|||
130244702|NCT00758043|468856981|FG002|Overall Study|Lost to Follow-up|2|||
130244703|NCT00758043|468856982|FG003|Overall Study|Lost to Follow-up|5|||
130244704|NCT00758043|468856979|FG000|Overall Study|Withdrawal by Subject|0|||
130244705|NCT00758043|468856980|FG001|Overall Study|Withdrawal by Subject|1|||
130244706|NCT00758043|468856981|FG002|Overall Study|Withdrawal by Subject|1|||
130244707|NCT00758043|468856982|FG003|Overall Study|Withdrawal by Subject|4|||
130244708|NCT00758043|468856979|FG000|Overall Study|Required Prohibited Medication|0|||
130244709|NCT00758043|468856980|FG001|Overall Study|Required Prohibited Medication|0|||
130244710|NCT00758043|468856981|FG002|Overall Study|Required Prohibited Medication|1|||
130244711|NCT00758043|468856982|FG003|Overall Study|Required Prohibited Medication|3|||
130244712|NCT00758043|468856979|FG000|Overall Study|Non-Compliant With study Drug|0|||
130244713|NCT00758043|468856980|FG001|Overall Study|Non-Compliant With study Drug|0|||
130244714|NCT00758043|468856981|FG002|Overall Study|Non-Compliant With study Drug|0|||
130244715|NCT00758043|468856982|FG003|Overall Study|Non-Compliant With study Drug|1|||
130244716|NCT00758043|468856979|FG000|Overall Study|Other Reasons|0|||
130244717|NCT00758043|468856980|FG001|Overall Study|Other Reasons|1|||
130244718|NCT00758043|468856981|FG002|Overall Study|Other Reasons|0|||
130244719|NCT00758043|468856982|FG003|Overall Study|Other Reasons|5|||
130244720|NCT02400580|468856987|FG000|Overall Study|Withdrawal by Subject|1|||
130244721|NCT02400580|468856988|FG001|Overall Study|Withdrawal by Subject|1|||
130244722|NCT02400580|468856987|FG000|Overall Study|Adverse Event|1|||
130244723|NCT02400580|468856988|FG001|Overall Study|Adverse Event|0|||
130244724|NCT00965094|468856989|FG000|Overall Study|Adverse Event|5|||
130244725|NCT00965094|468856990|FG001|Overall Study|Adverse Event|0|||
130244726|NCT00965094|468856989|FG000|Overall Study|Lost to Follow-up|0|||
130244727|NCT00965094|468856990|FG001|Overall Study|Lost to Follow-up|1|||
130244728|NCT01336972|468856994|FG000|Overall Study|Adverse Event|1|||
130244729|NCT01336972|468856995|FG001|Overall Study|Adverse Event|1|||
130244730|NCT01336972|468856996|FG002|Overall Study|Adverse Event|0|||
130244731|NCT02441114|468856997|FG000|Washout2|Withdrawal by Subject|4|||
130244732|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
130244733|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
130244734|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
130244735|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
130244736|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
130244737|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
130244738|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
130244739|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
130244740|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
130699073|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
130699074|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
130244741|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
130244742|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
130244743|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
130244744|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
130244745|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
130244746|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
130244747|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
130244748|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130363272|NCT01402011|469299654|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
130363273|NCT01402011|469299655|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
130363274|NCT01402011|469299653|FG000|Active Treatment Period|Withdrawal by Subject|1|||
130363275|NCT01402011|469299654|FG001|Active Treatment Period|Withdrawal by Subject|3|||
130363276|NCT01402011|469299655|FG002|Active Treatment Period|Withdrawal by Subject|0|||
130363277|NCT01402011|469299653|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
130363278|NCT01402011|469299654|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
130363279|NCT01402011|469299655|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
130363280|NCT02569671|469299656|FG000|Overall Study|Lost to Follow-up|2|||
130363281|NCT02569671|469299657|FG001|Overall Study|Lost to Follow-up|1|||
130363282|NCT02569671|469299656|FG000|Overall Study|Withdrawal by Subject|1|||
130363283|NCT02569671|469299657|FG001|Overall Study|Withdrawal by Subject|3|||
130363284|NCT02612129|469299658|FG000|Single Dose Treatment Period|Screening Failure|1|||
130363285|NCT02612129|469299659|FG001|Single Dose Treatment Period|Screening Failure|0|||
130363286|NCT02612129|469299660|FG002|Single Dose Treatment Period|Screening Failure|0|||
130363287|NCT02612129|469299658|FG000|Continuous Treatment Period|Early Escape|0|||
130363288|NCT02612129|469299659|FG001|Continuous Treatment Period|Early Escape|2|||
130363289|NCT02612129|469299660|FG002|Continuous Treatment Period|Early Escape|0|||
130363290|NCT02612129|469299658|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
130699075|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
130451155|NCT00049517|469616173|FG002|Induction|Withdrawal by Subject|0|||
130244749|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130244750|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
130244751|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
130244752|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
130244753|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
130244754|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
130244755|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
130244756|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
130244757|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
130244758|NCT01371565|468857003|FG000|Overall Study|Withdrawal by Subject|1|||
130244759|NCT01371565|468857003|FG000|Overall Study|Death|1|||
130244760|NCT01371565|468857003|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
130244761|NCT04270760|468857004|FG000|Overall Study|Withdrawal by Subject|0|||
130244762|NCT04270760|468857005|FG001|Overall Study|Withdrawal by Subject|1|||
130244763|NCT04270760|468857006|FG002|Overall Study|Withdrawal by Subject|3|||
130244764|NCT04270760|468857007|FG003|Overall Study|Withdrawal by Subject|0|||
130244765|NCT04270760|468857008|FG004|Overall Study|Withdrawal by Subject|0|||
130244766|NCT04270760|468857004|FG000|Overall Study|Lost to Follow-up|1|||
130244767|NCT04270760|468857005|FG001|Overall Study|Lost to Follow-up|2|||
130244768|NCT04270760|468857006|FG002|Overall Study|Lost to Follow-up|1|||
130244769|NCT04270760|468857007|FG003|Overall Study|Lost to Follow-up|0|||
130244770|NCT04270760|468857008|FG004|Overall Study|Lost to Follow-up|0|||
130244771|NCT04270760|468857004|FG000|Overall Study|Death|0|||
130244772|NCT04270760|468857005|FG001|Overall Study|Death|0|||
130244773|NCT04270760|468857006|FG002|Overall Study|Death|0|||
130244774|NCT04270760|468857007|FG003|Overall Study|Death|0|||
130244775|NCT04270760|468857008|FG004|Overall Study|Death|1|||
130244776|NCT02070991|468857009|FG000|Overall Study|Death|2|||
130244777|NCT02070991|468857010|FG001|Overall Study|Death|0|||
130244778|NCT02070991|468857009|FG000|Overall Study|Withdrawal by Subject|1|||
130244779|NCT02070991|468857010|FG001|Overall Study|Withdrawal by Subject|0|||
130244780|NCT00827242|468857011|FG000|Overall Study|Withdrawal by Subject|2|||
130244781|NCT00827242|468857012|FG001|Overall Study|Withdrawal by Subject|4|||
130244782|NCT00827242|468857011|FG000|Overall Study|Protocol Violation|1|||
130244783|NCT00827242|468857012|FG001|Overall Study|Protocol Violation|3|||
130244784|NCT00827242|468857011|FG000|Overall Study|Lost to Follow-up|0|||
130244785|NCT00827242|468857012|FG001|Overall Study|Lost to Follow-up|3|||
130244786|NCT00827242|468857011|FG000|Overall Study|Adverse Event Excluding Death|2|||
130244787|NCT00827242|468857012|FG001|Overall Study|Adverse Event Excluding Death|1|||
130244788|NCT00827242|468857011|FG000|Overall Study|Entry Criteria Not Met|4|||
130244789|NCT00827242|468857012|FG001|Overall Study|Entry Criteria Not Met|1|||
130244790|NCT00827242|468857011|FG000|Overall Study|Physician Decision|2|||
130244791|NCT00827242|468857012|FG001|Overall Study|Physician Decision|0|||
130244792|NCT00827242|468857011|FG000|Overall Study|Death|1|||
130244793|NCT00827242|468857012|FG001|Overall Study|Death|0|||
130244794|NCT00827242|468857011|FG000|Overall Study|Lack of Efficacy|1|||
130244795|NCT00827242|468857012|FG001|Overall Study|Lack of Efficacy|0|||
130244796|NCT02609633|468857017|FG000|Overall Study|Consent Withdrawn|0|||
130244797|NCT02609633|468857018|FG001|Overall Study|Consent Withdrawn|1|||
130244798|NCT02609633|468857017|FG000|Overall Study|Protocol Deviation|1|||
130244799|NCT02609633|468857018|FG001|Overall Study|Protocol Deviation|0|||
130244800|NCT02609633|468857017|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
130244801|NCT02609633|468857018|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
130244802|NCT02609633|468857017|FG000|Overall Study|Reason not Specified|2|||
130244803|NCT02609633|468857018|FG001|Overall Study|Reason not Specified|1|||
130244804|NCT05987540|468857019|FG000|Overall Study|Withdrawal by Subject|2|||
130244805|NCT05987540|468857019|FG000|Overall Study|Death|1|||
130244806|NCT05987540|468857019|FG000|Overall Study|Study Termination|1|||
130244807|NCT05987540|468857019|FG000|Overall Study|Adverse Event|2|||
130244808|NCT00471107|468857020|FG000|Overall Study|Technical problems/data loss|3|||
130244809|NCT00471107|468857021|FG001|Overall Study|Technical problems/data loss|1|||
130244810|NCT00471107|468857022|FG002|Overall Study|Technical problems/data loss|3|||
130244811|NCT01769443|468857023|FG000|Overall Study|Study closure|1|||
130244812|NCT01769443|468857024|FG001|Overall Study|Study closure|0|||
130244813|NCT04996264|468857025|FG000|Overall Study|Lost to Follow-up|0|||
130244814|NCT04996264|468857026|FG001|Overall Study|Lost to Follow-up|1|||
130244815|NCT04996264|468857025|FG000|Overall Study|Withdrawal by Subject|4|||
130244816|NCT04996264|468857026|FG001|Overall Study|Withdrawal by Subject|3|||
130244817|NCT04996264|468857025|FG000|Overall Study|1 left AMA|0|||
130244818|NCT04996264|468857026|FG001|Overall Study|1 left AMA|1|||
130244819|NCT04996264|468857025|FG000|Overall Study|Subject changed hospitals|0|||
130363291|NCT02612129|469299659|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
130363292|NCT02612129|469299660|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
130363293|NCT02612129|469299658|FG000|Continuous Treatment Period|Safety Reasons|0|||
130451156|NCT00049517|469616174|FG003|Induction|Withdrawal by Subject|0|||
130699076|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
130451157|NCT00049517|469616175|FG004|Induction|Withdrawal by Subject|1|||
130451158|NCT00049517|469616176|FG005|Induction|Withdrawal by Subject|3|||
130451159|NCT00049517|469616171|FG000|Induction|Alternative therapy|0|||
130451160|NCT00049517|469616172|FG001|Induction|Alternative therapy|0|||
130451161|NCT00049517|469616173|FG002|Induction|Alternative therapy|0|||
130451162|NCT00049517|469616174|FG003|Induction|Alternative therapy|0|||
130451163|NCT00049517|469616175|FG004|Induction|Alternative therapy|2|||
130451164|NCT00049517|469616176|FG005|Induction|Alternative therapy|2|||
130451165|NCT00049517|469616171|FG000|Induction|Other complicating disease|0|||
130451166|NCT00049517|469616172|FG001|Induction|Other complicating disease|0|||
130451167|NCT00049517|469616173|FG002|Induction|Other complicating disease|0|||
130451168|NCT00049517|469616174|FG003|Induction|Other complicating disease|0|||
130451169|NCT00049517|469616175|FG004|Induction|Other complicating disease|3|||
130451170|NCT00049517|469616176|FG005|Induction|Other complicating disease|0|||
130451171|NCT00049517|469616171|FG000|Induction|Reasons not reported|0|||
130451172|NCT00049517|469616172|FG001|Induction|Reasons not reported|0|||
130451173|NCT00049517|469616173|FG002|Induction|Reasons not reported|0|||
130451174|NCT00049517|469616174|FG003|Induction|Reasons not reported|0|||
130451175|NCT00049517|469616175|FG004|Induction|Reasons not reported|22|||
130451176|NCT00049517|469616176|FG005|Induction|Reasons not reported|25|||
130451177|NCT00049517|469616171|FG000|Conditioning/Transplant|Disease progression|14|||
130451178|NCT00049517|469616172|FG001|Conditioning/Transplant|Disease progression|6|||
130451179|NCT00049517|469616173|FG002|Conditioning/Transplant|Disease progression|10|||
130451180|NCT00049517|469616174|FG003|Conditioning/Transplant|Disease progression|6|||
130451181|NCT00049517|469616175|FG004|Conditioning/Transplant|Disease progression|0|||
130451182|NCT00049517|469616176|FG005|Conditioning/Transplant|Disease progression|0|||
130451183|NCT00049517|469616171|FG000|Conditioning/Transplant|Adverse Event|2|||
130451184|NCT00049517|469616172|FG001|Conditioning/Transplant|Adverse Event|1|||
130451185|NCT00049517|469616173|FG002|Conditioning/Transplant|Adverse Event|4|||
130451186|NCT00049517|469616174|FG003|Conditioning/Transplant|Adverse Event|8|||
130451187|NCT00049517|469616175|FG004|Conditioning/Transplant|Adverse Event|0|||
130451188|NCT00049517|469616176|FG005|Conditioning/Transplant|Adverse Event|0|||
130451189|NCT00049517|469616171|FG000|Conditioning/Transplant|Death|1|||
130451190|NCT00049517|469616172|FG001|Conditioning/Transplant|Death|0|||
130451191|NCT00049517|469616173|FG002|Conditioning/Transplant|Death|0|||
130451192|NCT00049517|469616174|FG003|Conditioning/Transplant|Death|2|||
130451193|NCT00049517|469616175|FG004|Conditioning/Transplant|Death|0|||
130451194|NCT00049517|469616176|FG005|Conditioning/Transplant|Death|0|||
130451195|NCT00049517|469616171|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
130451196|NCT00049517|469616172|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
130451197|NCT00049517|469616173|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
130451198|NCT00049517|469616174|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
130451199|NCT00049517|469616175|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
130451200|NCT00049517|469616176|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
130451201|NCT00049517|469616171|FG000|Conditioning/Transplant|Alternative therapy|4|||
130451202|NCT00049517|469616172|FG001|Conditioning/Transplant|Alternative therapy|4|||
130451203|NCT00049517|469616173|FG002|Conditioning/Transplant|Alternative therapy|2|||
130451204|NCT00049517|469616174|FG003|Conditioning/Transplant|Alternative therapy|1|||
130451205|NCT00049517|469616175|FG004|Conditioning/Transplant|Alternative therapy|1|||
130451206|NCT00049517|469616176|FG005|Conditioning/Transplant|Alternative therapy|0|||
130451207|NCT00049517|469616171|FG000|Conditioning/Transplant|Other complicating disease|2|||
130451208|NCT00049517|469616172|FG001|Conditioning/Transplant|Other complicating disease|0|||
130451209|NCT00049517|469616173|FG002|Conditioning/Transplant|Other complicating disease|0|||
130451210|NCT00049517|469616174|FG003|Conditioning/Transplant|Other complicating disease|4|||
130451211|NCT00049517|469616175|FG004|Conditioning/Transplant|Other complicating disease|0|||
130451212|NCT00049517|469616176|FG005|Conditioning/Transplant|Other complicating disease|1|||
130451213|NCT00049517|469616171|FG000|Conditioning/Transplant|Reasons not reported|25|||
130451214|NCT00049517|469616172|FG001|Conditioning/Transplant|Reasons not reported|31|||
130699077|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
130699078|NCT02623218|470522783|FG000|Overall Study|Lost to Follow-up|0|||
130451215|NCT00049517|469616173|FG002|Conditioning/Transplant|Reasons not reported|18|||
130451216|NCT00049517|469616174|FG003|Conditioning/Transplant|Reasons not reported|15|||
130451217|NCT00049517|469616175|FG004|Conditioning/Transplant|Reasons not reported|5|||
130451218|NCT00049517|469616176|FG005|Conditioning/Transplant|Reasons not reported|5|||
130451219|NCT01211665|469616179|FG000|Overall Study|Withdrawal by Subject|1|||
130451220|NCT01211665|469616180|FG001|Overall Study|Withdrawal by Subject|0|||
130451221|NCT01211665|469616179|FG000|Overall Study|Death|1|||
130451222|NCT01211665|469616180|FG001|Overall Study|Death|0|||
130451223|NCT01390857|469616183|FG000|Overall Study|Protocol Violation|2|||
130451224|NCT01390857|469616183|FG000|Overall Study|Lost to Follow-up|1|||
130451225|NCT01390857|469616183|FG000|Overall Study|No Visit after the First Visit|7|||
130451226|NCT01123161|469616184|FG000|Overall Study|Lost to Follow-up|1|||
130699079|NCT02623218|470522784|FG001|Overall Study|Lost to Follow-up|1|||
130244820|NCT04996264|468857026|FG001|Overall Study|Subject changed hospitals|1|||
130244821|NCT04996264|468857025|FG000|Overall Study|unable to complete due to work|0|||
130244822|NCT04996264|468857026|FG001|Overall Study|unable to complete due to work|1|||
130244823|NCT04433975|468857027|FG000|1-month Follow Up|Withdrawal by Subject|1|||
130244824|NCT04433975|468857028|FG001|1-month Follow Up|Withdrawal by Subject|1|||
130244825|NCT04433975|468857027|FG000|1-month Follow Up|Lost to Follow-up|21|||
130244826|NCT04433975|468857028|FG001|1-month Follow Up|Lost to Follow-up|25|||
130244827|NCT04433975|468857027|FG000|3-month Follow Up|Lost to Follow-up|20|||
130244828|NCT04433975|468857028|FG001|3-month Follow Up|Lost to Follow-up|24|||
130244829|NCT04433975|468857027|FG000|3-month Follow Up|Death|1|||
130244830|NCT04433975|468857028|FG001|3-month Follow Up|Death|0|||
130244831|NCT04433975|468857027|FG000|3-month Follow Up|Withdrawal by Subject|2|||
130244832|NCT04433975|468857028|FG001|3-month Follow Up|Withdrawal by Subject|0|||
130244833|NCT04433975|468857027|FG000|6-month Follow Up|Lost to Follow-up|23|||
130244834|NCT04433975|468857028|FG001|6-month Follow Up|Lost to Follow-up|28|||
130244835|NCT04433975|468857027|FG000|6-month Follow Up|Withdrawal by Subject|1|||
130244836|NCT04433975|468857028|FG001|6-month Follow Up|Withdrawal by Subject|1|||
130244837|NCT04433975|468857027|FG000|9-month Follow Up|Lost to Follow-up|27|||
130244838|NCT04433975|468857028|FG001|9-month Follow Up|Lost to Follow-up|36|||
130244839|NCT04433975|468857027|FG000|9-month Follow Up|Death|0|||
130244840|NCT04433975|468857028|FG001|9-month Follow Up|Death|1|||
130244841|NCT04433975|468857027|FG000|12-month Follow Up|Lost to Follow-up|27|||
130244842|NCT04433975|468857028|FG001|12-month Follow Up|Lost to Follow-up|31|||
130244843|NCT04606771|468857029|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
130244844|NCT04606771|468857030|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
130244845|NCT04606771|468857029|FG000|Overall Study|Death|5|||
130244846|NCT04606771|468857030|FG001|Overall Study|Death|6|||
130244847|NCT04606771|468857029|FG000|Overall Study|Wrong randomisation|0|||
130244848|NCT04606771|468857030|FG001|Overall Study|Wrong randomisation|1|||
130244849|NCT04392635|468857031|FG000|Overall Study|Lost to Follow-up|0|||
130244850|NCT04392635|468857032|FG001|Overall Study|Lost to Follow-up|1|||
130244851|NCT02030418|468857033|FG000|Overall Study|Death|78|||
130244852|NCT02030418|468857033|FG000|Overall Study|Missed 12-Month Visit|9|||
130244853|NCT02030418|468857033|FG000|Overall Study|Withdrawn|57|||
130244854|NCT01149538|468857036|FG000|Overall Study|Lost to Follow-up|0|||
130244855|NCT01149538|468857037|FG001|Overall Study|Lost to Follow-up|1|||
130244856|NCT01149538|468857036|FG000|Overall Study|Withdrawal by Subject|5|||
130244857|NCT01149538|468857037|FG001|Overall Study|Withdrawal by Subject|3|||
130244858|NCT00250718|468857038|FG000|Overall Study|Death|1|||
130244859|NCT00250718|468857038|FG000|Overall Study|Adverse Event|1|||
130244860|NCT00250718|468857038|FG000|Overall Study|Withdrawal by Subject|1|||
130244861|NCT06100250|468857039|FG000|Overall Study|Lost to Follow-up|5|||
130363294|NCT02612129|469299659|FG001|Continuous Treatment Period|Safety Reasons|3|||
130363295|NCT02612129|469299660|FG002|Continuous Treatment Period|Safety Reasons|0|||
130363296|NCT02612129|469299658|FG000|Continuous Treatment Period|Death|0|||
130363297|NCT02612129|469299659|FG001|Continuous Treatment Period|Death|1|||
130363298|NCT02612129|469299660|FG002|Continuous Treatment Period|Death|0|||
130363299|NCT02612129|469299658|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
130363300|NCT02612129|469299659|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
130363301|NCT02612129|469299660|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
130363302|NCT03487549|469299661|FG000|Overall Study|Protocol Violation|0|||
130363303|NCT03487549|469299662|FG001|Overall Study|Protocol Violation|1|||
130363304|NCT03487549|469299661|FG000|Overall Study|Lost to Follow-up|2|||
130363305|NCT03487549|469299662|FG001|Overall Study|Lost to Follow-up|1|||
130363306|NCT03487549|469299661|FG000|Overall Study|Withdrawal by Subject|2|||
130363307|NCT03487549|469299662|FG001|Overall Study|Withdrawal by Subject|0|||
130363308|NCT00717093|469301949|FG000|Overall Study|Adverse Event|19|||
130363309|NCT00717093|469301950|FG001|Overall Study|Adverse Event|9|||
130363310|NCT00717093|469301949|FG000|Overall Study|Lack of Efficacy|3|||
130363311|NCT00717093|469301950|FG001|Overall Study|Lack of Efficacy|13|||
130363312|NCT00717093|469301949|FG000|Overall Study|Lost to Follow-up|9|||
130363313|NCT00717093|469301950|FG001|Overall Study|Lost to Follow-up|6|||
130363314|NCT00717093|469301949|FG000|Overall Study|Withdrawal by Subject|12|||
130363315|NCT00717093|469301950|FG001|Overall Study|Withdrawal by Subject|19|||
130363316|NCT00717093|469301949|FG000|Overall Study|Other|0|||
130363317|NCT00717093|469301950|FG001|Overall Study|Other|1|||
130244862|NCT02021318|468857040|FG000|Overall Study|Adverse Event|2|||
130244863|NCT02021318|468857041|FG001|Overall Study|Adverse Event|1|||
130244864|NCT02021318|468857040|FG000|Overall Study|Death|33|||
130244865|NCT02021318|468857041|FG001|Overall Study|Death|34|||
130244866|NCT02021318|468857040|FG000|Overall Study|Lost to Follow-up|3|||
130244867|NCT02021318|468857041|FG001|Overall Study|Lost to Follow-up|3|||
130244868|NCT02021318|468857040|FG000|Overall Study|Progressive Disease|0|||
130244869|NCT02021318|468857041|FG001|Overall Study|Progressive Disease|1|||
130244870|NCT02021318|468857040|FG000|Overall Study|Withdrawal by Subject|30|||
130244871|NCT02021318|468857041|FG001|Overall Study|Withdrawal by Subject|18|||
130244872|NCT02021318|468857040|FG000|Overall Study|Physician Decision|3|||
130244873|NCT02021318|468857041|FG001|Overall Study|Physician Decision|3|||
130244874|NCT02021318|468857040|FG000|Overall Study|Miscellaneous|2|||
130244875|NCT02021318|468857041|FG001|Overall Study|Miscellaneous|3|||
130244876|NCT00421993|468857045|FG000|Overall Study|Withdrawal by Subject|22|||
130244877|NCT00421993|468857046|FG001|Overall Study|Withdrawal by Subject|23|||
130244878|NCT00421993|468857047|FG002|Overall Study|Withdrawal by Subject|23|||
130244879|NCT00421993|468857048|FG003|Overall Study|Withdrawal by Subject|24|||
130244880|NCT00421993|468857045|FG000|Overall Study|Lost to Follow-up|18|||
130244881|NCT00421993|468857046|FG001|Overall Study|Lost to Follow-up|19|||
130244882|NCT00421993|468857047|FG002|Overall Study|Lost to Follow-up|22|||
130244883|NCT00421993|468857048|FG003|Overall Study|Lost to Follow-up|20|||
130244884|NCT00421993|468857045|FG000|Overall Study|Adverse Event|11|||
130244885|NCT00421993|468857046|FG001|Overall Study|Adverse Event|1|||
130244886|NCT00421993|468857047|FG002|Overall Study|Adverse Event|6|||
130244887|NCT00421993|468857048|FG003|Overall Study|Adverse Event|4|||
130244888|NCT00421993|468857045|FG000|Overall Study|Protocol Violation|2|||
130244889|NCT00421993|468857046|FG001|Overall Study|Protocol Violation|2|||
130244890|NCT00421993|468857047|FG002|Overall Study|Protocol Violation|0|||
130244891|NCT00421993|468857048|FG003|Overall Study|Protocol Violation|1|||
130244892|NCT00421993|468857045|FG000|Overall Study|Lack of Efficacy|0|||
130244893|NCT00421993|468857046|FG001|Overall Study|Lack of Efficacy|3|||
130244894|NCT00421993|468857047|FG002|Overall Study|Lack of Efficacy|0|||
130244895|NCT00421993|468857048|FG003|Overall Study|Lack of Efficacy|5|||
130244896|NCT00421993|468857045|FG000|Overall Study|Pregnancy|0|||
130244897|NCT00421993|468857046|FG001|Overall Study|Pregnancy|1|||
130244898|NCT00421993|468857047|FG002|Overall Study|Pregnancy|1|||
130244899|NCT00421993|468857048|FG003|Overall Study|Pregnancy|2|||
130244900|NCT00421993|468857045|FG000|Overall Study|Subject transportation issues|0|||
130244901|NCT00421993|468857046|FG001|Overall Study|Subject transportation issues|0|||
130244902|NCT00421993|468857047|FG002|Overall Study|Subject transportation issues|0|||
130244903|NCT00421993|468857048|FG003|Overall Study|Subject transportation issues|1|||
130244904|NCT01980888|468857049|FG000|Overall Study|Study Terminated by Sponsor|116|||
130244905|NCT01980888|468857050|FG001|Overall Study|Study Terminated by Sponsor|122|||
130244906|NCT01980888|468857049|FG000|Overall Study|Withdrew Consent|17|||
130363318|NCT00717093|469301949|FG000|Overall Study|Randomized but not treated|1|||
130363319|NCT00717093|469301950|FG001|Overall Study|Randomized but not treated|0|||
130363320|NCT00531934|469301951|FG000|Overall Study|Adverse Event|4|||
130363321|NCT00531934|469301952|FG001|Overall Study|Adverse Event|8|||
130363322|NCT00531934|469301951|FG000|Overall Study|Progression|52|||
130363323|NCT00531934|469301952|FG001|Overall Study|Progression|42|||
130451227|NCT01123161|469616185|FG001|Overall Study|Lost to Follow-up|0|||
130451228|NCT01123161|469616184|FG000|Overall Study|Withdrawal by Subject|1|||
130451229|NCT01123161|469616185|FG001|Overall Study|Withdrawal by Subject|0|||
130451230|NCT04541186|469616192|FG000|Main Study|Adverse Event|0|||
130451231|NCT04541186|469616193|FG001|Main Study|Adverse Event|0|||
130451232|NCT04541186|469616194|FG002|Main Study|Adverse Event|4|||
130451233|NCT04541186|469616195|FG003|Main Study|Adverse Event|0|||
130451234|NCT04541186|469616196|FG004|Main Study|Adverse Event|0|||
130451235|NCT04541186|469616192|FG000|Main Study|Investigator Decision|0|||
130451236|NCT04541186|469616193|FG001|Main Study|Investigator Decision|0|||
130451237|NCT04541186|469616194|FG002|Main Study|Investigator Decision|1|||
130451238|NCT04541186|469616195|FG003|Main Study|Investigator Decision|1|||
130451239|NCT04541186|469616196|FG004|Main Study|Investigator Decision|0|||
130451240|NCT04541186|469616192|FG000|Main Study|Withdrawal by Subject|1|||
130451241|NCT04541186|469616193|FG001|Main Study|Withdrawal by Subject|1|||
130451242|NCT04541186|469616194|FG002|Main Study|Withdrawal by Subject|0|||
130451243|NCT04541186|469616195|FG003|Main Study|Withdrawal by Subject|0|||
130451244|NCT04541186|469616196|FG004|Main Study|Withdrawal by Subject|0|||
130244907|NCT01980888|468857050|FG001|Overall Study|Withdrew Consent|6|||
130363324|NCT00531934|469301951|FG000|Overall Study|Death|7|||
130244908|NCT01980888|468857049|FG000|Overall Study|Investigator's Discretion|8|||
130244909|NCT01980888|468857050|FG001|Overall Study|Investigator's Discretion|3|||
130244910|NCT01980888|468857049|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130451245|NCT04541186|469616192|FG000|Main Study|COVID-19-related Dose Interruption|0|||
130363325|NCT00531934|469301952|FG001|Overall Study|Death|10|||
130451246|NCT04541186|469616193|FG001|Main Study|COVID-19-related Dose Interruption|0|||
130451247|NCT04541186|469616194|FG002|Main Study|COVID-19-related Dose Interruption|0|||
130363326|NCT00531934|469301951|FG000|Overall Study|Withdrawal by Subject|1|||
130451248|NCT04541186|469616195|FG003|Main Study|COVID-19-related Dose Interruption|0|||
130244911|NCT01980888|468857050|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130244912|NCT05762744|468857056|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
130244913|NCT05762744|468857057|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
130244914|NCT05762744|468857056|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130451249|NCT04541186|469616196|FG004|Main Study|COVID-19-related Dose Interruption|1|||
130451250|NCT04541186|469616192|FG000|Main Study|Randomized in Error Not Treated|0|||
130451251|NCT04541186|469616193|FG001|Main Study|Randomized in Error Not Treated|0|||
130451252|NCT04541186|469616194|FG002|Main Study|Randomized in Error Not Treated|1|||
130451253|NCT04541186|469616195|FG003|Main Study|Randomized in Error Not Treated|0|||
130451254|NCT04541186|469616196|FG004|Main Study|Randomized in Error Not Treated|0|||
130451255|NCT04541186|469616192|FG000|Fibrate Expansion Study|Other than Specified|0|||
130451256|NCT04541186|469616193|FG001|Fibrate Expansion Study|Other than Specified|0|||
130451257|NCT04541186|469616194|FG002|Fibrate Expansion Study|Other than Specified|0|||
130451258|NCT04541186|469616195|FG003|Fibrate Expansion Study|Other than Specified|0|||
130451259|NCT04541186|469616196|FG004|Fibrate Expansion Study|Other than Specified|1|||
130451260|NCT00691028|469616197|FG000|Open-label Period|Adverse Event|0|||
130451261|NCT00691028|469616198|FG001|Open-label Period|Adverse Event|0|||
130451262|NCT00691028|469616199|FG002|Open-label Period|Adverse Event|0|||
130451263|NCT00691028|469616200|FG003|Open-label Period|Adverse Event|16|||
130451264|NCT00691028|469616197|FG000|Open-label Period|Withdrawal by Subject|0|||
130451265|NCT00691028|469616198|FG001|Open-label Period|Withdrawal by Subject|0|||
130451266|NCT00691028|469616199|FG002|Open-label Period|Withdrawal by Subject|0|||
130451267|NCT00691028|469616200|FG003|Open-label Period|Withdrawal by Subject|3|||
130244915|NCT05762744|468857057|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130244916|NCT01671059|468857058|FG000|Overall Study|Adverse Event|4|||
130244917|NCT01671059|468857058|FG000|Overall Study|Lack of Efficacy|1|||
130244918|NCT01030900|468857065|FG000|Overall Study|Not treated due to congestive heart failure|1|||
130244919|NCT01030900|468857065|FG000|Overall Study|Not treated due to rapid disease|1|||
130244920|NCT01179399|468857066|FG000|Overall Study|Adverse Event|1|||
130244921|NCT01179399|468857066|FG000|Overall Study|Lack of Efficacy|30|||
130244922|NCT01179399|468857066|FG000|Overall Study|Withdrawal by Subject|1|||
130451268|NCT00691028|469616197|FG000|Open-label Period|not come to a hospital|0|||
130451269|NCT00691028|469616198|FG001|Open-label Period|not come to a hospital|0|||
130451270|NCT00691028|469616199|FG002|Open-label Period|not come to a hospital|0|||
130451271|NCT00691028|469616200|FG003|Open-label Period|not come to a hospital|1|||
130451272|NCT00691028|469616197|FG000|Double-blind Period|Adverse Event|8|||
130451273|NCT00691028|469616198|FG001|Double-blind Period|Adverse Event|9|||
130451274|NCT00691028|469616199|FG002|Double-blind Period|Adverse Event|6|||
130451275|NCT00691028|469616200|FG003|Double-blind Period|Adverse Event|0|||
130451276|NCT00691028|469616197|FG000|Double-blind Period|Lack of Efficacy|4|||
130451277|NCT00691028|469616198|FG001|Double-blind Period|Lack of Efficacy|3|||
130451278|NCT00691028|469616199|FG002|Double-blind Period|Lack of Efficacy|2|||
130451279|NCT00691028|469616200|FG003|Double-blind Period|Lack of Efficacy|0|||
130451280|NCT00691028|469616197|FG000|Double-blind Period|Withdrawal by Subject|1|||
130451281|NCT00691028|469616198|FG001|Double-blind Period|Withdrawal by Subject|0|||
130451282|NCT00691028|469616199|FG002|Double-blind Period|Withdrawal by Subject|1|||
130451283|NCT00691028|469616200|FG003|Double-blind Period|Withdrawal by Subject|0|||
130451284|NCT00691028|469616197|FG000|Double-blind Period|not come to a hospital.|0|||
130699080|NCT02623218|470522785|FG002|Overall Study|Lost to Follow-up|0|||
130699081|NCT02623218|470522786|FG003|Overall Study|Lost to Follow-up|0|||
130699082|NCT02623218|470522787|FG004|Overall Study|Lost to Follow-up|0|||
130244923|NCT00441896|468857067|FG000|Overall Study|Withdrawal by Subject|0|||
130699083|NCT01726803|470522788|FG000|Overall Study|Lost to Follow-up|6|||
130699084|NCT01726803|470522789|FG001|Overall Study|Lost to Follow-up|1|||
130699085|NCT01726803|470522788|FG000|Overall Study|Withdrawal by Subject|1|||
130699086|NCT01726803|470522789|FG001|Overall Study|Withdrawal by Subject|0|||
130699087|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
130699088|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130699089|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130699090|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
130699091|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699092|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
130699093|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699094|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699095|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699096|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
130699097|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699098|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699099|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
130699100|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
130699101|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
130699102|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
130699103|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130699104|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
130699105|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
130699106|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130699107|NCT01970592|470522795|FG000|Overall Study|Withdrawal by Subject|4|||
130244924|NCT00441896|468857068|FG001|Overall Study|Withdrawal by Subject|0|||
130244925|NCT00441896|468857069|FG002|Overall Study|Withdrawal by Subject|0|||
130244926|NCT00441896|468857070|FG003|Overall Study|Withdrawal by Subject|1|||
130244927|NCT00441896|468857071|FG004|Overall Study|Withdrawal by Subject|0|||
130244928|NCT00441896|468857072|FG005|Overall Study|Withdrawal by Subject|0|||
130244929|NCT00441896|468857073|FG006|Overall Study|Withdrawal by Subject|0|||
130244930|NCT00441896|468857074|FG007|Overall Study|Withdrawal by Subject|0|||
130244931|NCT00441896|468857075|FG008|Overall Study|Withdrawal by Subject|0|||
130244932|NCT00441896|468857076|FG009|Overall Study|Withdrawal by Subject|0|||
130244933|NCT00441896|468857067|FG000|Overall Study|Other|0|||
130244934|NCT00441896|468857068|FG001|Overall Study|Other|0|||
130244935|NCT00441896|468857069|FG002|Overall Study|Other|0|||
130244936|NCT00441896|468857070|FG003|Overall Study|Other|0|||
130244937|NCT00441896|468857071|FG004|Overall Study|Other|1|||
130244938|NCT00441896|468857072|FG005|Overall Study|Other|0|||
130244939|NCT00441896|468857073|FG006|Overall Study|Other|0|||
130244940|NCT00441896|468857074|FG007|Overall Study|Other|0|||
130244941|NCT00441896|468857075|FG008|Overall Study|Other|0|||
130244942|NCT00441896|468857076|FG009|Overall Study|Other|0|||
130244943|NCT01301092|468857077|FG000|Overall Study|Lost to Follow-up|0|||
130244944|NCT01301092|468857078|FG001|Overall Study|Lost to Follow-up|0|||
130244945|NCT01301092|468857079|FG002|Overall Study|Lost to Follow-up|1|||
130244946|NCT03334175|468857080|FG000|Overall Study|Lost to Follow-up|0|||
130244947|NCT03334175|468857081|FG001|Overall Study|Lost to Follow-up|1|||
130244948|NCT01350973|468857082|FG000|Overall Study|Adverse Event|4|||
130244949|NCT01350973|468857083|FG001|Overall Study|Adverse Event|7|||
130244950|NCT01350973|468857084|FG002|Overall Study|Adverse Event|7|||
130244951|NCT01350973|468857082|FG000|Overall Study|Voluntary Withdrawal|2|||
130244952|NCT01350973|468857083|FG001|Overall Study|Voluntary Withdrawal|1|||
130244953|NCT01350973|468857084|FG002|Overall Study|Voluntary Withdrawal|1|||
130244954|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130244955|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
130244956|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130244957|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130244958|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130244959|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130244960|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130244961|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
130244962|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
130244963|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
130244964|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
130244965|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
130451285|NCT00691028|469616198|FG001|Double-blind Period|not come to a hospital.|1|||
130451286|NCT00691028|469616199|FG002|Double-blind Period|not come to a hospital.|0|||
130451287|NCT00691028|469616200|FG003|Double-blind Period|not come to a hospital.|0|||
130451288|NCT03085017|469616201|FG000|Overall Study|Death|0|||
130451289|NCT03085017|469616202|FG001|Overall Study|Death|3|||
130451290|NCT00058058|469616203|FG000|Overall Study|Withdrawal by Subject|4|||
130451291|NCT00058058|469616203|FG000|Overall Study|Ineligible|20|||
130451292|NCT00058058|469616203|FG000|Overall Study|Claustrophobic|5|||
130451293|NCT00058058|469616203|FG000|Overall Study|technical issues|6|||
130451294|NCT00058058|469616203|FG000|Overall Study|Poor positioning, illness,pain|3|||
130451295|NCT03255018|469616214|FG000|Overall Study|Death on study|0|||
130451296|NCT03255018|469616215|FG001|Overall Study|Death on study|5|||
130451297|NCT03255018|469616214|FG000|Overall Study|Withdrawal by Subject|0|||
130451298|NCT03255018|469616215|FG001|Overall Study|Withdrawal by Subject|2|||
130451299|NCT01360840|469616220|FG000|Overall Study|Ongoing at data cut-off|10|||
130451300|NCT01360840|469616221|FG001|Overall Study|Ongoing at data cut-off|10|||
130451301|NCT01360840|469616222|FG002|Overall Study|Ongoing at data cut-off|9|||
130451302|NCT01813422|469616223|FG000|Overall Study|Withdrawal by Subject|14|||
130451303|NCT01813422|469616224|FG001|Overall Study|Withdrawal by Subject|8|||
130451304|NCT01813422|469616223|FG000|Overall Study|Death|2|||
130451305|NCT01813422|469616224|FG001|Overall Study|Death|3|||
130451306|NCT01813422|469616223|FG000|Overall Study|Sponsor Decision|2|||
130244966|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
130244967|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130244968|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130244969|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130244970|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130451307|NCT01813422|469616224|FG001|Overall Study|Sponsor Decision|1|||
130451308|NCT01813422|469616223|FG000|Overall Study|Lost to Follow-up|2|||
130451309|NCT01813422|469616224|FG001|Overall Study|Lost to Follow-up|4|||
130451310|NCT01763047|469616227|FG000|Period 1|Test Article Not Available|4|||
130451311|NCT01763047|469616228|FG001|Period 1|Test Article Not Available|1|||
130451312|NCT01763047|469616227|FG000|Period 1|Protocol Violation|4|||
130244971|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
130244972|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130244973|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130244974|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
130244975|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130244976|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
130244977|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130244978|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130244979|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130244980|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
130244981|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130244982|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130244983|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
130244984|NCT02638493|468857091|FG000|Overall Study|Inability to provide semen samples|2|||
130244985|NCT02638493|468857092|FG001|Overall Study|Inability to provide semen samples|0|||
130244986|NCT02638493|468857093|FG002|Overall Study|Inability to provide semen samples|0|||
130244987|NCT01033071|468857094|FG000|Overall Study|Adverse Event|28|||
130244988|NCT01033071|468857095|FG001|Overall Study|Adverse Event|51|||
130244989|NCT01033071|468857096|FG002|Overall Study|Adverse Event|26|||
130244990|NCT01033071|468857094|FG000|Overall Study|Protocol Violation|0|||
130244991|NCT01033071|468857095|FG001|Overall Study|Protocol Violation|2|||
130244992|NCT01033071|468857096|FG002|Overall Study|Protocol Violation|1|||
130244993|NCT01033071|468857094|FG000|Overall Study|Lost to Follow-up|4|||
130244994|NCT01033071|468857095|FG001|Overall Study|Lost to Follow-up|5|||
130244995|NCT01033071|468857096|FG002|Overall Study|Lost to Follow-up|5|||
130244996|NCT01033071|468857094|FG000|Overall Study|Withdrawal by Subject|17|||
130244997|NCT01033071|468857095|FG001|Overall Study|Withdrawal by Subject|14|||
130244998|NCT01033071|468857096|FG002|Overall Study|Withdrawal by Subject|11|||
130244999|NCT01033071|468857094|FG000|Overall Study|Lack of Efficacy|0|||
130245000|NCT01033071|468857095|FG001|Overall Study|Lack of Efficacy|1|||
130245001|NCT01033071|468857096|FG002|Overall Study|Lack of Efficacy|1|||
130245002|NCT01033071|468857094|FG000|Overall Study|Other|6|||
130245003|NCT01033071|468857095|FG001|Overall Study|Other|4|||
130245004|NCT01033071|468857096|FG002|Overall Study|Other|3|||
130245005|NCT01695772|468857100|FG000|Overall Study|Withdrawal by Subject|18|||
130245006|NCT01695772|468857100|FG000|Overall Study|Progressive Disease|8|||
130245007|NCT01695772|468857100|FG000|Overall Study|Investigator Decision|5|||
130245008|NCT01695772|468857100|FG000|Overall Study|Lost to Follow-up|4|||
130245009|NCT01695772|468857100|FG000|Overall Study|Protocol Violation|2|||
130245010|NCT01695772|468857100|FG000|Overall Study|Unspecified Reason|1|||
130245011|NCT04073407|468857104|FG000|Part 1|Withdrawal by Subject|1|||
130245012|NCT04073407|468857105|FG001|Part 1|Withdrawal by Subject|0|||
130245013|NCT04073407|468857104|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
130245014|NCT04073407|468857105|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
130245015|NCT04073407|468857104|FG000|Part 2|Withdrawal by Subject|0|||
130245016|NCT04073407|468857105|FG001|Part 2|Withdrawal by Subject|1|||
130363327|NCT00531934|469301952|FG001|Overall Study|Withdrawal by Subject|1|||
130363328|NCT00531934|469301951|FG000|Overall Study|Other|2|||
130363329|NCT00531934|469301952|FG001|Overall Study|Other|2|||
130363330|NCT01543698|469301957|FG000|Phase 1b|Disease progression|2|||
130363331|NCT01543698|469301958|FG001|Phase 1b|Disease progression|4|||
130363332|NCT01543698|469301959|FG002|Phase 1b|Disease progression|3|||
130699108|NCT01970592|470522795|FG000|Overall Study|Physician Decision|1|||
130699109|NCT01970592|470522795|FG000|Overall Study|Adverse Event|1|||
130699110|NCT01320722|470522798|FG000|Overall Study|Did not Receive Intervention|3|||
130699111|NCT01320722|470522799|FG001|Overall Study|Did not Receive Intervention|2|||
130699112|NCT01320722|470522800|FG002|Overall Study|Did not Receive Intervention|1|||
130699113|NCT01320722|470522801|FG003|Overall Study|Did not Receive Intervention|1|||
130245017|NCT04941898|468859507|FG000|Overall Study|Protocol Violation|1|||
130245018|NCT02724644|468859508|FG000|Overall Study|Adverse Event|7|||
130245019|NCT02724644|468859509|FG001|Overall Study|Adverse Event|1|||
130245020|NCT02724644|468859508|FG000|Overall Study|Lost to Follow-up|6|||
130245021|NCT02724644|468859509|FG001|Overall Study|Lost to Follow-up|2|||
130245022|NCT02724644|468859508|FG000|Overall Study|Withdrawal by Subject|7|||
130699114|NCT01320722|470522802|FG004|Overall Study|Did not Receive Intervention|2|||
130245023|NCT02724644|468859509|FG001|Overall Study|Withdrawal by Subject|1|||
130245024|NCT02724644|468859508|FG000|Overall Study|Administrative|1|||
130245025|NCT02724644|468859509|FG001|Overall Study|Administrative|0|||
130245026|NCT00884949|468859510|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
130245027|NCT00884949|468859510|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
130245028|NCT03022630|468859511|FG000|Overall Study|Death|9|||
130245029|NCT03022630|468859512|FG001|Overall Study|Death|7|||
130363333|NCT01543698|469301960|FG003|Phase 1b|Disease progression|2|||
130363334|NCT01543698|469301961|FG004|Phase 1b|Disease progression|10|||
130699115|NCT01320722|470522798|FG000|Overall Study|Lost to Follow-up|0|||
130245030|NCT03022630|468859511|FG000|Overall Study|Withdrawal by Subject|0|||
130245031|NCT03022630|468859512|FG001|Overall Study|Withdrawal by Subject|5|||
130245032|NCT01567085|468859515|FG000|Overall Study|Death|6|||
130245033|NCT01567085|468859515|FG000|Overall Study|Adverse Event|6|||
130245034|NCT01567085|468859515|FG000|Overall Study|Lost to Follow-up|3|||
130245035|NCT01567085|468859515|FG000|Overall Study|Graft loss|2|||
130245036|NCT01567085|468859515|FG000|Overall Study|Renal transplantectomy|1|||
130245037|NCT01567085|468859515|FG000|Overall Study|Returned to chronic dialysis|1|||
130245038|NCT01567085|468859515|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
130245039|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245040|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
130245041|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130451313|NCT01763047|469616228|FG001|Period 1|Protocol Violation|4|||
130451314|NCT01763047|469616227|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
130451315|NCT01763047|469616228|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
130451316|NCT01763047|469616227|FG000|Period 1|Adverse Event|0|||
130451317|NCT01763047|469616228|FG001|Period 1|Adverse Event|1|||
130451318|NCT01763047|469616227|FG000|Period 1|Unsatisfactory Visual Response|0|||
130451319|NCT01763047|469616228|FG001|Period 1|Unsatisfactory Visual Response|3|||
130451320|NCT01763047|469616227|FG000|Period 1|Lens Power Not Available|0|||
130451321|NCT01763047|469616228|FG001|Period 1|Lens Power Not Available|1|||
130451322|NCT01763047|469616227|FG000|Period 1|Study Site office Closed|0|||
130451323|NCT01763047|469616228|FG001|Period 1|Study Site office Closed|1|||
130451324|NCT01763047|469616227|FG000|Period 2|Lens Discomfort|1|||
130451325|NCT01763047|469616228|FG001|Period 2|Lens Discomfort|0|||
130451326|NCT01763047|469616227|FG000|Period 2|No longer meets Eligibility Criteria|1|||
130451327|NCT01763047|469616228|FG001|Period 2|No longer meets Eligibility Criteria|0|||
130451328|NCT01763047|469616227|FG000|Period 2|Study Site office Closed|1|||
130451329|NCT01763047|469616228|FG001|Period 2|Study Site office Closed|1|||
130451330|NCT01763047|469616227|FG000|Period 2|Unsatisfactory Visual Response|1|||
130451331|NCT01763047|469616228|FG001|Period 2|Unsatisfactory Visual Response|1|||
130451332|NCT01763047|469616227|FG000|Period 2|Protocol Violation|0|||
130451333|NCT01763047|469616228|FG001|Period 2|Protocol Violation|2|||
130451334|NCT01763047|469616227|FG000|Period 2|Unsatisfactory lens Fitting|0|||
130451335|NCT01763047|469616228|FG001|Period 2|Unsatisfactory lens Fitting|1|||
130451336|NCT02095158|469616234|FG000|Overall Study|Adverse Event|14|||
130451337|NCT02095158|469616234|FG000|Overall Study|Lack of Efficacy|3|||
130451338|NCT02095158|469616234|FG000|Overall Study|Pregnancy|1|||
130451339|NCT02095158|469616234|FG000|Overall Study|Lost to Follow-up|20|||
130451340|NCT02095158|469616234|FG000|Overall Study|Personal Reasons|35|||
130451341|NCT02095158|469616234|FG000|Overall Study|Protocol Violation|1|||
130451342|NCT02095158|469616234|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130451343|NCT02282527|469616235|FG000|Overall Study|Lost to Follow-up|0|||
130451344|NCT02282527|469616236|FG001|Overall Study|Lost to Follow-up|1|||
130451345|NCT02282527|469616235|FG000|Overall Study|Lack of home health aid|1|||
130451346|NCT02282527|469616236|FG001|Overall Study|Lack of home health aid|0|||
130451347|NCT00941031|469616237|FG000|Induction Period|Lack of Efficacy|2|||
130451348|NCT00941031|469616238|FG001|Induction Period|Lack of Efficacy|1|||
130451349|NCT00941031|469616239|FG002|Induction Period|Lack of Efficacy|0|||
130451350|NCT00941031|469616240|FG003|Induction Period|Lack of Efficacy|5|||
130451351|NCT00941031|469616241|FG004|Induction Period|Lack of Efficacy|0|||
130451352|NCT00941031|469616242|FG005|Induction Period|Lack of Efficacy|0|||
130451353|NCT00941031|469616243|FG006|Induction Period|Lack of Efficacy|0|||
130451354|NCT00941031|469616237|FG000|Induction Period|Withdrawal by Subject|1|||
130451355|NCT00941031|469616238|FG001|Induction Period|Withdrawal by Subject|2|||
130245042|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130451356|NCT00941031|469616239|FG002|Induction Period|Withdrawal by Subject|2|||
130245043|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245044|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245045|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
130245046|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245047|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130451357|NCT00941031|469616240|FG003|Induction Period|Withdrawal by Subject|2|||
130451358|NCT00941031|469616241|FG004|Induction Period|Withdrawal by Subject|0|||
130451359|NCT00941031|469616242|FG005|Induction Period|Withdrawal by Subject|0|||
130451360|NCT00941031|469616243|FG006|Induction Period|Withdrawal by Subject|0|||
130451361|NCT00941031|469616237|FG000|Induction Period|Adminstative Problems|1|||
130451362|NCT00941031|469616238|FG001|Induction Period|Adminstative Problems|1|||
130451363|NCT00941031|469616239|FG002|Induction Period|Adminstative Problems|1|||
130451364|NCT00941031|469616240|FG003|Induction Period|Adminstative Problems|0|||
130451365|NCT00941031|469616241|FG004|Induction Period|Adminstative Problems|0|||
130451366|NCT00941031|469616242|FG005|Induction Period|Adminstative Problems|0|||
130699116|NCT01320722|470522799|FG001|Overall Study|Lost to Follow-up|1|||
130699117|NCT01320722|470522800|FG002|Overall Study|Lost to Follow-up|0|||
130699118|NCT01320722|470522801|FG003|Overall Study|Lost to Follow-up|1|||
130451367|NCT00941031|469616243|FG006|Induction Period|Adminstative Problems|0|||
130451368|NCT00941031|469616237|FG000|Induction Period|Adverse Event|1|||
130451369|NCT00941031|469616238|FG001|Induction Period|Adverse Event|0|||
130451370|NCT00941031|469616239|FG002|Induction Period|Adverse Event|3|||
130451371|NCT00941031|469616240|FG003|Induction Period|Adverse Event|2|||
130451372|NCT00941031|469616241|FG004|Induction Period|Adverse Event|0|||
130451373|NCT00941031|469616242|FG005|Induction Period|Adverse Event|0|||
130451374|NCT00941031|469616243|FG006|Induction Period|Adverse Event|0|||
130451375|NCT00941031|469616237|FG000|Maintenance Period|Withdrawal by Subject|0|||
130451376|NCT00941031|469616238|FG001|Maintenance Period|Withdrawal by Subject|0|||
130451377|NCT00941031|469616239|FG002|Maintenance Period|Withdrawal by Subject|0|||
130451378|NCT00941031|469616240|FG003|Maintenance Period|Withdrawal by Subject|0|||
130451379|NCT00941031|469616241|FG004|Maintenance Period|Withdrawal by Subject|6|||
130451380|NCT00941031|469616242|FG005|Maintenance Period|Withdrawal by Subject|2|||
130451381|NCT00941031|469616243|FG006|Maintenance Period|Withdrawal by Subject|13|||
130451382|NCT00941031|469616237|FG000|Maintenance Period|Administrative Problems|0|||
130451383|NCT00941031|469616238|FG001|Maintenance Period|Administrative Problems|0|||
130451384|NCT00941031|469616239|FG002|Maintenance Period|Administrative Problems|0|||
130451385|NCT00941031|469616240|FG003|Maintenance Period|Administrative Problems|0|||
130451386|NCT00941031|469616241|FG004|Maintenance Period|Administrative Problems|1|||
130451387|NCT00941031|469616242|FG005|Maintenance Period|Administrative Problems|0|||
130451388|NCT00941031|469616243|FG006|Maintenance Period|Administrative Problems|1|||
130451389|NCT00941031|469616237|FG000|Maintenance Period|Protocol Violation|0|||
130451390|NCT00941031|469616238|FG001|Maintenance Period|Protocol Violation|0|||
130451391|NCT00941031|469616239|FG002|Maintenance Period|Protocol Violation|0|||
130451392|NCT00941031|469616240|FG003|Maintenance Period|Protocol Violation|0|||
130451393|NCT00941031|469616241|FG004|Maintenance Period|Protocol Violation|0|||
130451394|NCT00941031|469616242|FG005|Maintenance Period|Protocol Violation|0|||
130451395|NCT00941031|469616243|FG006|Maintenance Period|Protocol Violation|1|||
130451396|NCT00941031|469616237|FG000|Maintenance Period|Adverse Event|0|||
130451397|NCT00941031|469616238|FG001|Maintenance Period|Adverse Event|0|||
130451398|NCT00941031|469616239|FG002|Maintenance Period|Adverse Event|0|||
130451399|NCT00941031|469616240|FG003|Maintenance Period|Adverse Event|0|||
130451400|NCT00941031|469616241|FG004|Maintenance Period|Adverse Event|0|||
130451401|NCT00941031|469616242|FG005|Maintenance Period|Adverse Event|2|||
130451402|NCT00941031|469616243|FG006|Maintenance Period|Adverse Event|8|||
130451403|NCT00941031|469616237|FG000|Maintenance Period|Lost to Follow-up|0|||
130451404|NCT00941031|469616238|FG001|Maintenance Period|Lost to Follow-up|0|||
130451405|NCT00941031|469616239|FG002|Maintenance Period|Lost to Follow-up|0|||
130451406|NCT00941031|469616240|FG003|Maintenance Period|Lost to Follow-up|0|||
130451407|NCT00941031|469616241|FG004|Maintenance Period|Lost to Follow-up|2|||
130451408|NCT00941031|469616242|FG005|Maintenance Period|Lost to Follow-up|2|||
130451409|NCT00941031|469616243|FG006|Maintenance Period|Lost to Follow-up|7|||
130451410|NCT00941031|469616237|FG000|Maintenance Period|Lack of Efficacy|0|||
130451411|NCT00941031|469616238|FG001|Maintenance Period|Lack of Efficacy|0|||
130451412|NCT00941031|469616239|FG002|Maintenance Period|Lack of Efficacy|0|||
130451413|NCT00941031|469616240|FG003|Maintenance Period|Lack of Efficacy|0|||
130451414|NCT00941031|469616241|FG004|Maintenance Period|Lack of Efficacy|0|||
130451415|NCT00941031|469616242|FG005|Maintenance Period|Lack of Efficacy|0|||
130451416|NCT00941031|469616243|FG006|Maintenance Period|Lack of Efficacy|13|||
130451417|NCT01872611|469616244|FG000|Overall Study|Adverse Event|3|||
130451418|NCT01872611|469616245|FG001|Overall Study|Adverse Event|1|||
130451419|NCT01872611|469616244|FG000|Overall Study|Adverse Event, prior to treatment|0|||
130451420|NCT01872611|469616245|FG001|Overall Study|Adverse Event, prior to treatment|1|||
130451421|NCT01872611|469616244|FG000|Overall Study|Death|0|||
130451422|NCT01872611|469616245|FG001|Overall Study|Death|1|||
130451423|NCT01872611|469616244|FG000|Overall Study|Death, prior to treatment|0|||
130451424|NCT01872611|469616245|FG001|Overall Study|Death, prior to treatment|1|||
130451425|NCT01872611|469616244|FG000|Overall Study|Lost to Follow-up|8|||
130451426|NCT01872611|469616245|FG001|Overall Study|Lost to Follow-up|1|||
130451427|NCT01872611|469616244|FG000|Overall Study|Physician Decision|1|||
130451428|NCT01872611|469616245|FG001|Overall Study|Physician Decision|0|||
130451429|NCT01872611|469616244|FG000|Overall Study|Withdrawal by Subject|6|||
130699119|NCT01320722|470522802|FG004|Overall Study|Lost to Follow-up|3|||
130451430|NCT01872611|469616245|FG001|Overall Study|Withdrawal by Subject|1|||
130451431|NCT01872611|469616244|FG000|Overall Study|Reason not provided|6|||
130699120|NCT01320722|470522798|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
130451432|NCT01872611|469616245|FG001|Overall Study|Reason not provided|6|||
130451433|NCT03124108|469616246|FG000|Overall Study|Adverse Event|0|||
130451434|NCT03124108|469616247|FG001|Overall Study|Adverse Event|1|||
130451435|NCT03124108|469616248|FG002|Overall Study|Adverse Event|0|||
130451436|NCT00631917|469616249|FG000|Overall Study|Adverse Event|34|||
130451437|NCT00631917|469616250|FG001|Overall Study|Adverse Event|45|||
130451438|NCT00631917|469616249|FG000|Overall Study|Abnormal laboratory value(s)|2|||
130451439|NCT00631917|469616250|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130451440|NCT00631917|469616249|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130245048|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245049|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245050|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245051|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
130245052|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245053|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245054|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245055|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245056|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245057|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
130245058|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
130363335|NCT01543698|469301962|FG005|Phase 1b|Disease progression|6|||
130363336|NCT01543698|469301963|FG006|Phase 1b|Disease progression|5|||
130363337|NCT01543698|469301964|FG007|Phase 1b|Disease progression|3|||
130363338|NCT01543698|469301965|FG008|Phase 1b|Disease progression|4|||
130363339|NCT01543698|469301966|FG009|Phase 1b|Disease progression|5|||
130363340|NCT01543698|469301967|FG010|Phase 1b|Disease progression|1|||
130363341|NCT01543698|469301968|FG011|Phase 1b|Disease progression|0|||
130363342|NCT01543698|469301969|FG012|Phase 1b|Disease progression|0|||
130363343|NCT01543698|469301970|FG013|Phase 1b|Disease progression|0|||
130363344|NCT01543698|469301971|FG014|Phase 1b|Disease progression|0|||
130363345|NCT01543698|469301957|FG000|Phase 1b|Death|0|||
130363346|NCT01543698|469301958|FG001|Phase 1b|Death|0|||
130363347|NCT01543698|469301959|FG002|Phase 1b|Death|1|||
130363348|NCT01543698|469301960|FG003|Phase 1b|Death|1|||
130363349|NCT01543698|469301961|FG004|Phase 1b|Death|0|||
130363350|NCT01543698|469301962|FG005|Phase 1b|Death|0|||
130363351|NCT01543698|469301963|FG006|Phase 1b|Death|0|||
130363352|NCT01543698|469301964|FG007|Phase 1b|Death|0|||
130363353|NCT01543698|469301965|FG008|Phase 1b|Death|0|||
130363354|NCT01543698|469301966|FG009|Phase 1b|Death|0|||
130363355|NCT01543698|469301967|FG010|Phase 1b|Death|1|||
130363356|NCT01543698|469301968|FG011|Phase 1b|Death|0|||
130363357|NCT01543698|469301969|FG012|Phase 1b|Death|0|||
130363358|NCT01543698|469301970|FG013|Phase 1b|Death|0|||
130363359|NCT01543698|469301971|FG014|Phase 1b|Death|0|||
130363360|NCT01543698|469301957|FG000|Phase 1b|Withdrawal by Subject|0|||
130363361|NCT01543698|469301958|FG001|Phase 1b|Withdrawal by Subject|1|||
130363362|NCT01543698|469301959|FG002|Phase 1b|Withdrawal by Subject|0|||
130363363|NCT01543698|469301960|FG003|Phase 1b|Withdrawal by Subject|1|||
130363364|NCT01543698|469301961|FG004|Phase 1b|Withdrawal by Subject|0|||
130363365|NCT01543698|469301962|FG005|Phase 1b|Withdrawal by Subject|0|||
130363366|NCT01543698|469301963|FG006|Phase 1b|Withdrawal by Subject|1|||
130363367|NCT01543698|469301964|FG007|Phase 1b|Withdrawal by Subject|0|||
130363368|NCT01543698|469301965|FG008|Phase 1b|Withdrawal by Subject|0|||
130363369|NCT01543698|469301966|FG009|Phase 1b|Withdrawal by Subject|0|||
130363370|NCT01543698|469301967|FG010|Phase 1b|Withdrawal by Subject|0|||
130363371|NCT01543698|469301968|FG011|Phase 1b|Withdrawal by Subject|0|||
130363372|NCT01543698|469301969|FG012|Phase 1b|Withdrawal by Subject|0|||
130363373|NCT01543698|469301970|FG013|Phase 1b|Withdrawal by Subject|0|||
130363374|NCT01543698|469301971|FG014|Phase 1b|Withdrawal by Subject|0|||
130363375|NCT01543698|469301957|FG000|Phase 1b|Adverse Event|1|||
130363376|NCT01543698|469301958|FG001|Phase 1b|Adverse Event|0|||
130363377|NCT01543698|469301959|FG002|Phase 1b|Adverse Event|0|||
130363378|NCT01543698|469301960|FG003|Phase 1b|Adverse Event|1|||
130363379|NCT01543698|469301961|FG004|Phase 1b|Adverse Event|2|||
130363380|NCT01543698|469301962|FG005|Phase 1b|Adverse Event|2|||
130363381|NCT01543698|469301963|FG006|Phase 1b|Adverse Event|0|||
130363382|NCT01543698|469301964|FG007|Phase 1b|Adverse Event|0|||
130363383|NCT01543698|469301965|FG008|Phase 1b|Adverse Event|1|||
130363384|NCT01543698|469301966|FG009|Phase 1b|Adverse Event|1|||
130363385|NCT01543698|469301967|FG010|Phase 1b|Adverse Event|2|||
130363386|NCT01543698|469301968|FG011|Phase 1b|Adverse Event|0|||
130363387|NCT01543698|469301969|FG012|Phase 1b|Adverse Event|0|||
130363388|NCT01543698|469301970|FG013|Phase 1b|Adverse Event|0|||
130363389|NCT01543698|469301971|FG014|Phase 1b|Adverse Event|0|||
130363390|NCT01543698|469301957|FG000|Phase 1b|Administrative problems|1|||
130363391|NCT01543698|469301958|FG001|Phase 1b|Administrative problems|0|||
130363392|NCT01543698|469301959|FG002|Phase 1b|Administrative problems|0|||
130363393|NCT01543698|469301960|FG003|Phase 1b|Administrative problems|0|||
130363394|NCT01543698|469301961|FG004|Phase 1b|Administrative problems|1|||
130363395|NCT01543698|469301962|FG005|Phase 1b|Administrative problems|0|||
130363396|NCT01543698|469301963|FG006|Phase 1b|Administrative problems|0|||
130363397|NCT01543698|469301964|FG007|Phase 1b|Administrative problems|1|||
130363398|NCT01543698|469301965|FG008|Phase 1b|Administrative problems|0|||
130363399|NCT01543698|469301966|FG009|Phase 1b|Administrative problems|0|||
130363400|NCT01543698|469301967|FG010|Phase 1b|Administrative problems|2|||
130363401|NCT01543698|469301968|FG011|Phase 1b|Administrative problems|0|||
130363402|NCT01543698|469301969|FG012|Phase 1b|Administrative problems|0|||
130363403|NCT01543698|469301970|FG013|Phase 1b|Administrative problems|0|||
130363404|NCT01543698|469301971|FG014|Phase 1b|Administrative problems|0|||
130363405|NCT01543698|469301957|FG000|Phase 1b|Protocol Violation|2|||
130699121|NCT01320722|470522799|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
130245059|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245060|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245061|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245062|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245063|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245064|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245065|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
130245066|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245067|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245068|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245069|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245070|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245071|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
130245072|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130699122|NCT01320722|470522800|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
130699123|NCT01320722|470522801|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
130245073|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245074|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245075|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
130245076|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
130245077|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
130245078|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
130245079|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
130245080|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
130245081|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245082|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245083|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
130245084|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245085|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245086|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245087|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245088|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245089|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245090|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245091|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245092|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
130245093|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245094|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
130363406|NCT01543698|469301958|FG001|Phase 1b|Protocol Violation|0|||
130363407|NCT01543698|469301959|FG002|Phase 1b|Protocol Violation|0|||
130363408|NCT01543698|469301960|FG003|Phase 1b|Protocol Violation|0|||
130363409|NCT01543698|469301961|FG004|Phase 1b|Protocol Violation|0|||
130363410|NCT01543698|469301962|FG005|Phase 1b|Protocol Violation|0|||
130363411|NCT01543698|469301963|FG006|Phase 1b|Protocol Violation|0|||
130363412|NCT01543698|469301964|FG007|Phase 1b|Protocol Violation|0|||
130363413|NCT01543698|469301965|FG008|Phase 1b|Protocol Violation|0|||
130363414|NCT01543698|469301966|FG009|Phase 1b|Protocol Violation|0|||
130363415|NCT01543698|469301967|FG010|Phase 1b|Protocol Violation|0|||
130363416|NCT01543698|469301968|FG011|Phase 1b|Protocol Violation|0|||
130363417|NCT01543698|469301969|FG012|Phase 1b|Protocol Violation|0|||
130363418|NCT01543698|469301970|FG013|Phase 1b|Protocol Violation|0|||
130363419|NCT01543698|469301971|FG014|Phase 1b|Protocol Violation|0|||
130363420|NCT01543698|469301957|FG000|Phase 2|Protocol Violation|0|||
130363421|NCT01543698|469301958|FG001|Phase 2|Protocol Violation|0|||
130363422|NCT01543698|469301959|FG002|Phase 2|Protocol Violation|0|||
130363423|NCT01543698|469301960|FG003|Phase 2|Protocol Violation|0|||
130363424|NCT01543698|469301961|FG004|Phase 2|Protocol Violation|0|||
130363425|NCT01543698|469301962|FG005|Phase 2|Protocol Violation|0|||
130363426|NCT01543698|469301963|FG006|Phase 2|Protocol Violation|0|||
130363427|NCT01543698|469301964|FG007|Phase 2|Protocol Violation|0|||
130363428|NCT01543698|469301965|FG008|Phase 2|Protocol Violation|0|||
130363429|NCT01543698|469301966|FG009|Phase 2|Protocol Violation|0|||
130363430|NCT01543698|469301967|FG010|Phase 2|Protocol Violation|0|||
130363431|NCT01543698|469301968|FG011|Phase 2|Protocol Violation|0|||
130699124|NCT01320722|470522802|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
130363432|NCT01543698|469301969|FG012|Phase 2|Protocol Violation|1|||
130363433|NCT01543698|469301970|FG013|Phase 2|Protocol Violation|0|||
130363434|NCT01543698|469301971|FG014|Phase 2|Protocol Violation|0|||
130363435|NCT01543698|469301957|FG000|Phase 2|Disease progression|0|||
130363436|NCT01543698|469301958|FG001|Phase 2|Disease progression|0|||
130363437|NCT01543698|469301959|FG002|Phase 2|Disease progression|0|||
130245095|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245096|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245097|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
130699125|NCT01320722|470522798|FG000|Overall Study|Participant Developed a Rash|0|||
130245098|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
130245099|NCT04575324|468859527|FG000|Overall Study|Lost to Follow-up|29|||
130245100|NCT04575324|468859528|FG001|Overall Study|Lost to Follow-up|25|||
130245101|NCT04575324|468859527|FG000|Overall Study|Death|1|||
130245102|NCT04575324|468859528|FG001|Overall Study|Death|2|||
130245103|NCT04575324|468859527|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
130245104|NCT04575324|468859528|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
130245105|NCT01002105|468859532|FG000|Overall Study|Lost to Follow-up|10|||
130245106|NCT01002105|468859533|FG001|Overall Study|Lost to Follow-up|16|||
130245107|NCT01002105|468859532|FG000|Overall Study|non compliance|5|||
130245108|NCT01002105|468859533|FG001|Overall Study|non compliance|3|||
130245109|NCT01002105|468859532|FG000|Overall Study|condition worsened|4|||
130245110|NCT01002105|468859533|FG001|Overall Study|condition worsened|2|||
130245111|NCT00327171|468859536|FG000|Overall Study|Did not receive study medication|3|||
130245112|NCT00327171|468859537|FG001|Overall Study|Did not receive study medication|0|||
130245113|NCT00327171|468859536|FG000|Overall Study|Adverse Event|23|||
130245114|NCT00327171|468859537|FG001|Overall Study|Adverse Event|23|||
130245115|NCT00327171|468859536|FG000|Overall Study|Disease progression/lack of efficacy|68|||
130245116|NCT00327171|468859537|FG001|Overall Study|Disease progression/lack of efficacy|69|||
130245117|NCT00327171|468859536|FG000|Overall Study|Investigator/participant request|1|||
130245118|NCT00327171|468859537|FG001|Overall Study|Investigator/participant request|8|||
130245119|NCT00327171|468859536|FG000|Overall Study|Clinical progression|12|||
130245120|NCT00327171|468859537|FG001|Overall Study|Clinical progression|8|||
130245121|NCT00327171|468859536|FG000|Overall Study|Undisclosed history of ischemia|0|||
130245122|NCT00327171|468859537|FG001|Overall Study|Undisclosed history of ischemia|1|||
130245123|NCT00327171|468859536|FG000|Overall Study|Other|1|||
130245124|NCT00327171|468859537|FG001|Overall Study|Other|0|||
130245125|NCT01166945|468859538|FG000|Randomized|diagnosed with Group A strep|4|||
130245126|NCT01166945|468859539|FG001|Randomized|diagnosed with Group A strep|4|||
130245127|NCT01166945|468859538|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
130245128|NCT01166945|468859539|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
130245129|NCT01166945|468859538|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
130245130|NCT01166945|468859539|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
130245131|NCT01166945|468859538|FG000|Day 30|Lost to Follow-up|4|||
130245132|NCT01166945|468859539|FG001|Day 30|Lost to Follow-up|3|||
130245133|NCT00784927|468859543|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
130699126|NCT01320722|470522799|FG001|Overall Study|Participant Developed a Rash|0|||
130699127|NCT01320722|470522800|FG002|Overall Study|Participant Developed a Rash|2|||
130363438|NCT01543698|469301960|FG003|Phase 2|Disease progression|0|||
130363439|NCT01543698|469301961|FG004|Phase 2|Disease progression|0|||
130363440|NCT01543698|469301962|FG005|Phase 2|Disease progression|0|||
130363441|NCT01543698|469301963|FG006|Phase 2|Disease progression|0|||
130363442|NCT01543698|469301964|FG007|Phase 2|Disease progression|0|||
130363443|NCT01543698|469301965|FG008|Phase 2|Disease progression|0|||
130363444|NCT01543698|469301966|FG009|Phase 2|Disease progression|0|||
130363445|NCT01543698|469301967|FG010|Phase 2|Disease progression|0|||
130363446|NCT01543698|469301968|FG011|Phase 2|Disease progression|10|||
130363447|NCT01543698|469301969|FG012|Phase 2|Disease progression|21|||
130363448|NCT01543698|469301970|FG013|Phase 2|Disease progression|30|||
130363449|NCT01543698|469301971|FG014|Phase 2|Disease progression|25|||
130363450|NCT01543698|469301957|FG000|Phase 2|Death|0|||
130363451|NCT01543698|469301958|FG001|Phase 2|Death|0|||
130363452|NCT01543698|469301959|FG002|Phase 2|Death|0|||
130363453|NCT01543698|469301960|FG003|Phase 2|Death|0|||
130363454|NCT01543698|469301961|FG004|Phase 2|Death|0|||
130363455|NCT01543698|469301962|FG005|Phase 2|Death|0|||
130363456|NCT01543698|469301963|FG006|Phase 2|Death|0|||
130363457|NCT01543698|469301964|FG007|Phase 2|Death|0|||
130363458|NCT01543698|469301965|FG008|Phase 2|Death|0|||
130363459|NCT01543698|469301966|FG009|Phase 2|Death|0|||
130451441|NCT00631917|469616250|FG001|Overall Study|Abnormal test procedure result(s)|2|||
130451442|NCT00631917|469616249|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
130451443|NCT00631917|469616250|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
130245134|NCT00784927|468859543|FG000|Overall Study|Protocol Violation|1|||
130245135|NCT00784927|468859543|FG000|Overall Study|Ineligible|1|||
130245136|NCT00422461|468859550|FG000|Overall Study|Adverse Event|1|||
130245137|NCT00422461|468859551|FG001|Overall Study|Adverse Event|2|||
130245138|NCT00422461|468859552|FG002|Overall Study|Adverse Event|1|||
130363460|NCT01543698|469301967|FG010|Phase 2|Death|0|||
130363461|NCT01543698|469301968|FG011|Phase 2|Death|0|||
130363462|NCT01543698|469301969|FG012|Phase 2|Death|1|||
130363463|NCT01543698|469301970|FG013|Phase 2|Death|1|||
130363464|NCT01543698|469301971|FG014|Phase 2|Death|1|||
130363465|NCT01543698|469301957|FG000|Phase 2|Administrative problems|0|||
130363466|NCT01543698|469301958|FG001|Phase 2|Administrative problems|0|||
130363467|NCT01543698|469301959|FG002|Phase 2|Administrative problems|0|||
130245139|NCT00422461|468859553|FG003|Overall Study|Adverse Event|1|||
130245140|NCT00422461|468859550|FG000|Overall Study|Other|0|||
130245141|NCT00422461|468859551|FG001|Overall Study|Other|0|||
130245142|NCT00422461|468859552|FG002|Overall Study|Other|0|||
130245143|NCT00422461|468859553|FG003|Overall Study|Other|2|||
130245144|NCT00422461|468859550|FG000|Overall Study|Participants no longer willing to participate in study|1|||
130451444|NCT00631917|469616249|FG000|Overall Study|No longer required study drug|0|||
130451445|NCT00631917|469616250|FG001|Overall Study|No longer required study drug|1|||
130451446|NCT00631917|469616249|FG000|Overall Study|Protocol deviation|6|||
130451447|NCT00631917|469616250|FG001|Overall Study|Protocol deviation|5|||
130451448|NCT00631917|469616249|FG000|Overall Study|Subject withdrew consent|25|||
130451449|NCT00631917|469616250|FG001|Overall Study|Subject withdrew consent|33|||
130451450|NCT00631917|469616249|FG000|Overall Study|Lost to Follow-up|7|||
130451451|NCT00631917|469616250|FG001|Overall Study|Lost to Follow-up|7|||
130245145|NCT00422461|468859551|FG001|Overall Study|Participants no longer willing to participate in study|0|||
130245146|NCT00422461|468859552|FG002|Overall Study|Participants no longer willing to participate in study|0|||
130245147|NCT00422461|468859553|FG003|Overall Study|Participants no longer willing to participate in study|0|||
130245148|NCT00422461|468859550|FG000|Overall Study|Randomized but not treated|1|||
130245149|NCT00422461|468859551|FG001|Overall Study|Randomized but not treated|1|||
130245150|NCT00422461|468859552|FG002|Overall Study|Randomized but not treated|0|||
130245151|NCT00422461|468859553|FG003|Overall Study|Randomized but not treated|0|||
130245152|NCT01471574|468859554|FG000|Treatment Period|Lack of Efficacy|12|||
130245153|NCT01471574|468859555|FG001|Treatment Period|Lack of Efficacy|4|||
130245154|NCT01471574|468859556|FG002|Treatment Period|Lack of Efficacy|14|||
130245155|NCT01471574|468859557|FG003|Treatment Period|Lack of Efficacy|1|||
130245156|NCT01471574|468859554|FG000|Treatment Period|Adverse Event|7|||
130363468|NCT01543698|469301960|FG003|Phase 2|Administrative problems|0|||
130363469|NCT01543698|469301961|FG004|Phase 2|Administrative problems|0|||
130363470|NCT01543698|469301962|FG005|Phase 2|Administrative problems|0|||
130363471|NCT01543698|469301963|FG006|Phase 2|Administrative problems|0|||
130363472|NCT01543698|469301964|FG007|Phase 2|Administrative problems|0|||
130245157|NCT01471574|468859555|FG001|Treatment Period|Adverse Event|3|||
130245158|NCT01471574|468859556|FG002|Treatment Period|Adverse Event|6|||
130363473|NCT01543698|469301965|FG008|Phase 2|Administrative problems|0|||
130363474|NCT01543698|469301966|FG009|Phase 2|Administrative problems|0|||
130363475|NCT01543698|469301967|FG010|Phase 2|Administrative problems|0|||
130363476|NCT01543698|469301968|FG011|Phase 2|Administrative problems|0|||
130363477|NCT01543698|469301969|FG012|Phase 2|Administrative problems|0|||
130363478|NCT01543698|469301970|FG013|Phase 2|Administrative problems|3|||
130363479|NCT01543698|469301971|FG014|Phase 2|Administrative problems|1|||
130363480|NCT01543698|469301957|FG000|Phase 2|Withdrawal by Subject|0|||
130363481|NCT01543698|469301958|FG001|Phase 2|Withdrawal by Subject|0|||
130363482|NCT01543698|469301959|FG002|Phase 2|Withdrawal by Subject|0|||
130363483|NCT01543698|469301960|FG003|Phase 2|Withdrawal by Subject|0|||
130363484|NCT01543698|469301961|FG004|Phase 2|Withdrawal by Subject|0|||
130363485|NCT01543698|469301962|FG005|Phase 2|Withdrawal by Subject|0|||
130363486|NCT01543698|469301963|FG006|Phase 2|Withdrawal by Subject|0|||
130363487|NCT01543698|469301964|FG007|Phase 2|Withdrawal by Subject|0|||
130363488|NCT01543698|469301965|FG008|Phase 2|Withdrawal by Subject|0|||
130363489|NCT01543698|469301966|FG009|Phase 2|Withdrawal by Subject|0|||
130363490|NCT01543698|469301967|FG010|Phase 2|Withdrawal by Subject|0|||
130363491|NCT01543698|469301968|FG011|Phase 2|Withdrawal by Subject|0|||
130363492|NCT01543698|469301969|FG012|Phase 2|Withdrawal by Subject|0|||
130363493|NCT01543698|469301970|FG013|Phase 2|Withdrawal by Subject|3|||
130363494|NCT01543698|469301971|FG014|Phase 2|Withdrawal by Subject|1|||
130363495|NCT01543698|469301957|FG000|Phase 2|Adverse Event|0|||
130363496|NCT01543698|469301958|FG001|Phase 2|Adverse Event|0|||
130363497|NCT01543698|469301959|FG002|Phase 2|Adverse Event|0|||
130363498|NCT01543698|469301960|FG003|Phase 2|Adverse Event|0|||
130363499|NCT01543698|469301961|FG004|Phase 2|Adverse Event|0|||
130363500|NCT01543698|469301962|FG005|Phase 2|Adverse Event|0|||
130363501|NCT01543698|469301963|FG006|Phase 2|Adverse Event|0|||
130363502|NCT01543698|469301964|FG007|Phase 2|Adverse Event|0|||
130363503|NCT01543698|469301965|FG008|Phase 2|Adverse Event|0|||
130363504|NCT01543698|469301966|FG009|Phase 2|Adverse Event|0|||
130363505|NCT01543698|469301967|FG010|Phase 2|Adverse Event|0|||
130363506|NCT01543698|469301968|FG011|Phase 2|Adverse Event|1|||
130363507|NCT01543698|469301969|FG012|Phase 2|Adverse Event|3|||
130363508|NCT01543698|469301970|FG013|Phase 2|Adverse Event|5|||
130363509|NCT01543698|469301971|FG014|Phase 2|Adverse Event|14|||
130451452|NCT00631917|469616249|FG000|Overall Study|Administrative problems|2|||
130451453|NCT00631917|469616250|FG001|Overall Study|Administrative problems|0|||
130245159|NCT01471574|468859557|FG003|Treatment Period|Adverse Event|1|||
130245160|NCT01471574|468859554|FG000|Treatment Period|Withdrawal by Subject|5|||
130363510|NCT00217620|469301972|FG000|Overall Study|Adverse Event|2|||
130363511|NCT00217620|469301972|FG000|Overall Study|Progression|31|||
130363512|NCT00217620|469301972|FG000|Overall Study|Not Protocol Specified|4|||
130363513|NCT00217620|469301972|FG000|Overall Study|Ineligible|13|||
130363514|NCT00217620|469301972|FG000|Overall Study|Never received treatment|1|||
130363515|NCT00150709|469301973|FG000|Overall Study|Protocol Violation|7|||
130451454|NCT00631917|469616249|FG000|Overall Study|Death|1|||
130451455|NCT00631917|469616250|FG001|Overall Study|Death|0|||
130451456|NCT05650333|469616251|FG000|Treatment Period (7 Days)|Adverse Event|1|||
130451457|NCT02616263|469616252|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
130451458|NCT02616263|469616253|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
130451459|NCT02616263|469616252|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
130451460|NCT02616263|469616253|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
130451461|NCT02616263|469616252|FG000|6 Month to 1.5 Year|Death|1|||
130451462|NCT02616263|469616253|FG001|6 Month to 1.5 Year|Death|0|||
130451463|NCT02616263|469616252|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
130451464|NCT02616263|469616253|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
130451465|NCT02616263|469616252|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
130451466|NCT02616263|469616253|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
130451467|NCT02616263|469616252|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
130451468|NCT02616263|469616253|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
130451469|NCT02939183|469616256|FG000|Overall Study|Death|0|||
130451470|NCT02939183|469616257|FG001|Overall Study|Death|0|||
130451471|NCT02939183|469616258|FG002|Overall Study|Death|1|||
130451472|NCT02939183|469616259|FG003|Overall Study|Death|0|||
130451473|NCT02939183|469616260|FG004|Overall Study|Death|0|||
130451474|NCT02939183|469616261|FG005|Overall Study|Death|2|||
130451475|NCT02939183|469616262|FG006|Overall Study|Death|1|||
130451476|NCT02939183|469616263|FG007|Overall Study|Death|0|||
130451477|NCT02939183|469616264|FG008|Overall Study|Death|0|||
130451478|NCT02939183|469616256|FG000|Overall Study|Sponsor decision|0|||
130451479|NCT02939183|469616257|FG001|Overall Study|Sponsor decision|1|||
130451480|NCT02939183|469616258|FG002|Overall Study|Sponsor decision|0|||
130451481|NCT02939183|469616259|FG003|Overall Study|Sponsor decision|1|||
130451482|NCT02939183|469616260|FG004|Overall Study|Sponsor decision|2|||
130451483|NCT02939183|469616261|FG005|Overall Study|Sponsor decision|0|||
130451484|NCT02939183|469616262|FG006|Overall Study|Sponsor decision|3|||
130451485|NCT02939183|469616263|FG007|Overall Study|Sponsor decision|1|||
130451486|NCT02939183|469616264|FG008|Overall Study|Sponsor decision|4|||
130451487|NCT02939183|469616256|FG000|Overall Study|Withdrawal by Subject|0|||
130451488|NCT02939183|469616257|FG001|Overall Study|Withdrawal by Subject|2|||
130451489|NCT02939183|469616258|FG002|Overall Study|Withdrawal by Subject|0|||
130451490|NCT02939183|469616259|FG003|Overall Study|Withdrawal by Subject|1|||
130451491|NCT02939183|469616260|FG004|Overall Study|Withdrawal by Subject|0|||
130451492|NCT02939183|469616261|FG005|Overall Study|Withdrawal by Subject|0|||
130451493|NCT02939183|469616262|FG006|Overall Study|Withdrawal by Subject|2|||
130451494|NCT02939183|469616263|FG007|Overall Study|Withdrawal by Subject|2|||
130451495|NCT02939183|469616264|FG008|Overall Study|Withdrawal by Subject|2|||
130451496|NCT02939183|469616256|FG000|Overall Study|Not treated due to adverse event|0|||
130451497|NCT02939183|469616257|FG001|Overall Study|Not treated due to adverse event|0|||
130451498|NCT02939183|469616258|FG002|Overall Study|Not treated due to adverse event|0|||
130451499|NCT02939183|469616259|FG003|Overall Study|Not treated due to adverse event|1|||
130451500|NCT02939183|469616260|FG004|Overall Study|Not treated due to adverse event|0|||
130451501|NCT02939183|469616261|FG005|Overall Study|Not treated due to adverse event|0|||
130451502|NCT02939183|469616262|FG006|Overall Study|Not treated due to adverse event|1|||
130451503|NCT02939183|469616263|FG007|Overall Study|Not treated due to adverse event|0|||
130451504|NCT02939183|469616264|FG008|Overall Study|Not treated due to adverse event|0|||
130451505|NCT03424239|469616270|FG000|Overall Study|Withdrawal by Subject|2|||
130451506|NCT00318656|469616271|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
130451507|NCT00318656|469616272|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
130451508|NCT00318656|469616271|FG000|Overall Study|Did not receive any treatment|0|||
130451509|NCT00318656|469616272|FG001|Overall Study|Did not receive any treatment|1|||
130451510|NCT03905135|469616273|FG000|Dose Escalation|Adverse Event|1|||
130451511|NCT03905135|469616274|FG001|Dose Escalation|Adverse Event|1|||
130451512|NCT03905135|469616273|FG000|Dose Escalation|Progressive disease|3|||
130451513|NCT03905135|469616274|FG001|Dose Escalation|Progressive disease|1|||
130451514|NCT03905135|469616273|FG000|Dose Escalation|Intercurrent illness|1|||
130451515|NCT03905135|469616274|FG001|Dose Escalation|Intercurrent illness|0|||
130451516|NCT01740557|469616275|FG000|Overall Study|Ineligible|1|||
130451517|NCT01740557|469616275|FG000|Overall Study|Screen failure|1|||
130451518|NCT00490555|469616276|FG000|Overall Study|noncompliant with drug administration|0|||
130451519|NCT00490555|469616277|FG001|Overall Study|noncompliant with drug administration|0|||
130451520|NCT00490555|469616278|FG002|Overall Study|noncompliant with drug administration|2|||
130451521|NCT00490555|469616279|FG003|Overall Study|noncompliant with drug administration|0|||
130451522|NCT02042443|469616282|FG000|Overall Study|Adverse Event|2|||
130451523|NCT02042443|469616283|FG001|Overall Study|Adverse Event|1|||
130451524|NCT02042443|469616282|FG000|Overall Study|Withdrawal by Subject|0|||
130451525|NCT02042443|469616283|FG001|Overall Study|Withdrawal by Subject|1|||
130451526|NCT02042443|469616282|FG000|Overall Study|Progression|21|||
130451527|NCT02042443|469616283|FG001|Overall Study|Progression|17|||
130451528|NCT02042443|469616282|FG000|Overall Study|not protocol specified|1|||
130451529|NCT02042443|469616283|FG001|Overall Study|not protocol specified|1|||
130245161|NCT01471574|468859555|FG001|Treatment Period|Withdrawal by Subject|1|||
130245162|NCT01471574|468859556|FG002|Treatment Period|Withdrawal by Subject|1|||
130245163|NCT01471574|468859557|FG003|Treatment Period|Withdrawal by Subject|0|||
130245164|NCT01471574|468859554|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
130245165|NCT01471574|468859555|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
130363516|NCT00150709|469301974|FG001|Overall Study|Protocol Violation|8|||
130363517|NCT00150709|469301975|FG002|Overall Study|Protocol Violation|3|||
130363518|NCT00150709|469301976|FG003|Overall Study|Protocol Violation|1|||
130363519|NCT00150709|469301973|FG000|Overall Study|Adverse Event|8|||
130363520|NCT00150709|469301974|FG001|Overall Study|Adverse Event|2|||
130363521|NCT00150709|469301975|FG002|Overall Study|Adverse Event|2|||
130363522|NCT00150709|469301976|FG003|Overall Study|Adverse Event|3|||
130363523|NCT00150709|469301973|FG000|Overall Study|Lack of Efficacy|6|||
130363524|NCT00150709|469301974|FG001|Overall Study|Lack of Efficacy|11|||
130363525|NCT00150709|469301975|FG002|Overall Study|Lack of Efficacy|9|||
130363526|NCT00150709|469301976|FG003|Overall Study|Lack of Efficacy|0|||
130363527|NCT00150709|469301973|FG000|Overall Study|Withdrawal by Subject|7|||
130363528|NCT00150709|469301974|FG001|Overall Study|Withdrawal by Subject|10|||
130363529|NCT00150709|469301975|FG002|Overall Study|Withdrawal by Subject|5|||
130363530|NCT00150709|469301976|FG003|Overall Study|Withdrawal by Subject|0|||
130363531|NCT00150709|469301973|FG000|Overall Study|Lost to Follow-up|3|||
130363532|NCT00150709|469301974|FG001|Overall Study|Lost to Follow-up|2|||
130363533|NCT00150709|469301975|FG002|Overall Study|Lost to Follow-up|0|||
130363534|NCT00150709|469301976|FG003|Overall Study|Lost to Follow-up|0|||
130363535|NCT00150709|469301973|FG000|Overall Study|Sponsor decision|0|||
130363536|NCT00150709|469301974|FG001|Overall Study|Sponsor decision|0|||
130363537|NCT00150709|469301975|FG002|Overall Study|Sponsor decision|0|||
130363538|NCT00150709|469301976|FG003|Overall Study|Sponsor decision|1|||
130363539|NCT00150709|469301973|FG000|Overall Study|Site/Investigator discontinued the study|5|||
130363540|NCT00150709|469301974|FG001|Overall Study|Site/Investigator discontinued the study|5|||
130363541|NCT00150709|469301975|FG002|Overall Study|Site/Investigator discontinued the study|2|||
130363542|NCT00150709|469301976|FG003|Overall Study|Site/Investigator discontinued the study|0|||
130363543|NCT00150709|469301973|FG000|Overall Study|Decision of parent(s)|1|||
130363544|NCT00150709|469301974|FG001|Overall Study|Decision of parent(s)|2|||
130363545|NCT00150709|469301975|FG002|Overall Study|Decision of parent(s)|0|||
130363546|NCT00150709|469301976|FG003|Overall Study|Decision of parent(s)|0|||
130363547|NCT00150709|469301973|FG000|Overall Study|Decision of parent(s) and investigator|3|||
130363548|NCT00150709|469301974|FG001|Overall Study|Decision of parent(s) and investigator|0|||
130363549|NCT00150709|469301975|FG002|Overall Study|Decision of parent(s) and investigator|0|||
130363550|NCT00150709|469301976|FG003|Overall Study|Decision of parent(s) and investigator|0|||
130363551|NCT00150709|469301973|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
130363552|NCT00150709|469301974|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
130363553|NCT00150709|469301975|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
130363554|NCT00150709|469301976|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
130363555|NCT00150709|469301973|FG000|Overall Study|Investigator decision|1|||
130363556|NCT00150709|469301974|FG001|Overall Study|Investigator decision|0|||
130245166|NCT01471574|468859556|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
130245167|NCT01471574|468859557|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
130363557|NCT00150709|469301975|FG002|Overall Study|Investigator decision|0|||
130363558|NCT00150709|469301976|FG003|Overall Study|Investigator decision|1|||
130363559|NCT00150709|469301973|FG000|Overall Study|Subject relocated|2|||
130363560|NCT00150709|469301974|FG001|Overall Study|Subject relocated|2|||
130363561|NCT00150709|469301975|FG002|Overall Study|Subject relocated|1|||
130363562|NCT00150709|469301976|FG003|Overall Study|Subject relocated|0|||
130363563|NCT00150709|469301973|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
130363564|NCT00150709|469301974|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
130363565|NCT00150709|469301975|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
130363566|NCT00150709|469301976|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
130363567|NCT00150709|469301973|FG000|Overall Study|Convenience|0|||
130363568|NCT00150709|469301974|FG001|Overall Study|Convenience|1|||
130363569|NCT00150709|469301975|FG002|Overall Study|Convenience|0|||
130363570|NCT00150709|469301976|FG003|Overall Study|Convenience|0|||
130363571|NCT00150709|469301973|FG000|Overall Study|Subject entered new drug study|0|||
130363572|NCT00150709|469301974|FG001|Overall Study|Subject entered new drug study|1|||
130363573|NCT00150709|469301975|FG002|Overall Study|Subject entered new drug study|0|||
130363574|NCT00150709|469301976|FG003|Overall Study|Subject entered new drug study|0|||
130363575|NCT00150709|469301973|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
130363576|NCT00150709|469301974|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
130363577|NCT00150709|469301975|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
130363578|NCT00150709|469301976|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
130363579|NCT00150709|469301973|FG000|Overall Study|Lack of ease of swallowing|0|||
130363580|NCT00150709|469301974|FG001|Overall Study|Lack of ease of swallowing|1|||
130363581|NCT00150709|469301975|FG002|Overall Study|Lack of ease of swallowing|0|||
130245168|NCT01471574|468859554|FG000|Treatment Period|Lost to Follow-up|1|||
130451530|NCT02042443|469616282|FG000|Overall Study|Not eligible/not analyzable|3|||
130451531|NCT02042443|469616283|FG001|Overall Study|Not eligible/not analyzable|6|||
130451532|NCT01007149|469616286|FG000|Overall Study|Administrative problems|0|||
130451533|NCT01007149|469616287|FG001|Overall Study|Administrative problems|1|||
130451534|NCT02784704|469616288|FG000|Overall Study|Adverse Event|4|||
130451535|NCT02784704|469616289|FG001|Overall Study|Adverse Event|2|||
130451536|NCT02784704|469616288|FG000|Overall Study|Lost to Follow-up|6|||
130451537|NCT02784704|469616289|FG001|Overall Study|Lost to Follow-up|4|||
130451538|NCT02784704|469616288|FG000|Overall Study|Withdrawal by Subject|1|||
130451539|NCT02784704|469616289|FG001|Overall Study|Withdrawal by Subject|3|||
130451540|NCT02784704|469616288|FG000|Overall Study|Subject Non Compliance|2|||
130451541|NCT02784704|469616289|FG001|Overall Study|Subject Non Compliance|0|||
130451542|NCT01913340|469616290|FG000|Overall Study|Death|2|||
130451543|NCT01913340|469616291|FG001|Overall Study|Death|5|||
130451544|NCT01913340|469616290|FG000|Overall Study|Lost to Follow-up|1|||
130451545|NCT01913340|469616291|FG001|Overall Study|Lost to Follow-up|1|||
130451546|NCT05750745|469616293|FG000|Overall Study|Adverse Event|1|||
130451547|NCT05750745|469616294|FG001|Overall Study|Adverse Event|0|||
130451548|NCT05750745|469616295|FG002|Overall Study|Adverse Event|0|||
130451549|NCT05750745|469616293|FG000|Overall Study|Protocol Violation|1|||
130451550|NCT05750745|469616294|FG001|Overall Study|Protocol Violation|0|||
130451551|NCT05750745|469616295|FG002|Overall Study|Protocol Violation|0|||
130451552|NCT05750745|469616293|FG000|Overall Study|Withdrawal by Subject|0|||
130451553|NCT05750745|469616294|FG001|Overall Study|Withdrawal by Subject|1|||
130451554|NCT05750745|469616295|FG002|Overall Study|Withdrawal by Subject|0|||
130451555|NCT00783692|469616298|FG000|Induction Phase|Adverse Event|7|||
130451556|NCT00783692|469616299|FG001|Induction Phase|Adverse Event|9|||
130451557|NCT00783692|469616300|FG002|Induction Phase|Adverse Event|24|||
130451558|NCT00783692|469616301|FG003|Induction Phase|Adverse Event|0|||
130451559|NCT00783692|469616302|FG004|Induction Phase|Adverse Event|0|||
130451560|NCT00783692|469616303|FG005|Induction Phase|Adverse Event|0|||
130451561|NCT00783692|469616304|FG006|Induction Phase|Adverse Event|0|||
130451562|NCT00783692|469616298|FG000|Induction Phase|Protocol Violation|0|||
130451563|NCT00783692|469616299|FG001|Induction Phase|Protocol Violation|0|||
130451564|NCT00783692|469616300|FG002|Induction Phase|Protocol Violation|1|||
130451565|NCT00783692|469616301|FG003|Induction Phase|Protocol Violation|0|||
130451566|NCT00783692|469616302|FG004|Induction Phase|Protocol Violation|0|||
130451567|NCT00783692|469616303|FG005|Induction Phase|Protocol Violation|0|||
130451568|NCT00783692|469616304|FG006|Induction Phase|Protocol Violation|0|||
130451569|NCT00783692|469616298|FG000|Induction Phase|Lack of Efficacy|1|||
130451570|NCT00783692|469616299|FG001|Induction Phase|Lack of Efficacy|3|||
130451571|NCT00783692|469616300|FG002|Induction Phase|Lack of Efficacy|28|||
130451572|NCT00783692|469616301|FG003|Induction Phase|Lack of Efficacy|0|||
130451573|NCT00783692|469616302|FG004|Induction Phase|Lack of Efficacy|0|||
130451574|NCT00783692|469616303|FG005|Induction Phase|Lack of Efficacy|0|||
130451575|NCT00783692|469616304|FG006|Induction Phase|Lack of Efficacy|0|||
130451576|NCT00783692|469616298|FG000|Induction Phase|Withdrawal by Subject|3|||
130451577|NCT00783692|469616299|FG001|Induction Phase|Withdrawal by Subject|9|||
130451578|NCT00783692|469616300|FG002|Induction Phase|Withdrawal by Subject|16|||
130451579|NCT00783692|469616301|FG003|Induction Phase|Withdrawal by Subject|0|||
130451580|NCT00783692|469616302|FG004|Induction Phase|Withdrawal by Subject|0|||
130451581|NCT00783692|469616303|FG005|Induction Phase|Withdrawal by Subject|0|||
130451582|NCT00783692|469616304|FG006|Induction Phase|Withdrawal by Subject|0|||
130451583|NCT00783692|469616298|FG000|Induction Phase|Lost to Follow-up|0|||
130451584|NCT00783692|469616299|FG001|Induction Phase|Lost to Follow-up|0|||
130451585|NCT00783692|469616300|FG002|Induction Phase|Lost to Follow-up|3|||
130451586|NCT00783692|469616301|FG003|Induction Phase|Lost to Follow-up|0|||
130451587|NCT00783692|469616302|FG004|Induction Phase|Lost to Follow-up|0|||
130451588|NCT00783692|469616303|FG005|Induction Phase|Lost to Follow-up|0|||
130451589|NCT00783692|469616304|FG006|Induction Phase|Lost to Follow-up|0|||
130451590|NCT00783692|469616298|FG000|Induction Phase|Other|0|||
130451591|NCT00783692|469616299|FG001|Induction Phase|Other|0|||
130451592|NCT00783692|469616300|FG002|Induction Phase|Other|2|||
130451593|NCT00783692|469616301|FG003|Induction Phase|Other|0|||
130451594|NCT00783692|469616302|FG004|Induction Phase|Other|0|||
130451595|NCT00783692|469616303|FG005|Induction Phase|Other|0|||
130451596|NCT00783692|469616304|FG006|Induction Phase|Other|0|||
130451597|NCT00783692|469616298|FG000|Maintenance Phase|Adverse Event|7|||
130451598|NCT00783692|469616299|FG001|Maintenance Phase|Adverse Event|0|||
130451599|NCT00783692|469616300|FG002|Maintenance Phase|Adverse Event|0|||
130451600|NCT00783692|469616301|FG003|Maintenance Phase|Adverse Event|15|||
130451601|NCT00783692|469616302|FG004|Maintenance Phase|Adverse Event|12|||
130451602|NCT00783692|469616303|FG005|Maintenance Phase|Adverse Event|9|||
130451603|NCT00783692|469616304|FG006|Maintenance Phase|Adverse Event|38|||
130451604|NCT00783692|469616298|FG000|Maintenance Phase|Protocol Violation|0|||
130451605|NCT00783692|469616299|FG001|Maintenance Phase|Protocol Violation|0|||
130451606|NCT00783692|469616300|FG002|Maintenance Phase|Protocol Violation|0|||
130451607|NCT00783692|469616301|FG003|Maintenance Phase|Protocol Violation|1|||
130451608|NCT00783692|469616302|FG004|Maintenance Phase|Protocol Violation|2|||
130451609|NCT00783692|469616303|FG005|Maintenance Phase|Protocol Violation|3|||
130451610|NCT00783692|469616304|FG006|Maintenance Phase|Protocol Violation|4|||
130451611|NCT00783692|469616298|FG000|Maintenance Phase|Lack of Efficacy|79|||
130451612|NCT00783692|469616299|FG001|Maintenance Phase|Lack of Efficacy|0|||
130451613|NCT00783692|469616300|FG002|Maintenance Phase|Lack of Efficacy|0|||
130451614|NCT00783692|469616301|FG003|Maintenance Phase|Lack of Efficacy|64|||
130451615|NCT00783692|469616302|FG004|Maintenance Phase|Lack of Efficacy|58|||
130451616|NCT00783692|469616303|FG005|Maintenance Phase|Lack of Efficacy|48|||
130451617|NCT00783692|469616304|FG006|Maintenance Phase|Lack of Efficacy|177|||
130451618|NCT00783692|469616298|FG000|Maintenance Phase|Withdrawal by Subject|7|||
130451619|NCT00783692|469616299|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130451620|NCT00783692|469616300|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130451621|NCT00783692|469616301|FG003|Maintenance Phase|Withdrawal by Subject|7|||
130451622|NCT00783692|469616302|FG004|Maintenance Phase|Withdrawal by Subject|6|||
130451623|NCT00783692|469616303|FG005|Maintenance Phase|Withdrawal by Subject|9|||
130451624|NCT00783692|469616304|FG006|Maintenance Phase|Withdrawal by Subject|24|||
130451625|NCT00783692|469616298|FG000|Maintenance Phase|Lost to Follow-up|2|||
130451626|NCT00783692|469616299|FG001|Maintenance Phase|Lost to Follow-up|0|||
130451627|NCT00783692|469616300|FG002|Maintenance Phase|Lost to Follow-up|0|||
130451628|NCT00783692|469616301|FG003|Maintenance Phase|Lost to Follow-up|1|||
130451629|NCT00783692|469616302|FG004|Maintenance Phase|Lost to Follow-up|3|||
130451630|NCT00783692|469616303|FG005|Maintenance Phase|Lost to Follow-up|2|||
130451631|NCT00783692|469616304|FG006|Maintenance Phase|Lost to Follow-up|5|||
130451632|NCT00783692|469616298|FG000|Maintenance Phase|Other|0|||
130451633|NCT00783692|469616299|FG001|Maintenance Phase|Other|0|||
130451634|NCT00783692|469616300|FG002|Maintenance Phase|Other|0|||
130451635|NCT00783692|469616301|FG003|Maintenance Phase|Other|1|||
130451636|NCT00783692|469616302|FG004|Maintenance Phase|Other|0|||
130451637|NCT00783692|469616303|FG005|Maintenance Phase|Other|1|||
130451638|NCT00783692|469616304|FG006|Maintenance Phase|Other|1|||
130451639|NCT00768066|469616307|FG000|Overall Study|Did not receive study product injection.|3|||
130451640|NCT00768066|469616308|FG001|Overall Study|Did not receive study product injection.|3|||
130451641|NCT00768066|469616309|FG002|Overall Study|Did not receive study product injection.|0|||
130451642|NCT04831775|469616310|FG000|Overall Study|Lost to Follow-up|11|||
130451643|NCT04831775|469616311|FG001|Overall Study|Lost to Follow-up|13|||
130451644|NCT03015740|469616312|FG000|Overall Study|Adverse Event|1|||
130451645|NCT03015740|469616313|FG001|Overall Study|Adverse Event|0|||
130451646|NCT03015740|469616314|FG002|Overall Study|Adverse Event|0|||
130451647|NCT03015740|469616312|FG000|Overall Study|Death|3|||
130451648|NCT03015740|469616313|FG001|Overall Study|Death|5|||
130451649|NCT03015740|469616314|FG002|Overall Study|Death|0|||
130451650|NCT03015740|469616312|FG000|Overall Study|Withdrawal by Subject|2|||
130451651|NCT03015740|469616313|FG001|Overall Study|Withdrawal by Subject|0|||
130451652|NCT03015740|469616314|FG002|Overall Study|Withdrawal by Subject|0|||
130451653|NCT02449044|469616315|FG000|Overall Study|Lost to Follow-up|2|||
130451654|NCT02449044|469616315|FG000|Overall Study|Withdrawal by Subject|13|||
130451655|NCT02449044|469616315|FG000|Overall Study|Adverse Event|30|||
130451656|NCT02449044|469616315|FG000|Overall Study|Met Withdrawal Criteria|7|||
130451657|NCT02449044|469616315|FG000|Overall Study|Physician Decision|9|||
130451658|NCT02449044|469616315|FG000|Overall Study|Sponsor Discontinued Trial|3|||
130451659|NCT00359619|469618200|FG000|Overall Study|Adverse Event|0|||
130451660|NCT00359619|469618201|FG001|Overall Study|Adverse Event|0|||
130451661|NCT00359619|469618202|FG002|Overall Study|Adverse Event|1|||
130451662|NCT00359619|469618203|FG003|Overall Study|Adverse Event|0|||
130451663|NCT00359619|469618204|FG004|Overall Study|Adverse Event|0|||
130451664|NCT00359619|469618205|FG005|Overall Study|Adverse Event|0|||
130451665|NCT00359619|469618206|FG006|Overall Study|Adverse Event|1|||
130451666|NCT00359619|469618200|FG000|Overall Study|Withdrawal by Subject|3|||
130451667|NCT00359619|469618201|FG001|Overall Study|Withdrawal by Subject|1|||
130451668|NCT00359619|469618202|FG002|Overall Study|Withdrawal by Subject|4|||
130699128|NCT01320722|470522801|FG003|Overall Study|Participant Developed a Rash|1|||
130699129|NCT01320722|470522802|FG004|Overall Study|Participant Developed a Rash|1|||
130699130|NCT01320722|470522798|FG000|Overall Study|Non-compliant with Medication|0|||
130451669|NCT00359619|469618203|FG003|Overall Study|Withdrawal by Subject|2|||
130451670|NCT00359619|469618204|FG004|Overall Study|Withdrawal by Subject|2|||
130699131|NCT01320722|470522799|FG001|Overall Study|Non-compliant with Medication|0|||
130699132|NCT01320722|470522800|FG002|Overall Study|Non-compliant with Medication|1|||
130699133|NCT01320722|470522801|FG003|Overall Study|Non-compliant with Medication|0|||
130451671|NCT00359619|469618205|FG005|Overall Study|Withdrawal by Subject|0|||
130451672|NCT00359619|469618206|FG006|Overall Study|Withdrawal by Subject|3|||
130451673|NCT00359619|469618200|FG000|Overall Study|Other|1|||
130699134|NCT01320722|470522802|FG004|Overall Study|Non-compliant with Medication|0|||
130451674|NCT00359619|469618201|FG001|Overall Study|Other|0|||
130451675|NCT00359619|469618202|FG002|Overall Study|Other|0|||
130699135|NCT01320722|470522798|FG000|Overall Study|Adverse Event|0|||
130699136|NCT01320722|470522799|FG001|Overall Study|Adverse Event|0|||
130451676|NCT00359619|469618203|FG003|Overall Study|Other|0|||
130451677|NCT00359619|469618204|FG004|Overall Study|Other|0|||
130451678|NCT00359619|469618205|FG005|Overall Study|Other|0|||
130451679|NCT00359619|469618206|FG006|Overall Study|Other|0|||
130451680|NCT00359619|469618200|FG000|Overall Study|Lost to Follow-up|4|||
130451681|NCT00359619|469618201|FG001|Overall Study|Lost to Follow-up|4|||
130451682|NCT00359619|469618202|FG002|Overall Study|Lost to Follow-up|2|||
130451683|NCT00359619|469618203|FG003|Overall Study|Lost to Follow-up|1|||
130451684|NCT00359619|469618204|FG004|Overall Study|Lost to Follow-up|1|||
130451685|NCT00359619|469618205|FG005|Overall Study|Lost to Follow-up|5|||
130451686|NCT00359619|469618206|FG006|Overall Study|Lost to Follow-up|0|||
130451687|NCT00256308|469618209|FG000|Overall Study|Death|2|||
130451688|NCT01419717|469618210|FG000|Overall Study|Protocol-specified Criteria|62|||
130451689|NCT01419717|469618210|FG000|Overall Study|Adverse Event|19|||
130451690|NCT01419717|469618210|FG000|Overall Study|Death|17|||
130451691|NCT01419717|469618210|FG000|Overall Study|Withdrawal by Subject|10|||
130451692|NCT01419717|469618210|FG000|Overall Study|Disease Progression|9|||
130451693|NCT01419717|469618210|FG000|Overall Study|Other|4|||
130451694|NCT01419717|469618210|FG000|Overall Study|Lost to Follow-up|2|||
130451695|NCT01419717|469618210|FG000|Overall Study|Administrative Decision|1|||
130451696|NCT01419717|469618210|FG000|Overall Study|Noncompliance|1|||
130451697|NCT02857283|469618211|FG000|First Exposure|Withdrawal by Subject|1|||
130451698|NCT02857283|469618212|FG001|First Exposure|Withdrawal by Subject|0|||
130451699|NCT00587288|469618213|FG000|Overall Study|Adverse Event|0|||
130451700|NCT00587288|469618214|FG001|Overall Study|Adverse Event|1|||
130451701|NCT00587288|469618213|FG000|Overall Study|Lack of Efficacy|2|||
130451702|NCT00587288|469618214|FG001|Overall Study|Lack of Efficacy|8|||
130451703|NCT00587288|469618213|FG000|Overall Study|Protocol Violation|1|||
130451704|NCT00587288|469618214|FG001|Overall Study|Protocol Violation|0|||
130451705|NCT05074498|469618219|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
130451706|NCT05074498|469618220|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
130451707|NCT05074498|469618221|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
130451708|NCT05074498|469618222|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
130451709|NCT05074498|469618223|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
130451710|NCT05074498|469618224|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
130451711|NCT05074498|469618219|FG000|Part 1 (Upto Day 104)|Other|1|||
130451712|NCT05074498|469618220|FG001|Part 1 (Upto Day 104)|Other|0|||
130451713|NCT05074498|469618221|FG002|Part 1 (Upto Day 104)|Other|0|||
130451714|NCT05074498|469618222|FG003|Part 1 (Upto Day 104)|Other|0|||
130451715|NCT05074498|469618223|FG004|Part 1 (Upto Day 104)|Other|0|||
130451716|NCT05074498|469618224|FG005|Part 1 (Upto Day 104)|Other|0|||
130451717|NCT05074498|469618219|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
130451718|NCT05074498|469618220|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
130451719|NCT05074498|469618221|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
130451720|NCT05074498|469618222|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
130451721|NCT05074498|469618223|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
130451722|NCT05074498|469618224|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
130451723|NCT05074498|469618219|FG000|Part 2 (Upto Day 104)|Death|0|||
130451724|NCT05074498|469618220|FG001|Part 2 (Upto Day 104)|Death|0|||
130451725|NCT05074498|469618221|FG002|Part 2 (Upto Day 104)|Death|0|||
130451726|NCT05074498|469618222|FG003|Part 2 (Upto Day 104)|Death|0|||
130451727|NCT05074498|469618223|FG004|Part 2 (Upto Day 104)|Death|1|||
130451728|NCT05074498|469618224|FG005|Part 2 (Upto Day 104)|Death|0|||
130451729|NCT05074498|469618219|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
130451730|NCT05074498|469618220|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
130451731|NCT05074498|469618221|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
130451732|NCT05074498|469618222|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
130451733|NCT05074498|469618223|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
130451734|NCT05074498|469618224|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
130451735|NCT05074498|469618219|FG000|Part 2 (Upto Day 104)|Other|0|||
130451736|NCT05074498|469618220|FG001|Part 2 (Upto Day 104)|Other|0|||
130451737|NCT05074498|469618221|FG002|Part 2 (Upto Day 104)|Other|0|||
130451738|NCT05074498|469618222|FG003|Part 2 (Upto Day 104)|Other|0|||
130451739|NCT05074498|469618223|FG004|Part 2 (Upto Day 104)|Other|1|||
130451740|NCT05074498|469618224|FG005|Part 2 (Upto Day 104)|Other|0|||
130451741|NCT01240356|469618225|FG000|Overall Study|Withdrawal by Subject|2|||
130451742|NCT01240356|469618226|FG001|Overall Study|Withdrawal by Subject|0|||
130451743|NCT01240356|469618225|FG000|Overall Study|MRI contraindication|1|||
130451744|NCT01240356|469618226|FG001|Overall Study|MRI contraindication|0|||
130451745|NCT01244984|469618233|FG000|Overall Study|Adverse Event|2|||
130451746|NCT01244984|469618234|FG001|Overall Study|Adverse Event|11|||
130451747|NCT01244984|469618235|FG002|Overall Study|Adverse Event|2|||
130451748|NCT01244984|469618233|FG000|Overall Study|Protocol Violation|1|||
130451749|NCT01244984|469618234|FG001|Overall Study|Protocol Violation|0|||
130451750|NCT01244984|469618235|FG002|Overall Study|Protocol Violation|0|||
130451751|NCT01244984|469618233|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
130451752|NCT01244984|469618234|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
130451753|NCT01244984|469618235|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
130451754|NCT01244984|469618233|FG000|Overall Study|Withdrawal by Subject|1|||
130451755|NCT01244984|469618234|FG001|Overall Study|Withdrawal by Subject|2|||
130451756|NCT01244984|469618235|FG002|Overall Study|Withdrawal by Subject|2|||
130451757|NCT02072226|469618237|FG000|Overall Study|Lost to Follow-up|11|||
130451758|NCT02072226|469618238|FG001|Overall Study|Lost to Follow-up|7|||
130245169|NCT01471574|468859555|FG001|Treatment Period|Lost to Follow-up|2|||
130245170|NCT01471574|468859556|FG002|Treatment Period|Lost to Follow-up|2|||
130245171|NCT01471574|468859557|FG003|Treatment Period|Lost to Follow-up|0|||
130245172|NCT01471574|468859554|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
130245173|NCT01471574|468859555|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130245174|NCT01471574|468859556|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130451759|NCT02072226|469618237|FG000|Overall Study|Patient Non-compliance|2|||
130451760|NCT02072226|469618238|FG001|Overall Study|Patient Non-compliance|3|||
130245175|NCT01471574|468859557|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130245176|NCT01471574|468859554|FG000|Treatment Period|Other|1|||
130245177|NCT01471574|468859555|FG001|Treatment Period|Other|0|||
130245178|NCT01471574|468859556|FG002|Treatment Period|Other|0|||
130245179|NCT01471574|468859557|FG003|Treatment Period|Other|0|||
130245180|NCT01471574|468859554|FG000|Follow-up Period|Withdrawal by Subject|3|||
130245181|NCT01471574|468859555|FG001|Follow-up Period|Withdrawal by Subject|0|||
130451761|NCT02072226|469618237|FG000|Overall Study|Death|1|||
130451762|NCT02072226|469618238|FG001|Overall Study|Death|0|||
130451763|NCT02072226|469618237|FG000|Overall Study|Patient Withdrawal of Consent|1|||
130451764|NCT02072226|469618238|FG001|Overall Study|Patient Withdrawal of Consent|0|||
130451765|NCT01124162|469618242|FG000|First Intervention|Adverse Event|2|||
130451766|NCT01124162|469618243|FG001|First Intervention|Adverse Event|0|||
130451767|NCT01124162|469618242|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130451768|NCT01124162|469618243|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130451769|NCT02680756|469618246|FG000|Overall Study|Adverse Event|10|||
130451770|NCT02680756|469618247|FG001|Overall Study|Adverse Event|2|||
130451771|NCT02680756|469618246|FG000|Overall Study|Lost to Follow-up|7|||
130451772|NCT02680756|469618247|FG001|Overall Study|Lost to Follow-up|6|||
130451773|NCT02680756|469618246|FG000|Overall Study|Withdrawal by Subject|5|||
130451774|NCT02680756|469618247|FG001|Overall Study|Withdrawal by Subject|5|||
130451775|NCT02680756|469618246|FG000|Overall Study|Physician Decision|4|||
130451776|NCT02680756|469618247|FG001|Overall Study|Physician Decision|1|||
130451777|NCT02680756|469618246|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
130245182|NCT01471574|468859556|FG002|Follow-up Period|Withdrawal by Subject|3|||
130245183|NCT01471574|468859557|FG003|Follow-up Period|Withdrawal by Subject|1|||
130245184|NCT01471574|468859554|FG000|Follow-up Period|Lost to Follow-up|4|||
130245185|NCT01471574|468859555|FG001|Follow-up Period|Lost to Follow-up|1|||
130245186|NCT01471574|468859556|FG002|Follow-up Period|Lost to Follow-up|3|||
130245187|NCT01471574|468859557|FG003|Follow-up Period|Lost to Follow-up|2|||
130245188|NCT01471574|468859554|FG000|Follow-up Period|Death|0|||
130451778|NCT02680756|469618247|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
130451779|NCT02680756|469618246|FG000|Overall Study|Blood transfusion for any reason|0|||
130451780|NCT02680756|469618247|FG001|Overall Study|Blood transfusion for any reason|1|||
130451781|NCT02680756|469618246|FG000|Overall Study|Death|1|||
130451782|NCT02680756|469618247|FG001|Overall Study|Death|0|||
130451783|NCT02680756|469618246|FG000|Overall Study|Protocol Violation|1|||
130451784|NCT02680756|469618247|FG001|Overall Study|Protocol Violation|0|||
130451785|NCT02680756|469618246|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
130451786|NCT02680756|469618247|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
130451787|NCT02680756|469618246|FG000|Overall Study|None of above or not recorded|3|||
130451788|NCT02680756|469618247|FG001|Overall Study|None of above or not recorded|2|||
130451789|NCT01516892|469618249|FG000|Overall Study|Adverse Event|25|||
130451790|NCT01516892|469618249|FG000|Overall Study|Lack of Efficacy|35|||
130451791|NCT01516892|469618249|FG000|Overall Study|Pregnancy|5|||
130245189|NCT01471574|468859555|FG001|Follow-up Period|Death|0|||
130451792|NCT01516892|469618249|FG000|Overall Study|Lost to Follow-up|82|||
130451793|NCT01516892|469618249|FG000|Overall Study|Subject Withdrew Consent|92|||
130451794|NCT01516892|469618249|FG000|Overall Study|Protocol Violation|60|||
130451795|NCT01516892|469618249|FG000|Overall Study|Other Miscellaneous Reasons|43|||
130451796|NCT01516892|469618249|FG000|Overall Study|Missing|1|||
130451797|NCT04381494|469618250|FG000|Overall Study|Early termination of trial|19|||
130451798|NCT04381494|469618250|FG000|Overall Study|Investigator's discretion|1|||
130245190|NCT01471574|468859556|FG002|Follow-up Period|Death|1|||
130245191|NCT01471574|468859557|FG003|Follow-up Period|Death|0|||
130245192|NCT01471574|468859554|FG000|Follow-up Period|Follow-up no longer required|0|||
130245193|NCT01471574|468859555|FG001|Follow-up Period|Follow-up no longer required|1|||
130451799|NCT04381494|469618250|FG000|Overall Study|Withdrawal by Subject|9|||
130451800|NCT04381494|469618250|FG000|Overall Study|NSCLC disease progression|4|||
130451801|NCT04381494|469618250|FG000|Overall Study|Device-Related Adverse Event|2|||
130451802|NCT04310579|469618251|FG000|Overall Study|Adverse Event|0|||
130451803|NCT04310579|469618252|FG001|Overall Study|Adverse Event|0|||
130245194|NCT01471574|468859556|FG002|Follow-up Period|Follow-up no longer required|0|||
130451804|NCT04310579|469618253|FG002|Overall Study|Adverse Event|0|||
130245195|NCT01471574|468859557|FG003|Follow-up Period|Follow-up no longer required|0|||
130245196|NCT01795937|468859558|FG000|Overall Study|Withdrawal by Subject|1|||
130245197|NCT01795937|468859559|FG001|Overall Study|Withdrawal by Subject|0|||
130245198|NCT01795937|468859560|FG002|Overall Study|Withdrawal by Subject|0|||
130245199|NCT01795937|468859558|FG000|Overall Study|Physician Decision|0|||
130245200|NCT01795937|468859559|FG001|Overall Study|Physician Decision|1|||
130245201|NCT01795937|468859560|FG002|Overall Study|Physician Decision|0|||
130245202|NCT04027946|468859561|FG000|Overall Study|Screen failures|3|||
130245203|NCT01028053|468859566|FG000|Overall Study|Screen Failure|113|||
130245204|NCT01028053|468859566|FG000|Overall Study|Patient Request|11|||
130245205|NCT01028053|468859566|FG000|Overall Study|Protocol Violation|1|||
130245206|NCT01028053|468859566|FG000|Overall Study|Physician Decision|2|||
130245207|NCT01028053|468859566|FG000|Overall Study|Technical Problem|1|||
130245208|NCT01028053|468859566|FG000|Overall Study|Terminated by Sponsor|1|||
130245209|NCT01028053|468859566|FG000|Overall Study|Various reasons|4|||
130245210|NCT00983957|468859570|FG000|Overall Study|Adverse Event|1|||
130245211|NCT00983957|468859570|FG000|Overall Study|Personal Reasons|1|||
130245212|NCT00986232|468859571|FG000|Overall Study|Adverse Event|1|||
130245213|NCT00986232|468859572|FG001|Overall Study|Adverse Event|2|||
130245214|NCT00986232|468859573|FG002|Overall Study|Adverse Event|3|||
130245215|NCT00986232|468859574|FG003|Overall Study|Adverse Event|0|||
130245216|NCT00986232|468859571|FG000|Overall Study|Lost to Follow-up|19|||
130245217|NCT00986232|468859572|FG001|Overall Study|Lost to Follow-up|12|||
130245218|NCT00986232|468859573|FG002|Overall Study|Lost to Follow-up|12|||
130245219|NCT00986232|468859574|FG003|Overall Study|Lost to Follow-up|7|||
130245220|NCT00986232|468859571|FG000|Overall Study|Protocol Violation|2|||
130245221|NCT00986232|468859572|FG001|Overall Study|Protocol Violation|3|||
130245222|NCT00986232|468859573|FG002|Overall Study|Protocol Violation|0|||
130245223|NCT00986232|468859574|FG003|Overall Study|Protocol Violation|1|||
130245224|NCT00986232|468859571|FG000|Overall Study|Withdrawal by Subject|13|||
130245225|NCT00986232|468859572|FG001|Overall Study|Withdrawal by Subject|16|||
130245226|NCT00986232|468859573|FG002|Overall Study|Withdrawal by Subject|12|||
130245227|NCT00986232|468859574|FG003|Overall Study|Withdrawal by Subject|3|||
130245228|NCT00986232|468859571|FG000|Overall Study|Missed one or more bleeds|13|||
130245229|NCT00986232|468859572|FG001|Overall Study|Missed one or more bleeds|10|||
130245230|NCT00986232|468859573|FG002|Overall Study|Missed one or more bleeds|6|||
130245231|NCT00986232|468859574|FG003|Overall Study|Missed one or more bleeds|7|||
130245232|NCT00986232|468859571|FG000|Overall Study|Incomplete safety follow-up|3|||
130245233|NCT00986232|468859572|FG001|Overall Study|Incomplete safety follow-up|7|||
130245234|NCT00986232|468859573|FG002|Overall Study|Incomplete safety follow-up|2|||
130245235|NCT00986232|468859574|FG003|Overall Study|Incomplete safety follow-up|2|||
130245236|NCT00790933|468859575|FG000|Overall Study|Adverse Event|94|||
130245237|NCT00790933|468859576|FG001|Overall Study|Adverse Event|119|||
130245238|NCT00790933|468859577|FG002|Overall Study|Adverse Event|65|||
130245239|NCT00790933|468859578|FG003|Overall Study|Adverse Event|5|||
130245240|NCT00790933|468859579|FG004|Overall Study|Adverse Event|69|||
130245241|NCT00790933|468859575|FG000|Overall Study|Protocol Violation(s)|8|||
130245242|NCT00790933|468859576|FG001|Overall Study|Protocol Violation(s)|18|||
130245243|NCT00790933|468859577|FG002|Overall Study|Protocol Violation(s)|7|||
130245244|NCT00790933|468859578|FG003|Overall Study|Protocol Violation(s)|0|||
130245245|NCT00790933|468859579|FG004|Overall Study|Protocol Violation(s)|12|||
130245246|NCT00790933|468859575|FG000|Overall Study|Lack of Efficacy|192|||
130245247|NCT00790933|468859576|FG001|Overall Study|Lack of Efficacy|176|||
130245248|NCT00790933|468859577|FG002|Overall Study|Lack of Efficacy|130|||
130245249|NCT00790933|468859578|FG003|Overall Study|Lack of Efficacy|1|||
130245250|NCT00790933|468859579|FG004|Overall Study|Lack of Efficacy|121|||
130245251|NCT00790933|468859575|FG000|Overall Study|Study Terminated by Sponsor|0|||
130245252|NCT00790933|468859576|FG001|Overall Study|Study Terminated by Sponsor|0|||
130245253|NCT00790933|468859577|FG002|Overall Study|Study Terminated by Sponsor|1|||
130245254|NCT00790933|468859578|FG003|Overall Study|Study Terminated by Sponsor|0|||
130245255|NCT00790933|468859579|FG004|Overall Study|Study Terminated by Sponsor|0|||
130245256|NCT00790933|468859575|FG000|Overall Study|Withdrawal by Subject|123|||
130451805|NCT04310579|469618254|FG003|Overall Study|Adverse Event|0|||
130245257|NCT00790933|468859576|FG001|Overall Study|Withdrawal by Subject|120|||
130245258|NCT00790933|468859577|FG002|Overall Study|Withdrawal by Subject|52|||
130245259|NCT00790933|468859578|FG003|Overall Study|Withdrawal by Subject|6|||
130245260|NCT00790933|468859579|FG004|Overall Study|Withdrawal by Subject|50|||
130245261|NCT00790933|468859575|FG000|Overall Study|Lost to Follow-up|13|||
130245262|NCT00790933|468859576|FG001|Overall Study|Lost to Follow-up|31|||
130245263|NCT00790933|468859577|FG002|Overall Study|Lost to Follow-up|10|||
130245264|NCT00790933|468859578|FG003|Overall Study|Lost to Follow-up|1|||
130245265|NCT00790933|468859579|FG004|Overall Study|Lost to Follow-up|15|||
130245266|NCT00790933|468859575|FG000|Overall Study|Reason Not Specified|8|||
130245267|NCT00790933|468859576|FG001|Overall Study|Reason Not Specified|16|||
130245268|NCT00790933|468859577|FG002|Overall Study|Reason Not Specified|4|||
130245269|NCT00790933|468859578|FG003|Overall Study|Reason Not Specified|1|||
130245270|NCT00790933|468859579|FG004|Overall Study|Reason Not Specified|9|||
130245271|NCT00245570|468859582|FG000|Washout Between Periods III and IV|Adverse Event|0|||
130699137|NCT01320722|470522800|FG002|Overall Study|Adverse Event|3|||
130699138|NCT01320722|470522801|FG003|Overall Study|Adverse Event|6|||
130699139|NCT01320722|470522802|FG004|Overall Study|Adverse Event|0|||
130699140|NCT01320722|470522798|FG000|Overall Study|Not Compliant with Study Procedures|0|||
130699141|NCT01320722|470522799|FG001|Overall Study|Not Compliant with Study Procedures|0|||
130699142|NCT01320722|470522800|FG002|Overall Study|Not Compliant with Study Procedures|0|||
130699143|NCT01320722|470522801|FG003|Overall Study|Not Compliant with Study Procedures|4|||
130699144|NCT01320722|470522802|FG004|Overall Study|Not Compliant with Study Procedures|0|||
130699145|NCT01320722|470522798|FG000|Overall Study|Pregnancy|0|||
130699146|NCT01320722|470522799|FG001|Overall Study|Pregnancy|0|||
130699147|NCT01320722|470522800|FG002|Overall Study|Pregnancy|0|||
130699148|NCT01320722|470522801|FG003|Overall Study|Pregnancy|1|||
130699149|NCT01320722|470522802|FG004|Overall Study|Pregnancy|0|||
130699150|NCT01320722|470522798|FG000|Overall Study|Started an Exclusionary Medication|0|||
130699151|NCT01320722|470522799|FG001|Overall Study|Started an Exclusionary Medication|0|||
130699152|NCT01320722|470522800|FG002|Overall Study|Started an Exclusionary Medication|0|||
130245272|NCT00245570|468859583|FG001|Washout Between Periods III and IV|Adverse Event|1|||
130245273|NCT00245570|468859584|FG002|Washout Between Periods III and IV|Adverse Event|0|||
130245274|NCT00245570|468859585|FG003|Washout Between Periods III and IV|Adverse Event|0|||
130245275|NCT00245570|468859586|FG004|Washout Between Periods III and IV|Adverse Event|0|||
130245276|NCT00245570|468859587|FG005|Washout Between Periods III and IV|Adverse Event|0|||
130245277|NCT01829165|468859588|FG000|Overall Study|Did not complete intervention|2|||
130245278|NCT01829165|468859589|FG001|Overall Study|Did not complete intervention|0|||
130245279|NCT04233580|468859610|FG000|Overall Study|Adverse Event|3|||
130245280|NCT04233580|468859611|FG001|Overall Study|Adverse Event|3|||
130245281|NCT04233580|468859610|FG000|Overall Study|Withdrawal by Subject|2|||
130245282|NCT04233580|468859611|FG001|Overall Study|Withdrawal by Subject|1|||
130245283|NCT03954938|468859612|FG000|Overall Study|Withdrawal by Subject|2|||
130245284|NCT03954938|468859612|FG000|Overall Study|Adverse Event|1|||
130245285|NCT02421510|468859613|FG000|Overall Study|Other|4|||
130245286|NCT02421510|468859614|FG001|Overall Study|Other|2|||
130245287|NCT02421510|468859615|FG002|Overall Study|Other|3|||
130245288|NCT02421510|468859613|FG000|Overall Study|Protocol Violation|1|||
130245289|NCT02421510|468859614|FG001|Overall Study|Protocol Violation|2|||
130245290|NCT02421510|468859615|FG002|Overall Study|Protocol Violation|0|||
130245291|NCT02421510|468859613|FG000|Overall Study|Death|1|||
130245292|NCT02421510|468859614|FG001|Overall Study|Death|0|||
130245293|NCT02421510|468859615|FG002|Overall Study|Death|0|||
130245294|NCT02421510|468859613|FG000|Overall Study|Noncompliance with study drug|1|||
130245295|NCT02421510|468859614|FG001|Overall Study|Noncompliance with study drug|0|||
130245296|NCT02421510|468859615|FG002|Overall Study|Noncompliance with study drug|0|||
130245297|NCT02421510|468859613|FG000|Overall Study|Physician Decision|1|||
130245298|NCT02421510|468859614|FG001|Overall Study|Physician Decision|1|||
130245299|NCT02421510|468859615|FG002|Overall Study|Physician Decision|3|||
130245300|NCT02421510|468859613|FG000|Overall Study|Adverse Event|9|||
130245301|NCT02421510|468859614|FG001|Overall Study|Adverse Event|10|||
130245302|NCT02421510|468859615|FG002|Overall Study|Adverse Event|18|||
130245303|NCT02421510|468859613|FG000|Overall Study|Pregnancy|1|||
130245304|NCT02421510|468859614|FG001|Overall Study|Pregnancy|1|||
130245305|NCT02421510|468859615|FG002|Overall Study|Pregnancy|0|||
130245306|NCT02421510|468859613|FG000|Overall Study|Withdrawal by Subject|14|||
130245307|NCT02421510|468859614|FG001|Overall Study|Withdrawal by Subject|18|||
130245308|NCT02421510|468859615|FG002|Overall Study|Withdrawal by Subject|12|||
130245309|NCT02421510|468859613|FG000|Overall Study|Lost to Follow-up|1|||
130245310|NCT02421510|468859614|FG001|Overall Study|Lost to Follow-up|1|||
130245311|NCT02421510|468859615|FG002|Overall Study|Lost to Follow-up|0|||
130245312|NCT00899847|468859616|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
130245313|NCT00724893|468859619|FG000|Overall Study|Adverse Event|76|||
130245314|NCT00724893|468859620|FG001|Overall Study|Adverse Event|142|||
130245315|NCT00724893|468859619|FG000|Overall Study|Withdrawal by Subject|0|||
130245316|NCT00724893|468859620|FG001|Overall Study|Withdrawal by Subject|1|||
130245317|NCT00724893|468859619|FG000|Overall Study|Lack of virologic response|94|||
130245318|NCT00724893|468859620|FG001|Overall Study|Lack of virologic response|202|||
130245319|NCT00724893|468859619|FG000|Overall Study|Reason not specified|193|||
130245320|NCT00724893|468859620|FG001|Overall Study|Reason not specified|7|||
130699153|NCT01320722|470522801|FG003|Overall Study|Started an Exclusionary Medication|0|||
130245321|NCT00724893|468859619|FG000|Overall Study|Patient choice|0|||
130245322|NCT00724893|468859620|FG001|Overall Study|Patient choice|26|||
130699154|NCT01320722|470522802|FG004|Overall Study|Started an Exclusionary Medication|1|||
130699155|NCT01320722|470522798|FG000|Overall Study|Withdrew due to Health Condition|0|||
130245323|NCT00724893|468859619|FG000|Overall Study|Geographic reasons|0|||
130245324|NCT00724893|468859620|FG001|Overall Study|Geographic reasons|11|||
130245325|NCT00724893|468859619|FG000|Overall Study|Incarceration|0|||
130245326|NCT00724893|468859620|FG001|Overall Study|Incarceration|9|||
130245327|NCT00724893|468859619|FG000|Overall Study|Substance abuse|0|||
130699156|NCT01320722|470522799|FG001|Overall Study|Withdrew due to Health Condition|0|||
130699157|NCT01320722|470522800|FG002|Overall Study|Withdrew due to Health Condition|0|||
130245328|NCT00724893|468859620|FG001|Overall Study|Substance abuse|3|||
130245329|NCT00724893|468859619|FG000|Overall Study|Financial reasons|0|||
130245330|NCT00724893|468859620|FG001|Overall Study|Financial reasons|2|||
130245331|NCT00724893|468859619|FG000|Overall Study|Assigned shorter treatment|0|||
130245332|NCT00724893|468859620|FG001|Overall Study|Assigned shorter treatment|2|||
130245333|NCT00724893|468859619|FG000|Overall Study|Lost to Follow-up|0|||
130245334|NCT00724893|468859620|FG001|Overall Study|Lost to Follow-up|52|||
130245335|NCT00724893|468859619|FG000|Overall Study|Unknown, missing data|1|||
130245336|NCT00724893|468859620|FG001|Overall Study|Unknown, missing data|1|||
130245337|NCT01279200|468859623|FG000|Overall Study|Withdrawal by Subject|1|||
130245338|NCT01279200|468859624|FG001|Overall Study|Withdrawal by Subject|3|||
130245339|NCT01279200|468859623|FG000|Overall Study|Patient withdrawal due to high cost|0|||
130245340|NCT01279200|468859624|FG001|Overall Study|Patient withdrawal due to high cost|1|||
130245341|NCT01279200|468859623|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
130245342|NCT01279200|468859624|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
130245343|NCT01279200|468859623|FG000|Overall Study|ultrasound screening failure|0|||
130245344|NCT01279200|468859624|FG001|Overall Study|ultrasound screening failure|1|||
130245345|NCT01279200|468859623|FG000|Overall Study|Lost to Follow-up|0|||
130245346|NCT01279200|468859624|FG001|Overall Study|Lost to Follow-up|1|||
130245347|NCT01279200|468859623|FG000|Overall Study|Adverse Event|1|||
130245348|NCT01279200|468859624|FG001|Overall Study|Adverse Event|0|||
130245349|NCT00888849|468859627|FG000|Overall Study|Death|4|||
130245350|NCT00888849|468859628|FG001|Overall Study|Death|7|||
130245351|NCT00888849|468859627|FG000|Overall Study|Lost to Follow-up|1|||
130245352|NCT00888849|468859628|FG001|Overall Study|Lost to Follow-up|2|||
130245353|NCT00896233|468859633|FG000|Overall Study|Claustrophobia during MRI|1|||
130245354|NCT04280562|468859634|FG000|Study|Adverse Event|2|||
130245355|NCT04280562|468859635|FG001|Study|Adverse Event|0|||
130245356|NCT04280562|468859634|FG000|Study|Lost to Follow-up|3|||
130245357|NCT04280562|468859635|FG001|Study|Lost to Follow-up|3|||
130245358|NCT05507450|468859639|FG000|Overall Study|Death|0|||
130245359|NCT05507450|468859640|FG001|Overall Study|Death|0|||
130245360|NCT05507450|468859641|FG002|Overall Study|Death|1|||
130245361|NCT05507450|468859642|FG003|Overall Study|Death|0|||
130245362|NCT05507450|468859639|FG000|Overall Study|Lost to Follow-up|22|||
130245363|NCT05507450|468859640|FG001|Overall Study|Lost to Follow-up|20|||
130245364|NCT05507450|468859641|FG002|Overall Study|Lost to Follow-up|20|||
130245365|NCT05507450|468859642|FG003|Overall Study|Lost to Follow-up|7|||
130245366|NCT05507450|468859639|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130245367|NCT05507450|468859640|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130245368|NCT05507450|468859641|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130245369|NCT05507450|468859642|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130245370|NCT05507450|468859639|FG000|Overall Study|Withdrawal by Subject|4|||
130245371|NCT05507450|468859640|FG001|Overall Study|Withdrawal by Subject|11|||
130245372|NCT05507450|468859641|FG002|Overall Study|Withdrawal by Subject|7|||
130245373|NCT05507450|468859642|FG003|Overall Study|Withdrawal by Subject|3|||
130245374|NCT05507450|468859639|FG000|Overall Study|Participant left the country|0|||
130245375|NCT05507450|468859640|FG001|Overall Study|Participant left the country|0|||
130245376|NCT05507450|468859641|FG002|Overall Study|Participant left the country|1|||
130245377|NCT05507450|468859642|FG003|Overall Study|Participant left the country|0|||
130245378|NCT00514917|468859646|FG000|Overall Study|Death|4|||
130245379|NCT00514917|468859647|FG001|Overall Study|Death|10|||
130245380|NCT00514917|468859646|FG000|Overall Study|Protocol Violation|1|||
130245381|NCT00514917|468859647|FG001|Overall Study|Protocol Violation|0|||
130245382|NCT00514917|468859646|FG000|Overall Study|Lost to Follow-up|4|||
130245383|NCT00514917|468859647|FG001|Overall Study|Lost to Follow-up|3|||
130245384|NCT00514917|468859646|FG000|Overall Study|Withdrawal by Subject|18|||
130245385|NCT00514917|468859647|FG001|Overall Study|Withdrawal by Subject|16|||
130245386|NCT00514917|468859646|FG000|Overall Study|Discontinued due to study closure|88|||
130245387|NCT00514917|468859647|FG001|Overall Study|Discontinued due to study closure|81|||
130363582|NCT00150709|469301976|FG003|Overall Study|Lack of ease of swallowing|0|||
130363583|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Adverse Event|16|||
130699158|NCT01320722|470522801|FG003|Overall Study|Withdrew due to Health Condition|0|||
130699159|NCT01320722|470522802|FG004|Overall Study|Withdrew due to Health Condition|1|||
130699160|NCT00160524|470522803|FG000|Overall Study|Adverse Event|119|||
130245388|NCT00514917|468859646|FG000|Overall Study|Undefined|11|||
130245389|NCT00514917|468859647|FG001|Overall Study|Undefined|5|||
130245390|NCT02697422|468859648|FG000|Overall Study|Declined exit survey|9|||
130245391|NCT02697422|468859649|FG001|Overall Study|Declined exit survey|2|||
130245392|NCT02697422|468859648|FG000|Overall Study|Lost to Follow-up|13|||
130245393|NCT02697422|468859649|FG001|Overall Study|Lost to Follow-up|8|||
130245394|NCT02697422|468859648|FG000|Overall Study|Death|2|||
130245395|NCT02697422|468859649|FG001|Overall Study|Death|1|||
130245396|NCT02697422|468859648|FG000|Overall Study|Withdrawal by Subject|0|||
130245397|NCT02697422|468859649|FG001|Overall Study|Withdrawal by Subject|1|||
130245398|NCT02697422|468859648|FG000|Overall Study|Physician Decision|1|||
130245399|NCT02697422|468859649|FG001|Overall Study|Physician Decision|1|||
130245400|NCT02697422|468859648|FG000|Overall Study|Exit survey data lost|1|||
130245401|NCT02697422|468859649|FG001|Overall Study|Exit survey data lost|0|||
130245402|NCT03983109|468859652|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
130245403|NCT03983109|468859653|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
130245404|NCT04149353|468859656|FG000|Overall Study|Study terminated|1|||
130245405|NCT00309244|468859659|FG000|Overall Study|Adverse Event|29|||
130245406|NCT00309244|468859660|FG001|Overall Study|Adverse Event|12|||
130245407|NCT00309244|468859659|FG000|Overall Study|Lost to Follow-up|6|||
130245408|NCT00309244|468859660|FG001|Overall Study|Lost to Follow-up|22|||
130245409|NCT00309244|468859659|FG000|Overall Study|Physician Decision|5|||
130245410|NCT00309244|468859660|FG001|Overall Study|Physician Decision|8|||
130245411|NCT00309244|468859659|FG000|Overall Study|Protocol Violation|6|||
130245412|NCT00309244|468859660|FG001|Overall Study|Protocol Violation|3|||
130245413|NCT00309244|468859659|FG000|Overall Study|Withdrawal by Subject|50|||
130245414|NCT00309244|468859660|FG001|Overall Study|Withdrawal by Subject|32|||
130363584|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Adverse Event|17|||
130363585|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Adverse Event|13|||
130363586|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Adverse Event|18|||
130363587|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Adverse Event|0|||
130363588|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Adverse Event|0|||
130363589|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Adverse Event|0|||
130363590|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Adverse Event|0|||
130363591|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
130363592|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
130363593|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
130363594|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
130363595|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
130363596|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
130363597|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
130363598|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
130363599|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
130363600|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
130363601|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
130363602|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
130363603|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
130363604|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
130363605|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
130363606|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
130363607|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
130363608|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
130363609|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
130363610|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
130363611|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
130363612|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
130363613|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
130363614|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
130363615|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
130363616|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130363617|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
130363618|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
130363619|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130363620|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130363621|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130363622|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130245415|NCT00309244|468859659|FG000|Overall Study|Various|7|||
130245416|NCT00309244|468859660|FG001|Overall Study|Various|7|||
130363623|NCT02975336|469301977|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
130363624|NCT02975336|469301978|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
130363625|NCT02975336|469301979|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
130363626|NCT02975336|469301980|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
130363627|NCT02975336|469301981|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
130363628|NCT02975336|469301982|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
130363629|NCT02975336|469301983|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
130363630|NCT02975336|469301984|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
130363631|NCT02975336|469301977|FG000|LTE (104 Weeks)|Adverse Event|0|||
130363632|NCT02975336|469301978|FG001|LTE (104 Weeks)|Adverse Event|0|||
130363633|NCT02975336|469301979|FG002|LTE (104 Weeks)|Adverse Event|0|||
130363634|NCT02975336|469301980|FG003|LTE (104 Weeks)|Adverse Event|0|||
130245417|NCT00309244|468859659|FG000|Overall Study|Randomized but not dosed|11|||
130363635|NCT02975336|469301981|FG004|LTE (104 Weeks)|Adverse Event|7|||
130363636|NCT02975336|469301982|FG005|LTE (104 Weeks)|Adverse Event|4|||
130363637|NCT02975336|469301983|FG006|LTE (104 Weeks)|Adverse Event|2|||
130363638|NCT02975336|469301984|FG007|LTE (104 Weeks)|Adverse Event|0|||
130363639|NCT02975336|469301977|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
130363640|NCT02975336|469301978|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
130363641|NCT02975336|469301979|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
130363642|NCT02975336|469301980|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
130245418|NCT00309244|468859660|FG001|Overall Study|Randomized but not dosed|12|||
130245419|NCT00309244|468859659|FG000|Overall Study|Death|4|||
130245420|NCT00309244|468859660|FG001|Overall Study|Death|1|||
130245421|NCT01263028|468859661|FG000|Overall Study|Withdrawal by Subject|1|||
130245422|NCT01263028|468859661|FG000|Overall Study|Adverse Event|1|||
130245423|NCT01263028|468859661|FG000|Overall Study|Study terminated due to low enrollment.|4|||
130245424|NCT03019588|468859662|FG000|Overall Study|Death|44|||
130245425|NCT03019588|468859663|FG001|Overall Study|Death|46|||
130245426|NCT03019588|468859662|FG000|Overall Study|Study terminated by Sponsor|3|||
130245427|NCT03019588|468859663|FG001|Overall Study|Study terminated by Sponsor|1|||
130245428|NCT00887588|468859664|FG000|Core Period|Death|1|||
130451806|NCT04310579|469618255|FG004|Overall Study|Adverse Event|0|||
130451807|NCT04310579|469618256|FG005|Overall Study|Adverse Event|0|||
130451808|NCT04310579|469618257|FG006|Overall Study|Adverse Event|2|||
130451809|NCT04310579|469618258|FG007|Overall Study|Adverse Event|0|||
130451810|NCT04310579|469618259|FG008|Overall Study|Adverse Event|1|||
130245429|NCT00887588|468859665|FG001|Core Period|Death|1|||
130245430|NCT00887588|468859664|FG000|Core Period|Lost to Follow-up|3|||
130245431|NCT00887588|468859665|FG001|Core Period|Lost to Follow-up|1|||
130245432|NCT00887588|468859664|FG000|Core Period|Withdrawal by Subject|6|||
130245433|NCT00887588|468859665|FG001|Core Period|Withdrawal by Subject|8|||
130245434|NCT00887588|468859664|FG000|Core Period|Adverse Event|9|||
130245435|NCT00887588|468859665|FG001|Core Period|Adverse Event|11|||
130245436|NCT00887588|468859664|FG000|Extension Period|Adverse Event|4|||
130245437|NCT00887588|468859665|FG001|Extension Period|Adverse Event|4|||
130245438|NCT00887588|468859664|FG000|Extension Period|Death|0|||
130245439|NCT00887588|468859665|FG001|Extension Period|Death|1|||
130245440|NCT00887588|468859664|FG000|Extension Period|Protocol deviation|1|||
130245441|NCT00887588|468859665|FG001|Extension Period|Protocol deviation|0|||
130245442|NCT00887588|468859664|FG000|Extension Period|Lost to Follow-up|1|||
130245443|NCT00887588|468859665|FG001|Extension Period|Lost to Follow-up|0|||
130245444|NCT00366535|468859666|FG000|First Phase: 12 Weeks|Adverse Event|1|||
130245445|NCT00366535|468859667|FG001|First Phase: 12 Weeks|Adverse Event|3|||
130245446|NCT00366535|468859666|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
130245447|NCT00366535|468859667|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
130245448|NCT00366535|468859666|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
130245449|NCT00366535|468859667|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
130245450|NCT00366535|468859666|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130245451|NCT00366535|468859667|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130245452|NCT03753542|468859672|FG000|Overall Study|Lost to Follow-up|9|||
130245453|NCT03753542|468859673|FG001|Overall Study|Lost to Follow-up|14|||
130451811|NCT04310579|469618260|FG009|Overall Study|Adverse Event|1|||
130451812|NCT04310579|469618261|FG010|Overall Study|Adverse Event|0|||
130451813|NCT04310579|469618251|FG000|Overall Study|Withdrawal by Subject|0|||
130451814|NCT04310579|469618252|FG001|Overall Study|Withdrawal by Subject|0|||
130451815|NCT04310579|469618253|FG002|Overall Study|Withdrawal by Subject|0|||
130451816|NCT04310579|469618254|FG003|Overall Study|Withdrawal by Subject|0|||
130451817|NCT04310579|469618255|FG004|Overall Study|Withdrawal by Subject|0|||
130451818|NCT04310579|469618256|FG005|Overall Study|Withdrawal by Subject|1|||
130451819|NCT04310579|469618257|FG006|Overall Study|Withdrawal by Subject|0|||
130451820|NCT04310579|469618258|FG007|Overall Study|Withdrawal by Subject|0|||
130451821|NCT04310579|469618259|FG008|Overall Study|Withdrawal by Subject|0|||
130451822|NCT04310579|469618260|FG009|Overall Study|Withdrawal by Subject|0|||
130451823|NCT04310579|469618261|FG010|Overall Study|Withdrawal by Subject|0|||
130245454|NCT03554473|468861551|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
130245455|NCT03554473|468861552|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130245456|NCT03554473|468861553|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130245457|NCT03554473|468861551|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
130245458|NCT03554473|468861552|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130245459|NCT03554473|468861553|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130245460|NCT03554473|468861551|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130245461|NCT03554473|468861552|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130245462|NCT03554473|468861553|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
130245463|NCT04971837|468861557|FG000|Overall Study|Long Term Illness|1|||
130245464|NCT04971837|468861557|FG000|Overall Study|BMI too low|9|||
130245465|NCT04971837|468861557|FG000|Overall Study|geographic location|1|||
130245466|NCT04971837|468861557|FG000|Overall Study|Discontinued scheduling conflict|1|||
130245467|NCT00160615|468861558|FG000|Overall Study|Adverse Event|5|||
130245468|NCT00160615|468861559|FG001|Overall Study|Adverse Event|12|||
130451824|NCT04310579|469618251|FG000|Overall Study|Positive COVID-19 test|0|||
130451825|NCT04310579|469618252|FG001|Overall Study|Positive COVID-19 test|0|||
130451826|NCT04310579|469618253|FG002|Overall Study|Positive COVID-19 test|0|||
130451827|NCT04310579|469618254|FG003|Overall Study|Positive COVID-19 test|0|||
130245469|NCT00160615|468861558|FG000|Overall Study|Withdrawal by Subject|0|||
130245470|NCT00160615|468861559|FG001|Overall Study|Withdrawal by Subject|2|||
130245471|NCT00160615|468861558|FG000|Overall Study|Lack of Efficacy|11|||
130245472|NCT00160615|468861559|FG001|Overall Study|Lack of Efficacy|23|||
130245473|NCT00160615|468861558|FG000|Overall Study|Patient decision|1|||
130245474|NCT00160615|468861559|FG001|Overall Study|Patient decision|2|||
130245475|NCT00160615|468861558|FG000|Overall Study|Investigator decision|1|||
130245476|NCT00160615|468861559|FG001|Overall Study|Investigator decision|1|||
130245477|NCT00160615|468861558|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
130245478|NCT00160615|468861559|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
130245479|NCT00160615|468861558|FG000|Overall Study|Switch to surgical treatment|0|||
130245480|NCT00160615|468861559|FG001|Overall Study|Switch to surgical treatment|2|||
130245481|NCT00160615|468861558|FG000|Overall Study|Non-compliance was suspected|0|||
130245482|NCT00160615|468861559|FG001|Overall Study|Non-compliance was suspected|1|||
130245483|NCT00160615|468861558|FG000|Overall Study|Poor compliance|0|||
130245484|NCT00160615|468861559|FG001|Overall Study|Poor compliance|1|||
130245485|NCT03166631|468861560|FG000|Overall Study|Progressive disease|2|||
130245486|NCT03166631|468861561|FG001|Overall Study|Progressive disease|1|||
130245487|NCT03166631|468861562|FG002|Overall Study|Progressive disease|3|||
130245488|NCT03166631|468861563|FG003|Overall Study|Progressive disease|4|||
130245489|NCT03166631|468861564|FG004|Overall Study|Progressive disease|2|||
130245490|NCT03166631|468861565|FG005|Overall Study|Progressive disease|2|||
130245491|NCT03166631|468861566|FG006|Overall Study|Progressive disease|5|||
130245492|NCT03166631|468861567|FG007|Overall Study|Progressive disease|6|||
130245493|NCT03166631|468861568|FG008|Overall Study|Progressive disease|11|||
130245494|NCT03166631|468861569|FG009|Overall Study|Progressive disease|5|||
130245495|NCT03166631|468861570|FG010|Overall Study|Progressive disease|7|||
130245496|NCT03166631|468861560|FG000|Overall Study|Physician Decision|0|||
130245497|NCT03166631|468861561|FG001|Overall Study|Physician Decision|0|||
130245498|NCT03166631|468861562|FG002|Overall Study|Physician Decision|0|||
130245499|NCT03166631|468861563|FG003|Overall Study|Physician Decision|0|||
130245500|NCT03166631|468861564|FG004|Overall Study|Physician Decision|0|||
130245501|NCT03166631|468861565|FG005|Overall Study|Physician Decision|0|||
130245502|NCT03166631|468861566|FG006|Overall Study|Physician Decision|1|||
130245503|NCT03166631|468861567|FG007|Overall Study|Physician Decision|0|||
130245504|NCT03166631|468861568|FG008|Overall Study|Physician Decision|1|||
130245505|NCT03166631|468861569|FG009|Overall Study|Physician Decision|0|||
130245506|NCT03166631|468861570|FG010|Overall Study|Physician Decision|1|||
130245507|NCT03166631|468861560|FG000|Overall Study|Death|0|||
130245508|NCT03166631|468861561|FG001|Overall Study|Death|0|||
130245509|NCT03166631|468861562|FG002|Overall Study|Death|0|||
130245510|NCT03166631|468861563|FG003|Overall Study|Death|0|||
130245511|NCT03166631|468861564|FG004|Overall Study|Death|1|||
130245512|NCT03166631|468861565|FG005|Overall Study|Death|0|||
130245513|NCT03166631|468861566|FG006|Overall Study|Death|1|||
130245514|NCT03166631|468861567|FG007|Overall Study|Death|0|||
130245515|NCT03166631|468861568|FG008|Overall Study|Death|0|||
130245516|NCT03166631|468861569|FG009|Overall Study|Death|0|||
130245517|NCT03166631|468861570|FG010|Overall Study|Death|0|||
130245518|NCT03166631|468861560|FG000|Overall Study|Adverse Event|1|||
130245519|NCT03166631|468861561|FG001|Overall Study|Adverse Event|0|||
130245520|NCT03166631|468861562|FG002|Overall Study|Adverse Event|0|||
130245521|NCT03166631|468861563|FG003|Overall Study|Adverse Event|0|||
130245522|NCT03166631|468861564|FG004|Overall Study|Adverse Event|0|||
130245523|NCT03166631|468861565|FG005|Overall Study|Adverse Event|1|||
130245524|NCT03166631|468861566|FG006|Overall Study|Adverse Event|1|||
130245525|NCT03166631|468861567|FG007|Overall Study|Adverse Event|0|||
130245526|NCT03166631|468861568|FG008|Overall Study|Adverse Event|1|||
130245527|NCT03166631|468861569|FG009|Overall Study|Adverse Event|2|||
130245528|NCT03166631|468861570|FG010|Overall Study|Adverse Event|1|||
130245529|NCT03166631|468861560|FG000|Overall Study|Withdrawal by Subject|0|||
130245530|NCT03166631|468861561|FG001|Overall Study|Withdrawal by Subject|0|||
130245531|NCT03166631|468861562|FG002|Overall Study|Withdrawal by Subject|0|||
130245532|NCT03166631|468861563|FG003|Overall Study|Withdrawal by Subject|0|||
130245533|NCT03166631|468861564|FG004|Overall Study|Withdrawal by Subject|0|||
130245534|NCT03166631|468861565|FG005|Overall Study|Withdrawal by Subject|0|||
130245535|NCT03166631|468861566|FG006|Overall Study|Withdrawal by Subject|0|||
130245536|NCT03166631|468861567|FG007|Overall Study|Withdrawal by Subject|0|||
130245537|NCT03166631|468861568|FG008|Overall Study|Withdrawal by Subject|1|||
130245538|NCT03166631|468861569|FG009|Overall Study|Withdrawal by Subject|1|||
130245539|NCT03166631|468861570|FG010|Overall Study|Withdrawal by Subject|0|||
130245540|NCT00567580|468861573|FG000|Overall Study|Protocol Violation|28|||
130245541|NCT00567580|468861574|FG001|Overall Study|Protocol Violation|24|||
130245542|NCT00567580|468861575|FG002|Overall Study|Protocol Violation|24|||
130245543|NCT00382070|468861576|FG000|Overall Study|No follow up data mapped to Other|17|||
130245544|NCT00382070|468861577|FG001|Overall Study|No follow up data mapped to Other|19|||
130245545|NCT00382070|468861576|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
130245546|NCT00382070|468861577|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
130245547|NCT00382070|468861576|FG000|Overall Study|No clinical assessment|9|||
130699161|NCT00160524|470522803|FG000|Overall Study|Adverse Event and Other|94|||
130699162|NCT00160524|470522803|FG000|Overall Study|Protocol Violation|16|||
130699163|NCT00160524|470522803|FG000|Overall Study|Protocol Violation and Other|2|||
130699164|NCT00160524|470522803|FG000|Overall Study|Withdrawal by Subject|141|||
130699165|NCT00160524|470522803|FG000|Overall Study|Withdrawal by Subject and Other|17|||
130245548|NCT00382070|468861577|FG001|Overall Study|No clinical assessment|11|||
130245549|NCT00284934|468861578|FG000|Overall Study|Adverse Event|1|||
130245550|NCT00284934|468861579|FG001|Overall Study|Adverse Event|2|||
130245551|NCT00284934|468861578|FG000|Overall Study|Other reasons|3|||
130245552|NCT00284934|468861579|FG001|Overall Study|Other reasons|1|||
130245553|NCT03309605|468861582|FG000|Overall Study|Adverse Event|0|||
130245554|NCT03309605|468861583|FG001|Overall Study|Adverse Event|0|||
130245555|NCT03309605|468861584|FG002|Overall Study|Adverse Event|0|||
130245556|NCT03309605|468861585|FG003|Overall Study|Adverse Event|1|||
130245557|NCT03309605|468861586|FG004|Overall Study|Adverse Event|0|||
130245558|NCT03309605|468861587|FG005|Overall Study|Adverse Event|0|||
130245559|NCT03309605|468861588|FG006|Overall Study|Adverse Event|2|||
130245560|NCT03309605|468861589|FG007|Overall Study|Adverse Event|1|||
130245561|NCT03309605|468861582|FG000|Overall Study|Withdrawal by Subject|0|||
130245562|NCT03309605|468861583|FG001|Overall Study|Withdrawal by Subject|0|||
130245563|NCT03309605|468861584|FG002|Overall Study|Withdrawal by Subject|0|||
130245564|NCT03309605|468861585|FG003|Overall Study|Withdrawal by Subject|0|||
130245565|NCT03309605|468861586|FG004|Overall Study|Withdrawal by Subject|1|||
130245566|NCT03309605|468861587|FG005|Overall Study|Withdrawal by Subject|0|||
130245567|NCT03309605|468861588|FG006|Overall Study|Withdrawal by Subject|1|||
130245568|NCT03309605|468861589|FG007|Overall Study|Withdrawal by Subject|1|||
130245569|NCT03197935|468861590|FG000|Overall Study|Death due to any cause|26|||
130245570|NCT03197935|468861591|FG001|Overall Study|Death due to any cause|15|||
130245571|NCT03197935|468861590|FG000|Overall Study|Lost to Follow-up|3|||
130245572|NCT03197935|468861591|FG001|Overall Study|Lost to Follow-up|5|||
130245573|NCT03197935|468861590|FG000|Overall Study|Physician Decision|2|||
130245574|NCT03197935|468861591|FG001|Overall Study|Physician Decision|1|||
130245575|NCT03197935|468861590|FG000|Overall Study|Withdrawal by Subject|16|||
130245576|NCT03197935|468861591|FG001|Overall Study|Withdrawal by Subject|8|||
130245577|NCT02082483|468861592|FG000|Overall Study|Lost to Follow-up|1|||
130245578|NCT02082483|468861593|FG001|Overall Study|Lost to Follow-up|1|||
130245579|NCT02082483|468861592|FG000|Overall Study|Withdrawal by Subject|2|||
130245580|NCT02082483|468861593|FG001|Overall Study|Withdrawal by Subject|1|||
130245581|NCT02082483|468861592|FG000|Overall Study|Physician Decision|1|||
130699166|NCT00160524|470522803|FG000|Overall Study|Physician Decision|27|||
130699167|NCT00160524|470522803|FG000|Overall Study|Physician Decision and Other|6|||
130699168|NCT00160524|470522803|FG000|Overall Study|Lost to Follow-up|13|||
130699169|NCT00160524|470522803|FG000|Overall Study|Lost to Follow-up and Other|1|||
130699170|NCT00160524|470522803|FG000|Overall Study|Lack of Efficacy|21|||
130699171|NCT00160524|470522803|FG000|Overall Study|Lack of Efficacy and Other|1|||
130699172|NCT00160524|470522803|FG000|Overall Study|Other|20|||
130699173|NCT01547728|470522815|FG000|Overall Study|Change in procedure and equipment|1|||
130245582|NCT02082483|468861593|FG001|Overall Study|Physician Decision|1|||
130245583|NCT02082483|468861592|FG000|Overall Study|Death|2|||
130245584|NCT02082483|468861593|FG001|Overall Study|Death|3|||
130245585|NCT00864513|468861595|FG000|Overall Study|Withdrawal by Subject|3|||
130245586|NCT05938010|468861596|FG000|Overall Study|Lost to Follow-up|2|||
130245587|NCT03073109|468861597|FG000|Overall Study|Adverse Event|0|||
130245588|NCT03073109|468861598|FG001|Overall Study|Adverse Event|1|||
130245589|NCT03073109|468861597|FG000|Overall Study|Other|2|||
130245590|NCT03073109|468861598|FG001|Overall Study|Other|0|||
130245591|NCT03073109|468861597|FG000|Overall Study|Lost to Follow-up|8|||
130245592|NCT03073109|468861598|FG001|Overall Study|Lost to Follow-up|1|||
130245593|NCT01562444|468861601|FG000|Overall Study|Did not meet entry criteria|2|||
130245594|NCT01562444|468861602|FG001|Overall Study|Did not meet entry criteria|0|||
130245595|NCT01562444|468861603|FG002|Overall Study|Did not meet entry criteria|3|||
130245596|NCT01562444|468861601|FG000|Overall Study|Did not comply with blood draw schedule|1|||
130245597|NCT01562444|468861602|FG001|Overall Study|Did not comply with blood draw schedule|0|||
130245598|NCT01562444|468861603|FG002|Overall Study|Did not comply with blood draw schedule|1|||
130245599|NCT01562444|468861601|FG000|Overall Study|Unavailable serological results|0|||
130363643|NCT02975336|469301981|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
130363644|NCT02975336|469301982|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
130363645|NCT02975336|469301983|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
130363646|NCT02975336|469301984|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
130363647|NCT02975336|469301977|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
130363648|NCT02975336|469301978|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
130363649|NCT02975336|469301979|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
130363650|NCT02975336|469301980|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
130363651|NCT02975336|469301981|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
130363652|NCT02975336|469301982|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
130363653|NCT02975336|469301983|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
130363654|NCT02975336|469301984|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
130363655|NCT02975336|469301977|FG000|LTE (104 Weeks)|Other|0|||
130245600|NCT01562444|468861602|FG001|Overall Study|Unavailable serological results|2|||
130245601|NCT01562444|468861603|FG002|Overall Study|Unavailable serological results|2|||
130245602|NCT01562444|468861601|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
130245603|NCT01562444|468861602|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
130245604|NCT01562444|468861603|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
130245605|NCT01562444|468861601|FG000|Overall Study|Protocol forbidden medication|1|||
130245606|NCT01562444|468861602|FG001|Overall Study|Protocol forbidden medication|0|||
130245607|NCT01562444|468861603|FG002|Overall Study|Protocol forbidden medication|0|||
130245608|NCT00574951|468861611|FG000|Overall Study|Ineligible - improper prior treatment|1|||
130245609|NCT01160744|468861616|FG000|Overall Study|Withdrawal by Subject|11|||
130245610|NCT01160744|468861617|FG001|Overall Study|Withdrawal by Subject|5|||
130245611|NCT01160744|468861618|FG002|Overall Study|Withdrawal by Subject|6|||
130245612|NCT01160744|468861619|FG003|Overall Study|Withdrawal by Subject|4|||
130245613|NCT01160744|468861616|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245614|NCT01160744|468861617|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245615|NCT01160744|468861618|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
130245616|NCT01160744|468861619|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245617|NCT02301429|468861620|FG000|Overall Study|not acceptable vascular anatomy|3|||
130245618|NCT02217982|468861621|FG000|Overall Study|Trial discontinued|1|||
130245619|NCT02217982|468861622|FG001|Overall Study|Trial discontinued|0|||
130245620|NCT02217982|468861621|FG000|Overall Study|Adverse Event|0|||
130245621|NCT02217982|468861622|FG001|Overall Study|Adverse Event|1|||
130245622|NCT01755637|468861627|FG000|Period 1|Adverse Event|0|||
130245623|NCT01755637|468861628|FG001|Period 1|Adverse Event|1|||
130245624|NCT01814332|468861630|FG000|Overall Study|Adverse Event|8|||
130245625|NCT01814332|468861631|FG001|Overall Study|Adverse Event|3|||
130245626|NCT01814332|468861630|FG000|Overall Study|Withdrawal by Subject|3|||
130245627|NCT01814332|468861631|FG001|Overall Study|Withdrawal by Subject|8|||
130245628|NCT01814332|468861630|FG000|Overall Study|Protocol Violation|0|||
130245629|NCT01814332|468861631|FG001|Overall Study|Protocol Violation|4|||
130245630|NCT01814332|468861630|FG000|Overall Study|Lost to Follow-up|5|||
130245631|NCT01814332|468861631|FG001|Overall Study|Lost to Follow-up|1|||
130245632|NCT01096186|468861632|FG000|Overall Study|Adverse Event|16|||
130245633|NCT01096186|468861632|FG000|Overall Study|Death|4|||
130245634|NCT01096186|468861632|FG000|Overall Study|Lack of Efficacy|4|||
130245635|NCT01096186|468861632|FG000|Overall Study|Lost to Follow-up|2|||
130245636|NCT01096186|468861632|FG000|Overall Study|Withdrawal by Subject|22|||
130245637|NCT01096186|468861632|FG000|Overall Study|Physician Decision|1|||
130245638|NCT01096186|468861632|FG000|Overall Study|Noncompliance with study drug|1|||
130451828|NCT04310579|469618255|FG004|Overall Study|Positive COVID-19 test|0|||
130451829|NCT04310579|469618256|FG005|Overall Study|Positive COVID-19 test|0|||
130451830|NCT04310579|469618257|FG006|Overall Study|Positive COVID-19 test|0|||
130451831|NCT04310579|469618258|FG007|Overall Study|Positive COVID-19 test|0|||
130451832|NCT04310579|469618259|FG008|Overall Study|Positive COVID-19 test|0|||
130451833|NCT04310579|469618260|FG009|Overall Study|Positive COVID-19 test|0|||
130451834|NCT04310579|469618261|FG010|Overall Study|Positive COVID-19 test|1|||
130451835|NCT03635112|469618262|FG000|Overall Study|Adverse Event|5|||
130451836|NCT03635112|469618263|FG001|Overall Study|Adverse Event|9|||
130451837|NCT03635112|469618264|FG002|Overall Study|Adverse Event|14|||
130451838|NCT03635112|469618262|FG000|Overall Study|Lost to Follow-up|1|||
130451839|NCT03635112|469618263|FG001|Overall Study|Lost to Follow-up|0|||
130451840|NCT03635112|469618264|FG002|Overall Study|Lost to Follow-up|1|||
130451841|NCT03635112|469618262|FG000|Overall Study|Physician Decision|5|||
130451842|NCT03635112|469618263|FG001|Overall Study|Physician Decision|7|||
130245639|NCT00122187|468861637|FG000|Overall Study|Withdrew because of resource limitations|2|||
130245640|NCT00122187|468861638|FG001|Overall Study|Withdrew because of resource limitations|2|||
130245641|NCT02061592|468861639|FG000|Period 1|Withdrawal by Subject|1|||
130245642|NCT02061592|468861640|FG001|Period 1|Withdrawal by Subject|0|||
130245643|NCT02061592|468861639|FG000|Period 1|Protocol Violation|1|||
130245644|NCT02061592|468861640|FG001|Period 1|Protocol Violation|0|||
130245645|NCT02061592|468861639|FG000|Period 2|Lost to Follow-up|0|||
130245646|NCT02061592|468861640|FG001|Period 2|Lost to Follow-up|1|||
130245647|NCT03338023|468861641|FG000|Overall Study|Withdrawal by Subject|3|||
130245648|NCT03338023|468861642|FG001|Overall Study|Withdrawal by Subject|4|||
130245649|NCT03338023|468861641|FG000|Overall Study|Protocol Violation|3|||
130245650|NCT03338023|468861642|FG001|Overall Study|Protocol Violation|3|||
130245651|NCT03338023|468861641|FG000|Overall Study|Lost to Follow-up|2|||
130245652|NCT03338023|468861642|FG001|Overall Study|Lost to Follow-up|1|||
130451843|NCT03635112|469618264|FG002|Overall Study|Physician Decision|5|||
130451844|NCT03635112|469618262|FG000|Overall Study|Protocol Violation|0|||
130451845|NCT03635112|469618263|FG001|Overall Study|Protocol Violation|0|||
130245653|NCT03338023|468861641|FG000|Overall Study|Physician Decision|1|||
130245654|NCT03338023|468861642|FG001|Overall Study|Physician Decision|2|||
130245655|NCT00685698|468861643|FG000|Overall Study|Withdrawal by Subject|1|||
130245656|NCT00685698|468861643|FG000|Overall Study|Protocol Violation|6|||
130245657|NCT00685698|468861643|FG000|Overall Study|Adverse Event|3|||
130245658|NCT00685698|468861643|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
130245659|NCT00685698|468861643|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
130245660|NCT00685698|468861643|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
130245661|NCT05061706|468861645|FG000|Overall Study|Adverse Event|29|||
130245662|NCT05061706|468861646|FG001|Overall Study|Adverse Event|1|||
130245663|NCT05061706|468861645|FG000|Overall Study|Lack of Efficacy|0|||
130245664|NCT05061706|468861646|FG001|Overall Study|Lack of Efficacy|1|||
130245665|NCT05061706|468861645|FG000|Overall Study|Lost to Follow-up|2|||
130245666|NCT05061706|468861646|FG001|Overall Study|Lost to Follow-up|2|||
130245667|NCT05061706|468861645|FG000|Overall Study|Protocol Violation|3|||
130245668|NCT05061706|468861646|FG001|Overall Study|Protocol Violation|1|||
130245669|NCT05061706|468861645|FG000|Overall Study|Withdrawal by Subject|3|||
130245670|NCT05061706|468861646|FG001|Overall Study|Withdrawal by Subject|9|||
130245671|NCT01873833|468861648|FG000|Overall Study|Withdrawal by Subject|1|||
130245672|NCT02068599|468861654|FG000|Overall Study|Adverse Event|4|||
130245673|NCT02068599|468861655|FG001|Overall Study|Adverse Event|1|||
130245674|NCT02068599|468861656|FG002|Overall Study|Adverse Event|1|||
130245675|NCT02068599|468861654|FG000|Overall Study|Withdrawal by Subject|2|||
130245676|NCT02068599|468861655|FG001|Overall Study|Withdrawal by Subject|7|||
130245677|NCT02068599|468861656|FG002|Overall Study|Withdrawal by Subject|5|||
130245678|NCT02068599|468861654|FG000|Overall Study|Protocol Violation|4|||
130245679|NCT02068599|468861655|FG001|Overall Study|Protocol Violation|2|||
130245680|NCT02068599|468861656|FG002|Overall Study|Protocol Violation|3|||
130245681|NCT02068599|468861654|FG000|Overall Study|Lost to Follow-up|1|||
130245682|NCT02068599|468861655|FG001|Overall Study|Lost to Follow-up|0|||
130245683|NCT02068599|468861656|FG002|Overall Study|Lost to Follow-up|0|||
130245684|NCT02068599|468861654|FG000|Overall Study|Lack of Efficacy|0|||
130245685|NCT02068599|468861655|FG001|Overall Study|Lack of Efficacy|0|||
130245686|NCT02068599|468861656|FG002|Overall Study|Lack of Efficacy|3|||
130245687|NCT02068599|468861654|FG000|Overall Study|Noncompliance|0|||
130245688|NCT02068599|468861655|FG001|Overall Study|Noncompliance|0|||
130245689|NCT02068599|468861656|FG002|Overall Study|Noncompliance|1|||
130245690|NCT01871727|468861657|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
130245691|NCT01871727|468861658|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130245692|NCT01871727|468861659|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130245693|NCT01871727|468861660|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130245694|NCT01871727|468861661|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130245695|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
130245696|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
130245697|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
130363656|NCT02975336|469301978|FG001|LTE (104 Weeks)|Other|0|||
130363657|NCT02975336|469301979|FG002|LTE (104 Weeks)|Other|0|||
130363658|NCT02975336|469301980|FG003|LTE (104 Weeks)|Other|0|||
130363659|NCT02975336|469301981|FG004|LTE (104 Weeks)|Other|55|||
130363660|NCT02975336|469301982|FG005|LTE (104 Weeks)|Other|63|||
130363661|NCT02975336|469301983|FG006|LTE (104 Weeks)|Other|76|||
130363662|NCT02975336|469301984|FG007|LTE (104 Weeks)|Other|72|||
130363663|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
130363664|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
130363665|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
130363666|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
130363667|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
130363668|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
130363669|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
130363670|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
130363671|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
130363672|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363673|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363674|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363675|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363676|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363677|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130363678|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130245698|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
130245699|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
130245700|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245701|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245702|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130363679|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
130363680|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363681|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130245703|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245704|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
130245705|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245706|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245707|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245708|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245709|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
130245710|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245711|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245712|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245713|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245714|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
130245715|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245716|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245717|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245718|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245719|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
130245720|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245721|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245722|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245723|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245724|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
130245725|NCT00356421|468861663|FG000|Overall Study|Lack of Efficacy|3|||
130245726|NCT00356421|468861664|FG001|Overall Study|Lack of Efficacy|0|||
130245727|NCT00356421|468861663|FG000|Overall Study|Withdrawal by Subject|9|||
130245728|NCT00356421|468861664|FG001|Overall Study|Withdrawal by Subject|2|||
130245729|NCT00356421|468861663|FG000|Overall Study|Related to study drug|15|||
130245730|NCT00356421|468861664|FG001|Overall Study|Related to study drug|12|||
130245731|NCT00356421|468861663|FG000|Overall Study|Not related to study drug|5|||
130245732|NCT00356421|468861664|FG001|Overall Study|Not related to study drug|3|||
130245733|NCT00501085|468861665|FG000|Overall Study|Lost to Follow-up|195|||
130245734|NCT00501085|468861665|FG000|Overall Study|Withdrawal by Subject|34|||
130245735|NCT00501085|468861665|FG000|Overall Study|Subject Decision|1|||
130245736|NCT00501085|468861665|FG000|Overall Study|Revision Surgery|7|||
130245737|NCT00501085|468861665|FG000|Overall Study|Explantation Surgery|26|||
130245738|NCT00501085|468861665|FG000|Overall Study|Adverse Event|4|||
130245739|NCT00501085|468861665|FG000|Overall Study|Non-Compliance|24|||
130245740|NCT00501085|468861665|FG000|Overall Study|Study closed by sponsor|109|||
130245741|NCT00501085|468861665|FG000|Overall Study|Other loss to follow-up|32|||
130245742|NCT02958527|468861666|FG000|Overall Study|Not collected CRFs|12|||
130245743|NCT02945046|468861667|FG000|Overall Study|Adverse Event|1|||
130245744|NCT02945046|468861668|FG001|Overall Study|Adverse Event|0|||
130245745|NCT02945046|468861669|FG002|Overall Study|Adverse Event|2|||
130245746|NCT02945046|468861667|FG000|Overall Study|Withdrawal by Subject|3|||
130245747|NCT02945046|468861668|FG001|Overall Study|Withdrawal by Subject|3|||
130245748|NCT02945046|468861669|FG002|Overall Study|Withdrawal by Subject|3|||
130245749|NCT02945046|468861667|FG000|Overall Study|Protocol Violation|2|||
130245750|NCT02945046|468861668|FG001|Overall Study|Protocol Violation|3|||
130245751|NCT02945046|468861669|FG002|Overall Study|Protocol Violation|2|||
130245752|NCT02945046|468861667|FG000|Overall Study|Lost to Follow-up|1|||
130245753|NCT02945046|468861668|FG001|Overall Study|Lost to Follow-up|1|||
130245754|NCT02945046|468861669|FG002|Overall Study|Lost to Follow-up|0|||
130245755|NCT02945046|468861667|FG000|Overall Study|Lack of Efficacy|1|||
130245756|NCT02945046|468861668|FG001|Overall Study|Lack of Efficacy|2|||
130245757|NCT02945046|468861669|FG002|Overall Study|Lack of Efficacy|1|||
130245758|NCT02945046|468861667|FG000|Overall Study|Other than specified|5|||
130245759|NCT02945046|468861668|FG001|Overall Study|Other than specified|4|||
130245760|NCT02945046|468861669|FG002|Overall Study|Other than specified|7|||
130245761|NCT03113136|468861670|FG000|Overall Study|Lost to Follow-up|22|||
130245762|NCT03113136|468861671|FG001|Overall Study|Lost to Follow-up|47|||
130245763|NCT03113136|468861672|FG002|Overall Study|Lost to Follow-up|54|||
130245764|NCT03113136|468861670|FG000|Overall Study|Withdrawal by Subject|4|||
130363682|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363683|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363684|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363685|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363686|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130363687|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
130363688|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130451846|NCT03635112|469618264|FG002|Overall Study|Protocol Violation|1|||
130245765|NCT03113136|468861671|FG001|Overall Study|Withdrawal by Subject|13|||
130245766|NCT03113136|468861672|FG002|Overall Study|Withdrawal by Subject|14|||
130245767|NCT03113136|468861670|FG000|Overall Study|Ineligible|0|||
130451847|NCT03635112|469618262|FG000|Overall Study|Study Terminated by Sponsor|11|||
130245768|NCT03113136|468861671|FG001|Overall Study|Ineligible|2|||
130245769|NCT03113136|468861672|FG002|Overall Study|Ineligible|1|||
130245770|NCT03113136|468861670|FG000|Overall Study|Study Team Decision|1|||
130245771|NCT03113136|468861671|FG001|Overall Study|Study Team Decision|4|||
130245772|NCT03113136|468861672|FG002|Overall Study|Study Team Decision|0|||
130245773|NCT01666314|468861676|FG000|Overall Study|Adverse Event|3|||
130245774|NCT01666314|468861677|FG001|Overall Study|Adverse Event|13|||
130245775|NCT01666314|468861678|FG002|Overall Study|Adverse Event|7|||
130245776|NCT01666314|468861679|FG003|Overall Study|Adverse Event|7|||
130245777|NCT01666314|468861676|FG000|Overall Study|Progressive Disease|11|||
130245778|NCT01666314|468861677|FG001|Overall Study|Progressive Disease|9|||
130245779|NCT01666314|468861678|FG002|Overall Study|Progressive Disease|19|||
130245780|NCT01666314|468861679|FG003|Overall Study|Progressive Disease|20|||
130245781|NCT01666314|468861676|FG000|Overall Study|Symptomatic Deterioration|1|||
130245782|NCT01666314|468861677|FG001|Overall Study|Symptomatic Deterioration|0|||
130245783|NCT01666314|468861678|FG002|Overall Study|Symptomatic Deterioration|2|||
130245784|NCT01666314|468861679|FG003|Overall Study|Symptomatic Deterioration|0|||
130245785|NCT01666314|468861676|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
130245786|NCT01666314|468861677|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
130245787|NCT01666314|468861678|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130245788|NCT01666314|468861679|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
130245789|NCT01666314|468861676|FG000|Overall Study|Withdrawal by Subject|1|||
130245790|NCT01666314|468861677|FG001|Overall Study|Withdrawal by Subject|1|||
130245791|NCT01666314|468861678|FG002|Overall Study|Withdrawal by Subject|2|||
130245792|NCT01666314|468861679|FG003|Overall Study|Withdrawal by Subject|3|||
130245793|NCT01666314|468861676|FG000|Overall Study|Reason not Specified|10|||
130245794|NCT01666314|468861677|FG001|Overall Study|Reason not Specified|7|||
130245795|NCT01666314|468861678|FG002|Overall Study|Reason not Specified|5|||
130245796|NCT01666314|468861679|FG003|Overall Study|Reason not Specified|5|||
130245797|NCT02114684|468861682|FG000|Overall Study|Death|6|||
130245798|NCT02114684|468861683|FG001|Overall Study|Death|4|||
130245799|NCT02114684|468861682|FG000|Overall Study|Lost to Follow-up|1|||
130245800|NCT02114684|468861683|FG001|Overall Study|Lost to Follow-up|2|||
130245801|NCT02114684|468861682|FG000|Overall Study|Withdrawal by Subject|1|||
130245802|NCT02114684|468861683|FG001|Overall Study|Withdrawal by Subject|2|||
130245803|NCT02114684|468861682|FG000|Overall Study|Relocation|3|||
130245804|NCT02114684|468861683|FG001|Overall Study|Relocation|1|||
130245805|NCT02114684|468861682|FG000|Overall Study|Rifampicin resistant on culture|0|||
130245806|NCT02114684|468861683|FG001|Overall Study|Rifampicin resistant on culture|1|||
130245807|NCT02114684|468861682|FG000|Overall Study|Patient Incarcerated|1|||
130245808|NCT02114684|468861683|FG001|Overall Study|Patient Incarcerated|0|||
130245809|NCT04625972|468861686|FG000|Overall Study|Death|3|||
130245810|NCT04625972|468861687|FG001|Overall Study|Death|2|||
130245811|NCT04625972|468861686|FG000|Overall Study|Lost to Follow-up|82|||
130245812|NCT04625972|468861687|FG001|Overall Study|Lost to Follow-up|38|||
130245813|NCT04625972|468861686|FG000|Overall Study|Physician Decision|2|||
130245814|NCT04625972|468861687|FG001|Overall Study|Physician Decision|0|||
130245815|NCT04625972|468861686|FG000|Overall Study|Protocol Violation|0|||
130245816|NCT04625972|468861687|FG001|Overall Study|Protocol Violation|1|||
130245817|NCT04625972|468861686|FG000|Overall Study|Withdrawal by Subject|37|||
130245818|NCT04625972|468861687|FG001|Overall Study|Withdrawal by Subject|24|||
130245819|NCT04625972|468861686|FG000|Overall Study|Not specified elsewhere|8|||
130245820|NCT04625972|468861687|FG001|Overall Study|Not specified elsewhere|6|||
130245821|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
130245822|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
130245823|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130245824|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130245825|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
130245826|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
130245827|NCT03020888|468861694|FG000|Overall Study|Physician Decision|4|||
130245828|NCT03020888|468861694|FG000|Overall Study|Withdrawal by Subject|6|||
130245829|NCT03020888|468861694|FG000|Overall Study|Insurance coverage|2|||
130245830|NCT03020888|468861694|FG000|Overall Study|Lost to Follow-up|1|||
130245831|NCT01198548|468861701|FG000|Overall Study|Disease Progression|9|||
130451848|NCT03635112|469618263|FG001|Overall Study|Study Terminated by Sponsor|17|||
130245832|NCT01198548|468861701|FG000|Overall Study|Administrative Decision|1|||
130245833|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
130245834|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
130245835|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
130245836|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Physician Decision|2|||
130245837|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Physician Decision|4|||
130245838|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Physician Decision|0|||
130245839|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
130245840|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
130245841|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
130245842|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
130245843|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
130245844|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
130245845|NCT01245062|468861703|FG000|Cross-over Phase|Lost to Follow-up|0|||
130245846|NCT01245062|468861704|FG001|Cross-over Phase|Lost to Follow-up|0|||
130245847|NCT01245062|468861705|FG002|Cross-over Phase|Lost to Follow-up|1|||
130245848|NCT01245062|468861703|FG000|Cross-over Phase|Physician Decision|0|||
130245849|NCT01245062|468861704|FG001|Cross-over Phase|Physician Decision|0|||
130245850|NCT01245062|468861705|FG002|Cross-over Phase|Physician Decision|1|||
130245851|NCT01245062|468861703|FG000|Cross-over Phase|Withdrew Consent|0|||
130245852|NCT01245062|468861704|FG001|Cross-over Phase|Withdrew Consent|0|||
130245853|NCT01245062|468861705|FG002|Cross-over Phase|Withdrew Consent|4|||
130245854|NCT01245062|468861703|FG000|Cross-over Phase|Study closed/ terminated|0|||
130245855|NCT01245062|468861704|FG001|Cross-over Phase|Study closed/ terminated|0|||
130245856|NCT01245062|468861705|FG002|Cross-over Phase|Study closed/ terminated|11|||
130245857|NCT02015104|468861706|FG000|Overall Study|Withdrew consent after first dose drug|1|||
130245858|NCT02015104|468861707|FG001|Overall Study|Withdrew consent after first dose drug|0|||
130245859|NCT02015104|468861706|FG000|Overall Study|Withdrew consent prior to treatment|0|||
130245860|NCT02015104|468861707|FG001|Overall Study|Withdrew consent prior to treatment|1|||
130245861|NCT05788328|468863545|FG000|Treatment Period 4 (5 Days)|Other|1|||
130245862|NCT05788328|468863545|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
130245863|NCT00145327|468863546|FG000|Overall Study|Withdrawal by Subject|77|||
130245864|NCT00145327|468863547|FG001|Overall Study|Withdrawal by Subject|72|||
130245865|NCT00145327|468863548|FG002|Overall Study|Withdrawal by Subject|164|||
130245866|NCT00145327|468863546|FG000|Overall Study|Death|26|||
130245867|NCT00145327|468863547|FG001|Overall Study|Death|18|||
130245868|NCT00145327|468863548|FG002|Overall Study|Death|30|||
130245869|NCT00145327|468863546|FG000|Overall Study|Adverse Event|14|||
130245870|NCT00145327|468863547|FG001|Overall Study|Adverse Event|11|||
130245871|NCT00145327|468863548|FG002|Overall Study|Adverse Event|22|||
130245872|NCT00145327|468863546|FG000|Overall Study|Lost to Follow-up|9|||
130245873|NCT00145327|468863547|FG001|Overall Study|Lost to Follow-up|14|||
130245874|NCT00145327|468863548|FG002|Overall Study|Lost to Follow-up|14|||
130245875|NCT00145327|468863546|FG000|Overall Study|Administrative problems|12|||
130245876|NCT00145327|468863547|FG001|Overall Study|Administrative problems|9|||
130245877|NCT00145327|468863548|FG002|Overall Study|Administrative problems|13|||
130245878|NCT00145327|468863546|FG000|Overall Study|Protocol Violation|2|||
130245879|NCT00145327|468863547|FG001|Overall Study|Protocol Violation|0|||
130245880|NCT00145327|468863548|FG002|Overall Study|Protocol Violation|2|||
130245881|NCT00145327|468863546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130245882|NCT00145327|468863547|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130245883|NCT00145327|468863548|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130245884|NCT00145327|468863546|FG000|Overall Study|Missing - not stated|1|||
130245885|NCT00145327|468863547|FG001|Overall Study|Missing - not stated|0|||
130245886|NCT00145327|468863548|FG002|Overall Study|Missing - not stated|1|||
130245887|NCT03315689|468863549|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
130245888|NCT03315689|468863550|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
130363689|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130363690|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130699174|NCT01547728|470522815|FG000|Overall Study|Drug not ready for subject|1|||
130699175|NCT01547728|470522815|FG000|Overall Study|Screen failure|39|||
130699176|NCT03828539|470522816|FG000|Overall Study|Adverse Event|3|||
130699177|NCT03828539|470522817|FG001|Overall Study|Adverse Event|12|||
130699178|NCT03828539|470522816|FG000|Overall Study|Patient's/guardian's decision|3|||
130699179|NCT03828539|470522817|FG001|Overall Study|Patient's/guardian's decision|5|||
130699180|NCT03828539|470522816|FG000|Overall Study|Lost to Follow-up|4|||
130699181|NCT03828539|470522817|FG001|Overall Study|Lost to Follow-up|2|||
130699182|NCT03828539|470522816|FG000|Overall Study|Protocol Violation|3|||
130699183|NCT03828539|470522817|FG001|Overall Study|Protocol Violation|2|||
130699184|NCT03828539|470522816|FG000|Overall Study|Withdrawal of informed consent|2|||
130699185|NCT03828539|470522817|FG001|Overall Study|Withdrawal of informed consent|1|||
130699186|NCT03828539|470522816|FG000|Overall Study|New therapy for study indication|1|||
130699187|NCT03828539|470522817|FG001|Overall Study|New therapy for study indication|0|||
130245889|NCT03315689|468863549|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
130245890|NCT03315689|468863550|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
130245891|NCT03315689|468863549|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
130245892|NCT03315689|468863550|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
130245893|NCT00762788|468863551|FG000|Overall Study|Lost to Follow-up|26|||
130245894|NCT00762788|468863552|FG001|Overall Study|Lost to Follow-up|37|||
130245895|NCT00762788|468863553|FG002|Overall Study|Lost to Follow-up|21|||
130245896|NCT00762788|468863554|FG003|Overall Study|Lost to Follow-up|26|||
130245897|NCT00762788|468863555|FG004|Overall Study|Lost to Follow-up|13|||
130245898|NCT00762788|468863556|FG005|Overall Study|Lost to Follow-up|21|||
130699188|NCT01341405|470522818|FG000|Overall Study|Adverse Event|0|||
130699189|NCT01341405|470522819|FG001|Overall Study|Adverse Event|1|||
130245899|NCT00669331|468863558|FG000|Randomisation to First Dose|Adverse Event|1|||
130245900|NCT00669331|468863559|FG001|Randomisation to First Dose|Adverse Event|0|||
130245901|NCT00669331|468863558|FG000|Randomisation to First Dose|Protocol Violation|1|||
130245902|NCT00669331|468863559|FG001|Randomisation to First Dose|Protocol Violation|0|||
130245903|NCT00669331|468863558|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
130245904|NCT00669331|468863559|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
130245905|NCT00669331|468863558|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
130245906|NCT00669331|468863559|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
130245907|NCT00669331|468863558|FG000|Randomisation to First Dose|Death|1|||
130245908|NCT00669331|468863559|FG001|Randomisation to First Dose|Death|0|||
130245909|NCT00669331|468863558|FG000|Randomisation to First Dose|Sponsor decision|0|||
130699190|NCT01341405|470522820|FG002|Overall Study|Adverse Event|1|||
130699191|NCT01341405|470522818|FG000|Overall Study|Withdrawal by Subject|3|||
130699192|NCT01341405|470522819|FG001|Overall Study|Withdrawal by Subject|2|||
130699193|NCT01341405|470522820|FG002|Overall Study|Withdrawal by Subject|1|||
130699194|NCT00057941|470522821|FG000|Overall Study|Death|1|||
130699195|NCT00057941|470522822|FG001|Overall Study|Death|2|||
130699196|NCT00057941|470522821|FG000|Overall Study|Adverse Event|7|||
130699197|NCT00057941|470522822|FG001|Overall Study|Adverse Event|9|||
130699198|NCT00057941|470522821|FG000|Overall Study|Lack of Efficacy|54|||
130699199|NCT00057941|470522822|FG001|Overall Study|Lack of Efficacy|53|||
130699200|NCT00057941|470522821|FG000|Overall Study|Withdrawal by Subject|6|||
130699201|NCT00057941|470522822|FG001|Overall Study|Withdrawal by Subject|1|||
130699202|NCT00057941|470522821|FG000|Overall Study|still on treatment|3|||
130699203|NCT00057941|470522822|FG001|Overall Study|still on treatment|1|||
130699204|NCT00057941|470522821|FG000|Overall Study|insurance, symptomatic deterioration|1|||
130699205|NCT00057941|470522822|FG001|Overall Study|insurance, symptomatic deterioration|3|||
130699206|NCT00057941|470522821|FG000|Overall Study|Ineligible|2|||
130699207|NCT00057941|470522822|FG001|Overall Study|Ineligible|5|||
130699208|NCT04142658|470522824|FG000|Overall Study|Death|2|||
130699209|NCT04142658|470522825|FG001|Overall Study|Death|1|||
130699210|NCT04142658|470522824|FG000|Overall Study|Lost to Follow-up|4|||
130699211|NCT04142658|470522825|FG001|Overall Study|Lost to Follow-up|13|||
130699212|NCT04142658|470522824|FG000|Overall Study|Withdrawal by Subject|9|||
130699213|NCT04142658|470522825|FG001|Overall Study|Withdrawal by Subject|16|||
130699214|NCT00830167|470522830|FG000|Overall Study|Lack of Efficacy|26|||
130699215|NCT00830167|470522831|FG001|Overall Study|Lack of Efficacy|10|||
130699216|NCT00830167|470522830|FG000|Overall Study|Adverse Event|8|||
130699217|NCT00830167|470522831|FG001|Overall Study|Adverse Event|24|||
130699218|NCT00830167|470522830|FG000|Overall Study|Not meeting entrance criteria|2|||
130699219|NCT00830167|470522831|FG001|Overall Study|Not meeting entrance criteria|5|||
130699220|NCT00830167|470522830|FG000|Overall Study|Withdrawal by Subject|2|||
130699221|NCT00830167|470522831|FG001|Overall Study|Withdrawal by Subject|0|||
130699222|NCT00830167|470522830|FG000|Overall Study|Lost to Follow-up|0|||
130699223|NCT00830167|470522831|FG001|Overall Study|Lost to Follow-up|1|||
130699224|NCT00830167|470522830|FG000|Overall Study|Protocol Violation|0|||
130699225|NCT00830167|470522831|FG001|Overall Study|Protocol Violation|1|||
130699226|NCT00830167|470522830|FG000|Overall Study|Other|2|||
130699227|NCT00830167|470522831|FG001|Overall Study|Other|2|||
130699228|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
130699229|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
130699230|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
130699231|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
130699232|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
130699233|NCT01898598|470522836|FG000|Overall Study|Adverse Event|1|||
130699234|NCT01898598|470522837|FG001|Overall Study|Adverse Event|0|||
130699235|NCT01898598|470522836|FG000|Overall Study|Withdrawal by Subject|3|||
130699236|NCT01898598|470522837|FG001|Overall Study|Withdrawal by Subject|0|||
130699237|NCT01898598|470522836|FG000|Overall Study|Lost to Follow-up|0|||
130245910|NCT00669331|468863559|FG001|Randomisation to First Dose|Sponsor decision|1|||
130245911|NCT00669331|468863558|FG000|Randomisation to First Dose|Randomised in error|3|||
130699238|NCT01898598|470522837|FG001|Overall Study|Lost to Follow-up|1|||
130699239|NCT01898598|470522836|FG000|Overall Study|Other|0|||
130699240|NCT01898598|470522837|FG001|Overall Study|Other|1|||
130699241|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
130699242|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
130245912|NCT00669331|468863559|FG001|Randomisation to First Dose|Randomised in error|10|||
130699243|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
130245913|NCT00669331|468863558|FG000|Blinded Treatment Period|Adverse Event|16|||
130245914|NCT00669331|468863559|FG001|Blinded Treatment Period|Adverse Event|10|||
130245915|NCT00669331|468863558|FG000|Blinded Treatment Period|Protocol Violation|1|||
130245916|NCT00669331|468863559|FG001|Blinded Treatment Period|Protocol Violation|1|||
130245917|NCT00669331|468863558|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
130245918|NCT00669331|468863559|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
130245919|NCT00669331|468863558|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
130245920|NCT00669331|468863559|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
130245921|NCT00669331|468863558|FG000|Blinded Treatment Period|Death|0|||
130245922|NCT00669331|468863559|FG001|Blinded Treatment Period|Death|2|||
130245923|NCT00669331|468863558|FG000|Blinded Treatment Period|Physician Decision|3|||
130245924|NCT00669331|468863559|FG001|Blinded Treatment Period|Physician Decision|3|||
130245925|NCT00669331|468863558|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130245926|NCT00669331|468863559|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130245927|NCT01454063|468863560|FG000|Randomized|Adverse Event|1|||
130245928|NCT01454063|468863561|FG001|Randomized|Adverse Event|1|||
130245929|NCT01454063|468863560|FG000|Randomized|Protocol Violation|0|||
130245930|NCT01454063|468863561|FG001|Randomized|Protocol Violation|1|||
130245931|NCT03055195|468863562|FG000|Overall Study|Lack of Efficacy|1|||
130245932|NCT03055195|468863563|FG001|Overall Study|Lack of Efficacy|0|||
130245933|NCT03055195|468863562|FG000|Overall Study|Withdrawal by Subject|6|||
130245934|NCT03055195|468863563|FG001|Overall Study|Withdrawal by Subject|7|||
130245935|NCT03055195|468863562|FG000|Overall Study|Study Terminated by Sponsor|2|||
130245936|NCT03055195|468863563|FG001|Overall Study|Study Terminated by Sponsor|6|||
130245937|NCT03055195|468863562|FG000|Overall Study|Protocol Violation|2|||
130245938|NCT03055195|468863563|FG001|Overall Study|Protocol Violation|1|||
130245939|NCT03055195|468863562|FG000|Overall Study|Physician Decision|1|||
130245940|NCT03055195|468863563|FG001|Overall Study|Physician Decision|0|||
130245941|NCT02568423|468863566|FG000|Overall Study|Lost to Follow-up|0|||
130245942|NCT02568423|468863567|FG001|Overall Study|Lost to Follow-up|2|||
130245943|NCT02568423|468863568|FG002|Overall Study|Lost to Follow-up|0|||
130245944|NCT02568423|468863569|FG003|Overall Study|Lost to Follow-up|0|||
130245945|NCT02568423|468863570|FG004|Overall Study|Lost to Follow-up|0|||
130245946|NCT02568423|468863571|FG005|Overall Study|Lost to Follow-up|0|||
130245947|NCT02568423|468863572|FG006|Overall Study|Lost to Follow-up|0|||
130245948|NCT02568423|468863573|FG007|Overall Study|Lost to Follow-up|0|||
130245949|NCT02568423|468863566|FG000|Overall Study|Physician Decision|0|||
130245950|NCT02568423|468863567|FG001|Overall Study|Physician Decision|0|||
130245951|NCT02568423|468863568|FG002|Overall Study|Physician Decision|0|||
130245952|NCT02568423|468863569|FG003|Overall Study|Physician Decision|0|||
130245953|NCT02568423|468863570|FG004|Overall Study|Physician Decision|0|||
130245954|NCT02568423|468863571|FG005|Overall Study|Physician Decision|1|||
130245955|NCT02568423|468863572|FG006|Overall Study|Physician Decision|0|||
130245956|NCT02568423|468863573|FG007|Overall Study|Physician Decision|0|||
130245957|NCT01027416|468863576|FG000|Overall Study|Withdrawal by Subject|0|||
130245958|NCT01027416|468863577|FG001|Overall Study|Withdrawal by Subject|1|||
130245959|NCT01027416|468863576|FG000|Overall Study|Physician Decision|1|||
130245960|NCT01027416|468863577|FG001|Overall Study|Physician Decision|4|||
130245961|NCT01960842|468863584|FG000|Overall Study|Adverse Event|1|||
130245962|NCT01960842|468863584|FG000|Overall Study|Withdrawal by Subject|2|||
130245963|NCT00397930|468863585|FG000|Overall Study|Personal reasons|14|||
130245964|NCT00397930|468863586|FG001|Overall Study|Personal reasons|8|||
130245965|NCT00397930|468863585|FG000|Overall Study|Other medical|9|||
130699244|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
130699245|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Missing data|4|||
130245966|NCT00397930|468863586|FG001|Overall Study|Other medical|4|||
130245967|NCT00397930|468863585|FG000|Overall Study|Unknown reasons|9|||
130245968|NCT00397930|468863586|FG001|Overall Study|Unknown reasons|14|||
130245969|NCT00397930|468863585|FG000|Overall Study|Noncompliant|3|||
130245970|NCT00397930|468863586|FG001|Overall Study|Noncompliant|2|||
130245971|NCT00397930|468863585|FG000|Overall Study|Too time-consuming|2|||
130245972|NCT00397930|468863586|FG001|Overall Study|Too time-consuming|9|||
130245973|NCT00397930|468863585|FG000|Overall Study|Started own yoga program|1|||
130245974|NCT00397930|468863586|FG001|Overall Study|Started own yoga program|1|||
130245975|NCT00397930|468863585|FG000|Overall Study|Did not want to be in control group|0|||
130699246|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
130699247|NCT00860262|470522839|FG000|Overall Study|Adverse Event|9|||
130699248|NCT00860262|470522840|FG001|Overall Study|Adverse Event|6|||
130245976|NCT00397930|468863586|FG001|Overall Study|Did not want to be in control group|1|||
130245977|NCT00397930|468863585|FG000|Overall Study|Withdrawal by Subject|0|||
130245978|NCT00397930|468863586|FG001|Overall Study|Withdrawal by Subject|8|||
130245979|NCT00397930|468863585|FG000|Overall Study|Missing data|0|||
130245980|NCT00397930|468863586|FG001|Overall Study|Missing data|4|||
130245981|NCT02391584|468863587|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
130245982|NCT02391584|468863588|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
130245983|NCT02391584|468863587|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
130699249|NCT00860262|470522841|FG002|Overall Study|Adverse Event|7|||
130699250|NCT00860262|470522839|FG000|Overall Study|Protocol Violation|0|||
130699251|NCT00860262|470522840|FG001|Overall Study|Protocol Violation|1|||
130699252|NCT00860262|470522841|FG002|Overall Study|Protocol Violation|0|||
130699253|NCT00860262|470522839|FG000|Overall Study|Lost to Follow-up|2|||
130699254|NCT00860262|470522840|FG001|Overall Study|Lost to Follow-up|0|||
130245984|NCT02391584|468863588|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
130245985|NCT02391584|468863587|FG000|3 Month|Lost to Follow-up|1|||
130245986|NCT02391584|468863588|FG001|3 Month|Lost to Follow-up|0|||
130245987|NCT02391584|468863587|FG000|6 Month|Withdrawal by Subject|1|||
130245988|NCT02391584|468863588|FG001|6 Month|Withdrawal by Subject|0|||
130245989|NCT02391584|468863587|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
130245990|NCT02391584|468863588|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
130245991|NCT02056288|468863591|FG000|In-Hospital Data|Surgery cancelled|1|||
130245992|NCT02056288|468863592|FG001|In-Hospital Data|Surgery cancelled|0|||
130245993|NCT02056288|468863591|FG000|In-Hospital Data|Protocol Violation|3|||
130245994|NCT02056288|468863592|FG001|In-Hospital Data|Protocol Violation|0|||
130245995|NCT02056288|468863591|FG000|In-Hospital Data|Physician Decision|1|||
130245996|NCT02056288|468863592|FG001|In-Hospital Data|Physician Decision|0|||
130245997|NCT02056288|468863591|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
130245998|NCT02056288|468863592|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
130245999|NCT00500110|468863599|FG000|Overall Study|Withdrawal by Subject|3|||
130246000|NCT01502072|468863600|FG000|Overall Study|Withdrawal by Subject|1|||
130246001|NCT01502072|468863601|FG001|Overall Study|Withdrawal by Subject|0|||
130246002|NCT01502072|468863602|FG002|Overall Study|Withdrawal by Subject|0|||
130246003|NCT01502072|468863600|FG000|Overall Study|Death|0|||
130246004|NCT01502072|468863601|FG001|Overall Study|Death|1|||
130246005|NCT01502072|468863602|FG002|Overall Study|Death|0|||
130246006|NCT00617903|468863608|FG000|Overall Study|Withdrawal by Subject|2|||
130246007|NCT00617903|468863609|FG001|Overall Study|Withdrawal by Subject|3|||
130246008|NCT00617903|468863608|FG000|Overall Study|Lost to Follow-up|1|||
130699255|NCT00860262|470522841|FG002|Overall Study|Lost to Follow-up|1|||
130699256|NCT00860262|470522839|FG000|Overall Study|Withdrawal by Subject|4|||
130699257|NCT00860262|470522840|FG001|Overall Study|Withdrawal by Subject|8|||
130363691|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130363692|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130363693|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130246009|NCT00617903|468863609|FG001|Overall Study|Lost to Follow-up|1|||
130246010|NCT00617903|468863608|FG000|Overall Study|Lack of Efficacy|0|||
130246011|NCT00617903|468863609|FG001|Overall Study|Lack of Efficacy|1|||
130246012|NCT00617903|468863608|FG000|Overall Study|Adverse Event|0|||
130246013|NCT00617903|468863609|FG001|Overall Study|Adverse Event|1|||
130246014|NCT00617903|468863608|FG000|Overall Study|noncompliance|0|||
130246015|NCT00617903|468863609|FG001|Overall Study|noncompliance|1|||
130363694|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130363695|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
130246016|NCT04676646|468863610|FG000|Open-label Run-in Phase|Adverse Event|3|||
130246017|NCT04676646|468863611|FG001|Open-label Run-in Phase|Adverse Event|0|||
130246018|NCT04676646|468863612|FG002|Open-label Run-in Phase|Adverse Event|0|||
130246019|NCT04676646|468863610|FG000|Open-label Run-in Phase|Death|3|||
130246020|NCT04676646|468863611|FG001|Open-label Run-in Phase|Death|0|||
130246021|NCT04676646|468863612|FG002|Open-label Run-in Phase|Death|0|||
130246022|NCT04676646|468863610|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
130246023|NCT04676646|468863611|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130246024|NCT04676646|468863612|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130246025|NCT04676646|468863610|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
130246026|NCT04676646|468863611|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130246027|NCT04676646|468863612|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130246028|NCT04676646|468863610|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
130246029|NCT04676646|468863611|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
130246030|NCT04676646|468863612|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
130246031|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
130363696|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130246032|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
130246033|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
130246034|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
130363697|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130699258|NCT00860262|470522841|FG002|Overall Study|Withdrawal by Subject|6|||
130699259|NCT00860262|470522839|FG000|Overall Study|Lack of Efficacy|0|||
130246035|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130246036|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130363698|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130699260|NCT00860262|470522840|FG001|Overall Study|Lack of Efficacy|4|||
130246037|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
130246038|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130246039|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130246040|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
130246041|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
130246042|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
130246043|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Death|0|||
130246044|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Death|1|||
130246045|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Death|2|||
130246046|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
130246047|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
130246048|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
130246049|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130699261|NCT00860262|470522841|FG002|Overall Study|Lack of Efficacy|3|||
130699262|NCT00860262|470522839|FG000|Overall Study|Other|5|||
130699263|NCT00860262|470522840|FG001|Overall Study|Other|3|||
130699264|NCT00860262|470522841|FG002|Overall Study|Other|1|||
130699265|NCT00124618|470522842|FG000|Overall Study|Ineligible|1|||
130246050|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
130246051|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130246052|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130246053|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
130246054|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130246055|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130246056|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
130246057|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130246058|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130246059|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130246060|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
130246061|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130246062|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
130246063|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130363699|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130363700|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130363701|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130363702|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130363703|NCT00533897|469301987|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
130363704|NCT00533897|469301988|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363705|NCT00533897|469301989|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363706|NCT00533897|469301990|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363707|NCT00533897|469301991|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363708|NCT00533897|469301992|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363709|NCT00533897|469301993|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363710|NCT00533897|469301994|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130363711|NCT00533897|469301987|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363712|NCT00533897|469301988|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
130363713|NCT00533897|469301989|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
130363714|NCT00533897|469301990|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363715|NCT00533897|469301991|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363716|NCT00533897|469301992|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363717|NCT00533897|469301993|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363718|NCT00533897|469301994|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130363719|NCT00533897|469301987|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363720|NCT00533897|469301988|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363721|NCT00533897|469301989|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
130363722|NCT00533897|469301990|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363723|NCT00533897|469301991|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363724|NCT00533897|469301992|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363725|NCT00533897|469301993|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130699266|NCT01596127|470522843|FG000|Overall Study|Patient Ineligible|1|||
130451849|NCT03635112|469618264|FG002|Overall Study|Study Terminated by Sponsor|21|||
130451850|NCT03635112|469618262|FG000|Overall Study|Withdrawal by Subject|4|||
130451851|NCT03635112|469618263|FG001|Overall Study|Withdrawal by Subject|9|||
130451852|NCT03635112|469618264|FG002|Overall Study|Withdrawal by Subject|7|||
130451853|NCT03635112|469618262|FG000|Overall Study|Miscellaneous|0|||
130451854|NCT03635112|469618263|FG001|Overall Study|Miscellaneous|0|||
130451855|NCT03635112|469618264|FG002|Overall Study|Miscellaneous|1|||
130699267|NCT00633022|470522844|FG000|Overall Study|Adverse Event|1|||
130699268|NCT00633022|470522845|FG001|Overall Study|Adverse Event|0|||
130699269|NCT00633022|470522846|FG002|Overall Study|Adverse Event|5|||
130699270|NCT00633022|470522844|FG000|Overall Study|Physician Decision|0|||
130699271|NCT00633022|470522845|FG001|Overall Study|Physician Decision|1|||
130699272|NCT00633022|470522846|FG002|Overall Study|Physician Decision|0|||
130246064|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
130246065|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130246066|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130246067|NCT03123588|468863620|FG000|Overall Study|Study Terminated by Sponsor|2|||
130246068|NCT03123588|468863621|FG001|Overall Study|Study Terminated by Sponsor|5|||
130246069|NCT03123588|468863620|FG000|Overall Study|Withdrawal by Subject|1|||
130246070|NCT03123588|468863621|FG001|Overall Study|Withdrawal by Subject|0|||
130246071|NCT03123588|468863620|FG000|Overall Study|Adverse Event|1|||
130246072|NCT03123588|468863621|FG001|Overall Study|Adverse Event|0|||
130246073|NCT03123588|468863620|FG000|Overall Study|Physician Decision|2|||
130246074|NCT03123588|468863621|FG001|Overall Study|Physician Decision|1|||
130246075|NCT01058005|468863622|FG000|Overall Study|Adverse Event|0|||
130246076|NCT01058005|468863623|FG001|Overall Study|Adverse Event|2|||
130246077|NCT01058005|468863624|FG002|Overall Study|Adverse Event|1|||
130246078|NCT01058005|468863622|FG000|Overall Study|Physician Decision|2|||
130246079|NCT01058005|468863623|FG001|Overall Study|Physician Decision|2|||
130246080|NCT01058005|468863624|FG002|Overall Study|Physician Decision|0|||
130246081|NCT01058005|468863622|FG000|Overall Study|Withdrawal by Subject|4|||
130246082|NCT01058005|468863623|FG001|Overall Study|Withdrawal by Subject|5|||
130246083|NCT01058005|468863624|FG002|Overall Study|Withdrawal by Subject|11|||
130246084|NCT01058005|468863622|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
130246085|NCT01058005|468863623|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
130246086|NCT01058005|468863624|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
130246087|NCT01058005|468863622|FG000|Overall Study|Reason Missing|5|||
130363726|NCT00533897|469301994|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130363727|NCT00533897|469301987|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363728|NCT00533897|469301988|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363729|NCT00533897|469301989|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363730|NCT00533897|469301990|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363731|NCT00533897|469301991|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363732|NCT00533897|469301992|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
130363733|NCT00533897|469301993|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363734|NCT00533897|469301994|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130363735|NCT00533897|469301987|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363736|NCT00533897|469301988|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363737|NCT00533897|469301989|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363738|NCT00533897|469301990|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363739|NCT00533897|469301991|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363740|NCT00533897|469301992|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
130363741|NCT00533897|469301993|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363742|NCT00533897|469301994|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130363743|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363744|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363745|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363746|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363747|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363748|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130363749|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
130363750|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
130363751|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Death|0|||
130363752|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Death|0|||
130363753|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Death|0|||
130246088|NCT01058005|468863623|FG001|Overall Study|Reason Missing|3|||
130246089|NCT01058005|468863624|FG002|Overall Study|Reason Missing|1|||
130246090|NCT02287025|468863625|FG000|Overall Study|Not treated|2|||
130246091|NCT02287025|468863626|FG001|Overall Study|Not treated|0|||
130363754|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Death|0|||
130451856|NCT03006341|469618268|FG000|Overall Study|Not linked in the EMR|25069|||
130451857|NCT03006341|469618269|FG001|Overall Study|Not linked in the EMR|67505|||
130699273|NCT04388787|470522847|FG000|Blinded Period|Patient could not follow instructions|1|||
130699274|NCT04388787|470522847|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
130699275|NCT00688844|470522848|FG000|Overall Study|Lost to Follow-up|10|||
130451858|NCT03006341|469618270|FG002|Overall Study|Not linked in the EMR|30993|||
130451859|NCT03006341|469618271|FG003|Overall Study|Not linked in the EMR|10685|||
130451860|NCT02950545|469618274|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130451861|NCT02950545|469618275|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130451862|NCT02950545|469618276|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130451863|NCT02950545|469618277|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130451864|NCT02950545|469618278|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130451865|NCT02950545|469618279|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
130451866|NCT02950545|469618274|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
130451867|NCT02950545|469618275|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
130451868|NCT02950545|469618276|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
130451869|NCT02950545|469618277|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
130451870|NCT02950545|469618278|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
130451871|NCT02950545|469618279|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
130451872|NCT02950545|469618274|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
130451873|NCT02950545|469618275|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
130451874|NCT02950545|469618276|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
130451875|NCT02950545|469618277|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
130451876|NCT02950545|469618278|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
130451877|NCT02950545|469618279|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
130451878|NCT02950545|469618274|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
130451879|NCT02950545|469618275|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
130451880|NCT02950545|469618276|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
130451881|NCT02950545|469618277|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
130451882|NCT02950545|469618278|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
130451883|NCT02950545|469618279|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
130451884|NCT02950545|469618274|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
130451885|NCT02950545|469618275|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
130451886|NCT02950545|469618276|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
130451887|NCT02950545|469618277|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
130451888|NCT02950545|469618278|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
130451889|NCT02950545|469618279|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
130451890|NCT03101592|469618280|FG000|Overall Study|participant files could not be located|111|||
130451891|NCT03101592|469618281|FG001|Overall Study|participant files could not be located|170|||
130451892|NCT03101592|469618282|FG002|Overall Study|participant files could not be located|118|||
130451893|NCT01770860|469618283|FG000|Overall Study|Withdrawal by Subject|4|||
130451894|NCT01770860|469618283|FG000|Overall Study|Lost to Follow-up|1|||
130451895|NCT01770860|469618283|FG000|Overall Study|Administrative decision made by the PI|1|||
130451896|NCT03398356|469618286|FG000|Before Treatment|Lost to Follow-up|1|||
130451897|NCT03398356|469618287|FG001|Before Treatment|Lost to Follow-up|2|||
130451898|NCT03398356|469618288|FG002|Before Treatment|Lost to Follow-up|0|||
130451899|NCT03398356|469618286|FG000|Before Treatment|drug intolerance|2|||
130451900|NCT03398356|469618287|FG001|Before Treatment|drug intolerance|1|||
130451901|NCT03398356|469618288|FG002|Before Treatment|drug intolerance|0|||
130451902|NCT03398356|469618286|FG000|Before Treatment|Withdrawal by Subject|0|||
130451903|NCT03398356|469618287|FG001|Before Treatment|Withdrawal by Subject|5|||
130451904|NCT03398356|469618288|FG002|Before Treatment|Withdrawal by Subject|0|||
130451905|NCT03398356|469618286|FG000|Before Treatment|Physician Decision|0|||
130451906|NCT03398356|469618287|FG001|Before Treatment|Physician Decision|0|||
130451907|NCT03398356|469618288|FG002|Before Treatment|Physician Decision|11|||
130451908|NCT03398356|469618286|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
130451909|NCT03398356|469618287|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
130451910|NCT03398356|469618288|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
130451911|NCT03432533|469618291|FG000|Overall Study|Lost to Follow-up|1|||
130451912|NCT03432533|469618292|FG001|Overall Study|Lost to Follow-up|2|||
130451913|NCT03432533|469618291|FG000|Overall Study|Withdrawal by Subject|14|||
130451914|NCT03432533|469618292|FG001|Overall Study|Withdrawal by Subject|9|||
130451915|NCT01648283|469618293|FG000|Overall Study|Withdrawal by Subject|14|||
130451916|NCT01446003|469618295|FG000|Period 1|Protocol Violation|2|||
130451917|NCT01446003|469618296|FG001|Period 1|Protocol Violation|0|||
130451918|NCT01446003|469618295|FG000|Period 2|Adverse Event|1|||
130451919|NCT01446003|469618296|FG001|Period 2|Adverse Event|0|||
130451920|NCT05550337|469618300|FG000|Overall Study|Lack of Efficacy|0|||
130451921|NCT05550337|469618301|FG001|Overall Study|Lack of Efficacy|0|||
130451922|NCT05550337|469618302|FG002|Overall Study|Lack of Efficacy|1|||
130451923|NCT05550337|469618300|FG000|Overall Study|Adverse Event|1|||
130451924|NCT05550337|469618301|FG001|Overall Study|Adverse Event|5|||
130451925|NCT05550337|469618302|FG002|Overall Study|Adverse Event|0|||
130451926|NCT05550337|469618300|FG000|Overall Study|Withdrawal by Subject|8|||
130699276|NCT01374451|470522849|FG000|Overall Study|Administrative problems|1|||
130246092|NCT02287025|468863625|FG000|Overall Study|Progression of disease|3|||
130246093|NCT02287025|468863626|FG001|Overall Study|Progression of disease|2|||
130246094|NCT02287025|468863625|FG000|Overall Study|Adverse Event|2|||
130246095|NCT02287025|468863626|FG001|Overall Study|Adverse Event|4|||
130246096|NCT02287025|468863625|FG000|Overall Study|Withdrawal by Subject|2|||
130246097|NCT02287025|468863626|FG001|Overall Study|Withdrawal by Subject|2|||
130246098|NCT02287025|468863625|FG000|Overall Study|Screening failed|1|||
130246099|NCT02287025|468863626|FG001|Overall Study|Screening failed|1|||
130246100|NCT04053452|468863627|FG000|Overall Study|Withdrawal by Subject|1|||
130246101|NCT04053452|468863628|FG001|Overall Study|Withdrawal by Subject|0|||
130246102|NCT04053452|468863627|FG000|Overall Study|Time restraint due to inpatient needs|1|||
130246103|NCT04053452|468863628|FG001|Overall Study|Time restraint due to inpatient needs|2|||
130246104|NCT01421134|468863629|FG000|Overall Study|Adverse Event|3|||
130246105|NCT01421134|468863630|FG001|Overall Study|Adverse Event|5|||
130246106|NCT01421134|468863629|FG000|Overall Study|Lack of Efficacy|2|||
130246107|NCT01421134|468863630|FG001|Overall Study|Lack of Efficacy|4|||
130246108|NCT01421134|468863629|FG000|Overall Study|Protocol Violation|0|||
130246109|NCT01421134|468863630|FG001|Overall Study|Protocol Violation|3|||
130246110|NCT01421134|468863629|FG000|Overall Study|Withdrawal by Subject|1|||
130246111|NCT01421134|468863630|FG001|Overall Study|Withdrawal by Subject|1|||
130246112|NCT01421134|468863629|FG000|Overall Study|Administrative|0|||
130246113|NCT01421134|468863630|FG001|Overall Study|Administrative|1|||
130246114|NCT01421134|468863629|FG000|Overall Study|Lost to Follow-up|1|||
130246115|NCT01421134|468863630|FG001|Overall Study|Lost to Follow-up|1|||
130246116|NCT02346370|468863633|FG000|Overall Study|Not treated|1|||
130246117|NCT02346370|468863634|FG001|Overall Study|Not treated|0|||
130246118|NCT02346370|468863635|FG002|Overall Study|Not treated|0|||
130246119|NCT02346370|468863633|FG000|Overall Study|Withdrawal of consent|1|||
130246120|NCT02346370|468863634|FG001|Overall Study|Withdrawal of consent|0|||
130246121|NCT02346370|468863635|FG002|Overall Study|Withdrawal of consent|0|||
130246122|NCT02346370|468863633|FG000|Overall Study|Death|1|||
130246123|NCT02346370|468863634|FG001|Overall Study|Death|3|||
130699277|NCT01374451|470522850|FG001|Overall Study|Administrative problems|0|||
130699278|NCT01223027|470522851|FG000|Overall Study|Adverse Event|20|||
130699279|NCT01223027|470522852|FG001|Overall Study|Adverse Event|10|||
130699280|NCT01223027|470522851|FG000|Overall Study|Death|42|||
130699281|NCT01223027|470522852|FG001|Overall Study|Death|42|||
130699282|NCT01223027|470522851|FG000|Overall Study|Lost to Follow-up|2|||
130699283|NCT01223027|470522852|FG001|Overall Study|Lost to Follow-up|1|||
130699284|NCT01223027|470522851|FG000|Overall Study|Physician Decision|4|||
130699285|NCT01223027|470522852|FG001|Overall Study|Physician Decision|8|||
130699286|NCT01223027|470522851|FG000|Overall Study|Progressive Disease|167|||
130699287|NCT01223027|470522852|FG001|Overall Study|Progressive Disease|183|||
130699288|NCT01223027|470522851|FG000|Overall Study|Protocol Violation|2|||
130699289|NCT01223027|470522852|FG001|Overall Study|Protocol Violation|1|||
130699290|NCT01223027|470522851|FG000|Overall Study|Subject/guardian decicion|18|||
130699291|NCT01223027|470522852|FG001|Overall Study|Subject/guardian decicion|16|||
130699292|NCT01223027|470522851|FG000|Overall Study|New therapy for study indication|17|||
130699293|NCT01223027|470522852|FG001|Overall Study|New therapy for study indication|8|||
130699294|NCT01223027|470522851|FG000|Overall Study|Study terminated by sponsor|2|||
130699295|NCT01223027|470522852|FG001|Overall Study|Study terminated by sponsor|8|||
130699296|NCT00724958|470522856|FG000|Overall Study|Adverse Event|28|||
130699297|NCT00724958|470522856|FG000|Overall Study|Loss of Response|40|||
130699298|NCT00724958|470522856|FG000|Overall Study|No Response|18|||
130699299|NCT00724958|470522856|FG000|Overall Study|Remission|7|||
130699300|NCT00724958|470522856|FG000|Overall Study|Other Reason|76|||
130699301|NCT00724958|470522856|FG000|Overall Study|No documentation for end of therapy|13|||
130699302|NCT01520987|470524611|FG000|Overall Study|Withdrawal by Subject|1|||
130699303|NCT01520987|470524612|FG001|Overall Study|Withdrawal by Subject|0|||
130699304|NCT01520987|470524613|FG002|Overall Study|Withdrawal by Subject|0|||
130699305|NCT01520987|470524614|FG003|Overall Study|Withdrawal by Subject|0|||
130699306|NCT01520987|470524615|FG004|Overall Study|Withdrawal by Subject|0|||
130699307|NCT01520987|470524616|FG005|Overall Study|Withdrawal by Subject|1|||
130699308|NCT01520987|470524617|FG006|Overall Study|Withdrawal by Subject|0|||
130699309|NCT01520987|470524618|FG007|Overall Study|Withdrawal by Subject|0|||
130699310|NCT04729101|470524619|FG000|Overall Study|Adverse Event|1|||
130699311|NCT04729101|470524620|FG001|Overall Study|Adverse Event|0|||
130699312|NCT04729101|470524619|FG000|Overall Study|Physician Decision|1|||
130699313|NCT04729101|470524620|FG001|Overall Study|Physician Decision|0|||
130699314|NCT04729101|470524619|FG000|Overall Study|Withdrawal by Subject|1|||
130699315|NCT04729101|470524620|FG001|Overall Study|Withdrawal by Subject|0|||
130699316|NCT02940522|470524621|FG000|Overall Study|Lost to Follow-up|1|||
130699317|NCT02940522|470524622|FG001|Overall Study|Lost to Follow-up|2|||
130699318|NCT02940522|470524621|FG000|Overall Study|Withdrawal by Subject|1|||
130699319|NCT02940522|470524622|FG001|Overall Study|Withdrawal by Subject|0|||
130699320|NCT00274625|470524623|FG000|Overall Study|Lost to Follow-up|46|||
130699321|NCT00274625|470524624|FG001|Overall Study|Lost to Follow-up|54|||
130246124|NCT02346370|468863635|FG002|Overall Study|Death|1|||
130246125|NCT02346370|468863633|FG000|Overall Study|Sponsor discontinued study|5|||
130246126|NCT02346370|468863634|FG001|Overall Study|Sponsor discontinued study|0|||
130246127|NCT02346370|468863635|FG002|Overall Study|Sponsor discontinued study|2|||
130246128|NCT02346370|468863633|FG000|Overall Study|Radiologic progression|0|||
130246129|NCT02346370|468863634|FG001|Overall Study|Radiologic progression|0|||
130246130|NCT02346370|468863635|FG002|Overall Study|Radiologic progression|1|||
130246131|NCT02346370|468863633|FG000|Overall Study|Physician Decision|0|||
130246132|NCT02346370|468863634|FG001|Overall Study|Physician Decision|1|||
130246133|NCT02346370|468863635|FG002|Overall Study|Physician Decision|0|||
130246134|NCT03528577|468863636|FG000|Sequence 1|Failed Spirometry|1|||
130246135|NCT03528577|468863636|FG000|Sequence 1|Restricted medication|1|||
130246136|NCT03528577|468863636|FG000|Sequence 2|Adverse Event|1|||
130246137|NCT03528577|468863636|FG000|Sequence 2|Withdrawal by Subject|1|||
130246138|NCT03528577|468863636|FG000|Sequence 2|Failed Spirometry|1|||
130246139|NCT03528577|468863636|FG000|Sequence 3|Failed Spirometry|1|||
130246140|NCT03528577|468863636|FG000|Sequence 4|Failed Spirometry|2|||
130246141|NCT03528577|468863636|FG000|Sequence 4|Adverse Event|1|||
130246142|NCT04882215|468863637|FG000|Overall Study|Withdrawal by Subject|5|||
130246143|NCT04882215|468863638|FG001|Overall Study|Withdrawal by Subject|0|||
130246144|NCT04263532|468863639|FG000|Overall Study|Withdrawal by Subject|2|||
130246145|NCT04263532|468863640|FG001|Overall Study|Withdrawal by Subject|0|||
130246146|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
130246147|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
130246148|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130246149|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130246150|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
130246151|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246152|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246153|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246154|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
130246155|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
130246156|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130246157|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130246158|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130246159|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130246160|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130246161|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130246162|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130246163|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130246164|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130246165|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130246166|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246167|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246168|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246169|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
130246170|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246171|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246172|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
130246173|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246174|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246175|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246176|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246177|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
130246178|NCT01290731|468863649|FG000|Overall Study|Withdrawal by Subject|1|||
130246179|NCT01399099|468863650|FG000|Overall Study|Lost to Follow-up|14|||
130246180|NCT01399099|468863650|FG000|Overall Study|Physician Decision|1|||
130246181|NCT01399099|468863650|FG000|Overall Study|Protocol Violation|1|||
130246182|NCT01399099|468863650|FG000|Overall Study|Skin Irritation|13|||
130246183|NCT01399099|468863650|FG000|Overall Study|Infection|1|||
130246184|NCT01399099|468863650|FG000|Overall Study|Miscellaneous|4|||
130246185|NCT01668537|468863651|FG000|Overall Study|Request to Discontinue Prematurely|1|||
130246186|NCT01668537|468863652|FG001|Overall Study|Request to Discontinue Prematurely|1|||
130246187|NCT01668537|468863651|FG000|Overall Study|Subject unwilling/unable to comply|5|||
130246188|NCT01668537|468863652|FG001|Overall Study|Subject unwilling/unable to comply|0|||
130246189|NCT01668537|468863651|FG000|Overall Study|Reason Precludes Participation|1|||
130246190|NCT01668537|468863652|FG001|Overall Study|Reason Precludes Participation|0|||
130246191|NCT01668537|468863651|FG000|Overall Study|Lost to Follow-up|13|||
130246192|NCT01668537|468863652|FG001|Overall Study|Lost to Follow-up|6|||
130246193|NCT01668537|468863651|FG000|Overall Study|Other|2|||
130246194|NCT01668537|468863652|FG001|Overall Study|Other|3|||
130246195|NCT05064800|468863653|FG000|Period 3|Withdrawal by Subject|0|||
130246196|NCT05064800|468863654|FG001|Period 3|Withdrawal by Subject|0|||
130451927|NCT05550337|469618301|FG001|Overall Study|Withdrawal by Subject|14|||
130246197|NCT05064800|468863655|FG002|Period 3|Withdrawal by Subject|0|||
130246198|NCT05064800|468863656|FG003|Period 3|Withdrawal by Subject|0|||
130246199|NCT05064800|468863657|FG004|Period 3|Withdrawal by Subject|1|||
130246200|NCT05064800|468863658|FG005|Period 3|Withdrawal by Subject|0|||
130246201|NCT04477486|468863659|FG000|Overall Study|Death|2|||
130246202|NCT04477486|468863659|FG000|Overall Study|Ongoing at Time of Analysis|11|||
130246203|NCT01078545|468863662|FG000|Overall Study|Lost to Follow-up|13|||
130246204|NCT01078545|468863662|FG000|Overall Study|Physician Decision|6|||
130246205|NCT01078545|468863662|FG000|Overall Study|Withdrawal by Subject|3|||
130246206|NCT01078545|468863662|FG000|Overall Study|Death|3|||
130246207|NCT01078545|468863662|FG000|Overall Study|Participant moved to another physician|1|||
130246208|NCT02497755|468863663|FG000|Overall Study|Protocol Violation|1|||
130246209|NCT02497755|468863664|FG001|Overall Study|Protocol Violation|0|||
130246210|NCT01774370|468863667|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
130246211|NCT01774370|468863667|FG000|Overall Study|Administered prior to the contract date|4|||
130246212|NCT01774370|468863667|FG000|Overall Study|Subjects of contraindications|34|||
130246213|NCT01774370|468863667|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
130246214|NCT01774370|468863667|FG000|Overall Study|Follow-up failure|34|||
130246215|NCT05436288|468863668|FG000|Overall Study|Lost to Follow-up|1|||
130246216|NCT05436288|468863668|FG000|Overall Study|Adverse Event|1|||
130246217|NCT01436500|468863672|FG000|Overall Study|Death|1|||
130246218|NCT01436500|468863673|FG001|Overall Study|Death|0|||
130246219|NCT01436500|468863674|FG002|Overall Study|Death|0|||
130246220|NCT01436500|468863675|FG003|Overall Study|Death|0|||
130246221|NCT01436500|468863676|FG004|Overall Study|Death|0|||
130246222|NCT01436500|468863672|FG000|Overall Study|Adverse Event|0|||
130246223|NCT01436500|468863673|FG001|Overall Study|Adverse Event|2|||
130246224|NCT01436500|468863674|FG002|Overall Study|Adverse Event|2|||
130246225|NCT01436500|468863675|FG003|Overall Study|Adverse Event|0|||
130246226|NCT01436500|468863676|FG004|Overall Study|Adverse Event|1|||
130246227|NCT01436500|468863672|FG000|Overall Study|Withdrawal by Subject|0|||
130246228|NCT01436500|468863673|FG001|Overall Study|Withdrawal by Subject|0|||
130246229|NCT01436500|468863674|FG002|Overall Study|Withdrawal by Subject|2|||
130246230|NCT01436500|468863675|FG003|Overall Study|Withdrawal by Subject|0|||
130246231|NCT01436500|468863676|FG004|Overall Study|Withdrawal by Subject|2|||
130246232|NCT01436500|468863672|FG000|Overall Study|Physician Decision|0|||
130246233|NCT01436500|468863673|FG001|Overall Study|Physician Decision|0|||
130246234|NCT01436500|468863674|FG002|Overall Study|Physician Decision|1|||
130246235|NCT01436500|468863675|FG003|Overall Study|Physician Decision|0|||
130246236|NCT01436500|468863676|FG004|Overall Study|Physician Decision|0|||
130246237|NCT01436500|468863672|FG000|Overall Study|liver transplant|1|||
130246238|NCT01436500|468863673|FG001|Overall Study|liver transplant|0|||
130246239|NCT01436500|468863674|FG002|Overall Study|liver transplant|0|||
130246240|NCT01436500|468863675|FG003|Overall Study|liver transplant|0|||
130246241|NCT01436500|468863676|FG004|Overall Study|liver transplant|0|||
130246242|NCT01436500|468863672|FG000|Overall Study|initiation of dialysis|0|||
130246243|NCT01436500|468863673|FG001|Overall Study|initiation of dialysis|0|||
130246244|NCT01436500|468863674|FG002|Overall Study|initiation of dialysis|0|||
130246245|NCT01436500|468863675|FG003|Overall Study|initiation of dialysis|0|||
130246246|NCT01436500|468863676|FG004|Overall Study|initiation of dialysis|1|||
130246247|NCT01436500|468863672|FG000|Overall Study|discontinued study drug|1|||
130246248|NCT01436500|468863673|FG001|Overall Study|discontinued study drug|0|||
130246249|NCT01436500|468863674|FG002|Overall Study|discontinued study drug|0|||
130246250|NCT01436500|468863675|FG003|Overall Study|discontinued study drug|0|||
130246251|NCT01436500|468863676|FG004|Overall Study|discontinued study drug|0|||
130246252|NCT01436500|468863672|FG000|Overall Study|Other|0|||
130246253|NCT01436500|468863673|FG001|Overall Study|Other|1|||
130246254|NCT01436500|468863674|FG002|Overall Study|Other|0|||
130246255|NCT01436500|468863675|FG003|Overall Study|Other|1|||
130246256|NCT01436500|468863676|FG004|Overall Study|Other|0|||
130246257|NCT01487161|468863678|FG000|Overall Study|Adverse Event|1|||
130246258|NCT01487161|468863679|FG001|Overall Study|Adverse Event|0|||
130246259|NCT01487161|468863680|FG002|Overall Study|Adverse Event|0|||
130246260|NCT01487161|468863681|FG003|Overall Study|Adverse Event|0|||
130246261|NCT01487161|468863678|FG000|Overall Study|Withdrawal by Subject|1|||
130246262|NCT01487161|468863679|FG001|Overall Study|Withdrawal by Subject|1|||
130246263|NCT01487161|468863680|FG002|Overall Study|Withdrawal by Subject|1|||
130246264|NCT01487161|468863681|FG003|Overall Study|Withdrawal by Subject|2|||
130246265|NCT01487161|468863678|FG000|Overall Study|missing data|0|||
130451928|NCT05550337|469618302|FG002|Overall Study|Withdrawal by Subject|10|||
130246266|NCT01487161|468863679|FG001|Overall Study|missing data|1|||
130451929|NCT05550337|469618300|FG000|Overall Study|Pregnancy|0|||
130246267|NCT01487161|468863680|FG002|Overall Study|missing data|0|||
130246268|NCT01487161|468863681|FG003|Overall Study|missing data|0|||
130246269|NCT02675452|468863685|FG000|Overall Study|Sponsor decision|0|||
130246270|NCT02675452|468863686|FG001|Overall Study|Sponsor decision|0|||
130246271|NCT02675452|468863687|FG002|Overall Study|Sponsor decision|0|||
130246272|NCT02675452|468863688|FG003|Overall Study|Sponsor decision|0|||
130246273|NCT02675452|468863689|FG004|Overall Study|Sponsor decision|0|||
130246274|NCT02675452|468863690|FG005|Overall Study|Sponsor decision|0|||
130246275|NCT02675452|468863691|FG006|Overall Study|Sponsor decision|0|||
130246276|NCT02675452|468863692|FG007|Overall Study|Sponsor decision|0|||
130246277|NCT02675452|468863693|FG008|Overall Study|Sponsor decision|0|||
130246278|NCT02675452|468863694|FG009|Overall Study|Sponsor decision|1|||
130246279|NCT02675452|468863695|FG010|Overall Study|Sponsor decision|0|||
130246280|NCT02675452|468863696|FG011|Overall Study|Sponsor decision|0|||
130246281|NCT02675452|468863697|FG012|Overall Study|Sponsor decision|0|||
130246282|NCT02675452|468863698|FG013|Overall Study|Sponsor decision|2|||
130246283|NCT02675452|468863699|FG014|Overall Study|Sponsor decision|1|||
130246284|NCT02675452|468863700|FG015|Overall Study|Sponsor decision|0|||
130246285|NCT02675452|468863701|FG016|Overall Study|Sponsor decision|1|||
130246286|NCT02675452|468863702|FG017|Overall Study|Sponsor decision|0|||
130246287|NCT02675452|468863703|FG018|Overall Study|Sponsor decision|0|||
130246288|NCT02675452|468863704|FG019|Overall Study|Sponsor decision|0|||
130246289|NCT02675452|468863705|FG020|Overall Study|Sponsor decision|0|||
130246290|NCT02675452|468863706|FG021|Overall Study|Sponsor decision|0|||
130246291|NCT02675452|468863707|FG022|Overall Study|Sponsor decision|0|||
130246292|NCT02675452|468863708|FG023|Overall Study|Sponsor decision|0|||
130246293|NCT02675452|468863709|FG024|Overall Study|Sponsor decision|0|||
130246294|NCT02675452|468863710|FG025|Overall Study|Sponsor decision|0|||
130246295|NCT02675452|468863711|FG026|Overall Study|Sponsor decision|2|||
130363755|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Death|0|||
130363756|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Death|0|||
130363757|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Death|1|||
130363758|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Death|3|||
130363759|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363760|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363761|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363762|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363763|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363764|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
130363765|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
130363766|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
130363767|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363768|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363769|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363770|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363771|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363772|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363773|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
130363774|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130363775|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Adverse Event|0|||
130363776|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Adverse Event|0|||
130363777|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Adverse Event|0|||
130363778|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Adverse Event|0|||
130363779|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Adverse Event|0|||
130363780|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Adverse Event|0|||
130363781|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Adverse Event|2|||
130363782|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Adverse Event|5|||
130363783|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Pregnancy|0|||
130363784|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Pregnancy|0|||
130363785|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Pregnancy|0|||
130363786|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Pregnancy|0|||
130363787|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Pregnancy|0|||
130363788|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Pregnancy|0|||
130363789|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Pregnancy|0|||
130363790|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Pregnancy|2|||
130363791|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363792|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363793|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363794|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363795|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363796|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
130363797|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
130363798|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
130363799|NCT00533897|469301987|FG000|Long Term Extension (LTE)|Other|0|||
130363800|NCT00533897|469301988|FG001|Long Term Extension (LTE)|Other|0|||
130363801|NCT00533897|469301989|FG002|Long Term Extension (LTE)|Other|0|||
130363802|NCT00533897|469301990|FG003|Long Term Extension (LTE)|Other|0|||
130246296|NCT02675452|468863712|FG027|Overall Study|Sponsor decision|0|||
130363803|NCT00533897|469301991|FG004|Long Term Extension (LTE)|Other|0|||
130246297|NCT02675452|468863713|FG028|Overall Study|Sponsor decision|0|||
130246298|NCT02675452|468863685|FG000|Overall Study|Withdrawal by Subject|0|||
130246299|NCT02675452|468863686|FG001|Overall Study|Withdrawal by Subject|0|||
130246300|NCT02675452|468863687|FG002|Overall Study|Withdrawal by Subject|0|||
130246301|NCT02675452|468863688|FG003|Overall Study|Withdrawal by Subject|0|||
130246302|NCT02675452|468863689|FG004|Overall Study|Withdrawal by Subject|0|||
130246303|NCT02675452|468863690|FG005|Overall Study|Withdrawal by Subject|0|||
130246304|NCT02675452|468863691|FG006|Overall Study|Withdrawal by Subject|0|||
130246305|NCT02675452|468863692|FG007|Overall Study|Withdrawal by Subject|0|||
130246306|NCT02675452|468863693|FG008|Overall Study|Withdrawal by Subject|0|||
130246307|NCT02675452|468863694|FG009|Overall Study|Withdrawal by Subject|1|||
130246308|NCT02675452|468863695|FG010|Overall Study|Withdrawal by Subject|0|||
130246309|NCT02675452|468863696|FG011|Overall Study|Withdrawal by Subject|1|||
130246310|NCT02675452|468863697|FG012|Overall Study|Withdrawal by Subject|0|||
130246311|NCT02675452|468863698|FG013|Overall Study|Withdrawal by Subject|1|||
130246312|NCT02675452|468863699|FG014|Overall Study|Withdrawal by Subject|1|||
130246313|NCT02675452|468863700|FG015|Overall Study|Withdrawal by Subject|0|||
130246314|NCT02675452|468863701|FG016|Overall Study|Withdrawal by Subject|2|||
130246315|NCT02675452|468863702|FG017|Overall Study|Withdrawal by Subject|0|||
130246316|NCT02675452|468863703|FG018|Overall Study|Withdrawal by Subject|0|||
130246317|NCT02675452|468863704|FG019|Overall Study|Withdrawal by Subject|0|||
130246318|NCT02675452|468863705|FG020|Overall Study|Withdrawal by Subject|0|||
130246319|NCT02675452|468863706|FG021|Overall Study|Withdrawal by Subject|0|||
130246320|NCT02675452|468863707|FG022|Overall Study|Withdrawal by Subject|3|||
130246321|NCT02675452|468863708|FG023|Overall Study|Withdrawal by Subject|0|||
130246322|NCT02675452|468863709|FG024|Overall Study|Withdrawal by Subject|1|||
130246323|NCT02675452|468863710|FG025|Overall Study|Withdrawal by Subject|0|||
130246324|NCT02675452|468863711|FG026|Overall Study|Withdrawal by Subject|1|||
130246325|NCT02675452|468863712|FG027|Overall Study|Withdrawal by Subject|3|||
130246326|NCT02675452|468863713|FG028|Overall Study|Withdrawal by Subject|4|||
130246327|NCT02675452|468863685|FG000|Overall Study|Death|0|||
130246328|NCT02675452|468863686|FG001|Overall Study|Death|0|||
130246329|NCT02675452|468863687|FG002|Overall Study|Death|1|||
130246330|NCT02675452|468863688|FG003|Overall Study|Death|0|||
130246331|NCT02675452|468863689|FG004|Overall Study|Death|0|||
130246332|NCT02675452|468863690|FG005|Overall Study|Death|1|||
130246333|NCT02675452|468863691|FG006|Overall Study|Death|0|||
130246334|NCT02675452|468863692|FG007|Overall Study|Death|0|||
130246335|NCT02675452|468863693|FG008|Overall Study|Death|1|||
130246336|NCT02675452|468863694|FG009|Overall Study|Death|0|||
130246337|NCT02675452|468863695|FG010|Overall Study|Death|0|||
130246338|NCT02675452|468863696|FG011|Overall Study|Death|0|||
130246339|NCT02675452|468863697|FG012|Overall Study|Death|1|||
130246340|NCT02675452|468863698|FG013|Overall Study|Death|0|||
130246341|NCT02675452|468863699|FG014|Overall Study|Death|0|||
130246342|NCT02675452|468863700|FG015|Overall Study|Death|2|||
130246343|NCT02675452|468863701|FG016|Overall Study|Death|0|||
130246344|NCT02675452|468863702|FG017|Overall Study|Death|0|||
130246345|NCT02675452|468863703|FG018|Overall Study|Death|4|||
130246346|NCT02675452|468863704|FG019|Overall Study|Death|3|||
130246347|NCT02675452|468863705|FG020|Overall Study|Death|3|||
130246348|NCT02675452|468863706|FG021|Overall Study|Death|3|||
130246349|NCT02675452|468863707|FG022|Overall Study|Death|7|||
130246350|NCT02675452|468863708|FG023|Overall Study|Death|5|||
130246351|NCT02675452|468863709|FG024|Overall Study|Death|3|||
130246352|NCT02675452|468863710|FG025|Overall Study|Death|4|||
130246353|NCT02675452|468863711|FG026|Overall Study|Death|7|||
130246354|NCT02675452|468863712|FG027|Overall Study|Death|6|||
130246355|NCT02675452|468863713|FG028|Overall Study|Death|9|||
130699322|NCT00274625|470524623|FG000|Overall Study|Excluded from analysis|14|||
130699323|NCT00274625|470524624|FG001|Overall Study|Excluded from analysis|8|||
130699324|NCT01754376|470524628|FG000|Overall Study|Adverse Event|1|||
130699325|NCT01754376|470524628|FG000|Overall Study|Lack of Efficacy|2|||
130699326|NCT04264819|470524629|FG000|Overall Study|Physician Decision|19|||
130699327|NCT04264819|470524629|FG000|Overall Study|Adverse Event|12|||
130699328|NCT04264819|470524629|FG000|Overall Study|Withdrawal by Subject|11|||
130699329|NCT04264819|470524629|FG000|Overall Study|Lost to Follow-up|2|||
130699330|NCT04264819|470524629|FG000|Overall Study|Death|2|||
130699331|NCT04768296|470524630|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
130699332|NCT04768296|470524631|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
130699333|NCT03087786|470524632|FG000|Overall Study|Withdrawal by Subject|2|||
130699334|NCT03087786|470524633|FG001|Overall Study|Withdrawal by Subject|0|||
130699335|NCT01453153|470524638|FG000|Overall Study|Physician Decision|0|||
130699336|NCT01453153|470524639|FG001|Overall Study|Physician Decision|0|||
130699337|NCT01453153|470524640|FG002|Overall Study|Physician Decision|1|||
130699338|NCT01453153|470524638|FG000|Overall Study|Progressive Disease|3|||
130699339|NCT01453153|470524639|FG001|Overall Study|Progressive Disease|2|||
130699340|NCT01453153|470524640|FG002|Overall Study|Progressive Disease|16|||
130699341|NCT01453153|470524638|FG000|Overall Study|Withdrawal by Subject|0|||
130699342|NCT01453153|470524639|FG001|Overall Study|Withdrawal by Subject|1|||
130699343|NCT01453153|470524640|FG002|Overall Study|Withdrawal by Subject|2|||
130246356|NCT02675452|468863685|FG000|Overall Study|Lost to Follow-up|0|||
130246357|NCT02675452|468863686|FG001|Overall Study|Lost to Follow-up|1|||
130246358|NCT02675452|468863687|FG002|Overall Study|Lost to Follow-up|0|||
130246359|NCT02675452|468863688|FG003|Overall Study|Lost to Follow-up|0|||
130246360|NCT02675452|468863689|FG004|Overall Study|Lost to Follow-up|0|||
130246361|NCT02675452|468863690|FG005|Overall Study|Lost to Follow-up|0|||
130246362|NCT02675452|468863691|FG006|Overall Study|Lost to Follow-up|0|||
130246363|NCT02675452|468863692|FG007|Overall Study|Lost to Follow-up|0|||
130246364|NCT02675452|468863693|FG008|Overall Study|Lost to Follow-up|0|||
130246365|NCT02675452|468863694|FG009|Overall Study|Lost to Follow-up|0|||
130246366|NCT02675452|468863695|FG010|Overall Study|Lost to Follow-up|0|||
130246367|NCT02675452|468863696|FG011|Overall Study|Lost to Follow-up|0|||
130246368|NCT02675452|468863697|FG012|Overall Study|Lost to Follow-up|1|||
130246369|NCT02675452|468863698|FG013|Overall Study|Lost to Follow-up|0|||
130246370|NCT02675452|468863699|FG014|Overall Study|Lost to Follow-up|0|||
130246371|NCT02675452|468863700|FG015|Overall Study|Lost to Follow-up|0|||
130246372|NCT02675452|468863701|FG016|Overall Study|Lost to Follow-up|0|||
130246373|NCT02675452|468863702|FG017|Overall Study|Lost to Follow-up|0|||
130246374|NCT02675452|468863703|FG018|Overall Study|Lost to Follow-up|0|||
130246375|NCT02675452|468863704|FG019|Overall Study|Lost to Follow-up|0|||
130246376|NCT02675452|468863705|FG020|Overall Study|Lost to Follow-up|0|||
130246377|NCT02675452|468863706|FG021|Overall Study|Lost to Follow-up|0|||
130246378|NCT02675452|468863707|FG022|Overall Study|Lost to Follow-up|0|||
130246379|NCT02675452|468863708|FG023|Overall Study|Lost to Follow-up|0|||
130246380|NCT02675452|468863709|FG024|Overall Study|Lost to Follow-up|0|||
130246381|NCT02675452|468863710|FG025|Overall Study|Lost to Follow-up|0|||
130246382|NCT02675452|468863711|FG026|Overall Study|Lost to Follow-up|1|||
130246383|NCT02675452|468863712|FG027|Overall Study|Lost to Follow-up|0|||
130246384|NCT02675452|468863713|FG028|Overall Study|Lost to Follow-up|0|||
130246385|NCT02675452|468863685|FG000|Overall Study|Other|0|||
130246386|NCT02675452|468863686|FG001|Overall Study|Other|0|||
130246387|NCT02675452|468863687|FG002|Overall Study|Other|0|||
130246388|NCT02675452|468863688|FG003|Overall Study|Other|0|||
130246389|NCT02675452|468863689|FG004|Overall Study|Other|0|||
130246390|NCT02675452|468863690|FG005|Overall Study|Other|0|||
130246391|NCT02675452|468863691|FG006|Overall Study|Other|0|||
130246392|NCT02675452|468863692|FG007|Overall Study|Other|0|||
130246393|NCT02675452|468863693|FG008|Overall Study|Other|0|||
130246394|NCT02675452|468863694|FG009|Overall Study|Other|0|||
130246395|NCT02675452|468863695|FG010|Overall Study|Other|0|||
130246396|NCT02675452|468863696|FG011|Overall Study|Other|0|||
130246397|NCT02675452|468863697|FG012|Overall Study|Other|0|||
130246398|NCT02675452|468863698|FG013|Overall Study|Other|0|||
130246399|NCT02675452|468863699|FG014|Overall Study|Other|0|||
130246400|NCT02675452|468863700|FG015|Overall Study|Other|0|||
130246401|NCT02675452|468863701|FG016|Overall Study|Other|0|||
130246402|NCT02675452|468863702|FG017|Overall Study|Other|0|||
130246403|NCT02675452|468863703|FG018|Overall Study|Other|0|||
130246404|NCT02675452|468863704|FG019|Overall Study|Other|0|||
130246405|NCT02675452|468863705|FG020|Overall Study|Other|0|||
130246406|NCT02675452|468863706|FG021|Overall Study|Other|0|||
130246407|NCT02675452|468863707|FG022|Overall Study|Other|0|||
130246408|NCT02675452|468863708|FG023|Overall Study|Other|0|||
130246409|NCT02675452|468863709|FG024|Overall Study|Other|0|||
130246410|NCT02675452|468863710|FG025|Overall Study|Other|0|||
130246411|NCT02675452|468863711|FG026|Overall Study|Other|1|||
130246412|NCT02675452|468863712|FG027|Overall Study|Other|0|||
130246413|NCT02675452|468863713|FG028|Overall Study|Other|0|||
130246414|NCT02939781|468863714|FG000|Overall Study|Protocol Violation|8|||
130246415|NCT02939781|468863714|FG000|Overall Study|Withdrawal by Subject|1|||
130246416|NCT00541775|468863715|FG000|Overall Study|Adverse Event|3|||
130246417|NCT00541775|468863716|FG001|Overall Study|Adverse Event|2|||
130246418|NCT00541775|468863717|FG002|Overall Study|Adverse Event|1|||
130363804|NCT00533897|469301992|FG005|Long Term Extension (LTE)|Other|0|||
130363805|NCT00533897|469301993|FG006|Long Term Extension (LTE)|Other|1|||
130363806|NCT00533897|469301994|FG007|Long Term Extension (LTE)|Other|6|||
130246419|NCT00541775|468863715|FG000|Overall Study|Lack of Efficacy|0|||
130246420|NCT00541775|468863716|FG001|Overall Study|Lack of Efficacy|0|||
130246421|NCT00541775|468863717|FG002|Overall Study|Lack of Efficacy|3|||
130246422|NCT00541775|468863715|FG000|Overall Study|Lost to Follow-up|0|||
130363807|NCT01816074|469301996|FG000|Phase 1|Time commitment issues|0|||
130363808|NCT01816074|469301997|FG001|Phase 1|Time commitment issues|0|||
130246423|NCT00541775|468863716|FG001|Overall Study|Lost to Follow-up|0|||
130246424|NCT00541775|468863717|FG002|Overall Study|Lost to Follow-up|2|||
130246425|NCT00541775|468863715|FG000|Overall Study|Protocol Violation|1|||
130246426|NCT00541775|468863716|FG001|Overall Study|Protocol Violation|0|||
130246427|NCT00541775|468863717|FG002|Overall Study|Protocol Violation|0|||
130246428|NCT00541775|468863715|FG000|Overall Study|Withdrawal by Subject and Other|5|||
130246429|NCT00541775|468863716|FG001|Overall Study|Withdrawal by Subject and Other|0|||
130246430|NCT00541775|468863717|FG002|Overall Study|Withdrawal by Subject and Other|2|||
130363809|NCT01816074|469301998|FG002|Phase 1|Time commitment issues|1|||
130246431|NCT00032487|468863718|FG000|Overall Study|Withdrawal by Subject|67|||
130246432|NCT00032487|468863719|FG001|Overall Study|Withdrawal by Subject|43|||
130246433|NCT00032487|468863718|FG000|Overall Study|Adverse Event|3|||
130246434|NCT00032487|468863719|FG001|Overall Study|Adverse Event|7|||
130246435|NCT00032487|468863718|FG000|Overall Study|Lost to Follow-up|57|||
130246436|NCT00032487|468863719|FG001|Overall Study|Lost to Follow-up|58|||
130246437|NCT00032487|468863718|FG000|Overall Study|Had other reason|12|||
130451930|NCT05550337|469618301|FG001|Overall Study|Pregnancy|0|||
130451931|NCT05550337|469618302|FG002|Overall Study|Pregnancy|1|||
130246438|NCT00032487|468863719|FG001|Overall Study|Had other reason|12|||
130246439|NCT02569242|468863721|FG000|Overall Study|Death|1|||
130246440|NCT02569242|468863722|FG001|Overall Study|Death|0|||
130451932|NCT05550337|469618300|FG000|Overall Study|Protocol Violation|1|||
130451933|NCT05550337|469618301|FG001|Overall Study|Protocol Violation|3|||
130451934|NCT05550337|469618302|FG002|Overall Study|Protocol Violation|4|||
130451935|NCT05550337|469618300|FG000|Overall Study|Physician Decision|2|||
130451936|NCT05550337|469618301|FG001|Overall Study|Physician Decision|1|||
130451937|NCT05550337|469618302|FG002|Overall Study|Physician Decision|1|||
130451938|NCT05550337|469618300|FG000|Overall Study|Lost to Follow-up|16|||
130451939|NCT05550337|469618301|FG001|Overall Study|Lost to Follow-up|11|||
130451940|NCT05550337|469618302|FG002|Overall Study|Lost to Follow-up|11|||
130451941|NCT03115346|469618304|FG000|Overall Study|Did not have AAA surgery|28|||
130451942|NCT03115346|469618305|FG001|Overall Study|Did not have AAA surgery|15|||
130451943|NCT03115346|469618304|FG000|Overall Study|Death|3|||
130246441|NCT02569242|468863721|FG000|Overall Study|Withdrawal by Subject|0|||
130246442|NCT02569242|468863722|FG001|Overall Study|Withdrawal by Subject|1|||
130246443|NCT00689052|468863723|FG000|Overall Study|Adverse Event|4|||
130246444|NCT00689052|468863724|FG001|Overall Study|Adverse Event|6|||
130246445|NCT00689052|468863723|FG000|Overall Study|Protocol Violation|1|||
130246446|NCT00689052|468863724|FG001|Overall Study|Protocol Violation|0|||
130246447|NCT00689052|468863723|FG000|Overall Study|Lost to Follow-up|2|||
130246448|NCT00689052|468863724|FG001|Overall Study|Lost to Follow-up|0|||
130246449|NCT00689052|468863723|FG000|Overall Study|Withdrawal by Subject|2|||
130246450|NCT00689052|468863724|FG001|Overall Study|Withdrawal by Subject|0|||
130246451|NCT00689052|468863723|FG000|Overall Study|Early termination of the trial|22|||
130246452|NCT00689052|468863724|FG001|Overall Study|Early termination of the trial|24|||
130246453|NCT03003468|468863725|FG000|Overall Study|Withdrawal by Subject|0|||
130246454|NCT03003468|468863726|FG001|Overall Study|Withdrawal by Subject|0|||
130246455|NCT03003468|468863727|FG002|Overall Study|Withdrawal by Subject|1|||
130451944|NCT03115346|469618305|FG001|Overall Study|Death|1|||
130451945|NCT03115346|469618304|FG000|Overall Study|Withdrawal by Subject|0|||
130451946|NCT03115346|469618305|FG001|Overall Study|Withdrawal by Subject|3|||
130451947|NCT03115346|469618304|FG000|Overall Study|Lost to Follow-up|0|||
130451948|NCT03115346|469618305|FG001|Overall Study|Lost to Follow-up|3|||
130451949|NCT01737268|469618307|FG000|Overall Study|Adverse Event|6|||
130451950|NCT01737268|469618307|FG000|Overall Study|Worsening of Target Disease|2|||
130451951|NCT01737268|469618307|FG000|Overall Study|In consideration of the patient's safety|1|||
130451952|NCT03499600|469618313|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
130451953|NCT03499600|469618314|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
130246456|NCT03003468|468863725|FG000|Overall Study|No measurable lesions|0|||
130246457|NCT03003468|468863726|FG001|Overall Study|No measurable lesions|0|||
130246458|NCT03003468|468863727|FG002|Overall Study|No measurable lesions|1|||
130246459|NCT03259308|468863735|FG000|Overall Study|Adverse Event|5|||
130246460|NCT03259308|468863736|FG001|Overall Study|Adverse Event|4|||
130246461|NCT03259308|468863737|FG002|Overall Study|Adverse Event|1|||
130246462|NCT03259308|468863735|FG000|Overall Study|Withdrawal by Subject|2|||
130246463|NCT03259308|468863736|FG001|Overall Study|Withdrawal by Subject|1|||
130246464|NCT03259308|468863737|FG002|Overall Study|Withdrawal by Subject|3|||
130246465|NCT03259308|468863735|FG000|Overall Study|Lost to Follow-up|0|||
130246466|NCT03259308|468863736|FG001|Overall Study|Lost to Follow-up|0|||
130246467|NCT03259308|468863737|FG002|Overall Study|Lost to Follow-up|1|||
130246468|NCT03259308|468863735|FG000|Overall Study|Pregnancy|0|||
130246469|NCT03259308|468863736|FG001|Overall Study|Pregnancy|0|||
130246470|NCT03259308|468863737|FG002|Overall Study|Pregnancy|1|||
130246471|NCT03259308|468863735|FG000|Overall Study|Protocol Deviation|0|||
130246472|NCT03259308|468863736|FG001|Overall Study|Protocol Deviation|3|||
130246473|NCT03259308|468863737|FG002|Overall Study|Protocol Deviation|0|||
130246474|NCT03259308|468863735|FG000|Overall Study|Lack of Efficacy|0|||
130451954|NCT01137292|469618315|FG000|Overall Study|Death|30|||
130451955|NCT01137292|469618315|FG000|Overall Study|Adverse Event|3|||
130246475|NCT03259308|468863736|FG001|Overall Study|Lack of Efficacy|0|||
130246476|NCT03259308|468863737|FG002|Overall Study|Lack of Efficacy|1|||
130246477|NCT01727154|468863738|FG000|Overall Study|Death|17|||
130246478|NCT01727154|468863738|FG000|Overall Study|Withdrawal by Subject|14|||
130246479|NCT01727154|468863738|FG000|Overall Study|Subject Withdrew Consent|18|||
130246480|NCT01727154|468863738|FG000|Overall Study|Study Terminated|6|||
130451956|NCT01137292|469618315|FG000|Overall Study|Lack of Efficacy|13|||
130451957|NCT01137292|469618315|FG000|Overall Study|Lost to Follow-up|1|||
130451958|NCT01137292|469618315|FG000|Overall Study|Other|7|||
130451959|NCT02014558|469618318|FG000|Overall Study|Never Received Study Drug|0|||
130246481|NCT01727154|468863738|FG000|Overall Study|No Discontinuation Documentation|4|||
130246482|NCT00003474|468863739|FG000|Overall Study|Not Evaluable|14|||
130246483|NCT06025695|468863740|FG000|Overall Study|Adverse Event|5|||
130246484|NCT06025695|468863741|FG001|Overall Study|Adverse Event|6|||
130246485|NCT06025695|468863740|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
130246486|NCT06025695|468863741|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
130246487|NCT06025695|468863740|FG000|Overall Study|Other|23|||
130246488|NCT06025695|468863741|FG001|Overall Study|Other|19|||
130246489|NCT06025695|468863740|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
130246490|NCT06025695|468863741|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
130246491|NCT03834883|468863742|FG000|Second Treatment|Withdrawal by Subject|1|||
130246492|NCT03834883|468863743|FG001|Second Treatment|Withdrawal by Subject|0|||
130246493|NCT03834883|468863744|FG002|Second Treatment|Withdrawal by Subject|0|||
130246494|NCT03834883|468863745|FG003|Second Treatment|Withdrawal by Subject|0|||
130246495|NCT03834883|468863742|FG000|Second Treatment|COVID-19 pandemic|1|||
130246496|NCT03834883|468863743|FG001|Second Treatment|COVID-19 pandemic|0|||
130246497|NCT03834883|468863744|FG002|Second Treatment|COVID-19 pandemic|1|||
130246498|NCT03834883|468863745|FG003|Second Treatment|COVID-19 pandemic|1|||
130246499|NCT01629563|468865330|FG000|Overall Study|Adverse Event|16|||
130246500|NCT01629563|468865331|FG001|Overall Study|Adverse Event|16|||
130246501|NCT01629563|468865330|FG000|Overall Study|Death|2|||
130246502|NCT01629563|468865331|FG001|Overall Study|Death|0|||
130246503|NCT01629563|468865330|FG000|Overall Study|Lack of Efficacy|2|||
130246504|NCT01629563|468865331|FG001|Overall Study|Lack of Efficacy|3|||
130246505|NCT01629563|468865330|FG000|Overall Study|Lost to Follow-up|1|||
130246506|NCT01629563|468865331|FG001|Overall Study|Lost to Follow-up|0|||
130246507|NCT01629563|468865330|FG000|Overall Study|Pregnancy|1|||
130246508|NCT01629563|468865331|FG001|Overall Study|Pregnancy|2|||
130246509|NCT01629563|468865330|FG000|Overall Study|Protocol Violation|0|||
130246510|NCT01629563|468865331|FG001|Overall Study|Protocol Violation|1|||
130246511|NCT01629563|468865330|FG000|Overall Study|Withdrawal by Subject|27|||
130246512|NCT01629563|468865331|FG001|Overall Study|Withdrawal by Subject|20|||
130246513|NCT01629563|468865330|FG000|Overall Study|surgery|0|||
130246514|NCT01629563|468865331|FG001|Overall Study|surgery|3|||
130246515|NCT01629563|468865330|FG000|Overall Study|Lack of return of menses|12|||
130246516|NCT01629563|468865331|FG001|Overall Study|Lack of return of menses|7|||
130246517|NCT01629563|468865330|FG000|Overall Study|Protocol Violation|0|||
130246518|NCT01629563|468865331|FG001|Overall Study|Protocol Violation|1|||
130246519|NCT00454142|468865332|FG000|Overall Study|Withdrawal by Subject|1|||
130246520|NCT02545127|468865335|FG000|Overall Study|Lost to Follow-up|1|||
130246521|NCT02545127|468865336|FG001|Overall Study|Lost to Follow-up|0|||
130246522|NCT02802865|468865337|FG000|Overall Study|Pregnancy|1|||
130246523|NCT02802865|468865338|FG001|Overall Study|Pregnancy|1|||
130246524|NCT02802865|468865337|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
130246525|NCT02802865|468865338|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
130246526|NCT01783015|468865339|FG000|Blinded Treatment|Adverse Event|0|||
130246527|NCT01783015|468865340|FG001|Blinded Treatment|Adverse Event|1|||
130246528|NCT01783015|468865341|FG002|Blinded Treatment|Adverse Event|0|||
130246529|NCT01783015|468865339|FG000|Blinded Treatment|Protocol Violation|0|||
130246530|NCT01783015|468865340|FG001|Blinded Treatment|Protocol Violation|1|||
130246531|NCT01783015|468865341|FG002|Blinded Treatment|Protocol Violation|0|||
130246532|NCT01783015|468865339|FG000|Blinded Treatment|Withdrawal by Subject|0|||
130246533|NCT01783015|468865340|FG001|Blinded Treatment|Withdrawal by Subject|1|||
130246534|NCT01783015|468865341|FG002|Blinded Treatment|Withdrawal by Subject|0|||
130246535|NCT01783015|468865339|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
130246536|NCT01783015|468865340|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
130246537|NCT01783015|468865341|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
130246538|NCT01783015|468865339|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
130363810|NCT01816074|469301999|FG003|Phase 1|Time commitment issues|0|||
130363811|NCT01816074|469301996|FG000|Phase 2|Time commitment Issues|0|||
130363812|NCT01816074|469301997|FG001|Phase 2|Time commitment Issues|2|||
130363813|NCT01816074|469301998|FG002|Phase 2|Time commitment Issues|0|||
130363814|NCT01816074|469301999|FG003|Phase 2|Time commitment Issues|0|||
130363815|NCT01816074|469301996|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
130363816|NCT01816074|469301997|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
130363817|NCT01816074|469301998|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
130363818|NCT01816074|469301999|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
130246539|NCT01783015|468865340|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
130246540|NCT01783015|468865341|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
130246541|NCT00509600|468865342|FG000|Overall Study|Adverse Event|1|||
130246542|NCT02930941|468865344|FG000|Overall Study|Lost to Follow-up|1|||
130363819|NCT01816074|469301996|FG000|Phase 2|Physician Decision|0|||
130363820|NCT01816074|469301997|FG001|Phase 2|Physician Decision|0|||
130363821|NCT01816074|469301998|FG002|Phase 2|Physician Decision|0|||
130246543|NCT02930941|468865345|FG001|Overall Study|Lost to Follow-up|2|||
130246544|NCT00289978|468865346|FG000|Overall Study|Withdrawal by Subject|31|||
130246545|NCT00289978|468865347|FG001|Overall Study|Withdrawal by Subject|17|||
130246546|NCT00289978|468865348|FG002|Overall Study|Withdrawal by Subject|28|||
130246547|NCT00289978|468865346|FG000|Overall Study|Adverse Event|22|||
130246548|NCT00289978|468865347|FG001|Overall Study|Adverse Event|13|||
130246549|NCT00289978|468865348|FG002|Overall Study|Adverse Event|18|||
130246550|NCT00289978|468865346|FG000|Overall Study|Lack of Efficacy|13|||
130246551|NCT00289978|468865347|FG001|Overall Study|Lack of Efficacy|6|||
130246552|NCT00289978|468865348|FG002|Overall Study|Lack of Efficacy|25|||
130246553|NCT00289978|468865346|FG000|Overall Study|Abnormal laboratory value(s)|20|||
130246554|NCT00289978|468865347|FG001|Overall Study|Abnormal laboratory value(s)|9|||
130246555|NCT00289978|468865348|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130246556|NCT00289978|468865346|FG000|Overall Study|Lost to Follow-up|3|||
130246557|NCT00289978|468865347|FG001|Overall Study|Lost to Follow-up|5|||
130246558|NCT00289978|468865348|FG002|Overall Study|Lost to Follow-up|7|||
130246559|NCT00289978|468865346|FG000|Overall Study|Protocol Violation|5|||
130246560|NCT00289978|468865347|FG001|Overall Study|Protocol Violation|5|||
130246561|NCT00289978|468865348|FG002|Overall Study|Protocol Violation|4|||
130246562|NCT00289978|468865346|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130246563|NCT00289978|468865347|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130246564|NCT00289978|468865348|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130246565|NCT00289978|468865346|FG000|Overall Study|Death|1|||
130246566|NCT00289978|468865347|FG001|Overall Study|Death|0|||
130246567|NCT00289978|468865348|FG002|Overall Study|Death|2|||
130246568|NCT00720083|468865351|FG000|Overall Study|Ineligible|1|||
130246569|NCT00720083|468865352|FG001|Overall Study|Ineligible|2|||
130246570|NCT01967277|468865354|FG000|Overall Study|Lost to Follow-up|1|||
130363822|NCT01816074|469301999|FG003|Phase 2|Physician Decision|1|||
130363823|NCT01816074|469301996|FG000|Phase 2|Withdrawal by Subject|1|||
130363824|NCT01816074|469301997|FG001|Phase 2|Withdrawal by Subject|0|||
130363825|NCT01816074|469301998|FG002|Phase 2|Withdrawal by Subject|0|||
130363826|NCT01816074|469301999|FG003|Phase 2|Withdrawal by Subject|0|||
130363827|NCT03228433|469302002|FG000|Overall Study|Lost to Follow-up|1|||
130363828|NCT03228433|469302003|FG001|Overall Study|Lost to Follow-up|0|||
130363829|NCT03228433|469302004|FG002|Overall Study|Lost to Follow-up|0|||
130363830|NCT03228433|469302005|FG003|Overall Study|Lost to Follow-up|0|||
130363831|NCT03228433|469302006|FG004|Overall Study|Lost to Follow-up|0|||
130246571|NCT01967277|468865355|FG001|Overall Study|Lost to Follow-up|2|||
130246572|NCT01967277|468865354|FG000|Overall Study|Unrelated illness|0|||
130246573|NCT01967277|468865355|FG001|Overall Study|Unrelated illness|1|||
130246574|NCT00585585|468865358|FG000|Overall Study|Adverse Event|1|||
130246575|NCT00103506|468865359|FG000|Overall Study|Study closed by sponsor|34|||
130246576|NCT00103506|468865360|FG001|Overall Study|Study closed by sponsor|37|||
130246577|NCT00103506|468865359|FG000|Overall Study|Death|257|||
130246578|NCT00103506|468865360|FG001|Overall Study|Death|253|||
130246579|NCT00103506|468865359|FG000|Overall Study|Lost to Follow-up|13|||
130246580|NCT00103506|468865360|FG001|Overall Study|Lost to Follow-up|13|||
130246581|NCT00103506|468865359|FG000|Overall Study|Withdrawal by Subject|18|||
130246582|NCT00103506|468865360|FG001|Overall Study|Withdrawal by Subject|21|||
130246583|NCT00585169|468865361|FG000|Overall Study|Withdrawal by Subject|1|||
130246584|NCT00710970|468865362|FG000|Overall Study|Never took drug|3|||
130363832|NCT03228433|469302007|FG005|Overall Study|Lost to Follow-up|0|||
130363833|NCT03228433|469302002|FG000|Overall Study|Positive alcohol test|0|||
130363834|NCT03228433|469302003|FG001|Overall Study|Positive alcohol test|0|||
130363835|NCT03228433|469302004|FG002|Overall Study|Positive alcohol test|0|||
130246585|NCT01028560|468865363|FG000|Overall Study|Lack of Efficacy|3|||
130246586|NCT01028560|468865364|FG001|Overall Study|Lack of Efficacy|6|||
130246587|NCT01028560|468865363|FG000|Overall Study|Withdrawal by Subject|7|||
130246588|NCT01028560|468865364|FG001|Overall Study|Withdrawal by Subject|12|||
130246589|NCT03055221|468865365|FG000|Overall Study|Adverse Event|2|||
130363836|NCT03228433|469302005|FG003|Overall Study|Positive alcohol test|1|||
130363837|NCT03228433|469302006|FG004|Overall Study|Positive alcohol test|0|||
130363838|NCT03228433|469302007|FG005|Overall Study|Positive alcohol test|0|||
130246590|NCT03055221|468865365|FG000|Overall Study|Withdrawal by Subject|4|||
130363839|NCT01030536|469302010|FG000|Overall Study|Withdrawal by Subject|0|||
130363840|NCT01030536|469302011|FG001|Overall Study|Withdrawal by Subject|0|||
130246591|NCT03055221|468865365|FG000|Overall Study|Death|6|||
130246592|NCT03055221|468865365|FG000|Overall Study|Physician Decision|1|||
130363841|NCT01030536|469302012|FG002|Overall Study|Withdrawal by Subject|1|||
130246593|NCT03055221|468865365|FG000|Overall Study|Study terminated by Sponsor|3|||
130363842|NCT01030536|469302013|FG003|Overall Study|Withdrawal by Subject|0|||
130451960|NCT02014558|469618319|FG001|Overall Study|Never Received Study Drug|0|||
130246594|NCT03055221|468865365|FG000|Overall Study|Lost to Follow-up|4|||
130246595|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
130246596|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
130246597|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
130246598|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
130246599|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
130246600|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
130246601|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
130246602|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
130246603|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
130246604|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
130246605|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130246606|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130246607|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
130246608|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
130246609|NCT01243424|468865366|FG000|Discontinuation From Treatment|Not treated|5|||
130246610|NCT01243424|468865367|FG001|Discontinuation From Treatment|Not treated|4|||
130246611|NCT01243424|468865366|FG000|Discontinuation From Treatment|Adverse Event|457|||
130246612|NCT01243424|468865367|FG001|Discontinuation From Treatment|Adverse Event|523|||
130246613|NCT01243424|468865366|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
130246614|NCT01243424|468865367|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
130246615|NCT01243424|468865366|FG000|Discontinuation From Treatment|Protocol Violation|46|||
130246616|NCT01243424|468865367|FG001|Discontinuation From Treatment|Protocol Violation|47|||
130246617|NCT01243424|468865366|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
130246618|NCT01243424|468865367|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
130246619|NCT01243424|468865366|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
130246620|NCT01243424|468865367|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
130246621|NCT01243424|468865366|FG000|Discontinuation From Treatment|Other than listed above|230|||
130246622|NCT01243424|468865367|FG001|Discontinuation From Treatment|Other than listed above|211|||
130246623|NCT00710554|468865377|FG000|Overall Study|Adverse Event|24|||
130246624|NCT00710554|468865378|FG001|Overall Study|Adverse Event|7|||
130246625|NCT00710554|468865377|FG000|Overall Study|Withdrawal by Subject|7|||
130246626|NCT00710554|468865378|FG001|Overall Study|Withdrawal by Subject|3|||
130246627|NCT00710554|468865377|FG000|Overall Study|Lost to Follow-up|7|||
130246628|NCT00710554|468865378|FG001|Overall Study|Lost to Follow-up|1|||
130246629|NCT00710554|468865377|FG000|Overall Study|Lack of Efficacy|11|||
130246630|NCT00710554|468865378|FG001|Overall Study|Lack of Efficacy|12|||
130246631|NCT00710554|468865377|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
130246632|NCT00710554|468865378|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
130246633|NCT01301001|468865383|FG000|First Intervention|Lost to Follow-up|4|||
130246634|NCT01301001|468865384|FG001|First Intervention|Lost to Follow-up|4|||
130246635|NCT01301001|468865383|FG000|First Intervention|Withdrawal by Subject|1|||
130246636|NCT01301001|468865384|FG001|First Intervention|Withdrawal by Subject|4|||
130246637|NCT01301001|468865383|FG000|First Intervention|Adverse Event|5|||
130246638|NCT01301001|468865384|FG001|First Intervention|Adverse Event|0|||
130246639|NCT01301001|468865383|FG000|First Intervention|Protocol Violation|0|||
130246640|NCT01301001|468865384|FG001|First Intervention|Protocol Violation|1|||
130246641|NCT01301001|468865383|FG000|Second Intervention|Adverse Event|2|||
130246642|NCT01301001|468865384|FG001|Second Intervention|Adverse Event|0|||
130246643|NCT01301001|468865383|FG000|Second Intervention|Withdrawal by Subject|2|||
130246644|NCT01301001|468865384|FG001|Second Intervention|Withdrawal by Subject|0|||
130246645|NCT01441414|468865387|FG000|Overall Study|Participant died|9|||
130246646|NCT01441414|468865387|FG000|Overall Study|Other reasons|3|||
130246647|NCT01441414|468865387|FG000|Overall Study|Study terminated by sponsor|2|||
130246648|NCT01441414|468865387|FG000|Overall Study|Subject refused further follow-up|1|||
130246649|NCT01433978|468865388|FG000|Core Study|Adverse Event, Non-Fatal|0|||
130246650|NCT01433978|468865389|FG001|Core Study|Adverse Event, Non-Fatal|1|||
130246651|NCT01433978|468865390|FG002|Core Study|Adverse Event, Non-Fatal|0|||
130246652|NCT01433978|468865388|FG000|Core Study|Lack of Efficacy|5|||
130246653|NCT01433978|468865389|FG001|Core Study|Lack of Efficacy|1|||
130246654|NCT01433978|468865390|FG002|Core Study|Lack of Efficacy|0|||
130246655|NCT01433978|468865388|FG000|Core Study|Study Terminated by Sponsor|6|||
130246656|NCT01433978|468865389|FG001|Core Study|Study Terminated by Sponsor|9|||
130246657|NCT01433978|468865390|FG002|Core Study|Study Terminated by Sponsor|0|||
130246658|NCT01433978|468865388|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
130246659|NCT01433978|468865389|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
130246660|NCT01433978|468865390|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
130363843|NCT01030536|469302014|FG004|Overall Study|Withdrawal by Subject|0|||
130246661|NCT01433978|468865388|FG000|Extension Phase|Lack of Efficacy|0|||
130363844|NCT01030536|469302010|FG000|Overall Study|undefined|1|||
130363845|NCT01030536|469302011|FG001|Overall Study|undefined|0|||
130363846|NCT01030536|469302012|FG002|Overall Study|undefined|1|||
130363847|NCT01030536|469302013|FG003|Overall Study|undefined|1|||
130246662|NCT01433978|468865389|FG001|Extension Phase|Lack of Efficacy|0|||
130246663|NCT01433978|468865390|FG002|Extension Phase|Lack of Efficacy|1|||
130246664|NCT01433978|468865388|FG000|Extension Phase|Study Terminated by Sponsor|0|||
130246665|NCT01433978|468865389|FG001|Extension Phase|Study Terminated by Sponsor|0|||
130246666|NCT01433978|468865390|FG002|Extension Phase|Study Terminated by Sponsor|4|||
130246667|NCT01773889|468865391|FG000|Overall Study|lack of funding|2|||
130246668|NCT02565186|468865392|FG000|Overall Study|Adverse Event|113|||
130246669|NCT02565186|468865393|FG001|Overall Study|Adverse Event|148|||
130246670|NCT02565186|468865392|FG000|Overall Study|Lost to Follow-up|102|||
130246671|NCT02565186|468865393|FG001|Overall Study|Lost to Follow-up|93|||
130246672|NCT02565186|468865392|FG000|Overall Study|Non-Compliance|57|||
130246673|NCT02565186|468865393|FG001|Overall Study|Non-Compliance|55|||
130246674|NCT02565186|468865392|FG000|Overall Study|Withdrawal by Subject|229|||
130246675|NCT02565186|468865393|FG001|Overall Study|Withdrawal by Subject|214|||
130246676|NCT02565186|468865392|FG000|Overall Study|Physician Decision|18|||
130246677|NCT02565186|468865393|FG001|Overall Study|Physician Decision|16|||
130246678|NCT02565186|468865392|FG000|Overall Study|Sponsor Request|5|||
130246679|NCT02565186|468865393|FG001|Overall Study|Sponsor Request|9|||
130246680|NCT02565186|468865392|FG000|Overall Study|Missing|1|||
130246681|NCT02565186|468865393|FG001|Overall Study|Missing|0|||
130246682|NCT02565186|468865392|FG000|Overall Study|Did Not Receive Study Drug|55|||
130246683|NCT02565186|468865393|FG001|Overall Study|Did Not Receive Study Drug|86|||
130246684|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
130246685|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
130246686|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
130246687|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
130246688|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
130246689|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
130246690|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
130246691|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
130246692|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
130246693|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
130246694|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
130246695|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
130246696|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
130246697|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
130246698|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
130246699|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
130246700|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
130246701|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
130246702|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130246703|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
130246704|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
130246705|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
130246706|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
130246707|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
130246708|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
130246709|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
130246710|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
130246711|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130246712|NCT05156125|468865396|FG000|Overall Study|Lack of Efficacy|1|||
130246713|NCT05156125|468865397|FG001|Overall Study|Lack of Efficacy|1|||
130246714|NCT05156125|468865398|FG002|Overall Study|Lack of Efficacy|1|||
130246715|NCT05156125|468865396|FG000|Overall Study|Physician Decision|0|||
130699344|NCT01453153|470524638|FG000|Overall Study|Adverse Event|1|||
130246716|NCT05156125|468865397|FG001|Overall Study|Physician Decision|0|||
130246717|NCT05156125|468865398|FG002|Overall Study|Physician Decision|1|||
130246718|NCT05156125|468865396|FG000|Overall Study|Non-compliance|0|||
130246719|NCT05156125|468865397|FG001|Overall Study|Non-compliance|1|||
130699345|NCT01453153|470524639|FG001|Overall Study|Adverse Event|1|||
130699346|NCT01453153|470524640|FG002|Overall Study|Adverse Event|1|||
130699347|NCT01802216|470524642|FG000|4 Month Visit|Participant did not show to visit|3|||
130699348|NCT01802216|470524643|FG001|4 Month Visit|Participant did not show to visit|4|||
130699349|NCT01802216|470524642|FG000|8 Month Visit|Participant did not show to visit|3|||
130699350|NCT01802216|470524643|FG001|8 Month Visit|Participant did not show to visit|5|||
130699351|NCT01802216|470524642|FG000|12 Month Visit|Participant did not show to visit|3|||
130699352|NCT01802216|470524643|FG001|12 Month Visit|Participant did not show to visit|4|||
130699353|NCT00880334|470524644|FG000|Randomized Phase|Physician Decision|1|||
130699354|NCT00880334|470524645|FG001|Randomized Phase|Physician Decision|0|||
130699355|NCT00880334|470524644|FG000|Randomized Phase|Withdrawal by Subject|2|||
130699356|NCT00880334|470524645|FG001|Randomized Phase|Withdrawal by Subject|1|||
130699357|NCT00880334|470524644|FG000|Randomized Phase|Inadequate Labs|1|||
130699358|NCT00880334|470524645|FG001|Randomized Phase|Inadequate Labs|1|||
130699359|NCT00880334|470524644|FG000|Randomized Phase|Brain Metastasis|0|||
130699360|NCT00880334|470524645|FG001|Randomized Phase|Brain Metastasis|1|||
130699361|NCT00880334|470524644|FG000|Randomized Phase|Crossover Participants|0|||
130699362|NCT00880334|470524645|FG001|Randomized Phase|Crossover Participants|37|||
130699363|NCT05061992|470524650|FG000|Overall Study|Excess bowel movements|1|||
130699364|NCT05061992|470524651|FG001|Overall Study|Excess bowel movements|0|||
130699365|NCT05061992|470524650|FG000|Overall Study|Complications of Medical Care|1|||
130699366|NCT05061992|470524651|FG001|Overall Study|Complications of Medical Care|0|||
130699367|NCT05061992|470524650|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
130246720|NCT05156125|468865398|FG002|Overall Study|Non-compliance|1|||
130246721|NCT05156125|468865396|FG000|Overall Study|Withdrawal by Subject|0|||
130246722|NCT05156125|468865397|FG001|Overall Study|Withdrawal by Subject|0|||
130246723|NCT05156125|468865398|FG002|Overall Study|Withdrawal by Subject|1|||
130246724|NCT05156125|468865396|FG000|Overall Study|Adverse Event|2|||
130246725|NCT05156125|468865397|FG001|Overall Study|Adverse Event|1|||
130246726|NCT05156125|468865398|FG002|Overall Study|Adverse Event|0|||
130246727|NCT02852434|468865399|FG000|Overall Study|Withdrawal by Subject|0|||
130246728|NCT02852434|468865400|FG001|Overall Study|Withdrawal by Subject|1|||
130246729|NCT02852434|468865399|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
130246730|NCT02852434|468865400|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
130246731|NCT02018887|468865403|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
130246732|NCT02018887|468865404|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246733|NCT02018887|468865405|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246734|NCT02018887|468865406|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246735|NCT02018887|468865407|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246736|NCT02018887|468865408|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246737|NCT02018887|468865409|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246738|NCT02018887|468865410|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246739|NCT02018887|468865411|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246740|NCT02018887|468865412|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246741|NCT02018887|468865413|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246742|NCT02018887|468865403|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246743|NCT02018887|468865404|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246744|NCT02018887|468865405|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246745|NCT02018887|468865406|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246746|NCT02018887|468865407|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130246747|NCT02018887|468865408|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246748|NCT02018887|468865409|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130246749|NCT02018887|468865410|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
130246750|NCT02018887|468865411|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246751|NCT02018887|468865412|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246752|NCT02018887|468865413|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246753|NCT02018887|468865403|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
130246754|NCT02018887|468865404|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
130246755|NCT02018887|468865405|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
130246756|NCT02018887|468865406|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
130246757|NCT02018887|468865407|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
130246758|NCT02018887|468865408|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
130246759|NCT02018887|468865409|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
130246760|NCT02018887|468865410|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
130246761|NCT02018887|468865411|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
130246762|NCT02018887|468865412|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
130246763|NCT02018887|468865413|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
130246764|NCT02018887|468865403|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
130246765|NCT02018887|468865404|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
130246766|NCT02018887|468865405|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
130246767|NCT02018887|468865406|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
130246768|NCT02018887|468865407|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
130246769|NCT02018887|468865408|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
130246770|NCT02018887|468865409|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
130246771|NCT02018887|468865410|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
130246772|NCT02018887|468865411|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
130246773|NCT02018887|468865412|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
130246774|NCT02018887|468865413|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
130246775|NCT01145222|468865414|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246776|NCT01145222|468865415|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246777|NCT01145222|468865416|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
130246778|NCT01145222|468865417|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246779|NCT01145222|468865414|FG000|Overall Study|Poor bowel preparation|0|||
130246780|NCT01145222|468865415|FG001|Overall Study|Poor bowel preparation|0|||
130246781|NCT01145222|468865416|FG002|Overall Study|Poor bowel preparation|0|||
130451961|NCT02014558|469618320|FG002|Overall Study|Never Received Study Drug|0|||
130451962|NCT02014558|469618321|FG003|Overall Study|Never Received Study Drug|0|||
130451963|NCT02014558|469618322|FG004|Overall Study|Never Received Study Drug|1|||
130451964|NCT02014558|469618323|FG005|Overall Study|Never Received Study Drug|0|||
130246782|NCT01145222|468865417|FG003|Overall Study|Poor bowel preparation|1|||
130246783|NCT00927186|468865418|FG000|12 Months Primary Study|Adverse Event|5|||
130246784|NCT00927186|468865419|FG001|12 Months Primary Study|Adverse Event|2|||
130246785|NCT00927186|468865418|FG000|12 Months Primary Study|Lost to Follow-up|1|||
130246786|NCT00927186|468865419|FG001|12 Months Primary Study|Lost to Follow-up|0|||
130246787|NCT00927186|468865418|FG000|12 Months Primary Study|Protocol Violation|0|||
130699368|NCT05061992|470524651|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
130451965|NCT02014558|469618324|FG006|Overall Study|Never Received Study Drug|1|||
130451966|NCT02014558|469618325|FG007|Overall Study|Never Received Study Drug|0|||
130451967|NCT02014558|469618326|FG008|Overall Study|Never Received Study Drug|2|||
130451968|NCT02014558|469618327|FG009|Overall Study|Never Received Study Drug|0|||
130451969|NCT02014558|469618328|FG010|Overall Study|Never Received Study Drug|2|||
130451970|NCT02014558|469618329|FG011|Overall Study|Never Received Study Drug|2|||
130699369|NCT05061992|470524650|FG000|Overall Study|Withdrawal by Subject|0|||
130246788|NCT00927186|468865419|FG001|12 Months Primary Study|Protocol Violation|1|||
130246789|NCT00927186|468865418|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
130246790|NCT00927186|468865419|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
130246791|NCT01698008|468865420|FG000|Overall Study|Withdrawal by Subject|1|||
130246792|NCT01698008|468865421|FG001|Overall Study|Withdrawal by Subject|2|||
130246793|NCT01011283|468865423|FG000|Overall Study|Adverse Event|4|||
130246794|NCT01011283|468865424|FG001|Overall Study|Adverse Event|2|||
130246795|NCT01011283|468865423|FG000|Overall Study|Progressive Disease|0|||
130246796|NCT01011283|468865424|FG001|Overall Study|Progressive Disease|2|||
130246797|NCT01011283|468865423|FG000|Overall Study|Terminated by Sponsor|5|||
130246798|NCT01011283|468865424|FG001|Overall Study|Terminated by Sponsor|5|||
130246799|NCT01011283|468865423|FG000|Overall Study|Other|2|||
130246800|NCT01011283|468865424|FG001|Overall Study|Other|2|||
130246801|NCT02959892|468865428|FG000|Overall Study|PET tracer synthesis failure|1|||
130246802|NCT02959892|468865429|FG001|Overall Study|PET tracer synthesis failure|0|||
130246803|NCT02959892|468865428|FG000|Overall Study|Study termination|0|||
130246804|NCT02959892|468865429|FG001|Overall Study|Study termination|1|||
130246805|NCT00799864|468865433|FG000|Overall Study|Participant reached a virologic endpoint|9|||
130246806|NCT00799864|468865434|FG001|Overall Study|Participant reached a virologic endpoint|2|||
130246807|NCT00799864|468865435|FG002|Overall Study|Participant reached a virologic endpoint|2|||
130246808|NCT00799864|468865436|FG003|Overall Study|Participant reached a virologic endpoint|0|||
130246809|NCT00799864|468865437|FG004|Overall Study|Participant reached a virologic endpoint|0|||
130246810|NCT00799864|468865433|FG000|Overall Study|Other|2|||
130246811|NCT00799864|468865434|FG001|Overall Study|Other|1|||
130246812|NCT00799864|468865435|FG002|Overall Study|Other|0|||
130246813|NCT00799864|468865436|FG003|Overall Study|Other|0|||
130246814|NCT00799864|468865437|FG004|Overall Study|Other|0|||
130246815|NCT03364686|468865438|FG000|Overall Study|Physician Decision|2|||
130246816|NCT01210443|468865441|FG000|Overall Study|Study terminated by sponsor|2|||
130246817|NCT01936974|468865442|FG000|Overall Study|Physician Decision|2|||
130246818|NCT01936974|468865443|FG001|Overall Study|Physician Decision|5|||
130246819|NCT04584554|468865446|FG000|Overall Study|Withdrawal by Subject|2|||
130246820|NCT04584554|468865447|FG001|Overall Study|Withdrawal by Subject|2|||
130246821|NCT02807181|468865448|FG000|Overall Study|Death|28|||
130246822|NCT02807181|468865449|FG001|Overall Study|Death|24|||
130246823|NCT02807181|468865448|FG000|Overall Study|Withdrawal by Subject|1|||
130246824|NCT02807181|468865449|FG001|Overall Study|Withdrawal by Subject|1|||
130246825|NCT02807181|468865448|FG000|Overall Study|Lost to Follow-up|0|||
130246826|NCT02807181|468865449|FG001|Overall Study|Lost to Follow-up|2|||
130246827|NCT02807181|468865448|FG000|Overall Study|Subject decision|1|||
130246828|NCT02807181|468865449|FG001|Overall Study|Subject decision|0|||
130246829|NCT02807181|468865448|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
130246830|NCT02807181|468865449|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
130246831|NCT02807181|468865448|FG000|Overall Study|In Study|3|||
130246832|NCT02807181|468865449|FG001|Overall Study|In Study|3|||
130246833|NCT02807181|468865448|FG000|Overall Study|Post Progression|3|||
130246834|NCT02807181|468865449|FG001|Overall Study|Post Progression|2|||
130451971|NCT02014558|469618330|FG012|Overall Study|Never Received Study Drug|0|||
130699370|NCT05061992|470524651|FG001|Overall Study|Withdrawal by Subject|1|||
130699371|NCT02473393|470524652|FG000|Overall Study|Adverse Event|0|||
130699372|NCT02473393|470524653|FG001|Overall Study|Adverse Event|0|||
130699373|NCT02473393|470524654|FG002|Overall Study|Adverse Event|1|||
130699374|NCT02473393|470524655|FG003|Overall Study|Adverse Event|0|||
130246835|NCT00063999|468865450|FG000|Overall Study|Withdrawal by Subject|1|||
130451972|NCT02014558|469618318|FG000|Overall Study|Adverse Event|0|||
130451973|NCT02014558|469618319|FG001|Overall Study|Adverse Event|0|||
130699375|NCT02473393|470524652|FG000|Overall Study|Withdrawal by Subject|0|||
130699376|NCT02473393|470524653|FG001|Overall Study|Withdrawal by Subject|0|||
130699377|NCT02473393|470524654|FG002|Overall Study|Withdrawal by Subject|1|||
130699378|NCT02473393|470524655|FG003|Overall Study|Withdrawal by Subject|1|||
130246836|NCT00063999|468865451|FG001|Overall Study|Withdrawal by Subject|0|||
130246837|NCT00063999|468865450|FG000|Overall Study|Ineligible|44|||
130246838|NCT00063999|468865451|FG001|Overall Study|Ineligible|24|||
130246839|NCT03767894|468865452|FG000|Overall Study|Withdrawal by Subject|1|||
130246840|NCT04243837|468865456|FG000|Overall Study|Adverse Event|2|||
130246841|NCT04243837|468865457|FG001|Overall Study|Adverse Event|1|||
130451974|NCT02014558|469618320|FG002|Overall Study|Adverse Event|0|||
130246842|NCT04243837|468865456|FG000|Overall Study|Withdrawal by Subject|4|||
130246843|NCT04243837|468865457|FG001|Overall Study|Withdrawal by Subject|2|||
130246844|NCT04243837|468865456|FG000|Overall Study|Covid-19 lock down|1|||
130246845|NCT04243837|468865457|FG001|Overall Study|Covid-19 lock down|0|||
130246846|NCT04243837|468865456|FG000|Overall Study|Study Terminated by Sponsor|11|||
130246847|NCT04243837|468865457|FG001|Overall Study|Study Terminated by Sponsor|12|||
130246848|NCT02280499|468865461|FG000|Overall Study|Death|14|||
130246849|NCT02280499|468865461|FG000|Overall Study|Lost to Follow-up|42|||
130246850|NCT02280499|468865461|FG000|Overall Study|Adverse Event|5|||
130246851|NCT00977561|468865465|FG000|Overall Study|Death|3|||
130246852|NCT00977561|468865466|FG001|Overall Study|Death|2|||
130246853|NCT00977561|468865465|FG000|Overall Study|Study terminated|0|||
130246854|NCT00977561|468865466|FG001|Overall Study|Study terminated|2|||
130246855|NCT00977561|468865465|FG000|Overall Study|Other|2|||
130246856|NCT00977561|468865466|FG001|Overall Study|Other|0|||
130246857|NCT04689009|468865473|FG000|Overall Study|Adverse Event|1|||
130246858|NCT04689009|468865474|FG001|Overall Study|Adverse Event|0|||
130246859|NCT04689009|468865473|FG000|Overall Study|Lost to Follow-up|1|||
130246860|NCT04689009|468865474|FG001|Overall Study|Lost to Follow-up|2|||
130246861|NCT04689009|468865473|FG000|Overall Study|Withdrawal by Subject|4|||
130246862|NCT04689009|468865474|FG001|Overall Study|Withdrawal by Subject|3|||
130246863|NCT04689009|468865473|FG000|Overall Study|Protocol Violation|1|||
130246864|NCT04689009|468865474|FG001|Overall Study|Protocol Violation|0|||
130246865|NCT02187055|468865475|FG000|Overall Study|Lack of Efficacy|10|||
130246866|NCT02187055|468865476|FG001|Overall Study|Lack of Efficacy|3|||
130246867|NCT02187055|468865477|FG002|Overall Study|Lack of Efficacy|7|||
130246868|NCT02187055|468865475|FG000|Overall Study|Lost to Follow-up|2|||
130246869|NCT02187055|468865476|FG001|Overall Study|Lost to Follow-up|7|||
130246870|NCT02187055|468865477|FG002|Overall Study|Lost to Follow-up|3|||
130246871|NCT02187055|468865475|FG000|Overall Study|No longer meets eligibility criteria|0|||
130246872|NCT02187055|468865476|FG001|Overall Study|No longer meets eligibility criteria|2|||
130246873|NCT02187055|468865477|FG002|Overall Study|No longer meets eligibility criteria|0|||
130246874|NCT02187055|468865475|FG000|Overall Study|No longer willing to participate|6|||
130246875|NCT02187055|468865476|FG001|Overall Study|No longer willing to participate|8|||
130246876|NCT02187055|468865477|FG002|Overall Study|No longer willing to participate|10|||
130246877|NCT02187055|468865475|FG000|Overall Study|Other|5|||
130246878|NCT02187055|468865476|FG001|Overall Study|Other|6|||
130246879|NCT02187055|468865477|FG002|Overall Study|Other|3|||
130246880|NCT02187055|468865475|FG000|Overall Study|Protocol Violation|9|||
130246881|NCT02187055|468865476|FG001|Overall Study|Protocol Violation|9|||
130246882|NCT02187055|468865477|FG002|Overall Study|Protocol Violation|4|||
130246883|NCT02187055|468865475|FG000|Overall Study|Pregnancy|3|||
130246884|NCT02187055|468865476|FG001|Overall Study|Pregnancy|1|||
130246885|NCT02187055|468865477|FG002|Overall Study|Pregnancy|0|||
130246886|NCT02187055|468865475|FG000|Overall Study|Withdrawal by Subject|11|||
130246887|NCT02187055|468865476|FG001|Overall Study|Withdrawal by Subject|11|||
130246888|NCT02187055|468865477|FG002|Overall Study|Withdrawal by Subject|11|||
130246889|NCT02187055|468865475|FG000|Overall Study|Adverse Event|21|||
130246890|NCT02187055|468865476|FG001|Overall Study|Adverse Event|26|||
130246891|NCT02187055|468865477|FG002|Overall Study|Adverse Event|36|||
130246892|NCT02187055|468865475|FG000|Overall Study|Death|2|||
130246893|NCT02187055|468865476|FG001|Overall Study|Death|0|||
130246894|NCT02187055|468865477|FG002|Overall Study|Death|0|||
130246895|NCT05737745|468865478|FG000|Overall Study|Withdrawal by Subject|0|||
130246896|NCT05737745|468865479|FG001|Overall Study|Withdrawal by Subject|6|||
130246897|NCT05737745|468865480|FG002|Overall Study|Withdrawal by Subject|1|||
130246898|NCT00165698|468865481|FG000|Overall Study|Adverse Event|2|||
130246899|NCT00165698|468865482|FG001|Overall Study|Adverse Event|10|||
130246900|NCT00165698|468865481|FG000|Overall Study|Lost to Follow-up|2|||
130246901|NCT00165698|468865482|FG001|Overall Study|Lost to Follow-up|2|||
130246902|NCT00165698|468865481|FG000|Overall Study|Withdrawal by Subject|2|||
130246903|NCT00165698|468865482|FG001|Overall Study|Withdrawal by Subject|1|||
130246904|NCT00165698|468865481|FG000|Overall Study|Protocol Violation|1|||
130246905|NCT00165698|468865482|FG001|Overall Study|Protocol Violation|0|||
130246906|NCT00165698|468865481|FG000|Overall Study|Not Taken/Lost the medicine|1|||
130246907|NCT00165698|468865482|FG001|Overall Study|Not Taken/Lost the medicine|2|||
130246908|NCT02547935|468865483|FG000|Overall Study|Other|0|||
130246909|NCT02547935|468865484|FG001|Overall Study|Other|1|||
130246910|NCT02547935|468865485|FG002|Overall Study|Other|0|||
130246911|NCT02547935|468865483|FG000|Overall Study|Withdrawal by Subject|2|||
130246912|NCT02547935|468865484|FG001|Overall Study|Withdrawal by Subject|3|||
130246913|NCT02547935|468865485|FG002|Overall Study|Withdrawal by Subject|4|||
130246914|NCT02547935|468865483|FG000|Overall Study|Screen Failure|2|||
130246915|NCT02547935|468865484|FG001|Overall Study|Screen Failure|0|||
130246916|NCT02547935|468865485|FG002|Overall Study|Screen Failure|0|||
130246917|NCT02547935|468865483|FG000|Overall Study|Physician Decision|0|||
130246918|NCT02547935|468865484|FG001|Overall Study|Physician Decision|1|||
130246919|NCT02547935|468865485|FG002|Overall Study|Physician Decision|0|||
130246920|NCT02547935|468865483|FG000|Overall Study|Lost to Follow-up|0|||
130246921|NCT02547935|468865484|FG001|Overall Study|Lost to Follow-up|2|||
130246922|NCT02547935|468865485|FG002|Overall Study|Lost to Follow-up|1|||
130246923|NCT02547935|468865483|FG000|Overall Study|Death|1|||
130246924|NCT02547935|468865484|FG001|Overall Study|Death|1|||
130246925|NCT02547935|468865485|FG002|Overall Study|Death|0|||
130451975|NCT02014558|469618321|FG003|Overall Study|Adverse Event|0|||
130451976|NCT02014558|469618322|FG004|Overall Study|Adverse Event|1|||
130451977|NCT02014558|469618323|FG005|Overall Study|Adverse Event|0|||
130451978|NCT02014558|469618324|FG006|Overall Study|Adverse Event|0|||
130451979|NCT02014558|469618325|FG007|Overall Study|Adverse Event|0|||
130451980|NCT02014558|469618326|FG008|Overall Study|Adverse Event|2|||
130451981|NCT02014558|469618327|FG009|Overall Study|Adverse Event|2|||
130451982|NCT02014558|469618328|FG010|Overall Study|Adverse Event|5|||
130451983|NCT02014558|469618329|FG011|Overall Study|Adverse Event|21|||
130451984|NCT02014558|469618330|FG012|Overall Study|Adverse Event|3|||
130451985|NCT02014558|469618318|FG000|Overall Study|Death|1|||
130451986|NCT02014558|469618319|FG001|Overall Study|Death|0|||
130451987|NCT02014558|469618320|FG002|Overall Study|Death|0|||
130451988|NCT02014558|469618321|FG003|Overall Study|Death|0|||
130451989|NCT02014558|469618322|FG004|Overall Study|Death|0|||
130451990|NCT02014558|469618323|FG005|Overall Study|Death|0|||
130451991|NCT02014558|469618324|FG006|Overall Study|Death|1|||
130451992|NCT02014558|469618325|FG007|Overall Study|Death|1|||
130451993|NCT02014558|469618326|FG008|Overall Study|Death|2|||
130451994|NCT02014558|469618327|FG009|Overall Study|Death|5|||
130451995|NCT02014558|469618328|FG010|Overall Study|Death|5|||
130451996|NCT02014558|469618329|FG011|Overall Study|Death|19|||
130451997|NCT02014558|469618330|FG012|Overall Study|Death|2|||
130451998|NCT02014558|469618318|FG000|Overall Study|Lack of Efficacy|1|||
130451999|NCT02014558|469618319|FG001|Overall Study|Lack of Efficacy|2|||
130452000|NCT02014558|469618320|FG002|Overall Study|Lack of Efficacy|1|||
130452001|NCT02014558|469618321|FG003|Overall Study|Lack of Efficacy|1|||
130452002|NCT02014558|469618322|FG004|Overall Study|Lack of Efficacy|0|||
130452003|NCT02014558|469618323|FG005|Overall Study|Lack of Efficacy|0|||
130452004|NCT02014558|469618324|FG006|Overall Study|Lack of Efficacy|1|||
130452005|NCT02014558|469618325|FG007|Overall Study|Lack of Efficacy|3|||
130452006|NCT02014558|469618326|FG008|Overall Study|Lack of Efficacy|3|||
130452007|NCT02014558|469618327|FG009|Overall Study|Lack of Efficacy|3|||
130452008|NCT02014558|469618328|FG010|Overall Study|Lack of Efficacy|16|||
130452009|NCT02014558|469618329|FG011|Overall Study|Lack of Efficacy|8|||
130452010|NCT02014558|469618330|FG012|Overall Study|Lack of Efficacy|5|||
130452011|NCT02014558|469618318|FG000|Overall Study|Lost to Follow-up|0|||
130452012|NCT02014558|469618319|FG001|Overall Study|Lost to Follow-up|0|||
130452013|NCT02014558|469618320|FG002|Overall Study|Lost to Follow-up|0|||
130452014|NCT02014558|469618321|FG003|Overall Study|Lost to Follow-up|0|||
130452015|NCT02014558|469618322|FG004|Overall Study|Lost to Follow-up|0|||
130452016|NCT02014558|469618323|FG005|Overall Study|Lost to Follow-up|0|||
130452017|NCT02014558|469618324|FG006|Overall Study|Lost to Follow-up|0|||
130452018|NCT02014558|469618325|FG007|Overall Study|Lost to Follow-up|0|||
130452019|NCT02014558|469618326|FG008|Overall Study|Lost to Follow-up|0|||
130452020|NCT02014558|469618327|FG009|Overall Study|Lost to Follow-up|0|||
130452021|NCT02014558|469618328|FG010|Overall Study|Lost to Follow-up|1|||
130452022|NCT02014558|469618329|FG011|Overall Study|Lost to Follow-up|0|||
130452023|NCT02014558|469618330|FG012|Overall Study|Lost to Follow-up|0|||
130452024|NCT02014558|469618318|FG000|Overall Study|Progressive Disease|1|||
130452025|NCT02014558|469618319|FG001|Overall Study|Progressive Disease|0|||
130452026|NCT02014558|469618320|FG002|Overall Study|Progressive Disease|1|||
130452027|NCT02014558|469618321|FG003|Overall Study|Progressive Disease|1|||
130452028|NCT02014558|469618322|FG004|Overall Study|Progressive Disease|1|||
130452029|NCT02014558|469618323|FG005|Overall Study|Progressive Disease|2|||
130452030|NCT02014558|469618324|FG006|Overall Study|Progressive Disease|1|||
130452031|NCT02014558|469618325|FG007|Overall Study|Progressive Disease|6|||
130699379|NCT02274558|470524656|FG000|Overall Study|Adverse Event|2|||
130699380|NCT02274558|470524657|FG001|Overall Study|Adverse Event|4|||
130699381|NCT02274558|470524658|FG002|Overall Study|Adverse Event|2|||
130699382|NCT02274558|470524656|FG000|Overall Study|Non-compliance|2|||
130699383|NCT02274558|470524657|FG001|Overall Study|Non-compliance|1|||
130246926|NCT02487199|468865488|FG000|Overall Study|Withdrew Consent|0|||
130699384|NCT02274558|470524658|FG002|Overall Study|Non-compliance|0|||
130452032|NCT02014558|469618326|FG008|Overall Study|Progressive Disease|5|||
130452033|NCT02014558|469618327|FG009|Overall Study|Progressive Disease|6|||
130452034|NCT02014558|469618328|FG010|Overall Study|Progressive Disease|22|||
130452035|NCT02014558|469618329|FG011|Overall Study|Progressive Disease|31|||
130452036|NCT02014558|469618330|FG012|Overall Study|Progressive Disease|6|||
130452037|NCT02014558|469618318|FG000|Overall Study|Withdrawal by Subject|0|||
130452038|NCT02014558|469618319|FG001|Overall Study|Withdrawal by Subject|0|||
130452039|NCT02014558|469618320|FG002|Overall Study|Withdrawal by Subject|0|||
130452040|NCT02014558|469618321|FG003|Overall Study|Withdrawal by Subject|0|||
130452041|NCT02014558|469618322|FG004|Overall Study|Withdrawal by Subject|1|||
130452042|NCT02014558|469618323|FG005|Overall Study|Withdrawal by Subject|0|||
130452043|NCT02014558|469618324|FG006|Overall Study|Withdrawal by Subject|0|||
130452044|NCT02014558|469618325|FG007|Overall Study|Withdrawal by Subject|0|||
130452045|NCT02014558|469618326|FG008|Overall Study|Withdrawal by Subject|0|||
130452046|NCT02014558|469618327|FG009|Overall Study|Withdrawal by Subject|2|||
130452047|NCT02014558|469618328|FG010|Overall Study|Withdrawal by Subject|6|||
130452048|NCT02014558|469618329|FG011|Overall Study|Withdrawal by Subject|10|||
130246927|NCT02487199|468865489|FG001|Overall Study|Withdrew Consent|1|||
130246928|NCT05206604|468867707|FG000|Overall Study|Non-compliance with study drug|0|||
130246929|NCT05206604|468867708|FG001|Overall Study|Non-compliance with study drug|0|||
130246930|NCT05206604|468867709|FG002|Overall Study|Non-compliance with study drug|0|||
130246931|NCT05206604|468867710|FG003|Overall Study|Non-compliance with study drug|0|||
130246932|NCT05206604|468867711|FG004|Overall Study|Non-compliance with study drug|0|||
130246933|NCT05206604|468867712|FG005|Overall Study|Non-compliance with study drug|1|||
130246934|NCT05206604|468867713|FG006|Overall Study|Non-compliance with study drug|0|||
130246935|NCT05206604|468867714|FG007|Overall Study|Non-compliance with study drug|0|||
130246936|NCT03735498|468867715|FG000|Overall Study|Withdrawal by Subject|3|||
130246937|NCT03735498|468867715|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
130246938|NCT02014103|468867716|FG000|Overall Study|Protocol Violation|7|||
130246939|NCT02014103|468867717|FG001|Overall Study|Protocol Violation|7|||
130246940|NCT02014103|468867716|FG000|Overall Study|Adverse Event|1|||
130246941|NCT02014103|468867717|FG001|Overall Study|Adverse Event|0|||
130246942|NCT02014103|468867716|FG000|Overall Study|Lost venous access|1|||
130246943|NCT02014103|468867717|FG001|Overall Study|Lost venous access|0|||
130246944|NCT02014103|468867716|FG000|Overall Study|Withdrawal by Subject|0|||
130246945|NCT02014103|468867717|FG001|Overall Study|Withdrawal by Subject|2|||
130246946|NCT04289298|468867719|FG000|Overall Study|Lost to Follow-up|5|||
130246947|NCT04289298|468867720|FG001|Overall Study|Lost to Follow-up|0|||
130246948|NCT04289298|468867719|FG000|Overall Study|Withdrawal by Subject|2|||
130246949|NCT04289298|468867720|FG001|Overall Study|Withdrawal by Subject|0|||
130246950|NCT00620035|468867721|FG000|Overall Study|Adverse Event|106|||
130246951|NCT00620035|468867721|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130246952|NCT00620035|468867721|FG000|Overall Study|Other Reason|38|||
130246953|NCT01108796|468867724|FG000|Overall Study|Adverse Event|0|||
130246954|NCT01108796|468867725|FG001|Overall Study|Adverse Event|1|||
130246955|NCT01108796|468867724|FG000|Overall Study|Lost to Follow-up|7|||
130246956|NCT01108796|468867725|FG001|Overall Study|Lost to Follow-up|6|||
130246957|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
130246958|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
130246959|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130246960|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130246961|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246962|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246963|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246964|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
130246965|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246966|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
130246967|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246968|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246969|NCT00985192|468867731|FG000|Overall Study|Withdrawal by Subject|1|||
130246970|NCT00985192|468867731|FG000|Overall Study|Disease Progression|1|||
130246971|NCT00985192|468867731|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
130246972|NCT03387046|468867734|FG000|Overall Study|Adverse Event|1|||
130246973|NCT03387046|468867735|FG001|Overall Study|Adverse Event|1|||
130246974|NCT03794544|468867736|FG000|Overall Study|Withdrawal by Subject|1|||
130246975|NCT03794544|468867737|FG001|Overall Study|Withdrawal by Subject|1|||
130246976|NCT03794544|468867738|FG002|Overall Study|Withdrawal by Subject|0|||
130246977|NCT03794544|468867739|FG003|Overall Study|Withdrawal by Subject|0|||
130246978|NCT03794544|468867736|FG000|Overall Study|Death|0|||
130246979|NCT03794544|468867737|FG001|Overall Study|Death|0|||
130246980|NCT03794544|468867738|FG002|Overall Study|Death|0|||
130246981|NCT03794544|468867739|FG003|Overall Study|Death|1|||
130246982|NCT03794544|468867736|FG000|Overall Study|Lost to Follow-up|0|||
130246983|NCT03794544|468867737|FG001|Overall Study|Lost to Follow-up|1|||
130246984|NCT03794544|468867738|FG002|Overall Study|Lost to Follow-up|1|||
130246985|NCT03794544|468867739|FG003|Overall Study|Lost to Follow-up|0|||
130363848|NCT01030536|469302014|FG004|Overall Study|undefined|0|||
130363849|NCT01030536|469302010|FG000|Overall Study|Adverse Event|0|||
130363850|NCT01030536|469302011|FG001|Overall Study|Adverse Event|3|||
130363851|NCT01030536|469302012|FG002|Overall Study|Adverse Event|1|||
130363852|NCT01030536|469302013|FG003|Overall Study|Adverse Event|0|||
130246986|NCT03794544|468867736|FG000|Overall Study|Other|0|||
130246987|NCT03794544|468867737|FG001|Overall Study|Other|1|||
130246988|NCT03794544|468867738|FG002|Overall Study|Other|0|||
130246989|NCT03794544|468867739|FG003|Overall Study|Other|0|||
130246990|NCT00676052|468867742|FG000|Overall Study|Adverse Event|0|||
130363853|NCT01030536|469302014|FG004|Overall Study|Adverse Event|1|||
130246991|NCT00676052|468867743|FG001|Overall Study|Adverse Event|1|||
130246992|NCT00676052|468867744|FG002|Overall Study|Adverse Event|1|||
130246993|NCT00676052|468867745|FG003|Overall Study|Adverse Event|2|||
130246994|NCT00676052|468867746|FG004|Overall Study|Adverse Event|2|||
130246995|NCT00676052|468867747|FG005|Overall Study|Adverse Event|2|||
130363854|NCT01030536|469302010|FG000|Overall Study|Progressive disease|6|||
130363855|NCT01030536|469302011|FG001|Overall Study|Progressive disease|2|||
130246996|NCT00676052|468867742|FG000|Overall Study|Lack of Efficacy|2|||
130246997|NCT00676052|468867743|FG001|Overall Study|Lack of Efficacy|2|||
130246998|NCT00676052|468867744|FG002|Overall Study|Lack of Efficacy|1|||
130246999|NCT00676052|468867745|FG003|Overall Study|Lack of Efficacy|1|||
130247000|NCT00676052|468867746|FG004|Overall Study|Lack of Efficacy|2|||
130247001|NCT00676052|468867747|FG005|Overall Study|Lack of Efficacy|1|||
130247002|NCT00676052|468867742|FG000|Overall Study|Protocol Violation|5|||
130247003|NCT00676052|468867743|FG001|Overall Study|Protocol Violation|3|||
130247004|NCT00676052|468867744|FG002|Overall Study|Protocol Violation|2|||
130247005|NCT00676052|468867745|FG003|Overall Study|Protocol Violation|2|||
130247006|NCT00676052|468867746|FG004|Overall Study|Protocol Violation|1|||
130247007|NCT00676052|468867747|FG005|Overall Study|Protocol Violation|2|||
130247008|NCT00676052|468867742|FG000|Overall Study|Lost to Follow-up|0|||
130247009|NCT00676052|468867743|FG001|Overall Study|Lost to Follow-up|0|||
130247010|NCT00676052|468867744|FG002|Overall Study|Lost to Follow-up|0|||
130247011|NCT00676052|468867745|FG003|Overall Study|Lost to Follow-up|0|||
130247012|NCT00676052|468867746|FG004|Overall Study|Lost to Follow-up|1|||
130247013|NCT00676052|468867747|FG005|Overall Study|Lost to Follow-up|0|||
130247014|NCT00676052|468867742|FG000|Overall Study|Physician Decision|1|||
130247015|NCT00676052|468867743|FG001|Overall Study|Physician Decision|1|||
130247016|NCT00676052|468867744|FG002|Overall Study|Physician Decision|1|||
130247017|NCT00676052|468867745|FG003|Overall Study|Physician Decision|0|||
130247018|NCT00676052|468867746|FG004|Overall Study|Physician Decision|0|||
130247019|NCT00676052|468867747|FG005|Overall Study|Physician Decision|1|||
130247020|NCT00676052|468867742|FG000|Overall Study|Withdrawal by Subject|1|||
130247021|NCT00676052|468867743|FG001|Overall Study|Withdrawal by Subject|0|||
130247022|NCT00676052|468867744|FG002|Overall Study|Withdrawal by Subject|1|||
130247023|NCT00676052|468867745|FG003|Overall Study|Withdrawal by Subject|0|||
130247024|NCT00676052|468867746|FG004|Overall Study|Withdrawal by Subject|0|||
130247025|NCT00676052|468867747|FG005|Overall Study|Withdrawal by Subject|0|||
130247026|NCT00120250|468867748|FG000|Overall Study|Lost to Follow-up|1|||
130247027|NCT00120250|468867749|FG001|Overall Study|Lost to Follow-up|1|||
130247028|NCT00120250|468867748|FG000|Overall Study|Protocol Violation|0|||
130247029|NCT00120250|468867749|FG001|Overall Study|Protocol Violation|1|||
130247030|NCT01964560|468867765|FG000|Overall Study|Adverse Event|23|||
130247031|NCT01964560|468867765|FG000|Overall Study|Lack of Efficacy|46|||
130247032|NCT01964560|468867765|FG000|Overall Study|Protocol deviation|2|||
130247033|NCT01964560|468867765|FG000|Overall Study|Lost to Follow-up|4|||
130247034|NCT01964560|468867765|FG000|Overall Study|Withdrawal by Subject|64|||
130247035|NCT01964560|468867765|FG000|Overall Study|Surgery-hemispherotomy|1|||
130247036|NCT01964560|468867765|FG000|Overall Study|Surgery|1|||
130247037|NCT01964560|468867765|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
130247038|NCT01964560|468867765|FG000|Overall Study|Patient and Investigator choice|1|||
130247039|NCT01964560|468867765|FG000|Overall Study|Patient was prescribed CBD|1|||
130247040|NCT01964560|468867765|FG000|Overall Study|Participant moved to another country|1|||
130247041|NCT00378560|468867766|FG000|Overall Study|Adverse Event|1|||
130247042|NCT00378560|468867767|FG001|Overall Study|Adverse Event|0|||
130247043|NCT00378560|468867766|FG000|Overall Study|Lost to Follow-up|24|||
130247044|NCT00378560|468867767|FG001|Overall Study|Lost to Follow-up|29|||
130247045|NCT00378560|468867766|FG000|Overall Study|Protocol Violation|2|||
130247046|NCT00378560|468867767|FG001|Overall Study|Protocol Violation|0|||
130363856|NCT01030536|469302012|FG002|Overall Study|Progressive disease|3|||
130699385|NCT02274558|470524656|FG000|Overall Study|Withdrawal by Subject|1|||
130699386|NCT02274558|470524657|FG001|Overall Study|Withdrawal by Subject|5|||
130699387|NCT02274558|470524658|FG002|Overall Study|Withdrawal by Subject|4|||
130699388|NCT02274558|470524656|FG000|Overall Study|Death|0|||
130699389|NCT02274558|470524657|FG001|Overall Study|Death|0|||
130699390|NCT02274558|470524658|FG002|Overall Study|Death|1|||
130699391|NCT02274558|470524656|FG000|Overall Study|Lost to Follow-up|2|||
130699392|NCT02274558|470524657|FG001|Overall Study|Lost to Follow-up|1|||
130699393|NCT02274558|470524658|FG002|Overall Study|Lost to Follow-up|1|||
130247047|NCT00378560|468867766|FG000|Overall Study|Withdrawal by Subject|17|||
130247048|NCT00378560|468867767|FG001|Overall Study|Withdrawal by Subject|21|||
130247049|NCT00378560|468867766|FG000|Overall Study|Moved|4|||
130247050|NCT00378560|468867767|FG001|Overall Study|Moved|3|||
130247051|NCT00378560|468867766|FG000|Overall Study|Pregnancy|7|||
130247052|NCT00378560|468867767|FG001|Overall Study|Pregnancy|5|||
130247053|NCT00378560|468867766|FG000|Overall Study|Laboratory test values abnormal|1|||
130247054|NCT00378560|468867767|FG001|Overall Study|Laboratory test values abnormal|0|||
130247055|NCT04389671|468867768|FG000|Overall Study|Death|7|||
130247056|NCT04865978|468867770|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
130247057|NCT04865978|468867771|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
130247058|NCT03835117|468867772|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
130247059|NCT03835117|468867773|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
130247060|NCT01543503|468867777|FG000|Overall Study|Lost to Follow-up|32|||
130247061|NCT01543503|468867778|FG001|Overall Study|Lost to Follow-up|36|||
130363857|NCT01030536|469302013|FG003|Overall Study|Progressive disease|2|||
130363858|NCT01030536|469302014|FG004|Overall Study|Progressive disease|0|||
130452049|NCT02014558|469618330|FG012|Overall Study|Withdrawal by Subject|0|||
130452050|NCT02014558|469618318|FG000|Overall Study|Miscellaneous|2|||
130452051|NCT02014558|469618319|FG001|Overall Study|Miscellaneous|1|||
130452052|NCT02014558|469618320|FG002|Overall Study|Miscellaneous|1|||
130452053|NCT02014558|469618321|FG003|Overall Study|Miscellaneous|1|||
130452054|NCT02014558|469618322|FG004|Overall Study|Miscellaneous|0|||
130452055|NCT02014558|469618323|FG005|Overall Study|Miscellaneous|1|||
130452056|NCT02014558|469618324|FG006|Overall Study|Miscellaneous|0|||
130452057|NCT02014558|469618325|FG007|Overall Study|Miscellaneous|1|||
130452058|NCT02014558|469618326|FG008|Overall Study|Miscellaneous|1|||
130452059|NCT02014558|469618327|FG009|Overall Study|Miscellaneous|3|||
130452060|NCT02014558|469618328|FG010|Overall Study|Miscellaneous|12|||
130452061|NCT02014558|469618329|FG011|Overall Study|Miscellaneous|11|||
130452062|NCT02014558|469618330|FG012|Overall Study|Miscellaneous|1|||
130452063|NCT04580407|469618331|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
130452064|NCT02068885|469618334|FG000|Overall Study|Withdrew|3|||
130452065|NCT02068885|469618335|FG001|Overall Study|Withdrew|5|||
130452066|NCT02068885|469618336|FG002|Overall Study|Withdrew|8|||
130452067|NCT00828919|469618342|FG000|Overall Study|Death|0|||
130452068|NCT00828919|469618343|FG001|Overall Study|Death|1|||
130452069|NCT00828919|469618344|FG002|Overall Study|Death|2|||
130452070|NCT00828919|469618345|FG003|Overall Study|Death|0|||
130452071|NCT00828919|469618346|FG004|Overall Study|Death|0|||
130452072|NCT00828919|469618342|FG000|Overall Study|Adverse Event|2|||
130452073|NCT00828919|469618343|FG001|Overall Study|Adverse Event|2|||
130452074|NCT00828919|469618344|FG002|Overall Study|Adverse Event|2|||
130452075|NCT00828919|469618345|FG003|Overall Study|Adverse Event|1|||
130452076|NCT00828919|469618346|FG004|Overall Study|Adverse Event|3|||
130452077|NCT00828919|469618342|FG000|Overall Study|Objective progression or relapse|4|||
130452078|NCT00828919|469618343|FG001|Overall Study|Objective progression or relapse|4|||
130452079|NCT00828919|469618344|FG002|Overall Study|Objective progression or relapse|11|||
130452080|NCT00828919|469618345|FG003|Overall Study|Objective progression or relapse|0|||
130452081|NCT00828919|469618346|FG004|Overall Study|Objective progression or relapse|5|||
130247062|NCT01543503|468867777|FG000|Overall Study|Adverse Event|9|||
130247063|NCT01543503|468867778|FG001|Overall Study|Adverse Event|13|||
130247064|NCT01543503|468867777|FG000|Overall Study|Lack of Efficacy|4|||
130247065|NCT01543503|468867778|FG001|Overall Study|Lack of Efficacy|16|||
130247066|NCT01543503|468867777|FG000|Overall Study|Participant withdrew informed consent|8|||
130247067|NCT01543503|468867778|FG001|Overall Study|Participant withdrew informed consent|10|||
130247068|NCT01543503|468867777|FG000|Overall Study|Change of jobs|0|||
130247069|NCT01543503|468867778|FG001|Overall Study|Change of jobs|1|||
130247070|NCT01543503|468867777|FG000|Overall Study|Intolerance to the biologic treatment|0|||
130247071|NCT01543503|468867778|FG001|Overall Study|Intolerance to the biologic treatment|1|||
130247072|NCT01543503|468867777|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
130247073|NCT01543503|468867778|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
130247074|NCT01543503|468867777|FG000|Overall Study|Participant did not complete last visit|0|||
130247075|NCT01543503|468867778|FG001|Overall Study|Participant did not complete last visit|2|||
130452082|NCT00828919|469618342|FG000|Overall Study|No longer willing to participate in study|0|||
130452083|NCT00828919|469618343|FG001|Overall Study|No longer willing to participate in study|0|||
130452084|NCT00828919|469618344|FG002|Overall Study|No longer willing to participate in study|2|||
130452085|NCT00828919|469618345|FG003|Overall Study|No longer willing to participate in study|0|||
130452086|NCT00828919|469618346|FG004|Overall Study|No longer willing to participate in study|0|||
130452087|NCT00828919|469618342|FG000|Overall Study|Insufficient Clinical Response|0|||
130452088|NCT00828919|469618343|FG001|Overall Study|Insufficient Clinical Response|1|||
130452089|NCT00828919|469618344|FG002|Overall Study|Insufficient Clinical Response|2|||
130452090|NCT00828919|469618345|FG003|Overall Study|Insufficient Clinical Response|0|||
130452091|NCT00828919|469618346|FG004|Overall Study|Insufficient Clinical Response|0|||
130452092|NCT00828919|469618342|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
130452093|NCT00828919|469618343|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
130452094|NCT00828919|469618344|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
130452095|NCT00828919|469618345|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
130452096|NCT00828919|469618346|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
130452097|NCT00828919|469618342|FG000|Overall Study|Other|1|||
130452098|NCT00828919|469618343|FG001|Overall Study|Other|0|||
130452099|NCT00828919|469618344|FG002|Overall Study|Other|1|||
130452100|NCT00828919|469618345|FG003|Overall Study|Other|1|||
130452101|NCT00828919|469618346|FG004|Overall Study|Other|0|||
130452102|NCT00828919|469618342|FG000|Overall Study|Lost to Follow-up|0|||
130452103|NCT00828919|469618343|FG001|Overall Study|Lost to Follow-up|1|||
130452104|NCT00828919|469618344|FG002|Overall Study|Lost to Follow-up|0|||
130452105|NCT00828919|469618345|FG003|Overall Study|Lost to Follow-up|0|||
130699394|NCT02274558|470524656|FG000|Overall Study|Physician Decision|0|||
130247076|NCT01543503|468867777|FG000|Overall Study|Refused to continue treatment|7|||
130247077|NCT01543503|468867778|FG001|Overall Study|Refused to continue treatment|0|||
130247078|NCT01543503|468867777|FG000|Overall Study|Incorrect medication received|1|||
130247079|NCT01543503|468867778|FG001|Overall Study|Incorrect medication received|0|||
130247080|NCT01543503|468867777|FG000|Overall Study|Participant moved to another city|2|||
130247081|NCT01543503|468867778|FG001|Overall Study|Participant moved to another city|0|||
130247082|NCT01543503|468867777|FG000|Overall Study|Participant will not return for visits|0|||
130247083|NCT01543503|468867778|FG001|Overall Study|Participant will not return for visits|2|||
130699395|NCT02274558|470524657|FG001|Overall Study|Physician Decision|2|||
130699396|NCT02274558|470524658|FG002|Overall Study|Physician Decision|1|||
130699397|NCT05393271|470524664|FG000|Overall Study|Physician Decision|0|||
130699398|NCT05393271|470524665|FG001|Overall Study|Physician Decision|0|||
130699399|NCT05393271|470524666|FG002|Overall Study|Physician Decision|0|||
130699400|NCT05393271|470524667|FG003|Overall Study|Physician Decision|0|||
130247084|NCT01543503|468867777|FG000|Overall Study|Participant transferred to another city|1|||
130247085|NCT01543503|468867778|FG001|Overall Study|Participant transferred to another city|0|||
130247086|NCT01543503|468867777|FG000|Overall Study|Participant moved to Scotland|1|||
130247087|NCT01543503|468867778|FG001|Overall Study|Participant moved to Scotland|0|||
130247088|NCT01543503|468867777|FG000|Overall Study|Participant decision to stop treatment|1|||
130247089|NCT01543503|468867778|FG001|Overall Study|Participant decision to stop treatment|0|||
130247090|NCT01543503|468867777|FG000|Overall Study|Investigator did not wish to participate|1|||
130247091|NCT01543503|468867778|FG001|Overall Study|Investigator did not wish to participate|1|||
130247092|NCT01543503|468867777|FG000|Overall Study|Participant recruited after closing date|0|||
130247093|NCT01543503|468867778|FG001|Overall Study|Participant recruited after closing date|1|||
130247094|NCT01543503|468867777|FG000|Overall Study|Site stopped participation|5|||
130247095|NCT01543503|468867778|FG001|Overall Study|Site stopped participation|1|||
130247096|NCT01543503|468867777|FG000|Overall Study|Participant did not attend a visit|1|||
130247097|NCT01543503|468867778|FG001|Overall Study|Participant did not attend a visit|0|||
130247098|NCT01543503|468867777|FG000|Overall Study|Moved to other rheumatologic site|0|||
130247099|NCT01543503|468867778|FG001|Overall Study|Moved to other rheumatologic site|1|||
130247100|NCT01543503|468867777|FG000|Overall Study|Participant consented to another study|0|||
130247101|NCT01543503|468867778|FG001|Overall Study|Participant consented to another study|2|||
130247102|NCT01543503|468867777|FG000|Overall Study|Participant went to United States|1|||
130247103|NCT01543503|468867778|FG001|Overall Study|Participant went to United States|0|||
130247104|NCT01543503|468867777|FG000|Overall Study|Screen failure|1|||
130247105|NCT01543503|468867778|FG001|Overall Study|Screen failure|0|||
130247106|NCT01309100|468867781|FG000|Overall Study|Protocol Violation|1|||
130247107|NCT01309100|468867781|FG000|Overall Study|Positive Slit lamp finding|1|||
130247108|NCT01968785|468867784|FG000|Overall Study|Withdrawal by Subject|1|||
130247109|NCT01968785|468867785|FG001|Overall Study|Withdrawal by Subject|0|||
130247110|NCT04560309|468867789|FG000|Overall Study|Meet drop out criteria|1|||
130247111|NCT04560309|468867790|FG001|Overall Study|Meet drop out criteria|1|||
130247112|NCT04146909|468867791|FG000|Overall Study|Withdrawal by Subject|3|||
130247113|NCT04146909|468867791|FG000|Overall Study|Did not qualify after consented|1|||
130247114|NCT05085405|468867792|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247115|NCT05085405|468867793|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247116|NCT05085405|468867794|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
130247117|NCT05085405|468867795|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
130247118|NCT05085405|468867796|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247119|NCT05085405|468867797|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247120|NCT05085405|468867792|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247121|NCT05085405|468867793|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247122|NCT05085405|468867794|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247123|NCT05085405|468867795|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
130247124|NCT05085405|468867796|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247125|NCT05085405|468867797|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247126|NCT04000724|468867805|FG000|Overall Study|Withdrawal by Subject|5|||
130247127|NCT04000724|468867806|FG001|Overall Study|Withdrawal by Subject|3|||
130247128|NCT04000724|468867807|FG002|Overall Study|Withdrawal by Subject|4|||
130247129|NCT04000724|468867805|FG000|Overall Study|Lost to Follow-up|11|||
130247130|NCT04000724|468867806|FG001|Overall Study|Lost to Follow-up|7|||
130247131|NCT04000724|468867807|FG002|Overall Study|Lost to Follow-up|13|||
130247132|NCT00455455|468867808|FG000|Washout|Withdrawal by Subject|0|||
130699401|NCT05393271|470524668|FG004|Overall Study|Physician Decision|0|||
130699402|NCT05393271|470524669|FG005|Overall Study|Physician Decision|0|||
130699403|NCT05393271|470524670|FG006|Overall Study|Physician Decision|1|||
130699404|NCT05393271|470524671|FG007|Overall Study|Physician Decision|0|||
130247133|NCT00455455|468867809|FG001|Washout|Withdrawal by Subject|1|||
130247134|NCT00455455|468867808|FG000|Washout|Withdrawal by Subject|1|||
130247135|NCT00455455|468867809|FG001|Washout|Withdrawal by Subject|0|||
130247136|NCT03808909|468867810|FG000|Overall Study|Lost to Follow-up|3|||
130247137|NCT03808909|468867811|FG001|Overall Study|Lost to Follow-up|0|||
130247138|NCT01827943|468867812|FG000|Overall Study|Protocol Violation|8|||
130247139|NCT01827943|468867812|FG000|Overall Study|Never treated because of an rapid progression|1|||
130247140|NCT03335566|468867813|FG000|Overall Study|Adverse Event|0|||
130247141|NCT03335566|468867814|FG001|Overall Study|Adverse Event|1|||
130247142|NCT03335566|468867813|FG000|Overall Study|Lost to Follow-up|1|||
130247143|NCT03335566|468867814|FG001|Overall Study|Lost to Follow-up|0|||
130247144|NCT03335566|468867813|FG000|Overall Study|Technical Problems|1|||
130247145|NCT03335566|468867814|FG001|Overall Study|Technical Problems|0|||
130247146|NCT03335566|468867813|FG000|Overall Study|Protocol Violation|1|||
130247147|NCT03335566|468867814|FG001|Overall Study|Protocol Violation|0|||
130247148|NCT03335566|468867813|FG000|Overall Study|Other than specified above|1|||
130247149|NCT03335566|468867814|FG001|Overall Study|Other than specified above|2|||
130247150|NCT01084135|468867815|FG000|20 Week|Physician Decision|0|||
130247151|NCT01084135|468867816|FG001|20 Week|Physician Decision|1|||
130247152|NCT00663351|468867817|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
130247153|NCT00663351|468867818|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
130247154|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
130247155|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
130247156|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
130247157|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
130247158|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
130247159|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
130247160|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
130247161|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
130247162|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
130247163|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
130247164|NCT00567112|468867819|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130247165|NCT00567112|468867820|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
130247166|NCT00567112|468867821|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130247167|NCT00567112|468867819|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
130247168|NCT00567112|468867820|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130247169|NCT00567112|468867821|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130247170|NCT00567112|468867819|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
130247171|NCT00567112|468867820|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
130247172|NCT00567112|468867821|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
130247173|NCT00545948|468867824|FG000|Overall Study|Not Treated|1|||
130247174|NCT00545948|468867825|FG001|Overall Study|Not Treated|1|||
130247175|NCT00545948|468867826|FG002|Overall Study|Not Treated|7|||
130247176|NCT03467945|468867827|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130247177|NCT03467945|468867828|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130247178|NCT03467945|468867829|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130247179|NCT03467945|468867830|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130247180|NCT03467945|468867827|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130247181|NCT03467945|468867828|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130247182|NCT03467945|468867829|FG002|Treatment Period 3|Withdrawal by Subject|2|||
130247183|NCT03467945|468867830|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130247184|NCT03520387|468867845|FG000|Pre-Randomization|Withdrawal by Subject|1|||
130247185|NCT03520387|468867846|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130247186|NCT03520387|468867847|FG002|Pre-Randomization|Withdrawal by Subject|0|||
130247187|NCT03520387|468867848|FG003|Pre-Randomization|Withdrawal by Subject|0|||
130247188|NCT03520387|468867849|FG004|Pre-Randomization|Withdrawal by Subject|0|||
130247189|NCT03520387|468867845|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
130247190|NCT03520387|468867846|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247191|NCT03520387|468867847|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247192|NCT03520387|468867848|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247193|NCT03520387|468867849|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247194|NCT03336866|468867850|FG000|Overall Study|Lost to Follow-up|2|||
130247195|NCT03336866|468867851|FG001|Overall Study|Lost to Follow-up|0|||
130247196|NCT03336866|468867852|FG002|Overall Study|Lost to Follow-up|3|||
130247197|NCT03336866|468867850|FG000|Overall Study|Withdrawal by Subject|1|||
130247198|NCT03336866|468867851|FG001|Overall Study|Withdrawal by Subject|1|||
130452106|NCT00828919|469618346|FG004|Overall Study|Lost to Follow-up|0|||
130452107|NCT05567159|469618349|FG000|Overall Study|Adverse Event|4|||
130247199|NCT03336866|468867852|FG002|Overall Study|Withdrawal by Subject|0|||
130247200|NCT03336866|468867850|FG000|Overall Study|Noncompliance with clinic house rules|0|||
130247201|NCT03336866|468867851|FG001|Overall Study|Noncompliance with clinic house rules|0|||
130247202|NCT03336866|468867852|FG002|Overall Study|Noncompliance with clinic house rules|1|||
130247203|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Death|0|||
130247204|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Death|2|||
130247205|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Death|2|||
130247206|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Death|0|||
130247207|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
130247208|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
130247209|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
130247210|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
130247211|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
130247212|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
130247213|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
130247214|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
130247215|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
130247216|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
130247217|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
130247218|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
130247219|NCT04913675|468867853|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247220|NCT04913675|468867854|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247221|NCT04913675|468867855|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247222|NCT04913675|468867856|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
130247223|NCT02975700|468867857|FG000|Overall Study|Adverse Event|1|||
130247224|NCT02975700|468867857|FG000|Overall Study|Progressive disease|3|||
130247225|NCT02975700|468867857|FG000|Overall Study|Failed screening criteria|2|||
130247226|NCT05660538|468867859|FG000|Overall Study|Adverse Event|0|||
130247227|NCT05660538|468867860|FG001|Overall Study|Adverse Event|0|||
130247228|NCT05660538|468867861|FG002|Overall Study|Adverse Event|1|||
130247229|NCT05660538|468867862|FG003|Overall Study|Adverse Event|0|||
130247230|NCT05660538|468867859|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130247231|NCT05660538|468867860|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130247232|NCT05660538|468867861|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
130247233|NCT05660538|468867862|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
130247234|NCT05660538|468867859|FG000|Overall Study|Lost to Follow-up|0|||
130247235|NCT05660538|468867860|FG001|Overall Study|Lost to Follow-up|0|||
130247236|NCT05660538|468867861|FG002|Overall Study|Lost to Follow-up|1|||
130247237|NCT05660538|468867862|FG003|Overall Study|Lost to Follow-up|1|||
130247238|NCT05660538|468867859|FG000|Overall Study|Death|0|||
130247239|NCT05660538|468867860|FG001|Overall Study|Death|0|||
130247240|NCT05660538|468867861|FG002|Overall Study|Death|1|||
130247241|NCT05660538|468867862|FG003|Overall Study|Death|0|||
130247242|NCT05660538|468867859|FG000|Overall Study|Physician Decision|0|||
130247243|NCT05660538|468867860|FG001|Overall Study|Physician Decision|0|||
130247244|NCT05660538|468867861|FG002|Overall Study|Physician Decision|0|||
130247245|NCT05660538|468867862|FG003|Overall Study|Physician Decision|1|||
130247246|NCT05660538|468867859|FG000|Overall Study|Sponsor Decision|1|||
130247247|NCT05660538|468867860|FG001|Overall Study|Sponsor Decision|0|||
130247248|NCT05660538|468867861|FG002|Overall Study|Sponsor Decision|0|||
130247249|NCT05660538|468867862|FG003|Overall Study|Sponsor Decision|0|||
130247250|NCT05660538|468867859|FG000|Overall Study|Other|1|||
130247251|NCT05660538|468867860|FG001|Overall Study|Other|0|||
130247252|NCT05660538|468867861|FG002|Overall Study|Other|0|||
130247253|NCT05660538|468867862|FG003|Overall Study|Other|1|||
130247254|NCT05660538|468867859|FG000|Overall Study|Randomized but did not receive study drug|1|||
130247255|NCT05660538|468867860|FG001|Overall Study|Randomized but did not receive study drug|0|||
130247256|NCT05660538|468867861|FG002|Overall Study|Randomized but did not receive study drug|0|||
130247257|NCT05660538|468867862|FG003|Overall Study|Randomized but did not receive study drug|1|||
130247258|NCT05660538|468867859|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247259|NCT05660538|468867860|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
130247260|NCT05660538|468867861|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247261|NCT05660538|468867862|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247262|NCT04518410|468867864|FG000|Overall Study|Lost to Follow-up|1|||
130247263|NCT04518410|468867865|FG001|Overall Study|Lost to Follow-up|1|||
130247264|NCT04518410|468867866|FG002|Overall Study|Lost to Follow-up|8|||
130247265|NCT04518410|468867867|FG003|Overall Study|Lost to Follow-up|5|||
130247266|NCT04518410|468867868|FG004|Overall Study|Lost to Follow-up|92|||
130247267|NCT04518410|468867869|FG005|Overall Study|Lost to Follow-up|25|||
130247268|NCT04518410|468867870|FG006|Overall Study|Lost to Follow-up|25|||
130247269|NCT04518410|468867871|FG007|Overall Study|Lost to Follow-up|3|||
130247270|NCT04518410|468867872|FG008|Overall Study|Lost to Follow-up|2|||
130247271|NCT04518410|468867873|FG009|Overall Study|Lost to Follow-up|13|||
130247272|NCT04518410|468867874|FG010|Overall Study|Lost to Follow-up|9|||
130247273|NCT04518410|468867875|FG011|Overall Study|Lost to Follow-up|13|||
130247274|NCT04518410|468867876|FG012|Overall Study|Lost to Follow-up|9|||
130247275|NCT04518410|468867877|FG013|Overall Study|Lost to Follow-up|13|||
130247276|NCT04518410|468867878|FG014|Overall Study|Lost to Follow-up|8|||
130247277|NCT04518410|468867879|FG015|Overall Study|Lost to Follow-up|10|||
130247278|NCT04518410|468867880|FG016|Overall Study|Lost to Follow-up|6|||
130247279|NCT04518410|468867881|FG017|Overall Study|Lost to Follow-up|13|||
130247280|NCT04518410|468867882|FG018|Overall Study|Lost to Follow-up|21|||
130247281|NCT04518410|468867883|FG019|Overall Study|Lost to Follow-up|6|||
130247282|NCT04518410|468867884|FG020|Overall Study|Lost to Follow-up|7|||
130247283|NCT04518410|468867885|FG021|Overall Study|Lost to Follow-up|21|||
130247284|NCT04518410|468867886|FG022|Overall Study|Lost to Follow-up|1|||
130247285|NCT04518410|468867887|FG023|Overall Study|Lost to Follow-up|7|||
130247286|NCT04518410|468867888|FG024|Overall Study|Lost to Follow-up|6|||
130247287|NCT04518410|468867864|FG000|Overall Study|Withdrawal by Subject|1|||
130247288|NCT04518410|468867865|FG001|Overall Study|Withdrawal by Subject|2|||
130699405|NCT05393271|470524672|FG008|Overall Study|Physician Decision|0|||
130699406|NCT05393271|470524673|FG009|Overall Study|Physician Decision|0|||
130699407|NCT05393271|470524674|FG010|Overall Study|Physician Decision|0|||
130699408|NCT02943993|470524675|FG000|Overall Study|Withdrawal by Subject|52|||
130699409|NCT02943993|470524675|FG000|Overall Study|Transfer to another institution|6|||
130699410|NCT02943993|470524675|FG000|Overall Study|Lost to Follow-up|135|||
130699411|NCT02943993|470524675|FG000|Overall Study|Death|98|||
130699412|NCT02943993|470524675|FG000|Overall Study|Other reason for premature termination|32|||
130699413|NCT02943993|470524675|FG000|Overall Study|Missing reason for termination|7|||
130699414|NCT02483416|470524679|FG000|Overall Study|Other reason|0|||
130699415|NCT02483416|470524680|FG001|Overall Study|Other reason|1|||
130699416|NCT02483416|470524679|FG000|Overall Study|Treatment stop|3|||
130699417|NCT02483416|470524680|FG001|Overall Study|Treatment stop|0|||
130699418|NCT04968925|470524681|FG000|Phase I- Period 1|COVID-19 related|0|||
130699419|NCT04968925|470524682|FG001|Phase I- Period 1|COVID-19 related|1|||
130699420|NCT04968925|470524683|FG002|Phase I- Period 1|COVID-19 related|0|||
130699421|NCT04968925|470524684|FG003|Phase I- Period 1|COVID-19 related|0|||
130699422|NCT04968925|470524681|FG000|Phase I- Period 1|Subject enrolled in error|1|||
130699423|NCT04968925|470524682|FG001|Phase I- Period 1|Subject enrolled in error|1|||
130699424|NCT04968925|470524683|FG002|Phase I- Period 1|Subject enrolled in error|0|||
130699425|NCT04968925|470524684|FG003|Phase I- Period 1|Subject enrolled in error|0|||
130699426|NCT04968925|470524681|FG000|Phase II- Period 1|COVID-19 Related|0|||
130699427|NCT04968925|470524682|FG001|Phase II- Period 1|COVID-19 Related|0|||
130699428|NCT04968925|470524683|FG002|Phase II- Period 1|COVID-19 Related|6|||
130699429|NCT04968925|470524684|FG003|Phase II- Period 1|COVID-19 Related|6|||
130699430|NCT04968925|470524681|FG000|Phase II- Period 1|Subject enrolled in error|0|||
130247289|NCT04518410|468867866|FG002|Overall Study|Withdrawal by Subject|2|||
130247290|NCT04518410|468867867|FG003|Overall Study|Withdrawal by Subject|3|||
130247291|NCT04518410|468867868|FG004|Overall Study|Withdrawal by Subject|20|||
130699431|NCT04968925|470524682|FG001|Phase II- Period 1|Subject enrolled in error|0|||
130699432|NCT04968925|470524683|FG002|Phase II- Period 1|Subject enrolled in error|1|||
130699433|NCT04968925|470524684|FG003|Phase II- Period 1|Subject enrolled in error|0|||
130699434|NCT04968925|470524681|FG000|Phase II -Period 2|COVID-19 related|0|||
130247292|NCT04518410|468867869|FG005|Overall Study|Withdrawal by Subject|20|||
130247293|NCT04518410|468867870|FG006|Overall Study|Withdrawal by Subject|25|||
130247294|NCT04518410|468867871|FG007|Overall Study|Withdrawal by Subject|6|||
130247295|NCT04518410|468867872|FG008|Overall Study|Withdrawal by Subject|1|||
130247296|NCT04518410|468867873|FG009|Overall Study|Withdrawal by Subject|12|||
130247297|NCT04518410|468867874|FG010|Overall Study|Withdrawal by Subject|5|||
130247298|NCT04518410|468867875|FG011|Overall Study|Withdrawal by Subject|7|||
130247299|NCT04518410|468867876|FG012|Overall Study|Withdrawal by Subject|2|||
130247300|NCT04518410|468867877|FG013|Overall Study|Withdrawal by Subject|13|||
130247301|NCT04518410|468867878|FG014|Overall Study|Withdrawal by Subject|4|||
130247302|NCT04518410|468867879|FG015|Overall Study|Withdrawal by Subject|9|||
130247303|NCT04518410|468867880|FG016|Overall Study|Withdrawal by Subject|0|||
130247304|NCT04518410|468867881|FG017|Overall Study|Withdrawal by Subject|15|||
130247305|NCT04518410|468867882|FG018|Overall Study|Withdrawal by Subject|12|||
130247306|NCT04518410|468867883|FG019|Overall Study|Withdrawal by Subject|9|||
130247307|NCT04518410|468867884|FG020|Overall Study|Withdrawal by Subject|14|||
130247308|NCT04518410|468867885|FG021|Overall Study|Withdrawal by Subject|3|||
130247309|NCT04518410|468867886|FG022|Overall Study|Withdrawal by Subject|2|||
130247310|NCT04518410|468867887|FG023|Overall Study|Withdrawal by Subject|9|||
130247311|NCT04518410|468867888|FG024|Overall Study|Withdrawal by Subject|8|||
130247312|NCT04518410|468867864|FG000|Overall Study|Other|1|||
130247313|NCT04518410|468867865|FG001|Overall Study|Other|0|||
130247314|NCT04518410|468867866|FG002|Overall Study|Other|0|||
130247315|NCT04518410|468867867|FG003|Overall Study|Other|1|||
130247316|NCT04518410|468867868|FG004|Overall Study|Other|6|||
130247317|NCT04518410|468867869|FG005|Overall Study|Other|6|||
130247318|NCT04518410|468867870|FG006|Overall Study|Other|5|||
130247319|NCT04518410|468867871|FG007|Overall Study|Other|2|||
130247320|NCT04518410|468867872|FG008|Overall Study|Other|0|||
130247321|NCT04518410|468867873|FG009|Overall Study|Other|1|||
130247322|NCT04518410|468867874|FG010|Overall Study|Other|0|||
130247323|NCT04518410|468867875|FG011|Overall Study|Other|2|||
130247324|NCT04518410|468867876|FG012|Overall Study|Other|0|||
130247325|NCT04518410|468867877|FG013|Overall Study|Other|0|||
130247326|NCT04518410|468867878|FG014|Overall Study|Other|0|||
130247327|NCT04518410|468867879|FG015|Overall Study|Other|3|||
130247328|NCT04518410|468867880|FG016|Overall Study|Other|1|||
130247329|NCT04518410|468867881|FG017|Overall Study|Other|1|||
130247330|NCT04518410|468867882|FG018|Overall Study|Other|1|||
130247331|NCT04518410|468867883|FG019|Overall Study|Other|0|||
130247332|NCT04518410|468867884|FG020|Overall Study|Other|1|||
130247333|NCT04518410|468867885|FG021|Overall Study|Other|0|||
130247334|NCT04518410|468867886|FG022|Overall Study|Other|1|||
130247335|NCT04518410|468867887|FG023|Overall Study|Other|2|||
130247336|NCT04518410|468867888|FG024|Overall Study|Other|2|||
130247337|NCT04518410|468867864|FG000|Overall Study|Protocol Violation|0|||
130247338|NCT04518410|468867865|FG001|Overall Study|Protocol Violation|0|||
130247339|NCT04518410|468867866|FG002|Overall Study|Protocol Violation|0|||
130247340|NCT04518410|468867867|FG003|Overall Study|Protocol Violation|2|||
130247341|NCT04518410|468867868|FG004|Overall Study|Protocol Violation|17|||
130247342|NCT04518410|468867869|FG005|Overall Study|Protocol Violation|1|||
130247343|NCT04518410|468867870|FG006|Overall Study|Protocol Violation|2|||
130247344|NCT04518410|468867871|FG007|Overall Study|Protocol Violation|1|||
130247345|NCT04518410|468867872|FG008|Overall Study|Protocol Violation|0|||
130247346|NCT04518410|468867873|FG009|Overall Study|Protocol Violation|0|||
130247347|NCT04518410|468867874|FG010|Overall Study|Protocol Violation|0|||
130247348|NCT04518410|468867875|FG011|Overall Study|Protocol Violation|0|||
130247349|NCT04518410|468867876|FG012|Overall Study|Protocol Violation|0|||
130247350|NCT04518410|468867877|FG013|Overall Study|Protocol Violation|0|||
130247351|NCT04518410|468867878|FG014|Overall Study|Protocol Violation|0|||
130247352|NCT04518410|468867879|FG015|Overall Study|Protocol Violation|0|||
130247353|NCT04518410|468867880|FG016|Overall Study|Protocol Violation|1|||
130363859|NCT01030536|469302010|FG000|Overall Study|Death|0|||
130363860|NCT01030536|469302011|FG001|Overall Study|Death|1|||
130247354|NCT04518410|468867881|FG017|Overall Study|Protocol Violation|1|||
130363861|NCT01030536|469302012|FG002|Overall Study|Death|0|||
130363862|NCT01030536|469302013|FG003|Overall Study|Death|0|||
130247355|NCT04518410|468867882|FG018|Overall Study|Protocol Violation|0|||
130247356|NCT04518410|468867883|FG019|Overall Study|Protocol Violation|0|||
130247357|NCT04518410|468867884|FG020|Overall Study|Protocol Violation|1|||
130247358|NCT04518410|468867885|FG021|Overall Study|Protocol Violation|2|||
130247359|NCT04518410|468867886|FG022|Overall Study|Protocol Violation|0|||
130247360|NCT04518410|468867887|FG023|Overall Study|Protocol Violation|3|||
130247361|NCT04518410|468867888|FG024|Overall Study|Protocol Violation|0|||
130247362|NCT04518410|468867864|FG000|Overall Study|Death|0|||
130363863|NCT01030536|469302014|FG004|Overall Study|Death|0|||
130247363|NCT04518410|468867865|FG001|Overall Study|Death|0|||
130247364|NCT04518410|468867866|FG002|Overall Study|Death|0|||
130247365|NCT04518410|468867867|FG003|Overall Study|Death|0|||
130247366|NCT04518410|468867868|FG004|Overall Study|Death|12|||
130247367|NCT04518410|468867869|FG005|Overall Study|Death|2|||
130363864|NCT01419626|469302019|FG000|Overall Study|Protocol Violation|3|||
130247368|NCT04518410|468867870|FG006|Overall Study|Death|11|||
130247369|NCT04518410|468867871|FG007|Overall Study|Death|0|||
130247370|NCT04518410|468867872|FG008|Overall Study|Death|1|||
130247371|NCT04518410|468867873|FG009|Overall Study|Death|0|||
130247372|NCT04518410|468867874|FG010|Overall Study|Death|0|||
130247373|NCT04518410|468867875|FG011|Overall Study|Death|0|||
130247374|NCT04518410|468867876|FG012|Overall Study|Death|0|||
130247375|NCT04518410|468867877|FG013|Overall Study|Death|1|||
130247376|NCT04518410|468867878|FG014|Overall Study|Death|1|||
130247377|NCT04518410|468867879|FG015|Overall Study|Death|0|||
130247378|NCT04518410|468867880|FG016|Overall Study|Death|0|||
130247379|NCT04518410|468867881|FG017|Overall Study|Death|1|||
130247380|NCT04518410|468867882|FG018|Overall Study|Death|4|||
130247381|NCT04518410|468867883|FG019|Overall Study|Death|4|||
130247382|NCT04518410|468867884|FG020|Overall Study|Death|1|||
130247383|NCT04518410|468867885|FG021|Overall Study|Death|0|||
130247384|NCT04518410|468867886|FG022|Overall Study|Death|0|||
130247385|NCT04518410|468867887|FG023|Overall Study|Death|0|||
130247386|NCT04518410|468867888|FG024|Overall Study|Death|0|||
130247387|NCT04518410|468867864|FG000|Overall Study|Requirement to start alternative therapy|0|||
130247388|NCT04518410|468867865|FG001|Overall Study|Requirement to start alternative therapy|0|||
130247389|NCT04518410|468867866|FG002|Overall Study|Requirement to start alternative therapy|1|||
130247390|NCT04518410|468867867|FG003|Overall Study|Requirement to start alternative therapy|0|||
130247391|NCT04518410|468867868|FG004|Overall Study|Requirement to start alternative therapy|0|||
130247392|NCT04518410|468867869|FG005|Overall Study|Requirement to start alternative therapy|0|||
130247393|NCT04518410|468867870|FG006|Overall Study|Requirement to start alternative therapy|0|||
130247394|NCT04518410|468867871|FG007|Overall Study|Requirement to start alternative therapy|0|||
130247395|NCT04518410|468867872|FG008|Overall Study|Requirement to start alternative therapy|0|||
130247396|NCT04518410|468867873|FG009|Overall Study|Requirement to start alternative therapy|0|||
130247397|NCT04518410|468867874|FG010|Overall Study|Requirement to start alternative therapy|0|||
130247398|NCT04518410|468867875|FG011|Overall Study|Requirement to start alternative therapy|0|||
130247399|NCT04518410|468867876|FG012|Overall Study|Requirement to start alternative therapy|0|||
130247400|NCT04518410|468867877|FG013|Overall Study|Requirement to start alternative therapy|0|||
130247401|NCT04518410|468867878|FG014|Overall Study|Requirement to start alternative therapy|0|||
130247402|NCT04518410|468867879|FG015|Overall Study|Requirement to start alternative therapy|0|||
130247403|NCT04518410|468867880|FG016|Overall Study|Requirement to start alternative therapy|0|||
130247404|NCT04518410|468867881|FG017|Overall Study|Requirement to start alternative therapy|0|||
130247405|NCT04518410|468867882|FG018|Overall Study|Requirement to start alternative therapy|0|||
130247406|NCT04518410|468867883|FG019|Overall Study|Requirement to start alternative therapy|0|||
130247407|NCT04518410|468867884|FG020|Overall Study|Requirement to start alternative therapy|0|||
130247408|NCT04518410|468867885|FG021|Overall Study|Requirement to start alternative therapy|0|||
130247409|NCT04518410|468867886|FG022|Overall Study|Requirement to start alternative therapy|0|||
130247410|NCT04518410|468867887|FG023|Overall Study|Requirement to start alternative therapy|0|||
130247411|NCT04518410|468867888|FG024|Overall Study|Requirement to start alternative therapy|0|||
130247412|NCT04518410|468867864|FG000|Overall Study|Randomized but not treated|0|||
130247413|NCT04518410|468867865|FG001|Overall Study|Randomized but not treated|0|||
130247414|NCT04518410|468867866|FG002|Overall Study|Randomized but not treated|0|||
130247415|NCT04518410|468867867|FG003|Overall Study|Randomized but not treated|2|||
130247416|NCT04518410|468867868|FG004|Overall Study|Randomized but not treated|6|||
130247417|NCT04518410|468867869|FG005|Overall Study|Randomized but not treated|4|||
130247418|NCT04518410|468867870|FG006|Overall Study|Randomized but not treated|3|||
130247419|NCT04518410|468867871|FG007|Overall Study|Randomized but not treated|3|||
130247420|NCT04518410|468867872|FG008|Overall Study|Randomized but not treated|0|||
130247421|NCT04518410|468867873|FG009|Overall Study|Randomized but not treated|4|||
130247422|NCT04518410|468867874|FG010|Overall Study|Randomized but not treated|0|||
130247423|NCT04518410|468867875|FG011|Overall Study|Randomized but not treated|0|||
130247424|NCT04518410|468867876|FG012|Overall Study|Randomized but not treated|1|||
130363865|NCT01419626|469302020|FG001|Overall Study|Protocol Violation|2|||
130363866|NCT01419626|469302021|FG002|Overall Study|Protocol Violation|2|||
130247425|NCT04518410|468867877|FG013|Overall Study|Randomized but not treated|3|||
130363867|NCT01419626|469302019|FG000|Overall Study|Withdrawal by Subject|1|||
130247426|NCT04518410|468867878|FG014|Overall Study|Randomized but not treated|3|||
130247427|NCT04518410|468867879|FG015|Overall Study|Randomized but not treated|3|||
130247428|NCT04518410|468867880|FG016|Overall Study|Randomized but not treated|4|||
130247429|NCT04518410|468867881|FG017|Overall Study|Randomized but not treated|5|||
130363868|NCT01419626|469302020|FG001|Overall Study|Withdrawal by Subject|0|||
130363869|NCT01419626|469302021|FG002|Overall Study|Withdrawal by Subject|0|||
130247430|NCT04518410|468867882|FG018|Overall Study|Randomized but not treated|4|||
130247431|NCT04518410|468867883|FG019|Overall Study|Randomized but not treated|0|||
130247432|NCT04518410|468867884|FG020|Overall Study|Randomized but not treated|0|||
130247433|NCT04518410|468867885|FG021|Overall Study|Randomized but not treated|5|||
130247434|NCT04518410|468867886|FG022|Overall Study|Randomized but not treated|0|||
130363870|NCT01419626|469302019|FG000|Overall Study|Lost to Follow-up|0|||
130363871|NCT01419626|469302020|FG001|Overall Study|Lost to Follow-up|1|||
130247435|NCT04518410|468867887|FG023|Overall Study|Randomized but not treated|3|||
130247436|NCT04518410|468867888|FG024|Overall Study|Randomized but not treated|1|||
130247437|NCT04518410|468867864|FG000|Overall Study|Screen Fail but Randomized|0|||
130247438|NCT04518410|468867865|FG001|Overall Study|Screen Fail but Randomized|0|||
130247439|NCT04518410|468867866|FG002|Overall Study|Screen Fail but Randomized|0|||
130247440|NCT04518410|468867867|FG003|Overall Study|Screen Fail but Randomized|0|||
130247441|NCT04518410|468867868|FG004|Overall Study|Screen Fail but Randomized|2|||
130247442|NCT04518410|468867869|FG005|Overall Study|Screen Fail but Randomized|0|||
130699435|NCT04968925|470524682|FG001|Phase II -Period 2|COVID-19 related|0|||
130699436|NCT04968925|470524683|FG002|Phase II -Period 2|COVID-19 related|4|||
130699437|NCT04968925|470524684|FG003|Phase II -Period 2|COVID-19 related|3|||
130699438|NCT04968925|470524681|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
130699439|NCT04968925|470524682|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
130699440|NCT04968925|470524683|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
130699441|NCT04968925|470524684|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
130699442|NCT00487695|470524689|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
130699443|NCT00487695|470524690|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
130699444|NCT00487695|470524689|FG000|First Procedure|active wheezing (did not have procedure)|1|||
130699445|NCT00487695|470524690|FG001|First Procedure|active wheezing (did not have procedure)|0|||
130699446|NCT00487695|470524689|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
130699447|NCT00487695|470524690|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
130699448|NCT00487695|470524689|FG000|Second Procedure|active wheezing|0|||
130699449|NCT00487695|470524690|FG001|Second Procedure|active wheezing|1|||
130699450|NCT00487695|470524689|FG000|Second Procedure|Withdrawal by Subject|1|||
130247443|NCT04518410|468867870|FG006|Overall Study|Screen Fail but Randomized|0|||
130247444|NCT04518410|468867871|FG007|Overall Study|Screen Fail but Randomized|0|||
130247445|NCT04518410|468867872|FG008|Overall Study|Screen Fail but Randomized|0|||
130452108|NCT05567159|469618349|FG000|Overall Study|Physician Decision|3|||
130452109|NCT05567159|469618349|FG000|Overall Study|Protocol deviation|1|||
130452110|NCT02501811|469618352|FG000|Overall Study|Death|1|||
130452111|NCT02501811|469618353|FG001|Overall Study|Death|3|||
130452112|NCT02501811|469618354|FG002|Overall Study|Death|2|||
130452113|NCT02501811|469618355|FG003|Overall Study|Death|3|||
130452114|NCT02501811|469618352|FG000|Overall Study|Withdrawal by Subject|3|||
130452115|NCT02501811|469618353|FG001|Overall Study|Withdrawal by Subject|3|||
130452116|NCT02501811|469618354|FG002|Overall Study|Withdrawal by Subject|2|||
130452117|NCT02501811|469618355|FG003|Overall Study|Withdrawal by Subject|3|||
130452118|NCT02501811|469618352|FG000|Overall Study|Lost to Follow-up|0|||
130452119|NCT02501811|469618353|FG001|Overall Study|Lost to Follow-up|0|||
130699451|NCT00487695|470524690|FG001|Second Procedure|Withdrawal by Subject|2|||
130247446|NCT04518410|468867873|FG009|Overall Study|Screen Fail but Randomized|0|||
130247447|NCT04518410|468867874|FG010|Overall Study|Screen Fail but Randomized|0|||
130247448|NCT04518410|468867875|FG011|Overall Study|Screen Fail but Randomized|0|||
130699452|NCT04542694|470524691|FG000|Overall Study|The need for prohibited therapy|2|||
130699453|NCT04542694|470524692|FG001|Overall Study|The need for prohibited therapy|0|||
130452120|NCT02501811|469618354|FG002|Overall Study|Lost to Follow-up|2|||
130699454|NCT04542694|470524691|FG000|Overall Study|Adverse Event|1|||
130699455|NCT04542694|470524692|FG001|Overall Study|Adverse Event|0|||
130363872|NCT01419626|469302021|FG002|Overall Study|Lost to Follow-up|1|||
130363873|NCT01365052|469302022|FG000|Overall Study|Adverse Event|4|||
130363874|NCT01365052|469302023|FG001|Overall Study|Adverse Event|4|||
130363875|NCT01146912|469302024|FG000|Overall Study|Already received influenza vaccination|817|||
130363876|NCT01146912|469302025|FG001|Overall Study|Already received influenza vaccination|822|||
130363877|NCT01146912|469302026|FG002|Overall Study|Already received influenza vaccination|13|||
130363878|NCT01146912|469302027|FG003|Overall Study|Already received influenza vaccination|15|||
130363879|NCT01146912|469302028|FG004|Overall Study|Already received influenza vaccination|41|||
130363880|NCT01146912|469302029|FG005|Overall Study|Already received influenza vaccination|61|||
130363881|NCT01146912|469302030|FG006|Overall Study|Already received influenza vaccination|56|||
130363882|NCT01146912|469302031|FG007|Overall Study|Already received influenza vaccination|0|||
130363883|NCT01146912|469302024|FG000|Overall Study|< 14 weeks gestational age|0|||
130363884|NCT01146912|469302025|FG001|Overall Study|< 14 weeks gestational age|0|||
130363885|NCT01146912|469302026|FG002|Overall Study|< 14 weeks gestational age|3|||
130363886|NCT01146912|469302027|FG003|Overall Study|< 14 weeks gestational age|2|||
130363887|NCT01146912|469302028|FG004|Overall Study|< 14 weeks gestational age|0|||
130363888|NCT01146912|469302029|FG005|Overall Study|< 14 weeks gestational age|0|||
130363889|NCT01146912|469302030|FG006|Overall Study|< 14 weeks gestational age|0|||
130363890|NCT01146912|469302031|FG007|Overall Study|< 14 weeks gestational age|0|||
130363891|NCT01146912|469302024|FG000|Overall Study|Duplicate patient|0|||
130363892|NCT01146912|469302025|FG001|Overall Study|Duplicate patient|0|||
130363893|NCT01146912|469302026|FG002|Overall Study|Duplicate patient|1|||
130363894|NCT01146912|469302027|FG003|Overall Study|Duplicate patient|0|||
130363895|NCT01146912|469302028|FG004|Overall Study|Duplicate patient|0|||
130363896|NCT01146912|469302029|FG005|Overall Study|Duplicate patient|0|||
130247449|NCT04518410|468867876|FG012|Overall Study|Screen Fail but Randomized|0|||
130247450|NCT04518410|468867877|FG013|Overall Study|Screen Fail but Randomized|0|||
130247451|NCT04518410|468867878|FG014|Overall Study|Screen Fail but Randomized|0|||
130247452|NCT04518410|468867879|FG015|Overall Study|Screen Fail but Randomized|0|||
130247453|NCT04518410|468867880|FG016|Overall Study|Screen Fail but Randomized|0|||
130247454|NCT04518410|468867881|FG017|Overall Study|Screen Fail but Randomized|0|||
130247455|NCT04518410|468867882|FG018|Overall Study|Screen Fail but Randomized|0|||
130247456|NCT04518410|468867883|FG019|Overall Study|Screen Fail but Randomized|0|||
130247457|NCT04518410|468867884|FG020|Overall Study|Screen Fail but Randomized|0|||
130247458|NCT04518410|468867885|FG021|Overall Study|Screen Fail but Randomized|0|||
130247459|NCT04518410|468867886|FG022|Overall Study|Screen Fail but Randomized|0|||
130247460|NCT04518410|468867887|FG023|Overall Study|Screen Fail but Randomized|0|||
130247461|NCT04518410|468867888|FG024|Overall Study|Screen Fail but Randomized|0|||
130247462|NCT04518410|468867864|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247463|NCT04518410|468867865|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247464|NCT04518410|468867866|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247465|NCT04518410|468867867|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247466|NCT04518410|468867868|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
130247467|NCT04518410|468867869|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
130247468|NCT04518410|468867870|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
130247469|NCT04518410|468867871|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247470|NCT04518410|468867872|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
130247471|NCT04518410|468867873|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130247472|NCT04518410|468867874|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247473|NCT04518410|468867875|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247474|NCT04518410|468867876|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247475|NCT04518410|468867877|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247476|NCT04518410|468867878|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247477|NCT04518410|468867879|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130363897|NCT01146912|469302030|FG006|Overall Study|Duplicate patient|0|||
130363898|NCT01146912|469302031|FG007|Overall Study|Duplicate patient|0|||
130363899|NCT01145625|469302034|FG000|Overall Study|Lost to Follow-up|8|||
130363900|NCT01145625|469302035|FG001|Overall Study|Lost to Follow-up|9|||
130699456|NCT04542694|470524691|FG000|Overall Study|Protocol Violation|1|||
130699457|NCT04542694|470524692|FG001|Overall Study|Protocol Violation|0|||
130699458|NCT00969124|470524693|FG000|Overall Study|Protocol Violation|2|||
130699459|NCT00969124|470524693|FG000|Overall Study|Inadequate bowel preparation|15|||
130363901|NCT01145625|469302034|FG000|Overall Study|Adverse Event|6|||
130699460|NCT00969124|470524693|FG000|Overall Study|Inability to reach cecum|9|||
130247478|NCT04518410|468867880|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130247479|NCT04518410|468867881|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130247480|NCT04518410|468867882|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
130247481|NCT04518410|468867883|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130247482|NCT04518410|468867884|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
130247483|NCT04518410|468867885|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130247484|NCT04518410|468867886|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130247485|NCT04518410|468867887|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247486|NCT04518410|468867888|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130247487|NCT04518410|468867864|FG000|Overall Study|Dual Enrolled Subject|0|||
130247488|NCT04518410|468867865|FG001|Overall Study|Dual Enrolled Subject|0|||
130247489|NCT04518410|468867866|FG002|Overall Study|Dual Enrolled Subject|0|||
130247490|NCT04518410|468867867|FG003|Overall Study|Dual Enrolled Subject|0|||
130247491|NCT04518410|468867868|FG004|Overall Study|Dual Enrolled Subject|0|||
130247492|NCT04518410|468867869|FG005|Overall Study|Dual Enrolled Subject|0|||
130247493|NCT04518410|468867870|FG006|Overall Study|Dual Enrolled Subject|0|||
130247494|NCT04518410|468867871|FG007|Overall Study|Dual Enrolled Subject|0|||
130247495|NCT04518410|468867872|FG008|Overall Study|Dual Enrolled Subject|0|||
130247496|NCT04518410|468867873|FG009|Overall Study|Dual Enrolled Subject|0|||
130247497|NCT04518410|468867874|FG010|Overall Study|Dual Enrolled Subject|0|||
130247498|NCT04518410|468867875|FG011|Overall Study|Dual Enrolled Subject|0|||
130247499|NCT04518410|468867876|FG012|Overall Study|Dual Enrolled Subject|0|||
130247500|NCT04518410|468867877|FG013|Overall Study|Dual Enrolled Subject|0|||
130247501|NCT04518410|468867878|FG014|Overall Study|Dual Enrolled Subject|0|||
130247502|NCT04518410|468867879|FG015|Overall Study|Dual Enrolled Subject|0|||
130247503|NCT04518410|468867880|FG016|Overall Study|Dual Enrolled Subject|0|||
130247504|NCT04518410|468867881|FG017|Overall Study|Dual Enrolled Subject|1|||
130247505|NCT04518410|468867882|FG018|Overall Study|Dual Enrolled Subject|0|||
130247506|NCT04518410|468867883|FG019|Overall Study|Dual Enrolled Subject|0|||
130247507|NCT04518410|468867884|FG020|Overall Study|Dual Enrolled Subject|0|||
130247508|NCT04518410|468867885|FG021|Overall Study|Dual Enrolled Subject|0|||
130247509|NCT04518410|468867886|FG022|Overall Study|Dual Enrolled Subject|0|||
130247510|NCT04518410|468867887|FG023|Overall Study|Dual Enrolled Subject|0|||
130452121|NCT02501811|469618355|FG003|Overall Study|Lost to Follow-up|1|||
130452122|NCT02624778|469619755|FG000|Overall Study|Lost to Follow-up|0|||
130452123|NCT02624778|469619756|FG001|Overall Study|Lost to Follow-up|0|||
130452124|NCT02624778|469619757|FG002|Overall Study|Lost to Follow-up|1|||
130452125|NCT02624778|469619758|FG003|Overall Study|Lost to Follow-up|0|||
130247511|NCT04518410|468867888|FG024|Overall Study|Dual Enrolled Subject|0|||
130247512|NCT03462563|468867889|FG000|Overall Study|Death|1|||
130247513|NCT03462563|468867890|FG001|Overall Study|Death|1|||
130247514|NCT03462563|468867889|FG000|Overall Study|Termination of study|2|||
130247515|NCT03462563|468867890|FG001|Overall Study|Termination of study|1|||
130247516|NCT03462563|468867889|FG000|Overall Study|Adverse Event|1|||
130247517|NCT03462563|468867890|FG001|Overall Study|Adverse Event|3|||
130247518|NCT03462563|468867889|FG000|Overall Study|Unspecified reason|10|||
130452126|NCT02624778|469619759|FG004|Overall Study|Lost to Follow-up|0|||
130452127|NCT02624778|469619760|FG005|Overall Study|Lost to Follow-up|0|||
130247519|NCT03462563|468867890|FG001|Overall Study|Unspecified reason|12|||
130247520|NCT03462563|468867889|FG000|Overall Study|Physician Decision|1|||
130247521|NCT03462563|468867890|FG001|Overall Study|Physician Decision|0|||
130247522|NCT01740427|468867891|FG000|Overall Study|Objective Progression or Relapse|286|||
130247523|NCT01740427|468867892|FG001|Overall Study|Objective Progression or Relapse|172|||
130247524|NCT01740427|468867891|FG000|Overall Study|Adverse Event|32|||
130247525|NCT01740427|468867892|FG001|Overall Study|Adverse Event|9|||
130247526|NCT01740427|468867891|FG000|Overall Study|Global Deterioration of Health Status|28|||
130247527|NCT01740427|468867892|FG001|Overall Study|Global Deterioration of Health Status|12|||
130247528|NCT01740427|468867891|FG000|Overall Study|Participant Refused Continued Treatment|27|||
130247529|NCT01740427|468867892|FG001|Overall Study|Participant Refused Continued Treatment|15|||
130247530|NCT01740427|468867891|FG000|Overall Study|Unspecified reasons|52|||
130247531|NCT01740427|468867892|FG001|Overall Study|Unspecified reasons|8|||
130247532|NCT01740427|468867891|FG000|Overall Study|Death|10|||
130247533|NCT01740427|468867892|FG001|Overall Study|Death|3|||
130247534|NCT01740427|468867891|FG000|Overall Study|Protocol Violation|5|||
130247535|NCT01740427|468867892|FG001|Overall Study|Protocol Violation|3|||
130247536|NCT01740427|468867891|FG000|Overall Study|Lost to Follow-up|3|||
130247537|NCT01740427|468867892|FG001|Overall Study|Lost to Follow-up|0|||
130247538|NCT01740427|468867891|FG000|Overall Study|Site Terminated by Sponsor|1|||
130247539|NCT01740427|468867892|FG001|Overall Study|Site Terminated by Sponsor|0|||
130247540|NCT04796207|468867893|FG000|Overall Study|Lost to Follow-up|7|||
130247541|NCT04796207|468867894|FG001|Overall Study|Lost to Follow-up|2|||
130247542|NCT02405962|468867897|FG000|Overall Study|Lost to Follow-up|1|||
130247543|NCT02405962|468867898|FG001|Overall Study|Lost to Follow-up|4|||
130247544|NCT02405962|468867897|FG000|Overall Study|A participant has moved to another place|0|||
130247545|NCT02405962|468867898|FG001|Overall Study|A participant has moved to another place|1|||
130247546|NCT03679884|468867899|FG000|Overall Study|Other|12|||
130247547|NCT03679884|468867900|FG001|Overall Study|Other|12|||
130247548|NCT03679884|468867901|FG002|Overall Study|Other|12|||
130247549|NCT03679884|468867902|FG003|Overall Study|Other|7|||
130247550|NCT03679884|468867903|FG004|Overall Study|Other|8|||
130247551|NCT03679884|468867899|FG000|Overall Study|Lack of Efficacy|15|||
130247552|NCT03679884|468867900|FG001|Overall Study|Lack of Efficacy|29|||
130247553|NCT03679884|468867901|FG002|Overall Study|Lack of Efficacy|13|||
130247554|NCT03679884|468867902|FG003|Overall Study|Lack of Efficacy|29|||
130247555|NCT03679884|468867903|FG004|Overall Study|Lack of Efficacy|10|||
130247556|NCT03679884|468867899|FG000|Overall Study|Death|1|||
130247557|NCT03679884|468867900|FG001|Overall Study|Death|0|||
130247558|NCT03679884|468867901|FG002|Overall Study|Death|0|||
130247559|NCT03679884|468867902|FG003|Overall Study|Death|0|||
130247560|NCT03679884|468867903|FG004|Overall Study|Death|0|||
130247561|NCT03679884|468867899|FG000|Overall Study|Adverse Event|2|||
130247562|NCT03679884|468867900|FG001|Overall Study|Adverse Event|10|||
130247563|NCT03679884|468867901|FG002|Overall Study|Adverse Event|9|||
130247564|NCT03679884|468867902|FG003|Overall Study|Adverse Event|6|||
130247565|NCT03679884|468867903|FG004|Overall Study|Adverse Event|6|||
130247566|NCT03679884|468867899|FG000|Overall Study|Withdrawal by Subject|12|||
130247567|NCT03679884|468867900|FG001|Overall Study|Withdrawal by Subject|23|||
130363902|NCT01145625|469302035|FG001|Overall Study|Adverse Event|4|||
130363903|NCT01145625|469302034|FG000|Overall Study|Protocol Violation|3|||
130363904|NCT01145625|469302035|FG001|Overall Study|Protocol Violation|1|||
130363905|NCT01145625|469302034|FG000|Overall Study|Withdrawal by Subject|7|||
130363906|NCT01145625|469302035|FG001|Overall Study|Withdrawal by Subject|16|||
130363907|NCT01145625|469302034|FG000|Overall Study|Pregnancy|0|||
130363908|NCT01145625|469302035|FG001|Overall Study|Pregnancy|1|||
130363909|NCT02202980|469302038|FG000|Overall Study|Lack of Efficacy|1|||
130363910|NCT02202980|469302039|FG001|Overall Study|Lack of Efficacy|0|||
130363911|NCT02202980|469302040|FG002|Overall Study|Lack of Efficacy|7|||
130363912|NCT02202980|469302041|FG003|Overall Study|Lack of Efficacy|0|||
130363913|NCT02202980|469302042|FG004|Overall Study|Lack of Efficacy|3|||
130363914|NCT02202980|469302043|FG005|Overall Study|Lack of Efficacy|1|||
130363915|NCT02202980|469302044|FG006|Overall Study|Lack of Efficacy|11|||
130247568|NCT03679884|468867901|FG002|Overall Study|Withdrawal by Subject|8|||
130247569|NCT03679884|468867902|FG003|Overall Study|Withdrawal by Subject|8|||
130247570|NCT03679884|468867903|FG004|Overall Study|Withdrawal by Subject|9|||
130247571|NCT03679884|468867899|FG000|Overall Study|Lost to Follow-up|1|||
130247572|NCT03679884|468867900|FG001|Overall Study|Lost to Follow-up|4|||
130247573|NCT03679884|468867901|FG002|Overall Study|Lost to Follow-up|2|||
130247574|NCT03679884|468867902|FG003|Overall Study|Lost to Follow-up|0|||
130247575|NCT03679884|468867903|FG004|Overall Study|Lost to Follow-up|3|||
130247576|NCT01107457|468867904|FG000|Part A|Adverse Event|1|||
130363916|NCT02202980|469302045|FG007|Overall Study|Lack of Efficacy|2|||
130363917|NCT02202980|469302046|FG008|Overall Study|Lack of Efficacy|2|||
130247577|NCT01107457|468867905|FG001|Part A|Adverse Event|2|||
130247578|NCT01107457|468867906|FG002|Part A|Adverse Event|1|||
130247579|NCT01107457|468867907|FG003|Part A|Adverse Event|0|||
130247580|NCT01107457|468867908|FG004|Part A|Adverse Event|0|||
130247581|NCT01107457|468867909|FG005|Part A|Adverse Event|0|||
130247582|NCT01107457|468867904|FG000|Part A|Withdrawal by Subject|3|||
130247583|NCT01107457|468867905|FG001|Part A|Withdrawal by Subject|3|||
130247584|NCT01107457|468867906|FG002|Part A|Withdrawal by Subject|0|||
130247585|NCT01107457|468867907|FG003|Part A|Withdrawal by Subject|3|||
130247586|NCT01107457|468867908|FG004|Part A|Withdrawal by Subject|1|||
130247587|NCT01107457|468867909|FG005|Part A|Withdrawal by Subject|0|||
130247588|NCT01107457|468867904|FG000|Part A|Lost to Follow-up|0|||
130247589|NCT01107457|468867905|FG001|Part A|Lost to Follow-up|1|||
130247590|NCT01107457|468867906|FG002|Part A|Lost to Follow-up|0|||
130247591|NCT01107457|468867907|FG003|Part A|Lost to Follow-up|0|||
130247592|NCT01107457|468867908|FG004|Part A|Lost to Follow-up|0|||
130247593|NCT01107457|468867909|FG005|Part A|Lost to Follow-up|0|||
130247594|NCT01107457|468867904|FG000|Part A|Lack of Efficacy|1|||
130247595|NCT01107457|468867905|FG001|Part A|Lack of Efficacy|0|||
130247596|NCT01107457|468867906|FG002|Part A|Lack of Efficacy|0|||
130247597|NCT01107457|468867907|FG003|Part A|Lack of Efficacy|0|||
130247598|NCT01107457|468867908|FG004|Part A|Lack of Efficacy|0|||
130247599|NCT01107457|468867909|FG005|Part A|Lack of Efficacy|0|||
130247600|NCT01107457|468867904|FG000|Part A|Protocol Violation|0|||
130247601|NCT01107457|468867905|FG001|Part A|Protocol Violation|1|||
130247602|NCT01107457|468867906|FG002|Part A|Protocol Violation|0|||
130247603|NCT01107457|468867907|FG003|Part A|Protocol Violation|0|||
130247604|NCT01107457|468867908|FG004|Part A|Protocol Violation|0|||
130247605|NCT01107457|468867909|FG005|Part A|Protocol Violation|0|||
130247606|NCT01107457|468867904|FG000|Part B and C|Adverse Event|0|||
130247607|NCT01107457|468867905|FG001|Part B and C|Adverse Event|0|||
130247608|NCT01107457|468867906|FG002|Part B and C|Adverse Event|0|||
130247609|NCT01107457|468867907|FG003|Part B and C|Adverse Event|0|||
130247610|NCT01107457|468867908|FG004|Part B and C|Adverse Event|0|||
130247611|NCT01107457|468867909|FG005|Part B and C|Adverse Event|12|||
130247612|NCT01107457|468867904|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247613|NCT01107457|468867905|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247614|NCT01107457|468867906|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247615|NCT01107457|468867907|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247616|NCT01107457|468867908|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247617|NCT01107457|468867909|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
130247618|NCT01107457|468867904|FG000|Part B and C|Physician Decision|0|||
130247619|NCT01107457|468867905|FG001|Part B and C|Physician Decision|0|||
130247620|NCT01107457|468867906|FG002|Part B and C|Physician Decision|0|||
130247621|NCT01107457|468867907|FG003|Part B and C|Physician Decision|0|||
130247622|NCT01107457|468867908|FG004|Part B and C|Physician Decision|0|||
130247623|NCT01107457|468867909|FG005|Part B and C|Physician Decision|3|||
130247624|NCT01107457|468867904|FG000|Part B and C|Lack of Efficacy|0|||
130247625|NCT01107457|468867905|FG001|Part B and C|Lack of Efficacy|0|||
130247626|NCT01107457|468867906|FG002|Part B and C|Lack of Efficacy|0|||
130247627|NCT01107457|468867907|FG003|Part B and C|Lack of Efficacy|0|||
130247628|NCT01107457|468867908|FG004|Part B and C|Lack of Efficacy|0|||
130247629|NCT01107457|468867909|FG005|Part B and C|Lack of Efficacy|7|||
130247630|NCT01107457|468867904|FG000|Part B and C|Lost to Follow-up|0|||
130247631|NCT01107457|468867905|FG001|Part B and C|Lost to Follow-up|0|||
130247632|NCT01107457|468867906|FG002|Part B and C|Lost to Follow-up|0|||
130247633|NCT01107457|468867907|FG003|Part B and C|Lost to Follow-up|0|||
130452128|NCT02624778|469619761|FG006|Overall Study|Lost to Follow-up|0|||
130452129|NCT02624778|469619762|FG007|Overall Study|Lost to Follow-up|0|||
130247634|NCT01107457|468867908|FG004|Part B and C|Lost to Follow-up|0|||
130247635|NCT01107457|468867909|FG005|Part B and C|Lost to Follow-up|10|||
130247636|NCT01107457|468867904|FG000|Part B and C|Protocol Violation|0|||
130247637|NCT01107457|468867905|FG001|Part B and C|Protocol Violation|0|||
130247638|NCT01107457|468867906|FG002|Part B and C|Protocol Violation|0|||
130247639|NCT01107457|468867907|FG003|Part B and C|Protocol Violation|0|||
130247640|NCT01107457|468867908|FG004|Part B and C|Protocol Violation|0|||
130247641|NCT01107457|468867909|FG005|Part B and C|Protocol Violation|1|||
130247642|NCT01107457|468867904|FG000|Part B and C|Sponsor Decision|0|||
130247643|NCT01107457|468867905|FG001|Part B and C|Sponsor Decision|0|||
130247644|NCT01107457|468867906|FG002|Part B and C|Sponsor Decision|0|||
130247645|NCT01107457|468867907|FG003|Part B and C|Sponsor Decision|0|||
130452130|NCT02624778|469619763|FG008|Overall Study|Lost to Follow-up|0|||
130247646|NCT01107457|468867908|FG004|Part B and C|Sponsor Decision|0|||
130247647|NCT01107457|468867909|FG005|Part B and C|Sponsor Decision|66|||
130247648|NCT01107457|468867904|FG000|Part B and C|Withdrawal by Subject|0|||
130247649|NCT01107457|468867905|FG001|Part B and C|Withdrawal by Subject|0|||
130247650|NCT01107457|468867906|FG002|Part B and C|Withdrawal by Subject|0|||
130247651|NCT01107457|468867907|FG003|Part B and C|Withdrawal by Subject|0|||
130247652|NCT01107457|468867908|FG004|Part B and C|Withdrawal by Subject|0|||
130247653|NCT01107457|468867909|FG005|Part B and C|Withdrawal by Subject|16|||
130247654|NCT01107457|468867904|FG000|Part B and C|Clinical Relapse|0|||
130247655|NCT01107457|468867905|FG001|Part B and C|Clinical Relapse|0|||
130452131|NCT02624778|469619755|FG000|Overall Study|Withdrawal by Subject|0|||
130247656|NCT01107457|468867906|FG002|Part B and C|Clinical Relapse|0|||
130247657|NCT01107457|468867907|FG003|Part B and C|Clinical Relapse|0|||
130247658|NCT01107457|468867908|FG004|Part B and C|Clinical Relapse|0|||
130247659|NCT01107457|468867909|FG005|Part B and C|Clinical Relapse|4|||
130247660|NCT00105508|468867910|FG000|Overall Study|Prephase Dropout|1|||
130247661|NCT00105508|468867911|FG001|Overall Study|Prephase Dropout|0|||
130247662|NCT00105508|468867910|FG000|Overall Study|Adverse Event|16|||
130247663|NCT00105508|468867911|FG001|Overall Study|Adverse Event|19|||
130247664|NCT00105508|468867910|FG000|Overall Study|Insufficient Efficacy|1|||
130247665|NCT00105508|468867911|FG001|Overall Study|Insufficient Efficacy|0|||
130247666|NCT00105508|468867910|FG000|Overall Study|Withdrawal by Subject|10|||
130247667|NCT00105508|468867911|FG001|Overall Study|Withdrawal by Subject|6|||
130247668|NCT00105508|468867910|FG000|Overall Study|Lost to Follow-up|3|||
130247669|NCT00105508|468867911|FG001|Overall Study|Lost to Follow-up|0|||
130247670|NCT00105508|468867910|FG000|Overall Study|Protocol Violation|1|||
130247671|NCT00105508|468867911|FG001|Overall Study|Protocol Violation|2|||
130247672|NCT00105508|468867910|FG000|Overall Study|Other|8|||
130247673|NCT00105508|468867911|FG001|Overall Study|Other|9|||
130699461|NCT00969124|470524693|FG000|Overall Study|Previously unrecognized disease|3|||
130699462|NCT00969124|470524693|FG000|Overall Study|Technical error|1|||
130699463|NCT00687739|470524694|FG000|Overall Study|Lost to Follow-up|2|||
130699464|NCT00687739|470524695|FG001|Overall Study|Lost to Follow-up|2|||
130699465|NCT00687739|470524696|FG002|Overall Study|Lost to Follow-up|1|||
130699466|NCT00687739|470524697|FG003|Overall Study|Lost to Follow-up|2|||
130699467|NCT00687739|470524694|FG000|Overall Study|Adverse Event|0|||
130699468|NCT00687739|470524695|FG001|Overall Study|Adverse Event|1|||
130699469|NCT00687739|470524696|FG002|Overall Study|Adverse Event|1|||
130699470|NCT00687739|470524697|FG003|Overall Study|Adverse Event|0|||
130699471|NCT01957150|470524699|FG000|Overall Study|Adverse Event|23|||
130699472|NCT01957150|470524700|FG001|Overall Study|Adverse Event|20|||
130699473|NCT01957150|470524699|FG000|Overall Study|Withdrawal by Subject|13|||
130699474|NCT01957150|470524700|FG001|Overall Study|Withdrawal by Subject|17|||
130699475|NCT01957150|470524699|FG000|Overall Study|Physician Decision|3|||
130699476|NCT01957150|470524700|FG001|Overall Study|Physician Decision|6|||
130699477|NCT01957150|470524699|FG000|Overall Study|Lost to Follow-up|4|||
130699478|NCT01957150|470524700|FG001|Overall Study|Lost to Follow-up|4|||
130699479|NCT01957150|470524699|FG000|Overall Study|Protocol Violation|1|||
130699480|NCT01957150|470524700|FG001|Overall Study|Protocol Violation|0|||
130699481|NCT01957150|470524699|FG000|Overall Study|Lack of Efficacy|11|||
130699482|NCT01957150|470524700|FG001|Overall Study|Lack of Efficacy|11|||
130699483|NCT02451358|470524703|FG000|Overall Study|Withdrawal by Subject|1|||
130699484|NCT02451358|470524704|FG001|Overall Study|Withdrawal by Subject|1|||
130699485|NCT02451358|470524705|FG002|Overall Study|Withdrawal by Subject|0|||
130699486|NCT02451358|470524706|FG003|Overall Study|Withdrawal by Subject|0|||
130699487|NCT02451358|470524703|FG000|Overall Study|Protocol Violation|0|||
130699488|NCT02451358|470524704|FG001|Overall Study|Protocol Violation|1|||
130699489|NCT02451358|470524705|FG002|Overall Study|Protocol Violation|1|||
130699490|NCT02451358|470524706|FG003|Overall Study|Protocol Violation|0|||
130699491|NCT00252564|470524711|FG000|Overall Study|Adverse Event|17|||
130699492|NCT00252564|470524712|FG001|Overall Study|Adverse Event|13|||
130699493|NCT00252564|470524711|FG000|Overall Study|Unrelated Complication|2|||
130699494|NCT00252564|470524712|FG001|Overall Study|Unrelated Complication|1|||
130699495|NCT00252564|470524711|FG000|Overall Study|Disease Progression|14|||
130699496|NCT00252564|470524712|FG001|Overall Study|Disease Progression|20|||
130699497|NCT00252564|470524711|FG000|Overall Study|Death|0|||
130699498|NCT00252564|470524712|FG001|Overall Study|Death|3|||
130699499|NCT00252564|470524711|FG000|Overall Study|Physician Decision|1|||
130699500|NCT00252564|470524712|FG001|Overall Study|Physician Decision|0|||
130699501|NCT00252564|470524711|FG000|Overall Study|Lost to Follow-up|1|||
130699502|NCT00252564|470524712|FG001|Overall Study|Lost to Follow-up|0|||
130699503|NCT00252564|470524711|FG000|Overall Study|Patient Request|4|||
130699504|NCT00252564|470524712|FG001|Overall Study|Patient Request|5|||
130699505|NCT00252564|470524711|FG000|Overall Study|Withdrawal by Subject|0|||
130363918|NCT02202980|469302047|FG009|Overall Study|Lack of Efficacy|0|||
130363919|NCT02202980|469302048|FG010|Overall Study|Lack of Efficacy|0|||
130699506|NCT00252564|470524712|FG001|Overall Study|Withdrawal by Subject|2|||
130699507|NCT03414034|470524716|FG000|Overall Study|Adverse Event|6|||
130363920|NCT02202980|469302049|FG011|Overall Study|Lack of Efficacy|3|||
130363921|NCT02202980|469302050|FG012|Overall Study|Lack of Efficacy|10|||
130699508|NCT03414034|470524717|FG001|Overall Study|Adverse Event|1|||
130699509|NCT03414034|470524718|FG002|Overall Study|Adverse Event|1|||
130699510|NCT03414034|470524716|FG000|Overall Study|Death|0|||
130699511|NCT03414034|470524717|FG001|Overall Study|Death|0|||
130699512|NCT03414034|470524718|FG002|Overall Study|Death|1|||
130699513|NCT03414034|470524716|FG000|Overall Study|Non-compliance With Study Drug|0|||
130699514|NCT03414034|470524717|FG001|Overall Study|Non-compliance With Study Drug|0|||
130699515|NCT03414034|470524718|FG002|Overall Study|Non-compliance With Study Drug|1|||
130699516|NCT03414034|470524716|FG000|Overall Study|Physician Decision|1|||
130699517|NCT03414034|470524717|FG001|Overall Study|Physician Decision|3|||
130247674|NCT00086307|468867912|FG000|Overall Study|Lack of Efficacy|1|||
130247675|NCT00086307|468867913|FG001|Overall Study|Lack of Efficacy|1|||
130247676|NCT00086307|468867914|FG002|Overall Study|Lack of Efficacy|2|||
130699518|NCT03414034|470524718|FG002|Overall Study|Physician Decision|2|||
130247677|NCT00086307|468867912|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
130247678|NCT00086307|468867913|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
130247679|NCT00086307|468867914|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
130247680|NCT00086307|468867912|FG000|Overall Study|Nausea and headaches|0|||
130247681|NCT00086307|468867913|FG001|Overall Study|Nausea and headaches|0|||
130247682|NCT00086307|468867914|FG002|Overall Study|Nausea and headaches|1|||
130247683|NCT00086307|468867912|FG000|Overall Study|Constipation and sleepiness|0|||
130247684|NCT00086307|468867913|FG001|Overall Study|Constipation and sleepiness|0|||
130247685|NCT00086307|468867914|FG002|Overall Study|Constipation and sleepiness|1|||
130247686|NCT00086307|468867912|FG000|Overall Study|Suicidal ideation|0|||
130247687|NCT00086307|468867913|FG001|Overall Study|Suicidal ideation|0|||
130247688|NCT00086307|468867914|FG002|Overall Study|Suicidal ideation|1|||
130247689|NCT00086307|468867912|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
130247690|NCT00086307|468867913|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
130247691|NCT00086307|468867914|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
130247692|NCT00086307|468867912|FG000|Overall Study|Withdrawal by Subject|0|||
130247693|NCT00086307|468867913|FG001|Overall Study|Withdrawal by Subject|0|||
130247694|NCT00086307|468867914|FG002|Overall Study|Withdrawal by Subject|2|||
130247695|NCT00362609|468867915|FG000|Overall Study|Withdrawal by Subject|0|||
130247696|NCT00362609|468867916|FG001|Overall Study|Withdrawal by Subject|1|||
130247697|NCT00362609|468867915|FG000|Overall Study|Protocol Violation|0|||
130247698|NCT00362609|468867916|FG001|Overall Study|Protocol Violation|1|||
130247699|NCT01800058|468867918|FG000|Overall Study|Lost to Follow-up|1|||
130247700|NCT03787212|468869666|FG000|Period 1|Study Termination|2|||
130247701|NCT03787212|468869667|FG001|Period 1|Study Termination|2|||
130247702|NCT04193176|468869668|FG000|Overall Study|Withdrawal by Subject|6|||
130247703|NCT04193176|468869669|FG001|Overall Study|Withdrawal by Subject|10|||
130247704|NCT02370394|468869670|FG000|Overall Study|Lost to Follow-up|2|||
130247705|NCT02370394|468869671|FG001|Overall Study|Lost to Follow-up|1|||
130247706|NCT02370394|468869670|FG000|Overall Study|Withdrawal by Subject|0|||
130247707|NCT02370394|468869671|FG001|Overall Study|Withdrawal by Subject|1|||
130247708|NCT00520572|468869673|FG000|Overall Study|Adverse Event|9|||
130247709|NCT00520572|468869674|FG001|Overall Study|Adverse Event|3|||
130247710|NCT00520572|468869675|FG002|Overall Study|Adverse Event|6|||
130247711|NCT00520572|468869676|FG003|Overall Study|Adverse Event|9|||
130247712|NCT00520572|468869677|FG004|Overall Study|Adverse Event|7|||
130247713|NCT00520572|468869678|FG005|Overall Study|Adverse Event|2|||
130247714|NCT00520572|468869673|FG000|Overall Study|Withdrawal by Subject|0|||
130247715|NCT00520572|468869674|FG001|Overall Study|Withdrawal by Subject|9|||
130247716|NCT00520572|468869675|FG002|Overall Study|Withdrawal by Subject|5|||
130247717|NCT00520572|468869676|FG003|Overall Study|Withdrawal by Subject|2|||
130247718|NCT00520572|468869677|FG004|Overall Study|Withdrawal by Subject|2|||
130247719|NCT00520572|468869678|FG005|Overall Study|Withdrawal by Subject|0|||
130247720|NCT00520572|468869673|FG000|Overall Study|Protocol Violation|0|||
130247721|NCT00520572|468869674|FG001|Overall Study|Protocol Violation|0|||
130247722|NCT00520572|468869675|FG002|Overall Study|Protocol Violation|1|||
130247723|NCT00520572|468869676|FG003|Overall Study|Protocol Violation|0|||
130247724|NCT00520572|468869677|FG004|Overall Study|Protocol Violation|0|||
130247725|NCT00520572|468869678|FG005|Overall Study|Protocol Violation|0|||
130247726|NCT00520572|468869673|FG000|Overall Study|Lack of Efficacy|1|||
130699519|NCT03414034|470524716|FG000|Overall Study|Withdrawal of Informed Consent|2|||
130247727|NCT00520572|468869674|FG001|Overall Study|Lack of Efficacy|1|||
130247728|NCT00520572|468869675|FG002|Overall Study|Lack of Efficacy|1|||
130247729|NCT00520572|468869676|FG003|Overall Study|Lack of Efficacy|2|||
130247730|NCT00520572|468869677|FG004|Overall Study|Lack of Efficacy|1|||
130247731|NCT00520572|468869678|FG005|Overall Study|Lack of Efficacy|0|||
130247732|NCT00520572|468869673|FG000|Overall Study|Lost to Follow-up|0|||
130363922|NCT02202980|469302051|FG013|Overall Study|Lack of Efficacy|0|||
130363923|NCT02202980|469302038|FG000|Overall Study|Protocol Violation|0|||
130363924|NCT02202980|469302039|FG001|Overall Study|Protocol Violation|0|||
130363925|NCT02202980|469302040|FG002|Overall Study|Protocol Violation|0|||
130363926|NCT02202980|469302041|FG003|Overall Study|Protocol Violation|3|||
130363927|NCT02202980|469302042|FG004|Overall Study|Protocol Violation|3|||
130363928|NCT02202980|469302043|FG005|Overall Study|Protocol Violation|0|||
130363929|NCT02202980|469302044|FG006|Overall Study|Protocol Violation|0|||
130363930|NCT02202980|469302045|FG007|Overall Study|Protocol Violation|0|||
130363931|NCT02202980|469302046|FG008|Overall Study|Protocol Violation|0|||
130363932|NCT02202980|469302047|FG009|Overall Study|Protocol Violation|0|||
130247733|NCT00520572|468869674|FG001|Overall Study|Lost to Follow-up|0|||
130247734|NCT00520572|468869675|FG002|Overall Study|Lost to Follow-up|0|||
130247735|NCT00520572|468869676|FG003|Overall Study|Lost to Follow-up|0|||
130247736|NCT00520572|468869677|FG004|Overall Study|Lost to Follow-up|1|||
130247737|NCT00520572|468869678|FG005|Overall Study|Lost to Follow-up|0|||
130247738|NCT00520572|468869673|FG000|Overall Study|Incorrect enrollment|1|||
130247739|NCT00520572|468869674|FG001|Overall Study|Incorrect enrollment|0|||
130247740|NCT00520572|468869675|FG002|Overall Study|Incorrect enrollment|1|||
130363933|NCT02202980|469302048|FG010|Overall Study|Protocol Violation|0|||
130247741|NCT00520572|468869676|FG003|Overall Study|Incorrect enrollment|0|||
130247742|NCT00520572|468869677|FG004|Overall Study|Incorrect enrollment|1|||
130247743|NCT00520572|468869678|FG005|Overall Study|Incorrect enrollment|0|||
130247744|NCT00520572|468869673|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247745|NCT00520572|468869674|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
130247746|NCT00520572|468869675|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247747|NCT00520572|468869676|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247748|NCT00520572|468869677|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247749|NCT00520572|468869678|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247750|NCT00520572|468869673|FG000|Overall Study|Long break in taking Medication|0|||
130247751|NCT00520572|468869674|FG001|Overall Study|Long break in taking Medication|0|||
130247752|NCT00520572|468869675|FG002|Overall Study|Long break in taking Medication|0|||
130247753|NCT00520572|468869676|FG003|Overall Study|Long break in taking Medication|1|||
130247754|NCT00520572|468869677|FG004|Overall Study|Long break in taking Medication|0|||
130247755|NCT00520572|468869678|FG005|Overall Study|Long break in taking Medication|0|||
130247756|NCT00520572|468869673|FG000|Overall Study|Did not receive Treatment|1|||
130247757|NCT00520572|468869674|FG001|Overall Study|Did not receive Treatment|0|||
130247758|NCT00520572|468869675|FG002|Overall Study|Did not receive Treatment|1|||
130247759|NCT00520572|468869676|FG003|Overall Study|Did not receive Treatment|0|||
130247760|NCT00520572|468869677|FG004|Overall Study|Did not receive Treatment|0|||
130247761|NCT00520572|468869678|FG005|Overall Study|Did not receive Treatment|0|||
130247762|NCT02181621|468869679|FG000|Overall Study|Adverse Event|1|||
130247763|NCT02181621|468869680|FG001|Overall Study|Adverse Event|0|||
130247764|NCT02181621|468869679|FG000|Overall Study|Previously Enrolled|0|||
130247765|NCT02181621|468869680|FG001|Overall Study|Previously Enrolled|1|||
130247766|NCT02181621|468869679|FG000|Overall Study|Enrollment Hold|1|||
130247767|NCT02181621|468869680|FG001|Overall Study|Enrollment Hold|1|||
130247768|NCT00960856|468869681|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247769|NCT00960856|468869682|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130247770|NCT00960856|468869683|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247771|NCT00960856|468869684|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247772|NCT00960856|468869681|FG000|Washout Period of 7 Days|Adverse Event|0|||
130247773|NCT00960856|468869682|FG001|Washout Period of 7 Days|Adverse Event|0|||
130247774|NCT00960856|468869683|FG002|Washout Period of 7 Days|Adverse Event|1|||
130247775|NCT00960856|468869684|FG003|Washout Period of 7 Days|Adverse Event|0|||
130247776|NCT00337194|468869687|FG000|Overall Study|Adverse Event|5|||
130247777|NCT00337194|468869688|FG001|Overall Study|Adverse Event|1|||
130247778|NCT00337194|468869687|FG000|Overall Study|Death|2|||
130247779|NCT00337194|468869688|FG001|Overall Study|Death|0|||
130247780|NCT00337194|468869687|FG000|Overall Study|Withdrawal by Subject|1|||
130247781|NCT00337194|468869688|FG001|Overall Study|Withdrawal by Subject|0|||
130247782|NCT00337194|468869687|FG000|Overall Study|Disease progression|1|||
130247783|NCT00337194|468869688|FG001|Overall Study|Disease progression|2|||
130247784|NCT00337194|468869687|FG000|Overall Study|Subsequent non-protocol therapy|3|||
130247785|NCT00337194|468869688|FG001|Overall Study|Subsequent non-protocol therapy|1|||
130247786|NCT03188705|468869689|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
130699520|NCT03414034|470524717|FG001|Overall Study|Withdrawal of Informed Consent|1|||
130699521|NCT03414034|470524718|FG002|Overall Study|Withdrawal of Informed Consent|4|||
130699522|NCT03414034|470524716|FG000|Overall Study|Progressive Disease|15|||
130699523|NCT03414034|470524717|FG001|Overall Study|Progressive Disease|15|||
130699524|NCT03414034|470524718|FG002|Overall Study|Progressive Disease|17|||
130699525|NCT03414034|470524716|FG000|Overall Study|Miscellaneous|0|||
130247787|NCT03188705|468869689|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
130247788|NCT01174459|468869690|FG000|Overall Study|case report form (CRF) not collected|5|||
130247789|NCT01717859|468869692|FG000|Overall Study|Adverse Event|5|||
130247790|NCT01717859|468869692|FG000|Overall Study|Moved out of state|1|||
130247791|NCT01717859|468869692|FG000|Overall Study|Patient concerned about mental health|1|||
130247792|NCT01717859|468869692|FG000|Overall Study|Lost to Follow-up|1|||
130247793|NCT01717859|468869692|FG000|Overall Study|Withdrawal by Subject|2|||
130247794|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|No Data|249|||
130247795|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|No Data|66|||
130247796|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|No Data|2|||
130247797|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Other|33|||
130247798|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Other|20|||
130247799|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Other|0|||
130247800|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
130247801|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
130247802|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
130452132|NCT02624778|469619756|FG001|Overall Study|Withdrawal by Subject|1|||
130452133|NCT02624778|469619757|FG002|Overall Study|Withdrawal by Subject|0|||
130699526|NCT03414034|470524717|FG001|Overall Study|Miscellaneous|0|||
130699527|NCT03414034|470524718|FG002|Overall Study|Miscellaneous|2|||
130247803|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
130247804|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
130452134|NCT02624778|469619758|FG003|Overall Study|Withdrawal by Subject|0|||
130452135|NCT02624778|469619759|FG004|Overall Study|Withdrawal by Subject|0|||
130452136|NCT02624778|469619760|FG005|Overall Study|Withdrawal by Subject|1|||
130452137|NCT02624778|469619761|FG006|Overall Study|Withdrawal by Subject|1|||
130452138|NCT02624778|469619762|FG007|Overall Study|Withdrawal by Subject|1|||
130452139|NCT02624778|469619763|FG008|Overall Study|Withdrawal by Subject|1|||
130452140|NCT02624778|469619755|FG000|Overall Study|Adverse Event|0|||
130452141|NCT02624778|469619756|FG001|Overall Study|Adverse Event|0|||
130452142|NCT02624778|469619757|FG002|Overall Study|Adverse Event|0|||
130452143|NCT02624778|469619758|FG003|Overall Study|Adverse Event|0|||
130452144|NCT02624778|469619759|FG004|Overall Study|Adverse Event|0|||
130452145|NCT02624778|469619760|FG005|Overall Study|Adverse Event|0|||
130452146|NCT02624778|469619761|FG006|Overall Study|Adverse Event|0|||
130452147|NCT02624778|469619762|FG007|Overall Study|Adverse Event|0|||
130452148|NCT02624778|469619763|FG008|Overall Study|Adverse Event|2|||
130452149|NCT02624778|469619755|FG000|Overall Study|Death|0|||
130452150|NCT02624778|469619756|FG001|Overall Study|Death|0|||
130452151|NCT02624778|469619757|FG002|Overall Study|Death|0|||
130452152|NCT02624778|469619758|FG003|Overall Study|Death|0|||
130452153|NCT02624778|469619759|FG004|Overall Study|Death|0|||
130452154|NCT02624778|469619760|FG005|Overall Study|Death|0|||
130452155|NCT02624778|469619761|FG006|Overall Study|Death|1|||
130452156|NCT02624778|469619762|FG007|Overall Study|Death|0|||
130452157|NCT02624778|469619763|FG008|Overall Study|Death|0|||
130452158|NCT02624778|469619755|FG000|Overall Study|Physician Decision|0|||
130452159|NCT02624778|469619756|FG001|Overall Study|Physician Decision|0|||
130452160|NCT02624778|469619757|FG002|Overall Study|Physician Decision|0|||
130452161|NCT02624778|469619758|FG003|Overall Study|Physician Decision|0|||
130452162|NCT02624778|469619759|FG004|Overall Study|Physician Decision|0|||
130452163|NCT02624778|469619760|FG005|Overall Study|Physician Decision|0|||
130452164|NCT02624778|469619761|FG006|Overall Study|Physician Decision|0|||
130452165|NCT02624778|469619762|FG007|Overall Study|Physician Decision|3|||
130452166|NCT02624778|469619763|FG008|Overall Study|Physician Decision|3|||
130452167|NCT01537133|469619771|FG000|Overall Study|Withdrawal by Subject|2|||
130452168|NCT01537133|469619772|FG001|Overall Study|Withdrawal by Subject|0|||
130452169|NCT01537133|469619773|FG002|Overall Study|Withdrawal by Subject|0|||
130452170|NCT01537133|469619774|FG003|Overall Study|Withdrawal by Subject|0|||
130452171|NCT01537133|469619771|FG000|Overall Study|Lost to Follow-up|1|||
130452172|NCT01537133|469619772|FG001|Overall Study|Lost to Follow-up|0|||
130452173|NCT01537133|469619773|FG002|Overall Study|Lost to Follow-up|0|||
130452174|NCT01537133|469619774|FG003|Overall Study|Lost to Follow-up|0|||
130452175|NCT00531479|469619775|FG000|Overall Study|Death|68|||
130452176|NCT00531479|469619776|FG001|Overall Study|Death|71|||
130452177|NCT00531479|469619775|FG000|Overall Study|Lost to Follow-up|0|||
130452178|NCT00531479|469619776|FG001|Overall Study|Lost to Follow-up|2|||
130452179|NCT00531479|469619775|FG000|Overall Study|Other|0|||
130452180|NCT00531479|469619776|FG001|Overall Study|Other|1|||
130452181|NCT00531479|469619775|FG000|Overall Study|Withdrawal by Subject|6|||
130452182|NCT00531479|469619776|FG001|Overall Study|Withdrawal by Subject|6|||
130452183|NCT00531479|469619775|FG000|Overall Study|Did not receive treatment|2|||
130452184|NCT00531479|469619776|FG001|Overall Study|Did not receive treatment|3|||
130452185|NCT02501629|469619784|FG000|Overall Study|Death|0|||
130452186|NCT02501629|469619785|FG001|Overall Study|Death|1|||
130452187|NCT02501629|469619784|FG000|Overall Study|Withdrawn from study by sponsor|1|||
130452188|NCT02501629|469619785|FG001|Overall Study|Withdrawn from study by sponsor|0|||
130452189|NCT02501629|469619784|FG000|Overall Study|Early termination by sponsor|1|||
130452190|NCT02501629|469619785|FG001|Overall Study|Early termination by sponsor|0|||
130452191|NCT02501629|469619784|FG000|Overall Study|Withdrawal by Subject|3|||
130452192|NCT02501629|469619785|FG001|Overall Study|Withdrawal by Subject|5|||
130452193|NCT02501629|469619784|FG000|Overall Study|Subject did not return to site|0|||
130247805|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
130452194|NCT02501629|469619785|FG001|Overall Study|Subject did not return to site|1|||
130452195|NCT00868231|469619788|FG000|Treatment Period 1|Adverse Event|0|||
130452196|NCT00868231|469619789|FG001|Treatment Period 1|Adverse Event|0|||
130452197|NCT00868231|469619790|FG002|Treatment Period 1|Adverse Event|0|||
130452198|NCT00868231|469619791|FG003|Treatment Period 1|Adverse Event|0|||
130452199|NCT00868231|469619792|FG004|Treatment Period 1|Adverse Event|1|||
130452200|NCT00868231|469619793|FG005|Treatment Period 1|Adverse Event|0|||
130452201|NCT00868231|469619788|FG000|Treatment Period 2|Adverse Event|1|||
130452202|NCT00868231|469619789|FG001|Treatment Period 2|Adverse Event|0|||
130452203|NCT00868231|469619790|FG002|Treatment Period 2|Adverse Event|0|||
130452204|NCT00868231|469619791|FG003|Treatment Period 2|Adverse Event|0|||
130452205|NCT00868231|469619792|FG004|Treatment Period 2|Adverse Event|0|||
130452206|NCT00868231|469619793|FG005|Treatment Period 2|Adverse Event|0|||
130452207|NCT00868231|469619788|FG000|Treatment Period 3|Adverse Event|0|||
130452208|NCT00868231|469619789|FG001|Treatment Period 3|Adverse Event|0|||
130452209|NCT00868231|469619790|FG002|Treatment Period 3|Adverse Event|1|||
130452210|NCT00868231|469619791|FG003|Treatment Period 3|Adverse Event|0|||
130452211|NCT00868231|469619792|FG004|Treatment Period 3|Adverse Event|0|||
130452212|NCT00868231|469619793|FG005|Treatment Period 3|Adverse Event|0|||
130452213|NCT00601640|469619801|FG000|Overall Study|Withdrawal by Subject|3|||
130247806|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
130247807|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
130247808|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
130247809|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Other|5|||
130247810|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Other|1|||
130247811|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Other|0|||
130247812|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|No Data|43|||
130247813|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|No Data|11|||
130247814|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|No Data|0|||
130247815|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
130247816|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
130247817|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
130247818|NCT03994120|468869696|FG000|Overall Study|Lost to Follow-up|3|||
130247819|NCT03994120|468869697|FG001|Overall Study|Lost to Follow-up|1|||
130247820|NCT01111292|468869698|FG000|Treatment|Physician Decision|1|||
130247821|NCT01111292|468869699|FG001|Treatment|Physician Decision|1|||
130247822|NCT00564070|468869702|FG000|Overall Study|Lost to Follow-up|9|||
130247823|NCT00564070|468869703|FG001|Overall Study|Lost to Follow-up|7|||
130247824|NCT00564070|468869702|FG000|Overall Study|Worsening depression, referred to care|3|||
130247825|NCT00564070|468869703|FG001|Overall Study|Worsening depression, referred to care|0|||
130247826|NCT03142334|468869707|FG000|Overall Study|Death|18|||
130247827|NCT03142334|468869708|FG001|Overall Study|Death|33|||
130247828|NCT03142334|468869707|FG000|Overall Study|Withdrawal by Subject|15|||
130247829|NCT03142334|468869708|FG001|Overall Study|Withdrawal by Subject|11|||
130247830|NCT03142334|468869707|FG000|Overall Study|Ongoing on trial follow up|463|||
130247831|NCT03142334|468869708|FG001|Overall Study|Ongoing on trial follow up|454|||
130247832|NCT01217047|468869709|FG000|Overall Study|Lost to Follow-up|0|||
130247833|NCT01217047|468869710|FG001|Overall Study|Lost to Follow-up|1|||
130247834|NCT01217047|468869711|FG002|Overall Study|Lost to Follow-up|0|||
130452214|NCT00601640|469619802|FG001|Overall Study|Withdrawal by Subject|0|||
130452215|NCT00601640|469619803|FG002|Overall Study|Withdrawal by Subject|7|||
130452216|NCT00601640|469619801|FG000|Overall Study|Death|1|||
130452217|NCT00601640|469619802|FG001|Overall Study|Death|0|||
130452218|NCT00601640|469619803|FG002|Overall Study|Death|0|||
130452219|NCT00601640|469619801|FG000|Overall Study|Adverse Event|0|||
130452220|NCT00601640|469619802|FG001|Overall Study|Adverse Event|4|||
130452221|NCT00601640|469619803|FG002|Overall Study|Adverse Event|2|||
130452222|NCT00601640|469619801|FG000|Overall Study|intercurrent illness|1|||
130452223|NCT00601640|469619802|FG001|Overall Study|intercurrent illness|0|||
130452224|NCT00601640|469619803|FG002|Overall Study|intercurrent illness|0|||
130452225|NCT00601640|469619801|FG000|Overall Study|change in eligibility status|0|||
130452226|NCT00601640|469619802|FG001|Overall Study|change in eligibility status|1|||
130452227|NCT00601640|469619803|FG002|Overall Study|change in eligibility status|1|||
130452228|NCT00530777|469619804|FG000|Overall Study|Lost to Follow-up|0|||
130452229|NCT00530777|469619805|FG001|Overall Study|Lost to Follow-up|1|||
130452230|NCT00530777|469619804|FG000|Overall Study|Death|1|||
130452231|NCT00530777|469619805|FG001|Overall Study|Death|2|||
130452232|NCT00530777|469619804|FG000|Overall Study|Physician Decision|1|||
130452233|NCT00530777|469619805|FG001|Overall Study|Physician Decision|0|||
130452234|NCT00530777|469619804|FG000|Overall Study|Withdrawal by Subject|0|||
130452235|NCT00530777|469619805|FG001|Overall Study|Withdrawal by Subject|1|||
130452236|NCT00530777|469619804|FG000|Overall Study|Unable to adhere to visit schedule|5|||
130452237|NCT00530777|469619805|FG001|Overall Study|Unable to adhere to visit schedule|1|||
130452238|NCT03382821|469619812|FG000|Overall Study|Did not receive allocated intervention.|0|||
130452239|NCT03382821|469619813|FG001|Overall Study|Did not receive allocated intervention.|3|||
130452240|NCT00282438|469619814|FG000|Overall Study|Lack of Efficacy|1|||
130452241|NCT00282438|469619815|FG001|Overall Study|Lack of Efficacy|0|||
130452242|NCT00282438|469619814|FG000|Overall Study|Death|0|||
130452243|NCT00282438|469619815|FG001|Overall Study|Death|1|||
130452244|NCT01008748|469619825|FG000|Overall Study|Lost to Follow-up|80|||
130452245|NCT01008748|469619825|FG000|Overall Study|Other|1|||
130452246|NCT02775435|469619826|FG000|Overall Study|Adverse Event|32|||
130452247|NCT02775435|469619827|FG001|Overall Study|Adverse Event|27|||
130452248|NCT02775435|469619826|FG000|Overall Study|Lost to Follow-up|2|||
130452249|NCT02775435|469619827|FG001|Overall Study|Lost to Follow-up|2|||
130452250|NCT02775435|469619826|FG000|Overall Study|Sponsor decision|44|||
130452251|NCT02775435|469619827|FG001|Overall Study|Sponsor decision|19|||
130452252|NCT02775435|469619826|FG000|Overall Study|Withdrawal by Subject|4|||
130452253|NCT02775435|469619827|FG001|Overall Study|Withdrawal by Subject|9|||
130247835|NCT05529173|468869712|FG000|Overall Study|Physician Decision|3|||
130247836|NCT05529173|468869713|FG001|Overall Study|Physician Decision|6|||
130247837|NCT05529173|468869712|FG000|Overall Study|Sample shipment delay more than one day|4|||
130247838|NCT05529173|468869713|FG001|Overall Study|Sample shipment delay more than one day|0|||
130247839|NCT00609973|468869722|FG000|Overall Study|Adverse Event|2|||
130247840|NCT00609973|468869723|FG001|Overall Study|Adverse Event|1|||
130247841|NCT00609973|468869722|FG000|Overall Study|Protocol Violation|4|||
130247842|NCT00609973|468869723|FG001|Overall Study|Protocol Violation|3|||
130452254|NCT02775435|469619826|FG000|Overall Study|Death|196|||
130452255|NCT02775435|469619827|FG001|Overall Study|Death|224|||
130247843|NCT00609973|468869722|FG000|Overall Study|Lost to Follow-up|2|||
130247844|NCT00609973|468869723|FG001|Overall Study|Lost to Follow-up|1|||
130247845|NCT00609973|468869722|FG000|Overall Study|Withdrawal by Subject|0|||
130247846|NCT00609973|468869723|FG001|Overall Study|Withdrawal by Subject|1|||
130247847|NCT00191152|468869724|FG000|Initial Treatment|Adverse Event|43|||
130247848|NCT00191152|468869725|FG001|Initial Treatment|Adverse Event|67|||
130247849|NCT00191152|468869724|FG000|Initial Treatment|Physician Decision|40|||
130247850|NCT00191152|468869725|FG001|Initial Treatment|Physician Decision|31|||
130247851|NCT00191152|468869724|FG000|Initial Treatment|Withdrawal by Subject|40|||
130247852|NCT00191152|468869725|FG001|Initial Treatment|Withdrawal by Subject|28|||
130247853|NCT00191152|468869724|FG000|Initial Treatment|Lost to Follow-up|0|||
130247854|NCT00191152|468869725|FG001|Initial Treatment|Lost to Follow-up|6|||
130247855|NCT00191152|468869724|FG000|Initial Treatment|Other|18|||
130247856|NCT00191152|468869725|FG001|Initial Treatment|Other|21|||
130247857|NCT00191152|468869724|FG000|Crossover Treatment|Adverse Event|8|||
130247858|NCT00191152|468869725|FG001|Crossover Treatment|Adverse Event|8|||
130247859|NCT00191152|468869724|FG000|Crossover Treatment|Physician Decision|7|||
130247860|NCT00191152|468869725|FG001|Crossover Treatment|Physician Decision|7|||
130247861|NCT00191152|468869724|FG000|Crossover Treatment|Withdrawal by Subject|6|||
130247862|NCT00191152|468869725|FG001|Crossover Treatment|Withdrawal by Subject|9|||
130247863|NCT00191152|468869724|FG000|Crossover Treatment|Lost to Follow-up|2|||
130247864|NCT00191152|468869725|FG001|Crossover Treatment|Lost to Follow-up|1|||
130247865|NCT00191152|468869724|FG000|Crossover Treatment|Other|4|||
130247866|NCT00191152|468869725|FG001|Crossover Treatment|Other|3|||
130247867|NCT00114777|468869726|FG000|Randomization to Month 36|Death|10|||
130247868|NCT00114777|468869727|FG001|Randomization to Month 36|Death|4|||
130247869|NCT00114777|468869728|FG002|Randomization to Month 36|Death|3|||
130247870|NCT00114777|468869726|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
130247871|NCT00114777|468869727|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
130247872|NCT00114777|468869728|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
130247873|NCT00114777|468869726|FG000|Randomization to Month 36|Lack of Efficacy|19|||
130247874|NCT00114777|468869727|FG001|Randomization to Month 36|Lack of Efficacy|15|||
130247875|NCT00114777|468869728|FG002|Randomization to Month 36|Lack of Efficacy|17|||
130247876|NCT00114777|468869726|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
130247877|NCT00114777|468869727|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
130247878|NCT00114777|468869728|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
130247879|NCT00114777|468869726|FG000|Randomization to Month 36|Adverse Event|34|||
130247880|NCT00114777|468869727|FG001|Randomization to Month 36|Adverse Event|35|||
130247881|NCT00114777|468869728|FG002|Randomization to Month 36|Adverse Event|44|||
130247882|NCT00114777|468869726|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
130247883|NCT00114777|468869727|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
130247884|NCT00114777|468869728|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
130247885|NCT00114777|468869726|FG000|Randomization to Month 36|Other|9|||
130247886|NCT00114777|468869727|FG001|Randomization to Month 36|Other|3|||
130247887|NCT00114777|468869728|FG002|Randomization to Month 36|Other|12|||
130247888|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Death|8|||
130247889|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Death|13|||
130247890|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Death|7|||
130247891|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130247892|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
130247893|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130247894|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130247895|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
130247896|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130363934|NCT02202980|469302049|FG011|Overall Study|Protocol Violation|0|||
130363935|NCT02202980|469302050|FG012|Overall Study|Protocol Violation|0|||
130363936|NCT02202980|469302051|FG013|Overall Study|Protocol Violation|0|||
130363937|NCT02202980|469302038|FG000|Overall Study|Lost to Follow-up|0|||
130363938|NCT02202980|469302039|FG001|Overall Study|Lost to Follow-up|1|||
130363939|NCT02202980|469302040|FG002|Overall Study|Lost to Follow-up|1|||
130363940|NCT02202980|469302041|FG003|Overall Study|Lost to Follow-up|1|||
130363941|NCT02202980|469302042|FG004|Overall Study|Lost to Follow-up|0|||
130363942|NCT02202980|469302043|FG005|Overall Study|Lost to Follow-up|0|||
130363943|NCT02202980|469302044|FG006|Overall Study|Lost to Follow-up|0|||
130363944|NCT02202980|469302045|FG007|Overall Study|Lost to Follow-up|1|||
130247897|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130247898|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130247899|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
130247900|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
130247901|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
130247902|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
130247903|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
130247904|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
130452256|NCT03537651|469619830|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
130699528|NCT01332968|470524719|FG000|Induction Period|Adverse Event|23|||
130247905|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
130247906|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130247907|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130247908|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
130247909|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130247910|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130247911|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
130247912|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Other|2|||
130247913|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Other|0|||
130247914|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Other|2|||
130247915|NCT00629239|468869733|FG000|Overall Study|Adverse Event|7|||
130247916|NCT00629239|468869734|FG001|Overall Study|Adverse Event|4|||
130247917|NCT00629239|468869733|FG000|Overall Study|Physician Decision|1|||
130247918|NCT00629239|468869734|FG001|Overall Study|Physician Decision|0|||
130247919|NCT01851369|468869735|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247920|NCT01851369|468869736|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247921|NCT01851369|468869737|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247922|NCT01851369|468869738|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247923|NCT01851369|468869739|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247924|NCT01851369|468869740|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
130247925|NCT01851369|468869741|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247926|NCT01851369|468869742|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247927|NCT01851369|468869743|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247928|NCT01851369|468869744|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247929|NCT01851369|468869745|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247930|NCT01851369|468869746|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247931|NCT01851369|468869747|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247932|NCT02453191|468869750|FG000|Overall Study|Withdrawal by Subject|1|||
130247933|NCT01520714|468869751|FG000|Overall Study|Protocol Violation|0|||
130247934|NCT01520714|468869752|FG001|Overall Study|Protocol Violation|3|||
130247935|NCT01520714|468869751|FG000|Overall Study|Adverse Event|0|||
130247936|NCT01520714|468869752|FG001|Overall Study|Adverse Event|2|||
130247937|NCT01520714|468869751|FG000|Overall Study|Lack of Efficacy|0|||
130247938|NCT01520714|468869752|FG001|Overall Study|Lack of Efficacy|1|||
130247939|NCT00183391|468869753|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
130247940|NCT00183391|468869754|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
130247941|NCT00183391|468869753|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
130247942|NCT00183391|468869754|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
130247943|NCT02336503|468869756|FG000|Overall Study|Lost to Follow-up|0|||
130247944|NCT02336503|468869757|FG001|Overall Study|Lost to Follow-up|3|||
130247945|NCT02336503|468869758|FG002|Overall Study|Lost to Follow-up|0|||
130247946|NCT02336503|468869759|FG003|Overall Study|Lost to Follow-up|2|||
130247947|NCT02336503|468869756|FG000|Overall Study|Withdrawal by Subject|2|||
130247948|NCT02336503|468869757|FG001|Overall Study|Withdrawal by Subject|0|||
130247949|NCT02336503|468869758|FG002|Overall Study|Withdrawal by Subject|0|||
130247950|NCT02336503|468869759|FG003|Overall Study|Withdrawal by Subject|4|||
130247951|NCT02336503|468869756|FG000|Overall Study|Adverse Event|0|||
130247952|NCT02336503|468869757|FG001|Overall Study|Adverse Event|0|||
130247953|NCT02336503|468869758|FG002|Overall Study|Adverse Event|1|||
130247954|NCT02336503|468869759|FG003|Overall Study|Adverse Event|0|||
130247955|NCT02460380|468869760|FG000|Overall Study|Withdrawal by Subject|10|||
130247956|NCT02460380|468869761|FG001|Overall Study|Withdrawal by Subject|5|||
130247957|NCT00395512|468869762|FG000|Overall Study|Adverse Event|3|||
130247958|NCT00395512|468869763|FG001|Overall Study|Adverse Event|8|||
130247959|NCT00395512|468869764|FG002|Overall Study|Adverse Event|6|||
130247960|NCT00395512|468869765|FG003|Overall Study|Adverse Event|6|||
130247961|NCT00395512|468869762|FG000|Overall Study|Protocol Violation|2|||
130247962|NCT00395512|468869763|FG001|Overall Study|Protocol Violation|3|||
130247963|NCT00395512|468869764|FG002|Overall Study|Protocol Violation|6|||
130247964|NCT00395512|468869765|FG003|Overall Study|Protocol Violation|7|||
130247965|NCT00395512|468869762|FG000|Overall Study|Lost to Follow-up|2|||
130363945|NCT02202980|469302046|FG008|Overall Study|Lost to Follow-up|1|||
130247966|NCT00395512|468869763|FG001|Overall Study|Lost to Follow-up|6|||
130247967|NCT00395512|468869764|FG002|Overall Study|Lost to Follow-up|5|||
130247968|NCT00395512|468869765|FG003|Overall Study|Lost to Follow-up|5|||
130247969|NCT00395512|468869762|FG000|Overall Study|Withdrawal by Subject|6|||
130247970|NCT00395512|468869763|FG001|Overall Study|Withdrawal by Subject|5|||
130247971|NCT00395512|468869764|FG002|Overall Study|Withdrawal by Subject|5|||
130247972|NCT00395512|468869765|FG003|Overall Study|Withdrawal by Subject|12|||
130247973|NCT00395512|468869762|FG000|Overall Study|Physician Decision|6|||
130247974|NCT00395512|468869763|FG001|Overall Study|Physician Decision|4|||
130247975|NCT00395512|468869764|FG002|Overall Study|Physician Decision|2|||
130452257|NCT03537651|469619830|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
130452258|NCT03537651|469619830|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
130452259|NCT03537651|469619830|FG000|Part A (Up to 96 Weeks)|Other|1|||
130452260|NCT03537651|469619830|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
130452261|NCT03537651|469619830|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130452262|NCT03537651|469619830|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
130452263|NCT03537651|469619830|FG000|Part B (Up to 192 Weeks)|Other|1|||
130452264|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
130452265|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
130452266|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
130452267|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Death|3|||
130452268|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Death|0|||
130452269|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Death|0|||
130452270|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
130452271|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130452272|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130452273|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
130452274|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
130452275|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
130452276|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
130452277|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
130452278|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
130452279|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
130452280|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
130452281|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
130452282|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
130699529|NCT01332968|470524720|FG001|Induction Period|Adverse Event|26|||
130699530|NCT01332968|470524721|FG002|Induction Period|Adverse Event|0|||
130699531|NCT01332968|470524722|FG003|Induction Period|Adverse Event|0|||
130699532|NCT01332968|470524723|FG004|Induction Period|Adverse Event|0|||
130699533|NCT01332968|470524724|FG005|Induction Period|Adverse Event|0|||
130699534|NCT01332968|470524725|FG006|Induction Period|Adverse Event|0|||
130452283|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
130452284|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
130452285|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Other|1|||
130452286|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Other|0|||
130452287|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Other|0|||
130452288|NCT02403323|469619831|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
130452289|NCT02403323|469619832|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130452290|NCT02403323|469619833|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130452291|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130452292|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
130452293|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130452294|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
130452295|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
130452296|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
130452297|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
130452298|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
130452299|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
130452300|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130452301|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
130452302|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130452303|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130452304|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
130452305|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
130452306|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
130452307|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
130452308|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
130452309|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
130452310|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
130452311|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
130452312|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
130452313|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
130452314|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
130699535|NCT01332968|470524726|FG007|Induction Period|Adverse Event|0|||
130699536|NCT01332968|470524719|FG000|Induction Period|Death|1|||
130699537|NCT01332968|470524720|FG001|Induction Period|Death|4|||
130699538|NCT01332968|470524721|FG002|Induction Period|Death|0|||
130699539|NCT01332968|470524722|FG003|Induction Period|Death|0|||
130247976|NCT00395512|468869765|FG003|Overall Study|Physician Decision|2|||
130247977|NCT00395512|468869762|FG000|Overall Study|Other|1|||
130247978|NCT00395512|468869763|FG001|Overall Study|Other|1|||
130699540|NCT01332968|470524723|FG004|Induction Period|Death|0|||
130699541|NCT01332968|470524724|FG005|Induction Period|Death|0|||
130247979|NCT00395512|468869764|FG002|Overall Study|Other|0|||
130699542|NCT01332968|470524725|FG006|Induction Period|Death|0|||
130699543|NCT01332968|470524726|FG007|Induction Period|Death|0|||
130699544|NCT01332968|470524719|FG000|Induction Period|Non-compliance|1|||
130247980|NCT00395512|468869765|FG003|Overall Study|Other|0|||
130247981|NCT00395512|468869762|FG000|Overall Study|Hyperglycemic Rescue|18|||
130247982|NCT00395512|468869763|FG001|Overall Study|Hyperglycemic Rescue|10|||
130247983|NCT00395512|468869764|FG002|Overall Study|Hyperglycemic Rescue|4|||
130247984|NCT00395512|468869765|FG003|Overall Study|Hyperglycemic Rescue|6|||
130247985|NCT01986751|468869770|FG000|Overall Study|improperly consented|10|||
130247986|NCT01986751|468869771|FG001|Overall Study|improperly consented|2|||
130247987|NCT01478087|468869772|FG000|Overall Study|due to sponsor closing study|1|||
130363946|NCT02202980|469302047|FG009|Overall Study|Lost to Follow-up|0|||
130363947|NCT02202980|469302048|FG010|Overall Study|Lost to Follow-up|0|||
130363948|NCT02202980|469302049|FG011|Overall Study|Lost to Follow-up|0|||
130363949|NCT02202980|469302050|FG012|Overall Study|Lost to Follow-up|1|||
130363950|NCT02202980|469302051|FG013|Overall Study|Lost to Follow-up|0|||
130363951|NCT02202980|469302038|FG000|Overall Study|Withdrew Consent|0|||
130363952|NCT02202980|469302039|FG001|Overall Study|Withdrew Consent|1|||
130363953|NCT02202980|469302040|FG002|Overall Study|Withdrew Consent|2|||
130363954|NCT02202980|469302041|FG003|Overall Study|Withdrew Consent|0|||
130363955|NCT02202980|469302042|FG004|Overall Study|Withdrew Consent|0|||
130363956|NCT02202980|469302043|FG005|Overall Study|Withdrew Consent|0|||
130363957|NCT02202980|469302044|FG006|Overall Study|Withdrew Consent|0|||
130363958|NCT02202980|469302045|FG007|Overall Study|Withdrew Consent|0|||
130363959|NCT02202980|469302046|FG008|Overall Study|Withdrew Consent|1|||
130363960|NCT02202980|469302047|FG009|Overall Study|Withdrew Consent|0|||
130363961|NCT02202980|469302048|FG010|Overall Study|Withdrew Consent|0|||
130363962|NCT02202980|469302049|FG011|Overall Study|Withdrew Consent|0|||
130363963|NCT02202980|469302050|FG012|Overall Study|Withdrew Consent|0|||
130363964|NCT02202980|469302051|FG013|Overall Study|Withdrew Consent|0|||
130363965|NCT02130570|469302053|FG000|Overall Study|Death|3|||
130363966|NCT02130570|469302054|FG001|Overall Study|Death|5|||
130363967|NCT02130570|469302053|FG000|Overall Study|Withdrawal by Subject|6|||
130363968|NCT02130570|469302054|FG001|Overall Study|Withdrawal by Subject|3|||
130363969|NCT02130570|469302053|FG000|Overall Study|Part of practice that discontinued study|0|||
130363970|NCT02130570|469302054|FG001|Overall Study|Part of practice that discontinued study|5|||
130363971|NCT01696695|469302057|FG000|Overall Study|Disease progression|373|||
130363972|NCT01696695|469302057|FG000|Overall Study|Death|29|||
130363973|NCT01696695|469302057|FG000|Overall Study|Adverse Event|74|||
130363974|NCT01696695|469302057|FG000|Overall Study|Withdrawal by Subject|92|||
130363975|NCT01696695|469302057|FG000|Overall Study|Lost to Follow-up|48|||
130363976|NCT01696695|469302057|FG000|Overall Study|Other|74|||
130363977|NCT01696695|469302057|FG000|Overall Study|Major Protocol Violation|192|||
130363978|NCT01180647|469302060|FG000|Overall Study|Lost to Follow-up|5|||
130363979|NCT01180647|469302061|FG001|Overall Study|Lost to Follow-up|6|||
130363980|NCT00386607|469302062|FG000|Core|Adverse Event|40|||
130363981|NCT00386607|469302063|FG001|Core|Adverse Event|0|||
130363982|NCT00386607|469302062|FG000|Core|Abnormal laboratory value(s)|3|||
130363983|NCT00386607|469302063|FG001|Core|Abnormal laboratory value(s)|0|||
130363984|NCT00386607|469302062|FG000|Core|Unsatisfactory therapeutic effect|23|||
130363985|NCT00386607|469302063|FG001|Core|Unsatisfactory therapeutic effect|0|||
130363986|NCT00386607|469302062|FG000|Core|Condition no longer requires study drug|4|||
130363987|NCT00386607|469302063|FG001|Core|Condition no longer requires study drug|0|||
130363988|NCT00386607|469302062|FG000|Core|Patient withdrew consent|15|||
130363989|NCT00386607|469302063|FG001|Core|Patient withdrew consent|0|||
130363990|NCT00386607|469302062|FG000|Core|Lost to Follow-up|23|||
130363991|NCT00386607|469302063|FG001|Core|Lost to Follow-up|0|||
130363992|NCT00386607|469302062|FG000|Core|Administrative problems|1|||
130363993|NCT00386607|469302063|FG001|Core|Administrative problems|0|||
130363994|NCT00386607|469302062|FG000|Core|Protocol Deviation|6|||
130363995|NCT00386607|469302063|FG001|Core|Protocol Deviation|0|||
130363996|NCT00386607|469302062|FG000|Extension|Adverse Event|0|||
130247988|NCT03566550|468869773|FG000|Overall Study|Withdrawal by Subject|0|||
130363997|NCT00386607|469302063|FG001|Extension|Adverse Event|6|||
130363998|NCT00386607|469302062|FG000|Extension|Abnormal laboratory value(s)|0|||
130247989|NCT03566550|468869774|FG001|Overall Study|Withdrawal by Subject|1|||
130247990|NCT04576949|468869780|FG000|Overall Study|Adverse Event|1|||
130363999|NCT00386607|469302063|FG001|Extension|Abnormal laboratory value(s)|1|||
130364000|NCT00386607|469302062|FG000|Extension|Administrative problems|0|||
130364001|NCT00386607|469302063|FG001|Extension|Administrative problems|1|||
130364002|NCT00386607|469302062|FG000|Extension|Lost to Follow-up|0|||
130699545|NCT01332968|470524720|FG001|Induction Period|Non-compliance|0|||
130364003|NCT00386607|469302063|FG001|Extension|Lost to Follow-up|3|||
130364004|NCT00386607|469302062|FG000|Extension|Patient withdrew consent|0|||
130699546|NCT01332968|470524721|FG002|Induction Period|Non-compliance|0|||
130699547|NCT01332968|470524722|FG003|Induction Period|Non-compliance|0|||
130699548|NCT01332968|470524723|FG004|Induction Period|Non-compliance|0|||
130699549|NCT01332968|470524724|FG005|Induction Period|Non-compliance|0|||
130699550|NCT01332968|470524725|FG006|Induction Period|Non-compliance|0|||
130699551|NCT01332968|470524726|FG007|Induction Period|Non-compliance|0|||
130699552|NCT01332968|470524719|FG000|Induction Period|Other|2|||
130699553|NCT01332968|470524720|FG001|Induction Period|Other|2|||
130699554|NCT01332968|470524721|FG002|Induction Period|Other|0|||
130699555|NCT01332968|470524722|FG003|Induction Period|Other|0|||
130699556|NCT01332968|470524723|FG004|Induction Period|Other|0|||
130699557|NCT01332968|470524724|FG005|Induction Period|Other|0|||
130699558|NCT01332968|470524725|FG006|Induction Period|Other|0|||
130699559|NCT01332968|470524726|FG007|Induction Period|Other|0|||
130699560|NCT01332968|470524719|FG000|Induction Period|Physician Decision|6|||
130699561|NCT01332968|470524720|FG001|Induction Period|Physician Decision|1|||
130699562|NCT01332968|470524721|FG002|Induction Period|Physician Decision|0|||
130699563|NCT01332968|470524722|FG003|Induction Period|Physician Decision|0|||
130699564|NCT01332968|470524723|FG004|Induction Period|Physician Decision|0|||
130247991|NCT04576949|468869781|FG001|Overall Study|Adverse Event|3|||
130247992|NCT04576949|468869782|FG002|Overall Study|Adverse Event|2|||
130247993|NCT04576949|468869780|FG000|Overall Study|Withdrawal by Subject|41|||
130247994|NCT04576949|468869781|FG001|Overall Study|Withdrawal by Subject|26|||
130247995|NCT04576949|468869782|FG002|Overall Study|Withdrawal by Subject|18|||
130247996|NCT04576949|468869780|FG000|Overall Study|Physician Decision|3|||
130247997|NCT04576949|468869781|FG001|Overall Study|Physician Decision|0|||
130247998|NCT04576949|468869782|FG002|Overall Study|Physician Decision|0|||
130247999|NCT04576949|468869780|FG000|Overall Study|Death|0|||
130248000|NCT04576949|468869781|FG001|Overall Study|Death|1|||
130248001|NCT04576949|468869782|FG002|Overall Study|Death|0|||
130248002|NCT04576949|468869780|FG000|Overall Study|Lost to Follow-up|29|||
130248003|NCT04576949|468869781|FG001|Overall Study|Lost to Follow-up|37|||
130248004|NCT04576949|468869782|FG002|Overall Study|Lost to Follow-up|24|||
130248005|NCT04576949|468869780|FG000|Overall Study|Other, Not Specified|2|||
130248006|NCT04576949|468869781|FG001|Overall Study|Other, Not Specified|3|||
130248007|NCT04576949|468869782|FG002|Overall Study|Other, Not Specified|1|||
130248008|NCT04576949|468869780|FG000|Overall Study|Other|1|||
130248009|NCT04576949|468869781|FG001|Overall Study|Other|0|||
130248010|NCT04576949|468869782|FG002|Overall Study|Other|0|||
130248011|NCT00052715|468869783|FG000|Overall Study|wrong histology|1|||
130248012|NCT01063881|468869784|FG000|Overall Study|Adverse Event|12|||
130248013|NCT01063881|468869785|FG001|Overall Study|Adverse Event|2|||
130248014|NCT01063881|468869786|FG002|Overall Study|Adverse Event|0|||
130452315|NCT02403323|469619831|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
130452316|NCT02403323|469619832|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
130452317|NCT02403323|469619833|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
130452318|NCT00197236|469619837|FG000|Overall Study|Adverse Event|1|||
130452319|NCT00197236|469619838|FG001|Overall Study|Adverse Event|0|||
130452320|NCT00197236|469619839|FG002|Overall Study|Adverse Event|1|||
130452321|NCT00197236|469619837|FG000|Overall Study|Lost to Follow-up|5|||
130452322|NCT00197236|469619838|FG001|Overall Study|Lost to Follow-up|14|||
130452323|NCT00197236|469619839|FG002|Overall Study|Lost to Follow-up|6|||
130452324|NCT00197236|469619837|FG000|Overall Study|Protocol Violation|0|||
130452325|NCT00197236|469619838|FG001|Overall Study|Protocol Violation|0|||
130452326|NCT00197236|469619839|FG002|Overall Study|Protocol Violation|1|||
130452327|NCT00197236|469619837|FG000|Overall Study|Withdrawal by Subject|7|||
130452328|NCT00197236|469619838|FG001|Overall Study|Withdrawal by Subject|3|||
130452329|NCT00197236|469619839|FG002|Overall Study|Withdrawal by Subject|11|||
130452330|NCT00197236|469619837|FG000|Overall Study|Study drug/medication expiration|1|||
130452331|NCT00197236|469619838|FG001|Overall Study|Study drug/medication expiration|0|||
130452332|NCT00197236|469619839|FG002|Overall Study|Study drug/medication expiration|3|||
130699565|NCT01332968|470524724|FG005|Induction Period|Physician Decision|0|||
130699566|NCT01332968|470524725|FG006|Induction Period|Physician Decision|0|||
130699567|NCT01332968|470524726|FG007|Induction Period|Physician Decision|0|||
130699568|NCT01332968|470524719|FG000|Induction Period|Progressive Disease|15|||
130699569|NCT01332968|470524720|FG001|Induction Period|Progressive Disease|7|||
130699570|NCT01332968|470524721|FG002|Induction Period|Progressive Disease|0|||
130248015|NCT01063881|468869784|FG000|Overall Study|Lost to Follow-up|13|||
130248016|NCT01063881|468869785|FG001|Overall Study|Lost to Follow-up|7|||
130248017|NCT01063881|468869786|FG002|Overall Study|Lost to Follow-up|1|||
130452333|NCT00197236|469619837|FG000|Overall Study|Returned out of specified time window|0|||
130452334|NCT00197236|469619838|FG001|Overall Study|Returned out of specified time window|0|||
130452335|NCT00197236|469619839|FG002|Overall Study|Returned out of specified time window|1|||
130248018|NCT01063881|468869784|FG000|Overall Study|Withdrawal by Subject|25|||
130699571|NCT01332968|470524722|FG003|Induction Period|Progressive Disease|0|||
130699572|NCT01332968|470524723|FG004|Induction Period|Progressive Disease|0|||
130699573|NCT01332968|470524724|FG005|Induction Period|Progressive Disease|0|||
130248019|NCT01063881|468869785|FG001|Overall Study|Withdrawal by Subject|1|||
130552987|NCT00810394|469991639|FG000|Overall Study|Withdrawal by Subject|3|||
130552988|NCT03217266|469993474|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
130552989|NCT03217266|469993475|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
130552990|NCT03217266|469993476|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
130552991|NCT03217266|469993477|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
130552992|NCT03217266|469993474|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
130552993|NCT03217266|469993475|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
130552994|NCT03217266|469993476|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
130552995|NCT03217266|469993477|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
130552996|NCT03217266|469993474|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
130552997|NCT03217266|469993475|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
130552998|NCT03217266|469993476|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
130552999|NCT03217266|469993477|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
130553000|NCT01390181|469993478|FG000|Overall Study|Lost to Follow-up|1|||
130553001|NCT01390181|469993478|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
130553002|NCT02805725|469993479|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
130553003|NCT02805725|469993480|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
130553004|NCT02805725|469993481|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
130553005|NCT02805725|469993482|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
130553006|NCT02805725|469993483|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
130553007|NCT02805725|469993479|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
130553008|NCT02805725|469993480|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
130553009|NCT02805725|469993481|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
130553010|NCT02805725|469993482|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
130553011|NCT02805725|469993483|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
130553012|NCT02805725|469993479|FG000|Phase II|Protocol Violation|0|||
130553013|NCT02805725|469993480|FG001|Phase II|Protocol Violation|0|||
130553014|NCT02805725|469993481|FG002|Phase II|Protocol Violation|0|||
130553015|NCT02805725|469993482|FG003|Phase II|Protocol Violation|0|||
130553016|NCT02805725|469993483|FG004|Phase II|Protocol Violation|6|||
130553017|NCT01195545|469993484|FG000|Overall Study|Protocol Violation|4|||
130553018|NCT02425644|469993486|FG000|Overall Study|Lost to Follow-up|2|||
130553019|NCT02425644|469993487|FG001|Overall Study|Lost to Follow-up|3|||
130553020|NCT02425644|469993486|FG000|Overall Study|Withdrawal by Subject|41|||
130553021|NCT02425644|469993487|FG001|Overall Study|Withdrawal by Subject|36|||
130553022|NCT02425644|469993486|FG000|Overall Study|Lack of Efficacy|3|||
130553023|NCT02425644|469993487|FG001|Overall Study|Lack of Efficacy|10|||
130553024|NCT02425644|469993486|FG000|Overall Study|Adverse Event|13|||
130553025|NCT02425644|469993487|FG001|Overall Study|Adverse Event|3|||
130553026|NCT02425644|469993486|FG000|Overall Study|Death|0|||
130553027|NCT02425644|469993487|FG001|Overall Study|Death|2|||
130553028|NCT02425644|469993486|FG000|Overall Study|Other|18|||
130553029|NCT02425644|469993487|FG001|Overall Study|Other|17|||
130553030|NCT01256658|469993488|FG000|Period 1|Lost to Follow-up|837|||
130553031|NCT01256658|469993489|FG001|Period 1|Lost to Follow-up|661|||
130553032|NCT01256658|469993488|FG000|Period 1|Withdrawal by Subject|35|||
130553033|NCT01256658|469993489|FG001|Period 1|Withdrawal by Subject|43|||
130553034|NCT01256658|469993488|FG000|Period 1|Death|48|||
130553035|NCT01256658|469993489|FG001|Period 1|Death|44|||
130553036|NCT00909792|469993490|FG000|Period 1|Did not meet inclusion criteria|0|||
130699574|NCT01332968|470524725|FG006|Induction Period|Progressive Disease|0|||
130699575|NCT01332968|470524726|FG007|Induction Period|Progressive Disease|0|||
130699576|NCT01332968|470524719|FG000|Induction Period|Protocol Violation|3|||
130699577|NCT01332968|470524720|FG001|Induction Period|Protocol Violation|4|||
130248020|NCT01063881|468869786|FG002|Overall Study|Withdrawal by Subject|0|||
130248021|NCT01063881|468869784|FG000|Overall Study|Reason for not completed not specified|5|||
130364005|NCT00386607|469302063|FG001|Extension|Patient withdrew consent|5|||
130248022|NCT01063881|468869785|FG001|Overall Study|Reason for not completed not specified|1|||
130248023|NCT01063881|468869786|FG002|Overall Study|Reason for not completed not specified|0|||
130248024|NCT01489358|468869787|FG000|Overall Study|Lost to Follow-up|0|||
130248025|NCT01489358|468869788|FG001|Overall Study|Lost to Follow-up|0|||
130248026|NCT01489358|468869789|FG002|Overall Study|Lost to Follow-up|2|||
130364006|NCT00386607|469302062|FG000|Extension|Unsatisfactory therapeutic effect|0|||
130364007|NCT00386607|469302063|FG001|Extension|Unsatisfactory therapeutic effect|1|||
130364008|NCT01927627|469302065|FG000|Overall Study|Adverse Event|3|||
130364009|NCT01927627|469302065|FG000|Overall Study|Lack of Efficacy|1|||
130553037|NCT00909792|469993491|FG001|Period 1|Did not meet inclusion criteria|1|||
130553038|NCT00909792|469993490|FG000|Period 2|Biomicroscopy|1|||
130553039|NCT00909792|469993491|FG001|Period 2|Biomicroscopy|0|||
130553040|NCT00909792|469993490|FG000|Period 2|Lost to Follow-up|0|||
130553041|NCT00909792|469993491|FG001|Period 2|Lost to Follow-up|1|||
130553042|NCT00567268|469993492|FG000|Overall Study|Protocol Violation|7|||
130553043|NCT00567268|469993492|FG000|Overall Study|Lost to Follow-up|36|||
130553044|NCT00567268|469993492|FG000|Overall Study|No Visit After First Day of Treatment|2|||
130553045|NCT00567268|469993492|FG000|Overall Study|No Drug Administration|4|||
130248027|NCT00736476|468869790|FG000|Overall Study|Adverse Event|1|||
130248028|NCT00736476|468869791|FG001|Overall Study|Adverse Event|0|||
130248029|NCT03518203|468869796|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
130248030|NCT03518203|468869796|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
130248031|NCT03511066|468869799|FG000|Overall Study|Withdrawal by Subject|1|||
130248032|NCT03511066|468869800|FG001|Overall Study|Withdrawal by Subject|2|||
130248033|NCT03511066|468869801|FG002|Overall Study|Withdrawal by Subject|3|||
130248034|NCT03511066|468869799|FG000|Overall Study|Lost to Follow-up|2|||
130248035|NCT03511066|468869800|FG001|Overall Study|Lost to Follow-up|3|||
130248036|NCT03511066|468869801|FG002|Overall Study|Lost to Follow-up|0|||
130248037|NCT02362412|468869802|FG000|Treatment Period III|Lost to Follow-up|0|||
130248038|NCT02362412|468869803|FG001|Treatment Period III|Lost to Follow-up|1|||
130248039|NCT01541254|468869804|FG000|Overall Study|Withdrawal by Subject|1|||
130248040|NCT01541254|468869804|FG000|Overall Study|excluded - metal allergy|1|||
130248041|NCT01541254|468869804|FG000|Overall Study|enrolled after study closed|1|||
130248042|NCT01541254|468869804|FG000|Overall Study|GI bleed prior to procedure|1|||
130248043|NCT01541254|468869804|FG000|Overall Study|stent not required|1|||
130248044|NCT01541254|468869804|FG000|Overall Study|alternate stent used|1|||
130248045|NCT05103332|468869807|FG000|Overall Study|Lost to Follow-up|0|||
130248046|NCT05103332|468869808|FG001|Overall Study|Lost to Follow-up|2|||
130248047|NCT05103332|468869809|FG002|Overall Study|Lost to Follow-up|1|||
130248048|NCT05103332|468869810|FG003|Overall Study|Lost to Follow-up|0|||
130248049|NCT05103332|468869811|FG004|Overall Study|Lost to Follow-up|0|||
130248050|NCT05103332|468869812|FG005|Overall Study|Lost to Follow-up|2|||
130248051|NCT05103332|468869807|FG000|Overall Study|Physician Decision|0|||
130248052|NCT05103332|468869808|FG001|Overall Study|Physician Decision|1|||
130248053|NCT05103332|468869809|FG002|Overall Study|Physician Decision|0|||
130248054|NCT05103332|468869810|FG003|Overall Study|Physician Decision|1|||
130248055|NCT05103332|468869811|FG004|Overall Study|Physician Decision|0|||
130248056|NCT05103332|468869812|FG005|Overall Study|Physician Decision|0|||
130248057|NCT05103332|468869807|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
130248058|NCT05103332|468869808|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
130248059|NCT05103332|468869809|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
130248060|NCT05103332|468869810|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
130248061|NCT05103332|468869811|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
130248062|NCT05103332|468869812|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
130248063|NCT05103332|468869807|FG000|Overall Study|Unspeccified|0|||
130248064|NCT05103332|468869808|FG001|Overall Study|Unspeccified|0|||
130248065|NCT05103332|468869809|FG002|Overall Study|Unspeccified|0|||
130248066|NCT05103332|468869810|FG003|Overall Study|Unspeccified|1|||
130248067|NCT05103332|468869811|FG004|Overall Study|Unspeccified|0|||
130248068|NCT05103332|468869812|FG005|Overall Study|Unspeccified|0|||
130248069|NCT02218268|468869813|FG000|24 Hour Washout|Physician Decision|11|||
130248070|NCT02218268|468869814|FG001|24 Hour Washout|Physician Decision|9|||
130248071|NCT03651336|468869815|FG000|Overall Study|Withdrawal by Subject|4|||
130248072|NCT01125748|468869818|FG000|Overall Study|Adverse Event|0|||
130248073|NCT01125748|468869819|FG001|Overall Study|Adverse Event|2|||
130248074|NCT01125748|468869818|FG000|Overall Study|Lost to Follow-up|0|||
130248075|NCT01125748|468869819|FG001|Overall Study|Lost to Follow-up|1|||
130248076|NCT01125748|468869818|FG000|Overall Study|Physician Decision|8|||
130248077|NCT01125748|468869819|FG001|Overall Study|Physician Decision|7|||
130248078|NCT01125748|468869818|FG000|Overall Study|Patient Decision to Withdraw|2|||
130248079|NCT01125748|468869819|FG001|Overall Study|Patient Decision to Withdraw|4|||
130248080|NCT01028391|468869820|FG000|Overall Study|Adverse Event|4|||
130248081|NCT01028391|468869821|FG001|Overall Study|Adverse Event|0|||
130248082|NCT01028391|468869820|FG000|Overall Study|Lack of Efficacy|0|||
130248083|NCT01028391|468869821|FG001|Overall Study|Lack of Efficacy|2|||
130248084|NCT01028391|468869820|FG000|Overall Study|Lost to Follow-up|3|||
130248085|NCT01028391|468869821|FG001|Overall Study|Lost to Follow-up|4|||
130248086|NCT01028391|468869820|FG000|Overall Study|Physician Decision|0|||
130248087|NCT01028391|468869821|FG001|Overall Study|Physician Decision|1|||
130248088|NCT01028391|468869820|FG000|Overall Study|Withdrawal by Subject|6|||
130248089|NCT01028391|468869821|FG001|Overall Study|Withdrawal by Subject|3|||
130248090|NCT01028391|468869820|FG000|Overall Study|Needed excluded medication|1|||
130248091|NCT01028391|468869821|FG001|Overall Study|Needed excluded medication|1|||
130699578|NCT01332968|470524721|FG002|Induction Period|Protocol Violation|0|||
130248092|NCT01227395|468869822|FG000|Overall Study|Protocol Violation|0|||
130248093|NCT01227395|468869823|FG001|Overall Study|Protocol Violation|1|||
130248094|NCT00683384|468869828|FG000|Overall Study|Death|1|||
130248095|NCT00683384|468869828|FG000|Overall Study|Adverse Event|1|||
130248096|NCT00120874|468869830|FG000|Overall Study|Death|0|||
130452336|NCT03885596|469619840|FG000|Overall Study|Withdrawal by Subject|2|||
130699579|NCT01332968|470524722|FG003|Induction Period|Protocol Violation|0|||
130248097|NCT00120874|468869831|FG001|Overall Study|Death|1|||
130248098|NCT03882801|468871389|FG000|Period 1|Adverse Event|0|||
130248099|NCT03882801|468871390|FG001|Period 1|Adverse Event|1|||
130248100|NCT03882801|468871389|FG000|Period 1|Non-compliance with study drug|1|||
130248101|NCT03882801|468871390|FG001|Period 1|Non-compliance with study drug|1|||
130248102|NCT03882801|468871389|FG000|Period 1|Never treated with study drug|1|||
130248103|NCT03882801|468871390|FG001|Period 1|Never treated with study drug|0|||
130248104|NCT03882801|468871389|FG000|Washout Period|Physician Decision|0|||
130248105|NCT03882801|468871390|FG001|Washout Period|Physician Decision|1|||
130248106|NCT03882801|468871389|FG000|Period 2|Non-compliance with study drug|0|||
130248107|NCT03882801|468871390|FG001|Period 2|Non-compliance with study drug|1|||
130248108|NCT03548415|468871397|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130248109|NCT03548415|468871398|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130248110|NCT03548415|468871399|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
130248111|NCT03548415|468871400|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
130452337|NCT03885596|469619841|FG001|Overall Study|Withdrawal by Subject|1|||
130452338|NCT03885596|469619842|FG002|Overall Study|Withdrawal by Subject|0|||
130452339|NCT03885596|469619843|FG003|Overall Study|Withdrawal by Subject|0|||
130452340|NCT03852433|469619844|FG000|Overall Study|Withdrawal of consent|5|||
130452341|NCT03852433|469619845|FG001|Overall Study|Withdrawal of consent|8|||
130452342|NCT03852433|469619846|FG002|Overall Study|Withdrawal of consent|1|||
130452343|NCT03852433|469619847|FG003|Overall Study|Withdrawal of consent|1|||
130452344|NCT03852433|469619844|FG000|Overall Study|Adverse Event|1|||
130452345|NCT03852433|469619845|FG001|Overall Study|Adverse Event|1|||
130452346|NCT03852433|469619846|FG002|Overall Study|Adverse Event|1|||
130452347|NCT03852433|469619847|FG003|Overall Study|Adverse Event|1|||
130452348|NCT03852433|469619844|FG000|Overall Study|Lost to Follow-up|0|||
130452349|NCT03852433|469619845|FG001|Overall Study|Lost to Follow-up|1|||
130452350|NCT03852433|469619846|FG002|Overall Study|Lost to Follow-up|0|||
130452351|NCT03852433|469619847|FG003|Overall Study|Lost to Follow-up|1|||
130452352|NCT03852433|469619844|FG000|Overall Study|Pregnancy|0|||
130452353|NCT03852433|469619845|FG001|Overall Study|Pregnancy|1|||
130452354|NCT03852433|469619846|FG002|Overall Study|Pregnancy|1|||
130452355|NCT03852433|469619847|FG003|Overall Study|Pregnancy|0|||
130452356|NCT03852433|469619844|FG000|Overall Study|Protocol Violation|0|||
130452357|NCT03852433|469619845|FG001|Overall Study|Protocol Violation|0|||
130452358|NCT03852433|469619846|FG002|Overall Study|Protocol Violation|1|||
130452359|NCT03852433|469619847|FG003|Overall Study|Protocol Violation|1|||
130452360|NCT03852433|469619844|FG000|Overall Study|Death|0|||
130452361|NCT03852433|469619845|FG001|Overall Study|Death|0|||
130452362|NCT03852433|469619846|FG002|Overall Study|Death|1|||
130452363|NCT03852433|469619847|FG003|Overall Study|Death|0|||
130452364|NCT03852433|469619844|FG000|Overall Study|Lack of Efficacy|0|||
130452365|NCT03852433|469619845|FG001|Overall Study|Lack of Efficacy|1|||
130452366|NCT03852433|469619846|FG002|Overall Study|Lack of Efficacy|0|||
130452367|NCT03852433|469619847|FG003|Overall Study|Lack of Efficacy|0|||
130452368|NCT03852433|469619844|FG000|Overall Study|Non-compliance with study drug|0|||
130452369|NCT03852433|469619845|FG001|Overall Study|Non-compliance with study drug|0|||
130452370|NCT03852433|469619846|FG002|Overall Study|Non-compliance with study drug|0|||
130452371|NCT03852433|469619847|FG003|Overall Study|Non-compliance with study drug|1|||
130452372|NCT03852433|469619844|FG000|Overall Study|Physician Decision|1|||
130452373|NCT03852433|469619845|FG001|Overall Study|Physician Decision|0|||
130452374|NCT03852433|469619846|FG002|Overall Study|Physician Decision|0|||
130452375|NCT03852433|469619847|FG003|Overall Study|Physician Decision|0|||
130452376|NCT03852433|469619844|FG000|Overall Study|Randomized but never treated|1|||
130452377|NCT03852433|469619845|FG001|Overall Study|Randomized but never treated|0|||
130452378|NCT03852433|469619846|FG002|Overall Study|Randomized but never treated|0|||
130452379|NCT03852433|469619847|FG003|Overall Study|Randomized but never treated|0|||
130452380|NCT01076335|469619848|FG000|Overall Study|Withdrawal by Subject|3|||
130452381|NCT01076335|469619848|FG000|Overall Study|Withdrawal without treatment|1|||
130452382|NCT05015478|469619849|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
130452383|NCT05015478|469619850|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
130452384|NCT05015478|469619851|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
130452385|NCT05015478|469619852|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
130452386|NCT00654238|469619856|FG000|Overall Study|Screen Failures|4|||
130452387|NCT01268566|469619859|FG000|Overall Study|Lost to Follow-up|1|||
130452388|NCT01268566|469619859|FG000|Overall Study|Withdrawal by Subject|12|||
130452389|NCT01268566|469619859|FG000|Overall Study|Death|30|||
130452390|NCT02138916|469619861|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
130452391|NCT02138916|469619862|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
130248112|NCT03548415|468871401|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
130248113|NCT01803737|468871402|FG000|Overall Study|Lack of Time|1|||
130452392|NCT02138916|469619863|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
130452393|NCT02138916|469619861|FG000|Overall Study|Death|14|||
130452394|NCT02138916|469619862|FG001|Overall Study|Death|11|||
130452395|NCT02138916|469619863|FG002|Overall Study|Death|12|||
130452396|NCT02138916|469619861|FG000|Overall Study|Withdrawal by Subject|27|||
130452397|NCT02138916|469619862|FG001|Overall Study|Withdrawal by Subject|31|||
130452398|NCT02138916|469619863|FG002|Overall Study|Withdrawal by Subject|32|||
130248114|NCT01803737|468871403|FG001|Overall Study|Lack of Time|0|||
130248115|NCT01803737|468871402|FG000|Overall Study|Medical Reason|0|||
130248116|NCT01803737|468871403|FG001|Overall Study|Medical Reason|1|||
130248117|NCT01803737|468871402|FG000|Overall Study|Lost to Follow-up|0|||
130248118|NCT01803737|468871403|FG001|Overall Study|Lost to Follow-up|2|||
130248119|NCT01529112|468871404|FG000|Overall Study|Adverse Event|2|||
130248120|NCT01529112|468871405|FG001|Overall Study|Adverse Event|0|||
130248121|NCT01529112|468871404|FG000|Overall Study|Death|59|||
130248122|NCT01529112|468871405|FG001|Overall Study|Death|38|||
130248123|NCT01529112|468871404|FG000|Overall Study|Protocol Violation|1|||
130248124|NCT01529112|468871405|FG001|Overall Study|Protocol Violation|0|||
130248125|NCT01529112|468871404|FG000|Overall Study|Withdrawal by Subject|7|||
130248126|NCT01529112|468871405|FG001|Overall Study|Withdrawal by Subject|3|||
130248127|NCT03607695|468871406|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
130248128|NCT03607695|468871406|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
130248129|NCT02741193|468871407|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
130248130|NCT02741193|468871407|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
130248131|NCT02502383|468871408|FG000|Overall Study|Lost to Follow-up|130|||
130248132|NCT02502383|468871409|FG001|Overall Study|Lost to Follow-up|131|||
130248133|NCT02502383|468871408|FG000|Overall Study|Withdrawal by Subject|31|||
130248134|NCT02502383|468871409|FG001|Overall Study|Withdrawal by Subject|24|||
130248135|NCT00458705|468871412|FG000|Overall Study|Adverse Event|4|||
130248136|NCT00458705|468871412|FG000|Overall Study|Not Treated|1|||
130248137|NCT00604383|468871413|FG000|Overall Study|Withdrawal by Subject|33|||
130248138|NCT00604383|468871414|FG001|Overall Study|Withdrawal by Subject|31|||
130248139|NCT00604383|468871413|FG000|Overall Study|Lost to Follow-up|24|||
130248140|NCT00604383|468871414|FG001|Overall Study|Lost to Follow-up|19|||
130248141|NCT00604383|468871413|FG000|Overall Study|Death|14|||
130248142|NCT00604383|468871414|FG001|Overall Study|Death|22|||
130248143|NCT00604383|468871413|FG000|Overall Study|Adverse Event|16|||
130248144|NCT00604383|468871414|FG001|Overall Study|Adverse Event|9|||
130248145|NCT00604383|468871413|FG000|Overall Study|Physician Decision|0|||
130248146|NCT00604383|468871414|FG001|Overall Study|Physician Decision|3|||
130248147|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
130248148|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
130248149|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
130248150|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
130248151|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
130248152|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
130248153|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
130248154|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
130248155|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Other|1|||
130248156|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Other|1|||
130248157|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Other|0|||
130248158|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Other|0|||
130248159|NCT01122680|468871417|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
130248160|NCT01122680|468871418|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
130248161|NCT01122680|468871419|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
130248162|NCT01122680|468871420|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
130248163|NCT01122680|468871417|FG000|Period 2 (4 Weeks)|Other|1|||
130248164|NCT01122680|468871418|FG001|Period 2 (4 Weeks)|Other|0|||
130248165|NCT01122680|468871419|FG002|Period 2 (4 Weeks)|Other|0|||
130248166|NCT01122680|468871420|FG003|Period 2 (4 Weeks)|Other|0|||
130248167|NCT01122680|468871417|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
130248168|NCT01122680|468871418|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
130248169|NCT01122680|468871419|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
130248170|NCT01122680|468871420|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
130248171|NCT01122680|468871417|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248172|NCT01122680|468871418|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
130248173|NCT01122680|468871419|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248174|NCT01122680|468871420|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248175|NCT00225758|468871421|FG000|Overall Study|Adverse Event|4|||
130248176|NCT01530997|468871425|FG000|Overall Study|Physician Decision|1|||
130248177|NCT01530997|468871425|FG000|Overall Study|Withdrawal by Subject|1|||
130248178|NCT03892915|468871426|FG000|Overall Study|Lost to Follow-up|6|||
130248179|NCT03892915|468871427|FG001|Overall Study|Lost to Follow-up|12|||
130248180|NCT03892915|468871426|FG000|Overall Study|Death|0|||
130248181|NCT03892915|468871427|FG001|Overall Study|Death|2|||
130248182|NCT03892915|468871426|FG000|Overall Study|Withdrawal by Subject|1|||
130248183|NCT03892915|468871427|FG001|Overall Study|Withdrawal by Subject|1|||
130248184|NCT03892915|468871426|FG000|Overall Study|unsuccessful delivery|13|||
130248185|NCT03892915|468871427|FG001|Overall Study|unsuccessful delivery|18|||
130248186|NCT02181738|468871430|FG000|Overall Study|Participant Withdrew Consent|2|||
130248187|NCT02181738|468871431|FG001|Overall Study|Participant Withdrew Consent|1|||
130248188|NCT02181738|468871432|FG002|Overall Study|Participant Withdrew Consent|1|||
130248189|NCT02181738|468871433|FG003|Overall Study|Participant Withdrew Consent|1|||
130248190|NCT02181738|468871430|FG000|Overall Study|Lost to Follow-up|1|||
130248191|NCT02181738|468871431|FG001|Overall Study|Lost to Follow-up|2|||
130553046|NCT00567268|469993492|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
130553047|NCT01717989|469993493|FG000|Overall Study|Ineligibility determined|6|||
130553048|NCT01717989|469993493|FG000|Overall Study|Protocol deviation|6|||
130553049|NCT01717989|469993493|FG000|Overall Study|Withdrawal by Subject|11|||
130553050|NCT01717989|469993493|FG000|Overall Study|Physician Decision|2|||
130553051|NCT01717989|469993493|FG000|Overall Study|Lost to Follow-up|11|||
130553052|NCT01717989|469993493|FG000|Overall Study|Death|439|||
130553053|NCT01717989|469993493|FG000|Overall Study|Protocol-specified criteria|551|||
130553054|NCT01717989|469993493|FG000|Overall Study|Other|40|||
130553055|NCT02525861|469993499|FG000|Overall Study|Adverse Event|1|||
130553056|NCT02525861|469993500|FG001|Overall Study|Adverse Event|0|||
130553057|NCT02525861|469993499|FG000|Overall Study|Withdrawal by Subject|0|||
130553058|NCT02525861|469993500|FG001|Overall Study|Withdrawal by Subject|1|||
130553059|NCT02525861|469993499|FG000|Overall Study|Physician Decision|0|||
130553060|NCT02525861|469993500|FG001|Overall Study|Physician Decision|1|||
130553061|NCT01794520|469993501|FG000|Overall Study|Adverse events- related to progression|0|||
130553062|NCT01794520|469993502|FG001|Overall Study|Adverse events- related to progression|0|||
130553063|NCT01794520|469993503|FG002|Overall Study|Adverse events- related to progression|1|||
130553064|NCT01794520|469993504|FG003|Overall Study|Adverse events- related to progression|2|||
130553065|NCT01794520|469993505|FG004|Overall Study|Adverse events- related to progression|0|||
130553066|NCT01794520|469993506|FG005|Overall Study|Adverse events- related to progression|1|||
130553067|NCT01794520|469993507|FG006|Overall Study|Adverse events- related to progression|0|||
130553068|NCT01794520|469993501|FG000|Overall Study|Adverse event- not related to progression|1|||
130553069|NCT01794520|469993502|FG001|Overall Study|Adverse event- not related to progression|1|||
130553070|NCT01794520|469993503|FG002|Overall Study|Adverse event- not related to progression|0|||
130553071|NCT01794520|469993504|FG003|Overall Study|Adverse event- not related to progression|0|||
130553072|NCT01794520|469993505|FG004|Overall Study|Adverse event- not related to progression|2|||
130553073|NCT01794520|469993506|FG005|Overall Study|Adverse event- not related to progression|0|||
130553074|NCT01794520|469993507|FG006|Overall Study|Adverse event- not related to progression|0|||
130553075|NCT01794520|469993501|FG000|Overall Study|Progressive disease|5|||
130553076|NCT01794520|469993502|FG001|Overall Study|Progressive disease|6|||
130553077|NCT01794520|469993503|FG002|Overall Study|Progressive disease|2|||
130553078|NCT01794520|469993504|FG003|Overall Study|Progressive disease|5|||
130553079|NCT01794520|469993505|FG004|Overall Study|Progressive disease|27|||
130699580|NCT01332968|470524723|FG004|Induction Period|Protocol Violation|0|||
130699581|NCT01332968|470524724|FG005|Induction Period|Protocol Violation|0|||
130248192|NCT02181738|468871432|FG002|Overall Study|Lost to Follow-up|1|||
130248193|NCT02181738|468871433|FG003|Overall Study|Lost to Follow-up|1|||
130248194|NCT02181738|468871430|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248195|NCT02181738|468871431|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248196|NCT02181738|468871432|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248197|NCT02181738|468871433|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
130248198|NCT02181738|468871430|FG000|Overall Study|Poor/Non-Compliance|1|||
130248199|NCT02181738|468871431|FG001|Overall Study|Poor/Non-Compliance|0|||
130248200|NCT02181738|468871432|FG002|Overall Study|Poor/Non-Compliance|2|||
130248201|NCT02181738|468871433|FG003|Overall Study|Poor/Non-Compliance|1|||
130248202|NCT02181738|468871430|FG000|Overall Study|Disease Progression|28|||
130248203|NCT02181738|468871431|FG001|Overall Study|Disease Progression|35|||
130248204|NCT02181738|468871432|FG002|Overall Study|Disease Progression|40|||
130248205|NCT02181738|468871433|FG003|Overall Study|Disease Progression|0|||
130248206|NCT02181738|468871430|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130248207|NCT02181738|468871431|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
130248208|NCT02181738|468871432|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130248209|NCT02181738|468871433|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
130248210|NCT02181738|468871430|FG000|Overall Study|Study Drug Toxicity|6|||
130248211|NCT02181738|468871431|FG001|Overall Study|Study Drug Toxicity|11|||
130248212|NCT02181738|468871432|FG002|Overall Study|Study Drug Toxicity|8|||
130248213|NCT02181738|468871433|FG003|Overall Study|Study Drug Toxicity|1|||
130248214|NCT02181738|468871430|FG000|Overall Study|Other Reasons|14|||
130248215|NCT02181738|468871431|FG001|Overall Study|Other Reasons|16|||
130248216|NCT02181738|468871432|FG002|Overall Study|Other Reasons|28|||
130248217|NCT02181738|468871433|FG003|Overall Study|Other Reasons|0|||
130248218|NCT02181738|468871430|FG000|Overall Study|Maximum Clinical Benefit|3|||
130248219|NCT02181738|468871431|FG001|Overall Study|Maximum Clinical Benefit|0|||
130248220|NCT02181738|468871432|FG002|Overall Study|Maximum Clinical Benefit|1|||
130364010|NCT01927627|469302065|FG000|Overall Study|Financial Concerns|1|||
130364011|NCT00467857|469302066|FG000|Overall Study|Adverse Event|1|||
130364012|NCT00467857|469302067|FG001|Overall Study|Adverse Event|0|||
130553080|NCT01794520|469993506|FG005|Overall Study|Progressive disease|18|||
130553081|NCT01794520|469993507|FG006|Overall Study|Progressive disease|0|||
130553082|NCT01794520|469993501|FG000|Overall Study|Withdrew consent|0|||
130553083|NCT01794520|469993502|FG001|Overall Study|Withdrew consent|0|||
130553084|NCT01794520|469993503|FG002|Overall Study|Withdrew consent|1|||
130553085|NCT01794520|469993504|FG003|Overall Study|Withdrew consent|1|||
130699582|NCT01332968|470524725|FG006|Induction Period|Protocol Violation|0|||
130699583|NCT01332968|470524726|FG007|Induction Period|Protocol Violation|0|||
130699584|NCT01332968|470524719|FG000|Induction Period|Withdrawal by Subject|3|||
130699585|NCT01332968|470524720|FG001|Induction Period|Withdrawal by Subject|5|||
130699586|NCT01332968|470524721|FG002|Induction Period|Withdrawal by Subject|0|||
130699587|NCT01332968|470524722|FG003|Induction Period|Withdrawal by Subject|0|||
130248221|NCT02181738|468871433|FG003|Overall Study|Maximum Clinical Benefit|0|||
130248222|NCT02181738|468871430|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130248223|NCT02181738|468871431|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130248224|NCT02181738|468871432|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130248225|NCT02181738|468871433|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130248226|NCT02318277|468871436|FG000|Overall Study|Physician Decision|0|||
130248227|NCT02318277|468871437|FG001|Overall Study|Physician Decision|0|||
130248228|NCT02318277|468871438|FG002|Overall Study|Physician Decision|0|||
130248229|NCT02318277|468871439|FG003|Overall Study|Physician Decision|0|||
130248230|NCT02318277|468871440|FG004|Overall Study|Physician Decision|0|||
130248231|NCT02318277|468871441|FG005|Overall Study|Physician Decision|0|||
130248232|NCT02318277|468871442|FG006|Overall Study|Physician Decision|0|||
130248233|NCT02318277|468871443|FG007|Overall Study|Physician Decision|1|||
130248234|NCT02318277|468871436|FG000|Overall Study|Other|0|||
130248235|NCT02318277|468871437|FG001|Overall Study|Other|0|||
130248236|NCT02318277|468871438|FG002|Overall Study|Other|0|||
130248237|NCT02318277|468871439|FG003|Overall Study|Other|0|||
130248238|NCT02318277|468871440|FG004|Overall Study|Other|0|||
130248239|NCT02318277|468871441|FG005|Overall Study|Other|0|||
130248240|NCT02318277|468871442|FG006|Overall Study|Other|1|||
130248241|NCT02318277|468871443|FG007|Overall Study|Other|0|||
130248242|NCT02318277|468871436|FG000|Overall Study|Withdrawal by Subject|0|||
130248243|NCT02318277|468871437|FG001|Overall Study|Withdrawal by Subject|0|||
130248244|NCT02318277|468871438|FG002|Overall Study|Withdrawal by Subject|1|||
130248245|NCT02318277|468871439|FG003|Overall Study|Withdrawal by Subject|0|||
130248246|NCT02318277|468871440|FG004|Overall Study|Withdrawal by Subject|1|||
130248247|NCT02318277|468871441|FG005|Overall Study|Withdrawal by Subject|1|||
130248248|NCT02318277|468871442|FG006|Overall Study|Withdrawal by Subject|6|||
130248249|NCT02318277|468871443|FG007|Overall Study|Withdrawal by Subject|14|||
130248250|NCT02318277|468871436|FG000|Overall Study|Participant trial terminated by sponsor|0|||
130248251|NCT02318277|468871437|FG001|Overall Study|Participant trial terminated by sponsor|0|||
130248252|NCT02318277|468871438|FG002|Overall Study|Participant trial terminated by sponsor|1|||
130248253|NCT02318277|468871439|FG003|Overall Study|Participant trial terminated by sponsor|0|||
130248254|NCT02318277|468871440|FG004|Overall Study|Participant trial terminated by sponsor|1|||
130248255|NCT02318277|468871441|FG005|Overall Study|Participant trial terminated by sponsor|2|||
130248256|NCT02318277|468871442|FG006|Overall Study|Participant trial terminated by sponsor|5|||
130248257|NCT02318277|468871443|FG007|Overall Study|Participant trial terminated by sponsor|16|||
130248258|NCT02318277|468871436|FG000|Overall Study|Lost to Follow-up|1|||
130248259|NCT02318277|468871437|FG001|Overall Study|Lost to Follow-up|0|||
130248260|NCT02318277|468871438|FG002|Overall Study|Lost to Follow-up|1|||
130248261|NCT02318277|468871439|FG003|Overall Study|Lost to Follow-up|0|||
130248262|NCT02318277|468871440|FG004|Overall Study|Lost to Follow-up|0|||
130248263|NCT02318277|468871441|FG005|Overall Study|Lost to Follow-up|0|||
130248264|NCT02318277|468871442|FG006|Overall Study|Lost to Follow-up|3|||
130248265|NCT02318277|468871443|FG007|Overall Study|Lost to Follow-up|4|||
130248266|NCT02318277|468871436|FG000|Overall Study|Death|5|||
130248267|NCT02318277|468871437|FG001|Overall Study|Death|3|||
130248268|NCT02318277|468871438|FG002|Overall Study|Death|1|||
130248269|NCT02318277|468871439|FG003|Overall Study|Death|4|||
130248270|NCT02318277|468871440|FG004|Overall Study|Death|6|||
130248271|NCT02318277|468871441|FG005|Overall Study|Death|5|||
130248272|NCT02318277|468871442|FG006|Overall Study|Death|34|||
130248273|NCT02318277|468871443|FG007|Overall Study|Death|58|||
130248274|NCT02318277|468871436|FG000|Overall Study|Transitioned to Hospice|0|||
130248275|NCT02318277|468871437|FG001|Overall Study|Transitioned to Hospice|0|||
130699588|NCT01332968|470524723|FG004|Induction Period|Withdrawal by Subject|0|||
130699589|NCT01332968|470524724|FG005|Induction Period|Withdrawal by Subject|0|||
130248276|NCT02318277|468871438|FG002|Overall Study|Transitioned to Hospice|0|||
130248277|NCT02318277|468871439|FG003|Overall Study|Transitioned to Hospice|0|||
130248278|NCT02318277|468871440|FG004|Overall Study|Transitioned to Hospice|0|||
130248279|NCT02318277|468871441|FG005|Overall Study|Transitioned to Hospice|1|||
130364013|NCT00467857|469302066|FG000|Overall Study|Withdrew consent|2|||
130699590|NCT01332968|470524725|FG006|Induction Period|Withdrawal by Subject|0|||
130699591|NCT01332968|470524726|FG007|Induction Period|Withdrawal by Subject|0|||
130248280|NCT02318277|468871442|FG006|Overall Study|Transitioned to Hospice|0|||
130248281|NCT02318277|468871443|FG007|Overall Study|Transitioned to Hospice|0|||
130248282|NCT01691482|468871444|FG000|Treatment Period 2|Adverse Event|0|||
130248283|NCT01691482|468871445|FG001|Treatment Period 2|Adverse Event|1|||
130248284|NCT01691482|468871444|FG000|Treatment Period 2|Protocol Violation|1|||
130248285|NCT01691482|468871445|FG001|Treatment Period 2|Protocol Violation|1|||
130248286|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
130248287|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
130248288|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
130248289|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130248290|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130248291|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
130248292|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248293|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248294|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248295|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130248296|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130364014|NCT00467857|469302067|FG001|Overall Study|Withdrew consent|0|||
130364015|NCT00467857|469302066|FG000|Overall Study|Death|0|||
130364016|NCT00467857|469302067|FG001|Overall Study|Death|1|||
130364017|NCT00467857|469302066|FG000|Overall Study|Discharged from court service|0|||
130364018|NCT00467857|469302067|FG001|Overall Study|Discharged from court service|1|||
130364019|NCT00467857|469302066|FG000|Overall Study|Emergency care required|0|||
130364020|NCT00467857|469302067|FG001|Overall Study|Emergency care required|1|||
130364021|NCT00467857|469302066|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
130364022|NCT00467857|469302067|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
130364023|NCT00467857|469302066|FG000|Overall Study|Discontinuation reason missing|0|||
130364024|NCT00467857|469302067|FG001|Overall Study|Discontinuation reason missing|3|||
130364025|NCT03208127|469302070|FG000|Overall Study|Death|1|||
130364026|NCT00579098|469302075|FG000|Overall Study|Lost to Follow-up|2|||
130364027|NCT00579098|469302076|FG001|Overall Study|Lost to Follow-up|0|||
130364028|NCT00579098|469302075|FG000|Overall Study|Adverse Event|2|||
130364029|NCT00579098|469302076|FG001|Overall Study|Adverse Event|3|||
130364030|NCT00579098|469302075|FG000|Overall Study|Withdrawal by Subject|2|||
130364031|NCT00579098|469302076|FG001|Overall Study|Withdrawal by Subject|3|||
130364032|NCT00579098|469302075|FG000|Overall Study|AF returned after ablation|3|||
130364033|NCT00579098|469302076|FG001|Overall Study|AF returned after ablation|2|||
130364034|NCT02121522|469302077|FG000|Overall Study|Adverse Event|1|||
130364035|NCT00338104|469302079|FG000|Overall Study|Protocol Violation|2|||
130364036|NCT00338104|469302080|FG001|Overall Study|Protocol Violation|1|||
130364037|NCT00338104|469302081|FG002|Overall Study|Protocol Violation|3|||
130364038|NCT00633750|469302083|FG000|Overall Study|Adverse Event|2|||
130364039|NCT00633750|469302083|FG000|Overall Study|Withdrawal by Subject|3|||
130364040|NCT03666624|469302087|FG000|Overall Study|participant grieving over recent death of parent|1|||
130364041|NCT03666624|469302088|FG001|Overall Study|participant grieving over recent death of parent|0|||
130364042|NCT03021304|469302093|FG000|Overall Study|Lack of Efficacy|1|||
130364043|NCT00569270|469302094|FG000|Period: First Intervention|Protocol Violation|0|||
130364044|NCT00569270|469302095|FG001|Period: First Intervention|Protocol Violation|1|||
130364045|NCT00492531|469302097|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
130364046|NCT00492531|469302098|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
130364047|NCT03822182|469302099|FG000|Overall Study|Protocol Violation|0|||
130364048|NCT03822182|469302100|FG001|Overall Study|Protocol Violation|1|||
130364049|NCT03822182|469302101|FG002|Overall Study|Protocol Violation|1|||
130364050|NCT00810355|469302102|FG000|Overall Study|Lost to Follow-up|13|||
130364051|NCT00810355|469302103|FG001|Overall Study|Lost to Follow-up|17|||
130364052|NCT00810355|469302104|FG002|Overall Study|Lost to Follow-up|11|||
130364053|NCT00810355|469302102|FG000|Overall Study|Withdrawal by Subject|1|||
130364054|NCT00810355|469302103|FG001|Overall Study|Withdrawal by Subject|0|||
130364055|NCT00810355|469302104|FG002|Overall Study|Withdrawal by Subject|0|||
130364056|NCT00843856|469302107|FG000|Overall Study|Lost to Follow-up|1|||
130364057|NCT00843856|469302108|FG001|Overall Study|Lost to Follow-up|2|||
130364058|NCT01893203|469302109|FG000|Overall Study|Withdrawal by Subject|1|||
130364059|NCT00621959|469302110|FG000|Overall Study|Adverse Event|4|||
130364060|NCT00621959|469302111|FG001|Overall Study|Adverse Event|2|||
130364061|NCT00621959|469302110|FG000|Overall Study|Lack of Efficacy|1|||
130364062|NCT00621959|469302111|FG001|Overall Study|Lack of Efficacy|1|||
130364063|NCT00621959|469302110|FG000|Overall Study|Lost to Follow-up|0|||
130364064|NCT00621959|469302111|FG001|Overall Study|Lost to Follow-up|2|||
130364065|NCT00621959|469302110|FG000|Overall Study|Withdrawal by Subject|1|||
130364066|NCT00621959|469302111|FG001|Overall Study|Withdrawal by Subject|1|||
130364067|NCT00621959|469302110|FG000|Overall Study|Other|1|||
130364068|NCT00621959|469302111|FG001|Overall Study|Other|3|||
130364069|NCT01758523|469302112|FG000|Overall Study|Adverse Event|2|||
130364070|NCT01758523|469302113|FG001|Overall Study|Adverse Event|1|||
130364071|NCT01758523|469302112|FG000|Overall Study|Lack of Efficacy|4|||
130364072|NCT01758523|469302113|FG001|Overall Study|Lack of Efficacy|2|||
130364073|NCT01758523|469302112|FG000|Overall Study|Lost to Follow-up|3|||
130364074|NCT01758523|469302113|FG001|Overall Study|Lost to Follow-up|4|||
130364075|NCT01758523|469302112|FG000|Overall Study|Withdrawal by Subject|12|||
130364076|NCT01758523|469302113|FG001|Overall Study|Withdrawal by Subject|7|||
130364077|NCT00590135|469302114|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
130364078|NCT04729621|469302115|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
130248297|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130248298|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130248299|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130248300|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
130248301|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
130248302|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130248303|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130248304|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130248305|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
130248306|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130248307|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130248308|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130248309|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
130248310|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
130248311|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
130248312|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
130248313|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130248314|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130248315|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
130248316|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130248317|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130248318|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
130248319|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
130248320|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
130248321|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
130248322|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
130248323|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
130248324|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
130248325|NCT02829957|468871450|FG000|Overall Study|Lost to Follow-up|2|||
130248326|NCT02829957|468871451|FG001|Overall Study|Lost to Follow-up|1|||
130248327|NCT00754559|468871452|FG000|Overall Study|Adverse Event|15|||
130248328|NCT00754559|468871452|FG000|Overall Study|Protocol Violation|11|||
130248329|NCT00754559|468871452|FG000|Overall Study|Lack of Efficacy|10|||
130248330|NCT00754559|468871452|FG000|Overall Study|Lost to Follow-up|2|||
130248331|NCT00754559|468871452|FG000|Overall Study|Administrative reason|1|||
130248332|NCT00754559|468871452|FG000|Overall Study|Other|5|||
130248333|NCT00754559|468871452|FG000|Overall Study|Withdrawal by Subject|3|||
130248334|NCT01663987|468871453|FG000|Overall Study|Adverse Event|7|||
130248335|NCT01663987|468871454|FG001|Overall Study|Adverse Event|2|||
130248336|NCT01663987|468871453|FG000|Overall Study|Lost to Follow-up|1|||
130248337|NCT01663987|468871454|FG001|Overall Study|Lost to Follow-up|1|||
130248338|NCT01663987|468871453|FG000|Overall Study|Withdrawal by Subject|2|||
130248339|NCT01663987|468871454|FG001|Overall Study|Withdrawal by Subject|3|||
130248340|NCT01663987|468871453|FG000|Overall Study|Other reason not defined above|3|||
130248341|NCT01663987|468871454|FG001|Overall Study|Other reason not defined above|0|||
130248342|NCT01370538|468871456|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
130248343|NCT01370538|468871457|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
130248344|NCT01370538|468871456|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130248345|NCT01370538|468871457|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130248346|NCT01370538|468871456|FG000|Overall Study|Adverse Event|1|||
130248347|NCT01370538|468871457|FG001|Overall Study|Adverse Event|0|||
130248348|NCT01370538|468871456|FG000|Overall Study|Protocol Violation|8|||
130248349|NCT01370538|468871457|FG001|Overall Study|Protocol Violation|5|||
130248350|NCT01370538|468871456|FG000|Overall Study|Development of study specific withdrawal|1|||
130248351|NCT01370538|468871457|FG001|Overall Study|Development of study specific withdrawal|1|||
130248352|NCT01370538|468871456|FG000|Overall Study|Lost to follow up|6|||
130248353|NCT01370538|468871457|FG001|Overall Study|Lost to follow up|10|||
130248354|NCT04193527|468871458|FG000|Overall Study|Other|1|||
130364079|NCT04729621|469302116|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
130364080|NCT04729621|469302117|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130364081|NCT04729621|469302118|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130364082|NCT04729621|469302119|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130364083|NCT04729621|469302115|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
130364084|NCT04729621|469302116|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
130248355|NCT04193527|468871459|FG001|Overall Study|Other|1|||
130553086|NCT01794520|469993505|FG004|Overall Study|Withdrew consent|0|||
130248356|NCT04193527|468871460|FG002|Overall Study|Other|0|||
130248357|NCT00676689|468871461|FG000|Overall Study|Screen Failure|2|||
130248358|NCT00676689|468871461|FG000|Overall Study|Death|2|||
130248359|NCT00676689|468871461|FG000|Overall Study|Lost to Follow-up|4|||
130248360|NCT00676689|468871461|FG000|Overall Study|Physician Decision|1|||
130248361|NCT00676689|468871461|FG000|Overall Study|Withdrawal by Subject|3|||
130248362|NCT00676689|468871461|FG000|Overall Study|Continuing FU|49|||
130699592|NCT01332968|470524719|FG000|Induction Period|Randomised but not treated|4|||
130699593|NCT01332968|470524720|FG001|Induction Period|Randomised but not treated|7|||
130699594|NCT01332968|470524721|FG002|Induction Period|Randomised but not treated|0|||
130248363|NCT02366130|468871462|FG000|Overall Study|Withdrawal by Subject|3|||
130248364|NCT02366130|468871462|FG000|Overall Study|Ineligible|6|||
130248365|NCT01945242|468871463|FG000|Overall Study|Physician Decision|3|||
130248366|NCT01945242|468871464|FG001|Overall Study|Physician Decision|3|||
130248367|NCT05661734|468871465|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130248368|NCT05661734|468871465|FG000|Overall Study|Lost to Follow-up|13|||
130248369|NCT05661734|468871465|FG000|Overall Study|Enrolled but not dosed|2|||
130248370|NCT01026038|468871466|FG000|Overall Study|Lost to Follow-up|1|||
130248371|NCT01026038|468871467|FG001|Overall Study|Lost to Follow-up|1|||
130248372|NCT01026038|468871468|FG002|Overall Study|Lost to Follow-up|0|||
130248373|NCT03601052|468871469|FG000|Overall Study|Lost to Follow-up|2|||
130248374|NCT01348490|468871470|FG000|Overall Study|Death|1|||
130248375|NCT01348490|468871470|FG000|Overall Study|Adverse Event|3|||
130248376|NCT01348490|468871470|FG000|Overall Study|Consent withdrawn|7|||
130248377|NCT01348490|468871470|FG000|Overall Study|Disease progression|3|||
130248378|NCT01348490|468871470|FG000|Overall Study|Lost to Follow-up|1|||
130248379|NCT01348490|468871470|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
130248380|NCT01348490|468871470|FG000|Overall Study|Other Unspecified|8|||
130248381|NCT00300495|468871471|FG000|Overall Study|Protocol Violation|4|||
130248382|NCT00300495|468871472|FG001|Overall Study|Protocol Violation|1|||
130248383|NCT01184118|468871473|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
130248384|NCT01184118|468871473|FG000|Overall Study|No physiologic confirmation of asthma|8|||
130248385|NCT01184118|468871473|FG000|Overall Study|FEV1 <60% predicted|2|||
130248386|NCT01184118|468871473|FG000|Overall Study|Exclusionary medical condition|2|||
130248387|NCT01184118|468871473|FG000|Overall Study|Withdrawal by Subject|5|||
130248388|NCT03632720|468871474|FG000|Overall Study|Adverse Event|2|||
130248389|NCT03632720|468871475|FG001|Overall Study|Adverse Event|0|||
130248390|NCT03632720|468871476|FG002|Overall Study|Adverse Event|0|||
130248391|NCT03632720|468871474|FG000|Overall Study|Lost to Follow-up|0|||
130248392|NCT03632720|468871475|FG001|Overall Study|Lost to Follow-up|1|||
130248393|NCT03632720|468871476|FG002|Overall Study|Lost to Follow-up|0|||
130248394|NCT03632720|468871474|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
130248395|NCT03632720|468871475|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
130248396|NCT03632720|468871476|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
130248397|NCT03632720|468871474|FG000|Overall Study|Screen failure|0|||
130248398|NCT03632720|468871475|FG001|Overall Study|Screen failure|1|||
130248399|NCT03632720|468871476|FG002|Overall Study|Screen failure|0|||
130248400|NCT00682435|468871477|FG000|Overall Study|Insufficient data|5|||
130248401|NCT00682435|468871477|FG000|Overall Study|Erroneously enrolled twice|2|||
130248402|NCT01049828|468871479|FG000|Overall Study|Claustrophibia and Frustration|2|||
130248403|NCT00290238|468871480|FG000|Overall Study|Study terminated|27|||
130248404|NCT00290238|468871481|FG001|Overall Study|Study terminated|27|||
130248405|NCT00290238|468871480|FG000|Overall Study|Lost to Follow-up|0|||
130248406|NCT00290238|468871481|FG001|Overall Study|Lost to Follow-up|1|||
130248407|NCT00290238|468871480|FG000|Overall Study|Withdrawal by Subject|15|||
130248408|NCT00290238|468871481|FG001|Overall Study|Withdrawal by Subject|13|||
130248409|NCT02186171|468871482|FG000|Overall Study|Withdrawal by Subject|1|||
130248410|NCT02186171|468871483|FG001|Overall Study|Withdrawal by Subject|9|||
130248411|NCT02186171|468871482|FG000|Overall Study|Lost to Follow-up|2|||
130248412|NCT02186171|468871483|FG001|Overall Study|Lost to Follow-up|2|||
130248413|NCT02186171|468871482|FG000|Overall Study|Death|1|||
130248414|NCT02186171|468871483|FG001|Overall Study|Death|2|||
130248415|NCT02186171|468871482|FG000|Overall Study|Protocol-specified Criteria|0|||
130248416|NCT02186171|468871483|FG001|Overall Study|Protocol-specified Criteria|2|||
130452399|NCT02138916|469619861|FG000|Overall Study|Study specific withdrawal criteria|0|||
130452400|NCT02138916|469619862|FG001|Overall Study|Study specific withdrawal criteria|0|||
130699595|NCT01332968|470524722|FG003|Induction Period|Randomised but not treated|0|||
130699596|NCT01332968|470524723|FG004|Induction Period|Randomised but not treated|0|||
130699597|NCT01332968|470524724|FG005|Induction Period|Randomised but not treated|0|||
130699598|NCT01332968|470524725|FG006|Induction Period|Randomised but not treated|0|||
130699599|NCT01332968|470524726|FG007|Induction Period|Randomised but not treated|0|||
130248417|NCT02946996|468871484|FG000|Overall Study|non-evaluable|3|||
130248418|NCT02946996|468871485|FG001|Overall Study|non-evaluable|6|||
130248419|NCT02946996|468871486|FG002|Overall Study|non-evaluable|5|||
130248420|NCT06868667|468871490|FG000|Overall Study|Death|0|||
130248421|NCT06868667|468871491|FG001|Overall Study|Death|4|||
130248422|NCT06868667|468871490|FG000|Overall Study|Lost to Follow-up|0|||
130248423|NCT06868667|468871491|FG001|Overall Study|Lost to Follow-up|1|||
130248424|NCT06868667|468871490|FG000|Overall Study|Withdrawal by Subject|1|||
130248425|NCT06868667|468871491|FG001|Overall Study|Withdrawal by Subject|0|||
130248426|NCT06868667|468871490|FG000|Overall Study|Ongoing|9|||
130248427|NCT06868667|468871491|FG001|Overall Study|Ongoing|9|||
130248428|NCT05330429|468871494|FG000|Overall Study|Study Terminated by Sponsor|4|||
130248429|NCT05330429|468871495|FG001|Overall Study|Study Terminated by Sponsor|33|||
130248430|NCT05330429|468871496|FG002|Overall Study|Study Terminated by Sponsor|12|||
130248431|NCT05330429|468871494|FG000|Overall Study|Death|5|||
130248432|NCT05330429|468871495|FG001|Overall Study|Death|2|||
130248433|NCT05330429|468871496|FG002|Overall Study|Death|4|||
130248434|NCT05330429|468871494|FG000|Overall Study|Withdrew Consent|0|||
130248435|NCT05330429|468871495|FG001|Overall Study|Withdrew Consent|5|||
130248436|NCT05330429|468871496|FG002|Overall Study|Withdrew Consent|4|||
130248437|NCT05330429|468871494|FG000|Overall Study|Investigator's Discretion|0|||
130248438|NCT05330429|468871495|FG001|Overall Study|Investigator's Discretion|1|||
130248439|NCT05330429|468871496|FG002|Overall Study|Investigator's Discretion|3|||
130248440|NCT05330429|468871494|FG000|Overall Study|Subject Decision|1|||
130248441|NCT05330429|468871495|FG001|Overall Study|Subject Decision|2|||
130248442|NCT05330429|468871496|FG002|Overall Study|Subject Decision|0|||
130248443|NCT05330429|468871494|FG000|Overall Study|Lost to Follow-up|0|||
130248444|NCT05330429|468871495|FG001|Overall Study|Lost to Follow-up|1|||
130248445|NCT05330429|468871496|FG002|Overall Study|Lost to Follow-up|0|||
130248446|NCT03572218|468871497|FG000|Overall Study|Lost to Follow-up|3|||
130248447|NCT03572218|468871498|FG001|Overall Study|Lost to Follow-up|2|||
130248448|NCT03572218|468871497|FG000|Overall Study|No longer available for study visits|2|||
130248449|NCT03572218|468871498|FG001|Overall Study|No longer available for study visits|1|||
130248450|NCT03572218|468871497|FG000|Overall Study|No longer interested|1|||
130248451|NCT03572218|468871498|FG001|Overall Study|No longer interested|2|||
130248452|NCT00286455|468871499|FG000|Overall Study|Hyperglycemia rescue|19|||
130248453|NCT00286455|468871500|FG001|Overall Study|Hyperglycemia rescue|13|||
130248454|NCT00286455|468871501|FG002|Overall Study|Hyperglycemia rescue|10|||
130248455|NCT00286455|468871499|FG000|Overall Study|Adverse Event|1|||
130248456|NCT00286455|468871500|FG001|Overall Study|Adverse Event|3|||
130248457|NCT00286455|468871501|FG002|Overall Study|Adverse Event|2|||
130248458|NCT00286455|468871499|FG000|Overall Study|Lost to Follow-up|0|||
130248459|NCT00286455|468871500|FG001|Overall Study|Lost to Follow-up|3|||
130248460|NCT00286455|468871501|FG002|Overall Study|Lost to Follow-up|3|||
130248461|NCT00286455|468871499|FG000|Overall Study|Physician Decision|3|||
130248462|NCT00286455|468871500|FG001|Overall Study|Physician Decision|0|||
130248463|NCT00286455|468871501|FG002|Overall Study|Physician Decision|2|||
130248464|NCT00286455|468871499|FG000|Overall Study|Protocol Violation|1|||
130248465|NCT00286455|468871500|FG001|Overall Study|Protocol Violation|1|||
130248466|NCT00286455|468871501|FG002|Overall Study|Protocol Violation|0|||
130248467|NCT00286455|468871499|FG000|Overall Study|Participant Non-compliance|1|||
130248468|NCT00286455|468871500|FG001|Overall Study|Participant Non-compliance|0|||
130248469|NCT00286455|468871501|FG002|Overall Study|Participant Non-compliance|0|||
130248470|NCT00286455|468871499|FG000|Overall Study|Withdrawal by Subject|0|||
130248471|NCT00286455|468871500|FG001|Overall Study|Withdrawal by Subject|8|||
130248472|NCT00286455|468871501|FG002|Overall Study|Withdrawal by Subject|7|||
130248473|NCT06097273|468871502|FG000|Overall Study|Death|2|||
130248474|NCT06097273|468871503|FG001|Overall Study|Death|1|||
130248475|NCT06097273|468871504|FG002|Overall Study|Death|2|||
130248476|NCT06097273|468871505|FG003|Overall Study|Death|2|||
130248477|NCT06097273|468871502|FG000|Overall Study|Lost to Follow-up|27|||
130364085|NCT04729621|469302117|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130364086|NCT04729621|469302118|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130364087|NCT04729621|469302119|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130364088|NCT04729621|469302115|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
130364089|NCT04729621|469302116|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
130364090|NCT04729621|469302117|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130364091|NCT04729621|469302118|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130364092|NCT04729621|469302119|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130364093|NCT04729621|469302115|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130364094|NCT04729621|469302116|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130364095|NCT04729621|469302117|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
130452401|NCT02138916|469619863|FG002|Overall Study|Study specific withdrawal criteria|1|||
130452402|NCT02138916|469619861|FG000|Overall Study|incorrect enrolment|1|||
130452403|NCT02138916|469619862|FG001|Overall Study|incorrect enrolment|1|||
130452404|NCT02138916|469619863|FG002|Overall Study|incorrect enrolment|0|||
130452405|NCT02138916|469619861|FG000|Overall Study|Severe non-compliance|1|||
130248478|NCT06097273|468871503|FG001|Overall Study|Lost to Follow-up|18|||
130248479|NCT06097273|468871504|FG002|Overall Study|Lost to Follow-up|36|||
130248480|NCT06097273|468871505|FG003|Overall Study|Lost to Follow-up|31|||
130248481|NCT06097273|468871502|FG000|Overall Study|Physician Decision|0|||
130248482|NCT06097273|468871503|FG001|Overall Study|Physician Decision|1|||
130248483|NCT06097273|468871504|FG002|Overall Study|Physician Decision|0|||
130248484|NCT06097273|468871505|FG003|Overall Study|Physician Decision|3|||
130248485|NCT06097273|468871502|FG000|Overall Study|Protocol Violation|1|||
130248486|NCT06097273|468871503|FG001|Overall Study|Protocol Violation|1|||
130248487|NCT06097273|468871504|FG002|Overall Study|Protocol Violation|2|||
130248488|NCT06097273|468871505|FG003|Overall Study|Protocol Violation|1|||
130248489|NCT06097273|468871502|FG000|Overall Study|Withdrawal by Subject|14|||
130248490|NCT06097273|468871503|FG001|Overall Study|Withdrawal by Subject|11|||
130248491|NCT06097273|468871504|FG002|Overall Study|Withdrawal by Subject|14|||
130248492|NCT06097273|468871505|FG003|Overall Study|Withdrawal by Subject|15|||
130248493|NCT06097273|468871502|FG000|Overall Study|Other Than Specified|7|||
130248494|NCT06097273|468871503|FG001|Overall Study|Other Than Specified|3|||
130248495|NCT06097273|468871504|FG002|Overall Study|Other Than Specified|11|||
130248496|NCT06097273|468871505|FG003|Overall Study|Other Than Specified|6|||
130248497|NCT00394472|468872924|FG000|Overall Study|Protocol Violation|1|||
130248498|NCT00394472|468872925|FG001|Overall Study|Protocol Violation|3|||
130248499|NCT00394472|468872924|FG000|Overall Study|incorrect enrolment|4|||
130248500|NCT00394472|468872925|FG001|Overall Study|incorrect enrolment|2|||
130248501|NCT00394472|468872924|FG000|Overall Study|Adverse Event|4|||
130248502|NCT00394472|468872925|FG001|Overall Study|Adverse Event|2|||
130248503|NCT00394472|468872924|FG000|Overall Study|Withdrawal by Subject|0|||
130248504|NCT00394472|468872925|FG001|Overall Study|Withdrawal by Subject|2|||
130248505|NCT00394472|468872924|FG000|Overall Study|Physician Decision|0|||
130248506|NCT00394472|468872925|FG001|Overall Study|Physician Decision|1|||
130248507|NCT00394472|468872924|FG000|Overall Study|Lost to Follow-up|0|||
130248508|NCT00394472|468872925|FG001|Overall Study|Lost to Follow-up|1|||
130248509|NCT03931785|468872926|FG000|Overall Study|Lost to Follow-up|4|||
130248510|NCT03931785|468872927|FG001|Overall Study|Lost to Follow-up|1|||
130248511|NCT03931785|468872928|FG002|Overall Study|Lost to Follow-up|4|||
130248512|NCT03931785|468872929|FG003|Overall Study|Lost to Follow-up|3|||
130248513|NCT03931785|468872926|FG000|Overall Study|Adverse Event|1|||
130248514|NCT03931785|468872927|FG001|Overall Study|Adverse Event|0|||
130248515|NCT03931785|468872928|FG002|Overall Study|Adverse Event|3|||
130248516|NCT03931785|468872929|FG003|Overall Study|Adverse Event|4|||
130248517|NCT03931785|468872926|FG000|Overall Study|Protocol Violation|0|||
130248518|NCT03931785|468872927|FG001|Overall Study|Protocol Violation|1|||
130248519|NCT03931785|468872928|FG002|Overall Study|Protocol Violation|0|||
130248520|NCT03931785|468872929|FG003|Overall Study|Protocol Violation|0|||
130248521|NCT03931785|468872926|FG000|Overall Study|Noncompliance With Study drug|0|||
130248522|NCT03931785|468872927|FG001|Overall Study|Noncompliance With Study drug|1|||
130248523|NCT03931785|468872928|FG002|Overall Study|Noncompliance With Study drug|0|||
130248524|NCT03931785|468872929|FG003|Overall Study|Noncompliance With Study drug|0|||
130248525|NCT03931785|468872926|FG000|Overall Study|Other Not specified|0|||
130248526|NCT03931785|468872927|FG001|Overall Study|Other Not specified|2|||
130248527|NCT03931785|468872928|FG002|Overall Study|Other Not specified|2|||
130248528|NCT03931785|468872929|FG003|Overall Study|Other Not specified|2|||
130248529|NCT03931785|468872926|FG000|Overall Study|Withdrawal by Subject|0|||
130248530|NCT03931785|468872927|FG001|Overall Study|Withdrawal by Subject|2|||
130248531|NCT03931785|468872928|FG002|Overall Study|Withdrawal by Subject|4|||
130248532|NCT03931785|468872929|FG003|Overall Study|Withdrawal by Subject|1|||
130248533|NCT03931785|468872926|FG000|Overall Study|Pregnancy|0|||
130248534|NCT03931785|468872927|FG001|Overall Study|Pregnancy|0|||
130248535|NCT03931785|468872928|FG002|Overall Study|Pregnancy|0|||
130248536|NCT03931785|468872929|FG003|Overall Study|Pregnancy|1|||
130248537|NCT04605588|468872933|FG000|Overall Study|Withdrawal by Subject|1|||
130248538|NCT04605588|468872934|FG001|Overall Study|Withdrawal by Subject|0|||
130248539|NCT01230814|468872935|FG000|Overall Study|Lost to Follow-up|11|||
130248540|NCT01230814|468872936|FG001|Overall Study|Lost to Follow-up|3|||
130248541|NCT01230814|468872935|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
130248542|NCT01230814|468872936|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
130248543|NCT01748552|468872939|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
130248544|NCT01748552|468872940|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
130248545|NCT01748552|468872941|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
130248546|NCT01748552|468872942|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
130248547|NCT01748552|468872943|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
130248548|NCT01748552|468872944|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
130452406|NCT02138916|469619862|FG001|Overall Study|Severe non-compliance|2|||
130452407|NCT02138916|469619863|FG002|Overall Study|Severe non-compliance|1|||
130452408|NCT02138916|469619861|FG000|Overall Study|Lost to Follow-up|4|||
130452409|NCT02138916|469619862|FG001|Overall Study|Lost to Follow-up|2|||
130452410|NCT02138916|469619863|FG002|Overall Study|Lost to Follow-up|3|||
130452411|NCT02138916|469619861|FG000|Overall Study|Adverse Event|4|||
130452412|NCT02138916|469619862|FG001|Overall Study|Adverse Event|4|||
130248549|NCT01748552|468872945|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
130248550|NCT01748552|468872946|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
130248551|NCT01748552|468872947|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
130248552|NCT01748552|468872948|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
130248553|NCT01748552|468872949|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
130248554|NCT01748552|468872950|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
130248555|NCT01748552|468872939|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130452413|NCT02138916|469619863|FG002|Overall Study|Adverse Event|3|||
130452414|NCT01348087|469619864|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
130248556|NCT01748552|468872940|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248557|NCT01748552|468872941|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248558|NCT01748552|468872942|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248559|NCT01748552|468872943|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248560|NCT01748552|468872944|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248561|NCT01748552|468872945|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248562|NCT01748552|468872946|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248563|NCT01748552|468872947|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248564|NCT01748552|468872948|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248565|NCT01748552|468872949|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248566|NCT01748552|468872950|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248567|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
130248568|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
130248569|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
130248570|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
130248571|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
130248572|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130248573|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130248574|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
130248575|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248576|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248577|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248578|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
130248579|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
130248580|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130248581|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130248582|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
130248583|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
130248584|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
130248585|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
130248586|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
130248587|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
130248588|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130248589|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
130248590|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130248591|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
130248592|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248593|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248594|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248595|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130248596|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130248597|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
130248598|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
130248599|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248600|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248601|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
130248602|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248603|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248604|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248605|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248606|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
130248607|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
130248608|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
130248609|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
130248610|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
130248611|NCT00004228|468872961|FG000|Overall Study|Adverse Event|0|||
130248612|NCT00004228|468872962|FG001|Overall Study|Adverse Event|1|||
130248613|NCT00004228|468872963|FG002|Overall Study|Adverse Event|0|||
130248614|NCT00004228|468872964|FG003|Overall Study|Adverse Event|0|||
130248615|NCT00004228|468872965|FG004|Overall Study|Adverse Event|1|||
130248616|NCT00004228|468872966|FG005|Overall Study|Adverse Event|0|||
130248617|NCT00004228|468872967|FG006|Overall Study|Adverse Event|0|||
130248618|NCT00004228|468872961|FG000|Overall Study|Death|0|||
130248619|NCT00004228|468872962|FG001|Overall Study|Death|1|||
130248620|NCT00004228|468872963|FG002|Overall Study|Death|2|||
130248621|NCT00004228|468872964|FG003|Overall Study|Death|0|||
130248622|NCT00004228|468872965|FG004|Overall Study|Death|1|||
130248623|NCT00004228|468872966|FG005|Overall Study|Death|0|||
130248624|NCT00004228|468872967|FG006|Overall Study|Death|0|||
130248625|NCT00004228|468872961|FG000|Overall Study|Lack of Efficacy|1|||
130248626|NCT00004228|468872962|FG001|Overall Study|Lack of Efficacy|6|||
130248627|NCT00004228|468872963|FG002|Overall Study|Lack of Efficacy|5|||
130248628|NCT00004228|468872964|FG003|Overall Study|Lack of Efficacy|3|||
130248629|NCT00004228|468872965|FG004|Overall Study|Lack of Efficacy|9|||
130248630|NCT00004228|468872966|FG005|Overall Study|Lack of Efficacy|8|||
130248631|NCT00004228|468872967|FG006|Overall Study|Lack of Efficacy|4|||
130248632|NCT00004228|468872961|FG000|Overall Study|Lost to Follow-up|0|||
130248633|NCT00004228|468872962|FG001|Overall Study|Lost to Follow-up|0|||
130248634|NCT00004228|468872963|FG002|Overall Study|Lost to Follow-up|1|||
130248635|NCT00004228|468872964|FG003|Overall Study|Lost to Follow-up|0|||
130248636|NCT00004228|468872965|FG004|Overall Study|Lost to Follow-up|0|||
130248637|NCT00004228|468872966|FG005|Overall Study|Lost to Follow-up|0|||
130248638|NCT00004228|468872967|FG006|Overall Study|Lost to Follow-up|0|||
130248639|NCT00004228|468872961|FG000|Overall Study|Physician Decision|1|||
130248640|NCT00004228|468872962|FG001|Overall Study|Physician Decision|0|||
130248641|NCT00004228|468872963|FG002|Overall Study|Physician Decision|3|||
130248642|NCT00004228|468872964|FG003|Overall Study|Physician Decision|2|||
130248643|NCT00004228|468872965|FG004|Overall Study|Physician Decision|1|||
130248644|NCT00004228|468872966|FG005|Overall Study|Physician Decision|1|||
130248645|NCT00004228|468872967|FG006|Overall Study|Physician Decision|1|||
130248646|NCT00004228|468872961|FG000|Overall Study|Protocol Violation|0|||
130248647|NCT00004228|468872962|FG001|Overall Study|Protocol Violation|5|||
130248648|NCT00004228|468872963|FG002|Overall Study|Protocol Violation|2|||
130248649|NCT00004228|468872964|FG003|Overall Study|Protocol Violation|1|||
130248650|NCT00004228|468872965|FG004|Overall Study|Protocol Violation|1|||
130248651|NCT00004228|468872966|FG005|Overall Study|Protocol Violation|2|||
130248652|NCT00004228|468872967|FG006|Overall Study|Protocol Violation|0|||
130248653|NCT00004228|468872961|FG000|Overall Study|Withdrawal by Subject|3|||
130248654|NCT00004228|468872962|FG001|Overall Study|Withdrawal by Subject|0|||
130248655|NCT00004228|468872963|FG002|Overall Study|Withdrawal by Subject|1|||
130248656|NCT00004228|468872964|FG003|Overall Study|Withdrawal by Subject|0|||
130248657|NCT00004228|468872965|FG004|Overall Study|Withdrawal by Subject|2|||
130248658|NCT00004228|468872966|FG005|Overall Study|Withdrawal by Subject|1|||
130248659|NCT00004228|468872967|FG006|Overall Study|Withdrawal by Subject|2|||
130248660|NCT00004228|468872961|FG000|Overall Study|Other|0|||
130248661|NCT00004228|468872962|FG001|Overall Study|Other|0|||
130248662|NCT00004228|468872963|FG002|Overall Study|Other|1|||
130248663|NCT00004228|468872964|FG003|Overall Study|Other|0|||
130248664|NCT00004228|468872965|FG004|Overall Study|Other|0|||
130248665|NCT00004228|468872966|FG005|Overall Study|Other|0|||
130248666|NCT00004228|468872967|FG006|Overall Study|Other|0|||
130248667|NCT00004228|468872961|FG000|Overall Study|ineligible|4|||
130248668|NCT00004228|468872962|FG001|Overall Study|ineligible|2|||
130248669|NCT00004228|468872963|FG002|Overall Study|ineligible|4|||
130248670|NCT00004228|468872964|FG003|Overall Study|ineligible|1|||
130248671|NCT00004228|468872965|FG004|Overall Study|ineligible|1|||
130248672|NCT00004228|468872966|FG005|Overall Study|ineligible|2|||
130248673|NCT00004228|468872967|FG006|Overall Study|ineligible|5|||
130248674|NCT02255279|468872968|FG000|Overall Study|Lost to Follow-up|2|||
130248675|NCT02255279|468872969|FG001|Overall Study|Lost to Follow-up|2|||
130248676|NCT02255279|468872968|FG000|Overall Study|Protocol Violation|0|||
130248677|NCT02255279|468872969|FG001|Overall Study|Protocol Violation|1|||
130248678|NCT02255279|468872968|FG000|Overall Study|Withdrawal by Subject|3|||
130248679|NCT02255279|468872969|FG001|Overall Study|Withdrawal by Subject|6|||
130248680|NCT00363467|468872970|FG000|Overall Study|Physician Decision|1|||
130248681|NCT00903344|468872971|FG000|Overall Study|Pregnancy|2|||
130248682|NCT00903344|468872972|FG001|Overall Study|Pregnancy|3|||
130248683|NCT00903344|468872971|FG000|Overall Study|Lost to Follow-up|3|||
130248684|NCT00903344|468872972|FG001|Overall Study|Lost to Follow-up|0|||
130248685|NCT01524705|468872973|FG000|Overall Study|Adverse Event|2|||
130248686|NCT01524705|468872974|FG001|Overall Study|Adverse Event|0|||
130248687|NCT01524705|468872973|FG000|Overall Study|Death|1|||
130248688|NCT01524705|468872974|FG001|Overall Study|Death|0|||
130248689|NCT01524705|468872973|FG000|Overall Study|Lost to Follow-up|0|||
130248690|NCT01524705|468872974|FG001|Overall Study|Lost to Follow-up|1|||
130248691|NCT01524705|468872973|FG000|Overall Study|Withdrawal by Subject|0|||
130248692|NCT01524705|468872974|FG001|Overall Study|Withdrawal by Subject|1|||
130248693|NCT01524705|468872973|FG000|Overall Study|Pancreatic Cancer|0|||
130248694|NCT01524705|468872974|FG001|Overall Study|Pancreatic Cancer|1|||
130248695|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
130248696|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
130248697|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
130248698|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
130248699|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130248700|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
130248701|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
130248702|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
130248703|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
130248704|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
130248705|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
130248706|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130248707|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
130248708|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
130248709|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
130248710|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
130248711|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130248712|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130248713|NCT01755156|468872975|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
130248714|NCT01755156|468872976|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
130248715|NCT01755156|468872975|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
130248716|NCT01755156|468872976|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
130248717|NCT00527748|468872979|FG000|Overall Study|Other|3|||
130248718|NCT01093885|468872981|FG000|Overall Study|Adverse Event|4|||
130248719|NCT01093885|468872981|FG000|Overall Study|Lost to Follow-up|1|||
130248720|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
130248721|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130248722|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130248723|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
130248724|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130248725|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130248726|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
130248727|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130248728|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130248729|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
130248730|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130248731|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130248732|NCT00292370|468872982|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
130248733|NCT00292370|468872983|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
130248734|NCT00292370|468872984|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
130248735|NCT00292370|468872982|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
130248736|NCT00292370|468872983|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
130248737|NCT00292370|468872984|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
130248738|NCT02533674|468872985|FG000|Dose Level I|Progressive disease|1|||
130248739|NCT02533674|468872986|FG001|Dose Level I|Progressive disease|0|||
130248740|NCT02533674|468872987|FG002|Dose Level I|Progressive disease|0|||
130248741|NCT02533674|468872988|FG003|Dose Level I|Progressive disease|0|||
130248742|NCT02533674|468872989|FG004|Dose Level I|Progressive disease|0|||
130248743|NCT02533674|468872990|FG005|Dose Level I|Progressive disease|0|||
130248744|NCT02533674|468872991|FG006|Dose Level I|Progressive disease|0|||
130248745|NCT02533674|468872992|FG007|Dose Level I|Progressive disease|0|||
130248746|NCT02533674|468872985|FG000|Dose Level I|Withdrawal by Subject|1|||
130248747|NCT02533674|468872986|FG001|Dose Level I|Withdrawal by Subject|0|||
130248748|NCT02533674|468872987|FG002|Dose Level I|Withdrawal by Subject|0|||
130248749|NCT02533674|468872988|FG003|Dose Level I|Withdrawal by Subject|0|||
130248750|NCT02533674|468872989|FG004|Dose Level I|Withdrawal by Subject|0|||
130248751|NCT02533674|468872990|FG005|Dose Level I|Withdrawal by Subject|0|||
130248752|NCT02533674|468872991|FG006|Dose Level I|Withdrawal by Subject|0|||
130248753|NCT02533674|468872992|FG007|Dose Level I|Withdrawal by Subject|0|||
130248754|NCT02533674|468872985|FG000|Dose Level I|Physician Decision|1|||
130248755|NCT02533674|468872986|FG001|Dose Level I|Physician Decision|0|||
130248756|NCT02533674|468872987|FG002|Dose Level I|Physician Decision|0|||
130248757|NCT02533674|468872988|FG003|Dose Level I|Physician Decision|0|||
130248758|NCT02533674|468872989|FG004|Dose Level I|Physician Decision|0|||
130248759|NCT02533674|468872990|FG005|Dose Level I|Physician Decision|0|||
130248760|NCT02533674|468872991|FG006|Dose Level I|Physician Decision|0|||
130248761|NCT02533674|468872992|FG007|Dose Level I|Physician Decision|0|||
130248762|NCT02533674|468872985|FG000|Dose Level I|Death|1|||
130248763|NCT02533674|468872986|FG001|Dose Level I|Death|0|||
130248764|NCT02533674|468872987|FG002|Dose Level I|Death|0|||
130248765|NCT02533674|468872988|FG003|Dose Level I|Death|0|||
130248766|NCT02533674|468872989|FG004|Dose Level I|Death|0|||
130248767|NCT02533674|468872990|FG005|Dose Level I|Death|0|||
130364096|NCT04729621|469302118|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
130364097|NCT04729621|469302119|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
130364098|NCT04729621|469302115|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130364099|NCT04729621|469302116|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130364100|NCT04729621|469302117|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130364101|NCT04729621|469302118|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
130248768|NCT02533674|468872991|FG006|Dose Level I|Death|0|||
130248769|NCT02533674|468872992|FG007|Dose Level I|Death|0|||
130248770|NCT02533674|468872985|FG000|Dose Level I|Never Treated|1|||
130248771|NCT02533674|468872986|FG001|Dose Level I|Never Treated|0|||
130699600|NCT01332968|470524719|FG000|Maintenance/Observation Period|Adverse Event|0|||
130699601|NCT01332968|470524720|FG001|Maintenance/Observation Period|Adverse Event|0|||
130248772|NCT02533674|468872987|FG002|Dose Level I|Never Treated|0|||
130248773|NCT02533674|468872988|FG003|Dose Level I|Never Treated|0|||
130248774|NCT02533674|468872989|FG004|Dose Level I|Never Treated|0|||
130248775|NCT02533674|468872990|FG005|Dose Level I|Never Treated|0|||
130248776|NCT02533674|468872991|FG006|Dose Level I|Never Treated|0|||
130248777|NCT02533674|468872992|FG007|Dose Level I|Never Treated|0|||
130248778|NCT02533674|468872985|FG000|Dose Level II|Progressive disease|0|||
130248779|NCT02533674|468872986|FG001|Dose Level II|Progressive disease|3|||
130248780|NCT02533674|468872987|FG002|Dose Level II|Progressive disease|0|||
130248781|NCT02533674|468872988|FG003|Dose Level II|Progressive disease|0|||
130248782|NCT02533674|468872989|FG004|Dose Level II|Progressive disease|0|||
130248783|NCT02533674|468872990|FG005|Dose Level II|Progressive disease|0|||
130248784|NCT02533674|468872991|FG006|Dose Level II|Progressive disease|0|||
130248785|NCT02533674|468872992|FG007|Dose Level II|Progressive disease|0|||
130248786|NCT02533674|468872985|FG000|Dose Level II|Withdrawal by Subject|0|||
130248787|NCT02533674|468872986|FG001|Dose Level II|Withdrawal by Subject|1|||
130248788|NCT02533674|468872987|FG002|Dose Level II|Withdrawal by Subject|0|||
130248789|NCT02533674|468872988|FG003|Dose Level II|Withdrawal by Subject|0|||
130248790|NCT02533674|468872989|FG004|Dose Level II|Withdrawal by Subject|0|||
130248791|NCT02533674|468872990|FG005|Dose Level II|Withdrawal by Subject|0|||
130248792|NCT02533674|468872991|FG006|Dose Level II|Withdrawal by Subject|0|||
130699602|NCT01332968|470524721|FG002|Maintenance/Observation Period|Adverse Event|53|||
130699603|NCT01332968|470524722|FG003|Maintenance/Observation Period|Adverse Event|66|||
130248793|NCT02533674|468872992|FG007|Dose Level II|Withdrawal by Subject|0|||
130248794|NCT02533674|468872985|FG000|Dose Level II|Treatment-related AE|0|||
130248795|NCT02533674|468872986|FG001|Dose Level II|Treatment-related AE|1|||
130248796|NCT02533674|468872987|FG002|Dose Level II|Treatment-related AE|0|||
130248797|NCT02533674|468872988|FG003|Dose Level II|Treatment-related AE|0|||
130248798|NCT02533674|468872989|FG004|Dose Level II|Treatment-related AE|0|||
130248799|NCT02533674|468872990|FG005|Dose Level II|Treatment-related AE|0|||
130248800|NCT02533674|468872991|FG006|Dose Level II|Treatment-related AE|0|||
130248801|NCT02533674|468872992|FG007|Dose Level II|Treatment-related AE|0|||
130248802|NCT02533674|468872985|FG000|Dose Level II|Physician Decision|0|||
130248803|NCT02533674|468872986|FG001|Dose Level II|Physician Decision|1|||
130699604|NCT01332968|470524723|FG004|Maintenance/Observation Period|Adverse Event|0|||
130699605|NCT01332968|470524724|FG005|Maintenance/Observation Period|Adverse Event|0|||
130248804|NCT02533674|468872987|FG002|Dose Level II|Physician Decision|0|||
130248805|NCT02533674|468872988|FG003|Dose Level II|Physician Decision|0|||
130248806|NCT02533674|468872989|FG004|Dose Level II|Physician Decision|0|||
130248807|NCT02533674|468872990|FG005|Dose Level II|Physician Decision|0|||
130248808|NCT02533674|468872991|FG006|Dose Level II|Physician Decision|0|||
130248809|NCT02533674|468872992|FG007|Dose Level II|Physician Decision|0|||
130248810|NCT02533674|468872985|FG000|Dose Level II|Non-treatment-related AE|0|||
130248811|NCT02533674|468872986|FG001|Dose Level II|Non-treatment-related AE|1|||
130248812|NCT02533674|468872987|FG002|Dose Level II|Non-treatment-related AE|0|||
130248813|NCT02533674|468872988|FG003|Dose Level II|Non-treatment-related AE|0|||
130248814|NCT02533674|468872989|FG004|Dose Level II|Non-treatment-related AE|0|||
130248815|NCT02533674|468872990|FG005|Dose Level II|Non-treatment-related AE|0|||
130248816|NCT02533674|468872991|FG006|Dose Level II|Non-treatment-related AE|0|||
130248817|NCT02533674|468872992|FG007|Dose Level II|Non-treatment-related AE|0|||
130248818|NCT02533674|468872985|FG000|Dose Level III|Progressive disease|0|||
130248819|NCT02533674|468872986|FG001|Dose Level III|Progressive disease|0|||
130248820|NCT02533674|468872987|FG002|Dose Level III|Progressive disease|2|||
130248821|NCT02533674|468872988|FG003|Dose Level III|Progressive disease|0|||
130248822|NCT02533674|468872989|FG004|Dose Level III|Progressive disease|0|||
130248823|NCT02533674|468872990|FG005|Dose Level III|Progressive disease|0|||
130248824|NCT02533674|468872991|FG006|Dose Level III|Progressive disease|0|||
130248825|NCT02533674|468872992|FG007|Dose Level III|Progressive disease|0|||
130248826|NCT02533674|468872985|FG000|Dose Level III|Withdrawal by Subject|0|||
130248827|NCT02533674|468872986|FG001|Dose Level III|Withdrawal by Subject|0|||
130699606|NCT01332968|470524725|FG006|Maintenance/Observation Period|Adverse Event|0|||
130699607|NCT01332968|470524726|FG007|Maintenance/Observation Period|Adverse Event|0|||
130248828|NCT02533674|468872987|FG002|Dose Level III|Withdrawal by Subject|1|||
130248829|NCT02533674|468872988|FG003|Dose Level III|Withdrawal by Subject|0|||
130248830|NCT02533674|468872989|FG004|Dose Level III|Withdrawal by Subject|0|||
130248831|NCT02533674|468872990|FG005|Dose Level III|Withdrawal by Subject|0|||
130248832|NCT02533674|468872991|FG006|Dose Level III|Withdrawal by Subject|0|||
130248833|NCT02533674|468872992|FG007|Dose Level III|Withdrawal by Subject|0|||
130248834|NCT02533674|468872985|FG000|Dose Level III|Treatment-related AE|0|||
130248835|NCT02533674|468872986|FG001|Dose Level III|Treatment-related AE|0|||
130248836|NCT02533674|468872987|FG002|Dose Level III|Treatment-related AE|1|||
130248837|NCT02533674|468872988|FG003|Dose Level III|Treatment-related AE|0|||
130248838|NCT02533674|468872989|FG004|Dose Level III|Treatment-related AE|0|||
130248839|NCT02533674|468872990|FG005|Dose Level III|Treatment-related AE|0|||
130248840|NCT02533674|468872991|FG006|Dose Level III|Treatment-related AE|0|||
130248841|NCT02533674|468872992|FG007|Dose Level III|Treatment-related AE|0|||
130248842|NCT02533674|468872985|FG000|Dose Level IV|Progressive disease|0|||
130248843|NCT02533674|468872986|FG001|Dose Level IV|Progressive disease|0|||
130248844|NCT02533674|468872987|FG002|Dose Level IV|Progressive disease|0|||
130248845|NCT02533674|468872988|FG003|Dose Level IV|Progressive disease|3|||
130248846|NCT02533674|468872989|FG004|Dose Level IV|Progressive disease|0|||
130248847|NCT02533674|468872990|FG005|Dose Level IV|Progressive disease|0|||
130248848|NCT02533674|468872991|FG006|Dose Level IV|Progressive disease|0|||
130248849|NCT02533674|468872992|FG007|Dose Level IV|Progressive disease|0|||
130248850|NCT02533674|468872985|FG000|Dose Level IV|Withdrawal by Subject|0|||
130699608|NCT01332968|470524719|FG000|Maintenance/Observation Period|Death|0|||
130699609|NCT01332968|470524720|FG001|Maintenance/Observation Period|Death|0|||
130699610|NCT01332968|470524721|FG002|Maintenance/Observation Period|Death|5|||
130699611|NCT01332968|470524722|FG003|Maintenance/Observation Period|Death|6|||
130699612|NCT01332968|470524723|FG004|Maintenance/Observation Period|Death|0|||
130699613|NCT01332968|470524724|FG005|Maintenance/Observation Period|Death|0|||
130699614|NCT01332968|470524725|FG006|Maintenance/Observation Period|Death|0|||
130699615|NCT01332968|470524726|FG007|Maintenance/Observation Period|Death|0|||
130699616|NCT01332968|470524719|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
130699617|NCT01332968|470524720|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
130699618|NCT01332968|470524721|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
130699619|NCT01332968|470524722|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
130699620|NCT01332968|470524723|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
130699621|NCT01332968|470524724|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
130699622|NCT01332968|470524725|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
130699623|NCT01332968|470524726|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
130699624|NCT01332968|470524719|FG000|Maintenance/Observation Period|Non-compliance|0|||
130699625|NCT01332968|470524720|FG001|Maintenance/Observation Period|Non-compliance|0|||
130699626|NCT01332968|470524721|FG002|Maintenance/Observation Period|Non-compliance|4|||
130699627|NCT01332968|470524722|FG003|Maintenance/Observation Period|Non-compliance|3|||
130699628|NCT01332968|470524723|FG004|Maintenance/Observation Period|Non-compliance|0|||
130699629|NCT01332968|470524724|FG005|Maintenance/Observation Period|Non-compliance|0|||
130699630|NCT01332968|470524725|FG006|Maintenance/Observation Period|Non-compliance|0|||
130699631|NCT01332968|470524726|FG007|Maintenance/Observation Period|Non-compliance|0|||
130699632|NCT01332968|470524719|FG000|Maintenance/Observation Period|Other|0|||
130699633|NCT01332968|470524720|FG001|Maintenance/Observation Period|Other|0|||
130699634|NCT01332968|470524721|FG002|Maintenance/Observation Period|Other|4|||
130699635|NCT01332968|470524722|FG003|Maintenance/Observation Period|Other|7|||
130699636|NCT01332968|470524723|FG004|Maintenance/Observation Period|Other|0|||
130699637|NCT01332968|470524724|FG005|Maintenance/Observation Period|Other|0|||
130699638|NCT01332968|470524725|FG006|Maintenance/Observation Period|Other|0|||
130699639|NCT01332968|470524726|FG007|Maintenance/Observation Period|Other|0|||
130699640|NCT01332968|470524719|FG000|Maintenance/Observation Period|Physician Decision|0|||
130699641|NCT01332968|470524720|FG001|Maintenance/Observation Period|Physician Decision|0|||
130699642|NCT01332968|470524721|FG002|Maintenance/Observation Period|Physician Decision|14|||
130699643|NCT01332968|470524722|FG003|Maintenance/Observation Period|Physician Decision|19|||
130699644|NCT01332968|470524723|FG004|Maintenance/Observation Period|Physician Decision|0|||
130699645|NCT01332968|470524724|FG005|Maintenance/Observation Period|Physician Decision|1|||
130699646|NCT01332968|470524725|FG006|Maintenance/Observation Period|Physician Decision|0|||
130699647|NCT01332968|470524726|FG007|Maintenance/Observation Period|Physician Decision|0|||
130699648|NCT01332968|470524719|FG000|Maintenance/Observation Period|Progressive Disease|0|||
130699649|NCT01332968|470524720|FG001|Maintenance/Observation Period|Progressive Disease|0|||
130699650|NCT01332968|470524721|FG002|Maintenance/Observation Period|Progressive Disease|72|||
130699651|NCT01332968|470524722|FG003|Maintenance/Observation Period|Progressive Disease|40|||
130699652|NCT01332968|470524723|FG004|Maintenance/Observation Period|Progressive Disease|0|||
130699653|NCT01332968|470524724|FG005|Maintenance/Observation Period|Progressive Disease|0|||
130699654|NCT01332968|470524725|FG006|Maintenance/Observation Period|Progressive Disease|0|||
130699655|NCT01332968|470524726|FG007|Maintenance/Observation Period|Progressive Disease|0|||
130248851|NCT02533674|468872986|FG001|Dose Level IV|Withdrawal by Subject|0|||
130699656|NCT01332968|470524719|FG000|Maintenance/Observation Period|Protocol Violation|0|||
130699657|NCT01332968|470524720|FG001|Maintenance/Observation Period|Protocol Violation|0|||
130699658|NCT01332968|470524721|FG002|Maintenance/Observation Period|Protocol Violation|1|||
130699659|NCT01332968|470524722|FG003|Maintenance/Observation Period|Protocol Violation|1|||
130699660|NCT01332968|470524723|FG004|Maintenance/Observation Period|Protocol Violation|0|||
130248852|NCT02533674|468872987|FG002|Dose Level IV|Withdrawal by Subject|0|||
130248853|NCT02533674|468872988|FG003|Dose Level IV|Withdrawal by Subject|1|||
130248854|NCT02533674|468872989|FG004|Dose Level IV|Withdrawal by Subject|0|||
130248855|NCT02533674|468872990|FG005|Dose Level IV|Withdrawal by Subject|0|||
130248856|NCT02533674|468872991|FG006|Dose Level IV|Withdrawal by Subject|0|||
130248857|NCT02533674|468872992|FG007|Dose Level IV|Withdrawal by Subject|0|||
130248858|NCT02533674|468872985|FG000|Dose Level IV|Physician Decision|0|||
130248859|NCT02533674|468872986|FG001|Dose Level IV|Physician Decision|0|||
130248860|NCT02533674|468872987|FG002|Dose Level IV|Physician Decision|0|||
130248861|NCT02533674|468872988|FG003|Dose Level IV|Physician Decision|1|||
130248862|NCT02533674|468872989|FG004|Dose Level IV|Physician Decision|0|||
130248863|NCT02533674|468872990|FG005|Dose Level IV|Physician Decision|0|||
130248864|NCT02533674|468872991|FG006|Dose Level IV|Physician Decision|0|||
130248865|NCT02533674|468872992|FG007|Dose Level IV|Physician Decision|0|||
130248866|NCT02533674|468872985|FG000|Dose Level V|Progressive disease|0|||
130248867|NCT02533674|468872986|FG001|Dose Level V|Progressive disease|0|||
130248868|NCT02533674|468872987|FG002|Dose Level V|Progressive disease|0|||
130248869|NCT02533674|468872988|FG003|Dose Level V|Progressive disease|0|||
130248870|NCT02533674|468872989|FG004|Dose Level V|Progressive disease|3|||
130248871|NCT02533674|468872990|FG005|Dose Level V|Progressive disease|0|||
130248872|NCT02533674|468872991|FG006|Dose Level V|Progressive disease|0|||
130248873|NCT02533674|468872992|FG007|Dose Level V|Progressive disease|0|||
130248874|NCT02533674|468872985|FG000|Dose Level V|Withdrawal by Subject|0|||
130248875|NCT02533674|468872986|FG001|Dose Level V|Withdrawal by Subject|0|||
130248876|NCT02533674|468872987|FG002|Dose Level V|Withdrawal by Subject|0|||
130248877|NCT02533674|468872988|FG003|Dose Level V|Withdrawal by Subject|0|||
130248878|NCT02533674|468872989|FG004|Dose Level V|Withdrawal by Subject|1|||
130248879|NCT02533674|468872990|FG005|Dose Level V|Withdrawal by Subject|0|||
130248880|NCT02533674|468872991|FG006|Dose Level V|Withdrawal by Subject|0|||
130248881|NCT02533674|468872992|FG007|Dose Level V|Withdrawal by Subject|0|||
130248882|NCT02533674|468872985|FG000|Dose Level V|Physician Decision|0|||
130248883|NCT02533674|468872986|FG001|Dose Level V|Physician Decision|0|||
130248884|NCT02533674|468872987|FG002|Dose Level V|Physician Decision|0|||
130248885|NCT02533674|468872988|FG003|Dose Level V|Physician Decision|0|||
130248886|NCT02533674|468872989|FG004|Dose Level V|Physician Decision|1|||
130248887|NCT02533674|468872990|FG005|Dose Level V|Physician Decision|0|||
130248888|NCT02533674|468872991|FG006|Dose Level V|Physician Decision|0|||
130248889|NCT02533674|468872992|FG007|Dose Level V|Physician Decision|0|||
130248890|NCT02533674|468872985|FG000|Dose Level VI|Progressive disease|0|||
130248891|NCT02533674|468872986|FG001|Dose Level VI|Progressive disease|0|||
130248892|NCT02533674|468872987|FG002|Dose Level VI|Progressive disease|0|||
130248893|NCT02533674|468872988|FG003|Dose Level VI|Progressive disease|0|||
130248894|NCT02533674|468872989|FG004|Dose Level VI|Progressive disease|0|||
130248895|NCT02533674|468872990|FG005|Dose Level VI|Progressive disease|7|||
130248896|NCT02533674|468872991|FG006|Dose Level VI|Progressive disease|0|||
130248897|NCT02533674|468872992|FG007|Dose Level VI|Progressive disease|0|||
130248898|NCT02533674|468872985|FG000|Dose Level VI|Withdrawal by Subject|0|||
130248899|NCT02533674|468872986|FG001|Dose Level VI|Withdrawal by Subject|0|||
130248900|NCT02533674|468872987|FG002|Dose Level VI|Withdrawal by Subject|0|||
130248901|NCT02533674|468872988|FG003|Dose Level VI|Withdrawal by Subject|0|||
130248902|NCT02533674|468872989|FG004|Dose Level VI|Withdrawal by Subject|0|||
130248903|NCT02533674|468872990|FG005|Dose Level VI|Withdrawal by Subject|1|||
130452415|NCT01348087|469619864|FG000|Overall Study|Administrative problems|79|||
130452416|NCT01348087|469619864|FG000|Overall Study|protocol deviation|1|||
130452417|NCT01348087|469619864|FG000|Overall Study|Lost to Follow-up|1|||
130452418|NCT01348087|469619864|FG000|Overall Study|Subject withdrew consent|7|||
130452419|NCT01348087|469619864|FG000|Overall Study|Adverse Event|25|||
130452420|NCT00117988|469619867|FG000|Overall Study|Death|3|||
130452421|NCT00117988|469619867|FG000|Overall Study|Adverse Event|1|||
130452422|NCT05096884|469619868|FG000|Overall Study|Excluded based on negative tilt table test|4|||
130452423|NCT04794179|469619869|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
130452424|NCT04794179|469619870|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
130452425|NCT01096056|469619871|FG000|Overall Study|Lost to Follow-up|0|||
130452426|NCT01096056|469619872|FG001|Overall Study|Lost to Follow-up|1|||
130452427|NCT03781804|469619876|FG000|Overall Study|Adverse Event|2|||
130452428|NCT03781804|469619877|FG001|Overall Study|Adverse Event|2|||
130452429|NCT03781804|469619878|FG002|Overall Study|Adverse Event|3|||
130452430|NCT03781804|469619876|FG000|Overall Study|Lost to Follow-up|1|||
130452431|NCT03781804|469619877|FG001|Overall Study|Lost to Follow-up|1|||
130248904|NCT02533674|468872991|FG006|Dose Level VI|Withdrawal by Subject|0|||
130248905|NCT02533674|468872992|FG007|Dose Level VI|Withdrawal by Subject|0|||
130248906|NCT02533674|468872985|FG000|Dose Level VI|Treatment-related AE|0|||
130248907|NCT02533674|468872986|FG001|Dose Level VI|Treatment-related AE|0|||
130248908|NCT02533674|468872987|FG002|Dose Level VI|Treatment-related AE|0|||
130248909|NCT02533674|468872988|FG003|Dose Level VI|Treatment-related AE|0|||
130248910|NCT02533674|468872989|FG004|Dose Level VI|Treatment-related AE|0|||
130452432|NCT03781804|469619878|FG002|Overall Study|Lost to Follow-up|2|||
130452433|NCT03781804|469619876|FG000|Overall Study|Lack of Efficacy|4|||
130248911|NCT02533674|468872990|FG005|Dose Level VI|Treatment-related AE|1|||
130248912|NCT02533674|468872991|FG006|Dose Level VI|Treatment-related AE|0|||
130248913|NCT02533674|468872992|FG007|Dose Level VI|Treatment-related AE|0|||
130248914|NCT02533674|468872985|FG000|Dose Level VII|Progressive disease|0|||
130248915|NCT02533674|468872986|FG001|Dose Level VII|Progressive disease|0|||
130248916|NCT02533674|468872987|FG002|Dose Level VII|Progressive disease|0|||
130248917|NCT02533674|468872988|FG003|Dose Level VII|Progressive disease|0|||
130248918|NCT02533674|468872989|FG004|Dose Level VII|Progressive disease|0|||
130248919|NCT02533674|468872990|FG005|Dose Level VII|Progressive disease|0|||
130248920|NCT02533674|468872991|FG006|Dose Level VII|Progressive disease|10|||
130248921|NCT02533674|468872992|FG007|Dose Level VII|Progressive disease|0|||
130248922|NCT02533674|468872985|FG000|Dose Level VII|Withdrawal by Subject|0|||
130248923|NCT02533674|468872986|FG001|Dose Level VII|Withdrawal by Subject|0|||
130248924|NCT02533674|468872987|FG002|Dose Level VII|Withdrawal by Subject|0|||
130248925|NCT02533674|468872988|FG003|Dose Level VII|Withdrawal by Subject|0|||
130248926|NCT02533674|468872989|FG004|Dose Level VII|Withdrawal by Subject|0|||
130248927|NCT02533674|468872990|FG005|Dose Level VII|Withdrawal by Subject|0|||
130248928|NCT02533674|468872991|FG006|Dose Level VII|Withdrawal by Subject|3|||
130248929|NCT02533674|468872992|FG007|Dose Level VII|Withdrawal by Subject|0|||
130248930|NCT02533674|468872985|FG000|Dose Level VII|Treatment-related AE|0|||
130248931|NCT02533674|468872986|FG001|Dose Level VII|Treatment-related AE|0|||
130248932|NCT02533674|468872987|FG002|Dose Level VII|Treatment-related AE|0|||
130452434|NCT03781804|469619877|FG001|Overall Study|Lack of Efficacy|2|||
130248933|NCT02533674|468872988|FG003|Dose Level VII|Treatment-related AE|0|||
130248934|NCT02533674|468872989|FG004|Dose Level VII|Treatment-related AE|0|||
130248935|NCT02533674|468872990|FG005|Dose Level VII|Treatment-related AE|0|||
130248936|NCT02533674|468872991|FG006|Dose Level VII|Treatment-related AE|1|||
130248937|NCT02533674|468872992|FG007|Dose Level VII|Treatment-related AE|0|||
130248938|NCT02533674|468872985|FG000|Dose Level VII|Death|0|||
130248939|NCT02533674|468872986|FG001|Dose Level VII|Death|0|||
130248940|NCT02533674|468872987|FG002|Dose Level VII|Death|0|||
130248941|NCT02533674|468872988|FG003|Dose Level VII|Death|0|||
130248942|NCT02533674|468872989|FG004|Dose Level VII|Death|0|||
130248943|NCT02533674|468872990|FG005|Dose Level VII|Death|0|||
130248944|NCT02533674|468872991|FG006|Dose Level VII|Death|2|||
130248945|NCT02533674|468872992|FG007|Dose Level VII|Death|0|||
130248946|NCT02533674|468872985|FG000|Dose Level VIII|Progressive disease|0|||
130248947|NCT02533674|468872986|FG001|Dose Level VIII|Progressive disease|0|||
130248948|NCT02533674|468872987|FG002|Dose Level VIII|Progressive disease|0|||
130248949|NCT02533674|468872988|FG003|Dose Level VIII|Progressive disease|0|||
130248950|NCT02533674|468872989|FG004|Dose Level VIII|Progressive disease|0|||
130248951|NCT02533674|468872990|FG005|Dose Level VIII|Progressive disease|0|||
130248952|NCT02533674|468872991|FG006|Dose Level VIII|Progressive disease|0|||
130248953|NCT02533674|468872992|FG007|Dose Level VIII|Progressive disease|3|||
130248954|NCT02533674|468872985|FG000|Dose Level VIII|Withdrawal by Subject|0|||
130248955|NCT02533674|468872986|FG001|Dose Level VIII|Withdrawal by Subject|0|||
130248956|NCT02533674|468872987|FG002|Dose Level VIII|Withdrawal by Subject|0|||
130248957|NCT02533674|468872988|FG003|Dose Level VIII|Withdrawal by Subject|0|||
130248958|NCT02533674|468872989|FG004|Dose Level VIII|Withdrawal by Subject|0|||
130248959|NCT02533674|468872990|FG005|Dose Level VIII|Withdrawal by Subject|0|||
130248960|NCT02533674|468872991|FG006|Dose Level VIII|Withdrawal by Subject|0|||
130248961|NCT02533674|468872992|FG007|Dose Level VIII|Withdrawal by Subject|1|||
130248962|NCT02533674|468872985|FG000|Dose Level VIII|Treatment-related AE|0|||
130248963|NCT02533674|468872986|FG001|Dose Level VIII|Treatment-related AE|0|||
130248964|NCT02533674|468872987|FG002|Dose Level VIII|Treatment-related AE|0|||
130248965|NCT02533674|468872988|FG003|Dose Level VIII|Treatment-related AE|0|||
130248966|NCT02533674|468872989|FG004|Dose Level VIII|Treatment-related AE|0|||
130248967|NCT02533674|468872990|FG005|Dose Level VIII|Treatment-related AE|0|||
130248968|NCT02533674|468872991|FG006|Dose Level VIII|Treatment-related AE|0|||
130248969|NCT02533674|468872992|FG007|Dose Level VIII|Treatment-related AE|1|||
130248970|NCT02533674|468872985|FG000|Dose Level VIII|Never treated|0|||
130248971|NCT02533674|468872986|FG001|Dose Level VIII|Never treated|0|||
130248972|NCT02533674|468872987|FG002|Dose Level VIII|Never treated|0|||
130248973|NCT02533674|468872988|FG003|Dose Level VIII|Never treated|0|||
130452435|NCT03781804|469619878|FG002|Overall Study|Lack of Efficacy|9|||
130452436|NCT03781804|469619876|FG000|Overall Study|Protocol Violation|0|||
130248974|NCT02533674|468872989|FG004|Dose Level VIII|Never treated|0|||
130248975|NCT02533674|468872990|FG005|Dose Level VIII|Never treated|0|||
130248976|NCT02533674|468872991|FG006|Dose Level VIII|Never treated|0|||
130248977|NCT02533674|468872992|FG007|Dose Level VIII|Never treated|1|||
130248978|NCT01560988|468872993|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
130248979|NCT01560988|468872994|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
130248980|NCT01560988|468872993|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
130248981|NCT01560988|468872994|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
130248982|NCT01560988|468872993|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
130248983|NCT01560988|468872994|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
130248984|NCT01346709|468872995|FG000|Overall Study|Protocol Violation|35|||
130248985|NCT01346709|468872995|FG000|Overall Study|Lost to Follow-up|31|||
130452437|NCT03781804|469619877|FG001|Overall Study|Protocol Violation|0|||
130699661|NCT01332968|470524724|FG005|Maintenance/Observation Period|Protocol Violation|0|||
130699662|NCT01332968|470524725|FG006|Maintenance/Observation Period|Protocol Violation|0|||
130699663|NCT01332968|470524726|FG007|Maintenance/Observation Period|Protocol Violation|0|||
130699664|NCT01332968|470524719|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699665|NCT01332968|470524720|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699666|NCT01332968|470524721|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
130699667|NCT01332968|470524722|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
130248986|NCT01346709|468872995|FG000|Overall Study|Missing data in candidate risk factor|285|||
130248987|NCT01292473|468872999|FG000|Overall Study|Adverse Event|1|||
130248988|NCT01292473|468873000|FG001|Overall Study|Adverse Event|0|||
130248989|NCT01292473|468873001|FG002|Overall Study|Adverse Event|1|||
130248990|NCT01292473|468873002|FG003|Overall Study|Adverse Event|1|||
130248991|NCT01292473|468872999|FG000|Overall Study|Lost to Follow-up|1|||
130248992|NCT01292473|468873000|FG001|Overall Study|Lost to Follow-up|1|||
130248993|NCT01292473|468873001|FG002|Overall Study|Lost to Follow-up|2|||
130248994|NCT01292473|468873002|FG003|Overall Study|Lost to Follow-up|2|||
130248995|NCT01292473|468872999|FG000|Overall Study|Withdrawal by Subject|3|||
130248996|NCT01292473|468873000|FG001|Overall Study|Withdrawal by Subject|4|||
130248997|NCT01292473|468873001|FG002|Overall Study|Withdrawal by Subject|3|||
130248998|NCT01292473|468873002|FG003|Overall Study|Withdrawal by Subject|3|||
130248999|NCT01292473|468872999|FG000|Overall Study|Physician Decision|0|||
130249000|NCT01292473|468873000|FG001|Overall Study|Physician Decision|1|||
130249001|NCT01292473|468873001|FG002|Overall Study|Physician Decision|0|||
130249002|NCT01292473|468873002|FG003|Overall Study|Physician Decision|0|||
130249003|NCT01292473|468872999|FG000|Overall Study|Disease Progression|0|||
130249004|NCT01292473|468873000|FG001|Overall Study|Disease Progression|1|||
130249005|NCT01292473|468873001|FG002|Overall Study|Disease Progression|3|||
130249006|NCT01292473|468873002|FG003|Overall Study|Disease Progression|6|||
130249007|NCT02123511|468873007|FG000|Overall Study|Cancelled treatment|1|||
130249008|NCT02123511|468873008|FG001|Overall Study|Cancelled treatment|0|||
130249009|NCT02123511|468873007|FG000|Overall Study|Incomplete data|1|||
130249010|NCT02123511|468873008|FG001|Overall Study|Incomplete data|3|||
130249011|NCT02123511|468873007|FG000|Overall Study|Ineligible|0|||
130249012|NCT02123511|468873008|FG001|Overall Study|Ineligible|1|||
130249013|NCT04821245|468873009|FG000|Overall Study|Withdrawal by Subject|3|||
130249014|NCT04821245|468873009|FG000|Overall Study|Physician Decision|1|||
130249015|NCT04821245|468873009|FG000|Overall Study|Protocol Violation|5|||
130249016|NCT01975285|468873019|FG000|Overall Study|Failed Block and follow up|2|||
130249017|NCT01975285|468873020|FG001|Overall Study|Failed Block and follow up|2|||
130452438|NCT03781804|469619878|FG002|Overall Study|Protocol Violation|1|||
130452439|NCT03781804|469619876|FG000|Overall Study|Withdrawal by Subject|0|||
130452440|NCT03781804|469619877|FG001|Overall Study|Withdrawal by Subject|1|||
130452441|NCT03781804|469619878|FG002|Overall Study|Withdrawal by Subject|1|||
130452442|NCT03781804|469619876|FG000|Overall Study|Reason not provided|2|||
130452443|NCT03781804|469619877|FG001|Overall Study|Reason not provided|2|||
130452444|NCT03781804|469619878|FG002|Overall Study|Reason not provided|0|||
130452445|NCT00337818|469619879|FG000|Overall Study|Lost to Follow-up|289|||
130452446|NCT00337818|469619880|FG001|Overall Study|Lost to Follow-up|91|||
130452447|NCT00337818|469619881|FG002|Overall Study|Lost to Follow-up|107|||
130452448|NCT04678830|469619882|FG000|Overall Study|Lack of Efficacy|2|||
130452449|NCT04678830|469619883|FG001|Overall Study|Lack of Efficacy|0|||
130452450|NCT04678830|469619882|FG000|Overall Study|Withdrawal by Subject|0|||
130452451|NCT04678830|469619883|FG001|Overall Study|Withdrawal by Subject|1|||
130452452|NCT01190176|469619886|FG000|Overall Study|Withdrawal by Subject|1|||
130452453|NCT01190176|469619886|FG000|Overall Study|Lost to Follow-up|1|||
130452454|NCT02189863|469619887|FG000|First 2 Weeks|Motion Sickness|4|||
130452455|NCT02189863|469619888|FG001|First 2 Weeks|Motion Sickness|2|||
130452456|NCT03697460|469619889|FG000|Overall Study|Withdrawal by Subject|3|||
130699668|NCT01332968|470524723|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
130249018|NCT00576407|468873025|FG000|Overall Study|Death|7|||
130452457|NCT03369951|469619891|FG000|Overall Study|Withdrawal by Subject|3|||
130452458|NCT03369951|469619891|FG000|Overall Study|Death|1|||
130452459|NCT03369951|469619891|FG000|Overall Study|Lost to Follow-up|1|||
130452460|NCT03369951|469619891|FG000|Overall Study|Protocol Violation|1|||
130452461|NCT03677375|469619896|FG000|Overall Study|Incomplete procedure|8|||
130452462|NCT03677375|469619896|FG000|Overall Study|Adverse Event|3|||
130452463|NCT03677375|469619896|FG000|Overall Study|Physician Decision|1|||
130249019|NCT00576407|468873025|FG000|Overall Study|Physician Decision|1|||
130249020|NCT00756444|468873026|FG000|Overall Study|Adverse Event|1|||
130249021|NCT00756444|468873027|FG001|Overall Study|Adverse Event|1|||
130249022|NCT00756444|468873026|FG000|Overall Study|Withdrawal by Subject|6|||
130249023|NCT00756444|468873027|FG001|Overall Study|Withdrawal by Subject|8|||
130249024|NCT00756444|468873026|FG000|Overall Study|Lost to Follow-up|0|||
130452464|NCT00445692|469619897|FG000|Overall Study|Adverse Event|11|||
130699669|NCT01332968|470524724|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
130553087|NCT01794520|469993506|FG005|Overall Study|Withdrew consent|0|||
130249025|NCT00756444|468873027|FG001|Overall Study|Lost to Follow-up|1|||
130249026|NCT00756444|468873026|FG000|Overall Study|Death|5|||
130249027|NCT00756444|468873027|FG001|Overall Study|Death|4|||
130249028|NCT00756444|468873026|FG000|Overall Study|Disease Progression|2|||
130249029|NCT00756444|468873027|FG001|Overall Study|Disease Progression|7|||
130553088|NCT01794520|469993507|FG006|Overall Study|Withdrew consent|0|||
130553089|NCT01794520|469993501|FG000|Overall Study|Lost to Follow-up|0|||
130553090|NCT01794520|469993502|FG001|Overall Study|Lost to Follow-up|0|||
130553091|NCT01794520|469993503|FG002|Overall Study|Lost to Follow-up|0|||
130553092|NCT01794520|469993504|FG003|Overall Study|Lost to Follow-up|0|||
130553093|NCT01794520|469993505|FG004|Overall Study|Lost to Follow-up|1|||
130553094|NCT01794520|469993506|FG005|Overall Study|Lost to Follow-up|0|||
130553095|NCT01794520|469993507|FG006|Overall Study|Lost to Follow-up|0|||
130553096|NCT01794520|469993501|FG000|Overall Study|Toxicity|0|||
130553097|NCT01794520|469993502|FG001|Overall Study|Toxicity|2|||
130553098|NCT01794520|469993503|FG002|Overall Study|Toxicity|0|||
130553099|NCT01794520|469993504|FG003|Overall Study|Toxicity|0|||
130553100|NCT01794520|469993505|FG004|Overall Study|Toxicity|0|||
130553101|NCT01794520|469993506|FG005|Overall Study|Toxicity|0|||
130553102|NCT01794520|469993507|FG006|Overall Study|Toxicity|0|||
130553103|NCT01794520|469993501|FG000|Overall Study|Study terminated by sponsor|0|||
130553104|NCT01794520|469993502|FG001|Overall Study|Study terminated by sponsor|0|||
130553105|NCT01794520|469993503|FG002|Overall Study|Study terminated by sponsor|1|||
130249030|NCT00756444|468873026|FG000|Overall Study|Ineligibility Determined|1|||
130249031|NCT00756444|468873027|FG001|Overall Study|Ineligibility Determined|0|||
130249032|NCT03071965|468873028|FG000|Overall Study|Adverse Event|0|||
130249033|NCT03071965|468873029|FG001|Overall Study|Adverse Event|0|||
130249034|NCT03071965|468873030|FG002|Overall Study|Adverse Event|1|||
130249035|NCT03071965|468873031|FG003|Overall Study|Adverse Event|0|||
130249036|NCT03071965|468873028|FG000|Overall Study|Death|0|||
130249037|NCT03071965|468873029|FG001|Overall Study|Death|0|||
130249038|NCT03071965|468873030|FG002|Overall Study|Death|1|||
130249039|NCT03071965|468873031|FG003|Overall Study|Death|1|||
130249040|NCT03071965|468873028|FG000|Overall Study|COVID-19|0|||
130249041|NCT03071965|468873029|FG001|Overall Study|COVID-19|1|||
130553106|NCT01794520|469993504|FG003|Overall Study|Study terminated by sponsor|0|||
130553107|NCT01794520|469993505|FG004|Overall Study|Study terminated by sponsor|1|||
130249042|NCT03071965|468873030|FG002|Overall Study|COVID-19|0|||
130249043|NCT03071965|468873031|FG003|Overall Study|COVID-19|1|||
130249044|NCT03071965|468873028|FG000|Overall Study|Other Health Reason|0|||
130249045|NCT03071965|468873029|FG001|Overall Study|Other Health Reason|0|||
130249046|NCT03071965|468873030|FG002|Overall Study|Other Health Reason|0|||
130249047|NCT03071965|468873031|FG003|Overall Study|Other Health Reason|1|||
130249048|NCT05587998|468873032|FG000|Overall Study|Withdrawal by Subject|1|||
130553108|NCT01794520|469993506|FG005|Overall Study|Study terminated by sponsor|0|||
130553109|NCT01794520|469993507|FG006|Overall Study|Study terminated by sponsor|7|||
130553110|NCT01794520|469993501|FG000|Overall Study|Death|0|||
130553111|NCT01794520|469993502|FG001|Overall Study|Death|0|||
130553112|NCT01794520|469993503|FG002|Overall Study|Death|0|||
130249049|NCT05587998|468873033|FG001|Overall Study|Withdrawal by Subject|1|||
130249050|NCT05587998|468873032|FG000|Overall Study|Not treated|3|||
130249051|NCT05587998|468873033|FG001|Overall Study|Not treated|1|||
130249052|NCT05587998|468873032|FG000|Overall Study|Non-compliance with study procedures|0|||
130249053|NCT05587998|468873033|FG001|Overall Study|Non-compliance with study procedures|1|||
130553113|NCT01794520|469993504|FG003|Overall Study|Death|0|||
130553114|NCT01794520|469993505|FG004|Overall Study|Death|1|||
130699670|NCT01332968|470524725|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699671|NCT01332968|470524726|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699672|NCT01332968|470524719|FG000|Follow-Up Period|Adverse Event|0|||
130699673|NCT01332968|470524720|FG001|Follow-Up Period|Adverse Event|0|||
130699674|NCT01332968|470524721|FG002|Follow-Up Period|Adverse Event|0|||
130699675|NCT01332968|470524722|FG003|Follow-Up Period|Adverse Event|0|||
130699676|NCT01332968|470524723|FG004|Follow-Up Period|Adverse Event|0|||
130249054|NCT03225989|468873034|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
130249055|NCT03225989|468873035|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130249056|NCT03225989|468873036|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130249057|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130249058|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
130249059|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130249060|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130249061|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
130249062|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130249063|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130249064|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
130249065|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130249066|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130249067|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
130249068|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130249069|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130249070|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130249071|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
130249072|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130249073|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130249074|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
130364102|NCT04729621|469302119|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130364103|NCT04729621|469302115|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
130364104|NCT04729621|469302116|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
130364105|NCT04729621|469302117|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
130364106|NCT04729621|469302118|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
130364107|NCT04729621|469302119|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
130364108|NCT03439657|469302120|FG000|Overall Study|Adverse Event|2|||
130364109|NCT03439657|469302121|FG001|Overall Study|Adverse Event|3|||
130364110|NCT03439657|469302120|FG000|Overall Study|Lost to Follow-up|1|||
130364111|NCT03439657|469302121|FG001|Overall Study|Lost to Follow-up|0|||
130364112|NCT03439657|469302120|FG000|Overall Study|Protocol Violation|1|||
130364113|NCT03439657|469302121|FG001|Overall Study|Protocol Violation|1|||
130364114|NCT03439657|469302120|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
130364115|NCT03439657|469302121|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
130364116|NCT00319501|469302127|FG000|Double-blind Period|Withdrawal by Subject|0|||
130364117|NCT00319501|469302128|FG001|Double-blind Period|Withdrawal by Subject|3|||
130364118|NCT00319501|469302127|FG000|Double-blind Period|Sponsor Request|1|||
130364119|NCT00319501|469302128|FG001|Double-blind Period|Sponsor Request|0|||
130364120|NCT00319501|469302127|FG000|Double-blind Period|Did not receive treatment|42|||
130364121|NCT00319501|469302128|FG001|Double-blind Period|Did not receive treatment|29|||
130364122|NCT00319501|469302127|FG000|Open-label Period|Adverse Event|5|||
130364123|NCT00319501|469302128|FG001|Open-label Period|Adverse Event|0|||
130364124|NCT00319501|469302127|FG000|Open-label Period|Protocol Violation|6|||
130364125|NCT00319501|469302128|FG001|Open-label Period|Protocol Violation|0|||
130364126|NCT00319501|469302127|FG000|Open-label Period|Withdrawal by Subject|38|||
130364127|NCT00319501|469302128|FG001|Open-label Period|Withdrawal by Subject|0|||
130364128|NCT00319501|469302127|FG000|Open-label Period|Principal Investigator decision|6|||
130364129|NCT00319501|469302128|FG001|Open-label Period|Principal Investigator decision|0|||
130364130|NCT00319501|469302127|FG000|Open-label Period|Sponsor request|12|||
130364131|NCT00319501|469302128|FG001|Open-label Period|Sponsor request|0|||
130364132|NCT00319501|469302127|FG000|Open-label Period|Lost to Follow-up|5|||
130364133|NCT00319501|469302128|FG001|Open-label Period|Lost to Follow-up|0|||
130364134|NCT00319501|469302127|FG000|Open-label Period|Did not receive treatment|33|||
130364135|NCT00319501|469302128|FG001|Open-label Period|Did not receive treatment|0|||
130364136|NCT00319501|469302127|FG000|Open-label Period|Other|11|||
130553115|NCT01794520|469993506|FG005|Overall Study|Death|0|||
130364137|NCT00319501|469302128|FG001|Open-label Period|Other|0|||
130364138|NCT00319501|469302127|FG000|Open-label Extension Period|Adverse Event|2|||
130364139|NCT00319501|469302128|FG001|Open-label Extension Period|Adverse Event|0|||
130553116|NCT01794520|469993507|FG006|Overall Study|Death|22|||
130699677|NCT01332968|470524724|FG005|Follow-Up Period|Adverse Event|0|||
130699678|NCT01332968|470524725|FG006|Follow-Up Period|Adverse Event|0|||
130699679|NCT01332968|470524726|FG007|Follow-Up Period|Adverse Event|4|||
130699680|NCT01332968|470524719|FG000|Follow-Up Period|Death|0|||
130699681|NCT01332968|470524720|FG001|Follow-Up Period|Death|0|||
130699682|NCT01332968|470524721|FG002|Follow-Up Period|Death|0|||
130699683|NCT01332968|470524722|FG003|Follow-Up Period|Death|0|||
130699684|NCT01332968|470524723|FG004|Follow-Up Period|Death|0|||
130249075|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130249076|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130249077|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
130249078|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130249079|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130249080|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
130249081|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130249082|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130249083|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
130249084|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130249085|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130249086|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
130249087|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130249088|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130249089|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
130249090|NCT00601107|468873037|FG000|Overall Study|Adverse Event|0|||
130249091|NCT00601107|468873038|FG001|Overall Study|Adverse Event|1|||
130249092|NCT00601107|468873039|FG002|Overall Study|Adverse Event|3|||
130249093|NCT00601107|468873040|FG003|Overall Study|Adverse Event|0|||
130249094|NCT00601107|468873037|FG000|Overall Study|Withdrawal by Subject|5|||
130249095|NCT00601107|468873038|FG001|Overall Study|Withdrawal by Subject|4|||
130249096|NCT00601107|468873039|FG002|Overall Study|Withdrawal by Subject|7|||
130249097|NCT00601107|468873040|FG003|Overall Study|Withdrawal by Subject|4|||
130249098|NCT00601107|468873037|FG000|Overall Study|Lost to Follow-up|3|||
130249099|NCT00601107|468873038|FG001|Overall Study|Lost to Follow-up|3|||
130249100|NCT00601107|468873039|FG002|Overall Study|Lost to Follow-up|0|||
130249101|NCT00601107|468873040|FG003|Overall Study|Lost to Follow-up|3|||
130249102|NCT00601107|468873037|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249103|NCT00601107|468873038|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249104|NCT00601107|468873039|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249105|NCT00601107|468873040|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
130249106|NCT00601107|468873037|FG000|Overall Study|Worsening of Psoriasis|4|||
130249107|NCT00601107|468873038|FG001|Overall Study|Worsening of Psoriasis|1|||
130249108|NCT00601107|468873039|FG002|Overall Study|Worsening of Psoriasis|1|||
130249109|NCT00601107|468873040|FG003|Overall Study|Worsening of Psoriasis|4|||
130249110|NCT00601107|468873037|FG000|Overall Study|Undefined|1|||
130249111|NCT00601107|468873038|FG001|Overall Study|Undefined|0|||
130249112|NCT00601107|468873039|FG002|Overall Study|Undefined|1|||
130249113|NCT00601107|468873040|FG003|Overall Study|Undefined|0|||
130249114|NCT01181128|468873041|FG000|Overall Study|Withdrawal by Subject|2|||
130249115|NCT01181128|468873042|FG001|Overall Study|Withdrawal by Subject|2|||
130249116|NCT01181128|468873043|FG002|Overall Study|Withdrawal by Subject|0|||
130452465|NCT00445692|469619897|FG000|Overall Study|Lack of Efficacy|5|||
130452466|NCT03425539|469619899|FG000|Overall Study|Randomized but not treated|0|||
130452467|NCT03425539|469619900|FG001|Overall Study|Randomized but not treated|1|||
130452468|NCT03425539|469619899|FG000|Overall Study|Adverse Event|2|||
130452469|NCT03425539|469619900|FG001|Overall Study|Adverse Event|2|||
130452470|NCT03425539|469619899|FG000|Overall Study|Withdrawal by Subject|3|||
130452471|NCT03425539|469619900|FG001|Overall Study|Withdrawal by Subject|0|||
130452472|NCT03425539|469619899|FG000|Overall Study|Lost to Follow-up|0|||
130452473|NCT03425539|469619900|FG001|Overall Study|Lost to Follow-up|1|||
130452474|NCT02040844|469619901|FG000|Overall Study|Adverse Event|0|||
130452475|NCT02040844|469619902|FG001|Overall Study|Adverse Event|0|||
130452476|NCT02040844|469619903|FG002|Overall Study|Adverse Event|1|||
130452477|NCT02040844|469619901|FG000|Overall Study|Withdrawal by Subject|16|||
130452478|NCT02040844|469619902|FG001|Overall Study|Withdrawal by Subject|22|||
130452479|NCT02040844|469619903|FG002|Overall Study|Withdrawal by Subject|25|||
130452480|NCT02040844|469619901|FG000|Overall Study|Lost to Follow-up|12|||
130452481|NCT02040844|469619902|FG001|Overall Study|Lost to Follow-up|9|||
130452482|NCT02040844|469619903|FG002|Overall Study|Lost to Follow-up|13|||
130452483|NCT02040844|469619901|FG000|Overall Study|Missing|13|||
130452484|NCT02040844|469619902|FG001|Overall Study|Missing|3|||
130699685|NCT01332968|470524724|FG005|Follow-Up Period|Death|0|||
130249117|NCT01181128|468873041|FG000|Overall Study|Death|1|||
130249118|NCT01181128|468873042|FG001|Overall Study|Death|0|||
130452485|NCT02040844|469619903|FG002|Overall Study|Missing|2|||
130452486|NCT02040844|469619901|FG000|Overall Study|Non-specified|8|||
130452487|NCT02040844|469619902|FG001|Overall Study|Non-specified|2|||
130699686|NCT01332968|470524725|FG006|Follow-Up Period|Death|27|||
130699687|NCT01332968|470524726|FG007|Follow-Up Period|Death|30|||
130699688|NCT01332968|470524719|FG000|Follow-Up Period|Lost to Follow-up|0|||
130699689|NCT01332968|470524720|FG001|Follow-Up Period|Lost to Follow-up|0|||
130249119|NCT01181128|468873043|FG002|Overall Study|Death|0|||
130249120|NCT01181128|468873041|FG000|Overall Study|Physician Decision|2|||
130249121|NCT01181128|468873042|FG001|Overall Study|Physician Decision|0|||
130249122|NCT01181128|468873043|FG002|Overall Study|Physician Decision|0|||
130249123|NCT01181128|468873041|FG000|Overall Study|Adverse Event|0|||
130249124|NCT01181128|468873042|FG001|Overall Study|Adverse Event|2|||
130249125|NCT01181128|468873043|FG002|Overall Study|Adverse Event|0|||
130249126|NCT01181128|468873041|FG000|Overall Study|Other|1|||
130249127|NCT01181128|468873042|FG001|Overall Study|Other|1|||
130249128|NCT01181128|468873043|FG002|Overall Study|Other|1|||
130249129|NCT01362270|468873044|FG000|Overall Study|Withdrawal by Subject|1|||
130249130|NCT01362270|468873045|FG001|Overall Study|Withdrawal by Subject|0|||
130249131|NCT01362270|468873044|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
130249132|NCT01362270|468873045|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
130249133|NCT01362270|468873044|FG000|Overall Study|Met excl. criteria before 1st session|1|||
130249134|NCT01362270|468873045|FG001|Overall Study|Met excl. criteria before 1st session|1|||
130249135|NCT04595370|468873048|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
130249136|NCT04595370|468873049|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249137|NCT04595370|468873050|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249138|NCT04595370|468873051|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249139|NCT04595370|468873052|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249140|NCT04595370|468873053|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130452488|NCT02040844|469619903|FG002|Overall Study|Non-specified|5|||
130452489|NCT02040844|469619901|FG000|Overall Study|Concomitant medication|1|||
130452490|NCT02040844|469619902|FG001|Overall Study|Concomitant medication|3|||
130452491|NCT02040844|469619903|FG002|Overall Study|Concomitant medication|1|||
130452492|NCT01560949|469619910|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
130452493|NCT01560949|469619910|FG000|Surgery Phase|Physician Decision|3|||
130452494|NCT00681811|469619913|FG000|Overall Study|Adverse Event|1|||
130452495|NCT00681811|469619914|FG001|Overall Study|Adverse Event|1|||
130452496|NCT00681811|469619913|FG000|Overall Study|Withdrawal by Subject|2|||
130452497|NCT00681811|469619914|FG001|Overall Study|Withdrawal by Subject|2|||
130452498|NCT00681811|469619913|FG000|Overall Study|Non-compliance|0|||
130452499|NCT00681811|469619914|FG001|Overall Study|Non-compliance|1|||
130452500|NCT01562743|469619917|FG000|Overall Study|Adverse Event|29|||
130452501|NCT01562743|469619917|FG000|Overall Study|Lack of Efficacy|3|||
130452502|NCT01562743|469619917|FG000|Overall Study|Withdrawal by Subject|13|||
130452503|NCT01562743|469619917|FG000|Overall Study|Protocol Violation|1|||
130452504|NCT01562743|469619917|FG000|Overall Study|Discontinuation criteria|2|||
130452505|NCT01562743|469619917|FG000|Overall Study|Lost to Follow-up|2|||
130452506|NCT01562743|469619917|FG000|Overall Study|Physician Decision|2|||
130452507|NCT00797862|469621637|FG000|Overall Study|Adverse Event|86|||
130452508|NCT00797862|469621638|FG001|Overall Study|Adverse Event|44|||
130452509|NCT00797862|469621639|FG002|Overall Study|Adverse Event|58|||
130452510|NCT00797862|469621637|FG000|Overall Study|Abnormal Test Procedure Result|0|||
130452511|NCT00797862|469621638|FG001|Overall Study|Abnormal Test Procedure Result|1|||
130452512|NCT00797862|469621639|FG002|Overall Study|Abnormal Test Procedure Result|1|||
130452513|NCT00797862|469621637|FG000|Overall Study|Lack of Efficacy|1|||
130452514|NCT00797862|469621638|FG001|Overall Study|Lack of Efficacy|7|||
130452515|NCT00797862|469621639|FG002|Overall Study|Lack of Efficacy|6|||
130452516|NCT00797862|469621637|FG000|Overall Study|No longer required study medication|1|||
130452517|NCT00797862|469621638|FG001|Overall Study|No longer required study medication|0|||
130452518|NCT00797862|469621639|FG002|Overall Study|No longer required study medication|0|||
130452519|NCT00797862|469621637|FG000|Overall Study|Withdrawal by Subject|14|||
130452520|NCT00797862|469621638|FG001|Overall Study|Withdrawal by Subject|7|||
130452521|NCT00797862|469621639|FG002|Overall Study|Withdrawal by Subject|7|||
130452522|NCT00797862|469621637|FG000|Overall Study|Lost to Follow-up|11|||
130452523|NCT00797862|469621638|FG001|Overall Study|Lost to Follow-up|0|||
130452524|NCT00797862|469621639|FG002|Overall Study|Lost to Follow-up|5|||
130452525|NCT00797862|469621637|FG000|Overall Study|Administrative Problem|4|||
130452526|NCT00797862|469621638|FG001|Overall Study|Administrative Problem|0|||
130452527|NCT00797862|469621639|FG002|Overall Study|Administrative Problem|0|||
130452528|NCT00797862|469621637|FG000|Overall Study|Protocol Violation|4|||
130452529|NCT00797862|469621638|FG001|Overall Study|Protocol Violation|6|||
130699690|NCT01332968|470524721|FG002|Follow-Up Period|Lost to Follow-up|0|||
130249141|NCT04595370|468873048|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130452530|NCT00797862|469621639|FG002|Overall Study|Protocol Violation|8|||
130699691|NCT01332968|470524722|FG003|Follow-Up Period|Lost to Follow-up|0|||
130699692|NCT01332968|470524723|FG004|Follow-Up Period|Lost to Follow-up|0|||
130452531|NCT00797862|469621637|FG000|Overall Study|Mis-randomized|3|||
130452532|NCT00797862|469621638|FG001|Overall Study|Mis-randomized|3|||
130452533|NCT00797862|469621639|FG002|Overall Study|Mis-randomized|1|||
130452534|NCT00409708|469621643|FG000|Treatment|Abnormal test procedure result(s)|1|||
130249142|NCT04595370|468873049|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249143|NCT04595370|468873050|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
130249144|NCT04595370|468873051|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249145|NCT04595370|468873052|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249146|NCT04595370|468873053|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249147|NCT04595370|468873048|FG000|Overall Study|Adverse Event|0|||
130249148|NCT04595370|468873049|FG001|Overall Study|Adverse Event|4|||
130249149|NCT04595370|468873050|FG002|Overall Study|Adverse Event|3|||
130249150|NCT04595370|468873051|FG003|Overall Study|Adverse Event|1|||
130249151|NCT04595370|468873052|FG004|Overall Study|Adverse Event|1|||
130249152|NCT04595370|468873053|FG005|Overall Study|Adverse Event|1|||
130249153|NCT04595370|468873048|FG000|Overall Study|Withdrawal of Consent|1|||
130249154|NCT04595370|468873049|FG001|Overall Study|Withdrawal of Consent|1|||
130249155|NCT04595370|468873050|FG002|Overall Study|Withdrawal of Consent|1|||
130249156|NCT04595370|468873051|FG003|Overall Study|Withdrawal of Consent|0|||
130249157|NCT04595370|468873052|FG004|Overall Study|Withdrawal of Consent|0|||
130249158|NCT04595370|468873053|FG005|Overall Study|Withdrawal of Consent|0|||
130249159|NCT04595370|468873048|FG000|Overall Study|Death|0|||
130249160|NCT04595370|468873049|FG001|Overall Study|Death|1|||
130249161|NCT04595370|468873050|FG002|Overall Study|Death|0|||
130249162|NCT04595370|468873051|FG003|Overall Study|Death|0|||
130249163|NCT04595370|468873052|FG004|Overall Study|Death|1|||
130249164|NCT04595370|468873053|FG005|Overall Study|Death|0|||
130249165|NCT04595370|468873048|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249166|NCT04595370|468873049|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249167|NCT04595370|468873050|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130249168|NCT04595370|468873051|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249169|NCT04595370|468873052|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249170|NCT04595370|468873053|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249171|NCT04595370|468873048|FG000|Overall Study|Withdrawal by Subject|0|||
130249172|NCT04595370|468873049|FG001|Overall Study|Withdrawal by Subject|0|||
130249173|NCT04595370|468873050|FG002|Overall Study|Withdrawal by Subject|1|||
130249174|NCT04595370|468873051|FG003|Overall Study|Withdrawal by Subject|0|||
130249175|NCT04595370|468873052|FG004|Overall Study|Withdrawal by Subject|2|||
130249176|NCT04595370|468873053|FG005|Overall Study|Withdrawal by Subject|0|||
130364140|NCT00319501|469302127|FG000|Open-label Extension Period|Did not receive treatment|18|||
130364141|NCT00319501|469302128|FG001|Open-label Extension Period|Did not receive treatment|0|||
130364142|NCT00319501|469302127|FG000|Open-label Extension Period|Other|1|||
130364143|NCT00319501|469302128|FG001|Open-label Extension Period|Other|0|||
130364144|NCT00319501|469302127|FG000|Open-label Extension Period|Principal investigator decision|2|||
130364145|NCT00319501|469302128|FG001|Open-label Extension Period|Principal investigator decision|0|||
130364146|NCT00319501|469302127|FG000|Open-label Extension Period|Sponsor request|26|||
130364147|NCT00319501|469302128|FG001|Open-label Extension Period|Sponsor request|0|||
130364148|NCT00319501|469302127|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
130364149|NCT00319501|469302128|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130364150|NCT02764697|469302135|FG000|Overall Study|Lack of Efficacy|3|||
130364151|NCT00302107|469302136|FG000|Overall Study|Lost to Follow-up|6|||
130364152|NCT00302107|469302137|FG001|Overall Study|Lost to Follow-up|5|||
130364153|NCT00302107|469302136|FG000|Overall Study|Protocol Violation|1|||
130364154|NCT00302107|469302137|FG001|Overall Study|Protocol Violation|0|||
130364155|NCT00302107|469302136|FG000|Overall Study|Relocation|0|||
130364156|NCT00302107|469302137|FG001|Overall Study|Relocation|1|||
130364157|NCT00302107|469302136|FG000|Overall Study|Withdrawal by Subject|0|||
130364158|NCT00302107|469302137|FG001|Overall Study|Withdrawal by Subject|3|||
130364159|NCT00302107|469302136|FG000|Overall Study|Adverse Event|1|||
130364160|NCT00302107|469302137|FG001|Overall Study|Adverse Event|0|||
130364161|NCT01790932|469302138|FG000|Overall Study|Disease Progression|41|||
130364162|NCT01790932|469302138|FG000|Overall Study|Adverse Event|7|||
130364163|NCT01790932|469302138|FG000|Overall Study|Physician Decision|1|||
130364164|NCT01790932|469302138|FG000|Overall Study|Withdrawal by Subject|1|||
130364165|NCT04223973|469302139|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
130364166|NCT04223973|469302140|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
130452535|NCT00409708|469621644|FG001|Treatment|Abnormal test procedure result(s)|0|||
130452536|NCT00409708|469621643|FG000|Treatment|Lack of Efficacy|0|||
130249177|NCT04595370|468873048|FG000|Overall Study|Lost to Follow-up|0|||
130249178|NCT04595370|468873049|FG001|Overall Study|Lost to Follow-up|0|||
130249179|NCT04595370|468873050|FG002|Overall Study|Lost to Follow-up|0|||
130249180|NCT04595370|468873051|FG003|Overall Study|Lost to Follow-up|0|||
130249181|NCT04595370|468873052|FG004|Overall Study|Lost to Follow-up|1|||
130249182|NCT04595370|468873053|FG005|Overall Study|Lost to Follow-up|0|||
130364167|NCT04223973|469302139|FG000|Overall Study|Adverse Event|4|||
130364168|NCT04223973|469302140|FG001|Overall Study|Adverse Event|0|||
130364169|NCT04223973|469302139|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
130699693|NCT01332968|470524724|FG005|Follow-Up Period|Lost to Follow-up|0|||
130249183|NCT04595370|468873048|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249184|NCT04595370|468873049|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130249185|NCT04595370|468873050|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130249186|NCT04595370|468873051|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249187|NCT04595370|468873052|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
130249188|NCT04595370|468873053|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249189|NCT01341990|468873054|FG000|Overall Study|Adverse Event|0|||
130249190|NCT01341990|468873055|FG001|Overall Study|Adverse Event|1|||
130249191|NCT01341990|468873054|FG000|Overall Study|Torn Study Lens|1|||
130249192|NCT01341990|468873055|FG001|Overall Study|Torn Study Lens|0|||
130249193|NCT01341990|468873054|FG000|Overall Study|Withdrawal by Subject|2|||
130249194|NCT01341990|468873055|FG001|Overall Study|Withdrawal by Subject|0|||
130249195|NCT01751685|468873057|FG000|6-mo Followup|Missed study visit|1|||
130249196|NCT01751685|468873058|FG001|6-mo Followup|Missed study visit|0|||
130249197|NCT01751685|468873057|FG000|6-mo Followup|Withdrawal by Subject|2|||
130249198|NCT01751685|468873058|FG001|6-mo Followup|Withdrawal by Subject|2|||
130249199|NCT01751685|468873057|FG000|6-mo Followup|Lost to Follow-up|0|||
130249200|NCT01751685|468873058|FG001|6-mo Followup|Lost to Follow-up|1|||
130249201|NCT01751685|468873057|FG000|12-mo Followup|Lost to Follow-up|5|||
130249202|NCT01751685|468873058|FG001|12-mo Followup|Lost to Follow-up|0|||
130249203|NCT04401293|468873059|FG000|Overall Study|Withdrawal by Subject|1|||
130249204|NCT04401293|468873060|FG001|Overall Study|Withdrawal by Subject|3|||
130249205|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
130249206|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
130249207|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
130249208|NCT00837330|468873062|FG000|Overall Study|Lost to Follow-up|1|||
130249209|NCT00837330|468873063|FG001|Overall Study|Lost to Follow-up|3|||
130249210|NCT01117350|468873071|FG000|Comparative Period|Not Treated|5|||
130249211|NCT01117350|468873072|FG001|Comparative Period|Not Treated|8|||
130249212|NCT01117350|468873071|FG000|Comparative Period|Adverse Event|6|||
130249213|NCT01117350|468873072|FG001|Comparative Period|Adverse Event|33|||
130249214|NCT01117350|468873071|FG000|Comparative Period|Lost to Follow-up|11|||
130249215|NCT01117350|468873072|FG001|Comparative Period|Lost to Follow-up|7|||
130249216|NCT01117350|468873071|FG000|Comparative Period|Withdrawal by Subject|9|||
130249217|NCT01117350|468873072|FG001|Comparative Period|Withdrawal by Subject|13|||
130249218|NCT01117350|468873071|FG000|Comparative Period|Protocol Violation|8|||
130249219|NCT01117350|468873072|FG001|Comparative Period|Protocol Violation|12|||
130249220|NCT01117350|468873071|FG000|Comparative Period|Lack of Efficacy|1|||
130249221|NCT01117350|468873072|FG001|Comparative Period|Lack of Efficacy|0|||
130249222|NCT01117350|468873071|FG000|Comparative Period|Physician Decision|0|||
130249223|NCT01117350|468873072|FG001|Comparative Period|Physician Decision|1|||
130249224|NCT01117350|468873071|FG000|Comparative Period|Move to another city/country|2|||
130249225|NCT01117350|468873072|FG001|Comparative Period|Move to another city/country|1|||
130249226|NCT01117350|468873071|FG000|Extension Period|Not included in extension, not treated|0|||
130249227|NCT01117350|468873072|FG001|Extension Period|Not included in extension, not treated|50|||
130249228|NCT01117350|468873071|FG000|Extension Period|Adverse Event|0|||
130249229|NCT01117350|468873072|FG001|Extension Period|Adverse Event|2|||
130364170|NCT04223973|469302140|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
130364171|NCT04223973|469302139|FG000|Overall Study|Physician Decision|1|||
130364172|NCT04223973|469302140|FG001|Overall Study|Physician Decision|1|||
130364173|NCT04223973|469302139|FG000|Overall Study|Withdrawal by Subject|0|||
130364174|NCT04223973|469302140|FG001|Overall Study|Withdrawal by Subject|1|||
130364175|NCT01757535|469302141|FG000|Overall Study|Disease Relapse|151|||
130364176|NCT01757535|469302142|FG001|Overall Study|Disease Relapse|181|||
130364177|NCT01757535|469302141|FG000|Overall Study|Other Reasons|28|||
130364178|NCT01757535|469302142|FG001|Overall Study|Other Reasons|27|||
130364179|NCT01757535|469302141|FG000|Overall Study|Adverse Event|31|||
130364180|NCT01757535|469302142|FG001|Overall Study|Adverse Event|11|||
130364181|NCT01757535|469302141|FG000|Overall Study|Withdrew Consent|19|||
130364182|NCT01757535|469302142|FG001|Overall Study|Withdrew Consent|13|||
130364183|NCT01757535|469302141|FG000|Overall Study|Physician Decision|7|||
130364184|NCT01757535|469302142|FG001|Overall Study|Physician Decision|0|||
130364185|NCT01757535|469302141|FG000|Overall Study|Death|2|||
130364186|NCT01757535|469302142|FG001|Overall Study|Death|2|||
130364187|NCT00825682|469303371|FG000|Overall Study|personal reasons/ inconvenience|13|||
130249230|NCT01117350|468873071|FG000|Extension Period|Protocol Violation|0|||
130249231|NCT01117350|468873072|FG001|Extension Period|Protocol Violation|2|||
130364188|NCT00825682|469303372|FG001|Overall Study|personal reasons/ inconvenience|5|||
130364189|NCT01644565|469303375|FG000|Overall Study|Undisclosed Medical History|1|||
130699694|NCT01332968|470524725|FG006|Follow-Up Period|Lost to Follow-up|11|||
130249232|NCT01117350|468873071|FG000|Extension Period|Lost to Follow-up|0|||
130249233|NCT01117350|468873072|FG001|Extension Period|Lost to Follow-up|2|||
130249234|NCT01117350|468873071|FG000|Extension Period|Withdrawal by Subject|0|||
130553117|NCT01794520|469993501|FG000|Overall Study|Other, not specified|0|||
130553118|NCT01794520|469993502|FG001|Overall Study|Other, not specified|0|||
130553119|NCT01794520|469993503|FG002|Overall Study|Other, not specified|1|||
130553120|NCT01794520|469993504|FG003|Overall Study|Other, not specified|1|||
130553121|NCT01794520|469993505|FG004|Overall Study|Other, not specified|4|||
130553122|NCT01794520|469993506|FG005|Overall Study|Other, not specified|1|||
130553123|NCT01794520|469993507|FG006|Overall Study|Other, not specified|2|||
130553124|NCT04796896|469993509|FG000|Overall Study|Adverse Event|1|||
130553125|NCT04796896|469993510|FG001|Overall Study|Adverse Event|0|||
130553126|NCT04796896|469993511|FG002|Overall Study|Adverse Event|0|||
130553127|NCT04796896|469993512|FG003|Overall Study|Adverse Event|0|||
130553128|NCT04796896|469993513|FG004|Overall Study|Adverse Event|0|||
130553129|NCT04796896|469993514|FG005|Overall Study|Adverse Event|1|||
130553130|NCT04796896|469993515|FG006|Overall Study|Adverse Event|1|||
130553131|NCT04796896|469993516|FG007|Overall Study|Adverse Event|0|||
130553132|NCT04796896|469993517|FG008|Overall Study|Adverse Event|1|||
130553133|NCT04796896|469993518|FG009|Overall Study|Adverse Event|1|||
130553134|NCT04796896|469993519|FG010|Overall Study|Adverse Event|1|||
130553135|NCT04796896|469993520|FG011|Overall Study|Adverse Event|0|||
130553136|NCT04796896|469993509|FG000|Overall Study|Lost to Follow-up|24|||
130553137|NCT04796896|469993510|FG001|Overall Study|Lost to Follow-up|15|||
130553138|NCT04796896|469993511|FG002|Overall Study|Lost to Follow-up|6|||
130553139|NCT04796896|469993512|FG003|Overall Study|Lost to Follow-up|4|||
130553140|NCT04796896|469993513|FG004|Overall Study|Lost to Follow-up|21|||
130553141|NCT04796896|469993514|FG005|Overall Study|Lost to Follow-up|55|||
130553142|NCT04796896|469993515|FG006|Overall Study|Lost to Follow-up|237|||
130553143|NCT04796896|469993516|FG007|Overall Study|Lost to Follow-up|52|||
130553144|NCT04796896|469993517|FG008|Overall Study|Lost to Follow-up|221|||
130553145|NCT04796896|469993518|FG009|Overall Study|Lost to Follow-up|43|||
130553146|NCT04796896|469993519|FG010|Overall Study|Lost to Follow-up|142|||
130553147|NCT04796896|469993520|FG011|Overall Study|Lost to Follow-up|18|||
130553148|NCT04796896|469993509|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
130553149|NCT04796896|469993510|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
130553150|NCT04796896|469993511|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
130553151|NCT04796896|469993512|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
130553152|NCT04796896|469993513|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
130553153|NCT04796896|469993514|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
130553154|NCT04796896|469993515|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
130553155|NCT04796896|469993516|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
130553156|NCT04796896|469993517|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
130553157|NCT04796896|469993518|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
130553158|NCT04796896|469993519|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
130553159|NCT04796896|469993520|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
130553160|NCT04796896|469993509|FG000|Overall Study|Physician Decision|1|||
130553161|NCT04796896|469993510|FG001|Overall Study|Physician Decision|0|||
130553162|NCT04796896|469993511|FG002|Overall Study|Physician Decision|0|||
130553163|NCT04796896|469993512|FG003|Overall Study|Physician Decision|0|||
130553164|NCT04796896|469993513|FG004|Overall Study|Physician Decision|0|||
130553165|NCT04796896|469993514|FG005|Overall Study|Physician Decision|3|||
130553166|NCT04796896|469993515|FG006|Overall Study|Physician Decision|18|||
130553167|NCT04796896|469993516|FG007|Overall Study|Physician Decision|1|||
130553168|NCT04796896|469993517|FG008|Overall Study|Physician Decision|7|||
130553169|NCT04796896|469993518|FG009|Overall Study|Physician Decision|0|||
130553170|NCT04796896|469993519|FG010|Overall Study|Physician Decision|5|||
130553171|NCT04796896|469993520|FG011|Overall Study|Physician Decision|0|||
130553172|NCT04796896|469993509|FG000|Overall Study|Withdrawal by Subject|36|||
130553173|NCT04796896|469993510|FG001|Overall Study|Withdrawal by Subject|31|||
130553174|NCT04796896|469993511|FG002|Overall Study|Withdrawal by Subject|11|||
130553175|NCT04796896|469993512|FG003|Overall Study|Withdrawal by Subject|8|||
130553176|NCT04796896|469993513|FG004|Overall Study|Withdrawal by Subject|16|||
130553177|NCT04796896|469993514|FG005|Overall Study|Withdrawal by Subject|162|||
130553178|NCT04796896|469993515|FG006|Overall Study|Withdrawal by Subject|299|||
130553179|NCT04796896|469993516|FG007|Overall Study|Withdrawal by Subject|149|||
130553180|NCT04796896|469993517|FG008|Overall Study|Withdrawal by Subject|303|||
130553181|NCT04796896|469993518|FG009|Overall Study|Withdrawal by Subject|94|||
130553182|NCT04796896|469993519|FG010|Overall Study|Withdrawal by Subject|192|||
130553183|NCT04796896|469993520|FG011|Overall Study|Withdrawal by Subject|16|||
130553184|NCT04796896|469993509|FG000|Overall Study|Other Than Specified|6|||
130553185|NCT04796896|469993510|FG001|Overall Study|Other Than Specified|5|||
130553186|NCT04796896|469993511|FG002|Overall Study|Other Than Specified|3|||
130553187|NCT04796896|469993512|FG003|Overall Study|Other Than Specified|2|||
130553188|NCT04796896|469993513|FG004|Overall Study|Other Than Specified|6|||
130553189|NCT04796896|469993514|FG005|Overall Study|Other Than Specified|31|||
130553190|NCT04796896|469993515|FG006|Overall Study|Other Than Specified|86|||
130553191|NCT04796896|469993516|FG007|Overall Study|Other Than Specified|66|||
130553192|NCT04796896|469993517|FG008|Overall Study|Other Than Specified|388|||
130553193|NCT04796896|469993518|FG009|Overall Study|Other Than Specified|48|||
130553194|NCT04796896|469993519|FG010|Overall Study|Other Than Specified|258|||
130553195|NCT04796896|469993520|FG011|Overall Study|Other Than Specified|4|||
130553196|NCT04796896|469993509|FG000|Overall Study|Protocol Deviation|0|||
130553197|NCT04796896|469993510|FG001|Overall Study|Protocol Deviation|0|||
130553198|NCT04796896|469993511|FG002|Overall Study|Protocol Deviation|0|||
130553199|NCT04796896|469993512|FG003|Overall Study|Protocol Deviation|1|||
130553200|NCT04796896|469993513|FG004|Overall Study|Protocol Deviation|1|||
130553201|NCT04796896|469993514|FG005|Overall Study|Protocol Deviation|2|||
130553202|NCT04796896|469993515|FG006|Overall Study|Protocol Deviation|2|||
130553203|NCT04796896|469993516|FG007|Overall Study|Protocol Deviation|2|||
130553204|NCT04796896|469993517|FG008|Overall Study|Protocol Deviation|2|||
130553205|NCT04796896|469993518|FG009|Overall Study|Protocol Deviation|1|||
130553206|NCT04796896|469993519|FG010|Overall Study|Protocol Deviation|0|||
130553207|NCT04796896|469993520|FG011|Overall Study|Protocol Deviation|0|||
130553208|NCT04796896|469993509|FG000|Overall Study|Missing|0|||
130553209|NCT04796896|469993510|FG001|Overall Study|Missing|0|||
130553210|NCT04796896|469993511|FG002|Overall Study|Missing|0|||
130553211|NCT04796896|469993512|FG003|Overall Study|Missing|0|||
130553212|NCT04796896|469993513|FG004|Overall Study|Missing|0|||
130553213|NCT04796896|469993514|FG005|Overall Study|Missing|0|||
130553214|NCT04796896|469993515|FG006|Overall Study|Missing|2|||
130553215|NCT04796896|469993516|FG007|Overall Study|Missing|1|||
130553216|NCT04796896|469993517|FG008|Overall Study|Missing|2|||
130553217|NCT04796896|469993518|FG009|Overall Study|Missing|1|||
130553218|NCT04796896|469993519|FG010|Overall Study|Missing|1|||
130249235|NCT01117350|468873072|FG001|Extension Period|Withdrawal by Subject|3|||
130249236|NCT01117350|468873071|FG000|Extension Period|Lack of Efficacy|0|||
130249237|NCT01117350|468873072|FG001|Extension Period|Lack of Efficacy|2|||
130249238|NCT01117350|468873071|FG000|Extension Period|Inclusion criteria not respected|0|||
130249239|NCT01117350|468873072|FG001|Extension Period|Inclusion criteria not respected|1|||
130249240|NCT01117350|468873071|FG000|Extension Period|Prohibited medication|0|||
130249241|NCT01117350|468873072|FG001|Extension Period|Prohibited medication|1|||
130249242|NCT00450749|468873083|FG000|Overall Study|Withdrawal by Subject|0|||
130249243|NCT00450749|468873084|FG001|Overall Study|Withdrawal by Subject|0|||
130249244|NCT00450749|468873085|FG002|Overall Study|Withdrawal by Subject|2|||
130249245|NCT00450749|468873083|FG000|Overall Study|Noncompliant|0|||
130452537|NCT00409708|469621644|FG001|Treatment|Lack of Efficacy|1|||
130452538|NCT00409708|469621643|FG000|Treatment|Protocol Violation|6|||
130452539|NCT00409708|469621644|FG001|Treatment|Protocol Violation|2|||
130452540|NCT00409708|469621643|FG000|Treatment|Withdrawal by Subject|3|||
130452541|NCT00409708|469621644|FG001|Treatment|Withdrawal by Subject|8|||
130452542|NCT00409708|469621643|FG000|Treatment|Lost to Follow-up|0|||
130452543|NCT00409708|469621644|FG001|Treatment|Lost to Follow-up|6|||
130452544|NCT00409708|469621643|FG000|Treatment|Administrative problems|5|||
130452545|NCT00409708|469621644|FG001|Treatment|Administrative problems|0|||
130452546|NCT00409708|469621643|FG000|Washout|Lack of Efficacy|9|||
130249246|NCT00450749|468873084|FG001|Overall Study|Noncompliant|1|||
130249247|NCT00450749|468873085|FG002|Overall Study|Noncompliant|0|||
130249248|NCT01245049|468873086|FG000|Overall Study|Migrated/moved from study area|0|||
130249249|NCT01245049|468873087|FG001|Overall Study|Migrated/moved from study area|1|||
130249250|NCT01245049|468873086|FG000|Overall Study|Withdrawal by Subject|0|||
130249251|NCT01245049|468873087|FG001|Overall Study|Withdrawal by Subject|1|||
130249252|NCT01245049|468873086|FG000|Overall Study|Lost to Follow-up|1|||
130249253|NCT01245049|468873087|FG001|Overall Study|Lost to Follow-up|2|||
130249254|NCT01027754|468874902|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
130249255|NCT01027754|468874903|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
130553219|NCT04796896|469993520|FG011|Overall Study|Missing|0|||
130553220|NCT04796896|469993509|FG000|Overall Study|Death|0|||
130553221|NCT04796896|469993510|FG001|Overall Study|Death|0|||
130553222|NCT04796896|469993511|FG002|Overall Study|Death|0|||
130249256|NCT01027754|468874902|FG000|Overall Study|Withdrawal by Subject|0|||
130553223|NCT04796896|469993512|FG003|Overall Study|Death|0|||
130553224|NCT04796896|469993513|FG004|Overall Study|Death|0|||
130699695|NCT01332968|470524726|FG007|Follow-Up Period|Lost to Follow-up|15|||
130249257|NCT01027754|468874903|FG001|Overall Study|Withdrawal by Subject|5|||
130249258|NCT01213251|468874904|FG000|Overall Study|Death|2|||
130249259|NCT01213251|468874905|FG001|Overall Study|Death|1|||
130249260|NCT01213251|468874906|FG002|Overall Study|Death|2|||
130553225|NCT04796896|469993514|FG005|Overall Study|Death|0|||
130452547|NCT00409708|469621644|FG001|Washout|Lack of Efficacy|1|||
130553226|NCT04796896|469993515|FG006|Overall Study|Death|0|||
130553227|NCT04796896|469993516|FG007|Overall Study|Death|0|||
130553228|NCT04796896|469993517|FG008|Overall Study|Death|1|||
130553229|NCT04796896|469993518|FG009|Overall Study|Death|0|||
130249261|NCT01213251|468874904|FG000|Overall Study|Exit|3|||
130452548|NCT00409708|469621643|FG000|Washout|Protocol Violation|0|||
130553230|NCT04796896|469993519|FG010|Overall Study|Death|0|||
130553231|NCT04796896|469993520|FG011|Overall Study|Death|0|||
130553232|NCT04356183|469993521|FG000|Overall Study|Lost to Follow-up|1|||
130452549|NCT00409708|469621644|FG001|Washout|Protocol Violation|1|||
130452550|NCT00409708|469621643|FG000|Washout|Withdrawal by Subject|11|||
130452551|NCT00409708|469621644|FG001|Washout|Withdrawal by Subject|5|||
130452552|NCT00409708|469621643|FG000|Washout|Lost to Follow-up|1|||
130452553|NCT00409708|469621644|FG001|Washout|Lost to Follow-up|3|||
130452554|NCT01474538|469621646|FG000|Treatment Period 1|Death|1|||
130452555|NCT01474538|469621647|FG001|Treatment Period 1|Death|0|||
130452556|NCT01474538|469621646|FG000|Treatment Period 1|Physician Decision|1|||
130452557|NCT01474538|469621647|FG001|Treatment Period 1|Physician Decision|0|||
130452558|NCT01474538|469621646|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130452559|NCT01474538|469621647|FG001|Treatment Period 1|Withdrawal by Subject|3|||
130452560|NCT01474538|469621646|FG000|Treatment Period 1|Protocol Violation|0|||
130452561|NCT01474538|469621647|FG001|Treatment Period 1|Protocol Violation|1|||
130452562|NCT01474538|469621646|FG000|Treatment Period 2|Death|1|||
130452563|NCT01474538|469621647|FG001|Treatment Period 2|Death|0|||
130452564|NCT01474538|469621646|FG000|Treatment Period 2|Adverse Event|1|||
130452565|NCT01474538|469621647|FG001|Treatment Period 2|Adverse Event|1|||
130452566|NCT01474538|469621646|FG000|Treatment Period 2|Withdrawal by Subject|2|||
130452567|NCT01474538|469621647|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130452568|NCT01474538|469621646|FG000|Treatment Period 2|Sponsor decision|1|||
130452569|NCT01474538|469621647|FG001|Treatment Period 2|Sponsor decision|0|||
130452570|NCT01474538|469621646|FG000|Treatment Period 2|Physician Decision|0|||
130452571|NCT01474538|469621647|FG001|Treatment Period 2|Physician Decision|1|||
130452572|NCT01474538|469621646|FG000|Treatment Period 2|Protocol Violation|1|||
130452573|NCT01474538|469621647|FG001|Treatment Period 2|Protocol Violation|0|||
130452574|NCT03120676|469621650|FG000|Overall Study|Not treated|1|||
130452575|NCT00926393|469621651|FG000|Overall Study|Withdrawal by Subject|1|||
130452576|NCT00926393|469621652|FG001|Overall Study|Withdrawal by Subject|2|||
130452577|NCT00926393|469621651|FG000|Overall Study|Adverse Event|1|||
130452578|NCT00926393|469621652|FG001|Overall Study|Adverse Event|1|||
130452579|NCT05349864|469621653|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
130452580|NCT05349864|469621654|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
130452581|NCT02333630|469621655|FG000|Overall Study|Lost to Follow-up|5|||
130452582|NCT02333630|469621656|FG001|Overall Study|Lost to Follow-up|2|||
130452583|NCT00984282|469621657|FG000|Double Blind Treatment|Adverse Event|40|||
130452584|NCT00984282|469621658|FG001|Double Blind Treatment|Adverse Event|6|||
130452585|NCT00984282|469621657|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
130452586|NCT00984282|469621658|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
130452587|NCT00984282|469621657|FG000|Double Blind Treatment|Physician Decision|1|||
130452588|NCT00984282|469621658|FG001|Double Blind Treatment|Physician Decision|2|||
130452589|NCT00984282|469621657|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
130452590|NCT00984282|469621658|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
130452591|NCT00984282|469621657|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
130452592|NCT00984282|469621658|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
130452593|NCT00984282|469621657|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
130452594|NCT00984282|469621658|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
130699696|NCT01332968|470524719|FG000|Follow-Up Period|Non-compliance|0|||
130699697|NCT01332968|470524720|FG001|Follow-Up Period|Non-compliance|0|||
130699698|NCT01332968|470524721|FG002|Follow-Up Period|Non-compliance|0|||
130249262|NCT01213251|468874905|FG001|Overall Study|Exit|2|||
130249263|NCT01213251|468874906|FG002|Overall Study|Exit|8|||
130249264|NCT01213251|468874904|FG000|Overall Study|Protocol Violation|1|||
130249265|NCT01213251|468874905|FG001|Overall Study|Protocol Violation|1|||
130249266|NCT01213251|468874906|FG002|Overall Study|Protocol Violation|0|||
130249267|NCT01213251|468874904|FG000|Overall Study|Missed 18-Month Follow-up|0|||
130249268|NCT01213251|468874905|FG001|Overall Study|Missed 18-Month Follow-up|0|||
130249269|NCT01213251|468874906|FG002|Overall Study|Missed 18-Month Follow-up|1|||
130249270|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130249271|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249272|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249273|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249274|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249275|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130249276|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130452595|NCT00984282|469621657|FG000|Double Blind Treatment|Lost to Follow-up|3|||
130452596|NCT00984282|469621658|FG001|Double Blind Treatment|Lost to Follow-up|0|||
130452597|NCT00984282|469621657|FG000|Double Blind Treatment|Death|8|||
130452598|NCT00984282|469621658|FG001|Double Blind Treatment|Death|4|||
130452599|NCT00984282|469621657|FG000|Double Blind Treatment|Not treated|0|||
130249277|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
130452600|NCT00984282|469621658|FG001|Double Blind Treatment|Not treated|1|||
130452601|NCT00984282|469621657|FG000|Double Blind Treatment|Switched to commercial drug|6|||
130452602|NCT00984282|469621658|FG001|Double Blind Treatment|Switched to commercial drug|1|||
130452603|NCT00984282|469621657|FG000|Double Blind Treatment|protocol driven decision point|1|||
130699699|NCT01332968|470524722|FG003|Follow-Up Period|Non-compliance|0|||
130249278|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249279|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
130249280|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249281|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249282|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249283|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249284|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
130249285|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249286|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249287|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249288|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249289|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249290|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249291|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
130249292|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249293|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249294|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249295|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249296|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
130249297|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130699700|NCT01332968|470524723|FG004|Follow-Up Period|Non-compliance|0|||
130249298|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249299|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
130249300|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249301|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249302|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249303|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249304|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249305|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249306|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249307|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249308|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249309|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249310|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130249311|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130249312|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249313|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249314|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249315|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249316|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249317|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249318|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249319|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130249320|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249321|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130249322|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249323|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130364190|NCT01644565|469303376|FG001|Overall Study|Undisclosed Medical History|0|||
130364191|NCT01644565|469303377|FG002|Overall Study|Undisclosed Medical History|0|||
130364192|NCT01644565|469303378|FG003|Overall Study|Undisclosed Medical History|0|||
130364193|NCT01644565|469303379|FG004|Overall Study|Undisclosed Medical History|0|||
130364194|NCT01644565|469303380|FG005|Overall Study|Undisclosed Medical History|0|||
130364195|NCT01644565|469303381|FG006|Overall Study|Undisclosed Medical History|0|||
130364196|NCT01644565|469303382|FG007|Overall Study|Undisclosed Medical History|0|||
130364197|NCT01644565|469303383|FG008|Overall Study|Undisclosed Medical History|0|||
130364198|NCT01644565|469303375|FG000|Overall Study|Lost to Follow-up|0|||
130364199|NCT01644565|469303376|FG001|Overall Study|Lost to Follow-up|0|||
130364200|NCT01644565|469303377|FG002|Overall Study|Lost to Follow-up|0|||
130364201|NCT01644565|469303378|FG003|Overall Study|Lost to Follow-up|1|||
130364202|NCT01644565|469303379|FG004|Overall Study|Lost to Follow-up|0|||
130364203|NCT01644565|469303380|FG005|Overall Study|Lost to Follow-up|0|||
130699701|NCT01332968|470524724|FG005|Follow-Up Period|Non-compliance|0|||
130699702|NCT01332968|470524725|FG006|Follow-Up Period|Non-compliance|4|||
130249324|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249325|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249326|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249327|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249328|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249329|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249330|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249331|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249332|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249333|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130249334|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130249335|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249336|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249337|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249338|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249339|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249340|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249341|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249342|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249343|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
130249344|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249345|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249346|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249347|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
130249348|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
130249349|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249350|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249351|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249352|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249353|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249354|NCT03312114|468874914|FG000|Overall Study|All the five enrolled dropped out of the|5|||
130249355|NCT01313676|468874915|FG000|Overall Study|Adverse Event|395|||
130249356|NCT01313676|468874916|FG001|Overall Study|Adverse Event|365|||
130249357|NCT01313676|468874917|FG002|Overall Study|Adverse Event|372|||
130249358|NCT01313676|468874918|FG003|Overall Study|Adverse Event|333|||
130249359|NCT01313676|468874915|FG000|Overall Study|Lack of Efficacy|98|||
130249360|NCT01313676|468874916|FG001|Overall Study|Lack of Efficacy|90|||
130249361|NCT01313676|468874917|FG002|Overall Study|Lack of Efficacy|65|||
130249362|NCT01313676|468874918|FG003|Overall Study|Lack of Efficacy|46|||
130249363|NCT01313676|468874915|FG000|Overall Study|Protocol Violation|37|||
130249364|NCT01313676|468874916|FG001|Overall Study|Protocol Violation|44|||
130249365|NCT01313676|468874917|FG002|Overall Study|Protocol Violation|46|||
130249366|NCT01313676|468874918|FG003|Overall Study|Protocol Violation|44|||
130249367|NCT01313676|468874915|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
130249368|NCT01313676|468874916|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
130249369|NCT01313676|468874917|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
130249370|NCT01313676|468874918|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
130452604|NCT00984282|469621658|FG001|Double Blind Treatment|protocol driven decision point|1|||
130452605|NCT00984282|469621657|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
130452606|NCT00984282|469621658|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
130452607|NCT00984282|469621657|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
130452608|NCT00984282|469621658|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
130452609|NCT00984282|469621657|FG000|Open-label Treatment|Adverse Event|20|||
130452610|NCT00984282|469621658|FG001|Open-label Treatment|Adverse Event|30|||
130452611|NCT00984282|469621657|FG000|Open-label Treatment|Withdrawal by Subject|6|||
130452612|NCT00984282|469621658|FG001|Open-label Treatment|Withdrawal by Subject|21|||
130452613|NCT00984282|469621657|FG000|Open-label Treatment|Death|7|||
130452614|NCT00984282|469621658|FG001|Open-label Treatment|Death|15|||
130452615|NCT00984282|469621657|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
130452616|NCT00984282|469621658|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
130452617|NCT00984282|469621657|FG000|Open-label Treatment|Lost to Follow-up|1|||
130452618|NCT00984282|469621658|FG001|Open-label Treatment|Lost to Follow-up|1|||
130699703|NCT01332968|470524726|FG007|Follow-Up Period|Non-compliance|9|||
130699704|NCT01332968|470524719|FG000|Follow-Up Period|Other|0|||
130699705|NCT01332968|470524720|FG001|Follow-Up Period|Other|0|||
130699706|NCT01332968|470524721|FG002|Follow-Up Period|Other|0|||
130699707|NCT01332968|470524722|FG003|Follow-Up Period|Other|0|||
130249371|NCT01313676|468874915|FG000|Overall Study|Study Closed/terminated|7|||
130699708|NCT01332968|470524723|FG004|Follow-Up Period|Other|0|||
130249372|NCT01313676|468874916|FG001|Overall Study|Study Closed/terminated|6|||
130249373|NCT01313676|468874917|FG002|Overall Study|Study Closed/terminated|9|||
130249374|NCT01313676|468874918|FG003|Overall Study|Study Closed/terminated|9|||
130249375|NCT01313676|468874915|FG000|Overall Study|Lost to Follow-up|0|||
130249376|NCT01313676|468874916|FG001|Overall Study|Lost to Follow-up|0|||
130249377|NCT01313676|468874917|FG002|Overall Study|Lost to Follow-up|1|||
130249378|NCT01313676|468874918|FG003|Overall Study|Lost to Follow-up|0|||
130249379|NCT01313676|468874915|FG000|Overall Study|Physician Decision|53|||
130249380|NCT01313676|468874916|FG001|Overall Study|Physician Decision|64|||
130699709|NCT01332968|470524724|FG005|Follow-Up Period|Other|0|||
130699710|NCT01332968|470524725|FG006|Follow-Up Period|Other|18|||
130699711|NCT01332968|470524726|FG007|Follow-Up Period|Other|21|||
130249381|NCT01313676|468874917|FG002|Overall Study|Physician Decision|62|||
130249382|NCT01313676|468874918|FG003|Overall Study|Physician Decision|48|||
130249383|NCT01313676|468874915|FG000|Overall Study|Decision by Participant or Proxy|643|||
130249384|NCT01313676|468874916|FG001|Overall Study|Decision by Participant or Proxy|527|||
130249385|NCT01313676|468874917|FG002|Overall Study|Decision by Participant or Proxy|515|||
130249386|NCT01313676|468874918|FG003|Overall Study|Decision by Participant or Proxy|492|||
130249387|NCT01313676|468874915|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
130249388|NCT01313676|468874916|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
130699712|NCT01332968|470524719|FG000|Follow-Up Period|Physician Decision|0|||
130699713|NCT01332968|470524720|FG001|Follow-Up Period|Physician Decision|0|||
130699714|NCT01332968|470524721|FG002|Follow-Up Period|Physician Decision|0|||
130249389|NCT01313676|468874917|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
130249390|NCT01313676|468874918|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
130249391|NCT01313676|468874915|FG000|Overall Study|Investigator Site Closed|12|||
130249392|NCT01313676|468874916|FG001|Overall Study|Investigator Site Closed|11|||
130364204|NCT01644565|469303381|FG006|Overall Study|Lost to Follow-up|0|||
130364205|NCT01644565|469303382|FG007|Overall Study|Lost to Follow-up|2|||
130364206|NCT01644565|469303383|FG008|Overall Study|Lost to Follow-up|0|||
130364207|NCT01644565|469303375|FG000|Overall Study|Family emergency|0|||
130364208|NCT01644565|469303376|FG001|Overall Study|Family emergency|0|||
130364209|NCT01644565|469303377|FG002|Overall Study|Family emergency|0|||
130364210|NCT01644565|469303378|FG003|Overall Study|Family emergency|0|||
130364211|NCT01644565|469303379|FG004|Overall Study|Family emergency|1|||
130364212|NCT01644565|469303380|FG005|Overall Study|Family emergency|0|||
130364213|NCT01644565|469303381|FG006|Overall Study|Family emergency|0|||
130364214|NCT01644565|469303382|FG007|Overall Study|Family emergency|0|||
130364215|NCT01644565|469303383|FG008|Overall Study|Family emergency|0|||
130364216|NCT01644565|469303375|FG000|Overall Study|Relocation|0|||
130364217|NCT01644565|469303376|FG001|Overall Study|Relocation|0|||
130364218|NCT01644565|469303377|FG002|Overall Study|Relocation|0|||
130364219|NCT01644565|469303378|FG003|Overall Study|Relocation|0|||
130364220|NCT01644565|469303379|FG004|Overall Study|Relocation|0|||
130364221|NCT01644565|469303380|FG005|Overall Study|Relocation|0|||
130364222|NCT01644565|469303381|FG006|Overall Study|Relocation|0|||
130364223|NCT01644565|469303382|FG007|Overall Study|Relocation|0|||
130364224|NCT01644565|469303383|FG008|Overall Study|Relocation|1|||
130364225|NCT01550289|469303384|FG000|Overall Study|Protocol Violation|1|||
130364226|NCT01550289|469303385|FG001|Overall Study|Protocol Violation|0|||
130364227|NCT01550289|469303384|FG000|Overall Study|Lost to Follow-up|1|||
130364228|NCT01550289|469303385|FG001|Overall Study|Lost to Follow-up|1|||
130364229|NCT01550289|469303384|FG000|Overall Study|Withdrawal by Subject|11|||
130364230|NCT01550289|469303385|FG001|Overall Study|Withdrawal by Subject|3|||
130364231|NCT01897454|469303386|FG000|Overall Study|Withdrawal by Subject|1|||
130364232|NCT00094172|469303389|FG000|Overall Study|Adverse Event|0|||
130364233|NCT00094172|469303390|FG001|Overall Study|Adverse Event|1|||
130364234|NCT00094172|469303389|FG000|Overall Study|Lost to Follow-up|2|||
130364235|NCT00094172|469303390|FG001|Overall Study|Lost to Follow-up|0|||
130364236|NCT00094172|469303389|FG000|Overall Study|Protocol Violation|0|||
130364237|NCT00094172|469303390|FG001|Overall Study|Protocol Violation|1|||
130364238|NCT00094172|469303389|FG000|Overall Study|Withdrawal by Subject|10|||
130364239|NCT00094172|469303390|FG001|Overall Study|Withdrawal by Subject|5|||
130364240|NCT00094172|469303389|FG000|Overall Study|Primary endpoint met.|1|||
130364241|NCT00094172|469303390|FG001|Overall Study|Primary endpoint met.|0|||
130364242|NCT00094172|469303389|FG000|Overall Study|Started other MS therapy due to disease|1|||
130364243|NCT00094172|469303390|FG001|Overall Study|Started other MS therapy due to disease|0|||
130364244|NCT01392443|469303395|FG000|Overall Study|Disease progression|30|||
130364245|NCT01392443|469303395|FG000|Overall Study|Adverse Event|24|||
130364246|NCT01392443|469303395|FG000|Overall Study|Death|7|||
130364247|NCT01392443|469303395|FG000|Overall Study|Withdrawal by Subject|5|||
130364248|NCT01392443|469303395|FG000|Overall Study|Lost to Follow-up|1|||
130364249|NCT01392443|469303395|FG000|Overall Study|Protocol Violation|1|||
130364250|NCT01977794|469303396|FG000|Overall Study|Adverse Event|2|||
130364251|NCT01977794|469303397|FG001|Overall Study|Adverse Event|2|||
130364252|NCT01977794|469303396|FG000|Overall Study|Lost to Follow-up|2|||
130699715|NCT01332968|470524722|FG003|Follow-Up Period|Physician Decision|0|||
130699716|NCT01332968|470524723|FG004|Follow-Up Period|Physician Decision|0|||
130699717|NCT01332968|470524724|FG005|Follow-Up Period|Physician Decision|0|||
130249393|NCT01313676|468874917|FG002|Overall Study|Investigator Site Closed|15|||
130249394|NCT01313676|468874918|FG003|Overall Study|Investigator Site Closed|10|||
130249395|NCT01313676|468874915|FG000|Overall Study|Missing|1|||
130249396|NCT01313676|468874916|FG001|Overall Study|Missing|1|||
130249397|NCT01313676|468874917|FG002|Overall Study|Missing|1|||
130249398|NCT01313676|468874918|FG003|Overall Study|Missing|0|||
130249399|NCT00944645|468874919|FG000|Period 2|Adverse Event|1|||
130249400|NCT00944645|468874920|FG001|Period 2|Adverse Event|0|||
130249401|NCT00944645|468874919|FG000|Period 2|Lost to Follow-up|0|||
130249402|NCT00944645|468874920|FG001|Period 2|Lost to Follow-up|3|||
130249403|NCT00944645|468874919|FG000|Period 2|Withdrawal by Subject|7|||
130249404|NCT00944645|468874920|FG001|Period 2|Withdrawal by Subject|6|||
130249405|NCT03537729|468874921|FG000|Overall Study|Death|2|||
130249406|NCT03537729|468874922|FG001|Overall Study|Death|2|||
130249407|NCT03537729|468874923|FG002|Overall Study|Death|7|||
130249408|NCT03537729|468874921|FG000|Overall Study|Withdrawal by Subject|3|||
130249409|NCT03537729|468874922|FG001|Overall Study|Withdrawal by Subject|3|||
130249410|NCT03537729|468874923|FG002|Overall Study|Withdrawal by Subject|0|||
130249411|NCT03537729|468874921|FG000|Overall Study|Subject Moved|8|||
130249412|NCT03537729|468874922|FG001|Overall Study|Subject Moved|5|||
130249413|NCT03537729|468874923|FG002|Overall Study|Subject Moved|4|||
130249414|NCT03537729|468874921|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
130249415|NCT03537729|468874922|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130249416|NCT03537729|468874923|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130249417|NCT03537729|468874921|FG000|Overall Study|COVID-19 Site Restrictions|11|||
130249418|NCT03537729|468874922|FG001|Overall Study|COVID-19 Site Restrictions|15|||
130249419|NCT03537729|468874923|FG002|Overall Study|COVID-19 Site Restrictions|18|||
130249420|NCT03537729|468874921|FG000|Overall Study|Decline in Health|5|||
130249421|NCT03537729|468874922|FG001|Overall Study|Decline in Health|9|||
130249422|NCT03537729|468874923|FG002|Overall Study|Decline in Health|4|||
130249423|NCT03537729|468874921|FG000|Overall Study|Determined Ineligible|0|||
130699718|NCT01332968|470524725|FG006|Follow-Up Period|Physician Decision|12|||
130699719|NCT01332968|470524726|FG007|Follow-Up Period|Physician Decision|15|||
130249424|NCT03537729|468874922|FG001|Overall Study|Determined Ineligible|0|||
130249425|NCT03537729|468874923|FG002|Overall Study|Determined Ineligible|1|||
130249426|NCT02562040|468874925|FG000|Overall Study|Lost to Follow-up|20|||
130249427|NCT02562040|468874926|FG001|Overall Study|Lost to Follow-up|28|||
130249428|NCT02562040|468874925|FG000|Overall Study|Withdrawal by Subject|8|||
130249429|NCT02562040|468874926|FG001|Overall Study|Withdrawal by Subject|7|||
130249430|NCT02562040|468874925|FG000|Overall Study|Adverse Event|1|||
130249431|NCT02562040|468874926|FG001|Overall Study|Adverse Event|0|||
130249432|NCT01902303|468874927|FG000|Overall Study|Adverse Event|0|||
130249433|NCT01902303|468874928|FG001|Overall Study|Adverse Event|1|||
130249434|NCT01902303|468874927|FG000|Overall Study|Lost to Follow-up|0|||
130249435|NCT01902303|468874928|FG001|Overall Study|Lost to Follow-up|1|||
130249436|NCT01902303|468874927|FG000|Overall Study|Protocol Violation|2|||
130249437|NCT01902303|468874928|FG001|Overall Study|Protocol Violation|2|||
130249438|NCT01902303|468874927|FG000|Overall Study|subject lost investigational product|0|||
130364253|NCT01977794|469303397|FG001|Overall Study|Lost to Follow-up|1|||
130364254|NCT01977794|469303396|FG000|Overall Study|Protocol Violation|1|||
130364255|NCT01977794|469303397|FG001|Overall Study|Protocol Violation|0|||
130364256|NCT01977794|469303396|FG000|Overall Study|Death|1|||
130364257|NCT01977794|469303397|FG001|Overall Study|Death|1|||
130364258|NCT01977794|469303396|FG000|Overall Study|Withdrew consent|2|||
130364259|NCT01977794|469303397|FG001|Overall Study|Withdrew consent|1|||
130364260|NCT01977794|469303396|FG000|Overall Study|Other|0|||
130364261|NCT01977794|469303397|FG001|Overall Study|Other|1|||
130364262|NCT00827502|469303400|FG000|Overall Study|randomized but not treated|11|||
130364263|NCT00827502|469303400|FG000|Overall Study|Adverse Event|1|||
130364264|NCT00827502|469303400|FG000|Overall Study|Lost to Follow-up|4|||
130364265|NCT00827502|469303400|FG000|Overall Study|Withdrawal by Subject|5|||
130364266|NCT02478632|469303401|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
130364267|NCT02478632|469303402|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
130364268|NCT02478632|469303401|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
130364269|NCT02478632|469303402|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
130364270|NCT02478632|469303401|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
130364271|NCT02478632|469303402|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
130364272|NCT03019185|469303403|FG000|Overall Study|Lost to Follow-up|3|||
130364273|NCT03019185|469303404|FG001|Overall Study|Lost to Follow-up|0|||
130364274|NCT03019185|469303405|FG002|Overall Study|Lost to Follow-up|2|||
130364275|NCT03019185|469303403|FG000|Overall Study|Withdrawal by Subject|1|||
130364276|NCT03019185|469303404|FG001|Overall Study|Withdrawal by Subject|1|||
130364277|NCT03019185|469303405|FG002|Overall Study|Withdrawal by Subject|0|||
130364278|NCT03019185|469303403|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
130364279|NCT03019185|469303404|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
130249439|NCT01902303|468874928|FG001|Overall Study|subject lost investigational product|1|||
130249440|NCT01902303|468874927|FG000|Overall Study|Did not develop a cold sore|21|||
130249441|NCT01902303|468874928|FG001|Overall Study|Did not develop a cold sore|19|||
130249442|NCT02821000|468874929|FG000|Overall Study|Death|89|||
130249443|NCT02821000|468874929|FG000|Overall Study|Sponsor Decision|12|||
130249444|NCT02821000|468874929|FG000|Overall Study|Withdrawal by Subject|2|||
130249445|NCT00326495|468874930|FG000|Overall Study|Switched to alternative treatment|1|||
130249446|NCT00326495|468874930|FG000|Overall Study|Disease progression before treatment|1|||
130249447|NCT00326495|468874930|FG000|Overall Study|Refused further treatment|2|||
130249448|NCT00326495|468874930|FG000|Overall Study|Subject off study before assessment|1|||
130249449|NCT04359680|468874931|FG000|Overall Study|Withdrawal by Subject|29|||
130249450|NCT04359680|468874932|FG001|Overall Study|Withdrawal by Subject|24|||
130249451|NCT04359680|468874931|FG000|Overall Study|Adverse Event|6|||
130249452|NCT04359680|468874932|FG001|Overall Study|Adverse Event|2|||
130249453|NCT04359680|468874931|FG000|Overall Study|Lost to Follow-up|56|||
130249454|NCT04359680|468874932|FG001|Overall Study|Lost to Follow-up|59|||
130249455|NCT04359680|468874931|FG000|Overall Study|Protocol Violation|3|||
130249456|NCT04359680|468874932|FG001|Overall Study|Protocol Violation|5|||
130249457|NCT04359680|468874931|FG000|Overall Study|Physician Decision|1|||
130249458|NCT04359680|468874932|FG001|Overall Study|Physician Decision|1|||
130249459|NCT04359680|468874931|FG000|Overall Study|Sponsor Decision|0|||
130249460|NCT04359680|468874932|FG001|Overall Study|Sponsor Decision|1|||
130249461|NCT01654250|468874933|FG000|Overall Study|Lost to Follow-up|1|||
130249462|NCT01654250|468874934|FG001|Overall Study|Lost to Follow-up|0|||
130249463|NCT01862029|468874935|FG000|Overall Study|Physician Decision|1|||
130249464|NCT01530256|468874937|FG000|Overall Study|Death|2|||
130249465|NCT02004275|468874938|FG000|Phase 1|Ineligible|0|||
130249466|NCT02004275|468874939|FG001|Phase 1|Ineligible|0|||
130249467|NCT02004275|468874940|FG002|Phase 1|Ineligible|0|||
130249468|NCT02004275|468874941|FG003|Phase 1|Ineligible|1|||
130249469|NCT02004275|468874942|FG004|Phase 1|Ineligible|1|||
130249470|NCT02004275|468874943|FG005|Phase 1|Ineligible|0|||
130249471|NCT02004275|468874938|FG000|Phase 1|Protocol Violation|0|||
130249472|NCT02004275|468874939|FG001|Phase 1|Protocol Violation|0|||
130249473|NCT02004275|468874940|FG002|Phase 1|Protocol Violation|0|||
130249474|NCT02004275|468874941|FG003|Phase 1|Protocol Violation|1|||
130249475|NCT02004275|468874942|FG004|Phase 1|Protocol Violation|0|||
130249476|NCT02004275|468874943|FG005|Phase 1|Protocol Violation|5|||
130249477|NCT02004275|468874938|FG000|Phase 2 Part 1|Ineligible|6|||
130249478|NCT02004275|468874939|FG001|Phase 2 Part 1|Ineligible|9|||
130249479|NCT02004275|468874940|FG002|Phase 2 Part 1|Ineligible|0|||
130249480|NCT02004275|468874941|FG003|Phase 2 Part 1|Ineligible|0|||
130249481|NCT02004275|468874942|FG004|Phase 2 Part 1|Ineligible|0|||
130249482|NCT02004275|468874943|FG005|Phase 2 Part 1|Ineligible|0|||
130249483|NCT02004275|468874938|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
130249484|NCT02004275|468874939|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
130249485|NCT02004275|468874940|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
130249486|NCT02004275|468874941|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
130249487|NCT02004275|468874942|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
130249488|NCT02004275|468874943|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
130249489|NCT02595437|468874945|FG000|Triferic Via IV|Withdrawal by Subject|1|||
130249490|NCT04914000|468874952|FG000|Overall Study|Lost to Follow-up|8|||
130249491|NCT04914000|468874952|FG000|Overall Study|Withdrawal by Subject|1|||
130249492|NCT01429623|468874953|FG000|Overall Study|Death|1|||
130249493|NCT01429623|468874954|FG001|Overall Study|Death|0|||
130249494|NCT01429623|468874953|FG000|Overall Study|Adverse Event|7|||
130249495|NCT01429623|468874954|FG001|Overall Study|Adverse Event|14|||
130249496|NCT01429623|468874953|FG000|Overall Study|Withdrawal by Subject|19|||
130249497|NCT01429623|468874954|FG001|Overall Study|Withdrawal by Subject|13|||
130249498|NCT01429623|468874953|FG000|Overall Study|Physician Decision|2|||
130249499|NCT01429623|468874954|FG001|Overall Study|Physician Decision|3|||
130249500|NCT01429623|468874953|FG000|Overall Study|Protocol Violation|3|||
130249501|NCT01429623|468874954|FG001|Overall Study|Protocol Violation|2|||
130364280|NCT03019185|469303405|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
130364281|NCT03019185|469303403|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
130249502|NCT01429623|468874953|FG000|Overall Study|Assorted|1|||
130249503|NCT01429623|468874954|FG001|Overall Study|Assorted|2|||
130249504|NCT01429623|468874953|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
130249505|NCT01429623|468874954|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
130249506|NCT01429623|468874953|FG000|Overall Study|No post baseline data|4|||
130364282|NCT03019185|469303404|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
130249507|NCT01429623|468874954|FG001|Overall Study|No post baseline data|4|||
130249508|NCT01896986|468874955|FG000|Overall Study|samples lost|14|||
130364283|NCT03019185|469303405|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
130249509|NCT01896986|468874956|FG001|Overall Study|samples lost|23|||
130249510|NCT01750281|468874957|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
130249511|NCT01750281|468874958|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
130364284|NCT03355365|469303406|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
130364285|NCT03355365|469303407|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
130249512|NCT01750281|468874959|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
130249513|NCT01750281|468874957|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
130249514|NCT01750281|468874958|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
130249515|NCT01750281|468874959|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
130249516|NCT01750281|468874957|FG000|Overall Study|Did not receive treatment|0|||
130249517|NCT01750281|468874958|FG001|Overall Study|Did not receive treatment|1|||
130249518|NCT01750281|468874959|FG002|Overall Study|Did not receive treatment|0|||
130249519|NCT01061710|468874965|FG000|Overall Study|Protocol Violation|14|||
130249520|NCT03757715|468874967|FG000|Overall Study|Lost to Follow-up|4|||
130249521|NCT03757715|468874968|FG001|Overall Study|Lost to Follow-up|9|||
130249522|NCT03757715|468874967|FG000|Overall Study|Withdrawal by Subject|1|||
130249523|NCT03757715|468874968|FG001|Overall Study|Withdrawal by Subject|1|||
130249524|NCT00281580|468874969|FG000|Overall Study|Adverse Event|2|||
130249525|NCT00281580|468874970|FG001|Overall Study|Adverse Event|0|||
130249526|NCT00281580|468874971|FG002|Overall Study|Adverse Event|2|||
130249527|NCT00281580|468874972|FG003|Overall Study|Adverse Event|4|||
130249528|NCT00281580|468874973|FG004|Overall Study|Adverse Event|1|||
130249529|NCT00281580|468874974|FG005|Overall Study|Adverse Event|0|||
130249530|NCT00281580|468874975|FG006|Overall Study|Adverse Event|1|||
130249531|NCT00281580|468874976|FG007|Overall Study|Adverse Event|0|||
130249532|NCT00281580|468874977|FG008|Overall Study|Adverse Event|1|||
130249533|NCT00281580|468874978|FG009|Overall Study|Adverse Event|6|||
130249534|NCT00281580|468874979|FG010|Overall Study|Adverse Event|0|||
130249535|NCT00281580|468874980|FG011|Overall Study|Adverse Event|5|||
130249536|NCT00281580|468874981|FG012|Overall Study|Adverse Event|8|||
130249537|NCT00281580|468874982|FG013|Overall Study|Adverse Event|2|||
130249538|NCT00281580|468874983|FG014|Overall Study|Adverse Event|3|||
130249539|NCT00281580|468874984|FG015|Overall Study|Adverse Event|3|||
130249540|NCT00281580|468874969|FG000|Overall Study|Protocol Violation|0|||
130249541|NCT00281580|468874970|FG001|Overall Study|Protocol Violation|0|||
130249542|NCT00281580|468874971|FG002|Overall Study|Protocol Violation|1|||
130249543|NCT00281580|468874972|FG003|Overall Study|Protocol Violation|1|||
130249544|NCT00281580|468874973|FG004|Overall Study|Protocol Violation|0|||
130249545|NCT00281580|468874974|FG005|Overall Study|Protocol Violation|0|||
130249546|NCT00281580|468874975|FG006|Overall Study|Protocol Violation|1|||
130249547|NCT00281580|468874976|FG007|Overall Study|Protocol Violation|0|||
130249548|NCT00281580|468874977|FG008|Overall Study|Protocol Violation|2|||
130249549|NCT00281580|468874978|FG009|Overall Study|Protocol Violation|0|||
130249550|NCT00281580|468874979|FG010|Overall Study|Protocol Violation|1|||
130249551|NCT00281580|468874980|FG011|Overall Study|Protocol Violation|2|||
130249552|NCT00281580|468874981|FG012|Overall Study|Protocol Violation|0|||
130249553|NCT00281580|468874982|FG013|Overall Study|Protocol Violation|1|||
130249554|NCT00281580|468874983|FG014|Overall Study|Protocol Violation|1|||
130249555|NCT00281580|468874984|FG015|Overall Study|Protocol Violation|3|||
130249556|NCT00281580|468874969|FG000|Overall Study|Withdrawal by Subject|3|||
130249557|NCT00281580|468874970|FG001|Overall Study|Withdrawal by Subject|0|||
130249558|NCT00281580|468874971|FG002|Overall Study|Withdrawal by Subject|1|||
130249559|NCT00281580|468874972|FG003|Overall Study|Withdrawal by Subject|1|||
130249560|NCT00281580|468874973|FG004|Overall Study|Withdrawal by Subject|1|||
130249561|NCT00281580|468874974|FG005|Overall Study|Withdrawal by Subject|2|||
130249562|NCT00281580|468874975|FG006|Overall Study|Withdrawal by Subject|2|||
130249563|NCT00281580|468874976|FG007|Overall Study|Withdrawal by Subject|0|||
130249564|NCT00281580|468874977|FG008|Overall Study|Withdrawal by Subject|1|||
130249565|NCT00281580|468874978|FG009|Overall Study|Withdrawal by Subject|4|||
130249566|NCT00281580|468874979|FG010|Overall Study|Withdrawal by Subject|1|||
130249567|NCT00281580|468874980|FG011|Overall Study|Withdrawal by Subject|1|||
130249568|NCT00281580|468874981|FG012|Overall Study|Withdrawal by Subject|2|||
130249569|NCT00281580|468874982|FG013|Overall Study|Withdrawal by Subject|2|||
130249570|NCT00281580|468874983|FG014|Overall Study|Withdrawal by Subject|1|||
130452619|NCT00984282|469621657|FG000|Open-label Treatment|Patient convenience|1|||
130452620|NCT00984282|469621658|FG001|Open-label Treatment|Patient convenience|0|||
130452621|NCT00984282|469621657|FG000|Open-label Treatment|Non-compliant with study medication|1|||
130452622|NCT00984282|469621658|FG001|Open-label Treatment|Non-compliant with study medication|0|||
130452623|NCT00984282|469621657|FG000|Open-label Treatment|Target lesion removed|0|||
130452624|NCT00984282|469621658|FG001|Open-label Treatment|Target lesion removed|1|||
130452625|NCT00984282|469621657|FG000|Open-label Treatment|Protocol driven decision point|1|||
130452626|NCT00984282|469621658|FG001|Open-label Treatment|Protocol driven decision point|1|||
130452627|NCT00984282|469621657|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
130452628|NCT00984282|469621658|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
130249571|NCT00281580|468874984|FG015|Overall Study|Withdrawal by Subject|5|||
130249572|NCT00281580|468874969|FG000|Overall Study|Lack of Efficacy|2|||
130249573|NCT00281580|468874970|FG001|Overall Study|Lack of Efficacy|1|||
130249574|NCT00281580|468874971|FG002|Overall Study|Lack of Efficacy|1|||
130553233|NCT04356183|469993522|FG001|Overall Study|Lost to Follow-up|0|||
130249575|NCT00281580|468874972|FG003|Overall Study|Lack of Efficacy|6|||
130249576|NCT00281580|468874973|FG004|Overall Study|Lack of Efficacy|2|||
130249577|NCT00281580|468874974|FG005|Overall Study|Lack of Efficacy|0|||
130249578|NCT00281580|468874975|FG006|Overall Study|Lack of Efficacy|0|||
130249579|NCT00281580|468874976|FG007|Overall Study|Lack of Efficacy|0|||
130249580|NCT00281580|468874977|FG008|Overall Study|Lack of Efficacy|0|||
130249581|NCT00281580|468874978|FG009|Overall Study|Lack of Efficacy|0|||
130249582|NCT00281580|468874979|FG010|Overall Study|Lack of Efficacy|0|||
130249583|NCT00281580|468874980|FG011|Overall Study|Lack of Efficacy|1|||
130249584|NCT00281580|468874981|FG012|Overall Study|Lack of Efficacy|0|||
130249585|NCT00281580|468874982|FG013|Overall Study|Lack of Efficacy|2|||
130249586|NCT00281580|468874983|FG014|Overall Study|Lack of Efficacy|1|||
130249587|NCT00281580|468874984|FG015|Overall Study|Lack of Efficacy|0|||
130249588|NCT00281580|468874969|FG000|Overall Study|Lost to Follow-up|0|||
130249589|NCT00281580|468874970|FG001|Overall Study|Lost to Follow-up|0|||
130249590|NCT00281580|468874971|FG002|Overall Study|Lost to Follow-up|0|||
130249591|NCT00281580|468874972|FG003|Overall Study|Lost to Follow-up|3|||
130249592|NCT00281580|468874973|FG004|Overall Study|Lost to Follow-up|0|||
130249593|NCT00281580|468874974|FG005|Overall Study|Lost to Follow-up|1|||
130249594|NCT00281580|468874975|FG006|Overall Study|Lost to Follow-up|0|||
130249595|NCT00281580|468874976|FG007|Overall Study|Lost to Follow-up|1|||
130249596|NCT00281580|468874977|FG008|Overall Study|Lost to Follow-up|2|||
130249597|NCT00281580|468874978|FG009|Overall Study|Lost to Follow-up|1|||
130249598|NCT00281580|468874979|FG010|Overall Study|Lost to Follow-up|1|||
130249599|NCT00281580|468874980|FG011|Overall Study|Lost to Follow-up|0|||
130249600|NCT00281580|468874981|FG012|Overall Study|Lost to Follow-up|1|||
130249601|NCT00281580|468874982|FG013|Overall Study|Lost to Follow-up|0|||
130249602|NCT00281580|468874983|FG014|Overall Study|Lost to Follow-up|0|||
130249603|NCT00281580|468874984|FG015|Overall Study|Lost to Follow-up|0|||
130249604|NCT00281580|468874969|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
130249605|NCT00281580|468874970|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
130249606|NCT00281580|468874971|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
130364286|NCT03355365|469303406|FG000|Year 1, First Intervention|Protocol Violation|1|||
130364287|NCT03355365|469303407|FG001|Year 1, First Intervention|Protocol Violation|0|||
130364288|NCT03355365|469303406|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
130364289|NCT03355365|469303407|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
130364290|NCT03355365|469303406|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
130364291|NCT03355365|469303407|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
130364292|NCT03355365|469303406|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
130364293|NCT03355365|469303407|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
130364294|NCT03355365|469303406|FG000|Year 2, Crossover Intervention|severe COVID|0|||
130364295|NCT03355365|469303407|FG001|Year 2, Crossover Intervention|severe COVID|1|||
130364296|NCT03355365|469303406|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
130364297|NCT03355365|469303407|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
130364298|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Adverse Event|3|||
130364299|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Adverse Event|0|||
130364300|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
130364301|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
130364302|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
130364303|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
130364304|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Physician Decision|0|||
130364305|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Physician Decision|2|||
130364306|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
130364307|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
130364308|NCT02110238|469303408|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
130364309|NCT02110238|469303409|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
130364310|NCT02110238|469303408|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
130364311|NCT02110238|469303409|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
130364312|NCT02110238|469303408|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
130364313|NCT02110238|469303409|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
130249607|NCT00281580|468874972|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
130249608|NCT00281580|468874973|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
130249609|NCT00281580|468874974|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
130249610|NCT00281580|468874975|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
130364314|NCT02110238|469303408|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
130364315|NCT02110238|469303409|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
130249611|NCT00281580|468874976|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
130249612|NCT00281580|468874977|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
130249613|NCT00281580|468874978|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
130249614|NCT00281580|468874979|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
130249615|NCT00281580|468874980|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
130249616|NCT00281580|468874981|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
130249617|NCT00281580|468874982|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
130249618|NCT00281580|468874983|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
130249619|NCT00281580|468874984|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
130364316|NCT02110238|469303408|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
130364317|NCT02110238|469303409|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
130364318|NCT02110238|469303408|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
130364319|NCT02110238|469303409|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
130364320|NCT00142935|469303412|FG000|Overall Study|Other reason|1|||
130364321|NCT00142935|469303413|FG001|Overall Study|Other reason|1|||
130364322|NCT00142935|469303414|FG002|Overall Study|Other reason|1|||
130364323|NCT00142935|469303412|FG000|Overall Study|Lost to Follow-up|2|||
130364324|NCT00142935|469303413|FG001|Overall Study|Lost to Follow-up|5|||
130364325|NCT00142935|469303414|FG002|Overall Study|Lost to Follow-up|5|||
130364326|NCT00142935|469303412|FG000|Overall Study|Death|0|||
130364327|NCT00142935|469303413|FG001|Overall Study|Death|2|||
130364328|NCT00142935|469303414|FG002|Overall Study|Death|1|||
130364329|NCT01330030|469303419|FG000|Overall Study|Lost to Follow-up|16|||
130364330|NCT01330030|469303420|FG001|Overall Study|Lost to Follow-up|17|||
130364331|NCT02980783|469303421|FG000|Overall Study|Lost to Follow-up|1|||
130364332|NCT01781975|469303437|FG000|Overall Study|Death|1|||
130364333|NCT01781975|469303438|FG001|Overall Study|Death|0|||
130364334|NCT01781975|469303437|FG000|Overall Study|Withdrawal by Subject|1|||
130364335|NCT01781975|469303438|FG001|Overall Study|Withdrawal by Subject|1|||
130364336|NCT02404220|469303440|FG000|Overall Study|Adverse Event|0|||
130364337|NCT02404220|469303441|FG001|Overall Study|Adverse Event|0|||
130364338|NCT02404220|469303442|FG002|Overall Study|Adverse Event|1|||
130364339|NCT02404220|469303443|FG003|Overall Study|Adverse Event|0|||
130364340|NCT02404220|469303440|FG000|Overall Study|Death|5|||
130364341|NCT02404220|469303441|FG001|Overall Study|Death|5|||
130364342|NCT02404220|469303442|FG002|Overall Study|Death|3|||
130364343|NCT02404220|469303443|FG003|Overall Study|Death|8|||
130364344|NCT02404220|469303440|FG000|Overall Study|Progressive Disease|0|||
130364345|NCT02404220|469303441|FG001|Overall Study|Progressive Disease|0|||
130364346|NCT02404220|469303442|FG002|Overall Study|Progressive Disease|1|||
130364347|NCT02404220|469303443|FG003|Overall Study|Progressive Disease|1|||
130364348|NCT02404220|469303440|FG000|Overall Study|Study Terminated by Sponsor|0|||
130364349|NCT02404220|469303441|FG001|Overall Study|Study Terminated by Sponsor|0|||
130364350|NCT02404220|469303442|FG002|Overall Study|Study Terminated by Sponsor|2|||
130364351|NCT02404220|469303443|FG003|Overall Study|Study Terminated by Sponsor|1|||
130364352|NCT02404220|469303440|FG000|Overall Study|Withdrawal by Subject|0|||
130364353|NCT02404220|469303441|FG001|Overall Study|Withdrawal by Subject|1|||
130364354|NCT02404220|469303442|FG002|Overall Study|Withdrawal by Subject|0|||
130364355|NCT02404220|469303443|FG003|Overall Study|Withdrawal by Subject|0|||
130364356|NCT02404220|469303440|FG000|Overall Study|Enrolled but Never Treated|0|||
130364357|NCT02404220|469303441|FG001|Overall Study|Enrolled but Never Treated|2|||
130364358|NCT02404220|469303442|FG002|Overall Study|Enrolled but Never Treated|0|||
130364359|NCT02404220|469303443|FG003|Overall Study|Enrolled but Never Treated|0|||
130364360|NCT01622231|469303444|FG000|Overall Study|Physician Decision|1|||
130364361|NCT01622231|469303444|FG000|Overall Study|Withdrawal by Subject|1|||
130364362|NCT02905149|469303445|FG000|Overall Study|Lost to Follow-up|2|||
130364363|NCT02905149|469303446|FG001|Overall Study|Lost to Follow-up|0|||
130364364|NCT02329080|469303447|FG000|Overall Study|Adverse Event|1|||
130364365|NCT02329080|469303447|FG000|Overall Study|Death|4|||
130364366|NCT02329080|469303447|FG000|Overall Study|Lack of Efficacy|22|||
130364367|NCT02329080|469303447|FG000|Overall Study|Lost to Follow-up|1|||
130364368|NCT02329080|469303447|FG000|Overall Study|Physician Decision|2|||
130364369|NCT02329080|469303447|FG000|Overall Study|Partial response|4|||
130249620|NCT03302936|468874985|FG000|Overall Study|Protocol Violation|3|||
130249621|NCT03302936|468874986|FG001|Overall Study|Protocol Violation|4|||
130249622|NCT01550965|468874987|FG000|Overall Study|Adverse Event|26|||
130364370|NCT02329080|469303447|FG000|Overall Study|Complete response|4|||
130364371|NCT01609231|469303454|FG000|Overall Study|Adverse Event|1|||
130364372|NCT01609231|469303455|FG001|Overall Study|Adverse Event|3|||
130364373|NCT01609231|469303454|FG000|Overall Study|Physician Decision|1|||
130364374|NCT01609231|469303455|FG001|Overall Study|Physician Decision|0|||
130364375|NCT01609231|469303454|FG000|Overall Study|Withdrawal by Subject|1|||
130364376|NCT01609231|469303455|FG001|Overall Study|Withdrawal by Subject|0|||
130364377|NCT04295772|469303459|FG000|Overall Study|Protocol Violation|1|||
130364378|NCT04295772|469303460|FG001|Overall Study|Protocol Violation|0|||
130364379|NCT04295772|469303459|FG000|Overall Study|Ongoing for safety monitoring|14|||
130364380|NCT04295772|469303460|FG001|Overall Study|Ongoing for safety monitoring|1|||
130553234|NCT04356183|469993521|FG000|Overall Study|Withdrawal by Subject|1|||
130553235|NCT04356183|469993522|FG001|Overall Study|Withdrawal by Subject|1|||
130553236|NCT01177787|469993523|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
130364381|NCT04295772|469303459|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
130364382|NCT04295772|469303460|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
130364383|NCT02846324|469303461|FG000|Overall Study|Other|1|||
130364384|NCT02846324|469303462|FG001|Overall Study|Other|0|||
130364385|NCT02846324|469303463|FG002|Overall Study|Other|0|||
130364386|NCT02846324|469303464|FG003|Overall Study|Other|0|||
130364387|NCT02846324|469303461|FG000|Overall Study|Withdrawal by Subject|1|||
130364388|NCT02846324|469303462|FG001|Overall Study|Withdrawal by Subject|0|||
130364389|NCT02846324|469303463|FG002|Overall Study|Withdrawal by Subject|4|||
130364390|NCT02846324|469303464|FG003|Overall Study|Withdrawal by Subject|0|||
130364391|NCT04203797|469303469|FG000|Overall Study|Adverse Event|1|||
130364392|NCT04203797|469303470|FG001|Overall Study|Adverse Event|0|||
130364393|NCT04203797|469303469|FG000|Overall Study|Did not complete End of Study follow-up|1|||
130364394|NCT04203797|469303470|FG001|Overall Study|Did not complete End of Study follow-up|0|||
130364395|NCT00516074|469303471|FG000|Overall Study|Adverse Event|0|||
130364396|NCT00516074|469303472|FG001|Overall Study|Adverse Event|1|||
130364397|NCT00516074|469303471|FG000|Overall Study|Subject Decision|4|||
130364398|NCT00516074|469303472|FG001|Overall Study|Subject Decision|2|||
130364399|NCT00516074|469303471|FG000|Overall Study|Loss of Glucose Control|2|||
130364400|NCT00516074|469303472|FG001|Overall Study|Loss of Glucose Control|0|||
130364401|NCT03540030|469303473|FG000|Overall Study|Withdrawal by Subject|2|||
130364402|NCT03540030|469303474|FG001|Overall Study|Withdrawal by Subject|1|||
130364403|NCT03540030|469303473|FG000|Overall Study|screen fail|7|||
130364404|NCT03540030|469303474|FG001|Overall Study|screen fail|1|||
130364405|NCT03540030|469303473|FG000|Overall Study|never had surgery after signing consent|9|||
130364406|NCT03540030|469303474|FG001|Overall Study|never had surgery after signing consent|1|||
130364407|NCT00003487|469303476|FG000|Overall Study|Not evaluable|2|||
130364408|NCT03855228|469303478|FG000|Overall Study|Adverse Event|2|||
130364409|NCT03855228|469303479|FG001|Overall Study|Adverse Event|4|||
130364410|NCT03855228|469303480|FG002|Overall Study|Adverse Event|4|||
130364411|NCT03855228|469303481|FG003|Overall Study|Adverse Event|8|||
130364412|NCT03855228|469303478|FG000|Overall Study|Treatment Failure|1|||
130364413|NCT03855228|469303479|FG001|Overall Study|Treatment Failure|2|||
130364414|NCT03855228|469303480|FG002|Overall Study|Treatment Failure|1|||
130364415|NCT03855228|469303481|FG003|Overall Study|Treatment Failure|8|||
130364416|NCT03855228|469303478|FG000|Overall Study|Lost to Follow-up|0|||
130364417|NCT03855228|469303479|FG001|Overall Study|Lost to Follow-up|0|||
130364418|NCT03855228|469303480|FG002|Overall Study|Lost to Follow-up|0|||
130364419|NCT03855228|469303481|FG003|Overall Study|Lost to Follow-up|1|||
130364420|NCT03855228|469303478|FG000|Overall Study|Protocol Violation|0|||
130364421|NCT03855228|469303479|FG001|Overall Study|Protocol Violation|1|||
130364422|NCT03855228|469303480|FG002|Overall Study|Protocol Violation|2|||
130364423|NCT03855228|469303481|FG003|Overall Study|Protocol Violation|1|||
130364424|NCT03855228|469303478|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
130364425|NCT03855228|469303479|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
130364426|NCT03855228|469303480|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
130364427|NCT03855228|469303481|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
130364428|NCT00913380|469303484|FG000|Clinical Outcomes|Lost to Follow-up|6|||
130364429|NCT00913380|469303485|FG001|Clinical Outcomes|Lost to Follow-up|6|||
130364430|NCT02004522|469303489|FG000|Overall Study|Adverse Event|55|||
130364431|NCT02004522|469303490|FG001|Overall Study|Adverse Event|6|||
130364432|NCT02004522|469303489|FG000|Overall Study|Withdrawal by Subject|13|||
130364433|NCT02004522|469303490|FG001|Overall Study|Withdrawal by Subject|7|||
130364434|NCT02004522|469303489|FG000|Overall Study|Death|12|||
130364435|NCT02004522|469303490|FG001|Overall Study|Death|3|||
130364436|NCT02004522|469303489|FG000|Overall Study|Physician Decision|3|||
130364437|NCT02004522|469303490|FG001|Overall Study|Physician Decision|4|||
130364438|NCT02004522|469303489|FG000|Overall Study|Protocol Violation|1|||
130364439|NCT02004522|469303490|FG001|Overall Study|Protocol Violation|0|||
130364440|NCT02004522|469303489|FG000|Overall Study|Other is reason listed by PI|4|||
130364441|NCT02004522|469303490|FG001|Overall Study|Other is reason listed by PI|1|||
130364442|NCT02004522|469303489|FG000|Overall Study|Never Dosed|2|||
130364443|NCT02004522|469303490|FG001|Overall Study|Never Dosed|4|||
130364444|NCT02004522|469303489|FG000|Overall Study|Disease Progression|35|||
130364445|NCT02004522|469303490|FG001|Overall Study|Disease Progression|31|||
130364446|NCT02004522|469303489|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
130364447|NCT02004522|469303490|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
130364448|NCT01787331|469303491|FG000|Overall Study|Physician Decision|1|||
130364449|NCT01787331|469303491|FG000|Overall Study|Withdrawal by Subject|1|||
130364450|NCT00667875|469303492|FG000|Overall Study|Adverse Event|0|||
130364451|NCT00667875|469303493|FG001|Overall Study|Adverse Event|2|||
130364452|NCT00667875|469303494|FG002|Overall Study|Adverse Event|6|||
130364453|NCT00667875|469303492|FG000|Overall Study|Withdrawal by Subject|10|||
130553237|NCT01177787|469993523|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
130249623|NCT01550965|468874987|FG000|Overall Study|Withdrawal by Subject|10|||
130249624|NCT01550965|468874987|FG000|Overall Study|Lost to Follow-up|2|||
130249625|NCT01550965|468874987|FG000|Overall Study|Lack of Efficacy|59|||
130249626|NCT01550965|468874987|FG000|Overall Study|Other|13|||
130249627|NCT03016403|468874990|FG000|Baseline|Death|5|||
130249628|NCT03016403|468874991|FG001|Baseline|Death|8|||
130249629|NCT03016403|468874992|FG002|Baseline|Death|1|||
130452629|NCT00984282|469621657|FG000|Open-label Treatment|Switched to commercial drug|6|||
130452630|NCT00984282|469621658|FG001|Open-label Treatment|Switched to commercial drug|7|||
130452631|NCT00984282|469621657|FG000|Open-label Treatment|Physician Decision|1|||
130452632|NCT00984282|469621658|FG001|Open-label Treatment|Physician Decision|0|||
130452633|NCT00984282|469621657|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
130452634|NCT00984282|469621658|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
130452635|NCT00984282|469621657|FG000|Long Term Follow-up|Death|27|||
130452636|NCT00984282|469621658|FG001|Long Term Follow-up|Death|68|||
130452637|NCT00984282|469621657|FG000|Long Term Follow-up|Lost to Follow-up|3|||
130452638|NCT00984282|469621658|FG001|Long Term Follow-up|Lost to Follow-up|6|||
130452639|NCT00984282|469621657|FG000|Long Term Follow-up|Protocol driven decision point|25|||
130452640|NCT00984282|469621658|FG001|Long Term Follow-up|Protocol driven decision point|26|||
130452641|NCT00984282|469621657|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
130452642|NCT00984282|469621658|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
130452643|NCT00984282|469621657|FG000|Long Term Follow-up|Switched to commercial drug|4|||
130452644|NCT00984282|469621658|FG001|Long Term Follow-up|Switched to commercial drug|2|||
130452645|NCT00984282|469621657|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
130452646|NCT00984282|469621658|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
130452647|NCT02223793|469621659|FG000|Overall Study|Lost to Follow-up|10|||
130452648|NCT02223793|469621660|FG001|Overall Study|Lost to Follow-up|1|||
130452649|NCT02223793|469621661|FG002|Overall Study|Lost to Follow-up|2|||
130452650|NCT02223793|469621659|FG000|Overall Study|Withdrawal by Subject|3|||
130452651|NCT02223793|469621660|FG001|Overall Study|Withdrawal by Subject|2|||
130452652|NCT02223793|469621661|FG002|Overall Study|Withdrawal by Subject|3|||
130452653|NCT02223793|469621659|FG000|Overall Study|Moved/studycenter unable to participate|4|||
130452654|NCT02223793|469621660|FG001|Overall Study|Moved/studycenter unable to participate|6|||
130452655|NCT02223793|469621661|FG002|Overall Study|Moved/studycenter unable to participate|8|||
130452656|NCT02359435|469621663|FG000|Overall Study|Lost to Follow-up|4|||
130452657|NCT02359435|469621664|FG001|Overall Study|Lost to Follow-up|4|||
130452658|NCT01289119|469621667|FG000|Overall Study|Adverse Event|2|||
130452659|NCT01289119|469621668|FG001|Overall Study|Adverse Event|1|||
130452660|NCT01289119|469621669|FG002|Overall Study|Adverse Event|0|||
130452661|NCT01289119|469621670|FG003|Overall Study|Adverse Event|2|||
130452662|NCT01289119|469621671|FG004|Overall Study|Adverse Event|1|||
130452663|NCT01289119|469621672|FG005|Overall Study|Adverse Event|0|||
130452664|NCT01289119|469621667|FG000|Overall Study|Major Protocol Deviation|2|||
130452665|NCT01289119|469621668|FG001|Overall Study|Major Protocol Deviation|1|||
130452666|NCT01289119|469621669|FG002|Overall Study|Major Protocol Deviation|3|||
130452667|NCT01289119|469621670|FG003|Overall Study|Major Protocol Deviation|0|||
130452668|NCT01289119|469621671|FG004|Overall Study|Major Protocol Deviation|2|||
130452669|NCT01289119|469621672|FG005|Overall Study|Major Protocol Deviation|1|||
130452670|NCT01289119|469621667|FG000|Overall Study|Lost to Follow-up|0|||
130452671|NCT01289119|469621668|FG001|Overall Study|Lost to Follow-up|3|||
130452672|NCT01289119|469621669|FG002|Overall Study|Lost to Follow-up|0|||
130452673|NCT01289119|469621670|FG003|Overall Study|Lost to Follow-up|0|||
130452674|NCT01289119|469621671|FG004|Overall Study|Lost to Follow-up|0|||
130452675|NCT01289119|469621672|FG005|Overall Study|Lost to Follow-up|1|||
130452676|NCT01289119|469621667|FG000|Overall Study|Withdrawal by Subject|4|||
130452677|NCT01289119|469621668|FG001|Overall Study|Withdrawal by Subject|2|||
130452678|NCT01289119|469621669|FG002|Overall Study|Withdrawal by Subject|4|||
130452679|NCT01289119|469621670|FG003|Overall Study|Withdrawal by Subject|3|||
130452680|NCT01289119|469621671|FG004|Overall Study|Withdrawal by Subject|1|||
130452681|NCT01289119|469621672|FG005|Overall Study|Withdrawal by Subject|1|||
130452682|NCT01289119|469621667|FG000|Overall Study|Pregnancy|0|||
130452683|NCT01289119|469621668|FG001|Overall Study|Pregnancy|1|||
130452684|NCT01289119|469621669|FG002|Overall Study|Pregnancy|0|||
130452685|NCT01289119|469621670|FG003|Overall Study|Pregnancy|0|||
130452686|NCT01289119|469621671|FG004|Overall Study|Pregnancy|0|||
130452687|NCT01289119|469621672|FG005|Overall Study|Pregnancy|0|||
130452688|NCT01289119|469621667|FG000|Overall Study|Lack of Efficacy|0|||
130452689|NCT01289119|469621668|FG001|Overall Study|Lack of Efficacy|1|||
130452690|NCT01289119|469621669|FG002|Overall Study|Lack of Efficacy|1|||
130452691|NCT01289119|469621670|FG003|Overall Study|Lack of Efficacy|1|||
130452692|NCT01289119|469621671|FG004|Overall Study|Lack of Efficacy|1|||
130452693|NCT01289119|469621672|FG005|Overall Study|Lack of Efficacy|1|||
130452694|NCT01289119|469621667|FG000|Overall Study|Other|1|||
130452695|NCT01289119|469621668|FG001|Overall Study|Other|0|||
130452696|NCT01289119|469621669|FG002|Overall Study|Other|1|||
130452697|NCT01289119|469621670|FG003|Overall Study|Other|0|||
130452698|NCT01289119|469621671|FG004|Overall Study|Other|0|||
130249630|NCT03016403|468874993|FG003|Baseline|Death|0|||
130249631|NCT03016403|468874990|FG000|Baseline|Withdrawal by Subject|2|||
130249632|NCT03016403|468874991|FG001|Baseline|Withdrawal by Subject|8|||
130249633|NCT03016403|468874992|FG002|Baseline|Withdrawal by Subject|4|||
130249634|NCT03016403|468874993|FG003|Baseline|Withdrawal by Subject|10|||
130249635|NCT03016403|468874990|FG000|Baseline|Lost to Follow-up|9|||
130249636|NCT03016403|468874991|FG001|Baseline|Lost to Follow-up|11|||
130452699|NCT01289119|469621672|FG005|Overall Study|Other|0|||
130452700|NCT01704846|469621673|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130452701|NCT01704846|469621674|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130452702|NCT02321540|469621675|FG000|Overall Study|Death|0|||
130452703|NCT02321540|469621676|FG001|Overall Study|Death|1|||
130452704|NCT02321540|469621675|FG000|Overall Study|Progression|3|||
130452705|NCT02321540|469621676|FG001|Overall Study|Progression|9|||
130452706|NCT00530335|469621677|FG000|Overall Study|Adverse Event|3|||
130452707|NCT00530335|469621677|FG000|Overall Study|Protocol Violation|1|||
130452708|NCT00530335|469621677|FG000|Overall Study|Withdrawal by Subject|1|||
130452709|NCT00530335|469621677|FG000|Overall Study|Physician Decision|1|||
130452710|NCT04577183|469621678|FG000|Overall Study|Death|1|||
130452711|NCT04577183|469621678|FG000|Overall Study|Withdrawal by Subject|3|||
130452712|NCT04577183|469621678|FG000|Overall Study|Early termination|2|||
130452713|NCT00938340|469621682|FG000|Overall Study|Withdrawal by Subject|3|||
130452714|NCT00938340|469621682|FG000|Overall Study|Protocol Violation|1|||
130452715|NCT00938340|469621682|FG000|Overall Study|Adverse Event|1|||
130452716|NCT02534896|469621683|FG000|Overall Study|Adverse Event|2|||
130452717|NCT02534896|469621684|FG001|Overall Study|Adverse Event|1|||
130452718|NCT02534896|469621685|FG002|Overall Study|Adverse Event|1|||
130452719|NCT02534896|469621683|FG000|Overall Study|Insufficient therapeutic response|2|||
130452720|NCT02534896|469621684|FG001|Overall Study|Insufficient therapeutic response|0|||
130452721|NCT02534896|469621685|FG002|Overall Study|Insufficient therapeutic response|0|||
130452722|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
130452723|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
130452724|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
130452725|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
130452726|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Adverse Event|198|||
130452727|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Adverse Event|0|||
130452728|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Adverse Event|0|||
130452729|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Adverse Event|0|||
130452730|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Death|62|||
130452731|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Death|0|||
130452732|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Death|0|||
130452733|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Death|0|||
130452734|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
130452735|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
130452736|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
130452737|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
130452738|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Complicating disease|13|||
130452739|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Complicating disease|0|||
130452740|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Complicating disease|0|||
130452741|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Complicating disease|0|||
130452742|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
130249637|NCT03016403|468874992|FG002|Baseline|Lost to Follow-up|6|||
130249638|NCT03016403|468874993|FG003|Baseline|Lost to Follow-up|24|||
130249639|NCT03016403|468874990|FG000|6-week Follow-up|Death|1|||
130249640|NCT03016403|468874991|FG001|6-week Follow-up|Death|4|||
130249641|NCT03016403|468874992|FG002|6-week Follow-up|Death|0|||
130249642|NCT03016403|468874993|FG003|6-week Follow-up|Death|0|||
130249643|NCT03016403|468874990|FG000|6-week Follow-up|Lost to Follow-up|2|||
130249644|NCT03016403|468874991|FG001|6-week Follow-up|Lost to Follow-up|7|||
130249645|NCT03016403|468874992|FG002|6-week Follow-up|Lost to Follow-up|4|||
130249646|NCT03016403|468874993|FG003|6-week Follow-up|Lost to Follow-up|8|||
130452743|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
130452744|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
130452745|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
130452746|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
130452747|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
130452748|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
130452749|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
130452750|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Non-compliance|4|||
130249647|NCT03016403|468874990|FG000|6-week Follow-up|Withdrawal by Subject|0|||
130452751|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Non-compliance|0|||
130452752|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Non-compliance|0|||
130452753|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Non-compliance|0|||
130452754|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Pain|4|||
130249648|NCT03016403|468874991|FG001|6-week Follow-up|Withdrawal by Subject|2|||
130249649|NCT03016403|468874992|FG002|6-week Follow-up|Withdrawal by Subject|0|||
130249650|NCT03016403|468874993|FG003|6-week Follow-up|Withdrawal by Subject|1|||
130249651|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
130249652|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
130249653|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
130249654|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
130249655|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130249656|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
130249657|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
130249658|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130249659|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249660|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249661|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249662|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
130249663|NCT05463705|468874994|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
130249664|NCT05463705|468874995|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
130249665|NCT05463705|468874996|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
130249666|NCT05463705|468874997|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
130249667|NCT05463705|468874998|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
130249668|NCT05463705|468874999|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
130249669|NCT00621322|468875000|FG000|Overall Study|Lost to Follow-up|0|||
130249670|NCT00621322|468875001|FG001|Overall Study|Lost to Follow-up|0|||
130249671|NCT00621322|468875002|FG002|Overall Study|Lost to Follow-up|0|||
130249672|NCT00621322|468875003|FG003|Overall Study|Lost to Follow-up|0|||
130249673|NCT00621322|468875004|FG004|Overall Study|Lost to Follow-up|1|||
130249674|NCT00621322|468875005|FG005|Overall Study|Lost to Follow-up|0|||
130364454|NCT00667875|469303493|FG001|Overall Study|Withdrawal by Subject|9|||
130364455|NCT00667875|469303494|FG002|Overall Study|Withdrawal by Subject|7|||
130364456|NCT00450255|469303495|FG000|Overall Study|Prior RFA ablation of liver|1|||
130364457|NCT01696071|469303496|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
130364458|NCT01696071|469303497|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
130364459|NCT00142298|469303500|FG000|Overall Study|Adverse Event|10|||
130364460|NCT00142298|469303501|FG001|Overall Study|Adverse Event|10|||
130364461|NCT00142298|469303502|FG002|Overall Study|Adverse Event|1|||
130364462|NCT00142298|469303503|FG003|Overall Study|Adverse Event|5|||
130364463|NCT00142298|469303504|FG004|Overall Study|Adverse Event|2|||
130364464|NCT00142298|469303505|FG005|Overall Study|Adverse Event|2|||
130364465|NCT00142298|469303506|FG006|Overall Study|Adverse Event|0|||
130364466|NCT00142298|469303507|FG007|Overall Study|Adverse Event|0|||
130364467|NCT00142298|469303508|FG008|Overall Study|Adverse Event|0|||
130364468|NCT00142298|469303509|FG009|Overall Study|Adverse Event|0|||
130364469|NCT00142298|469303500|FG000|Overall Study|Clinical disease progression|1|||
130364470|NCT00142298|469303501|FG001|Overall Study|Clinical disease progression|0|||
130364471|NCT00142298|469303502|FG002|Overall Study|Clinical disease progression|0|||
130364472|NCT00142298|469303503|FG003|Overall Study|Clinical disease progression|0|||
130364473|NCT00142298|469303504|FG004|Overall Study|Clinical disease progression|0|||
130364474|NCT00142298|469303505|FG005|Overall Study|Clinical disease progression|0|||
130364475|NCT00142298|469303506|FG006|Overall Study|Clinical disease progression|0|||
130364476|NCT00142298|469303507|FG007|Overall Study|Clinical disease progression|0|||
130364477|NCT00142298|469303508|FG008|Overall Study|Clinical disease progression|0|||
130364478|NCT00142298|469303509|FG009|Overall Study|Clinical disease progression|0|||
130364479|NCT00142298|469303500|FG000|Overall Study|Death|1|||
130364480|NCT00142298|469303501|FG001|Overall Study|Death|1|||
130364481|NCT00142298|469303502|FG002|Overall Study|Death|1|||
130364482|NCT00142298|469303503|FG003|Overall Study|Death|0|||
130364483|NCT00142298|469303504|FG004|Overall Study|Death|0|||
130364484|NCT00142298|469303505|FG005|Overall Study|Death|6|||
130364485|NCT00142298|469303506|FG006|Overall Study|Death|0|||
130364486|NCT00142298|469303507|FG007|Overall Study|Death|0|||
130364487|NCT00142298|469303508|FG008|Overall Study|Death|0|||
130364488|NCT00142298|469303509|FG009|Overall Study|Death|0|||
130364489|NCT00142298|469303500|FG000|Overall Study|Lack of Efficacy|44|||
130364490|NCT00142298|469303501|FG001|Overall Study|Lack of Efficacy|62|||
130364491|NCT00142298|469303502|FG002|Overall Study|Lack of Efficacy|9|||
130364492|NCT00142298|469303503|FG003|Overall Study|Lack of Efficacy|12|||
130364493|NCT00142298|469303504|FG004|Overall Study|Lack of Efficacy|1|||
130364494|NCT00142298|469303505|FG005|Overall Study|Lack of Efficacy|0|||
130364495|NCT00142298|469303506|FG006|Overall Study|Lack of Efficacy|0|||
130249675|NCT00621322|468875000|FG000|Overall Study|Physician Decision|0|||
130364496|NCT00142298|469303507|FG007|Overall Study|Lack of Efficacy|1|||
130364497|NCT00142298|469303508|FG008|Overall Study|Lack of Efficacy|0|||
130364498|NCT00142298|469303509|FG009|Overall Study|Lack of Efficacy|0|||
130364499|NCT00142298|469303500|FG000|Overall Study|Non-compliance|15|||
130364500|NCT00142298|469303501|FG001|Overall Study|Non-compliance|13|||
130364501|NCT00142298|469303502|FG002|Overall Study|Non-compliance|0|||
130364502|NCT00142298|469303503|FG003|Overall Study|Non-compliance|6|||
130364503|NCT00142298|469303504|FG004|Overall Study|Non-compliance|1|||
130249676|NCT00621322|468875001|FG001|Overall Study|Physician Decision|0|||
130249677|NCT00621322|468875002|FG002|Overall Study|Physician Decision|1|||
130249678|NCT00621322|468875003|FG003|Overall Study|Physician Decision|1|||
130249679|NCT00621322|468875004|FG004|Overall Study|Physician Decision|0|||
130249680|NCT00621322|468875005|FG005|Overall Study|Physician Decision|0|||
130249681|NCT00621322|468875000|FG000|Overall Study|Withdrawal by Subject|0|||
130249682|NCT00621322|468875001|FG001|Overall Study|Withdrawal by Subject|0|||
130249683|NCT00621322|468875002|FG002|Overall Study|Withdrawal by Subject|0|||
130249684|NCT00621322|468875003|FG003|Overall Study|Withdrawal by Subject|1|||
130249685|NCT00621322|468875004|FG004|Overall Study|Withdrawal by Subject|0|||
130249686|NCT00621322|468875005|FG005|Overall Study|Withdrawal by Subject|2|||
130249687|NCT00621322|468875000|FG000|Overall Study|Migrated/moved from study area|1|||
130249688|NCT00621322|468875001|FG001|Overall Study|Migrated/moved from study area|0|||
130249689|NCT00621322|468875002|FG002|Overall Study|Migrated/moved from study area|1|||
130249690|NCT00621322|468875003|FG003|Overall Study|Migrated/moved from study area|1|||
130249691|NCT00621322|468875004|FG004|Overall Study|Migrated/moved from study area|0|||
130249692|NCT00621322|468875005|FG005|Overall Study|Migrated/moved from study area|2|||
130452755|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Pain|0|||
130249693|NCT01655069|468875011|FG000|Overall Study|Physician Decision|0|||
130249694|NCT01655069|468875012|FG001|Overall Study|Physician Decision|0|||
130249695|NCT01655069|468875013|FG002|Overall Study|Physician Decision|0|||
130249696|NCT01655069|468875014|FG003|Overall Study|Physician Decision|1|||
130364504|NCT00142298|469303505|FG005|Overall Study|Non-compliance|0|||
130364505|NCT00142298|469303506|FG006|Overall Study|Non-compliance|0|||
130364506|NCT00142298|469303507|FG007|Overall Study|Non-compliance|3|||
130364507|NCT00142298|469303508|FG008|Overall Study|Non-compliance|3|||
130364508|NCT00142298|469303509|FG009|Overall Study|Non-compliance|0|||
130364509|NCT00142298|469303500|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
130364510|NCT00142298|469303501|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
130364511|NCT00142298|469303502|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
130364512|NCT00142298|469303503|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
130364513|NCT00142298|469303504|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
130364514|NCT00142298|469303505|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
130364515|NCT00142298|469303506|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
130364516|NCT00142298|469303507|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
130364517|NCT00142298|469303508|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
130364518|NCT00142298|469303509|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
130364519|NCT00142298|469303500|FG000|Overall Study|Pregnancy|4|||
130364520|NCT00142298|469303501|FG001|Overall Study|Pregnancy|4|||
130364521|NCT00142298|469303502|FG002|Overall Study|Pregnancy|2|||
130364522|NCT00142298|469303503|FG003|Overall Study|Pregnancy|3|||
130364523|NCT00142298|469303504|FG004|Overall Study|Pregnancy|0|||
130364524|NCT00142298|469303505|FG005|Overall Study|Pregnancy|0|||
130364525|NCT00142298|469303506|FG006|Overall Study|Pregnancy|0|||
130364526|NCT00142298|469303507|FG007|Overall Study|Pregnancy|0|||
130364527|NCT00142298|469303508|FG008|Overall Study|Pregnancy|1|||
130364528|NCT00142298|469303509|FG009|Overall Study|Pregnancy|0|||
130364529|NCT00142298|469303500|FG000|Overall Study|Virologic breakthrough|19|||
130364530|NCT00142298|469303501|FG001|Overall Study|Virologic breakthrough|23|||
130364531|NCT00142298|469303502|FG002|Overall Study|Virologic breakthrough|9|||
130364532|NCT00142298|469303503|FG003|Overall Study|Virologic breakthrough|7|||
130364533|NCT00142298|469303504|FG004|Overall Study|Virologic breakthrough|2|||
130364534|NCT00142298|469303505|FG005|Overall Study|Virologic breakthrough|3|||
130364535|NCT00142298|469303506|FG006|Overall Study|Virologic breakthrough|3|||
130364536|NCT00142298|469303507|FG007|Overall Study|Virologic breakthrough|0|||
130364537|NCT00142298|469303508|FG008|Overall Study|Virologic breakthrough|0|||
130364538|NCT00142298|469303509|FG009|Overall Study|Virologic breakthrough|0|||
130364539|NCT00142298|469303500|FG000|Overall Study|Other- not specified|0|||
130364540|NCT00142298|469303501|FG001|Overall Study|Other- not specified|3|||
130364541|NCT00142298|469303502|FG002|Overall Study|Other- not specified|0|||
130364542|NCT00142298|469303503|FG003|Overall Study|Other- not specified|1|||
130364543|NCT00142298|469303504|FG004|Overall Study|Other- not specified|0|||
130364544|NCT00142298|469303505|FG005|Overall Study|Other- not specified|0|||
130364545|NCT00142298|469303506|FG006|Overall Study|Other- not specified|0|||
130364546|NCT00142298|469303507|FG007|Overall Study|Other- not specified|0|||
130364547|NCT00142298|469303508|FG008|Overall Study|Other- not specified|0|||
130364548|NCT00142298|469303509|FG009|Overall Study|Other- not specified|0|||
130364549|NCT00142298|469303500|FG000|Overall Study|Lost to Follow-up|0|||
130364550|NCT00142298|469303501|FG001|Overall Study|Lost to Follow-up|0|||
130364551|NCT00142298|469303502|FG002|Overall Study|Lost to Follow-up|0|||
130364552|NCT00142298|469303503|FG003|Overall Study|Lost to Follow-up|0|||
130364553|NCT00142298|469303504|FG004|Overall Study|Lost to Follow-up|0|||
130364554|NCT00142298|469303505|FG005|Overall Study|Lost to Follow-up|0|||
130364555|NCT00142298|469303506|FG006|Overall Study|Lost to Follow-up|2|||
130364556|NCT00142298|469303507|FG007|Overall Study|Lost to Follow-up|0|||
130364557|NCT00142298|469303508|FG008|Overall Study|Lost to Follow-up|0|||
130364558|NCT00142298|469303509|FG009|Overall Study|Lost to Follow-up|0|||
130553238|NCT01177787|469993523|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
130553239|NCT00402363|469993526|FG000|Overall Study|Adverse Event|9|||
130553240|NCT00402363|469993527|FG001|Overall Study|Adverse Event|14|||
130553241|NCT00402363|469993528|FG002|Overall Study|Adverse Event|2|||
130249697|NCT01655069|468875011|FG000|Overall Study|Adverse Event|6|||
130249698|NCT01655069|468875012|FG001|Overall Study|Adverse Event|7|||
130249699|NCT01655069|468875013|FG002|Overall Study|Adverse Event|2|||
130249700|NCT01655069|468875014|FG003|Overall Study|Adverse Event|3|||
130249701|NCT01655069|468875011|FG000|Overall Study|Lack of Efficacy|0|||
130249702|NCT01655069|468875012|FG001|Overall Study|Lack of Efficacy|1|||
130553242|NCT00402363|469993529|FG003|Overall Study|Adverse Event|2|||
130553243|NCT00402363|469993526|FG000|Overall Study|Withdrew Consent|10|||
130553244|NCT00402363|469993527|FG001|Overall Study|Withdrew Consent|5|||
130553245|NCT00402363|469993528|FG002|Overall Study|Withdrew Consent|2|||
130553246|NCT00402363|469993529|FG003|Overall Study|Withdrew Consent|1|||
130553247|NCT00402363|469993526|FG000|Overall Study|Protocol Violation|3|||
130553248|NCT00402363|469993527|FG001|Overall Study|Protocol Violation|5|||
130553249|NCT00402363|469993528|FG002|Overall Study|Protocol Violation|0|||
130553250|NCT00402363|469993529|FG003|Overall Study|Protocol Violation|3|||
130553251|NCT00402363|469993526|FG000|Overall Study|Lost to Follow-up|5|||
130553252|NCT00402363|469993527|FG001|Overall Study|Lost to Follow-up|4|||
130553253|NCT00402363|469993528|FG002|Overall Study|Lost to Follow-up|0|||
130553254|NCT00402363|469993529|FG003|Overall Study|Lost to Follow-up|2|||
130553255|NCT00402363|469993526|FG000|Overall Study|"Captured as Other"|6|||
130553256|NCT00402363|469993527|FG001|Overall Study|"Captured as Other"|2|||
130553257|NCT00402363|469993528|FG002|Overall Study|"Captured as Other"|2|||
130553258|NCT00402363|469993529|FG003|Overall Study|"Captured as Other"|2|||
130553259|NCT00293722|469993530|FG000|Overall Study|Other|427|||
130553260|NCT02824263|469993531|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
130553261|NCT02824263|469993532|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
130553262|NCT02824263|469993531|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
130553263|NCT02824263|469993532|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
130553264|NCT00667355|469993533|FG000|Overall Study|Adverse Event|5|||
130553265|NCT00667355|469993533|FG000|Overall Study|Lost to Follow-up|1|||
130553266|NCT00667355|469993533|FG000|Overall Study|Other reason was not specified|5|||
130553267|NCT00068588|469993538|FG000|Overall Study|Adverse Event|0|||
130553268|NCT00068588|469993539|FG001|Overall Study|Adverse Event|0|||
130553269|NCT00068588|469993540|FG002|Overall Study|Adverse Event|2|||
130553270|NCT00068588|469993538|FG000|Overall Study|Withdrawal by Subject|0|||
130553271|NCT00068588|469993539|FG001|Overall Study|Withdrawal by Subject|0|||
130553272|NCT00068588|469993540|FG002|Overall Study|Withdrawal by Subject|1|||
130553273|NCT00068588|469993538|FG000|Overall Study|Poor KPS|0|||
130553274|NCT00068588|469993539|FG001|Overall Study|Poor KPS|0|||
130553275|NCT00068588|469993540|FG002|Overall Study|Poor KPS|1|||
130553276|NCT05193500|469993541|FG000|Overall Study|Withdrawal by Subject|7|||
130553277|NCT05193500|469993542|FG001|Overall Study|Withdrawal by Subject|4|||
130553278|NCT05193500|469993543|FG002|Overall Study|Withdrawal by Subject|3|||
130553279|NCT05193500|469993544|FG003|Overall Study|Withdrawal by Subject|5|||
130553280|NCT02604433|469993547|FG000|Overall Study|Withdrawal by Subject|37|||
130553281|NCT02604433|469993548|FG001|Overall Study|Withdrawal by Subject|16|||
130249703|NCT01655069|468875013|FG002|Overall Study|Lack of Efficacy|0|||
130249704|NCT01655069|468875014|FG003|Overall Study|Lack of Efficacy|0|||
130249705|NCT01655069|468875011|FG000|Overall Study|No Treatment Needed|0|||
130249706|NCT01655069|468875012|FG001|Overall Study|No Treatment Needed|1|||
130249707|NCT01655069|468875013|FG002|Overall Study|No Treatment Needed|0|||
130249708|NCT01655069|468875014|FG003|Overall Study|No Treatment Needed|0|||
130553282|NCT02604433|469993547|FG000|Overall Study|Adverse Event|4|||
130553283|NCT02604433|469993548|FG001|Overall Study|Adverse Event|0|||
130553284|NCT02604433|469993547|FG000|Overall Study|Other reasons|3|||
130553285|NCT02604433|469993548|FG001|Overall Study|Other reasons|5|||
130249709|NCT01655069|468875011|FG000|Overall Study|Withdrawal by Subject|2|||
130249710|NCT01655069|468875012|FG001|Overall Study|Withdrawal by Subject|3|||
130249711|NCT01655069|468875013|FG002|Overall Study|Withdrawal by Subject|0|||
130553286|NCT02604433|469993547|FG000|Overall Study|Death|4|||
130553287|NCT02604433|469993548|FG001|Overall Study|Death|1|||
130553288|NCT02604433|469993547|FG000|Overall Study|Transition to Rollover Protocol|169|||
130553289|NCT02604433|469993548|FG001|Overall Study|Transition to Rollover Protocol|82|||
130553290|NCT02604433|469993547|FG000|Overall Study|Physician Decision|1|||
130553291|NCT02604433|469993548|FG001|Overall Study|Physician Decision|1|||
130553292|NCT02604433|469993547|FG000|Overall Study|Lack of Efficacy|0|||
130553293|NCT02604433|469993548|FG001|Overall Study|Lack of Efficacy|1|||
130553294|NCT03437278|469993549|FG000|Overall Study|Adverse Event|0|||
130553295|NCT03437278|469993550|FG001|Overall Study|Adverse Event|0|||
130249712|NCT01655069|468875014|FG003|Overall Study|Withdrawal by Subject|0|||
130249713|NCT06399471|468875015|FG000|Overall Study|Withdrawal by Subject|1|||
130249714|NCT00986102|468875016|FG000|Overall Study|Lost to Follow-up|0|||
130553296|NCT03437278|469993551|FG002|Overall Study|Adverse Event|1|||
130249715|NCT00986102|468875017|FG001|Overall Study|Lost to Follow-up|1|||
130249716|NCT00986102|468875018|FG002|Overall Study|Lost to Follow-up|0|||
130249717|NCT00986102|468875019|FG003|Overall Study|Lost to Follow-up|1|||
130249718|NCT00986102|468875016|FG000|Overall Study|Withdrawal by Subject|1|||
130249719|NCT00986102|468875017|FG001|Overall Study|Withdrawal by Subject|1|||
130249720|NCT00986102|468875018|FG002|Overall Study|Withdrawal by Subject|0|||
130249721|NCT00986102|468875019|FG003|Overall Study|Withdrawal by Subject|0|||
130249722|NCT06083493|468875020|FG000|Overall Study|Technical issues with the interventional device|2|||
130249723|NCT06083493|468875021|FG001|Overall Study|Technical issues with the interventional device|2|||
130249724|NCT06083493|468875020|FG000|Overall Study|Performed incorrect visual task|1|||
130249725|NCT06083493|468875021|FG001|Overall Study|Performed incorrect visual task|0|||
130249726|NCT06083493|468875020|FG000|Overall Study|Insufficient baseline performance|0|||
130249727|NCT06083493|468875021|FG001|Overall Study|Insufficient baseline performance|1|||
130249728|NCT00147537|468875022|FG000|Phase 1b|Death|0|||
130249729|NCT00147537|468875023|FG001|Phase 1b|Death|1|||
130249730|NCT00147537|468875024|FG002|Phase 1b|Death|2|||
130249731|NCT00147537|468875025|FG003|Phase 1b|Death|1|||
130249732|NCT00147537|468875026|FG004|Phase 1b|Death|2|||
130249733|NCT00147537|468875027|FG005|Phase 1b|Death|2|||
130249734|NCT00147537|468875028|FG006|Phase 1b|Death|1|||
130249735|NCT00147537|468875029|FG007|Phase 1b|Death|3|||
130249736|NCT00147537|468875030|FG008|Phase 1b|Death|9|||
130249737|NCT00147537|468875031|FG009|Phase 1b|Death|0|||
130249738|NCT00147537|468875032|FG010|Phase 1b|Death|0|||
130249739|NCT00147537|468875022|FG000|Phase 1b|Lost to Follow-up|2|||
130249740|NCT00147537|468875023|FG001|Phase 1b|Lost to Follow-up|1|||
130249741|NCT00147537|468875024|FG002|Phase 1b|Lost to Follow-up|0|||
130249742|NCT00147537|468875025|FG003|Phase 1b|Lost to Follow-up|0|||
130249743|NCT00147537|468875026|FG004|Phase 1b|Lost to Follow-up|0|||
130249744|NCT00147537|468875027|FG005|Phase 1b|Lost to Follow-up|0|||
130249745|NCT00147537|468875028|FG006|Phase 1b|Lost to Follow-up|2|||
130249746|NCT00147537|468875029|FG007|Phase 1b|Lost to Follow-up|0|||
130249747|NCT00147537|468875030|FG008|Phase 1b|Lost to Follow-up|1|||
130249748|NCT00147537|468875031|FG009|Phase 1b|Lost to Follow-up|0|||
130249749|NCT00147537|468875032|FG010|Phase 1b|Lost to Follow-up|0|||
130249750|NCT00147537|468875022|FG000|Phase 1b|Other|0|||
130249751|NCT00147537|468875023|FG001|Phase 1b|Other|0|||
130249752|NCT00147537|468875024|FG002|Phase 1b|Other|2|||
130249753|NCT00147537|468875025|FG003|Phase 1b|Other|1|||
130249754|NCT00147537|468875026|FG004|Phase 1b|Other|1|||
130249755|NCT00147537|468875027|FG005|Phase 1b|Other|1|||
130249756|NCT00147537|468875028|FG006|Phase 1b|Other|14|||
130249757|NCT00147537|468875029|FG007|Phase 1b|Other|4|||
130249758|NCT00147537|468875030|FG008|Phase 1b|Other|4|||
130249759|NCT00147537|468875031|FG009|Phase 1b|Other|0|||
130249760|NCT00147537|468875032|FG010|Phase 1b|Other|0|||
130249761|NCT00147537|468875022|FG000|Phase 1b|Withdrawal by Subject|0|||
130249762|NCT00147537|468875023|FG001|Phase 1b|Withdrawal by Subject|0|||
130249763|NCT00147537|468875024|FG002|Phase 1b|Withdrawal by Subject|0|||
130249764|NCT00147537|468875025|FG003|Phase 1b|Withdrawal by Subject|0|||
130249765|NCT00147537|468875026|FG004|Phase 1b|Withdrawal by Subject|0|||
130249766|NCT00147537|468875027|FG005|Phase 1b|Withdrawal by Subject|0|||
130249767|NCT00147537|468875028|FG006|Phase 1b|Withdrawal by Subject|0|||
130249768|NCT00147537|468875029|FG007|Phase 1b|Withdrawal by Subject|0|||
130249769|NCT00147537|468875030|FG008|Phase 1b|Withdrawal by Subject|2|||
130249770|NCT00147537|468875031|FG009|Phase 1b|Withdrawal by Subject|0|||
130249771|NCT00147537|468875032|FG010|Phase 1b|Withdrawal by Subject|0|||
130249772|NCT00147537|468875022|FG000|Phase 1b|Randomized but not treated|0|||
130249773|NCT00147537|468875023|FG001|Phase 1b|Randomized but not treated|0|||
130249774|NCT00147537|468875024|FG002|Phase 1b|Randomized but not treated|0|||
130249775|NCT00147537|468875025|FG003|Phase 1b|Randomized but not treated|0|||
130249776|NCT00147537|468875026|FG004|Phase 1b|Randomized but not treated|0|||
130249777|NCT00147537|468875027|FG005|Phase 1b|Randomized but not treated|0|||
130249778|NCT00147537|468875028|FG006|Phase 1b|Randomized but not treated|1|||
130249779|NCT00147537|468875029|FG007|Phase 1b|Randomized but not treated|0|||
130249780|NCT00147537|468875030|FG008|Phase 1b|Randomized but not treated|1|||
130249781|NCT00147537|468875031|FG009|Phase 1b|Randomized but not treated|0|||
130249782|NCT00147537|468875032|FG010|Phase 1b|Randomized but not treated|0|||
130249783|NCT00147537|468875022|FG000|Phase 2|Death|0|||
130249784|NCT00147537|468875023|FG001|Phase 2|Death|0|||
130249785|NCT00147537|468875024|FG002|Phase 2|Death|0|||
130249786|NCT00147537|468875025|FG003|Phase 2|Death|0|||
130249787|NCT00147537|468875026|FG004|Phase 2|Death|0|||
130249788|NCT00147537|468875027|FG005|Phase 2|Death|0|||
130249789|NCT00147537|468875028|FG006|Phase 2|Death|0|||
130249790|NCT00147537|468875029|FG007|Phase 2|Death|0|||
130249791|NCT00147537|468875030|FG008|Phase 2|Death|0|||
130249792|NCT00147537|468875031|FG009|Phase 2|Death|85|||
130249793|NCT00147537|468875032|FG010|Phase 2|Death|31|||
130249794|NCT00147537|468875022|FG000|Phase 2|Lost to Follow-up|0|||
130249795|NCT00147537|468875023|FG001|Phase 2|Lost to Follow-up|0|||
130249796|NCT00147537|468875024|FG002|Phase 2|Lost to Follow-up|0|||
130249797|NCT00147537|468875025|FG003|Phase 2|Lost to Follow-up|0|||
130249798|NCT00147537|468875026|FG004|Phase 2|Lost to Follow-up|0|||
130249799|NCT00147537|468875027|FG005|Phase 2|Lost to Follow-up|0|||
130249800|NCT00147537|468875028|FG006|Phase 2|Lost to Follow-up|0|||
130249801|NCT00147537|468875029|FG007|Phase 2|Lost to Follow-up|0|||
130249802|NCT00147537|468875030|FG008|Phase 2|Lost to Follow-up|0|||
130249803|NCT00147537|468875031|FG009|Phase 2|Lost to Follow-up|12|||
130249804|NCT00147537|468875032|FG010|Phase 2|Lost to Follow-up|4|||
130249805|NCT00147537|468875022|FG000|Phase 2|Other|0|||
130249806|NCT00147537|468875023|FG001|Phase 2|Other|0|||
130249807|NCT00147537|468875024|FG002|Phase 2|Other|0|||
130249808|NCT00147537|468875025|FG003|Phase 2|Other|0|||
130249809|NCT00147537|468875026|FG004|Phase 2|Other|0|||
130249810|NCT00147537|468875027|FG005|Phase 2|Other|0|||
130249811|NCT00147537|468875028|FG006|Phase 2|Other|0|||
130249812|NCT00147537|468875029|FG007|Phase 2|Other|0|||
130249813|NCT00147537|468875030|FG008|Phase 2|Other|0|||
130249814|NCT00147537|468875031|FG009|Phase 2|Other|47|||
130249815|NCT00147537|468875032|FG010|Phase 2|Other|12|||
130249816|NCT00147537|468875022|FG000|Phase 2|Withdrawal by Subject|0|||
130249817|NCT00147537|468875023|FG001|Phase 2|Withdrawal by Subject|0|||
130249818|NCT00147537|468875024|FG002|Phase 2|Withdrawal by Subject|0|||
130249819|NCT00147537|468875025|FG003|Phase 2|Withdrawal by Subject|0|||
130249820|NCT00147537|468875026|FG004|Phase 2|Withdrawal by Subject|0|||
130249821|NCT00147537|468875027|FG005|Phase 2|Withdrawal by Subject|0|||
130249822|NCT00147537|468875028|FG006|Phase 2|Withdrawal by Subject|0|||
130249823|NCT00147537|468875029|FG007|Phase 2|Withdrawal by Subject|0|||
130249824|NCT00147537|468875030|FG008|Phase 2|Withdrawal by Subject|0|||
130249825|NCT00147537|468875031|FG009|Phase 2|Withdrawal by Subject|16|||
130249826|NCT00147537|468875032|FG010|Phase 2|Withdrawal by Subject|4|||
130249827|NCT00147537|468875022|FG000|Phase 2|Randomized but not treated|0|||
130249828|NCT00147537|468875023|FG001|Phase 2|Randomized but not treated|0|||
130249829|NCT00147537|468875024|FG002|Phase 2|Randomized but not treated|0|||
130249830|NCT00147537|468875025|FG003|Phase 2|Randomized but not treated|0|||
130249831|NCT00147537|468875026|FG004|Phase 2|Randomized but not treated|0|||
130249832|NCT00147537|468875027|FG005|Phase 2|Randomized but not treated|0|||
130249833|NCT00147537|468875028|FG006|Phase 2|Randomized but not treated|0|||
130249834|NCT00147537|468875029|FG007|Phase 2|Randomized but not treated|0|||
130249835|NCT00147537|468875030|FG008|Phase 2|Randomized but not treated|0|||
130249836|NCT00147537|468875031|FG009|Phase 2|Randomized but not treated|1|||
130249837|NCT00147537|468875032|FG010|Phase 2|Randomized but not treated|1|||
130249838|NCT00345592|468875033|FG000|Overall Study|Death|14|||
130249839|NCT00345592|468875034|FG001|Overall Study|Death|16|||
130249840|NCT00345592|468875033|FG000|Overall Study|Withdrawal by Subject|11|||
130249841|NCT00345592|468875034|FG001|Overall Study|Withdrawal by Subject|8|||
130249842|NCT02006654|468875036|FG000|Overall Study|Withdrawal before treatment|4|||
130249843|NCT02006654|468875037|FG001|Overall Study|Withdrawal before treatment|2|||
130249844|NCT02006654|468875036|FG000|Overall Study|Adverse Event|16|||
130249845|NCT02006654|468875037|FG001|Overall Study|Adverse Event|17|||
130249846|NCT02006654|468875036|FG000|Overall Study|Death|1|||
130364559|NCT00142298|469303500|FG000|Overall Study|Treatment Failure|0|||
130364560|NCT00142298|469303501|FG001|Overall Study|Treatment Failure|0|||
130364561|NCT00142298|469303502|FG002|Overall Study|Treatment Failure|0|||
130364562|NCT00142298|469303503|FG003|Overall Study|Treatment Failure|0|||
130364563|NCT00142298|469303504|FG004|Overall Study|Treatment Failure|0|||
130364564|NCT00142298|469303505|FG005|Overall Study|Treatment Failure|2|||
130364565|NCT00142298|469303506|FG006|Overall Study|Treatment Failure|2|||
130364566|NCT00142298|469303507|FG007|Overall Study|Treatment Failure|0|||
130364567|NCT00142298|469303508|FG008|Overall Study|Treatment Failure|0|||
130364568|NCT00142298|469303509|FG009|Overall Study|Treatment Failure|0|||
130364569|NCT00300274|469303510|FG000|Overall Study|Withdrawal by Subject|12|||
130364570|NCT00300274|469303511|FG001|Overall Study|Withdrawal by Subject|3|||
130364571|NCT00300274|469303512|FG002|Overall Study|Withdrawal by Subject|14|||
130364572|NCT00300274|469303510|FG000|Overall Study|Lost to Follow-up|3|||
130364573|NCT00300274|469303511|FG001|Overall Study|Lost to Follow-up|4|||
130364574|NCT00300274|469303512|FG002|Overall Study|Lost to Follow-up|5|||
130364575|NCT00300274|469303510|FG000|Overall Study|Death|31|||
130364576|NCT00300274|469303511|FG001|Overall Study|Death|20|||
130364577|NCT00300274|469303512|FG002|Overall Study|Death|25|||
130364578|NCT00300274|469303510|FG000|Overall Study|Re-transplant|0|||
130364579|NCT00300274|469303511|FG001|Overall Study|Re-transplant|0|||
130452756|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Pain|0|||
130249847|NCT02006654|468875037|FG001|Overall Study|Death|0|||
130249848|NCT02006654|468875036|FG000|Overall Study|Withdrawal by Subject|14|||
130249849|NCT02006654|468875037|FG001|Overall Study|Withdrawal by Subject|12|||
130249850|NCT02006654|468875036|FG000|Overall Study|Protocol Violation|5|||
130249851|NCT02006654|468875037|FG001|Overall Study|Protocol Violation|8|||
130249852|NCT02006654|468875036|FG000|Overall Study|Lost to Follow-up|1|||
130364580|NCT00300274|469303512|FG002|Overall Study|Re-transplant|1|||
130364581|NCT05147428|469303515|FG000|Overall Study|Removed prior to mailing|289|||
130364582|NCT05147428|469303516|FG001|Overall Study|Removed prior to mailing|306|||
130364583|NCT05147428|469303517|FG002|Overall Study|Removed prior to mailing|270|||
130364584|NCT05147428|469303515|FG000|Overall Study|Died or disenrolled during blackout period|239|||
130364585|NCT05147428|469303516|FG001|Overall Study|Died or disenrolled during blackout period|278|||
130249853|NCT02006654|468875037|FG001|Overall Study|Lost to Follow-up|0|||
130249854|NCT02006654|468875036|FG000|Overall Study|patient's will|2|||
130249855|NCT02006654|468875037|FG001|Overall Study|patient's will|1|||
130249856|NCT02006654|468875036|FG000|Overall Study|insufficient compliance|1|||
130249857|NCT02006654|468875037|FG001|Overall Study|insufficient compliance|0|||
130249858|NCT02006654|468875036|FG000|Overall Study|worsening cognitive condition|0|||
130249859|NCT02006654|468875037|FG001|Overall Study|worsening cognitive condition|1|||
130249860|NCT02006654|468875036|FG000|Overall Study|faecal incontinence|0|||
130249861|NCT02006654|468875037|FG001|Overall Study|faecal incontinence|1|||
130249862|NCT02006654|468875036|FG000|Overall Study|mood disorder|0|||
130249863|NCT02006654|468875037|FG001|Overall Study|mood disorder|1|||
130249864|NCT02006654|468875036|FG000|Overall Study|disallowed medication|1|||
130249865|NCT02006654|468875037|FG001|Overall Study|disallowed medication|0|||
130249866|NCT02006654|468875036|FG000|Overall Study|moving out of state|0|||
130249867|NCT02006654|468875037|FG001|Overall Study|moving out of state|1|||
130249868|NCT03438656|468875038|FG000|Overall Study|Lost to Follow-up|2|||
130249869|NCT03721965|468875039|FG000|Overall Study|Death|1|||
130249870|NCT03721965|468875039|FG000|Overall Study|Study Terminated by Sponsor|1|||
130249871|NCT00563316|468875040|FG000|Overall Study|Adverse Event|2|||
130249872|NCT00563316|468875040|FG000|Overall Study|Physician Decision|1|||
130249873|NCT00563316|468875040|FG000|Overall Study|Lost to Follow-up|2|||
130249874|NCT00563316|468875040|FG000|Overall Study|Death|1|||
130249875|NCT00563316|468875040|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
130249876|NCT00563316|468875040|FG000|Overall Study|Other|1|||
130249877|NCT01108055|468875047|FG000|Overall Study|Ineligible|11|||
130249878|NCT01108055|468875047|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
130249879|NCT03339453|468875049|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
130249880|NCT03339453|468875050|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
130249881|NCT00800384|468875053|FG000|Overall Study|Withdrawal by Subject|24|||
130249882|NCT00800384|468875054|FG001|Overall Study|Withdrawal by Subject|17|||
130249883|NCT00800384|468875053|FG000|Overall Study|Lost to Follow-up|17|||
130249884|NCT00800384|468875054|FG001|Overall Study|Lost to Follow-up|26|||
130249885|NCT00504556|468876772|FG000|Overall Study|Adverse Event|11|||
130249886|NCT00504556|468876773|FG001|Overall Study|Adverse Event|11|||
130249887|NCT00504556|468876774|FG002|Overall Study|Adverse Event|14|||
130249888|NCT00504556|468876775|FG003|Overall Study|Adverse Event|13|||
130249889|NCT00504556|468876776|FG004|Overall Study|Adverse Event|5|||
130249890|NCT00504556|468876772|FG000|Overall Study|Death|3|||
130249891|NCT00504556|468876773|FG001|Overall Study|Death|3|||
130249892|NCT00504556|468876774|FG002|Overall Study|Death|1|||
130249893|NCT00504556|468876775|FG003|Overall Study|Death|0|||
130249894|NCT00504556|468876776|FG004|Overall Study|Death|2|||
130249895|NCT00504556|468876772|FG000|Overall Study|Protocol Violation|1|||
130249896|NCT00504556|468876773|FG001|Overall Study|Protocol Violation|3|||
130249897|NCT00504556|468876774|FG002|Overall Study|Protocol Violation|2|||
130249898|NCT00504556|468876775|FG003|Overall Study|Protocol Violation|1|||
130249899|NCT00504556|468876776|FG004|Overall Study|Protocol Violation|2|||
130249900|NCT00504556|468876772|FG000|Overall Study|Lost to Follow-up|0|||
130249901|NCT00504556|468876773|FG001|Overall Study|Lost to Follow-up|0|||
130364586|NCT05147428|469303517|FG002|Overall Study|Died or disenrolled during blackout period|273|||
130364587|NCT01367002|469304821|FG000|Overall Study|Withdrawal by Subject|1|||
130364588|NCT01367002|469304822|FG001|Overall Study|Withdrawal by Subject|0|||
130364589|NCT01367002|469304821|FG000|Overall Study|Physician Decision|0|||
130364590|NCT01367002|469304822|FG001|Overall Study|Physician Decision|2|||
130364591|NCT02468674|469304823|FG000|Overall Study|Adverse Event|0|||
130364592|NCT02468674|469304824|FG001|Overall Study|Adverse Event|0|||
130364593|NCT02468674|469304825|FG002|Overall Study|Adverse Event|0|||
130364594|NCT02468674|469304826|FG003|Overall Study|Adverse Event|1|||
130364595|NCT02468674|469304827|FG004|Overall Study|Adverse Event|0|||
130364596|NCT02468674|469304828|FG005|Overall Study|Adverse Event|1|||
130364597|NCT02468674|469304829|FG006|Overall Study|Adverse Event|0|||
130364598|NCT02468674|469304830|FG007|Overall Study|Adverse Event|0|||
130364599|NCT02468674|469304831|FG008|Overall Study|Adverse Event|0|||
130364600|NCT02468674|469304823|FG000|Overall Study|Lost to Follow-up|1|||
130364601|NCT02468674|469304824|FG001|Overall Study|Lost to Follow-up|0|||
130364602|NCT02468674|469304825|FG002|Overall Study|Lost to Follow-up|0|||
130249902|NCT00504556|468876774|FG002|Overall Study|Lost to Follow-up|1|||
130249903|NCT00504556|468876775|FG003|Overall Study|Lost to Follow-up|1|||
130249904|NCT00504556|468876776|FG004|Overall Study|Lost to Follow-up|1|||
130364603|NCT02468674|469304826|FG003|Overall Study|Lost to Follow-up|0|||
130249905|NCT00504556|468876772|FG000|Overall Study|Withdrawal by Subject|16|||
130249906|NCT00504556|468876773|FG001|Overall Study|Withdrawal by Subject|16|||
130249907|NCT00504556|468876774|FG002|Overall Study|Withdrawal by Subject|7|||
130249908|NCT00504556|468876775|FG003|Overall Study|Withdrawal by Subject|8|||
130249909|NCT00504556|468876776|FG004|Overall Study|Withdrawal by Subject|12|||
130364604|NCT02468674|469304827|FG004|Overall Study|Lost to Follow-up|0|||
130364605|NCT02468674|469304828|FG005|Overall Study|Lost to Follow-up|0|||
130364606|NCT02468674|469304829|FG006|Overall Study|Lost to Follow-up|0|||
130364607|NCT02468674|469304830|FG007|Overall Study|Lost to Follow-up|1|||
130452757|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Pain|0|||
130452758|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
130452759|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
130452760|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
130452761|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
130452762|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Hospice care|1|||
130699720|NCT01332968|470524719|FG000|Follow-Up Period|Progressive Disease|0|||
130699721|NCT01332968|470524720|FG001|Follow-Up Period|Progressive Disease|0|||
130699722|NCT01332968|470524721|FG002|Follow-Up Period|Progressive Disease|0|||
130249910|NCT00504556|468876772|FG000|Overall Study|administrative reasons|0|||
130249911|NCT00504556|468876773|FG001|Overall Study|administrative reasons|2|||
130249912|NCT00504556|468876774|FG002|Overall Study|administrative reasons|2|||
130249913|NCT00504556|468876775|FG003|Overall Study|administrative reasons|1|||
130249914|NCT00504556|468876776|FG004|Overall Study|administrative reasons|2|||
130249915|NCT00504556|468876772|FG000|Overall Study|did not meet entry criteria|2|||
130249916|NCT00504556|468876773|FG001|Overall Study|did not meet entry criteria|0|||
130249917|NCT00504556|468876774|FG002|Overall Study|did not meet entry criteria|1|||
130249918|NCT00504556|468876775|FG003|Overall Study|did not meet entry criteria|1|||
130249919|NCT00504556|468876776|FG004|Overall Study|did not meet entry criteria|0|||
130249920|NCT00504556|468876772|FG000|Overall Study|data monitor committee decision|0|||
130249921|NCT00504556|468876773|FG001|Overall Study|data monitor committee decision|0|||
130249922|NCT00504556|468876774|FG002|Overall Study|data monitor committee decision|0|||
130249923|NCT00504556|468876775|FG003|Overall Study|data monitor committee decision|100|||
130249924|NCT00504556|468876776|FG004|Overall Study|data monitor committee decision|0|||
130249925|NCT00504556|468876772|FG000|Overall Study|Other|2|||
130249926|NCT00504556|468876773|FG001|Overall Study|Other|2|||
130249927|NCT00504556|468876774|FG002|Overall Study|Other|2|||
130249928|NCT00504556|468876775|FG003|Overall Study|Other|3|||
130249929|NCT00504556|468876776|FG004|Overall Study|Other|0|||
130249930|NCT00504556|468876772|FG000|Overall Study|not in safety analysis set|0|||
130249931|NCT00504556|468876773|FG001|Overall Study|not in safety analysis set|1|||
130249932|NCT00504556|468876774|FG002|Overall Study|not in safety analysis set|1|||
130249933|NCT00504556|468876775|FG003|Overall Study|not in safety analysis set|0|||
130249934|NCT00504556|468876776|FG004|Overall Study|not in safety analysis set|1|||
130249935|NCT03280615|468876777|FG000|Overall Study|Lost to Follow-up|1|||
130249936|NCT03280615|468876778|FG001|Overall Study|Lost to Follow-up|2|||
130249937|NCT03280615|468876777|FG000|Overall Study|Adverse Event|1|||
130249938|NCT03280615|468876778|FG001|Overall Study|Adverse Event|1|||
130249939|NCT03280615|468876777|FG000|Overall Study|Withdrawal by Subject|2|||
130249940|NCT03280615|468876778|FG001|Overall Study|Withdrawal by Subject|2|||
130249941|NCT01013870|468876781|FG000|Overall Study|Lost to Follow-up|1|||
130249942|NCT01013870|468876782|FG001|Overall Study|Lost to Follow-up|3|||
130249943|NCT01386645|468876783|FG000|Overall Study|Physician Decision|0|||
130249944|NCT01386645|468876784|FG001|Overall Study|Physician Decision|0|||
130249945|NCT01386645|468876785|FG002|Overall Study|Physician Decision|1|||
130249946|NCT01386645|468876783|FG000|Overall Study|Withdrawal by Subject|0|||
130249947|NCT01386645|468876784|FG001|Overall Study|Withdrawal by Subject|1|||
130249948|NCT01386645|468876785|FG002|Overall Study|Withdrawal by Subject|1|||
130249949|NCT00432991|468876786|FG000|Overall Study|Protocol Violation|7|||
130249950|NCT00432991|468876787|FG001|Overall Study|Protocol Violation|12|||
130249951|NCT03142451|468876797|FG000|Overall Study|Adverse Event|5|||
130249952|NCT03142451|468876798|FG001|Overall Study|Adverse Event|2|||
130249953|NCT03142451|468876797|FG000|Overall Study|Lost to Follow-up|25|||
130249954|NCT03142451|468876798|FG001|Overall Study|Lost to Follow-up|8|||
130249955|NCT03142451|468876797|FG000|Overall Study|Participant request|24|||
130249956|NCT03142451|468876798|FG001|Overall Study|Participant request|12|||
130452763|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Hospice care|0|||
130452764|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Hospice care|0|||
130452765|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Hospice care|0|||
130452766|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Physician Decision|1|||
130699723|NCT01332968|470524722|FG003|Follow-Up Period|Progressive Disease|0|||
130699724|NCT01332968|470524723|FG004|Follow-Up Period|Progressive Disease|0|||
130249957|NCT03142451|468876797|FG000|Overall Study|Protocol Violation|3|||
130249958|NCT03142451|468876798|FG001|Overall Study|Protocol Violation|1|||
130249959|NCT03142451|468876797|FG000|Overall Study|Other|1|||
130249960|NCT03142451|468876798|FG001|Overall Study|Other|1|||
130249961|NCT00090402|468876799|FG000|Overall Study|Death|1|||
130249962|NCT00090402|468876800|FG001|Overall Study|Death|1|||
130249963|NCT00090402|468876801|FG002|Overall Study|Death|0|||
130249964|NCT00090402|468876799|FG000|Overall Study|subject moved|0|||
130249965|NCT00090402|468876800|FG001|Overall Study|subject moved|1|||
130249966|NCT00090402|468876801|FG002|Overall Study|subject moved|0|||
130249967|NCT00090402|468876799|FG000|Overall Study|stopped taking study medication|1|||
130249968|NCT00090402|468876800|FG001|Overall Study|stopped taking study medication|0|||
130249969|NCT00090402|468876801|FG002|Overall Study|stopped taking study medication|1|||
130249970|NCT04621786|468876812|FG000|Overall Study|Lost to Follow-up|9|||
130249971|NCT04621786|468876812|FG000|Overall Study|Protocol Violation|3|||
130699725|NCT01332968|470524724|FG005|Follow-Up Period|Progressive Disease|0|||
130249972|NCT02365064|468876815|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
130249973|NCT02365064|468876816|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
130249974|NCT02365064|468876815|FG000|Overall Study|Withdrawal by Subject|6|||
130249975|NCT02365064|468876816|FG001|Overall Study|Withdrawal by Subject|9|||
130249976|NCT02365064|468876815|FG000|Overall Study|Treatment intolerance|2|||
130249977|NCT02365064|468876816|FG001|Overall Study|Treatment intolerance|4|||
130249978|NCT01716559|468876817|FG000|Overall Study|Adverse Event|11|||
130249979|NCT01716559|468876817|FG000|Overall Study|Death|21|||
130249980|NCT01716559|468876817|FG000|Overall Study|Withdrawal by Subject|4|||
130249981|NCT01716559|468876817|FG000|Overall Study|Other withdrawal reason|75|||
130249982|NCT01133977|468876820|FG000|Overall Study|Adverse Event|0|||
130249983|NCT01133977|468876821|FG001|Overall Study|Adverse Event|0|||
130249984|NCT01133977|468876822|FG002|Overall Study|Adverse Event|1|||
130249985|NCT01133977|468876823|FG003|Overall Study|Adverse Event|0|||
130249986|NCT01133977|468876824|FG004|Overall Study|Adverse Event|0|||
130249987|NCT01133977|468876820|FG000|Overall Study|Death|1|||
130249988|NCT01133977|468876821|FG001|Overall Study|Death|1|||
130249989|NCT01133977|468876822|FG002|Overall Study|Death|1|||
130249990|NCT01133977|468876823|FG003|Overall Study|Death|7|||
130249991|NCT01133977|468876824|FG004|Overall Study|Death|3|||
130249992|NCT01133977|468876820|FG000|Overall Study|Started a New Line of Therapy|2|||
130249993|NCT01133977|468876821|FG001|Overall Study|Started a New Line of Therapy|6|||
130249994|NCT01133977|468876822|FG002|Overall Study|Started a New Line of Therapy|4|||
130249995|NCT01133977|468876823|FG003|Overall Study|Started a New Line of Therapy|25|||
130249996|NCT01133977|468876824|FG004|Overall Study|Started a New Line of Therapy|33|||
130249997|NCT01133977|468876820|FG000|Overall Study|Lost to Follow-up|0|||
130249998|NCT01133977|468876821|FG001|Overall Study|Lost to Follow-up|0|||
130249999|NCT01133977|468876822|FG002|Overall Study|Lost to Follow-up|0|||
130250000|NCT01133977|468876823|FG003|Overall Study|Lost to Follow-up|2|||
130250001|NCT01133977|468876824|FG004|Overall Study|Lost to Follow-up|1|||
130250002|NCT01133977|468876820|FG000|Overall Study|Withdrawal by Subject|0|||
130250003|NCT01133977|468876821|FG001|Overall Study|Withdrawal by Subject|0|||
130250004|NCT01133977|468876822|FG002|Overall Study|Withdrawal by Subject|0|||
130250005|NCT01133977|468876823|FG003|Overall Study|Withdrawal by Subject|5|||
130250006|NCT01133977|468876824|FG004|Overall Study|Withdrawal by Subject|1|||
130250007|NCT02773537|468876825|FG000|Overall Study|Lost to Follow-up|0|||
130250008|NCT02773537|468876826|FG001|Overall Study|Lost to Follow-up|1|||
130250009|NCT02773537|468876827|FG002|Overall Study|Lost to Follow-up|4|||
130250010|NCT00662038|468876828|FG000|Overall Study|Reason not specified|3|||
130250011|NCT00662038|468876828|FG000|Overall Study|Withdrawn consent|22|||
130250012|NCT00662038|468876828|FG000|Overall Study|Withdrawal by Subject|83|||
130250013|NCT00662038|468876828|FG000|Overall Study|Sponsor decision|1|||
130250014|NCT00662038|468876828|FG000|Overall Study|Physician Decision|19|||
130250015|NCT00662038|468876828|FG000|Overall Study|Lung transplantation|44|||
130250016|NCT00662038|468876828|FG000|Overall Study|Lost to Follow-up|1|||
130452767|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Physician Decision|0|||
130452768|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Physician Decision|0|||
130452769|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Physician Decision|0|||
130250017|NCT00662038|468876828|FG000|Overall Study|Death|95|||
130250018|NCT00662038|468876828|FG000|Overall Study|Adverse Event|358|||
130250019|NCT00662038|468876828|FG000|Overall Study|Continued treatment|5|||
130250020|NCT01840163|468876829|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
130250021|NCT01840163|468876830|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
130250022|NCT01840163|468876829|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
130250023|NCT01840163|468876830|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
130250024|NCT01840163|468876829|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
130250025|NCT01840163|468876830|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
130250026|NCT00397046|468876831|FG000|Overall Study|Disease Progression|3|||
130250027|NCT00397046|468876832|FG001|Overall Study|Disease Progression|3|||
130250028|NCT00397046|468876833|FG002|Overall Study|Disease Progression|10|||
130250029|NCT00397046|468876834|FG003|Overall Study|Disease Progression|5|||
130250030|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
130250031|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
130452770|NCT01107626|469621690|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
130452771|NCT01107626|469621691|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
130452772|NCT01107626|469621692|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
130250032|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130250033|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130250034|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130250035|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130250036|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
130250037|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250038|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250039|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
130364608|NCT02468674|469304831|FG008|Overall Study|Lost to Follow-up|1|||
130364609|NCT02468674|469304823|FG000|Overall Study|Physician Decision|0|||
130250040|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
130250041|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
130250042|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Other|6|||
130250043|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Other|3|||
130250044|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Other|0|||
130250045|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130250046|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130250047|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130250048|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
130250049|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
130364610|NCT02468674|469304824|FG001|Overall Study|Physician Decision|0|||
130364611|NCT02468674|469304825|FG002|Overall Study|Physician Decision|0|||
130364612|NCT02468674|469304826|FG003|Overall Study|Physician Decision|0|||
130364613|NCT02468674|469304827|FG004|Overall Study|Physician Decision|0|||
130364614|NCT02468674|469304828|FG005|Overall Study|Physician Decision|0|||
130364615|NCT02468674|469304829|FG006|Overall Study|Physician Decision|1|||
130364616|NCT02468674|469304830|FG007|Overall Study|Physician Decision|0|||
130364617|NCT02468674|469304831|FG008|Overall Study|Physician Decision|0|||
130364618|NCT02468674|469304823|FG000|Overall Study|Patient/Guardian Decision|0|||
130250050|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
130250051|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Adverse Event|0|||
130364619|NCT02468674|469304824|FG001|Overall Study|Patient/Guardian Decision|0|||
130452773|NCT01107626|469621693|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
130452774|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
130250052|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Adverse Event|0|||
130452775|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
130452776|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
130452777|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
130250053|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Adverse Event|21|||
130250054|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
130250055|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
130250056|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
130250057|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250058|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250059|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
130250060|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
130250061|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
130364620|NCT02468674|469304825|FG002|Overall Study|Patient/Guardian Decision|0|||
130452778|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
130452779|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
130452780|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
130452781|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
130452782|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Death|0|||
130452783|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Death|8|||
130452784|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Death|2|||
130452785|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Death|13|||
130452786|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
130452787|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
130452788|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
130452789|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
130452790|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
130452791|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
130452792|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
130452793|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
130452794|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
130452795|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
130452796|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
130452797|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
130452798|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
130452799|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
130553297|NCT03437278|469993549|FG000|Overall Study|Progressive disease|1|||
130250062|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
130250063|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Administrative|0|||
130364621|NCT02468674|469304826|FG003|Overall Study|Patient/Guardian Decision|0|||
130364622|NCT02468674|469304827|FG004|Overall Study|Patient/Guardian Decision|1|||
130364623|NCT02468674|469304828|FG005|Overall Study|Patient/Guardian Decision|0|||
130364624|NCT02468674|469304829|FG006|Overall Study|Patient/Guardian Decision|0|||
130364625|NCT02468674|469304830|FG007|Overall Study|Patient/Guardian Decision|2|||
130364626|NCT02468674|469304831|FG008|Overall Study|Patient/Guardian Decision|1|||
130364627|NCT02468674|469304823|FG000|Overall Study|Protocol Deviation|0|||
130364628|NCT02468674|469304824|FG001|Overall Study|Protocol Deviation|0|||
130364629|NCT02468674|469304825|FG002|Overall Study|Protocol Deviation|0|||
130364630|NCT02468674|469304826|FG003|Overall Study|Protocol Deviation|0|||
130364631|NCT02468674|469304827|FG004|Overall Study|Protocol Deviation|0|||
130364632|NCT02468674|469304828|FG005|Overall Study|Protocol Deviation|0|||
130364633|NCT02468674|469304829|FG006|Overall Study|Protocol Deviation|0|||
130364634|NCT02468674|469304830|FG007|Overall Study|Protocol Deviation|1|||
130364635|NCT02468674|469304831|FG008|Overall Study|Protocol Deviation|1|||
130364636|NCT03689530|469304837|FG000|Overall Study|Withdrawal by Subject|53|||
130364637|NCT03689530|469304838|FG001|Overall Study|Withdrawal by Subject|16|||
130364638|NCT04622306|469304842|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
130364639|NCT04622306|469304843|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
130364640|NCT04622306|469304844|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
130364641|NCT04622306|469304845|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
130364642|NCT04622306|469304846|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
130364643|NCT04622306|469304847|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
130364644|NCT04622306|469304842|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130364645|NCT04622306|469304843|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130364646|NCT04622306|469304844|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
130364647|NCT04622306|469304845|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
130364648|NCT04622306|469304846|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130364649|NCT04622306|469304847|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130364650|NCT00736944|469304848|FG000|Induction|Death|1|||
130364651|NCT00736944|469304848|FG000|Definitive Treatment|Physician Decision|1|||
130364652|NCT01601132|469304849|FG000|Overall Study|Patient withdrew consent|1|||
130364653|NCT01601132|469304849|FG000|Overall Study|Protocol deviation|1|||
130364654|NCT01952145|469304851|FG000|Overall Study|Protocol Violation|2|||
130364655|NCT01952145|469304852|FG001|Overall Study|Protocol Violation|1|||
130364656|NCT01952145|469304851|FG000|Overall Study|Death|0|||
130364657|NCT01952145|469304852|FG001|Overall Study|Death|1|||
130364658|NCT01952145|469304851|FG000|Overall Study|Adverse Event|9|||
130364659|NCT01952145|469304852|FG001|Overall Study|Adverse Event|0|||
130364660|NCT01952145|469304851|FG000|Overall Study|Withdrawal Criteria|16|||
130364661|NCT01952145|469304852|FG001|Overall Study|Withdrawal Criteria|11|||
130364662|NCT01952145|469304851|FG000|Overall Study|Unclassified|1|||
130364663|NCT01952145|469304852|FG001|Overall Study|Unclassified|1|||
130364664|NCT04138810|469304856|FG000|Overall Study|Withdrawal by Subject|0|||
130364665|NCT04138810|469304857|FG001|Overall Study|Withdrawal by Subject|1|||
130364666|NCT04138810|469304856|FG000|Overall Study|Subject cancelled surgery|1|||
130452800|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
130452801|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
130452802|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
130452803|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
130452804|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
130452805|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
130452806|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
130452807|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
130699726|NCT01332968|470524725|FG006|Follow-Up Period|Progressive Disease|126|||
130699727|NCT01332968|470524726|FG007|Follow-Up Period|Progressive Disease|106|||
130699728|NCT01332968|470524719|FG000|Follow-Up Period|Protocol Violation|0|||
130699729|NCT01332968|470524720|FG001|Follow-Up Period|Protocol Violation|0|||
130364667|NCT04138810|469304857|FG001|Overall Study|Subject cancelled surgery|0|||
130364668|NCT02589405|469304860|FG000|Overall Study|Adverse Event|3|||
130364669|NCT02589405|469304860|FG000|Overall Study|Withdrawal by Subject|1|||
130364670|NCT04545060|469304863|FG000|Overall Study|Adverse Event|0|||
130364671|NCT04545060|469304864|FG001|Overall Study|Adverse Event|1|||
130364672|NCT04545060|469304863|FG000|Overall Study|Death|0|||
130364673|NCT04545060|469304864|FG001|Overall Study|Death|5|||
130364674|NCT04545060|469304863|FG000|Overall Study|Lost to Follow-up|10|||
130364675|NCT04545060|469304864|FG001|Overall Study|Lost to Follow-up|13|||
130364676|NCT04545060|469304863|FG000|Overall Study|Physician Decision|3|||
130364677|NCT04545060|469304864|FG001|Overall Study|Physician Decision|0|||
130364678|NCT04545060|469304863|FG000|Overall Study|Withdrawal by Subject|17|||
130364679|NCT04545060|469304864|FG001|Overall Study|Withdrawal by Subject|22|||
130364680|NCT00619177|469304867|FG000|Overall Study|Adverse Event|18|||
130364681|NCT00619177|469304867|FG000|Overall Study|Lost to Follow-up|2|||
130364682|NCT00619177|469304867|FG000|Overall Study|Lack of Efficacy|1|||
130364683|NCT00619177|469304867|FG000|Overall Study|Missing termination information|481|||
130452808|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
130452809|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
130699730|NCT01332968|470524721|FG002|Follow-Up Period|Protocol Violation|0|||
130364684|NCT00619177|469304867|FG000|Overall Study|Not specified reasons|6|||
130364685|NCT03082261|469304868|FG000|Overall Study|Death|4|||
130250064|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Administrative|0|||
130250065|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Administrative|36|||
130250066|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Other|0|||
130250067|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Other|0|||
130250068|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Other|9|||
130250069|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
130250070|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
130250071|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
130250072|NCT00493285|468876848|FG000|Overall Study|Lost to Follow-up|0|||
130250073|NCT00493285|468876849|FG001|Overall Study|Lost to Follow-up|0|||
130250074|NCT00493285|468876850|FG002|Overall Study|Lost to Follow-up|0|||
130250075|NCT00493285|468876851|FG003|Overall Study|Lost to Follow-up|0|||
130250076|NCT00493285|468876852|FG004|Overall Study|Lost to Follow-up|1|||
130250077|NCT00493285|468876853|FG005|Overall Study|Lost to Follow-up|0|||
130250078|NCT04535362|468876854|FG000|Overall Study|Lost to Follow-up|3|||
130250079|NCT04535362|468876855|FG001|Overall Study|Lost to Follow-up|1|||
130250080|NCT03791060|468876856|FG000|Overall Study|Withdrawal by Subject|1|||
130250081|NCT03774810|468876857|FG000|Phase 1|Lack of Efficacy|21|||
130250082|NCT03774810|468876858|FG001|Phase 1|Lack of Efficacy|0|||
130250083|NCT03774810|468876859|FG002|Phase 1|Lack of Efficacy|0|||
130250084|NCT03774810|468876860|FG003|Phase 1|Lack of Efficacy|0|||
130250085|NCT03774810|468876861|FG004|Phase 1|Lack of Efficacy|0|||
130250086|NCT03774810|468876857|FG000|Phase 1|Withdrawal by Subject|9|||
130250087|NCT03774810|468876858|FG001|Phase 1|Withdrawal by Subject|0|||
130250088|NCT03774810|468876859|FG002|Phase 1|Withdrawal by Subject|0|||
130250089|NCT03774810|468876860|FG003|Phase 1|Withdrawal by Subject|0|||
130250090|NCT03774810|468876861|FG004|Phase 1|Withdrawal by Subject|0|||
130250091|NCT03774810|468876857|FG000|Phase 1|Lost to Follow-up|2|||
130250092|NCT03774810|468876858|FG001|Phase 1|Lost to Follow-up|0|||
130250093|NCT03774810|468876859|FG002|Phase 1|Lost to Follow-up|0|||
130250094|NCT03774810|468876860|FG003|Phase 1|Lost to Follow-up|0|||
130250095|NCT03774810|468876861|FG004|Phase 1|Lost to Follow-up|0|||
130250096|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
130250097|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
130250098|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
130250099|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
130250100|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
130250101|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
130250102|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
130250103|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
130250104|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
130250105|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
130250106|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250107|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
130250108|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250109|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250110|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250111|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
130250112|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
130250113|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130250114|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
130250115|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130250116|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
130250117|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
130250118|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
130250119|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
130250120|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
130250121|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250122|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250123|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250124|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
130452810|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
130452811|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
130452812|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
130250125|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
130250126|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
130250127|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
130250128|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
130250129|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
130250130|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
130452813|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
130452814|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
130452815|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
130364686|NCT03082261|469304868|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
130364687|NCT03082261|469304868|FG000|Overall Study|Insurance denial|1|||
130364688|NCT03082261|469304868|FG000|Overall Study|Peripheral lead added|1|||
130364689|NCT03082261|469304868|FG000|Overall Study|Withdrawal by Subject|40|||
130364690|NCT03082261|469304868|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
130364691|NCT03082261|469304868|FG000|Overall Study|Subject implanted with device other than study device|1|||
130364692|NCT03082261|469304868|FG000|Overall Study|Lost to Follow-up|14|||
130364693|NCT03082261|469304868|FG000|Overall Study|Subject moved to a different state|1|||
130364694|NCT03082261|469304868|FG000|Overall Study|Subject non-compliance|2|||
130364695|NCT03082261|469304868|FG000|Overall Study|Subject participation terminated by investigator|9|||
130364696|NCT03082261|469304868|FG000|Overall Study|Subject participation terminated by sponsor|4|||
130364697|NCT03082261|469304868|FG000|Overall Study|System explant|19|||
130364698|NCT03082261|469304868|FG000|Overall Study|Unable to place lead(s)|2|||
130364699|NCT03082261|469304868|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
130364700|NCT01032174|469304873|FG000|Overall Study|Adverse Event|0|||
130364701|NCT01032174|469304874|FG001|Overall Study|Adverse Event|1|||
130364702|NCT00702689|469304875|FG000|Overall Study|Withdrawal by Subject|4|||
130364703|NCT00702689|469304875|FG000|Overall Study|Recurrent malignancy|1|||
130364704|NCT00702689|469304875|FG000|Overall Study|Adverse Event|1|||
130364705|NCT01281137|469304878|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
130364706|NCT01281137|469304879|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
130364707|NCT01281137|469304878|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
130364708|NCT01281137|469304879|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
130364709|NCT01281137|469304878|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
130364710|NCT01281137|469304879|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
130364711|NCT01281137|469304878|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
130364712|NCT01281137|469304879|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
130364713|NCT01281137|469304878|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
130364714|NCT01281137|469304879|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
130364715|NCT02761733|469304882|FG000|Overall Study|Death|3|||
130364716|NCT02761733|469304883|FG001|Overall Study|Death|5|||
130364717|NCT02761733|469304884|FG002|Overall Study|Death|1|||
130364718|NCT02761733|469304885|FG003|Overall Study|Death|1|||
130364719|NCT02761733|469304882|FG000|Overall Study|Lost to Follow-up|6|||
130364720|NCT02761733|469304883|FG001|Overall Study|Lost to Follow-up|7|||
130364721|NCT02761733|469304884|FG002|Overall Study|Lost to Follow-up|0|||
130364722|NCT02761733|469304885|FG003|Overall Study|Lost to Follow-up|3|||
130364723|NCT02761733|469304882|FG000|Overall Study|Physician Decision|4|||
130364724|NCT02761733|469304883|FG001|Overall Study|Physician Decision|0|||
130364725|NCT02761733|469304884|FG002|Overall Study|Physician Decision|0|||
130364726|NCT02761733|469304885|FG003|Overall Study|Physician Decision|0|||
130364727|NCT02761733|469304882|FG000|Overall Study|Withdrawal by Subject|2|||
130364728|NCT02761733|469304883|FG001|Overall Study|Withdrawal by Subject|0|||
130364729|NCT02761733|469304884|FG002|Overall Study|Withdrawal by Subject|0|||
130452816|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
130452817|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
130452818|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
130699731|NCT01332968|470524722|FG003|Follow-Up Period|Protocol Violation|0|||
130699732|NCT01332968|470524723|FG004|Follow-Up Period|Protocol Violation|0|||
130699733|NCT01332968|470524724|FG005|Follow-Up Period|Protocol Violation|0|||
130699734|NCT01332968|470524725|FG006|Follow-Up Period|Protocol Violation|1|||
130699735|NCT01332968|470524726|FG007|Follow-Up Period|Protocol Violation|0|||
130699736|NCT01332968|470524719|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130699737|NCT01332968|470524720|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130699738|NCT01332968|470524721|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130699739|NCT01332968|470524722|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130699740|NCT01332968|470524723|FG004|Follow-Up Period|Withdrawal by Subject|0|||
130699741|NCT01332968|470524724|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130699742|NCT01332968|470524725|FG006|Follow-Up Period|Withdrawal by Subject|29|||
130699743|NCT01332968|470524726|FG007|Follow-Up Period|Withdrawal by Subject|32|||
130699744|NCT01332968|470524719|FG000|Follow-Up Period|No reason provided|0|||
130699745|NCT01332968|470524720|FG001|Follow-Up Period|No reason provided|0|||
130364730|NCT02761733|469304885|FG003|Overall Study|Withdrawal by Subject|0|||
130452819|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
130452820|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
130699746|NCT01332968|470524721|FG002|Follow-Up Period|No reason provided|0|||
130699747|NCT01332968|470524722|FG003|Follow-Up Period|No reason provided|0|||
130699748|NCT01332968|470524723|FG004|Follow-Up Period|No reason provided|0|||
130250131|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
130250132|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130250133|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130250134|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
130250135|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
130250136|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
130250137|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
130250138|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
130699749|NCT01332968|470524724|FG005|Follow-Up Period|No reason provided|0|||
130699750|NCT01332968|470524725|FG006|Follow-Up Period|No reason provided|2|||
130699751|NCT01332968|470524726|FG007|Follow-Up Period|No reason provided|3|||
130250139|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
130250140|NCT00290758|468876871|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
130250141|NCT00290758|468876872|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
130250142|NCT00474968|468876873|FG000|Overall Study|Withdrawal by Subject|8|||
130250143|NCT00474968|468876874|FG001|Overall Study|Withdrawal by Subject|7|||
130250144|NCT00474968|468876873|FG000|Overall Study|Protocol Violation|9|||
130250145|NCT00474968|468876874|FG001|Overall Study|Protocol Violation|8|||
130250146|NCT00474968|468876873|FG000|Overall Study|Sample not collected|1|||
130250147|NCT00474968|468876874|FG001|Overall Study|Sample not collected|1|||
130250148|NCT00981175|468876875|FG000|Primary Dose Vaccination|Adverse Event|1|||
130250149|NCT00981175|468876876|FG001|Primary Dose Vaccination|Adverse Event|0|||
130250150|NCT00981175|468876875|FG000|Primary Dose Vaccination|Protocol Violation|0|||
130250151|NCT00981175|468876876|FG001|Primary Dose Vaccination|Protocol Violation|1|||
130250152|NCT00981175|468876875|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
130250153|NCT00981175|468876876|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
130250154|NCT00981175|468876875|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
130699752|NCT03480022|470524727|FG000|Overall Study|Pregnancy|2|||
130250155|NCT00981175|468876876|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
130250156|NCT02619812|468876877|FG000|Overall Study|Withdrawal by Subject|0|||
130699753|NCT03480022|470524728|FG001|Overall Study|Pregnancy|0|||
130699754|NCT03480022|470524727|FG000|Overall Study|Adverse Event|6|||
130699755|NCT03480022|470524728|FG001|Overall Study|Adverse Event|0|||
130699756|NCT03480022|470524727|FG000|Overall Study|Lack of Efficacy|0|||
130699757|NCT03480022|470524728|FG001|Overall Study|Lack of Efficacy|2|||
130699758|NCT03480022|470524727|FG000|Overall Study|Physician Decision|0|||
130699759|NCT03480022|470524728|FG001|Overall Study|Physician Decision|1|||
130250157|NCT02619812|468876878|FG001|Overall Study|Withdrawal by Subject|0|||
130250158|NCT02619812|468876879|FG002|Overall Study|Withdrawal by Subject|1|||
130250159|NCT02619812|468876880|FG003|Overall Study|Withdrawal by Subject|2|||
130250160|NCT04189588|468876882|FG000|Overall Study|Death|0|||
130250161|NCT04189588|468876883|FG001|Overall Study|Death|1|||
130250162|NCT04189588|468876882|FG000|Overall Study|Lost to Follow-up|0|||
130250163|NCT04189588|468876883|FG001|Overall Study|Lost to Follow-up|1|||
130250164|NCT01658735|468876884|FG000|Overall Study|Lack of Efficacy|1|||
130250165|NCT01658735|468876885|FG001|Overall Study|Lack of Efficacy|0|||
130250166|NCT01658735|468876886|FG002|Overall Study|Lack of Efficacy|1|||
130250167|NCT01658735|468876884|FG000|Overall Study|Lost to Follow-up|1|||
130250168|NCT01658735|468876885|FG001|Overall Study|Lost to Follow-up|1|||
130250169|NCT01658735|468876886|FG002|Overall Study|Lost to Follow-up|0|||
130250170|NCT01658735|468876884|FG000|Overall Study|Protocol Violation|0|||
130250171|NCT01658735|468876885|FG001|Overall Study|Protocol Violation|1|||
130250172|NCT01658735|468876886|FG002|Overall Study|Protocol Violation|0|||
130250173|NCT01658735|468876884|FG000|Overall Study|Withdrawal by Subject|3|||
130250174|NCT01658735|468876885|FG001|Overall Study|Withdrawal by Subject|5|||
130250175|NCT01658735|468876886|FG002|Overall Study|Withdrawal by Subject|3|||
130250176|NCT03156621|468876887|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
130364731|NCT02761733|469304882|FG000|Overall Study|Discharged from Study Site|10|||
130364732|NCT02761733|469304883|FG001|Overall Study|Discharged from Study Site|9|||
130364733|NCT02761733|469304884|FG002|Overall Study|Discharged from Study Site|25|||
130364734|NCT02761733|469304885|FG003|Overall Study|Discharged from Study Site|11|||
130699760|NCT03480022|470524727|FG000|Overall Study|Withdrawal by Subject|2|||
130699761|NCT03480022|470524728|FG001|Overall Study|Withdrawal by Subject|0|||
130699762|NCT03480022|470524727|FG000|Overall Study|Medication concerns|1|||
130699763|NCT03480022|470524728|FG001|Overall Study|Medication concerns|0|||
130699764|NCT03480022|470524727|FG000|Overall Study|Family member COVID exposure|0|||
130250177|NCT03156621|468876888|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
130250178|NCT03156621|468876887|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130250179|NCT03156621|468876888|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130250180|NCT01379937|468876889|FG000|Overall Study|Protocol Violation|0|||
130250181|NCT01379937|468876890|FG001|Overall Study|Protocol Violation|0|||
130250182|NCT01379937|468876891|FG002|Overall Study|Protocol Violation|0|||
130699765|NCT03480022|470524728|FG001|Overall Study|Family member COVID exposure|1|||
130250183|NCT01379937|468876892|FG003|Overall Study|Protocol Violation|1|||
130250184|NCT01379937|468876889|FG000|Overall Study|Consent withdrawal|0|||
130250185|NCT01379937|468876890|FG001|Overall Study|Consent withdrawal|1|||
130250186|NCT01379937|468876891|FG002|Overall Study|Consent withdrawal|0|||
130250187|NCT01379937|468876892|FG003|Overall Study|Consent withdrawal|0|||
130250188|NCT01379937|468876889|FG000|Overall Study|Lost to Follow-up|1|||
130250189|NCT01379937|468876890|FG001|Overall Study|Lost to Follow-up|2|||
130250190|NCT01379937|468876891|FG002|Overall Study|Lost to Follow-up|2|||
130250191|NCT01379937|468876892|FG003|Overall Study|Lost to Follow-up|0|||
130250192|NCT04034056|468876898|FG000|Overall Study|Withdrawal by Subject|2|||
130250193|NCT04034056|468876898|FG000|Overall Study|Reason Not Specified|13|||
130250194|NCT04034056|468876898|FG000|Overall Study|Adverse Event|56|||
130250195|NCT01260311|468876902|FG000|Overall Study|Adverse Event|11|||
130250196|NCT01260311|468876902|FG000|Overall Study|Lack of Efficacy|4|||
130250197|NCT01260311|468876902|FG000|Overall Study|Lost to Follow-up|25|||
130250198|NCT01260311|468876902|FG000|Overall Study|Withdrawal by Subject|6|||
130250199|NCT01260311|468876902|FG000|Overall Study|Financial Constraints|77|||
130250200|NCT01260311|468876902|FG000|Overall Study|Gone to Province|2|||
130250201|NCT01260311|468876902|FG000|Overall Study|Medication Stopped|1|||
130250202|NCT01260311|468876902|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
130250203|NCT01089543|468876909|FG000|Overall Study|Withdrawal by Subject|2|||
130250204|NCT01089543|468876910|FG001|Overall Study|Withdrawal by Subject|3|||
130250205|NCT01089543|468876911|FG002|Overall Study|Withdrawal by Subject|3|||
130250206|NCT01089543|468876912|FG003|Overall Study|Withdrawal by Subject|1|||
130250207|NCT01089543|468876909|FG000|Overall Study|Physician Decision|1|||
130250208|NCT01089543|468876910|FG001|Overall Study|Physician Decision|0|||
130250209|NCT01089543|468876911|FG002|Overall Study|Physician Decision|0|||
130250210|NCT01089543|468876912|FG003|Overall Study|Physician Decision|1|||
130250211|NCT01089543|468876909|FG000|Overall Study|Adverse Event|0|||
130250212|NCT01089543|468876910|FG001|Overall Study|Adverse Event|1|||
130250213|NCT01089543|468876911|FG002|Overall Study|Adverse Event|0|||
130250214|NCT01089543|468876912|FG003|Overall Study|Adverse Event|0|||
130250215|NCT01248468|468876914|FG000|Overall Study|Administrative problem|1|||
130250216|NCT01248468|468876915|FG001|Overall Study|Administrative problem|0|||
130250217|NCT01248468|468876916|FG002|Overall Study|Administrative problem|0|||
130250218|NCT01248468|468876914|FG000|Overall Study|Lost to Follow-up|9|||
130250219|NCT01248468|468876915|FG001|Overall Study|Lost to Follow-up|12|||
130250220|NCT01248468|468876916|FG002|Overall Study|Lost to Follow-up|4|||
130250221|NCT01248468|468876914|FG000|Overall Study|Pregnancy|1|||
130250222|NCT01248468|468876915|FG001|Overall Study|Pregnancy|0|||
130250223|NCT01248468|468876916|FG002|Overall Study|Pregnancy|0|||
130250224|NCT01248468|468876914|FG000|Overall Study|Withdrawal by Subject|4|||
130250225|NCT01248468|468876915|FG001|Overall Study|Withdrawal by Subject|2|||
130250226|NCT01248468|468876916|FG002|Overall Study|Withdrawal by Subject|0|||
130250227|NCT00468546|468876918|FG000|Week 24 Analysis|Lack of Efficacy|83|||
130250228|NCT00468546|468876919|FG001|Week 24 Analysis|Lack of Efficacy|37|||
130250229|NCT00468546|468876918|FG000|Week 24 Analysis|Refused treatment|5|||
130452821|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
130452822|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
130452823|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
130452824|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
130452825|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
130452826|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Pain|0|||
130452827|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Pain|0|||
130452828|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Pain|0|||
130452829|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Pain|1|||
130452830|NCT01107626|469621690|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
130452831|NCT01107626|469621691|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
130452832|NCT01107626|469621692|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
130250230|NCT00468546|468876919|FG001|Week 24 Analysis|Refused treatment|5|||
130250231|NCT00468546|468876918|FG000|Week 24 Analysis|Adverse Event|1|||
130250232|NCT00468546|468876919|FG001|Week 24 Analysis|Adverse Event|8|||
130250233|NCT00468546|468876918|FG000|Week 24 Analysis|Failure to return|3|||
130452833|NCT01107626|469621693|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
130452834|NCT04353037|469621694|FG000|Overall Study|Lost to Follow-up|0|||
130452835|NCT04353037|469621695|FG001|Overall Study|Lost to Follow-up|1|||
130452836|NCT04353037|469621696|FG002|Overall Study|Lost to Follow-up|2|||
130452837|NCT04353037|469621697|FG003|Overall Study|Lost to Follow-up|3|||
130452838|NCT04353037|469621694|FG000|Overall Study|Withdrawal by Subject|0|||
130250234|NCT00468546|468876919|FG001|Week 24 Analysis|Failure to return|4|||
130250235|NCT00468546|468876918|FG000|Week 24 Analysis|Rescue therapy|2|||
130250236|NCT00468546|468876919|FG001|Week 24 Analysis|Rescue therapy|0|||
130250237|NCT00468546|468876918|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
130250238|NCT00468546|468876919|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
130250239|NCT00468546|468876918|FG000|Week 24 Analysis|Due to clinical hold|1|||
130250240|NCT00468546|468876919|FG001|Week 24 Analysis|Due to clinical hold|0|||
130250241|NCT00468546|468876918|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
130250242|NCT00468546|468876919|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
130250243|NCT00468546|468876918|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
130250244|NCT00468546|468876919|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
130250245|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
130250246|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
130250247|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Death|1|||
130250248|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Death|0|||
130250249|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
130699766|NCT00640926|470524729|FG000|Overall Study|Adverse Event|2|||
130699767|NCT00640926|470524730|FG001|Overall Study|Adverse Event|3|||
130699768|NCT00640926|470524731|FG002|Overall Study|Adverse Event|2|||
130699769|NCT00640926|470524729|FG000|Overall Study|Lack of Efficacy|0|||
130699770|NCT00640926|470524730|FG001|Overall Study|Lack of Efficacy|2|||
130699771|NCT00640926|470524731|FG002|Overall Study|Lack of Efficacy|1|||
130699772|NCT00640926|470524729|FG000|Overall Study|Protocol Violation|2|||
130699773|NCT00640926|470524730|FG001|Overall Study|Protocol Violation|0|||
130699774|NCT00640926|470524731|FG002|Overall Study|Protocol Violation|2|||
130699775|NCT00640926|470524729|FG000|Overall Study|Lost to Follow-up|3|||
130699776|NCT00640926|470524730|FG001|Overall Study|Lost to Follow-up|1|||
130699777|NCT00640926|470524731|FG002|Overall Study|Lost to Follow-up|2|||
130250250|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
130250251|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
130250252|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
130250253|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
130250254|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
130250255|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
130250256|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
130250257|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
130250258|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
130250259|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Other|17|||
130250260|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Other|14|||
130250261|NCT00472641|468876920|FG000|Overall Study|Lack of Efficacy|3|||
130250262|NCT00472641|468876920|FG000|Overall Study|Adverse Event|3|||
130250263|NCT00472641|468876920|FG000|Overall Study|Lost to Follow-up|1|||
130250264|NCT00478140|468876921|FG000|Overall Study|Clinical Disease Progression|1|||
130250265|NCT01189227|468876924|FG000|Overall Study|Study terminated due to low accrual|6|||
130250266|NCT01189227|468876925|FG001|Overall Study|Study terminated due to low accrual|3|||
130250267|NCT03211832|468876926|FG000|Overall Study|No longer with agency|32|||
130250268|NCT03211832|468876927|FG001|Overall Study|No longer with agency|49|||
130250269|NCT03211832|468876928|FG002|Overall Study|No longer with agency|30|||
130250270|NCT03211832|468876926|FG000|Overall Study|Declined survey|3|||
130250271|NCT03211832|468876927|FG001|Overall Study|Declined survey|3|||
130250272|NCT03211832|468876928|FG002|Overall Study|Declined survey|2|||
130250273|NCT03211832|468876926|FG000|Overall Study|Not available during data collection|1|||
130250274|NCT03211832|468876927|FG001|Overall Study|Not available during data collection|0|||
130250275|NCT03211832|468876928|FG002|Overall Study|Not available during data collection|2|||
130250276|NCT02489045|468876934|FG000|Overall Study|unable to collect usable data|53|||
130250277|NCT02489045|468876934|FG000|Follow-up|Lost to Follow-up|10|||
130250278|NCT03111732|468876939|FG000|Overall Study|Enrolled in different study|1|||
130250279|NCT03111732|468876939|FG000|Overall Study|Progressive disease|3|||
130250280|NCT03111732|468876939|FG000|Overall Study|Withdrawal by Subject|1|||
130250281|NCT02151604|468876941|FG000|Overall Study|Lost to Follow-up|3|||
130250282|NCT02151604|468876941|FG000|Overall Study|Withdrawal by Subject|2|||
130250283|NCT02151604|468876941|FG000|Overall Study|Physician Decision|3|||
130250284|NCT02151604|468876941|FG000|Overall Study|Death|1|||
130250285|NCT04495478|468876942|FG000|Overall Study|Withdrawal by Subject|0|||
130250286|NCT04495478|468876943|FG001|Overall Study|Withdrawal by Subject|0|||
130250287|NCT04495478|468876944|FG002|Overall Study|Withdrawal by Subject|0|||
130364735|NCT02761733|469304882|FG000|Overall Study|Cognitive Impairment|5|||
130250288|NCT04495478|468876945|FG003|Overall Study|Withdrawal by Subject|1|||
130250289|NCT04495478|468876946|FG004|Overall Study|Withdrawal by Subject|0|||
130250290|NCT04495478|468876947|FG005|Overall Study|Withdrawal by Subject|0|||
130364736|NCT02761733|469304883|FG001|Overall Study|Cognitive Impairment|0|||
130364737|NCT02761733|469304884|FG002|Overall Study|Cognitive Impairment|1|||
130364738|NCT02761733|469304885|FG003|Overall Study|Cognitive Impairment|0|||
130364739|NCT01986907|469304888|FG000|Overall Study|Adverse Event|11|||
130364740|NCT01986907|469304888|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
130364741|NCT01986907|469304888|FG000|Overall Study|Protocol Violation|4|||
130699778|NCT00640926|470524729|FG000|Overall Study|Withdrawal by Subject|1|||
130699779|NCT00640926|470524730|FG001|Overall Study|Withdrawal by Subject|0|||
130699780|NCT00640926|470524731|FG002|Overall Study|Withdrawal by Subject|1|||
130699781|NCT03922750|470524732|FG000|Overall Study|Unclassified|0|||
130699782|NCT03922750|470524733|FG001|Overall Study|Unclassified|0|||
130699783|NCT03922750|470524734|FG002|Overall Study|Unclassified|1|||
130250291|NCT04495478|468876948|FG006|Overall Study|Withdrawal by Subject|0|||
130250292|NCT04495478|468876942|FG000|Overall Study|Physician Decision|0|||
130250293|NCT04495478|468876943|FG001|Overall Study|Physician Decision|1|||
130250294|NCT04495478|468876944|FG002|Overall Study|Physician Decision|0|||
130250295|NCT04495478|468876945|FG003|Overall Study|Physician Decision|0|||
130250296|NCT04495478|468876946|FG004|Overall Study|Physician Decision|1|||
130250297|NCT04495478|468876947|FG005|Overall Study|Physician Decision|0|||
130250298|NCT04495478|468876948|FG006|Overall Study|Physician Decision|0|||
130250299|NCT03004183|468878815|FG000|Overall Study|Adverse Event|7|||
130250300|NCT03004183|468878815|FG000|Overall Study|Lost to Follow-up|1|||
130250301|NCT03004183|468878815|FG000|Overall Study|Physician Decision|40|||
130250302|NCT03004183|468878815|FG000|Overall Study|Withdrawal by Subject|1|||
130250303|NCT03004183|468878815|FG000|Overall Study|COVID-19|1|||
130250304|NCT02529488|468878816|FG000|Overall Study|Adverse Event|1|||
130250305|NCT02529488|468878816|FG000|Overall Study|Death|3|||
130250306|NCT02698787|468878817|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
130250307|NCT02698787|468878818|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
130364742|NCT01986907|469304888|FG000|Overall Study|Withdrawal by Subject|76|||
130364743|NCT01986907|469304888|FG000|Overall Study|Lost to Follow-up|38|||
130364744|NCT01986907|469304888|FG000|Overall Study|Death|9|||
130364745|NCT03576495|469304904|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
130364746|NCT03576495|469304905|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
130364747|NCT03608254|469304907|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
130364748|NCT03608254|469304907|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
130364749|NCT00239590|469304909|FG000|Randomized|Lost to Follow-up|0|||
130364750|NCT00239590|469304910|FG001|Randomized|Lost to Follow-up|1|||
130364751|NCT00239590|469304909|FG000|Randomized|Withdrawal by Subject|0|||
130364752|NCT00239590|469304910|FG001|Randomized|Withdrawal by Subject|1|||
130364753|NCT00239590|469304909|FG000|Completed Study Protocol|Adverse Event|1|||
130364754|NCT00239590|469304910|FG001|Completed Study Protocol|Adverse Event|1|||
130364755|NCT00239590|469304909|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
130364756|NCT00239590|469304910|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
130364757|NCT02362269|469304913|FG000|Overall Study|Moved|1|||
130364758|NCT02362269|469304914|FG001|Overall Study|Moved|0|||
130364759|NCT02362269|469304913|FG000|Overall Study|Lost to Follow-up|0|||
130364760|NCT02362269|469304914|FG001|Overall Study|Lost to Follow-up|6|||
130364761|NCT01903031|469304915|FG000|Overall Study|Not Able to Attend Clinic|1|||
130364762|NCT01903031|469304916|FG001|Overall Study|Not Able to Attend Clinic|1|||
130699784|NCT03922750|470524732|FG000|Overall Study|Adverse Event|0|||
130699785|NCT03922750|470524733|FG001|Overall Study|Adverse Event|1|||
130699786|NCT03922750|470524734|FG002|Overall Study|Adverse Event|0|||
130699787|NCT02985398|470524735|FG000|Overall Study|Adverse Event|1|||
130699788|NCT02985398|470524735|FG000|Overall Study|Lost to Follow-up|4|||
130699789|NCT02985398|470524735|FG000|Overall Study|Withdrawal by Subject|8|||
130699790|NCT02985398|470524735|FG000|Overall Study|Study Burden|9|||
130699791|NCT04164758|470524740|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
130699792|NCT04164758|470524741|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
130699793|NCT04164758|470524742|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
130699794|NCT04164758|470524740|FG000|Overall Study|Adverse Event|0|||
130699795|NCT04164758|470524741|FG001|Overall Study|Adverse Event|1|||
130699796|NCT04164758|470524742|FG002|Overall Study|Adverse Event|0|||
130699797|NCT01670097|470524743|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
130699798|NCT01670097|470524744|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
130699799|NCT01670097|470524743|FG000|Overall Study|Study burden|1|||
130699800|NCT01670097|470524744|FG001|Overall Study|Study burden|0|||
130699801|NCT01670097|470524743|FG000|Overall Study|COPD exacerbation|0|||
130699802|NCT01670097|470524744|FG001|Overall Study|COPD exacerbation|1|||
130699803|NCT01670097|470524743|FG000|Overall Study|Neutropenia|0|||
130699804|NCT01670097|470524744|FG001|Overall Study|Neutropenia|1|||
130699805|NCT01670097|470524743|FG000|Overall Study|Clinical deterioration|0|||
130699806|NCT01670097|470524744|FG001|Overall Study|Clinical deterioration|1|||
130250308|NCT02933151|468878827|FG000|Overall Study|Lost to Follow-up|19|||
130250309|NCT02933151|468878828|FG001|Overall Study|Lost to Follow-up|18|||
130250310|NCT02933151|468878827|FG000|Overall Study|Death|1732|||
130250311|NCT02933151|468878828|FG001|Overall Study|Death|1827|||
130250312|NCT02933151|468878827|FG000|Overall Study|Transplant|210|||
130364763|NCT01903031|469304917|FG002|Overall Study|Not Able to Attend Clinic|0|||
130364764|NCT01903031|469304915|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
130699807|NCT01670097|470524743|FG000|Overall Study|Disease progression|0|||
130699808|NCT01670097|470524744|FG001|Overall Study|Disease progression|1|||
130699809|NCT00697827|470524745|FG000|Overall Study|enrolled but not treated|2|||
130699810|NCT00697827|470524746|FG001|Overall Study|enrolled but not treated|1|||
130699811|NCT05665387|470524749|FG000|Overall Study|Withdrawal by Subject|1|||
130699812|NCT05665387|470524750|FG001|Overall Study|Withdrawal by Subject|0|||
130250313|NCT02933151|468878828|FG001|Overall Study|Transplant|278|||
130250314|NCT02933151|468878827|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
130250315|NCT02933151|468878828|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
130250316|NCT02933151|468878827|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
130250317|NCT02933151|468878828|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
130250318|NCT02933151|468878827|FG000|Overall Study|Recovered Kidney Function|47|||
130250319|NCT02933151|468878828|FG001|Overall Study|Recovered Kidney Function|29|||
130250320|NCT03048019|468878829|FG000|Overall Study|Adverse Event|1|||
130250321|NCT03048019|468878830|FG001|Overall Study|Adverse Event|0|||
130250322|NCT03400787|468878831|FG000|Overall Study|Lost to Follow-up|1|||
130250323|NCT03400787|468878832|FG001|Overall Study|Lost to Follow-up|0|||
130250324|NCT03400787|468878831|FG000|Overall Study|Death|1|||
130250325|NCT03400787|468878832|FG001|Overall Study|Death|0|||
130250326|NCT03400787|468878831|FG000|Overall Study|Protocol Violation|0|||
130250327|NCT03400787|468878832|FG001|Overall Study|Protocol Violation|2|||
130250328|NCT03400787|468878831|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
130250329|NCT03400787|468878832|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
130250330|NCT04432298|468878836|FG000|Overall Study|Other than specified|1|||
130250331|NCT04432298|468878837|FG001|Overall Study|Other than specified|0|||
130250332|NCT04432298|468878836|FG000|Overall Study|Lost to Follow-up|0|||
130250333|NCT04432298|468878837|FG001|Overall Study|Lost to Follow-up|1|||
130250334|NCT04432298|468878836|FG000|Overall Study|Death|3|||
130250335|NCT04432298|468878837|FG001|Overall Study|Death|2|||
130250336|NCT04432298|468878836|FG000|Overall Study|Withdrawal by Subject|2|||
130250337|NCT04432298|468878837|FG001|Overall Study|Withdrawal by Subject|0|||
130250338|NCT02451007|468878842|FG000|Overall Study|Withdrawal by Subject|4|||
130250339|NCT02451007|468878842|FG000|Overall Study|Adverse Event|1|||
130250340|NCT02451007|468878842|FG000|Overall Study|Disease Progression|2|||
130250341|NCT00348374|468878843|FG000|Overall Study|Adverse Event|1|||
130250342|NCT00348374|468878844|FG001|Overall Study|Adverse Event|4|||
130250343|NCT00348374|468878843|FG000|Overall Study|Lost to Follow-up|1|||
130250344|NCT00348374|468878844|FG001|Overall Study|Lost to Follow-up|3|||
130250345|NCT00348374|468878843|FG000|Overall Study|Withdrawal by Subject|5|||
130250346|NCT00348374|468878844|FG001|Overall Study|Withdrawal by Subject|5|||
130250347|NCT00348374|468878843|FG000|Overall Study|Other|11|||
130250348|NCT00348374|468878844|FG001|Overall Study|Other|12|||
130250349|NCT00348374|468878843|FG000|Overall Study|ongoing at date of cutoff|1|||
130250350|NCT00348374|468878844|FG001|Overall Study|ongoing at date of cutoff|1|||
130250351|NCT00348374|468878843|FG000|Overall Study|randomized but did not receive treatment|0|||
130250352|NCT00348374|468878844|FG001|Overall Study|randomized but did not receive treatment|7|||
130250353|NCT02070380|468878853|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
130250354|NCT02070380|468878854|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
130250355|NCT02070380|468878855|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
130250356|NCT02070380|468878856|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
130250357|NCT02070380|468878853|FG000|Second Injection|Image sets missing or technically inadeq|0|||
130250358|NCT02070380|468878854|FG001|Second Injection|Image sets missing or technically inadeq|1|||
130250359|NCT02070380|468878855|FG002|Second Injection|Image sets missing or technically inadeq|0|||
130250360|NCT02070380|468878856|FG003|Second Injection|Image sets missing or technically inadeq|0|||
130250361|NCT02070380|468878853|FG000|Second Injection|Protocol Violation|0|||
130250362|NCT02070380|468878854|FG001|Second Injection|Protocol Violation|1|||
130250363|NCT02070380|468878855|FG002|Second Injection|Protocol Violation|1|||
130250364|NCT02070380|468878856|FG003|Second Injection|Protocol Violation|5|||
130250365|NCT02105012|468878869|FG000|Overall Study|Withdrawal by Subject|11|||
130250366|NCT02105012|468878869|FG000|Overall Study|Protocol Specified Criteria|9|||
130250367|NCT02105012|468878869|FG000|Overall Study|Lost to Follow-up|4|||
130250368|NCT02105012|468878869|FG000|Overall Study|Protocol Violation|4|||
130553298|NCT03437278|469993550|FG001|Overall Study|Progressive disease|0|||
130553299|NCT03437278|469993551|FG002|Overall Study|Progressive disease|0|||
130553300|NCT03437278|469993549|FG000|Overall Study|Physician Decision|1|||
130553301|NCT03437278|469993550|FG001|Overall Study|Physician Decision|0|||
130553302|NCT03437278|469993551|FG002|Overall Study|Physician Decision|1|||
130553303|NCT02202551|469993552|FG000|Overall Study|Adverse Event|8|||
130699813|NCT05665387|470524751|FG002|Overall Study|Withdrawal by Subject|1|||
130699814|NCT03732833|470524754|FG000|Overall Study|Adverse Event|0|||
130250369|NCT02105012|468878869|FG000|Overall Study|Physician Decision|3|||
130250370|NCT02105012|468878869|FG000|Overall Study|Adverse Event|1|||
130250371|NCT02105012|468878869|FG000|Overall Study|Lack of Efficacy|1|||
130250372|NCT03436420|468878870|FG000|Overall Study|Lack of Efficacy|3|||
130250373|NCT01104870|468878873|FG000|Overall Study|Adverse Event|1|||
130250374|NCT01104870|468878874|FG001|Overall Study|Adverse Event|1|||
130250375|NCT01104870|468878875|FG002|Overall Study|Adverse Event|0|||
130250376|NCT01104870|468878873|FG000|Overall Study|Death|0|||
130250377|NCT01104870|468878874|FG001|Overall Study|Death|0|||
130250378|NCT01104870|468878875|FG002|Overall Study|Death|1|||
130250379|NCT01104870|468878873|FG000|Overall Study|Withdrawal by Subject|0|||
130553304|NCT02202551|469993553|FG001|Overall Study|Adverse Event|19|||
130553305|NCT02202551|469993554|FG002|Overall Study|Adverse Event|5|||
130553306|NCT02202551|469993555|FG003|Overall Study|Adverse Event|9|||
130699815|NCT03732833|470524755|FG001|Overall Study|Adverse Event|3|||
130250380|NCT01104870|468878874|FG001|Overall Study|Withdrawal by Subject|0|||
130250381|NCT01104870|468878875|FG002|Overall Study|Withdrawal by Subject|1|||
130250382|NCT04985682|468878876|FG000|Overall Study|Withdrawal by Subject|1|||
130250383|NCT00079781|468878888|FG000|Pre-implant Period|Withdrawal by Subject|2|||
130250384|NCT00079781|468878889|FG001|Pre-implant Period|Withdrawal by Subject|0|||
130250385|NCT00079781|468878890|FG002|Pre-implant Period|Withdrawal by Subject|0|||
130250386|NCT00079781|468878888|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
130250387|NCT00079781|468878889|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
130250388|NCT00079781|468878890|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
130250389|NCT00079781|468878888|FG000|Follow-up Period|Withdrawal by Subject|3|||
130250390|NCT00079781|468878889|FG001|Follow-up Period|Withdrawal by Subject|0|||
130250391|NCT00079781|468878890|FG002|Follow-up Period|Withdrawal by Subject|1|||
130250392|NCT00079781|468878888|FG000|Follow-up Period|Lost to Follow-up|1|||
130250393|NCT00079781|468878889|FG001|Follow-up Period|Lost to Follow-up|0|||
130250394|NCT00079781|468878890|FG002|Follow-up Period|Lost to Follow-up|0|||
130250395|NCT00079781|468878888|FG000|Follow-up Period|Death|0|||
130250396|NCT00079781|468878889|FG001|Follow-up Period|Death|0|||
130250397|NCT00079781|468878890|FG002|Follow-up Period|Death|1|||
130250398|NCT04641975|468878891|FG000|Overall Study|Protocol Violation|1|||
130250399|NCT04641975|468878892|FG001|Overall Study|Protocol Violation|2|||
130250400|NCT04641975|468878893|FG002|Overall Study|Protocol Violation|0|||
130250401|NCT04641975|468878894|FG003|Overall Study|Protocol Violation|0|||
130250402|NCT04641975|468878891|FG000|Overall Study|Adverse Event|0|||
130250403|NCT04641975|468878892|FG001|Overall Study|Adverse Event|0|||
130250404|NCT04641975|468878893|FG002|Overall Study|Adverse Event|1|||
130250405|NCT04641975|468878894|FG003|Overall Study|Adverse Event|1|||
130250406|NCT04641975|468878891|FG000|Overall Study|Withdrawal by Subject|1|||
130250407|NCT04641975|468878892|FG001|Overall Study|Withdrawal by Subject|0|||
130250408|NCT04641975|468878893|FG002|Overall Study|Withdrawal by Subject|0|||
130250409|NCT04641975|468878894|FG003|Overall Study|Withdrawal by Subject|0|||
130250410|NCT01259024|468878896|FG000|Overall Study|Physician Decision|1|||
130250411|NCT01657500|468878897|FG000|Overall Study|set impropperly matched|3|||
130250412|NCT01657500|468878898|FG001|Overall Study|set impropperly matched|3|||
130250413|NCT01657500|468878897|FG000|Overall Study|Lost to Follow-up|2|||
130250414|NCT01657500|468878898|FG001|Overall Study|Lost to Follow-up|2|||
130250415|NCT02067156|468878899|FG000|Overall Study|Lost to Follow-up|4|||
130250416|NCT03596983|468878900|FG000|Overall Study|Withdrawal by Subject|3|||
130250417|NCT04008069|468878901|FG000|Open-Label Period|Adverse Event|1|||
130250418|NCT04008069|468878902|FG001|Open-Label Period|Adverse Event|0|||
130250419|NCT04008069|468878903|FG002|Open-Label Period|Adverse Event|0|||
130250420|NCT04008069|468878901|FG000|Open-Label Period|Lack of Efficacy|4|||
130250421|NCT04008069|468878902|FG001|Open-Label Period|Lack of Efficacy|0|||
130250422|NCT04008069|468878903|FG002|Open-Label Period|Lack of Efficacy|0|||
130250423|NCT04008069|468878901|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
130250424|NCT04008069|468878902|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
130250425|NCT04008069|468878903|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
130250426|NCT04008069|468878901|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130250427|NCT04008069|468878902|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130250428|NCT04008069|468878903|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
130250429|NCT02134028|468878905|FG000|Overall Study|Lack of Efficacy|1|||
130250430|NCT02134028|468878906|FG001|Overall Study|Lack of Efficacy|0|||
130250431|NCT02134028|468878907|FG002|Overall Study|Lack of Efficacy|3|||
130250432|NCT02134028|468878908|FG003|Overall Study|Lack of Efficacy|2|||
130250433|NCT02134028|468878909|FG004|Overall Study|Lack of Efficacy|1|||
130250434|NCT02134028|468878910|FG005|Overall Study|Lack of Efficacy|2|||
130250435|NCT02134028|468878911|FG006|Overall Study|Lack of Efficacy|1|||
130250436|NCT02134028|468878912|FG007|Overall Study|Lack of Efficacy|0|||
130250437|NCT02134028|468878905|FG000|Overall Study|Poor compliance to protocol|1|||
130250438|NCT02134028|468878906|FG001|Overall Study|Poor compliance to protocol|1|||
130250439|NCT02134028|468878907|FG002|Overall Study|Poor compliance to protocol|3|||
130250440|NCT02134028|468878908|FG003|Overall Study|Poor compliance to protocol|7|||
130250441|NCT02134028|468878909|FG004|Overall Study|Poor compliance to protocol|1|||
130699816|NCT03732833|470524756|FG002|Overall Study|Adverse Event|1|||
130699817|NCT03732833|470524754|FG000|Overall Study|Withdrawal by Subject|11|||
130250442|NCT02134028|468878910|FG005|Overall Study|Poor compliance to protocol|1|||
130250443|NCT02134028|468878911|FG006|Overall Study|Poor compliance to protocol|0|||
130250444|NCT02134028|468878912|FG007|Overall Study|Poor compliance to protocol|0|||
130250445|NCT02134028|468878905|FG000|Overall Study|Other unspecified|4|||
130250446|NCT02134028|468878906|FG001|Overall Study|Other unspecified|22|||
130250447|NCT02134028|468878907|FG002|Overall Study|Other unspecified|33|||
130250448|NCT02134028|468878908|FG003|Overall Study|Other unspecified|64|||
130250449|NCT02134028|468878909|FG004|Overall Study|Other unspecified|8|||
130250450|NCT02134028|468878910|FG005|Overall Study|Other unspecified|6|||
130250451|NCT02134028|468878911|FG006|Overall Study|Other unspecified|2|||
130250452|NCT02134028|468878912|FG007|Overall Study|Other unspecified|1|||
130250453|NCT02134028|468878905|FG000|Overall Study|Adverse Event|3|||
130250454|NCT02134028|468878906|FG001|Overall Study|Adverse Event|19|||
130250455|NCT02134028|468878907|FG002|Overall Study|Adverse Event|13|||
130250456|NCT02134028|468878908|FG003|Overall Study|Adverse Event|32|||
130250457|NCT02134028|468878909|FG004|Overall Study|Adverse Event|4|||
130250458|NCT02134028|468878910|FG005|Overall Study|Adverse Event|5|||
130250459|NCT02134028|468878911|FG006|Overall Study|Adverse Event|1|||
130250460|NCT02134028|468878912|FG007|Overall Study|Adverse Event|2|||
130250461|NCT00819832|468878915|FG000|Overall Study|Sponsor Termination of Study|3|||
130250462|NCT00819832|468878916|FG001|Overall Study|Sponsor Termination of Study|0|||
130250463|NCT00819832|468878917|FG002|Overall Study|Sponsor Termination of Study|0|||
130250464|NCT00819832|468878918|FG003|Overall Study|Sponsor Termination of Study|0|||
130250465|NCT00819832|468878919|FG004|Overall Study|Sponsor Termination of Study|0|||
130250466|NCT00819832|468878920|FG005|Overall Study|Sponsor Termination of Study|0|||
130250467|NCT01452789|468878929|FG000|Overall Study|Withdrawal by Subject|3|||
130250468|NCT01452789|468878930|FG001|Overall Study|Withdrawal by Subject|2|||
130250469|NCT01340170|468878931|FG000|Overall Study|Lost to Follow-up|2|||
130250470|NCT01340170|468878932|FG001|Overall Study|Lost to Follow-up|4|||
130250471|NCT01340170|468878933|FG002|Overall Study|Lost to Follow-up|0|||
130250472|NCT01340170|468878931|FG000|Overall Study|Implant failure|1|||
130250473|NCT01340170|468878932|FG001|Overall Study|Implant failure|3|||
130250474|NCT01340170|468878933|FG002|Overall Study|Implant failure|0|||
130250475|NCT03878602|468878934|FG000|Overall Study|cord blood donation|7|||
130250476|NCT03878602|468878935|FG001|Overall Study|cord blood donation|1|||
130250477|NCT03878602|468878934|FG000|Overall Study|incomplete data collection|2|||
130250478|NCT03878602|468878935|FG001|Overall Study|incomplete data collection|0|||
130250479|NCT00066170|468878936|FG000|Overall Study|Adverse Event|2|||
130250480|NCT00066170|468878937|FG001|Overall Study|Adverse Event|4|||
130250481|NCT00066170|468878938|FG002|Overall Study|Adverse Event|1|||
130250482|NCT00066170|468878939|FG003|Overall Study|Adverse Event|7|||
130250483|NCT00066170|468878936|FG000|Overall Study|Serious Adverse Event|0|||
130250484|NCT00066170|468878937|FG001|Overall Study|Serious Adverse Event|0|||
130250485|NCT00066170|468878938|FG002|Overall Study|Serious Adverse Event|1|||
130250486|NCT00066170|468878939|FG003|Overall Study|Serious Adverse Event|1|||
130250487|NCT00066170|468878936|FG000|Overall Study|Lost to Follow-up|0|||
130250488|NCT00066170|468878937|FG001|Overall Study|Lost to Follow-up|1|||
130250489|NCT00066170|468878938|FG002|Overall Study|Lost to Follow-up|0|||
130250490|NCT00066170|468878939|FG003|Overall Study|Lost to Follow-up|0|||
130250491|NCT00066170|468878936|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
130250492|NCT00066170|468878937|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
130250493|NCT00066170|468878938|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
130250494|NCT00066170|468878939|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
130250495|NCT00066170|468878936|FG000|Overall Study|Protocol Violation|3|||
130250496|NCT00066170|468878937|FG001|Overall Study|Protocol Violation|0|||
130250497|NCT00066170|468878938|FG002|Overall Study|Protocol Violation|0|||
130250498|NCT00066170|468878939|FG003|Overall Study|Protocol Violation|0|||
130250499|NCT00066170|468878936|FG000|Overall Study|Other|1|||
130250500|NCT00066170|468878937|FG001|Overall Study|Other|5|||
130250501|NCT00066170|468878938|FG002|Overall Study|Other|2|||
130250502|NCT00066170|468878939|FG003|Overall Study|Other|0|||
130250503|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Adverse Event|14|||
130250504|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Adverse Event|27|||
130250505|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Adverse Event|60|||
130250506|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Adverse Event|0|||
130250507|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Adverse Event|0|||
130250508|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Pregnancy|0|||
130250509|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Pregnancy|7|||
130250510|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Pregnancy|9|||
130250511|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Pregnancy|0|||
130250512|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Pregnancy|0|||
130250513|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
130250514|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
130250515|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
130364765|NCT01903031|469304916|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
130364766|NCT01903031|469304917|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
130250516|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
130250517|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
130250518|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
130250519|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
130250520|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
130250521|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
130250522|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
130364767|NCT01903031|469304915|FG000|Overall Study|Adverse Event|0|||
130364768|NCT01903031|469304916|FG001|Overall Study|Adverse Event|1|||
130364769|NCT01903031|469304917|FG002|Overall Study|Adverse Event|0|||
130250523|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Death|1|||
130250524|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Death|2|||
130250525|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Death|2|||
130250526|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Death|0|||
130364770|NCT01903031|469304915|FG000|Overall Study|Withdrawal by Subject|0|||
130250527|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Death|0|||
130250528|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
130250529|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
130250530|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
130250531|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130250532|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130250533|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
130250534|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
130250535|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
130250536|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
130250537|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
130250538|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
130250539|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250540|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250541|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250542|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250543|NCT00098293|468878940|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250544|NCT00098293|468878941|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250545|NCT00098293|468878942|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
130250546|NCT00098293|468878943|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250547|NCT00098293|468878944|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250548|NCT00098293|468878940|FG000|Open-label (OL) Phase|Adverse Event|0|||
130250549|NCT00098293|468878941|FG001|Open-label (OL) Phase|Adverse Event|3|||
130250550|NCT00098293|468878942|FG002|Open-label (OL) Phase|Adverse Event|7|||
130250551|NCT00098293|468878943|FG003|Open-label (OL) Phase|Adverse Event|6|||
130250552|NCT00098293|468878944|FG004|Open-label (OL) Phase|Adverse Event|0|||
130250553|NCT00098293|468878940|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
130364771|NCT01903031|469304916|FG001|Overall Study|Withdrawal by Subject|1|||
130364772|NCT01903031|469304917|FG002|Overall Study|Withdrawal by Subject|1|||
130364773|NCT01903031|469304915|FG000|Overall Study|Protocol Violation|0|||
130250554|NCT00098293|468878941|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
130250555|NCT00098293|468878942|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
130250556|NCT00098293|468878943|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
130250557|NCT00098293|468878944|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
130364774|NCT01903031|469304916|FG001|Overall Study|Protocol Violation|0|||
130364775|NCT01903031|469304917|FG002|Overall Study|Protocol Violation|2|||
130250558|NCT00098293|468878940|FG000|Open-label (OL) Phase|Pregnancy|0|||
130250559|NCT00098293|468878941|FG001|Open-label (OL) Phase|Pregnancy|1|||
130250560|NCT00098293|468878942|FG002|Open-label (OL) Phase|Pregnancy|0|||
130250561|NCT00098293|468878943|FG003|Open-label (OL) Phase|Pregnancy|3|||
130250562|NCT00098293|468878944|FG004|Open-label (OL) Phase|Pregnancy|0|||
130250563|NCT00098293|468878940|FG000|Open-label (OL) Phase|Protocol Violation|0|||
130250564|NCT00098293|468878941|FG001|Open-label (OL) Phase|Protocol Violation|6|||
130250565|NCT00098293|468878942|FG002|Open-label (OL) Phase|Protocol Violation|13|||
130250566|NCT00098293|468878943|FG003|Open-label (OL) Phase|Protocol Violation|16|||
130250567|NCT00098293|468878944|FG004|Open-label (OL) Phase|Protocol Violation|0|||
130250568|NCT00098293|468878940|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
130250569|NCT00098293|468878941|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
130250570|NCT00098293|468878942|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
130250571|NCT00098293|468878943|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
130250572|NCT00098293|468878944|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
130250573|NCT00098293|468878940|FG000|Open-label (OL) Phase|Death|0|||
130250574|NCT00098293|468878941|FG001|Open-label (OL) Phase|Death|2|||
130250575|NCT00098293|468878942|FG002|Open-label (OL) Phase|Death|3|||
130250576|NCT00098293|468878943|FG003|Open-label (OL) Phase|Death|0|||
130250577|NCT00098293|468878944|FG004|Open-label (OL) Phase|Death|0|||
130250578|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Death|0|||
130250579|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Death|0|||
130250580|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Death|0|||
130250581|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Death|0|||
130250582|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Death|1|||
130250583|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250584|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250585|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250586|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250587|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
130250588|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250589|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250590|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250591|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250592|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
130250593|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Other|0|||
130364776|NCT01903031|469304915|FG000|Overall Study|Lost to Follow-up|0|||
130364777|NCT01903031|469304916|FG001|Overall Study|Lost to Follow-up|0|||
130364778|NCT01903031|469304917|FG002|Overall Study|Lost to Follow-up|1|||
130364779|NCT01903031|469304915|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
130364780|NCT01903031|469304916|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
130364781|NCT01903031|469304917|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
130364782|NCT00447005|469304918|FG000|Overall Study|Adverse Event|1|||
130364783|NCT00447005|469304918|FG000|Overall Study|Lack of Efficacy|11|||
130364784|NCT01484275|469304922|FG000|Overall Study|Study terminated by sponsor|28|||
130364785|NCT01484275|469304923|FG001|Overall Study|Study terminated by sponsor|32|||
130364786|NCT01484275|469304922|FG000|Overall Study|Other|10|||
130364787|NCT01484275|469304923|FG001|Overall Study|Other|0|||
130364788|NCT01484275|469304922|FG000|Overall Study|Death|3|||
130364789|NCT01484275|469304923|FG001|Overall Study|Death|4|||
130364790|NCT01484275|469304922|FG000|Overall Study|Withdrawal by Subject|1|||
130364791|NCT01484275|469304923|FG001|Overall Study|Withdrawal by Subject|5|||
130364792|NCT01484275|469304922|FG000|Overall Study|Lost to Follow-up|1|||
130364793|NCT01484275|469304923|FG001|Overall Study|Lost to Follow-up|1|||
130364794|NCT04154930|469304928|FG000|Overall Study|Withdrawal by Subject|15|||
130364795|NCT04154930|469304929|FG001|Overall Study|Withdrawal by Subject|6|||
130364796|NCT04154930|469304928|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
130364797|NCT04154930|469304929|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
130364798|NCT04154930|469304928|FG000|Overall Study|Lost to Follow-up|14|||
130364799|NCT04154930|469304929|FG001|Overall Study|Lost to Follow-up|6|||
130364800|NCT04154930|469304928|FG000|Overall Study|Other|6|||
130364801|NCT04154930|469304929|FG001|Overall Study|Other|0|||
130364802|NCT00722800|469304934|FG000|Overall Study|Withdrawal by Subject|1|||
130364803|NCT00722800|469304935|FG001|Overall Study|Withdrawal by Subject|0|||
130553307|NCT02202551|469993552|FG000|Overall Study|Death|3|||
130250594|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Other|0|||
130250595|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Other|0|||
130250596|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Other|0|||
130250597|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Other|22|||
130364804|NCT00722800|469304934|FG000|Overall Study|Physician Decision|1|||
130364805|NCT00722800|469304935|FG001|Overall Study|Physician Decision|0|||
130364806|NCT02130297|469304938|FG000|Overall Study|Lost to Follow-up|4|||
130364807|NCT00806351|469304952|FG000|Overall Study|Death|5|||
130250598|NCT01370642|468878945|FG000|Overall Study|Adverse Event|2|||
130364808|NCT00806351|469304953|FG001|Overall Study|Death|4|||
130364809|NCT00508755|469304958|FG000|Overall Study|Withdrawal by Subject|1|||
130452839|NCT04353037|469621695|FG001|Overall Study|Withdrawal by Subject|2|||
130452840|NCT04353037|469621696|FG002|Overall Study|Withdrawal by Subject|3|||
130452841|NCT04353037|469621697|FG003|Overall Study|Withdrawal by Subject|5|||
130452842|NCT04353037|469621694|FG000|Overall Study|Adverse Event|0|||
130452843|NCT04353037|469621695|FG001|Overall Study|Adverse Event|0|||
130452844|NCT04353037|469621696|FG002|Overall Study|Adverse Event|2|||
130452845|NCT04353037|469621697|FG003|Overall Study|Adverse Event|0|||
130452846|NCT04353037|469621694|FG000|Overall Study|Exposure Change|0|||
130452847|NCT04353037|469621695|FG001|Overall Study|Exposure Change|0|||
130452848|NCT04353037|469621696|FG002|Overall Study|Exposure Change|0|||
130452849|NCT04353037|469621697|FG003|Overall Study|Exposure Change|2|||
130250599|NCT01370642|468878946|FG001|Overall Study|Adverse Event|1|||
130250600|NCT01370642|468878947|FG002|Overall Study|Adverse Event|1|||
130250601|NCT01370642|468878945|FG000|Overall Study|Detectable HCV RNA|0|||
130250602|NCT01370642|468878946|FG001|Overall Study|Detectable HCV RNA|0|||
130250603|NCT01370642|468878947|FG002|Overall Study|Detectable HCV RNA|22|||
130250604|NCT01370642|468878945|FG000|Overall Study|Lost to Follow-up|0|||
130250605|NCT01370642|468878946|FG001|Overall Study|Lost to Follow-up|0|||
130250606|NCT01370642|468878947|FG002|Overall Study|Lost to Follow-up|1|||
130250607|NCT01370642|468878945|FG000|Overall Study|Physician Decision|4|||
130250608|NCT01370642|468878946|FG001|Overall Study|Physician Decision|1|||
130250609|NCT01370642|468878947|FG002|Overall Study|Physician Decision|2|||
130250610|NCT01370642|468878945|FG000|Overall Study|Withdrawal by Subject|2|||
130250611|NCT01370642|468878946|FG001|Overall Study|Withdrawal by Subject|4|||
130250612|NCT01370642|468878947|FG002|Overall Study|Withdrawal by Subject|3|||
130250613|NCT01796470|468878948|FG000|Overall Study|Adverse Event|4|||
130250614|NCT01796470|468878949|FG001|Overall Study|Adverse Event|2|||
130250615|NCT01796470|468878950|FG002|Overall Study|Adverse Event|2|||
130250616|NCT01796470|468878951|FG003|Overall Study|Adverse Event|1|||
130250617|NCT01796470|468878952|FG004|Overall Study|Adverse Event|3|||
130250618|NCT01796470|468878948|FG000|Overall Study|Death|2|||
130250619|NCT01796470|468878949|FG001|Overall Study|Death|0|||
130250620|NCT01796470|468878950|FG002|Overall Study|Death|0|||
130250621|NCT01796470|468878951|FG003|Overall Study|Death|0|||
130250622|NCT01796470|468878952|FG004|Overall Study|Death|1|||
130250623|NCT01796470|468878948|FG000|Overall Study|Initiated New Therapy|9|||
130250624|NCT01796470|468878949|FG001|Overall Study|Initiated New Therapy|0|||
130250625|NCT01796470|468878950|FG002|Overall Study|Initiated New Therapy|0|||
130250626|NCT01796470|468878951|FG003|Overall Study|Initiated New Therapy|0|||
130250627|NCT01796470|468878952|FG004|Overall Study|Initiated New Therapy|2|||
130250628|NCT01796470|468878948|FG000|Overall Study|Lost to Follow-up|0|||
130250629|NCT01796470|468878949|FG001|Overall Study|Lost to Follow-up|1|||
130250630|NCT01796470|468878950|FG002|Overall Study|Lost to Follow-up|0|||
130250631|NCT01796470|468878951|FG003|Overall Study|Lost to Follow-up|0|||
130250632|NCT01796470|468878952|FG004|Overall Study|Lost to Follow-up|0|||
130250633|NCT01796470|468878948|FG000|Overall Study|Physician Decision|5|||
130250634|NCT01796470|468878949|FG001|Overall Study|Physician Decision|4|||
130250635|NCT01796470|468878950|FG002|Overall Study|Physician Decision|1|||
130250636|NCT01796470|468878951|FG003|Overall Study|Physician Decision|0|||
130250637|NCT01796470|468878952|FG004|Overall Study|Physician Decision|1|||
130250638|NCT01796470|468878948|FG000|Overall Study|Progressive Disease|7|||
130250639|NCT01796470|468878949|FG001|Overall Study|Progressive Disease|7|||
130250640|NCT01796470|468878950|FG002|Overall Study|Progressive Disease|3|||
130250641|NCT01796470|468878951|FG003|Overall Study|Progressive Disease|2|||
130250642|NCT01796470|468878952|FG004|Overall Study|Progressive Disease|0|||
130250643|NCT01796470|468878948|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
130250644|NCT01796470|468878949|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
130250645|NCT01796470|468878950|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
130250646|NCT01796470|468878951|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
130250647|NCT01796470|468878952|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
130452850|NCT03710564|469621698|FG000|Overall Study|Study Terminated by Sponsor|104|||
130452851|NCT03710564|469621699|FG001|Overall Study|Study Terminated by Sponsor|55|||
130452852|NCT03710564|469621698|FG000|Overall Study|Withdrawal by Subject|57|||
130250648|NCT01796470|468878948|FG000|Overall Study|Withdrawal by Subject|7|||
130250649|NCT01796470|468878949|FG001|Overall Study|Withdrawal by Subject|0|||
130250650|NCT01796470|468878950|FG002|Overall Study|Withdrawal by Subject|0|||
130250651|NCT01796470|468878951|FG003|Overall Study|Withdrawal by Subject|0|||
130452853|NCT03710564|469621699|FG001|Overall Study|Withdrawal by Subject|25|||
130452854|NCT03710564|469621698|FG000|Overall Study|Death|10|||
130452855|NCT03710564|469621699|FG001|Overall Study|Death|4|||
130250652|NCT01796470|468878952|FG004|Overall Study|Withdrawal by Subject|1|||
130250653|NCT01927861|468878953|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
130250654|NCT01927861|468878954|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
130250655|NCT01927861|468878953|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
130250656|NCT01927861|468878954|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
130250657|NCT00987935|468878955|FG000|Overall Study|Progressive disease|3|||
130250658|NCT00987935|468878956|FG001|Overall Study|Progressive disease|2|||
130250659|NCT00987935|468878957|FG002|Overall Study|Progressive disease|3|||
130452856|NCT03710564|469621698|FG000|Overall Study|Lost to Follow-up|5|||
130250660|NCT00987935|468878958|FG003|Overall Study|Progressive disease|2|||
130250661|NCT00987935|468878959|FG004|Overall Study|Progressive disease|5|||
130250662|NCT00987935|468878960|FG005|Overall Study|Progressive disease|3|||
130250663|NCT00987935|468878961|FG006|Overall Study|Progressive disease|9|||
130250664|NCT00987935|468878962|FG007|Overall Study|Progressive disease|48|||
130250665|NCT00987935|468878963|FG008|Overall Study|Progressive disease|23|||
130250666|NCT00987935|468878955|FG000|Overall Study|Adverse Event|0|||
130250667|NCT00987935|468878956|FG001|Overall Study|Adverse Event|1|||
130250668|NCT00987935|468878957|FG002|Overall Study|Adverse Event|0|||
130250669|NCT00987935|468878958|FG003|Overall Study|Adverse Event|1|||
130250670|NCT00987935|468878959|FG004|Overall Study|Adverse Event|1|||
130250671|NCT00987935|468878960|FG005|Overall Study|Adverse Event|0|||
130250672|NCT00987935|468878961|FG006|Overall Study|Adverse Event|2|||
130250673|NCT00987935|468878962|FG007|Overall Study|Adverse Event|10|||
130250674|NCT00987935|468878963|FG008|Overall Study|Adverse Event|6|||
130250675|NCT00987935|468878955|FG000|Overall Study|Refused to continue taking trial med.|1|||
130250676|NCT00987935|468878956|FG001|Overall Study|Refused to continue taking trial med.|0|||
130250677|NCT00987935|468878957|FG002|Overall Study|Refused to continue taking trial med.|0|||
130250678|NCT00987935|468878958|FG003|Overall Study|Refused to continue taking trial med.|0|||
130250679|NCT00987935|468878959|FG004|Overall Study|Refused to continue taking trial med.|1|||
130250680|NCT00987935|468878960|FG005|Overall Study|Refused to continue taking trial med.|0|||
130250681|NCT00987935|468878961|FG006|Overall Study|Refused to continue taking trial med.|4|||
130250682|NCT00987935|468878962|FG007|Overall Study|Refused to continue taking trial med.|4|||
130250683|NCT00987935|468878963|FG008|Overall Study|Refused to continue taking trial med.|2|||
130250684|NCT00987935|468878955|FG000|Overall Study|Reason other than those specified above|0|||
130250685|NCT00987935|468878956|FG001|Overall Study|Reason other than those specified above|0|||
130250686|NCT00987935|468878957|FG002|Overall Study|Reason other than those specified above|0|||
130250687|NCT00987935|468878958|FG003|Overall Study|Reason other than those specified above|0|||
130250688|NCT00987935|468878959|FG004|Overall Study|Reason other than those specified above|0|||
130250689|NCT00987935|468878960|FG005|Overall Study|Reason other than those specified above|0|||
130250690|NCT00987935|468878961|FG006|Overall Study|Reason other than those specified above|0|||
130250691|NCT00987935|468878962|FG007|Overall Study|Reason other than those specified above|0|||
130250692|NCT00987935|468878963|FG008|Overall Study|Reason other than those specified above|1|||
130250693|NCT02176525|468878964|FG000|Overall Study|Adverse Event|0|||
130250694|NCT02176525|468878965|FG001|Overall Study|Adverse Event|0|||
130250695|NCT02176525|468878966|FG002|Overall Study|Adverse Event|0|||
130250696|NCT02176525|468878967|FG003|Overall Study|Adverse Event|1|||
130250697|NCT02176525|468878968|FG004|Overall Study|Adverse Event|1|||
130250698|NCT02176525|468878969|FG005|Overall Study|Adverse Event|0|||
130250699|NCT02176525|468878970|FG006|Overall Study|Adverse Event|1|||
130250700|NCT02176525|468878971|FG007|Overall Study|Adverse Event|0|||
130250701|NCT02176525|468878964|FG000|Overall Study|not treated|1|||
130250702|NCT02176525|468878965|FG001|Overall Study|not treated|0|||
130250703|NCT02176525|468878966|FG002|Overall Study|not treated|0|||
130250704|NCT02176525|468878967|FG003|Overall Study|not treated|0|||
130250705|NCT02176525|468878968|FG004|Overall Study|not treated|0|||
130250706|NCT02176525|468878969|FG005|Overall Study|not treated|1|||
130250707|NCT02176525|468878970|FG006|Overall Study|not treated|0|||
130250708|NCT02176525|468878971|FG007|Overall Study|not treated|0|||
130250709|NCT01905267|468878972|FG000|Overall Study|Physician Decision|2|||
130250710|NCT01905267|468878973|FG001|Overall Study|Physician Decision|2|||
130250711|NCT01608308|468878974|FG000|Overall Study|pretreatment medical and billing reasons|0|||
130250712|NCT01608308|468878975|FG001|Overall Study|pretreatment medical and billing reasons|2|||
130699818|NCT03732833|470524755|FG001|Overall Study|Withdrawal by Subject|13|||
130699819|NCT03732833|470524756|FG002|Overall Study|Withdrawal by Subject|8|||
130250713|NCT05652140|468878976|FG000|Overall Study|Lost to Follow-up|7|||
130250714|NCT05652140|468878977|FG001|Overall Study|Lost to Follow-up|16|||
130250715|NCT05652140|468878978|FG002|Overall Study|Lost to Follow-up|22|||
130250716|NCT05652140|468878979|FG003|Overall Study|Lost to Follow-up|31|||
130250717|NCT06048705|468878982|FG000|Overall Study|Physician Decision|1|||
130250718|NCT06048705|468878983|FG001|Overall Study|Physician Decision|0|||
130250719|NCT06048705|468878984|FG002|Overall Study|Physician Decision|0|||
130250720|NCT06048705|468878982|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130250721|NCT06048705|468878983|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130364810|NCT04439201|469304964|FG000|Overall Study|Ineligible|2|||
130364811|NCT04439201|469304964|FG000|Overall Study|Never start protocol therapy|1|||
130364812|NCT04439201|469304964|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
130364813|NCT04439201|469304964|FG000|Overall Study|Mutation status not confirmed|4|||
130364814|NCT04439201|469304964|FG000|Overall Study|Adverse Event|1|||
130364815|NCT04439201|469304964|FG000|Overall Study|Death|7|||
130364816|NCT04439201|469304964|FG000|Overall Study|Withdrawal by Subject|2|||
130364817|NCT04439201|469304964|FG000|Overall Study|Disease progression|20|||
130364818|NCT04439201|469304964|FG000|Overall Study|Alternative therapy|1|||
130364819|NCT04439201|469304964|FG000|Overall Study|Physician Decision|1|||
130364820|NCT03730012|469304965|FG000|Overall Study|Adverse Event|0|||
130364821|NCT03730012|469304966|FG001|Overall Study|Adverse Event|1|||
130250722|NCT06048705|468878984|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
130250723|NCT06048705|468878982|FG000|Overall Study|Death prior to lymphodepletion|0|||
130250724|NCT06048705|468878983|FG001|Overall Study|Death prior to lymphodepletion|0|||
130250725|NCT06048705|468878984|FG002|Overall Study|Death prior to lymphodepletion|1|||
130250726|NCT01016015|468878985|FG000|Overall Study|Not Treated|3|||
130250727|NCT01016015|468878985|FG000|Overall Study|Withdrawal by Subject|1|||
130250728|NCT01016015|468878985|FG000|Overall Study|Adverse Event|15|||
130250729|NCT04648241|468878986|FG000|Overall Study|Lost to Follow-up|1|||
130250730|NCT04648241|468878987|FG001|Overall Study|Lost to Follow-up|0|||
130250731|NCT02057666|468878988|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
130250732|NCT02057666|468878989|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
130250733|NCT02057666|468878988|FG000|Double Blind Treatment Period|Poor tolerability|7|||
130250734|NCT02057666|468878989|FG001|Double Blind Treatment Period|Poor tolerability|2|||
130250735|NCT02057666|468878988|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
130250736|NCT02057666|468878989|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
130250737|NCT02057666|468878988|FG000|Double Blind Treatment Period|Physician Decision|1|||
130250738|NCT02057666|468878989|FG001|Double Blind Treatment Period|Physician Decision|0|||
130250739|NCT02057666|468878988|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
130250740|NCT02057666|468878989|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
130250741|NCT02057666|468878988|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
130250742|NCT02057666|468878989|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
130250743|NCT02057666|468878988|FG000|Double Blind Treatment Period|Sponsor's request|70|||
130250744|NCT02057666|468878989|FG001|Double Blind Treatment Period|Sponsor's request|34|||
130250745|NCT02057666|468878988|FG000|Open-Label Treatment Period|Poor tolerability|0|||
130250746|NCT02057666|468878989|FG001|Open-Label Treatment Period|Poor tolerability|1|||
130250747|NCT02057666|468878988|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
130250748|NCT02057666|468878989|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
130250749|NCT02057666|468878988|FG000|Open-Label Treatment Period|Sponsor's request|0|||
130250750|NCT02057666|468878989|FG001|Open-Label Treatment Period|Sponsor's request|4|||
130250751|NCT00236197|468878994|FG000|Overall Study|Withdrawal by Subject|3|||
130250752|NCT00236197|468878995|FG001|Overall Study|Withdrawal by Subject|2|||
130250753|NCT00236197|468878994|FG000|Overall Study|Lost to Follow-up|1|||
130250754|NCT00236197|468878995|FG001|Overall Study|Lost to Follow-up|5|||
130250755|NCT00236197|468878994|FG000|Overall Study|Protocol Violation|0|||
130250756|NCT00236197|468878995|FG001|Overall Study|Protocol Violation|3|||
130250757|NCT00236197|468878994|FG000|Overall Study|Medication non-compliance|1|||
130250758|NCT00236197|468878995|FG001|Overall Study|Medication non-compliance|2|||
130250759|NCT00236197|468878994|FG000|Overall Study|Other|0|||
130250760|NCT00236197|468878995|FG001|Overall Study|Other|2|||
130250761|NCT01793129|468881076|FG000|Overall Study|Lost to Follow-up|3|||
130250762|NCT01793129|468881077|FG001|Overall Study|Lost to Follow-up|7|||
130250763|NCT01793129|468881076|FG000|Overall Study|Withdrawal by Subject|0|||
130250764|NCT01793129|468881077|FG001|Overall Study|Withdrawal by Subject|2|||
130250765|NCT01428713|468881080|FG000|Overall Study|Non-compliance|2|||
130250766|NCT01428713|468881081|FG001|Overall Study|Non-compliance|2|||
130250767|NCT01428713|468881080|FG000|Overall Study|Withdrawal by Subject|1|||
130250768|NCT01428713|468881081|FG001|Overall Study|Withdrawal by Subject|1|||
130250769|NCT01428713|468881080|FG000|Overall Study|Adverse Event|0|||
130250770|NCT01428713|468881081|FG001|Overall Study|Adverse Event|2|||
130364822|NCT03730012|469304965|FG000|Overall Study|Lack of Efficacy|1|||
130364823|NCT03730012|469304966|FG001|Overall Study|Lack of Efficacy|5|||
130364824|NCT03730012|469304965|FG000|Overall Study|Withdrawal by Subject|0|||
130364825|NCT03730012|469304966|FG001|Overall Study|Withdrawal by Subject|1|||
130364826|NCT03730012|469304965|FG000|Overall Study|Miscellaneous|2|||
130364827|NCT03730012|469304966|FG001|Overall Study|Miscellaneous|1|||
130364828|NCT04680052|469306755|FG000|Overall Study|Ongoing|244|||
130364829|NCT04680052|469306756|FG001|Overall Study|Ongoing|229|||
130364830|NCT04680052|469306757|FG002|Overall Study|Ongoing|39|||
130364831|NCT04680052|469306758|FG003|Overall Study|Ongoing|46|||
130364832|NCT04680052|469306755|FG000|Overall Study|Death|15|||
130364833|NCT04680052|469306756|FG001|Overall Study|Death|22|||
130364834|NCT04680052|469306757|FG002|Overall Study|Death|7|||
130250771|NCT00862277|468881082|FG000|Overall Study|Protocol Violation|1|||
130364835|NCT04680052|469306758|FG003|Overall Study|Death|1|||
130364836|NCT04680052|469306755|FG000|Overall Study|Lost to Follow-up|3|||
130250772|NCT00862277|468881083|FG001|Overall Study|Protocol Violation|2|||
130250773|NCT00862277|468881084|FG002|Overall Study|Protocol Violation|5|||
130250774|NCT01052428|468881085|FG000|Overall Study|Death|1|||
130250775|NCT01052428|468881086|FG001|Overall Study|Death|0|||
130250776|NCT01052428|468881085|FG000|Overall Study|Withdrawal by Subject|0|||
130250777|NCT01052428|468881086|FG001|Overall Study|Withdrawal by Subject|1|||
130250778|NCT00871000|468881087|FG000|Overall Study|Withdrawal by Subject|1|||
130364837|NCT04680052|469306756|FG001|Overall Study|Lost to Follow-up|2|||
130364838|NCT04680052|469306757|FG002|Overall Study|Lost to Follow-up|0|||
130364839|NCT04680052|469306758|FG003|Overall Study|Lost to Follow-up|1|||
130699820|NCT03732833|470524754|FG000|Overall Study|Lost to Follow-up|3|||
130699821|NCT03732833|470524755|FG001|Overall Study|Lost to Follow-up|5|||
130699822|NCT03732833|470524756|FG002|Overall Study|Lost to Follow-up|4|||
130699823|NCT03732833|470524754|FG000|Overall Study|Pregnancy|0|||
130699824|NCT03732833|470524755|FG001|Overall Study|Pregnancy|2|||
130250779|NCT00871000|468881088|FG001|Overall Study|Withdrawal by Subject|0|||
130250780|NCT00605657|468881090|FG000|Overall Study|Adverse Event|1|||
130250781|NCT00605657|468881090|FG000|Overall Study|Protocol Violation|1|||
130250782|NCT01034657|468881092|FG000|Core Phase|Withdrawal by Subject|1|||
130250783|NCT01034657|468881093|FG001|Core Phase|Withdrawal by Subject|0|||
130250784|NCT01034657|468881094|FG002|Core Phase|Withdrawal by Subject|0|||
130250785|NCT01034657|468881092|FG000|Core Phase|Lack of Efficacy|2|||
130250786|NCT01034657|468881093|FG001|Core Phase|Lack of Efficacy|0|||
130250787|NCT01034657|468881094|FG002|Core Phase|Lack of Efficacy|0|||
130250788|NCT01034657|468881092|FG000|Core Phase|Abnormal laboratory value|1|||
130250789|NCT01034657|468881093|FG001|Core Phase|Abnormal laboratory value|0|||
130250790|NCT01034657|468881094|FG002|Core Phase|Abnormal laboratory value|0|||
130250791|NCT01034657|468881092|FG000|Core Phase|Adverse Event|8|||
130250792|NCT01034657|468881093|FG001|Core Phase|Adverse Event|0|||
130250793|NCT01034657|468881094|FG002|Core Phase|Adverse Event|0|||
130250794|NCT01034657|468881092|FG000|Core Phase|Protocol Violation|2|||
130250795|NCT01034657|468881093|FG001|Core Phase|Protocol Violation|0|||
130250796|NCT01034657|468881094|FG002|Core Phase|Protocol Violation|0|||
130250797|NCT01034657|468881092|FG000|Randomized Phase|Withdrawal by Subject|0|||
130250798|NCT01034657|468881093|FG001|Randomized Phase|Withdrawal by Subject|2|||
130250799|NCT01034657|468881094|FG002|Randomized Phase|Withdrawal by Subject|0|||
130250800|NCT01034657|468881092|FG000|Randomized Phase|Lack of Efficacy|5|||
130250801|NCT01034657|468881093|FG001|Randomized Phase|Lack of Efficacy|1|||
130250802|NCT01034657|468881094|FG002|Randomized Phase|Lack of Efficacy|0|||
130452857|NCT03710564|469621699|FG001|Overall Study|Lost to Follow-up|4|||
130452858|NCT03710564|469621698|FG000|Overall Study|Protocol Violation|3|||
130452859|NCT03710564|469621699|FG001|Overall Study|Protocol Violation|2|||
130452860|NCT03710564|469621698|FG000|Overall Study|Adverse Event|3|||
130452861|NCT03710564|469621699|FG001|Overall Study|Adverse Event|0|||
130452862|NCT03710564|469621698|FG000|Overall Study|Physician Decision|2|||
130452863|NCT03710564|469621699|FG001|Overall Study|Physician Decision|3|||
130452864|NCT00003656|469621700|FG000|Overall Study|Adverse Event|0|||
130452865|NCT00003656|469621701|FG001|Overall Study|Adverse Event|1|||
130452866|NCT01941316|469621702|FG000|Overall Study|Adverse Event|0|||
130452867|NCT01941316|469621703|FG001|Overall Study|Adverse Event|1|||
130452868|NCT01941316|469621704|FG002|Overall Study|Adverse Event|0|||
130452869|NCT01941316|469621705|FG003|Overall Study|Adverse Event|7|||
130452870|NCT01941316|469621702|FG000|Overall Study|Progressive Disease|3|||
130452871|NCT01941316|469621703|FG001|Overall Study|Progressive Disease|6|||
130452872|NCT01941316|469621704|FG002|Overall Study|Progressive Disease|2|||
130452873|NCT01941316|469621705|FG003|Overall Study|Progressive Disease|29|||
130452874|NCT01941316|469621702|FG000|Overall Study|Withdrawal by Subject|0|||
130452875|NCT01941316|469621703|FG001|Overall Study|Withdrawal by Subject|2|||
130452876|NCT01941316|469621704|FG002|Overall Study|Withdrawal by Subject|1|||
130452877|NCT01941316|469621705|FG003|Overall Study|Withdrawal by Subject|8|||
130452878|NCT01941316|469621702|FG000|Overall Study|Death|0|||
130452879|NCT01941316|469621703|FG001|Overall Study|Death|0|||
130452880|NCT01941316|469621704|FG002|Overall Study|Death|0|||
130452881|NCT01941316|469621705|FG003|Overall Study|Death|3|||
130452882|NCT01941316|469621702|FG000|Overall Study|Physician Decision|0|||
130452883|NCT01941316|469621703|FG001|Overall Study|Physician Decision|0|||
130452884|NCT01941316|469621704|FG002|Overall Study|Physician Decision|0|||
130452885|NCT01941316|469621705|FG003|Overall Study|Physician Decision|3|||
130452886|NCT01941316|469621702|FG000|Overall Study|Protocol Violation|0|||
130250803|NCT01034657|468881092|FG000|Randomized Phase|Abnormal laboratory value|0|||
130452887|NCT01941316|469621703|FG001|Overall Study|Protocol Violation|0|||
130699825|NCT03732833|470524756|FG002|Overall Study|Pregnancy|0|||
130250804|NCT01034657|468881093|FG001|Randomized Phase|Abnormal laboratory value|1|||
130250805|NCT01034657|468881094|FG002|Randomized Phase|Abnormal laboratory value|0|||
130250806|NCT01034657|468881092|FG000|Randomized Phase|Adverse Event|0|||
130250807|NCT01034657|468881093|FG001|Randomized Phase|Adverse Event|2|||
130250808|NCT01034657|468881094|FG002|Randomized Phase|Adverse Event|1|||
130250809|NCT01791205|468881095|FG000|Phase II|Lack of Efficacy|6|||
130250810|NCT01791205|468881096|FG001|Phase II|Lack of Efficacy|0|||
130452888|NCT01941316|469621704|FG002|Overall Study|Protocol Violation|0|||
130452889|NCT01941316|469621705|FG003|Overall Study|Protocol Violation|3|||
130452890|NCT01941316|469621702|FG000|Overall Study|Intercurrent illness|0|||
130452891|NCT01941316|469621703|FG001|Overall Study|Intercurrent illness|0|||
130452892|NCT01941316|469621704|FG002|Overall Study|Intercurrent illness|0|||
130452893|NCT01941316|469621705|FG003|Overall Study|Intercurrent illness|1|||
130452894|NCT01941316|469621702|FG000|Overall Study|Other, not specified|0|||
130699826|NCT03732833|470524754|FG000|Overall Study|Physician Decision|2|||
130699827|NCT03732833|470524755|FG001|Overall Study|Physician Decision|3|||
130250811|NCT01791205|468881095|FG000|Phase II|Adverse Event|2|||
130452895|NCT01941316|469621703|FG001|Overall Study|Other, not specified|0|||
130250812|NCT01791205|468881096|FG001|Phase II|Adverse Event|0|||
130250813|NCT01791205|468881095|FG000|Phase II|Safety|1|||
130250814|NCT01791205|468881096|FG001|Phase II|Safety|0|||
130250815|NCT01791205|468881095|FG000|Phase II|Lost to Follow-up|1|||
130250816|NCT01791205|468881096|FG001|Phase II|Lost to Follow-up|0|||
130250817|NCT01791205|468881095|FG000|Phase II|Remission of disease|1|||
130250818|NCT01791205|468881096|FG001|Phase II|Remission of disease|0|||
130250819|NCT01791205|468881095|FG000|Phase II|Physician's decision|1|||
130553308|NCT02202551|469993553|FG001|Overall Study|Death|2|||
130699828|NCT03732833|470524756|FG002|Overall Study|Physician Decision|1|||
130699829|NCT03732833|470524754|FG000|Overall Study|Covid-19 related and other reasons|2|||
130699830|NCT03732833|470524755|FG001|Overall Study|Covid-19 related and other reasons|7|||
130699831|NCT03732833|470524756|FG002|Overall Study|Covid-19 related and other reasons|3|||
130699832|NCT00550147|470524757|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
130699833|NCT00550147|470524757|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
130699834|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
130699835|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
130699836|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
130699837|NCT02311894|470524759|FG000|Overall Study|Discontinued in error|1|||
130699838|NCT02311894|470524759|FG000|Overall Study|Lost to Follow-up|1|||
130699839|NCT02311894|470524759|FG000|Overall Study|Adverse Event|1|||
130699840|NCT02311894|470524759|FG000|Overall Study|Withdrawal by Subject|1|||
130699841|NCT00751023|470524760|FG000|Overall Study|Lost to Follow-up|11|||
130699842|NCT00751023|470524761|FG001|Overall Study|Lost to Follow-up|7|||
130699843|NCT02616380|470524764|FG000|Overall Study|Lost to Follow-up|1|||
130699844|NCT02616380|470524764|FG000|Overall Study|Other|2|||
130699845|NCT03407729|470524765|FG000|Overall Study|Lost to Follow-up|2|||
130699846|NCT03407729|470524766|FG001|Overall Study|Lost to Follow-up|0|||
130699847|NCT03407729|470524765|FG000|Overall Study|Unable to schedule|0|||
130699848|NCT03407729|470524766|FG001|Overall Study|Unable to schedule|3|||
130699849|NCT03950674|470524767|FG000|Overall Study|Death|16|||
130699850|NCT03950674|470524768|FG001|Overall Study|Death|15|||
130699851|NCT03950674|470524767|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
130699852|NCT03950674|470524768|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
130699853|NCT00609154|470524771|FG000|Overall Study|Protocol Violation|1|||
130699854|NCT00609154|470524772|FG001|Overall Study|Protocol Violation|2|||
130699855|NCT00609154|470524771|FG000|Overall Study|Unable to establish IV access|0|||
130699856|NCT00609154|470524772|FG001|Overall Study|Unable to establish IV access|4|||
130699857|NCT00609154|470524771|FG000|Overall Study|Adverse Event|0|||
130699858|NCT00609154|470524772|FG001|Overall Study|Adverse Event|2|||
130699859|NCT03833427|470524773|FG000|Overall Study|Death|4|||
130699860|NCT03833427|470524774|FG001|Overall Study|Death|2|||
130699861|NCT03833427|470524775|FG002|Overall Study|Death|9|||
130699862|NCT03833427|470524776|FG003|Overall Study|Death|11|||
130699863|NCT03833427|470524777|FG004|Overall Study|Death|0|||
130699864|NCT03833427|470524778|FG005|Overall Study|Death|0|||
130699865|NCT03833427|470524779|FG006|Overall Study|Death|0|||
130699866|NCT03833427|470524773|FG000|Overall Study|Withdrawal by Subject|0|||
130699867|NCT03833427|470524774|FG001|Overall Study|Withdrawal by Subject|1|||
130699868|NCT03833427|470524775|FG002|Overall Study|Withdrawal by Subject|1|||
130699869|NCT03833427|470524776|FG003|Overall Study|Withdrawal by Subject|0|||
130699870|NCT03833427|470524777|FG004|Overall Study|Withdrawal by Subject|0|||
130699871|NCT03833427|470524778|FG005|Overall Study|Withdrawal by Subject|0|||
130699872|NCT03833427|470524779|FG006|Overall Study|Withdrawal by Subject|0|||
130699873|NCT03833427|470524773|FG000|Overall Study|Sponsor Decision|0|||
130699874|NCT03833427|470524774|FG001|Overall Study|Sponsor Decision|0|||
130699875|NCT03833427|470524775|FG002|Overall Study|Sponsor Decision|1|||
130699876|NCT03833427|470524776|FG003|Overall Study|Sponsor Decision|3|||
130699877|NCT03833427|470524777|FG004|Overall Study|Sponsor Decision|0|||
130699878|NCT03833427|470524778|FG005|Overall Study|Sponsor Decision|0|||
130699879|NCT03833427|470524779|FG006|Overall Study|Sponsor Decision|0|||
130699880|NCT01499160|470524784|FG000|Overall Study|Adverse Event|1|||
130699881|NCT01499160|470524784|FG000|Overall Study|Withdrawal by Subject|1|||
130699882|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
130699883|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
130699884|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
130699885|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
130699886|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
130699887|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
130699888|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
130699889|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
130699890|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
130250820|NCT01791205|468881096|FG001|Phase II|Physician's decision|0|||
130364840|NCT04680052|469306755|FG000|Overall Study|Withdrawal by Subject|11|||
130250821|NCT02242903|468881107|FG000|Overall Study|Withdrawal by Subject|1|||
130250822|NCT02242903|468881108|FG001|Overall Study|Withdrawal by Subject|0|||
130250823|NCT02242903|468881109|FG002|Overall Study|Withdrawal by Subject|0|||
130250824|NCT02242903|468881110|FG003|Overall Study|Withdrawal by Subject|0|||
130250825|NCT02242903|468881111|FG004|Overall Study|Withdrawal by Subject|0|||
130250826|NCT02242903|468881112|FG005|Overall Study|Withdrawal by Subject|0|||
130250827|NCT02242903|468881113|FG006|Overall Study|Withdrawal by Subject|0|||
130250830|NCT03473301|468881122|FG000|Overall Study|Protocol Violation|4|||
130250831|NCT03473301|468881123|FG001|Overall Study|Protocol Violation|0|||
130250832|NCT03473301|468881124|FG002|Overall Study|Protocol Violation|0|||
130250833|NCT03473301|468881122|FG000|Overall Study|Withdrawal by Subject|0|||
130250834|NCT03473301|468881123|FG001|Overall Study|Withdrawal by Subject|1|||
130250835|NCT03473301|468881124|FG002|Overall Study|Withdrawal by Subject|0|||
130250836|NCT03473301|468881122|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
130250837|NCT03473301|468881123|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
130250838|NCT03473301|468881124|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
130250839|NCT05287685|468881125|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
130250840|NCT05287685|468881126|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
130250841|NCT05287685|468881125|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
130250842|NCT05287685|468881126|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
130250843|NCT04135352|468881127|FG000|Overall Study|Not treated-randomization error|0|||
130250844|NCT04135352|468881128|FG001|Overall Study|Not treated-randomization error|0|||
130250845|NCT04135352|468881129|FG002|Overall Study|Not treated-randomization error|1|||
130250846|NCT04135352|468881130|FG003|Overall Study|Not treated-randomization error|0|||
130250847|NCT04135352|468881131|FG004|Overall Study|Not treated-randomization error|0|||
130250848|NCT04135352|468881132|FG005|Overall Study|Not treated-randomization error|0|||
130250849|NCT04135352|468881133|FG006|Overall Study|Not treated-randomization error|0|||
130250850|NCT04135352|468881134|FG007|Overall Study|Not treated-randomization error|0|||
130250851|NCT04135352|468881127|FG000|Overall Study|Withdrawal by Subject|0|||
130250852|NCT04135352|468881128|FG001|Overall Study|Withdrawal by Subject|0|||
130250853|NCT04135352|468881129|FG002|Overall Study|Withdrawal by Subject|2|||
130250854|NCT04135352|468881130|FG003|Overall Study|Withdrawal by Subject|0|||
130250855|NCT04135352|468881131|FG004|Overall Study|Withdrawal by Subject|0|||
130250856|NCT04135352|468881132|FG005|Overall Study|Withdrawal by Subject|0|||
130250857|NCT04135352|468881133|FG006|Overall Study|Withdrawal by Subject|0|||
130250858|NCT04135352|468881134|FG007|Overall Study|Withdrawal by Subject|0|||
130250859|NCT04135352|468881127|FG000|Overall Study|Sponsor Decision|0|||
130250860|NCT04135352|468881128|FG001|Overall Study|Sponsor Decision|0|||
130250861|NCT04135352|468881129|FG002|Overall Study|Sponsor Decision|2|||
130250862|NCT04135352|468881130|FG003|Overall Study|Sponsor Decision|5|||
130250863|NCT04135352|468881131|FG004|Overall Study|Sponsor Decision|1|||
130250864|NCT04135352|468881132|FG005|Overall Study|Sponsor Decision|4|||
130250865|NCT04135352|468881133|FG006|Overall Study|Sponsor Decision|0|||
130250866|NCT04135352|468881134|FG007|Overall Study|Sponsor Decision|0|||
130250867|NCT04135352|468881127|FG000|Overall Study|Physician Decision|0|||
130250868|NCT04135352|468881128|FG001|Overall Study|Physician Decision|0|||
130250869|NCT04135352|468881129|FG002|Overall Study|Physician Decision|1|||
130250870|NCT04135352|468881130|FG003|Overall Study|Physician Decision|0|||
130250871|NCT04135352|468881131|FG004|Overall Study|Physician Decision|1|||
130250872|NCT04135352|468881132|FG005|Overall Study|Physician Decision|0|||
130250873|NCT04135352|468881133|FG006|Overall Study|Physician Decision|0|||
130250874|NCT04135352|468881134|FG007|Overall Study|Physician Decision|0|||
130250875|NCT04135352|468881127|FG000|Overall Study|Death|3|||
130250876|NCT04135352|468881128|FG001|Overall Study|Death|4|||
130250877|NCT04135352|468881129|FG002|Overall Study|Death|7|||
130250878|NCT04135352|468881130|FG003|Overall Study|Death|0|||
130250879|NCT04135352|468881131|FG004|Overall Study|Death|3|||
130250880|NCT04135352|468881132|FG005|Overall Study|Death|1|||
130250881|NCT04135352|468881133|FG006|Overall Study|Death|0|||
130250882|NCT04135352|468881134|FG007|Overall Study|Death|0|||
130250883|NCT03093870|468881135|FG000|Overall Study|Withdrawal by Subject|2|||
130250884|NCT03093870|468881136|FG001|Overall Study|Withdrawal by Subject|6|||
130553309|NCT02202551|469993554|FG002|Overall Study|Death|1|||
130699891|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
130699892|NCT00593827|470524788|FG000|Overall Study|On Active Treatment/Pending|0|||
130699893|NCT00593827|470524789|FG001|Overall Study|On Active Treatment/Pending|2|||
130699894|NCT00663234|470524790|FG000|Overall Study|Not willing to adhere to requirements|1|||
130250885|NCT03093870|468881137|FG002|Overall Study|Withdrawal by Subject|5|||
130250886|NCT03093870|468881135|FG000|Overall Study|Death|1|||
130250887|NCT03093870|468881136|FG001|Overall Study|Death|35|||
130250888|NCT03093870|468881137|FG002|Overall Study|Death|35|||
130250889|NCT03093870|468881135|FG000|Overall Study|Radiographic disease progression|10|||
130250890|NCT03093870|468881136|FG001|Overall Study|Radiographic disease progression|0|||
130250891|NCT03093870|468881137|FG002|Overall Study|Radiographic disease progression|0|||
130250892|NCT03093870|468881135|FG000|Overall Study|Clinical disease progression|1|||
130250893|NCT03093870|468881136|FG001|Overall Study|Clinical disease progression|0|||
130250894|NCT03093870|468881137|FG002|Overall Study|Clinical disease progression|0|||
130250895|NCT03093870|468881135|FG000|Overall Study|Physician Decision|2|||
130250896|NCT03093870|468881136|FG001|Overall Study|Physician Decision|0|||
130250897|NCT03093870|468881137|FG002|Overall Study|Physician Decision|0|||
130250898|NCT03093870|468881135|FG000|Overall Study|Adverse Event|7|||
130250899|NCT03093870|468881136|FG001|Overall Study|Adverse Event|0|||
130250900|NCT03093870|468881137|FG002|Overall Study|Adverse Event|0|||
130250901|NCT03093870|468881135|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
130250902|NCT03093870|468881136|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130250903|NCT03093870|468881137|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130250904|NCT03093870|468881135|FG000|Overall Study|Lost to Follow-up|0|||
130250905|NCT03093870|468881136|FG001|Overall Study|Lost to Follow-up|0|||
130250906|NCT03093870|468881137|FG002|Overall Study|Lost to Follow-up|1|||
130250907|NCT03722030|468881143|FG000|Overall Study|Withdrawal by Subject|1|||
130250908|NCT03722030|468881144|FG001|Overall Study|Withdrawal by Subject|0|||
130250909|NCT02191397|468881146|FG000|Overall Study|Adverse Event|28|||
130250910|NCT02191397|468881147|FG001|Overall Study|Adverse Event|17|||
130250911|NCT02191397|468881146|FG000|Overall Study|Lack of Efficacy|10|||
130250912|NCT02191397|468881147|FG001|Overall Study|Lack of Efficacy|5|||
130250913|NCT02191397|468881146|FG000|Overall Study|Protocol Violation|0|||
130250914|NCT02191397|468881147|FG001|Overall Study|Protocol Violation|3|||
130250915|NCT02191397|468881146|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
130250916|NCT02191397|468881147|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
130250917|NCT02191397|468881146|FG000|Overall Study|Lost to Follow-up|10|||
130250918|NCT02191397|468881147|FG001|Overall Study|Lost to Follow-up|11|||
130250919|NCT02191397|468881146|FG000|Overall Study|Physician Decision|8|||
130250920|NCT02191397|468881147|FG001|Overall Study|Physician Decision|3|||
130250921|NCT02191397|468881146|FG000|Overall Study|Withdrawal by Subject|22|||
130250922|NCT02191397|468881147|FG001|Overall Study|Withdrawal by Subject|27|||
130250923|NCT03721107|468881148|FG000|Overall Study|Adverse Event|1|||
130250924|NCT03721107|468881149|FG001|Overall Study|Adverse Event|1|||
130250925|NCT03721107|468881150|FG002|Overall Study|Adverse Event|6|||
130250926|NCT03721107|468881151|FG003|Overall Study|Adverse Event|5|||
130250927|NCT03721107|468881148|FG000|Overall Study|Lost to Follow-up|2|||
130250928|NCT03721107|468881149|FG001|Overall Study|Lost to Follow-up|0|||
130250929|NCT03721107|468881150|FG002|Overall Study|Lost to Follow-up|3|||
130250930|NCT03721107|468881151|FG003|Overall Study|Lost to Follow-up|0|||
130250931|NCT03721107|468881148|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250932|NCT03721107|468881149|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250933|NCT03721107|468881150|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250934|NCT03721107|468881151|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
130250935|NCT03721107|468881148|FG000|Overall Study|Physician Decision|0|||
130250936|NCT03721107|468881149|FG001|Overall Study|Physician Decision|1|||
130250937|NCT03721107|468881150|FG002|Overall Study|Physician Decision|0|||
130250938|NCT03721107|468881151|FG003|Overall Study|Physician Decision|0|||
130250939|NCT03721107|468881148|FG000|Overall Study|Pregnancy|0|||
130250940|NCT03721107|468881149|FG001|Overall Study|Pregnancy|0|||
130250941|NCT03721107|468881150|FG002|Overall Study|Pregnancy|1|||
130250942|NCT03721107|468881151|FG003|Overall Study|Pregnancy|0|||
130250943|NCT03721107|468881148|FG000|Overall Study|Withdrawal by Subject|1|||
130250944|NCT03721107|468881149|FG001|Overall Study|Withdrawal by Subject|1|||
130250945|NCT03721107|468881150|FG002|Overall Study|Withdrawal by Subject|5|||
130250946|NCT03721107|468881151|FG003|Overall Study|Withdrawal by Subject|5|||
130250947|NCT03721107|468881148|FG000|Overall Study|Other|1|||
130250948|NCT03721107|468881149|FG001|Overall Study|Other|0|||
130250949|NCT03721107|468881150|FG002|Overall Study|Other|0|||
130250950|NCT03721107|468881151|FG003|Overall Study|Other|1|||
130250951|NCT03888482|468881152|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
130250952|NCT03888482|468881153|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
130250953|NCT03888482|468881152|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
130250954|NCT03888482|468881153|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
130250955|NCT02554474|468881154|FG000|Overall Study|Protocol Violation|1|||
130250956|NCT02554474|468881155|FG001|Overall Study|Protocol Violation|1|||
130250957|NCT02554474|468881154|FG000|Overall Study|Health issue not related to the study|1|||
130250958|NCT02554474|468881155|FG001|Overall Study|Health issue not related to the study|0|||
130452896|NCT01941316|469621704|FG002|Overall Study|Other, not specified|0|||
130699895|NCT01709903|470524793|FG000|Overall Study|administrative problems|2|||
130699896|NCT01709903|470524794|FG001|Overall Study|administrative problems|6|||
130699897|NCT01709903|470524793|FG000|Overall Study|Abnormal test procedure results|1|||
130699898|NCT01709903|470524794|FG001|Overall Study|Abnormal test procedure results|0|||
130699899|NCT01709903|470524793|FG000|Overall Study|In ability to use device|1|||
130699900|NCT01709903|470524794|FG001|Overall Study|In ability to use device|1|||
130699901|NCT01709903|470524793|FG000|Overall Study|no longer needed study drug|0|||
130699902|NCT01709903|470524794|FG001|Overall Study|no longer needed study drug|1|||
130699903|NCT01709903|470524793|FG000|Overall Study|Lost to Follow-up|0|||
130699904|NCT01709903|470524794|FG001|Overall Study|Lost to Follow-up|2|||
130699905|NCT01709903|470524793|FG000|Overall Study|Death|2|||
130699906|NCT01709903|470524794|FG001|Overall Study|Death|0|||
130699907|NCT01709903|470524793|FG000|Overall Study|Protocol Violation|3|||
130699908|NCT01709903|470524794|FG001|Overall Study|Protocol Violation|2|||
130250959|NCT02554474|468881154|FG000|Overall Study|Withdrawal by Subject|1|||
130250960|NCT02554474|468881155|FG001|Overall Study|Withdrawal by Subject|1|||
130250961|NCT02991859|468881156|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250962|NCT02991859|468881157|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130250963|NCT02991859|468881158|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130553310|NCT02202551|469993555|FG003|Overall Study|Death|1|||
130699909|NCT01709903|470524793|FG000|Overall Study|Lack of Efficacy|3|||
130250964|NCT02991859|468881159|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250965|NCT02991859|468881160|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130250966|NCT02991859|468881161|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250967|NCT02991859|468881162|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250968|NCT02991859|468881163|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250969|NCT02991859|468881164|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250970|NCT02991859|468881165|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250971|NCT02991859|468881166|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250972|NCT02991859|468881167|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250973|NCT02991859|468881168|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250974|NCT02991859|468881169|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250975|NCT02991859|468881170|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250976|NCT02991859|468881171|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250977|NCT02991859|468881172|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250978|NCT02991859|468881156|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250979|NCT02991859|468881157|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250980|NCT02991859|468881158|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250981|NCT02991859|468881159|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250982|NCT02991859|468881160|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250983|NCT02991859|468881161|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250984|NCT02991859|468881162|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250985|NCT02991859|468881163|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250986|NCT02991859|468881164|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250987|NCT02991859|468881165|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250988|NCT02991859|468881166|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250989|NCT02991859|468881167|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250990|NCT02991859|468881168|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130250991|NCT02991859|468881169|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130250992|NCT02991859|468881170|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250993|NCT02991859|468881171|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250994|NCT02991859|468881172|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250995|NCT02991859|468881156|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250996|NCT02991859|468881157|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250997|NCT02991859|468881158|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250998|NCT02991859|468881159|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250999|NCT02991859|468881160|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130699910|NCT01709903|470524794|FG001|Overall Study|Lack of Efficacy|3|||
130699911|NCT01709903|470524793|FG000|Overall Study|Withdrawal by Subject|6|||
130699912|NCT01709903|470524794|FG001|Overall Study|Withdrawal by Subject|6|||
130699913|NCT01709903|470524793|FG000|Overall Study|Adverse Event|11|||
130699914|NCT01709903|470524794|FG001|Overall Study|Adverse Event|18|||
130699915|NCT02061280|470524795|FG000|Overall Study|Protocol Violation|12|||
130699916|NCT02061280|470524796|FG001|Overall Study|Protocol Violation|8|||
130699917|NCT02061280|470524795|FG000|Overall Study|moved out of state|0|||
130699918|NCT02061280|470524796|FG001|Overall Study|moved out of state|1|||
130699919|NCT02061280|470524795|FG000|Overall Study|Withdrawal by Subject|1|||
130699920|NCT02061280|470524796|FG001|Overall Study|Withdrawal by Subject|2|||
130699921|NCT02061280|470524795|FG000|Overall Study|Lost to Follow-up|5|||
130699922|NCT02061280|470524796|FG001|Overall Study|Lost to Follow-up|1|||
130699923|NCT05135273|470526328|FG000|Overall Study|Recruited into the army|0|||
130699924|NCT05135273|470526329|FG001|Overall Study|Recruited into the army|0|||
130699925|NCT05135273|470526330|FG002|Overall Study|Recruited into the army|0|||
130699926|NCT05135273|470526331|FG003|Overall Study|Recruited into the army|0|||
130699927|NCT05135273|470526332|FG004|Overall Study|Recruited into the army|1|||
130699928|NCT05135273|470526333|FG005|Overall Study|Recruited into the army|0|||
130699929|NCT05135273|470526334|FG006|Overall Study|Recruited into the army|0|||
130699930|NCT05135273|470526335|FG007|Overall Study|Recruited into the army|0|||
130699931|NCT05135273|470526328|FG000|Overall Study|Moved away from study site|0|||
130699932|NCT05135273|470526329|FG001|Overall Study|Moved away from study site|0|||
130699933|NCT05135273|470526330|FG002|Overall Study|Moved away from study site|0|||
130699934|NCT05135273|470526331|FG003|Overall Study|Moved away from study site|0|||
130699935|NCT05135273|470526332|FG004|Overall Study|Moved away from study site|0|||
130699936|NCT05135273|470526333|FG005|Overall Study|Moved away from study site|1|||
130699937|NCT05135273|470526334|FG006|Overall Study|Moved away from study site|1|||
130699938|NCT05135273|470526335|FG007|Overall Study|Moved away from study site|0|||
130699939|NCT05135273|470526328|FG000|Overall Study|Travel|0|||
130699940|NCT05135273|470526329|FG001|Overall Study|Travel|0|||
130699941|NCT05135273|470526330|FG002|Overall Study|Travel|0|||
130553311|NCT02202551|469993552|FG000|Overall Study|Lost to Follow-up|0|||
130699942|NCT05135273|470526331|FG003|Overall Study|Travel|0|||
130699943|NCT05135273|470526332|FG004|Overall Study|Travel|0|||
130699944|NCT05135273|470526333|FG005|Overall Study|Travel|0|||
130553312|NCT02202551|469993553|FG001|Overall Study|Lost to Follow-up|1|||
130699945|NCT05135273|470526334|FG006|Overall Study|Travel|0|||
130699946|NCT05135273|470526335|FG007|Overall Study|Travel|1|||
130699947|NCT02710214|470526336|FG000|Overall Study|Lost to Follow-up|1|||
130699948|NCT02710214|470526337|FG001|Overall Study|Lost to Follow-up|0|||
130699949|NCT02710214|470526336|FG000|Overall Study|Lack of Efficacy|0|||
130699950|NCT02710214|470526337|FG001|Overall Study|Lack of Efficacy|1|||
130699951|NCT02710214|470526336|FG000|Overall Study|Death|0|||
130699952|NCT02710214|470526337|FG001|Overall Study|Death|1|||
130699953|NCT01705717|470526347|FG000|Overall Study|Adverse Event|2|||
130699954|NCT01705717|470526348|FG001|Overall Study|Adverse Event|2|||
130699955|NCT01705717|470526347|FG000|Overall Study|Lack of Efficacy|0|||
130699956|NCT01705717|470526348|FG001|Overall Study|Lack of Efficacy|1|||
130699957|NCT01705717|470526347|FG000|Overall Study|Other|0|||
130699958|NCT01705717|470526348|FG001|Overall Study|Other|2|||
130699959|NCT01188226|470526354|FG000|Overall Study|Withdrawal by Subject|4|||
130699960|NCT01662024|470526355|FG000|Overall Study|Pregnancy|2|||
130699961|NCT01662024|470526355|FG000|Overall Study|Withdrawal by Subject|3|||
130699962|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
130699963|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
130699964|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
130699965|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
130699966|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
130699967|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
130699968|NCT04980456|470526356|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
130699969|NCT04980456|470526357|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
130699970|NCT04832971|470526358|FG000|Overall Study|Death|1|||
130699971|NCT04832971|470526359|FG001|Overall Study|Death|0|||
130699972|NCT04832971|470526360|FG002|Overall Study|Death|0|||
130699973|NCT04832971|470526361|FG003|Overall Study|Death|0|||
130699974|NCT04832971|470526358|FG000|Overall Study|Lost to Follow-up|1|||
130699975|NCT04832971|470526359|FG001|Overall Study|Lost to Follow-up|1|||
130699976|NCT04832971|470526360|FG002|Overall Study|Lost to Follow-up|1|||
130699977|NCT04832971|470526361|FG003|Overall Study|Lost to Follow-up|0|||
130699978|NCT04832971|470526358|FG000|Overall Study|Withdrawal by Subject|1|||
130699979|NCT04832971|470526359|FG001|Overall Study|Withdrawal by Subject|3|||
130699980|NCT04832971|470526360|FG002|Overall Study|Withdrawal by Subject|2|||
130251000|NCT02991859|468881161|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
130251001|NCT02991859|468881162|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251002|NCT02991859|468881163|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251003|NCT02991859|468881164|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251004|NCT02991859|468881165|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251005|NCT02991859|468881166|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251006|NCT02991859|468881167|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251007|NCT02991859|468881168|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251008|NCT02991859|468881169|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251009|NCT02991859|468881170|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251010|NCT02991859|468881171|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251011|NCT02991859|468881172|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251012|NCT02991859|468881156|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251013|NCT02991859|468881157|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251014|NCT02991859|468881158|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251015|NCT02991859|468881159|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251016|NCT02991859|468881160|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251017|NCT02991859|468881161|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251018|NCT02991859|468881162|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251019|NCT02991859|468881163|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251020|NCT02991859|468881164|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251021|NCT02991859|468881165|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
130251022|NCT02991859|468881166|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251023|NCT02991859|468881167|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251024|NCT02991859|468881168|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251025|NCT02991859|468881169|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251026|NCT02991859|468881170|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130699981|NCT04832971|470526361|FG003|Overall Study|Withdrawal by Subject|2|||
130699982|NCT04832971|470526358|FG000|Overall Study|Other, Not Specified|0|||
130699983|NCT04832971|470526359|FG001|Overall Study|Other, Not Specified|0|||
130699984|NCT04832971|470526360|FG002|Overall Study|Other, Not Specified|1|||
130699985|NCT04832971|470526361|FG003|Overall Study|Other, Not Specified|0|||
130699986|NCT02293460|470526362|FG000|Overall Study|Protocol Violation|1|||
130699987|NCT02293460|470526362|FG000|Overall Study|Lack of Efficacy|2|||
130251027|NCT02991859|468881171|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251028|NCT02991859|468881172|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251029|NCT02991859|468881156|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251030|NCT02991859|468881157|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251031|NCT02991859|468881158|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251032|NCT02991859|468881159|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130699988|NCT02293460|470526362|FG000|Overall Study|Adverse Event|2|||
130699989|NCT02293460|470526362|FG000|Overall Study|Withdrawal by Subject|1|||
130699990|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
130699991|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
130699992|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
130251033|NCT02991859|468881160|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251034|NCT02991859|468881161|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251035|NCT02991859|468881162|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251036|NCT02991859|468881163|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251037|NCT02991859|468881164|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
130251038|NCT02991859|468881165|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251039|NCT02991859|468881166|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251040|NCT02991859|468881167|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251041|NCT02991859|468881168|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251042|NCT02991859|468881169|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251043|NCT02991859|468881170|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251044|NCT02991859|468881171|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251045|NCT02991859|468881172|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251046|NCT04223687|468881178|FG000|Overall Study|Missing primary outcome|1|||
130251047|NCT04223687|468881179|FG001|Overall Study|Missing primary outcome|0|||
130251048|NCT00425854|468881180|FG000|Overall Study|Progressive Disease|19|||
130251049|NCT00425854|468881181|FG001|Overall Study|Progressive Disease|12|||
130251050|NCT00425854|468881180|FG000|Overall Study|Dose reduction toxicity AE|8|||
130251051|NCT00425854|468881181|FG001|Overall Study|Dose reduction toxicity AE|7|||
130251052|NCT00425854|468881180|FG000|Overall Study|Other Adverse Event|2|||
130251053|NCT00425854|468881181|FG001|Overall Study|Other Adverse Event|2|||
130251054|NCT03163264|468881187|FG000|Overall Study|Withdrawal by Subject|13|||
130251055|NCT03163264|468881188|FG001|Overall Study|Withdrawal by Subject|3|||
130251056|NCT03163264|468881189|FG002|Overall Study|Withdrawal by Subject|4|||
130251057|NCT03163264|468881190|FG003|Overall Study|Withdrawal by Subject|2|||
130251058|NCT03163264|468881187|FG000|Overall Study|Lost to Follow-up|17|||
130251059|NCT03163264|468881188|FG001|Overall Study|Lost to Follow-up|20|||
130251060|NCT03163264|468881189|FG002|Overall Study|Lost to Follow-up|0|||
130251061|NCT03163264|468881190|FG003|Overall Study|Lost to Follow-up|0|||
130251062|NCT03163264|468881187|FG000|Overall Study|Death|0|||
130251063|NCT03163264|468881188|FG001|Overall Study|Death|2|||
130251064|NCT03163264|468881189|FG002|Overall Study|Death|0|||
130251065|NCT03163264|468881190|FG003|Overall Study|Death|0|||
130251066|NCT02614066|468881191|FG000|Overall Study|Death|6|||
130251067|NCT02614066|468881192|FG001|Overall Study|Death|14|||
130251068|NCT02614066|468881193|FG002|Overall Study|Death|11|||
130251069|NCT02614066|468881194|FG003|Overall Study|Death|29|||
130251070|NCT02614066|468881191|FG000|Overall Study|Full consent withdrawn|0|||
130251071|NCT02614066|468881192|FG001|Overall Study|Full consent withdrawn|1|||
130251072|NCT02614066|468881193|FG002|Overall Study|Full consent withdrawn|0|||
130251073|NCT02614066|468881194|FG003|Overall Study|Full consent withdrawn|8|||
130251074|NCT02614066|468881191|FG000|Overall Study|Lost to Follow-up|0|||
130251075|NCT02614066|468881192|FG001|Overall Study|Lost to Follow-up|2|||
130251076|NCT02614066|468881193|FG002|Overall Study|Lost to Follow-up|2|||
130251077|NCT02614066|468881194|FG003|Overall Study|Lost to Follow-up|2|||
130251078|NCT02614066|468881191|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
130251079|NCT02614066|468881192|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
130251080|NCT02614066|468881193|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
130251081|NCT02614066|468881194|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
130251082|NCT02614066|468881191|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
130699993|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
130699994|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
130699995|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
130699996|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130699997|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130699998|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
130699999|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
130700000|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
130700001|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
130251083|NCT02614066|468881192|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
130251084|NCT02614066|468881193|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
130251085|NCT02614066|468881194|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
130251086|NCT02614066|468881191|FG000|Overall Study|Reason not specified|0|||
130251087|NCT02614066|468881192|FG001|Overall Study|Reason not specified|2|||
130364841|NCT04680052|469306756|FG001|Overall Study|Withdrawal by Subject|19|||
130700002|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
130251088|NCT02614066|468881193|FG002|Overall Study|Reason not specified|1|||
130251089|NCT02614066|468881194|FG003|Overall Study|Reason not specified|1|||
130251090|NCT05259722|468881201|FG000|Overall Study|Adverse Event|2|||
130251091|NCT05259722|468881202|FG001|Overall Study|Adverse Event|24|||
130251092|NCT05259722|468881201|FG000|Overall Study|Lost to Follow-up|5|||
130251093|NCT05259722|468881202|FG001|Overall Study|Lost to Follow-up|1|||
130251094|NCT05259722|468881201|FG000|Overall Study|Lack of Efficacy|8|||
130251095|NCT05259722|468881202|FG001|Overall Study|Lack of Efficacy|26|||
130251096|NCT05259722|468881201|FG000|Overall Study|Withdrawal by Subject|15|||
130251097|NCT05259722|468881202|FG001|Overall Study|Withdrawal by Subject|33|||
130251098|NCT05259722|468881201|FG000|Overall Study|Various reasons|3|||
130251099|NCT05259722|468881202|FG001|Overall Study|Various reasons|9|||
130251100|NCT05259722|468881201|FG000|Overall Study|Not exposed to IMP|1|||
130251101|NCT05259722|468881202|FG001|Overall Study|Not exposed to IMP|12|||
130251102|NCT05259722|468881201|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
130251103|NCT05259722|468881202|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
130251105|NCT00962650|468881204|FG000|Overall Study|Transgastric DP was not completed|2|||
130251106|NCT00231465|468881206|FG000|Overall Study|Completed only one cycle|1|||
130251107|NCT00231465|468881206|FG000|Overall Study|Did not have follow up CT scans|1|||
130251108|NCT01185366|468881207|FG000|First Line Therapy|Insurance Coverage Denied|1|||
130251109|NCT01185366|468881208|FG001|First Line Therapy|Insurance Coverage Denied|1|||
130251110|NCT01185366|468881207|FG000|First Line Therapy|Withdrawal by Subject|1|||
130251111|NCT01185366|468881208|FG001|First Line Therapy|Withdrawal by Subject|0|||
130251112|NCT01185366|468881207|FG000|First Line Therapy|Lack of Metastatic Site|1|||
130251113|NCT01185366|468881208|FG001|First Line Therapy|Lack of Metastatic Site|0|||
130251114|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
130251115|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
130251116|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
130251117|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
130251118|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
130251119|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
130251120|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
130251121|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
130251122|NCT02774278|468881213|FG000|Overall Study|Lack of Efficacy|199|||
130251123|NCT02774278|468881213|FG000|Overall Study|Death|29|||
130251124|NCT02774278|468881213|FG000|Overall Study|Adverse event/intercurrent illness|16|||
130251125|NCT02774278|468881213|FG000|Overall Study|Refused treatment/did not cooperate|9|||
130251126|NCT02774278|468881213|FG000|Overall Study|Administrative reasons|6|||
130251127|NCT02774278|468881213|FG000|Overall Study|Withdrawal by Subject|3|||
130251128|NCT02774278|468881213|FG000|Overall Study|Protocol Violation|2|||
130251129|NCT00127933|468881216|FG000|Overall Study|Randomized but not dosed|1|||
130251130|NCT00127933|468881217|FG001|Overall Study|Randomized but not dosed|0|||
130251131|NCT01783938|468881219|FG000|Overall Study|Disease Progression|18|||
130251132|NCT01783938|468881220|FG001|Overall Study|Disease Progression|41|||
130251133|NCT01783938|468881219|FG000|Overall Study|Study Drug Toxicity|27|||
130251134|NCT01783938|468881220|FG001|Overall Study|Study Drug Toxicity|14|||
130251135|NCT01783938|468881219|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
130251136|NCT01783938|468881220|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130251137|NCT01783938|468881219|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
130251138|NCT01783938|468881220|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
130251139|NCT01783938|468881219|FG000|Overall Study|Participant Withdrew Consent|2|||
130251140|NCT01783938|468881220|FG001|Overall Study|Participant Withdrew Consent|0|||
130251141|NCT01783938|468881219|FG000|Overall Study|Maximum Clinical Benefit|1|||
130251142|NCT01783938|468881220|FG001|Overall Study|Maximum Clinical Benefit|0|||
130251143|NCT01783938|468881219|FG000|Overall Study|Other Reasons|3|||
130251144|NCT01783938|468881220|FG001|Overall Study|Other Reasons|1|||
130700003|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
130700004|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
130700005|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
130700006|NCT04592419|470526366|FG000|Open-Label Extension Period|Adverse Event|1|||
130700007|NCT04592419|470526367|FG001|Open-Label Extension Period|Adverse Event|2|||
130700008|NCT04592419|470526366|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
130700009|NCT04592419|470526367|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
130700010|NCT04592419|470526366|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
130251145|NCT00498485|468881221|FG000|Overall Study|Adverse Event|1|||
130251146|NCT00498485|468881222|FG001|Overall Study|Adverse Event|5|||
130251147|NCT03072875|468881223|FG000|Overall Study|Lost to Follow-up|1|||
130251148|NCT03478787|468881224|FG000|Overall Study|Adverse Event|5|||
130251149|NCT03478787|468881225|FG001|Overall Study|Adverse Event|1|||
130251150|NCT03478787|468881224|FG000|Overall Study|Protocol Violation|3|||
130251151|NCT03478787|468881225|FG001|Overall Study|Protocol Violation|0|||
130251152|NCT03478787|468881224|FG000|Overall Study|Lack of Efficacy|7|||
130251153|NCT03478787|468881225|FG001|Overall Study|Lack of Efficacy|1|||
130251154|NCT03478787|468881224|FG000|Overall Study|Lost to Follow-up|9|||
130251155|NCT03478787|468881225|FG001|Overall Study|Lost to Follow-up|5|||
130251156|NCT03478787|468881224|FG000|Overall Study|Withdrawal by Subject|2|||
130251157|NCT03478787|468881225|FG001|Overall Study|Withdrawal by Subject|6|||
130251158|NCT03478787|468881224|FG000|Overall Study|Other, Not Specified|3|||
130251159|NCT03478787|468881225|FG001|Overall Study|Other, Not Specified|0|||
130251160|NCT01539525|468881226|FG000|Overall Study|Lost to Follow-up|19|||
130251161|NCT01539525|468881227|FG001|Overall Study|Lost to Follow-up|12|||
130251162|NCT01539525|468881228|FG002|Overall Study|Lost to Follow-up|11|||
130251163|NCT01539525|468881226|FG000|Overall Study|Withdrawal by Subject|0|||
130251164|NCT01539525|468881227|FG001|Overall Study|Withdrawal by Subject|3|||
130251165|NCT01539525|468881228|FG002|Overall Study|Withdrawal by Subject|2|||
130251166|NCT01539525|468881226|FG000|Overall Study|Protocol Violation|1|||
130251167|NCT01539525|468881227|FG001|Overall Study|Protocol Violation|1|||
130251168|NCT01539525|468881228|FG002|Overall Study|Protocol Violation|4|||
130251169|NCT01712074|468881229|FG000|Placebo Run-in Period|Adverse Event|2|||
130251170|NCT01712074|468881230|FG001|Placebo Run-in Period|Adverse Event|0|||
130251171|NCT01712074|468881231|FG002|Placebo Run-in Period|Adverse Event|0|||
130251172|NCT01712074|468881229|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
130251173|NCT01712074|468881230|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
130251174|NCT01712074|468881231|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
130251175|NCT01712074|468881229|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
130251176|NCT01712074|468881230|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130251177|NCT01712074|468881231|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130251178|NCT01712074|468881229|FG000|Placebo Run-in Period|Other|1|||
130251179|NCT01712074|468881230|FG001|Placebo Run-in Period|Other|0|||
130251180|NCT01712074|468881231|FG002|Placebo Run-in Period|Other|0|||
130251181|NCT01712074|468881229|FG000|Placebo Run-in Period|No longer willing to participate|1|||
130251182|NCT01712074|468881230|FG001|Placebo Run-in Period|No longer willing to participate|0|||
130251183|NCT01712074|468881231|FG002|Placebo Run-in Period|No longer willing to participate|0|||
130251184|NCT01712074|468881229|FG000|Double Blind Period|Adverse Event|0|||
130251185|NCT01712074|468881230|FG001|Double Blind Period|Adverse Event|2|||
130251186|NCT01712074|468881231|FG002|Double Blind Period|Adverse Event|1|||
130251187|NCT01712074|468881229|FG000|Double Blind Period|No longer willing to participate|0|||
130251188|NCT01712074|468881230|FG001|Double Blind Period|No longer willing to participate|2|||
130251189|NCT01712074|468881231|FG002|Double Blind Period|No longer willing to participate|4|||
130251190|NCT01712074|468881229|FG000|Double Blind Period|Death|0|||
130251191|NCT01712074|468881230|FG001|Double Blind Period|Death|1|||
130251192|NCT01712074|468881231|FG002|Double Blind Period|Death|0|||
130251193|NCT01712074|468881229|FG000|Double Blind Period|Lost to Follow-up|0|||
130251194|NCT01712074|468881230|FG001|Double Blind Period|Lost to Follow-up|2|||
130251195|NCT01712074|468881231|FG002|Double Blind Period|Lost to Follow-up|1|||
130251196|NCT01712074|468881229|FG000|Double Blind Period|Other|0|||
130251197|NCT01712074|468881230|FG001|Double Blind Period|Other|4|||
130251198|NCT01712074|468881231|FG002|Double Blind Period|Other|1|||
130251199|NCT01712074|468881229|FG000|Double Blind Period|Protocol Violation|0|||
130251200|NCT01712074|468881230|FG001|Double Blind Period|Protocol Violation|0|||
130251201|NCT01712074|468881231|FG002|Double Blind Period|Protocol Violation|1|||
130251202|NCT01712074|468881229|FG000|Double Blind Period|No longer met eligibility criteria|0|||
130251203|NCT01712074|468881230|FG001|Double Blind Period|No longer met eligibility criteria|3|||
130251204|NCT01712074|468881231|FG002|Double Blind Period|No longer met eligibility criteria|0|||
130251205|NCT02268851|468881232|FG000|Overall Study|Death|0|||
130251206|NCT02268851|468881233|FG001|Overall Study|Death|0|||
130251207|NCT02268851|468881234|FG002|Overall Study|Death|0|||
130251208|NCT02268851|468881235|FG003|Overall Study|Death|1|||
130251209|NCT02268851|468881236|FG004|Overall Study|Death|2|||
130251210|NCT02268851|468881237|FG005|Overall Study|Death|1|||
130251211|NCT02268851|468881232|FG000|Overall Study|Adverse Event|0|||
130452897|NCT01941316|469621705|FG003|Overall Study|Other, not specified|1|||
130452898|NCT01835899|469621715|FG000|Overall Study|Adverse Event|0|||
130251212|NCT02268851|468881233|FG001|Overall Study|Adverse Event|0|||
130251213|NCT02268851|468881234|FG002|Overall Study|Adverse Event|0|||
130251214|NCT02268851|468881235|FG003|Overall Study|Adverse Event|0|||
130251215|NCT02268851|468881236|FG004|Overall Study|Adverse Event|2|||
130251216|NCT02268851|468881237|FG005|Overall Study|Adverse Event|2|||
130251217|NCT02268851|468881232|FG000|Overall Study|Withdrawal by Subject|0|||
130251218|NCT02268851|468881233|FG001|Overall Study|Withdrawal by Subject|0|||
130251219|NCT02268851|468881234|FG002|Overall Study|Withdrawal by Subject|0|||
130251220|NCT02268851|468881235|FG003|Overall Study|Withdrawal by Subject|2|||
130251221|NCT02268851|468881236|FG004|Overall Study|Withdrawal by Subject|0|||
130251222|NCT02268851|468881237|FG005|Overall Study|Withdrawal by Subject|1|||
130251223|NCT02268851|468881232|FG000|Overall Study|Progressive Disease|1|||
130251224|NCT02268851|468881233|FG001|Overall Study|Progressive Disease|3|||
130251225|NCT02268851|468881234|FG002|Overall Study|Progressive Disease|0|||
130251226|NCT02268851|468881235|FG003|Overall Study|Progressive Disease|0|||
130251227|NCT02268851|468881236|FG004|Overall Study|Progressive Disease|1|||
130251228|NCT02268851|468881237|FG005|Overall Study|Progressive Disease|4|||
130251229|NCT02268851|468881232|FG000|Overall Study|Physician Decision|0|||
130251230|NCT02268851|468881233|FG001|Overall Study|Physician Decision|0|||
130251231|NCT02268851|468881234|FG002|Overall Study|Physician Decision|1|||
130251232|NCT02268851|468881235|FG003|Overall Study|Physician Decision|0|||
130251233|NCT02268851|468881236|FG004|Overall Study|Physician Decision|0|||
130251234|NCT02268851|468881237|FG005|Overall Study|Physician Decision|1|||
130251235|NCT02268851|468881232|FG000|Overall Study|Patient Compliance|0|||
130251236|NCT02268851|468881233|FG001|Overall Study|Patient Compliance|0|||
130251237|NCT02268851|468881234|FG002|Overall Study|Patient Compliance|0|||
130251238|NCT02268851|468881235|FG003|Overall Study|Patient Compliance|0|||
130251239|NCT02268851|468881236|FG004|Overall Study|Patient Compliance|1|||
130251240|NCT02268851|468881237|FG005|Overall Study|Patient Compliance|1|||
130251241|NCT02268851|468881232|FG000|Overall Study|Co-Morbid Condition|0|||
130251242|NCT02268851|468881233|FG001|Overall Study|Co-Morbid Condition|0|||
130251243|NCT02268851|468881234|FG002|Overall Study|Co-Morbid Condition|0|||
130251244|NCT02268851|468881235|FG003|Overall Study|Co-Morbid Condition|0|||
130251245|NCT02268851|468881236|FG004|Overall Study|Co-Morbid Condition|1|||
130251246|NCT02268851|468881237|FG005|Overall Study|Co-Morbid Condition|1|||
130251247|NCT02539394|468881240|FG000|Overall Study|Protocol Violation|1|||
130251248|NCT02539394|468881241|FG001|Overall Study|Protocol Violation|3|||
130251249|NCT02539394|468881240|FG000|Overall Study|Lost to Follow-up|1|||
130251250|NCT02539394|468881241|FG001|Overall Study|Lost to Follow-up|2|||
130251251|NCT02539394|468881240|FG000|Overall Study|Incomplete dataset|6|||
130251252|NCT02539394|468881241|FG001|Overall Study|Incomplete dataset|6|||
130251253|NCT01472835|468881242|FG000|Overall Study|Lost to Follow-up|2|||
130251254|NCT01472835|468881243|FG001|Overall Study|Lost to Follow-up|0|||
130251255|NCT02205359|468881260|FG000|Overall Study|Death|293|||
130251256|NCT02205359|468881261|FG001|Overall Study|Death|327|||
130251257|NCT02205359|468881260|FG000|Overall Study|Lost to Follow-up|182|||
130251258|NCT02205359|468881261|FG001|Overall Study|Lost to Follow-up|162|||
130251259|NCT02205359|468881260|FG000|Overall Study|Physician Decision|51|||
130251260|NCT02205359|468881261|FG001|Overall Study|Physician Decision|53|||
130251261|NCT02205359|468881260|FG000|Overall Study|Withdrawal by Subject|167|||
130251262|NCT02205359|468881261|FG001|Overall Study|Withdrawal by Subject|169|||
130251263|NCT02792257|468881268|FG000|Overall Study|Lost to Follow-up|3|||
130251264|NCT02792257|468881269|FG001|Overall Study|Lost to Follow-up|4|||
130251265|NCT02792257|468881268|FG000|Overall Study|Allergy|0|||
130251266|NCT02792257|468881269|FG001|Overall Study|Allergy|1|||
130251267|NCT02792257|468881268|FG000|Overall Study|Protocol Violation|2|||
130251268|NCT02792257|468881269|FG001|Overall Study|Protocol Violation|0|||
130251269|NCT02792257|468881268|FG000|Overall Study|Excessive Agitation|0|||
130251270|NCT02792257|468881269|FG001|Overall Study|Excessive Agitation|1|||
130251271|NCT02792257|468881268|FG000|Overall Study|Not Feeling Well|0|||
130251272|NCT02792257|468881269|FG001|Overall Study|Not Feeling Well|1|||
130251273|NCT00553475|468881270|FG000|Overall Study|Adverse Event|7|||
130251274|NCT00553475|468881271|FG001|Overall Study|Adverse Event|17|||
130251275|NCT00553475|468881272|FG002|Overall Study|Adverse Event|13|||
130251276|NCT00553475|468881270|FG000|Overall Study|Lack of Efficacy|7|||
130251277|NCT00553475|468881271|FG001|Overall Study|Lack of Efficacy|1|||
130251278|NCT00553475|468881272|FG002|Overall Study|Lack of Efficacy|0|||
130251279|NCT00553475|468881270|FG000|Overall Study|Withdrawal by Subject|1|||
130251280|NCT00553475|468881271|FG001|Overall Study|Withdrawal by Subject|1|||
130251281|NCT00553475|468881272|FG002|Overall Study|Withdrawal by Subject|0|||
130251282|NCT00553475|468881270|FG000|Overall Study|Physician Decision|1|||
130251283|NCT00553475|468881271|FG001|Overall Study|Physician Decision|0|||
130251284|NCT00553475|468881272|FG002|Overall Study|Physician Decision|0|||
130251285|NCT00553475|468881270|FG000|Overall Study|Due to moving|0|||
130251286|NCT00553475|468881271|FG001|Overall Study|Due to moving|1|||
130251287|NCT00553475|468881272|FG002|Overall Study|Due to moving|0|||
130251288|NCT01905683|468881275|FG000|Overall Study|Protocol Violation|1|||
130251289|NCT01905683|468881275|FG000|Overall Study|Re-injection criteria not met; others|13|||
130251290|NCT01905683|468881275|FG000|Overall Study|Physician Decision|1|||
130251291|NCT01905683|468881275|FG000|Overall Study|Lack of Efficacy|8|||
130251292|NCT01905683|468881275|FG000|Overall Study|Withdrawal by Subject|20|||
130251293|NCT01905683|468881275|FG000|Overall Study|Adverse Event|4|||
130251294|NCT01905683|468881275|FG000|Overall Study|Lost to Follow-up|4|||
130251295|NCT00537082|468881277|FG000|Overall Study|Adverse Event|6|||
130251296|NCT00537082|468881278|FG001|Overall Study|Adverse Event|6|||
130251297|NCT00537082|468881279|FG002|Overall Study|Adverse Event|3|||
130251298|NCT00537082|468881277|FG000|Overall Study|Protocol Violation|0|||
130251299|NCT00537082|468881278|FG001|Overall Study|Protocol Violation|2|||
130251300|NCT00537082|468881279|FG002|Overall Study|Protocol Violation|1|||
130251301|NCT00537082|468881277|FG000|Overall Study|Lack of Efficacy|0|||
130251302|NCT00537082|468881278|FG001|Overall Study|Lack of Efficacy|0|||
130251303|NCT00537082|468881279|FG002|Overall Study|Lack of Efficacy|2|||
130251304|NCT00537082|468881277|FG000|Overall Study|Withdrawal by Subject|0|||
130251305|NCT00537082|468881278|FG001|Overall Study|Withdrawal by Subject|1|||
130251306|NCT00537082|468881279|FG002|Overall Study|Withdrawal by Subject|0|||
130251307|NCT00537082|468881277|FG000|Overall Study|Discontinued before initiating treatment|3|||
130251308|NCT00537082|468881278|FG001|Overall Study|Discontinued before initiating treatment|0|||
130251309|NCT00537082|468881279|FG002|Overall Study|Discontinued before initiating treatment|0|||
130251310|NCT02568254|468881280|FG000|Period 2|Adverse Event|0|||
130251311|NCT02568254|468881281|FG001|Period 2|Adverse Event|0|||
130251312|NCT02568254|468881282|FG002|Period 2|Adverse Event|1|||
130251313|NCT02568254|468881283|FG003|Period 2|Adverse Event|0|||
130251314|NCT02568254|468881284|FG004|Period 2|Adverse Event|0|||
130251315|NCT02568254|468881285|FG005|Period 2|Adverse Event|0|||
130251316|NCT02568254|468881280|FG000|Period 3|Unstatisfactory Lens fitting|0|||
130251317|NCT02568254|468881281|FG001|Period 3|Unstatisfactory Lens fitting|0|||
130251318|NCT02568254|468881282|FG002|Period 3|Unstatisfactory Lens fitting|0|||
130251319|NCT02568254|468881283|FG003|Period 3|Unstatisfactory Lens fitting|0|||
130251320|NCT02568254|468881284|FG004|Period 3|Unstatisfactory Lens fitting|1|||
130251321|NCT02568254|468881285|FG005|Period 3|Unstatisfactory Lens fitting|0|||
130251322|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
130251323|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
130251324|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
130251325|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Adverse Event|5|||
130251326|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Adverse Event|1|||
130251327|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Adverse Event|0|||
130251328|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
130251329|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
130251330|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
130251331|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Death|8|||
130251332|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Death|24|||
130251333|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Death|0|||
130251334|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
130251335|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
130251336|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
130251337|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
130251338|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
130251339|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
130251340|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
130251341|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130251342|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130251343|NCT02931539|468881286|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130251344|NCT02931539|468881287|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130251345|NCT02931539|468881288|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
130251346|NCT03178942|468881291|FG000|Overall Study|Withdrawal by Subject|2|||
130251347|NCT03178942|468881292|FG001|Overall Study|Withdrawal by Subject|0|||
130251348|NCT03178942|468881291|FG000|Overall Study|Lost to Follow-up|1|||
130251349|NCT03178942|468881292|FG001|Overall Study|Lost to Follow-up|2|||
130251350|NCT01926509|468883076|FG000|Overall Study|vital sign met discontinuation criteria|1|||
130251351|NCT01926509|468883077|FG001|Overall Study|vital sign met discontinuation criteria|0|||
130251352|NCT01926509|468883078|FG002|Overall Study|vital sign met discontinuation criteria|0|||
130251353|NCT01926509|468883079|FG003|Overall Study|vital sign met discontinuation criteria|0|||
130251354|NCT03681093|468883080|FG000|Overall Study|Subject decision|0|||
130251355|NCT03681093|468883081|FG001|Overall Study|Subject decision|2|||
130251356|NCT03681093|468883082|FG002|Overall Study|Subject decision|1|||
130251357|NCT01882829|468883086|FG000|Overall Study|Adverse Event|4|||
130251358|NCT01882829|468883086|FG000|Overall Study|Protocol Violation|1|||
130251359|NCT01882829|468883086|FG000|Overall Study|Withdrawal by Subject|1|||
130251360|NCT02469961|468883088|FG000|Overall Study|Physician Decision|4|||
130251361|NCT02469961|468883089|FG001|Overall Study|Physician Decision|1|||
130251362|NCT05130281|468883093|FG000|Overall Study|Withdrawal by Subject|0|||
130251363|NCT05130281|468883094|FG001|Overall Study|Withdrawal by Subject|0|||
130251364|NCT05130281|468883095|FG002|Overall Study|Withdrawal by Subject|1|||
130452899|NCT01835899|469621716|FG001|Overall Study|Adverse Event|0|||
130452900|NCT01835899|469621717|FG002|Overall Study|Adverse Event|1|||
130452901|NCT01835899|469621715|FG000|Overall Study|Other than stated above|0|||
130452902|NCT01835899|469621716|FG001|Overall Study|Other than stated above|1|||
130251365|NCT06844812|468883096|FG000|Overall Study|Lost to Follow-up|5|||
130251366|NCT06844812|468883096|FG000|Overall Study|stigmatization concerns|2|||
130251367|NCT06844812|468883096|FG000|Overall Study|medication refusal|2|||
130251368|NCT06844812|468883096|FG000|Overall Study|concerns about possible side effects|2|||
130251369|NCT06844812|468883096|FG000|Overall Study|wanting to seek another specialist opinion|2|||
130251370|NCT06844812|468883096|FG000|Overall Study|side effects (dizziness)|1|||
130251371|NCT00368849|468883099|FG000|Overall Study|Withdrawal by Subject|0|||
130251372|NCT00368849|468883100|FG001|Overall Study|Withdrawal by Subject|1|||
130251373|NCT00368849|468883099|FG000|Overall Study|Physician Decision|0|||
130251374|NCT00368849|468883100|FG001|Overall Study|Physician Decision|1|||
130251375|NCT01699685|468883104|FG000|Period 1|Adverse Event|1|||
130251376|NCT01699685|468883105|FG001|Period 1|Adverse Event|1|||
130251377|NCT01699685|468883104|FG000|Period 1|Medical or ethical, noncompliance|2|||
130251378|NCT01699685|468883105|FG001|Period 1|Medical or ethical, noncompliance|0|||
130251379|NCT01699685|468883104|FG000|Period 1|Other|0|||
130251380|NCT01699685|468883105|FG001|Period 1|Other|1|||
130251381|NCT01699685|468883104|FG000|Period 1|Patient request|0|||
130251382|NCT01699685|468883105|FG001|Period 1|Patient request|1|||
130251383|NCT01699685|468883104|FG000|Period 2|Lost to Follow-up|1|||
130251384|NCT01699685|468883105|FG001|Period 2|Lost to Follow-up|0|||
130251385|NCT03635996|468883106|FG000|Overall Study|Study terminated by Sponsor|94|||
130251386|NCT03635996|468883106|FG000|Overall Study|Withdrawal by Subject|20|||
130251387|NCT03635996|468883106|FG000|Overall Study|Ablation|26|||
130251388|NCT03635996|468883106|FG000|Overall Study|Adverse Event|7|||
130251389|NCT03635996|468883106|FG000|Overall Study|Physician Decision|3|||
130251390|NCT03635996|468883106|FG000|Overall Study|Prohibited medication|5|||
130251391|NCT03635996|468883106|FG000|Overall Study|Did not meet eligibility criteria|5|||
130251392|NCT03635996|468883106|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
130251393|NCT03635996|468883106|FG000|Overall Study|Protocol Violation|1|||
130251394|NCT03635996|468883106|FG000|Overall Study|Lost to Follow-up|1|||
130251395|NCT05058456|468883107|FG000|Overall Study|Death|1|||
130251396|NCT05058456|468883107|FG000|Overall Study|End of Study data not yet due for release|34|||
130251397|NCT01832038|468883108|FG000|Overall Study|Death|5|||
130251398|NCT01832038|468883108|FG000|Overall Study|Adverse Event|50|||
130251399|NCT01832038|468883108|FG000|Overall Study|Lack of Efficacy|81|||
130251400|NCT01832038|468883108|FG000|Overall Study|Protocol Violation|7|||
130251401|NCT01832038|468883108|FG000|Overall Study|Lost to Follow-up|10|||
130251402|NCT01832038|468883108|FG000|Overall Study|Withdrawal by Subject|49|||
130251403|NCT01832038|468883108|FG000|Overall Study|Visit non-compliance|2|||
130251404|NCT01832038|468883108|FG000|Overall Study|Subject refused to return visit|2|||
130251405|NCT01832038|468883108|FG000|Overall Study|Not convenient to come back to site|2|||
130251406|NCT01832038|468883108|FG000|Overall Study|Participant was asked to quit|5|||
130251407|NCT01832038|468883108|FG000|Overall Study|Back home|1|||
130251408|NCT01832038|468883108|FG000|Overall Study|Pregnancy|1|||
130251409|NCT01832038|468883108|FG000|Overall Study|Low compliance|3|||
130251410|NCT01832038|468883108|FG000|Overall Study|Prohibit procedure|2|||
130251411|NCT01832038|468883108|FG000|Overall Study|Not possible to visit the hospital|1|||
130251412|NCT01832038|468883108|FG000|Overall Study|Changes of implementation system|3|||
130251413|NCT01832038|468883108|FG000|Overall Study|Plan to pregnancy|7|||
130251414|NCT01832038|468883108|FG000|Overall Study|Bad mood and has suicidal thought|1|||
130251415|NCT01832038|468883108|FG000|Overall Study|Prohibited concomitant medication|1|||
130251416|NCT01832038|468883108|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
130251417|NCT01832038|468883108|FG000|Overall Study|Subject considered the efficacy was poor|1|||
130251418|NCT00107614|468883114|FG000|Overall Study|Physician Decision|10|||
130251419|NCT00107614|468883114|FG000|Overall Study|Death|2|||
130251420|NCT00101400|468883121|FG000|Survival Follow-Up|Alive|7|||
130251421|NCT05333965|468883142|FG000|First Intervention|Adverse Event|0|||
130251422|NCT05333965|468883143|FG001|First Intervention|Adverse Event|1|||
130251423|NCT05333965|468883142|FG000|First Intervention|Withdrawal by Subject|0|||
130251424|NCT05333965|468883143|FG001|First Intervention|Withdrawal by Subject|1|||
130251425|NCT00382863|468883144|FG000|Overall Study|Death|9|||
130251426|NCT00382863|468883145|FG001|Overall Study|Death|9|||
130251427|NCT00382863|468883144|FG000|Overall Study|Lost to Follow-up|1|||
130251428|NCT00382863|468883145|FG001|Overall Study|Lost to Follow-up|2|||
130251429|NCT00382863|468883144|FG000|Overall Study|Withdrawal by Subject|5|||
130251430|NCT00382863|468883145|FG001|Overall Study|Withdrawal by Subject|25|||
130251431|NCT02168439|468883146|FG000|Overall Study|Protocol Violation|0|||
130251432|NCT02168439|468883147|FG001|Overall Study|Protocol Violation|2|||
130700011|NCT04592419|470526367|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
130700012|NCT04592419|470526366|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130251433|NCT02180672|468883150|FG000|Overall Study|Lost to Follow-up|5|||
130251434|NCT02180672|468883151|FG001|Overall Study|Lost to Follow-up|7|||
130251435|NCT02837952|468883152|FG000|Overall Study|Adverse Event|0|||
130251436|NCT02837952|468883153|FG001|Overall Study|Adverse Event|1|||
130251437|NCT02837952|468883152|FG000|Overall Study|Withdrawal by Subject|4|||
130364842|NCT04680052|469306757|FG002|Overall Study|Withdrawal by Subject|7|||
130364843|NCT04680052|469306758|FG003|Overall Study|Withdrawal by Subject|5|||
130364844|NCT04680052|469306755|FG000|Overall Study|Missing|0|||
130364845|NCT04680052|469306756|FG001|Overall Study|Missing|1|||
130364846|NCT04680052|469306757|FG002|Overall Study|Missing|0|||
130364847|NCT04680052|469306758|FG003|Overall Study|Missing|0|||
130364848|NCT04680052|469306755|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130364849|NCT04680052|469306756|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
130553313|NCT02202551|469993554|FG002|Overall Study|Lost to Follow-up|0|||
130251438|NCT02837952|468883153|FG001|Overall Study|Withdrawal by Subject|5|||
130251439|NCT02837952|468883152|FG000|Overall Study|Medication Error|1|||
130251440|NCT02837952|468883153|FG001|Overall Study|Medication Error|0|||
130251441|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Adverse Event|2|||
130251442|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Adverse Event|0|||
130251443|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Physician Decision|0|||
130251444|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Physician Decision|1|||
130251445|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
130251446|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
130251447|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
130251448|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
130251449|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
130251450|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
130251451|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
130251452|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
130251453|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
130251454|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
130251455|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
130251456|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
130251457|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
130251458|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
130251459|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
130251460|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
130251461|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
130251462|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
130251463|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
130251464|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
130251465|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
130251466|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
130251467|NCT03021005|468883157|FG000|Overall Study|Lost to Follow-up|39|||
130251468|NCT03021005|468883158|FG001|Overall Study|Lost to Follow-up|26|||
130251469|NCT00215553|468883165|FG000|Overall Study|Adverse Event|0|||
130251470|NCT00215553|468883166|FG001|Overall Study|Adverse Event|1|||
130251471|NCT00215553|468883167|FG002|Overall Study|Adverse Event|2|||
130251472|NCT00215553|468883168|FG003|Overall Study|Adverse Event|1|||
130251473|NCT00215553|468883169|FG004|Overall Study|Adverse Event|2|||
130251474|NCT00215553|468883170|FG005|Overall Study|Adverse Event|6|||
130251475|NCT00215553|468883171|FG006|Overall Study|Adverse Event|0|||
130251476|NCT00276380|468883175|FG000|Overall Study|Adverse Event|5|||
130251477|NCT00276380|468883176|FG001|Overall Study|Adverse Event|3|||
130251478|NCT00276380|468883175|FG000|Overall Study|Lost to Follow-up|1|||
130251479|NCT00276380|468883176|FG001|Overall Study|Lost to Follow-up|1|||
130251480|NCT00276380|468883175|FG000|Overall Study|Withdrawal by Subject|3|||
130251481|NCT00276380|468883176|FG001|Overall Study|Withdrawal by Subject|6|||
130251482|NCT00276380|468883175|FG000|Overall Study|Death|5|||
130452903|NCT01835899|469621717|FG002|Overall Study|Other than stated above|0|||
130452904|NCT03168438|469621719|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
130452905|NCT03168438|469621720|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
130452906|NCT03563053|469621732|FG000|Overall Study|Withdrawal by Subject|17|||
130452907|NCT03563053|469621732|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
130452908|NCT03563053|469621732|FG000|Overall Study|Adverse Event|3|||
130452909|NCT03563053|469621732|FG000|Overall Study|Physician Decision|1|||
130452910|NCT03563053|469621732|FG000|Overall Study|study terminated by sponsor|71|||
130452911|NCT01836458|469621733|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130452912|NCT01836458|469621734|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130452913|NCT01836458|469621735|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130452914|NCT01836458|469621736|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
130452915|NCT00561574|469621742|FG000|Overall Study|Adverse Event|21|||
130452916|NCT00561574|469621743|FG001|Overall Study|Adverse Event|24|||
130452917|NCT00561574|469621742|FG000|Overall Study|Lack of Efficacy|11|||
130452918|NCT00561574|469621743|FG001|Overall Study|Lack of Efficacy|21|||
130452919|NCT00561574|469621742|FG000|Overall Study|Withdrawal by Subject|4|||
130452920|NCT00561574|469621743|FG001|Overall Study|Withdrawal by Subject|4|||
130452921|NCT00561574|469621742|FG000|Overall Study|Reason Unrelated to Trial|6|||
130452922|NCT00561574|469621743|FG001|Overall Study|Reason Unrelated to Trial|2|||
130251483|NCT00276380|468883176|FG001|Overall Study|Death|3|||
130452923|NCT00561574|469621742|FG000|Overall Study|Lost to Follow-up|1|||
130452924|NCT00561574|469621743|FG001|Overall Study|Lost to Follow-up|0|||
130452925|NCT00561574|469621742|FG000|Overall Study|Other|5|||
130452926|NCT00561574|469621743|FG001|Overall Study|Other|7|||
130251484|NCT00276380|468883175|FG000|Overall Study|Abnormal aPPT Levels|0|||
130251485|NCT00276380|468883176|FG001|Overall Study|Abnormal aPPT Levels|1|||
130251486|NCT00552279|468883177|FG000|Overall Study|Adverse Event|0|||
130452927|NCT03971357|469621744|FG000|Overall Study|Lack of Efficacy|0|||
130452928|NCT03971357|469621745|FG001|Overall Study|Lack of Efficacy|1|||
130452929|NCT00630864|469621752|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
130553314|NCT02202551|469993555|FG003|Overall Study|Lost to Follow-up|1|||
130251487|NCT00552279|468883178|FG001|Overall Study|Adverse Event|1|||
130251488|NCT00552279|468883177|FG000|Overall Study|Withdrawal by Subject|12|||
130251489|NCT00552279|468883178|FG001|Overall Study|Withdrawal by Subject|1|||
130251490|NCT00552279|468883177|FG000|Overall Study|Lost to Follow-up|1|||
130251491|NCT00552279|468883178|FG001|Overall Study|Lost to Follow-up|0|||
130251492|NCT00552279|468883177|FG000|Overall Study|Other|1|||
130251493|NCT00552279|468883178|FG001|Overall Study|Other|1|||
130251494|NCT04829214|468883179|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
130251495|NCT04829214|468883180|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
130251496|NCT04829214|468883179|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
130251497|NCT04829214|468883180|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
130251498|NCT02739828|468883181|FG000|Overall Study|Adverse Event|1|||
130251499|NCT02739828|468883181|FG000|Overall Study|Lost to Follow-up|4|||
130251500|NCT01392495|468883182|FG000|Overall Study|Death|3|||
130251501|NCT01392495|468883182|FG000|Overall Study|Administrative problems|8|||
130251502|NCT01392495|468883182|FG000|Overall Study|Withdrawal by Subject|2|||
130251503|NCT01392495|468883182|FG000|Overall Study|Adverse Event|3|||
130251504|NCT02571244|468883183|FG000|Overall Study|Lost to Follow-up|0|||
130251505|NCT02571244|468883184|FG001|Overall Study|Lost to Follow-up|1|||
130251506|NCT02571244|468883183|FG000|Overall Study|Unable to reach out post discharge|3|||
130251507|NCT02571244|468883184|FG001|Overall Study|Unable to reach out post discharge|0|||
130251508|NCT04629521|468883185|FG000|Overall Study|Death|1|||
130700013|NCT04592419|470526367|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
130700014|NCT04592419|470526366|FG000|Open-Label Extension Period|Sponsor Request|73|||
130700015|NCT04592419|470526367|FG001|Open-Label Extension Period|Sponsor Request|84|||
130700016|NCT04129944|470526370|FG000|Overall Study|Death|0|||
130700017|NCT04129944|470526371|FG001|Overall Study|Death|0|||
130700018|NCT04129944|470526372|FG002|Overall Study|Death|0|||
130700019|NCT04129944|470526373|FG003|Overall Study|Death|1|||
130700020|NCT04129944|470526370|FG000|Overall Study|Lost to Follow-up|1|||
130700021|NCT04129944|470526371|FG001|Overall Study|Lost to Follow-up|0|||
130700022|NCT04129944|470526372|FG002|Overall Study|Lost to Follow-up|0|||
130700023|NCT04129944|470526373|FG003|Overall Study|Lost to Follow-up|0|||
130700024|NCT04129944|470526370|FG000|Overall Study|Withdrawal by Subject|1|||
130700025|NCT04129944|470526371|FG001|Overall Study|Withdrawal by Subject|0|||
130700026|NCT04129944|470526372|FG002|Overall Study|Withdrawal by Subject|1|||
130700027|NCT04129944|470526373|FG003|Overall Study|Withdrawal by Subject|2|||
130251509|NCT04629521|468883185|FG000|Overall Study|Lost to Follow-up|3|||
130251510|NCT04629521|468883185|FG000|Overall Study|Subject withdrew consent|3|||
130251511|NCT04629521|468883185|FG000|Overall Study|Enrolled in error|1|||
130251512|NCT01065766|468883194|FG000|Overall Study|Assessed before the contracted date|1|||
130251513|NCT01065766|468883194|FG000|Overall Study|Contraindication to administration|6|||
130251514|NCT01065766|468883194|FG000|Overall Study|Violated dosage/administration|25|||
130251515|NCT04818086|468883197|FG000|Overall Study|Physician Decision|1|||
130251516|NCT04818086|468883198|FG001|Overall Study|Physician Decision|0|||
130251517|NCT04818086|468883197|FG000|Overall Study|Withdrawal by Subject|0|||
130251518|NCT04818086|468883198|FG001|Overall Study|Withdrawal by Subject|1|||
130251519|NCT04128228|468883200|FG000|Overall Study|Withdrawal by Subject|3|||
130251520|NCT04128228|468883201|FG001|Overall Study|Withdrawal by Subject|3|||
130251521|NCT04128228|468883202|FG002|Overall Study|Withdrawal by Subject|0|||
130251522|NCT04128228|468883203|FG003|Overall Study|Withdrawal by Subject|0|||
130251523|NCT04128228|468883200|FG000|Overall Study|noncompliance|2|||
130251524|NCT04128228|468883201|FG001|Overall Study|noncompliance|2|||
130251525|NCT04128228|468883202|FG002|Overall Study|noncompliance|0|||
130251526|NCT04128228|468883203|FG003|Overall Study|noncompliance|0|||
130251527|NCT01602666|468883204|FG000|Induction Chemotherapy|Death|2|||
130251528|NCT01602666|468883205|FG001|Induction Chemotherapy|Death|1|||
130251529|NCT01602666|468883204|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
130251530|NCT01602666|468883205|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
130251531|NCT01602666|468883204|FG000|Induction Chemotherapy|Physician Decision|12|||
130251532|NCT01602666|468883205|FG001|Induction Chemotherapy|Physician Decision|5|||
130251533|NCT01602666|468883204|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
130251534|NCT01602666|468883205|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
130251535|NCT01602666|468883204|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
130553315|NCT02202551|469993552|FG000|Overall Study|Needed to take excluded medication|0|||
130700028|NCT02419573|470526374|FG000|Overall Study|Lost to Follow-up|3|||
130700029|NCT02419573|470526375|FG001|Overall Study|Lost to Follow-up|0|||
130700030|NCT02419573|470526374|FG000|Overall Study|Withdrawal by Subject|1|||
130251536|NCT01602666|468883205|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
130553316|NCT02202551|469993553|FG001|Overall Study|Needed to take excluded medication|2|||
130251537|NCT01602666|468883204|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
130251538|NCT01602666|468883205|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
130251539|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
130251540|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
130251541|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
130251542|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
130251543|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
130700031|NCT02419573|470526375|FG001|Overall Study|Withdrawal by Subject|0|||
130700032|NCT00493792|470526376|FG000|Overall Study|Death|55|||
130251544|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
130251545|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
130251546|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
130251547|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
130251548|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
130251549|NCT00215657|468883210|FG000|Overall Study|Adverse Event|5|||
130251550|NCT00215657|468883211|FG001|Overall Study|Adverse Event|1|||
130251551|NCT00215657|468883212|FG002|Overall Study|Adverse Event|3|||
130251552|NCT00215657|468883213|FG003|Overall Study|Adverse Event|0|||
130251553|NCT00215657|468883214|FG004|Overall Study|Adverse Event|3|||
130251554|NCT00215657|468883215|FG005|Overall Study|Adverse Event|1|||
130251555|NCT00215657|468883216|FG006|Overall Study|Adverse Event|0|||
130251556|NCT00215657|468883217|FG007|Overall Study|Adverse Event|3|||
130251557|NCT00215657|468883210|FG000|Overall Study|Withdrawal by Subject|6|||
130251558|NCT00215657|468883211|FG001|Overall Study|Withdrawal by Subject|3|||
130251559|NCT00215657|468883212|FG002|Overall Study|Withdrawal by Subject|3|||
130251560|NCT00215657|468883213|FG003|Overall Study|Withdrawal by Subject|1|||
130251561|NCT00215657|468883214|FG004|Overall Study|Withdrawal by Subject|6|||
130251562|NCT00215657|468883215|FG005|Overall Study|Withdrawal by Subject|1|||
130251563|NCT00215657|468883216|FG006|Overall Study|Withdrawal by Subject|10|||
130251564|NCT00215657|468883217|FG007|Overall Study|Withdrawal by Subject|3|||
130251565|NCT00215657|468883210|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
130251566|NCT00215657|468883211|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
130251567|NCT00215657|468883212|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
130251568|NCT00215657|468883213|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
130251569|NCT00215657|468883214|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
130251570|NCT00215657|468883215|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
130251571|NCT00215657|468883216|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
130251572|NCT00215657|468883217|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
130251573|NCT00215657|468883210|FG000|Overall Study|Insufficient testosterone response|5|||
130251574|NCT00215657|468883211|FG001|Overall Study|Insufficient testosterone response|4|||
130251575|NCT00215657|468883212|FG002|Overall Study|Insufficient testosterone response|1|||
130251576|NCT00215657|468883213|FG003|Overall Study|Insufficient testosterone response|12|||
130251577|NCT00215657|468883214|FG004|Overall Study|Insufficient testosterone response|8|||
130251578|NCT00215657|468883215|FG005|Overall Study|Insufficient testosterone response|12|||
130251579|NCT00215657|468883216|FG006|Overall Study|Insufficient testosterone response|4|||
130251580|NCT00215657|468883217|FG007|Overall Study|Insufficient testosterone response|7|||
130251581|NCT00215657|468883210|FG000|Overall Study|Other|3|||
130251582|NCT00215657|468883211|FG001|Overall Study|Other|1|||
130251583|NCT00215657|468883212|FG002|Overall Study|Other|2|||
130251584|NCT00215657|468883213|FG003|Overall Study|Other|3|||
130251585|NCT00215657|468883214|FG004|Overall Study|Other|5|||
130251586|NCT00215657|468883215|FG005|Overall Study|Other|4|||
130251587|NCT00215657|468883216|FG006|Overall Study|Other|6|||
130251588|NCT00215657|468883217|FG007|Overall Study|Other|1|||
130251589|NCT03769467|468883218|FG000|Overall Study|Adverse Event|1|||
130251590|NCT03769467|468883219|FG001|Overall Study|Adverse Event|1|||
130251591|NCT03769467|468883220|FG002|Overall Study|Adverse Event|0|||
130251592|NCT03769467|468883218|FG000|Overall Study|Death|3|||
130251593|NCT03769467|468883219|FG001|Overall Study|Death|3|||
130251594|NCT03769467|468883220|FG002|Overall Study|Death|0|||
130251595|NCT03769467|468883218|FG000|Overall Study|Study Terminated By Sponsor|2|||
130251596|NCT03769467|468883219|FG001|Overall Study|Study Terminated By Sponsor|1|||
130251597|NCT03769467|468883220|FG002|Overall Study|Study Terminated By Sponsor|0|||
130251598|NCT03769467|468883218|FG000|Overall Study|Withdrawal by Subject|0|||
130251599|NCT03769467|468883219|FG001|Overall Study|Withdrawal by Subject|1|||
130700033|NCT00493792|470526377|FG001|Overall Study|Death|50|||
130700034|NCT00493792|470526376|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
130700035|NCT00493792|470526377|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
130700036|NCT02246764|470526390|FG000|Overall Study|Adverse Event|15|||
130251600|NCT03769467|468883220|FG002|Overall Study|Withdrawal by Subject|0|||
130251601|NCT04754399|468883221|FG000|Overall Study|Adverse Event|5|||
130251602|NCT04754399|468883221|FG000|Overall Study|Withdrawal by Subject|6|||
130251603|NCT04565756|468883222|FG000|Overall Study|Withdrawal by Subject|0|||
130251604|NCT04565756|468883223|FG001|Overall Study|Withdrawal by Subject|0|||
130251605|NCT04565756|468883224|FG002|Overall Study|Withdrawal by Subject|0|||
130251606|NCT04565756|468883225|FG003|Overall Study|Withdrawal by Subject|0|||
130251607|NCT04565756|468883226|FG004|Overall Study|Withdrawal by Subject|1|||
130700037|NCT02246764|470526391|FG001|Overall Study|Adverse Event|29|||
130700038|NCT02246764|470526392|FG002|Overall Study|Adverse Event|1|||
130700039|NCT02246764|470526390|FG000|Overall Study|Withdrawal by Subject|0|||
130251608|NCT04565756|468883227|FG005|Overall Study|Withdrawal by Subject|0|||
130251609|NCT04565756|468883222|FG000|Overall Study|Protocol Violation|0|||
130251610|NCT04565756|468883223|FG001|Overall Study|Protocol Violation|0|||
130251611|NCT04565756|468883224|FG002|Overall Study|Protocol Violation|0|||
130251612|NCT04565756|468883225|FG003|Overall Study|Protocol Violation|0|||
130251613|NCT04565756|468883226|FG004|Overall Study|Protocol Violation|0|||
130251614|NCT04565756|468883227|FG005|Overall Study|Protocol Violation|1|||
130251615|NCT00968968|468883230|FG000|Overall Study|Study closed/terminated|10|||
130251616|NCT00968968|468883231|FG001|Overall Study|Study closed/terminated|10|||
130251617|NCT00968968|468883230|FG000|Overall Study|Protocol defined stopping criteria|3|||
130251618|NCT00968968|468883231|FG001|Overall Study|Protocol defined stopping criteria|1|||
130251619|NCT00968968|468883230|FG000|Overall Study|Withdrawal by Subject|2|||
130251620|NCT00968968|468883231|FG001|Overall Study|Withdrawal by Subject|0|||
130251621|NCT00968968|468883230|FG000|Overall Study|Physician Decision|1|||
130251622|NCT00968968|468883231|FG001|Overall Study|Physician Decision|2|||
130251623|NCT00968968|468883230|FG000|Overall Study|Lost to Follow-up|0|||
130251624|NCT00968968|468883231|FG001|Overall Study|Lost to Follow-up|1|||
130251625|NCT03624036|468883232|FG000|Overall Study|Death|2|||
130251626|NCT03624036|468883233|FG001|Overall Study|Death|3|||
130251627|NCT03624036|468883234|FG002|Overall Study|Death|0|||
130251628|NCT03624036|468883235|FG003|Overall Study|Death|1|||
130251629|NCT03624036|468883232|FG000|Overall Study|Withdrawal by Subject|1|||
130251630|NCT03624036|468883233|FG001|Overall Study|Withdrawal by Subject|0|||
130251631|NCT03624036|468883234|FG002|Overall Study|Withdrawal by Subject|1|||
130251632|NCT03624036|468883235|FG003|Overall Study|Withdrawal by Subject|0|||
130251633|NCT03624036|468883232|FG000|Overall Study|Enrolled but Never Treated|1|||
130251634|NCT03624036|468883233|FG001|Overall Study|Enrolled but Never Treated|0|||
130251635|NCT03624036|468883234|FG002|Overall Study|Enrolled but Never Treated|0|||
130251636|NCT03624036|468883235|FG003|Overall Study|Enrolled but Never Treated|0|||
130251637|NCT03624036|468883232|FG000|Overall Study|Reason not Specified|3|||
130251638|NCT03624036|468883233|FG001|Overall Study|Reason not Specified|0|||
130251639|NCT03624036|468883234|FG002|Overall Study|Reason not Specified|2|||
130251640|NCT03624036|468883235|FG003|Overall Study|Reason not Specified|2|||
130251641|NCT00930176|468883241|FG000|Overall Study|Death|1|||
130251642|NCT02413346|468883243|FG000|Overall Study|Adverse Event|6|||
130251643|NCT02413346|468883244|FG001|Overall Study|Adverse Event|6|||
130251644|NCT02413346|468883243|FG000|Overall Study|Withdrawal by Subject|30|||
130251645|NCT02413346|468883244|FG001|Overall Study|Withdrawal by Subject|40|||
130251646|NCT02413346|468883243|FG000|Overall Study|Lost to Follow-up|17|||
130251647|NCT02413346|468883244|FG001|Overall Study|Lost to Follow-up|21|||
130251648|NCT02413346|468883243|FG000|Overall Study|Protocol Violation|2|||
130251649|NCT02413346|468883244|FG001|Overall Study|Protocol Violation|0|||
130251650|NCT02413346|468883243|FG000|Overall Study|Other Miscellaneous Reasons|4|||
130251651|NCT02413346|468883244|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130251652|NCT00954538|468883248|FG000|Part III|Withdrawal by Subject|0|||
130251653|NCT00954538|468883249|FG001|Part III|Withdrawal by Subject|0|||
130251654|NCT00954538|468883250|FG002|Part III|Withdrawal by Subject|0|||
130251655|NCT00954538|468883251|FG003|Part III|Withdrawal by Subject|0|||
130251656|NCT00954538|468883252|FG004|Part III|Withdrawal by Subject|1|||
130251657|NCT00954538|468883253|FG005|Part III|Withdrawal by Subject|0|||
130251658|NCT00992394|468883254|FG000|Overall Study|Lack of Efficacy|6|||
130251659|NCT00992394|468883255|FG001|Overall Study|Lack of Efficacy|3|||
130251660|NCT00992394|468883254|FG000|Overall Study|Adverse Event|4|||
130251661|NCT00992394|468883255|FG001|Overall Study|Adverse Event|5|||
130452930|NCT00630864|469621752|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
130452931|NCT00124982|469621753|FG000|Short-term Period|Death|1|||
130452932|NCT00124982|469621754|FG001|Short-term Period|Death|1|||
130452933|NCT00124982|469621755|FG002|Short-term Period|Death|0|||
130452934|NCT00124982|469621753|FG000|Short-term Period|Adverse Event|17|||
130452935|NCT00124982|469621754|FG001|Short-term Period|Adverse Event|22|||
130452936|NCT00124982|469621755|FG002|Short-term Period|Adverse Event|0|||
130452937|NCT00124982|469621753|FG000|Short-term Period|Lack of Efficacy|32|||
130452938|NCT00124982|469621754|FG001|Short-term Period|Lack of Efficacy|73|||
130251662|NCT00992394|468883254|FG000|Overall Study|Withdrawal by Subject|8|||
130251663|NCT00992394|468883255|FG001|Overall Study|Withdrawal by Subject|2|||
130251664|NCT00992394|468883254|FG000|Overall Study|Physician Decision|1|||
130251665|NCT00992394|468883255|FG001|Overall Study|Physician Decision|0|||
130251666|NCT00992394|468883254|FG000|Overall Study|Protocol Violation|2|||
130251667|NCT00992394|468883255|FG001|Overall Study|Protocol Violation|4|||
130251668|NCT00992394|468883254|FG000|Overall Study|Lost to Follow-up|2|||
130251669|NCT00992394|468883255|FG001|Overall Study|Lost to Follow-up|0|||
130251670|NCT00992394|468883254|FG000|Overall Study|Other event|1|||
130452939|NCT00124982|469621755|FG002|Short-term Period|Lack of Efficacy|0|||
130452940|NCT00124982|469621753|FG000|Short-term Period|Lost to Follow-up|8|||
130452941|NCT00124982|469621754|FG001|Short-term Period|Lost to Follow-up|5|||
130251671|NCT00992394|468883255|FG001|Overall Study|Other event|0|||
130251672|NCT00655746|468883258|FG000|Overall Study|Withdrawal by Subject|1|||
130251673|NCT03061214|468883262|FG000|Overall Study|Withdrawal by Subject|21|||
130251674|NCT03061214|468883263|FG001|Overall Study|Withdrawal by Subject|26|||
130251675|NCT03061214|468883264|FG002|Overall Study|Withdrawal by Subject|9|||
130251676|NCT03061214|468883262|FG000|Overall Study|Lost to Follow-up|3|||
130251677|NCT03061214|468883263|FG001|Overall Study|Lost to Follow-up|1|||
130251678|NCT03061214|468883264|FG002|Overall Study|Lost to Follow-up|1|||
130251679|NCT03061214|468883262|FG000|Overall Study|Death|1|||
130251680|NCT03061214|468883263|FG001|Overall Study|Death|1|||
130251681|NCT03061214|468883264|FG002|Overall Study|Death|0|||
130251682|NCT01569763|468885382|FG000|Overall Study|Lack of Efficacy|2|||
130251683|NCT01569763|468885383|FG001|Overall Study|Lack of Efficacy|7|||
130251684|NCT01569763|468885382|FG000|Overall Study|Adverse Event|1|||
130251685|NCT01569763|468885383|FG001|Overall Study|Adverse Event|0|||
130251686|NCT02730169|468885384|FG000|Overall Study|Protocol Violation|1|||
130251687|NCT02730169|468885385|FG001|Overall Study|Protocol Violation|0|||
130251688|NCT02730169|468885386|FG002|Overall Study|Protocol Violation|0|||
130251689|NCT02730169|468885387|FG003|Overall Study|Protocol Violation|1|||
130251690|NCT02730169|468885384|FG000|Overall Study|Adverse Event|2|||
130251691|NCT02730169|468885385|FG001|Overall Study|Adverse Event|3|||
130251692|NCT02730169|468885386|FG002|Overall Study|Adverse Event|3|||
130251693|NCT02730169|468885387|FG003|Overall Study|Adverse Event|0|||
130251694|NCT02730169|468885384|FG000|Overall Study|Adverse Event of Special Interest|0|||
130251695|NCT02730169|468885385|FG001|Overall Study|Adverse Event of Special Interest|1|||
130251696|NCT02730169|468885386|FG002|Overall Study|Adverse Event of Special Interest|2|||
130251697|NCT02730169|468885387|FG003|Overall Study|Adverse Event of Special Interest|0|||
130251698|NCT02730169|468885384|FG000|Overall Study|Withdrawal by Subject|6|||
130251699|NCT02730169|468885385|FG001|Overall Study|Withdrawal by Subject|11|||
130251700|NCT02730169|468885386|FG002|Overall Study|Withdrawal by Subject|6|||
130251701|NCT02730169|468885387|FG003|Overall Study|Withdrawal by Subject|8|||
130251702|NCT02730169|468885384|FG000|Overall Study|Lost to Follow-up|5|||
130251703|NCT02730169|468885385|FG001|Overall Study|Lost to Follow-up|6|||
130251704|NCT02730169|468885386|FG002|Overall Study|Lost to Follow-up|5|||
130251705|NCT02730169|468885387|FG003|Overall Study|Lost to Follow-up|6|||
130251706|NCT02730169|468885384|FG000|Overall Study|Other|0|||
130251707|NCT02730169|468885385|FG001|Overall Study|Other|0|||
130251708|NCT02730169|468885386|FG002|Overall Study|Other|1|||
130251709|NCT02730169|468885387|FG003|Overall Study|Other|1|||
130251710|NCT03211858|468885395|FG000|Overall Study|Adverse Event|8|||
130251711|NCT03211858|468885396|FG001|Overall Study|Adverse Event|6|||
130251712|NCT03211858|468885395|FG000|Overall Study|Lack of Efficacy|0|||
130251713|NCT03211858|468885396|FG001|Overall Study|Lack of Efficacy|4|||
130251714|NCT03211858|468885395|FG000|Overall Study|Poor compliance to protocol|6|||
130251715|NCT03211858|468885396|FG001|Overall Study|Poor compliance to protocol|2|||
130251716|NCT03211858|468885395|FG000|Overall Study|Non-serious Hypoglycemia|1|||
130251717|NCT03211858|468885396|FG001|Overall Study|Non-serious Hypoglycemia|0|||
130251718|NCT03211858|468885395|FG000|Overall Study|Other than specified above|22|||
130251719|NCT03211858|468885396|FG001|Overall Study|Other than specified above|21|||
130251720|NCT03810365|468885397|FG000|Overall Study|Lost to Follow-up|2|||
130251721|NCT03810365|468885398|FG001|Overall Study|Lost to Follow-up|2|||
130251722|NCT03810365|468885397|FG000|Overall Study|Withdrawal by Subject|4|||
130251723|NCT03810365|468885398|FG001|Overall Study|Withdrawal by Subject|5|||
130251724|NCT02402907|468885407|FG000|Overall Study|Delivered vaginally|9|||
130251725|NCT02402907|468885408|FG001|Overall Study|Delivered vaginally|3|||
130251726|NCT02402907|468885407|FG000|Overall Study|Delivered outside of Sinai|1|||
130376664|NCT01327885|469345896|FG001|Overall Study|Clinical progression|27|||
130700040|NCT02246764|470526391|FG001|Overall Study|Withdrawal by Subject|0|||
130700041|NCT02246764|470526392|FG002|Overall Study|Withdrawal by Subject|1|||
130700042|NCT02246764|470526390|FG000|Overall Study|Disallowed Concomitant Medication|1|||
130700043|NCT02246764|470526391|FG001|Overall Study|Disallowed Concomitant Medication|0|||
130700044|NCT02246764|470526392|FG002|Overall Study|Disallowed Concomitant Medication|0|||
130700045|NCT02246764|470526390|FG000|Overall Study|Physician Decision|0|||
130700046|NCT02246764|470526391|FG001|Overall Study|Physician Decision|2|||
130700047|NCT02246764|470526392|FG002|Overall Study|Physician Decision|1|||
130700048|NCT02246764|470526390|FG000|Overall Study|Protocol Violation|2|||
130700049|NCT02246764|470526391|FG001|Overall Study|Protocol Violation|1|||
130251727|NCT02402907|468885408|FG001|Overall Study|Delivered outside of Sinai|1|||
130251728|NCT02402907|468885407|FG000|Overall Study|Lost to follow up after C-Section|10|||
130251729|NCT02402907|468885408|FG001|Overall Study|Lost to follow up after C-Section|23|||
130251730|NCT00449787|468885409|FG000|Overall Study|Lost to Follow-up|10|||
130251731|NCT00449787|468885410|FG001|Overall Study|Lost to Follow-up|8|||
130251732|NCT00449787|468885409|FG000|Overall Study|Did not require medication|95|||
130251733|NCT00449787|468885410|FG001|Overall Study|Did not require medication|92|||
130251734|NCT03701074|468885411|FG000|Overall Study|Physician Decision|1|||
130251735|NCT03701074|468885412|FG001|Overall Study|Physician Decision|0|||
130251736|NCT01423084|468885413|FG000|Overall Study|Adverse Event|0|||
130251737|NCT01423084|468885414|FG001|Overall Study|Adverse Event|1|||
130251738|NCT01423084|468885413|FG000|Overall Study|Withdrawal by Subject|2|||
130251739|NCT01423084|468885414|FG001|Overall Study|Withdrawal by Subject|3|||
130251740|NCT00661687|468885418|FG000|Overall Study|Study related symptoms and complaints|5|||
130251741|NCT00661687|468885418|FG000|Overall Study|Positive slit lamp findings|4|||
130700050|NCT02246764|470526392|FG002|Overall Study|Protocol Violation|1|||
130700051|NCT02754492|470526395|FG000|Overall Study|Protocol Violation|2|||
130700052|NCT02754492|470526396|FG001|Overall Study|Protocol Violation|2|||
130251742|NCT00661687|468885418|FG000|Overall Study|Inability to maintain wearing schedule|3|||
130251743|NCT00661687|468885418|FG000|Overall Study|Physician Decision|1|||
130251744|NCT00661687|468885418|FG000|Overall Study|Adverse Event|2|||
130251745|NCT03574389|468885419|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
130251746|NCT03574389|468885420|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
130251747|NCT03574389|468885421|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
130251748|NCT03574389|468885422|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
130251749|NCT03574389|468885423|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
130251750|NCT03574389|468885424|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
130251751|NCT03574389|468885425|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
130251752|NCT03574389|468885419|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
130251753|NCT03574389|468885420|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
130251754|NCT03574389|468885421|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
130251755|NCT03574389|468885422|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
130251756|NCT03574389|468885423|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251757|NCT03574389|468885424|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251758|NCT03574389|468885425|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251759|NCT03574389|468885419|FG000|Vaccination Period|Other|6|||
130251760|NCT03574389|468885420|FG001|Vaccination Period|Other|0|||
130251761|NCT03574389|468885421|FG002|Vaccination Period|Other|0|||
130251762|NCT03574389|468885422|FG003|Vaccination Period|Other|0|||
130251763|NCT03574389|468885423|FG004|Vaccination Period|Other|0|||
130251764|NCT03574389|468885424|FG005|Vaccination Period|Other|0|||
130251765|NCT03574389|468885425|FG006|Vaccination Period|Other|0|||
130251766|NCT03574389|468885419|FG000|Vaccination Period|Adverse Event|0|||
130251767|NCT03574389|468885420|FG001|Vaccination Period|Adverse Event|1|||
130251768|NCT03574389|468885421|FG002|Vaccination Period|Adverse Event|0|||
130251769|NCT03574389|468885422|FG003|Vaccination Period|Adverse Event|0|||
130251770|NCT03574389|468885423|FG004|Vaccination Period|Adverse Event|0|||
130251771|NCT03574389|468885424|FG005|Vaccination Period|Adverse Event|0|||
130251772|NCT03574389|468885425|FG006|Vaccination Period|Adverse Event|0|||
130251773|NCT03574389|468885419|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
130251774|NCT03574389|468885420|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
130251775|NCT03574389|468885421|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
130251776|NCT03574389|468885422|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
130251777|NCT03574389|468885423|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
130251778|NCT03574389|468885424|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
130251779|NCT03574389|468885425|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
130251780|NCT02094885|468885428|FG000|Overall Study|Death|1|||
130251781|NCT02094885|468885429|FG001|Overall Study|Death|5|||
130251782|NCT02094885|468885428|FG000|Overall Study|Withdrawn due to age|1|||
130251783|NCT02094885|468885429|FG001|Overall Study|Withdrawn due to age|0|||
130251784|NCT03707821|468885432|FG000|Overall Study|Protocol Violation|0|||
130251785|NCT03707821|468885433|FG001|Overall Study|Protocol Violation|1|||
130251786|NCT03707821|468885432|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130251787|NCT03707821|468885433|FG001|Overall Study|Unsatisfactory Visual Response|0|||
130251788|NCT03707821|468885432|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130251789|NCT03707821|468885433|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130251790|NCT00756314|468885434|FG000|Overall Study|Lost to Follow-up|2|||
130251791|NCT00756314|468885435|FG001|Overall Study|Lost to Follow-up|59|||
130251792|NCT02605967|468885436|FG000|Overall Study|subject / guardian decision|1|||
130251793|NCT02605967|468885437|FG001|Overall Study|subject / guardian decision|2|||
130251794|NCT02605967|468885436|FG000|Overall Study|Physician Decision|10|||
130251795|NCT02605967|468885437|FG001|Overall Study|Physician Decision|1|||
130251796|NCT02605967|468885436|FG000|Overall Study|Death|4|||
130452942|NCT00124982|469621755|FG002|Short-term Period|Lost to Follow-up|0|||
130452943|NCT00124982|469621753|FG000|Short-term Period|Withdrawal of Consent|7|||
130452944|NCT00124982|469621754|FG001|Short-term Period|Withdrawal of Consent|9|||
130452945|NCT00124982|469621755|FG002|Short-term Period|Withdrawal of Consent|0|||
130452946|NCT00124982|469621753|FG000|Short-term Period|Poor/Non-compliance|3|||
130452947|NCT00124982|469621754|FG001|Short-term Period|Poor/Non-compliance|1|||
130700053|NCT02754492|470526397|FG002|Overall Study|Protocol Violation|0|||
130700054|NCT02754492|470526398|FG003|Overall Study|Protocol Violation|1|||
130700055|NCT02754492|470526395|FG000|Overall Study|Withdrawal by Subject|2|||
130700056|NCT02754492|470526396|FG001|Overall Study|Withdrawal by Subject|0|||
130251797|NCT02605967|468885437|FG001|Overall Study|Death|2|||
130251798|NCT02605967|468885436|FG000|Overall Study|Adverse Event|1|||
130251799|NCT02605967|468885437|FG001|Overall Study|Adverse Event|0|||
130251800|NCT02605967|468885436|FG000|Overall Study|progressive disease|66|||
130251801|NCT02605967|468885437|FG001|Overall Study|progressive disease|35|||
130251802|NCT00159874|468885442|FG000|Overall Study|Adverse Event|2|||
130251803|NCT00159874|468885443|FG001|Overall Study|Adverse Event|2|||
130251804|NCT00159874|468885444|FG002|Overall Study|Adverse Event|5|||
130251805|NCT00159874|468885445|FG003|Overall Study|Adverse Event|1|||
130452948|NCT00124982|469621755|FG002|Short-term Period|Poor/Non-compliance|0|||
130452949|NCT00124982|469621753|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
130452950|NCT00124982|469621754|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
130452951|NCT00124982|469621755|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
130452952|NCT00124982|469621753|FG000|Short-term Period|Participant Decision|1|||
130452953|NCT00124982|469621754|FG001|Short-term Period|Participant Decision|0|||
130452954|NCT00124982|469621755|FG002|Short-term Period|Participant Decision|0|||
130452955|NCT00124982|469621753|FG000|Short-term Period|Participant Chose Own Doctor|0|||
130452956|NCT00124982|469621754|FG001|Short-term Period|Participant Chose Own Doctor|1|||
130452957|NCT00124982|469621755|FG002|Short-term Period|Participant Chose Own Doctor|0|||
130452958|NCT00124982|469621753|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
130452959|NCT00124982|469621754|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
130452960|NCT00124982|469621755|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
130452961|NCT00124982|469621753|FG000|Short-term Period|Participant Had Lymphopenia|1|||
130452962|NCT00124982|469621754|FG001|Short-term Period|Participant Had Lymphopenia|0|||
130452963|NCT00124982|469621755|FG002|Short-term Period|Participant Had Lymphopenia|0|||
130452964|NCT00124982|469621753|FG000|Long-term Period|Death|0|||
130452965|NCT00124982|469621754|FG001|Long-term Period|Death|0|||
130452966|NCT00124982|469621755|FG002|Long-term Period|Death|1|||
130452967|NCT00124982|469621753|FG000|Long-term Period|Adverse Event|0|||
130452968|NCT00124982|469621754|FG001|Long-term Period|Adverse Event|0|||
130452969|NCT00124982|469621755|FG002|Long-term Period|Adverse Event|17|||
130452970|NCT00124982|469621753|FG000|Long-term Period|Lack of Efficacy|0|||
130452971|NCT00124982|469621754|FG001|Long-term Period|Lack of Efficacy|0|||
130452972|NCT00124982|469621755|FG002|Long-term Period|Lack of Efficacy|46|||
130452973|NCT00124982|469621753|FG000|Long-term Period|Lost to Follow-up|0|||
130452974|NCT00124982|469621754|FG001|Long-term Period|Lost to Follow-up|0|||
130452975|NCT00124982|469621755|FG002|Long-term Period|Lost to Follow-up|4|||
130452976|NCT00124982|469621753|FG000|Long-term Period|Withdrawal by Subject|0|||
130452977|NCT00124982|469621754|FG001|Long-term Period|Withdrawal by Subject|0|||
130452978|NCT00124982|469621755|FG002|Long-term Period|Withdrawal by Subject|16|||
130452979|NCT00124982|469621753|FG000|Long-term Period|Pregnancy|0|||
130452980|NCT00124982|469621754|FG001|Long-term Period|Pregnancy|0|||
130452981|NCT00124982|469621755|FG002|Long-term Period|Pregnancy|1|||
130452982|NCT00124982|469621753|FG000|Long-term Period|Poor/Non-compliance|0|||
130452983|NCT00124982|469621754|FG001|Long-term Period|Poor/Non-compliance|0|||
130452984|NCT00124982|469621755|FG002|Long-term Period|Poor/Non-compliance|2|||
130452985|NCT00124982|469621753|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
130452986|NCT00124982|469621754|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
130452987|NCT00124982|469621755|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
130452988|NCT00124982|469621753|FG000|Long-term Period|Neurologist Recommendation|0|||
130452989|NCT00124982|469621754|FG001|Long-term Period|Neurologist Recommendation|0|||
130452990|NCT00124982|469621755|FG002|Long-term Period|Neurologist Recommendation|1|||
130452991|NCT00430677|469621758|FG000|Short-term Period|Death|1|||
130452992|NCT00430677|469621759|FG001|Short-term Period|Death|1|||
130452993|NCT00430677|469621760|FG002|Short-term Period|Death|5|||
130452994|NCT00430677|469621758|FG000|Short-term Period|Adverse Event|15|||
130452995|NCT00430677|469621759|FG001|Short-term Period|Adverse Event|13|||
130452996|NCT00430677|469621760|FG002|Short-term Period|Adverse Event|9|||
130452997|NCT00430677|469621758|FG000|Short-term Period|Lack of Efficacy|5|||
130452998|NCT00430677|469621759|FG001|Short-term Period|Lack of Efficacy|6|||
130452999|NCT00430677|469621760|FG002|Short-term Period|Lack of Efficacy|4|||
130453000|NCT00430677|469621758|FG000|Short-term Period|Withdrawal by Subject|1|||
130251806|NCT00159874|468885446|FG004|Overall Study|Adverse Event|1|||
130251807|NCT00159874|468885447|FG005|Overall Study|Adverse Event|2|||
130251808|NCT00159874|468885448|FG006|Overall Study|Adverse Event|0|||
130251809|NCT00159874|468885442|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
130251810|NCT00159874|468885443|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
130251811|NCT00159874|468885444|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
130251812|NCT00159874|468885445|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
130251813|NCT00159874|468885446|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
130251814|NCT00159874|468885447|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
130251815|NCT00159874|468885448|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
130453001|NCT00430677|469621759|FG001|Short-term Period|Withdrawal by Subject|1|||
130453002|NCT00430677|469621760|FG002|Short-term Period|Withdrawal by Subject|2|||
130453003|NCT00430677|469621758|FG000|Short-term Period|Participant no longer met study criteria|1|||
130453004|NCT00430677|469621759|FG001|Short-term Period|Participant no longer met study criteria|1|||
130453005|NCT00430677|469621760|FG002|Short-term Period|Participant no longer met study criteria|2|||
130453006|NCT00430677|469621758|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
130251816|NCT00159874|468885442|FG000|Overall Study|Lack of Efficacy|2|||
130251817|NCT00159874|468885443|FG001|Overall Study|Lack of Efficacy|0|||
130453007|NCT00430677|469621759|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
130453008|NCT00430677|469621760|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
130453009|NCT00430677|469621758|FG000|Short-term Period|Pregnancy|0|||
130251818|NCT00159874|468885444|FG002|Overall Study|Lack of Efficacy|1|||
130251819|NCT00159874|468885445|FG003|Overall Study|Lack of Efficacy|1|||
130251820|NCT00159874|468885446|FG004|Overall Study|Lack of Efficacy|0|||
130251821|NCT00159874|468885447|FG005|Overall Study|Lack of Efficacy|3|||
130251822|NCT00159874|468885448|FG006|Overall Study|Lack of Efficacy|0|||
130453010|NCT00430677|469621759|FG001|Short-term Period|Pregnancy|2|||
130453011|NCT00430677|469621760|FG002|Short-term Period|Pregnancy|0|||
130453012|NCT00430677|469621758|FG000|Long-term Extension Period|Death|1|||
130453013|NCT00430677|469621759|FG001|Long-term Extension Period|Death|0|||
130453014|NCT00430677|469621760|FG002|Long-term Extension Period|Death|0|||
130453015|NCT00430677|469621758|FG000|Long-term Extension Period|Adverse Event|3|||
130453016|NCT00430677|469621759|FG001|Long-term Extension Period|Adverse Event|2|||
130453017|NCT00430677|469621760|FG002|Long-term Extension Period|Adverse Event|5|||
130453018|NCT00430677|469621758|FG000|Long-term Extension Period|Lack of Efficacy|5|||
130453019|NCT00430677|469621759|FG001|Long-term Extension Period|Lack of Efficacy|3|||
130453020|NCT00430677|469621760|FG002|Long-term Extension Period|Lack of Efficacy|8|||
130453021|NCT00430677|469621758|FG000|Long-term Extension Period|Lost to Follow-up|1|||
130453022|NCT00430677|469621759|FG001|Long-term Extension Period|Lost to Follow-up|1|||
130453023|NCT00430677|469621760|FG002|Long-term Extension Period|Lost to Follow-up|1|||
130453024|NCT00430677|469621758|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
130453025|NCT00430677|469621759|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
130453026|NCT00430677|469621760|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
130251823|NCT00159874|468885442|FG000|Overall Study|Lost to Follow-up|1|||
130251824|NCT00159874|468885443|FG001|Overall Study|Lost to Follow-up|0|||
130251825|NCT00159874|468885444|FG002|Overall Study|Lost to Follow-up|3|||
130251826|NCT00159874|468885445|FG003|Overall Study|Lost to Follow-up|0|||
130251827|NCT00159874|468885446|FG004|Overall Study|Lost to Follow-up|1|||
130251828|NCT00159874|468885447|FG005|Overall Study|Lost to Follow-up|2|||
130251829|NCT00159874|468885448|FG006|Overall Study|Lost to Follow-up|1|||
130251830|NCT00159874|468885442|FG000|Overall Study|Other|8|||
130453027|NCT00430677|469621758|FG000|Long-term Extension Period|Pregnancy|1|||
130453028|NCT00430677|469621759|FG001|Long-term Extension Period|Pregnancy|1|||
130453029|NCT00430677|469621760|FG002|Long-term Extension Period|Pregnancy|0|||
130453030|NCT00430677|469621758|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
130251831|NCT00159874|468885443|FG001|Overall Study|Other|8|||
130251832|NCT00159874|468885444|FG002|Overall Study|Other|8|||
130251833|NCT00159874|468885445|FG003|Overall Study|Other|0|||
130251834|NCT00159874|468885446|FG004|Overall Study|Other|2|||
130251835|NCT00159874|468885447|FG005|Overall Study|Other|1|||
130251836|NCT00159874|468885448|FG006|Overall Study|Other|3|||
130251837|NCT00159874|468885442|FG000|Overall Study|Protocol Violation|0|||
130251838|NCT00159874|468885443|FG001|Overall Study|Protocol Violation|5|||
130251839|NCT00159874|468885444|FG002|Overall Study|Protocol Violation|2|||
130251840|NCT00159874|468885445|FG003|Overall Study|Protocol Violation|0|||
130251841|NCT00159874|468885446|FG004|Overall Study|Protocol Violation|0|||
130251842|NCT00159874|468885447|FG005|Overall Study|Protocol Violation|0|||
130251843|NCT00159874|468885448|FG006|Overall Study|Protocol Violation|0|||
130251844|NCT00159874|468885442|FG000|Overall Study|Death|3|||
130251845|NCT00159874|468885443|FG001|Overall Study|Death|8|||
130251846|NCT00159874|468885444|FG002|Overall Study|Death|15|||
130251847|NCT00159874|468885445|FG003|Overall Study|Death|0|||
130251848|NCT00159874|468885446|FG004|Overall Study|Death|1|||
130251849|NCT00159874|468885447|FG005|Overall Study|Death|2|||
130251850|NCT00159874|468885448|FG006|Overall Study|Death|0|||
130251851|NCT00159874|468885442|FG000|Overall Study|Withdrawal by Subject|2|||
130251852|NCT00159874|468885443|FG001|Overall Study|Withdrawal by Subject|6|||
130251853|NCT00159874|468885444|FG002|Overall Study|Withdrawal by Subject|8|||
130251854|NCT00159874|468885445|FG003|Overall Study|Withdrawal by Subject|4|||
130251855|NCT00159874|468885446|FG004|Overall Study|Withdrawal by Subject|3|||
130251856|NCT00159874|468885447|FG005|Overall Study|Withdrawal by Subject|2|||
130251857|NCT00159874|468885448|FG006|Overall Study|Withdrawal by Subject|1|||
130251858|NCT00159874|468885442|FG000|Overall Study|Pregnancy|1|||
130251859|NCT00159874|468885443|FG001|Overall Study|Pregnancy|1|||
130251860|NCT00159874|468885444|FG002|Overall Study|Pregnancy|0|||
130251861|NCT00159874|468885445|FG003|Overall Study|Pregnancy|0|||
130453031|NCT00430677|469621759|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
130553317|NCT02202551|469993554|FG002|Overall Study|Needed to take excluded medication|0|||
130251862|NCT00159874|468885446|FG004|Overall Study|Pregnancy|0|||
130251863|NCT00159874|468885447|FG005|Overall Study|Pregnancy|0|||
130251864|NCT00159874|468885448|FG006|Overall Study|Pregnancy|0|||
130251865|NCT05122143|468885451|FG000|Overall Study|Adverse Event|1|||
130251866|NCT05122143|468885452|FG001|Overall Study|Adverse Event|0|||
130251867|NCT05122143|468885453|FG002|Overall Study|Adverse Event|0|||
130251868|NCT05122143|468885454|FG003|Overall Study|Adverse Event|0|||
130251869|NCT05122143|468885455|FG004|Overall Study|Adverse Event|1|||
130251870|NCT05122143|468885456|FG005|Overall Study|Adverse Event|0|||
130251871|NCT05122143|468885451|FG000|Overall Study|Protocol non-compliance|0|||
130251872|NCT05122143|468885452|FG001|Overall Study|Protocol non-compliance|0|||
130251873|NCT05122143|468885453|FG002|Overall Study|Protocol non-compliance|1|||
130251874|NCT05122143|468885454|FG003|Overall Study|Protocol non-compliance|0|||
130251875|NCT05122143|468885455|FG004|Overall Study|Protocol non-compliance|0|||
130251876|NCT05122143|468885456|FG005|Overall Study|Protocol non-compliance|0|||
130251877|NCT05122143|468885451|FG000|Overall Study|Covid contact|0|||
130251878|NCT05122143|468885452|FG001|Overall Study|Covid contact|0|||
130251879|NCT05122143|468885453|FG002|Overall Study|Covid contact|0|||
130251880|NCT05122143|468885454|FG003|Overall Study|Covid contact|0|||
130251881|NCT05122143|468885455|FG004|Overall Study|Covid contact|1|||
130251882|NCT05122143|468885456|FG005|Overall Study|Covid contact|0|||
130251883|NCT01475825|468885457|FG000|Overall Study|Adverse Event|41|||
130251884|NCT01475825|468885458|FG001|Overall Study|Adverse Event|15|||
130251885|NCT01475825|468885459|FG002|Overall Study|Adverse Event|27|||
130251886|NCT01475825|468885460|FG003|Overall Study|Adverse Event|11|||
130251887|NCT01475825|468885457|FG000|Overall Study|Death|1|||
130251888|NCT01475825|468885458|FG001|Overall Study|Death|0|||
130251889|NCT01475825|468885459|FG002|Overall Study|Death|1|||
130251890|NCT01475825|468885460|FG003|Overall Study|Death|0|||
130251891|NCT01475825|468885457|FG000|Overall Study|Lack of Efficacy|0|||
130251892|NCT01475825|468885458|FG001|Overall Study|Lack of Efficacy|0|||
130251893|NCT01475825|468885459|FG002|Overall Study|Lack of Efficacy|1|||
130251894|NCT01475825|468885460|FG003|Overall Study|Lack of Efficacy|0|||
130251895|NCT01475825|468885457|FG000|Overall Study|Lost to Follow-up|0|||
130251896|NCT01475825|468885458|FG001|Overall Study|Lost to Follow-up|0|||
130251897|NCT01475825|468885459|FG002|Overall Study|Lost to Follow-up|3|||
130251898|NCT01475825|468885460|FG003|Overall Study|Lost to Follow-up|1|||
130251899|NCT01475825|468885457|FG000|Overall Study|Non-compliance with Study Drug|1|||
130251900|NCT01475825|468885458|FG001|Overall Study|Non-compliance with Study Drug|2|||
130251901|NCT01475825|468885459|FG002|Overall Study|Non-compliance with Study Drug|4|||
130251902|NCT01475825|468885460|FG003|Overall Study|Non-compliance with Study Drug|0|||
130251903|NCT01475825|468885457|FG000|Overall Study|Other: Not available|0|||
130251904|NCT01475825|468885458|FG001|Overall Study|Other: Not available|0|||
130251905|NCT01475825|468885459|FG002|Overall Study|Other: Not available|2|||
130251906|NCT01475825|468885460|FG003|Overall Study|Other: Not available|0|||
130251907|NCT01475825|468885457|FG000|Overall Study|Protocol Violation|1|||
130364850|NCT04680052|469306757|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130251908|NCT01475825|468885458|FG001|Overall Study|Protocol Violation|0|||
130251909|NCT01475825|468885459|FG002|Overall Study|Protocol Violation|0|||
130251910|NCT01475825|468885460|FG003|Overall Study|Protocol Violation|0|||
130364851|NCT04680052|469306758|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130364852|NCT04680052|469306755|FG000|Overall Study|Physician Decision|0|||
130364853|NCT04680052|469306756|FG001|Overall Study|Physician Decision|1|||
130364854|NCT04680052|469306757|FG002|Overall Study|Physician Decision|0|||
130364855|NCT04680052|469306758|FG003|Overall Study|Physician Decision|0|||
130364856|NCT03320057|469306759|FG000|Overall Study|Lost to Follow-up|4|||
130364857|NCT03320057|469306760|FG001|Overall Study|Lost to Follow-up|17|||
130364858|NCT03320057|469306759|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
130364859|NCT03320057|469306760|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
130364860|NCT06956170|469306761|FG000|Overall Study|Death|2|||
130364861|NCT06956170|469306762|FG001|Overall Study|Death|1|||
130364862|NCT06956170|469306761|FG000|Overall Study|Withdrawal by Subject|1|||
130364863|NCT06956170|469306762|FG001|Overall Study|Withdrawal by Subject|0|||
130364864|NCT06956170|469306761|FG000|Overall Study|Ongoing|7|||
130364865|NCT06956170|469306762|FG001|Overall Study|Ongoing|10|||
130364866|NCT01516437|469306763|FG000|Overall Study|Reason not specified|0|||
130700057|NCT02754492|470526397|FG002|Overall Study|Withdrawal by Subject|0|||
130700058|NCT02754492|470526398|FG003|Overall Study|Withdrawal by Subject|0|||
130700059|NCT02754492|470526395|FG000|Overall Study|Equipment malfuntion|0|||
130700060|NCT02754492|470526396|FG001|Overall Study|Equipment malfuntion|0|||
130700061|NCT02754492|470526397|FG002|Overall Study|Equipment malfuntion|2|||
130700062|NCT02754492|470526398|FG003|Overall Study|Equipment malfuntion|5|||
130700063|NCT02754492|470526395|FG000|Overall Study|Adverse Event|0|||
130700064|NCT02754492|470526396|FG001|Overall Study|Adverse Event|0|||
130700065|NCT02754492|470526397|FG002|Overall Study|Adverse Event|0|||
130700066|NCT02754492|470526398|FG003|Overall Study|Adverse Event|13|||
130700067|NCT02754492|470526395|FG000|Overall Study|Venous access issues not resulting in AE|0|||
130700068|NCT02754492|470526396|FG001|Overall Study|Venous access issues not resulting in AE|0|||
130700069|NCT02754492|470526397|FG002|Overall Study|Venous access issues not resulting in AE|0|||
130700070|NCT02754492|470526398|FG003|Overall Study|Venous access issues not resulting in AE|4|||
130700071|NCT01408888|470526399|FG000|First Intervention|Adverse Event|0|||
130700072|NCT01408888|470526400|FG001|First Intervention|Adverse Event|1|||
130700073|NCT01408888|470526399|FG000|First Intervention|Withdrawal by Subject|0|||
130251911|NCT01475825|468885457|FG000|Overall Study|Physician Decision|0|||
130251912|NCT01475825|468885458|FG001|Overall Study|Physician Decision|1|||
130251913|NCT01475825|468885459|FG002|Overall Study|Physician Decision|0|||
130251914|NCT01475825|468885460|FG003|Overall Study|Physician Decision|0|||
130251915|NCT01475825|468885457|FG000|Overall Study|Withdrawal by Subject|8|||
130251916|NCT01475825|468885458|FG001|Overall Study|Withdrawal by Subject|3|||
130251917|NCT01475825|468885459|FG002|Overall Study|Withdrawal by Subject|11|||
130251918|NCT01475825|468885460|FG003|Overall Study|Withdrawal by Subject|7|||
130251919|NCT01475825|468885457|FG000|Overall Study|Did not enter OLC|15|||
130251920|NCT01475825|468885458|FG001|Overall Study|Did not enter OLC|11|||
130251921|NCT01475825|468885459|FG002|Overall Study|Did not enter OLC|15|||
130251922|NCT01475825|468885460|FG003|Overall Study|Did not enter OLC|11|||
130251923|NCT00309946|468885463|FG000|Overall Study|Withdrawal by Subject|1|||
130251924|NCT02624687|468885467|FG000|Overall Study|Withdrawal by Subject|1|||
130251925|NCT02624687|468885468|FG001|Overall Study|Withdrawal by Subject|1|||
130251926|NCT02624687|468885467|FG000|Overall Study|medical leave from work|0|||
130251927|NCT02624687|468885468|FG001|Overall Study|medical leave from work|1|||
130251928|NCT03111108|468885469|FG000|Overall Study|Death|0|||
130251929|NCT03111108|468885470|FG001|Overall Study|Death|1|||
130251930|NCT03111108|468885469|FG000|Overall Study|Withdrawal by Subject|1|||
130251931|NCT03111108|468885470|FG001|Overall Study|Withdrawal by Subject|0|||
130251932|NCT02771145|468885471|FG000|Overall Study|Adverse Event|3|||
130251933|NCT02771145|468885471|FG000|Overall Study|Lost to Follow-up|1|||
130251934|NCT02264821|468885472|FG000|Overall Study|Protocol Violation|1|||
130251935|NCT02264821|468885473|FG001|Overall Study|Protocol Violation|3|||
130251936|NCT02264821|468885474|FG002|Overall Study|Protocol Violation|6|||
130251937|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
130251938|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
130251939|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
130251940|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
130251941|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
130251942|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
130251943|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130251944|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130251945|NCT00511199|468885479|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
130251946|NCT00511199|468885480|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
130251947|NCT00511199|468885479|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
130251948|NCT00511199|468885480|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
130251949|NCT00511199|468885479|FG000|Overall Study|Withdrawal of Informed Consent|19|||
130251950|NCT00511199|468885480|FG001|Overall Study|Withdrawal of Informed Consent|4|||
130251951|NCT00511199|468885479|FG000|Overall Study|Pregnancy|6|||
130251952|NCT00511199|468885480|FG001|Overall Study|Pregnancy|3|||
130251953|NCT00511199|468885479|FG000|Overall Study|Pregnancy Wish|16|||
130251954|NCT00511199|468885480|FG001|Overall Study|Pregnancy Wish|8|||
130251955|NCT00511199|468885479|FG000|Overall Study|Lost to Follow-up|40|||
130251956|NCT00511199|468885480|FG001|Overall Study|Lost to Follow-up|17|||
130364867|NCT01516437|469306764|FG001|Overall Study|Reason not specified|0|||
130364868|NCT01516437|469306765|FG002|Overall Study|Reason not specified|1|||
130364869|NCT01516437|469306766|FG003|Overall Study|Reason not specified|1|||
130364870|NCT00316719|469306769|FG000|Overall Study|Adverse Event|0|||
130364871|NCT00316719|469306770|FG001|Overall Study|Adverse Event|6|||
130364872|NCT00316719|469306769|FG000|Overall Study|Consent withdrawn|2|||
130364873|NCT00316719|469306770|FG001|Overall Study|Consent withdrawn|0|||
130700074|NCT01408888|470526400|FG001|First Intervention|Withdrawal by Subject|2|||
130700075|NCT01408888|470526399|FG000|Second Intervention|Withdrawal by Subject|1|||
130700076|NCT01408888|470526400|FG001|Second Intervention|Withdrawal by Subject|0|||
130700077|NCT01408888|470526399|FG000|Second Intervention|Adverse Event|1|||
130700078|NCT01408888|470526400|FG001|Second Intervention|Adverse Event|0|||
130700079|NCT00695110|470526403|FG000|Treatment Period 1|Adverse Event|1|||
130700080|NCT00695110|470526403|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130700081|NCT00695110|470526403|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130700082|NCT00695110|470526403|FG000|Treatment Period 4|Adverse Event|1|||
130700083|NCT00611884|470526406|FG000|Overall Study|Adverse Event|1|||
130700084|NCT00611884|470526407|FG001|Overall Study|Adverse Event|0|||
130700085|NCT00611884|470526408|FG002|Overall Study|Adverse Event|0|||
130700086|NCT00611884|470526409|FG003|Overall Study|Adverse Event|1|||
130700087|NCT00611884|470526406|FG000|Overall Study|Non-Compliance|1|||
130700088|NCT00611884|470526407|FG001|Overall Study|Non-Compliance|4|||
130700089|NCT00611884|470526408|FG002|Overall Study|Non-Compliance|2|||
130700090|NCT00611884|470526409|FG003|Overall Study|Non-Compliance|2|||
130251957|NCT00511199|468885479|FG000|Overall Study|Other Reason|78|||
130251958|NCT00511199|468885480|FG001|Overall Study|Other Reason|37|||
130251959|NCT01953354|468885486|FG000|Overall Study|Withdrawal by Subject|0|||
130251960|NCT01953354|468885487|FG001|Overall Study|Withdrawal by Subject|1|||
130251961|NCT01953354|468885486|FG000|Overall Study|Decision of Sponsor|0|||
130364874|NCT02400333|469306773|FG000|Overall Study|Withdrawal by Subject|0|||
130700091|NCT00611884|470526406|FG000|Overall Study|Lack of Efficacy|0|||
130251962|NCT01953354|468885487|FG001|Overall Study|Decision of Sponsor|1|||
130251963|NCT01953354|468885486|FG000|Overall Study|Disease Exacerbation|1|||
130251964|NCT01953354|468885487|FG001|Overall Study|Disease Exacerbation|0|||
130251965|NCT01570192|468885488|FG000|Overall Study|no qualifying organism|6|||
130251966|NCT01570192|468885489|FG001|Overall Study|no qualifying organism|12|||
130251967|NCT01570192|468885488|FG000|Overall Study|changed to palliative care|1|||
130251968|NCT01570192|468885489|FG001|Overall Study|changed to palliative care|0|||
130251969|NCT01570192|468885488|FG000|Overall Study|Physician Decision|0|||
130251970|NCT01570192|468885489|FG001|Overall Study|Physician Decision|1|||
130251971|NCT01696214|468885490|FG000|Overall Study|Lost to Follow-up|1|||
130251972|NCT01696214|468885491|FG001|Overall Study|Lost to Follow-up|0|||
130251973|NCT01696214|468885492|FG002|Overall Study|Lost to Follow-up|0|||
130251974|NCT01696214|468885493|FG003|Overall Study|Lost to Follow-up|0|||
130251975|NCT00806026|468885494|FG000|Overall Study|Death|0|||
130251976|NCT00806026|468885495|FG001|Overall Study|Death|0|||
130251977|NCT00806026|468885496|FG002|Overall Study|Death|0|||
130251978|NCT00806026|468885497|FG003|Overall Study|Death|1|||
130251979|NCT00806026|468885498|FG004|Overall Study|Death|0|||
130251980|NCT00806026|468885499|FG005|Overall Study|Death|0|||
130251981|NCT00806026|468885494|FG000|Overall Study|Did not meet entrance criteria|4|||
130251982|NCT00806026|468885495|FG001|Overall Study|Did not meet entrance criteria|1|||
130251983|NCT00806026|468885496|FG002|Overall Study|Did not meet entrance criteria|2|||
130251984|NCT00806026|468885497|FG003|Overall Study|Did not meet entrance criteria|1|||
130251985|NCT00806026|468885498|FG004|Overall Study|Did not meet entrance criteria|0|||
130251986|NCT00806026|468885499|FG005|Overall Study|Did not meet entrance criteria|0|||
130251987|NCT00806026|468885494|FG000|Overall Study|Lack of Efficacy|5|||
130251988|NCT00806026|468885495|FG001|Overall Study|Lack of Efficacy|18|||
130251989|NCT00806026|468885496|FG002|Overall Study|Lack of Efficacy|13|||
130251990|NCT00806026|468885497|FG003|Overall Study|Lack of Efficacy|4|||
130251991|NCT00806026|468885498|FG004|Overall Study|Lack of Efficacy|8|||
130251992|NCT00806026|468885499|FG005|Overall Study|Lack of Efficacy|7|||
130251993|NCT00806026|468885494|FG000|Overall Study|Lost to Follow-up|8|||
130251994|NCT00806026|468885495|FG001|Overall Study|Lost to Follow-up|15|||
130251995|NCT00806026|468885496|FG002|Overall Study|Lost to Follow-up|8|||
130251996|NCT00806026|468885497|FG003|Overall Study|Lost to Follow-up|2|||
130251997|NCT00806026|468885498|FG004|Overall Study|Lost to Follow-up|6|||
130251998|NCT00806026|468885499|FG005|Overall Study|Lost to Follow-up|6|||
130251999|NCT00806026|468885494|FG000|Overall Study|Withdrawal by Subject|14|||
130252000|NCT00806026|468885495|FG001|Overall Study|Withdrawal by Subject|17|||
130252001|NCT00806026|468885496|FG002|Overall Study|Withdrawal by Subject|9|||
130252002|NCT00806026|468885497|FG003|Overall Study|Withdrawal by Subject|2|||
130252003|NCT00806026|468885498|FG004|Overall Study|Withdrawal by Subject|5|||
130252004|NCT00806026|468885499|FG005|Overall Study|Withdrawal by Subject|3|||
130252005|NCT00806026|468885494|FG000|Overall Study|Other|3|||
130252006|NCT00806026|468885495|FG001|Overall Study|Other|6|||
130252007|NCT00806026|468885496|FG002|Overall Study|Other|8|||
130252008|NCT00806026|468885497|FG003|Overall Study|Other|2|||
130252009|NCT00806026|468885498|FG004|Overall Study|Other|0|||
130252010|NCT00806026|468885499|FG005|Overall Study|Other|4|||
130252011|NCT00806026|468885494|FG000|Overall Study|Protocol Violation|6|||
130252012|NCT00806026|468885495|FG001|Overall Study|Protocol Violation|9|||
130252013|NCT00806026|468885496|FG002|Overall Study|Protocol Violation|9|||
130252014|NCT00806026|468885497|FG003|Overall Study|Protocol Violation|0|||
130252015|NCT00806026|468885498|FG004|Overall Study|Protocol Violation|2|||
130252016|NCT00806026|468885499|FG005|Overall Study|Protocol Violation|3|||
130252017|NCT00806026|468885494|FG000|Overall Study|Adverse Event|52|||
130252018|NCT00806026|468885495|FG001|Overall Study|Adverse Event|35|||
130252019|NCT00806026|468885496|FG002|Overall Study|Adverse Event|44|||
130252020|NCT00806026|468885497|FG003|Overall Study|Adverse Event|17|||
130252021|NCT00806026|468885498|FG004|Overall Study|Adverse Event|9|||
130252022|NCT00806026|468885499|FG005|Overall Study|Adverse Event|9|||
130252023|NCT03180138|468885500|FG000|Overall Study|Mobile-phone could not be verified|2|||
130252024|NCT03180138|468885501|FG001|Overall Study|Mobile-phone could not be verified|13|||
130252025|NCT03180138|468885502|FG002|Overall Study|Mobile-phone could not be verified|15|||
130252026|NCT03180138|468885500|FG000|Overall Study|No prior immunization records|17|||
130252027|NCT03180138|468885501|FG001|Overall Study|No prior immunization records|0|||
130700092|NCT00611884|470526407|FG001|Overall Study|Lack of Efficacy|1|||
130252028|NCT03180138|468885502|FG002|Overall Study|No prior immunization records|6|||
130252029|NCT03180138|468885500|FG000|Overall Study|Found to be >24 mon after randomization|3|||
130376665|NCT01327885|469345895|FG000|Overall Study|Adverse Event|14|||
130252030|NCT03180138|468885501|FG001|Overall Study|Found to be >24 mon after randomization|0|||
130252031|NCT03180138|468885502|FG002|Overall Study|Found to be >24 mon after randomization|3|||
130252032|NCT00452530|468885504|FG000|Overall Study|Death|1|||
130252033|NCT00452530|468885505|FG001|Overall Study|Death|0|||
130252034|NCT00452530|468885504|FG000|Overall Study|Adverse Event|40|||
130700093|NCT00611884|470526408|FG002|Overall Study|Lack of Efficacy|0|||
130700094|NCT00611884|470526409|FG003|Overall Study|Lack of Efficacy|0|||
130700095|NCT00611884|470526406|FG000|Overall Study|Unclassified|7|||
130700096|NCT00611884|470526407|FG001|Overall Study|Unclassified|4|||
130700097|NCT00611884|470526408|FG002|Overall Study|Unclassified|2|||
130700098|NCT00611884|470526409|FG003|Overall Study|Unclassified|3|||
130700099|NCT00981799|470526410|FG000|Overall Study|Adverse Event|1|||
130700100|NCT00981799|470526411|FG001|Overall Study|Adverse Event|1|||
130700101|NCT00981799|470526412|FG002|Overall Study|Adverse Event|0|||
130700102|NCT00981799|470526413|FG003|Overall Study|Adverse Event|0|||
130252035|NCT00452530|468885505|FG001|Overall Study|Adverse Event|44|||
130252036|NCT00452530|468885504|FG000|Overall Study|Withdrawal by Subject|68|||
130252037|NCT00452530|468885505|FG001|Overall Study|Withdrawal by Subject|57|||
130252038|NCT00452530|468885504|FG000|Overall Study|Lost to Follow-up|1|||
130252039|NCT00452530|468885505|FG001|Overall Study|Lost to Follow-up|0|||
130252040|NCT00452530|468885504|FG000|Overall Study|Poor compliance/noncompliance|1|||
130252041|NCT00452530|468885505|FG001|Overall Study|Poor compliance/noncompliance|2|||
130252042|NCT00452530|468885504|FG000|Overall Study|No longer met study criteria|18|||
130252043|NCT00452530|468885505|FG001|Overall Study|No longer met study criteria|22|||
130252044|NCT00452530|468885504|FG000|Overall Study|Other|7|||
130252045|NCT00452530|468885505|FG001|Overall Study|Other|11|||
130252046|NCT02100644|468885506|FG000|LTG Escalation Phase|Adverse Event|9|||
130252047|NCT02100644|468885507|FG001|LTG Escalation Phase|Adverse Event|0|||
130252048|NCT02100644|468885508|FG002|LTG Escalation Phase|Adverse Event|0|||
130252049|NCT02100644|468885506|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
130252050|NCT02100644|468885507|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130700103|NCT01190930|470526414|FG000|Induction|Adverse Event|17|||
130700104|NCT01190930|470526415|FG001|Induction|Adverse Event|0|||
130700105|NCT01190930|470526416|FG002|Induction|Adverse Event|0|||
130700106|NCT01190930|470526417|FG003|Induction|Adverse Event|0|||
130700107|NCT01190930|470526418|FG004|Induction|Adverse Event|0|||
130700108|NCT01190930|470526419|FG005|Induction|Adverse Event|0|||
130700109|NCT01190930|470526420|FG006|Induction|Adverse Event|0|||
130700110|NCT01190930|470526421|FG007|Induction|Adverse Event|0|||
130700111|NCT01190930|470526422|FG008|Induction|Adverse Event|0|||
130700112|NCT01190930|470526423|FG009|Induction|Adverse Event|0|||
130700113|NCT01190930|470526414|FG000|Induction|Death|34|||
130700114|NCT01190930|470526415|FG001|Induction|Death|0|||
130700115|NCT01190930|470526416|FG002|Induction|Death|0|||
130700116|NCT01190930|470526417|FG003|Induction|Death|0|||
130700117|NCT01190930|470526418|FG004|Induction|Death|0|||
130700118|NCT01190930|470526419|FG005|Induction|Death|0|||
130700119|NCT01190930|470526420|FG006|Induction|Death|0|||
130700120|NCT01190930|470526421|FG007|Induction|Death|0|||
130700121|NCT01190930|470526422|FG008|Induction|Death|0|||
130700122|NCT01190930|470526423|FG009|Induction|Death|0|||
130700123|NCT01190930|470526414|FG000|Induction|Lost to Follow-up|1|||
130700124|NCT01190930|470526415|FG001|Induction|Lost to Follow-up|0|||
130700125|NCT01190930|470526416|FG002|Induction|Lost to Follow-up|0|||
130700126|NCT01190930|470526417|FG003|Induction|Lost to Follow-up|0|||
130700127|NCT01190930|470526418|FG004|Induction|Lost to Follow-up|0|||
130700128|NCT01190930|470526419|FG005|Induction|Lost to Follow-up|0|||
130700129|NCT01190930|470526420|FG006|Induction|Lost to Follow-up|0|||
130700130|NCT01190930|470526421|FG007|Induction|Lost to Follow-up|0|||
130700131|NCT01190930|470526422|FG008|Induction|Lost to Follow-up|0|||
130700132|NCT01190930|470526423|FG009|Induction|Lost to Follow-up|0|||
130700133|NCT01190930|470526414|FG000|Induction|Physician Decision|125|||
130700134|NCT01190930|470526415|FG001|Induction|Physician Decision|3|||
130700135|NCT01190930|470526416|FG002|Induction|Physician Decision|0|||
130700136|NCT01190930|470526417|FG003|Induction|Physician Decision|0|||
130700137|NCT01190930|470526418|FG004|Induction|Physician Decision|0|||
130700138|NCT01190930|470526419|FG005|Induction|Physician Decision|0|||
130700139|NCT01190930|470526420|FG006|Induction|Physician Decision|0|||
130700140|NCT01190930|470526421|FG007|Induction|Physician Decision|0|||
130700141|NCT01190930|470526422|FG008|Induction|Physician Decision|0|||
130700142|NCT01190930|470526423|FG009|Induction|Physician Decision|0|||
130700143|NCT01190930|470526414|FG000|Induction|Withdrawal by Subject|9|||
130700144|NCT01190930|470526415|FG001|Induction|Withdrawal by Subject|0|||
130700145|NCT01190930|470526416|FG002|Induction|Withdrawal by Subject|0|||
130700146|NCT01190930|470526417|FG003|Induction|Withdrawal by Subject|0|||
130700147|NCT01190930|470526418|FG004|Induction|Withdrawal by Subject|0|||
130700148|NCT01190930|470526419|FG005|Induction|Withdrawal by Subject|0|||
130700149|NCT01190930|470526420|FG006|Induction|Withdrawal by Subject|0|||
130700150|NCT01190930|470526421|FG007|Induction|Withdrawal by Subject|0|||
130700151|NCT01190930|470526422|FG008|Induction|Withdrawal by Subject|0|||
130700152|NCT01190930|470526423|FG009|Induction|Withdrawal by Subject|0|||
130700153|NCT01190930|470526414|FG000|Induction|Refusal|235|||
130700154|NCT01190930|470526415|FG001|Induction|Refusal|0|||
130700155|NCT01190930|470526416|FG002|Induction|Refusal|0|||
130700156|NCT01190930|470526417|FG003|Induction|Refusal|0|||
130700157|NCT01190930|470526418|FG004|Induction|Refusal|0|||
130700158|NCT01190930|470526419|FG005|Induction|Refusal|0|||
130700159|NCT01190930|470526420|FG006|Induction|Refusal|0|||
130700160|NCT01190930|470526421|FG007|Induction|Refusal|0|||
130700161|NCT01190930|470526422|FG008|Induction|Refusal|0|||
130700162|NCT01190930|470526423|FG009|Induction|Refusal|0|||
130700163|NCT01190930|470526414|FG000|Induction|Inevaluable|23|||
130700164|NCT01190930|470526415|FG001|Induction|Inevaluable|1|||
130700165|NCT01190930|470526416|FG002|Induction|Inevaluable|0|||
130700166|NCT01190930|470526417|FG003|Induction|Inevaluable|0|||
130700167|NCT01190930|470526418|FG004|Induction|Inevaluable|0|||
130700168|NCT01190930|470526419|FG005|Induction|Inevaluable|0|||
130700169|NCT01190930|470526420|FG006|Induction|Inevaluable|0|||
130700170|NCT01190930|470526421|FG007|Induction|Inevaluable|0|||
130700171|NCT01190930|470526422|FG008|Induction|Inevaluable|0|||
130252051|NCT02100644|468885508|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130700172|NCT01190930|470526423|FG009|Induction|Inevaluable|0|||
130700173|NCT01190930|470526414|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
130700174|NCT01190930|470526415|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700175|NCT01190930|470526416|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700176|NCT01190930|470526417|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700177|NCT01190930|470526418|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700178|NCT01190930|470526419|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700179|NCT01190930|470526420|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700180|NCT01190930|470526421|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700181|NCT01190930|470526422|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700182|NCT01190930|470526423|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700183|NCT01190930|470526414|FG000|Induction|High Risk Downs|80|||
130700184|NCT01190930|470526415|FG001|Induction|High Risk Downs|0|||
130700185|NCT01190930|470526416|FG002|Induction|High Risk Downs|0|||
130252052|NCT02100644|468885506|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
130252053|NCT02100644|468885507|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
130252054|NCT02100644|468885508|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
130252055|NCT00728182|468885509|FG000|Overall Study|Adverse Event|1|||
130252056|NCT00728182|468885510|FG001|Overall Study|Adverse Event|0|||
130252057|NCT00728182|468885509|FG000|Overall Study|Lost to Follow-up|2|||
130252058|NCT00728182|468885510|FG001|Overall Study|Lost to Follow-up|0|||
130252059|NCT00728182|468885509|FG000|Overall Study|Death|0|||
130252060|NCT00728182|468885510|FG001|Overall Study|Death|2|||
130252061|NCT00728182|468885509|FG000|Overall Study|Protocol Noncompliance|0|||
130252062|NCT00728182|468885510|FG001|Overall Study|Protocol Noncompliance|1|||
130252063|NCT01898091|468885512|FG000|Overall Study|Lost to Follow-up|1|||
130252064|NCT01898091|468885513|FG001|Overall Study|Lost to Follow-up|1|||
130252065|NCT01898091|468885512|FG000|Overall Study|Withdrawal by Subject|1|||
130252066|NCT01898091|468885513|FG001|Overall Study|Withdrawal by Subject|5|||
130252067|NCT01618708|468885514|FG000|Overall Study|Adverse Event|10|||
130252068|NCT01618708|468885515|FG001|Overall Study|Adverse Event|10|||
130252069|NCT01618708|468885514|FG000|Overall Study|Lost to Follow-up|3|||
130252070|NCT01618708|468885515|FG001|Overall Study|Lost to Follow-up|3|||
130252071|NCT01618708|468885514|FG000|Overall Study|Withdrawal by Subject|17|||
130252072|NCT01618708|468885515|FG001|Overall Study|Withdrawal by Subject|22|||
130252073|NCT01618708|468885514|FG000|Overall Study|Lack of Efficacy|8|||
130364875|NCT02400333|469306774|FG001|Overall Study|Withdrawal by Subject|1|||
130252074|NCT01618708|468885515|FG001|Overall Study|Lack of Efficacy|8|||
130252075|NCT01618708|468885514|FG000|Overall Study|Technical problems|2|||
130252076|NCT01618708|468885515|FG001|Overall Study|Technical problems|0|||
130252077|NCT01618708|468885514|FG000|Overall Study|Other than specified above|1|||
130700186|NCT01190930|470526417|FG003|Induction|High Risk Downs|0|||
130252078|NCT01618708|468885515|FG001|Overall Study|Other than specified above|1|||
130252079|NCT01618708|468885514|FG000|Overall Study|Randomized but not treated|3|||
130252080|NCT01618708|468885515|FG001|Overall Study|Randomized but not treated|2|||
130252081|NCT01630811|468885518|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130252082|NCT01630811|468885519|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130252083|NCT01725308|468885520|FG000|Treatment Period I|Did Not Receive Drug|1|||
130252084|NCT01725308|468885521|FG001|Treatment Period I|Did Not Receive Drug|0|||
130252085|NCT01725308|468885522|FG002|Treatment Period I|Did Not Receive Drug|0|||
130252086|NCT01725308|468885520|FG000|Treatment Period I|Adverse Event|5|||
130252087|NCT01725308|468885521|FG001|Treatment Period I|Adverse Event|4|||
130252088|NCT01725308|468885522|FG002|Treatment Period I|Adverse Event|21|||
130252089|NCT01725308|468885520|FG000|Treatment Period I|Insufficient Response|7|||
130252090|NCT01725308|468885521|FG001|Treatment Period I|Insufficient Response|0|||
130252091|NCT01725308|468885522|FG002|Treatment Period I|Insufficient Response|5|||
130252092|NCT01725308|468885520|FG000|Treatment Period I|Worsening of the Target Disease|8|||
130252093|NCT01725308|468885521|FG001|Treatment Period I|Worsening of the Target Disease|0|||
130252094|NCT01725308|468885522|FG002|Treatment Period I|Worsening of the Target Disease|2|||
130252095|NCT01725308|468885520|FG000|Treatment Period I|Changes in the Episodes|3|||
130252096|NCT01725308|468885521|FG001|Treatment Period I|Changes in the Episodes|0|||
130252097|NCT01725308|468885522|FG002|Treatment Period I|Changes in the Episodes|2|||
130252098|NCT01725308|468885520|FG000|Treatment Period I|Withdrawal of Consent|12|||
130252099|NCT01725308|468885521|FG001|Treatment Period I|Withdrawal of Consent|7|||
130252100|NCT01725308|468885522|FG002|Treatment Period I|Withdrawal of Consent|5|||
130252101|NCT01725308|468885520|FG000|Treatment Period I|Lost to Follow-up|3|||
130252102|NCT01725308|468885521|FG001|Treatment Period I|Lost to Follow-up|2|||
130252103|NCT01725308|468885522|FG002|Treatment Period I|Lost to Follow-up|2|||
130252104|NCT01725308|468885520|FG000|Treatment Period I|Protocol Deviations|3|||
130252105|NCT01725308|468885521|FG001|Treatment Period I|Protocol Deviations|1|||
130252106|NCT01725308|468885522|FG002|Treatment Period I|Protocol Deviations|1|||
130252107|NCT01725308|468885520|FG000|Treatment Period I|Miscellaneous|2|||
130252108|NCT01725308|468885521|FG001|Treatment Period I|Miscellaneous|0|||
130252109|NCT01725308|468885522|FG002|Treatment Period I|Miscellaneous|3|||
130252110|NCT01725308|468885520|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
130252111|NCT01725308|468885521|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
130252112|NCT01725308|468885522|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
130252113|NCT01725308|468885520|FG000|Treatment Period II|Did Not Receive Drug|4|||
130252114|NCT01725308|468885521|FG001|Treatment Period II|Did Not Receive Drug|0|||
130252115|NCT01725308|468885522|FG002|Treatment Period II|Did Not Receive Drug|0|||
130252116|NCT01725308|468885520|FG000|Treatment Period II|Adverse Event|13|||
130252117|NCT01725308|468885521|FG001|Treatment Period II|Adverse Event|8|||
130252118|NCT01725308|468885522|FG002|Treatment Period II|Adverse Event|20|||
130252119|NCT01725308|468885520|FG000|Treatment Period II|Insufficient Response|2|||
130252120|NCT01725308|468885521|FG001|Treatment Period II|Insufficient Response|4|||
130252121|NCT01725308|468885522|FG002|Treatment Period II|Insufficient Response|6|||
130252122|NCT01725308|468885520|FG000|Treatment Period II|Worsening of the Target Disease|1|||
130252123|NCT01725308|468885521|FG001|Treatment Period II|Worsening of the Target Disease|4|||
130252124|NCT01725308|468885522|FG002|Treatment Period II|Worsening of the Target Disease|2|||
130252125|NCT01725308|468885520|FG000|Treatment Period II|Changes in the Episodes|1|||
130252126|NCT01725308|468885521|FG001|Treatment Period II|Changes in the Episodes|0|||
130252127|NCT01725308|468885522|FG002|Treatment Period II|Changes in the Episodes|5|||
130252128|NCT01725308|468885520|FG000|Treatment Period II|Withdrawal of Consent|28|||
130252129|NCT01725308|468885521|FG001|Treatment Period II|Withdrawal of Consent|2|||
130252130|NCT01725308|468885522|FG002|Treatment Period II|Withdrawal of Consent|16|||
130252131|NCT01725308|468885520|FG000|Treatment Period II|Lost to Follow-up|1|||
130252132|NCT01725308|468885521|FG001|Treatment Period II|Lost to Follow-up|5|||
130252133|NCT01725308|468885522|FG002|Treatment Period II|Lost to Follow-up|3|||
130252134|NCT01725308|468885520|FG000|Treatment Period II|Protocol Deviations|0|||
130252135|NCT01725308|468885521|FG001|Treatment Period II|Protocol Deviations|0|||
130252136|NCT01725308|468885522|FG002|Treatment Period II|Protocol Deviations|1|||
130252137|NCT01725308|468885520|FG000|Treatment Period II|Miscellaneous|5|||
130252138|NCT01725308|468885521|FG001|Treatment Period II|Miscellaneous|3|||
130700187|NCT01190930|470526418|FG004|Induction|High Risk Downs|0|||
130700188|NCT01190930|470526419|FG005|Induction|High Risk Downs|0|||
130252139|NCT01725308|468885522|FG002|Treatment Period II|Miscellaneous|7|||
130252140|NCT03511209|468885526|FG000|Overall Study|Withdrawal by Subject|2|||
130252141|NCT03511209|468885527|FG001|Overall Study|Withdrawal by Subject|4|||
130252142|NCT03511209|468885526|FG000|Overall Study|Death|1|||
130252143|NCT03511209|468885527|FG001|Overall Study|Death|0|||
130252144|NCT03511209|468885526|FG000|Overall Study|Lost to Follow-up|0|||
130700189|NCT01190930|470526420|FG006|Induction|High Risk Downs|0|||
130252145|NCT03511209|468885527|FG001|Overall Study|Lost to Follow-up|2|||
130700190|NCT01190930|470526421|FG007|Induction|High Risk Downs|0|||
130700191|NCT01190930|470526422|FG008|Induction|High Risk Downs|0|||
130252146|NCT00401830|468885531|FG000|Overall Study|Adverse Event|10|||
130700192|NCT01190930|470526423|FG009|Induction|High Risk Downs|0|||
130252147|NCT00401830|468885532|FG001|Overall Study|Adverse Event|18|||
130252148|NCT00401830|468885531|FG000|Overall Study|Lack of Efficacy|11|||
130252149|NCT00401830|468885532|FG001|Overall Study|Lack of Efficacy|5|||
130252150|NCT00401830|468885531|FG000|Overall Study|Withdrawal by Subject|4|||
130252151|NCT00401830|468885532|FG001|Overall Study|Withdrawal by Subject|3|||
130252152|NCT00401830|468885531|FG000|Overall Study|Protocol Violation|3|||
130252153|NCT00401830|468885532|FG001|Overall Study|Protocol Violation|3|||
130252154|NCT00401830|468885531|FG000|Overall Study|Non-compliance with drug study|1|||
130252155|NCT00401830|468885532|FG001|Overall Study|Non-compliance with drug study|0|||
130252156|NCT00401830|468885531|FG000|Overall Study|Lost to Follow-up|1|||
130252157|NCT00401830|468885532|FG001|Overall Study|Lost to Follow-up|3|||
130252158|NCT00401830|468885531|FG000|Overall Study|Other: Personal / Family problems|1|||
130252159|NCT00401830|468885532|FG001|Overall Study|Other: Personal / Family problems|0|||
130252160|NCT03378635|468885535|FG000|Overall Study|Adverse Event|1|||
130252161|NCT03378635|468885536|FG001|Overall Study|Adverse Event|0|||
130252162|NCT03378635|468885537|FG002|Overall Study|Adverse Event|0|||
130252163|NCT03378635|468885535|FG000|Overall Study|Withdrawal by Subject|1|||
130252164|NCT03378635|468885536|FG001|Overall Study|Withdrawal by Subject|0|||
130252165|NCT03378635|468885537|FG002|Overall Study|Withdrawal by Subject|0|||
130252166|NCT01316900|468885541|FG000|Overall Study|Adverse Event|10|||
130252167|NCT01316900|468885542|FG001|Overall Study|Adverse Event|10|||
130252168|NCT01316900|468885543|FG002|Overall Study|Adverse Event|15|||
130252169|NCT01316900|468885544|FG003|Overall Study|Adverse Event|9|||
130252170|NCT01316900|468885541|FG000|Overall Study|Lack of Efficacy|17|||
130252171|NCT01316900|468885542|FG001|Overall Study|Lack of Efficacy|9|||
130252172|NCT01316900|468885543|FG002|Overall Study|Lack of Efficacy|5|||
130252173|NCT01316900|468885544|FG003|Overall Study|Lack of Efficacy|7|||
130252174|NCT01316900|468885541|FG000|Overall Study|Protocol Violation|7|||
130252175|NCT01316900|468885542|FG001|Overall Study|Protocol Violation|1|||
130252176|NCT01316900|468885543|FG002|Overall Study|Protocol Violation|4|||
130252177|NCT01316900|468885544|FG003|Overall Study|Protocol Violation|0|||
130252178|NCT01316900|468885541|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130252179|NCT01316900|468885542|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
130252180|NCT01316900|468885543|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
130252181|NCT01316900|468885544|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
130252182|NCT01316900|468885541|FG000|Overall Study|Lost to Follow-up|1|||
130252183|NCT01316900|468885542|FG001|Overall Study|Lost to Follow-up|0|||
130252184|NCT01316900|468885543|FG002|Overall Study|Lost to Follow-up|1|||
130252185|NCT01316900|468885544|FG003|Overall Study|Lost to Follow-up|1|||
130252186|NCT01316900|468885541|FG000|Overall Study|Withdrawal by Subject|7|||
130252187|NCT01316900|468885542|FG001|Overall Study|Withdrawal by Subject|8|||
130252188|NCT01316900|468885543|FG002|Overall Study|Withdrawal by Subject|6|||
130252189|NCT01316900|468885544|FG003|Overall Study|Withdrawal by Subject|9|||
130252190|NCT01684033|468885545|FG000|Period 1, First 30 Days|Adverse Event|1|||
130252191|NCT01684033|468885546|FG001|Period 1, First 30 Days|Adverse Event|1|||
130252192|NCT01684033|468885545|FG000|Period 1, First 30 Days|Noncompliance|1|||
130252193|NCT01684033|468885546|FG001|Period 1, First 30 Days|Noncompliance|0|||
130252194|NCT01684033|468885545|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
130252195|NCT01684033|468885546|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
130252196|NCT01684033|468885545|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
130252197|NCT01684033|468885546|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
130252198|NCT01684033|468885545|FG000|Period 2, Second 30 Days|Adverse Event|1|||
130252199|NCT01684033|468885546|FG001|Period 2, Second 30 Days|Adverse Event|0|||
130252200|NCT02496156|468885547|FG000|Overall Study|Lost to Follow-up|5|||
130252201|NCT02496156|468885548|FG001|Overall Study|Lost to Follow-up|0|||
130252202|NCT02496156|468885547|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
130252203|NCT02496156|468885548|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
130252204|NCT00089583|468885549|FG000|Overall Study|Adverse Event|0|||
130252205|NCT00089583|468885550|FG001|Overall Study|Adverse Event|3|||
130252206|NCT00089583|468885549|FG000|Overall Study|Insufficient Viral Load Response|5|||
130252207|NCT00089583|468885550|FG001|Overall Study|Insufficient Viral Load Response|5|||
130252208|NCT00089583|468885549|FG000|Overall Study|Withdrawal by Subject|0|||
130252209|NCT00089583|468885550|FG001|Overall Study|Withdrawal by Subject|4|||
130252210|NCT00089583|468885549|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
130252211|NCT00089583|468885550|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
130252212|NCT00089583|468885549|FG000|Overall Study|Participant Refused Study Medication|0|||
130252213|NCT00089583|468885550|FG001|Overall Study|Participant Refused Study Medication|2|||
130252214|NCT00089583|468885549|FG000|Overall Study|Non-Compliance|0|||
130364876|NCT02400333|469306775|FG002|Overall Study|Withdrawal by Subject|0|||
130252215|NCT00089583|468885550|FG001|Overall Study|Non-Compliance|4|||
130252216|NCT00089583|468885549|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
130252217|NCT00089583|468885550|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
130252218|NCT00089583|468885549|FG000|Overall Study|Participant Management Criteria Met|0|||
130252219|NCT00089583|468885550|FG001|Overall Study|Participant Management Criteria Met|1|||
130252220|NCT00089583|468885549|FG000|Overall Study|Reason Not Provided|0|||
130252221|NCT00089583|468885550|FG001|Overall Study|Reason Not Provided|1|||
130252222|NCT00089583|468885549|FG000|Overall Study|Protocol Violation|0|||
130252223|NCT00089583|468885550|FG001|Overall Study|Protocol Violation|3|||
130252224|NCT00089583|468885549|FG000|Overall Study|Principal Investigator Decision|0|||
130252225|NCT00089583|468885550|FG001|Overall Study|Principal Investigator Decision|10|||
130252226|NCT00089583|468885549|FG000|Overall Study|Start of Disallowed Medication|0|||
130252227|NCT00089583|468885550|FG001|Overall Study|Start of Disallowed Medication|1|||
130252228|NCT00089583|468885549|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
130252229|NCT00089583|468885550|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
130252230|NCT00089583|468885549|FG000|Overall Study|Participant Incarcerated|0|||
130252231|NCT00089583|468885550|FG001|Overall Study|Participant Incarcerated|1|||
130252232|NCT00507507|468885551|FG000|Treatment Period|Lost to Follow-up|0|||
130252233|NCT00507507|468885552|FG001|Treatment Period|Lost to Follow-up|2|||
130252234|NCT00507507|468885551|FG000|Treatment Period|Physician Decision|4|||
130252235|NCT00507507|468885552|FG001|Treatment Period|Physician Decision|1|||
130252236|NCT00507507|468885551|FG000|Treatment Period|Protocol Violation|1|||
130252237|NCT00507507|468885552|FG001|Treatment Period|Protocol Violation|2|||
130252238|NCT00507507|468885551|FG000|Treatment Period|Adverse Event|1|||
130252239|NCT00507507|468885552|FG001|Treatment Period|Adverse Event|1|||
130252240|NCT00507507|468885551|FG000|Treatment Period|Withdrawal by Subject|46|||
130252241|NCT00507507|468885552|FG001|Treatment Period|Withdrawal by Subject|47|||
130252242|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
130252243|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
130252244|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
130252245|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
130252246|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
130252247|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
130252248|NCT02916433|468885553|FG000|Overall Study|Withdrawal by Subject|1|||
130252249|NCT02916433|468885554|FG001|Overall Study|Withdrawal by Subject|0|||
130252250|NCT02916433|468885553|FG000|Overall Study|Physician Decision|1|||
130252251|NCT02916433|468885554|FG001|Overall Study|Physician Decision|0|||
130252252|NCT03760666|468885555|FG000|Overall Study|Adverse Event|2|||
130252253|NCT03760666|468885556|FG001|Overall Study|Adverse Event|4|||
130252254|NCT03760666|468885557|FG002|Overall Study|Adverse Event|1|||
130252255|NCT03760666|468885555|FG000|Overall Study|AML Disease Progression|3|||
130252256|NCT03760666|468885556|FG001|Overall Study|AML Disease Progression|3|||
130252257|NCT03760666|468885557|FG002|Overall Study|AML Disease Progression|0|||
130252258|NCT03760666|468885555|FG000|Overall Study|Physician Decision|0|||
130252259|NCT03760666|468885556|FG001|Overall Study|Physician Decision|3|||
130252260|NCT03760666|468885557|FG002|Overall Study|Physician Decision|0|||
130252261|NCT03760666|468885555|FG000|Overall Study|Withdrawal by Subject|0|||
130252262|NCT03760666|468885556|FG001|Overall Study|Withdrawal by Subject|1|||
130252263|NCT03760666|468885557|FG002|Overall Study|Withdrawal by Subject|0|||
130252264|NCT01623154|468885558|FG000|Overall Study|Did not drink Pranactin Citric|4|||
130252265|NCT00890097|468885559|FG000|Overall Study|Adverse Event|21|||
130252266|NCT00890097|468885560|FG001|Overall Study|Adverse Event|32|||
130252267|NCT00890097|468885561|FG002|Overall Study|Adverse Event|28|||
130453032|NCT00430677|469621760|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
130453033|NCT00430677|469621758|FG000|Long-term Extension Period|Other|2|||
130453034|NCT00430677|469621759|FG001|Long-term Extension Period|Other|1|||
130453035|NCT00430677|469621760|FG002|Long-term Extension Period|Other|1|||
130453036|NCT00430677|469621758|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
130252268|NCT00890097|468885559|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
130252269|NCT00890097|468885560|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
130252270|NCT00890097|468885561|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
130252271|NCT00890097|468885559|FG000|Overall Study|Withdrew Consent|9|||
130252272|NCT00890097|468885560|FG001|Overall Study|Withdrew Consent|6|||
130453037|NCT00430677|469621759|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
130453038|NCT00430677|469621760|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
130453039|NCT01555762|469621761|FG000|Overall Study|No information on Bevacizumab intake|11|||
130453040|NCT01555762|469621761|FG000|Overall Study|Missing start date of infusion|8|||
130553318|NCT02202551|469993555|FG003|Overall Study|Needed to take excluded medication|1|||
130453041|NCT01555762|469621761|FG000|Overall Study|75 years old or more ticked No|1|||
130553319|NCT02202551|469993552|FG000|Overall Study|Subject moved away|0|||
130553320|NCT02202551|469993553|FG001|Overall Study|Subject moved away|1|||
130553321|NCT02202551|469993554|FG002|Overall Study|Subject moved away|0|||
130700193|NCT01190930|470526414|FG000|Induction|Enrollment onto another COG Protocol|1|||
130700194|NCT01190930|470526415|FG001|Induction|Enrollment onto another COG Protocol|0|||
130700195|NCT01190930|470526416|FG002|Induction|Enrollment onto another COG Protocol|0|||
130252273|NCT00890097|468885561|FG002|Overall Study|Withdrew Consent|9|||
130252274|NCT00890097|468885559|FG000|Overall Study|Lost to Follow-up|5|||
130252275|NCT00890097|468885560|FG001|Overall Study|Lost to Follow-up|5|||
130252276|NCT00890097|468885561|FG002|Overall Study|Lost to Follow-up|5|||
130453042|NCT01555762|469621761|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
130252277|NCT00890097|468885559|FG000|Overall Study|Noncompliance|0|||
130252278|NCT00890097|468885560|FG001|Overall Study|Noncompliance|4|||
130252279|NCT00890097|468885561|FG002|Overall Study|Noncompliance|4|||
130252280|NCT00890097|468885559|FG000|Overall Study|Sponsor Decision|7|||
130252281|NCT00890097|468885560|FG001|Overall Study|Sponsor Decision|11|||
130252282|NCT00890097|468885561|FG002|Overall Study|Sponsor Decision|7|||
130252283|NCT00890097|468885559|FG000|Overall Study|Did not attend final visit|2|||
130252284|NCT00890097|468885560|FG001|Overall Study|Did not attend final visit|3|||
130252285|NCT00890097|468885561|FG002|Overall Study|Did not attend final visit|0|||
130252286|NCT00890097|468885559|FG000|Overall Study|Subject Decision|3|||
130252287|NCT00890097|468885560|FG001|Overall Study|Subject Decision|2|||
130252288|NCT00890097|468885561|FG002|Overall Study|Subject Decision|6|||
130252289|NCT00890097|468885559|FG000|Overall Study|Randomization Error|2|||
130252290|NCT00890097|468885560|FG001|Overall Study|Randomization Error|0|||
130252291|NCT00890097|468885561|FG002|Overall Study|Randomization Error|0|||
130252292|NCT00890097|468885559|FG000|Overall Study|Failed inclusion criteria|3|||
130252293|NCT00890097|468885560|FG001|Overall Study|Failed inclusion criteria|4|||
130252294|NCT00890097|468885561|FG002|Overall Study|Failed inclusion criteria|0|||
130252295|NCT00890097|468885559|FG000|Overall Study|Transportation|0|||
130252296|NCT00890097|468885560|FG001|Overall Study|Transportation|2|||
130252297|NCT00890097|468885561|FG002|Overall Study|Transportation|0|||
130252298|NCT00890097|468885559|FG000|Overall Study|Subject Moved|0|||
130252299|NCT00890097|468885560|FG001|Overall Study|Subject Moved|4|||
130252300|NCT00890097|468885561|FG002|Overall Study|Subject Moved|0|||
130252301|NCT00890097|468885559|FG000|Overall Study|Protocol Deviation|1|||
130252302|NCT00890097|468885560|FG001|Overall Study|Protocol Deviation|1|||
130252303|NCT00890097|468885561|FG002|Overall Study|Protocol Deviation|1|||
130252304|NCT02656173|468885565|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
130252305|NCT02656173|468885566|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
130252306|NCT02656173|468885565|FG000|Overall Study|Adverse Event|7|||
130252307|NCT02656173|468885566|FG001|Overall Study|Adverse Event|5|||
130252308|NCT02656173|468885565|FG000|Overall Study|Withdrawal by Subject|1|||
130252309|NCT02656173|468885566|FG001|Overall Study|Withdrawal by Subject|3|||
130252310|NCT02656173|468885565|FG000|Overall Study|Protocol Violation|0|||
130252311|NCT02656173|468885566|FG001|Overall Study|Protocol Violation|1|||
130252312|NCT02656173|468885565|FG000|Overall Study|Miscellaneous|2|||
130252313|NCT02656173|468885566|FG001|Overall Study|Miscellaneous|0|||
130252314|NCT01064622|468885567|FG000|Randomized Phase II|Withdrawal by Subject|2|||
130252315|NCT01064622|468885568|FG001|Randomized Phase II|Withdrawal by Subject|2|||
130252316|NCT01064622|468885567|FG000|Randomized Phase II|Protocol Violation|0|||
130252317|NCT01064622|468885568|FG001|Randomized Phase II|Protocol Violation|1|||
130252318|NCT03449147|468885569|FG000|52-week Treatment Period|Death|0|||
130252319|NCT03449147|468885570|FG001|52-week Treatment Period|Death|1|||
130252320|NCT03449147|468885571|FG002|52-week Treatment Period|Death|0|||
130252321|NCT03449147|468885569|FG000|52-week Treatment Period|Lost to Follow-up|6|||
130252322|NCT03449147|468885570|FG001|52-week Treatment Period|Lost to Follow-up|2|||
130252323|NCT03449147|468885571|FG002|52-week Treatment Period|Lost to Follow-up|5|||
130252324|NCT03449147|468885569|FG000|52-week Treatment Period|Other|0|||
130252325|NCT03449147|468885570|FG001|52-week Treatment Period|Other|1|||
130252326|NCT03449147|468885571|FG002|52-week Treatment Period|Other|2|||
130252327|NCT03449147|468885569|FG000|52-week Treatment Period|Physician Decision|1|||
130252328|NCT03449147|468885570|FG001|52-week Treatment Period|Physician Decision|0|||
130252329|NCT03449147|468885571|FG002|52-week Treatment Period|Physician Decision|3|||
130252330|NCT03449147|468885569|FG000|52-week Treatment Period|Screen Failure|1|||
130453043|NCT01555762|469621761|FG000|Overall Study|Death linked to progression of disease|165|||
130700196|NCT01190930|470526417|FG003|Induction|Enrollment onto another COG Protocol|0|||
130252331|NCT03449147|468885570|FG001|52-week Treatment Period|Screen Failure|2|||
130252332|NCT03449147|468885571|FG002|52-week Treatment Period|Screen Failure|0|||
130252333|NCT03449147|468885569|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
130252334|NCT03449147|468885570|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
130252335|NCT03449147|468885571|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
130252336|NCT03449147|468885569|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
130700197|NCT01190930|470526418|FG004|Induction|Enrollment onto another COG Protocol|0|||
130700198|NCT01190930|470526419|FG005|Induction|Enrollment onto another COG Protocol|0|||
130252337|NCT03449147|468885570|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130252338|NCT03449147|468885571|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130700199|NCT01190930|470526420|FG006|Induction|Enrollment onto another COG Protocol|0|||
130700200|NCT01190930|470526421|FG007|Induction|Enrollment onto another COG Protocol|0|||
130252339|NCT03449147|468885569|FG000|12-Week Off-Treatment Durability Period|Other|0|||
130252340|NCT03449147|468885570|FG001|12-Week Off-Treatment Durability Period|Other|1|||
130252341|NCT03449147|468885571|FG002|12-Week Off-Treatment Durability Period|Other|0|||
130252342|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Death|2|||
130252343|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
130252344|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
130252345|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
130252346|NCT00974233|468885575|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
130252347|NCT00974233|468885575|FG000|Maintenance Lenalidomide|Adverse Event|8|||
130252348|NCT01691092|468885576|FG000|Overall Study|Lost to Follow-up|10|||
130252349|NCT01691092|468885576|FG000|Overall Study|Physician Decision|4|||
130252350|NCT01691092|468885576|FG000|Overall Study|Withdrawal by Subject|3|||
130252351|NCT01691092|468885576|FG000|Overall Study|non-compliance|3|||
130252352|NCT01691092|468885576|FG000|Overall Study|used for different study|2|||
130252353|NCT01691092|468885576|FG000|Overall Study|screen fail|19|||
130252354|NCT01657942|468885577|FG000|Overall Study|Alternative Treatment|7|||
130252355|NCT01657942|468885577|FG000|Overall Study|Lost to Follow-up|1|||
130252356|NCT00185614|468887313|FG000|Inter-treatment Period|Physician Decision|1|||
130252357|NCT00185614|468887313|FG000|Inter-treatment Period|Relapse|2|||
130252358|NCT00185614|468887313|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
130252359|NCT03160573|468887314|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
130252360|NCT03160573|468887315|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
130252361|NCT03160573|468887316|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130252362|NCT03160573|468887317|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130252363|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130252364|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130252365|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
130252366|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
130252367|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
130252368|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
130252369|NCT02144337|468887318|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
130252370|NCT02144337|468887319|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
130252371|NCT02144337|468887318|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
130252372|NCT02144337|468887319|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
130252373|NCT01730729|468887322|FG000|Overall Study|Adverse Event|1|||
130252374|NCT01730729|468887322|FG000|Overall Study|Death|1|||
130252375|NCT01730729|468887322|FG000|Overall Study|Progressive Disease|12|||
130252376|NCT01661595|468887323|FG000|Phase 1: Week 0-4|Adverse Event|1|||
130252377|NCT01661595|468887324|FG001|Phase 1: Week 0-4|Adverse Event|0|||
130252378|NCT01661595|468887325|FG002|Phase 1: Week 0-4|Adverse Event|0|||
130252379|NCT01661595|468887326|FG003|Phase 1: Week 0-4|Adverse Event|0|||
130252380|NCT01661595|468887323|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
130252381|NCT01661595|468887324|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
130252382|NCT01661595|468887325|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
130252383|NCT01661595|468887326|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
130252384|NCT00912509|468887327|FG000|Overall Study|Lost to Follow-up|1|||
130252385|NCT00912509|468887328|FG001|Overall Study|Lost to Follow-up|0|||
130252386|NCT00912509|468887327|FG000|Overall Study|Lack of Efficacy|4|||
130252387|NCT00912509|468887328|FG001|Overall Study|Lack of Efficacy|3|||
130252388|NCT02715856|468887329|FG000|Overall Study|Software Issues|12|||
130252389|NCT02715856|468887330|FG001|Overall Study|Software Issues|7|||
130252390|NCT02715856|468887329|FG000|Overall Study|Death|6|||
130252391|NCT02715856|468887330|FG001|Overall Study|Death|5|||
130252392|NCT02715856|468887329|FG000|Overall Study|Non- Compliant|0|||
130252393|NCT02715856|468887330|FG001|Overall Study|Non- Compliant|40|||
130252394|NCT02462057|468887331|FG000|Overall Study|Left Vitality|32|||
130252395|NCT02462057|468887332|FG001|Overall Study|Left Vitality|27|||
130252396|NCT02462057|468887333|FG002|Overall Study|Left Vitality|23|||
130252397|NCT02462057|468887334|FG003|Overall Study|Left Vitality|35|||
130252398|NCT02462057|468887335|FG004|Overall Study|Left Vitality|33|||
130252399|NCT02462057|468887331|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
130252400|NCT02462057|468887332|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
130252401|NCT02462057|468887333|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
130252402|NCT02462057|468887334|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
130252403|NCT02462057|468887335|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
130252404|NCT01682603|468887336|FG000|Overall Study|Lost to Follow-up|3|||
130252405|NCT02336555|468887337|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130252406|NCT02336555|468887338|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130252407|NCT02336555|468887337|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
130252408|NCT02336555|468887338|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
130252409|NCT02336555|468887337|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
130252410|NCT02336555|468887338|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
130252411|NCT00993473|468887339|FG000|Overall Study|Adverse Event|0|||
130252412|NCT00993473|468887340|FG001|Overall Study|Adverse Event|2|||
130364877|NCT02400333|469306776|FG003|Overall Study|Withdrawal by Subject|1|||
130364878|NCT02400333|469306773|FG000|Overall Study|Protocol Violation|1|||
130364879|NCT02400333|469306774|FG001|Overall Study|Protocol Violation|0|||
130364880|NCT02400333|469306775|FG002|Overall Study|Protocol Violation|2|||
130364881|NCT02400333|469306776|FG003|Overall Study|Protocol Violation|1|||
130364882|NCT02280304|469306777|FG000|Overall Study|Lost to Follow-up|7|||
130364883|NCT02280304|469306778|FG001|Overall Study|Lost to Follow-up|8|||
130364884|NCT01890473|469306785|FG000|Overall Study|Lost to Follow-up|1|||
130252413|NCT00993473|468887339|FG000|Overall Study|Protocol Violation|1|||
130252414|NCT00993473|468887340|FG001|Overall Study|Protocol Violation|2|||
130252415|NCT00993473|468887339|FG000|Overall Study|Lost to Follow-up|1|||
130252416|NCT00993473|468887340|FG001|Overall Study|Lost to Follow-up|0|||
130252417|NCT00993473|468887339|FG000|Overall Study|Withdrawal by Subject|1|||
130252418|NCT00993473|468887340|FG001|Overall Study|Withdrawal by Subject|5|||
130252419|NCT00993473|468887339|FG000|Overall Study|Technical problem with CGM device|0|||
130252420|NCT00993473|468887340|FG001|Overall Study|Technical problem with CGM device|1|||
130252421|NCT00993473|468887339|FG000|Overall Study|Family event|1|||
130252422|NCT00993473|468887340|FG001|Overall Study|Family event|0|||
130252423|NCT01772693|468887341|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
130252424|NCT01772693|468887342|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
130252425|NCT01772693|468887341|FG000|Overall Study|Withdrawal by Subject|2|||
130252426|NCT01772693|468887342|FG001|Overall Study|Withdrawal by Subject|0|||
130252427|NCT01772693|468887341|FG000|Overall Study|Alternative Treatment|2|||
130252428|NCT01772693|468887342|FG001|Overall Study|Alternative Treatment|0|||
130252429|NCT01959919|468887343|FG000|Overall Study|Did not meet the eligibility criteria|2|||
130252430|NCT01697501|468887344|FG000|Overall Study|Protocol Violation|2|||
130252431|NCT00128492|468887345|FG000|Overall Study|AE unrelated to study|2|||
130252432|NCT00128492|468887346|FG001|Overall Study|AE unrelated to study|9|||
130252433|NCT00128492|468887345|FG000|Overall Study|Study drug intolerance (AE)|2|||
130252434|NCT00128492|468887346|FG001|Overall Study|Study drug intolerance (AE)|8|||
130252435|NCT00128492|468887345|FG000|Overall Study|AE related to study|1|||
130252436|NCT00128492|468887346|FG001|Overall Study|AE related to study|4|||
130252437|NCT00128492|468887345|FG000|Overall Study|Death|1|||
130252438|NCT00128492|468887346|FG001|Overall Study|Death|0|||
130252439|NCT00128492|468887345|FG000|Overall Study|Lost to Follow-up|1|||
130252440|NCT00128492|468887346|FG001|Overall Study|Lost to Follow-up|5|||
130252441|NCT00128492|468887345|FG000|Overall Study|Noncompliance|0|||
130252442|NCT00128492|468887346|FG001|Overall Study|Noncompliance|5|||
130252443|NCT00128492|468887345|FG000|Overall Study|Personal or administrative|10|||
130252444|NCT00128492|468887346|FG001|Overall Study|Personal or administrative|22|||
130252445|NCT00128492|468887345|FG000|Overall Study|Withdrawal by Subject|3|||
130252446|NCT00128492|468887346|FG001|Overall Study|Withdrawal by Subject|5|||
130252447|NCT00128492|468887345|FG000|Overall Study|Pregnancy|0|||
130252448|NCT00128492|468887346|FG001|Overall Study|Pregnancy|1|||
130252449|NCT00692237|468887348|FG000|Overall Study|Withdrawal by Subject|1|||
130252450|NCT00692237|468887349|FG001|Overall Study|Withdrawal by Subject|3|||
130252451|NCT00692237|468887348|FG000|Overall Study|Adverse Event|0|||
130252452|NCT00692237|468887349|FG001|Overall Study|Adverse Event|1|||
130252453|NCT01347086|468887350|FG000|Overall Study|failed screening visit|0|||
130252454|NCT01347086|468887351|FG001|Overall Study|failed screening visit|0|||
130252455|NCT01347086|468887352|FG002|Overall Study|failed screening visit|1|||
130252456|NCT01347086|468887353|FG003|Overall Study|failed screening visit|0|||
130700201|NCT01190930|470526422|FG008|Induction|Enrollment onto another COG Protocol|0|||
130700202|NCT01190930|470526423|FG009|Induction|Enrollment onto another COG Protocol|0|||
130700203|NCT01190930|470526414|FG000|Induction|Average Risk|1847|||
130700204|NCT01190930|470526415|FG001|Induction|Average Risk|0|||
130700205|NCT01190930|470526416|FG002|Induction|Average Risk|0|||
130700206|NCT01190930|470526417|FG003|Induction|Average Risk|0|||
130700207|NCT01190930|470526418|FG004|Induction|Average Risk|0|||
130700208|NCT01190930|470526419|FG005|Induction|Average Risk|0|||
130700209|NCT01190930|470526420|FG006|Induction|Average Risk|0|||
130700210|NCT01190930|470526421|FG007|Induction|Average Risk|0|||
130700211|NCT01190930|470526422|FG008|Induction|Average Risk|0|||
130700212|NCT01190930|470526423|FG009|Induction|Average Risk|0|||
130700213|NCT01190930|470526414|FG000|Induction|High Risk|1227|||
130700214|NCT01190930|470526415|FG001|Induction|High Risk|0|||
130700215|NCT01190930|470526416|FG002|Induction|High Risk|0|||
130700216|NCT01190930|470526417|FG003|Induction|High Risk|0|||
130700217|NCT01190930|470526418|FG004|Induction|High Risk|0|||
130700218|NCT01190930|470526419|FG005|Induction|High Risk|0|||
130700219|NCT01190930|470526420|FG006|Induction|High Risk|0|||
130700220|NCT01190930|470526421|FG007|Induction|High Risk|0|||
130700221|NCT01190930|470526422|FG008|Induction|High Risk|0|||
130700222|NCT01190930|470526423|FG009|Induction|High Risk|0|||
130700223|NCT01190930|470526414|FG000|Induction|Low Risk|443|||
130700224|NCT01190930|470526415|FG001|Induction|Low Risk|0|||
130700225|NCT01190930|470526416|FG002|Induction|Low Risk|0|||
130252457|NCT01347086|468887354|FG004|Overall Study|failed screening visit|0|||
130700226|NCT01190930|470526417|FG003|Induction|Low Risk|0|||
130700227|NCT01190930|470526418|FG004|Induction|Low Risk|0|||
130700228|NCT01190930|470526419|FG005|Induction|Low Risk|0|||
130700229|NCT01190930|470526420|FG006|Induction|Low Risk|0|||
130252458|NCT01347086|468887355|FG005|Overall Study|failed screening visit|0|||
130252459|NCT01347086|468887356|FG006|Overall Study|failed screening visit|1|||
130700230|NCT01190930|470526421|FG007|Induction|Low Risk|0|||
130700231|NCT01190930|470526422|FG008|Induction|Low Risk|0|||
130700232|NCT01190930|470526423|FG009|Induction|Low Risk|0|||
130700233|NCT01190930|470526414|FG000|Induction|Very High Risk|1012|||
130700234|NCT01190930|470526415|FG001|Induction|Very High Risk|0|||
130700235|NCT01190930|470526416|FG002|Induction|Very High Risk|0|||
130700236|NCT01190930|470526417|FG003|Induction|Very High Risk|0|||
130700237|NCT01190930|470526418|FG004|Induction|Very High Risk|0|||
130252460|NCT01347086|468887357|FG007|Overall Study|failed screening visit|1|||
130252461|NCT01347086|468887358|FG008|Overall Study|failed screening visit|0|||
130252462|NCT01347086|468887359|FG009|Overall Study|failed screening visit|1|||
130252463|NCT00395447|468887360|FG000|Overall Study|Death|37|||
130252464|NCT00395447|468887361|FG001|Overall Study|Death|32|||
130252465|NCT00395447|468887360|FG000|Overall Study|Lost to Follow-up|52|||
130252466|NCT00395447|468887361|FG001|Overall Study|Lost to Follow-up|43|||
130252467|NCT00395447|468887360|FG000|Overall Study|Withdrawal by Subject|24|||
130252468|NCT00395447|468887361|FG001|Overall Study|Withdrawal by Subject|19|||
130252469|NCT00395447|468887360|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
130252470|NCT00395447|468887361|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
130252471|NCT02150863|468887363|FG000|Overall Study|Lost to Follow-up|0|||
130252472|NCT02150863|468887364|FG001|Overall Study|Lost to Follow-up|1|||
130252473|NCT02150863|468887365|FG002|Overall Study|Lost to Follow-up|0|||
130252474|NCT01651208|468887366|FG000|Overall Study|Lost to Follow-up|14|||
130252475|NCT01651208|468887367|FG001|Overall Study|Lost to Follow-up|16|||
130252476|NCT00104884|468887372|FG000|Overall Study|Disease progression|4|||
130252477|NCT05071027|468887376|FG000|Overall Study|Lost to Follow-up|1|||
130252478|NCT05071027|468887377|FG001|Overall Study|Lost to Follow-up|4|||
130252479|NCT02314247|468887382|FG000|Overall Study|Adverse Event|2|||
130252480|NCT02314247|468887383|FG001|Overall Study|Adverse Event|1|||
130252481|NCT02314247|468887384|FG002|Overall Study|Adverse Event|0|||
130252482|NCT02314247|468887382|FG000|Overall Study|Withdrawal by Subject|1|||
130252483|NCT02314247|468887383|FG001|Overall Study|Withdrawal by Subject|3|||
130252484|NCT02314247|468887384|FG002|Overall Study|Withdrawal by Subject|1|||
130252485|NCT02314247|468887382|FG000|Overall Study|Progression of Disease|6|||
130364885|NCT01890473|469306786|FG001|Overall Study|Lost to Follow-up|0|||
130364886|NCT01890473|469306785|FG000|Overall Study|Poor/non-compliance|1|||
130364887|NCT01890473|469306786|FG001|Overall Study|Poor/non-compliance|0|||
130364888|NCT00934089|469306787|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
130364889|NCT00934089|469306788|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
130364890|NCT00934089|469306787|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
130364891|NCT00934089|469306788|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
130364892|NCT00003473|469306789|FG000|Overall Study|Three patients were not evaluable.|3|||
130364893|NCT01546207|469306792|FG000|Overall Study|Death|1|||
130364894|NCT00713323|469306793|FG000|Overall Study|Adverse Event|75|||
130364895|NCT00713323|469306793|FG000|Overall Study|Withdrawal by Subject|15|||
130364896|NCT00713323|469306793|FG000|Overall Study|Lost to Follow-up|11|||
130364897|NCT00713323|469306793|FG000|Overall Study|Lack of Efficacy|36|||
130364898|NCT00713323|469306793|FG000|Overall Study|Low creatine clearance at screening|1|||
130364899|NCT00713323|469306793|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
130364900|NCT00713323|469306793|FG000|Overall Study|Surgery cured allodynic pain|1|||
130364901|NCT00713323|469306793|FG000|Overall Study|Pain free|1|||
130364902|NCT00713323|469306793|FG000|Overall Study|Non-compliance|1|||
130364903|NCT00713323|469306793|FG000|Overall Study|Pain resolved|1|||
130364904|NCT00713323|469306793|FG000|Overall Study|Subject travelling to USA|1|||
130364905|NCT00713323|469306793|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
130364906|NCT00713323|469306793|FG000|Overall Study|Treatment that may interact with Sativex|1|||
130364907|NCT01947582|469306799|FG000|Overall Study|Withdrawal by Subject|1|||
130364908|NCT01826604|469306800|FG000|Overall Study|Lost to Follow-up|8|||
130364909|NCT01826604|469306801|FG001|Overall Study|Lost to Follow-up|9|||
130364910|NCT00491075|469306802|FG000|Overall Study|Withdrawal by Subject|1|||
130364911|NCT00491075|469306802|FG000|Overall Study|Physician Decision|1|||
130364912|NCT01603355|469306803|FG000|Overall Study|Lack of Efficacy|2|||
130364913|NCT05350410|469306807|FG000|Overall Study|Withdrawal by Subject|1|||
130364914|NCT00753766|469306808|FG000|Overall Study|Physician Decision|1|||
130364915|NCT00753766|469306809|FG001|Overall Study|Physician Decision|0|||
130364916|NCT00839852|469306810|FG000|Overall Study|Adverse Event|10|||
130364917|NCT00839852|469306810|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130364918|NCT00839852|469306810|FG000|Overall Study|Protocol Violation|9|||
130364919|NCT00839852|469306810|FG000|Overall Study|Withdrawal of Consent|16|||
130364920|NCT00839852|469306810|FG000|Overall Study|Lost to Follow-up|7|||
130364921|NCT00839852|469306810|FG000|Overall Study|Lack of Compliance While in Jail|1|||
130364922|NCT00839852|469306810|FG000|Overall Study|Pregnancy|1|||
130364923|NCT00494299|469306811|FG000|Overall Study|Adverse Event|93|||
130364924|NCT00494299|469306812|FG001|Overall Study|Adverse Event|13|||
130364925|NCT00494299|469306811|FG000|Overall Study|Lost to Follow-up|1|||
130364926|NCT00494299|469306812|FG001|Overall Study|Lost to Follow-up|0|||
130364927|NCT00494299|469306811|FG000|Overall Study|Physician Decision|0|||
130364928|NCT00494299|469306812|FG001|Overall Study|Physician Decision|2|||
130252486|NCT02314247|468887383|FG001|Overall Study|Progression of Disease|2|||
130252487|NCT02314247|468887384|FG002|Overall Study|Progression of Disease|0|||
130364929|NCT00494299|469306811|FG000|Overall Study|Protocol Violation|1|||
130252488|NCT02965976|468887385|FG000|Overall Study|Withdrawal by Subject|2|||
130252489|NCT02965976|468887386|FG001|Overall Study|Withdrawal by Subject|0|||
130252490|NCT01687595|468887387|FG000|Overall Study|Withdrawal by Subject|8|||
130252491|NCT01687595|468887388|FG001|Overall Study|Withdrawal by Subject|0|||
130252492|NCT01687595|468887387|FG000|Overall Study|Lost to Follow-up|3|||
130252493|NCT01687595|468887388|FG001|Overall Study|Lost to Follow-up|1|||
130252494|NCT01687595|468887387|FG000|Overall Study|Investigator's decision|1|||
130252495|NCT01687595|468887388|FG001|Overall Study|Investigator's decision|0|||
130252496|NCT01687595|468887387|FG000|Overall Study|Sponsor's decision|1|||
130252497|NCT01687595|468887388|FG001|Overall Study|Sponsor's decision|0|||
130252498|NCT01687595|468887387|FG000|Overall Study|Noncompliance|1|||
130252499|NCT01687595|468887388|FG001|Overall Study|Noncompliance|2|||
130252500|NCT01687595|468887387|FG000|Overall Study|Other than specified|56|||
130252501|NCT01687595|468887388|FG001|Overall Study|Other than specified|7|||
130252502|NCT00489359|468887391|FG000|Overall Study|Death|0|||
130252503|NCT00489359|468887392|FG001|Overall Study|Death|2|||
130252504|NCT00489359|468887391|FG000|Overall Study|Progressive Disease|5|||
130252505|NCT00489359|468887392|FG001|Overall Study|Progressive Disease|6|||
130252506|NCT00489359|468887391|FG000|Overall Study|Lost to Follow-up|1|||
130252507|NCT00489359|468887392|FG001|Overall Study|Lost to Follow-up|0|||
130252508|NCT00489359|468887391|FG000|Overall Study|Withdrawal by Subject|1|||
130252509|NCT00489359|468887392|FG001|Overall Study|Withdrawal by Subject|5|||
130252510|NCT00489359|468887391|FG000|Overall Study|Adverse Event|0|||
130252511|NCT00489359|468887392|FG001|Overall Study|Adverse Event|16|||
130252512|NCT04191733|468887394|FG000|Overall Study|Withdrawn due to study closure|13|||
130252513|NCT04191733|468887395|FG001|Overall Study|Withdrawn due to study closure|14|||
130252514|NCT04191733|468887394|FG000|Overall Study|Withdrawal by Subject|2|||
130252515|NCT04191733|468887395|FG001|Overall Study|Withdrawal by Subject|4|||
130252516|NCT04191733|468887394|FG000|Overall Study|Physician Decision|1|||
130252517|NCT04191733|468887395|FG001|Overall Study|Physician Decision|1|||
130252518|NCT04191733|468887394|FG000|Overall Study|Lost to Follow-up|5|||
130252519|NCT04191733|468887395|FG001|Overall Study|Lost to Follow-up|6|||
130252520|NCT04191733|468887394|FG000|Overall Study|Death|0|||
130252521|NCT04191733|468887395|FG001|Overall Study|Death|1|||
130252522|NCT01903733|468887398|FG000|Overall Study|Death|23|||
130252523|NCT01903733|468887399|FG001|Overall Study|Death|54|||
130252524|NCT01903733|468887400|FG002|Overall Study|Death|30|||
130252525|NCT01903733|468887401|FG003|Overall Study|Death|98|||
130252526|NCT01903733|468887398|FG000|Overall Study|Participant refused further follow-up|35|||
130252527|NCT01903733|468887399|FG001|Overall Study|Participant refused further follow-up|38|||
130252528|NCT01903733|468887400|FG002|Overall Study|Participant refused further follow-up|13|||
130252529|NCT01903733|468887401|FG003|Overall Study|Participant refused further follow-up|9|||
130252530|NCT01903733|468887398|FG000|Overall Study|Lost to Follow-up|18|||
130252531|NCT01903733|468887399|FG001|Overall Study|Lost to Follow-up|19|||
130252532|NCT01903733|468887400|FG002|Overall Study|Lost to Follow-up|6|||
130700238|NCT01190930|470526419|FG005|Induction|Very High Risk|0|||
130700239|NCT01190930|470526420|FG006|Induction|Very High Risk|0|||
130252533|NCT01903733|468887401|FG003|Overall Study|Lost to Follow-up|9|||
130252534|NCT01903733|468887398|FG000|Overall Study|Other|10|||
130252535|NCT01903733|468887399|FG001|Overall Study|Other|15|||
130252536|NCT01903733|468887400|FG002|Overall Study|Other|12|||
130252537|NCT01903733|468887401|FG003|Overall Study|Other|3|||
130252538|NCT01903733|468887398|FG000|Overall Study|Missing|2|||
130252539|NCT01903733|468887399|FG001|Overall Study|Missing|0|||
130252540|NCT01903733|468887400|FG002|Overall Study|Missing|0|||
130364930|NCT00494299|469306812|FG001|Overall Study|Protocol Violation|2|||
130700240|NCT01190930|470526421|FG007|Induction|Very High Risk|0|||
130700241|NCT01190930|470526422|FG008|Induction|Very High Risk|0|||
130700242|NCT01190930|470526423|FG009|Induction|Very High Risk|0|||
130700243|NCT01190930|470526414|FG000|Induction|Philadelphia chromosome-positive|99|||
130700244|NCT01190930|470526415|FG001|Induction|Philadelphia chromosome-positive|0|||
130700245|NCT01190930|470526416|FG002|Induction|Philadelphia chromosome-positive|0|||
130700246|NCT01190930|470526417|FG003|Induction|Philadelphia chromosome-positive|0|||
130700247|NCT01190930|470526418|FG004|Induction|Philadelphia chromosome-positive|0|||
130700248|NCT01190930|470526419|FG005|Induction|Philadelphia chromosome-positive|0|||
130700249|NCT01190930|470526420|FG006|Induction|Philadelphia chromosome-positive|0|||
130700250|NCT01190930|470526421|FG007|Induction|Philadelphia chromosome-positive|0|||
130700251|NCT01190930|470526422|FG008|Induction|Philadelphia chromosome-positive|0|||
130700252|NCT01190930|470526423|FG009|Induction|Philadelphia chromosome-positive|0|||
130700253|NCT01190930|470526414|FG000|Induction|Incomplete Induction data|63|||
130252541|NCT01903733|468887401|FG003|Overall Study|Missing|0|||
130252542|NCT01903733|468887398|FG000|Overall Study|Investigator request|18|||
130252543|NCT01903733|468887399|FG001|Overall Study|Investigator request|0|||
130252544|NCT01903733|468887400|FG002|Overall Study|Investigator request|0|||
130252545|NCT01903733|468887401|FG003|Overall Study|Investigator request|0|||
130252546|NCT01714063|468887402|FG000|Overall Study|Equipment malfunction|2|||
130700254|NCT01190930|470526415|FG001|Induction|Incomplete Induction data|0|||
130700255|NCT01190930|470526416|FG002|Induction|Incomplete Induction data|0|||
130700256|NCT01190930|470526417|FG003|Induction|Incomplete Induction data|0|||
130252547|NCT02294019|468887404|FG000|Overall Study|Adverse Event|2|||
130252548|NCT02294019|468887404|FG000|Overall Study|Protocol Violation|68|||
130252549|NCT02294019|468887404|FG000|Overall Study|Lost to Follow-up|31|||
130252550|NCT02294019|468887404|FG000|Overall Study|Other|1|||
130252551|NCT02294019|468887404|FG000|Overall Study|Withdrawal by Subject|1|||
130252552|NCT02369159|468887405|FG000|Overall Study|Adverse Event|0|||
130252553|NCT02369159|468887406|FG001|Overall Study|Adverse Event|1|||
130252554|NCT02369159|468887405|FG000|Overall Study|Lost to Follow-up|1|||
130252555|NCT02369159|468887406|FG001|Overall Study|Lost to Follow-up|1|||
130252556|NCT02369159|468887405|FG000|Overall Study|Withdrawal by Subject|7|||
130252557|NCT02369159|468887406|FG001|Overall Study|Withdrawal by Subject|0|||
130252558|NCT03769116|468887407|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
130252559|NCT03769116|468887408|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
130252560|NCT03769116|468887407|FG000|Part 3 - Open Label|Physician Decision|1|||
130252561|NCT03769116|468887408|FG001|Part 3 - Open Label|Physician Decision|0|||
130252562|NCT03769116|468887407|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
130252563|NCT03769116|468887408|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
130252564|NCT01887600|468887410|FG000|Overall Study|Death|39|||
130252565|NCT01887600|468887411|FG001|Overall Study|Death|16|||
130252566|NCT01887600|468887410|FG000|Overall Study|Lack of Efficacy|3|||
130252567|NCT01887600|468887411|FG001|Overall Study|Lack of Efficacy|26|||
130252568|NCT01887600|468887410|FG000|Overall Study|Lost to Follow-up|5|||
130252569|NCT01887600|468887411|FG001|Overall Study|Lost to Follow-up|1|||
130252570|NCT01887600|468887410|FG000|Overall Study|Physician Decision|7|||
130252571|NCT01887600|468887411|FG001|Overall Study|Physician Decision|8|||
130252572|NCT01887600|468887410|FG000|Overall Study|Protocol Deviation|3|||
130252573|NCT01887600|468887411|FG001|Overall Study|Protocol Deviation|0|||
130252574|NCT01887600|468887410|FG000|Overall Study|Withdrawal by Subject|58|||
130252575|NCT01887600|468887411|FG001|Overall Study|Withdrawal by Subject|52|||
130252576|NCT01887600|468887410|FG000|Overall Study|Adverse Event|21|||
130252577|NCT01887600|468887411|FG001|Overall Study|Adverse Event|9|||
130252578|NCT01887600|468887410|FG000|Overall Study|Non-compliance with study drug|3|||
130252579|NCT01887600|468887411|FG001|Overall Study|Non-compliance with study drug|0|||
130252580|NCT01887600|468887410|FG000|Overall Study|Miscellaneous|6|||
130252581|NCT01887600|468887411|FG001|Overall Study|Miscellaneous|2|||
130252582|NCT01887600|468887410|FG000|Overall Study|Progressive Disease|1|||
130252583|NCT01887600|468887411|FG001|Overall Study|Progressive Disease|0|||
130252584|NCT03688139|468887412|FG000|Overall Study|Lost to Follow-up|2|||
130252585|NCT03688139|468887413|FG001|Overall Study|Lost to Follow-up|0|||
130252586|NCT03688139|468887412|FG000|Overall Study|Physician Decision|0|||
130252587|NCT03688139|468887413|FG001|Overall Study|Physician Decision|1|||
130252588|NCT03688139|468887412|FG000|Overall Study|Withdrawal by Subject|2|||
130252589|NCT03688139|468887413|FG001|Overall Study|Withdrawal by Subject|3|||
130252590|NCT00420056|468887414|FG000|Overall Study|Objective progression or relapse|17|||
130252591|NCT00025233|468887418|FG000|Overall Study|Ineligible: wrong cell type|1|||
130252592|NCT00025233|468887418|FG000|Overall Study|Ineligible: wrong primary|1|||
130252593|NCT00025233|468887418|FG000|Overall Study|Ineligible: improper prior treatment|1|||
130252594|NCT00025233|468887418|FG000|Overall Study|Never treated|1|||
130252595|NCT03425188|468887419|FG000|Overall Study|Withdrawal by Subject|1|||
130252596|NCT00655356|468887420|FG000|Overall Study|Withdrawal by Subject|3|||
130252597|NCT00655356|468887421|FG001|Overall Study|Withdrawal by Subject|4|||
130252598|NCT00655356|468887420|FG000|Overall Study|Sponsor Request|10|||
130252599|NCT00655356|468887421|FG001|Overall Study|Sponsor Request|4|||
130252600|NCT00655356|468887420|FG000|Overall Study|Adverse Event|1|||
130252601|NCT00655356|468887421|FG001|Overall Study|Adverse Event|1|||
130252602|NCT00655356|468887420|FG000|Overall Study|Protocol Violation|2|||
130252603|NCT00655356|468887421|FG001|Overall Study|Protocol Violation|1|||
130252604|NCT00655356|468887420|FG000|Overall Study|Other Reason|1|||
130252605|NCT00655356|468887421|FG001|Overall Study|Other Reason|0|||
130252606|NCT01412983|468887422|FG000|1st Period|Ineligible|0|||
130252607|NCT01412983|468887423|FG001|1st Period|Ineligible|1|||
130252608|NCT01412983|468887422|FG000|1st Period|Positive slit lamp finding|0|||
130252609|NCT01412983|468887423|FG001|1st Period|Positive slit lamp finding|1|||
130252610|NCT01412983|468887422|FG000|1st Period|Unacceptable lens movement|0|||
130252611|NCT01412983|468887423|FG001|1st Period|Unacceptable lens movement|1|||
130252612|NCT01412983|468887422|FG000|1st Period|Inability to maintain wear|0|||
130252613|NCT01412983|468887423|FG001|1st Period|Inability to maintain wear|1|||
130252614|NCT01694771|468887424|FG000|Overall Study|Adverse Event|18|||
130252615|NCT01694771|468887425|FG001|Overall Study|Adverse Event|16|||
130252616|NCT01694771|468887424|FG000|Overall Study|Lack of Efficacy|1|||
130252617|NCT01694771|468887425|FG001|Overall Study|Lack of Efficacy|0|||
130364931|NCT00494299|469306811|FG000|Overall Study|Withdrawal by Subject|8|||
130252618|NCT01694771|468887424|FG000|Overall Study|Non compliance protocol|7|||
130252619|NCT01694771|468887425|FG001|Overall Study|Non compliance protocol|6|||
130252620|NCT01694771|468887424|FG000|Overall Study|Lost to Follow-up|2|||
130252621|NCT01694771|468887425|FG001|Overall Study|Lost to Follow-up|3|||
130252622|NCT01694771|468887424|FG000|Overall Study|Consent withdrawn|7|||
130252623|NCT01694771|468887425|FG001|Overall Study|Consent withdrawn|9|||
130252624|NCT01694771|468887424|FG000|Overall Study|Other reasons|5|||
130252625|NCT01694771|468887425|FG001|Overall Study|Other reasons|6|||
130252626|NCT00289900|468887426|FG000|Overall Study|Adverse Event|28|||
130252627|NCT00289900|468887427|FG001|Overall Study|Adverse Event|40|||
130252628|NCT00289900|468887428|FG002|Overall Study|Adverse Event|13|||
130252629|NCT00289900|468887429|FG003|Overall Study|Adverse Event|19|||
130252630|NCT00289900|468887430|FG004|Overall Study|Adverse Event|20|||
130252631|NCT00289900|468887431|FG005|Overall Study|Adverse Event|33|||
130252632|NCT00289900|468887426|FG000|Overall Study|Lost to Follow-up|7|||
130252633|NCT00289900|468887427|FG001|Overall Study|Lost to Follow-up|7|||
130252634|NCT00289900|468887428|FG002|Overall Study|Lost to Follow-up|8|||
130252635|NCT00289900|468887429|FG003|Overall Study|Lost to Follow-up|8|||
130252636|NCT00289900|468887430|FG004|Overall Study|Lost to Follow-up|4|||
130252637|NCT00289900|468887431|FG005|Overall Study|Lost to Follow-up|8|||
130252638|NCT00289900|468887426|FG000|Overall Study|Participant had flushing|18|||
130252639|NCT00289900|468887427|FG001|Overall Study|Participant had flushing|42|||
130252640|NCT00289900|468887428|FG002|Overall Study|Participant had flushing|1|||
130252641|NCT00289900|468887429|FG003|Overall Study|Participant had flushing|2|||
130252642|NCT00289900|468887430|FG004|Overall Study|Participant had flushing|0|||
130252643|NCT00289900|468887431|FG005|Overall Study|Participant had flushing|4|||
130252644|NCT00289900|468887426|FG000|Overall Study|Other|0|||
130252645|NCT00289900|468887427|FG001|Overall Study|Other|0|||
130252646|NCT00289900|468887428|FG002|Overall Study|Other|0|||
130252647|NCT00289900|468887429|FG003|Overall Study|Other|5|||
130252648|NCT00289900|468887430|FG004|Overall Study|Other|1|||
130252649|NCT00289900|468887431|FG005|Overall Study|Other|0|||
130252650|NCT00289900|468887426|FG000|Overall Study|Participant moved|1|||
130252651|NCT00289900|468887427|FG001|Overall Study|Participant moved|0|||
130252652|NCT00289900|468887428|FG002|Overall Study|Participant moved|0|||
130252653|NCT00289900|468887429|FG003|Overall Study|Participant moved|1|||
130252654|NCT00289900|468887430|FG004|Overall Study|Participant moved|1|||
130252655|NCT00289900|468887431|FG005|Overall Study|Participant moved|1|||
130252656|NCT00289900|468887426|FG000|Overall Study|Withdrawal by Subject|10|||
130252657|NCT00289900|468887427|FG001|Overall Study|Withdrawal by Subject|21|||
130252658|NCT00289900|468887428|FG002|Overall Study|Withdrawal by Subject|8|||
130252659|NCT00289900|468887429|FG003|Overall Study|Withdrawal by Subject|18|||
130252660|NCT00289900|468887430|FG004|Overall Study|Withdrawal by Subject|12|||
130252661|NCT00289900|468887431|FG005|Overall Study|Withdrawal by Subject|11|||
130252662|NCT00289900|468887426|FG000|Overall Study|Protocol Violation|3|||
130252663|NCT00289900|468887427|FG001|Overall Study|Protocol Violation|9|||
130252664|NCT00289900|468887428|FG002|Overall Study|Protocol Violation|2|||
130252665|NCT00289900|468887429|FG003|Overall Study|Protocol Violation|6|||
130252666|NCT00289900|468887430|FG004|Overall Study|Protocol Violation|7|||
130252667|NCT00289900|468887431|FG005|Overall Study|Protocol Violation|4|||
130252668|NCT00289900|468887426|FG000|Overall Study|site terminated|1|||
130252669|NCT00289900|468887427|FG001|Overall Study|site terminated|0|||
130252670|NCT00289900|468887428|FG002|Overall Study|site terminated|1|||
130252671|NCT00289900|468887429|FG003|Overall Study|site terminated|0|||
130252672|NCT00289900|468887430|FG004|Overall Study|site terminated|0|||
130252673|NCT00289900|468887431|FG005|Overall Study|site terminated|0|||
130252674|NCT00289900|468887426|FG000|Overall Study|Not treated|0|||
130252675|NCT00289900|468887427|FG001|Overall Study|Not treated|1|||
130252676|NCT00289900|468887428|FG002|Overall Study|Not treated|0|||
130252677|NCT00289900|468887429|FG003|Overall Study|Not treated|0|||
130252678|NCT00289900|468887430|FG004|Overall Study|Not treated|0|||
130252679|NCT00289900|468887431|FG005|Overall Study|Not treated|0|||
130252680|NCT01152385|468887432|FG000|Overall Study|Withdrawal by Subject|3|||
130252681|NCT01152385|468887433|FG001|Overall Study|Withdrawal by Subject|1|||
130252682|NCT01152385|468887434|FG002|Overall Study|Withdrawal by Subject|1|||
130252683|NCT01152385|468887435|FG003|Overall Study|Withdrawal by Subject|1|||
130252684|NCT01152385|468887432|FG000|Overall Study|Protocol Violation|0|||
130252685|NCT01152385|468887433|FG001|Overall Study|Protocol Violation|0|||
130252686|NCT01152385|468887434|FG002|Overall Study|Protocol Violation|0|||
130252687|NCT01152385|468887435|FG003|Overall Study|Protocol Violation|1|||
130252688|NCT01152385|468887432|FG000|Overall Study|Adverse Event|1|||
130252689|NCT01152385|468887433|FG001|Overall Study|Adverse Event|1|||
130252690|NCT01152385|468887434|FG002|Overall Study|Adverse Event|0|||
130252691|NCT01152385|468887435|FG003|Overall Study|Adverse Event|0|||
130252692|NCT01152385|468887432|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130252693|NCT01152385|468887433|FG001|Overall Study|Study-specific withdrawal criteria|1|||
130252694|NCT01152385|468887434|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130252695|NCT01152385|468887435|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130252696|NCT01152385|468887432|FG000|Overall Study|Other|4|||
130252697|NCT01152385|468887433|FG001|Overall Study|Other|3|||
130252698|NCT01152385|468887434|FG002|Overall Study|Other|2|||
130252699|NCT01152385|468887435|FG003|Overall Study|Other|3|||
130252700|NCT05486065|468887436|FG000|Overall Study|Withdrawal by Subject|1|||
130700257|NCT01190930|470526418|FG004|Induction|Incomplete Induction data|0|||
130700258|NCT01190930|470526419|FG005|Induction|Incomplete Induction data|0|||
130700259|NCT01190930|470526420|FG006|Induction|Incomplete Induction data|0|||
130700260|NCT01190930|470526421|FG007|Induction|Incomplete Induction data|0|||
130700261|NCT01190930|470526422|FG008|Induction|Incomplete Induction data|0|||
130700262|NCT01190930|470526423|FG009|Induction|Incomplete Induction data|0|||
130700263|NCT01190930|470526414|FG000|Induction|Progressive disease|0|||
130700264|NCT01190930|470526415|FG001|Induction|Progressive disease|1|||
130700265|NCT01190930|470526416|FG002|Induction|Progressive disease|0|||
130700266|NCT01190930|470526417|FG003|Induction|Progressive disease|0|||
130700267|NCT01190930|470526418|FG004|Induction|Progressive disease|0|||
130700268|NCT01190930|470526419|FG005|Induction|Progressive disease|0|||
130700269|NCT01190930|470526420|FG006|Induction|Progressive disease|0|||
130700270|NCT01190930|470526421|FG007|Induction|Progressive disease|0|||
130700271|NCT01190930|470526422|FG008|Induction|Progressive disease|0|||
130700272|NCT01190930|470526423|FG009|Induction|Progressive disease|0|||
130252701|NCT05486065|468887437|FG001|Overall Study|Withdrawal by Subject|5|||
130252702|NCT05486065|468887438|FG002|Overall Study|Withdrawal by Subject|4|||
130252703|NCT05486065|468887439|FG003|Overall Study|Withdrawal by Subject|3|||
130252704|NCT05486065|468887436|FG000|Overall Study|Lost to Follow-up|4|||
130252705|NCT05486065|468887437|FG001|Overall Study|Lost to Follow-up|2|||
130252706|NCT05486065|468887438|FG002|Overall Study|Lost to Follow-up|2|||
130252707|NCT05486065|468887439|FG003|Overall Study|Lost to Follow-up|2|||
130252708|NCT05486065|468887436|FG000|Overall Study|Physician Decision|0|||
130700273|NCT01190930|470526414|FG000|Induction|No treatment|3|||
130700274|NCT01190930|470526415|FG001|Induction|No treatment|0|||
130700275|NCT01190930|470526416|FG002|Induction|No treatment|0|||
130700276|NCT01190930|470526417|FG003|Induction|No treatment|0|||
130700277|NCT01190930|470526418|FG004|Induction|No treatment|0|||
130700278|NCT01190930|470526419|FG005|Induction|No treatment|0|||
130700279|NCT01190930|470526420|FG006|Induction|No treatment|0|||
130700280|NCT01190930|470526421|FG007|Induction|No treatment|0|||
130700281|NCT01190930|470526422|FG008|Induction|No treatment|0|||
130700282|NCT01190930|470526423|FG009|Induction|No treatment|0|||
130700283|NCT01190930|470526414|FG000|Induction|Ineligible|69|||
130700284|NCT01190930|470526415|FG001|Induction|Ineligible|4|||
130700285|NCT01190930|470526416|FG002|Induction|Ineligible|0|||
130700286|NCT01190930|470526417|FG003|Induction|Ineligible|0|||
130700287|NCT01190930|470526418|FG004|Induction|Ineligible|0|||
130700288|NCT01190930|470526419|FG005|Induction|Ineligible|0|||
130700289|NCT01190930|470526420|FG006|Induction|Ineligible|0|||
130700290|NCT01190930|470526421|FG007|Induction|Ineligible|0|||
130700291|NCT01190930|470526422|FG008|Induction|Ineligible|0|||
130700292|NCT01190930|470526423|FG009|Induction|Ineligible|0|||
130700293|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
130700294|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
130700295|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
130700296|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
130700297|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
130700298|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
130700299|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
130700300|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
130700301|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
130252709|NCT05486065|468887437|FG001|Overall Study|Physician Decision|1|||
130252710|NCT05486065|468887438|FG002|Overall Study|Physician Decision|1|||
130252711|NCT05486065|468887439|FG003|Overall Study|Physician Decision|0|||
130252712|NCT05486065|468887436|FG000|Overall Study|Failure to meet randomization criteria|0|||
130252713|NCT05486065|468887437|FG001|Overall Study|Failure to meet randomization criteria|0|||
130364932|NCT00494299|469306812|FG001|Overall Study|Withdrawal by Subject|3|||
130364933|NCT00494299|469306811|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
130364934|NCT00494299|469306812|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
130364935|NCT00494299|469306811|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
130376666|NCT01327885|469345896|FG001|Overall Study|Adverse Event|10|||
130700302|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
130700303|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Death|0|||
130700304|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Death|0|||
130700305|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Death|8|||
130700306|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Death|4|||
130700307|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Death|0|||
130700308|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Death|0|||
130700309|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Death|0|||
130700310|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Death|0|||
130700311|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Death|0|||
130700312|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Death|0|||
130700313|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
130700314|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
130700315|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
130700316|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
130252714|NCT05486065|468887438|FG002|Overall Study|Failure to meet randomization criteria|0|||
130252715|NCT05486065|468887439|FG003|Overall Study|Failure to meet randomization criteria|1|||
130252716|NCT03810495|468887444|FG000|Overall Study|Lost to Follow-up|2|||
130252717|NCT03810495|468887444|FG000|Overall Study|Withdrawal by Subject|1|||
130252718|NCT03289741|468887445|FG000|Overall Study|Adverse Event|1|||
130252719|NCT03289741|468887446|FG001|Overall Study|Adverse Event|1|||
130252720|NCT03289741|468887445|FG000|Overall Study|Physician Decision|2|||
130252721|NCT03289741|468887446|FG001|Overall Study|Physician Decision|2|||
130252722|NCT03289741|468887445|FG000|Overall Study|Withdrawal by Subject|1|||
130252723|NCT03289741|468887446|FG001|Overall Study|Withdrawal by Subject|0|||
130252724|NCT02536339|468887448|FG000|Overall Study|Death|20|||
130252725|NCT02536339|468887448|FG000|Overall Study|Withdrawal by Subject|3|||
130252726|NCT02536339|468887448|FG000|Overall Study|Lost to Follow-up|2|||
130252727|NCT02536339|468887448|FG000|Overall Study|Treatment discontinued|2|||
130252728|NCT02536339|468887448|FG000|Overall Study|Physician Decision|1|||
130252729|NCT02037984|468887449|FG000|Overall Study|Lack of Efficacy|0|||
130252730|NCT02037984|468887450|FG001|Overall Study|Lack of Efficacy|0|||
130252731|NCT02037984|468887451|FG002|Overall Study|Lack of Efficacy|3|||
130252732|NCT02037984|468887452|FG003|Overall Study|Lack of Efficacy|10|||
130252733|NCT02037984|468887453|FG004|Overall Study|Lack of Efficacy|2|||
130252734|NCT02037984|468887454|FG005|Overall Study|Lack of Efficacy|2|||
130252735|NCT02037984|468887455|FG006|Overall Study|Lack of Efficacy|4|||
130252736|NCT02037984|468887456|FG007|Overall Study|Lack of Efficacy|3|||
130252737|NCT02037984|468887449|FG000|Overall Study|Lost to Follow-up|1|||
130252738|NCT02037984|468887450|FG001|Overall Study|Lost to Follow-up|0|||
130252739|NCT02037984|468887451|FG002|Overall Study|Lost to Follow-up|3|||
130252740|NCT02037984|468887452|FG003|Overall Study|Lost to Follow-up|5|||
130252741|NCT02037984|468887453|FG004|Overall Study|Lost to Follow-up|2|||
130252742|NCT02037984|468887454|FG005|Overall Study|Lost to Follow-up|2|||
130252743|NCT02037984|468887455|FG006|Overall Study|Lost to Follow-up|2|||
130252744|NCT02037984|468887456|FG007|Overall Study|Lost to Follow-up|4|||
130252745|NCT02037984|468887449|FG000|Overall Study|Physician Decision|0|||
130252746|NCT02037984|468887450|FG001|Overall Study|Physician Decision|0|||
130252747|NCT02037984|468887451|FG002|Overall Study|Physician Decision|0|||
130252748|NCT02037984|468887452|FG003|Overall Study|Physician Decision|0|||
130252749|NCT02037984|468887453|FG004|Overall Study|Physician Decision|0|||
130252750|NCT02037984|468887454|FG005|Overall Study|Physician Decision|0|||
130252751|NCT02037984|468887455|FG006|Overall Study|Physician Decision|1|||
130252752|NCT02037984|468887456|FG007|Overall Study|Physician Decision|0|||
130252753|NCT02037984|468887449|FG000|Overall Study|Protocol Violation|0|||
130252754|NCT02037984|468887450|FG001|Overall Study|Protocol Violation|0|||
130252755|NCT02037984|468887451|FG002|Overall Study|Protocol Violation|0|||
130252756|NCT02037984|468887452|FG003|Overall Study|Protocol Violation|0|||
130252757|NCT02037984|468887453|FG004|Overall Study|Protocol Violation|0|||
130252758|NCT02037984|468887454|FG005|Overall Study|Protocol Violation|1|||
130252759|NCT02037984|468887455|FG006|Overall Study|Protocol Violation|2|||
130252760|NCT02037984|468887456|FG007|Overall Study|Protocol Violation|0|||
130252761|NCT02037984|468887449|FG000|Overall Study|Technical Problems|0|||
130252762|NCT02037984|468887450|FG001|Overall Study|Technical Problems|0|||
130252763|NCT02037984|468887451|FG002|Overall Study|Technical Problems|3|||
130252764|NCT02037984|468887452|FG003|Overall Study|Technical Problems|3|||
130252765|NCT02037984|468887453|FG004|Overall Study|Technical Problems|2|||
130252766|NCT02037984|468887454|FG005|Overall Study|Technical Problems|3|||
130252767|NCT02037984|468887455|FG006|Overall Study|Technical Problems|4|||
130252768|NCT02037984|468887456|FG007|Overall Study|Technical Problems|2|||
130252769|NCT02037984|468887449|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130252770|NCT02037984|468887450|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130252771|NCT02037984|468887451|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
130364936|NCT00494299|469306812|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
130364937|NCT00494299|469306811|FG000|Overall Study|Site Closed by Sponsor|6|||
130364938|NCT00494299|469306812|FG001|Overall Study|Site Closed by Sponsor|0|||
130364939|NCT00494299|469306811|FG000|Overall Study|Protocol Driven Decision Point|11|||
130364940|NCT00494299|469306812|FG001|Overall Study|Protocol Driven Decision Point|22|||
130364941|NCT02805972|469306817|FG000|Washout Period|Lost to Follow-up|3|||
130364942|NCT02805972|469306818|FG001|Washout Period|Lost to Follow-up|0|||
130252772|NCT02037984|468887452|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
130252773|NCT02037984|468887453|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
130252774|NCT02037984|468887454|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
130252775|NCT02037984|468887455|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
130252776|NCT02037984|468887456|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
130252777|NCT02037984|468887449|FG000|Overall Study|Withdrawal by Subject|0|||
130252778|NCT02037984|468887450|FG001|Overall Study|Withdrawal by Subject|0|||
130252779|NCT02037984|468887451|FG002|Overall Study|Withdrawal by Subject|0|||
130252780|NCT02037984|468887452|FG003|Overall Study|Withdrawal by Subject|1|||
130252781|NCT02037984|468887453|FG004|Overall Study|Withdrawal by Subject|1|||
130252782|NCT02037984|468887454|FG005|Overall Study|Withdrawal by Subject|3|||
130252783|NCT02037984|468887455|FG006|Overall Study|Withdrawal by Subject|0|||
130364943|NCT01206166|469306820|FG000|Overall Study|No evaluable data|2|||
130553322|NCT02202551|469993555|FG003|Overall Study|Subject moved away|0|||
130553323|NCT02202551|469993552|FG000|Overall Study|DBS surgery|3|||
130553324|NCT02202551|469993553|FG001|Overall Study|DBS surgery|0|||
130553325|NCT02202551|469993554|FG002|Overall Study|DBS surgery|0|||
130553326|NCT02202551|469993555|FG003|Overall Study|DBS surgery|0|||
130553327|NCT02202551|469993552|FG000|Overall Study|Dyskinesia upon taper|1|||
130553328|NCT02202551|469993553|FG001|Overall Study|Dyskinesia upon taper|0|||
130553329|NCT02202551|469993554|FG002|Overall Study|Dyskinesia upon taper|0|||
130553330|NCT02202551|469993555|FG003|Overall Study|Dyskinesia upon taper|0|||
130553331|NCT02202551|469993552|FG000|Overall Study|Lack of Efficacy|0|||
130553332|NCT02202551|469993553|FG001|Overall Study|Lack of Efficacy|1|||
130553333|NCT02202551|469993554|FG002|Overall Study|Lack of Efficacy|0|||
130553334|NCT02202551|469993555|FG003|Overall Study|Lack of Efficacy|0|||
130553335|NCT02202551|469993552|FG000|Overall Study|Physician Decision|1|||
130553336|NCT02202551|469993553|FG001|Overall Study|Physician Decision|0|||
130553337|NCT02202551|469993554|FG002|Overall Study|Physician Decision|0|||
130553338|NCT02202551|469993555|FG003|Overall Study|Physician Decision|0|||
130553339|NCT02202551|469993552|FG000|Overall Study|Site closure|3|||
130553340|NCT02202551|469993553|FG001|Overall Study|Site closure|0|||
130553341|NCT02202551|469993554|FG002|Overall Study|Site closure|0|||
130553342|NCT02202551|469993555|FG003|Overall Study|Site closure|1|||
130553343|NCT02202551|469993552|FG000|Overall Study|Unable to complete visits per protocol|1|||
130553344|NCT02202551|469993553|FG001|Overall Study|Unable to complete visits per protocol|0|||
130553345|NCT02202551|469993554|FG002|Overall Study|Unable to complete visits per protocol|0|||
130553346|NCT02202551|469993555|FG003|Overall Study|Unable to complete visits per protocol|0|||
130553347|NCT02202551|469993552|FG000|Overall Study|Worsening Dyskinesia|0|||
130553348|NCT02202551|469993553|FG001|Overall Study|Worsening Dyskinesia|0|||
130553349|NCT02202551|469993554|FG002|Overall Study|Worsening Dyskinesia|0|||
130553350|NCT02202551|469993555|FG003|Overall Study|Worsening Dyskinesia|1|||
130553351|NCT02202551|469993552|FG000|Overall Study|Protocol Violation|0|||
130553352|NCT02202551|469993553|FG001|Overall Study|Protocol Violation|1|||
130553353|NCT02202551|469993554|FG002|Overall Study|Protocol Violation|0|||
130553354|NCT02202551|469993555|FG003|Overall Study|Protocol Violation|0|||
130553355|NCT02202551|469993552|FG000|Overall Study|Sponsor's decision|2|||
130553356|NCT02202551|469993553|FG001|Overall Study|Sponsor's decision|0|||
130553357|NCT02202551|469993554|FG002|Overall Study|Sponsor's decision|0|||
130553358|NCT02202551|469993555|FG003|Overall Study|Sponsor's decision|0|||
130553359|NCT02202551|469993552|FG000|Overall Study|Subject unwilling to proceed|1|||
130553360|NCT02202551|469993553|FG001|Overall Study|Subject unwilling to proceed|5|||
130553361|NCT02202551|469993554|FG002|Overall Study|Subject unwilling to proceed|3|||
130553362|NCT02202551|469993555|FG003|Overall Study|Subject unwilling to proceed|5|||
130553363|NCT02202551|469993552|FG000|Overall Study|Subject consent withdrawn|0|||
130553364|NCT02202551|469993553|FG001|Overall Study|Subject consent withdrawn|3|||
130553365|NCT02202551|469993554|FG002|Overall Study|Subject consent withdrawn|1|||
130553366|NCT02202551|469993555|FG003|Overall Study|Subject consent withdrawn|2|||
130553367|NCT02202551|469993552|FG000|Overall Study|eGFR<50mL/min/m2|2|||
130553368|NCT02202551|469993553|FG001|Overall Study|eGFR<50mL/min/m2|2|||
130553369|NCT02202551|469993554|FG002|Overall Study|eGFR<50mL/min/m2|0|||
130553370|NCT02202551|469993555|FG003|Overall Study|eGFR<50mL/min/m2|1|||
130553371|NCT02147353|469993556|FG000|Overall Study|Lost to Follow-up|2|||
130553372|NCT02147353|469993557|FG001|Overall Study|Lost to Follow-up|0|||
130553373|NCT02147353|469993556|FG000|Overall Study|unable to make visits|4|||
130553374|NCT02147353|469993557|FG001|Overall Study|unable to make visits|0|||
130553375|NCT02147353|469993556|FG000|Overall Study|medication noncompliance|3|||
130553376|NCT02147353|469993557|FG001|Overall Study|medication noncompliance|0|||
130553377|NCT03037619|469993559|FG000|Overall Study|Lost to Follow-up|0|||
130553378|NCT03037619|469993560|FG001|Overall Study|Lost to Follow-up|1|||
130553379|NCT01498289|469993561|FG000|Overall Study|Adverse Event|16|||
130553380|NCT01498289|469993562|FG001|Overall Study|Adverse Event|18|||
130553381|NCT01498289|469993561|FG000|Overall Study|Death|6|||
130252784|NCT02037984|468887456|FG007|Overall Study|Withdrawal by Subject|1|||
130252785|NCT05520333|468888976|FG000|Overall Study|Lost to Follow-up|3|||
130553382|NCT01498289|469993562|FG001|Overall Study|Death|8|||
130553383|NCT01498289|469993561|FG000|Overall Study|Withdrawal unrelated to AE|16|||
130553384|NCT01498289|469993562|FG001|Overall Study|Withdrawal unrelated to AE|16|||
130252786|NCT05520333|468888977|FG001|Overall Study|Lost to Follow-up|6|||
130252787|NCT02457546|468888978|FG000|Overall Study|Other reasons|4|||
130553385|NCT01498289|469993561|FG000|Overall Study|Progression/relapse|53|||
130553386|NCT01498289|469993562|FG001|Overall Study|Progression/relapse|59|||
130553387|NCT01498289|469993561|FG000|Overall Study|Not protocol specified|7|||
130553388|NCT01498289|469993562|FG001|Overall Study|Not protocol specified|2|||
130553389|NCT01498289|469993561|FG000|Overall Study|Reason under review|0|||
130553390|NCT01498289|469993562|FG001|Overall Study|Reason under review|1|||
130553391|NCT03267940|469993563|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
130553392|NCT03267940|469993564|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
130553393|NCT03267940|469993565|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
130553394|NCT03267940|469993566|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
130700317|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
130700318|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
130252788|NCT02457546|468888979|FG001|Overall Study|Other reasons|1|||
130252789|NCT02457546|468888978|FG000|Overall Study|Refused to complete study/procedures|1|||
130252790|NCT02457546|468888979|FG001|Overall Study|Refused to complete study/procedures|1|||
130252791|NCT02457546|468888978|FG000|Overall Study|Lost to Follow-up|4|||
130252792|NCT02457546|468888979|FG001|Overall Study|Lost to Follow-up|1|||
130252793|NCT02457546|468888978|FG000|Overall Study|Adverse Event|0|||
130553395|NCT03267940|469993567|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
130553396|NCT03267940|469993568|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
130553397|NCT03267940|469993563|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
130553398|NCT03267940|469993564|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
130553399|NCT03267940|469993565|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
130553400|NCT03267940|469993566|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
130553401|NCT03267940|469993567|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
130553402|NCT03267940|469993568|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
130553403|NCT03267940|469993563|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
130553404|NCT03267940|469993564|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
130553405|NCT03267940|469993565|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
130553406|NCT03267940|469993566|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
130553407|NCT03267940|469993567|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
130553408|NCT03267940|469993568|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
130553409|NCT03267940|469993563|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
130553410|NCT03267940|469993564|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
130553411|NCT03267940|469993565|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
130553412|NCT03267940|469993566|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
130553413|NCT03267940|469993567|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
130553414|NCT03267940|469993568|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
130553415|NCT03267940|469993563|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
130553416|NCT03267940|469993564|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
130553417|NCT03267940|469993565|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
130553418|NCT03267940|469993566|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
130553419|NCT03267940|469993567|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
130553420|NCT03267940|469993568|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
130553421|NCT03267940|469993563|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
130553422|NCT03267940|469993564|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
130553423|NCT03267940|469993565|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
130553424|NCT03267940|469993566|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
130553425|NCT03267940|469993567|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
130553426|NCT03267940|469993568|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
130553427|NCT03267940|469993563|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
130553428|NCT03267940|469993564|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
130553429|NCT03267940|469993565|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
130553430|NCT03267940|469993566|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
130553431|NCT03267940|469993567|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
130553432|NCT03267940|469993568|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
130553433|NCT03267940|469993563|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
130553434|NCT03267940|469993564|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
130553435|NCT03267940|469993565|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
130553436|NCT03267940|469993566|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
130553437|NCT03267940|469993567|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
130700319|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
130700320|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
130700321|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
130700322|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
130700323|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700324|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
130700325|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
130700326|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
130252794|NCT02457546|468888979|FG001|Overall Study|Adverse Event|1|||
130252795|NCT01633112|468888980|FG000|Overall Study|Lack of Efficacy|1|||
130252796|NCT01633112|468888981|FG001|Overall Study|Lack of Efficacy|6|||
130252797|NCT01633112|468888982|FG002|Overall Study|Lack of Efficacy|13|||
130252798|NCT01633112|468888980|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130364944|NCT01206166|469306821|FG001|Overall Study|No evaluable data|3|||
130252799|NCT01633112|468888981|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130252800|NCT01633112|468888982|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130252801|NCT01633112|468888980|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130252802|NCT01633112|468888981|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130252803|NCT01633112|468888982|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130252804|NCT01633112|468888980|FG000|Overall Study|Administrative problems|1|||
130252805|NCT01633112|468888981|FG001|Overall Study|Administrative problems|2|||
130252806|NCT01633112|468888982|FG002|Overall Study|Administrative problems|5|||
130252807|NCT01633112|468888980|FG000|Overall Study|Adverse Event|16|||
130252808|NCT01633112|468888981|FG001|Overall Study|Adverse Event|18|||
130252809|NCT01633112|468888982|FG002|Overall Study|Adverse Event|20|||
130252810|NCT01633112|468888980|FG000|Overall Study|Lost to Follow-up|7|||
130252811|NCT01633112|468888981|FG001|Overall Study|Lost to Follow-up|19|||
130252812|NCT01633112|468888982|FG002|Overall Study|Lost to Follow-up|6|||
130252813|NCT01633112|468888980|FG000|Overall Study|Protocol Violation|4|||
130252814|NCT01633112|468888981|FG001|Overall Study|Protocol Violation|0|||
130252815|NCT01633112|468888982|FG002|Overall Study|Protocol Violation|2|||
130252816|NCT01633112|468888980|FG000|Overall Study|Subject no longer requires study drug|0|||
130252817|NCT01633112|468888981|FG001|Overall Study|Subject no longer requires study drug|0|||
130252818|NCT01633112|468888982|FG002|Overall Study|Subject no longer requires study drug|1|||
130252819|NCT01633112|468888980|FG000|Overall Study|Withdrawal by Subject|20|||
130252820|NCT01633112|468888981|FG001|Overall Study|Withdrawal by Subject|12|||
130252821|NCT01633112|468888982|FG002|Overall Study|Withdrawal by Subject|41|||
130252822|NCT01633112|468888980|FG000|Overall Study|missing Study Completion CRF|1|||
130700327|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700328|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700329|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700330|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700331|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700332|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700333|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Refusal|0|||
130252823|NCT01633112|468888981|FG001|Overall Study|missing Study Completion CRF|1|||
130252824|NCT01633112|468888982|FG002|Overall Study|missing Study Completion CRF|4|||
130252825|NCT01908699|468888983|FG000|Overall Study|Adverse Event|8|||
130252826|NCT01908699|468888984|FG001|Overall Study|Adverse Event|12|||
130252827|NCT01908699|468888983|FG000|Overall Study|Lack of Efficacy|2|||
130252828|NCT01908699|468888984|FG001|Overall Study|Lack of Efficacy|2|||
130252829|NCT01908699|468888983|FG000|Overall Study|Lost to Follow-up|2|||
130252830|NCT01908699|468888984|FG001|Overall Study|Lost to Follow-up|4|||
130252831|NCT01908699|468888983|FG000|Overall Study|Physician Decision|8|||
130252832|NCT01908699|468888984|FG001|Overall Study|Physician Decision|8|||
130252833|NCT01908699|468888983|FG000|Overall Study|Withdrawal by Subject|15|||
130252834|NCT01908699|468888984|FG001|Overall Study|Withdrawal by Subject|10|||
130252835|NCT01908699|468888983|FG000|Overall Study|Pregnancy|0|||
130252836|NCT01908699|468888984|FG001|Overall Study|Pregnancy|1|||
130252837|NCT01908699|468888983|FG000|Overall Study|Randomized in Error|1|||
130252838|NCT01908699|468888984|FG001|Overall Study|Randomized in Error|0|||
130252839|NCT01908699|468888983|FG000|Overall Study|Death|9|||
130252840|NCT01908699|468888984|FG001|Overall Study|Death|12|||
130252841|NCT01908699|468888983|FG000|Overall Study|Progressive Disease|30|||
130252842|NCT01908699|468888984|FG001|Overall Study|Progressive Disease|29|||
130252843|NCT03439072|468888985|FG000|Overall Study|Withdrawal by Subject|2|||
130252844|NCT03439072|468888986|FG001|Overall Study|Withdrawal by Subject|3|||
130252845|NCT03439072|468888985|FG000|Overall Study|Physician Decision|0|||
130252846|NCT03439072|468888986|FG001|Overall Study|Physician Decision|1|||
130252847|NCT01537432|468888990|FG000|Overall Study|Lost to Follow-up|3|||
130252848|NCT01537432|468888991|FG001|Overall Study|Lost to Follow-up|1|||
130252849|NCT01537432|468888990|FG000|Overall Study|Withdrawal by Subject|0|||
130252850|NCT01537432|468888991|FG001|Overall Study|Withdrawal by Subject|1|||
130700334|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Refusal|2|||
130700335|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Refusal|694|||
130252851|NCT01537432|468888990|FG000|Overall Study|Administrative problems|1|||
130252852|NCT01537432|468888991|FG001|Overall Study|Administrative problems|0|||
130252853|NCT01537432|468888990|FG000|Overall Study|Adverse Event|1|||
130252854|NCT01537432|468888991|FG001|Overall Study|Adverse Event|0|||
130252855|NCT01537432|468888990|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130252856|NCT01537432|468888991|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130252857|NCT00889005|468888992|FG000|Overall Study|Lost to Follow-up|4|||
130252858|NCT00889005|468888993|FG001|Overall Study|Lost to Follow-up|2|||
130252859|NCT00889005|468888992|FG000|Overall Study|Withdrawal by Subject|4|||
130700336|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Refusal|4|||
130252860|NCT00889005|468888993|FG001|Overall Study|Withdrawal by Subject|0|||
130252861|NCT05166902|468888994|FG000|First Intervention|Lost to Follow-up|0|||
130252862|NCT05166902|468888995|FG001|First Intervention|Lost to Follow-up|1|||
130252863|NCT01998477|468888996|FG000|Overall Study|Lost to Follow-up|4|||
130700337|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Refusal|0|||
130252864|NCT01998477|468888997|FG001|Overall Study|Lost to Follow-up|5|||
130252865|NCT01998477|468888996|FG000|Overall Study|Withdrawal by Subject|6|||
130252866|NCT01998477|468888997|FG001|Overall Study|Withdrawal by Subject|0|||
130252867|NCT00779909|468888998|FG000|Overall Study|Lost to Follow-up|1|||
130252868|NCT00779909|468888999|FG001|Overall Study|Lost to Follow-up|0|||
130252869|NCT00779909|468889000|FG002|Overall Study|Lost to Follow-up|0|||
130252870|NCT00779909|468889001|FG003|Overall Study|Lost to Follow-up|1|||
130252871|NCT00779909|468888998|FG000|Overall Study|Withdrawal by Subject|0|||
130252872|NCT00779909|468888999|FG001|Overall Study|Withdrawal by Subject|1|||
130252873|NCT00779909|468889000|FG002|Overall Study|Withdrawal by Subject|0|||
130252874|NCT00779909|468889001|FG003|Overall Study|Withdrawal by Subject|0|||
130252875|NCT03523585|468889002|FG000|Overall Study|Progressive Disease|174|||
130252876|NCT03523585|468889003|FG001|Overall Study|Progressive Disease|64|||
130252877|NCT03523585|468889004|FG002|Overall Study|Progressive Disease|77|||
130252878|NCT03523585|468889002|FG000|Overall Study|Adverse Event|74|||
130252879|NCT03523585|468889003|FG001|Overall Study|Adverse Event|5|||
130252880|NCT03523585|468889004|FG002|Overall Study|Adverse Event|9|||
130252881|NCT03523585|468889002|FG000|Overall Study|Withdrawal by Subject|30|||
130252882|NCT03523585|468889003|FG001|Overall Study|Withdrawal by Subject|11|||
130252883|NCT03523585|468889004|FG002|Overall Study|Withdrawal by Subject|6|||
130252884|NCT03523585|468889002|FG000|Overall Study|Clinical Progression|23|||
130252885|NCT03523585|468889003|FG001|Overall Study|Clinical Progression|5|||
130252886|NCT03523585|468889004|FG002|Overall Study|Clinical Progression|10|||
130252887|NCT03523585|468889002|FG000|Overall Study|Death|4|||
130252888|NCT03523585|468889003|FG001|Overall Study|Death|0|||
130252889|NCT03523585|468889004|FG002|Overall Study|Death|1|||
130252890|NCT03523585|468889002|FG000|Overall Study|Physician Decision|2|||
130252891|NCT03523585|468889003|FG001|Overall Study|Physician Decision|1|||
130252892|NCT03523585|468889004|FG002|Overall Study|Physician Decision|0|||
130252893|NCT03523585|468889002|FG000|Overall Study|Lost to Follow-up|1|||
130252894|NCT03523585|468889003|FG001|Overall Study|Lost to Follow-up|0|||
130252895|NCT03523585|468889004|FG002|Overall Study|Lost to Follow-up|0|||
130252896|NCT03523585|468889002|FG000|Overall Study|Miscellaneous|1|||
130252897|NCT03523585|468889003|FG001|Overall Study|Miscellaneous|0|||
130252898|NCT03523585|468889004|FG002|Overall Study|Miscellaneous|0|||
130252899|NCT03523585|468889002|FG000|Overall Study|Protocol Deviation|1|||
130252900|NCT03523585|468889003|FG001|Overall Study|Protocol Deviation|0|||
130252901|NCT03523585|468889004|FG002|Overall Study|Protocol Deviation|1|||
130252902|NCT03523585|468889002|FG000|Overall Study|Randomized But Not Treated|2|||
130252903|NCT03523585|468889003|FG001|Overall Study|Randomized But Not Treated|4|||
130252904|NCT03523585|468889004|FG002|Overall Study|Randomized But Not Treated|3|||
130252905|NCT02872142|468889010|FG000|Overall Study|Adverse Event|2|||
130252906|NCT02872142|468889010|FG000|Overall Study|Death|1|||
130252907|NCT02872142|468889010|FG000|Overall Study|Participant Decision|3|||
130252908|NCT01903720|468889011|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
130252909|NCT01903720|468889011|FG000|Overall Study|Adverse Event|1|||
130252910|NCT01903720|468889011|FG000|Overall Study|Rescinding of informed consent|2|||
130252911|NCT01903720|468889011|FG000|Overall Study|Lost to Follow-up|2|||
130252912|NCT01903720|468889011|FG000|Overall Study|Treatment with alternative drug|1|||
130252913|NCT02244957|468889012|FG000|Overall Study|Lack of Efficacy|1|||
130252914|NCT02244957|468889013|FG001|Overall Study|Lack of Efficacy|0|||
130252915|NCT00836901|468889014|FG000|First Intervention|Withdrawal by Subject|1|||
130252916|NCT00836901|468889015|FG001|First Intervention|Withdrawal by Subject|0|||
130252917|NCT00830336|468889016|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130252918|NCT00830336|468889017|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130252919|NCT03760081|468889018|FG000|Overall Study|Miscellaneous|0|||
130252920|NCT03760081|468889019|FG001|Overall Study|Miscellaneous|1|||
130252921|NCT03760081|468889018|FG000|Overall Study|Progressive Disease|5|||
130252922|NCT03760081|468889019|FG001|Overall Study|Progressive Disease|10|||
130252923|NCT03760081|468889018|FG000|Overall Study|Death|1|||
130252924|NCT03760081|468889019|FG001|Overall Study|Death|1|||
130252925|NCT05261490|468889020|FG000|Overall Study|Other|1|||
130252926|NCT05261490|468889021|FG001|Overall Study|Other|0|||
130252927|NCT05261490|468889022|FG002|Overall Study|Other|0|||
130252928|NCT05261490|468889020|FG000|Overall Study|Study Terminated by Sponsor|1|||
130252929|NCT05261490|468889021|FG001|Overall Study|Study Terminated by Sponsor|1|||
130252930|NCT05261490|468889022|FG002|Overall Study|Study Terminated by Sponsor|4|||
130252931|NCT05261490|468889020|FG000|Overall Study|Death|1|||
130252932|NCT05261490|468889021|FG001|Overall Study|Death|2|||
130252933|NCT05261490|468889022|FG002|Overall Study|Death|0|||
130252934|NCT01646216|468889034|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
130252935|NCT01646216|468889035|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
130252936|NCT01646216|468889034|FG000|Overall Study|Did not complete training|0|||
130252937|NCT01646216|468889035|FG001|Overall Study|Did not complete training|2|||
130252938|NCT01646216|468889034|FG000|Overall Study|Investigator decision|1|||
130252939|NCT01646216|468889035|FG001|Overall Study|Investigator decision|1|||
130252940|NCT02395627|468889036|FG000|Overall Study|Withdrawal by Subject|0|||
130252941|NCT02395627|468889037|FG001|Overall Study|Withdrawal by Subject|2|||
130252942|NCT02395627|468889038|FG002|Overall Study|Withdrawal by Subject|0|||
130553438|NCT03267940|469993568|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
130553439|NCT03267940|469993563|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
130553440|NCT03267940|469993564|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
130553441|NCT03267940|469993565|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
130553442|NCT03267940|469993566|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
130553443|NCT03267940|469993567|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
130553444|NCT03267940|469993568|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
130553445|NCT00388154|469993569|FG000|Overall Study|Withdrawal by Subject|1|||
130553446|NCT01948908|469993570|FG000|Overall Study|Protocol Violation|1|||
130553447|NCT01948908|469993571|FG001|Overall Study|Protocol Violation|0|||
130553448|NCT01948908|469993572|FG002|Overall Study|Protocol Violation|2|||
130553449|NCT00381303|469993573|FG000|Overall Study|Lost to Follow-up|25|||
130553450|NCT00381303|469993574|FG001|Overall Study|Lost to Follow-up|9|||
130553451|NCT00381303|469993573|FG000|Overall Study|AE/HIV-related event|22|||
130553452|NCT00381303|469993574|FG001|Overall Study|AE/HIV-related event|6|||
130553453|NCT00381303|469993573|FG000|Overall Study|Non-Adherence|13|||
130553454|NCT00381303|469993574|FG001|Overall Study|Non-Adherence|6|||
130553455|NCT00381303|469993573|FG000|Overall Study|Withdrawal by Subject|13|||
130553456|NCT00381303|469993574|FG001|Overall Study|Withdrawal by Subject|6|||
130553457|NCT00381303|469993573|FG000|Overall Study|Virologic failure|6|||
130553458|NCT00381303|469993574|FG001|Overall Study|Virologic failure|4|||
130553459|NCT00381303|469993573|FG000|Overall Study|Ineligible to continue the trial|2|||
130553460|NCT00381303|469993574|FG001|Overall Study|Ineligible to continue the trial|1|||
130252943|NCT02395627|468889036|FG000|Overall Study|Did not receive pembrolizumab|3|||
130252944|NCT02395627|468889037|FG001|Overall Study|Did not receive pembrolizumab|1|||
130252945|NCT02395627|468889038|FG002|Overall Study|Did not receive pembrolizumab|0|||
130252946|NCT02633527|468889039|FG000|Overall Study|Failed to meet eligibility|0|||
130252947|NCT02633527|468889040|FG001|Overall Study|Failed to meet eligibility|1|||
130252948|NCT02633527|468889041|FG002|Overall Study|Failed to meet eligibility|1|||
130252949|NCT02633527|468889042|FG003|Overall Study|Failed to meet eligibility|0|||
130252950|NCT02633527|468889043|FG004|Overall Study|Failed to meet eligibility|1|||
130252951|NCT02633527|468889039|FG000|Overall Study|Adverse Event|0|||
130252952|NCT02633527|468889040|FG001|Overall Study|Adverse Event|4|||
130252953|NCT02633527|468889041|FG002|Overall Study|Adverse Event|3|||
130252954|NCT02633527|468889042|FG003|Overall Study|Adverse Event|1|||
130252955|NCT02633527|468889043|FG004|Overall Study|Adverse Event|5|||
130252956|NCT02633527|468889039|FG000|Overall Study|Lost to Follow-up|1|||
130252957|NCT02633527|468889040|FG001|Overall Study|Lost to Follow-up|2|||
130252958|NCT02633527|468889041|FG002|Overall Study|Lost to Follow-up|5|||
130252959|NCT02633527|468889042|FG003|Overall Study|Lost to Follow-up|5|||
130252960|NCT02633527|468889043|FG004|Overall Study|Lost to Follow-up|4|||
130252961|NCT02633527|468889039|FG000|Overall Study|Withdrawal by Subject|0|||
130252962|NCT02633527|468889040|FG001|Overall Study|Withdrawal by Subject|3|||
130252963|NCT02633527|468889041|FG002|Overall Study|Withdrawal by Subject|5|||
130252964|NCT02633527|468889042|FG003|Overall Study|Withdrawal by Subject|4|||
130252965|NCT02633527|468889043|FG004|Overall Study|Withdrawal by Subject|4|||
130252966|NCT02633527|468889039|FG000|Overall Study|Protocol Violation|0|||
130252967|NCT02633527|468889040|FG001|Overall Study|Protocol Violation|1|||
130252968|NCT02633527|468889041|FG002|Overall Study|Protocol Violation|1|||
130252969|NCT02633527|468889042|FG003|Overall Study|Protocol Violation|1|||
130252970|NCT02633527|468889043|FG004|Overall Study|Protocol Violation|1|||
130252971|NCT02633527|468889039|FG000|Overall Study|Physician Decision|0|||
130252972|NCT02633527|468889040|FG001|Overall Study|Physician Decision|0|||
130252973|NCT02633527|468889041|FG002|Overall Study|Physician Decision|0|||
130252974|NCT02633527|468889042|FG003|Overall Study|Physician Decision|0|||
130252975|NCT02633527|468889043|FG004|Overall Study|Physician Decision|1|||
130252976|NCT02633527|468889039|FG000|Overall Study|Administrative reason|1|||
130252977|NCT02633527|468889040|FG001|Overall Study|Administrative reason|0|||
130252978|NCT02633527|468889041|FG002|Overall Study|Administrative reason|0|||
130252979|NCT02633527|468889042|FG003|Overall Study|Administrative reason|1|||
130252980|NCT02633527|468889043|FG004|Overall Study|Administrative reason|0|||
130252981|NCT02633527|468889039|FG000|Overall Study|Multiple reasons|1|||
130252982|NCT02633527|468889040|FG001|Overall Study|Multiple reasons|0|||
130252983|NCT02633527|468889041|FG002|Overall Study|Multiple reasons|2|||
130252984|NCT02633527|468889042|FG003|Overall Study|Multiple reasons|2|||
130252985|NCT02633527|468889043|FG004|Overall Study|Multiple reasons|1|||
130252986|NCT01681849|468889044|FG000|Overall Study|Protocol Violation|2|||
130252987|NCT01681849|468889045|FG001|Overall Study|Protocol Violation|0|||
130252988|NCT01681849|468889046|FG002|Overall Study|Protocol Violation|0|||
130252989|NCT01681849|468889044|FG000|Overall Study|Withdrawal by Subject|3|||
130252990|NCT01681849|468889045|FG001|Overall Study|Withdrawal by Subject|5|||
130252991|NCT01681849|468889046|FG002|Overall Study|Withdrawal by Subject|33|||
130553461|NCT00381303|469993573|FG000|Overall Study|Pregnancy|2|||
130553462|NCT00381303|469993574|FG001|Overall Study|Pregnancy|0|||
130553463|NCT00381303|469993573|FG000|Overall Study|Physician Decision|1|||
130553464|NCT00381303|469993574|FG001|Overall Study|Physician Decision|0|||
130553465|NCT00381303|469993573|FG000|Overall Study|Physician's decision to close the site|3|||
130252992|NCT01681849|468889044|FG000|Overall Study|Lost to Follow-up|3|||
130252993|NCT01681849|468889045|FG001|Overall Study|Lost to Follow-up|2|||
130252994|NCT01681849|468889046|FG002|Overall Study|Lost to Follow-up|6|||
130252995|NCT02852005|468889049|FG000|Overall Study|Lost to Follow-up|0|||
130252996|NCT02852005|468889050|FG001|Overall Study|Lost to Follow-up|0|||
130252997|NCT02852005|468889051|FG002|Overall Study|Lost to Follow-up|0|||
130252998|NCT02852005|468889052|FG003|Overall Study|Lost to Follow-up|0|||
130252999|NCT02852005|468889053|FG004|Overall Study|Lost to Follow-up|1|||
130253000|NCT02852005|468889049|FG000|Overall Study|Withdrawal by Subject|1|||
130253001|NCT02852005|468889050|FG001|Overall Study|Withdrawal by Subject|0|||
130253002|NCT02852005|468889051|FG002|Overall Study|Withdrawal by Subject|0|||
130253003|NCT02852005|468889052|FG003|Overall Study|Withdrawal by Subject|0|||
130253004|NCT02852005|468889053|FG004|Overall Study|Withdrawal by Subject|0|||
130253005|NCT02420314|468889056|FG000|Overall Study|Withdrawal by Subject|1|||
130253006|NCT02420314|468889056|FG000|Overall Study|Protocol Violation|1|||
130253007|NCT03760068|468889058|FG000|Overall Study|Withdrawal by Subject|7|||
130253008|NCT03760068|468889059|FG001|Overall Study|Withdrawal by Subject|8|||
130253009|NCT03760068|468889058|FG000|Overall Study|Adverse Event|1|||
130253010|NCT03760068|468889059|FG001|Overall Study|Adverse Event|2|||
130253011|NCT03760068|468889058|FG000|Overall Study|Administrative Decision by Sponsor|0|||
130253012|NCT03760068|468889059|FG001|Overall Study|Administrative Decision by Sponsor|2|||
130253013|NCT03760068|468889058|FG000|Overall Study|Physician Decision|1|||
130253014|NCT03760068|468889059|FG001|Overall Study|Physician Decision|2|||
130253015|NCT03760068|468889058|FG000|Overall Study|Lost to Follow-up|4|||
130253016|NCT03760068|468889059|FG001|Overall Study|Lost to Follow-up|9|||
130253017|NCT03760068|468889058|FG000|Overall Study|Subject Moved Out of State|1|||
130253018|NCT03760068|468889059|FG001|Overall Study|Subject Moved Out of State|0|||
130253019|NCT03460704|468889063|FG000|Overall Study|Withdrawal by Subject|11|||
130253020|NCT03460704|468889064|FG001|Overall Study|Withdrawal by Subject|14|||
130253021|NCT03460704|468889063|FG000|Overall Study|Study terminated by the Sponsor|29|||
130253022|NCT03460704|468889064|FG001|Overall Study|Study terminated by the Sponsor|19|||
130253023|NCT03460704|468889063|FG000|Overall Study|Adverse Event|10|||
130253024|NCT03460704|468889064|FG001|Overall Study|Adverse Event|5|||
130253025|NCT03460704|468889063|FG000|Overall Study|Death|3|||
130253026|NCT03460704|468889064|FG001|Overall Study|Death|2|||
130253027|NCT03460704|468889063|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130253028|NCT03460704|468889064|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130253029|NCT03460704|468889063|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130253030|NCT03460704|468889064|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130253031|NCT03460704|468889063|FG000|Overall Study|Other|2|||
130253032|NCT03460704|468889064|FG001|Overall Study|Other|1|||
130253033|NCT02913326|468889069|FG000|Overall Study|Reason not listed|0|||
130253034|NCT02913326|468889070|FG001|Overall Study|Reason not listed|1|||
130253035|NCT02913326|468889069|FG000|Overall Study|Lost to Follow-up|0|||
130253036|NCT02913326|468889070|FG001|Overall Study|Lost to Follow-up|1|||
130253037|NCT02913326|468889069|FG000|Overall Study|Adverse Event|1|||
130253038|NCT02913326|468889070|FG001|Overall Study|Adverse Event|0|||
130253039|NCT01767857|468889071|FG000|Overall Study|Adverse Event|27|||
130253040|NCT01767857|468889072|FG001|Overall Study|Adverse Event|7|||
130253041|NCT01767857|468889071|FG000|Overall Study|Death|28|||
130253042|NCT01767857|468889072|FG001|Overall Study|Death|13|||
130253043|NCT01767857|468889071|FG000|Overall Study|Lack of Efficacy|299|||
130253044|NCT01767857|468889072|FG001|Overall Study|Lack of Efficacy|151|||
130253045|NCT01767857|468889071|FG000|Overall Study|Lost to Follow-up|1|||
130253046|NCT01767857|468889072|FG001|Overall Study|Lost to Follow-up|1|||
130253047|NCT01767857|468889071|FG000|Overall Study|Withdrawal by Subject|38|||
130253048|NCT01767857|468889072|FG001|Overall Study|Withdrawal by Subject|18|||
130253049|NCT01767857|468889071|FG000|Overall Study|Physician Decision|17|||
130253050|NCT01767857|468889072|FG001|Overall Study|Physician Decision|10|||
130253051|NCT01767857|468889071|FG000|Overall Study|Protocol Terminated|1|||
130253052|NCT01767857|468889072|FG001|Overall Study|Protocol Terminated|0|||
130253053|NCT01767857|468889071|FG000|Overall Study|Randomized But Never Treated|19|||
130253054|NCT01767857|468889072|FG001|Overall Study|Randomized But Never Treated|13|||
130253055|NCT01390584|468889096|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130253056|NCT01390584|468889097|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130253057|NCT01390584|468889098|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
130253058|NCT01720602|468889099|FG000|Overall Study|Adverse Event|3|||
130253059|NCT01720602|468889099|FG000|Overall Study|Progressive disease on therapy|2|||
130253060|NCT00452400|468889100|FG000|Overall Study|Adverse Event|1|||
130253061|NCT00452400|468889101|FG001|Overall Study|Adverse Event|1|||
130253062|NCT00452400|468889102|FG002|Overall Study|Adverse Event|5|||
130253063|NCT00452400|468889103|FG003|Overall Study|Adverse Event|0|||
130253064|NCT00452400|468889104|FG004|Overall Study|Adverse Event|2|||
130253065|NCT00452400|468889100|FG000|Overall Study|Protocol Violation|0|||
130253066|NCT00452400|468889101|FG001|Overall Study|Protocol Violation|0|||
130253067|NCT00452400|468889102|FG002|Overall Study|Protocol Violation|1|||
130253068|NCT00452400|468889103|FG003|Overall Study|Protocol Violation|0|||
130253069|NCT00452400|468889104|FG004|Overall Study|Protocol Violation|0|||
130253070|NCT00452400|468889100|FG000|Overall Study|Lost to Follow-up|1|||
130253071|NCT00452400|468889101|FG001|Overall Study|Lost to Follow-up|0|||
130253072|NCT00452400|468889102|FG002|Overall Study|Lost to Follow-up|0|||
130253073|NCT00452400|468889103|FG003|Overall Study|Lost to Follow-up|0|||
130253074|NCT00452400|468889104|FG004|Overall Study|Lost to Follow-up|0|||
130253075|NCT00452400|468889100|FG000|Overall Study|Withdrawal by Subject|1|||
130253076|NCT00452400|468889101|FG001|Overall Study|Withdrawal by Subject|0|||
130253077|NCT00452400|468889102|FG002|Overall Study|Withdrawal by Subject|1|||
130253078|NCT00452400|468889103|FG003|Overall Study|Withdrawal by Subject|0|||
130253079|NCT00452400|468889104|FG004|Overall Study|Withdrawal by Subject|0|||
130253080|NCT00452400|468889100|FG000|Overall Study|Lack of Efficacy|2|||
130253081|NCT00452400|468889101|FG001|Overall Study|Lack of Efficacy|0|||
130253082|NCT00452400|468889102|FG002|Overall Study|Lack of Efficacy|0|||
130253083|NCT00452400|468889103|FG003|Overall Study|Lack of Efficacy|0|||
130253084|NCT00452400|468889104|FG004|Overall Study|Lack of Efficacy|0|||
130253085|NCT00452400|468889100|FG000|Overall Study|Other reasons not listed above|0|||
130253086|NCT00452400|468889101|FG001|Overall Study|Other reasons not listed above|0|||
130253087|NCT00452400|468889102|FG002|Overall Study|Other reasons not listed above|0|||
130253088|NCT00452400|468889103|FG003|Overall Study|Other reasons not listed above|1|||
130253089|NCT00452400|468889104|FG004|Overall Study|Other reasons not listed above|1|||
130253090|NCT01943825|468889105|FG000|Overall Study|Lost to Follow-up|9|||
130253091|NCT01943825|468889106|FG001|Overall Study|Lost to Follow-up|3|||
130253092|NCT01943825|468889107|FG002|Overall Study|Lost to Follow-up|12|||
130253093|NCT01943825|468889108|FG003|Overall Study|Lost to Follow-up|8|||
130253094|NCT01943825|468889105|FG000|Overall Study|Withdrawal by Subject|1|||
130253095|NCT01943825|468889106|FG001|Overall Study|Withdrawal by Subject|0|||
130253096|NCT01943825|468889107|FG002|Overall Study|Withdrawal by Subject|3|||
130253097|NCT01943825|468889108|FG003|Overall Study|Withdrawal by Subject|2|||
130253098|NCT01943825|468889105|FG000|Overall Study|Other than specified above|0|||
130253099|NCT01943825|468889106|FG001|Overall Study|Other than specified above|1|||
130253100|NCT01943825|468889107|FG002|Overall Study|Other than specified above|0|||
130253101|NCT01943825|468889108|FG003|Overall Study|Other than specified above|1|||
130253102|NCT01835431|468889109|FG000|Overall Study|Adverse Event|1|||
130253103|NCT01835431|468889110|FG001|Overall Study|Adverse Event|0|||
130253104|NCT01835431|468889109|FG000|Overall Study|other|0|||
130253105|NCT01835431|468889110|FG001|Overall Study|other|2|||
130253106|NCT01835431|468889109|FG000|Overall Study|Withdrawal by Subject|6|||
130253107|NCT01835431|468889110|FG001|Overall Study|Withdrawal by Subject|10|||
130253108|NCT01835431|468889109|FG000|Overall Study|Protocol Violation|1|||
130253109|NCT01835431|468889110|FG001|Overall Study|Protocol Violation|0|||
130253110|NCT00562861|468889113|FG000|Overall Study|Adverse Event|1|||
130253111|NCT00562861|468889114|FG001|Overall Study|Adverse Event|1|||
130253112|NCT00562861|468889113|FG000|Overall Study|Lack of Efficacy|5|||
130253113|NCT00562861|468889114|FG001|Overall Study|Lack of Efficacy|5|||
130253114|NCT00562861|468889113|FG000|Overall Study|noncompliance, moved|7|||
130253115|NCT00562861|468889114|FG001|Overall Study|noncompliance, moved|2|||
130253116|NCT00562861|468889113|FG000|Overall Study|Lost to Follow-up|7|||
130253117|NCT00562861|468889114|FG001|Overall Study|Lost to Follow-up|3|||
130253118|NCT04349098|468889115|FG000|Overall Study|Death|16|||
130253119|NCT04349098|468889116|FG001|Overall Study|Death|8|||
130253120|NCT04349098|468889115|FG000|Overall Study|Lost to Follow-up|11|||
130253121|NCT04349098|468889116|FG001|Overall Study|Lost to Follow-up|8|||
130253122|NCT04349098|468889115|FG000|Overall Study|Withdrawal by Subject|8|||
130253123|NCT04349098|468889116|FG001|Overall Study|Withdrawal by Subject|5|||
130253124|NCT04349098|468889115|FG000|Overall Study|Other|3|||
130253125|NCT04349098|468889116|FG001|Overall Study|Other|5|||
130253126|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
130253127|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
130253128|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130253129|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
130253130|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
130253131|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
130253132|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
130253133|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130253134|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130253135|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
130253136|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130253137|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130253138|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130253139|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130253140|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
130253141|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
130253142|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
130253143|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
130253144|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
130364945|NCT02716805|469306822|FG000|Overall Study|Progressive disease|2|||
130364946|NCT02716805|469306823|FG001|Overall Study|Progressive disease|0|||
130364947|NCT02716805|469306824|FG002|Overall Study|Progressive disease|0|||
130364948|NCT02716805|469306825|FG003|Overall Study|Progressive disease|0|||
130364949|NCT00932126|469306826|FG000|Overall Study|Adverse Event|0|||
130364950|NCT00932126|469306827|FG001|Overall Study|Adverse Event|0|||
130364951|NCT00932126|469306828|FG002|Overall Study|Adverse Event|0|||
130364952|NCT00932126|469306829|FG003|Overall Study|Adverse Event|0|||
130364953|NCT00932126|469306830|FG004|Overall Study|Adverse Event|0|||
130364954|NCT00932126|469306831|FG005|Overall Study|Adverse Event|0|||
130364955|NCT00932126|469306832|FG006|Overall Study|Adverse Event|1|||
130364956|NCT00932126|469306833|FG007|Overall Study|Adverse Event|2|||
130364957|NCT00932126|469306826|FG000|Overall Study|Protocol Violation|0|||
130253145|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
130253146|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
130253147|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
130253148|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
130253149|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
130253150|NCT03927846|468889121|FG000|Overall Study|Lost to Follow-up|10|||
130253151|NCT03927846|468889122|FG001|Overall Study|Lost to Follow-up|11|||
130253152|NCT03878069|468889123|FG000|Overall Study|Death|0|||
130253153|NCT03878069|468889124|FG001|Overall Study|Death|1|||
130253154|NCT03878069|468889125|FG002|Overall Study|Death|0|||
130253155|NCT00834587|468889126|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130253156|NCT00834587|468889127|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130253157|NCT02113878|468890639|FG000|Overall Study|Adverse Event|1|||
130253158|NCT02113878|468890640|FG001|Overall Study|Adverse Event|0|||
130253159|NCT02113878|468890639|FG000|Overall Study|Withdrawal by Subject|1|||
130253160|NCT02113878|468890640|FG001|Overall Study|Withdrawal by Subject|0|||
130253161|NCT02113878|468890639|FG000|Overall Study|patient non-compliance|1|||
130253162|NCT02113878|468890640|FG001|Overall Study|patient non-compliance|0|||
130253163|NCT04744831|468890641|FG000|Overall Study|Progressive Disease|31|||
130253164|NCT04744831|468890642|FG001|Overall Study|Progressive Disease|27|||
130253165|NCT04744831|468890643|FG002|Overall Study|Progressive Disease|25|||
130253166|NCT04744831|468890641|FG000|Overall Study|Adverse Event|3|||
130364958|NCT00932126|469306827|FG001|Overall Study|Protocol Violation|0|||
130364959|NCT00932126|469306828|FG002|Overall Study|Protocol Violation|0|||
130364960|NCT00932126|469306829|FG003|Overall Study|Protocol Violation|0|||
130700338|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Refusal|3|||
130700339|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Refusal|0|||
130700340|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Refusal|0|||
130700341|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Refusal|0|||
130700342|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Refusal|0|||
130700343|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
130700344|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
130700345|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
130700346|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
130700347|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
130700348|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
130700349|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
130700350|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
130700351|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
130700352|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
130700353|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700354|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
130700355|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700356|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700357|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700358|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700359|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700360|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700361|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700362|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700363|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
130700364|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
130700365|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
130700366|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
130700367|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
130700368|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
130700369|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
130700370|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
130700371|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
130700372|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
130700373|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Relapse|0|||
130700374|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Relapse|0|||
130700375|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Relapse|1|||
130700376|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Relapse|0|||
130700377|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Relapse|0|||
130700378|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Relapse|0|||
130253167|NCT04744831|468890642|FG001|Overall Study|Adverse Event|3|||
130253168|NCT04744831|468890643|FG002|Overall Study|Adverse Event|3|||
130253169|NCT04744831|468890641|FG000|Overall Study|Clinical Progression|3|||
130253170|NCT04744831|468890642|FG001|Overall Study|Clinical Progression|2|||
130253171|NCT04744831|468890643|FG002|Overall Study|Clinical Progression|5|||
130253172|NCT04744831|468890641|FG000|Overall Study|Other|0|||
130253173|NCT04744831|468890642|FG001|Overall Study|Other|2|||
130253174|NCT04744831|468890643|FG002|Overall Study|Other|1|||
130253175|NCT04744831|468890641|FG000|Overall Study|Death|0|||
130253176|NCT04744831|468890642|FG001|Overall Study|Death|2|||
130253177|NCT04744831|468890643|FG002|Overall Study|Death|1|||
130253178|NCT00530257|468890649|FG000|Overall Study|Lost to Follow-up|1|||
130253179|NCT01897896|468890653|FG000|Overall Study|Death|1|||
130253180|NCT01897896|468890654|FG001|Overall Study|Death|0|||
130253181|NCT01897896|468890653|FG000|Overall Study|Adverse Event|11|||
130253182|NCT01897896|468890654|FG001|Overall Study|Adverse Event|1|||
130253183|NCT01897896|468890653|FG000|Overall Study|Lost to Follow-up|1|||
130253184|NCT01897896|468890654|FG001|Overall Study|Lost to Follow-up|0|||
130253185|NCT01897896|468890653|FG000|Overall Study|Non-compliance with study drug dosing|1|||
130253186|NCT01897896|468890654|FG001|Overall Study|Non-compliance with study drug dosing|1|||
130253187|NCT01897896|468890653|FG000|Overall Study|Withdrawal by Subject|7|||
130253188|NCT01897896|468890654|FG001|Overall Study|Withdrawal by Subject|1|||
130253189|NCT01897896|468890653|FG000|Overall Study|Require drug that interfere with study|1|||
130253190|NCT01897896|468890654|FG001|Overall Study|Require drug that interfere with study|4|||
130700379|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Relapse|0|||
130700380|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Relapse|0|||
130700381|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Relapse|0|||
130700382|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Relapse|0|||
130253191|NCT01897896|468890653|FG000|Overall Study|Protocol Violation|1|||
130253192|NCT01897896|468890654|FG001|Overall Study|Protocol Violation|1|||
130253193|NCT01897896|468890653|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
130253194|NCT01897896|468890654|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
130253195|NCT01897896|468890653|FG000|Overall Study|Caregiver can no longer participate|0|||
130253196|NCT01897896|468890654|FG001|Overall Study|Caregiver can no longer participate|2|||
130253197|NCT01897896|468890653|FG000|Overall Study|Other than specified|2|||
130253198|NCT01897896|468890654|FG001|Overall Study|Other than specified|1|||
130253199|NCT05069415|468890655|FG000|Overall Study|Withdrawal by Subject|2|||
130253200|NCT05069415|468890656|FG001|Overall Study|Withdrawal by Subject|0|||
130253201|NCT05069415|468890655|FG000|Overall Study|Adverse Event|2|||
130253202|NCT05069415|468890656|FG001|Overall Study|Adverse Event|0|||
130253203|NCT00203242|468890657|FG000|Overall Study|Lost to Follow-up|1|||
130253204|NCT00866775|468890658|FG000|Overall Study|Adverse Event|5|||
130253205|NCT00866775|468890659|FG001|Overall Study|Adverse Event|19|||
130253206|NCT00866775|468890658|FG000|Overall Study|Death|1|||
130253207|NCT00866775|468890659|FG001|Overall Study|Death|0|||
130253208|NCT00866775|468890658|FG000|Overall Study|Lost to Follow-up|0|||
130253209|NCT00866775|468890659|FG001|Overall Study|Lost to Follow-up|4|||
130253210|NCT00866775|468890658|FG000|Overall Study|Physician Decision|0|||
130253211|NCT00866775|468890659|FG001|Overall Study|Physician Decision|3|||
130253212|NCT00866775|468890658|FG000|Overall Study|Protocol Violation|3|||
130253213|NCT00866775|468890659|FG001|Overall Study|Protocol Violation|4|||
130253214|NCT00866775|468890658|FG000|Overall Study|Withdrawal by Subject|4|||
130253215|NCT00866775|468890659|FG001|Overall Study|Withdrawal by Subject|4|||
130253216|NCT00866775|468890658|FG000|Overall Study|met exit criteria|23|||
130253217|NCT00866775|468890659|FG001|Overall Study|met exit criteria|17|||
130253218|NCT00866775|468890658|FG000|Overall Study|discontinued due to communication error|0|||
130253219|NCT00866775|468890659|FG001|Overall Study|discontinued due to communication error|1|||
130253220|NCT01500135|468890660|FG000|Overall Study|Withdrawal of Consent|4|||
130364961|NCT00932126|469306830|FG004|Overall Study|Protocol Violation|1|||
130253221|NCT01500135|468890661|FG001|Overall Study|Withdrawal of Consent|0|||
130364962|NCT00932126|469306831|FG005|Overall Study|Protocol Violation|0|||
130364963|NCT00932126|469306832|FG006|Overall Study|Protocol Violation|0|||
130364964|NCT00932126|469306833|FG007|Overall Study|Protocol Violation|0|||
130364965|NCT00932126|469306826|FG000|Overall Study|Withdrawal by Subject|0|||
130364966|NCT00932126|469306827|FG001|Overall Study|Withdrawal by Subject|0|||
130364967|NCT00932126|469306828|FG002|Overall Study|Withdrawal by Subject|1|||
130364968|NCT00932126|469306829|FG003|Overall Study|Withdrawal by Subject|0|||
130364969|NCT00932126|469306830|FG004|Overall Study|Withdrawal by Subject|0|||
130364970|NCT00932126|469306831|FG005|Overall Study|Withdrawal by Subject|0|||
130364971|NCT00932126|469306832|FG006|Overall Study|Withdrawal by Subject|0|||
130364972|NCT00932126|469306833|FG007|Overall Study|Withdrawal by Subject|1|||
130364973|NCT00932126|469306826|FG000|Overall Study|Objective progression or relapse|3|||
130364974|NCT00932126|469306827|FG001|Overall Study|Objective progression or relapse|3|||
130364975|NCT00932126|469306828|FG002|Overall Study|Objective progression or relapse|2|||
130364976|NCT00932126|469306829|FG003|Overall Study|Objective progression or relapse|3|||
130364977|NCT00932126|469306830|FG004|Overall Study|Objective progression or relapse|3|||
130364978|NCT00932126|469306831|FG005|Overall Study|Objective progression or relapse|3|||
130364979|NCT00932126|469306832|FG006|Overall Study|Objective progression or relapse|3|||
130364980|NCT00932126|469306833|FG007|Overall Study|Objective progression or relapse|5|||
130364981|NCT00932126|469306826|FG000|Overall Study|Other|0|||
130364982|NCT00932126|469306827|FG001|Overall Study|Other|0|||
130364983|NCT00932126|469306828|FG002|Overall Study|Other|0|||
130364984|NCT00932126|469306829|FG003|Overall Study|Other|0|||
130364985|NCT00932126|469306830|FG004|Overall Study|Other|1|||
130364986|NCT00932126|469306831|FG005|Overall Study|Other|0|||
130364987|NCT00932126|469306832|FG006|Overall Study|Other|1|||
130364988|NCT00932126|469306833|FG007|Overall Study|Other|2|||
130364989|NCT00066365|469306834|FG000|Overall Study|Adverse Event|1|||
130364990|NCT00066365|469306835|FG001|Overall Study|Adverse Event|0|||
130364991|NCT00066365|469306834|FG000|Overall Study|Lack of Efficacy|15|||
130364992|NCT00066365|469306835|FG001|Overall Study|Lack of Efficacy|12|||
130364993|NCT00066365|469306834|FG000|Overall Study|Physician Decision|1|||
130364994|NCT00066365|469306835|FG001|Overall Study|Physician Decision|0|||
130364995|NCT00066365|469306834|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
130364996|NCT00066365|469306835|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
130364997|NCT00066365|469306834|FG000|Overall Study|Ineligible|4|||
130364998|NCT00066365|469306835|FG001|Overall Study|Ineligible|2|||
130364999|NCT02635776|469306840|FG000|Overall Study|Physician Decision|1|||
130365000|NCT02635776|469306841|FG001|Overall Study|Physician Decision|0|||
130365001|NCT02635776|469306840|FG000|Overall Study|Adverse Event|51|||
130365002|NCT02635776|469306841|FG001|Overall Study|Adverse Event|3|||
130253222|NCT01500135|468890660|FG000|Overall Study|Lost to Follow-up|6|||
130253223|NCT01500135|468890661|FG001|Overall Study|Lost to Follow-up|4|||
130365003|NCT02635776|469306840|FG000|Overall Study|Withdrawal by Subject|41|||
130365004|NCT02635776|469306841|FG001|Overall Study|Withdrawal by Subject|7|||
130365005|NCT02635776|469306840|FG000|Overall Study|Lost to Follow-up|4|||
130253224|NCT01500135|468890660|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
130253225|NCT01500135|468890661|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
130253226|NCT01500135|468890660|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
130253227|NCT01500135|468890661|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
130253228|NCT01500135|468890660|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
130253229|NCT01500135|468890661|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
130253230|NCT01500135|468890660|FG000|Overall Study|Participant was a Safety Concern|1|||
130253231|NCT01500135|468890661|FG001|Overall Study|Participant was a Safety Concern|0|||
130253232|NCT01500135|468890660|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
130253233|NCT01500135|468890661|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
130253234|NCT02003898|468890666|FG000|Overall Study|Death|3|||
130253235|NCT02003898|468890666|FG000|Overall Study|Lost to Follow-up|12|||
130253236|NCT02003898|468890666|FG000|Overall Study|Withdrawal by Subject|52|||
130253237|NCT05345405|468890669|FG000|Overall Study|Withdrawal by Subject|2|||
130253238|NCT05345405|468890670|FG001|Overall Study|Withdrawal by Subject|0|||
130253239|NCT05345405|468890671|FG002|Overall Study|Withdrawal by Subject|0|||
130253240|NCT05345405|468890669|FG000|Overall Study|Did not meet eligibility criteria|0|||
130253241|NCT05345405|468890670|FG001|Overall Study|Did not meet eligibility criteria|2|||
130253242|NCT05345405|468890671|FG002|Overall Study|Did not meet eligibility criteria|0|||
130253243|NCT05345405|468890669|FG000|Overall Study|Lost to Follow-up|0|||
130253244|NCT05345405|468890670|FG001|Overall Study|Lost to Follow-up|0|||
130253245|NCT05345405|468890671|FG002|Overall Study|Lost to Follow-up|1|||
130253246|NCT03766906|468890673|FG000|Overall Study|Withdrawal by Subject|6|||
130253247|NCT03268499|468890678|FG000|Overall Study|Withdrawal by Subject|2|||
130253248|NCT03268499|468890679|FG001|Overall Study|Withdrawal by Subject|1|||
130253249|NCT03533491|468890680|FG000|Overall Study|Lost to Follow-up|2|||
130253250|NCT01725282|468890683|FG000|Overall Study|Adverse Event|1|||
130253251|NCT01725282|468890684|FG001|Overall Study|Adverse Event|3|||
130253252|NCT01725282|468890685|FG002|Overall Study|Adverse Event|6|||
130253253|NCT01725282|468890686|FG003|Overall Study|Adverse Event|4|||
130253254|NCT01725282|468890683|FG000|Overall Study|Exacerbation of Target Disease|1|||
130253255|NCT01725282|468890684|FG001|Overall Study|Exacerbation of Target Disease|0|||
130253256|NCT01725282|468890685|FG002|Overall Study|Exacerbation of Target Disease|0|||
130253257|NCT01725282|468890686|FG003|Overall Study|Exacerbation of Target Disease|1|||
130365006|NCT02635776|469306841|FG001|Overall Study|Lost to Follow-up|0|||
130365007|NCT02635776|469306840|FG000|Overall Study|Other reasons|5|||
130365008|NCT02635776|469306841|FG001|Overall Study|Other reasons|1|||
130365009|NCT00788073|469306842|FG000|STX209 Then Placebo|Adverse Event|1|||
130365010|NCT00788073|469306843|FG001|STX209 Then Placebo|Adverse Event|0|||
130365011|NCT00788073|469306842|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
130365012|NCT00788073|469306843|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
130365013|NCT00788073|469306842|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
130365014|NCT00788073|469306843|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
130365015|NCT00788073|469306842|FG000|STX209 Then Placebo|unable to return due to travel|0|||
130365016|NCT00788073|469306843|FG001|STX209 Then Placebo|unable to return due to travel|1|||
130365017|NCT00788073|469306842|FG000|Placebo Then STX209|Adverse Event|2|||
130365018|NCT00788073|469306843|FG001|Placebo Then STX209|Adverse Event|0|||
130365019|NCT00788073|469306842|FG000|Placebo Then STX209|Protocol Violation|0|||
130365020|NCT00788073|469306843|FG001|Placebo Then STX209|Protocol Violation|1|||
130365021|NCT02058693|469306844|FG000|Phase 1|Withdrawal by Subject|3|||
130365022|NCT02058693|469306845|FG001|Phase 1|Withdrawal by Subject|2|||
130365023|NCT02058693|469306844|FG000|Phase 1|Adverse Event|0|||
130365024|NCT02058693|469306845|FG001|Phase 1|Adverse Event|1|||
130365025|NCT02058693|469306844|FG000|Phase 1|Lack of Efficacy|1|||
130365026|NCT02058693|469306845|FG001|Phase 1|Lack of Efficacy|0|||
130365027|NCT02058693|469306844|FG000|Phase 1|Physician Decision|1|||
130365028|NCT02058693|469306845|FG001|Phase 1|Physician Decision|1|||
130365029|NCT02058693|469306844|FG000|Phase 2|Withdrawal by Subject|0|||
130365030|NCT02058693|469306845|FG001|Phase 2|Withdrawal by Subject|2|||
130365031|NCT02925117|469306848|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
130365032|NCT02925117|469306849|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
130365033|NCT02925117|469306850|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
130365034|NCT02925117|469306851|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
130365035|NCT02925117|469306852|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365036|NCT02925117|469306853|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365037|NCT02925117|469306854|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365038|NCT02925117|469306855|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365039|NCT02925117|469306856|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365040|NCT02925117|469306857|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365041|NCT02925117|469306858|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365042|NCT02925117|469306859|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130365043|NCT02925117|469306848|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
130365044|NCT02925117|469306849|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
130365045|NCT02925117|469306850|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
130365046|NCT02925117|469306851|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130253258|NCT01725282|468890683|FG000|Overall Study|Met Exclusion Criteria|0|||
130253259|NCT01725282|468890684|FG001|Overall Study|Met Exclusion Criteria|0|||
130253260|NCT01725282|468890685|FG002|Overall Study|Met Exclusion Criteria|1|||
130253261|NCT01725282|468890686|FG003|Overall Study|Met Exclusion Criteria|0|||
130253262|NCT01725282|468890683|FG000|Overall Study|Study Site Withdrawal|0|||
130253263|NCT01725282|468890684|FG001|Overall Study|Study Site Withdrawal|1|||
130253264|NCT01725282|468890685|FG002|Overall Study|Study Site Withdrawal|0|||
130253265|NCT01725282|468890686|FG003|Overall Study|Study Site Withdrawal|0|||
130253266|NCT01725282|468890683|FG000|Overall Study|Withdrawal by Subject|0|||
130253267|NCT01725282|468890684|FG001|Overall Study|Withdrawal by Subject|0|||
130253268|NCT01725282|468890685|FG002|Overall Study|Withdrawal by Subject|1|||
130253269|NCT01725282|468890686|FG003|Overall Study|Withdrawal by Subject|1|||
130253270|NCT01725282|468890683|FG000|Overall Study|Lack of Efficacy|0|||
130253271|NCT01725282|468890684|FG001|Overall Study|Lack of Efficacy|1|||
130253272|NCT01725282|468890685|FG002|Overall Study|Lack of Efficacy|0|||
130253273|NCT01725282|468890686|FG003|Overall Study|Lack of Efficacy|1|||
130253274|NCT04064567|468890687|FG000|Overall Study|Lost to Follow-up|23|||
130253275|NCT04064567|468890688|FG001|Overall Study|Lost to Follow-up|22|||
130253276|NCT04064567|468890687|FG000|Overall Study|Withdrawal by Subject|0|||
130253277|NCT04064567|468890688|FG001|Overall Study|Withdrawal by Subject|1|||
130253278|NCT04064567|468890687|FG000|Overall Study|Reincarcerated|7|||
130253279|NCT04064567|468890688|FG001|Overall Study|Reincarcerated|10|||
130253280|NCT04064567|468890687|FG000|Overall Study|Moved out of U.S.|0|||
130253281|NCT04064567|468890688|FG001|Overall Study|Moved out of U.S.|1|||
130253282|NCT04576481|468890690|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
130253283|NCT04576481|468890691|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130253284|NCT04576481|468890692|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
130253285|NCT04576481|468890693|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130253286|NCT01682720|468890694|FG000|Overall Study|Randomized but Not Treated|0|||
130253287|NCT01682720|468890695|FG001|Overall Study|Randomized but Not Treated|1|||
130253288|NCT01682720|468890696|FG002|Overall Study|Randomized but Not Treated|1|||
130253289|NCT01682720|468890697|FG003|Overall Study|Randomized but Not Treated|0|||
130253290|NCT01682720|468890694|FG000|Overall Study|Terminated by Sponsor|83|||
130253291|NCT01682720|468890695|FG001|Overall Study|Terminated by Sponsor|0|||
130253292|NCT01682720|468890696|FG002|Overall Study|Terminated by Sponsor|0|||
130253293|NCT01682720|468890697|FG003|Overall Study|Terminated by Sponsor|0|||
130253294|NCT01682720|468890694|FG000|Overall Study|Efficacy Failure|0|||
130253295|NCT01682720|468890695|FG001|Overall Study|Efficacy Failure|3|||
130253296|NCT01682720|468890696|FG002|Overall Study|Efficacy Failure|3|||
130253297|NCT01682720|468890697|FG003|Overall Study|Efficacy Failure|30|||
130253298|NCT01682720|468890694|FG000|Overall Study|Lost to Follow-up|1|||
130253299|NCT01682720|468890695|FG001|Overall Study|Lost to Follow-up|1|||
130253300|NCT01682720|468890696|FG002|Overall Study|Lost to Follow-up|0|||
130253301|NCT01682720|468890697|FG003|Overall Study|Lost to Follow-up|6|||
130253302|NCT01682720|468890694|FG000|Overall Study|Subject Withdrew Consent|0|||
130253303|NCT01682720|468890695|FG001|Overall Study|Subject Withdrew Consent|0|||
130253304|NCT01682720|468890696|FG002|Overall Study|Subject Withdrew Consent|2|||
130253305|NCT01682720|468890697|FG003|Overall Study|Subject Withdrew Consent|2|||
130253306|NCT01682720|468890694|FG000|Overall Study|Adverse Event|1|||
130253307|NCT01682720|468890695|FG001|Overall Study|Adverse Event|0|||
130253308|NCT01682720|468890696|FG002|Overall Study|Adverse Event|1|||
130253309|NCT01682720|468890697|FG003|Overall Study|Adverse Event|1|||
130253310|NCT00069953|468890698|FG000|Overall Study|Protocol Violation|2|||
130253311|NCT02034565|468890699|FG000|Overall Study|Adverse Event|1|||
130253312|NCT02034565|468890700|FG001|Overall Study|Adverse Event|0|||
130253313|NCT00113373|468890701|FG000|Overall Study|Ineligible: wrong primary|1|||
130253314|NCT00113373|468890701|FG000|Overall Study|Ineligible: second primary|1|||
130253315|NCT00113373|468890701|FG000|Overall Study|Never Treated|1|||
130365047|NCT02925117|469306852|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365048|NCT02925117|469306853|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365049|NCT02925117|469306854|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365050|NCT02925117|469306855|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365051|NCT02925117|469306856|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365052|NCT02925117|469306857|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365053|NCT02925117|469306858|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365054|NCT02925117|469306859|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130365055|NCT02925117|469306848|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
130253316|NCT04525183|468890705|FG000|Overall Study|Withdrawal by Subject|0|||
130253317|NCT04525183|468890706|FG001|Overall Study|Withdrawal by Subject|0|||
130253318|NCT04525183|468890707|FG002|Overall Study|Withdrawal by Subject|3|||
130253319|NCT04525183|468890705|FG000|Overall Study|Study non-compliance|0|||
130253320|NCT04525183|468890706|FG001|Overall Study|Study non-compliance|0|||
130253321|NCT04525183|468890707|FG002|Overall Study|Study non-compliance|1|||
130253322|NCT04525183|468890705|FG000|Overall Study|Recurrent disease before starting on study|0|||
130365056|NCT02925117|469306849|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
130253323|NCT04525183|468890706|FG001|Overall Study|Recurrent disease before starting on study|0|||
130253324|NCT04525183|468890707|FG002|Overall Study|Recurrent disease before starting on study|1|||
130253325|NCT00979407|468890708|FG000|Overall Study|Withdrawal by Subject|3|||
130253326|NCT00979407|468890709|FG001|Overall Study|Withdrawal by Subject|4|||
130253327|NCT00979407|468890708|FG000|Overall Study|Lost to Follow-up|3|||
130253328|NCT00979407|468890709|FG001|Overall Study|Lost to Follow-up|3|||
130253329|NCT01166646|468890710|FG000|Overall Study|Protocol Violation|0|||
130253330|NCT01166646|468890711|FG001|Overall Study|Protocol Violation|1|||
130253331|NCT01166646|468890710|FG000|Overall Study|Adverse Event|1|||
130253332|NCT01166646|468890711|FG001|Overall Study|Adverse Event|0|||
130253333|NCT01335685|468890715|FG000|Overall Study|Study Terminated by Sponsor|2|||
130253334|NCT01335685|468890716|FG001|Overall Study|Study Terminated by Sponsor|1|||
130253335|NCT01335685|468890717|FG002|Overall Study|Study Terminated by Sponsor|1|||
130253336|NCT01335685|468890718|FG003|Overall Study|Study Terminated by Sponsor|10|||
130253337|NCT01335685|468890719|FG004|Overall Study|Study Terminated by Sponsor|0|||
130253338|NCT01335685|468890720|FG005|Overall Study|Study Terminated by Sponsor|4|||
130253339|NCT01335685|468890721|FG006|Overall Study|Study Terminated by Sponsor|2|||
130253340|NCT01335685|468890722|FG007|Overall Study|Study Terminated by Sponsor|3|||
130253341|NCT01335685|468890715|FG000|Overall Study|Withdrawal by Subject|1|||
130253342|NCT01335685|468890716|FG001|Overall Study|Withdrawal by Subject|0|||
130253343|NCT01335685|468890717|FG002|Overall Study|Withdrawal by Subject|0|||
130253344|NCT01335685|468890718|FG003|Overall Study|Withdrawal by Subject|1|||
130253345|NCT01335685|468890719|FG004|Overall Study|Withdrawal by Subject|0|||
130253346|NCT01335685|468890720|FG005|Overall Study|Withdrawal by Subject|0|||
130253347|NCT01335685|468890721|FG006|Overall Study|Withdrawal by Subject|0|||
130253348|NCT01335685|468890722|FG007|Overall Study|Withdrawal by Subject|0|||
130253349|NCT01335685|468890715|FG000|Overall Study|Reason not Specified|0|||
130253350|NCT01335685|468890716|FG001|Overall Study|Reason not Specified|0|||
130253351|NCT01335685|468890717|FG002|Overall Study|Reason not Specified|1|||
130253352|NCT01335685|468890718|FG003|Overall Study|Reason not Specified|0|||
130253353|NCT01335685|468890719|FG004|Overall Study|Reason not Specified|0|||
130253354|NCT01335685|468890720|FG005|Overall Study|Reason not Specified|1|||
130253355|NCT01335685|468890721|FG006|Overall Study|Reason not Specified|0|||
130253356|NCT01335685|468890722|FG007|Overall Study|Reason not Specified|0|||
130253357|NCT03777020|468890727|FG000|Overall Study|Withdrawal by Subject|4|||
130253358|NCT03777020|468890728|FG001|Overall Study|Withdrawal by Subject|4|||
130253359|NCT03777020|468890727|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
130253360|NCT03777020|468890728|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
130253361|NCT00489476|468890729|FG000|Overall Study|Lost to Follow-up|0|||
130253362|NCT00489476|468890730|FG001|Overall Study|Lost to Follow-up|1|||
130253363|NCT00489476|468890731|FG002|Overall Study|Lost to Follow-up|0|||
130253364|NCT00489476|468890732|FG003|Overall Study|Lost to Follow-up|0|||
130253365|NCT00803049|468890733|FG000|Overall Study|Adverse Event|21|||
130253366|NCT00803049|468890734|FG001|Overall Study|Adverse Event|33|||
130253367|NCT00803049|468890735|FG002|Overall Study|Adverse Event|13|||
130253368|NCT00803049|468890736|FG003|Overall Study|Adverse Event|27|||
130253369|NCT00803049|468890733|FG000|Overall Study|Lack of Efficacy|10|||
130253370|NCT00803049|468890734|FG001|Overall Study|Lack of Efficacy|19|||
130253371|NCT00803049|468890735|FG002|Overall Study|Lack of Efficacy|6|||
130253372|NCT00803049|468890736|FG003|Overall Study|Lack of Efficacy|13|||
130253373|NCT00803049|468890733|FG000|Overall Study|Lost to Follow-up|0|||
130253374|NCT00803049|468890734|FG001|Overall Study|Lost to Follow-up|2|||
130253375|NCT00803049|468890735|FG002|Overall Study|Lost to Follow-up|0|||
130253376|NCT00803049|468890736|FG003|Overall Study|Lost to Follow-up|3|||
130253377|NCT00803049|468890733|FG000|Overall Study|Death|2|||
130253378|NCT00803049|468890734|FG001|Overall Study|Death|1|||
130253379|NCT00803049|468890735|FG002|Overall Study|Death|0|||
130253380|NCT00803049|468890736|FG003|Overall Study|Death|2|||
130253381|NCT00803049|468890733|FG000|Overall Study|Progressive Disease|6|||
130253382|NCT00803049|468890734|FG001|Overall Study|Progressive Disease|10|||
130253383|NCT00803049|468890735|FG002|Overall Study|Progressive Disease|6|||
130253384|NCT00803049|468890736|FG003|Overall Study|Progressive Disease|6|||
130253385|NCT00803049|468890733|FG000|Overall Study|Withdrawal by Subject|19|||
130253386|NCT00803049|468890734|FG001|Overall Study|Withdrawal by Subject|43|||
130253387|NCT00803049|468890735|FG002|Overall Study|Withdrawal by Subject|16|||
130253388|NCT00803049|468890736|FG003|Overall Study|Withdrawal by Subject|44|||
130253389|NCT00803049|468890733|FG000|Overall Study|Protocol Violation|0|||
130253390|NCT00803049|468890734|FG001|Overall Study|Protocol Violation|1|||
130253391|NCT00803049|468890735|FG002|Overall Study|Protocol Violation|1|||
130253392|NCT00803049|468890736|FG003|Overall Study|Protocol Violation|0|||
130253393|NCT00803049|468890733|FG000|Overall Study|Randomized and Not Treated|0|||
130253394|NCT00803049|468890734|FG001|Overall Study|Randomized and Not Treated|0|||
130253395|NCT00803049|468890735|FG002|Overall Study|Randomized and Not Treated|0|||
130253396|NCT00803049|468890736|FG003|Overall Study|Randomized and Not Treated|2|||
130253397|NCT00803049|468890733|FG000|Overall Study|Other than Specified Above|3|||
130253398|NCT00803049|468890734|FG001|Overall Study|Other than Specified Above|9|||
130253399|NCT00803049|468890735|FG002|Overall Study|Other than Specified Above|2|||
130253400|NCT00803049|468890736|FG003|Overall Study|Other than Specified Above|5|||
130700383|NCT01190930|470526414|FG000|Maintenance|Adverse Event|0|||
130700384|NCT01190930|470526415|FG001|Maintenance|Adverse Event|0|||
130700385|NCT01190930|470526416|FG002|Maintenance|Adverse Event|0|||
130700386|NCT01190930|470526417|FG003|Maintenance|Adverse Event|0|||
130700387|NCT01190930|470526418|FG004|Maintenance|Adverse Event|0|||
130700388|NCT01190930|470526419|FG005|Maintenance|Adverse Event|1|||
130700389|NCT01190930|470526420|FG006|Maintenance|Adverse Event|1|||
130700390|NCT01190930|470526421|FG007|Maintenance|Adverse Event|3|||
130700391|NCT01190930|470526422|FG008|Maintenance|Adverse Event|3|||
130700392|NCT01190930|470526423|FG009|Maintenance|Adverse Event|0|||
130700393|NCT01190930|470526414|FG000|Maintenance|Death|0|||
130700394|NCT01190930|470526415|FG001|Maintenance|Death|0|||
130700395|NCT01190930|470526416|FG002|Maintenance|Death|0|||
130700396|NCT01190930|470526417|FG003|Maintenance|Death|1|||
130700397|NCT01190930|470526418|FG004|Maintenance|Death|0|||
130700398|NCT01190930|470526419|FG005|Maintenance|Death|0|||
130700399|NCT01190930|470526420|FG006|Maintenance|Death|2|||
130700400|NCT01190930|470526421|FG007|Maintenance|Death|2|||
130700401|NCT01190930|470526422|FG008|Maintenance|Death|2|||
130700402|NCT01190930|470526423|FG009|Maintenance|Death|2|||
130700403|NCT01190930|470526414|FG000|Maintenance|Lost to Follow-up|0|||
130700404|NCT01190930|470526415|FG001|Maintenance|Lost to Follow-up|0|||
130700405|NCT01190930|470526416|FG002|Maintenance|Lost to Follow-up|0|||
130700406|NCT01190930|470526417|FG003|Maintenance|Lost to Follow-up|0|||
130700407|NCT01190930|470526418|FG004|Maintenance|Lost to Follow-up|0|||
130700408|NCT01190930|470526419|FG005|Maintenance|Lost to Follow-up|0|||
130700409|NCT01190930|470526420|FG006|Maintenance|Lost to Follow-up|1|||
130700410|NCT01190930|470526421|FG007|Maintenance|Lost to Follow-up|1|||
130700411|NCT01190930|470526422|FG008|Maintenance|Lost to Follow-up|1|||
130700412|NCT01190930|470526423|FG009|Maintenance|Lost to Follow-up|0|||
130700413|NCT01190930|470526414|FG000|Maintenance|Physician Decision|0|||
130700414|NCT01190930|470526415|FG001|Maintenance|Physician Decision|1|||
130700415|NCT01190930|470526416|FG002|Maintenance|Physician Decision|0|||
130700416|NCT01190930|470526417|FG003|Maintenance|Physician Decision|5|||
130700417|NCT01190930|470526418|FG004|Maintenance|Physician Decision|9|||
130700418|NCT01190930|470526419|FG005|Maintenance|Physician Decision|4|||
130700419|NCT01190930|470526420|FG006|Maintenance|Physician Decision|8|||
130700420|NCT01190930|470526421|FG007|Maintenance|Physician Decision|8|||
130700421|NCT01190930|470526422|FG008|Maintenance|Physician Decision|10|||
130700422|NCT01190930|470526423|FG009|Maintenance|Physician Decision|17|||
130700423|NCT01190930|470526414|FG000|Maintenance|Withdrawal by Subject|0|||
130700424|NCT01190930|470526415|FG001|Maintenance|Withdrawal by Subject|0|||
130700425|NCT01190930|470526416|FG002|Maintenance|Withdrawal by Subject|0|||
130700426|NCT01190930|470526417|FG003|Maintenance|Withdrawal by Subject|0|||
130700427|NCT01190930|470526418|FG004|Maintenance|Withdrawal by Subject|0|||
130700428|NCT01190930|470526419|FG005|Maintenance|Withdrawal by Subject|0|||
130700429|NCT01190930|470526420|FG006|Maintenance|Withdrawal by Subject|2|||
130700430|NCT01190930|470526421|FG007|Maintenance|Withdrawal by Subject|1|||
130700431|NCT01190930|470526422|FG008|Maintenance|Withdrawal by Subject|4|||
130700432|NCT01190930|470526423|FG009|Maintenance|Withdrawal by Subject|1|||
130700433|NCT01190930|470526414|FG000|Maintenance|Refusal|0|||
130700434|NCT01190930|470526415|FG001|Maintenance|Refusal|1|||
130700435|NCT01190930|470526416|FG002|Maintenance|Refusal|0|||
130700436|NCT01190930|470526417|FG003|Maintenance|Refusal|2|||
130700437|NCT01190930|470526418|FG004|Maintenance|Refusal|0|||
130700438|NCT01190930|470526419|FG005|Maintenance|Refusal|4|||
130700439|NCT01190930|470526420|FG006|Maintenance|Refusal|5|||
130700440|NCT01190930|470526421|FG007|Maintenance|Refusal|17|||
130700441|NCT01190930|470526422|FG008|Maintenance|Refusal|13|||
130700442|NCT01190930|470526423|FG009|Maintenance|Refusal|6|||
130700443|NCT01190930|470526414|FG000|Maintenance|second malignant neoplasm|0|||
130700444|NCT01190930|470526415|FG001|Maintenance|second malignant neoplasm|0|||
130700445|NCT01190930|470526416|FG002|Maintenance|second malignant neoplasm|0|||
130253401|NCT04126174|468890737|FG000|Overall Study|Lost to Follow-up|3|||
130253402|NCT04126174|468890738|FG001|Overall Study|Lost to Follow-up|3|||
130700446|NCT01190930|470526417|FG003|Maintenance|second malignant neoplasm|1|||
130700447|NCT01190930|470526418|FG004|Maintenance|second malignant neoplasm|0|||
130700448|NCT01190930|470526419|FG005|Maintenance|second malignant neoplasm|1|||
130700449|NCT01190930|470526420|FG006|Maintenance|second malignant neoplasm|0|||
130700450|NCT01190930|470526421|FG007|Maintenance|second malignant neoplasm|0|||
130700451|NCT01190930|470526422|FG008|Maintenance|second malignant neoplasm|1|||
130700452|NCT01190930|470526423|FG009|Maintenance|second malignant neoplasm|0|||
130700453|NCT01190930|470526414|FG000|Maintenance|Inevaluable|0|||
130700454|NCT01190930|470526415|FG001|Maintenance|Inevaluable|0|||
130700455|NCT01190930|470526416|FG002|Maintenance|Inevaluable|0|||
130700456|NCT01190930|470526417|FG003|Maintenance|Inevaluable|0|||
130700457|NCT01190930|470526418|FG004|Maintenance|Inevaluable|0|||
130700458|NCT01190930|470526419|FG005|Maintenance|Inevaluable|1|||
130700459|NCT01190930|470526420|FG006|Maintenance|Inevaluable|1|||
130700460|NCT01190930|470526421|FG007|Maintenance|Inevaluable|1|||
130700461|NCT01190930|470526422|FG008|Maintenance|Inevaluable|0|||
130700462|NCT01190930|470526423|FG009|Maintenance|Inevaluable|0|||
130700463|NCT01190930|470526414|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
130700464|NCT01190930|470526415|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
130253403|NCT01514422|468890739|FG000|Overall Study|Lost to Follow-up|1|||
130253404|NCT04439903|468890752|FG000|Overall Study|Withdrawal by Subject|2|||
130253405|NCT04439903|468890752|FG000|Overall Study|Screen Failure|1|||
130253406|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
130253407|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
130253408|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
130253409|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
130253410|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
130253411|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130253412|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130253413|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130253414|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130253415|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130253416|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
130253417|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
130253418|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253419|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253420|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253421|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
130253422|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130253423|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130253424|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130253425|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130253426|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130253427|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
130253428|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130253429|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130253430|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130253431|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
130253432|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
130253433|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
130253434|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
130253435|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
130253436|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Death|0|||
130253437|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Death|0|||
130253438|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Death|0|||
130253439|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Death|0|||
130253440|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Death|1|||
130253441|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
130253442|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130253443|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130253444|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130253445|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130253446|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253447|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253448|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
130253449|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253450|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253451|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
130253452|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
130253453|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
130253454|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
130253455|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
130253456|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
130253457|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
130253458|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
130253459|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
130253460|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
130253461|NCT04042311|468890758|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
130253462|NCT04042311|468890758|FG000|Overall Study|Unable to tolerate|4|||
130253463|NCT04042311|468890758|FG000|Overall Study|Concurrent illness|2|||
130253464|NCT04042311|468890758|FG000|Overall Study|Adverse Event|2|||
130253465|NCT04042311|468890758|FG000|Overall Study|No longer meeting inclusion criteria|2|||
130253466|NCT04042311|468890758|FG000|Overall Study|No reason given|1|||
130253467|NCT04042311|468890758|FG000|Overall Study|Withdrawal by Subject|4|||
130253468|NCT03382873|468890759|FG000|Overall Study|Lost to Follow-up|9|||
130253469|NCT03382873|468890760|FG001|Overall Study|Lost to Follow-up|10|||
130253470|NCT03382873|468890759|FG000|Overall Study|Withdrawal by Subject|6|||
130253471|NCT03382873|468890760|FG001|Overall Study|Withdrawal by Subject|11|||
130253472|NCT03382873|468890759|FG000|Overall Study|Visit not completed due to pandemic|16|||
130253473|NCT03382873|468890760|FG001|Overall Study|Visit not completed due to pandemic|41|||
130253474|NCT01044459|468890771|FG000|Overall Study|Withdrawal by Subject|21|||
130700465|NCT01190930|470526416|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
130700466|NCT01190930|470526417|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
130700467|NCT01190930|470526418|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
130700468|NCT01190930|470526419|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
130700469|NCT01190930|470526420|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
130700470|NCT01190930|470526421|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
130253475|NCT01044459|468890772|FG001|Overall Study|Withdrawal by Subject|28|||
130253476|NCT01044459|468890771|FG000|Overall Study|Terminated by Sponsor|22|||
130253477|NCT01044459|468890772|FG001|Overall Study|Terminated by Sponsor|21|||
130253478|NCT01044459|468890771|FG000|Overall Study|Adverse Event|22|||
130700471|NCT01190930|470526422|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
130253479|NCT01044459|468890772|FG001|Overall Study|Adverse Event|20|||
130253480|NCT01044459|468890771|FG000|Overall Study|Lack of Efficacy|23|||
130253481|NCT01044459|468890772|FG001|Overall Study|Lack of Efficacy|12|||
130253482|NCT01044459|468890771|FG000|Overall Study|Protocol Violation|11|||
130253483|NCT01044459|468890772|FG001|Overall Study|Protocol Violation|16|||
130253484|NCT01044459|468890771|FG000|Overall Study|Other Reason|7|||
130253485|NCT01044459|468890772|FG001|Overall Study|Other Reason|14|||
130253486|NCT01044459|468890771|FG000|Overall Study|COPD exacerbation|9|||
130253487|NCT01044459|468890772|FG001|Overall Study|COPD exacerbation|8|||
130253488|NCT01044459|468890771|FG000|Overall Study|Lost to Follow-up|18|||
130700472|NCT01190930|470526423|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
130700473|NCT01190930|470526414|FG000|Maintenance|Relapse|0|||
130700474|NCT01190930|470526415|FG001|Maintenance|Relapse|0|||
130700475|NCT01190930|470526416|FG002|Maintenance|Relapse|0|||
130700476|NCT01190930|470526417|FG003|Maintenance|Relapse|2|||
130700477|NCT01190930|470526418|FG004|Maintenance|Relapse|0|||
130700478|NCT01190930|470526419|FG005|Maintenance|Relapse|1|||
130700479|NCT01190930|470526420|FG006|Maintenance|Relapse|6|||
130700480|NCT01190930|470526421|FG007|Maintenance|Relapse|13|||
130700481|NCT01190930|470526422|FG008|Maintenance|Relapse|11|||
130700482|NCT01190930|470526423|FG009|Maintenance|Relapse|11|||
130700483|NCT01190930|470526414|FG000|Maintenance|Still on therapy|0|||
130700484|NCT01190930|470526415|FG001|Maintenance|Still on therapy|8|||
130700485|NCT01190930|470526416|FG002|Maintenance|Still on therapy|0|||
130700486|NCT01190930|470526417|FG003|Maintenance|Still on therapy|29|||
130700487|NCT01190930|470526418|FG004|Maintenance|Still on therapy|0|||
130700488|NCT01190930|470526419|FG005|Maintenance|Still on therapy|0|||
130700489|NCT01190930|470526420|FG006|Maintenance|Still on therapy|0|||
130700490|NCT01190930|470526421|FG007|Maintenance|Still on therapy|0|||
130700491|NCT01190930|470526422|FG008|Maintenance|Still on therapy|0|||
130700492|NCT01190930|470526423|FG009|Maintenance|Still on therapy|0|||
130700493|NCT02167594|470526424|FG000|Overall Study|Withdrawal by Subject|2|||
130700494|NCT02167594|470526425|FG001|Overall Study|Withdrawal by Subject|0|||
130700495|NCT02167594|470526426|FG002|Overall Study|Withdrawal by Subject|0|||
130700496|NCT02167594|470526424|FG000|Overall Study|Death|0|||
130700497|NCT02167594|470526425|FG001|Overall Study|Death|1|||
130700498|NCT02167594|470526426|FG002|Overall Study|Death|0|||
130700499|NCT02161549|470526427|FG000|Overall Study|Physician Decision|6|||
130700500|NCT02161549|470526428|FG001|Overall Study|Physician Decision|2|||
130700501|NCT01583530|470526429|FG000|Overall Study|Adverse Event|0|||
130700502|NCT01583530|470526430|FG001|Overall Study|Adverse Event|0|||
130700503|NCT01583530|470526431|FG002|Overall Study|Adverse Event|0|||
130700504|NCT01583530|470526432|FG003|Overall Study|Adverse Event|0|||
130700505|NCT01583530|470526433|FG004|Overall Study|Adverse Event|0|||
130700506|NCT01583530|470526434|FG005|Overall Study|Adverse Event|1|||
130700507|NCT01583530|470526429|FG000|Overall Study|Withdrawal by Subject|0|||
130700508|NCT01583530|470526430|FG001|Overall Study|Withdrawal by Subject|3|||
130700509|NCT01583530|470526431|FG002|Overall Study|Withdrawal by Subject|0|||
130700510|NCT01583530|470526432|FG003|Overall Study|Withdrawal by Subject|1|||
130700511|NCT01583530|470526433|FG004|Overall Study|Withdrawal by Subject|1|||
130700512|NCT01583530|470526434|FG005|Overall Study|Withdrawal by Subject|2|||
130700513|NCT01583530|470526429|FG000|Overall Study|Lost to Follow-up|0|||
130700514|NCT01583530|470526430|FG001|Overall Study|Lost to Follow-up|0|||
130700515|NCT01583530|470526431|FG002|Overall Study|Lost to Follow-up|0|||
130700516|NCT01583530|470526432|FG003|Overall Study|Lost to Follow-up|0|||
130700517|NCT01583530|470526433|FG004|Overall Study|Lost to Follow-up|3|||
130700518|NCT01583530|470526434|FG005|Overall Study|Lost to Follow-up|0|||
130700519|NCT01583530|470526429|FG000|Overall Study|Lack of compliance|0|||
130700520|NCT01583530|470526430|FG001|Overall Study|Lack of compliance|0|||
130700521|NCT01583530|470526431|FG002|Overall Study|Lack of compliance|0|||
130253489|NCT01044459|468890772|FG001|Overall Study|Lost to Follow-up|12|||
130253490|NCT04105725|468890773|FG000|Primary Intervention|Lost to Follow-up|0|||
130253491|NCT04105725|468890774|FG001|Primary Intervention|Lost to Follow-up|2|||
130700522|NCT01583530|470526432|FG003|Overall Study|Lack of compliance|0|||
130700523|NCT01583530|470526433|FG004|Overall Study|Lack of compliance|1|||
130700524|NCT01583530|470526434|FG005|Overall Study|Lack of compliance|0|||
130253492|NCT04105725|468890773|FG000|Primary Intervention|Withdrawal by Subject|0|||
130700525|NCT04010227|470526435|FG000|Overall Study|Death|1|||
130700526|NCT04010227|470526436|FG001|Overall Study|Death|2|||
130253493|NCT04105725|468890774|FG001|Primary Intervention|Withdrawal by Subject|1|||
130253494|NCT05346640|468890775|FG000|Overall Study|Lack of Efficacy|2|||
130253495|NCT05346640|468890775|FG000|Overall Study|Lost to Follow-up|14|||
130253496|NCT05346640|468890775|FG000|Overall Study|Protocol Violation|4|||
130253497|NCT05346640|468890775|FG000|Overall Study|Withdrawal by Subject|2|||
130253498|NCT05346640|468890775|FG000|Overall Study|Physiological Complications|3|||
130253499|NCT05346640|468890775|FG000|Overall Study|Other Reason|3|||
130253500|NCT00480025|468890776|FG000|Overall Study|Protocol Violation|12|||
130253501|NCT00480025|468890777|FG001|Overall Study|Protocol Violation|7|||
130253502|NCT00480025|468890776|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
130253503|NCT00480025|468890777|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
130253504|NCT00480025|468890776|FG000|Overall Study|Disease Progression / Recurrence|449|||
130253505|NCT00480025|468890777|FG001|Overall Study|Disease Progression / Recurrence|224|||
130253506|NCT00480025|468890776|FG000|Overall Study|Adverse Event|44|||
130253507|NCT00480025|468890777|FG001|Overall Study|Adverse Event|12|||
130253508|NCT00480025|468890776|FG000|Overall Study|Other|70|||
130253509|NCT00480025|468890777|FG001|Overall Study|Other|29|||
130253510|NCT00480025|468890776|FG000|Overall Study|SAE including intercurrent illness|76|||
130253511|NCT00480025|468890777|FG001|Overall Study|SAE including intercurrent illness|42|||
130253512|NCT04634331|468890782|FG000|Overall Study|Withdrawal by Subject|2|||
130253513|NCT04634331|468890783|FG001|Overall Study|Withdrawal by Subject|2|||
130253514|NCT03726879|468890784|FG000|Overall Study|Death|11|||
130253515|NCT03726879|468890785|FG001|Overall Study|Death|13|||
130253516|NCT03726879|468890784|FG000|Overall Study|Physician Decision|0|||
130253517|NCT03726879|468890785|FG001|Overall Study|Physician Decision|2|||
130253518|NCT03726879|468890784|FG000|Overall Study|Protocol Violation|0|||
130253519|NCT03726879|468890785|FG001|Overall Study|Protocol Violation|1|||
130253520|NCT03726879|468890784|FG000|Overall Study|Withdrawal by Subject|5|||
130253521|NCT03726879|468890785|FG001|Overall Study|Withdrawal by Subject|6|||
130253522|NCT03726879|468890784|FG000|Overall Study|TSH result is unstable|0|||
130253523|NCT03726879|468890785|FG001|Overall Study|TSH result is unstable|1|||
130253524|NCT03726879|468890784|FG000|Overall Study|Disease relapse|1|||
130253525|NCT03726879|468890785|FG001|Overall Study|Disease relapse|0|||
130253526|NCT03726879|468890784|FG000|Overall Study|Lost to Follow-up|3|||
130253527|NCT03726879|468890785|FG001|Overall Study|Lost to Follow-up|0|||
130253528|NCT02766478|468890786|FG000|Overall Study|Withdrawal by Subject|1|||
130253529|NCT02766478|468890787|FG001|Overall Study|Withdrawal by Subject|1|||
130253530|NCT05626686|468890788|FG000|Overall Study|Protocol Violation|3|||
130253531|NCT05626686|468890788|FG000|Overall Study|Withdrawal by Subject|3|||
130253532|NCT01093573|468890789|FG000|Overall Study|Physician Decision|0|||
130253533|NCT01093573|468890790|FG001|Overall Study|Physician Decision|0|||
130253534|NCT01093573|468890791|FG002|Overall Study|Physician Decision|1|||
130253535|NCT01093573|468890789|FG000|Overall Study|Insurance Denied|0|||
130253536|NCT01093573|468890790|FG001|Overall Study|Insurance Denied|0|||
130253537|NCT01093573|468890791|FG002|Overall Study|Insurance Denied|1|||
130253538|NCT01197300|468892164|FG000|Overall Study|Lost to Follow-up|0|||
130253539|NCT01197300|468892165|FG001|Overall Study|Lost to Follow-up|1|||
130253540|NCT01197300|468892164|FG000|Overall Study|Protocol Violation|0|||
130253541|NCT01197300|468892165|FG001|Overall Study|Protocol Violation|1|||
130253542|NCT00581100|468892166|FG000|Overall Study|Death|1|||
130253543|NCT00581100|468892167|FG001|Overall Study|Death|0|||
130253544|NCT00581100|468892166|FG000|Overall Study|Adverse Event|2|||
130253545|NCT00581100|468892167|FG001|Overall Study|Adverse Event|1|||
130253546|NCT00581100|468892166|FG000|Overall Study|Withdrawal by Subject|1|||
130253547|NCT00581100|468892167|FG001|Overall Study|Withdrawal by Subject|4|||
130253548|NCT00581100|468892166|FG000|Overall Study|Other|3|||
130253549|NCT00581100|468892167|FG001|Overall Study|Other|0|||
130253550|NCT03058952|468892170|FG000|Overall Study|Adverse Event|1|||
130253551|NCT03058952|468892171|FG001|Overall Study|Adverse Event|0|||
130253552|NCT03058952|468892170|FG000|Overall Study|Lost to Follow-up|15|||
130253553|NCT03058952|468892171|FG001|Overall Study|Lost to Follow-up|15|||
130253554|NCT03058952|468892170|FG000|Overall Study|Withdrawal by Subject|7|||
130253555|NCT03058952|468892171|FG001|Overall Study|Withdrawal by Subject|11|||
130253556|NCT00590317|468892172|FG000|Overall Study|Lack of Efficacy|1|||
130253557|NCT00590317|468892173|FG001|Overall Study|Lack of Efficacy|5|||
130253558|NCT03837509|468892174|FG000|Phase 1|Death|5|||
130253559|NCT03837509|468892175|FG001|Phase 1|Death|2|||
130253560|NCT03837509|468892176|FG002|Phase 1|Death|0|||
130253561|NCT03837509|468892177|FG003|Phase 1|Death|0|||
130253562|NCT03837509|468892178|FG004|Phase 1|Death|0|||
130253563|NCT03837509|468892174|FG000|Phase 2|Death|0|||
130253564|NCT03837509|468892175|FG001|Phase 2|Death|0|||
130253565|NCT03837509|468892176|FG002|Phase 2|Death|0|||
130253566|NCT03837509|468892177|FG003|Phase 2|Death|1|||
130253567|NCT03837509|468892178|FG004|Phase 2|Death|1|||
130253568|NCT03682367|468892188|FG000|Overall Study|Protocol Violation|2|||
130253569|NCT03682367|468892189|FG001|Overall Study|Protocol Violation|1|||
130253570|NCT03682367|468892188|FG000|Overall Study|Closed Study Early|0|||
130253571|NCT03682367|468892189|FG001|Overall Study|Closed Study Early|3|||
130253572|NCT00129974|468892190|FG000|Overall Study|Other|1|||
130253573|NCT00414609|468892191|FG000|Core Study|Adverse Event|9|||
130253574|NCT00414609|468892192|FG001|Core Study|Adverse Event|11|||
130253575|NCT00414609|468892193|FG002|Core Study|Adverse Event|0|||
130253576|NCT00414609|468892191|FG000|Core Study|Abnormal laboratory values|0|||
130253577|NCT00414609|468892192|FG001|Core Study|Abnormal laboratory values|1|||
130253578|NCT00414609|468892193|FG002|Core Study|Abnormal laboratory values|0|||
130253579|NCT00414609|468892191|FG000|Core Study|Abnormal test procedure results|1|||
130253580|NCT00414609|468892192|FG001|Core Study|Abnormal test procedure results|1|||
130253581|NCT00414609|468892193|FG002|Core Study|Abnormal test procedure results|0|||
130253582|NCT00414609|468892191|FG000|Core Study|Protocol deviation|0|||
130253583|NCT00414609|468892192|FG001|Core Study|Protocol deviation|1|||
130253584|NCT00414609|468892193|FG002|Core Study|Protocol deviation|0|||
130253585|NCT00414609|468892191|FG000|Core Study|Patient withdrew consent|10|||
130253586|NCT00414609|468892192|FG001|Core Study|Patient withdrew consent|11|||
130253587|NCT00414609|468892193|FG002|Core Study|Patient withdrew consent|0|||
130253588|NCT00414609|468892191|FG000|Core Study|Lost to Follow-up|7|||
130253589|NCT00414609|468892192|FG001|Core Study|Lost to Follow-up|4|||
130253590|NCT00414609|468892193|FG002|Core Study|Lost to Follow-up|0|||
130253591|NCT00414609|468892191|FG000|Core Study|Administrative problems|0|||
130253592|NCT00414609|468892192|FG001|Core Study|Administrative problems|2|||
130253593|NCT00414609|468892193|FG002|Core Study|Administrative problems|0|||
130253594|NCT00414609|468892191|FG000|Core Study|Death|7|||
130253595|NCT00414609|468892192|FG001|Core Study|Death|14|||
130253596|NCT00414609|468892193|FG002|Core Study|Death|0|||
130253597|NCT00414609|468892191|FG000|Extension Study|Adverse Event|0|||
130253598|NCT00414609|468892192|FG001|Extension Study|Adverse Event|0|||
130253599|NCT00414609|468892193|FG002|Extension Study|Adverse Event|14|||
130253600|NCT00414609|468892191|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
130253601|NCT00414609|468892192|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130253602|NCT00414609|468892193|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
130253603|NCT00414609|468892191|FG000|Extension Study|Withdrawal by Subject|0|||
130253604|NCT00414609|468892192|FG001|Extension Study|Withdrawal by Subject|0|||
130253605|NCT00414609|468892193|FG002|Extension Study|Withdrawal by Subject|13|||
130253606|NCT00414609|468892191|FG000|Extension Study|Lost to Follow-up|0|||
130253607|NCT00414609|468892192|FG001|Extension Study|Lost to Follow-up|0|||
130253608|NCT00414609|468892193|FG002|Extension Study|Lost to Follow-up|10|||
130253609|NCT00414609|468892191|FG000|Extension Study|Administrative problems|0|||
130253610|NCT00414609|468892192|FG001|Extension Study|Administrative problems|0|||
130253611|NCT00414609|468892193|FG002|Extension Study|Administrative problems|1|||
130253612|NCT00414609|468892191|FG000|Extension Study|Death|0|||
130253613|NCT00414609|468892192|FG001|Extension Study|Death|0|||
130253614|NCT00414609|468892193|FG002|Extension Study|Death|17|||
130253615|NCT01853280|468892198|FG000|Overall Study|Lack of Efficacy|2|||
130253616|NCT01853280|468892199|FG001|Overall Study|Lack of Efficacy|2|||
130253617|NCT01853280|468892198|FG000|Overall Study|Lost to Follow-up|0|||
130253618|NCT01853280|468892199|FG001|Overall Study|Lost to Follow-up|1|||
130253619|NCT01853280|468892198|FG000|Overall Study|Physician Decision|0|||
130365057|NCT02925117|469306850|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130253620|NCT01853280|468892199|FG001|Overall Study|Physician Decision|1|||
130253621|NCT01853280|468892198|FG000|Overall Study|Withdrawal by Subject|0|||
130253622|NCT01853280|468892199|FG001|Overall Study|Withdrawal by Subject|1|||
130253623|NCT01853280|468892198|FG000|Overall Study|Ineligible|0|||
130253624|NCT01853280|468892199|FG001|Overall Study|Ineligible|1|||
130253625|NCT03032484|468892200|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
130253626|NCT03032484|468892201|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
130253627|NCT03032484|468892200|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
130253628|NCT03032484|468892201|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
130253629|NCT01229111|468892202|FG000|Overall Study|Death|1|||
130253630|NCT04893811|468892203|FG000|Vaccination Phase|Death|1|||
130253631|NCT04893811|468892204|FG001|Vaccination Phase|Death|0|||
130253632|NCT04893811|468892203|FG000|Vaccination Phase|Lost to Follow-up|1|||
130253633|NCT04893811|468892204|FG001|Vaccination Phase|Lost to Follow-up|1|||
130253634|NCT04893811|468892203|FG000|Vaccination Phase|Protocol Violation|2|||
130253635|NCT04893811|468892204|FG001|Vaccination Phase|Protocol Violation|0|||
130253636|NCT04893811|468892203|FG000|Vaccination Phase|Withdrawal by Subject|2|||
130253637|NCT04893811|468892204|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130376667|NCT01327885|469345895|FG000|Overall Study|Subject choice|5|||
130253638|NCT04893811|468892203|FG000|Vaccination Phase|Other|0|||
130253639|NCT04893811|468892204|FG001|Vaccination Phase|Other|1|||
130253640|NCT04893811|468892203|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
130253641|NCT04893811|468892204|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
130253642|NCT04893811|468892203|FG000|Follow-up Phase|Lost to Follow-up|0|||
130253643|NCT04893811|468892204|FG001|Follow-up Phase|Lost to Follow-up|1|||
130253644|NCT05463952|468892216|FG000|Treatment|Progressive disease|4|||
130253645|NCT05463952|468892216|FG000|Treatment|Ongoing|2|||
130253646|NCT01946880|468892217|FG000|Overall Study|Lost to Follow-up|1|||
130253647|NCT01946880|468892218|FG001|Overall Study|Lost to Follow-up|0|||
130253648|NCT01946880|468892217|FG000|Overall Study|Physician Decision|1|||
130253649|NCT01946880|468892218|FG001|Overall Study|Physician Decision|1|||
130253650|NCT01946880|468892217|FG000|Overall Study|Withdrawal by Subject|3|||
130253651|NCT01946880|468892218|FG001|Overall Study|Withdrawal by Subject|2|||
130253652|NCT01946880|468892217|FG000|Overall Study|Met Primary Endpoint|1|||
130253653|NCT01946880|468892218|FG001|Overall Study|Met Primary Endpoint|0|||
130253654|NCT01946880|468892217|FG000|Overall Study|Personal and Family Issues|1|||
130253655|NCT01946880|468892218|FG001|Overall Study|Personal and Family Issues|0|||
130253656|NCT02758626|468892221|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
130253657|NCT02758626|468892222|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
130253658|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130253659|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130253660|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130253661|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130253662|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
130253663|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
130253664|NCT04204902|468892224|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
130253665|NCT04204902|468892225|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
130253666|NCT00456365|468892228|FG000|Overall Study|Lost to Follow-up|1|||
130253667|NCT00456365|468892229|FG001|Overall Study|Lost to Follow-up|3|||
130253668|NCT00456365|468892228|FG000|Overall Study|Withdrawal by Subject|4|||
130253669|NCT00456365|468892229|FG001|Overall Study|Withdrawal by Subject|7|||
130253670|NCT00456365|468892228|FG000|Overall Study|Pregnancy|1|||
130253671|NCT00456365|468892229|FG001|Overall Study|Pregnancy|1|||
130253672|NCT00456365|468892228|FG000|Overall Study|oncologic diagnosis|1|||
130253673|NCT00456365|468892229|FG001|Overall Study|oncologic diagnosis|1|||
130253674|NCT05451329|468892230|FG000|Overall Study|Adverse Event|1|||
130253675|NCT05451329|468892231|FG001|Overall Study|Adverse Event|1|||
130253676|NCT05451329|468892232|FG002|Overall Study|Adverse Event|0|||
130253677|NCT05451329|468892230|FG000|Overall Study|Withdrawal by Subject|1|||
130253678|NCT05451329|468892231|FG001|Overall Study|Withdrawal by Subject|0|||
130253679|NCT05451329|468892232|FG002|Overall Study|Withdrawal by Subject|0|||
130253680|NCT05451329|468892230|FG000|Overall Study|Investigational Product Lot exchange|1|||
130253681|NCT05451329|468892231|FG001|Overall Study|Investigational Product Lot exchange|1|||
130253682|NCT05451329|468892232|FG002|Overall Study|Investigational Product Lot exchange|0|||
130253683|NCT02202577|468892233|FG000|Overall Study|Lost to Follow-up|6|||
130253684|NCT02202577|468892234|FG001|Overall Study|Lost to Follow-up|16|||
130253685|NCT02202577|468892233|FG000|Overall Study|Protocol Violation|7|||
130253686|NCT02202577|468892234|FG001|Overall Study|Protocol Violation|3|||
130253687|NCT00829868|468892235|FG000|Washout|Physician Decision|1|||
130253688|NCT00829868|468892236|FG001|Washout|Physician Decision|0|||
130253689|NCT02799043|468892237|FG000|Overall Study|Adverse Event|0|||
130253690|NCT02799043|468892238|FG001|Overall Study|Adverse Event|1|||
130253691|NCT02799043|468892237|FG000|Overall Study|Death|1|||
130253692|NCT02799043|468892238|FG001|Overall Study|Death|1|||
130253693|NCT02799043|468892237|FG000|Overall Study|Lost to Follow-up|3|||
130700527|NCT04010227|470526435|FG000|Overall Study|Medical Reasons|4|||
130700528|NCT04010227|470526436|FG001|Overall Study|Medical Reasons|3|||
130253694|NCT02799043|468892238|FG001|Overall Study|Lost to Follow-up|6|||
130253695|NCT02799043|468892237|FG000|Overall Study|Withdrawal by Subject|4|||
130253696|NCT02799043|468892238|FG001|Overall Study|Withdrawal by Subject|4|||
130253697|NCT02799043|468892237|FG000|Overall Study|Moved to different country|0|||
130253698|NCT02799043|468892238|FG001|Overall Study|Moved to different country|1|||
130253699|NCT02799043|468892237|FG000|Overall Study|Trial Screen Failure|1|||
130253700|NCT02799043|468892238|FG001|Overall Study|Trial Screen Failure|0|||
130700529|NCT04010227|470526435|FG000|Overall Study|Withdrawal by Subject|2|||
130253701|NCT02799043|468892237|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130253702|NCT02799043|468892238|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130253703|NCT06091956|468892239|FG000|Overall Study|Withdrawal by Subject|1|||
130253704|NCT06091956|468892239|FG000|Overall Study|Complicating Disease|1|||
130700530|NCT04010227|470526436|FG001|Overall Study|Withdrawal by Subject|0|||
130720850|NCT04126213|470601547|FG002|Overall Study|Withdrawal by Subject|1|||
130253705|NCT01421459|468892248|FG000|Overall Study|Adverse Event|6|||
130253706|NCT01421459|468892249|FG001|Overall Study|Adverse Event|10|||
130253707|NCT01421459|468892248|FG000|Overall Study|Death|1|||
130253708|NCT01421459|468892249|FG001|Overall Study|Death|1|||
130253709|NCT01421459|468892248|FG000|Overall Study|Lack of Efficacy|1|||
130253710|NCT01421459|468892249|FG001|Overall Study|Lack of Efficacy|2|||
130253711|NCT01421459|468892248|FG000|Overall Study|Lost to Follow-up|8|||
130253712|NCT01421459|468892249|FG001|Overall Study|Lost to Follow-up|9|||
130253713|NCT01421459|468892248|FG000|Overall Study|Physician Decision|9|||
130253714|NCT01421459|468892249|FG001|Overall Study|Physician Decision|9|||
130253715|NCT01421459|468892248|FG000|Overall Study|Protocol Violation|8|||
130253716|NCT01421459|468892249|FG001|Overall Study|Protocol Violation|5|||
130253717|NCT01421459|468892248|FG000|Overall Study|Withdrawal by Subject|12|||
130253718|NCT01421459|468892249|FG001|Overall Study|Withdrawal by Subject|16|||
130253719|NCT02899754|468892250|FG000|Overall Study|Lost to Follow-up|7|||
130253720|NCT02899754|468892251|FG001|Overall Study|Lost to Follow-up|9|||
130253721|NCT03996395|468892258|FG000|Overall Study|Lost to Follow-up|4|||
130253722|NCT03996395|468892258|FG000|Overall Study|Withdrawal by Subject|1|||
130253723|NCT03996395|468892258|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
130253724|NCT00392288|468892259|FG000|Overall Study|Adverse Event|17|||
130553466|NCT00381303|469993574|FG001|Overall Study|Physician's decision to close the site|1|||
130553467|NCT00381303|469993573|FG000|Overall Study|Subject moved out of state|2|||
130553468|NCT00381303|469993574|FG001|Overall Study|Subject moved out of state|0|||
130553469|NCT00381303|469993573|FG000|Overall Study|Subject taking too many different meds|1|||
130553470|NCT00381303|469993574|FG001|Overall Study|Subject taking too many different meds|0|||
130553471|NCT00381303|469993573|FG000|Overall Study|No virologic response by week 12|1|||
130553472|NCT00381303|469993574|FG001|Overall Study|No virologic response by week 12|0|||
130553473|NCT00381303|469993573|FG000|Overall Study|Subject was too busy for appointments|1|||
130553474|NCT00381303|469993574|FG001|Overall Study|Subject was too busy for appointments|0|||
130553475|NCT00381303|469993573|FG000|Overall Study|Subject did not continue visits|1|||
130553476|NCT00381303|469993574|FG001|Overall Study|Subject did not continue visits|0|||
130553477|NCT00381303|469993573|FG000|Overall Study|Subject primary physician's decision|1|||
130553478|NCT00381303|469993574|FG001|Overall Study|Subject primary physician's decision|0|||
130553479|NCT01211522|469993575|FG000|Overall Study|Withdrawal by Subject|3|||
130553480|NCT01211522|469993576|FG001|Overall Study|Withdrawal by Subject|7|||
130553481|NCT01211522|469993577|FG002|Overall Study|Withdrawal by Subject|5|||
130553482|NCT01777269|469993579|FG000|Overall Study|Adverse Event|24|||
130553483|NCT01777269|469993580|FG001|Overall Study|Adverse Event|33|||
130553484|NCT01777269|469993579|FG000|Overall Study|Lack of Efficacy|8|||
130700531|NCT04010227|470526435|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130700532|NCT04010227|470526436|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130700533|NCT01841073|470526437|FG000|Overall Study|Adverse Event|1|||
130700534|NCT01841073|470526438|FG001|Overall Study|Adverse Event|1|||
130700535|NCT01841073|470526437|FG000|Overall Study|Physician Decision|1|||
130700536|NCT01841073|470526438|FG001|Overall Study|Physician Decision|0|||
130700537|NCT01841073|470526437|FG000|Overall Study|Lost to Follow-up|0|||
130700538|NCT01841073|470526438|FG001|Overall Study|Lost to Follow-up|2|||
130700539|NCT00283842|470526443|FG000|Overall Study|Adverse Event|8|||
130700540|NCT00283842|470526444|FG001|Overall Study|Adverse Event|7|||
130700541|NCT00283842|470526445|FG002|Overall Study|Adverse Event|21|||
130700542|NCT00283842|470526446|FG003|Overall Study|Adverse Event|21|||
130700543|NCT00283842|470526447|FG004|Overall Study|Adverse Event|5|||
130700544|NCT00283842|470526443|FG000|Overall Study|Protocol Violation|1|||
130700545|NCT00283842|470526444|FG001|Overall Study|Protocol Violation|5|||
130700546|NCT00283842|470526445|FG002|Overall Study|Protocol Violation|4|||
130700547|NCT00283842|470526446|FG003|Overall Study|Protocol Violation|0|||
130700548|NCT00283842|470526447|FG004|Overall Study|Protocol Violation|0|||
130700549|NCT00283842|470526443|FG000|Overall Study|Protocol deviation|0|||
130700550|NCT00283842|470526444|FG001|Overall Study|Protocol deviation|0|||
130700551|NCT00283842|470526445|FG002|Overall Study|Protocol deviation|0|||
130700552|NCT00283842|470526446|FG003|Overall Study|Protocol deviation|0|||
130700553|NCT00283842|470526447|FG004|Overall Study|Protocol deviation|2|||
130700554|NCT00283842|470526443|FG000|Overall Study|Withdrawal by Subject|2|||
130700555|NCT00283842|470526444|FG001|Overall Study|Withdrawal by Subject|1|||
130700556|NCT00283842|470526445|FG002|Overall Study|Withdrawal by Subject|1|||
130700557|NCT00283842|470526446|FG003|Overall Study|Withdrawal by Subject|5|||
130700558|NCT00283842|470526447|FG004|Overall Study|Withdrawal by Subject|4|||
130253725|NCT00392288|468892260|FG001|Overall Study|Adverse Event|7|||
130253726|NCT00392288|468892261|FG002|Overall Study|Adverse Event|8|||
130253727|NCT00392288|468892259|FG000|Overall Study|Lack of Efficacy|8|||
130253728|NCT00392288|468892260|FG001|Overall Study|Lack of Efficacy|5|||
130253729|NCT00392288|468892261|FG002|Overall Study|Lack of Efficacy|3|||
130253730|NCT00392288|468892259|FG000|Overall Study|Protocol Violation|1|||
130253731|NCT00392288|468892260|FG001|Overall Study|Protocol Violation|3|||
130253732|NCT00392288|468892261|FG002|Overall Study|Protocol Violation|1|||
130253733|NCT00392288|468892259|FG000|Overall Study|Lost to Follow-up|1|||
130253734|NCT00392288|468892260|FG001|Overall Study|Lost to Follow-up|1|||
130253735|NCT00392288|468892261|FG002|Overall Study|Lost to Follow-up|1|||
130553485|NCT01777269|469993580|FG001|Overall Study|Lack of Efficacy|10|||
130553486|NCT01777269|469993579|FG000|Overall Study|Protocol Violation|4|||
130553487|NCT01777269|469993580|FG001|Overall Study|Protocol Violation|4|||
130700559|NCT00283842|470526443|FG000|Overall Study|Lack of Efficacy|1|||
130700560|NCT00283842|470526444|FG001|Overall Study|Lack of Efficacy|3|||
130700561|NCT00283842|470526445|FG002|Overall Study|Lack of Efficacy|1|||
130700562|NCT00283842|470526446|FG003|Overall Study|Lack of Efficacy|0|||
130700563|NCT00283842|470526447|FG004|Overall Study|Lack of Efficacy|3|||
130700564|NCT00283842|470526443|FG000|Overall Study|Lost to Follow-up|0|||
130253736|NCT00392288|468892259|FG000|Overall Study|Withdrawal by Subject|1|||
130253737|NCT00392288|468892260|FG001|Overall Study|Withdrawal by Subject|0|||
130700565|NCT00283842|470526444|FG001|Overall Study|Lost to Follow-up|2|||
130700566|NCT00283842|470526445|FG002|Overall Study|Lost to Follow-up|4|||
130700567|NCT00283842|470526446|FG003|Overall Study|Lost to Follow-up|1|||
130700568|NCT00283842|470526447|FG004|Overall Study|Lost to Follow-up|1|||
130700569|NCT01824498|470526448|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
130700570|NCT01824498|470526449|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
130253738|NCT00392288|468892261|FG002|Overall Study|Withdrawal by Subject|2|||
130253739|NCT00392288|468892259|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
130253740|NCT00392288|468892260|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
130253741|NCT00392288|468892261|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
130253742|NCT00392288|468892259|FG000|Overall Study|Other|3|||
130253743|NCT00392288|468892260|FG001|Overall Study|Other|4|||
130253744|NCT00392288|468892261|FG002|Overall Study|Other|1|||
130253745|NCT02544763|468892262|FG000|Overall Study|Adverse Event|8|||
130253746|NCT02544763|468892263|FG001|Overall Study|Adverse Event|8|||
130253747|NCT02544763|468892264|FG002|Overall Study|Adverse Event|0|||
130253748|NCT02544763|468892262|FG000|Overall Study|Withdrawn by parent/guardian|1|||
130253749|NCT02544763|468892263|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130253750|NCT02544763|468892264|FG002|Overall Study|Withdrawn by parent/guardian|1|||
130253751|NCT02544763|468892262|FG000|Overall Study|Met withdrawal criteria|0|||
130253752|NCT02544763|468892263|FG001|Overall Study|Met withdrawal criteria|2|||
130253753|NCT02544763|468892264|FG002|Overall Study|Met withdrawal criteria|0|||
130253754|NCT02544763|468892262|FG000|Overall Study|Physician Decision|0|||
130253755|NCT02544763|468892263|FG001|Overall Study|Physician Decision|1|||
130253756|NCT02544763|468892264|FG002|Overall Study|Physician Decision|0|||
130253757|NCT02544763|468892262|FG000|Overall Study|Difficulties taking IMP|1|||
130253758|NCT02544763|468892263|FG001|Overall Study|Difficulties taking IMP|0|||
130253759|NCT02544763|468892264|FG002|Overall Study|Difficulties taking IMP|0|||
130253760|NCT02097225|468892265|FG000|Dose Level 4|Adverse Event|0|||
130253761|NCT02097225|468892266|FG001|Dose Level 4|Adverse Event|0|||
130253762|NCT02097225|468892267|FG002|Dose Level 4|Adverse Event|0|||
130253763|NCT02097225|468892268|FG003|Dose Level 4|Adverse Event|0|||
130253764|NCT02097225|468892269|FG004|Dose Level 4|Adverse Event|1|||
130253765|NCT01027351|468892271|FG000|Overall Study|Withdrawal by Subject|1|||
130253766|NCT01027351|468892272|FG001|Overall Study|Withdrawal by Subject|0|||
130253767|NCT01027351|468892273|FG002|Overall Study|Withdrawal by Subject|1|||
130253768|NCT01027351|468892274|FG003|Overall Study|Withdrawal by Subject|0|||
130253769|NCT01027351|468892275|FG004|Overall Study|Withdrawal by Subject|3|||
130253770|NCT01027351|468892276|FG005|Overall Study|Withdrawal by Subject|5|||
130253771|NCT01027351|468892271|FG000|Overall Study|Lost to Follow-up|1|||
130253772|NCT01027351|468892272|FG001|Overall Study|Lost to Follow-up|1|||
130253773|NCT01027351|468892273|FG002|Overall Study|Lost to Follow-up|0|||
130253774|NCT01027351|468892274|FG003|Overall Study|Lost to Follow-up|1|||
130253775|NCT01027351|468892275|FG004|Overall Study|Lost to Follow-up|6|||
130253776|NCT01027351|468892276|FG005|Overall Study|Lost to Follow-up|0|||
130253777|NCT01027351|468892271|FG000|Overall Study|Inappropriate enrollment|0|||
130253778|NCT01027351|468892272|FG001|Overall Study|Inappropriate enrollment|0|||
130253779|NCT01027351|468892273|FG002|Overall Study|Inappropriate enrollment|0|||
130253780|NCT01027351|468892274|FG003|Overall Study|Inappropriate enrollment|0|||
130253781|NCT01027351|468892275|FG004|Overall Study|Inappropriate enrollment|1|||
130253782|NCT01027351|468892276|FG005|Overall Study|Inappropriate enrollment|0|||
130253783|NCT01027351|468892271|FG000|Overall Study|Protocol Violation|1|||
130253784|NCT01027351|468892272|FG001|Overall Study|Protocol Violation|0|||
130253785|NCT01027351|468892273|FG002|Overall Study|Protocol Violation|0|||
130253786|NCT01027351|468892274|FG003|Overall Study|Protocol Violation|1|||
130253787|NCT01027351|468892275|FG004|Overall Study|Protocol Violation|1|||
130553488|NCT01777269|469993579|FG000|Overall Study|Participants reached stopping criteria|1|||
130553489|NCT01777269|469993580|FG001|Overall Study|Participants reached stopping criteria|1|||
130700571|NCT01824498|470526450|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
130253788|NCT01027351|468892276|FG005|Overall Study|Protocol Violation|0|||
130253789|NCT02757963|468892277|FG000|Overall Study|Adverse Event|3|||
130253790|NCT02757963|468892277|FG000|Overall Study|Reached Stopping Criteria|1054|||
130253791|NCT02757963|468892277|FG000|Overall Study|Lost to Follow-up|5|||
130253792|NCT02757963|468892277|FG000|Overall Study|Physician Decision|1|||
130253793|NCT02757963|468892277|FG000|Overall Study|Withdrawal by Subject|34|||
130700572|NCT01824498|470526451|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
130253794|NCT02971137|468892278|FG000|Overall Study|Lost to Follow-up|44|||
130253795|NCT02971137|468892279|FG001|Overall Study|Lost to Follow-up|56|||
130253796|NCT00911157|468892280|FG000|Overall Study|Adverse Event|4|||
130253797|NCT00911157|468892281|FG001|Overall Study|Adverse Event|1|||
130253798|NCT00911157|468892280|FG000|Overall Study|Withdrawal by Subject|1|||
130253799|NCT00911157|468892281|FG001|Overall Study|Withdrawal by Subject|1|||
130253800|NCT00911157|468892280|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
130253801|NCT00911157|468892281|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
130253802|NCT00911157|468892280|FG000|Overall Study|Need to treat for lung cancer|1|||
130253803|NCT00911157|468892281|FG001|Overall Study|Need to treat for lung cancer|0|||
130253804|NCT04755231|468892282|FG000|Overall Study|Lost to Follow-up|5|||
130253805|NCT04755231|468892282|FG000|Overall Study|Withdrawal by Subject|5|||
130253806|NCT04650893|468892283|FG000|Overall Study|Lost to Follow-up|11|||
130253807|NCT04650893|468892284|FG001|Overall Study|Lost to Follow-up|10|||
130253808|NCT04650893|468892285|FG002|Overall Study|Lost to Follow-up|11|||
130253809|NCT00176254|468892298|FG000|Overall Study|Lost to Follow-up|1|||
130253810|NCT01251965|468893914|FG000|Overall Study|Participant/physician decision|1|||
130253811|NCT01251965|468893915|FG001|Overall Study|Participant/physician decision|2|||
130253812|NCT01251965|468893916|FG002|Overall Study|Participant/physician decision|0|||
130253813|NCT01251965|468893914|FG000|Overall Study|Death|0|||
130253814|NCT01251965|468893915|FG001|Overall Study|Death|0|||
130253815|NCT01251965|468893916|FG002|Overall Study|Death|11|||
130253816|NCT04616196|468893917|FG000|Overall Study|Progressive Disease|3|||
130253817|NCT04616196|468893918|FG001|Overall Study|Progressive Disease|0|||
130253818|NCT04616196|468893919|FG002|Overall Study|Progressive Disease|4|||
130253819|NCT04616196|468893920|FG003|Overall Study|Progressive Disease|1|||
130700573|NCT01824498|470526452|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
130700574|NCT01824498|470526453|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
130700575|NCT04320745|470526454|FG000|Overall Study|Adverse Event|26|||
130700576|NCT04320745|470526454|FG000|Overall Study|Withdrawal by Subject|4|||
130700577|NCT04320745|470526454|FG000|Overall Study|Lost to Follow-up|12|||
130700578|NCT04320745|470526454|FG000|Overall Study|Protocol Deviation|2|||
130700579|NCT04320745|470526454|FG000|Overall Study|Non-compliance With Study Drug|2|||
130700580|NCT04320745|470526454|FG000|Overall Study|Reason Not Specified|1|||
130700581|NCT00046839|470526455|FG000|Overall Study|Ineligible / No protocol treatment|0|||
130700582|NCT00046839|470526456|FG001|Overall Study|Ineligible / No protocol treatment|2|||
130700583|NCT00046839|470526455|FG000|Overall Study|Withdrawal of consent|1|||
130700584|NCT00046839|470526456|FG001|Overall Study|Withdrawal of consent|0|||
130253820|NCT04616196|468893917|FG000|Overall Study|Death|2|||
130253821|NCT04616196|468893918|FG001|Overall Study|Death|4|||
130253822|NCT04616196|468893919|FG002|Overall Study|Death|1|||
130253823|NCT04616196|468893920|FG003|Overall Study|Death|0|||
130253824|NCT04616196|468893917|FG000|Overall Study|Withdrawal by Subject|0|||
130253825|NCT04616196|468893918|FG001|Overall Study|Withdrawal by Subject|2|||
130253826|NCT04616196|468893919|FG002|Overall Study|Withdrawal by Subject|0|||
130253827|NCT04616196|468893920|FG003|Overall Study|Withdrawal by Subject|0|||
130253828|NCT04616196|468893917|FG000|Overall Study|Lost to Follow-up|1|||
130253829|NCT04616196|468893918|FG001|Overall Study|Lost to Follow-up|0|||
130253830|NCT04616196|468893919|FG002|Overall Study|Lost to Follow-up|0|||
130253831|NCT04616196|468893920|FG003|Overall Study|Lost to Follow-up|0|||
130253832|NCT04616196|468893917|FG000|Overall Study|Sponsor request|2|||
130700585|NCT02472639|470526458|FG000|Overall Study|Physician Decision|4|||
130700586|NCT02472639|470526459|FG001|Overall Study|Physician Decision|3|||
130700587|NCT00702507|470526462|FG000|Initial Treatment Phase|Adverse Event|2|||
130700588|NCT00702507|470526462|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
130700589|NCT00702507|470526462|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130700590|NCT00702507|470526462|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
130700591|NCT00702507|470526462|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
130700592|NCT00702507|470526462|FG000|Follow-up Phase|Protocol Violation|2|||
130700593|NCT00702507|470526462|FG000|Follow-up Phase|Lost to Follow-up|23|||
130700594|NCT00702507|470526462|FG000|Follow-up Phase|Late Enrollment|1|||
130700595|NCT02308696|470526463|FG000|Overall Study|Lost to Follow-up|28|||
130700596|NCT02308696|470526464|FG001|Overall Study|Lost to Follow-up|21|||
130700597|NCT02308696|470526463|FG000|Overall Study|Death|8|||
130700598|NCT02308696|470526464|FG001|Overall Study|Death|4|||
130253833|NCT04616196|468893918|FG001|Overall Study|Sponsor request|1|||
130253834|NCT04616196|468893919|FG002|Overall Study|Sponsor request|1|||
130253835|NCT04616196|468893920|FG003|Overall Study|Sponsor request|2|||
130253836|NCT05401409|468893921|FG000|Overall Study|Lost to Follow-up|1|||
130253837|NCT05401409|468893922|FG001|Overall Study|Lost to Follow-up|0|||
130253838|NCT02371889|468893923|FG000|Overall Study|Adverse medication effect|11|||
130253839|NCT02371889|468893924|FG001|Overall Study|Adverse medication effect|2|||
130253840|NCT02371889|468893923|FG000|Overall Study|Lost to Follow-up|6|||
130253841|NCT02371889|468893924|FG001|Overall Study|Lost to Follow-up|5|||
130253842|NCT02371889|468893923|FG000|Overall Study|Personal time constraints|2|||
130253843|NCT02371889|468893924|FG001|Overall Study|Personal time constraints|4|||
130253844|NCT02371889|468893923|FG000|Overall Study|Lack of Efficacy|0|||
130253845|NCT02371889|468893924|FG001|Overall Study|Lack of Efficacy|2|||
130253846|NCT02371889|468893923|FG000|Overall Study|Relapse|0|||
130253847|NCT02371889|468893924|FG001|Overall Study|Relapse|1|||
130253848|NCT02579759|468893925|FG000|Overall Study|Protocol Violation|2|||
130253849|NCT02579759|468893926|FG001|Overall Study|Protocol Violation|0|||
130253850|NCT02579759|468893927|FG002|Overall Study|Protocol Violation|0|||
130253851|NCT02579759|468893925|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130253852|NCT02579759|468893926|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
130253853|NCT02579759|468893927|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130253854|NCT02579759|468893925|FG000|Overall Study|BfArM hold|13|||
130253855|NCT02579759|468893926|FG001|Overall Study|BfArM hold|12|||
130253856|NCT02579759|468893927|FG002|Overall Study|BfArM hold|12|||
130253857|NCT02579759|468893925|FG000|Overall Study|Sponsor stopped Dose 2|0|||
130253858|NCT02579759|468893926|FG001|Overall Study|Sponsor stopped Dose 2|41|||
130253859|NCT02579759|468893927|FG002|Overall Study|Sponsor stopped Dose 2|0|||
130253860|NCT02579759|468893925|FG000|Overall Study|Non compliance|0|||
130253861|NCT02579759|468893926|FG001|Overall Study|Non compliance|1|||
130700599|NCT02308696|470526463|FG000|Overall Study|Moved to a Higher Level of Care|17|||
130253862|NCT02579759|468893927|FG002|Overall Study|Non compliance|0|||
130253863|NCT02579759|468893925|FG000|Overall Study|Pregnancy|0|||
130253864|NCT02579759|468893926|FG001|Overall Study|Pregnancy|1|||
130253865|NCT02579759|468893927|FG002|Overall Study|Pregnancy|0|||
130700600|NCT02308696|470526464|FG001|Overall Study|Moved to a Higher Level of Care|6|||
130700601|NCT01211262|470526467|FG000|Overall Study|Progressive Disease|18|||
130700602|NCT01211262|470526468|FG001|Overall Study|Progressive Disease|9|||
130700603|NCT01211262|470526467|FG000|Overall Study|Adverse Event|4|||
130700604|NCT01211262|470526468|FG001|Overall Study|Adverse Event|0|||
130700605|NCT01211262|470526467|FG000|Overall Study|Withdrawal of Consent|1|||
130700606|NCT01211262|470526468|FG001|Overall Study|Withdrawal of Consent|0|||
130700607|NCT01211262|470526467|FG000|Overall Study|Other|0|||
130700608|NCT01211262|470526468|FG001|Overall Study|Other|1|||
130700609|NCT01277510|470526471|FG000|Double-blind Phase|Non-compliance|0|||
130700610|NCT01277510|470526472|FG001|Double-blind Phase|Non-compliance|1|||
130700611|NCT01277510|470526471|FG000|Double-blind Phase|Adverse Event|1|||
130700612|NCT01277510|470526472|FG001|Double-blind Phase|Adverse Event|0|||
130700613|NCT01277510|470526471|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130700614|NCT01277510|470526472|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130700615|NCT01277510|470526471|FG000|Double-blind Phase|Administrative decision|7|||
130700616|NCT01277510|470526472|FG001|Double-blind Phase|Administrative decision|9|||
130700617|NCT01277510|470526471|FG000|Double-blind Phase|Death|0|||
130700618|NCT01277510|470526472|FG001|Double-blind Phase|Death|1|||
130700619|NCT01277510|470526471|FG000|Double-blind Phase|Protocol-specified criteria|2|||
130700620|NCT01277510|470526472|FG001|Double-blind Phase|Protocol-specified criteria|6|||
130700621|NCT01277510|470526471|FG000|Double-blind Phase|Other|1|||
130700622|NCT01277510|470526472|FG001|Double-blind Phase|Other|1|||
130700623|NCT01277510|470526471|FG000|Open-label Phase|Administrative decision|4|||
130700624|NCT01277510|470526472|FG001|Open-label Phase|Administrative decision|3|||
130700625|NCT01277510|470526471|FG000|Open-label Phase|Protocol-specified criteria|1|||
130700626|NCT01277510|470526472|FG001|Open-label Phase|Protocol-specified criteria|0|||
130700627|NCT01277510|470526471|FG000|Open-label Phase|Never received investigational product|2|||
130700628|NCT01277510|470526472|FG001|Open-label Phase|Never received investigational product|0|||
130700629|NCT04768114|470526473|FG000|Overall Study|Lost to Follow-up|5|||
130700630|NCT04768114|470526474|FG001|Overall Study|Lost to Follow-up|10|||
130700631|NCT04768114|470526473|FG000|Overall Study|Withdrawal by Subject|0|||
130700632|NCT04768114|470526474|FG001|Overall Study|Withdrawal by Subject|1|||
130700633|NCT03980522|470526478|FG000|Treatment Period|Adverse Event|1|||
130700634|NCT03980522|470526479|FG001|Treatment Period|Adverse Event|0|||
130700635|NCT03980522|470526480|FG002|Treatment Period|Adverse Event|0|||
130700636|NCT03980522|470526481|FG003|Treatment Period|Adverse Event|0|||
130700637|NCT03980522|470526482|FG004|Treatment Period|Adverse Event|0|||
130700638|NCT04892147|470526483|FG000|Overall Study|Withdrawal by Subject|2|||
130700639|NCT04892147|470526484|FG001|Overall Study|Withdrawal by Subject|0|||
130700640|NCT05263505|470526485|FG000|Overall Study|Adverse Event|0|||
130700641|NCT05263505|470526486|FG001|Overall Study|Adverse Event|1|||
130700642|NCT03428945|470526488|FG000|Overall Study|Lost to Follow-up|5|||
130253866|NCT02579759|468893925|FG000|Overall Study|Inclusion/exclusion criteria|0|||
130253867|NCT02579759|468893926|FG001|Overall Study|Inclusion/exclusion criteria|0|||
130700643|NCT03428945|470526489|FG001|Overall Study|Lost to Follow-up|3|||
130700644|NCT03428945|470526488|FG000|Overall Study|Withdrawal by Subject|10|||
130700645|NCT03428945|470526489|FG001|Overall Study|Withdrawal by Subject|10|||
130700646|NCT01598896|470526491|FG000|Overall Study|Withdrawal by Subject|0|||
130700647|NCT01598896|470526492|FG001|Overall Study|Withdrawal by Subject|1|||
130700648|NCT01598896|470526491|FG000|Overall Study|Lack of Efficacy|0|||
130700649|NCT01598896|470526492|FG001|Overall Study|Lack of Efficacy|1|||
130700650|NCT01562613|470526493|FG000|Overall Study|Lost to Follow-up|2|||
130700651|NCT01562613|470526493|FG000|Overall Study|Withdrawal by Subject|2|||
130253868|NCT02579759|468893927|FG002|Overall Study|Inclusion/exclusion criteria|1|||
130253869|NCT02579759|468893925|FG000|Overall Study|Adverse Event|4|||
130253870|NCT02579759|468893926|FG001|Overall Study|Adverse Event|3|||
130253871|NCT02579759|468893927|FG002|Overall Study|Adverse Event|1|||
130700652|NCT04640194|470526498|FG000|Overall Study|Adverse Event|3|||
130253872|NCT02579759|468893925|FG000|Overall Study|Withdrawal by Subject|3|||
130253873|NCT02579759|468893926|FG001|Overall Study|Withdrawal by Subject|3|||
130253874|NCT02579759|468893927|FG002|Overall Study|Withdrawal by Subject|5|||
130253875|NCT02579759|468893925|FG000|Overall Study|Lost to Follow-up|2|||
130253876|NCT02579759|468893926|FG001|Overall Study|Lost to Follow-up|2|||
130253877|NCT02579759|468893927|FG002|Overall Study|Lost to Follow-up|2|||
130253878|NCT02410200|468893930|FG000|Overall Study|Adverse Event|2|||
130253879|NCT01050218|468893935|FG000|Overall Study|Adverse Event|37|||
130253880|NCT01050218|468893935|FG000|Overall Study|Lack of Efficacy|8|||
130253881|NCT01050218|468893935|FG000|Overall Study|Protocol Violation|3|||
130253882|NCT01050218|468893935|FG000|Overall Study|Withdrawal by Subject|18|||
130253883|NCT01050218|468893935|FG000|Overall Study|Discontinued by sponsor|18|||
130253884|NCT01050218|468893935|FG000|Overall Study|Compliance|2|||
130253885|NCT01050218|468893935|FG000|Overall Study|Failed to return|7|||
130253886|NCT01050218|468893935|FG000|Overall Study|Serious Adverse Event|1|||
130253887|NCT01050218|468893935|FG000|Overall Study|Family emergency|1|||
130253888|NCT01149460|468893936|FG000|Overall Study|Withdrawal by Subject|0|||
130253889|NCT01149460|468893937|FG001|Overall Study|Withdrawal by Subject|2|||
130253890|NCT02801578|468893944|FG000|Overall Study|Adverse Event|2|||
130253891|NCT00668642|468893945|FG000|First Off-cycle|Cancer progression|1|||
130253892|NCT00668642|468893946|FG001|First Off-cycle|Cancer progression|0|||
130253893|NCT00668642|468893945|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
130253894|NCT00668642|468893946|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
130253895|NCT03412591|468893947|FG000|Overall Study|Withdrawal by Subject|1|||
130253896|NCT03412591|468893948|FG001|Overall Study|Withdrawal by Subject|8|||
130253897|NCT03412591|468893947|FG000|Overall Study|Adverse Event|0|||
130253898|NCT03412591|468893948|FG001|Overall Study|Adverse Event|1|||
130253899|NCT02272985|468893949|FG000|Overall Study|Withdrawal by Subject|1|||
130253900|NCT02272985|468893949|FG000|Overall Study|hip fracture|1|||
130253901|NCT02272985|468893949|FG000|Overall Study|kidney transplantation|1|||
130253902|NCT00770679|468893950|FG000|Overall Study|Lost to Follow-up|3|||
130253903|NCT00770679|468893950|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
130253904|NCT00266032|468893956|FG000|Treatment|Adverse Event|42|||
130253905|NCT00266032|468893957|FG001|Treatment|Adverse Event|26|||
130253906|NCT00266032|468893958|FG002|Treatment|Adverse Event|10|||
130253907|NCT00266032|468893956|FG000|Treatment|Lost to Follow-up|19|||
130253908|NCT00266032|468893957|FG001|Treatment|Lost to Follow-up|4|||
130253909|NCT00266032|468893958|FG002|Treatment|Lost to Follow-up|2|||
130253910|NCT00266032|468893956|FG000|Treatment|Pregnancy|3|||
130253911|NCT00266032|468893957|FG001|Treatment|Pregnancy|2|||
130253912|NCT00266032|468893958|FG002|Treatment|Pregnancy|2|||
130253913|NCT00266032|468893956|FG000|Treatment|Protocol Violation|6|||
130253914|NCT00266032|468893957|FG001|Treatment|Protocol Violation|14|||
130253915|NCT00266032|468893958|FG002|Treatment|Protocol Violation|13|||
130253916|NCT00266032|468893956|FG000|Treatment|Withdrawal by Subject|28|||
130253917|NCT00266032|468893957|FG001|Treatment|Withdrawal by Subject|13|||
130253918|NCT00266032|468893958|FG002|Treatment|Withdrawal by Subject|12|||
130253919|NCT00266032|468893956|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
130253920|NCT00266032|468893957|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
130253921|NCT00266032|468893958|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
130253922|NCT00266032|468893956|FG000|Open-label Safety Extension|Adverse Event|5|||
130253923|NCT00266032|468893957|FG001|Open-label Safety Extension|Adverse Event|0|||
130253924|NCT00266032|468893958|FG002|Open-label Safety Extension|Adverse Event|4|||
130253925|NCT00266032|468893956|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
130253926|NCT00266032|468893957|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
130253927|NCT00266032|468893958|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
130253928|NCT00266032|468893956|FG000|Open-label Safety Extension|Pregnancy|4|||
130253929|NCT00266032|468893957|FG001|Open-label Safety Extension|Pregnancy|1|||
130253930|NCT00266032|468893958|FG002|Open-label Safety Extension|Pregnancy|2|||
130253931|NCT00266032|468893956|FG000|Open-label Safety Extension|Protocol Violation|1|||
130253932|NCT00266032|468893957|FG001|Open-label Safety Extension|Protocol Violation|3|||
130253933|NCT00266032|468893958|FG002|Open-label Safety Extension|Protocol Violation|2|||
130253934|NCT00266032|468893956|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
130253935|NCT00266032|468893957|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
130253936|NCT00266032|468893958|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
130253937|NCT00266032|468893956|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
130253938|NCT00266032|468893957|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
130253939|NCT00266032|468893958|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
130253940|NCT00814983|468893961|FG000|Overall Study|Screen failure|1|||
130365058|NCT02925117|469306851|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365059|NCT02925117|469306852|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365060|NCT02925117|469306853|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130253941|NCT00814983|468893962|FG001|Overall Study|Screen failure|0|||
130253942|NCT00814983|468893961|FG000|Overall Study|Withdrawal by Subject|1|||
130253943|NCT00814983|468893962|FG001|Overall Study|Withdrawal by Subject|0|||
130365061|NCT02925117|469306854|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130253944|NCT00814983|468893961|FG000|Overall Study|Graft failure|1|||
130253945|NCT00814983|468893962|FG001|Overall Study|Graft failure|0|||
130253946|NCT03627468|468893963|FG000|Overall Study|Adverse Event|5|||
130253947|NCT03627468|468893964|FG001|Overall Study|Adverse Event|33|||
130253948|NCT03627468|468893963|FG000|Overall Study|Withdrawal by Subject|13|||
130253949|NCT03627468|468893964|FG001|Overall Study|Withdrawal by Subject|23|||
130253950|NCT03627468|468893963|FG000|Overall Study|Physician Decision|1|||
130253951|NCT03627468|468893964|FG001|Overall Study|Physician Decision|0|||
130253952|NCT03627468|468893963|FG000|Overall Study|Protocol Violation|0|||
130253953|NCT03627468|468893964|FG001|Overall Study|Protocol Violation|2|||
130253954|NCT03627468|468893963|FG000|Overall Study|Lost to Follow-up|10|||
130253955|NCT03627468|468893964|FG001|Overall Study|Lost to Follow-up|16|||
130253956|NCT03627468|468893963|FG000|Overall Study|Death|1|||
130253957|NCT03627468|468893964|FG001|Overall Study|Death|0|||
130253958|NCT03627468|468893963|FG000|Overall Study|Pregnancy|1|||
130253959|NCT03627468|468893964|FG001|Overall Study|Pregnancy|1|||
130253960|NCT03627468|468893963|FG000|Overall Study|Lack of Efficacy|0|||
130253961|NCT03627468|468893964|FG001|Overall Study|Lack of Efficacy|2|||
130253962|NCT03627468|468893963|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
130253963|NCT03627468|468893964|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
130253964|NCT04157738|468893965|FG000|Overall Study|Moved out of state|0|||
130253965|NCT04157738|468893966|FG001|Overall Study|Moved out of state|2|||
130253966|NCT04157738|468893965|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
130253967|NCT04157738|468893966|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
130253968|NCT00160563|468893967|FG000|Overall Study|Adverse Event|1|||
130253969|NCT00160563|468893968|FG001|Overall Study|Adverse Event|1|||
130253970|NCT00160563|468893969|FG002|Overall Study|Adverse Event|1|||
130253971|NCT00160563|468893967|FG000|Overall Study|Lost to Follow-up|1|||
130253972|NCT00160563|468893968|FG001|Overall Study|Lost to Follow-up|1|||
130253973|NCT00160563|468893969|FG002|Overall Study|Lost to Follow-up|2|||
130253974|NCT00160563|468893967|FG000|Overall Study|Protocol Violation|0|||
130253975|NCT00160563|468893968|FG001|Overall Study|Protocol Violation|0|||
130253976|NCT00160563|468893969|FG002|Overall Study|Protocol Violation|3|||
130253977|NCT00160563|468893967|FG000|Overall Study|Withdrawal by Subject|1|||
130253978|NCT00160563|468893968|FG001|Overall Study|Withdrawal by Subject|2|||
130253979|NCT00160563|468893969|FG002|Overall Study|Withdrawal by Subject|3|||
130253980|NCT00160563|468893967|FG000|Overall Study|Other (listed in the study report)|48|||
130253981|NCT00160563|468893968|FG001|Overall Study|Other (listed in the study report)|40|||
130253982|NCT00160563|468893969|FG002|Overall Study|Other (listed in the study report)|81|||
130253983|NCT00160563|468893967|FG000|Overall Study|Missing reason|0|||
130253984|NCT00160563|468893968|FG001|Overall Study|Missing reason|1|||
130253985|NCT00160563|468893969|FG002|Overall Study|Missing reason|0|||
130253986|NCT01514357|468893973|FG000|Overall Study|Screen failure|2|||
130253987|NCT01514357|468893974|FG001|Overall Study|Screen failure|0|||
130253988|NCT01514357|468893973|FG000|Overall Study|Withdrawal by Subject|2|||
130253989|NCT01514357|468893974|FG001|Overall Study|Withdrawal by Subject|0|||
130253990|NCT00752219|468893975|FG000|Overall Study|Clinical failure|0|||
130253991|NCT00752219|468893976|FG001|Overall Study|Clinical failure|1|||
130253992|NCT00752219|468893975|FG000|Overall Study|Adverse Event|5|||
130253993|NCT00752219|468893976|FG001|Overall Study|Adverse Event|3|||
130253994|NCT00752219|468893975|FG000|Overall Study|Protocol deviation|1|||
130253995|NCT00752219|468893976|FG001|Overall Study|Protocol deviation|0|||
130253996|NCT00752219|468893975|FG000|Overall Study|Lost to Follow-up|1|||
130253997|NCT00752219|468893976|FG001|Overall Study|Lost to Follow-up|2|||
130253998|NCT00752219|468893975|FG000|Overall Study|Randomized but not treated|1|||
130253999|NCT00752219|468893976|FG001|Overall Study|Randomized but not treated|0|||
130254000|NCT00752219|468893975|FG000|Overall Study|Other|3|||
130254001|NCT00752219|468893976|FG001|Overall Study|Other|0|||
130700653|NCT04640194|470526499|FG001|Overall Study|Adverse Event|7|||
130700654|NCT04640194|470526500|FG002|Overall Study|Adverse Event|0|||
130700655|NCT04640194|470526501|FG003|Overall Study|Adverse Event|5|||
130700656|NCT04640194|470526502|FG004|Overall Study|Adverse Event|0|||
130700657|NCT04640194|470526503|FG005|Overall Study|Adverse Event|4|||
130700658|NCT04640194|470526504|FG006|Overall Study|Adverse Event|0|||
130700659|NCT04640194|470526498|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
130254002|NCT01047540|468893982|FG000|Overall Study|Protocol Violation|1|||
130254003|NCT01047540|468893983|FG001|Overall Study|Protocol Violation|0|||
130254004|NCT01047540|468893984|FG002|Overall Study|Protocol Violation|0|||
130254005|NCT01047540|468893985|FG003|Overall Study|Protocol Violation|0|||
130254006|NCT01047540|468893986|FG004|Overall Study|Protocol Violation|0|||
130254007|NCT01047540|468893982|FG000|Overall Study|Lost to Follow-up|1|||
130254008|NCT01047540|468893983|FG001|Overall Study|Lost to Follow-up|0|||
130254009|NCT01047540|468893984|FG002|Overall Study|Lost to Follow-up|0|||
130700660|NCT04640194|470526499|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
130254010|NCT01047540|468893985|FG003|Overall Study|Lost to Follow-up|0|||
130254011|NCT01047540|468893986|FG004|Overall Study|Lost to Follow-up|0|||
130700661|NCT04640194|470526500|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
130254012|NCT01047540|468893982|FG000|Overall Study|Withdrawal by Subject|1|||
130254013|NCT01047540|468893983|FG001|Overall Study|Withdrawal by Subject|0|||
130254014|NCT01047540|468893984|FG002|Overall Study|Withdrawal by Subject|3|||
130254015|NCT01047540|468893985|FG003|Overall Study|Withdrawal by Subject|0|||
130254016|NCT01047540|468893986|FG004|Overall Study|Withdrawal by Subject|1|||
130254017|NCT01047540|468893982|FG000|Overall Study|Pregnancy|1|||
130254018|NCT01047540|468893983|FG001|Overall Study|Pregnancy|0|||
130254019|NCT01047540|468893984|FG002|Overall Study|Pregnancy|0|||
130254020|NCT01047540|468893985|FG003|Overall Study|Pregnancy|0|||
130254021|NCT01047540|468893986|FG004|Overall Study|Pregnancy|0|||
130254022|NCT01047540|468893982|FG000|Overall Study|Adverse Event|1|||
130254023|NCT01047540|468893983|FG001|Overall Study|Adverse Event|0|||
130254024|NCT01047540|468893984|FG002|Overall Study|Adverse Event|0|||
130254025|NCT01047540|468893985|FG003|Overall Study|Adverse Event|0|||
130254026|NCT01047540|468893986|FG004|Overall Study|Adverse Event|0|||
130254027|NCT01437189|468893990|FG000|Overall Study|Adverse Event|3|||
130254028|NCT01437189|468893990|FG000|Overall Study|Lack of Efficacy|4|||
130254029|NCT01437189|468893990|FG000|Overall Study|Withdrawal by Subject|8|||
130254030|NCT00347269|468893991|FG000|Overall Study|Lost to Follow-up|74|||
130254031|NCT00347269|468893992|FG001|Overall Study|Lost to Follow-up|65|||
130254032|NCT00347269|468893991|FG000|Overall Study|Withdrawal by Subject|18|||
130254033|NCT00347269|468893992|FG001|Overall Study|Withdrawal by Subject|38|||
130254034|NCT00347269|468893991|FG000|Overall Study|Death|2|||
130254035|NCT00347269|468893992|FG001|Overall Study|Death|3|||
130254036|NCT03654326|468893993|FG000|Overall Study|Withdrawal by Subject|5|||
130254037|NCT03654326|468893994|FG001|Overall Study|Withdrawal by Subject|3|||
130254038|NCT03654326|468893993|FG000|Overall Study|Physician Decision|0|||
130254039|NCT03654326|468893994|FG001|Overall Study|Physician Decision|1|||
130254040|NCT03654326|468893993|FG000|Overall Study|Unable to adhere to study schedule|0|||
130254041|NCT03654326|468893994|FG001|Overall Study|Unable to adhere to study schedule|1|||
130254042|NCT03654326|468893993|FG000|Overall Study|Lost to Follow-up|1|||
130254043|NCT03654326|468893994|FG001|Overall Study|Lost to Follow-up|1|||
130254044|NCT04102514|468893995|FG000|Overall Study|Death|3|||
130254045|NCT04102514|468893996|FG001|Overall Study|Death|0|||
130254046|NCT04102514|468893997|FG002|Overall Study|Death|0|||
130254047|NCT04102514|468893998|FG003|Overall Study|Death|0|||
130254048|NCT04102514|468893995|FG000|Overall Study|Lost to Follow-up|0|||
130254049|NCT04102514|468893996|FG001|Overall Study|Lost to Follow-up|0|||
130254050|NCT04102514|468893997|FG002|Overall Study|Lost to Follow-up|3|||
130254051|NCT04102514|468893998|FG003|Overall Study|Lost to Follow-up|0|||
130254052|NCT04102514|468893995|FG000|Overall Study|Physician Decision|0|||
130254053|NCT04102514|468893996|FG001|Overall Study|Physician Decision|0|||
130254054|NCT04102514|468893997|FG002|Overall Study|Physician Decision|1|||
130254055|NCT04102514|468893998|FG003|Overall Study|Physician Decision|0|||
130254056|NCT04102514|468893995|FG000|Overall Study|Withdrawal by Subject|7|||
130254057|NCT04102514|468893996|FG001|Overall Study|Withdrawal by Subject|13|||
130254058|NCT04102514|468893997|FG002|Overall Study|Withdrawal by Subject|7|||
130254059|NCT04102514|468893998|FG003|Overall Study|Withdrawal by Subject|14|||
130254060|NCT04102514|468893995|FG000|Overall Study|Moved to longterm care facility|6|||
130254061|NCT04102514|468893996|FG001|Overall Study|Moved to longterm care facility|0|||
130254062|NCT04102514|468893997|FG002|Overall Study|Moved to longterm care facility|4|||
130254063|NCT04102514|468893998|FG003|Overall Study|Moved to longterm care facility|0|||
130254064|NCT01689649|468893999|FG000|Overall Study|Lack of Efficacy|3|||
130254065|NCT01689649|468893999|FG000|Overall Study|Non-compliance|11|||
130254066|NCT01689649|468893999|FG000|Overall Study|Protocol Violation|3|||
130254067|NCT01689649|468893999|FG000|Overall Study|Lost to Follow-up|5|||
130254068|NCT00835549|468894000|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
130254069|NCT00835549|468894001|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130254070|NCT00835042|468894002|FG000|First Intervention|Withdrawal by Subject|3|||
130254071|NCT00835042|468894003|FG001|First Intervention|Withdrawal by Subject|0|||
130553490|NCT01777269|469993579|FG000|Overall Study|Lost to Follow-up|4|||
130254072|NCT00835042|468894002|FG000|First Intervention|Adverse Event|1|||
130254073|NCT00835042|468894003|FG001|First Intervention|Adverse Event|2|||
130254074|NCT00835042|468894002|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
130254075|NCT00835042|468894003|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
130254076|NCT00619918|468894004|FG000|Overall Study|Withdrawal by Subject|4|||
130254077|NCT00619918|468894005|FG001|Overall Study|Withdrawal by Subject|3|||
130254078|NCT00619918|468894004|FG000|Overall Study|Physician Decision|2|||
130254079|NCT00619918|468894005|FG001|Overall Study|Physician Decision|4|||
130254080|NCT00619918|468894004|FG000|Overall Study|Transfer to outside facility|3|||
130254081|NCT00619918|468894005|FG001|Overall Study|Transfer to outside facility|3|||
130254082|NCT00619918|468894004|FG000|Overall Study|Left before receiving first dose|7|||
130254083|NCT00619918|468894005|FG001|Overall Study|Left before receiving first dose|6|||
130254084|NCT00619918|468894004|FG000|Overall Study|ICU admission|4|||
130254085|NCT00619918|468894005|FG001|Overall Study|ICU admission|6|||
130254086|NCT05524948|468894030|FG000|Overall Study|Withdrawal by Subject|1|||
130254087|NCT05524948|468894031|FG001|Overall Study|Withdrawal by Subject|0|||
130254088|NCT05524948|468894030|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
130254089|NCT05524948|468894031|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
130254090|NCT00595075|468894034|FG000|Overall Study|Withdrawal by Subject|1|||
130254091|NCT00595075|468894035|FG001|Overall Study|Withdrawal by Subject|0|||
130254092|NCT02096354|468894038|FG000|Overall Study|Physician Decision|4|||
130254093|NCT02096354|468894039|FG001|Overall Study|Physician Decision|5|||
130254094|NCT02096354|468894040|FG002|Overall Study|Physician Decision|0|||
130254095|NCT02096354|468894038|FG000|Overall Study|Withdrawal by Subject|3|||
130254096|NCT02096354|468894039|FG001|Overall Study|Withdrawal by Subject|1|||
130254097|NCT02096354|468894040|FG002|Overall Study|Withdrawal by Subject|0|||
130254098|NCT02096354|468894038|FG000|Overall Study|Adverse Event|7|||
130254099|NCT02096354|468894039|FG001|Overall Study|Adverse Event|4|||
130254100|NCT02096354|468894040|FG002|Overall Study|Adverse Event|0|||
130254101|NCT02096354|468894038|FG000|Overall Study|Ineligible|0|||
130254102|NCT02096354|468894039|FG001|Overall Study|Ineligible|0|||
130254103|NCT02096354|468894040|FG002|Overall Study|Ineligible|11|||
130254104|NCT03715829|468894041|FG000|Dose Ranging Period|Adverse Event|2|||
130254105|NCT03715829|468894042|FG001|Dose Ranging Period|Adverse Event|4|||
130254106|NCT03715829|468894043|FG002|Dose Ranging Period|Adverse Event|5|||
130254107|NCT03715829|468894044|FG003|Dose Ranging Period|Adverse Event|2|||
130254108|NCT03715829|468894045|FG004|Dose Ranging Period|Adverse Event|3|||
130254109|NCT03715829|468894046|FG005|Dose Ranging Period|Adverse Event|3|||
130254110|NCT03715829|468894047|FG006|Dose Ranging Period|Adverse Event|0|||
130254111|NCT03715829|468894048|FG007|Dose Ranging Period|Adverse Event|0|||
130254112|NCT03715829|468894049|FG008|Dose Ranging Period|Adverse Event|0|||
130254113|NCT03715829|468894050|FG009|Dose Ranging Period|Adverse Event|0|||
130254114|NCT03715829|468894051|FG010|Dose Ranging Period|Adverse Event|0|||
130254115|NCT03715829|468894041|FG000|Dose Ranging Period|Lack of Efficacy|0|||
130254116|NCT03715829|468894042|FG001|Dose Ranging Period|Lack of Efficacy|1|||
130254117|NCT03715829|468894043|FG002|Dose Ranging Period|Lack of Efficacy|0|||
130254118|NCT03715829|468894044|FG003|Dose Ranging Period|Lack of Efficacy|1|||
130254119|NCT03715829|468894045|FG004|Dose Ranging Period|Lack of Efficacy|0|||
130254120|NCT03715829|468894046|FG005|Dose Ranging Period|Lack of Efficacy|0|||
130254121|NCT03715829|468894047|FG006|Dose Ranging Period|Lack of Efficacy|0|||
130254122|NCT03715829|468894048|FG007|Dose Ranging Period|Lack of Efficacy|0|||
130254123|NCT03715829|468894049|FG008|Dose Ranging Period|Lack of Efficacy|0|||
130254124|NCT03715829|468894050|FG009|Dose Ranging Period|Lack of Efficacy|0|||
130254125|NCT03715829|468894051|FG010|Dose Ranging Period|Lack of Efficacy|0|||
130254126|NCT03715829|468894041|FG000|Dose Ranging Period|Lost to Follow-up|2|||
130365062|NCT02925117|469306855|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365063|NCT02925117|469306856|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365064|NCT02925117|469306857|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365065|NCT02925117|469306858|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365066|NCT02925117|469306859|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130365067|NCT02925117|469306848|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
130365068|NCT02925117|469306849|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
130365069|NCT02925117|469306850|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
130365070|NCT02925117|469306851|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
130365071|NCT02925117|469306852|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
130365072|NCT02925117|469306853|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
130365073|NCT02925117|469306854|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
130365074|NCT02925117|469306855|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
130365075|NCT02925117|469306856|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
130365076|NCT02925117|469306857|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
130365077|NCT02925117|469306858|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
130365078|NCT02925117|469306859|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
130365079|NCT02925117|469306848|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365080|NCT02925117|469306849|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365081|NCT02925117|469306850|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365082|NCT02925117|469306851|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365083|NCT02925117|469306852|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365084|NCT02925117|469306853|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
130365085|NCT02925117|469306854|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365086|NCT02925117|469306855|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130254127|NCT03715829|468894042|FG001|Dose Ranging Period|Lost to Follow-up|0|||
130254128|NCT03715829|468894043|FG002|Dose Ranging Period|Lost to Follow-up|1|||
130254129|NCT03715829|468894044|FG003|Dose Ranging Period|Lost to Follow-up|1|||
130254130|NCT03715829|468894045|FG004|Dose Ranging Period|Lost to Follow-up|1|||
130254131|NCT03715829|468894046|FG005|Dose Ranging Period|Lost to Follow-up|2|||
130254132|NCT03715829|468894047|FG006|Dose Ranging Period|Lost to Follow-up|0|||
130254133|NCT03715829|468894048|FG007|Dose Ranging Period|Lost to Follow-up|0|||
130254134|NCT03715829|468894049|FG008|Dose Ranging Period|Lost to Follow-up|0|||
130254135|NCT03715829|468894050|FG009|Dose Ranging Period|Lost to Follow-up|0|||
130254136|NCT03715829|468894051|FG010|Dose Ranging Period|Lost to Follow-up|0|||
130365087|NCT02925117|469306856|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130365088|NCT02925117|469306857|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130700662|NCT04640194|470526501|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
130700663|NCT04640194|470526502|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
130700664|NCT04640194|470526503|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
130700665|NCT04640194|470526504|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
130700666|NCT04640194|470526498|FG000|Overall Study|fibrinogen level too low|0|||
130700667|NCT04640194|470526499|FG001|Overall Study|fibrinogen level too low|0|||
130700668|NCT04640194|470526500|FG002|Overall Study|fibrinogen level too low|0|||
130700669|NCT04640194|470526501|FG003|Overall Study|fibrinogen level too low|1|||
130700670|NCT04640194|470526502|FG004|Overall Study|fibrinogen level too low|0|||
130700671|NCT04640194|470526503|FG005|Overall Study|fibrinogen level too low|0|||
130700672|NCT04640194|470526504|FG006|Overall Study|fibrinogen level too low|0|||
130700673|NCT04640194|470526498|FG000|Overall Study|mild bleeding|0|||
130700674|NCT04640194|470526499|FG001|Overall Study|mild bleeding|0|||
130700675|NCT04640194|470526500|FG002|Overall Study|mild bleeding|0|||
130700676|NCT04640194|470526501|FG003|Overall Study|mild bleeding|1|||
130700677|NCT04640194|470526502|FG004|Overall Study|mild bleeding|0|||
130254137|NCT03715829|468894041|FG000|Dose Ranging Period|Protocol Violation|0|||
130254138|NCT03715829|468894042|FG001|Dose Ranging Period|Protocol Violation|0|||
130254139|NCT03715829|468894043|FG002|Dose Ranging Period|Protocol Violation|0|||
130254140|NCT03715829|468894044|FG003|Dose Ranging Period|Protocol Violation|1|||
130254141|NCT03715829|468894045|FG004|Dose Ranging Period|Protocol Violation|0|||
130254142|NCT03715829|468894046|FG005|Dose Ranging Period|Protocol Violation|0|||
130254143|NCT03715829|468894047|FG006|Dose Ranging Period|Protocol Violation|0|||
130254144|NCT03715829|468894048|FG007|Dose Ranging Period|Protocol Violation|0|||
130254145|NCT03715829|468894049|FG008|Dose Ranging Period|Protocol Violation|0|||
130254146|NCT03715829|468894050|FG009|Dose Ranging Period|Protocol Violation|0|||
130254147|NCT03715829|468894051|FG010|Dose Ranging Period|Protocol Violation|0|||
130254148|NCT03715829|468894041|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
130254149|NCT03715829|468894042|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
130254150|NCT03715829|468894043|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
130254151|NCT03715829|468894044|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
130254152|NCT03715829|468894045|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
130254153|NCT03715829|468894046|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
130254154|NCT03715829|468894047|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
130254155|NCT03715829|468894048|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
130254156|NCT03715829|468894049|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
130254157|NCT03715829|468894050|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
130254158|NCT03715829|468894051|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
130254159|NCT03715829|468894041|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254160|NCT03715829|468894042|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254161|NCT03715829|468894043|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
130254162|NCT03715829|468894044|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254163|NCT03715829|468894045|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254164|NCT03715829|468894046|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254165|NCT03715829|468894047|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254166|NCT03715829|468894048|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254167|NCT03715829|468894049|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254168|NCT03715829|468894050|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254169|NCT03715829|468894051|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254170|NCT03715829|468894041|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254171|NCT03715829|468894042|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254172|NCT03715829|468894043|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130254173|NCT03715829|468894044|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254174|NCT03715829|468894045|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130254175|NCT03715829|468894046|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254176|NCT03715829|468894047|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254177|NCT03715829|468894048|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254178|NCT03715829|468894049|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254179|NCT03715829|468894050|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130700678|NCT04640194|470526503|FG005|Overall Study|mild bleeding|0|||
130700679|NCT04640194|470526504|FG006|Overall Study|mild bleeding|0|||
130700680|NCT04640194|470526498|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700681|NCT04640194|470526499|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
130700682|NCT04640194|470526500|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700683|NCT04640194|470526501|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700684|NCT04640194|470526502|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700685|NCT04640194|470526503|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700686|NCT04640194|470526504|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700687|NCT04773600|470526515|FG000|Overall Study|Withdrawal by Subject|15|||
130254180|NCT03715829|468894051|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254181|NCT03715829|468894041|FG000|Dose Ranging Period|Other|0|||
130254182|NCT03715829|468894042|FG001|Dose Ranging Period|Other|0|||
130254183|NCT03715829|468894043|FG002|Dose Ranging Period|Other|2|||
130254184|NCT03715829|468894044|FG003|Dose Ranging Period|Other|0|||
130254185|NCT03715829|468894045|FG004|Dose Ranging Period|Other|0|||
130254186|NCT03715829|468894046|FG005|Dose Ranging Period|Other|3|||
130254187|NCT03715829|468894047|FG006|Dose Ranging Period|Other|0|||
130254188|NCT03715829|468894048|FG007|Dose Ranging Period|Other|0|||
130254189|NCT03715829|468894049|FG008|Dose Ranging Period|Other|0|||
130254190|NCT03715829|468894050|FG009|Dose Ranging Period|Other|0|||
130254191|NCT03715829|468894051|FG010|Dose Ranging Period|Other|0|||
130254192|NCT03715829|468894041|FG000|Extension Period|Adverse Event|0|||
130254193|NCT03715829|468894042|FG001|Extension Period|Adverse Event|0|||
130254194|NCT03715829|468894043|FG002|Extension Period|Adverse Event|0|||
130254195|NCT03715829|468894044|FG003|Extension Period|Adverse Event|0|||
130254196|NCT03715829|468894045|FG004|Extension Period|Adverse Event|0|||
130254197|NCT03715829|468894046|FG005|Extension Period|Adverse Event|0|||
130254198|NCT03715829|468894047|FG006|Extension Period|Adverse Event|3|||
130254199|NCT03715829|468894048|FG007|Extension Period|Adverse Event|1|||
130254200|NCT03715829|468894049|FG008|Extension Period|Adverse Event|6|||
130254201|NCT03715829|468894050|FG009|Extension Period|Adverse Event|0|||
130254202|NCT03715829|468894051|FG010|Extension Period|Adverse Event|0|||
130254203|NCT03715829|468894041|FG000|Extension Period|Lack of Efficacy|0|||
130254204|NCT03715829|468894042|FG001|Extension Period|Lack of Efficacy|0|||
130254205|NCT03715829|468894043|FG002|Extension Period|Lack of Efficacy|0|||
130254206|NCT03715829|468894044|FG003|Extension Period|Lack of Efficacy|0|||
130254207|NCT03715829|468894045|FG004|Extension Period|Lack of Efficacy|0|||
130254208|NCT03715829|468894046|FG005|Extension Period|Lack of Efficacy|0|||
130254209|NCT03715829|468894047|FG006|Extension Period|Lack of Efficacy|1|||
130254210|NCT03715829|468894048|FG007|Extension Period|Lack of Efficacy|9|||
130254211|NCT03715829|468894049|FG008|Extension Period|Lack of Efficacy|2|||
130254212|NCT03715829|468894050|FG009|Extension Period|Lack of Efficacy|0|||
130254213|NCT03715829|468894051|FG010|Extension Period|Lack of Efficacy|0|||
130254214|NCT03715829|468894041|FG000|Extension Period|Lost to Follow-up|0|||
130254215|NCT03715829|468894042|FG001|Extension Period|Lost to Follow-up|0|||
130254216|NCT03715829|468894043|FG002|Extension Period|Lost to Follow-up|0|||
130254217|NCT03715829|468894044|FG003|Extension Period|Lost to Follow-up|0|||
130254218|NCT03715829|468894045|FG004|Extension Period|Lost to Follow-up|0|||
130254219|NCT03715829|468894046|FG005|Extension Period|Lost to Follow-up|0|||
130254220|NCT03715829|468894047|FG006|Extension Period|Lost to Follow-up|0|||
130254221|NCT03715829|468894048|FG007|Extension Period|Lost to Follow-up|0|||
130254222|NCT03715829|468894049|FG008|Extension Period|Lost to Follow-up|2|||
130254223|NCT03715829|468894050|FG009|Extension Period|Lost to Follow-up|0|||
130254224|NCT03715829|468894051|FG010|Extension Period|Lost to Follow-up|0|||
130254225|NCT03715829|468894041|FG000|Extension Period|Protocol Violation|0|||
130254226|NCT03715829|468894042|FG001|Extension Period|Protocol Violation|0|||
130254227|NCT03715829|468894043|FG002|Extension Period|Protocol Violation|0|||
130254228|NCT03715829|468894044|FG003|Extension Period|Protocol Violation|0|||
130254229|NCT03715829|468894045|FG004|Extension Period|Protocol Violation|0|||
130254230|NCT03715829|468894046|FG005|Extension Period|Protocol Violation|0|||
130254231|NCT03715829|468894047|FG006|Extension Period|Protocol Violation|0|||
130254232|NCT03715829|468894048|FG007|Extension Period|Protocol Violation|0|||
130254233|NCT03715829|468894049|FG008|Extension Period|Protocol Violation|1|||
130254234|NCT03715829|468894050|FG009|Extension Period|Protocol Violation|0|||
130254235|NCT03715829|468894051|FG010|Extension Period|Protocol Violation|0|||
130254236|NCT03715829|468894041|FG000|Extension Period|Withdrawal by Subject|0|||
130254237|NCT03715829|468894042|FG001|Extension Period|Withdrawal by Subject|0|||
130254238|NCT03715829|468894043|FG002|Extension Period|Withdrawal by Subject|0|||
130254239|NCT03715829|468894044|FG003|Extension Period|Withdrawal by Subject|0|||
130254240|NCT03715829|468894045|FG004|Extension Period|Withdrawal by Subject|0|||
130254241|NCT03715829|468894046|FG005|Extension Period|Withdrawal by Subject|0|||
130254242|NCT03715829|468894047|FG006|Extension Period|Withdrawal by Subject|3|||
130254243|NCT03715829|468894048|FG007|Extension Period|Withdrawal by Subject|3|||
130254244|NCT03715829|468894049|FG008|Extension Period|Withdrawal by Subject|12|||
130254245|NCT03715829|468894050|FG009|Extension Period|Withdrawal by Subject|3|||
130254246|NCT03715829|468894051|FG010|Extension Period|Withdrawal by Subject|0|||
130254247|NCT03715829|468894041|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
130365089|NCT02925117|469306858|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
130365090|NCT02925117|469306859|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
130365091|NCT02925117|469306848|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130254248|NCT03715829|468894042|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254249|NCT03715829|468894043|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254250|NCT03715829|468894044|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254251|NCT03715829|468894045|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254252|NCT03715829|468894046|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254253|NCT03715829|468894047|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254254|NCT03715829|468894048|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
130254255|NCT03715829|468894049|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
130254256|NCT03715829|468894050|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254257|NCT03715829|468894051|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254258|NCT03715829|468894041|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254259|NCT03715829|468894042|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254260|NCT03715829|468894043|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254261|NCT03715829|468894044|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254262|NCT03715829|468894045|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254263|NCT03715829|468894046|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254264|NCT03715829|468894047|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254265|NCT03715829|468894048|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254266|NCT03715829|468894049|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
130254267|NCT03715829|468894050|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254268|NCT03715829|468894051|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254269|NCT03715829|468894041|FG000|Extension Period|Other|0|||
130254270|NCT03715829|468894042|FG001|Extension Period|Other|0|||
130254271|NCT03715829|468894043|FG002|Extension Period|Other|0|||
130254272|NCT03715829|468894044|FG003|Extension Period|Other|0|||
130254273|NCT03715829|468894045|FG004|Extension Period|Other|0|||
130254274|NCT03715829|468894046|FG005|Extension Period|Other|0|||
130254275|NCT03715829|468894047|FG006|Extension Period|Other|1|||
130254276|NCT03715829|468894048|FG007|Extension Period|Other|2|||
130254277|NCT03715829|468894049|FG008|Extension Period|Other|4|||
130254278|NCT03715829|468894050|FG009|Extension Period|Other|0|||
130254279|NCT03715829|468894051|FG010|Extension Period|Other|0|||
130254280|NCT03579719|468894052|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
130254281|NCT00855166|468894053|FG000|Overall Study|Adverse Event|0|||
130254282|NCT00855166|468894054|FG001|Overall Study|Adverse Event|2|||
130254283|NCT00855166|468894053|FG000|Overall Study|Death|0|||
130254284|NCT00855166|468894054|FG001|Overall Study|Death|1|||
130254285|NCT00855166|468894053|FG000|Overall Study|Withdrawal by Subject|1|||
130254286|NCT00855166|468894054|FG001|Overall Study|Withdrawal by Subject|4|||
130254287|NCT00855166|468894053|FG000|Overall Study|Poor/non-compliance|2|||
130254288|NCT00855166|468894054|FG001|Overall Study|Poor/non-compliance|0|||
130254289|NCT00855166|468894053|FG000|Overall Study|Administrative reasons by sponsor|1|||
130254290|NCT00855166|468894054|FG001|Overall Study|Administrative reasons by sponsor|0|||
130254291|NCT00855166|468894053|FG000|Overall Study|Subject no longer meets study criteria|1|||
130254292|NCT00855166|468894054|FG001|Overall Study|Subject no longer meets study criteria|1|||
130254293|NCT01422382|468894055|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
130254294|NCT04818229|468894058|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
130254295|NCT04818229|468894059|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
130254296|NCT04818229|468894060|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
130254297|NCT04818229|468894058|FG000|Overall Study|Adverse Event|3|||
130254298|NCT04818229|468894059|FG001|Overall Study|Adverse Event|1|||
130254299|NCT04818229|468894060|FG002|Overall Study|Adverse Event|1|||
130254300|NCT04818229|468894058|FG000|Overall Study|Withdrawal by Subject|0|||
130254301|NCT04818229|468894059|FG001|Overall Study|Withdrawal by Subject|0|||
130254302|NCT04818229|468894060|FG002|Overall Study|Withdrawal by Subject|2|||
130254303|NCT04818229|468894058|FG000|Overall Study|Lost to Follow-up|0|||
130254304|NCT04818229|468894059|FG001|Overall Study|Lost to Follow-up|0|||
130254305|NCT04818229|468894060|FG002|Overall Study|Lost to Follow-up|1|||
130254306|NCT04082364|468894061|FG000|Overall Study|Death|23|||
130254307|NCT04082364|468894062|FG001|Overall Study|Death|1|||
130254308|NCT04082364|468894063|FG002|Overall Study|Death|1|||
130254309|NCT04082364|468894064|FG003|Overall Study|Death|2|||
130254310|NCT04082364|468894065|FG004|Overall Study|Death|1|||
130254311|NCT04082364|468894061|FG000|Overall Study|Lost to Follow-up|1|||
130254312|NCT04082364|468894062|FG001|Overall Study|Lost to Follow-up|0|||
130254313|NCT04082364|468894063|FG002|Overall Study|Lost to Follow-up|0|||
130254314|NCT04082364|468894064|FG003|Overall Study|Lost to Follow-up|0|||
130254315|NCT04082364|468894065|FG004|Overall Study|Lost to Follow-up|1|||
130254316|NCT04082364|468894061|FG000|Overall Study|Physician Decision|1|||
130254317|NCT04082364|468894062|FG001|Overall Study|Physician Decision|1|||
130254318|NCT04082364|468894063|FG002|Overall Study|Physician Decision|0|||
130254319|NCT04082364|468894064|FG003|Overall Study|Physician Decision|2|||
130254320|NCT04082364|468894065|FG004|Overall Study|Physician Decision|1|||
130254321|NCT04082364|468894061|FG000|Overall Study|Withdrawal by Subject|1|||
130254322|NCT04082364|468894062|FG001|Overall Study|Withdrawal by Subject|1|||
130254323|NCT04082364|468894063|FG002|Overall Study|Withdrawal by Subject|0|||
130254324|NCT04082364|468894064|FG003|Overall Study|Withdrawal by Subject|0|||
130254325|NCT04082364|468894065|FG004|Overall Study|Withdrawal by Subject|1|||
130254326|NCT04082364|468894061|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
130254327|NCT04082364|468894062|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
130700688|NCT04773600|470526516|FG001|Overall Study|Withdrawal by Subject|9|||
130254328|NCT04082364|468894063|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
130254329|NCT04082364|468894064|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
130254330|NCT04082364|468894065|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
130254331|NCT04082364|468894061|FG000|Overall Study|Disease progression|0|||
130254332|NCT04082364|468894062|FG001|Overall Study|Disease progression|0|||
130254333|NCT04082364|468894063|FG002|Overall Study|Disease progression|0|||
130254334|NCT04082364|468894064|FG003|Overall Study|Disease progression|1|||
130254335|NCT04082364|468894065|FG004|Overall Study|Disease progression|0|||
130254336|NCT03186378|468894066|FG000|Overall Study|Lost to Follow-up|1|||
130254337|NCT03186378|468894067|FG001|Overall Study|Lost to Follow-up|0|||
130254338|NCT02181413|468894068|FG000|Overall Study|Withdrawal by Subject|45|||
130254339|NCT02181413|468894069|FG001|Overall Study|Withdrawal by Subject|61|||
130254340|NCT02181413|468894068|FG000|Overall Study|Reason Not Specified|2|||
130254341|NCT02181413|468894069|FG001|Overall Study|Reason Not Specified|5|||
130254342|NCT02181413|468894068|FG000|Overall Study|Lost to Follow-up|8|||
130254343|NCT02181413|468894069|FG001|Overall Study|Lost to Follow-up|7|||
130254344|NCT02514746|468894070|FG000|Overall Study|Chronically Ill|1|||
130254345|NCT02514746|468894071|FG001|Overall Study|Chronically Ill|2|||
130254346|NCT02514746|468894070|FG000|Overall Study|Physician Decision|4|||
130254347|NCT02514746|468894071|FG001|Overall Study|Physician Decision|2|||
130254348|NCT02514746|468894070|FG000|Overall Study|Withdrawal by Subject|12|||
130254349|NCT02514746|468894071|FG001|Overall Study|Withdrawal by Subject|10|||
130254350|NCT02514746|468894070|FG000|Overall Study|Other|5|||
130254351|NCT02514746|468894071|FG001|Overall Study|Other|1|||
130254352|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130254353|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254354|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254355|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254356|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130254357|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254358|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254359|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254360|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254361|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254362|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254363|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130254364|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130254365|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254366|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254367|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254368|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254369|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254370|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254371|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254372|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
130254373|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254374|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
130254375|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254376|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130254377|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254378|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254379|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130254380|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254381|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254382|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254383|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254384|NCT03973489|468894080|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130254385|NCT03973489|468894081|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130254386|NCT03973489|468894082|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130254387|NCT03973489|468894083|FG003|Second Intervention (1 Day)|Adverse Event|1|||
130254388|NCT03973489|468894084|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130254389|NCT03973489|468894085|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130254390|NCT03973489|468894086|FG006|Second Intervention (1 Day)|Adverse Event|0|||
130254391|NCT03973489|468894087|FG007|Second Intervention (1 Day)|Adverse Event|0|||
130553491|NCT01777269|469993580|FG001|Overall Study|Lost to Follow-up|0|||
130553492|NCT01777269|469993579|FG000|Overall Study|Physician Decision|5|||
130700689|NCT04773600|470526515|FG000|Overall Study|Lost to Follow-up|10|||
130700690|NCT04773600|470526516|FG001|Overall Study|Lost to Follow-up|6|||
130700691|NCT04773600|470526515|FG000|Overall Study|Adverse Event|8|||
130700692|NCT04773600|470526516|FG001|Overall Study|Adverse Event|2|||
130553493|NCT01777269|469993580|FG001|Overall Study|Physician Decision|2|||
130553494|NCT01777269|469993579|FG000|Overall Study|Withdrawal by Subject|9|||
130254392|NCT03301415|468894088|FG000|Overall Study|Lost to Follow-up|2|||
130254393|NCT03301415|468894088|FG000|Overall Study|Unable to comply with visit schedule|2|||
130254394|NCT03247673|468894089|FG000|Overall Study|Withdrawal by Subject|1|||
130254395|NCT03247673|468894090|FG001|Overall Study|Withdrawal by Subject|0|||
130254396|NCT03247673|468894091|FG002|Overall Study|Withdrawal by Subject|3|||
130254397|NCT03247673|468894089|FG000|Overall Study|Lost to Follow-up|0|||
130254398|NCT03247673|468894090|FG001|Overall Study|Lost to Follow-up|0|||
130254399|NCT03247673|468894091|FG002|Overall Study|Lost to Follow-up|1|||
130254400|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
130254401|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254402|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254403|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254404|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254405|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
130254406|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254407|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254408|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254409|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254410|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
130254411|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254412|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254413|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254414|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254415|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
130254416|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254417|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254418|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254419|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254420|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
130254421|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254422|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254423|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254424|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254425|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
130254426|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254427|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254428|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254429|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254430|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
130254431|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254432|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254433|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254434|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254435|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
130254436|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254437|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254438|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254439|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254440|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254441|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254442|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254443|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
130254444|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254445|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130254446|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130254447|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
130254448|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130254449|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130254450|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254451|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
130553495|NCT01777269|469993580|FG001|Overall Study|Withdrawal by Subject|9|||
130553496|NCT01966471|469993582|FG000|Overall Study|Death|44|||
130254452|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254453|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254454|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254455|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254456|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
130254457|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254458|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254459|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254460|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254461|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
130254462|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254463|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254464|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254465|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254466|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254467|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
130254468|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254469|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254470|NCT04129398|468895746|FG000|Overall Study|Physician Decision|2|||
130254471|NCT02363283|468895751|FG000|Overall Study|Withdrawal by Subject|1|||
130254472|NCT02363283|468895751|FG000|Overall Study|Not eligible due to transaminitis|1|||
130254473|NCT00003907|468895761|FG000|Overall Study|Adverse Event|2|||
130254474|NCT00003907|468895762|FG001|Overall Study|Adverse Event|11|||
130254475|NCT00003907|468895761|FG000|Overall Study|Death|2|||
130254476|NCT00003907|468895762|FG001|Overall Study|Death|0|||
130254477|NCT00003907|468895761|FG000|Overall Study|Withdrawal by Subject|1|||
130254478|NCT00003907|468895762|FG001|Overall Study|Withdrawal by Subject|3|||
130254479|NCT00003907|468895761|FG000|Overall Study|Progressive disease|4|||
130254480|NCT00003907|468895762|FG001|Overall Study|Progressive disease|4|||
130254481|NCT00003907|468895761|FG000|Overall Study|Complicating disease|1|||
130254482|NCT00003907|468895762|FG001|Overall Study|Complicating disease|0|||
130254483|NCT00003907|468895761|FG000|Overall Study|Other|1|||
130254484|NCT00003907|468895762|FG001|Overall Study|Other|3|||
130254485|NCT00003907|468895761|FG000|Overall Study|ineligible or not treated|2|||
130254486|NCT00003907|468895762|FG001|Overall Study|ineligible or not treated|2|||
130254487|NCT01517178|468895763|FG000|Period 1|Adverse Event|1|||
130254488|NCT01517178|468895764|FG001|Period 1|Adverse Event|2|||
130254489|NCT01517178|468895763|FG000|Period 1|Lack of Efficacy|0|||
130254490|NCT01517178|468895764|FG001|Period 1|Lack of Efficacy|1|||
130254491|NCT01517178|468895763|FG000|Period 1|E.g. study termination|3|||
130254492|NCT01517178|468895764|FG001|Period 1|E.g. study termination|1|||
130254493|NCT01517178|468895763|FG000|Period 1|Withdrawal by Subject|0|||
130254494|NCT01517178|468895764|FG001|Period 1|Withdrawal by Subject|1|||
130254495|NCT01517178|468895763|FG000|Period 2|Adverse Event|1|||
130254496|NCT01517178|468895764|FG001|Period 2|Adverse Event|0|||
130254497|NCT01517178|468895763|FG000|Period 2|Withdrawal by Subject|3|||
130254498|NCT01517178|468895764|FG001|Period 2|Withdrawal by Subject|0|||
130254499|NCT01517178|468895763|FG000|Period 2|E.g. study termination|2|||
130254500|NCT01517178|468895764|FG001|Period 2|E.g. study termination|2|||
130254501|NCT01557569|468895767|FG000|Overall Study|Adverse Event|2|||
130254502|NCT01557569|468895768|FG001|Overall Study|Adverse Event|0|||
130700693|NCT04773600|470526515|FG000|Overall Study|Lack of Efficacy|2|||
130700694|NCT04773600|470526516|FG001|Overall Study|Lack of Efficacy|3|||
130700695|NCT04773600|470526515|FG000|Overall Study|Noncompliance|2|||
130254503|NCT01557569|468895767|FG000|Overall Study|high blood pressure|0|||
130254504|NCT01557569|468895768|FG001|Overall Study|high blood pressure|1|||
130254505|NCT01557569|468895767|FG000|Overall Study|Withdrawal by Subject|3|||
130254506|NCT01557569|468895768|FG001|Overall Study|Withdrawal by Subject|5|||
130254507|NCT01557569|468895767|FG000|Overall Study|noncompliance with rules of residential|0|||
130254508|NCT01557569|468895768|FG001|Overall Study|noncompliance with rules of residential|1|||
130254509|NCT04691115|468895774|FG000|Overall Study|Withdrawal by Subject|0|||
130254510|NCT04691115|468895775|FG001|Overall Study|Withdrawal by Subject|0|||
130254511|NCT04691115|468895776|FG002|Overall Study|Withdrawal by Subject|0|||
130254512|NCT04691115|468895777|FG003|Overall Study|Withdrawal by Subject|0|||
130254513|NCT04691115|468895778|FG004|Overall Study|Withdrawal by Subject|0|||
130254514|NCT04691115|468895779|FG005|Overall Study|Withdrawal by Subject|1|||
130254515|NCT04691115|468895780|FG006|Overall Study|Withdrawal by Subject|0|||
130254516|NCT04691115|468895781|FG007|Overall Study|Withdrawal by Subject|0|||
130254517|NCT04691115|468895782|FG008|Overall Study|Withdrawal by Subject|0|||
130254518|NCT04691115|468895783|FG009|Overall Study|Withdrawal by Subject|0|||
130254519|NCT04691115|468895784|FG010|Overall Study|Withdrawal by Subject|0|||
130254520|NCT04691115|468895785|FG011|Overall Study|Withdrawal by Subject|0|||
130254521|NCT04691115|468895786|FG012|Overall Study|Withdrawal by Subject|0|||
130700696|NCT04773600|470526516|FG001|Overall Study|Noncompliance|0|||
130254522|NCT04691115|468895787|FG013|Overall Study|Withdrawal by Subject|0|||
130254523|NCT04661839|468895792|FG000|Overall Study|Not Treated|0|||
130254524|NCT04661839|468895793|FG001|Overall Study|Not Treated|0|||
130254525|NCT04661839|468895794|FG002|Overall Study|Not Treated|1|||
130254526|NCT04661839|468895795|FG003|Overall Study|Not Treated|0|||
130254527|NCT04661839|468895792|FG000|Overall Study|Lost to Follow-up|1|||
130254528|NCT04661839|468895793|FG001|Overall Study|Lost to Follow-up|0|||
130254529|NCT04661839|468895794|FG002|Overall Study|Lost to Follow-up|0|||
130254530|NCT04661839|468895795|FG003|Overall Study|Lost to Follow-up|1|||
130254531|NCT03647137|468895796|FG000|Overall Study|Scan Limitation|2|||
130254532|NCT03647137|468895797|FG001|Overall Study|Scan Limitation|1|||
130254533|NCT03647137|468895798|FG002|Overall Study|Scan Limitation|1|||
130254534|NCT03647137|468895799|FG003|Overall Study|Scan Limitation|2|||
130254535|NCT03253627|468895802|FG000|Overall Study|Lost to Follow-up|1|||
130254536|NCT03253627|468895803|FG001|Overall Study|Lost to Follow-up|2|||
130254537|NCT03253627|468895802|FG000|Overall Study|Withdrawal by Subject|0|||
130254538|NCT03253627|468895803|FG001|Overall Study|Withdrawal by Subject|2|||
130254539|NCT03253627|468895802|FG000|Overall Study|Inability to complete MRI|1|||
130254540|NCT03253627|468895803|FG001|Overall Study|Inability to complete MRI|0|||
130254541|NCT03829683|468895806|FG000|Overall Study|Lost to Follow-up|1|||
130254542|NCT03829683|468895807|FG001|Overall Study|Lost to Follow-up|0|||
130254543|NCT03829683|468895806|FG000|Overall Study|Physician Decision|3|||
130254544|NCT03829683|468895807|FG001|Overall Study|Physician Decision|1|||
130254545|NCT03829683|468895806|FG000|Overall Study|Withdrawal by Subject|0|||
130254546|NCT03829683|468895807|FG001|Overall Study|Withdrawal by Subject|1|||
130254547|NCT03829683|468895806|FG000|Overall Study|Discharge from hospital|1|||
130254548|NCT03829683|468895807|FG001|Overall Study|Discharge from hospital|0|||
130254549|NCT01922895|468895811|FG000|Overall Study|Death|0|||
130254550|NCT01922895|468895812|FG001|Overall Study|Death|1|||
130254551|NCT01922895|468895811|FG000|Overall Study|Withdrawal by Subject|1|||
130254552|NCT01922895|468895812|FG001|Overall Study|Withdrawal by Subject|2|||
130254553|NCT01922895|468895811|FG000|Overall Study|Lost to Follow-up|5|||
130254554|NCT01922895|468895812|FG001|Overall Study|Lost to Follow-up|11|||
130254555|NCT01916226|468895813|FG000|Overall Study|Adverse Event|1|||
130254556|NCT01916226|468895814|FG001|Overall Study|Adverse Event|0|||
130254557|NCT01916226|468895815|FG002|Overall Study|Adverse Event|1|||
130254558|NCT01916226|468895816|FG003|Overall Study|Adverse Event|1|||
130254559|NCT01916226|468895813|FG000|Overall Study|Lack of Efficacy|0|||
130254560|NCT01916226|468895814|FG001|Overall Study|Lack of Efficacy|0|||
130254561|NCT01916226|468895815|FG002|Overall Study|Lack of Efficacy|2|||
130254562|NCT01916226|468895816|FG003|Overall Study|Lack of Efficacy|1|||
130254563|NCT01916226|468895813|FG000|Overall Study|Protocol Violation|0|||
130254564|NCT01916226|468895814|FG001|Overall Study|Protocol Violation|1|||
130254565|NCT01916226|468895815|FG002|Overall Study|Protocol Violation|0|||
130254566|NCT01916226|468895816|FG003|Overall Study|Protocol Violation|1|||
130254567|NCT01916226|468895813|FG000|Overall Study|Physician Decision|0|||
130254568|NCT01916226|468895814|FG001|Overall Study|Physician Decision|0|||
130254569|NCT01916226|468895815|FG002|Overall Study|Physician Decision|0|||
130254570|NCT01916226|468895816|FG003|Overall Study|Physician Decision|1|||
130254571|NCT03163667|468895817|FG000|Overall Study|Death|15|||
130254572|NCT03163667|468895818|FG001|Overall Study|Death|27|||
130254573|NCT03163667|468895817|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
130254574|NCT03163667|468895818|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
130254575|NCT05430919|468895819|FG000|Overall Study|Protocol Violation|0|||
130254576|NCT05430919|468895820|FG001|Overall Study|Protocol Violation|0|||
130254577|NCT05430919|468895821|FG002|Overall Study|Protocol Violation|1|||
130254578|NCT05430919|468895822|FG003|Overall Study|Protocol Violation|0|||
130254579|NCT05430919|468895819|FG000|Overall Study|Lost to Follow-up|0|||
130254580|NCT05430919|468895820|FG001|Overall Study|Lost to Follow-up|1|||
130254581|NCT05430919|468895821|FG002|Overall Study|Lost to Follow-up|0|||
130700697|NCT04773600|470526515|FG000|Overall Study|Protocol Violation|2|||
130254582|NCT05430919|468895822|FG003|Overall Study|Lost to Follow-up|0|||
130254583|NCT05430919|468895819|FG000|Overall Study|Withdrawal by Subject|3|||
130254584|NCT05430919|468895820|FG001|Overall Study|Withdrawal by Subject|0|||
130700698|NCT04773600|470526516|FG001|Overall Study|Protocol Violation|0|||
130254585|NCT05430919|468895821|FG002|Overall Study|Withdrawal by Subject|0|||
130254586|NCT05430919|468895822|FG003|Overall Study|Withdrawal by Subject|1|||
130254587|NCT01848457|468895825|FG000|Overall Study|Death|1|||
130700699|NCT04773600|470526515|FG000|Overall Study|Physician Decision|0|||
130254588|NCT01848457|468895826|FG001|Overall Study|Death|0|||
130254589|NCT01848457|468895827|FG002|Overall Study|Death|0|||
130254590|NCT01848457|468895828|FG003|Overall Study|Death|0|||
130254591|NCT02940223|468895831|FG000|Overall Study|Failed Requirement|2|||
130254592|NCT02940223|468895832|FG001|Overall Study|Failed Requirement|0|||
130254593|NCT01813357|468895835|FG000|Overall Study|Lost to Follow-up|5|||
130254594|NCT01813357|468895836|FG001|Overall Study|Lost to Follow-up|6|||
130254595|NCT03773562|468895837|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
130254596|NCT03773562|468895837|FG000|Overall Study|Lost to Follow-up|10|||
130254597|NCT03773562|468895837|FG000|Overall Study|Withdrawal by Subject|1|||
130254598|NCT03131479|468895838|FG000|Overall Study|Adverse Event|0|||
130254599|NCT03131479|468895839|FG001|Overall Study|Adverse Event|0|||
130254600|NCT03131479|468895840|FG002|Overall Study|Adverse Event|1|||
130254601|NCT03131479|468895841|FG003|Overall Study|Adverse Event|1|||
130254602|NCT03131479|468895842|FG004|Overall Study|Adverse Event|0|||
130254603|NCT03131479|468895838|FG000|Overall Study|Subject/Guardian Decision|0|||
130254604|NCT03131479|468895839|FG001|Overall Study|Subject/Guardian Decision|0|||
130254605|NCT03131479|468895840|FG002|Overall Study|Subject/Guardian Decision|0|||
130254606|NCT03131479|468895841|FG003|Overall Study|Subject/Guardian Decision|1|||
130254607|NCT03131479|468895842|FG004|Overall Study|Subject/Guardian Decision|0|||
130254608|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
130254609|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
130254610|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
130254611|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
130254612|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
130254613|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
130254614|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
130254615|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130254616|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130254617|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
130254618|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
130254619|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
130254620|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
130254621|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130254622|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130254623|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
130254624|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
130254625|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
130254626|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
130254627|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130254628|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130254629|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
130254630|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
130254631|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
130254632|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
130254633|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
130254634|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
130254635|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
130254636|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
130254637|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
130254638|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254639|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130254640|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130254641|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
130254642|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254643|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254644|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254645|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254646|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254647|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
130254648|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254649|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254650|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254651|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
130254652|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254653|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
130254654|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254655|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254656|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254657|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
130254658|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
130254659|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
130254660|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254661|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254662|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254663|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
130254664|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130254665|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130254666|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254667|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254668|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254669|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254670|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254671|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254672|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
130254673|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
130254674|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254675|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254676|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254677|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254678|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
130254679|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
130254680|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254681|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254682|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254683|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254684|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
130254685|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
130254686|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254687|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254688|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254689|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254690|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
130254691|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
130254692|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
130254693|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
130254694|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
130254695|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
130254696|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
130254697|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
130254698|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
130254699|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
130254700|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
130254701|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
130254702|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
130254703|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
130254704|NCT00050011|468895850|FG000|Overall Study|Adverse Event|41|||
130254705|NCT00050011|468895851|FG001|Overall Study|Adverse Event|46|||
130254706|NCT00050011|468895850|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130254707|NCT00050011|468895851|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130254708|NCT00050011|468895850|FG000|Overall Study|Abnormal test procedure results|0|||
130254709|NCT00050011|468895851|FG001|Overall Study|Abnormal test procedure results|1|||
130254710|NCT00050011|468895850|FG000|Overall Study|Lack of Efficacy|16|||
130254711|NCT00050011|468895851|FG001|Overall Study|Lack of Efficacy|21|||
130254712|NCT00050011|468895850|FG000|Overall Study|Participant condition no longer required|1|||
130254713|NCT00050011|468895851|FG001|Overall Study|Participant condition no longer required|0|||
130254714|NCT00050011|468895850|FG000|Overall Study|Protocol Violation|4|||
130254715|NCT00050011|468895851|FG001|Overall Study|Protocol Violation|10|||
130254716|NCT00050011|468895850|FG000|Overall Study|Withdrawal by Subject|34|||
130254717|NCT00050011|468895851|FG001|Overall Study|Withdrawal by Subject|26|||
130254718|NCT00050011|468895850|FG000|Overall Study|Lost to Follow-up|7|||
130254719|NCT00050011|468895851|FG001|Overall Study|Lost to Follow-up|9|||
130254720|NCT00050011|468895850|FG000|Overall Study|Administrative problems|10|||
130254721|NCT00050011|468895851|FG001|Overall Study|Administrative problems|6|||
130254722|NCT00050011|468895850|FG000|Overall Study|Death|7|||
130254723|NCT00050011|468895851|FG001|Overall Study|Death|4|||
130254724|NCT00050011|468895850|FG000|Overall Study|Unknown - Reason is missing|0|||
130254725|NCT00050011|468895851|FG001|Overall Study|Unknown - Reason is missing|2|||
130254726|NCT04806373|468895852|FG000|Overall Study|Withdrawal by Subject|1|||
130254727|NCT04806373|468895853|FG001|Overall Study|Withdrawal by Subject|1|||
130254728|NCT05810597|468895854|FG000|Period 1|Adverse Event|2|||
130254729|NCT05810597|468895855|FG001|Period 1|Adverse Event|0|||
130254730|NCT05810597|468895854|FG000|Period 1|Physician Decision|1|||
130254731|NCT05810597|468895855|FG001|Period 1|Physician Decision|0|||
130254732|NCT05021224|468895860|FG000|Overall Study|Did not complete all survey items|4|||
130254733|NCT05021224|468895861|FG001|Overall Study|Did not complete all survey items|1|||
130254734|NCT05021224|468895862|FG002|Overall Study|Did not complete all survey items|0|||
130254735|NCT05021224|468895863|FG003|Overall Study|Did not complete all survey items|2|||
130254736|NCT02061085|468895864|FG000|Overall Study|Adverse Event|8|||
130254737|NCT04903093|468895869|FG000|Overall Study|Withdrawal by Subject|0|||
130700700|NCT04773600|470526516|FG001|Overall Study|Physician Decision|1|||
130700701|NCT04773600|470526515|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
130700702|NCT04773600|470526516|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
130700703|NCT04773600|470526515|FG000|Overall Study|Emergency Travel Out of Country|1|||
130700704|NCT04773600|470526516|FG001|Overall Study|Emergency Travel Out of Country|0|||
130700705|NCT00500318|470528239|FG000|Overall Study|Adverse Event|3|||
130700706|NCT00500318|470528240|FG001|Overall Study|Adverse Event|8|||
130700707|NCT00500318|470528239|FG000|Overall Study|Protocol Violation|1|||
130700708|NCT00500318|470528240|FG001|Overall Study|Protocol Violation|3|||
130700709|NCT00500318|470528239|FG000|Overall Study|Withdrawal by Subject|1|||
130700710|NCT00500318|470528240|FG001|Overall Study|Withdrawal by Subject|2|||
130700711|NCT00500318|470528239|FG000|Overall Study|Lack of Efficacy|0|||
130700712|NCT00500318|470528240|FG001|Overall Study|Lack of Efficacy|3|||
130700713|NCT00500318|470528239|FG000|Overall Study|Other Reason|0|||
130700714|NCT00500318|470528240|FG001|Overall Study|Other Reason|1|||
130700715|NCT03243396|470528243|FG000|Overall Study|Lost to Follow-up|2|||
130700716|NCT03243396|470528244|FG001|Overall Study|Lost to Follow-up|3|||
130700717|NCT03243396|470528245|FG002|Overall Study|Lost to Follow-up|15|||
130700718|NCT03243396|470528246|FG003|Overall Study|Lost to Follow-up|8|||
130700719|NCT03243396|470528247|FG004|Overall Study|Lost to Follow-up|1|||
130700720|NCT03243396|470528248|FG005|Overall Study|Lost to Follow-up|4|||
130700721|NCT03243396|470528249|FG006|Overall Study|Lost to Follow-up|9|||
130700722|NCT03687242|470528250|FG000|Overall Study|Adverse Event|1|||
130700723|NCT02655224|470528251|FG000|Overall Study|Adverse Event|1|||
130700724|NCT02655224|470528252|FG001|Overall Study|Adverse Event|1|||
130700725|NCT01257581|470528253|FG000|Overall Study|Early Termination|3|||
130700726|NCT01257581|470528254|FG001|Overall Study|Early Termination|1|||
130700727|NCT01257581|470528255|FG002|Overall Study|Early Termination|2|||
130700728|NCT01257581|470528253|FG000|Overall Study|Death|2|||
130700729|NCT01257581|470528254|FG001|Overall Study|Death|2|||
130700730|NCT01257581|470528255|FG002|Overall Study|Death|4|||
130700731|NCT02104817|470528259|FG000|Overall Study|Death|363|||
130700732|NCT02104817|470528260|FG001|Overall Study|Death|330|||
130700733|NCT02104817|470528259|FG000|Overall Study|Lost to Follow-up|3|||
130700734|NCT02104817|470528260|FG001|Overall Study|Lost to Follow-up|2|||
130700735|NCT02104817|470528259|FG000|Overall Study|Protocol Violation|0|||
130700736|NCT02104817|470528260|FG001|Overall Study|Protocol Violation|1|||
130700737|NCT02104817|470528259|FG000|Overall Study|Study terminated by sponsor|5854|||
130700738|NCT02104817|470528260|FG001|Overall Study|Study terminated by sponsor|5901|||
130700739|NCT02104817|470528259|FG000|Overall Study|Withdrawal by Subject|111|||
130700740|NCT02104817|470528260|FG001|Overall Study|Withdrawal by Subject|78|||
130700741|NCT02104817|470528259|FG000|Overall Study|Other reasons|128|||
130700742|NCT02104817|470528260|FG001|Overall Study|Other reasons|135|||
130700743|NCT02575339|470528264|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130700744|NCT02575339|470528265|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130700745|NCT02575339|470528266|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130700746|NCT02575339|470528264|FG000|Study Treatment|Disease Progression|5|||
130700747|NCT02575339|470528265|FG001|Study Treatment|Disease Progression|2|||
130700748|NCT02575339|470528266|FG002|Study Treatment|Disease Progression|0|||
130700749|NCT02575339|470528264|FG000|Study Treatment|Adverse Event|1|||
130700750|NCT02575339|470528265|FG001|Study Treatment|Adverse Event|2|||
130700751|NCT02575339|470528266|FG002|Study Treatment|Adverse Event|0|||
130700752|NCT02575339|470528264|FG000|Follow up|Death|6|||
130700753|NCT02575339|470528265|FG001|Follow up|Death|2|||
130700754|NCT02575339|470528266|FG002|Follow up|Death|0|||
130700755|NCT02575339|470528264|FG000|Follow up|Study Terminated|0|||
130700756|NCT02575339|470528265|FG001|Follow up|Study Terminated|2|||
130700757|NCT02575339|470528266|FG002|Follow up|Study Terminated|0|||
130700758|NCT02575339|470528264|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
130700759|NCT02575339|470528265|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
130254738|NCT04903093|468895870|FG001|Overall Study|Withdrawal by Subject|0|||
130254739|NCT04903093|468895871|FG002|Overall Study|Withdrawal by Subject|0|||
130254740|NCT04903093|468895872|FG003|Overall Study|Withdrawal by Subject|1|||
130254741|NCT04903093|468895873|FG004|Overall Study|Withdrawal by Subject|0|||
130700760|NCT02575339|470528266|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
130700761|NCT04633642|470528267|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
130700762|NCT04633642|470528268|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
130254742|NCT04903093|468895874|FG005|Overall Study|Withdrawal by Subject|0|||
130254743|NCT02412436|468895875|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
130700763|NCT03223909|470528269|FG000|Overall Study|Protocol Violation|48|||
130700764|NCT03223909|470528270|FG001|Overall Study|Protocol Violation|45|||
130700765|NCT03223909|470528271|FG002|Overall Study|Protocol Violation|16|||
130700766|NCT01628549|470528272|FG000|Overall Study|Adverse Event|1|||
130700767|NCT01628549|470528273|FG001|Overall Study|Adverse Event|1|||
130700768|NCT01628549|470528274|FG002|Overall Study|Adverse Event|0|||
130700769|NCT01628549|470528275|FG003|Overall Study|Adverse Event|4|||
130254744|NCT02412436|468895875|FG000|Overall Study|Lost to Follow-up|6|||
130254745|NCT02412436|468895875|FG000|Overall Study|Unable to get to clinic|3|||
130254746|NCT02412436|468895875|FG000|Overall Study|Death|1|||
130254747|NCT02412436|468895875|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
130254748|NCT04090749|468895881|FG000|Open Label Pilot|Lost to Follow-up|1|||
130254749|NCT04090749|468895882|FG001|Open Label Pilot|Lost to Follow-up|0|||
130254750|NCT04090749|468895883|FG002|Open Label Pilot|Lost to Follow-up|0|||
130254751|NCT04090749|468895881|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130700770|NCT01628549|470528272|FG000|Overall Study|Lost to Follow-up|3|||
130254752|NCT04090749|468895882|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
130254753|NCT04090749|468895883|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130254754|NCT04090749|468895881|FG000|Pilot Trial|Lost to Follow-up|0|||
130254755|NCT04090749|468895882|FG001|Pilot Trial|Lost to Follow-up|1|||
130254756|NCT04090749|468895883|FG002|Pilot Trial|Lost to Follow-up|1|||
130254757|NCT02184442|468895884|FG000|Overall Study|Death|61|||
130254758|NCT02184442|468895885|FG001|Overall Study|Death|65|||
130254759|NCT02184442|468895884|FG000|Overall Study|Withdrawal by Subject|3|||
130254760|NCT02184442|468895885|FG001|Overall Study|Withdrawal by Subject|11|||
130254761|NCT01852214|468895886|FG000|Period 1|Adverse Event|1|||
130254762|NCT01852214|468895887|FG001|Period 1|Adverse Event|2|||
130254763|NCT01852214|468895886|FG000|Period 1|Withdrawal by Subject|0|||
130254764|NCT01852214|468895887|FG001|Period 1|Withdrawal by Subject|1|||
130254765|NCT01852214|468895886|FG000|Washout Period|Withdrawal by Subject|0|||
130254766|NCT01852214|468895887|FG001|Washout Period|Withdrawal by Subject|1|||
130254767|NCT04091438|468895888|FG000|Treatment Period 1 (1 Day)|Other|1|||
130254768|NCT04091438|468895889|FG001|Treatment Period 1 (1 Day)|Other|0|||
130254769|NCT04091438|468895888|FG000|Washout Period (1 Day)|Protocol deviation|0|||
130254770|NCT04091438|468895889|FG001|Washout Period (1 Day)|Protocol deviation|1|||
130254771|NCT04091438|468895888|FG000|Washout Period (1 Day)|Other|0|||
130254772|NCT04091438|468895889|FG001|Washout Period (1 Day)|Other|1|||
130254773|NCT00421408|468895890|FG000|Overall Study|Lost to Follow-up|30|||
130254774|NCT00421408|468895891|FG001|Overall Study|Lost to Follow-up|20|||
130254775|NCT00421408|468895890|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
130254776|NCT00421408|468895891|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
130254777|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130254778|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130254779|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130254780|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130254781|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130254782|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130254783|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Other|2|||
130254784|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Other|1|||
130254785|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Other|1|||
130254786|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130254787|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130254788|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
130254789|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130254790|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130254791|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130254792|NCT03249558|468895903|FG000|Overall Study|Lost to Follow-up|2|||
130254793|NCT03249558|468895904|FG001|Overall Study|Lost to Follow-up|1|||
130254794|NCT03249558|468895905|FG002|Overall Study|Lost to Follow-up|4|||
130254795|NCT03249558|468895903|FG000|Overall Study|Physician Decision|1|||
130254796|NCT03249558|468895904|FG001|Overall Study|Physician Decision|0|||
130254797|NCT03249558|468895905|FG002|Overall Study|Physician Decision|0|||
130254798|NCT03249558|468895903|FG000|Overall Study|Withdrawal by Subject|6|||
130254799|NCT03249558|468895904|FG001|Overall Study|Withdrawal by Subject|5|||
130254800|NCT03249558|468895905|FG002|Overall Study|Withdrawal by Subject|7|||
130254801|NCT03249558|468895903|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
130254802|NCT03249558|468895904|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
130254803|NCT03249558|468895905|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
130254804|NCT03249558|468895903|FG000|Overall Study|Protocol Violation|1|||
130254805|NCT03249558|468895904|FG001|Overall Study|Protocol Violation|1|||
130254806|NCT03249558|468895905|FG002|Overall Study|Protocol Violation|2|||
130254807|NCT02613507|468895907|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
130700771|NCT01628549|470528273|FG001|Overall Study|Lost to Follow-up|4|||
130254808|NCT02613507|468895908|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
130254809|NCT02613507|468895907|FG000|Pre-Treamtent|Participant withdrew consent|0|||
130254810|NCT02613507|468895908|FG001|Pre-Treamtent|Participant withdrew consent|4|||
130365092|NCT02925117|469306849|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130700772|NCT01628549|470528274|FG002|Overall Study|Lost to Follow-up|3|||
130700773|NCT01628549|470528275|FG003|Overall Study|Lost to Follow-up|3|||
130254811|NCT02613507|468895907|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
130254812|NCT02613507|468895908|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
130254813|NCT02613507|468895907|FG000|Treatment|Not reported|3|||
130254814|NCT02613507|468895908|FG001|Treatment|Not reported|0|||
130254815|NCT02613507|468895907|FG000|Treatment|Other reasons|8|||
130254816|NCT02613507|468895908|FG001|Treatment|Other reasons|0|||
130254817|NCT02613507|468895907|FG000|Treatment|Participant no longer meets criteria|3|||
130254818|NCT02613507|468895908|FG001|Treatment|Participant no longer meets criteria|0|||
130254819|NCT02613507|468895907|FG000|Treatment|Maximum clinical benefit|5|||
130254820|NCT02613507|468895908|FG001|Treatment|Maximum clinical benefit|10|||
130254821|NCT02613507|468895907|FG000|Treatment|Lost to Follow-up|1|||
130254822|NCT02613507|468895908|FG001|Treatment|Lost to Follow-up|0|||
130254823|NCT02613507|468895907|FG000|Treatment|Participant withdrew consent|0|||
130254824|NCT02613507|468895908|FG001|Treatment|Participant withdrew consent|2|||
130254825|NCT02613507|468895907|FG000|Treatment|Participant request to discontinue study treatment|13|||
130254826|NCT02613507|468895908|FG001|Treatment|Participant request to discontinue study treatment|17|||
130254827|NCT02613507|468895907|FG000|Treatment|Adverse event unrelated to study drug|20|||
130254828|NCT02613507|468895908|FG001|Treatment|Adverse event unrelated to study drug|3|||
130254829|NCT02613507|468895907|FG000|Treatment|Death|2|||
130254830|NCT02613507|468895908|FG001|Treatment|Death|0|||
130254831|NCT02613507|468895907|FG000|Treatment|Study drug toxicity|19|||
130254832|NCT02613507|468895908|FG001|Treatment|Study drug toxicity|14|||
130254833|NCT02613507|468895907|FG000|Treatment|Disease progression|263|||
130254834|NCT02613507|468895908|FG001|Treatment|Disease progression|110|||
130254835|NCT03941093|468895909|FG000|Overall Study|Protocol Violation|0|||
130254836|NCT03941093|468895910|FG001|Overall Study|Protocol Violation|1|||
130254837|NCT03941093|468895909|FG000|Overall Study|Withdrawal by Subject|9|||
130254838|NCT03941093|468895910|FG001|Overall Study|Withdrawal by Subject|6|||
130254839|NCT00561821|468895914|FG000|Overall Study|Not treated|0|||
130254840|NCT00561821|468895915|FG001|Overall Study|Not treated|0|||
130254841|NCT00561821|468895916|FG002|Overall Study|Not treated|1|||
130254842|NCT00561821|468895917|FG003|Overall Study|Not treated|0|||
130254843|NCT00561821|468895914|FG000|Overall Study|Withdrawal by Subject|0|||
130254844|NCT00561821|468895915|FG001|Overall Study|Withdrawal by Subject|1|||
130254845|NCT00561821|468895916|FG002|Overall Study|Withdrawal by Subject|0|||
130254846|NCT00561821|468895917|FG003|Overall Study|Withdrawal by Subject|2|||
130254847|NCT00561821|468895914|FG000|Overall Study|Reasons not related to trial|2|||
130254848|NCT00561821|468895915|FG001|Overall Study|Reasons not related to trial|1|||
130254849|NCT00561821|468895916|FG002|Overall Study|Reasons not related to trial|0|||
130254850|NCT00561821|468895917|FG003|Overall Study|Reasons not related to trial|0|||
130254851|NCT00561821|468895914|FG000|Overall Study|Other (reason not specified)|1|||
130254852|NCT00561821|468895915|FG001|Overall Study|Other (reason not specified)|1|||
130700774|NCT01628549|470528272|FG000|Overall Study|Withdrawal by Subject|3|||
130700775|NCT01628549|470528273|FG001|Overall Study|Withdrawal by Subject|4|||
130700776|NCT01628549|470528274|FG002|Overall Study|Withdrawal by Subject|4|||
130700777|NCT01628549|470528275|FG003|Overall Study|Withdrawal by Subject|1|||
130700778|NCT01628549|470528272|FG000|Overall Study|Protocol Violation|2|||
130700779|NCT01628549|470528273|FG001|Overall Study|Protocol Violation|1|||
130700780|NCT01628549|470528274|FG002|Overall Study|Protocol Violation|1|||
130700781|NCT01628549|470528275|FG003|Overall Study|Protocol Violation|0|||
130700782|NCT01628549|470528272|FG000|Overall Study|withdrawn for noncompliance|0|||
130700783|NCT01628549|470528273|FG001|Overall Study|withdrawn for noncompliance|2|||
130700784|NCT01628549|470528274|FG002|Overall Study|withdrawn for noncompliance|1|||
130700785|NCT01628549|470528275|FG003|Overall Study|withdrawn for noncompliance|0|||
130700786|NCT01628549|470528272|FG000|Overall Study|abnormal laboratory test results|0|||
130700787|NCT01628549|470528273|FG001|Overall Study|abnormal laboratory test results|0|||
130700788|NCT01628549|470528274|FG002|Overall Study|abnormal laboratory test results|1|||
130700789|NCT01628549|470528275|FG003|Overall Study|abnormal laboratory test results|0|||
130700790|NCT01628549|470528272|FG000|Overall Study|positive pregnancy test|0|||
130700791|NCT01628549|470528273|FG001|Overall Study|positive pregnancy test|0|||
130700792|NCT01628549|470528274|FG002|Overall Study|positive pregnancy test|0|||
130700793|NCT01628549|470528275|FG003|Overall Study|positive pregnancy test|1|||
130700794|NCT00177164|470528279|FG000|Overall Study|Protocol Violation|0|||
130700795|NCT00177164|470528280|FG001|Overall Study|Protocol Violation|7|||
130700796|NCT00177164|470528279|FG000|Overall Study|Lost to Follow-up|4|||
130700797|NCT00177164|470528280|FG001|Overall Study|Lost to Follow-up|5|||
130700798|NCT00177164|470528279|FG000|Overall Study|increase in alcohol and drug use|1|||
130700799|NCT00177164|470528280|FG001|Overall Study|increase in alcohol and drug use|2|||
130700800|NCT00177164|470528279|FG000|Overall Study|Adverse Event|1|||
130700801|NCT00177164|470528280|FG001|Overall Study|Adverse Event|0|||
130700802|NCT00177164|470528279|FG000|Overall Study|discharge from hospital|1|||
130700803|NCT00177164|470528280|FG001|Overall Study|discharge from hospital|0|||
130700804|NCT00177164|470528279|FG000|Overall Study|Lack of Efficacy|2|||
130700805|NCT00177164|470528280|FG001|Overall Study|Lack of Efficacy|1|||
130700806|NCT00177164|470528279|FG000|Overall Study|Pregnancy|0|||
130700807|NCT00177164|470528280|FG001|Overall Study|Pregnancy|1|||
130700808|NCT00965757|470528281|FG000|Double-blind Phase|Progression of concomitant disease|1|||
130700809|NCT00965757|470528282|FG001|Double-blind Phase|Progression of concomitant disease|2|||
130700810|NCT00965757|470528283|FG002|Double-blind Phase|Progression of concomitant disease|0|||
130700811|NCT00965757|470528284|FG003|Double-blind Phase|Progression of concomitant disease|0|||
130700812|NCT00965757|470528281|FG000|Double-blind Phase|Adverse drug reaction|2|||
130700813|NCT00965757|470528282|FG001|Double-blind Phase|Adverse drug reaction|1|||
130700814|NCT00965757|470528283|FG002|Double-blind Phase|Adverse drug reaction|0|||
130700815|NCT00965757|470528284|FG003|Double-blind Phase|Adverse drug reaction|0|||
130700816|NCT00965757|470528281|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
130700817|NCT00965757|470528282|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
130254853|NCT00561821|468895916|FG002|Overall Study|Other (reason not specified)|0|||
130254854|NCT00561821|468895917|FG003|Overall Study|Other (reason not specified)|0|||
130254855|NCT00561821|468895914|FG000|Overall Study|Adverse Event|2|||
130254856|NCT00561821|468895915|FG001|Overall Study|Adverse Event|3|||
130254857|NCT00561821|468895916|FG002|Overall Study|Adverse Event|1|||
130700818|NCT00965757|470528283|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
130700819|NCT00965757|470528284|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
130700820|NCT00965757|470528281|FG000|Double-blind Phase|Lack of Efficacy|7|||
130700821|NCT00965757|470528282|FG001|Double-blind Phase|Lack of Efficacy|11|||
130700822|NCT00965757|470528283|FG002|Double-blind Phase|Lack of Efficacy|0|||
130700823|NCT00965757|470528284|FG003|Double-blind Phase|Lack of Efficacy|0|||
130700824|NCT00965757|470528281|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
130700825|NCT00965757|470528282|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700826|NCT00965757|470528283|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700827|NCT00965757|470528284|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700828|NCT00965757|470528281|FG000|Double-blind Phase|Lost to Follow-up|0|||
130700829|NCT00965757|470528282|FG001|Double-blind Phase|Lost to Follow-up|1|||
130700830|NCT00965757|470528283|FG002|Double-blind Phase|Lost to Follow-up|0|||
130700831|NCT00965757|470528284|FG003|Double-blind Phase|Lost to Follow-up|0|||
130700832|NCT00965757|470528281|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
130700833|NCT00965757|470528282|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
130700834|NCT00965757|470528283|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130700835|NCT00965757|470528284|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130700836|NCT00965757|470528281|FG000|Double-blind Phase|Other|1|||
130700837|NCT00965757|470528282|FG001|Double-blind Phase|Other|0|||
130700838|NCT00965757|470528283|FG002|Double-blind Phase|Other|0|||
130700839|NCT00965757|470528284|FG003|Double-blind Phase|Other|0|||
130700840|NCT00965757|470528281|FG000|Extension Phase|Progression of concomitant disease|0|||
130700841|NCT00965757|470528282|FG001|Extension Phase|Progression of concomitant disease|0|||
130254858|NCT00561821|468895917|FG003|Overall Study|Adverse Event|1|||
130254859|NCT03379870|468896995|FG000|Overall Study|Lost to Follow-up|1|||
130254860|NCT03379870|468896996|FG001|Overall Study|Lost to Follow-up|0|||
130254861|NCT03379870|468896995|FG000|Overall Study|Protocol Violation|1|||
130254862|NCT03379870|468896996|FG001|Overall Study|Protocol Violation|1|||
130254863|NCT01394185|468896997|FG000|Overall Study|Withdrawal by Subject|2|||
130254864|NCT01394185|468896998|FG001|Overall Study|Withdrawal by Subject|0|||
130254865|NCT01394185|468896999|FG002|Overall Study|Withdrawal by Subject|0|||
130254866|NCT01394185|468897000|FG003|Overall Study|Withdrawal by Subject|0|||
130254867|NCT01394185|468897001|FG004|Overall Study|Withdrawal by Subject|1|||
130254868|NCT01394185|468897002|FG005|Overall Study|Withdrawal by Subject|0|||
130254869|NCT01394185|468896997|FG000|Overall Study|Change in protocol|3|||
130254870|NCT01394185|468896998|FG001|Overall Study|Change in protocol|0|||
130254871|NCT01394185|468896999|FG002|Overall Study|Change in protocol|0|||
130254872|NCT01394185|468897000|FG003|Overall Study|Change in protocol|0|||
130254873|NCT01394185|468897001|FG004|Overall Study|Change in protocol|3|||
130254874|NCT01394185|468897002|FG005|Overall Study|Change in protocol|0|||
130254875|NCT01394185|468896997|FG000|Overall Study|Protocol Violation|1|||
130254876|NCT01394185|468896998|FG001|Overall Study|Protocol Violation|0|||
130254877|NCT01394185|468896999|FG002|Overall Study|Protocol Violation|0|||
130254878|NCT01394185|468897000|FG003|Overall Study|Protocol Violation|1|||
130254879|NCT01394185|468897001|FG004|Overall Study|Protocol Violation|0|||
130254880|NCT01394185|468897002|FG005|Overall Study|Protocol Violation|1|||
130254881|NCT00267488|468897006|FG000|Overall Study|Sponsor Terminated Study|9|||
130254882|NCT00267488|468897006|FG000|Overall Study|Protocol Violation|1|||
130254883|NCT00267488|468897006|FG000|Overall Study|Other (Disease Progression)|1|||
130254884|NCT00831389|468897007|FG000|Overall Study|Withdrawal by Subject|0|||
130254885|NCT00831389|468897008|FG001|Overall Study|Withdrawal by Subject|1|||
130254886|NCT00278161|468897010|FG000|Overall Study|Death|11|||
130254887|NCT01592747|468897011|FG000|Overall Study|Loss of Therapeutic Response|107|||
130254888|NCT01592747|468897012|FG001|Overall Study|Loss of Therapeutic Response|108|||
130254889|NCT01592747|468897013|FG002|Overall Study|Loss of Therapeutic Response|100|||
130254890|NCT01592747|468897011|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130254891|NCT01592747|468897012|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130254892|NCT01592747|468897013|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
130254893|NCT01592747|468897011|FG000|Overall Study|Adverse Event|1|||
130254894|NCT01592747|468897012|FG001|Overall Study|Adverse Event|0|||
130254895|NCT01592747|468897013|FG002|Overall Study|Adverse Event|0|||
130254896|NCT01592747|468897011|FG000|Overall Study|Protocol Violation|4|||
130254897|NCT01592747|468897012|FG001|Overall Study|Protocol Violation|0|||
130254898|NCT01592747|468897013|FG002|Overall Study|Protocol Violation|4|||
130254899|NCT01592747|468897011|FG000|Overall Study|Lack of Efficacy|0|||
130254900|NCT01592747|468897012|FG001|Overall Study|Lack of Efficacy|1|||
130254901|NCT01592747|468897013|FG002|Overall Study|Lack of Efficacy|0|||
130254902|NCT01592747|468897011|FG000|Overall Study|Withdrawal by Subject|2|||
130254903|NCT01592747|468897012|FG001|Overall Study|Withdrawal by Subject|0|||
130254904|NCT01592747|468897013|FG002|Overall Study|Withdrawal by Subject|2|||
130254905|NCT01592747|468897011|FG000|Overall Study|Lost to Follow-up|1|||
130254906|NCT01592747|468897012|FG001|Overall Study|Lost to Follow-up|0|||
130254907|NCT01592747|468897013|FG002|Overall Study|Lost to Follow-up|1|||
130254908|NCT01592747|468897011|FG000|Overall Study|Other Reasons|1|||
130254909|NCT01592747|468897012|FG001|Overall Study|Other Reasons|1|||
130254910|NCT01592747|468897013|FG002|Overall Study|Other Reasons|0|||
130254911|NCT00124657|468897014|FG000|Overall Study|Toxicity|0|||
130254912|NCT00124657|468897015|FG001|Overall Study|Toxicity|0|||
130254913|NCT00124657|468897016|FG002|Overall Study|Toxicity|1|||
130254914|NCT00124657|468897014|FG000|Overall Study|Non-compliance|1|||
130254915|NCT00124657|468897015|FG001|Overall Study|Non-compliance|0|||
130254916|NCT00124657|468897016|FG002|Overall Study|Non-compliance|4|||
130254917|NCT00124657|468897014|FG000|Overall Study|Progressive disease|14|||
130254918|NCT00124657|468897015|FG001|Overall Study|Progressive disease|5|||
130700842|NCT00965757|470528283|FG002|Extension Phase|Progression of concomitant disease|4|||
130700843|NCT00965757|470528284|FG003|Extension Phase|Progression of concomitant disease|2|||
130254919|NCT00124657|468897016|FG002|Overall Study|Progressive disease|27|||
130254920|NCT00124657|468897014|FG000|Overall Study|Intercurrent illness|1|||
130254921|NCT00124657|468897015|FG001|Overall Study|Intercurrent illness|0|||
130254922|NCT00124657|468897016|FG002|Overall Study|Intercurrent illness|0|||
130254923|NCT01935947|468897017|FG000|Overall Study|Adverse Event|0|||
130254924|NCT01935947|468897018|FG001|Overall Study|Adverse Event|2|||
130254925|NCT01935947|468897019|FG002|Overall Study|Adverse Event|0|||
130254926|NCT01935947|468897017|FG000|Overall Study|Diease Progression|2|||
130254927|NCT01935947|468897018|FG001|Overall Study|Diease Progression|2|||
130254928|NCT01935947|468897019|FG002|Overall Study|Diease Progression|2|||
130254929|NCT01935947|468897017|FG000|Overall Study|Death|1|||
130254930|NCT01935947|468897018|FG001|Overall Study|Death|0|||
130254931|NCT01935947|468897019|FG002|Overall Study|Death|0|||
130254932|NCT01148771|468897020|FG000|Washout Period|Withdrawal by Subject|0|||
130254933|NCT01148771|468897021|FG001|Washout Period|Withdrawal by Subject|1|||
130254934|NCT02951819|468897026|FG000|Overall Study|Death|9|||
130254935|NCT02951819|468897027|FG001|Overall Study|Death|7|||
130254936|NCT02951819|468897026|FG000|Overall Study|Withdrawal by Subject|3|||
130254937|NCT02951819|468897027|FG001|Overall Study|Withdrawal by Subject|0|||
130254938|NCT02951819|468897026|FG000|Overall Study|Adverse Event|1|||
130254939|NCT02951819|468897027|FG001|Overall Study|Adverse Event|0|||
130254940|NCT02951819|468897026|FG000|Overall Study|Lack of Efficacy|4|||
130254941|NCT02951819|468897027|FG001|Overall Study|Lack of Efficacy|0|||
130254942|NCT02951819|468897026|FG000|Overall Study|Lost to Follow-up|1|||
130254943|NCT02951819|468897027|FG001|Overall Study|Lost to Follow-up|0|||
130254944|NCT02951819|468897026|FG000|Overall Study|Progressive Disease|1|||
130254945|NCT02951819|468897027|FG001|Overall Study|Progressive Disease|0|||
130254946|NCT02951819|468897026|FG000|Overall Study|Other|9|||
130254947|NCT02951819|468897027|FG001|Overall Study|Other|0|||
130254948|NCT01443026|468897030|FG000|Overall Study|Physician Decision|1|||
130254949|NCT01443026|468897031|FG001|Overall Study|Physician Decision|0|||
130254950|NCT01443026|468897030|FG000|Overall Study|Death|0|||
130254951|NCT01443026|468897031|FG001|Overall Study|Death|1|||
130254952|NCT01443026|468897030|FG000|Overall Study|Withdrawal by Subject|0|||
130254953|NCT01443026|468897031|FG001|Overall Study|Withdrawal by Subject|3|||
130254954|NCT01443026|468897030|FG000|Overall Study|Lost to Follow-up|2|||
130254955|NCT01443026|468897031|FG001|Overall Study|Lost to Follow-up|1|||
130254956|NCT00581919|468897032|FG000|Overall Study|Adverse Event|8|||
130254957|NCT00581919|468897032|FG000|Overall Study|Death|1|||
130254958|NCT00581919|468897032|FG000|Overall Study|Disease Progression|10|||
130700844|NCT00965757|470528281|FG000|Extension Phase|Adverse drug reaction|0|||
130700845|NCT00965757|470528282|FG001|Extension Phase|Adverse drug reaction|0|||
130700846|NCT00965757|470528283|FG002|Extension Phase|Adverse drug reaction|6|||
130700847|NCT00965757|470528284|FG003|Extension Phase|Adverse drug reaction|3|||
130700848|NCT00965757|470528281|FG000|Extension Phase|Abnormal Laboratory Value|0|||
130700849|NCT00965757|470528282|FG001|Extension Phase|Abnormal Laboratory Value|0|||
130700850|NCT00965757|470528283|FG002|Extension Phase|Abnormal Laboratory Value|6|||
130700851|NCT00965757|470528284|FG003|Extension Phase|Abnormal Laboratory Value|1|||
130700852|NCT00965757|470528281|FG000|Extension Phase|Lack of Efficacy|0|||
130700853|NCT00965757|470528282|FG001|Extension Phase|Lack of Efficacy|0|||
130700854|NCT00965757|470528283|FG002|Extension Phase|Lack of Efficacy|8|||
130700855|NCT00965757|470528284|FG003|Extension Phase|Lack of Efficacy|12|||
130700856|NCT00965757|470528281|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700857|NCT00965757|470528282|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700858|NCT00965757|470528283|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
130700859|NCT00965757|470528284|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700860|NCT00965757|470528281|FG000|Extension Phase|Lost to Follow-up|0|||
130700861|NCT00965757|470528282|FG001|Extension Phase|Lost to Follow-up|0|||
130700862|NCT00965757|470528283|FG002|Extension Phase|Lost to Follow-up|0|||
130700863|NCT00965757|470528284|FG003|Extension Phase|Lost to Follow-up|1|||
130700864|NCT00965757|470528281|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
130700865|NCT00965757|470528282|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
130700866|NCT00965757|470528283|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
130700867|NCT00965757|470528284|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
130700868|NCT00965757|470528281|FG000|Extension Phase|Protocol Violation|0|||
130700869|NCT00965757|470528282|FG001|Extension Phase|Protocol Violation|0|||
130700870|NCT00965757|470528283|FG002|Extension Phase|Protocol Violation|0|||
130700871|NCT00965757|470528284|FG003|Extension Phase|Protocol Violation|1|||
130700872|NCT00965757|470528281|FG000|Extension Phase|Other|0|||
130700873|NCT00965757|470528282|FG001|Extension Phase|Other|0|||
130700874|NCT00965757|470528283|FG002|Extension Phase|Other|2|||
130700875|NCT00965757|470528284|FG003|Extension Phase|Other|1|||
130700876|NCT01344018|470528290|FG000|Overall Study|Death|22|||
130700877|NCT01344018|470528291|FG001|Overall Study|Death|25|||
130700878|NCT01344018|470528290|FG000|Overall Study|Lost to Follow-up|4|||
130700879|NCT01344018|470528291|FG001|Overall Study|Lost to Follow-up|7|||
130700880|NCT05070754|470528292|FG000|Overall Study|Withdrawal by Subject|0|||
130700881|NCT05070754|470528293|FG001|Overall Study|Withdrawal by Subject|0|||
130700882|NCT05070754|470528294|FG002|Overall Study|Withdrawal by Subject|0|||
130700883|NCT05070754|470528295|FG003|Overall Study|Withdrawal by Subject|1|||
130700884|NCT05070754|470528292|FG000|Overall Study|Protocol Violation|0|||
130700885|NCT05070754|470528293|FG001|Overall Study|Protocol Violation|0|||
130700886|NCT05070754|470528294|FG002|Overall Study|Protocol Violation|0|||
130254959|NCT00581919|468897032|FG000|Overall Study|Physician Decision|1|||
130254960|NCT00581919|468897032|FG000|Overall Study|Other Complicating Disease|1|||
130254961|NCT00581919|468897032|FG000|Overall Study|Started Non-Protocol Therapy|2|||
130254962|NCT00581919|468897032|FG000|Overall Study|Withdrawal by Subject|1|||
130254963|NCT02655601|468897033|FG000|Overall Study|Adverse Event|0|||
130254964|NCT02655601|468897034|FG001|Overall Study|Adverse Event|0|||
130254965|NCT02655601|468897035|FG002|Overall Study|Adverse Event|0|||
130254966|NCT02655601|468897036|FG003|Overall Study|Adverse Event|1|||
130254967|NCT02655601|468897037|FG004|Overall Study|Adverse Event|1|||
130254968|NCT02655601|468897038|FG005|Overall Study|Adverse Event|0|||
130254969|NCT02655601|468897033|FG000|Overall Study|Physician Decision|0|||
130254970|NCT02655601|468897034|FG001|Overall Study|Physician Decision|0|||
130254971|NCT02655601|468897035|FG002|Overall Study|Physician Decision|0|||
130254972|NCT02655601|468897036|FG003|Overall Study|Physician Decision|0|||
130254973|NCT02655601|468897037|FG004|Overall Study|Physician Decision|1|||
130254974|NCT02655601|468897038|FG005|Overall Study|Physician Decision|1|||
130254975|NCT02655601|468897033|FG000|Overall Study|Withdrawal by Subject|0|||
130254976|NCT02655601|468897034|FG001|Overall Study|Withdrawal by Subject|0|||
130254977|NCT02655601|468897035|FG002|Overall Study|Withdrawal by Subject|0|||
130254978|NCT02655601|468897036|FG003|Overall Study|Withdrawal by Subject|0|||
130254979|NCT02655601|468897037|FG004|Overall Study|Withdrawal by Subject|4|||
130254980|NCT02655601|468897038|FG005|Overall Study|Withdrawal by Subject|8|||
130254981|NCT02655601|468897033|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
130254982|NCT02655601|468897034|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254983|NCT02655601|468897035|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254984|NCT02655601|468897036|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254985|NCT02655601|468897037|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254986|NCT02655601|468897038|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254987|NCT02528305|468897042|FG000|Overall Study|Withdrawal by Subject|1|||
130254988|NCT02528305|468897042|FG000|Overall Study|Adverse Event|1|||
130254989|NCT02528305|468897042|FG000|Overall Study|Physician Decision|1|||
130254990|NCT00787800|468897043|FG000|Overall Study|Withdrawal by Subject|3|||
130254991|NCT00787800|468897044|FG001|Overall Study|Withdrawal by Subject|5|||
130254992|NCT00787800|468897043|FG000|Overall Study|Death|0|||
130254993|NCT00787800|468897044|FG001|Overall Study|Death|2|||
130254994|NCT04309500|468897046|FG000|Overall Study|Lost to Follow-up|1|||
130254995|NCT04309500|468897047|FG001|Overall Study|Lost to Follow-up|0|||
130254996|NCT04309500|468897048|FG002|Overall Study|Lost to Follow-up|0|||
130254997|NCT04309500|468897049|FG003|Overall Study|Lost to Follow-up|0|||
130254998|NCT00773461|468897050|FG000|Overall Study|Adverse Event|1|||
130254999|NCT00773461|468897051|FG001|Overall Study|Adverse Event|3|||
130255000|NCT00773461|468897050|FG000|Overall Study|Withdrawal by Subject|4|||
130255001|NCT00773461|468897051|FG001|Overall Study|Withdrawal by Subject|1|||
130255002|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
130255003|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
130255004|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
130255005|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
130255006|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
130255007|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
130255008|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130255009|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130255010|NCT00913835|468897052|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
130255011|NCT00913835|468897053|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
130255012|NCT00637156|468897054|FG000|Overall Study|Withdrawal by Subject|0|||
130255013|NCT00637156|468897055|FG001|Overall Study|Withdrawal by Subject|7|||
130255014|NCT00637156|468897054|FG000|Overall Study|Death|0|||
130255015|NCT00637156|468897055|FG001|Overall Study|Death|1|||
130255016|NCT00637156|468897054|FG000|Overall Study|Lost to Follow-up|10|||
130255017|NCT00637156|468897055|FG001|Overall Study|Lost to Follow-up|16|||
130255018|NCT00461812|468897056|FG000|Overall Study|study terminated|10|||
130255019|NCT01308788|468897057|FG000|2-year Treatment|medication change by treating physician|4|||
130255020|NCT01308788|468897058|FG001|2-year Treatment|medication change by treating physician|11|||
130255021|NCT03193437|468897059|FG000|Overall Study|Adverse Event|4|||
130255022|NCT03193437|468897059|FG000|Overall Study|Withdrawal by Subject|2|||
130255023|NCT03193437|468897059|FG000|Overall Study|Disease Progression|2|||
130255024|NCT05487378|468897060|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
130255025|NCT05487378|468897061|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
130255026|NCT05487378|468897060|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
130255027|NCT05487378|468897061|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
130255028|NCT02414841|468897062|FG000|Overall Study|Withdrawal by Subject|7|||
130255029|NCT02414841|468897063|FG001|Overall Study|Withdrawal by Subject|5|||
130255030|NCT02414841|468897062|FG000|Overall Study|Lost to Follow-up|13|||
130255031|NCT02414841|468897063|FG001|Overall Study|Lost to Follow-up|6|||
130255032|NCT02414841|468897062|FG000|Overall Study|Death|17|||
130255033|NCT02414841|468897063|FG001|Overall Study|Death|14|||
130255034|NCT02414841|468897062|FG000|Overall Study|Received a Kidney Transplant|13|||
130255035|NCT02414841|468897063|FG001|Overall Study|Received a Kidney Transplant|4|||
130255036|NCT02414841|468897062|FG000|Overall Study|Randomized But Not Treated|6|||
130255037|NCT02414841|468897063|FG001|Overall Study|Randomized But Not Treated|4|||
130255038|NCT00964678|468897079|FG000|Overall Study|Physician Decision|4|||
130255039|NCT03359395|468897082|FG000|First Intervention A / B|Withdrawal by Subject|1|||
130255040|NCT03359395|468897083|FG001|First Intervention A / B|Withdrawal by Subject|0|||
130255041|NCT03359395|468897082|FG000|First Intervention A / B|Lost to Follow-up|2|||
130255042|NCT03359395|468897083|FG001|First Intervention A / B|Lost to Follow-up|3|||
130255043|NCT03359395|468897082|FG000|Second Intervention B/A|Exclusion criteria|0|||
130255044|NCT03359395|468897083|FG001|Second Intervention B/A|Exclusion criteria|1|||
130255045|NCT03359395|468897082|FG000|Second Intervention B/A|Lost to Follow-up|3|||
130255046|NCT03359395|468897083|FG001|Second Intervention B/A|Lost to Follow-up|2|||
130255047|NCT03164356|468897086|FG000|Overall Study|Lost to Follow-up|1|||
130255048|NCT03164356|468897087|FG001|Overall Study|Lost to Follow-up|1|||
130255049|NCT03164356|468897088|FG002|Overall Study|Lost to Follow-up|2|||
130255050|NCT03164356|468897089|FG003|Overall Study|Lost to Follow-up|1|||
130255051|NCT03164356|468897086|FG000|Overall Study|Physician Decision|0|||
130255052|NCT03164356|468897087|FG001|Overall Study|Physician Decision|0|||
130255053|NCT03164356|468897088|FG002|Overall Study|Physician Decision|3|||
130255054|NCT03164356|468897089|FG003|Overall Study|Physician Decision|0|||
130255055|NCT03164356|468897086|FG000|Overall Study|Protocol Violation|2|||
130255056|NCT03164356|468897087|FG001|Overall Study|Protocol Violation|1|||
130255057|NCT03164356|468897088|FG002|Overall Study|Protocol Violation|0|||
130255058|NCT03164356|468897089|FG003|Overall Study|Protocol Violation|0|||
130255059|NCT03164356|468897086|FG000|Overall Study|Withdrawal by Subject|1|||
130255060|NCT03164356|468897087|FG001|Overall Study|Withdrawal by Subject|0|||
130255061|NCT03164356|468897088|FG002|Overall Study|Withdrawal by Subject|0|||
130255062|NCT03164356|468897089|FG003|Overall Study|Withdrawal by Subject|0|||
130255063|NCT03164356|468897086|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130255064|NCT03164356|468897087|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130376668|NCT01327885|469345896|FG001|Overall Study|Subject choice|10|||
130255065|NCT03164356|468897088|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130255066|NCT03164356|468897089|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130255067|NCT03164356|468897086|FG000|Overall Study|Subject Incarcerated|0|||
130255068|NCT03164356|468897087|FG001|Overall Study|Subject Incarcerated|1|||
130255069|NCT03164356|468897088|FG002|Overall Study|Subject Incarcerated|0|||
130255070|NCT03164356|468897089|FG003|Overall Study|Subject Incarcerated|0|||
130255071|NCT03164356|468897086|FG000|Overall Study|Prosthetist unable to participate|0|||
130255072|NCT03164356|468897087|FG001|Overall Study|Prosthetist unable to participate|2|||
130255073|NCT03164356|468897088|FG002|Overall Study|Prosthetist unable to participate|1|||
130255074|NCT03164356|468897089|FG003|Overall Study|Prosthetist unable to participate|0|||
130255075|NCT05943990|468897091|FG000|Overall Study|Study Terminated by Sponsor|0|||
130255076|NCT05943990|468897092|FG001|Overall Study|Study Terminated by Sponsor|0|||
130255077|NCT05943990|468897093|FG002|Overall Study|Study Terminated by Sponsor|1|||
130255078|NCT02657356|468897934|FG000|Overall Study|Death|1|||
130255079|NCT02657356|468897935|FG001|Overall Study|Death|0|||
130255080|NCT02657356|468897934|FG000|Overall Study|Withdrawal by Subject|5|||
130255081|NCT02657356|468897935|FG001|Overall Study|Withdrawal by Subject|6|||
130255082|NCT02657356|468897934|FG000|Overall Study|Terminated by Sponsor|8|||
130255083|NCT02657356|468897935|FG001|Overall Study|Terminated by Sponsor|5|||
130255084|NCT02657356|468897934|FG000|Overall Study|Rolled over to EAP study|6|||
130255085|NCT02657356|468897935|FG001|Overall Study|Rolled over to EAP study|4|||
130255086|NCT03443401|468897942|FG000|Overall Study|Lost to Follow-up|13|||
130255087|NCT03443401|468897942|FG000|Overall Study|Influential outlier|1|||
130255088|NCT00980044|468897943|FG000|Overall Study|Withdrawal by Subject|5|||
130255089|NCT00980044|468897944|FG001|Overall Study|Withdrawal by Subject|7|||
130255090|NCT00980044|468897945|FG002|Overall Study|Withdrawal by Subject|3|||
130255091|NCT00980044|468897943|FG000|Overall Study|Protocol Violation|0|||
130255092|NCT00980044|468897944|FG001|Overall Study|Protocol Violation|0|||
130255093|NCT00980044|468897945|FG002|Overall Study|Protocol Violation|2|||
130255094|NCT02904265|468897946|FG000|Overall Study|Physician Decision|1|||
130255095|NCT02904265|468897947|FG001|Overall Study|Physician Decision|2|||
130255096|NCT00833703|468897949|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
130255097|NCT00833703|468897950|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
130255098|NCT05538728|468897951|FG000|Overall Study|Withdrawal by Subject|1|||
130255099|NCT05538728|468897952|FG001|Overall Study|Withdrawal by Subject|1|||
130255100|NCT02254460|468897953|FG000|Overall Study|Adverse Event|1|||
130255101|NCT02254460|468897954|FG001|Overall Study|Adverse Event|0|||
130255102|NCT01904279|468897957|FG000|Overall Study|Lack of Efficacy|2|||
130255103|NCT01904279|468897958|FG001|Overall Study|Lack of Efficacy|3|||
130255104|NCT01904279|468897957|FG000|Overall Study|Withdrawal by Subject|1|||
130255105|NCT01904279|468897958|FG001|Overall Study|Withdrawal by Subject|0|||
130255106|NCT01356940|468897961|FG000|First Intervention (28 Days)|Adverse Event|1|||
130700887|NCT05070754|470528295|FG003|Overall Study|Protocol Violation|1|||
130700888|NCT01398787|470528296|FG000|Overall Study|Adverse Event|1|||
130700889|NCT02351167|470528297|FG000|Overall Study|Withdrawal by Subject|19|||
130700890|NCT02351167|470528298|FG001|Overall Study|Withdrawal by Subject|18|||
130700891|NCT02351167|470528299|FG002|Overall Study|Withdrawal by Subject|21|||
130700892|NCT00668395|470528302|FG000|Overall Study|Withdrawal by Subject|4|||
130255107|NCT01356940|468897962|FG001|First Intervention (28 Days)|Adverse Event|0|||
130255108|NCT01356940|468897961|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
130255109|NCT01356940|468897962|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
130255110|NCT01344356|468897965|FG000|Overall Study|Physician Decision|0|||
130255111|NCT01344356|468897966|FG001|Overall Study|Physician Decision|3|||
130255112|NCT01344356|468897965|FG000|Overall Study|Lost to Follow-up|0|||
130255113|NCT01344356|468897966|FG001|Overall Study|Lost to Follow-up|6|||
130255114|NCT00095576|468897967|FG000|Overall Study|Adverse Event|5|||
130255115|NCT00095576|468897968|FG001|Overall Study|Adverse Event|3|||
130255116|NCT00095576|468897967|FG000|Overall Study|Lost to Follow-up|233|||
130255117|NCT00095576|468897968|FG001|Overall Study|Lost to Follow-up|229|||
130255118|NCT00095576|468897967|FG000|Overall Study|Protocol Violation|1|||
130255119|NCT00095576|468897968|FG001|Overall Study|Protocol Violation|0|||
130255120|NCT00095576|468897967|FG000|Overall Study|Withdrawal by Subject|34|||
130700893|NCT00668395|470528303|FG001|Overall Study|Withdrawal by Subject|4|||
130700894|NCT00668395|470528304|FG002|Overall Study|Withdrawal by Subject|1|||
130255121|NCT00095576|468897968|FG001|Overall Study|Withdrawal by Subject|47|||
130255122|NCT00095576|468897967|FG000|Overall Study|Option to switch to a rollover study|1097|||
130255123|NCT00095576|468897968|FG001|Overall Study|Option to switch to a rollover study|1099|||
130255124|NCT00095576|468897967|FG000|Overall Study|Site terminated|75|||
130255125|NCT00095576|468897968|FG001|Overall Study|Site terminated|67|||
130255126|NCT00095576|468897967|FG000|Overall Study|Subject moved|30|||
130255127|NCT00095576|468897968|FG001|Overall Study|Subject moved|36|||
130255128|NCT00505687|468897969|FG000|Overall Study|Important protocol violation|2|||
130700895|NCT00668395|470528302|FG000|Overall Study|Adverse Event|1|||
130700896|NCT00668395|470528303|FG001|Overall Study|Adverse Event|1|||
130255129|NCT00505687|468897969|FG000|Overall Study|Lack of Efficacy|15|||
130255130|NCT00505687|468897969|FG000|Overall Study|Adverse Event|48|||
130255131|NCT00505687|468897969|FG000|Overall Study|Subject withdrew consent|15|||
130255132|NCT00505687|468897969|FG000|Overall Study|Lost to Follow-up|1|||
130255133|NCT00505687|468897969|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
130255134|NCT00505687|468897969|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
130255135|NCT00505687|468897969|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
130255136|NCT00505687|468897969|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
130255137|NCT00505687|468897969|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
130255138|NCT00505687|468897969|FG000|Overall Study|Other: Disease Progression|1|||
130255139|NCT00505687|468897969|FG000|Overall Study|Other: As Per Sponsor|8|||
130255140|NCT00480532|468897970|FG000|Overall Study|Withdrawal by Subject|2|||
130255141|NCT00480532|468897971|FG001|Overall Study|Withdrawal by Subject|4|||
130255142|NCT00480532|468897972|FG002|Overall Study|Withdrawal by Subject|3|||
130255143|NCT00480532|468897973|FG003|Overall Study|Withdrawal by Subject|1|||
130255144|NCT00480532|468897970|FG000|Overall Study|Protocol Violation|0|||
130255145|NCT00480532|468897971|FG001|Overall Study|Protocol Violation|0|||
130255146|NCT00480532|468897972|FG002|Overall Study|Protocol Violation|1|||
130255147|NCT00480532|468897973|FG003|Overall Study|Protocol Violation|0|||
130255148|NCT01817777|468897974|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
130255149|NCT01817777|468897975|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130255150|NCT01817777|468897976|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130255151|NCT01817777|468897974|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
130255152|NCT01817777|468897975|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
130255153|NCT01817777|468897976|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
130553497|NCT01966471|469993583|FG001|Overall Study|Death|56|||
130553498|NCT01966471|469993582|FG000|Overall Study|Lost to Follow-up|46|||
130700897|NCT00668395|470528304|FG002|Overall Study|Adverse Event|0|||
130700898|NCT00668395|470528302|FG000|Overall Study|Physician Decision|1|||
130700899|NCT00668395|470528303|FG001|Overall Study|Physician Decision|1|||
130700900|NCT00668395|470528304|FG002|Overall Study|Physician Decision|0|||
130700901|NCT02858037|470528307|FG000|Overall Study|Death|1|||
130700902|NCT02858037|470528307|FG000|Overall Study|Withdrawal by Subject|18|||
130700903|NCT02858037|470528307|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
130700904|NCT02858037|470528307|FG000|Overall Study|Lost to Follow-up|3|||
130700905|NCT02858037|470528307|FG000|Overall Study|Other|4|||
130700906|NCT04049097|470528310|FG000|Overall Study|Adverse Event|18|||
130700907|NCT04049097|470528310|FG000|Overall Study|Death|2|||
130700908|NCT04049097|470528310|FG000|Overall Study|Lost to Follow-up|1|||
130700909|NCT04049097|470528310|FG000|Overall Study|Physician Decision|2|||
130700910|NCT04049097|470528310|FG000|Overall Study|Withdrawal by Subject|9|||
130700911|NCT04049097|470528310|FG000|Overall Study|Protocol Violation|2|||
130700912|NCT04049097|470528310|FG000|Overall Study|Other|1|||
130700913|NCT04049097|470528310|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
130700914|NCT01963260|470528319|FG000|Overall Study|Withdrawal by Subject|2|||
130700915|NCT01963260|470528320|FG001|Overall Study|Withdrawal by Subject|0|||
130700916|NCT01963260|470528321|FG002|Overall Study|Withdrawal by Subject|0|||
130700917|NCT01963260|470528322|FG003|Overall Study|Withdrawal by Subject|1|||
130700918|NCT01963260|470528323|FG004|Overall Study|Withdrawal by Subject|2|||
130700919|NCT01963260|470528324|FG005|Overall Study|Withdrawal by Subject|0|||
130700920|NCT01963260|470528325|FG006|Overall Study|Withdrawal by Subject|0|||
130700921|NCT01963260|470528326|FG007|Overall Study|Withdrawal by Subject|0|||
130700922|NCT01963260|470528327|FG008|Overall Study|Withdrawal by Subject|0|||
130700923|NCT01963260|470528328|FG009|Overall Study|Withdrawal by Subject|0|||
130700924|NCT01091363|470528329|FG000|Overall Study|Withdrawal by Subject|11|||
130700925|NCT01091363|470528330|FG001|Overall Study|Withdrawal by Subject|15|||
130700926|NCT01091363|470528329|FG000|Overall Study|Lost to Follow-up|2|||
130700927|NCT01091363|470528330|FG001|Overall Study|Lost to Follow-up|2|||
130700928|NCT01781234|470528331|FG000|Overall Study|Adverse Event|2|||
130700929|NCT01781234|470528332|FG001|Overall Study|Adverse Event|0|||
130255154|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130255155|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
130255156|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130255157|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
130700930|NCT01781234|470528331|FG000|Overall Study|Protocol Violation|3|||
130700931|NCT01781234|470528332|FG001|Overall Study|Protocol Violation|0|||
130700932|NCT01781234|470528331|FG000|Overall Study|Withdrawal by Subject|4|||
130700933|NCT01781234|470528332|FG001|Overall Study|Withdrawal by Subject|3|||
130700934|NCT05889039|470528335|FG000|Overall Study|error in completing survey|0|||
130700935|NCT05889039|470528336|FG001|Overall Study|error in completing survey|2|||
130255158|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
130255159|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
130255160|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
130700936|NCT05889039|470528337|FG002|Overall Study|error in completing survey|0|||
130700937|NCT05889039|470528338|FG003|Overall Study|error in completing survey|0|||
130255161|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
130255162|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
130255163|NCT00443456|468897977|FG000|Overall Study|Adverse Event|16|||
130255164|NCT00443456|468897977|FG000|Overall Study|Move|1|||
130255165|NCT00443456|468897977|FG000|Overall Study|Withdrawal by Subject|1|||
130255166|NCT00557440|468897978|FG000|Treatment Period 1|Adverse Event|0|||
130255167|NCT00557440|468897979|FG001|Treatment Period 1|Adverse Event|0|||
130255168|NCT00557440|468897980|FG002|Treatment Period 1|Adverse Event|1|||
130255169|NCT03524157|468897981|FG000|Overall Study|cytology not readable|0|||
130255170|NCT03524157|468897982|FG001|Overall Study|cytology not readable|0|||
130255171|NCT03524157|468897983|FG002|Overall Study|cytology not readable|1|||
130255172|NCT02157610|468897984|FG000|Overall Study|Death|4|||
130255173|NCT02157610|468897985|FG001|Overall Study|Death|4|||
130255174|NCT01378195|468897986|FG000|Overall Study|Lost to Follow-up|29|||
130255175|NCT01378195|468897987|FG001|Overall Study|Lost to Follow-up|18|||
130255176|NCT00425555|468897988|FG000|Overall Study|Withdrawal by Subject|11|||
130255177|NCT00425555|468897989|FG001|Overall Study|Withdrawal by Subject|8|||
130255178|NCT00425555|468897988|FG000|Overall Study|Lost to Follow-up|0|||
130255179|NCT00425555|468897989|FG001|Overall Study|Lost to Follow-up|1|||
130255180|NCT00425555|468897988|FG000|Overall Study|Administrative problems|3|||
130255181|NCT00425555|468897989|FG001|Overall Study|Administrative problems|0|||
130255182|NCT00425555|468897988|FG000|Overall Study|Death|1|||
130255183|NCT00425555|468897989|FG001|Overall Study|Death|2|||
130700938|NCT05889039|470528335|FG000|Overall Study|Lost to Follow-up|4|||
130255184|NCT00425555|468897988|FG000|Overall Study|New cancer therapy|2|||
130255185|NCT00425555|468897989|FG001|Overall Study|New cancer therapy|1|||
130255186|NCT00425555|468897988|FG000|Overall Study|Disease progression|36|||
130255187|NCT00425555|468897989|FG001|Overall Study|Disease progression|33|||
130255188|NCT00425555|468897988|FG000|Overall Study|Adverse Event|25|||
130255189|NCT00425555|468897989|FG001|Overall Study|Adverse Event|15|||
130255190|NCT00425555|468897988|FG000|Overall Study|Protocol Violation|1|||
130255191|NCT00425555|468897989|FG001|Overall Study|Protocol Violation|0|||
130255192|NCT05418426|468897990|FG000|Overall Study|Adverse Event|0|||
130255193|NCT05418426|468897991|FG001|Overall Study|Adverse Event|1|||
130255194|NCT05418426|468897992|FG002|Overall Study|Adverse Event|0|||
130700939|NCT05889039|470528336|FG001|Overall Study|Lost to Follow-up|0|||
130700940|NCT05889039|470528337|FG002|Overall Study|Lost to Follow-up|0|||
130700941|NCT05889039|470528338|FG003|Overall Study|Lost to Follow-up|0|||
130700942|NCT02661022|470528339|FG000|Overall Study|Withdrawal by Subject|3|||
130700943|NCT02661022|470528340|FG001|Overall Study|Withdrawal by Subject|0|||
130255195|NCT05418426|468897990|FG000|Overall Study|Withdrawal by Subject|0|||
130255196|NCT05418426|468897991|FG001|Overall Study|Withdrawal by Subject|1|||
130255197|NCT05418426|468897992|FG002|Overall Study|Withdrawal by Subject|0|||
130255198|NCT05418426|468897990|FG000|Overall Study|Protocol Violation|0|||
130255199|NCT05418426|468897991|FG001|Overall Study|Protocol Violation|0|||
130255200|NCT05418426|468897992|FG002|Overall Study|Protocol Violation|1|||
130255201|NCT01674062|468897993|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130255202|NCT01674062|468897994|FG001|Overall Study|Insufficient Therapeutic Response|26|||
130700944|NCT02661022|470528339|FG000|Overall Study|Adverse Event|1|||
130700945|NCT02661022|470528340|FG001|Overall Study|Adverse Event|1|||
130700946|NCT02661022|470528339|FG000|Overall Study|Physician Decision|1|||
130700947|NCT02661022|470528340|FG001|Overall Study|Physician Decision|0|||
130700948|NCT02661022|470528339|FG000|Overall Study|Progressive Disease|2|||
130700949|NCT02661022|470528340|FG001|Overall Study|Progressive Disease|1|||
130700950|NCT01785615|470528347|FG000|Dietary Phase|Lost to Follow-up|0|||
130700951|NCT01785615|470528348|FG001|Dietary Phase|Lost to Follow-up|0|||
130700952|NCT01785615|470528349|FG002|Dietary Phase|Lost to Follow-up|0|||
130700953|NCT01785615|470528350|FG003|Dietary Phase|Lost to Follow-up|24|||
130700954|NCT01881737|470528351|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
130700955|NCT01881737|470528351|FG000|Overall Study|Withdrawal by Subject|1|||
130700956|NCT01881737|470528351|FG000|Overall Study|Worsening of baseline behavior|1|||
130700957|NCT04106817|470528356|FG000|Overall Study|Lost to Follow-up|1|||
130700958|NCT04106817|470528357|FG001|Overall Study|Lost to Follow-up|0|||
130700959|NCT04106817|470528358|FG002|Overall Study|Lost to Follow-up|0|||
130700960|NCT02260635|470528359|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
130700961|NCT02260635|470528360|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
130700962|NCT02260635|470528359|FG000|Open-Label Extension|Study Termination|25|||
130700963|NCT02260635|470528360|FG001|Open-Label Extension|Study Termination|25|||
130700964|NCT02260635|470528359|FG000|Open-Label Extension|Withdrawal by Subject|1|||
130255203|NCT01674062|468897993|FG000|Overall Study|Other|8|||
130255204|NCT01674062|468897994|FG001|Overall Study|Other|1|||
130255205|NCT01674062|468897993|FG000|Overall Study|Adverse Event|1|||
130255206|NCT01674062|468897994|FG001|Overall Study|Adverse Event|1|||
130255207|NCT01674062|468897993|FG000|Overall Study|Death|0|||
130255208|NCT01674062|468897994|FG001|Overall Study|Death|1|||
130553499|NCT01966471|469993583|FG001|Overall Study|Lost to Follow-up|39|||
130553500|NCT01966471|469993582|FG000|Overall Study|Various reasons|4|||
130553501|NCT01966471|469993583|FG001|Overall Study|Various reasons|4|||
130553502|NCT01966471|469993582|FG000|Overall Study|Physician Decision|7|||
130553503|NCT01966471|469993583|FG001|Overall Study|Physician Decision|5|||
130553504|NCT01966471|469993582|FG000|Overall Study|Study Terminated By Sponsor|758|||
130553505|NCT01966471|469993583|FG001|Overall Study|Study Terminated By Sponsor|773|||
130553506|NCT01966471|469993582|FG000|Overall Study|Withdrawal by Subject|59|||
130553507|NCT01966471|469993583|FG001|Overall Study|Withdrawal by Subject|51|||
130553508|NCT01030198|469993584|FG000|Overall Study|Could not measure efficacy accurately|0|||
130553509|NCT01030198|469993585|FG001|Overall Study|Could not measure efficacy accurately|7|||
130553510|NCT02370043|469993586|FG000|Overall Study|Withdrawal by Subject|0|||
130553511|NCT02370043|469993587|FG001|Overall Study|Withdrawal by Subject|0|||
130553512|NCT02370043|469993588|FG002|Overall Study|Withdrawal by Subject|0|||
130553513|NCT02370043|469993589|FG003|Overall Study|Withdrawal by Subject|0|||
130553514|NCT02370043|469993590|FG004|Overall Study|Withdrawal by Subject|1|||
130553515|NCT02370043|469993591|FG005|Overall Study|Withdrawal by Subject|1|||
130553516|NCT00688181|469993592|FG000|Overall Study|Lost to Follow-up|17|||
130553517|NCT00688181|469993592|FG000|Overall Study|Unknown Reason|4|||
130553518|NCT00688181|469993592|FG000|Overall Study|Non-clinical Reason|2|||
130553519|NCT01050205|469993593|FG000|Overall Study|Lost to Follow-up|7|||
130553520|NCT01050205|469993594|FG001|Overall Study|Lost to Follow-up|1|||
130553521|NCT01050205|469993593|FG000|Overall Study|Withdrawal by Subject|1|||
130553522|NCT01050205|469993594|FG001|Overall Study|Withdrawal by Subject|1|||
130553523|NCT01050205|469993593|FG000|Overall Study|Relocated from area|1|||
130553524|NCT01050205|469993594|FG001|Overall Study|Relocated from area|2|||
130553525|NCT01050205|469993593|FG000|Overall Study|Discontinued Intervention|2|||
130553526|NCT01050205|469993594|FG001|Overall Study|Discontinued Intervention|0|||
130553527|NCT01119001|469993595|FG000|Overall Study|Withdrawal by Subject|2|||
130553528|NCT00954421|469993596|FG000|Screening|screen failures|3|||
130553529|NCT00954421|469993596|FG000|6 Months of DBS|Withdrawal by Subject|1|||
130553530|NCT00954421|469993596|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
130553531|NCT00777946|469993597|FG000|Overall Study|Adverse Event|11|||
130553532|NCT00777946|469993598|FG001|Overall Study|Adverse Event|1|||
130553533|NCT00777946|469993599|FG002|Overall Study|Adverse Event|3|||
130553534|NCT00777946|469993597|FG000|Overall Study|Lack of Efficacy|0|||
130553535|NCT00777946|469993598|FG001|Overall Study|Lack of Efficacy|0|||
130553536|NCT00777946|469993599|FG002|Overall Study|Lack of Efficacy|9|||
130553537|NCT00777946|469993597|FG000|Overall Study|Condition no longer required study drug|1|||
130553538|NCT00777946|469993598|FG001|Overall Study|Condition no longer required study drug|0|||
130553539|NCT00777946|469993599|FG002|Overall Study|Condition no longer required study drug|0|||
130553540|NCT00777946|469993597|FG000|Overall Study|Patient withdrew consent|3|||
130553541|NCT00777946|469993598|FG001|Overall Study|Patient withdrew consent|2|||
130553542|NCT00777946|469993599|FG002|Overall Study|Patient withdrew consent|3|||
130553543|NCT00777946|469993597|FG000|Overall Study|Lost to Follow-up|3|||
130553544|NCT00777946|469993598|FG001|Overall Study|Lost to Follow-up|1|||
130553545|NCT00777946|469993599|FG002|Overall Study|Lost to Follow-up|0|||
130553546|NCT00777946|469993597|FG000|Overall Study|Protocol deviation|2|||
130553547|NCT00777946|469993598|FG001|Overall Study|Protocol deviation|1|||
130553548|NCT00777946|469993599|FG002|Overall Study|Protocol deviation|1|||
130553549|NCT00777946|469993597|FG000|Overall Study|Randomized in error|1|||
130553550|NCT00777946|469993598|FG001|Overall Study|Randomized in error|1|||
130553551|NCT00777946|469993599|FG002|Overall Study|Randomized in error|0|||
130553552|NCT01853982|469993600|FG000|Overall Study|Withdrawal by Subject|1|||
130553553|NCT01853982|469993601|FG001|Overall Study|Withdrawal by Subject|0|||
130553554|NCT01853982|469993600|FG000|Overall Study|Death|1|||
130553555|NCT01853982|469993601|FG001|Overall Study|Death|0|||
130255209|NCT01674062|468897993|FG000|Overall Study|Programming Error|1|||
130255210|NCT01674062|468897994|FG001|Overall Study|Programming Error|0|||
130255211|NCT04620668|468897995|FG000|Overall Study|Withdrawal by Subject|2|||
130255212|NCT04620668|468897996|FG001|Overall Study|Withdrawal by Subject|0|||
130553556|NCT01853982|469993600|FG000|Overall Study|Lost to Follow-up|0|||
130700965|NCT02260635|470528360|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130255213|NCT04620668|468897995|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
130255214|NCT04620668|468897996|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
130553557|NCT01853982|469993601|FG001|Overall Study|Lost to Follow-up|1|||
130553558|NCT05066724|469993606|FG000|Overall Study|Adverse Event|1|||
130553559|NCT05066724|469993606|FG000|Overall Study|Non-Compliance With Study Drug|5|||
130553560|NCT05066724|469993606|FG000|Overall Study|Withdrawal by Subject|6|||
130553561|NCT05066724|469993606|FG000|Overall Study|Physician Decision|2|||
130553562|NCT00475033|469993610|FG000|Infant Series|Failed to return|3|||
130553563|NCT00475033|469993611|FG001|Infant Series|Failed to return|4|||
130553564|NCT00475033|469993610|FG000|Infant Series|Parent or legal guardian request|1|||
130376669|NCT01327885|469345895|FG000|Overall Study|Other|8|||
130553565|NCT00475033|469993611|FG001|Infant Series|Parent or legal guardian request|5|||
130553566|NCT00475033|469993610|FG000|Infant Series|Protocol Violation|1|||
130553567|NCT00475033|469993611|FG001|Infant Series|Protocol Violation|2|||
130255215|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: missing data|2|||
130255216|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: missing data|0|||
130255217|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
130255218|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
130255219|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
130255220|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
130255221|NCT02796651|468898004|FG000|Overall Study|Adverse Event|6|||
130255222|NCT02796651|468898004|FG000|Overall Study|Lost to Follow-up|1|||
130255223|NCT02796651|468898004|FG000|Overall Study|Withdrawal by Subject|4|||
130255224|NCT02796651|468898004|FG000|Overall Study|Protocol Violation|4|||
130255225|NCT02796651|468898004|FG000|Overall Study|Lack of Efficacy|1|||
130255226|NCT02796651|468898004|FG000|Overall Study|Other|10|||
130255227|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
130255228|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
130255229|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
130255230|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
130255231|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130255232|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130255233|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
130255234|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130255235|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130255236|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
130255237|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255238|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255239|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
130255240|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
130255241|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
130255242|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
130255243|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130255244|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130255245|NCT05014919|468898005|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130255246|NCT05014919|468898006|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130255247|NCT05014919|468898007|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
130255248|NCT05014919|468898005|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255249|NCT05014919|468898006|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130255250|NCT05014919|468898007|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130255251|NCT00680914|468898008|FG000|Overall Study|Consent withdrawal|6|||
130255252|NCT00680914|468898009|FG001|Overall Study|Consent withdrawal|3|||
130255253|NCT00680914|468898008|FG000|Overall Study|Lost to Follow-up|4|||
130255254|NCT00680914|468898009|FG001|Overall Study|Lost to Follow-up|0|||
130255255|NCT00680914|468898008|FG000|Overall Study|serious adverse event (SAE)|0|||
130255256|NCT00680914|468898009|FG001|Overall Study|serious adverse event (SAE)|1|||
130255257|NCT02971163|468898010|FG000|Overall Study|Lost to Follow-up|4|||
130255258|NCT02971163|468898011|FG001|Overall Study|Lost to Follow-up|2|||
130255259|NCT00539500|468898012|FG000|Overall Study|Disease Progression|1|||
130255260|NCT00539500|468898012|FG000|Overall Study|Lost to Follow-up|2|||
130255261|NCT01491919|468898017|FG000|Overall Study|Insufficient PK sampling|1|||
130255262|NCT01491919|468898018|FG001|Overall Study|Insufficient PK sampling|2|||
130255263|NCT01491919|468898019|FG002|Overall Study|Insufficient PK sampling|1|||
130255264|NCT04003389|468898020|FG000|Overall Study|Adverse Event|27|||
130255265|NCT04003389|468898021|FG001|Overall Study|Adverse Event|34|||
130255266|NCT04003389|468898022|FG002|Overall Study|Adverse Event|28|||
130255267|NCT04003389|468898020|FG000|Overall Study|Lost to Follow-up|39|||
130255268|NCT04003389|468898021|FG001|Overall Study|Lost to Follow-up|30|||
130255269|NCT04003389|468898022|FG002|Overall Study|Lost to Follow-up|33|||
130255270|NCT04003389|468898020|FG000|Overall Study|Protocol Violation|1|||
130255271|NCT04003389|468898021|FG001|Overall Study|Protocol Violation|6|||
130255272|NCT04003389|468898022|FG002|Overall Study|Protocol Violation|5|||
130255273|NCT04003389|468898020|FG000|Overall Study|Withdrawal by Subject|119|||
130255274|NCT04003389|468898021|FG001|Overall Study|Withdrawal by Subject|79|||
130255275|NCT04003389|468898022|FG002|Overall Study|Withdrawal by Subject|85|||
130255276|NCT04003389|468898020|FG000|Overall Study|Miscellaneous|14|||
130255277|NCT04003389|468898021|FG001|Overall Study|Miscellaneous|11|||
130255278|NCT04003389|468898022|FG002|Overall Study|Miscellaneous|14|||
130255279|NCT04003389|468898020|FG000|Overall Study|Participant did not receive study drug|1|||
130553568|NCT00475033|469993610|FG000|Infant Series|Lost to Follow-up|2|||
130255280|NCT04003389|468898021|FG001|Overall Study|Participant did not receive study drug|0|||
130255281|NCT04003389|468898022|FG002|Overall Study|Participant did not receive study drug|0|||
130255282|NCT02871219|468898023|FG000|Overall Study|Adverse Event|15|||
130255283|NCT02871219|468898023|FG000|Overall Study|Death|3|||
130255284|NCT02871219|468898023|FG000|Overall Study|Progression|3|||
130255285|NCT02871219|468898023|FG000|Overall Study|Infections|7|||
130255286|NCT02871219|468898023|FG000|Overall Study|Infusion Related|4|||
130255287|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
130255288|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255289|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255290|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255291|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130255292|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130255293|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130255294|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130255295|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
130255296|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
130255297|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130255298|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130255299|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255300|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
130255301|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255302|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255303|NCT05375929|468898031|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
130255304|NCT05375929|468898032|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255305|NCT05375929|468898033|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255306|NCT05375929|468898034|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255307|NCT05375929|468898031|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255308|NCT05375929|468898032|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
130255309|NCT05375929|468898033|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255310|NCT05375929|468898034|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255311|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255312|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255313|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255314|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
130255315|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255316|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255317|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
130255318|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255319|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255320|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255321|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
130255322|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255323|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255324|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255325|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
130255326|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255327|NCT00322218|468898041|FG000|Overall Study|Death|3|||
130255328|NCT00322218|468898042|FG001|Overall Study|Death|6|||
130255329|NCT00908141|468898043|FG000|Overall Study|Withdrawal by Subject|0|||
130255330|NCT00908141|468898044|FG001|Overall Study|Withdrawal by Subject|1|||
130255331|NCT02520154|468898045|FG000|Overall Study|Death|1|||
130255332|NCT02520154|468898045|FG000|Overall Study|Withdrawal by Subject|2|||
130255333|NCT02520154|468898045|FG000|Overall Study|Physician Decision|2|||
130255334|NCT04280783|468899639|FG000|Overall Study|Family issues unrelated to the study.|1|||
130255335|NCT04280783|468899640|FG001|Overall Study|Family issues unrelated to the study.|0|||
130255336|NCT04280783|468899639|FG000|Overall Study|Withdrawal by Subject|0|||
130255337|NCT04280783|468899640|FG001|Overall Study|Withdrawal by Subject|1|||
130255338|NCT02254291|468899642|FG000|Overall Study|Withdrawal by Subject|0|||
130255339|NCT02254291|468899643|FG001|Overall Study|Withdrawal by Subject|3|||
130255340|NCT02254291|468899644|FG002|Overall Study|Withdrawal by Subject|1|||
130700966|NCT00152516|470528361|FG000|Overall Study|Adverse Event|18|||
130255341|NCT02254291|468899642|FG000|Overall Study|Missing follow-up information|0|||
130255342|NCT02254291|468899643|FG001|Overall Study|Missing follow-up information|0|||
130255343|NCT02254291|468899644|FG002|Overall Study|Missing follow-up information|1|||
130255344|NCT00488293|468899649|FG000|Overall Study|Lost to Follow-up|28|||
130255345|NCT00488293|468899650|FG001|Overall Study|Lost to Follow-up|25|||
130255346|NCT00488293|468899649|FG000|Overall Study|Withdrawal by Subject|5|||
130255347|NCT00488293|468899650|FG001|Overall Study|Withdrawal by Subject|3|||
130553569|NCT00475033|469993611|FG001|Infant Series|Lost to Follow-up|0|||
130553570|NCT00475033|469993610|FG000|Infant Series|Adverse Event|0|||
130553571|NCT00475033|469993611|FG001|Infant Series|Adverse Event|2|||
130553572|NCT00475033|469993610|FG000|After the Infant Series|Adverse Event|0|||
130255348|NCT00488293|468899649|FG000|Overall Study|Death|2|||
130553573|NCT00475033|469993611|FG001|After the Infant Series|Adverse Event|4|||
130255349|NCT00488293|468899650|FG001|Overall Study|Death|1|||
130255350|NCT00488293|468899649|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
130255351|NCT00488293|468899650|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
130255352|NCT00500331|468899651|FG000|Overall Study|Adverse Event|0|||
130255353|NCT00500331|468899652|FG001|Overall Study|Adverse Event|2|||
130255354|NCT00500331|468899653|FG002|Overall Study|Adverse Event|0|||
130255355|NCT00500331|468899654|FG003|Overall Study|Adverse Event|1|||
130255356|NCT00500331|468899655|FG004|Overall Study|Adverse Event|2|||
130255357|NCT00500331|468899656|FG005|Overall Study|Adverse Event|2|||
130255358|NCT00500331|468899657|FG006|Overall Study|Adverse Event|0|||
130553574|NCT00475033|469993610|FG000|After the Infant Series|Parent or legal guardian request|2|||
130553575|NCT00475033|469993611|FG001|After the Infant Series|Parent or legal guardian request|2|||
130553576|NCT00475033|469993610|FG000|After the Infant Series|Failed to return|2|||
130553577|NCT00475033|469993611|FG001|After the Infant Series|Failed to return|1|||
130553578|NCT00475033|469993610|FG000|After the Infant Series|Protocol Violation|1|||
130553579|NCT00475033|469993611|FG001|After the Infant Series|Protocol Violation|0|||
130553580|NCT00475033|469993610|FG000|After the Infant Series|Lost to Follow-up|1|||
130553581|NCT00475033|469993611|FG001|After the Infant Series|Lost to Follow-up|0|||
130553582|NCT00475033|469993610|FG000|After the Infant Series|Other|0|||
130553583|NCT00475033|469993611|FG001|After the Infant Series|Other|1|||
130553584|NCT00475033|469993610|FG000|Toddler Dose|Parent or legal guardian request|2|||
130553585|NCT00475033|469993611|FG001|Toddler Dose|Parent or legal guardian request|0|||
130553586|NCT00475033|469993610|FG000|Toddler Dose|Failed to return|1|||
130553587|NCT00475033|469993611|FG001|Toddler Dose|Failed to return|0|||
130553588|NCT00475033|469993610|FG000|Toddler Dose|Lost to Follow-up|1|||
130553589|NCT00475033|469993611|FG001|Toddler Dose|Lost to Follow-up|0|||
130553590|NCT03444324|469993614|FG000|Overall Study|Withdrawal by Subject|0|||
130553591|NCT03444324|469993615|FG001|Overall Study|Withdrawal by Subject|1|||
130553592|NCT03444324|469993614|FG000|Overall Study|Lost to Follow-up|4|||
130553593|NCT03444324|469993615|FG001|Overall Study|Lost to Follow-up|2|||
130553594|NCT03444324|469993614|FG000|Overall Study|Protocol Violation|0|||
130553595|NCT03444324|469993615|FG001|Overall Study|Protocol Violation|1|||
130553596|NCT03444324|469993614|FG000|Overall Study|Lack of Trial Compliance|1|||
130700967|NCT00152516|470528361|FG000|Overall Study|Lack and Loss of Efficacy|30|||
130255359|NCT00500331|468899651|FG000|Overall Study|Lost to Follow-up|1|||
130255360|NCT00500331|468899652|FG001|Overall Study|Lost to Follow-up|1|||
130255361|NCT00500331|468899653|FG002|Overall Study|Lost to Follow-up|1|||
130255362|NCT00500331|468899654|FG003|Overall Study|Lost to Follow-up|2|||
130255363|NCT00500331|468899655|FG004|Overall Study|Lost to Follow-up|1|||
130255364|NCT00500331|468899656|FG005|Overall Study|Lost to Follow-up|0|||
130255365|NCT00500331|468899657|FG006|Overall Study|Lost to Follow-up|0|||
130255366|NCT00500331|468899651|FG000|Overall Study|Protocol Violation|3|||
130255367|NCT00500331|468899652|FG001|Overall Study|Protocol Violation|1|||
130553597|NCT03444324|469993615|FG001|Overall Study|Lack of Trial Compliance|1|||
130553598|NCT03444324|469993614|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
130700968|NCT00152516|470528361|FG000|Overall Study|Lost to Follow-up|5|||
130700969|NCT00152516|470528361|FG000|Overall Study|Withdrawal by Subject|8|||
130700970|NCT00152516|470528361|FG000|Overall Study|Protocol Violation|3|||
130700971|NCT00152516|470528361|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
130700972|NCT00152516|470528361|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
130255368|NCT00500331|468899653|FG002|Overall Study|Protocol Violation|1|||
130255369|NCT00500331|468899654|FG003|Overall Study|Protocol Violation|0|||
130553599|NCT03444324|469993615|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
130553600|NCT06515483|469993616|FG000|Overall Study|Subject withdraw due to family issues|1|||
130553601|NCT06515483|469993617|FG001|Overall Study|Subject withdraw due to family issues|0|||
130553602|NCT01676909|469994764|FG000|Overall Study|Withdrawal by Subject|3|||
130553603|NCT01676909|469994765|FG001|Overall Study|Withdrawal by Subject|5|||
130700973|NCT00152516|470528361|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
130553604|NCT01676909|469994764|FG000|Overall Study|Lost to Follow-up|15|||
130553605|NCT01676909|469994765|FG001|Overall Study|Lost to Follow-up|9|||
130553606|NCT01176968|469994766|FG000|Overall Study|Adverse Event|10|||
130553607|NCT01176968|469994767|FG001|Overall Study|Adverse Event|11|||
130553608|NCT01176968|469994766|FG000|Overall Study|Death|2|||
130700974|NCT00152516|470528361|FG000|Overall Study|Other: Non-Compliance|2|||
130255370|NCT00500331|468899655|FG004|Overall Study|Protocol Violation|1|||
130255371|NCT00500331|468899656|FG005|Overall Study|Protocol Violation|1|||
130255372|NCT00500331|468899657|FG006|Overall Study|Protocol Violation|1|||
130255373|NCT00500331|468899651|FG000|Overall Study|Withdrawal by Subject|4|||
130255374|NCT00500331|468899652|FG001|Overall Study|Withdrawal by Subject|0|||
130376670|NCT01327885|469345896|FG001|Overall Study|Other|6|||
130255375|NCT00500331|468899653|FG002|Overall Study|Withdrawal by Subject|1|||
130255376|NCT00500331|468899654|FG003|Overall Study|Withdrawal by Subject|5|||
130255377|NCT00500331|468899655|FG004|Overall Study|Withdrawal by Subject|0|||
130255378|NCT00500331|468899656|FG005|Overall Study|Withdrawal by Subject|1|||
130255379|NCT00500331|468899657|FG006|Overall Study|Withdrawal by Subject|1|||
130255380|NCT00500331|468899651|FG000|Overall Study|Lack of Efficacy|3|||
130255381|NCT00500331|468899652|FG001|Overall Study|Lack of Efficacy|1|||
130255382|NCT00500331|468899653|FG002|Overall Study|Lack of Efficacy|0|||
130255383|NCT00500331|468899654|FG003|Overall Study|Lack of Efficacy|0|||
130255384|NCT00500331|468899655|FG004|Overall Study|Lack of Efficacy|0|||
130255385|NCT00500331|468899656|FG005|Overall Study|Lack of Efficacy|0|||
130255386|NCT00500331|468899657|FG006|Overall Study|Lack of Efficacy|0|||
130255387|NCT00500331|468899651|FG000|Overall Study|Liver function test abnormality|0|||
130255388|NCT00500331|468899652|FG001|Overall Study|Liver function test abnormality|0|||
130255389|NCT00500331|468899653|FG002|Overall Study|Liver function test abnormality|1|||
130255390|NCT00500331|468899654|FG003|Overall Study|Liver function test abnormality|0|||
130255391|NCT00500331|468899655|FG004|Overall Study|Liver function test abnormality|0|||
130255392|NCT00500331|468899656|FG005|Overall Study|Liver function test abnormality|0|||
130255393|NCT00500331|468899657|FG006|Overall Study|Liver function test abnormality|0|||
130255394|NCT00500331|468899651|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
130255395|NCT00500331|468899652|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
130255396|NCT00500331|468899653|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
130255397|NCT00500331|468899654|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
130255398|NCT00500331|468899655|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
130255399|NCT00500331|468899656|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
130255400|NCT00500331|468899657|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
130255401|NCT00500331|468899651|FG000|Overall Study|Didn't return for continuation of study|1|||
130255402|NCT00500331|468899652|FG001|Overall Study|Didn't return for continuation of study|0|||
130255403|NCT00500331|468899653|FG002|Overall Study|Didn't return for continuation of study|0|||
130255404|NCT00500331|468899654|FG003|Overall Study|Didn't return for continuation of study|0|||
130255405|NCT00500331|468899655|FG004|Overall Study|Didn't return for continuation of study|0|||
130255406|NCT00500331|468899656|FG005|Overall Study|Didn't return for continuation of study|0|||
130255407|NCT00500331|468899657|FG006|Overall Study|Didn't return for continuation of study|0|||
130255408|NCT00500331|468899651|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
130255409|NCT00500331|468899652|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255410|NCT00500331|468899653|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255411|NCT00500331|468899654|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255412|NCT00500331|468899655|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255413|NCT00500331|468899656|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255414|NCT00500331|468899657|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255415|NCT00500331|468899651|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
130255416|NCT00500331|468899652|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
130255417|NCT00500331|468899653|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
130255418|NCT00500331|468899654|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
130255419|NCT00500331|468899655|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
130255420|NCT00500331|468899656|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
130255421|NCT00500331|468899657|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
130255422|NCT00500331|468899651|FG000|Overall Study|Participant was randomized by mistake|1|||
130255423|NCT00500331|468899652|FG001|Overall Study|Participant was randomized by mistake|0|||
130255424|NCT00500331|468899653|FG002|Overall Study|Participant was randomized by mistake|0|||
130255425|NCT00500331|468899654|FG003|Overall Study|Participant was randomized by mistake|0|||
130255426|NCT00500331|468899655|FG004|Overall Study|Participant was randomized by mistake|0|||
130255427|NCT00500331|468899656|FG005|Overall Study|Participant was randomized by mistake|0|||
130255428|NCT00500331|468899657|FG006|Overall Study|Participant was randomized by mistake|0|||
130255429|NCT00500331|468899651|FG000|Overall Study|Diabetologist nurse in the study|0|||
130255430|NCT00500331|468899652|FG001|Overall Study|Diabetologist nurse in the study|0|||
130255431|NCT00500331|468899653|FG002|Overall Study|Diabetologist nurse in the study|1|||
130255432|NCT00500331|468899654|FG003|Overall Study|Diabetologist nurse in the study|0|||
130255433|NCT00500331|468899655|FG004|Overall Study|Diabetologist nurse in the study|0|||
130255434|NCT00500331|468899656|FG005|Overall Study|Diabetologist nurse in the study|0|||
130255435|NCT00500331|468899657|FG006|Overall Study|Diabetologist nurse in the study|0|||
130255436|NCT00500331|468899651|FG000|Overall Study|State ban of biological samples export|0|||
130255437|NCT00500331|468899652|FG001|Overall Study|State ban of biological samples export|0|||
130255438|NCT00500331|468899653|FG002|Overall Study|State ban of biological samples export|0|||
130255439|NCT00500331|468899654|FG003|Overall Study|State ban of biological samples export|1|||
130255440|NCT00500331|468899655|FG004|Overall Study|State ban of biological samples export|0|||
130255441|NCT00500331|468899656|FG005|Overall Study|State ban of biological samples export|0|||
130255442|NCT00500331|468899657|FG006|Overall Study|State ban of biological samples export|0|||
130255443|NCT00500331|468899651|FG000|Overall Study|Protocol violated|0|||
130255444|NCT00500331|468899652|FG001|Overall Study|Protocol violated|0|||
130255445|NCT00500331|468899653|FG002|Overall Study|Protocol violated|0|||
130255446|NCT00500331|468899654|FG003|Overall Study|Protocol violated|1|||
130255447|NCT00500331|468899655|FG004|Overall Study|Protocol violated|0|||
130255448|NCT00500331|468899656|FG005|Overall Study|Protocol violated|0|||
130255449|NCT00500331|468899657|FG006|Overall Study|Protocol violated|0|||
130255450|NCT03436732|468899658|FG000|Overall Study|Not treated-enrolled in different study|1|||
130255451|NCT03436732|468899659|FG001|Overall Study|Not treated-enrolled in different study|0|||
130255452|NCT03436732|468899658|FG000|Overall Study|Off study after cycle 1|1|||
130255453|NCT03436732|468899659|FG001|Overall Study|Off study after cycle 1|0|||
130255454|NCT03436732|468899658|FG000|Overall Study|Adverse Event|2|||
130255455|NCT03436732|468899659|FG001|Overall Study|Adverse Event|0|||
130255456|NCT03436732|468899658|FG000|Overall Study|Death|0|||
130255457|NCT03436732|468899659|FG001|Overall Study|Death|1|||
130255458|NCT03345550|468899660|FG000|Overall Study|Withdrawal by Subject|1|||
130255459|NCT03345550|468899661|FG001|Overall Study|Withdrawal by Subject|0|||
130255460|NCT03345550|468899660|FG000|Overall Study|Lost to Follow-up|4|||
130255461|NCT03345550|468899661|FG001|Overall Study|Lost to Follow-up|5|||
130255462|NCT00959049|468899662|FG000|Overall Study|Adverse Event|1|||
130255463|NCT00959049|468899663|FG001|Overall Study|Adverse Event|0|||
130255464|NCT00959049|468899664|FG002|Overall Study|Adverse Event|0|||
130255465|NCT00959049|468899665|FG003|Overall Study|Adverse Event|0|||
130255466|NCT00959049|468899666|FG004|Overall Study|Adverse Event|0|||
130255467|NCT00959049|468899667|FG005|Overall Study|Adverse Event|0|||
130255468|NCT00959049|468899662|FG000|Overall Study|Lost to Follow-up|17|||
130255469|NCT00959049|468899663|FG001|Overall Study|Lost to Follow-up|5|||
130255470|NCT00959049|468899664|FG002|Overall Study|Lost to Follow-up|1|||
130255471|NCT00959049|468899665|FG003|Overall Study|Lost to Follow-up|10|||
130255472|NCT00959049|468899666|FG004|Overall Study|Lost to Follow-up|9|||
130255473|NCT00959049|468899667|FG005|Overall Study|Lost to Follow-up|1|||
130255474|NCT00959049|468899662|FG000|Overall Study|Contraindicated medication|0|||
130255475|NCT00959049|468899663|FG001|Overall Study|Contraindicated medication|0|||
130255476|NCT00959049|468899664|FG002|Overall Study|Contraindicated medication|0|||
130255477|NCT00959049|468899665|FG003|Overall Study|Contraindicated medication|1|||
130255478|NCT00959049|468899666|FG004|Overall Study|Contraindicated medication|0|||
130255479|NCT00959049|468899667|FG005|Overall Study|Contraindicated medication|0|||
130255480|NCT00959049|468899662|FG000|Overall Study|Withdrawal by Subject|0|||
130255481|NCT00959049|468899663|FG001|Overall Study|Withdrawal by Subject|2|||
130255482|NCT00959049|468899664|FG002|Overall Study|Withdrawal by Subject|0|||
130255483|NCT00959049|468899665|FG003|Overall Study|Withdrawal by Subject|0|||
130255484|NCT00959049|468899666|FG004|Overall Study|Withdrawal by Subject|0|||
130255485|NCT00959049|468899667|FG005|Overall Study|Withdrawal by Subject|0|||
130255486|NCT00137449|468899668|FG000|Overall Study|Disease Progression|8|||
130255487|NCT00137449|468899669|FG001|Overall Study|Disease Progression|13|||
130255488|NCT00137449|468899668|FG000|Overall Study|Death|4|||
130255489|NCT00137449|468899669|FG001|Overall Study|Death|3|||
130255490|NCT00137449|468899668|FG000|Overall Study|Adverse Event|3|||
130255491|NCT00137449|468899669|FG001|Overall Study|Adverse Event|1|||
130255492|NCT00137449|468899668|FG000|Overall Study|Withdrawal by Subject|1|||
130255493|NCT00137449|468899669|FG001|Overall Study|Withdrawal by Subject|1|||
130255494|NCT02489279|468899670|FG000|Overall Study|Lost to Follow-up|12|||
130255495|NCT02489279|468899671|FG001|Overall Study|Lost to Follow-up|10|||
130255496|NCT02263547|468899672|FG000|Overall Study|Adverse Event|1|||
130255497|NCT02263547|468899672|FG000|Overall Study|Lost to Follow-up|2|||
130255498|NCT00586157|468899673|FG000|First Intervention|Worsening behavior|1|||
130255499|NCT00586157|468899674|FG001|First Intervention|Worsening behavior|0|||
130255500|NCT00586157|468899673|FG000|Second Intervention|Withdrawal by Subject|1|||
130255501|NCT00586157|468899674|FG001|Second Intervention|Withdrawal by Subject|0|||
130255502|NCT00586157|468899673|FG000|Second Intervention|Worsening behavior|1|||
130255503|NCT00586157|468899674|FG001|Second Intervention|Worsening behavior|0|||
130255504|NCT00586157|468899673|FG000|Second Intervention|Adverse Event|0|||
130255505|NCT00586157|468899674|FG001|Second Intervention|Adverse Event|1|||
130255506|NCT02378480|468899676|FG000|Overall Study|Physician Decision|1|||
130255507|NCT02378480|468899677|FG001|Overall Study|Physician Decision|1|||
130255508|NCT02378480|468899676|FG000|Overall Study|Death|1|||
130255509|NCT02378480|468899677|FG001|Overall Study|Death|2|||
130255510|NCT02378480|468899676|FG000|Overall Study|Randomized, but Not Treated|6|||
130255511|NCT02378480|468899677|FG001|Overall Study|Randomized, but Not Treated|4|||
130255512|NCT02378480|468899676|FG000|Overall Study|Adverse Event|0|||
130255513|NCT02378480|468899677|FG001|Overall Study|Adverse Event|1|||
130255514|NCT02378480|468899676|FG000|Overall Study|Missed EOT/PTE Visit|1|||
130255515|NCT02378480|468899677|FG001|Overall Study|Missed EOT/PTE Visit|2|||
130255516|NCT02378480|468899676|FG000|Overall Study|Withdrawal by Subject|9|||
130255517|NCT02378480|468899677|FG001|Overall Study|Withdrawal by Subject|4|||
130255518|NCT02378480|468899676|FG000|Overall Study|Lost to Follow-up|10|||
130255519|NCT02378480|468899677|FG001|Overall Study|Lost to Follow-up|18|||
130255520|NCT02014467|468899683|FG000|Overall Study|Adverse Event|4|||
130255521|NCT02014467|468899684|FG001|Overall Study|Adverse Event|0|||
130255522|NCT02014467|468899683|FG000|Overall Study|Protocol Violation|3|||
130255523|NCT02014467|468899684|FG001|Overall Study|Protocol Violation|0|||
130255524|NCT02014467|468899683|FG000|Overall Study|Physician Decision|2|||
130255525|NCT02014467|468899684|FG001|Overall Study|Physician Decision|3|||
130255526|NCT02014467|468899683|FG000|Overall Study|Withdrawal by Subject|16|||
130255527|NCT02014467|468899684|FG001|Overall Study|Withdrawal by Subject|4|||
130255528|NCT01230060|468899685|FG000|Overall Study|Withdrawal by Subject|1|||
130255529|NCT01217892|468899687|FG000|Overall Study|Adverse Event|1|||
130255530|NCT01217892|468899688|FG001|Overall Study|Adverse Event|1|||
130255531|NCT01217892|468899689|FG002|Overall Study|Adverse Event|1|||
130255532|NCT01217892|468899690|FG003|Overall Study|Adverse Event|0|||
130255533|NCT01217892|468899687|FG000|Overall Study|Withdrawal by Subject|0|||
130255534|NCT01217892|468899688|FG001|Overall Study|Withdrawal by Subject|2|||
130255535|NCT01217892|468899689|FG002|Overall Study|Withdrawal by Subject|1|||
130255536|NCT01217892|468899690|FG003|Overall Study|Withdrawal by Subject|0|||
130255537|NCT01217892|468899687|FG000|Overall Study|Lab value|1|||
130255538|NCT01217892|468899688|FG001|Overall Study|Lab value|0|||
130255539|NCT01217892|468899689|FG002|Overall Study|Lab value|1|||
130255540|NCT01217892|468899690|FG003|Overall Study|Lab value|0|||
130255541|NCT01217892|468899687|FG000|Overall Study|Subject no longer meets study criteria|5|||
130255542|NCT01217892|468899688|FG001|Overall Study|Subject no longer meets study criteria|2|||
130255543|NCT01217892|468899689|FG002|Overall Study|Subject no longer meets study criteria|4|||
130255544|NCT01217892|468899690|FG003|Overall Study|Subject no longer meets study criteria|8|||
130255545|NCT01217892|468899687|FG000|Overall Study|Incorrect enrollment|0|||
130255546|NCT01217892|468899688|FG001|Overall Study|Incorrect enrollment|1|||
130255547|NCT01217892|468899689|FG002|Overall Study|Incorrect enrollment|1|||
130255548|NCT01217892|468899690|FG003|Overall Study|Incorrect enrollment|0|||
130255549|NCT01217892|468899687|FG000|Overall Study|Poor/Non-Compliance|0|||
130255550|NCT01217892|468899688|FG001|Overall Study|Poor/Non-Compliance|0|||
130255551|NCT01217892|468899689|FG002|Overall Study|Poor/Non-Compliance|1|||
130255552|NCT01217892|468899690|FG003|Overall Study|Poor/Non-Compliance|0|||
130255553|NCT01052779|468899691|FG000|Overall Study|Adverse Event|1|||
130255554|NCT01052779|468899692|FG001|Overall Study|Adverse Event|4|||
130255555|NCT01052779|468899691|FG000|Overall Study|Withdrawal by Subject|1|||
130255556|NCT01052779|468899692|FG001|Overall Study|Withdrawal by Subject|2|||
130255557|NCT01052779|468899691|FG000|Overall Study|Other-Protocol Violation|1|||
130255558|NCT01052779|468899692|FG001|Overall Study|Other-Protocol Violation|1|||
130255559|NCT01052779|468899691|FG000|Overall Study|Other-Surgery|0|||
130255560|NCT01052779|468899692|FG001|Overall Study|Other-Surgery|2|||
130255561|NCT01052779|468899691|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
130255562|NCT01052779|468899692|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
130255563|NCT03802916|468899693|FG000|Overall Study|Adverse Event|0|||
130255564|NCT03802916|468899694|FG001|Overall Study|Adverse Event|1|||
130255565|NCT03802916|468899693|FG000|Overall Study|Withdrawal by Subject|0|||
130255566|NCT03802916|468899694|FG001|Overall Study|Withdrawal by Subject|1|||
130255567|NCT03663582|468899695|FG000|Overall Study|Physician Decision|1|||
130255568|NCT03242434|468899698|FG000|Overall Study|Death|0|||
130255569|NCT03242434|468899699|FG001|Overall Study|Death|2|||
130255570|NCT04507763|468899700|FG000|Overall Study|Participants did not meet entrance criteria|201|||
130255571|NCT03427619|468899701|FG000|Overall Study|Physician Decision|3|||
130255572|NCT03427619|468899701|FG000|Overall Study|Withdrawal by Subject|4|||
130255573|NCT03427619|468899701|FG000|Overall Study|Lost to Follow-up|5|||
130255574|NCT03427619|468899701|FG000|Overall Study|Administrative|4|||
130255575|NCT03427619|468899701|FG000|Overall Study|Other|2|||
130255576|NCT03427619|468899701|FG000|Overall Study|Unknown or Missing Completion Status|48|||
130255577|NCT05763381|468899702|FG000|Overall Study|Lost to Follow-up|2|||
130255578|NCT05763381|468899703|FG001|Overall Study|Lost to Follow-up|3|||
130553609|NCT01176968|469994767|FG001|Overall Study|Death|3|||
130255579|NCT05763381|468899702|FG000|Overall Study|Withdrawal by Subject|1|||
130255580|NCT05763381|468899703|FG001|Overall Study|Withdrawal by Subject|2|||
130255581|NCT02853136|468899704|FG000|Wash-out|Adverse Event|0|||
130255582|NCT02853136|468899705|FG001|Wash-out|Adverse Event|0|||
130255583|NCT02853136|468899706|FG002|Wash-out|Adverse Event|0|||
130255584|NCT02853136|468899707|FG003|Wash-out|Adverse Event|1|||
130255585|NCT00841815|468899708|FG000|Washout|Withdrawal by Subject|0|||
130255586|NCT00841815|468899709|FG001|Washout|Withdrawal by Subject|1|||
130255587|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|0|||
130255588|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|1|||
130255589|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|1|||
130255590|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|0|||
130255591|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|1|||
130255592|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|0|||
130255593|NCT03787615|468899713|FG000|Overall Study|Withdrawal by Subject|2|||
130255594|NCT03787615|468899713|FG000|Overall Study|Lost to Follow-up|2|||
130255595|NCT02697448|468899714|FG000|Overall Study|Protocol Violation|2|||
130255596|NCT02697448|468899715|FG001|Overall Study|Protocol Violation|4|||
130255597|NCT02697448|468899714|FG000|Overall Study|Clinical concerns during ablation|1|||
130255598|NCT02697448|468899715|FG001|Overall Study|Clinical concerns during ablation|1|||
130255599|NCT02697448|468899714|FG000|Overall Study|No data collected|2|||
130255600|NCT02697448|468899715|FG001|Overall Study|No data collected|0|||
130255601|NCT03464461|468899716|FG000|Overall Study|exclusionary medication given ,|1|||
130255602|NCT03464461|468899717|FG001|Overall Study|exclusionary medication given ,|2|||
130255603|NCT03464461|468899718|FG002|Overall Study|exclusionary medication given ,|0|||
130255604|NCT03464461|468899716|FG000|Overall Study|Physician Decision|0|||
130255605|NCT03464461|468899717|FG001|Overall Study|Physician Decision|1|||
130255606|NCT03464461|468899718|FG002|Overall Study|Physician Decision|0|||
130255607|NCT03685149|468899720|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
130255608|NCT03685149|468899721|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
130255609|NCT03685149|468899720|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130255610|NCT03685149|468899721|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130255611|NCT03685149|468899720|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
130255612|NCT03685149|468899721|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
130255613|NCT04876391|468899722|FG000|Overall Study|Withdrawal by Subject|1|||
130255614|NCT04876391|468899723|FG001|Overall Study|Withdrawal by Subject|10|||
130365093|NCT02925117|469306850|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130365094|NCT02925117|469306851|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130255615|NCT04876391|468899722|FG000|Overall Study|Lost to Follow-up|2|||
130255616|NCT04876391|468899723|FG001|Overall Study|Lost to Follow-up|4|||
130255617|NCT04876391|468899722|FG000|Overall Study|Lack of Efficacy|0|||
130255618|NCT04876391|468899723|FG001|Overall Study|Lack of Efficacy|2|||
130365095|NCT02925117|469306852|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130255619|NCT04876391|468899722|FG000|Overall Study|Adverse Event|3|||
130255620|NCT04876391|468899723|FG001|Overall Study|Adverse Event|1|||
130255621|NCT04876391|468899722|FG000|Overall Study|Patient non-compliance|0|||
130255622|NCT04876391|468899723|FG001|Overall Study|Patient non-compliance|1|||
130255623|NCT04876391|468899722|FG000|Overall Study|Personal reasons|0|||
130255624|NCT04876391|468899723|FG001|Overall Study|Personal reasons|1|||
130255625|NCT04876391|468899722|FG000|Overall Study|Withdrawn as per protocol|2|||
130255626|NCT04876391|468899723|FG001|Overall Study|Withdrawn as per protocol|2|||
130255627|NCT00209131|468899728|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
130255628|NCT00209131|468899729|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
130255629|NCT05360784|468899730|FG000|Overall Study|Discontinued|25|||
130255630|NCT05360784|468899731|FG001|Overall Study|Discontinued|11|||
130255631|NCT05142306|468899735|FG000|Overall Study|Withdrawal by Subject|0|||
130255632|NCT05142306|468899736|FG001|Overall Study|Withdrawal by Subject|0|||
130255633|NCT05142306|468899737|FG002|Overall Study|Withdrawal by Subject|1|||
130255634|NCT02251041|468899738|FG000|Overall Study|Did not receive intervention|15|||
130255635|NCT02251041|468899739|FG001|Overall Study|Did not receive intervention|4|||
130255636|NCT04079920|468899740|FG000|Overall Study|Adverse event, not related to study drug|2|||
130255637|NCT04079920|468899740|FG000|Overall Study|Adverse event related to study drug|10|||
130255638|NCT04079920|468899740|FG000|Overall Study|Death|2|||
130255639|NCT04079920|468899740|FG000|Overall Study|Lost to Follow-up|22|||
130255640|NCT04079920|468899740|FG000|Overall Study|Physician Decision|1|||
130255641|NCT04079920|468899740|FG000|Overall Study|Withdrawal by Subject|11|||
130255642|NCT04918771|468899741|FG000|Overall Study|Withdrawal by Subject|4|||
130255643|NCT04918771|468899742|FG001|Overall Study|Withdrawal by Subject|5|||
130255644|NCT04918771|468899741|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
130255645|NCT04918771|468899742|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
130255646|NCT01299961|468899749|FG000|Overall Study|Adverse Event|3|||
130255647|NCT01299961|468899749|FG000|Overall Study|Lack of Efficacy|2|||
130255648|NCT01299961|468899749|FG000|Overall Study|Lost to Follow-up|1|||
130255649|NCT02904096|468899750|FG000|Overall Study|Adverse Event|1|||
130255650|NCT02904096|468899751|FG001|Overall Study|Adverse Event|0|||
130255651|NCT02904096|468899750|FG000|Overall Study|Withdrawal by Subject|4|||
130255652|NCT02904096|468899751|FG001|Overall Study|Withdrawal by Subject|3|||
130255653|NCT02904096|468899750|FG000|Overall Study|Lost to Follow-up|10|||
130255654|NCT02904096|468899751|FG001|Overall Study|Lost to Follow-up|17|||
130255655|NCT02904096|468899750|FG000|Overall Study|Non-compliant|3|||
130255656|NCT02904096|468899751|FG001|Overall Study|Non-compliant|1|||
130255657|NCT02904096|468899750|FG000|Overall Study|Sponsor instructed|1|||
130255658|NCT02904096|468899751|FG001|Overall Study|Sponsor instructed|0|||
130255659|NCT05305651|468899752|FG000|Overall Study|Death|1|||
130255660|NCT05305651|468899752|FG000|Overall Study|Withdrawal by Subject|4|||
130255661|NCT05305651|468899752|FG000|Overall Study|Lost to Follow-up|4|||
130255662|NCT00526799|468899753|FG000|Overall Study|Withdrawal by Subject|1|||
130255663|NCT00526799|468899754|FG001|Overall Study|Withdrawal by Subject|0|||
130255664|NCT00526799|468899753|FG000|Overall Study|Intercurrent Complicating Disease|0|||
130255665|NCT00526799|468899754|FG001|Overall Study|Intercurrent Complicating Disease|1|||
130255666|NCT02298946|468899755|FG000|Overall Study|Did not receive treatment|2|||
130255667|NCT02298946|468899756|FG001|Overall Study|Did not receive treatment|0|||
130255668|NCT02298946|468899755|FG000|Overall Study|Unevaluable|2|||
130255669|NCT02298946|468899756|FG001|Overall Study|Unevaluable|1|||
130255670|NCT03648372|468899763|FG000|Overall Study|Withdrawal by Subject|2|||
130255671|NCT03648372|468899764|FG001|Overall Study|Withdrawal by Subject|0|||
130255672|NCT03648372|468899765|FG002|Overall Study|Withdrawal by Subject|0|||
130255673|NCT03648372|468899766|FG003|Overall Study|Withdrawal by Subject|0|||
130255674|NCT03648372|468899767|FG004|Overall Study|Withdrawal by Subject|0|||
130255675|NCT03648372|468899768|FG005|Overall Study|Withdrawal by Subject|1|||
130255676|NCT03648372|468899769|FG006|Overall Study|Withdrawal by Subject|2|||
130255677|NCT03648372|468899770|FG007|Overall Study|Withdrawal by Subject|0|||
130255678|NCT03648372|468899771|FG008|Overall Study|Withdrawal by Subject|0|||
130255679|NCT03648372|468899772|FG009|Overall Study|Withdrawal by Subject|0|||
130255680|NCT03648372|468899773|FG010|Overall Study|Withdrawal by Subject|2|||
130255681|NCT03648372|468899774|FG011|Overall Study|Withdrawal by Subject|0|||
130255682|NCT03648372|468899775|FG012|Overall Study|Withdrawal by Subject|2|||
130255683|NCT03648372|468899776|FG013|Overall Study|Withdrawal by Subject|0|||
130255684|NCT03648372|468899777|FG014|Overall Study|Withdrawal by Subject|0|||
130255685|NCT03648372|468899778|FG015|Overall Study|Withdrawal by Subject|0|||
130255686|NCT03648372|468899779|FG016|Overall Study|Withdrawal by Subject|1|||
130255687|NCT03648372|468899780|FG017|Overall Study|Withdrawal by Subject|0|||
130255688|NCT03648372|468899781|FG018|Overall Study|Withdrawal by Subject|0|||
130255689|NCT03648372|468899782|FG019|Overall Study|Withdrawal by Subject|0|||
130255690|NCT03648372|468899783|FG020|Overall Study|Withdrawal by Subject|0|||
130255691|NCT03648372|468899763|FG000|Overall Study|Progressive Disease|2|||
130255692|NCT03648372|468899764|FG001|Overall Study|Progressive Disease|3|||
130255693|NCT03648372|468899765|FG002|Overall Study|Progressive Disease|4|||
130255694|NCT03648372|468899766|FG003|Overall Study|Progressive Disease|3|||
130255695|NCT03648372|468899767|FG004|Overall Study|Progressive Disease|2|||
130255696|NCT03648372|468899768|FG005|Overall Study|Progressive Disease|2|||
130255697|NCT03648372|468899769|FG006|Overall Study|Progressive Disease|3|||
130255698|NCT03648372|468899770|FG007|Overall Study|Progressive Disease|3|||
130255699|NCT03648372|468899771|FG008|Overall Study|Progressive Disease|5|||
130255700|NCT03648372|468899772|FG009|Overall Study|Progressive Disease|5|||
130255701|NCT03648372|468899773|FG010|Overall Study|Progressive Disease|2|||
130255702|NCT03648372|468899774|FG011|Overall Study|Progressive Disease|3|||
130255703|NCT03648372|468899775|FG012|Overall Study|Progressive Disease|3|||
130255704|NCT03648372|468899776|FG013|Overall Study|Progressive Disease|3|||
130255705|NCT03648372|468899777|FG014|Overall Study|Progressive Disease|6|||
130255706|NCT03648372|468899778|FG015|Overall Study|Progressive Disease|0|||
130255707|NCT03648372|468899779|FG016|Overall Study|Progressive Disease|0|||
130255708|NCT03648372|468899780|FG017|Overall Study|Progressive Disease|0|||
130255709|NCT03648372|468899781|FG018|Overall Study|Progressive Disease|0|||
130255710|NCT03648372|468899782|FG019|Overall Study|Progressive Disease|0|||
130255711|NCT03648372|468899783|FG020|Overall Study|Progressive Disease|0|||
130255712|NCT03648372|468899763|FG000|Overall Study|Other|0|||
130255713|NCT03648372|468899764|FG001|Overall Study|Other|0|||
130255714|NCT03648372|468899765|FG002|Overall Study|Other|0|||
130255715|NCT03648372|468899766|FG003|Overall Study|Other|0|||
130255716|NCT03648372|468899767|FG004|Overall Study|Other|1|||
130255717|NCT03648372|468899768|FG005|Overall Study|Other|0|||
130255718|NCT03648372|468899769|FG006|Overall Study|Other|0|||
130255719|NCT03648372|468899770|FG007|Overall Study|Other|0|||
130255720|NCT03648372|468899771|FG008|Overall Study|Other|0|||
130255721|NCT03648372|468899772|FG009|Overall Study|Other|0|||
130255722|NCT03648372|468899773|FG010|Overall Study|Other|1|||
130255723|NCT03648372|468899774|FG011|Overall Study|Other|2|||
130255724|NCT03648372|468899775|FG012|Overall Study|Other|1|||
130255725|NCT03648372|468899776|FG013|Overall Study|Other|3|||
130255726|NCT03648372|468899777|FG014|Overall Study|Other|0|||
130255727|NCT03648372|468899778|FG015|Overall Study|Other|5|||
130255728|NCT03648372|468899779|FG016|Overall Study|Other|1|||
130255729|NCT03648372|468899780|FG017|Overall Study|Other|5|||
130255730|NCT03648372|468899781|FG018|Overall Study|Other|0|||
130255731|NCT03648372|468899782|FG019|Overall Study|Other|1|||
130255732|NCT03648372|468899783|FG020|Overall Study|Other|0|||
130255733|NCT03648372|468899763|FG000|Overall Study|Lost to Follow-up|0|||
130255734|NCT03648372|468899764|FG001|Overall Study|Lost to Follow-up|0|||
130255735|NCT03648372|468899765|FG002|Overall Study|Lost to Follow-up|0|||
130255736|NCT03648372|468899766|FG003|Overall Study|Lost to Follow-up|0|||
130255737|NCT03648372|468899767|FG004|Overall Study|Lost to Follow-up|0|||
130255738|NCT03648372|468899768|FG005|Overall Study|Lost to Follow-up|0|||
130255739|NCT03648372|468899769|FG006|Overall Study|Lost to Follow-up|0|||
130255740|NCT03648372|468899770|FG007|Overall Study|Lost to Follow-up|0|||
130255741|NCT03648372|468899771|FG008|Overall Study|Lost to Follow-up|0|||
130255742|NCT03648372|468899772|FG009|Overall Study|Lost to Follow-up|0|||
130255743|NCT03648372|468899773|FG010|Overall Study|Lost to Follow-up|0|||
130255744|NCT03648372|468899774|FG011|Overall Study|Lost to Follow-up|0|||
130255745|NCT03648372|468899775|FG012|Overall Study|Lost to Follow-up|0|||
130255746|NCT03648372|468899776|FG013|Overall Study|Lost to Follow-up|1|||
130255747|NCT03648372|468899777|FG014|Overall Study|Lost to Follow-up|0|||
130255748|NCT03648372|468899778|FG015|Overall Study|Lost to Follow-up|1|||
130255749|NCT03648372|468899779|FG016|Overall Study|Lost to Follow-up|0|||
130255750|NCT03648372|468899780|FG017|Overall Study|Lost to Follow-up|1|||
130255751|NCT03648372|468899781|FG018|Overall Study|Lost to Follow-up|0|||
130255752|NCT03648372|468899782|FG019|Overall Study|Lost to Follow-up|0|||
130255753|NCT03648372|468899783|FG020|Overall Study|Lost to Follow-up|0|||
130255754|NCT03648372|468899763|FG000|Overall Study|Start of a New Systemic Treatment|0|||
130255755|NCT03648372|468899764|FG001|Overall Study|Start of a New Systemic Treatment|0|||
130255756|NCT03648372|468899765|FG002|Overall Study|Start of a New Systemic Treatment|0|||
130255757|NCT03648372|468899766|FG003|Overall Study|Start of a New Systemic Treatment|0|||
130255758|NCT03648372|468899767|FG004|Overall Study|Start of a New Systemic Treatment|0|||
130255759|NCT03648372|468899768|FG005|Overall Study|Start of a New Systemic Treatment|0|||
130255760|NCT03648372|468899769|FG006|Overall Study|Start of a New Systemic Treatment|0|||
130255761|NCT03648372|468899770|FG007|Overall Study|Start of a New Systemic Treatment|2|||
130255762|NCT03648372|468899771|FG008|Overall Study|Start of a New Systemic Treatment|0|||
130255763|NCT03648372|468899772|FG009|Overall Study|Start of a New Systemic Treatment|0|||
130255764|NCT03648372|468899773|FG010|Overall Study|Start of a New Systemic Treatment|1|||
130255765|NCT03648372|468899774|FG011|Overall Study|Start of a New Systemic Treatment|0|||
130255766|NCT03648372|468899775|FG012|Overall Study|Start of a New Systemic Treatment|0|||
130255767|NCT03648372|468899776|FG013|Overall Study|Start of a New Systemic Treatment|0|||
130255768|NCT03648372|468899777|FG014|Overall Study|Start of a New Systemic Treatment|0|||
130255769|NCT03648372|468899778|FG015|Overall Study|Start of a New Systemic Treatment|0|||
130255770|NCT03648372|468899779|FG016|Overall Study|Start of a New Systemic Treatment|0|||
130255771|NCT03648372|468899780|FG017|Overall Study|Start of a New Systemic Treatment|0|||
130255772|NCT03648372|468899781|FG018|Overall Study|Start of a New Systemic Treatment|0|||
130255773|NCT03648372|468899782|FG019|Overall Study|Start of a New Systemic Treatment|0|||
130255774|NCT03648372|468899783|FG020|Overall Study|Start of a New Systemic Treatment|0|||
130255775|NCT05654181|468901117|FG000|Overall Study|Adverse Event|1|||
130255776|NCT05654181|468901118|FG001|Overall Study|Adverse Event|0|||
130255777|NCT05654181|468901119|FG002|Overall Study|Adverse Event|0|||
130255778|NCT05654181|468901120|FG003|Overall Study|Adverse Event|0|||
130255779|NCT05654181|468901121|FG004|Overall Study|Adverse Event|0|||
130255780|NCT05654181|468901122|FG005|Overall Study|Adverse Event|0|||
130255781|NCT05654181|468901123|FG006|Overall Study|Adverse Event|0|||
130255782|NCT05654181|468901124|FG007|Overall Study|Adverse Event|1|||
130255783|NCT05654181|468901125|FG008|Overall Study|Adverse Event|0|||
130255784|NCT05654181|468901126|FG009|Overall Study|Adverse Event|0|||
130255785|NCT05654181|468901117|FG000|Overall Study|Withdrawal by Subject|0|||
130255786|NCT05654181|468901118|FG001|Overall Study|Withdrawal by Subject|0|||
130255787|NCT05654181|468901119|FG002|Overall Study|Withdrawal by Subject|0|||
130255788|NCT05654181|468901120|FG003|Overall Study|Withdrawal by Subject|0|||
130255789|NCT05654181|468901121|FG004|Overall Study|Withdrawal by Subject|0|||
130255790|NCT05654181|468901122|FG005|Overall Study|Withdrawal by Subject|0|||
130255791|NCT05654181|468901123|FG006|Overall Study|Withdrawal by Subject|0|||
130255792|NCT05654181|468901124|FG007|Overall Study|Withdrawal by Subject|1|||
130255793|NCT05654181|468901125|FG008|Overall Study|Withdrawal by Subject|0|||
130255794|NCT05654181|468901126|FG009|Overall Study|Withdrawal by Subject|0|||
130255795|NCT05654181|468901117|FG000|Overall Study|Other|0|||
130255796|NCT05654181|468901118|FG001|Overall Study|Other|0|||
130255797|NCT05654181|468901119|FG002|Overall Study|Other|0|||
130255798|NCT05654181|468901120|FG003|Overall Study|Other|0|||
130255799|NCT05654181|468901121|FG004|Overall Study|Other|1|||
130255800|NCT05654181|468901122|FG005|Overall Study|Other|1|||
130255801|NCT05654181|468901123|FG006|Overall Study|Other|0|||
130255802|NCT05654181|468901124|FG007|Overall Study|Other|0|||
130255803|NCT05654181|468901125|FG008|Overall Study|Other|0|||
130255804|NCT05654181|468901126|FG009|Overall Study|Other|0|||
130255805|NCT04101331|468901127|FG000|Overall Study|Adverse Event|9|||
130255806|NCT04101331|468901127|FG000|Overall Study|Disease progression|82|||
130255807|NCT04101331|468901127|FG000|Overall Study|Withdrawal by Subject|1|||
130255808|NCT04101331|468901127|FG000|Overall Study|Investigator decision|6|||
130255809|NCT04101331|468901127|FG000|Overall Study|Death|6|||
130255810|NCT04101331|468901127|FG000|Overall Study|Allogenic transplant|1|||
130255811|NCT04110145|468901128|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255812|NCT04110145|468901129|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255813|NCT04110145|468901130|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255814|NCT04110145|468901131|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
130255815|NCT04110145|468901132|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255816|NCT00567502|468901140|FG000|Overall Study|Lost to Follow-up|91|||
130255817|NCT00567502|468901141|FG001|Overall Study|Lost to Follow-up|14|||
130255818|NCT00567502|468901142|FG002|Overall Study|Lost to Follow-up|351|||
130255819|NCT00567502|468901143|FG003|Overall Study|Lost to Follow-up|2|||
130255820|NCT00567502|468901140|FG000|Overall Study|Death|65|||
130255821|NCT00567502|468901141|FG001|Overall Study|Death|16|||
130255822|NCT00567502|468901142|FG002|Overall Study|Death|360|||
130255823|NCT00567502|468901143|FG003|Overall Study|Death|5|||
130255824|NCT00567502|468901140|FG000|Overall Study|Other|64|||
130255825|NCT00567502|468901141|FG001|Overall Study|Other|2|||
130255826|NCT00567502|468901142|FG002|Overall Study|Other|134|||
130255827|NCT00567502|468901143|FG003|Overall Study|Other|6|||
130255828|NCT00567502|468901140|FG000|Overall Study|Participant request|12|||
130255829|NCT00567502|468901141|FG001|Overall Study|Participant request|1|||
130255830|NCT00567502|468901142|FG002|Overall Study|Participant request|33|||
130255831|NCT00567502|468901143|FG003|Overall Study|Participant request|1|||
130255832|NCT00567502|468901140|FG000|Overall Study|Sponsor request|9|||
130255833|NCT00567502|468901141|FG001|Overall Study|Sponsor request|0|||
130255834|NCT00567502|468901142|FG002|Overall Study|Sponsor request|30|||
130255835|NCT00567502|468901143|FG003|Overall Study|Sponsor request|1|||
130255836|NCT00567502|468901140|FG000|Overall Study|Never Initiated Treatment|0|||
130255837|NCT00567502|468901141|FG001|Overall Study|Never Initiated Treatment|0|||
130255838|NCT00567502|468901142|FG002|Overall Study|Never Initiated Treatment|0|||
130255839|NCT00567502|468901143|FG003|Overall Study|Never Initiated Treatment|72|||
130255840|NCT00337168|468901144|FG000|Overall Study|Death|5|||
130255841|NCT00337168|468901144|FG000|Overall Study|Not protocol specified|2|||
130255842|NCT00337168|468901144|FG000|Overall Study|Did not start therapy|1|||
130255843|NCT03283241|468901145|FG000|Overall Study|Adverse Event|4|||
130255844|NCT03283241|468901146|FG001|Overall Study|Adverse Event|1|||
130255845|NCT03283241|468901145|FG000|Overall Study|Withdrawal by Subject|0|||
130255846|NCT03283241|468901146|FG001|Overall Study|Withdrawal by Subject|1|||
130255847|NCT03283241|468901145|FG000|Overall Study|Subject relocated to Finland|0|||
130255848|NCT03283241|468901146|FG001|Overall Study|Subject relocated to Finland|1|||
130255849|NCT00666263|468901149|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
130255850|NCT00666263|468901150|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
130255851|NCT00666263|468901149|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
130255852|NCT00666263|468901150|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
130255853|NCT00666263|468901149|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
130553610|NCT01176968|469994766|FG000|Overall Study|Lack of Efficacy|0|||
130255854|NCT00666263|468901150|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
130255855|NCT01225952|468901151|FG000|Overall Study|Lost to Follow-up|1|||
130255856|NCT01225952|468901152|FG001|Overall Study|Lost to Follow-up|0|||
130255857|NCT01225952|468901153|FG002|Overall Study|Lost to Follow-up|0|||
130255858|NCT01225952|468901151|FG000|Overall Study|Study Eye Explanted|0|||
130255859|NCT01225952|468901152|FG001|Overall Study|Study Eye Explanted|0|||
130255860|NCT01225952|468901153|FG002|Overall Study|Study Eye Explanted|1|||
130255861|NCT01225952|468901151|FG000|Overall Study|Withdrawal by Subject|4|||
130255862|NCT01225952|468901152|FG001|Overall Study|Withdrawal by Subject|4|||
130255863|NCT01225952|468901153|FG002|Overall Study|Withdrawal by Subject|5|||
130255864|NCT01225952|468901151|FG000|Overall Study|Surgical complications|1|||
130255865|NCT01225952|468901152|FG001|Overall Study|Surgical complications|0|||
130255866|NCT01225952|468901153|FG002|Overall Study|Surgical complications|0|||
130255867|NCT01285102|468901155|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
130255868|NCT03729609|468901171|FG000|Overall Study|Protocol Violation|1|||
130255869|NCT00605189|468901177|FG000|Overall Study|Adverse Event|1|||
130255870|NCT00605189|468901178|FG001|Overall Study|Adverse Event|0|||
130255871|NCT00605189|468901179|FG002|Overall Study|Adverse Event|0|||
130255872|NCT00605189|468901177|FG000|Overall Study|Other|2|||
130255873|NCT00605189|468901178|FG001|Overall Study|Other|2|||
130255874|NCT00605189|468901179|FG002|Overall Study|Other|0|||
130255875|NCT02919618|468901180|FG000|Overall Study|Death|1|||
130255876|NCT02592863|468901181|FG000|Overall Study|Withdrawal by Subject|2|||
130255877|NCT02592863|468901182|FG001|Overall Study|Withdrawal by Subject|2|||
130255878|NCT02592863|468901181|FG000|Overall Study|Lost to Follow-up|1|||
130255879|NCT02592863|468901182|FG001|Overall Study|Lost to Follow-up|1|||
130255880|NCT02743221|468901183|FG000|Overall Study|Progressive disease|29|||
130255881|NCT02743221|468901184|FG001|Overall Study|Progressive disease|38|||
130255882|NCT02743221|468901183|FG000|Overall Study|Adverse Event|17|||
130255883|NCT02743221|468901184|FG001|Overall Study|Adverse Event|14|||
130255884|NCT02743221|468901183|FG000|Overall Study|non medical reason|8|||
130255885|NCT02743221|468901184|FG001|Overall Study|non medical reason|2|||
130255886|NCT02743221|468901183|FG000|Overall Study|Physician Decision|2|||
130255887|NCT02743221|468901184|FG001|Overall Study|Physician Decision|5|||
130255888|NCT02743221|468901183|FG000|Overall Study|Patient not eligible, not treated|0|||
130255889|NCT02743221|468901184|FG001|Overall Study|Patient not eligible, not treated|1|||
130255890|NCT03411044|468901186|FG000|Overall Study|Death|30|||
130255891|NCT03411044|468901186|FG000|Overall Study|Withdrawal by Subject|48|||
130255892|NCT03411044|468901186|FG000|Overall Study|Lost to Follow-up|78|||
130255893|NCT03411044|468901186|FG000|Overall Study|Adverse Event|30|||
130255894|NCT03411044|468901186|FG000|Overall Study|Missing status|4|||
130255895|NCT02609503|468901187|FG000|Overall Study|Adverse Event|1|||
130255896|NCT02609503|468901187|FG000|Overall Study|Death|1|||
130255897|NCT02609503|468901187|FG000|Overall Study|Withdrawal by Subject|1|||
130255898|NCT02609503|468901187|FG000|Overall Study|Disease progression|1|||
130255899|NCT01969409|468901190|FG000|Overall Study|Death|2|||
130255900|NCT01969409|468901191|FG001|Overall Study|Death|2|||
130255901|NCT01969409|468901190|FG000|Overall Study|Transplant|1|||
130255902|NCT01969409|468901191|FG001|Overall Study|Transplant|1|||
130255903|NCT01969409|468901190|FG000|Overall Study|Withdrawal by Subject|0|||
130255904|NCT01969409|468901191|FG001|Overall Study|Withdrawal by Subject|1|||
130255905|NCT02226653|468901195|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
130255906|NCT02226653|468901196|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
130255907|NCT02226653|468901195|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
130255908|NCT02226653|468901196|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
130255909|NCT03078868|468901198|FG000|Overall Study|Physician Decision|3|||
130365096|NCT02925117|469306853|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
130365097|NCT02925117|469306854|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
130365098|NCT02925117|469306855|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
130365099|NCT02925117|469306856|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130365100|NCT02925117|469306857|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130365101|NCT02925117|469306858|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130365102|NCT02925117|469306859|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130365103|NCT02925117|469306848|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130553611|NCT01176968|469994767|FG001|Overall Study|Lack of Efficacy|1|||
130255910|NCT00967499|468901201|FG000|Overall Study|Adverse Event|0|||
130255911|NCT00967499|468901202|FG001|Overall Study|Adverse Event|1|||
130255912|NCT00967499|468901201|FG000|Overall Study|Protocol Violation|1|||
130255913|NCT00967499|468901202|FG001|Overall Study|Protocol Violation|0|||
130553612|NCT01176968|469994766|FG000|Overall Study|Lost to Follow-up|16|||
130255914|NCT00967499|468901201|FG000|Overall Study|Sponsor Decision|1|||
130255915|NCT00967499|468901202|FG001|Overall Study|Sponsor Decision|0|||
130255916|NCT00967499|468901201|FG000|Overall Study|Randomized but not treated|63|||
130255917|NCT00967499|468901202|FG001|Overall Study|Randomized but not treated|59|||
130255918|NCT05535972|468901204|FG000|Overall Study|Withdrawal by Subject|31|||
130255919|NCT05535972|468901204|FG000|Overall Study|Lost to Follow-up|5|||
130255920|NCT05535972|468901204|FG000|Overall Study|Adverse Event|6|||
130255921|NCT05535972|468901204|FG000|Overall Study|Protocol Deviation|2|||
130255922|NCT04629196|468901208|FG000|Overall Study|Subject discontinued study drug|1|||
130255923|NCT04629196|468901209|FG001|Overall Study|Subject discontinued study drug|0|||
130255924|NCT04629196|468901208|FG000|Overall Study|Subject study drug dosing increased|1|||
130255925|NCT04629196|468901209|FG001|Overall Study|Subject study drug dosing increased|1|||
130255926|NCT04629196|468901208|FG000|Overall Study|Withdrawal by Subject|1|||
130255927|NCT04629196|468901209|FG001|Overall Study|Withdrawal by Subject|2|||
130255928|NCT01450631|468901213|FG000|Overall Study|Lost to Follow-up|2|||
130255929|NCT01450631|468901214|FG001|Overall Study|Lost to Follow-up|4|||
130255930|NCT01450631|468901213|FG000|Overall Study|Withdrawal by Subject|1|||
130255931|NCT01450631|468901214|FG001|Overall Study|Withdrawal by Subject|0|||
130255932|NCT00835354|468901215|FG000|First Intervention|Adverse Event|0|||
130255933|NCT00835354|468901216|FG001|First Intervention|Adverse Event|1|||
130255934|NCT03204812|468901217|FG000|Overall Study|Adverse Event|3|||
130255935|NCT01385995|468901218|FG000|Period 1, 2 Months|Physician Decision|1|||
130255936|NCT01385995|468901219|FG001|Period 1, 2 Months|Physician Decision|0|||
130255937|NCT00112385|468901220|FG000|Overall Study|Lost to Follow-up|1|||
130255938|NCT00112385|468901221|FG001|Overall Study|Lost to Follow-up|0|||
130255939|NCT00112385|468901220|FG000|Overall Study|Withdrawal by Subject|0|||
130255940|NCT00112385|468901221|FG001|Overall Study|Withdrawal by Subject|1|||
130255941|NCT04191135|468901244|FG000|Induction Treatment|Not Treated|2|||
130255942|NCT04191135|468901245|FG001|Induction Treatment|Not Treated|0|||
130255943|NCT04191135|468901246|FG002|Induction Treatment|Not Treated|0|||
130255944|NCT04191135|468901244|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
130255945|NCT04191135|468901245|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130255946|NCT04191135|468901246|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130255947|NCT04191135|468901244|FG000|Induction Treatment|Adverse Event|25|||
130255948|NCT04191135|468901245|FG001|Induction Treatment|Adverse Event|0|||
130255949|NCT04191135|468901246|FG002|Induction Treatment|Adverse Event|0|||
130255950|NCT04191135|468901244|FG000|Induction Treatment|Clinical Progression|8|||
130255951|NCT04191135|468901245|FG001|Induction Treatment|Clinical Progression|0|||
130255952|NCT04191135|468901246|FG002|Induction Treatment|Clinical Progression|0|||
130255953|NCT04191135|468901244|FG000|Induction Treatment|Excluded Medication|1|||
130255954|NCT04191135|468901245|FG001|Induction Treatment|Excluded Medication|0|||
130255955|NCT04191135|468901246|FG002|Induction Treatment|Excluded Medication|0|||
130255956|NCT04191135|468901244|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
130255957|NCT04191135|468901245|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130255958|NCT04191135|468901246|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130255959|NCT04191135|468901244|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
130255960|NCT04191135|468901245|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130255961|NCT04191135|468901246|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130255962|NCT04191135|468901244|FG000|Induction Treatment|Physician Decision|2|||
130255963|NCT04191135|468901245|FG001|Induction Treatment|Physician Decision|0|||
130255964|NCT04191135|468901246|FG002|Induction Treatment|Physician Decision|0|||
130255965|NCT04191135|468901244|FG000|Induction Treatment|Progressive Disease|135|||
130255966|NCT04191135|468901245|FG001|Induction Treatment|Progressive Disease|0|||
130255967|NCT04191135|468901246|FG002|Induction Treatment|Progressive Disease|0|||
130255968|NCT04191135|468901244|FG000|Induction Treatment|Protocol Violation|10|||
130255969|NCT04191135|468901245|FG001|Induction Treatment|Protocol Violation|0|||
130255970|NCT04191135|468901246|FG002|Induction Treatment|Protocol Violation|0|||
130255971|NCT04191135|468901244|FG000|Induction Treatment|Withdrawal by Subject|4|||
130255972|NCT04191135|468901245|FG001|Induction Treatment|Withdrawal by Subject|0|||
130255973|NCT04191135|468901246|FG002|Induction Treatment|Withdrawal by Subject|0|||
130255974|NCT04191135|468901244|FG000|Randomized Treatment|Death|0|||
130255975|NCT04191135|468901245|FG001|Randomized Treatment|Death|50|||
130255976|NCT04191135|468901246|FG002|Randomized Treatment|Death|54|||
130255977|NCT04191135|468901244|FG000|Randomized Treatment|Lost to Follow-up|0|||
130255978|NCT04191135|468901245|FG001|Randomized Treatment|Lost to Follow-up|0|||
130255979|NCT04191135|468901246|FG002|Randomized Treatment|Lost to Follow-up|1|||
130255980|NCT04191135|468901244|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130255981|NCT04191135|468901245|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130700975|NCT00152516|470528361|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
130700976|NCT00152516|470528361|FG000|Overall Study|Other: Moved Out Of State|1|||
130700977|NCT00152516|470528361|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
130700978|NCT00152516|470528361|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
130700979|NCT00360490|470528362|FG000|Overall Study|Adverse Event|4|||
130700980|NCT00360490|470528363|FG001|Overall Study|Adverse Event|2|||
130700981|NCT00360490|470528362|FG000|Overall Study|Lost to Follow-up|2|||
130255982|NCT04191135|468901246|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130255983|NCT04191135|468901244|FG000|Randomized Treatment|Ongoing in Trial|0|||
130255984|NCT04191135|468901245|FG001|Randomized Treatment|Ongoing in Trial|83|||
130255985|NCT04191135|468901246|FG002|Randomized Treatment|Ongoing in Trial|81|||
130255986|NCT03514134|468903087|FG000|Overall Study|Lost to Follow-up|0|||
130255987|NCT03514134|468903088|FG001|Overall Study|Lost to Follow-up|1|||
130255988|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
130255989|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
130255990|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
130255991|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
130255992|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
130255993|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
130255994|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
130255995|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
130255996|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
130255997|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
130255998|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
130255999|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256000|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256001|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256002|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
130256003|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256004|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256005|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256006|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256007|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256008|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256009|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256010|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256011|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256012|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
130256013|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256014|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256015|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256016|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256017|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256018|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256019|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256020|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256021|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130256022|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130256023|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256024|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256025|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256026|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256027|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256028|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256029|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256030|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256031|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256032|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256033|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256034|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256035|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256036|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256037|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256038|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256039|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256040|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256041|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256042|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256043|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256044|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256045|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256046|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256047|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256048|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
130256049|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256050|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256051|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
130256052|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256053|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256054|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256055|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256056|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256057|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256058|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256059|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256060|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256061|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256062|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
130256063|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256064|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256065|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256066|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256067|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256068|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130553613|NCT01176968|469994767|FG001|Overall Study|Lost to Follow-up|14|||
130553614|NCT01176968|469994766|FG000|Overall Study|Withdrawal by Subject|48|||
130553615|NCT01176968|469994767|FG001|Overall Study|Withdrawal by Subject|48|||
130553616|NCT01176968|469994766|FG000|Overall Study|Protocol Violation|2|||
130256069|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256070|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256071|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256072|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
130256073|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
130256074|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256075|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256076|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256077|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256078|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256079|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256080|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256081|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256082|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256083|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256084|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256085|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
130256086|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
130256087|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256088|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256089|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256090|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256091|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256092|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256093|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256094|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256095|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256096|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
130256097|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256098|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256099|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256100|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256101|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256102|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256103|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256104|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256105|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256106|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256107|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256108|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
130256109|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256110|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130553617|NCT01176968|469994767|FG001|Overall Study|Protocol Violation|1|||
130553618|NCT01176968|469994766|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130553619|NCT01176968|469994767|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130553620|NCT01176968|469994766|FG000|Overall Study|Study terminated by sponsor|0|||
130553621|NCT01176968|469994767|FG001|Overall Study|Study terminated by sponsor|1|||
130553622|NCT01176968|469994766|FG000|Overall Study|Reason not defined|5|||
130553623|NCT01176968|469994767|FG001|Overall Study|Reason not defined|3|||
130553624|NCT00833911|469994768|FG000|Titration|Adverse Event|18|||
130256111|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256112|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256113|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256114|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256115|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256116|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256117|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256118|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130256119|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130256120|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256121|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256122|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256123|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256124|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256125|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256126|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256127|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256128|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256129|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
130700982|NCT00360490|470528363|FG001|Overall Study|Lost to Follow-up|1|||
130700983|NCT00360490|470528362|FG000|Overall Study|Physician Decision|2|||
130700984|NCT00360490|470528363|FG001|Overall Study|Physician Decision|1|||
130700985|NCT00360490|470528362|FG000|Overall Study|Protocol Violation|0|||
130700986|NCT00360490|470528363|FG001|Overall Study|Protocol Violation|4|||
130256130|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256131|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256132|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130700987|NCT00360490|470528362|FG000|Overall Study|Withdrawal by Subject|1|||
130700988|NCT00360490|470528363|FG001|Overall Study|Withdrawal by Subject|3|||
130700989|NCT01517867|470528364|FG000|Overall Study|never started treatment|29|||
130700990|NCT01517867|470528365|FG001|Overall Study|never started treatment|32|||
130700991|NCT01517867|470528364|FG000|Overall Study|Withdrawal by Subject|34|||
130700992|NCT01517867|470528365|FG001|Overall Study|Withdrawal by Subject|30|||
130700993|NCT01517867|470528364|FG000|Overall Study|Still in treatment at study end|0|||
130700994|NCT01517867|470528365|FG001|Overall Study|Still in treatment at study end|3|||
130700995|NCT01266603|470528367|FG000|Overall Study|Adverse Event|1|||
130700996|NCT01266603|470528367|FG000|Overall Study|Lack of Efficacy|14|||
130700997|NCT01266603|470528367|FG000|Overall Study|Withdrawal by Subject|1|||
130700998|NCT01266603|470528367|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
130700999|NCT02466386|470528368|FG000|Overall Study|Adverse Event|5|||
130701000|NCT02466386|470528368|FG000|Overall Study|Protocol Violation|2|||
130701001|NCT02466386|470528368|FG000|Overall Study|Withdrawal by Subject|14|||
130701002|NCT02466386|470528368|FG000|Overall Study|Lost to Follow-up|5|||
130701003|NCT02466386|470528368|FG000|Overall Study|Lack of Efficacy|8|||
130701004|NCT02466386|470528368|FG000|Overall Study|Other|10|||
130701005|NCT03919695|470528369|FG000|3-month Follow-up|Death|1|||
130701006|NCT03919695|470528370|FG001|3-month Follow-up|Death|1|||
130701007|NCT03919695|470528369|FG000|3-month Follow-up|unable to contact|0|||
130701008|NCT03919695|470528370|FG001|3-month Follow-up|unable to contact|3|||
130701009|NCT03919695|470528369|FG000|3-month Follow-up|in prison|0|||
130701010|NCT03919695|470528370|FG001|3-month Follow-up|in prison|1|||
130701011|NCT03919695|470528369|FG000|6-month Follow-up|Death|0|||
130701012|NCT03919695|470528370|FG001|6-month Follow-up|Death|1|||
130701013|NCT03919695|470528369|FG000|6-month Follow-up|Lost to Follow-up|1|||
130701014|NCT03919695|470528370|FG001|6-month Follow-up|Lost to Follow-up|2|||
130701015|NCT03919695|470528369|FG000|6-month Follow-up|in prison|0|||
130701016|NCT03919695|470528370|FG001|6-month Follow-up|in prison|2|||
130701017|NCT03919695|470528369|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
130701018|NCT03919695|470528370|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
130701019|NCT03919695|470528369|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
130701020|NCT03919695|470528370|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
130701021|NCT01688882|470528371|FG000|Overall Study|Adverse Event|1|||
130701022|NCT01688882|470528372|FG001|Overall Study|Adverse Event|0|||
130701023|NCT01688882|470528371|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130701024|NCT01688882|470528372|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130256133|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130701025|NCT01688882|470528371|FG000|Overall Study|Administrative problems|1|||
130701026|NCT01688882|470528372|FG001|Overall Study|Administrative problems|0|||
130701027|NCT02387762|470528374|FG000|Overall Study|Withdrawal by Subject|1|||
130701028|NCT02387762|470528375|FG001|Overall Study|Withdrawal by Subject|0|||
130701029|NCT00642811|470528386|FG000|Overall Study|Adverse Event|2|||
130701030|NCT00642811|470528387|FG001|Overall Study|Adverse Event|3|||
130701031|NCT00642811|470528388|FG002|Overall Study|Adverse Event|0|||
130553625|NCT00833911|469994768|FG000|Titration|Withdrawal by Subject|3|||
130553626|NCT00833911|469994768|FG000|Maintenance Phase I|Adverse Event|73|||
130553627|NCT00833911|469994768|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
130553628|NCT00833911|469994768|FG000|Maintenance Phase I|Physician Decision|10|||
130553629|NCT00833911|469994768|FG000|Maintenance Phase I|Lack of Efficacy|4|||
130553630|NCT00833911|469994768|FG000|Maintenance Phase II|Adverse Event|6|||
130553631|NCT00833911|469994768|FG000|Maintenance Phase II|Physician Decision|2|||
130553632|NCT00833911|469994768|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
130553633|NCT00833911|469994768|FG000|Maintenance Phase II|Lack of Efficacy|1|||
130553634|NCT00718640|469994769|FG000|Overall Study|Adverse Event|4|||
130553635|NCT00718640|469994769|FG000|Overall Study|Death|1|||
130553636|NCT00718640|469994769|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
130553637|NCT01137955|469994772|FG000|Overall Study|Withdrawal by Subject|5|||
130553638|NCT01137955|469994773|FG001|Overall Study|Withdrawal by Subject|4|||
130256134|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256135|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256136|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256137|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256138|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256139|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256140|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130256141|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130256142|NCT00003645|468903100|FG000|Overall Study|Death|4|||
130256143|NCT00003645|468903101|FG001|Overall Study|Death|1|||
130256144|NCT00003645|468903100|FG000|Overall Study|Lost to Follow-up|7|||
130256145|NCT00003645|468903101|FG001|Overall Study|Lost to Follow-up|8|||
130256146|NCT00003645|468903100|FG000|Overall Study|Withdrawal by Subject|1|||
130256147|NCT00003645|468903101|FG001|Overall Study|Withdrawal by Subject|3|||
130256148|NCT03768336|468903104|FG000|Overall Study|Lost to Follow-up|3|||
130256149|NCT03768336|468903105|FG001|Overall Study|Lost to Follow-up|2|||
130256150|NCT03768336|468903104|FG000|Overall Study|Became Ineligible|2|||
130256151|NCT03768336|468903105|FG001|Overall Study|Became Ineligible|0|||
130256152|NCT03768336|468903104|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
130256153|NCT03768336|468903105|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
130256154|NCT03768336|468903104|FG000|Overall Study|Missed final survey (post-treatment|0|||
130256155|NCT03768336|468903105|FG001|Overall Study|Missed final survey (post-treatment|1|||
130256156|NCT03977155|468903106|FG000|Overall Study|Adverse Event|3|||
130256157|NCT03977155|468903107|FG001|Overall Study|Adverse Event|0|||
130256158|NCT03977155|468903108|FG002|Overall Study|Adverse Event|0|||
130256159|NCT03977155|468903106|FG000|Overall Study|Lost to Follow-up|0|||
130256160|NCT03977155|468903107|FG001|Overall Study|Lost to Follow-up|1|||
130256161|NCT03977155|468903108|FG002|Overall Study|Lost to Follow-up|0|||
130256162|NCT03977155|468903106|FG000|Overall Study|Withdrawal by Subject|1|||
130256163|NCT03977155|468903107|FG001|Overall Study|Withdrawal by Subject|1|||
130256164|NCT03977155|468903108|FG002|Overall Study|Withdrawal by Subject|2|||
130256165|NCT03977155|468903106|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
130256166|NCT03977155|468903107|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
130256167|NCT03977155|468903108|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
130256168|NCT03502681|468903111|FG000|Overall Study|Adverse Event|1|||
130256169|NCT03502681|468903112|FG001|Overall Study|Adverse Event|1|||
130256170|NCT03502681|468903111|FG000|Overall Study|Disease Progression|2|||
130256171|NCT03502681|468903112|FG001|Overall Study|Disease Progression|1|||
130256172|NCT01444781|468903113|FG000|Overall Study|Lost to Follow-up|0|||
130256173|NCT01444781|468903114|FG001|Overall Study|Lost to Follow-up|3|||
130256174|NCT01444781|468903115|FG002|Overall Study|Lost to Follow-up|1|||
130256175|NCT01444781|468903113|FG000|Overall Study|Withdrawal by Subject|3|||
130256176|NCT01444781|468903114|FG001|Overall Study|Withdrawal by Subject|1|||
130256177|NCT01444781|468903115|FG002|Overall Study|Withdrawal by Subject|2|||
130256178|NCT06790303|468903116|FG000|Overall Study|Study Terminated by sponsor|4|||
130256179|NCT06790303|468903116|FG000|Overall Study|Death|4|||
130256180|NCT00321932|468903122|FG000|Overall Study|Death|3|||
130256181|NCT00321932|468903123|FG001|Overall Study|Death|6|||
130256182|NCT00321932|468903122|FG000|Overall Study|Withdrawal by Subject|3|||
130256183|NCT00321932|468903123|FG001|Overall Study|Withdrawal by Subject|6|||
130256184|NCT00321932|468903122|FG000|Overall Study|Early relapse|2|||
130256185|NCT00321932|468903123|FG001|Overall Study|Early relapse|8|||
130256186|NCT00321932|468903122|FG000|Overall Study|Missing data|2|||
130256187|NCT00321932|468903123|FG001|Overall Study|Missing data|1|||
130256188|NCT03360344|468903126|FG000|Overall Study|Withdrawal by Subject|0|||
130256189|NCT03360344|468903127|FG001|Overall Study|Withdrawal by Subject|1|||
130553639|NCT01207596|469994774|FG000|Overall Study|Physician Decision|4|||
130256190|NCT03360344|468903128|FG002|Overall Study|Withdrawal by Subject|1|||
130256191|NCT03257657|468903133|FG000|Overall Study|Lost to Follow-up|0|||
130256192|NCT03257657|468903134|FG001|Overall Study|Lost to Follow-up|3|||
130256193|NCT03257657|468903133|FG000|Overall Study|Withdrawn|0|||
130256194|NCT03257657|468903134|FG001|Overall Study|Withdrawn|1|||
130256195|NCT03257657|468903133|FG000|Overall Study|Noted not eligible right after enrolled|0|||
130256196|NCT03257657|468903134|FG001|Overall Study|Noted not eligible right after enrolled|1|||
130256197|NCT01905540|468903149|FG000|Period 3|Other|1|||
130256198|NCT01905540|468903150|FG001|Period 3|Other|0|||
130256199|NCT01905540|468903151|FG002|Period 3|Other|1|||
130256200|NCT01905540|468903152|FG003|Period 3|Other|1|||
130256201|NCT02367885|468903153|FG000|Overall Study|Lost to Follow-up|1|||
130256202|NCT02367885|468903154|FG001|Overall Study|Lost to Follow-up|0|||
130256203|NCT02367885|468903155|FG002|Overall Study|Lost to Follow-up|0|||
130256204|NCT02367885|468903153|FG000|Overall Study|Withdrawal by Subject|1|||
130256205|NCT02367885|468903154|FG001|Overall Study|Withdrawal by Subject|0|||
130256206|NCT02367885|468903155|FG002|Overall Study|Withdrawal by Subject|0|||
130256207|NCT01602484|468903156|FG000|Overall Study|Airway issues unrelated to study|0|||
130256208|NCT01602484|468903157|FG001|Overall Study|Airway issues unrelated to study|1|||
130256209|NCT02743962|468903160|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
130256210|NCT02743962|468903161|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
130256211|NCT02327169|468903163|FG000|Overall Study|Progressive Disease|1|||
130256212|NCT02327169|468903164|FG001|Overall Study|Progressive Disease|3|||
130256213|NCT02327169|468903165|FG002|Overall Study|Progressive Disease|4|||
130256214|NCT02327169|468903166|FG003|Overall Study|Progressive Disease|3|||
130256215|NCT02327169|468903167|FG004|Overall Study|Progressive Disease|4|||
130256216|NCT02327169|468903168|FG005|Overall Study|Progressive Disease|3|||
130256217|NCT02327169|468903169|FG006|Overall Study|Progressive Disease|3|||
130256218|NCT02327169|468903170|FG007|Overall Study|Progressive Disease|3|||
130256219|NCT02327169|468903171|FG008|Overall Study|Progressive Disease|4|||
130256220|NCT02327169|468903172|FG009|Overall Study|Progressive Disease|4|||
130256221|NCT02327169|468903173|FG010|Overall Study|Progressive Disease|4|||
130256222|NCT02327169|468903174|FG011|Overall Study|Progressive Disease|3|||
130256223|NCT02327169|468903175|FG012|Overall Study|Progressive Disease|1|||
130256224|NCT02327169|468903176|FG013|Overall Study|Progressive Disease|3|||
130256225|NCT02327169|468903177|FG014|Overall Study|Progressive Disease|3|||
130256226|NCT02327169|468903163|FG000|Overall Study|Adverse Event|2|||
130256227|NCT02327169|468903164|FG001|Overall Study|Adverse Event|0|||
130256228|NCT02327169|468903165|FG002|Overall Study|Adverse Event|1|||
130256229|NCT02327169|468903166|FG003|Overall Study|Adverse Event|0|||
130256230|NCT02327169|468903167|FG004|Overall Study|Adverse Event|1|||
130256231|NCT02327169|468903168|FG005|Overall Study|Adverse Event|0|||
130256232|NCT02327169|468903169|FG006|Overall Study|Adverse Event|0|||
130256233|NCT02327169|468903170|FG007|Overall Study|Adverse Event|0|||
130256234|NCT02327169|468903171|FG008|Overall Study|Adverse Event|0|||
130256235|NCT02327169|468903172|FG009|Overall Study|Adverse Event|2|||
130256236|NCT02327169|468903173|FG010|Overall Study|Adverse Event|0|||
130256237|NCT02327169|468903174|FG011|Overall Study|Adverse Event|3|||
130256238|NCT02327169|468903175|FG012|Overall Study|Adverse Event|0|||
130256239|NCT02327169|468903176|FG013|Overall Study|Adverse Event|2|||
130256240|NCT02327169|468903177|FG014|Overall Study|Adverse Event|1|||
130256241|NCT02327169|468903163|FG000|Overall Study|Symptomatic Deterioration|0|||
130256242|NCT02327169|468903164|FG001|Overall Study|Symptomatic Deterioration|0|||
130256243|NCT02327169|468903165|FG002|Overall Study|Symptomatic Deterioration|1|||
130256244|NCT02327169|468903166|FG003|Overall Study|Symptomatic Deterioration|0|||
130256245|NCT02327169|468903167|FG004|Overall Study|Symptomatic Deterioration|1|||
130256246|NCT02327169|468903168|FG005|Overall Study|Symptomatic Deterioration|1|||
130256247|NCT02327169|468903169|FG006|Overall Study|Symptomatic Deterioration|0|||
130256248|NCT02327169|468903170|FG007|Overall Study|Symptomatic Deterioration|0|||
130256249|NCT02327169|468903171|FG008|Overall Study|Symptomatic Deterioration|2|||
130256250|NCT02327169|468903172|FG009|Overall Study|Symptomatic Deterioration|1|||
130256251|NCT02327169|468903173|FG010|Overall Study|Symptomatic Deterioration|0|||
130256252|NCT02327169|468903174|FG011|Overall Study|Symptomatic Deterioration|0|||
130256253|NCT02327169|468903175|FG012|Overall Study|Symptomatic Deterioration|0|||
130256254|NCT02327169|468903176|FG013|Overall Study|Symptomatic Deterioration|2|||
130256255|NCT02327169|468903177|FG014|Overall Study|Symptomatic Deterioration|1|||
130256256|NCT02327169|468903163|FG000|Overall Study|Reason Not Specified|0|||
130256257|NCT02327169|468903164|FG001|Overall Study|Reason Not Specified|0|||
130256258|NCT02327169|468903165|FG002|Overall Study|Reason Not Specified|1|||
130256259|NCT02327169|468903166|FG003|Overall Study|Reason Not Specified|0|||
130256260|NCT02327169|468903167|FG004|Overall Study|Reason Not Specified|0|||
130256261|NCT02327169|468903168|FG005|Overall Study|Reason Not Specified|0|||
130256262|NCT02327169|468903169|FG006|Overall Study|Reason Not Specified|0|||
130256263|NCT02327169|468903170|FG007|Overall Study|Reason Not Specified|0|||
130256264|NCT02327169|468903171|FG008|Overall Study|Reason Not Specified|0|||
130256265|NCT02327169|468903172|FG009|Overall Study|Reason Not Specified|1|||
130256266|NCT02327169|468903173|FG010|Overall Study|Reason Not Specified|2|||
130256267|NCT02327169|468903174|FG011|Overall Study|Reason Not Specified|1|||
130256268|NCT02327169|468903175|FG012|Overall Study|Reason Not Specified|0|||
130256269|NCT02327169|468903176|FG013|Overall Study|Reason Not Specified|0|||
130256270|NCT02327169|468903177|FG014|Overall Study|Reason Not Specified|2|||
130256271|NCT02327169|468903163|FG000|Overall Study|Withdrawal by Subject|1|||
130256272|NCT02327169|468903164|FG001|Overall Study|Withdrawal by Subject|0|||
130256273|NCT02327169|468903165|FG002|Overall Study|Withdrawal by Subject|0|||
130256274|NCT02327169|468903166|FG003|Overall Study|Withdrawal by Subject|0|||
130256275|NCT02327169|468903167|FG004|Overall Study|Withdrawal by Subject|1|||
130256276|NCT02327169|468903168|FG005|Overall Study|Withdrawal by Subject|0|||
130256277|NCT02327169|468903169|FG006|Overall Study|Withdrawal by Subject|0|||
130256278|NCT02327169|468903170|FG007|Overall Study|Withdrawal by Subject|1|||
130256279|NCT02327169|468903171|FG008|Overall Study|Withdrawal by Subject|0|||
130553640|NCT01207596|469994774|FG000|Overall Study|Lack of Efficacy|1|||
130553641|NCT01207596|469994774|FG000|Overall Study|Adverse Event|3|||
130553642|NCT01207596|469994774|FG000|Overall Study|Withdrawal by Subject|1|||
130553643|NCT02030405|469994784|FG000|Overall Study|Withdrawal by Subject|1|||
130553644|NCT02030405|469994784|FG000|Overall Study|Lost to Follow-up|1|||
130553645|NCT00986440|469994785|FG000|Overall Study|Progressive disease|27|||
130553646|NCT00986440|469994786|FG001|Overall Study|Progressive disease|37|||
130553647|NCT00986440|469994785|FG000|Overall Study|Serious adverse event or adverse event|9|||
130553648|NCT00986440|469994786|FG001|Overall Study|Serious adverse event or adverse event|2|||
130553649|NCT00986440|469994785|FG000|Overall Study|Withdrawal by Subject|1|||
130553650|NCT00986440|469994786|FG001|Overall Study|Withdrawal by Subject|2|||
130553651|NCT00986440|469994785|FG000|Overall Study|Screen failure (not dosed)|4|||
130553652|NCT00986440|469994786|FG001|Overall Study|Screen failure (not dosed)|2|||
130553653|NCT00803270|469994787|FG000|Overall Study|Lost to Follow-up|1|||
130553654|NCT00803270|469994788|FG001|Overall Study|Lost to Follow-up|2|||
130553655|NCT00593957|469994792|FG000|Overall Study|Physician Decision|0|||
130553656|NCT00593957|469994793|FG001|Overall Study|Physician Decision|1|||
130553657|NCT00593957|469994794|FG002|Overall Study|Physician Decision|2|||
130553658|NCT00494481|469994797|FG000|Overall Study|Condition under investigation worsened|11|||
130553659|NCT00494481|469994798|FG001|Overall Study|Condition under investigation worsened|13|||
130553660|NCT00494481|469994797|FG000|Overall Study|Adverse Event|15|||
130701032|NCT00642811|470528389|FG003|Overall Study|Adverse Event|0|||
130701033|NCT00642811|470528390|FG004|Overall Study|Adverse Event|0|||
130701034|NCT00642811|470528391|FG005|Overall Study|Adverse Event|1|||
130701035|NCT00642811|470528386|FG000|Overall Study|Developement of discontinuation criteria|0|||
130701036|NCT00642811|470528387|FG001|Overall Study|Developement of discontinuation criteria|0|||
130701037|NCT00642811|470528388|FG002|Overall Study|Developement of discontinuation criteria|0|||
130701038|NCT00642811|470528389|FG003|Overall Study|Developement of discontinuation criteria|0|||
130701039|NCT00642811|470528390|FG004|Overall Study|Developement of discontinuation criteria|1|||
130701040|NCT00642811|470528391|FG005|Overall Study|Developement of discontinuation criteria|0|||
130701041|NCT00642811|470528386|FG000|Overall Study|Severe Non-compliance to protocol|1|||
130701042|NCT00642811|470528387|FG001|Overall Study|Severe Non-compliance to protocol|0|||
130701043|NCT00642811|470528388|FG002|Overall Study|Severe Non-compliance to protocol|0|||
130701044|NCT00642811|470528389|FG003|Overall Study|Severe Non-compliance to protocol|0|||
130701045|NCT00642811|470528390|FG004|Overall Study|Severe Non-compliance to protocol|0|||
130701046|NCT00642811|470528391|FG005|Overall Study|Severe Non-compliance to protocol|0|||
130701047|NCT00642811|470528386|FG000|Overall Study|Other|0|||
130701048|NCT00642811|470528387|FG001|Overall Study|Other|1|||
130701049|NCT00642811|470528388|FG002|Overall Study|Other|0|||
130701050|NCT00642811|470528389|FG003|Overall Study|Other|1|||
130701051|NCT00642811|470528390|FG004|Overall Study|Other|0|||
130701052|NCT00642811|470528391|FG005|Overall Study|Other|0|||
130701053|NCT01120691|470528392|FG000|Overall Study|Adverse Event|59|||
130701054|NCT01120691|470528393|FG001|Overall Study|Adverse Event|67|||
130256280|NCT02327169|468903172|FG009|Overall Study|Withdrawal by Subject|0|||
130256281|NCT02327169|468903173|FG010|Overall Study|Withdrawal by Subject|0|||
130256282|NCT02327169|468903174|FG011|Overall Study|Withdrawal by Subject|0|||
130553661|NCT00494481|469994798|FG001|Overall Study|Adverse Event|11|||
130553662|NCT00494481|469994797|FG000|Overall Study|Other|1|||
130553663|NCT00494481|469994798|FG001|Overall Study|Other|0|||
130701055|NCT01120691|470528394|FG002|Overall Study|Adverse Event|47|||
130553664|NCT00494481|469994797|FG000|Overall Study|Never received IP|2|||
130553665|NCT00494481|469994798|FG001|Overall Study|Never received IP|0|||
130365104|NCT02925117|469306849|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130365105|NCT02925117|469306850|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130365106|NCT02925117|469306851|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130365107|NCT02925117|469306852|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130365108|NCT02925117|469306853|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
130365109|NCT02925117|469306854|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130365110|NCT02925117|469306855|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130365111|NCT02925117|469306856|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130365112|NCT02925117|469306857|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130365113|NCT02925117|469306858|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130365114|NCT02925117|469306859|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130365115|NCT02925117|469306848|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
130365116|NCT02925117|469306849|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
130365117|NCT02925117|469306850|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
130365118|NCT02925117|469306851|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
130365119|NCT02925117|469306852|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
130701056|NCT01120691|470528392|FG000|Overall Study|Subject withdrew consent|33|||
130701057|NCT01120691|470528393|FG001|Overall Study|Subject withdrew consent|50|||
130701058|NCT01120691|470528394|FG002|Overall Study|Subject withdrew consent|44|||
130701059|NCT01120691|470528392|FG000|Overall Study|Death|21|||
130701060|NCT01120691|470528393|FG001|Overall Study|Death|22|||
130701061|NCT01120691|470528394|FG002|Overall Study|Death|24|||
130701062|NCT01120691|470528392|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130701063|NCT01120691|470528393|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
130701064|NCT01120691|470528394|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
130701065|NCT01120691|470528392|FG000|Overall Study|Administrative problems|15|||
130701066|NCT01120691|470528393|FG001|Overall Study|Administrative problems|8|||
130701067|NCT01120691|470528394|FG002|Overall Study|Administrative problems|9|||
130701068|NCT01120691|470528392|FG000|Overall Study|Protocol deviation|13|||
130701069|NCT01120691|470528393|FG001|Overall Study|Protocol deviation|12|||
130701070|NCT01120691|470528394|FG002|Overall Study|Protocol deviation|12|||
130701071|NCT01120691|470528392|FG000|Overall Study|Lost to Follow-up|5|||
130701072|NCT01120691|470528393|FG001|Overall Study|Lost to Follow-up|6|||
130701073|NCT01120691|470528394|FG002|Overall Study|Lost to Follow-up|4|||
130701074|NCT01120691|470528392|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130701075|NCT01120691|470528393|FG001|Overall Study|Abnormal test procedure result(s)|2|||
130701076|NCT01120691|470528394|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130701077|NCT01120691|470528392|FG000|Overall Study|Patient's inability to use the device|3|||
130701078|NCT01120691|470528393|FG001|Overall Study|Patient's inability to use the device|1|||
130701079|NCT01120691|470528394|FG002|Overall Study|Patient's inability to use the device|0|||
130701080|NCT01120691|470528392|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130701081|NCT01120691|470528393|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130701082|NCT01120691|470528394|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130701083|NCT04553406|470528397|FG000|Overall Study|Study Discontinuation|0|||
130701084|NCT04553406|470528398|FG001|Overall Study|Study Discontinuation|1|||
130701085|NCT03370510|470528399|FG000|Overall Study|COVID-19|2|||
130701086|NCT03370510|470528400|FG001|Overall Study|COVID-19|0|||
130701087|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
130701088|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
130701089|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
130701090|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
130701091|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
130701092|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
130701093|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Death|2|||
130701094|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Death|2|||
130701095|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
130701096|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
130701097|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
130701098|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
130701099|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
130701100|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
130701101|NCT01525628|470528405|FG000|Overall Study|Adverse Event|1|||
130701102|NCT01525628|470528406|FG001|Overall Study|Adverse Event|1|||
130701103|NCT01525628|470528407|FG002|Overall Study|Adverse Event|2|||
130365120|NCT02925117|469306853|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
130365121|NCT02925117|469306854|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
130365122|NCT02925117|469306855|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
130701104|NCT01525628|470528408|FG003|Overall Study|Adverse Event|0|||
130701105|NCT01525628|470528409|FG004|Overall Study|Adverse Event|1|||
130701106|NCT01525628|470528405|FG000|Overall Study|Lack of Efficacy|0|||
130365123|NCT02925117|469306856|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
130701107|NCT01525628|470528406|FG001|Overall Study|Lack of Efficacy|2|||
130701108|NCT01525628|470528407|FG002|Overall Study|Lack of Efficacy|2|||
130701109|NCT01525628|470528408|FG003|Overall Study|Lack of Efficacy|1|||
130701110|NCT01525628|470528409|FG004|Overall Study|Lack of Efficacy|2|||
130256283|NCT02327169|468903175|FG012|Overall Study|Withdrawal by Subject|0|||
130256284|NCT02327169|468903176|FG013|Overall Study|Withdrawal by Subject|0|||
130256285|NCT02327169|468903177|FG014|Overall Study|Withdrawal by Subject|3|||
130256286|NCT02327169|468903163|FG000|Overall Study|Lost to Follow-up|0|||
130256287|NCT02327169|468903164|FG001|Overall Study|Lost to Follow-up|0|||
130256288|NCT02327169|468903165|FG002|Overall Study|Lost to Follow-up|0|||
130256289|NCT02327169|468903166|FG003|Overall Study|Lost to Follow-up|0|||
130256290|NCT02327169|468903167|FG004|Overall Study|Lost to Follow-up|1|||
130256291|NCT02327169|468903168|FG005|Overall Study|Lost to Follow-up|0|||
130256292|NCT02327169|468903169|FG006|Overall Study|Lost to Follow-up|0|||
130701111|NCT01525628|470528405|FG000|Overall Study|Protocol Violation|0|||
130701112|NCT01525628|470528406|FG001|Overall Study|Protocol Violation|0|||
130701113|NCT01525628|470528407|FG002|Overall Study|Protocol Violation|1|||
130701114|NCT01525628|470528408|FG003|Overall Study|Protocol Violation|0|||
130701115|NCT01525628|470528409|FG004|Overall Study|Protocol Violation|0|||
130701116|NCT01525628|470528405|FG000|Overall Study|Lost to Follow-up|1|||
130701117|NCT01525628|470528406|FG001|Overall Study|Lost to Follow-up|1|||
130701118|NCT01525628|470528407|FG002|Overall Study|Lost to Follow-up|0|||
130701119|NCT01525628|470528408|FG003|Overall Study|Lost to Follow-up|0|||
130701120|NCT01525628|470528409|FG004|Overall Study|Lost to Follow-up|0|||
130701121|NCT01525628|470528405|FG000|Overall Study|Withdrawal by Subject|0|||
130701122|NCT01525628|470528406|FG001|Overall Study|Withdrawal by Subject|1|||
130701123|NCT01525628|470528407|FG002|Overall Study|Withdrawal by Subject|0|||
130701124|NCT01525628|470528408|FG003|Overall Study|Withdrawal by Subject|0|||
130701125|NCT01525628|470528409|FG004|Overall Study|Withdrawal by Subject|0|||
130701126|NCT01525628|470528405|FG000|Overall Study|Other reason not defined above|0|||
130701127|NCT01525628|470528406|FG001|Overall Study|Other reason not defined above|0|||
130553666|NCT02973048|469994799|FG000|Overall Study|Epidural catheter insertion failure|1|||
130553667|NCT02973048|469994800|FG001|Overall Study|Epidural catheter insertion failure|0|||
130553668|NCT02973048|469994799|FG000|Overall Study|Withdrawal by Subject|0|||
130701128|NCT01525628|470528407|FG002|Overall Study|Other reason not defined above|0|||
130701129|NCT01525628|470528408|FG003|Overall Study|Other reason not defined above|3|||
130701130|NCT01525628|470528409|FG004|Overall Study|Other reason not defined above|0|||
130701131|NCT03573336|470528410|FG000|Overall Study|Study terminated|2|||
130701132|NCT03573336|470528411|FG001|Overall Study|Study terminated|4|||
130701133|NCT03573336|470528412|FG002|Overall Study|Study terminated|2|||
130701134|NCT00239005|470528413|FG000|Overall Study|Adverse Event|6|||
130701135|NCT00239005|470528414|FG001|Overall Study|Adverse Event|6|||
130701136|NCT00239005|470528413|FG000|Overall Study|Withdrawal by Subject|3|||
130701137|NCT00239005|470528414|FG001|Overall Study|Withdrawal by Subject|4|||
130701138|NCT00239005|470528413|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
130701139|NCT00239005|470528414|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
130701140|NCT00239005|470528413|FG000|Overall Study|Protocol Violation|1|||
130701141|NCT00239005|470528414|FG001|Overall Study|Protocol Violation|0|||
130701142|NCT00239005|470528413|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
130701143|NCT00239005|470528414|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
130701144|NCT00239005|470528413|FG000|Overall Study|Lost to Follow-up|0|||
130701145|NCT00239005|470528414|FG001|Overall Study|Lost to Follow-up|1|||
130701146|NCT02614898|470528415|FG000|Overall Study|Participated until study termination|10|||
130701147|NCT02614898|470528416|FG001|Overall Study|Participated until study termination|26|||
130701148|NCT02614898|470528415|FG000|Overall Study|Lost to Follow-up|0|||
130701149|NCT02614898|470528416|FG001|Overall Study|Lost to Follow-up|2|||
130701150|NCT02614898|470528415|FG000|Overall Study|Physician Decision|1|||
130701151|NCT02614898|470528416|FG001|Overall Study|Physician Decision|8|||
130701152|NCT02614898|470528415|FG000|Overall Study|Study Terminated by Sponsor|3|||
130701153|NCT02614898|470528416|FG001|Overall Study|Study Terminated by Sponsor|0|||
130701154|NCT02614898|470528415|FG000|Overall Study|Withdrawal by Subject|0|||
130701155|NCT02614898|470528416|FG001|Overall Study|Withdrawal by Subject|2|||
130701156|NCT02614898|470528415|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130701157|NCT02614898|470528416|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130256293|NCT02327169|468903170|FG007|Overall Study|Lost to Follow-up|0|||
130701158|NCT02614898|470528415|FG000|Overall Study|Other-Additional Information Unavailable|0|||
130701159|NCT02614898|470528416|FG001|Overall Study|Other-Additional Information Unavailable|11|||
130701160|NCT02614898|470528415|FG000|Overall Study|Missing|0|||
130256294|NCT02327169|468903171|FG008|Overall Study|Lost to Follow-up|0|||
130256295|NCT02327169|468903172|FG009|Overall Study|Lost to Follow-up|0|||
130256296|NCT02327169|468903173|FG010|Overall Study|Lost to Follow-up|0|||
130256297|NCT02327169|468903174|FG011|Overall Study|Lost to Follow-up|0|||
130553669|NCT02973048|469994800|FG001|Overall Study|Withdrawal by Subject|3|||
130701161|NCT02614898|470528416|FG001|Overall Study|Missing|1|||
130701162|NCT03382041|470528417|FG000|Overall Study|Consent Form Lost|2|||
130701163|NCT03382041|470528418|FG001|Overall Study|Consent Form Lost|1|||
130701164|NCT03382041|470528417|FG000|Overall Study|Withdrawal by Subject|1|||
130701165|NCT03382041|470528418|FG001|Overall Study|Withdrawal by Subject|4|||
130701166|NCT03382041|470528417|FG000|Overall Study|Lost to Follow-up|1|||
130701167|NCT03382041|470528418|FG001|Overall Study|Lost to Follow-up|4|||
130701168|NCT00787605|470528419|FG000|Overall Study|Administrative Problems|3|||
130701169|NCT00787605|470528420|FG001|Overall Study|Administrative Problems|0|||
130701170|NCT00787605|470528419|FG000|Overall Study|Adverse Event|14|||
130701171|NCT00787605|470528420|FG001|Overall Study|Adverse Event|25|||
130701172|NCT00787605|470528419|FG000|Overall Study|Lost to Follow-up|3|||
130701173|NCT00787605|470528420|FG001|Overall Study|Lost to Follow-up|6|||
130701174|NCT00787605|470528419|FG000|Overall Study|Protocol Violation|7|||
130701175|NCT00787605|470528420|FG001|Overall Study|Protocol Violation|3|||
130701176|NCT00787605|470528419|FG000|Overall Study|Withdrawal by Subject|6|||
130701177|NCT00787605|470528420|FG001|Overall Study|Withdrawal by Subject|13|||
130701178|NCT00787605|470528419|FG000|Overall Study|Lack of Efficacy|13|||
130701179|NCT00787605|470528420|FG001|Overall Study|Lack of Efficacy|9|||
130701180|NCT03493919|470528427|FG000|Overall Study|Other|2|||
130701181|NCT03493919|470528428|FG001|Overall Study|Other|0|||
130701182|NCT03493919|470528429|FG002|Overall Study|Other|1|||
130701183|NCT03493919|470528430|FG003|Overall Study|Other|0|||
130256298|NCT02327169|468903175|FG012|Overall Study|Lost to Follow-up|0|||
130256299|NCT02327169|468903176|FG013|Overall Study|Lost to Follow-up|0|||
130256300|NCT02327169|468903177|FG014|Overall Study|Lost to Follow-up|0|||
130256301|NCT01381679|468903182|FG000|Overall Study|Adverse Event|3|||
130256302|NCT01381679|468903182|FG000|Overall Study|Lost to Follow-up|885|||
130256303|NCT05473715|468903183|FG000|Overall Study|Trial terminate|2|||
130256304|NCT05473715|468903184|FG001|Overall Study|Trial terminate|1|||
130256305|NCT00427700|468903188|FG000|Overall Study|Lost to Follow-up|2|||
130256306|NCT00427700|468903189|FG001|Overall Study|Lost to Follow-up|5|||
130256307|NCT00427700|468903188|FG000|Overall Study|no induction of menses|1|||
130365124|NCT02925117|469306857|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
130365125|NCT02925117|469306858|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
130365126|NCT02925117|469306859|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
130365127|NCT00347360|469306864|FG000|Overall Study|Adverse Event|1|||
130365128|NCT00347360|469306865|FG001|Overall Study|Adverse Event|2|||
130365129|NCT00347360|469306866|FG002|Overall Study|Adverse Event|0|||
130365130|NCT00347360|469306867|FG003|Overall Study|Adverse Event|4|||
130365131|NCT00347360|469306868|FG004|Overall Study|Adverse Event|1|||
130365132|NCT00347360|469306869|FG005|Overall Study|Adverse Event|2|||
130365133|NCT00347360|469306870|FG006|Overall Study|Adverse Event|2|||
130365134|NCT00347360|469306871|FG007|Overall Study|Adverse Event|0|||
130365135|NCT00347360|469306872|FG008|Overall Study|Adverse Event|2|||
130365136|NCT00347360|469306873|FG009|Overall Study|Adverse Event|3|||
130365137|NCT00347360|469306874|FG010|Overall Study|Adverse Event|3|||
130365138|NCT00347360|469306875|FG011|Overall Study|Adverse Event|1|||
130365139|NCT00347360|469306876|FG012|Overall Study|Adverse Event|3|||
130365140|NCT00347360|469306877|FG013|Overall Study|Adverse Event|2|||
130365141|NCT00347360|469306878|FG014|Overall Study|Adverse Event|2|||
130365142|NCT00347360|469306864|FG000|Overall Study|Lost to Follow-up|0|||
130365143|NCT00347360|469306865|FG001|Overall Study|Lost to Follow-up|0|||
130365144|NCT00347360|469306866|FG002|Overall Study|Lost to Follow-up|0|||
130365145|NCT00347360|469306867|FG003|Overall Study|Lost to Follow-up|2|||
130365146|NCT00347360|469306868|FG004|Overall Study|Lost to Follow-up|1|||
130365147|NCT00347360|469306869|FG005|Overall Study|Lost to Follow-up|1|||
130365148|NCT00347360|469306870|FG006|Overall Study|Lost to Follow-up|0|||
130365149|NCT00347360|469306871|FG007|Overall Study|Lost to Follow-up|1|||
130365150|NCT00347360|469306872|FG008|Overall Study|Lost to Follow-up|1|||
130365151|NCT00347360|469306873|FG009|Overall Study|Lost to Follow-up|2|||
130365152|NCT00347360|469306874|FG010|Overall Study|Lost to Follow-up|0|||
130365153|NCT00347360|469306875|FG011|Overall Study|Lost to Follow-up|0|||
130365154|NCT00347360|469306876|FG012|Overall Study|Lost to Follow-up|1|||
130365155|NCT00347360|469306877|FG013|Overall Study|Lost to Follow-up|0|||
130365156|NCT00347360|469306878|FG014|Overall Study|Lost to Follow-up|0|||
130365157|NCT00347360|469306864|FG000|Overall Study|Protocol Violation|2|||
130365158|NCT00347360|469306865|FG001|Overall Study|Protocol Violation|3|||
130365159|NCT00347360|469306866|FG002|Overall Study|Protocol Violation|1|||
130365160|NCT00347360|469306867|FG003|Overall Study|Protocol Violation|2|||
130365161|NCT00347360|469306868|FG004|Overall Study|Protocol Violation|1|||
130365162|NCT00347360|469306869|FG005|Overall Study|Protocol Violation|2|||
130365163|NCT00347360|469306870|FG006|Overall Study|Protocol Violation|0|||
130365164|NCT00347360|469306871|FG007|Overall Study|Protocol Violation|0|||
130365165|NCT00347360|469306872|FG008|Overall Study|Protocol Violation|1|||
130365166|NCT00347360|469306873|FG009|Overall Study|Protocol Violation|2|||
130365167|NCT00347360|469306874|FG010|Overall Study|Protocol Violation|0|||
130365168|NCT00347360|469306875|FG011|Overall Study|Protocol Violation|0|||
130365169|NCT00347360|469306876|FG012|Overall Study|Protocol Violation|0|||
130365170|NCT00347360|469306877|FG013|Overall Study|Protocol Violation|1|||
130365171|NCT00347360|469306878|FG014|Overall Study|Protocol Violation|0|||
130365172|NCT00347360|469306864|FG000|Overall Study|Withdrawal by Subject|0|||
130365173|NCT00347360|469306865|FG001|Overall Study|Withdrawal by Subject|1|||
130365174|NCT00347360|469306866|FG002|Overall Study|Withdrawal by Subject|2|||
130365175|NCT00347360|469306867|FG003|Overall Study|Withdrawal by Subject|4|||
130365176|NCT00347360|469306868|FG004|Overall Study|Withdrawal by Subject|1|||
130365177|NCT00347360|469306869|FG005|Overall Study|Withdrawal by Subject|2|||
130365178|NCT00347360|469306870|FG006|Overall Study|Withdrawal by Subject|1|||
130365179|NCT00347360|469306871|FG007|Overall Study|Withdrawal by Subject|1|||
130365180|NCT00347360|469306872|FG008|Overall Study|Withdrawal by Subject|1|||
130365181|NCT00347360|469306873|FG009|Overall Study|Withdrawal by Subject|1|||
130365182|NCT00347360|469306874|FG010|Overall Study|Withdrawal by Subject|0|||
130365183|NCT00347360|469306875|FG011|Overall Study|Withdrawal by Subject|3|||
130365184|NCT00347360|469306876|FG012|Overall Study|Withdrawal by Subject|4|||
130365185|NCT00347360|469306877|FG013|Overall Study|Withdrawal by Subject|2|||
130365186|NCT00347360|469306878|FG014|Overall Study|Withdrawal by Subject|1|||
130365187|NCT00347360|469306864|FG000|Overall Study|Lack of Efficacy|1|||
130365188|NCT00347360|469306865|FG001|Overall Study|Lack of Efficacy|1|||
130365189|NCT00347360|469306866|FG002|Overall Study|Lack of Efficacy|3|||
130365190|NCT00347360|469306867|FG003|Overall Study|Lack of Efficacy|1|||
130365191|NCT00347360|469306868|FG004|Overall Study|Lack of Efficacy|0|||
130365192|NCT00347360|469306869|FG005|Overall Study|Lack of Efficacy|1|||
130365193|NCT00347360|469306870|FG006|Overall Study|Lack of Efficacy|0|||
130365194|NCT00347360|469306871|FG007|Overall Study|Lack of Efficacy|1|||
130256308|NCT00427700|468903189|FG001|Overall Study|no induction of menses|4|||
130256309|NCT00427700|468903188|FG000|Overall Study|Pregnancy|0|||
130256310|NCT00427700|468903189|FG001|Overall Study|Pregnancy|2|||
130256311|NCT02014376|468903190|FG000|Overall Study|Adverse Event|1|||
130256312|NCT02014376|468903191|FG001|Overall Study|Adverse Event|1|||
130256313|NCT02014376|468903192|FG002|Overall Study|Adverse Event|0|||
130256314|NCT02014376|468903190|FG000|Overall Study|Lost to Follow-up|2|||
130256315|NCT02014376|468903191|FG001|Overall Study|Lost to Follow-up|0|||
130256316|NCT02014376|468903192|FG002|Overall Study|Lost to Follow-up|0|||
130256317|NCT01051661|468903195|FG000|Overall Study|Adverse Event|1|||
130256318|NCT01051661|468903196|FG001|Overall Study|Adverse Event|1|||
130553670|NCT00332189|469994801|FG000|Overall Study|Adverse Event|3|||
130256319|NCT01051661|468903197|FG002|Overall Study|Adverse Event|1|||
130256320|NCT01051661|468903198|FG003|Overall Study|Adverse Event|1|||
130256321|NCT01051661|468903199|FG004|Overall Study|Adverse Event|0|||
130256322|NCT01051661|468903200|FG005|Overall Study|Adverse Event|0|||
130256323|NCT01051661|468903195|FG000|Overall Study|Lost to Follow-up|13|||
130256324|NCT01051661|468903196|FG001|Overall Study|Lost to Follow-up|22|||
130256325|NCT01051661|468903197|FG002|Overall Study|Lost to Follow-up|15|||
130256326|NCT01051661|468903198|FG003|Overall Study|Lost to Follow-up|17|||
130256327|NCT01051661|468903199|FG004|Overall Study|Lost to Follow-up|10|||
130256328|NCT01051661|468903200|FG005|Overall Study|Lost to Follow-up|24|||
130256329|NCT01051661|468903195|FG000|Overall Study|Migrated/moved from study area|1|||
130256330|NCT01051661|468903196|FG001|Overall Study|Migrated/moved from study area|6|||
130256331|NCT01051661|468903197|FG002|Overall Study|Migrated/moved from study area|6|||
130256332|NCT01051661|468903198|FG003|Overall Study|Migrated/moved from study area|8|||
130256333|NCT01051661|468903199|FG004|Overall Study|Migrated/moved from study area|7|||
130256334|NCT01051661|468903200|FG005|Overall Study|Migrated/moved from study area|3|||
130256335|NCT01051661|468903195|FG000|Overall Study|Refused blood sampling|0|||
130256336|NCT01051661|468903196|FG001|Overall Study|Refused blood sampling|0|||
130256337|NCT01051661|468903197|FG002|Overall Study|Refused blood sampling|0|||
130256338|NCT01051661|468903198|FG003|Overall Study|Refused blood sampling|0|||
130256339|NCT01051661|468903199|FG004|Overall Study|Refused blood sampling|0|||
130256340|NCT01051661|468903200|FG005|Overall Study|Refused blood sampling|1|||
130256341|NCT01051661|468903195|FG000|Overall Study|Data not reliable|1|||
130256342|NCT01051661|468903196|FG001|Overall Study|Data not reliable|0|||
130256343|NCT01051661|468903197|FG002|Overall Study|Data not reliable|0|||
130256344|NCT01051661|468903198|FG003|Overall Study|Data not reliable|0|||
130256345|NCT01051661|468903199|FG004|Overall Study|Data not reliable|0|||
130256346|NCT01051661|468903200|FG005|Overall Study|Data not reliable|1|||
130256347|NCT01051661|468903195|FG000|Overall Study|Unable to attend visit(s)|2|||
130256348|NCT01051661|468903196|FG001|Overall Study|Unable to attend visit(s)|4|||
130256349|NCT01051661|468903197|FG002|Overall Study|Unable to attend visit(s)|2|||
130256350|NCT01051661|468903198|FG003|Overall Study|Unable to attend visit(s)|1|||
130256351|NCT01051661|468903199|FG004|Overall Study|Unable to attend visit(s)|3|||
130256352|NCT01051661|468903200|FG005|Overall Study|Unable to attend visit(s)|2|||
130256353|NCT01051661|468903195|FG000|Overall Study|Consent not received from both parents|0|||
130256354|NCT01051661|468903196|FG001|Overall Study|Consent not received from both parents|0|||
130256355|NCT01051661|468903197|FG002|Overall Study|Consent not received from both parents|0|||
130256356|NCT01051661|468903198|FG003|Overall Study|Consent not received from both parents|0|||
130256357|NCT01051661|468903199|FG004|Overall Study|Consent not received from both parents|0|||
130256358|NCT01051661|468903200|FG005|Overall Study|Consent not received from both parents|1|||
130256359|NCT01051661|468903195|FG000|Overall Study|Failure to comply with protocol|0|||
130701184|NCT03493919|470528427|FG000|Overall Study|Withdrawal by Subject|9|||
130701185|NCT03493919|470528428|FG001|Overall Study|Withdrawal by Subject|3|||
130256360|NCT01051661|468903196|FG001|Overall Study|Failure to comply with protocol|0|||
130256361|NCT01051661|468903197|FG002|Overall Study|Failure to comply with protocol|2|||
130256362|NCT01051661|468903198|FG003|Overall Study|Failure to comply with protocol|0|||
130256363|NCT01051661|468903199|FG004|Overall Study|Failure to comply with protocol|0|||
130256364|NCT01051661|468903200|FG005|Overall Study|Failure to comply with protocol|0|||
130256365|NCT01051661|468903195|FG000|Overall Study|Subject lost legal representation|0|||
130256366|NCT01051661|468903196|FG001|Overall Study|Subject lost legal representation|0|||
130256367|NCT01051661|468903197|FG002|Overall Study|Subject lost legal representation|0|||
130256368|NCT01051661|468903198|FG003|Overall Study|Subject lost legal representation|0|||
130256369|NCT01051661|468903199|FG004|Overall Study|Subject lost legal representation|1|||
130256370|NCT01051661|468903200|FG005|Overall Study|Subject lost legal representation|0|||
130256371|NCT01051661|468903195|FG000|Overall Study|Protocol Violation|0|||
130256372|NCT01051661|468903196|FG001|Overall Study|Protocol Violation|0|||
130256373|NCT01051661|468903197|FG002|Overall Study|Protocol Violation|0|||
130256374|NCT01051661|468903198|FG003|Overall Study|Protocol Violation|1|||
130256375|NCT01051661|468903199|FG004|Overall Study|Protocol Violation|2|||
130256376|NCT01051661|468903200|FG005|Overall Study|Protocol Violation|1|||
130256377|NCT01051661|468903195|FG000|Overall Study|Withdrawal by Subject|16|||
130256378|NCT01051661|468903196|FG001|Overall Study|Withdrawal by Subject|30|||
130256379|NCT01051661|468903197|FG002|Overall Study|Withdrawal by Subject|13|||
130256380|NCT01051661|468903198|FG003|Overall Study|Withdrawal by Subject|28|||
130256381|NCT01051661|468903199|FG004|Overall Study|Withdrawal by Subject|12|||
130701186|NCT03493919|470528429|FG002|Overall Study|Withdrawal by Subject|1|||
130256382|NCT01051661|468903200|FG005|Overall Study|Withdrawal by Subject|34|||
130256383|NCT04642079|468903201|FG000|Overall Study|Lost to Follow-up|2|||
130365195|NCT00347360|469306872|FG008|Overall Study|Lack of Efficacy|1|||
130256384|NCT04642079|468903202|FG001|Overall Study|Lost to Follow-up|5|||
130256385|NCT04642079|468903203|FG002|Overall Study|Lost to Follow-up|2|||
130256386|NCT04642079|468903204|FG003|Overall Study|Lost to Follow-up|0|||
130256387|NCT04642079|468903201|FG000|Overall Study|Withdrawal by Subject|0|||
130256388|NCT04642079|468903202|FG001|Overall Study|Withdrawal by Subject|4|||
130701187|NCT03493919|470528430|FG003|Overall Study|Withdrawal by Subject|1|||
130256389|NCT04642079|468903203|FG002|Overall Study|Withdrawal by Subject|1|||
130256390|NCT04642079|468903204|FG003|Overall Study|Withdrawal by Subject|2|||
130256391|NCT04642079|468903201|FG000|Overall Study|Other|0|||
130256392|NCT04642079|468903202|FG001|Overall Study|Other|0|||
130256393|NCT04642079|468903203|FG002|Overall Study|Other|0|||
130256394|NCT04642079|468903204|FG003|Overall Study|Other|1|||
130256395|NCT04642079|468903201|FG000|Overall Study|No longer met eligibility criteria|1|||
130256396|NCT04642079|468903202|FG001|Overall Study|No longer met eligibility criteria|0|||
130256397|NCT04642079|468903203|FG002|Overall Study|No longer met eligibility criteria|1|||
130256398|NCT04642079|468903204|FG003|Overall Study|No longer met eligibility criteria|1|||
130701188|NCT03493919|470528427|FG000|Overall Study|Lost to Follow-up|5|||
130701189|NCT03493919|470528428|FG001|Overall Study|Lost to Follow-up|0|||
130701190|NCT03493919|470528429|FG002|Overall Study|Lost to Follow-up|0|||
130701191|NCT03493919|470528430|FG003|Overall Study|Lost to Follow-up|3|||
130701192|NCT03493919|470528427|FG000|Overall Study|Adverse Event|0|||
130701193|NCT03493919|470528428|FG001|Overall Study|Adverse Event|1|||
130701194|NCT03493919|470528429|FG002|Overall Study|Adverse Event|0|||
130701195|NCT03493919|470528430|FG003|Overall Study|Adverse Event|0|||
130701196|NCT00965731|470528434|FG000|Overall Study|Death|0|||
130701197|NCT00965731|470528435|FG001|Overall Study|Death|4|||
130701198|NCT00965731|470528434|FG000|Overall Study|Withdrawal by Subject|0|||
130701199|NCT00965731|470528435|FG001|Overall Study|Withdrawal by Subject|1|||
130701200|NCT00965731|470528434|FG000|Overall Study|Other|7|||
130701201|NCT00965731|470528435|FG001|Overall Study|Other|15|||
130701202|NCT00559637|470530313|FG000|Overall Study|Adverse Event|22|||
130701203|NCT00559637|470530313|FG000|Overall Study|Withdrawal by Subject|4|||
130701204|NCT00559637|470530313|FG000|Overall Study|Protocol Violation|6|||
130701205|NCT00559637|470530313|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
130701206|NCT00559637|470530313|FG000|Overall Study|Failure to return|6|||
130701207|NCT00559637|470530313|FG000|Overall Study|Insufficient response|3|||
130701208|NCT00559637|470530313|FG000|Overall Study|Started requiring dialysis after month 7|2|||
130701209|NCT00559637|470530313|FG000|Overall Study|Suspected lung cancer|1|||
130701210|NCT00559637|470530313|FG000|Overall Study|Participation in another study|1|||
130701211|NCT00559637|470530313|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
130701212|NCT00559637|470530313|FG000|Overall Study|Change of center|1|||
130701213|NCT00559637|470530313|FG000|Overall Study|Change of home|1|||
130701214|NCT00559637|470530313|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
130701215|NCT02832167|470530314|FG000|Treatment Period 1|Disease progression|90|||
130701216|NCT02832167|470530314|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
130701217|NCT02832167|470530314|FG000|Treatment Period 1|Death|2|||
130701218|NCT02832167|470530314|FG000|Treatment Period 1|Study Drug Toxicity|6|||
130701219|NCT02832167|470530314|FG000|Treatment Period 1|Participant request to discontinue|9|||
130701220|NCT02832167|470530314|FG000|Treatment Period 1|No longer meet study criteria|1|||
130701221|NCT02832167|470530314|FG000|Treatment Period 1|Participant withdrew consent|3|||
130701222|NCT02832167|470530314|FG000|Treatment Period 1|Other reasons|6|||
130701223|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
130701224|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
130701225|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Death|2|||
130701226|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
130701227|NCT02832167|470530314|FG000|Treatment Period 2|Disease progression|69|||
130701228|NCT02832167|470530314|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
130701229|NCT02832167|470530314|FG000|Treatment Period 2|Maximum clinical benefit|1|||
130701230|NCT02832167|470530314|FG000|Treatment Period 2|Study Drug Toxicity|5|||
130701231|NCT02832167|470530314|FG000|Treatment Period 2|Participant request to discontinue|2|||
130701232|NCT02832167|470530314|FG000|Treatment Period 2|Participant withdrew consent|3|||
130701233|NCT02832167|470530314|FG000|Treatment Period 2|Other reasons|3|||
130701234|NCT00224484|470530315|FG000|Overall Study|Serious Adverse Event|1|||
130701235|NCT00224484|470530316|FG001|Overall Study|Serious Adverse Event|1|||
130701236|NCT00224484|470530317|FG002|Overall Study|Serious Adverse Event|0|||
130701237|NCT00224484|470530315|FG000|Overall Study|Non-Serious Adverse Event|5|||
130701238|NCT00224484|470530316|FG001|Overall Study|Non-Serious Adverse Event|7|||
130701239|NCT00224484|470530317|FG002|Overall Study|Non-Serious Adverse Event|3|||
130701240|NCT00224484|470530315|FG000|Overall Study|Protocol Violation|2|||
130701241|NCT00224484|470530316|FG001|Overall Study|Protocol Violation|2|||
130256399|NCT00635050|468903209|FG000|Overall Study|Withdrawal by Subject|1|||
130701242|NCT00224484|470530317|FG002|Overall Study|Protocol Violation|0|||
130701243|NCT00224484|470530315|FG000|Overall Study|Withdrawal by Subject|49|||
130701244|NCT00224484|470530316|FG001|Overall Study|Withdrawal by Subject|18|||
130701245|NCT00224484|470530317|FG002|Overall Study|Withdrawal by Subject|16|||
130701246|NCT00224484|470530315|FG000|Overall Study|Migrated/moved from study area|18|||
130701247|NCT00224484|470530316|FG001|Overall Study|Migrated/moved from study area|5|||
130701248|NCT00224484|470530317|FG002|Overall Study|Migrated/moved from study area|5|||
130701249|NCT00224484|470530315|FG000|Overall Study|Lost to Follow-up|66|||
130256400|NCT03038620|468903210|FG000|Overall Study|Lost to Follow-up|18|||
130256401|NCT03038620|468903211|FG001|Overall Study|Lost to Follow-up|23|||
130701250|NCT00224484|470530316|FG001|Overall Study|Lost to Follow-up|28|||
130701251|NCT00224484|470530317|FG002|Overall Study|Lost to Follow-up|36|||
130701252|NCT00224484|470530315|FG000|Overall Study|Reason not specified|5|||
130701253|NCT00224484|470530316|FG001|Overall Study|Reason not specified|4|||
130701254|NCT00224484|470530317|FG002|Overall Study|Reason not specified|2|||
130701255|NCT02805309|470530318|FG000|Overall Study|Lost to Follow-up|2|||
130701256|NCT02805309|470530319|FG001|Overall Study|Lost to Follow-up|2|||
130701257|NCT02805309|470530320|FG002|Overall Study|Lost to Follow-up|2|||
130701258|NCT02805309|470530318|FG000|Overall Study|Post-Randomization Exclusion|0|||
130701259|NCT02805309|470530319|FG001|Overall Study|Post-Randomization Exclusion|2|||
130701260|NCT02805309|470530320|FG002|Overall Study|Post-Randomization Exclusion|1|||
130701261|NCT04675775|470530326|FG000|Overall Study|Withdrawal by Subject|7|||
130701262|NCT00348816|470530327|FG000|Overall Study|Noncompliance with radiation treatment|1|||
130701263|NCT02050321|470530334|FG000|Overall Study|Withdrawal by Subject|1|||
130701264|NCT02050321|470530334|FG000|Overall Study|Adverse Event|1|||
130701265|NCT00113919|470530335|FG000|Overall Study|Physician Decision|8|||
130701266|NCT00113919|470530335|FG000|Overall Study|Death|6|||
130701267|NCT00715676|470530336|FG000|Overall Study|Adverse Event|3|||
130701268|NCT00715676|470530337|FG001|Overall Study|Adverse Event|5|||
130701269|NCT00715676|470530338|FG002|Overall Study|Adverse Event|21|||
130701270|NCT00715676|470530336|FG000|Overall Study|Withdrawal by Subject|1|||
130701271|NCT00715676|470530337|FG001|Overall Study|Withdrawal by Subject|3|||
130701272|NCT00715676|470530338|FG002|Overall Study|Withdrawal by Subject|8|||
130701273|NCT00715676|470530336|FG000|Overall Study|Lost to Follow-up|1|||
130701274|NCT00715676|470530337|FG001|Overall Study|Lost to Follow-up|2|||
130701275|NCT00715676|470530338|FG002|Overall Study|Lost to Follow-up|1|||
130701276|NCT00715676|470530336|FG000|Overall Study|Terminated by Sponsor|1|||
130701277|NCT00715676|470530337|FG001|Overall Study|Terminated by Sponsor|0|||
130701278|NCT00715676|470530338|FG002|Overall Study|Terminated by Sponsor|0|||
130701279|NCT00715676|470530336|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
130701280|NCT00715676|470530337|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
130701281|NCT00715676|470530338|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
130701282|NCT00715676|470530336|FG000|Overall Study|Use of Exclusionary Medication|0|||
130701283|NCT00715676|470530337|FG001|Overall Study|Use of Exclusionary Medication|0|||
130701284|NCT00715676|470530338|FG002|Overall Study|Use of Exclusionary Medication|1|||
130701285|NCT00715676|470530336|FG000|Overall Study|Elevated Blood Glucose|0|||
130701286|NCT00715676|470530337|FG001|Overall Study|Elevated Blood Glucose|1|||
130701287|NCT00715676|470530338|FG002|Overall Study|Elevated Blood Glucose|0|||
130701288|NCT04994431|470530339|FG000|Overall Study|Adverse Event|1|||
130701289|NCT04994431|470530340|FG001|Overall Study|Adverse Event|0|||
130701290|NCT00372996|470530341|FG000|Overall Study|Death|11|||
130701291|NCT00372996|470530342|FG001|Overall Study|Death|4|||
130701292|NCT00372996|470530343|FG002|Overall Study|Death|8|||
130701293|NCT00372996|470530344|FG003|Overall Study|Death|7|||
130701294|NCT00372996|470530341|FG000|Overall Study|Lost to Follow-up|0|||
130701295|NCT00372996|470530342|FG001|Overall Study|Lost to Follow-up|2|||
130701296|NCT00372996|470530343|FG002|Overall Study|Lost to Follow-up|0|||
130701297|NCT00372996|470530344|FG003|Overall Study|Lost to Follow-up|1|||
130701298|NCT00372996|470530341|FG000|Overall Study|Withdrawal by Subject|12|||
130701299|NCT00372996|470530342|FG001|Overall Study|Withdrawal by Subject|6|||
130701300|NCT00372996|470530343|FG002|Overall Study|Withdrawal by Subject|9|||
130701301|NCT00372996|470530344|FG003|Overall Study|Withdrawal by Subject|5|||
130701302|NCT00372996|470530341|FG000|Overall Study|Study Terminated by Sponsor|4|||
130701303|NCT00372996|470530342|FG001|Overall Study|Study Terminated by Sponsor|0|||
130701304|NCT00372996|470530343|FG002|Overall Study|Study Terminated by Sponsor|4|||
130701305|NCT00372996|470530344|FG003|Overall Study|Study Terminated by Sponsor|0|||
130701306|NCT00372996|470530341|FG000|Overall Study|Other|10|||
130701307|NCT00372996|470530342|FG001|Overall Study|Other|2|||
130365196|NCT00347360|469306873|FG009|Overall Study|Lack of Efficacy|0|||
130365197|NCT00347360|469306874|FG010|Overall Study|Lack of Efficacy|0|||
130365198|NCT00347360|469306875|FG011|Overall Study|Lack of Efficacy|0|||
130365199|NCT00347360|469306876|FG012|Overall Study|Lack of Efficacy|0|||
130365200|NCT00347360|469306877|FG013|Overall Study|Lack of Efficacy|0|||
130365201|NCT00347360|469306878|FG014|Overall Study|Lack of Efficacy|0|||
130365202|NCT00347360|469306864|FG000|Overall Study|Reason not listed/blank|1|||
130365203|NCT00347360|469306865|FG001|Overall Study|Reason not listed/blank|0|||
130365204|NCT00347360|469306866|FG002|Overall Study|Reason not listed/blank|0|||
130365205|NCT00347360|469306867|FG003|Overall Study|Reason not listed/blank|0|||
130365206|NCT00347360|469306868|FG004|Overall Study|Reason not listed/blank|0|||
130365207|NCT00347360|469306869|FG005|Overall Study|Reason not listed/blank|0|||
130365208|NCT00347360|469306870|FG006|Overall Study|Reason not listed/blank|1|||
130365209|NCT00347360|469306871|FG007|Overall Study|Reason not listed/blank|0|||
130365210|NCT00347360|469306872|FG008|Overall Study|Reason not listed/blank|0|||
130701308|NCT00372996|470530343|FG002|Overall Study|Other|7|||
130701309|NCT00372996|470530344|FG003|Overall Study|Other|7|||
130701310|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
130701311|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
130256402|NCT03038620|468903210|FG000|Overall Study|Withdrawal by Subject|0|||
130256403|NCT03038620|468903211|FG001|Overall Study|Withdrawal by Subject|15|||
130256404|NCT03038620|468903210|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
130256405|NCT03038620|468903211|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
130256406|NCT00759395|468903217|FG000|Overall Study|Adverse Event|1|||
130256407|NCT00759395|468903218|FG001|Overall Study|Adverse Event|0|||
130256408|NCT00759395|468903217|FG000|Overall Study|Withdrawal by Subject|1|||
130256409|NCT00759395|468903218|FG001|Overall Study|Withdrawal by Subject|0|||
130256410|NCT00759395|468903217|FG000|Overall Study|Lack of Efficacy|0|||
130256411|NCT00759395|468903218|FG001|Overall Study|Lack of Efficacy|2|||
130256412|NCT01435356|468903219|FG000|Overall Study|Adverse Event|2|||
130256413|NCT01435356|468903220|FG001|Overall Study|Adverse Event|0|||
130256414|NCT01435356|468903219|FG000|Overall Study|Disease progression/recurrence|17|||
130256415|NCT01435356|468903220|FG001|Overall Study|Disease progression/recurrence|10|||
130256416|NCT01435356|468903219|FG000|Overall Study|Protocol Violation|0|||
130256417|NCT01435356|468903220|FG001|Overall Study|Protocol Violation|1|||
130256418|NCT01435356|468903219|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
130256419|NCT01435356|468903220|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
130256420|NCT01435356|468903219|FG000|Overall Study|Withdrawal by Subject|1|||
130256421|NCT01435356|468903220|FG001|Overall Study|Withdrawal by Subject|1|||
130256422|NCT01435356|468903219|FG000|Overall Study|Facial palsy|1|||
130256423|NCT01435356|468903220|FG001|Overall Study|Facial palsy|0|||
130256424|NCT01435356|468903219|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
130256425|NCT01435356|468903220|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
130256426|NCT01435356|468903219|FG000|Overall Study|Physician Decision|1|||
130256427|NCT01435356|468903220|FG001|Overall Study|Physician Decision|0|||
130256428|NCT01435356|468903219|FG000|Overall Study|Patient decision|3|||
130256429|NCT01435356|468903220|FG001|Overall Study|Patient decision|0|||
130256430|NCT01435356|468903219|FG000|Overall Study|Patient moved to another city|1|||
130256431|NCT01435356|468903220|FG001|Overall Study|Patient moved to another city|1|||
130256432|NCT00437073|468903221|FG000|Overall Study|Sponsor Terminated Study|1|||
130256433|NCT00437073|468903222|FG001|Overall Study|Sponsor Terminated Study|0|||
130256434|NCT00437073|468903221|FG000|Overall Study|Physician Decision|0|||
130256435|NCT00437073|468903222|FG001|Overall Study|Physician Decision|1|||
130256436|NCT04875533|468903223|FG000|Overall Study|Adverse Event|6|||
130256437|NCT04875533|468903224|FG001|Overall Study|Adverse Event|4|||
130256438|NCT04875533|468903223|FG000|Overall Study|Protocol Violation|4|||
130256439|NCT04875533|468903224|FG001|Overall Study|Protocol Violation|0|||
130256440|NCT04875533|468903223|FG000|Overall Study|Withdrawal by Subject|8|||
130256441|NCT04875533|468903224|FG001|Overall Study|Withdrawal by Subject|5|||
130256442|NCT04875533|468903223|FG000|Overall Study|No longer meets eligibility criteria|1|||
130256443|NCT04875533|468903224|FG001|Overall Study|No longer meets eligibility criteria|0|||
130256444|NCT04875533|468903223|FG000|Overall Study|Other|0|||
130256445|NCT04875533|468903224|FG001|Overall Study|Other|2|||
130256446|NCT02657343|468903227|FG000|Overall Study|Death|0|||
130256447|NCT02657343|468903228|FG001|Overall Study|Death|2|||
130256448|NCT02657343|468903229|FG002|Overall Study|Death|0|||
130256449|NCT02657343|468903230|FG003|Overall Study|Death|0|||
130256450|NCT02657343|468903231|FG004|Overall Study|Death|0|||
130256451|NCT02657343|468903232|FG005|Overall Study|Death|0|||
130256452|NCT02657343|468903227|FG000|Overall Study|Patient went to hospice|1|||
130256453|NCT02657343|468903228|FG001|Overall Study|Patient went to hospice|0|||
130256454|NCT02657343|468903229|FG002|Overall Study|Patient went to hospice|0|||
130256455|NCT02657343|468903230|FG003|Overall Study|Patient went to hospice|0|||
130256456|NCT02657343|468903231|FG004|Overall Study|Patient went to hospice|0|||
130256457|NCT02657343|468903232|FG005|Overall Study|Patient went to hospice|0|||
130256458|NCT02657343|468903227|FG000|Overall Study|Withdrawal by Subject|0|||
130256459|NCT02657343|468903228|FG001|Overall Study|Withdrawal by Subject|0|||
130256460|NCT02657343|468903229|FG002|Overall Study|Withdrawal by Subject|0|||
130256461|NCT02657343|468903230|FG003|Overall Study|Withdrawal by Subject|0|||
130256462|NCT02657343|468903231|FG004|Overall Study|Withdrawal by Subject|1|||
130256463|NCT02657343|468903232|FG005|Overall Study|Withdrawal by Subject|0|||
130256464|NCT02011542|468903234|FG000|Overall Study|Physician Decision|1|||
130256465|NCT00982280|468903238|FG000|Observation Period|Not eligible to be dosed|19|||
130256466|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
130256467|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
130256468|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
130256469|NCT00982280|468903238|FG000|Maintenance Period|Adverse Event|1|||
130256470|NCT01979185|468903239|FG000|Period 2|Other|0|||
130256471|NCT01979185|468903240|FG001|Period 2|Other|1|||
130256472|NCT00980798|468903241|FG000|Overall Study|Adverse Event|7|||
130256473|NCT00980798|468903242|FG001|Overall Study|Adverse Event|36|||
130256474|NCT00980798|468903241|FG000|Overall Study|Lack of Efficacy|16|||
130256475|NCT00980798|468903242|FG001|Overall Study|Lack of Efficacy|5|||
130256476|NCT00980798|468903241|FG000|Overall Study|Lost to Follow-up|0|||
130256477|NCT00980798|468903242|FG001|Overall Study|Lost to Follow-up|1|||
130256478|NCT00980798|468903241|FG000|Overall Study|Physician Decision|2|||
130701312|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
130701313|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
130701314|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
130701315|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
130701316|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130701317|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130701318|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
130701319|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
130701320|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
130701321|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
130701322|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
130701323|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130701324|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
130701325|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
130701326|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
130701327|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
130701328|NCT01067521|470530348|FG000|Open-Label Period|Death|3|||
130701329|NCT01067521|470530349|FG001|Open-Label Period|Death|1|||
130256479|NCT00980798|468903242|FG001|Overall Study|Physician Decision|1|||
130256480|NCT00980798|468903241|FG000|Overall Study|Withdrawal by Subject|8|||
130256481|NCT00980798|468903242|FG001|Overall Study|Withdrawal by Subject|11|||
130256482|NCT00980798|468903241|FG000|Overall Study|Other|0|||
130256483|NCT00980798|468903242|FG001|Overall Study|Other|1|||
130256484|NCT04221438|468903243|FG000|Overall Study|Adverse Event|1|||
130256485|NCT04221438|468903243|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
130256486|NCT04724837|468903246|FG000|Overall Study|Other|4|||
130256487|NCT04724837|468903247|FG001|Overall Study|Other|16|||
130256488|NCT04724837|468903248|FG002|Overall Study|Other|0|||
130256489|NCT04724837|468903246|FG000|Overall Study|Withdrawal by Subject|2|||
130256490|NCT04724837|468903247|FG001|Overall Study|Withdrawal by Subject|9|||
130256491|NCT04724837|468903248|FG002|Overall Study|Withdrawal by Subject|9|||
130256492|NCT04724837|468903246|FG000|Overall Study|Adverse Event|2|||
130256493|NCT04724837|468903247|FG001|Overall Study|Adverse Event|7|||
130256494|NCT04724837|468903248|FG002|Overall Study|Adverse Event|4|||
130256495|NCT04724837|468903246|FG000|Overall Study|Lost to Follow-up|0|||
130256496|NCT04724837|468903247|FG001|Overall Study|Lost to Follow-up|1|||
130256497|NCT04724837|468903248|FG002|Overall Study|Lost to Follow-up|3|||
130256498|NCT04724837|468903246|FG000|Overall Study|Physician Decision|1|||
130256499|NCT04724837|468903247|FG001|Overall Study|Physician Decision|2|||
130256500|NCT04724837|468903248|FG002|Overall Study|Physician Decision|0|||
130256501|NCT04724837|468903246|FG000|Overall Study|Death|0|||
130256502|NCT04724837|468903247|FG001|Overall Study|Death|0|||
130256503|NCT04724837|468903248|FG002|Overall Study|Death|1|||
130256504|NCT04724837|468903246|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130256505|NCT04724837|468903247|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130256506|NCT04724837|468903248|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
130256507|NCT04724837|468903246|FG000|Overall Study|Study Terminated by Sponsor|0|||
130256508|NCT04724837|468903247|FG001|Overall Study|Study Terminated by Sponsor|1|||
130256509|NCT04724837|468903248|FG002|Overall Study|Study Terminated by Sponsor|0|||
130256510|NCT00522379|468903249|FG000|Overall Study|Adverse Event|12|||
130256511|NCT00522379|468903250|FG001|Overall Study|Adverse Event|15|||
130256512|NCT00522379|468903251|FG002|Overall Study|Adverse Event|12|||
130256513|NCT00522379|468903252|FG003|Overall Study|Adverse Event|5|||
130256514|NCT00522379|468903253|FG004|Overall Study|Adverse Event|17|||
130256515|NCT00522379|468903249|FG000|Overall Study|Lack of Efficacy|3|||
130701330|NCT01067521|470530348|FG000|Open-Label Period|Adverse Event|30|||
130701331|NCT01067521|470530349|FG001|Open-Label Period|Adverse Event|28|||
130701332|NCT01067521|470530348|FG000|Open-Label Period|Withdrawal by Subject|160|||
130701333|NCT01067521|470530349|FG001|Open-Label Period|Withdrawal by Subject|88|||
130701334|NCT01067521|470530348|FG000|Open-Label Period|Physician Decision|13|||
130701335|NCT01067521|470530349|FG001|Open-Label Period|Physician Decision|11|||
130701336|NCT01067521|470530348|FG000|Open-Label Period|Non-compliance with study drug|5|||
130701337|NCT01067521|470530349|FG001|Open-Label Period|Non-compliance with study drug|0|||
130701338|NCT01067521|470530348|FG000|Open-Label Period|Protocol Violation|3|||
130701339|NCT01067521|470530349|FG001|Open-Label Period|Protocol Violation|0|||
130701340|NCT01067521|470530348|FG000|Open-Label Period|Pregnancy|14|||
130701341|NCT01067521|470530349|FG001|Open-Label Period|Pregnancy|8|||
130256516|NCT00522379|468903250|FG001|Overall Study|Lack of Efficacy|0|||
130256517|NCT00522379|468903251|FG002|Overall Study|Lack of Efficacy|2|||
130256518|NCT00522379|468903252|FG003|Overall Study|Lack of Efficacy|2|||
130256519|NCT00522379|468903253|FG004|Overall Study|Lack of Efficacy|7|||
130256520|NCT00522379|468903249|FG000|Overall Study|Withdrawal by Subject|2|||
130256521|NCT00522379|468903250|FG001|Overall Study|Withdrawal by Subject|3|||
130256522|NCT00522379|468903251|FG002|Overall Study|Withdrawal by Subject|1|||
130553671|NCT00332189|469994801|FG000|Overall Study|Uncooperative/Noncompliant|3|||
130553672|NCT00332189|469994801|FG000|Overall Study|Withdrawal by Subject|9|||
130553673|NCT00332189|469994801|FG000|Overall Study|Lack of Efficacy|4|||
130553674|NCT00332189|469994801|FG000|Overall Study|Moved out of country|2|||
130553675|NCT02279862|469994803|FG000|Overall Study|Study drug toxicity|3|||
130553676|NCT02279862|469994804|FG001|Overall Study|Study drug toxicity|6|||
130553677|NCT02279862|469994803|FG000|Overall Study|No longer meets criteria|0|||
130553678|NCT02279862|469994804|FG001|Overall Study|No longer meets criteria|1|||
130553679|NCT02279862|469994803|FG000|Overall Study|Administrative reason by sponsor|0|||
130553680|NCT02279862|469994804|FG001|Overall Study|Administrative reason by sponsor|1|||
130553681|NCT02279862|469994803|FG000|Overall Study|Disease progression|5|||
130553682|NCT02279862|469994804|FG001|Overall Study|Disease progression|2|||
130553683|NCT02279862|469994803|FG000|Overall Study|Study closed by sponsor|16|||
130553684|NCT02279862|469994804|FG001|Overall Study|Study closed by sponsor|13|||
130701342|NCT01067521|470530348|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
130701343|NCT01067521|470530349|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
130701344|NCT01067521|470530348|FG000|Open-Label Period|Lost to Follow-up|21|||
130701345|NCT01067521|470530349|FG001|Open-Label Period|Lost to Follow-up|20|||
130701346|NCT02760433|470530351|FG000|Overall Study|Lost to Follow-up|1|||
130701347|NCT02760433|470530352|FG001|Overall Study|Lost to Follow-up|0|||
130701348|NCT02760433|470530353|FG002|Overall Study|Lost to Follow-up|1|||
130701349|NCT02760433|470530354|FG003|Overall Study|Lost to Follow-up|0|||
130701350|NCT02760433|470530355|FG004|Overall Study|Lost to Follow-up|0|||
130701351|NCT02760433|470530351|FG000|Overall Study|Withdrawal by Subject|23|||
130701352|NCT02760433|470530352|FG001|Overall Study|Withdrawal by Subject|9|||
130701353|NCT02760433|470530353|FG002|Overall Study|Withdrawal by Subject|0|||
130701354|NCT02760433|470530354|FG003|Overall Study|Withdrawal by Subject|2|||
130701355|NCT02760433|470530355|FG004|Overall Study|Withdrawal by Subject|9|||
130701356|NCT02760433|470530351|FG000|Overall Study|Lack of Response At Week 14|0|||
130701357|NCT02760433|470530352|FG001|Overall Study|Lack of Response At Week 14|0|||
130701358|NCT02760433|470530353|FG002|Overall Study|Lack of Response At Week 14|0|||
130701359|NCT02760433|470530354|FG003|Overall Study|Lack of Response At Week 14|0|||
130701360|NCT02760433|470530355|FG004|Overall Study|Lack of Response At Week 14|1|||
130701361|NCT02760433|470530351|FG000|Overall Study|Subject refused to continue the study|1|||
130701362|NCT02760433|470530352|FG001|Overall Study|Subject refused to continue the study|0|||
130701363|NCT02760433|470530353|FG002|Overall Study|Subject refused to continue the study|0|||
130701364|NCT02760433|470530354|FG003|Overall Study|Subject refused to continue the study|0|||
130701365|NCT02760433|470530355|FG004|Overall Study|Subject refused to continue the study|0|||
130701366|NCT02760433|470530351|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
130701367|NCT02760433|470530352|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701368|NCT02760433|470530353|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701369|NCT02760433|470530354|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701370|NCT02760433|470530355|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701371|NCT02760433|470530351|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701372|NCT02760433|470530352|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
130701373|NCT02760433|470530353|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130256523|NCT00522379|468903252|FG003|Overall Study|Withdrawal by Subject|2|||
130256524|NCT00522379|468903253|FG004|Overall Study|Withdrawal by Subject|0|||
130256525|NCT00522379|468903249|FG000|Overall Study|Protocol Violation|1|||
130256526|NCT00522379|468903250|FG001|Overall Study|Protocol Violation|1|||
130256527|NCT00522379|468903251|FG002|Overall Study|Protocol Violation|2|||
130256528|NCT00522379|468903252|FG003|Overall Study|Protocol Violation|0|||
130256529|NCT00522379|468903253|FG004|Overall Study|Protocol Violation|0|||
130256530|NCT00522379|468903249|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
130256531|NCT00522379|468903250|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
130256532|NCT00522379|468903251|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
130256533|NCT00522379|468903252|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
130256534|NCT00522379|468903253|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
130256535|NCT00522379|468903249|FG000|Overall Study|Lost to Follow-up|1|||
130256536|NCT00522379|468903250|FG001|Overall Study|Lost to Follow-up|0|||
130256537|NCT00522379|468903251|FG002|Overall Study|Lost to Follow-up|4|||
130256538|NCT00522379|468903252|FG003|Overall Study|Lost to Follow-up|2|||
130256539|NCT00522379|468903253|FG004|Overall Study|Lost to Follow-up|2|||
130256540|NCT00522379|468903249|FG000|Overall Study|Randomization error|0|||
130256541|NCT00522379|468903250|FG001|Overall Study|Randomization error|0|||
130553685|NCT02279862|469994803|FG000|Overall Study|Other|1|||
130553686|NCT02279862|469994804|FG001|Overall Study|Other|2|||
130553687|NCT02279862|469994803|FG000|Overall Study|Withdrawal by Subject|1|||
130553688|NCT02279862|469994804|FG001|Overall Study|Withdrawal by Subject|0|||
130553689|NCT03707925|469994806|FG000|Overall Study|Inevaluable|1|||
130701374|NCT02760433|470530354|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701375|NCT02760433|470530355|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701376|NCT02151149|470530356|FG000|Treatment Period|Death|2|||
130701377|NCT02151149|470530357|FG001|Treatment Period|Death|3|||
130701378|NCT02151149|470530356|FG000|Treatment Period|Adverse Event|17|||
130701379|NCT02151149|470530357|FG001|Treatment Period|Adverse Event|14|||
130701380|NCT02151149|470530356|FG000|Treatment Period|Progressive Disease|25|||
130701381|NCT02151149|470530357|FG001|Treatment Period|Progressive Disease|24|||
130701382|NCT02151149|470530356|FG000|Treatment Period|Symptomatic Deterioration|2|||
130256542|NCT00522379|468903251|FG002|Overall Study|Randomization error|0|||
130701383|NCT02151149|470530357|FG001|Treatment Period|Symptomatic Deterioration|10|||
130701384|NCT02151149|470530356|FG000|Treatment Period|Withdrawal by Subject|13|||
130701385|NCT02151149|470530357|FG001|Treatment Period|Withdrawal by Subject|11|||
130701386|NCT02151149|470530356|FG000|Treatment Period|Miscellaneous|8|||
130701387|NCT02151149|470530357|FG001|Treatment Period|Miscellaneous|7|||
130701388|NCT02151149|470530356|FG000|Treatment Period|Participants randomized but not treated|3|||
130701389|NCT02151149|470530357|FG001|Treatment Period|Participants randomized but not treated|2|||
130701390|NCT02151149|470530356|FG000|Follow-Up Period|Lost to Follow-up|2|||
130701391|NCT02151149|470530357|FG001|Follow-Up Period|Lost to Follow-up|3|||
130701392|NCT02151149|470530356|FG000|Follow-Up Period|Death|37|||
130701393|NCT02151149|470530357|FG001|Follow-Up Period|Death|34|||
130701394|NCT00766493|470530358|FG000|30 Days Post-Procedure|Discontinued|7|||
130701395|NCT00766493|470530358|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
130701396|NCT00766493|470530358|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
130701397|NCT03419962|470530361|FG000|Overall Study|Change to other medication|1|||
130701398|NCT03419962|470530361|FG000|Overall Study|Refusal of continuing with trial drug|1|||
130701399|NCT03419962|470530361|FG000|Overall Study|Lost to Follow-up|3|||
130701400|NCT03419962|470530361|FG000|Overall Study|Difficulty in inhaling the doses|1|||
130701401|NCT03419962|470530361|FG000|Overall Study|Missing completion data|31|||
130701402|NCT02914457|470530362|FG000|Overall Study|Withdrawal by Subject|1|||
130701403|NCT02914457|470530362|FG000|Overall Study|Physician Decision|1|||
130701404|NCT02914457|470530362|FG000|Overall Study|No veins available for lead placement|1|||
130701405|NCT02914457|470530362|FG000|Overall Study|Electrical instability of patient|1|||
130701406|NCT02914457|470530362|FG000|Overall Study|ECG acquisition error due to sweating|1|||
130701407|NCT02914457|470530362|FG000|Overall Study|Protocol Violation|1|||
130701408|NCT03439085|470530366|FG000|Overall Study|Death|2|||
130701409|NCT03439085|470530366|FG000|Overall Study|Screen Failure|20|||
130701410|NCT01863433|470530367|FG000|Overall Study|Protocol Violation|1|||
130701411|NCT01292837|470530368|FG000|Overall Study|Adverse Event|1|||
130701412|NCT01292837|470530368|FG000|Overall Study|Further treatment determined|1|||
130701413|NCT01206439|470530369|FG000|Overall Study|subject did not meet inclusion criteria|1|||
130701414|NCT04531527|470530370|FG000|Overall Study|Found to be Ineligible|3|||
130701415|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
130701416|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
130701417|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
130701418|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
130256543|NCT00522379|468903252|FG003|Overall Study|Randomization error|0|||
130256544|NCT00522379|468903253|FG004|Overall Study|Randomization error|1|||
130256545|NCT00522379|468903249|FG000|Overall Study|Dispensing error|1|||
130256546|NCT00522379|468903250|FG001|Overall Study|Dispensing error|0|||
130256547|NCT00522379|468903251|FG002|Overall Study|Dispensing error|0|||
130256548|NCT00522379|468903252|FG003|Overall Study|Dispensing error|1|||
130256549|NCT00522379|468903253|FG004|Overall Study|Dispensing error|0|||
130256550|NCT00522379|468903249|FG000|Overall Study|Subject Moved|1|||
130256551|NCT00522379|468903250|FG001|Overall Study|Subject Moved|1|||
130256552|NCT00522379|468903251|FG002|Overall Study|Subject Moved|0|||
130701419|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
130701420|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
130701421|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
130701422|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
130701423|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
130701424|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
130701425|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
130701426|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
130701427|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
130701428|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
130256553|NCT00522379|468903252|FG003|Overall Study|Subject Moved|0|||
130256554|NCT00522379|468903253|FG004|Overall Study|Subject Moved|0|||
130256555|NCT00522379|468903249|FG000|Overall Study|Sponsor Request|0|||
130256556|NCT00522379|468903250|FG001|Overall Study|Sponsor Request|1|||
130256557|NCT00522379|468903251|FG002|Overall Study|Sponsor Request|0|||
130701429|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
130701430|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
130701431|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
130701432|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
130701433|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
130701434|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
130701435|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
130701436|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130701437|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130701438|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130701439|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130701440|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130701441|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
130701442|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
130701443|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
130701444|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
130701445|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130701446|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130701447|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130701448|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130701449|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
130701450|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130701451|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
130701452|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
130701453|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
130701454|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
130701455|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
130701456|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130701457|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130701458|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
130701459|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130256558|NCT00522379|468903252|FG003|Overall Study|Sponsor Request|0|||
130256559|NCT00522379|468903253|FG004|Overall Study|Sponsor Request|0|||
130256560|NCT00522379|468903249|FG000|Overall Study|Family Problem|0|||
130256561|NCT00522379|468903250|FG001|Overall Study|Family Problem|0|||
130256562|NCT00522379|468903251|FG002|Overall Study|Family Problem|1|||
130256563|NCT00522379|468903252|FG003|Overall Study|Family Problem|0|||
130256564|NCT00522379|468903253|FG004|Overall Study|Family Problem|0|||
130256565|NCT00522379|468903249|FG000|Overall Study|Site Closed|0|||
130256566|NCT00522379|468903250|FG001|Overall Study|Site Closed|0|||
130256567|NCT00522379|468903251|FG002|Overall Study|Site Closed|0|||
130256568|NCT00522379|468903252|FG003|Overall Study|Site Closed|1|||
130256569|NCT00522379|468903253|FG004|Overall Study|Site Closed|0|||
130256570|NCT00522379|468903249|FG000|Overall Study|Subject Withdrawal|0|||
130256571|NCT00522379|468903250|FG001|Overall Study|Subject Withdrawal|0|||
130256572|NCT00522379|468903251|FG002|Overall Study|Subject Withdrawal|0|||
130256573|NCT00522379|468903252|FG003|Overall Study|Subject Withdrawal|1|||
130256574|NCT00522379|468903253|FG004|Overall Study|Subject Withdrawal|0|||
130256575|NCT03034044|468903258|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
130701460|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
130701461|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130701462|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130701463|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
130701464|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130701465|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130701466|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
130701467|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130701468|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
130701469|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130701470|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130701471|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130701472|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
130701473|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130256576|NCT02402647|468903261|FG000|Overall Study|Lost to Follow-up|13|||
130256577|NCT02402647|468903262|FG001|Overall Study|Lost to Follow-up|7|||
130256578|NCT02402647|468903261|FG000|Overall Study|Protocol Violation|1|||
130256579|NCT02402647|468903262|FG001|Overall Study|Protocol Violation|1|||
130256580|NCT02402647|468903261|FG000|Overall Study|scheduled and timed out|2|||
130256581|NCT02402647|468903262|FG001|Overall Study|scheduled and timed out|1|||
130256582|NCT02402647|468903261|FG000|Overall Study|medical illness|2|||
130256583|NCT02402647|468903262|FG001|Overall Study|medical illness|4|||
130256584|NCT02402647|468903261|FG000|Overall Study|Moved|2|||
130256585|NCT02402647|468903262|FG001|Overall Study|Moved|0|||
130256586|NCT02402647|468903261|FG000|Overall Study|loved one illness|1|||
130256587|NCT02402647|468903262|FG001|Overall Study|loved one illness|0|||
130256588|NCT02402647|468903261|FG000|Overall Study|deceased preexisting condition|2|||
130256589|NCT02402647|468903262|FG001|Overall Study|deceased preexisting condition|0|||
130256590|NCT02402647|468903261|FG000|Overall Study|Other|2|||
130256591|NCT02402647|468903262|FG001|Overall Study|Other|1|||
130256592|NCT04197583|468903263|FG000|Overall Study|Study Stent Replacement|34|||
130256593|NCT04197583|468903264|FG001|Overall Study|Study Stent Replacement|8|||
130256594|NCT04197583|468903263|FG000|Overall Study|Lost to Follow-up|14|||
130256595|NCT04197583|468903264|FG001|Overall Study|Lost to Follow-up|3|||
130256596|NCT04197583|468903263|FG000|Overall Study|Death|3|||
130256597|NCT04197583|468903264|FG001|Overall Study|Death|0|||
130256598|NCT04197583|468903263|FG000|Overall Study|Physician Decision|1|||
130256599|NCT04197583|468903264|FG001|Overall Study|Physician Decision|0|||
130256600|NCT04197583|468903263|FG000|Overall Study|Withdrawal by Subject|1|||
130256601|NCT04197583|468903264|FG001|Overall Study|Withdrawal by Subject|1|||
130256602|NCT04197583|468903263|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
130256603|NCT04197583|468903264|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
130256604|NCT04197583|468903263|FG000|Overall Study|Screen Failure|0|||
130256605|NCT04197583|468903264|FG001|Overall Study|Screen Failure|20|||
130256606|NCT00323622|468903266|FG000|Overall Study|Other|30|||
130256607|NCT00323622|468903267|FG001|Overall Study|Other|91|||
130256608|NCT00323622|468903268|FG002|Overall Study|Other|4|||
130256609|NCT00323622|468903269|FG003|Overall Study|Other|12|||
130256610|NCT00323622|468903270|FG004|Overall Study|Other|32|||
130256611|NCT00323622|468903271|FG005|Overall Study|Other|74|||
130256612|NCT00323622|468903272|FG006|Overall Study|Other|5|||
130256613|NCT00323622|468903273|FG007|Overall Study|Other|13|||
130256614|NCT00323622|468903266|FG000|Overall Study|Death|1|||
130256615|NCT00323622|468903267|FG001|Overall Study|Death|1|||
130256616|NCT00323622|468903268|FG002|Overall Study|Death|0|||
130256617|NCT00323622|468903269|FG003|Overall Study|Death|0|||
130256618|NCT00323622|468903270|FG004|Overall Study|Death|7|||
130256619|NCT00323622|468903271|FG005|Overall Study|Death|0|||
130256620|NCT00323622|468903272|FG006|Overall Study|Death|0|||
130256621|NCT00323622|468903273|FG007|Overall Study|Death|2|||
130256622|NCT03033784|468904875|FG000|Overall Study|Anxiety related to MRI scanner|0|||
130256623|NCT03033784|468904876|FG001|Overall Study|Anxiety related to MRI scanner|1|||
130256624|NCT03033784|468904877|FG002|Overall Study|Anxiety related to MRI scanner|0|||
130256625|NCT03033784|468904878|FG003|Overall Study|Anxiety related to MRI scanner|0|||
130256626|NCT03033784|468904879|FG004|Overall Study|Anxiety related to MRI scanner|0|||
130256627|NCT03033784|468904880|FG005|Overall Study|Anxiety related to MRI scanner|0|||
130256628|NCT03033784|468904881|FG006|Overall Study|Anxiety related to MRI scanner|0|||
130256629|NCT03033784|468904882|FG007|Overall Study|Anxiety related to MRI scanner|0|||
130256630|NCT03033784|468904883|FG008|Overall Study|Anxiety related to MRI scanner|0|||
130256631|NCT03033784|468904884|FG009|Overall Study|Anxiety related to MRI scanner|0|||
130256632|NCT03033784|468904885|FG010|Overall Study|Anxiety related to MRI scanner|0|||
130256633|NCT03033784|468904886|FG011|Overall Study|Anxiety related to MRI scanner|0|||
130256634|NCT03033784|468904887|FG012|Overall Study|Anxiety related to MRI scanner|0|||
130256635|NCT03033784|468904875|FG000|Overall Study|Withdrawal by Subject|0|||
130256636|NCT03033784|468904876|FG001|Overall Study|Withdrawal by Subject|0|||
130256637|NCT03033784|468904877|FG002|Overall Study|Withdrawal by Subject|0|||
130256638|NCT03033784|468904878|FG003|Overall Study|Withdrawal by Subject|0|||
130256639|NCT03033784|468904879|FG004|Overall Study|Withdrawal by Subject|0|||
130256640|NCT03033784|468904880|FG005|Overall Study|Withdrawal by Subject|0|||
130256641|NCT03033784|468904881|FG006|Overall Study|Withdrawal by Subject|0|||
130256642|NCT03033784|468904882|FG007|Overall Study|Withdrawal by Subject|0|||
130256643|NCT03033784|468904883|FG008|Overall Study|Withdrawal by Subject|0|||
130256644|NCT03033784|468904884|FG009|Overall Study|Withdrawal by Subject|0|||
130256645|NCT03033784|468904885|FG010|Overall Study|Withdrawal by Subject|0|||
130256646|NCT03033784|468904886|FG011|Overall Study|Withdrawal by Subject|0|||
130256647|NCT03033784|468904887|FG012|Overall Study|Withdrawal by Subject|2|||
130256648|NCT03332056|468904889|FG000|Overall Study|Incomplete questionnaires|8|||
130256649|NCT03332056|468904890|FG001|Overall Study|Incomplete questionnaires|9|||
130256650|NCT03332056|468904889|FG000|Overall Study|Passed stone prior to surgery date|1|||
130256651|NCT03332056|468904890|FG001|Overall Study|Passed stone prior to surgery date|0|||
130256652|NCT03332056|468904889|FG000|Overall Study|Did not require a ureteral stent|0|||
130256653|NCT03332056|468904890|FG001|Overall Study|Did not require a ureteral stent|1|||
130256654|NCT02374255|468904891|FG000|Overall Study|Withdrawal by Subject|2|||
130701474|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130256655|NCT02374255|468904892|FG001|Overall Study|Withdrawal by Subject|0|||
130256656|NCT02374255|468904893|FG002|Overall Study|Withdrawal by Subject|0|||
130256657|NCT02374255|468904894|FG003|Overall Study|Withdrawal by Subject|0|||
130256658|NCT02093520|468904895|FG000|Overall Study|Not treated|6|||
130701475|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
130701476|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130701477|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
130701478|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130701479|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130701480|NCT03496298|470530385|FG000|Overall Study|Adverse Event|49|||
130701481|NCT03496298|470530386|FG001|Overall Study|Adverse Event|68|||
130701482|NCT03496298|470530387|FG002|Overall Study|Adverse Event|79|||
130701483|NCT03496298|470530385|FG000|Overall Study|Study terminated by Sponsor|1050|||
130701484|NCT03496298|470530386|FG001|Overall Study|Study terminated by Sponsor|1063|||
130701485|NCT03496298|470530387|FG002|Overall Study|Study terminated by Sponsor|1071|||
130701486|NCT03496298|470530385|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
130701487|NCT03496298|470530386|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
130701488|NCT03496298|470530387|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
130701489|NCT03496298|470530385|FG000|Overall Study|Withdrawal by Subject|176|||
130701490|NCT03496298|470530386|FG001|Overall Study|Withdrawal by Subject|154|||
130701491|NCT03496298|470530387|FG002|Overall Study|Withdrawal by Subject|151|||
130701492|NCT03496298|470530385|FG000|Overall Study|Other|29|||
130701493|NCT03496298|470530386|FG001|Overall Study|Other|20|||
130256659|NCT02093520|468904896|FG001|Overall Study|Not treated|22|||
130256660|NCT03014089|468904897|FG000|Overall Study|Withdrawal by Subject|0|||
130256661|NCT03014089|468904898|FG001|Overall Study|Withdrawal by Subject|1|||
130256662|NCT03014089|468904899|FG002|Overall Study|Withdrawal by Subject|1|||
130256663|NCT03014089|468904900|FG003|Overall Study|Withdrawal by Subject|1|||
130256664|NCT03014089|468904897|FG000|Overall Study|Lost to Follow-up|1|||
130256665|NCT03014089|468904898|FG001|Overall Study|Lost to Follow-up|0|||
130256666|NCT03014089|468904899|FG002|Overall Study|Lost to Follow-up|0|||
130256667|NCT03014089|468904900|FG003|Overall Study|Lost to Follow-up|0|||
130256668|NCT03014089|468904897|FG000|Overall Study|Adverse Event|1|||
130256669|NCT03014089|468904898|FG001|Overall Study|Adverse Event|0|||
130256670|NCT03014089|468904899|FG002|Overall Study|Adverse Event|1|||
130256671|NCT03014089|468904900|FG003|Overall Study|Adverse Event|0|||
130256672|NCT01992757|468904909|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
130256673|NCT00688740|468904910|FG000|Overall Study|Adverse Event|45|||
130256674|NCT00688740|468904911|FG001|Overall Study|Adverse Event|8|||
130256675|NCT00688740|468904910|FG000|Overall Study|Death|2|||
130256676|NCT00688740|468904911|FG001|Overall Study|Death|2|||
130256677|NCT00688740|468904910|FG000|Overall Study|Lost to Follow-up|0|||
130256678|NCT00688740|468904911|FG001|Overall Study|Lost to Follow-up|1|||
130256679|NCT00688740|468904910|FG000|Overall Study|Consent Withdrawn|17|||
130256680|NCT00688740|468904911|FG001|Overall Study|Consent Withdrawn|17|||
130256681|NCT00688740|468904910|FG000|Overall Study|Breast Cancer Relapse|1|||
130256682|NCT00688740|468904911|FG001|Overall Study|Breast Cancer Relapse|4|||
130256683|NCT00688740|468904910|FG000|Overall Study|Violation of Inclusion Criteria|1|||
130256684|NCT00688740|468904911|FG001|Overall Study|Violation of Inclusion Criteria|3|||
130256685|NCT00856557|468904912|FG000|Overall Study|No patients with contextual flags|12|||
130256686|NCT00856557|468904913|FG001|Overall Study|No patients with contextual flags|16|||
130256687|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
130256688|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130256689|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130256690|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
130256691|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
130256692|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
130256693|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
130256694|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130256695|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130256696|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
130256697|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
130256698|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
130256699|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
130256700|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
130553690|NCT03431857|469994807|FG000|Overall Study|Death|6|||
130701494|NCT03496298|470530387|FG002|Overall Study|Other|23|||
130701495|NCT03496298|470530385|FG000|Overall Study|Randomized and not treated|1|||
130701496|NCT03496298|470530386|FG001|Overall Study|Randomized and not treated|1|||
130701497|NCT03496298|470530387|FG002|Overall Study|Randomized and not treated|1|||
130701498|NCT01438476|470530390|FG000|Overall Study|Protocol Violation|1|||
130256701|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
130256702|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
130256703|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
130553691|NCT03431857|469994807|FG000|Overall Study|Lost to Follow-up|41|||
130553692|NCT03431857|469994807|FG000|Overall Study|Adverse Event|6|||
130553693|NCT03431857|469994807|FG000|Overall Study|Withdrawal by Subject|1|||
130553694|NCT00651157|469994810|FG000|Overall Study|Death|1|||
130553695|NCT00651157|469994810|FG000|Overall Study|Protocol Violation|1|||
130553696|NCT01163721|469994812|FG000|Overall Study|Adverse Event|5|||
130553697|NCT01163721|469994813|FG001|Overall Study|Adverse Event|6|||
130553698|NCT01163721|469994812|FG000|Overall Study|Withdrawal by Subject|3|||
130553699|NCT01163721|469994813|FG001|Overall Study|Withdrawal by Subject|4|||
130553700|NCT01163721|469994812|FG000|Overall Study|Lost to Follow-up|0|||
130553701|NCT01163721|469994813|FG001|Overall Study|Lost to Follow-up|1|||
130553702|NCT01163721|469994812|FG000|Overall Study|Physician Decision|0|||
130553703|NCT01163721|469994813|FG001|Overall Study|Physician Decision|1|||
130553704|NCT01472380|469994816|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
130553705|NCT01472380|469994816|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
130553706|NCT02511678|469994817|FG000|Overall Study|Withdrawal by Subject|2|||
130553707|NCT02511678|469994817|FG000|Overall Study|Lost to Follow-up|4|||
130553708|NCT02511678|469994817|FG000|Overall Study|Death|19|||
130553709|NCT02511678|469994817|FG000|Overall Study|Adverse Event|1|||
130553710|NCT02511678|469994817|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
130553711|NCT02511678|469994817|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
130553712|NCT02511678|469994817|FG000|Overall Study|Required Radiofrequency Ablation|1|||
130553713|NCT02511678|469994817|FG000|Overall Study|Biopsy was Negative|1|||
130553714|NCT02511678|469994817|FG000|Overall Study|Protocol Violation|1|||
130553715|NCT02511678|469994817|FG000|Overall Study|Received Radiation Treatment|1|||
130553716|NCT01295281|469994818|FG000|First Intervention (7 Days)|Death|0|||
130553717|NCT01295281|469994819|FG001|First Intervention (7 Days)|Death|1|||
130553718|NCT00292461|469994820|FG000|Overall Study|Adverse Event|4|||
130553719|NCT00292461|469994821|FG001|Overall Study|Adverse Event|2|||
130553720|NCT00292461|469994820|FG000|Overall Study|Lack of Efficacy|1|||
130553721|NCT00292461|469994821|FG001|Overall Study|Lack of Efficacy|0|||
130553722|NCT00292461|469994820|FG000|Overall Study|Withdrawal by Subject|0|||
130553723|NCT00292461|469994821|FG001|Overall Study|Withdrawal by Subject|1|||
130553724|NCT00292461|469994820|FG000|Overall Study|Protocol Violation|4|||
130553725|NCT00292461|469994821|FG001|Overall Study|Protocol Violation|3|||
130553726|NCT00292461|469994820|FG000|Overall Study|Lost to Follow-up|1|||
130553727|NCT00292461|469994821|FG001|Overall Study|Lost to Follow-up|0|||
130553728|NCT05125679|469994825|FG000|Overall Study|Study Terminated by Sponsor|2|||
130553729|NCT05125679|469994826|FG001|Overall Study|Study Terminated by Sponsor|5|||
130553730|NCT04484259|469994843|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130553731|NCT04484259|469994844|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130553732|NCT04484259|469994845|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130553733|NCT04484259|469994846|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
130553734|NCT04484259|469994847|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130553735|NCT04484259|469994843|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
130553736|NCT04484259|469994844|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
130553737|NCT04484259|469994845|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
130553738|NCT04484259|469994846|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
130553739|NCT04484259|469994847|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
130553740|NCT04484259|469994843|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
130553741|NCT04484259|469994844|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
130553742|NCT04484259|469994845|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
130553743|NCT04484259|469994846|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
130553744|NCT04484259|469994847|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
130553745|NCT04484259|469994843|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130553746|NCT04484259|469994844|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130553747|NCT04484259|469994845|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130553748|NCT04484259|469994846|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
130553749|NCT04484259|469994847|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130553750|NCT04484259|469994843|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130553751|NCT04484259|469994844|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130553752|NCT04484259|469994845|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130553753|NCT04484259|469994846|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130553754|NCT04484259|469994847|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
130701499|NCT01438476|470530391|FG001|Overall Study|Protocol Violation|0|||
130701500|NCT01438476|470530390|FG000|Overall Study|Withdrawal by Subject|1|||
130701501|NCT01438476|470530391|FG001|Overall Study|Withdrawal by Subject|0|||
130701502|NCT01438476|470530390|FG000|Overall Study|No Surgery- Disease|8|||
130701503|NCT01438476|470530391|FG001|Overall Study|No Surgery- Disease|10|||
130553755|NCT04484259|469994843|FG000|Randomized Treatment|Withdrawal by Subject|1|||
130553756|NCT04484259|469994844|FG001|Randomized Treatment|Withdrawal by Subject|0|||
130553757|NCT04484259|469994845|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130553758|NCT04484259|469994846|FG003|Randomized Treatment|Withdrawal by Subject|0|||
130701504|NCT01438476|470530390|FG000|Overall Study|Communication barrier|0|||
130701505|NCT01438476|470530391|FG001|Overall Study|Communication barrier|1|||
130701506|NCT02522780|470530396|FG000|Overall Study|Consent withdrawn by subject|5|||
130701507|NCT02522780|470530397|FG001|Overall Study|Consent withdrawn by subject|7|||
130701508|NCT02522780|470530396|FG000|Overall Study|Protocol deviation|1|||
130701509|NCT02522780|470530397|FG001|Overall Study|Protocol deviation|3|||
130701510|NCT02522780|470530396|FG000|Overall Study|Subject refused endoscopic procedure|0|||
130701511|NCT02522780|470530397|FG001|Overall Study|Subject refused endoscopic procedure|1|||
130701512|NCT02522780|470530396|FG000|Overall Study|Adverse event, non-fatal|11|||
130701513|NCT02522780|470530397|FG001|Overall Study|Adverse event, non-fatal|16|||
130701514|NCT02058160|470530398|FG000|Overall Study|Randomized but not treated|2|||
130701515|NCT02058160|470530399|FG001|Overall Study|Randomized but not treated|4|||
130701516|NCT02058160|470530398|FG000|Overall Study|Poor compliance to protocol|4|||
130701517|NCT02058160|470530399|FG001|Overall Study|Poor compliance to protocol|1|||
130256704|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
130256705|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
130256706|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130256707|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130256708|NCT01432444|468904914|FG000|Treatment Phase|Lost to Follow-up|0|||
130256709|NCT01432444|468904915|FG001|Treatment Phase|Lost to Follow-up|33|||
130256710|NCT01432444|468904916|FG002|Treatment Phase|Lost to Follow-up|0|||
130256711|NCT01432444|468904914|FG000|Treatment Phase|Adverse Event|0|||
130256712|NCT01432444|468904915|FG001|Treatment Phase|Adverse Event|37|||
130256713|NCT01432444|468904916|FG002|Treatment Phase|Adverse Event|0|||
130256714|NCT01432444|468904914|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
130256715|NCT01432444|468904915|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
130256716|NCT01432444|468904916|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
130256717|NCT01432444|468904914|FG000|Treatment Phase|Physician Decision|0|||
130256718|NCT01432444|468904915|FG001|Treatment Phase|Physician Decision|5|||
130256719|NCT01432444|468904916|FG002|Treatment Phase|Physician Decision|0|||
130256720|NCT01432444|468904914|FG000|Treatment Phase|Withdrawal by Subject|0|||
130256721|NCT01432444|468904915|FG001|Treatment Phase|Withdrawal by Subject|41|||
130256722|NCT01432444|468904916|FG002|Treatment Phase|Withdrawal by Subject|0|||
130256723|NCT01432444|468904914|FG000|Treatment Phase|Protocol Deviation|0|||
130256724|NCT01432444|468904915|FG001|Treatment Phase|Protocol Deviation|3|||
130553759|NCT04484259|469994847|FG004|Randomized Treatment|Withdrawal by Subject|0|||
130553760|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
130553761|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
130553762|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
130553763|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
130553764|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
130553765|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
130553766|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
130256725|NCT01432444|468904916|FG002|Treatment Phase|Protocol Deviation|0|||
130256726|NCT01432444|468904914|FG000|Treatment Phase|Lack of Efficacy|0|||
130256727|NCT01432444|468904915|FG001|Treatment Phase|Lack of Efficacy|10|||
130256728|NCT01432444|468904916|FG002|Treatment Phase|Lack of Efficacy|0|||
130256729|NCT01432444|468904914|FG000|Extension Phase|Lost to Follow-up|0|||
130256730|NCT01432444|468904915|FG001|Extension Phase|Lost to Follow-up|0|||
130256731|NCT01432444|468904916|FG002|Extension Phase|Lost to Follow-up|17|||
130256732|NCT01432444|468904914|FG000|Extension Phase|Adverse Event|0|||
130256733|NCT01432444|468904915|FG001|Extension Phase|Adverse Event|0|||
130256734|NCT01432444|468904916|FG002|Extension Phase|Adverse Event|10|||
130256735|NCT01432444|468904914|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
130256736|NCT01432444|468904915|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
130256737|NCT01432444|468904916|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
130256738|NCT01432444|468904914|FG000|Extension Phase|Met Withdrawal Criteria|0|||
130256739|NCT01432444|468904915|FG001|Extension Phase|Met Withdrawal Criteria|0|||
130256740|NCT01432444|468904916|FG002|Extension Phase|Met Withdrawal Criteria|144|||
130256741|NCT01432444|468904914|FG000|Extension Phase|Physician Decision|0|||
130256742|NCT01432444|468904915|FG001|Extension Phase|Physician Decision|0|||
130256743|NCT01432444|468904916|FG002|Extension Phase|Physician Decision|1|||
130256744|NCT01432444|468904914|FG000|Extension Phase|Withdrawal by Subject|0|||
130256745|NCT01432444|468904915|FG001|Extension Phase|Withdrawal by Subject|0|||
130256746|NCT01432444|468904916|FG002|Extension Phase|Withdrawal by Subject|13|||
130701518|NCT02058160|470530398|FG000|Overall Study|Adverse Event|12|||
130256747|NCT03673176|468904917|FG000|Overall Study|Death prior to intervention|1|||
130701519|NCT02058160|470530399|FG001|Overall Study|Adverse Event|3|||
130256748|NCT03673176|468904917|FG000|Overall Study|Death following intervention|3|||
130256749|NCT03673176|468904917|FG000|Overall Study|Withdrawal by Subject|1|||
130701520|NCT02058160|470530398|FG000|Overall Study|Lost to Follow-up|1|||
130256750|NCT02301897|468904918|FG000|Treatment Course 1|Non-Compliance|0|||
130256751|NCT02301897|468904919|FG001|Treatment Course 1|Non-Compliance|0|||
130701521|NCT02058160|470530399|FG001|Overall Study|Lost to Follow-up|0|||
130701522|NCT02058160|470530398|FG000|Overall Study|Other than specified above|12|||
130256752|NCT02301897|468904920|FG002|Treatment Course 1|Non-Compliance|1|||
130256753|NCT02301897|468904918|FG000|Treatment Course 1|Adverse Event|1|||
130256754|NCT02301897|468904919|FG001|Treatment Course 1|Adverse Event|1|||
130256755|NCT02301897|468904920|FG002|Treatment Course 1|Adverse Event|0|||
130256756|NCT02301897|468904918|FG000|Treatment Course 1|Lost to Follow-up|1|||
130256757|NCT02301897|468904919|FG001|Treatment Course 1|Lost to Follow-up|2|||
130256758|NCT02301897|468904920|FG002|Treatment Course 1|Lost to Follow-up|1|||
130256759|NCT02301897|468904918|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
130256760|NCT02301897|468904919|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
130256761|NCT02301897|468904920|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
130365211|NCT00347360|469306873|FG009|Overall Study|Reason not listed/blank|0|||
130701523|NCT02058160|470530399|FG001|Overall Study|Other than specified above|6|||
130701524|NCT03310619|470530400|FG000|Pre-Treatment Period|Death|1|||
130701525|NCT03310619|470530401|FG001|Pre-Treatment Period|Death|0|||
130701526|NCT03310619|470530402|FG002|Pre-Treatment Period|Death|0|||
130701527|NCT03310619|470530403|FG003|Pre-Treatment Period|Death|0|||
130701528|NCT03310619|470530404|FG004|Pre-Treatment Period|Death|1|||
130701529|NCT03310619|470530405|FG005|Pre-Treatment Period|Death|0|||
130701530|NCT03310619|470530406|FG006|Pre-Treatment Period|Death|0|||
130701531|NCT03310619|470530407|FG007|Pre-Treatment Period|Death|0|||
130701532|NCT03310619|470530400|FG000|Pre-Treatment Period|Other reasons|2|||
130701533|NCT03310619|470530401|FG001|Pre-Treatment Period|Other reasons|1|||
130701534|NCT03310619|470530402|FG002|Pre-Treatment Period|Other reasons|2|||
130701535|NCT03310619|470530403|FG003|Pre-Treatment Period|Other reasons|0|||
130701536|NCT03310619|470530404|FG004|Pre-Treatment Period|Other reasons|0|||
130701537|NCT03310619|470530405|FG005|Pre-Treatment Period|Other reasons|0|||
130701538|NCT03310619|470530406|FG006|Pre-Treatment Period|Other reasons|2|||
130701539|NCT03310619|470530407|FG007|Pre-Treatment Period|Other reasons|0|||
130701540|NCT03310619|470530400|FG000|Treatment Period|Death|1|||
130701541|NCT03310619|470530401|FG001|Treatment Period|Death|2|||
130701542|NCT03310619|470530402|FG002|Treatment Period|Death|0|||
130701543|NCT03310619|470530403|FG003|Treatment Period|Death|0|||
130701544|NCT03310619|470530404|FG004|Treatment Period|Death|1|||
130701545|NCT03310619|470530405|FG005|Treatment Period|Death|0|||
130701546|NCT03310619|470530406|FG006|Treatment Period|Death|2|||
130701547|NCT03310619|470530407|FG007|Treatment Period|Death|0|||
130701548|NCT03310619|470530400|FG000|Treatment Period|Adverse Event|0|||
130701549|NCT03310619|470530401|FG001|Treatment Period|Adverse Event|1|||
130701550|NCT03310619|470530402|FG002|Treatment Period|Adverse Event|4|||
130701551|NCT03310619|470530403|FG003|Treatment Period|Adverse Event|1|||
130701552|NCT03310619|470530404|FG004|Treatment Period|Adverse Event|0|||
130256762|NCT02301897|468904918|FG000|Treatment Course 1|Withdrawal by Subject|0|||
130256763|NCT02301897|468904919|FG001|Treatment Course 1|Withdrawal by Subject|0|||
130256764|NCT02301897|468904920|FG002|Treatment Course 1|Withdrawal by Subject|2|||
130256765|NCT02301897|468904918|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
130256766|NCT02301897|468904919|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
130256767|NCT02301897|468904920|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
130256768|NCT02301897|468904918|FG000|Treatment Course 2|Lost to Follow-up|0|||
130256769|NCT02301897|468904919|FG001|Treatment Course 2|Lost to Follow-up|2|||
130256770|NCT02301897|468904920|FG002|Treatment Course 2|Lost to Follow-up|0|||
130256771|NCT02301897|468904918|FG000|Treatment Course 2|Pregnancy|0|||
130256772|NCT02301897|468904919|FG001|Treatment Course 2|Pregnancy|1|||
130256773|NCT02301897|468904920|FG002|Treatment Course 2|Pregnancy|1|||
130256774|NCT02301897|468904918|FG000|Treatment Course 2|Withdrawal by Subject|0|||
130256775|NCT02301897|468904919|FG001|Treatment Course 2|Withdrawal by Subject|2|||
130256776|NCT02301897|468904920|FG002|Treatment Course 2|Withdrawal by Subject|0|||
130256777|NCT02301897|468904918|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
130701553|NCT03310619|470530405|FG005|Treatment Period|Adverse Event|0|||
130701554|NCT03310619|470530406|FG006|Treatment Period|Adverse Event|0|||
130701555|NCT03310619|470530407|FG007|Treatment Period|Adverse Event|0|||
130256778|NCT02301897|468904919|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
130256779|NCT02301897|468904920|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
130256780|NCT02439957|468904921|FG000|Overall Study|Study Terminated|3|||
130256781|NCT02439957|468904922|FG001|Overall Study|Study Terminated|3|||
130701556|NCT03310619|470530400|FG000|Treatment Period|Withdrawal by participant|0|||
130701557|NCT03310619|470530401|FG001|Treatment Period|Withdrawal by participant|0|||
130701558|NCT03310619|470530402|FG002|Treatment Period|Withdrawal by participant|1|||
130701559|NCT03310619|470530403|FG003|Treatment Period|Withdrawal by participant|0|||
130701560|NCT03310619|470530404|FG004|Treatment Period|Withdrawal by participant|0|||
130701561|NCT03310619|470530405|FG005|Treatment Period|Withdrawal by participant|0|||
130701562|NCT03310619|470530406|FG006|Treatment Period|Withdrawal by participant|0|||
130701563|NCT03310619|470530407|FG007|Treatment Period|Withdrawal by participant|0|||
130256782|NCT00478257|468904927|FG000|Overall Study|Withdrawal by Subject|8|||
130256783|NCT00478257|468904928|FG001|Overall Study|Withdrawal by Subject|3|||
130256784|NCT03931330|468904929|FG000|Overall Study|Physician Decision|1|||
130256785|NCT03412929|468904930|FG000|Overall Study|Protocol Violation|3|||
130701564|NCT03310619|470530400|FG000|Treatment Period|Lost to Follow-up|0|||
130701565|NCT03310619|470530401|FG001|Treatment Period|Lost to Follow-up|0|||
130701566|NCT03310619|470530402|FG002|Treatment Period|Lost to Follow-up|0|||
130701567|NCT03310619|470530403|FG003|Treatment Period|Lost to Follow-up|0|||
130701568|NCT03310619|470530404|FG004|Treatment Period|Lost to Follow-up|0|||
130701569|NCT03310619|470530405|FG005|Treatment Period|Lost to Follow-up|0|||
130701570|NCT03310619|470530406|FG006|Treatment Period|Lost to Follow-up|0|||
130701571|NCT03310619|470530407|FG007|Treatment Period|Lost to Follow-up|1|||
130701572|NCT03310619|470530400|FG000|Treatment Period|Study terminated by sponsor|0|||
130701573|NCT03310619|470530401|FG001|Treatment Period|Study terminated by sponsor|0|||
130256786|NCT04023487|468904933|FG000|Overall Study|Lost to Follow-up|5|||
130256787|NCT04023487|468904934|FG001|Overall Study|Lost to Follow-up|4|||
130256788|NCT04023487|468904933|FG000|Overall Study|Pregnancy|1|||
130256789|NCT04023487|468904934|FG001|Overall Study|Pregnancy|2|||
130256790|NCT04023487|468904933|FG000|Overall Study|Withdrawal by Subject|4|||
130256791|NCT04023487|468904934|FG001|Overall Study|Withdrawal by Subject|5|||
130256792|NCT04023487|468904933|FG000|Overall Study|Partially completed testing|8|||
130365212|NCT00347360|469306874|FG010|Overall Study|Reason not listed/blank|0|||
130365213|NCT00347360|469306875|FG011|Overall Study|Reason not listed/blank|0|||
130365214|NCT00347360|469306876|FG012|Overall Study|Reason not listed/blank|0|||
130365215|NCT00347360|469306877|FG013|Overall Study|Reason not listed/blank|1|||
130256793|NCT04023487|468904934|FG001|Overall Study|Partially completed testing|4|||
130365216|NCT00347360|469306878|FG014|Overall Study|Reason not listed/blank|0|||
130365217|NCT00347360|469306864|FG000|Overall Study|Per sponsors instruction|0|||
130365218|NCT00347360|469306865|FG001|Overall Study|Per sponsors instruction|1|||
130256794|NCT04770285|468904937|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
130256795|NCT04770285|468904938|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
130256796|NCT04770285|468904937|FG000|Overall Study|Lack of Efficacy|0|||
130256797|NCT04770285|468904938|FG001|Overall Study|Lack of Efficacy|1|||
130256798|NCT04770285|468904937|FG000|Overall Study|Lost to Follow-up|11|||
130256799|NCT04770285|468904938|FG001|Overall Study|Lost to Follow-up|8|||
130256800|NCT04770285|468904937|FG000|Overall Study|Protocol Deviation|6|||
130256801|NCT04770285|468904938|FG001|Overall Study|Protocol Deviation|6|||
130256802|NCT04770285|468904937|FG000|Overall Study|Technical Problem|0|||
130256803|NCT04770285|468904938|FG001|Overall Study|Technical Problem|1|||
130256804|NCT04770285|468904937|FG000|Overall Study|Withdrawal by Subject|9|||
130256805|NCT04770285|468904938|FG001|Overall Study|Withdrawal by Subject|8|||
130256806|NCT04770285|468904937|FG000|Overall Study|Reason Not Specified|0|||
130256807|NCT04770285|468904938|FG001|Overall Study|Reason Not Specified|1|||
130256808|NCT03766399|468904939|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256809|NCT03766399|468904940|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256810|NCT03766399|468904941|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130701574|NCT03310619|470530402|FG002|Treatment Period|Study terminated by sponsor|0|||
130701575|NCT03310619|470530403|FG003|Treatment Period|Study terminated by sponsor|0|||
130701576|NCT03310619|470530404|FG004|Treatment Period|Study terminated by sponsor|0|||
130701577|NCT03310619|470530405|FG005|Treatment Period|Study terminated by sponsor|0|||
130701578|NCT03310619|470530406|FG006|Treatment Period|Study terminated by sponsor|0|||
130701579|NCT03310619|470530407|FG007|Treatment Period|Study terminated by sponsor|1|||
130701580|NCT03310619|470530400|FG000|Treatment Period|Physician Decision|0|||
130701581|NCT03310619|470530401|FG001|Treatment Period|Physician Decision|0|||
130701582|NCT03310619|470530402|FG002|Treatment Period|Physician Decision|0|||
130701583|NCT03310619|470530403|FG003|Treatment Period|Physician Decision|0|||
130701584|NCT03310619|470530404|FG004|Treatment Period|Physician Decision|3|||
130701585|NCT03310619|470530405|FG005|Treatment Period|Physician Decision|0|||
130701586|NCT03310619|470530406|FG006|Treatment Period|Physician Decision|0|||
130701587|NCT03310619|470530407|FG007|Treatment Period|Physician Decision|0|||
130701588|NCT03310619|470530400|FG000|Treatment Period|Other reasons|1|||
130701589|NCT03310619|470530401|FG001|Treatment Period|Other reasons|0|||
130701590|NCT03310619|470530402|FG002|Treatment Period|Other reasons|2|||
130701591|NCT03310619|470530403|FG003|Treatment Period|Other reasons|0|||
130701592|NCT03310619|470530404|FG004|Treatment Period|Other reasons|0|||
130701593|NCT03310619|470530405|FG005|Treatment Period|Other reasons|0|||
130701594|NCT03310619|470530406|FG006|Treatment Period|Other reasons|0|||
130701595|NCT03310619|470530407|FG007|Treatment Period|Other reasons|0|||
130701596|NCT02427399|470530408|FG000|Overall Study|Protocol Violation|14|||
130701597|NCT02427399|470530409|FG001|Overall Study|Protocol Violation|16|||
130701598|NCT02427399|470530410|FG002|Overall Study|Protocol Violation|12|||
130701599|NCT02427399|470530411|FG003|Overall Study|Protocol Violation|18|||
130701600|NCT02427399|470530412|FG004|Overall Study|Protocol Violation|15|||
130701601|NCT02289820|470530413|FG000|Overall Study|Withdrawal by Subject|2|||
130701602|NCT02289820|470530414|FG001|Overall Study|Withdrawal by Subject|1|||
130701603|NCT02289820|470530415|FG002|Overall Study|Withdrawal by Subject|2|||
130701604|NCT02289820|470530416|FG003|Overall Study|Withdrawal by Subject|1|||
130701605|NCT02289820|470530417|FG004|Overall Study|Withdrawal by Subject|0|||
130701606|NCT02289820|470530418|FG005|Overall Study|Withdrawal by Subject|0|||
130256811|NCT03766399|468904942|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256812|NCT03766399|468904943|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130701607|NCT02289820|470530419|FG006|Overall Study|Withdrawal by Subject|1|||
130701608|NCT02289820|470530413|FG000|Overall Study|Death|0|||
130256813|NCT03766399|468904944|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256814|NCT03766399|468904945|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256815|NCT03766399|468904946|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256816|NCT03766399|468904947|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130365219|NCT00347360|469306866|FG002|Overall Study|Per sponsors instruction|0|||
130365220|NCT00347360|469306867|FG003|Overall Study|Per sponsors instruction|0|||
130365221|NCT00347360|469306868|FG004|Overall Study|Per sponsors instruction|0|||
130256817|NCT03766399|468904948|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256818|NCT03766399|468904949|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256819|NCT03766399|468904950|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256820|NCT03766399|468904951|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256821|NCT03766399|468904952|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
130256822|NCT03766399|468904953|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256823|NCT03766399|468904954|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256824|NCT03766399|468904955|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256825|NCT03766399|468904956|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256826|NCT00645658|468904957|FG000|Overall Study|Withdrawal by Subject|1|||
130256827|NCT00645658|468904958|FG001|Overall Study|Withdrawal by Subject|0|||
130256828|NCT00645658|468904957|FG000|Overall Study|Did not complete all assesments|0|||
130256829|NCT00645658|468904958|FG001|Overall Study|Did not complete all assesments|2|||
130256830|NCT03895372|468904961|FG000|Investigational Treatment Period|Adverse Event|1|||
130256831|NCT03895372|468904962|FG001|Investigational Treatment Period|Adverse Event|0|||
130256832|NCT03895372|468904963|FG002|Investigational Treatment Period|Adverse Event|0|||
130256833|NCT03895372|468904964|FG003|Investigational Treatment Period|Adverse Event|0|||
130256834|NCT03895372|468904965|FG004|Investigational Treatment Period|Adverse Event|0|||
130256835|NCT03895372|468904966|FG005|Investigational Treatment Period|Adverse Event|0|||
130256836|NCT03895372|468904967|FG006|Investigational Treatment Period|Adverse Event|4|||
130256837|NCT03895372|468904968|FG007|Investigational Treatment Period|Adverse Event|3|||
130256838|NCT03895372|468904961|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
130256839|NCT03895372|468904962|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
130256840|NCT03895372|468904963|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
130256841|NCT03895372|468904964|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
130256842|NCT03895372|468904965|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
130256843|NCT03895372|468904966|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
130256844|NCT03895372|468904967|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
130256845|NCT03895372|468904968|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
130256846|NCT03895372|468904961|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
130256847|NCT03895372|468904962|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
130256848|NCT03895372|468904963|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
130256849|NCT03895372|468904964|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
130256850|NCT03895372|468904965|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
130256851|NCT03895372|468904966|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
130256852|NCT03895372|468904967|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
130256853|NCT03895372|468904968|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
130256854|NCT03895372|468904961|FG000|Investigational Treatment Period|Other|0|||
130256855|NCT03895372|468904962|FG001|Investigational Treatment Period|Other|0|||
130256856|NCT03895372|468904963|FG002|Investigational Treatment Period|Other|0|||
130256857|NCT03895372|468904964|FG003|Investigational Treatment Period|Other|0|||
130256858|NCT03895372|468904965|FG004|Investigational Treatment Period|Other|0|||
130256859|NCT03895372|468904966|FG005|Investigational Treatment Period|Other|1|||
130256860|NCT03895372|468904967|FG006|Investigational Treatment Period|Other|0|||
130256861|NCT03895372|468904968|FG007|Investigational Treatment Period|Other|2|||
130256862|NCT03895372|468904961|FG000|Investigational Treatment Period|Protocol Violation|0|||
130256863|NCT03895372|468904962|FG001|Investigational Treatment Period|Protocol Violation|0|||
130256864|NCT03895372|468904963|FG002|Investigational Treatment Period|Protocol Violation|0|||
130256865|NCT03895372|468904964|FG003|Investigational Treatment Period|Protocol Violation|1|||
130256866|NCT03895372|468904965|FG004|Investigational Treatment Period|Protocol Violation|0|||
130256867|NCT03895372|468904966|FG005|Investigational Treatment Period|Protocol Violation|0|||
130256868|NCT03895372|468904967|FG006|Investigational Treatment Period|Protocol Violation|0|||
130256869|NCT03895372|468904968|FG007|Investigational Treatment Period|Protocol Violation|0|||
130256870|NCT03895372|468904961|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
130256871|NCT03895372|468904962|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
130256872|NCT03895372|468904963|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
130256873|NCT03895372|468904964|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
130256874|NCT03895372|468904965|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
130256875|NCT03895372|468904966|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
130256876|NCT03895372|468904967|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
130256877|NCT03895372|468904968|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
130256878|NCT03895372|468904961|FG000|Extension Treatment Period|Adverse Event|0|||
130256879|NCT03895372|468904962|FG001|Extension Treatment Period|Adverse Event|1|||
130256880|NCT03895372|468904963|FG002|Extension Treatment Period|Adverse Event|0|||
130256881|NCT03895372|468904964|FG003|Extension Treatment Period|Adverse Event|1|||
130256882|NCT03895372|468904965|FG004|Extension Treatment Period|Adverse Event|0|||
130256883|NCT03895372|468904966|FG005|Extension Treatment Period|Adverse Event|0|||
130256884|NCT03895372|468904967|FG006|Extension Treatment Period|Adverse Event|3|||
130256885|NCT03895372|468904968|FG007|Extension Treatment Period|Adverse Event|3|||
130256886|NCT03895372|468904961|FG000|Extension Treatment Period|Other|1|||
130256887|NCT03895372|468904962|FG001|Extension Treatment Period|Other|3|||
130256888|NCT03895372|468904963|FG002|Extension Treatment Period|Other|0|||
130256889|NCT03895372|468904964|FG003|Extension Treatment Period|Other|0|||
130256890|NCT03895372|468904965|FG004|Extension Treatment Period|Other|1|||
130256891|NCT03895372|468904966|FG005|Extension Treatment Period|Other|0|||
130256892|NCT03895372|468904967|FG006|Extension Treatment Period|Other|0|||
130256893|NCT03895372|468904968|FG007|Extension Treatment Period|Other|2|||
130256894|NCT03895372|468904961|FG000|Extension Treatment Period|Pregnancy|0|||
130256895|NCT03895372|468904962|FG001|Extension Treatment Period|Pregnancy|0|||
130256896|NCT03895372|468904963|FG002|Extension Treatment Period|Pregnancy|0|||
130256897|NCT03895372|468904964|FG003|Extension Treatment Period|Pregnancy|0|||
130256898|NCT03895372|468904965|FG004|Extension Treatment Period|Pregnancy|1|||
130256899|NCT03895372|468904966|FG005|Extension Treatment Period|Pregnancy|0|||
130256900|NCT03895372|468904967|FG006|Extension Treatment Period|Pregnancy|0|||
130256901|NCT03895372|468904968|FG007|Extension Treatment Period|Pregnancy|0|||
130256902|NCT03895372|468904961|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
130256903|NCT03895372|468904962|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
130256904|NCT03895372|468904963|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130256905|NCT03895372|468904964|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
130256906|NCT03895372|468904965|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
130256907|NCT03895372|468904966|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
130256908|NCT03895372|468904967|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
130256909|NCT03895372|468904968|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
130256910|NCT01472185|468904973|FG000|Overall Study|Randomized but Not Treated|0|||
130256911|NCT01472185|468904974|FG001|Overall Study|Randomized but Not Treated|1|||
130256912|NCT01472185|468904973|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
130256913|NCT01472185|468904974|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
130256914|NCT01472185|468904973|FG000|Overall Study|Hyperglycemia|5|||
130256915|NCT01472185|468904974|FG001|Overall Study|Hyperglycemia|2|||
130256916|NCT01472185|468904973|FG000|Overall Study|Investigator's Discretion|3|||
130256917|NCT01472185|468904974|FG001|Overall Study|Investigator's Discretion|1|||
130256918|NCT01472185|468904973|FG000|Overall Study|Lost to Follow-up|4|||
130256919|NCT01472185|468904974|FG001|Overall Study|Lost to Follow-up|1|||
130256920|NCT01472185|468904973|FG000|Overall Study|Protocol Violation|5|||
130256921|NCT01472185|468904974|FG001|Overall Study|Protocol Violation|1|||
130256922|NCT01472185|468904973|FG000|Overall Study|Subject Noncompliance|8|||
130256923|NCT01472185|468904974|FG001|Overall Study|Subject Noncompliance|15|||
130256924|NCT01472185|468904973|FG000|Overall Study|Subject Withdrew Consent|6|||
130256925|NCT01472185|468904974|FG001|Overall Study|Subject Withdrew Consent|3|||
130256926|NCT05889468|468904975|FG000|Overall Study|Lost to Follow-up|9|||
130256927|NCT05889468|468904976|FG001|Overall Study|Lost to Follow-up|2|||
130256928|NCT05889468|468904975|FG000|Overall Study|Withdrawal by Subject|2|||
130256929|NCT05889468|468904976|FG001|Overall Study|Withdrawal by Subject|2|||
130256930|NCT01309230|468904977|FG000|Overall Study|Withdrawal by Subject|0|||
130256931|NCT01309230|468904978|FG001|Overall Study|Withdrawal by Subject|2|||
130256932|NCT01309230|468904977|FG000|Overall Study|Observation arm closed|0|||
130256933|NCT01309230|468904978|FG001|Overall Study|Observation arm closed|2|||
130256934|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
130256935|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
130256936|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
130256937|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
130256938|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
130256939|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
130256940|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
130256941|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
130256942|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
130256943|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
130701609|NCT02289820|470530414|FG001|Overall Study|Death|0|||
130256944|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256945|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256946|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256947|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256948|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256949|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256950|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256951|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
130256952|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256953|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256954|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256955|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256956|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256957|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256958|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256959|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
130256960|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256961|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256962|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256963|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130701610|NCT02289820|470530415|FG002|Overall Study|Death|1|||
130701611|NCT02289820|470530416|FG003|Overall Study|Death|0|||
130701612|NCT02289820|470530417|FG004|Overall Study|Death|0|||
130701613|NCT02289820|470530418|FG005|Overall Study|Death|0|||
130701614|NCT02289820|470530419|FG006|Overall Study|Death|0|||
130701615|NCT02289820|470530413|FG000|Overall Study|Lost to Follow-up|0|||
130701616|NCT02289820|470530414|FG001|Overall Study|Lost to Follow-up|0|||
130701617|NCT02289820|470530415|FG002|Overall Study|Lost to Follow-up|3|||
130701618|NCT02289820|470530416|FG003|Overall Study|Lost to Follow-up|1|||
130701619|NCT02289820|470530417|FG004|Overall Study|Lost to Follow-up|0|||
130701620|NCT02289820|470530418|FG005|Overall Study|Lost to Follow-up|1|||
130701621|NCT02289820|470530419|FG006|Overall Study|Lost to Follow-up|1|||
130701622|NCT02289820|470530413|FG000|Overall Study|withdrawal of consent|0|||
130701623|NCT02289820|470530414|FG001|Overall Study|withdrawal of consent|1|||
130701624|NCT02289820|470530415|FG002|Overall Study|withdrawal of consent|0|||
130701625|NCT02289820|470530416|FG003|Overall Study|withdrawal of consent|0|||
130701626|NCT02289820|470530417|FG004|Overall Study|withdrawal of consent|0|||
130701627|NCT02289820|470530418|FG005|Overall Study|withdrawal of consent|0|||
130701628|NCT02289820|470530419|FG006|Overall Study|withdrawal of consent|0|||
130701629|NCT00926367|470530422|FG000|Overall Study|Withdrawal by Subject|0|||
130701630|NCT00926367|470530423|FG001|Overall Study|Withdrawal by Subject|1|||
130701631|NCT00926367|470530422|FG000|Overall Study|Lost to Follow-up|1|||
130701632|NCT00926367|470530423|FG001|Overall Study|Lost to Follow-up|0|||
130701633|NCT00926367|470530422|FG000|Overall Study|Skin Irritation|1|||
130701634|NCT00926367|470530423|FG001|Overall Study|Skin Irritation|2|||
130701635|NCT03294317|470530424|FG000|Overall Study|Physician Decision|1|||
130701636|NCT03294317|470530424|FG000|Overall Study|Withdrawal by Subject|6|||
130701637|NCT03294317|470530424|FG000|Overall Study|Lost to Follow-up|1|||
130701638|NCT03294317|470530424|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
130701639|NCT03294317|470530424|FG000|Overall Study|Failed HB lead implant|8|||
130701640|NCT03294317|470530424|FG000|Overall Study|Received CRT instead|1|||
130701641|NCT03294317|470530424|FG000|Overall Study|Exited after lead revision|2|||
130701642|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
130701643|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
130701644|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
130256964|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256965|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256966|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256967|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256968|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256969|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256970|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
130256971|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256972|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
130256973|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256974|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130701645|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130701646|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
130701647|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130701648|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130701649|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
130701650|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130701651|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Other|1|||
130701652|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Other|4|||
130701653|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Other|5|||
130256975|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256976|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256977|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256978|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256979|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256980|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256981|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
130256982|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256983|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256984|NCT00049543|468904997|FG000|Overall Study|still on treatment|2|||
130256985|NCT00049543|468904998|FG001|Overall Study|still on treatment|9|||
130256986|NCT03485157|468904999|FG000|Double Blind Phase|Lost to Follow-up|4|||
130256987|NCT03485157|468905000|FG001|Double Blind Phase|Lost to Follow-up|4|||
130256988|NCT03485157|468904999|FG000|Double Blind Phase|Adverse Event|2|||
130256989|NCT03485157|468905000|FG001|Double Blind Phase|Adverse Event|1|||
130256990|NCT03485157|468904999|FG000|Double Blind Phase|Withdrawal by Subject|6|||
130256991|NCT03485157|468905000|FG001|Double Blind Phase|Withdrawal by Subject|9|||
130256992|NCT03485157|468904999|FG000|Double Blind Phase|Removal by PI|3|||
130256993|NCT03485157|468905000|FG001|Double Blind Phase|Removal by PI|7|||
130256994|NCT03485157|468904999|FG000|Open Label Phase|Lost to Follow-up|1|||
130256995|NCT03485157|468905000|FG001|Open Label Phase|Lost to Follow-up|2|||
130256996|NCT03485157|468904999|FG000|Open Label Phase|Adverse Event|0|||
130256997|NCT03485157|468905000|FG001|Open Label Phase|Adverse Event|1|||
130256998|NCT03485157|468904999|FG000|Open Label Phase|Withdrawal by Subject|1|||
130256999|NCT03485157|468905000|FG001|Open Label Phase|Withdrawal by Subject|2|||
130257000|NCT03485157|468904999|FG000|Open Label Phase|Removal by PI|2|||
130257001|NCT03485157|468905000|FG001|Open Label Phase|Removal by PI|0|||
130257002|NCT04562090|468905001|FG000|Overall Study|Withdrawal by Subject|3|||
130257003|NCT04562090|468905002|FG001|Overall Study|Withdrawal by Subject|4|||
130257004|NCT04562090|468905001|FG000|Overall Study|Protocol Violation|2|||
130257005|NCT04562090|468905002|FG001|Overall Study|Protocol Violation|0|||
130257006|NCT04562090|468905001|FG000|Overall Study|Lack of Efficacy|0|||
130257007|NCT04562090|468905002|FG001|Overall Study|Lack of Efficacy|1|||
130257008|NCT04562090|468905001|FG000|Overall Study|Adverse Event|1|||
130257009|NCT04562090|468905002|FG001|Overall Study|Adverse Event|4|||
130257010|NCT04562090|468905001|FG000|Overall Study|Miscellaneous|0|||
130257011|NCT04562090|468905002|FG001|Overall Study|Miscellaneous|3|||
130257012|NCT03633058|468905003|FG000|Overall Study|Adverse Event|0|||
130257013|NCT03633058|468905004|FG001|Overall Study|Adverse Event|0|||
130257014|NCT03633058|468905005|FG002|Overall Study|Adverse Event|1|||
130257015|NCT03633058|468905006|FG003|Overall Study|Adverse Event|0|||
130257016|NCT03312543|468905007|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
130257017|NCT03312543|468905008|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
130257018|NCT03312543|468905007|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
130257019|NCT03312543|468905008|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
130257020|NCT03312543|468905007|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
130257021|NCT03312543|468905008|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
130257022|NCT03312543|468905007|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130257023|NCT03312543|468905008|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130257024|NCT03312543|468905007|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130257025|NCT03312543|468905008|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130257026|NCT03312543|468905007|FG000|Regression (Week 12 to Week 24)|Death|0|||
130257027|NCT03312543|468905008|FG001|Regression (Week 12 to Week 24)|Death|1|||
130257028|NCT04134936|468905009|FG000|Overall Study|Adverse Event|3|||
130257029|NCT04134936|468905010|FG001|Overall Study|Adverse Event|2|||
130257030|NCT04134936|468905009|FG000|Overall Study|Withdrawal by Subject|2|||
130257031|NCT04134936|468905010|FG001|Overall Study|Withdrawal by Subject|3|||
130257032|NCT04134936|468905009|FG000|Overall Study|Physician Decision|0|||
130257033|NCT04134936|468905010|FG001|Overall Study|Physician Decision|1|||
130257034|NCT04134936|468905009|FG000|Overall Study|Progressive disease, joined another trial|1|||
130257035|NCT04134936|468905010|FG001|Overall Study|Progressive disease, joined another trial|0|||
130257036|NCT04134936|468905009|FG000|Overall Study|Progressive disease|1|||
130257037|NCT04134936|468905010|FG001|Overall Study|Progressive disease|0|||
130257038|NCT02420717|468905013|FG000|Overall Study|Did not receive all study medication|2|||
130257039|NCT02420717|468905014|FG001|Overall Study|Did not receive all study medication|0|||
130257040|NCT02420717|468905015|FG002|Overall Study|Did not receive all study medication|0|||
130257041|NCT04144517|468905018|FG000|Overall Study|Physician Decision|0|||
130257042|NCT04144517|468905019|FG001|Overall Study|Physician Decision|1|||
130257043|NCT04144517|468905018|FG000|Overall Study|Other|2|||
130257044|NCT04144517|468905019|FG001|Overall Study|Other|2|||
130257045|NCT04144517|468905018|FG000|Overall Study|Death|6|||
130257046|NCT04144517|468905019|FG001|Overall Study|Death|3|||
130257047|NCT00835367|468905025|FG000|Washout|Adverse Event|2|||
130257048|NCT00835367|468905026|FG001|Washout|Adverse Event|0|||
130257049|NCT00835367|468905025|FG000|Washout|Withdrawal by Subject|1|||
130257050|NCT00835367|468905026|FG001|Washout|Withdrawal by Subject|0|||
130257051|NCT00835367|468905025|FG000|Second Intervention|Adverse Event|1|||
130257052|NCT00835367|468905026|FG001|Second Intervention|Adverse Event|1|||
130257053|NCT00936936|468906552|FG000|Overall Study|Adverse Event|7|||
130257054|NCT00936936|468906553|FG001|Overall Study|Adverse Event|1|||
130257055|NCT00936936|468906552|FG000|Overall Study|Disease Progression|2|||
130257056|NCT00936936|468906553|FG001|Overall Study|Disease Progression|2|||
130257057|NCT00936936|468906552|FG000|Overall Study|Unrelated|3|||
130257058|NCT00936936|468906553|FG001|Overall Study|Unrelated|1|||
130257059|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
130257060|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
130257061|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
130257062|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
130257063|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
130257064|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
130257065|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
130257066|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
130257067|NCT01373281|468906554|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
130257068|NCT01373281|468906555|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
130257069|NCT01373281|468906554|FG000|Surveillance Expansion Period|Protocol Violation|9|||
130257070|NCT01373281|468906555|FG001|Surveillance Expansion Period|Protocol Violation|1|||
130257071|NCT01373281|468906554|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
130257072|NCT01373281|468906555|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
130257073|NCT01373281|468906554|FG000|Surveillance Expansion Period|Serious adverse event|3|||
130257074|NCT01373281|468906555|FG001|Surveillance Expansion Period|Serious adverse event|4|||
130257075|NCT00851084|468906556|FG000|Overall Study|Randomized but not treated|1|||
130257076|NCT00851084|468906557|FG001|Overall Study|Randomized but not treated|0|||
130257077|NCT00851084|468906556|FG000|Overall Study|Adverse Event|26|||
130257078|NCT00851084|468906557|FG001|Overall Study|Adverse Event|36|||
130257079|NCT00851084|468906556|FG000|Overall Study|Disease progression|52|||
130257080|NCT00851084|468906557|FG001|Overall Study|Disease progression|47|||
130701654|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
130701655|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
130701656|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
130701657|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
130701658|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130701659|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130701660|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
130701661|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
130701662|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
130701663|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130701664|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
130701665|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130701666|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130701667|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130701668|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
130701669|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Other|1|||
130701670|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Other|4|||
130701671|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Other|2|||
130701672|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130701673|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130701674|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130701675|NCT03847974|470530434|FG000|Overall Study|relocated out of region|3|||
130701676|NCT03847974|470530434|FG000|Overall Study|Withdrawal by Subject|2|||
130701677|NCT03847974|470530434|FG000|Overall Study|Adverse Event|1|||
130701678|NCT01924364|470530435|FG000|Overall Study|Physician Decision|3|||
130701679|NCT02911935|470530436|FG000|Overall Study|Lost to Follow-up|5|||
130701680|NCT02911935|470530437|FG001|Overall Study|Lost to Follow-up|7|||
130701681|NCT01685216|470530440|FG000|Overall Study|Did not receive study drug|1|||
130701682|NCT00756717|470530441|FG000|Overall Study|Withdrawal by Subject|2|||
130701683|NCT00685750|470530442|FG000|Overall Study|Tumor sampling failure|0|||
130701684|NCT00685750|470530443|FG001|Overall Study|Tumor sampling failure|0|||
130701685|NCT00685750|470530444|FG002|Overall Study|Tumor sampling failure|1|||
130701686|NCT00685750|470530445|FG003|Overall Study|Tumor sampling failure|0|||
130701687|NCT00685750|470530446|FG004|Overall Study|Tumor sampling failure|0|||
130257081|NCT00851084|468906556|FG000|Overall Study|Poor compliance to protocol|1|||
130257082|NCT00851084|468906557|FG001|Overall Study|Poor compliance to protocol|1|||
130257083|NCT00851084|468906556|FG000|Overall Study|Physician Decision|13|||
130257084|NCT00851084|468906557|FG001|Overall Study|Physician Decision|14|||
130257085|NCT00851084|468906556|FG000|Overall Study|Consent withdrawn|0|||
130257086|NCT00851084|468906557|FG001|Overall Study|Consent withdrawn|2|||
130257087|NCT00851084|468906556|FG000|Overall Study|Withdrawal by Subject|11|||
130257088|NCT00851084|468906557|FG001|Overall Study|Withdrawal by Subject|12|||
130257089|NCT00851084|468906556|FG000|Overall Study|Metastatic surgery|6|||
130257090|NCT00851084|468906557|FG001|Overall Study|Metastatic surgery|6|||
130257091|NCT00851084|468906556|FG000|Overall Study|Other|7|||
130257092|NCT00851084|468906557|FG001|Overall Study|Other|1|||
130257093|NCT00734032|468906558|FG000|Overall Study|Adverse Event|0|||
130257094|NCT00734032|468906559|FG001|Overall Study|Adverse Event|1|||
130257095|NCT00734032|468906560|FG002|Overall Study|Adverse Event|0|||
130257096|NCT00734032|468906561|FG003|Overall Study|Adverse Event|0|||
130257097|NCT00133705|468906564|FG000|Overall Study|Withdrawal by Subject|2|||
130257098|NCT00133705|468906565|FG001|Overall Study|Withdrawal by Subject|3|||
130257099|NCT04992273|468906567|FG000|Overall Study|Lost to Follow-up|0|||
130257100|NCT04992273|468906568|FG001|Overall Study|Lost to Follow-up|1|||
130257101|NCT03440411|468906569|FG000|Overall Study|Adverse Event|0|||
130257102|NCT03440411|468906570|FG001|Overall Study|Adverse Event|0|||
130257103|NCT03440411|468906571|FG002|Overall Study|Adverse Event|1|||
130257104|NCT03440411|468906572|FG003|Overall Study|Adverse Event|0|||
130257105|NCT03440411|468906569|FG000|Overall Study|PD|2|||
130257106|NCT03440411|468906570|FG001|Overall Study|PD|1|||
130257107|NCT03440411|468906571|FG002|Overall Study|PD|1|||
130257108|NCT03440411|468906572|FG003|Overall Study|PD|1|||
130701688|NCT00685750|470530447|FG005|Overall Study|Tumor sampling failure|0|||
130701689|NCT00685750|470530448|FG006|Overall Study|Tumor sampling failure|0|||
130701690|NCT00685750|470530442|FG000|Overall Study|Patient didn't receive the treatment|0|||
130701691|NCT00685750|470530443|FG001|Overall Study|Patient didn't receive the treatment|0|||
130701692|NCT00685750|470530444|FG002|Overall Study|Patient didn't receive the treatment|0|||
130257109|NCT03440411|468906569|FG000|Overall Study|Withdrawal by Subject|1|||
130257110|NCT03440411|468906570|FG001|Overall Study|Withdrawal by Subject|0|||
130257111|NCT03440411|468906571|FG002|Overall Study|Withdrawal by Subject|0|||
130257112|NCT03440411|468906572|FG003|Overall Study|Withdrawal by Subject|0|||
130257113|NCT03440411|468906569|FG000|Overall Study|Closed study by sponsor|0|||
130257114|NCT03440411|468906570|FG001|Overall Study|Closed study by sponsor|0|||
130257115|NCT03440411|468906571|FG002|Overall Study|Closed study by sponsor|0|||
130257116|NCT03440411|468906572|FG003|Overall Study|Closed study by sponsor|1|||
130257117|NCT00863304|468906575|FG000|Overall Study|Adverse Event|10|||
130257118|NCT00863304|468906576|FG001|Overall Study|Adverse Event|4|||
130257119|NCT00863304|468906577|FG002|Overall Study|Adverse Event|14|||
130257120|NCT00863304|468906578|FG003|Overall Study|Adverse Event|16|||
130257121|NCT00863304|468906575|FG000|Overall Study|Lost to Follow-up|1|||
130257122|NCT00863304|468906576|FG001|Overall Study|Lost to Follow-up|5|||
130257123|NCT00863304|468906577|FG002|Overall Study|Lost to Follow-up|4|||
130701693|NCT00685750|470530445|FG003|Overall Study|Patient didn't receive the treatment|0|||
130701694|NCT00685750|470530446|FG004|Overall Study|Patient didn't receive the treatment|0|||
130701695|NCT00685750|470530447|FG005|Overall Study|Patient didn't receive the treatment|0|||
130701696|NCT00685750|470530448|FG006|Overall Study|Patient didn't receive the treatment|1|||
130701697|NCT00685750|470530442|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130701698|NCT00685750|470530443|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130701699|NCT00685750|470530444|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130701700|NCT00685750|470530445|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130701701|NCT00685750|470530446|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130701702|NCT00685750|470530447|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
130701703|NCT00685750|470530448|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
130701704|NCT04979858|470530449|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
130701705|NCT04979858|470530450|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
130701706|NCT02654015|470530451|FG000|Overall Study|Death|12|||
130701707|NCT02654015|470530451|FG000|Overall Study|Lost to Follow-up|3|||
130701708|NCT05317195|470530454|FG000|Randomization|Withdrawal by Subject|1|||
130701709|NCT05317195|470530454|FG000|Randomization|Discontinued|6|||
130701710|NCT05317195|470530454|FG000|Admission|Withdrawal by Subject|2|||
130701711|NCT03259789|470530455|FG000|Overall Study|Adverse Event|3|||
130701712|NCT03259789|470530456|FG001|Overall Study|Adverse Event|2|||
130701713|NCT03259789|470530457|FG002|Overall Study|Adverse Event|1|||
130701714|NCT03259789|470530455|FG000|Overall Study|Withdrawal by Subject|9|||
130701715|NCT03259789|470530456|FG001|Overall Study|Withdrawal by Subject|5|||
130701716|NCT03259789|470530457|FG002|Overall Study|Withdrawal by Subject|1|||
130701717|NCT03259789|470530455|FG000|Overall Study|Lost to Follow-up|5|||
130701718|NCT03259789|470530456|FG001|Overall Study|Lost to Follow-up|9|||
130701719|NCT03259789|470530457|FG002|Overall Study|Lost to Follow-up|4|||
130701720|NCT03259789|470530455|FG000|Overall Study|Physician Decision|0|||
130701721|NCT03259789|470530456|FG001|Overall Study|Physician Decision|1|||
130701722|NCT03259789|470530457|FG002|Overall Study|Physician Decision|0|||
130701723|NCT02063217|470530458|FG000|Overall Study|Withdrawal by Subject|1|||
130701724|NCT02063217|470530459|FG001|Overall Study|Withdrawal by Subject|0|||
130701725|NCT02063217|470530460|FG002|Overall Study|Withdrawal by Subject|0|||
130701726|NCT00889252|470530461|FG000|Overall Study|Adverse Event|2|||
130701727|NCT00889252|470530462|FG001|Overall Study|Adverse Event|4|||
130701728|NCT00889252|470530461|FG000|Overall Study|Withdrawal by Subject|3|||
130701729|NCT00889252|470530462|FG001|Overall Study|Withdrawal by Subject|0|||
130701730|NCT00889252|470530461|FG000|Overall Study|Protocol Violation|2|||
130701731|NCT00889252|470530462|FG001|Overall Study|Protocol Violation|0|||
130701732|NCT01160640|470530466|FG000|Overall Study|Physician Decision|3|||
130701733|NCT01160640|470530467|FG001|Overall Study|Physician Decision|3|||
130701734|NCT01160640|470530466|FG000|Overall Study|Incarceration|1|||
130701735|NCT01160640|470530467|FG001|Overall Study|Incarceration|0|||
130701736|NCT01160640|470530466|FG000|Overall Study|Withdrawal by Subject|0|||
130701737|NCT01160640|470530467|FG001|Overall Study|Withdrawal by Subject|3|||
130701738|NCT03108820|470530469|FG000|Overall Study|Lost to Follow-up|30|||
130701739|NCT03108820|470530470|FG001|Overall Study|Lost to Follow-up|28|||
130701740|NCT03108820|470530469|FG000|Overall Study|Withdrawal by Subject|32|||
130701741|NCT03108820|470530470|FG001|Overall Study|Withdrawal by Subject|24|||
130701742|NCT03108820|470530469|FG000|Overall Study|Death|6|||
130701743|NCT03108820|470530470|FG001|Overall Study|Death|11|||
130701744|NCT00089973|470530473|FG000|Overall Study|Adverse Event|3|||
130701745|NCT00089973|470530473|FG000|Overall Study|Withdrawal by Subject|1|||
130701746|NCT00089973|470530473|FG000|Overall Study|Disease progression|45|||
130701747|NCT00089973|470530473|FG000|Overall Study|Death|1|||
130701748|NCT04428645|470530474|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
130701749|NCT01074008|470532635|FG000|Overall Study|Adverse Event|0|||
130701750|NCT01074008|470532636|FG001|Overall Study|Adverse Event|1|||
130701751|NCT01074008|470532637|FG002|Overall Study|Adverse Event|0|||
130701752|NCT01074008|470532638|FG003|Overall Study|Adverse Event|0|||
130701753|NCT01074008|470532639|FG004|Overall Study|Adverse Event|0|||
130701754|NCT01074008|470532640|FG005|Overall Study|Adverse Event|0|||
130701755|NCT01074008|470532641|FG006|Overall Study|Adverse Event|0|||
130257124|NCT00863304|468906578|FG003|Overall Study|Lost to Follow-up|2|||
130257125|NCT00863304|468906575|FG000|Overall Study|Lack of Efficacy|57|||
130257126|NCT00863304|468906576|FG001|Overall Study|Lack of Efficacy|26|||
130257127|NCT00863304|468906577|FG002|Overall Study|Lack of Efficacy|30|||
130257128|NCT00863304|468906578|FG003|Overall Study|Lack of Efficacy|28|||
130257129|NCT00863304|468906575|FG000|Overall Study|Withdrawal by Subject|19|||
130257130|NCT00863304|468906576|FG001|Overall Study|Withdrawal by Subject|14|||
130257131|NCT00863304|468906577|FG002|Overall Study|Withdrawal by Subject|20|||
130257132|NCT00863304|468906578|FG003|Overall Study|Withdrawal by Subject|18|||
130257133|NCT00863304|468906575|FG000|Overall Study|Other|1|||
130257134|NCT00863304|468906576|FG001|Overall Study|Other|0|||
130257135|NCT00863304|468906577|FG002|Overall Study|Other|0|||
130257136|NCT00863304|468906578|FG003|Overall Study|Other|1|||
130257137|NCT00863304|468906575|FG000|Overall Study|Protocol Violation|2|||
130257138|NCT00863304|468906576|FG001|Overall Study|Protocol Violation|6|||
130257139|NCT00863304|468906577|FG002|Overall Study|Protocol Violation|2|||
130257140|NCT00863304|468906578|FG003|Overall Study|Protocol Violation|0|||
130257141|NCT00863304|468906575|FG000|Overall Study|Randomized, but not Treated|3|||
130257142|NCT00863304|468906576|FG001|Overall Study|Randomized, but not Treated|1|||
130257143|NCT00863304|468906577|FG002|Overall Study|Randomized, but not Treated|4|||
130553767|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
130553768|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
130553769|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
130553770|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
130553771|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
130553772|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
130553773|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
130553774|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
130553775|NCT04908189|469994848|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
130553776|NCT04908189|469994849|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
130553777|NCT04908189|469994850|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
130553778|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
130553779|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
130553780|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
130553781|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
130553782|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
130553783|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
130257144|NCT00863304|468906578|FG003|Overall Study|Randomized, but not Treated|1|||
130257145|NCT00863304|468906575|FG000|Overall Study|Entered extension study|101|||
130257146|NCT00863304|468906576|FG001|Overall Study|Entered extension study|129|||
130257147|NCT00863304|468906577|FG002|Overall Study|Entered extension study|113|||
130553784|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
130553785|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
130257148|NCT00863304|468906578|FG003|Overall Study|Entered extension study|125|||
130257149|NCT03528902|468906581|FG000|Overall Study|Adverse Event|1|||
130257150|NCT03528902|468906582|FG001|Overall Study|Adverse Event|0|||
130257151|NCT05030766|468906583|FG000|Phase 1 Participants|Lost to Follow-up|12|||
130257152|NCT05030766|468906584|FG001|Phase 1 Participants|Lost to Follow-up|22|||
130257153|NCT05030766|468906585|FG002|Phase 1 Participants|Lost to Follow-up|0|||
130257154|NCT05030766|468906586|FG003|Phase 1 Participants|Lost to Follow-up|0|||
130257155|NCT05030766|468906583|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
130257156|NCT05030766|468906584|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
130257157|NCT05030766|468906585|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130257158|NCT05030766|468906586|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130257159|NCT05030766|468906583|FG000|Phase 2 Participants|Lost to Follow-up|0|||
130257160|NCT05030766|468906584|FG001|Phase 2 Participants|Lost to Follow-up|0|||
130257161|NCT05030766|468906585|FG002|Phase 2 Participants|Lost to Follow-up|6|||
130257162|NCT05030766|468906586|FG003|Phase 2 Participants|Lost to Follow-up|2|||
130257163|NCT00023595|468906587|FG000|5 Year Follow up|Lost to Follow-up|2|||
130257164|NCT00023595|468906588|FG001|5 Year Follow up|Lost to Follow-up|2|||
130257165|NCT00023595|468906589|FG002|5 Year Follow up|Lost to Follow-up|1|||
130257166|NCT00023595|468906590|FG003|5 Year Follow up|Lost to Follow-up|7|||
130257167|NCT00023595|468906591|FG004|5 Year Follow up|Lost to Follow-up|3|||
130257168|NCT00023595|468906587|FG000|10 Year Follow up|Lost to Follow-up|12|||
130257169|NCT00023595|468906588|FG001|10 Year Follow up|Lost to Follow-up|10|||
130257170|NCT00023595|468906589|FG002|10 Year Follow up|Lost to Follow-up|3|||
130257171|NCT00023595|468906590|FG003|10 Year Follow up|Lost to Follow-up|0|||
130257172|NCT00023595|468906591|FG004|10 Year Follow up|Lost to Follow-up|0|||
130257173|NCT03900650|468906592|FG000|Overall Study|Withdrawal by Subject|1|||
130257174|NCT03900650|468906593|FG001|Overall Study|Withdrawal by Subject|1|||
130257175|NCT03900650|468906594|FG002|Overall Study|Withdrawal by Subject|0|||
130257176|NCT03900650|468906595|FG003|Overall Study|Withdrawal by Subject|0|||
130257177|NCT03900650|468906592|FG000|Overall Study|Withdrawn by staff|1|||
130257178|NCT03900650|468906593|FG001|Overall Study|Withdrawn by staff|0|||
130257179|NCT03900650|468906594|FG002|Overall Study|Withdrawn by staff|0|||
130257180|NCT03900650|468906595|FG003|Overall Study|Withdrawn by staff|0|||
130257181|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
130257182|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
130257183|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
130257184|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
130257185|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
130257186|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130257187|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
130257188|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130257189|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130257190|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130257191|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
130257192|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
130257193|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
130701756|NCT01074008|470532642|FG007|Overall Study|Adverse Event|0|||
130701757|NCT01074008|470532643|FG008|Overall Study|Adverse Event|0|||
130701758|NCT01074008|470532635|FG000|Overall Study|Withdrawal by Subject|1|||
130701759|NCT01074008|470532636|FG001|Overall Study|Withdrawal by Subject|1|||
130701760|NCT01074008|470532637|FG002|Overall Study|Withdrawal by Subject|1|||
130701761|NCT01074008|470532638|FG003|Overall Study|Withdrawal by Subject|0|||
130701762|NCT01074008|470532639|FG004|Overall Study|Withdrawal by Subject|1|||
130701763|NCT01074008|470532640|FG005|Overall Study|Withdrawal by Subject|0|||
130701764|NCT01074008|470532641|FG006|Overall Study|Withdrawal by Subject|0|||
130701765|NCT01074008|470532642|FG007|Overall Study|Withdrawal by Subject|0|||
130257194|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
130257195|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
130257196|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
130257197|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
130257198|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
130257199|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
130257200|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
130257201|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
130257202|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
130257203|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
130257204|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
130701766|NCT01074008|470532643|FG008|Overall Study|Withdrawal by Subject|0|||
130257205|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
130257206|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
130257207|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
130701767|NCT01074008|470532635|FG000|Overall Study|Lost to Follow-up|0|||
130257208|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
130257209|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
130257210|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
130701768|NCT01074008|470532636|FG001|Overall Study|Lost to Follow-up|1|||
130701769|NCT01074008|470532637|FG002|Overall Study|Lost to Follow-up|1|||
130701770|NCT01074008|470532638|FG003|Overall Study|Lost to Follow-up|1|||
130701771|NCT01074008|470532639|FG004|Overall Study|Lost to Follow-up|1|||
130701772|NCT01074008|470532640|FG005|Overall Study|Lost to Follow-up|0|||
130257211|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130257212|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130257213|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
130257214|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
130257215|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
130257216|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
130257217|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
130257218|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
130257219|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
130257220|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
130257221|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
130701773|NCT01074008|470532641|FG006|Overall Study|Lost to Follow-up|1|||
130701774|NCT01074008|470532642|FG007|Overall Study|Lost to Follow-up|0|||
130701775|NCT01074008|470532643|FG008|Overall Study|Lost to Follow-up|4|||
130701776|NCT00108628|470532649|FG000|Overall Study|Withdrawal by Subject|17|||
130257222|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
130257223|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
130257224|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
130257225|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
130257226|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
130257227|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
130257228|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
130701777|NCT00108628|470532650|FG001|Overall Study|Withdrawal by Subject|9|||
130257229|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
130257230|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
130257231|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
130257232|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
130257233|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
130257234|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
130257235|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
130257236|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
130257237|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
130257238|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
130257239|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
130257240|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
130257241|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
130257242|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
130257243|NCT02106832|468906598|FG000|Overall Study|Adverse Event|1|||
130257244|NCT02106832|468906599|FG001|Overall Study|Adverse Event|2|||
130257245|NCT02106832|468906600|FG002|Overall Study|Adverse Event|3|||
130257246|NCT02106832|468906601|FG003|Overall Study|Adverse Event|0|||
130257247|NCT02106832|468906598|FG000|Overall Study|Death|4|||
130257248|NCT02106832|468906599|FG001|Overall Study|Death|4|||
130257249|NCT02106832|468906600|FG002|Overall Study|Death|1|||
130257250|NCT02106832|468906601|FG003|Overall Study|Death|4|||
130257251|NCT02106832|468906598|FG000|Overall Study|Deterioration of general conditions|0|||
130701778|NCT00108628|470532649|FG000|Overall Study|Lack of Efficacy|2|||
130701779|NCT00108628|470532650|FG001|Overall Study|Lack of Efficacy|1|||
130701780|NCT00108628|470532649|FG000|Overall Study|Death|1|||
130701781|NCT00108628|470532650|FG001|Overall Study|Death|0|||
130701782|NCT01350934|470532651|FG000|Base Study|Adverse Event|6|||
130701783|NCT01350934|470532652|FG001|Base Study|Adverse Event|0|||
130257252|NCT02106832|468906599|FG001|Overall Study|Deterioration of general conditions|0|||
130365222|NCT00347360|469306869|FG005|Overall Study|Per sponsors instruction|0|||
130365223|NCT00347360|469306870|FG006|Overall Study|Per sponsors instruction|0|||
130365224|NCT00347360|469306871|FG007|Overall Study|Per sponsors instruction|0|||
130701784|NCT01350934|470532651|FG000|Base Study|Lost to Follow-up|1|||
130701785|NCT01350934|470532652|FG001|Base Study|Lost to Follow-up|0|||
130257253|NCT02106832|468906600|FG002|Overall Study|Deterioration of general conditions|1|||
130257254|NCT02106832|468906601|FG003|Overall Study|Deterioration of general conditions|0|||
130257255|NCT02106832|468906598|FG000|Overall Study|Lost to Follow-up|0|||
130257256|NCT02106832|468906599|FG001|Overall Study|Lost to Follow-up|1|||
130701786|NCT01350934|470532651|FG000|Base Study|Protocol Violation|1|||
130701787|NCT01350934|470532652|FG001|Base Study|Protocol Violation|1|||
130701788|NCT01350934|470532651|FG000|Base Study|Withdrawal by Subject|1|||
130701789|NCT01350934|470532652|FG001|Base Study|Withdrawal by Subject|2|||
130257257|NCT02106832|468906600|FG002|Overall Study|Lost to Follow-up|1|||
130257258|NCT02106832|468906601|FG003|Overall Study|Lost to Follow-up|3|||
130257259|NCT02106832|468906598|FG000|Overall Study|Physician Decision|1|||
130257260|NCT02106832|468906599|FG001|Overall Study|Physician Decision|0|||
130257261|NCT02106832|468906600|FG002|Overall Study|Physician Decision|0|||
130257262|NCT02106832|468906601|FG003|Overall Study|Physician Decision|0|||
130257263|NCT02106832|468906598|FG000|Overall Study|Protocol Violation|0|||
130257264|NCT02106832|468906599|FG001|Overall Study|Protocol Violation|0|||
130257265|NCT02106832|468906600|FG002|Overall Study|Protocol Violation|0|||
130257266|NCT02106832|468906601|FG003|Overall Study|Protocol Violation|1|||
130257267|NCT02106832|468906598|FG000|Overall Study|Withdrawal by Subject|17|||
130257268|NCT02106832|468906599|FG001|Overall Study|Withdrawal by Subject|17|||
130257269|NCT02106832|468906600|FG002|Overall Study|Withdrawal by Subject|10|||
130257270|NCT02106832|468906601|FG003|Overall Study|Withdrawal by Subject|7|||
130257271|NCT02106832|468906598|FG000|Overall Study|Technical problems|0|||
130257272|NCT02106832|468906599|FG001|Overall Study|Technical problems|1|||
130257273|NCT02106832|468906600|FG002|Overall Study|Technical problems|0|||
130257274|NCT02106832|468906601|FG003|Overall Study|Technical problems|0|||
130257275|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257276|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257277|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
130257278|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130257279|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257280|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130257281|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130257282|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257283|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257284|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130701790|NCT01350934|470532651|FG000|Base Study|Non-Compliance With Study Drug|2|||
130701791|NCT01350934|470532652|FG001|Base Study|Non-Compliance With Study Drug|0|||
130257285|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257286|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257287|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257288|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130257289|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
130257290|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130257291|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257292|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257293|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
130257294|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130257295|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130257296|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130257297|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130257298|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
130257299|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130257300|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130257301|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130257302|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130257303|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130257304|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130257305|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
130257306|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257307|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130257308|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130257309|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257310|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257311|NCT05205616|468906614|FG000|Overall Study|Lost to Follow-up|4|||
130257312|NCT05205616|468906615|FG001|Overall Study|Lost to Follow-up|4|||
130257313|NCT00663260|468906624|FG000|Overall Study|Lack of Efficacy|2|||
130257314|NCT00663260|468906625|FG001|Overall Study|Lack of Efficacy|0|||
130257315|NCT00663260|468906626|FG002|Overall Study|Lack of Efficacy|0|||
130257316|NCT00663260|468906624|FG000|Overall Study|Adverse Event|12|||
130257317|NCT00663260|468906625|FG001|Overall Study|Adverse Event|7|||
130701792|NCT01350934|470532651|FG000|Extension Study|Adverse Event|2|||
130257318|NCT00663260|468906626|FG002|Overall Study|Adverse Event|6|||
130257319|NCT00663260|468906624|FG000|Overall Study|Withdrawal by Subject|3|||
130257320|NCT00663260|468906625|FG001|Overall Study|Withdrawal by Subject|1|||
130257321|NCT00663260|468906626|FG002|Overall Study|Withdrawal by Subject|6|||
130257322|NCT00663260|468906624|FG000|Overall Study|Death|1|||
130257323|NCT00663260|468906625|FG001|Overall Study|Death|0|||
130257324|NCT00663260|468906626|FG002|Overall Study|Death|1|||
130257325|NCT00663260|468906624|FG000|Overall Study|Lost to Follow-up|0|||
130257326|NCT00663260|468906625|FG001|Overall Study|Lost to Follow-up|1|||
130257327|NCT00663260|468906626|FG002|Overall Study|Lost to Follow-up|0|||
130257328|NCT00663260|468906624|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
130257329|NCT00663260|468906625|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
130257330|NCT00663260|468906626|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
130257331|NCT02231580|468906635|FG000|Overall Study|Adverse Event|5|||
130257332|NCT02231580|468906636|FG001|Overall Study|Adverse Event|0|||
130257333|NCT03620981|468906637|FG000|Overall Study|Adverse Event|14|||
130257334|NCT03620981|468906638|FG001|Overall Study|Adverse Event|38|||
130257335|NCT03620981|468906639|FG002|Overall Study|Adverse Event|25|||
130257336|NCT03620981|468906637|FG000|Overall Study|Lack of Efficacy|2|||
130257337|NCT03620981|468906638|FG001|Overall Study|Lack of Efficacy|1|||
130257338|NCT03620981|468906639|FG002|Overall Study|Lack of Efficacy|1|||
130257339|NCT03620981|468906637|FG000|Overall Study|Physician Decision|7|||
130257340|NCT03620981|468906638|FG001|Overall Study|Physician Decision|4|||
130257341|NCT03620981|468906639|FG002|Overall Study|Physician Decision|4|||
130257342|NCT03620981|468906637|FG000|Overall Study|Protocol Violation|1|||
130257343|NCT03620981|468906638|FG001|Overall Study|Protocol Violation|2|||
130257344|NCT03620981|468906639|FG002|Overall Study|Protocol Violation|1|||
130257345|NCT03620981|468906637|FG000|Overall Study|Withdrawal by Legal Representative|2|||
130257346|NCT03620981|468906638|FG001|Overall Study|Withdrawal by Legal Representative|1|||
130257347|NCT03620981|468906639|FG002|Overall Study|Withdrawal by Legal Representative|1|||
130257348|NCT03620981|468906637|FG000|Overall Study|Withdrawal by Care Giver|2|||
130257349|NCT03620981|468906638|FG001|Overall Study|Withdrawal by Care Giver|0|||
130257350|NCT03620981|468906639|FG002|Overall Study|Withdrawal by Care Giver|1|||
130257351|NCT03620981|468906637|FG000|Overall Study|Non-compliance with Study Drug|1|||
130257352|NCT03620981|468906638|FG001|Overall Study|Non-compliance with Study Drug|1|||
130257353|NCT03620981|468906639|FG002|Overall Study|Non-compliance with Study Drug|0|||
130257354|NCT02607722|468906642|FG000|Overall Study|No data reliability|1|||
130257355|NCT02607722|468906642|FG000|Overall Study|no patient visit|18|||
130257356|NCT02607722|468906642|FG000|Overall Study|missing info in CRF|13|||
130257357|NCT02607722|468906642|FG000|Overall Study|Withdrawal by Subject|616|||
130257358|NCT02607722|468906642|FG000|Overall Study|Lost to Follow-up|312|||
130257359|NCT02607722|468906642|FG000|Overall Study|Improved|22|||
130257360|NCT02607722|468906642|FG000|Overall Study|Lack of Efficacy|316|||
130257361|NCT02607722|468906642|FG000|Overall Study|Adverse Event|2553|||
130257362|NCT02607722|468906642|FG000|Overall Study|Not treated|1|||
130257363|NCT02607722|468906642|FG000|Overall Study|No CRF collected|138|||
130257364|NCT02607722|468906642|FG000|Overall Study|without CRF|4225|||
130257365|NCT02607722|468906642|FG000|Overall Study|Physician Decision|367|||
130257366|NCT04347538|468906643|FG000|Overall Study|Lost to Follow-up|4|||
130257367|NCT04347538|468906644|FG001|Overall Study|Lost to Follow-up|5|||
130257368|NCT04347538|468906645|FG002|Overall Study|Lost to Follow-up|7|||
130365225|NCT00347360|469306872|FG008|Overall Study|Per sponsors instruction|0|||
130701793|NCT01350934|470532652|FG001|Extension Study|Adverse Event|1|||
130701794|NCT01350934|470532651|FG000|Extension Study|Lost to Follow-up|2|||
130701795|NCT01350934|470532652|FG001|Extension Study|Lost to Follow-up|0|||
130701796|NCT01350934|470532651|FG000|Extension Study|Protocol Violation|1|||
130701797|NCT01350934|470532652|FG001|Extension Study|Protocol Violation|1|||
130701798|NCT01350934|470532651|FG000|Extension Study|Lack of Efficacy|0|||
130701799|NCT01350934|470532652|FG001|Extension Study|Lack of Efficacy|1|||
130701800|NCT01350934|470532651|FG000|Extension Study|Withdrawal by Subject|0|||
130701801|NCT01350934|470532652|FG001|Extension Study|Withdrawal by Subject|1|||
130701802|NCT03547635|470532655|FG000|Overall Study|Adverse Event|5|||
130701803|NCT03547635|470532656|FG001|Overall Study|Adverse Event|2|||
130257369|NCT02135133|468906646|FG000|Overall Study|Adverse Event|10|||
130257370|NCT02135133|468906646|FG000|Overall Study|regulatory mandate|5|||
130257371|NCT03238196|468906647|FG000|Overall Study|Adverse Event|3|||
130257372|NCT03238196|468906648|FG001|Overall Study|Adverse Event|0|||
130257373|NCT03238196|468906649|FG002|Overall Study|Adverse Event|2|||
130257374|NCT03238196|468906650|FG003|Overall Study|Adverse Event|2|||
130257375|NCT03238196|468906647|FG000|Overall Study|Withdrawal by Subject|4|||
130257376|NCT03238196|468906648|FG001|Overall Study|Withdrawal by Subject|1|||
130257377|NCT03238196|468906649|FG002|Overall Study|Withdrawal by Subject|1|||
130257378|NCT03238196|468906650|FG003|Overall Study|Withdrawal by Subject|0|||
130365226|NCT00347360|469306873|FG009|Overall Study|Per sponsors instruction|0|||
130365227|NCT00347360|469306874|FG010|Overall Study|Per sponsors instruction|0|||
130257379|NCT03238196|468906647|FG000|Overall Study|Disease progression|14|||
130257380|NCT03238196|468906648|FG001|Overall Study|Disease progression|2|||
130257381|NCT03238196|468906649|FG002|Overall Study|Disease progression|3|||
130257382|NCT03238196|468906650|FG003|Overall Study|Disease progression|2|||
130257383|NCT03238196|468906647|FG000|Overall Study|Still on treatment|1|||
130257384|NCT03238196|468906648|FG001|Overall Study|Still on treatment|0|||
130257385|NCT03238196|468906649|FG002|Overall Study|Still on treatment|0|||
130257386|NCT03238196|468906650|FG003|Overall Study|Still on treatment|0|||
130257387|NCT05081843|468906651|FG000|Overall Study|Lost to Follow-up|135|||
130257388|NCT05081843|468906652|FG001|Overall Study|Lost to Follow-up|145|||
130257389|NCT02303821|468906653|FG000|Overall Study|Withdrawal by Subject|0|||
130553786|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
130553787|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
130553788|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
130553789|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
130257390|NCT02303821|468906654|FG001|Overall Study|Withdrawal by Subject|0|||
130257391|NCT02303821|468906655|FG002|Overall Study|Withdrawal by Subject|0|||
130257392|NCT02303821|468906656|FG003|Overall Study|Withdrawal by Subject|0|||
130553790|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
130553791|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
130553792|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
130553793|NCT04908189|469994848|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
130553794|NCT04908189|469994849|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
130553795|NCT04908189|469994850|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
130553796|NCT04683731|469994851|FG000|Overall Study|Withdrawal by Subject|1|||
130553797|NCT04683731|469994852|FG001|Overall Study|Withdrawal by Subject|0|||
130553798|NCT04683731|469994853|FG002|Overall Study|Withdrawal by Subject|3|||
130553799|NCT04683731|469994854|FG003|Overall Study|Withdrawal by Subject|2|||
130553800|NCT04683731|469994851|FG000|Overall Study|Determined patient was not eligible|3|||
130553801|NCT04683731|469994852|FG001|Overall Study|Determined patient was not eligible|3|||
130553802|NCT04683731|469994853|FG002|Overall Study|Determined patient was not eligible|12|||
130553803|NCT04683731|469994854|FG003|Overall Study|Determined patient was not eligible|3|||
130553804|NCT01411839|469994856|FG000|Overall Study|Lost to Follow-up|4|||
130553805|NCT01411839|469994857|FG001|Overall Study|Lost to Follow-up|3|||
130553806|NCT00458341|469994858|FG000|Cycle 1|Adverse Event|1|||
130701804|NCT03547635|470532657|FG002|Overall Study|Adverse Event|3|||
130701805|NCT03547635|470532655|FG000|Overall Study|Lost to Follow-up|1|||
130701806|NCT03547635|470532656|FG001|Overall Study|Lost to Follow-up|3|||
130701807|NCT03547635|470532657|FG002|Overall Study|Lost to Follow-up|4|||
130701808|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Subject|1|||
130701809|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Subject|0|||
130701810|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Subject|0|||
130701811|NCT03547635|470532655|FG000|Overall Study|Withdrawal By PI|0|||
130701812|NCT03547635|470532656|FG001|Overall Study|Withdrawal By PI|1|||
130701813|NCT03547635|470532657|FG002|Overall Study|Withdrawal By PI|0|||
130701814|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Sponsor|0|||
130701815|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Sponsor|0|||
130701816|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Sponsor|1|||
130701817|NCT03547635|470532655|FG000|Overall Study|Errant Randomization before Treatment|0|||
130701818|NCT03547635|470532656|FG001|Overall Study|Errant Randomization before Treatment|1|||
130701819|NCT03547635|470532657|FG002|Overall Study|Errant Randomization before Treatment|0|||
130701820|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Subject|1|||
130701821|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Subject|0|||
130701822|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Subject|0|||
130701823|NCT00676650|470532660|FG000|Overall Study|Death|45|||
130701824|NCT00676650|470532661|FG001|Overall Study|Death|14|||
130701825|NCT00676650|470532660|FG000|Overall Study|Adverse Event|159|||
130701826|NCT00676650|470532661|FG001|Overall Study|Adverse Event|21|||
130701827|NCT00676650|470532660|FG000|Overall Study|Global deterioration of health status|66|||
130701828|NCT00676650|470532661|FG001|Overall Study|Global deterioration of health status|31|||
130701829|NCT00676650|470532660|FG000|Overall Study|Lost to Follow-up|0|||
130701830|NCT00676650|470532661|FG001|Overall Study|Lost to Follow-up|1|||
130701831|NCT00676650|470532660|FG000|Overall Study|Objective progression or relapse|189|||
130701832|NCT00676650|470532661|FG001|Overall Study|Objective progression or relapse|140|||
130701833|NCT00676650|470532660|FG000|Overall Study|Other|14|||
130701834|NCT00676650|470532661|FG001|Overall Study|Other|10|||
130701835|NCT00676650|470532660|FG000|Overall Study|Protocol Violation|3|||
130701836|NCT00676650|470532661|FG001|Overall Study|Protocol Violation|1|||
130701837|NCT00676650|470532660|FG000|Overall Study|Study terminated by sponsor|57|||
130701838|NCT00676650|470532661|FG001|Overall Study|Study terminated by sponsor|43|||
130257393|NCT02303821|468906657|FG004|Overall Study|Withdrawal by Subject|0|||
130257394|NCT02303821|468906658|FG005|Overall Study|Withdrawal by Subject|0|||
130553807|NCT00458341|469994859|FG001|Cycle 1|Adverse Event|0|||
130553808|NCT05461794|469994862|FG000|Overall Study|Withdrawal by Subject|1|||
130701839|NCT00676650|470532660|FG000|Overall Study|Withdrawal by Subject|48|||
130701840|NCT00676650|470532661|FG001|Overall Study|Withdrawal by Subject|24|||
130701841|NCT00676650|470532660|FG000|Overall Study|Randomized but not treated|3|||
130701842|NCT00676650|470532661|FG001|Overall Study|Randomized but not treated|4|||
130701843|NCT02297841|470532662|FG000|Overall Study|Withdrawal by Subject|1|||
130257395|NCT02303821|468906659|FG006|Overall Study|Withdrawal by Subject|0|||
130553809|NCT05461794|469994863|FG001|Overall Study|Withdrawal by Subject|1|||
130701844|NCT02297841|470532662|FG000|Overall Study|Protocol Violation|7|||
130701845|NCT00683592|470532663|FG000|Overall Study|Adverse Event|12|||
130257396|NCT02303821|468906660|FG007|Overall Study|Withdrawal by Subject|2|||
130257397|NCT02303821|468906653|FG000|Overall Study|Death|0|||
130257398|NCT02303821|468906654|FG001|Overall Study|Death|2|||
130257399|NCT02303821|468906655|FG002|Overall Study|Death|0|||
130257400|NCT02303821|468906656|FG003|Overall Study|Death|0|||
130257401|NCT02303821|468906657|FG004|Overall Study|Death|0|||
130257402|NCT02303821|468906658|FG005|Overall Study|Death|3|||
130257403|NCT02303821|468906659|FG006|Overall Study|Death|41|||
130365228|NCT00347360|469306875|FG011|Overall Study|Per sponsors instruction|0|||
130553810|NCT05461794|469994864|FG002|Overall Study|Withdrawal by Subject|3|||
130553811|NCT05461794|469994862|FG000|Overall Study|Study Terminated By Sponsor|18|||
130553812|NCT05461794|469994863|FG001|Overall Study|Study Terminated By Sponsor|13|||
130553813|NCT05461794|469994864|FG002|Overall Study|Study Terminated By Sponsor|16|||
130701846|NCT00683592|470532664|FG001|Overall Study|Adverse Event|4|||
130701847|NCT00683592|470532663|FG000|Overall Study|Withdrawal by Subject|11|||
130701848|NCT00683592|470532664|FG001|Overall Study|Withdrawal by Subject|11|||
130701849|NCT00683592|470532663|FG000|Overall Study|Lost to Follow-up|17|||
130701850|NCT00683592|470532664|FG001|Overall Study|Lost to Follow-up|17|||
130701851|NCT00683592|470532663|FG000|Overall Study|Lack of Efficacy|3|||
130701852|NCT00683592|470532664|FG001|Overall Study|Lack of Efficacy|7|||
130701853|NCT00683592|470532663|FG000|Overall Study|Physician Decision|0|||
130701854|NCT00683592|470532664|FG001|Overall Study|Physician Decision|1|||
130701855|NCT00683592|470532663|FG000|Overall Study|Non-compliance|3|||
130701856|NCT00683592|470532664|FG001|Overall Study|Non-compliance|5|||
130701857|NCT00683592|470532663|FG000|Overall Study|Other|1|||
130701858|NCT00683592|470532664|FG001|Overall Study|Other|1|||
130701859|NCT00329160|470532674|FG000|Overall Study|Adverse Event|27|||
130701860|NCT00329160|470532674|FG000|Overall Study|Withdrawal by Subject|13|||
130701861|NCT00329160|470532674|FG000|Overall Study|Protocol Violation|2|||
130701862|NCT00329160|470532674|FG000|Overall Study|Did not Receive Study Drug|1|||
130701863|NCT00329160|470532674|FG000|Overall Study|Incomplete IVUS|45|||
130701864|NCT04501094|470532675|FG000|Overall Study|Death (unrelated to research)|1|||
130701865|NCT04501094|470532676|FG001|Overall Study|Death (unrelated to research)|0|||
130701866|NCT00685035|470532678|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
130701867|NCT00685035|470532679|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
130701868|NCT00063258|470532680|FG000|Overall Study|Physician Decision|2|||
130701869|NCT00063258|470532681|FG001|Overall Study|Physician Decision|0|||
130701870|NCT00063258|470532680|FG000|Overall Study|Lack of Efficacy|2|||
130701871|NCT00063258|470532681|FG001|Overall Study|Lack of Efficacy|0|||
130701872|NCT00784979|470532684|FG000|Overall Study|incomplete data|6|||
130701873|NCT04241133|470532686|FG000|Overall Study|COVID19 Precautions|14|||
130701874|NCT04241133|470532687|FG001|Overall Study|COVID19 Precautions|34|||
130701875|NCT01235715|470532691|FG000|Overall Study|Physician Decision|0|||
130701876|NCT01235715|470532692|FG001|Overall Study|Physician Decision|2|||
130701877|NCT02994394|470532693|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701878|NCT02994394|470532694|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701879|NCT02994394|470532695|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
130701880|NCT02994394|470532696|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701881|NCT02994394|470532697|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701882|NCT02994394|470532698|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701883|NCT02994394|470532693|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701884|NCT02994394|470532694|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
130701885|NCT02994394|470532695|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701886|NCT02994394|470532696|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701887|NCT02994394|470532697|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
130701888|NCT02994394|470532698|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701889|NCT04982445|470532699|FG000|Overall Study|Protocol Violation|1|||
130701890|NCT04982445|470532699|FG000|Overall Study|Withdrawal by Subject|4|||
130701891|NCT04982445|470532699|FG000|Overall Study|Lost to Follow-up|1|||
130701892|NCT00396630|470532700|FG000|Overall Study|Lost to Follow-up|1|||
130701893|NCT00396630|470532701|FG001|Overall Study|Lost to Follow-up|1|||
130701894|NCT00396630|470532700|FG000|Overall Study|Withdrawal by Subject|1|||
130701895|NCT00396630|470532701|FG001|Overall Study|Withdrawal by Subject|1|||
130701896|NCT00396630|470532700|FG000|Overall Study|Not vaccinated at Visit 3|3|||
130701897|NCT00396630|470532701|FG001|Overall Study|Not vaccinated at Visit 3|3|||
130701898|NCT02327325|470532702|FG000|Overall Study|Withdrawal by Subject|1|||
130701899|NCT02327325|470532703|FG001|Overall Study|Withdrawal by Subject|4|||
130701900|NCT02327325|470532704|FG002|Overall Study|Withdrawal by Subject|4|||
130701901|NCT02327325|470532702|FG000|Overall Study|Excluded by Study Team|0|||
130701902|NCT02327325|470532703|FG001|Overall Study|Excluded by Study Team|0|||
130701903|NCT02327325|470532704|FG002|Overall Study|Excluded by Study Team|1|||
130701904|NCT01755975|470532707|FG000|Overall Study|Adverse Event|0|||
130701905|NCT01755975|470532708|FG001|Overall Study|Adverse Event|0|||
130701906|NCT01755975|470532709|FG002|Overall Study|Adverse Event|1|||
130701907|NCT01755975|470532710|FG003|Overall Study|Adverse Event|0|||
130701908|NCT01755975|470532711|FG004|Overall Study|Adverse Event|2|||
130701909|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
130257404|NCT02303821|468906660|FG007|Overall Study|Death|29|||
130257405|NCT02303821|468906653|FG000|Overall Study|Lost to Follow-up|0|||
130257406|NCT02303821|468906654|FG001|Overall Study|Lost to Follow-up|0|||
130257407|NCT02303821|468906655|FG002|Overall Study|Lost to Follow-up|0|||
130257408|NCT02303821|468906656|FG003|Overall Study|Lost to Follow-up|0|||
130257409|NCT02303821|468906657|FG004|Overall Study|Lost to Follow-up|0|||
130257410|NCT02303821|468906658|FG005|Overall Study|Lost to Follow-up|0|||
130257411|NCT02303821|468906659|FG006|Overall Study|Lost to Follow-up|1|||
130257412|NCT02303821|468906660|FG007|Overall Study|Lost to Follow-up|0|||
130257413|NCT02303821|468906653|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130553814|NCT05461794|469994862|FG000|Overall Study|Death|20|||
130553815|NCT05461794|469994863|FG001|Overall Study|Death|5|||
130553816|NCT05461794|469994864|FG002|Overall Study|Death|19|||
130553817|NCT00467285|469994865|FG000|Overall Study|Lost to Follow-up|4|||
130257414|NCT02303821|468906654|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257415|NCT02303821|468906655|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257416|NCT02303821|468906656|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257417|NCT02303821|468906657|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257418|NCT02303821|468906658|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257419|NCT02303821|468906659|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
130257420|NCT02303821|468906660|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257421|NCT02303821|468906653|FG000|Overall Study|Decision by sponsor|0|||
130553818|NCT00467285|469994866|FG001|Overall Study|Lost to Follow-up|4|||
130553819|NCT01658826|469994878|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
130553820|NCT01658826|469994879|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
130553821|NCT01658826|469994878|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
130257422|NCT02303821|468906654|FG001|Overall Study|Decision by sponsor|0|||
130257423|NCT02303821|468906655|FG002|Overall Study|Decision by sponsor|0|||
130257424|NCT02303821|468906656|FG003|Overall Study|Decision by sponsor|0|||
130257425|NCT02303821|468906657|FG004|Overall Study|Decision by sponsor|0|||
130257426|NCT02303821|468906658|FG005|Overall Study|Decision by sponsor|1|||
130257427|NCT02303821|468906659|FG006|Overall Study|Decision by sponsor|0|||
130257428|NCT02303821|468906660|FG007|Overall Study|Decision by sponsor|0|||
130257429|NCT02303821|468906653|FG000|Overall Study|Protocol-specified criteria|0|||
130257430|NCT02303821|468906654|FG001|Overall Study|Protocol-specified criteria|1|||
130257431|NCT02303821|468906655|FG002|Overall Study|Protocol-specified criteria|0|||
130257432|NCT02303821|468906656|FG003|Overall Study|Protocol-specified criteria|0|||
130257433|NCT02303821|468906657|FG004|Overall Study|Protocol-specified criteria|0|||
130257434|NCT02303821|468906658|FG005|Overall Study|Protocol-specified criteria|1|||
130257435|NCT02303821|468906659|FG006|Overall Study|Protocol-specified criteria|0|||
130257436|NCT02303821|468906660|FG007|Overall Study|Protocol-specified criteria|0|||
130701910|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
130701911|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
130701912|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
130701913|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
130701914|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
130257437|NCT04938427|468906663|FG000|Overall Study|Adverse Event|5|||
130257438|NCT04938427|468906664|FG001|Overall Study|Adverse Event|19|||
130257439|NCT04938427|468906663|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130257440|NCT04938427|468906664|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130257441|NCT04938427|468906663|FG000|Overall Study|Withdrawal by Subject|1|||
130257442|NCT04938427|468906664|FG001|Overall Study|Withdrawal by Subject|0|||
130257443|NCT04938427|468906663|FG000|Overall Study|Reason Not Specified|2|||
130257444|NCT04938427|468906664|FG001|Overall Study|Reason Not Specified|1|||
130257445|NCT05852340|468906673|FG000|Period 5|Not completing the meal|0|||
130257446|NCT05852340|468906674|FG001|Period 5|Not completing the meal|1|||
130701915|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130701916|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130701917|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Other|0|||
130701918|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Other|3|||
130701919|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Other|0|||
130701920|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Other|0|||
130257447|NCT05852340|468906675|FG002|Period 5|Not completing the meal|0|||
130257448|NCT05852340|468906676|FG003|Period 5|Not completing the meal|0|||
130701921|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Adverse Event|0|||
130257449|NCT05852340|468906673|FG000|Period 5|Adverse Event|0|||
130553822|NCT01658826|469994879|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
130553823|NCT01658826|469994878|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
130701922|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Adverse Event|0|||
130257450|NCT05852340|468906674|FG001|Period 5|Adverse Event|0|||
130257451|NCT05852340|468906675|FG002|Period 5|Adverse Event|0|||
130257452|NCT05852340|468906676|FG003|Period 5|Adverse Event|1|||
130257453|NCT05852470|468906677|FG000|Overall Study|Withdrawal by Subject|0|||
130257454|NCT05852470|468906678|FG001|Overall Study|Withdrawal by Subject|1|||
130257455|NCT01346592|468906684|FG000|Overall Study|Lost to Follow-up|62|||
130257456|NCT01346592|468906685|FG001|Overall Study|Lost to Follow-up|29|||
130257457|NCT01346592|468906686|FG002|Overall Study|Lost to Follow-up|29|||
130257458|NCT01346592|468906684|FG000|Overall Study|Protocol Violation|2|||
130257459|NCT01346592|468906685|FG001|Overall Study|Protocol Violation|1|||
130701923|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Adverse Event|1|||
130701924|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Adverse Event|1|||
130701925|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130701926|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130701927|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
130701928|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
130701929|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Other|0|||
130701930|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Other|0|||
130701931|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Other|1|||
130701932|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Other|2|||
130701933|NCT02457819|470532718|FG000|Overall Study|reason not given|8|||
130701934|NCT02457819|470532718|FG000|Overall Study|Withdrawal by Subject|24|||
130701935|NCT02457819|470532718|FG000|Overall Study|Protocol Violation|1|||
130701936|NCT02457819|470532718|FG000|Overall Study|non compliance with study drug|4|||
130701937|NCT02457819|470532718|FG000|Overall Study|Lost to Follow-up|10|||
130701938|NCT02457819|470532718|FG000|Overall Study|Lack of Efficacy|19|||
130701939|NCT02457819|470532718|FG000|Overall Study|Adverse Event|33|||
130701940|NCT01729026|470532720|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130701941|NCT01729026|470532721|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130701942|NCT01729026|470532720|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
130701943|NCT01729026|470532721|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
130701944|NCT03710590|470532722|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
130701945|NCT03710590|470532723|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
130701946|NCT00852917|470532724|FG000|Overall Study|Adverse Event|13|||
130701947|NCT00852917|470532725|FG001|Overall Study|Adverse Event|20|||
130701948|NCT00852917|470532726|FG002|Overall Study|Adverse Event|35|||
130701949|NCT00852917|470532727|FG003|Overall Study|Adverse Event|17|||
130701950|NCT00852917|470532724|FG000|Overall Study|Lack of Efficacy|21|||
130701951|NCT00852917|470532725|FG001|Overall Study|Lack of Efficacy|11|||
130701952|NCT00852917|470532726|FG002|Overall Study|Lack of Efficacy|11|||
130701953|NCT00852917|470532727|FG003|Overall Study|Lack of Efficacy|47|||
130701954|NCT00852917|470532724|FG000|Overall Study|Withdrawal by Subject|4|||
130701955|NCT00852917|470532725|FG001|Overall Study|Withdrawal by Subject|8|||
130701956|NCT00852917|470532726|FG002|Overall Study|Withdrawal by Subject|10|||
130701957|NCT00852917|470532727|FG003|Overall Study|Withdrawal by Subject|9|||
130701958|NCT00852917|470532724|FG000|Overall Study|Physician Decision|6|||
130701959|NCT00852917|470532725|FG001|Overall Study|Physician Decision|7|||
130701960|NCT00852917|470532726|FG002|Overall Study|Physician Decision|2|||
130701961|NCT00852917|470532727|FG003|Overall Study|Physician Decision|19|||
130701962|NCT00852917|470532724|FG000|Overall Study|Death|0|||
130701963|NCT00852917|470532725|FG001|Overall Study|Death|0|||
130701964|NCT00852917|470532726|FG002|Overall Study|Death|0|||
130701965|NCT00852917|470532727|FG003|Overall Study|Death|1|||
130701966|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
130701967|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
130701968|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
130701969|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
130701970|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
130701971|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
130701972|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
130701973|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
130701974|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
130701975|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
130701976|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130701977|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130701978|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
130701979|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
130257460|NCT01346592|468906686|FG002|Overall Study|Protocol Violation|0|||
130257461|NCT01346592|468906684|FG000|Overall Study|Death|1|||
130701980|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
130701981|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
130701982|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
130701983|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
130701984|NCT04886063|470532733|FG000|Overall Study|Adverse Event|50|||
130701985|NCT04886063|470532733|FG000|Overall Study|Lack of Efficacy|31|||
130701986|NCT04886063|470532733|FG000|Overall Study|Withdrawal by Subject|45|||
130701987|NCT04886063|470532733|FG000|Overall Study|Physician Decision|3|||
130701988|NCT04886063|470532733|FG000|Overall Study|Protocol Violation|3|||
130257462|NCT01346592|468906685|FG001|Overall Study|Death|3|||
130257463|NCT01346592|468906686|FG002|Overall Study|Death|4|||
130257464|NCT01346592|468906684|FG000|Overall Study|Adverse Event|0|||
130257465|NCT01346592|468906685|FG001|Overall Study|Adverse Event|1|||
130257466|NCT01346592|468906686|FG002|Overall Study|Adverse Event|0|||
130257467|NCT01346592|468906684|FG000|Overall Study|Withdrawal by Subject|77|||
130257468|NCT01346592|468906685|FG001|Overall Study|Withdrawal by Subject|51|||
130257469|NCT01346592|468906686|FG002|Overall Study|Withdrawal by Subject|38|||
130257470|NCT01346592|468906684|FG000|Overall Study|Inappropriate enrollment|3|||
130257471|NCT01346592|468906685|FG001|Overall Study|Inappropriate enrollment|1|||
130257472|NCT01346592|468906686|FG002|Overall Study|Inappropriate enrollment|1|||
130257473|NCT01346592|468906684|FG000|Overall Study|Administrative reason|1|||
130257474|NCT01346592|468906685|FG001|Overall Study|Administrative reason|0|||
130257475|NCT01346592|468906686|FG002|Overall Study|Administrative reason|0|||
130257476|NCT01346592|468906684|FG000|Overall Study|Unable to Classify|7|||
130257477|NCT01346592|468906685|FG001|Overall Study|Unable to Classify|3|||
130257478|NCT01346592|468906686|FG002|Overall Study|Unable to Classify|6|||
130257479|NCT02679274|468906687|FG000|Overall Study|Withdrawal by Subject|1|||
130257480|NCT02679274|468906688|FG001|Overall Study|Withdrawal by Subject|0|||
130257481|NCT02038036|468906691|FG000|Core Study|Adverse Event|7|||
130365229|NCT00347360|469306876|FG012|Overall Study|Per sponsors instruction|0|||
130365230|NCT00347360|469306877|FG013|Overall Study|Per sponsors instruction|0|||
130365231|NCT00347360|469306878|FG014|Overall Study|Per sponsors instruction|0|||
130365232|NCT00347360|469306864|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
130365233|NCT00347360|469306865|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
130365234|NCT00347360|469306866|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
130365235|NCT00347360|469306867|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
130365236|NCT00347360|469306868|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
130365237|NCT00347360|469306869|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
130365238|NCT00347360|469306870|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
130365239|NCT00347360|469306871|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
130365240|NCT00347360|469306872|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
130365241|NCT00347360|469306873|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
130365242|NCT00347360|469306874|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
130365243|NCT00347360|469306875|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
130365244|NCT00347360|469306876|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
130365245|NCT00347360|469306877|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
130365246|NCT00347360|469306878|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
130365247|NCT00347360|469306864|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
130365248|NCT00347360|469306865|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
130365249|NCT00347360|469306866|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
130257482|NCT02038036|468906692|FG001|Core Study|Adverse Event|7|||
130257483|NCT02038036|468906691|FG000|Core Study|Death|1|||
130257484|NCT02038036|468906692|FG001|Core Study|Death|1|||
130257485|NCT02038036|468906691|FG000|Core Study|Disease progression|2|||
130257486|NCT02038036|468906692|FG001|Core Study|Disease progression|2|||
130257487|NCT02038036|468906691|FG000|Core Study|Lost to Follow-up|0|||
130257488|NCT02038036|468906692|FG001|Core Study|Lost to Follow-up|1|||
130257489|NCT02038036|468906691|FG000|Core Study|Physician Decision|2|||
130257490|NCT02038036|468906692|FG001|Core Study|Physician Decision|1|||
130257491|NCT02038036|468906691|FG000|Core Study|Subject/guardian decision|0|||
130257492|NCT02038036|468906692|FG001|Core Study|Subject/guardian decision|1|||
130257493|NCT02038036|468906691|FG000|Core Study|Withdrawal by Subject|3|||
130257494|NCT02038036|468906692|FG001|Core Study|Withdrawal by Subject|1|||
130257495|NCT02038036|468906691|FG000|Crossover Period|Withdrawal by Subject|0|||
130257496|NCT02038036|468906692|FG001|Crossover Period|Withdrawal by Subject|3|||
130257497|NCT02038036|468906691|FG000|Crossover Period|Adverse Event|0|||
130257498|NCT02038036|468906692|FG001|Crossover Period|Adverse Event|9|||
130257499|NCT02038036|468906691|FG000|Crossover Period|Death|0|||
130257500|NCT02038036|468906692|FG001|Crossover Period|Death|2|||
130257501|NCT02038036|468906691|FG000|Crossover Period|Disease progression|0|||
130257502|NCT02038036|468906692|FG001|Crossover Period|Disease progression|3|||
130257503|NCT02038036|468906691|FG000|Crossover Period|Lost to Follow-up|0|||
130257504|NCT02038036|468906692|FG001|Crossover Period|Lost to Follow-up|1|||
130257505|NCT02038036|468906691|FG000|Crossover Period|Physician Decision|0|||
130257506|NCT02038036|468906692|FG001|Crossover Period|Physician Decision|2|||
130257507|NCT01972659|468906700|FG000|Overall Study|Protocol Violation|2|||
130257508|NCT01972659|468906701|FG001|Overall Study|Protocol Violation|2|||
130257509|NCT01972659|468906700|FG000|Overall Study|problems realted to acceleromyograph|2|||
130257510|NCT01972659|468906701|FG001|Overall Study|problems realted to acceleromyograph|1|||
130257511|NCT01397253|468908504|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
130257512|NCT01397253|468908505|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
130257513|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130257514|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130257515|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130257516|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
130257517|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130257518|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130257519|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
130257520|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
130257521|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
130257522|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257523|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257524|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
130257525|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257526|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257527|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257528|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257529|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257530|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257531|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257532|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257533|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257534|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257535|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257536|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
130257537|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257538|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257539|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257540|NCT03322566|468908522|FG000|Overall Study|Death|34|||
130257541|NCT03322566|468908523|FG001|Overall Study|Death|35|||
130365250|NCT00347360|469306867|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
130365251|NCT00347360|469306868|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
130365252|NCT00347360|469306869|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
130365253|NCT00347360|469306870|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
130365254|NCT00347360|469306871|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
130365255|NCT00347360|469306872|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
130701989|NCT04886063|470532733|FG000|Overall Study|Site closure|4|||
130701990|NCT04886063|470532733|FG000|Overall Study|Nursing home replacement|3|||
130701991|NCT04886063|470532733|FG000|Overall Study|Lost to Follow-up|5|||
130701992|NCT04886063|470532733|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
130701993|NCT04886063|470532733|FG000|Overall Study|>1 reason|20|||
130701994|NCT02005276|470532734|FG000|Overall Study|No longer interested|5|||
130701995|NCT02005276|470532735|FG001|Overall Study|No longer interested|2|||
130701996|NCT02005276|470532736|FG002|Overall Study|No longer interested|3|||
130701997|NCT02005276|470532737|FG003|Overall Study|No longer interested|3|||
130701998|NCT01849458|470532742|FG000|Overall Study|Lost to Follow-up|4|||
130701999|NCT01115933|470532749|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
130702000|NCT01294449|470532750|FG000|Overall Study|Death|11|||
130702001|NCT01294449|470532751|FG001|Overall Study|Death|12|||
130702002|NCT01294449|470532750|FG000|Overall Study|Withdrawal by Subject|1|||
130702003|NCT01294449|470532751|FG001|Overall Study|Withdrawal by Subject|3|||
130702004|NCT00603512|470532752|FG000|Overall Study|Adverse Event|0|||
130702005|NCT00603512|470532753|FG001|Overall Study|Adverse Event|2|||
130702006|NCT00603512|470532754|FG002|Overall Study|Adverse Event|4|||
130702007|NCT00603512|470532755|FG003|Overall Study|Adverse Event|4|||
130702008|NCT00603512|470532756|FG004|Overall Study|Adverse Event|2|||
130702009|NCT00603512|470532752|FG000|Overall Study|Lack of Efficacy|0|||
130702010|NCT00603512|470532753|FG001|Overall Study|Lack of Efficacy|1|||
130702011|NCT00603512|470532754|FG002|Overall Study|Lack of Efficacy|0|||
130702012|NCT00603512|470532755|FG003|Overall Study|Lack of Efficacy|0|||
130702013|NCT00603512|470532756|FG004|Overall Study|Lack of Efficacy|1|||
130702014|NCT00603512|470532752|FG000|Overall Study|Other|2|||
130702015|NCT00603512|470532753|FG001|Overall Study|Other|1|||
130702016|NCT00603512|470532754|FG002|Overall Study|Other|0|||
130702017|NCT00603512|470532755|FG003|Overall Study|Other|1|||
130702018|NCT00603512|470532756|FG004|Overall Study|Other|1|||
130702019|NCT00603512|470532752|FG000|Overall Study|Withdrawal by Subject|0|||
130702020|NCT00603512|470532753|FG001|Overall Study|Withdrawal by Subject|0|||
130702021|NCT00603512|470532754|FG002|Overall Study|Withdrawal by Subject|0|||
130702022|NCT00603512|470532755|FG003|Overall Study|Withdrawal by Subject|0|||
130702023|NCT00603512|470532756|FG004|Overall Study|Withdrawal by Subject|1|||
130702024|NCT00603512|470532752|FG000|Overall Study|Randomized but not treated|0|||
130702025|NCT00603512|470532753|FG001|Overall Study|Randomized but not treated|1|||
130702026|NCT00603512|470532754|FG002|Overall Study|Randomized but not treated|1|||
130702027|NCT00603512|470532755|FG003|Overall Study|Randomized but not treated|2|||
130702028|NCT00603512|470532756|FG004|Overall Study|Randomized but not treated|0|||
130702029|NCT01896505|470532757|FG000|Overall Study|Adverse Event|1|||
130702030|NCT01896505|470532758|FG001|Overall Study|Adverse Event|0|||
130702031|NCT01896505|470532759|FG002|Overall Study|Adverse Event|2|||
130702032|NCT01896505|470532760|FG003|Overall Study|Adverse Event|1|||
130702033|NCT01896505|470532761|FG004|Overall Study|Adverse Event|1|||
130702034|NCT01896505|470532762|FG005|Overall Study|Adverse Event|0|||
130702035|NCT01896505|470532757|FG000|Overall Study|Physician Decision|1|||
130702036|NCT01896505|470532758|FG001|Overall Study|Physician Decision|3|||
130702037|NCT01896505|470532759|FG002|Overall Study|Physician Decision|2|||
130702038|NCT01896505|470532760|FG003|Overall Study|Physician Decision|0|||
130702039|NCT01896505|470532761|FG004|Overall Study|Physician Decision|0|||
130702040|NCT01896505|470532762|FG005|Overall Study|Physician Decision|1|||
130702041|NCT01896505|470532757|FG000|Overall Study|Withdrawal by Subject|1|||
130702042|NCT01896505|470532758|FG001|Overall Study|Withdrawal by Subject|0|||
130702043|NCT01896505|470532759|FG002|Overall Study|Withdrawal by Subject|3|||
130702044|NCT01896505|470532760|FG003|Overall Study|Withdrawal by Subject|1|||
130702045|NCT01896505|470532761|FG004|Overall Study|Withdrawal by Subject|0|||
130702046|NCT01896505|470532762|FG005|Overall Study|Withdrawal by Subject|0|||
130702047|NCT01896505|470532757|FG000|Overall Study|Disease Progression|7|||
130702048|NCT01896505|470532758|FG001|Overall Study|Disease Progression|5|||
130702049|NCT01896505|470532759|FG002|Overall Study|Disease Progression|8|||
130702050|NCT01896505|470532760|FG003|Overall Study|Disease Progression|4|||
130702051|NCT01896505|470532761|FG004|Overall Study|Disease Progression|4|||
130702052|NCT01896505|470532762|FG005|Overall Study|Disease Progression|4|||
130702053|NCT01896505|470532757|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
130702054|NCT01896505|470532758|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
130702055|NCT01896505|470532759|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
130702056|NCT01896505|470532760|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
130702057|NCT01896505|470532761|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
130257542|NCT03322566|468908524|FG002|Overall Study|Death|23|||
130257543|NCT03322566|468908522|FG000|Overall Study|Physician Decision|6|||
130257544|NCT03322566|468908523|FG001|Overall Study|Physician Decision|7|||
130257545|NCT03322566|468908524|FG002|Overall Study|Physician Decision|2|||
130257546|NCT03322566|468908522|FG000|Overall Study|Withdrawal by Subject|4|||
130257547|NCT03322566|468908523|FG001|Overall Study|Withdrawal by Subject|3|||
130702058|NCT01896505|470532762|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
130702059|NCT01896505|470532757|FG000|Overall Study|Intercurrent illness|0|||
130702060|NCT01896505|470532758|FG001|Overall Study|Intercurrent illness|1|||
130702061|NCT01896505|470532759|FG002|Overall Study|Intercurrent illness|0|||
130702062|NCT01896505|470532760|FG003|Overall Study|Intercurrent illness|0|||
130702063|NCT01896505|470532761|FG004|Overall Study|Intercurrent illness|0|||
130702064|NCT01896505|470532762|FG005|Overall Study|Intercurrent illness|0|||
130702065|NCT01896505|470532757|FG000|Overall Study|Death|0|||
130702066|NCT01896505|470532758|FG001|Overall Study|Death|0|||
130702067|NCT01896505|470532759|FG002|Overall Study|Death|1|||
130702068|NCT01896505|470532760|FG003|Overall Study|Death|1|||
130702069|NCT01896505|470532761|FG004|Overall Study|Death|0|||
130702070|NCT01896505|470532762|FG005|Overall Study|Death|1|||
130702071|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702072|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
130702073|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702074|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702075|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702076|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
130702077|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
130702078|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
130702079|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
130702080|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
130702081|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
130702082|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702083|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702084|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702085|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702086|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702087|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
130702088|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
130702089|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702090|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702091|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702092|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702093|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
130702094|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702095|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702096|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
130702097|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
130702098|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
130702099|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130702100|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130702101|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
130702102|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702103|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130257548|NCT03322566|468908524|FG002|Overall Study|Withdrawal by Subject|6|||
130257549|NCT03322566|468908522|FG000|Overall Study|Lost to Follow-up|0|||
130257550|NCT03322566|468908523|FG001|Overall Study|Lost to Follow-up|0|||
130257551|NCT03322566|468908524|FG002|Overall Study|Lost to Follow-up|1|||
130257552|NCT03322566|468908522|FG000|Overall Study|Study terminated by sponsor|1|||
130702104|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702105|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702106|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130702107|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
130702108|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130702109|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
130702110|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
130257553|NCT03322566|468908523|FG001|Overall Study|Study terminated by sponsor|0|||
130702111|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
130702112|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130702113|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130702114|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
130702115|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
130257554|NCT03322566|468908524|FG002|Overall Study|Study terminated by sponsor|1|||
130257555|NCT03847519|468908525|FG000|Overall Study|Death|5|||
130257556|NCT03847519|468908526|FG001|Overall Study|Death|8|||
130257557|NCT03847519|468908527|FG002|Overall Study|Death|1|||
130257558|NCT03847519|468908525|FG000|Overall Study|Lost to Follow-up|1|||
130257559|NCT03847519|468908526|FG001|Overall Study|Lost to Follow-up|2|||
130257560|NCT03847519|468908527|FG002|Overall Study|Lost to Follow-up|0|||
130257561|NCT03847519|468908525|FG000|Overall Study|Study Terminated by Sponsor|0|||
130257562|NCT03847519|468908526|FG001|Overall Study|Study Terminated by Sponsor|3|||
130257563|NCT03847519|468908527|FG002|Overall Study|Study Terminated by Sponsor|2|||
130257564|NCT02314923|468908530|FG000|Overall Study|Death|0|||
130257565|NCT02314923|468908531|FG001|Overall Study|Death|0|||
130257566|NCT02314923|468908532|FG002|Overall Study|Death|0|||
130702116|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
130702117|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130702118|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130702119|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130702120|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130702121|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702122|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130702123|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702124|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130702125|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702126|NCT04974580|470532768|FG000|Overall Study|Lost to Follow-up|33|||
130702127|NCT04974580|470532769|FG001|Overall Study|Lost to Follow-up|39|||
130702128|NCT04974580|470532770|FG002|Overall Study|Lost to Follow-up|30|||
130702129|NCT04974580|470532771|FG003|Overall Study|Lost to Follow-up|29|||
130702130|NCT00250705|470532774|FG000|Overall Study|Lack of Efficacy|2|||
130702131|NCT02416934|470532799|FG000|Overall Study|given steroids|1|||
130702132|NCT02416934|470532800|FG001|Overall Study|given steroids|2|||
130257567|NCT02314923|468908533|FG003|Overall Study|Death|1|||
130257568|NCT02314923|468908534|FG004|Overall Study|Death|0|||
130257569|NCT02314923|468908535|FG005|Overall Study|Death|0|||
130257570|NCT02314923|468908536|FG006|Overall Study|Death|0|||
130257571|NCT02314923|468908537|FG007|Overall Study|Death|0|||
130257572|NCT02314923|468908538|FG008|Overall Study|Death|0|||
130257573|NCT02314923|468908539|FG009|Overall Study|Death|0|||
130257574|NCT02314923|468908530|FG000|Overall Study|Lost to Follow-up|2|||
130257575|NCT02314923|468908531|FG001|Overall Study|Lost to Follow-up|3|||
130257576|NCT02314923|468908532|FG002|Overall Study|Lost to Follow-up|1|||
130257577|NCT02314923|468908533|FG003|Overall Study|Lost to Follow-up|0|||
130257578|NCT02314923|468908534|FG004|Overall Study|Lost to Follow-up|0|||
130257579|NCT02314923|468908535|FG005|Overall Study|Lost to Follow-up|0|||
130257580|NCT02314923|468908536|FG006|Overall Study|Lost to Follow-up|3|||
130257581|NCT02314923|468908537|FG007|Overall Study|Lost to Follow-up|4|||
130257582|NCT02314923|468908538|FG008|Overall Study|Lost to Follow-up|2|||
130257583|NCT02314923|468908539|FG009|Overall Study|Lost to Follow-up|0|||
130257584|NCT02314923|468908530|FG000|Overall Study|Withdrawal by Subject|0|||
130257585|NCT02314923|468908531|FG001|Overall Study|Withdrawal by Subject|0|||
130257586|NCT02314923|468908532|FG002|Overall Study|Withdrawal by Subject|1|||
130257587|NCT02314923|468908533|FG003|Overall Study|Withdrawal by Subject|0|||
130257588|NCT02314923|468908534|FG004|Overall Study|Withdrawal by Subject|1|||
130257589|NCT02314923|468908535|FG005|Overall Study|Withdrawal by Subject|0|||
130257590|NCT02314923|468908536|FG006|Overall Study|Withdrawal by Subject|1|||
130257591|NCT02314923|468908537|FG007|Overall Study|Withdrawal by Subject|0|||
130257592|NCT02314923|468908538|FG008|Overall Study|Withdrawal by Subject|0|||
130257593|NCT02314923|468908539|FG009|Overall Study|Withdrawal by Subject|0|||
130257594|NCT02314923|468908530|FG000|Overall Study|Physician Decision|0|||
130257595|NCT02314923|468908531|FG001|Overall Study|Physician Decision|1|||
130257596|NCT02314923|468908532|FG002|Overall Study|Physician Decision|0|||
130257597|NCT02314923|468908533|FG003|Overall Study|Physician Decision|0|||
130257598|NCT02314923|468908534|FG004|Overall Study|Physician Decision|0|||
130257599|NCT02314923|468908535|FG005|Overall Study|Physician Decision|0|||
130257600|NCT02314923|468908536|FG006|Overall Study|Physician Decision|0|||
130257601|NCT02314923|468908537|FG007|Overall Study|Physician Decision|0|||
130257602|NCT02314923|468908538|FG008|Overall Study|Physician Decision|0|||
130257603|NCT02314923|468908539|FG009|Overall Study|Physician Decision|0|||
130257604|NCT02314923|468908530|FG000|Overall Study|Participant unavailable|0|||
130257605|NCT02314923|468908531|FG001|Overall Study|Participant unavailable|0|||
130257606|NCT02314923|468908532|FG002|Overall Study|Participant unavailable|0|||
130257607|NCT02314923|468908533|FG003|Overall Study|Participant unavailable|0|||
130257608|NCT02314923|468908534|FG004|Overall Study|Participant unavailable|0|||
130257609|NCT02314923|468908535|FG005|Overall Study|Participant unavailable|1|||
130257610|NCT02314923|468908536|FG006|Overall Study|Participant unavailable|0|||
130257611|NCT02314923|468908537|FG007|Overall Study|Participant unavailable|0|||
130257612|NCT02314923|468908538|FG008|Overall Study|Participant unavailable|0|||
130257613|NCT02314923|468908539|FG009|Overall Study|Participant unavailable|0|||
130257614|NCT02314923|468908530|FG000|Overall Study|Screen failure|0|||
130257615|NCT02314923|468908531|FG001|Overall Study|Screen failure|0|||
130257616|NCT02314923|468908532|FG002|Overall Study|Screen failure|0|||
130257617|NCT02314923|468908533|FG003|Overall Study|Screen failure|0|||
130257618|NCT02314923|468908534|FG004|Overall Study|Screen failure|0|||
130257619|NCT02314923|468908535|FG005|Overall Study|Screen failure|0|||
130257620|NCT02314923|468908536|FG006|Overall Study|Screen failure|1|||
130257621|NCT02314923|468908537|FG007|Overall Study|Screen failure|0|||
130257622|NCT02314923|468908538|FG008|Overall Study|Screen failure|0|||
130257623|NCT02314923|468908539|FG009|Overall Study|Screen failure|0|||
130257624|NCT02314923|468908530|FG000|Overall Study|Participant relocation|1|||
130257625|NCT02314923|468908531|FG001|Overall Study|Participant relocation|0|||
130257626|NCT02314923|468908532|FG002|Overall Study|Participant relocation|0|||
130257627|NCT02314923|468908533|FG003|Overall Study|Participant relocation|0|||
130257628|NCT02314923|468908534|FG004|Overall Study|Participant relocation|0|||
130257629|NCT02314923|468908535|FG005|Overall Study|Participant relocation|0|||
130257630|NCT02314923|468908536|FG006|Overall Study|Participant relocation|0|||
130257631|NCT02314923|468908537|FG007|Overall Study|Participant relocation|1|||
130257632|NCT02314923|468908538|FG008|Overall Study|Participant relocation|0|||
130257633|NCT02314923|468908539|FG009|Overall Study|Participant relocation|0|||
130257634|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Adverse Event|20|||
130257635|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Adverse Event|10|||
130257636|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Adverse Event|5|||
130257637|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Adverse Event|0|||
130257638|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Adverse Event|0|||
130257639|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Adverse Event|0|||
130257640|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Adverse Event|0|||
130257641|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Adverse Event|0|||
130257642|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Adverse Event|0|||
130257643|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Adverse Event|0|||
130257644|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Adverse Event|0|||
130257645|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Adverse Event|0|||
130257646|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257647|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257648|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
130257649|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257650|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257651|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257652|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257653|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257654|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257655|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257656|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257657|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257658|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
130257659|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
130257660|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
130257661|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
130257662|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
130257663|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
130257664|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
130257665|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
130257666|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
130257667|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
130257668|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
130257669|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
130257670|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
130257671|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
130257672|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
130257673|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
130257674|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
130257675|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
130257676|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
130257677|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
130257678|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
130257679|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
130257680|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
130257681|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
130257682|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Other|50|||
130257683|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Other|38|||
130257684|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Other|24|||
130257685|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Other|0|||
130257686|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Other|0|||
130257687|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Other|0|||
130702133|NCT02416934|470532799|FG000|Overall Study|Lost to Follow-up|0|||
130702134|NCT02416934|470532800|FG001|Overall Study|Lost to Follow-up|2|||
130702135|NCT02416934|470532799|FG000|Overall Study|Withdrawal by Subject|1|||
130702136|NCT02416934|470532800|FG001|Overall Study|Withdrawal by Subject|0|||
130702137|NCT02416934|470532799|FG000|Overall Study|recruited during continuing renewal proc|0|||
130702138|NCT02416934|470532800|FG001|Overall Study|recruited during continuing renewal proc|1|||
130702139|NCT02416934|470532799|FG000|Overall Study|Protocol Violation|0|||
130702140|NCT02416934|470532800|FG001|Overall Study|Protocol Violation|1|||
130702141|NCT02416934|470532799|FG000|Overall Study|surgery started late|0|||
130702142|NCT02416934|470532800|FG001|Overall Study|surgery started late|1|||
130702143|NCT02416934|470532799|FG000|Overall Study|re-operation|1|||
130702144|NCT02416934|470532800|FG001|Overall Study|re-operation|0|||
130702145|NCT01020526|470532801|FG000|Overall Study|Withdrawal by Subject|5|||
130702146|NCT01020526|470532801|FG000|Overall Study|Other reasons|3|||
130702147|NCT01020526|470532801|FG000|Overall Study|Insufficient clinical response|3|||
130702148|NCT01020526|470532801|FG000|Overall Study|Lost to Follow-up|1|||
130702149|NCT01020526|470532801|FG000|Overall Study|Adverse Event|2|||
130702150|NCT00398073|470532802|FG000|Overall Study|Withdrawal by Subject|1|||
130702151|NCT00398073|470532803|FG001|Overall Study|Withdrawal by Subject|0|||
130702152|NCT02169336|470532808|FG000|Overall Study|Lack of Efficacy|1|||
130702153|NCT02169336|470532809|FG001|Overall Study|Lack of Efficacy|1|||
130702154|NCT02169336|470532810|FG002|Overall Study|Lack of Efficacy|0|||
130702155|NCT02169336|470532808|FG000|Overall Study|Adverse Event|2|||
130702156|NCT02169336|470532809|FG001|Overall Study|Adverse Event|3|||
130702157|NCT02169336|470532810|FG002|Overall Study|Adverse Event|1|||
130553824|NCT01658826|469994879|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
130553825|NCT01658826|469994878|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
130553826|NCT01658826|469994879|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
130553827|NCT01658826|469994878|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
130553828|NCT01658826|469994879|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
130702158|NCT02169336|470532808|FG000|Overall Study|Withdrawal by Subject|1|||
130257688|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Other|0|||
130257689|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Other|0|||
130257690|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Other|0|||
130257691|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Other|0|||
130257692|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Other|0|||
130257693|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Other|0|||
130257694|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257695|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257696|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257697|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130257698|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130257699|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
130257700|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257701|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257702|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257703|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257704|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257705|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257706|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Death|0|||
130257707|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Death|0|||
130257708|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Death|0|||
130257709|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Death|0|||
130553829|NCT01658826|469994878|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
130257710|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Death|1|||
130257711|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Death|0|||
130257712|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Death|0|||
130553830|NCT01658826|469994879|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
130559415|NCT01621542|470016493|FG003|Overall Study|Withdrawal by Subject|3|||
130702159|NCT02169336|470532809|FG001|Overall Study|Withdrawal by Subject|0|||
130257713|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Death|0|||
130257714|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Death|0|||
130257715|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Death|0|||
130702160|NCT02169336|470532810|FG002|Overall Study|Withdrawal by Subject|0|||
130702161|NCT02169336|470532808|FG000|Overall Study|Physician Decision|0|||
130702162|NCT02169336|470532809|FG001|Overall Study|Physician Decision|0|||
130257716|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Death|0|||
130257717|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Death|0|||
130257718|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130702163|NCT02169336|470532810|FG002|Overall Study|Physician Decision|1|||
130702164|NCT02169336|470532808|FG000|Overall Study|Subject declined to continue dosing|0|||
130702165|NCT02169336|470532809|FG001|Overall Study|Subject declined to continue dosing|0|||
130257719|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257720|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257721|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
130257722|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257723|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257724|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257725|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257726|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257727|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257728|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257729|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257730|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257731|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257732|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257733|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
130365256|NCT00347360|469306873|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
130257734|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257735|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
130257736|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257737|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257738|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257739|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257740|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257741|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257742|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Other|0|||
130257743|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Other|0|||
130257744|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Other|0|||
130257745|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Other|15|||
130257746|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Other|20|||
130257747|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Other|44|||
130257748|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Other|0|||
130257749|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Other|0|||
130257750|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Other|0|||
130257751|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Other|0|||
130257752|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Other|0|||
130257753|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Other|0|||
130257754|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257755|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257756|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130365257|NCT00347360|469306874|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
130702166|NCT02169336|470532810|FG002|Overall Study|Subject declined to continue dosing|1|||
130702167|NCT01148225|470532811|FG000|Overall Study|Other|185|||
130702168|NCT02490800|470532812|FG000|Overall Study|Adverse Event|0|||
130702169|NCT02490800|470532813|FG001|Overall Study|Adverse Event|0|||
130702170|NCT02490800|470532814|FG002|Overall Study|Adverse Event|0|||
130702171|NCT02490800|470532815|FG003|Overall Study|Adverse Event|2|||
130702172|NCT02490800|470532816|FG004|Overall Study|Adverse Event|3|||
130702173|NCT02490800|470532817|FG005|Overall Study|Adverse Event|2|||
130702174|NCT02490800|470532818|FG006|Overall Study|Adverse Event|0|||
130702175|NCT02490800|470532819|FG007|Overall Study|Adverse Event|0|||
130702176|NCT02490800|470532820|FG008|Overall Study|Adverse Event|0|||
130702177|NCT02490800|470532821|FG009|Overall Study|Adverse Event|0|||
130702178|NCT02490800|470532822|FG010|Overall Study|Adverse Event|0|||
130702179|NCT02490800|470532823|FG011|Overall Study|Adverse Event|2|||
130702180|NCT02490800|470532824|FG012|Overall Study|Adverse Event|2|||
130702181|NCT02490800|470532812|FG000|Overall Study|Withdrawal by Subject|0|||
130702182|NCT02490800|470532813|FG001|Overall Study|Withdrawal by Subject|0|||
130702183|NCT02490800|470532814|FG002|Overall Study|Withdrawal by Subject|0|||
130702184|NCT02490800|470532815|FG003|Overall Study|Withdrawal by Subject|1|||
130702185|NCT02490800|470532816|FG004|Overall Study|Withdrawal by Subject|0|||
130702186|NCT02490800|470532817|FG005|Overall Study|Withdrawal by Subject|0|||
130257757|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257758|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257759|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257760|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257761|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
130257762|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257763|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257764|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257765|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130702187|NCT02490800|470532818|FG006|Overall Study|Withdrawal by Subject|0|||
130702188|NCT02490800|470532819|FG007|Overall Study|Withdrawal by Subject|0|||
130702189|NCT02490800|470532820|FG008|Overall Study|Withdrawal by Subject|1|||
130702190|NCT02490800|470532821|FG009|Overall Study|Withdrawal by Subject|0|||
130702191|NCT02490800|470532822|FG010|Overall Study|Withdrawal by Subject|0|||
130702192|NCT02490800|470532823|FG011|Overall Study|Withdrawal by Subject|0|||
130702193|NCT02490800|470532824|FG012|Overall Study|Withdrawal by Subject|0|||
130702194|NCT02490800|470532812|FG000|Overall Study|Progressive disease|3|||
130702195|NCT02490800|470532813|FG001|Overall Study|Progressive disease|3|||
130702196|NCT02490800|470532814|FG002|Overall Study|Progressive disease|3|||
130702197|NCT02490800|470532815|FG003|Overall Study|Progressive disease|4|||
130702198|NCT02490800|470532816|FG004|Overall Study|Progressive disease|4|||
130257766|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257767|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257768|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257769|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257770|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257771|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257772|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257773|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257774|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
130257775|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257776|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257777|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257778|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257779|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257780|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257781|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257782|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257783|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257784|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
130257785|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
130257786|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
130257787|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257788|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257789|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257790|NCT00725985|468908540|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257791|NCT00725985|468908541|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257792|NCT00725985|468908542|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257793|NCT00725985|468908543|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257794|NCT00725985|468908544|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257795|NCT00725985|468908545|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257796|NCT00725985|468908546|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257797|NCT00725985|468908547|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257798|NCT00725985|468908548|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257799|NCT00725985|468908549|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
130257800|NCT00725985|468908550|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
130702199|NCT02490800|470532817|FG005|Overall Study|Progressive disease|1|||
130702200|NCT02490800|470532818|FG006|Overall Study|Progressive disease|4|||
130702201|NCT02490800|470532819|FG007|Overall Study|Progressive disease|3|||
130702202|NCT02490800|470532820|FG008|Overall Study|Progressive disease|6|||
130702203|NCT02490800|470532821|FG009|Overall Study|Progressive disease|2|||
130257801|NCT00725985|468908551|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
130257802|NCT02546323|468908552|FG000|Overall Study|Withdrawal by Subject|36|||
130257803|NCT02546323|468908553|FG001|Overall Study|Withdrawal by Subject|33|||
130257804|NCT02546323|468908552|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
130257805|NCT02546323|468908553|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
130702204|NCT02490800|470532822|FG010|Overall Study|Progressive disease|7|||
130257806|NCT02546323|468908552|FG000|Overall Study|Adverse Event|17|||
130257807|NCT02546323|468908553|FG001|Overall Study|Adverse Event|11|||
130257808|NCT02546323|468908552|FG000|Overall Study|Patient Specific Reasons|1|||
130257809|NCT02546323|468908553|FG001|Overall Study|Patient Specific Reasons|2|||
130257810|NCT02546323|468908552|FG000|Overall Study|Lost to Follow-up|2|||
130257811|NCT02546323|468908553|FG001|Overall Study|Lost to Follow-up|3|||
130257812|NCT02546323|468908552|FG000|Overall Study|Non-compliance with Study Drug|2|||
130257813|NCT02546323|468908553|FG001|Overall Study|Non-compliance with Study Drug|2|||
130257814|NCT02546323|468908552|FG000|Overall Study|Met Withdrawal Criteria|2|||
130257815|NCT02546323|468908553|FG001|Overall Study|Met Withdrawal Criteria|14|||
130257816|NCT04476784|468908554|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
130257817|NCT04476784|468908555|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
130257818|NCT03605693|468908562|FG000|Overall Study|Lost to Follow-up|4|||
130702205|NCT02490800|470532823|FG011|Overall Study|Progressive disease|1|||
130702206|NCT02490800|470532824|FG012|Overall Study|Progressive disease|10|||
130702207|NCT02490800|470532812|FG000|Overall Study|Patient enrolled in post-trial access|0|||
130702208|NCT02490800|470532813|FG001|Overall Study|Patient enrolled in post-trial access|0|||
130257819|NCT03605693|468908563|FG001|Overall Study|Lost to Follow-up|0|||
130257820|NCT03605693|468908562|FG000|Overall Study|Physician Decision|1|||
130257821|NCT03605693|468908563|FG001|Overall Study|Physician Decision|0|||
130257822|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
130257823|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
130257824|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
130257825|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
130257826|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130257827|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130257828|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
130257829|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
130257830|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
130257831|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130257832|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
130257833|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130257834|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
130257835|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
130257836|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
130257837|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130257838|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130257839|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
130257840|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
130257841|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
130257842|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
130257843|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
130257844|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
130257845|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
130257846|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
130257847|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
130257848|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
130257849|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
130257850|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
130257851|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
130257852|NCT03093415|468908564|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
130257853|NCT03093415|468908565|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
130257854|NCT03093415|468908566|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
130257855|NCT04581395|468908571|FG000|Overall Study|Protocol Violation|4|||
130257856|NCT04581395|468908572|FG001|Overall Study|Protocol Violation|3|||
130257857|NCT04581395|468908573|FG002|Overall Study|Protocol Violation|2|||
130257858|NCT04581395|468908571|FG000|Overall Study|Physician Decision|0|||
130257859|NCT04581395|468908572|FG001|Overall Study|Physician Decision|1|||
130257860|NCT04581395|468908573|FG002|Overall Study|Physician Decision|0|||
130257861|NCT00815633|468908574|FG000|Overall Study|study terminated|1|||
130257862|NCT00721110|468908575|FG000|Overall Study|Ultram use|1|||
130257863|NCT00721110|468908576|FG001|Overall Study|Ultram use|0|||
130257864|NCT00721110|468908577|FG002|Overall Study|Ultram use|0|||
130257865|NCT00721110|468908578|FG003|Overall Study|Ultram use|0|||
130257866|NCT00721110|468908575|FG000|Overall Study|vertical incision|0|||
130257867|NCT00721110|468908576|FG001|Overall Study|vertical incision|0|||
130257868|NCT00721110|468908577|FG002|Overall Study|vertical incision|1|||
130257869|NCT00721110|468908578|FG003|Overall Study|vertical incision|0|||
130257870|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
130257871|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130702209|NCT02490800|470532814|FG002|Overall Study|Patient enrolled in post-trial access|0|||
130702210|NCT02490800|470532815|FG003|Overall Study|Patient enrolled in post-trial access|0|||
130702211|NCT02490800|470532816|FG004|Overall Study|Patient enrolled in post-trial access|0|||
130702212|NCT02490800|470532817|FG005|Overall Study|Patient enrolled in post-trial access|0|||
130702213|NCT02490800|470532818|FG006|Overall Study|Patient enrolled in post-trial access|0|||
130257872|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130702214|NCT02490800|470532819|FG007|Overall Study|Patient enrolled in post-trial access|0|||
130257873|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130702215|NCT02490800|470532820|FG008|Overall Study|Patient enrolled in post-trial access|0|||
130702216|NCT02490800|470532821|FG009|Overall Study|Patient enrolled in post-trial access|1|||
130702217|NCT02490800|470532822|FG010|Overall Study|Patient enrolled in post-trial access|1|||
130702218|NCT02490800|470532823|FG011|Overall Study|Patient enrolled in post-trial access|0|||
130702219|NCT02490800|470532824|FG012|Overall Study|Patient enrolled in post-trial access|6|||
130702220|NCT01337596|470532825|FG000|Overall Study|Withdrawal by Subject|0|||
130702221|NCT01337596|470532826|FG001|Overall Study|Withdrawal by Subject|0|||
130702222|NCT01337596|470532827|FG002|Overall Study|Withdrawal by Subject|0|||
130702223|NCT01337596|470532828|FG003|Overall Study|Withdrawal by Subject|0|||
130702224|NCT01337596|470532829|FG004|Overall Study|Withdrawal by Subject|2|||
130702225|NCT01337596|470532830|FG005|Overall Study|Withdrawal by Subject|0|||
130702226|NCT01337596|470532831|FG006|Overall Study|Withdrawal by Subject|0|||
130702227|NCT01337596|470532832|FG007|Overall Study|Withdrawal by Subject|0|||
130702228|NCT01337596|470532833|FG008|Overall Study|Withdrawal by Subject|0|||
130702229|NCT01992094|470532834|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
130702230|NCT01992094|470532835|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
130702231|NCT01992094|470532836|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130702232|NCT01992094|470532834|FG000|Overall Study|Adverse Event|1|||
130702233|NCT01992094|470532835|FG001|Overall Study|Adverse Event|0|||
130702234|NCT01992094|470532836|FG002|Overall Study|Adverse Event|0|||
130702235|NCT01992094|470532834|FG000|Overall Study|Death|5|||
130257874|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257875|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257876|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257877|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
130257878|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
130257879|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
130257880|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
130257881|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
130257882|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
130257883|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
130257884|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
130257885|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
130257886|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
130257887|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
130257888|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
130257889|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
130257890|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
130257891|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
130257892|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
130257893|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
130257894|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
130257895|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
130257896|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
130257897|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
130257898|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
130257899|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
130257900|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
130257901|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
130257902|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
130257903|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
130257904|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
130257905|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
130702236|NCT01992094|470532835|FG001|Overall Study|Death|5|||
130702237|NCT01992094|470532836|FG002|Overall Study|Death|2|||
130702238|NCT01992094|470532834|FG000|Overall Study|Lost to Follow-up|26|||
130702239|NCT01992094|470532835|FG001|Overall Study|Lost to Follow-up|9|||
130257906|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
130257907|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
130257908|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
130257909|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
130257910|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
130257911|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
130702240|NCT01992094|470532836|FG002|Overall Study|Lost to Follow-up|13|||
130702241|NCT01992094|470532834|FG000|Overall Study|OTHER|4|||
130702242|NCT01992094|470532835|FG001|Overall Study|OTHER|0|||
130257912|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
130257913|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130702243|NCT01992094|470532836|FG002|Overall Study|OTHER|0|||
130702244|NCT01992094|470532834|FG000|Overall Study|Protocol Violation|1|||
130702245|NCT01992094|470532835|FG001|Overall Study|Protocol Violation|0|||
130702246|NCT01992094|470532836|FG002|Overall Study|Protocol Violation|1|||
130257914|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257915|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130702247|NCT01992094|470532834|FG000|Overall Study|Withdrawal by Subject|7|||
130702248|NCT01992094|470532835|FG001|Overall Study|Withdrawal by Subject|3|||
130257916|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257917|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257918|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257919|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257920|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
130257921|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257922|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257923|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257924|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257925|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257926|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Death on study|0|||
130257927|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Death on study|0|||
130257928|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Death on study|0|||
130257929|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Death on study|1|||
130257930|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Death on study|0|||
130257931|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Death on study|0|||
130257932|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Death on study|0|||
130257933|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
130257934|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
130257935|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
130257936|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
130257937|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
130257938|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
130257939|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
130257940|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257941|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257942|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257943|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257944|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
130257945|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257946|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257947|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
130257948|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
130257949|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
130257950|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
130257951|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
130257952|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
130257953|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
130257954|NCT02457065|468908586|FG000|Overall Study|Lost to Follow-up|9|||
130257955|NCT02457065|468908587|FG001|Overall Study|Lost to Follow-up|11|||
130257956|NCT01554904|468908588|FG000|Overall Study|Withdrawal by Subject|3|||
130257957|NCT01554904|468908588|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
130257958|NCT01605097|468908590|FG000|Overall Study|Protocol Violation|1|||
130257959|NCT02038647|468908591|FG000|Overall Study|Progressive Disease|50|||
130257960|NCT02038647|468908592|FG001|Overall Study|Progressive Disease|59|||
130257961|NCT02038647|468908591|FG000|Overall Study|Adverse Event|18|||
130365258|NCT00347360|469306875|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
130365259|NCT00347360|469306876|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
130365260|NCT00347360|469306877|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
130365261|NCT00347360|469306878|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
130365262|NCT00347360|469306864|FG000|Overall Study|Abnormal lab values|0|||
130365263|NCT00347360|469306865|FG001|Overall Study|Abnormal lab values|0|||
130365264|NCT00347360|469306866|FG002|Overall Study|Abnormal lab values|0|||
130365265|NCT00347360|469306867|FG003|Overall Study|Abnormal lab values|0|||
130365266|NCT00347360|469306868|FG004|Overall Study|Abnormal lab values|0|||
130365267|NCT00347360|469306869|FG005|Overall Study|Abnormal lab values|0|||
130365268|NCT00347360|469306870|FG006|Overall Study|Abnormal lab values|1|||
130365269|NCT00347360|469306871|FG007|Overall Study|Abnormal lab values|0|||
130365270|NCT00347360|469306872|FG008|Overall Study|Abnormal lab values|0|||
130365271|NCT00347360|469306873|FG009|Overall Study|Abnormal lab values|0|||
130365272|NCT00347360|469306874|FG010|Overall Study|Abnormal lab values|0|||
130365273|NCT00347360|469306875|FG011|Overall Study|Abnormal lab values|0|||
130365274|NCT00347360|469306876|FG012|Overall Study|Abnormal lab values|0|||
130365275|NCT00347360|469306877|FG013|Overall Study|Abnormal lab values|0|||
130365276|NCT00347360|469306878|FG014|Overall Study|Abnormal lab values|0|||
130365277|NCT00347360|469306864|FG000|Overall Study|PI recommended early withdrawal|0|||
130365278|NCT00347360|469306865|FG001|Overall Study|PI recommended early withdrawal|0|||
130365279|NCT00347360|469306866|FG002|Overall Study|PI recommended early withdrawal|0|||
130365280|NCT00347360|469306867|FG003|Overall Study|PI recommended early withdrawal|0|||
130365281|NCT00347360|469306868|FG004|Overall Study|PI recommended early withdrawal|0|||
130365282|NCT00347360|469306869|FG005|Overall Study|PI recommended early withdrawal|0|||
130257962|NCT02038647|468908592|FG001|Overall Study|Adverse Event|10|||
130257963|NCT02038647|468908591|FG000|Overall Study|Symptomatic Deterioration|7|||
130257964|NCT02038647|468908592|FG001|Overall Study|Symptomatic Deterioration|7|||
130257965|NCT02038647|468908591|FG000|Overall Study|Withdrawal by Subject|5|||
130257966|NCT02038647|468908592|FG001|Overall Study|Withdrawal by Subject|2|||
130257967|NCT02038647|468908591|FG000|Overall Study|Not Reported|0|||
130257968|NCT02038647|468908592|FG001|Overall Study|Not Reported|1|||
130257969|NCT02038647|468908591|FG000|Overall Study|Ongoing at Datacut|9|||
130257970|NCT02038647|468908592|FG001|Overall Study|Ongoing at Datacut|10|||
130257971|NCT02757430|468908593|FG000|Overall Study|Physician Decision|6|||
130257972|NCT02757430|468908593|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
130257973|NCT02757430|468908593|FG000|Overall Study|No informed consent|1|||
130257974|NCT02757430|468908593|FG000|Overall Study|No procedure performed|2|||
130257975|NCT04716894|468908615|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
130257976|NCT04716894|468908615|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
130257977|NCT04507269|468908619|FG000|Overall Study|Withdrawal by Subject|1|||
130257978|NCT04507269|468908620|FG001|Overall Study|Withdrawal by Subject|1|||
130257979|NCT04507269|468908621|FG002|Overall Study|Withdrawal by Subject|0|||
130257980|NCT04507269|468908622|FG003|Overall Study|Withdrawal by Subject|0|||
130257981|NCT04507269|468908623|FG004|Overall Study|Withdrawal by Subject|0|||
130257982|NCT04507269|468908624|FG005|Overall Study|Withdrawal by Subject|0|||
130257983|NCT04507269|468908619|FG000|Overall Study|Lost to Follow-up|0|||
130257984|NCT04507269|468908620|FG001|Overall Study|Lost to Follow-up|0|||
130257985|NCT04507269|468908621|FG002|Overall Study|Lost to Follow-up|0|||
130257986|NCT04507269|468908622|FG003|Overall Study|Lost to Follow-up|0|||
130257987|NCT04507269|468908623|FG004|Overall Study|Lost to Follow-up|1|||
130257988|NCT04507269|468908624|FG005|Overall Study|Lost to Follow-up|0|||
130257989|NCT00071032|468908627|FG000|Overall Study|Lost to Follow-up|1|||
130365283|NCT00347360|469306870|FG006|Overall Study|PI recommended early withdrawal|0|||
130257990|NCT00071032|468908628|FG001|Overall Study|Lost to Follow-up|1|||
130257991|NCT00071032|468908627|FG000|Overall Study|Withdrawal by Subject|8|||
130365284|NCT00347360|469306871|FG007|Overall Study|PI recommended early withdrawal|0|||
130365285|NCT00347360|469306872|FG008|Overall Study|PI recommended early withdrawal|0|||
130365286|NCT00347360|469306873|FG009|Overall Study|PI recommended early withdrawal|1|||
130365287|NCT00347360|469306874|FG010|Overall Study|PI recommended early withdrawal|0|||
130365288|NCT00347360|469306875|FG011|Overall Study|PI recommended early withdrawal|0|||
130365289|NCT00347360|469306876|FG012|Overall Study|PI recommended early withdrawal|0|||
130365290|NCT00347360|469306877|FG013|Overall Study|PI recommended early withdrawal|0|||
130365291|NCT00347360|469306878|FG014|Overall Study|PI recommended early withdrawal|0|||
130365292|NCT00347360|469306864|FG000|Overall Study|Did not meet criteria before ABPM|0|||
130365293|NCT00347360|469306865|FG001|Overall Study|Did not meet criteria before ABPM|0|||
130365294|NCT00347360|469306866|FG002|Overall Study|Did not meet criteria before ABPM|0|||
130365295|NCT00347360|469306867|FG003|Overall Study|Did not meet criteria before ABPM|0|||
130365296|NCT00347360|469306868|FG004|Overall Study|Did not meet criteria before ABPM|0|||
130365297|NCT00347360|469306869|FG005|Overall Study|Did not meet criteria before ABPM|0|||
130365298|NCT00347360|469306870|FG006|Overall Study|Did not meet criteria before ABPM|0|||
130365299|NCT00347360|469306871|FG007|Overall Study|Did not meet criteria before ABPM|0|||
130365300|NCT00347360|469306872|FG008|Overall Study|Did not meet criteria before ABPM|0|||
130365301|NCT00347360|469306873|FG009|Overall Study|Did not meet criteria before ABPM|0|||
130365302|NCT00347360|469306874|FG010|Overall Study|Did not meet criteria before ABPM|1|||
130365303|NCT00347360|469306875|FG011|Overall Study|Did not meet criteria before ABPM|0|||
130365304|NCT00347360|469306876|FG012|Overall Study|Did not meet criteria before ABPM|0|||
130365305|NCT00347360|469306877|FG013|Overall Study|Did not meet criteria before ABPM|0|||
130365306|NCT00347360|469306878|FG014|Overall Study|Did not meet criteria before ABPM|0|||
130365307|NCT00347360|469306864|FG000|Overall Study|Randomized in error|0|||
130365308|NCT00347360|469306865|FG001|Overall Study|Randomized in error|0|||
130365309|NCT00347360|469306866|FG002|Overall Study|Randomized in error|0|||
130365310|NCT00347360|469306867|FG003|Overall Study|Randomized in error|0|||
130365311|NCT00347360|469306868|FG004|Overall Study|Randomized in error|0|||
130365312|NCT00347360|469306869|FG005|Overall Study|Randomized in error|0|||
130365313|NCT00347360|469306870|FG006|Overall Study|Randomized in error|0|||
130365314|NCT00347360|469306871|FG007|Overall Study|Randomized in error|0|||
130365315|NCT00347360|469306872|FG008|Overall Study|Randomized in error|0|||
130365316|NCT00347360|469306873|FG009|Overall Study|Randomized in error|0|||
130257992|NCT00071032|468908628|FG001|Overall Study|Withdrawal by Subject|6|||
130257993|NCT00071032|468908627|FG000|Overall Study|Missing Primary Outcome|0|||
130257994|NCT00071032|468908628|FG001|Overall Study|Missing Primary Outcome|1|||
130257995|NCT06071104|468908630|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
130257996|NCT03518060|468908631|FG000|Overall Study|Death|1|||
130257997|NCT03518060|468908631|FG000|Overall Study|Poor adherence|1|||
130257998|NCT03518060|468908631|FG000|Overall Study|Withdrawal of informed consent|2|||
130365317|NCT00347360|469306874|FG010|Overall Study|Randomized in error|0|||
130365318|NCT00347360|469306875|FG011|Overall Study|Randomized in error|1|||
130559416|NCT01621542|470016494|FG004|Overall Study|Withdrawal by Subject|3|||
130702249|NCT01992094|470532836|FG002|Overall Study|Withdrawal by Subject|4|||
130257999|NCT03518060|468908631|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
130258000|NCT03518060|468908631|FG000|Overall Study|Physician Decision|7|||
130258001|NCT03518060|468908631|FG000|Overall Study|Adverse drug reactions|23|||
130258002|NCT03518060|468908631|FG000|Overall Study|Withdrawal by Subject|25|||
130258003|NCT03518060|468908631|FG000|Overall Study|Lost to Follow-up|13|||
130258004|NCT01903863|468908633|FG000|Overall Study|Physician Decision|2|||
130258005|NCT01903863|468908634|FG001|Overall Study|Physician Decision|0|||
130258006|NCT04727151|468908639|FG000|Overall Study|Death|0|||
130258007|NCT04727151|468908640|FG001|Overall Study|Death|0|||
130258008|NCT04727151|468908641|FG002|Overall Study|Death|0|||
130258009|NCT04727151|468908642|FG003|Overall Study|Death|0|||
130258010|NCT04727151|468908643|FG004|Overall Study|Death|3|||
130258011|NCT04727151|468908639|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258012|NCT04727151|468908640|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258013|NCT04727151|468908641|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258014|NCT04727151|468908642|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258015|NCT04727151|468908643|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
130258016|NCT01969058|468908644|FG000|Overall Study|Withdrawal by Subject|2|||
130258017|NCT01969058|468908645|FG001|Overall Study|Withdrawal by Subject|0|||
130258018|NCT01969058|468908644|FG000|Overall Study|Adverse Event|1|||
130258019|NCT01969058|468908645|FG001|Overall Study|Adverse Event|0|||
130258020|NCT04976855|468908648|FG000|Part I|Withdrawal by Subject|0|||
130258021|NCT04976855|468908649|FG001|Part I|Withdrawal by Subject|1|||
130258022|NCT04976855|468908650|FG002|Part I|Withdrawal by Subject|0|||
130258023|NCT04976855|468908651|FG003|Part I|Withdrawal by Subject|0|||
130258024|NCT04976855|468908652|FG004|Part I|Withdrawal by Subject|0|||
130258025|NCT04976855|468908653|FG005|Part I|Withdrawal by Subject|0|||
130258026|NCT04976855|468908654|FG006|Part I|Withdrawal by Subject|0|||
130258027|NCT04976855|468908648|FG000|Part II|Adverse Event|0|||
130258028|NCT04976855|468908649|FG001|Part II|Adverse Event|0|||
130258029|NCT04976855|468908650|FG002|Part II|Adverse Event|0|||
130258030|NCT04976855|468908651|FG003|Part II|Adverse Event|1|||
130258031|NCT04976855|468908652|FG004|Part II|Adverse Event|0|||
130258032|NCT04976855|468908653|FG005|Part II|Adverse Event|0|||
130258033|NCT04976855|468908654|FG006|Part II|Adverse Event|0|||
130258034|NCT04976855|468908648|FG000|Part II|Withdrawal by Subject|0|||
130258035|NCT04976855|468908649|FG001|Part II|Withdrawal by Subject|0|||
130258036|NCT04976855|468908650|FG002|Part II|Withdrawal by Subject|0|||
130258037|NCT04976855|468908651|FG003|Part II|Withdrawal by Subject|0|||
130258038|NCT04976855|468908652|FG004|Part II|Withdrawal by Subject|1|||
130258039|NCT04976855|468908653|FG005|Part II|Withdrawal by Subject|0|||
130258040|NCT04976855|468908654|FG006|Part II|Withdrawal by Subject|0|||
130258041|NCT04976855|468908648|FG000|Part II|Lost to Follow-up|0|||
130258042|NCT04976855|468908649|FG001|Part II|Lost to Follow-up|0|||
130258043|NCT04976855|468908650|FG002|Part II|Lost to Follow-up|0|||
130258044|NCT04976855|468908651|FG003|Part II|Lost to Follow-up|0|||
130258045|NCT04976855|468908652|FG004|Part II|Lost to Follow-up|0|||
130258046|NCT04976855|468908653|FG005|Part II|Lost to Follow-up|1|||
130258047|NCT04976855|468908654|FG006|Part II|Lost to Follow-up|0|||
130258048|NCT05318287|468908655|FG000|Overall Study|Lost to Follow-up|8|||
130258049|NCT03537508|468908656|FG000|Overall Study|Adverse Event|2|||
130258050|NCT03537508|468908657|FG001|Overall Study|Adverse Event|1|||
130258051|NCT03537508|468908656|FG000|Overall Study|Protocol Violation|65|||
130258052|NCT03537508|468908657|FG001|Overall Study|Protocol Violation|48|||
130258053|NCT03537508|468908656|FG000|Overall Study|Lost to Follow-up|86|||
130258054|NCT03537508|468908657|FG001|Overall Study|Lost to Follow-up|60|||
130258055|NCT03537508|468908656|FG000|Overall Study|Withdrawal by parent/guardian|263|||
130258056|NCT03537508|468908657|FG001|Overall Study|Withdrawal by parent/guardian|149|||
130258057|NCT00835172|468908692|FG000|Washout|Protocol Violation|0|||
130258058|NCT00835172|468908693|FG001|Washout|Protocol Violation|1|||
130258059|NCT02495883|468908696|FG000|Overall Study|Excessive head motion|1|||
130702250|NCT01214239|470532837|FG000|Overall Study|Adverse Event|3|||
130702251|NCT01214239|470532838|FG001|Overall Study|Adverse Event|4|||
130702252|NCT01214239|470532837|FG000|Overall Study|Protocol Violation|2|||
130702253|NCT01214239|470532838|FG001|Overall Study|Protocol Violation|1|||
130702254|NCT01214239|470532837|FG000|Overall Study|Lost to Follow-up|1|||
130258060|NCT02495883|468908697|FG001|Overall Study|Excessive head motion|0|||
130258061|NCT02776735|468908698|FG000|Overall Study|Adverse Event|0|||
130258062|NCT02776735|468908699|FG001|Overall Study|Adverse Event|0|||
130258063|NCT02776735|468908700|FG002|Overall Study|Adverse Event|0|||
130258064|NCT02776735|468908701|FG003|Overall Study|Adverse Event|1|||
130258065|NCT02776735|468908702|FG004|Overall Study|Adverse Event|0|||
130258066|NCT02776735|468908703|FG005|Overall Study|Adverse Event|1|||
130702255|NCT01214239|470532838|FG001|Overall Study|Lost to Follow-up|1|||
130702256|NCT01214239|470532837|FG000|Overall Study|Withdrawal by Subject|4|||
130258067|NCT02776735|468908698|FG000|Overall Study|Lost to Follow-up|0|||
130258068|NCT02776735|468908699|FG001|Overall Study|Lost to Follow-up|0|||
130258069|NCT02776735|468908700|FG002|Overall Study|Lost to Follow-up|0|||
130258070|NCT02776735|468908701|FG003|Overall Study|Lost to Follow-up|1|||
130258071|NCT02776735|468908702|FG004|Overall Study|Lost to Follow-up|0|||
130702257|NCT01214239|470532838|FG001|Overall Study|Withdrawal by Subject|9|||
130702258|NCT01214239|470532837|FG000|Overall Study|Lack of Efficacy|1|||
130702259|NCT01214239|470532838|FG001|Overall Study|Lack of Efficacy|2|||
130702260|NCT01214239|470532837|FG000|Overall Study|patient's private reason|1|||
130702261|NCT01214239|470532838|FG001|Overall Study|patient's private reason|1|||
130702262|NCT01049581|470532839|FG000|Overall Study|Lost to Follow-up|2|||
130702263|NCT01049581|470532840|FG001|Overall Study|Lost to Follow-up|1|||
130702264|NCT03203642|470532841|FG000|Overall Study|Adverse Event|3|||
130702265|NCT03203642|470532842|FG001|Overall Study|Adverse Event|1|||
130702266|NCT03203642|470532841|FG000|Overall Study|Withdrawal by Subject|6|||
130702267|NCT03203642|470532842|FG001|Overall Study|Withdrawal by Subject|6|||
130702268|NCT03203642|470532841|FG000|Overall Study|Lost to Follow-up|2|||
130702269|NCT03203642|470532842|FG001|Overall Study|Lost to Follow-up|1|||
130702270|NCT03203642|470532841|FG000|Overall Study|Termination of the study by sponsor|1|||
130702271|NCT03203642|470532842|FG001|Overall Study|Termination of the study by sponsor|1|||
130702272|NCT03203642|470532841|FG000|Overall Study|Participant moved|0|||
130702273|NCT03203642|470532842|FG001|Overall Study|Participant moved|1|||
130702274|NCT03203642|470532841|FG000|Overall Study|Investigator's decision|3|||
130702275|NCT03203642|470532842|FG001|Overall Study|Investigator's decision|0|||
130702276|NCT03203642|470532841|FG000|Overall Study|Other than above specified|0|||
130702277|NCT03203642|470532842|FG001|Overall Study|Other than above specified|1|||
130702278|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
130702279|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
130702280|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702281|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702282|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702283|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702284|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702285|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702286|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130258072|NCT02776735|468908703|FG005|Overall Study|Lost to Follow-up|0|||
130258073|NCT02776735|468908698|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130258074|NCT02776735|468908699|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130258075|NCT02776735|468908700|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130258076|NCT02776735|468908701|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130258077|NCT02776735|468908702|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130258078|NCT02776735|468908703|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130258079|NCT02776735|468908698|FG000|Overall Study|Withdrawal by Subject|1|||
130258080|NCT02776735|468908699|FG001|Overall Study|Withdrawal by Subject|0|||
130258081|NCT02776735|468908700|FG002|Overall Study|Withdrawal by Subject|0|||
130258082|NCT02776735|468908701|FG003|Overall Study|Withdrawal by Subject|0|||
130258083|NCT02776735|468908702|FG004|Overall Study|Withdrawal by Subject|0|||
130258084|NCT02776735|468908703|FG005|Overall Study|Withdrawal by Subject|1|||
130258085|NCT02776735|468908698|FG000|Overall Study|Other|0|||
130258086|NCT02776735|468908699|FG001|Overall Study|Other|0|||
130258087|NCT02776735|468908700|FG002|Overall Study|Other|3|||
130258088|NCT02776735|468908701|FG003|Overall Study|Other|0|||
130258089|NCT02776735|468908702|FG004|Overall Study|Other|0|||
130258090|NCT02776735|468908703|FG005|Overall Study|Other|0|||
130258091|NCT00791648|468910306|FG000|Overall Study|Physician Decision|0|||
130258092|NCT00791648|468910307|FG001|Overall Study|Physician Decision|1|||
130258093|NCT00791648|468910306|FG000|Overall Study|Withdrawal by Subject|0|||
130258094|NCT00791648|468910307|FG001|Overall Study|Withdrawal by Subject|1|||
130258095|NCT04976777|468910308|FG000|Overall Study|COVID-19 Infection|1|||
130258096|NCT04976777|468910309|FG001|Overall Study|COVID-19 Infection|0|||
130258097|NCT00462826|468910310|FG000|Overall Study|Ineligible - second primary|1|||
130258098|NCT00462826|468910310|FG000|Overall Study|Ineligible - wrong cell type|1|||
130258099|NCT00462826|468910310|FG000|Overall Study|Ineligible - wrong primary|2|||
130258100|NCT00462826|468910310|FG000|Overall Study|Never treated|1|||
130258101|NCT02332928|468910313|FG000|Overall Study|Withdrawal by Subject|0|||
130258102|NCT02332928|468910314|FG001|Overall Study|Withdrawal by Subject|2|||
130258103|NCT02332928|468910313|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
130258104|NCT02332928|468910314|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
130258105|NCT04484857|468910315|FG000|Overall Study|Adverse Event|2|||
130258106|NCT04484857|468910315|FG000|Overall Study|Death|10|||
130258107|NCT04484857|468910315|FG000|Overall Study|Withdrawal by Subject|3|||
130258108|NCT04484857|468910315|FG000|Overall Study|Transferred/Relocation|5|||
130702287|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702288|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
130702289|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702290|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702291|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702292|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130258109|NCT04484857|468910315|FG000|Overall Study|Kidney Transplant|7|||
130553831|NCT01658826|469994878|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
130553832|NCT01658826|469994879|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
130553833|NCT01658826|469994878|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
130553834|NCT01658826|469994879|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
130553835|NCT01658826|469994878|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
130553836|NCT01658826|469994879|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
130553837|NCT01422850|469994882|FG000|Overall Study|Physician Decision|3|||
130553838|NCT04484831|469994883|FG000|Overall Study|Withdrawal by Subject|1|||
130553839|NCT04484831|469994884|FG001|Overall Study|Withdrawal by Subject|0|||
130553840|NCT02244996|469994885|FG000|Overall Study|Lack of Efficacy|2|||
130553841|NCT02244996|469994886|FG001|Overall Study|Lack of Efficacy|6|||
130553842|NCT01335009|469994887|FG000|Overall Study|Too ill to travel to study sites|1|||
130553843|NCT01335009|469994888|FG001|Overall Study|Too ill to travel to study sites|0|||
130553844|NCT01335009|469994887|FG000|Overall Study|Death|28|||
130553845|NCT01335009|469994888|FG001|Overall Study|Death|32|||
130553846|NCT01335009|469994887|FG000|Overall Study|Withdrawal by Subject|1|||
130553847|NCT01335009|469994888|FG001|Overall Study|Withdrawal by Subject|1|||
130553848|NCT01335009|469994887|FG000|Overall Study|Lost to Follow-up|1|||
130553849|NCT01335009|469994888|FG001|Overall Study|Lost to Follow-up|0|||
130553850|NCT04821869|469994889|FG000|Overall Study|Adverse Event|4|||
130553851|NCT04821869|469994889|FG000|Overall Study|Withdrawal by Subject|2|||
130553852|NCT04821869|469994889|FG000|Overall Study|Did not meet FEV1 criteria|1|||
130553853|NCT00658684|469994890|FG000|Overall Study|Adverse Event|10|||
130553854|NCT00658684|469994891|FG001|Overall Study|Adverse Event|8|||
130553855|NCT00658684|469994892|FG002|Overall Study|Adverse Event|2|||
130553856|NCT00658684|469994893|FG003|Overall Study|Adverse Event|0|||
130553857|NCT00658684|469994890|FG000|Overall Study|Withdrawal by Subject|6|||
130553858|NCT00658684|469994891|FG001|Overall Study|Withdrawal by Subject|4|||
130553859|NCT00658684|469994892|FG002|Overall Study|Withdrawal by Subject|1|||
130553860|NCT00658684|469994893|FG003|Overall Study|Withdrawal by Subject|1|||
130553861|NCT00658684|469994890|FG000|Overall Study|Lack of Efficacy|1|||
130553862|NCT00658684|469994891|FG001|Overall Study|Lack of Efficacy|1|||
130553863|NCT00658684|469994892|FG002|Overall Study|Lack of Efficacy|0|||
130553864|NCT00658684|469994893|FG003|Overall Study|Lack of Efficacy|0|||
130553865|NCT00658684|469994890|FG000|Overall Study|Protocol Violation|1|||
130553866|NCT00658684|469994891|FG001|Overall Study|Protocol Violation|1|||
130553867|NCT00658684|469994892|FG002|Overall Study|Protocol Violation|0|||
130553868|NCT00658684|469994893|FG003|Overall Study|Protocol Violation|0|||
130553869|NCT00658684|469994890|FG000|Overall Study|Pregnancy|1|||
130553870|NCT00658684|469994891|FG001|Overall Study|Pregnancy|1|||
130553871|NCT00658684|469994892|FG002|Overall Study|Pregnancy|0|||
130553872|NCT00658684|469994893|FG003|Overall Study|Pregnancy|0|||
130553873|NCT00146328|469996452|FG000|Overall Study|Adverse Event|39|||
130553874|NCT00146328|469996453|FG001|Overall Study|Adverse Event|48|||
130553875|NCT00146328|469996454|FG002|Overall Study|Adverse Event|79|||
130553876|NCT00146328|469996452|FG000|Overall Study|Protocol Violation|11|||
130553877|NCT00146328|469996453|FG001|Overall Study|Protocol Violation|6|||
130553878|NCT00146328|469996454|FG002|Overall Study|Protocol Violation|12|||
130553879|NCT00146328|469996452|FG000|Overall Study|Lost to Follow-up|7|||
130553880|NCT00146328|469996453|FG001|Overall Study|Lost to Follow-up|4|||
130553881|NCT00146328|469996454|FG002|Overall Study|Lost to Follow-up|7|||
130553882|NCT00146328|469996452|FG000|Overall Study|Withdrawal by Subject|16|||
130553883|NCT00146328|469996453|FG001|Overall Study|Withdrawal by Subject|16|||
130553884|NCT00146328|469996454|FG002|Overall Study|Withdrawal by Subject|22|||
130553885|NCT00146328|469996452|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
130553886|NCT00146328|469996453|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
130553887|NCT00146328|469996454|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
130553888|NCT00146328|469996452|FG000|Overall Study|Trial ended/site closed|8|||
130553889|NCT00146328|469996453|FG001|Overall Study|Trial ended/site closed|2|||
130553890|NCT00146328|469996454|FG002|Overall Study|Trial ended/site closed|19|||
130553891|NCT00146328|469996452|FG000|Overall Study|Patient decision to end|0|||
130702293|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702294|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
130553892|NCT00146328|469996453|FG001|Overall Study|Patient decision to end|1|||
130702295|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
130365319|NCT00347360|469306876|FG012|Overall Study|Randomized in error|0|||
130365320|NCT00347360|469306877|FG013|Overall Study|Randomized in error|0|||
130365321|NCT00347360|469306878|FG014|Overall Study|Randomized in error|0|||
130365322|NCT00347360|469306864|FG000|Overall Study|Failed inclusion criteria #4|0|||
130365323|NCT00347360|469306865|FG001|Overall Study|Failed inclusion criteria #4|0|||
130365324|NCT00347360|469306866|FG002|Overall Study|Failed inclusion criteria #4|0|||
130365325|NCT00347360|469306867|FG003|Overall Study|Failed inclusion criteria #4|0|||
130365326|NCT00347360|469306868|FG004|Overall Study|Failed inclusion criteria #4|0|||
130365327|NCT00347360|469306869|FG005|Overall Study|Failed inclusion criteria #4|0|||
130258110|NCT04484857|468910315|FG000|Overall Study|Other than specified|4|||
130258111|NCT04484857|468910315|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
130258112|NCT01822925|468910316|FG000|Overall Study|Adverse Event|1|||
130258113|NCT01822925|468910317|FG001|Overall Study|Adverse Event|1|||
130258114|NCT01822925|468910318|FG002|Overall Study|Adverse Event|1|||
130258115|NCT01822925|468910319|FG003|Overall Study|Adverse Event|1|||
130258116|NCT01822925|468910316|FG000|Overall Study|Lost to Follow-up|0|||
130258117|NCT01822925|468910317|FG001|Overall Study|Lost to Follow-up|1|||
130258118|NCT01822925|468910318|FG002|Overall Study|Lost to Follow-up|0|||
130258119|NCT01822925|468910319|FG003|Overall Study|Lost to Follow-up|0|||
130258120|NCT01822925|468910316|FG000|Overall Study|Protocol Violation|1|||
130258121|NCT01822925|468910317|FG001|Overall Study|Protocol Violation|0|||
130258122|NCT01822925|468910318|FG002|Overall Study|Protocol Violation|0|||
130258123|NCT01822925|468910319|FG003|Overall Study|Protocol Violation|1|||
130258124|NCT01822925|468910316|FG000|Overall Study|Withdrawal by Subject|2|||
130258125|NCT01822925|468910317|FG001|Overall Study|Withdrawal by Subject|0|||
130258126|NCT01822925|468910318|FG002|Overall Study|Withdrawal by Subject|2|||
130258127|NCT01822925|468910319|FG003|Overall Study|Withdrawal by Subject|2|||
130258128|NCT01822925|468910316|FG000|Overall Study|Taking prohibited medication|2|||
130258129|NCT01822925|468910317|FG001|Overall Study|Taking prohibited medication|0|||
130258130|NCT01822925|468910318|FG002|Overall Study|Taking prohibited medication|0|||
130258131|NCT01822925|468910319|FG003|Overall Study|Taking prohibited medication|1|||
130258132|NCT04617860|468910324|FG000|Overall Study|Adverse Event|0|||
130258133|NCT04617860|468910325|FG001|Overall Study|Adverse Event|2|||
130258134|NCT04617860|468910326|FG002|Overall Study|Adverse Event|2|||
130258135|NCT04617860|468910324|FG000|Overall Study|Withdrawal by Subject|0|||
130258136|NCT04617860|468910325|FG001|Overall Study|Withdrawal by Subject|0|||
130258137|NCT04617860|468910326|FG002|Overall Study|Withdrawal by Subject|2|||
130258138|NCT04617860|468910324|FG000|Overall Study|Physician Decision|0|||
130258139|NCT04617860|468910325|FG001|Overall Study|Physician Decision|1|||
130258140|NCT04617860|468910326|FG002|Overall Study|Physician Decision|0|||
130258141|NCT04617860|468910324|FG000|Overall Study|Sponsor Decision|0|||
130258142|NCT04617860|468910325|FG001|Overall Study|Sponsor Decision|3|||
130258143|NCT04617860|468910326|FG002|Overall Study|Sponsor Decision|1|||
130258144|NCT04617860|468910324|FG000|Overall Study|Termination of Study by Sponsor|8|||
130258145|NCT04617860|468910325|FG001|Overall Study|Termination of Study by Sponsor|4|||
130258146|NCT04617860|468910326|FG002|Overall Study|Termination of Study by Sponsor|13|||
130258147|NCT01055028|468910327|FG000|Screening|Screen Failure|1|||
130258148|NCT01055028|468910328|FG001|Screening|Screen Failure|1|||
130258149|NCT01055028|468910327|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
130258150|NCT01055028|468910328|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
130258151|NCT01055028|468910327|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130258152|NCT01055028|468910328|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130258153|NCT01055028|468910327|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
130258154|NCT01055028|468910328|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
130258155|NCT06582732|468910329|FG000|Initial Study Period|Adverse Event|0|||
130258156|NCT06582732|468910330|FG001|Initial Study Period|Adverse Event|0|||
130258157|NCT06582732|468910331|FG002|Initial Study Period|Adverse Event|0|||
130258158|NCT06582732|468910332|FG003|Initial Study Period|Adverse Event|2|||
130258159|NCT06582732|468910333|FG004|Initial Study Period|Adverse Event|0|||
130258160|NCT06582732|468910334|FG005|Initial Study Period|Adverse Event|0|||
130258161|NCT06582732|468910335|FG006|Initial Study Period|Adverse Event|0|||
130258162|NCT06582732|468910329|FG000|Initial Study Period|Death|1|||
130258163|NCT06582732|468910330|FG001|Initial Study Period|Death|0|||
130258164|NCT06582732|468910331|FG002|Initial Study Period|Death|0|||
130258165|NCT06582732|468910332|FG003|Initial Study Period|Death|0|||
130258166|NCT06582732|468910333|FG004|Initial Study Period|Death|1|||
130258167|NCT06582732|468910334|FG005|Initial Study Period|Death|0|||
130258168|NCT06582732|468910335|FG006|Initial Study Period|Death|0|||
130258169|NCT06582732|468910329|FG000|Initial Study Period|Lost to Follow-up|0|||
130258170|NCT06582732|468910330|FG001|Initial Study Period|Lost to Follow-up|0|||
130702296|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
130258171|NCT06582732|468910331|FG002|Initial Study Period|Lost to Follow-up|2|||
130258172|NCT06582732|468910332|FG003|Initial Study Period|Lost to Follow-up|0|||
130258173|NCT06582732|468910333|FG004|Initial Study Period|Lost to Follow-up|0|||
130258174|NCT06582732|468910334|FG005|Initial Study Period|Lost to Follow-up|0|||
130258175|NCT06582732|468910335|FG006|Initial Study Period|Lost to Follow-up|0|||
130258176|NCT06582732|468910329|FG000|Initial Study Period|Withdrawal by Subject|0|||
130702297|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
130702298|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
130258177|NCT06582732|468910330|FG001|Initial Study Period|Withdrawal by Subject|1|||
130258178|NCT06582732|468910331|FG002|Initial Study Period|Withdrawal by Subject|0|||
130258179|NCT06582732|468910332|FG003|Initial Study Period|Withdrawal by Subject|1|||
130702299|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130258180|NCT06582732|468910333|FG004|Initial Study Period|Withdrawal by Subject|3|||
130702300|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130702301|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130702302|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702303|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702304|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130702305|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702306|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130702307|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702308|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702309|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130258181|NCT06582732|468910334|FG005|Initial Study Period|Withdrawal by Subject|1|||
130258182|NCT06582732|468910335|FG006|Initial Study Period|Withdrawal by Subject|2|||
130702310|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702311|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702312|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130258183|NCT06582732|468910329|FG000|Initial Study Period|Moved Away|0|||
130258184|NCT06582732|468910330|FG001|Initial Study Period|Moved Away|0|||
130258185|NCT06582732|468910331|FG002|Initial Study Period|Moved Away|0|||
130258186|NCT06582732|468910332|FG003|Initial Study Period|Moved Away|0|||
130258187|NCT06582732|468910333|FG004|Initial Study Period|Moved Away|1|||
130258188|NCT06582732|468910334|FG005|Initial Study Period|Moved Away|0|||
130258189|NCT06582732|468910335|FG006|Initial Study Period|Moved Away|0|||
130258190|NCT01182350|468910336|FG000|Overall Study|Adverse Event|5|||
130258191|NCT01182350|468910337|FG001|Overall Study|Adverse Event|0|||
130553893|NCT00146328|469996454|FG002|Overall Study|Patient decision to end|6|||
130553894|NCT00146328|469996452|FG000|Overall Study|Enroll into other trial|2|||
130553895|NCT00146328|469996453|FG001|Overall Study|Enroll into other trial|4|||
130553896|NCT00146328|469996454|FG002|Overall Study|Enroll into other trial|2|||
130553897|NCT00146328|469996452|FG000|Overall Study|Death|0|||
130553898|NCT00146328|469996453|FG001|Overall Study|Death|1|||
130553899|NCT00146328|469996454|FG002|Overall Study|Death|1|||
130553900|NCT00146328|469996452|FG000|Overall Study|Moved|2|||
130553901|NCT00146328|469996453|FG001|Overall Study|Moved|0|||
130553902|NCT00146328|469996454|FG002|Overall Study|Moved|0|||
130553903|NCT00146328|469996452|FG000|Overall Study|Interaction with other medication|2|||
130553904|NCT00146328|469996453|FG001|Overall Study|Interaction with other medication|0|||
130553905|NCT00146328|469996454|FG002|Overall Study|Interaction with other medication|1|||
130553906|NCT00300781|469996455|FG000|Overall Study|Disease Progression|55|||
130553907|NCT00300781|469996456|FG001|Overall Study|Disease Progression|52|||
130553908|NCT00300781|469996455|FG000|Overall Study|Adverse Event|5|||
130553909|NCT00300781|469996456|FG001|Overall Study|Adverse Event|6|||
130553910|NCT00300781|469996455|FG000|Overall Study|Withdrawal by Subject|1|||
130553911|NCT00300781|469996456|FG001|Overall Study|Withdrawal by Subject|2|||
130553912|NCT00300781|469996455|FG000|Overall Study|Physician Decision|1|||
130553913|NCT00300781|469996456|FG001|Overall Study|Physician Decision|0|||
130553914|NCT00300781|469996455|FG000|Overall Study|Not Recorded|0|||
130553915|NCT00300781|469996456|FG001|Overall Study|Not Recorded|1|||
130553916|NCT00300781|469996455|FG000|Overall Study|Symptomatic Deterioration|1|||
130553917|NCT00300781|469996456|FG001|Overall Study|Symptomatic Deterioration|0|||
130553918|NCT00300781|469996455|FG000|Overall Study|Lost to Follow-up|0|||
130553919|NCT00300781|469996456|FG001|Overall Study|Lost to Follow-up|1|||
130553920|NCT02072434|469996457|FG000|Overall Study|Protocol Violation|10|||
130553921|NCT02072434|469996458|FG001|Overall Study|Protocol Violation|9|||
130553922|NCT02072434|469996457|FG000|Overall Study|Physician Decision|5|||
130553923|NCT02072434|469996458|FG001|Overall Study|Physician Decision|10|||
130702313|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
130702314|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702315|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702316|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130258192|NCT01182350|468910338|FG002|Overall Study|Adverse Event|0|||
130553924|NCT02072434|469996457|FG000|Overall Study|Adverse event, serious fatal|1|||
130258193|NCT01182350|468910339|FG003|Overall Study|Adverse Event|0|||
130258194|NCT01182350|468910340|FG004|Overall Study|Adverse Event|0|||
130258195|NCT01182350|468910336|FG000|Overall Study|Disease Progression|15|||
130553925|NCT02072434|469996458|FG001|Overall Study|Adverse event, serious fatal|6|||
130553926|NCT02072434|469996457|FG000|Overall Study|Adverse Event|7|||
130553927|NCT02072434|469996458|FG001|Overall Study|Adverse Event|6|||
130553928|NCT02072434|469996457|FG000|Overall Study|Withdrawal by Subject|17|||
130258196|NCT01182350|468910337|FG001|Overall Study|Disease Progression|12|||
130258197|NCT01182350|468910338|FG002|Overall Study|Disease Progression|0|||
130258198|NCT01182350|468910339|FG003|Overall Study|Disease Progression|1|||
130258199|NCT01182350|468910340|FG004|Overall Study|Disease Progression|0|||
130258200|NCT01182350|468910336|FG000|Overall Study|Death|0|||
130553929|NCT02072434|469996458|FG001|Overall Study|Withdrawal by Subject|29|||
130553930|NCT02072434|469996457|FG000|Overall Study|Other|14|||
130258201|NCT01182350|468910337|FG001|Overall Study|Death|1|||
130258202|NCT01182350|468910338|FG002|Overall Study|Death|1|||
130258203|NCT01182350|468910339|FG003|Overall Study|Death|0|||
130258204|NCT01182350|468910340|FG004|Overall Study|Death|0|||
130258205|NCT01182350|468910336|FG000|Overall Study|Withdrawal by Subject|3|||
130258206|NCT01182350|468910337|FG001|Overall Study|Withdrawal by Subject|1|||
130258207|NCT01182350|468910338|FG002|Overall Study|Withdrawal by Subject|0|||
130258208|NCT01182350|468910339|FG003|Overall Study|Withdrawal by Subject|1|||
130258209|NCT01182350|468910340|FG004|Overall Study|Withdrawal by Subject|0|||
130258210|NCT01182350|468910336|FG000|Overall Study|Alternative Therapy|2|||
130258211|NCT01182350|468910337|FG001|Overall Study|Alternative Therapy|0|||
130258212|NCT01182350|468910338|FG002|Overall Study|Alternative Therapy|1|||
130258213|NCT01182350|468910339|FG003|Overall Study|Alternative Therapy|0|||
130258214|NCT01182350|468910340|FG004|Overall Study|Alternative Therapy|0|||
130258215|NCT01182350|468910336|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
130258216|NCT01182350|468910337|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130258217|NCT01182350|468910338|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130258218|NCT01182350|468910339|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130258219|NCT01182350|468910340|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130258220|NCT01182350|468910336|FG000|Overall Study|Unevaluable for Biopsy|0|||
130258221|NCT01182350|468910337|FG001|Overall Study|Unevaluable for Biopsy|0|||
130258222|NCT01182350|468910338|FG002|Overall Study|Unevaluable for Biopsy|0|||
130258223|NCT01182350|468910339|FG003|Overall Study|Unevaluable for Biopsy|0|||
130258224|NCT01182350|468910340|FG004|Overall Study|Unevaluable for Biopsy|3|||
130258225|NCT03898180|468910341|FG000|Overall Study|Death|178|||
130258226|NCT03898180|468910342|FG001|Overall Study|Death|173|||
130258227|NCT03898180|468910341|FG000|Overall Study|Physician Decision|1|||
130258228|NCT03898180|468910342|FG001|Overall Study|Physician Decision|0|||
130258229|NCT03898180|468910341|FG000|Overall Study|Sponsor Decision|3|||
130258230|NCT03898180|468910342|FG001|Overall Study|Sponsor Decision|0|||
130258231|NCT03898180|468910341|FG000|Overall Study|Lost to Follow-up|1|||
130258232|NCT03898180|468910342|FG001|Overall Study|Lost to Follow-up|0|||
130258233|NCT03898180|468910341|FG000|Overall Study|Withdrawal by Subject|5|||
130258234|NCT03898180|468910342|FG001|Overall Study|Withdrawal by Subject|4|||
130258235|NCT02507934|468910343|FG000|Overall Study|Lost to Follow-up|2|||
130258236|NCT02507934|468910344|FG001|Overall Study|Lost to Follow-up|0|||
130258237|NCT02507934|468910343|FG000|Overall Study|Withdrawal by Subject|2|||
130258238|NCT02507934|468910344|FG001|Overall Study|Withdrawal by Subject|0|||
130258239|NCT03559530|468910345|FG000|Overall Study|non-location of medical records|44|||
130258240|NCT03559530|468910346|FG001|Overall Study|non-location of medical records|0|||
130258241|NCT03559530|468910345|FG000|Overall Study|culture results not considered for treat|29|||
130258242|NCT03559530|468910346|FG001|Overall Study|culture results not considered for treat|0|||
130258243|NCT03559530|468910345|FG000|Overall Study|duplicate cases|8|||
130258244|NCT03559530|468910346|FG001|Overall Study|duplicate cases|0|||
130258245|NCT03559530|468910345|FG000|Overall Study|other species of Acinetobacte|7|||
130258246|NCT03559530|468910346|FG001|Overall Study|other species of Acinetobacte|0|||
130258247|NCT03559530|468910345|FG000|Overall Study|contamination / colonization|3|||
130258248|NCT03559530|468910346|FG001|Overall Study|contamination / colonization|0|||
130258249|NCT03331354|468910347|FG000|Overall Study|Withdrawal by Subject|1|||
130258250|NCT03331354|468910348|FG001|Overall Study|Withdrawal by Subject|3|||
130258251|NCT03331354|468910347|FG000|Overall Study|Lost to Follow-up|3|||
130258252|NCT03331354|468910348|FG001|Overall Study|Lost to Follow-up|3|||
130258253|NCT03331354|468910347|FG000|Overall Study|Found employment before initiated active intervention|0|||
130258254|NCT03331354|468910348|FG001|Overall Study|Found employment before initiated active intervention|4|||
130258255|NCT01646827|468910349|FG000|Overall Study|Lost to Follow-up|0|||
130258256|NCT01646827|468910350|FG001|Overall Study|Lost to Follow-up|3|||
130258257|NCT01646827|468910349|FG000|Overall Study|Physician Decision|1|||
130258258|NCT01646827|468910350|FG001|Overall Study|Physician Decision|2|||
130258259|NCT01646827|468910349|FG000|Overall Study|Withdrawal by Subject|1|||
130258260|NCT01646827|468910350|FG001|Overall Study|Withdrawal by Subject|0|||
130258261|NCT00928668|468910353|FG000|Overall Study|Adverse Event|1|||
130258262|NCT00928668|468910354|FG001|Overall Study|Adverse Event|0|||
130258263|NCT00928668|468910355|FG002|Overall Study|Adverse Event|0|||
130258264|NCT00928668|468910356|FG003|Overall Study|Adverse Event|0|||
130258265|NCT00928668|468910357|FG004|Overall Study|Adverse Event|0|||
130258266|NCT00928668|468910353|FG000|Overall Study|Protocol Violation|0|||
130258267|NCT00928668|468910354|FG001|Overall Study|Protocol Violation|0|||
130258268|NCT00928668|468910355|FG002|Overall Study|Protocol Violation|0|||
130258269|NCT00928668|468910356|FG003|Overall Study|Protocol Violation|0|||
130258270|NCT00928668|468910357|FG004|Overall Study|Protocol Violation|1|||
130258271|NCT00928668|468910353|FG000|Overall Study|Withdrawal by Subject|0|||
130258272|NCT00928668|468910354|FG001|Overall Study|Withdrawal by Subject|1|||
130258273|NCT00928668|468910355|FG002|Overall Study|Withdrawal by Subject|1|||
130258274|NCT00928668|468910356|FG003|Overall Study|Withdrawal by Subject|0|||
130258275|NCT00928668|468910357|FG004|Overall Study|Withdrawal by Subject|0|||
130258276|NCT00928668|468910353|FG000|Overall Study|Other reasons not listed above|0|||
130702317|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702318|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702319|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702320|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
130258277|NCT00928668|468910354|FG001|Overall Study|Other reasons not listed above|0|||
130258278|NCT00928668|468910355|FG002|Overall Study|Other reasons not listed above|0|||
130258279|NCT00928668|468910356|FG003|Overall Study|Other reasons not listed above|1|||
130258280|NCT00928668|468910357|FG004|Overall Study|Other reasons not listed above|0|||
130258281|NCT01767987|468910361|FG000|Overall Study|Physician Decision|4|||
130258282|NCT01767987|468910362|FG001|Overall Study|Physician Decision|1|||
130258283|NCT03232567|468910363|FG000|Overall Study|Withdrawal by Subject|0|||
130258284|NCT03232567|468910364|FG001|Overall Study|Withdrawal by Subject|1|||
130258285|NCT03232567|468910365|FG002|Overall Study|Withdrawal by Subject|0|||
130258286|NCT03232567|468910366|FG003|Overall Study|Withdrawal by Subject|0|||
130258287|NCT05837481|468910368|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
130258288|NCT05837481|468910369|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
130258289|NCT03038087|468910382|FG000|Overall Study|lost data|1|||
130258290|NCT00654355|468910383|FG000|Overall Study|Lost to Follow-up|2|||
130258291|NCT00654355|468910384|FG001|Overall Study|Lost to Follow-up|2|||
130258292|NCT05805150|468910391|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
130258293|NCT05805150|468910392|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
130258294|NCT02284893|468910393|FG000|26 Week (Short Term)|Adverse Event|1|||
130258295|NCT02284893|468910394|FG001|26 Week (Short Term)|Adverse Event|9|||
130258296|NCT02284893|468910393|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
130258297|NCT02284893|468910394|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
130258298|NCT02284893|468910393|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
130258299|NCT02284893|468910394|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
130258300|NCT02284893|468910393|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
130258301|NCT02284893|468910394|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
130258302|NCT02284893|468910393|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
130258303|NCT02284893|468910394|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
130258304|NCT02284893|468910393|FG000|26 Week (Short Term)|Other|1|||
130258305|NCT02284893|468910394|FG001|26 Week (Short Term)|Other|1|||
130258306|NCT02284893|468910393|FG000|52 Week (Long Term)|Adverse Event|3|||
130258307|NCT02284893|468910394|FG001|52 Week (Long Term)|Adverse Event|1|||
130258308|NCT02284893|468910393|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
130258309|NCT02284893|468910394|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
130258310|NCT02284893|468910393|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
130258311|NCT02284893|468910394|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
130258312|NCT02284893|468910393|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
130258313|NCT02284893|468910394|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
130258314|NCT02284893|468910393|FG000|52 Week (Long Term)|Non-Compliance|2|||
130258315|NCT02284893|468910394|FG001|52 Week (Long Term)|Non-Compliance|3|||
130258316|NCT00105066|468910401|FG000|Overall Study|Adverse Event|2|||
130258317|NCT00105066|468910402|FG001|Overall Study|Adverse Event|5|||
130258318|NCT01506726|468910415|FG000|Overall Study|Adverse Event|1|||
130258319|NCT01506726|468910416|FG001|Overall Study|Adverse Event|2|||
130258320|NCT02259231|468910423|FG000|Overall Study|Adverse Event|1|||
130258321|NCT02259231|468910424|FG001|Overall Study|Adverse Event|1|||
130258322|NCT02259231|468910425|FG002|Overall Study|Adverse Event|2|||
130258323|NCT02259231|468910426|FG003|Overall Study|Adverse Event|0|||
130258324|NCT02259231|468910427|FG004|Overall Study|Adverse Event|0|||
130258325|NCT02259231|468910428|FG005|Overall Study|Adverse Event|0|||
130258326|NCT02259231|468910429|FG006|Overall Study|Adverse Event|0|||
130258327|NCT02259231|468910423|FG000|Overall Study|Progressive Disease|4|||
130258328|NCT02259231|468910424|FG001|Overall Study|Progressive Disease|5|||
130258329|NCT02259231|468910425|FG002|Overall Study|Progressive Disease|4|||
130258330|NCT02259231|468910426|FG003|Overall Study|Progressive Disease|5|||
130258331|NCT02259231|468910427|FG004|Overall Study|Progressive Disease|4|||
130258332|NCT02259231|468910428|FG005|Overall Study|Progressive Disease|5|||
130258333|NCT02259231|468910429|FG006|Overall Study|Progressive Disease|4|||
130258334|NCT02259231|468910423|FG000|Overall Study|Sponsor termination of study|1|||
130258335|NCT02259231|468910424|FG001|Overall Study|Sponsor termination of study|0|||
130258336|NCT02259231|468910425|FG002|Overall Study|Sponsor termination of study|0|||
130258337|NCT02259231|468910426|FG003|Overall Study|Sponsor termination of study|1|||
130258338|NCT02259231|468910427|FG004|Overall Study|Sponsor termination of study|2|||
130258339|NCT02259231|468910428|FG005|Overall Study|Sponsor termination of study|1|||
130258340|NCT02259231|468910429|FG006|Overall Study|Sponsor termination of study|1|||
130258341|NCT00847730|468910433|FG000|Overall Study|Multiple interruptions in therapy|8|||
130258342|NCT04116489|468910437|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
130258343|NCT04116489|468910437|FG000|Overall Study|Withdrawal by Subject|1|||
130702321|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
130702322|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702323|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702324|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702325|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702326|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702327|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702328|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
130702329|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702330|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702331|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702332|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702333|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702334|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
130702335|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130258344|NCT02255656|468910442|FG000|Overall Study|Adverse Event|11|||
130258345|NCT02255656|468910442|FG000|Overall Study|Poor compliance to protocol|3|||
130258346|NCT02255656|468910442|FG000|Overall Study|Lost to Follow-up|30|||
130258347|NCT02255656|468910442|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
130258348|NCT02255656|468910442|FG000|Overall Study|Other|126|||
130258349|NCT03734536|468910443|FG000|Overall Study|Withdrew Consent|1|||
130258350|NCT03734536|468910444|FG001|Overall Study|Withdrew Consent|5|||
130258351|NCT03734536|468910443|FG000|Overall Study|Lost to Follow-up|10|||
130258352|NCT03734536|468910444|FG001|Overall Study|Lost to Follow-up|7|||
130258353|NCT01877278|468910445|FG000|Overall Study|Lost to Follow-up|3|||
130258354|NCT01877278|468910446|FG001|Overall Study|Lost to Follow-up|3|||
130258355|NCT05185453|468910453|FG000|Overall Study|Lost to Follow-up|13|||
130258356|NCT05185453|468910454|FG001|Overall Study|Lost to Follow-up|3|||
130258357|NCT02457793|468910455|FG000|Overall Study|Reason not specified|0|||
130258358|NCT02457793|468910456|FG001|Overall Study|Reason not specified|0|||
130258359|NCT02457793|468910457|FG002|Overall Study|Reason not specified|0|||
130258360|NCT02457793|468910458|FG003|Overall Study|Reason not specified|1|||
130258361|NCT02457793|468910459|FG004|Overall Study|Reason not specified|1|||
130258362|NCT02457793|468910460|FG005|Overall Study|Reason not specified|1|||
130258363|NCT02457793|468910455|FG000|Overall Study|Withdrawal by Subject|0|||
130258364|NCT02457793|468910456|FG001|Overall Study|Withdrawal by Subject|4|||
130258365|NCT02457793|468910457|FG002|Overall Study|Withdrawal by Subject|2|||
130258366|NCT02457793|468910458|FG003|Overall Study|Withdrawal by Subject|2|||
130258367|NCT02457793|468910459|FG004|Overall Study|Withdrawal by Subject|2|||
130258368|NCT02457793|468910460|FG005|Overall Study|Withdrawal by Subject|2|||
130258369|NCT02457793|468910455|FG000|Overall Study|Adverse Event|0|||
130258370|NCT02457793|468910456|FG001|Overall Study|Adverse Event|0|||
130258371|NCT02457793|468910457|FG002|Overall Study|Adverse Event|0|||
130258372|NCT02457793|468910458|FG003|Overall Study|Adverse Event|1|||
130258373|NCT02457793|468910459|FG004|Overall Study|Adverse Event|0|||
130258374|NCT02457793|468910460|FG005|Overall Study|Adverse Event|0|||
130258375|NCT02457793|468910455|FG000|Overall Study|Physician Decision|1|||
130258376|NCT02457793|468910456|FG001|Overall Study|Physician Decision|0|||
130258377|NCT02457793|468910457|FG002|Overall Study|Physician Decision|1|||
130258378|NCT02457793|468910458|FG003|Overall Study|Physician Decision|1|||
130258379|NCT02457793|468910459|FG004|Overall Study|Physician Decision|1|||
130258380|NCT02457793|468910460|FG005|Overall Study|Physician Decision|3|||
130258381|NCT02757768|468910465|FG000|Overall Study|Randomized Never Received Study Drug|3|||
130258382|NCT02757768|468910466|FG001|Overall Study|Randomized Never Received Study Drug|4|||
130258383|NCT02757768|468910465|FG000|Overall Study|Adverse Event|5|||
130258384|NCT02757768|468910466|FG001|Overall Study|Adverse Event|3|||
130258385|NCT02757768|468910465|FG000|Overall Study|Lack of Efficacy|2|||
130258386|NCT02757768|468910466|FG001|Overall Study|Lack of Efficacy|1|||
130258387|NCT02757768|468910465|FG000|Overall Study|Lost to Follow-up|1|||
130258388|NCT02757768|468910466|FG001|Overall Study|Lost to Follow-up|0|||
130258389|NCT02757768|468910465|FG000|Overall Study|Protocol Deviation|2|||
130258390|NCT02757768|468910466|FG001|Overall Study|Protocol Deviation|9|||
130258391|NCT02757768|468910465|FG000|Overall Study|Withdrawal by Subject|16|||
130258392|NCT02757768|468910466|FG001|Overall Study|Withdrawal by Subject|9|||
130258393|NCT02757768|468910465|FG000|Overall Study|Miscellaneous|4|||
130258394|NCT02757768|468910466|FG001|Overall Study|Miscellaneous|2|||
130258395|NCT05929326|468910467|FG000|Overall Study|unqualified sample|2|||
130258396|NCT05929326|468910468|FG001|Overall Study|unqualified sample|3|||
130258397|NCT05929326|468910469|FG002|Overall Study|unqualified sample|7|||
130258398|NCT04890509|468910470|FG000|Overall Study|Death|4|||
130258399|NCT04890509|468910471|FG001|Overall Study|Death|4|||
130258400|NCT02278003|468911768|FG000|Overall Study|Withdrawal by Subject|11|||
130258401|NCT02278003|468911769|FG001|Overall Study|Withdrawal by Subject|0|||
130258402|NCT02278003|468911768|FG000|Overall Study|Not Treated|1|||
130258403|NCT02278003|468911769|FG001|Overall Study|Not Treated|0|||
130258404|NCT02278003|468911768|FG000|Overall Study|Recognition task improperly completed|7|||
130258405|NCT02278003|468911769|FG001|Overall Study|Recognition task improperly completed|0|||
130702336|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702337|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702338|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702339|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702340|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702341|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702342|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
130258406|NCT04123704|468911772|FG000|Overall Study|Disease progression|2|||
130258407|NCT00939185|468911773|FG000|Overall Study|Adverse Event|3|||
130258408|NCT00939185|468911773|FG000|Overall Study|Lack of Efficacy|1|||
130258409|NCT00939185|468911773|FG000|Overall Study|Lost to Follow-up|6|||
130258410|NCT00939185|468911773|FG000|Overall Study|Other|3|||
130258411|NCT00939185|468911773|FG000|Overall Study|Withdrawal by Subject|2|||
130258412|NCT00939185|468911773|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
130258413|NCT00363298|468911774|FG000|First Study Week|Lack of Efficacy|6|||
130258414|NCT00363298|468911775|FG001|First Study Week|Lack of Efficacy|5|||
130258415|NCT00363298|468911774|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
130258416|NCT00363298|468911775|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
130258417|NCT03552029|468911776|FG000|Overall Study|Death|3|||
130258418|NCT03552029|468911777|FG001|Overall Study|Death|0|||
130258419|NCT03552029|468911776|FG000|Overall Study|Adverse Event|1|||
130258420|NCT03552029|468911777|FG001|Overall Study|Adverse Event|0|||
130258421|NCT03552029|468911776|FG000|Overall Study|Lack of Efficacy|0|||
130258422|NCT03552029|468911777|FG001|Overall Study|Lack of Efficacy|2|||
130258423|NCT03552029|468911776|FG000|Overall Study|Physician Decision|0|||
130258424|NCT03552029|468911777|FG001|Overall Study|Physician Decision|1|||
130258425|NCT03552029|468911776|FG000|Overall Study|Study terminated by Sponsor|0|||
130258426|NCT03552029|468911777|FG001|Overall Study|Study terminated by Sponsor|1|||
130258427|NCT03552029|468911776|FG000|Overall Study|Other|0|||
130258428|NCT03552029|468911777|FG001|Overall Study|Other|2|||
130258429|NCT03468998|468911783|FG000|Overall Study|Withdrawal by Subject|1|||
130258430|NCT03468998|468911784|FG001|Overall Study|Withdrawal by Subject|1|||
130258431|NCT03468998|468911785|FG002|Overall Study|Withdrawal by Subject|0|||
130258432|NCT03468998|468911786|FG003|Overall Study|Withdrawal by Subject|4|||
130258433|NCT03468998|468911787|FG004|Overall Study|Withdrawal by Subject|1|||
130258434|NCT03468998|468911788|FG005|Overall Study|Withdrawal by Subject|0|||
130258435|NCT00836706|468911791|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130258436|NCT00836706|468911792|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130258437|NCT02989857|468911793|FG000|Randomization Phase|Not Treated|3|||
130258438|NCT02989857|468911794|FG001|Randomization Phase|Not Treated|2|||
130258439|NCT02989857|468911795|FG002|Randomization Phase|Not Treated|0|||
130258440|NCT00633126|468911800|FG000|Overall Study|Did not receive full dose|1|||
130258441|NCT02538614|468911813|FG000|Overall Study|Progressive Disease|2|||
130365328|NCT00347360|469306870|FG006|Overall Study|Failed inclusion criteria #4|0|||
130365329|NCT00347360|469306871|FG007|Overall Study|Failed inclusion criteria #4|0|||
130365330|NCT00347360|469306872|FG008|Overall Study|Failed inclusion criteria #4|0|||
130365331|NCT00347360|469306873|FG009|Overall Study|Failed inclusion criteria #4|0|||
130365332|NCT00347360|469306874|FG010|Overall Study|Failed inclusion criteria #4|0|||
130365333|NCT00347360|469306875|FG011|Overall Study|Failed inclusion criteria #4|1|||
130365334|NCT00347360|469306876|FG012|Overall Study|Failed inclusion criteria #4|0|||
130365335|NCT00347360|469306877|FG013|Overall Study|Failed inclusion criteria #4|0|||
130365336|NCT00347360|469306878|FG014|Overall Study|Failed inclusion criteria #4|0|||
130365337|NCT00347360|469306864|FG000|Overall Study|Prolonged duration between visits|0|||
130365338|NCT00347360|469306865|FG001|Overall Study|Prolonged duration between visits|0|||
130365339|NCT00347360|469306866|FG002|Overall Study|Prolonged duration between visits|0|||
130720851|NCT04126213|470601548|FG003|Overall Study|Withdrawal by Subject|1|||
130258442|NCT01425814|468911818|FG000|Period 1|Stability criteria not fulfilled|0|||
130365340|NCT00347360|469306867|FG003|Overall Study|Prolonged duration between visits|0|||
130365341|NCT00347360|469306868|FG004|Overall Study|Prolonged duration between visits|0|||
130365342|NCT00347360|469306869|FG005|Overall Study|Prolonged duration between visits|0|||
130365343|NCT00347360|469306870|FG006|Overall Study|Prolonged duration between visits|0|||
130258443|NCT01425814|468911819|FG001|Period 1|Stability criteria not fulfilled|1|||
130258444|NCT01425814|468911820|FG002|Period 1|Stability criteria not fulfilled|0|||
130258445|NCT01425814|468911821|FG003|Period 1|Stability criteria not fulfilled|0|||
130365344|NCT00347360|469306871|FG007|Overall Study|Prolonged duration between visits|0|||
130365345|NCT00347360|469306872|FG008|Overall Study|Prolonged duration between visits|0|||
130365346|NCT00347360|469306873|FG009|Overall Study|Prolonged duration between visits|0|||
130258446|NCT01425814|468911822|FG004|Period 1|Stability criteria not fulfilled|0|||
130258447|NCT01425814|468911823|FG005|Period 1|Stability criteria not fulfilled|0|||
130258448|NCT01425814|468911818|FG000|Period 2|Stability criteria not fulfilled|0|||
130258449|NCT01425814|468911819|FG001|Period 2|Stability criteria not fulfilled|1|||
130258450|NCT01425814|468911820|FG002|Period 2|Stability criteria not fulfilled|0|||
130258451|NCT01425814|468911821|FG003|Period 2|Stability criteria not fulfilled|0|||
130258452|NCT01425814|468911822|FG004|Period 2|Stability criteria not fulfilled|0|||
130258453|NCT01425814|468911823|FG005|Period 2|Stability criteria not fulfilled|0|||
130258454|NCT01425814|468911818|FG000|Period 3|Adverse Event|0|||
130258455|NCT01425814|468911819|FG001|Period 3|Adverse Event|0|||
130702343|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702344|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702345|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702346|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702347|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
130702348|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
130702349|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702350|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130702351|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702352|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702353|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702354|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702355|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702356|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130702357|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702358|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
130702359|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702360|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702361|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702362|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702363|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702364|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702365|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702366|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
130702367|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702368|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130258456|NCT01425814|468911820|FG002|Period 3|Adverse Event|0|||
130258457|NCT01425814|468911821|FG003|Period 3|Adverse Event|0|||
130258458|NCT01425814|468911822|FG004|Period 3|Adverse Event|0|||
130258459|NCT01425814|468911823|FG005|Period 3|Adverse Event|1|||
130258460|NCT01425814|468911818|FG000|Period 4|Adverse Event|1|||
130258461|NCT01425814|468911819|FG001|Period 4|Adverse Event|0|||
130258462|NCT01425814|468911820|FG002|Period 4|Adverse Event|1|||
130258463|NCT01425814|468911821|FG003|Period 4|Adverse Event|0|||
130258464|NCT01425814|468911822|FG004|Period 4|Adverse Event|0|||
130258465|NCT01425814|468911823|FG005|Period 4|Adverse Event|0|||
130258466|NCT01425814|468911818|FG000|Period 5|Stability criteria not fulfilled|0|||
130258467|NCT01425814|468911819|FG001|Period 5|Stability criteria not fulfilled|0|||
130258468|NCT01425814|468911820|FG002|Period 5|Stability criteria not fulfilled|1|||
130258469|NCT01425814|468911821|FG003|Period 5|Stability criteria not fulfilled|0|||
130258470|NCT01425814|468911822|FG004|Period 5|Stability criteria not fulfilled|0|||
130258471|NCT01425814|468911823|FG005|Period 5|Stability criteria not fulfilled|1|||
130258472|NCT00565747|468911825|FG000|Overall Study|No embryo transfer|67|||
130258473|NCT00565747|468911826|FG001|Overall Study|No embryo transfer|73|||
130258474|NCT02684461|468911829|FG000|Overall Study|Adverse Event|1|||
130258475|NCT02684461|468911830|FG001|Overall Study|Adverse Event|0|||
130258476|NCT02684461|468911831|FG002|Overall Study|Adverse Event|0|||
130258477|NCT02684461|468911829|FG000|Overall Study|Lack of Efficacy|1|||
130258478|NCT02684461|468911830|FG001|Overall Study|Lack of Efficacy|2|||
130258479|NCT02684461|468911831|FG002|Overall Study|Lack of Efficacy|0|||
130258480|NCT02390076|468911832|FG000|Overall Study|Lost to Follow-up|2|||
130258481|NCT02390076|468911833|FG001|Overall Study|Lost to Follow-up|1|||
130258482|NCT02390076|468911834|FG002|Overall Study|Lost to Follow-up|4|||
130258483|NCT01358734|468911840|FG000|Overall Study|Adverse Event|4|||
130258484|NCT01358734|468911841|FG001|Overall Study|Adverse Event|7|||
130258485|NCT01358734|468911842|FG002|Overall Study|Adverse Event|3|||
130258486|NCT01358734|468911840|FG000|Overall Study|Lack of Efficacy|0|||
130258487|NCT01358734|468911841|FG001|Overall Study|Lack of Efficacy|1|||
130258488|NCT01358734|468911842|FG002|Overall Study|Lack of Efficacy|3|||
130258489|NCT01358734|468911840|FG000|Overall Study|Withdrawal by Subject|1|||
130258490|NCT01358734|468911841|FG001|Overall Study|Withdrawal by Subject|6|||
130702369|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702370|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702371|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702372|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702373|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130258491|NCT01358734|468911842|FG002|Overall Study|Withdrawal by Subject|3|||
130258492|NCT01358734|468911840|FG000|Overall Study|Death|3|||
130258493|NCT01358734|468911841|FG001|Overall Study|Death|7|||
130258494|NCT01358734|468911842|FG002|Overall Study|Death|2|||
130258495|NCT01358734|468911840|FG000|Overall Study|Progressive Disease|5|||
130258496|NCT01358734|468911841|FG001|Overall Study|Progressive Disease|13|||
130258497|NCT01358734|468911842|FG002|Overall Study|Progressive Disease|16|||
130258498|NCT01358734|468911840|FG000|Overall Study|Non-compliance with study drug|0|||
130258499|NCT01358734|468911841|FG001|Overall Study|Non-compliance with study drug|0|||
130258500|NCT01358734|468911842|FG002|Overall Study|Non-compliance with study drug|1|||
130258501|NCT01358734|468911840|FG000|Overall Study|Other|2|||
130258502|NCT01358734|468911841|FG001|Overall Study|Other|5|||
130258503|NCT01358734|468911842|FG002|Overall Study|Other|4|||
130258504|NCT01358734|468911840|FG000|Overall Study|Protocol Violation|0|||
130258505|NCT01358734|468911841|FG001|Overall Study|Protocol Violation|0|||
130258506|NCT01358734|468911842|FG002|Overall Study|Protocol Violation|2|||
130258507|NCT03243084|468911846|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
130553931|NCT02072434|469996458|FG001|Overall Study|Other|29|||
130553932|NCT02072434|469996457|FG000|Overall Study|Lost to Follow-up|0|||
130553933|NCT02072434|469996458|FG001|Overall Study|Lost to Follow-up|1|||
130258508|NCT03243084|468911847|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
130258509|NCT02095106|468911848|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130258510|NCT02095106|468911849|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130258511|NCT00553254|468911852|FG000|Overall Study|Death|3|||
130258512|NCT00553254|468911853|FG001|Overall Study|Death|6|||
130258513|NCT00553254|468911854|FG002|Overall Study|Death|25|||
130258514|NCT00553254|468911852|FG000|Overall Study|Lost to Follow-up|0|||
130258515|NCT00553254|468911853|FG001|Overall Study|Lost to Follow-up|0|||
130258516|NCT00553254|468911854|FG002|Overall Study|Lost to Follow-up|2|||
130258517|NCT00553254|468911852|FG000|Overall Study|Withdrawal by Subject|2|||
130258518|NCT00553254|468911853|FG001|Overall Study|Withdrawal by Subject|0|||
130258519|NCT00553254|468911854|FG002|Overall Study|Withdrawal by Subject|2|||
130258520|NCT00553254|468911852|FG000|Overall Study|Study terminated by Sponsor|0|||
130258521|NCT00553254|468911853|FG001|Overall Study|Study terminated by Sponsor|0|||
130258522|NCT00553254|468911854|FG002|Overall Study|Study terminated by Sponsor|1|||
130258523|NCT00553254|468911852|FG000|Overall Study|Other|1|||
130258524|NCT00553254|468911853|FG001|Overall Study|Other|0|||
130258525|NCT00553254|468911854|FG002|Overall Study|Other|13|||
130258526|NCT02300233|468911862|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
130258527|NCT02300233|468911863|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130258528|NCT02300233|468911864|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
130258529|NCT02300233|468911862|FG000|Overall Study|Withdrawal by Subject|1|||
130258530|NCT02300233|468911863|FG001|Overall Study|Withdrawal by Subject|0|||
130258531|NCT02300233|468911864|FG002|Overall Study|Withdrawal by Subject|3|||
130258532|NCT02300233|468911862|FG000|Overall Study|Investigator Judgement|0|||
130258533|NCT02300233|468911863|FG001|Overall Study|Investigator Judgement|0|||
130258534|NCT02300233|468911864|FG002|Overall Study|Investigator Judgement|1|||
130258535|NCT02300233|468911862|FG000|Overall Study|Reason Not Specified|0|||
130258536|NCT02300233|468911863|FG001|Overall Study|Reason Not Specified|0|||
130258537|NCT02300233|468911864|FG002|Overall Study|Reason Not Specified|5|||
130258538|NCT00833690|468911865|FG000|Overall Study|Withdrawal by Subject|1|||
130258539|NCT00833690|468911866|FG001|Overall Study|Withdrawal by Subject|0|||
130258540|NCT00833690|468911867|FG002|Overall Study|Withdrawal by Subject|0|||
130258541|NCT00833690|468911865|FG000|Overall Study|Discontinued study drug|3|||
130258542|NCT00833690|468911866|FG001|Overall Study|Discontinued study drug|2|||
130258543|NCT00833690|468911867|FG002|Overall Study|Discontinued study drug|0|||
130258544|NCT05448950|468911868|FG000|Overall Study|Death|2|||
130553934|NCT02634346|469996459|FG000|Overall Study|Withdrawal by Subject|8|||
130258545|NCT05448950|468911868|FG000|Overall Study|Withdrawal by Subject|1|||
130258546|NCT05448950|468911868|FG000|Overall Study|AVG abandoned|4|||
130258547|NCT04752566|468911869|FG000|Overall Study|Protocol Violation|0|||
130258548|NCT04752566|468911870|FG001|Overall Study|Protocol Violation|1|||
130258549|NCT04752566|468911869|FG000|Overall Study|Death|1|||
130258550|NCT04752566|468911870|FG001|Overall Study|Death|0|||
130258551|NCT04752566|468911869|FG000|Overall Study|Adverse Event|1|||
130258552|NCT04752566|468911870|FG001|Overall Study|Adverse Event|0|||
130258553|NCT04752566|468911869|FG000|Overall Study|Withdrawal by Subject|2|||
130258554|NCT04752566|468911870|FG001|Overall Study|Withdrawal by Subject|0|||
130258555|NCT04752566|468911869|FG000|Overall Study|Physician Decision|1|||
130258556|NCT04752566|468911870|FG001|Overall Study|Physician Decision|1|||
130365347|NCT00347360|469306874|FG010|Overall Study|Prolonged duration between visits|0|||
130365348|NCT00347360|469306875|FG011|Overall Study|Prolonged duration between visits|0|||
130258557|NCT01153516|468911871|FG000|Overall Study|Both subjects refused surgery|2|||
130258558|NCT01153516|468911872|FG001|Overall Study|Both subjects refused surgery|0|||
130258559|NCT03773484|468911873|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
130258560|NCT01889251|468911874|FG000|Overall Study|Adverse Event|1|||
130258561|NCT01889251|468911875|FG001|Overall Study|Adverse Event|0|||
130258562|NCT01344226|468911880|FG000|Overall Study|Protocol Violation|2|||
130258563|NCT01344226|468911880|FG000|Overall Study|Withdrawal by Subject|3|||
130258564|NCT01344226|468911880|FG000|Overall Study|Lack of Efficacy|3|||
130258565|NCT02302222|468911883|FG000|Overall Study|Physician Decision|0|||
130258566|NCT02302222|468911884|FG001|Overall Study|Physician Decision|4|||
130258567|NCT02302222|468911883|FG000|Overall Study|Lost to Follow-up|1|||
130258568|NCT02302222|468911884|FG001|Overall Study|Lost to Follow-up|0|||
130258569|NCT02302222|468911883|FG000|Overall Study|Treatment discontinued before day 5|0|||
130258570|NCT02302222|468911884|FG001|Overall Study|Treatment discontinued before day 5|1|||
130258571|NCT02302222|468911883|FG000|Overall Study|Withdrawn prior to any treatment|0|||
130258572|NCT02302222|468911884|FG001|Overall Study|Withdrawn prior to any treatment|1|||
130258573|NCT03781570|468911890|FG000|Overall Study|Technical Issues (equipment failure)|31|||
130258574|NCT03781570|468911890|FG000|Overall Study|Withdrawal by Subject|7|||
130258575|NCT03781570|468911890|FG000|Overall Study|Physical Constraints|11|||
130258576|NCT01107496|468911891|FG000|Overall Study|Adverse Event|1|||
130258577|NCT01107496|468911892|FG001|Overall Study|Adverse Event|0|||
130258578|NCT01107496|468911891|FG000|Overall Study|Lack of Efficacy|1|||
130258579|NCT01107496|468911892|FG001|Overall Study|Lack of Efficacy|0|||
130258580|NCT01107496|468911891|FG000|Overall Study|Protocol Violation|0|||
130258581|NCT01107496|468911892|FG001|Overall Study|Protocol Violation|1|||
130258582|NCT01107496|468911891|FG000|Overall Study|Lost to Follow-up|0|||
130258583|NCT01107496|468911892|FG001|Overall Study|Lost to Follow-up|1|||
130258584|NCT03709472|468911893|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
130258585|NCT03709472|468911894|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
130365349|NCT00347360|469306876|FG012|Overall Study|Prolonged duration between visits|1|||
130365350|NCT00347360|469306877|FG013|Overall Study|Prolonged duration between visits|0|||
130365351|NCT00347360|469306878|FG014|Overall Study|Prolonged duration between visits|0|||
130365352|NCT00347360|469306864|FG000|Overall Study|Subject left town, ran out of study drug|0|||
130365353|NCT00347360|469306865|FG001|Overall Study|Subject left town, ran out of study drug|0|||
130365354|NCT00347360|469306866|FG002|Overall Study|Subject left town, ran out of study drug|0|||
130365355|NCT00347360|469306867|FG003|Overall Study|Subject left town, ran out of study drug|0|||
130365356|NCT00347360|469306868|FG004|Overall Study|Subject left town, ran out of study drug|0|||
130365357|NCT00347360|469306869|FG005|Overall Study|Subject left town, ran out of study drug|0|||
130365358|NCT00347360|469306870|FG006|Overall Study|Subject left town, ran out of study drug|0|||
130702374|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
130702375|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702376|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702377|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702378|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702379|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
130702380|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
130702381|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
130702382|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702383|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702384|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702385|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702386|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702387|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702388|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702389|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
130702390|NCT01958060|470534431|FG000|Overall Study|Not treated|2|||
130702391|NCT01958060|470534432|FG001|Overall Study|Not treated|0|||
130702392|NCT01958060|470534433|FG002|Overall Study|Not treated|0|||
130702393|NCT01958060|470534434|FG003|Overall Study|Not treated|0|||
130702394|NCT01958060|470534435|FG004|Overall Study|Not treated|1|||
130702395|NCT01958060|470534436|FG005|Overall Study|Not treated|0|||
130702396|NCT01636934|470534456|FG000|Overall Study|Withdrawal by Subject|3|||
130702397|NCT01636934|470534457|FG001|Overall Study|Withdrawal by Subject|2|||
130702398|NCT01636934|470534456|FG000|Overall Study|Chemo cancel|1|||
130258586|NCT03709472|468911893|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
130258587|NCT03709472|468911894|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
130258588|NCT03559556|468911895|FG000|Overall Study|Withdrawal by Subject|1|||
130258589|NCT02496000|468911897|FG000|Overall Study|Withdrawal by Subject|1|||
130258590|NCT02496000|468911898|FG001|Overall Study|Withdrawal by Subject|2|||
130258591|NCT02496000|468911899|FG002|Overall Study|Withdrawal by Subject|0|||
130258592|NCT02496000|468911897|FG000|Overall Study|Lost to Follow-up|1|||
130258593|NCT02496000|468911898|FG001|Overall Study|Lost to Follow-up|0|||
130258594|NCT02496000|468911899|FG002|Overall Study|Lost to Follow-up|1|||
130258595|NCT02496000|468911897|FG000|Overall Study|Protocol Violation|0|||
130258596|NCT02496000|468911898|FG001|Overall Study|Protocol Violation|0|||
130258597|NCT02496000|468911899|FG002|Overall Study|Protocol Violation|1|||
130258598|NCT02496000|468911897|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
130258599|NCT02496000|468911898|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
130258600|NCT02496000|468911899|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
130258601|NCT02496000|468911897|FG000|Overall Study|undetermined|0|||
130258602|NCT02496000|468911898|FG001|Overall Study|undetermined|1|||
130258603|NCT02496000|468911899|FG002|Overall Study|undetermined|0|||
130258604|NCT03274466|468911900|FG000|Overall Study|Withdrawal by Subject|7|||
130258605|NCT03274466|468911901|FG001|Overall Study|Withdrawal by Subject|3|||
130258606|NCT03274466|468911900|FG000|Overall Study|Protocol Specified Withdrawal|5|||
130258607|NCT03274466|468911901|FG001|Overall Study|Protocol Specified Withdrawal|11|||
130258608|NCT03274466|468911900|FG000|Overall Study|Lost to Follow-up|5|||
130258609|NCT03274466|468911901|FG001|Overall Study|Lost to Follow-up|7|||
130258610|NCT03274466|468911900|FG000|Overall Study|Subject Non-compliance|0|||
130258611|NCT03274466|468911901|FG001|Overall Study|Subject Non-compliance|1|||
130258612|NCT03274466|468911900|FG000|Overall Study|Adverse Event|3|||
130258613|NCT03274466|468911901|FG001|Overall Study|Adverse Event|3|||
130258614|NCT03274466|468911900|FG000|Overall Study|Physician Decision|0|||
130258615|NCT03274466|468911901|FG001|Overall Study|Physician Decision|1|||
130258616|NCT03274466|468911900|FG000|Overall Study|Protocol Violation|3|||
130258617|NCT03274466|468911901|FG001|Overall Study|Protocol Violation|3|||
130258618|NCT00618787|468911902|FG000|Overall Study|Adverse Event|0|||
130258619|NCT00618787|468911903|FG001|Overall Study|Adverse Event|1|||
130258620|NCT00618787|468911902|FG000|Overall Study|Withdrawal by Subject|2|||
130258621|NCT00618787|468911903|FG001|Overall Study|Withdrawal by Subject|1|||
130258622|NCT00618787|468911902|FG000|Overall Study|Lost to Follow-up|1|||
130258623|NCT00618787|468911903|FG001|Overall Study|Lost to Follow-up|0|||
130258624|NCT01107886|468911904|FG000|Overall Study|Lost to Follow-up|15|||
130258625|NCT01107886|468911905|FG001|Overall Study|Lost to Follow-up|13|||
130258626|NCT01107886|468911904|FG000|Overall Study|Withdrawal by Subject|180|||
130258627|NCT01107886|468911905|FG001|Overall Study|Withdrawal by Subject|196|||
130258628|NCT01107886|468911904|FG000|Overall Study|Administrative withdrawal of consent|7|||
130258629|NCT01107886|468911905|FG001|Overall Study|Administrative withdrawal of consent|5|||
130258630|NCT01649869|468911910|FG000|Overall Study|Family member illness|1|||
130258631|NCT01649869|468911911|FG001|Overall Study|Family member illness|0|||
130258632|NCT01649869|468911910|FG000|Overall Study|Required treatment outside protocol|1|||
130258633|NCT01649869|468911911|FG001|Overall Study|Required treatment outside protocol|0|||
130258634|NCT01649869|468911910|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
130258635|NCT01649869|468911911|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
130258636|NCT02333799|468914660|FG000|Treatment Period|Withdrawal by Subject|1|||
130258637|NCT02333799|468914660|FG000|Treatment Period|Death|6|||
130258638|NCT02333799|468914660|FG000|6 Month Follow Up Period|Physician Decision|1|||
130258639|NCT02333799|468914660|FG000|6 Month Follow Up Period|Death|1|||
130258640|NCT02333799|468914660|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
130258641|NCT02333799|468914660|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
130258642|NCT01657370|468914664|FG000|Overall Study|Withdrawal by Subject|0|||
130258643|NCT01657370|468914665|FG001|Overall Study|Withdrawal by Subject|0|||
130258644|NCT01657370|468914666|FG002|Overall Study|Withdrawal by Subject|1|||
130258645|NCT01657370|468914667|FG003|Overall Study|Withdrawal by Subject|0|||
130258646|NCT01657370|468914668|FG004|Overall Study|Withdrawal by Subject|0|||
130258647|NCT01657370|468914669|FG005|Overall Study|Withdrawal by Subject|1|||
130258648|NCT01657370|468914664|FG000|Overall Study|Physician Decision|2|||
130258649|NCT01657370|468914665|FG001|Overall Study|Physician Decision|3|||
130258650|NCT01657370|468914666|FG002|Overall Study|Physician Decision|1|||
130258651|NCT01657370|468914667|FG003|Overall Study|Physician Decision|2|||
130258652|NCT01657370|468914668|FG004|Overall Study|Physician Decision|5|||
130258653|NCT01657370|468914669|FG005|Overall Study|Physician Decision|0|||
130258654|NCT01657370|468914664|FG000|Overall Study|Lack of Qualifying Event|1|||
130258655|NCT01657370|468914665|FG001|Overall Study|Lack of Qualifying Event|0|||
130258656|NCT01657370|468914666|FG002|Overall Study|Lack of Qualifying Event|3|||
130258657|NCT01657370|468914667|FG003|Overall Study|Lack of Qualifying Event|2|||
130258658|NCT01657370|468914668|FG004|Overall Study|Lack of Qualifying Event|1|||
130258659|NCT01657370|468914669|FG005|Overall Study|Lack of Qualifying Event|2|||
130258660|NCT01657370|468914664|FG000|Overall Study|Adverse Event|0|||
130258661|NCT01657370|468914665|FG001|Overall Study|Adverse Event|0|||
130258662|NCT01657370|468914666|FG002|Overall Study|Adverse Event|0|||
130258663|NCT01657370|468914667|FG003|Overall Study|Adverse Event|0|||
130258664|NCT01657370|468914668|FG004|Overall Study|Adverse Event|1|||
130258665|NCT01657370|468914669|FG005|Overall Study|Adverse Event|0|||
130258666|NCT01657370|468914664|FG000|Overall Study|Protocol Violation|1|||
130258667|NCT01657370|468914665|FG001|Overall Study|Protocol Violation|1|||
130258668|NCT01657370|468914666|FG002|Overall Study|Protocol Violation|1|||
130258669|NCT01657370|468914667|FG003|Overall Study|Protocol Violation|1|||
130258670|NCT01657370|468914668|FG004|Overall Study|Protocol Violation|0|||
130258671|NCT01657370|468914669|FG005|Overall Study|Protocol Violation|0|||
130258672|NCT01657370|468914664|FG000|Overall Study|Lost to Follow-up|2|||
130258673|NCT01657370|468914665|FG001|Overall Study|Lost to Follow-up|0|||
130365359|NCT00347360|469306871|FG007|Overall Study|Subject left town, ran out of study drug|0|||
130553935|NCT02634346|469996460|FG001|Overall Study|Withdrawal by Subject|9|||
130702399|NCT01636934|470534457|FG001|Overall Study|Chemo cancel|0|||
130702400|NCT01636934|470534456|FG000|Overall Study|Too ill to continue|1|||
130702401|NCT01636934|470534457|FG001|Overall Study|Too ill to continue|0|||
130702402|NCT01636934|470534456|FG000|Overall Study|Never started study medication|1|||
130702403|NCT01636934|470534457|FG001|Overall Study|Never started study medication|1|||
130702404|NCT01011335|470534458|FG000|Overall Study|Lost to Follow-up|0|||
130702405|NCT01011335|470534459|FG001|Overall Study|Lost to Follow-up|0|||
130702406|NCT01011335|470534460|FG002|Overall Study|Lost to Follow-up|1|||
130702407|NCT01011335|470534461|FG003|Overall Study|Lost to Follow-up|1|||
130702408|NCT01011335|470534462|FG004|Overall Study|Lost to Follow-up|1|||
130702409|NCT01011335|470534463|FG005|Overall Study|Lost to Follow-up|1|||
130702410|NCT01011335|470534464|FG006|Overall Study|Lost to Follow-up|2|||
130702411|NCT01011335|470534465|FG007|Overall Study|Lost to Follow-up|2|||
130702412|NCT01011335|470534466|FG008|Overall Study|Lost to Follow-up|1|||
130702413|NCT01011335|470534467|FG009|Overall Study|Lost to Follow-up|0|||
130702414|NCT01011335|470534468|FG010|Overall Study|Lost to Follow-up|0|||
130702415|NCT01011335|470534469|FG011|Overall Study|Lost to Follow-up|1|||
130702416|NCT01011335|470534470|FG012|Overall Study|Lost to Follow-up|2|||
130702417|NCT01011335|470534458|FG000|Overall Study|Protocol Violation|0|||
130702418|NCT01011335|470534459|FG001|Overall Study|Protocol Violation|1|||
130702419|NCT01011335|470534460|FG002|Overall Study|Protocol Violation|0|||
130702420|NCT01011335|470534461|FG003|Overall Study|Protocol Violation|0|||
130702421|NCT01011335|470534462|FG004|Overall Study|Protocol Violation|0|||
130702422|NCT01011335|470534463|FG005|Overall Study|Protocol Violation|0|||
130702423|NCT01011335|470534464|FG006|Overall Study|Protocol Violation|0|||
130702424|NCT01011335|470534465|FG007|Overall Study|Protocol Violation|0|||
130702425|NCT01011335|470534466|FG008|Overall Study|Protocol Violation|0|||
130702426|NCT01011335|470534467|FG009|Overall Study|Protocol Violation|0|||
130702427|NCT01011335|470534468|FG010|Overall Study|Protocol Violation|0|||
130702428|NCT01011335|470534469|FG011|Overall Study|Protocol Violation|0|||
130702429|NCT01011335|470534470|FG012|Overall Study|Protocol Violation|0|||
130702430|NCT01011335|470534458|FG000|Overall Study|Moved/deployed or no booster|1|||
130702431|NCT01011335|470534459|FG001|Overall Study|Moved/deployed or no booster|0|||
130702432|NCT01011335|470534460|FG002|Overall Study|Moved/deployed or no booster|0|||
130702433|NCT01011335|470534461|FG003|Overall Study|Moved/deployed or no booster|1|||
130702434|NCT01011335|470534462|FG004|Overall Study|Moved/deployed or no booster|0|||
130702435|NCT01011335|470534463|FG005|Overall Study|Moved/deployed or no booster|0|||
130702436|NCT01011335|470534464|FG006|Overall Study|Moved/deployed or no booster|1|||
130702437|NCT01011335|470534465|FG007|Overall Study|Moved/deployed or no booster|0|||
130702438|NCT01011335|470534466|FG008|Overall Study|Moved/deployed or no booster|1|||
130702439|NCT01011335|470534467|FG009|Overall Study|Moved/deployed or no booster|0|||
130702440|NCT01011335|470534468|FG010|Overall Study|Moved/deployed or no booster|2|||
130702441|NCT01011335|470534469|FG011|Overall Study|Moved/deployed or no booster|0|||
130702442|NCT01011335|470534470|FG012|Overall Study|Moved/deployed or no booster|0|||
130702443|NCT01011335|470534458|FG000|Overall Study|Adverse Event|0|||
130702444|NCT01011335|470534459|FG001|Overall Study|Adverse Event|0|||
130702445|NCT01011335|470534460|FG002|Overall Study|Adverse Event|0|||
130702446|NCT01011335|470534461|FG003|Overall Study|Adverse Event|0|||
130702447|NCT01011335|470534462|FG004|Overall Study|Adverse Event|0|||
130702448|NCT01011335|470534463|FG005|Overall Study|Adverse Event|0|||
130702449|NCT01011335|470534464|FG006|Overall Study|Adverse Event|0|||
130702450|NCT01011335|470534465|FG007|Overall Study|Adverse Event|0|||
130702451|NCT01011335|470534466|FG008|Overall Study|Adverse Event|0|||
130702452|NCT01011335|470534467|FG009|Overall Study|Adverse Event|0|||
130702453|NCT01011335|470534468|FG010|Overall Study|Adverse Event|4|||
130702454|NCT01011335|470534469|FG011|Overall Study|Adverse Event|0|||
130702455|NCT01011335|470534470|FG012|Overall Study|Adverse Event|1|||
130702456|NCT02459418|470534475|FG000|Overall Study|Exclusion Criteria|4|||
130553936|NCT02634346|469996461|FG002|Overall Study|Withdrawal by Subject|8|||
130258674|NCT01657370|468914666|FG002|Overall Study|Lost to Follow-up|1|||
130258675|NCT01657370|468914667|FG003|Overall Study|Lost to Follow-up|0|||
130258676|NCT01657370|468914668|FG004|Overall Study|Lost to Follow-up|0|||
130553937|NCT02634346|469996459|FG000|Overall Study|Adverse Event|2|||
130702457|NCT02459418|470534476|FG001|Overall Study|Exclusion Criteria|0|||
130702458|NCT02459418|470534475|FG000|Overall Study|Protocol Violation|0|||
130702459|NCT02459418|470534476|FG001|Overall Study|Protocol Violation|2|||
130702460|NCT02459418|470534475|FG000|Overall Study|Physician Decision|0|||
130702461|NCT02459418|470534476|FG001|Overall Study|Physician Decision|2|||
130702462|NCT02459418|470534475|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
130702463|NCT02459418|470534476|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
130702464|NCT02459418|470534475|FG000|Overall Study|Adverse Event|0|||
130702465|NCT02459418|470534476|FG001|Overall Study|Adverse Event|1|||
130702466|NCT02459418|470534475|FG000|Overall Study|Withdrawal by Subject|1|||
130258677|NCT01657370|468914669|FG005|Overall Study|Lost to Follow-up|1|||
130258678|NCT03440385|468914680|FG000|Overall Study|Other Reason|4|||
130258679|NCT03440385|468914681|FG001|Overall Study|Other Reason|1|||
130258680|NCT03440385|468914680|FG000|Overall Study|Site Closed|1|||
130258681|NCT03440385|468914681|FG001|Overall Study|Site Closed|0|||
130258682|NCT03440385|468914680|FG000|Overall Study|Lost to Follow-up|2|||
130258683|NCT03440385|468914681|FG001|Overall Study|Lost to Follow-up|0|||
130258684|NCT03440385|468914680|FG000|Overall Study|Withdrawal by Subject|12|||
130258685|NCT03440385|468914681|FG001|Overall Study|Withdrawal by Subject|6|||
130258686|NCT03440385|468914680|FG000|Overall Study|Lack of Efficacy|9|||
130258687|NCT03440385|468914681|FG001|Overall Study|Lack of Efficacy|2|||
130258688|NCT03440385|468914680|FG000|Overall Study|Adverse Event|15|||
130258689|NCT03440385|468914681|FG001|Overall Study|Adverse Event|11|||
130258690|NCT01168596|468914687|FG000|Overall Study|Withdrawal by Subject|3|||
130258691|NCT01168596|468914688|FG001|Overall Study|Withdrawal by Subject|1|||
130258692|NCT00876447|468914691|FG000|Overall Study|Other miscellaneous reasons|3|||
130258693|NCT00876447|468914692|FG001|Overall Study|Other miscellaneous reasons|8|||
130258694|NCT00876447|468914691|FG000|Overall Study|Site closure|19|||
130258695|NCT00876447|468914692|FG001|Overall Study|Site closure|14|||
130258696|NCT00876447|468914691|FG000|Overall Study|Protocol Violation|9|||
130258697|NCT00876447|468914692|FG001|Overall Study|Protocol Violation|3|||
130258698|NCT00876447|468914691|FG000|Overall Study|Personal reasons|30|||
130258699|NCT00876447|468914692|FG001|Overall Study|Personal reasons|28|||
130258700|NCT00876447|468914691|FG000|Overall Study|Lost to Follow-up|6|||
130258701|NCT00876447|468914692|FG001|Overall Study|Lost to Follow-up|15|||
130258702|NCT00876447|468914691|FG000|Overall Study|Pregnancy|4|||
130258703|NCT00876447|468914692|FG001|Overall Study|Pregnancy|2|||
130258704|NCT00876447|468914691|FG000|Overall Study|Lack of Efficacy|5|||
130258705|NCT00876447|468914692|FG001|Overall Study|Lack of Efficacy|3|||
130258706|NCT00876447|468914691|FG000|Overall Study|Adverse Event|4|||
130258707|NCT00876447|468914692|FG001|Overall Study|Adverse Event|8|||
130258708|NCT00189423|468914699|FG000|Overall Study|Death|746|||
130258709|NCT00189423|468914700|FG001|Overall Study|Death|747|||
130258710|NCT00189423|468914699|FG000|Overall Study|Withdrawal by Subject|9|||
130258711|NCT00189423|468914700|FG001|Overall Study|Withdrawal by Subject|9|||
130258712|NCT00189423|468914699|FG000|Overall Study|Lost to Follow-up|10|||
130258713|NCT00189423|468914700|FG001|Overall Study|Lost to Follow-up|10|||
130258714|NCT04622592|468914702|FG000|Overall Study|Death|0|||
130258715|NCT04622592|468914703|FG001|Overall Study|Death|0|||
130258716|NCT04622592|468914704|FG002|Overall Study|Death|1|||
130258717|NCT04622592|468914705|FG003|Overall Study|Death|0|||
130258718|NCT04622592|468914706|FG004|Overall Study|Death|0|||
130258719|NCT04622592|468914707|FG005|Overall Study|Death|0|||
130258720|NCT04622592|468914708|FG006|Overall Study|Death|0|||
130258721|NCT04622592|468914709|FG007|Overall Study|Death|1|||
130258722|NCT04622592|468914702|FG000|Overall Study|Lost to Follow-up|0|||
130365360|NCT00347360|469306872|FG008|Overall Study|Subject left town, ran out of study drug|0|||
130365361|NCT00347360|469306873|FG009|Overall Study|Subject left town, ran out of study drug|0|||
130365362|NCT00347360|469306874|FG010|Overall Study|Subject left town, ran out of study drug|0|||
130702467|NCT02459418|470534476|FG001|Overall Study|Withdrawal by Subject|1|||
130702468|NCT02459418|470534475|FG000|Overall Study|Elevated Creatine Kinase|1|||
130702469|NCT02459418|470534476|FG001|Overall Study|Elevated Creatine Kinase|0|||
130702470|NCT02459418|470534475|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
130702471|NCT02459418|470534476|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
130702472|NCT01872715|470534477|FG000|Overall Study|Adverse Event|1|||
130702473|NCT01872715|470534477|FG000|Overall Study|Protocol Violation|1|||
130702474|NCT01872715|470534477|FG000|Overall Study|Withdrawal by Subject|2|||
130258723|NCT04622592|468914703|FG001|Overall Study|Lost to Follow-up|0|||
130258724|NCT04622592|468914704|FG002|Overall Study|Lost to Follow-up|0|||
130258725|NCT04622592|468914705|FG003|Overall Study|Lost to Follow-up|3|||
130258726|NCT04622592|468914706|FG004|Overall Study|Lost to Follow-up|1|||
130258727|NCT04622592|468914707|FG005|Overall Study|Lost to Follow-up|0|||
130702475|NCT03303417|470534478|FG000|Overall Study|Withdrawal by Subject|1|||
130702476|NCT03303417|470534479|FG001|Overall Study|Withdrawal by Subject|1|||
130258728|NCT04622592|468914708|FG006|Overall Study|Lost to Follow-up|2|||
130258729|NCT04622592|468914709|FG007|Overall Study|Lost to Follow-up|2|||
130258730|NCT04622592|468914702|FG000|Overall Study|Physician Decision|0|||
130258731|NCT04622592|468914703|FG001|Overall Study|Physician Decision|0|||
130258732|NCT04622592|468914704|FG002|Overall Study|Physician Decision|0|||
130258733|NCT04622592|468914705|FG003|Overall Study|Physician Decision|0|||
130258734|NCT04622592|468914706|FG004|Overall Study|Physician Decision|1|||
130553938|NCT02634346|469996460|FG001|Overall Study|Adverse Event|2|||
130702477|NCT01765270|470534482|FG000|Overall Study|Physician Decision|1|||
130702478|NCT01765270|470534483|FG001|Overall Study|Physician Decision|0|||
130702479|NCT01765270|470534482|FG000|Overall Study|Withdrawal by Subject|0|||
130702480|NCT01765270|470534483|FG001|Overall Study|Withdrawal by Subject|1|||
130702481|NCT03431337|470534484|FG000|Overall Study|Lost to Follow-up|21|||
130702482|NCT03431337|470534485|FG001|Overall Study|Lost to Follow-up|19|||
130702483|NCT03431337|470534484|FG000|Overall Study|Withdrawal by Subject|8|||
130702484|NCT03431337|470534485|FG001|Overall Study|Withdrawal by Subject|3|||
130702485|NCT03619876|470534488|FG000|Overall Study|Withdrawal by Subject|1|||
130702486|NCT03619876|470534489|FG001|Overall Study|Withdrawal by Subject|2|||
130702487|NCT03619876|470534488|FG000|Overall Study|Withdrawal due to incidental finding|0|||
130702488|NCT03619876|470534489|FG001|Overall Study|Withdrawal due to incidental finding|2|||
130702489|NCT00835796|470534493|FG000|First Intervention|Withdrawal by Subject|0|||
130702490|NCT00835796|470534494|FG001|First Intervention|Withdrawal by Subject|1|||
130702491|NCT00651183|470534499|FG000|Overall Study|Lack of Efficacy|1|||
130702492|NCT00651183|470534500|FG001|Overall Study|Lack of Efficacy|0|||
130702493|NCT00651183|470534499|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
130258735|NCT04622592|468914707|FG005|Overall Study|Physician Decision|0|||
130258736|NCT04622592|468914708|FG006|Overall Study|Physician Decision|0|||
130258737|NCT04622592|468914709|FG007|Overall Study|Physician Decision|0|||
130258738|NCT04622592|468914702|FG000|Overall Study|Withdrawal by Subject|1|||
130258739|NCT04622592|468914703|FG001|Overall Study|Withdrawal by Subject|0|||
130258740|NCT04622592|468914704|FG002|Overall Study|Withdrawal by Subject|2|||
130258741|NCT04622592|468914705|FG003|Overall Study|Withdrawal by Subject|0|||
130258742|NCT04622592|468914706|FG004|Overall Study|Withdrawal by Subject|0|||
130258743|NCT04622592|468914707|FG005|Overall Study|Withdrawal by Subject|0|||
130258744|NCT04622592|468914708|FG006|Overall Study|Withdrawal by Subject|1|||
130258745|NCT04622592|468914709|FG007|Overall Study|Withdrawal by Subject|4|||
130258746|NCT04622592|468914702|FG000|Overall Study|Other than specified above|0|||
130258747|NCT04622592|468914703|FG001|Overall Study|Other than specified above|0|||
130258748|NCT04622592|468914704|FG002|Overall Study|Other than specified above|1|||
130258749|NCT04622592|468914705|FG003|Overall Study|Other than specified above|0|||
130258750|NCT04622592|468914706|FG004|Overall Study|Other than specified above|0|||
130258751|NCT04622592|468914707|FG005|Overall Study|Other than specified above|0|||
130258752|NCT04622592|468914708|FG006|Overall Study|Other than specified above|0|||
130258753|NCT04622592|468914709|FG007|Overall Study|Other than specified above|0|||
130258754|NCT00183248|468914714|FG000|Overall Study|Lost to Follow-up|0|||
130258755|NCT00183248|468914715|FG001|Overall Study|Lost to Follow-up|1|||
130258756|NCT00183248|468914714|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
130258757|NCT00183248|468914715|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
130258758|NCT03309202|468914716|FG000|Overall Study|Lost to Follow-up|1|||
130258759|NCT03309202|468914717|FG001|Overall Study|Lost to Follow-up|0|||
130258760|NCT03309202|468914718|FG002|Overall Study|Lost to Follow-up|0|||
130258761|NCT03309202|468914719|FG003|Overall Study|Lost to Follow-up|0|||
130258762|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130258763|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130365363|NCT00347360|469306875|FG011|Overall Study|Subject left town, ran out of study drug|0|||
130365364|NCT00347360|469306876|FG012|Overall Study|Subject left town, ran out of study drug|0|||
130365365|NCT00347360|469306877|FG013|Overall Study|Subject left town, ran out of study drug|1|||
130365366|NCT00347360|469306878|FG014|Overall Study|Subject left town, ran out of study drug|0|||
130365367|NCT00347360|469306864|FG000|Overall Study|Subject refuse to sign updated consent|0|||
130365368|NCT00347360|469306865|FG001|Overall Study|Subject refuse to sign updated consent|0|||
130365369|NCT00347360|469306866|FG002|Overall Study|Subject refuse to sign updated consent|0|||
130365370|NCT00347360|469306867|FG003|Overall Study|Subject refuse to sign updated consent|0|||
130365371|NCT00347360|469306868|FG004|Overall Study|Subject refuse to sign updated consent|0|||
130365372|NCT00347360|469306869|FG005|Overall Study|Subject refuse to sign updated consent|0|||
130365373|NCT00347360|469306870|FG006|Overall Study|Subject refuse to sign updated consent|0|||
130365374|NCT00347360|469306871|FG007|Overall Study|Subject refuse to sign updated consent|0|||
130365375|NCT00347360|469306872|FG008|Overall Study|Subject refuse to sign updated consent|0|||
130365376|NCT00347360|469306873|FG009|Overall Study|Subject refuse to sign updated consent|0|||
130365377|NCT00347360|469306874|FG010|Overall Study|Subject refuse to sign updated consent|0|||
130702494|NCT00651183|470534500|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
130258764|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
130258765|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
130258766|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130258767|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130258768|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
130258769|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130258770|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130258771|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130702495|NCT00651183|470534499|FG000|Overall Study|Tolerability insufficient|5|||
130702496|NCT00651183|470534500|FG001|Overall Study|Tolerability insufficient|2|||
130702497|NCT00651183|470534499|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
130702498|NCT00651183|470534500|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
130258772|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130258773|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
130258774|NCT02138825|468914723|FG000|Main Study Treatment|Adverse Event|11|||
130258775|NCT02138825|468914724|FG001|Main Study Treatment|Adverse Event|3|||
130258776|NCT02138825|468914723|FG000|Main Study Treatment|Death|1|||
130258777|NCT02138825|468914724|FG001|Main Study Treatment|Death|2|||
130258778|NCT02138825|468914723|FG000|Main Study Treatment|Protocol Violation|2|||
130258779|NCT02138825|468914724|FG001|Main Study Treatment|Protocol Violation|2|||
130258780|NCT02138825|468914723|FG000|Main Study Treatment|Sponsor decision|12|||
130258781|NCT02138825|468914724|FG001|Main Study Treatment|Sponsor decision|18|||
130258782|NCT02138825|468914723|FG000|Main Study Treatment|Study terminated by sponsor|10|||
130258783|NCT02138825|468914724|FG001|Main Study Treatment|Study terminated by sponsor|9|||
130258784|NCT02138825|468914723|FG000|Main Study Treatment|Withdrawal by Subject|3|||
130258785|NCT02138825|468914724|FG001|Main Study Treatment|Withdrawal by Subject|1|||
130258786|NCT02138825|468914723|FG000|Main Study Treatment|Medical decision|1|||
130258787|NCT02138825|468914724|FG001|Main Study Treatment|Medical decision|0|||
130258788|NCT02138825|468914723|FG000|Long-term Extension|Study termination by sponsor|32|||
130702499|NCT00651183|470534499|FG000|Overall Study|Withdrawal by Subject|6|||
130702500|NCT00651183|470534500|FG001|Overall Study|Withdrawal by Subject|3|||
130702501|NCT00651183|470534499|FG000|Overall Study|Lost to Follow-up|3|||
130258789|NCT02138825|468914724|FG001|Long-term Extension|Study termination by sponsor|38|||
130258790|NCT02138825|468914723|FG000|Safety Follow-up|Adverse Event|4|||
130258791|NCT02138825|468914724|FG001|Safety Follow-up|Adverse Event|3|||
130258792|NCT02138825|468914723|FG000|Safety Follow-up|Death|11|||
130258793|NCT02138825|468914724|FG001|Safety Follow-up|Death|5|||
130258794|NCT02138825|468914723|FG000|Safety Follow-up|Withdrawal by Subject|5|||
130258795|NCT02138825|468914724|FG001|Safety Follow-up|Withdrawal by Subject|3|||
130258796|NCT02138825|468914723|FG000|Safety Follow-up|clinic worsening|1|||
130258797|NCT02138825|468914724|FG001|Safety Follow-up|clinic worsening|0|||
130258798|NCT02138825|468914723|FG000|Safety Follow-up|withdrawal by PI|1|||
130258799|NCT02138825|468914724|FG001|Safety Follow-up|withdrawal by PI|0|||
130258800|NCT02138825|468914723|FG000|Safety Follow-up|logistical difficulties|0|||
130258801|NCT02138825|468914724|FG001|Safety Follow-up|logistical difficulties|1|||
130258802|NCT02138825|468914723|FG000|Safety Follow-up|progressive disease|0|||
130258803|NCT02138825|468914724|FG001|Safety Follow-up|progressive disease|2|||
130258804|NCT02138825|468914723|FG000|Safety Follow-up|too unwell to attend the visit|0|||
130258805|NCT02138825|468914724|FG001|Safety Follow-up|too unwell to attend the visit|1|||
130258806|NCT02138825|468914723|FG000|Safety Follow-up|treatment unblinded|0|||
130258807|NCT02138825|468914724|FG001|Safety Follow-up|treatment unblinded|1|||
130258808|NCT02138825|468914723|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
130258809|NCT02138825|468914724|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
130258810|NCT03493958|468914725|FG000|Overall Study|Withdrawal by Subject|6|||
130258811|NCT03493958|468914725|FG000|Overall Study|Lost to Follow-up|7|||
130258812|NCT03493958|468914725|FG000|Overall Study|Did not complete all required study procedures|2|||
130258813|NCT00904371|468914728|FG000|Overall Study|Adverse Event|2|||
130258814|NCT00904371|468914728|FG000|Overall Study|Lost to Follow-up|4|||
130258815|NCT00904371|468914728|FG000|Overall Study|Discontinued at target blood pressure|2|||
130258816|NCT00904371|468914728|FG000|Overall Study|Continued with Tritace|1|||
130258817|NCT00583219|468914733|FG000|Phase 2|Withdrawal by Subject|1|||
130258818|NCT02090764|468914734|FG000|Overall Study|Adverse Event|1|||
130258819|NCT02090764|468914735|FG001|Overall Study|Adverse Event|3|||
130258820|NCT02090764|468914734|FG000|Overall Study|Lack of Efficacy|0|||
130258821|NCT02090764|468914735|FG001|Overall Study|Lack of Efficacy|13|||
130258822|NCT02090764|468914734|FG000|Overall Study|Withdrawal by Subject|2|||
130258823|NCT02090764|468914735|FG001|Overall Study|Withdrawal by Subject|1|||
130258824|NCT02090764|468914734|FG000|Overall Study|Intercurrent illness and other|1|||
130702502|NCT00651183|470534500|FG001|Overall Study|Lost to Follow-up|1|||
130258825|NCT02090764|468914735|FG001|Overall Study|Intercurrent illness and other|1|||
130258826|NCT02090764|468914734|FG000|Overall Study|Lost to Follow-up|2|||
130553939|NCT02634346|469996461|FG002|Overall Study|Adverse Event|7|||
130702503|NCT00651183|470534499|FG000|Overall Study|Other reasons|4|||
130258827|NCT02090764|468914735|FG001|Overall Study|Lost to Follow-up|2|||
130258828|NCT00754572|468914736|FG000|Overall Study|Adverse Event|19|||
130258829|NCT00754572|468914736|FG000|Overall Study|Other|39|||
130258830|NCT00754572|468914736|FG000|Overall Study|Protocol Violation|3|||
130258831|NCT00754572|468914736|FG000|Overall Study|Withdrawal by Subject|3|||
130258832|NCT00754572|468914736|FG000|Overall Study|Lack of Efficacy|2|||
130258833|NCT00754572|468914736|FG000|Overall Study|Death|1|||
130258834|NCT00754572|468914736|FG000|Overall Study|Administrative Reason|3|||
130258835|NCT00754572|468914736|FG000|Overall Study|Lost to Follow-up|1|||
130702504|NCT00651183|470534500|FG001|Overall Study|Other reasons|2|||
130258836|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258837|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130258838|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258839|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258840|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
130258841|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130258842|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130258843|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
130258844|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
130258845|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
130258846|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130258847|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130365378|NCT00347360|469306875|FG011|Overall Study|Subject refuse to sign updated consent|0|||
130702505|NCT00651183|470534499|FG000|Overall Study|missing|1|||
130702506|NCT00651183|470534500|FG001|Overall Study|missing|0|||
130258848|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130258849|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130258850|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130365379|NCT00347360|469306876|FG012|Overall Study|Subject refuse to sign updated consent|0|||
130702507|NCT03330236|470534501|FG000|Overall Study|Death|2|||
130702508|NCT03330236|470534502|FG001|Overall Study|Death|1|||
130702509|NCT03330236|470534501|FG000|Overall Study|Withdrawal by Subject|2|||
130702510|NCT03330236|470534502|FG001|Overall Study|Withdrawal by Subject|4|||
130702511|NCT03330236|470534501|FG000|Overall Study|Lost to Follow-up|0|||
130702512|NCT03330236|470534502|FG001|Overall Study|Lost to Follow-up|2|||
130702513|NCT03330236|470534501|FG000|Overall Study|Physician Decision|2|||
130702514|NCT03330236|470534502|FG001|Overall Study|Physician Decision|0|||
130702515|NCT03330236|470534501|FG000|Overall Study|Protocol Violation|4|||
130702516|NCT03330236|470534502|FG001|Overall Study|Protocol Violation|3|||
130702517|NCT03330236|470534501|FG000|Overall Study|SedLine malfunction/blinding|19|||
130702518|NCT03330236|470534502|FG001|Overall Study|SedLine malfunction/blinding|14|||
130702519|NCT03330236|470534501|FG000|Overall Study|Volatile anesthetics used|11|||
130702520|NCT03330236|470534502|FG001|Overall Study|Volatile anesthetics used|8|||
130702521|NCT03330236|470534501|FG000|Overall Study|Surgery aborted/converted to open|60|||
130702522|NCT03330236|470534502|FG001|Overall Study|Surgery aborted/converted to open|52|||
130702523|NCT01901848|470534504|FG000|Randomized and Treated|Lost to Follow-up|3|||
130702524|NCT01901848|470534505|FG001|Randomized and Treated|Lost to Follow-up|6|||
130702525|NCT01901848|470534504|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
130702526|NCT01901848|470534505|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
130702527|NCT00763555|470534506|FG000|Overall Study|Adverse Event|2|||
130702528|NCT00763555|470534507|FG001|Overall Study|Adverse Event|1|||
130702529|NCT00763555|470534506|FG000|Overall Study|Withdrawal by Subject|2|||
130702530|NCT00763555|470534507|FG001|Overall Study|Withdrawal by Subject|6|||
130702531|NCT00763555|470534506|FG000|Overall Study|Lost to Follow-up|0|||
130702532|NCT00763555|470534507|FG001|Overall Study|Lost to Follow-up|3|||
130702533|NCT02488824|470534508|FG000|Overall Study|Adverse Event|1|||
130702534|NCT02488824|470534509|FG001|Overall Study|Adverse Event|1|||
130702535|NCT00848042|470534511|FG000|Overall Study|Death|1|||
130702536|NCT00848042|470534512|FG001|Overall Study|Death|2|||
130365380|NCT00347360|469306877|FG013|Overall Study|Subject refuse to sign updated consent|0|||
130365381|NCT00347360|469306878|FG014|Overall Study|Subject refuse to sign updated consent|1|||
130553940|NCT02634346|469996459|FG000|Overall Study|Lack of Efficacy|1|||
130702537|NCT00848042|470534513|FG002|Overall Study|Death|0|||
130702538|NCT00848042|470534511|FG000|Overall Study|Other Therapy|3|||
130702539|NCT00848042|470534512|FG001|Overall Study|Other Therapy|0|||
130702540|NCT00848042|470534513|FG002|Overall Study|Other Therapy|0|||
130702541|NCT00979212|470534516|FG000|Overall Study|Protocol Violation|1|||
130702542|NCT00979212|470534517|FG001|Overall Study|Protocol Violation|8|||
130702543|NCT00979212|470534516|FG000|Overall Study|No protocol therapy received|1|||
130702544|NCT00979212|470534517|FG001|Overall Study|No protocol therapy received|0|||
130702545|NCT02448563|470534524|FG000|Overall Study|Lost to Follow-up|16|||
130702546|NCT02448563|470534525|FG001|Overall Study|Lost to Follow-up|10|||
130702547|NCT02448563|470534524|FG000|Overall Study|Withdrawal by Subject|0|||
130702548|NCT02448563|470534525|FG001|Overall Study|Withdrawal by Subject|1|||
130702549|NCT02340962|470534527|FG000|Overall Study|Lost to Follow-up|1|||
130702550|NCT02340962|470534528|FG001|Overall Study|Lost to Follow-up|0|||
130702551|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
130702552|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702553|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702554|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702555|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702556|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702557|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
130702558|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702559|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130702560|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
130702561|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
130702562|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130702563|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702564|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702565|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
130702566|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702567|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702568|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702569|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
130702570|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702571|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130702572|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
130702573|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130702574|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
130702575|NCT00434837|470534540|FG000|Overall Study|Lost to Follow-up|20|||
130702576|NCT00434837|470534541|FG001|Overall Study|Lost to Follow-up|23|||
130702577|NCT00434837|470534542|FG002|Overall Study|Lost to Follow-up|30|||
130702578|NCT00515216|470534543|FG000|Overall Study|Withdrawal by Subject|1|||
130702579|NCT02786927|470534545|FG000|Overall Study|Adverse Event|1|||
130702580|NCT02786927|470534545|FG000|Overall Study|Protocol Violation|4|||
130702581|NCT01801917|470534546|FG000|Period 1 - Randomized|Adverse Event|1|||
130702582|NCT01801917|470534547|FG001|Period 1 - Randomized|Adverse Event|0|||
130702583|NCT01801917|470534548|FG002|Period 1 - Randomized|Adverse Event|1|||
130702584|NCT01801917|470534549|FG003|Period 1 - Randomized|Adverse Event|0|||
130702585|NCT04307849|470534550|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702586|NCT04307849|470534551|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702587|NCT04307849|470534552|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130702588|NCT04307849|470534553|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702589|NCT04307849|470534554|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
130702590|NCT04307849|470534555|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130702591|NCT04307849|470534550|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702592|NCT04307849|470534551|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702593|NCT04307849|470534552|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
130702594|NCT04307849|470534553|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702595|NCT04307849|470534554|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702596|NCT04307849|470534555|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702597|NCT04307849|470534550|FG000|Overall Study|Family member did not want them to continue|0|||
130702598|NCT04307849|470534551|FG001|Overall Study|Family member did not want them to continue|0|||
130702599|NCT04307849|470534552|FG002|Overall Study|Family member did not want them to continue|1|||
130702600|NCT04307849|470534553|FG003|Overall Study|Family member did not want them to continue|0|||
130702601|NCT04307849|470534554|FG004|Overall Study|Family member did not want them to continue|0|||
130702602|NCT04307849|470534555|FG005|Overall Study|Family member did not want them to continue|0|||
130702603|NCT04307849|470534550|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
130702604|NCT04307849|470534551|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
130702605|NCT04307849|470534552|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
130258851|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130258852|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258853|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
130258854|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258855|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258856|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
130258857|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258858|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258859|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258860|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130258861|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130258862|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
130258863|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130258864|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130258865|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130258866|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
130258867|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130258868|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Death|0|||
130258869|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Death|0|||
130258870|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Death|1|||
130258871|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Death|0|||
130258872|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258873|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258874|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
130258875|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258876|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258877|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258878|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
130258879|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258880|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258881|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
130258882|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258883|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
130258884|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130258885|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
130258886|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130258887|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258888|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258889|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258890|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130702606|NCT04307849|470534553|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
130702607|NCT04307849|470534554|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
130702608|NCT04307849|470534555|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
130702609|NCT05467982|470534558|FG000|Overall Study|Death|0|||
130702610|NCT05467982|470534559|FG001|Overall Study|Death|1|||
130702611|NCT05467982|470534558|FG000|Overall Study|Lost to Follow-up|3|||
130702612|NCT05467982|470534559|FG001|Overall Study|Lost to Follow-up|1|||
130702613|NCT01833169|470534565|FG000|Overall Study|Disease Progression|99|||
130702614|NCT01833169|470534565|FG000|Overall Study|Adverse Event|33|||
130702615|NCT01833169|470534565|FG000|Overall Study|Withdrawal by Subject|9|||
130702616|NCT01833169|470534565|FG000|Overall Study|Death|3|||
130702617|NCT01833169|470534565|FG000|Overall Study|Physician Decision|2|||
130702618|NCT00105157|470534566|FG000|Double-Blind (DB)|Never Treated|1|||
130702619|NCT00105157|470534567|FG001|Double-Blind (DB)|Never Treated|0|||
130702620|NCT00105157|470534568|FG002|Double-Blind (DB)|Never Treated|0|||
130702621|NCT00105157|470534569|FG003|Double-Blind (DB)|Never Treated|0|||
130702622|NCT00105157|470534566|FG000|Double-Blind (DB)|Adverse Event|2|||
130702623|NCT00105157|470534567|FG001|Double-Blind (DB)|Adverse Event|0|||
130702624|NCT00105157|470534568|FG002|Double-Blind (DB)|Adverse Event|1|||
130702625|NCT00105157|470534569|FG003|Double-Blind (DB)|Adverse Event|1|||
130258891|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258892|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258893|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258894|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258895|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130702626|NCT00105157|470534566|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
130702627|NCT00105157|470534567|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
130702628|NCT00105157|470534568|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
130702629|NCT00105157|470534569|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
130702630|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Adverse Event|3|||
130702631|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Adverse Event|1|||
130702632|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Adverse Event|0|||
130702633|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Adverse Event|0|||
130702634|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
130702635|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
130702636|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
130702637|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
130702638|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702639|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702640|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702641|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
130702642|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
130702643|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
130702644|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
130702645|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
130702646|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
130702647|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702648|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702649|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702650|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
130702651|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
130702652|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
130702653|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
130702654|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702655|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702656|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702657|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
130702658|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
130702659|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
130702660|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
130702661|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
130702662|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130702663|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130258896|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
130258897|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
130258898|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
130258899|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
130258900|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
130258901|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
130258902|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
130258903|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
130258904|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
130258905|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
130258906|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
130258907|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
130258908|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
130258909|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
130258910|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
130258911|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
130702664|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130702665|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130702666|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702667|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702668|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702669|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
130702670|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702671|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
130702672|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702673|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702674|NCT02212457|470534572|FG000|Overall Study|Adverse Event|1|||
130702675|NCT02212457|470534573|FG001|Overall Study|Adverse Event|2|||
130702676|NCT02212457|470534574|FG002|Overall Study|Adverse Event|2|||
130702677|NCT02212457|470534575|FG003|Overall Study|Adverse Event|2|||
130365382|NCT00347360|469306864|FG000|Overall Study|Visits conflicted with new job|0|||
130258912|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130258913|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130258914|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258915|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258916|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258917|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258918|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258919|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258920|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258921|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258922|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258923|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258924|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258925|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258926|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258927|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258928|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
130258929|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258930|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
130258931|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258932|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258933|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258934|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258935|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258936|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258937|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258938|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258939|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258940|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258941|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258942|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258943|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258944|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258945|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258946|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258947|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130258948|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258949|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258950|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130258951|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258952|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258953|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258954|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258955|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258956|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258957|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258958|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258959|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258960|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258961|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258962|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
130258963|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258964|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258965|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258966|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258967|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258968|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258969|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258970|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258971|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258972|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258973|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258974|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258975|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130553941|NCT02634346|469996460|FG001|Overall Study|Lack of Efficacy|2|||
130258976|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258977|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258978|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258979|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258980|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258981|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258982|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258983|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258984|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258985|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258986|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258987|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258988|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258989|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258990|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258991|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258992|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
130258993|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
130258994|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
130258995|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
130258996|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
130258997|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
130258998|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
130258999|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
130259000|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
130259001|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
130259002|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
130259003|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
130259004|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
130259005|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
130259006|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
130259007|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
130259008|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259009|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259010|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259011|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130365383|NCT00347360|469306865|FG001|Overall Study|Visits conflicted with new job|0|||
130365384|NCT00347360|469306866|FG002|Overall Study|Visits conflicted with new job|0|||
130365385|NCT00347360|469306867|FG003|Overall Study|Visits conflicted with new job|0|||
130365386|NCT00347360|469306868|FG004|Overall Study|Visits conflicted with new job|0|||
130365387|NCT00347360|469306869|FG005|Overall Study|Visits conflicted with new job|0|||
130365388|NCT00347360|469306870|FG006|Overall Study|Visits conflicted with new job|1|||
130365389|NCT00347360|469306871|FG007|Overall Study|Visits conflicted with new job|0|||
130365390|NCT00347360|469306872|FG008|Overall Study|Visits conflicted with new job|0|||
130365391|NCT00347360|469306873|FG009|Overall Study|Visits conflicted with new job|0|||
130365392|NCT00347360|469306874|FG010|Overall Study|Visits conflicted with new job|0|||
130365393|NCT00347360|469306875|FG011|Overall Study|Visits conflicted with new job|0|||
130365394|NCT00347360|469306876|FG012|Overall Study|Visits conflicted with new job|0|||
130365395|NCT00347360|469306877|FG013|Overall Study|Visits conflicted with new job|0|||
130365396|NCT00347360|469306878|FG014|Overall Study|Visits conflicted with new job|0|||
130365397|NCT01449539|469306879|FG000|Overall Study|Withdrawal by Subject|3|||
130365398|NCT01449539|469306879|FG000|Overall Study|Toxicity not study related|1|||
130365399|NCT01387789|469306882|FG000|Overall Study|Adverse Event|5|||
130365400|NCT01387789|469306882|FG000|Overall Study|Lack of Efficacy|2|||
130365401|NCT01387789|469306882|FG000|Overall Study|Lost to Follow-up|1|||
130365402|NCT02187744|469306883|FG000|Study|Participant refused further follow-up|1|||
130365403|NCT02187744|469306884|FG001|Study|Participant refused further follow-up|0|||
130365404|NCT02187744|469306883|FG000|Study|Other|2|||
130365405|NCT02187744|469306884|FG001|Study|Other|1|||
130365406|NCT02187744|469306883|FG000|Study|Lost to Follow-up|0|||
130365407|NCT02187744|469306884|FG001|Study|Lost to Follow-up|2|||
130365408|NCT02187744|469306883|FG000|Study|Related adverse event, not serious|0|||
130365409|NCT02187744|469306884|FG001|Study|Related adverse event, not serious|2|||
130365410|NCT02187744|469306883|FG000|Study|Death|1|||
130259012|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
130259013|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259014|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259015|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259016|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259017|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259018|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130702678|NCT02212457|470534576|FG004|Overall Study|Adverse Event|0|||
130702679|NCT02212457|470534577|FG005|Overall Study|Adverse Event|1|||
130702680|NCT02212457|470534572|FG000|Overall Study|Withdrawal by Subject|8|||
130702681|NCT02212457|470534573|FG001|Overall Study|Withdrawal by Subject|10|||
130702682|NCT02212457|470534574|FG002|Overall Study|Withdrawal by Subject|8|||
130702683|NCT02212457|470534575|FG003|Overall Study|Withdrawal by Subject|6|||
130702684|NCT02212457|470534576|FG004|Overall Study|Withdrawal by Subject|5|||
130702685|NCT02212457|470534577|FG005|Overall Study|Withdrawal by Subject|4|||
130702686|NCT02212457|470534572|FG000|Overall Study|Lost to Follow-up|6|||
130702687|NCT02212457|470534573|FG001|Overall Study|Lost to Follow-up|7|||
130702688|NCT02212457|470534574|FG002|Overall Study|Lost to Follow-up|4|||
130702689|NCT02212457|470534575|FG003|Overall Study|Lost to Follow-up|1|||
130702690|NCT02212457|470534576|FG004|Overall Study|Lost to Follow-up|8|||
130702691|NCT02212457|470534577|FG005|Overall Study|Lost to Follow-up|4|||
130702692|NCT02212457|470534572|FG000|Overall Study|Protocol Violation|2|||
130702693|NCT02212457|470534573|FG001|Overall Study|Protocol Violation|1|||
130702694|NCT02212457|470534574|FG002|Overall Study|Protocol Violation|0|||
130702695|NCT02212457|470534575|FG003|Overall Study|Protocol Violation|1|||
130702696|NCT02212457|470534576|FG004|Overall Study|Protocol Violation|2|||
130702697|NCT02212457|470534577|FG005|Overall Study|Protocol Violation|3|||
130702698|NCT02212457|470534572|FG000|Overall Study|Other|2|||
130702699|NCT02212457|470534573|FG001|Overall Study|Other|1|||
130702700|NCT02212457|470534574|FG002|Overall Study|Other|2|||
130702701|NCT02212457|470534575|FG003|Overall Study|Other|1|||
130702702|NCT02212457|470534576|FG004|Overall Study|Other|0|||
130702703|NCT02212457|470534577|FG005|Overall Study|Other|1|||
130702704|NCT00420095|470534578|FG000|Overall Study|Adverse Event|1|||
130702705|NCT00420095|470534579|FG001|Overall Study|Adverse Event|0|||
130702706|NCT00420095|470534578|FG000|Overall Study|Protocol Violation|1|||
130702707|NCT00420095|470534579|FG001|Overall Study|Protocol Violation|1|||
130702708|NCT00420095|470534578|FG000|Overall Study|Lost to Follow-up|1|||
130702709|NCT00420095|470534579|FG001|Overall Study|Lost to Follow-up|0|||
130702710|NCT00393705|470534580|FG000|Overall Study|Adverse Event|0|||
130702711|NCT00393705|470534581|FG001|Overall Study|Adverse Event|2|||
130702712|NCT00393705|470534580|FG000|Overall Study|Death|0|||
130702713|NCT00393705|470534581|FG001|Overall Study|Death|1|||
130702714|NCT00393705|470534580|FG000|Overall Study|Lost to Follow-up|2|||
130702715|NCT00393705|470534581|FG001|Overall Study|Lost to Follow-up|2|||
130702716|NCT00393705|470534580|FG000|Overall Study|Entry Criteria Not Met|10|||
130702717|NCT00393705|470534581|FG001|Overall Study|Entry Criteria Not Met|10|||
130702718|NCT00393705|470534580|FG000|Overall Study|Protocol Violation|4|||
130702719|NCT00393705|470534581|FG001|Overall Study|Protocol Violation|3|||
130702720|NCT00393705|470534580|FG000|Overall Study|Withdrawal by Subject|5|||
130553942|NCT02634346|469996461|FG002|Overall Study|Lack of Efficacy|8|||
130553943|NCT02634346|469996459|FG000|Overall Study|Lost to Follow-up|1|||
130702721|NCT00393705|470534581|FG001|Overall Study|Withdrawal by Subject|3|||
130702722|NCT00393705|470534580|FG000|Overall Study|Physician Decision|2|||
130702723|NCT00393705|470534581|FG001|Overall Study|Physician Decision|2|||
130702724|NCT03185741|470534582|FG000|Baseline|Withdrawal by Subject|1|||
130365411|NCT02187744|469306884|FG001|Study|Death|0|||
130702725|NCT03185741|470534583|FG001|Baseline|Withdrawal by Subject|3|||
130702726|NCT03185741|470534584|FG002|Baseline|Withdrawal by Subject|2|||
130702727|NCT03185741|470534582|FG000|Baseline|Lost to Follow-up|1|||
130702728|NCT03185741|470534583|FG001|Baseline|Lost to Follow-up|2|||
130702729|NCT03185741|470534584|FG002|Baseline|Lost to Follow-up|3|||
130702730|NCT03185741|470534582|FG000|3Month|Death|1|||
130702731|NCT03185741|470534583|FG001|3Month|Death|1|||
130702732|NCT03185741|470534584|FG002|3Month|Death|2|||
130702733|NCT03185741|470534582|FG000|3Month|Withdrawal by Subject|1|||
130702734|NCT03185741|470534583|FG001|3Month|Withdrawal by Subject|5|||
130702735|NCT03185741|470534584|FG002|3Month|Withdrawal by Subject|1|||
130702736|NCT03185741|470534582|FG000|3Month|Lost to Follow-up|7|||
130702737|NCT03185741|470534583|FG001|3Month|Lost to Follow-up|9|||
130702738|NCT03185741|470534584|FG002|3Month|Lost to Follow-up|8|||
130702739|NCT03185741|470534582|FG000|3Month|Unavailable for 3Month|11|||
130702740|NCT03185741|470534583|FG001|3Month|Unavailable for 3Month|10|||
130702741|NCT03185741|470534584|FG002|3Month|Unavailable for 3Month|11|||
130702742|NCT03185741|470534582|FG000|3Month|Protocol Violation|0|||
130702743|NCT03185741|470534583|FG001|3Month|Protocol Violation|0|||
130702744|NCT03185741|470534584|FG002|3Month|Protocol Violation|3|||
130702745|NCT03185741|470534582|FG000|6Month|Death|1|||
130702746|NCT03185741|470534583|FG001|6Month|Death|1|||
130702747|NCT03185741|470534584|FG002|6Month|Death|2|||
130702748|NCT03185741|470534582|FG000|6Month|Withdrawal by Subject|2|||
130702749|NCT03185741|470534583|FG001|6Month|Withdrawal by Subject|3|||
130702750|NCT03185741|470534584|FG002|6Month|Withdrawal by Subject|1|||
130702751|NCT03185741|470534582|FG000|6Month|Lost to Follow-up|16|||
130702752|NCT03185741|470534583|FG001|6Month|Lost to Follow-up|15|||
130702753|NCT03185741|470534584|FG002|6Month|Lost to Follow-up|16|||
130702754|NCT00654641|470534586|FG000|Overall Study|Lost to Follow-up|2|||
130702755|NCT00654641|470534587|FG001|Overall Study|Lost to Follow-up|3|||
130702756|NCT03365791|470534588|FG000|Overall Study|Adverse Event|5|||
130702757|NCT03365791|470534588|FG000|Overall Study|Death|1|||
130702758|NCT03365791|470534588|FG000|Overall Study|Lost to Follow-up|1|||
130702759|NCT03365791|470534588|FG000|Overall Study|Physician Decision|9|||
130702760|NCT03365791|470534588|FG000|Overall Study|Progressive disease|51|||
130259019|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259020|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259021|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259022|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259023|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259024|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259025|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259026|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259027|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259028|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259029|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259030|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259031|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259032|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259033|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
130259034|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259035|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259036|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
130259037|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259038|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259039|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
130259040|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259041|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259042|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259043|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259044|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259045|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259046|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259047|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259048|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130259049|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
130259050|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259051|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
130259052|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259053|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130259054|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259055|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
130259056|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259057|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259058|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259059|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259060|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259061|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259062|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259063|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259064|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130702761|NCT03365791|470534588|FG000|Overall Study|Subject/guardian decision|5|||
130702762|NCT03693950|470534589|FG000|Overall Study|Withdrawal by Subject|1|||
130702763|NCT03693950|470534590|FG001|Overall Study|Withdrawal by Subject|0|||
130702764|NCT02129062|470535871|FG000|Overall Study|Death|1|||
130702765|NCT02129062|470535871|FG000|Overall Study|Disease Progression|2|||
130702766|NCT02722616|470535872|FG000|Overall Study|Sponsor closed study after one month|2|||
130702767|NCT02722616|470535873|FG001|Overall Study|Sponsor closed study after one month|0|||
130702768|NCT02722616|470535874|FG002|Overall Study|Sponsor closed study after one month|0|||
130702769|NCT01923311|470535875|FG000|Overall Study|Pregnancy|1|||
130702770|NCT01923311|470535876|FG001|Overall Study|Pregnancy|0|||
130702771|NCT01923311|470535875|FG000|Overall Study|Investigator's Discretion|1|||
130702772|NCT01923311|470535876|FG001|Overall Study|Investigator's Discretion|0|||
130702773|NCT01923311|470535875|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130259065|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130259066|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259067|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259068|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130553944|NCT02634346|469996460|FG001|Overall Study|Lost to Follow-up|0|||
130259069|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259070|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259071|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130259072|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259073|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259074|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259075|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259076|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259077|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259078|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259079|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259080|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259081|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259082|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259083|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
130259084|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
130259085|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130259086|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130259087|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
130259088|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
130259089|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
130259090|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
130259091|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
130259092|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
130259093|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
130259094|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
130259095|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
130259096|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
130259097|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
130259098|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
130259099|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
130259100|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
130259101|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
130259102|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
130259103|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
130259104|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259105|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259106|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259107|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259108|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259109|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259110|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259111|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259112|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259113|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259114|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259115|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259116|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259117|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
130702774|NCT01923311|470535876|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130259118|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259119|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259120|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259121|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259122|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259123|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259124|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259125|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259126|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259127|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259128|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259129|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259130|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259131|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259132|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130553945|NCT02634346|469996461|FG002|Overall Study|Lost to Follow-up|0|||
130702775|NCT01923311|470535875|FG000|Overall Study|Withdrew Consent|1|||
130259133|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
130259134|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259135|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259136|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259137|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259138|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259139|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259140|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259141|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259142|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259143|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259144|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259145|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
130259146|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259147|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259148|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259149|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259150|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259151|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259152|NCT02661815|468914759|FG000|Overall Study|Withdrawal by Subject|1|||
130259153|NCT02661815|468914760|FG001|Overall Study|Withdrawal by Subject|0|||
130259154|NCT02661815|468914761|FG002|Overall Study|Withdrawal by Subject|0|||
130259155|NCT02661815|468914762|FG003|Overall Study|Withdrawal by Subject|0|||
130259156|NCT01728246|468914765|FG000|Overall Study|Participant needed rescue medication|1|||
130259157|NCT01728246|468914766|FG001|Overall Study|Participant needed rescue medication|5|||
130259158|NCT01728246|468914765|FG000|Overall Study|Protocol Violation|1|||
130259159|NCT01728246|468914766|FG001|Overall Study|Protocol Violation|0|||
130259160|NCT01728246|468914765|FG000|Overall Study|Withdrawal by Subject|2|||
130259161|NCT01728246|468914766|FG001|Overall Study|Withdrawal by Subject|3|||
130259162|NCT01728246|468914765|FG000|Overall Study|Lost to Follow-up|23|||
130259163|NCT01728246|468914766|FG001|Overall Study|Lost to Follow-up|22|||
130259164|NCT01728246|468914765|FG000|Overall Study|Lack of Efficacy|1|||
130259165|NCT01728246|468914766|FG001|Overall Study|Lack of Efficacy|1|||
130259166|NCT01728246|468914765|FG000|Overall Study|Adverse Event|8|||
130259167|NCT01728246|468914766|FG001|Overall Study|Adverse Event|5|||
130259168|NCT01983111|468914767|FG000|Overall Study|Withdrawal by Subject|8|||
130259169|NCT01983111|468914768|FG001|Overall Study|Withdrawal by Subject|6|||
130259170|NCT01983111|468914767|FG000|Overall Study|Adverse Event|4|||
130259171|NCT01983111|468914768|FG001|Overall Study|Adverse Event|0|||
130259172|NCT01983111|468914767|FG000|Overall Study|Protocol Violation|0|||
130259173|NCT01983111|468914768|FG001|Overall Study|Protocol Violation|1|||
130259174|NCT00855335|468914769|FG000|Overall Study|Lost to Follow-up|0|||
130259175|NCT00855335|468914770|FG001|Overall Study|Lost to Follow-up|0|||
130259176|NCT00855335|468914771|FG002|Overall Study|Lost to Follow-up|3|||
130259177|NCT00855335|468914772|FG003|Overall Study|Lost to Follow-up|1|||
130259178|NCT00855335|468914773|FG004|Overall Study|Lost to Follow-up|0|||
130259179|NCT00855335|468914769|FG000|Overall Study|Withdrawal by Subject|0|||
130259180|NCT00855335|468914770|FG001|Overall Study|Withdrawal by Subject|0|||
130259181|NCT00855335|468914771|FG002|Overall Study|Withdrawal by Subject|0|||
130259182|NCT00855335|468914772|FG003|Overall Study|Withdrawal by Subject|1|||
130259183|NCT00855335|468914773|FG004|Overall Study|Withdrawal by Subject|0|||
130259184|NCT00855335|468914769|FG000|Overall Study|Adverse Event|2|||
130259185|NCT00855335|468914770|FG001|Overall Study|Adverse Event|0|||
130259186|NCT00855335|468914771|FG002|Overall Study|Adverse Event|0|||
130259187|NCT00855335|468914772|FG003|Overall Study|Adverse Event|0|||
130259188|NCT00855335|468914773|FG004|Overall Study|Adverse Event|0|||
130259189|NCT00855335|468914769|FG000|Overall Study|Physician Decision|1|||
130259190|NCT00855335|468914770|FG001|Overall Study|Physician Decision|1|||
130259191|NCT00855335|468914771|FG002|Overall Study|Physician Decision|0|||
130259192|NCT00855335|468914772|FG003|Overall Study|Physician Decision|0|||
130259193|NCT00855335|468914773|FG004|Overall Study|Physician Decision|0|||
130702776|NCT01923311|470535876|FG001|Overall Study|Withdrew Consent|0|||
130702777|NCT01923311|470535875|FG000|Overall Study|Study Terminated by Sponsor|12|||
130702778|NCT01923311|470535876|FG001|Overall Study|Study Terminated by Sponsor|0|||
130259194|NCT00855335|468914769|FG000|Overall Study|Other|2|||
130259195|NCT00855335|468914770|FG001|Overall Study|Other|1|||
130259196|NCT00855335|468914771|FG002|Overall Study|Other|2|||
130259197|NCT00855335|468914772|FG003|Overall Study|Other|5|||
130702779|NCT02031237|470535877|FG000|Overall Study|Death|1|||
130702780|NCT02031237|470535878|FG001|Overall Study|Death|5|||
130702781|NCT02031237|470535879|FG002|Overall Study|Death|0|||
130702782|NCT02031237|470535877|FG000|Overall Study|Physician Decision|0|||
130702783|NCT02031237|470535878|FG001|Overall Study|Physician Decision|1|||
130259198|NCT00855335|468914773|FG004|Overall Study|Other|1|||
130259199|NCT03502200|468914774|FG000|Overall Study|Adverse Event|1|||
130259200|NCT03502200|468914775|FG001|Overall Study|Adverse Event|0|||
130259201|NCT03502200|468914774|FG000|Overall Study|Lost to Follow-up|36|||
130259202|NCT03502200|468914775|FG001|Overall Study|Lost to Follow-up|38|||
130259203|NCT03502200|468914774|FG000|Overall Study|Study Team Decision|1|||
130259204|NCT03502200|468914775|FG001|Overall Study|Study Team Decision|1|||
130259205|NCT03502200|468914774|FG000|Overall Study|Withdrawal by Subject|5|||
130259206|NCT03502200|468914775|FG001|Overall Study|Withdrawal by Subject|7|||
130259207|NCT03502200|468914774|FG000|Overall Study|Death|0|||
130259208|NCT03502200|468914775|FG001|Overall Study|Death|2|||
130259209|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Adverse Event|3|||
130259210|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Adverse Event|0|||
130259211|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Adverse Event|0|||
130259212|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
130259213|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130259214|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130259215|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
130259216|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
130259217|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
130259218|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
130259219|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
130259220|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
130259221|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
130259222|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130259223|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130259224|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
130259225|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
130259226|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
130259227|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130259228|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130259229|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Adverse Event|14|||
130259230|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
130259231|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
130259232|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
130259233|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130259234|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130259235|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
130259236|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
130259237|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
130259238|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
130259239|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130259240|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
130259241|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
130259242|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
130259243|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130259244|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130259245|NCT00787150|468914782|FG000|Overall Study|Adverse Event|4|||
130259246|NCT00787150|468914783|FG001|Overall Study|Adverse Event|4|||
130259247|NCT00787150|468914784|FG002|Overall Study|Adverse Event|4|||
130259248|NCT00787150|468914782|FG000|Overall Study|Physician Decision|1|||
130259249|NCT00787150|468914783|FG001|Overall Study|Physician Decision|2|||
130259250|NCT00787150|468914784|FG002|Overall Study|Physician Decision|1|||
130259251|NCT00787150|468914782|FG000|Overall Study|Withdrawal by Subject|2|||
130259252|NCT00787150|468914783|FG001|Overall Study|Withdrawal by Subject|1|||
130259253|NCT00787150|468914784|FG002|Overall Study|Withdrawal by Subject|0|||
130259254|NCT00787150|468914782|FG000|Overall Study|Dosing incorrect study durg|2|||
130259255|NCT00787150|468914783|FG001|Overall Study|Dosing incorrect study durg|0|||
130259256|NCT00787150|468914784|FG002|Overall Study|Dosing incorrect study durg|0|||
130259257|NCT01849276|468914791|FG000|Followed for Survival for 5 Years|Death|1|||
130259258|NCT01849276|468914791|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
130259259|NCT00879398|468914794|FG000|Overall Study|Visit Stop|399|||
130259260|NCT00879398|468914794|FG000|Overall Study|Lack of Efficacy|64|||
130259261|NCT00879398|468914794|FG000|Overall Study|Adverse Event|41|||
130259262|NCT00879398|468914794|FG000|Overall Study|Other Reasons|171|||
130259263|NCT01380080|468914796|FG000|Overall Study|Death|36|||
130259264|NCT01380080|468914797|FG001|Overall Study|Death|44|||
130259265|NCT01380080|468914796|FG000|Overall Study|Site is closing|28|||
130259266|NCT01380080|468914797|FG001|Overall Study|Site is closing|31|||
130259267|NCT01380080|468914796|FG000|Overall Study|Not able to get to clinic|7|||
130702784|NCT02031237|470535879|FG002|Overall Study|Physician Decision|0|||
130702785|NCT02031237|470535877|FG000|Overall Study|Withdrawal by Subject|2|||
130702786|NCT02031237|470535878|FG001|Overall Study|Withdrawal by Subject|2|||
130702787|NCT02031237|470535879|FG002|Overall Study|Withdrawal by Subject|0|||
130259268|NCT01380080|468914797|FG001|Overall Study|Not able to get to clinic|1|||
130259269|NCT01380080|468914796|FG000|Overall Study|Not willing to adhere to requirements|6|||
130259270|NCT01380080|468914797|FG001|Overall Study|Not willing to adhere to requirements|2|||
130259271|NCT01380080|468914796|FG000|Overall Study|Withdrawal by Subject|5|||
130259272|NCT01380080|468914797|FG001|Overall Study|Withdrawal by Subject|2|||
130259273|NCT01380080|468914796|FG000|Overall Study|Lost to Follow-up|3|||
130259274|NCT01380080|468914797|FG001|Overall Study|Lost to Follow-up|3|||
130259275|NCT04251533|468914798|FG000|Overall Study|Progressive disease|33|||
130259276|NCT04251533|468914799|FG001|Overall Study|Progressive disease|29|||
130702788|NCT02031237|470535877|FG000|Overall Study|Protocol Violation|2|||
130702789|NCT02031237|470535878|FG001|Overall Study|Protocol Violation|6|||
130259277|NCT04251533|468914800|FG002|Overall Study|Progressive disease|22|||
130259278|NCT04251533|468914798|FG000|Overall Study|Death|5|||
130259279|NCT04251533|468914799|FG001|Overall Study|Death|1|||
130259280|NCT04251533|468914800|FG002|Overall Study|Death|3|||
130259281|NCT04251533|468914798|FG000|Overall Study|Physician Decision|3|||
130259282|NCT04251533|468914799|FG001|Overall Study|Physician Decision|2|||
130259283|NCT04251533|468914800|FG002|Overall Study|Physician Decision|4|||
130259284|NCT04251533|468914798|FG000|Overall Study|Participant decision|1|||
130259285|NCT04251533|468914799|FG001|Overall Study|Participant decision|3|||
130259286|NCT04251533|468914800|FG002|Overall Study|Participant decision|1|||
130259287|NCT04251533|468914798|FG000|Overall Study|Adverse Event|2|||
130259288|NCT04251533|468914799|FG001|Overall Study|Adverse Event|1|||
130259289|NCT04251533|468914800|FG002|Overall Study|Adverse Event|1|||
130259290|NCT00210132|468914805|FG000|Overall Study|Protocol Violation|1|||
130259291|NCT00210132|468914806|FG001|Overall Study|Protocol Violation|4|||
130259292|NCT01722669|468914811|FG000|Overall Study|Withdrawal by Subject|0|||
130259293|NCT01722669|468914812|FG001|Overall Study|Withdrawal by Subject|0|||
130259294|NCT01722669|468914813|FG002|Overall Study|Withdrawal by Subject|0|||
130259295|NCT01722669|468914814|FG003|Overall Study|Withdrawal by Subject|0|||
130259296|NCT01722669|468914815|FG004|Overall Study|Withdrawal by Subject|0|||
130259297|NCT01722669|468914816|FG005|Overall Study|Withdrawal by Subject|2|||
130259298|NCT03211416|468914817|FG000|Overall Study|Adverse Event|7|||
130259299|NCT03211416|468914817|FG000|Overall Study|Lack of Efficacy|2|||
130259300|NCT03211416|468914817|FG000|Overall Study|Physician Decision|1|||
130259301|NCT03448393|468914821|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259302|NCT03448393|468914822|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259303|NCT03448393|468914823|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
130259304|NCT03448393|468914824|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259305|NCT03448393|468914825|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259306|NCT03448393|468914826|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259307|NCT03448393|468914827|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259308|NCT03448393|468914828|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259309|NCT03448393|468914829|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
130259310|NCT03448393|468914821|FG000|Dose Expansion|Not treated - screen failure|0|||
130259311|NCT03448393|468914822|FG001|Dose Expansion|Not treated - screen failure|0|||
130259312|NCT03448393|468914823|FG002|Dose Expansion|Not treated - screen failure|0|||
130259313|NCT03448393|468914824|FG003|Dose Expansion|Not treated - screen failure|0|||
130259314|NCT03448393|468914825|FG004|Dose Expansion|Not treated - screen failure|0|||
130259315|NCT03448393|468914826|FG005|Dose Expansion|Not treated - screen failure|0|||
130259316|NCT03448393|468914827|FG006|Dose Expansion|Not treated - screen failure|0|||
130259317|NCT03448393|468914828|FG007|Dose Expansion|Not treated - screen failure|0|||
130259318|NCT03448393|468914829|FG008|Dose Expansion|Not treated - screen failure|7|||
130259319|NCT01587196|468914830|FG000|Overall Study|Lost to Follow-up|50|||
130259320|NCT01587196|468914830|FG000|Overall Study|Withdrawal by Subject|4|||
130259321|NCT00643279|468914836|FG000|Overall Study|Death|13|||
130259322|NCT00643279|468914837|FG001|Overall Study|Death|11|||
130259323|NCT00643279|468914836|FG000|Overall Study|Withdrawal by Subject|3|||
130259324|NCT00643279|468914837|FG001|Overall Study|Withdrawal by Subject|0|||
130259325|NCT00643279|468914836|FG000|Overall Study|Lost to Follow-up|0|||
130259326|NCT00643279|468914837|FG001|Overall Study|Lost to Follow-up|1|||
130259327|NCT00643279|468914836|FG000|Overall Study|Physician Decision|0|||
130259328|NCT00643279|468914837|FG001|Overall Study|Physician Decision|1|||
130702790|NCT02031237|470535879|FG002|Overall Study|Protocol Violation|0|||
130702791|NCT02031237|470535877|FG000|Overall Study|Alternate Treatment Given|0|||
130702792|NCT02031237|470535878|FG001|Overall Study|Alternate Treatment Given|0|||
130702793|NCT02031237|470535879|FG002|Overall Study|Alternate Treatment Given|3|||
130702794|NCT02415387|470535895|FG000|Overall Study|Withdrawal by Subject|6|||
130702795|NCT02415387|470535896|FG001|Overall Study|Withdrawal by Subject|1|||
130702796|NCT02415387|470535895|FG000|Overall Study|blood draw problem|0|||
130702797|NCT02415387|470535896|FG001|Overall Study|blood draw problem|1|||
130702798|NCT02415387|470535895|FG000|Overall Study|Protocol Violation|1|||
130702799|NCT02415387|470535896|FG001|Overall Study|Protocol Violation|0|||
130259329|NCT05715827|468914838|FG000|Overall Study|Physician Decision|0|||
130259330|NCT05715827|468914839|FG001|Overall Study|Physician Decision|1|||
130259331|NCT05715827|468914838|FG000|Overall Study|console communication error|0|||
130259332|NCT05715827|468914839|FG001|Overall Study|console communication error|1|||
130259333|NCT03814044|468914840|FG000|Overall Study|Protocol deviation|1|||
130259334|NCT03557502|468914841|FG000|Protocol 2|Withdrawal by Subject|1|||
130259335|NCT03557502|468914842|FG001|Protocol 2|Withdrawal by Subject|1|||
130259336|NCT03557502|468914841|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130259337|NCT03557502|468914842|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130259338|NCT03021486|468916145|FG000|Overall Study|Withdrawal by Subject|1|||
130259339|NCT03021486|468916146|FG001|Overall Study|Withdrawal by Subject|1|||
130259340|NCT03021486|468916147|FG002|Overall Study|Withdrawal by Subject|3|||
130259341|NCT03021486|468916145|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
130259342|NCT03021486|468916146|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
130259343|NCT03021486|468916147|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
130259344|NCT04887831|468916148|FG000|Overall Study|Death|26|||
130259345|NCT04887831|468916149|FG001|Overall Study|Death|26|||
130259346|NCT04887831|468916148|FG000|Overall Study|Lost to Follow-up|0|||
130259347|NCT04887831|468916149|FG001|Overall Study|Lost to Follow-up|1|||
130259348|NCT04887831|468916148|FG000|Overall Study|Withdrawal by Subject|2|||
130259349|NCT04887831|468916149|FG001|Overall Study|Withdrawal by Subject|1|||
130259350|NCT04887831|468916148|FG000|Overall Study|Study Terminated by Sponsor|18|||
130259351|NCT04887831|468916149|FG001|Overall Study|Study Terminated by Sponsor|17|||
130259352|NCT04887831|468916148|FG000|Overall Study|Other|1|||
130259353|NCT04887831|468916149|FG001|Overall Study|Other|0|||
130259354|NCT00730327|468916150|FG000|Overall Study|Lost to Follow-up|14|||
130259355|NCT00730327|468916151|FG001|Overall Study|Lost to Follow-up|16|||
130259356|NCT00730327|468916150|FG000|Overall Study|Adverse Event|8|||
130259357|NCT00730327|468916151|FG001|Overall Study|Adverse Event|1|||
130259358|NCT00730327|468916150|FG000|Overall Study|Withdrawal by Subject|3|||
130259359|NCT00730327|468916151|FG001|Overall Study|Withdrawal by Subject|13|||
130259360|NCT00730327|468916150|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
130259361|NCT00730327|468916151|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
130259362|NCT02552225|468916152|FG000|Overall Study|Withdrawal by Subject|1|||
130259363|NCT02552225|468916153|FG001|Overall Study|Withdrawal by Subject|0|||
130259364|NCT02297516|468916154|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
130259365|NCT02297516|468916155|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
130702800|NCT01765751|470535903|FG000|Overall Study|Lost to Follow-up|0|||
130259366|NCT02297516|468916154|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
130259367|NCT02297516|468916155|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
130259368|NCT02297516|468916154|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
130259369|NCT02297516|468916155|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
130702801|NCT01765751|470535904|FG001|Overall Study|Lost to Follow-up|2|||
130702802|NCT01765751|470535905|FG002|Overall Study|Lost to Follow-up|1|||
130259370|NCT03674281|468916156|FG000|Overall Study|screen failure|2|||
130259371|NCT03674281|468916157|FG001|Overall Study|screen failure|0|||
130259372|NCT03674281|468916158|FG002|Overall Study|screen failure|0|||
130259373|NCT03674281|468916156|FG000|Overall Study|Withdrawal by Subject|1|||
130259374|NCT03674281|468916157|FG001|Overall Study|Withdrawal by Subject|3|||
130259375|NCT03674281|468916158|FG002|Overall Study|Withdrawal by Subject|3|||
130259376|NCT00366457|468916161|FG000|Overall Study|never began study therapy|2|||
130259377|NCT01497197|468916162|FG000|Overall Study|Lost to Follow-up|1|||
130259378|NCT01497197|468916163|FG001|Overall Study|Lost to Follow-up|0|||
130259379|NCT01497197|468916162|FG000|Overall Study|Protocol Violation|0|||
130259380|NCT01497197|468916163|FG001|Overall Study|Protocol Violation|2|||
130259381|NCT01497197|468916162|FG000|Overall Study|Withdrawal by Subject|2|||
130259382|NCT01497197|468916163|FG001|Overall Study|Withdrawal by Subject|1|||
130259383|NCT01497197|468916162|FG000|Overall Study|Excessive/lack of response to treatment|1|||
130259384|NCT01497197|468916163|FG001|Overall Study|Excessive/lack of response to treatment|0|||
130259385|NCT01497197|468916162|FG000|Overall Study|Risk of OHSS|1|||
130259386|NCT01497197|468916163|FG001|Overall Study|Risk of OHSS|0|||
130702803|NCT03429049|470535909|FG000|Overall Study|Adverse Event|2|||
130259387|NCT01497197|468916162|FG000|Overall Study|No oocytes retrieved|3|||
130259388|NCT01497197|468916163|FG001|Overall Study|No oocytes retrieved|2|||
130259389|NCT01497197|468916162|FG000|Overall Study|No fertilisation|6|||
130259390|NCT01497197|468916163|FG001|Overall Study|No fertilisation|5|||
130259391|NCT01497197|468916162|FG000|Overall Study|Intention to freeze all embryos|0|||
130259392|NCT01497197|468916163|FG001|Overall Study|Intention to freeze all embryos|1|||
130259393|NCT01497197|468916162|FG000|Overall Study|All embryos discarded|0|||
130259394|NCT01497197|468916163|FG001|Overall Study|All embryos discarded|3|||
130702804|NCT03429049|470535910|FG001|Overall Study|Adverse Event|3|||
130702805|NCT03429049|470535909|FG000|Overall Study|Death|0|||
130702806|NCT03429049|470535910|FG001|Overall Study|Death|1|||
130259395|NCT01497197|468916162|FG000|Overall Study|Other|3|||
130259396|NCT01497197|468916163|FG001|Overall Study|Other|1|||
130259397|NCT00415636|468916166|FG000|Overall Study|Symptomatic deterioration|1|||
130259398|NCT00415636|468916167|FG001|Overall Study|Symptomatic deterioration|0|||
130259399|NCT00415636|468916168|FG002|Overall Study|Symptomatic deterioration|1|||
130259400|NCT00415636|468916169|FG003|Overall Study|Symptomatic deterioration|2|||
130259401|NCT00415636|468916170|FG004|Overall Study|Symptomatic deterioration|0|||
130259402|NCT00415636|468916171|FG005|Overall Study|Symptomatic deterioration|1|||
130259403|NCT00415636|468916166|FG000|Overall Study|Adverse Event|0|||
130259404|NCT00415636|468916167|FG001|Overall Study|Adverse Event|0|||
130259405|NCT00415636|468916168|FG002|Overall Study|Adverse Event|0|||
130259406|NCT00415636|468916169|FG003|Overall Study|Adverse Event|1|||
130259407|NCT00415636|468916170|FG004|Overall Study|Adverse Event|1|||
130259408|NCT00415636|468916171|FG005|Overall Study|Adverse Event|0|||
130259409|NCT00415636|468916166|FG000|Overall Study|Withdrawal by Subject|0|||
130259410|NCT00415636|468916167|FG001|Overall Study|Withdrawal by Subject|0|||
130259411|NCT00415636|468916168|FG002|Overall Study|Withdrawal by Subject|0|||
130259412|NCT00415636|468916169|FG003|Overall Study|Withdrawal by Subject|0|||
130259413|NCT00415636|468916170|FG004|Overall Study|Withdrawal by Subject|1|||
130259414|NCT00415636|468916171|FG005|Overall Study|Withdrawal by Subject|0|||
130259415|NCT00415636|468916166|FG000|Overall Study|Disease progression|0|||
130259416|NCT00415636|468916167|FG001|Overall Study|Disease progression|0|||
130259417|NCT00415636|468916168|FG002|Overall Study|Disease progression|0|||
130259418|NCT00415636|468916169|FG003|Overall Study|Disease progression|3|||
130259419|NCT00415636|468916170|FG004|Overall Study|Disease progression|0|||
130259420|NCT00415636|468916171|FG005|Overall Study|Disease progression|1|||
130259421|NCT05201807|468916177|FG000|Overall Study|Adverse Event|1|||
130259422|NCT05201807|468916177|FG000|Overall Study|COVID-19 Related|1|||
130259423|NCT01209767|468916178|FG000|Overall Study|Withdrawal by Subject|1|||
130259424|NCT01209767|468916178|FG000|Overall Study|Lost to Follow-up|3|||
130259425|NCT01702298|468916179|FG000|Overall Study|Withdrawal by Subject|1|||
130259426|NCT04507204|468916180|FG000|Overall Study|Adverse Event|8|||
130259427|NCT04507204|468916181|FG001|Overall Study|Adverse Event|13|||
130259428|NCT04507204|468916180|FG000|Overall Study|Death|0|||
130259429|NCT04507204|468916181|FG001|Overall Study|Death|1|||
130259430|NCT04507204|468916180|FG000|Overall Study|Lost to Follow-up|15|||
130259431|NCT04507204|468916181|FG001|Overall Study|Lost to Follow-up|14|||
130259432|NCT04507204|468916180|FG000|Overall Study|Poor Compliance with Protocol|2|||
130259433|NCT04507204|468916181|FG001|Overall Study|Poor Compliance with Protocol|4|||
130259434|NCT04507204|468916180|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
130259435|NCT04507204|468916181|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
130259436|NCT04507204|468916180|FG000|Overall Study|Withdrawal of Patient Consent|21|||
130259437|NCT04507204|468916181|FG001|Overall Study|Withdrawal of Patient Consent|13|||
130259438|NCT03580044|468916185|FG000|Overall Study|Death|2|||
130259439|NCT03580044|468916186|FG001|Overall Study|Death|1|||
130259440|NCT03580044|468916185|FG000|Overall Study|Withdrawal by Subject|1|||
130259441|NCT03580044|468916186|FG001|Overall Study|Withdrawal by Subject|1|||
130259442|NCT01664624|468916189|FG000|Overall Study|Adverse Event|0|||
130259443|NCT01664624|468916190|FG001|Overall Study|Adverse Event|1|||
130259444|NCT01664624|468916191|FG002|Overall Study|Adverse Event|0|||
130259445|NCT01664624|468916192|FG003|Overall Study|Adverse Event|0|||
130259446|NCT01206517|468916193|FG000|Overall Study|Withdrawal by Subject|0|||
130259447|NCT01206517|468916194|FG001|Overall Study|Withdrawal by Subject|0|||
130259448|NCT01206517|468916195|FG002|Overall Study|Withdrawal by Subject|2|||
130259449|NCT01206517|468916196|FG003|Overall Study|Withdrawal by Subject|0|||
130259450|NCT01206517|468916197|FG004|Overall Study|Withdrawal by Subject|1|||
130259451|NCT01206517|468916198|FG005|Overall Study|Withdrawal by Subject|0|||
130259452|NCT01029535|468916199|FG000|Overall Study|Lost to Follow-up|24|||
130259453|NCT01029535|468916199|FG000|Overall Study|Protocol Violation|2|||
130259454|NCT01029535|468916199|FG000|Overall Study|Participant Withdrew Consent|2|||
130259455|NCT01029535|468916199|FG000|Overall Study|Adverse Event|1|||
130259456|NCT01029535|468916199|FG000|Overall Study|Use of Another Treatment|1|||
130365412|NCT02187744|469306883|FG000|Study|Related adverse event, serious non-fatal|0|||
130365413|NCT02187744|469306884|FG001|Study|Related adverse event, serious non-fatal|1|||
130702807|NCT03429049|470535909|FG000|Overall Study|Lack of Efficacy|4|||
130259457|NCT01029535|468916199|FG000|Overall Study|Death|1|||
130259458|NCT01198587|468916203|FG000|Overall Study|Lost to Follow-up|8|||
130259459|NCT01198587|468916204|FG001|Overall Study|Lost to Follow-up|0|||
130365414|NCT02187744|469306883|FG000|Treatment|Death|1|||
130365415|NCT02187744|469306884|FG001|Treatment|Death|0|||
130259460|NCT01198587|468916205|FG002|Overall Study|Lost to Follow-up|9|||
130259461|NCT01198587|468916206|FG003|Overall Study|Lost to Follow-up|0|||
130259462|NCT00573768|468916207|FG000|Overall Study|Adverse Event|1|||
130259463|NCT00573768|468916208|FG001|Overall Study|Adverse Event|1|||
130259464|NCT00573768|468916209|FG002|Overall Study|Adverse Event|2|||
130259465|NCT00573768|468916207|FG000|Overall Study|Protocol Violation|1|||
130259466|NCT00573768|468916208|FG001|Overall Study|Protocol Violation|0|||
130259467|NCT00573768|468916209|FG002|Overall Study|Protocol Violation|1|||
130259468|NCT00573768|468916207|FG000|Overall Study|Withdrawal by Subject|0|||
130259469|NCT00573768|468916208|FG001|Overall Study|Withdrawal by Subject|1|||
130259470|NCT00573768|468916209|FG002|Overall Study|Withdrawal by Subject|0|||
130259471|NCT00573768|468916207|FG000|Overall Study|Lost to Follow-up|0|||
130259472|NCT00573768|468916208|FG001|Overall Study|Lost to Follow-up|0|||
130259473|NCT00573768|468916209|FG002|Overall Study|Lost to Follow-up|1|||
130259474|NCT04067011|468916215|FG000|Overall Study|Not Treated|8|||
130259475|NCT04067011|468916216|FG001|Overall Study|Not Treated|7|||
130259476|NCT04067011|468916217|FG002|Overall Study|Not Treated|5|||
130259477|NCT04067011|468916215|FG000|Overall Study|Adverse Event|2|||
130259478|NCT04067011|468916216|FG001|Overall Study|Adverse Event|1|||
130259479|NCT04067011|468916217|FG002|Overall Study|Adverse Event|0|||
130259480|NCT04067011|468916215|FG000|Overall Study|Withdrawal by Subject|6|||
130259481|NCT04067011|468916216|FG001|Overall Study|Withdrawal by Subject|2|||
130259482|NCT04067011|468916217|FG002|Overall Study|Withdrawal by Subject|1|||
130259483|NCT04067011|468916215|FG000|Overall Study|Lost to Follow-up|0|||
130259484|NCT04067011|468916216|FG001|Overall Study|Lost to Follow-up|0|||
130259485|NCT04067011|468916217|FG002|Overall Study|Lost to Follow-up|1|||
130259486|NCT04067011|468916215|FG000|Overall Study|Physician Decision|1|||
130259487|NCT04067011|468916216|FG001|Overall Study|Physician Decision|1|||
130259488|NCT04067011|468916217|FG002|Overall Study|Physician Decision|0|||
130259489|NCT04067011|468916215|FG000|Overall Study|Other Reasons|2|||
130259490|NCT04067011|468916216|FG001|Overall Study|Other Reasons|0|||
130259491|NCT04067011|468916217|FG002|Overall Study|Other Reasons|1|||
130259492|NCT04067011|468916215|FG000|Overall Study|Missing|0|||
130259493|NCT04067011|468916216|FG001|Overall Study|Missing|2|||
130259494|NCT04067011|468916217|FG002|Overall Study|Missing|0|||
130259495|NCT03746015|468916218|FG000|Overall Study|Withdrawal of Consent|1|||
130259496|NCT03746015|468916219|FG001|Overall Study|Withdrawal of Consent|0|||
130259497|NCT03746015|468916220|FG002|Overall Study|Withdrawal of Consent|0|||
130259498|NCT05209386|468916221|FG000|Overall Study|Withdrawal by Subject|8|||
130259499|NCT05209386|468916221|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
130259500|NCT05134649|468916222|FG000|Overall Study|Lost to Follow-up|12|||
130259501|NCT05134649|468916222|FG000|Overall Study|Withdrawal by Subject|14|||
130259502|NCT05134649|468916222|FG000|Overall Study|Pregnancy|1|||
130259503|NCT05134649|468916222|FG000|Overall Study|Other, not specified|3|||
130259504|NCT01559935|468916223|FG000|Car Phase|Toxicity|4|||
130259505|NCT01559935|468916223|FG000|Car Phase|Death|1|||
130259506|NCT01559935|468916223|FG000|Car Phase|Lack of Efficacy|2|||
130259507|NCT01559935|468916223|FG000|Car Phase|Lost to Follow-up|1|||
130259508|NCT01559935|468916223|FG000|Car Phase|Physician Decision|1|||
130259509|NCT01559935|468916223|FG000|Car Phase|Withdrawal by Subject|2|||
130702808|NCT03429049|470535910|FG001|Overall Study|Lack of Efficacy|2|||
130259510|NCT01559935|468916223|FG000|Car Phase|Per protocol|1|||
130259511|NCT01559935|468916223|FG000|Car Phase|Insurance|1|||
130259512|NCT01559935|468916223|FG000|Car Phase|non-compliance|1|||
130259513|NCT01559935|468916223|FG000|BiRD Phase|Toxicity|1|||
130259514|NCT01559935|468916223|FG000|BiRD Phase|Lack of Efficacy|1|||
130259515|NCT01559935|468916223|FG000|BiRD Phase|Withdrawal by Subject|2|||
130259516|NCT01559935|468916223|FG000|Maintenance Phase|Remains on study|28|||
130259517|NCT01559935|468916223|FG000|Maintenance Phase|Toxicity|1|||
130259518|NCT01559935|468916223|FG000|Maintenance Phase|Lack of Efficacy|18|||
130259519|NCT01559935|468916223|FG000|Maintenance Phase|Withdrawal by Subject|5|||
130259520|NCT01559935|468916223|FG000|Maintenance Phase|Non-compliance|2|||
130259521|NCT01143402|468916227|FG000|Overall Study|Rapid clinical decline|1|||
130259522|NCT01143402|468916228|FG001|Overall Study|Rapid clinical decline|1|||
130259523|NCT01143402|468916229|FG002|Overall Study|Rapid clinical decline|0|||
130259524|NCT01143402|468916227|FG000|Overall Study|Not Treated|0|||
130259525|NCT01143402|468916228|FG001|Overall Study|Not Treated|0|||
130259526|NCT01143402|468916229|FG002|Overall Study|Not Treated|1|||
130259527|NCT02526290|468916230|FG000|Overall Study|Adverse Event|3|||
130259528|NCT02526290|468916230|FG000|Overall Study|Withdrawal by Subject|4|||
130259529|NCT02526290|468916230|FG000|Overall Study|Physician Decision|1|||
130702809|NCT03429049|470535909|FG000|Overall Study|Lost to Follow-up|9|||
130702810|NCT03429049|470535910|FG001|Overall Study|Lost to Follow-up|8|||
130702811|NCT03429049|470535909|FG000|Overall Study|Physician Decision|1|||
130702812|NCT03429049|470535910|FG001|Overall Study|Physician Decision|0|||
130259530|NCT02706392|468916231|FG000|Overall Study|Death|1|||
130259531|NCT02706392|468916232|FG001|Overall Study|Death|0|||
130259532|NCT02706392|468916233|FG002|Overall Study|Death|2|||
130259533|NCT02706392|468916234|FG003|Overall Study|Death|2|||
130259534|NCT02706392|468916235|FG004|Overall Study|Death|5|||
130259535|NCT02706392|468916236|FG005|Overall Study|Death|2|||
130259536|NCT00619866|468916239|FG000|Weeks 1 - 12|Adverse Event|0|||
130702813|NCT03429049|470535909|FG000|Overall Study|Protocol Violation|3|||
130259537|NCT00619866|468916240|FG001|Weeks 1 - 12|Adverse Event|1|||
130259538|NCT00619866|468916241|FG002|Weeks 1 - 12|Adverse Event|2|||
130259539|NCT00619866|468916242|FG003|Weeks 1 - 12|Adverse Event|0|||
130702814|NCT03429049|470535910|FG001|Overall Study|Protocol Violation|0|||
130259540|NCT00619866|468916243|FG004|Weeks 1 - 12|Adverse Event|0|||
130259541|NCT00619866|468916239|FG000|Weeks 1 - 12|Non-compliance|0|||
130259542|NCT00619866|468916240|FG001|Weeks 1 - 12|Non-compliance|0|||
130259543|NCT00619866|468916241|FG002|Weeks 1 - 12|Non-compliance|1|||
130259544|NCT00619866|468916242|FG003|Weeks 1 - 12|Non-compliance|0|||
130259545|NCT00619866|468916243|FG004|Weeks 1 - 12|Non-compliance|0|||
130259546|NCT00619866|468916239|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
130259547|NCT00619866|468916240|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
130259548|NCT00619866|468916241|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
130259549|NCT00619866|468916242|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
130259550|NCT00619866|468916243|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
130259551|NCT00619866|468916239|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
130259552|NCT00619866|468916240|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
130259553|NCT00619866|468916241|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
130259554|NCT00619866|468916242|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
130259555|NCT00619866|468916243|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
130259556|NCT00619866|468916239|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
130259557|NCT00619866|468916240|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
130259558|NCT00619866|468916241|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
130259559|NCT00619866|468916242|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
130259560|NCT00619866|468916243|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
130259561|NCT00619866|468916239|FG000|Weeks 1 - 12|Sponsor Decision|0|||
130259562|NCT00619866|468916240|FG001|Weeks 1 - 12|Sponsor Decision|1|||
130259563|NCT00619866|468916241|FG002|Weeks 1 - 12|Sponsor Decision|0|||
130259564|NCT00619866|468916242|FG003|Weeks 1 - 12|Sponsor Decision|0|||
130259565|NCT00619866|468916243|FG004|Weeks 1 - 12|Sponsor Decision|0|||
130259566|NCT00619866|468916239|FG000|Weeks 13 - 24|Adverse Event|0|||
130259567|NCT00619866|468916240|FG001|Weeks 13 - 24|Adverse Event|0|||
130259568|NCT00619866|468916241|FG002|Weeks 13 - 24|Adverse Event|2|||
130259569|NCT00619866|468916242|FG003|Weeks 13 - 24|Adverse Event|1|||
130259570|NCT00619866|468916243|FG004|Weeks 13 - 24|Adverse Event|0|||
130259571|NCT00619866|468916239|FG000|Weeks 13 - 24|Protocol Deviation|0|||
130259572|NCT00619866|468916240|FG001|Weeks 13 - 24|Protocol Deviation|0|||
130259573|NCT00619866|468916241|FG002|Weeks 13 - 24|Protocol Deviation|0|||
130259574|NCT00619866|468916242|FG003|Weeks 13 - 24|Protocol Deviation|1|||
130259575|NCT00619866|468916243|FG004|Weeks 13 - 24|Protocol Deviation|0|||
130259576|NCT00619866|468916239|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
130259577|NCT00619866|468916240|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
130259578|NCT00619866|468916241|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
130259579|NCT00619866|468916242|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
130259580|NCT00619866|468916243|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
130259581|NCT00619866|468916239|FG000|Weeks 13 - 24|Non-compliance|0|||
130259582|NCT00619866|468916240|FG001|Weeks 13 - 24|Non-compliance|1|||
130259583|NCT00619866|468916241|FG002|Weeks 13 - 24|Non-compliance|1|||
130259584|NCT00619866|468916242|FG003|Weeks 13 - 24|Non-compliance|0|||
130259585|NCT00619866|468916243|FG004|Weeks 13 - 24|Non-compliance|0|||
130259586|NCT00619866|468916239|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
130259587|NCT00619866|468916240|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
130259588|NCT00619866|468916241|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
130259589|NCT00619866|468916242|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
130259590|NCT00619866|468916243|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
130259591|NCT01968980|468916247|FG000|Overall Study|Death|0|||
130259592|NCT01968980|468916248|FG001|Overall Study|Death|1|||
130259593|NCT01968980|468916247|FG000|Overall Study|Adverse Event|1|||
130259594|NCT01968980|468916248|FG001|Overall Study|Adverse Event|3|||
130259595|NCT01968980|468916247|FG000|Overall Study|Does not meet entry criteria|1|||
130259596|NCT01968980|468916248|FG001|Overall Study|Does not meet entry criteria|3|||
130259597|NCT01968980|468916247|FG000|Overall Study|Withdrawal by Subject|13|||
130259598|NCT01968980|468916248|FG001|Overall Study|Withdrawal by Subject|5|||
130259599|NCT01968980|468916247|FG000|Overall Study|Other unspecified|1|||
130259600|NCT01968980|468916248|FG001|Overall Study|Other unspecified|2|||
130259601|NCT02589938|468916254|FG000|Overall Study|Withdrawal by Subject|11|||
130259602|NCT02589938|468916255|FG001|Overall Study|Withdrawal by Subject|5|||
130259603|NCT02589938|468916256|FG002|Overall Study|Withdrawal by Subject|6|||
130259604|NCT02589938|468916254|FG000|Overall Study|Lost to Follow-up|3|||
130259605|NCT02589938|468916255|FG001|Overall Study|Lost to Follow-up|3|||
130259606|NCT02589938|468916256|FG002|Overall Study|Lost to Follow-up|3|||
130259607|NCT02589938|468916254|FG000|Overall Study|Death|1|||
130259608|NCT02589938|468916255|FG001|Overall Study|Death|0|||
130259609|NCT02589938|468916256|FG002|Overall Study|Death|1|||
130553946|NCT02634346|469996459|FG000|Overall Study|Protocol Violation|0|||
130702815|NCT03429049|470535909|FG000|Overall Study|Sponsor Decision|2|||
130259610|NCT02589938|468916254|FG000|Overall Study|Protocol Violation|6|||
130259611|NCT02589938|468916255|FG001|Overall Study|Protocol Violation|2|||
130259612|NCT02589938|468916256|FG002|Overall Study|Protocol Violation|3|||
130259613|NCT02589938|468916254|FG000|Overall Study|Physician Decision|1|||
130259614|NCT02589938|468916255|FG001|Overall Study|Physician Decision|0|||
130702816|NCT03429049|470535910|FG001|Overall Study|Sponsor Decision|0|||
130259615|NCT02589938|468916256|FG002|Overall Study|Physician Decision|0|||
130259616|NCT02589938|468916254|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
130259617|NCT02589938|468916255|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
130259618|NCT02589938|468916256|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
130259619|NCT02521285|468916257|FG000|Overall Study|Lost to Follow-up|1|||
130259620|NCT02521285|468916258|FG001|Overall Study|Lost to Follow-up|1|||
130259621|NCT02521285|468916257|FG000|Overall Study|Withdrawal by Subject|1|||
130259622|NCT02521285|468916258|FG001|Overall Study|Withdrawal by Subject|1|||
130259623|NCT02521285|468916257|FG000|Overall Study|Adverse Event|0|||
130259624|NCT02521285|468916258|FG001|Overall Study|Adverse Event|1|||
130259625|NCT01121757|468916259|FG000|First Drug|Death|1|||
130259626|NCT01121757|468916260|FG001|First Drug|Death|0|||
130259627|NCT01121757|468916259|FG000|First Drug|Disease Progression|0|||
130259628|NCT01121757|468916260|FG001|First Drug|Disease Progression|2|||
130259629|NCT01121757|468916259|FG000|Combination|Physician Decision|0|||
130259630|NCT01121757|468916260|FG001|Combination|Physician Decision|1|||
130259631|NCT01121757|468916259|FG000|Combination|Disease Progression|2|||
130259632|NCT01121757|468916260|FG001|Combination|Disease Progression|0|||
130259633|NCT03636022|468916261|FG000|Overall Study|Withdrawal by Subject|1|||
130259634|NCT03636022|468916262|FG001|Overall Study|Withdrawal by Subject|3|||
130259635|NCT03189719|468916263|FG000|Overall Study|Death|325|||
130259636|NCT03189719|468916264|FG001|Overall Study|Death|361|||
130259637|NCT03189719|468916263|FG000|Overall Study|Physician Decision|1|||
130259638|NCT03189719|468916264|FG001|Overall Study|Physician Decision|0|||
130259639|NCT03189719|468916263|FG000|Overall Study|Sponsor Decision|40|||
130259640|NCT03189719|468916264|FG001|Overall Study|Sponsor Decision|12|||
130259641|NCT03189719|468916263|FG000|Overall Study|Withdrawal by Subject|7|||
130259642|NCT03189719|468916264|FG001|Overall Study|Withdrawal by Subject|3|||
130259643|NCT03012880|468916265|FG000|Overall Study|Withdrawal by Subject|1|||
130259644|NCT03012880|468916266|FG001|Overall Study|Withdrawal by Subject|0|||
130259645|NCT03012880|468916265|FG000|Overall Study|Ineligible|1|||
130259646|NCT03012880|468916266|FG001|Overall Study|Ineligible|0|||
130259647|NCT04569084|468916267|FG000|Overall Study|Adverse Event|10|||
130259648|NCT04569084|468916268|FG001|Overall Study|Adverse Event|14|||
130259649|NCT04569084|468916267|FG000|Overall Study|Death|2|||
130259650|NCT04569084|468916268|FG001|Overall Study|Death|3|||
130259651|NCT04569084|468916267|FG000|Overall Study|Lost to Follow-up|1|||
130259652|NCT04569084|468916268|FG001|Overall Study|Lost to Follow-up|1|||
130259653|NCT04569084|468916267|FG000|Overall Study|Physician Decision|3|||
130259654|NCT04569084|468916268|FG001|Overall Study|Physician Decision|3|||
130259655|NCT04569084|468916267|FG000|Overall Study|Protocol Violation|2|||
130259656|NCT04569084|468916268|FG001|Overall Study|Protocol Violation|1|||
130259657|NCT04569084|468916267|FG000|Overall Study|Withdrawal by Subject|20|||
130259658|NCT04569084|468916268|FG001|Overall Study|Withdrawal by Subject|21|||
130259659|NCT04569084|468916267|FG000|Overall Study|Study terminated by sponsor|26|||
130259660|NCT04569084|468916268|FG001|Overall Study|Study terminated by sponsor|23|||
130259661|NCT04569084|468916267|FG000|Overall Study|Other|3|||
130259662|NCT04569084|468916268|FG001|Overall Study|Other|5|||
130259663|NCT04795531|468917695|FG000|Overall Study|Withdrawal by Subject|4|||
130259664|NCT04795531|468917696|FG001|Overall Study|Withdrawal by Subject|4|||
130259665|NCT04795531|468917695|FG000|Overall Study|Lost to Follow-up|0|||
130259666|NCT04795531|468917696|FG001|Overall Study|Lost to Follow-up|1|||
130259667|NCT04795531|468917695|FG000|Overall Study|Physician Decision|0|||
130259668|NCT04795531|468917696|FG001|Overall Study|Physician Decision|2|||
130259669|NCT04795531|468917695|FG000|Overall Study|Death|2|||
130259670|NCT04795531|468917696|FG001|Overall Study|Death|1|||
130259671|NCT04043286|468917697|FG000|Overall Study|Withdrawal by Subject|2|||
130259672|NCT04043286|468917698|FG001|Overall Study|Withdrawal by Subject|2|||
130259673|NCT01323192|468917699|FG000|Overall Study|Adverse Event|6|||
130259674|NCT01323192|468917700|FG001|Overall Study|Adverse Event|1|||
130259675|NCT01323192|468917699|FG000|Overall Study|Withdrawal by Subject|3|||
130259676|NCT01323192|468917700|FG001|Overall Study|Withdrawal by Subject|1|||
130259677|NCT01323192|468917699|FG000|Overall Study|Noncompliance with study medication|0|||
130259678|NCT01323192|468917700|FG001|Overall Study|Noncompliance with study medication|3|||
130259679|NCT01323192|468917699|FG000|Overall Study|Nonmedical reasons|0|||
130259680|NCT01323192|468917700|FG001|Overall Study|Nonmedical reasons|1|||
130259681|NCT02296476|468917701|FG000|Overall Study|Disease Progression|6|||
130259682|NCT02296476|468917702|FG001|Overall Study|Disease Progression|4|||
130259683|NCT02296476|468917703|FG002|Overall Study|Disease Progression|2|||
130259684|NCT00442702|468917704|FG000|Titration Period|Adverse Event|2|||
130259685|NCT00442702|468917705|FG001|Titration Period|Adverse Event|0|||
130259686|NCT00442702|468917704|FG000|Titration Period|Death|3|||
130259687|NCT00442702|468917705|FG001|Titration Period|Death|2|||
130259688|NCT00442702|468917704|FG000|Titration Period|Insufficient Therapeutic Response|1|||
130259689|NCT00442702|468917705|FG001|Titration Period|Insufficient Therapeutic Response|0|||
130259690|NCT00442702|468917704|FG000|Titration Period|Refused Treatment|4|||
130259691|NCT00442702|468917705|FG001|Titration Period|Refused Treatment|1|||
130259692|NCT00442702|468917704|FG000|Titration Period|Failure to return|1|||
130259693|NCT00442702|468917705|FG001|Titration Period|Failure to return|0|||
130259694|NCT00442702|468917704|FG000|Titration Period|Hospitalized in another hospital|1|||
130259695|NCT00442702|468917705|FG001|Titration Period|Hospitalized in another hospital|0|||
130259696|NCT00442702|468917704|FG000|Evaluation Period|Adverse Event|1|||
130259697|NCT00442702|468917705|FG001|Evaluation Period|Adverse Event|0|||
130259698|NCT00442702|468917704|FG000|Evaluation Period|Death|1|||
130259699|NCT00442702|468917705|FG001|Evaluation Period|Death|1|||
130259700|NCT00442702|468917704|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
130259701|NCT00442702|468917705|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
130259702|NCT00442702|468917704|FG000|Evaluation Period|Refused treatment|1|||
130259703|NCT00442702|468917705|FG001|Evaluation Period|Refused treatment|1|||
130259704|NCT00442702|468917704|FG000|Evaluation Period|Renal transplant|0|||
130259705|NCT00442702|468917705|FG001|Evaluation Period|Renal transplant|1|||
130259706|NCT00442702|468917704|FG000|Evaluation Period|Failure to return|1|||
130259707|NCT00442702|468917705|FG001|Evaluation Period|Failure to return|0|||
130259708|NCT00442702|468917704|FG000|Evaluation Period|Site closure|0|||
130259709|NCT00442702|468917705|FG001|Evaluation Period|Site closure|1|||
130259710|NCT03122184|468917712|FG000|Overall Study|Lost to Follow-up|4|||
130259711|NCT03122184|468917713|FG001|Overall Study|Lost to Follow-up|6|||
130259712|NCT03122184|468917712|FG000|Overall Study|Withdrawal by Subject|3|||
130259713|NCT03122184|468917713|FG001|Overall Study|Withdrawal by Subject|0|||
130259714|NCT03122184|468917712|FG000|Overall Study|Terminated due to cognitive problem|1|||
130259715|NCT03122184|468917713|FG001|Overall Study|Terminated due to cognitive problem|0|||
130259716|NCT02835690|468917714|FG000|Overall Study|Death|12|||
130259717|NCT02835690|468917715|FG001|Overall Study|Death|11|||
130259718|NCT02835690|468917716|FG002|Overall Study|Death|13|||
130259719|NCT02835690|468917714|FG000|Overall Study|Transferred to Extension Study|2|||
130259720|NCT02835690|468917715|FG001|Overall Study|Transferred to Extension Study|2|||
130259721|NCT02835690|468917716|FG002|Overall Study|Transferred to Extension Study|1|||
130259722|NCT02835690|468917714|FG000|Overall Study|Did Not Continue on Extension Study|0|||
130259723|NCT02835690|468917715|FG001|Overall Study|Did Not Continue on Extension Study|0|||
130259724|NCT02835690|468917716|FG002|Overall Study|Did Not Continue on Extension Study|1|||
130259725|NCT02835690|468917714|FG000|Overall Study|Not Treated|0|||
130259726|NCT02835690|468917715|FG001|Overall Study|Not Treated|2|||
130259727|NCT02835690|468917716|FG002|Overall Study|Not Treated|0|||
130259728|NCT00710593|468917717|FG000|Overall Study|Incarceration|1|||
130259729|NCT00710593|468917718|FG001|Overall Study|Incarceration|0|||
130259730|NCT00710593|468917717|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
130259731|NCT00710593|468917718|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
130259732|NCT00710593|468917717|FG000|Overall Study|Lost to Follow-up|3|||
130259733|NCT00710593|468917718|FG001|Overall Study|Lost to Follow-up|1|||
130259734|NCT00710593|468917717|FG000|Overall Study|Moved out of area|1|||
130259735|NCT00710593|468917718|FG001|Overall Study|Moved out of area|0|||
130259736|NCT00710593|468917717|FG000|Overall Study|Failure to adhere or complete study eval|1|||
130259737|NCT00710593|468917718|FG001|Overall Study|Failure to adhere or complete study eval|1|||
130259738|NCT00710593|468917717|FG000|Overall Study|Protocol Violation|1|||
130259739|NCT00710593|468917718|FG001|Overall Study|Protocol Violation|1|||
130259740|NCT00710593|468917717|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
130259741|NCT00710593|468917718|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
130259742|NCT04490278|468917719|FG000|Overall Study|Lost to Follow-up|6|||
130259743|NCT02829996|468917720|FG000|Overall Study|Withdrawal by Subject|1|||
130259744|NCT02829996|468917721|FG001|Overall Study|Withdrawal by Subject|0|||
130259745|NCT02829996|468917722|FG002|Overall Study|Withdrawal by Subject|0|||
130259746|NCT02829996|468917723|FG003|Overall Study|Withdrawal by Subject|0|||
130259747|NCT02829996|468917724|FG004|Overall Study|Withdrawal by Subject|0|||
130259748|NCT03186638|468917725|FG000|Overall Study|Withdrawal by Subject|4|||
130259749|NCT03186638|468917726|FG001|Overall Study|Withdrawal by Subject|4|||
130259750|NCT03186638|468917725|FG000|Overall Study|Withdrawn due to medical problem|3|||
130259751|NCT03186638|468917726|FG001|Overall Study|Withdrawn due to medical problem|2|||
130259752|NCT03186638|468917725|FG000|Overall Study|Lost to Follow-up|1|||
130259753|NCT03186638|468917726|FG001|Overall Study|Lost to Follow-up|0|||
130259754|NCT01263119|468917727|FG000|Period 1|Protocol Violation|2|||
130259755|NCT01263119|468917727|FG000|Period 2|Adverse Event|2|||
130259756|NCT04047446|468917728|FG000|Overall Study|Physician Decision|1|||
130259757|NCT04047446|468917729|FG001|Overall Study|Physician Decision|0|||
130259758|NCT02367456|468917730|FG000|Overall Study|Death|8|||
130259759|NCT02367456|468917731|FG001|Overall Study|Death|24|||
130259760|NCT02367456|468917732|FG002|Overall Study|Death|17|||
130259761|NCT02367456|468917730|FG000|Overall Study|Lost to Follow-up|1|||
130259762|NCT02367456|468917731|FG001|Overall Study|Lost to Follow-up|3|||
130259763|NCT02367456|468917732|FG002|Overall Study|Lost to Follow-up|1|||
130259764|NCT02367456|468917730|FG000|Overall Study|Other reason|3|||
130259765|NCT02367456|468917731|FG001|Overall Study|Other reason|3|||
130259766|NCT02367456|468917732|FG002|Overall Study|Other reason|9|||
130365416|NCT02187744|469306883|FG000|Treatment|Related adverse event, serious non-fatal|0|||
130259767|NCT02367456|468917730|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
130259768|NCT02367456|468917731|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
130259769|NCT02367456|468917732|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
130259770|NCT04573972|468917735|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
130259771|NCT04573972|468917736|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
130259772|NCT01517984|468917737|FG000|Overall Study|Lost to Follow-up|0|||
130259773|NCT01517984|468917738|FG001|Overall Study|Lost to Follow-up|1|||
130259774|NCT01517984|468917739|FG002|Overall Study|Lost to Follow-up|0|||
130259775|NCT01517984|468917740|FG003|Overall Study|Lost to Follow-up|0|||
130259776|NCT01517984|468917737|FG000|Overall Study|Withdrawal by Subject|1|||
130259777|NCT01517984|468917738|FG001|Overall Study|Withdrawal by Subject|8|||
130259778|NCT01517984|468917739|FG002|Overall Study|Withdrawal by Subject|4|||
130259779|NCT01517984|468917740|FG003|Overall Study|Withdrawal by Subject|1|||
130259780|NCT01517984|468917737|FG000|Overall Study|Screen Failure|4|||
130259781|NCT01517984|468917738|FG001|Overall Study|Screen Failure|0|||
130259782|NCT01517984|468917739|FG002|Overall Study|Screen Failure|0|||
130259783|NCT01517984|468917740|FG003|Overall Study|Screen Failure|0|||
130259784|NCT01517984|468917737|FG000|Overall Study|Ineligible for randomization|0|||
130259785|NCT01517984|468917738|FG001|Overall Study|Ineligible for randomization|14|||
130259786|NCT01517984|468917739|FG002|Overall Study|Ineligible for randomization|0|||
130259787|NCT01517984|468917740|FG003|Overall Study|Ineligible for randomization|0|||
130259788|NCT01500317|468917741|FG000|Overall Study|Withdrawal by Subject|3|||
130259789|NCT01500317|468917742|FG001|Overall Study|Withdrawal by Subject|2|||
130259790|NCT01500317|468917743|FG002|Overall Study|Withdrawal by Subject|0|||
130259791|NCT00335829|468917744|FG000|Overall Study|Withdrawal by Subject|1|||
130259792|NCT00335829|468917744|FG000|Overall Study|Lost to Follow-up|1|||
130259793|NCT00335829|468917744|FG000|Overall Study|Adverse Event|1|||
130259794|NCT01038323|468917748|FG000|Overall Study|Withdrawal by Subject|3|||
130259795|NCT01038323|468917749|FG001|Overall Study|Withdrawal by Subject|2|||
130259796|NCT01038323|468917750|FG002|Overall Study|Withdrawal by Subject|4|||
130259797|NCT00862940|468917753|FG000|Overall Study|Adverse Event|15|||
130259798|NCT00862940|468917754|FG001|Overall Study|Adverse Event|12|||
130259799|NCT00862940|468917753|FG000|Overall Study|Lack of Efficacy|1|||
130259800|NCT00862940|468917754|FG001|Overall Study|Lack of Efficacy|3|||
130259801|NCT00862940|468917753|FG000|Overall Study|Protocol Violation|2|||
130259802|NCT00862940|468917754|FG001|Overall Study|Protocol Violation|5|||
130259803|NCT00862940|468917753|FG000|Overall Study|Withdrawal by Subject|4|||
130259804|NCT00862940|468917754|FG001|Overall Study|Withdrawal by Subject|6|||
130259805|NCT00862940|468917753|FG000|Overall Study|Non-compliance|4|||
130259806|NCT00862940|468917754|FG001|Overall Study|Non-compliance|0|||
130259807|NCT00862940|468917753|FG000|Overall Study|Lost to Follow-up|0|||
130259808|NCT00862940|468917754|FG001|Overall Study|Lost to Follow-up|1|||
130259809|NCT00862940|468917753|FG000|Overall Study|Administrative or other reason(s)|4|||
130259810|NCT00862940|468917754|FG001|Overall Study|Administrative or other reason(s)|3|||
130259811|NCT05552859|468917755|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130259812|NCT05552859|468917756|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130259813|NCT05901636|468917757|FG000|Overall Study|Lost to Follow-up|0|||
130259814|NCT05901636|468917758|FG001|Overall Study|Lost to Follow-up|1|||
130259815|NCT05901636|468917759|FG002|Overall Study|Lost to Follow-up|0|||
130259816|NCT05901636|468917760|FG003|Overall Study|Lost to Follow-up|1|||
130259817|NCT05901636|468917761|FG004|Overall Study|Lost to Follow-up|1|||
130259818|NCT05901636|468917762|FG005|Overall Study|Lost to Follow-up|3|||
130259819|NCT05901636|468917763|FG006|Overall Study|Lost to Follow-up|1|||
130259820|NCT05901636|468917757|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
130259821|NCT05901636|468917758|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
130259822|NCT05901636|468917759|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
130259823|NCT05901636|468917760|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
130259824|NCT05901636|468917761|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
130259825|NCT05901636|468917762|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
130259826|NCT05901636|468917763|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
130259827|NCT05901636|468917757|FG000|Overall Study|Withdrawal by Subject|1|||
130259828|NCT05901636|468917758|FG001|Overall Study|Withdrawal by Subject|1|||
130259829|NCT05901636|468917759|FG002|Overall Study|Withdrawal by Subject|0|||
130259830|NCT05901636|468917760|FG003|Overall Study|Withdrawal by Subject|0|||
130259831|NCT05901636|468917761|FG004|Overall Study|Withdrawal by Subject|1|||
130259832|NCT05901636|468917762|FG005|Overall Study|Withdrawal by Subject|1|||
130259833|NCT05901636|468917763|FG006|Overall Study|Withdrawal by Subject|0|||
130259834|NCT05901636|468917757|FG000|Overall Study|Other|0|||
130259835|NCT05901636|468917758|FG001|Overall Study|Other|0|||
130259836|NCT05901636|468917759|FG002|Overall Study|Other|1|||
130259837|NCT05901636|468917760|FG003|Overall Study|Other|1|||
130259838|NCT05901636|468917761|FG004|Overall Study|Other|0|||
130259839|NCT05901636|468917762|FG005|Overall Study|Other|0|||
130259840|NCT05901636|468917763|FG006|Overall Study|Other|0|||
130259841|NCT00432965|468917764|FG000|Overall Study|Lost to Follow-up|22|||
130259842|NCT00432965|468917765|FG001|Overall Study|Lost to Follow-up|19|||
130259843|NCT00432965|468917764|FG000|Overall Study|Withdrawal by Subject|13|||
130259844|NCT00432965|468917765|FG001|Overall Study|Withdrawal by Subject|13|||
130259845|NCT00432965|468917764|FG000|Overall Study|Physician Decision|14|||
130259846|NCT00432965|468917765|FG001|Overall Study|Physician Decision|13|||
130259847|NCT00432965|468917764|FG000|Overall Study|Lack of Efficacy|8|||
130259848|NCT00432965|468917765|FG001|Overall Study|Lack of Efficacy|13|||
130259849|NCT00432965|468917764|FG000|Overall Study|Non-compliance|7|||
130259850|NCT00432965|468917765|FG001|Overall Study|Non-compliance|0|||
130259851|NCT00432965|468917764|FG000|Overall Study|Adverse Event|22|||
130259852|NCT00432965|468917765|FG001|Overall Study|Adverse Event|19|||
130259853|NCT00432965|468917764|FG000|Overall Study|Death|3|||
130259854|NCT00432965|468917765|FG001|Overall Study|Death|4|||
130259855|NCT00432965|468917764|FG000|Overall Study|Exclusionary Methods|1|||
130259856|NCT00432965|468917765|FG001|Overall Study|Exclusionary Methods|2|||
130259857|NCT00432965|468917764|FG000|Overall Study|Incomplete Data|4|||
130259858|NCT00432965|468917765|FG001|Overall Study|Incomplete Data|3|||
130259859|NCT03330847|468917775|FG000|Overall Study|Patients ongoing study|62|||
130259860|NCT03330847|468917776|FG001|Overall Study|Patients ongoing study|65|||
130259861|NCT03330847|468917777|FG002|Overall Study|Patients ongoing study|15|||
130259862|NCT01355627|468917778|FG000|Overall Study|Request By the Patient to Discontinue|5|||
130259863|NCT01355627|468917779|FG001|Overall Study|Request By the Patient to Discontinue|7|||
130259864|NCT01355627|468917778|FG000|Overall Study|Lost to Follow-up|8|||
130259865|NCT01355627|468917779|FG001|Overall Study|Lost to Follow-up|7|||
130259866|NCT01355627|468917778|FG000|Overall Study|Fatal Adverse Event|19|||
130259867|NCT01355627|468917779|FG001|Overall Study|Fatal Adverse Event|23|||
130259868|NCT01355627|468917778|FG000|Overall Study|Other|1|||
130259869|NCT01355627|468917779|FG001|Overall Study|Other|1|||
130259870|NCT02293551|468917782|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
130259871|NCT02293551|468917783|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
130259872|NCT02293551|468917784|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
130259873|NCT02293551|468917785|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
130259874|NCT02293551|468917786|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
130259875|NCT02293551|468917787|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
130259876|NCT02293551|468917782|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
130259877|NCT02293551|468917783|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
130259878|NCT02293551|468917784|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
130259879|NCT02293551|468917785|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
130259880|NCT02293551|468917786|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
130259881|NCT02293551|468917787|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
130259882|NCT02293551|468917782|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259883|NCT02293551|468917783|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259884|NCT02293551|468917784|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
130553947|NCT02634346|469996460|FG001|Overall Study|Protocol Violation|1|||
130259885|NCT02293551|468917785|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
130259886|NCT02293551|468917786|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259887|NCT02293551|468917787|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
130259888|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
130259889|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
130259890|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
130259891|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
130259892|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
130259893|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
130259894|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
130259895|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
130259896|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
130259897|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
130259898|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
130259899|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
130259900|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
130259901|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
130259902|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
130259903|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
130259904|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
130259905|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
130702817|NCT03429049|470535909|FG000|Overall Study|Withdrawal by Subject|4|||
130702818|NCT03429049|470535910|FG001|Overall Study|Withdrawal by Subject|20|||
130702819|NCT03429049|470535909|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
130702820|NCT03429049|470535910|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
130702821|NCT01841060|470535914|FG000|Overall Study|Protocol Violation|10|||
130259906|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
130259907|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
130259908|NCT02769481|468917790|FG000|Overall Study|Protocol Violation|1|||
130259909|NCT02769481|468917791|FG001|Overall Study|Protocol Violation|0|||
130259910|NCT02769481|468917790|FG000|Overall Study|Adverse Event|3|||
130259911|NCT02769481|468917791|FG001|Overall Study|Adverse Event|6|||
130259912|NCT02769481|468917790|FG000|Overall Study|Entry Criteria Not Met|1|||
130553948|NCT02634346|469996461|FG002|Overall Study|Protocol Violation|0|||
130259913|NCT02769481|468917791|FG001|Overall Study|Entry Criteria Not Met|2|||
130259914|NCT02769481|468917790|FG000|Overall Study|Withdrawal by Subject|14|||
130259915|NCT02769481|468917791|FG001|Overall Study|Withdrawal by Subject|16|||
130259916|NCT02769481|468917790|FG000|Overall Study|Lost to Follow-up|9|||
130259917|NCT02769481|468917791|FG001|Overall Study|Lost to Follow-up|9|||
130259918|NCT02769481|468917790|FG000|Overall Study|Physician Decision|0|||
130259919|NCT02769481|468917791|FG001|Overall Study|Physician Decision|1|||
130259920|NCT02769481|468917790|FG000|Overall Study|Terminated by Sponsor|1|||
130259921|NCT02769481|468917791|FG001|Overall Study|Terminated by Sponsor|0|||
130259922|NCT02769481|468917790|FG000|Overall Study|Death|0|||
130259923|NCT02769481|468917791|FG001|Overall Study|Death|1|||
130259924|NCT02769481|468917790|FG000|Overall Study|Undefined|4|||
130259925|NCT02769481|468917791|FG001|Overall Study|Undefined|1|||
130259926|NCT00642759|468917792|FG000|Overall Study|Protocol Violation|1|||
130259927|NCT03510715|468917793|FG000|Overall Study|Adverse Event|1|||
130259928|NCT03510715|468917794|FG001|Overall Study|Adverse Event|0|||
130259929|NCT03612570|468917801|FG000|Overall Study|Lost to Follow-up|1|||
130259930|NCT04756531|468917802|FG000|Overall Study|Adverse Event|0|||
130259931|NCT04756531|468917803|FG001|Overall Study|Adverse Event|0|||
130259932|NCT04756531|468917804|FG002|Overall Study|Adverse Event|0|||
130259933|NCT04756531|468917805|FG003|Overall Study|Adverse Event|0|||
130259934|NCT04756531|468917806|FG004|Overall Study|Adverse Event|1|||
130259935|NCT04756531|468917807|FG005|Overall Study|Adverse Event|0|||
130259936|NCT04756531|468917808|FG006|Overall Study|Adverse Event|0|||
130259937|NCT04756531|468917809|FG007|Overall Study|Adverse Event|0|||
130259938|NCT04756531|468917810|FG008|Overall Study|Adverse Event|0|||
130259939|NCT04756531|468917811|FG009|Overall Study|Adverse Event|0|||
130259940|NCT04756531|468917812|FG010|Overall Study|Adverse Event|0|||
130259941|NCT04756531|468917813|FG011|Overall Study|Adverse Event|0|||
130259942|NCT04756531|468917814|FG012|Overall Study|Adverse Event|0|||
130259943|NCT04756531|468917815|FG013|Overall Study|Adverse Event|0|||
130259944|NCT04756531|468917816|FG014|Overall Study|Adverse Event|0|||
130259945|NCT04756531|468917817|FG015|Overall Study|Adverse Event|0|||
130259946|NCT04756531|468917818|FG016|Overall Study|Adverse Event|0|||
130259947|NCT04756531|468917819|FG017|Overall Study|Adverse Event|0|||
130259948|NCT04756531|468917802|FG000|Overall Study|Withdrawal by Subject|0|||
130259949|NCT04756531|468917803|FG001|Overall Study|Withdrawal by Subject|0|||
130259950|NCT04756531|468917804|FG002|Overall Study|Withdrawal by Subject|0|||
130259951|NCT04756531|468917805|FG003|Overall Study|Withdrawal by Subject|0|||
130259952|NCT04756531|468917806|FG004|Overall Study|Withdrawal by Subject|0|||
130259953|NCT04756531|468917807|FG005|Overall Study|Withdrawal by Subject|0|||
130259954|NCT04756531|468917808|FG006|Overall Study|Withdrawal by Subject|1|||
130259955|NCT04756531|468917809|FG007|Overall Study|Withdrawal by Subject|0|||
130259956|NCT04756531|468917810|FG008|Overall Study|Withdrawal by Subject|0|||
130259957|NCT04756531|468917811|FG009|Overall Study|Withdrawal by Subject|0|||
130259958|NCT04756531|468917812|FG010|Overall Study|Withdrawal by Subject|0|||
130259959|NCT04756531|468917813|FG011|Overall Study|Withdrawal by Subject|0|||
130259960|NCT04756531|468917814|FG012|Overall Study|Withdrawal by Subject|0|||
130259961|NCT04756531|468917815|FG013|Overall Study|Withdrawal by Subject|0|||
130259962|NCT04756531|468917816|FG014|Overall Study|Withdrawal by Subject|0|||
130259963|NCT04756531|468917817|FG015|Overall Study|Withdrawal by Subject|0|||
130259964|NCT04756531|468917818|FG016|Overall Study|Withdrawal by Subject|0|||
130259965|NCT04756531|468917819|FG017|Overall Study|Withdrawal by Subject|0|||
130702822|NCT00653159|470535915|FG000|Overall Study|Adverse Event|4|||
130702823|NCT00653159|470535916|FG001|Overall Study|Adverse Event|1|||
130702824|NCT00653159|470535915|FG000|Overall Study|Lost to Follow-up|1|||
130259966|NCT01994876|468917820|FG000|Test Period 1|Withdrawal by Subject|0|||
130259967|NCT01994876|468917821|FG001|Test Period 1|Withdrawal by Subject|1|||
130259968|NCT01994876|468917820|FG000|Test Period 1|Adverse Event|0|||
130259969|NCT01994876|468917821|FG001|Test Period 1|Adverse Event|1|||
130259970|NCT01994876|468917820|FG000|Test Period 2|Adverse Event|1|||
130259971|NCT01994876|468917821|FG001|Test Period 2|Adverse Event|0|||
130259972|NCT01994876|468917820|FG000|Test Period 2|Protocol Violation|0|||
130259973|NCT01994876|468917821|FG001|Test Period 2|Protocol Violation|1|||
130259974|NCT01346176|468917822|FG000|Recruited|Protocol Violation|1|||
130259975|NCT01346176|468917823|FG001|Recruited|Protocol Violation|0|||
130259976|NCT01346176|468917824|FG002|Recruited|Protocol Violation|0|||
130259977|NCT01346176|468917822|FG000|Completed Advance Directive|Death|3|||
130259978|NCT01346176|468917823|FG001|Completed Advance Directive|Death|2|||
130259979|NCT01346176|468917824|FG002|Completed Advance Directive|Death|2|||
130259980|NCT01346176|468917822|FG000|Completed Advance Directive|Became Ineligible|3|||
130259981|NCT01346176|468917823|FG001|Completed Advance Directive|Became Ineligible|0|||
130259982|NCT01346176|468917824|FG002|Completed Advance Directive|Became Ineligible|1|||
130259983|NCT01346176|468917822|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
130259984|NCT01346176|468917823|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
130259985|NCT01346176|468917824|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
130259986|NCT01346176|468917822|FG000|Completed Satisfaction Survey|Death|3|||
130702825|NCT00653159|470535916|FG001|Overall Study|Lost to Follow-up|2|||
130702826|NCT05258630|470535917|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130702827|NCT05258630|470535918|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130702828|NCT05258630|470535917|FG000|Overall Study|Lost to Follow-up|0|||
130702829|NCT05258630|470535918|FG001|Overall Study|Lost to Follow-up|2|||
130702830|NCT00109837|470535919|FG000|Overall Study|Adverse Event|2|||
130702831|NCT00109837|470535919|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
130702832|NCT00109837|470535919|FG000|Overall Study|Death|1|||
130702833|NCT00109837|470535919|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
130702834|NCT00109837|470535919|FG000|Overall Study|Not treated|1|||
130702835|NCT00109837|470535919|FG000|Overall Study|Ineligible|1|||
130702836|NCT01848210|470535920|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
130702837|NCT01848210|470535921|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
130702838|NCT01848210|470535920|FG000|Overall Study|Lost to Follow-up|24|||
130702839|NCT01848210|470535921|FG001|Overall Study|Lost to Follow-up|12|||
130702840|NCT01848210|470535920|FG000|Overall Study|Protocol Violation|3|||
130702841|NCT01848210|470535921|FG001|Overall Study|Protocol Violation|5|||
130702842|NCT01848210|470535920|FG000|Overall Study|Use of Forbidden Drugs|9|||
130702843|NCT01848210|470535921|FG001|Overall Study|Use of Forbidden Drugs|10|||
130702844|NCT01848210|470535920|FG000|Overall Study|Impedition Condition|5|||
130702845|NCT01848210|470535921|FG001|Overall Study|Impedition Condition|9|||
130702846|NCT01848210|470535920|FG000|Overall Study|Adverse Event|7|||
130702847|NCT01848210|470535921|FG001|Overall Study|Adverse Event|9|||
130702848|NCT01848210|470535920|FG000|Overall Study|Discontinuation Criterion|5|||
130702849|NCT01848210|470535921|FG001|Overall Study|Discontinuation Criterion|7|||
130702850|NCT01848210|470535920|FG000|Overall Study|Hypesensitivity|1|||
130702851|NCT01848210|470535921|FG001|Overall Study|Hypesensitivity|0|||
130702852|NCT01848210|470535920|FG000|Overall Study|Hepatic Function Alteration|4|||
130702853|NCT01848210|470535921|FG001|Overall Study|Hepatic Function Alteration|0|||
130702854|NCT01848210|470535920|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
130702855|NCT01848210|470535921|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
130702856|NCT01848210|470535920|FG000|Overall Study|Administrative|1|||
130702857|NCT01848210|470535921|FG001|Overall Study|Administrative|0|||
130702858|NCT00381849|470535922|FG000|Wash Out|Withdrawal by Subject|0|||
130702859|NCT00381849|470535923|FG001|Wash Out|Withdrawal by Subject|1|||
130702860|NCT00894933|470535929|FG000|Overall Study|Lost to Follow-up|2|||
130702861|NCT00894933|470535929|FG000|Overall Study|Cancelled Procedure|1|||
130702862|NCT00894933|470535929|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
130702863|NCT00631007|470535930|FG000|Overall Study|Adverse Event|0|||
130702864|NCT00631007|470535931|FG001|Overall Study|Adverse Event|2|||
130702865|NCT00631007|470535932|FG002|Overall Study|Adverse Event|0|||
130702866|NCT00631007|470535933|FG003|Overall Study|Adverse Event|2|||
130702867|NCT00631007|470535934|FG004|Overall Study|Adverse Event|3|||
130702868|NCT00631007|470535935|FG005|Overall Study|Adverse Event|2|||
130702869|NCT00631007|470535930|FG000|Overall Study|Lost to Follow-up|2|||
130702870|NCT00631007|470535931|FG001|Overall Study|Lost to Follow-up|1|||
130702871|NCT00631007|470535932|FG002|Overall Study|Lost to Follow-up|2|||
130259987|NCT01346176|468917823|FG001|Completed Satisfaction Survey|Death|0|||
130259988|NCT01346176|468917824|FG002|Completed Satisfaction Survey|Death|2|||
130259989|NCT01346176|468917822|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
130259990|NCT01346176|468917823|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
130259991|NCT01346176|468917824|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
130259992|NCT01400412|468917825|FG000|Overall Study|Lost to Follow-up|4|||
130259993|NCT01400412|468917826|FG001|Overall Study|Lost to Follow-up|7|||
130259994|NCT01400412|468917825|FG000|Overall Study|Withdrawal by Subject|3|||
130259995|NCT01400412|468917826|FG001|Overall Study|Withdrawal by Subject|4|||
130259996|NCT01400412|468917825|FG000|Overall Study|Unable to complete|3|||
130259997|NCT01400412|468917826|FG001|Overall Study|Unable to complete|3|||
130259998|NCT01400412|468917825|FG000|Overall Study|Never started study treatment|0|||
130259999|NCT01400412|468917826|FG001|Overall Study|Never started study treatment|3|||
130260000|NCT01276704|468918911|FG000|Overall Study|Lost to Follow-up|2|||
130260001|NCT01276704|468918912|FG001|Overall Study|Lost to Follow-up|3|||
130260002|NCT01276704|468918911|FG000|Overall Study|Non-compliant|2|||
130260003|NCT01276704|468918912|FG001|Overall Study|Non-compliant|2|||
130702872|NCT00631007|470535933|FG003|Overall Study|Lost to Follow-up|4|||
130702873|NCT00631007|470535934|FG004|Overall Study|Lost to Follow-up|5|||
130702874|NCT00631007|470535935|FG005|Overall Study|Lost to Follow-up|3|||
130702875|NCT00631007|470535930|FG000|Overall Study|Physician Decision|1|||
130702876|NCT00631007|470535931|FG001|Overall Study|Physician Decision|0|||
130702877|NCT00631007|470535932|FG002|Overall Study|Physician Decision|1|||
130260004|NCT01276704|468918911|FG000|Overall Study|Withdrawal by Subject|7|||
130260005|NCT01276704|468918912|FG001|Overall Study|Withdrawal by Subject|1|||
130702878|NCT00631007|470535933|FG003|Overall Study|Physician Decision|0|||
130702879|NCT00631007|470535934|FG004|Overall Study|Physician Decision|0|||
130702880|NCT00631007|470535935|FG005|Overall Study|Physician Decision|2|||
130702881|NCT00631007|470535930|FG000|Overall Study|Persistent Hyperglycemia|2|||
130702882|NCT00631007|470535931|FG001|Overall Study|Persistent Hyperglycemia|2|||
130702883|NCT00631007|470535932|FG002|Overall Study|Persistent Hyperglycemia|5|||
130702884|NCT00631007|470535933|FG003|Overall Study|Persistent Hyperglycemia|1|||
130260006|NCT01276704|468918911|FG000|Overall Study|Physician Decision|3|||
130260007|NCT01276704|468918912|FG001|Overall Study|Physician Decision|5|||
130702885|NCT00631007|470535934|FG004|Overall Study|Persistent Hyperglycemia|2|||
130260008|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
130260009|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
130260010|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130260011|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130260012|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
130260013|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
130260014|NCT02986074|468918915|FG000|First Trial Period|Adverse Event|1|||
130260015|NCT02986074|468918916|FG001|First Trial Period|Adverse Event|0|||
130260016|NCT02986074|468918917|FG002|First Trial Period|Adverse Event|0|||
130260017|NCT02986074|468918918|FG003|First Trial Period|Adverse Event|0|||
130260018|NCT02986074|468918915|FG000|Follow up Period|system explant|0|||
130260019|NCT02986074|468918916|FG001|Follow up Period|system explant|0|||
130260020|NCT02986074|468918917|FG002|Follow up Period|system explant|1|||
130260021|NCT02986074|468918918|FG003|Follow up Period|system explant|2|||
130260022|NCT02986074|468918915|FG000|Follow up Period|Physician Decision|0|||
130260023|NCT02986074|468918916|FG001|Follow up Period|Physician Decision|0|||
130260024|NCT02986074|468918917|FG002|Follow up Period|Physician Decision|0|||
130260025|NCT02986074|468918918|FG003|Follow up Period|Physician Decision|1|||
130260026|NCT00069641|468918923|FG000|Overall Study|Death|1|||
130260027|NCT00069641|468918924|FG001|Overall Study|Death|0|||
130260028|NCT00069641|468918925|FG002|Overall Study|Death|1|||
130260029|NCT01645176|468918926|FG000|Overall Study|Lack of Efficacy|4|||
130702886|NCT00631007|470535935|FG005|Overall Study|Persistent Hyperglycemia|5|||
130702887|NCT00631007|470535930|FG000|Overall Study|Withdrawal by Subject|4|||
130702888|NCT00631007|470535931|FG001|Overall Study|Withdrawal by Subject|5|||
130260030|NCT01645176|468918926|FG000|Overall Study|did not complete final MRI|1|||
130260031|NCT01948427|468918927|FG000|Overall Study|Serious Adverse Event|3|||
130260032|NCT01948427|468918928|FG001|Overall Study|Serious Adverse Event|0|||
130260033|NCT01948427|468918929|FG002|Overall Study|Serious Adverse Event|0|||
130260034|NCT01948427|468918930|FG003|Overall Study|Serious Adverse Event|0|||
130260035|NCT01948427|468918931|FG004|Overall Study|Serious Adverse Event|1|||
130260036|NCT01948427|468918927|FG000|Overall Study|Investigator Request|0|||
130260037|NCT01948427|468918928|FG001|Overall Study|Investigator Request|8|||
130260038|NCT01948427|468918929|FG002|Overall Study|Investigator Request|0|||
130260039|NCT01948427|468918930|FG003|Overall Study|Investigator Request|0|||
130260040|NCT01948427|468918931|FG004|Overall Study|Investigator Request|6|||
130260041|NCT01948427|468918927|FG000|Overall Study|Lost to Follow-up|1|||
130260042|NCT01948427|468918928|FG001|Overall Study|Lost to Follow-up|0|||
130260043|NCT01948427|468918929|FG002|Overall Study|Lost to Follow-up|0|||
130260044|NCT01948427|468918930|FG003|Overall Study|Lost to Follow-up|0|||
130260045|NCT01948427|468918931|FG004|Overall Study|Lost to Follow-up|4|||
130260046|NCT01948427|468918927|FG000|Overall Study|Withdrawal by Subject|2|||
130260047|NCT01948427|468918928|FG001|Overall Study|Withdrawal by Subject|0|||
130260048|NCT01948427|468918929|FG002|Overall Study|Withdrawal by Subject|0|||
130702889|NCT00631007|470535932|FG002|Overall Study|Withdrawal by Subject|2|||
130702890|NCT00631007|470535933|FG003|Overall Study|Withdrawal by Subject|2|||
130702891|NCT00631007|470535934|FG004|Overall Study|Withdrawal by Subject|1|||
130702892|NCT00631007|470535935|FG005|Overall Study|Withdrawal by Subject|3|||
130702893|NCT00631007|470535930|FG000|Overall Study|Other|2|||
130702894|NCT00631007|470535931|FG001|Overall Study|Other|1|||
130702895|NCT00631007|470535932|FG002|Overall Study|Other|0|||
130702896|NCT00631007|470535933|FG003|Overall Study|Other|0|||
130702897|NCT00631007|470535934|FG004|Overall Study|Other|1|||
130702898|NCT00631007|470535935|FG005|Overall Study|Other|0|||
130702899|NCT00683787|470535936|FG000|Overall Study|Progression|3|||
130702900|NCT00683787|470535937|FG001|Overall Study|Progression|3|||
130702901|NCT00683787|470535938|FG002|Overall Study|Progression|0|||
130702902|NCT00683787|470535936|FG000|Overall Study|Adverse Event|0|||
130702903|NCT00683787|470535937|FG001|Overall Study|Adverse Event|0|||
130702904|NCT00683787|470535938|FG002|Overall Study|Adverse Event|2|||
130702905|NCT04167618|470535939|FG000|Overall Study|Trial terminated by sponsor|1|||
130260049|NCT01948427|468918930|FG003|Overall Study|Withdrawal by Subject|0|||
130260050|NCT01948427|468918931|FG004|Overall Study|Withdrawal by Subject|1|||
130260051|NCT01948427|468918927|FG000|Overall Study|Other, Not Specified|1|||
130260052|NCT01948427|468918928|FG001|Overall Study|Other, Not Specified|9|||
130260053|NCT01948427|468918929|FG002|Overall Study|Other, Not Specified|0|||
130702906|NCT04167618|470535940|FG001|Overall Study|Trial terminated by sponsor|1|||
130702907|NCT00996437|470535941|FG000|Overall Study|Death|1|||
130702908|NCT00996437|470535942|FG001|Overall Study|Death|0|||
130260054|NCT01948427|468918930|FG003|Overall Study|Other, Not Specified|0|||
130260055|NCT01948427|468918931|FG004|Overall Study|Other, Not Specified|2|||
130260056|NCT00402987|468918932|FG000|Overall Study|Lack of Efficacy|0|||
130260057|NCT00402987|468918933|FG001|Overall Study|Lack of Efficacy|0|||
130260058|NCT00402987|468918934|FG002|Overall Study|Lack of Efficacy|1|||
130702909|NCT00996437|470535941|FG000|Overall Study|Dropped|2|||
130702910|NCT00996437|470535942|FG001|Overall Study|Dropped|2|||
130702911|NCT00996437|470535941|FG000|Overall Study|Missed|2|||
130702912|NCT00996437|470535942|FG001|Overall Study|Missed|5|||
130702913|NCT02576717|470535945|FG000|Overall Study|Other Reasons|16|||
130702914|NCT02576717|470535946|FG001|Overall Study|Other Reasons|18|||
130702915|NCT02576717|470535947|FG002|Overall Study|Other Reasons|15|||
130702916|NCT02576717|470535945|FG000|Overall Study|Covid-19 Pandemic|0|||
130702917|NCT02576717|470535946|FG001|Overall Study|Covid-19 Pandemic|1|||
130702918|NCT02576717|470535947|FG002|Overall Study|Covid-19 Pandemic|1|||
130702919|NCT02576717|470535945|FG000|Overall Study|Sponsor Decision|0|||
130702920|NCT02576717|470535946|FG001|Overall Study|Sponsor Decision|0|||
130702921|NCT02576717|470535947|FG002|Overall Study|Sponsor Decision|1|||
130702922|NCT02576717|470535945|FG000|Overall Study|Physician Decision|3|||
130702923|NCT02576717|470535946|FG001|Overall Study|Physician Decision|8|||
130702924|NCT02576717|470535947|FG002|Overall Study|Physician Decision|9|||
130702925|NCT02576717|470535945|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
130702926|NCT02576717|470535946|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
130702927|NCT02576717|470535947|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
130702928|NCT02576717|470535945|FG000|Overall Study|Death|3|||
130702929|NCT02576717|470535946|FG001|Overall Study|Death|5|||
130260059|NCT00402987|468918935|FG003|Overall Study|Lack of Efficacy|0|||
130260060|NCT01668004|468918936|FG000|Overall Study|Adverse Event|7|||
130260061|NCT01668004|468918936|FG000|Overall Study|Withdrawal by Subject|2|||
130260062|NCT01668004|468918936|FG000|Overall Study|Lost to Follow-up|5|||
130260063|NCT01668004|468918936|FG000|Overall Study|Lack of Efficacy|9|||
130260064|NCT01668004|468918936|FG000|Overall Study|Non-compliance with treatment|2|||
130260065|NCT02448381|468918941|FG000|Overall Study|Adverse Event|2|||
130260066|NCT02448381|468918942|FG001|Overall Study|Adverse Event|0|||
130260067|NCT02448381|468918941|FG000|Overall Study|Lost to Follow-up|16|||
130260068|NCT02448381|468918942|FG001|Overall Study|Lost to Follow-up|9|||
130260069|NCT02448381|468918941|FG000|Overall Study|Physician Decision|1|||
130260070|NCT02448381|468918942|FG001|Overall Study|Physician Decision|1|||
130260071|NCT02448381|468918941|FG000|Overall Study|Pregnancy|1|||
130260072|NCT02448381|468918942|FG001|Overall Study|Pregnancy|0|||
130260073|NCT02448381|468918941|FG000|Overall Study|Withdrawal by Subject|13|||
130260074|NCT02448381|468918942|FG001|Overall Study|Withdrawal by Subject|9|||
130260075|NCT02448381|468918941|FG000|Overall Study|Noncompliance with Study Procedures|2|||
130260076|NCT02448381|468918942|FG001|Overall Study|Noncompliance with Study Procedures|0|||
130260077|NCT01170663|468918945|FG000|Overall Study|Lost to Follow-up|3|||
130260078|NCT01170663|468918946|FG001|Overall Study|Lost to Follow-up|9|||
130260079|NCT01170663|468918945|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
130260080|NCT01170663|468918946|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
130260081|NCT02303262|468918949|FG000|Overall Study|Withdrawal by Subject|2|||
130260082|NCT04462471|468918950|FG000|Overall Study|Adverse Event|0|||
130260083|NCT04462471|468918951|FG001|Overall Study|Adverse Event|1|||
130260084|NCT04462471|468918952|FG002|Overall Study|Adverse Event|0|||
130260085|NCT04462471|468918953|FG003|Overall Study|Adverse Event|0|||
130260086|NCT04462471|468918950|FG000|Overall Study|Disease progression|1|||
130260087|NCT04462471|468918951|FG001|Overall Study|Disease progression|0|||
130260088|NCT04462471|468918952|FG002|Overall Study|Disease progression|0|||
130260089|NCT04462471|468918953|FG003|Overall Study|Disease progression|0|||
130260090|NCT04138056|468918958|FG000|Primary Study|Lost to Follow-up|3|||
130260091|NCT04138056|468918959|FG001|Primary Study|Lost to Follow-up|4|||
130260092|NCT04138056|468918960|FG002|Primary Study|Lost to Follow-up|1|||
130260093|NCT04138056|468918961|FG003|Primary Study|Lost to Follow-up|1|||
130702930|NCT02576717|470535947|FG002|Overall Study|Death|3|||
130702931|NCT02576717|470535945|FG000|Overall Study|Lost to Follow-up|9|||
130702932|NCT02576717|470535946|FG001|Overall Study|Lost to Follow-up|10|||
130702933|NCT02576717|470535947|FG002|Overall Study|Lost to Follow-up|19|||
130702934|NCT02576717|470535945|FG000|Overall Study|Protocol Violation|4|||
130260094|NCT04138056|468918962|FG004|Primary Study|Lost to Follow-up|4|||
130260095|NCT04138056|468918958|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
130702935|NCT02576717|470535946|FG001|Overall Study|Protocol Violation|0|||
130702936|NCT02576717|470535947|FG002|Overall Study|Protocol Violation|5|||
130702937|NCT02576717|470535945|FG000|Overall Study|Lack of Efficacy|24|||
130702938|NCT02576717|470535946|FG001|Overall Study|Lack of Efficacy|28|||
130702939|NCT02576717|470535947|FG002|Overall Study|Lack of Efficacy|20|||
130702940|NCT02576717|470535945|FG000|Overall Study|Adverse Event|26|||
130702941|NCT02576717|470535946|FG001|Overall Study|Adverse Event|32|||
130702942|NCT02576717|470535947|FG002|Overall Study|Adverse Event|26|||
130702943|NCT00399893|470535948|FG000|Overall Study|Withdrawal by Subject|1|||
130702944|NCT00399893|470535949|FG001|Overall Study|Withdrawal by Subject|0|||
130702945|NCT01363011|470535950|FG000|Main Study|Adverse Event|2|||
130702946|NCT01363011|470535951|FG001|Main Study|Adverse Event|3|||
130702947|NCT01363011|470535950|FG000|Main Study|Investigator's Discretion|1|||
130702948|NCT01363011|470535951|FG001|Main Study|Investigator's Discretion|1|||
130702949|NCT01363011|470535950|FG000|Main Study|Withdrew Consent|1|||
130702950|NCT01363011|470535951|FG001|Main Study|Withdrew Consent|4|||
130702951|NCT01363011|470535950|FG000|Main Study|Protocol Violation|0|||
130702952|NCT01363011|470535951|FG001|Main Study|Protocol Violation|1|||
130702953|NCT01363011|470535950|FG000|Extension Phase|Adverse Event|1|||
130702954|NCT01363011|470535951|FG001|Extension Phase|Adverse Event|1|||
130702955|NCT01363011|470535950|FG000|Extension Phase|Lack of Efficacy|0|||
130702956|NCT01363011|470535951|FG001|Extension Phase|Lack of Efficacy|1|||
130702957|NCT01363011|470535950|FG000|Extension Phase|Investigator's Discretion|2|||
130702958|NCT01363011|470535951|FG001|Extension Phase|Investigator's Discretion|2|||
130702959|NCT01363011|470535950|FG000|Extension Phase|Withdrew Consent|0|||
130702960|NCT01363011|470535951|FG001|Extension Phase|Withdrew Consent|1|||
130702961|NCT01363011|470535950|FG000|Extension Phase|Lost to Follow-up|0|||
130702962|NCT01363011|470535951|FG001|Extension Phase|Lost to Follow-up|2|||
130702963|NCT01363011|470535950|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
130702964|NCT01363011|470535951|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
130702965|NCT00407745|470535953|FG000|Overall Study|Lack of Efficacy|1|||
130702966|NCT00407745|470535954|FG001|Overall Study|Lack of Efficacy|2|||
130702967|NCT00407745|470535953|FG000|Overall Study|Withdrawal by Subject|3|||
130702968|NCT00407745|470535954|FG001|Overall Study|Withdrawal by Subject|3|||
130702969|NCT00407745|470535953|FG000|Overall Study|Protocol Violation|5|||
130260096|NCT04138056|468918959|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
130260097|NCT04138056|468918960|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
130260098|NCT04138056|468918961|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
130260099|NCT04138056|468918962|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
130260100|NCT04138056|468918958|FG000|Extension Study|Lost to Follow-up|1|||
130260101|NCT04138056|468918959|FG001|Extension Study|Lost to Follow-up|2|||
130260102|NCT04138056|468918960|FG002|Extension Study|Lost to Follow-up|1|||
130260103|NCT04138056|468918961|FG003|Extension Study|Lost to Follow-up|0|||
130260104|NCT04138056|468918962|FG004|Extension Study|Lost to Follow-up|1|||
130260105|NCT01656161|468918963|FG000|Overall Study|Death|3|||
130260106|NCT01656161|468918963|FG000|Overall Study|Adverse Event|2|||
130365417|NCT02187744|469306884|FG001|Treatment|Related adverse event, serious non-fatal|1|||
130365418|NCT02187744|469306883|FG000|Treatment|Related adverse event, not serious|0|||
130365419|NCT02187744|469306884|FG001|Treatment|Related adverse event, not serious|2|||
130365420|NCT02187744|469306883|FG000|Treatment|Lost to Follow-up|0|||
130365421|NCT02187744|469306884|FG001|Treatment|Lost to Follow-up|1|||
130365422|NCT02187744|469306883|FG000|Treatment|Other|2|||
130365423|NCT02187744|469306884|FG001|Treatment|Other|0|||
130365424|NCT02187744|469306883|FG000|Treatment|Participant refused continued treatment|1|||
130365425|NCT02187744|469306884|FG001|Treatment|Participant refused continued treatment|1|||
130365426|NCT01972568|469306885|FG000|Overall Study|Other events|3|||
130365427|NCT01972568|469306886|FG001|Overall Study|Other events|0|||
130365428|NCT01972568|469306887|FG002|Overall Study|Other events|0|||
130365429|NCT01972568|469306885|FG000|Overall Study|Lack of Efficacy|0|||
130365430|NCT01972568|469306886|FG001|Overall Study|Lack of Efficacy|1|||
130365431|NCT01972568|469306887|FG002|Overall Study|Lack of Efficacy|2|||
130365432|NCT01972568|469306885|FG000|Overall Study|Protocol Violation|1|||
130702970|NCT00407745|470535954|FG001|Overall Study|Protocol Violation|3|||
130702971|NCT00407745|470535953|FG000|Overall Study|Adverse Event|8|||
130702972|NCT00407745|470535954|FG001|Overall Study|Adverse Event|8|||
130702973|NCT00407745|470535953|FG000|Overall Study|Other|2|||
130365433|NCT01972568|469306886|FG001|Overall Study|Protocol Violation|2|||
130365434|NCT01972568|469306887|FG002|Overall Study|Protocol Violation|2|||
130365435|NCT01972568|469306885|FG000|Overall Study|Withdrawal by Subject|6|||
130365436|NCT01972568|469306886|FG001|Overall Study|Withdrawal by Subject|3|||
130365437|NCT01972568|469306887|FG002|Overall Study|Withdrawal by Subject|7|||
130365438|NCT01972568|469306885|FG000|Overall Study|Lost to Follow-up|1|||
130365439|NCT01972568|469306886|FG001|Overall Study|Lost to Follow-up|0|||
130365440|NCT01972568|469306887|FG002|Overall Study|Lost to Follow-up|0|||
130702974|NCT00407745|470535954|FG001|Overall Study|Other|0|||
130702975|NCT00407745|470535953|FG000|Overall Study|Randomized, unknown if treated|0|||
130702976|NCT00407745|470535954|FG001|Overall Study|Randomized, unknown if treated|1|||
130702977|NCT01201759|470535955|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
130260107|NCT01656161|468918963|FG000|Overall Study|Protocol Violation|1|||
130260108|NCT01656161|468918963|FG000|Overall Study|Withdrawal by Subject|1|||
130260109|NCT01215851|468918964|FG000|Treatment Period|Adverse Event|1|||
130260110|NCT01215851|468918965|FG001|Treatment Period|Adverse Event|1|||
130260111|NCT01215851|468918966|FG002|Treatment Period|Adverse Event|1|||
130260112|NCT01215851|468918967|FG003|Treatment Period|Adverse Event|3|||
130260113|NCT01215851|468918968|FG004|Treatment Period|Adverse Event|0|||
130260114|NCT01215851|468918969|FG005|Treatment Period|Adverse Event|1|||
130260115|NCT01215851|468918964|FG000|Follow up Period|Lost to Follow-up|0|||
130260116|NCT01215851|468918965|FG001|Follow up Period|Lost to Follow-up|0|||
130260117|NCT01215851|468918966|FG002|Follow up Period|Lost to Follow-up|0|||
130702978|NCT01201759|470535956|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
130702979|NCT01201759|470535955|FG000|Visit 3 - Washout|Adverse Event|0|||
130702980|NCT01201759|470535956|FG001|Visit 3 - Washout|Adverse Event|3|||
130702981|NCT01201759|470535955|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
130702982|NCT01201759|470535956|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
130702983|NCT01201759|470535955|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
130260118|NCT01215851|468918967|FG003|Follow up Period|Lost to Follow-up|0|||
130260119|NCT01215851|468918968|FG004|Follow up Period|Lost to Follow-up|0|||
130365441|NCT01972568|469306885|FG000|Overall Study|Adverse Event|5|||
130365442|NCT01972568|469306886|FG001|Overall Study|Adverse Event|6|||
130365443|NCT01972568|469306887|FG002|Overall Study|Adverse Event|5|||
130365444|NCT00306189|469306890|FG000|Overall Study|Physician Decision|0|||
130365445|NCT00306189|469306891|FG001|Overall Study|Physician Decision|0|||
130365446|NCT00306189|469306892|FG002|Overall Study|Physician Decision|0|||
130365447|NCT00306189|469306893|FG003|Overall Study|Physician Decision|1|||
130365448|NCT00306189|469306890|FG000|Overall Study|Adverse Event|3|||
130365449|NCT00306189|469306891|FG001|Overall Study|Adverse Event|3|||
130365450|NCT00306189|469306892|FG002|Overall Study|Adverse Event|2|||
130365451|NCT00306189|469306893|FG003|Overall Study|Adverse Event|2|||
130365452|NCT00306189|469306890|FG000|Overall Study|Withdrawal by Subject|4|||
130365453|NCT00306189|469306891|FG001|Overall Study|Withdrawal by Subject|2|||
130365454|NCT00306189|469306892|FG002|Overall Study|Withdrawal by Subject|8|||
130365455|NCT00306189|469306893|FG003|Overall Study|Withdrawal by Subject|1|||
130365456|NCT00306189|469306890|FG000|Overall Study|Ineligibility determined|1|||
130365457|NCT00306189|469306891|FG001|Overall Study|Ineligibility determined|1|||
130365458|NCT00306189|469306892|FG002|Overall Study|Ineligibility determined|1|||
130365459|NCT00306189|469306893|FG003|Overall Study|Ineligibility determined|1|||
130365460|NCT00306189|469306890|FG000|Overall Study|Other|1|||
130365461|NCT00306189|469306891|FG001|Overall Study|Other|0|||
130365462|NCT00306189|469306892|FG002|Overall Study|Other|0|||
130365463|NCT00306189|469306893|FG003|Overall Study|Other|0|||
130365464|NCT02572401|469306894|FG000|Overall Study|Lost to Follow-up|5|||
130365465|NCT02572401|469306895|FG001|Overall Study|Lost to Follow-up|8|||
130365466|NCT02572401|469306896|FG002|Overall Study|Lost to Follow-up|9|||
130365467|NCT02572401|469306897|FG003|Overall Study|Lost to Follow-up|9|||
130365468|NCT02572401|469306894|FG000|Overall Study|Death|0|||
130365469|NCT02572401|469306895|FG001|Overall Study|Death|0|||
130365470|NCT02572401|469306896|FG002|Overall Study|Death|0|||
130365471|NCT02572401|469306897|FG003|Overall Study|Death|1|||
130365472|NCT00957580|469306900|FG000|Overall Study|Ongoing at data cut-off|0|||
130365473|NCT00957580|469306901|FG001|Overall Study|Ongoing at data cut-off|1|||
130365474|NCT00957580|469306902|FG002|Overall Study|Ongoing at data cut-off|0|||
130365475|NCT00957580|469306900|FG000|Overall Study|Enrolled but not treated|0|||
130365476|NCT00957580|469306901|FG001|Overall Study|Enrolled but not treated|1|||
130365477|NCT00957580|469306902|FG002|Overall Study|Enrolled but not treated|0|||
130365478|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130365479|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130365480|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130365481|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
130365482|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130365483|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130365484|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130365485|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130365486|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130365487|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
130365488|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130365489|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130702984|NCT01201759|470535956|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
130260120|NCT01215851|468918969|FG005|Follow up Period|Lost to Follow-up|1|||
130260121|NCT03510273|468918970|FG000|Overall Study|Withdrawal by Subject|2|||
130260122|NCT03510273|468918970|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
130260123|NCT03510273|468918970|FG000|Overall Study|Moved away from study area|4|||
130365490|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130365491|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130260124|NCT01276106|468918973|FG000|Overall Study|Adverse Event|3|||
130260125|NCT01276106|468918974|FG001|Overall Study|Adverse Event|3|||
130260126|NCT01276106|468918975|FG002|Overall Study|Adverse Event|11|||
130260127|NCT01276106|468918976|FG003|Overall Study|Adverse Event|3|||
130260128|NCT01276106|468918973|FG000|Overall Study|Withdrawal by Subject|6|||
130260129|NCT01276106|468918974|FG001|Overall Study|Withdrawal by Subject|3|||
130260130|NCT01276106|468918975|FG002|Overall Study|Withdrawal by Subject|1|||
130260131|NCT01276106|468918976|FG003|Overall Study|Withdrawal by Subject|6|||
130260132|NCT01276106|468918973|FG000|Overall Study|Lack of Efficacy|0|||
130260133|NCT01276106|468918974|FG001|Overall Study|Lack of Efficacy|1|||
130260134|NCT01276106|468918975|FG002|Overall Study|Lack of Efficacy|0|||
130260135|NCT01276106|468918976|FG003|Overall Study|Lack of Efficacy|1|||
130260136|NCT01276106|468918973|FG000|Overall Study|Lost to Follow-up|2|||
130260137|NCT01276106|468918974|FG001|Overall Study|Lost to Follow-up|1|||
130260138|NCT01276106|468918975|FG002|Overall Study|Lost to Follow-up|1|||
130260139|NCT01276106|468918976|FG003|Overall Study|Lost to Follow-up|0|||
130260140|NCT01276106|468918973|FG000|Overall Study|Physician Decision|0|||
130260141|NCT01276106|468918974|FG001|Overall Study|Physician Decision|0|||
130260142|NCT01276106|468918975|FG002|Overall Study|Physician Decision|1|||
130260143|NCT01276106|468918976|FG003|Overall Study|Physician Decision|1|||
130260144|NCT01276106|468918973|FG000|Overall Study|Protocol Violation|1|||
130260145|NCT01276106|468918974|FG001|Overall Study|Protocol Violation|1|||
130260146|NCT01276106|468918975|FG002|Overall Study|Protocol Violation|0|||
130260147|NCT01276106|468918976|FG003|Overall Study|Protocol Violation|2|||
130260148|NCT01276106|468918973|FG000|Overall Study|Insufficient therapeutic effects|0|||
130260149|NCT01276106|468918974|FG001|Overall Study|Insufficient therapeutic effects|0|||
130260150|NCT01276106|468918975|FG002|Overall Study|Insufficient therapeutic effects|2|||
130260151|NCT01276106|468918976|FG003|Overall Study|Insufficient therapeutic effects|0|||
130260152|NCT04583618|468918981|FG000|Overall Study|Adverse Event|0|||
130260153|NCT04583618|468918982|FG001|Overall Study|Adverse Event|0|||
130260154|NCT04583618|468918983|FG002|Overall Study|Adverse Event|1|||
130260155|NCT04583618|468918984|FG003|Overall Study|Adverse Event|0|||
130260156|NCT04583618|468918985|FG004|Overall Study|Adverse Event|0|||
130260157|NCT04583618|468918981|FG000|Overall Study|Protocol deviation|1|||
130260158|NCT04583618|468918982|FG001|Overall Study|Protocol deviation|1|||
130260159|NCT04583618|468918983|FG002|Overall Study|Protocol deviation|1|||
130260160|NCT04583618|468918984|FG003|Overall Study|Protocol deviation|0|||
130260161|NCT04583618|468918985|FG004|Overall Study|Protocol deviation|0|||
130260162|NCT04583618|468918981|FG000|Overall Study|Withdrawal by Subject|2|||
130260163|NCT04583618|468918982|FG001|Overall Study|Withdrawal by Subject|1|||
130260164|NCT04583618|468918983|FG002|Overall Study|Withdrawal by Subject|3|||
130260165|NCT04583618|468918984|FG003|Overall Study|Withdrawal by Subject|1|||
130260166|NCT04583618|468918985|FG004|Overall Study|Withdrawal by Subject|1|||
130260167|NCT04583618|468918981|FG000|Overall Study|Lost to Follow-up|0|||
130260168|NCT04583618|468918982|FG001|Overall Study|Lost to Follow-up|1|||
130260169|NCT04583618|468918983|FG002|Overall Study|Lost to Follow-up|3|||
130260170|NCT04583618|468918984|FG003|Overall Study|Lost to Follow-up|1|||
130260171|NCT04583618|468918985|FG004|Overall Study|Lost to Follow-up|1|||
130260172|NCT02711202|468918986|FG000|Overall Study|Adverse Event|3|||
130260173|NCT02711202|468918987|FG001|Overall Study|Adverse Event|0|||
130260174|NCT02711202|468918986|FG000|Overall Study|graft loss|1|||
130260175|NCT02711202|468918987|FG001|Overall Study|graft loss|0|||
130260176|NCT05643495|468918992|FG000|Overall Study|Adverse Event|0|||
130260177|NCT05643495|468918993|FG001|Overall Study|Adverse Event|1|||
130260178|NCT05643495|468918992|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130260179|NCT05643495|468918993|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130260180|NCT02257528|468918994|FG000|Overall Study|Never received study treatment|1|||
130260181|NCT06272383|468918995|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
130260182|NCT06272383|468918996|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
130260183|NCT02661672|468919002|FG000|Overall Study|Lost to Follow-up|1|||
130260184|NCT02661672|468919002|FG000|Overall Study|Death|4|||
130260185|NCT02581930|468919003|FG000|Overall Study|Withdrawal by Subject|1|||
130260186|NCT02581930|468919003|FG000|Overall Study|patient declined further treatment|1|||
130260187|NCT04696146|468921287|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
130260188|NCT04696146|468921288|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
130260189|NCT04696146|468921287|FG000|Overall Study|Off hours issue with product|1|||
130260190|NCT04696146|468921288|FG001|Overall Study|Off hours issue with product|0|||
130260191|NCT00529633|468921293|FG000|Overall Study|Withdrawal by Subject|1|||
130260192|NCT00529633|468921294|FG001|Overall Study|Withdrawal by Subject|1|||
130260193|NCT01576783|468921298|FG000|Overall Study|Change in Medical Care|1|||
130260194|NCT01576783|468921299|FG001|Overall Study|Change in Medical Care|0|||
130260195|NCT01576783|468921298|FG000|Overall Study|Lost to Follow-up|14|||
130260196|NCT01576783|468921299|FG001|Overall Study|Lost to Follow-up|16|||
130260197|NCT01576783|468921298|FG000|Overall Study|Withdrawal by Subject|5|||
130260198|NCT01576783|468921299|FG001|Overall Study|Withdrawal by Subject|1|||
130260199|NCT01897493|468921300|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
130260200|NCT05489328|468921301|FG000|Overall Study|Lost to Follow-up|0|||
130260201|NCT05489328|468921302|FG001|Overall Study|Lost to Follow-up|0|||
130260202|NCT05489328|468921303|FG002|Overall Study|Lost to Follow-up|1|||
130260203|NCT05489328|468921304|FG003|Overall Study|Lost to Follow-up|0|||
130260204|NCT05489328|468921305|FG004|Overall Study|Lost to Follow-up|2|||
130260205|NCT05489328|468921306|FG005|Overall Study|Lost to Follow-up|0|||
130260206|NCT05489328|468921307|FG006|Overall Study|Lost to Follow-up|0|||
130260207|NCT05489328|468921308|FG007|Overall Study|Lost to Follow-up|1|||
130260208|NCT05489328|468921309|FG008|Overall Study|Lost to Follow-up|0|||
130260209|NCT05489328|468921301|FG000|Overall Study|Withdrawal by Subject|0|||
130260210|NCT05489328|468921302|FG001|Overall Study|Withdrawal by Subject|0|||
130260211|NCT05489328|468921303|FG002|Overall Study|Withdrawal by Subject|0|||
130260212|NCT05489328|468921304|FG003|Overall Study|Withdrawal by Subject|0|||
130260213|NCT05489328|468921305|FG004|Overall Study|Withdrawal by Subject|0|||
130260214|NCT05489328|468921306|FG005|Overall Study|Withdrawal by Subject|0|||
130260215|NCT05489328|468921307|FG006|Overall Study|Withdrawal by Subject|1|||
130260216|NCT05489328|468921308|FG007|Overall Study|Withdrawal by Subject|1|||
130260217|NCT05489328|468921309|FG008|Overall Study|Withdrawal by Subject|0|||
130260218|NCT05489328|468921301|FG000|Overall Study|Other|0|||
130260219|NCT05489328|468921302|FG001|Overall Study|Other|0|||
130260220|NCT05489328|468921303|FG002|Overall Study|Other|0|||
130260221|NCT05489328|468921304|FG003|Overall Study|Other|0|||
130260222|NCT05489328|468921305|FG004|Overall Study|Other|0|||
130260223|NCT05489328|468921306|FG005|Overall Study|Other|0|||
130260224|NCT05489328|468921307|FG006|Overall Study|Other|0|||
130260225|NCT05489328|468921308|FG007|Overall Study|Other|1|||
130260226|NCT05489328|468921309|FG008|Overall Study|Other|1|||
130260227|NCT01083602|468921310|FG000|Overall Study|Adverse Event|11|||
130260228|NCT01083602|468921310|FG000|Overall Study|New Cancer Therapy|2|||
130260229|NCT01083602|468921310|FG000|Overall Study|Death|1|||
130260230|NCT01083602|468921310|FG000|Overall Study|Withdrawal by Subject|5|||
130260231|NCT01083602|468921310|FG000|Overall Study|Lack of Efficacy|36|||
130260232|NCT03698279|468921312|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130260233|NCT03698279|468921313|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130260234|NCT03698279|468921314|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130260235|NCT03698279|468921315|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130260236|NCT03698279|468921316|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130260237|NCT03698279|468921317|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130260238|NCT03698279|468921312|FG000|Overall Study|Protocol deviation|1|||
130260239|NCT03698279|468921313|FG001|Overall Study|Protocol deviation|0|||
130260240|NCT03698279|468921314|FG002|Overall Study|Protocol deviation|1|||
130260241|NCT03698279|468921315|FG003|Overall Study|Protocol deviation|0|||
130260242|NCT03698279|468921316|FG004|Overall Study|Protocol deviation|0|||
130260243|NCT03698279|468921317|FG005|Overall Study|Protocol deviation|0|||
130260244|NCT03698279|468921312|FG000|Overall Study|Withdrawal by Subject|0|||
130260245|NCT03698279|468921313|FG001|Overall Study|Withdrawal by Subject|0|||
130260246|NCT03698279|468921314|FG002|Overall Study|Withdrawal by Subject|1|||
130260247|NCT03698279|468921315|FG003|Overall Study|Withdrawal by Subject|0|||
130260248|NCT03698279|468921316|FG004|Overall Study|Withdrawal by Subject|0|||
130260249|NCT03698279|468921317|FG005|Overall Study|Withdrawal by Subject|0|||
130260250|NCT03698279|468921312|FG000|Overall Study|Lost to Follow-up|3|||
130702985|NCT01186016|470535957|FG000|Overall Study|Withdrawal by Subject|46|||
130260251|NCT03698279|468921313|FG001|Overall Study|Lost to Follow-up|1|||
130260252|NCT03698279|468921314|FG002|Overall Study|Lost to Follow-up|4|||
130260253|NCT03698279|468921315|FG003|Overall Study|Lost to Follow-up|5|||
130260254|NCT03698279|468921316|FG004|Overall Study|Lost to Follow-up|0|||
130260255|NCT03698279|468921317|FG005|Overall Study|Lost to Follow-up|0|||
130260256|NCT02276040|468921320|FG000|Overall Study|Physician Decision|15|||
130260257|NCT03801525|468921321|FG000|Overall Study|Adverse Event|17|||
130260258|NCT03801525|468921322|FG001|Overall Study|Adverse Event|1|||
130260259|NCT03801525|468921323|FG002|Overall Study|Adverse Event|0|||
130260260|NCT03801525|468921321|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
130260261|NCT03801525|468921322|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130260262|NCT03801525|468921323|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130260263|NCT03801525|468921321|FG000|Overall Study|Death|29|||
130260264|NCT03801525|468921322|FG001|Overall Study|Death|1|||
130260265|NCT03801525|468921323|FG002|Overall Study|Death|4|||
130260266|NCT03801525|468921321|FG000|Overall Study|Disease Progression|6|||
130260267|NCT03801525|468921322|FG001|Overall Study|Disease Progression|0|||
130260268|NCT03801525|468921323|FG002|Overall Study|Disease Progression|1|||
130260269|NCT03801525|468921321|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
130260270|NCT03801525|468921322|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
130260271|NCT03801525|468921323|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
130260272|NCT03801525|468921321|FG000|Overall Study|Investigator Decision|18|||
130260273|NCT03801525|468921322|FG001|Overall Study|Investigator Decision|1|||
130260274|NCT03801525|468921323|FG002|Overall Study|Investigator Decision|0|||
130260275|NCT03801525|468921321|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
130260276|NCT03801525|468921322|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130260277|NCT03801525|468921323|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130260278|NCT03801525|468921321|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
130260279|NCT03801525|468921322|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
130260280|NCT03801525|468921323|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
130260281|NCT03801525|468921321|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
130260282|NCT03801525|468921322|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
130260283|NCT03801525|468921323|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
130260284|NCT03801525|468921321|FG000|Overall Study|Withdrawal of Subject Consent|38|||
130260285|NCT03801525|468921322|FG001|Overall Study|Withdrawal of Subject Consent|2|||
130260286|NCT03801525|468921323|FG002|Overall Study|Withdrawal of Subject Consent|1|||
130260287|NCT03801525|468921321|FG000|Overall Study|Reason not Specified|4|||
130260288|NCT03801525|468921322|FG001|Overall Study|Reason not Specified|0|||
130260289|NCT03801525|468921323|FG002|Overall Study|Reason not Specified|4|||
130260290|NCT04388826|468921325|FG000|Overall Study|Lost to Follow-up|3|||
130260291|NCT04388826|468921326|FG001|Overall Study|Lost to Follow-up|2|||
130260292|NCT04388826|468921325|FG000|Overall Study|Adverse Event|1|||
130260293|NCT04388826|468921326|FG001|Overall Study|Adverse Event|0|||
130260294|NCT00329420|468921327|FG000|Re-induction Phase|Lack of Efficacy|0|||
130260295|NCT00329420|468921328|FG001|Re-induction Phase|Lack of Efficacy|1|||
130260296|NCT00329420|468921329|FG002|Re-induction Phase|Lack of Efficacy|0|||
130260297|NCT00329420|468921327|FG000|Re-induction Phase|Withdrawal of Consent|0|||
130260298|NCT00329420|468921328|FG001|Re-induction Phase|Withdrawal of Consent|0|||
130260299|NCT00329420|468921329|FG002|Re-induction Phase|Withdrawal of Consent|1|||
130260300|NCT00329420|468921327|FG000|Re-induction Phase|Did not respond to re-induction|6|||
130260301|NCT00329420|468921328|FG001|Re-induction Phase|Did not respond to re-induction|5|||
130260302|NCT00329420|468921329|FG002|Re-induction Phase|Did not respond to re-induction|7|||
130260303|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
130260304|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130260305|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130260306|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130260307|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130260308|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
130260309|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
130260310|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130260311|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130260312|NCT02862574|468921330|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130260313|NCT02862574|468921331|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130260314|NCT02862574|468921332|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130260315|NCT02862574|468921330|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
130260316|NCT02862574|468921331|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
130260317|NCT02862574|468921332|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
130260318|NCT02862574|468921330|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
130260319|NCT02862574|468921331|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
130260320|NCT02862574|468921332|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
130260321|NCT03386773|468921333|FG000|Overall Study|Lost to Follow-up|24|||
130260322|NCT03386773|468921334|FG001|Overall Study|Lost to Follow-up|33|||
130260323|NCT03386773|468921333|FG000|Overall Study|Withdrawal by Subject|3|||
130260324|NCT03386773|468921334|FG001|Overall Study|Withdrawal by Subject|2|||
130260325|NCT03639610|468921335|FG000|Overall Study|Adverse Event|7|||
130260326|NCT03639610|468921336|FG001|Overall Study|Adverse Event|1|||
130260327|NCT03639610|468921337|FG002|Overall Study|Adverse Event|0|||
130260328|NCT03639610|468921335|FG000|Overall Study|Physician Decision|3|||
130260329|NCT03639610|468921336|FG001|Overall Study|Physician Decision|1|||
130260330|NCT03639610|468921337|FG002|Overall Study|Physician Decision|0|||
130260331|NCT03639610|468921335|FG000|Overall Study|Disease progression|8|||
130260332|NCT03639610|468921336|FG001|Overall Study|Disease progression|5|||
130260333|NCT03639610|468921337|FG002|Overall Study|Disease progression|3|||
130260334|NCT03639610|468921335|FG000|Overall Study|Study terminated by sponsor|2|||
130260335|NCT03639610|468921336|FG001|Overall Study|Study terminated by sponsor|1|||
130260336|NCT03639610|468921337|FG002|Overall Study|Study terminated by sponsor|1|||
130260337|NCT03639610|468921335|FG000|Overall Study|Patient request to stop treatment|1|||
130260338|NCT03639610|468921336|FG001|Overall Study|Patient request to stop treatment|2|||
130260339|NCT03639610|468921337|FG002|Overall Study|Patient request to stop treatment|0|||
130260340|NCT02410772|468921340|FG000|Overall Study|Death|3|||
130260341|NCT02410772|468921341|FG001|Overall Study|Death|4|||
130260342|NCT02410772|468921342|FG002|Overall Study|Death|8|||
130260343|NCT02410772|468921340|FG000|Overall Study|Lost to Follow-up|31|||
130260344|NCT02410772|468921341|FG001|Overall Study|Lost to Follow-up|23|||
130365492|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130702986|NCT01186016|470535958|FG001|Overall Study|Withdrawal by Subject|29|||
130702987|NCT01098539|470535959|FG000|Overall Study|Adverse Event|26|||
130702988|NCT01098539|470535960|FG001|Overall Study|Adverse Event|26|||
130702989|NCT01098539|470535959|FG000|Overall Study|Protocol Violation|1|||
130702990|NCT01098539|470535960|FG001|Overall Study|Protocol Violation|4|||
130702991|NCT01098539|470535959|FG000|Overall Study|Noncompliance|3|||
130702992|NCT01098539|470535960|FG001|Overall Study|Noncompliance|5|||
130702993|NCT01098539|470535959|FG000|Overall Study|Lost to Follow-up|4|||
130702994|NCT01098539|470535960|FG001|Overall Study|Lost to Follow-up|4|||
130702995|NCT01098539|470535959|FG000|Overall Study|Withdrawal by Subject|12|||
130702996|NCT01098539|470535960|FG001|Overall Study|Withdrawal by Subject|26|||
130702997|NCT01098539|470535959|FG000|Overall Study|Physician Decision|5|||
130702998|NCT01098539|470535960|FG001|Overall Study|Physician Decision|3|||
130702999|NCT00721955|470535961|FG000|Overall Study|Adverse Event|0|||
130703000|NCT00721955|470535962|FG001|Overall Study|Adverse Event|0|||
130703001|NCT00721955|470535963|FG002|Overall Study|Adverse Event|2|||
130703002|NCT01055886|470535965|FG000|Overall Study|Withdrawal by Subject|4|||
130703003|NCT01055886|470535966|FG001|Overall Study|Withdrawal by Subject|9|||
130703004|NCT01055886|470535965|FG000|Overall Study|Lost to Follow-up|1|||
130703005|NCT01055886|470535966|FG001|Overall Study|Lost to Follow-up|1|||
130703006|NCT01055886|470535965|FG000|Overall Study|Withdrawal by PI|0|||
130703007|NCT01055886|470535966|FG001|Overall Study|Withdrawal by PI|1|||
130703008|NCT01077258|470535969|FG000|Overall Study|Lost to Follow-up|1390|||
130703009|NCT01077258|470535969|FG000|Overall Study|Adverse drug reaction|218|||
130703010|NCT01077258|470535969|FG000|Overall Study|Lack of Efficacy|663|||
130703011|NCT01077258|470535969|FG000|Overall Study|Clinical remission|37|||
130703012|NCT01077258|470535969|FG000|Overall Study|Other reasons|260|||
130703013|NCT00726895|470535970|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130703014|NCT00726895|470535971|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130703015|NCT00265785|470535974|FG000|Overall Study|Adverse Event|4|||
130703016|NCT00265785|470535974|FG000|Overall Study|Withdrawal by Subject|3|||
130703017|NCT00265785|470535974|FG000|Overall Study|Progression/Relapse|15|||
130703018|NCT00265785|470535974|FG000|Overall Study|Not protocol specified|2|||
130703019|NCT00265785|470535974|FG000|Overall Study|Ineligible|1|||
130703020|NCT00265785|470535974|FG000|Overall Study|Did not receive protocol treatment|2|||
130703021|NCT00585312|470535990|FG000|Overall Study|Adverse Event|3|||
130703022|NCT00585312|470535991|FG001|Overall Study|Adverse Event|0|||
130703023|NCT00585312|470535990|FG000|Overall Study|Lack of Efficacy|6|||
130703024|NCT00585312|470535991|FG001|Overall Study|Lack of Efficacy|11|||
130703025|NCT00585312|470535990|FG000|Overall Study|Lost to Follow-up|1|||
130703026|NCT00585312|470535991|FG001|Overall Study|Lost to Follow-up|1|||
130703027|NCT00585312|470535990|FG000|Overall Study|Reason not specified|2|||
130703028|NCT00585312|470535991|FG001|Overall Study|Reason not specified|0|||
130703029|NCT00585312|470535990|FG000|Overall Study|Withdrawal by Subject|5|||
130703030|NCT00585312|470535991|FG001|Overall Study|Withdrawal by Subject|1|||
130703031|NCT00585312|470535990|FG000|Overall Study|Study terminated by the sponsor|34|||
130703032|NCT00585312|470535991|FG001|Overall Study|Study terminated by the sponsor|31|||
130703033|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
130703034|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130703035|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
130703036|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
130703037|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
130703038|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130703039|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130703040|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
130703041|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
130703042|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130703043|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
130703044|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
130703045|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
130703046|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
130703047|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703048|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703049|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
130703050|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
130703051|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703052|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703053|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703054|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Death|0|||
130703055|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Death|0|||
130703056|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Death|1|||
130703057|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Death|0|||
130703058|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Death|0|||
130703059|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Death|0|||
130703060|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Death|0|||
130703061|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703062|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703063|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703064|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703065|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703066|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703067|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
130703068|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703069|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703070|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703071|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703072|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703073|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703074|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
130703075|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703076|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703077|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703078|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703079|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703080|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703081|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
130703082|NCT01634854|470536007|FG000|Overall Study|Cesarean delivery|2|||
130703083|NCT01634854|470536008|FG001|Overall Study|Cesarean delivery|7|||
130260345|NCT02410772|468921342|FG002|Overall Study|Lost to Follow-up|22|||
130260346|NCT02410772|468921340|FG000|Overall Study|Pregnancy|8|||
130260347|NCT02410772|468921341|FG001|Overall Study|Pregnancy|4|||
130260348|NCT02410772|468921342|FG002|Overall Study|Pregnancy|5|||
130260349|NCT02410772|468921340|FG000|Overall Study|Protocol Violation|8|||
130260350|NCT02410772|468921341|FG001|Overall Study|Protocol Violation|8|||
130260351|NCT02410772|468921342|FG002|Overall Study|Protocol Violation|4|||
130260352|NCT02410772|468921340|FG000|Overall Study|Baseline Drug Resistance|49|||
130260353|NCT02410772|468921341|FG001|Overall Study|Baseline Drug Resistance|40|||
130260354|NCT02410772|468921342|FG002|Overall Study|Baseline Drug Resistance|51|||
130260355|NCT02410772|468921340|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
130260356|NCT02410772|468921341|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
130260357|NCT02410772|468921342|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
130260358|NCT02410772|468921340|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
130260359|NCT02410772|468921341|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
130260360|NCT02410772|468921342|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
130260361|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
130260362|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
130260363|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130260364|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130260365|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130260366|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130260367|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130260368|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130260369|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
130260370|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
130260371|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130260372|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130703084|NCT01169038|470536009|FG000|Overall Study|Death|1|||
130703085|NCT01169038|470536009|FG000|Overall Study|Adverse Event|5|||
130260373|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
130703086|NCT01169038|470536009|FG000|Overall Study|Required antibiotic administration|1|||
130260374|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130553949|NCT00568321|469996466|FG000|Overall Study|Adverse Event|1|||
130553950|NCT00568321|469996467|FG001|Overall Study|Adverse Event|0|||
130260375|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130260376|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130260377|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260378|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
130260379|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260380|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260381|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
130260382|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
130260383|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
130260384|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
130260385|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260386|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260387|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
130260388|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260389|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260390|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260391|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260392|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
130260393|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260394|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260395|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
130260396|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260397|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260398|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260399|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
130260400|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260401|NCT02234362|468921347|FG000|Overall Study|Not eligible after first screening visit|17|||
130260402|NCT02234362|468921347|FG000|Overall Study|Lost to Follow-up|6|||
130260403|NCT02234362|468921347|FG000|Overall Study|Withdrawal by Subject|3|||
130260404|NCT00560417|468921348|FG000|Overall Study|Adverse Event|3|||
130260405|NCT00560417|468921349|FG001|Overall Study|Adverse Event|2|||
130260406|NCT00560417|468921348|FG000|Overall Study|Entry Criteria Not Met|1|||
130260407|NCT00560417|468921349|FG001|Overall Study|Entry Criteria Not Met|0|||
130260408|NCT00560417|468921348|FG000|Overall Study|Lost to Follow-up|0|||
130260409|NCT00560417|468921349|FG001|Overall Study|Lost to Follow-up|1|||
130260410|NCT00560417|468921348|FG000|Overall Study|Physician Decision|2|||
130260411|NCT00560417|468921349|FG001|Overall Study|Physician Decision|6|||
130260412|NCT00560417|468921348|FG000|Overall Study|Protocol Violation|6|||
130260413|NCT00560417|468921349|FG001|Overall Study|Protocol Violation|5|||
130260414|NCT00560417|468921348|FG000|Overall Study|Sponsor Decision|2|||
130260415|NCT00560417|468921349|FG001|Overall Study|Sponsor Decision|0|||
130260416|NCT00560417|468921348|FG000|Overall Study|Withdrawal by Subject|3|||
130260417|NCT00560417|468921349|FG001|Overall Study|Withdrawal by Subject|3|||
130260418|NCT02164864|468921352|FG000|Overall Study|Trial disease worsening|7|||
130260419|NCT02164864|468921353|FG001|Overall Study|Trial disease worsening|5|||
130260420|NCT02164864|468921354|FG002|Overall Study|Trial disease worsening|1|||
130260421|NCT02164864|468921352|FG000|Overall Study|Other pre-existing disease worsening|6|||
130260422|NCT02164864|468921353|FG001|Overall Study|Other pre-existing disease worsening|4|||
130260423|NCT02164864|468921354|FG002|Overall Study|Other pre-existing disease worsening|9|||
130260424|NCT02164864|468921352|FG000|Overall Study|Other Adverse Event (AE)|52|||
130260425|NCT02164864|468921353|FG001|Overall Study|Other Adverse Event (AE)|32|||
130260426|NCT02164864|468921354|FG002|Overall Study|Other Adverse Event (AE)|49|||
130260427|NCT02164864|468921352|FG000|Overall Study|Protocol Violation|2|||
130260428|NCT02164864|468921353|FG001|Overall Study|Protocol Violation|4|||
130260429|NCT02164864|468921354|FG002|Overall Study|Protocol Violation|1|||
130260430|NCT02164864|468921352|FG000|Overall Study|Lost to Follow-up|4|||
130260431|NCT02164864|468921353|FG001|Overall Study|Lost to Follow-up|3|||
130260432|NCT02164864|468921354|FG002|Overall Study|Lost to Follow-up|2|||
130260433|NCT02164864|468921352|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
130260434|NCT02164864|468921353|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
130260435|NCT02164864|468921354|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
130260436|NCT02164864|468921352|FG000|Overall Study|Other than stated|3|||
130260437|NCT02164864|468921353|FG001|Overall Study|Other than stated|4|||
130260438|NCT02164864|468921354|FG002|Overall Study|Other than stated|14|||
130260439|NCT02569853|468921355|FG000|Overall Study|Adverse Event|2|||
130260440|NCT02569853|468921356|FG001|Overall Study|Adverse Event|0|||
130260441|NCT02569853|468921355|FG000|Overall Study|Withdrawal by Subject|3|||
130260442|NCT02569853|468921356|FG001|Overall Study|Withdrawal by Subject|2|||
130260443|NCT02569853|468921355|FG000|Overall Study|Lost to Follow-up|3|||
130260444|NCT02569853|468921356|FG001|Overall Study|Lost to Follow-up|3|||
130260445|NCT02569853|468921355|FG000|Overall Study|Protocol Violation|1|||
130260446|NCT02569853|468921356|FG001|Overall Study|Protocol Violation|1|||
130260447|NCT02569853|468921355|FG000|Overall Study|Did not experience migraine attack|10|||
130260448|NCT02569853|468921356|FG001|Overall Study|Did not experience migraine attack|7|||
130260449|NCT02569853|468921355|FG000|Overall Study|Physician Decision|1|||
130260450|NCT02569853|468921356|FG001|Overall Study|Physician Decision|1|||
130260451|NCT00261833|468921357|FG000|Overall Study|Death|1|||
130260452|NCT00261833|468921358|FG001|Overall Study|Death|3|||
130260453|NCT00261833|468921357|FG000|Overall Study|Adverse Event|1|||
130260454|NCT00261833|468921358|FG001|Overall Study|Adverse Event|4|||
130260455|NCT00261833|468921357|FG000|Overall Study|Withdrawal by Subject|5|||
130260456|NCT00261833|468921358|FG001|Overall Study|Withdrawal by Subject|7|||
130260457|NCT00261833|468921357|FG000|Overall Study|Protocol Violation|0|||
130260458|NCT00261833|468921358|FG001|Overall Study|Protocol Violation|1|||
130260459|NCT00261833|468921357|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
130260460|NCT00261833|468921358|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
130260461|NCT00261833|468921357|FG000|Overall Study|Lung transplantation|1|||
130260462|NCT00261833|468921358|FG001|Overall Study|Lung transplantation|1|||
130260463|NCT00261833|468921357|FG000|Overall Study|Missing reason|1|||
130260464|NCT00261833|468921358|FG001|Overall Study|Missing reason|0|||
130260465|NCT00261833|468921357|FG000|Overall Study|Not interested in being participant|0|||
130260466|NCT00261833|468921358|FG001|Overall Study|Not interested in being participant|1|||
130260467|NCT00622726|468921359|FG000|March, 2008 to August, 2010|Death|5|||
130260468|NCT00622726|468921360|FG001|March, 2008 to August, 2010|Death|2|||
130260469|NCT00622726|468921359|FG000|August, 2010 to April, 2013|Death|1|||
130260470|NCT00622726|468921360|FG001|August, 2010 to April, 2013|Death|5|||
130260471|NCT02434081|468921363|FG000|Overall Study|Death (never started treatment)|2|||
130260472|NCT02434081|468921363|FG000|Overall Study|Death|2|||
130260473|NCT02434081|468921363|FG000|Overall Study|Progression|20|||
130260474|NCT02434081|468921363|FG000|Overall Study|Adverse Event|20|||
130260475|NCT02434081|468921363|FG000|Overall Study|Physician Decision|2|||
130260476|NCT02434081|468921363|FG000|Overall Study|Withdrawal by Subject|1|||
130260477|NCT02434081|468921363|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
130260478|NCT00419744|468921364|FG000|Overall Study|Adverse Event|39|||
130260479|NCT00419744|468921365|FG001|Overall Study|Adverse Event|40|||
130260480|NCT00419744|468921366|FG002|Overall Study|Adverse Event|50|||
130260481|NCT00419744|468921364|FG000|Overall Study|Withdrawal by Subject|45|||
130260482|NCT00419744|468921365|FG001|Overall Study|Withdrawal by Subject|49|||
130260483|NCT00419744|468921366|FG002|Overall Study|Withdrawal by Subject|52|||
130260484|NCT00419744|468921364|FG000|Overall Study|Lost to Follow-up|8|||
130260485|NCT00419744|468921365|FG001|Overall Study|Lost to Follow-up|10|||
130260486|NCT00419744|468921366|FG002|Overall Study|Lost to Follow-up|6|||
130260487|NCT00419744|468921364|FG000|Overall Study|Protocol Violation|4|||
130260488|NCT00419744|468921365|FG001|Overall Study|Protocol Violation|7|||
130260489|NCT00419744|468921366|FG002|Overall Study|Protocol Violation|8|||
130260490|NCT00419744|468921364|FG000|Overall Study|Randomized in error|9|||
130260491|NCT00419744|468921365|FG001|Overall Study|Randomized in error|6|||
130260492|NCT00419744|468921366|FG002|Overall Study|Randomized in error|7|||
130260493|NCT00419744|468921364|FG000|Overall Study|Moving out of state|2|||
130260494|NCT00419744|468921365|FG001|Overall Study|Moving out of state|0|||
130260495|NCT00419744|468921366|FG002|Overall Study|Moving out of state|1|||
130260496|NCT00419744|468921364|FG000|Overall Study|Physician Decision|10|||
130260497|NCT00419744|468921365|FG001|Overall Study|Physician Decision|5|||
130260498|NCT00419744|468921366|FG002|Overall Study|Physician Decision|6|||
130260499|NCT00419744|468921364|FG000|Overall Study|Spirometry mouthpiece issues|0|||
130260500|NCT00419744|468921365|FG001|Overall Study|Spirometry mouthpiece issues|1|||
130703087|NCT01488448|470536010|FG000|Overall Study|Withdrawal by Subject|3|||
130703088|NCT01488448|470536011|FG001|Overall Study|Withdrawal by Subject|1|||
130703089|NCT01488448|470536010|FG000|Overall Study|Adverse Event|9|||
130703090|NCT01488448|470536011|FG001|Overall Study|Adverse Event|4|||
130703091|NCT01488448|470536010|FG000|Overall Study|Physician Decision|4|||
130260501|NCT00419744|468921366|FG002|Overall Study|Spirometry mouthpiece issues|2|||
130260502|NCT00419744|468921364|FG000|Overall Study|Incorrect medication kit dispensed|0|||
130260503|NCT00419744|468921365|FG001|Overall Study|Incorrect medication kit dispensed|0|||
130260504|NCT00419744|468921366|FG002|Overall Study|Incorrect medication kit dispensed|1|||
130260505|NCT02037529|468921370|FG000|Overall Study|Withdrawal by Subject|1|||
130260506|NCT02037529|468921371|FG001|Overall Study|Withdrawal by Subject|3|||
130260507|NCT02037529|468921370|FG000|Overall Study|Adverse Event|0|||
130260508|NCT02037529|468921371|FG001|Overall Study|Adverse Event|1|||
130260509|NCT02131766|468921372|FG000|Overall Study|Withdrawal by Subject|4|||
130260510|NCT00718315|468921373|FG000|Overall Study|Adverse Event|1|||
130260511|NCT00718315|468921374|FG001|Overall Study|Adverse Event|2|||
130260512|NCT00718315|468921375|FG002|Overall Study|Adverse Event|3|||
130703092|NCT01488448|470536011|FG001|Overall Study|Physician Decision|9|||
130260513|NCT00718315|468921373|FG000|Overall Study|Death|6|||
130260514|NCT00718315|468921374|FG001|Overall Study|Death|6|||
130260515|NCT00718315|468921375|FG002|Overall Study|Death|5|||
130260516|NCT00718315|468921373|FG000|Overall Study|Lost to Follow-up|2|||
130260517|NCT00718315|468921374|FG001|Overall Study|Lost to Follow-up|3|||
130260518|NCT00718315|468921375|FG002|Overall Study|Lost to Follow-up|4|||
130260519|NCT00718315|468921373|FG000|Overall Study|Protocol Violation|5|||
130260520|NCT00718315|468921374|FG001|Overall Study|Protocol Violation|5|||
130260521|NCT00718315|468921375|FG002|Overall Study|Protocol Violation|3|||
130260522|NCT00718315|468921373|FG000|Overall Study|Erlotinib dose decreased|4|||
130260523|NCT00718315|468921374|FG001|Overall Study|Erlotinib dose decreased|3|||
130260524|NCT00718315|468921375|FG002|Overall Study|Erlotinib dose decreased|1|||
130260525|NCT00718315|468921373|FG000|Overall Study|Use of Minocyclin|1|||
130260526|NCT00718315|468921374|FG001|Overall Study|Use of Minocyclin|1|||
130260527|NCT00718315|468921375|FG002|Overall Study|Use of Minocyclin|1|||
130260528|NCT00718315|468921373|FG000|Overall Study|Disease progression|0|||
130260529|NCT00718315|468921374|FG001|Overall Study|Disease progression|1|||
130260530|NCT00718315|468921375|FG002|Overall Study|Disease progression|1|||
130260531|NCT00718315|468921373|FG000|Overall Study|Other|0|||
130260532|NCT00718315|468921374|FG001|Overall Study|Other|0|||
130260533|NCT00718315|468921375|FG002|Overall Study|Other|1|||
130260534|NCT00718315|468921373|FG000|Overall Study|Use of ATB and Corticoids|0|||
130260535|NCT00718315|468921374|FG001|Overall Study|Use of ATB and Corticoids|1|||
130260536|NCT00718315|468921375|FG002|Overall Study|Use of ATB and Corticoids|2|||
130260537|NCT02006927|468921378|FG000|Overall Study|Adverse Event|2|||
130260538|NCT02006927|468921378|FG000|Overall Study|Withdrawal by Subject|1|||
130260539|NCT02746809|468921383|FG000|Enrollment|Inclusion Exclusion not met|9|||
130260540|NCT02746809|468921383|FG000|Enrollment|Withdrawal by Subject|1|||
130260541|NCT02746809|468921383|FG000|Enrollment|Expected Enrollment Met|2|||
130260542|NCT02746809|468921383|FG000|Procedure|Death|1|||
130260543|NCT02746809|468921383|FG000|1-Month|Death|5|||
130260544|NCT02746809|468921383|FG000|6-Month|Death|2|||
130260545|NCT02746809|468921383|FG000|6-Month|Withdrawal by Subject|1|||
130260546|NCT02746809|468921383|FG000|12-Month|Death|3|||
130260547|NCT02746809|468921383|FG000|12-Month|Withdrawal by Subject|2|||
130260548|NCT02746809|468921383|FG000|24-Month|Death|1|||
130260549|NCT02746809|468921383|FG000|24-Month|Withdrawal by Subject|1|||
130260550|NCT02746809|468921383|FG000|36-Month|Death|8|||
130260551|NCT02746809|468921383|FG000|36-Month|Withdrawal by Subject|1|||
130260552|NCT02746809|468921383|FG000|48-Month|Death|7|||
130260553|NCT02746809|468921383|FG000|48-Month|Withdrawal by Subject|1|||
130260554|NCT02746809|468921383|FG000|60-Month|Death|1|||
130260555|NCT02746809|468921383|FG000|60-Month|Lost to Follow-up|2|||
130260556|NCT00673920|468921384|FG000|Baseline up to Week 48|Withdrew consent|1|||
130260557|NCT00673920|468921385|FG001|Baseline up to Week 48|Withdrew consent|0|||
130260558|NCT00673920|468921386|FG002|Baseline up to Week 48|Withdrew consent|2|||
130260559|NCT00673920|468921387|FG003|Baseline up to Week 48|Withdrew consent|0|||
130260560|NCT00673920|468921388|FG004|Baseline up to Week 48|Withdrew consent|0|||
130260561|NCT00673920|468921389|FG005|Baseline up to Week 48|Withdrew consent|0|||
130260562|NCT00673920|468921390|FG006|Baseline up to Week 48|Withdrew consent|0|||
130260563|NCT00673920|468921391|FG007|Baseline up to Week 48|Withdrew consent|0|||
130260564|NCT00673920|468921384|FG000|Baseline up to Week 48|Refused treatment|1|||
130260565|NCT00673920|468921385|FG001|Baseline up to Week 48|Refused treatment|0|||
130260566|NCT00673920|468921386|FG002|Baseline up to Week 48|Refused treatment|0|||
130260567|NCT00673920|468921387|FG003|Baseline up to Week 48|Refused treatment|0|||
130260568|NCT00673920|468921388|FG004|Baseline up to Week 48|Refused treatment|0|||
130260569|NCT00673920|468921389|FG005|Baseline up to Week 48|Refused treatment|0|||
130260570|NCT00673920|468921390|FG006|Baseline up to Week 48|Refused treatment|0|||
130260571|NCT00673920|468921391|FG007|Baseline up to Week 48|Refused treatment|0|||
130260572|NCT00673920|468921384|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
130260573|NCT00673920|468921385|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
130260574|NCT00673920|468921386|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260575|NCT00673920|468921387|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260576|NCT00673920|468921388|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260577|NCT00673920|468921389|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260578|NCT00673920|468921390|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260579|NCT00673920|468921391|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260580|NCT00673920|468921384|FG000|Baseline up to Week 48|Protocol Violation|0|||
130260581|NCT00673920|468921385|FG001|Baseline up to Week 48|Protocol Violation|0|||
130260582|NCT00673920|468921386|FG002|Baseline up to Week 48|Protocol Violation|1|||
130260583|NCT00673920|468921387|FG003|Baseline up to Week 48|Protocol Violation|0|||
130260584|NCT00673920|468921388|FG004|Baseline up to Week 48|Protocol Violation|0|||
130260585|NCT00673920|468921389|FG005|Baseline up to Week 48|Protocol Violation|0|||
130260586|NCT00673920|468921390|FG006|Baseline up to Week 48|Protocol Violation|0|||
130260587|NCT00673920|468921391|FG007|Baseline up to Week 48|Protocol Violation|0|||
130260588|NCT00673920|468921384|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260589|NCT00673920|468921385|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130553951|NCT00568321|469996468|FG002|Overall Study|Adverse Event|0|||
130703093|NCT01488448|470536010|FG000|Overall Study|Protocol Violation|4|||
130703094|NCT01488448|470536011|FG001|Overall Study|Protocol Violation|3|||
130703095|NCT02329431|470536012|FG000|Overall Study|Lost to Follow-up|20|||
130703096|NCT02329431|470536013|FG001|Overall Study|Lost to Follow-up|13|||
130703097|NCT01475487|470536014|FG000|Overall Study|had to leave early for personal reasons|2|||
130703098|NCT01475487|470536015|FG001|Overall Study|had to leave early for personal reasons|1|||
130703099|NCT01977456|470536016|FG000|Overall Study|Death|5|||
130703100|NCT01142661|470536017|FG000|Overall Study|Adverse Event|2|||
130703101|NCT01142661|470536017|FG000|Overall Study|Withdrawal by Subject|1|||
130703102|NCT01142661|470536017|FG000|Overall Study|Physician Decision|1|||
130703103|NCT02426541|470537830|FG000|Overall Study|Protocol Violation|1|||
130703104|NCT02426541|470537831|FG001|Overall Study|Protocol Violation|0|||
130703105|NCT04412057|470537832|FG000|Overall Study|Death|3|||
130703106|NCT04412057|470537833|FG001|Overall Study|Death|7|||
130703107|NCT04412057|470537832|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
130703108|NCT04412057|470537833|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
130703109|NCT01961882|470537836|FG000|Overall Study|Adverse Event|3|||
130703110|NCT01961882|470537837|FG001|Overall Study|Adverse Event|2|||
130703111|NCT01961882|470537836|FG000|Overall Study|Physician Decision|1|||
130703112|NCT01961882|470537837|FG001|Overall Study|Physician Decision|0|||
130703113|NCT01961882|470537836|FG000|Overall Study|Withdrawal by Subject|4|||
130703114|NCT01961882|470537837|FG001|Overall Study|Withdrawal by Subject|1|||
130703115|NCT01961882|470537836|FG000|Overall Study|Relapse of AML|39|||
130703116|NCT01961882|470537837|FG001|Overall Study|Relapse of AML|37|||
130260590|NCT00673920|468921386|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
130260591|NCT00673920|468921387|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260592|NCT00673920|468921388|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260593|NCT00673920|468921389|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260594|NCT00673920|468921390|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260595|NCT00673920|468921391|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260596|NCT00673920|468921384|FG000|Baseline up to Week 48|Administrative/Other|0|||
130260597|NCT00673920|468921385|FG001|Baseline up to Week 48|Administrative/Other|1|||
130260598|NCT00673920|468921386|FG002|Baseline up to Week 48|Administrative/Other|2|||
130260599|NCT00673920|468921387|FG003|Baseline up to Week 48|Administrative/Other|0|||
130260600|NCT00673920|468921388|FG004|Baseline up to Week 48|Administrative/Other|0|||
130260601|NCT00673920|468921389|FG005|Baseline up to Week 48|Administrative/Other|0|||
130260602|NCT00673920|468921390|FG006|Baseline up to Week 48|Administrative/Other|0|||
130260603|NCT00673920|468921391|FG007|Baseline up to Week 48|Administrative/Other|0|||
130260604|NCT00673920|468921384|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260605|NCT00673920|468921385|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130260606|NCT00673920|468921386|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130260607|NCT00673920|468921387|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260608|NCT00673920|468921388|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260609|NCT00673920|468921389|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260610|NCT00673920|468921390|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260611|NCT00673920|468921391|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260612|NCT00673920|468921384|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260613|NCT00673920|468921385|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260614|NCT00673920|468921386|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260615|NCT00673920|468921387|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260616|NCT00673920|468921388|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260617|NCT00673920|468921389|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260618|NCT00673920|468921390|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
130260619|NCT00673920|468921391|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260620|NCT00673920|468921384|FG000|Week 24 to Week 48|Failure to return|0|||
130703117|NCT01961882|470537836|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130703118|NCT01961882|470537837|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130703119|NCT01961882|470537836|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
130703120|NCT01961882|470537837|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
130703121|NCT00108082|470537841|FG000|Overall Study|Adverse Event|14|||
130703122|NCT00108082|470537842|FG001|Overall Study|Adverse Event|12|||
130703123|NCT00108082|470537843|FG002|Overall Study|Adverse Event|17|||
130703124|NCT00108082|470537841|FG000|Overall Study|Lost to Follow-up|6|||
130703125|NCT00108082|470537842|FG001|Overall Study|Lost to Follow-up|3|||
130703126|NCT00108082|470537843|FG002|Overall Study|Lost to Follow-up|7|||
130365493|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
130365494|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130703127|NCT00108082|470537841|FG000|Overall Study|Consent Withdrawn|3|||
130703128|NCT00108082|470537842|FG001|Overall Study|Consent Withdrawn|3|||
130703129|NCT00108082|470537843|FG002|Overall Study|Consent Withdrawn|5|||
130703130|NCT00108082|470537841|FG000|Overall Study|Protocol Violation|1|||
130260621|NCT00673920|468921385|FG001|Week 24 to Week 48|Failure to return|0|||
130260622|NCT00673920|468921386|FG002|Week 24 to Week 48|Failure to return|0|||
130260623|NCT00673920|468921387|FG003|Week 24 to Week 48|Failure to return|0|||
130260624|NCT00673920|468921388|FG004|Week 24 to Week 48|Failure to return|0|||
130260625|NCT00673920|468921389|FG005|Week 24 to Week 48|Failure to return|1|||
130260626|NCT00673920|468921390|FG006|Week 24 to Week 48|Failure to return|0|||
130260627|NCT00673920|468921391|FG007|Week 24 to Week 48|Failure to return|0|||
130260628|NCT00673920|468921384|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260629|NCT00673920|468921385|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260630|NCT00673920|468921386|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260631|NCT00673920|468921387|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260632|NCT00673920|468921388|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260633|NCT00673920|468921389|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
130260634|NCT00673920|468921390|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260635|NCT00673920|468921391|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260636|NCT00673920|468921384|FG000|Week 24 to Week 48|Death|0|||
130260637|NCT00673920|468921385|FG001|Week 24 to Week 48|Death|0|||
130260638|NCT00673920|468921386|FG002|Week 24 to Week 48|Death|0|||
130260639|NCT00673920|468921387|FG003|Week 24 to Week 48|Death|0|||
130260640|NCT00673920|468921388|FG004|Week 24 to Week 48|Death|0|||
130260641|NCT00673920|468921389|FG005|Week 24 to Week 48|Death|1|||
130260642|NCT00673920|468921390|FG006|Week 24 to Week 48|Death|0|||
130260643|NCT00673920|468921391|FG007|Week 24 to Week 48|Death|0|||
130260644|NCT00673920|468921384|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
130260645|NCT00673920|468921385|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
130260646|NCT00673920|468921386|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
130260647|NCT00673920|468921387|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
130260648|NCT00673920|468921388|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
130260649|NCT00673920|468921389|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
130260650|NCT00673920|468921390|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
130260651|NCT00673920|468921391|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
130260652|NCT01164007|468921394|FG000|Overall Study|Adverse Event|5|||
130260653|NCT01164007|468921394|FG000|Overall Study|Progression of Disease|30|||
130260654|NCT01164007|468921394|FG000|Overall Study|Protocol Violation|1|||
130260655|NCT01164007|468921394|FG000|Overall Study|Withdrawal by Subject|1|||
130260656|NCT01164007|468921394|FG000|Overall Study|Medical Decision|3|||
130260657|NCT00894387|468921397|FG000|Overall Study|Adverse Event|44|||
130260658|NCT00894387|468921398|FG001|Overall Study|Adverse Event|45|||
130260659|NCT00894387|468921397|FG000|Overall Study|Abnormal Laboratory values|2|||
130260660|NCT00894387|468921398|FG001|Overall Study|Abnormal Laboratory values|2|||
130260661|NCT00894387|468921397|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130260662|NCT00894387|468921398|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130260663|NCT00894387|468921397|FG000|Overall Study|Lost to Follow-up|3|||
130260664|NCT00894387|468921398|FG001|Overall Study|Lost to Follow-up|5|||
130260665|NCT00894387|468921397|FG000|Overall Study|Administrative problems|2|||
130260666|NCT00894387|468921398|FG001|Overall Study|Administrative problems|2|||
130260667|NCT00894387|468921397|FG000|Overall Study|Death|77|||
130260668|NCT00894387|468921398|FG001|Overall Study|Death|76|||
130260669|NCT00894387|468921397|FG000|Overall Study|Protocol Deviation|4|||
130703131|NCT00108082|470537842|FG001|Overall Study|Protocol Violation|2|||
130703132|NCT00108082|470537843|FG002|Overall Study|Protocol Violation|0|||
130260670|NCT00894387|468921398|FG001|Overall Study|Protocol Deviation|0|||
130260671|NCT00894387|468921397|FG000|Overall Study|Patient's request|25|||
130260672|NCT00894387|468921398|FG001|Overall Study|Patient's request|30|||
130260673|NCT00894387|468921397|FG000|Overall Study|Other (Missing)|5|||
130260674|NCT00894387|468921398|FG001|Overall Study|Other (Missing)|3|||
130260675|NCT00894387|468921397|FG000|Overall Study|Mis-randomized|13|||
130703133|NCT00108082|470537841|FG000|Overall Study|Lack of Efficacy|3|||
130703134|NCT00108082|470537842|FG001|Overall Study|Lack of Efficacy|1|||
130703135|NCT00108082|470537843|FG002|Overall Study|Lack of Efficacy|2|||
130703136|NCT00108082|470537841|FG000|Overall Study|Amendment 4: > Month 12|5|||
130703137|NCT00108082|470537842|FG001|Overall Study|Amendment 4: > Month 12|7|||
130703138|NCT00108082|470537843|FG002|Overall Study|Amendment 4: > Month 12|5|||
130703139|NCT00108082|470537841|FG000|Overall Study|Woman of Child-bearing Potential|2|||
130703140|NCT00108082|470537842|FG001|Overall Study|Woman of Child-bearing Potential|0|||
130703141|NCT00108082|470537843|FG002|Overall Study|Woman of Child-bearing Potential|2|||
130703142|NCT00108082|470537841|FG000|Overall Study|Incorrectly Randomized|0|||
130703143|NCT00108082|470537842|FG001|Overall Study|Incorrectly Randomized|0|||
130703144|NCT00108082|470537843|FG002|Overall Study|Incorrectly Randomized|2|||
130703145|NCT00108082|470537841|FG000|Overall Study|Non-compliance|1|||
130703146|NCT00108082|470537842|FG001|Overall Study|Non-compliance|0|||
130703147|NCT00108082|470537843|FG002|Overall Study|Non-compliance|2|||
130260676|NCT00894387|468921398|FG001|Overall Study|Mis-randomized|9|||
130260677|NCT00894387|468921397|FG000|Overall Study|GCP non-compliance|0|||
130703148|NCT00108082|470537841|FG000|Overall Study|Stopped Study Medication|0|||
130703149|NCT00108082|470537842|FG001|Overall Study|Stopped Study Medication|0|||
130703150|NCT00108082|470537843|FG002|Overall Study|Stopped Study Medication|1|||
130260678|NCT00894387|468921398|FG001|Overall Study|GCP non-compliance|2|||
130260679|NCT04856527|468921399|FG000|Overall Study|Unable to complete experimental task|2|||
130260680|NCT04856527|468921400|FG001|Overall Study|Unable to complete experimental task|0|||
130260681|NCT01816295|468921401|FG000|Double Blind Phase|Adverse Event|11|||
130260682|NCT01816295|468921402|FG001|Double Blind Phase|Adverse Event|8|||
130260683|NCT01816295|468921401|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
130260684|NCT01816295|468921402|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
130260685|NCT01816295|468921401|FG000|Double Blind Phase|Lost to Follow-up|3|||
130260686|NCT01816295|468921402|FG001|Double Blind Phase|Lost to Follow-up|5|||
130260687|NCT01816295|468921401|FG000|Double Blind Phase|Physician Decision|2|||
130260688|NCT01816295|468921402|FG001|Double Blind Phase|Physician Decision|2|||
130260689|NCT01816295|468921401|FG000|Double Blind Phase|Protocol Violation|17|||
130703151|NCT00108082|470537841|FG000|Overall Study|Site Closed Study|0|||
130703152|NCT00108082|470537842|FG001|Overall Study|Site Closed Study|2|||
130703153|NCT00108082|470537843|FG002|Overall Study|Site Closed Study|0|||
130703154|NCT00108082|470537841|FG000|Overall Study|Protocol Amendment|0|||
130703155|NCT00108082|470537842|FG001|Overall Study|Protocol Amendment|1|||
130703156|NCT00108082|470537843|FG002|Overall Study|Protocol Amendment|0|||
130703157|NCT00108082|470537841|FG000|Overall Study|Study Medication Not Tapered|0|||
130703158|NCT00108082|470537842|FG001|Overall Study|Study Medication Not Tapered|1|||
130703159|NCT00108082|470537843|FG002|Overall Study|Study Medication Not Tapered|0|||
130703160|NCT00108082|470537841|FG000|Overall Study|Subject Left Site Location|1|||
130703161|NCT00108082|470537842|FG001|Overall Study|Subject Left Site Location|0|||
130703162|NCT00108082|470537843|FG002|Overall Study|Subject Left Site Location|0|||
130703163|NCT00108082|470537841|FG000|Overall Study|Investigator Not at Site|1|||
130703164|NCT00108082|470537842|FG001|Overall Study|Investigator Not at Site|0|||
130703165|NCT00108082|470537843|FG002|Overall Study|Investigator Not at Site|0|||
130703166|NCT00108082|470537841|FG000|Overall Study|Blood Pressure Not Controlled|1|||
130703167|NCT00108082|470537842|FG001|Overall Study|Blood Pressure Not Controlled|0|||
130703168|NCT00108082|470537843|FG002|Overall Study|Blood Pressure Not Controlled|0|||
130703169|NCT02940730|470537849|FG000|Intervention 2|Physician Decision|7|||
130260690|NCT01816295|468921402|FG001|Double Blind Phase|Protocol Violation|11|||
130260691|NCT01816295|468921401|FG000|Double Blind Phase|Sponsor Decision|8|||
130260692|NCT01816295|468921402|FG001|Double Blind Phase|Sponsor Decision|8|||
130260693|NCT01816295|468921401|FG000|Double Blind Phase|Withdrawal by Subject|22|||
130260694|NCT01816295|468921402|FG001|Double Blind Phase|Withdrawal by Subject|20|||
130260695|NCT01816295|468921401|FG000|OLE Phase|Adverse Event|17|||
130260696|NCT01816295|468921402|FG001|OLE Phase|Adverse Event|15|||
130260697|NCT01816295|468921401|FG000|OLE Phase|Death|1|||
130260698|NCT01816295|468921402|FG001|OLE Phase|Death|0|||
130260699|NCT01816295|468921401|FG000|OLE Phase|Entry Criteria Not Met|3|||
130260700|NCT01816295|468921402|FG001|OLE Phase|Entry Criteria Not Met|5|||
130260701|NCT01816295|468921401|FG000|OLE Phase|Lost to Follow-up|5|||
130260702|NCT01816295|468921402|FG001|OLE Phase|Lost to Follow-up|5|||
130260703|NCT01816295|468921401|FG000|OLE Phase|Physician Decision|3|||
130260704|NCT01816295|468921402|FG001|OLE Phase|Physician Decision|1|||
130260705|NCT01816295|468921401|FG000|OLE Phase|Protocol Violation|4|||
130260706|NCT01816295|468921402|FG001|OLE Phase|Protocol Violation|4|||
130260707|NCT01816295|468921401|FG000|OLE Phase|Sponsor Decision|7|||
130260708|NCT01816295|468921402|FG001|OLE Phase|Sponsor Decision|9|||
130260709|NCT01816295|468921401|FG000|OLE Phase|Withdrawal by Subject|10|||
130260710|NCT01816295|468921402|FG001|OLE Phase|Withdrawal by Subject|10|||
130260711|NCT01816295|468921401|FG000|OLE Phase|Lack of Efficacy|3|||
130260712|NCT01816295|468921402|FG001|OLE Phase|Lack of Efficacy|7|||
130260713|NCT04165824|468921403|FG000|Overall Study|Adverse Event|23|||
130260714|NCT04165824|468921403|FG000|Overall Study|Physician Decision|1|||
130260715|NCT04165824|468921403|FG000|Overall Study|Withdrawal by Subject|17|||
130260716|NCT04165824|468921403|FG000|Overall Study|Other|5|||
130260717|NCT05200845|468921410|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130260718|NCT05200845|468921411|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130260719|NCT05200845|468921412|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
130260720|NCT05200845|468921413|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
130260721|NCT05200845|468921410|FG000|Overall Study|Withdrawal by Subject|0|||
130260722|NCT05200845|468921411|FG001|Overall Study|Withdrawal by Subject|1|||
130260723|NCT05200845|468921412|FG002|Overall Study|Withdrawal by Subject|1|||
130260724|NCT05200845|468921413|FG003|Overall Study|Withdrawal by Subject|0|||
130260725|NCT01911260|468921420|FG000|Supplementation Period|transference or evasion of school|7|||
130703170|NCT02940730|470537850|FG001|Intervention 2|Physician Decision|0|||
130703171|NCT03036839|470537854|FG000|Overall Study|Adverse Event|0|||
130703172|NCT03036839|470537855|FG001|Overall Study|Adverse Event|0|||
130703173|NCT03036839|470537856|FG002|Overall Study|Adverse Event|1|||
130260726|NCT01911260|468921421|FG001|Supplementation Period|transference or evasion of school|9|||
130703174|NCT03036839|470537854|FG000|Overall Study|Death|3|||
130703175|NCT03036839|470537855|FG001|Overall Study|Death|0|||
130703176|NCT03036839|470537856|FG002|Overall Study|Death|3|||
130703177|NCT03036839|470537854|FG000|Overall Study|Withdrew Consent|0|||
130703178|NCT03036839|470537855|FG001|Overall Study|Withdrew Consent|0|||
130260727|NCT01911260|468921422|FG002|Supplementation Period|transference or evasion of school|7|||
130260728|NCT01911260|468921423|FG003|Supplementation Period|transference or evasion of school|6|||
130260729|NCT01911260|468921420|FG000|Supplementation Period|Adverse Event|2|||
130260730|NCT01911260|468921421|FG001|Supplementation Period|Adverse Event|0|||
130260731|NCT01911260|468921422|FG002|Supplementation Period|Adverse Event|1|||
130260732|NCT01911260|468921423|FG003|Supplementation Period|Adverse Event|0|||
130703179|NCT03036839|470537856|FG002|Overall Study|Withdrew Consent|1|||
130703180|NCT00412737|470537858|FG000|Overall Study|Death|1|||
130260733|NCT01911260|468921420|FG000|Supplementation Period|refused to receive supplement|1|||
130703181|NCT00412737|470537859|FG001|Overall Study|Death|0|||
130703182|NCT00412737|470537858|FG000|Overall Study|Adverse Event|3|||
130703183|NCT00412737|470537859|FG001|Overall Study|Adverse Event|2|||
130703184|NCT00412737|470537858|FG000|Overall Study|Refused Treatment|6|||
130703185|NCT00412737|470537859|FG001|Overall Study|Refused Treatment|2|||
130703186|NCT00412737|470537858|FG000|Overall Study|Failure to Return|6|||
130703187|NCT00412737|470537859|FG001|Overall Study|Failure to Return|2|||
130703188|NCT01091103|470537866|FG000|Overall Study|Adverse Event|1|||
130703189|NCT01091103|470537866|FG000|Overall Study|Progressive Disease|3|||
130703190|NCT01270620|470537867|FG000|Overall Study|Withdrawal by Subject|1|||
130260734|NCT01911260|468921421|FG001|Supplementation Period|refused to receive supplement|0|||
130260735|NCT01911260|468921422|FG002|Supplementation Period|refused to receive supplement|1|||
130260736|NCT01911260|468921423|FG003|Supplementation Period|refused to receive supplement|0|||
130260737|NCT01911260|468921420|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
130260738|NCT01911260|468921421|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
130260739|NCT01911260|468921422|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
130260740|NCT01911260|468921423|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
130260741|NCT01911260|468921420|FG000|Follow-up Period|transference or evasion of school|13|||
130260742|NCT01911260|468921421|FG001|Follow-up Period|transference or evasion of school|20|||
130260743|NCT01911260|468921422|FG002|Follow-up Period|transference or evasion of school|15|||
130260744|NCT01911260|468921423|FG003|Follow-up Period|transference or evasion of school|12|||
130260745|NCT01242514|468921432|FG000|Overall Study|e.g., project closure|1042|||
130260746|NCT01242514|468921433|FG001|Overall Study|e.g., project closure|305|||
130260747|NCT01242514|468921434|FG002|Overall Study|e.g., project closure|171|||
130260748|NCT01242514|468921432|FG000|Overall Study|Subject decision|33|||
130260749|NCT01242514|468921433|FG001|Overall Study|Subject decision|8|||
130703191|NCT01270620|470537868|FG001|Overall Study|Withdrawal by Subject|3|||
130703192|NCT00906373|470537871|FG000|Overall Study|Withdrawal by Subject|0|||
130260750|NCT01242514|468921434|FG002|Overall Study|Subject decision|2|||
130260751|NCT01242514|468921432|FG000|Overall Study|Severe non-compliance to protocol|5|||
130260752|NCT01242514|468921433|FG001|Overall Study|Severe non-compliance to protocol|2|||
130260753|NCT01242514|468921434|FG002|Overall Study|Severe non-compliance to protocol|1|||
130260754|NCT01242514|468921432|FG000|Overall Study|Lack of therapeutic response|99|||
130703193|NCT00906373|470537872|FG001|Overall Study|Withdrawal by Subject|5|||
130703194|NCT00906373|470537871|FG000|Overall Study|Other|0|||
130703195|NCT00906373|470537872|FG001|Overall Study|Other|1|||
130703196|NCT00906373|470537871|FG000|Overall Study|Still on treatment at cutoff date|0|||
130260755|NCT01242514|468921433|FG001|Overall Study|Lack of therapeutic response|16|||
130260756|NCT01242514|468921434|FG002|Overall Study|Lack of therapeutic response|10|||
130260757|NCT01242514|468921432|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
130260758|NCT01242514|468921433|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
130260759|NCT01242514|468921434|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
130260760|NCT01242514|468921432|FG000|Overall Study|Lost to Follow-up|14|||
130260761|NCT01242514|468921433|FG001|Overall Study|Lost to Follow-up|5|||
130260762|NCT01242514|468921434|FG002|Overall Study|Lost to Follow-up|4|||
130260763|NCT01242514|468921432|FG000|Overall Study|Adverse Event|129|||
130260764|NCT01242514|468921433|FG001|Overall Study|Adverse Event|18|||
130260765|NCT01242514|468921434|FG002|Overall Study|Adverse Event|19|||
130260766|NCT04079738|468921448|FG000|Study Treatment|Death|1|||
130260767|NCT04079738|468921449|FG001|Study Treatment|Death|0|||
130260768|NCT04079738|468921450|FG002|Study Treatment|Death|0|||
130260769|NCT04079738|468921451|FG003|Study Treatment|Death|0|||
130260770|NCT04079738|468921448|FG000|Study Treatment|Adverse Event|2|||
130260771|NCT04079738|468921449|FG001|Study Treatment|Adverse Event|0|||
130260772|NCT04079738|468921450|FG002|Study Treatment|Adverse Event|0|||
130260773|NCT04079738|468921451|FG003|Study Treatment|Adverse Event|0|||
130260774|NCT04079738|468921448|FG000|Study Treatment|withdrawal before treatment|1|||
130260775|NCT04079738|468921449|FG001|Study Treatment|withdrawal before treatment|0|||
130260776|NCT04079738|468921450|FG002|Study Treatment|withdrawal before treatment|0|||
130365495|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130260777|NCT04079738|468921451|FG003|Study Treatment|withdrawal before treatment|0|||
130260778|NCT04079738|468921448|FG000|Study Treatment|symptomatic deterioration|2|||
130260779|NCT04079738|468921449|FG001|Study Treatment|symptomatic deterioration|0|||
130260780|NCT04079738|468921450|FG002|Study Treatment|symptomatic deterioration|0|||
130260781|NCT04079738|468921451|FG003|Study Treatment|symptomatic deterioration|0|||
130260782|NCT04079738|468921448|FG000|Study Treatment|Disease Progression|1|||
130260783|NCT04079738|468921449|FG001|Study Treatment|Disease Progression|0|||
130260784|NCT04079738|468921450|FG002|Study Treatment|Disease Progression|0|||
130260785|NCT04079738|468921451|FG003|Study Treatment|Disease Progression|0|||
130260786|NCT04079738|468921448|FG000|Study Treatment|withdrawal after treatment|1|||
130260787|NCT04079738|468921449|FG001|Study Treatment|withdrawal after treatment|0|||
130260788|NCT04079738|468921450|FG002|Study Treatment|withdrawal after treatment|0|||
130260789|NCT04079738|468921451|FG003|Study Treatment|withdrawal after treatment|0|||
130260790|NCT04079738|468921448|FG000|Follow up|Withdrawal by Subject|3|||
130260791|NCT04079738|468921449|FG001|Follow up|Withdrawal by Subject|0|||
130260792|NCT04079738|468921450|FG002|Follow up|Withdrawal by Subject|0|||
130260793|NCT04079738|468921451|FG003|Follow up|Withdrawal by Subject|0|||
130260794|NCT04079738|468921448|FG000|Follow up|Death|5|||
130260795|NCT04079738|468921449|FG001|Follow up|Death|0|||
130260796|NCT04079738|468921450|FG002|Follow up|Death|0|||
130260797|NCT04079738|468921451|FG003|Follow up|Death|0|||
130260798|NCT00789555|468921452|FG000|Overall Study|Protocol Amendment|78|||
130260799|NCT00789555|468921453|FG001|Overall Study|Protocol Amendment|76|||
130703197|NCT00906373|470537872|FG001|Overall Study|Still on treatment at cutoff date|2|||
130703198|NCT01597479|470537873|FG000|Overall Study|Protocol Violation|1|||
130703199|NCT01597479|470537874|FG001|Overall Study|Protocol Violation|0|||
130703200|NCT01597479|470537873|FG000|Overall Study|Lost to Follow-up|1|||
130703201|NCT01597479|470537874|FG001|Overall Study|Lost to Follow-up|0|||
130703202|NCT04317599|470537879|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
130703203|NCT04317599|470537879|FG000|Overall Study|treatment outside standard of care|4|||
130703204|NCT00809965|470537880|FG000|Overall Study|Death|194|||
130703205|NCT00809965|470537881|FG001|Overall Study|Death|147|||
130703206|NCT00809965|470537882|FG002|Overall Study|Death|196|||
130703207|NCT00809965|470537880|FG000|Overall Study|Lost to Follow-up|17|||
130703208|NCT00809965|470537881|FG001|Overall Study|Lost to Follow-up|10|||
130703209|NCT00809965|470537882|FG002|Overall Study|Lost to Follow-up|18|||
130703210|NCT00809965|470537880|FG000|Overall Study|Withdrawal by Subject|405|||
130703211|NCT00809965|470537881|FG001|Overall Study|Withdrawal by Subject|448|||
130703212|NCT00809965|470537882|FG002|Overall Study|Withdrawal by Subject|441|||
130703213|NCT00809965|470537880|FG000|Overall Study|Other Reason|167|||
130703214|NCT00809965|470537881|FG001|Overall Study|Other Reason|170|||
130703215|NCT00809965|470537882|FG002|Overall Study|Other Reason|189|||
130703216|NCT02780167|470537883|FG000|Overall Study|Adverse Event|9|||
130703217|NCT02780167|470537884|FG001|Overall Study|Adverse Event|8|||
130703218|NCT02780167|470537885|FG002|Overall Study|Adverse Event|8|||
130703219|NCT02780167|470537886|FG003|Overall Study|Adverse Event|12|||
130703220|NCT02780167|470537887|FG004|Overall Study|Adverse Event|8|||
130703221|NCT02780167|470537883|FG000|Overall Study|Lack of Efficacy|6|||
130703222|NCT02780167|470537884|FG001|Overall Study|Lack of Efficacy|5|||
130703223|NCT02780167|470537885|FG002|Overall Study|Lack of Efficacy|6|||
130703224|NCT02780167|470537886|FG003|Overall Study|Lack of Efficacy|1|||
130703225|NCT02780167|470537887|FG004|Overall Study|Lack of Efficacy|0|||
130703226|NCT02780167|470537883|FG000|Overall Study|Lost to Follow-up|2|||
130703227|NCT02780167|470537884|FG001|Overall Study|Lost to Follow-up|0|||
130703228|NCT02780167|470537885|FG002|Overall Study|Lost to Follow-up|1|||
130703229|NCT02780167|470537886|FG003|Overall Study|Lost to Follow-up|0|||
130260800|NCT00789555|468921454|FG002|Overall Study|Protocol Amendment|80|||
130260801|NCT00789555|468921452|FG000|Overall Study|Adverse Event|17|||
130260802|NCT00789555|468921453|FG001|Overall Study|Adverse Event|7|||
130260803|NCT00789555|468921454|FG002|Overall Study|Adverse Event|10|||
130260804|NCT00789555|468921452|FG000|Overall Study|Lost to Follow-up|9|||
130260805|NCT00789555|468921453|FG001|Overall Study|Lost to Follow-up|10|||
130260806|NCT00789555|468921454|FG002|Overall Study|Lost to Follow-up|18|||
130260807|NCT00789555|468921452|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
130260808|NCT00789555|468921453|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
130260809|NCT00789555|468921454|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
130260810|NCT00789555|468921452|FG000|Overall Study|Treatment failure|11|||
130260811|NCT00789555|468921453|FG001|Overall Study|Treatment failure|8|||
130260812|NCT00789555|468921454|FG002|Overall Study|Treatment failure|12|||
130260813|NCT00789555|468921452|FG000|Overall Study|Protocol Violation|6|||
130260814|NCT00789555|468921453|FG001|Overall Study|Protocol Violation|9|||
130260815|NCT00789555|468921454|FG002|Overall Study|Protocol Violation|13|||
130260816|NCT00404248|468921455|FG000|Overall Study|pts declining status|0|||
130260817|NCT00404248|468921456|FG001|Overall Study|pts declining status|1|||
130260818|NCT00404248|468921457|FG002|Overall Study|pts declining status|0|||
130260819|NCT00404248|468921458|FG003|Overall Study|pts declining status|0|||
130260820|NCT00404248|468921459|FG004|Overall Study|pts declining status|0|||
130260821|NCT00404248|468921460|FG005|Overall Study|pts declining status|0|||
130260822|NCT00404248|468921461|FG006|Overall Study|pts declining status|0|||
130260823|NCT00404248|468921462|FG007|Overall Study|pts declining status|0|||
130260824|NCT00404248|468921463|FG008|Overall Study|pts declining status|0|||
130260825|NCT04646005|468921464|FG000|Overall Study|Adverse Event|1|||
130260826|NCT04646005|468921464|FG000|Overall Study|Progressive Disease|71|||
130553952|NCT00568321|469996466|FG000|Overall Study|Lack of Efficacy|8|||
130703230|NCT02780167|470537887|FG004|Overall Study|Lost to Follow-up|0|||
130703231|NCT02780167|470537883|FG000|Overall Study|Does not meet entrance criteria|0|||
130703232|NCT02780167|470537884|FG001|Overall Study|Does not meet entrance criteria|0|||
130703233|NCT02780167|470537885|FG002|Overall Study|Does not meet entrance criteria|1|||
130260827|NCT04646005|468921464|FG000|Overall Study|Death|20|||
130260828|NCT04646005|468921464|FG000|Overall Study|Withdrawal by Subject|12|||
130260829|NCT04646005|468921464|FG000|Overall Study|Sponsor Request|9|||
130703234|NCT02780167|470537886|FG003|Overall Study|Does not meet entrance criteria|0|||
130703235|NCT02780167|470537887|FG004|Overall Study|Does not meet entrance criteria|0|||
130703236|NCT02780167|470537883|FG000|Overall Study|No longer meets eligibility criteria|0|||
130703237|NCT02780167|470537884|FG001|Overall Study|No longer meets eligibility criteria|0|||
130703238|NCT02780167|470537885|FG002|Overall Study|No longer meets eligibility criteria|0|||
130703239|NCT02780167|470537886|FG003|Overall Study|No longer meets eligibility criteria|1|||
130260830|NCT04398706|468921465|FG000|Overall Study|Adverse Event|0|||
130260831|NCT04398706|468921466|FG001|Overall Study|Adverse Event|0|||
130260832|NCT04398706|468921467|FG002|Overall Study|Adverse Event|0|||
130260833|NCT04398706|468921468|FG003|Overall Study|Adverse Event|0|||
130260834|NCT04398706|468921469|FG004|Overall Study|Adverse Event|0|||
130260835|NCT04398706|468921470|FG005|Overall Study|Adverse Event|1|||
130260836|NCT04398706|468921471|FG006|Overall Study|Adverse Event|1|||
130260837|NCT04398706|468921472|FG007|Overall Study|Adverse Event|0|||
130703240|NCT02780167|470537887|FG004|Overall Study|No longer meets eligibility criteria|1|||
130703241|NCT02780167|470537883|FG000|Overall Study|Protocol Violation|5|||
130703242|NCT02780167|470537884|FG001|Overall Study|Protocol Violation|5|||
130703243|NCT02780167|470537885|FG002|Overall Study|Protocol Violation|1|||
130703244|NCT02780167|470537886|FG003|Overall Study|Protocol Violation|1|||
130703245|NCT02780167|470537887|FG004|Overall Study|Protocol Violation|2|||
130703246|NCT02780167|470537883|FG000|Overall Study|Withdrawal by Subject|6|||
130703247|NCT02780167|470537884|FG001|Overall Study|Withdrawal by Subject|4|||
130703248|NCT02780167|470537885|FG002|Overall Study|Withdrawal by Subject|4|||
130703249|NCT02780167|470537886|FG003|Overall Study|Withdrawal by Subject|3|||
130703250|NCT02780167|470537887|FG004|Overall Study|Withdrawal by Subject|4|||
130703251|NCT02780167|470537883|FG000|Overall Study|Other|0|||
130703252|NCT02780167|470537884|FG001|Overall Study|Other|0|||
130703253|NCT02780167|470537885|FG002|Overall Study|Other|3|||
130703254|NCT02780167|470537886|FG003|Overall Study|Other|1|||
130703255|NCT02780167|470537887|FG004|Overall Study|Other|2|||
130703256|NCT02315066|470537888|FG000|Overall Study|Lost to Follow-up|0|||
130703257|NCT02315066|470537889|FG001|Overall Study|Lost to Follow-up|1|||
130703258|NCT02315066|470537890|FG002|Overall Study|Lost to Follow-up|1|||
130703259|NCT02315066|470537891|FG003|Overall Study|Lost to Follow-up|0|||
130703260|NCT02315066|470537892|FG004|Overall Study|Lost to Follow-up|1|||
130703261|NCT02315066|470537893|FG005|Overall Study|Lost to Follow-up|0|||
130703262|NCT02315066|470537894|FG006|Overall Study|Lost to Follow-up|2|||
130703263|NCT02315066|470537895|FG007|Overall Study|Lost to Follow-up|1|||
130703264|NCT02315066|470537896|FG008|Overall Study|Lost to Follow-up|0|||
130703265|NCT02315066|470537897|FG009|Overall Study|Lost to Follow-up|0|||
130703266|NCT02315066|470537898|FG010|Overall Study|Lost to Follow-up|1|||
130703267|NCT02315066|470537899|FG011|Overall Study|Lost to Follow-up|2|||
130260838|NCT04398706|468921465|FG000|Overall Study|Lost to Follow-up|0|||
130260839|NCT04398706|468921466|FG001|Overall Study|Lost to Follow-up|1|||
130260840|NCT04398706|468921467|FG002|Overall Study|Lost to Follow-up|2|||
130260841|NCT04398706|468921468|FG003|Overall Study|Lost to Follow-up|1|||
130260842|NCT04398706|468921469|FG004|Overall Study|Lost to Follow-up|6|||
130703268|NCT02315066|470537900|FG012|Overall Study|Lost to Follow-up|0|||
130260843|NCT04398706|468921470|FG005|Overall Study|Lost to Follow-up|3|||
130260844|NCT04398706|468921471|FG006|Overall Study|Lost to Follow-up|8|||
130260845|NCT04398706|468921472|FG007|Overall Study|Lost to Follow-up|2|||
130260846|NCT04398706|468921465|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130260847|NCT04398706|468921466|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130260848|NCT04398706|468921467|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130260849|NCT04398706|468921468|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130260850|NCT04398706|468921469|FG004|Overall Study|Withdrawal by parent/guardian|19|||
130260851|NCT04398706|468921470|FG005|Overall Study|Withdrawal by parent/guardian|23|||
130260852|NCT04398706|468921471|FG006|Overall Study|Withdrawal by parent/guardian|13|||
130260853|NCT04398706|468921472|FG007|Overall Study|Withdrawal by parent/guardian|11|||
130260854|NCT04398706|468921465|FG000|Overall Study|Protocol deviation|0|||
130260855|NCT04398706|468921466|FG001|Overall Study|Protocol deviation|1|||
130260856|NCT04398706|468921467|FG002|Overall Study|Protocol deviation|0|||
130260857|NCT04398706|468921468|FG003|Overall Study|Protocol deviation|0|||
130260858|NCT04398706|468921469|FG004|Overall Study|Protocol deviation|6|||
130260859|NCT04398706|468921470|FG005|Overall Study|Protocol deviation|4|||
130260860|NCT04398706|468921471|FG006|Overall Study|Protocol deviation|6|||
130260861|NCT04398706|468921472|FG007|Overall Study|Protocol deviation|3|||
130260862|NCT04577404|468921473|FG000|Overall Study|Adverse Event|31|||
130260863|NCT04577404|468921473|FG000|Overall Study|Death|1|||
130703269|NCT02315066|470537901|FG013|Overall Study|Lost to Follow-up|4|||
130703270|NCT02315066|470537888|FG000|Overall Study|Death|2|||
130703271|NCT02315066|470537889|FG001|Overall Study|Death|7|||
130703272|NCT02315066|470537890|FG002|Overall Study|Death|6|||
130703273|NCT02315066|470537891|FG003|Overall Study|Death|11|||
130260864|NCT04577404|468921473|FG000|Overall Study|Lack of Efficacy|3|||
130365496|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
130703274|NCT02315066|470537892|FG004|Overall Study|Death|10|||
130260865|NCT04577404|468921473|FG000|Overall Study|Physician Decision|7|||
130260866|NCT04577404|468921473|FG000|Overall Study|Withdrawal by Subject|21|||
130260867|NCT04577404|468921473|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
130260868|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130260869|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130260870|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130703275|NCT02315066|470537893|FG005|Overall Study|Death|3|||
130703276|NCT02315066|470537894|FG006|Overall Study|Death|9|||
130260871|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130260872|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260873|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260874|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
130260875|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260876|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260877|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260878|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
130260879|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260880|NCT04237584|468921474|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130260881|NCT04237584|468921475|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130260882|NCT04237584|468921476|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
130260883|NCT04237584|468921477|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
130260884|NCT04237584|468921474|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260885|NCT04237584|468921475|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260886|NCT04237584|468921476|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
130260887|NCT04237584|468921477|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260888|NCT03586973|468921478|FG000|Overall Study|Death|15|||
130260889|NCT03586973|468921479|FG001|Overall Study|Death|8|||
130260890|NCT03586973|468921478|FG000|Overall Study|Site Terminated by Sponsor|3|||
130260891|NCT03586973|468921479|FG001|Overall Study|Site Terminated by Sponsor|6|||
130260892|NCT03586973|468921478|FG000|Overall Study|Withdrawal by Subject|1|||
130260893|NCT03586973|468921479|FG001|Overall Study|Withdrawal by Subject|0|||
130260894|NCT03586973|468921478|FG000|Overall Study|Lost to Follow-up|1|||
130260895|NCT03586973|468921479|FG001|Overall Study|Lost to Follow-up|0|||
130260896|NCT03423979|468921485|FG000|Overall Study|Death|1|||
130260897|NCT05239221|468921486|FG000|Overall Study|Adverse Event|0|||
130260898|NCT05239221|468921487|FG001|Overall Study|Adverse Event|0|||
130260899|NCT05239221|468921488|FG002|Overall Study|Adverse Event|0|||
130260900|NCT05239221|468921489|FG003|Overall Study|Adverse Event|0|||
130260901|NCT05239221|468921490|FG004|Overall Study|Adverse Event|0|||
130260902|NCT05239221|468921491|FG005|Overall Study|Adverse Event|0|||
130260903|NCT05239221|468921492|FG006|Overall Study|Adverse Event|1|||
130260904|NCT05239221|468921493|FG007|Overall Study|Adverse Event|0|||
130260905|NCT05239221|468921494|FG008|Overall Study|Adverse Event|0|||
130260906|NCT05239221|468921495|FG009|Overall Study|Adverse Event|0|||
130260907|NCT05239221|468921496|FG010|Overall Study|Adverse Event|1|||
130260908|NCT05239221|468921497|FG011|Overall Study|Adverse Event|1|||
130260909|NCT05239221|468921498|FG012|Overall Study|Adverse Event|0|||
130260910|NCT05239221|468921499|FG013|Overall Study|Adverse Event|0|||
130260911|NCT05239221|468921500|FG014|Overall Study|Adverse Event|0|||
130260912|NCT05239221|468921501|FG015|Overall Study|Adverse Event|0|||
130260913|NCT05239221|468921486|FG000|Overall Study|Withdrawal by Subject|0|||
130260914|NCT05239221|468921487|FG001|Overall Study|Withdrawal by Subject|0|||
130260915|NCT05239221|468921488|FG002|Overall Study|Withdrawal by Subject|0|||
130260916|NCT05239221|468921489|FG003|Overall Study|Withdrawal by Subject|0|||
130260917|NCT05239221|468921490|FG004|Overall Study|Withdrawal by Subject|0|||
130260918|NCT05239221|468921491|FG005|Overall Study|Withdrawal by Subject|0|||
130260919|NCT05239221|468921492|FG006|Overall Study|Withdrawal by Subject|0|||
130260920|NCT05239221|468921493|FG007|Overall Study|Withdrawal by Subject|0|||
130260921|NCT05239221|468921494|FG008|Overall Study|Withdrawal by Subject|0|||
130260922|NCT05239221|468921495|FG009|Overall Study|Withdrawal by Subject|0|||
130260923|NCT05239221|468921496|FG010|Overall Study|Withdrawal by Subject|1|||
130260924|NCT05239221|468921497|FG011|Overall Study|Withdrawal by Subject|0|||
130260925|NCT05239221|468921498|FG012|Overall Study|Withdrawal by Subject|0|||
130260926|NCT05239221|468921499|FG013|Overall Study|Withdrawal by Subject|0|||
130260927|NCT05239221|468921500|FG014|Overall Study|Withdrawal by Subject|0|||
130260928|NCT05239221|468921501|FG015|Overall Study|Withdrawal by Subject|1|||
130260929|NCT00805389|468922902|FG000|Overall Study|Adverse Event|0|||
130260930|NCT00805389|468922903|FG001|Overall Study|Adverse Event|0|||
130260931|NCT00805389|468922904|FG002|Overall Study|Adverse Event|1|||
130260932|NCT00805389|468922905|FG003|Overall Study|Adverse Event|2|||
130260933|NCT00805389|468922906|FG004|Overall Study|Adverse Event|0|||
130260934|NCT00805389|468922902|FG000|Overall Study|Lost to Follow-up|4|||
130260935|NCT00805389|468922903|FG001|Overall Study|Lost to Follow-up|3|||
130553953|NCT00568321|469996467|FG001|Overall Study|Lack of Efficacy|5|||
130553954|NCT00568321|469996468|FG002|Overall Study|Lack of Efficacy|6|||
130260936|NCT00805389|468922904|FG002|Overall Study|Lost to Follow-up|6|||
130260937|NCT00805389|468922905|FG003|Overall Study|Lost to Follow-up|10|||
130260938|NCT00805389|468922906|FG004|Overall Study|Lost to Follow-up|9|||
130260939|NCT00805389|468922902|FG000|Overall Study|Protocol Violation|0|||
130260940|NCT00805389|468922903|FG001|Overall Study|Protocol Violation|0|||
130260941|NCT00805389|468922904|FG002|Overall Study|Protocol Violation|1|||
130260942|NCT00805389|468922905|FG003|Overall Study|Protocol Violation|0|||
130703277|NCT02315066|470537895|FG007|Overall Study|Death|9|||
130703278|NCT02315066|470537896|FG008|Overall Study|Death|10|||
130703279|NCT02315066|470537897|FG009|Overall Study|Death|8|||
130703280|NCT02315066|470537898|FG010|Overall Study|Death|10|||
130260943|NCT00805389|468922906|FG004|Overall Study|Protocol Violation|0|||
130260944|NCT00805389|468922902|FG000|Overall Study|Withdrawal by Subject|3|||
130260945|NCT00805389|468922903|FG001|Overall Study|Withdrawal by Subject|2|||
130260946|NCT00805389|468922904|FG002|Overall Study|Withdrawal by Subject|4|||
130260947|NCT00805389|468922905|FG003|Overall Study|Withdrawal by Subject|5|||
130260948|NCT00805389|468922906|FG004|Overall Study|Withdrawal by Subject|4|||
130260949|NCT02239926|468922909|FG000|Overall Study|Withdrawal by Subject|0|||
130260950|NCT02239926|468922910|FG001|Overall Study|Withdrawal by Subject|1|||
130260951|NCT03983421|468922913|FG000|Overall Study|Lost to Follow-up|1|||
130260952|NCT02724839|468922916|FG000|Overall Study|Withdrawal by Subject|1|||
130260953|NCT02724839|468922917|FG001|Overall Study|Withdrawal by Subject|1|||
130260954|NCT02724839|468922918|FG002|Overall Study|Withdrawal by Subject|0|||
130260955|NCT02724839|468922916|FG000|Overall Study|Lost to Follow-up|0|||
130260956|NCT02724839|468922917|FG001|Overall Study|Lost to Follow-up|3|||
130260957|NCT02724839|468922918|FG002|Overall Study|Lost to Follow-up|2|||
130260958|NCT02724839|468922916|FG000|Overall Study|Physician Decision|0|||
130260959|NCT02724839|468922917|FG001|Overall Study|Physician Decision|0|||
130260960|NCT02724839|468922918|FG002|Overall Study|Physician Decision|3|||
130260961|NCT00557193|468922919|FG000|Induction|Adverse Event|2|||
130260962|NCT00557193|468922920|FG001|Induction|Adverse Event|0|||
130260963|NCT00557193|468922921|FG002|Induction|Adverse Event|0|||
130260964|NCT00557193|468922922|FG003|Induction|Adverse Event|0|||
130260965|NCT00557193|468922923|FG004|Induction|Adverse Event|0|||
130260966|NCT00557193|468922924|FG005|Induction|Adverse Event|0|||
130703281|NCT02315066|470537899|FG011|Overall Study|Death|7|||
130703282|NCT02315066|470537900|FG012|Overall Study|Death|8|||
130260967|NCT00557193|468922919|FG000|Induction|Death|6|||
130260968|NCT00557193|468922920|FG001|Induction|Death|0|||
130703283|NCT02315066|470537901|FG013|Overall Study|Death|21|||
130703284|NCT02315066|470537888|FG000|Overall Study|Other|0|||
130703285|NCT02315066|470537889|FG001|Overall Study|Other|0|||
130703286|NCT02315066|470537890|FG002|Overall Study|Other|0|||
130703287|NCT02315066|470537891|FG003|Overall Study|Other|0|||
130703288|NCT02315066|470537892|FG004|Overall Study|Other|0|||
130703289|NCT02315066|470537893|FG005|Overall Study|Other|0|||
130703290|NCT02315066|470537894|FG006|Overall Study|Other|0|||
130703291|NCT02315066|470537895|FG007|Overall Study|Other|1|||
130703292|NCT02315066|470537896|FG008|Overall Study|Other|1|||
130703293|NCT02315066|470537897|FG009|Overall Study|Other|2|||
130703294|NCT02315066|470537898|FG010|Overall Study|Other|0|||
130703295|NCT02315066|470537899|FG011|Overall Study|Other|0|||
130703296|NCT02315066|470537900|FG012|Overall Study|Other|0|||
130260969|NCT00557193|468922921|FG002|Induction|Death|0|||
130260970|NCT00557193|468922922|FG003|Induction|Death|0|||
130260971|NCT00557193|468922923|FG004|Induction|Death|0|||
130260972|NCT00557193|468922924|FG005|Induction|Death|0|||
130260973|NCT00557193|468922919|FG000|Induction|Physician Decision|3|||
130453044|NCT01555762|469621761|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
130453045|NCT01555762|469621761|FG000|Overall Study|Investigator's decision|10|||
130453046|NCT01555762|469621761|FG000|Overall Study|Participant not wishing to continue|5|||
130453047|NCT01555762|469621761|FG000|Overall Study|Missing data|1|||
130453048|NCT01555762|469621761|FG000|Overall Study|Death linked to an adverse event|14|||
130453049|NCT01333514|469621762|FG000|Overall Study|Withdrawal by Subject|1|||
130453050|NCT01333514|469621763|FG001|Overall Study|Withdrawal by Subject|0|||
130453051|NCT00836810|469621764|FG000|Overall Study|New diagnosis|1|||
130703297|NCT02315066|470537901|FG013|Overall Study|Other|0|||
130703298|NCT02315066|470537888|FG000|Overall Study|Subject refused further follow-up|0|||
130260974|NCT00557193|468922920|FG001|Induction|Physician Decision|0|||
130260975|NCT00557193|468922921|FG002|Induction|Physician Decision|0|||
130260976|NCT00557193|468922922|FG003|Induction|Physician Decision|0|||
130260977|NCT00557193|468922923|FG004|Induction|Physician Decision|0|||
130260978|NCT00557193|468922924|FG005|Induction|Physician Decision|0|||
130453052|NCT00836810|469621765|FG001|Overall Study|New diagnosis|0|||
130703299|NCT02315066|470537889|FG001|Overall Study|Subject refused further follow-up|2|||
130703300|NCT02315066|470537890|FG002|Overall Study|Subject refused further follow-up|2|||
130703301|NCT02315066|470537891|FG003|Overall Study|Subject refused further follow-up|0|||
130703302|NCT02315066|470537892|FG004|Overall Study|Subject refused further follow-up|0|||
130703303|NCT02315066|470537893|FG005|Overall Study|Subject refused further follow-up|0|||
130260979|NCT00557193|468922919|FG000|Induction|Withdrawal by Subject|1|||
130260980|NCT00557193|468922920|FG001|Induction|Withdrawal by Subject|0|||
130260981|NCT00557193|468922921|FG002|Induction|Withdrawal by Subject|0|||
130260982|NCT00557193|468922922|FG003|Induction|Withdrawal by Subject|0|||
130260983|NCT00557193|468922923|FG004|Induction|Withdrawal by Subject|0|||
130260984|NCT00557193|468922924|FG005|Induction|Withdrawal by Subject|0|||
130260985|NCT00557193|468922919|FG000|Induction|Refusal of Further Protocol Therapy|2|||
130453053|NCT03102242|469621768|FG000|Overall Study|Adverse Event|2|||
130260986|NCT00557193|468922920|FG001|Induction|Refusal of Further Protocol Therapy|0|||
130260987|NCT00557193|468922921|FG002|Induction|Refusal of Further Protocol Therapy|0|||
130260988|NCT00557193|468922922|FG003|Induction|Refusal of Further Protocol Therapy|0|||
130260989|NCT00557193|468922923|FG004|Induction|Refusal of Further Protocol Therapy|0|||
130260990|NCT00557193|468922924|FG005|Induction|Refusal of Further Protocol Therapy|0|||
130260991|NCT00557193|468922919|FG000|Induction|Ineligible|8|||
130260992|NCT00557193|468922920|FG001|Induction|Ineligible|0|||
130260993|NCT00557193|468922921|FG002|Induction|Ineligible|0|||
130260994|NCT00557193|468922922|FG003|Induction|Ineligible|0|||
130453054|NCT00389519|469621769|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
130260995|NCT00557193|468922923|FG004|Induction|Ineligible|0|||
130260996|NCT00557193|468922924|FG005|Induction|Ineligible|0|||
130260997|NCT00557193|468922919|FG000|Induction|Inevaluable for post Induction|2|||
130260998|NCT00557193|468922920|FG001|Induction|Inevaluable for post Induction|0|||
130260999|NCT00557193|468922921|FG002|Induction|Inevaluable for post Induction|0|||
130261000|NCT00557193|468922922|FG003|Induction|Inevaluable for post Induction|0|||
130261001|NCT00557193|468922923|FG004|Induction|Inevaluable for post Induction|0|||
130453055|NCT00389519|469621770|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
130453056|NCT00389519|469621771|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
130453057|NCT00389519|469621772|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
130453058|NCT00389519|469621769|FG000|Placebo Run-In|Withdrawal by Subject|19|||
130453059|NCT00389519|469621770|FG001|Placebo Run-In|Withdrawal by Subject|0|||
130453060|NCT00389519|469621771|FG002|Placebo Run-In|Withdrawal by Subject|0|||
130453061|NCT00389519|469621772|FG003|Placebo Run-In|Withdrawal by Subject|0|||
130453062|NCT00389519|469621769|FG000|Placebo Run-In|Reason not specified|40|||
130453063|NCT00389519|469621770|FG001|Placebo Run-In|Reason not specified|0|||
130453064|NCT00389519|469621771|FG002|Placebo Run-In|Reason not specified|0|||
130453065|NCT00389519|469621772|FG003|Placebo Run-In|Reason not specified|0|||
130453066|NCT00389519|469621769|FG000|Randomized|Did not receive study drug|2|||
130453067|NCT00389519|469621770|FG001|Randomized|Did not receive study drug|0|||
130453068|NCT00389519|469621771|FG002|Randomized|Did not receive study drug|0|||
130453069|NCT00389519|469621772|FG003|Randomized|Did not receive study drug|0|||
130453070|NCT00389519|469621769|FG000|Treated|Adverse Event|1|||
130453071|NCT00389519|469621770|FG001|Treated|Adverse Event|0|||
130453072|NCT00389519|469621771|FG002|Treated|Adverse Event|0|||
130453073|NCT00389519|469621772|FG003|Treated|Adverse Event|2|||
130453074|NCT00389519|469621769|FG000|Treated|Reason not specified|1|||
130453075|NCT00389519|469621770|FG001|Treated|Reason not specified|1|||
130453076|NCT00389519|469621771|FG002|Treated|Reason not specified|0|||
130453077|NCT00389519|469621772|FG003|Treated|Reason not specified|2|||
130453078|NCT01311713|469621775|FG000|Overall Study|Death|0|||
130453079|NCT01311713|469621776|FG001|Overall Study|Death|0|||
130453080|NCT01311713|469621777|FG002|Overall Study|Death|1|||
130703304|NCT02315066|470537894|FG006|Overall Study|Subject refused further follow-up|2|||
130703305|NCT02315066|470537895|FG007|Overall Study|Subject refused further follow-up|3|||
130703306|NCT02315066|470537896|FG008|Overall Study|Subject refused further follow-up|0|||
130703307|NCT02315066|470537897|FG009|Overall Study|Subject refused further follow-up|1|||
130703308|NCT02315066|470537898|FG010|Overall Study|Subject refused further follow-up|1|||
130703309|NCT02315066|470537899|FG011|Overall Study|Subject refused further follow-up|2|||
130703310|NCT02315066|470537900|FG012|Overall Study|Subject refused further follow-up|2|||
130703311|NCT02315066|470537901|FG013|Overall Study|Subject refused further follow-up|4|||
130703312|NCT02315066|470537888|FG000|Overall Study|Study ongoing at date of cut-off|0|||
130703313|NCT02315066|470537889|FG001|Overall Study|Study ongoing at date of cut-off|0|||
130703314|NCT02315066|470537890|FG002|Overall Study|Study ongoing at date of cut-off|0|||
130703315|NCT02315066|470537891|FG003|Overall Study|Study ongoing at date of cut-off|0|||
130703316|NCT02315066|470537892|FG004|Overall Study|Study ongoing at date of cut-off|0|||
130703317|NCT02315066|470537893|FG005|Overall Study|Study ongoing at date of cut-off|0|||
130703318|NCT02315066|470537894|FG006|Overall Study|Study ongoing at date of cut-off|0|||
130703319|NCT02315066|470537895|FG007|Overall Study|Study ongoing at date of cut-off|0|||
130703320|NCT02315066|470537896|FG008|Overall Study|Study ongoing at date of cut-off|0|||
130703321|NCT02315066|470537897|FG009|Overall Study|Study ongoing at date of cut-off|0|||
130703322|NCT02315066|470537898|FG010|Overall Study|Study ongoing at date of cut-off|0|||
130703323|NCT02315066|470537899|FG011|Overall Study|Study ongoing at date of cut-off|0|||
130703324|NCT02315066|470537900|FG012|Overall Study|Study ongoing at date of cut-off|0|||
130703325|NCT02315066|470537901|FG013|Overall Study|Study ongoing at date of cut-off|1|||
130703326|NCT03180801|470537902|FG000|Overall Study|Physician Decision|3|||
130703327|NCT03180801|470537903|FG001|Overall Study|Physician Decision|3|||
130703328|NCT03180801|470537904|FG002|Overall Study|Physician Decision|1|||
130703329|NCT03180801|470537902|FG000|Overall Study|Non-compliance|1|||
130703330|NCT03180801|470537903|FG001|Overall Study|Non-compliance|4|||
130703331|NCT03180801|470537904|FG002|Overall Study|Non-compliance|0|||
130703332|NCT03180801|470537902|FG000|Overall Study|Inoculation Target Reached|1|||
130703333|NCT03180801|470537903|FG001|Overall Study|Inoculation Target Reached|1|||
130703334|NCT03180801|470537904|FG002|Overall Study|Inoculation Target Reached|3|||
130703335|NCT03180801|470537902|FG000|Overall Study|Adverse Event|1|||
130703336|NCT03180801|470537903|FG001|Overall Study|Adverse Event|0|||
130703337|NCT03180801|470537904|FG002|Overall Study|Adverse Event|2|||
130261002|NCT00557193|468922924|FG005|Induction|Inevaluable for post Induction|0|||
130703338|NCT03180801|470537902|FG000|Overall Study|Withdrawal by Subject|2|||
130703339|NCT03180801|470537903|FG001|Overall Study|Withdrawal by Subject|2|||
130261003|NCT00557193|468922919|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
130453081|NCT01311713|469621778|FG003|Overall Study|Death|1|||
130453082|NCT01311713|469621779|FG004|Overall Study|Death|0|||
130453083|NCT01311713|469621780|FG005|Overall Study|Death|1|||
130453084|NCT01311713|469621781|FG006|Overall Study|Death|0|||
130453085|NCT01311713|469621775|FG000|Overall Study|Adverse Event|0|||
130703340|NCT03180801|470537904|FG002|Overall Study|Withdrawal by Subject|1|||
130703341|NCT03180801|470537902|FG000|Overall Study|Lost to Follow-up|0|||
130703342|NCT03180801|470537903|FG001|Overall Study|Lost to Follow-up|2|||
130703343|NCT03180801|470537904|FG002|Overall Study|Lost to Follow-up|3|||
130703344|NCT00112294|470537906|FG000|Overall Study|Still on study|5|||
130703345|NCT00112294|470537907|FG001|Overall Study|Still on study|0|||
130703346|NCT01142908|470537908|FG000|Overall Study|Lost to Follow-up|19|||
130703347|NCT01142908|470537909|FG001|Overall Study|Lost to Follow-up|13|||
130703348|NCT01142908|470537908|FG000|Overall Study|Death|1|||
130703349|NCT01142908|470537909|FG001|Overall Study|Death|4|||
130703350|NCT01142908|470537908|FG000|Overall Study|Excluded - did not meet criteria|9|||
130703351|NCT01142908|470537909|FG001|Overall Study|Excluded - did not meet criteria|5|||
130261004|NCT00557193|468922920|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261005|NCT00557193|468922921|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261006|NCT00557193|468922922|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261007|NCT00557193|468922923|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261008|NCT00557193|468922924|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261009|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130261010|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130261011|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
130261012|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130261013|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130261014|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
130261015|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
130261016|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
130261017|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
130261018|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
130261019|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
130261020|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
130261021|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130261022|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
130261023|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
130261024|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
130261025|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130261026|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130261027|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130261028|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
130261029|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130261030|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130261031|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130261032|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
130261033|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
130261034|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
130261035|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
130261036|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
130261037|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
130261038|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
130261039|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261040|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261041|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
130261042|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261043|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261044|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130703352|NCT01142908|470537908|FG000|Overall Study|Withdrawal by Subject|3|||
130703353|NCT01142908|470537909|FG001|Overall Study|Withdrawal by Subject|0|||
130703354|NCT00035555|470537910|FG000|Overall Study|Adverse Event|5|||
130703355|NCT00035555|470537911|FG001|Overall Study|Adverse Event|8|||
130703356|NCT00035555|470537912|FG002|Overall Study|Adverse Event|9|||
130703357|NCT00035555|470537910|FG000|Overall Study|Allograft loss|1|||
130703358|NCT00035555|470537911|FG001|Overall Study|Allograft loss|1|||
130703359|NCT00035555|470537912|FG002|Overall Study|Allograft loss|2|||
130703360|NCT00035555|470537910|FG000|Overall Study|Death|0|||
130703361|NCT00035555|470537911|FG001|Overall Study|Death|0|||
130703362|NCT00035555|470537912|FG002|Overall Study|Death|2|||
130703363|NCT00035555|470537910|FG000|Overall Study|Lost to Follow-up|0|||
130261045|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261046|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261047|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
130261048|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261049|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261050|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261051|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130703364|NCT00035555|470537911|FG001|Overall Study|Lost to Follow-up|0|||
130261052|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261053|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
130261054|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261055|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261056|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
130261057|NCT03984825|468922925|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
130261058|NCT03984825|468922925|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
130261059|NCT03984825|468922925|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
130261060|NCT00976456|468922928|FG000|Overall Study|Adverse Event|17|||
130261061|NCT00976456|468922929|FG001|Overall Study|Adverse Event|22|||
130261062|NCT00976456|468922928|FG000|Overall Study|Death|7|||
130261063|NCT00976456|468922929|FG001|Overall Study|Death|9|||
130261064|NCT00976456|468922928|FG000|Overall Study|Lack of Efficacy|5|||
130703365|NCT00035555|470537912|FG002|Overall Study|Lost to Follow-up|1|||
130703366|NCT00035555|470537910|FG000|Overall Study|Noncompliance|0|||
130703367|NCT00035555|470537911|FG001|Overall Study|Noncompliance|1|||
130703368|NCT00035555|470537912|FG002|Overall Study|Noncompliance|1|||
130703369|NCT00035555|470537910|FG000|Overall Study|Prohibited medication|1|||
130703370|NCT00035555|470537911|FG001|Overall Study|Prohibited medication|1|||
130703371|NCT00035555|470537912|FG002|Overall Study|Prohibited medication|0|||
130703372|NCT00035555|470537910|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
130703373|NCT00035555|470537911|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
130703374|NCT00035555|470537912|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
130703375|NCT00035555|470537910|FG000|Overall Study|Withdrawal by Subject|2|||
130703376|NCT00035555|470537911|FG001|Overall Study|Withdrawal by Subject|0|||
130703377|NCT00035555|470537912|FG002|Overall Study|Withdrawal by Subject|2|||
130703378|NCT00035555|470537910|FG000|Overall Study|Investigator deemed not a good candidate|0|||
130703379|NCT00035555|470537911|FG001|Overall Study|Investigator deemed not a good candidate|0|||
130703380|NCT00035555|470537912|FG002|Overall Study|Investigator deemed not a good candidate|1|||
130703381|NCT00035555|470537910|FG000|Overall Study|Received cyclosporin in error|0|||
130703382|NCT00035555|470537911|FG001|Overall Study|Received cyclosporin in error|0|||
130703383|NCT00035555|470537912|FG002|Overall Study|Received cyclosporin in error|1|||
130703384|NCT02972515|470537915|FG000|Overall Study|Lost to Follow-up|78|||
130703385|NCT01450800|470537916|FG000|Overall Study|Protocol Violation|1|||
130703386|NCT01450800|470537917|FG001|Overall Study|Protocol Violation|3|||
130703387|NCT01086969|470537925|FG000|Overall Study|Withdrawal by Subject|1|||
130703388|NCT01086969|470537926|FG001|Overall Study|Withdrawal by Subject|2|||
130703389|NCT01086969|470537927|FG002|Overall Study|Withdrawal by Subject|0|||
130703390|NCT04253236|470537928|FG000|Overall Study|Adverse Event|1|||
130703391|NCT04253236|470537929|FG001|Overall Study|Adverse Event|0|||
130703392|NCT04253236|470537928|FG000|Overall Study|Safety Concerns|1|||
130703393|NCT04253236|470537929|FG001|Overall Study|Safety Concerns|0|||
130703394|NCT04253236|470537928|FG000|Overall Study|Study Terminated by Sponsor|1|||
130703395|NCT04253236|470537929|FG001|Overall Study|Study Terminated by Sponsor|0|||
130703396|NCT04291508|470537930|FG000|Overall Study|Withdrawal by Subject|1|||
130703397|NCT04291508|470537931|FG001|Overall Study|Withdrawal by Subject|0|||
130703398|NCT04291508|470537932|FG002|Overall Study|Withdrawal by Subject|1|||
130703399|NCT04291508|470537933|FG003|Overall Study|Withdrawal by Subject|0|||
130703400|NCT04291508|470537930|FG000|Overall Study|lost to follow up|4|||
130261065|NCT00976456|468922929|FG001|Overall Study|Lack of Efficacy|2|||
130365497|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365498|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365499|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365500|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365501|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365502|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Other|0|||
130365503|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Other|0|||
130365504|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Other|1|||
130365505|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Other|1|||
130365506|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Other|2|||
130703401|NCT04291508|470537931|FG001|Overall Study|lost to follow up|0|||
130703402|NCT04291508|470537932|FG002|Overall Study|lost to follow up|1|||
130703403|NCT04291508|470537933|FG003|Overall Study|lost to follow up|0|||
130703404|NCT03566238|470537934|FG000|Overall Study|Adverse Event|0|||
130261066|NCT00976456|468922928|FG000|Overall Study|Withdrawal by Subject|3|||
130261067|NCT00976456|468922929|FG001|Overall Study|Withdrawal by Subject|1|||
130261068|NCT00976456|468922928|FG000|Overall Study|screening failure, unknown|11|||
130261069|NCT00976456|468922929|FG001|Overall Study|screening failure, unknown|4|||
130261070|NCT02735200|468922932|FG000|Overall Study|Lost to Follow-up|0|||
130261071|NCT02735200|468922933|FG001|Overall Study|Lost to Follow-up|5|||
130261072|NCT02735200|468922932|FG000|Overall Study|Withdrawal by Subject|8|||
130261073|NCT02735200|468922933|FG001|Overall Study|Withdrawal by Subject|0|||
130261074|NCT01463527|468922934|FG000|Overall Study|Protocol Violation|1|||
130261075|NCT01463527|468922935|FG001|Overall Study|Protocol Violation|1|||
130261076|NCT01463527|468922934|FG000|Overall Study|Crying >20% of sedation|5|||
130261077|NCT01463527|468922935|FG001|Overall Study|Crying >20% of sedation|6|||
130261078|NCT05136170|468922936|FG000|Overall Study|Withdrawal by Subject|2|||
130261079|NCT05136170|468922937|FG001|Overall Study|Withdrawal by Subject|2|||
130261080|NCT05136170|468922936|FG000|Overall Study|Can no longer make office visits|1|||
130261081|NCT05136170|468922937|FG001|Overall Study|Can no longer make office visits|0|||
130261082|NCT01493414|468922940|FG000|Overall Study|Adverse Event|405|||
130261083|NCT01493414|468922940|FG000|Overall Study|Disease progression|204|||
130261084|NCT01493414|468922940|FG000|Overall Study|Death|101|||
130261085|NCT01493414|468922940|FG000|Overall Study|Physician Decision|93|||
130261086|NCT01493414|468922940|FG000|Overall Study|Withdrawal by Subject|79|||
130261087|NCT01493414|468922940|FG000|Overall Study|Protocol deviation|27|||
130261088|NCT01493414|468922940|FG000|Overall Study|Administrative problems|25|||
130261089|NCT01493414|468922940|FG000|Overall Study|Lost to Follow-up|16|||
130261090|NCT01977222|468922945|FG000|Overall Study|Withdrawal by Subject|1|||
130261091|NCT01612676|468922948|FG000|Overall Study|Adverse Event|2|||
130261092|NCT01612676|468922949|FG001|Overall Study|Adverse Event|3|||
130261093|NCT01612676|468922950|FG002|Overall Study|Adverse Event|1|||
130261094|NCT01612676|468922951|FG003|Overall Study|Adverse Event|3|||
130261095|NCT01612676|468922948|FG000|Overall Study|Protocol Violation|0|||
130703405|NCT03566238|470537935|FG001|Overall Study|Adverse Event|1|||
130703406|NCT03566238|470537936|FG002|Overall Study|Adverse Event|0|||
130703407|NCT03566238|470537934|FG000|Overall Study|Lack of Efficacy|4|||
130703408|NCT03566238|470537935|FG001|Overall Study|Lack of Efficacy|2|||
130703409|NCT03566238|470537936|FG002|Overall Study|Lack of Efficacy|5|||
130703410|NCT03566238|470537934|FG000|Overall Study|Other|1|||
130703411|NCT03566238|470537935|FG001|Overall Study|Other|0|||
130703412|NCT03566238|470537936|FG002|Overall Study|Other|0|||
130703413|NCT04203667|470537944|FG000|Overall Study|Withdrawal by Subject|1|||
130703414|NCT04203667|470537944|FG000|Overall Study|Lost to Follow-up|1|||
130703415|NCT04203667|470537944|FG000|Overall Study|Death|1|||
130703416|NCT04203667|470537944|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
130703417|NCT01183884|470537945|FG000|Overall Study|Progressive Disease|26|||
130703418|NCT01183884|470537945|FG000|Overall Study|Adverse Event|3|||
130703419|NCT01183884|470537945|FG000|Overall Study|Withdrawal by Subject|1|||
130703420|NCT01183884|470537945|FG000|Overall Study|Other Complicating Disease|3|||
130703421|NCT01183884|470537945|FG000|Overall Study|Not Treated|1|||
130703422|NCT01183884|470537945|FG000|Overall Study|Other|4|||
130703423|NCT00127166|470537946|FG000|Period I|Protocol Violation|0|||
130703424|NCT00127166|470537947|FG001|Period I|Protocol Violation|2|||
130703425|NCT00127166|470537946|FG000|Period I|Withdrawal by Subject|2|||
130703426|NCT00127166|470537947|FG001|Period I|Withdrawal by Subject|0|||
130261096|NCT01612676|468922949|FG001|Overall Study|Protocol Violation|1|||
130261097|NCT01612676|468922950|FG002|Overall Study|Protocol Violation|0|||
130261098|NCT01612676|468922951|FG003|Overall Study|Protocol Violation|0|||
130261099|NCT00107276|468922955|FG000|Overall Study|Progression|46|||
130261100|NCT00107276|468922955|FG000|Overall Study|Adverse Event|6|||
130261101|NCT00107276|468922955|FG000|Overall Study|M.D. decision|2|||
130261102|NCT00107276|468922955|FG000|Overall Study|Patient refusal|1|||
130261103|NCT00107276|468922955|FG000|Overall Study|Death|1|||
130261104|NCT00107276|468922955|FG000|Overall Study|Ineligible|16|||
130261105|NCT02980107|468922956|FG000|Overall Study|Withdrawal by Subject|51|||
130453086|NCT01311713|469621776|FG001|Overall Study|Adverse Event|1|||
130453087|NCT01311713|469621777|FG002|Overall Study|Adverse Event|0|||
130703427|NCT00127166|470537946|FG000|Period I|Patient did not meet inclusion criteria|1|||
130703428|NCT00127166|470537947|FG001|Period I|Patient did not meet inclusion criteria|0|||
130261106|NCT02980107|468922957|FG001|Overall Study|Withdrawal by Subject|62|||
130261107|NCT00945659|468922958|FG000|Overall Study|Lost to Follow-up|7|||
130261108|NCT00945659|468922959|FG001|Overall Study|Lost to Follow-up|20|||
130703429|NCT00127166|470537946|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
130703430|NCT00127166|470537947|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
130703431|NCT00127166|470537946|FG000|Period II|Withdrawal by Subject|2|||
130261109|NCT00945659|468922960|FG002|Overall Study|Lost to Follow-up|17|||
130261110|NCT04562116|468922961|FG000|Overall Study|Lost to Follow-up|1|||
130261111|NCT04562116|468922961|FG000|Overall Study|Withdrawal by Subject|3|||
130261112|NCT02412670|468922964|FG000|Overall Study|Adverse Event|4|||
130261113|NCT02412670|468922965|FG001|Overall Study|Adverse Event|1|||
130703432|NCT00127166|470537947|FG001|Period II|Withdrawal by Subject|0|||
130261114|NCT02412670|468922964|FG000|Overall Study|Physician Decision|1|||
130261115|NCT02412670|468922965|FG001|Overall Study|Physician Decision|0|||
130261116|NCT02412670|468922964|FG000|Overall Study|Withdrawal by Subject|1|||
130261117|NCT02412670|468922965|FG001|Overall Study|Withdrawal by Subject|0|||
130261118|NCT02412670|468922964|FG000|Overall Study|Ineligible|1|||
130261119|NCT02412670|468922965|FG001|Overall Study|Ineligible|0|||
130261120|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Adverse Event|6|||
130261121|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Adverse Event|15|||
130261122|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Adverse Event|0|||
130261123|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Death|0|||
130261124|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Death|2|||
130261125|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Death|0|||
130261126|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
130261127|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
130261128|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
130261129|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
130261130|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
130261131|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
130261132|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Physician Decision|1|||
130261133|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Physician Decision|1|||
130261134|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Physician Decision|0|||
130261135|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
130261136|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
130261137|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
130261138|NCT02921256|468922971|FG000|Arm Ib v Arm III|Adverse Event|9|||
130261139|NCT02921256|468922972|FG001|Arm Ib v Arm III|Adverse Event|0|||
130261140|NCT02921256|468922973|FG002|Arm Ib v Arm III|Adverse Event|4|||
130261141|NCT02921256|468922971|FG000|Arm Ib v Arm III|Death|1|||
130261142|NCT02921256|468922972|FG001|Arm Ib v Arm III|Death|0|||
130261143|NCT02921256|468922973|FG002|Arm Ib v Arm III|Death|1|||
130261144|NCT02921256|468922971|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
130261145|NCT02921256|468922972|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
130261146|NCT02921256|468922973|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
130261147|NCT02921256|468922971|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
130261148|NCT02921256|468922972|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
130261149|NCT02921256|468922973|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
130261150|NCT02921256|468922971|FG000|Arm Ib v Arm III|Physician Decision|4|||
130261151|NCT02921256|468922972|FG001|Arm Ib v Arm III|Physician Decision|0|||
130261152|NCT02921256|468922973|FG002|Arm Ib v Arm III|Physician Decision|1|||
130261153|NCT02921256|468922971|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
130261154|NCT02921256|468922972|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
130261155|NCT02921256|468922973|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
130261156|NCT02943473|468922974|FG000|Overall Study|enrolled but not dosed|1|||
130261157|NCT02943473|468922974|FG000|Overall Study|screen failure|1|||
130261158|NCT02943473|468922974|FG000|Overall Study|Physician Decision|4|||
130261159|NCT04211363|468922977|FG000|Overall Study|Adverse Event|5|||
130261160|NCT04211363|468922978|FG001|Overall Study|Adverse Event|2|||
130261161|NCT04211363|468922977|FG000|Overall Study|Physician Decision|0|||
130261162|NCT04211363|468922978|FG001|Overall Study|Physician Decision|1|||
130261163|NCT04211363|468922977|FG000|Overall Study|Protocol Violation|1|||
130261164|NCT04211363|468922978|FG001|Overall Study|Protocol Violation|0|||
130261165|NCT04211363|468922977|FG000|Overall Study|Pregnancy|1|||
130261166|NCT04211363|468922978|FG001|Overall Study|Pregnancy|0|||
130261167|NCT04211363|468922977|FG000|Overall Study|Lost to Follow-up|12|||
130261168|NCT04211363|468922978|FG001|Overall Study|Lost to Follow-up|4|||
130261169|NCT04211363|468922977|FG000|Overall Study|Withdrawal by Subject|11|||
130261170|NCT04211363|468922978|FG001|Overall Study|Withdrawal by Subject|11|||
130261171|NCT04211363|468922977|FG000|Overall Study|Other|1|||
130261172|NCT04211363|468922978|FG001|Overall Study|Other|2|||
130261173|NCT03097289|468922979|FG000|Overall Study|Adverse Event|1|||
130261174|NCT03097289|468922979|FG000|Overall Study|Equipment failure|2|||
130261175|NCT03097289|468922979|FG000|Overall Study|Collected platelet product unusable|3|||
130261176|NCT01823289|468922980|FG000|Overall Study|Lost to Follow-up|5|||
130261177|NCT01823289|468922980|FG000|Overall Study|Adverse Event|5|||
130261178|NCT01823289|468922980|FG000|Overall Study|Lack of Efficacy|1|||
130261179|NCT01823289|468922980|FG000|Overall Study|Physician Decision|9|||
130261180|NCT01823289|468922980|FG000|Overall Study|Administered contraindicated medicine|1|||
130261181|NCT01823289|468922980|FG000|Overall Study|Transaminase increased more than 3 times|1|||
130261182|NCT01823289|468922980|FG000|Overall Study|Drug affected efficacy and safety|1|||
130261183|NCT01823289|468922980|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
130261184|NCT01736917|468922981|FG000|Overall Study|Adverse Event|1|||
130261185|NCT01736917|468922981|FG000|Overall Study|Protocol Violation|10|||
130261186|NCT01734902|468922982|FG000|Overall Study|Other than listed|0|||
130261187|NCT01734902|468922983|FG001|Overall Study|Other than listed|2|||
130703433|NCT00127166|470537946|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
130261188|NCT00060944|468922984|FG000|Overall Study|Adverse Event|12|||
130261189|NCT00060944|468922985|FG001|Overall Study|Adverse Event|10|||
130261190|NCT00060944|468922984|FG000|Overall Study|Death|2|||
130261191|NCT00060944|468922985|FG001|Overall Study|Death|3|||
130261192|NCT00060944|468922984|FG000|Overall Study|Withdrawal by Subject|18|||
130261193|NCT00060944|468922985|FG001|Overall Study|Withdrawal by Subject|5|||
130261194|NCT00060944|468922984|FG000|Overall Study|Disease Progression|93|||
130261195|NCT00060944|468922985|FG001|Overall Study|Disease Progression|94|||
130261196|NCT00060944|468922984|FG000|Overall Study|Lost to Follow-up|1|||
130261197|NCT00060944|468922985|FG001|Overall Study|Lost to Follow-up|0|||
130261198|NCT00060944|468922984|FG000|Overall Study|Subject Ineligible To Continue|2|||
130261199|NCT00060944|468922985|FG001|Overall Study|Subject Ineligible To Continue|1|||
130261200|NCT00060944|468922984|FG000|Overall Study|Treatment Switch|0|||
130261201|NCT00060944|468922985|FG001|Overall Study|Treatment Switch|13|||
130261202|NCT00060944|468922984|FG000|Overall Study|Other|2|||
130261203|NCT00060944|468922985|FG001|Overall Study|Other|4|||
130261204|NCT00060944|468922984|FG000|Overall Study|randomized but not treated|6|||
130261205|NCT00060944|468922985|FG001|Overall Study|randomized but not treated|4|||
130453088|NCT01311713|469621778|FG003|Overall Study|Adverse Event|2|||
130453089|NCT01311713|469621779|FG004|Overall Study|Adverse Event|0|||
130453090|NCT01311713|469621780|FG005|Overall Study|Adverse Event|0|||
130453091|NCT01311713|469621781|FG006|Overall Study|Adverse Event|2|||
130453092|NCT01311713|469621775|FG000|Overall Study|Withdrawal by Subject|0|||
130453093|NCT01311713|469621776|FG001|Overall Study|Withdrawal by Subject|1|||
130453094|NCT01311713|469621777|FG002|Overall Study|Withdrawal by Subject|1|||
130453095|NCT01311713|469621778|FG003|Overall Study|Withdrawal by Subject|0|||
130453096|NCT01311713|469621779|FG004|Overall Study|Withdrawal by Subject|0|||
130453097|NCT01311713|469621780|FG005|Overall Study|Withdrawal by Subject|1|||
130453098|NCT01311713|469621781|FG006|Overall Study|Withdrawal by Subject|2|||
130453099|NCT01311713|469621775|FG000|Overall Study|Disease progression|3|||
130703434|NCT00127166|470537947|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
130703435|NCT00708682|470537948|FG000|Infant Series|Adverse Event|1|||
130703436|NCT00708682|470537948|FG000|Infant Series|Lost to Follow-up|4|||
130703437|NCT00708682|470537948|FG000|Infant Series|Protocol Violation|1|||
130703438|NCT00708682|470537948|FG000|Infant Series|Parent/legal guardian request|6|||
130703439|NCT00708682|470537948|FG000|Infant Series|Failed to return|2|||
130703440|NCT00708682|470537948|FG000|Infant Series|Other|19|||
130703441|NCT00708682|470537948|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
130703442|NCT00708682|470537948|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
130703443|NCT00708682|470537948|FG000|Toddler Dose|Lost to Follow-up|3|||
130703444|NCT00708682|470537948|FG000|Toddler Dose|Failed to Return|4|||
130703445|NCT04718129|470537953|FG000|Overall Study|Lost to Follow-up|6|||
130703446|NCT04718129|470537954|FG001|Overall Study|Lost to Follow-up|7|||
130703447|NCT01835548|470537958|FG000|Dose Optimization Period|Adverse Event|0|||
130703448|NCT01835548|470537959|FG001|Dose Optimization Period|Adverse Event|0|||
130703449|NCT01835548|470537960|FG002|Dose Optimization Period|Adverse Event|1|||
130703450|NCT01835548|470537958|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
130703451|NCT01835548|470537959|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
130703452|NCT01835548|470537960|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
130703453|NCT01835548|470537958|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130261206|NCT03213509|468922987|FG000|Overall Study|Did not consent for verbal autopsy|4|||
130261207|NCT03213509|468922988|FG001|Overall Study|Did not consent for verbal autopsy|5|||
130261208|NCT04549454|468922991|FG000|T1 to T2|Lost to Follow-up|22|||
130261209|NCT04549454|468922992|FG001|T1 to T2|Lost to Follow-up|26|||
130261210|NCT04549454|468922991|FG000|T1 to T3|Lost to Follow-up|31|||
130261211|NCT04549454|468922992|FG001|T1 to T3|Lost to Follow-up|36|||
130453100|NCT01311713|469621776|FG001|Overall Study|Disease progression|4|||
130453101|NCT01311713|469621777|FG002|Overall Study|Disease progression|3|||
130453102|NCT01311713|469621778|FG003|Overall Study|Disease progression|2|||
130453103|NCT01311713|469621779|FG004|Overall Study|Disease progression|4|||
130703454|NCT01835548|470537959|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130703455|NCT01835548|470537960|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130703456|NCT01835548|470537958|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130703457|NCT01835548|470537959|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130261212|NCT00867035|468922993|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
130261213|NCT00867035|468922994|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
130261214|NCT00867035|468922993|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
130261215|NCT00867035|468922994|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
130261216|NCT00016354|468922995|FG000|Overall Study|Lack of Efficacy|0|||
130703458|NCT01835548|470537960|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130703459|NCT03257254|470537961|FG000|Overall Study|Withdrawal by Subject|7|||
130703460|NCT03257254|470537961|FG000|Overall Study|Lost to Follow-up|9|||
130703461|NCT03257254|470537961|FG000|Overall Study|Study discontinued by sponsor|5|||
130703462|NCT03168906|470537962|FG000|Overall Study|Lack of Efficacy|6|||
130703463|NCT03168906|470537963|FG001|Overall Study|Lack of Efficacy|6|||
130703464|NCT01321697|470537964|FG000|Overall Study|Study Terminated|7|||
130261217|NCT00016354|468922996|FG001|Overall Study|Lack of Efficacy|0|||
130261218|NCT00016354|468922997|FG002|Overall Study|Lack of Efficacy|0|||
130261219|NCT00016354|468922998|FG003|Overall Study|Lack of Efficacy|0|||
130453104|NCT01311713|469621780|FG005|Overall Study|Disease progression|4|||
130453105|NCT01311713|469621781|FG006|Overall Study|Disease progression|5|||
130261220|NCT00016354|468922999|FG004|Overall Study|Lack of Efficacy|0|||
130261221|NCT00016354|468923000|FG005|Overall Study|Lack of Efficacy|0|||
130261222|NCT00016354|468923001|FG006|Overall Study|Lack of Efficacy|0|||
130261223|NCT00016354|468923002|FG007|Overall Study|Lack of Efficacy|1|||
130453106|NCT01311713|469621775|FG000|Overall Study|Lost to Follow-up|0|||
130453107|NCT01311713|469621776|FG001|Overall Study|Lost to Follow-up|0|||
130453108|NCT01311713|469621777|FG002|Overall Study|Lost to Follow-up|1|||
130453109|NCT01311713|469621778|FG003|Overall Study|Lost to Follow-up|0|||
130703465|NCT00857818|470537967|FG000|Overall Study|Lack of Efficacy|1|||
130703466|NCT00857818|470537968|FG001|Overall Study|Lack of Efficacy|0|||
130703467|NCT00857818|470537967|FG000|Overall Study|Adverse Event|3|||
130703468|NCT00857818|470537968|FG001|Overall Study|Adverse Event|0|||
130703469|NCT00857818|470537967|FG000|Overall Study|Withdrawal by Subject|0|||
130703470|NCT00857818|470537968|FG001|Overall Study|Withdrawal by Subject|4|||
130703471|NCT00857818|470537967|FG000|Overall Study|Sponsor terminated study|6|||
130703472|NCT00857818|470537968|FG001|Overall Study|Sponsor terminated study|4|||
130703473|NCT00857818|470537967|FG000|Overall Study|Investigator decision|1|||
130703474|NCT00857818|470537968|FG001|Overall Study|Investigator decision|0|||
130703475|NCT02625974|470537970|FG000|Part 1|Lost to Follow-up|9|||
130703476|NCT02625974|470537971|FG001|Part 1|Lost to Follow-up|3|||
130703477|NCT02625974|470537970|FG000|Part 2|Lost to Follow-up|4|||
130703478|NCT02625974|470537971|FG001|Part 2|Lost to Follow-up|6|||
130703479|NCT02625974|470537970|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
130703480|NCT02625974|470537971|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
130703481|NCT00434590|470537972|FG000|Overall Study|Administrative problems|5|||
130703482|NCT00434590|470537973|FG001|Overall Study|Administrative problems|5|||
130703483|NCT02175368|470537975|FG000|Overall Study|Lost to Follow-up|1|||
130703484|NCT02875028|470537976|FG000|Washout Period|Withdrawal by Subject|0|||
130703485|NCT02875028|470537977|FG001|Washout Period|Withdrawal by Subject|1|||
130703486|NCT03180528|470539597|FG000|Overall Study|Adverse Event|1|||
130703487|NCT03180528|470539597|FG000|Overall Study|Withdrawal by Subject|1|||
130703488|NCT03180528|470539597|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
130703489|NCT02447887|470539598|FG000|Overall Study|Study was terminated|3|||
130703490|NCT01560819|470539604|FG000|Overall Study|Physician Decision|1|||
130703491|NCT01560819|470539605|FG001|Overall Study|Physician Decision|0|||
130703492|NCT02674633|470539606|FG000|Overall Study|Lost to Follow-up|3|||
130453110|NCT01311713|469621779|FG004|Overall Study|Lost to Follow-up|0|||
130453111|NCT01311713|469621780|FG005|Overall Study|Lost to Follow-up|0|||
130453112|NCT01311713|469621781|FG006|Overall Study|Lost to Follow-up|0|||
130453113|NCT01311713|469621775|FG000|Overall Study|Stopped taking study medication|0|||
130453114|NCT01311713|469621776|FG001|Overall Study|Stopped taking study medication|0|||
130453115|NCT01311713|469621777|FG002|Overall Study|Stopped taking study medication|0|||
130453116|NCT01311713|469621778|FG003|Overall Study|Stopped taking study medication|1|||
130453117|NCT01311713|469621779|FG004|Overall Study|Stopped taking study medication|1|||
130453118|NCT01311713|469621780|FG005|Overall Study|Stopped taking study medication|0|||
130453119|NCT01311713|469621781|FG006|Overall Study|Stopped taking study medication|0|||
130453120|NCT01311713|469621775|FG000|Overall Study|Enrolled but not treated|0|||
130453121|NCT01311713|469621776|FG001|Overall Study|Enrolled but not treated|0|||
130453122|NCT01311713|469621777|FG002|Overall Study|Enrolled but not treated|1|||
130453123|NCT01311713|469621778|FG003|Overall Study|Enrolled but not treated|0|||
130453124|NCT01311713|469621779|FG004|Overall Study|Enrolled but not treated|0|||
130453125|NCT01311713|469621780|FG005|Overall Study|Enrolled but not treated|0|||
130453126|NCT01311713|469621781|FG006|Overall Study|Enrolled but not treated|0|||
130453127|NCT01311713|469621775|FG000|Overall Study|Other than specified|0|||
130703493|NCT02674633|470539607|FG001|Overall Study|Lost to Follow-up|2|||
130703494|NCT02674633|470539606|FG000|Overall Study|Physician Decision|1|||
130703495|NCT02674633|470539607|FG001|Overall Study|Physician Decision|0|||
130261224|NCT03110562|468923003|FG000|Initial Treatment Period|Disease Progression|1|||
130703496|NCT02674633|470539606|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130453128|NCT01311713|469621776|FG001|Overall Study|Other than specified|1|||
130453129|NCT01311713|469621777|FG002|Overall Study|Other than specified|2|||
130453130|NCT01311713|469621778|FG003|Overall Study|Other than specified|0|||
130453131|NCT01311713|469621779|FG004|Overall Study|Other than specified|0|||
130703497|NCT02674633|470539607|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130703498|NCT00460109|470539608|FG000|Overall Study|Death|1|||
130703499|NCT02344745|470539609|FG000|Overall Study|Data collection sheets were lost|2|||
130703500|NCT02344745|470539610|FG001|Overall Study|Data collection sheets were lost|0|||
130703501|NCT02788513|470539611|FG000|Overall Study|Withdrawal by Subject|3|||
130703502|NCT02788513|470539612|FG001|Overall Study|Withdrawal by Subject|0|||
130703503|NCT02788513|470539613|FG002|Overall Study|Withdrawal by Subject|2|||
130261225|NCT03110562|468923004|FG001|Initial Treatment Period|Disease Progression|1|||
130453132|NCT01311713|469621780|FG005|Overall Study|Other than specified|0|||
130453133|NCT01311713|469621781|FG006|Overall Study|Other than specified|0|||
130453134|NCT00946192|469621782|FG000|Overall Study|Lost to Follow-up|6|||
130453135|NCT00946192|469621783|FG001|Overall Study|Lost to Follow-up|11|||
130453136|NCT00946192|469621784|FG002|Overall Study|Lost to Follow-up|9|||
130261226|NCT03110562|468923005|FG002|Initial Treatment Period|Disease Progression|0|||
130261227|NCT03110562|468923006|FG003|Initial Treatment Period|Disease Progression|0|||
130261228|NCT03110562|468923003|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
130261229|NCT03110562|468923004|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
130261230|NCT03110562|468923005|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
130261231|NCT03110562|468923006|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
130703504|NCT02788513|470539614|FG003|Overall Study|Withdrawal by Subject|3|||
130703505|NCT02788513|470539615|FG004|Overall Study|Withdrawal by Subject|1|||
130261232|NCT03110562|468923003|FG000|Initial Treatment Period|Adverse Event|1|||
130261233|NCT03110562|468923004|FG001|Initial Treatment Period|Adverse Event|0|||
130261234|NCT03110562|468923005|FG002|Initial Treatment Period|Adverse Event|0|||
130261235|NCT03110562|468923006|FG003|Initial Treatment Period|Adverse Event|0|||
130261236|NCT03110562|468923003|FG000|Initial Treatment Period|Death|74|||
130261237|NCT03110562|468923004|FG001|Initial Treatment Period|Death|82|||
130261238|NCT03110562|468923005|FG002|Initial Treatment Period|Death|0|||
130261239|NCT03110562|468923006|FG003|Initial Treatment Period|Death|0|||
130261240|NCT03110562|468923003|FG000|Initial Treatment Period|Lost to Follow-up|13|||
130261241|NCT03110562|468923004|FG001|Initial Treatment Period|Lost to Follow-up|8|||
130261242|NCT03110562|468923005|FG002|Initial Treatment Period|Lost to Follow-up|0|||
130261243|NCT03110562|468923006|FG003|Initial Treatment Period|Lost to Follow-up|0|||
130261244|NCT03110562|468923003|FG000|Initial Treatment Period|Protocol Deviation|1|||
130261245|NCT03110562|468923004|FG001|Initial Treatment Period|Protocol Deviation|0|||
130261246|NCT03110562|468923005|FG002|Initial Treatment Period|Protocol Deviation|0|||
130261247|NCT03110562|468923006|FG003|Initial Treatment Period|Protocol Deviation|0|||
130261248|NCT03110562|468923003|FG000|Initial Treatment Period|Physician Decision|2|||
130261249|NCT03110562|468923004|FG001|Initial Treatment Period|Physician Decision|1|||
130261250|NCT03110562|468923005|FG002|Initial Treatment Period|Physician Decision|0|||
130261251|NCT03110562|468923006|FG003|Initial Treatment Period|Physician Decision|0|||
130261252|NCT03110562|468923003|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
130261253|NCT03110562|468923004|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
130261254|NCT03110562|468923005|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130261255|NCT03110562|468923006|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130261256|NCT03110562|468923003|FG000|Initial Treatment Period|Other|5|||
130261257|NCT03110562|468923004|FG001|Initial Treatment Period|Other|4|||
130261258|NCT03110562|468923005|FG002|Initial Treatment Period|Other|0|||
130261259|NCT03110562|468923006|FG003|Initial Treatment Period|Other|0|||
130261260|NCT03110562|468923003|FG000|Initial Treatment Period|Randomized but never treated|0|||
130261261|NCT03110562|468923004|FG001|Initial Treatment Period|Randomized but never treated|3|||
130261262|NCT03110562|468923005|FG002|Initial Treatment Period|Randomized but never treated|0|||
130261263|NCT03110562|468923006|FG003|Initial Treatment Period|Randomized but never treated|0|||
130261264|NCT03110562|468923003|FG000|Crossover Period|Disease Progression|0|||
130261265|NCT03110562|468923004|FG001|Crossover Period|Disease Progression|0|||
130261266|NCT03110562|468923005|FG002|Crossover Period|Disease Progression|1|||
130261267|NCT03110562|468923006|FG003|Crossover Period|Disease Progression|0|||
130261268|NCT03110562|468923003|FG000|Crossover Period|Withdrawal by Subject|0|||
130261269|NCT03110562|468923004|FG001|Crossover Period|Withdrawal by Subject|0|||
130261270|NCT03110562|468923005|FG002|Crossover Period|Withdrawal by Subject|8|||
130261271|NCT03110562|468923006|FG003|Crossover Period|Withdrawal by Subject|6|||
130261272|NCT03110562|468923003|FG000|Crossover Period|Death|0|||
130261273|NCT03110562|468923004|FG001|Crossover Period|Death|0|||
130261274|NCT03110562|468923005|FG002|Crossover Period|Death|37|||
130261275|NCT03110562|468923006|FG003|Crossover Period|Death|3|||
130261276|NCT03110562|468923003|FG000|Crossover Period|Lost to Follow-up|0|||
130261277|NCT03110562|468923004|FG001|Crossover Period|Lost to Follow-up|0|||
130261278|NCT03110562|468923005|FG002|Crossover Period|Lost to Follow-up|0|||
130261279|NCT03110562|468923006|FG003|Crossover Period|Lost to Follow-up|1|||
130261280|NCT03110562|468923003|FG000|Crossover Period|Other|0|||
130261281|NCT03110562|468923004|FG001|Crossover Period|Other|0|||
130261282|NCT03110562|468923005|FG002|Crossover Period|Other|1|||
130261283|NCT03110562|468923006|FG003|Crossover Period|Other|1|||
130261284|NCT03110562|468923003|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
130703506|NCT02788513|470539611|FG000|Overall Study|Lost to Follow-up|1|||
130703507|NCT02788513|470539612|FG001|Overall Study|Lost to Follow-up|0|||
130703508|NCT02788513|470539613|FG002|Overall Study|Lost to Follow-up|0|||
130703509|NCT02788513|470539614|FG003|Overall Study|Lost to Follow-up|0|||
130703510|NCT02788513|470539615|FG004|Overall Study|Lost to Follow-up|1|||
130261285|NCT03110562|468923004|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
130261286|NCT03110562|468923005|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
130261287|NCT03110562|468923006|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
130261288|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261289|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130703511|NCT02788513|470539611|FG000|Overall Study|Adverse Event|5|||
130703512|NCT02788513|470539612|FG001|Overall Study|Adverse Event|8|||
130261290|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261291|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261292|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261293|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261294|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261295|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261296|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261297|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261298|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Death|2|||
130261299|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Death|1|||
130261300|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Death|3|||
130261301|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Death|1|||
130261302|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Death|2|||
130261303|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Death|3|||
130261304|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Death|3|||
130261305|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Death|0|||
130261306|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Death|0|||
130261307|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Death|0|||
130261308|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261309|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261310|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261311|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261312|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261313|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
130261314|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261315|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261316|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261317|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261318|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261319|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261320|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261321|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261322|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261323|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261324|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261325|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
130261326|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
130261327|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
130261328|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
130261329|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
130261330|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
130261331|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
130261332|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
130261333|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
130261334|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
130261335|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
130261336|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
130261337|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
130261338|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261339|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261340|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261341|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261342|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261343|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261344|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261345|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
130261346|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
130261347|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261348|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261349|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261350|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261351|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130703513|NCT02788513|470539613|FG002|Overall Study|Adverse Event|4|||
130453137|NCT00946192|469621782|FG000|Overall Study|Withdrawal by Subject|10|||
130453138|NCT00946192|469621783|FG001|Overall Study|Withdrawal by Subject|7|||
130703514|NCT02788513|470539614|FG003|Overall Study|Adverse Event|2|||
130703515|NCT02788513|470539615|FG004|Overall Study|Adverse Event|2|||
130703516|NCT02788513|470539611|FG000|Overall Study|Protocol Violation|0|||
130703517|NCT02788513|470539612|FG001|Overall Study|Protocol Violation|0|||
130703518|NCT02788513|470539613|FG002|Overall Study|Protocol Violation|1|||
130703519|NCT02788513|470539614|FG003|Overall Study|Protocol Violation|1|||
130703520|NCT02788513|470539615|FG004|Overall Study|Protocol Violation|0|||
130703521|NCT02788513|470539611|FG000|Overall Study|Subject decided to stop taking treatment|0|||
130703522|NCT02788513|470539612|FG001|Overall Study|Subject decided to stop taking treatment|0|||
130703523|NCT02788513|470539613|FG002|Overall Study|Subject decided to stop taking treatment|1|||
130703524|NCT02788513|470539614|FG003|Overall Study|Subject decided to stop taking treatment|0|||
130703525|NCT02788513|470539615|FG004|Overall Study|Subject decided to stop taking treatment|0|||
130703526|NCT02788513|470539611|FG000|Overall Study|Decision by the study team|0|||
130703527|NCT02788513|470539612|FG001|Overall Study|Decision by the study team|0|||
130703528|NCT02788513|470539613|FG002|Overall Study|Decision by the study team|0|||
130703529|NCT02788513|470539614|FG003|Overall Study|Decision by the study team|0|||
130703530|NCT02788513|470539615|FG004|Overall Study|Decision by the study team|1|||
130703531|NCT05996198|470539616|FG000|Overall Study|Withdrawal by Subject|1|||
130703532|NCT05996198|470539617|FG001|Overall Study|Withdrawal by Subject|0|||
130703533|NCT02014441|470539619|FG000|Overall Study|Withdrawal by Subject|12|||
130703534|NCT00114231|470539621|FG000|Overall Study|No consent|2|||
130703535|NCT00114231|470539622|FG001|Overall Study|No consent|0|||
130703536|NCT00114231|470539621|FG000|Overall Study|QARC requirement not met|1|||
130703537|NCT00114231|470539622|FG001|Overall Study|QARC requirement not met|0|||
130703538|NCT00114231|470539621|FG000|Overall Study|Suspected metastatic disease|1|||
130703539|NCT00114231|470539622|FG001|Overall Study|Suspected metastatic disease|0|||
130703540|NCT00114231|470539621|FG000|Overall Study|No adenocarcinoma|1|||
130703541|NCT00114231|470539622|FG001|Overall Study|No adenocarcinoma|0|||
130703542|NCT00114231|470539621|FG000|Overall Study|Low creatinine clearance|0|||
130703543|NCT00114231|470539622|FG001|Overall Study|Low creatinine clearance|1|||
130703544|NCT00114231|470539621|FG000|Overall Study|Tumor size > 4cm|1|||
130703545|NCT00114231|470539622|FG001|Overall Study|Tumor size > 4cm|0|||
130703546|NCT00114231|470539621|FG000|Overall Study|Tumor fixed on digital exam|0|||
130703547|NCT00114231|470539622|FG001|Overall Study|Tumor fixed on digital exam|1|||
130703548|NCT00114231|470539621|FG000|Overall Study|No Absolute Neutrophil Count|2|||
130703549|NCT00114231|470539622|FG001|Overall Study|No Absolute Neutrophil Count|0|||
130703550|NCT00114231|470539621|FG000|Overall Study|Biopsy done after registration|1|||
130703551|NCT00114231|470539622|FG001|Overall Study|Biopsy done after registration|0|||
130703552|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
130703553|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
130703554|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
130261352|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261353|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261354|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261355|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261356|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261357|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
130261358|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Death|0|||
130261359|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Death|0|||
130261360|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Death|0|||
130261361|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Death|0|||
130261362|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Death|0|||
130261363|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Death|0|||
130261364|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Death|0|||
130261365|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Death|4|||
130261366|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Death|8|||
130261367|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Death|10|||
130261368|NCT01334918|468923904|FG000|Overall Study|Did not receive study drug|6|||
130261369|NCT01334918|468923905|FG001|Overall Study|Did not receive study drug|0|||
130261370|NCT01334918|468923904|FG000|Overall Study|Adverse Event|2|||
130261371|NCT01334918|468923905|FG001|Overall Study|Adverse Event|0|||
130261372|NCT01334918|468923904|FG000|Overall Study|Withdrawal by Subject|0|||
130261373|NCT01334918|468923905|FG001|Overall Study|Withdrawal by Subject|1|||
130261374|NCT05878067|468923908|FG000|Overall Study|Lost to Follow-up|2|||
130261375|NCT00949533|468923909|FG000|Overall Study|Lost to Follow-up|0|||
130261376|NCT00949533|468923910|FG001|Overall Study|Lost to Follow-up|1|||
130261377|NCT01959529|468923911|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
130703555|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
130261378|NCT01959529|468923912|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
130261379|NCT01959529|468923911|FG000|Overall Study|Lost to Follow-up|4|||
130261380|NCT01959529|468923912|FG001|Overall Study|Lost to Follow-up|1|||
130261381|NCT01959529|468923911|FG000|Overall Study|Other|70|||
130261382|NCT01959529|468923912|FG001|Overall Study|Other|68|||
130261383|NCT01959529|468923911|FG000|Overall Study|Hypoglycaemia|1|||
130261384|NCT01959529|468923912|FG001|Overall Study|Hypoglycaemia|1|||
130261385|NCT01959529|468923911|FG000|Overall Study|Lack of glycaemic control|1|||
130261386|NCT01959529|468923912|FG001|Overall Study|Lack of glycaemic control|1|||
130261387|NCT00399035|468923920|FG000|Overall Study|Death|289|||
130453139|NCT00946192|469621784|FG002|Overall Study|Withdrawal by Subject|3|||
130453140|NCT00946192|469621782|FG000|Overall Study|Did not start medication|2|||
130453141|NCT00946192|469621783|FG001|Overall Study|Did not start medication|0|||
130261388|NCT00399035|468923921|FG001|Overall Study|Death|141|||
130261389|NCT00399035|468923922|FG002|Overall Study|Death|234|||
130261390|NCT00399035|468923920|FG000|Overall Study|Lost to Follow-up|2|||
130261391|NCT00399035|468923921|FG001|Overall Study|Lost to Follow-up|1|||
130261392|NCT00399035|468923922|FG002|Overall Study|Lost to Follow-up|5|||
130261393|NCT00399035|468923920|FG000|Overall Study|Withdrawal by Subject|19|||
130261394|NCT00399035|468923921|FG001|Overall Study|Withdrawal by Subject|15|||
130261395|NCT00399035|468923922|FG002|Overall Study|Withdrawal by Subject|12|||
130261396|NCT00399035|468923920|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130261397|NCT00399035|468923921|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
130261398|NCT00399035|468923922|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130261399|NCT00399035|468923920|FG000|Overall Study|Severe non-compliance with protocol|2|||
130261400|NCT00399035|468923921|FG001|Overall Study|Severe non-compliance with protocol|1|||
130261401|NCT00399035|468923922|FG002|Overall Study|Severe non-compliance with protocol|0|||
130261402|NCT00854360|468923923|FG000|Overall Study|Adverse Event|0|||
130261403|NCT00854360|468923924|FG001|Overall Study|Adverse Event|1|||
130261404|NCT00854360|468923925|FG002|Overall Study|Adverse Event|2|||
130261405|NCT00854360|468923926|FG003|Overall Study|Adverse Event|6|||
130261406|NCT00854360|468923923|FG000|Overall Study|Withdrawal by Subject|0|||
130261407|NCT00854360|468923924|FG001|Overall Study|Withdrawal by Subject|0|||
130261408|NCT00854360|468923925|FG002|Overall Study|Withdrawal by Subject|0|||
130261409|NCT00854360|468923926|FG003|Overall Study|Withdrawal by Subject|1|||
130261410|NCT00854360|468923923|FG000|Overall Study|Pregnancy|0|||
130261411|NCT00854360|468923924|FG001|Overall Study|Pregnancy|1|||
130261412|NCT00854360|468923925|FG002|Overall Study|Pregnancy|0|||
130261413|NCT00854360|468923926|FG003|Overall Study|Pregnancy|0|||
130261414|NCT00854360|468923923|FG000|Overall Study|Lack of Efficacy|2|||
130261415|NCT00854360|468923924|FG001|Overall Study|Lack of Efficacy|1|||
130261416|NCT00854360|468923925|FG002|Overall Study|Lack of Efficacy|0|||
130261417|NCT00854360|468923926|FG003|Overall Study|Lack of Efficacy|0|||
130261418|NCT00854360|468923923|FG000|Overall Study|Other|0|||
130261419|NCT00854360|468923924|FG001|Overall Study|Other|0|||
130261420|NCT00854360|468923925|FG002|Overall Study|Other|0|||
130261421|NCT00854360|468923926|FG003|Overall Study|Other|3|||
130453142|NCT00946192|469621784|FG002|Overall Study|Did not start medication|0|||
130453143|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
130453144|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
130453145|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
130453146|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
130453147|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
130453148|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
130453149|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
130703556|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
130261422|NCT01128569|468923930|FG000|Washout Period 1|Adverse Event|0|||
130261423|NCT01128569|468923931|FG001|Washout Period 1|Adverse Event|0|||
130261424|NCT01128569|468923932|FG002|Washout Period 1|Adverse Event|1|||
130261425|NCT01128569|468923933|FG003|Washout Period 1|Adverse Event|0|||
130261426|NCT01128569|468923934|FG004|Washout Period 1|Adverse Event|0|||
130261427|NCT01128569|468923935|FG005|Washout Period 1|Adverse Event|0|||
130261428|NCT01128569|468923930|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130261429|NCT01128569|468923931|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130261430|NCT01128569|468923932|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130261431|NCT01128569|468923933|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130261432|NCT01128569|468923934|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130261433|NCT01128569|468923935|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130261434|NCT02493764|468923939|FG000|Overall Study|Adverse Event|2|||
130261435|NCT02493764|468923940|FG001|Overall Study|Adverse Event|2|||
130261436|NCT02493764|468923939|FG000|Overall Study|Death|44|||
130261437|NCT02493764|468923940|FG001|Overall Study|Death|58|||
130261438|NCT02493764|468923939|FG000|Overall Study|Lost to Follow-up|2|||
130261439|NCT02493764|468923940|FG001|Overall Study|Lost to Follow-up|1|||
130261440|NCT02493764|468923939|FG000|Overall Study|Protocol Violation|6|||
130261441|NCT02493764|468923940|FG001|Overall Study|Protocol Violation|7|||
130261442|NCT02493764|468923939|FG000|Overall Study|Physician Decision|1|||
130261443|NCT02493764|468923940|FG001|Overall Study|Physician Decision|1|||
130365507|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Other|0|||
130365508|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Other|0|||
130365509|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Other|0|||
130365510|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
130365511|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
130365512|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
130365513|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
130365514|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
130365515|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
130261444|NCT02493764|468923939|FG000|Overall Study|Participant moved|17|||
130261445|NCT02493764|468923940|FG001|Overall Study|Participant moved|5|||
130261446|NCT02493764|468923939|FG000|Overall Study|Withdrawal parent/guardian|0|||
130261447|NCT02493764|468923940|FG001|Overall Study|Withdrawal parent/guardian|1|||
130261448|NCT02493764|468923939|FG000|Overall Study|Withdrawal by Subject|11|||
130261449|NCT02493764|468923940|FG001|Overall Study|Withdrawal by Subject|7|||
130261450|NCT01561976|468923943|FG000|Period 1|Adverse Event|0|||
130261451|NCT01561976|468923944|FG001|Period 1|Adverse Event|0|||
130261452|NCT01561976|468923945|FG002|Period 1|Adverse Event|1|||
130261453|NCT01561976|468923946|FG003|Period 1|Adverse Event|0|||
130261454|NCT01561976|468923947|FG004|Period 1|Adverse Event|0|||
130261455|NCT01561976|468923948|FG005|Period 1|Adverse Event|0|||
130261456|NCT01561976|468923943|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130261457|NCT01561976|468923944|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130261458|NCT01561976|468923945|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130261459|NCT01561976|468923946|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130261460|NCT01561976|468923947|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130261461|NCT01561976|468923948|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130261462|NCT01561976|468923943|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261463|NCT01561976|468923944|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261464|NCT01561976|468923945|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261465|NCT01561976|468923946|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130453150|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
130453151|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Death|1|||
130453152|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Death|0|||
130453153|NCT01080131|469621785|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
130453154|NCT01080131|469621786|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
130453155|NCT01080131|469621785|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
130453156|NCT01080131|469621786|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
130453157|NCT01080131|469621785|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
130453158|NCT01080131|469621786|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
130453159|NCT01080131|469621785|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
130453160|NCT01080131|469621786|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
130453161|NCT01080131|469621785|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
130453162|NCT01080131|469621786|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
130453163|NCT01080131|469621785|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
130453164|NCT01080131|469621786|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
130453165|NCT01080131|469621785|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
130453166|NCT01080131|469621786|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
130453167|NCT01080131|469621785|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
130453168|NCT01080131|469621786|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
130453169|NCT04155424|469621787|FG000|Overall Study|Other than specified|3|||
130453170|NCT04155424|469621787|FG000|Overall Study|Withdrawal by Subject|1|||
130453171|NCT04155424|469621787|FG000|Overall Study|Adverse Event|1|||
130453172|NCT04159506|469621788|FG000|Overall Study|Lost to Follow-up|2|||
130453173|NCT04159506|469621789|FG001|Overall Study|Lost to Follow-up|5|||
130453174|NCT01456780|469623477|FG000|Overall Study|Lost to Follow-up|3|||
130453175|NCT01456780|469623478|FG001|Overall Study|Lost to Follow-up|3|||
130453176|NCT01456780|469623479|FG002|Overall Study|Lost to Follow-up|0|||
130453177|NCT00315055|469623480|FG000|Overall Study|Protocol Violation|2|||
130453178|NCT00315055|469623481|FG001|Overall Study|Protocol Violation|4|||
130453179|NCT00315055|469623480|FG000|Overall Study|Lost to Follow-up|1|||
130453180|NCT00315055|469623481|FG001|Overall Study|Lost to Follow-up|1|||
130453181|NCT01168401|469623482|FG000|Overall Study|Lost to Follow-up|1|||
130453182|NCT01168401|469623483|FG001|Overall Study|Lost to Follow-up|1|||
130453183|NCT01168401|469623484|FG002|Overall Study|Lost to Follow-up|2|||
130453184|NCT01168401|469623485|FG003|Overall Study|Lost to Follow-up|1|||
130453185|NCT01168401|469623486|FG004|Overall Study|Lost to Follow-up|0|||
130453186|NCT01168401|469623487|FG005|Overall Study|Lost to Follow-up|0|||
130453187|NCT01168401|469623488|FG006|Overall Study|Lost to Follow-up|0|||
130453188|NCT01168401|469623489|FG007|Overall Study|Lost to Follow-up|0|||
130453189|NCT01168401|469623490|FG008|Overall Study|Lost to Follow-up|0|||
130453190|NCT01168401|469623491|FG009|Overall Study|Lost to Follow-up|0|||
130553955|NCT00568321|469996466|FG000|Overall Study|Lost to Follow-up|0|||
130261466|NCT01561976|468923947|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130453191|NCT01168401|469623492|FG010|Overall Study|Lost to Follow-up|0|||
130453192|NCT01168401|469623482|FG000|Overall Study|Withdrawal by Subject|0|||
130453193|NCT01168401|469623483|FG001|Overall Study|Withdrawal by Subject|0|||
130553956|NCT00568321|469996467|FG001|Overall Study|Lost to Follow-up|0|||
130553957|NCT00568321|469996468|FG002|Overall Study|Lost to Follow-up|1|||
130453194|NCT01168401|469623484|FG002|Overall Study|Withdrawal by Subject|0|||
130453195|NCT01168401|469623485|FG003|Overall Study|Withdrawal by Subject|1|||
130453196|NCT01168401|469623486|FG004|Overall Study|Withdrawal by Subject|0|||
130261467|NCT01561976|468923948|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130261468|NCT01561976|468923943|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
130261469|NCT01561976|468923944|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
130261470|NCT01561976|468923945|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
130261471|NCT01561976|468923946|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
130261472|NCT01561976|468923947|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
130261473|NCT01561976|468923948|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
130261474|NCT04403919|468923949|FG000|Overall Study|Lost to Follow-up|0|||
130261475|NCT04403919|468923950|FG001|Overall Study|Lost to Follow-up|0|||
130261476|NCT04403919|468923951|FG002|Overall Study|Lost to Follow-up|0|||
130261477|NCT04403919|468923952|FG003|Overall Study|Lost to Follow-up|1|||
130261478|NCT01156844|468923953|FG000|Overall Study|Adverse Event|0|||
130261479|NCT01156844|468923954|FG001|Overall Study|Adverse Event|0|||
130261480|NCT01156844|468923955|FG002|Overall Study|Adverse Event|1|||
130261481|NCT01156844|468923956|FG003|Overall Study|Adverse Event|1|||
130261482|NCT01156844|468923953|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130261483|NCT01156844|468923954|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130261484|NCT01156844|468923955|FG002|Overall Study|Abnormal test procedure result(s)|2|||
130703557|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
130703558|NCT01933919|470539623|FG000|Open-label Long-term Phase|Adverse Event|2|||
130703559|NCT01933919|470539624|FG001|Open-label Long-term Phase|Adverse Event|0|||
130703560|NCT01933919|470539623|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
130261485|NCT01156844|468923956|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130261486|NCT01156844|468923953|FG000|Overall Study|Withdrawal by Subject|0|||
130261487|NCT01156844|468923954|FG001|Overall Study|Withdrawal by Subject|0|||
130261488|NCT01156844|468923955|FG002|Overall Study|Withdrawal by Subject|2|||
130261489|NCT01156844|468923956|FG003|Overall Study|Withdrawal by Subject|2|||
130261490|NCT01156844|468923953|FG000|Overall Study|Lost to Follow-up|0|||
130261491|NCT01156844|468923954|FG001|Overall Study|Lost to Follow-up|0|||
130261492|NCT01156844|468923955|FG002|Overall Study|Lost to Follow-up|1|||
130261493|NCT01156844|468923956|FG003|Overall Study|Lost to Follow-up|0|||
130261494|NCT01156844|468923953|FG000|Overall Study|Administrative problems|0|||
130703561|NCT01933919|470539624|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
130703562|NCT01933919|470539623|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
130703563|NCT01933919|470539624|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
130703564|NCT01933919|470539623|FG000|Open-label Long-term Phase|Other|1|||
130703565|NCT01933919|470539624|FG001|Open-label Long-term Phase|Other|2|||
130703566|NCT02510261|470539631|FG000|Overall Study|Adverse Event|5|||
130261495|NCT01156844|468923954|FG001|Overall Study|Administrative problems|1|||
130261496|NCT01156844|468923955|FG002|Overall Study|Administrative problems|0|||
130703567|NCT02510261|470539632|FG001|Overall Study|Adverse Event|8|||
130703568|NCT02510261|470539633|FG002|Overall Study|Adverse Event|0|||
130703569|NCT02510261|470539631|FG000|Overall Study|Physician Decision|1|||
130703570|NCT02510261|470539632|FG001|Overall Study|Physician Decision|5|||
130703571|NCT02510261|470539633|FG002|Overall Study|Physician Decision|0|||
130703572|NCT02510261|470539631|FG000|Overall Study|Death|19|||
130703573|NCT02510261|470539632|FG001|Overall Study|Death|19|||
130703574|NCT02510261|470539633|FG002|Overall Study|Death|0|||
130703575|NCT02510261|470539631|FG000|Overall Study|Withdrawal by Subject|3|||
130703576|NCT02510261|470539632|FG001|Overall Study|Withdrawal by Subject|10|||
130703577|NCT02510261|470539633|FG002|Overall Study|Withdrawal by Subject|3|||
130703578|NCT01064531|470539635|FG000|Overall Study|Lost to Follow-up|0|||
130703579|NCT01064531|470539636|FG001|Overall Study|Lost to Follow-up|2|||
130703580|NCT01064531|470539635|FG000|Overall Study|Physician Decision|0|||
130703581|NCT01064531|470539636|FG001|Overall Study|Physician Decision|1|||
130703582|NCT01064531|470539635|FG000|Overall Study|Withdrawal by Subject|2|||
130703583|NCT01064531|470539636|FG001|Overall Study|Withdrawal by Subject|2|||
130703584|NCT01064531|470539635|FG000|Overall Study|Revision due to femoral stem loosening|1|||
130703585|NCT01064531|470539636|FG001|Overall Study|Revision due to femoral stem loosening|0|||
130703586|NCT01064531|470539635|FG000|Overall Study|Revision due to dislocation|0|||
130703587|NCT01064531|470539636|FG001|Overall Study|Revision due to dislocation|1|||
130703588|NCT01064531|470539635|FG000|Overall Study|Death|0|||
130261497|NCT01156844|468923956|FG003|Overall Study|Administrative problems|1|||
130261498|NCT01156844|468923953|FG000|Overall Study|Protocol deviation|2|||
130703589|NCT01064531|470539636|FG001|Overall Study|Death|1|||
130703590|NCT03449199|470539637|FG000|Overall Study|Lost to Follow-up|1|||
130703591|NCT03449199|470539638|FG001|Overall Study|Lost to Follow-up|1|||
130703592|NCT03449199|470539639|FG002|Overall Study|Lost to Follow-up|0|||
130703593|NCT03449199|470539637|FG000|Overall Study|Protocol Deviation|0|||
130703594|NCT03449199|470539638|FG001|Overall Study|Protocol Deviation|0|||
130703595|NCT03449199|470539639|FG002|Overall Study|Protocol Deviation|1|||
130261499|NCT01156844|468923954|FG001|Overall Study|Protocol deviation|0|||
130261500|NCT01156844|468923955|FG002|Overall Study|Protocol deviation|0|||
130261501|NCT01156844|468923956|FG003|Overall Study|Protocol deviation|0|||
130703596|NCT03449199|470539637|FG000|Overall Study|Withdrawal by Subject|0|||
130703597|NCT03449199|470539638|FG001|Overall Study|Withdrawal by Subject|0|||
130703598|NCT03449199|470539639|FG002|Overall Study|Withdrawal by Subject|1|||
130261502|NCT04846231|468923959|FG000|Overall Study|Lost to Follow-up|1|||
130261503|NCT04846231|468923960|FG001|Overall Study|Lost to Follow-up|0|||
130261504|NCT04846231|468923961|FG002|Overall Study|Lost to Follow-up|0|||
130261505|NCT04846231|468923962|FG003|Overall Study|Lost to Follow-up|0|||
130261506|NCT04846231|468923963|FG004|Overall Study|Lost to Follow-up|0|||
130261507|NCT04846231|468923964|FG005|Overall Study|Lost to Follow-up|0|||
130261508|NCT04846231|468923965|FG006|Overall Study|Lost to Follow-up|0|||
130261509|NCT04846231|468923966|FG007|Overall Study|Lost to Follow-up|1|||
130261510|NCT04846231|468923959|FG000|Overall Study|Withdrawal by Subject|0|||
130261511|NCT04846231|468923960|FG001|Overall Study|Withdrawal by Subject|1|||
130261512|NCT04846231|468923961|FG002|Overall Study|Withdrawal by Subject|2|||
130261513|NCT04846231|468923962|FG003|Overall Study|Withdrawal by Subject|1|||
130261514|NCT04846231|468923963|FG004|Overall Study|Withdrawal by Subject|0|||
130261515|NCT04846231|468923964|FG005|Overall Study|Withdrawal by Subject|0|||
130261516|NCT04846231|468923965|FG006|Overall Study|Withdrawal by Subject|0|||
130261517|NCT04846231|468923966|FG007|Overall Study|Withdrawal by Subject|0|||
130261518|NCT04846231|468923959|FG000|Overall Study|Protocol Violation|0|||
130261519|NCT04846231|468923960|FG001|Overall Study|Protocol Violation|1|||
130261520|NCT04846231|468923961|FG002|Overall Study|Protocol Violation|0|||
130261521|NCT04846231|468923962|FG003|Overall Study|Protocol Violation|0|||
130261522|NCT04846231|468923963|FG004|Overall Study|Protocol Violation|0|||
130261523|NCT04846231|468923964|FG005|Overall Study|Protocol Violation|0|||
130261524|NCT04846231|468923965|FG006|Overall Study|Protocol Violation|0|||
130261525|NCT04846231|468923966|FG007|Overall Study|Protocol Violation|0|||
130261526|NCT04846231|468923959|FG000|Overall Study|Adverse Event|0|||
130261527|NCT04846231|468923960|FG001|Overall Study|Adverse Event|0|||
130261528|NCT04846231|468923961|FG002|Overall Study|Adverse Event|0|||
130261529|NCT04846231|468923962|FG003|Overall Study|Adverse Event|0|||
130261530|NCT04846231|468923963|FG004|Overall Study|Adverse Event|0|||
130261531|NCT04846231|468923964|FG005|Overall Study|Adverse Event|0|||
130261532|NCT04846231|468923965|FG006|Overall Study|Adverse Event|1|||
130261533|NCT04846231|468923966|FG007|Overall Study|Adverse Event|1|||
130261534|NCT01448616|468923967|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
130261535|NCT01448616|468923968|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261536|NCT01448616|468923969|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261537|NCT01448616|468923970|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261538|NCT01448616|468923967|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
130261539|NCT01448616|468923968|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261540|NCT01448616|468923969|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261541|NCT01448616|468923970|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261542|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
130261543|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
130261544|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
130261545|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
130261546|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130261547|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130261548|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
130261549|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
130261550|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
130261551|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
130261552|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130261553|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130261554|NCT02170064|468923971|FG000|Overall Study|Withdrawal by Subject|5|||
130261555|NCT02170064|468923972|FG001|Overall Study|Withdrawal by Subject|1|||
130261556|NCT02170064|468923973|FG002|Overall Study|Withdrawal by Subject|1|||
130261557|NCT02170064|468923971|FG000|Overall Study|Physician Decision|1|||
130261558|NCT02170064|468923972|FG001|Overall Study|Physician Decision|1|||
130261559|NCT02170064|468923973|FG002|Overall Study|Physician Decision|0|||
130261560|NCT03323164|468923974|FG000|Overall Study|Poor quality imaging/scans|2|||
130261561|NCT03323164|468923975|FG001|Overall Study|Poor quality imaging/scans|2|||
130261562|NCT00654732|468923976|FG000|Overall Study|Adverse Event|4|||
130261563|NCT00654732|468923977|FG001|Overall Study|Adverse Event|6|||
130261564|NCT01959932|468923978|FG000|Overall Study|Withdrawal by Subject|1|||
130261565|NCT01959932|468923979|FG001|Overall Study|Withdrawal by Subject|0|||
130261566|NCT01959932|468923980|FG002|Overall Study|Withdrawal by Subject|0|||
130261567|NCT00397540|468923981|FG000|Overall Study|short follow-up duration < 12 months|1|||
130261568|NCT00397540|468923982|FG001|Overall Study|short follow-up duration < 12 months|0|||
130261569|NCT00776230|468923985|FG000|Overall Study|Lost to Follow-up|2|||
130261570|NCT00776230|468923986|FG001|Overall Study|Lost to Follow-up|1|||
130703599|NCT02618382|470539641|FG000|Overall Study|Physician Decision|1|||
130261571|NCT00776230|468923987|FG002|Overall Study|Lost to Follow-up|5|||
130261572|NCT00776230|468923985|FG000|Overall Study|Not vaccinated at Day 0|1|||
130261573|NCT00776230|468923986|FG001|Overall Study|Not vaccinated at Day 0|0|||
130261574|NCT00776230|468923987|FG002|Overall Study|Not vaccinated at Day 0|0|||
130261575|NCT00776230|468923985|FG000|Overall Study|Withdrawal by Subject|0|||
130261576|NCT00776230|468923986|FG001|Overall Study|Withdrawal by Subject|1|||
130261577|NCT00776230|468923987|FG002|Overall Study|Withdrawal by Subject|0|||
130261578|NCT00776230|468923985|FG000|Overall Study|Subject missed Visit 4|0|||
130261579|NCT00776230|468923986|FG001|Overall Study|Subject missed Visit 4|1|||
130703600|NCT02618382|470539641|FG000|Overall Study|Withdrawal by Subject|1|||
130261580|NCT00776230|468923987|FG002|Overall Study|Subject missed Visit 4|0|||
130261581|NCT00746811|468923988|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
130261582|NCT00746811|468923989|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
130261583|NCT02993263|468924001|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
130261584|NCT00545779|468924002|FG000|Overall Study|Violation of selection criteria at entry|8|||
130261585|NCT00545779|468924002|FG000|Overall Study|Other protocol violation|1|||
130261586|NCT00545779|468924002|FG000|Overall Study|Did not cooperate|7|||
130261587|NCT00545779|468924002|FG000|Overall Study|Withdrawal by Subject|20|||
130261588|NCT00545779|468924002|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
130261589|NCT00545779|468924002|FG000|Overall Study|Failure to return|3|||
130261590|NCT01405196|468924003|FG000|Overall Study|Study Terminated by Sponsor|0|||
130261591|NCT01405196|468924004|FG001|Overall Study|Study Terminated by Sponsor|0|||
130261592|NCT01405196|468924005|FG002|Overall Study|Study Terminated by Sponsor|9|||
130261593|NCT01405196|468924006|FG003|Overall Study|Study Terminated by Sponsor|0|||
130261594|NCT01405196|468924003|FG000|Overall Study|Other|2|||
130261595|NCT01405196|468924004|FG001|Overall Study|Other|2|||
130261596|NCT01405196|468924005|FG002|Overall Study|Other|5|||
130261597|NCT01405196|468924006|FG003|Overall Study|Other|0|||
130261598|NCT01405196|468924003|FG000|Overall Study|Withdrawal by Subject|4|||
130261599|NCT01405196|468924004|FG001|Overall Study|Withdrawal by Subject|6|||
130261600|NCT01405196|468924005|FG002|Overall Study|Withdrawal by Subject|3|||
130261601|NCT01405196|468924006|FG003|Overall Study|Withdrawal by Subject|6|||
130261602|NCT01405196|468924003|FG000|Overall Study|Adverse Event|2|||
130261603|NCT01405196|468924004|FG001|Overall Study|Adverse Event|2|||
130261604|NCT01405196|468924005|FG002|Overall Study|Adverse Event|0|||
130261605|NCT01405196|468924006|FG003|Overall Study|Adverse Event|2|||
130261606|NCT01405196|468924003|FG000|Overall Study|Death|1|||
130261607|NCT01405196|468924004|FG001|Overall Study|Death|0|||
130261608|NCT01405196|468924005|FG002|Overall Study|Death|3|||
130261609|NCT01405196|468924006|FG003|Overall Study|Death|0|||
130261610|NCT01405196|468924003|FG000|Overall Study|Lost to Follow-up|2|||
130261611|NCT01405196|468924004|FG001|Overall Study|Lost to Follow-up|2|||
130261612|NCT01405196|468924005|FG002|Overall Study|Lost to Follow-up|3|||
130261613|NCT01405196|468924006|FG003|Overall Study|Lost to Follow-up|1|||
130261614|NCT01729039|468924009|FG000|Overall Study|disqualified|2|||
130261615|NCT01729039|468924010|FG001|Overall Study|disqualified|5|||
130261616|NCT01729039|468924009|FG000|Overall Study|Withdrawal by Subject|8|||
130261617|NCT01729039|468924010|FG001|Overall Study|Withdrawal by Subject|7|||
130261618|NCT00698841|468924011|FG000|Overall Study|Withdrawal by Subject|2|||
130261619|NCT00698841|468924011|FG000|Overall Study|Adverse Event|3|||
130261620|NCT00698841|468924011|FG000|Overall Study|Disease progression|7|||
130261621|NCT00698841|468924011|FG000|Overall Study|Failure to meet eligibility criteria|2|||
130261622|NCT00698841|468924011|FG000|Overall Study|Study drug toxicity|2|||
130261623|NCT00698841|468924011|FG000|Overall Study|Other|2|||
130261624|NCT02611037|468924012|FG000|Overall Study|Withdrawal prior to treatment|2|||
130261625|NCT02611037|468924013|FG001|Overall Study|Withdrawal prior to treatment|0|||
130261626|NCT00829998|468924014|FG000|Washout|Adverse Event|0|||
130261627|NCT00829998|468924015|FG001|Washout|Adverse Event|1|||
130261628|NCT05788991|468924018|FG000|Overall Study|Not treated with study medication|1|||
130261629|NCT05788991|468924019|FG001|Overall Study|Not treated with study medication|3|||
130261630|NCT05788991|468924018|FG000|Overall Study|Withdrawal by Subject|1|||
130261631|NCT05788991|468924019|FG001|Overall Study|Withdrawal by Subject|0|||
130261632|NCT05788991|468924018|FG000|Overall Study|Lack of Efficacy|0|||
130261633|NCT05788991|468924019|FG001|Overall Study|Lack of Efficacy|1|||
130261634|NCT05788991|468924018|FG000|Overall Study|Protocol Violation|1|||
130261635|NCT05788991|468924019|FG001|Overall Study|Protocol Violation|2|||
130261636|NCT05270863|468924020|FG000|Visit 2 First Intervention|Randomization error|0|||
130261637|NCT05270863|468924021|FG001|Visit 2 First Intervention|Randomization error|0|||
130261638|NCT05270863|468924022|FG002|Visit 2 First Intervention|Randomization error|0|||
130261639|NCT05270863|468924023|FG003|Visit 2 First Intervention|Randomization error|1|||
130261640|NCT05270863|468924024|FG004|Visit 2 First Intervention|Randomization error|0|||
130261641|NCT05270863|468924025|FG005|Visit 2 First Intervention|Randomization error|0|||
130261642|NCT05270863|468924020|FG000|First Washout|Withdrawal by Subject|0|||
130261643|NCT05270863|468924021|FG001|First Washout|Withdrawal by Subject|0|||
130261644|NCT05270863|468924022|FG002|First Washout|Withdrawal by Subject|0|||
130453197|NCT01168401|469623487|FG005|Overall Study|Withdrawal by Subject|0|||
130453198|NCT01168401|469623488|FG006|Overall Study|Withdrawal by Subject|0|||
130261645|NCT05270863|468924023|FG003|First Washout|Withdrawal by Subject|0|||
130261646|NCT05270863|468924024|FG004|First Washout|Withdrawal by Subject|1|||
130261647|NCT05270863|468924025|FG005|First Washout|Withdrawal by Subject|1|||
130261648|NCT05270863|468924020|FG000|First Washout|Lost to Follow-up|0|||
130261649|NCT05270863|468924021|FG001|First Washout|Lost to Follow-up|0|||
130261650|NCT05270863|468924022|FG002|First Washout|Lost to Follow-up|0|||
130261651|NCT05270863|468924023|FG003|First Washout|Lost to Follow-up|0|||
130261652|NCT05270863|468924024|FG004|First Washout|Lost to Follow-up|0|||
130261653|NCT05270863|468924025|FG005|First Washout|Lost to Follow-up|1|||
130261654|NCT05270863|468924020|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
130261655|NCT05270863|468924021|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261656|NCT05270863|468924022|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
130261657|NCT05270863|468924023|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261658|NCT05270863|468924024|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261659|NCT05270863|468924025|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261660|NCT05270863|468924020|FG000|Second Washout|Withdrawal by Subject|1|||
130261661|NCT05270863|468924021|FG001|Second Washout|Withdrawal by Subject|1|||
130261662|NCT05270863|468924022|FG002|Second Washout|Withdrawal by Subject|0|||
130261663|NCT05270863|468924023|FG003|Second Washout|Withdrawal by Subject|0|||
130261664|NCT05270863|468924024|FG004|Second Washout|Withdrawal by Subject|0|||
130261665|NCT05270863|468924025|FG005|Second Washout|Withdrawal by Subject|0|||
130261666|NCT05270863|468924020|FG000|Second Washout|Lost to Follow-up|0|||
130261667|NCT05270863|468924021|FG001|Second Washout|Lost to Follow-up|0|||
130261668|NCT05270863|468924022|FG002|Second Washout|Lost to Follow-up|0|||
130261669|NCT05270863|468924023|FG003|Second Washout|Lost to Follow-up|1|||
130261670|NCT05270863|468924024|FG004|Second Washout|Lost to Follow-up|0|||
130261671|NCT05270863|468924025|FG005|Second Washout|Lost to Follow-up|0|||
130261672|NCT04464473|468924026|FG000|Overall Study|New piercing could not be removed for scanning|0|||
130261673|NCT04464473|468924027|FG001|Overall Study|New piercing could not be removed for scanning|0|||
130261674|NCT04464473|468924028|FG002|Overall Study|New piercing could not be removed for scanning|0|||
130261675|NCT04464473|468924029|FG003|Overall Study|New piercing could not be removed for scanning|1|||
130261676|NCT04464473|468924030|FG004|Overall Study|New piercing could not be removed for scanning|0|||
130261677|NCT04464473|468924031|FG005|Overall Study|New piercing could not be removed for scanning|0|||
130261678|NCT04464473|468924026|FG000|Overall Study|Adverse Event|0|||
130261679|NCT04464473|468924027|FG001|Overall Study|Adverse Event|0|||
130261680|NCT04464473|468924028|FG002|Overall Study|Adverse Event|0|||
130261681|NCT04464473|468924029|FG003|Overall Study|Adverse Event|1|||
130261682|NCT04464473|468924030|FG004|Overall Study|Adverse Event|0|||
130261683|NCT04464473|468924031|FG005|Overall Study|Adverse Event|0|||
130261684|NCT04464473|468924026|FG000|Overall Study|Lost to Follow-up|0|||
130261685|NCT04464473|468924027|FG001|Overall Study|Lost to Follow-up|0|||
130261686|NCT04464473|468924028|FG002|Overall Study|Lost to Follow-up|0|||
130261687|NCT04464473|468924029|FG003|Overall Study|Lost to Follow-up|1|||
130261688|NCT04464473|468924030|FG004|Overall Study|Lost to Follow-up|0|||
130261689|NCT04464473|468924031|FG005|Overall Study|Lost to Follow-up|0|||
130261690|NCT02114177|468925702|FG000|Overall Study|Lost to Follow-up|1|||
130261691|NCT02114177|468925703|FG001|Overall Study|Lost to Follow-up|2|||
130261692|NCT02114177|468925702|FG000|Overall Study|Withdrawal by Subject|6|||
130261693|NCT02114177|468925703|FG001|Overall Study|Withdrawal by Subject|1|||
130261694|NCT02114177|468925702|FG000|Overall Study|Other|2|||
130261695|NCT02114177|468925703|FG001|Overall Study|Other|1|||
130261696|NCT01585025|468925704|FG000|Overall Study|Withdrawal by Subject|0|||
130261697|NCT01585025|468925705|FG001|Overall Study|Withdrawal by Subject|3|||
130261698|NCT01585025|468925706|FG002|Overall Study|Withdrawal by Subject|4|||
130261699|NCT00503984|468925707|FG000|Overall Study|Protocol Violation|0|||
130261700|NCT00503984|468925708|FG001|Overall Study|Protocol Violation|1|||
130261701|NCT00503984|468925709|FG002|Overall Study|Protocol Violation|0|||
130261702|NCT00503984|468925710|FG003|Overall Study|Protocol Violation|0|||
130261703|NCT00503984|468925711|FG004|Overall Study|Protocol Violation|0|||
130261704|NCT00503984|468925712|FG005|Overall Study|Protocol Violation|0|||
130261705|NCT00503984|468925707|FG000|Overall Study|Adverse Event|0|||
130261706|NCT00503984|468925708|FG001|Overall Study|Adverse Event|1|||
130261707|NCT00503984|468925709|FG002|Overall Study|Adverse Event|0|||
130261708|NCT00503984|468925710|FG003|Overall Study|Adverse Event|0|||
130261709|NCT00503984|468925711|FG004|Overall Study|Adverse Event|0|||
130261710|NCT00503984|468925712|FG005|Overall Study|Adverse Event|0|||
130261711|NCT00503984|468925707|FG000|Overall Study|Death|0|||
130261712|NCT00503984|468925708|FG001|Overall Study|Death|0|||
130261713|NCT00503984|468925709|FG002|Overall Study|Death|0|||
130553958|NCT00568321|469996466|FG000|Overall Study|Withdrawal by Subject|2|||
130261714|NCT00503984|468925710|FG003|Overall Study|Death|0|||
130261715|NCT00503984|468925711|FG004|Overall Study|Death|1|||
130261716|NCT00503984|468925712|FG005|Overall Study|Death|0|||
130261717|NCT01246960|468925713|FG000|Overall Study|Lost to Follow-up|3|||
130261718|NCT01246960|468925714|FG001|Overall Study|Lost to Follow-up|1|||
130261719|NCT01246960|468925713|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
130553959|NCT00568321|469996467|FG001|Overall Study|Withdrawal by Subject|0|||
130261720|NCT01246960|468925714|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
130261721|NCT00140140|468925721|FG000|Overall Study|Unacceptable toxicity|1|||
130261722|NCT00140140|468925722|FG001|Overall Study|Unacceptable toxicity|1|||
130261723|NCT00140140|468925723|FG002|Overall Study|Unacceptable toxicity|2|||
130261724|NCT00140140|468925721|FG000|Overall Study|Physician Decision|1|||
130261725|NCT00140140|468925722|FG001|Overall Study|Physician Decision|1|||
130261726|NCT00140140|468925723|FG002|Overall Study|Physician Decision|0|||
130261727|NCT03376516|468925724|FG000|Overall Study|Not treated|1|||
130261728|NCT03376516|468925724|FG000|Overall Study|Consent withdrawn|1|||
130261729|NCT01359956|468925725|FG000|Overall Study|Death|58|||
130261730|NCT01359956|468925726|FG001|Overall Study|Death|60|||
130261731|NCT01359956|468925727|FG002|Overall Study|Death|66|||
130261732|NCT01359956|468925728|FG003|Overall Study|Death|57|||
130261733|NCT01359956|468925725|FG000|Overall Study|Lost to Follow-up|3|||
130261734|NCT01359956|468925726|FG001|Overall Study|Lost to Follow-up|4|||
130261735|NCT01359956|468925727|FG002|Overall Study|Lost to Follow-up|1|||
130261736|NCT01359956|468925728|FG003|Overall Study|Lost to Follow-up|1|||
130261737|NCT00582907|468925729|FG000|1st Course|Withdrawal by Subject|1|||
130261738|NCT00582907|468925730|FG001|1st Course|Withdrawal by Subject|0|||
130261739|NCT00582907|468925731|FG002|1st Course|Withdrawal by Subject|0|||
130261740|NCT00582907|468925732|FG003|1st Course|Withdrawal by Subject|0|||
130261741|NCT00582907|468925729|FG000|1st Course|Lost to Follow-up|0|||
130261742|NCT00582907|468925730|FG001|1st Course|Lost to Follow-up|0|||
130261743|NCT00582907|468925731|FG002|1st Course|Lost to Follow-up|0|||
130261744|NCT00582907|468925732|FG003|1st Course|Lost to Follow-up|1|||
130261745|NCT00582907|468925729|FG000|2nd Course|Lack of Efficacy|1|||
130261746|NCT00582907|468925730|FG001|2nd Course|Lack of Efficacy|0|||
130261747|NCT00582907|468925731|FG002|2nd Course|Lack of Efficacy|0|||
130261748|NCT00582907|468925732|FG003|2nd Course|Lack of Efficacy|0|||
130261749|NCT00370292|468925733|FG000|Overall Study|Disease Progression|4|||
130261750|NCT00370292|468925733|FG000|Overall Study|Adverse Event|7|||
130261751|NCT00370292|468925733|FG000|Overall Study|Physician Decision|2|||
130261752|NCT02704208|468925734|FG000|Overall Study|Lost to Follow-up|42|||
130261753|NCT02704208|468925735|FG001|Overall Study|Lost to Follow-up|37|||
130261754|NCT03545672|468925736|FG000|Overall Study|Uncertain diagnosis|2|||
130261755|NCT03545672|468925737|FG001|Overall Study|Uncertain diagnosis|1|||
130261756|NCT03545672|468925736|FG000|Overall Study|Protocol Violation|2|||
130261757|NCT03545672|468925737|FG001|Overall Study|Protocol Violation|2|||
130261758|NCT00598650|468925738|FG000|Overall Study|Withdrawal by Subject|3|||
130261759|NCT00598650|468925738|FG000|Overall Study|Adverse Event|18|||
130261760|NCT00598650|468925738|FG000|Overall Study|No treatment for 3 weeks|1|||
130261761|NCT00598650|468925738|FG000|Overall Study|Not eligible|1|||
130261762|NCT00598650|468925738|FG000|Overall Study|Prohibited Concomitant Medication|2|||
130261763|NCT00598650|468925738|FG000|Overall Study|Physician Decision|2|||
130261764|NCT01628913|468925739|FG000|Overall Study|Adverse Event|12|||
130261765|NCT01628913|468925740|FG001|Overall Study|Adverse Event|5|||
130261766|NCT01628913|468925739|FG000|Overall Study|Disease Progression|11|||
130261767|NCT01628913|468925740|FG001|Overall Study|Disease Progression|14|||
130261768|NCT01628913|468925739|FG000|Overall Study|Protocol Violation|1|||
130261769|NCT01628913|468925740|FG001|Overall Study|Protocol Violation|0|||
130261770|NCT01628913|468925739|FG000|Overall Study|Death|1|||
130261771|NCT01628913|468925740|FG001|Overall Study|Death|0|||
130261772|NCT01628913|468925739|FG000|Overall Study|study terminated by Sponsor|4|||
130703601|NCT02618382|470539641|FG000|Overall Study|Protocol Violation|1|||
130703602|NCT03235479|470539644|FG000|Overall Study|Lost to Follow-up|8|||
130703603|NCT03235479|470539645|FG001|Overall Study|Lost to Follow-up|11|||
130703604|NCT03235479|470539644|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
130703605|NCT03235479|470539645|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
130703606|NCT03235479|470539644|FG000|Overall Study|Pregnancy|1|||
130703607|NCT03235479|470539645|FG001|Overall Study|Pregnancy|0|||
130703608|NCT03235479|470539644|FG000|Overall Study|Protocol Deviation|1|||
130703609|NCT03235479|470539645|FG001|Overall Study|Protocol Deviation|3|||
130703610|NCT03235479|470539644|FG000|Overall Study|Technical Problems|3|||
130703611|NCT03235479|470539645|FG001|Overall Study|Technical Problems|2|||
130703612|NCT03235479|470539644|FG000|Overall Study|Withdrawal by Subject|2|||
130703613|NCT03235479|470539645|FG001|Overall Study|Withdrawal by Subject|2|||
130703614|NCT03235479|470539644|FG000|Overall Study|Other Reasons|3|||
130703615|NCT03235479|470539645|FG001|Overall Study|Other Reasons|5|||
130703616|NCT00309985|470539648|FG000|Overall Study|Disease progression|12|||
130703617|NCT00309985|470539649|FG001|Overall Study|Disease progression|0|||
130703618|NCT00309985|470539648|FG000|Overall Study|Adverse Event|30|||
130703619|NCT00309985|470539649|FG001|Overall Study|Adverse Event|0|||
130703620|NCT00309985|470539648|FG000|Overall Study|Death|2|||
130703621|NCT00309985|470539649|FG001|Overall Study|Death|0|||
130703622|NCT00309985|470539648|FG000|Overall Study|Withdrawal by Subject|5|||
130703623|NCT00309985|470539649|FG001|Overall Study|Withdrawal by Subject|1|||
130703624|NCT00309985|470539648|FG000|Overall Study|Physician Decision|3|||
130703625|NCT00309985|470539649|FG001|Overall Study|Physician Decision|0|||
130703626|NCT00309985|470539648|FG000|Overall Study|Never started treatment|7|||
130261773|NCT01628913|468925740|FG001|Overall Study|study terminated by Sponsor|9|||
130261774|NCT01628913|468925739|FG000|Overall Study|Withdrawal by Subject|1|||
130261775|NCT01628913|468925740|FG001|Overall Study|Withdrawal by Subject|0|||
130261776|NCT01628913|468925739|FG000|Overall Study|Physician Decision|1|||
130261777|NCT01628913|468925740|FG001|Overall Study|Physician Decision|3|||
130703627|NCT00309985|470539649|FG001|Overall Study|Never started treatment|0|||
130703628|NCT00309985|470539648|FG000|Overall Study|Complicating disease|1|||
130261778|NCT02935192|468925742|FG000|Overall Study|Withdrawal by Subject|8|||
130261779|NCT02935192|468925743|FG001|Overall Study|Withdrawal by Subject|4|||
130703629|NCT00309985|470539649|FG001|Overall Study|Complicating disease|0|||
130261780|NCT00560508|468925744|FG000|12 Week Double-blind Period|Adverse Event|3|||
130261781|NCT00560508|468925745|FG001|12 Week Double-blind Period|Adverse Event|2|||
130261782|NCT00560508|468925744|FG000|12 Week Double-blind Period|Protocol Violation|1|||
130261783|NCT00560508|468925745|FG001|12 Week Double-blind Period|Protocol Violation|0|||
130261784|NCT00560508|468925744|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
130261785|NCT00560508|468925745|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
130261786|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130261787|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130261788|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130261789|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130261790|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
130261791|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
130703630|NCT00309985|470539648|FG000|Overall Study|Non-compliance|1|||
130703631|NCT00309985|470539649|FG001|Overall Study|Non-compliance|0|||
130703632|NCT00309985|470539648|FG000|Overall Study|Chemotherapy discontinued only|1|||
130703633|NCT00309985|470539649|FG001|Overall Study|Chemotherapy discontinued only|0|||
130703634|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
130703635|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
130703636|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130703637|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130703638|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130703639|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
130703640|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130703641|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130703642|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
130703643|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130261792|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130703644|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130703645|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130703646|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130703647|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
130703648|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130703649|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130703650|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Death|2|||
130703651|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Death|1|||
130703652|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Death|0|||
130703653|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Death|0|||
130703654|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130703655|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130703656|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130703657|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130703658|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130703659|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130703660|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130703661|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130703662|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703663|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
130703664|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703665|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703666|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130703667|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130703668|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
130703669|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
130703670|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130703671|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130703672|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130703673|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130703674|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703675|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703676|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703677|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
130703678|NCT01355302|470539665|FG000|Phase 1b|Death|4|||
130703679|NCT01355302|470539666|FG001|Phase 1b|Death|0|||
130703680|NCT01355302|470539667|FG002|Phase 1b|Death|0|||
130703681|NCT01355302|470539665|FG000|Phase 1b|Study terminated by sponsor|2|||
130703682|NCT01355302|470539666|FG001|Phase 1b|Study terminated by sponsor|0|||
130703683|NCT01355302|470539667|FG002|Phase 1b|Study terminated by sponsor|0|||
130703684|NCT00693225|470539668|FG000|Overall Study|Lost to Follow-up|1|||
130703685|NCT00693225|470539669|FG001|Overall Study|Lost to Follow-up|2|||
130703686|NCT00693225|470539668|FG000|Overall Study|Adverse Event|1|||
130703687|NCT00693225|470539669|FG001|Overall Study|Adverse Event|3|||
130703688|NCT02531594|470539670|FG000|Overall Study|Withdrawal by Subject|7|||
130703689|NCT02531594|470539671|FG001|Overall Study|Withdrawal by Subject|8|||
130703690|NCT03750695|470539674|FG000|Overall Study|Lost to Follow-up|0|||
130703691|NCT03750695|470539675|FG001|Overall Study|Lost to Follow-up|1|||
130703692|NCT03843125|470539676|FG000|Overall Study|Adverse Event|17|||
130703693|NCT03843125|470539677|FG001|Overall Study|Adverse Event|13|||
130703694|NCT03843125|470539678|FG002|Overall Study|Adverse Event|5|||
130703695|NCT03843125|470539679|FG003|Overall Study|Adverse Event|9|||
130703696|NCT03843125|470539676|FG000|Overall Study|Death|0|||
130703697|NCT03843125|470539677|FG001|Overall Study|Death|6|||
130703698|NCT03843125|470539678|FG002|Overall Study|Death|2|||
130703699|NCT03843125|470539679|FG003|Overall Study|Death|0|||
130703700|NCT03843125|470539676|FG000|Overall Study|Lack of Efficacy|14|||
130703701|NCT03843125|470539677|FG001|Overall Study|Lack of Efficacy|11|||
130703702|NCT03843125|470539678|FG002|Overall Study|Lack of Efficacy|9|||
130703703|NCT03843125|470539679|FG003|Overall Study|Lack of Efficacy|4|||
130703704|NCT03843125|470539676|FG000|Overall Study|Lost to Follow-up|3|||
130703705|NCT03843125|470539677|FG001|Overall Study|Lost to Follow-up|4|||
130703706|NCT03843125|470539678|FG002|Overall Study|Lost to Follow-up|0|||
130703707|NCT03843125|470539679|FG003|Overall Study|Lost to Follow-up|2|||
130261793|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130261794|NCT04102007|468925746|FG000|Overall Study|Adverse Event|4|||
130261795|NCT04102007|468925746|FG000|Overall Study|Lost to Follow-up|3|||
130261796|NCT04102007|468925746|FG000|Overall Study|Withdrawal by Subject|12|||
130261797|NCT04102007|468925746|FG000|Overall Study|Eligibility Violation|5|||
130261798|NCT04102007|468925746|FG000|Overall Study|Lack of Efficacy|6|||
130261799|NCT04102007|468925746|FG000|Overall Study|Protocol Deviation|5|||
130365516|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
130703708|NCT03843125|470539676|FG000|Overall Study|Other|12|||
130703709|NCT03843125|470539677|FG001|Overall Study|Other|14|||
130703710|NCT03843125|470539678|FG002|Overall Study|Other|3|||
130703711|NCT03843125|470539679|FG003|Overall Study|Other|4|||
130261800|NCT04102007|468925746|FG000|Overall Study|Protocol Compliance|1|||
130261801|NCT04102007|468925746|FG000|Overall Study|Withdrew Treatment|2|||
130261802|NCT04102007|468925746|FG000|Overall Study|Pregnancy|1|||
130261803|NCT00892008|468925752|FG000|Overall Study|Death|5|||
130261804|NCT00892008|468925752|FG000|Overall Study|Lack of Efficacy|3|||
130261805|NCT00892008|468925752|FG000|Overall Study|Lost to Follow-up|142|||
130261806|NCT00892008|468925752|FG000|Overall Study|Other|378|||
130261807|NCT00892008|468925752|FG000|Overall Study|Adverse Event|37|||
130261808|NCT03610048|468925755|FG000|Overall Study|Study terminated by sponsor|84|||
130261809|NCT03610048|468925755|FG000|Overall Study|Adverse Event|32|||
130261810|NCT03610048|468925755|FG000|Overall Study|Withdrawal by Subject|31|||
130703712|NCT03843125|470539676|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
130703713|NCT03843125|470539677|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
130703714|NCT03843125|470539678|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
130703715|NCT03843125|470539679|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
130261811|NCT03610048|468925755|FG000|Overall Study|Lost to Follow-up|8|||
130261812|NCT03610048|468925755|FG000|Overall Study|Other|4|||
130261813|NCT03610048|468925755|FG000|Overall Study|Physician Decision|1|||
130261814|NCT03610048|468925755|FG000|Overall Study|Pregnancy|1|||
130261815|NCT01155050|468925756|FG000|Overall Study|Lost to Follow-up|15|||
130261816|NCT01155050|468925757|FG001|Overall Study|Lost to Follow-up|20|||
130261817|NCT01155050|468925758|FG002|Overall Study|Lost to Follow-up|19|||
130261818|NCT01155050|468925759|FG003|Overall Study|Lost to Follow-up|22|||
130261819|NCT00652834|468925760|FG000|Overall Study|Withdrawal by Subject|3|||
130261820|NCT00652834|468925760|FG000|Overall Study|Lost to Follow-up|2|||
130261821|NCT00320606|468925761|FG000|Overall Study|Adverse Event|1|||
130261822|NCT00320606|468925761|FG000|Overall Study|Protocol Violation|1|||
130261823|NCT00320606|468925761|FG000|Overall Study|Withdrawal by Subject|1|||
130261824|NCT00806585|468925762|FG000|Overall Study|Study terminated by Sponsor|0|||
130261825|NCT00806585|468925763|FG001|Overall Study|Study terminated by Sponsor|0|||
130261826|NCT00806585|468925764|FG002|Overall Study|Study terminated by Sponsor|1|||
130261827|NCT00806585|468925765|FG003|Overall Study|Study terminated by Sponsor|2|||
130261828|NCT00806585|468925766|FG004|Overall Study|Study terminated by Sponsor|0|||
130261829|NCT00806585|468925762|FG000|Overall Study|Protocol Violation|3|||
130261830|NCT00806585|468925763|FG001|Overall Study|Protocol Violation|1|||
130261831|NCT00806585|468925764|FG002|Overall Study|Protocol Violation|2|||
130261832|NCT00806585|468925765|FG003|Overall Study|Protocol Violation|0|||
130261833|NCT00806585|468925766|FG004|Overall Study|Protocol Violation|0|||
130261834|NCT00806585|468925762|FG000|Overall Study|Physician Decision|0|||
130261835|NCT00806585|468925763|FG001|Overall Study|Physician Decision|2|||
130261836|NCT00806585|468925764|FG002|Overall Study|Physician Decision|3|||
130261837|NCT00806585|468925765|FG003|Overall Study|Physician Decision|0|||
130261838|NCT00806585|468925766|FG004|Overall Study|Physician Decision|1|||
130261839|NCT00806585|468925762|FG000|Overall Study|Lost to Follow-up|2|||
130261840|NCT00806585|468925763|FG001|Overall Study|Lost to Follow-up|1|||
130261841|NCT00806585|468925764|FG002|Overall Study|Lost to Follow-up|2|||
130703716|NCT03843125|470539676|FG000|Overall Study|Study Terminated by Sponsor|318|||
130703717|NCT03843125|470539677|FG001|Overall Study|Study Terminated by Sponsor|318|||
130261842|NCT00806585|468925765|FG003|Overall Study|Lost to Follow-up|2|||
130261843|NCT00806585|468925766|FG004|Overall Study|Lost to Follow-up|5|||
130261844|NCT00806585|468925762|FG000|Overall Study|Lack of Efficacy|1|||
130261845|NCT00806585|468925763|FG001|Overall Study|Lack of Efficacy|0|||
130261846|NCT00806585|468925764|FG002|Overall Study|Lack of Efficacy|0|||
130261847|NCT00806585|468925765|FG003|Overall Study|Lack of Efficacy|0|||
130261848|NCT00806585|468925766|FG004|Overall Study|Lack of Efficacy|0|||
130261849|NCT00806585|468925762|FG000|Overall Study|Adverse Event|1|||
130261850|NCT00806585|468925763|FG001|Overall Study|Adverse Event|5|||
130261851|NCT00806585|468925764|FG002|Overall Study|Adverse Event|3|||
130261852|NCT00806585|468925765|FG003|Overall Study|Adverse Event|4|||
130261853|NCT00806585|468925766|FG004|Overall Study|Adverse Event|2|||
130261854|NCT00806585|468925762|FG000|Overall Study|Withdrawal by Subject|10|||
130261855|NCT00806585|468925763|FG001|Overall Study|Withdrawal by Subject|8|||
130261856|NCT00806585|468925764|FG002|Overall Study|Withdrawal by Subject|9|||
130261857|NCT00806585|468925765|FG003|Overall Study|Withdrawal by Subject|3|||
130261858|NCT00806585|468925766|FG004|Overall Study|Withdrawal by Subject|11|||
130261859|NCT00806585|468925762|FG000|Overall Study|Completion status unknown|15|||
130261860|NCT00806585|468925763|FG001|Overall Study|Completion status unknown|14|||
130261861|NCT00806585|468925764|FG002|Overall Study|Completion status unknown|12|||
130261862|NCT00806585|468925765|FG003|Overall Study|Completion status unknown|4|||
130261863|NCT00806585|468925766|FG004|Overall Study|Completion status unknown|12|||
130261864|NCT00474903|468925767|FG000|Overall Study|Protocol Violation|1|||
130261865|NCT00474903|468925768|FG001|Overall Study|Protocol Violation|5|||
130261866|NCT00474903|468925769|FG002|Overall Study|Protocol Violation|2|||
130261867|NCT00399529|468925770|FG000|Overall Study|Off Study Prior to Treatment|2|||
130261868|NCT01936831|468925771|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261869|NCT01936831|468925772|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261870|NCT01936831|468925773|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130703718|NCT03843125|470539678|FG002|Overall Study|Study Terminated by Sponsor|163|||
130703719|NCT03843125|470539679|FG003|Overall Study|Study Terminated by Sponsor|163|||
130261871|NCT01936831|468925774|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261872|NCT01936831|468925775|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261873|NCT01936831|468925776|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
130261874|NCT01936831|468925777|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261875|NCT01936831|468925778|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261876|NCT01936831|468925779|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261877|NCT03435380|468925780|FG000|Overall Study|Death|1|||
130261878|NCT03435380|468925781|FG001|Overall Study|Death|2|||
130261879|NCT03435380|468925782|FG002|Overall Study|Death|1|||
130261880|NCT03435380|468925780|FG000|Overall Study|Lost to Follow-up|12|||
130261881|NCT03435380|468925781|FG001|Overall Study|Lost to Follow-up|8|||
130261882|NCT03435380|468925782|FG002|Overall Study|Lost to Follow-up|6|||
130261883|NCT03435380|468925780|FG000|Overall Study|Physician Decision|1|||
130261884|NCT03435380|468925781|FG001|Overall Study|Physician Decision|0|||
130261885|NCT03435380|468925782|FG002|Overall Study|Physician Decision|0|||
130261886|NCT03435380|468925780|FG000|Overall Study|Withdrawal by Subject|0|||
130261887|NCT03435380|468925781|FG001|Overall Study|Withdrawal by Subject|1|||
130261888|NCT03435380|468925782|FG002|Overall Study|Withdrawal by Subject|1|||
130261889|NCT03435380|468925780|FG000|Overall Study|Ineligible|0|||
130261890|NCT03435380|468925781|FG001|Overall Study|Ineligible|1|||
130261891|NCT03435380|468925782|FG002|Overall Study|Ineligible|1|||
130261892|NCT02133573|468925788|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
130261893|NCT02133573|468925789|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
130261894|NCT02133573|468925788|FG000|Overall Study|Child Deaths|3|||
130261895|NCT02133573|468925789|FG001|Overall Study|Child Deaths|5|||
130261896|NCT02133573|468925788|FG000|Overall Study|Child Declined Follow Ups|2|||
130261897|NCT02133573|468925789|FG001|Overall Study|Child Declined Follow Ups|1|||
130261898|NCT02133573|468925788|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
130261899|NCT02133573|468925789|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
130261900|NCT02519842|468925790|FG000|Base Study: Cycle 1|Screening Failure|1|||
130261901|NCT02519842|468925791|FG001|Base Study: Cycle 1|Screening Failure|1|||
130261902|NCT02519842|468925792|FG002|Base Study: Cycle 1|Screening Failure|0|||
130261903|NCT02519842|468925790|FG000|Base Study: Cycle 1|Adverse Event|1|||
130261904|NCT02519842|468925791|FG001|Base Study: Cycle 1|Adverse Event|0|||
130261905|NCT02519842|468925792|FG002|Base Study: Cycle 1|Adverse Event|0|||
130261906|NCT02519842|468925790|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130261907|NCT02519842|468925791|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
130261908|NCT02519842|468925792|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130261909|NCT02519842|468925790|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130261910|NCT02519842|468925791|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
130261911|NCT02519842|468925792|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130261912|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
130261913|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
130261914|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
130261915|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
130261916|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
130261917|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
130261918|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130703720|NCT03843125|470539676|FG000|Overall Study|Withdrawal by Subject|23|||
130703721|NCT03843125|470539677|FG001|Overall Study|Withdrawal by Subject|12|||
130703722|NCT03843125|470539678|FG002|Overall Study|Withdrawal by Subject|6|||
130703723|NCT03843125|470539679|FG003|Overall Study|Withdrawal by Subject|9|||
130703724|NCT03843125|470539676|FG000|Overall Study|Missing data|0|||
130703725|NCT03843125|470539677|FG001|Overall Study|Missing data|1|||
130703726|NCT03843125|470539678|FG002|Overall Study|Missing data|1|||
130703727|NCT03843125|470539679|FG003|Overall Study|Missing data|0|||
130703728|NCT03173560|470539680|FG000|Overall Study|Death|70|||
130703729|NCT03173560|470539681|FG001|Overall Study|Death|60|||
130703730|NCT03173560|470539680|FG000|Overall Study|Lost to Follow-up|1|||
130703731|NCT03173560|470539681|FG001|Overall Study|Lost to Follow-up|4|||
130703732|NCT03173560|470539680|FG000|Overall Study|Withdrawal by Subject|10|||
130703733|NCT03173560|470539681|FG001|Overall Study|Withdrawal by Subject|5|||
130703734|NCT03173560|470539680|FG000|Overall Study|Other|0|||
130703735|NCT03173560|470539681|FG001|Overall Study|Other|1|||
130703736|NCT04254809|470539683|FG000|Overall Study|Lost to Follow-up|5|||
130703737|NCT04254809|470539684|FG001|Overall Study|Lost to Follow-up|10|||
130703738|NCT04480307|470539685|FG000|Overall Study|Withdrawal by Subject|0|||
130703739|NCT04480307|470539686|FG001|Overall Study|Withdrawal by Subject|1|||
130703740|NCT04480307|470539687|FG002|Overall Study|Withdrawal by Subject|0|||
130703741|NCT04480307|470539688|FG003|Overall Study|Withdrawal by Subject|0|||
130703742|NCT04480307|470539685|FG000|Overall Study|Adverse Event|0|||
130703743|NCT04480307|470539686|FG001|Overall Study|Adverse Event|0|||
130703744|NCT04480307|470539687|FG002|Overall Study|Adverse Event|0|||
130261919|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130261920|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
130261921|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130261922|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130261923|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
130261924|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Death|0|||
130261925|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Death|0|||
130261926|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Death|1|||
130261927|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130261928|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130365517|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
130261929|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
130261930|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130261931|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130261932|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
130261933|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130261934|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130261935|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
130261936|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130261937|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130261938|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
130261939|NCT02115321|468925795|FG000|Overall Study|Death|1|||
130261940|NCT02115321|468925796|FG001|Overall Study|Death|0|||
130261941|NCT01307449|468925797|FG000|Overall Study|Adverse Event|1|||
130261942|NCT01307449|468925798|FG001|Overall Study|Adverse Event|0|||
130261943|NCT01307449|468925799|FG002|Overall Study|Adverse Event|0|||
130261944|NCT01307449|468925800|FG003|Overall Study|Adverse Event|0|||
130261945|NCT03218917|468925801|FG000|Overall Study|Adverse Event|3|||
130261946|NCT03218917|468925802|FG001|Overall Study|Adverse Event|3|||
130261947|NCT03218917|468925803|FG002|Overall Study|Adverse Event|2|||
130365518|NCT01090492|469306903|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
130365519|NCT01090492|469306904|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
130365520|NCT01090492|469306905|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
130703745|NCT04480307|470539688|FG003|Overall Study|Adverse Event|1|||
130703746|NCT02608476|470539689|FG000|Overall Study|Withdrawal by Subject|30|||
130703747|NCT02608476|470539690|FG001|Overall Study|Withdrawal by Subject|37|||
130703748|NCT02608476|470539689|FG000|Overall Study|Lost to Follow-up|24|||
130703749|NCT02608476|470539690|FG001|Overall Study|Lost to Follow-up|24|||
130703750|NCT02608476|470539689|FG000|Overall Study|Adverse Event|2|||
130703751|NCT02608476|470539690|FG001|Overall Study|Adverse Event|8|||
130703752|NCT02608476|470539689|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
130703753|NCT02608476|470539690|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130703754|NCT02608476|470539689|FG000|Overall Study|Noncompliance with treatment|1|||
130703755|NCT02608476|470539690|FG001|Overall Study|Noncompliance with treatment|5|||
130703756|NCT02608476|470539689|FG000|Overall Study|Lack of Efficacy|3|||
130703757|NCT02608476|470539690|FG001|Overall Study|Lack of Efficacy|1|||
130703758|NCT02608476|470539689|FG000|Overall Study|Other|0|||
130703759|NCT02608476|470539690|FG001|Overall Study|Other|1|||
130703760|NCT02608476|470539689|FG000|Overall Study|Physician Decision|1|||
130453199|NCT01168401|469623489|FG007|Overall Study|Withdrawal by Subject|0|||
130453200|NCT01168401|469623490|FG008|Overall Study|Withdrawal by Subject|0|||
130453201|NCT01168401|469623491|FG009|Overall Study|Withdrawal by Subject|0|||
130453202|NCT01168401|469623492|FG010|Overall Study|Withdrawal by Subject|0|||
130453203|NCT00672256|469623496|FG000|Overall Study|PI dropped, bad data|44|||
130453204|NCT01720043|469623502|FG000|Overall Study|Withdrawal by Subject|1|||
130453205|NCT01688973|469623503|FG000|Overall Study|Ineligible|2|||
130453206|NCT01688973|469623504|FG001|Overall Study|Ineligible|3|||
130453207|NCT03441360|469623505|FG000|Overall Study|Radiological disease progression|5|||
130703761|NCT02608476|470539690|FG001|Overall Study|Physician Decision|0|||
130703762|NCT02608476|470539689|FG000|Overall Study|Pregnancy|0|||
130703763|NCT02608476|470539690|FG001|Overall Study|Pregnancy|1|||
130703764|NCT02608476|470539689|FG000|Overall Study|Progressive disease|1|||
130703765|NCT02608476|470539690|FG001|Overall Study|Progressive disease|0|||
130703766|NCT02795676|470539691|FG000|Overall Study|Adverse Event|2|||
130703767|NCT02795676|470539692|FG001|Overall Study|Adverse Event|0|||
130703768|NCT02795676|470539691|FG000|Overall Study|Withdrawal by Subject|3|||
130703769|NCT02795676|470539692|FG001|Overall Study|Withdrawal by Subject|1|||
130703770|NCT01609582|470539703|FG000|Overall Study|Adverse Event|20|||
130703771|NCT01609582|470539704|FG001|Overall Study|Adverse Event|18|||
130703772|NCT01609582|470539703|FG000|Overall Study|Lost to Follow-up|10|||
130703773|NCT01609582|470539704|FG001|Overall Study|Lost to Follow-up|10|||
130703774|NCT01609582|470539703|FG000|Overall Study|Withdrawal by Subject|21|||
130261948|NCT03218917|468925801|FG000|Overall Study|Subject withdrew consent|2|||
130261949|NCT03218917|468925802|FG001|Overall Study|Subject withdrew consent|4|||
130261950|NCT03218917|468925803|FG002|Overall Study|Subject withdrew consent|10|||
130261951|NCT03218917|468925801|FG000|Overall Study|Physician Decision|0|||
130261952|NCT03218917|468925802|FG001|Overall Study|Physician Decision|1|||
130261953|NCT03218917|468925803|FG002|Overall Study|Physician Decision|1|||
130261954|NCT03218917|468925801|FG000|Overall Study|Lost to Follow-up|1|||
130261955|NCT03218917|468925802|FG001|Overall Study|Lost to Follow-up|0|||
130261956|NCT03218917|468925803|FG002|Overall Study|Lost to Follow-up|0|||
130261957|NCT03218917|468925801|FG000|Overall Study|Reason Missing|0|||
130261958|NCT03218917|468925802|FG001|Overall Study|Reason Missing|2|||
130261959|NCT03218917|468925803|FG002|Overall Study|Reason Missing|0|||
130261960|NCT03218917|468925801|FG000|Overall Study|Death|0|||
130261961|NCT03218917|468925802|FG001|Overall Study|Death|1|||
130261962|NCT03218917|468925803|FG002|Overall Study|Death|0|||
130261963|NCT03218917|468925801|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130261964|NCT03218917|468925802|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130261965|NCT03218917|468925803|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130261966|NCT01788943|468925806|FG000|Overall Study|Withdrawal by Subject|1|||
130261967|NCT01788943|468925807|FG001|Overall Study|Withdrawal by Subject|0|||
130261968|NCT01119287|468925808|FG000|Overall Study|Patient Decision, not related to AE|0|||
130261969|NCT01119287|468925809|FG001|Overall Study|Patient Decision, not related to AE|0|||
130261970|NCT01119287|468925810|FG002|Overall Study|Patient Decision, not related to AE|2|||
130261971|NCT01119287|468925811|FG003|Overall Study|Patient Decision, not related to AE|2|||
130261972|NCT01119287|468925812|FG004|Overall Study|Patient Decision, not related to AE|1|||
130261973|NCT01119287|468925813|FG005|Overall Study|Patient Decision, not related to AE|0|||
130261974|NCT00565409|468925821|FG000|Period 1 Open Label|Adverse Event|17|||
130261975|NCT00565409|468925822|FG001|Period 1 Open Label|Adverse Event|0|||
130261976|NCT00565409|468925823|FG002|Period 1 Open Label|Adverse Event|0|||
130261977|NCT00565409|468925824|FG003|Period 1 Open Label|Adverse Event|0|||
130261978|NCT00565409|468925821|FG000|Period 1 Open Label|Death|2|||
130261979|NCT00565409|468925822|FG001|Period 1 Open Label|Death|0|||
130261980|NCT00565409|468925823|FG002|Period 1 Open Label|Death|0|||
130261981|NCT00565409|468925824|FG003|Period 1 Open Label|Death|0|||
130261982|NCT00565409|468925821|FG000|Period 1 Open Label|Lost to Follow-up|1|||
130261983|NCT00565409|468925822|FG001|Period 1 Open Label|Lost to Follow-up|0|||
130261984|NCT00565409|468925823|FG002|Period 1 Open Label|Lost to Follow-up|0|||
130261985|NCT00565409|468925824|FG003|Period 1 Open Label|Lost to Follow-up|0|||
130261986|NCT00565409|468925821|FG000|Period 1 Open Label|Other|21|||
130261987|NCT00565409|468925822|FG001|Period 1 Open Label|Other|0|||
130703775|NCT01609582|470539704|FG001|Overall Study|Withdrawal by Subject|15|||
130703776|NCT01609582|470539703|FG000|Overall Study|Study Terminated by Sponsor|1543|||
130365521|NCT01090492|469306906|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
130365522|NCT01090492|469306907|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
130365523|NCT01090492|469306908|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
130365524|NCT01090492|469306909|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
130365525|NCT01090492|469306910|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
130365526|NCT01090492|469306903|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130365527|NCT01090492|469306904|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130365528|NCT01090492|469306905|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130365529|NCT01090492|469306906|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130365530|NCT01090492|469306907|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130365531|NCT01090492|469306908|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130365532|NCT01090492|469306909|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130365533|NCT01090492|469306910|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130365534|NCT01090492|469306903|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130365535|NCT01090492|469306904|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
130703777|NCT01609582|470539704|FG001|Overall Study|Study Terminated by Sponsor|1548|||
130703778|NCT01609582|470539703|FG000|Overall Study|Other|9|||
130703779|NCT01609582|470539704|FG001|Overall Study|Other|10|||
130703780|NCT01609582|470539703|FG000|Overall Study|Randomized, but not treated|0|||
130703781|NCT01609582|470539704|FG001|Overall Study|Randomized, but not treated|3|||
130703782|NCT00819767|470539705|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130703783|NCT00819767|470539706|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130703784|NCT00587431|470539709|FG000|Overall Study|Adverse Event|1|||
130703785|NCT00587431|470539710|FG001|Overall Study|Adverse Event|0|||
130703786|NCT00587431|470539709|FG000|Overall Study|Withdrawal by Subject|0|||
130703787|NCT00587431|470539710|FG001|Overall Study|Withdrawal by Subject|1|||
130703788|NCT02762994|470539711|FG000|Overall Study|Withdrawal by Subject|0|||
130703789|NCT02762994|470539712|FG001|Overall Study|Withdrawal by Subject|1|||
130703790|NCT02762994|470539713|FG002|Overall Study|Withdrawal by Subject|2|||
130703791|NCT02762994|470539714|FG003|Overall Study|Withdrawal by Subject|0|||
130703792|NCT02762994|470539711|FG000|Overall Study|Protocol Violation|1|||
130703793|NCT02762994|470539712|FG001|Overall Study|Protocol Violation|0|||
130703794|NCT02762994|470539713|FG002|Overall Study|Protocol Violation|0|||
130703795|NCT02762994|470539714|FG003|Overall Study|Protocol Violation|2|||
130703796|NCT01701973|470539718|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703797|NCT01701973|470539719|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
130703798|NCT01701973|470539720|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703799|NCT01701973|470539721|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703800|NCT01701973|470539722|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703801|NCT01701973|470539723|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703802|NCT01701973|470539724|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703803|NCT01701973|470539725|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703804|NCT04330157|470539728|FG000|Overall Study|Protocol Violation|4|||
130703805|NCT04330157|470539728|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
130703806|NCT01263561|470539729|FG000|Overall Study|Death|1|||
130703807|NCT01263561|470539730|FG001|Overall Study|Death|2|||
130703808|NCT01396421|470539731|FG000|Overall Study|Lost to Follow-up|0|||
130703809|NCT01396421|470539732|FG001|Overall Study|Lost to Follow-up|0|||
130703810|NCT01396421|470539733|FG002|Overall Study|Lost to Follow-up|0|||
130703811|NCT01396421|470539734|FG003|Overall Study|Lost to Follow-up|1|||
130703812|NCT01396421|470539731|FG000|Overall Study|Adverse Event|17|||
130703813|NCT01396421|470539732|FG001|Overall Study|Adverse Event|15|||
130703814|NCT01396421|470539733|FG002|Overall Study|Adverse Event|12|||
130703815|NCT01396421|470539734|FG003|Overall Study|Adverse Event|32|||
130703816|NCT01396421|470539731|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130703817|NCT01396421|470539732|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
130703818|NCT01396421|470539733|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
130703819|NCT01396421|470539734|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
130703820|NCT01396421|470539731|FG000|Overall Study|Physician Decision|1|||
130703821|NCT01396421|470539732|FG001|Overall Study|Physician Decision|1|||
130703822|NCT01396421|470539733|FG002|Overall Study|Physician Decision|0|||
130703823|NCT01396421|470539734|FG003|Overall Study|Physician Decision|3|||
130703824|NCT01396421|470539731|FG000|Overall Study|Withdrawal by Subject|31|||
130703825|NCT01396421|470539732|FG001|Overall Study|Withdrawal by Subject|24|||
130703826|NCT01396421|470539733|FG002|Overall Study|Withdrawal by Subject|13|||
130703827|NCT01396421|470539734|FG003|Overall Study|Withdrawal by Subject|21|||
130703828|NCT01396421|470539731|FG000|Overall Study|Protocol Deviation|2|||
130703829|NCT01396421|470539732|FG001|Overall Study|Protocol Deviation|1|||
130703830|NCT01396421|470539733|FG002|Overall Study|Protocol Deviation|1|||
130703831|NCT01396421|470539734|FG003|Overall Study|Protocol Deviation|0|||
130703832|NCT01396421|470539731|FG000|Overall Study|Lack of Efficacy|7|||
130703833|NCT01396421|470539732|FG001|Overall Study|Lack of Efficacy|17|||
130703834|NCT01396421|470539733|FG002|Overall Study|Lack of Efficacy|7|||
130703835|NCT01396421|470539734|FG003|Overall Study|Lack of Efficacy|18|||
130703836|NCT03689894|470539739|FG000|Overall Study|Adverse Event|1|||
130703837|NCT00569777|470539740|FG000|Overall Study|Withdrawal by Subject|4|||
130703838|NCT00569777|470539741|FG001|Overall Study|Withdrawal by Subject|0|||
130703839|NCT00569777|470539740|FG000|Overall Study|Adverse Event|3|||
130703840|NCT00569777|470539741|FG001|Overall Study|Adverse Event|0|||
130703841|NCT00569777|470539740|FG000|Overall Study|Lost to Follow-up|1|||
130703842|NCT00569777|470539741|FG001|Overall Study|Lost to Follow-up|0|||
130703843|NCT00569777|470539740|FG000|Overall Study|scheduled eye surgery|0|||
130703844|NCT00569777|470539741|FG001|Overall Study|scheduled eye surgery|1|||
130703845|NCT00569777|470539740|FG000|Overall Study|did not meet exclusion criteria|1|||
130703846|NCT00569777|470539741|FG001|Overall Study|did not meet exclusion criteria|2|||
130703847|NCT00569777|470539740|FG000|Overall Study|pregnant|1|||
130703848|NCT00569777|470539741|FG001|Overall Study|pregnant|0|||
130703849|NCT02030535|470539746|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
130703850|NCT01588548|470539747|FG000|Overall Study|Withdrawal by Subject|0|||
130703851|NCT01588548|470539748|FG001|Overall Study|Withdrawal by Subject|1|||
130703852|NCT01588548|470539749|FG002|Overall Study|Withdrawal by Subject|1|||
130703853|NCT01588548|470539750|FG003|Overall Study|Withdrawal by Subject|1|||
130703854|NCT01588548|470539751|FG004|Overall Study|Withdrawal by Subject|2|||
130703855|NCT01588548|470539752|FG005|Overall Study|Withdrawal by Subject|3|||
130703856|NCT01588548|470539747|FG000|Overall Study|Adverse Event|0|||
130261988|NCT00565409|468925823|FG002|Period 1 Open Label|Other|0|||
130261989|NCT00565409|468925824|FG003|Period 1 Open Label|Other|0|||
130261990|NCT00565409|468925821|FG000|Period 1 Open Label|Protocol Violation|14|||
130261991|NCT00565409|468925822|FG001|Period 1 Open Label|Protocol Violation|0|||
130261992|NCT00565409|468925823|FG002|Period 1 Open Label|Protocol Violation|0|||
130261993|NCT00565409|468925824|FG003|Period 1 Open Label|Protocol Violation|0|||
130261994|NCT00565409|468925821|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
130261995|NCT00565409|468925822|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261996|NCT00565409|468925823|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261997|NCT00565409|468925824|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261998|NCT00565409|468925821|FG000|Period 1 Open Label|no conclusion of participation record|1|||
130261999|NCT00565409|468925822|FG001|Period 1 Open Label|no conclusion of participation record|0|||
130262000|NCT00565409|468925823|FG002|Period 1 Open Label|no conclusion of participation record|0|||
130262001|NCT00565409|468925824|FG003|Period 1 Open Label|no conclusion of participation record|0|||
130262002|NCT00565409|468925821|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
130262003|NCT00565409|468925822|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262004|NCT00565409|468925823|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262005|NCT00565409|468925824|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262006|NCT00565409|468925821|FG000|Period 2 Double-Blind|Adverse Event|0|||
130262007|NCT00565409|468925822|FG001|Period 2 Double-Blind|Adverse Event|7|||
130262008|NCT00565409|468925823|FG002|Period 2 Double-Blind|Adverse Event|4|||
130262009|NCT00565409|468925824|FG003|Period 2 Double-Blind|Adverse Event|5|||
130262010|NCT00565409|468925821|FG000|Period 2 Double-Blind|Death|0|||
130262011|NCT00565409|468925822|FG001|Period 2 Double-Blind|Death|2|||
130262012|NCT00565409|468925823|FG002|Period 2 Double-Blind|Death|0|||
130262013|NCT00565409|468925824|FG003|Period 2 Double-Blind|Death|0|||
130262014|NCT00565409|468925821|FG000|Period 2 Double-Blind|Protocol Violation|0|||
130262015|NCT00565409|468925822|FG001|Period 2 Double-Blind|Protocol Violation|4|||
130262016|NCT00565409|468925823|FG002|Period 2 Double-Blind|Protocol Violation|6|||
130262017|NCT00565409|468925824|FG003|Period 2 Double-Blind|Protocol Violation|2|||
130262018|NCT00565409|468925821|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
130262019|NCT00565409|468925822|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
130262020|NCT00565409|468925823|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
130262021|NCT00565409|468925824|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
130262022|NCT00565409|468925821|FG000|Period 2 Double-Blind|Other|0|||
130262023|NCT00565409|468925822|FG001|Period 2 Double-Blind|Other|4|||
130262024|NCT00565409|468925823|FG002|Period 2 Double-Blind|Other|5|||
130262025|NCT00565409|468925824|FG003|Period 2 Double-Blind|Other|9|||
130262026|NCT00565409|468925821|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
130262027|NCT00565409|468925822|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
130262028|NCT00565409|468925823|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
130262029|NCT00565409|468925824|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
130262030|NCT02257684|468925826|FG000|Overall Study|Adverse Event|2|||
130262031|NCT02257684|468925826|FG000|Overall Study|Lack of Efficacy|1|||
130262032|NCT02257684|468925826|FG000|Overall Study|Sponsor's Decision|1|||
130262033|NCT01570387|468925827|FG000|Overall Study|Adverse Event|1|||
130262034|NCT01570387|468925828|FG001|Overall Study|Adverse Event|0|||
130262035|NCT01570387|468925829|FG002|Overall Study|Adverse Event|0|||
130262036|NCT01570387|468925830|FG003|Overall Study|Adverse Event|0|||
130262037|NCT01570387|468925827|FG000|Overall Study|Death|0|||
130703857|NCT01588548|470539748|FG001|Overall Study|Adverse Event|0|||
130703858|NCT01588548|470539749|FG002|Overall Study|Adverse Event|1|||
130703859|NCT01588548|470539750|FG003|Overall Study|Adverse Event|2|||
130262038|NCT01570387|468925828|FG001|Overall Study|Death|0|||
130262039|NCT01570387|468925829|FG002|Overall Study|Death|0|||
130262040|NCT01570387|468925830|FG003|Overall Study|Death|1|||
130262041|NCT01570387|468925827|FG000|Overall Study|Withdrawal by Subject|0|||
130262042|NCT01570387|468925828|FG001|Overall Study|Withdrawal by Subject|0|||
130262043|NCT01570387|468925829|FG002|Overall Study|Withdrawal by Subject|0|||
130262044|NCT01570387|468925830|FG003|Overall Study|Withdrawal by Subject|1|||
130262045|NCT01987557|468925831|FG000|Overall Study|Protocol Violation|1|||
130262046|NCT01987557|468925832|FG001|Overall Study|Protocol Violation|0|||
130262047|NCT01987557|468925833|FG002|Overall Study|Protocol Violation|1|||
130262048|NCT01987557|468925831|FG000|Overall Study|Withdrawal by Subject|2|||
130262049|NCT01987557|468925832|FG001|Overall Study|Withdrawal by Subject|1|||
130262050|NCT01987557|468925833|FG002|Overall Study|Withdrawal by Subject|2|||
130262051|NCT01987557|468925831|FG000|Overall Study|Adverse Event|0|||
130262052|NCT01987557|468925832|FG001|Overall Study|Adverse Event|2|||
130262053|NCT01987557|468925833|FG002|Overall Study|Adverse Event|0|||
130262054|NCT00431964|468925842|FG000|Overall Study|Adverse Event|1|||
130262055|NCT00431964|468925843|FG001|Overall Study|Adverse Event|0|||
130262056|NCT00431964|468925842|FG000|Overall Study|Lost to Follow-up|1|||
130262057|NCT00431964|468925843|FG001|Overall Study|Lost to Follow-up|2|||
130262058|NCT00431964|468925842|FG000|Overall Study|Physician Decision|2|||
130262059|NCT00431964|468925843|FG001|Overall Study|Physician Decision|2|||
130262060|NCT00431964|468925842|FG000|Overall Study|Withdrawal by Subject|2|||
130262061|NCT00431964|468925843|FG001|Overall Study|Withdrawal by Subject|1|||
130262062|NCT00431964|468925842|FG000|Overall Study|Parental Consent Withdrawn|0|||
130262063|NCT00431964|468925843|FG001|Overall Study|Parental Consent Withdrawn|2|||
130262064|NCT00431964|468925842|FG000|Overall Study|Due to Unstable Health|0|||
130262065|NCT00431964|468925843|FG001|Overall Study|Due to Unstable Health|1|||
130262066|NCT03434834|468925849|FG000|Overall Study|unable to swallow OCT probe|16|||
130262067|NCT00518180|468925852|FG000|Overall Study|Withdrawal by Subject|29|||
130262068|NCT00518180|468925853|FG001|Overall Study|Withdrawal by Subject|30|||
130262069|NCT00518180|468925854|FG002|Overall Study|Withdrawal by Subject|42|||
130262070|NCT00518180|468925852|FG000|Overall Study|Lost to Follow-up|30|||
130262071|NCT00518180|468925853|FG001|Overall Study|Lost to Follow-up|28|||
130262072|NCT00518180|468925854|FG002|Overall Study|Lost to Follow-up|34|||
130262073|NCT00518180|468925852|FG000|Overall Study|Administrative reason|0|||
130262074|NCT00518180|468925853|FG001|Overall Study|Administrative reason|2|||
130262075|NCT00518180|468925854|FG002|Overall Study|Administrative reason|2|||
130262076|NCT00518180|468925852|FG000|Overall Study|Protocol Violation|5|||
130262077|NCT00518180|468925853|FG001|Overall Study|Protocol Violation|7|||
130262078|NCT00518180|468925854|FG002|Overall Study|Protocol Violation|4|||
130262079|NCT00518180|468925852|FG000|Overall Study|Unable to classify|0|||
130262080|NCT00518180|468925853|FG001|Overall Study|Unable to classify|2|||
130262081|NCT00518180|468925854|FG002|Overall Study|Unable to classify|0|||
130262082|NCT00518180|468925852|FG000|Overall Study|Adverse Event|1|||
130262083|NCT00518180|468925853|FG001|Overall Study|Adverse Event|0|||
130262084|NCT00518180|468925854|FG002|Overall Study|Adverse Event|0|||
130262085|NCT00485173|468925859|FG000|Overall Study|Death|4|||
130262086|NCT00485173|468925860|FG001|Overall Study|Death|3|||
130262087|NCT00485173|468925859|FG000|Overall Study|Lost to Follow-up|32|||
130262088|NCT00485173|468925860|FG001|Overall Study|Lost to Follow-up|61|||
130262089|NCT00829244|468925861|FG000|Overall Study|Adverse Event|1|||
130365536|NCT01090492|469306905|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130262090|NCT00829244|468925862|FG001|Overall Study|Adverse Event|3|||
130262091|NCT00829244|468925861|FG000|Overall Study|Protocol Violation|1|||
130262092|NCT00829244|468925862|FG001|Overall Study|Protocol Violation|0|||
130365537|NCT01090492|469306906|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130365538|NCT01090492|469306907|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130262093|NCT00829244|468925861|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
130262094|NCT00829244|468925862|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
130262095|NCT00829244|468925861|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
130262096|NCT00829244|468925862|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
130262097|NCT00829244|468925861|FG000|Overall Study|No fertilization|2|||
130262098|NCT00829244|468925862|FG001|Overall Study|No fertilization|2|||
130262099|NCT00829244|468925861|FG000|Overall Study|All embryos discarded|0|||
130262100|NCT00829244|468925862|FG001|Overall Study|All embryos discarded|3|||
130262101|NCT00829244|468925861|FG000|Overall Study|No embryo cleavage|0|||
130262102|NCT00829244|468925862|FG001|Overall Study|No embryo cleavage|2|||
130453208|NCT03441360|469623506|FG001|Overall Study|Radiological disease progression|6|||
130453209|NCT03441360|469623507|FG002|Overall Study|Radiological disease progression|4|||
130453210|NCT03441360|469623505|FG000|Overall Study|Clinical disease progression|2|||
130453211|NCT03441360|469623506|FG001|Overall Study|Clinical disease progression|2|||
130453212|NCT03441360|469623507|FG002|Overall Study|Clinical disease progression|0|||
130453213|NCT03441360|469623505|FG000|Overall Study|Adverse Event|1|||
130453214|NCT03441360|469623506|FG001|Overall Study|Adverse Event|0|||
130453215|NCT03441360|469623507|FG002|Overall Study|Adverse Event|1|||
130453216|NCT00269399|469623508|FG000|Overall Study|Lack of Efficacy|27|||
130453217|NCT00269399|469623509|FG001|Overall Study|Lack of Efficacy|10|||
130453218|NCT00269399|469623508|FG000|Overall Study|Adverse Event|10|||
130453219|NCT00269399|469623509|FG001|Overall Study|Adverse Event|4|||
130262103|NCT03342560|468925863|FG000|Overall Study|Lost to Follow-up|2|||
130262104|NCT02604511|468925864|FG000|Overall Study|Adverse Event|3|||
130262105|NCT02604511|468925864|FG000|Overall Study|Disease Progression|4|||
130262106|NCT02604511|468925864|FG000|Overall Study|Withdrawal by Subject|3|||
130262107|NCT02604511|468925864|FG000|Overall Study|Participant ineligible|1|||
130262108|NCT02604511|468925864|FG000|Overall Study|Intercurrent illness|1|||
130262109|NCT03770286|468925865|FG000|Overall Study|Lost to Follow-up|6|||
130262110|NCT03770286|468925866|FG001|Overall Study|Lost to Follow-up|4|||
130262111|NCT03770286|468925867|FG002|Overall Study|Lost to Follow-up|3|||
130262112|NCT03770286|468925865|FG000|Overall Study|Protocol Violation|1|||
130262113|NCT03770286|468925866|FG001|Overall Study|Protocol Violation|0|||
130262114|NCT03770286|468925867|FG002|Overall Study|Protocol Violation|2|||
130262115|NCT02297412|468925868|FG000|Overall Study|Canceled|1|||
130262116|NCT02297412|468925869|FG001|Overall Study|Canceled|1|||
130262117|NCT02031302|468925870|FG000|Overall Study|Death|115|||
130262118|NCT02031302|468925871|FG001|Overall Study|Death|0|||
130262119|NCT02031302|468925870|FG000|Overall Study|Not treated with study valve system|18|||
130262120|NCT02031302|468925871|FG001|Overall Study|Not treated with study valve system|0|||
130262121|NCT02031302|468925870|FG000|Overall Study|Missed Follow Up|27|||
130262122|NCT02031302|468925871|FG001|Overall Study|Missed Follow Up|0|||
130262123|NCT02031302|468925870|FG000|Overall Study|Lost to Follow-up|4|||
130262124|NCT02031302|468925871|FG001|Overall Study|Lost to Follow-up|0|||
130262125|NCT04712669|468925876|FG000|Double Blind Phase|Adverse Event|4|||
130262126|NCT04712669|468925877|FG001|Double Blind Phase|Adverse Event|4|||
130262127|NCT04712669|468925878|FG002|Double Blind Phase|Adverse Event|3|||
130262128|NCT04712669|468925879|FG003|Double Blind Phase|Adverse Event|0|||
130262129|NCT04712669|468925880|FG004|Double Blind Phase|Adverse Event|0|||
130262130|NCT04712669|468925881|FG005|Double Blind Phase|Adverse Event|0|||
130262131|NCT04712669|468925882|FG006|Double Blind Phase|Adverse Event|0|||
130262132|NCT04712669|468925883|FG007|Double Blind Phase|Adverse Event|0|||
130262133|NCT04712669|468925876|FG000|Double Blind Phase|Physician Decision|1|||
130262134|NCT04712669|468925877|FG001|Double Blind Phase|Physician Decision|0|||
130262135|NCT04712669|468925878|FG002|Double Blind Phase|Physician Decision|0|||
130262136|NCT04712669|468925879|FG003|Double Blind Phase|Physician Decision|0|||
130262137|NCT04712669|468925880|FG004|Double Blind Phase|Physician Decision|0|||
130262138|NCT04712669|468925881|FG005|Double Blind Phase|Physician Decision|0|||
130262139|NCT04712669|468925882|FG006|Double Blind Phase|Physician Decision|0|||
130262140|NCT04712669|468925883|FG007|Double Blind Phase|Physician Decision|0|||
130262141|NCT04712669|468925876|FG000|Double Blind Phase|Withdrawal by Subject|3|||
130262142|NCT04712669|468925877|FG001|Double Blind Phase|Withdrawal by Subject|6|||
130262143|NCT04712669|468925878|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130262144|NCT04712669|468925879|FG003|Double Blind Phase|Withdrawal by Subject|0|||
130262145|NCT04712669|468925880|FG004|Double Blind Phase|Withdrawal by Subject|0|||
130262146|NCT04712669|468925881|FG005|Double Blind Phase|Withdrawal by Subject|0|||
130262147|NCT04712669|468925882|FG006|Double Blind Phase|Withdrawal by Subject|0|||
130262148|NCT04712669|468925883|FG007|Double Blind Phase|Withdrawal by Subject|0|||
130262149|NCT04712669|468925876|FG000|Double Blind Phase|Termination by Sponsor|0|||
130262150|NCT04712669|468925877|FG001|Double Blind Phase|Termination by Sponsor|0|||
130262151|NCT04712669|468925878|FG002|Double Blind Phase|Termination by Sponsor|1|||
130453220|NCT00269399|469623508|FG000|Overall Study|Withdrawal by Subject|2|||
130453221|NCT00269399|469623509|FG001|Overall Study|Withdrawal by Subject|5|||
130453222|NCT00269399|469623508|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
130453223|NCT00269399|469623509|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
130703860|NCT01588548|470539751|FG004|Overall Study|Adverse Event|1|||
130703861|NCT01588548|470539752|FG005|Overall Study|Adverse Event|0|||
130262152|NCT04712669|468925879|FG003|Double Blind Phase|Termination by Sponsor|0|||
130262153|NCT04712669|468925880|FG004|Double Blind Phase|Termination by Sponsor|0|||
130262154|NCT04712669|468925881|FG005|Double Blind Phase|Termination by Sponsor|0|||
130262155|NCT04712669|468925882|FG006|Double Blind Phase|Termination by Sponsor|0|||
130262156|NCT04712669|468925883|FG007|Double Blind Phase|Termination by Sponsor|0|||
130262157|NCT04712669|468925876|FG000|Open Label Phase|Adverse Event|0|||
130262158|NCT04712669|468925877|FG001|Open Label Phase|Adverse Event|0|||
130262159|NCT04712669|468925878|FG002|Open Label Phase|Adverse Event|0|||
130262160|NCT04712669|468925879|FG003|Open Label Phase|Adverse Event|1|||
130262161|NCT04712669|468925880|FG004|Open Label Phase|Adverse Event|1|||
130365539|NCT01090492|469306908|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130365540|NCT01090492|469306909|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130365541|NCT01090492|469306910|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130365542|NCT01090492|469306903|FG000|Second Intervention Period (4 Weeks)|Other|0|||
130365543|NCT01090492|469306904|FG001|Second Intervention Period (4 Weeks)|Other|1|||
130365544|NCT01090492|469306905|FG002|Second Intervention Period (4 Weeks)|Other|1|||
130365545|NCT01090492|469306906|FG003|Second Intervention Period (4 Weeks)|Other|0|||
130365546|NCT01090492|469306907|FG004|Second Intervention Period (4 Weeks)|Other|0|||
130365547|NCT01090492|469306908|FG005|Second Intervention Period (4 Weeks)|Other|0|||
130365548|NCT01090492|469306909|FG006|Second Intervention Period (4 Weeks)|Other|0|||
130365549|NCT01090492|469306910|FG007|Second Intervention Period (4 Weeks)|Other|0|||
130365550|NCT01090492|469306903|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130365551|NCT01090492|469306904|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130365552|NCT01090492|469306905|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130365553|NCT01090492|469306906|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130365554|NCT01090492|469306907|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130365555|NCT01090492|469306908|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130365556|NCT01090492|469306909|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
130365557|NCT01090492|469306910|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130365558|NCT01090492|469306903|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365559|NCT01090492|469306904|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365560|NCT01090492|469306905|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365561|NCT01090492|469306906|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365562|NCT01090492|469306907|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365563|NCT01090492|469306908|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130365564|NCT01090492|469306909|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
130453224|NCT00269399|469623508|FG000|Overall Study|Other|0|||
130453225|NCT00269399|469623509|FG001|Overall Study|Other|4|||
130453226|NCT00269399|469623508|FG000|Overall Study|Development of exclusion criteria|0|||
130703862|NCT01588548|470539747|FG000|Overall Study|Condition Under Investigation Worsened|3|||
130703863|NCT01588548|470539748|FG001|Overall Study|Condition Under Investigation Worsened|6|||
130703864|NCT01588548|470539749|FG002|Overall Study|Condition Under Investigation Worsened|4|||
130703865|NCT01588548|470539750|FG003|Overall Study|Condition Under Investigation Worsened|4|||
130703866|NCT01588548|470539751|FG004|Overall Study|Condition Under Investigation Worsened|3|||
130703867|NCT01588548|470539752|FG005|Overall Study|Condition Under Investigation Worsened|3|||
130703868|NCT00537017|470539753|FG000|Treatment Phase|Adverse Event|19|||
130703869|NCT00537017|470539753|FG000|Treatment Phase|Withdrawal by Subject|13|||
130703870|NCT00537017|470539753|FG000|Treatment Phase|Protocol Violation|2|||
130703871|NCT00537017|470539753|FG000|Follow-up Phase|Withdrawal by Subject|9|||
130703872|NCT01362296|470539754|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
130703873|NCT01362296|470539755|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
130703874|NCT01362296|470539756|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
130703875|NCT01362296|470539757|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
130703876|NCT01362296|470539754|FG000|Randomized Phase (RP)|Physician Decision|1|||
130703877|NCT01362296|470539755|FG001|Randomized Phase (RP)|Physician Decision|9|||
130703878|NCT01362296|470539756|FG002|Randomized Phase (RP)|Physician Decision|0|||
130703879|NCT01362296|470539757|FG003|Randomized Phase (RP)|Physician Decision|0|||
130703880|NCT01362296|470539754|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
130703881|NCT01362296|470539755|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
130703882|NCT01362296|470539756|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
130703883|NCT01362296|470539757|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
130703884|NCT01362296|470539754|FG000|Randomized Phase (RP)|Adverse Event|20|||
130703885|NCT01362296|470539755|FG001|Randomized Phase (RP)|Adverse Event|4|||
130703886|NCT01362296|470539756|FG002|Randomized Phase (RP)|Adverse Event|0|||
130703887|NCT01362296|470539757|FG003|Randomized Phase (RP)|Adverse Event|0|||
130703888|NCT01362296|470539754|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
130703889|NCT01362296|470539755|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
130703890|NCT01362296|470539756|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
130703891|NCT01362296|470539757|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
130703892|NCT01362296|470539754|FG000|Crossover Phase|PD including Death due to PD|0|||
130703893|NCT01362296|470539755|FG001|Crossover Phase|PD including Death due to PD|0|||
130703894|NCT01362296|470539756|FG002|Crossover Phase|PD including Death due to PD|16|||
130703895|NCT01362296|470539757|FG003|Crossover Phase|PD including Death due to PD|1|||
130703896|NCT01362296|470539754|FG000|Crossover Phase|Withdrawal by Subject|0|||
130703897|NCT01362296|470539755|FG001|Crossover Phase|Withdrawal by Subject|0|||
130703898|NCT01362296|470539756|FG002|Crossover Phase|Withdrawal by Subject|2|||
130703899|NCT01362296|470539757|FG003|Crossover Phase|Withdrawal by Subject|1|||
130703900|NCT01362296|470539754|FG000|Crossover Phase|Adverse Event|0|||
130703901|NCT01362296|470539755|FG001|Crossover Phase|Adverse Event|0|||
130703902|NCT01362296|470539756|FG002|Crossover Phase|Adverse Event|4|||
130262162|NCT04712669|468925881|FG005|Open Label Phase|Adverse Event|3|||
130262163|NCT04712669|468925882|FG006|Open Label Phase|Adverse Event|1|||
130262164|NCT04712669|468925883|FG007|Open Label Phase|Adverse Event|2|||
130262165|NCT04712669|468925876|FG000|Open Label Phase|Death|0|||
130262166|NCT04712669|468925877|FG001|Open Label Phase|Death|0|||
130262167|NCT04712669|468925878|FG002|Open Label Phase|Death|0|||
130262168|NCT04712669|468925879|FG003|Open Label Phase|Death|1|||
130262169|NCT04712669|468925880|FG004|Open Label Phase|Death|0|||
130262170|NCT04712669|468925881|FG005|Open Label Phase|Death|0|||
130262171|NCT04712669|468925882|FG006|Open Label Phase|Death|0|||
130262172|NCT04712669|468925883|FG007|Open Label Phase|Death|0|||
130262173|NCT04712669|468925876|FG000|Open Label Phase|Lack of Efficacy|0|||
130262174|NCT04712669|468925877|FG001|Open Label Phase|Lack of Efficacy|0|||
130262175|NCT04712669|468925878|FG002|Open Label Phase|Lack of Efficacy|0|||
130262176|NCT04712669|468925879|FG003|Open Label Phase|Lack of Efficacy|0|||
130262177|NCT04712669|468925880|FG004|Open Label Phase|Lack of Efficacy|1|||
130262178|NCT04712669|468925881|FG005|Open Label Phase|Lack of Efficacy|0|||
130262179|NCT04712669|468925882|FG006|Open Label Phase|Lack of Efficacy|0|||
130262180|NCT04712669|468925883|FG007|Open Label Phase|Lack of Efficacy|0|||
130262181|NCT04712669|468925876|FG000|Open Label Phase|Lost to Follow-up|0|||
130262182|NCT04712669|468925877|FG001|Open Label Phase|Lost to Follow-up|0|||
130262183|NCT04712669|468925878|FG002|Open Label Phase|Lost to Follow-up|0|||
130262184|NCT04712669|468925879|FG003|Open Label Phase|Lost to Follow-up|0|||
130262185|NCT04712669|468925880|FG004|Open Label Phase|Lost to Follow-up|0|||
130262186|NCT04712669|468925881|FG005|Open Label Phase|Lost to Follow-up|0|||
130262187|NCT04712669|468925882|FG006|Open Label Phase|Lost to Follow-up|1|||
130262188|NCT04712669|468925883|FG007|Open Label Phase|Lost to Follow-up|1|||
130262189|NCT04712669|468925876|FG000|Open Label Phase|Physician Decision|0|||
130262190|NCT04712669|468925877|FG001|Open Label Phase|Physician Decision|0|||
130262191|NCT04712669|468925878|FG002|Open Label Phase|Physician Decision|0|||
130262192|NCT04712669|468925879|FG003|Open Label Phase|Physician Decision|1|||
130262193|NCT04712669|468925880|FG004|Open Label Phase|Physician Decision|0|||
130262194|NCT04712669|468925881|FG005|Open Label Phase|Physician Decision|0|||
130262195|NCT04712669|468925882|FG006|Open Label Phase|Physician Decision|0|||
130262196|NCT04712669|468925883|FG007|Open Label Phase|Physician Decision|0|||
130262197|NCT04712669|468925876|FG000|Open Label Phase|Withdrawal by Subject|0|||
130262198|NCT04712669|468925877|FG001|Open Label Phase|Withdrawal by Subject|0|||
130262199|NCT04712669|468925878|FG002|Open Label Phase|Withdrawal by Subject|0|||
130262200|NCT04712669|468925879|FG003|Open Label Phase|Withdrawal by Subject|1|||
130262201|NCT04712669|468925880|FG004|Open Label Phase|Withdrawal by Subject|5|||
130262202|NCT04712669|468925881|FG005|Open Label Phase|Withdrawal by Subject|5|||
130262203|NCT04712669|468925882|FG006|Open Label Phase|Withdrawal by Subject|0|||
130262204|NCT04712669|468925883|FG007|Open Label Phase|Withdrawal by Subject|4|||
130262205|NCT04712669|468925876|FG000|Open Label Phase|Termination by Sponsor|0|||
130262206|NCT04712669|468925877|FG001|Open Label Phase|Termination by Sponsor|0|||
130262207|NCT04712669|468925878|FG002|Open Label Phase|Termination by Sponsor|0|||
130262208|NCT04712669|468925879|FG003|Open Label Phase|Termination by Sponsor|11|||
130262209|NCT04712669|468925880|FG004|Open Label Phase|Termination by Sponsor|9|||
130262210|NCT04712669|468925881|FG005|Open Label Phase|Termination by Sponsor|14|||
130262211|NCT04712669|468925882|FG006|Open Label Phase|Termination by Sponsor|0|||
130262212|NCT04712669|468925883|FG007|Open Label Phase|Termination by Sponsor|14|||
130262213|NCT03802396|468925884|FG000|Overall Study|Withdrawal by Subject|2|||
130262214|NCT03802396|468925885|FG001|Overall Study|Withdrawal by Subject|0|||
130262215|NCT03802396|468925884|FG000|Overall Study|Surgery Cancelled|1|||
130262216|NCT03802396|468925885|FG001|Overall Study|Surgery Cancelled|0|||
130262217|NCT02561962|468925889|FG000|Overall Study|Withdrawal by Subject|1|||
130262218|NCT02561962|468925890|FG001|Overall Study|Withdrawal by Subject|0|||
130262219|NCT02561962|468925891|FG002|Overall Study|Withdrawal by Subject|0|||
130262220|NCT02561962|468925892|FG003|Overall Study|Withdrawal by Subject|0|||
130262221|NCT02561962|468925893|FG004|Overall Study|Withdrawal by Subject|1|||
130262222|NCT02561962|468925894|FG005|Overall Study|Withdrawal by Subject|1|||
130262223|NCT02561962|468925895|FG006|Overall Study|Withdrawal by Subject|2|||
130262224|NCT02561962|468925896|FG007|Overall Study|Withdrawal by Subject|1|||
130262225|NCT02561962|468925897|FG008|Overall Study|Withdrawal by Subject|0|||
130262226|NCT02561962|468925889|FG000|Overall Study|Decision by sponsor|0|||
130262227|NCT02561962|468925890|FG001|Overall Study|Decision by sponsor|0|||
130262228|NCT02561962|468925891|FG002|Overall Study|Decision by sponsor|0|||
130262229|NCT02561962|468925892|FG003|Overall Study|Decision by sponsor|0|||
130262230|NCT02561962|468925893|FG004|Overall Study|Decision by sponsor|1|||
130262231|NCT02561962|468925894|FG005|Overall Study|Decision by sponsor|1|||
130262232|NCT02561962|468925895|FG006|Overall Study|Decision by sponsor|0|||
130262233|NCT02561962|468925896|FG007|Overall Study|Decision by sponsor|3|||
130262234|NCT02561962|468925897|FG008|Overall Study|Decision by sponsor|0|||
130262235|NCT02561962|468925889|FG000|Overall Study|Lost to Follow-up|0|||
130262236|NCT02561962|468925890|FG001|Overall Study|Lost to Follow-up|0|||
130262237|NCT02561962|468925891|FG002|Overall Study|Lost to Follow-up|0|||
130262238|NCT02561962|468925892|FG003|Overall Study|Lost to Follow-up|0|||
130365565|NCT01090492|469306910|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130262239|NCT02561962|468925893|FG004|Overall Study|Lost to Follow-up|0|||
130262240|NCT02561962|468925894|FG005|Overall Study|Lost to Follow-up|1|||
130262241|NCT02561962|468925895|FG006|Overall Study|Lost to Follow-up|0|||
130262242|NCT02561962|468925896|FG007|Overall Study|Lost to Follow-up|0|||
130262243|NCT02561962|468925897|FG008|Overall Study|Lost to Follow-up|0|||
130262244|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
130262245|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130262246|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130262247|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
130262248|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130703903|NCT01362296|470539757|FG003|Crossover Phase|Adverse Event|0|||
130703904|NCT01362296|470539754|FG000|Crossover Phase|Study Closed/Terminated|0|||
130703905|NCT01362296|470539755|FG001|Crossover Phase|Study Closed/Terminated|0|||
130703906|NCT01362296|470539756|FG002|Crossover Phase|Study Closed/Terminated|1|||
130703907|NCT01362296|470539757|FG003|Crossover Phase|Study Closed/Terminated|0|||
130703908|NCT04149535|470539762|FG000|Overall Study|Death|11|||
130703909|NCT04149535|470539763|FG001|Overall Study|Death|7|||
130703910|NCT04149535|470539762|FG000|Overall Study|Physician Decision|10|||
130703911|NCT04149535|470539763|FG001|Overall Study|Physician Decision|4|||
130703912|NCT04149535|470539762|FG000|Overall Study|Withdrawal by Subject|6|||
130703913|NCT04149535|470539763|FG001|Overall Study|Withdrawal by Subject|7|||
130262249|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130262250|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
130262251|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
130262252|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
130262253|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
130262254|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
130262255|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
130262256|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130262257|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130262258|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
130262259|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
130262260|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130262261|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130703914|NCT04149535|470539762|FG000|Overall Study|Not described|2|||
130703915|NCT04149535|470539763|FG001|Overall Study|Not described|0|||
130703916|NCT02839798|470541141|FG000|Overall Study|Withdrawal by Subject|2|||
130703917|NCT04703855|470541142|FG000|Overall Study|Heart Transplant|1|||
130262262|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
130262263|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130262264|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130262265|NCT01819272|468927684|FG000|Overall Study|Adverse Event|1|||
130262266|NCT01819272|468927685|FG001|Overall Study|Adverse Event|0|||
130262267|NCT01819272|468927686|FG002|Overall Study|Adverse Event|0|||
130262268|NCT01819272|468927687|FG003|Overall Study|Adverse Event|2|||
130262269|NCT01819272|468927688|FG004|Overall Study|Adverse Event|0|||
130262270|NCT01819272|468927689|FG005|Overall Study|Adverse Event|0|||
130262271|NCT01819272|468927684|FG000|Overall Study|Lost to Follow-up|3|||
130262272|NCT01819272|468927685|FG001|Overall Study|Lost to Follow-up|0|||
130262273|NCT01819272|468927686|FG002|Overall Study|Lost to Follow-up|1|||
130262274|NCT01819272|468927687|FG003|Overall Study|Lost to Follow-up|0|||
130262275|NCT01819272|468927688|FG004|Overall Study|Lost to Follow-up|0|||
130262276|NCT01819272|468927689|FG005|Overall Study|Lost to Follow-up|3|||
130262277|NCT01819272|468927684|FG000|Overall Study|Protocol Violation|0|||
130262278|NCT01819272|468927685|FG001|Overall Study|Protocol Violation|0|||
130262279|NCT01819272|468927686|FG002|Overall Study|Protocol Violation|0|||
130262280|NCT01819272|468927687|FG003|Overall Study|Protocol Violation|1|||
130262281|NCT01819272|468927688|FG004|Overall Study|Protocol Violation|2|||
130262282|NCT01819272|468927689|FG005|Overall Study|Protocol Violation|3|||
130262283|NCT01819272|468927684|FG000|Overall Study|Physician Decision|0|||
130262284|NCT01819272|468927685|FG001|Overall Study|Physician Decision|1|||
130262285|NCT01819272|468927686|FG002|Overall Study|Physician Decision|0|||
130262286|NCT01819272|468927687|FG003|Overall Study|Physician Decision|0|||
130262287|NCT01819272|468927688|FG004|Overall Study|Physician Decision|0|||
130262288|NCT01819272|468927689|FG005|Overall Study|Physician Decision|0|||
130262289|NCT01819272|468927684|FG000|Overall Study|Withdrawal of Consent|0|||
130262290|NCT01819272|468927685|FG001|Overall Study|Withdrawal of Consent|1|||
130262291|NCT01819272|468927686|FG002|Overall Study|Withdrawal of Consent|2|||
130262292|NCT01819272|468927687|FG003|Overall Study|Withdrawal of Consent|1|||
130262293|NCT01819272|468927688|FG004|Overall Study|Withdrawal of Consent|0|||
130262294|NCT01819272|468927689|FG005|Overall Study|Withdrawal of Consent|1|||
130262295|NCT01819272|468927684|FG000|Overall Study|Loss of Glucose Control|2|||
130262296|NCT01819272|468927685|FG001|Overall Study|Loss of Glucose Control|1|||
130262297|NCT01819272|468927686|FG002|Overall Study|Loss of Glucose Control|0|||
130262298|NCT01819272|468927687|FG003|Overall Study|Loss of Glucose Control|1|||
130262299|NCT01819272|468927688|FG004|Overall Study|Loss of Glucose Control|2|||
130262300|NCT01819272|468927689|FG005|Overall Study|Loss of Glucose Control|0|||
130262301|NCT01732536|468927690|FG000|Overall Study|Withdrawal by Subject|1|||
130262302|NCT01732536|468927691|FG001|Overall Study|Withdrawal by Subject|1|||
130262303|NCT01581684|468927692|FG000|Overall Study|Other reason not defined|0|||
130365566|NCT00945893|469306911|FG000|Overall Study|Lost to Follow-up|2|||
130703918|NCT00401245|470541143|FG000|Double Blind Titration Phase|Adverse Event|3|||
130703919|NCT00401245|470541144|FG001|Double Blind Titration Phase|Adverse Event|2|||
130703920|NCT00401245|470541145|FG002|Double Blind Titration Phase|Adverse Event|5|||
130703921|NCT00401245|470541146|FG003|Double Blind Titration Phase|Adverse Event|12|||
130262304|NCT01581684|468927693|FG001|Overall Study|Other reason not defined|0|||
130262305|NCT01581684|468927694|FG002|Overall Study|Other reason not defined|0|||
130262306|NCT01581684|468927695|FG003|Overall Study|Other reason not defined|0|||
130262307|NCT01581684|468927696|FG004|Overall Study|Other reason not defined|0|||
130262308|NCT01581684|468927697|FG005|Overall Study|Other reason not defined|0|||
130262309|NCT01581684|468927698|FG006|Overall Study|Other reason not defined|0|||
130262310|NCT01581684|468927699|FG007|Overall Study|Other reason not defined|0|||
130262311|NCT01581684|468927700|FG008|Overall Study|Other reason not defined|1|||
130262312|NCT01581684|468927701|FG009|Overall Study|Other reason not defined|0|||
130262313|NCT03728933|468927702|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130262314|NCT03728933|468927703|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130262315|NCT03728933|468927704|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130262316|NCT03728933|468927702|FG000|Overall Study|Withdrawal by Subject|0|||
130262317|NCT03728933|468927703|FG001|Overall Study|Withdrawal by Subject|0|||
130262318|NCT03728933|468927704|FG002|Overall Study|Withdrawal by Subject|1|||
130262319|NCT03728933|468927702|FG000|Overall Study|Lost to Follow-up|0|||
130262320|NCT03728933|468927703|FG001|Overall Study|Lost to Follow-up|1|||
130262321|NCT03728933|468927704|FG002|Overall Study|Lost to Follow-up|0|||
130262322|NCT03728933|468927702|FG000|Overall Study|Adverse Event|1|||
130262323|NCT03728933|468927703|FG001|Overall Study|Adverse Event|0|||
130262324|NCT03728933|468927704|FG002|Overall Study|Adverse Event|0|||
130262325|NCT01784029|468927705|FG000|Overall Study|Lost to Follow-up|19|||
130262326|NCT01784029|468927706|FG001|Overall Study|Lost to Follow-up|20|||
130262327|NCT01784029|468927707|FG002|Overall Study|Lost to Follow-up|22|||
130262328|NCT00639457|468927708|FG000|Overall Study|Withdrawal by Subject|2|||
130262329|NCT00639457|468927709|FG001|Overall Study|Withdrawal by Subject|3|||
130262330|NCT03235050|468927710|FG000|Overall Study|Adverse Event|0|||
130262331|NCT03235050|468927711|FG001|Overall Study|Adverse Event|0|||
130262332|NCT03235050|468927712|FG002|Overall Study|Adverse Event|1|||
130262333|NCT03235050|468927713|FG003|Overall Study|Adverse Event|4|||
130262334|NCT03235050|468927714|FG004|Overall Study|Adverse Event|1|||
130262335|NCT03235050|468927710|FG000|Overall Study|Death|0|||
130262336|NCT03235050|468927711|FG001|Overall Study|Death|0|||
130262337|NCT03235050|468927712|FG002|Overall Study|Death|0|||
130262338|NCT03235050|468927713|FG003|Overall Study|Death|2|||
130262339|NCT03235050|468927714|FG004|Overall Study|Death|1|||
130262340|NCT03235050|468927710|FG000|Overall Study|Lost to Follow-up|1|||
130262341|NCT03235050|468927711|FG001|Overall Study|Lost to Follow-up|2|||
130262342|NCT03235050|468927712|FG002|Overall Study|Lost to Follow-up|1|||
130262343|NCT03235050|468927713|FG003|Overall Study|Lost to Follow-up|2|||
130262344|NCT03235050|468927714|FG004|Overall Study|Lost to Follow-up|0|||
130262345|NCT03235050|468927710|FG000|Overall Study|Withdrawal by Subject|3|||
130262346|NCT03235050|468927711|FG001|Overall Study|Withdrawal by Subject|2|||
130262347|NCT03235050|468927712|FG002|Overall Study|Withdrawal by Subject|2|||
130262348|NCT03235050|468927713|FG003|Overall Study|Withdrawal by Subject|5|||
130262349|NCT03235050|468927714|FG004|Overall Study|Withdrawal by Subject|7|||
130262350|NCT03235050|468927710|FG000|Overall Study|Other reasons|0|||
130262351|NCT03235050|468927711|FG001|Overall Study|Other reasons|1|||
130262352|NCT03235050|468927712|FG002|Overall Study|Other reasons|0|||
130262353|NCT03235050|468927713|FG003|Overall Study|Other reasons|1|||
130262354|NCT03235050|468927714|FG004|Overall Study|Other reasons|2|||
130262355|NCT00276419|468927715|FG000|First Intervention|Adverse Event|1|||
130262356|NCT00276419|468927716|FG001|First Intervention|Adverse Event|0|||
130365567|NCT00945893|469306912|FG001|Overall Study|Lost to Follow-up|8|||
130703922|NCT00401245|470541147|FG004|Double Blind Titration Phase|Adverse Event|0|||
130703923|NCT00401245|470541148|FG005|Double Blind Titration Phase|Adverse Event|0|||
130703924|NCT00401245|470541149|FG006|Double Blind Titration Phase|Adverse Event|0|||
130703925|NCT00401245|470541150|FG007|Double Blind Titration Phase|Adverse Event|0|||
130703926|NCT00401245|470541143|FG000|Double Blind Titration Phase|Other|0|||
130703927|NCT00401245|470541144|FG001|Double Blind Titration Phase|Other|0|||
130703928|NCT00401245|470541145|FG002|Double Blind Titration Phase|Other|1|||
130703929|NCT00401245|470541146|FG003|Double Blind Titration Phase|Other|0|||
130703930|NCT00401245|470541147|FG004|Double Blind Titration Phase|Other|0|||
130365568|NCT00945893|469306911|FG000|Overall Study|Withdrawal of consent|1|||
130262357|NCT00276419|468927715|FG000|First Intervention|Withdrawal by Subject|0|||
130262358|NCT00276419|468927716|FG001|First Intervention|Withdrawal by Subject|2|||
130262359|NCT02415556|468927719|FG000|Overall Study|Adverse Event|3|||
130262360|NCT02415556|468927720|FG001|Overall Study|Adverse Event|4|||
130262361|NCT02415556|468927721|FG002|Overall Study|Adverse Event|2|||
130262362|NCT02415556|468927722|FG003|Overall Study|Adverse Event|4|||
130262363|NCT02415556|468927719|FG000|Overall Study|Lost to Follow-up|4|||
130365569|NCT00945893|469306912|FG001|Overall Study|Withdrawal of consent|2|||
130262364|NCT02415556|468927720|FG001|Overall Study|Lost to Follow-up|5|||
130262365|NCT02415556|468927721|FG002|Overall Study|Lost to Follow-up|4|||
130262366|NCT02415556|468927722|FG003|Overall Study|Lost to Follow-up|1|||
130262367|NCT02415556|468927719|FG000|Overall Study|Withdrawal by Subject|13|||
130262368|NCT02415556|468927720|FG001|Overall Study|Withdrawal by Subject|4|||
130703931|NCT00401245|470541148|FG005|Double Blind Titration Phase|Other|0|||
130703932|NCT00401245|470541149|FG006|Double Blind Titration Phase|Other|0|||
130703933|NCT00401245|470541150|FG007|Double Blind Titration Phase|Other|0|||
130703934|NCT00401245|470541143|FG000|Double Blind Titration Phase|Protocol Violation|0|||
130703935|NCT00401245|470541144|FG001|Double Blind Titration Phase|Protocol Violation|0|||
130703936|NCT00401245|470541145|FG002|Double Blind Titration Phase|Protocol Violation|0|||
130703937|NCT00401245|470541146|FG003|Double Blind Titration Phase|Protocol Violation|1|||
130703938|NCT00401245|470541147|FG004|Double Blind Titration Phase|Protocol Violation|0|||
130703939|NCT00401245|470541148|FG005|Double Blind Titration Phase|Protocol Violation|0|||
130703940|NCT00401245|470541149|FG006|Double Blind Titration Phase|Protocol Violation|0|||
130703941|NCT00401245|470541150|FG007|Double Blind Titration Phase|Protocol Violation|0|||
130703942|NCT00401245|470541143|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
130703943|NCT00401245|470541144|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
130703944|NCT00401245|470541145|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703945|NCT00401245|470541146|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
130703946|NCT00401245|470541147|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703947|NCT00401245|470541148|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703948|NCT00401245|470541149|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703949|NCT00401245|470541150|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703950|NCT00401245|470541143|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703951|NCT00401245|470541144|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130703952|NCT00401245|470541145|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703953|NCT00401245|470541146|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130703954|NCT00401245|470541147|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703955|NCT00401245|470541148|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703956|NCT00401245|470541149|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703957|NCT00401245|470541150|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703958|NCT00401245|470541143|FG000|Open Label Phase|Adverse Event|5|||
130703959|NCT00401245|470541144|FG001|Open Label Phase|Adverse Event|14|||
130703960|NCT00401245|470541145|FG002|Open Label Phase|Adverse Event|6|||
130703961|NCT00401245|470541146|FG003|Open Label Phase|Adverse Event|7|||
130703962|NCT00401245|470541147|FG004|Open Label Phase|Adverse Event|0|||
130703963|NCT00401245|470541148|FG005|Open Label Phase|Adverse Event|0|||
130703964|NCT00401245|470541149|FG006|Open Label Phase|Adverse Event|0|||
130703965|NCT00401245|470541150|FG007|Open Label Phase|Adverse Event|0|||
130703966|NCT00401245|470541143|FG000|Open Label Phase|Lost to Follow-up|5|||
130703967|NCT00401245|470541144|FG001|Open Label Phase|Lost to Follow-up|7|||
130703968|NCT00401245|470541145|FG002|Open Label Phase|Lost to Follow-up|5|||
130703969|NCT00401245|470541146|FG003|Open Label Phase|Lost to Follow-up|4|||
130703970|NCT00401245|470541147|FG004|Open Label Phase|Lost to Follow-up|0|||
130703971|NCT00401245|470541148|FG005|Open Label Phase|Lost to Follow-up|0|||
130703972|NCT00401245|470541149|FG006|Open Label Phase|Lost to Follow-up|0|||
130703973|NCT00401245|470541150|FG007|Open Label Phase|Lost to Follow-up|0|||
130703974|NCT00401245|470541143|FG000|Open Label Phase|Other|4|||
130703975|NCT00401245|470541144|FG001|Open Label Phase|Other|8|||
130703976|NCT00401245|470541145|FG002|Open Label Phase|Other|7|||
130262369|NCT02415556|468927721|FG002|Overall Study|Withdrawal by Subject|14|||
130262370|NCT02415556|468927722|FG003|Overall Study|Withdrawal by Subject|12|||
130262371|NCT02415556|468927719|FG000|Overall Study|Physician Decision|1|||
130262372|NCT02415556|468927720|FG001|Overall Study|Physician Decision|3|||
130262373|NCT02415556|468927721|FG002|Overall Study|Physician Decision|1|||
130262374|NCT02415556|468927722|FG003|Overall Study|Physician Decision|2|||
130262375|NCT02415556|468927719|FG000|Overall Study|Censored - study completion|4|||
130262376|NCT02415556|468927720|FG001|Overall Study|Censored - study completion|5|||
130262377|NCT02415556|468927721|FG002|Overall Study|Censored - study completion|1|||
130262378|NCT02415556|468927722|FG003|Overall Study|Censored - study completion|0|||
130262379|NCT02415556|468927719|FG000|Overall Study|Family-related issues|0|||
130262380|NCT02415556|468927720|FG001|Overall Study|Family-related issues|0|||
130262381|NCT02415556|468927721|FG002|Overall Study|Family-related issues|0|||
130262382|NCT02415556|468927722|FG003|Overall Study|Family-related issues|1|||
130262383|NCT00105534|468927723|FG000|Overall Study|Adverse Event|2|||
130262384|NCT00105534|468927724|FG001|Overall Study|Adverse Event|5|||
130262385|NCT00105534|468927723|FG000|Overall Study|Protocol Violation|1|||
130262386|NCT00105534|468927724|FG001|Overall Study|Protocol Violation|4|||
130703977|NCT00401245|470541146|FG003|Open Label Phase|Other|8|||
130262387|NCT00105534|468927723|FG000|Overall Study|Withdrawal by Subject|6|||
130262388|NCT00105534|468927724|FG001|Overall Study|Withdrawal by Subject|6|||
130262389|NCT00105534|468927723|FG000|Overall Study|Lost to Follow-up|5|||
130262390|NCT00105534|468927724|FG001|Overall Study|Lost to Follow-up|1|||
130262391|NCT00105534|468927723|FG000|Overall Study|Lack of Efficacy|7|||
130365570|NCT03113071|469306913|FG000|Overall Study|Withdrawal by Subject|1|||
130703978|NCT00401245|470541147|FG004|Open Label Phase|Other|0|||
130262392|NCT00105534|468927724|FG001|Overall Study|Lack of Efficacy|15|||
130262393|NCT00105534|468927723|FG000|Overall Study|Treatment unmasked|1|||
130262394|NCT00105534|468927724|FG001|Overall Study|Treatment unmasked|0|||
130262395|NCT00105534|468927723|FG000|Overall Study|Other Reason|0|||
130262396|NCT00105534|468927724|FG001|Overall Study|Other Reason|2|||
130262397|NCT01621178|468927725|FG000|Overall Study|Adverse Event|5|||
130262398|NCT01621178|468927726|FG001|Overall Study|Adverse Event|2|||
130262399|NCT01621178|468927727|FG002|Overall Study|Adverse Event|8|||
130262400|NCT01621178|468927725|FG000|Overall Study|Death|6|||
130262401|NCT01621178|468927726|FG001|Overall Study|Death|7|||
130262402|NCT01621178|468927727|FG002|Overall Study|Death|2|||
130262403|NCT01621178|468927725|FG000|Overall Study|Lost to Follow-up|1|||
130262404|NCT01621178|468927726|FG001|Overall Study|Lost to Follow-up|2|||
130262405|NCT01621178|468927727|FG002|Overall Study|Lost to Follow-up|1|||
130262406|NCT01621178|468927725|FG000|Overall Study|Withdrawal by Subject|14|||
130262407|NCT01621178|468927726|FG001|Overall Study|Withdrawal by Subject|17|||
130262408|NCT01621178|468927727|FG002|Overall Study|Withdrawal by Subject|18|||
130262409|NCT01621178|468927725|FG000|Overall Study|Physician Decision|5|||
130262410|NCT01621178|468927726|FG001|Overall Study|Physician Decision|2|||
130262411|NCT01621178|468927727|FG002|Overall Study|Physician Decision|7|||
130262412|NCT02896257|468927728|FG000|Providers|Without eligible patients|21|||
130262413|NCT02896257|468927729|FG001|Providers|Without eligible patients|28|||
130262414|NCT02896257|468927728|FG000|Patients|PFT entry criteria not met|43|||
130262415|NCT02896257|468927729|FG001|Patients|PFT entry criteria not met|50|||
130262416|NCT02896257|468927728|FG000|Patients|No capacity to review|8|||
130262417|NCT02896257|468927729|FG001|Patients|No capacity to review|11|||
130262418|NCT02896257|468927728|FG000|Patients|Appointment rescheduled/cancelled|5|||
130262419|NCT02896257|468927729|FG001|Patients|Appointment rescheduled/cancelled|7|||
130262420|NCT02896257|468927728|FG000|Patients|PCP not assigned a clinic|4|||
130262421|NCT02896257|468927729|FG001|Patients|PCP not assigned a clinic|0|||
130262422|NCT02896257|468927728|FG000|Patients|No history of COPD|0|||
130262423|NCT02896257|468927729|FG001|Patients|No history of COPD|1|||
130262424|NCT02896257|468927728|FG000|Patients|Deceased between review and index date|0|||
130262425|NCT02896257|468927729|FG001|Patients|Deceased between review and index date|1|||
130262426|NCT02896257|468927728|FG000|Patients|No ICS Rx upon review|1|||
130262427|NCT02896257|468927729|FG001|Patients|No ICS Rx upon review|1|||
130262428|NCT02896257|468927728|FG000|Patients|Protocol Violation|2|||
130262429|NCT02896257|468927729|FG001|Patients|Protocol Violation|1|||
130262430|NCT02896257|468927728|FG000|Patients|Hospice care|0|||
130262431|NCT02896257|468927729|FG001|Patients|Hospice care|1|||
130262432|NCT04778592|468927734|FG000|Overall Study|Adverse Event|1|||
130262433|NCT04778592|468927735|FG001|Overall Study|Adverse Event|2|||
130262434|NCT04778592|468927734|FG000|Overall Study|Withdrawal by Subject|1|||
130262435|NCT04778592|468927735|FG001|Overall Study|Withdrawal by Subject|2|||
130262436|NCT01192126|468927736|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
130262437|NCT01192126|468927737|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
130262438|NCT01192126|468927736|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
130262439|NCT01192126|468927737|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
130262440|NCT02660229|468927738|FG000|Overall Study|Adverse Event|2|||
130262441|NCT02660229|468927739|FG001|Overall Study|Adverse Event|0|||
130262442|NCT02660229|468927738|FG000|Overall Study|Withdrawal by Subject|0|||
130262443|NCT02660229|468927739|FG001|Overall Study|Withdrawal by Subject|1|||
130262444|NCT01146613|468927740|FG000|Overall Study|Lost to Follow-up|3|||
130262445|NCT01146613|468927741|FG001|Overall Study|Lost to Follow-up|8|||
130262446|NCT01146613|468927740|FG000|Overall Study|Lack of Efficacy|0|||
130262447|NCT01146613|468927741|FG001|Overall Study|Lack of Efficacy|1|||
130262448|NCT01146613|468927740|FG000|Overall Study|Death|1|||
130262449|NCT01146613|468927741|FG001|Overall Study|Death|0|||
130262450|NCT01146613|468927740|FG000|Overall Study|Physician Decision|1|||
130262451|NCT01146613|468927741|FG001|Overall Study|Physician Decision|0|||
130262452|NCT01146613|468927740|FG000|Overall Study|Withdrawal by Subject|0|||
130262453|NCT01146613|468927741|FG001|Overall Study|Withdrawal by Subject|3|||
130262454|NCT01146613|468927740|FG000|Overall Study|schedule conflict|1|||
130262455|NCT01146613|468927741|FG001|Overall Study|schedule conflict|0|||
130262456|NCT01146613|468927740|FG000|Overall Study|Outpatient detox|1|||
130262457|NCT01146613|468927741|FG001|Overall Study|Outpatient detox|0|||
130262458|NCT00329030|468927742|FG000|Overall Study|Withdrawal by Subject|1|||
130553960|NCT00568321|469996468|FG002|Overall Study|Withdrawal by Subject|0|||
130262459|NCT00329030|468927743|FG001|Overall Study|Withdrawal by Subject|3|||
130262460|NCT00329030|468927742|FG000|Overall Study|Progressive Disease|6|||
130262461|NCT00329030|468927743|FG001|Overall Study|Progressive Disease|2|||
130262462|NCT00329030|468927742|FG000|Overall Study|Ineligible Pathology|1|||
130262463|NCT00329030|468927743|FG001|Overall Study|Ineligible Pathology|1|||
130262464|NCT02441218|468927750|FG000|Overall Study|Death|503|||
130262465|NCT02441218|468927751|FG001|Overall Study|Death|553|||
130553961|NCT00568321|469996466|FG000|Overall Study|Protocol Violation|0|||
130262466|NCT02441218|468927750|FG000|Overall Study|Withdrawal by Subject|73|||
130262467|NCT02441218|468927751|FG001|Overall Study|Withdrawal by Subject|58|||
130553962|NCT00568321|469996467|FG001|Overall Study|Protocol Violation|0|||
130262468|NCT02441218|468927750|FG000|Overall Study|Lost to Follow-up|2|||
130262469|NCT02441218|468927751|FG001|Overall Study|Lost to Follow-up|1|||
130262470|NCT01541371|468927752|FG000|Overall Study|Withdrawal by Subject|14|||
130262471|NCT01541371|468927752|FG000|Overall Study|Lost to Follow-up|21|||
130262472|NCT01541371|468927752|FG000|Overall Study|Adverse Event|15|||
130262473|NCT01541371|468927752|FG000|Overall Study|Lack of Efficacy|12|||
130262474|NCT01541371|468927752|FG000|Overall Study|Protocol Violation|6|||
130262475|NCT01541371|468927752|FG000|Overall Study|Study medication non-compliance|3|||
130262476|NCT01541371|468927752|FG000|Overall Study|Other|6|||
130262477|NCT02271880|468927755|FG000|Overall Study|Premature discontinuation of study|3|||
130262478|NCT02271880|468927756|FG001|Overall Study|Premature discontinuation of study|4|||
130262479|NCT02431325|468927757|FG000|Overall Study|Adverse Event|3|||
130262480|NCT02431325|468927758|FG001|Overall Study|Adverse Event|0|||
130262481|NCT02431325|468927757|FG000|Overall Study|Lost to Follow-up|0|||
130262482|NCT02431325|468927758|FG001|Overall Study|Lost to Follow-up|1|||
130262483|NCT02431325|468927757|FG000|Overall Study|Withdrawal by Subject|1|||
130262484|NCT02431325|468927758|FG001|Overall Study|Withdrawal by Subject|2|||
130262485|NCT02431325|468927757|FG000|Overall Study|Declined to take study medication|1|||
130262486|NCT02431325|468927758|FG001|Overall Study|Declined to take study medication|0|||
130262487|NCT02431325|468927757|FG000|Overall Study|Withdrew before starting study medication|1|||
130262488|NCT02431325|468927758|FG001|Overall Study|Withdrew before starting study medication|0|||
130262489|NCT02431325|468927757|FG000|Overall Study|Placebo shortage|2|||
130262490|NCT02431325|468927758|FG001|Overall Study|Placebo shortage|0|||
130262491|NCT00744861|468927759|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
130262492|NCT00744861|468927760|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
130262493|NCT00744861|468927761|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
130262494|NCT00744861|468927762|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
130262495|NCT00744861|468927759|FG000|Feasibility Stage 1|Pregnancy|0|||
130262496|NCT00744861|468927760|FG001|Feasibility Stage 1|Pregnancy|1|||
130262497|NCT00744861|468927761|FG002|Feasibility Stage 1|Pregnancy|0|||
130262498|NCT00744861|468927762|FG003|Feasibility Stage 1|Pregnancy|0|||
130262499|NCT00744861|468927759|FG000|Pivotal Stage 2|Adverse Event|0|||
130262500|NCT00744861|468927760|FG001|Pivotal Stage 2|Adverse Event|0|||
130262501|NCT00744861|468927761|FG002|Pivotal Stage 2|Adverse Event|6|||
130262502|NCT00744861|468927762|FG003|Pivotal Stage 2|Adverse Event|11|||
130262503|NCT00744861|468927759|FG000|Pivotal Stage 2|Death|0|||
130262504|NCT00744861|468927760|FG001|Pivotal Stage 2|Death|0|||
130262505|NCT00744861|468927761|FG002|Pivotal Stage 2|Death|0|||
130262506|NCT00744861|468927762|FG003|Pivotal Stage 2|Death|1|||
130262507|NCT00744861|468927759|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
130262508|NCT00744861|468927760|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
130262509|NCT00744861|468927761|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
130262510|NCT00744861|468927762|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
130262511|NCT00744861|468927759|FG000|Pivotal Stage 2|Physician Decision|0|||
130262512|NCT00744861|468927760|FG001|Pivotal Stage 2|Physician Decision|0|||
130262513|NCT00744861|468927761|FG002|Pivotal Stage 2|Physician Decision|3|||
130262514|NCT00744861|468927762|FG003|Pivotal Stage 2|Physician Decision|1|||
130262515|NCT00744861|468927759|FG000|Pivotal Stage 2|Protocol Violation|0|||
130703979|NCT00401245|470541148|FG005|Open Label Phase|Other|0|||
130703980|NCT00401245|470541149|FG006|Open Label Phase|Other|0|||
130262516|NCT00744861|468927760|FG001|Pivotal Stage 2|Protocol Violation|0|||
130262517|NCT00744861|468927761|FG002|Pivotal Stage 2|Protocol Violation|0|||
130262518|NCT00744861|468927762|FG003|Pivotal Stage 2|Protocol Violation|1|||
130262519|NCT00744861|468927759|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
130262520|NCT00744861|468927760|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
130262521|NCT00744861|468927761|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
130262522|NCT00744861|468927762|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
130262523|NCT00744861|468927759|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130262524|NCT00744861|468927760|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130262525|NCT00744861|468927761|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
130262526|NCT00744861|468927762|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
130262527|NCT00181844|468927763|FG000|Signed Consent|Withdrawal by Subject|5|||
130262528|NCT00181844|468927763|FG000|Signed Consent|Did not meet entrance criteria|7|||
130262529|NCT00181844|468927763|FG000|Exposed to Study Medication|Adverse Event|10|||
130262530|NCT00181844|468927763|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
130262531|NCT00181844|468927763|FG000|Exposed to Study Medication|Non-compliance|2|||
130262532|NCT00181844|468927763|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
130262533|NCT00181844|468927763|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
130262534|NCT04661033|468927764|FG000|Overall Study|Adverse Event|0|||
130262535|NCT04661033|468927765|FG001|Overall Study|Adverse Event|0|||
130262536|NCT04661033|468927766|FG002|Overall Study|Adverse Event|1|||
130262537|NCT04661033|468927767|FG003|Overall Study|Adverse Event|0|||
130262538|NCT04661033|468927764|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
130262539|NCT04661033|468927765|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130262540|NCT04661033|468927766|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130553963|NCT00568321|469996468|FG002|Overall Study|Protocol Violation|1|||
130262541|NCT04661033|468927767|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130262542|NCT04661033|468927764|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
130262543|NCT04661033|468927765|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
130262544|NCT04661033|468927766|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
130262545|NCT04661033|468927767|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
130262546|NCT04661033|468927764|FG000|Overall Study|Early discontinuation as per PI|1|||
130262547|NCT04661033|468927765|FG001|Overall Study|Early discontinuation as per PI|0|||
130262548|NCT04661033|468927766|FG002|Overall Study|Early discontinuation as per PI|0|||
130262549|NCT04661033|468927767|FG003|Overall Study|Early discontinuation as per PI|0|||
130262550|NCT04064905|468927768|FG000|Overall Study|Lost to Follow-up|0|||
130262551|NCT04064905|468927769|FG001|Overall Study|Lost to Follow-up|3|||
130262552|NCT04064905|468927770|FG002|Overall Study|Lost to Follow-up|1|||
130262553|NCT04064905|468927771|FG003|Overall Study|Lost to Follow-up|4|||
130262554|NCT04064905|468927772|FG004|Overall Study|Lost to Follow-up|2|||
130262555|NCT01567722|468927773|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
130262556|NCT01567722|468927774|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130262557|NCT01567722|468927775|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130262558|NCT01567722|468927773|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
130262559|NCT01567722|468927774|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130262560|NCT01567722|468927775|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130262561|NCT01567722|468927773|FG000|Overall Study|Protocol closure by the OCG|2|||
130262562|NCT01567722|468927774|FG001|Overall Study|Protocol closure by the OCG|0|||
130262563|NCT01567722|468927775|FG002|Overall Study|Protocol closure by the OCG|0|||
130262564|NCT01567722|468927773|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
130262565|NCT01567722|468927774|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130262566|NCT01567722|468927775|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130262567|NCT00382174|468927776|FG000|Overall Study|Lost to Follow-up|1|||
130262568|NCT00382174|468927777|FG001|Overall Study|Lost to Follow-up|4|||
130262569|NCT00382174|468927778|FG002|Overall Study|Lost to Follow-up|5|||
130262570|NCT00382174|468927776|FG000|Overall Study|Adverse Event|1|||
130262571|NCT00382174|468927777|FG001|Overall Study|Adverse Event|4|||
130262572|NCT00382174|468927778|FG002|Overall Study|Adverse Event|5|||
130262573|NCT00382174|468927776|FG000|Overall Study|Withdrawal by Subject|1|||
130262574|NCT00382174|468927777|FG001|Overall Study|Withdrawal by Subject|4|||
130262575|NCT00382174|468927778|FG002|Overall Study|Withdrawal by Subject|5|||
130262576|NCT00382174|468927776|FG000|Overall Study|Non compliance|1|||
130262577|NCT00382174|468927777|FG001|Overall Study|Non compliance|0|||
130262578|NCT00382174|468927778|FG002|Overall Study|Non compliance|1|||
130262579|NCT00382174|468927776|FG000|Overall Study|Physician Decision|0|||
130262580|NCT00382174|468927777|FG001|Overall Study|Physician Decision|2|||
130262581|NCT00382174|468927778|FG002|Overall Study|Physician Decision|2|||
130262582|NCT00382174|468927776|FG000|Overall Study|Failed to meet criteria|0|||
130262583|NCT00382174|468927777|FG001|Overall Study|Failed to meet criteria|1|||
130262584|NCT00382174|468927778|FG002|Overall Study|Failed to meet criteria|1|||
130262585|NCT00382174|468927776|FG000|Overall Study|Wounds merged|0|||
130262586|NCT00382174|468927777|FG001|Overall Study|Wounds merged|2|||
130262587|NCT00382174|468927778|FG002|Overall Study|Wounds merged|2|||
130262588|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130262589|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130262590|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
130262591|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Death|0|||
130262592|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Death|0|||
130262593|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Death|1|||
130262594|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
130262595|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
130262596|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
130262597|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130262598|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130262599|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
130262600|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
130262601|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
130262602|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
130262603|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Graft loss|0|||
130262604|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Graft loss|0|||
130262605|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Graft loss|7|||
130262606|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130262607|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130262608|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
130262609|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130262610|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130262611|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
130262612|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
130262613|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
130262614|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
130262615|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130262616|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130262617|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
130262618|NCT00956293|468927790|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
130262619|NCT00956293|468927791|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
130262620|NCT00956293|468927792|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
130262621|NCT00956293|468927790|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
130262622|NCT00956293|468927791|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
130262623|NCT00956293|468927792|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
130262624|NCT00956293|468927790|FG000|Main Period (Randomization)|Adverse Event|0|||
130262625|NCT00956293|468927791|FG001|Main Period (Randomization)|Adverse Event|15|||
130262626|NCT00956293|468927792|FG002|Main Period (Randomization)|Adverse Event|0|||
130262627|NCT00956293|468927790|FG000|Follow-up Period|Follow-up period was terminated.|20|||
130262628|NCT00956293|468927791|FG001|Follow-up Period|Follow-up period was terminated.|32|||
130262629|NCT00956293|468927792|FG002|Follow-up Period|Follow-up period was terminated.|0|||
130262630|NCT03383666|468927793|FG000|Overall Study|Withdrawal by Subject|2|||
130262631|NCT03383666|468927793|FG000|Overall Study|Lost to Follow-up|2|||
130262632|NCT03507127|468927796|FG000|Overall Study|Withdrawal by Subject|1|||
130262633|NCT03507127|468927797|FG001|Overall Study|Withdrawal by Subject|0|||
130262634|NCT03507127|468927796|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
130262635|NCT03507127|468927797|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
130262636|NCT03508050|468927798|FG000|Overall Study|Pleural adhesions|1|||
130262637|NCT03508050|468927799|FG001|Overall Study|Pleural adhesions|0|||
130262638|NCT03508050|468927798|FG000|Overall Study|Mucus plug|1|||
130262639|NCT03508050|468927799|FG001|Overall Study|Mucus plug|0|||
130262640|NCT03508050|468927798|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
130262641|NCT03508050|468927799|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
130262642|NCT03508050|468927798|FG000|Overall Study|Sustained desaturation|0|||
130262643|NCT03508050|468927799|FG001|Overall Study|Sustained desaturation|1|||
130262644|NCT01240863|468927800|FG000|Open-label Titration Period|Adverse Event|47|||
130262645|NCT01240863|468927801|FG001|Open-label Titration Period|Adverse Event|0|||
130262646|NCT01240863|468927802|FG002|Open-label Titration Period|Adverse Event|0|||
130262647|NCT01240863|468927800|FG000|Open-label Titration Period|Lack of Efficacy|19|||
130262648|NCT01240863|468927801|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130262649|NCT01240863|468927802|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130262650|NCT01240863|468927800|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
130262651|NCT01240863|468927801|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130262652|NCT01240863|468927802|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130262653|NCT01240863|468927800|FG000|Open-label Titration Period|Protocol Violation|7|||
130262654|NCT01240863|468927801|FG001|Open-label Titration Period|Protocol Violation|0|||
130262655|NCT01240863|468927802|FG002|Open-label Titration Period|Protocol Violation|0|||
130262656|NCT01240863|468927800|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
130262657|NCT01240863|468927801|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
130262658|NCT01240863|468927802|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
130262659|NCT01240863|468927800|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
130262660|NCT01240863|468927801|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
130262661|NCT01240863|468927802|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
130262662|NCT01240863|468927800|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
130262663|NCT01240863|468927801|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
130262664|NCT01240863|468927802|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
130262665|NCT01240863|468927800|FG000|Open-label Titration Period|Other|7|||
130262666|NCT01240863|468927801|FG001|Open-label Titration Period|Other|0|||
130365571|NCT03113071|469306914|FG001|Overall Study|Withdrawal by Subject|0|||
130365572|NCT01602120|469306915|FG000|Overall Study|Adverse Event|3|||
130365573|NCT01602120|469306916|FG001|Overall Study|Adverse Event|6|||
130365574|NCT01602120|469306917|FG002|Overall Study|Adverse Event|0|||
130365575|NCT01602120|469306918|FG003|Overall Study|Adverse Event|2|||
130262667|NCT01240863|468927802|FG002|Open-label Titration Period|Other|0|||
130262668|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
130262669|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
130262670|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
130262671|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130262672|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
130262673|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
130262674|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130262675|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130703981|NCT00401245|470541150|FG007|Open Label Phase|Other|0|||
130703982|NCT00401245|470541143|FG000|Open Label Phase|Protocol Violation|0|||
130262676|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130262677|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130262678|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
130262679|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
130262680|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
130262681|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
130262682|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
130262683|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
130553964|NCT00568321|469996466|FG000|Overall Study|Randomized, not treated|2|||
130703983|NCT00401245|470541144|FG001|Open Label Phase|Protocol Violation|1|||
130703984|NCT00401245|470541145|FG002|Open Label Phase|Protocol Violation|0|||
130703985|NCT00401245|470541146|FG003|Open Label Phase|Protocol Violation|1|||
130262684|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130262685|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130262686|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
130262687|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130262688|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
130262689|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130262690|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
130262691|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130262692|NCT02081586|468927803|FG000|Overall Study|Lost to Follow-up|0|||
130262693|NCT02081586|468927804|FG001|Overall Study|Lost to Follow-up|1|||
130262694|NCT02081586|468927805|FG002|Overall Study|Lost to Follow-up|0|||
130262695|NCT02081586|468927806|FG003|Overall Study|Lost to Follow-up|1|||
130262696|NCT02081586|468927803|FG000|Overall Study|Head injury not related to study|0|||
130262697|NCT02081586|468927804|FG001|Overall Study|Head injury not related to study|0|||
130262698|NCT02081586|468927805|FG002|Overall Study|Head injury not related to study|1|||
130262699|NCT02081586|468927806|FG003|Overall Study|Head injury not related to study|0|||
130262700|NCT01677988|468927809|FG000|Overall Study|Lack of Efficacy|2|||
130262701|NCT00659425|468927813|FG000|Overall Study|Disease progression|1|||
130262702|NCT00659425|468927814|FG001|Overall Study|Disease progression|0|||
130262703|NCT00659425|468927815|FG002|Overall Study|Disease progression|0|||
130262704|NCT00659425|468927816|FG003|Overall Study|Disease progression|1|||
130262705|NCT00659425|468927817|FG004|Overall Study|Disease progression|0|||
130262706|NCT00659425|468927818|FG005|Overall Study|Disease progression|2|||
130262707|NCT00659425|468927819|FG006|Overall Study|Disease progression|4|||
130262708|NCT00659425|468927820|FG007|Overall Study|Disease progression|3|||
130262709|NCT00659425|468927821|FG008|Overall Study|Disease progression|5|||
130262710|NCT00659425|468927822|FG009|Overall Study|Disease progression|3|||
130703986|NCT00401245|470541147|FG004|Open Label Phase|Protocol Violation|0|||
130703987|NCT00401245|470541148|FG005|Open Label Phase|Protocol Violation|0|||
130703988|NCT00401245|470541149|FG006|Open Label Phase|Protocol Violation|0|||
130262711|NCT00659425|468927813|FG000|Overall Study|Death|0|||
130262712|NCT00659425|468927814|FG001|Overall Study|Death|0|||
130262713|NCT00659425|468927815|FG002|Overall Study|Death|0|||
130262714|NCT00659425|468927816|FG003|Overall Study|Death|1|||
130262715|NCT00659425|468927817|FG004|Overall Study|Death|0|||
130262716|NCT00659425|468927818|FG005|Overall Study|Death|0|||
130262717|NCT00659425|468927819|FG006|Overall Study|Death|1|||
130703989|NCT00401245|470541150|FG007|Open Label Phase|Protocol Violation|0|||
130703990|NCT00401245|470541143|FG000|Open Label Phase|Withdrawal by Subject|3|||
130703991|NCT00401245|470541144|FG001|Open Label Phase|Withdrawal by Subject|3|||
130703992|NCT00401245|470541145|FG002|Open Label Phase|Withdrawal by Subject|2|||
130703993|NCT00401245|470541146|FG003|Open Label Phase|Withdrawal by Subject|1|||
130703994|NCT00401245|470541147|FG004|Open Label Phase|Withdrawal by Subject|0|||
130703995|NCT00401245|470541148|FG005|Open Label Phase|Withdrawal by Subject|0|||
130262718|NCT00659425|468927820|FG007|Overall Study|Death|0|||
130262719|NCT00659425|468927821|FG008|Overall Study|Death|0|||
130262720|NCT00659425|468927822|FG009|Overall Study|Death|0|||
130262721|NCT00659425|468927813|FG000|Overall Study|Adverse Event|0|||
130262722|NCT00659425|468927814|FG001|Overall Study|Adverse Event|0|||
130262723|NCT00659425|468927815|FG002|Overall Study|Adverse Event|0|||
130553965|NCT00568321|469996467|FG001|Overall Study|Randomized, not treated|0|||
130703996|NCT00401245|470541149|FG006|Open Label Phase|Withdrawal by Subject|0|||
130262724|NCT00659425|468927816|FG003|Overall Study|Adverse Event|0|||
130262725|NCT00659425|468927817|FG004|Overall Study|Adverse Event|0|||
130262726|NCT00659425|468927818|FG005|Overall Study|Adverse Event|1|||
130262727|NCT00659425|468927819|FG006|Overall Study|Adverse Event|0|||
130262728|NCT00659425|468927820|FG007|Overall Study|Adverse Event|3|||
130262729|NCT00659425|468927821|FG008|Overall Study|Adverse Event|1|||
130262730|NCT00659425|468927822|FG009|Overall Study|Adverse Event|4|||
130262731|NCT00659425|468927813|FG000|Overall Study|Investigator Discretion|0|||
130262732|NCT00659425|468927814|FG001|Overall Study|Investigator Discretion|0|||
130262733|NCT00659425|468927815|FG002|Overall Study|Investigator Discretion|0|||
130262734|NCT00659425|468927816|FG003|Overall Study|Investigator Discretion|0|||
130262735|NCT00659425|468927817|FG004|Overall Study|Investigator Discretion|0|||
130262736|NCT00659425|468927818|FG005|Overall Study|Investigator Discretion|1|||
130262737|NCT00659425|468927819|FG006|Overall Study|Investigator Discretion|0|||
130262738|NCT00659425|468927820|FG007|Overall Study|Investigator Discretion|3|||
130262739|NCT00659425|468927821|FG008|Overall Study|Investigator Discretion|0|||
130262740|NCT00659425|468927822|FG009|Overall Study|Investigator Discretion|0|||
130262741|NCT00659425|468927813|FG000|Overall Study|Other|0|||
130262742|NCT00659425|468927814|FG001|Overall Study|Other|1|||
130262743|NCT00659425|468927815|FG002|Overall Study|Other|1|||
130262744|NCT00659425|468927816|FG003|Overall Study|Other|2|||
130262745|NCT00659425|468927817|FG004|Overall Study|Other|4|||
130262746|NCT00659425|468927818|FG005|Overall Study|Other|0|||
130262747|NCT00659425|468927819|FG006|Overall Study|Other|3|||
130262748|NCT00659425|468927820|FG007|Overall Study|Other|2|||
130262749|NCT00659425|468927821|FG008|Overall Study|Other|0|||
130262750|NCT00659425|468927822|FG009|Overall Study|Other|6|||
130262751|NCT00271544|468927823|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
130262752|NCT00271544|468927823|FG000|Overall Study|Model 4196 lead not attempted|9|||
130262753|NCT00271544|468927823|FG000|Overall Study|Implant not attempted|4|||
130262754|NCT03358030|468927824|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
130262755|NCT03358030|468927825|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
130262756|NCT03358030|468927826|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
130262757|NCT03358030|468927827|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
130262758|NCT03358030|468927824|FG000|Overall Study|Ineligibility|0|||
130262759|NCT03358030|468927825|FG001|Overall Study|Ineligibility|0|||
130262760|NCT03358030|468927826|FG002|Overall Study|Ineligibility|0|||
130262761|NCT03358030|468927827|FG003|Overall Study|Ineligibility|2|||
130262762|NCT03358030|468927824|FG000|Overall Study|Voluntary Withdrawal|1|||
130262763|NCT03358030|468927825|FG001|Overall Study|Voluntary Withdrawal|1|||
130262764|NCT03358030|468927826|FG002|Overall Study|Voluntary Withdrawal|3|||
130262765|NCT03358030|468927827|FG003|Overall Study|Voluntary Withdrawal|1|||
130262766|NCT03358030|468927824|FG000|Overall Study|Other|0|||
130262767|NCT03358030|468927825|FG001|Overall Study|Other|0|||
130262768|NCT03358030|468927826|FG002|Overall Study|Other|1|||
130262769|NCT03358030|468927827|FG003|Overall Study|Other|0|||
130262770|NCT02505425|468927828|FG000|Overall Study|Lost to Follow-up|41|||
130262771|NCT02505425|468927829|FG001|Overall Study|Lost to Follow-up|61|||
130262772|NCT02505425|468927830|FG002|Overall Study|Lost to Follow-up|31|||
130262773|NCT02505425|468927831|FG003|Overall Study|Lost to Follow-up|19|||
130262774|NCT02505425|468927828|FG000|Overall Study|Withdrawal by Subject|39|||
130262775|NCT02505425|468927829|FG001|Overall Study|Withdrawal by Subject|9|||
130262776|NCT02505425|468927830|FG002|Overall Study|Withdrawal by Subject|19|||
130262777|NCT02505425|468927831|FG003|Overall Study|Withdrawal by Subject|7|||
130262778|NCT02505425|468927828|FG000|Overall Study|Death|8|||
130262779|NCT02505425|468927829|FG001|Overall Study|Death|12|||
130262780|NCT02505425|468927830|FG002|Overall Study|Death|0|||
130703997|NCT00401245|470541150|FG007|Open Label Phase|Withdrawal by Subject|0|||
130262781|NCT02505425|468927831|FG003|Overall Study|Death|0|||
130703998|NCT00401245|470541143|FG000|Open Label Phase|Lack of Efficacy|4|||
130703999|NCT00401245|470541144|FG001|Open Label Phase|Lack of Efficacy|2|||
130704000|NCT00401245|470541145|FG002|Open Label Phase|Lack of Efficacy|3|||
130704001|NCT00401245|470541146|FG003|Open Label Phase|Lack of Efficacy|0|||
130262782|NCT02781558|468927835|FG000|Overall Study|Lost to Follow-up|2|||
130262783|NCT02781558|468927836|FG001|Overall Study|Lost to Follow-up|2|||
130262784|NCT02781558|468927835|FG000|Overall Study|Adverse Event|1|||
130262785|NCT02781558|468927836|FG001|Overall Study|Adverse Event|0|||
130262786|NCT04704193|468927837|FG000|Overall Study|Withdrawal by Subject|1|||
130704002|NCT00401245|470541147|FG004|Open Label Phase|Lack of Efficacy|0|||
130262787|NCT01492426|468929184|FG000|Treatment|Death|0|||
130262788|NCT01492426|468929185|FG001|Treatment|Death|1|||
130262789|NCT01492426|468929184|FG000|Treatment|Other|1|||
130262790|NCT01492426|468929185|FG001|Treatment|Other|0|||
130262791|NCT01492426|468929184|FG000|Treatment|Adverse Event|25|||
130262792|NCT01492426|468929185|FG001|Treatment|Adverse Event|25|||
130262793|NCT01492426|468929184|FG000|Treatment|Lack of Efficacy|38|||
130262794|NCT01492426|468929185|FG001|Treatment|Lack of Efficacy|5|||
130262795|NCT01492426|468929184|FG000|Treatment|Participant withdrew consent|1|||
130262796|NCT01492426|468929185|FG001|Treatment|Participant withdrew consent|2|||
130704003|NCT00401245|470541148|FG005|Open Label Phase|Lack of Efficacy|0|||
130262797|NCT01492426|468929184|FG000|Treatment|Poor compliance/noncompliance|1|||
130262798|NCT01492426|468929185|FG001|Treatment|Poor compliance/noncompliance|0|||
130262799|NCT01492426|468929184|FG000|Treatment|Subject requested discontinue study drug|7|||
130262800|NCT01492426|468929185|FG001|Treatment|Subject requested discontinue study drug|3|||
130262801|NCT01492426|468929184|FG000|Treatment|Lost to Follow-up|9|||
130262802|NCT01492426|468929185|FG001|Treatment|Lost to Follow-up|4|||
130262803|NCT01492426|468929184|FG000|Treatment|Participant does not meet study criteria|1|||
130262804|NCT01492426|468929185|FG001|Treatment|Participant does not meet study criteria|0|||
130262805|NCT01492426|468929184|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
130262806|NCT01492426|468929185|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
130262807|NCT01492426|468929184|FG000|Follow-Up|Death|1|||
130262808|NCT01492426|468929185|FG001|Follow-Up|Death|0|||
130262809|NCT01492426|468929184|FG000|Follow-Up|Other|4|||
130262810|NCT01492426|468929185|FG001|Follow-Up|Other|2|||
130262811|NCT01492426|468929184|FG000|Follow-Up|Participant Withdrew Consent|6|||
130262812|NCT01492426|468929185|FG001|Follow-Up|Participant Withdrew Consent|1|||
130262813|NCT01492426|468929184|FG000|Follow-Up|Lost to Follow-up|12|||
130262814|NCT01492426|468929185|FG001|Follow-Up|Lost to Follow-up|6|||
130262815|NCT01978145|468929186|FG000|Treatment Period 1|Adverse Event|1|||
130262816|NCT01978145|468929187|FG001|Treatment Period 1|Adverse Event|9|||
130262817|NCT01978145|468929186|FG000|Treatment Period 1|Physician Decision|1|||
130262818|NCT01978145|468929187|FG001|Treatment Period 1|Physician Decision|0|||
130262819|NCT01978145|468929186|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130262820|NCT01978145|468929187|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130262821|NCT01978145|468929186|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
130262822|NCT01978145|468929187|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
130262823|NCT01978145|468929186|FG000|Washout Period 1|Adverse Event|0|||
130262824|NCT01978145|468929187|FG001|Washout Period 1|Adverse Event|1|||
130262825|NCT01978145|468929186|FG000|Washout Period 1|Withdrawal by Subject|1|||
130262826|NCT01978145|468929187|FG001|Washout Period 1|Withdrawal by Subject|1|||
130262827|NCT01978145|468929186|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
130262828|NCT01978145|468929187|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
130262829|NCT01978145|468929186|FG000|Treatment Period 2|Adverse Event|3|||
130262830|NCT01978145|468929187|FG001|Treatment Period 2|Adverse Event|3|||
130262831|NCT01978145|468929186|FG000|Treatment Period 2|Protocol Violation|0|||
130262832|NCT01978145|468929187|FG001|Treatment Period 2|Protocol Violation|1|||
130262833|NCT01978145|468929186|FG000|Treatment Period 2|Lost to Follow-up|1|||
130262834|NCT01978145|468929187|FG001|Treatment Period 2|Lost to Follow-up|1|||
130262835|NCT01978145|468929186|FG000|Treatment Period 2|Withdrawal by Subject|7|||
130262836|NCT01978145|468929187|FG001|Treatment Period 2|Withdrawal by Subject|4|||
130262837|NCT01978145|468929186|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
130262838|NCT01978145|468929187|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
130262839|NCT01173679|468929192|FG000|Overall Study|Death|1|||
130262840|NCT01250054|468929193|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
130262841|NCT01250054|468929194|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
130262842|NCT02777086|468929195|FG000|Overall Study|Lost to Follow-up|96|||
130262843|NCT02777086|468929196|FG001|Overall Study|Lost to Follow-up|99|||
130262844|NCT01133665|468929199|FG000|Overall Study|Physician Decision|2|||
130262845|NCT02122380|468929200|FG000|First Intervention (30 Days)|Adverse Event|1|||
130262846|NCT02122380|468929201|FG001|First Intervention (30 Days)|Adverse Event|0|||
130262847|NCT02122380|468929200|FG000|First Intervention (30 Days)|Physician Decision|0|||
130262848|NCT02122380|468929201|FG001|First Intervention (30 Days)|Physician Decision|1|||
130262849|NCT02122380|468929200|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
130262850|NCT02122380|468929201|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
130262851|NCT02122380|468929200|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
130262852|NCT02122380|468929201|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
130262853|NCT02122380|468929200|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
130262854|NCT02122380|468929201|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
130262855|NCT02465931|468929204|FG000|Overall Study|Lost to Follow-up|9|||
130262856|NCT02465931|468929205|FG001|Overall Study|Lost to Follow-up|11|||
130262857|NCT02465931|468929204|FG000|Overall Study|Protocol Violation|1|||
130262858|NCT02465931|468929205|FG001|Overall Study|Protocol Violation|0|||
130262859|NCT02465931|468929204|FG000|Overall Study|Withdrawal by Subject|1|||
130262860|NCT02465931|468929205|FG001|Overall Study|Withdrawal by Subject|0|||
130262861|NCT03423602|468929207|FG000|Overall Study|Death|1|||
130262862|NCT03423602|468929207|FG000|Overall Study|Lost to Follow-up|6|||
130262863|NCT03423602|468929207|FG000|Overall Study|Protocol Violation|1|||
130262864|NCT03423602|468929207|FG000|Overall Study|Withdrawal by Subject|4|||
130262865|NCT03423121|468929208|FG000|Overall Study|Lost to Follow-up|2|||
130262866|NCT03423121|468929209|FG001|Overall Study|Lost to Follow-up|6|||
130262867|NCT03423121|468929208|FG000|Overall Study|Adverse Event|1|||
130262868|NCT03423121|468929209|FG001|Overall Study|Adverse Event|0|||
130365576|NCT01602120|469306915|FG000|Overall Study|Death|0|||
130262869|NCT02136914|468929215|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
130262870|NCT02136914|468929216|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
130262871|NCT02136914|468929215|FG000|Overall Study|Withdrawal by Subject|3|||
130262872|NCT02136914|468929216|FG001|Overall Study|Withdrawal by Subject|10|||
130262873|NCT02136914|468929215|FG000|Overall Study|Subject Unwilling to Proceed|7|||
130262874|NCT02136914|468929216|FG001|Overall Study|Subject Unwilling to Proceed|2|||
130262875|NCT02136914|468929215|FG000|Overall Study|Lost to Follow-up|1|||
130262876|NCT02136914|468929216|FG001|Overall Study|Lost to Follow-up|1|||
130262877|NCT02136914|468929215|FG000|Overall Study|Did Not Receive Study Drug|2|||
130262878|NCT02136914|468929216|FG001|Overall Study|Did Not Receive Study Drug|0|||
130262879|NCT02136914|468929215|FG000|Overall Study|Lack of Efficacy|1|||
130262880|NCT02136914|468929216|FG001|Overall Study|Lack of Efficacy|0|||
130262881|NCT02136914|468929215|FG000|Overall Study|Death|0|||
130262882|NCT02136914|468929216|FG001|Overall Study|Death|1|||
130262883|NCT01493089|468929219|FG000|Overall Study|Protocol Violation|2|||
130262884|NCT01493089|468929220|FG001|Overall Study|Protocol Violation|2|||
130262885|NCT01493089|468929219|FG000|Overall Study|Withdrawal by Subject|1|||
130262886|NCT01493089|468929220|FG001|Overall Study|Withdrawal by Subject|0|||
130262887|NCT01493089|468929219|FG000|Overall Study|Physician Decision|0|||
130262888|NCT01493089|468929220|FG001|Overall Study|Physician Decision|1|||
130262889|NCT03012334|468929221|FG000|Period 1|Withdrawal by Subject|0|||
130262890|NCT03012334|468929222|FG001|Period 1|Withdrawal by Subject|0|||
130262891|NCT03012334|468929223|FG002|Period 1|Withdrawal by Subject|0|||
130262892|NCT03012334|468929224|FG003|Period 1|Withdrawal by Subject|0|||
130262893|NCT03012334|468929225|FG004|Period 1|Withdrawal by Subject|0|||
130262894|NCT03012334|468929226|FG005|Period 1|Withdrawal by Subject|0|||
130262895|NCT03012334|468929227|FG006|Period 1|Withdrawal by Subject|0|||
130262896|NCT03012334|468929228|FG007|Period 1|Withdrawal by Subject|0|||
130262897|NCT03012334|468929229|FG008|Period 1|Withdrawal by Subject|0|||
130262898|NCT03012334|468929230|FG009|Period 1|Withdrawal by Subject|1|||
130262899|NCT03012334|468929221|FG000|Period 2|Withdrawal by Subject|0|||
130262900|NCT03012334|468929222|FG001|Period 2|Withdrawal by Subject|1|||
130262901|NCT03012334|468929223|FG002|Period 2|Withdrawal by Subject|0|||
130262902|NCT03012334|468929224|FG003|Period 2|Withdrawal by Subject|0|||
130262903|NCT03012334|468929225|FG004|Period 2|Withdrawal by Subject|0|||
130262904|NCT03012334|468929226|FG005|Period 2|Withdrawal by Subject|0|||
130262905|NCT03012334|468929227|FG006|Period 2|Withdrawal by Subject|0|||
130262906|NCT03012334|468929228|FG007|Period 2|Withdrawal by Subject|0|||
130262907|NCT03012334|468929229|FG008|Period 2|Withdrawal by Subject|0|||
130262908|NCT03012334|468929230|FG009|Period 2|Withdrawal by Subject|0|||
130262909|NCT03012334|468929221|FG000|Period 2|Protocol Violation|0|||
130262910|NCT03012334|468929222|FG001|Period 2|Protocol Violation|0|||
130262911|NCT03012334|468929223|FG002|Period 2|Protocol Violation|1|||
130262912|NCT03012334|468929224|FG003|Period 2|Protocol Violation|0|||
130262913|NCT03012334|468929225|FG004|Period 2|Protocol Violation|0|||
130262914|NCT03012334|468929226|FG005|Period 2|Protocol Violation|0|||
130262915|NCT03012334|468929227|FG006|Period 2|Protocol Violation|0|||
130262916|NCT03012334|468929228|FG007|Period 2|Protocol Violation|1|||
130262917|NCT03012334|468929229|FG008|Period 2|Protocol Violation|0|||
130262918|NCT03012334|468929230|FG009|Period 2|Protocol Violation|0|||
130262919|NCT03012334|468929221|FG000|Period 4|Non-Compliance|0|||
130262920|NCT03012334|468929222|FG001|Period 4|Non-Compliance|0|||
130262921|NCT03012334|468929223|FG002|Period 4|Non-Compliance|0|||
130262922|NCT03012334|468929224|FG003|Period 4|Non-Compliance|0|||
130262923|NCT03012334|468929225|FG004|Period 4|Non-Compliance|0|||
130262924|NCT03012334|468929226|FG005|Period 4|Non-Compliance|0|||
130262925|NCT03012334|468929227|FG006|Period 4|Non-Compliance|1|||
130262926|NCT03012334|468929228|FG007|Period 4|Non-Compliance|0|||
130262927|NCT03012334|468929229|FG008|Period 4|Non-Compliance|0|||
130262928|NCT03012334|468929230|FG009|Period 4|Non-Compliance|0|||
130262929|NCT03012334|468929221|FG000|Period 4|Adverse Event|0|||
130262930|NCT03012334|468929222|FG001|Period 4|Adverse Event|0|||
130262931|NCT03012334|468929223|FG002|Period 4|Adverse Event|0|||
130262932|NCT03012334|468929224|FG003|Period 4|Adverse Event|0|||
130262933|NCT03012334|468929225|FG004|Period 4|Adverse Event|0|||
130262934|NCT03012334|468929226|FG005|Period 4|Adverse Event|0|||
130262935|NCT03012334|468929227|FG006|Period 4|Adverse Event|0|||
130262936|NCT03012334|468929228|FG007|Period 4|Adverse Event|0|||
130262937|NCT03012334|468929229|FG008|Period 4|Adverse Event|1|||
130262938|NCT03012334|468929230|FG009|Period 4|Adverse Event|0|||
130262939|NCT00325143|468929231|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
130262940|NCT00325143|468929231|FG000|Overall Study|Migrated/moved from study area|1|||
130262941|NCT00325143|468929231|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
130262942|NCT00325143|468929231|FG000|Overall Study|Withdrawal by Subject|8|||
130262943|NCT01073293|468929232|FG000|Overall Study|Lost to Follow-up|0|||
130262944|NCT01073293|468929233|FG001|Overall Study|Lost to Follow-up|1|||
130262945|NCT01073293|468929232|FG000|Overall Study|Withdrawal by Subject|5|||
130262946|NCT01073293|468929233|FG001|Overall Study|Withdrawal by Subject|10|||
130262947|NCT00256126|468929234|FG000|Overall Study|Adverse Event|1|||
130262948|NCT00256126|468929235|FG001|Overall Study|Adverse Event|0|||
130262949|NCT00256126|468929234|FG000|Overall Study|Other|1|||
130262950|NCT00256126|468929235|FG001|Overall Study|Other|2|||
130262951|NCT00454116|468929238|FG000|Overall Study|Adverse Event|5|||
130262952|NCT00454116|468929239|FG001|Overall Study|Adverse Event|11|||
130262953|NCT00454116|468929240|FG002|Overall Study|Adverse Event|9|||
130262954|NCT00454116|468929238|FG000|Overall Study|Condition under investigation worsened|17|||
130262955|NCT00454116|468929239|FG001|Overall Study|Condition under investigation worsened|13|||
130262956|NCT00454116|468929240|FG002|Overall Study|Condition under investigation worsened|18|||
130262957|NCT00454116|468929238|FG000|Overall Study|Withdrawal by Subject|3|||
130262958|NCT00454116|468929239|FG001|Overall Study|Withdrawal by Subject|3|||
130262959|NCT00454116|468929240|FG002|Overall Study|Withdrawal by Subject|1|||
130704004|NCT00401245|470541149|FG006|Open Label Phase|Lack of Efficacy|0|||
130262960|NCT00454116|468929238|FG000|Overall Study|Other|2|||
130262961|NCT00454116|468929239|FG001|Overall Study|Other|2|||
130262962|NCT00454116|468929240|FG002|Overall Study|Other|0|||
130262963|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Physician Decision|2|||
130262964|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Physician Decision|0|||
130704005|NCT00401245|470541150|FG007|Open Label Phase|Lack of Efficacy|0|||
130704006|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Adverse Event|0|||
130704007|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Adverse Event|0|||
130704008|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Adverse Event|0|||
130704009|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Adverse Event|0|||
130704010|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Adverse Event|1|||
130704011|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Adverse Event|1|||
130704012|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Adverse Event|2|||
130704013|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Adverse Event|4|||
130704014|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Investigator request|0|||
130704015|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Investigator request|0|||
130704016|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Investigator request|0|||
130704017|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Investigator request|0|||
130704018|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Investigator request|0|||
130704019|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Investigator request|0|||
130704020|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Investigator request|0|||
130704021|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Investigator request|1|||
130704022|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Other|0|||
130704023|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Other|0|||
130704024|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Other|0|||
130704025|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Other|0|||
130704026|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Other|1|||
130704027|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Other|0|||
130704028|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Other|2|||
130262965|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Physician Decision|0|||
130262966|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Adverse Event|33|||
130262967|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Adverse Event|0|||
130262968|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Adverse Event|0|||
130262969|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
130262970|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130262971|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130262972|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
130262973|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130262974|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130262975|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
130262976|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
130262977|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
130262978|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
130262979|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
130262980|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
130262981|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
130262982|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
130262983|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
130262984|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
130262985|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
130262986|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
130262987|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130704029|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Other|2|||
130704030|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704031|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130262988|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130262989|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
130262990|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130262991|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130262992|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
130704032|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704033|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704034|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130704035|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130704036|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
130704037|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704038|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704039|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704040|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704041|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704042|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704043|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
130704044|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704045|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704046|NCT01989676|470541151|FG000|Overall Study|Death|52|||
130704047|NCT01989676|470541152|FG001|Overall Study|Death|60|||
130704048|NCT01989676|470541151|FG000|Overall Study|Protocol Violation|2|||
130704049|NCT01989676|470541152|FG001|Overall Study|Protocol Violation|1|||
130704050|NCT01989676|470541151|FG000|Overall Study|Lost to Follow-up|8|||
130704051|NCT01989676|470541152|FG001|Overall Study|Lost to Follow-up|18|||
130704052|NCT01989676|470541151|FG000|Overall Study|No longer willing to participate in study|26|||
130704053|NCT01989676|470541152|FG001|Overall Study|No longer willing to participate in study|26|||
130704054|NCT01989676|470541151|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
130704055|NCT01989676|470541152|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
130704056|NCT01989676|470541151|FG000|Overall Study|Other|4|||
130704057|NCT01989676|470541152|FG001|Overall Study|Other|3|||
130704058|NCT03941834|470541153|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130704059|NCT03941834|470541154|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
130704060|NCT03941834|470541155|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130704061|NCT03941834|470541153|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
130704062|NCT03941834|470541154|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130704063|NCT03941834|470541155|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130704064|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130704065|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130704066|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
130704067|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130704068|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130704069|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
130704070|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
130704071|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
130704072|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
130704073|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130704074|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130704075|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
130704076|NCT00991510|470541158|FG000|Period I (Days 1-14)|Adverse Event|1|||
130704077|NCT00991510|470541159|FG001|Period I (Days 1-14)|Adverse Event|0|||
130262993|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
130704078|NCT00991510|470541158|FG000|Period III (Days 29-112)|Adverse Event|1|||
130262994|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
130262995|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
130262996|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130262997|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130262998|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
130262999|NCT03338400|468929246|FG000|Overall Study|Lost to Follow-up|1|||
130263000|NCT03338400|468929247|FG001|Overall Study|Lost to Follow-up|2|||
130263001|NCT01627691|468929248|FG000|Overall Study|Death|11|||
130263002|NCT01627691|468929248|FG000|Overall Study|Lost to Follow-up|3|||
130263003|NCT01627691|468929248|FG000|Overall Study|Withdrawal by Subject|1|||
130263004|NCT01627691|468929248|FG000|Overall Study|Missed the visit|3|||
130263005|NCT00186628|468929255|FG000|Overall Study|Death|2|||
130263006|NCT00186628|468929255|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
130263007|NCT02927795|468929256|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
130263008|NCT02927795|468929256|FG000|Overall Study|Not Treated|4|||
130263009|NCT01076010|468929257|FG000|Overall Study|Death|15|||
130263010|NCT01076010|468929258|FG001|Overall Study|Death|1|||
130263011|NCT01076010|468929259|FG002|Overall Study|Death|0|||
130263012|NCT01076010|468929257|FG000|Overall Study|Adverse Event|7|||
130263013|NCT01076010|468929258|FG001|Overall Study|Adverse Event|2|||
130704079|NCT00991510|470541159|FG001|Period III (Days 29-112)|Adverse Event|1|||
130704080|NCT01124695|470541160|FG000|Overall Study|Disease progression|77|||
130704081|NCT01124695|470541160|FG000|Overall Study|Adverse Event|11|||
130704082|NCT01124695|470541160|FG000|Overall Study|Death|1|||
130704083|NCT01124695|470541160|FG000|Overall Study|Withdrawal by Subject|7|||
130263014|NCT01076010|468929259|FG002|Overall Study|Adverse Event|0|||
130704084|NCT01124695|470541160|FG000|Overall Study|Physician Decision|3|||
130704085|NCT01124695|470541160|FG000|Overall Study|Alternative therapy|9|||
130704086|NCT01124695|470541160|FG000|Overall Study|No documentation that patient went off treatment|4|||
130704087|NCT01124695|470541160|FG000|Overall Study|Ineligible|9|||
130704088|NCT01124695|470541160|FG000|Overall Study|Ineligible and never start treatment|2|||
130704089|NCT02443324|470541164|FG000|Overall Study|Death|4|||
130704090|NCT02443324|470541165|FG001|Overall Study|Death|1|||
130704091|NCT02443324|470541166|FG002|Overall Study|Death|0|||
130704092|NCT02443324|470541167|FG003|Overall Study|Death|3|||
130704093|NCT02443324|470541168|FG004|Overall Study|Death|1|||
130704094|NCT02443324|470541169|FG005|Overall Study|Death|3|||
130704095|NCT02443324|470541170|FG006|Overall Study|Death|2|||
130704096|NCT02443324|470541164|FG000|Overall Study|Lost to Follow-up|0|||
130704097|NCT02443324|470541165|FG001|Overall Study|Lost to Follow-up|0|||
130704098|NCT02443324|470541166|FG002|Overall Study|Lost to Follow-up|0|||
130704099|NCT02443324|470541167|FG003|Overall Study|Lost to Follow-up|1|||
130704100|NCT02443324|470541168|FG004|Overall Study|Lost to Follow-up|0|||
130704101|NCT02443324|470541169|FG005|Overall Study|Lost to Follow-up|1|||
130704102|NCT02443324|470541170|FG006|Overall Study|Lost to Follow-up|0|||
130704103|NCT02443324|470541164|FG000|Overall Study|Physician Decision|0|||
130704104|NCT02443324|470541165|FG001|Overall Study|Physician Decision|3|||
130704105|NCT02443324|470541166|FG002|Overall Study|Physician Decision|5|||
130704106|NCT02443324|470541167|FG003|Overall Study|Physician Decision|1|||
130704107|NCT02443324|470541168|FG004|Overall Study|Physician Decision|1|||
130704108|NCT02443324|470541169|FG005|Overall Study|Physician Decision|0|||
130704109|NCT02443324|470541170|FG006|Overall Study|Physician Decision|2|||
130704110|NCT02443324|470541164|FG000|Overall Study|Progressive Disease|20|||
130704111|NCT02443324|470541165|FG001|Overall Study|Progressive Disease|20|||
130704112|NCT02443324|470541166|FG002|Overall Study|Progressive Disease|13|||
130704113|NCT02443324|470541167|FG003|Overall Study|Progressive Disease|10|||
130263015|NCT01076010|468929257|FG000|Overall Study|Progressive disease|90|||
130263016|NCT01076010|468929258|FG001|Overall Study|Progressive disease|30|||
130263017|NCT01076010|468929259|FG002|Overall Study|Progressive disease|1|||
130365577|NCT01602120|469306916|FG001|Overall Study|Death|4|||
130704114|NCT02443324|470541168|FG004|Overall Study|Progressive Disease|13|||
130553966|NCT00568321|469996468|FG002|Overall Study|Randomized, not treated|1|||
130704115|NCT02443324|470541169|FG005|Overall Study|Progressive Disease|17|||
130704116|NCT02443324|470541170|FG006|Overall Study|Progressive Disease|10|||
130704117|NCT02443324|470541164|FG000|Overall Study|Withdrawal by Subject|0|||
130704118|NCT02443324|470541165|FG001|Overall Study|Withdrawal by Subject|0|||
130704119|NCT02443324|470541166|FG002|Overall Study|Withdrawal by Subject|3|||
130704120|NCT02443324|470541167|FG003|Overall Study|Withdrawal by Subject|1|||
130704121|NCT02443324|470541168|FG004|Overall Study|Withdrawal by Subject|1|||
130704122|NCT02443324|470541169|FG005|Overall Study|Withdrawal by Subject|0|||
130704123|NCT02443324|470541170|FG006|Overall Study|Withdrawal by Subject|1|||
130704124|NCT02443324|470541164|FG000|Overall Study|Adverse Event|0|||
130263018|NCT01076010|468929257|FG000|Overall Study|Lack of Efficacy|4|||
130263019|NCT01076010|468929258|FG001|Overall Study|Lack of Efficacy|0|||
130263020|NCT01076010|468929259|FG002|Overall Study|Lack of Efficacy|0|||
130704125|NCT02443324|470541165|FG001|Overall Study|Adverse Event|1|||
130704126|NCT02443324|470541166|FG002|Overall Study|Adverse Event|3|||
130704127|NCT02443324|470541167|FG003|Overall Study|Adverse Event|0|||
130704128|NCT02443324|470541168|FG004|Overall Study|Adverse Event|4|||
130704129|NCT02443324|470541169|FG005|Overall Study|Adverse Event|3|||
130704130|NCT02443324|470541170|FG006|Overall Study|Adverse Event|3|||
130263021|NCT01076010|468929257|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130263022|NCT01076010|468929258|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
130263023|NCT01076010|468929259|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130263024|NCT01076010|468929257|FG000|Overall Study|Significant Surgical Procedure|0|||
130263025|NCT01076010|468929258|FG001|Overall Study|Significant Surgical Procedure|1|||
130263026|NCT01076010|468929259|FG002|Overall Study|Significant Surgical Procedure|0|||
130263027|NCT01076010|468929257|FG000|Overall Study|Protocol Violation|0|||
130263028|NCT01076010|468929258|FG001|Overall Study|Protocol Violation|1|||
130263029|NCT01076010|468929259|FG002|Overall Study|Protocol Violation|0|||
130263030|NCT01076010|468929257|FG000|Overall Study|Noncompliance|1|||
130263031|NCT01076010|468929258|FG001|Overall Study|Noncompliance|1|||
130263032|NCT01076010|468929259|FG002|Overall Study|Noncompliance|0|||
130263033|NCT01076010|468929257|FG000|Overall Study|Withdrawal by Subject|3|||
130263034|NCT01076010|468929258|FG001|Overall Study|Withdrawal by Subject|0|||
130263035|NCT01076010|468929259|FG002|Overall Study|Withdrawal by Subject|1|||
130263036|NCT01076010|468929257|FG000|Overall Study|Other|5|||
130263037|NCT01076010|468929258|FG001|Overall Study|Other|2|||
130263038|NCT01076010|468929259|FG002|Overall Study|Other|0|||
130263039|NCT00760552|468929281|FG000|Overall Study|Death|2|||
130263040|NCT00760552|468929282|FG001|Overall Study|Death|0|||
130263041|NCT00760552|468929281|FG000|Overall Study|Lost to Follow-up|11|||
130263042|NCT00760552|468929282|FG001|Overall Study|Lost to Follow-up|10|||
130263043|NCT02536664|468929290|FG000|Overall Study|Inadequate completion of documentation|2|||
130263044|NCT02536664|468929291|FG001|Overall Study|Inadequate completion of documentation|4|||
130263045|NCT02536664|468929290|FG000|Overall Study|Progression|13|||
130263046|NCT02536664|468929291|FG001|Overall Study|Progression|18|||
130263047|NCT02536664|468929290|FG000|Overall Study|Death due to lymphoma|2|||
130263048|NCT02536664|468929291|FG001|Overall Study|Death due to lymphoma|1|||
130263049|NCT02536664|468929290|FG000|Overall Study|Death due to other reason|3|||
130263050|NCT02536664|468929291|FG001|Overall Study|Death due to other reason|2|||
130263051|NCT02536664|468929290|FG000|Overall Study|Intolerability|8|||
130263052|NCT02536664|468929291|FG001|Overall Study|Intolerability|6|||
130263053|NCT02536664|468929290|FG000|Overall Study|Withdrawal by Subject|8|||
130263054|NCT02536664|468929291|FG001|Overall Study|Withdrawal by Subject|5|||
130263055|NCT02536664|468929290|FG000|Overall Study|Other|18|||
130263056|NCT02536664|468929291|FG001|Overall Study|Other|24|||
130263057|NCT02536664|468929290|FG000|Overall Study|Missing|53|||
130263058|NCT02536664|468929291|FG001|Overall Study|Missing|20|||
130263059|NCT03961308|468929304|FG000|Overall Study|Withdrawal by Subject|1|||
130263060|NCT03961308|468929305|FG001|Overall Study|Withdrawal by Subject|0|||
130263061|NCT03961308|468929304|FG000|Overall Study|Other|1|||
130263062|NCT03961308|468929305|FG001|Overall Study|Other|0|||
130263063|NCT03961308|468929304|FG000|Overall Study|Lost to Follow-up|0|||
130263064|NCT03961308|468929305|FG001|Overall Study|Lost to Follow-up|1|||
130263065|NCT03961308|468929304|FG000|Overall Study|Adverse Event|0|||
130263066|NCT03961308|468929305|FG001|Overall Study|Adverse Event|1|||
130263067|NCT03710889|468929306|FG000|Overall Study|Adverse Event|2|||
130263068|NCT03710889|468929306|FG000|Overall Study|Protocol Deviation|1|||
130263069|NCT00570713|468929307|FG000|Overall Study|Adverse Event|16|||
130263070|NCT00570713|468929308|FG001|Overall Study|Adverse Event|9|||
130263071|NCT00570713|468929307|FG000|Overall Study|Death|7|||
130263072|NCT00570713|468929308|FG001|Overall Study|Death|7|||
130263073|NCT00570713|468929307|FG000|Overall Study|Lack of Efficacy|40|||
130263074|NCT00570713|468929308|FG001|Overall Study|Lack of Efficacy|49|||
130263075|NCT00570713|468929307|FG000|Overall Study|Physician Decision|2|||
130263076|NCT00570713|468929308|FG001|Overall Study|Physician Decision|2|||
130263077|NCT00570713|468929307|FG000|Overall Study|Withdrawal by Subject|3|||
130263078|NCT00570713|468929308|FG001|Overall Study|Withdrawal by Subject|3|||
130263079|NCT00570713|468929307|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
130263080|NCT00570713|468929308|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
130704131|NCT02443324|470541164|FG000|Overall Study|Enrolled but Never Treated|0|||
130704132|NCT02443324|470541165|FG001|Overall Study|Enrolled but Never Treated|0|||
130704133|NCT02443324|470541166|FG002|Overall Study|Enrolled but Never Treated|1|||
130704134|NCT02443324|470541167|FG003|Overall Study|Enrolled but Never Treated|0|||
130704135|NCT02443324|470541168|FG004|Overall Study|Enrolled but Never Treated|1|||
130704136|NCT02443324|470541169|FG005|Overall Study|Enrolled but Never Treated|0|||
130263081|NCT04881760|468929309|FG000|Overall Study|Adverse Event|0|||
130263082|NCT04881760|468929310|FG001|Overall Study|Adverse Event|1|||
130263083|NCT04881760|468929311|FG002|Overall Study|Adverse Event|1|||
130263084|NCT04881760|468929312|FG003|Overall Study|Adverse Event|0|||
130263085|NCT04881760|468929313|FG004|Overall Study|Adverse Event|1|||
130263086|NCT04881760|468929314|FG005|Overall Study|Adverse Event|1|||
130263087|NCT04881760|468929315|FG006|Overall Study|Adverse Event|2|||
130263088|NCT04881760|468929309|FG000|Overall Study|Death|0|||
130263089|NCT04881760|468929310|FG001|Overall Study|Death|0|||
130263090|NCT04881760|468929311|FG002|Overall Study|Death|0|||
130263091|NCT04881760|468929312|FG003|Overall Study|Death|1|||
130263092|NCT04881760|468929313|FG004|Overall Study|Death|0|||
130263093|NCT04881760|468929314|FG005|Overall Study|Death|0|||
130263094|NCT04881760|468929315|FG006|Overall Study|Death|0|||
130263095|NCT04881760|468929309|FG000|Overall Study|Lost to Follow-up|5|||
130263096|NCT04881760|468929310|FG001|Overall Study|Lost to Follow-up|7|||
130263097|NCT04881760|468929311|FG002|Overall Study|Lost to Follow-up|5|||
130263098|NCT04881760|468929312|FG003|Overall Study|Lost to Follow-up|1|||
130263099|NCT04881760|468929313|FG004|Overall Study|Lost to Follow-up|2|||
130263100|NCT04881760|468929314|FG005|Overall Study|Lost to Follow-up|4|||
130263101|NCT04881760|468929315|FG006|Overall Study|Lost to Follow-up|4|||
130263102|NCT04881760|468929309|FG000|Overall Study|Withdrawal by Subject|13|||
130263103|NCT04881760|468929310|FG001|Overall Study|Withdrawal by Subject|1|||
130263104|NCT04881760|468929311|FG002|Overall Study|Withdrawal by Subject|1|||
130263105|NCT04881760|468929312|FG003|Overall Study|Withdrawal by Subject|4|||
130263106|NCT04881760|468929313|FG004|Overall Study|Withdrawal by Subject|2|||
130263107|NCT04881760|468929314|FG005|Overall Study|Withdrawal by Subject|1|||
130263108|NCT04881760|468929315|FG006|Overall Study|Withdrawal by Subject|2|||
130263109|NCT04881760|468929309|FG000|Overall Study|Randomized but Never Treated|0|||
130263110|NCT04881760|468929310|FG001|Overall Study|Randomized but Never Treated|0|||
130263111|NCT04881760|468929311|FG002|Overall Study|Randomized but Never Treated|0|||
130263112|NCT04881760|468929312|FG003|Overall Study|Randomized but Never Treated|1|||
130263113|NCT04881760|468929313|FG004|Overall Study|Randomized but Never Treated|0|||
130263114|NCT04881760|468929314|FG005|Overall Study|Randomized but Never Treated|0|||
130263115|NCT04881760|468929315|FG006|Overall Study|Randomized but Never Treated|0|||
130263116|NCT04881760|468929309|FG000|Overall Study|Inadvertent Enrollment|2|||
130263117|NCT04881760|468929310|FG001|Overall Study|Inadvertent Enrollment|0|||
130263118|NCT04881760|468929311|FG002|Overall Study|Inadvertent Enrollment|0|||
130263119|NCT04881760|468929312|FG003|Overall Study|Inadvertent Enrollment|0|||
130263120|NCT04881760|468929313|FG004|Overall Study|Inadvertent Enrollment|0|||
130263121|NCT04881760|468929314|FG005|Overall Study|Inadvertent Enrollment|0|||
130263122|NCT04881760|468929315|FG006|Overall Study|Inadvertent Enrollment|0|||
130263123|NCT04881760|468929309|FG000|Overall Study|Site Closure|0|||
130263124|NCT04881760|468929310|FG001|Overall Study|Site Closure|0|||
130263125|NCT04881760|468929311|FG002|Overall Study|Site Closure|0|||
130263126|NCT04881760|468929312|FG003|Overall Study|Site Closure|1|||
130263127|NCT04881760|468929313|FG004|Overall Study|Site Closure|0|||
130263128|NCT04881760|468929314|FG005|Overall Study|Site Closure|0|||
130263129|NCT04881760|468929315|FG006|Overall Study|Site Closure|0|||
130263130|NCT01538199|468929319|FG000|Overall Study|Lost to Follow-up|1|||
130263131|NCT01538199|468929320|FG001|Overall Study|Lost to Follow-up|2|||
130263132|NCT01538199|468929321|FG002|Overall Study|Lost to Follow-up|1|||
130263133|NCT01538199|468929322|FG003|Overall Study|Lost to Follow-up|0|||
130263134|NCT01538199|468929319|FG000|Overall Study|participant did not have time|1|||
130263135|NCT01538199|468929320|FG001|Overall Study|participant did not have time|0|||
130263136|NCT01538199|468929321|FG002|Overall Study|participant did not have time|0|||
130263137|NCT01538199|468929322|FG003|Overall Study|participant did not have time|2|||
130263138|NCT01538199|468929319|FG000|Overall Study|Lack of Efficacy|0|||
130263139|NCT01538199|468929320|FG001|Overall Study|Lack of Efficacy|1|||
130263140|NCT01538199|468929321|FG002|Overall Study|Lack of Efficacy|0|||
130263141|NCT01538199|468929322|FG003|Overall Study|Lack of Efficacy|0|||
130263142|NCT05899829|468929325|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130704137|NCT02443324|470541170|FG006|Overall Study|Enrolled but Never Treated|1|||
130704138|NCT00298740|470541171|FG000|Overall Study|Lack of Efficacy|6|||
130704139|NCT00298740|470541171|FG000|Overall Study|Withdrawal by Subject|3|||
130704140|NCT00684567|470541172|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
130704141|NCT00684567|470541172|FG000|Monotherapy Period|Adverse Event|2|||
130704142|NCT00684567|470541172|FG000|Monotherapy Period|Death|1|||
130704143|NCT00684567|470541172|FG000|Monotherapy Period|Progression of primary disease|11|||
130704144|NCT03136406|470541175|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
130704145|NCT00988208|470541178|FG000|Overall Study|Adverse Event|71|||
130704146|NCT00988208|470541179|FG001|Overall Study|Adverse Event|122|||
130704147|NCT00988208|470541178|FG000|Overall Study|Disease Progression|103|||
130704148|NCT00988208|470541179|FG001|Overall Study|Disease Progression|89|||
130704149|NCT00988208|470541178|FG000|Overall Study|Withdrawal by Subject|50|||
130704150|NCT00988208|470541179|FG001|Overall Study|Withdrawal by Subject|57|||
130704151|NCT00988208|470541178|FG000|Overall Study|Death|9|||
130704152|NCT00988208|470541179|FG001|Overall Study|Death|15|||
130704153|NCT00988208|470541178|FG000|Overall Study|Lost to Follow-up|2|||
130704154|NCT00988208|470541179|FG001|Overall Study|Lost to Follow-up|3|||
130704155|NCT00988208|470541178|FG000|Overall Study|Protocol Violation|9|||
130263143|NCT05899829|468929326|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130263144|NCT05899829|468929325|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
130263145|NCT05899829|468929326|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
130263146|NCT01280968|468929327|FG000|Overall Study|Lost to Follow-up|8|||
130263147|NCT01280968|468929328|FG001|Overall Study|Lost to Follow-up|2|||
130365578|NCT01602120|469306917|FG002|Overall Study|Death|0|||
130263148|NCT01280968|468929327|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
130263149|NCT01280968|468929328|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
130263150|NCT01280968|468929327|FG000|Overall Study|Commuting Problems|2|||
130263151|NCT01280968|468929328|FG001|Overall Study|Commuting Problems|0|||
130263152|NCT01280968|468929327|FG000|Overall Study|Anxiety|2|||
130263153|NCT01280968|468929328|FG001|Overall Study|Anxiety|0|||
130263154|NCT01280968|468929327|FG000|Overall Study|Adverse Event|1|||
130263155|NCT01280968|468929328|FG001|Overall Study|Adverse Event|0|||
130263156|NCT01280968|468929327|FG000|Overall Study|Scheduling Conflicts|1|||
130263157|NCT01280968|468929328|FG001|Overall Study|Scheduling Conflicts|1|||
130263158|NCT01280968|468929327|FG000|Overall Study|Pre-existing Neurological Condition|1|||
130263159|NCT01280968|468929328|FG001|Overall Study|Pre-existing Neurological Condition|0|||
130263160|NCT01280968|468929327|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
130263161|NCT01280968|468929328|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
130263162|NCT00542178|468929329|FG000|Overall Study|did not complete year 4 follow-up|75|||
130263163|NCT00542178|468929330|FG001|Overall Study|did not complete year 4 follow-up|80|||
130263164|NCT00542178|468929331|FG002|Overall Study|did not complete year 4 follow-up|74|||
130263165|NCT00542178|468929332|FG003|Overall Study|did not complete year 4 follow-up|62|||
130263166|NCT00542178|468929333|FG004|Overall Study|did not complete year 4 follow-up|64|||
130263167|NCT00542178|468929334|FG005|Overall Study|did not complete year 4 follow-up|89|||
130263168|NCT00542178|468929335|FG006|Overall Study|did not complete year 4 follow-up|87|||
130263169|NCT00542178|468929336|FG007|Overall Study|did not complete year 4 follow-up|85|||
130263170|NCT03984188|468929342|FG000|Overall Study|Death|2|||
130263171|NCT03984188|468929343|FG001|Overall Study|Death|4|||
130263172|NCT03984188|468929342|FG000|Overall Study|Physician Decision|0|||
130263173|NCT03984188|468929343|FG001|Overall Study|Physician Decision|2|||
130263174|NCT03984188|468929342|FG000|Overall Study|Lost to Follow-up|3|||
130263175|NCT03984188|468929343|FG001|Overall Study|Lost to Follow-up|2|||
130263176|NCT03984188|468929342|FG000|Overall Study|Withdrawal by Subject|6|||
130263177|NCT03984188|468929343|FG001|Overall Study|Withdrawal by Subject|0|||
130263178|NCT00652743|468930966|FG000|Months 12-18|Lost to Follow-up|1|||
130263179|NCT00652743|468930967|FG001|Months 12-18|Lost to Follow-up|2|||
130263180|NCT00652743|468930968|FG002|Months 12-18|Lost to Follow-up|7|||
130263181|NCT00652743|468930966|FG000|Months 24-30|Other|5|||
130263182|NCT00652743|468930967|FG001|Months 24-30|Other|1|||
130263183|NCT00652743|468930968|FG002|Months 24-30|Other|11|||
130263184|NCT00652743|468930966|FG000|Months 36-42|Serious Adverse Events|0|||
130263185|NCT00652743|468930967|FG001|Months 36-42|Serious Adverse Events|1|||
130263186|NCT00652743|468930968|FG002|Months 36-42|Serious Adverse Events|1|||
130263187|NCT00652743|468930966|FG000|Months 36-42|Withdrawal by Subject|1|||
130263188|NCT00652743|468930967|FG001|Months 36-42|Withdrawal by Subject|1|||
130263189|NCT00652743|468930968|FG002|Months 36-42|Withdrawal by Subject|0|||
130263190|NCT00652743|468930966|FG000|Months 36-42|Lost to Follow-up|0|||
130263191|NCT00652743|468930967|FG001|Months 36-42|Lost to Follow-up|1|||
130263192|NCT00652743|468930968|FG002|Months 36-42|Lost to Follow-up|0|||
130263193|NCT00652743|468930966|FG000|Months 36-42|Migrated/moved from study area|1|||
130263194|NCT00652743|468930967|FG001|Months 36-42|Migrated/moved from study area|0|||
130263195|NCT00652743|468930968|FG002|Months 36-42|Migrated/moved from study area|0|||
130263196|NCT00652743|468930966|FG000|Months 36-42|Other|4|||
130263197|NCT00652743|468930967|FG001|Months 36-42|Other|2|||
130263198|NCT00652743|468930968|FG002|Months 36-42|Other|8|||
130263199|NCT00272792|468930973|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
130263200|NCT00272792|468930974|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
130263201|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
130263202|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
130263203|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
130263204|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
130263205|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
130263206|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
130263207|NCT05111145|468930975|FG000|Overall Study|Commercial drug is available for participant|76|||
130263208|NCT05111145|468930975|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
130263209|NCT02336815|468930976|FG000|Overall Study|Disease Progression|45|||
130263210|NCT02336815|468930977|FG001|Overall Study|Disease Progression|70|||
130263211|NCT02336815|468930976|FG000|Overall Study|Adverse Event|18|||
130263212|NCT02336815|468930977|FG001|Overall Study|Adverse Event|39|||
130263213|NCT02336815|468930976|FG000|Overall Study|Physician Decision|11|||
130263214|NCT02336815|468930977|FG001|Overall Study|Physician Decision|4|||
130263215|NCT02336815|468930976|FG000|Overall Study|Withdrawal by Subject|3|||
130263216|NCT02336815|468930977|FG001|Overall Study|Withdrawal by Subject|2|||
130263217|NCT02336815|468930976|FG000|Overall Study|Lost to Follow-up|1|||
130263218|NCT02336815|468930977|FG001|Overall Study|Lost to Follow-up|3|||
130263219|NCT02336815|468930976|FG000|Overall Study|Other|1|||
130263220|NCT02336815|468930977|FG001|Overall Study|Other|5|||
130263221|NCT04099277|468930978|FG000|Overall Study|Physician Decision|1|||
130263222|NCT04099277|468930978|FG000|Overall Study|Withdrawal by Subject|1|||
130263223|NCT00492557|468930979|FG000|Overall Study|Subject request|12|||
130263224|NCT00492557|468930980|FG001|Overall Study|Subject request|11|||
130263225|NCT00492557|468930979|FG000|Overall Study|Protocol Violation|7|||
130263226|NCT00492557|468930980|FG001|Overall Study|Protocol Violation|8|||
130263227|NCT00492557|468930979|FG000|Overall Study|Other|2|||
130263228|NCT00492557|468930980|FG001|Overall Study|Other|2|||
130263229|NCT00492557|468930979|FG000|Overall Study|Death|1|||
130263230|NCT00492557|468930980|FG001|Overall Study|Death|1|||
130263231|NCT00492557|468930979|FG000|Overall Study|Adverse Event|1|||
130263232|NCT00492557|468930980|FG001|Overall Study|Adverse Event|0|||
130263233|NCT00492557|468930979|FG000|Overall Study|Failed to return|1|||
130263234|NCT00492557|468930980|FG001|Overall Study|Failed to return|0|||
130263235|NCT00492557|468930979|FG000|Overall Study|Lost to Follow-up|0|||
130263236|NCT00492557|468930980|FG001|Overall Study|Lost to Follow-up|1|||
130263237|NCT01354223|468930981|FG000|Overall Study|Withdrawal by Subject|3|||
130263238|NCT01354223|468930982|FG001|Overall Study|Withdrawal by Subject|1|||
130263239|NCT00948688|468930988|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
130263240|NCT00948688|468930989|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
130263241|NCT00948688|468930988|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
130263242|NCT00948688|468930989|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
130263243|NCT00948688|468930988|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
130263244|NCT00948688|468930989|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
130263245|NCT01135992|468930990|FG000|Overall Study|Adverse Event|1|||
130263246|NCT01135992|468930990|FG000|Overall Study|Lack of Efficacy|1|||
130263247|NCT01135992|468930990|FG000|Overall Study|Protocol Violation|2|||
130263248|NCT01135992|468930990|FG000|Overall Study|Withdrawal criteria|10|||
130263249|NCT01135992|468930990|FG000|Overall Study|Unclassified|7|||
130263250|NCT02852967|468930991|FG000|Overall Study|Adverse Event|3|||
130263251|NCT02852967|468930992|FG001|Overall Study|Adverse Event|1|||
130263252|NCT02852967|468930993|FG002|Overall Study|Adverse Event|0|||
130263253|NCT02852967|468930994|FG003|Overall Study|Adverse Event|1|||
130263254|NCT02852967|468930995|FG004|Overall Study|Adverse Event|0|||
130263255|NCT02852967|468930991|FG000|Overall Study|Death|1|||
130263256|NCT02852967|468930992|FG001|Overall Study|Death|0|||
130263257|NCT02852967|468930993|FG002|Overall Study|Death|0|||
130263258|NCT02852967|468930994|FG003|Overall Study|Death|0|||
130263259|NCT02852967|468930995|FG004|Overall Study|Death|0|||
130263260|NCT02852967|468930991|FG000|Overall Study|Lost to Follow-up|1|||
130263261|NCT02852967|468930992|FG001|Overall Study|Lost to Follow-up|2|||
130263262|NCT02852967|468930993|FG002|Overall Study|Lost to Follow-up|3|||
130263263|NCT02852967|468930994|FG003|Overall Study|Lost to Follow-up|4|||
130263264|NCT02852967|468930995|FG004|Overall Study|Lost to Follow-up|4|||
130263265|NCT02852967|468930991|FG000|Overall Study|Withdrawal by Subject|6|||
130263266|NCT02852967|468930992|FG001|Overall Study|Withdrawal by Subject|12|||
130263267|NCT02852967|468930993|FG002|Overall Study|Withdrawal by Subject|7|||
130263268|NCT02852967|468930994|FG003|Overall Study|Withdrawal by Subject|10|||
130263269|NCT02852967|468930995|FG004|Overall Study|Withdrawal by Subject|10|||
130263270|NCT02852967|468930991|FG000|Overall Study|SAE|0|||
130263271|NCT02852967|468930992|FG001|Overall Study|SAE|0|||
130263272|NCT02852967|468930993|FG002|Overall Study|SAE|0|||
130263273|NCT02852967|468930994|FG003|Overall Study|SAE|3|||
130263274|NCT02852967|468930995|FG004|Overall Study|SAE|0|||
130263275|NCT02852967|468930991|FG000|Overall Study|Elevated Liver Enzymes|2|||
130263276|NCT02852967|468930992|FG001|Overall Study|Elevated Liver Enzymes|0|||
130263277|NCT02852967|468930993|FG002|Overall Study|Elevated Liver Enzymes|0|||
130263278|NCT02852967|468930994|FG003|Overall Study|Elevated Liver Enzymes|2|||
130263279|NCT02852967|468930995|FG004|Overall Study|Elevated Liver Enzymes|2|||
130263280|NCT02852967|468930991|FG000|Overall Study|Physician Decision|0|||
130263281|NCT02852967|468930992|FG001|Overall Study|Physician Decision|0|||
130263282|NCT02852967|468930993|FG002|Overall Study|Physician Decision|0|||
130263283|NCT02852967|468930994|FG003|Overall Study|Physician Decision|1|||
130263284|NCT02852967|468930995|FG004|Overall Study|Physician Decision|0|||
130263285|NCT02852967|468930991|FG000|Overall Study|Lack of Efficacy|0|||
130263286|NCT02852967|468930992|FG001|Overall Study|Lack of Efficacy|1|||
130365579|NCT01602120|469306918|FG003|Overall Study|Death|0|||
130553967|NCT02175004|469996469|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
130263287|NCT02852967|468930993|FG002|Overall Study|Lack of Efficacy|0|||
130263288|NCT02852967|468930994|FG003|Overall Study|Lack of Efficacy|0|||
130263289|NCT02852967|468930995|FG004|Overall Study|Lack of Efficacy|0|||
130263290|NCT02852967|468930991|FG000|Overall Study|Non-compliance|0|||
130263291|NCT02852967|468930992|FG001|Overall Study|Non-compliance|0|||
130263292|NCT02852967|468930993|FG002|Overall Study|Non-compliance|1|||
130263293|NCT02852967|468930994|FG003|Overall Study|Non-compliance|1|||
130263294|NCT02852967|468930995|FG004|Overall Study|Non-compliance|0|||
130263295|NCT02852967|468930991|FG000|Overall Study|Dispensing Drug Violation|0|||
130263296|NCT02852967|468930992|FG001|Overall Study|Dispensing Drug Violation|0|||
130263297|NCT02852967|468930993|FG002|Overall Study|Dispensing Drug Violation|1|||
130263298|NCT02852967|468930994|FG003|Overall Study|Dispensing Drug Violation|0|||
130263299|NCT02852967|468930995|FG004|Overall Study|Dispensing Drug Violation|0|||
130263300|NCT02852967|468930991|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
130263301|NCT02852967|468930992|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
130263302|NCT02852967|468930993|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
130263303|NCT02852967|468930994|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
130263304|NCT02852967|468930995|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
130263305|NCT01693367|468930996|FG000|Overall Study|Withdrawal by Subject|1|||
130263306|NCT01693367|468930997|FG001|Overall Study|Withdrawal by Subject|1|||
130263307|NCT01693367|468930996|FG000|Overall Study|Physician Decision|0|||
130263308|NCT01693367|468930997|FG001|Overall Study|Physician Decision|1|||
130263309|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
130263310|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
130263311|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
130263312|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
130263313|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
130263314|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
130263315|NCT02949011|468931000|FG000|Overall Study|Adverse Event|6|||
130263316|NCT02949011|468931001|FG001|Overall Study|Adverse Event|7|||
130263317|NCT02949011|468931002|FG002|Overall Study|Adverse Event|3|||
130263318|NCT02949011|468931000|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130263319|NCT02949011|468931001|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130263320|NCT02949011|468931002|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
130263321|NCT02949011|468931000|FG000|Overall Study|Protocol Deviation|5|||
130263322|NCT02949011|468931001|FG001|Overall Study|Protocol Deviation|3|||
130263323|NCT02949011|468931002|FG002|Overall Study|Protocol Deviation|3|||
130263324|NCT02949011|468931000|FG000|Overall Study|Lack of Efficacy|0|||
130263325|NCT02949011|468931001|FG001|Overall Study|Lack of Efficacy|2|||
130263326|NCT02949011|468931002|FG002|Overall Study|Lack of Efficacy|0|||
130263327|NCT02949011|468931000|FG000|Overall Study|Withdrawal by Subject|13|||
130263328|NCT02949011|468931001|FG001|Overall Study|Withdrawal by Subject|13|||
130263329|NCT02949011|468931002|FG002|Overall Study|Withdrawal by Subject|21|||
130263330|NCT02949011|468931000|FG000|Overall Study|Lost to Follow-up|7|||
130263331|NCT02949011|468931001|FG001|Overall Study|Lost to Follow-up|5|||
130263332|NCT02949011|468931002|FG002|Overall Study|Lost to Follow-up|5|||
130263333|NCT02949011|468931000|FG000|Overall Study|Death|0|||
130263334|NCT02949011|468931001|FG001|Overall Study|Death|0|||
130263335|NCT02949011|468931002|FG002|Overall Study|Death|1|||
130263336|NCT02949011|468931000|FG000|Overall Study|Miscellaneous|2|||
130263337|NCT02949011|468931001|FG001|Overall Study|Miscellaneous|4|||
130263338|NCT02949011|468931002|FG002|Overall Study|Miscellaneous|6|||
130263339|NCT00163189|468931003|FG000|Overall Study|Other|6|||
130263340|NCT00163189|468931003|FG000|Overall Study|Lost to Follow-up|1|||
130263341|NCT00163189|468931003|FG000|Overall Study|Protocol Violation|2|||
130263342|NCT00163189|468931003|FG000|Overall Study|Death|3|||
130263343|NCT00163189|468931003|FG000|Overall Study|Adverse Event|6|||
130263344|NCT00163189|468931003|FG000|Overall Study|Lack of Efficacy|7|||
130263345|NCT00163189|468931003|FG000|Overall Study|Study terminated by sponsor|11|||
130263346|NCT00163189|468931003|FG000|Overall Study|Withdrawal by Subject|11|||
130263347|NCT00163189|468931003|FG000|Overall Study|Did not meet continuation criterion|16|||
130704156|NCT00988208|470541179|FG001|Overall Study|Protocol Violation|2|||
130704157|NCT00988208|470541178|FG000|Overall Study|Sponsor Decision|102|||
130704158|NCT00988208|470541179|FG001|Overall Study|Sponsor Decision|78|||
130704159|NCT00988208|470541178|FG000|Overall Study|Clinical Progression|17|||
130704160|NCT00988208|470541179|FG001|Overall Study|Clinical Progression|16|||
130704161|NCT00988208|470541178|FG000|Overall Study|Biochemical Progression|21|||
130704162|NCT00988208|470541179|FG001|Overall Study|Biochemical Progression|7|||
130704163|NCT00988208|470541178|FG000|Overall Study|Clinical Deterioration|7|||
130704164|NCT00988208|470541179|FG001|Overall Study|Clinical Deterioration|14|||
130704165|NCT00988208|470541178|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
130704166|NCT00988208|470541179|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
130704167|NCT00988208|470541178|FG000|Overall Study|Other|8|||
130704168|NCT00988208|470541179|FG001|Overall Study|Other|3|||
130704169|NCT01315028|470541183|FG000|Overall Study|Lost to Follow-up|1|||
130704170|NCT01315028|470541184|FG001|Overall Study|Lost to Follow-up|0|||
130704171|NCT01315028|470541183|FG000|Overall Study|Death|0|||
130704172|NCT01315028|470541184|FG001|Overall Study|Death|1|||
130704173|NCT00725764|470541187|FG000|Overall Study|Withdrawal by Subject|2|||
130263348|NCT02154061|468931004|FG000|Overall Study|Pregnancy|1|||
130263349|NCT02154061|468931005|FG001|Overall Study|Pregnancy|0|||
130263350|NCT02154061|468931004|FG000|Overall Study|enrolled but not vaccinated|1|||
130263351|NCT02154061|468931005|FG001|Overall Study|enrolled but not vaccinated|0|||
130553968|NCT02175004|469996470|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
130704174|NCT00725764|470541187|FG000|Overall Study|Physician Decision|1|||
130704175|NCT00725764|470541187|FG000|Overall Study|Progressive Disease|7|||
130263352|NCT00506142|468931006|FG000|Overall Study|Adverse Event|8|||
130263353|NCT00506142|468931007|FG001|Overall Study|Adverse Event|7|||
130263354|NCT00506142|468931006|FG000|Overall Study|Lack of Efficacy|21|||
130263355|NCT00506142|468931007|FG001|Overall Study|Lack of Efficacy|7|||
130263356|NCT00506142|468931006|FG000|Overall Study|Withdrawal by Subject|4|||
130263357|NCT00506142|468931007|FG001|Overall Study|Withdrawal by Subject|5|||
130263358|NCT00506142|468931006|FG000|Overall Study|Physician Decision|1|||
130263359|NCT00506142|468931007|FG001|Overall Study|Physician Decision|0|||
130263360|NCT00506142|468931006|FG000|Overall Study|New health condition|1|||
130263361|NCT00506142|468931007|FG001|Overall Study|New health condition|0|||
130263362|NCT01917318|468931010|FG000|First Treatment|Withdrawal by Subject|0|||
130263363|NCT01917318|468931011|FG001|First Treatment|Withdrawal by Subject|1|||
130263364|NCT00742625|468931012|FG000|Remission Induction|Progression|6|||
130263365|NCT00742625|468931012|FG000|Remission Induction|Failed induction|8|||
130263366|NCT00742625|468931012|FG000|Remission Induction|Adverse Event|3|||
130263367|NCT00742625|468931012|FG000|Remission Induction|Death|10|||
130263368|NCT00742625|468931012|FG000|Remission Induction|Refusal|5|||
130263369|NCT00742625|468931012|FG000|Remission Induction|Non protocol treatment|17|||
130263370|NCT00742625|468931012|FG000|Remission Induction|Other, not specified|5|||
130263371|NCT00742625|468931012|FG000|Consolidation|Progression|5|||
130263372|NCT00742625|468931012|FG000|Consolidation|Adverse Event|1|||
130263373|NCT00742625|468931012|FG000|Consolidation|Death|1|||
130263374|NCT00742625|468931012|FG000|Consolidation|Refused|1|||
130263375|NCT00742625|468931012|FG000|Consolidation|Non protocol therapy|13|||
130263376|NCT01865487|468931015|FG000|Overall Study|Lost to Follow-up|0|||
130263377|NCT01865487|468931016|FG001|Overall Study|Lost to Follow-up|0|||
130263378|NCT01865487|468931017|FG002|Overall Study|Lost to Follow-up|0|||
130263379|NCT01865487|468931018|FG003|Overall Study|Lost to Follow-up|1|||
130263380|NCT01865487|468931019|FG004|Overall Study|Lost to Follow-up|0|||
130263381|NCT01865487|468931020|FG005|Overall Study|Lost to Follow-up|0|||
130263382|NCT01865487|468931021|FG006|Overall Study|Lost to Follow-up|1|||
130263383|NCT01865487|468931022|FG007|Overall Study|Lost to Follow-up|0|||
130263384|NCT01865487|468931023|FG008|Overall Study|Lost to Follow-up|0|||
130263385|NCT01865487|468931024|FG009|Overall Study|Lost to Follow-up|0|||
130263386|NCT01865487|468931015|FG000|Overall Study|Withdrawal by Subject|0|||
130263387|NCT01865487|468931016|FG001|Overall Study|Withdrawal by Subject|0|||
130263388|NCT01865487|468931017|FG002|Overall Study|Withdrawal by Subject|0|||
130263389|NCT01865487|468931018|FG003|Overall Study|Withdrawal by Subject|0|||
130263390|NCT01865487|468931019|FG004|Overall Study|Withdrawal by Subject|1|||
130263391|NCT01865487|468931020|FG005|Overall Study|Withdrawal by Subject|0|||
130263392|NCT01865487|468931021|FG006|Overall Study|Withdrawal by Subject|0|||
130263393|NCT01865487|468931022|FG007|Overall Study|Withdrawal by Subject|0|||
130263394|NCT01865487|468931023|FG008|Overall Study|Withdrawal by Subject|0|||
130263395|NCT01865487|468931024|FG009|Overall Study|Withdrawal by Subject|0|||
130263396|NCT01213082|468931028|FG000|Overall Study|Lost to Follow-up|6|||
130263397|NCT01213082|468931029|FG001|Overall Study|Lost to Follow-up|7|||
130263398|NCT01213082|468931030|FG002|Overall Study|Lost to Follow-up|4|||
130263399|NCT01213082|468931028|FG000|Overall Study|Physician Decision|0|||
130263400|NCT01213082|468931029|FG001|Overall Study|Physician Decision|0|||
130263401|NCT01213082|468931030|FG002|Overall Study|Physician Decision|1|||
130263402|NCT03848416|468931031|FG000|Overall Study|Withdrawal by Subject|1|||
130263403|NCT03848416|468931032|FG001|Overall Study|Withdrawal by Subject|0|||
130263404|NCT03848416|468931033|FG002|Overall Study|Withdrawal by Subject|0|||
130263405|NCT03848416|468931031|FG000|Overall Study|Death|0|||
130263406|NCT03848416|468931032|FG001|Overall Study|Death|0|||
130263407|NCT03848416|468931033|FG002|Overall Study|Death|1|||
130263408|NCT02639390|468931034|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
130263409|NCT02639390|468931035|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
130263410|NCT01908140|468931036|FG000|Overall Study|Other or Progressive Disease|5|||
130263411|NCT01908140|468931037|FG001|Overall Study|Other or Progressive Disease|12|||
130263412|NCT01908140|468931036|FG000|Overall Study|Lack of Efficacy|7|||
130263413|NCT01908140|468931037|FG001|Overall Study|Lack of Efficacy|5|||
130263414|NCT01908140|468931036|FG000|Overall Study|Withdrawal by Subject|23|||
130263415|NCT01908140|468931037|FG001|Overall Study|Withdrawal by Subject|24|||
130263416|NCT01908140|468931036|FG000|Overall Study|Lost to Follow-up|1|||
130263417|NCT01908140|468931037|FG001|Overall Study|Lost to Follow-up|6|||
130263418|NCT01908140|468931036|FG000|Overall Study|Protocol Violation|8|||
130263419|NCT01908140|468931037|FG001|Overall Study|Protocol Violation|9|||
130263420|NCT01908140|468931036|FG000|Overall Study|Adverse Event|22|||
130263421|NCT01908140|468931037|FG001|Overall Study|Adverse Event|23|||
130263422|NCT02013609|468931038|FG000|Overall Study|Withdrawal by Subject|9|||
130453227|NCT00269399|469623509|FG001|Overall Study|Development of exclusion criteria|1|||
130453228|NCT03396835|469623510|FG000|Overall Study|Withdrawn prior to completion|1|||
130263423|NCT02013609|468931038|FG000|Overall Study|Lost to Follow-up|3|||
130263424|NCT02013609|468931038|FG000|Overall Study|Adverse Event|3|||
130453229|NCT03396835|469623510|FG000|Overall Study|Did not meet criteria for data analysis|1|||
130263425|NCT02013609|468931038|FG000|Overall Study|Met Withdrawal Criteria|3|||
130263426|NCT00783432|468931039|FG000|Overall Study|Adverse Event|22|||
130263427|NCT00783432|468931040|FG001|Overall Study|Adverse Event|17|||
130263428|NCT00783432|468931039|FG000|Overall Study|Lack of Efficacy|20|||
130263429|NCT00783432|468931040|FG001|Overall Study|Lack of Efficacy|21|||
130263430|NCT00783432|468931039|FG000|Overall Study|Lost to Follow-up|11|||
130263431|NCT00783432|468931040|FG001|Overall Study|Lost to Follow-up|6|||
130263432|NCT00783432|468931039|FG000|Overall Study|Withdrawal by Subject|23|||
130263433|NCT00783432|468931040|FG001|Overall Study|Withdrawal by Subject|20|||
130263434|NCT00783432|468931039|FG000|Overall Study|subject moved|3|||
130263435|NCT00783432|468931040|FG001|Overall Study|subject moved|5|||
130263436|NCT00783432|468931039|FG000|Overall Study|Protocol Violation|6|||
130263437|NCT00783432|468931040|FG001|Overall Study|Protocol Violation|9|||
130263438|NCT01436110|468931041|FG000|Overall Study|Lack of Efficacy|23|||
130263439|NCT01436110|468931042|FG001|Overall Study|Lack of Efficacy|14|||
130263440|NCT01436110|468931043|FG002|Overall Study|Lack of Efficacy|9|||
130263441|NCT01436110|468931041|FG000|Overall Study|Withdrawal by Subject|6|||
130263442|NCT01436110|468931042|FG001|Overall Study|Withdrawal by Subject|8|||
130263443|NCT01436110|468931043|FG002|Overall Study|Withdrawal by Subject|4|||
130263444|NCT01436110|468931041|FG000|Overall Study|Adverse Event|2|||
130263445|NCT01436110|468931042|FG001|Overall Study|Adverse Event|1|||
130263446|NCT01436110|468931043|FG002|Overall Study|Adverse Event|2|||
130263447|NCT01436110|468931041|FG000|Overall Study|Physician Decision|3|||
130263448|NCT01436110|468931042|FG001|Overall Study|Physician Decision|1|||
130263449|NCT01436110|468931043|FG002|Overall Study|Physician Decision|1|||
130263450|NCT01436110|468931041|FG000|Overall Study|Lost to Follow-up|1|||
130263451|NCT01436110|468931042|FG001|Overall Study|Lost to Follow-up|1|||
130263452|NCT01436110|468931043|FG002|Overall Study|Lost to Follow-up|3|||
130263453|NCT01436110|468931041|FG000|Overall Study|Protocol Violation|3|||
130263454|NCT01436110|468931042|FG001|Overall Study|Protocol Violation|1|||
130263455|NCT01436110|468931043|FG002|Overall Study|Protocol Violation|1|||
130263456|NCT01436110|468931041|FG000|Overall Study|Did Not Receive Trial Medication|1|||
130263457|NCT01436110|468931042|FG001|Overall Study|Did Not Receive Trial Medication|0|||
130263458|NCT01436110|468931043|FG002|Overall Study|Did Not Receive Trial Medication|3|||
130263459|NCT03273907|468931045|FG000|Overall Study|Death|1|||
130263460|NCT03273907|468931045|FG000|Overall Study|Lost to Follow-up|4|||
130263461|NCT03273907|468931045|FG000|Overall Study|Withdrawal by Subject|2|||
130263462|NCT03273907|468931045|FG000|Overall Study|COVID 19|2|||
130263463|NCT01531998|468931046|FG000|Overall Study|Withdrawal by Subject|3|||
130263464|NCT02581891|468931047|FG000|Overall Study|Adverse Event|4|||
130263465|NCT02581891|468931048|FG001|Overall Study|Adverse Event|6|||
130263466|NCT02581891|468931047|FG000|Overall Study|Death|3|||
130263467|NCT02581891|468931048|FG001|Overall Study|Death|4|||
130263468|NCT02581891|468931047|FG000|Overall Study|Lost to Follow-up|1|||
130263469|NCT02581891|468931048|FG001|Overall Study|Lost to Follow-up|2|||
130263470|NCT02581891|468931047|FG000|Overall Study|Physician Decision|0|||
130263471|NCT02581891|468931048|FG001|Overall Study|Physician Decision|1|||
130263472|NCT02581891|468931047|FG000|Overall Study|Withdrawal by Subject|4|||
130263473|NCT02581891|468931048|FG001|Overall Study|Withdrawal by Subject|5|||
130263474|NCT02581891|468931047|FG000|Overall Study|Other Reasons|3|||
130263475|NCT02581891|468931048|FG001|Overall Study|Other Reasons|1|||
130263476|NCT02581891|468931047|FG000|Overall Study|Discontinued during followup|1|||
130263477|NCT02581891|468931048|FG001|Overall Study|Discontinued during followup|0|||
130263478|NCT03440008|468931049|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
130263479|NCT03440008|468931050|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
130263480|NCT03440008|468931049|FG000|Overall Study|Withdrawal by Subject|1|||
130263481|NCT03440008|468931050|FG001|Overall Study|Withdrawal by Subject|0|||
130263482|NCT03498716|468931058|FG000|Overall Study|Withdrawal by Subject|88|||
130263483|NCT03498716|468931059|FG001|Overall Study|Withdrawal by Subject|73|||
130263484|NCT03498716|468931058|FG000|Overall Study|Study Terminated By Sponsor|933|||
130263485|NCT03498716|468931059|FG001|Overall Study|Study Terminated By Sponsor|927|||
130263486|NCT03498716|468931058|FG000|Overall Study|Lost to Follow-up|15|||
130263487|NCT03498716|468931059|FG001|Overall Study|Lost to Follow-up|26|||
130263488|NCT03498716|468931058|FG000|Overall Study|Disease Relapse|0|||
130263489|NCT03498716|468931059|FG001|Overall Study|Disease Relapse|1|||
130263490|NCT03498716|468931058|FG000|Overall Study|Death|58|||
130704176|NCT00725764|470541187|FG000|Overall Study|Lost to Follow-up|1|||
130263491|NCT03498716|468931059|FG001|Overall Study|Death|72|||
130263492|NCT03498716|468931058|FG000|Overall Study|Physician Decision|4|||
130704177|NCT00725764|470541187|FG000|Overall Study|Death|1|||
130263493|NCT03498716|468931059|FG001|Overall Study|Physician Decision|2|||
130263494|NCT01188967|468931063|FG000|Overall Study|Withdrawal by Subject|1|||
130263495|NCT01188967|468931064|FG001|Overall Study|Withdrawal by Subject|1|||
130263496|NCT01188967|468931063|FG000|Overall Study|Physician Decision|1|||
130263497|NCT01188967|468931064|FG001|Overall Study|Physician Decision|1|||
130263498|NCT01188967|468931063|FG000|Overall Study|Lost to Follow-up|3|||
130263499|NCT01188967|468931064|FG001|Overall Study|Lost to Follow-up|2|||
130453230|NCT03467724|469623517|FG000|Overall Study|Lost to Follow-up|5|||
130453231|NCT03467724|469623517|FG000|Overall Study|Withdrawal by Subject|1|||
130263500|NCT01657305|468931065|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
130453232|NCT03467724|469623517|FG000|Overall Study|Protocol Violation|1|||
130263501|NCT01657305|468931065|FG000|Overall Study|Withdrawal by Subject|4|||
130263502|NCT01657305|468931065|FG000|Overall Study|Adverse Event|1|||
130453233|NCT03467724|469623517|FG000|Overall Study|Adverse Event|1|||
130453234|NCT02236559|469623521|FG000|Overall Study|Met Exclusion|3|||
130263503|NCT01657305|468931065|FG000|Overall Study|Lost to Follow-up|1|||
130263504|NCT01657305|468931065|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
130263505|NCT04103450|468931066|FG000|Overall Study|Adverse Event|4|||
130263506|NCT04103450|468931067|FG001|Overall Study|Adverse Event|2|||
130263507|NCT04103450|468931066|FG000|Overall Study|Lack of Efficacy|3|||
130263508|NCT04103450|468931067|FG001|Overall Study|Lack of Efficacy|0|||
130263509|NCT04103450|468931066|FG000|Overall Study|Withdrawal by Subject|5|||
130263510|NCT04103450|468931067|FG001|Overall Study|Withdrawal by Subject|3|||
130263511|NCT04103450|468931066|FG000|Overall Study|Lost to Follow-up|1|||
130263512|NCT04103450|468931067|FG001|Overall Study|Lost to Follow-up|2|||
130263513|NCT04103450|468931066|FG000|Overall Study|Physician Decision|1|||
130263514|NCT04103450|468931067|FG001|Overall Study|Physician Decision|2|||
130263515|NCT04103450|468931066|FG000|Overall Study|Protocol Violation|1|||
130263516|NCT04103450|468931067|FG001|Overall Study|Protocol Violation|0|||
130263517|NCT04103450|468931066|FG000|Overall Study|Other|1|||
130263518|NCT04103450|468931067|FG001|Overall Study|Other|1|||
130263519|NCT01696643|468931072|FG000|Overall Study|Adverse Event|15|||
130263520|NCT01696643|468931073|FG001|Overall Study|Adverse Event|7|||
130263521|NCT01696643|468931072|FG000|Overall Study|Death|1|||
130263522|NCT01696643|468931073|FG001|Overall Study|Death|2|||
130263523|NCT01696643|468931072|FG000|Overall Study|Lack of Efficacy|3|||
130263524|NCT01696643|468931073|FG001|Overall Study|Lack of Efficacy|0|||
130704178|NCT00725764|470541187|FG000|Overall Study|Participant non compliant with protocol|1|||
130704179|NCT00725764|470541187|FG000|Overall Study|Decline in performance status|1|||
130704180|NCT01928615|470541189|FG000|Overall Study|Study Terminated by Sponsor|2|||
130704181|NCT03023137|470541190|FG000|Overall Study|Multiple pregnancy|2|||
130704182|NCT03023137|470541191|FG001|Overall Study|Multiple pregnancy|4|||
130704183|NCT03023137|470541190|FG000|Overall Study|Lost to Follow-up|1|||
130704184|NCT03023137|470541191|FG001|Overall Study|Lost to Follow-up|1|||
130704185|NCT03023137|470541190|FG000|Overall Study|Protocol Violation|0|||
130704186|NCT03023137|470541191|FG001|Overall Study|Protocol Violation|4|||
130704187|NCT03023137|470541190|FG000|Overall Study|Lost the baby in a car accident|1|||
130704188|NCT03023137|470541191|FG001|Overall Study|Lost the baby in a car accident|0|||
130704189|NCT01203917|470541193|FG000|Overall Study|Death|29|||
130704190|NCT01203917|470541193|FG000|Overall Study|Lost to Follow-up|2|||
130704191|NCT01203917|470541193|FG000|Overall Study|Withdrawal by Subject|3|||
130704192|NCT01203917|470541193|FG000|Overall Study|Due to objective disease progression|1|||
130704193|NCT01203917|470541193|FG000|Overall Study|Due to EGFR M+I patient|1|||
130704194|NCT04660032|470541204|FG000|Overall Study|Protocol Violation|1|||
130704195|NCT04660032|470541205|FG001|Overall Study|Protocol Violation|1|||
130704196|NCT00090753|470541206|FG000|First Treatment Period|Adverse Event|20|||
130704197|NCT00090753|470541207|FG001|First Treatment Period|Adverse Event|8|||
130704198|NCT00090753|470541206|FG000|First Treatment Period|Death|88|||
130704199|NCT00090753|470541207|FG001|First Treatment Period|Death|62|||
130704200|NCT00090753|470541206|FG000|First Treatment Period|Lack of Efficacy|2|||
130704201|NCT00090753|470541207|FG001|First Treatment Period|Lack of Efficacy|1|||
130704202|NCT00090753|470541206|FG000|First Treatment Period|Refused Treatment|32|||
130704203|NCT00090753|470541207|FG001|First Treatment Period|Refused Treatment|25|||
130704204|NCT00090753|470541206|FG000|First Treatment Period|Lost to Follow-up|4|||
130704205|NCT00090753|470541207|FG001|First Treatment Period|Lost to Follow-up|4|||
130704206|NCT00090753|470541206|FG000|First Treatment Period|Renal Transplant|70|||
130704207|NCT00090753|470541207|FG001|First Treatment Period|Renal Transplant|50|||
130704208|NCT00090753|470541206|FG000|First Treatment Period|Mircera Commercialization|1|||
130704209|NCT00090753|470541207|FG001|First Treatment Period|Mircera Commercialization|0|||
130704210|NCT00090753|470541206|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
130704211|NCT00090753|470541207|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
130704212|NCT00090753|470541206|FG000|Extended Treatment Period|Adverse Event|11|||
130704213|NCT00090753|470541207|FG001|Extended Treatment Period|Adverse Event|0|||
130704214|NCT00090753|470541206|FG000|Extended Treatment Period|Death|58|||
130704215|NCT00090753|470541207|FG001|Extended Treatment Period|Death|30|||
130704216|NCT00090753|470541206|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130704217|NCT00090753|470541207|FG001|Extended Treatment Period|Lack of Efficacy|0|||
130704218|NCT00090753|470541206|FG000|Extended Treatment Period|Refused Treatment|18|||
130704219|NCT00090753|470541207|FG001|Extended Treatment Period|Refused Treatment|12|||
130263525|NCT01696643|468931072|FG000|Overall Study|Lost to Follow-up|67|||
130263526|NCT01696643|468931073|FG001|Overall Study|Lost to Follow-up|67|||
130263527|NCT01696643|468931072|FG000|Overall Study|Physician Decision|3|||
130263528|NCT01696643|468931073|FG001|Overall Study|Physician Decision|2|||
130704220|NCT00090753|470541206|FG000|Extended Treatment Period|Lost to Follow-up|3|||
130704221|NCT00090753|470541207|FG001|Extended Treatment Period|Lost to Follow-up|1|||
130263529|NCT01696643|468931072|FG000|Overall Study|Pregnancy|0|||
130263530|NCT01696643|468931073|FG001|Overall Study|Pregnancy|1|||
130263531|NCT01696643|468931072|FG000|Overall Study|Protocol Violation|7|||
130263532|NCT01696643|468931073|FG001|Overall Study|Protocol Violation|7|||
130263533|NCT01696643|468931072|FG000|Overall Study|Study Terminated by Sponsor|286|||
130263534|NCT01696643|468931073|FG001|Overall Study|Study Terminated by Sponsor|294|||
130263535|NCT01696643|468931072|FG000|Overall Study|Withdrawal by Subject|142|||
130263536|NCT01696643|468931073|FG001|Overall Study|Withdrawal by Subject|149|||
130263537|NCT01696643|468931072|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
130263538|NCT01696643|468931073|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
130263539|NCT01696643|468931072|FG000|Overall Study|Site Error|2|||
130263540|NCT01696643|468931073|FG001|Overall Study|Site Error|1|||
130263541|NCT01696643|468931072|FG000|Overall Study|Participant Incarcerated|0|||
130263542|NCT01696643|468931073|FG001|Overall Study|Participant Incarcerated|1|||
130263543|NCT01696643|468931072|FG000|Overall Study|Medical Monitor Decision|0|||
130263544|NCT01696643|468931073|FG001|Overall Study|Medical Monitor Decision|2|||
130263545|NCT01696643|468931072|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
130263546|NCT01696643|468931073|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
130263547|NCT02271529|468931076|FG000|Overall Study|Withdrawal by Subject|1|||
130365580|NCT01602120|469306915|FG000|Overall Study|Lost to Follow-up|0|||
130365581|NCT01602120|469306916|FG001|Overall Study|Lost to Follow-up|1|||
130365582|NCT01602120|469306917|FG002|Overall Study|Lost to Follow-up|0|||
130553969|NCT02175004|469996469|FG000|Overall Study|Investigator Judgment|1|||
130553970|NCT02175004|469996470|FG001|Overall Study|Investigator Judgment|4|||
130263548|NCT03768427|468931077|FG000|Overall Study|Death|0|||
130553971|NCT02175004|469996469|FG000|Overall Study|Voluntary Withdrawal|6|||
130553972|NCT02175004|469996470|FG001|Overall Study|Voluntary Withdrawal|19|||
130263549|NCT03768427|468931078|FG001|Overall Study|Death|0|||
130263550|NCT03768427|468931079|FG002|Overall Study|Death|1|||
130263551|NCT03768427|468931080|FG003|Overall Study|Death|0|||
130263552|NCT03768427|468931077|FG000|Overall Study|Lost to Follow-up|2|||
130263553|NCT03768427|468931078|FG001|Overall Study|Lost to Follow-up|0|||
130263554|NCT03768427|468931079|FG002|Overall Study|Lost to Follow-up|0|||
130263555|NCT03768427|468931080|FG003|Overall Study|Lost to Follow-up|0|||
130263556|NCT03768427|468931077|FG000|Overall Study|Physician Decision|3|||
130263557|NCT03768427|468931078|FG001|Overall Study|Physician Decision|2|||
130263558|NCT03768427|468931079|FG002|Overall Study|Physician Decision|4|||
130263559|NCT03768427|468931080|FG003|Overall Study|Physician Decision|4|||
130263560|NCT03768427|468931077|FG000|Overall Study|Withdrawal by Subject|7|||
130263561|NCT03768427|468931078|FG001|Overall Study|Withdrawal by Subject|2|||
130263562|NCT03768427|468931079|FG002|Overall Study|Withdrawal by Subject|6|||
130263563|NCT03768427|468931080|FG003|Overall Study|Withdrawal by Subject|7|||
130263564|NCT00902330|468931090|FG000|Overall Study|Too overwhelmed by treatment|2|||
130263565|NCT00902330|468931091|FG001|Overall Study|Too overwhelmed by treatment|5|||
130553973|NCT02175004|469996469|FG000|Overall Study|Liver Transplant|1|||
130553974|NCT02175004|469996470|FG001|Overall Study|Liver Transplant|0|||
130553975|NCT02175004|469996469|FG000|Overall Study|Disease Progression|1|||
130553976|NCT02175004|469996470|FG001|Overall Study|Disease Progression|0|||
130553977|NCT02175004|469996469|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
130553978|NCT02175004|469996470|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
130553979|NCT02960854|469996471|FG000|Overall Study|Not Disclosed|2|||
130553980|NCT02960854|469996472|FG001|Overall Study|Not Disclosed|2|||
130553981|NCT02960854|469996471|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
130553982|NCT02960854|469996472|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
130553983|NCT02960854|469996471|FG000|Overall Study|Subject Withdrew Consent|0|||
130553984|NCT02960854|469996472|FG001|Overall Study|Subject Withdrew Consent|1|||
130553985|NCT02960854|469996471|FG000|Overall Study|Death|4|||
130553986|NCT02960854|469996472|FG001|Overall Study|Death|6|||
130553987|NCT00221195|469996473|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
130704222|NCT00090753|470541206|FG000|Extended Treatment Period|Renal Transplant|15|||
130704223|NCT00090753|470541207|FG001|Extended Treatment Period|Renal Transplant|12|||
130704224|NCT00090753|470541206|FG000|Extended Treatment Period|Mircera Commercialization|188|||
130704225|NCT00090753|470541207|FG001|Extended Treatment Period|Mircera Commercialization|93|||
130704226|NCT00090753|470541206|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
130704227|NCT00090753|470541207|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
130704228|NCT00605176|470541210|FG000|Overall Study|Adverse Event|2|||
130704229|NCT00605176|470541211|FG001|Overall Study|Adverse Event|1|||
130704230|NCT00605176|470541212|FG002|Overall Study|Adverse Event|3|||
130704231|NCT00605176|470541210|FG000|Overall Study|Withdrawal by Subject|4|||
130704232|NCT00605176|470541211|FG001|Overall Study|Withdrawal by Subject|2|||
130704233|NCT00605176|470541212|FG002|Overall Study|Withdrawal by Subject|4|||
130704234|NCT00605176|470541210|FG000|Overall Study|Lost to Follow-up|2|||
130704235|NCT00605176|470541211|FG001|Overall Study|Lost to Follow-up|2|||
130704236|NCT00605176|470541212|FG002|Overall Study|Lost to Follow-up|1|||
130263566|NCT00902330|468931090|FG000|Overall Study|Adverse Event|1|||
130263567|NCT00902330|468931091|FG001|Overall Study|Adverse Event|0|||
130263568|NCT00902330|468931090|FG000|Overall Study|No post baseline data|1|||
130263569|NCT00902330|468931091|FG001|Overall Study|No post baseline data|0|||
130263570|NCT03950856|468931092|FG000|Overall Study|Death|1|||
130263571|NCT03950856|468931093|FG001|Overall Study|Death|2|||
130263572|NCT03950856|468931094|FG002|Overall Study|Death|0|||
130263573|NCT03950856|468931095|FG003|Overall Study|Death|0|||
130365583|NCT01602120|469306918|FG003|Overall Study|Lost to Follow-up|1|||
130263574|NCT03950856|468931092|FG000|Overall Study|Lost to Follow-up|5|||
130263575|NCT03950856|468931093|FG001|Overall Study|Lost to Follow-up|6|||
130263576|NCT03950856|468931094|FG002|Overall Study|Lost to Follow-up|8|||
130263577|NCT03950856|468931095|FG003|Overall Study|Lost to Follow-up|2|||
130263578|NCT03950856|468931092|FG000|Overall Study|Protocol Violation|2|||
130263579|NCT03950856|468931093|FG001|Overall Study|Protocol Violation|0|||
130263580|NCT03950856|468931094|FG002|Overall Study|Protocol Violation|0|||
130263581|NCT03950856|468931095|FG003|Overall Study|Protocol Violation|1|||
130263582|NCT03950856|468931092|FG000|Overall Study|Withdrawal by Subject|4|||
130263583|NCT03950856|468931093|FG001|Overall Study|Withdrawal by Subject|1|||
130263584|NCT03950856|468931094|FG002|Overall Study|Withdrawal by Subject|3|||
130263585|NCT03950856|468931095|FG003|Overall Study|Withdrawal by Subject|1|||
130263586|NCT03950856|468931092|FG000|Overall Study|Unable to phone|7|||
130263587|NCT03950856|468931093|FG001|Overall Study|Unable to phone|6|||
130263588|NCT03950856|468931094|FG002|Overall Study|Unable to phone|7|||
130263589|NCT03950856|468931095|FG003|Overall Study|Unable to phone|2|||
130263590|NCT01816984|468931096|FG000|Overall Study|declining health status|1|||
130263591|NCT02121509|468931097|FG000|Washout Period (35 Days)|Adverse Event|1|||
130263592|NCT02121509|468931098|FG001|Washout Period (35 Days)|Adverse Event|1|||
130263593|NCT02121509|468931099|FG002|Washout Period (35 Days)|Adverse Event|0|||
130263594|NCT02121509|468931100|FG003|Washout Period (35 Days)|Adverse Event|0|||
130263595|NCT02121509|468931097|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263596|NCT02121509|468931098|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
130263597|NCT02121509|468931099|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263598|NCT02121509|468931100|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263599|NCT02121509|468931097|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
130263600|NCT02121509|468931098|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263601|NCT02121509|468931099|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263602|NCT02121509|468931100|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263603|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
130263604|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
130263605|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
130263606|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130263607|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
130263608|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130263609|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
130263610|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
130263611|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
130263612|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
130263613|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
130263614|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
130263615|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
130263616|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
130263617|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
130263618|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
130263619|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
130263620|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
130263621|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
130263622|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130263623|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130263624|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
130263625|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
130263626|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
130263627|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130263628|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130263629|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
130263630|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130263631|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130263632|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
130263633|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130365584|NCT01602120|469306915|FG000|Overall Study|Protocol Violation|1|||
130263634|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130263635|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
130263636|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130263637|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130263638|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
130263639|NCT00636181|468931106|FG000|Overall Study|Withdrawal by Subject|8|||
130263640|NCT00636181|468931107|FG001|Overall Study|Withdrawal by Subject|6|||
130263641|NCT00636181|468931108|FG002|Overall Study|Withdrawal by Subject|10|||
130263642|NCT05076045|468931116|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
130263643|NCT05076045|468931117|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
130263644|NCT01174563|468931124|FG000|Overall Study|Progressive Disease|45|||
130263645|NCT01174563|468931124|FG000|Overall Study|Death|5|||
130263646|NCT01174563|468931124|FG000|Overall Study|Investigator's Discretion|5|||
130263647|NCT01174563|468931124|FG000|Overall Study|Participant Withdrew Consent|3|||
130263648|NCT01174563|468931124|FG000|Overall Study|Rash Adverse Event|1|||
130263649|NCT01174563|468931124|FG000|Overall Study|Sponsor's decision|1|||
130263650|NCT03402841|468931125|FG000|Overall Study|Withdrawal by Subject|3|||
130263651|NCT03402841|468931125|FG000|Overall Study|Lost to Follow-up|2|||
130263652|NCT03402841|468931125|FG000|Overall Study|Death|146|||
130263653|NCT01542788|468931130|FG000|Overall Study|Randomized but Not Treated|2|||
130263654|NCT01542788|468931131|FG001|Overall Study|Randomized but Not Treated|0|||
130263655|NCT01542788|468931130|FG000|Overall Study|Lack of Efficacy|41|||
130263656|NCT01542788|468931131|FG001|Overall Study|Lack of Efficacy|71|||
130263657|NCT01542788|468931130|FG000|Overall Study|Lost to Follow-up|5|||
130263658|NCT01542788|468931131|FG001|Overall Study|Lost to Follow-up|0|||
130263659|NCT01542788|468931130|FG000|Overall Study|Death|3|||
130263660|NCT01542788|468931131|FG001|Overall Study|Death|0|||
130263661|NCT01542788|468931130|FG000|Overall Study|Protocol Violation|2|||
130263662|NCT01542788|468931131|FG001|Overall Study|Protocol Violation|0|||
130263663|NCT01542788|468931130|FG000|Overall Study|Physician Decision|1|||
130263664|NCT01542788|468931131|FG001|Overall Study|Physician Decision|0|||
130263665|NCT01542788|468931130|FG000|Overall Study|Withdrawal by Subject|1|||
130263666|NCT01542788|468931131|FG001|Overall Study|Withdrawal by Subject|0|||
130316213|NCT00683878|469124330|FG001|Overall Study|Withdrawal by Subject|8|||
130316214|NCT00683878|469124331|FG002|Overall Study|Withdrawal by Subject|6|||
130316215|NCT00683878|469124329|FG000|Overall Study|Death|0|||
130316216|NCT00683878|469124330|FG001|Overall Study|Death|1|||
130365585|NCT01602120|469306916|FG001|Overall Study|Protocol Violation|1|||
130704237|NCT00605176|470541210|FG000|Overall Study|Non-complicance with study procedures|1|||
130704238|NCT00605176|470541211|FG001|Overall Study|Non-complicance with study procedures|0|||
130704239|NCT00605176|470541212|FG002|Overall Study|Non-complicance with study procedures|0|||
130704240|NCT00605176|470541210|FG000|Overall Study|Use of concomitant therapy|1|||
130704241|NCT00605176|470541211|FG001|Overall Study|Use of concomitant therapy|0|||
130704242|NCT00605176|470541212|FG002|Overall Study|Use of concomitant therapy|1|||
130365586|NCT01602120|469306917|FG002|Overall Study|Protocol Violation|0|||
130365587|NCT01602120|469306918|FG003|Overall Study|Protocol Violation|0|||
130704243|NCT00605176|470541210|FG000|Overall Study|Other (not due to AE)|1|||
130704244|NCT00605176|470541211|FG001|Overall Study|Other (not due to AE)|1|||
130704245|NCT00605176|470541212|FG002|Overall Study|Other (not due to AE)|0|||
130704246|NCT01256060|470541213|FG000|Overall Study|Lost to Follow-up|0|||
130704247|NCT01256060|470541214|FG001|Overall Study|Lost to Follow-up|1|||
130704248|NCT01256060|470541215|FG002|Overall Study|Lost to Follow-up|0|||
130704249|NCT01256060|470541216|FG003|Overall Study|Lost to Follow-up|0|||
130704250|NCT01466036|470541219|FG000|Overall Study|Death|1|||
130704251|NCT01466036|470541220|FG001|Overall Study|Death|1|||
130704252|NCT01466036|470541219|FG000|Overall Study|Physician Decision|0|||
130704253|NCT01466036|470541220|FG001|Overall Study|Physician Decision|4|||
130704254|NCT01466036|470541219|FG000|Overall Study|Adverse Event|2|||
130704255|NCT01466036|470541220|FG001|Overall Study|Adverse Event|6|||
130704256|NCT01466036|470541219|FG000|Overall Study|Withdrawal by Subject|2|||
130704257|NCT01466036|470541220|FG001|Overall Study|Withdrawal by Subject|8|||
130704258|NCT01466036|470541219|FG000|Overall Study|progression/relapse|14|||
130704259|NCT01466036|470541220|FG001|Overall Study|progression/relapse|21|||
130704260|NCT01466036|470541219|FG000|Overall Study|prolonged treatment delay|1|||
130704261|NCT01466036|470541220|FG001|Overall Study|prolonged treatment delay|1|||
130704262|NCT00985231|470541227|FG000|Overall Study|ineligible|1|||
130704263|NCT00985231|470541228|FG001|Overall Study|ineligible|0|||
130704264|NCT00985231|470541227|FG000|Overall Study|Protocol Violation|1|||
130704265|NCT00985231|470541228|FG001|Overall Study|Protocol Violation|0|||
130704266|NCT00985231|470541227|FG000|Overall Study|Withdrawal by Subject|1|||
130704267|NCT00985231|470541228|FG001|Overall Study|Withdrawal by Subject|0|||
130704268|NCT00985231|470541227|FG000|Overall Study|Lost to Follow-up|0|||
130704269|NCT00985231|470541228|FG001|Overall Study|Lost to Follow-up|1|||
130704270|NCT00985231|470541227|FG000|Overall Study|Study related symptoms & complaints|0|||
130704271|NCT00985231|470541228|FG001|Overall Study|Study related symptoms & complaints|2|||
130704272|NCT00808509|470541236|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
130704273|NCT00808509|470541237|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
130316217|NCT00683878|469124331|FG002|Overall Study|Death|0|||
130316218|NCT00683878|469124329|FG000|Overall Study|Lost to Follow-up|4|||
130316219|NCT00683878|469124330|FG001|Overall Study|Lost to Follow-up|2|||
130316220|NCT00683878|469124331|FG002|Overall Study|Lost to Follow-up|4|||
130316221|NCT00683878|469124329|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
130316222|NCT00683878|469124330|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
130316223|NCT00683878|469124331|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
130316224|NCT04319198|469124332|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
130316225|NCT04319198|469124333|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
130263667|NCT00269113|468933189|FG000|Overall Study|Adverse Event|14|||
130263668|NCT00269113|468933190|FG001|Overall Study|Adverse Event|7|||
130263669|NCT00269113|468933189|FG000|Overall Study|Lack of Efficacy|35|||
130263670|NCT00269113|468933190|FG001|Overall Study|Lack of Efficacy|18|||
130263671|NCT00269113|468933189|FG000|Overall Study|Early Improvement|2|||
130263672|NCT00269113|468933190|FG001|Overall Study|Early Improvement|0|||
130263673|NCT00269113|468933189|FG000|Overall Study|Withdrawal by Subject|0|||
130263674|NCT00269113|468933190|FG001|Overall Study|Withdrawal by Subject|2|||
130263675|NCT00269113|468933189|FG000|Overall Study|Death|6|||
130263676|NCT00269113|468933190|FG001|Overall Study|Death|2|||
130263677|NCT00269113|468933189|FG000|Overall Study|Lost to Follow-up|2|||
130263678|NCT00269113|468933190|FG001|Overall Study|Lost to Follow-up|1|||
130263679|NCT00269113|468933189|FG000|Overall Study|Protocol Violation|15|||
130263680|NCT00269113|468933190|FG001|Overall Study|Protocol Violation|5|||
130263681|NCT00269113|468933189|FG000|Overall Study|Other|0|||
130263682|NCT00269113|468933190|FG001|Overall Study|Other|2|||
130263683|NCT00322049|468933191|FG000|Overall Study|Moved out of area|0|||
130263684|NCT00322049|468933192|FG001|Overall Study|Moved out of area|0|||
130263685|NCT00322049|468933193|FG002|Overall Study|Moved out of area|0|||
130263686|NCT00322049|468933194|FG003|Overall Study|Moved out of area|1|||
130263687|NCT00322049|468933191|FG000|Overall Study|Infected with Dengue during study|0|||
130263688|NCT00322049|468933192|FG001|Overall Study|Infected with Dengue during study|1|||
130263689|NCT00322049|468933193|FG002|Overall Study|Infected with Dengue during study|0|||
130263690|NCT00322049|468933194|FG003|Overall Study|Infected with Dengue during study|0|||
130263691|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
130263692|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
130263693|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
130263694|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
130263695|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
130263696|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
130263697|NCT02026011|468933195|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
130263698|NCT02026011|468933196|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
130263699|NCT01770743|468933197|FG000|Overall Study|Adverse Event|1|||
130263700|NCT01770743|468933198|FG001|Overall Study|Adverse Event|0|||
130263701|NCT01770743|468933199|FG002|Overall Study|Adverse Event|0|||
130263702|NCT01770743|468933200|FG003|Overall Study|Adverse Event|0|||
130263703|NCT01770743|468933201|FG004|Overall Study|Adverse Event|0|||
130263704|NCT01770743|468933197|FG000|Overall Study|Withdrawal by Subject|0|||
130263705|NCT01770743|468933198|FG001|Overall Study|Withdrawal by Subject|0|||
130263706|NCT01770743|468933199|FG002|Overall Study|Withdrawal by Subject|1|||
130263707|NCT01770743|468933200|FG003|Overall Study|Withdrawal by Subject|1|||
130263708|NCT01770743|468933201|FG004|Overall Study|Withdrawal by Subject|1|||
130263709|NCT01770743|468933197|FG000|Overall Study|Lost to Follow-up|0|||
130263710|NCT01770743|468933198|FG001|Overall Study|Lost to Follow-up|2|||
130263711|NCT01770743|468933199|FG002|Overall Study|Lost to Follow-up|0|||
130263712|NCT01770743|468933200|FG003|Overall Study|Lost to Follow-up|0|||
130263713|NCT01770743|468933201|FG004|Overall Study|Lost to Follow-up|1|||
130263714|NCT01770743|468933197|FG000|Overall Study|Sponsor Terminated Subject|1|||
130263715|NCT01770743|468933198|FG001|Overall Study|Sponsor Terminated Subject|0|||
130263716|NCT01770743|468933199|FG002|Overall Study|Sponsor Terminated Subject|0|||
130263717|NCT01770743|468933200|FG003|Overall Study|Sponsor Terminated Subject|1|||
130263718|NCT01770743|468933201|FG004|Overall Study|Sponsor Terminated Subject|0|||
130263719|NCT01770743|468933197|FG000|Overall Study|Moving Out of State|0|||
130263720|NCT01770743|468933198|FG001|Overall Study|Moving Out of State|1|||
130263721|NCT01770743|468933199|FG002|Overall Study|Moving Out of State|0|||
130263722|NCT01770743|468933200|FG003|Overall Study|Moving Out of State|0|||
130263723|NCT01770743|468933201|FG004|Overall Study|Moving Out of State|0|||
130263724|NCT00755807|468933202|FG000|Acute Phase|Adverse Event|16|||
130263725|NCT00755807|468933203|FG001|Acute Phase|Adverse Event|5|||
130263726|NCT00755807|468933202|FG000|Acute Phase|Protocol Violation|1|||
130263727|NCT00755807|468933203|FG001|Acute Phase|Protocol Violation|3|||
130263728|NCT00755807|468933202|FG000|Acute Phase|Withdrawal by Subject|1|||
130263729|NCT00755807|468933203|FG001|Acute Phase|Withdrawal by Subject|2|||
130263730|NCT00755807|468933202|FG000|Acute Phase|Lack of Efficacy|0|||
130263731|NCT00755807|468933203|FG001|Acute Phase|Lack of Efficacy|1|||
130263732|NCT00755807|468933202|FG000|Acute Phase|Physician Decision|0|||
130263733|NCT00755807|468933203|FG001|Acute Phase|Physician Decision|1|||
130263734|NCT00755807|468933202|FG000|Open-label Extension Phase|Adverse Event|7|||
130263735|NCT00755807|468933203|FG001|Open-label Extension Phase|Adverse Event|7|||
130263736|NCT00755807|468933202|FG000|Open-label Extension Phase|Protocol Violation|5|||
130263737|NCT00755807|468933203|FG001|Open-label Extension Phase|Protocol Violation|2|||
130263738|NCT00755807|468933202|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
130263739|NCT00755807|468933203|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
130263740|NCT00755807|468933202|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
130263741|NCT00755807|468933203|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
130263742|NCT00755807|468933202|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
130263743|NCT00755807|468933203|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
130263744|NCT00755807|468933202|FG000|Open-label Extension Phase|Sponsor Decision|0|||
130263745|NCT00755807|468933203|FG001|Open-label Extension Phase|Sponsor Decision|1|||
130263746|NCT00529243|468933208|FG000|Overall Study|Adverse Event|1|||
130263747|NCT00529243|468933208|FG000|Overall Study|Death|1|||
130263748|NCT00529243|468933208|FG000|Overall Study|Relocated|1|||
130263749|NCT00952705|468933213|FG000|Overall Study|Lost to Follow-up|24|||
130263750|NCT00952705|468933214|FG001|Overall Study|Lost to Follow-up|8|||
130263751|NCT00952705|468933215|FG002|Overall Study|Lost to Follow-up|9|||
130263752|NCT00952705|468933213|FG000|Overall Study|Withdrawal by Subject|2|||
130263753|NCT00952705|468933214|FG001|Overall Study|Withdrawal by Subject|1|||
130263754|NCT00952705|468933215|FG002|Overall Study|Withdrawal by Subject|1|||
130263755|NCT00952705|468933213|FG000|Overall Study|Death|2|||
130263756|NCT00952705|468933214|FG001|Overall Study|Death|0|||
130263757|NCT00952705|468933215|FG002|Overall Study|Death|0|||
130263758|NCT00952705|468933213|FG000|Overall Study|Incarcerated post dose|5|||
130263759|NCT00952705|468933214|FG001|Overall Study|Incarcerated post dose|0|||
130263760|NCT00952705|468933215|FG002|Overall Study|Incarcerated post dose|0|||
130263761|NCT00952705|468933213|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
130263762|NCT00952705|468933214|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
130263763|NCT00952705|468933215|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
130263764|NCT02921789|468933216|FG000|Overall Study|Adverse Event|0|||
130263765|NCT02921789|468933217|FG001|Overall Study|Adverse Event|1|||
130263766|NCT02921789|468933216|FG000|Overall Study|Lost to Follow-up|1|||
130263767|NCT02921789|468933217|FG001|Overall Study|Lost to Follow-up|0|||
130263768|NCT02921789|468933216|FG000|Overall Study|Protocol Deviation|2|||
130263769|NCT02921789|468933217|FG001|Overall Study|Protocol Deviation|0|||
130263770|NCT02921789|468933216|FG000|Overall Study|Withdrawal by Subject|2|||
130263771|NCT02921789|468933217|FG001|Overall Study|Withdrawal by Subject|1|||
130263772|NCT02921789|468933216|FG000|Overall Study|Miscellaneous|3|||
130263773|NCT02921789|468933217|FG001|Overall Study|Miscellaneous|2|||
130263774|NCT03759600|468933220|FG000|Overall Study|Adverse Event|2|||
130263775|NCT03759600|468933220|FG000|Overall Study|Progressive Disease|15|||
130263776|NCT03759600|468933220|FG000|Overall Study|Site Terminated by Sponsor|3|||
130263777|NCT05173974|468933221|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263778|NCT05173974|468933222|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263779|NCT05173974|468933223|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263780|NCT05173974|468933224|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
130263781|NCT05173974|468933221|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263782|NCT05173974|468933222|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
130263783|NCT05173974|468933223|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263784|NCT05173974|468933224|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263785|NCT03289143|468933225|FG000|Overall Study|Caregiver Unavailability|1|||
130263786|NCT03289143|468933226|FG001|Overall Study|Caregiver Unavailability|1|||
130263787|NCT03289143|468933227|FG002|Overall Study|Caregiver Unavailability|0|||
130263788|NCT03289143|468933228|FG003|Overall Study|Caregiver Unavailability|0|||
130263789|NCT03289143|468933225|FG000|Overall Study|Research Department Closure|0|||
130263790|NCT03289143|468933226|FG001|Overall Study|Research Department Closure|0|||
130263791|NCT03289143|468933227|FG002|Overall Study|Research Department Closure|1|||
130263792|NCT03289143|468933228|FG003|Overall Study|Research Department Closure|0|||
130263793|NCT03289143|468933225|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263794|NCT03289143|468933226|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263795|NCT03289143|468933227|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
130263796|NCT03289143|468933228|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263797|NCT03289143|468933225|FG000|Overall Study|Medical Monitor Decision|1|||
130263798|NCT03289143|468933226|FG001|Overall Study|Medical Monitor Decision|0|||
130263799|NCT03289143|468933227|FG002|Overall Study|Medical Monitor Decision|0|||
130263800|NCT03289143|468933228|FG003|Overall Study|Medical Monitor Decision|0|||
130263801|NCT03289143|468933225|FG000|Overall Study|Participant Non-Compliance|0|||
130263802|NCT03289143|468933226|FG001|Overall Study|Participant Non-Compliance|0|||
130263803|NCT03289143|468933227|FG002|Overall Study|Participant Non-Compliance|1|||
130263804|NCT03289143|468933228|FG003|Overall Study|Participant Non-Compliance|0|||
130263805|NCT03289143|468933225|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263806|NCT03289143|468933226|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263807|NCT03289143|468933227|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
130263808|NCT03289143|468933228|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263809|NCT03289143|468933225|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130263810|NCT03289143|468933226|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130704274|NCT00808509|470541236|FG000|Randomized Phase|Reduced methotrexate dose|1|||
130263811|NCT03289143|468933227|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
130263812|NCT03289143|468933228|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130263813|NCT03289143|468933225|FG000|Overall Study|Caregiver Passed Away|1|||
130263814|NCT03289143|468933226|FG001|Overall Study|Caregiver Passed Away|0|||
130263815|NCT03289143|468933227|FG002|Overall Study|Caregiver Passed Away|0|||
130263816|NCT03289143|468933228|FG003|Overall Study|Caregiver Passed Away|0|||
130263817|NCT03289143|468933225|FG000|Overall Study|Physician Decision|0|||
130263818|NCT03289143|468933226|FG001|Overall Study|Physician Decision|2|||
130263819|NCT03289143|468933227|FG002|Overall Study|Physician Decision|2|||
130263820|NCT03289143|468933228|FG003|Overall Study|Physician Decision|2|||
130263821|NCT03289143|468933225|FG000|Overall Study|Protocol Deviation|2|||
130263822|NCT03289143|468933226|FG001|Overall Study|Protocol Deviation|1|||
130263823|NCT03289143|468933227|FG002|Overall Study|Protocol Deviation|3|||
130263824|NCT03289143|468933228|FG003|Overall Study|Protocol Deviation|1|||
130263825|NCT03289143|468933225|FG000|Overall Study|Study Terminated By Sponsor|101|||
130263826|NCT03289143|468933226|FG001|Overall Study|Study Terminated By Sponsor|75|||
130263827|NCT03289143|468933227|FG002|Overall Study|Study Terminated By Sponsor|100|||
130263828|NCT03289143|468933228|FG003|Overall Study|Study Terminated By Sponsor|69|||
130263829|NCT03289143|468933225|FG000|Overall Study|Withdrawal by Subject|14|||
130263830|NCT03289143|468933226|FG001|Overall Study|Withdrawal by Subject|6|||
130263831|NCT03289143|468933227|FG002|Overall Study|Withdrawal by Subject|14|||
130263832|NCT03289143|468933228|FG003|Overall Study|Withdrawal by Subject|12|||
130263833|NCT03289143|468933225|FG000|Overall Study|Adverse Event|10|||
130263834|NCT03289143|468933226|FG001|Overall Study|Adverse Event|7|||
130263835|NCT03289143|468933227|FG002|Overall Study|Adverse Event|6|||
130263836|NCT03289143|468933228|FG003|Overall Study|Adverse Event|5|||
130263837|NCT03289143|468933225|FG000|Overall Study|Death|2|||
130263838|NCT03289143|468933226|FG001|Overall Study|Death|0|||
130263839|NCT03289143|468933227|FG002|Overall Study|Death|2|||
130263840|NCT03289143|468933228|FG003|Overall Study|Death|1|||
130263841|NCT03289143|468933225|FG000|Overall Study|Lost to Follow-up|2|||
130263842|NCT03289143|468933226|FG001|Overall Study|Lost to Follow-up|1|||
130263843|NCT03289143|468933227|FG002|Overall Study|Lost to Follow-up|1|||
130263844|NCT03289143|468933228|FG003|Overall Study|Lost to Follow-up|0|||
130263845|NCT03289143|468933225|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
130263846|NCT03289143|468933226|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
130263847|NCT03289143|468933227|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
130263848|NCT03289143|468933228|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
130263849|NCT03289143|468933225|FG000|Overall Study|Withdrawal by Caregiver|0|||
130263850|NCT03289143|468933226|FG001|Overall Study|Withdrawal by Caregiver|1|||
130263851|NCT03289143|468933227|FG002|Overall Study|Withdrawal by Caregiver|0|||
130263852|NCT03289143|468933228|FG003|Overall Study|Withdrawal by Caregiver|0|||
130263853|NCT03289143|468933225|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263854|NCT03289143|468933226|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263855|NCT03289143|468933227|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
130263856|NCT03289143|468933228|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263857|NCT03289143|468933225|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263858|NCT03289143|468933226|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263859|NCT03289143|468933227|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263860|NCT03289143|468933228|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
130263861|NCT00730756|468933229|FG000|Overall Study|Adverse Event|2|||
130263862|NCT00730756|468933230|FG001|Overall Study|Adverse Event|0|||
130263863|NCT00730756|468933229|FG000|Overall Study|Lack of Efficacy|1|||
130263864|NCT00730756|468933230|FG001|Overall Study|Lack of Efficacy|1|||
130263865|NCT00730756|468933229|FG000|Overall Study|Protocol Deviation|1|||
130453235|NCT02236559|469623522|FG001|Overall Study|Met Exclusion|6|||
130453236|NCT02236559|469623521|FG000|Overall Study|Did not Meet Inclusion|3|||
130453237|NCT02236559|469623522|FG001|Overall Study|Did not Meet Inclusion|3|||
130453238|NCT02236559|469623521|FG000|Overall Study|Subject Did Not Consent|4|||
130453239|NCT02236559|469623522|FG001|Overall Study|Subject Did Not Consent|2|||
130453240|NCT02236559|469623521|FG000|Overall Study|Physician Decision|1|||
130453241|NCT02236559|469623522|FG001|Overall Study|Physician Decision|1|||
130453242|NCT02236559|469623521|FG000|Overall Study|Withdrawal by Subject|1|||
130263866|NCT00730756|468933230|FG001|Overall Study|Protocol Deviation|2|||
130453243|NCT02236559|469623522|FG001|Overall Study|Withdrawal by Subject|0|||
130453244|NCT01149681|469623523|FG000|Overall Study|Withdrawal by Subject|7|||
130263867|NCT00730756|468933229|FG000|Overall Study|Lost to Follow-up|0|||
130263868|NCT00730756|468933230|FG001|Overall Study|Lost to Follow-up|1|||
130263869|NCT00730756|468933229|FG000|Overall Study|Withdrew Consent|0|||
130263870|NCT00730756|468933230|FG001|Overall Study|Withdrew Consent|1|||
130453245|NCT01149681|469623523|FG000|Overall Study|Progressive disease|1|||
130263871|NCT00305877|468933231|FG000|Overall Study|Lack of Efficacy|6|||
130263872|NCT00305877|468933232|FG001|Overall Study|Lack of Efficacy|9|||
130263873|NCT00305877|468933231|FG000|Overall Study|Adverse Event|9|||
130263874|NCT00305877|468933232|FG001|Overall Study|Adverse Event|14|||
130263875|NCT00305877|468933231|FG000|Overall Study|Death|0|||
130263876|NCT00305877|468933232|FG001|Overall Study|Death|1|||
130263877|NCT00305877|468933231|FG000|Overall Study|Withdrawal by Subject|4|||
130263878|NCT00305877|468933232|FG001|Overall Study|Withdrawal by Subject|2|||
130263879|NCT00305877|468933231|FG000|Overall Study|Physician Decision|1|||
130263880|NCT00305877|468933232|FG001|Overall Study|Physician Decision|1|||
130263881|NCT00305877|468933231|FG000|Overall Study|Never start treatment|2|||
130263882|NCT00305877|468933232|FG001|Overall Study|Never start treatment|5|||
130263883|NCT00305877|468933231|FG000|Overall Study|Ineligible|2|||
130263884|NCT00305877|468933232|FG001|Overall Study|Ineligible|1|||
130263885|NCT00305877|468933231|FG000|Overall Study|Transportation issue with daily RT|0|||
130263886|NCT00305877|468933232|FG001|Overall Study|Transportation issue with daily RT|1|||
130263887|NCT01126190|468933235|FG000|Double-Blind Phase|Death|0|||
130263888|NCT01126190|468933236|FG001|Double-Blind Phase|Death|1|||
130365588|NCT01602120|469306915|FG000|Overall Study|Non-compliance|0|||
130365589|NCT01602120|469306916|FG001|Overall Study|Non-compliance|3|||
130365590|NCT01602120|469306917|FG002|Overall Study|Non-compliance|0|||
130365591|NCT01602120|469306918|FG003|Overall Study|Non-compliance|1|||
130263889|NCT01126190|468933237|FG002|Double-Blind Phase|Death|0|||
130263890|NCT01126190|468933235|FG000|Double-Blind Phase|Adverse Event|1|||
130263891|NCT01126190|468933236|FG001|Double-Blind Phase|Adverse Event|2|||
130263892|NCT01126190|468933237|FG002|Double-Blind Phase|Adverse Event|0|||
130263893|NCT01126190|468933235|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130263894|NCT01126190|468933236|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
130263895|NCT01126190|468933237|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130263896|NCT01126190|468933235|FG000|Double-Blind Phase|Request of Investigator|1|||
130263897|NCT01126190|468933236|FG001|Double-Blind Phase|Request of Investigator|0|||
130263898|NCT01126190|468933237|FG002|Double-Blind Phase|Request of Investigator|0|||
130263899|NCT01126190|468933235|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130263900|NCT01126190|468933236|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
130263901|NCT01126190|468933237|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130263902|NCT01126190|468933235|FG000|Double-Blind Phase|Non-compliance|1|||
130263903|NCT01126190|468933236|FG001|Double-Blind Phase|Non-compliance|0|||
130263904|NCT01126190|468933237|FG002|Double-Blind Phase|Non-compliance|0|||
130263905|NCT01126190|468933235|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130263906|NCT01126190|468933236|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130263907|NCT01126190|468933237|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130263908|NCT01126190|468933235|FG000|Open-Label Phase|Death|0|||
130263909|NCT01126190|468933236|FG001|Open-Label Phase|Death|0|||
130263910|NCT01126190|468933237|FG002|Open-Label Phase|Death|1|||
130263911|NCT01126190|468933235|FG000|Open-Label Phase|Adverse Event|0|||
130263912|NCT01126190|468933236|FG001|Open-Label Phase|Adverse Event|0|||
130263913|NCT01126190|468933237|FG002|Open-Label Phase|Adverse Event|4|||
130263914|NCT01126190|468933235|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130263915|NCT01126190|468933236|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130263916|NCT01126190|468933237|FG002|Open-Label Phase|Withdrawal by Subject|6|||
130263917|NCT00524121|468933238|FG000|Overall Study|Disease progression|6|||
130263918|NCT00524121|468933238|FG000|Overall Study|Adverse Event|4|||
130263919|NCT00524121|468933238|FG000|Overall Study|Patient refused|2|||
130263920|NCT00524121|468933238|FG000|Overall Study|Other|1|||
130263921|NCT00524121|468933238|FG000|Overall Study|Death|1|||
130263922|NCT00524121|468933238|FG000|Overall Study|Not treated (became ineligible)|4|||
130263923|NCT00524121|468933238|FG000|Overall Study|Not treated (changed mind)|1|||
130263924|NCT01114737|468933239|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130263925|NCT01114737|468933240|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130263926|NCT01114737|468933239|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
130365592|NCT01602120|469306915|FG000|Overall Study|Withdrawal by Subject|8|||
130365593|NCT01602120|469306916|FG001|Overall Study|Withdrawal by Subject|17|||
130365594|NCT01602120|469306917|FG002|Overall Study|Withdrawal by Subject|0|||
130365595|NCT01602120|469306918|FG003|Overall Study|Withdrawal by Subject|3|||
130365596|NCT01602120|469306915|FG000|Overall Study|Study Terminated by Sponsor|12|||
130263927|NCT01114737|468933240|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
130263928|NCT01114737|468933239|FG000|Randomized Treatment Period|Pregnancy|1|||
130365597|NCT01602120|469306916|FG001|Overall Study|Study Terminated by Sponsor|24|||
130365598|NCT01602120|469306917|FG002|Overall Study|Study Terminated by Sponsor|17|||
130365599|NCT01602120|469306918|FG003|Overall Study|Study Terminated by Sponsor|44|||
130365600|NCT01602120|469306915|FG000|Overall Study|Physician Decision|2|||
130365601|NCT01602120|469306916|FG001|Overall Study|Physician Decision|3|||
130263929|NCT01114737|468933240|FG001|Randomized Treatment Period|Pregnancy|0|||
130263930|NCT01114737|468933239|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
130263931|NCT01114737|468933240|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
130263932|NCT01114737|468933239|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
130263933|NCT01114737|468933240|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130263934|NCT01114737|468933239|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
130263935|NCT01114737|468933240|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
130263936|NCT01446874|468933241|FG000|Overall Study|Not eligible|1|||
130263937|NCT01446874|468933242|FG001|Overall Study|Not eligible|0|||
130263938|NCT01446874|468933243|FG002|Overall Study|Not eligible|0|||
130263939|NCT01446874|468933241|FG000|Overall Study|No surgery/No qualifying surgery|1|||
130365602|NCT01602120|469306917|FG002|Overall Study|Physician Decision|0|||
130365603|NCT01602120|469306918|FG003|Overall Study|Physician Decision|0|||
130263940|NCT01446874|468933242|FG001|Overall Study|No surgery/No qualifying surgery|0|||
130263941|NCT01446874|468933243|FG002|Overall Study|No surgery/No qualifying surgery|12|||
130263942|NCT01446874|468933241|FG000|Overall Study|Non-compliance|0|||
130263943|NCT01446874|468933242|FG001|Overall Study|Non-compliance|4|||
130704275|NCT00808509|470541237|FG001|Randomized Phase|Reduced methotrexate dose|2|||
130704276|NCT00808509|470541236|FG000|Randomized Phase|Patient refused rescue therapy|0|||
130704277|NCT00808509|470541237|FG001|Randomized Phase|Patient refused rescue therapy|3|||
130704278|NCT00436917|470541238|FG000|Overall Study|Withdrawal by Subject|13|||
130704279|NCT00436917|470541238|FG000|Overall Study|Adverse Event|2|||
130704280|NCT00436917|470541238|FG000|Overall Study|Physician Decision|1|||
130263944|NCT01446874|468933243|FG002|Overall Study|Non-compliance|0|||
130263945|NCT01446874|468933241|FG000|Overall Study|Antibiotics for pre-op infection|0|||
130263946|NCT01446874|468933242|FG001|Overall Study|Antibiotics for pre-op infection|0|||
130263947|NCT01446874|468933243|FG002|Overall Study|Antibiotics for pre-op infection|2|||
130263948|NCT01446874|468933241|FG000|Overall Study|Withdrawal by Subject|0|||
130263949|NCT01446874|468933242|FG001|Overall Study|Withdrawal by Subject|0|||
130263950|NCT01446874|468933243|FG002|Overall Study|Withdrawal by Subject|4|||
130263951|NCT00457392|468933244|FG000|Overall Study|Objective Progression or Relapse|229|||
130263952|NCT00457392|468933245|FG001|Overall Study|Objective Progression or Relapse|296|||
130263953|NCT00457392|468933244|FG000|Overall Study|Death|106|||
130263954|NCT00457392|468933245|FG001|Overall Study|Death|106|||
130263955|NCT00457392|468933244|FG000|Overall Study|Adverse Event|84|||
130263956|NCT00457392|468933245|FG001|Overall Study|Adverse Event|41|||
130263957|NCT00457392|468933244|FG000|Overall Study|Global Deterioration of Health Status|22|||
130263958|NCT00457392|468933245|FG001|Overall Study|Global Deterioration of Health Status|8|||
130263959|NCT00457392|468933244|FG000|Overall Study|Withdrawal by Subject|14|||
130263960|NCT00457392|468933245|FG001|Overall Study|Withdrawal by Subject|8|||
130263961|NCT00457392|468933244|FG000|Overall Study|Lost to Follow-up|6|||
130263962|NCT00457392|468933245|FG001|Overall Study|Lost to Follow-up|7|||
130263963|NCT00457392|468933244|FG000|Overall Study|Protocol Violation|4|||
130263964|NCT00457392|468933245|FG001|Overall Study|Protocol Violation|3|||
130263965|NCT00457392|468933244|FG000|Overall Study|Other|7|||
130263966|NCT00457392|468933245|FG001|Overall Study|Other|4|||
130263967|NCT00457392|468933244|FG000|Overall Study|Study Terminated by Sponsor|1|||
130263968|NCT00457392|468933245|FG001|Overall Study|Study Terminated by Sponsor|4|||
130263969|NCT00457392|468933244|FG000|Overall Study|Randomized, Not Treated|7|||
130263970|NCT00457392|468933245|FG001|Overall Study|Randomized, Not Treated|3|||
130263971|NCT01466491|468933247|FG000|Overall Study|Protocol Violation|0|||
130263972|NCT01466491|468933248|FG001|Overall Study|Protocol Violation|3|||
130263973|NCT01466491|468933249|FG002|Overall Study|Protocol Violation|2|||
130263974|NCT01466491|468933250|FG003|Overall Study|Protocol Violation|0|||
130263975|NCT01466491|468933247|FG000|Overall Study|Missing Data|0|||
130263976|NCT01466491|468933248|FG001|Overall Study|Missing Data|0|||
130263977|NCT01466491|468933249|FG002|Overall Study|Missing Data|1|||
130263978|NCT01466491|468933250|FG003|Overall Study|Missing Data|0|||
130263979|NCT02727322|468933251|FG000|Overall Study|Withdrawal by Subject|1|||
130263980|NCT02727322|468933252|FG001|Overall Study|Withdrawal by Subject|1|||
130263981|NCT02727322|468933251|FG000|Overall Study|Protocol Violation|1|||
130263982|NCT02727322|468933252|FG001|Overall Study|Protocol Violation|0|||
130263983|NCT00339040|468933253|FG000|Stage I|Not able to attend clinic|1|||
130263984|NCT00339040|468933254|FG001|Stage I|Not able to attend clinic|0|||
130263985|NCT00339040|468933253|FG000|Stage I|Protocol Violation|1|||
130263986|NCT00339040|468933254|FG001|Stage I|Protocol Violation|1|||
130263987|NCT00339040|468933253|FG000|Stage II|Lost to Follow-up|3|||
130263988|NCT00339040|468933254|FG001|Stage II|Lost to Follow-up|0|||
130263989|NCT00339040|468933253|FG000|Stage II|Withdrawal by Subject|1|||
130263990|NCT00339040|468933254|FG001|Stage II|Withdrawal by Subject|2|||
130263991|NCT00339040|468933253|FG000|Stage II|Protocol Violation|3|||
130263992|NCT00339040|468933254|FG001|Stage II|Protocol Violation|0|||
130365604|NCT01602120|469306915|FG000|Overall Study|Unspecified Reason|3|||
130263993|NCT00339040|468933253|FG000|Stage II|Not able to attend clinic|1|||
130263994|NCT00339040|468933254|FG001|Stage II|Not able to attend clinic|0|||
130365605|NCT01602120|469306916|FG001|Overall Study|Unspecified Reason|1|||
130263995|NCT00339040|468933253|FG000|Stage II|Site closing|2|||
130263996|NCT00339040|468933254|FG001|Stage II|Site closing|0|||
130365606|NCT01602120|469306917|FG002|Overall Study|Unspecified Reason|0|||
130263997|NCT03046446|468933257|FG000|Overall Study|Lack of Efficacy|7|||
130263998|NCT03046446|468933257|FG000|Overall Study|Adverse Event|6|||
130263999|NCT03046446|468933257|FG000|Overall Study|Lost to Follow-up|3|||
130264000|NCT03046446|468933257|FG000|Overall Study|Withdrawal by Subject|14|||
130264001|NCT03046446|468933257|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
130264002|NCT03046446|468933257|FG000|Overall Study|Disease Progression (see caveats)|25|||
130264003|NCT03046446|468933257|FG000|Overall Study|Non OA related knee surgery|1|||
130264004|NCT02808897|468933258|FG000|Overall Study|Lost to Follow-up|9|||
130264005|NCT02808897|468933259|FG001|Overall Study|Lost to Follow-up|11|||
130264006|NCT01870869|468933260|FG000|Overall Study|Implanted with nonstudy device|1|||
130704281|NCT00436917|470541238|FG000|Overall Study|Death|1|||
130704282|NCT00436917|470541238|FG000|Overall Study|Lost to Follow-up|1|||
130264007|NCT01870869|468933261|FG001|Overall Study|Implanted with nonstudy device|3|||
130264008|NCT01870869|468933262|FG002|Overall Study|Implanted with nonstudy device|14|||
130264009|NCT01870869|468933263|FG003|Overall Study|Implanted with nonstudy device|4|||
130264010|NCT01870869|468933260|FG000|Overall Study|Death|0|||
130264011|NCT01870869|468933261|FG001|Overall Study|Death|0|||
130264012|NCT01870869|468933262|FG002|Overall Study|Death|7|||
130264013|NCT01870869|468933263|FG003|Overall Study|Death|1|||
130264014|NCT01870869|468933260|FG000|Overall Study|Subject choice|6|||
130264015|NCT01870869|468933261|FG001|Overall Study|Subject choice|2|||
130264016|NCT01870869|468933262|FG002|Overall Study|Subject choice|22|||
130264017|NCT01870869|468933263|FG003|Overall Study|Subject choice|8|||
130264018|NCT01870869|468933260|FG000|Overall Study|Lost to Follow-up|10|||
130264019|NCT01870869|468933261|FG001|Overall Study|Lost to Follow-up|2|||
130264020|NCT01870869|468933262|FG002|Overall Study|Lost to Follow-up|25|||
130264021|NCT01870869|468933263|FG003|Overall Study|Lost to Follow-up|3|||
130264022|NCT01870869|468933260|FG000|Overall Study|Reason not Specified|1|||
130264023|NCT01870869|468933261|FG001|Overall Study|Reason not Specified|2|||
130264024|NCT01870869|468933262|FG002|Overall Study|Reason not Specified|20|||
130264025|NCT01870869|468933263|FG003|Overall Study|Reason not Specified|4|||
130264026|NCT01870869|468933260|FG000|Overall Study|Not evaluable|10|||
130264027|NCT01870869|468933261|FG001|Overall Study|Not evaluable|5|||
130264028|NCT01870869|468933262|FG002|Overall Study|Not evaluable|42|||
130264029|NCT01870869|468933263|FG003|Overall Study|Not evaluable|10|||
130264030|NCT03036852|468933264|FG000|Overall Study|Death|2|||
130264031|NCT03036852|468933264|FG000|Overall Study|Lack of Efficacy|2|||
130264032|NCT03036852|468933264|FG000|Overall Study|Adverse Event|1|||
130365607|NCT01602120|469306918|FG003|Overall Study|Unspecified Reason|2|||
130264033|NCT03036852|468933264|FG000|Overall Study|Lost to Follow-up|1|||
130264034|NCT00305448|468933267|FG000|Overall Study|Protocol Violation|0|||
130264035|NCT00305448|468933268|FG001|Overall Study|Protocol Violation|1|||
130264036|NCT00305448|468933269|FG002|Overall Study|Protocol Violation|0|||
130264037|NCT00305448|468933267|FG000|Overall Study|Withdrawal by Subject|2|||
130264038|NCT00305448|468933268|FG001|Overall Study|Withdrawal by Subject|0|||
130264039|NCT00305448|468933269|FG002|Overall Study|Withdrawal by Subject|1|||
130264040|NCT00305448|468933267|FG000|Overall Study|Adverse Event|1|||
130264041|NCT00305448|468933268|FG001|Overall Study|Adverse Event|0|||
130704283|NCT00436917|470541238|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
130704284|NCT00436917|470541238|FG000|Overall Study|Increased creatinine|1|||
130704285|NCT00436917|470541238|FG000|Overall Study|Personal conflicts of patient|1|||
130704286|NCT02169791|470541239|FG000|Overall Study|Death|6|||
130704287|NCT02169791|470541239|FG000|Overall Study|patient withdrew consent|1|||
130704288|NCT00220727|470541244|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
130704289|NCT00220727|470541245|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
130704290|NCT00761176|470541246|FG000|Overall Study|Death|1|||
130704291|NCT00761176|470541247|FG001|Overall Study|Death|0|||
130704292|NCT00761176|470541246|FG000|Overall Study|Withdrawal by Subject|1|||
130704293|NCT00761176|470541247|FG001|Overall Study|Withdrawal by Subject|1|||
130704294|NCT05103657|470541250|FG000|Overall Study|Other reasons than listed|9|||
130704295|NCT05103657|470541251|FG001|Overall Study|Other reasons than listed|8|||
130704296|NCT05103657|470541250|FG000|Overall Study|Protocol deviation|2|||
130704297|NCT05103657|470541251|FG001|Overall Study|Protocol deviation|2|||
130704298|NCT05103657|470541250|FG000|Overall Study|No reason available|5|||
130264042|NCT00305448|468933269|FG002|Overall Study|Adverse Event|1|||
130264043|NCT00305448|468933267|FG000|Overall Study|Disease Progression|27|||
130365608|NCT01187433|469306925|FG000|Overall Study|Protocol Violation|6|||
130264044|NCT00305448|468933268|FG001|Overall Study|Disease Progression|31|||
130264045|NCT00305448|468933269|FG002|Overall Study|Disease Progression|28|||
130365609|NCT01187433|469306926|FG001|Overall Study|Protocol Violation|2|||
130704299|NCT05103657|470541251|FG001|Overall Study|No reason available|4|||
130704300|NCT05103657|470541250|FG000|Overall Study|Burden of study procedures|3|||
130704301|NCT05103657|470541251|FG001|Overall Study|Burden of study procedures|1|||
130704302|NCT05103657|470541250|FG000|Overall Study|Perceived lack of efficacy|1|||
130704303|NCT05103657|470541251|FG001|Overall Study|Perceived lack of efficacy|1|||
130704304|NCT05103657|470541250|FG000|Overall Study|Adverse Event|6|||
130704305|NCT05103657|470541251|FG001|Overall Study|Adverse Event|14|||
130704306|NCT05103657|470541250|FG000|Overall Study|Not Treated|1|||
130264046|NCT00305448|468933267|FG000|Overall Study|Subjective Disease Progression|1|||
130264047|NCT00305448|468933268|FG001|Overall Study|Subjective Disease Progression|2|||
130264048|NCT00305448|468933269|FG002|Overall Study|Subjective Disease Progression|2|||
130264049|NCT00305448|468933267|FG000|Overall Study|Tumor Marker Elevation|0|||
130264050|NCT00305448|468933268|FG001|Overall Study|Tumor Marker Elevation|0|||
130264051|NCT00305448|468933269|FG002|Overall Study|Tumor Marker Elevation|1|||
130264052|NCT00002766|468933270|FG000|Overall Study|Withdrawal by Subject|0|||
130264053|NCT00002766|468933271|FG001|Overall Study|Withdrawal by Subject|1|||
130264054|NCT00002766|468933270|FG000|Overall Study|Patient Not Treated|1|||
130365610|NCT01187433|469306925|FG000|Overall Study|Withdrawal by Subject|5|||
130704307|NCT05103657|470541251|FG001|Overall Study|Not Treated|1|||
130720852|NCT04126213|470601549|FG004|Overall Study|Withdrawal by Subject|1|||
130704308|NCT04234464|470541255|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
130704309|NCT04234464|470541256|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
130704310|NCT03635983|470541257|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130704311|NCT03635983|470541258|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
130704312|NCT03635983|470541257|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130264055|NCT00002766|468933271|FG001|Overall Study|Patient Not Treated|2|||
130264056|NCT00002766|468933270|FG000|Overall Study|Adverse Event|1|||
130704313|NCT03635983|470541258|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130704314|NCT03635983|470541257|FG000|Pre-Treatment Period|Other reasons|0|||
130704315|NCT03635983|470541258|FG001|Pre-Treatment Period|Other reasons|1|||
130704316|NCT03635983|470541257|FG000|Pre-Treatment Period|Disease Progression|0|||
130704317|NCT03635983|470541258|FG001|Pre-Treatment Period|Disease Progression|1|||
130704318|NCT03635983|470541257|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
130704319|NCT03635983|470541258|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
130704320|NCT03635983|470541257|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
130704321|NCT03635983|470541258|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
130704322|NCT03635983|470541257|FG000|Treatment Period|Withdrawal by Subject|3|||
130264057|NCT00002766|468933271|FG001|Overall Study|Adverse Event|1|||
130264058|NCT00002766|468933270|FG000|Overall Study|Protocol Violation|1|||
130264059|NCT00002766|468933271|FG001|Overall Study|Protocol Violation|0|||
130264060|NCT00328172|468933274|FG000|Overall Study|Adverse Event|3|||
130264061|NCT00328172|468933275|FG001|Overall Study|Adverse Event|2|||
130264062|NCT00328172|468933276|FG002|Overall Study|Adverse Event|1|||
130264063|NCT00328172|468933277|FG003|Overall Study|Adverse Event|2|||
130264064|NCT00328172|468933278|FG004|Overall Study|Adverse Event|1|||
130264065|NCT00328172|468933274|FG000|Overall Study|Protocol Violation|0|||
130264066|NCT00328172|468933275|FG001|Overall Study|Protocol Violation|1|||
130264067|NCT00328172|468933276|FG002|Overall Study|Protocol Violation|1|||
130264068|NCT00328172|468933277|FG003|Overall Study|Protocol Violation|0|||
130264069|NCT00328172|468933278|FG004|Overall Study|Protocol Violation|0|||
130264070|NCT00328172|468933274|FG000|Overall Study|Lost to Follow-up|1|||
130264071|NCT00328172|468933275|FG001|Overall Study|Lost to Follow-up|1|||
130264072|NCT00328172|468933276|FG002|Overall Study|Lost to Follow-up|2|||
130264073|NCT00328172|468933277|FG003|Overall Study|Lost to Follow-up|1|||
130264074|NCT00328172|468933278|FG004|Overall Study|Lost to Follow-up|1|||
130264075|NCT00328172|468933274|FG000|Overall Study|Withdrawal by Subject|1|||
130264076|NCT00328172|468933275|FG001|Overall Study|Withdrawal by Subject|1|||
130264077|NCT00328172|468933276|FG002|Overall Study|Withdrawal by Subject|1|||
130264078|NCT00328172|468933277|FG003|Overall Study|Withdrawal by Subject|6|||
130264079|NCT00328172|468933278|FG004|Overall Study|Withdrawal by Subject|0|||
130264080|NCT00328172|468933274|FG000|Overall Study|Lack of Efficacy|14|||
130264081|NCT00328172|468933275|FG001|Overall Study|Lack of Efficacy|9|||
130264082|NCT00328172|468933276|FG002|Overall Study|Lack of Efficacy|4|||
130264083|NCT00328172|468933277|FG003|Overall Study|Lack of Efficacy|4|||
130264084|NCT00328172|468933278|FG004|Overall Study|Lack of Efficacy|3|||
130704323|NCT03635983|470541258|FG001|Treatment Period|Withdrawal by Subject|5|||
130704324|NCT03635983|470541257|FG000|Treatment Period|Death|3|||
130704325|NCT03635983|470541258|FG001|Treatment Period|Death|5|||
130264085|NCT00328172|468933274|FG000|Overall Study|Other reason (not specified)|3|||
130264086|NCT00328172|468933275|FG001|Overall Study|Other reason (not specified)|0|||
130264087|NCT00328172|468933276|FG002|Overall Study|Other reason (not specified)|1|||
130264088|NCT00328172|468933277|FG003|Overall Study|Other reason (not specified)|0|||
130264089|NCT00328172|468933278|FG004|Overall Study|Other reason (not specified)|0|||
130264090|NCT00077974|468933279|FG000|Overall Study|Adverse Event|22|||
130264091|NCT00077974|468933279|FG000|Overall Study|Protocol Violation|1|||
130264092|NCT00077974|468933279|FG000|Overall Study|Withdrawal by Subject|3|||
130264093|NCT00077974|468933279|FG000|Overall Study|Lack of Efficacy|76|||
130264094|NCT00077974|468933279|FG000|Overall Study|Decision of Sponsor|2|||
130264095|NCT00558636|468933290|FG000|Treatment|Adverse Event|9|||
130264096|NCT00558636|468933291|FG001|Treatment|Adverse Event|2|||
130264097|NCT00558636|468933290|FG000|Treatment|Withdrawal by Subject|2|||
130264098|NCT00558636|468933291|FG001|Treatment|Withdrawal by Subject|0|||
130264099|NCT00558636|468933290|FG000|Treatment|Premature termination of the study|35|||
130264100|NCT00558636|468933291|FG001|Treatment|Premature termination of the study|37|||
130264101|NCT00558636|468933290|FG000|Treatment|Disease progression|1|||
130264102|NCT00558636|468933291|FG001|Treatment|Disease progression|5|||
130264103|NCT00558636|468933290|FG000|Follow-up|Premature termination of the study|12|||
130264104|NCT00558636|468933291|FG001|Follow-up|Premature termination of the study|7|||
130264105|NCT04108273|468933292|FG000|Overall Study|COVID Pandemic|1|||
130704326|NCT03635983|470541257|FG000|Treatment Period|Poor/Non-compliance|2|||
130264106|NCT04108273|468933293|FG001|Overall Study|COVID Pandemic|0|||
130264107|NCT00698828|468933295|FG000|Overall Study|Adverse Event|3|||
130264108|NCT00698828|468933296|FG001|Overall Study|Adverse Event|4|||
130264109|NCT00698828|468933297|FG002|Overall Study|Adverse Event|4|||
130264110|NCT00698828|468933295|FG000|Overall Study|Death|0|||
130264111|NCT00698828|468933296|FG001|Overall Study|Death|0|||
130264112|NCT00698828|468933297|FG002|Overall Study|Death|1|||
130264113|NCT00698828|468933295|FG000|Overall Study|Exacerbation of COPD|1|||
130264114|NCT00698828|468933296|FG001|Overall Study|Exacerbation of COPD|3|||
130264115|NCT00698828|468933297|FG002|Overall Study|Exacerbation of COPD|0|||
130264116|NCT00698828|468933295|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
130264117|NCT00698828|468933296|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
130264118|NCT00698828|468933297|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
130264119|NCT00698828|468933295|FG000|Overall Study|Investigator/Sponsor decision|1|||
130264120|NCT00698828|468933296|FG001|Overall Study|Investigator/Sponsor decision|0|||
130264121|NCT00698828|468933297|FG002|Overall Study|Investigator/Sponsor decision|2|||
130264122|NCT00698828|468933295|FG000|Overall Study|Lost to Follow-up|1|||
130264123|NCT00698828|468933296|FG001|Overall Study|Lost to Follow-up|1|||
130264124|NCT00698828|468933297|FG002|Overall Study|Lost to Follow-up|0|||
130264125|NCT00698828|468933295|FG000|Overall Study|Withdrew consent|0|||
130264126|NCT00698828|468933296|FG001|Overall Study|Withdrew consent|7|||
130264127|NCT00698828|468933297|FG002|Overall Study|Withdrew consent|4|||
130264128|NCT00698828|468933295|FG000|Overall Study|Withdrew consent (not treated)|2|||
130264129|NCT00698828|468933296|FG001|Overall Study|Withdrew consent (not treated)|0|||
130704327|NCT03635983|470541258|FG001|Treatment Period|Poor/Non-compliance|1|||
130704328|NCT03635983|470541257|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
130704329|NCT03635983|470541258|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
130704330|NCT03635983|470541257|FG000|Treatment Period|Other reasons|7|||
130264130|NCT00698828|468933297|FG002|Overall Study|Withdrew consent (not treated)|0|||
130264131|NCT00856609|468933298|FG000|Overall Study|Adverse Event|1|||
130264132|NCT00856609|468933299|FG001|Overall Study|Adverse Event|0|||
130264133|NCT01088503|468933300|FG000|Overall Study|Withdrawal by Subject|118|||
130264134|NCT01088503|468933301|FG001|Overall Study|Withdrawal by Subject|327|||
130264135|NCT01088503|468933302|FG002|Overall Study|Withdrawal by Subject|10|||
130264136|NCT01088503|468933300|FG000|Overall Study|Death|64|||
130264137|NCT01088503|468933301|FG001|Overall Study|Death|358|||
130264138|NCT01088503|468933302|FG002|Overall Study|Death|7|||
130264139|NCT00110214|468933303|FG000|Overall Study|Never started treatment|21|||
130264140|NCT00110214|468933304|FG001|Overall Study|Never started treatment|20|||
130264141|NCT00110214|468933303|FG000|Overall Study|Disease progression or death|260|||
130264142|NCT00110214|468933304|FG001|Overall Study|Disease progression or death|151|||
130264143|NCT00110214|468933303|FG000|Overall Study|Adverse Event|115|||
130264144|NCT00110214|468933304|FG001|Overall Study|Adverse Event|192|||
130264145|NCT00110214|468933303|FG000|Overall Study|Refused further treatment|52|||
130264146|NCT00110214|468933304|FG001|Overall Study|Refused further treatment|65|||
130264147|NCT00110214|468933303|FG000|Overall Study|Other (not specified)|61|||
130264148|NCT00110214|468933304|FG001|Overall Study|Other (not specified)|75|||
130264149|NCT01016067|468933305|FG000|Overall Study|Lost to Follow-up|1|||
130264150|NCT01016067|468933306|FG001|Overall Study|Lost to Follow-up|2|||
130264151|NCT01016067|468933305|FG000|Overall Study|Physician Decision|1|||
130264152|NCT01016067|468933306|FG001|Overall Study|Physician Decision|1|||
130264153|NCT01016067|468933305|FG000|Overall Study|Withdrew due to Relocation|0|||
130264154|NCT01016067|468933306|FG001|Overall Study|Withdrew due to Relocation|1|||
130264155|NCT01534481|468933313|FG000|Overall Study|Lost to Follow-up|29|||
130264156|NCT01534481|468933314|FG001|Overall Study|Lost to Follow-up|24|||
130264157|NCT01534481|468933313|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
130264158|NCT01534481|468933314|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
130264159|NCT01130337|468933315|FG000|Overall Study|Withdrawal by Subject|3|||
130264160|NCT01130337|468933315|FG000|Overall Study|Principal investigator decision|1|||
130264161|NCT01130337|468933315|FG000|Overall Study|Death|1|||
130264162|NCT01130337|468933315|FG000|Overall Study|Disease progression|1|||
130264163|NCT01130337|468933315|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
130264164|NCT01130337|468933315|FG000|Overall Study|Surgical resection (R2)|1|||
130264165|NCT05525910|468933316|FG000|Period 4|Per sponsor due to study timelines|0|||
130264166|NCT05525910|468933317|FG001|Period 4|Per sponsor due to study timelines|0|||
130704331|NCT03635983|470541258|FG001|Treatment Period|Other reasons|4|||
130264167|NCT05525910|468933318|FG002|Period 4|Per sponsor due to study timelines|1|||
130264168|NCT05525910|468933319|FG003|Period 4|Per sponsor due to study timelines|1|||
130264169|NCT05525910|468933320|FG004|Period 4|Per sponsor due to study timelines|1|||
130264170|NCT03886493|468933321|FG000|Overall Study|Adverse Event|1|||
130264171|NCT03179761|468933323|FG000|Overall Study|Death|2|||
130264172|NCT03179761|468933324|FG001|Overall Study|Death|5|||
130264173|NCT03179761|468933323|FG000|Overall Study|Lost to Follow-up|2|||
130264174|NCT03179761|468933324|FG001|Overall Study|Lost to Follow-up|2|||
130264175|NCT03179761|468933323|FG000|Overall Study|Protocol Violation|1|||
130264176|NCT03179761|468933324|FG001|Overall Study|Protocol Violation|0|||
130264177|NCT03179761|468933323|FG000|Overall Study|Withdrawal by Subject|1|||
130264178|NCT03179761|468933324|FG001|Overall Study|Withdrawal by Subject|4|||
130264179|NCT03179761|468933323|FG000|Overall Study|Investigator Request|0|||
130264180|NCT03179761|468933324|FG001|Overall Study|Investigator Request|2|||
130264181|NCT00448448|468933325|FG000|Overall Study|Withdrawal by Subject|13|||
130264182|NCT00448448|468933326|FG001|Overall Study|Withdrawal by Subject|2|||
130264183|NCT00448448|468933325|FG000|Overall Study|On protocol when study ended|83|||
130264184|NCT00448448|468933326|FG001|Overall Study|On protocol when study ended|36|||
130264185|NCT00448448|468933325|FG000|Overall Study|Lost to Follow-up|2|||
130264186|NCT00448448|468933326|FG001|Overall Study|Lost to Follow-up|1|||
130264187|NCT00448448|468933325|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
130264188|NCT00448448|468933326|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
130264189|NCT00448448|468933325|FG000|Overall Study|Signed consent lost|0|||
130264190|NCT00448448|468933326|FG001|Overall Study|Signed consent lost|1|||
130264191|NCT02284191|468933327|FG000|Overall Study|Withdrawal by Subject|1|||
130264192|NCT02284191|468933328|FG001|Overall Study|Withdrawal by Subject|3|||
130264193|NCT02284191|468933327|FG000|Overall Study|Lost to Follow-up|1|||
130264194|NCT02284191|468933328|FG001|Overall Study|Lost to Follow-up|0|||
130264195|NCT01832727|468933331|FG000|Overall Study|Adverse Event|4|||
130264196|NCT01832727|468933332|FG001|Overall Study|Adverse Event|6|||
130264197|NCT01832727|468933333|FG002|Overall Study|Adverse Event|1|||
130264198|NCT01832727|468933334|FG003|Overall Study|Adverse Event|0|||
130264199|NCT01832727|468933335|FG004|Overall Study|Adverse Event|1|||
130264200|NCT01832727|468933336|FG005|Overall Study|Adverse Event|1|||
130264201|NCT01832727|468933337|FG006|Overall Study|Adverse Event|2|||
130264202|NCT01832727|468933338|FG007|Overall Study|Adverse Event|1|||
130264203|NCT01832727|468933339|FG008|Overall Study|Adverse Event|9|||
130264204|NCT01832727|468933331|FG000|Overall Study|Disease progression|3|||
130264205|NCT01832727|468933332|FG001|Overall Study|Disease progression|0|||
130264206|NCT01832727|468933333|FG002|Overall Study|Disease progression|2|||
130264207|NCT01832727|468933334|FG003|Overall Study|Disease progression|1|||
130264208|NCT01832727|468933335|FG004|Overall Study|Disease progression|3|||
130264209|NCT01832727|468933336|FG005|Overall Study|Disease progression|3|||
130264210|NCT01832727|468933337|FG006|Overall Study|Disease progression|6|||
130264211|NCT01832727|468933338|FG007|Overall Study|Disease progression|2|||
130264212|NCT01832727|468933339|FG008|Overall Study|Disease progression|7|||
130264213|NCT01832727|468933331|FG000|Overall Study|Lost to Follow-up|0|||
130264214|NCT01832727|468933332|FG001|Overall Study|Lost to Follow-up|0|||
130264215|NCT01832727|468933333|FG002|Overall Study|Lost to Follow-up|0|||
130264216|NCT01832727|468933334|FG003|Overall Study|Lost to Follow-up|1|||
130264217|NCT01832727|468933335|FG004|Overall Study|Lost to Follow-up|0|||
130264218|NCT01832727|468933336|FG005|Overall Study|Lost to Follow-up|0|||
130264219|NCT01832727|468933337|FG006|Overall Study|Lost to Follow-up|0|||
130264220|NCT01832727|468933338|FG007|Overall Study|Lost to Follow-up|0|||
130264221|NCT01832727|468933339|FG008|Overall Study|Lost to Follow-up|0|||
130264222|NCT01832727|468933331|FG000|Overall Study|Physician Decision|1|||
130264223|NCT01832727|468933332|FG001|Overall Study|Physician Decision|0|||
130264224|NCT01832727|468933333|FG002|Overall Study|Physician Decision|0|||
130264225|NCT01832727|468933334|FG003|Overall Study|Physician Decision|1|||
130264226|NCT01832727|468933335|FG004|Overall Study|Physician Decision|0|||
130264227|NCT01832727|468933336|FG005|Overall Study|Physician Decision|1|||
130264228|NCT01832727|468933337|FG006|Overall Study|Physician Decision|0|||
130264229|NCT01832727|468933338|FG007|Overall Study|Physician Decision|0|||
130264230|NCT01832727|468933339|FG008|Overall Study|Physician Decision|0|||
130264231|NCT01832727|468933331|FG000|Overall Study|Withdrawal by Subject|1|||
130264232|NCT01832727|468933332|FG001|Overall Study|Withdrawal by Subject|1|||
130264233|NCT01832727|468933333|FG002|Overall Study|Withdrawal by Subject|0|||
130264234|NCT01832727|468933334|FG003|Overall Study|Withdrawal by Subject|1|||
130264235|NCT01832727|468933335|FG004|Overall Study|Withdrawal by Subject|0|||
130264236|NCT01832727|468933336|FG005|Overall Study|Withdrawal by Subject|1|||
130264237|NCT01832727|468933337|FG006|Overall Study|Withdrawal by Subject|0|||
130264238|NCT01832727|468933338|FG007|Overall Study|Withdrawal by Subject|2|||
130264239|NCT01832727|468933339|FG008|Overall Study|Withdrawal by Subject|1|||
130264240|NCT01832727|468933331|FG000|Overall Study|Study terminated by sponsor|0|||
130264241|NCT01832727|468933332|FG001|Overall Study|Study terminated by sponsor|0|||
130264242|NCT01832727|468933333|FG002|Overall Study|Study terminated by sponsor|0|||
130264243|NCT01832727|468933334|FG003|Overall Study|Study terminated by sponsor|0|||
130264244|NCT01832727|468933335|FG004|Overall Study|Study terminated by sponsor|0|||
130264245|NCT01832727|468933336|FG005|Overall Study|Study terminated by sponsor|0|||
130264246|NCT01832727|468933337|FG006|Overall Study|Study terminated by sponsor|0|||
130264247|NCT01832727|468933338|FG007|Overall Study|Study terminated by sponsor|1|||
130264248|NCT01832727|468933339|FG008|Overall Study|Study terminated by sponsor|1|||
130264249|NCT02216526|468933340|FG000|Overall Study|Adverse Event|1|||
130264250|NCT02216526|468933341|FG001|Overall Study|Adverse Event|1|||
130264251|NCT02216526|468933342|FG002|Overall Study|Adverse Event|0|||
130264252|NCT02216526|468933340|FG000|Overall Study|Death|0|||
130264253|NCT02216526|468933341|FG001|Overall Study|Death|1|||
130264254|NCT02216526|468933342|FG002|Overall Study|Death|3|||
130264255|NCT02216526|468933340|FG000|Overall Study|Protocol Violation|2|||
130264256|NCT02216526|468933341|FG001|Overall Study|Protocol Violation|0|||
130264257|NCT02216526|468933342|FG002|Overall Study|Protocol Violation|2|||
130264258|NCT02216526|468933340|FG000|Overall Study|Hospitalization|2|||
130264259|NCT02216526|468933341|FG001|Overall Study|Hospitalization|1|||
130264260|NCT02216526|468933342|FG002|Overall Study|Hospitalization|3|||
130264261|NCT01133847|468933349|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
130264262|NCT01133847|468933350|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
130264263|NCT01133847|468933351|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
130264264|NCT01133847|468933349|FG000|Follow-Up Phase|Lost to Follow-up|1|||
130264265|NCT01133847|468933350|FG001|Follow-Up Phase|Lost to Follow-up|3|||
130264266|NCT01133847|468933351|FG002|Follow-Up Phase|Lost to Follow-up|7|||
130264267|NCT04436744|468933352|FG000|Overall Study|Adverse Event|1|||
130264268|NCT04436744|468933353|FG001|Overall Study|Adverse Event|1|||
130264269|NCT04436744|468933352|FG000|Overall Study|Death|1|||
130264270|NCT04436744|468933353|FG001|Overall Study|Death|0|||
130264271|NCT04436744|468933352|FG000|Overall Study|Lost to Follow-up|0|||
130264272|NCT04436744|468933353|FG001|Overall Study|Lost to Follow-up|2|||
130264273|NCT04436744|468933352|FG000|Overall Study|Physician Decision|0|||
130264274|NCT04436744|468933353|FG001|Overall Study|Physician Decision|1|||
130264275|NCT04436744|468933352|FG000|Overall Study|Progressive Disease|0|||
130264276|NCT04436744|468933353|FG001|Overall Study|Progressive Disease|4|||
130264277|NCT04436744|468933352|FG000|Overall Study|Protocol Deviation|1|||
130264278|NCT04436744|468933353|FG001|Overall Study|Protocol Deviation|1|||
130264279|NCT04436744|468933352|FG000|Overall Study|Withdrawal by Subject|1|||
130264280|NCT04436744|468933353|FG001|Overall Study|Withdrawal by Subject|2|||
130264281|NCT01463033|468933354|FG000|Overall Study|Lost to Follow-up|4|||
130264282|NCT01463033|468933355|FG001|Overall Study|Lost to Follow-up|4|||
130264283|NCT01463033|468933354|FG000|Overall Study|Death|3|||
130264284|NCT01463033|468933355|FG001|Overall Study|Death|2|||
130264285|NCT00967616|468933356|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
130264286|NCT00967616|468933357|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
130264287|NCT00967616|468933356|FG000|Overall Study|Death|0|||
130264288|NCT00967616|468933357|FG001|Overall Study|Death|3|||
130264289|NCT00967616|468933356|FG000|Overall Study|Withdrawal by Subject|8|||
130264290|NCT00967616|468933357|FG001|Overall Study|Withdrawal by Subject|4|||
130264291|NCT00967616|468933356|FG000|Overall Study|Progressive Disease|31|||
130264292|NCT00967616|468933357|FG001|Overall Study|Progressive Disease|18|||
130264293|NCT00967616|468933356|FG000|Overall Study|Other|8|||
130264294|NCT00967616|468933357|FG001|Overall Study|Other|8|||
130264295|NCT00967616|468933356|FG000|Overall Study|Protocol Violation|1|||
130264296|NCT00967616|468933357|FG001|Overall Study|Protocol Violation|0|||
130264297|NCT00575666|468933358|FG000|Overall Study|Withdrawal by Subject|3|||
130264298|NCT00575666|468933359|FG001|Overall Study|Withdrawal by Subject|2|||
130264299|NCT00575666|468933358|FG000|Overall Study|Physician Decision|1|||
130264300|NCT00575666|468933359|FG001|Overall Study|Physician Decision|1|||
130264301|NCT01368614|468933360|FG000|Screening Period|Screen Failure|58|||
130264302|NCT01368614|468933361|FG001|Screening Period|Screen Failure|0|||
130264303|NCT01368614|468933362|FG002|Screening Period|Screen Failure|0|||
130264304|NCT01368614|468933363|FG003|Screening Period|Screen Failure|0|||
130264305|NCT01368614|468933360|FG000|Study Period|Withdrawal by Subject|0|||
130264306|NCT01368614|468933361|FG001|Study Period|Withdrawal by Subject|1|||
130264307|NCT01368614|468933362|FG002|Study Period|Withdrawal by Subject|1|||
130264308|NCT01368614|468933363|FG003|Study Period|Withdrawal by Subject|3|||
130264309|NCT01368614|468933360|FG000|Study Period|Lost to Follow-up|0|||
130264310|NCT01368614|468933361|FG001|Study Period|Lost to Follow-up|0|||
130264311|NCT01368614|468933362|FG002|Study Period|Lost to Follow-up|1|||
130264312|NCT01368614|468933363|FG003|Study Period|Lost to Follow-up|0|||
130264313|NCT02951780|468933364|FG000|Period 1|Adverse Event|0|||
130264314|NCT02951780|468933365|FG001|Period 1|Adverse Event|0|||
130264315|NCT02951780|468933366|FG002|Period 1|Adverse Event|0|||
130553988|NCT00221195|469996474|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
130553989|NCT00221195|469996473|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
130264316|NCT02951780|468933367|FG003|Period 1|Adverse Event|1|||
130264317|NCT02951780|468933368|FG004|Period 1|Adverse Event|0|||
130264318|NCT02951780|468933369|FG005|Period 1|Adverse Event|0|||
130264319|NCT02951780|468933370|FG006|Period 1|Adverse Event|0|||
130264320|NCT02951780|468933371|FG007|Period 1|Adverse Event|0|||
130264321|NCT02951780|468933372|FG008|Period 1|Adverse Event|0|||
130264322|NCT02951780|468933364|FG000|Period 1|Scheduling Conflicts|0|||
130264323|NCT02951780|468933365|FG001|Period 1|Scheduling Conflicts|0|||
130264324|NCT02951780|468933366|FG002|Period 1|Scheduling Conflicts|0|||
130264325|NCT02951780|468933367|FG003|Period 1|Scheduling Conflicts|0|||
130264326|NCT02951780|468933368|FG004|Period 1|Scheduling Conflicts|0|||
130264327|NCT02951780|468933369|FG005|Period 1|Scheduling Conflicts|0|||
130264328|NCT02951780|468933370|FG006|Period 1|Scheduling Conflicts|0|||
130264329|NCT02951780|468933371|FG007|Period 1|Scheduling Conflicts|1|||
130264330|NCT02951780|468933372|FG008|Period 1|Scheduling Conflicts|0|||
130264331|NCT02951780|468933364|FG000|Period 2|Scheduling Conflicts|0|||
130264332|NCT02951780|468933365|FG001|Period 2|Scheduling Conflicts|0|||
130264333|NCT02951780|468933366|FG002|Period 2|Scheduling Conflicts|0|||
130264334|NCT02951780|468933367|FG003|Period 2|Scheduling Conflicts|0|||
130264335|NCT02951780|468933368|FG004|Period 2|Scheduling Conflicts|0|||
130264336|NCT02951780|468933369|FG005|Period 2|Scheduling Conflicts|0|||
130264337|NCT02951780|468933370|FG006|Period 2|Scheduling Conflicts|0|||
130264338|NCT02951780|468933371|FG007|Period 2|Scheduling Conflicts|1|||
130264339|NCT02951780|468933372|FG008|Period 2|Scheduling Conflicts|0|||
130264340|NCT01374425|468933373|FG000|Overall Study|Radiographic Disease Progression|86|||
130264341|NCT01374425|468933374|FG001|Overall Study|Radiographic Disease Progression|81|||
130264342|NCT01374425|468933373|FG000|Overall Study|Clinical Disease Progression|9|||
130264343|NCT01374425|468933374|FG001|Overall Study|Clinical Disease Progression|6|||
130264344|NCT01374425|468933373|FG000|Overall Study|Adverse Event|29|||
130264345|NCT01374425|468933374|FG001|Overall Study|Adverse Event|18|||
130264346|NCT01374425|468933373|FG000|Overall Study|Death (Progression of Disease)|1|||
130264347|NCT01374425|468933374|FG001|Overall Study|Death (Progression of Disease)|0|||
130264348|NCT01374425|468933373|FG000|Overall Study|Death (Adverse Event)|2|||
130264349|NCT01374425|468933374|FG001|Overall Study|Death (Adverse Event)|4|||
130264350|NCT01374425|468933373|FG000|Overall Study|Withdrawal by Subject|6|||
130264351|NCT01374425|468933374|FG001|Overall Study|Withdrawal by Subject|7|||
130264352|NCT01374425|468933373|FG000|Overall Study|Refused Treatment|10|||
130264353|NCT01374425|468933374|FG001|Overall Study|Refused Treatment|24|||
130264354|NCT01374425|468933373|FG000|Overall Study|Protocol Violation|2|||
130264355|NCT01374425|468933374|FG001|Overall Study|Protocol Violation|3|||
130264356|NCT01374425|468933373|FG000|Overall Study|Sponsor Decision|0|||
130264357|NCT01374425|468933374|FG001|Overall Study|Sponsor Decision|1|||
130264358|NCT01374425|468933373|FG000|Overall Study|Lost to Follow-up|2|||
130264359|NCT01374425|468933374|FG001|Overall Study|Lost to Follow-up|1|||
130264360|NCT01374425|468933373|FG000|Overall Study|Other|41|||
130264361|NCT01374425|468933374|FG001|Overall Study|Other|43|||
130264362|NCT02359903|468933375|FG000|Overall Study|Adverse Event|0|||
130264363|NCT02359903|468933376|FG001|Overall Study|Adverse Event|2|||
130264364|NCT03783780|468933384|FG000|Overall Study|Withdrawn prior to completion|1|||
130264365|NCT02629861|468933387|FG000|Overall Study|Adverse Event|7|||
130264366|NCT02629861|468933388|FG001|Overall Study|Adverse Event|5|||
130264367|NCT02629861|468933389|FG002|Overall Study|Adverse Event|4|||
130264368|NCT02629861|468933387|FG000|Overall Study|Withdrawal by Subject|5|||
130264369|NCT02629861|468933388|FG001|Overall Study|Withdrawal by Subject|8|||
130264370|NCT02629861|468933389|FG002|Overall Study|Withdrawal by Subject|13|||
130264371|NCT02629861|468933387|FG000|Overall Study|Protocol Violation|2|||
130704332|NCT03635983|470541257|FG000|Treatment Period|Disease progression|230|||
130704333|NCT03635983|470541258|FG001|Treatment Period|Disease progression|201|||
130264372|NCT02629861|468933388|FG001|Overall Study|Protocol Violation|3|||
130264373|NCT02629861|468933389|FG002|Overall Study|Protocol Violation|7|||
130264374|NCT02629861|468933387|FG000|Overall Study|Lost to Follow-up|12|||
130264375|NCT02629861|468933388|FG001|Overall Study|Lost to Follow-up|9|||
130264376|NCT02629861|468933389|FG002|Overall Study|Lost to Follow-up|4|||
130264377|NCT02629861|468933387|FG000|Overall Study|Other|1|||
130264378|NCT02629861|468933388|FG001|Overall Study|Other|1|||
130264379|NCT02629861|468933389|FG002|Overall Study|Other|0|||
130264380|NCT02629861|468933387|FG000|Overall Study|Pregnancy|2|||
130704334|NCT03635983|470541257|FG000|Treatment Period|Study drug toxicity|35|||
130264381|NCT02629861|468933388|FG001|Overall Study|Pregnancy|1|||
130264382|NCT02629861|468933389|FG002|Overall Study|Pregnancy|0|||
130264383|NCT00907621|468933390|FG000|Overall Study|Lost to Follow-up|6|||
130264384|NCT00907621|468933391|FG001|Overall Study|Lost to Follow-up|3|||
130264385|NCT00907621|468933390|FG000|Overall Study|intercurrent febrile illness|1|||
130264386|NCT00907621|468933391|FG001|Overall Study|intercurrent febrile illness|1|||
130704335|NCT03635983|470541258|FG001|Treatment Period|Study drug toxicity|36|||
130264387|NCT01816048|468933394|FG000|Overall Study|Adverse Event|1|||
130264388|NCT01816048|468933394|FG000|Overall Study|Death|1|||
130264389|NCT01816048|468933394|FG000|Overall Study|Withdrawal by Subject|1|||
130264390|NCT01816048|468933394|FG000|Overall Study|Disease Progression|3|||
130264391|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
130264392|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
130264393|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
130264394|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
130264395|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
130264396|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
130264397|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
130704336|NCT03635983|470541257|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
130704337|NCT03635983|470541258|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
130704338|NCT03635983|470541257|FG000|Treatment Period|Maximum clinical benefit|3|||
130704339|NCT03635983|470541258|FG001|Treatment Period|Maximum clinical benefit|5|||
130704340|NCT03635983|470541257|FG000|Treatment Period|Administrative reason by the sponsor|1|||
130704341|NCT03635983|470541258|FG001|Treatment Period|Administrative reason by the sponsor|2|||
130704342|NCT03635983|470541257|FG000|Treatment Period|Lost to Follow-up|0|||
130704343|NCT03635983|470541258|FG001|Treatment Period|Lost to Follow-up|1|||
130704344|NCT03430011|470541260|FG000|Pre-Treatment|Death|1|||
130704345|NCT03430011|470541261|FG001|Pre-Treatment|Death|0|||
130704346|NCT03430011|470541262|FG002|Pre-Treatment|Death|0|||
130704347|NCT03430011|470541263|FG003|Pre-Treatment|Death|0|||
130704348|NCT03430011|470541264|FG004|Pre-Treatment|Death|1|||
130704349|NCT03430011|470541265|FG005|Pre-Treatment|Death|0|||
130704350|NCT03430011|470541266|FG006|Pre-Treatment|Death|1|||
130704351|NCT03430011|470541267|FG007|Pre-Treatment|Death|0|||
130704352|NCT03430011|470541260|FG000|Pre-Treatment|Screen Fail|0|||
130264398|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130264399|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130264400|NCT03069716|468933395|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130264401|NCT03069716|468933396|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130264402|NCT03069716|468933397|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130264403|NCT01088906|468933401|FG000|Overall Study|Inclusion error|1|||
130704353|NCT03430011|470541261|FG001|Pre-Treatment|Screen Fail|0|||
130704354|NCT03430011|470541262|FG002|Pre-Treatment|Screen Fail|0|||
130704355|NCT03430011|470541263|FG003|Pre-Treatment|Screen Fail|0|||
130704356|NCT03430011|470541264|FG004|Pre-Treatment|Screen Fail|1|||
130704357|NCT03430011|470541265|FG005|Pre-Treatment|Screen Fail|0|||
130704358|NCT03430011|470541266|FG006|Pre-Treatment|Screen Fail|0|||
130704359|NCT03430011|470541267|FG007|Pre-Treatment|Screen Fail|0|||
130704360|NCT03430011|470541260|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
130264404|NCT01088906|468933401|FG000|Overall Study|Did not receive study treatment|3|||
130264405|NCT01088906|468933401|FG000|Overall Study|Missing data|1|||
130264406|NCT00457626|468933402|FG000|Overall Study|Adverse Event|3|||
130264407|NCT00457626|468933402|FG000|Overall Study|Administrative Problems|2|||
130264408|NCT00457626|468933402|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
130264409|NCT03384875|468933403|FG000|Overall Study|Death|1|||
130264410|NCT03384875|468933404|FG001|Overall Study|Death|1|||
130264411|NCT03384875|468933405|FG002|Overall Study|Death|0|||
130264412|NCT03384875|468933403|FG000|Overall Study|Reason not provided|1|||
130264413|NCT03384875|468933404|FG001|Overall Study|Reason not provided|0|||
130264414|NCT03384875|468933405|FG002|Overall Study|Reason not provided|0|||
130264415|NCT03549338|468935539|FG000|Overall Study|Progressive Disease|1|||
130264416|NCT03549338|468935540|FG001|Overall Study|Progressive Disease|0|||
130264417|NCT03549338|468935541|FG002|Overall Study|Progressive Disease|0|||
130264418|NCT03549338|468935539|FG000|Overall Study|Clinical Progression|0|||
130264419|NCT03549338|468935540|FG001|Overall Study|Clinical Progression|1|||
130264420|NCT03549338|468935541|FG002|Overall Study|Clinical Progression|0|||
130264421|NCT01944020|468935543|FG000|Overall Study|Withdrawal by Subject|5|||
130264422|NCT01944020|468935544|FG001|Overall Study|Withdrawal by Subject|0|||
130264423|NCT03257358|468935549|FG000|Overall Study|Adverse Event|25|||
130264424|NCT03257358|468935550|FG001|Overall Study|Adverse Event|12|||
130264425|NCT03257358|468935549|FG000|Overall Study|Lack of Efficacy|1|||
130264426|NCT03257358|468935550|FG001|Overall Study|Lack of Efficacy|1|||
130264427|NCT03257358|468935549|FG000|Overall Study|Lost to Follow-up|12|||
130264428|NCT03257358|468935550|FG001|Overall Study|Lost to Follow-up|4|||
130264429|NCT03257358|468935549|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
130264430|NCT03257358|468935550|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
130264431|NCT03257358|468935549|FG000|Overall Study|Physician Decision|2|||
130264432|NCT03257358|468935550|FG001|Overall Study|Physician Decision|2|||
130264433|NCT03257358|468935549|FG000|Overall Study|Protocol Violation|5|||
130264434|NCT03257358|468935550|FG001|Overall Study|Protocol Violation|3|||
130264435|NCT03257358|468935549|FG000|Overall Study|Technical problems|4|||
130264436|NCT03257358|468935550|FG001|Overall Study|Technical problems|1|||
130264437|NCT03257358|468935549|FG000|Overall Study|Withdrawal by Subject|8|||
130264438|NCT03257358|468935550|FG001|Overall Study|Withdrawal by Subject|3|||
130264439|NCT03257358|468935549|FG000|Overall Study|Withdrawal of informed consent|9|||
130264440|NCT03257358|468935550|FG001|Overall Study|Withdrawal of informed consent|5|||
130264441|NCT03257358|468935549|FG000|Overall Study|New therapy for study indication|1|||
130264442|NCT03257358|468935550|FG001|Overall Study|New therapy for study indication|0|||
130264443|NCT03257358|468935549|FG000|Overall Study|No longer requires treatment|0|||
130264444|NCT03257358|468935550|FG001|Overall Study|No longer requires treatment|1|||
130264445|NCT01977898|468935551|FG000|Overall Study|Non functioning catheter|1|||
130264446|NCT01977898|468935552|FG001|Overall Study|Non functioning catheter|1|||
130264447|NCT01049373|468935553|FG000|Overall Study|Protocol Violation|9|||
130264448|NCT01049373|468935554|FG001|Overall Study|Protocol Violation|9|||
130264449|NCT01049373|468935553|FG000|Overall Study|Withdrawal by Subject|8|||
130264450|NCT01049373|468935554|FG001|Overall Study|Withdrawal by Subject|5|||
130264451|NCT01049373|468935553|FG000|Overall Study|Adverse Event|3|||
130264452|NCT01049373|468935554|FG001|Overall Study|Adverse Event|3|||
130264453|NCT01049373|468935553|FG000|Overall Study|Lost to Follow-up|9|||
130264454|NCT01049373|468935554|FG001|Overall Study|Lost to Follow-up|4|||
130264455|NCT01049373|468935553|FG000|Overall Study|no evaluable study values|9|||
130264456|NCT01049373|468935554|FG001|Overall Study|no evaluable study values|21|||
130264457|NCT01049373|468935553|FG000|Overall Study|Other|1|||
130264458|NCT01049373|468935554|FG001|Overall Study|Other|1|||
130264459|NCT01049373|468935553|FG000|Overall Study|Non-cooperation|0|||
130264460|NCT01049373|468935554|FG001|Overall Study|Non-cooperation|1|||
130264461|NCT02391311|468935555|FG000|Overall Study|Lost to Follow-up|2|||
130264462|NCT02391311|468935556|FG001|Overall Study|Lost to Follow-up|1|||
130264463|NCT02391311|468935555|FG000|Overall Study|deemed ineligible after baseline|1|||
130264464|NCT02391311|468935556|FG001|Overall Study|deemed ineligible after baseline|1|||
130264465|NCT02897115|468935557|FG000|Overall Study|Early termination of study by sponsor|11|||
130264466|NCT02897115|468935558|FG001|Overall Study|Early termination of study by sponsor|8|||
130264467|NCT00487981|468935559|FG000|Overall Study|Hypothyroidism diagnosis|1|||
130264468|NCT00856323|468935560|FG000|Overall Study|Withdrawal by Subject|2|||
130264469|NCT02808429|468935565|FG000|Overall Study|Lost to Follow-up|1|||
130264470|NCT02808429|468935566|FG001|Overall Study|Lost to Follow-up|0|||
130264471|NCT02808429|468935567|FG002|Overall Study|Lost to Follow-up|0|||
130264472|NCT02808429|468935565|FG000|Overall Study|Protocol Violation|0|||
130264473|NCT02808429|468935566|FG001|Overall Study|Protocol Violation|1|||
130264474|NCT02808429|468935567|FG002|Overall Study|Protocol Violation|0|||
130264475|NCT02808429|468935565|FG000|Overall Study|Premature study termination by sponsor|2|||
130264476|NCT02808429|468935566|FG001|Overall Study|Premature study termination by sponsor|0|||
130264477|NCT02808429|468935567|FG002|Overall Study|Premature study termination by sponsor|1|||
130264478|NCT02808429|468935565|FG000|Overall Study|Relocation|0|||
130264479|NCT02808429|468935566|FG001|Overall Study|Relocation|0|||
130264480|NCT02808429|468935567|FG002|Overall Study|Relocation|1|||
130264481|NCT00811954|468935573|FG000|Overall Study|Death|10|||
130264482|NCT00811954|468935574|FG001|Overall Study|Death|6|||
130264483|NCT00811954|468935575|FG002|Overall Study|Death|13|||
130264484|NCT00811954|468935573|FG000|Overall Study|Lost to Follow-up|29|||
130264485|NCT00811954|468935574|FG001|Overall Study|Lost to Follow-up|23|||
130264486|NCT00811954|468935575|FG002|Overall Study|Lost to Follow-up|34|||
130264487|NCT00811954|468935573|FG000|Overall Study|Not able to get to clinic|28|||
130264488|NCT00811954|468935574|FG001|Overall Study|Not able to get to clinic|35|||
130264489|NCT00811954|468935575|FG002|Overall Study|Not able to get to clinic|30|||
130264490|NCT00811954|468935573|FG000|Overall Study|Not willing to adhere to requirements|12|||
130264491|NCT00811954|468935574|FG001|Overall Study|Not willing to adhere to requirements|2|||
130264492|NCT00811954|468935575|FG002|Overall Study|Not willing to adhere to requirements|16|||
130264493|NCT00811954|468935573|FG000|Overall Study|Withdraw consent prior study completion|4|||
130264494|NCT00811954|468935574|FG001|Overall Study|Withdraw consent prior study completion|6|||
130264495|NCT00811954|468935575|FG002|Overall Study|Withdraw consent prior study completion|5|||
130264496|NCT00811954|468935573|FG000|Overall Study|Site Closure|4|||
130264497|NCT00811954|468935574|FG001|Overall Study|Site Closure|0|||
130264498|NCT00811954|468935575|FG002|Overall Study|Site Closure|1|||
130264499|NCT00811954|468935573|FG000|Overall Study|Severe Debilitation|2|||
130264500|NCT00811954|468935574|FG001|Overall Study|Severe Debilitation|0|||
130264501|NCT00811954|468935575|FG002|Overall Study|Severe Debilitation|1|||
130264502|NCT00811954|468935573|FG000|Overall Study|Complete Protocol: No follow-up|0|||
130264503|NCT00811954|468935574|FG001|Overall Study|Complete Protocol: No follow-up|0|||
130264504|NCT00811954|468935575|FG002|Overall Study|Complete Protocol: No follow-up|1|||
130264505|NCT01063348|468935578|FG000|Overall Study|Lost to Follow-up|3|||
130264506|NCT01063348|468935579|FG001|Overall Study|Lost to Follow-up|10|||
130704361|NCT03430011|470541261|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704362|NCT03430011|470541262|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
130704363|NCT03430011|470541263|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704364|NCT03430011|470541264|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
130264507|NCT05518461|468935580|FG000|Overall Study|Lost to Follow-up|25|||
130264508|NCT04828707|468935581|FG000|Overall Study|Lost to Follow-up|3|||
130264509|NCT04828707|468935582|FG001|Overall Study|Lost to Follow-up|2|||
130264510|NCT04828707|468935581|FG000|Overall Study|Withdrawal by Subject|2|||
130264511|NCT04828707|468935582|FG001|Overall Study|Withdrawal by Subject|1|||
130453246|NCT01149681|469623523|FG000|Overall Study|Physician Decision|2|||
130453247|NCT01149681|469623523|FG000|Overall Study|adverse events nonrelated study drug|2|||
130264512|NCT03139448|468935583|FG000|Overall Study|Lack of Efficacy|6|||
130264513|NCT03139448|468935584|FG001|Overall Study|Lack of Efficacy|7|||
130264514|NCT03139448|468935583|FG000|Overall Study|Location of procedure changed|2|||
130264515|NCT03139448|468935584|FG001|Overall Study|Location of procedure changed|8|||
130264516|NCT03139448|468935583|FG000|Overall Study|Withdrawal by Subject|3|||
130264517|NCT03139448|468935584|FG001|Overall Study|Withdrawal by Subject|6|||
130264518|NCT03139448|468935583|FG000|Overall Study|Screen fail|1|||
130264519|NCT03139448|468935584|FG001|Overall Study|Screen fail|3|||
130264520|NCT03139448|468935583|FG000|Overall Study|Physician Decision|0|||
130264521|NCT03139448|468935584|FG001|Overall Study|Physician Decision|2|||
130264522|NCT00523978|468935587|FG000|Overall Study|Withdrawal by Subject|3|||
130264523|NCT00523978|468935588|FG001|Overall Study|Withdrawal by Subject|7|||
130264524|NCT00523978|468935587|FG000|Overall Study|Screen Failures|5|||
130264525|NCT00523978|468935588|FG001|Overall Study|Screen Failures|1|||
130264526|NCT00523978|468935587|FG000|Overall Study|Death|1|||
130264527|NCT00523978|468935588|FG001|Overall Study|Death|0|||
130264528|NCT00501644|468935590|FG000|Overall Study|Adverse Event|4|||
130264529|NCT00501644|468935590|FG000|Overall Study|Withdrawal by Subject|1|||
130264530|NCT02750514|468935591|FG000|Track 1|Disease progression|20|||
130264531|NCT02750514|468935592|FG001|Track 1|Disease progression|1|||
130264532|NCT02750514|468935593|FG002|Track 1|Disease progression|0|||
130264533|NCT02750514|468935594|FG003|Track 1|Disease progression|1|||
130264534|NCT02750514|468935595|FG004|Track 1|Disease progression|0|||
130264535|NCT02750514|468935591|FG000|Track 1|Adverse event unrelated to study drug|1|||
130264536|NCT02750514|468935592|FG001|Track 1|Adverse event unrelated to study drug|0|||
130264537|NCT02750514|468935593|FG002|Track 1|Adverse event unrelated to study drug|0|||
130264538|NCT02750514|468935594|FG003|Track 1|Adverse event unrelated to study drug|0|||
130264539|NCT02750514|468935595|FG004|Track 1|Adverse event unrelated to study drug|0|||
130264540|NCT02750514|468935591|FG000|Track 1|Study drug toxicity|4|||
130264541|NCT02750514|468935592|FG001|Track 1|Study drug toxicity|1|||
130264542|NCT02750514|468935593|FG002|Track 1|Study drug toxicity|0|||
130264543|NCT02750514|468935594|FG003|Track 1|Study drug toxicity|1|||
130264544|NCT02750514|468935595|FG004|Track 1|Study drug toxicity|0|||
130264545|NCT02750514|468935591|FG000|Track 1|Participant request to discontinue|1|||
130264546|NCT02750514|468935592|FG001|Track 1|Participant request to discontinue|0|||
130264547|NCT02750514|468935593|FG002|Track 1|Participant request to discontinue|0|||
130264548|NCT02750514|468935594|FG003|Track 1|Participant request to discontinue|0|||
130264549|NCT02750514|468935595|FG004|Track 1|Participant request to discontinue|0|||
130264550|NCT02750514|468935591|FG000|Track 1|Other reasons|1|||
130264551|NCT02750514|468935592|FG001|Track 1|Other reasons|0|||
130264552|NCT02750514|468935593|FG002|Track 1|Other reasons|0|||
130264553|NCT02750514|468935594|FG003|Track 1|Other reasons|0|||
130264554|NCT02750514|468935595|FG004|Track 1|Other reasons|0|||
130264555|NCT02750514|468935591|FG000|Track 2|Disease progression|4|||
130264556|NCT02750514|468935592|FG001|Track 2|Disease progression|5|||
130264557|NCT02750514|468935593|FG002|Track 2|Disease progression|2|||
130264558|NCT02750514|468935594|FG003|Track 2|Disease progression|5|||
130264559|NCT02750514|468935595|FG004|Track 2|Disease progression|0|||
130264560|NCT02750514|468935591|FG000|Track 2|Adverse event unrelated to study drug|1|||
130264561|NCT02750514|468935592|FG001|Track 2|Adverse event unrelated to study drug|0|||
130264562|NCT02750514|468935593|FG002|Track 2|Adverse event unrelated to study drug|0|||
130264563|NCT02750514|468935594|FG003|Track 2|Adverse event unrelated to study drug|0|||
130264564|NCT02750514|468935595|FG004|Track 2|Adverse event unrelated to study drug|0|||
130264565|NCT02750514|468935591|FG000|Track 2|Study drug toxicity|1|||
130264566|NCT02750514|468935592|FG001|Track 2|Study drug toxicity|2|||
130264567|NCT02750514|468935593|FG002|Track 2|Study drug toxicity|0|||
130264568|NCT02750514|468935594|FG003|Track 2|Study drug toxicity|2|||
130264569|NCT02750514|468935595|FG004|Track 2|Study drug toxicity|0|||
130365611|NCT01187433|469306926|FG001|Overall Study|Withdrawal by Subject|2|||
130365612|NCT00437983|469306928|FG000|Overall Study|Adverse Event|6|||
130365613|NCT00437983|469306929|FG001|Overall Study|Adverse Event|6|||
130704365|NCT03430011|470541265|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704366|NCT03430011|470541266|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704367|NCT03430011|470541267|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704368|NCT03430011|470541260|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
130264570|NCT02750514|468935591|FG000|Track 2|Participant withdrew consent|0|||
130264571|NCT02750514|468935592|FG001|Track 2|Participant withdrew consent|1|||
130264572|NCT02750514|468935593|FG002|Track 2|Participant withdrew consent|0|||
130264573|NCT02750514|468935594|FG003|Track 2|Participant withdrew consent|0|||
130365614|NCT00437983|469306928|FG000|Overall Study|Protocol Violation|2|||
130264574|NCT02750514|468935595|FG004|Track 2|Participant withdrew consent|0|||
130264575|NCT02750514|468935591|FG000|Track 3|Disease progression|0|||
130264576|NCT02750514|468935592|FG001|Track 3|Disease progression|24|||
130264577|NCT02750514|468935593|FG002|Track 3|Disease progression|13|||
130264578|NCT02750514|468935594|FG003|Track 3|Disease progression|14|||
130365615|NCT00437983|469306929|FG001|Overall Study|Protocol Violation|1|||
130264579|NCT02750514|468935595|FG004|Track 3|Disease progression|0|||
130264580|NCT02750514|468935591|FG000|Track 3|Adverse event unrelated to study drug|0|||
130264581|NCT02750514|468935592|FG001|Track 3|Adverse event unrelated to study drug|1|||
130264582|NCT02750514|468935593|FG002|Track 3|Adverse event unrelated to study drug|1|||
130365616|NCT00437983|469306928|FG000|Overall Study|Withdrawal by Subject|5|||
130365617|NCT00437983|469306929|FG001|Overall Study|Withdrawal by Subject|6|||
130365618|NCT00672646|469306932|FG000|Overall Study|Lost to Follow-up|0|||
130365619|NCT00672646|469306933|FG001|Overall Study|Lost to Follow-up|1|||
130365620|NCT00672646|469306934|FG002|Overall Study|Lost to Follow-up|2|||
130264583|NCT02750514|468935594|FG003|Track 3|Adverse event unrelated to study drug|1|||
130264584|NCT02750514|468935595|FG004|Track 3|Adverse event unrelated to study drug|0|||
130264585|NCT02750514|468935591|FG000|Track 3|Study drug toxicity|0|||
130264586|NCT02750514|468935592|FG001|Track 3|Study drug toxicity|3|||
130264587|NCT02750514|468935593|FG002|Track 3|Study drug toxicity|0|||
130264588|NCT02750514|468935594|FG003|Track 3|Study drug toxicity|1|||
130264589|NCT02750514|468935595|FG004|Track 3|Study drug toxicity|0|||
130264590|NCT02750514|468935591|FG000|Track 3|Participant request to discontinue|0|||
130264591|NCT02750514|468935592|FG001|Track 3|Participant request to discontinue|2|||
130264592|NCT02750514|468935593|FG002|Track 3|Participant request to discontinue|0|||
130264593|NCT02750514|468935594|FG003|Track 3|Participant request to discontinue|0|||
130264594|NCT02750514|468935595|FG004|Track 3|Participant request to discontinue|0|||
130264595|NCT02750514|468935591|FG000|Track 3|Participant withdrew consent|0|||
130264596|NCT02750514|468935592|FG001|Track 3|Participant withdrew consent|3|||
130365621|NCT00672646|469306932|FG000|Overall Study|Withdrawal by Subject|0|||
130365622|NCT00672646|469306933|FG001|Overall Study|Withdrawal by Subject|0|||
130365623|NCT00672646|469306934|FG002|Overall Study|Withdrawal by Subject|1|||
130264597|NCT02750514|468935593|FG002|Track 3|Participant withdrew consent|1|||
130264598|NCT02750514|468935594|FG003|Track 3|Participant withdrew consent|0|||
130264599|NCT02750514|468935595|FG004|Track 3|Participant withdrew consent|0|||
130264600|NCT02750514|468935591|FG000|Track 3|Other reasons|0|||
130264601|NCT02750514|468935592|FG001|Track 3|Other reasons|3|||
130264602|NCT02750514|468935593|FG002|Track 3|Other reasons|0|||
130264603|NCT02750514|468935594|FG003|Track 3|Other reasons|0|||
130264604|NCT02750514|468935595|FG004|Track 3|Other reasons|0|||
130264605|NCT02750514|468935591|FG000|Track 4|Study drug toxicity|0|||
130264606|NCT02750514|468935592|FG001|Track 4|Study drug toxicity|6|||
130264607|NCT02750514|468935593|FG002|Track 4|Study drug toxicity|0|||
130365624|NCT00242216|469306935|FG000|Overall Study|Lost to Follow-up|12|||
130365625|NCT00242216|469306936|FG001|Overall Study|Lost to Follow-up|17|||
130264608|NCT02750514|468935594|FG003|Track 4|Study drug toxicity|5|||
130264609|NCT02750514|468935595|FG004|Track 4|Study drug toxicity|0|||
130264610|NCT02750514|468935591|FG000|Track 4|Participant request to discontinue|0|||
130264611|NCT02750514|468935592|FG001|Track 4|Participant request to discontinue|1|||
130264612|NCT02750514|468935593|FG002|Track 4|Participant request to discontinue|0|||
130264613|NCT02750514|468935594|FG003|Track 4|Participant request to discontinue|1|||
130264614|NCT02750514|468935595|FG004|Track 4|Participant request to discontinue|0|||
130264615|NCT02750514|468935591|FG000|Track 4|Participant withdrew consent|0|||
130264616|NCT02750514|468935592|FG001|Track 4|Participant withdrew consent|1|||
130264617|NCT02750514|468935593|FG002|Track 4|Participant withdrew consent|0|||
130264618|NCT02750514|468935594|FG003|Track 4|Participant withdrew consent|0|||
130264619|NCT02750514|468935595|FG004|Track 4|Participant withdrew consent|0|||
130264620|NCT02750514|468935591|FG000|Track 4|Other reasons|0|||
130264621|NCT02750514|468935592|FG001|Track 4|Other reasons|5|||
130264622|NCT02750514|468935593|FG002|Track 4|Other reasons|0|||
130264623|NCT02750514|468935594|FG003|Track 4|Other reasons|3|||
130264624|NCT02750514|468935595|FG004|Track 4|Other reasons|0|||
130264625|NCT02750514|468935591|FG000|Track 4|Disease progression|0|||
130264626|NCT02750514|468935592|FG001|Track 4|Disease progression|33|||
130365626|NCT00242216|469306935|FG000|Overall Study|Death|4|||
130264627|NCT02750514|468935593|FG002|Track 4|Disease progression|0|||
130365627|NCT00242216|469306936|FG001|Overall Study|Death|2|||
130553990|NCT00221195|469996474|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
130264628|NCT02750514|468935594|FG003|Track 4|Disease progression|32|||
130264629|NCT02750514|468935595|FG004|Track 4|Disease progression|0|||
130264630|NCT02750514|468935591|FG000|Track 4|Adverse event unrelated to study drug|0|||
130264631|NCT02750514|468935592|FG001|Track 4|Adverse event unrelated to study drug|5|||
130264632|NCT02750514|468935593|FG002|Track 4|Adverse event unrelated to study drug|0|||
130264633|NCT02750514|468935594|FG003|Track 4|Adverse event unrelated to study drug|0|||
130264634|NCT02750514|468935595|FG004|Track 4|Adverse event unrelated to study drug|0|||
130264635|NCT02750514|468935591|FG000|Track 4|Death|0|||
130264636|NCT02750514|468935592|FG001|Track 4|Death|0|||
130264637|NCT02750514|468935593|FG002|Track 4|Death|0|||
130264638|NCT02750514|468935594|FG003|Track 4|Death|1|||
130264639|NCT02750514|468935595|FG004|Track 4|Death|0|||
130264640|NCT02750514|468935591|FG000|Track 5|Disease progression|0|||
130264641|NCT02750514|468935592|FG001|Track 5|Disease progression|0|||
130264642|NCT02750514|468935593|FG002|Track 5|Disease progression|0|||
130264643|NCT02750514|468935594|FG003|Track 5|Disease progression|0|||
130264644|NCT02750514|468935595|FG004|Track 5|Disease progression|34|||
130264645|NCT02750514|468935591|FG000|Track 5|Adverse event unrelated to study drug|0|||
130264646|NCT02750514|468935592|FG001|Track 5|Adverse event unrelated to study drug|0|||
130264647|NCT02750514|468935593|FG002|Track 5|Adverse event unrelated to study drug|0|||
130264648|NCT02750514|468935594|FG003|Track 5|Adverse event unrelated to study drug|0|||
130264649|NCT02750514|468935595|FG004|Track 5|Adverse event unrelated to study drug|2|||
130264650|NCT02750514|468935591|FG000|Track 5|Study drug toxicity|0|||
130264651|NCT02750514|468935592|FG001|Track 5|Study drug toxicity|0|||
130264652|NCT02750514|468935593|FG002|Track 5|Study drug toxicity|0|||
130264653|NCT02750514|468935594|FG003|Track 5|Study drug toxicity|0|||
130264654|NCT02750514|468935595|FG004|Track 5|Study drug toxicity|2|||
130264655|NCT02750514|468935591|FG000|Track 5|Participant request to discontinue|0|||
130264656|NCT02750514|468935592|FG001|Track 5|Participant request to discontinue|0|||
130264657|NCT02750514|468935593|FG002|Track 5|Participant request to discontinue|0|||
130264658|NCT02750514|468935594|FG003|Track 5|Participant request to discontinue|0|||
130264659|NCT02750514|468935595|FG004|Track 5|Participant request to discontinue|3|||
130264660|NCT02750514|468935591|FG000|Track 5|Other reasons|0|||
130264661|NCT02750514|468935592|FG001|Track 5|Other reasons|0|||
130264662|NCT02750514|468935593|FG002|Track 5|Other reasons|0|||
130264663|NCT02750514|468935594|FG003|Track 5|Other reasons|0|||
130264664|NCT02750514|468935595|FG004|Track 5|Other reasons|2|||
130264665|NCT02553629|468935596|FG000|Overall Study|Logistic reasons|3|||
130264666|NCT02553629|468935597|FG001|Overall Study|Logistic reasons|6|||
130264667|NCT01812057|468935598|FG000|Overall Study|Protocol Violation|1|||
130264668|NCT01812057|468935599|FG001|Overall Study|Protocol Violation|0|||
130264669|NCT01812057|468935598|FG000|Overall Study|Physician Decision|1|||
130264670|NCT01812057|468935599|FG001|Overall Study|Physician Decision|0|||
130264671|NCT00696878|468935602|FG000|Overall Study|Adverse Event|8|||
130264672|NCT00696878|468935602|FG000|Overall Study|Withdrawal by Subject|87|||
130264673|NCT00696878|468935602|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
130264674|NCT00696878|468935602|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
130264675|NCT00696878|468935602|FG000|Overall Study|Trial stopped|32|||
130264676|NCT00696878|468935602|FG000|Overall Study|Other reason (not specified)|55|||
130264677|NCT02259114|468935603|FG000|Overall Study|Progressive Disease|14|||
130264678|NCT02259114|468935604|FG001|Overall Study|Progressive Disease|2|||
130264679|NCT02259114|468935605|FG002|Overall Study|Progressive Disease|10|||
130264680|NCT02259114|468935606|FG003|Overall Study|Progressive Disease|2|||
130264681|NCT02259114|468935607|FG004|Overall Study|Progressive Disease|5|||
130264682|NCT02259114|468935603|FG000|Overall Study|Adverse Event|2|||
130264683|NCT02259114|468935604|FG001|Overall Study|Adverse Event|1|||
130264684|NCT02259114|468935605|FG002|Overall Study|Adverse Event|0|||
130264685|NCT02259114|468935606|FG003|Overall Study|Adverse Event|0|||
130264686|NCT02259114|468935607|FG004|Overall Study|Adverse Event|1|||
130264687|NCT02259114|468935603|FG000|Overall Study|Death|3|||
130264688|NCT02259114|468935604|FG001|Overall Study|Death|0|||
130264689|NCT02259114|468935605|FG002|Overall Study|Death|1|||
130264690|NCT02259114|468935606|FG003|Overall Study|Death|0|||
130264691|NCT02259114|468935607|FG004|Overall Study|Death|0|||
130264692|NCT02259114|468935603|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264693|NCT02259114|468935604|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264694|NCT02259114|468935605|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
130264695|NCT02259114|468935606|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264696|NCT02259114|468935607|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264697|NCT02259114|468935603|FG000|Overall Study|Withdrawal by Subject|0|||
130264698|NCT02259114|468935604|FG001|Overall Study|Withdrawal by Subject|0|||
130264699|NCT02259114|468935605|FG002|Overall Study|Withdrawal by Subject|1|||
130365628|NCT00242216|469306935|FG000|Overall Study|Lack of Efficacy|1|||
130365629|NCT00242216|469306936|FG001|Overall Study|Lack of Efficacy|2|||
130264700|NCT02259114|468935606|FG003|Overall Study|Withdrawal by Subject|1|||
130264701|NCT02259114|468935607|FG004|Overall Study|Withdrawal by Subject|0|||
130264702|NCT02259114|468935603|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130365630|NCT00242216|469306935|FG000|Overall Study|no medicaiton dispensed|1|||
130264703|NCT02259114|468935604|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130264704|NCT02259114|468935605|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264705|NCT02259114|468935606|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264706|NCT02259114|468935607|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264707|NCT02259114|468935603|FG000|Overall Study|Not Treated|1|||
130264708|NCT02259114|468935604|FG001|Overall Study|Not Treated|0|||
130264709|NCT02259114|468935605|FG002|Overall Study|Not Treated|0|||
130264710|NCT02259114|468935606|FG003|Overall Study|Not Treated|0|||
130264711|NCT02259114|468935607|FG004|Overall Study|Not Treated|0|||
130264712|NCT03937479|468935608|FG000|Overall Study|Adverse Event|2|||
130264713|NCT03937479|468935609|FG001|Overall Study|Adverse Event|3|||
130264714|NCT03937479|468935610|FG002|Overall Study|Adverse Event|0|||
130264715|NCT03937479|468935611|FG003|Overall Study|Adverse Event|0|||
130264716|NCT03937479|468935612|FG004|Overall Study|Adverse Event|1|||
130264717|NCT03937479|468935608|FG000|Overall Study|Withdrawal by Subject|3|||
130264718|NCT03937479|468935609|FG001|Overall Study|Withdrawal by Subject|5|||
130264719|NCT03937479|468935610|FG002|Overall Study|Withdrawal by Subject|2|||
130264720|NCT03937479|468935611|FG003|Overall Study|Withdrawal by Subject|2|||
130264721|NCT03937479|468935612|FG004|Overall Study|Withdrawal by Subject|1|||
130264722|NCT03937479|468935608|FG000|Overall Study|Protocol Violation|5|||
130264723|NCT03937479|468935609|FG001|Overall Study|Protocol Violation|6|||
130264724|NCT03937479|468935610|FG002|Overall Study|Protocol Violation|4|||
130264725|NCT03937479|468935611|FG003|Overall Study|Protocol Violation|3|||
130264726|NCT03937479|468935612|FG004|Overall Study|Protocol Violation|2|||
130264727|NCT03937479|468935608|FG000|Overall Study|Lost to Follow-up|0|||
130264728|NCT03937479|468935609|FG001|Overall Study|Lost to Follow-up|1|||
130264729|NCT03937479|468935610|FG002|Overall Study|Lost to Follow-up|0|||
130264730|NCT03937479|468935611|FG003|Overall Study|Lost to Follow-up|1|||
130264731|NCT03937479|468935612|FG004|Overall Study|Lost to Follow-up|0|||
130264732|NCT03937479|468935608|FG000|Overall Study|Physician Decision|0|||
130264733|NCT03937479|468935609|FG001|Overall Study|Physician Decision|0|||
130264734|NCT03937479|468935610|FG002|Overall Study|Physician Decision|1|||
130264735|NCT03937479|468935611|FG003|Overall Study|Physician Decision|0|||
130264736|NCT03937479|468935612|FG004|Overall Study|Physician Decision|1|||
130264737|NCT02712788|468935613|FG000|Overall Study|Physician Decision|1|||
130264738|NCT02712788|468935614|FG001|Overall Study|Physician Decision|0|||
130264739|NCT02712788|468935613|FG000|Overall Study|Protocol Violation|1|||
130264740|NCT02712788|468935614|FG001|Overall Study|Protocol Violation|0|||
130264741|NCT00940602|468935615|FG000|Overall Study|Administrative problems|1|||
130264742|NCT00940602|468935616|FG001|Overall Study|Administrative problems|1|||
130264743|NCT00940602|468935615|FG000|Overall Study|Patient/guardian decision|13|||
130264744|NCT00940602|468935616|FG001|Overall Study|Patient/guardian decision|28|||
130264745|NCT00940602|468935615|FG000|Overall Study|Physician Decision|8|||
130264746|NCT00940602|468935616|FG001|Overall Study|Physician Decision|5|||
130264747|NCT00940602|468935615|FG000|Overall Study|Pregnancy|1|||
130264748|NCT00940602|468935616|FG001|Overall Study|Pregnancy|0|||
130264749|NCT00940602|468935615|FG000|Overall Study|Protocol Deviation (untreated)|1|||
130264750|NCT00940602|468935616|FG001|Overall Study|Protocol Deviation (untreated)|0|||
130264751|NCT00940602|468935615|FG000|Overall Study|Disease progression|8|||
130264752|NCT00940602|468935616|FG001|Overall Study|Disease progression|2|||
130264753|NCT00940602|468935615|FG000|Overall Study|Death|38|||
130264754|NCT00940602|468935616|FG001|Overall Study|Death|19|||
130264755|NCT00940602|468935615|FG000|Overall Study|Lost to Follow-up|3|||
130264756|NCT00940602|468935616|FG001|Overall Study|Lost to Follow-up|1|||
130264757|NCT00940602|468935615|FG000|Overall Study|Patient withdrew consent|26|||
130264758|NCT00940602|468935616|FG001|Overall Study|Patient withdrew consent|13|||
130264759|NCT00940602|468935615|FG000|Overall Study|Adverse Event|7|||
130264760|NCT00940602|468935616|FG001|Overall Study|Adverse Event|2|||
130264761|NCT00940602|468935615|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
130264762|NCT00940602|468935616|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
130264763|NCT01880957|468935617|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
130264764|NCT01880957|468935618|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
130264765|NCT01880957|468935617|FG000|Overall Study|Lost to Follow-up|11|||
130264766|NCT01880957|468935618|FG001|Overall Study|Lost to Follow-up|0|||
130264767|NCT01880957|468935617|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
130264768|NCT01880957|468935618|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
130264769|NCT00508482|468935621|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
130264770|NCT00508482|468935622|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
130264771|NCT00508482|468935623|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
130264772|NCT00508482|468935621|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
130264773|NCT00508482|468935622|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
130264774|NCT00508482|468935623|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
130264775|NCT00508482|468935621|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
130264776|NCT00508482|468935622|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
130264777|NCT00508482|468935623|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
130264778|NCT02289469|468935624|FG000|Overall Study|Unable to match a control|6|||
130264779|NCT02289469|468935625|FG001|Overall Study|Unable to match a control|0|||
130264780|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
130453248|NCT00817635|469623524|FG000|Overall Study|Adverse Event|1|||
130264781|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130264782|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130264783|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
130264784|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
130264785|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
130264786|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
130264787|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130264788|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130264789|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
130264790|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130264791|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130264792|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130264793|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130264794|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
130264795|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130264796|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
130264797|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130264798|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130264799|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130264800|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
130264801|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
130264802|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
130264803|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
130264804|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Other Reason|0|||
130264805|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Other Reason|0|||
130264806|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Other Reason|1|||
130264807|NCT01077063|468935629|FG000|Overall Study|Adverse Event|3|||
130264808|NCT01077063|468935630|FG001|Overall Study|Adverse Event|0|||
130264809|NCT01077063|468935629|FG000|Overall Study|Death|1|||
130264810|NCT01077063|468935630|FG001|Overall Study|Death|1|||
130264811|NCT01077063|468935629|FG000|Overall Study|Withdrawal by Subject|0|||
130264812|NCT01077063|468935630|FG001|Overall Study|Withdrawal by Subject|2|||
130264813|NCT02750930|468935631|FG000|Overall Study|Study closed/terminated|8|||
130264814|NCT02761642|468935633|FG000|Overall Study|Did not Receive Study Treatment|3|||
130264815|NCT02761642|468935633|FG000|Overall Study|Adverse Event|13|||
130264816|NCT02761642|468935633|FG000|Overall Study|Withdrawal by Subject|2|||
130264817|NCT02761642|468935633|FG000|Overall Study|Non-compliant|7|||
130264818|NCT02761642|468935633|FG000|Overall Study|Death|3|||
130264819|NCT02761642|468935633|FG000|Overall Study|Lack of Efficacy|20|||
130264820|NCT02761642|468935633|FG000|Overall Study|Physician Decision|1|||
130264821|NCT02761642|468935633|FG000|Overall Study|Reason Unspecified|21|||
130264822|NCT02756403|468935638|FG000|Overall Study|Unable to swallow medication|0|||
130264823|NCT02756403|468935639|FG001|Overall Study|Unable to swallow medication|1|||
130264824|NCT02756403|468935640|FG002|Overall Study|Unable to swallow medication|1|||
130264825|NCT02756403|468935641|FG003|Overall Study|Unable to swallow medication|1|||
130264826|NCT02756403|468935638|FG000|Overall Study|Did not complete Procedure|0|||
130264827|NCT02756403|468935639|FG001|Overall Study|Did not complete Procedure|1|||
130264828|NCT02756403|468935640|FG002|Overall Study|Did not complete Procedure|0|||
130264829|NCT02756403|468935641|FG003|Overall Study|Did not complete Procedure|0|||
130264830|NCT02756403|468935638|FG000|Overall Study|Changed Mind About Procedure|0|||
130264831|NCT02756403|468935639|FG001|Overall Study|Changed Mind About Procedure|0|||
130264832|NCT02756403|468935640|FG002|Overall Study|Changed Mind About Procedure|1|||
130264833|NCT02756403|468935641|FG003|Overall Study|Changed Mind About Procedure|0|||
130264834|NCT02756403|468935638|FG000|Overall Study|Protocol Violation|0|||
130264835|NCT02756403|468935639|FG001|Overall Study|Protocol Violation|1|||
130264836|NCT02756403|468935640|FG002|Overall Study|Protocol Violation|0|||
130264837|NCT02756403|468935641|FG003|Overall Study|Protocol Violation|1|||
130264838|NCT01644643|468935642|FG000|Overall Study|Death|1|||
130264839|NCT01644643|468935643|FG001|Overall Study|Death|0|||
130264840|NCT01644643|468935644|FG002|Overall Study|Death|3|||
130264841|NCT01644643|468935645|FG003|Overall Study|Death|3|||
130453249|NCT00817635|469623525|FG001|Overall Study|Adverse Event|0|||
130264842|NCT01644643|468935642|FG000|Overall Study|Lost to Follow-up|0|||
130264843|NCT01644643|468935643|FG001|Overall Study|Lost to Follow-up|0|||
130264844|NCT01644643|468935644|FG002|Overall Study|Lost to Follow-up|0|||
130264845|NCT01644643|468935645|FG003|Overall Study|Lost to Follow-up|4|||
130264846|NCT01644643|468935642|FG000|Overall Study|Withdrawal by Subject|1|||
130453250|NCT00817635|469623526|FG002|Overall Study|Adverse Event|0|||
130453251|NCT00817635|469623527|FG003|Overall Study|Adverse Event|1|||
130264847|NCT01644643|468935643|FG001|Overall Study|Withdrawal by Subject|0|||
130264848|NCT01644643|468935644|FG002|Overall Study|Withdrawal by Subject|2|||
130264849|NCT01644643|468935645|FG003|Overall Study|Withdrawal by Subject|1|||
130264850|NCT01644643|468935642|FG000|Overall Study|Other Eligibility criteria|0|||
130264851|NCT01644643|468935643|FG001|Overall Study|Other Eligibility criteria|0|||
130264852|NCT01644643|468935644|FG002|Overall Study|Other Eligibility criteria|0|||
130453252|NCT00817635|469623528|FG004|Overall Study|Adverse Event|1|||
130264853|NCT01644643|468935645|FG003|Overall Study|Other Eligibility criteria|2|||
130264854|NCT00776789|468935650|FG000|Overall Study|Consent refusal|2|||
130264855|NCT00776789|468935651|FG001|Overall Study|Consent refusal|2|||
130264856|NCT00776789|468935650|FG000|Overall Study|Poor quality video|1|||
130264857|NCT00776789|468935651|FG001|Overall Study|Poor quality video|1|||
130264858|NCT02850978|468935652|FG000|Overall Study|Uncollectable CRF|27|||
130264859|NCT02850978|468935652|FG000|Overall Study|No visit since the first visit|35|||
130264860|NCT02850978|468935652|FG000|Overall Study|Adverse Event|81|||
130264861|NCT02850978|468935652|FG000|Overall Study|Lack of Efficacy|40|||
130264862|NCT02850978|468935652|FG000|Overall Study|Improvement in condition|34|||
130264863|NCT02850978|468935652|FG000|Overall Study|Lost to Follow-up|121|||
130264864|NCT02850978|468935652|FG000|Overall Study|Reason not listed|88|||
130264865|NCT00165789|468935656|FG000|Overall Study|Adverse Event|0|||
130264866|NCT00165789|468935657|FG001|Overall Study|Adverse Event|3|||
130264867|NCT00165789|468935658|FG002|Overall Study|Adverse Event|0|||
130264868|NCT00165789|468935659|FG003|Overall Study|Adverse Event|12|||
130264869|NCT00165789|468935656|FG000|Overall Study|Withdrawal by Subject|0|||
130264870|NCT00165789|468935657|FG001|Overall Study|Withdrawal by Subject|1|||
130264871|NCT00165789|468935658|FG002|Overall Study|Withdrawal by Subject|1|||
130264872|NCT00165789|468935659|FG003|Overall Study|Withdrawal by Subject|2|||
130264873|NCT00656370|468935664|FG000|Overall Study|Screen Failures|7|||
130264874|NCT00656370|468935664|FG000|Overall Study|Alternates|3|||
130264875|NCT01342094|468935665|FG000|Overall Study|Adverse Event|5|||
130264876|NCT01342094|468935666|FG001|Overall Study|Adverse Event|0|||
130264877|NCT01342094|468935665|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130264878|NCT01342094|468935666|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130264879|NCT01342094|468935665|FG000|Overall Study|Withdrawal by Subject|0|||
130264880|NCT01342094|468935666|FG001|Overall Study|Withdrawal by Subject|2|||
130264881|NCT03391882|468935671|FG000|Study Overall|Adverse Event|3|||
130264882|NCT03391882|468935672|FG001|Study Overall|Adverse Event|6|||
130264883|NCT03391882|468935673|FG002|Study Overall|Adverse Event|1|||
130264884|NCT03391882|468935674|FG003|Study Overall|Adverse Event|1|||
130264885|NCT03391882|468935675|FG004|Study Overall|Adverse Event|3|||
130264886|NCT03391882|468935676|FG005|Study Overall|Adverse Event|1|||
130264887|NCT03391882|468935671|FG000|Study Overall|Lack of Efficacy|13|||
130264888|NCT03391882|468935672|FG001|Study Overall|Lack of Efficacy|9|||
130264889|NCT03391882|468935673|FG002|Study Overall|Lack of Efficacy|0|||
130264890|NCT03391882|468935674|FG003|Study Overall|Lack of Efficacy|0|||
130264891|NCT03391882|468935675|FG004|Study Overall|Lack of Efficacy|0|||
130264892|NCT03391882|468935676|FG005|Study Overall|Lack of Efficacy|0|||
130264893|NCT03391882|468935671|FG000|Study Overall|Withdrawal by Subject|3|||
130264894|NCT03391882|468935672|FG001|Study Overall|Withdrawal by Subject|3|||
130264895|NCT03391882|468935673|FG002|Study Overall|Withdrawal by Subject|2|||
130264896|NCT03391882|468935674|FG003|Study Overall|Withdrawal by Subject|2|||
130264897|NCT03391882|468935675|FG004|Study Overall|Withdrawal by Subject|1|||
130264898|NCT03391882|468935676|FG005|Study Overall|Withdrawal by Subject|3|||
130264899|NCT03391882|468935671|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264900|NCT03391882|468935672|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
130264901|NCT03391882|468935673|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264902|NCT03391882|468935674|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264903|NCT03391882|468935675|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264904|NCT03391882|468935676|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264905|NCT03391882|468935671|FG000|Study Overall|Protocol Violation|1|||
130264906|NCT03391882|468935672|FG001|Study Overall|Protocol Violation|0|||
130264907|NCT03391882|468935673|FG002|Study Overall|Protocol Violation|0|||
130264908|NCT03391882|468935674|FG003|Study Overall|Protocol Violation|0|||
130264909|NCT03391882|468935675|FG004|Study Overall|Protocol Violation|0|||
130264910|NCT03391882|468935676|FG005|Study Overall|Protocol Violation|0|||
130264911|NCT03391882|468935671|FG000|Part A - Titration Phase|Adverse Event|3|||
130264912|NCT03391882|468935672|FG001|Part A - Titration Phase|Adverse Event|6|||
130264913|NCT03391882|468935673|FG002|Part A - Titration Phase|Adverse Event|0|||
130264914|NCT03391882|468935674|FG003|Part A - Titration Phase|Adverse Event|0|||
130264915|NCT03391882|468935675|FG004|Part A - Titration Phase|Adverse Event|0|||
130264916|NCT03391882|468935676|FG005|Part A - Titration Phase|Adverse Event|0|||
130264917|NCT03391882|468935671|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
130264918|NCT03391882|468935672|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
130264919|NCT03391882|468935673|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
130264920|NCT03391882|468935674|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
130264921|NCT03391882|468935675|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
130264922|NCT03391882|468935676|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
130264923|NCT03391882|468935671|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
130264924|NCT03391882|468935672|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
130264925|NCT03391882|468935673|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
130264926|NCT03391882|468935674|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
130264927|NCT03391882|468935675|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
130264928|NCT03391882|468935676|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
130553991|NCT00221195|469996473|FG000|Washout Period (Months 7-9)|Death|0|||
130264929|NCT03391882|468935671|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130365631|NCT00242216|469306936|FG001|Overall Study|no medicaiton dispensed|1|||
130264930|NCT03391882|468935672|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
130264931|NCT03391882|468935673|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264932|NCT03391882|468935674|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264933|NCT03391882|468935675|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264934|NCT03391882|468935676|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264935|NCT03391882|468935671|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
130264936|NCT03391882|468935672|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
130264937|NCT03391882|468935673|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264938|NCT03391882|468935674|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264939|NCT03391882|468935675|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264940|NCT03391882|468935676|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264941|NCT03391882|468935671|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
130264942|NCT03391882|468935672|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
130264943|NCT03391882|468935673|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
130264944|NCT03391882|468935674|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
130264945|NCT03391882|468935675|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
130264946|NCT03391882|468935676|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
130264947|NCT03391882|468935671|FG000|Part B - Treatment Phase|Adverse Event|0|||
130264948|NCT03391882|468935672|FG001|Part B - Treatment Phase|Adverse Event|0|||
130264949|NCT03391882|468935673|FG002|Part B - Treatment Phase|Adverse Event|1|||
130264950|NCT03391882|468935674|FG003|Part B - Treatment Phase|Adverse Event|1|||
130264951|NCT03391882|468935675|FG004|Part B - Treatment Phase|Adverse Event|3|||
130264952|NCT03391882|468935676|FG005|Part B - Treatment Phase|Adverse Event|1|||
130264953|NCT03391882|468935671|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
130264954|NCT03391882|468935672|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
130264955|NCT03391882|468935673|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
130264956|NCT03391882|468935674|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
130264957|NCT03391882|468935675|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
130264958|NCT03391882|468935676|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
130264959|NCT03913130|468935677|FG000|Overall Study|Sponsor Decision|1|||
130264960|NCT01085214|468935680|FG000|Overall Study|Alternate treatment required|1|||
130264961|NCT01634152|468935694|FG000|Overall Study|Adverse Event|2|||
130264962|NCT01634152|468935695|FG001|Overall Study|Adverse Event|0|||
130264963|NCT01634152|468935696|FG002|Overall Study|Adverse Event|2|||
130264964|NCT01634152|468935694|FG000|Overall Study|Consent withdrawn not due to AE|1|||
130264965|NCT01634152|468935695|FG001|Overall Study|Consent withdrawn not due to AE|0|||
130264966|NCT01634152|468935696|FG002|Overall Study|Consent withdrawn not due to AE|1|||
130264967|NCT01634152|468935694|FG000|Overall Study|Not treated|0|||
130264968|NCT01634152|468935695|FG001|Overall Study|Not treated|1|||
130264969|NCT01634152|468935696|FG002|Overall Study|Not treated|0|||
130264970|NCT01634152|468935694|FG000|Overall Study|Other reason not defined above|1|||
130264971|NCT01634152|468935695|FG001|Overall Study|Other reason not defined above|0|||
130365632|NCT00678080|469306937|FG000|Overall Study|Physician Decision|2|||
130264972|NCT01634152|468935696|FG002|Overall Study|Other reason not defined above|1|||
130264973|NCT01152437|468935697|FG000|Overall Study|Other Adverse Event|8|||
130264974|NCT01152437|468935698|FG001|Overall Study|Other Adverse Event|1|||
130264975|NCT01152437|468935699|FG002|Overall Study|Other Adverse Event|7|||
130264976|NCT01152437|468935697|FG000|Overall Study|Not treated|0|||
130264977|NCT01152437|468935698|FG001|Overall Study|Not treated|1|||
130264978|NCT01152437|468935699|FG002|Overall Study|Not treated|2|||
130264979|NCT01152437|468935697|FG000|Overall Study|Progressive disease|27|||
130264980|NCT01152437|468935698|FG001|Overall Study|Progressive disease|13|||
130264981|NCT01152437|468935699|FG002|Overall Study|Progressive disease|32|||
130264982|NCT01152437|468935697|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
130264983|NCT01152437|468935698|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
130264984|NCT01152437|468935699|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
130264985|NCT01985022|468935700|FG000|Overall Study|Lost to Follow-up|0|||
130264986|NCT01985022|468935701|FG001|Overall Study|Lost to Follow-up|1|||
130264987|NCT01985022|468935700|FG000|Overall Study|Protocol Violation|0|||
130365633|NCT00678080|469306938|FG001|Overall Study|Physician Decision|0|||
130365634|NCT00678080|469306937|FG000|Overall Study|Lost to Follow-up|1|||
130264988|NCT01985022|468935701|FG001|Overall Study|Protocol Violation|1|||
130264989|NCT01985022|468935700|FG000|Overall Study|Withdrawal by Subject|4|||
130553992|NCT00221195|469996474|FG001|Washout Period (Months 7-9)|Death|1|||
130365635|NCT00678080|469306938|FG001|Overall Study|Lost to Follow-up|0|||
130553993|NCT00221195|469996473|FG000|Therapy 2 (Months 10-15)|Death|1|||
130264990|NCT01985022|468935701|FG001|Overall Study|Withdrawal by Subject|1|||
130264991|NCT02317627|468935704|FG000|Overall Study|Withdrawal by Subject|0|||
130264992|NCT02317627|468935705|FG001|Overall Study|Withdrawal by Subject|1|||
130264993|NCT02317627|468935706|FG002|Overall Study|Withdrawal by Subject|1|||
130365636|NCT00678080|469306937|FG000|Overall Study|Withdrawal by Subject|0|||
130264994|NCT02317627|468935704|FG000|Overall Study|Lost to Follow-up|2|||
130264995|NCT02317627|468935705|FG001|Overall Study|Lost to Follow-up|0|||
130264996|NCT02317627|468935706|FG002|Overall Study|Lost to Follow-up|0|||
130264997|NCT02317627|468935704|FG000|Overall Study|Stopped by Investigator|0|||
130264998|NCT02317627|468935705|FG001|Overall Study|Stopped by Investigator|1|||
130264999|NCT02317627|468935706|FG002|Overall Study|Stopped by Investigator|0|||
130265000|NCT02317627|468935704|FG000|Overall Study|Adverse Event|0|||
130265001|NCT02317627|468935705|FG001|Overall Study|Adverse Event|2|||
130265002|NCT02317627|468935706|FG002|Overall Study|Adverse Event|3|||
130265003|NCT02317627|468935704|FG000|Overall Study|Non-compliance with study drug|0|||
130265004|NCT02317627|468935705|FG001|Overall Study|Non-compliance with study drug|1|||
130265005|NCT02317627|468935706|FG002|Overall Study|Non-compliance with study drug|0|||
130265006|NCT00279214|468935707|FG000|Overall Study|Physician Decision|3|||
130265007|NCT00279214|468935708|FG001|Overall Study|Physician Decision|2|||
130265008|NCT01214837|468935710|FG000|Overall Study|Death|0|||
130265009|NCT01214837|468935711|FG001|Overall Study|Death|0|||
130265010|NCT01214837|468935712|FG002|Overall Study|Death|1|||
130265011|NCT01214837|468935710|FG000|Overall Study|Adverse Event|1|||
130265012|NCT01214837|468935711|FG001|Overall Study|Adverse Event|2|||
130265013|NCT01214837|468935712|FG002|Overall Study|Adverse Event|1|||
130265014|NCT01214837|468935710|FG000|Overall Study|Withdrawal by Subject|27|||
130265015|NCT01214837|468935711|FG001|Overall Study|Withdrawal by Subject|36|||
130265016|NCT01214837|468935712|FG002|Overall Study|Withdrawal by Subject|28|||
130265017|NCT01214837|468935710|FG000|Overall Study|Lost to Follow-up|20|||
130265018|NCT01214837|468935711|FG001|Overall Study|Lost to Follow-up|15|||
130265019|NCT01214837|468935712|FG002|Overall Study|Lost to Follow-up|21|||
130265020|NCT01214837|468935710|FG000|Overall Study|Inappropriate Enrolment|0|||
130265021|NCT01214837|468935711|FG001|Overall Study|Inappropriate Enrolment|1|||
130265022|NCT01214837|468935712|FG002|Overall Study|Inappropriate Enrolment|2|||
130265023|NCT01214837|468935710|FG000|Overall Study|Administrative Reason|2|||
130265024|NCT01214837|468935711|FG001|Overall Study|Administrative Reason|6|||
130265025|NCT01214837|468935712|FG002|Overall Study|Administrative Reason|4|||
130265026|NCT01214837|468935710|FG000|Overall Study|Protocol Violation|3|||
130265027|NCT01214837|468935711|FG001|Overall Study|Protocol Violation|1|||
130265028|NCT01214837|468935712|FG002|Overall Study|Protocol Violation|5|||
130265029|NCT01214837|468935710|FG000|Overall Study|Unable to Classify|1|||
130265030|NCT01214837|468935711|FG001|Overall Study|Unable to Classify|3|||
130265031|NCT01214837|468935712|FG002|Overall Study|Unable to Classify|0|||
130265032|NCT00027560|468935713|FG000|Overall Study|Withdrawal by Subject|1|||
130265033|NCT00939107|468937191|FG000|Overall Study|Lost to Follow-up|14|||
130265034|NCT00939107|468937192|FG001|Overall Study|Lost to Follow-up|12|||
130265035|NCT02903823|468937193|FG000|Overall Study|Physician Decision|5|||
130265036|NCT02903823|468937193|FG000|Overall Study|Could not advance catheter|1|||
130265037|NCT02903823|468937193|FG000|Overall Study|Catheter dislodgement|1|||
130265038|NCT01123148|468937200|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
130265039|NCT01123148|468937200|FG000|Overall Study|Didn't meet milestone criteria|1|||
130265040|NCT00355030|468937201|FG000|Study Period 1 Treatment|Adverse Event|1|||
130265041|NCT00355030|468937202|FG001|Study Period 1 Treatment|Adverse Event|1|||
130265042|NCT00355030|468937201|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
130265043|NCT00355030|468937202|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
130265044|NCT00355030|468937201|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
130265045|NCT00355030|468937202|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
130265046|NCT00355030|468937201|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
130365637|NCT00678080|469306938|FG001|Overall Study|Withdrawal by Subject|1|||
130365638|NCT01034631|469308523|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
130365639|NCT01034631|469308524|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
130265047|NCT00355030|468937202|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
130365640|NCT01034631|469308525|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
130365641|NCT01034631|469308523|FG000|Phase II|Not Evaluable per protocol|0|||
130265048|NCT00355030|468937201|FG000|Study Period 1 Treatment|Physician Decision|0|||
130265049|NCT00355030|468937202|FG001|Study Period 1 Treatment|Physician Decision|1|||
130265050|NCT00355030|468937201|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
130265051|NCT00355030|468937202|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
130265052|NCT00355030|468937201|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
130365642|NCT01034631|469308524|FG001|Phase II|Not Evaluable per protocol|0|||
130265053|NCT00355030|468937202|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
130365643|NCT01034631|469308525|FG002|Phase II|Not Evaluable per protocol|2|||
130265054|NCT00355030|468937201|FG000|Study Period 1 Treatment|Other|2|||
130265055|NCT00355030|468937202|FG001|Study Period 1 Treatment|Other|6|||
130265056|NCT00355030|468937201|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
130265057|NCT00355030|468937202|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
130265058|NCT00355030|468937201|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130265059|NCT00355030|468937202|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130265060|NCT01747915|468937203|FG000|Overall Study|Other|1|||
130265061|NCT01747915|468937204|FG001|Overall Study|Other|1|||
130265062|NCT01747915|468937205|FG002|Overall Study|Other|1|||
130265063|NCT01747915|468937203|FG000|Overall Study|Adverse Event|8|||
130265064|NCT01747915|468937204|FG001|Overall Study|Adverse Event|5|||
130265065|NCT01747915|468937205|FG002|Overall Study|Adverse Event|2|||
130265066|NCT01747915|468937203|FG000|Overall Study|Death|0|||
130265067|NCT01747915|468937204|FG001|Overall Study|Death|0|||
130265068|NCT01747915|468937205|FG002|Overall Study|Death|1|||
130265069|NCT01747915|468937203|FG000|Overall Study|Lack of Efficacy|0|||
130365644|NCT01034631|469308523|FG000|Phase II|Determined Ineligible per protocol|0|||
130365645|NCT01034631|469308524|FG001|Phase II|Determined Ineligible per protocol|1|||
130365646|NCT01034631|469308525|FG002|Phase II|Determined Ineligible per protocol|0|||
130265070|NCT01747915|468937204|FG001|Overall Study|Lack of Efficacy|1|||
130265071|NCT01747915|468937205|FG002|Overall Study|Lack of Efficacy|0|||
130265072|NCT01747915|468937203|FG000|Overall Study|Lost to Follow-up|1|||
130265073|NCT01747915|468937204|FG001|Overall Study|Lost to Follow-up|0|||
130265074|NCT01747915|468937205|FG002|Overall Study|Lost to Follow-up|0|||
130265075|NCT01747915|468937203|FG000|Overall Study|Withdrawal by Subject|4|||
130265076|NCT01747915|468937204|FG001|Overall Study|Withdrawal by Subject|4|||
130265077|NCT01747915|468937205|FG002|Overall Study|Withdrawal by Subject|1|||
130265078|NCT01747915|468937203|FG000|Overall Study|Protocol Violation|1|||
130265079|NCT01747915|468937204|FG001|Overall Study|Protocol Violation|0|||
130265080|NCT01747915|468937205|FG002|Overall Study|Protocol Violation|0|||
130265081|NCT01747915|468937203|FG000|Overall Study|Pregnancy|0|||
130265082|NCT01747915|468937204|FG001|Overall Study|Pregnancy|0|||
130265083|NCT01747915|468937205|FG002|Overall Study|Pregnancy|1|||
130265084|NCT00812955|468937210|FG000|Overall Study|Adverse Event|7|||
130365647|NCT03372096|469308527|FG000|Overall Study|Study Closed|8|||
130365648|NCT00680017|469308528|FG000|Overall Study|Adverse Event|13|||
130365649|NCT00680017|469308529|FG001|Overall Study|Adverse Event|7|||
130365650|NCT00680017|469308528|FG000|Overall Study|Withdrawal by Subject|2|||
130365651|NCT00680017|469308529|FG001|Overall Study|Withdrawal by Subject|5|||
130365652|NCT00680017|469308528|FG000|Overall Study|Lost to Follow-up|2|||
130365653|NCT00680017|469308529|FG001|Overall Study|Lost to Follow-up|0|||
130365654|NCT05074667|469308530|FG000|Overall Study|Death|1|||
130365655|NCT05074667|469308530|FG000|Overall Study|Withdrawal by Subject|4|||
130365656|NCT05074667|469308530|FG000|Overall Study|Lost to Follow-up|10|||
130365657|NCT05154578|469308533|FG000|Overall Study|Withdrawal by Subject|2|||
130365658|NCT05154578|469308534|FG001|Overall Study|Withdrawal by Subject|3|||
130365659|NCT05154578|469308535|FG002|Overall Study|Withdrawal by Subject|2|||
130365660|NCT05154578|469308536|FG003|Overall Study|Withdrawal by Subject|4|||
130365661|NCT05154578|469308537|FG004|Overall Study|Withdrawal by Subject|0|||
130365662|NCT05154578|469308533|FG000|Overall Study|Lost to Follow-up|0|||
130365663|NCT05154578|469308534|FG001|Overall Study|Lost to Follow-up|1|||
130365664|NCT05154578|469308535|FG002|Overall Study|Lost to Follow-up|0|||
130365665|NCT05154578|469308536|FG003|Overall Study|Lost to Follow-up|3|||
130365666|NCT05154578|469308537|FG004|Overall Study|Lost to Follow-up|0|||
130365667|NCT05154578|469308533|FG000|Overall Study|Adverse Event|0|||
130365668|NCT05154578|469308534|FG001|Overall Study|Adverse Event|0|||
130365669|NCT05154578|469308535|FG002|Overall Study|Adverse Event|0|||
130365670|NCT05154578|469308536|FG003|Overall Study|Adverse Event|1|||
130365671|NCT05154578|469308537|FG004|Overall Study|Adverse Event|0|||
130365672|NCT05154578|469308533|FG000|Overall Study|Relocated to another province|0|||
130365673|NCT05154578|469308534|FG001|Overall Study|Relocated to another province|0|||
130365674|NCT05154578|469308535|FG002|Overall Study|Relocated to another province|1|||
130365675|NCT05154578|469308536|FG003|Overall Study|Relocated to another province|0|||
130365676|NCT05154578|469308537|FG004|Overall Study|Relocated to another province|1|||
130265085|NCT00812955|468937211|FG001|Overall Study|Adverse Event|6|||
130265086|NCT00812955|468937212|FG002|Overall Study|Adverse Event|3|||
130265087|NCT00812955|468937213|FG003|Overall Study|Adverse Event|4|||
130265088|NCT00812955|468937210|FG000|Overall Study|Lost to Follow-up|2|||
130265089|NCT00812955|468937211|FG001|Overall Study|Lost to Follow-up|1|||
130265090|NCT00812955|468937212|FG002|Overall Study|Lost to Follow-up|1|||
130265091|NCT00812955|468937213|FG003|Overall Study|Lost to Follow-up|2|||
130265092|NCT00812955|468937210|FG000|Overall Study|Withdrawal by Subject|1|||
130265093|NCT00812955|468937211|FG001|Overall Study|Withdrawal by Subject|0|||
130265094|NCT00812955|468937212|FG002|Overall Study|Withdrawal by Subject|1|||
130265095|NCT00812955|468937213|FG003|Overall Study|Withdrawal by Subject|2|||
130265096|NCT00812955|468937210|FG000|Overall Study|randomized in error|0|||
130265097|NCT00812955|468937211|FG001|Overall Study|randomized in error|0|||
130265098|NCT00812955|468937212|FG002|Overall Study|randomized in error|1|||
130265099|NCT00812955|468937213|FG003|Overall Study|randomized in error|0|||
130265100|NCT01772550|468937214|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
130265101|NCT01772550|468937215|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
130265102|NCT01772550|468937216|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
130265103|NCT01772550|468937214|FG000|Overall Study|Adverse Event|0|||
130265104|NCT01772550|468937215|FG001|Overall Study|Adverse Event|0|||
130265105|NCT01772550|468937216|FG002|Overall Study|Adverse Event|1|||
130265106|NCT01815424|468937217|FG000|Week 0 to 16|Adverse Event|1|||
130265107|NCT01815424|468937218|FG001|Week 0 to 16|Adverse Event|3|||
130265108|NCT01815424|468937219|FG002|Week 0 to 16|Adverse Event|3|||
130265109|NCT01815424|468937220|FG003|Week 0 to 16|Adverse Event|0|||
130265110|NCT01815424|468937221|FG004|Week 0 to 16|Adverse Event|0|||
130365677|NCT05154578|469308533|FG000|Overall Study|Baby loss|0|||
130365678|NCT05154578|469308534|FG001|Overall Study|Baby loss|1|||
130265111|NCT01815424|468937217|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
130365679|NCT05154578|469308535|FG002|Overall Study|Baby loss|0|||
130365680|NCT05154578|469308536|FG003|Overall Study|Baby loss|0|||
130365681|NCT05154578|469308537|FG004|Overall Study|Baby loss|0|||
130265112|NCT01815424|468937218|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265113|NCT01815424|468937219|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265114|NCT01815424|468937220|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265115|NCT01815424|468937221|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265116|NCT01815424|468937217|FG000|Week 0 to 16|Lost to Follow-up|0|||
130365682|NCT00864721|469308543|FG000|Overall Study|Patient request|11|||
130265117|NCT01815424|468937218|FG001|Week 0 to 16|Lost to Follow-up|1|||
130265118|NCT01815424|468937219|FG002|Week 0 to 16|Lost to Follow-up|0|||
130265119|NCT01815424|468937220|FG003|Week 0 to 16|Lost to Follow-up|0|||
130265120|NCT01815424|468937221|FG004|Week 0 to 16|Lost to Follow-up|0|||
130265121|NCT01815424|468937217|FG000|Week 0 to 16|Withdrawal by Subject|0|||
130265122|NCT01815424|468937218|FG001|Week 0 to 16|Withdrawal by Subject|0|||
130365683|NCT00864721|469308543|FG000|Overall Study|Hospitalized|1|||
130365684|NCT00864721|469308543|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
130365685|NCT00864721|469308543|FG000|Overall Study|Adverse Event|21|||
130365686|NCT01705730|469308545|FG000|Overall Study|Lack of Efficacy|1|||
130265123|NCT01815424|468937219|FG002|Week 0 to 16|Withdrawal by Subject|1|||
130265124|NCT01815424|468937220|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130265125|NCT01815424|468937221|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130265126|NCT01815424|468937217|FG000|Week 0 to 16|Other|1|||
130265127|NCT01815424|468937218|FG001|Week 0 to 16|Other|0|||
130265128|NCT01815424|468937219|FG002|Week 0 to 16|Other|3|||
130265129|NCT01815424|468937220|FG003|Week 0 to 16|Other|0|||
130265130|NCT01815424|468937221|FG004|Week 0 to 16|Other|0|||
130265131|NCT01815424|468937217|FG000|Week 0 to 16|Protocol Violation|1|||
130265132|NCT01815424|468937218|FG001|Week 0 to 16|Protocol Violation|0|||
130265133|NCT01815424|468937219|FG002|Week 0 to 16|Protocol Violation|0|||
130265134|NCT01815424|468937220|FG003|Week 0 to 16|Protocol Violation|0|||
130265135|NCT01815424|468937221|FG004|Week 0 to 16|Protocol Violation|0|||
130265136|NCT01815424|468937217|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
130265137|NCT01815424|468937218|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
130265138|NCT01815424|468937219|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
130265139|NCT01815424|468937220|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
130265140|NCT01815424|468937221|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
130265141|NCT01815424|468937217|FG000|Week 16 to 52|Other|0|||
130265142|NCT01815424|468937218|FG001|Week 16 to 52|Other|1|||
130265143|NCT01815424|468937219|FG002|Week 16 to 52|Other|0|||
130265144|NCT01815424|468937220|FG003|Week 16 to 52|Other|0|||
130265145|NCT01815424|468937221|FG004|Week 16 to 52|Other|0|||
130265146|NCT01815424|468937217|FG000|Week 16 to 52|Adverse Event|0|||
130265147|NCT01815424|468937218|FG001|Week 16 to 52|Adverse Event|0|||
130265148|NCT01815424|468937219|FG002|Week 16 to 52|Adverse Event|0|||
130265149|NCT01815424|468937220|FG003|Week 16 to 52|Adverse Event|0|||
130265150|NCT01815424|468937221|FG004|Week 16 to 52|Adverse Event|1|||
130265151|NCT01815424|468937217|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
130265152|NCT01815424|468937218|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
130265153|NCT01815424|468937219|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
130265154|NCT01815424|468937220|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
130265155|NCT01815424|468937221|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
130265156|NCT01815424|468937217|FG000|Week 16 to 52|Lost to Follow-up|0|||
130265157|NCT01815424|468937218|FG001|Week 16 to 52|Lost to Follow-up|2|||
130265158|NCT01815424|468937219|FG002|Week 16 to 52|Lost to Follow-up|0|||
130265159|NCT01815424|468937220|FG003|Week 16 to 52|Lost to Follow-up|2|||
130265160|NCT01815424|468937221|FG004|Week 16 to 52|Lost to Follow-up|1|||
130265161|NCT01815424|468937217|FG000|Week 16 to 52|Withdrawal by Subject|1|||
130265162|NCT01815424|468937218|FG001|Week 16 to 52|Withdrawal by Subject|2|||
130265163|NCT01815424|468937219|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130265164|NCT01815424|468937220|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130265165|NCT01815424|468937221|FG004|Week 16 to 52|Withdrawal by Subject|0|||
130265166|NCT01309204|468937222|FG000|Overall Study|Adverse Event|48|||
130265167|NCT01309204|468937223|FG001|Overall Study|Adverse Event|58|||
130265168|NCT01309204|468937222|FG000|Overall Study|Lost to Follow-up|2|||
130265169|NCT01309204|468937223|FG001|Overall Study|Lost to Follow-up|2|||
130265170|NCT01309204|468937222|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
130265171|NCT01309204|468937223|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
130265172|NCT01309204|468937222|FG000|Overall Study|Inadequate control of IOP|4|||
130265173|NCT01309204|468937223|FG001|Overall Study|Inadequate control of IOP|4|||
130365687|NCT01705730|469308545|FG000|Overall Study|Adverse Event|3|||
130365688|NCT01705730|469308545|FG000|Overall Study|Lost to Follow-up|1|||
130365689|NCT01705730|469308545|FG000|Overall Study|Reason not Specified|4|||
130365690|NCT01773733|469308546|FG000|Overall Study|Adverse Event|3286|||
130365691|NCT01773733|469308547|FG001|Overall Study|Adverse Event|540|||
130265174|NCT01309204|468937222|FG000|Overall Study|Other|4|||
130265175|NCT01309204|468937223|FG001|Overall Study|Other|1|||
130265176|NCT03374358|468937224|FG000|Overall Study|Withdrawal by Subject|0|||
130265177|NCT03374358|468937225|FG001|Overall Study|Withdrawal by Subject|2|||
130365692|NCT01773733|469308546|FG000|Overall Study|Pregnancy|28|||
130365693|NCT01773733|469308547|FG001|Overall Study|Pregnancy|0|||
130265178|NCT03183063|468937226|FG000|Overall Study|Withdrawal by Subject|2|||
130265179|NCT03183063|468937227|FG001|Overall Study|Withdrawal by Subject|0|||
130265180|NCT03183063|468937228|FG002|Overall Study|Withdrawal by Subject|0|||
130265181|NCT03183063|468937226|FG000|Overall Study|Physician Decision|3|||
130365694|NCT01773733|469308546|FG000|Overall Study|Other different categories of not compl|55415|||
130265182|NCT03183063|468937227|FG001|Overall Study|Physician Decision|4|||
130265183|NCT03183063|468937228|FG002|Overall Study|Physician Decision|4|||
130265184|NCT01127633|468937229|FG000|Overall Study|Adverse Event|74|||
130265185|NCT01127633|468937230|FG001|Overall Study|Adverse Event|73|||
130265186|NCT01127633|468937229|FG000|Overall Study|Death|40|||
130265187|NCT01127633|468937230|FG001|Overall Study|Death|43|||
130265188|NCT01127633|468937229|FG000|Overall Study|Lost to Follow-up|4|||
130265189|NCT01127633|468937230|FG001|Overall Study|Lost to Follow-up|0|||
130265190|NCT01127633|468937229|FG000|Overall Study|Parent/Caregiver Decision|246|||
130265191|NCT01127633|468937230|FG001|Overall Study|Parent/Caregiver Decision|228|||
130265192|NCT01127633|468937229|FG000|Overall Study|Physician Decision|60|||
130265193|NCT01127633|468937230|FG001|Overall Study|Physician Decision|45|||
130265194|NCT01127633|468937229|FG000|Overall Study|Withdrawal by Subject|57|||
130265195|NCT01127633|468937230|FG001|Overall Study|Withdrawal by Subject|72|||
130265196|NCT01127633|468937229|FG000|Overall Study|Sponsor Decision|163|||
130265197|NCT01127633|468937230|FG001|Overall Study|Sponsor Decision|195|||
130265198|NCT01127633|468937229|FG000|Overall Study|Protocol Violation|8|||
130265199|NCT01127633|468937230|FG001|Overall Study|Protocol Violation|16|||
130265200|NCT01127633|468937229|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
130265201|NCT01127633|468937230|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
130265202|NCT01127633|468937229|FG000|Overall Study|Not treated|1|||
130265203|NCT01127633|468937230|FG001|Overall Study|Not treated|0|||
130265204|NCT00688467|468937231|FG000|Treatment Period 1|Adverse Event|2|||
130265205|NCT00688467|468937232|FG001|Treatment Period 1|Adverse Event|1|||
130265206|NCT00688467|468937231|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
130265207|NCT00688467|468937232|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
130265208|NCT00688467|468937231|FG000|Treatment Period 2|Protocol Violation|0|||
130265209|NCT00688467|468937232|FG001|Treatment Period 2|Protocol Violation|1|||
130265210|NCT00688467|468937231|FG000|Treatment Period 2|Adverse Event|0|||
130265211|NCT00688467|468937232|FG001|Treatment Period 2|Adverse Event|1|||
130265212|NCT00925002|468937233|FG000|Overall Study|Other|1|||
130265213|NCT00925002|468937234|FG001|Overall Study|Other|4|||
130265214|NCT00925002|468937235|FG002|Overall Study|Other|0|||
130265215|NCT00925002|468937233|FG000|Overall Study|Death|1|||
130265216|NCT00925002|468937234|FG001|Overall Study|Death|1|||
130265217|NCT00925002|468937235|FG002|Overall Study|Death|5|||
130265218|NCT00925002|468937233|FG000|Overall Study|Adverse Event|3|||
130265219|NCT00925002|468937234|FG001|Overall Study|Adverse Event|1|||
130265220|NCT00925002|468937235|FG002|Overall Study|Adverse Event|2|||
130265221|NCT00925002|468937233|FG000|Overall Study|Participant withdrew consent|1|||
130265222|NCT00925002|468937234|FG001|Overall Study|Participant withdrew consent|3|||
130265223|NCT00925002|468937235|FG002|Overall Study|Participant withdrew consent|3|||
130265224|NCT00690794|468937236|FG000|Overall Study|Adverse Event|12|||
130265225|NCT00690794|468937237|FG001|Overall Study|Adverse Event|10|||
130265226|NCT00690794|468937236|FG000|Overall Study|Lost to Follow-up|1|||
130265227|NCT00690794|468937237|FG001|Overall Study|Lost to Follow-up|4|||
130265228|NCT00690794|468937236|FG000|Overall Study|Withdrawal by Subject|0|||
130265229|NCT00690794|468937237|FG001|Overall Study|Withdrawal by Subject|9|||
130265230|NCT00690794|468937236|FG000|Overall Study|Protocol Violation|6|||
130265231|NCT00690794|468937237|FG001|Overall Study|Protocol Violation|7|||
130265232|NCT00690794|468937236|FG000|Overall Study|Noncompliance|1|||
130265233|NCT00690794|468937237|FG001|Overall Study|Noncompliance|2|||
130265234|NCT00690794|468937236|FG000|Overall Study|Other not specified|1|||
130265235|NCT00690794|468937237|FG001|Overall Study|Other not specified|3|||
130265236|NCT01496287|468937238|FG000|Overall Study|Lost to Follow-up|1|||
130265237|NCT01496287|468937238|FG000|Overall Study|Incomplete anesthesia|5|||
130265238|NCT01343888|468937239|FG000|Overall Study|Adverse Event|12|||
130265239|NCT01343888|468937240|FG001|Overall Study|Adverse Event|22|||
130265240|NCT01343888|468937241|FG002|Overall Study|Adverse Event|5|||
130265241|NCT01343888|468937239|FG000|Overall Study|Lack of Efficacy|9|||
130553994|NCT00221195|469996474|FG001|Therapy 2 (Months 10-15)|Death|0|||
130553995|NCT00221195|469996473|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
130553996|NCT00221195|469996474|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
130265242|NCT01343888|468937240|FG001|Overall Study|Lack of Efficacy|9|||
130265243|NCT01343888|468937241|FG002|Overall Study|Lack of Efficacy|13|||
130265244|NCT01343888|468937239|FG000|Overall Study|Lost to Follow-up|0|||
130265245|NCT01343888|468937240|FG001|Overall Study|Lost to Follow-up|2|||
130265246|NCT01343888|468937241|FG002|Overall Study|Lost to Follow-up|1|||
130265247|NCT01343888|468937239|FG000|Overall Study|Protocol Violation|0|||
130265248|NCT01343888|468937240|FG001|Overall Study|Protocol Violation|2|||
130553997|NCT00823901|469996475|FG000|Overall Study|Adverse Event|1|||
130265249|NCT01343888|468937241|FG002|Overall Study|Protocol Violation|0|||
130265250|NCT01343888|468937239|FG000|Overall Study|Withdrawal by Subject|4|||
130265251|NCT01343888|468937240|FG001|Overall Study|Withdrawal by Subject|4|||
130265252|NCT01343888|468937241|FG002|Overall Study|Withdrawal by Subject|2|||
130265253|NCT01343888|468937239|FG000|Overall Study|other than stated above|0|||
130265254|NCT01343888|468937240|FG001|Overall Study|other than stated above|0|||
130265255|NCT01343888|468937241|FG002|Overall Study|other than stated above|1|||
130265256|NCT01990742|468937242|FG000|Overall Study|Withdrawal by facility|407|||
130365695|NCT01773733|469308547|FG001|Overall Study|Other different categories of not compl|7781|||
130265257|NCT01990742|468937243|FG001|Overall Study|Withdrawal by facility|1083|||
130265258|NCT01990742|468937242|FG000|Overall Study|Facility closed|0|||
130265259|NCT01990742|468937243|FG001|Overall Study|Facility closed|270|||
130265260|NCT03443687|468937244|FG000|Overall Study|Lost to Follow-up|3|||
130265261|NCT03443687|468937245|FG001|Overall Study|Lost to Follow-up|5|||
130265262|NCT03443687|468937244|FG000|Overall Study|Withdrawal by Subject|1|||
130265263|NCT03443687|468937245|FG001|Overall Study|Withdrawal by Subject|0|||
130265264|NCT03443687|468937244|FG000|Overall Study|Discontinued intervention|1|||
130265265|NCT03443687|468937245|FG001|Overall Study|Discontinued intervention|1|||
130265266|NCT00800735|468937247|FG000|Overall Study|Administrative/Other|2|||
130265267|NCT00800735|468937247|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130265268|NCT00800735|468937247|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
130265269|NCT00800735|468937247|FG000|Overall Study|Withdrew Consent|3|||
130265270|NCT02805790|468937248|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
130265271|NCT02805790|468937249|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130265272|NCT04460183|468937252|FG000|Overall Study|Lost to Follow-up|3|||
130265273|NCT04460183|468937253|FG001|Overall Study|Lost to Follow-up|1|||
130265274|NCT04460183|468937252|FG000|Overall Study|Withdrawal by Subject|1|||
130265275|NCT04460183|468937253|FG001|Overall Study|Withdrawal by Subject|0|||
130265276|NCT00825994|468937254|FG000|Overall Study|Withdrawal by Subject|2|||
130265277|NCT00825994|468937254|FG000|Overall Study|Lost to Follow-up|1|||
130265278|NCT00825994|468937254|FG000|Overall Study|Protocol Violation|1|||
130265279|NCT00825994|468937254|FG000|Overall Study|Placebo Responder at V2|1|||
130265280|NCT00332696|468937255|FG000|Overall Study|Death|24|||
130265281|NCT00332696|468937256|FG001|Overall Study|Death|14|||
130265282|NCT00332696|468937255|FG000|Overall Study|Insufficient therapeutic effect|4|||
130265283|NCT00332696|468937256|FG001|Overall Study|Insufficient therapeutic effect|11|||
130265284|NCT00332696|468937255|FG000|Overall Study|Adverse Event|1|||
130265285|NCT00332696|468937256|FG001|Overall Study|Adverse Event|2|||
130265286|NCT00332696|468937255|FG000|Overall Study|Condition does not justify treatment|0|||
130265287|NCT00332696|468937256|FG001|Overall Study|Condition does not justify treatment|2|||
130265288|NCT00332696|468937255|FG000|Overall Study|Lost to Follow-up|0|||
130265289|NCT00332696|468937256|FG001|Overall Study|Lost to Follow-up|1|||
130265290|NCT00332696|468937255|FG000|Overall Study|Withdrawal by Subject|1|||
130265291|NCT00332696|468937256|FG001|Overall Study|Withdrawal by Subject|0|||
130265292|NCT02394561|468937257|FG000|CORE Phase|Adverse Event|7|||
130265293|NCT02394561|468937258|FG001|CORE Phase|Adverse Event|9|||
130265294|NCT02394561|468937257|FG000|CORE Phase|Death|0|||
130265295|NCT02394561|468937258|FG001|CORE Phase|Death|1|||
130265296|NCT02394561|468937257|FG000|CORE Phase|Pregnancy|1|||
130265297|NCT02394561|468937258|FG001|CORE Phase|Pregnancy|0|||
130265298|NCT02394561|468937257|FG000|CORE Phase|Lost to Follow-up|1|||
130265299|NCT02394561|468937258|FG001|CORE Phase|Lost to Follow-up|0|||
130265300|NCT02394561|468937257|FG000|CORE Phase|Physician Decision|1|||
130265301|NCT02394561|468937258|FG001|CORE Phase|Physician Decision|1|||
130265302|NCT02394561|468937257|FG000|CORE Phase|Withdrawal by Subject|2|||
130265303|NCT02394561|468937258|FG001|CORE Phase|Withdrawal by Subject|2|||
130265304|NCT02394561|468937257|FG000|CORE Phase|Lack of Efficacy|1|||
130265305|NCT02394561|468937258|FG001|CORE Phase|Lack of Efficacy|6|||
130265306|NCT02394561|468937257|FG000|Extension Phase|Adverse Event|6|||
130265307|NCT02394561|468937258|FG001|Extension Phase|Adverse Event|1|||
130265308|NCT02394561|468937257|FG000|Extension Phase|Death|0|||
130265309|NCT02394561|468937258|FG001|Extension Phase|Death|1|||
130265310|NCT02394561|468937257|FG000|Extension Phase|Protocol Violation|1|||
130265311|NCT02394561|468937258|FG001|Extension Phase|Protocol Violation|0|||
130265312|NCT02394561|468937257|FG000|Extension Phase|Lost to Follow-up|1|||
130265313|NCT02394561|468937258|FG001|Extension Phase|Lost to Follow-up|0|||
130265314|NCT02394561|468937257|FG000|Extension Phase|Physician Decision|0|||
130265315|NCT02394561|468937258|FG001|Extension Phase|Physician Decision|2|||
130265316|NCT02394561|468937257|FG000|Extension Phase|Withdrawal by Subject|0|||
130265317|NCT02394561|468937258|FG001|Extension Phase|Withdrawal by Subject|5|||
130265318|NCT02394561|468937257|FG000|Extension Phase|Lack of Efficacy|3|||
130265319|NCT02394561|468937258|FG001|Extension Phase|Lack of Efficacy|3|||
130265320|NCT01882465|468937259|FG000|Period 1|Lens Discomfort|0|||
130265321|NCT01882465|468937260|FG001|Period 1|Lens Discomfort|0|||
130265322|NCT01882465|468937261|FG002|Period 1|Lens Discomfort|0|||
130265323|NCT01882465|468937262|FG003|Period 1|Lens Discomfort|1|||
130265324|NCT01882465|468937263|FG004|Period 1|Lens Discomfort|0|||
130265325|NCT01882465|468937264|FG005|Period 1|Lens Discomfort|0|||
130265326|NCT01882465|468937265|FG006|Period 1|Lens Discomfort|0|||
130265327|NCT01882465|468937259|FG000|Period 1|Withdrawal by Subject|0|||
130265328|NCT01882465|468937260|FG001|Period 1|Withdrawal by Subject|0|||
130265329|NCT01882465|468937261|FG002|Period 1|Withdrawal by Subject|0|||
130265330|NCT01882465|468937262|FG003|Period 1|Withdrawal by Subject|0|||
130265331|NCT01882465|468937263|FG004|Period 1|Withdrawal by Subject|0|||
130265332|NCT01882465|468937264|FG005|Period 1|Withdrawal by Subject|0|||
130265333|NCT01882465|468937265|FG006|Period 1|Withdrawal by Subject|1|||
130265334|NCT01882465|468937259|FG000|Period 2|Protocol Violation|0|||
130265335|NCT01882465|468937260|FG001|Period 2|Protocol Violation|0|||
130265336|NCT01882465|468937261|FG002|Period 2|Protocol Violation|0|||
130265337|NCT01882465|468937262|FG003|Period 2|Protocol Violation|0|||
130265338|NCT01882465|468937263|FG004|Period 2|Protocol Violation|1|||
130265339|NCT01882465|468937264|FG005|Period 2|Protocol Violation|0|||
130265340|NCT01882465|468937265|FG006|Period 2|Protocol Violation|0|||
130265341|NCT01378117|468937272|FG000|Overall Study|withdrawal|2|||
130265342|NCT01378117|468937273|FG001|Overall Study|withdrawal|1|||
130265343|NCT01378117|468937274|FG002|Overall Study|withdrawal|2|||
130265344|NCT01378117|468937272|FG000|Overall Study|discharged before med given|2|||
130265345|NCT01378117|468937273|FG001|Overall Study|discharged before med given|0|||
130265346|NCT01378117|468937274|FG002|Overall Study|discharged before med given|1|||
130265347|NCT02961244|468937276|FG000|Overall Study|Protocol Violation|0|||
130265348|NCT02961244|468937277|FG001|Overall Study|Protocol Violation|1|||
130265349|NCT02961244|468937276|FG000|Overall Study|Withdrawal by Subject|1|||
130265350|NCT02961244|468937277|FG001|Overall Study|Withdrawal by Subject|2|||
130265351|NCT02961244|468937276|FG000|Overall Study|Surgery plan change after study approval|0|||
130265352|NCT02961244|468937277|FG001|Overall Study|Surgery plan change after study approval|2|||
130265353|NCT02961244|468937276|FG000|Overall Study|Lost to Follow-up|0|||
130265354|NCT02961244|468937277|FG001|Overall Study|Lost to Follow-up|2|||
130265355|NCT02961244|468937276|FG000|Overall Study|İnadequate data|0|||
130265356|NCT02961244|468937277|FG001|Overall Study|İnadequate data|2|||
130265357|NCT01854528|468937278|FG000|Overall Study|Adverse Event|0|||
130265358|NCT01854528|468937279|FG001|Overall Study|Adverse Event|4|||
130265359|NCT01854528|468937278|FG000|Overall Study|Withdrawal by Subject|0|||
130265360|NCT01854528|468937279|FG001|Overall Study|Withdrawal by Subject|2|||
130265361|NCT01854528|468937278|FG000|Overall Study|Virologic Failure|0|||
130265362|NCT01854528|468937279|FG001|Overall Study|Virologic Failure|9|||
130265363|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
130265364|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
130265365|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
130265366|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
130265367|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130265368|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130265369|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
130265370|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130265371|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130265372|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130265373|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130265374|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
130265375|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
130265376|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
130265377|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
130265378|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
130265379|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130265380|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130265381|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130265382|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
130265383|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130265384|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130265385|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130265386|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
130265387|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130265388|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130453253|NCT00817635|469623524|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130453254|NCT00817635|469623525|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130453255|NCT00817635|469623526|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130453256|NCT00817635|469623527|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
130453257|NCT00817635|469623528|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
130453258|NCT00817635|469623524|FG000|Overall Study|Withdrawal by Subject|2|||
130453259|NCT00817635|469623525|FG001|Overall Study|Withdrawal by Subject|1|||
130453260|NCT00817635|469623526|FG002|Overall Study|Withdrawal by Subject|0|||
130453261|NCT00817635|469623527|FG003|Overall Study|Withdrawal by Subject|1|||
130453262|NCT00817635|469623528|FG004|Overall Study|Withdrawal by Subject|2|||
130453263|NCT00817635|469623524|FG000|Overall Study|Lost to Follow-up|0|||
130453264|NCT00817635|469623525|FG001|Overall Study|Lost to Follow-up|1|||
130453265|NCT00817635|469623526|FG002|Overall Study|Lost to Follow-up|0|||
130265389|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
130453266|NCT00817635|469623527|FG003|Overall Study|Lost to Follow-up|1|||
130453267|NCT00817635|469623528|FG004|Overall Study|Lost to Follow-up|0|||
130265390|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
130265391|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130265392|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130265393|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
130265394|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130265395|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130265396|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
130265397|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130265398|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130265399|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
130265400|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
130265401|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
130265402|NCT01904721|468937284|FG000|Overall Study|Other Reasons|0|||
130265403|NCT01904721|468937285|FG001|Overall Study|Other Reasons|0|||
130265404|NCT01904721|468937286|FG002|Overall Study|Other Reasons|1|||
130265405|NCT01904721|468937287|FG003|Overall Study|Other Reasons|1|||
130265406|NCT01904721|468937288|FG004|Overall Study|Other Reasons|2|||
130265407|NCT01904721|468937289|FG005|Overall Study|Other Reasons|2|||
130265408|NCT01904721|468937290|FG006|Overall Study|Other Reasons|2|||
130265409|NCT01904721|468937284|FG000|Overall Study|Personal Reasons|0|||
130265410|NCT01904721|468937285|FG001|Overall Study|Personal Reasons|0|||
130265411|NCT01904721|468937286|FG002|Overall Study|Personal Reasons|0|||
130265412|NCT01904721|468937287|FG003|Overall Study|Personal Reasons|0|||
130265413|NCT01904721|468937288|FG004|Overall Study|Personal Reasons|2|||
130265414|NCT01904721|468937289|FG005|Overall Study|Personal Reasons|3|||
130265415|NCT01904721|468937290|FG006|Overall Study|Personal Reasons|3|||
130265416|NCT01904721|468937284|FG000|Overall Study|Lost to Follow-up|0|||
130265417|NCT01904721|468937285|FG001|Overall Study|Lost to Follow-up|0|||
130265418|NCT01904721|468937286|FG002|Overall Study|Lost to Follow-up|0|||
130265419|NCT01904721|468937287|FG003|Overall Study|Lost to Follow-up|0|||
130265420|NCT01904721|468937288|FG004|Overall Study|Lost to Follow-up|1|||
130265421|NCT01904721|468937289|FG005|Overall Study|Lost to Follow-up|3|||
130265422|NCT01904721|468937290|FG006|Overall Study|Lost to Follow-up|1|||
130265423|NCT01904721|468937284|FG000|Overall Study|Lack of Efficacy|0|||
130265424|NCT01904721|468937285|FG001|Overall Study|Lack of Efficacy|0|||
130265425|NCT01904721|468937286|FG002|Overall Study|Lack of Efficacy|0|||
130265426|NCT01904721|468937287|FG003|Overall Study|Lack of Efficacy|0|||
130265427|NCT01904721|468937288|FG004|Overall Study|Lack of Efficacy|0|||
130265428|NCT01904721|468937289|FG005|Overall Study|Lack of Efficacy|0|||
130265429|NCT01904721|468937290|FG006|Overall Study|Lack of Efficacy|1|||
130265430|NCT01904721|468937284|FG000|Overall Study|Adverse Event|0|||
130265431|NCT01904721|468937285|FG001|Overall Study|Adverse Event|0|||
130265432|NCT01904721|468937286|FG002|Overall Study|Adverse Event|0|||
130265433|NCT01904721|468937287|FG003|Overall Study|Adverse Event|0|||
130265434|NCT01904721|468937288|FG004|Overall Study|Adverse Event|3|||
130265435|NCT01904721|468937289|FG005|Overall Study|Adverse Event|1|||
130265436|NCT01904721|468937290|FG006|Overall Study|Adverse Event|0|||
130265437|NCT01957865|468937291|FG000|Overall Study|Found HIV negative|0|||
130265438|NCT01957865|468937292|FG001|Overall Study|Found HIV negative|0|||
130265439|NCT01957865|468937293|FG002|Overall Study|Found HIV negative|1|||
130265440|NCT01957865|468937291|FG000|Overall Study|Lost to Follow-up|0|||
130265441|NCT01957865|468937292|FG001|Overall Study|Lost to Follow-up|2|||
130265442|NCT01957865|468937293|FG002|Overall Study|Lost to Follow-up|2|||
130265443|NCT01082614|468937294|FG000|Overall Study|Adverse Event|1|||
130265444|NCT01082614|468937295|FG001|Overall Study|Adverse Event|4|||
130265445|NCT01082614|468937294|FG000|Overall Study|Equipment Malfunction|0|||
130265446|NCT01082614|468937295|FG001|Overall Study|Equipment Malfunction|1|||
130265447|NCT01082614|468937294|FG000|Overall Study|Physician Decision|2|||
130265448|NCT01082614|468937295|FG001|Overall Study|Physician Decision|0|||
130265449|NCT00811720|468937299|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
130265450|NCT00811720|468937300|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
130265451|NCT00811720|468937299|FG000|All Treated Patients|Adverse Event|20|||
130265452|NCT00811720|468937300|FG001|All Treated Patients|Adverse Event|62|||
130265453|NCT00811720|468937299|FG000|All Treated Patients|Lack of Efficacy|22|||
130265454|NCT00811720|468937300|FG001|All Treated Patients|Lack of Efficacy|18|||
130265455|NCT00811720|468937299|FG000|All Treated Patients|Non-compliance|0|||
130265456|NCT00811720|468937300|FG001|All Treated Patients|Non-compliance|14|||
130265457|NCT00811720|468937299|FG000|All Treated Patients|Protocol Violation|9|||
130265458|NCT00811720|468937300|FG001|All Treated Patients|Protocol Violation|16|||
130265459|NCT00811720|468937299|FG000|All Treated Patients|Withdrawal by Subject|28|||
130265460|NCT00811720|468937300|FG001|All Treated Patients|Withdrawal by Subject|34|||
130265461|NCT00811720|468937299|FG000|All Treated Patients|Lost to Follow-up|10|||
130265462|NCT00811720|468937300|FG001|All Treated Patients|Lost to Follow-up|16|||
130265463|NCT00811720|468937299|FG000|All Treated Patients|Other Reason|7|||
130265464|NCT00811720|468937300|FG001|All Treated Patients|Other Reason|4|||
130265465|NCT00553631|468937301|FG000|Overall Study|Withdrawal by Subject|0|||
130265466|NCT00553631|468937302|FG001|Overall Study|Withdrawal by Subject|1|||
130265467|NCT00553631|468937301|FG000|Overall Study|Lost to Follow-up|1|||
130265468|NCT00553631|468937302|FG001|Overall Study|Lost to Follow-up|0|||
130265469|NCT01055613|468937303|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
130265470|NCT01055613|468937304|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130265471|NCT01055613|468937303|FG000|Overall Study|Unacceptable lens fit|1|||
130265472|NCT01055613|468937304|FG001|Overall Study|Unacceptable lens fit|0|||
130265473|NCT01055613|468937303|FG000|Overall Study|Discomfort|2|||
130265474|NCT01055613|468937304|FG001|Overall Study|Discomfort|1|||
130265475|NCT01055613|468937303|FG000|Overall Study|Lost to Follow-up|1|||
130265476|NCT01055613|468937304|FG001|Overall Study|Lost to Follow-up|1|||
130265477|NCT01055613|468937303|FG000|Overall Study|Protocol Violation|1|||
130265478|NCT01055613|468937304|FG001|Overall Study|Protocol Violation|1|||
130265479|NCT01055613|468937303|FG000|Overall Study|Subject Disinterest|1|||
130265480|NCT01055613|468937304|FG001|Overall Study|Subject Disinterest|1|||
130265481|NCT02765399|468937307|FG000|Overall Study|Nausea|1|||
130265482|NCT02765399|468937308|FG001|Overall Study|Nausea|0|||
130265483|NCT01182298|468937313|FG000|Overall Study|Lack of Efficacy|4|||
130265484|NCT01182298|468937313|FG000|Overall Study|Withdrawal by Subject|2|||
130265485|NCT01822665|468937329|FG000|Overall Study|Adverse Event|3|||
130265486|NCT01822665|468937329|FG000|Overall Study|Other Reason|5|||
130265487|NCT04540367|468937330|FG000|Overall Study|Withdrawal by Subject|0|||
130265488|NCT04540367|468937331|FG001|Overall Study|Withdrawal by Subject|0|||
130265489|NCT04540367|468937332|FG002|Overall Study|Withdrawal by Subject|0|||
130265490|NCT04540367|468937333|FG003|Overall Study|Withdrawal by Subject|2|||
130265491|NCT04540367|468937330|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130265492|NCT04540367|468937331|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130265493|NCT04540367|468937332|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
130265494|NCT04540367|468937333|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
130265495|NCT04540367|468937330|FG000|Overall Study|Adverse Event|0|||
130265496|NCT04540367|468937331|FG001|Overall Study|Adverse Event|0|||
130265497|NCT04540367|468937332|FG002|Overall Study|Adverse Event|1|||
130265498|NCT04540367|468937333|FG003|Overall Study|Adverse Event|1|||
130265499|NCT00959907|468937336|FG000|Overall Study|Protocol Violation|0|||
130265500|NCT00959907|468937337|FG001|Overall Study|Protocol Violation|1|||
130265501|NCT00959907|468937336|FG000|Overall Study|Adverse Event|1|||
130265502|NCT00959907|468937337|FG001|Overall Study|Adverse Event|0|||
130265503|NCT00959907|468937336|FG000|Overall Study|Withdrawal by Subject|2|||
130265504|NCT00959907|468937337|FG001|Overall Study|Withdrawal by Subject|0|||
130265505|NCT03958331|468937338|FG000|Overall Study|Withdrawal by Subject|3|||
130265506|NCT03958331|468937339|FG001|Overall Study|Withdrawal by Subject|1|||
130265507|NCT03958331|468937340|FG002|Overall Study|Withdrawal by Subject|5|||
130265508|NCT03958331|468937338|FG000|Overall Study|Weaned from medicine|2|||
130265509|NCT03958331|468937339|FG001|Overall Study|Weaned from medicine|0|||
130265510|NCT03958331|468937340|FG002|Overall Study|Weaned from medicine|0|||
130265511|NCT03958331|468937338|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
130265512|NCT03958331|468937339|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
130265513|NCT03958331|468937340|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
130265514|NCT04290624|468937341|FG000|Overall Study|Adverse Event|1|||
130265515|NCT04290624|468937342|FG001|Overall Study|Adverse Event|0|||
130265516|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
130265517|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
130265518|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
130265519|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
130265520|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
130265521|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Other than specified|2|||
130265522|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
130265523|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
130265524|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
130265525|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
130265526|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
130265527|NCT02735421|468938760|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
130265528|NCT02735421|468938760|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
130265529|NCT05010070|468938761|FG000|Overall Study|Lost to Follow-up|1|||
130265530|NCT05010070|468938761|FG000|Overall Study|Withdrawal by Subject|1|||
130365696|NCT00705289|469308548|FG000|Overall Study|Subject or treating physician's choice|131|||
130553998|NCT00823901|469996476|FG001|Overall Study|Adverse Event|1|||
130365697|NCT02601027|469308549|FG000|Registration to Surgery|Withdrawal by Subject|20|||
130365698|NCT02601027|469308550|FG001|Registration to Surgery|Withdrawal by Subject|10|||
130365699|NCT02609828|469308551|FG000|Overall Study|Adverse Event|8|||
130265531|NCT03247829|468938763|FG000|Overall Study|Death|3|||
130265532|NCT03247829|468938764|FG001|Overall Study|Death|4|||
130265533|NCT03247829|468938763|FG000|Overall Study|Enter Hospice Care|1|||
130265534|NCT03247829|468938764|FG001|Overall Study|Enter Hospice Care|0|||
130265535|NCT03247829|468938763|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
130265536|NCT03247829|468938764|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
130265537|NCT03247829|468938763|FG000|Overall Study|LVAD Explant|1|||
130265538|NCT03247829|468938764|FG001|Overall Study|LVAD Explant|1|||
130265539|NCT03247829|468938763|FG000|Overall Study|Transplant|1|||
130265540|NCT03247829|468938764|FG001|Overall Study|Transplant|1|||
130265541|NCT01783444|468938765|FG000|Treatment Phase|Adverse Event|9|||
130265542|NCT01783444|468938766|FG001|Treatment Phase|Adverse Event|20|||
130265543|NCT01783444|468938767|FG002|Treatment Phase|Adverse Event|19|||
130265544|NCT01783444|468938765|FG000|Treatment Phase|Disease Progression|76|||
130265545|NCT01783444|468938766|FG001|Treatment Phase|Disease Progression|66|||
130265546|NCT01783444|468938767|FG002|Treatment Phase|Disease Progression|64|||
130265547|NCT01783444|468938765|FG000|Treatment Phase|Death|2|||
130265548|NCT01783444|468938766|FG001|Treatment Phase|Death|2|||
130265549|NCT01783444|468938767|FG002|Treatment Phase|Death|2|||
130265550|NCT01783444|468938765|FG000|Treatment Phase|Protocol Violation|1|||
130265551|NCT01783444|468938766|FG001|Treatment Phase|Protocol Violation|1|||
130265552|NCT01783444|468938767|FG002|Treatment Phase|Protocol Violation|2|||
130265553|NCT01783444|468938765|FG000|Treatment Phase|Withdrawal by Subject|6|||
130265554|NCT01783444|468938766|FG001|Treatment Phase|Withdrawal by Subject|8|||
130265555|NCT01783444|468938767|FG002|Treatment Phase|Withdrawal by Subject|9|||
130265556|NCT01783444|468938765|FG000|Treatment Phase|Administrative problems|2|||
130265557|NCT01783444|468938766|FG001|Treatment Phase|Administrative problems|0|||
130265558|NCT01783444|468938767|FG002|Treatment Phase|Administrative problems|1|||
130265559|NCT01783444|468938765|FG000|Treatment Phase|Physician Decision|8|||
130265560|NCT01783444|468938766|FG001|Treatment Phase|Physician Decision|6|||
130265561|NCT01783444|468938767|FG002|Treatment Phase|Physician Decision|5|||
130265562|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
130265563|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
130265564|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
130265565|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
130265566|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
130265567|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
130265568|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
130265569|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130265570|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130265571|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130265572|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
130265573|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130265574|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
130265575|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
130265576|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
130265577|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
130265578|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
130265579|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
130265580|NCT01047007|468938773|FG000|Overall Study|Adverse Event|0|||
130265581|NCT01047007|468938774|FG001|Overall Study|Adverse Event|2|||
130265582|NCT01047007|468938775|FG002|Overall Study|Adverse Event|1|||
130265583|NCT01047007|468938776|FG003|Overall Study|Adverse Event|0|||
130265584|NCT01047007|468938773|FG000|Overall Study|Progressive Disease|2|||
130265585|NCT01047007|468938774|FG001|Overall Study|Progressive Disease|4|||
130265586|NCT01047007|468938775|FG002|Overall Study|Progressive Disease|1|||
130265587|NCT01047007|468938776|FG003|Overall Study|Progressive Disease|0|||
130265588|NCT01334554|468938777|FG000|Overall Study|Adverse Event|4|||
130265589|NCT01334554|468938778|FG001|Overall Study|Adverse Event|2|||
130265590|NCT02393859|468938779|FG000|Overall Study|Decision by Sponsor|2|||
130265591|NCT02393859|468938780|FG001|Overall Study|Decision by Sponsor|4|||
130265592|NCT02393859|468938779|FG000|Overall Study|Withdrawal by Subject|11|||
130265593|NCT02393859|468938780|FG001|Overall Study|Withdrawal by Subject|6|||
130265594|NCT02393859|468938779|FG000|Overall Study|Death|27|||
130265595|NCT02393859|468938780|FG001|Overall Study|Death|10|||
130265596|NCT02393859|468938779|FG000|Overall Study|Lost to Follow-up|1|||
130265597|NCT02393859|468938780|FG001|Overall Study|Lost to Follow-up|1|||
130265598|NCT00954447|468938781|FG000|Overall Study|Adverse Event|33|||
130265599|NCT00954447|468938782|FG001|Overall Study|Adverse Event|25|||
130365700|NCT02609828|469308552|FG001|Overall Study|Adverse Event|1|||
130365701|NCT02609828|469308553|FG002|Overall Study|Adverse Event|0|||
130265600|NCT00954447|468938781|FG000|Overall Study|Lack of Efficacy|17|||
130265601|NCT00954447|468938782|FG001|Overall Study|Lack of Efficacy|3|||
130265602|NCT00954447|468938781|FG000|Overall Study|Protocol Violation|5|||
130265603|NCT00954447|468938782|FG001|Overall Study|Protocol Violation|7|||
130265604|NCT00954447|468938781|FG000|Overall Study|Lost to Follow-up|8|||
130265605|NCT00954447|468938782|FG001|Overall Study|Lost to Follow-up|14|||
130265606|NCT00954447|468938781|FG000|Overall Study|Withdrawal by Subject|26|||
130265607|NCT00954447|468938782|FG001|Overall Study|Withdrawal by Subject|21|||
130265608|NCT00954447|468938781|FG000|Overall Study|Other|21|||
130265609|NCT00954447|468938782|FG001|Overall Study|Other|18|||
130365702|NCT02609828|469308554|FG003|Overall Study|Adverse Event|6|||
130365703|NCT02609828|469308551|FG000|Overall Study|Death|15|||
130365704|NCT02609828|469308552|FG001|Overall Study|Death|1|||
130265610|NCT04592341|468938783|FG000|Overall Study|Physician Decision|5|||
130265611|NCT04592341|468938783|FG000|Overall Study|Study Terminated by Sponsor|5|||
130265612|NCT04592341|468938783|FG000|Overall Study|Withdrawal by Subject|53|||
130265613|NCT04592341|468938783|FG000|Overall Study|Lost to Follow-up|3|||
130265614|NCT04592341|468938783|FG000|Overall Study|Death|1|||
130365705|NCT02609828|469308553|FG002|Overall Study|Death|1|||
130365706|NCT02609828|469308554|FG003|Overall Study|Death|19|||
130365707|NCT02609828|469308551|FG000|Overall Study|Insufficient clinical response|2|||
130365708|NCT02609828|469308552|FG001|Overall Study|Insufficient clinical response|1|||
130365709|NCT02609828|469308553|FG002|Overall Study|Insufficient clinical response|0|||
130265615|NCT04592341|468938783|FG000|Overall Study|Adverse Event|5|||
130365710|NCT02609828|469308554|FG003|Overall Study|Insufficient clinical response|0|||
130365711|NCT02609828|469308551|FG000|Overall Study|Lost to Follow-up|0|||
130553999|NCT00823901|469996475|FG000|Overall Study|Lack of Efficacy|1|||
130265616|NCT04592341|468938783|FG000|Overall Study|other|4|||
130265617|NCT00692003|468938784|FG000|Overall Study|Sponsor Decision|5|||
130265618|NCT00692003|468938785|FG001|Overall Study|Sponsor Decision|1|||
130265619|NCT01248793|468938786|FG000|Overall Study|Lost to Follow-up|0|||
130265620|NCT01248793|468938787|FG001|Overall Study|Lost to Follow-up|1|||
130265621|NCT01248793|468938786|FG000|Overall Study|Adverse Event|1|||
130265622|NCT01248793|468938787|FG001|Overall Study|Adverse Event|1|||
130265623|NCT01248793|468938786|FG000|Overall Study|Protocol Violation|0|||
130265624|NCT01248793|468938787|FG001|Overall Study|Protocol Violation|1|||
130365712|NCT02609828|469308552|FG001|Overall Study|Lost to Follow-up|0|||
130365713|NCT02609828|469308553|FG002|Overall Study|Lost to Follow-up|0|||
130265625|NCT01248793|468938786|FG000|Overall Study|Withdrawal by Subject|3|||
130265626|NCT01248793|468938787|FG001|Overall Study|Withdrawal by Subject|3|||
130265627|NCT01840943|468938788|FG000|Overall Study|Withdrawal by Subject|5|||
130265628|NCT01840943|468938789|FG001|Overall Study|Withdrawal by Subject|6|||
130365714|NCT02609828|469308554|FG003|Overall Study|Lost to Follow-up|1|||
130365715|NCT02609828|469308551|FG000|Overall Study|Protocol Violation|2|||
130265629|NCT01840943|468938788|FG000|Overall Study|Physician Decision|4|||
130265630|NCT01840943|468938789|FG001|Overall Study|Physician Decision|2|||
130265631|NCT01840943|468938788|FG000|Overall Study|Lost to Follow-up|4|||
130265632|NCT01840943|468938789|FG001|Overall Study|Lost to Follow-up|4|||
130265633|NCT02580877|468938792|FG000|Overall Study|Withdrawal by Subject|1|||
130265634|NCT02580877|468938793|FG001|Overall Study|Withdrawal by Subject|3|||
130265635|NCT02580877|468938792|FG000|Overall Study|Adverse Event|0|||
130265636|NCT02580877|468938793|FG001|Overall Study|Adverse Event|1|||
130265637|NCT03341637|468938794|FG000|Overall Study|Lost to Follow-up|1|||
130265638|NCT03341637|468938795|FG001|Overall Study|Lost to Follow-up|0|||
130265639|NCT03341637|468938794|FG000|Overall Study|Withdrawal by Subject|3|||
130265640|NCT03341637|468938795|FG001|Overall Study|Withdrawal by Subject|3|||
130265641|NCT03341637|468938794|FG000|Overall Study|Reason not Specified|1|||
130265642|NCT03341637|468938795|FG001|Overall Study|Reason not Specified|1|||
130265643|NCT00887159|468938802|FG000|Overall Study|Disease progression|6|||
130265644|NCT00887159|468938803|FG001|Overall Study|Disease progression|39|||
130265645|NCT00887159|468938804|FG002|Overall Study|Disease progression|33|||
130265646|NCT00887159|468938802|FG000|Overall Study|Adverse Event|3|||
130265647|NCT00887159|468938803|FG001|Overall Study|Adverse Event|4|||
130265648|NCT00887159|468938804|FG002|Overall Study|Adverse Event|17|||
130265649|NCT00887159|468938802|FG000|Overall Study|Death|2|||
130265650|NCT00887159|468938803|FG001|Overall Study|Death|2|||
130265651|NCT00887159|468938804|FG002|Overall Study|Death|0|||
130265652|NCT00887159|468938802|FG000|Overall Study|Withdrawal by Subject|4|||
130265653|NCT00887159|468938803|FG001|Overall Study|Withdrawal by Subject|4|||
130265654|NCT00887159|468938804|FG002|Overall Study|Withdrawal by Subject|2|||
130265655|NCT00887159|468938802|FG000|Overall Study|Alternative therapy|2|||
130265656|NCT00887159|468938803|FG001|Overall Study|Alternative therapy|0|||
130265657|NCT00887159|468938804|FG002|Overall Study|Alternative therapy|0|||
130265658|NCT00887159|468938802|FG000|Overall Study|Physician Decision|1|||
130265659|NCT00887159|468938803|FG001|Overall Study|Physician Decision|1|||
130265660|NCT00887159|468938804|FG002|Overall Study|Physician Decision|0|||
130265661|NCT00887159|468938802|FG000|Overall Study|Sympomatic deterioration|1|||
130265662|NCT00887159|468938803|FG001|Overall Study|Sympomatic deterioration|0|||
130265663|NCT00887159|468938804|FG002|Overall Study|Sympomatic deterioration|0|||
130265664|NCT00887159|468938802|FG000|Overall Study|Treatment delayed|1|||
130265665|NCT00887159|468938803|FG001|Overall Study|Treatment delayed|1|||
130265666|NCT00887159|468938804|FG002|Overall Study|Treatment delayed|0|||
130265667|NCT00887159|468938802|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
130265668|NCT00887159|468938803|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
130265669|NCT00887159|468938804|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
130265670|NCT00887159|468938802|FG000|Overall Study|Received more tx instead of observation|1|||
130265671|NCT00887159|468938803|FG001|Overall Study|Received more tx instead of observation|0|||
130265672|NCT00887159|468938804|FG002|Overall Study|Received more tx instead of observation|0|||
130265673|NCT00887159|468938802|FG000|Overall Study|Ineligible|5|||
130265674|NCT00887159|468938803|FG001|Overall Study|Ineligible|1|||
130265675|NCT00887159|468938804|FG002|Overall Study|Ineligible|0|||
130265676|NCT00887159|468938802|FG000|Overall Study|Never started assigned therapy|3|||
130265677|NCT00887159|468938803|FG001|Overall Study|Never started assigned therapy|3|||
130265678|NCT00887159|468938804|FG002|Overall Study|Never started assigned therapy|4|||
130265679|NCT01823107|468938814|FG000|Overall Study|Withdrawal by Subject|1|||
130265680|NCT01847092|468938816|FG000|Overall Study|Adverse Event|12|||
130265681|NCT01847092|468938817|FG001|Overall Study|Adverse Event|3|||
130265682|NCT01847092|468938816|FG000|Overall Study|Withdrawal by Subject|5|||
130265683|NCT01847092|468938817|FG001|Overall Study|Withdrawal by Subject|5|||
130265684|NCT01847092|468938816|FG000|Overall Study|Protocol Specified|8|||
130265685|NCT01847092|468938817|FG001|Overall Study|Protocol Specified|0|||
130265686|NCT01847092|468938816|FG000|Overall Study|Physician Decision|1|||
130265687|NCT01847092|468938817|FG001|Overall Study|Physician Decision|1|||
130265688|NCT01847092|468938816|FG000|Overall Study|Protocol Violation|0|||
130265689|NCT01847092|468938817|FG001|Overall Study|Protocol Violation|2|||
130265690|NCT01331681|468938818|FG000|Overall Study|Adverse Event|10|||
130265691|NCT01331681|468938819|FG001|Overall Study|Adverse Event|13|||
130265692|NCT01331681|468938820|FG002|Overall Study|Adverse Event|10|||
130265693|NCT01331681|468938818|FG000|Overall Study|Death|6|||
130265694|NCT01331681|468938819|FG001|Overall Study|Death|6|||
130265695|NCT01331681|468938820|FG002|Overall Study|Death|2|||
130265696|NCT01331681|468938818|FG000|Overall Study|Lack of Efficacy|0|||
130265697|NCT01331681|468938819|FG001|Overall Study|Lack of Efficacy|1|||
130265698|NCT01331681|468938820|FG002|Overall Study|Lack of Efficacy|0|||
130265699|NCT01331681|468938818|FG000|Overall Study|Withdrawal by Subject|12|||
130265700|NCT01331681|468938819|FG001|Overall Study|Withdrawal by Subject|8|||
130265701|NCT01331681|468938820|FG002|Overall Study|Withdrawal by Subject|15|||
130265702|NCT01331681|468938818|FG000|Overall Study|Protocol Violation|1|||
130265703|NCT01331681|468938819|FG001|Overall Study|Protocol Violation|1|||
130265704|NCT01331681|468938820|FG002|Overall Study|Protocol Violation|0|||
130265705|NCT01331681|468938818|FG000|Overall Study|Lost to Follow-up|2|||
130265706|NCT01331681|468938819|FG001|Overall Study|Lost to Follow-up|4|||
130265707|NCT01331681|468938820|FG002|Overall Study|Lost to Follow-up|1|||
130265708|NCT01331681|468938818|FG000|Overall Study|Physician Decision|2|||
130265709|NCT01331681|468938819|FG001|Overall Study|Physician Decision|0|||
130265710|NCT01331681|468938820|FG002|Overall Study|Physician Decision|4|||
130265711|NCT01331681|468938818|FG000|Overall Study|Therapeutic procedure required|1|||
130265712|NCT01331681|468938819|FG001|Overall Study|Therapeutic procedure required|0|||
130265713|NCT01331681|468938820|FG002|Overall Study|Therapeutic procedure required|0|||
130265714|NCT01331681|468938818|FG000|Overall Study|Sponsor decision|1|||
130265715|NCT01331681|468938819|FG001|Overall Study|Sponsor decision|1|||
130265716|NCT01331681|468938820|FG002|Overall Study|Sponsor decision|0|||
130265717|NCT01331681|468938818|FG000|Overall Study|Switching to other therapy|0|||
130265718|NCT01331681|468938819|FG001|Overall Study|Switching to other therapy|0|||
130265719|NCT01331681|468938820|FG002|Overall Study|Switching to other therapy|1|||
130265720|NCT01331681|468938818|FG000|Overall Study|Not Received Study Treatment|0|||
130265721|NCT01331681|468938819|FG001|Overall Study|Not Received Study Treatment|0|||
130265722|NCT01331681|468938820|FG002|Overall Study|Not Received Study Treatment|2|||
130265723|NCT00658541|468938822|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265724|NCT00658541|468938823|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265725|NCT00658541|468938822|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130265726|NCT00658541|468938823|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265727|NCT03326063|468938824|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
130265728|NCT03326063|468938825|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
130265729|NCT01876381|468938826|FG000|Overall Study|Lack of Efficacy|5|||
130265730|NCT01876381|468938826|FG000|Overall Study|Physician Decision|1|||
130265731|NCT01876381|468938826|FG000|Overall Study|Withdrawal by Subject|1|||
130265732|NCT00461708|468938827|FG000|Overall Study|Adverse Event|17|||
130265733|NCT00461708|468938828|FG001|Overall Study|Adverse Event|7|||
130265734|NCT00461708|468938827|FG000|Overall Study|Lack of Efficacy|68|||
130265735|NCT00461708|468938828|FG001|Overall Study|Lack of Efficacy|20|||
130265736|NCT00461708|468938827|FG000|Overall Study|Physician Decision|10|||
130265737|NCT00461708|468938828|FG001|Overall Study|Physician Decision|4|||
130265738|NCT00461708|468938827|FG000|Overall Study|Withdrawal by Subject|8|||
130265739|NCT00461708|468938828|FG001|Overall Study|Withdrawal by Subject|2|||
130265740|NCT00461708|468938827|FG000|Overall Study|Other|4|||
130265741|NCT00461708|468938828|FG001|Overall Study|Other|4|||
130265742|NCT00461708|468938827|FG000|Overall Study|Death|8|||
130265743|NCT00461708|468938828|FG001|Overall Study|Death|1|||
130265744|NCT02803203|468938829|FG000|Overall Study|Adverse Event|4|||
130265745|NCT02803203|468938829|FG000|Overall Study|Death|4|||
130265746|NCT02803203|468938829|FG000|Overall Study|Progressive disease|29|||
130265747|NCT02803203|468938829|FG000|Overall Study|Withdrawal by Subject|8|||
130265748|NCT02803203|468938829|FG000|Overall Study|Complete resection of target disease|2|||
130265749|NCT02803203|468938829|FG000|Overall Study|Switched to commercial Osi|1|||
130265750|NCT02803203|468938829|FG000|Overall Study|Participant moved away|1|||
130265751|NCT04577781|468938830|FG000|Overall Study|Adverse Event|2|||
130265752|NCT04577781|468938831|FG001|Overall Study|Adverse Event|2|||
130265753|NCT04577781|468938830|FG000|Overall Study|Physician Decision|1|||
130265754|NCT04577781|468938831|FG001|Overall Study|Physician Decision|0|||
130265755|NCT03894891|468938832|FG000|Overall Study|Withdrawal by Subject|1|||
130265756|NCT03894891|468938832|FG000|Overall Study|Completed protocol treatment per protocol|5|||
130265757|NCT00950651|468938836|FG000|Overall Study|Adverse Event|17|||
130265758|NCT00950651|468938837|FG001|Overall Study|Adverse Event|20|||
130265759|NCT00950651|468938836|FG000|Overall Study|Death|1|||
130265760|NCT00950651|468938837|FG001|Overall Study|Death|0|||
130265761|NCT00950651|468938836|FG000|Overall Study|Lack of Efficacy|2|||
130265762|NCT00950651|468938837|FG001|Overall Study|Lack of Efficacy|2|||
130265763|NCT00950651|468938836|FG000|Overall Study|Protocol Violation|3|||
130265764|NCT00950651|468938837|FG001|Overall Study|Protocol Violation|4|||
130265765|NCT00950651|468938836|FG000|Overall Study|Withdrawal by Subject|8|||
130265766|NCT00950651|468938837|FG001|Overall Study|Withdrawal by Subject|9|||
130265767|NCT01824290|468938839|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
130265768|NCT01824290|468938840|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265769|NCT01824290|468938841|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265770|NCT01824290|468938842|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265771|NCT01824290|468938839|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130265772|NCT01824290|468938840|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130265773|NCT01824290|468938841|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130265774|NCT01824290|468938842|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130265775|NCT01824290|468938839|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130265776|NCT01824290|468938840|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130265777|NCT01824290|468938841|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130365716|NCT02609828|469308552|FG001|Overall Study|Protocol Violation|0|||
130365717|NCT02609828|469308553|FG002|Overall Study|Protocol Violation|0|||
130365718|NCT02609828|469308554|FG003|Overall Study|Protocol Violation|1|||
130265778|NCT01824290|468938842|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130265779|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
130265780|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
130265781|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
130265782|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
130265783|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130265784|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130265785|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130265786|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130265787|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130265788|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130265789|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
130265790|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
130265791|NCT00527618|468938843|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
130265792|NCT00527618|468938844|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
130265793|NCT00527618|468938843|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
130265794|NCT00527618|468938844|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
130265795|NCT00527618|468938843|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
130265796|NCT00527618|468938844|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
130265797|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
130265798|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
130265799|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
130265800|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
130265801|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
130265802|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
130265803|NCT00114127|468938848|FG000|Overall Study|Adverse Event|2|||
130265804|NCT00114127|468938849|FG001|Overall Study|Adverse Event|1|||
130265805|NCT00114127|468938848|FG000|Overall Study|Lost to Follow-up|1|||
130265806|NCT00114127|468938849|FG001|Overall Study|Lost to Follow-up|0|||
130265807|NCT00114127|468938848|FG000|Overall Study|Withdrawal by Subject|1|||
130265808|NCT00114127|468938849|FG001|Overall Study|Withdrawal by Subject|3|||
130265809|NCT03188263|468938850|FG000|Overall Study|Withdrawal by Subject|3|||
130265810|NCT03188263|468938851|FG001|Overall Study|Withdrawal by Subject|0|||
130265811|NCT03188263|468938850|FG000|Overall Study|Physician Decision|1|||
130265812|NCT03188263|468938851|FG001|Overall Study|Physician Decision|0|||
130265813|NCT00881894|468938852|FG000|Overall Study|Consent withdrawn|0|||
130265814|NCT00881894|468938853|FG001|Overall Study|Consent withdrawn|1|||
130265815|NCT00881894|468938852|FG000|Overall Study|Other reasons for premature termination|1|||
130265816|NCT00881894|468938853|FG001|Overall Study|Other reasons for premature termination|2|||
130265817|NCT00421148|468938854|FG000|Overall Study|Lost to Follow-up|0|||
130265818|NCT00421148|468938855|FG001|Overall Study|Lost to Follow-up|0|||
130265819|NCT00421148|468938856|FG002|Overall Study|Lost to Follow-up|0|||
130265820|NCT00421148|468938857|FG003|Overall Study|Lost to Follow-up|0|||
130265821|NCT00421148|468938858|FG004|Overall Study|Lost to Follow-up|0|||
130265822|NCT00421148|468938859|FG005|Overall Study|Lost to Follow-up|0|||
130265823|NCT00421148|468938860|FG006|Overall Study|Lost to Follow-up|0|||
130365719|NCT02609828|469308551|FG000|Overall Study|Withdrawal by Subject|12|||
130365720|NCT02609828|469308552|FG001|Overall Study|Withdrawal by Subject|1|||
130265824|NCT00421148|468938861|FG007|Overall Study|Lost to Follow-up|0|||
130265825|NCT00421148|468938862|FG008|Overall Study|Lost to Follow-up|0|||
130265826|NCT00421148|468938863|FG009|Overall Study|Lost to Follow-up|0|||
130265827|NCT00421148|468938864|FG010|Overall Study|Lost to Follow-up|0|||
130265828|NCT00421148|468938865|FG011|Overall Study|Lost to Follow-up|0|||
130265829|NCT00421148|468938866|FG012|Overall Study|Lost to Follow-up|0|||
130265830|NCT00421148|468938867|FG013|Overall Study|Lost to Follow-up|0|||
130265831|NCT00421148|468938868|FG014|Overall Study|Lost to Follow-up|0|||
130265832|NCT00421148|468938869|FG015|Overall Study|Lost to Follow-up|0|||
130265833|NCT00421148|468938870|FG016|Overall Study|Lost to Follow-up|0|||
130265834|NCT00421148|468938871|FG017|Overall Study|Lost to Follow-up|1|||
130265835|NCT00421148|468938872|FG018|Overall Study|Lost to Follow-up|0|||
130265836|NCT00421148|468938873|FG019|Overall Study|Lost to Follow-up|0|||
130265837|NCT00421148|468938854|FG000|Overall Study|Withdrawal by Subject|0|||
130265838|NCT00421148|468938855|FG001|Overall Study|Withdrawal by Subject|0|||
130265839|NCT00421148|468938856|FG002|Overall Study|Withdrawal by Subject|0|||
130265840|NCT00421148|468938857|FG003|Overall Study|Withdrawal by Subject|0|||
130265841|NCT00421148|468938858|FG004|Overall Study|Withdrawal by Subject|0|||
130265842|NCT00421148|468938859|FG005|Overall Study|Withdrawal by Subject|0|||
130265843|NCT00421148|468938860|FG006|Overall Study|Withdrawal by Subject|0|||
130265844|NCT00421148|468938861|FG007|Overall Study|Withdrawal by Subject|0|||
130265845|NCT00421148|468938862|FG008|Overall Study|Withdrawal by Subject|0|||
130265846|NCT00421148|468938863|FG009|Overall Study|Withdrawal by Subject|0|||
130265847|NCT00421148|468938864|FG010|Overall Study|Withdrawal by Subject|0|||
130265848|NCT00421148|468938865|FG011|Overall Study|Withdrawal by Subject|0|||
130265849|NCT00421148|468938866|FG012|Overall Study|Withdrawal by Subject|0|||
130265850|NCT00421148|468938867|FG013|Overall Study|Withdrawal by Subject|0|||
130265851|NCT00421148|468938868|FG014|Overall Study|Withdrawal by Subject|0|||
130265852|NCT00421148|468938869|FG015|Overall Study|Withdrawal by Subject|0|||
130265853|NCT00421148|468938870|FG016|Overall Study|Withdrawal by Subject|0|||
130265854|NCT00421148|468938871|FG017|Overall Study|Withdrawal by Subject|1|||
130265855|NCT00421148|468938872|FG018|Overall Study|Withdrawal by Subject|0|||
130554000|NCT00823901|469996476|FG001|Overall Study|Lack of Efficacy|0|||
130265856|NCT00421148|468938873|FG019|Overall Study|Withdrawal by Subject|0|||
130265857|NCT00421148|468938854|FG000|Overall Study|Protocol Violation|0|||
130265858|NCT00421148|468938855|FG001|Overall Study|Protocol Violation|0|||
130265859|NCT00421148|468938856|FG002|Overall Study|Protocol Violation|0|||
130265860|NCT00421148|468938857|FG003|Overall Study|Protocol Violation|0|||
130554001|NCT00823901|469996475|FG000|Overall Study|Lost to Follow-up|2|||
130554002|NCT00823901|469996476|FG001|Overall Study|Lost to Follow-up|1|||
130265861|NCT00421148|468938858|FG004|Overall Study|Protocol Violation|0|||
130265862|NCT00421148|468938859|FG005|Overall Study|Protocol Violation|1|||
130265863|NCT00421148|468938860|FG006|Overall Study|Protocol Violation|0|||
130265864|NCT00421148|468938861|FG007|Overall Study|Protocol Violation|0|||
130265865|NCT00421148|468938862|FG008|Overall Study|Protocol Violation|0|||
130265866|NCT00421148|468938863|FG009|Overall Study|Protocol Violation|0|||
130265867|NCT00421148|468938864|FG010|Overall Study|Protocol Violation|0|||
130265868|NCT00421148|468938865|FG011|Overall Study|Protocol Violation|0|||
130265869|NCT00421148|468938866|FG012|Overall Study|Protocol Violation|0|||
130265870|NCT00421148|468938867|FG013|Overall Study|Protocol Violation|0|||
130265871|NCT00421148|468938868|FG014|Overall Study|Protocol Violation|0|||
130265872|NCT00421148|468938869|FG015|Overall Study|Protocol Violation|0|||
130265873|NCT00421148|468938870|FG016|Overall Study|Protocol Violation|0|||
130265874|NCT00421148|468938871|FG017|Overall Study|Protocol Violation|0|||
130265875|NCT00421148|468938872|FG018|Overall Study|Protocol Violation|1|||
130265876|NCT00421148|468938873|FG019|Overall Study|Protocol Violation|0|||
130265877|NCT00469833|468938874|FG000|Overall Study|No IV access|2|||
130265878|NCT01253369|468938875|FG000|Overall Study|Adverse Event|4|||
130265879|NCT01253369|468938875|FG000|Overall Study|Withdrawal by Subject|2|||
130265880|NCT01253369|468938875|FG000|Overall Study|Death|1|||
130265881|NCT01253369|468938875|FG000|Overall Study|Progressive disease|23|||
130265882|NCT01253369|468938875|FG000|Overall Study|Not Evaluable|3|||
130265883|NCT03289533|468938876|FG000|Overall Study|Death|12|||
130265884|NCT03289533|468938876|FG000|Overall Study|Terminated from study by sponsor|10|||
130265885|NCT01030822|468938877|FG000|Overall Study|Moved/migrated from study area|6|||
130265886|NCT01030822|468938878|FG001|Overall Study|Moved/migrated from study area|7|||
130265887|NCT01030822|468938879|FG002|Overall Study|Moved/migrated from study area|3|||
130265888|NCT01030822|468938877|FG000|Overall Study|Withdrawal by Subject|16|||
130265889|NCT01030822|468938878|FG001|Overall Study|Withdrawal by Subject|13|||
130265890|NCT01030822|468938879|FG002|Overall Study|Withdrawal by Subject|16|||
130265891|NCT01030822|468938877|FG000|Overall Study|Lost to Follow-up|9|||
130265892|NCT01030822|468938878|FG001|Overall Study|Lost to Follow-up|4|||
130265893|NCT01030822|468938879|FG002|Overall Study|Lost to Follow-up|7|||
130265894|NCT00539240|468938880|FG000|Overall Study|Withdrawal by Subject|0|||
130265895|NCT00539240|468938881|FG001|Overall Study|Withdrawal by Subject|2|||
130265896|NCT00539240|468938882|FG002|Overall Study|Withdrawal by Subject|0|||
130265897|NCT00539240|468938880|FG000|Overall Study|Protocol Violation|1|||
130265898|NCT00539240|468938881|FG001|Overall Study|Protocol Violation|1|||
130265899|NCT00539240|468938882|FG002|Overall Study|Protocol Violation|4|||
130265900|NCT00539240|468938880|FG000|Overall Study|Lost to Follow-up|2|||
130265901|NCT00539240|468938881|FG001|Overall Study|Lost to Follow-up|3|||
130265902|NCT00539240|468938882|FG002|Overall Study|Lost to Follow-up|1|||
130265903|NCT00539240|468938880|FG000|Overall Study|Adverse Event|3|||
130265904|NCT00539240|468938881|FG001|Overall Study|Adverse Event|1|||
130265905|NCT00539240|468938882|FG002|Overall Study|Adverse Event|10|||
130265906|NCT00363311|468938883|FG000|Overall Study|Adverse Event|6|||
130265907|NCT00363311|468938884|FG001|Overall Study|Adverse Event|4|||
130265908|NCT00363311|468938883|FG000|Overall Study|Lost to Follow-up|3|||
130265909|NCT00363311|468938884|FG001|Overall Study|Lost to Follow-up|0|||
130265910|NCT00363311|468938883|FG000|Overall Study|Protocol Violation|1|||
130265911|NCT00363311|468938884|FG001|Overall Study|Protocol Violation|2|||
130265912|NCT00363311|468938883|FG000|Overall Study|Withdrawal by Subject|12|||
130265913|NCT00363311|468938884|FG001|Overall Study|Withdrawal by Subject|6|||
130453268|NCT00817635|469623524|FG000|Overall Study|Administrative Problems|0|||
130453269|NCT00817635|469623525|FG001|Overall Study|Administrative Problems|0|||
130453270|NCT00817635|469623526|FG002|Overall Study|Administrative Problems|0|||
130453271|NCT00817635|469623527|FG003|Overall Study|Administrative Problems|0|||
130453272|NCT00817635|469623528|FG004|Overall Study|Administrative Problems|1|||
130453273|NCT00817635|469623524|FG000|Overall Study|Protocol Violation|5|||
130453274|NCT00817635|469623525|FG001|Overall Study|Protocol Violation|1|||
130453275|NCT00817635|469623526|FG002|Overall Study|Protocol Violation|3|||
130453276|NCT00817635|469623527|FG003|Overall Study|Protocol Violation|2|||
130453277|NCT00817635|469623528|FG004|Overall Study|Protocol Violation|3|||
130453278|NCT00763282|469623537|FG000|Overall Study|Withdrawal by Subject|6|||
130453279|NCT00763282|469623538|FG001|Overall Study|Withdrawal by Subject|5|||
130265914|NCT00363311|468938883|FG000|Overall Study|Physician Decision|1|||
130265915|NCT00363311|468938884|FG001|Overall Study|Physician Decision|1|||
130265916|NCT00363311|468938883|FG000|Overall Study|Sponsor Terminated Study|2|||
130265917|NCT00363311|468938884|FG001|Overall Study|Sponsor Terminated Study|2|||
130265918|NCT00363311|468938883|FG000|Overall Study|Disease Progression|46|||
130265919|NCT00363311|468938884|FG001|Overall Study|Disease Progression|26|||
130265920|NCT00363311|468938883|FG000|Overall Study|Non-Compliance|1|||
130265921|NCT00363311|468938884|FG001|Overall Study|Non-Compliance|1|||
130265922|NCT00363311|468938883|FG000|Overall Study|Participant Refused Biopsy|1|||
130453280|NCT00763282|469623537|FG000|Overall Study|Death|4|||
130265923|NCT00363311|468938884|FG001|Overall Study|Participant Refused Biopsy|0|||
130265924|NCT00363311|468938883|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
130265925|NCT00363311|468938884|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
130704369|NCT03430011|470541261|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
130704370|NCT03430011|470541262|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
130704371|NCT03430011|470541263|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
130704372|NCT03430011|470541264|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
130704373|NCT03430011|470541265|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
130265926|NCT00363311|468938883|FG000|Overall Study|Participant Opted for Treatment|1|||
130265927|NCT00363311|468938884|FG001|Overall Study|Participant Opted for Treatment|0|||
130265928|NCT00363311|468938883|FG000|Overall Study|Participant Moved to Another Country|1|||
130265929|NCT00363311|468938884|FG001|Overall Study|Participant Moved to Another Country|0|||
130265930|NCT00363311|468938883|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
130265931|NCT00363311|468938884|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
130265932|NCT00363311|468938883|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
130265933|NCT00363311|468938884|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
130265934|NCT00363311|468938883|FG000|Overall Study|Participant Moved to Louisiana|0|||
130265935|NCT00363311|468938884|FG001|Overall Study|Participant Moved to Louisiana|1|||
130265936|NCT01595529|468938885|FG000|Overall Study|Adverse Event|2|||
130265937|NCT01595529|468938886|FG001|Overall Study|Adverse Event|0|||
130265938|NCT01595529|468938885|FG000|Overall Study|Subject Non-Compliant|2|||
130265939|NCT01595529|468938886|FG001|Overall Study|Subject Non-Compliant|0|||
130265940|NCT01595529|468938885|FG000|Overall Study|Lost to Follow-up|8|||
130265941|NCT01595529|468938886|FG001|Overall Study|Lost to Follow-up|14|||
130265942|NCT01595529|468938885|FG000|Overall Study|Protocol Violation|1|||
130265943|NCT01595529|468938886|FG001|Overall Study|Protocol Violation|2|||
130265944|NCT01595529|468938885|FG000|Overall Study|Physician Decision|1|||
130265945|NCT01595529|468938886|FG001|Overall Study|Physician Decision|0|||
130265946|NCT01595529|468938885|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130265947|NCT01595529|468938886|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130265948|NCT01595529|468938885|FG000|Overall Study|Administrative Decision|1|||
130265949|NCT01595529|468938886|FG001|Overall Study|Administrative Decision|0|||
130265950|NCT01595529|468938885|FG000|Overall Study|Entry Failure/Screening Failure|6|||
130265951|NCT01595529|468938886|FG001|Overall Study|Entry Failure/Screening Failure|1|||
130265952|NCT04016714|468938887|FG000|Overall Study|Death|1|||
130265953|NCT04016714|468938888|FG001|Overall Study|Death|0|||
130265954|NCT04016714|468938887|FG000|Overall Study|Lost to Follow-up|3|||
130265955|NCT04016714|468938888|FG001|Overall Study|Lost to Follow-up|1|||
130265956|NCT04016714|468938887|FG000|Overall Study|Physician Decision|3|||
130265957|NCT04016714|468938888|FG001|Overall Study|Physician Decision|3|||
130265958|NCT04016714|468938887|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
130265959|NCT04016714|468938888|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
130265960|NCT00730886|468938891|FG000|Overall Study|Lost to Follow-up|1|||
130265961|NCT00730886|468938892|FG001|Overall Study|Lost to Follow-up|0|||
130265962|NCT00730886|468938891|FG000|Overall Study|Physician Decision|1|||
130265963|NCT00730886|468938892|FG001|Overall Study|Physician Decision|0|||
130265964|NCT01991483|468938893|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
130265965|NCT01991483|468938894|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
130265966|NCT01991483|468938895|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
130265967|NCT01991483|468938896|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
130265968|NCT01991483|468938893|FG000|Dose Level 600 mg|Physician Decision|0|||
130265969|NCT01991483|468938894|FG001|Dose Level 600 mg|Physician Decision|0|||
130265970|NCT01991483|468938895|FG002|Dose Level 600 mg|Physician Decision|1|||
130265971|NCT01991483|468938896|FG003|Dose Level 600 mg|Physician Decision|0|||
130265972|NCT01991483|468938893|FG000|Dose Level 1000 mg|Protocol Violation|0|||
130265973|NCT01991483|468938894|FG001|Dose Level 1000 mg|Protocol Violation|0|||
130265974|NCT01991483|468938895|FG002|Dose Level 1000 mg|Protocol Violation|0|||
130265975|NCT01991483|468938896|FG003|Dose Level 1000 mg|Protocol Violation|1|||
130265976|NCT01932788|468938904|FG000|Overall Study|Protocol Violation|18|||
130265977|NCT01932788|468938905|FG001|Overall Study|Protocol Violation|0|||
130265978|NCT01932788|468938904|FG000|Overall Study|Lost to Follow-up|18|||
130265979|NCT01932788|468938905|FG001|Overall Study|Lost to Follow-up|46|||
130265980|NCT01932788|468938904|FG000|Overall Study|Lack of Efficacy|2|||
130265981|NCT01932788|468938905|FG001|Overall Study|Lack of Efficacy|0|||
130265982|NCT01932788|468938904|FG000|Overall Study|Withdrawal by Subject|0|||
130704374|NCT03430011|470541266|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
130265983|NCT01932788|468938905|FG001|Overall Study|Withdrawal by Subject|5|||
130265984|NCT01171677|468938906|FG000|Overall Study|Withdrawal by Subject|0|||
130265985|NCT01171677|468938907|FG001|Overall Study|Withdrawal by Subject|3|||
130265986|NCT01171677|468938906|FG000|Overall Study|Adverse Event|1|||
130265987|NCT01171677|468938907|FG001|Overall Study|Adverse Event|0|||
130265988|NCT01171677|468938906|FG000|Overall Study|completed <70% IntenSati classes|5|||
130265989|NCT01171677|468938907|FG001|Overall Study|completed <70% IntenSati classes|0|||
130265990|NCT01847443|468938908|FG000|Study Period 1|Withdrawal by Subject|0|||
130265991|NCT01847443|468938909|FG001|Study Period 1|Withdrawal by Subject|1|||
130265992|NCT01847443|468938910|FG002|Study Period 1|Withdrawal by Subject|0|||
130453281|NCT00763282|469623538|FG001|Overall Study|Death|3|||
130265993|NCT01847443|468938911|FG003|Study Period 1|Withdrawal by Subject|0|||
130265994|NCT01847443|468938908|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
130265995|NCT01847443|468938909|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
130265996|NCT01847443|468938910|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
130265997|NCT01847443|468938911|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
130265998|NCT01847443|468938908|FG000|Washout Period Before Study Period 2|Other reason|1|||
130265999|NCT01847443|468938909|FG001|Washout Period Before Study Period 2|Other reason|0|||
130266000|NCT01847443|468938910|FG002|Washout Period Before Study Period 2|Other reason|0|||
130266001|NCT01847443|468938911|FG003|Washout Period Before Study Period 2|Other reason|0|||
130266002|NCT01847443|468938908|FG000|Washout Period Before Study Period 3|Other reason|1|||
130266003|NCT01847443|468938909|FG001|Washout Period Before Study Period 3|Other reason|0|||
130266004|NCT01847443|468938910|FG002|Washout Period Before Study Period 3|Other reason|0|||
130266005|NCT01847443|468938911|FG003|Washout Period Before Study Period 3|Other reason|0|||
130266006|NCT01847443|468938908|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
130266007|NCT01847443|468938909|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266008|NCT01847443|468938910|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266009|NCT01847443|468938911|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266010|NCT01847443|468938908|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
130266011|NCT01847443|468938909|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266012|NCT01847443|468938910|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266013|NCT01847443|468938911|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266014|NCT03571971|468938912|FG000|Overall Study|Lost to Follow-up|2|||
130266015|NCT03571971|468938913|FG001|Overall Study|Lost to Follow-up|2|||
130266016|NCT03571971|468938912|FG000|Overall Study|Protocol Violation|2|||
130266017|NCT03571971|468938913|FG001|Overall Study|Protocol Violation|3|||
130266018|NCT03571971|468938912|FG000|Overall Study|Withdrawal by Subject|2|||
130266019|NCT03571971|468938913|FG001|Overall Study|Withdrawal by Subject|0|||
130266020|NCT03571971|468938912|FG000|Overall Study|Incomplete primary outcome data|2|||
130266021|NCT03571971|468938913|FG001|Overall Study|Incomplete primary outcome data|0|||
130266022|NCT02806414|468938921|FG000|Overall Study|Lost to Follow-up|2|||
130266023|NCT00038948|468938926|FG000|Overall Study|Adverse Event|131|||
130266024|NCT00038948|468938927|FG001|Overall Study|Adverse Event|43|||
130266025|NCT00038948|468938926|FG000|Overall Study|Lost to Follow-up|4|||
130266026|NCT00038948|468938927|FG001|Overall Study|Lost to Follow-up|4|||
130266027|NCT00038948|468938926|FG000|Overall Study|Nonmedical event|5|||
130266028|NCT00038948|468938927|FG001|Overall Study|Nonmedical event|7|||
130266029|NCT00038948|468938926|FG000|Overall Study|Withdrawal by Subject|23|||
130266030|NCT00038948|468938927|FG001|Overall Study|Withdrawal by Subject|10|||
130266031|NCT00038948|468938926|FG000|Overall Study|Protocol Violation|3|||
130266032|NCT00038948|468938927|FG001|Overall Study|Protocol Violation|7|||
130266033|NCT00038948|468938926|FG000|Overall Study|Lack of Efficacy|3|||
130266034|NCT00038948|468938927|FG001|Overall Study|Lack of Efficacy|6|||
130266035|NCT00937495|468940505|FG000|Overall Study|Protocol Violation|2|||
130266036|NCT00441272|468940506|FG000|Overall Study|Study terminated prior to enrollment|25|||
130266037|NCT00441272|468940507|FG001|Overall Study|Study terminated prior to enrollment|25|||
130266038|NCT01856322|468940508|FG000|Overall Study|off study due to lack of accrual|0|||
130266039|NCT01856322|468940509|FG001|Overall Study|off study due to lack of accrual|0|||
130266040|NCT01856322|468940510|FG002|Overall Study|off study due to lack of accrual|3|||
130266041|NCT00427011|468940511|FG000|Overall Study|Adverse Event|10|||
130266042|NCT00427011|468940511|FG000|Overall Study|Withdrawal by Subject|1|||
130266043|NCT00427011|468940511|FG000|Overall Study|Lack of Efficacy|2|||
130266044|NCT00427011|468940511|FG000|Overall Study|Other|12|||
130266045|NCT00288015|468940515|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
130266046|NCT00288015|468940515|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
130266047|NCT00288015|468940515|FG000|First Response Assessment|Withdrawal by Subject|1|||
130266048|NCT00288015|468940515|FG000|First Response Assessment|Death|1|||
130266049|NCT00288015|468940515|FG000|First Response Assessment|Physician Decision|2|||
130266050|NCT00288015|468940515|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
130266051|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Death|13|||
130266052|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
130266053|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Other|9|||
130266054|NCT00443703|468940516|FG000|Overall Study|Never Treated|3|||
130266055|NCT00443703|468940517|FG001|Overall Study|Never Treated|1|||
130453282|NCT00763282|469623537|FG000|Overall Study|Lost to Follow-up|22|||
130266056|NCT00443703|468940516|FG000|Overall Study|Adverse Event|7|||
130266057|NCT00443703|468940517|FG001|Overall Study|Adverse Event|3|||
130266058|NCT00443703|468940516|FG000|Overall Study|Lack of Efficacy|3|||
130453283|NCT00763282|469623538|FG001|Overall Study|Lost to Follow-up|26|||
130266059|NCT00443703|468940517|FG001|Overall Study|Lack of Efficacy|1|||
130266060|NCT00443703|468940516|FG000|Overall Study|Lost to Follow-up|0|||
130266061|NCT00443703|468940517|FG001|Overall Study|Lost to Follow-up|4|||
130453284|NCT00742274|469623539|FG000|Overall Study|Death|1|||
130266062|NCT00443703|468940516|FG000|Overall Study|Physician Decision|4|||
130266063|NCT00443703|468940517|FG001|Overall Study|Physician Decision|2|||
130266064|NCT00443703|468940516|FG000|Overall Study|Protocol Violation|1|||
130266065|NCT00443703|468940517|FG001|Overall Study|Protocol Violation|1|||
130266066|NCT00443703|468940516|FG000|Overall Study|Withdrawal by Subject|9|||
130266067|NCT00443703|468940517|FG001|Overall Study|Withdrawal by Subject|6|||
130266068|NCT00443703|468940516|FG000|Overall Study|Progressive Disease|1|||
130266069|NCT00443703|468940517|FG001|Overall Study|Progressive Disease|0|||
130266070|NCT01333722|468940518|FG000|Overall Study|Lack of Efficacy|0|||
130266071|NCT01333722|468940519|FG001|Overall Study|Lack of Efficacy|2|||
130266072|NCT01333722|468940518|FG000|Overall Study|Withdrawal by Subject|0|||
130266073|NCT01333722|468940519|FG001|Overall Study|Withdrawal by Subject|1|||
130266074|NCT04776161|468940521|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
130266075|NCT04776161|468940522|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
130266076|NCT04776161|468940523|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
130266077|NCT04776161|468940521|FG000|Overall Study|Withdrawal by Subject|1|||
130266078|NCT04776161|468940522|FG001|Overall Study|Withdrawal by Subject|0|||
130266079|NCT04776161|468940523|FG002|Overall Study|Withdrawal by Subject|1|||
130266080|NCT04776161|468940521|FG000|Overall Study|Adverse Event|0|||
130266081|NCT04776161|468940522|FG001|Overall Study|Adverse Event|1|||
130266082|NCT04776161|468940523|FG002|Overall Study|Adverse Event|1|||
130266083|NCT00661830|468940527|FG000|Overall Study|Death|37|||
130266084|NCT00661830|468940528|FG001|Overall Study|Death|33|||
130266085|NCT00661830|468940527|FG000|Overall Study|Lost to Follow-up|1|||
130266086|NCT00661830|468940528|FG001|Overall Study|Lost to Follow-up|3|||
130266087|NCT00661830|468940527|FG000|Overall Study|Withdrawal by Subject|1|||
130266088|NCT00661830|468940528|FG001|Overall Study|Withdrawal by Subject|1|||
130266089|NCT00661830|468940527|FG000|Overall Study|Other reason|1|||
130266090|NCT00661830|468940528|FG001|Overall Study|Other reason|5|||
130266091|NCT00488514|468940529|FG000|Overall Study|Adverse Event|41|||
130266092|NCT00488514|468940529|FG000|Overall Study|Lost to Follow-up|44|||
130266093|NCT00488514|468940529|FG000|Overall Study|Protocol Violation|32|||
130266094|NCT00488514|468940529|FG000|Overall Study|Withdrawal by Subject|106|||
130266095|NCT00488514|468940529|FG000|Overall Study|Lack of Efficacy|28|||
130266096|NCT00488514|468940529|FG000|Overall Study|Did not meet criteria for treatment|30|||
130266097|NCT00488514|468940529|FG000|Overall Study|Postive drug screen|1|||
130266098|NCT00488514|468940529|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
130266099|NCT00488514|468940529|FG000|Overall Study|Investigator decision|1|||
130266100|NCT00488514|468940529|FG000|Overall Study|Participant had too few migraines|5|||
130266101|NCT00488514|468940529|FG000|Overall Study|Increase in number of migraines|2|||
130266102|NCT00488514|468940529|FG000|Overall Study|Increased use of concomitant medication|1|||
130266103|NCT00517699|468940530|FG000|Overall Study|Withdrawal by Subject|1|||
130266104|NCT00517699|468940530|FG000|Overall Study|Lack of Efficacy|1|||
130266105|NCT00517699|468940530|FG000|Overall Study|Administrative error|1|||
130266106|NCT00517699|468940530|FG000|Overall Study|Study terminated by Sponsor|2|||
130266107|NCT02332187|468940531|FG000|Overall Study|Withdrawal by Subject|2|||
130266108|NCT02332187|468940532|FG001|Overall Study|Withdrawal by Subject|2|||
130266109|NCT02332187|468940531|FG000|Overall Study|Adverse Event|0|||
130266110|NCT02332187|468940532|FG001|Overall Study|Adverse Event|1|||
130266111|NCT00980148|468940533|FG000|Overall Study|Discharged from facility|89|||
130266112|NCT00980148|468940534|FG001|Overall Study|Discharged from facility|96|||
130266113|NCT00980148|468940533|FG000|Overall Study|Received other antichlamydia treatment|20|||
130266114|NCT00980148|468940534|FG001|Overall Study|Received other antichlamydia treatment|14|||
130266115|NCT00980148|468940533|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
130266116|NCT00980148|468940534|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
130266117|NCT00980148|468940533|FG000|Overall Study|Various other reasons|8|||
130704375|NCT03430011|470541267|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
130266118|NCT00980148|468940534|FG001|Overall Study|Various other reasons|9|||
130266119|NCT03500211|468940535|FG000|Overall Study|Withdrawal by Subject|1|||
130266120|NCT03500211|468940536|FG001|Overall Study|Withdrawal by Subject|1|||
130266121|NCT01119443|468940540|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
130266122|NCT01119443|468940541|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
130704376|NCT03430011|470541260|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
130704377|NCT03430011|470541261|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
130704378|NCT03430011|470541262|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
130266123|NCT02329743|468940544|FG000|Overall Study|Adverse Event|1|||
130266124|NCT02329743|468940545|FG001|Overall Study|Adverse Event|1|||
130266125|NCT02329743|468940546|FG002|Overall Study|Adverse Event|3|||
130266126|NCT02329743|468940544|FG000|Overall Study|Lost to Follow-up|1|||
130266127|NCT02329743|468940545|FG001|Overall Study|Lost to Follow-up|0|||
130266128|NCT02329743|468940546|FG002|Overall Study|Lost to Follow-up|1|||
130365721|NCT02609828|469308553|FG002|Overall Study|Withdrawal by Subject|0|||
130365722|NCT02609828|469308554|FG003|Overall Study|Withdrawal by Subject|10|||
130266129|NCT02329743|468940544|FG000|Overall Study|Withdrawal by Subject|4|||
130266130|NCT02329743|468940545|FG001|Overall Study|Withdrawal by Subject|4|||
130365723|NCT02609828|469308551|FG000|Overall Study|Other|3|||
130266131|NCT02329743|468940546|FG002|Overall Study|Withdrawal by Subject|1|||
130266132|NCT02329743|468940544|FG000|Overall Study|Other|0|||
130266133|NCT02329743|468940545|FG001|Overall Study|Other|2|||
130266134|NCT02329743|468940546|FG002|Overall Study|Other|3|||
130266135|NCT00775268|468940550|FG000|Baseline|Drug not synthesize dose|1|||
130266136|NCT00775268|468940551|FG001|Baseline|Drug not synthesize dose|0|||
130266137|NCT00775268|468940550|FG000|Baseline|Not treated-ineligible per CT|0|||
130266138|NCT00775268|468940551|FG001|Baseline|Not treated-ineligible per CT|1|||
130266139|NCT00775268|468940550|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
130266140|NCT00775268|468940551|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
130266141|NCT00775268|468940550|FG000|After Completion|Participant missed scan appointment|1|||
130266142|NCT00775268|468940551|FG001|After Completion|Participant missed scan appointment|0|||
130266143|NCT03604497|468940552|FG000|Overall Study|Protocol Violation|52|||
130266144|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
130266145|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266146|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266147|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266148|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266149|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
130266150|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266151|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266152|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266153|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266154|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
130266155|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266156|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266157|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266158|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266159|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
130266160|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266161|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266162|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266163|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266164|NCT01194245|468940558|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266165|NCT01194245|468940559|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266166|NCT01194245|468940560|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266167|NCT01194245|468940561|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266168|NCT01194245|468940562|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130266169|NCT01194245|468940558|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130266170|NCT01194245|468940559|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130266171|NCT01194245|468940560|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266172|NCT01194245|468940561|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266173|NCT01194245|468940562|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266174|NCT00269087|468940563|FG000|Overall Study|Adverse Event|20|||
130704379|NCT03430011|470541263|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
130704380|NCT03430011|470541264|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
130704381|NCT03430011|470541265|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
130704382|NCT03430011|470541266|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
130704383|NCT03430011|470541267|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
130704384|NCT03430011|470541260|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
130704385|NCT03430011|470541261|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
130704386|NCT03430011|470541262|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
130704387|NCT03430011|470541263|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
130704388|NCT03430011|470541264|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
130266175|NCT00269087|468940563|FG000|Overall Study|Withdrawal by Subject|1|||
130266176|NCT00269087|468940563|FG000|Overall Study|Exacerbation of COPD|13|||
130266177|NCT02651116|468940566|FG000|Overall Study|Adverse Event|0|||
130266178|NCT02651116|468940567|FG001|Overall Study|Adverse Event|1|||
130266179|NCT02651116|468940566|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
130266180|NCT02651116|468940567|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
130266181|NCT00041470|468940576|FG000|Overall Study|Loss of Funding|38|||
130266182|NCT01193101|468940580|FG000|Overall Study|Adverse Event|0|||
130266183|NCT01193101|468940581|FG001|Overall Study|Adverse Event|1|||
130266184|NCT01193101|468940582|FG002|Overall Study|Adverse Event|1|||
130266185|NCT01193101|468940583|FG003|Overall Study|Adverse Event|3|||
130704389|NCT03430011|470541265|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
130704390|NCT03430011|470541266|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
130704391|NCT03430011|470541267|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
130266186|NCT01193101|468940580|FG000|Overall Study|Lack of Efficacy|3|||
130266187|NCT01193101|468940581|FG001|Overall Study|Lack of Efficacy|1|||
130704392|NCT03430011|470541260|FG000|JCARH125 Treatment|Death|4|||
130704393|NCT03430011|470541261|FG001|JCARH125 Treatment|Death|19|||
130704394|NCT03430011|470541262|FG002|JCARH125 Treatment|Death|10|||
130704395|NCT03430011|470541263|FG003|JCARH125 Treatment|Death|8|||
130704396|NCT03430011|470541264|FG004|JCARH125 Treatment|Death|5|||
130704397|NCT03430011|470541265|FG005|JCARH125 Treatment|Death|3|||
130704398|NCT03430011|470541266|FG006|JCARH125 Treatment|Death|4|||
130704399|NCT03430011|470541267|FG007|JCARH125 Treatment|Death|2|||
130704400|NCT03430011|470541260|FG000|JCARH125 Treatment|Other reasons|1|||
130704401|NCT03430011|470541261|FG001|JCARH125 Treatment|Other reasons|0|||
130704402|NCT03430011|470541262|FG002|JCARH125 Treatment|Other reasons|4|||
130704403|NCT03430011|470541263|FG003|JCARH125 Treatment|Other reasons|2|||
130704404|NCT03430011|470541264|FG004|JCARH125 Treatment|Other reasons|2|||
130704405|NCT03430011|470541265|FG005|JCARH125 Treatment|Other reasons|1|||
130704406|NCT03430011|470541266|FG006|JCARH125 Treatment|Other reasons|3|||
130704407|NCT03430011|470541267|FG007|JCARH125 Treatment|Other reasons|2|||
130704408|NCT04126343|470541268|FG000|Overall Study|Adverse Event|0|||
130704409|NCT04126343|470541269|FG001|Overall Study|Adverse Event|0|||
130704410|NCT04126343|470541270|FG002|Overall Study|Adverse Event|0|||
130704411|NCT04126343|470541271|FG003|Overall Study|Adverse Event|0|||
130704412|NCT04126343|470541272|FG004|Overall Study|Adverse Event|0|||
130704413|NCT04126343|470541273|FG005|Overall Study|Adverse Event|1|||
130704414|NCT04126343|470541268|FG000|Overall Study|Withdrawal by Subject|0|||
130704415|NCT04126343|470541269|FG001|Overall Study|Withdrawal by Subject|0|||
130704416|NCT04126343|470541270|FG002|Overall Study|Withdrawal by Subject|0|||
130704417|NCT04126343|470541271|FG003|Overall Study|Withdrawal by Subject|1|||
130266188|NCT01193101|468940582|FG002|Overall Study|Lack of Efficacy|0|||
130266189|NCT01193101|468940583|FG003|Overall Study|Lack of Efficacy|8|||
130266190|NCT01193101|468940580|FG000|Overall Study|Withdrawal by Subject|2|||
130266191|NCT01193101|468940581|FG001|Overall Study|Withdrawal by Subject|4|||
130266192|NCT01193101|468940582|FG002|Overall Study|Withdrawal by Subject|1|||
130266193|NCT01193101|468940583|FG003|Overall Study|Withdrawal by Subject|1|||
130266194|NCT01193101|468940580|FG000|Overall Study|Administrative problems|0|||
130266195|NCT01193101|468940581|FG001|Overall Study|Administrative problems|0|||
130266196|NCT01193101|468940582|FG002|Overall Study|Administrative problems|1|||
130266197|NCT01193101|468940583|FG003|Overall Study|Administrative problems|0|||
130266198|NCT01193101|468940580|FG000|Overall Study|Abnormal test procedure results|0|||
130266199|NCT01193101|468940581|FG001|Overall Study|Abnormal test procedure results|1|||
130266200|NCT01193101|468940582|FG002|Overall Study|Abnormal test procedure results|0|||
130266201|NCT01193101|468940583|FG003|Overall Study|Abnormal test procedure results|0|||
130266202|NCT02347085|468940586|FG000|Overall Study|Adverse Event|2|||
130266203|NCT02347085|468940586|FG000|Overall Study|Lack of Efficacy|1|||
130266204|NCT02347085|468940586|FG000|Overall Study|Withdrawal by Subject|4|||
130266205|NCT02347085|468940586|FG000|Overall Study|Lost to Follow-up|1|||
130266206|NCT02347085|468940586|FG000|Overall Study|Protocol Criteria|2|||
130266207|NCT00800982|468940587|FG000|Overall Study|Lost to Follow-up|1|||
130266208|NCT00800982|468940588|FG001|Overall Study|Lost to Follow-up|2|||
130266209|NCT00800982|468940587|FG000|Overall Study|Withdrawal by Subject|0|||
130266210|NCT00800982|468940588|FG001|Overall Study|Withdrawal by Subject|1|||
130266211|NCT00800982|468940587|FG000|Overall Study|Patient moved out of state|1|||
130266212|NCT00800982|468940588|FG001|Overall Study|Patient moved out of state|0|||
130266213|NCT00648037|468940589|FG000|Overall Study|Not Treated|1|||
130266214|NCT00648037|468940589|FG000|Overall Study|Withdrawal by Subject|1|||
130266215|NCT00648037|468940589|FG000|Overall Study|Adverse Event|11|||
130266216|NCT00648037|468940589|FG000|Overall Study|Relapse|2|||
130266217|NCT00648037|468940589|FG000|Overall Study|Other|1|||
130266218|NCT00699413|468940600|FG000|Overall Study|Withdrawal by Subject|0|||
130266219|NCT00699413|468940601|FG001|Overall Study|Withdrawal by Subject|2|||
130453285|NCT00742274|469623540|FG001|Overall Study|Death|0|||
130453286|NCT00742274|469623539|FG000|Overall Study|Withdrawal by Subject|1|||
130453287|NCT00742274|469623540|FG001|Overall Study|Withdrawal by Subject|2|||
130453288|NCT00742274|469623539|FG000|Overall Study|Removed for medical reasons|1|||
130453289|NCT00742274|469623540|FG001|Overall Study|Removed for medical reasons|1|||
130704418|NCT04126343|470541272|FG004|Overall Study|Withdrawal by Subject|0|||
130266220|NCT00699413|468940600|FG000|Overall Study|Study terminated by sponsor|4|||
130266221|NCT00699413|468940601|FG001|Overall Study|Study terminated by sponsor|2|||
130266222|NCT02103062|468940603|FG000|Overall Study|Adverse Event|1|||
130266223|NCT02103062|468940604|FG001|Overall Study|Adverse Event|2|||
130266224|NCT02103062|468940603|FG000|Overall Study|Progressive Disease|17|||
130266225|NCT02103062|468940604|FG001|Overall Study|Progressive Disease|20|||
130266226|NCT02103062|468940603|FG000|Overall Study|Death|0|||
130266227|NCT02103062|468940604|FG001|Overall Study|Death|1|||
130266228|NCT00120627|468940605|FG000|Overall Study|Withdrawal by Subject|5|||
130266229|NCT00120627|468940606|FG001|Overall Study|Withdrawal by Subject|5|||
130704419|NCT04126343|470541273|FG005|Overall Study|Withdrawal by Subject|0|||
130704420|NCT04126343|470541268|FG000|Overall Study|Related to COVID-19 pandemic|3|||
130704421|NCT04126343|470541269|FG001|Overall Study|Related to COVID-19 pandemic|4|||
130704422|NCT04126343|470541270|FG002|Overall Study|Related to COVID-19 pandemic|3|||
130266230|NCT02030821|468940607|FG000|Overall Study|Physician Decision|2|||
130266231|NCT02030821|468940608|FG001|Overall Study|Physician Decision|2|||
130266232|NCT02030821|468940609|FG002|Overall Study|Physician Decision|5|||
130266233|NCT02030821|468940610|FG003|Overall Study|Physician Decision|2|||
130266234|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
130266235|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266236|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266237|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266238|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266239|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266240|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
130266241|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
130266242|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
130266243|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
130266244|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
130266245|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
130266246|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
130266247|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266248|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266249|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266250|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266251|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266252|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
130266253|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
130266254|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
130266255|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
130266256|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
130266257|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
130266258|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130266259|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130266260|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266261|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266262|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266263|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266264|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266265|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
130266266|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266267|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266268|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266269|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266270|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266271|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266272|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
130266273|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266274|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266275|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266276|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
130266277|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
130266278|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
130266279|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
130266280|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
130266281|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
130266282|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266283|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266284|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266285|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130453290|NCT01674569|469623543|FG000|Overall Study|Adverse Event|0|||
130266286|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130266287|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266288|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
130266289|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
130266290|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
130266291|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
130266292|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
130453291|NCT01674569|469623544|FG001|Overall Study|Adverse Event|2|||
130453292|NCT01674569|469623545|FG002|Overall Study|Adverse Event|0|||
130453293|NCT01674569|469623546|FG003|Overall Study|Adverse Event|1|||
130453294|NCT01674569|469623547|FG004|Overall Study|Adverse Event|2|||
130266293|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
130266294|NCT03092479|468940630|FG000|Overall Study|Lost to Follow-up|3|||
130266295|NCT03092479|468940631|FG001|Overall Study|Lost to Follow-up|2|||
130266296|NCT03092479|468940630|FG000|Overall Study|Withdrawal by Subject|4|||
130266297|NCT03092479|468940631|FG001|Overall Study|Withdrawal by Subject|0|||
130266298|NCT00543985|468940634|FG000|Overall Study|Withdrawal by Subject|4|||
130266299|NCT02015039|468940635|FG000|Overall Study|Not eligible|0|||
130266300|NCT02015039|468940636|FG001|Overall Study|Not eligible|1|||
130266301|NCT04046939|468940640|FG000|Primary Assessment Period|Adverse Event|1|||
130266302|NCT04046939|468940641|FG001|Primary Assessment Period|Adverse Event|0|||
130266303|NCT04046939|468940642|FG002|Primary Assessment Period|Adverse Event|0|||
130266304|NCT04046939|468940643|FG003|Primary Assessment Period|Adverse Event|0|||
130266305|NCT04046939|468940640|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
130266306|NCT04046939|468940641|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
130266307|NCT04046939|468940642|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
130266308|NCT04046939|468940643|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
130266309|NCT04046939|468940640|FG000|Primary Assessment Period|Physician Decision|0|||
130266310|NCT04046939|468940641|FG001|Primary Assessment Period|Physician Decision|0|||
130266311|NCT04046939|468940642|FG002|Primary Assessment Period|Physician Decision|1|||
130266312|NCT04046939|468940643|FG003|Primary Assessment Period|Physician Decision|0|||
130266313|NCT04046939|468940640|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130266314|NCT04046939|468940641|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130266315|NCT04046939|468940642|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130266316|NCT04046939|468940643|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130266317|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Not Eligible|3|||
130266318|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
130266319|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
130266320|NCT00403130|468940644|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
130266321|NCT00806260|468940645|FG000|Period 1 (1 Day)|Adverse Event|0|||
130266322|NCT00806260|468940646|FG001|Period 1 (1 Day)|Adverse Event|0|||
130266323|NCT00806260|468940647|FG002|Period 1 (1 Day)|Adverse Event|0|||
130266324|NCT00806260|468940648|FG003|Period 1 (1 Day)|Adverse Event|0|||
130266325|NCT00806260|468940649|FG004|Period 1 (1 Day)|Adverse Event|3|||
130266326|NCT00806260|468940650|FG005|Period 1 (1 Day)|Adverse Event|0|||
130266327|NCT00806260|468940645|FG000|Period 2|Adverse Event|0|||
130266328|NCT00806260|468940646|FG001|Period 2|Adverse Event|0|||
130266329|NCT00806260|468940647|FG002|Period 2|Adverse Event|0|||
130266330|NCT00806260|468940648|FG003|Period 2|Adverse Event|1|||
130266331|NCT00806260|468940649|FG004|Period 2|Adverse Event|0|||
130266332|NCT00806260|468940650|FG005|Period 2|Adverse Event|0|||
130266333|NCT00806260|468940645|FG000|Period 2|Protocol Violation|1|||
130266334|NCT00806260|468940646|FG001|Period 2|Protocol Violation|0|||
130266335|NCT00806260|468940647|FG002|Period 2|Protocol Violation|1|||
130266336|NCT00806260|468940648|FG003|Period 2|Protocol Violation|0|||
130266337|NCT00806260|468940649|FG004|Period 2|Protocol Violation|0|||
130266338|NCT00806260|468940650|FG005|Period 2|Protocol Violation|0|||
130266339|NCT00806260|468940645|FG000|Period 2|Need to take concomitant medication|1|||
130266340|NCT00806260|468940646|FG001|Period 2|Need to take concomitant medication|0|||
130266341|NCT00806260|468940647|FG002|Period 2|Need to take concomitant medication|0|||
130266342|NCT00806260|468940648|FG003|Period 2|Need to take concomitant medication|0|||
130266343|NCT00806260|468940649|FG004|Period 2|Need to take concomitant medication|0|||
130266344|NCT00806260|468940650|FG005|Period 2|Need to take concomitant medication|0|||
130266345|NCT00806260|468940645|FG000|Period 2|sponsor request|0|||
130266346|NCT00806260|468940646|FG001|Period 2|sponsor request|0|||
130266347|NCT00806260|468940647|FG002|Period 2|sponsor request|1|||
130266348|NCT00806260|468940648|FG003|Period 2|sponsor request|1|||
130266349|NCT00806260|468940649|FG004|Period 2|sponsor request|0|||
130266350|NCT00806260|468940650|FG005|Period 2|sponsor request|0|||
130453295|NCT01674569|469623548|FG005|Overall Study|Adverse Event|2|||
130453296|NCT01674569|469623543|FG000|Overall Study|Protocol Violation|0|||
130453297|NCT01674569|469623544|FG001|Overall Study|Protocol Violation|1|||
130453298|NCT01674569|469623545|FG002|Overall Study|Protocol Violation|1|||
130453299|NCT01674569|469623546|FG003|Overall Study|Protocol Violation|0|||
130453300|NCT01674569|469623547|FG004|Overall Study|Protocol Violation|0|||
130453301|NCT01674569|469623548|FG005|Overall Study|Protocol Violation|0|||
130554003|NCT01369511|469996477|FG000|Overall Study|Adverse Event|1|||
130266351|NCT00806260|468940645|FG000|Period 3|Protocol Violation|0|||
130266352|NCT00806260|468940646|FG001|Period 3|Protocol Violation|1|||
130266353|NCT00806260|468940647|FG002|Period 3|Protocol Violation|1|||
130266354|NCT00806260|468940648|FG003|Period 3|Protocol Violation|0|||
130266355|NCT00806260|468940649|FG004|Period 3|Protocol Violation|0|||
130266356|NCT00806260|468940650|FG005|Period 3|Protocol Violation|0|||
130266357|NCT00806260|468940645|FG000|Period 3|Pregnancy|1|||
130266358|NCT00806260|468940646|FG001|Period 3|Pregnancy|0|||
130453302|NCT01674569|469623543|FG000|Overall Study|Withdrawal by Subject|0|||
130266359|NCT00806260|468940647|FG002|Period 3|Pregnancy|0|||
130453303|NCT01674569|469623544|FG001|Overall Study|Withdrawal by Subject|0|||
130453304|NCT01674569|469623545|FG002|Overall Study|Withdrawal by Subject|1|||
130266360|NCT00806260|468940648|FG003|Period 3|Pregnancy|0|||
130266361|NCT00806260|468940649|FG004|Period 3|Pregnancy|0|||
130266362|NCT00806260|468940650|FG005|Period 3|Pregnancy|0|||
130266363|NCT00237042|468940653|FG000|Treatment|Became ineligible post-randomization|0|||
130266364|NCT00237042|468940654|FG001|Treatment|Became ineligible post-randomization|1|||
130266365|NCT00237042|468940655|FG002|Treatment|Became ineligible post-randomization|16|||
130266366|NCT00237042|468940653|FG000|Treatment|Moved out of state|1|||
130266367|NCT00237042|468940654|FG001|Treatment|Moved out of state|1|||
130266368|NCT00237042|468940655|FG002|Treatment|Moved out of state|1|||
130266369|NCT00237042|468940653|FG000|Treatment|Completed no treatment|5|||
130266370|NCT00237042|468940654|FG001|Treatment|Completed no treatment|5|||
130266371|NCT00237042|468940655|FG002|Treatment|Completed no treatment|21|||
130266372|NCT00237042|468940653|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
130266373|NCT00237042|468940654|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
130266374|NCT00237042|468940655|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
130266375|NCT00237042|468940653|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
130266376|NCT00237042|468940654|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130266377|NCT00237042|468940655|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130266378|NCT01897532|468940656|FG000|Discontinuation From Treatment|Not Treated|7|||
130266379|NCT01897532|468940657|FG001|Discontinuation From Treatment|Not Treated|5|||
130266380|NCT01897532|468940656|FG000|Discontinuation From Treatment|Other reason than specified|196|||
130266381|NCT01897532|468940657|FG001|Discontinuation From Treatment|Other reason than specified|176|||
130266382|NCT01897532|468940656|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
130266383|NCT01897532|468940657|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
130266384|NCT01897532|468940656|FG000|Discontinuation From Treatment|Non compliance|24|||
130266385|NCT01897532|468940657|FG001|Discontinuation From Treatment|Non compliance|15|||
130266386|NCT01897532|468940656|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
130266387|NCT01897532|468940657|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
130266388|NCT01897532|468940656|FG000|Discontinuation From Trial|Not Treated|7|||
130266389|NCT01897532|468940657|FG001|Discontinuation From Trial|Not Treated|5|||
130266390|NCT01897532|468940656|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
130266391|NCT01897532|468940657|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
130266392|NCT03132467|468940658|FG000|Overall Study|Adverse Event|2|||
130266393|NCT03132467|468940658|FG000|Overall Study|Withdrawal by Subject|2|||
130266394|NCT02670473|468940661|FG000|Overall Study|Withdrawal by Subject|1|||
130266395|NCT05223673|468940662|FG000|Overall Study|Protocol Violation|1|||
130266396|NCT05223673|468940662|FG000|Overall Study|Study termination|6|||
130266397|NCT03559270|468940663|FG000|Overall Study|Adverse Event|6|||
130266398|NCT03559270|468940664|FG001|Overall Study|Adverse Event|5|||
130266399|NCT03559270|468940665|FG002|Overall Study|Adverse Event|3|||
130266400|NCT03559270|468940666|FG003|Overall Study|Adverse Event|0|||
130266401|NCT03559270|468940663|FG000|Overall Study|Lack of Efficacy|34|||
130266402|NCT03559270|468940664|FG001|Overall Study|Lack of Efficacy|52|||
130266403|NCT03559270|468940665|FG002|Overall Study|Lack of Efficacy|37|||
130266404|NCT03559270|468940666|FG003|Overall Study|Lack of Efficacy|2|||
130266405|NCT03559270|468940663|FG000|Overall Study|Death|0|||
130266406|NCT03559270|468940664|FG001|Overall Study|Death|2|||
130266407|NCT03559270|468940665|FG002|Overall Study|Death|0|||
130266408|NCT03559270|468940666|FG003|Overall Study|Death|0|||
130266409|NCT03559270|468940663|FG000|Overall Study|Lost to Follow-up|16|||
130266410|NCT03559270|468940664|FG001|Overall Study|Lost to Follow-up|4|||
130266411|NCT03559270|468940665|FG002|Overall Study|Lost to Follow-up|12|||
130266412|NCT03559270|468940666|FG003|Overall Study|Lost to Follow-up|3|||
130266413|NCT03559270|468940663|FG000|Overall Study|Sponsor Decision|38|||
130266414|NCT03559270|468940664|FG001|Overall Study|Sponsor Decision|31|||
130266415|NCT03559270|468940665|FG002|Overall Study|Sponsor Decision|35|||
130266416|NCT03559270|468940666|FG003|Overall Study|Sponsor Decision|18|||
130266417|NCT03559270|468940663|FG000|Overall Study|Withdrawal by Subject|19|||
130266418|NCT03559270|468940664|FG001|Overall Study|Withdrawal by Subject|21|||
130266419|NCT03559270|468940665|FG002|Overall Study|Withdrawal by Subject|18|||
130266420|NCT03559270|468940666|FG003|Overall Study|Withdrawal by Subject|7|||
130266421|NCT03559270|468940663|FG000|Overall Study|Physician Decision|3|||
130266422|NCT03559270|468940664|FG001|Overall Study|Physician Decision|2|||
130266423|NCT03559270|468940665|FG002|Overall Study|Physician Decision|1|||
130266424|NCT03559270|468940666|FG003|Overall Study|Physician Decision|0|||
130266425|NCT03559270|468940663|FG000|Overall Study|Pregnancy|0|||
130266426|NCT03559270|468940664|FG001|Overall Study|Pregnancy|1|||
130266427|NCT03559270|468940665|FG002|Overall Study|Pregnancy|0|||
130266428|NCT03559270|468940666|FG003|Overall Study|Pregnancy|0|||
130266429|NCT03559270|468940663|FG000|Overall Study|Protocol Violation|1|||
130266430|NCT03559270|468940664|FG001|Overall Study|Protocol Violation|0|||
130266431|NCT03559270|468940665|FG002|Overall Study|Protocol Violation|2|||
130266432|NCT03559270|468940666|FG003|Overall Study|Protocol Violation|0|||
130266433|NCT04472650|468942649|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
130266434|NCT04472650|468942650|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
130266435|NCT01669902|468942655|FG000|Overall Study|Adverse Event|11|||
130266436|NCT01669902|468942655|FG000|Overall Study|Lack of Efficacy|10|||
130554004|NCT01369511|469996478|FG001|Overall Study|Adverse Event|1|||
130266437|NCT01669902|468942655|FG000|Overall Study|Other|8|||
130266438|NCT01535287|468942658|FG000|Overall Study|drug not prepared in time|5|||
130266439|NCT01535287|468942659|FG001|Overall Study|drug not prepared in time|6|||
130266440|NCT00551031|468942662|FG000|Overall Study|Adverse Event|0|||
130266441|NCT00551031|468942663|FG001|Overall Study|Adverse Event|1|||
130266442|NCT00551031|468942664|FG002|Overall Study|Adverse Event|0|||
130266443|NCT00551031|468942665|FG003|Overall Study|Adverse Event|0|||
130266444|NCT00551031|468942666|FG004|Overall Study|Adverse Event|0|||
130266445|NCT00551031|468942662|FG000|Overall Study|Protocol Violation|1|||
130266446|NCT00551031|468942663|FG001|Overall Study|Protocol Violation|1|||
130266447|NCT00551031|468942664|FG002|Overall Study|Protocol Violation|0|||
130266448|NCT00551031|468942665|FG003|Overall Study|Protocol Violation|0|||
130266449|NCT00551031|468942666|FG004|Overall Study|Protocol Violation|0|||
130266450|NCT00551031|468942662|FG000|Overall Study|Lost to Follow-up|0|||
130266451|NCT00551031|468942663|FG001|Overall Study|Lost to Follow-up|1|||
130266452|NCT00551031|468942664|FG002|Overall Study|Lost to Follow-up|0|||
130266453|NCT00551031|468942665|FG003|Overall Study|Lost to Follow-up|1|||
130266454|NCT00551031|468942666|FG004|Overall Study|Lost to Follow-up|1|||
130266455|NCT00551031|468942662|FG000|Overall Study|Withdrawal by Subject|0|||
130266456|NCT00551031|468942663|FG001|Overall Study|Withdrawal by Subject|4|||
130266457|NCT00551031|468942664|FG002|Overall Study|Withdrawal by Subject|1|||
130266458|NCT00551031|468942665|FG003|Overall Study|Withdrawal by Subject|2|||
130266459|NCT00551031|468942666|FG004|Overall Study|Withdrawal by Subject|0|||
130266460|NCT00551031|468942662|FG000|Overall Study|Serious Adverse Event|0|||
130266461|NCT00551031|468942663|FG001|Overall Study|Serious Adverse Event|2|||
130266462|NCT00551031|468942664|FG002|Overall Study|Serious Adverse Event|1|||
130266463|NCT00551031|468942665|FG003|Overall Study|Serious Adverse Event|0|||
130266464|NCT00551031|468942666|FG004|Overall Study|Serious Adverse Event|0|||
130266465|NCT00551031|468942662|FG000|Overall Study|Did not receive vaccine|1|||
130266466|NCT00551031|468942663|FG001|Overall Study|Did not receive vaccine|2|||
130266467|NCT00551031|468942664|FG002|Overall Study|Did not receive vaccine|0|||
130266468|NCT00551031|468942665|FG003|Overall Study|Did not receive vaccine|0|||
130266469|NCT00551031|468942666|FG004|Overall Study|Did not receive vaccine|0|||
130266470|NCT04567524|468942667|FG000|Overall Study|Adverse Event|1|||
130266471|NCT04567524|468942668|FG001|Overall Study|Adverse Event|1|||
130266472|NCT04567524|468942669|FG002|Overall Study|Adverse Event|0|||
130266473|NCT04567524|468942670|FG003|Overall Study|Adverse Event|0|||
130266474|NCT04567524|468942667|FG000|Overall Study|Withdrawal by Subject|2|||
130266475|NCT04567524|468942668|FG001|Overall Study|Withdrawal by Subject|0|||
130266476|NCT04567524|468942669|FG002|Overall Study|Withdrawal by Subject|0|||
130266477|NCT04567524|468942670|FG003|Overall Study|Withdrawal by Subject|1|||
130266478|NCT02078752|468942680|FG000|Overall Study|Death|0|||
130266479|NCT02078752|468942681|FG001|Overall Study|Death|3|||
130266480|NCT02078752|468942682|FG002|Overall Study|Death|0|||
130266481|NCT02078752|468942683|FG003|Overall Study|Death|0|||
130266482|NCT02078752|468942684|FG004|Overall Study|Death|0|||
130266483|NCT02078752|468942685|FG005|Overall Study|Death|1|||
130266484|NCT02078752|468942686|FG006|Overall Study|Death|0|||
130266485|NCT02078752|468942687|FG007|Overall Study|Death|1|||
130266486|NCT02078752|468942688|FG008|Overall Study|Death|0|||
130266487|NCT02078752|468942689|FG009|Overall Study|Death|4|||
130266488|NCT02078752|468942680|FG000|Overall Study|Lost to Follow-up|1|||
130266489|NCT02078752|468942681|FG001|Overall Study|Lost to Follow-up|0|||
130266490|NCT02078752|468942682|FG002|Overall Study|Lost to Follow-up|0|||
130266491|NCT02078752|468942683|FG003|Overall Study|Lost to Follow-up|1|||
130266492|NCT02078752|468942684|FG004|Overall Study|Lost to Follow-up|0|||
130266493|NCT02078752|468942685|FG005|Overall Study|Lost to Follow-up|0|||
130266494|NCT02078752|468942686|FG006|Overall Study|Lost to Follow-up|0|||
130266495|NCT02078752|468942687|FG007|Overall Study|Lost to Follow-up|0|||
130266496|NCT02078752|468942688|FG008|Overall Study|Lost to Follow-up|0|||
130266497|NCT02078752|468942689|FG009|Overall Study|Lost to Follow-up|0|||
130266498|NCT02078752|468942680|FG000|Overall Study|Withdrawal by Subject|1|||
130266499|NCT02078752|468942681|FG001|Overall Study|Withdrawal by Subject|1|||
130266500|NCT02078752|468942682|FG002|Overall Study|Withdrawal by Subject|1|||
130266501|NCT02078752|468942683|FG003|Overall Study|Withdrawal by Subject|1|||
130266502|NCT02078752|468942684|FG004|Overall Study|Withdrawal by Subject|0|||
130266503|NCT02078752|468942685|FG005|Overall Study|Withdrawal by Subject|3|||
130266504|NCT02078752|468942686|FG006|Overall Study|Withdrawal by Subject|2|||
130365724|NCT02609828|469308552|FG001|Overall Study|Other|0|||
130365725|NCT02609828|469308553|FG002|Overall Study|Other|0|||
130365726|NCT02609828|469308554|FG003|Overall Study|Other|6|||
130365727|NCT02609828|469308551|FG000|Overall Study|Randomized but not treated|1|||
130365728|NCT02609828|469308552|FG001|Overall Study|Randomized but not treated|0|||
130365729|NCT02609828|469308553|FG002|Overall Study|Randomized but not treated|0|||
130365730|NCT02609828|469308554|FG003|Overall Study|Randomized but not treated|0|||
130365731|NCT03758066|469308555|FG000|Overall Study|Lost to Follow-up|14|||
130365732|NCT00762385|469308558|FG000|First Intervention|Lens Issue|1|||
130365733|NCT00762385|469308559|FG001|First Intervention|Lens Issue|1|||
130365734|NCT00762385|469308558|FG000|First Intervention|Lost to Follow-up|0|||
130365735|NCT00762385|469308559|FG001|First Intervention|Lost to Follow-up|2|||
130365736|NCT00762385|469308558|FG000|First Intervention|Ineligible|1|||
130365737|NCT00762385|469308559|FG001|First Intervention|Ineligible|0|||
130365738|NCT00762385|469308558|FG000|First Intervention|Protocol Violation|0|||
130365739|NCT00762385|469308559|FG001|First Intervention|Protocol Violation|1|||
130365740|NCT00762385|469308558|FG000|Second Intervention|Protocol Violation|3|||
130365741|NCT00762385|469308559|FG001|Second Intervention|Protocol Violation|3|||
130365742|NCT01540838|469308560|FG000|Overall Study|Open nasogastric tube|9|||
130365743|NCT01540838|469308561|FG001|Overall Study|Open nasogastric tube|7|||
130365744|NCT01540838|469308560|FG000|Overall Study|Treatment doses missing|8|||
130365745|NCT01540838|469308561|FG001|Overall Study|Treatment doses missing|12|||
130365746|NCT01540838|469308560|FG000|Overall Study|Additional antibiotic treatment|1|||
130365747|NCT01540838|469308561|FG001|Overall Study|Additional antibiotic treatment|2|||
130365748|NCT01540838|469308560|FG000|Overall Study|Died before treatment initiation|1|||
130365749|NCT01540838|469308561|FG001|Overall Study|Died before treatment initiation|1|||
130365750|NCT01540838|469308560|FG000|Overall Study|Not BM. Other treatment|3|||
130365751|NCT01540838|469308561|FG001|Overall Study|Not BM. Other treatment|1|||
130365752|NCT04891978|469308562|FG000|Baseline|Protocol Violation|2|||
130365753|NCT04891978|469308563|FG001|Baseline|Protocol Violation|1|||
130365754|NCT04891978|469308564|FG002|Baseline|Protocol Violation|0|||
130365755|NCT04891978|469308562|FG000|Baseline|Missing AIRQ|1|||
130365756|NCT04891978|469308563|FG001|Baseline|Missing AIRQ|0|||
130365757|NCT04891978|469308564|FG002|Baseline|Missing AIRQ|0|||
130365758|NCT04891978|469308562|FG000|Baseline|Did not attend a baseline visit|0|||
130365759|NCT04891978|469308563|FG001|Baseline|Did not attend a baseline visit|0|||
130365760|NCT04891978|469308564|FG002|Baseline|Did not attend a baseline visit|9|||
130365761|NCT03641339|469308565|FG000|Overall Study|Physician Decision|1|||
130365762|NCT03641339|469308566|FG001|Overall Study|Physician Decision|0|||
130365763|NCT03641339|469308567|FG002|Overall Study|Physician Decision|0|||
130365764|NCT03641339|469308568|FG003|Overall Study|Physician Decision|0|||
130365765|NCT03641339|469308569|FG004|Overall Study|Physician Decision|0|||
130365766|NCT03641339|469308570|FG005|Overall Study|Physician Decision|0|||
130365767|NCT03641339|469308565|FG000|Overall Study|Withdrawal by Subject|0|||
130365768|NCT03641339|469308566|FG001|Overall Study|Withdrawal by Subject|2|||
130365769|NCT03641339|469308567|FG002|Overall Study|Withdrawal by Subject|0|||
130365770|NCT03641339|469308568|FG003|Overall Study|Withdrawal by Subject|2|||
130365771|NCT03641339|469308569|FG004|Overall Study|Withdrawal by Subject|0|||
130365772|NCT03641339|469308570|FG005|Overall Study|Withdrawal by Subject|1|||
130365773|NCT03863197|469308571|FG000|Overall Study|Lost to Follow-up|2|||
130365774|NCT03863197|469308572|FG001|Overall Study|Lost to Follow-up|3|||
130365775|NCT03863197|469308571|FG000|Overall Study|Withdrawal by Subject|4|||
130365776|NCT03863197|469308572|FG001|Overall Study|Withdrawal by Subject|0|||
130365777|NCT03863197|469308571|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
130365778|NCT03863197|469308572|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
130365779|NCT05338216|469308573|FG000|Overall Study|Withdrawal by Subject|1|||
130365780|NCT05338216|469308574|FG001|Overall Study|Withdrawal by Subject|1|||
130365781|NCT01065597|469308575|FG000|Overall Study|Adverse Event|1|||
130365782|NCT00413244|469308578|FG000|Overall Study|Withdrawal by Subject|10|||
130365783|NCT00413244|469308579|FG001|Overall Study|Withdrawal by Subject|1|||
130365784|NCT00446251|469308580|FG000|Overall Study|On-study Transplants|2|||
130365785|NCT00446251|469308580|FG000|Overall Study|Rituximab Infusion Reaction|2|||
130704423|NCT04126343|470541271|FG003|Overall Study|Related to COVID-19 pandemic|3|||
130704424|NCT04126343|470541272|FG004|Overall Study|Related to COVID-19 pandemic|3|||
130704425|NCT04126343|470541273|FG005|Overall Study|Related to COVID-19 pandemic|3|||
130365786|NCT00446251|469308580|FG000|Overall Study|Lost to Follow-up|1|||
130365787|NCT02264639|469308582|FG000|Overall Study|Death (after completing single-dose phase)|1|||
130365788|NCT02264639|469308583|FG001|Overall Study|Death (after completing single-dose phase)|0|||
130365789|NCT02264639|469308584|FG002|Overall Study|Death (after completing single-dose phase)|0|||
130365790|NCT02264639|469308585|FG003|Overall Study|Death (after completing single-dose phase)|0|||
130365791|NCT02264639|469308586|FG004|Overall Study|Death (after completing single-dose phase)|0|||
130365792|NCT02264639|469308582|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
130365793|NCT02264639|469308583|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130554005|NCT01369511|469996479|FG002|Overall Study|Adverse Event|5|||
130266505|NCT02078752|468942687|FG007|Overall Study|Withdrawal by Subject|1|||
130266506|NCT02078752|468942688|FG008|Overall Study|Withdrawal by Subject|0|||
130266507|NCT02078752|468942689|FG009|Overall Study|Withdrawal by Subject|1|||
130266508|NCT02078752|468942680|FG000|Overall Study|Other|0|||
130266509|NCT02078752|468942681|FG001|Overall Study|Other|3|||
130266510|NCT02078752|468942682|FG002|Overall Study|Other|0|||
130266511|NCT02078752|468942683|FG003|Overall Study|Other|0|||
130266512|NCT02078752|468942684|FG004|Overall Study|Other|1|||
130266513|NCT02078752|468942685|FG005|Overall Study|Other|0|||
130266514|NCT02078752|468942686|FG006|Overall Study|Other|0|||
130266515|NCT02078752|468942687|FG007|Overall Study|Other|1|||
130266516|NCT02078752|468942688|FG008|Overall Study|Other|0|||
130266517|NCT02078752|468942689|FG009|Overall Study|Other|0|||
130266518|NCT02078752|468942680|FG000|Overall Study|Study terminated by sponsor|0|||
130266519|NCT02078752|468942681|FG001|Overall Study|Study terminated by sponsor|0|||
130266520|NCT02078752|468942682|FG002|Overall Study|Study terminated by sponsor|0|||
130266521|NCT02078752|468942683|FG003|Overall Study|Study terminated by sponsor|0|||
130266522|NCT02078752|468942684|FG004|Overall Study|Study terminated by sponsor|0|||
130266523|NCT02078752|468942685|FG005|Overall Study|Study terminated by sponsor|0|||
130266524|NCT02078752|468942686|FG006|Overall Study|Study terminated by sponsor|0|||
130266525|NCT02078752|468942687|FG007|Overall Study|Study terminated by sponsor|0|||
130266526|NCT02078752|468942688|FG008|Overall Study|Study terminated by sponsor|0|||
130266527|NCT02078752|468942689|FG009|Overall Study|Study terminated by sponsor|5|||
130266528|NCT00616642|468942695|FG000|Overall Study|Withdrawal by Subject|0|||
130266529|NCT00616642|468942696|FG001|Overall Study|Withdrawal by Subject|1|||
130266530|NCT01023217|468942705|FG000|Overall Study|Withdrawal by Subject|1|||
130266531|NCT01023217|468942706|FG001|Overall Study|Withdrawal by Subject|0|||
130266532|NCT00589797|468942707|FG000|Overall Study|Death|1|||
130266533|NCT00589797|468942708|FG001|Overall Study|Death|0|||
130266534|NCT00589797|468942707|FG000|Overall Study|Lost to Follow-up|12|||
130266535|NCT00589797|468942708|FG001|Overall Study|Lost to Follow-up|9|||
130266536|NCT00589797|468942707|FG000|Overall Study|Physician Decision|8|||
130266537|NCT00589797|468942708|FG001|Overall Study|Physician Decision|3|||
130266538|NCT00589797|468942707|FG000|Overall Study|Withdrawal by Subject|6|||
130266539|NCT00589797|468942708|FG001|Overall Study|Withdrawal by Subject|5|||
130266540|NCT00589797|468942707|FG000|Overall Study|Non-Randomized Training Subjects|46|||
130266541|NCT00589797|468942708|FG001|Overall Study|Non-Randomized Training Subjects|6|||
130266542|NCT01881009|468942709|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
130266543|NCT01881009|468942710|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
130266544|NCT02457247|468942711|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
130266545|NCT02457247|468942712|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
130266546|NCT02457247|468942713|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
130266547|NCT02457247|468942714|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
130266548|NCT02457247|468942711|FG000|Period 1|Significant Protocol Deviation|1|||
130266549|NCT02457247|468942712|FG001|Period 1|Significant Protocol Deviation|1|||
130266550|NCT02457247|468942713|FG002|Period 1|Significant Protocol Deviation|0|||
130266551|NCT02457247|468942714|FG003|Period 1|Significant Protocol Deviation|0|||
130266552|NCT02457247|468942711|FG000|Period 1|Voluntary Withdrawal|1|||
130266553|NCT02457247|468942712|FG001|Period 1|Voluntary Withdrawal|0|||
130266554|NCT02457247|468942713|FG002|Period 1|Voluntary Withdrawal|0|||
130266555|NCT02457247|468942714|FG003|Period 1|Voluntary Withdrawal|0|||
130266556|NCT02457247|468942711|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
130266557|NCT02457247|468942712|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
130266558|NCT02457247|468942713|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
130266559|NCT02457247|468942714|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
130266560|NCT02457247|468942711|FG000|Period 2|Significant Protocol Deviation|1|||
130266561|NCT02457247|468942712|FG001|Period 2|Significant Protocol Deviation|0|||
130266562|NCT02457247|468942713|FG002|Period 2|Significant Protocol Deviation|0|||
130266563|NCT02457247|468942714|FG003|Period 2|Significant Protocol Deviation|0|||
130266564|NCT02457247|468942711|FG000|Period 2|Lost to Follow-up|0|||
130266565|NCT02457247|468942712|FG001|Period 2|Lost to Follow-up|1|||
130266566|NCT02457247|468942713|FG002|Period 2|Lost to Follow-up|0|||
130704426|NCT00084799|470541274|FG000|Overall Study|Disease Progression|1|||
130266567|NCT02457247|468942714|FG003|Period 2|Lost to Follow-up|0|||
130266568|NCT02457247|468942711|FG000|Period 2|Voluntary Withdrawal|1|||
130266569|NCT02457247|468942712|FG001|Period 2|Voluntary Withdrawal|1|||
130266570|NCT02457247|468942713|FG002|Period 2|Voluntary Withdrawal|0|||
130266571|NCT02457247|468942714|FG003|Period 2|Voluntary Withdrawal|0|||
130266572|NCT01061385|468942715|FG000|Overall Study|Lost to Follow-up|1|||
130266573|NCT01061385|468942716|FG001|Overall Study|Lost to Follow-up|0|||
130704427|NCT00084799|470541275|FG001|Overall Study|Disease Progression|0|||
130554006|NCT01369511|469996480|FG003|Overall Study|Adverse Event|0|||
130266574|NCT01061385|468942715|FG000|Overall Study|subject decision not related to AE|0|||
130266575|NCT01061385|468942716|FG001|Overall Study|subject decision not related to AE|1|||
130704428|NCT01235442|470541276|FG000|Overall Study|Lost to Follow-up|12|||
130266576|NCT01492088|468942717|FG000|Overall Study|Withdrawal by Patient|0|||
130266577|NCT01492088|468942718|FG001|Overall Study|Withdrawal by Patient|2|||
130266578|NCT01492088|468942719|FG002|Overall Study|Withdrawal by Patient|0|||
130266579|NCT01492088|468942717|FG000|Overall Study|Death|1|||
130266580|NCT01492088|468942718|FG001|Overall Study|Death|6|||
130266581|NCT01492088|468942719|FG002|Overall Study|Death|2|||
130266582|NCT01492088|468942717|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
130266583|NCT01492088|468942718|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
130266584|NCT01492088|468942719|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
130266585|NCT01492088|468942717|FG000|Overall Study|Alive at Last Follow-up|0|||
130266586|NCT01492088|468942718|FG001|Overall Study|Alive at Last Follow-up|6|||
130266587|NCT01492088|468942719|FG002|Overall Study|Alive at Last Follow-up|11|||
130266588|NCT00533429|468942720|FG000|Overall Study|Adverse Event|3|||
130266589|NCT00533429|468942721|FG001|Overall Study|Adverse Event|1|||
130266590|NCT00533429|468942720|FG000|Overall Study|Death|1|||
130266591|NCT00533429|468942721|FG001|Overall Study|Death|0|||
130266592|NCT00533429|468942720|FG000|Overall Study|Withdrawal by Subject|2|||
130266593|NCT00533429|468942721|FG001|Overall Study|Withdrawal by Subject|0|||
130266594|NCT00533429|468942720|FG000|Overall Study|Progressive Disease|12|||
130266595|NCT00533429|468942721|FG001|Overall Study|Progressive Disease|13|||
130266596|NCT00533429|468942720|FG000|Overall Study|Symptomatic deterioration|1|||
130266597|NCT00533429|468942721|FG001|Overall Study|Symptomatic deterioration|2|||
130266598|NCT01464879|468942722|FG000|Overall Study|Physician Decision|1|||
130266599|NCT01464879|468942722|FG000|Overall Study|Non-compliance|1|||
130266600|NCT03824392|468942729|FG000|Overall Study|Adverse Event|1|||
130266601|NCT03824392|468942730|FG001|Overall Study|Adverse Event|0|||
130266602|NCT03824392|468942731|FG002|Overall Study|Adverse Event|0|||
130266603|NCT03824392|468942732|FG003|Overall Study|Adverse Event|0|||
130266604|NCT03824392|468942729|FG000|Overall Study|Investigator Decision|0|||
130266605|NCT03824392|468942730|FG001|Overall Study|Investigator Decision|1|||
130266606|NCT03824392|468942731|FG002|Overall Study|Investigator Decision|0|||
130266607|NCT03824392|468942732|FG003|Overall Study|Investigator Decision|0|||
130266608|NCT03824392|468942729|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
130266609|NCT03824392|468942730|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130266610|NCT03824392|468942731|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
130266611|NCT03824392|468942732|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130266612|NCT02230189|468942733|FG000|Overall Study|Withdrawal by Subject|3|||
130266613|NCT02230189|468942734|FG001|Overall Study|Withdrawal by Subject|0|||
130266614|NCT02230189|468942735|FG002|Overall Study|Withdrawal by Subject|1|||
130266615|NCT02230189|468942733|FG000|Overall Study|Lost to Follow-up|1|||
130266616|NCT02230189|468942734|FG001|Overall Study|Lost to Follow-up|0|||
130266617|NCT02230189|468942735|FG002|Overall Study|Lost to Follow-up|0|||
130266618|NCT02230189|468942733|FG000|Overall Study|Physician Decision|1|||
130266619|NCT02230189|468942734|FG001|Overall Study|Physician Decision|0|||
130266620|NCT02230189|468942735|FG002|Overall Study|Physician Decision|0|||
130266621|NCT01887717|468942736|FG000|Overall Study|Withdrawal by Subject|1|||
130266622|NCT01887717|468942737|FG001|Overall Study|Withdrawal by Subject|7|||
130266623|NCT01887717|468942736|FG000|Overall Study|Physician Decision|0|||
130266624|NCT01887717|468942737|FG001|Overall Study|Physician Decision|2|||
130266625|NCT01887717|468942736|FG000|Overall Study|Administrative reasons|5|||
130266626|NCT01887717|468942737|FG001|Overall Study|Administrative reasons|2|||
130266627|NCT00244621|468942738|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130266628|NCT00244621|468942739|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130266629|NCT00244621|468942740|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130266630|NCT00244621|468942738|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130266631|NCT00244621|468942739|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130266632|NCT00244621|468942740|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130266633|NCT00244621|468942738|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130266634|NCT00244621|468942739|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130266635|NCT00244621|468942740|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130266636|NCT00244621|468942738|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
130266637|NCT00244621|468942739|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
130266638|NCT00244621|468942740|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
130266639|NCT00244621|468942738|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130266640|NCT00244621|468942739|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130266641|NCT00244621|468942740|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130266642|NCT00244621|468942738|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130266643|NCT00244621|468942739|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130554007|NCT01369511|469996477|FG000|Overall Study|Entry criteria not met|2|||
130266644|NCT00244621|468942740|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130266645|NCT00244621|468942738|FG000|Open-label Treatment Period|Adverse Event|0|||
130266646|NCT00244621|468942739|FG001|Open-label Treatment Period|Adverse Event|0|||
130266647|NCT00244621|468942740|FG002|Open-label Treatment Period|Adverse Event|1|||
130266648|NCT00244621|468942738|FG000|Open-label Treatment Period|Moved abroad|0|||
130266649|NCT00244621|468942739|FG001|Open-label Treatment Period|Moved abroad|0|||
130266650|NCT00244621|468942740|FG002|Open-label Treatment Period|Moved abroad|1|||
130704429|NCT01235442|470541277|FG001|Overall Study|Lost to Follow-up|10|||
130266651|NCT02834819|468942741|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
130266652|NCT02834819|468942742|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
130266653|NCT04389866|468942745|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130266654|NCT04389866|468942746|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130266655|NCT01490918|468942749|FG000|Overall Study|Lost to Follow-up|2|||
130266656|NCT01490918|468942750|FG001|Overall Study|Lost to Follow-up|1|||
130266657|NCT01490918|468942751|FG002|Overall Study|Lost to Follow-up|0|||
130266658|NCT01490918|468942749|FG000|Overall Study|Withdrawal by Subject|7|||
130266659|NCT01490918|468942750|FG001|Overall Study|Withdrawal by Subject|8|||
130266660|NCT01490918|468942751|FG002|Overall Study|Withdrawal by Subject|3|||
130266661|NCT01490918|468942749|FG000|Overall Study|Adverse Event|0|||
130266662|NCT01490918|468942750|FG001|Overall Study|Adverse Event|0|||
130266663|NCT01490918|468942751|FG002|Overall Study|Adverse Event|1|||
130266664|NCT01490918|468942749|FG000|Overall Study|other cause|4|||
130266665|NCT01490918|468942750|FG001|Overall Study|other cause|5|||
130266666|NCT01490918|468942751|FG002|Overall Study|other cause|8|||
130266667|NCT02967679|468942754|FG000|Overall Study|Adverse Event|1|||
130704430|NCT01235442|470541276|FG000|Overall Study|Death|0|||
130704431|NCT01235442|470541277|FG001|Overall Study|Death|2|||
130266668|NCT00003631|468942757|FG000|Overall Study|Patient not treated|1|||
130266669|NCT00003631|468942758|FG001|Overall Study|Patient not treated|0|||
130266670|NCT00003631|468942759|FG002|Overall Study|Patient not treated|1|||
130266671|NCT00003631|468942757|FG000|Overall Study|Protocol Violation|1|||
130266672|NCT00003631|468942758|FG001|Overall Study|Protocol Violation|0|||
130266673|NCT00003631|468942759|FG002|Overall Study|Protocol Violation|0|||
130266674|NCT00003631|468942757|FG000|Overall Study|Adverse Event|1|||
130266675|NCT00003631|468942758|FG001|Overall Study|Adverse Event|1|||
130266676|NCT00003631|468942759|FG002|Overall Study|Adverse Event|5|||
130266677|NCT00003631|468942757|FG000|Overall Study|Death|0|||
130266678|NCT00003631|468942758|FG001|Overall Study|Death|0|||
130266679|NCT00003631|468942759|FG002|Overall Study|Death|1|||
130266680|NCT00003631|468942757|FG000|Overall Study|Evaluable for toxicity only|0|||
130266681|NCT00003631|468942758|FG001|Overall Study|Evaluable for toxicity only|0|||
130266682|NCT00003631|468942759|FG002|Overall Study|Evaluable for toxicity only|2|||
130266683|NCT00600067|468942760|FG000|Overall Study|Adverse Event|0|||
130266684|NCT00600067|468942761|FG001|Overall Study|Adverse Event|1|||
130266685|NCT00600067|468942760|FG000|Overall Study|Lost to Follow-up|2|||
130266686|NCT00600067|468942761|FG001|Overall Study|Lost to Follow-up|3|||
130266687|NCT00600067|468942760|FG000|Overall Study|protocol non-compliance|0|||
130266688|NCT00600067|468942761|FG001|Overall Study|protocol non-compliance|3|||
130266689|NCT00600067|468942760|FG000|Overall Study|Lack of Efficacy|1|||
130266690|NCT00600067|468942761|FG001|Overall Study|Lack of Efficacy|0|||
130266691|NCT04339413|468942764|FG000|Overall Study|Reason Not Specified|2|||
130266692|NCT04339413|468942765|FG001|Overall Study|Reason Not Specified|7|||
130266693|NCT04339413|468942764|FG000|Overall Study|Study Terminated by Sponsor|30|||
130266694|NCT04339413|468942765|FG001|Overall Study|Study Terminated by Sponsor|33|||
130266695|NCT04339413|468942764|FG000|Overall Study|Progressive Disease|9|||
130266696|NCT04339413|468942765|FG001|Overall Study|Progressive Disease|6|||
130266697|NCT04339413|468942764|FG000|Overall Study|Withdrawal by Subject|9|||
130266698|NCT04339413|468942765|FG001|Overall Study|Withdrawal by Subject|10|||
130266699|NCT04339413|468942764|FG000|Overall Study|Physician Decision|3|||
130266700|NCT04339413|468942765|FG001|Overall Study|Physician Decision|1|||
130266701|NCT04339413|468942764|FG000|Overall Study|Death|2|||
130266702|NCT04339413|468942765|FG001|Overall Study|Death|0|||
130266703|NCT04339413|468942764|FG000|Overall Study|Adverse Event|3|||
130266704|NCT04339413|468942765|FG001|Overall Study|Adverse Event|0|||
130266705|NCT00251693|468942771|FG000|Overall Study|Adverse Event|17|||
130266706|NCT00251693|468942772|FG001|Overall Study|Adverse Event|9|||
130266707|NCT00251693|468942773|FG002|Overall Study|Adverse Event|9|||
130266708|NCT00251693|468942771|FG000|Overall Study|Protocol Violation|2|||
130266709|NCT00251693|468942772|FG001|Overall Study|Protocol Violation|0|||
130266710|NCT00251693|468942773|FG002|Overall Study|Protocol Violation|2|||
130266711|NCT00251693|468942771|FG000|Overall Study|Lost to Follow-up|12|||
130266712|NCT00251693|468942772|FG001|Overall Study|Lost to Follow-up|7|||
130266713|NCT00251693|468942773|FG002|Overall Study|Lost to Follow-up|8|||
130266714|NCT00251693|468942771|FG000|Overall Study|Withdrawal by Subject|11|||
130266715|NCT00251693|468942772|FG001|Overall Study|Withdrawal by Subject|17|||
130266716|NCT00251693|468942773|FG002|Overall Study|Withdrawal by Subject|14|||
130266717|NCT00251693|468942771|FG000|Overall Study|Lack of Efficacy|0|||
130266718|NCT00251693|468942772|FG001|Overall Study|Lack of Efficacy|1|||
130266719|NCT00251693|468942773|FG002|Overall Study|Lack of Efficacy|0|||
130266720|NCT00251693|468942771|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
130266721|NCT00251693|468942772|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130266722|NCT00251693|468942773|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
130266723|NCT00251693|468942771|FG000|Overall Study|Noncompliant|0|||
130266724|NCT00251693|468942772|FG001|Overall Study|Noncompliant|0|||
130266725|NCT00251693|468942773|FG002|Overall Study|Noncompliant|2|||
130266726|NCT00251693|468942771|FG000|Overall Study|Possible Barrett's esophagus|3|||
130704432|NCT01235442|470541276|FG000|Overall Study|Pregnancy|1|||
130266727|NCT00251693|468942772|FG001|Overall Study|Possible Barrett's esophagus|5|||
130266728|NCT00251693|468942773|FG002|Overall Study|Possible Barrett's esophagus|2|||
130266729|NCT00251693|468942771|FG000|Overall Study|Subject request/subject unavailable|1|||
130266730|NCT00251693|468942772|FG001|Overall Study|Subject request/subject unavailable|2|||
130266731|NCT00251693|468942773|FG002|Overall Study|Subject request/subject unavailable|0|||
130266732|NCT00251693|468942771|FG000|Overall Study|Abnormal laboratory findings|0|||
130266733|NCT00251693|468942772|FG001|Overall Study|Abnormal laboratory findings|0|||
130266734|NCT00251693|468942773|FG002|Overall Study|Abnormal laboratory findings|1|||
130266735|NCT01284959|468942774|FG000|Overall Study|Withdrawal by Subject|1|||
130266736|NCT01284959|468942775|FG001|Overall Study|Withdrawal by Subject|0|||
130266737|NCT01284959|468942776|FG002|Overall Study|Withdrawal by Subject|0|||
130266738|NCT01284959|468942774|FG000|Overall Study|Adverse Event|0|||
130266739|NCT01284959|468942775|FG001|Overall Study|Adverse Event|0|||
130266740|NCT01284959|468942776|FG002|Overall Study|Adverse Event|1|||
130266741|NCT00401843|468942777|FG000|Overall Study|Achieved Complete Response|1|||
130266742|NCT00401843|468942778|FG001|Overall Study|Achieved Complete Response|5|||
130266743|NCT00401843|468942779|FG002|Overall Study|Achieved Complete Response|11|||
130266744|NCT00401843|468942777|FG000|Overall Study|Adverse Event|7|||
130266745|NCT00401843|468942778|FG001|Overall Study|Adverse Event|26|||
130266746|NCT00401843|468942779|FG002|Overall Study|Adverse Event|27|||
130266747|NCT00401843|468942777|FG000|Overall Study|Death|0|||
130266748|NCT00401843|468942778|FG001|Overall Study|Death|8|||
130266749|NCT00401843|468942779|FG002|Overall Study|Death|10|||
130266750|NCT00401843|468942777|FG000|Overall Study|Disease progression|10|||
130266751|NCT00401843|468942778|FG001|Overall Study|Disease progression|60|||
130266752|NCT00401843|468942779|FG002|Overall Study|Disease progression|49|||
130266753|NCT00401843|468942777|FG000|Overall Study|End of Study|1|||
130266754|NCT00401843|468942778|FG001|Overall Study|End of Study|1|||
130266755|NCT00401843|468942779|FG002|Overall Study|End of Study|2|||
130266756|NCT00401843|468942777|FG000|Overall Study|Lost to Follow-up|0|||
130266757|NCT00401843|468942778|FG001|Overall Study|Lost to Follow-up|0|||
130266758|NCT00401843|468942779|FG002|Overall Study|Lost to Follow-up|2|||
130266759|NCT00401843|468942777|FG000|Overall Study|Other Unspecified|0|||
130266760|NCT00401843|468942778|FG001|Overall Study|Other Unspecified|3|||
130266761|NCT00401843|468942779|FG002|Overall Study|Other Unspecified|5|||
130266762|NCT00401843|468942777|FG000|Overall Study|Physician Decision|0|||
130266763|NCT00401843|468942778|FG001|Overall Study|Physician Decision|16|||
130266764|NCT00401843|468942779|FG002|Overall Study|Physician Decision|10|||
130266765|NCT00401843|468942777|FG000|Overall Study|Protocol Violation|0|||
130266766|NCT00401843|468942778|FG001|Overall Study|Protocol Violation|0|||
130266767|NCT00401843|468942779|FG002|Overall Study|Protocol Violation|1|||
130266768|NCT00401843|468942777|FG000|Overall Study|Withdrawal by Subject|1|||
130266769|NCT00401843|468942778|FG001|Overall Study|Withdrawal by Subject|5|||
130266770|NCT00401843|468942779|FG002|Overall Study|Withdrawal by Subject|5|||
130266771|NCT00401843|468942777|FG000|Overall Study|Withdrawal of consent to study agent|1|||
130266772|NCT00401843|468942778|FG001|Overall Study|Withdrawal of consent to study agent|15|||
130266773|NCT00401843|468942779|FG002|Overall Study|Withdrawal of consent to study agent|17|||
130266774|NCT00401843|468942777|FG000|Overall Study|Randomized but not Treated|0|||
130266775|NCT00401843|468942778|FG001|Overall Study|Randomized but not Treated|2|||
130266776|NCT00401843|468942779|FG002|Overall Study|Randomized but not Treated|3|||
130266777|NCT00401843|468942777|FG000|Overall Study|Received incorrect treatment|0|||
130266778|NCT00401843|468942778|FG001|Overall Study|Received incorrect treatment|3|||
130266779|NCT00401843|468942779|FG002|Overall Study|Received incorrect treatment|0|||
130266780|NCT01508910|468942782|FG000|Treatment|Death|2|||
130266781|NCT01508910|468942783|FG001|Treatment|Death|3|||
130266782|NCT01508910|468942784|FG002|Treatment|Death|2|||
130266783|NCT01508910|468942785|FG003|Treatment|Death|0|||
130266784|NCT01508910|468942782|FG000|Treatment|Lost to Follow-up|0|||
130266785|NCT01508910|468942783|FG001|Treatment|Lost to Follow-up|0|||
130266786|NCT01508910|468942784|FG002|Treatment|Lost to Follow-up|2|||
130266787|NCT01508910|468942785|FG003|Treatment|Lost to Follow-up|1|||
130266788|NCT01508910|468942782|FG000|Treatment|Withdrawal by Subject|0|||
130266789|NCT01508910|468942783|FG001|Treatment|Withdrawal by Subject|1|||
130266790|NCT01508910|468942784|FG002|Treatment|Withdrawal by Subject|6|||
130266791|NCT01508910|468942785|FG003|Treatment|Withdrawal by Subject|1|||
130266792|NCT01508910|468942782|FG000|Treatment|Sponsor Decision|0|||
130266793|NCT01508910|468942783|FG001|Treatment|Sponsor Decision|0|||
130266794|NCT01508910|468942784|FG002|Treatment|Sponsor Decision|0|||
130266795|NCT01508910|468942785|FG003|Treatment|Sponsor Decision|1|||
130266796|NCT03192137|468942789|FG000|Overall Study|Adverse Event|10|||
130266797|NCT03192137|468942790|FG001|Overall Study|Adverse Event|11|||
130266798|NCT03192137|468942789|FG000|Overall Study|Physician Decision|1|||
130266799|NCT03192137|468942790|FG001|Overall Study|Physician Decision|0|||
130266800|NCT03192137|468942789|FG000|Overall Study|Lack of Efficacy|20|||
130266801|NCT03192137|468942790|FG001|Overall Study|Lack of Efficacy|37|||
130266802|NCT03192137|468942789|FG000|Overall Study|Withdrawal by Subject|3|||
130266803|NCT03192137|468942790|FG001|Overall Study|Withdrawal by Subject|3|||
130266804|NCT03192137|468942789|FG000|Overall Study|Protocol Violation|4|||
130554008|NCT01369511|469996478|FG001|Overall Study|Entry criteria not met|0|||
130704433|NCT01235442|470541277|FG001|Overall Study|Pregnancy|1|||
130266805|NCT03192137|468942790|FG001|Overall Study|Protocol Violation|3|||
130266806|NCT03192137|468942789|FG000|Overall Study|Surgery Cancelled|4|||
130266807|NCT03192137|468942790|FG001|Overall Study|Surgery Cancelled|1|||
130266808|NCT03192137|468942789|FG000|Overall Study|Other - Various Administrative Reasons|8|||
130266809|NCT03192137|468942790|FG001|Overall Study|Other - Various Administrative Reasons|3|||
130266810|NCT00657267|468942791|FG000|Overall Study|Progressive disease|45|||
130266811|NCT00657267|468942791|FG000|Overall Study|Adverse Event|9|||
130266812|NCT02737501|468942795|FG000|Randomized Phase|Died|41|||
130266813|NCT02737501|468942796|FG001|Randomized Phase|Died|29|||
130266814|NCT02737501|468942797|FG002|Randomized Phase|Died|0|||
130266815|NCT02737501|468942795|FG000|Randomized Phase|Withdrawal by Subject|16|||
130266816|NCT02737501|468942796|FG001|Randomized Phase|Withdrawal by Subject|6|||
130266817|NCT02737501|468942797|FG002|Randomized Phase|Withdrawal by Subject|0|||
130266818|NCT02737501|468942795|FG000|Randomized Phase|Lost to Follow-up|0|||
130266819|NCT02737501|468942796|FG001|Randomized Phase|Lost to Follow-up|1|||
130266820|NCT02737501|468942797|FG002|Randomized Phase|Lost to Follow-up|0|||
130266821|NCT02737501|468942795|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
130266822|NCT02737501|468942796|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
130266823|NCT02737501|468942797|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
130266824|NCT02737501|468942795|FG000|Randomized Phase|Reason not Specified|1|||
130266825|NCT02737501|468942796|FG001|Randomized Phase|Reason not Specified|1|||
130266826|NCT02737501|468942797|FG002|Randomized Phase|Reason not Specified|0|||
130266827|NCT02737501|468942795|FG000|Randomized Phase|Never Treated|1|||
130266828|NCT02737501|468942796|FG001|Randomized Phase|Never Treated|1|||
130266829|NCT02737501|468942797|FG002|Randomized Phase|Never Treated|0|||
130266830|NCT02737501|468942795|FG000|Crossover Phase|Died|0|||
130266831|NCT02737501|468942796|FG001|Crossover Phase|Died|0|||
130266832|NCT02737501|468942797|FG002|Crossover Phase|Died|22|||
130266833|NCT02737501|468942795|FG000|Crossover Phase|Withdrew Consent|0|||
130266834|NCT02737501|468942796|FG001|Crossover Phase|Withdrew Consent|0|||
130266835|NCT02737501|468942797|FG002|Crossover Phase|Withdrew Consent|9|||
130266836|NCT02737501|468942795|FG000|Crossover Phase|Physician Decision|0|||
130266837|NCT02737501|468942796|FG001|Crossover Phase|Physician Decision|0|||
130266838|NCT02737501|468942797|FG002|Crossover Phase|Physician Decision|1|||
130266839|NCT02737501|468942795|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
130266840|NCT02737501|468942796|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
130266841|NCT02737501|468942797|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
130266842|NCT01261975|468942798|FG000|Overall Study|Surgical complication|1|||
130266843|NCT04819113|468942801|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130266844|NCT04819113|468942801|FG000|Overall Study|Lost to Follow-up|1|||
130266845|NCT04819113|468942801|FG000|Overall Study|Withdrawn before vaccination|2|||
130266846|NCT04067492|468942802|FG000|Overall Study|Lost to Follow-up|0|||
130266847|NCT04067492|468942803|FG001|Overall Study|Lost to Follow-up|0|||
130266848|NCT04067492|468942804|FG002|Overall Study|Lost to Follow-up|0|||
130266849|NCT04067492|468942805|FG003|Overall Study|Lost to Follow-up|0|||
130266850|NCT04067492|468942806|FG004|Overall Study|Lost to Follow-up|0|||
130266851|NCT04067492|468942807|FG005|Overall Study|Lost to Follow-up|1|||
130266852|NCT04067492|468942802|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266853|NCT04067492|468942803|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
130266854|NCT04067492|468942804|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266855|NCT04067492|468942805|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266856|NCT04067492|468942806|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266857|NCT04067492|468942807|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266858|NCT04067492|468942802|FG000|Overall Study|COVID-19 epidemiological situation|0|||
130266859|NCT04067492|468942803|FG001|Overall Study|COVID-19 epidemiological situation|0|||
130266860|NCT04067492|468942804|FG002|Overall Study|COVID-19 epidemiological situation|0|||
130266861|NCT04067492|468942805|FG003|Overall Study|COVID-19 epidemiological situation|1|||
130266862|NCT04067492|468942806|FG004|Overall Study|COVID-19 epidemiological situation|0|||
130266863|NCT04067492|468942807|FG005|Overall Study|COVID-19 epidemiological situation|0|||
130266864|NCT00833027|468942808|FG000|Overall Study|Adverse Event|33|||
130266865|NCT00833027|468942808|FG000|Overall Study|Death|1|||
130266866|NCT00833027|468942808|FG000|Overall Study|Lack of Efficacy|12|||
130266867|NCT00833027|468942808|FG000|Overall Study|Lost to Follow-up|24|||
130266868|NCT00833027|468942808|FG000|Overall Study|Protocol Violation|115|||
130266869|NCT00833027|468942808|FG000|Overall Study|Withdrawal by Subject|16|||
130266870|NCT00833027|468942808|FG000|Overall Study|Missing|10|||
130266871|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Death|2|||
130266872|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
130266873|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
130266874|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Physician Decision|1|||
130266875|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
130266876|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
130704434|NCT01235442|470541276|FG000|Overall Study|Ineligibility determined|5|||
130266877|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Adverse Event|2|||
130266878|NCT00786422|468942810|FG000|Follow-up Period|Death|1|||
130266879|NCT00786422|468942810|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
130266880|NCT00444106|468942815|FG000|Overall Study|Lost to Follow-up|2|||
130266881|NCT00444106|468942816|FG001|Overall Study|Lost to Follow-up|1|||
130266882|NCT00444106|468942817|FG002|Overall Study|Lost to Follow-up|0|||
130266883|NCT00444106|468942815|FG000|Overall Study|Abnormal Test Procedure Results|0|||
130266884|NCT00444106|468942816|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130266885|NCT00444106|468942817|FG002|Overall Study|Abnormal Test Procedure Results|1|||
130266886|NCT04570384|468942818|FG000|Overall Study|Adverse Event|2|||
130266887|NCT04570384|468942819|FG001|Overall Study|Adverse Event|1|||
130266888|NCT04570384|468942818|FG000|Overall Study|Death|2|||
130266889|NCT04570384|468942819|FG001|Overall Study|Death|5|||
130266890|NCT04570384|468942818|FG000|Overall Study|Lost to Follow-up|1|||
130266891|NCT04570384|468942819|FG001|Overall Study|Lost to Follow-up|0|||
130266892|NCT04570384|468942818|FG000|Overall Study|Other|1|||
130266893|NCT04570384|468942819|FG001|Overall Study|Other|0|||
130266894|NCT04570384|468942818|FG000|Overall Study|Protocol Violation|0|||
130266895|NCT04570384|468942819|FG001|Overall Study|Protocol Violation|1|||
130266896|NCT04570384|468942818|FG000|Overall Study|Sponsor Decision|1|||
130266897|NCT04570384|468942819|FG001|Overall Study|Sponsor Decision|0|||
130266898|NCT04570384|468942818|FG000|Overall Study|Withdrawal by Subject|4|||
130266899|NCT04570384|468942819|FG001|Overall Study|Withdrawal by Subject|2|||
130266900|NCT01900665|468942820|FG000|Placebo Controlled Period|Death|9|||
130266901|NCT01900665|468942821|FG001|Placebo Controlled Period|Death|16|||
130266902|NCT01900665|468942820|FG000|Placebo Controlled Period|Adverse Event|48|||
130266903|NCT01900665|468942821|FG001|Placebo Controlled Period|Adverse Event|39|||
130266904|NCT01900665|468942820|FG000|Placebo Controlled Period|Protocol Violation|1|||
130266905|NCT01900665|468942821|FG001|Placebo Controlled Period|Protocol Violation|7|||
130266906|NCT01900665|468942820|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
130266907|NCT01900665|468942821|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
130266908|NCT01900665|468942820|FG000|Placebo Controlled Period|Physician Decision|11|||
130266909|NCT01900665|468942821|FG001|Placebo Controlled Period|Physician Decision|7|||
130266910|NCT01900665|468942820|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
130266911|NCT01900665|468942821|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
130266912|NCT01900665|468942820|FG000|Placebo Controlled Period|Caregiver Decision|33|||
130266913|NCT01900665|468942821|FG001|Placebo Controlled Period|Caregiver Decision|41|||
130266914|NCT01900665|468942820|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
130266915|NCT01900665|468942821|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
130266916|NCT01900665|468942820|FG000|Open Label Period|Adverse Event|16|||
130266917|NCT01900665|468942821|FG001|Open Label Period|Adverse Event|20|||
130266918|NCT01900665|468942820|FG000|Open Label Period|Death|5|||
130266919|NCT01900665|468942821|FG001|Open Label Period|Death|6|||
130266920|NCT01900665|468942820|FG000|Open Label Period|Lost to Follow-up|1|||
130266921|NCT01900665|468942821|FG001|Open Label Period|Lost to Follow-up|1|||
130266922|NCT01900665|468942820|FG000|Open Label Period|Parent/Caregiver Decision|33|||
130266923|NCT01900665|468942821|FG001|Open Label Period|Parent/Caregiver Decision|34|||
130266924|NCT01900665|468942820|FG000|Open Label Period|Physician Decision|4|||
130266925|NCT01900665|468942821|FG001|Open Label Period|Physician Decision|4|||
130266926|NCT01900665|468942820|FG000|Open Label Period|Protocol Violation|0|||
130266927|NCT01900665|468942821|FG001|Open Label Period|Protocol Violation|1|||
130266928|NCT01900665|468942820|FG000|Open Label Period|Sponsor Decision|802|||
130266929|NCT01900665|468942821|FG001|Open Label Period|Sponsor Decision|765|||
130266930|NCT01900665|468942820|FG000|Open Label Period|Withdrawal by Subject|20|||
130266931|NCT01900665|468942821|FG001|Open Label Period|Withdrawal by Subject|28|||
130266932|NCT04749914|468942822|FG000|Period 1|Adverse Event|1|||
130266933|NCT04749914|468942823|FG001|Period 1|Adverse Event|0|||
130266934|NCT04749914|468942824|FG002|Period 1|Adverse Event|0|||
130266935|NCT04749914|468942825|FG003|Period 1|Adverse Event|0|||
130266936|NCT04749914|468942822|FG000|Period 1|Withdrawal by Subject|1|||
130266937|NCT04749914|468942823|FG001|Period 1|Withdrawal by Subject|0|||
130266938|NCT04749914|468942824|FG002|Period 1|Withdrawal by Subject|1|||
130266939|NCT04749914|468942825|FG003|Period 1|Withdrawal by Subject|0|||
130266940|NCT01673126|468942826|FG000|Overall Study|change of diagnosis|4|||
130266941|NCT01673126|468942827|FG001|Overall Study|change of diagnosis|3|||
130266942|NCT01074931|468942832|FG000|Overall Study|Economic reasons|1|||
130266943|NCT01074931|468942832|FG000|Overall Study|Death|5|||
130266944|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
130266945|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
130266946|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130266947|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130266948|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266949|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
130266950|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266951|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266952|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266953|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
130266954|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266955|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266956|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266957|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
130266958|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266959|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266960|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266961|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
130266962|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266963|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266964|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266965|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266966|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266967|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
130266968|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266969|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266970|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266971|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
130266972|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266973|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266974|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266975|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
130266976|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130266977|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130266978|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
130266979|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
130266980|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130266981|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130266982|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
130266983|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
130266984|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
130266985|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
130266986|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
130266987|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
130266988|NCT01404234|468942837|FG000|Overall Study|Withdrawal by Subject|2|||
130266989|NCT01475721|468944320|FG000|Overall Study|Death|3|||
130266990|NCT01475721|468944321|FG001|Overall Study|Death|6|||
130266991|NCT01475721|468944320|FG000|Overall Study|Withdrawal by Subject|8|||
130266992|NCT01475721|468944321|FG001|Overall Study|Withdrawal by Subject|8|||
130266993|NCT00803738|468944323|FG000|Overall Study|Adverse Event|3|||
130266994|NCT00803738|468944324|FG001|Overall Study|Adverse Event|5|||
130266995|NCT00803738|468944323|FG000|Overall Study|Lost to Follow-up|4|||
130266996|NCT00803738|468944324|FG001|Overall Study|Lost to Follow-up|4|||
130266997|NCT00803738|468944323|FG000|Overall Study|Protocol Violation|18|||
130266998|NCT00803738|468944324|FG001|Overall Study|Protocol Violation|10|||
130266999|NCT00803738|468944323|FG000|Overall Study|Withdrawal by Subject|1|||
130267000|NCT00803738|468944324|FG001|Overall Study|Withdrawal by Subject|4|||
130267001|NCT00803738|468944323|FG000|Overall Study|Lack of Efficacy|10|||
130267002|NCT00803738|468944324|FG001|Overall Study|Lack of Efficacy|16|||
130267003|NCT00803738|468944323|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
130267004|NCT00803738|468944324|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
130267005|NCT00803738|468944323|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
130267006|NCT00803738|468944324|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
130267007|NCT02364037|468944325|FG000|Overall Study|Withdrawal by Subject|7|||
130267008|NCT02364037|468944326|FG001|Overall Study|Withdrawal by Subject|4|||
130267009|NCT02364037|468944325|FG000|Overall Study|Lost to Follow-up|37|||
130267010|NCT02364037|468944326|FG001|Overall Study|Lost to Follow-up|49|||
130267011|NCT00387088|468944329|FG000|Overall Study|Adverse Event|143|||
130267012|NCT00387088|468944330|FG001|Overall Study|Adverse Event|156|||
130267013|NCT00387088|468944329|FG000|Overall Study|Protocol Violation|47|||
130267014|NCT00387088|468944330|FG001|Overall Study|Protocol Violation|35|||
130267015|NCT00387088|468944329|FG000|Overall Study|Withdrawal by Subject|20|||
130267016|NCT00387088|468944330|FG001|Overall Study|Withdrawal by Subject|35|||
130267017|NCT00387088|468944329|FG000|Overall Study|Lack of Efficacy|28|||
130365794|NCT02264639|469308584|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130453305|NCT01674569|469623546|FG003|Overall Study|Withdrawal by Subject|0|||
130453306|NCT01674569|469623547|FG004|Overall Study|Withdrawal by Subject|0|||
130453307|NCT01674569|469623548|FG005|Overall Study|Withdrawal by Subject|0|||
130453308|NCT00335556|469623549|FG000|Overall Study|Death|0|||
130453309|NCT00335556|469623550|FG001|Overall Study|Death|5|||
130453310|NCT00335556|469623551|FG002|Overall Study|Death|0|||
130453311|NCT00335556|469623552|FG003|Overall Study|Death|0|||
130453312|NCT00335556|469623553|FG004|Overall Study|Death|1|||
130453313|NCT00335556|469623554|FG005|Overall Study|Death|0|||
130453314|NCT00335556|469623549|FG000|Overall Study|Lack of Efficacy|0|||
130453315|NCT00335556|469623550|FG001|Overall Study|Lack of Efficacy|19|||
130453316|NCT00335556|469623551|FG002|Overall Study|Lack of Efficacy|3|||
130453317|NCT00335556|469623552|FG003|Overall Study|Lack of Efficacy|3|||
130453318|NCT00335556|469623553|FG004|Overall Study|Lack of Efficacy|0|||
130453319|NCT00335556|469623554|FG005|Overall Study|Lack of Efficacy|1|||
130453320|NCT00335556|469623549|FG000|Overall Study|Physician Decision|0|||
130453321|NCT00335556|469623550|FG001|Overall Study|Physician Decision|6|||
130453322|NCT00335556|469623551|FG002|Overall Study|Physician Decision|2|||
130704435|NCT01235442|470541277|FG001|Overall Study|Ineligibility determined|4|||
130704436|NCT01235442|470541276|FG000|Overall Study|Protocol Violation|3|||
130267018|NCT00387088|468944330|FG001|Overall Study|Lack of Efficacy|67|||
130267019|NCT00387088|468944329|FG000|Overall Study|Lost to Follow-up|22|||
130267020|NCT00387088|468944330|FG001|Overall Study|Lost to Follow-up|28|||
130267021|NCT00387088|468944329|FG000|Overall Study|Other|58|||
130267022|NCT00387088|468944330|FG001|Overall Study|Other|52|||
130267023|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
130267024|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
130267025|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Adverse Event|2|||
130267026|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Adverse Event|1|||
130267027|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
130267028|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
130267029|NCT02848092|468944333|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
130267030|NCT02848092|468944334|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
130267031|NCT02848092|468944333|FG000|1-month Post-training Follow-up|fatigue|0|||
130267032|NCT02848092|468944334|FG001|1-month Post-training Follow-up|fatigue|1|||
130267033|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
130267034|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
130267035|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Adverse Event|1|||
130267036|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Adverse Event|1|||
130267037|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
130267038|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
130267039|NCT02848092|468944333|FG000|6-month Post-training Follow-up|frustrated with task|1|||
130267040|NCT02848092|468944334|FG001|6-month Post-training Follow-up|frustrated with task|0|||
130267041|NCT02848092|468944333|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
130267042|NCT02848092|468944334|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
130267043|NCT02848092|468944333|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
130267044|NCT02848092|468944334|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
130267045|NCT01639469|468944335|FG000|Overall Study|Death|4|||
130267046|NCT01639469|468944336|FG001|Overall Study|Death|2|||
130267047|NCT01639469|468944335|FG000|Overall Study|Lost to Follow-up|1|||
130267048|NCT01639469|468944336|FG001|Overall Study|Lost to Follow-up|1|||
130267049|NCT00420381|468944337|FG000|Overall Study|Protocol Violation|1|||
130267050|NCT00592631|468944338|FG000|Overall Study|Lost to Follow-up|0|||
130267051|NCT00592631|468944339|FG001|Overall Study|Lost to Follow-up|2|||
130267052|NCT02383862|468944342|FG000|3 Month Follow up|Lost to Follow-up|23|||
130267053|NCT02383862|468944343|FG001|3 Month Follow up|Lost to Follow-up|21|||
130267054|NCT01833494|468944344|FG000|Overall Study|Adverse Event|24|||
130267055|NCT01833494|468944344|FG000|Overall Study|Physician Decision|6|||
130267056|NCT01833494|468944344|FG000|Overall Study|Withdrawal by Subject|6|||
130267057|NCT01833494|468944344|FG000|Overall Study|Decrease in serum phosphorus|4|||
130267058|NCT01833494|468944344|FG000|Overall Study|Decrease in serum calcium|4|||
130704437|NCT01235442|470541277|FG001|Overall Study|Protocol Violation|3|||
130704438|NCT01235442|470541276|FG000|Overall Study|Adverse Event|4|||
130704439|NCT01235442|470541277|FG001|Overall Study|Adverse Event|6|||
130267059|NCT01833494|468944344|FG000|Overall Study|Increase in serum ferritin|1|||
130267060|NCT01694433|468944345|FG000|Overall Study|Adverse Event|7|||
130267061|NCT01694433|468944346|FG001|Overall Study|Adverse Event|0|||
130267062|NCT01694433|468944345|FG000|Overall Study|Physician Decision|1|||
130267063|NCT01694433|468944346|FG001|Overall Study|Physician Decision|0|||
130267064|NCT01694433|468944345|FG000|Overall Study|Withdrawal by Subject|3|||
130453323|NCT00335556|469623552|FG003|Overall Study|Physician Decision|1|||
130267065|NCT01694433|468944346|FG001|Overall Study|Withdrawal by Subject|4|||
130453324|NCT00335556|469623553|FG004|Overall Study|Physician Decision|0|||
130453325|NCT00335556|469623554|FG005|Overall Study|Physician Decision|0|||
130453326|NCT00335556|469623549|FG000|Overall Study|Ineligible|2|||
130704440|NCT01235442|470541276|FG000|Overall Study|Withdrawal by Subject|15|||
130267066|NCT00374595|468944349|FG000|Overall Study|Death|23|||
130267067|NCT00374595|468944349|FG000|Overall Study|Withdrawal by Subject|39|||
130267068|NCT00374595|468944349|FG000|Overall Study|Lost to Follow-up|3|||
130267069|NCT00374595|468944349|FG000|Overall Study|too much time commitment|1|||
130267070|NCT00374595|468944349|FG000|Overall Study|transfer care to other clinical site|1|||
130267071|NCT00374595|468944349|FG000|Overall Study|relocation|3|||
130267072|NCT03745768|468944351|FG000|Overall Study|discontinued study|2|||
130267073|NCT03745768|468944352|FG001|Overall Study|discontinued study|0|||
130267074|NCT00443118|468944353|FG000|Overall Study|unknown primary outcome|3|||
130267075|NCT00443118|468944354|FG001|Overall Study|unknown primary outcome|1|||
130267076|NCT00443118|468944355|FG002|Overall Study|unknown primary outcome|0|||
130267077|NCT00443118|468944353|FG000|Overall Study|Withdrawal by Subject|1|||
130267078|NCT00443118|468944354|FG001|Overall Study|Withdrawal by Subject|0|||
130267079|NCT00443118|468944355|FG002|Overall Study|Withdrawal by Subject|0|||
130267080|NCT01664247|468944358|FG000|Overall Study|Adverse Event|5|||
130267081|NCT01664247|468944359|FG001|Overall Study|Adverse Event|3|||
130267082|NCT01664247|468944358|FG000|Overall Study|Protocol Violation|3|||
130267083|NCT01664247|468944359|FG001|Overall Study|Protocol Violation|5|||
130267084|NCT01664247|468944358|FG000|Overall Study|Withdrawal Criteria|1|||
130267085|NCT01664247|468944359|FG001|Overall Study|Withdrawal Criteria|4|||
130267086|NCT01664247|468944358|FG000|Overall Study|Unclassified|5|||
130267087|NCT01664247|468944359|FG001|Overall Study|Unclassified|29|||
130267088|NCT01106157|468944360|FG000|Overall Study|Withdrawal by Subject|1|||
130267089|NCT01106157|468944361|FG001|Overall Study|Withdrawal by Subject|0|||
130267090|NCT01673646|468944365|FG000|Overall Study|Adverse Event|2|||
130267091|NCT01673646|468944366|FG001|Overall Study|Adverse Event|1|||
130267092|NCT01673646|468944367|FG002|Overall Study|Adverse Event|1|||
130453327|NCT00335556|469623550|FG001|Overall Study|Ineligible|0|||
130453328|NCT00335556|469623551|FG002|Overall Study|Ineligible|0|||
130453329|NCT00335556|469623552|FG003|Overall Study|Ineligible|0|||
130453330|NCT00335556|469623553|FG004|Overall Study|Ineligible|0|||
130453331|NCT00335556|469623554|FG005|Overall Study|Ineligible|0|||
130267093|NCT01673646|468944365|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130267094|NCT01673646|468944366|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130267095|NCT01673646|468944367|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130267096|NCT01673646|468944365|FG000|Overall Study|Condition no longer requires study drug|0|||
130267097|NCT01673646|468944366|FG001|Overall Study|Condition no longer requires study drug|1|||
130267098|NCT01673646|468944367|FG002|Overall Study|Condition no longer requires study drug|0|||
130267099|NCT01673646|468944365|FG000|Overall Study|Withdrawal by Subject|0|||
130267100|NCT01673646|468944366|FG001|Overall Study|Withdrawal by Subject|2|||
130267101|NCT01673646|468944367|FG002|Overall Study|Withdrawal by Subject|2|||
130267102|NCT01673646|468944365|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
130267103|NCT01673646|468944366|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
130267104|NCT01673646|468944367|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
130267105|NCT03064074|468944368|FG000|Overall Study|Physician Decision|0|||
130267106|NCT03064074|468944369|FG001|Overall Study|Physician Decision|0|||
130267107|NCT03064074|468944370|FG002|Overall Study|Physician Decision|0|||
130267108|NCT03064074|468944371|FG003|Overall Study|Physician Decision|1|||
130267109|NCT02141672|468944375|FG000|Overall Study|Adverse Event|0|||
130267110|NCT02141672|468944376|FG001|Overall Study|Adverse Event|1|||
130267111|NCT02141672|468944377|FG002|Overall Study|Adverse Event|0|||
130267112|NCT02141672|468944375|FG000|Overall Study|Death|10|||
130267113|NCT02141672|468944376|FG001|Overall Study|Death|2|||
130267114|NCT02141672|468944377|FG002|Overall Study|Death|1|||
130267115|NCT02141672|468944375|FG000|Overall Study|Lack of Efficacy|0|||
130267116|NCT02141672|468944376|FG001|Overall Study|Lack of Efficacy|0|||
130267117|NCT02141672|468944377|FG002|Overall Study|Lack of Efficacy|2|||
130267118|NCT02141672|468944375|FG000|Overall Study|Lost to Follow-up|1|||
130267119|NCT02141672|468944376|FG001|Overall Study|Lost to Follow-up|1|||
130267120|NCT02141672|468944377|FG002|Overall Study|Lost to Follow-up|3|||
130267121|NCT02141672|468944375|FG000|Overall Study|Physician Decision|1|||
130267122|NCT02141672|468944376|FG001|Overall Study|Physician Decision|2|||
130267123|NCT02141672|468944377|FG002|Overall Study|Physician Decision|5|||
130267124|NCT02141672|468944375|FG000|Overall Study|Protocol Violation|0|||
130267125|NCT02141672|468944376|FG001|Overall Study|Protocol Violation|0|||
130267126|NCT02141672|468944377|FG002|Overall Study|Protocol Violation|1|||
130267127|NCT02141672|468944375|FG000|Overall Study|Withdrawal by Subject|3|||
130267128|NCT02141672|468944376|FG001|Overall Study|Withdrawal by Subject|2|||
130267129|NCT02141672|468944377|FG002|Overall Study|Withdrawal by Subject|5|||
130267130|NCT02141672|468944375|FG000|Overall Study|refused to follow-up|1|||
130267131|NCT02141672|468944376|FG001|Overall Study|refused to follow-up|0|||
130267132|NCT02141672|468944377|FG002|Overall Study|refused to follow-up|1|||
130453332|NCT00335556|469623549|FG000|Overall Study|Refusal of further protocol therapy|0|||
130453333|NCT00335556|469623550|FG001|Overall Study|Refusal of further protocol therapy|4|||
130267133|NCT01118780|468944378|FG000|Overall Study|Adverse Event|15|||
130267134|NCT01118780|468944379|FG001|Overall Study|Adverse Event|15|||
130267135|NCT01118780|468944378|FG000|Overall Study|Death|1|||
130267136|NCT01118780|468944379|FG001|Overall Study|Death|0|||
130453334|NCT00335556|469623551|FG002|Overall Study|Refusal of further protocol therapy|0|||
130453335|NCT00335556|469623552|FG003|Overall Study|Refusal of further protocol therapy|1|||
130453336|NCT00335556|469623553|FG004|Overall Study|Refusal of further protocol therapy|0|||
130453337|NCT00335556|469623554|FG005|Overall Study|Refusal of further protocol therapy|0|||
130453338|NCT04555044|469623562|FG000|Overall Study|Adverse Event|0|||
130453339|NCT04555044|469623563|FG001|Overall Study|Adverse Event|1|||
130453340|NCT04088188|469623565|FG000|Overall Study|Withdrawal by Subject|2|||
130267137|NCT01118780|468944378|FG000|Overall Study|Lack of Efficacy|2|||
130267138|NCT01118780|468944379|FG001|Overall Study|Lack of Efficacy|6|||
130267139|NCT01118780|468944378|FG000|Overall Study|Physician Decision|2|||
130267140|NCT01118780|468944379|FG001|Overall Study|Physician Decision|0|||
130267141|NCT01118780|468944378|FG000|Overall Study|Protocol Violation|3|||
130267142|NCT01118780|468944379|FG001|Overall Study|Protocol Violation|6|||
130267143|NCT01118780|468944378|FG000|Overall Study|Withdrawal by Subject|13|||
130267144|NCT01118780|468944379|FG001|Overall Study|Withdrawal by Subject|8|||
130267145|NCT03962855|468944387|FG000|Overall Study|Death|0|||
130267146|NCT03962855|468944388|FG001|Overall Study|Death|1|||
130267147|NCT03962855|468944387|FG000|Overall Study|Lost to Follow-up|0|||
130267148|NCT03962855|468944388|FG001|Overall Study|Lost to Follow-up|1|||
130267149|NCT03962855|468944387|FG000|Overall Study|Adverse Event|0|||
130267150|NCT03962855|468944388|FG001|Overall Study|Adverse Event|1|||
130267151|NCT03962855|468944387|FG000|Overall Study|Physician Decision|0|||
130267152|NCT03962855|468944388|FG001|Overall Study|Physician Decision|2|||
130267153|NCT00127855|468944389|FG000|Primary Vaccination Course|Adverse Event|0|||
130267154|NCT00127855|468944390|FG001|Primary Vaccination Course|Adverse Event|0|||
130267155|NCT00127855|468944391|FG002|Primary Vaccination Course|Adverse Event|1|||
130267156|NCT00127855|468944392|FG003|Primary Vaccination Course|Adverse Event|0|||
130267157|NCT00127855|468944393|FG004|Primary Vaccination Course|Adverse Event|0|||
130267158|NCT00127855|468944389|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
130267159|NCT00127855|468944390|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
130267160|NCT00127855|468944391|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
130267161|NCT00127855|468944392|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
130267162|NCT00127855|468944393|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
130267163|NCT00127855|468944389|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
130267164|NCT00127855|468944390|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
130267165|NCT00127855|468944391|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
130267166|NCT00127855|468944392|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
130267167|NCT00127855|468944393|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
130267168|NCT00127855|468944389|FG000|Primary Vaccination Course|Other|0|||
130267169|NCT00127855|468944390|FG001|Primary Vaccination Course|Other|0|||
130267170|NCT00127855|468944391|FG002|Primary Vaccination Course|Other|0|||
130267171|NCT00127855|468944392|FG003|Primary Vaccination Course|Other|0|||
130267172|NCT00127855|468944393|FG004|Primary Vaccination Course|Other|1|||
130267173|NCT02343302|468944394|FG000|Overall Study|Physician Decision|1|||
130267174|NCT02343302|468944395|FG001|Overall Study|Physician Decision|1|||
130267175|NCT02655887|468944396|FG000|Overall Study|Lost to Follow-up|3|||
130267176|NCT02655887|468944396|FG000|Overall Study|Death|4|||
130267177|NCT02655887|468944396|FG000|Overall Study|Withdrawal by Subject|3|||
130267178|NCT02655887|468944396|FG000|Overall Study|Missed 12-month follow-up visit|4|||
130267179|NCT03465722|468944402|FG000|Overall Study|Withdrawal by Subject|21|||
130267180|NCT03465722|468944403|FG001|Overall Study|Withdrawal by Subject|14|||
130267181|NCT03465722|468944402|FG000|Overall Study|Death|89|||
130267182|NCT03465722|468944403|FG001|Overall Study|Death|87|||
130267183|NCT03465722|468944402|FG000|Overall Study|Lost to Follow-up|5|||
130267184|NCT03465722|468944403|FG001|Overall Study|Lost to Follow-up|3|||
130267185|NCT03465722|468944402|FG000|Overall Study|Administrative/Other|33|||
130267186|NCT03465722|468944403|FG001|Overall Study|Administrative/Other|32|||
130267187|NCT03465722|468944402|FG000|Overall Study|Not treated|1|||
130267188|NCT03465722|468944403|FG001|Overall Study|Not treated|2|||
130267189|NCT03465722|468944402|FG000|Overall Study|Sponsor decision|91|||
130267190|NCT03465722|468944403|FG001|Overall Study|Sponsor decision|98|||
130267191|NCT04940130|468944404|FG000|Overall Study|Travel|1|||
130267192|NCT04940130|468944405|FG001|Overall Study|Travel|0|||
130267193|NCT04940130|468944406|FG002|Overall Study|Travel|2|||
130267194|NCT04940130|468944404|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
130267195|NCT04940130|468944405|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
130267196|NCT04940130|468944406|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
130267197|NCT04940130|468944404|FG000|Overall Study|Adverse Event|0|||
130267198|NCT04940130|468944405|FG001|Overall Study|Adverse Event|0|||
130267199|NCT04940130|468944406|FG002|Overall Study|Adverse Event|2|||
130267200|NCT04940130|468944404|FG000|Overall Study|Disease progression/treatment failure|0|||
130267201|NCT04940130|468944405|FG001|Overall Study|Disease progression/treatment failure|0|||
130267202|NCT04940130|468944406|FG002|Overall Study|Disease progression/treatment failure|1|||
130267203|NCT04940130|468944404|FG000|Overall Study|Participant refusal|0|||
130267204|NCT04940130|468944405|FG001|Overall Study|Participant refusal|0|||
130267205|NCT04940130|468944406|FG002|Overall Study|Participant refusal|1|||
130267206|NCT02240121|468944409|FG000|Overall Study|Protocol Violation|1|||
130267207|NCT02240121|468944410|FG001|Overall Study|Protocol Violation|2|||
130267208|NCT02240121|468944409|FG000|Overall Study|Physician Decision|0|||
130267209|NCT02240121|468944410|FG001|Overall Study|Physician Decision|1|||
130267210|NCT02240121|468944409|FG000|Overall Study|Change in protocol interpretation|1|||
130267211|NCT02240121|468944410|FG001|Overall Study|Change in protocol interpretation|0|||
130267212|NCT02240121|468944409|FG000|Overall Study|Lack of Efficacy|2|||
130267213|NCT02240121|468944410|FG001|Overall Study|Lack of Efficacy|3|||
130267214|NCT02240121|468944409|FG000|Overall Study|Site closed|1|||
130267215|NCT02240121|468944410|FG001|Overall Study|Site closed|1|||
130267216|NCT02240121|468944409|FG000|Overall Study|Pregnancy|1|||
130267217|NCT02240121|468944410|FG001|Overall Study|Pregnancy|0|||
130267218|NCT02240121|468944409|FG000|Overall Study|Adverse Event|2|||
130267219|NCT02240121|468944410|FG001|Overall Study|Adverse Event|4|||
130267220|NCT02240121|468944409|FG000|Overall Study|Withdrawal by Subject|6|||
130267221|NCT02240121|468944410|FG001|Overall Study|Withdrawal by Subject|2|||
130267222|NCT02240121|468944409|FG000|Overall Study|Lost to Follow-up|3|||
130267223|NCT02240121|468944410|FG001|Overall Study|Lost to Follow-up|4|||
130267224|NCT02240121|468944409|FG000|Overall Study|Other than specified|1|||
130267225|NCT02240121|468944410|FG001|Overall Study|Other than specified|3|||
130267226|NCT04419467|468944413|FG000|Overall Study|Not treated with IP|0|||
130267227|NCT04419467|468944414|FG001|Overall Study|Not treated with IP|0|||
130267228|NCT04419467|468944415|FG002|Overall Study|Not treated with IP|2|||
130267229|NCT04419467|468944413|FG000|Overall Study|Adverse Event|0|||
130267230|NCT04419467|468944414|FG001|Overall Study|Adverse Event|2|||
130267231|NCT04419467|468944415|FG002|Overall Study|Adverse Event|0|||
130267232|NCT04419467|468944413|FG000|Overall Study|Death|1|||
130267233|NCT04419467|468944414|FG001|Overall Study|Death|0|||
130267234|NCT04419467|468944415|FG002|Overall Study|Death|0|||
130267235|NCT04419467|468944413|FG000|Overall Study|Lost to Follow-up|0|||
130267236|NCT04419467|468944414|FG001|Overall Study|Lost to Follow-up|1|||
130267237|NCT04419467|468944415|FG002|Overall Study|Lost to Follow-up|2|||
130267238|NCT04419467|468944413|FG000|Overall Study|Withdrawal by Subject|0|||
130267239|NCT04419467|468944414|FG001|Overall Study|Withdrawal by Subject|0|||
130267240|NCT04419467|468944415|FG002|Overall Study|Withdrawal by Subject|4|||
130267241|NCT04419467|468944413|FG000|Overall Study|Pandemic related|0|||
130267242|NCT04419467|468944414|FG001|Overall Study|Pandemic related|0|||
130267243|NCT04419467|468944415|FG002|Overall Study|Pandemic related|1|||
130267244|NCT04419467|468944413|FG000|Overall Study|Reason not known|1|||
130267245|NCT04419467|468944414|FG001|Overall Study|Reason not known|0|||
130267246|NCT04419467|468944415|FG002|Overall Study|Reason not known|0|||
130267247|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130267248|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130267249|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130267250|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
130267251|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
130267252|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
130267253|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130267254|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
130267255|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
130453341|NCT04088188|469623566|FG001|Overall Study|Withdrawal by Subject|0|||
130453342|NCT04088188|469623565|FG000|Overall Study|Adverse Event|2|||
130453343|NCT04088188|469623566|FG001|Overall Study|Adverse Event|0|||
130453344|NCT03601507|469623569|FG000|Overall Study|Adverse Event|1|||
130453345|NCT02107014|469623572|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
130453346|NCT03761784|469623573|FG000|Overall Study|Adverse Event|4|||
130453347|NCT03761784|469623574|FG001|Overall Study|Adverse Event|0|||
130453348|NCT03761784|469623573|FG000|Overall Study|Lost to Follow-up|10|||
130453349|NCT03761784|469623574|FG001|Overall Study|Lost to Follow-up|7|||
130453350|NCT03761784|469623573|FG000|Overall Study|Pregnancy|1|||
130453351|NCT03761784|469623574|FG001|Overall Study|Pregnancy|0|||
130453352|NCT03761784|469623573|FG000|Overall Study|Protocol Violation|2|||
130453353|NCT03761784|469623574|FG001|Overall Study|Protocol Violation|0|||
130453354|NCT03761784|469623573|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
130453355|NCT03761784|469623574|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
130453356|NCT03761784|469623573|FG000|Overall Study|Withdrawal by Subject|9|||
130453357|NCT03761784|469623574|FG001|Overall Study|Withdrawal by Subject|4|||
130267256|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130267257|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
130267258|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
130267259|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130267260|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130267261|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
130267262|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
130453358|NCT03761784|469623573|FG000|Overall Study|Physician Decision|1|||
130453359|NCT03761784|469623574|FG001|Overall Study|Physician Decision|0|||
130453360|NCT03761784|469623573|FG000|Overall Study|Other Than Specified|1|||
130704441|NCT01235442|470541277|FG001|Overall Study|Withdrawal by Subject|9|||
130704442|NCT01235442|470541276|FG000|Overall Study|Lack of Efficacy|1|||
130704443|NCT01235442|470541277|FG001|Overall Study|Lack of Efficacy|3|||
130704444|NCT01235442|470541276|FG000|Overall Study|Noncompliance|1|||
130267263|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
130267264|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
130267265|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
130267266|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
130267267|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
130267268|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
130267269|NCT02779777|468944418|FG000|Overall Study|Disease Progression|1|||
130267270|NCT02779777|468944419|FG001|Overall Study|Disease Progression|0|||
130267271|NCT02779777|468944420|FG002|Overall Study|Disease Progression|0|||
130267272|NCT02779777|468944418|FG000|Overall Study|Adverse Event|3|||
130267273|NCT02779777|468944419|FG001|Overall Study|Adverse Event|1|||
130267274|NCT02779777|468944420|FG002|Overall Study|Adverse Event|0|||
130267275|NCT02779777|468944418|FG000|Overall Study|Physician Decision|9|||
130267276|NCT02779777|468944419|FG001|Overall Study|Physician Decision|0|||
130267277|NCT02779777|468944420|FG002|Overall Study|Physician Decision|1|||
130267278|NCT02779777|468944418|FG000|Overall Study|Withdrawal by Subject|1|||
130267279|NCT02779777|468944419|FG001|Overall Study|Withdrawal by Subject|0|||
130267280|NCT02779777|468944420|FG002|Overall Study|Withdrawal by Subject|0|||
130267281|NCT04571060|468944421|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
130267282|NCT04571060|468944422|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
130267283|NCT04571060|468944421|FG000|Overall Study|Never treated migraine|47|||
130267284|NCT04571060|468944422|FG001|Overall Study|Never treated migraine|36|||
130267285|NCT04571060|468944421|FG000|Overall Study|Protocol Violation|4|||
130267286|NCT04571060|468944422|FG001|Overall Study|Protocol Violation|2|||
130267287|NCT04571060|468944421|FG000|Overall Study|Withdrawal by Subject|6|||
130267288|NCT04571060|468944422|FG001|Overall Study|Withdrawal by Subject|2|||
130267289|NCT04571060|468944421|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
130267290|NCT04571060|468944422|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
130267291|NCT00442416|468944423|FG000|Overall Study|Adverse Event|4|||
130267292|NCT00442416|468944424|FG001|Overall Study|Adverse Event|1|||
130267293|NCT00442416|468944423|FG000|Overall Study|Death|1|||
130267294|NCT00442416|468944424|FG001|Overall Study|Death|0|||
130267295|NCT00442416|468944423|FG000|Overall Study|Lack of Efficacy|2|||
130267296|NCT00442416|468944424|FG001|Overall Study|Lack of Efficacy|0|||
130267297|NCT00442416|468944423|FG000|Overall Study|Protocol Violation|2|||
130267298|NCT00442416|468944424|FG001|Overall Study|Protocol Violation|3|||
130267299|NCT00442416|468944423|FG000|Overall Study|Withdrew consent|1|||
130267300|NCT00442416|468944424|FG001|Overall Study|Withdrew consent|2|||
130267301|NCT00442416|468944423|FG000|Overall Study|Administrative/Other|27|||
130267302|NCT00442416|468944424|FG001|Overall Study|Administrative/Other|33|||
130267303|NCT00087698|468944425|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
130267304|NCT00087698|468944425|FG000|Overall Study|Death from Other Causes|3|||
130267305|NCT00087698|468944425|FG000|Overall Study|Adverse Event|4|||
130267306|NCT00087698|468944425|FG000|Overall Study|Withdrawal by Subject|4|||
130267307|NCT00087698|468944425|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
130267308|NCT00087698|468944425|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130267309|NCT00087698|468944425|FG000|Overall Study|Clinical Relapse|1|||
130267310|NCT00087698|468944425|FG000|Overall Study|Death from Study Disease|2|||
130267311|NCT00087698|468944425|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130267312|NCT00087698|468944425|FG000|Overall Study|Protocol Violation|1|||
130267313|NCT00142792|468944429|FG000|Overall Study|Death|0|||
130267314|NCT00142792|468944430|FG001|Overall Study|Death|0|||
130267315|NCT00142792|468944431|FG002|Overall Study|Death|1|||
130267316|NCT00142792|468944429|FG000|Overall Study|Withdrawal by Subject|3|||
130267317|NCT00142792|468944430|FG001|Overall Study|Withdrawal by Subject|2|||
130704445|NCT01235442|470541277|FG001|Overall Study|Noncompliance|2|||
130704446|NCT01235442|470541276|FG000|Overall Study|Administrative decision|1|||
130704447|NCT01235442|470541277|FG001|Overall Study|Administrative decision|2|||
130267318|NCT00142792|468944431|FG002|Overall Study|Withdrawal by Subject|3|||
130267319|NCT00142792|468944429|FG000|Overall Study|Lost to Follow-up|8|||
130267320|NCT00142792|468944430|FG001|Overall Study|Lost to Follow-up|11|||
130267321|NCT00142792|468944431|FG002|Overall Study|Lost to Follow-up|7|||
130267322|NCT00142792|468944429|FG000|Overall Study|No category|1|||
130365795|NCT02264639|469308585|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130365796|NCT02264639|469308586|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130267323|NCT00142792|468944430|FG001|Overall Study|No category|2|||
130365797|NCT02264639|469308582|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130267324|NCT00142792|468944431|FG002|Overall Study|No category|1|||
130267325|NCT01913327|468944438|FG000|Overall Study|Withdrawal by Subject|0|||
130704448|NCT01235442|470541276|FG000|Overall Study|Other unspecified|1|||
130704449|NCT01235442|470541277|FG001|Overall Study|Other unspecified|2|||
130704450|NCT03712124|470541278|FG000|Overall Study|Protocol Violation|1|||
130267326|NCT01913327|468944439|FG001|Overall Study|Withdrawal by Subject|1|||
130267327|NCT03816176|468944441|FG000|Overall Study|Miscellaneous|5|||
130267328|NCT03816176|468944441|FG000|Overall Study|Lack of Efficacy|4|||
130267329|NCT03816176|468944441|FG000|Overall Study|Adverse Event|3|||
130267330|NCT00756275|468945708|FG000|Overall Study|Lost to Follow-up|25|||
130267331|NCT00756275|468945709|FG001|Overall Study|Lost to Follow-up|21|||
130267332|NCT00756275|468945708|FG000|Overall Study|Withdrawal by Subject|4|||
130267333|NCT00756275|468945709|FG001|Overall Study|Withdrawal by Subject|7|||
130267334|NCT00938912|468945710|FG000|Overall Study|Withdrawal by Subject|28|||
130267335|NCT00938912|468945710|FG000|Overall Study|Lost to Follow-up|4|||
130267336|NCT00938912|468945710|FG000|Overall Study|Lack of Efficacy|43|||
130267337|NCT00938912|468945710|FG000|Overall Study|Adverse event, non-fatal|24|||
130267338|NCT00938912|468945710|FG000|Overall Study|Adverse event, fatal|1|||
130267339|NCT00938912|468945710|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
130267340|NCT00938912|468945710|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
130267341|NCT00938912|468945710|FG000|Overall Study|Participant needed prohibit medication|1|||
130267342|NCT00938912|468945710|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
130267343|NCT00938912|468945710|FG000|Overall Study|Did not meet Eligibility criteria|1|||
130267344|NCT00938912|468945710|FG000|Overall Study|Participant relocated not related to AE|1|||
130267345|NCT00938912|468945710|FG000|Overall Study|Participant moved to another city|1|||
130267346|NCT00938912|468945710|FG000|Overall Study|Participant experienced break through seizures|1|||
130267347|NCT00938912|468945710|FG000|Overall Study|No longer wished to participate in the study|1|||
130267348|NCT00938912|468945710|FG000|Overall Study|Protocol Deviation|2|||
130267349|NCT00456755|468945714|FG000|Overall Study|Lost to Follow-up|2|||
130267350|NCT00456755|468945715|FG001|Overall Study|Lost to Follow-up|1|||
130267351|NCT06164691|468945716|FG000|Overall Study|Withdrawal by Subject|2|||
130267352|NCT06164691|468945717|FG001|Overall Study|Withdrawal by Subject|0|||
130267353|NCT06164691|468945718|FG002|Overall Study|Withdrawal by Subject|0|||
130267354|NCT02477527|468945721|FG000|Overall Study|Lost to Follow-up|2|||
130267355|NCT02477527|468945721|FG000|Overall Study|Withdrawal by Subject|1|||
130267356|NCT02477527|468945721|FG000|Overall Study|Screen Failure|3|||
130267357|NCT01428219|468945737|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
130267358|NCT03432494|468945746|FG000|Overall Study|Death|1|||
130267359|NCT03432494|468945746|FG000|Overall Study|Noncompliance|1|||
130267360|NCT01696773|468945747|FG000|Days 15-27, Washout|Adverse Event|1|||
130267361|NCT01696773|468945748|FG001|Days 15-27, Washout|Adverse Event|0|||
130267362|NCT00347932|468945751|FG000|Overall Study|Adverse Event|4|||
130267363|NCT00347932|468945752|FG001|Overall Study|Adverse Event|5|||
130267364|NCT00347932|468945751|FG000|Overall Study|Lack of Efficacy|3|||
130267365|NCT00347932|468945752|FG001|Overall Study|Lack of Efficacy|14|||
130267366|NCT00347932|468945751|FG000|Overall Study|Lost to Follow-up|10|||
130267367|NCT00347932|468945752|FG001|Overall Study|Lost to Follow-up|9|||
130267368|NCT00347932|468945751|FG000|Overall Study|Withdrawal by Subject|10|||
130267369|NCT00347932|468945752|FG001|Overall Study|Withdrawal by Subject|16|||
130267370|NCT00347932|468945751|FG000|Overall Study|Did not meet inclusion criteria|4|||
130267371|NCT00347932|468945752|FG001|Overall Study|Did not meet inclusion criteria|8|||
130267372|NCT04512001|468945753|FG000|Week 0 to Week 24|Adverse Event|14|||
130267373|NCT04512001|468945754|FG001|Week 0 to Week 24|Adverse Event|10|||
130267374|NCT04512001|468945755|FG002|Week 0 to Week 24|Adverse Event|0|||
130267375|NCT04512001|468945756|FG003|Week 0 to Week 24|Adverse Event|0|||
130267376|NCT04512001|468945757|FG004|Week 0 to Week 24|Adverse Event|0|||
130267377|NCT04512001|468945753|FG000|Week 0 to Week 24|Death|0|||
130267378|NCT04512001|468945754|FG001|Week 0 to Week 24|Death|2|||
130267379|NCT04512001|468945755|FG002|Week 0 to Week 24|Death|0|||
130267380|NCT04512001|468945756|FG003|Week 0 to Week 24|Death|0|||
130267381|NCT04512001|468945757|FG004|Week 0 to Week 24|Death|0|||
130267382|NCT04512001|468945753|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
130453361|NCT03761784|469623574|FG001|Overall Study|Other Than Specified|0|||
130453362|NCT00586339|469623575|FG000|Overall Study|Withdrawal by Subject|1|||
130453363|NCT00586339|469623576|FG001|Overall Study|Withdrawal by Subject|3|||
130453364|NCT00586339|469623577|FG002|Overall Study|Withdrawal by Subject|1|||
130453365|NCT00586339|469623575|FG000|Overall Study|Migrated/moved from study area|3|||
130267383|NCT04512001|468945754|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
130267384|NCT04512001|468945755|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
130267385|NCT04512001|468945756|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
130453366|NCT00586339|469623576|FG001|Overall Study|Migrated/moved from study area|2|||
130453367|NCT00586339|469623577|FG002|Overall Study|Migrated/moved from study area|4|||
130267386|NCT04512001|468945757|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
130267387|NCT04512001|468945753|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130267388|NCT04512001|468945754|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130267389|NCT04512001|468945755|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267390|NCT04512001|468945756|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267391|NCT04512001|468945757|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267392|NCT04512001|468945753|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
130704451|NCT03712124|470541279|FG001|Overall Study|Protocol Violation|0|||
130704452|NCT02941523|470541281|FG000|Monotherapy|Withdrawal by Subject|0|||
130704453|NCT02941523|470541282|FG001|Monotherapy|Withdrawal by Subject|1|||
130704454|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
130704455|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
130704456|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Death|1|||
130267393|NCT04512001|468945754|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267394|NCT04512001|468945755|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267395|NCT04512001|468945756|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267396|NCT04512001|468945757|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267397|NCT04512001|468945753|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267398|NCT04512001|468945754|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
130267399|NCT04512001|468945755|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267400|NCT04512001|468945756|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267401|NCT04512001|468945757|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267402|NCT04512001|468945753|FG000|Week 24 to Week 63|Adverse Event|0|||
130267403|NCT04512001|468945754|FG001|Week 24 to Week 63|Adverse Event|0|||
130267404|NCT04512001|468945755|FG002|Week 24 to Week 63|Adverse Event|13|||
130267405|NCT04512001|468945756|FG003|Week 24 to Week 63|Adverse Event|8|||
130267406|NCT04512001|468945757|FG004|Week 24 to Week 63|Adverse Event|6|||
130267407|NCT04512001|468945753|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
130267408|NCT04512001|468945754|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
130267409|NCT04512001|468945755|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
130267410|NCT04512001|468945756|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
130267411|NCT04512001|468945757|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
130267412|NCT04512001|468945753|FG000|Week 24 to Week 63|Death|0|||
130267413|NCT04512001|468945754|FG001|Week 24 to Week 63|Death|0|||
130267414|NCT04512001|468945755|FG002|Week 24 to Week 63|Death|0|||
130267415|NCT04512001|468945756|FG003|Week 24 to Week 63|Death|1|||
130267416|NCT04512001|468945757|FG004|Week 24 to Week 63|Death|1|||
130267417|NCT04512001|468945753|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
130267418|NCT04512001|468945754|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
130267419|NCT04512001|468945755|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
130267420|NCT04512001|468945756|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
130267421|NCT04512001|468945757|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
130267422|NCT04512001|468945753|FG000|Week 24 to Week 63|Miscellaneous|0|||
130267423|NCT04512001|468945754|FG001|Week 24 to Week 63|Miscellaneous|0|||
130267424|NCT04512001|468945755|FG002|Week 24 to Week 63|Miscellaneous|3|||
130267425|NCT04512001|468945756|FG003|Week 24 to Week 63|Miscellaneous|2|||
130267426|NCT04512001|468945757|FG004|Week 24 to Week 63|Miscellaneous|1|||
130267427|NCT02776683|468945758|FG000|Pre-switch Period|Protocol Violation|1|||
130267428|NCT02776683|468945759|FG001|Pre-switch Period|Protocol Violation|0|||
130267429|NCT02776683|468945758|FG000|Pre-switch Period|Adverse Event|21|||
130267430|NCT02776683|468945759|FG001|Pre-switch Period|Adverse Event|0|||
130267431|NCT02776683|468945758|FG000|Pre-switch Period|Withdrawal by Subject|9|||
130267432|NCT02776683|468945759|FG001|Pre-switch Period|Withdrawal by Subject|0|||
130267433|NCT02776683|468945758|FG000|Pre-switch Period|Physician Decision|7|||
130267434|NCT02776683|468945759|FG001|Pre-switch Period|Physician Decision|0|||
130267435|NCT02776683|468945758|FG000|Pre-switch Period|Progressive disease|39|||
130267436|NCT02776683|468945759|FG001|Pre-switch Period|Progressive disease|0|||
130267437|NCT02776683|468945758|FG000|Pre-switch Period|Other than listed|3|||
130267438|NCT02776683|468945759|FG001|Pre-switch Period|Other than listed|0|||
130267439|NCT02776683|468945758|FG000|Post-switch Period|Adverse Event|0|||
130267440|NCT02776683|468945759|FG001|Post-switch Period|Adverse Event|3|||
130267441|NCT02776683|468945758|FG000|Post-switch Period|Withdrawal by Subject|0|||
130267442|NCT02776683|468945759|FG001|Post-switch Period|Withdrawal by Subject|2|||
130267443|NCT02776683|468945758|FG000|Post-switch Period|Physician Decision|0|||
130267444|NCT02776683|468945759|FG001|Post-switch Period|Physician Decision|3|||
130267445|NCT02776683|468945758|FG000|Post-switch Period|Progressive disease|0|||
130267446|NCT02776683|468945759|FG001|Post-switch Period|Progressive disease|20|||
130267447|NCT02776683|468945758|FG000|Post-switch Period|Other than listed|0|||
130267448|NCT02776683|468945759|FG001|Post-switch Period|Other than listed|15|||
130267449|NCT04232943|468945764|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130267450|NCT04232943|468945765|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
130267451|NCT04232943|468945766|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
130267452|NCT04232943|468945764|FG000|Overall Study|Withdrawal by Subject|1|||
130267453|NCT04232943|468945765|FG001|Overall Study|Withdrawal by Subject|1|||
130267454|NCT04232943|468945766|FG002|Overall Study|Withdrawal by Subject|0|||
130267455|NCT02298868|468945768|FG000|Overall Study|Adverse Event|1|||
130267456|NCT02298868|468945768|FG000|Overall Study|Death|1|||
130267457|NCT02298868|468945768|FG000|Overall Study|Patient underwent transplant|1|||
130704457|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Death|2|||
130704458|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Disease progression|2|||
130704459|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Disease progression|0|||
130267458|NCT01000506|468945769|FG000|Overall Study|Adverse Event|6|||
130267459|NCT01000506|468945770|FG001|Overall Study|Adverse Event|5|||
130267460|NCT01000506|468945771|FG002|Overall Study|Adverse Event|8|||
130267461|NCT01000506|468945772|FG003|Overall Study|Adverse Event|9|||
130267462|NCT01000506|468945769|FG000|Overall Study|Lack of Efficacy|8|||
130267463|NCT01000506|468945770|FG001|Overall Study|Lack of Efficacy|6|||
130267464|NCT01000506|468945771|FG002|Overall Study|Lack of Efficacy|4|||
130267465|NCT01000506|468945772|FG003|Overall Study|Lack of Efficacy|4|||
130267466|NCT01000506|468945769|FG000|Overall Study|Protocol Violation|1|||
130267467|NCT01000506|468945770|FG001|Overall Study|Protocol Violation|1|||
130267468|NCT01000506|468945771|FG002|Overall Study|Protocol Violation|0|||
130267469|NCT01000506|468945772|FG003|Overall Study|Protocol Violation|0|||
130267470|NCT01000506|468945769|FG000|Overall Study|Lost to Follow-up|1|||
130267471|NCT01000506|468945770|FG001|Overall Study|Lost to Follow-up|1|||
130267472|NCT01000506|468945771|FG002|Overall Study|Lost to Follow-up|4|||
130267473|NCT01000506|468945772|FG003|Overall Study|Lost to Follow-up|0|||
130267474|NCT01000506|468945769|FG000|Overall Study|Physician Decision|1|||
130267475|NCT01000506|468945770|FG001|Overall Study|Physician Decision|3|||
130267476|NCT01000506|468945771|FG002|Overall Study|Physician Decision|3|||
130267477|NCT01000506|468945772|FG003|Overall Study|Physician Decision|3|||
130267478|NCT01000506|468945769|FG000|Overall Study|Withdrawal by Subject|11|||
130267479|NCT01000506|468945770|FG001|Overall Study|Withdrawal by Subject|8|||
130267480|NCT01000506|468945771|FG002|Overall Study|Withdrawal by Subject|2|||
130267481|NCT01000506|468945772|FG003|Overall Study|Withdrawal by Subject|7|||
130267482|NCT02379052|468945773|FG000|Overall Study|Protocol Violation|0|||
130267483|NCT02379052|468945774|FG001|Overall Study|Protocol Violation|1|||
130267484|NCT02379052|468945773|FG000|Overall Study|Adverse Event|0|||
130267485|NCT02379052|468945774|FG001|Overall Study|Adverse Event|1|||
130267486|NCT02379052|468945773|FG000|Overall Study|Physician Decision|1|||
130267487|NCT02379052|468945774|FG001|Overall Study|Physician Decision|1|||
130267488|NCT02379052|468945773|FG000|Overall Study|Withdrawal by Subject|2|||
130267489|NCT02379052|468945774|FG001|Overall Study|Withdrawal by Subject|0|||
130267490|NCT02379052|468945773|FG000|Overall Study|Lost to Follow-up|2|||
130267491|NCT02379052|468945774|FG001|Overall Study|Lost to Follow-up|1|||
130267492|NCT02379052|468945773|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
130267493|NCT02379052|468945774|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
130267494|NCT02379052|468945773|FG000|Overall Study|Subject was Incarcerated|0|||
130267495|NCT02379052|468945774|FG001|Overall Study|Subject was Incarcerated|1|||
130267496|NCT00532844|468945775|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
130267497|NCT00532844|468945776|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
130267498|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
130267499|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
130267500|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
130267501|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
130267502|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
130267503|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
130267504|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
130267505|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
130267506|NCT03637491|468945777|FG000|Overall Study|Death|9|||
130267507|NCT03637491|468945778|FG001|Overall Study|Death|9|||
130267508|NCT03637491|468945779|FG002|Overall Study|Death|5|||
130267509|NCT03637491|468945780|FG003|Overall Study|Death|3|||
130267510|NCT03637491|468945777|FG000|Overall Study|Lost to Follow-up|0|||
130267511|NCT03637491|468945778|FG001|Overall Study|Lost to Follow-up|1|||
130267512|NCT03637491|468945779|FG002|Overall Study|Lost to Follow-up|0|||
130267513|NCT03637491|468945780|FG003|Overall Study|Lost to Follow-up|1|||
130267514|NCT03637491|468945777|FG000|Overall Study|Study Terminated By Sponsor|0|||
130267515|NCT03637491|468945778|FG001|Overall Study|Study Terminated By Sponsor|2|||
130267516|NCT03637491|468945779|FG002|Overall Study|Study Terminated By Sponsor|1|||
130267517|NCT03637491|468945780|FG003|Overall Study|Study Terminated By Sponsor|0|||
130554009|NCT01369511|469996479|FG002|Overall Study|Entry criteria not met|0|||
130267518|NCT03637491|468945777|FG000|Overall Study|Withdrawal by Subject|1|||
130267519|NCT03637491|468945778|FG001|Overall Study|Withdrawal by Subject|0|||
130267520|NCT03637491|468945779|FG002|Overall Study|Withdrawal by Subject|1|||
130267521|NCT03637491|468945780|FG003|Overall Study|Withdrawal by Subject|2|||
130267522|NCT00003869|468945796|FG000|Overall Study|Adverse Event|14|||
130267523|NCT00003869|468945797|FG001|Overall Study|Adverse Event|3|||
130267524|NCT00003869|468945796|FG000|Overall Study|Withdrawal by Subject|21|||
130267525|NCT00003869|468945797|FG001|Overall Study|Withdrawal by Subject|3|||
130267526|NCT00003869|468945796|FG000|Overall Study|Death|1|||
130267527|NCT00003869|468945797|FG001|Overall Study|Death|2|||
130267528|NCT00003869|468945796|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
130267529|NCT00003869|468945797|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
130267530|NCT03364231|468945798|FG000|Overall Study|Adverse Event|1|||
130267531|NCT03364231|468945799|FG001|Overall Study|Adverse Event|4|||
130267532|NCT03364231|468945798|FG000|Overall Study|Death|1|||
130267533|NCT03364231|468945799|FG001|Overall Study|Death|0|||
130267534|NCT03364231|468945798|FG000|Overall Study|Investigator Decision|2|||
130267535|NCT03364231|468945799|FG001|Overall Study|Investigator Decision|2|||
130267536|NCT03364231|468945798|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
130267537|NCT03364231|468945799|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
130267538|NCT03364231|468945798|FG000|Overall Study|Withdrawal of Subject Consent|1|||
130267539|NCT03364231|468945799|FG001|Overall Study|Withdrawal of Subject Consent|0|||
130267540|NCT03364231|468945798|FG000|Overall Study|Reason Not Specified|1|||
130267541|NCT03364231|468945799|FG001|Overall Study|Reason Not Specified|0|||
130267542|NCT03364231|468945798|FG000|Overall Study|Disease Progression|0|||
130267543|NCT03364231|468945799|FG001|Overall Study|Disease Progression|6|||
130267544|NCT04068922|468945800|FG000|Overall Study|Lost to Follow-up|5|||
130267545|NCT04068922|468945800|FG000|Overall Study|Withdrawal by Subject|7|||
130267546|NCT04068922|468945800|FG000|Overall Study|Adverse Event|1|||
130267547|NCT03542266|468945801|FG000|Treatment Phase|Withdrawal by Subject|1|||
130267548|NCT03542266|468945801|FG000|Treatment Phase|Adverse Event|1|||
130267549|NCT03542266|468945801|FG000|Treatment Phase|PD|1|||
130267550|NCT01070979|468945809|FG000|Overall Study|Adverse Event|2|||
130267551|NCT01070979|468945810|FG001|Overall Study|Adverse Event|3|||
130267552|NCT01070979|468945811|FG002|Overall Study|Adverse Event|3|||
130267553|NCT01070979|468945809|FG000|Overall Study|Lost to Follow-up|2|||
130267554|NCT01070979|468945810|FG001|Overall Study|Lost to Follow-up|1|||
130267555|NCT01070979|468945811|FG002|Overall Study|Lost to Follow-up|1|||
130267556|NCT01070979|468945809|FG000|Overall Study|Protocol Violation|0|||
130267557|NCT01070979|468945810|FG001|Overall Study|Protocol Violation|2|||
130267558|NCT01070979|468945811|FG002|Overall Study|Protocol Violation|6|||
130267559|NCT01070979|468945809|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
130267560|NCT01070979|468945810|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
130267561|NCT01070979|468945811|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
130267562|NCT01070979|468945809|FG000|Overall Study|Withdrawal by Subject|3|||
130267563|NCT01070979|468945810|FG001|Overall Study|Withdrawal by Subject|1|||
130267564|NCT01070979|468945811|FG002|Overall Study|Withdrawal by Subject|1|||
130267565|NCT01070979|468945809|FG000|Overall Study|No study drug taken|0|||
130267566|NCT01070979|468945810|FG001|Overall Study|No study drug taken|1|||
130267567|NCT01070979|468945811|FG002|Overall Study|No study drug taken|0|||
130267568|NCT03484429|468945813|FG000|Overall Study|Withdrawal by Subject|1|||
130267569|NCT03484429|468945814|FG001|Overall Study|Withdrawal by Subject|0|||
130267570|NCT03484429|468945813|FG000|Overall Study|Adverse Event|2|||
130267571|NCT03484429|468945814|FG001|Overall Study|Adverse Event|0|||
130267572|NCT05653700|468945815|FG000|Overall Study|Non Responders|9|||
130267573|NCT05653700|468945816|FG001|Overall Study|Non Responders|0|||
130267574|NCT02573948|468945819|FG000|Longitudinal Cohort|Death|9|||
130267575|NCT02573948|468945819|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
130267576|NCT02573948|468945819|FG000|Longitudinal Cohort|Incarcerated|25|||
130267577|NCT00707993|468945822|FG000|Overall Study|Adverse Event|16|||
130267578|NCT00707993|468945823|FG001|Overall Study|Adverse Event|20|||
130267579|NCT00707993|468945822|FG000|Overall Study|Protocol Violation|4|||
130267580|NCT00707993|468945823|FG001|Overall Study|Protocol Violation|7|||
130267581|NCT00707993|468945822|FG000|Overall Study|Lost to Follow-up|0|||
130267582|NCT00707993|468945823|FG001|Overall Study|Lost to Follow-up|4|||
130267583|NCT00707993|468945822|FG000|Overall Study|Withdrawal by Subject|12|||
130267584|NCT00707993|468945823|FG001|Overall Study|Withdrawal by Subject|16|||
130267585|NCT00707993|468945822|FG000|Overall Study|Hyperglycemic Rescue|55|||
130267586|NCT00707993|468945823|FG001|Overall Study|Hyperglycemic Rescue|47|||
130267587|NCT00707993|468945822|FG000|Overall Study|Other|2|||
130267588|NCT00707993|468945823|FG001|Overall Study|Other|0|||
130267589|NCT05414175|468945829|FG000|Overall Study|Withdrawal by Subject|1|||
130267590|NCT05414175|468945829|FG000|Overall Study|Other Reasons|1|||
130267591|NCT02112656|468945832|FG000|Overall Study|Death|78|||
130267592|NCT02112656|468945833|FG001|Overall Study|Death|82|||
130267593|NCT02112656|468945832|FG000|Overall Study|Withdrawal by Subject|9|||
130267594|NCT02112656|468945833|FG001|Overall Study|Withdrawal by Subject|11|||
130267595|NCT02112656|468945832|FG000|Overall Study|Lost to Follow-up|2|||
130267596|NCT02112656|468945833|FG001|Overall Study|Lost to Follow-up|4|||
130267597|NCT02112656|468945832|FG000|Overall Study|Noncompliance|1|||
130267598|NCT02112656|468945833|FG001|Overall Study|Noncompliance|2|||
130267599|NCT03761056|468945834|FG000|Overall Study|Death|8|||
130267600|NCT03761056|468945834|FG000|Overall Study|Enrolled but never treated|2|||
130267601|NCT03761056|468945834|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
130267602|NCT03761056|468945834|FG000|Overall Study|Investigator decision|1|||
130267603|NCT04749745|468945835|FG000|Overall Study|Withdrawal by Subject|1|||
130267604|NCT04749745|468945836|FG001|Overall Study|Withdrawal by Subject|0|||
130267605|NCT03965403|468945843|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
130267606|NCT00552071|468947040|FG000|Overall Study|Adverse Event|1|||
130267607|NCT00552071|468947041|FG001|Overall Study|Adverse Event|0|||
130267608|NCT00552071|468947040|FG000|Overall Study|Lack of Efficacy|1|||
130267609|NCT00552071|468947041|FG001|Overall Study|Lack of Efficacy|0|||
130267610|NCT00552071|468947040|FG000|Overall Study|Physician Decision|1|||
130267611|NCT00552071|468947041|FG001|Overall Study|Physician Decision|0|||
130267612|NCT00552071|468947040|FG000|Overall Study|Pregnancy|1|||
130267613|NCT00552071|468947041|FG001|Overall Study|Pregnancy|0|||
130267614|NCT00552071|468947040|FG000|Overall Study|Death|0|||
130267615|NCT00552071|468947041|FG001|Overall Study|Death|1|||
130267616|NCT00552071|468947040|FG000|Overall Study|Withdrawal by Subject|0|||
130267617|NCT00552071|468947041|FG001|Overall Study|Withdrawal by Subject|1|||
130267618|NCT01979614|468947042|FG000|Overall Study|Adverse Event|1|||
130267619|NCT01979614|468947043|FG001|Overall Study|Adverse Event|1|||
130267620|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130267621|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130267622|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
130267623|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
130267624|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130267625|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130704460|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
130704461|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
130704462|NCT04499482|470541283|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
130267626|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130267627|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
130365798|NCT02264639|469308583|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130365799|NCT02264639|469308584|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
130365800|NCT02264639|469308585|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130365801|NCT02264639|469308586|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130365802|NCT02264639|469308582|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130365803|NCT02264639|469308583|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130365804|NCT02264639|469308584|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130365805|NCT02264639|469308585|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130365806|NCT02264639|469308586|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
130365807|NCT01058655|469308587|FG000|Overall Study|Withdrawal by Subject|1|||
130365808|NCT01058655|469308588|FG001|Overall Study|Withdrawal by Subject|0|||
130365809|NCT01058655|469308589|FG002|Overall Study|Withdrawal by Subject|3|||
130365810|NCT01058655|469308590|FG003|Overall Study|Withdrawal by Subject|4|||
130365811|NCT01058655|469308587|FG000|Overall Study|Prolonged Treatment Delay|0|||
130365812|NCT01058655|469308588|FG001|Overall Study|Prolonged Treatment Delay|0|||
130365813|NCT01058655|469308589|FG002|Overall Study|Prolonged Treatment Delay|0|||
130365814|NCT01058655|469308590|FG003|Overall Study|Prolonged Treatment Delay|2|||
130365815|NCT01058655|469308587|FG000|Overall Study|Symptomatic Deterioration|0|||
130365816|NCT01058655|469308588|FG001|Overall Study|Symptomatic Deterioration|0|||
130365817|NCT01058655|469308589|FG002|Overall Study|Symptomatic Deterioration|0|||
130365818|NCT01058655|469308590|FG003|Overall Study|Symptomatic Deterioration|1|||
130365819|NCT01058655|469308587|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
130365820|NCT01058655|469308588|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
130365821|NCT01058655|469308589|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
130365822|NCT01058655|469308590|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
130365823|NCT01058655|469308587|FG000|Overall Study|Death|0|||
130365824|NCT01058655|469308588|FG001|Overall Study|Death|1|||
130365825|NCT01058655|469308589|FG002|Overall Study|Death|1|||
130365826|NCT01058655|469308590|FG003|Overall Study|Death|0|||
130365827|NCT01058655|469308587|FG000|Overall Study|Disease Progression|1|||
130365828|NCT01058655|469308588|FG001|Overall Study|Disease Progression|2|||
130365829|NCT01058655|469308589|FG002|Overall Study|Disease Progression|4|||
130365830|NCT01058655|469308590|FG003|Overall Study|Disease Progression|24|||
130365831|NCT01058655|469308587|FG000|Overall Study|Other|0|||
130365832|NCT01058655|469308588|FG001|Overall Study|Other|0|||
130365833|NCT01058655|469308589|FG002|Overall Study|Other|0|||
130365834|NCT01058655|469308590|FG003|Overall Study|Other|4|||
130365835|NCT04472429|469308591|FG000|Randomized Period|Ongoing|90|||
130365836|NCT04472429|469308592|FG001|Randomized Period|Ongoing|40|||
130365837|NCT04472429|469308593|FG002|Randomized Period|Ongoing|0|||
130365838|NCT04472429|469308591|FG000|Randomized Period|Death|52|||
130365839|NCT04472429|469308592|FG001|Randomized Period|Death|37|||
130365840|NCT04472429|469308593|FG002|Randomized Period|Death|0|||
130365841|NCT04472429|469308591|FG000|Randomized Period|Lost to Follow-up|4|||
130365842|NCT04472429|469308592|FG001|Randomized Period|Lost to Follow-up|0|||
130365843|NCT04472429|469308593|FG002|Randomized Period|Lost to Follow-up|0|||
130365844|NCT04472429|469308591|FG000|Randomized Period|Physician Decision|1|||
130365845|NCT04472429|469308592|FG001|Randomized Period|Physician Decision|2|||
130365846|NCT04472429|469308593|FG002|Randomized Period|Physician Decision|0|||
130365847|NCT04472429|469308591|FG000|Randomized Period|Withdrawal by Subject|6|||
130365848|NCT04472429|469308592|FG001|Randomized Period|Withdrawal by Subject|5|||
130365849|NCT04472429|469308593|FG002|Randomized Period|Withdrawal by Subject|0|||
130365850|NCT04472429|469308591|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
130267628|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130267629|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
130267630|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
130267631|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
130267632|NCT03333928|468947044|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
130267633|NCT03333928|468947045|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
130267634|NCT03333928|468947046|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
130267635|NCT03333928|468947044|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
130267636|NCT03333928|468947045|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130267637|NCT03333928|468947046|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130267638|NCT03333928|468947044|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
130267639|NCT03333928|468947045|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130267640|NCT03333928|468947046|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130267641|NCT03333928|468947044|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130267642|NCT03333928|468947045|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
130267643|NCT03333928|468947046|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130267644|NCT04072835|468947047|FG000|Overall Study|Overall trial ended|603|||
130267645|NCT04072835|468947047|FG000|Overall Study|Ablation|97|||
130267646|NCT04072835|468947047|FG000|Overall Study|Withdrawal of consent|66|||
130267647|NCT04072835|468947047|FG000|Overall Study|Physician Decision|50|||
130267648|NCT04072835|468947047|FG000|Overall Study|Lost to Follow-up|39|||
130267649|NCT04072835|468947047|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
130267650|NCT04072835|468947047|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
130267651|NCT04072835|468947047|FG000|Overall Study|Adverse Event|25|||
130267652|NCT04072835|468947047|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
130267653|NCT04072835|468947047|FG000|Overall Study|Death|11|||
130365851|NCT04472429|469308592|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
130365852|NCT04472429|469308593|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
130365853|NCT04472429|469308591|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
130365854|NCT04472429|469308592|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
130365855|NCT04472429|469308593|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
130365856|NCT04472429|469308591|FG000|Open-label Monotherapy Period|Ongoing|0|||
130365857|NCT04472429|469308592|FG001|Open-label Monotherapy Period|Ongoing|0|||
130365858|NCT04472429|469308593|FG002|Open-label Monotherapy Period|Ongoing|32|||
130365859|NCT04472429|469308591|FG000|Open-label Monotherapy Period|Death|0|||
130365860|NCT04472429|469308592|FG001|Open-label Monotherapy Period|Death|0|||
130365861|NCT04472429|469308593|FG002|Open-label Monotherapy Period|Death|35|||
130365862|NCT04472429|469308591|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
130365863|NCT04472429|469308592|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
130365864|NCT04472429|469308593|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
130365865|NCT01416272|469308596|FG000|Overall Study|Unacceptable distance visual acuity|2|||
130365866|NCT01416272|469308596|FG000|Overall Study|Lost to Follow-up|1|||
130365867|NCT01416272|469308596|FG000|Overall Study|Study related complaints|1|||
130365868|NCT02319837|469308597|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
130365869|NCT02319837|469308598|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
130365870|NCT02319837|469308599|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
130365871|NCT02319837|469308597|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
130365872|NCT02319837|469308598|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
130365873|NCT02319837|469308599|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
130365874|NCT02319837|469308597|FG000|Study Treatment Phase|Adverse Event|73|||
130365875|NCT02319837|469308598|FG001|Study Treatment Phase|Adverse Event|36|||
130365876|NCT02319837|469308599|FG002|Study Treatment Phase|Adverse Event|63|||
130365877|NCT02319837|469308597|FG000|Study Treatment Phase|Development of castration resistance|0|||
130365878|NCT02319837|469308598|FG001|Study Treatment Phase|Development of castration resistance|2|||
130365879|NCT02319837|469308599|FG002|Study Treatment Phase|Development of castration resistance|0|||
130365880|NCT02319837|469308597|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
130365881|NCT02319837|469308598|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
130365882|NCT02319837|469308599|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
130365883|NCT02319837|469308597|FG000|Study Treatment Phase|Protocol Violation|2|||
130365884|NCT02319837|469308598|FG001|Study Treatment Phase|Protocol Violation|2|||
130365885|NCT02319837|469308599|FG002|Study Treatment Phase|Protocol Violation|1|||
130365886|NCT02319837|469308597|FG000|Study Treatment Phase|Lost to Follow-up|0|||
130365887|NCT02319837|469308598|FG001|Study Treatment Phase|Lost to Follow-up|1|||
130365888|NCT02319837|469308599|FG002|Study Treatment Phase|Lost to Follow-up|0|||
130365889|NCT02319837|469308597|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
130267654|NCT04072835|468947047|FG000|Overall Study|Participant felt the drug did not work|8|||
130267655|NCT04072835|468947047|FG000|Overall Study|Participant tolerability|5|||
130267656|NCT04072835|468947047|FG000|Overall Study|Missing|5|||
130704463|NCT01899326|470541284|FG000|Overall Study|Withdrawal by Subject|1|||
130704464|NCT01899326|470541284|FG000|Overall Study|Adverse Event|2|||
130704465|NCT01899326|470541284|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
130704466|NCT00373425|470541285|FG000|Overall Study|Relapse of NSCLC|116|||
130704467|NCT00373425|470541286|FG001|Overall Study|Relapse of NSCLC|104|||
130704468|NCT00373425|470541287|FG002|Overall Study|Relapse of NSCLC|19|||
130267657|NCT04072835|468947047|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
130267658|NCT04072835|468947047|FG000|Overall Study|Pregnancy|3|||
130267659|NCT04723355|468947048|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
130267660|NCT04723355|468947048|FG000|Overall Study|Errors in the informed consent form|2|||
130267661|NCT00841776|468947051|FG000|Overall Study|Lack of Efficacy|0|||
130267662|NCT00841776|468947052|FG001|Overall Study|Lack of Efficacy|1|||
130267663|NCT00841776|468947051|FG000|Overall Study|Lost to Follow-up|2|||
130267664|NCT00841776|468947052|FG001|Overall Study|Lost to Follow-up|1|||
130267665|NCT00841776|468947051|FG000|Overall Study|Withdrawal by Subject|0|||
130267666|NCT00841776|468947052|FG001|Overall Study|Withdrawal by Subject|1|||
130267667|NCT02479880|468947055|FG000|Overall Study|Study Terminated by Sponsor|13|||
130365890|NCT02319837|469308598|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
130365891|NCT02319837|469308599|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
130365892|NCT02319837|469308597|FG000|Study Treatment Phase|Other|0|||
130365893|NCT02319837|469308598|FG001|Study Treatment Phase|Other|1|||
130365894|NCT02319837|469308599|FG002|Study Treatment Phase|Other|0|||
130365895|NCT02319837|469308597|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
130365896|NCT02319837|469308598|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
130365897|NCT02319837|469308599|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
130365898|NCT02319837|469308597|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
130365899|NCT02319837|469308598|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
130365900|NCT02319837|469308599|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
130365901|NCT02319837|469308597|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
130365902|NCT02319837|469308598|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
130365903|NCT02319837|469308599|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
130365904|NCT02319837|469308597|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
130365905|NCT02319837|469308598|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
130365906|NCT02319837|469308599|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
130365907|NCT02319837|469308597|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
130365908|NCT02319837|469308598|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
130365909|NCT02319837|469308599|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
130365910|NCT02319837|469308597|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
130365911|NCT02319837|469308598|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
130365912|NCT02319837|469308599|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
130365913|NCT02319837|469308597|FG000|Long-Term Follow-Up Phase|Death|33|||
130365914|NCT02319837|469308598|FG001|Long-Term Follow-Up Phase|Death|54|||
130365915|NCT02319837|469308599|FG002|Long-Term Follow-Up Phase|Death|42|||
130365916|NCT04545554|469308604|FG000|Overall Study|Withdrawal by Subject|0|||
130365917|NCT04545554|469308605|FG001|Overall Study|Withdrawal by Subject|0|||
130365918|NCT04545554|469308606|FG002|Overall Study|Withdrawal by Subject|0|||
130365919|NCT04545554|469308607|FG003|Overall Study|Withdrawal by Subject|1|||
130365920|NCT04545554|469308608|FG004|Overall Study|Withdrawal by Subject|0|||
130365921|NCT04545554|469308609|FG005|Overall Study|Withdrawal by Subject|0|||
130365922|NCT01313312|469308610|FG000|Overall Study|Adverse Event|5|||
130365923|NCT01313312|469308610|FG000|Overall Study|Withdrawal by Subject|18|||
130365924|NCT01313312|469308610|FG000|Overall Study|Lack of Efficacy|3|||
130365925|NCT01313312|469308610|FG000|Overall Study|Investigator Decision|1|||
130365926|NCT01313312|469308610|FG000|Overall Study|Observational Phase|1|||
130365927|NCT01313312|469308610|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
130365928|NCT01313312|469308610|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
130365929|NCT00660673|469308611|FG000|Overall Study|Adverse Event|84|||
130365930|NCT00660673|469308611|FG000|Overall Study|Lack of Efficacy|7|||
130365931|NCT00660673|469308611|FG000|Overall Study|Withdrawal by Subject|22|||
130365932|NCT00660673|469308611|FG000|Overall Study|Administrative|2|||
130365933|NCT00660673|469308611|FG000|Overall Study|Protocol Violation|2|||
130365934|NCT05306977|469308613|FG000|Overall Study|Withdrawal by Subject|1|||
130365935|NCT05213481|469308614|FG000|Overall Study|Adverse Event|3|||
130365936|NCT05213481|469308614|FG000|Overall Study|Lost to Follow-up|1|||
130365937|NCT00415168|469308618|FG000|Overall Study|Death|26|||
130365938|NCT00415168|469308618|FG000|Overall Study|Lost to Follow-up|3|||
130365939|NCT00415168|469308618|FG000|Overall Study|Physician Decision|13|||
130453368|NCT00586339|469623575|FG000|Overall Study|Lost to Follow-up|3|||
130453369|NCT00586339|469623576|FG001|Overall Study|Lost to Follow-up|2|||
130453370|NCT00586339|469623577|FG002|Overall Study|Lost to Follow-up|1|||
130453371|NCT04305912|469623580|FG000|First Intervention|COVID-19 Suspension|2|||
130453372|NCT04305912|469623581|FG001|First Intervention|COVID-19 Suspension|0|||
130453373|NCT04305912|469623580|FG000|First Intervention|Withdrawal by Subject|0|||
130453374|NCT04305912|469623581|FG001|First Intervention|Withdrawal by Subject|1|||
130453375|NCT04305912|469623580|FG000|Second Intervention|Adverse Event|0|||
130704469|NCT00373425|470541288|FG003|Overall Study|Relapse of NSCLC|2|||
130704470|NCT00373425|470541289|FG004|Overall Study|Relapse of NSCLC|26|||
130704471|NCT00373425|470541285|FG000|Overall Study|Adverse Event|191|||
130704472|NCT00373425|470541286|FG001|Overall Study|Adverse Event|22|||
130704473|NCT00373425|470541287|FG002|Overall Study|Adverse Event|59|||
130704474|NCT00373425|470541288|FG003|Overall Study|Adverse Event|0|||
130704475|NCT00373425|470541289|FG004|Overall Study|Adverse Event|34|||
130704476|NCT00373425|470541285|FG000|Overall Study|Patient request|35|||
130704477|NCT00373425|470541286|FG001|Overall Study|Patient request|18|||
130267668|NCT02479880|468947056|FG001|Overall Study|Study Terminated by Sponsor|12|||
130267669|NCT02479880|468947055|FG000|Overall Study|Pregnancy|0|||
130267670|NCT02479880|468947056|FG001|Overall Study|Pregnancy|1|||
130267671|NCT00856635|468947062|FG000|Overall Study|Lost to Follow-up|2|||
130267672|NCT00856635|468947063|FG001|Overall Study|Lost to Follow-up|5|||
130267673|NCT00856635|468947062|FG000|Overall Study|Pregnancy|1|||
130267674|NCT00856635|468947063|FG001|Overall Study|Pregnancy|0|||
130267675|NCT00856635|468947062|FG000|Overall Study|Withdrawal by Subject|3|||
130267676|NCT00856635|468947063|FG001|Overall Study|Withdrawal by Subject|1|||
130267677|NCT00856635|468947062|FG000|Overall Study|Serious Adverse Event|1|||
130704478|NCT00373425|470541287|FG002|Overall Study|Patient request|43|||
130704479|NCT00373425|470541288|FG003|Overall Study|Patient request|6|||
130704480|NCT00373425|470541289|FG004|Overall Study|Patient request|7|||
130704481|NCT00373425|470541285|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
130267678|NCT00856635|468947063|FG001|Overall Study|Serious Adverse Event|0|||
130267679|NCT00856635|468947062|FG000|Overall Study|Other|1|||
130267680|NCT00856635|468947063|FG001|Overall Study|Other|0|||
130267681|NCT00856635|468947062|FG000|Overall Study|Discontinued at Randomization|2|||
130267682|NCT00856635|468947063|FG001|Overall Study|Discontinued at Randomization|2|||
130267683|NCT01244035|468947064|FG000|Part 1: Period 1|Adverse Event|0|||
130267684|NCT01244035|468947065|FG001|Part 1: Period 1|Adverse Event|0|||
130267685|NCT01244035|468947066|FG002|Part 1: Period 1|Adverse Event|0|||
130267686|NCT01244035|468947067|FG003|Part 1: Period 1|Adverse Event|0|||
130267687|NCT01244035|468947068|FG004|Part 1: Period 1|Adverse Event|0|||
130267688|NCT01244035|468947069|FG005|Part 1: Period 1|Adverse Event|1|||
130267689|NCT01244035|468947064|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
130267690|NCT01244035|468947065|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
130267691|NCT01244035|468947066|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
130267692|NCT01244035|468947067|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
130267693|NCT01244035|468947068|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
130267694|NCT01244035|468947069|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
130267695|NCT01244035|468947064|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267696|NCT01244035|468947065|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130267697|NCT01244035|468947066|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
130267698|NCT01244035|468947067|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130267699|NCT01244035|468947068|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267700|NCT01244035|468947069|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267701|NCT01244035|468947064|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130704482|NCT00373425|470541286|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
130704483|NCT00373425|470541287|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
130704484|NCT00373425|470541288|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
130704485|NCT00373425|470541289|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
130704486|NCT00373425|470541285|FG000|Overall Study|Death|7|||
130704487|NCT00373425|470541286|FG001|Overall Study|Death|0|||
130704488|NCT00373425|470541287|FG002|Overall Study|Death|3|||
130704489|NCT00373425|470541288|FG003|Overall Study|Death|1|||
130704490|NCT00373425|470541289|FG004|Overall Study|Death|0|||
130704491|NCT00551616|470541292|FG000|Overall Study|Lost to Follow-up|48|||
130704492|NCT00551616|470541293|FG001|Overall Study|Lost to Follow-up|40|||
130267702|NCT01244035|468947065|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267703|NCT01244035|468947066|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
130453376|NCT04305912|469623581|FG001|Second Intervention|Adverse Event|1|||
130453377|NCT01649427|469623582|FG000|Overall Study|Adverse Event|1|||
130704493|NCT01083680|470541294|FG000|Overall Study|Lost to Follow-up|2758|||
130704494|NCT01083680|470541294|FG000|Overall Study|Withdrawal by Subject|1086|||
130704495|NCT03942211|470541295|FG000|Overall Study|Death|1|||
130704496|NCT03942211|470541296|FG001|Overall Study|Death|0|||
130704497|NCT03942211|470541295|FG000|Overall Study|Study terminated by sponsor|5|||
130704498|NCT03942211|470541296|FG001|Overall Study|Study terminated by sponsor|3|||
130704499|NCT03942211|470541295|FG000|Overall Study|Adverse Event|0|||
130704500|NCT03942211|470541296|FG001|Overall Study|Adverse Event|1|||
130267704|NCT01244035|468947067|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267705|NCT01244035|468947068|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267706|NCT01244035|468947069|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267707|NCT01244035|468947064|FG000|Part 1: Period 3|Adverse Event|0|||
130267708|NCT01244035|468947065|FG001|Part 1: Period 3|Adverse Event|0|||
130267709|NCT01244035|468947066|FG002|Part 1: Period 3|Adverse Event|0|||
130267710|NCT01244035|468947067|FG003|Part 1: Period 3|Adverse Event|0|||
130267711|NCT01244035|468947068|FG004|Part 1: Period 3|Adverse Event|0|||
130267712|NCT01244035|468947069|FG005|Part 1: Period 3|Adverse Event|1|||
130267713|NCT01244035|468947064|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
130267714|NCT01244035|468947065|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
130267715|NCT01244035|468947066|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
130267716|NCT01244035|468947067|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
130267717|NCT01244035|468947068|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
130267718|NCT01244035|468947069|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
130267719|NCT01244035|468947064|FG000|Part 1: Period 3|Protocol Deviation|0|||
130267720|NCT01244035|468947065|FG001|Part 1: Period 3|Protocol Deviation|1|||
130267721|NCT01244035|468947066|FG002|Part 1: Period 3|Protocol Deviation|0|||
130267722|NCT01244035|468947067|FG003|Part 1: Period 3|Protocol Deviation|0|||
130267723|NCT01244035|468947068|FG004|Part 1: Period 3|Protocol Deviation|0|||
130267724|NCT01244035|468947069|FG005|Part 1: Period 3|Protocol Deviation|0|||
130267725|NCT03688919|468947072|FG000|Overall Study|Lost to Follow-up|2|||
130267726|NCT03688919|468947073|FG001|Overall Study|Lost to Follow-up|1|||
130704501|NCT02219308|470541297|FG000|Overall Study|Withdrawal by Subject|1|||
130704502|NCT02219308|470541298|FG001|Overall Study|Withdrawal by Subject|2|||
130704503|NCT01976728|470542690|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
130704504|NCT01976728|470542691|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
130704505|NCT01976728|470542692|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
130704506|NCT01976728|470542693|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
130704507|NCT02356211|470542694|FG000|Overall Study|Withdrawal by Subject|2|||
130704508|NCT02356211|470542695|FG001|Overall Study|Withdrawal by Subject|2|||
130704509|NCT02356211|470542694|FG000|Overall Study|ineligible|1|||
130704510|NCT02356211|470542695|FG001|Overall Study|ineligible|8|||
130704511|NCT01563237|470542699|FG000|Overall Study|Lost to Follow-up|6|||
130267727|NCT03688919|468947072|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
130704512|NCT01563237|470542700|FG001|Overall Study|Lost to Follow-up|0|||
130704513|NCT01563237|470542699|FG000|Overall Study|Withdrawal by Subject|1|||
130704514|NCT01563237|470542700|FG001|Overall Study|Withdrawal by Subject|0|||
130704515|NCT01563237|470542699|FG000|Overall Study|Adverse Event|1|||
130704516|NCT01563237|470542700|FG001|Overall Study|Adverse Event|0|||
130704517|NCT01563237|470542699|FG000|Overall Study|Medical Reasons|1|||
130704518|NCT01563237|470542700|FG001|Overall Study|Medical Reasons|0|||
130704519|NCT01563237|470542699|FG000|Overall Study|Death|1|||
130704520|NCT01563237|470542700|FG001|Overall Study|Death|0|||
130704521|NCT00966381|470542701|FG000|Overall Study|Withdrawal by Subject|2|||
130704522|NCT00966381|470542702|FG001|Overall Study|Withdrawal by Subject|2|||
130704523|NCT00097786|470542706|FG000|Overall Study|lost to follow-up for all-cause death|296|||
130704524|NCT00097786|470542707|FG001|Overall Study|lost to follow-up for all-cause death|292|||
130704525|NCT00097786|470542708|FG002|Overall Study|lost to follow-up for all-cause death|313|||
130704526|NCT00097786|470542709|FG003|Overall Study|lost to follow-up for all-cause death|310|||
130704527|NCT02668822|470542710|FG000|Overall Study|Protocol Violation|2|||
130704528|NCT02668822|470542711|FG001|Overall Study|Protocol Violation|0|||
130704529|NCT02668822|470542710|FG000|Overall Study|Study Terminated by Sponsor|7|||
130704530|NCT02668822|470542711|FG001|Overall Study|Study Terminated by Sponsor|9|||
130704531|NCT01522950|470542712|FG000|Overall Study|Withdrawal by Subject|3|||
130704532|NCT01522950|470542713|FG001|Overall Study|Withdrawal by Subject|2|||
130704533|NCT01522950|470542714|FG002|Overall Study|Withdrawal by Subject|1|||
130704534|NCT01522950|470542712|FG000|Overall Study|Adverse Event|3|||
130704535|NCT01522950|470542713|FG001|Overall Study|Adverse Event|1|||
130453378|NCT01649427|469623583|FG001|Overall Study|Adverse Event|1|||
130453379|NCT01649427|469623582|FG000|Overall Study|Withdrawal by Subject|8|||
130453380|NCT01649427|469623583|FG001|Overall Study|Withdrawal by Subject|7|||
130453381|NCT01649427|469623582|FG000|Overall Study|Lost to Follow-up|0|||
130453382|NCT01649427|469623583|FG001|Overall Study|Lost to Follow-up|1|||
130453383|NCT01649427|469623582|FG000|Overall Study|Graft loss|0|||
130453384|NCT01649427|469623583|FG001|Overall Study|Graft loss|1|||
130453385|NCT01649427|469623582|FG000|Overall Study|Surgical problems during nephrectomy|2|||
130267728|NCT03688919|468947073|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
130267729|NCT02370368|468947074|FG000|Overall Study|Adverse Event|1|||
130267730|NCT02370368|468947075|FG001|Overall Study|Adverse Event|2|||
130267731|NCT02370368|468947074|FG000|Overall Study|Withdrawal by Subject|5|||
130267732|NCT02370368|468947075|FG001|Overall Study|Withdrawal by Subject|4|||
130267733|NCT03389308|468947078|FG000|Overall Study|Withdrawal by Subject|5|||
130453386|NCT01649427|469623583|FG001|Overall Study|Surgical problems during nephrectomy|2|||
130453387|NCT05196737|469623587|FG000|Non-intervention Week|Lost to Follow-up|2|||
130704536|NCT01522950|470542714|FG002|Overall Study|Adverse Event|1|||
130704537|NCT01522950|470542712|FG000|Overall Study|Protocol Violation|0|||
130267734|NCT03389308|468947078|FG000|Overall Study|Lost to Follow-up|3|||
130267735|NCT03389308|468947078|FG000|Overall Study|Adverse Event|2|||
130267736|NCT03389308|468947078|FG000|Overall Study|Sponsor Request|2|||
130267737|NCT03198767|468947079|FG000|Overall Study|Protocol Violation|0|||
130267738|NCT03198767|468947080|FG001|Overall Study|Protocol Violation|0|||
130267739|NCT03198767|468947081|FG002|Overall Study|Protocol Violation|0|||
130267740|NCT03198767|468947082|FG003|Overall Study|Protocol Violation|6|||
130267741|NCT03198767|468947083|FG004|Overall Study|Protocol Violation|0|||
130267742|NCT03198767|468947084|FG005|Overall Study|Protocol Violation|0|||
130267743|NCT03198767|468947085|FG006|Overall Study|Protocol Violation|0|||
130267744|NCT00570323|468947086|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
130267745|NCT00570323|468947087|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
130267746|NCT00570323|468947086|FG000|Started Treatment After Randomization|Protocol Violation|1|||
130267747|NCT00570323|468947087|FG001|Started Treatment After Randomization|Protocol Violation|0|||
130267748|NCT00570323|468947086|FG000|Started Treatment After Randomization|Physician Decision|1|||
130267749|NCT00570323|468947087|FG001|Started Treatment After Randomization|Physician Decision|0|||
130267750|NCT00570323|468947086|FG000|Complete Study After Start|Lost to Follow-up|0|||
130267751|NCT00570323|468947087|FG001|Complete Study After Start|Lost to Follow-up|1|||
130267752|NCT00570323|468947086|FG000|Complete Study After Start|Withdrawal by Subject|2|||
130267753|NCT00570323|468947087|FG001|Complete Study After Start|Withdrawal by Subject|0|||
130267754|NCT00570323|468947086|FG000|Complete Study After Start|Physician Decision|1|||
130267755|NCT00570323|468947087|FG001|Complete Study After Start|Physician Decision|0|||
130267756|NCT03896477|468947088|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
130267757|NCT03896477|468947089|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
130267758|NCT03896477|468947090|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
130267759|NCT03896477|468947088|FG000|Overall Study|Parent Requested Withdrawal|8|||
130267760|NCT03896477|468947089|FG001|Overall Study|Parent Requested Withdrawal|12|||
130267761|NCT03896477|468947090|FG002|Overall Study|Parent Requested Withdrawal|9|||
130267762|NCT03896477|468947088|FG000|Overall Study|Adverse Event|0|||
130267763|NCT03896477|468947089|FG001|Overall Study|Adverse Event|0|||
130267764|NCT03896477|468947090|FG002|Overall Study|Adverse Event|1|||
130267765|NCT03896477|468947088|FG000|Overall Study|Death|1|||
130267766|NCT03896477|468947089|FG001|Overall Study|Death|0|||
130267767|NCT03896477|468947090|FG002|Overall Study|Death|0|||
130267768|NCT03896477|468947088|FG000|Overall Study|Other|5|||
130453388|NCT05196737|469623587|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
130453389|NCT04888585|469623588|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
130453390|NCT04888585|469623589|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
130453391|NCT04888585|469623590|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
130453392|NCT04888585|469623591|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
130453393|NCT04888585|469623592|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
130453394|NCT04888585|469623593|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453395|NCT04888585|469623594|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453396|NCT04888585|469623595|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453397|NCT04888585|469623596|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453398|NCT04888585|469623597|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453399|NCT04888585|469623598|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130453400|NCT04888585|469623588|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453401|NCT04888585|469623589|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
130453402|NCT04888585|469623590|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
130453403|NCT04888585|469623591|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
130453404|NCT04888585|469623592|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
130453405|NCT04888585|469623593|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453406|NCT04888585|469623594|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453407|NCT04888585|469623595|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453408|NCT04888585|469623596|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453409|NCT04888585|469623597|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453410|NCT04888585|469623598|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130453411|NCT04888585|469623588|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130267769|NCT03896477|468947089|FG001|Overall Study|Other|6|||
130267770|NCT03896477|468947090|FG002|Overall Study|Other|7|||
130267771|NCT03896477|468947088|FG000|Overall Study|Lost to Follow-up|2|||
130267772|NCT03896477|468947089|FG001|Overall Study|Lost to Follow-up|1|||
130267773|NCT03896477|468947090|FG002|Overall Study|Lost to Follow-up|1|||
130267774|NCT01791517|468947091|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
130267775|NCT01791517|468947092|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
130267776|NCT01791517|468947093|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
130267777|NCT01791517|468947094|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
130453412|NCT04888585|469623589|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453413|NCT04888585|469623590|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
130704538|NCT01522950|470542713|FG001|Overall Study|Protocol Violation|0|||
130267778|NCT01791517|468947095|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
130267779|NCT01791517|468947096|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
130267780|NCT01791517|468947097|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
130267781|NCT01791517|468947098|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
130267782|NCT01791517|468947099|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
130267783|NCT01791517|468947100|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
130267784|NCT01791517|468947101|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
130267785|NCT01791517|468947102|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
130267786|NCT01791517|468947091|FG000|Phase I: Period 1|Adverse Event|0|||
130267787|NCT01791517|468947092|FG001|Phase I: Period 1|Adverse Event|0|||
130267788|NCT01791517|468947093|FG002|Phase I: Period 1|Adverse Event|1|||
130267789|NCT01791517|468947094|FG003|Phase I: Period 1|Adverse Event|1|||
130267790|NCT01791517|468947095|FG004|Phase I: Period 1|Adverse Event|0|||
130267791|NCT01791517|468947096|FG005|Phase I: Period 1|Adverse Event|0|||
130267792|NCT01791517|468947097|FG006|Phase I: Period 1|Adverse Event|0|||
130267793|NCT01791517|468947098|FG007|Phase I: Period 1|Adverse Event|0|||
130267794|NCT01791517|468947099|FG008|Phase I: Period 1|Adverse Event|0|||
130267795|NCT01791517|468947100|FG009|Phase I: Period 1|Adverse Event|0|||
130267796|NCT01791517|468947101|FG010|Phase I: Period 1|Adverse Event|0|||
130267797|NCT01791517|468947102|FG011|Phase I: Period 1|Adverse Event|0|||
130267798|NCT01791517|468947091|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
130267799|NCT01791517|468947092|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267800|NCT01791517|468947093|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267801|NCT01791517|468947094|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267802|NCT01791517|468947095|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267803|NCT01791517|468947096|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267804|NCT01791517|468947097|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267805|NCT01791517|468947098|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267806|NCT01791517|468947099|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267807|NCT01791517|468947100|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267808|NCT01791517|468947101|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267809|NCT01791517|468947102|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267810|NCT01791517|468947091|FG000|Phase I: Period 1|Protocol Violation|0|||
130267811|NCT01791517|468947092|FG001|Phase I: Period 1|Protocol Violation|1|||
130453414|NCT04888585|469623591|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453415|NCT04888585|469623592|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
130453416|NCT04888585|469623593|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453417|NCT04888585|469623594|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453418|NCT04888585|469623595|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453419|NCT04888585|469623596|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453420|NCT04888585|469623597|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453421|NCT04888585|469623598|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130453422|NCT04888585|469623588|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453423|NCT04888585|469623589|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453424|NCT04888585|469623590|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453425|NCT04888585|469623591|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453426|NCT04888585|469623592|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453427|NCT04888585|469623593|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453428|NCT04888585|469623594|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453429|NCT04888585|469623595|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
130453430|NCT04888585|469623596|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453431|NCT04888585|469623597|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
130453432|NCT04888585|469623598|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
130453433|NCT04888585|469623588|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130453434|NCT04888585|469623589|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130453435|NCT04888585|469623590|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130453436|NCT04888585|469623591|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130453437|NCT04888585|469623592|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130453438|NCT04888585|469623593|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
130267812|NCT01791517|468947093|FG002|Phase I: Period 1|Protocol Violation|0|||
130267813|NCT01791517|468947094|FG003|Phase I: Period 1|Protocol Violation|0|||
130267814|NCT01791517|468947095|FG004|Phase I: Period 1|Protocol Violation|0|||
130267815|NCT01791517|468947096|FG005|Phase I: Period 1|Protocol Violation|0|||
130267816|NCT01791517|468947097|FG006|Phase I: Period 1|Protocol Violation|0|||
130267817|NCT01791517|468947098|FG007|Phase I: Period 1|Protocol Violation|0|||
130453439|NCT04888585|469623594|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
130453440|NCT04888585|469623595|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
130267818|NCT01791517|468947099|FG008|Phase I: Period 1|Protocol Violation|0|||
130267819|NCT01791517|468947100|FG009|Phase I: Period 1|Protocol Violation|0|||
130267820|NCT01791517|468947101|FG010|Phase I: Period 1|Protocol Violation|0|||
130267821|NCT01791517|468947102|FG011|Phase I: Period 1|Protocol Violation|0|||
130267822|NCT01791517|468947091|FG000|Phase I: Period 1|Lost to Follow-up|0|||
130267823|NCT01791517|468947092|FG001|Phase I: Period 1|Lost to Follow-up|0|||
130267824|NCT01791517|468947093|FG002|Phase I: Period 1|Lost to Follow-up|0|||
130267825|NCT01791517|468947094|FG003|Phase I: Period 1|Lost to Follow-up|1|||
130267826|NCT01791517|468947095|FG004|Phase I: Period 1|Lost to Follow-up|0|||
130267827|NCT01791517|468947096|FG005|Phase I: Period 1|Lost to Follow-up|0|||
130267828|NCT01791517|468947097|FG006|Phase I: Period 1|Lost to Follow-up|1|||
130267829|NCT01791517|468947098|FG007|Phase I: Period 1|Lost to Follow-up|0|||
130267830|NCT01791517|468947099|FG008|Phase I: Period 1|Lost to Follow-up|1|||
130267831|NCT01791517|468947100|FG009|Phase I: Period 1|Lost to Follow-up|1|||
130267832|NCT01791517|468947101|FG010|Phase I: Period 1|Lost to Follow-up|0|||
130267833|NCT01791517|468947102|FG011|Phase I: Period 1|Lost to Follow-up|0|||
130267834|NCT01791517|468947091|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267835|NCT01791517|468947092|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267836|NCT01791517|468947093|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
130704539|NCT01522950|470542714|FG002|Overall Study|Protocol Violation|2|||
130267837|NCT01791517|468947094|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267838|NCT01791517|468947095|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267839|NCT01791517|468947096|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267840|NCT01791517|468947097|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267841|NCT01791517|468947098|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267842|NCT01791517|468947099|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267843|NCT01791517|468947100|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267844|NCT01791517|468947101|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267845|NCT01791517|468947102|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
130267846|NCT01791517|468947091|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
130267847|NCT01791517|468947092|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267848|NCT01791517|468947093|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267849|NCT01791517|468947094|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267850|NCT01791517|468947095|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267851|NCT01791517|468947096|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267852|NCT01791517|468947097|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267853|NCT01791517|468947098|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267854|NCT01791517|468947099|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267855|NCT01791517|468947100|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267856|NCT01791517|468947101|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267857|NCT01791517|468947102|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267858|NCT01791517|468947091|FG000|Phase I: Period 2|Protocol Violation|0|||
130267859|NCT01791517|468947092|FG001|Phase I: Period 2|Protocol Violation|0|||
130267860|NCT01791517|468947093|FG002|Phase I: Period 2|Protocol Violation|0|||
130267861|NCT01791517|468947094|FG003|Phase I: Period 2|Protocol Violation|1|||
130267862|NCT01791517|468947095|FG004|Phase I: Period 2|Protocol Violation|0|||
130267863|NCT01791517|468947096|FG005|Phase I: Period 2|Protocol Violation|0|||
130267864|NCT01791517|468947097|FG006|Phase I: Period 2|Protocol Violation|0|||
130267865|NCT01791517|468947098|FG007|Phase I: Period 2|Protocol Violation|0|||
130267866|NCT01791517|468947099|FG008|Phase I: Period 2|Protocol Violation|0|||
130267867|NCT01791517|468947100|FG009|Phase I: Period 2|Protocol Violation|0|||
130267868|NCT01791517|468947101|FG010|Phase I: Period 2|Protocol Violation|0|||
130267869|NCT01791517|468947102|FG011|Phase I: Period 2|Protocol Violation|0|||
130267870|NCT01791517|468947091|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
130267871|NCT01791517|468947092|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
130267872|NCT01791517|468947093|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
130267873|NCT01791517|468947094|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
130267874|NCT01791517|468947095|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
130267875|NCT01791517|468947096|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
130267876|NCT01791517|468947097|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
130267877|NCT01791517|468947098|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
130267878|NCT01791517|468947099|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
130267879|NCT01791517|468947100|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
130704540|NCT01522950|470542712|FG000|Overall Study|Death|0|||
130704541|NCT01522950|470542713|FG001|Overall Study|Death|1|||
130704542|NCT01522950|470542714|FG002|Overall Study|Death|1|||
130267880|NCT01791517|468947101|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
130267881|NCT01791517|468947102|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
130267882|NCT01791517|468947091|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267883|NCT01791517|468947092|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267884|NCT01791517|468947093|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267885|NCT01791517|468947094|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267886|NCT01791517|468947095|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267887|NCT01791517|468947096|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267888|NCT01791517|468947097|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267889|NCT01791517|468947098|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267890|NCT01791517|468947099|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130704543|NCT01522950|470542712|FG000|Overall Study|Study Medication Sensitivity|0|||
130267891|NCT01791517|468947100|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267892|NCT01791517|468947101|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
130267893|NCT01791517|468947102|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267894|NCT01791517|468947091|FG000|Phase I: Period 2|Lens Discomfort|0|||
130267895|NCT01791517|468947092|FG001|Phase I: Period 2|Lens Discomfort|0|||
130267896|NCT01791517|468947093|FG002|Phase I: Period 2|Lens Discomfort|0|||
130267897|NCT01791517|468947094|FG003|Phase I: Period 2|Lens Discomfort|0|||
130267898|NCT01791517|468947095|FG004|Phase I: Period 2|Lens Discomfort|0|||
130267899|NCT01791517|468947096|FG005|Phase I: Period 2|Lens Discomfort|1|||
130267900|NCT01791517|468947097|FG006|Phase I: Period 2|Lens Discomfort|0|||
130267901|NCT01791517|468947098|FG007|Phase I: Period 2|Lens Discomfort|0|||
130267902|NCT01791517|468947099|FG008|Phase I: Period 2|Lens Discomfort|0|||
130267903|NCT01791517|468947100|FG009|Phase I: Period 2|Lens Discomfort|0|||
130267904|NCT01791517|468947101|FG010|Phase I: Period 2|Lens Discomfort|0|||
130267905|NCT01791517|468947102|FG011|Phase I: Period 2|Lens Discomfort|0|||
130267906|NCT01791517|468947091|FG000|Phase I: Period 2|Lost to Follow-up|0|||
130267907|NCT01791517|468947092|FG001|Phase I: Period 2|Lost to Follow-up|3|||
130267908|NCT01791517|468947093|FG002|Phase I: Period 2|Lost to Follow-up|2|||
130267909|NCT01791517|468947094|FG003|Phase I: Period 2|Lost to Follow-up|0|||
130267910|NCT01791517|468947095|FG004|Phase I: Period 2|Lost to Follow-up|0|||
130267911|NCT01791517|468947096|FG005|Phase I: Period 2|Lost to Follow-up|0|||
130267912|NCT01791517|468947097|FG006|Phase I: Period 2|Lost to Follow-up|0|||
130267913|NCT01791517|468947098|FG007|Phase I: Period 2|Lost to Follow-up|0|||
130267914|NCT01791517|468947099|FG008|Phase I: Period 2|Lost to Follow-up|0|||
130267915|NCT01791517|468947100|FG009|Phase I: Period 2|Lost to Follow-up|0|||
130267916|NCT01791517|468947101|FG010|Phase I: Period 2|Lost to Follow-up|0|||
130267917|NCT01791517|468947102|FG011|Phase I: Period 2|Lost to Follow-up|0|||
130267918|NCT01791517|468947091|FG000|Phase I: Period 3|Lens Discomfort|0|||
130267919|NCT01791517|468947092|FG001|Phase I: Period 3|Lens Discomfort|0|||
130267920|NCT01791517|468947093|FG002|Phase I: Period 3|Lens Discomfort|0|||
130267921|NCT01791517|468947094|FG003|Phase I: Period 3|Lens Discomfort|0|||
130267922|NCT01791517|468947095|FG004|Phase I: Period 3|Lens Discomfort|0|||
130267923|NCT01791517|468947096|FG005|Phase I: Period 3|Lens Discomfort|0|||
130267924|NCT01791517|468947097|FG006|Phase I: Period 3|Lens Discomfort|0|||
130267925|NCT01791517|468947098|FG007|Phase I: Period 3|Lens Discomfort|0|||
130267926|NCT01791517|468947099|FG008|Phase I: Period 3|Lens Discomfort|0|||
130267927|NCT01791517|468947100|FG009|Phase I: Period 3|Lens Discomfort|0|||
130267928|NCT01791517|468947101|FG010|Phase I: Period 3|Lens Discomfort|0|||
130267929|NCT01791517|468947102|FG011|Phase I: Period 3|Lens Discomfort|1|||
130267930|NCT01791517|468947091|FG000|Phase I: Period 3|Lost to Follow-up|0|||
130267931|NCT01791517|468947092|FG001|Phase I: Period 3|Lost to Follow-up|1|||
130267932|NCT01791517|468947093|FG002|Phase I: Period 3|Lost to Follow-up|0|||
130267933|NCT01791517|468947094|FG003|Phase I: Period 3|Lost to Follow-up|0|||
130267934|NCT01791517|468947095|FG004|Phase I: Period 3|Lost to Follow-up|1|||
130267935|NCT01791517|468947096|FG005|Phase I: Period 3|Lost to Follow-up|0|||
130267936|NCT01791517|468947097|FG006|Phase I: Period 3|Lost to Follow-up|0|||
130267937|NCT01791517|468947098|FG007|Phase I: Period 3|Lost to Follow-up|0|||
130267938|NCT01791517|468947099|FG008|Phase I: Period 3|Lost to Follow-up|0|||
130267939|NCT01791517|468947100|FG009|Phase I: Period 3|Lost to Follow-up|0|||
130267940|NCT01791517|468947101|FG010|Phase I: Period 3|Lost to Follow-up|0|||
130267941|NCT01791517|468947102|FG011|Phase I: Period 3|Lost to Follow-up|0|||
130267942|NCT01791517|468947091|FG000|Phase I: Period 3|Adverse Event|0|||
130267943|NCT01791517|468947092|FG001|Phase I: Period 3|Adverse Event|0|||
130267944|NCT01791517|468947093|FG002|Phase I: Period 3|Adverse Event|0|||
130267945|NCT01791517|468947094|FG003|Phase I: Period 3|Adverse Event|1|||
130267946|NCT01791517|468947095|FG004|Phase I: Period 3|Adverse Event|0|||
130267947|NCT01791517|468947096|FG005|Phase I: Period 3|Adverse Event|0|||
130267948|NCT01791517|468947097|FG006|Phase I: Period 3|Adverse Event|0|||
130267949|NCT01791517|468947098|FG007|Phase I: Period 3|Adverse Event|0|||
130267950|NCT01791517|468947099|FG008|Phase I: Period 3|Adverse Event|0|||
130267951|NCT01791517|468947100|FG009|Phase I: Period 3|Adverse Event|0|||
130267952|NCT01791517|468947101|FG010|Phase I: Period 3|Adverse Event|0|||
130365940|NCT00415168|469308618|FG000|Overall Study|Sponsor Decision|4|||
130365941|NCT00415168|469308618|FG000|Overall Study|Withdrawal by Subject|6|||
130365942|NCT02059408|469308622|FG000|Overall Study|Did not get tested|0|||
130267953|NCT01791517|468947102|FG011|Phase I: Period 3|Adverse Event|0|||
130267954|NCT01791517|468947091|FG000|Phase II|Lost to Follow-up|1|||
130267955|NCT01791517|468947092|FG001|Phase II|Lost to Follow-up|0|||
130267956|NCT01791517|468947093|FG002|Phase II|Lost to Follow-up|1|||
130267957|NCT01791517|468947094|FG003|Phase II|Lost to Follow-up|0|||
130267958|NCT01791517|468947095|FG004|Phase II|Lost to Follow-up|1|||
130267959|NCT01791517|468947096|FG005|Phase II|Lost to Follow-up|2|||
130267960|NCT01791517|468947097|FG006|Phase II|Lost to Follow-up|0|||
130267961|NCT01791517|468947098|FG007|Phase II|Lost to Follow-up|1|||
130267962|NCT01791517|468947099|FG008|Phase II|Lost to Follow-up|1|||
130365943|NCT02059408|469308623|FG001|Overall Study|Did not get tested|330|||
130267963|NCT01791517|468947100|FG009|Phase II|Lost to Follow-up|1|||
130267964|NCT01791517|468947101|FG010|Phase II|Lost to Follow-up|0|||
130267965|NCT01791517|468947102|FG011|Phase II|Lost to Follow-up|0|||
130365944|NCT02059408|469308624|FG002|Overall Study|Did not get tested|358|||
130365945|NCT02993757|469308625|FG000|Overall Study|Non compliance with the protocol|155|||
130365946|NCT02993757|469308626|FG001|Overall Study|Non compliance with the protocol|170|||
130365947|NCT02993757|469308625|FG000|Overall Study|Lost to Follow-up|1|||
130365948|NCT02993757|469308626|FG001|Overall Study|Lost to Follow-up|0|||
130365949|NCT02993757|469308625|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
130365950|NCT02993757|469308626|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
130365951|NCT01681472|469308628|FG000|Overall Study|Adverse Event|0|||
130365952|NCT01681472|469308629|FG001|Overall Study|Adverse Event|1|||
130365953|NCT01681472|469308630|FG002|Overall Study|Adverse Event|0|||
130365954|NCT01681472|469308631|FG003|Overall Study|Adverse Event|0|||
130365955|NCT01999179|469308644|FG000|Overall Study|Adverse Event|1|||
130365956|NCT01999179|469308644|FG000|Overall Study|Lost to Follow-up|1|||
130365957|NCT01999179|469308644|FG000|Overall Study|Change in Therapy|3|||
130365958|NCT01999179|469308644|FG000|Overall Study|New catheter|2|||
130365959|NCT03128411|469308648|FG000|Treatment Phase|Adverse Event|21|||
130365960|NCT03128411|469308648|FG000|Treatment Phase|Physician Decision|1|||
130365961|NCT03128411|469308648|FG000|Treatment Phase|Other|2|||
130453441|NCT04888585|469623596|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
130453442|NCT04888585|469623597|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
130453443|NCT04888585|469623598|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
130453444|NCT04888585|469623588|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
130453445|NCT04888585|469623589|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
130453446|NCT04888585|469623590|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
130453447|NCT04888585|469623591|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
130453448|NCT04888585|469623592|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
130453449|NCT04888585|469623593|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
130453450|NCT04888585|469623594|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
130453451|NCT04888585|469623595|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
130453452|NCT04888585|469623596|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
130453453|NCT04888585|469623597|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
130453454|NCT04888585|469623598|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
130453455|NCT04888585|469623588|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
130453456|NCT04888585|469623589|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
130453457|NCT04888585|469623590|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
130453458|NCT04888585|469623591|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
130453459|NCT04888585|469623592|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
130453460|NCT04888585|469623593|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
130453461|NCT04888585|469623594|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
130453462|NCT04888585|469623595|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
130453463|NCT04888585|469623596|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
130267966|NCT01791517|468947091|FG000|Phase II|Withdrawal by Subject|1|||
130267967|NCT01791517|468947092|FG001|Phase II|Withdrawal by Subject|0|||
130267968|NCT01791517|468947093|FG002|Phase II|Withdrawal by Subject|0|||
130267969|NCT01791517|468947094|FG003|Phase II|Withdrawal by Subject|0|||
130267970|NCT01791517|468947095|FG004|Phase II|Withdrawal by Subject|0|||
130267971|NCT01791517|468947096|FG005|Phase II|Withdrawal by Subject|2|||
130267972|NCT01791517|468947097|FG006|Phase II|Withdrawal by Subject|0|||
130267973|NCT01791517|468947098|FG007|Phase II|Withdrawal by Subject|1|||
130267974|NCT01791517|468947099|FG008|Phase II|Withdrawal by Subject|0|||
130267975|NCT01791517|468947100|FG009|Phase II|Withdrawal by Subject|0|||
130267976|NCT01791517|468947101|FG010|Phase II|Withdrawal by Subject|1|||
130267977|NCT01791517|468947102|FG011|Phase II|Withdrawal by Subject|0|||
130267978|NCT01791517|468947091|FG000|Phase II|Lack of Efficacy|0|||
130267979|NCT01791517|468947092|FG001|Phase II|Lack of Efficacy|0|||
130267980|NCT01791517|468947093|FG002|Phase II|Lack of Efficacy|0|||
130267981|NCT01791517|468947094|FG003|Phase II|Lack of Efficacy|0|||
130267982|NCT01791517|468947095|FG004|Phase II|Lack of Efficacy|1|||
130267983|NCT01791517|468947096|FG005|Phase II|Lack of Efficacy|0|||
130267984|NCT01791517|468947097|FG006|Phase II|Lack of Efficacy|0|||
130267985|NCT01791517|468947098|FG007|Phase II|Lack of Efficacy|0|||
130267986|NCT01791517|468947099|FG008|Phase II|Lack of Efficacy|0|||
130267987|NCT01791517|468947100|FG009|Phase II|Lack of Efficacy|0|||
130267988|NCT01791517|468947101|FG010|Phase II|Lack of Efficacy|0|||
130267989|NCT01791517|468947102|FG011|Phase II|Lack of Efficacy|0|||
130365962|NCT03128411|469308648|FG000|Long Term Follow-up Phase|Death|2|||
130365963|NCT02900976|469308653|FG000|Overall Study|Adverse Event|0|||
130365964|NCT02900976|469308654|FG001|Overall Study|Adverse Event|1|||
130365965|NCT02900976|469308653|FG000|Overall Study|Physician Decision|0|||
130365966|NCT02900976|469308654|FG001|Overall Study|Physician Decision|2|||
130267990|NCT01791517|468947091|FG000|Phase II|Adverse Event|0|||
130267991|NCT01791517|468947092|FG001|Phase II|Adverse Event|0|||
130267992|NCT01791517|468947093|FG002|Phase II|Adverse Event|0|||
130267993|NCT01791517|468947094|FG003|Phase II|Adverse Event|0|||
130267994|NCT01791517|468947095|FG004|Phase II|Adverse Event|0|||
130267995|NCT01791517|468947096|FG005|Phase II|Adverse Event|0|||
130267996|NCT01791517|468947097|FG006|Phase II|Adverse Event|2|||
130267997|NCT01791517|468947098|FG007|Phase II|Adverse Event|1|||
130267998|NCT01791517|468947099|FG008|Phase II|Adverse Event|0|||
130267999|NCT01791517|468947100|FG009|Phase II|Adverse Event|1|||
130268000|NCT01791517|468947101|FG010|Phase II|Adverse Event|0|||
130268001|NCT01791517|468947102|FG011|Phase II|Adverse Event|0|||
130268002|NCT01791517|468947091|FG000|Phase II|Lens Handling Difficulties|0|||
130268003|NCT01791517|468947092|FG001|Phase II|Lens Handling Difficulties|0|||
130268004|NCT01791517|468947093|FG002|Phase II|Lens Handling Difficulties|0|||
130268005|NCT01791517|468947094|FG003|Phase II|Lens Handling Difficulties|0|||
130268006|NCT01791517|468947095|FG004|Phase II|Lens Handling Difficulties|0|||
130268007|NCT01791517|468947096|FG005|Phase II|Lens Handling Difficulties|0|||
130268008|NCT01791517|468947097|FG006|Phase II|Lens Handling Difficulties|0|||
130268009|NCT01791517|468947098|FG007|Phase II|Lens Handling Difficulties|0|||
130268010|NCT01791517|468947099|FG008|Phase II|Lens Handling Difficulties|1|||
130268011|NCT01791517|468947100|FG009|Phase II|Lens Handling Difficulties|0|||
130268012|NCT01791517|468947101|FG010|Phase II|Lens Handling Difficulties|0|||
130268013|NCT01791517|468947102|FG011|Phase II|Lens Handling Difficulties|0|||
130268014|NCT01791517|468947091|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
130268015|NCT01791517|468947092|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
130268016|NCT01791517|468947093|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
130268017|NCT01791517|468947094|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
130268018|NCT01791517|468947095|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
130268019|NCT01791517|468947096|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
130268020|NCT01791517|468947097|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
130268021|NCT01791517|468947098|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
130268022|NCT01791517|468947099|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
130268023|NCT01791517|468947100|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
130268024|NCT01791517|468947101|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
130268025|NCT01791517|468947102|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
130268026|NCT01791517|468947091|FG000|Phase II|Pre-Existing Ocular Issue|0|||
130268027|NCT01791517|468947092|FG001|Phase II|Pre-Existing Ocular Issue|0|||
130268028|NCT01791517|468947093|FG002|Phase II|Pre-Existing Ocular Issue|0|||
130268029|NCT01791517|468947094|FG003|Phase II|Pre-Existing Ocular Issue|0|||
130268030|NCT01791517|468947095|FG004|Phase II|Pre-Existing Ocular Issue|0|||
130268031|NCT01791517|468947096|FG005|Phase II|Pre-Existing Ocular Issue|0|||
130268032|NCT01791517|468947097|FG006|Phase II|Pre-Existing Ocular Issue|0|||
130268033|NCT01791517|468947098|FG007|Phase II|Pre-Existing Ocular Issue|0|||
130268034|NCT01791517|468947099|FG008|Phase II|Pre-Existing Ocular Issue|0|||
130268035|NCT01791517|468947100|FG009|Phase II|Pre-Existing Ocular Issue|0|||
130268036|NCT01791517|468947101|FG010|Phase II|Pre-Existing Ocular Issue|0|||
130268037|NCT01791517|468947102|FG011|Phase II|Pre-Existing Ocular Issue|1|||
130268038|NCT04011735|468947103|FG000|Overall Study|Withdrawal by Subject|1|||
130268039|NCT04011735|468947104|FG001|Overall Study|Withdrawal by Subject|0|||
130268040|NCT04011735|468947105|FG002|Overall Study|Withdrawal by Subject|1|||
130268041|NCT04011735|468947103|FG000|Overall Study|Met exclusion criteria after study entry|0|||
130268042|NCT04011735|468947104|FG001|Overall Study|Met exclusion criteria after study entry|1|||
130268043|NCT04011735|468947105|FG002|Overall Study|Met exclusion criteria after study entry|0|||
130268044|NCT00739310|468947110|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
130365967|NCT02900976|469308653|FG000|Overall Study|Progressive disease|0|||
130365968|NCT02900976|469308654|FG001|Overall Study|Progressive disease|6|||
130365969|NCT06934993|469308655|FG000|Overall Study|Withdrawal by Subject|29|||
130365970|NCT06934993|469308655|FG000|Overall Study|elevated postoperative creatinine level|11|||
130365971|NCT06934993|469308655|FG000|Overall Study|Death|3|||
130365972|NCT03128047|469308656|FG000|Overall Study|Withdrawal by Subject|1|||
130365973|NCT01995825|469310266|FG000|Overall Study|Withdrawal by Subject|1|||
130365974|NCT01995825|469310267|FG001|Overall Study|Withdrawal by Subject|0|||
130365975|NCT00403234|469310270|FG000|Overall Study|Withdrawal by Subject|0|||
130365976|NCT00403234|469310271|FG001|Overall Study|Withdrawal by Subject|1|||
130365977|NCT00403234|469310272|FG002|Overall Study|Withdrawal by Subject|0|||
130365978|NCT00403234|469310273|FG003|Overall Study|Withdrawal by Subject|0|||
130365979|NCT00403234|469310270|FG000|Overall Study|Adverse Event|1|||
130365980|NCT00403234|469310271|FG001|Overall Study|Adverse Event|0|||
130365981|NCT00403234|469310272|FG002|Overall Study|Adverse Event|1|||
130365982|NCT00403234|469310273|FG003|Overall Study|Adverse Event|0|||
130365983|NCT00739674|469310276|FG000|Overall Study|Screening failures|19|||
130365984|NCT00739674|469310277|FG001|Overall Study|Screening failures|17|||
130365985|NCT00739674|469310276|FG000|Overall Study|Site 212 removal|19|||
130365986|NCT00739674|469310277|FG001|Overall Study|Site 212 removal|13|||
130365987|NCT00739674|469310276|FG000|Overall Study|No follow-up data|33|||
130365988|NCT00739674|469310277|FG001|Overall Study|No follow-up data|18|||
130365989|NCT00739674|469310276|FG000|Overall Study|Dietician consultation >30 days|1|||
130365990|NCT00739674|469310277|FG001|Overall Study|Dietician consultation >30 days|9|||
130365991|NCT00739674|469310276|FG000|Overall Study|Adverse Event|22|||
130365992|NCT00739674|469310277|FG001|Overall Study|Adverse Event|13|||
130365993|NCT00739674|469310276|FG000|Overall Study|Death|1|||
130365994|NCT00739674|469310277|FG001|Overall Study|Death|0|||
130365995|NCT00739674|469310276|FG000|Overall Study|Lack of Efficacy|1|||
130365996|NCT00739674|469310277|FG001|Overall Study|Lack of Efficacy|0|||
130365997|NCT00739674|469310276|FG000|Overall Study|Lost to Follow-up|52|||
130365998|NCT00739674|469310277|FG001|Overall Study|Lost to Follow-up|30|||
130365999|NCT00739674|469310276|FG000|Overall Study|Protocol Violation|5|||
130366000|NCT00739674|469310277|FG001|Overall Study|Protocol Violation|5|||
130366001|NCT00739674|469310276|FG000|Overall Study|Withdrawal by Subject|9|||
130366002|NCT00739674|469310277|FG001|Overall Study|Withdrawal by Subject|9|||
130366003|NCT00739674|469310276|FG000|Overall Study|Reason missing|2|||
130366004|NCT00739674|469310277|FG001|Overall Study|Reason missing|0|||
130366005|NCT00739674|469310276|FG000|Overall Study|Clinic closed|6|||
130366006|NCT00739674|469310277|FG001|Overall Study|Clinic closed|4|||
130366007|NCT00739674|469310276|FG000|Overall Study|Patient moved|3|||
130366008|NCT00739674|469310277|FG001|Overall Study|Patient moved|2|||
130366009|NCT00739674|469310276|FG000|Overall Study|Non compliant|4|||
130366010|NCT00739674|469310277|FG001|Overall Study|Non compliant|0|||
130366011|NCT00739674|469310276|FG000|Overall Study|Unable to attend visit|3|||
130366012|NCT00739674|469310277|FG001|Overall Study|Unable to attend visit|1|||
130366013|NCT00739674|469310276|FG000|Overall Study|Home monitoring off meds|1|||
130366014|NCT00739674|469310277|FG001|Overall Study|Home monitoring off meds|0|||
130366015|NCT00739674|469310276|FG000|Overall Study|Erectile dysfunction|0|||
130366016|NCT00739674|469310277|FG001|Overall Study|Erectile dysfunction|1|||
130366017|NCT01594281|469310278|FG000|Interventional Core Phase|Protocol Deviation|1|||
130366018|NCT01594281|469310279|FG001|Interventional Core Phase|Protocol Deviation|0|||
130366019|NCT01594281|469310280|FG002|Interventional Core Phase|Protocol Deviation|0|||
130366020|NCT01594281|469310278|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
130366021|NCT01594281|469310279|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
130366022|NCT01594281|469310280|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
130366023|NCT01594281|469310278|FG000|Interventional Core Phase|Death|1|||
130366024|NCT01594281|469310279|FG001|Interventional Core Phase|Death|1|||
130366025|NCT01594281|469310280|FG002|Interventional Core Phase|Death|2|||
130453464|NCT04888585|469623597|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
130453465|NCT04888585|469623598|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
130453466|NCT04888585|469623588|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453467|NCT04888585|469623589|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453468|NCT04888585|469623590|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453469|NCT04888585|469623591|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453470|NCT04888585|469623592|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453471|NCT04888585|469623593|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453472|NCT04888585|469623594|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
130453473|NCT04888585|469623595|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
130453474|NCT04888585|469623596|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
130453475|NCT04888585|469623597|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
130453476|NCT04888585|469623598|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130453477|NCT04927975|469623599|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
130453478|NCT04927975|469623600|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
130453479|NCT04927975|469623601|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
130453480|NCT04927975|469623602|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
130453481|NCT04927975|469623603|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
130453482|NCT04927975|469623604|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
130453483|NCT04927975|469623599|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
130453484|NCT04927975|469623600|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
130453485|NCT04927975|469623601|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
130453486|NCT04927975|469623602|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
130453487|NCT04927975|469623603|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
130453488|NCT04927975|469623604|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
130453489|NCT04927975|469623599|FG000|Period 1 (Baseline-Week 24)|Death|0|||
130366026|NCT01594281|469310278|FG000|Interventional Core Phase|Lost to Follow-up|1|||
130366027|NCT01594281|469310279|FG001|Interventional Core Phase|Lost to Follow-up|4|||
130366028|NCT01594281|469310280|FG002|Interventional Core Phase|Lost to Follow-up|1|||
130453490|NCT04927975|469623600|FG001|Period 1 (Baseline-Week 24)|Death|0|||
130366029|NCT01594281|469310278|FG000|Interventional Core Phase|Adverse Event|4|||
130366030|NCT01594281|469310279|FG001|Interventional Core Phase|Adverse Event|4|||
130366031|NCT01594281|469310280|FG002|Interventional Core Phase|Adverse Event|4|||
130366032|NCT01594281|469310278|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
130366033|NCT01594281|469310279|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
130366034|NCT01594281|469310280|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
130366035|NCT01594281|469310278|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
130453491|NCT04927975|469623601|FG002|Period 1 (Baseline-Week 24)|Death|0|||
130453492|NCT04927975|469623602|FG003|Period 1 (Baseline-Week 24)|Death|0|||
130704544|NCT01522950|470542713|FG001|Overall Study|Study Medication Sensitivity|1|||
130704545|NCT01522950|470542714|FG002|Overall Study|Study Medication Sensitivity|0|||
130704546|NCT01844531|470542718|FG000|Overall Study|Withdrawal by Subject|0|||
130704547|NCT01844531|470542719|FG001|Overall Study|Withdrawal by Subject|1|||
130704548|NCT01844531|470542720|FG002|Overall Study|Withdrawal by Subject|0|||
130704549|NCT01844531|470542721|FG003|Overall Study|Withdrawal by Subject|0|||
130704550|NCT02000531|470542723|FG000|Overall Study|Lost to Follow-up|1|||
130704551|NCT02000531|470542724|FG001|Overall Study|Lost to Follow-up|0|||
130704552|NCT02000531|470542723|FG000|Overall Study|Discontinued due to data cut-off|3|||
130704553|NCT02000531|470542724|FG001|Overall Study|Discontinued due to data cut-off|8|||
130704554|NCT01345318|470542727|FG000|Overall Study|Adverse Event|16|||
130704555|NCT01345318|470542727|FG000|Overall Study|Lack of Efficacy|17|||
130704556|NCT01345318|470542727|FG000|Overall Study|Lost to Follow-up|2|||
130704557|NCT01345318|470542727|FG000|Overall Study|Protocol Violation|1|||
130704558|NCT01345318|470542727|FG000|Overall Study|Withdrawal by Subject|41|||
130704559|NCT01345318|470542727|FG000|Overall Study|Other|3|||
130704560|NCT00317642|470542728|FG000|Overall Study|Not Received Either Study Drug|1|||
130704561|NCT00317642|470542729|FG001|Overall Study|Not Received Either Study Drug|3|||
130704562|NCT00317642|470542728|FG000|Overall Study|Physician Decision|15|||
130704563|NCT00317642|470542729|FG001|Overall Study|Physician Decision|7|||
130704564|NCT00317642|470542728|FG000|Overall Study|Participant declined treatment|14|||
130704565|NCT00317642|470542729|FG001|Overall Study|Participant declined treatment|3|||
130704566|NCT00317642|470542728|FG000|Overall Study|Adverse Event|17|||
130704567|NCT00317642|470542729|FG001|Overall Study|Adverse Event|5|||
130704568|NCT00317642|470542728|FG000|Overall Study|Treatment Failure|56|||
130704569|NCT00317642|470542729|FG001|Overall Study|Treatment Failure|102|||
130704570|NCT00317642|470542728|FG000|Overall Study|Disease Recurrence|1|||
130704571|NCT00317642|470542729|FG001|Overall Study|Disease Recurrence|2|||
130704572|NCT00317642|470542728|FG000|Overall Study|Death|14|||
130704573|NCT00317642|470542729|FG001|Overall Study|Death|7|||
130704574|NCT00317642|470542728|FG000|Overall Study|Not Continue to Consolidation|2|||
130704575|NCT00317642|470542729|FG001|Overall Study|Not Continue to Consolidation|0|||
130704576|NCT00317642|470542728|FG000|Overall Study|Withdrawal by Subject|0|||
130704577|NCT00317642|470542729|FG001|Overall Study|Withdrawal by Subject|1|||
130704578|NCT00317642|470542728|FG000|Overall Study|Referred For Transplantation|1|||
130704579|NCT00317642|470542729|FG001|Overall Study|Referred For Transplantation|0|||
130704580|NCT00317642|470542728|FG000|Overall Study|AML Not Centrally Confirmed|1|||
130704581|NCT00317642|470542729|FG001|Overall Study|AML Not Centrally Confirmed|5|||
130704582|NCT01239472|470542734|FG000|Overall Study|Withdrawal by Subject|5|||
130704583|NCT01239472|470542735|FG001|Overall Study|Withdrawal by Subject|1|||
130704584|NCT01239472|470542734|FG000|Overall Study|Adverse Event|0|||
130704585|NCT01239472|470542735|FG001|Overall Study|Adverse Event|1|||
130704586|NCT01239472|470542734|FG000|Overall Study|Lack of Efficacy|0|||
130704587|NCT01239472|470542735|FG001|Overall Study|Lack of Efficacy|1|||
130704588|NCT01049412|470542739|FG000|Period I|Withdrawal by Subject|4|||
130704589|NCT01049412|470542740|FG001|Period I|Withdrawal by Subject|6|||
130704590|NCT01049412|470542739|FG000|Period I|Lost to Follow-up|2|||
130268045|NCT00739310|468947110|FG000|Overall Study|Withdrawal by Subject|1|||
130268046|NCT00739310|468947110|FG000|Overall Study|Lost to Follow-up|2|||
130268047|NCT02954887|468947111|FG000|Overall Study|Withdrawal by Subject|3|||
130268048|NCT02954887|468947111|FG000|Overall Study|Lack of Efficacy|3|||
130268049|NCT02954887|468947111|FG000|Overall Study|Other|1|||
130268050|NCT01071954|468947112|FG000|Overall Study|Noncompliance|4|||
130268051|NCT01071954|468947112|FG000|Overall Study|Adverse Event|1|||
130268052|NCT01071954|468947112|FG000|Overall Study|Withdrawal by Subject|11|||
130704591|NCT01049412|470542740|FG001|Period I|Lost to Follow-up|2|||
130704592|NCT01049412|470542739|FG000|Period I|Physician Decision|0|||
130704593|NCT01049412|470542740|FG001|Period I|Physician Decision|3|||
130704594|NCT01049412|470542739|FG000|Period I|Protocol Violation|1|||
130704595|NCT01049412|470542740|FG001|Period I|Protocol Violation|2|||
130704596|NCT01049412|470542739|FG000|Period I|Adverse Event|1|||
130704597|NCT01049412|470542740|FG001|Period I|Adverse Event|0|||
130704598|NCT01049412|470542739|FG000|Period II|Withdrawal by Subject|2|||
130704599|NCT01049412|470542740|FG001|Period II|Withdrawal by Subject|3|||
130704600|NCT01049412|470542739|FG000|Period II|Adverse Event|1|||
130704601|NCT01049412|470542740|FG001|Period II|Adverse Event|0|||
130704602|NCT01049412|470542739|FG000|Period II|Lost to Follow-up|1|||
130704603|NCT01049412|470542740|FG001|Period II|Lost to Follow-up|0|||
130704604|NCT01280617|470542741|FG000|Overall Study|Adverse Event|0|||
130704605|NCT01280617|470542742|FG001|Overall Study|Adverse Event|1|||
130704606|NCT05966090|470542743|FG000|Overall Study|Lost to Follow-up|6|||
130704607|NCT05966090|470542744|FG001|Overall Study|Lost to Follow-up|6|||
130704608|NCT05966090|470542743|FG000|Overall Study|Adverse Event|1|||
130268053|NCT01071954|468947112|FG000|Overall Study|Requirement for Alternative Therapy|5|||
130268054|NCT01071954|468947112|FG000|Overall Study|Administrative Decision|5|||
130704609|NCT05966090|470542744|FG001|Overall Study|Adverse Event|1|||
130704610|NCT05966090|470542743|FG000|Overall Study|Withdrawal by Subject|1|||
130704611|NCT05966090|470542744|FG001|Overall Study|Withdrawal by Subject|1|||
130704612|NCT05966090|470542743|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130453493|NCT04927975|469623603|FG004|Period 1 (Baseline-Week 24)|Death|0|||
130453494|NCT04927975|469623604|FG005|Period 1 (Baseline-Week 24)|Death|1|||
130453495|NCT04927975|469623599|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
130453496|NCT04927975|469623600|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
130453497|NCT04927975|469623601|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
130453498|NCT04927975|469623602|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
130453499|NCT04927975|469623603|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
130453500|NCT04927975|469623604|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
130453501|NCT04927975|469623599|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
130453502|NCT04927975|469623600|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
130453503|NCT04927975|469623601|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
130453504|NCT04927975|469623602|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
130453505|NCT04927975|469623603|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
130453506|NCT04927975|469623604|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
130453507|NCT03568162|469623606|FG000|Overall Study|Adverse Event|0|||
130453508|NCT03568162|469623607|FG001|Overall Study|Adverse Event|1|||
130453509|NCT03568162|469623608|FG002|Overall Study|Adverse Event|2|||
130453510|NCT03568162|469623609|FG003|Overall Study|Adverse Event|0|||
130453511|NCT03568162|469623610|FG004|Overall Study|Adverse Event|0|||
130453512|NCT03568162|469623611|FG005|Overall Study|Adverse Event|1|||
130453513|NCT03568162|469623606|FG000|Overall Study|Death|0|||
130453514|NCT03568162|469623607|FG001|Overall Study|Death|0|||
130453515|NCT03568162|469623608|FG002|Overall Study|Death|0|||
130453516|NCT03568162|469623609|FG003|Overall Study|Death|0|||
130453517|NCT03568162|469623610|FG004|Overall Study|Death|1|||
130453518|NCT03568162|469623611|FG005|Overall Study|Death|0|||
130453519|NCT03568162|469623606|FG000|Overall Study|Lost to Follow-up|3|||
130453520|NCT03568162|469623607|FG001|Overall Study|Lost to Follow-up|2|||
130453521|NCT03568162|469623608|FG002|Overall Study|Lost to Follow-up|4|||
130453522|NCT03568162|469623609|FG003|Overall Study|Lost to Follow-up|2|||
130453523|NCT03568162|469623610|FG004|Overall Study|Lost to Follow-up|3|||
130453524|NCT03568162|469623611|FG005|Overall Study|Lost to Follow-up|2|||
130453525|NCT03568162|469623606|FG000|Overall Study|Physician Decision|0|||
130453526|NCT03568162|469623607|FG001|Overall Study|Physician Decision|1|||
130453527|NCT03568162|469623608|FG002|Overall Study|Physician Decision|1|||
130453528|NCT03568162|469623609|FG003|Overall Study|Physician Decision|0|||
130453529|NCT03568162|469623610|FG004|Overall Study|Physician Decision|1|||
130453530|NCT03568162|469623611|FG005|Overall Study|Physician Decision|0|||
130453531|NCT03568162|469623606|FG000|Overall Study|Pregnancy|0|||
130453532|NCT03568162|469623607|FG001|Overall Study|Pregnancy|0|||
130453533|NCT03568162|469623608|FG002|Overall Study|Pregnancy|0|||
130453534|NCT03568162|469623609|FG003|Overall Study|Pregnancy|1|||
130453535|NCT03568162|469623610|FG004|Overall Study|Pregnancy|0|||
130453536|NCT03568162|469623611|FG005|Overall Study|Pregnancy|0|||
130453537|NCT03568162|469623606|FG000|Overall Study|Protocol Violation|1|||
130453538|NCT03568162|469623607|FG001|Overall Study|Protocol Violation|0|||
130453539|NCT03568162|469623608|FG002|Overall Study|Protocol Violation|1|||
130453540|NCT03568162|469623609|FG003|Overall Study|Protocol Violation|1|||
130453541|NCT03568162|469623610|FG004|Overall Study|Protocol Violation|1|||
130453542|NCT03568162|469623611|FG005|Overall Study|Protocol Violation|1|||
130453543|NCT03568162|469623606|FG000|Overall Study|Withdrawal by Subject|15|||
130453544|NCT03568162|469623607|FG001|Overall Study|Withdrawal by Subject|15|||
130268055|NCT01071954|468947112|FG000|Overall Study|Protocol Specified Criteria|1|||
130268056|NCT01459666|468947113|FG000|Overall Study|PI left institution|5|||
130268057|NCT01459666|468947114|FG001|Overall Study|PI left institution|4|||
130268058|NCT00590967|468947116|FG000|Overall Study|Withdrawal by Subject|1|||
130268059|NCT00590967|468947117|FG001|Overall Study|Withdrawal by Subject|1|||
130268060|NCT00590967|468947116|FG000|Overall Study|Ineligible|1|||
130268061|NCT00590967|468947117|FG001|Overall Study|Ineligible|0|||
130268062|NCT00590967|468947116|FG000|Overall Study|Poor performance status|0|||
130453545|NCT03568162|469623608|FG002|Overall Study|Withdrawal by Subject|26|||
130268063|NCT00590967|468947117|FG001|Overall Study|Poor performance status|1|||
130268064|NCT00590967|468947116|FG000|Overall Study|Non-compliant|0|||
130268065|NCT00590967|468947117|FG001|Overall Study|Non-compliant|2|||
130268066|NCT00590967|468947116|FG000|Overall Study|Did not sign consent form|0|||
130268067|NCT00590967|468947117|FG001|Overall Study|Did not sign consent form|1|||
130453546|NCT03568162|469623609|FG003|Overall Study|Withdrawal by Subject|22|||
130453547|NCT03568162|469623610|FG004|Overall Study|Withdrawal by Subject|6|||
130704613|NCT05966090|470542744|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130453548|NCT03568162|469623611|FG005|Overall Study|Withdrawal by Subject|9|||
130453549|NCT03568162|469623606|FG000|Overall Study|Others|3|||
130453550|NCT03568162|469623607|FG001|Overall Study|Others|4|||
130453551|NCT03568162|469623608|FG002|Overall Study|Others|1|||
130453552|NCT03568162|469623609|FG003|Overall Study|Others|4|||
130453553|NCT03568162|469623610|FG004|Overall Study|Others|2|||
130453554|NCT03568162|469623611|FG005|Overall Study|Others|1|||
130453555|NCT03717194|469623612|FG000|Overall Study|Withdrawal by Subject|2|||
130453556|NCT03717194|469623613|FG001|Overall Study|Withdrawal by Subject|4|||
130453557|NCT03717194|469623612|FG000|Overall Study|Adverse Event|1|||
130704614|NCT05966090|470542743|FG000|Overall Study|Other|1|||
130704615|NCT05966090|470542744|FG001|Overall Study|Other|1|||
130268068|NCT00590967|468947116|FG000|Overall Study|Did not receive chemo per protocol|1|||
130268069|NCT00590967|468947117|FG001|Overall Study|Did not receive chemo per protocol|0|||
130268070|NCT01847755|468947120|FG000|Overall Study|Adverse Event|2|||
130268071|NCT01847755|468947120|FG000|Overall Study|Withdrawal by Subject|2|||
130268072|NCT01847755|468947120|FG000|Overall Study|Physician Decision|1|||
130268073|NCT00920556|468947121|FG000|Overall Study|Adverse Event|16|||
130268074|NCT00920556|468947121|FG000|Overall Study|Physician Decision|7|||
130268075|NCT00920556|468947121|FG000|Overall Study|Withdrawal by Subject|1|||
130268076|NCT01299389|468947122|FG000|Double-blind|Adverse Event|45|||
130268077|NCT01299389|468947123|FG001|Double-blind|Adverse Event|27|||
130268078|NCT01299389|468947124|FG002|Double-blind|Adverse Event|0|||
130268079|NCT01299389|468947125|FG003|Double-blind|Adverse Event|0|||
130268080|NCT01299389|468947122|FG000|Double-blind|Lack of Efficacy|45|||
130268081|NCT01299389|468947123|FG001|Double-blind|Lack of Efficacy|21|||
130268082|NCT01299389|468947124|FG002|Double-blind|Lack of Efficacy|0|||
130268083|NCT01299389|468947125|FG003|Double-blind|Lack of Efficacy|0|||
130268084|NCT01299389|468947122|FG000|Double-blind|Lost to Follow-up|2|||
130268085|NCT01299389|468947123|FG001|Double-blind|Lost to Follow-up|1|||
130268086|NCT01299389|468947124|FG002|Double-blind|Lost to Follow-up|0|||
130268087|NCT01299389|468947125|FG003|Double-blind|Lost to Follow-up|0|||
130268088|NCT01299389|468947122|FG000|Double-blind|Withdrawal by Subject|16|||
130268089|NCT01299389|468947123|FG001|Double-blind|Withdrawal by Subject|13|||
130268090|NCT01299389|468947124|FG002|Double-blind|Withdrawal by Subject|0|||
130268091|NCT01299389|468947125|FG003|Double-blind|Withdrawal by Subject|0|||
130704616|NCT00337428|470542745|FG000|Overall Study|Withdrawal by Subject|1|||
130704617|NCT00337428|470542746|FG001|Overall Study|Withdrawal by Subject|2|||
130704618|NCT00337428|470542745|FG000|Overall Study|Lack of Time|1|||
130268092|NCT01299389|468947122|FG000|Double-blind|Other|1|||
130268093|NCT01299389|468947123|FG001|Double-blind|Other|1|||
130268094|NCT01299389|468947124|FG002|Double-blind|Other|0|||
130268095|NCT01299389|468947125|FG003|Double-blind|Other|0|||
130268096|NCT01299389|468947122|FG000|Double-blind|"fail to meet study population criteria"|0|||
130704619|NCT00337428|470542746|FG001|Overall Study|Lack of Time|1|||
130268097|NCT01299389|468947123|FG001|Double-blind|"fail to meet study population criteria"|1|||
130268098|NCT01299389|468947124|FG002|Double-blind|"fail to meet study population criteria"|0|||
130268099|NCT01299389|468947125|FG003|Double-blind|"fail to meet study population criteria"|0|||
130268100|NCT01299389|468947122|FG000|Post-observational|Other|0|||
130268101|NCT01299389|468947123|FG001|Post-observational|Other|0|||
130268102|NCT01299389|468947124|FG002|Post-observational|Other|12|||
130268103|NCT01299389|468947125|FG003|Post-observational|Other|6|||
130268104|NCT04245709|468947126|FG000|Overall Study|Adverse Event|13|||
130268105|NCT04245709|468947126|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
130268106|NCT00889707|468947130|FG000|Overall Study|Adverse Event|1|||
130268107|NCT00889707|468947131|FG001|Overall Study|Adverse Event|0|||
130268108|NCT00889707|468947130|FG000|Overall Study|Withdrawal by Subject|4|||
130268109|NCT00889707|468947131|FG001|Overall Study|Withdrawal by Subject|3|||
130268110|NCT00889707|468947130|FG000|Overall Study|Lost to Follow-up|0|||
130268111|NCT00889707|468947131|FG001|Overall Study|Lost to Follow-up|2|||
130268112|NCT00889707|468947130|FG000|Overall Study|Lack of Efficacy|2|||
130268113|NCT00889707|468947131|FG001|Overall Study|Lack of Efficacy|5|||
130268114|NCT02185534|468947132|FG000|First Period|Withdrawal by Subject|0|||
130268115|NCT02185534|468947133|FG001|First Period|Withdrawal by Subject|0|||
130268116|NCT02185534|468947134|FG002|First Period|Withdrawal by Subject|0|||
130268117|NCT02185534|468947135|FG003|First Period|Withdrawal by Subject|1|||
130268118|NCT02185534|468947136|FG004|First Period|Withdrawal by Subject|0|||
130268119|NCT02185534|468947137|FG005|First Period|Withdrawal by Subject|0|||
130268120|NCT02185534|468947132|FG000|First Washout Period|Withdrawal by Subject|1|||
130268121|NCT02185534|468947133|FG001|First Washout Period|Withdrawal by Subject|0|||
130268122|NCT02185534|468947134|FG002|First Washout Period|Withdrawal by Subject|0|||
130268123|NCT02185534|468947135|FG003|First Washout Period|Withdrawal by Subject|0|||
130268124|NCT02185534|468947136|FG004|First Washout Period|Withdrawal by Subject|1|||
130268125|NCT02185534|468947137|FG005|First Washout Period|Withdrawal by Subject|0|||
130268126|NCT02185534|468947132|FG000|First Washout Period|Protocol Violation|0|||
130268127|NCT02185534|468947133|FG001|First Washout Period|Protocol Violation|0|||
130268128|NCT02185534|468947134|FG002|First Washout Period|Protocol Violation|0|||
130268129|NCT02185534|468947135|FG003|First Washout Period|Protocol Violation|0|||
130268130|NCT02185534|468947136|FG004|First Washout Period|Protocol Violation|0|||
130704620|NCT00337428|470542745|FG000|Overall Study|Unwilling to Continue|1|||
130268131|NCT02185534|468947137|FG005|First Washout Period|Protocol Violation|1|||
130268132|NCT02948582|468947138|FG000|Washout Period 1|Adverse Event|0|||
130268133|NCT02948582|468947139|FG001|Washout Period 1|Adverse Event|2|||
130268134|NCT02948582|468947140|FG002|Washout Period 1|Adverse Event|0|||
130268135|NCT02948582|468947141|FG003|Washout Period 1|Adverse Event|0|||
130268136|NCT02948582|468947142|FG004|Washout Period 1|Adverse Event|0|||
130268137|NCT02948582|468947143|FG005|Washout Period 1|Adverse Event|0|||
130704621|NCT00337428|470542746|FG001|Overall Study|Unwilling to Continue|0|||
130704622|NCT00337428|470542745|FG000|Overall Study|Anorexia|1|||
130704623|NCT00337428|470542746|FG001|Overall Study|Anorexia|0|||
130268138|NCT02948582|468947138|FG000|Washout Period 1|Protocol Violation|0|||
130453558|NCT03717194|469623613|FG001|Overall Study|Adverse Event|1|||
130453559|NCT02081391|469623615|FG000|12-hour Treatment|Withdrawal by Subject|3|||
130453560|NCT02081391|469623616|FG001|12-hour Treatment|Withdrawal by Subject|2|||
130453561|NCT02081391|469623617|FG002|12-hour Treatment|Withdrawal by Subject|0|||
130453562|NCT02081391|469623618|FG003|12-hour Treatment|Withdrawal by Subject|0|||
130453563|NCT02081391|469623615|FG000|12-hour Treatment|Physician Decision|4|||
130453564|NCT02081391|469623616|FG001|12-hour Treatment|Physician Decision|1|||
130453565|NCT02081391|469623617|FG002|12-hour Treatment|Physician Decision|0|||
130453566|NCT02081391|469623618|FG003|12-hour Treatment|Physician Decision|0|||
130453567|NCT02081391|469623615|FG000|12-hour Treatment|Lack of Efficacy|3|||
130453568|NCT02081391|469623616|FG001|12-hour Treatment|Lack of Efficacy|0|||
130453569|NCT02081391|469623617|FG002|12-hour Treatment|Lack of Efficacy|0|||
130453570|NCT02081391|469623618|FG003|12-hour Treatment|Lack of Efficacy|0|||
130453571|NCT02081391|469623615|FG000|12-hour Treatment|Adverse Event|4|||
130453572|NCT02081391|469623616|FG001|12-hour Treatment|Adverse Event|2|||
130453573|NCT02081391|469623617|FG002|12-hour Treatment|Adverse Event|0|||
130453574|NCT02081391|469623618|FG003|12-hour Treatment|Adverse Event|0|||
130453575|NCT02081391|469623615|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
130453576|NCT02081391|469623616|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
130453577|NCT02081391|469623617|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
130453578|NCT02081391|469623618|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
130453579|NCT02081391|469623615|FG000|12-hour Treatment|Further reasons|2|||
130453580|NCT02081391|469623616|FG001|12-hour Treatment|Further reasons|1|||
130453581|NCT02081391|469623617|FG002|12-hour Treatment|Further reasons|0|||
130453582|NCT02081391|469623618|FG003|12-hour Treatment|Further reasons|0|||
130453583|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
130453584|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
130453585|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
130453586|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
130453587|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
130453588|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
130453589|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
130453590|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
130453591|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
130453592|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
130453593|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
130453594|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
130453595|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
130453596|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
130453597|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
130453598|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
130453599|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
130453600|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
130453601|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
130453602|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
130453603|NCT02081391|469623615|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
130453604|NCT02081391|469623616|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
130453605|NCT02081391|469623617|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
130453606|NCT02081391|469623618|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
130268139|NCT02948582|468947139|FG001|Washout Period 1|Protocol Violation|0|||
130268140|NCT02948582|468947140|FG002|Washout Period 1|Protocol Violation|0|||
130268141|NCT02948582|468947141|FG003|Washout Period 1|Protocol Violation|0|||
130268142|NCT02948582|468947142|FG004|Washout Period 1|Protocol Violation|0|||
130268143|NCT02948582|468947143|FG005|Washout Period 1|Protocol Violation|1|||
130268144|NCT02948582|468947138|FG000|Washout Period 2|Adverse Event|0|||
130268145|NCT02948582|468947139|FG001|Washout Period 2|Adverse Event|1|||
130268146|NCT02948582|468947140|FG002|Washout Period 2|Adverse Event|0|||
130268147|NCT02948582|468947141|FG003|Washout Period 2|Adverse Event|0|||
130268148|NCT02948582|468947142|FG004|Washout Period 2|Adverse Event|0|||
130268149|NCT02948582|468947143|FG005|Washout Period 2|Adverse Event|0|||
130268150|NCT02948582|468947138|FG000|Washout Period 2|personal reasons|0|||
130268151|NCT02948582|468947139|FG001|Washout Period 2|personal reasons|0|||
130268152|NCT02948582|468947140|FG002|Washout Period 2|personal reasons|0|||
130453607|NCT01458275|469623619|FG000|Overall Study|Adverse Event|3|||
130268153|NCT02948582|468947141|FG003|Washout Period 2|personal reasons|1|||
130268154|NCT02948582|468947142|FG004|Washout Period 2|personal reasons|0|||
130453608|NCT01458275|469623620|FG001|Overall Study|Adverse Event|4|||
130704624|NCT03756883|470542747|FG000|Overall Study|Adverse Event|2|||
130268155|NCT02948582|468947143|FG005|Washout Period 2|personal reasons|0|||
130366036|NCT01594281|469310279|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
130366037|NCT01594281|469310280|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
130366038|NCT01594281|469310278|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
130366039|NCT01594281|469310279|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
130366040|NCT01594281|469310280|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
130366041|NCT04805541|469310282|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
130366042|NCT00283400|469310286|FG000|Overall Study|Withdrawal by Subject|1|||
130366043|NCT00283400|469310287|FG001|Overall Study|Withdrawal by Subject|1|||
130366044|NCT00283400|469310288|FG002|Overall Study|Withdrawal by Subject|0|||
130366045|NCT00283400|469310289|FG003|Overall Study|Withdrawal by Subject|0|||
130366046|NCT00283400|469310286|FG000|Overall Study|Death|1|||
130366047|NCT00283400|469310287|FG001|Overall Study|Death|0|||
130366048|NCT00283400|469310288|FG002|Overall Study|Death|1|||
130366049|NCT00283400|469310289|FG003|Overall Study|Death|0|||
130366050|NCT01709513|469310290|FG000|Overall Study|Randomized but not treated|0|||
130366051|NCT01709513|469310291|FG001|Overall Study|Randomized but not treated|1|||
130366052|NCT01709513|469310292|FG002|Overall Study|Randomized but not treated|0|||
130366053|NCT01709513|469310290|FG000|Overall Study|Adverse Event|16|||
130366054|NCT01709513|469310291|FG001|Overall Study|Adverse Event|31|||
130366055|NCT01709513|469310292|FG002|Overall Study|Adverse Event|23|||
130366056|NCT01709513|469310290|FG000|Overall Study|Poor compliance to protocol|2|||
130366057|NCT01709513|469310291|FG001|Overall Study|Poor compliance to protocol|0|||
130366058|NCT01709513|469310292|FG002|Overall Study|Poor compliance to protocol|0|||
130366059|NCT01709513|469310290|FG000|Overall Study|Other|3|||
130366060|NCT01709513|469310291|FG001|Overall Study|Other|11|||
130366061|NCT01709513|469310292|FG002|Overall Study|Other|7|||
130366062|NCT01560403|469310293|FG000|Overall Study|Lost to Follow-up|0|||
130366063|NCT01560403|469310294|FG001|Overall Study|Lost to Follow-up|1|||
130366064|NCT03166735|469310295|FG000|Overall Study|Not Treated|1|||
130366065|NCT03166735|469310296|FG001|Overall Study|Not Treated|0|||
130366066|NCT03166735|469310297|FG002|Overall Study|Not Treated|0|||
130366067|NCT03166735|469310298|FG003|Overall Study|Not Treated|0|||
130366068|NCT03166735|469310299|FG004|Overall Study|Not Treated|0|||
130366069|NCT03166735|469310295|FG000|Overall Study|follow-up not completed as planned|0|||
130366070|NCT03166735|469310296|FG001|Overall Study|follow-up not completed as planned|1|||
130366071|NCT03166735|469310297|FG002|Overall Study|follow-up not completed as planned|1|||
130366072|NCT03166735|469310298|FG003|Overall Study|follow-up not completed as planned|0|||
130366073|NCT03166735|469310299|FG004|Overall Study|follow-up not completed as planned|1|||
130366074|NCT03166735|469310295|FG000|Overall Study|Withdrawal by Subject|0|||
130366075|NCT03166735|469310296|FG001|Overall Study|Withdrawal by Subject|0|||
130366076|NCT03166735|469310297|FG002|Overall Study|Withdrawal by Subject|1|||
130366077|NCT03166735|469310298|FG003|Overall Study|Withdrawal by Subject|1|||
130366078|NCT03166735|469310299|FG004|Overall Study|Withdrawal by Subject|2|||
130366079|NCT03166735|469310295|FG000|Overall Study|Lost to Follow-up|0|||
130453609|NCT01458275|469623621|FG002|Overall Study|Adverse Event|1|||
130453610|NCT01458275|469623619|FG000|Overall Study|Lost to Follow-up|3|||
130453611|NCT01458275|469623620|FG001|Overall Study|Lost to Follow-up|2|||
130453612|NCT01458275|469623621|FG002|Overall Study|Lost to Follow-up|5|||
130453613|NCT01458275|469623619|FG000|Overall Study|Protocol Violation|5|||
130453614|NCT01458275|469623620|FG001|Overall Study|Protocol Violation|5|||
130453615|NCT01458275|469623621|FG002|Overall Study|Protocol Violation|2|||
130453616|NCT01458275|469623619|FG000|Overall Study|Withdrawal by Subject|3|||
130453617|NCT01458275|469623620|FG001|Overall Study|Withdrawal by Subject|2|||
130453618|NCT01458275|469623621|FG002|Overall Study|Withdrawal by Subject|1|||
130453619|NCT02926937|469623622|FG000|Overall Study|Adverse Event|0|||
130453620|NCT02926937|469623623|FG001|Overall Study|Adverse Event|1|||
130453621|NCT02926937|469623624|FG002|Overall Study|Adverse Event|1|||
130453622|NCT02926937|469623622|FG000|Overall Study|Poor Compliance to Protocol|1|||
130704625|NCT03756883|470542748|FG001|Overall Study|Adverse Event|2|||
130704626|NCT03756883|470542749|FG002|Overall Study|Adverse Event|2|||
130704627|NCT03756883|470542747|FG000|Overall Study|Lack of Efficacy|0|||
130453623|NCT02926937|469623623|FG001|Overall Study|Poor Compliance to Protocol|0|||
130453624|NCT02926937|469623624|FG002|Overall Study|Poor Compliance to Protocol|0|||
130453625|NCT02926937|469623622|FG000|Overall Study|Lost to Follow-up|4|||
130453626|NCT02926937|469623623|FG001|Overall Study|Lost to Follow-up|5|||
130453627|NCT02926937|469623624|FG002|Overall Study|Lost to Follow-up|0|||
130366080|NCT03166735|469310296|FG001|Overall Study|Lost to Follow-up|2|||
130366081|NCT03166735|469310297|FG002|Overall Study|Lost to Follow-up|1|||
130366082|NCT03166735|469310298|FG003|Overall Study|Lost to Follow-up|0|||
130366083|NCT03166735|469310299|FG004|Overall Study|Lost to Follow-up|1|||
130366084|NCT01543958|469310300|FG000|Overall Study|Loss to follow-up|3|||
130366085|NCT01543958|469310300|FG000|Overall Study|ART initiation|1|||
130366086|NCT04019288|469310301|FG000|Overall Study|Death|1|||
130366087|NCT04019288|469310302|FG001|Overall Study|Death|0|||
130453628|NCT02926937|469623622|FG000|Overall Study|At the Participant's own Request|11|||
130453629|NCT02926937|469623623|FG001|Overall Study|At the Participant's own Request|5|||
130704628|NCT03756883|470542748|FG001|Overall Study|Lack of Efficacy|1|||
130704629|NCT03756883|470542749|FG002|Overall Study|Lack of Efficacy|2|||
130268156|NCT02948582|468947138|FG000|Washout Period 4|Adverse Event|1|||
130268157|NCT02948582|468947139|FG001|Washout Period 4|Adverse Event|0|||
130268158|NCT02948582|468947140|FG002|Washout Period 4|Adverse Event|1|||
130268159|NCT02948582|468947141|FG003|Washout Period 4|Adverse Event|0|||
130268160|NCT02948582|468947142|FG004|Washout Period 4|Adverse Event|0|||
130268161|NCT02948582|468947143|FG005|Washout Period 4|Adverse Event|0|||
130268162|NCT01151020|468947147|FG000|Overall Study|Death|25|||
130268163|NCT01151020|468947147|FG000|Overall Study|Conversion to open repair|1|||
130453630|NCT02926937|469623624|FG002|Overall Study|At the Participant's own Request|8|||
130453631|NCT02926937|469623622|FG000|Overall Study|Reason not Specified|3|||
130453632|NCT02926937|469623623|FG001|Overall Study|Reason not Specified|4|||
130453633|NCT02926937|469623624|FG002|Overall Study|Reason not Specified|2|||
130453634|NCT01559090|469623625|FG000|Stage I|Withdrawal by Subject|2|||
130453635|NCT01559090|469623626|FG001|Stage I|Withdrawal by Subject|2|||
130453636|NCT01559090|469623627|FG002|Stage I|Withdrawal by Subject|3|||
130453637|NCT01559090|469623625|FG000|Stage II|Withdrawal by Subject|1|||
130453638|NCT01559090|469623626|FG001|Stage II|Withdrawal by Subject|0|||
130453639|NCT01559090|469623627|FG002|Stage II|Withdrawal by Subject|0|||
130453640|NCT03722446|469623628|FG000|Overall Study|Protocol Violation|15|||
130453641|NCT03722446|469623629|FG001|Overall Study|Protocol Violation|2|||
130453642|NCT02908464|469623630|FG000|Overall Study|Withdrawal by Subject|2|||
130453643|NCT02908464|469623631|FG001|Overall Study|Withdrawal by Subject|1|||
130453644|NCT02908464|469623630|FG000|Overall Study|Found ineligible after randomization|0|||
130453645|NCT02908464|469623631|FG001|Overall Study|Found ineligible after randomization|2|||
130453646|NCT00991276|469625327|FG000|First Intervention Period|Adverse Event|0|||
130453647|NCT00991276|469625328|FG001|First Intervention Period|Adverse Event|1|||
130453648|NCT00991276|469625329|FG002|First Intervention Period|Adverse Event|0|||
130453649|NCT00991276|469625330|FG003|First Intervention Period|Adverse Event|1|||
130453650|NCT00991276|469625331|FG004|First Intervention Period|Adverse Event|0|||
130453651|NCT00991276|469625332|FG005|First Intervention Period|Adverse Event|0|||
130453652|NCT00991276|469625327|FG000|First Intervention Period|Protocol Violation|0|||
130453653|NCT00991276|469625328|FG001|First Intervention Period|Protocol Violation|0|||
130453654|NCT00991276|469625329|FG002|First Intervention Period|Protocol Violation|0|||
130453655|NCT00991276|469625330|FG003|First Intervention Period|Protocol Violation|0|||
130453656|NCT00991276|469625331|FG004|First Intervention Period|Protocol Violation|2|||
130453657|NCT00991276|469625332|FG005|First Intervention Period|Protocol Violation|0|||
130453658|NCT00991276|469625327|FG000|First Intervention Period|Insufficient clinical response|0|||
130453659|NCT00991276|469625328|FG001|First Intervention Period|Insufficient clinical response|0|||
130453660|NCT00991276|469625329|FG002|First Intervention Period|Insufficient clinical response|0|||
130453661|NCT00991276|469625330|FG003|First Intervention Period|Insufficient clinical response|0|||
130453662|NCT00991276|469625331|FG004|First Intervention Period|Insufficient clinical response|1|||
130453663|NCT00991276|469625332|FG005|First Intervention Period|Insufficient clinical response|0|||
130453664|NCT00991276|469625327|FG000|First Intervention Period|Other|0|||
130453665|NCT00991276|469625328|FG001|First Intervention Period|Other|0|||
130453666|NCT00991276|469625329|FG002|First Intervention Period|Other|0|||
130453667|NCT00991276|469625330|FG003|First Intervention Period|Other|1|||
130453668|NCT00991276|469625331|FG004|First Intervention Period|Other|1|||
130453669|NCT00991276|469625332|FG005|First Intervention Period|Other|0|||
130453670|NCT00991276|469625327|FG000|First Intervention Period|Withdrawal by Subject|0|||
130453671|NCT00991276|469625328|FG001|First Intervention Period|Withdrawal by Subject|1|||
130453672|NCT00991276|469625329|FG002|First Intervention Period|Withdrawal by Subject|0|||
130453673|NCT00991276|469625330|FG003|First Intervention Period|Withdrawal by Subject|1|||
130453674|NCT00991276|469625331|FG004|First Intervention Period|Withdrawal by Subject|0|||
130453675|NCT00991276|469625332|FG005|First Intervention Period|Withdrawal by Subject|1|||
130453676|NCT00991276|469625327|FG000|First Intervention Period|Lost to Follow-up|0|||
130453677|NCT00991276|469625328|FG001|First Intervention Period|Lost to Follow-up|1|||
130453678|NCT00991276|469625329|FG002|First Intervention Period|Lost to Follow-up|0|||
130453679|NCT00991276|469625330|FG003|First Intervention Period|Lost to Follow-up|1|||
130453680|NCT00991276|469625331|FG004|First Intervention Period|Lost to Follow-up|0|||
130453681|NCT00991276|469625332|FG005|First Intervention Period|Lost to Follow-up|0|||
130453682|NCT00991276|469625327|FG000|Second Intervention Period|Adverse Event|0|||
130453683|NCT00991276|469625328|FG001|Second Intervention Period|Adverse Event|2|||
130453684|NCT00991276|469625329|FG002|Second Intervention Period|Adverse Event|0|||
130453685|NCT00991276|469625330|FG003|Second Intervention Period|Adverse Event|1|||
130453686|NCT00991276|469625331|FG004|Second Intervention Period|Adverse Event|1|||
130268164|NCT01151020|468947147|FG000|Overall Study|Lost to Follow-up|4|||
130268165|NCT01151020|468947147|FG000|Overall Study|Withdrawal by Subject|22|||
130268166|NCT01151020|468947147|FG000|Overall Study|Patients did not receive the device|2|||
130268167|NCT02389465|468947148|FG000|Overall Study|Lost to Follow-up|1|||
130453687|NCT00991276|469625332|FG005|Second Intervention Period|Adverse Event|0|||
130453688|NCT00991276|469625327|FG000|Second Intervention Period|Protocol Violation|1|||
130453689|NCT00991276|469625328|FG001|Second Intervention Period|Protocol Violation|0|||
130554010|NCT01369511|469996480|FG003|Overall Study|Entry criteria not met|1|||
130554011|NCT01369511|469996477|FG000|Overall Study|Lost to Follow-up|0|||
130554012|NCT01369511|469996478|FG001|Overall Study|Lost to Follow-up|1|||
130554013|NCT01369511|469996479|FG002|Overall Study|Lost to Follow-up|1|||
130554014|NCT01369511|469996480|FG003|Overall Study|Lost to Follow-up|2|||
130554015|NCT01369511|469996477|FG000|Overall Study|Protocol Violation|0|||
130554016|NCT01369511|469996478|FG001|Overall Study|Protocol Violation|1|||
130554017|NCT01369511|469996479|FG002|Overall Study|Protocol Violation|0|||
130554018|NCT01369511|469996480|FG003|Overall Study|Protocol Violation|2|||
130554019|NCT01369511|469996477|FG000|Overall Study|Physician Decision|3|||
130554020|NCT01369511|469996478|FG001|Overall Study|Physician Decision|4|||
130554021|NCT01369511|469996479|FG002|Overall Study|Physician Decision|0|||
130554022|NCT01369511|469996480|FG003|Overall Study|Physician Decision|0|||
130554023|NCT01369511|469996477|FG000|Overall Study|Sponsor decision|2|||
130554024|NCT01369511|469996478|FG001|Overall Study|Sponsor decision|0|||
130554025|NCT01369511|469996479|FG002|Overall Study|Sponsor decision|1|||
130554026|NCT01369511|469996480|FG003|Overall Study|Sponsor decision|0|||
130554027|NCT01369511|469996477|FG000|Overall Study|Withdrawal by Subject|5|||
130554028|NCT01369511|469996478|FG001|Overall Study|Withdrawal by Subject|6|||
130554029|NCT01369511|469996479|FG002|Overall Study|Withdrawal by Subject|4|||
130554030|NCT01369511|469996480|FG003|Overall Study|Withdrawal by Subject|6|||
130554031|NCT01180998|469996483|FG000|Overall Study|Poor Vision|0|||
130554032|NCT01180998|469996484|FG001|Overall Study|Poor Vision|2|||
130554033|NCT01180998|469996485|FG002|Overall Study|Poor Vision|2|||
130554034|NCT01180998|469996483|FG000|Overall Study|Lost to Follow-up|0|||
130554035|NCT01180998|469996484|FG001|Overall Study|Lost to Follow-up|0|||
130554036|NCT01180998|469996485|FG002|Overall Study|Lost to Follow-up|1|||
130554037|NCT01180998|469996483|FG000|Overall Study|Protocol Violation|1|||
130554038|NCT01180998|469996484|FG001|Overall Study|Protocol Violation|2|||
130554039|NCT01180998|469996485|FG002|Overall Study|Protocol Violation|0|||
130554040|NCT01180998|469996483|FG000|Overall Study|Withdrawal by Subject|0|||
130554041|NCT01180998|469996484|FG001|Overall Study|Withdrawal by Subject|0|||
130554042|NCT01180998|469996485|FG002|Overall Study|Withdrawal by Subject|1|||
130554043|NCT01180998|469996483|FG000|Overall Study|Poor comfort|3|||
130554044|NCT01180998|469996484|FG001|Overall Study|Poor comfort|0|||
130554045|NCT01180998|469996485|FG002|Overall Study|Poor comfort|4|||
130554046|NCT01180998|469996483|FG000|Overall Study|Poor lens handling|0|||
130554047|NCT01180998|469996484|FG001|Overall Study|Poor lens handling|0|||
130554048|NCT01180998|469996485|FG002|Overall Study|Poor lens handling|2|||
130554049|NCT01376349|469996486|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
130554050|NCT01376349|469996487|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
130554051|NCT01376349|469996488|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
130554052|NCT01376349|469996486|FG000|Raondomized Treatment|Adverse Event|13|||
130554053|NCT01376349|469996487|FG001|Raondomized Treatment|Adverse Event|17|||
130268168|NCT02389465|468947149|FG001|Overall Study|Lost to Follow-up|3|||
130268169|NCT02389465|468947150|FG002|Overall Study|Lost to Follow-up|3|||
130268170|NCT02389465|468947151|FG003|Overall Study|Lost to Follow-up|0|||
130268171|NCT02389465|468947148|FG000|Overall Study|Physician Decision|0|||
130268172|NCT02389465|468947149|FG001|Overall Study|Physician Decision|0|||
130268173|NCT02389465|468947150|FG002|Overall Study|Physician Decision|0|||
130268174|NCT02389465|468947151|FG003|Overall Study|Physician Decision|1|||
130268175|NCT02389465|468947148|FG000|Overall Study|Withdrawal by Subject|0|||
130268176|NCT02389465|468947149|FG001|Overall Study|Withdrawal by Subject|1|||
130268177|NCT02389465|468947150|FG002|Overall Study|Withdrawal by Subject|2|||
130268178|NCT02389465|468947151|FG003|Overall Study|Withdrawal by Subject|2|||
130268179|NCT00846846|468947152|FG000|Overall Study|Death|56|||
130268180|NCT00846846|468947152|FG000|Overall Study|Withdrawal by Subject|19|||
130268181|NCT01220401|468947156|FG000|Overall Study|Withdrawal by Subject|2|||
130268182|NCT01220401|468947156|FG000|Overall Study|Protocol Violation|1|||
130268183|NCT04179305|468947158|FG000|Overall Study|Death|1|||
130268184|NCT04179305|468947159|FG001|Overall Study|Death|1|||
130268185|NCT04179305|468947160|FG002|Overall Study|Death|0|||
130554054|NCT01376349|469996488|FG002|Raondomized Treatment|Adverse Event|14|||
130554055|NCT01376349|469996486|FG000|Raondomized Treatment|Unkown|1|||
130268186|NCT04179305|468947161|FG003|Overall Study|Death|0|||
130268187|NCT04179305|468947158|FG000|Overall Study|Lost to Follow-up|1|||
130554056|NCT01376349|469996487|FG001|Raondomized Treatment|Unkown|2|||
130554057|NCT01376349|469996488|FG002|Raondomized Treatment|Unkown|1|||
130268188|NCT04179305|468947159|FG001|Overall Study|Lost to Follow-up|1|||
130268189|NCT04179305|468947160|FG002|Overall Study|Lost to Follow-up|0|||
130554058|NCT01376349|469996486|FG000|Raondomized Treatment|Alternative Treatment|0|||
130554059|NCT01376349|469996487|FG001|Raondomized Treatment|Alternative Treatment|0|||
130554060|NCT01376349|469996488|FG002|Raondomized Treatment|Alternative Treatment|1|||
130268190|NCT04179305|468947161|FG003|Overall Study|Lost to Follow-up|0|||
130554061|NCT00162032|469996489|FG000|Overall Study|Lost to Follow-up|4|||
130554062|NCT00162032|469996490|FG001|Overall Study|Lost to Follow-up|2|||
130554063|NCT00162032|469996489|FG000|Overall Study|Reason not specified|1|||
130554064|NCT00162032|469996490|FG001|Overall Study|Reason not specified|0|||
130554065|NCT00216203|469996491|FG000|Overall Study|Withdrawal by Subject|2|||
130366088|NCT04019288|469310303|FG002|Overall Study|Death|0|||
130366089|NCT04401423|469310304|FG000|Overall Study|Withdrawal by Subject|3|||
130366090|NCT04401423|469310305|FG001|Overall Study|Withdrawal by Subject|1|||
130366091|NCT04401423|469310304|FG000|Overall Study|Physician Decision|2|||
130366092|NCT04401423|469310305|FG001|Overall Study|Physician Decision|1|||
130366093|NCT01020981|469310308|FG000|Overall Study|Did not return mailed survey|74|||
130366094|NCT01020981|469310309|FG001|Overall Study|Did not return mailed survey|58|||
130366095|NCT01020981|469310308|FG000|Overall Study|Survey returned undeliverable|8|||
130366096|NCT01020981|469310309|FG001|Overall Study|Survey returned undeliverable|32|||
130366097|NCT01020981|469310308|FG000|Overall Study|Participant declined to complete survey|2|||
130366098|NCT01020981|469310309|FG001|Overall Study|Participant declined to complete survey|0|||
130366099|NCT00040365|469310312|FG000|Overall Study|Death|1|||
130366100|NCT00040365|469310312|FG000|Overall Study|Progressive disease|7|||
130366101|NCT00040365|469310312|FG000|Overall Study|Lost to Follow-up|3|||
130366102|NCT00541931|469310313|FG000|Overall Study|Adverse Event|1|||
130366103|NCT00541931|469310314|FG001|Overall Study|Adverse Event|0|||
130366104|NCT00541931|469310313|FG000|Overall Study|Lost to Follow-up|3|||
130366105|NCT00541931|469310314|FG001|Overall Study|Lost to Follow-up|3|||
130366106|NCT00541931|469310313|FG000|Overall Study|Withdrawal by Subject|1|||
130366107|NCT00541931|469310314|FG001|Overall Study|Withdrawal by Subject|0|||
130366108|NCT00541931|469310313|FG000|Overall Study|Transportation Issue|0|||
130366109|NCT00541931|469310314|FG001|Overall Study|Transportation Issue|1|||
130366110|NCT02555683|469310315|FG000|Overall Study|Physician Decision|1|||
130366111|NCT02555683|469310316|FG001|Overall Study|Physician Decision|0|||
130366112|NCT02555683|469310317|FG002|Overall Study|Physician Decision|2|||
130366113|NCT02555683|469310315|FG000|Overall Study|Lost to Follow-up|2|||
130366114|NCT02555683|469310316|FG001|Overall Study|Lost to Follow-up|1|||
130704630|NCT03756883|470542747|FG000|Overall Study|Lost to Follow-up|3|||
130704631|NCT03756883|470542748|FG001|Overall Study|Lost to Follow-up|3|||
130366115|NCT02555683|469310317|FG002|Overall Study|Lost to Follow-up|2|||
130366116|NCT02555683|469310315|FG000|Overall Study|Technical Problems|1|||
130366117|NCT02555683|469310316|FG001|Overall Study|Technical Problems|1|||
130366118|NCT02555683|469310317|FG002|Overall Study|Technical Problems|0|||
130366119|NCT02555683|469310315|FG000|Overall Study|Protocol deviation|0|||
130366120|NCT02555683|469310316|FG001|Overall Study|Protocol deviation|1|||
130366121|NCT02555683|469310317|FG002|Overall Study|Protocol deviation|0|||
130366122|NCT02555683|469310315|FG000|Overall Study|Lack of Efficacy|2|||
130366123|NCT02555683|469310316|FG001|Overall Study|Lack of Efficacy|0|||
130366124|NCT02555683|469310317|FG002|Overall Study|Lack of Efficacy|0|||
130366125|NCT02555683|469310315|FG000|Overall Study|Death|0|||
130366126|NCT02555683|469310316|FG001|Overall Study|Death|1|||
130453690|NCT00991276|469625329|FG002|Second Intervention Period|Protocol Violation|0|||
130453691|NCT00991276|469625330|FG003|Second Intervention Period|Protocol Violation|0|||
130453692|NCT00991276|469625331|FG004|Second Intervention Period|Protocol Violation|0|||
130453693|NCT00991276|469625332|FG005|Second Intervention Period|Protocol Violation|0|||
130453694|NCT00991276|469625327|FG000|Second Intervention Period|Other|0|||
130453695|NCT00991276|469625328|FG001|Second Intervention Period|Other|0|||
130453696|NCT00991276|469625329|FG002|Second Intervention Period|Other|0|||
130453697|NCT00991276|469625330|FG003|Second Intervention Period|Other|1|||
130453698|NCT00991276|469625331|FG004|Second Intervention Period|Other|0|||
130453699|NCT00991276|469625332|FG005|Second Intervention Period|Other|1|||
130453700|NCT00991276|469625327|FG000|Third Intervention Period|Protocol Violation|1|||
130453701|NCT00991276|469625328|FG001|Third Intervention Period|Protocol Violation|0|||
130453702|NCT00991276|469625329|FG002|Third Intervention Period|Protocol Violation|0|||
130453703|NCT00991276|469625330|FG003|Third Intervention Period|Protocol Violation|0|||
130453704|NCT00991276|469625331|FG004|Third Intervention Period|Protocol Violation|0|||
130704632|NCT03756883|470542749|FG002|Overall Study|Lost to Follow-up|0|||
130704633|NCT03756883|470542747|FG000|Overall Study|Protocol Violation|2|||
130704634|NCT03756883|470542748|FG001|Overall Study|Protocol Violation|0|||
130366127|NCT02555683|469310317|FG002|Overall Study|Death|2|||
130366128|NCT02555683|469310315|FG000|Overall Study|Adverse Event|1|||
130366129|NCT02555683|469310316|FG001|Overall Study|Adverse Event|0|||
130366130|NCT02555683|469310317|FG002|Overall Study|Adverse Event|1|||
130366131|NCT02555683|469310315|FG000|Overall Study|Subject/guardian decision|12|||
130366132|NCT02555683|469310316|FG001|Overall Study|Subject/guardian decision|12|||
130366133|NCT02555683|469310317|FG002|Overall Study|Subject/guardian decision|22|||
130704635|NCT03756883|470542749|FG002|Overall Study|Protocol Violation|1|||
130366134|NCT02555683|469310315|FG000|Overall Study|Death post Treatment/safety period|0|||
130366135|NCT02555683|469310316|FG001|Overall Study|Death post Treatment/safety period|1|||
130366136|NCT02555683|469310317|FG002|Overall Study|Death post Treatment/safety period|0|||
130366137|NCT01086033|469310320|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
130453705|NCT00991276|469625332|FG005|Third Intervention Period|Protocol Violation|0|||
130704636|NCT03756883|470542747|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130366138|NCT01086033|469310320|FG000|Overall Study|Lost to Follow-up|86|||
130366139|NCT01086033|469310320|FG000|Overall Study|Adverse Event|42|||
130366140|NCT01086033|469310320|FG000|Overall Study|Withdrawal by Subject|41|||
130366141|NCT01086033|469310320|FG000|Overall Study|Other|14|||
130268191|NCT04179305|468947158|FG000|Overall Study|Withdrawal by Subject|0|||
130268192|NCT04179305|468947159|FG001|Overall Study|Withdrawal by Subject|1|||
130268193|NCT04179305|468947160|FG002|Overall Study|Withdrawal by Subject|0|||
130268194|NCT04179305|468947161|FG003|Overall Study|Withdrawal by Subject|0|||
130268195|NCT04179305|468947158|FG000|Overall Study|Did not have scan|1|||
130268196|NCT04179305|468947159|FG001|Overall Study|Did not have scan|0|||
130268197|NCT04179305|468947160|FG002|Overall Study|Did not have scan|0|||
130268198|NCT04179305|468947161|FG003|Overall Study|Did not have scan|0|||
130268199|NCT04179305|468947158|FG000|Overall Study|In hospice care|3|||
130268200|NCT04179305|468947159|FG001|Overall Study|In hospice care|0|||
130268201|NCT04179305|468947160|FG002|Overall Study|In hospice care|0|||
130268202|NCT04179305|468947161|FG003|Overall Study|In hospice care|0|||
130268203|NCT00503425|468947164|FG000|Overall Study|Participant files lost|6|||
130268204|NCT00503425|468947164|FG000|Overall Study|Adverse Event|5|||
130268205|NCT00503425|468947164|FG000|Overall Study|Lack of Efficacy|25|||
130268206|NCT00503425|468947164|FG000|Overall Study|Withdrawal by Subject|8|||
130268207|NCT00503425|468947164|FG000|Overall Study|Lost to Follow-up|3|||
130268208|NCT00503425|468947164|FG000|Overall Study|Death|3|||
130268209|NCT00503425|468947164|FG000|Overall Study|Missing Data/Unknown|4|||
130268210|NCT00326599|468947165|FG000|Overall Study|Withdrawal by Subject|1|||
130453706|NCT00991276|469625327|FG000|Third Intervention Period|Other|0|||
130453707|NCT00991276|469625328|FG001|Third Intervention Period|Other|0|||
130453708|NCT00991276|469625329|FG002|Third Intervention Period|Other|0|||
130453709|NCT00991276|469625330|FG003|Third Intervention Period|Other|0|||
130453710|NCT00991276|469625331|FG004|Third Intervention Period|Other|0|||
130453711|NCT00991276|469625332|FG005|Third Intervention Period|Other|1|||
130453712|NCT00991276|469625327|FG000|Third Intervention Period|Adverse Event|0|||
130453713|NCT00991276|469625328|FG001|Third Intervention Period|Adverse Event|0|||
130453714|NCT00991276|469625329|FG002|Third Intervention Period|Adverse Event|1|||
130453715|NCT00991276|469625330|FG003|Third Intervention Period|Adverse Event|0|||
130453716|NCT00991276|469625331|FG004|Third Intervention Period|Adverse Event|0|||
130453717|NCT00991276|469625332|FG005|Third Intervention Period|Adverse Event|0|||
130453718|NCT00991276|469625327|FG000|Third Intervention Period|Withdrawal by Subject|0|||
130453719|NCT00991276|469625328|FG001|Third Intervention Period|Withdrawal by Subject|0|||
130453720|NCT00991276|469625329|FG002|Third Intervention Period|Withdrawal by Subject|0|||
130453721|NCT00991276|469625330|FG003|Third Intervention Period|Withdrawal by Subject|1|||
130453722|NCT00991276|469625331|FG004|Third Intervention Period|Withdrawal by Subject|0|||
130453723|NCT00991276|469625332|FG005|Third Intervention Period|Withdrawal by Subject|0|||
130453724|NCT01268891|469625333|FG000|Overall Study|Adverse Event|3|||
130453725|NCT01268891|469625334|FG001|Overall Study|Adverse Event|7|||
130453726|NCT01268891|469625333|FG000|Overall Study|Lack of Efficacy|1|||
130453727|NCT01268891|469625334|FG001|Overall Study|Lack of Efficacy|0|||
130453728|NCT01268891|469625333|FG000|Overall Study|Withdrawal of Consent|3|||
130453729|NCT01268891|469625334|FG001|Overall Study|Withdrawal of Consent|1|||
130453730|NCT01268891|469625333|FG000|Overall Study|Administrative or other reason(s)|1|||
130453731|NCT01268891|469625334|FG001|Overall Study|Administrative or other reason(s)|0|||
130453732|NCT00711646|469625337|FG000|Overall Study|Adverse Event|6|||
130453733|NCT00711646|469625338|FG001|Overall Study|Adverse Event|1|||
130453734|NCT00711646|469625337|FG000|Overall Study|Withdrawal by Subject|4|||
130453735|NCT00711646|469625338|FG001|Overall Study|Withdrawal by Subject|0|||
130453736|NCT00711646|469625337|FG000|Overall Study|Protocol Violation|0|||
130453737|NCT00711646|469625338|FG001|Overall Study|Protocol Violation|1|||
130453738|NCT00711646|469625337|FG000|Overall Study|Lost to Follow-up|1|||
130453739|NCT00711646|469625338|FG001|Overall Study|Lost to Follow-up|0|||
130453740|NCT00711646|469625337|FG000|Overall Study|administrative decision|0|||
130453741|NCT00711646|469625338|FG001|Overall Study|administrative decision|1|||
130453742|NCT00711646|469625337|FG000|Overall Study|patient non-compliance|1|||
130268211|NCT00326599|468947166|FG001|Overall Study|Withdrawal by Subject|0|||
130268212|NCT00326599|468947167|FG002|Overall Study|Withdrawal by Subject|5|||
130268213|NCT00326599|468947168|FG003|Overall Study|Withdrawal by Subject|2|||
130268214|NCT00326599|468947165|FG000|Overall Study|Adverse Event|1|||
130268215|NCT00326599|468947166|FG001|Overall Study|Adverse Event|0|||
130268216|NCT00326599|468947167|FG002|Overall Study|Adverse Event|32|||
130268217|NCT00326599|468947168|FG003|Overall Study|Adverse Event|3|||
130268218|NCT00326599|468947165|FG000|Overall Study|Disease Progression|3|||
130453743|NCT00711646|469625338|FG001|Overall Study|patient non-compliance|0|||
130453744|NCT03721016|469625340|FG000|Overall Study|Adverse Event|0|||
130453745|NCT03721016|469625341|FG001|Overall Study|Adverse Event|1|||
130453746|NCT03721016|469625342|FG002|Overall Study|Adverse Event|1|||
130453747|NCT03721016|469625340|FG000|Overall Study|Withdrawal by Subject|8|||
130268219|NCT00326599|468947166|FG001|Overall Study|Disease Progression|1|||
130268220|NCT00326599|468947167|FG002|Overall Study|Disease Progression|13|||
130268221|NCT00326599|468947168|FG003|Overall Study|Disease Progression|11|||
130268222|NCT00326599|468947165|FG000|Overall Study|Alternate Treatment|1|||
130453748|NCT03721016|469625341|FG001|Overall Study|Withdrawal by Subject|16|||
130453749|NCT03721016|469625342|FG002|Overall Study|Withdrawal by Subject|13|||
130268223|NCT00326599|468947166|FG001|Overall Study|Alternate Treatment|0|||
130268224|NCT00326599|468947167|FG002|Overall Study|Alternate Treatment|0|||
130268225|NCT00326599|468947168|FG003|Overall Study|Alternate Treatment|0|||
130268226|NCT00326599|468947165|FG000|Overall Study|Death|0|||
130268227|NCT00326599|468947166|FG001|Overall Study|Death|0|||
130268228|NCT00326599|468947167|FG002|Overall Study|Death|1|||
130268229|NCT00326599|468947168|FG003|Overall Study|Death|2|||
130268230|NCT00326599|468947165|FG000|Overall Study|Other Unspecified Reason|0|||
130268231|NCT00326599|468947166|FG001|Overall Study|Other Unspecified Reason|0|||
130268232|NCT00326599|468947167|FG002|Overall Study|Other Unspecified Reason|2|||
130268233|NCT00326599|468947168|FG003|Overall Study|Other Unspecified Reason|1|||
130268234|NCT00437268|468947173|FG000|Overall Study|Adverse Event|1|||
130268235|NCT00437268|468947174|FG001|Overall Study|Adverse Event|1|||
130268236|NCT00437268|468947173|FG000|Overall Study|Withdrawal by Subject|2|||
130268237|NCT00437268|468947174|FG001|Overall Study|Withdrawal by Subject|2|||
130268238|NCT00437268|468947173|FG000|Overall Study|Progressive disease|9|||
130268239|NCT00437268|468947174|FG001|Overall Study|Progressive disease|9|||
130268240|NCT00437268|468947173|FG000|Overall Study|Physician Decision|1|||
130268241|NCT00437268|468947174|FG001|Overall Study|Physician Decision|0|||
130268242|NCT00437268|468947173|FG000|Overall Study|Death|0|||
130268243|NCT00437268|468947174|FG001|Overall Study|Death|1|||
130268244|NCT00444925|468947175|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
130268245|NCT00444925|468947176|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130268246|NCT00444925|468947177|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130268247|NCT00444925|468947175|FG000|Double-blind Treatment Period|Death|2|||
130268248|NCT00444925|468947176|FG001|Double-blind Treatment Period|Death|0|||
130268249|NCT00444925|468947177|FG002|Double-blind Treatment Period|Death|0|||
130268250|NCT00444925|468947175|FG000|Double-blind Treatment Period|Adverse Event|6|||
130268251|NCT00444925|468947176|FG001|Double-blind Treatment Period|Adverse Event|28|||
130268252|NCT00444925|468947177|FG002|Double-blind Treatment Period|Adverse Event|44|||
130268253|NCT00444925|468947175|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130268254|NCT00444925|468947176|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
130268255|NCT00444925|468947177|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
130268256|NCT00444925|468947175|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
130268257|NCT00444925|468947176|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
130268258|NCT00444925|468947177|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130268259|NCT00444925|468947175|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
130268260|NCT00444925|468947176|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
130268261|NCT00444925|468947177|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
130268262|NCT00444925|468947175|FG000|Double-blind Treatment Period|Other|7|||
130268263|NCT00444925|468947176|FG001|Double-blind Treatment Period|Other|7|||
130268264|NCT00444925|468947177|FG002|Double-blind Treatment Period|Other|12|||
130268265|NCT00714948|468947184|FG000|Overall Study|Adverse Event|2|||
130453750|NCT03721016|469625340|FG000|Overall Study|Lost to Follow-up|4|||
130453751|NCT03721016|469625341|FG001|Overall Study|Lost to Follow-up|6|||
130453752|NCT03721016|469625342|FG002|Overall Study|Lost to Follow-up|5|||
130453753|NCT03721016|469625340|FG000|Overall Study|Physician Decision|0|||
130453754|NCT03721016|469625341|FG001|Overall Study|Physician Decision|1|||
130453755|NCT03721016|469625342|FG002|Overall Study|Physician Decision|2|||
130453756|NCT03721016|469625340|FG000|Overall Study|Protocol Violation|0|||
130453757|NCT03721016|469625341|FG001|Overall Study|Protocol Violation|1|||
130453758|NCT03721016|469625342|FG002|Overall Study|Protocol Violation|0|||
130453759|NCT03721016|469625340|FG000|Overall Study|Site terminated by sponsor|3|||
130453760|NCT03721016|469625341|FG001|Overall Study|Site terminated by sponsor|7|||
130453761|NCT03721016|469625342|FG002|Overall Study|Site terminated by sponsor|6|||
130453762|NCT03721016|469625340|FG000|Overall Study|Subject exited early due to COVID-19|1|||
130453763|NCT03721016|469625341|FG001|Overall Study|Subject exited early due to COVID-19|0|||
130453764|NCT03721016|469625342|FG002|Overall Study|Subject exited early due to COVID-19|0|||
130453765|NCT02232178|469625345|FG000|Overall Study|Lost to Follow-up|0|||
130453766|NCT02232178|469625346|FG001|Overall Study|Lost to Follow-up|1|||
130453767|NCT02232178|469625347|FG002|Overall Study|Lost to Follow-up|0|||
130453768|NCT02232178|469625345|FG000|Overall Study|ineligibility|0|||
130453769|NCT02232178|469625346|FG001|Overall Study|ineligibility|0|||
130453770|NCT02232178|469625347|FG002|Overall Study|ineligibility|1|||
130453771|NCT02232178|469625345|FG000|Overall Study|surgical complication|1|||
130453772|NCT02232178|469625346|FG001|Overall Study|surgical complication|0|||
130453773|NCT02232178|469625347|FG002|Overall Study|surgical complication|0|||
130453774|NCT01020838|469625351|FG000|Overall Study|Death|90|||
130268266|NCT03382912|468947185|FG000|Overall Study|Physician Decision|0|||
130268267|NCT03382912|468947186|FG001|Overall Study|Physician Decision|1|||
130268268|NCT03382912|468947185|FG000|Overall Study|Sponsor Decision|6|||
130268269|NCT03382912|468947186|FG001|Overall Study|Sponsor Decision|6|||
130268270|NCT03382912|468947185|FG000|Overall Study|Withdrawal by Subject|0|||
130453775|NCT01020838|469625351|FG000|Overall Study|Adverse Event|1|||
130268271|NCT03382912|468947186|FG001|Overall Study|Withdrawal by Subject|5|||
130268272|NCT05588440|468947187|FG000|Overall Study|Sponsor Decision|2|||
130453776|NCT01020838|469625351|FG000|Overall Study|Withdrawal by Subject|9|||
130453777|NCT01020838|469625351|FG000|Overall Study|Lost to Follow-up|6|||
130366142|NCT01086033|469310320|FG000|Overall Study|Other|13|||
130366143|NCT01086033|469310320|FG000|Overall Study|AE and Withdrew Consent|5|||
130366144|NCT01086033|469310320|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
130366145|NCT01086033|469310320|FG000|Overall Study|Withdrew consent and Other Reason|4|||
130366146|NCT01086033|469310320|FG000|Overall Study|AE and Lack of Efficacy|4|||
130366147|NCT01086033|469310320|FG000|Overall Study|Death|1|||
130366148|NCT01086033|469310320|FG000|Overall Study|AE and Lost to Follow-up|1|||
130366149|NCT01086033|469310320|FG000|Overall Study|AE and Other Reason|1|||
130366150|NCT01086033|469310320|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
130366151|NCT04572633|469310321|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
130366152|NCT02924571|469310322|FG000|Overall Study|Lost to Follow-up|1|||
130366153|NCT02924571|469310323|FG001|Overall Study|Lost to Follow-up|1|||
130366154|NCT02924571|469310324|FG002|Overall Study|Lost to Follow-up|0|||
130366155|NCT00434954|469310328|FG000|Overall Study|Adverse Event|17|||
130366156|NCT00434954|469310329|FG001|Overall Study|Adverse Event|2|||
130366157|NCT00434954|469310328|FG000|Overall Study|Entry criteria not met|14|||
130366158|NCT00434954|469310329|FG001|Overall Study|Entry criteria not met|16|||
130366159|NCT00434954|469310328|FG000|Overall Study|Lost to Follow-up|0|||
130366160|NCT00434954|469310329|FG001|Overall Study|Lost to Follow-up|1|||
130366161|NCT00434954|469310328|FG000|Overall Study|Physician Decision|6|||
130366162|NCT00434954|469310329|FG001|Overall Study|Physician Decision|3|||
130366163|NCT00434954|469310328|FG000|Overall Study|Protocol Violation|36|||
130366164|NCT00434954|469310329|FG001|Overall Study|Protocol Violation|27|||
130366165|NCT00434954|469310328|FG000|Overall Study|Sponsor decision|1|||
130366166|NCT00434954|469310329|FG001|Overall Study|Sponsor decision|0|||
130366167|NCT00434954|469310328|FG000|Overall Study|Subject decision|8|||
130366168|NCT00434954|469310329|FG001|Overall Study|Subject decision|22|||
130453778|NCT01020838|469625351|FG000|Overall Study|Most common: Study ended by sponsor|77|||
130453779|NCT01167426|469625353|FG000|Overall Study|Lost to Follow-up|6|||
130453780|NCT01167426|469625353|FG000|Overall Study|Protocol Violation|1|||
130453781|NCT01167426|469625353|FG000|Overall Study|Withdrawal by Subject|2|||
130453782|NCT01167426|469625353|FG000|Overall Study|Sponsor Decision|1|||
130453783|NCT02993471|469625354|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
130453784|NCT02993471|469625354|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
130453785|NCT01908634|469625355|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
130453786|NCT01908634|469625355|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
130453787|NCT04176458|469625357|FG000|Overall Study|Covid 19|4|||
130453788|NCT01570751|469625358|FG000|Period A (16 Weeks)|Protocol Violation|1|||
130453789|NCT01570751|469625359|FG001|Period A (16 Weeks)|Protocol Violation|1|||
130453790|NCT01570751|469625358|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
130453791|NCT01570751|469625359|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
130453792|NCT01570751|469625358|FG000|Period A (16 Weeks)|Unclassified|2|||
130453793|NCT01570751|469625359|FG001|Period A (16 Weeks)|Unclassified|3|||
130453794|NCT01570751|469625358|FG000|Period B (16 Weeks)|Adverse Event|1|||
130453795|NCT01570751|469625359|FG001|Period B (16 Weeks)|Adverse Event|0|||
130453796|NCT01570751|469625358|FG000|Period B (16 Weeks)|Protocol Violation|0|||
130453797|NCT01570751|469625359|FG001|Period B (16 Weeks)|Protocol Violation|1|||
130453798|NCT00588666|469625362|FG000|Overall Study|Adverse Event|4|||
130453799|NCT03102710|469625363|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
130453800|NCT03102710|469625364|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
130453801|NCT03102710|469625365|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
130453802|NCT03102710|469625363|FG000|Overall Study|Technical issues during final MRI scan|0|||
130453803|NCT03102710|469625364|FG001|Overall Study|Technical issues during final MRI scan|1|||
130453804|NCT03102710|469625365|FG002|Overall Study|Technical issues during final MRI scan|0|||
130453805|NCT03102710|469625363|FG000|Overall Study|Nausea during MRI scan|0|||
130453806|NCT03102710|469625364|FG001|Overall Study|Nausea during MRI scan|1|||
130453807|NCT03102710|469625365|FG002|Overall Study|Nausea during MRI scan|0|||
130453808|NCT03102710|469625363|FG000|Overall Study|Subject unable to attend final session|0|||
130453809|NCT03102710|469625364|FG001|Overall Study|Subject unable to attend final session|1|||
130453810|NCT03102710|469625365|FG002|Overall Study|Subject unable to attend final session|0|||
130453811|NCT04582877|469625366|FG000|Overall Study|Did not use device measurement|5|||
130453812|NCT04582877|469625366|FG000|Overall Study|No fractional flow reserve test results|2|||
130453813|NCT04582877|469625366|FG000|Overall Study|Protocol Violation|1|||
130453814|NCT04012853|469625367|FG000|Overall Study|Withdrawal by Subject|1|||
130453815|NCT04012853|469625368|FG001|Overall Study|Withdrawal by Subject|1|||
130453816|NCT04012853|469625367|FG000|Overall Study|Protocol Violation|1|||
130554066|NCT04098068|469996492|FG000|Overall Study|Disease Progression|7|||
130554067|NCT04098068|469996492|FG000|Overall Study|Withdrawal by Subject|2|||
130366169|NCT00894166|469310330|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
130366170|NCT00894166|469310331|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
130366171|NCT00894166|469310332|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
130366172|NCT00894166|469310333|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
130366173|NCT00894166|469310334|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
130453817|NCT04012853|469625368|FG001|Overall Study|Protocol Violation|0|||
130453818|NCT04012853|469625367|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
130453819|NCT04012853|469625368|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
130453820|NCT03055767|469625369|FG000|Open-Label Period|Lost to Follow-up|0|||
130453821|NCT03055767|469625370|FG001|Open-Label Period|Lost to Follow-up|0|||
130453822|NCT03055767|469625371|FG002|Open-Label Period|Lost to Follow-up|2|||
130554068|NCT04098068|469996492|FG000|Overall Study|New Cancer Diagnosis|1|||
130554069|NCT03871829|469996493|FG000|Overall Study|Lost to Follow-up|0|||
130554070|NCT03871829|469996494|FG001|Overall Study|Lost to Follow-up|1|||
130554071|NCT03871829|469996493|FG000|Overall Study|Withdrawal by Subject|1|||
130554072|NCT03871829|469996494|FG001|Overall Study|Withdrawal by Subject|1|||
130554073|NCT03871829|469996493|FG000|Overall Study|Death|12|||
130554074|NCT03871829|469996494|FG001|Overall Study|Death|8|||
130554075|NCT03871829|469996493|FG000|Overall Study|Study terminated by sponsor|31|||
130554076|NCT03871829|469996494|FG001|Overall Study|Study terminated by sponsor|34|||
130554077|NCT01106014|469996495|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
130554078|NCT01106014|469996496|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
130554079|NCT01106014|469996495|FG000|Overall Study|Adverse Event|78|||
130554080|NCT01106014|469996496|FG001|Overall Study|Adverse Event|42|||
130554081|NCT01106014|469996495|FG000|Overall Study|Withdrawal by Subject|43|||
130554082|NCT01106014|469996496|FG001|Overall Study|Withdrawal by Subject|37|||
130554083|NCT01106014|469996495|FG000|Overall Study|Administrative reason|7|||
130554084|NCT01106014|469996496|FG001|Overall Study|Administrative reason|6|||
130554085|NCT01106014|469996495|FG000|Overall Study|Lost to Follow-up|2|||
130554086|NCT01106014|469996496|FG001|Overall Study|Lost to Follow-up|3|||
130554087|NCT00784693|469996502|FG000|Overall Study|Lost to Follow-up|0|||
130554088|NCT00784693|469996503|FG001|Overall Study|Lost to Follow-up|1|||
130554089|NCT00784693|469996502|FG000|Overall Study|Lack of Efficacy|1|||
130554090|NCT00784693|469996503|FG001|Overall Study|Lack of Efficacy|1|||
130554091|NCT00784693|469996502|FG000|Overall Study|Withdrawal by Subject|0|||
130554092|NCT00784693|469996503|FG001|Overall Study|Withdrawal by Subject|4|||
130554093|NCT00784693|469996502|FG000|Overall Study|Randomized but not Treated|1|||
130554094|NCT00784693|469996503|FG001|Overall Study|Randomized but not Treated|0|||
130554095|NCT00784693|469996502|FG000|Overall Study|Other|1|||
130554096|NCT00784693|469996503|FG001|Overall Study|Other|0|||
130554097|NCT05458479|469996504|FG000|Overall Study|Lost to Follow-up|1|||
130554098|NCT00908232|469996505|FG000|Cycle 1 to 4|Death|5|||
130554099|NCT00908232|469996506|FG001|Cycle 1 to 4|Death|0|||
130554100|NCT00908232|469996507|FG002|Cycle 1 to 4|Death|0|||
130554101|NCT00908232|469996508|FG003|Cycle 1 to 4|Death|0|||
130554102|NCT00908232|469996505|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
130268273|NCT05588440|468947188|FG001|Overall Study|Sponsor Decision|0|||
130268274|NCT05588440|468947189|FG002|Overall Study|Sponsor Decision|1|||
130268275|NCT05588440|468947187|FG000|Overall Study|Death|1|||
130453823|NCT03055767|469625372|FG003|Open-Label Period|Lost to Follow-up|0|||
130453824|NCT03055767|469625369|FG000|Open-Label Period|Withdrawal by Subject|0|||
130453825|NCT03055767|469625370|FG001|Open-Label Period|Withdrawal by Subject|0|||
130453826|NCT03055767|469625371|FG002|Open-Label Period|Withdrawal by Subject|0|||
130453827|NCT03055767|469625372|FG003|Open-Label Period|Withdrawal by Subject|1|||
130453828|NCT02759731|469625373|FG000|Overall Study|Did not complete treatment.|8|||
130453829|NCT02317705|469625374|FG000|Overall Study|Withdrawal by Subject|3|||
130453830|NCT02317705|469625374|FG000|Overall Study|Physician Decision|1|||
130453831|NCT02317705|469625374|FG000|Overall Study|Drug not usable|1|||
130453832|NCT02219490|469625375|FG000|Overall Study|Adverse Event|24|||
130453833|NCT02219490|469625375|FG000|Overall Study|Withdrew consent|96|||
130453834|NCT02219490|469625375|FG000|Overall Study|Lost to Follow-up|126|||
130453835|NCT02219490|469625375|FG000|Overall Study|COVID-19 infection|2|||
130453836|NCT02219490|469625375|FG000|Overall Study|COVID-19 logistical restrictions|33|||
130453837|NCT02219490|469625375|FG000|Overall Study|Other, not specified|57|||
130268276|NCT05588440|468947188|FG001|Overall Study|Death|1|||
130268277|NCT05588440|468947189|FG002|Overall Study|Death|1|||
130268278|NCT05588440|468947187|FG000|Overall Study|Screen Fail|0|||
130268279|NCT05588440|468947188|FG001|Overall Study|Screen Fail|1|||
130268280|NCT05588440|468947189|FG002|Overall Study|Screen Fail|1|||
130453838|NCT01599325|469625376|FG000|Primary Parent Phase|Adverse Event|5|||
130453839|NCT01599325|469625376|FG000|Primary Parent Phase|Disease Progression|7|||
130453840|NCT01599325|469625376|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
130554103|NCT00908232|469996506|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
130554104|NCT00908232|469996507|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
130554105|NCT00908232|469996508|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
130554106|NCT00908232|469996505|FG000|Cycle 1 to 4|Progressive Disease|6|||
130554107|NCT00908232|469996506|FG001|Cycle 1 to 4|Progressive Disease|0|||
130554108|NCT00908232|469996507|FG002|Cycle 1 to 4|Progressive Disease|0|||
130554109|NCT00908232|469996508|FG003|Cycle 1 to 4|Progressive Disease|0|||
130268281|NCT05588440|468947187|FG000|Overall Study|Withdrawal by Subject|0|||
130268282|NCT05588440|468947188|FG001|Overall Study|Withdrawal by Subject|0|||
130554110|NCT00908232|469996505|FG000|Cycle 1 to 4|Adverse Event|12|||
130268283|NCT05588440|468947189|FG002|Overall Study|Withdrawal by Subject|1|||
130554111|NCT00908232|469996506|FG001|Cycle 1 to 4|Adverse Event|0|||
130554112|NCT00908232|469996507|FG002|Cycle 1 to 4|Adverse Event|0|||
130554113|NCT00908232|469996508|FG003|Cycle 1 to 4|Adverse Event|0|||
130554114|NCT00908232|469996505|FG000|Cycle 1 to 4|Other|1|||
130554115|NCT00908232|469996506|FG001|Cycle 1 to 4|Other|0|||
130554116|NCT00908232|469996507|FG002|Cycle 1 to 4|Other|0|||
130554117|NCT00908232|469996508|FG003|Cycle 1 to 4|Other|0|||
130554118|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
130554119|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
130554120|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
130554121|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
130268284|NCT02137070|468947190|FG000|Overall Study|Adverse Event|12|||
130268285|NCT02137070|468947191|FG001|Overall Study|Adverse Event|3|||
130268286|NCT02137070|468947190|FG000|Overall Study|Death|2|||
130268287|NCT02137070|468947191|FG001|Overall Study|Death|0|||
130453841|NCT01599325|469625376|FG000|Primary Parent Phase|Death|13|||
130453842|NCT01599325|469625376|FG000|Primary Parent Phase|Protocol Violation|1|||
130453843|NCT01599325|469625376|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
130453844|NCT01599325|469625376|FG000|Primary Parent Phase|Other|2|||
130453845|NCT01599325|469625376|FG000|Extension Phase|Study Closure|1|||
130453846|NCT01599325|469625376|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
130453847|NCT01599325|469625376|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
130453848|NCT01599325|469625376|FG000|Extension Phase|Disease Progression|1|||
130453849|NCT01599325|469625376|FG000|Extension Phase|Withdrawal by Subject|8|||
130453850|NCT02365298|469625379|FG000|Period 2|incorrect Rx dispensed|1|||
130453851|NCT02365298|469625380|FG001|Period 2|incorrect Rx dispensed|0|||
130453852|NCT02365298|469625379|FG000|Period 2|Discontinued at request of Sponsor|1|||
130453853|NCT02365298|469625380|FG001|Period 2|Discontinued at request of Sponsor|0|||
130453854|NCT02365298|469625379|FG000|Period 2|Test Article longer available|0|||
130453855|NCT02365298|469625380|FG001|Period 2|Test Article longer available|1|||
130453856|NCT02365298|469625379|FG000|Period 2|Protocol Violation|0|||
130453857|NCT02365298|469625380|FG001|Period 2|Protocol Violation|1|||
130453858|NCT01878890|469625381|FG000|Overall Study|Protocol Violation|0|||
130554122|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
130554123|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
130554124|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
130554125|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
130554126|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
130554127|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
130554128|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
130554129|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
130554130|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
130554131|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
130554132|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
130554133|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
130554134|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
130704637|NCT03756883|470542748|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130704638|NCT03756883|470542749|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
130704639|NCT03756883|470542747|FG000|Overall Study|Withdrawal by Subject|4|||
130704640|NCT03756883|470542748|FG001|Overall Study|Withdrawal by Subject|1|||
130704641|NCT03756883|470542749|FG002|Overall Study|Withdrawal by Subject|0|||
130704642|NCT03756883|470542747|FG000|Overall Study|Other Reasons|2|||
130554135|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
130704643|NCT03756883|470542748|FG001|Overall Study|Other Reasons|4|||
130704644|NCT03756883|470542749|FG002|Overall Study|Other Reasons|0|||
130453859|NCT01878890|469625382|FG001|Overall Study|Protocol Violation|1|||
130453860|NCT01878890|469625383|FG002|Overall Study|Protocol Violation|0|||
130453861|NCT01878890|469625384|FG003|Overall Study|Protocol Violation|0|||
130453862|NCT02974010|469625385|FG000|Overall Study|Lost to Follow-up|3|||
130453863|NCT02974010|469625386|FG001|Overall Study|Lost to Follow-up|1|||
130453864|NCT02974010|469625387|FG002|Overall Study|Lost to Follow-up|0|||
130453865|NCT02974010|469625388|FG003|Overall Study|Lost to Follow-up|0|||
130453866|NCT02974010|469625385|FG000|Overall Study|Withdrawal by Subject|2|||
130453867|NCT02974010|469625386|FG001|Overall Study|Withdrawal by Subject|1|||
130453868|NCT02974010|469625387|FG002|Overall Study|Withdrawal by Subject|0|||
130453869|NCT02974010|469625388|FG003|Overall Study|Withdrawal by Subject|0|||
130554136|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
130554137|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
130704645|NCT00529217|470542751|FG000|Overall Study|Lack of Efficacy|2|||
130453870|NCT02974010|469625385|FG000|Overall Study|Adverse Event|0|||
130704646|NCT00529217|470542751|FG000|Overall Study|Unable to adhere to study schedule|2|||
130268288|NCT02137070|468947190|FG000|Overall Study|Lost to Follow-up|24|||
130366174|NCT00894166|469310335|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
130366175|NCT00894166|469310336|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
130366176|NCT00894166|469310337|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
130366177|NCT00894166|469310330|FG000|Overall Study|Death|0|||
130366178|NCT00894166|469310331|FG001|Overall Study|Death|0|||
130366179|NCT00894166|469310332|FG002|Overall Study|Death|0|||
130366180|NCT00894166|469310333|FG003|Overall Study|Death|1|||
130366181|NCT00894166|469310334|FG004|Overall Study|Death|0|||
130366182|NCT00894166|469310335|FG005|Overall Study|Death|0|||
130366183|NCT00894166|469310336|FG006|Overall Study|Death|0|||
130366184|NCT00894166|469310337|FG007|Overall Study|Death|0|||
130366185|NCT03750955|469310344|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
130366186|NCT03750955|469310345|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
130366187|NCT03750955|469310344|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
130366188|NCT03750955|469310345|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
130366189|NCT01180985|469310348|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
130366190|NCT01180985|469310349|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
130366191|NCT00129272|469310354|FG000|Overall Study|Lost to Follow-up|12|||
130366192|NCT00129272|469310355|FG001|Overall Study|Lost to Follow-up|11|||
130366193|NCT00129272|469310354|FG000|Overall Study|Withdrawal by Subject|5|||
130366194|NCT00129272|469310355|FG001|Overall Study|Withdrawal by Subject|11|||
130366195|NCT03345914|469310356|FG000|Overall Study|Transition to another study at week 16|80|||
130366196|NCT03345914|469310357|FG001|Overall Study|Transition to another study at week 16|86|||
130366197|NCT03345914|469310358|FG002|Overall Study|Transition to another study at week 16|78|||
130366198|NCT03345914|469310356|FG000|Overall Study|Transition to OLE during follow-up|37|||
130366199|NCT03345914|469310357|FG001|Overall Study|Transition to OLE during follow-up|33|||
130366200|NCT03345914|469310358|FG002|Overall Study|Transition to OLE during follow-up|39|||
130366201|NCT03345914|469310356|FG000|Overall Study|Physician Decision|0|||
130366202|NCT03345914|469310357|FG001|Overall Study|Physician Decision|1|||
130366203|NCT03345914|469310358|FG002|Overall Study|Physician Decision|1|||
130366204|NCT03345914|469310356|FG000|Overall Study|Withdrawal by Subject|5|||
130366205|NCT03345914|469310357|FG001|Overall Study|Withdrawal by Subject|1|||
130366206|NCT03345914|469310358|FG002|Overall Study|Withdrawal by Subject|2|||
130366207|NCT03345914|469310356|FG000|Overall Study|Other|1|||
130366208|NCT03345914|469310357|FG001|Overall Study|Other|1|||
130366209|NCT03345914|469310358|FG002|Overall Study|Other|1|||
130366210|NCT03345914|469310356|FG000|Overall Study|Ongoing|0|||
130366211|NCT03345914|469310357|FG001|Overall Study|Ongoing|0|||
130366212|NCT03345914|469310358|FG002|Overall Study|Ongoing|1|||
130366213|NCT00885846|469310364|FG000|Overall Study|Withdrawal by Subject|2|||
130366214|NCT00885846|469310365|FG001|Overall Study|Withdrawal by Subject|5|||
130366215|NCT00885846|469310366|FG002|Overall Study|Withdrawal by Subject|2|||
130366216|NCT01786668|469310368|FG000|Overall Study|Adverse Event|0|||
130366217|NCT01786668|469310369|FG001|Overall Study|Adverse Event|1|||
130366218|NCT01786668|469310370|FG002|Overall Study|Adverse Event|1|||
130366219|NCT01786668|469310371|FG003|Overall Study|Adverse Event|2|||
130366220|NCT01786668|469310368|FG000|Overall Study|Withdrawal by Subject|0|||
130366221|NCT01786668|469310369|FG001|Overall Study|Withdrawal by Subject|0|||
130366222|NCT01786668|469310370|FG002|Overall Study|Withdrawal by Subject|3|||
130366223|NCT01786668|469310371|FG003|Overall Study|Withdrawal by Subject|1|||
130366224|NCT01786668|469310368|FG000|Overall Study|Pregnancy|0|||
130366225|NCT01786668|469310369|FG001|Overall Study|Pregnancy|0|||
130366226|NCT01786668|469310370|FG002|Overall Study|Pregnancy|0|||
130366227|NCT01786668|469310371|FG003|Overall Study|Pregnancy|1|||
130366228|NCT01786668|469310368|FG000|Overall Study|Lost to Follow-up|1|||
130366229|NCT01786668|469310369|FG001|Overall Study|Lost to Follow-up|0|||
130366230|NCT01786668|469310370|FG002|Overall Study|Lost to Follow-up|1|||
130366231|NCT01786668|469310371|FG003|Overall Study|Lost to Follow-up|0|||
130366232|NCT03570697|469310372|FG000|Overall Study|Lost to Follow-up|0|||
130268289|NCT02137070|468947191|FG001|Overall Study|Lost to Follow-up|9|||
130268290|NCT02137070|468947190|FG000|Overall Study|Physician Decision|0|||
130268291|NCT02137070|468947191|FG001|Overall Study|Physician Decision|1|||
130268292|NCT02137070|468947190|FG000|Overall Study|Protocol Violation|18|||
130268293|NCT02137070|468947191|FG001|Overall Study|Protocol Violation|4|||
130268294|NCT02137070|468947190|FG000|Overall Study|Withdrawal by Subject|18|||
130268295|NCT02137070|468947191|FG001|Overall Study|Withdrawal by Subject|1|||
130268296|NCT00678288|468949619|FG000|Overall Study|Adverse Event|0|||
130268297|NCT00678288|468949620|FG001|Overall Study|Adverse Event|2|||
130268298|NCT00678288|468949619|FG000|Overall Study|Withdrawal by Subject|1|||
130268299|NCT00678288|468949620|FG001|Overall Study|Withdrawal by Subject|1|||
130268300|NCT00678288|468949619|FG000|Overall Study|Study terminated by the sponsor|2|||
130268301|NCT00678288|468949620|FG001|Overall Study|Study terminated by the sponsor|0|||
130268302|NCT00678288|468949619|FG000|Overall Study|Not compliant with study medication|0|||
130268303|NCT00678288|468949620|FG001|Overall Study|Not compliant with study medication|1|||
130268304|NCT00678288|468949619|FG000|Overall Study|Switch to commercial drug|0|||
130268305|NCT00678288|468949620|FG001|Overall Study|Switch to commercial drug|1|||
130268306|NCT00678288|468949619|FG000|Overall Study|Reason not reported|1|||
130268307|NCT00678288|468949620|FG001|Overall Study|Reason not reported|0|||
130268308|NCT00678288|468949619|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
130268309|NCT00678288|468949620|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130268310|NCT02549989|468949621|FG000|Overall Study|Adverse Event|4|||
130268311|NCT02549989|468949621|FG000|Overall Study|Death|1|||
130268312|NCT02549989|468949621|FG000|Overall Study|Lack of Efficacy|19|||
130268313|NCT02549989|468949621|FG000|Overall Study|Withdrawal by Subject|3|||
130268314|NCT00972023|468949622|FG000|Overall Study|Withdrawal by Subject|1|||
130268315|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
130268316|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130704647|NCT01999894|470542752|FG000|Overall Study|Adverse Event|9|||
130268317|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268318|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268319|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268320|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268321|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268322|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268323|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268324|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268325|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
130268326|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
130268327|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268328|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268329|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268330|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268331|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268332|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268333|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
130268334|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
130268335|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
130268336|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268337|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268338|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268339|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268340|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268341|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268342|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130268343|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
130268344|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130268345|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268346|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268347|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268348|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268349|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268350|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130366233|NCT03570697|469310373|FG001|Overall Study|Lost to Follow-up|1|||
130704648|NCT01999894|470542752|FG000|Overall Study|Lack of Efficacy|5|||
130704649|NCT01999894|470542752|FG000|Overall Study|Protocol Violation|1|||
130453871|NCT02974010|469625386|FG001|Overall Study|Adverse Event|1|||
130453872|NCT02974010|469625387|FG002|Overall Study|Adverse Event|0|||
130453873|NCT02974010|469625388|FG003|Overall Study|Adverse Event|0|||
130453874|NCT02974010|469625385|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
130453875|NCT02974010|469625386|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
130453876|NCT02974010|469625387|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
130453877|NCT02974010|469625388|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
130453878|NCT02974010|469625385|FG000|Overall Study|Lack of Efficacy|0|||
130453879|NCT02974010|469625386|FG001|Overall Study|Lack of Efficacy|0|||
130453880|NCT02974010|469625387|FG002|Overall Study|Lack of Efficacy|1|||
130453881|NCT02974010|469625388|FG003|Overall Study|Lack of Efficacy|0|||
130453882|NCT00320489|469625389|FG000|Overall Study|Adverse Event|26|||
130453883|NCT00320489|469625390|FG001|Overall Study|Adverse Event|25|||
130453884|NCT00320489|469625389|FG000|Overall Study|Clinical Relapse|26|||
130453885|NCT00320489|469625390|FG001|Overall Study|Clinical Relapse|20|||
130453886|NCT00320489|469625389|FG000|Overall Study|Death|0|||
130453887|NCT00320489|469625390|FG001|Overall Study|Death|2|||
130453888|NCT00320489|469625389|FG000|Overall Study|Entry Criteria Exclusion|2|||
130453889|NCT00320489|469625390|FG001|Overall Study|Entry Criteria Exclusion|4|||
130453890|NCT00320489|469625389|FG000|Overall Study|Lack of Efficacy|16|||
130453891|NCT00320489|469625390|FG001|Overall Study|Lack of Efficacy|7|||
130453892|NCT00320489|469625389|FG000|Overall Study|Lost to Follow-up|21|||
130453893|NCT00320489|469625390|FG001|Overall Study|Lost to Follow-up|22|||
130453894|NCT00320489|469625389|FG000|Overall Study|Physician Decision|8|||
130453895|NCT00320489|469625390|FG001|Overall Study|Physician Decision|8|||
130453896|NCT00320489|469625389|FG000|Overall Study|Protocol Violation|4|||
130453897|NCT00320489|469625390|FG001|Overall Study|Protocol Violation|4|||
130453898|NCT00320489|469625389|FG000|Overall Study|Sponsor Decision|3|||
130453899|NCT00320489|469625390|FG001|Overall Study|Sponsor Decision|3|||
130453900|NCT00320489|469625389|FG000|Overall Study|Withdrawal by Subject|39|||
130453901|NCT00320489|469625390|FG001|Overall Study|Withdrawal by Subject|41|||
130453902|NCT03441984|469625391|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453903|NCT03441984|469625392|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453904|NCT03441984|469625393|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
130453905|NCT03441984|469625394|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453906|NCT03441984|469625395|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453907|NCT03441984|469625396|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453908|NCT03441984|469625397|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453909|NCT03441984|469625398|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453910|NCT03441984|469625399|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453911|NCT03441984|469625400|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453912|NCT03441984|469625401|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453913|NCT03441984|469625402|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
130453914|NCT00746330|469625404|FG000|Period 1|Abnormal test procedure result|0|||
130453915|NCT00746330|469625405|FG001|Period 1|Abnormal test procedure result|0|||
130453916|NCT00746330|469625406|FG002|Period 1|Abnormal test procedure result|1|||
130453917|NCT00746330|469625407|FG003|Period 1|Abnormal test procedure result|0|||
130453918|NCT01981850|469625408|FG000|Main Phase Stage 1|Death|2|||
130453919|NCT01981850|469625409|FG001|Main Phase Stage 1|Death|0|||
130453920|NCT01981850|469625410|FG002|Main Phase Stage 1|Death|0|||
130453921|NCT01981850|469625411|FG003|Main Phase Stage 1|Death|0|||
130453922|NCT01981850|469625412|FG004|Main Phase Stage 1|Death|0|||
130453923|NCT01981850|469625413|FG005|Main Phase Stage 1|Death|0|||
130453924|NCT01981850|469625414|FG006|Main Phase Stage 1|Death|0|||
130453925|NCT01981850|469625415|FG007|Main Phase Stage 1|Death|0|||
130453926|NCT01981850|469625416|FG008|Main Phase Stage 1|Death|0|||
130453927|NCT01981850|469625417|FG009|Main Phase Stage 1|Death|0|||
130453928|NCT01981850|469625408|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
130453929|NCT01981850|469625409|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453930|NCT01981850|469625410|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453931|NCT01981850|469625411|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453932|NCT01981850|469625412|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453933|NCT01981850|469625413|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453934|NCT01981850|469625414|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130704650|NCT01999894|470542752|FG000|Overall Study|Withdrawal by Subject|7|||
130453935|NCT01981850|469625415|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453936|NCT01981850|469625416|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130704651|NCT01999894|470542752|FG000|Overall Study|Lost to Follow-up|10|||
130704652|NCT01999894|470542752|FG000|Overall Study|Other Reason|3|||
130453937|NCT01981850|469625417|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130453938|NCT01981850|469625408|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
130704653|NCT01999894|470542752|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130704654|NCT01546519|470542753|FG000|Overall Study|Adverse Event|0|||
130704655|NCT01546519|470542754|FG001|Overall Study|Adverse Event|0|||
130366234|NCT03570697|469310372|FG000|Overall Study|Death|2|||
130366235|NCT03570697|469310373|FG001|Overall Study|Death|0|||
130366236|NCT03570697|469310372|FG000|Overall Study|Withdrawal by Subject|4|||
130366237|NCT03570697|469310373|FG001|Overall Study|Withdrawal by Subject|2|||
130366238|NCT01776840|469310374|FG000|Overall Study|Lost to Follow-up|12|||
130366239|NCT01776840|469310375|FG001|Overall Study|Lost to Follow-up|7|||
130366240|NCT01776840|469310374|FG000|Overall Study|Withdrawal by Subject|32|||
130366241|NCT01776840|469310375|FG001|Overall Study|Withdrawal by Subject|48|||
130366242|NCT01776840|469310374|FG000|Overall Study|Sponsor decision|89|||
130366243|NCT01776840|469310375|FG001|Overall Study|Sponsor decision|87|||
130366244|NCT03068455|469310379|FG000|Pre-treatment Period|Disease progression|0|||
130366245|NCT03068455|469310380|FG001|Pre-treatment Period|Disease progression|1|||
130366246|NCT03068455|469310379|FG000|Pre-treatment Period|Participant withdrew consent|1|||
130366247|NCT03068455|469310380|FG001|Pre-treatment Period|Participant withdrew consent|1|||
130366248|NCT03068455|469310379|FG000|Pre-treatment Period|Poor/non-compliance|0|||
130704656|NCT01546519|470542755|FG002|Overall Study|Adverse Event|1|||
130704657|NCT01546519|470542756|FG003|Overall Study|Adverse Event|1|||
130704658|NCT01546519|470542753|FG000|Overall Study|Death|0|||
130704659|NCT01546519|470542754|FG001|Overall Study|Death|1|||
130704660|NCT01546519|470542755|FG002|Overall Study|Death|3|||
130704661|NCT01546519|470542756|FG003|Overall Study|Death|1|||
130704662|NCT01546519|470542753|FG000|Overall Study|related to disease progression|2|||
130704663|NCT01546519|470542754|FG001|Overall Study|related to disease progression|2|||
130704664|NCT01546519|470542755|FG002|Overall Study|related to disease progression|2|||
130704665|NCT01546519|470542756|FG003|Overall Study|related to disease progression|1|||
130704666|NCT01546519|470542753|FG000|Overall Study|Physician Decision|6|||
130704667|NCT01546519|470542754|FG001|Overall Study|Physician Decision|5|||
130704668|NCT01546519|470542755|FG002|Overall Study|Physician Decision|2|||
130704669|NCT01546519|470542756|FG003|Overall Study|Physician Decision|3|||
130704670|NCT01546519|470542753|FG000|Overall Study|Withdrawal by Subject|1|||
130704671|NCT01546519|470542754|FG001|Overall Study|Withdrawal by Subject|0|||
130704672|NCT01546519|470542755|FG002|Overall Study|Withdrawal by Subject|0|||
130704673|NCT01546519|470542756|FG003|Overall Study|Withdrawal by Subject|0|||
130704674|NCT00779402|470542759|FG000|Treatment Phase 1|Disease Progression|1|||
130704675|NCT00779402|470542760|FG001|Treatment Phase 1|Disease Progression|0|||
130704676|NCT00779402|470542759|FG000|Treatment Phase 1|Adverse Event|2|||
130704677|NCT00779402|470542760|FG001|Treatment Phase 1|Adverse Event|0|||
130704678|NCT00779402|470542759|FG000|Treatment Phase 1|Protocol Violation|1|||
130704679|NCT00779402|470542760|FG001|Treatment Phase 1|Protocol Violation|0|||
130704680|NCT00779402|470542759|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
130704681|NCT00779402|470542760|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
130704682|NCT00779402|470542759|FG000|Treatment Phase 1|Lost to Follow-up|0|||
130704683|NCT00779402|470542760|FG001|Treatment Phase 1|Lost to Follow-up|1|||
130704684|NCT00779402|470542759|FG000|Treatment Phase 1|Death|0|||
130704685|NCT00779402|470542760|FG001|Treatment Phase 1|Death|1|||
130704686|NCT00779402|470542759|FG000|Treatment Phase 1|Intercurrent Illness|1|||
130704687|NCT00779402|470542760|FG001|Treatment Phase 1|Intercurrent Illness|1|||
130704688|NCT00779402|470542759|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
130704689|NCT00779402|470542760|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130704690|NCT00779402|470542759|FG000|Treatment Phase 1|Other|4|||
130704691|NCT00779402|470542760|FG001|Treatment Phase 1|Other|2|||
130704692|NCT00779402|470542759|FG000|Treatment Phase 1|Closure of Study|3|||
130704693|NCT00779402|470542760|FG001|Treatment Phase 1|Closure of Study|2|||
130704694|NCT00779402|470542759|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
130704695|NCT00779402|470542760|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
130704696|NCT00779402|470542759|FG000|Surveillance Phase|Protocol Violation|0|||
130704697|NCT00779402|470542760|FG001|Surveillance Phase|Protocol Violation|1|||
130704698|NCT00779402|470542759|FG000|Surveillance Phase|Patient refused to continue|22|||
130704699|NCT00779402|470542760|FG001|Surveillance Phase|Patient refused to continue|14|||
130704700|NCT00779402|470542759|FG000|Surveillance Phase|Lost to Follow-up|2|||
130704701|NCT00779402|470542760|FG001|Surveillance Phase|Lost to Follow-up|1|||
130704702|NCT00779402|470542759|FG000|Surveillance Phase|Death|0|||
130366249|NCT03068455|469310380|FG001|Pre-treatment Period|Poor/non-compliance|1|||
130554138|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
130704703|NCT00779402|470542760|FG001|Surveillance Phase|Death|1|||
130704704|NCT00779402|470542759|FG000|Surveillance Phase|Intercurrent Illness|2|||
130704705|NCT00779402|470542760|FG001|Surveillance Phase|Intercurrent Illness|0|||
130704706|NCT00779402|470542759|FG000|Surveillance Phase|Other|5|||
130704707|NCT00779402|470542760|FG001|Surveillance Phase|Other|5|||
130704708|NCT00779402|470542759|FG000|Surveillance Phase|Withdrawal by Subject|4|||
130366250|NCT03068455|469310379|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
130366251|NCT03068455|469310380|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
130366252|NCT03068455|469310379|FG000|Pre-treatment Period|Not reported|2|||
130366253|NCT03068455|469310380|FG001|Pre-treatment Period|Not reported|1|||
130704709|NCT00779402|470542760|FG001|Surveillance Phase|Withdrawal by Subject|1|||
130704710|NCT00779402|470542759|FG000|Surveillance Phase|Closure of study|5|||
130704711|NCT00779402|470542760|FG001|Surveillance Phase|Closure of study|6|||
130704712|NCT00779402|470542759|FG000|Surveillance Phase|Completed Protocol Visits|3|||
130704713|NCT00779402|470542760|FG001|Surveillance Phase|Completed Protocol Visits|2|||
130704714|NCT00779402|470542759|FG000|Long-term Follow-up|Patient refused to continue|2|||
130704715|NCT00779402|470542760|FG001|Long-term Follow-up|Patient refused to continue|0|||
130704716|NCT00779402|470542759|FG000|Long-term Follow-up|Other|5|||
130704717|NCT00779402|470542760|FG001|Long-term Follow-up|Other|0|||
130704718|NCT00779402|470542759|FG000|Long-term Follow-up|Closure of Study|8|||
130704719|NCT00779402|470542760|FG001|Long-term Follow-up|Closure of Study|4|||
130704720|NCT00779402|470542759|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
130704721|NCT00779402|470542760|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
130704722|NCT02274948|470542763|FG000|Overall Study|Lost to Follow-up|28|||
130704723|NCT02274948|470542764|FG001|Overall Study|Lost to Follow-up|25|||
130704724|NCT02274948|470542763|FG000|Overall Study|Withdrawal by Subject|64|||
130704725|NCT02274948|470542764|FG001|Overall Study|Withdrawal by Subject|58|||
130704726|NCT02274948|470542763|FG000|Overall Study|Stopped on family Practitioner advice|2|||
130704727|NCT02274948|470542764|FG001|Overall Study|Stopped on family Practitioner advice|5|||
130704728|NCT02274948|470542763|FG000|Overall Study|Left the area|4|||
130704729|NCT02274948|470542764|FG001|Overall Study|Left the area|3|||
130704730|NCT00707434|470542765|FG000|Overall Study|Adverse Event|1|||
130704731|NCT01386125|470542766|FG000|Overall Study|Lost to Follow-up|3|||
130704732|NCT01386125|470542767|FG001|Overall Study|Lost to Follow-up|9|||
130704733|NCT01386125|470542766|FG000|Overall Study|Physician Decision|0|||
130704734|NCT01386125|470542767|FG001|Overall Study|Physician Decision|1|||
130704735|NCT01386125|470542766|FG000|Overall Study|Protocol Violation|5|||
130704736|NCT01386125|470542767|FG001|Overall Study|Protocol Violation|7|||
130704737|NCT01386125|470542766|FG000|Overall Study|Disease Progress|1|||
130704738|NCT01386125|470542767|FG001|Overall Study|Disease Progress|2|||
130704739|NCT01386125|470542766|FG000|Overall Study|Withdrawal by Subject|13|||
130704740|NCT01386125|470542767|FG001|Overall Study|Withdrawal by Subject|12|||
130704741|NCT01386125|470542766|FG000|Overall Study|Adverse Event|2|||
130704742|NCT01386125|470542767|FG001|Overall Study|Adverse Event|5|||
130704743|NCT01386125|470542766|FG000|Overall Study|Lack of Efficacy|0|||
130704744|NCT01386125|470542767|FG001|Overall Study|Lack of Efficacy|1|||
130704745|NCT01386125|470542766|FG000|Overall Study|Participant Leaving Country|1|||
130704746|NCT01386125|470542767|FG001|Overall Study|Participant Leaving Country|0|||
130704747|NCT00732160|470542771|FG000|Overall Study|Adverse Event|1|||
130704748|NCT00732160|470542772|FG001|Overall Study|Adverse Event|0|||
130704749|NCT00732160|470542773|FG002|Overall Study|Adverse Event|1|||
130704750|NCT00732160|470542774|FG003|Overall Study|Adverse Event|1|||
130704751|NCT00732160|470542771|FG000|Overall Study|scheduling|4|||
130704752|NCT00732160|470542772|FG001|Overall Study|scheduling|4|||
130704753|NCT00732160|470542773|FG002|Overall Study|scheduling|2|||
130704754|NCT00732160|470542774|FG003|Overall Study|scheduling|1|||
130704755|NCT00676494|470542775|FG000|Overall Study|Missed Visit|8|||
130704756|NCT00676494|470542775|FG000|Overall Study|Withdrawal by Subject|6|||
130704757|NCT01264835|470542776|FG000|Overall Study|Lost to Follow-up|1|||
130704758|NCT01808248|470542779|FG000|Overall Study|Lack of Efficacy|3|||
130704759|NCT01808248|470542779|FG000|Overall Study|Withdrawal by Subject|1|||
130704760|NCT01808248|470542779|FG000|Overall Study|Lost to Follow-up|1|||
130704761|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
130704762|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
130704763|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
130704764|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
130704765|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
130704766|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
130704767|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
130704768|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
130704769|NCT03507686|470542783|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
130704770|NCT03507686|470542784|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
130704771|NCT03507686|470542783|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
130704772|NCT03507686|470542784|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
130704773|NCT02508116|470542785|FG000|Overall Study|Lost to Follow-up|2|||
130704774|NCT02508116|470542786|FG001|Overall Study|Lost to Follow-up|3|||
130704775|NCT02508116|470542785|FG000|Overall Study|Withdrawal by Subject|3|||
130704776|NCT02508116|470542786|FG001|Overall Study|Withdrawal by Subject|2|||
130704777|NCT02508116|470542785|FG000|Overall Study|Protocol Violation|1|||
130704778|NCT02508116|470542786|FG001|Overall Study|Protocol Violation|2|||
130704779|NCT02508116|470542785|FG000|Overall Study|Physician Decision|2|||
130704780|NCT02508116|470542786|FG001|Overall Study|Physician Decision|0|||
130704781|NCT00109850|470542789|FG000|Overall Study|Adverse Event|1|||
130704782|NCT00109850|470542789|FG000|Overall Study|Death|2|||
130704783|NCT00109850|470542789|FG000|Overall Study|Ineligible|1|||
130704784|NCT00983528|470542790|FG000|Overall Study|Death|4|||
130453939|NCT01981850|469625409|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
130453940|NCT01981850|469625410|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
130453941|NCT01981850|469625411|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
130453942|NCT01981850|469625412|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
130453943|NCT01981850|469625413|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
130453944|NCT01981850|469625414|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
130453945|NCT01981850|469625415|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
130453946|NCT01981850|469625416|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
130453947|NCT01981850|469625417|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
130453948|NCT01981850|469625408|FG000|Main Phase Stage 1|Various reasons|0|||
130453949|NCT01981850|469625409|FG001|Main Phase Stage 1|Various reasons|0|||
130453950|NCT01981850|469625410|FG002|Main Phase Stage 1|Various reasons|2|||
130453951|NCT01981850|469625411|FG003|Main Phase Stage 1|Various reasons|0|||
130453952|NCT01981850|469625412|FG004|Main Phase Stage 1|Various reasons|0|||
130453953|NCT01981850|469625413|FG005|Main Phase Stage 1|Various reasons|0|||
130453954|NCT01981850|469625414|FG006|Main Phase Stage 1|Various reasons|0|||
130453955|NCT01981850|469625415|FG007|Main Phase Stage 1|Various reasons|0|||
130453956|NCT01981850|469625416|FG008|Main Phase Stage 1|Various reasons|0|||
130453957|NCT01981850|469625417|FG009|Main Phase Stage 1|Various reasons|0|||
130453958|NCT01981850|469625408|FG000|Main Phase Stage 2|Adverse Event|0|||
130453959|NCT01981850|469625409|FG001|Main Phase Stage 2|Adverse Event|0|||
130453960|NCT01981850|469625410|FG002|Main Phase Stage 2|Adverse Event|0|||
130453961|NCT01981850|469625411|FG003|Main Phase Stage 2|Adverse Event|0|||
130453962|NCT01981850|469625412|FG004|Main Phase Stage 2|Adverse Event|6|||
130453963|NCT01981850|469625413|FG005|Main Phase Stage 2|Adverse Event|5|||
130453964|NCT01981850|469625414|FG006|Main Phase Stage 2|Adverse Event|7|||
130453965|NCT01981850|469625415|FG007|Main Phase Stage 2|Adverse Event|0|||
130453966|NCT01981850|469625416|FG008|Main Phase Stage 2|Adverse Event|0|||
130453967|NCT01981850|469625417|FG009|Main Phase Stage 2|Adverse Event|0|||
130453968|NCT01981850|469625408|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453969|NCT01981850|469625409|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453970|NCT01981850|469625410|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453971|NCT01981850|469625411|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453972|NCT01981850|469625412|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
130453973|NCT01981850|469625413|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
130453974|NCT01981850|469625414|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
130453975|NCT01981850|469625415|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453976|NCT01981850|469625416|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453977|NCT01981850|469625417|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
130453978|NCT01981850|469625408|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
130453979|NCT01981850|469625409|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
130453980|NCT01981850|469625410|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
130453981|NCT01981850|469625411|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
130453982|NCT01981850|469625412|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
130453983|NCT01981850|469625413|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
130453984|NCT01981850|469625414|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
130453985|NCT01981850|469625415|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
130453986|NCT01981850|469625416|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
130453987|NCT01981850|469625417|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
130453988|NCT01981850|469625408|FG000|Main Phase Stage 2|Various reasons|0|||
130453989|NCT01981850|469625409|FG001|Main Phase Stage 2|Various reasons|0|||
130453990|NCT01981850|469625410|FG002|Main Phase Stage 2|Various reasons|0|||
130453991|NCT01981850|469625411|FG003|Main Phase Stage 2|Various reasons|0|||
130453992|NCT01981850|469625412|FG004|Main Phase Stage 2|Various reasons|2|||
130453993|NCT01981850|469625413|FG005|Main Phase Stage 2|Various reasons|0|||
130453994|NCT01981850|469625414|FG006|Main Phase Stage 2|Various reasons|1|||
130453995|NCT01981850|469625415|FG007|Main Phase Stage 2|Various reasons|0|||
130453996|NCT01981850|469625416|FG008|Main Phase Stage 2|Various reasons|0|||
130453997|NCT01981850|469625417|FG009|Main Phase Stage 2|Various reasons|0|||
130453998|NCT01981850|469625408|FG000|Main Phase Stage 2|Progressive Disease|0|||
130453999|NCT01981850|469625409|FG001|Main Phase Stage 2|Progressive Disease|0|||
130454000|NCT01981850|469625410|FG002|Main Phase Stage 2|Progressive Disease|0|||
130454001|NCT01981850|469625411|FG003|Main Phase Stage 2|Progressive Disease|0|||
130454002|NCT01981850|469625412|FG004|Main Phase Stage 2|Progressive Disease|0|||
130454003|NCT01981850|469625413|FG005|Main Phase Stage 2|Progressive Disease|6|||
130454004|NCT01981850|469625414|FG006|Main Phase Stage 2|Progressive Disease|6|||
130454005|NCT01981850|469625415|FG007|Main Phase Stage 2|Progressive Disease|0|||
130454006|NCT01981850|469625416|FG008|Main Phase Stage 2|Progressive Disease|0|||
130454007|NCT01981850|469625417|FG009|Main Phase Stage 2|Progressive Disease|0|||
130454008|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Adverse Event|0|||
130454009|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Adverse Event|0|||
130454010|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Adverse Event|0|||
130554139|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
130454011|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Adverse Event|0|||
130454012|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Adverse Event|0|||
130268351|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130268352|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
130268353|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130268354|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268355|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268356|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130454013|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Adverse Event|0|||
130454014|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Adverse Event|0|||
130454015|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Adverse Event|2|||
130268357|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268358|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268359|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268360|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268361|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268362|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268363|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
130268364|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268365|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268366|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268367|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268368|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268369|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268370|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268371|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268372|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130268373|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130454016|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Adverse Event|1|||
130454017|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Adverse Event|8|||
130454018|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454019|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454020|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454021|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454022|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454023|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454024|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
130454025|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
130454026|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
130454027|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
130454028|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Various reasons|0|||
130454029|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Various reasons|0|||
130454030|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Various reasons|0|||
130454031|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Various reasons|0|||
130454032|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Various reasons|0|||
130454033|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Various reasons|0|||
130454034|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Various reasons|0|||
130454035|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Various reasons|3|||
130454036|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Various reasons|1|||
130454037|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Various reasons|3|||
130454038|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
130454039|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
130454040|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
130454041|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
130454042|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
130454043|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
130454044|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
130454045|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
130454046|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
130704785|NCT00983528|470542790|FG000|Overall Study|Lost to Follow-up|1|||
130704786|NCT00983528|470542790|FG000|Overall Study|Study Terminated|1|||
130704787|NCT00476593|470542791|FG000|Overall Study|Lost to Follow-up|10|||
130704788|NCT00476593|470542792|FG001|Overall Study|Lost to Follow-up|2|||
130704789|NCT00476593|470542793|FG002|Overall Study|Lost to Follow-up|8|||
130454047|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
130454048|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454049|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130268374|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130454050|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454051|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454052|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454053|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454054|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454055|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454056|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
130454057|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
130454058|NCT01981850|469625408|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
130454059|NCT01981850|469625409|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
130454060|NCT01981850|469625410|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
130704790|NCT00476593|470542794|FG003|Overall Study|Lost to Follow-up|22|||
130704791|NCT00575380|470542795|FG000|Overall Study|Withdrawal by Subject|1|||
130704792|NCT00575380|470542796|FG001|Overall Study|Withdrawal by Subject|0|||
130704793|NCT00575380|470542795|FG000|Overall Study|Adverse Event|0|||
130704794|NCT00575380|470542796|FG001|Overall Study|Adverse Event|1|||
130704795|NCT00575380|470542795|FG000|Overall Study|Various|0|||
130704796|NCT00575380|470542796|FG001|Overall Study|Various|2|||
130704797|NCT00559364|470542797|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
130704798|NCT00559364|470542798|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
130704799|NCT00330460|470542801|FG000|Overall Study|Physician Decision|1|||
130704800|NCT00330460|470542802|FG001|Overall Study|Physician Decision|0|||
130704801|NCT00330460|470542801|FG000|Overall Study|Adverse Event|10|||
130704802|NCT00330460|470542802|FG001|Overall Study|Adverse Event|8|||
130704803|NCT00330460|470542801|FG000|Overall Study|Withdrawal by Subject|18|||
130704804|NCT00330460|470542802|FG001|Overall Study|Withdrawal by Subject|17|||
130704805|NCT00330460|470542801|FG000|Overall Study|Death|1|||
130704806|NCT00330460|470542802|FG001|Overall Study|Death|1|||
130704807|NCT00330460|470542801|FG000|Overall Study|Ineligibility determined|1|||
130704808|NCT00330460|470542802|FG001|Overall Study|Ineligibility determined|3|||
130704809|NCT00330460|470542801|FG000|Overall Study|Lost to Follow-up|8|||
130704810|NCT00330460|470542802|FG001|Overall Study|Lost to Follow-up|3|||
130704811|NCT00330460|470542801|FG000|Overall Study|Noncompliance|2|||
130704812|NCT00330460|470542802|FG001|Overall Study|Noncompliance|1|||
130704813|NCT00330460|470542801|FG000|Overall Study|Other|1|||
130704814|NCT00330460|470542802|FG001|Overall Study|Other|0|||
130704815|NCT02412722|470542803|FG000|Overall Study|Adverse Event|0|||
130704816|NCT02412722|470542804|FG001|Overall Study|Adverse Event|2|||
130704817|NCT02412722|470542805|FG002|Overall Study|Adverse Event|0|||
130704818|NCT02412722|470542806|FG003|Overall Study|Adverse Event|3|||
130704819|NCT02412722|470542807|FG004|Overall Study|Adverse Event|0|||
130704820|NCT02412722|470542808|FG005|Overall Study|Adverse Event|3|||
130704821|NCT02412722|470542803|FG000|Overall Study|Progressive Disease|6|||
130704822|NCT02412722|470542804|FG001|Overall Study|Progressive Disease|4|||
130704823|NCT02412722|470542805|FG002|Overall Study|Progressive Disease|4|||
130704824|NCT02412722|470542806|FG003|Overall Study|Progressive Disease|9|||
130704825|NCT02412722|470542807|FG004|Overall Study|Progressive Disease|3|||
130704826|NCT02412722|470542808|FG005|Overall Study|Progressive Disease|3|||
130704827|NCT02412722|470542803|FG000|Overall Study|Withdrawal by Subject|2|||
130704828|NCT02412722|470542804|FG001|Overall Study|Withdrawal by Subject|0|||
130704829|NCT02412722|470542805|FG002|Overall Study|Withdrawal by Subject|1|||
130704830|NCT02412722|470542806|FG003|Overall Study|Withdrawal by Subject|2|||
130704831|NCT02412722|470542807|FG004|Overall Study|Withdrawal by Subject|1|||
130704832|NCT02412722|470542808|FG005|Overall Study|Withdrawal by Subject|1|||
130704833|NCT02412722|470542803|FG000|Overall Study|Lost to Follow-up|0|||
130704834|NCT02412722|470542804|FG001|Overall Study|Lost to Follow-up|0|||
130704835|NCT02412722|470542805|FG002|Overall Study|Lost to Follow-up|0|||
130704836|NCT02412722|470542806|FG003|Overall Study|Lost to Follow-up|0|||
130704837|NCT02412722|470542807|FG004|Overall Study|Lost to Follow-up|1|||
130704838|NCT02412722|470542808|FG005|Overall Study|Lost to Follow-up|0|||
130704839|NCT02412722|470542803|FG000|Overall Study|Received drug in run-in and discontinued|0|||
130704840|NCT02412722|470542804|FG001|Overall Study|Received drug in run-in and discontinued|2|||
130704841|NCT02412722|470542805|FG002|Overall Study|Received drug in run-in and discontinued|0|||
130704842|NCT02412722|470542806|FG003|Overall Study|Received drug in run-in and discontinued|0|||
130704843|NCT02412722|470542807|FG004|Overall Study|Received drug in run-in and discontinued|0|||
130704844|NCT02412722|470542808|FG005|Overall Study|Received drug in run-in and discontinued|0|||
130454061|NCT01981850|469625411|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
130704845|NCT02412722|470542803|FG000|Overall Study|Reason not Specified|3|||
130454062|NCT01981850|469625412|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
130554140|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
130704846|NCT02412722|470542804|FG001|Overall Study|Reason not Specified|0|||
130704847|NCT02412722|470542805|FG002|Overall Study|Reason not Specified|2|||
130704848|NCT02412722|470542806|FG003|Overall Study|Reason not Specified|1|||
130704849|NCT02412722|470542807|FG004|Overall Study|Reason not Specified|2|||
130268375|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
130268376|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
130268377|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
130554141|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
130554142|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
130554143|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
130554144|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
130554145|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
130554146|NCT00908232|469996505|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
130554147|NCT00908232|469996506|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
130554148|NCT00908232|469996507|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
130554149|NCT00908232|469996508|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
130554150|NCT02260882|469996509|FG000|Overall Study|Protocol Violation|0|||
130554151|NCT02260882|469996510|FG001|Overall Study|Protocol Violation|1|||
130554152|NCT02119325|469996511|FG000|Washout Period 1|Adverse Event|0|||
130554153|NCT02119325|469996512|FG001|Washout Period 1|Adverse Event|1|||
130554154|NCT01386658|469996513|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
130704850|NCT02412722|470542808|FG005|Overall Study|Reason not Specified|6|||
130704851|NCT04449341|470542809|FG000|Overall Study|Protocol Violation|1|||
130268378|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268379|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268380|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268381|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
130268382|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
130268383|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
130268384|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
130268385|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
130268386|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
130268387|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268388|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268389|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268390|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268391|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130268392|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268393|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268394|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
130268395|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130268396|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268397|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268398|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268399|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268400|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268401|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130268402|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
130268403|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268404|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130268405|NCT00532129|468949634|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
130268406|NCT00532129|468949634|FG000|Treatment Period|Physician Decision|15|||
130268407|NCT00532129|468949634|FG000|Treatment Period|Disease progression|3|||
130268408|NCT00532129|468949634|FG000|Treatment Period|Protocol Violation|1|||
130554155|NCT01386658|469996514|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
130554156|NCT01386658|469996513|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
130554157|NCT01386658|469996514|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
130554158|NCT00954174|469996520|FG000|Overall Study|Adverse Event|28|||
130554159|NCT00954174|469996521|FG001|Overall Study|Adverse Event|23|||
130704852|NCT04449341|470542810|FG001|Overall Study|Protocol Violation|0|||
130704853|NCT04314843|470542811|FG000|Overall Study|Death|2|||
130704854|NCT04314843|470542812|FG001|Overall Study|Death|2|||
130704855|NCT04314843|470542811|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130704856|NCT04314843|470542812|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130704857|NCT01644149|470542813|FG000|Overall Study|Withdrawal by Subject|1|||
130704858|NCT01644149|470542814|FG001|Overall Study|Withdrawal by Subject|0|||
130704859|NCT01644149|470542813|FG000|Overall Study|Lost to Follow-up|3|||
130704860|NCT01644149|470542814|FG001|Overall Study|Lost to Follow-up|1|||
130704861|NCT05766787|470542815|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
130704862|NCT05766787|470542816|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
130704863|NCT05766787|470542815|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
130268409|NCT00532129|468949634|FG000|Treatment Period|Other|5|||
130268410|NCT00532129|468949634|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
130268411|NCT00532129|468949634|FG000|Follow-up Period|Disease progression|57|||
130268412|NCT00532129|468949634|FG000|Follow-up Period|Lost to Follow-up|1|||
130268413|NCT00532129|468949634|FG000|Follow-up Period|Other|6|||
130268414|NCT00784368|468949635|FG000|Overall Study|Physician Decision|0|||
130268415|NCT00784368|468949636|FG001|Overall Study|Physician Decision|0|||
130268416|NCT00784368|468949637|FG002|Overall Study|Physician Decision|6|||
130268417|NCT00784368|468949635|FG000|Overall Study|Lack of Efficacy|2|||
130268418|NCT00784368|468949636|FG001|Overall Study|Lack of Efficacy|0|||
130268419|NCT00784368|468949637|FG002|Overall Study|Lack of Efficacy|1|||
130268420|NCT00784368|468949635|FG000|Overall Study|Adverse Event|6|||
130268421|NCT00784368|468949636|FG001|Overall Study|Adverse Event|9|||
130268422|NCT00784368|468949637|FG002|Overall Study|Adverse Event|2|||
130268423|NCT00784368|468949635|FG000|Overall Study|Diagnosis of fever|0|||
130268424|NCT00784368|468949636|FG001|Overall Study|Diagnosis of fever|0|||
130268425|NCT00784368|468949637|FG002|Overall Study|Diagnosis of fever|1|||
130268426|NCT00784368|468949635|FG000|Overall Study|Worsening of complications|0|||
130268427|NCT00784368|468949636|FG001|Overall Study|Worsening of complications|0|||
130268428|NCT00784368|468949637|FG002|Overall Study|Worsening of complications|1|||
130268429|NCT00784368|468949635|FG000|Overall Study|Worsening of symptoms|0|||
130268430|NCT00784368|468949636|FG001|Overall Study|Worsening of symptoms|1|||
130268431|NCT00784368|468949637|FG002|Overall Study|Worsening of symptoms|0|||
130268432|NCT00784368|468949635|FG000|Overall Study|Withdrawal of informed consent|0|||
130268433|NCT00784368|468949636|FG001|Overall Study|Withdrawal of informed consent|1|||
130268434|NCT00784368|468949637|FG002|Overall Study|Withdrawal of informed consent|0|||
130268435|NCT02237001|468949638|FG000|Overall Study|Lost to Follow-up|2|||
130268436|NCT02237001|468949638|FG000|Overall Study|Withdrawal by Subject|1|||
130268437|NCT02237001|468949638|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
130268438|NCT02237001|468949638|FG000|Overall Study|Re-operation|4|||
130268439|NCT02237001|468949638|FG000|Overall Study|Incarceration|1|||
130268440|NCT01713582|468949639|FG000|Overall Study|Disease progression|3|||
130268441|NCT01713582|468949640|FG001|Overall Study|Disease progression|3|||
130268442|NCT01713582|468949641|FG002|Overall Study|Disease progression|3|||
130454063|NCT01981850|469625413|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
130454064|NCT01981850|469625414|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
130268443|NCT01713582|468949642|FG003|Overall Study|Disease progression|2|||
130268444|NCT01713582|468949643|FG004|Overall Study|Disease progression|3|||
130454065|NCT01981850|469625415|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
130454066|NCT01981850|469625416|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
130454067|NCT01981850|469625417|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
130454068|NCT02524288|469625418|FG000|Overall Study|Adverse Event|115|||
130454069|NCT02524288|469625418|FG000|Overall Study|Lost to Follow-up|216|||
130454070|NCT02524288|469625418|FG000|Overall Study|Non-Compliance With Protocol|32|||
130454071|NCT02524288|469625418|FG000|Overall Study|Non-Compliance With Study Drug|14|||
130454072|NCT02524288|469625418|FG000|Overall Study|Pregnancy Wish|6|||
130454073|NCT02524288|469625418|FG000|Overall Study|Protocol Violation|6|||
130454074|NCT02524288|469625418|FG000|Overall Study|Screen Failure|2|||
130454075|NCT02524288|469625418|FG000|Overall Study|Site Discontinued Study Participation|1|||
130454076|NCT02524288|469625418|FG000|Overall Study|Study Terminated By Sponsor|1417|||
130454077|NCT02524288|469625418|FG000|Overall Study|Subject Moved|32|||
130454078|NCT02524288|469625418|FG000|Overall Study|Withdrawal by Subject|76|||
130454079|NCT02524288|469625418|FG000|Overall Study|Pregnancy|22|||
130454080|NCT02524288|469625418|FG000|Overall Study|Physician Decision|2|||
130454081|NCT00517933|469625419|FG000|Period 1|Death|2|||
130454082|NCT00517933|469625420|FG001|Period 1|Death|1|||
130454083|NCT00517933|469625419|FG000|Period 1|Adverse Event|4|||
130454084|NCT00517933|469625420|FG001|Period 1|Adverse Event|4|||
130454085|NCT00517933|469625419|FG000|Period 1|Lost to Follow-up|2|||
130454086|NCT00517933|469625420|FG001|Period 1|Lost to Follow-up|0|||
130454087|NCT00517933|469625419|FG000|Period 1|Underwent lung transplant|0|||
130454088|NCT00517933|469625420|FG001|Period 1|Underwent lung transplant|1|||
130704864|NCT05766787|470542816|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
130454089|NCT00517933|469625419|FG000|Period 2|Death|2|||
130454090|NCT00517933|469625420|FG001|Period 2|Death|4|||
130454091|NCT00517933|469625419|FG000|Period 2|Adverse Event|2|||
130268445|NCT01713582|468949644|FG005|Overall Study|Disease progression|3|||
130268446|NCT01713582|468949645|FG006|Overall Study|Disease progression|3|||
130268447|NCT01713582|468949646|FG007|Overall Study|Disease progression|3|||
130268448|NCT01713582|468949647|FG008|Overall Study|Disease progression|3|||
130268449|NCT01713582|468949648|FG009|Overall Study|Disease progression|11|||
130268450|NCT01713582|468949649|FG010|Overall Study|Disease progression|10|||
130268451|NCT01713582|468949650|FG011|Overall Study|Disease progression|5|||
130268452|NCT01713582|468949651|FG012|Overall Study|Disease progression|3|||
130454092|NCT00517933|469625420|FG001|Period 2|Adverse Event|4|||
130454093|NCT00517933|469625419|FG000|Period 2|Physician Decision|1|||
130454094|NCT00517933|469625420|FG001|Period 2|Physician Decision|0|||
130268453|NCT01713582|468949652|FG013|Overall Study|Disease progression|3|||
130268454|NCT01713582|468949653|FG014|Overall Study|Disease progression|6|||
130554160|NCT00954174|469996522|FG002|Overall Study|Adverse Event|4|||
130554161|NCT00954174|469996523|FG003|Overall Study|Adverse Event|9|||
130554162|NCT00954174|469996520|FG000|Overall Study|Death|4|||
130554163|NCT00954174|469996521|FG001|Overall Study|Death|2|||
130554164|NCT00954174|469996522|FG002|Overall Study|Death|0|||
130554165|NCT00954174|469996523|FG003|Overall Study|Death|0|||
130554166|NCT00954174|469996520|FG000|Overall Study|Lack of Efficacy|32|||
130554167|NCT00954174|469996521|FG001|Overall Study|Lack of Efficacy|22|||
130554168|NCT00954174|469996522|FG002|Overall Study|Lack of Efficacy|8|||
130554169|NCT00954174|469996523|FG003|Overall Study|Lack of Efficacy|6|||
130554170|NCT00954174|469996520|FG000|Overall Study|Withdrawal by Subject|14|||
130554171|NCT00954174|469996521|FG001|Overall Study|Withdrawal by Subject|10|||
130554172|NCT00954174|469996522|FG002|Overall Study|Withdrawal by Subject|4|||
130554173|NCT00954174|469996523|FG003|Overall Study|Withdrawal by Subject|3|||
130554174|NCT00954174|469996520|FG000|Overall Study|Medical Reason|4|||
130554175|NCT00954174|469996521|FG001|Overall Study|Medical Reason|2|||
130554176|NCT00954174|469996522|FG002|Overall Study|Medical Reason|1|||
130554177|NCT00954174|469996523|FG003|Overall Study|Medical Reason|0|||
130554178|NCT00954174|469996520|FG000|Overall Study|Ineligible|40|||
130554179|NCT00954174|469996521|FG001|Overall Study|Ineligible|47|||
130554180|NCT00954174|469996522|FG002|Overall Study|Ineligible|7|||
130554181|NCT00954174|469996523|FG003|Overall Study|Ineligible|4|||
130554182|NCT00954174|469996520|FG000|Overall Study|Never Treated|4|||
130554183|NCT00954174|469996521|FG001|Overall Study|Never Treated|17|||
130554184|NCT00954174|469996522|FG002|Overall Study|Never Treated|0|||
130704865|NCT05766787|470542815|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
130704866|NCT05766787|470542816|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
130268455|NCT01713582|468949654|FG015|Overall Study|Disease progression|6|||
130268456|NCT01713582|468949655|FG016|Overall Study|Disease progression|5|||
130268457|NCT01713582|468949656|FG017|Overall Study|Disease progression|2|||
130268458|NCT01713582|468949657|FG018|Overall Study|Disease progression|3|||
130268459|NCT01713582|468949658|FG019|Overall Study|Disease progression|5|||
130268460|NCT01713582|468949659|FG020|Overall Study|Disease progression|15|||
130268461|NCT01713582|468949639|FG000|Overall Study|Death|0|||
130268462|NCT01713582|468949640|FG001|Overall Study|Death|0|||
130366254|NCT03068455|469310379|FG000|Treatment Period|Disease progression|166|||
130366255|NCT03068455|469310380|FG001|Treatment Period|Disease progression|208|||
130366256|NCT03068455|469310379|FG000|Treatment Period|Study drug toxicity|317|||
130366257|NCT03068455|469310380|FG001|Treatment Period|Study drug toxicity|104|||
130366258|NCT03068455|469310379|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
130366259|NCT03068455|469310380|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
130366260|NCT03068455|469310379|FG000|Treatment Period|Participant request to stop therapy|33|||
130366261|NCT03068455|469310380|FG001|Treatment Period|Participant request to stop therapy|20|||
130366262|NCT03068455|469310379|FG000|Treatment Period|Participant withdrew consent|5|||
130366263|NCT03068455|469310380|FG001|Treatment Period|Participant withdrew consent|10|||
130366264|NCT03068455|469310379|FG000|Treatment Period|Poor/non-compliance|3|||
130366265|NCT03068455|469310380|FG001|Treatment Period|Poor/non-compliance|0|||
130366266|NCT03068455|469310379|FG000|Treatment Period|Participant no longer meets study criteria|1|||
130366267|NCT03068455|469310380|FG001|Treatment Period|Participant no longer meets study criteria|3|||
130366268|NCT03068455|469310379|FG000|Treatment Period|Other reasons|12|||
130366269|NCT03068455|469310380|FG001|Treatment Period|Other reasons|4|||
130366270|NCT00493025|469310381|FG000|Overall Study|Physician Decision|19|||
130366271|NCT03173313|469310383|FG000|Overall Study|Lost to Follow-up|2|||
130366272|NCT03173313|469310384|FG001|Overall Study|Lost to Follow-up|3|||
130366273|NCT03173313|469310383|FG000|Overall Study|Withdrawal by Subject|0|||
130366274|NCT03173313|469310384|FG001|Overall Study|Withdrawal by Subject|1|||
130366275|NCT03173313|469310383|FG000|Overall Study|Death|5|||
130366276|NCT03173313|469310384|FG001|Overall Study|Death|0|||
130366277|NCT03173313|469310383|FG000|Overall Study|Physician Decision|1|||
130366278|NCT03173313|469310384|FG001|Overall Study|Physician Decision|0|||
130366279|NCT03173313|469310383|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
130366280|NCT03173313|469310384|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
130554185|NCT00954174|469996523|FG003|Overall Study|Never Treated|3|||
130268463|NCT01713582|468949641|FG002|Overall Study|Death|0|||
130268464|NCT01713582|468949642|FG003|Overall Study|Death|1|||
130366281|NCT03173313|469310383|FG000|Overall Study|Bone Fracture|1|||
130366282|NCT03173313|469310384|FG001|Overall Study|Bone Fracture|0|||
130554186|NCT04209621|469996526|FG000|Overall Study|Death|1|||
130268465|NCT01713582|468949643|FG004|Overall Study|Death|1|||
130366283|NCT01876420|469310385|FG000|Overall Study|Missed 30 day visit|1|||
130366284|NCT04515394|469310389|FG000|Overall Study|Participant did not receive treatment|1|||
130366285|NCT01042678|469310390|FG000|Overall Study|Physician Decision|1|||
130554187|NCT04209621|469996526|FG000|Overall Study|Study Terminated Early|2|||
130554188|NCT02249767|469996527|FG000|Overall Study|Did not use medication|8|||
130554189|NCT02249767|469996528|FG001|Overall Study|Did not use medication|9|||
130554190|NCT02249767|469996529|FG002|Overall Study|Did not use medication|8|||
130268466|NCT01713582|468949644|FG005|Overall Study|Death|3|||
130268467|NCT01713582|468949645|FG006|Overall Study|Death|3|||
130366286|NCT01042678|469310391|FG001|Overall Study|Physician Decision|0|||
130366287|NCT01042678|469310392|FG002|Overall Study|Physician Decision|0|||
130366288|NCT01042678|469310393|FG003|Overall Study|Physician Decision|0|||
130366289|NCT01042678|469310394|FG004|Overall Study|Physician Decision|0|||
130366290|NCT01042678|469310395|FG005|Overall Study|Physician Decision|0|||
130366291|NCT01254331|469310400|FG000|Initial Phase|Adverse Event|3|||
130366292|NCT01254331|469310400|FG000|Initial Phase|Withdrawal by Subject|1|||
130366293|NCT01254331|469310400|FG000|Initial Phase|Pregnancy|1|||
130366294|NCT01254331|469310400|FG000|Extension Phase|Lack of Efficacy|1|||
130366295|NCT01254331|469310400|FG000|Extension Phase|Lost to Follow-up|3|||
130366296|NCT00892047|469310401|FG000|Overall Study|Adverse Event|2|||
130366297|NCT00892047|469310402|FG001|Overall Study|Adverse Event|2|||
130366298|NCT00892047|469310401|FG000|Overall Study|subject burden|2|||
130366299|NCT00892047|469310402|FG001|Overall Study|subject burden|3|||
130366300|NCT00892047|469310401|FG000|Overall Study|Lack of Efficacy|0|||
130366301|NCT00892047|469310402|FG001|Overall Study|Lack of Efficacy|2|||
130366302|NCT01612858|469310407|FG000|Overall Study|Withdrawal by Subject|5|||
130366303|NCT01612858|469310408|FG001|Overall Study|Withdrawal by Subject|1|||
130366304|NCT00660699|469310411|FG000|Overall Study|Withdrawal by Subject|2|||
130366305|NCT01752985|469310412|FG000|Treatment Period|Subject request to discontinue treatment|1|||
130366306|NCT01752985|469310413|FG001|Treatment Period|Subject request to discontinue treatment|0|||
130366307|NCT01752985|469310414|FG002|Treatment Period|Subject request to discontinue treatment|1|||
130366308|NCT01752985|469310412|FG000|Treatment Period|Subject no longer meets study criteria|0|||
130366309|NCT01752985|469310413|FG001|Treatment Period|Subject no longer meets study criteria|1|||
130366310|NCT01752985|469310414|FG002|Treatment Period|Subject no longer meets study criteria|1|||
130366311|NCT01752985|469310412|FG000|Treatment Period|Adverse Event|2|||
130366312|NCT01752985|469310413|FG001|Treatment Period|Adverse Event|1|||
130366313|NCT01752985|469310414|FG002|Treatment Period|Adverse Event|2|||
130366314|NCT01752985|469310412|FG000|Treatment Period|Withdrawal by Subject|1|||
130366315|NCT01752985|469310413|FG001|Treatment Period|Withdrawal by Subject|1|||
130366316|NCT01752985|469310414|FG002|Treatment Period|Withdrawal by Subject|0|||
130366317|NCT01752985|469310412|FG000|Treatment Period|Lost to Follow-up|0|||
130366318|NCT01752985|469310413|FG001|Treatment Period|Lost to Follow-up|0|||
130366319|NCT01752985|469310414|FG002|Treatment Period|Lost to Follow-up|1|||
130366320|NCT01385566|469311803|FG000|Overall Study|Lost to Follow-up|1|||
130366321|NCT01385566|469311804|FG001|Overall Study|Lost to Follow-up|0|||
130366322|NCT01385566|469311805|FG002|Overall Study|Lost to Follow-up|0|||
130366323|NCT01385566|469311806|FG003|Overall Study|Lost to Follow-up|0|||
130366324|NCT01385566|469311807|FG004|Overall Study|Lost to Follow-up|0|||
130366325|NCT01385566|469311808|FG005|Overall Study|Lost to Follow-up|0|||
130366326|NCT01385566|469311803|FG000|Overall Study|Withdrawal by Subject|0|||
130366327|NCT01385566|469311804|FG001|Overall Study|Withdrawal by Subject|0|||
130366328|NCT01385566|469311805|FG002|Overall Study|Withdrawal by Subject|0|||
130366329|NCT01385566|469311806|FG003|Overall Study|Withdrawal by Subject|1|||
130366330|NCT01385566|469311807|FG004|Overall Study|Withdrawal by Subject|0|||
130366331|NCT01385566|469311808|FG005|Overall Study|Withdrawal by Subject|0|||
130366332|NCT04092582|469311809|FG000|Overall Study|Death|1|||
130366333|NCT04092582|469311810|FG001|Overall Study|Death|1|||
130366334|NCT04092582|469311809|FG000|Overall Study|Withdrawal by Subject|4|||
130366335|NCT04092582|469311810|FG001|Overall Study|Withdrawal by Subject|1|||
130366336|NCT04092582|469311809|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
130366337|NCT04092582|469311810|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
130366338|NCT00560105|469311817|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
130366339|NCT00560105|469311818|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
130366340|NCT02025621|469311824|FG000|Overall Study|Withdrawal by Subject|1|||
130366341|NCT02025621|469311825|FG001|Overall Study|Withdrawal by Subject|0|||
130454095|NCT00517933|469625419|FG000|Period 2|Withdrawal by Subject|1|||
130454096|NCT00517933|469625420|FG001|Period 2|Withdrawal by Subject|3|||
130454097|NCT00517933|469625419|FG000|Period 2|Underwent lung transplant|0|||
130454098|NCT00517933|469625420|FG001|Period 2|Underwent lung transplant|2|||
130454099|NCT00121199|469625422|FG000|Overall Study|Adverse Event|11|||
130454100|NCT00121199|469625422|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130454101|NCT00121199|469625422|FG000|Overall Study|Progression/Relapse|1|||
130366342|NCT02025621|469311824|FG000|Overall Study|Death|0|||
130366343|NCT02025621|469311825|FG001|Overall Study|Death|1|||
130366344|NCT02025621|469311824|FG000|Overall Study|No longer eligible|10|||
130366345|NCT02025621|469311825|FG001|Overall Study|No longer eligible|15|||
130366346|NCT02025621|469311824|FG000|Overall Study|Surgery initiated before infusion|3|||
130366347|NCT02025621|469311825|FG001|Overall Study|Surgery initiated before infusion|3|||
130366348|NCT01871532|469311826|FG000|Overall Study|Withdrawal by Subject|1|||
130366349|NCT01871532|469311827|FG001|Overall Study|Withdrawal by Subject|2|||
130366350|NCT02195583|469311829|FG000|Overall Study|Lost to Follow-up|1|||
130366351|NCT02195583|469311829|FG000|Overall Study|Withdrawal by Subject|4|||
130366352|NCT02195583|469311829|FG000|Overall Study|Adverse Event|2|||
130366353|NCT02195583|469311829|FG000|Overall Study|Other Reason|2|||
130366354|NCT04218695|469311830|FG000|Overall Study|Adverse Event|1|||
130366355|NCT04218695|469311831|FG001|Overall Study|Adverse Event|0|||
130366356|NCT00983437|469311832|FG000|Overall Study|Adverse Event|9|||
130366357|NCT00983437|469311832|FG000|Overall Study|Lack of Efficacy|1|||
130366358|NCT00983437|469311832|FG000|Overall Study|Withdrawal by Subject|8|||
130366359|NCT00983437|469311832|FG000|Overall Study|Noncompliance to Study Procedures|1|||
130366360|NCT00983437|469311832|FG000|Overall Study|Lost to Follow-up|2|||
130366361|NCT00983437|469311832|FG000|Overall Study|Other Reason|26|||
130366362|NCT01945281|469311834|FG000|Overall Study|Adverse Event|1|||
130366363|NCT01945281|469311835|FG001|Overall Study|Adverse Event|0|||
130366364|NCT01945281|469311834|FG000|Overall Study|Death|3|||
130366365|NCT01945281|469311835|FG001|Overall Study|Death|3|||
130366366|NCT01945281|469311834|FG000|Overall Study|Physician Decision|1|||
130366367|NCT01945281|469311835|FG001|Overall Study|Physician Decision|1|||
130366368|NCT01945281|469311834|FG000|Overall Study|Technical Problems|1|||
130366369|NCT01945281|469311835|FG001|Overall Study|Technical Problems|0|||
130366370|NCT02747875|469311840|FG000|Overall Study|Physician Decision|1|||
130366371|NCT02747875|469311841|FG001|Overall Study|Physician Decision|0|||
130366372|NCT02747875|469311840|FG000|Overall Study|Adverse Event|0|||
130366373|NCT02747875|469311841|FG001|Overall Study|Adverse Event|1|||
130366374|NCT03478657|469311842|FG000|Overall Study|Withdrawal by Subject|0|||
130366375|NCT03478657|469311843|FG001|Overall Study|Withdrawal by Subject|1|||
130366376|NCT01702805|469311845|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130366377|NCT01702805|469311846|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
130366378|NCT01702805|469311845|FG000|Overall Study|Incomplete Follow-up|18|||
130366379|NCT01702805|469311846|FG001|Overall Study|Incomplete Follow-up|15|||
130366380|NCT01702805|469311845|FG000|Overall Study|Vital Status Assessment Only|40|||
130366381|NCT01702805|469311846|FG001|Overall Study|Vital Status Assessment Only|39|||
130366382|NCT01702805|469311845|FG000|Overall Study|Lost to Follow-up|5|||
130366383|NCT01702805|469311846|FG001|Overall Study|Lost to Follow-up|5|||
130454102|NCT00121199|469625422|FG000|Overall Study|Death|3|||
130454103|NCT00121199|469625422|FG000|Overall Study|Other - Not Protocol Specified|3|||
130454104|NCT00121199|469625422|FG000|Overall Study|Ineligible|9|||
130366384|NCT00181155|469311850|FG000|Overall Study|Physician Decision|1|||
130366385|NCT00181155|469311851|FG001|Overall Study|Physician Decision|0|||
130366386|NCT00181155|469311850|FG000|Overall Study|Withdrawal by Subject|1|||
130366387|NCT00181155|469311851|FG001|Overall Study|Withdrawal by Subject|0|||
130366388|NCT01788228|469311852|FG000|Overall Study|Migrated/moved from study area|1|||
130366389|NCT01788228|469311853|FG001|Overall Study|Migrated/moved from study area|0|||
130366390|NCT01548287|469311857|FG000|Screening|No reason provided|0|||
130366391|NCT01548287|469311858|FG001|Screening|No reason provided|0|||
130704867|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
130704868|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130704869|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130704870|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
130268468|NCT01713582|468949646|FG007|Overall Study|Death|2|||
130268469|NCT01713582|468949647|FG008|Overall Study|Death|3|||
130268470|NCT01713582|468949648|FG009|Overall Study|Death|4|||
130268471|NCT01713582|468949649|FG010|Overall Study|Death|3|||
130268472|NCT01713582|468949650|FG011|Overall Study|Death|0|||
130268473|NCT01713582|468949651|FG012|Overall Study|Death|0|||
130268474|NCT01713582|468949652|FG013|Overall Study|Death|0|||
130268475|NCT01713582|468949653|FG014|Overall Study|Death|0|||
130268476|NCT01713582|468949654|FG015|Overall Study|Death|0|||
130268477|NCT01713582|468949655|FG016|Overall Study|Death|0|||
130268478|NCT01713582|468949656|FG017|Overall Study|Death|0|||
130268479|NCT01713582|468949657|FG018|Overall Study|Death|0|||
130268480|NCT01713582|468949658|FG019|Overall Study|Death|0|||
130268481|NCT01713582|468949659|FG020|Overall Study|Death|0|||
130268482|NCT01713582|468949639|FG000|Overall Study|Adverse event-related|0|||
130268483|NCT01713582|468949640|FG001|Overall Study|Adverse event-related|0|||
130268484|NCT01713582|468949641|FG002|Overall Study|Adverse event-related|0|||
130268485|NCT01713582|468949642|FG003|Overall Study|Adverse event-related|0|||
130268486|NCT01713582|468949643|FG004|Overall Study|Adverse event-related|0|||
130268487|NCT01713582|468949644|FG005|Overall Study|Adverse event-related|0|||
130268488|NCT01713582|468949645|FG006|Overall Study|Adverse event-related|0|||
130268489|NCT01713582|468949646|FG007|Overall Study|Adverse event-related|0|||
130268490|NCT01713582|468949647|FG008|Overall Study|Adverse event-related|0|||
130268491|NCT01713582|468949648|FG009|Overall Study|Adverse event-related|1|||
130268492|NCT01713582|468949649|FG010|Overall Study|Adverse event-related|1|||
130268493|NCT01713582|468949650|FG011|Overall Study|Adverse event-related|0|||
130268494|NCT01713582|468949651|FG012|Overall Study|Adverse event-related|0|||
130268495|NCT01713582|468949652|FG013|Overall Study|Adverse event-related|0|||
130268496|NCT01713582|468949653|FG014|Overall Study|Adverse event-related|0|||
130268497|NCT01713582|468949654|FG015|Overall Study|Adverse event-related|0|||
130268498|NCT01713582|468949655|FG016|Overall Study|Adverse event-related|0|||
130268499|NCT01713582|468949656|FG017|Overall Study|Adverse event-related|0|||
130268500|NCT01713582|468949657|FG018|Overall Study|Adverse event-related|1|||
130268501|NCT01713582|468949658|FG019|Overall Study|Adverse event-related|0|||
130268502|NCT01713582|468949659|FG020|Overall Study|Adverse event-related|0|||
130268503|NCT01713582|468949639|FG000|Overall Study|Adverse event-unrelated|0|||
130268504|NCT01713582|468949640|FG001|Overall Study|Adverse event-unrelated|0|||
130454105|NCT04109118|469625425|FG000|Overall Study|Lost to Follow-up|3|||
130454106|NCT03235349|469625428|FG000|Overall Study|Adverse Event|1|||
130454107|NCT03235349|469625428|FG000|Overall Study|Other|1|||
130454108|NCT01729871|469625433|FG000|Overall Study|Adverse Event|7|||
130454109|NCT01729871|469625434|FG001|Overall Study|Adverse Event|7|||
130454110|NCT01729871|469625433|FG000|Overall Study|Death|0|||
130454111|NCT01729871|469625434|FG001|Overall Study|Death|1|||
130454112|NCT01729871|469625433|FG000|Overall Study|Lack of Efficacy|0|||
130268505|NCT01713582|468949641|FG002|Overall Study|Adverse event-unrelated|0|||
130268506|NCT01713582|468949642|FG003|Overall Study|Adverse event-unrelated|0|||
130704871|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
130704872|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
130704873|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
130268507|NCT01713582|468949643|FG004|Overall Study|Adverse event-unrelated|0|||
130268508|NCT01713582|468949644|FG005|Overall Study|Adverse event-unrelated|1|||
130268509|NCT01713582|468949645|FG006|Overall Study|Adverse event-unrelated|1|||
130268510|NCT01713582|468949646|FG007|Overall Study|Adverse event-unrelated|1|||
130268511|NCT01713582|468949647|FG008|Overall Study|Adverse event-unrelated|0|||
130268512|NCT01713582|468949648|FG009|Overall Study|Adverse event-unrelated|0|||
130268513|NCT01713582|468949649|FG010|Overall Study|Adverse event-unrelated|0|||
130268514|NCT01713582|468949650|FG011|Overall Study|Adverse event-unrelated|0|||
130454113|NCT01729871|469625434|FG001|Overall Study|Lack of Efficacy|1|||
130454114|NCT01729871|469625433|FG000|Overall Study|Physician Decision|0|||
130704874|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130268515|NCT01713582|468949651|FG012|Overall Study|Adverse event-unrelated|0|||
130268516|NCT01713582|468949652|FG013|Overall Study|Adverse event-unrelated|1|||
130268517|NCT01713582|468949653|FG014|Overall Study|Adverse event-unrelated|1|||
130268518|NCT01713582|468949654|FG015|Overall Study|Adverse event-unrelated|0|||
130268519|NCT01713582|468949655|FG016|Overall Study|Adverse event-unrelated|0|||
130268520|NCT01713582|468949656|FG017|Overall Study|Adverse event-unrelated|0|||
130268521|NCT01713582|468949657|FG018|Overall Study|Adverse event-unrelated|0|||
130454115|NCT01729871|469625434|FG001|Overall Study|Physician Decision|2|||
130454116|NCT01729871|469625433|FG000|Overall Study|Protocol Violation|1|||
130454117|NCT01729871|469625434|FG001|Overall Study|Protocol Violation|0|||
130268522|NCT01713582|468949658|FG019|Overall Study|Adverse event-unrelated|0|||
130454118|NCT01729871|469625433|FG000|Overall Study|Withdrawal by Subject|0|||
130268523|NCT01713582|468949659|FG020|Overall Study|Adverse event-unrelated|0|||
130268524|NCT01713582|468949639|FG000|Overall Study|Withdrawal of consent|0|||
130268525|NCT01713582|468949640|FG001|Overall Study|Withdrawal of consent|0|||
130268526|NCT01713582|468949641|FG002|Overall Study|Withdrawal of consent|1|||
130268527|NCT01713582|468949642|FG003|Overall Study|Withdrawal of consent|0|||
130268528|NCT01713582|468949643|FG004|Overall Study|Withdrawal of consent|0|||
130268529|NCT01713582|468949644|FG005|Overall Study|Withdrawal of consent|1|||
130268530|NCT01713582|468949645|FG006|Overall Study|Withdrawal of consent|0|||
130268531|NCT01713582|468949646|FG007|Overall Study|Withdrawal of consent|0|||
130268532|NCT01713582|468949647|FG008|Overall Study|Withdrawal of consent|0|||
130268533|NCT01713582|468949648|FG009|Overall Study|Withdrawal of consent|1|||
130268534|NCT01713582|468949649|FG010|Overall Study|Withdrawal of consent|0|||
130268535|NCT01713582|468949650|FG011|Overall Study|Withdrawal of consent|0|||
130268536|NCT01713582|468949651|FG012|Overall Study|Withdrawal of consent|0|||
130268537|NCT01713582|468949652|FG013|Overall Study|Withdrawal of consent|0|||
130268538|NCT01713582|468949653|FG014|Overall Study|Withdrawal of consent|0|||
130268539|NCT01713582|468949654|FG015|Overall Study|Withdrawal of consent|0|||
130268540|NCT01713582|468949655|FG016|Overall Study|Withdrawal of consent|0|||
130268541|NCT01713582|468949656|FG017|Overall Study|Withdrawal of consent|0|||
130268542|NCT01713582|468949657|FG018|Overall Study|Withdrawal of consent|1|||
130268543|NCT01713582|468949658|FG019|Overall Study|Withdrawal of consent|0|||
130268544|NCT01713582|468949659|FG020|Overall Study|Withdrawal of consent|0|||
130268545|NCT01713582|468949639|FG000|Overall Study|Lack of Efficacy|0|||
130268546|NCT01713582|468949640|FG001|Overall Study|Lack of Efficacy|0|||
130268547|NCT01713582|468949641|FG002|Overall Study|Lack of Efficacy|0|||
130268548|NCT01713582|468949642|FG003|Overall Study|Lack of Efficacy|0|||
130268549|NCT01713582|468949643|FG004|Overall Study|Lack of Efficacy|0|||
130268550|NCT01713582|468949644|FG005|Overall Study|Lack of Efficacy|0|||
130268551|NCT01713582|468949645|FG006|Overall Study|Lack of Efficacy|0|||
130268552|NCT01713582|468949646|FG007|Overall Study|Lack of Efficacy|0|||
130268553|NCT01713582|468949647|FG008|Overall Study|Lack of Efficacy|0|||
130268554|NCT01713582|468949648|FG009|Overall Study|Lack of Efficacy|1|||
130268555|NCT01713582|468949649|FG010|Overall Study|Lack of Efficacy|2|||
130268556|NCT01713582|468949650|FG011|Overall Study|Lack of Efficacy|0|||
130268557|NCT01713582|468949651|FG012|Overall Study|Lack of Efficacy|0|||
130268558|NCT01713582|468949652|FG013|Overall Study|Lack of Efficacy|0|||
130268559|NCT01713582|468949653|FG014|Overall Study|Lack of Efficacy|0|||
130268560|NCT01713582|468949654|FG015|Overall Study|Lack of Efficacy|0|||
130268561|NCT01713582|468949655|FG016|Overall Study|Lack of Efficacy|0|||
130268562|NCT01713582|468949656|FG017|Overall Study|Lack of Efficacy|0|||
130268563|NCT01713582|468949657|FG018|Overall Study|Lack of Efficacy|0|||
130268564|NCT01713582|468949658|FG019|Overall Study|Lack of Efficacy|0|||
130268565|NCT01713582|468949659|FG020|Overall Study|Lack of Efficacy|0|||
130268566|NCT01713582|468949639|FG000|Overall Study|Withdrawal by Subject|0|||
130268567|NCT01713582|468949640|FG001|Overall Study|Withdrawal by Subject|0|||
130268568|NCT01713582|468949641|FG002|Overall Study|Withdrawal by Subject|0|||
130268569|NCT01713582|468949642|FG003|Overall Study|Withdrawal by Subject|0|||
130268570|NCT01713582|468949643|FG004|Overall Study|Withdrawal by Subject|0|||
130268571|NCT01713582|468949644|FG005|Overall Study|Withdrawal by Subject|0|||
130268572|NCT01713582|468949645|FG006|Overall Study|Withdrawal by Subject|0|||
130268573|NCT01713582|468949646|FG007|Overall Study|Withdrawal by Subject|0|||
130268574|NCT01713582|468949647|FG008|Overall Study|Withdrawal by Subject|0|||
130268575|NCT01713582|468949648|FG009|Overall Study|Withdrawal by Subject|0|||
130268576|NCT01713582|468949649|FG010|Overall Study|Withdrawal by Subject|0|||
130268577|NCT01713582|468949650|FG011|Overall Study|Withdrawal by Subject|0|||
130268578|NCT01713582|468949651|FG012|Overall Study|Withdrawal by Subject|0|||
130268579|NCT01713582|468949652|FG013|Overall Study|Withdrawal by Subject|0|||
130268580|NCT01713582|468949653|FG014|Overall Study|Withdrawal by Subject|0|||
130268581|NCT01713582|468949654|FG015|Overall Study|Withdrawal by Subject|0|||
130268582|NCT01713582|468949655|FG016|Overall Study|Withdrawal by Subject|0|||
130268583|NCT01713582|468949656|FG017|Overall Study|Withdrawal by Subject|1|||
130268584|NCT01713582|468949657|FG018|Overall Study|Withdrawal by Subject|0|||
130268585|NCT01713582|468949658|FG019|Overall Study|Withdrawal by Subject|0|||
130268586|NCT01713582|468949659|FG020|Overall Study|Withdrawal by Subject|0|||
130268587|NCT01713582|468949639|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
130268588|NCT01713582|468949640|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
130268589|NCT01713582|468949641|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
130268590|NCT01713582|468949642|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
130268591|NCT01713582|468949643|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
130268592|NCT01713582|468949644|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
130268593|NCT01713582|468949645|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
130268594|NCT01713582|468949646|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
130454119|NCT01729871|469625434|FG001|Overall Study|Withdrawal by Subject|3|||
130268595|NCT01713582|468949647|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
130268596|NCT01713582|468949648|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
130268597|NCT01713582|468949649|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
130268598|NCT01713582|468949650|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
130268599|NCT01713582|468949651|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
130268600|NCT01713582|468949652|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
130268601|NCT01713582|468949653|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
130268602|NCT01713582|468949654|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
130268603|NCT01713582|468949655|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
130268604|NCT01713582|468949656|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
130366392|NCT01548287|469311859|FG002|Screening|No reason provided|0|||
130366393|NCT01548287|469311860|FG003|Screening|No reason provided|0|||
130454120|NCT01729871|469625433|FG000|Overall Study|Other|4|||
130454121|NCT01729871|469625434|FG001|Overall Study|Other|9|||
130454122|NCT00819910|469625435|FG000|Overall Study|Adverse Event|0|||
130454123|NCT00819910|469625436|FG001|Overall Study|Adverse Event|0|||
130454124|NCT00819910|469625437|FG002|Overall Study|Adverse Event|2|||
130454125|NCT00819910|469625438|FG003|Overall Study|Adverse Event|1|||
130454126|NCT00819910|469625435|FG000|Overall Study|Withdrawal by Subject|1|||
130454127|NCT00819910|469625436|FG001|Overall Study|Withdrawal by Subject|1|||
130454128|NCT00819910|469625437|FG002|Overall Study|Withdrawal by Subject|1|||
130454129|NCT00819910|469625438|FG003|Overall Study|Withdrawal by Subject|0|||
130454130|NCT00819910|469625435|FG000|Overall Study|Lost to Follow-up|1|||
130454131|NCT00819910|469625436|FG001|Overall Study|Lost to Follow-up|0|||
130454132|NCT00819910|469625437|FG002|Overall Study|Lost to Follow-up|0|||
130454133|NCT00819910|469625438|FG003|Overall Study|Lost to Follow-up|0|||
130454134|NCT00871429|469625439|FG000|Overall Study|Lost to Follow-up|6|||
130454135|NCT00871429|469625439|FG000|Overall Study|Withdrawal by Subject|17|||
130454136|NCT00871429|469625439|FG000|Overall Study|Questionnaire not completed|1|||
130454137|NCT01772719|469625443|FG000|Overall Study|Withdrawal by Subject|3|||
130454138|NCT01772719|469625443|FG000|Overall Study|Adverse Event|2|||
130454139|NCT01772719|469625443|FG000|Overall Study|Protocol Violation|1|||
130454140|NCT01772719|469625443|FG000|Overall Study|Lost to Follow-up|1|||
130454141|NCT00477412|469625444|FG000|Overall Study|Death|0|||
130454142|NCT00477412|469625445|FG001|Overall Study|Death|0|||
130454143|NCT00477412|469625446|FG002|Overall Study|Death|0|||
130454144|NCT00477412|469625447|FG003|Overall Study|Death|4|||
130454145|NCT00477412|469625444|FG000|Overall Study|Lost to Follow-up|0|||
130454146|NCT00477412|469625445|FG001|Overall Study|Lost to Follow-up|0|||
130454147|NCT00477412|469625446|FG002|Overall Study|Lost to Follow-up|0|||
130454148|NCT00477412|469625447|FG003|Overall Study|Lost to Follow-up|1|||
130454149|NCT00477412|469625444|FG000|Overall Study|Withdrawal by Subject|0|||
130454150|NCT00477412|469625445|FG001|Overall Study|Withdrawal by Subject|0|||
130454151|NCT00477412|469625446|FG002|Overall Study|Withdrawal by Subject|0|||
130454152|NCT00477412|469625447|FG003|Overall Study|Withdrawal by Subject|2|||
130366394|NCT01548287|469311861|FG004|Screening|No reason provided|9|||
130366395|NCT01548287|469311857|FG000|Screening|Did not meet eligibility criteria|0|||
130366396|NCT01548287|469311858|FG001|Screening|Did not meet eligibility criteria|0|||
130366397|NCT01548287|469311859|FG002|Screening|Did not meet eligibility criteria|0|||
130366398|NCT01548287|469311860|FG003|Screening|Did not meet eligibility criteria|0|||
130366399|NCT01548287|469311861|FG004|Screening|Did not meet eligibility criteria|74|||
130366400|NCT01548287|469311857|FG000|Randomized Period|Did not meet inclusion criteria|0|||
130366401|NCT01548287|469311858|FG001|Randomized Period|Did not meet inclusion criteria|0|||
130366402|NCT01548287|469311859|FG002|Randomized Period|Did not meet inclusion criteria|2|||
130366403|NCT01548287|469311860|FG003|Randomized Period|Did not meet inclusion criteria|0|||
130366404|NCT01548287|469311861|FG004|Randomized Period|Did not meet inclusion criteria|0|||
130366405|NCT01548287|469311857|FG000|Randomized Period|Adverse Event|0|||
130366406|NCT01548287|469311858|FG001|Randomized Period|Adverse Event|2|||
130366407|NCT01548287|469311859|FG002|Randomized Period|Adverse Event|5|||
130366408|NCT01548287|469311860|FG003|Randomized Period|Adverse Event|0|||
130366409|NCT01548287|469311861|FG004|Randomized Period|Adverse Event|0|||
130366410|NCT02762578|469311862|FG000|Overall Study|Adverse Event|1|||
130366411|NCT02762578|469311863|FG001|Overall Study|Adverse Event|6|||
130366412|NCT02762578|469311862|FG000|Overall Study|Protocol Violation|4|||
130454153|NCT00477412|469625444|FG000|Overall Study|Second Malignancy|0|||
130454154|NCT00477412|469625445|FG001|Overall Study|Second Malignancy|0|||
130454155|NCT00477412|469625446|FG002|Overall Study|Second Malignancy|0|||
130454156|NCT00477412|469625447|FG003|Overall Study|Second Malignancy|1|||
130454157|NCT00477412|469625444|FG000|Overall Study|Adverse Event|1|||
130454158|NCT00477412|469625445|FG001|Overall Study|Adverse Event|0|||
130454159|NCT00477412|469625446|FG002|Overall Study|Adverse Event|1|||
130454160|NCT00477412|469625447|FG003|Overall Study|Adverse Event|0|||
130366413|NCT02762578|469311863|FG001|Overall Study|Protocol Violation|2|||
130366414|NCT02762578|469311862|FG000|Overall Study|Withdrawal by Subject|4|||
130366415|NCT02762578|469311863|FG001|Overall Study|Withdrawal by Subject|2|||
130366416|NCT02762578|469311862|FG000|Overall Study|Unclassified|6|||
130454161|NCT00299702|469625449|FG000|Overall Study|Death|1|||
130268605|NCT01713582|468949657|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
130454162|NCT00299702|469625450|FG001|Overall Study|Death|0|||
130454163|NCT00299702|469625449|FG000|Overall Study|Adverse Event|0|||
130454164|NCT00299702|469625450|FG001|Overall Study|Adverse Event|4|||
130454165|NCT00299702|469625449|FG000|Overall Study|Lost to Follow-up|18|||
130454166|NCT00299702|469625450|FG001|Overall Study|Lost to Follow-up|10|||
130454167|NCT00299702|469625449|FG000|Overall Study|Withdrawal by Subject|25|||
130454168|NCT00299702|469625450|FG001|Overall Study|Withdrawal by Subject|23|||
130454169|NCT00299702|469625449|FG000|Overall Study|Pregnancy|0|||
130454170|NCT00299702|469625450|FG001|Overall Study|Pregnancy|1|||
130454171|NCT00299702|469625449|FG000|Overall Study|Insufficient Response|4|||
130454172|NCT00299702|469625450|FG001|Overall Study|Insufficient Response|3|||
130454173|NCT00299702|469625449|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
130454174|NCT00299702|469625450|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
130454175|NCT00751036|469625451|FG000|Overall Study|Disease Progression|28|||
130454176|NCT00751036|469625452|FG001|Overall Study|Disease Progression|29|||
130454177|NCT00751036|469625451|FG000|Overall Study|Adverse Event|6|||
130454178|NCT00751036|469625452|FG001|Overall Study|Adverse Event|4|||
130454179|NCT00751036|469625451|FG000|Overall Study|Administrative Problems|3|||
130454180|NCT00751036|469625452|FG001|Overall Study|Administrative Problems|4|||
130454181|NCT00751036|469625451|FG000|Overall Study|Withdrawal by Subject|5|||
130454182|NCT00751036|469625452|FG001|Overall Study|Withdrawal by Subject|2|||
130454183|NCT00751036|469625451|FG000|Overall Study|Death|3|||
130454184|NCT00751036|469625452|FG001|Overall Study|Death|3|||
130454185|NCT00751036|469625451|FG000|Overall Study|Lost to Follow-up|0|||
130454186|NCT00751036|469625452|FG001|Overall Study|Lost to Follow-up|1|||
130454187|NCT00751036|469625451|FG000|Overall Study|Protocol Violation|1|||
130454188|NCT00751036|469625452|FG001|Overall Study|Protocol Violation|0|||
130454189|NCT00751036|469625451|FG000|Overall Study|Missing end of Treatment Page|2|||
130454190|NCT00751036|469625452|FG001|Overall Study|Missing end of Treatment Page|3|||
130454191|NCT05460663|469625453|FG000|Overall Study|Withdrawal by Subject|2|||
130454192|NCT05460663|469625454|FG001|Overall Study|Withdrawal by Subject|5|||
130268606|NCT01713582|468949658|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
130454193|NCT05273801|469625455|FG000|Overall Study|Physician Decision|1|||
130454194|NCT05526911|469627462|FG000|Overall Study|Adverse Event|2|||
130454195|NCT05025449|469627463|FG000|Overall Study|Withdrawal by Subject|1|||
130454196|NCT05025449|469627463|FG000|Overall Study|Patient emergently taken to operating room|1|||
130454197|NCT00613301|469627464|FG000|Overall Study|Adverse Event|49|||
130454198|NCT00613301|469627464|FG000|Overall Study|Lost to Follow-up|88|||
130454199|NCT00613301|469627464|FG000|Overall Study|Withdrawal by Subject|5|||
130454200|NCT00613301|469627464|FG000|Overall Study|Death|6|||
130454201|NCT00613301|469627464|FG000|Overall Study|Lack of Efficacy|13|||
130454202|NCT00613301|469627464|FG000|Overall Study|Physician Decision|2|||
130454203|NCT00613301|469627464|FG000|Overall Study|No data was collected|53|||
130454204|NCT00613301|469627464|FG000|Overall Study|Irregularly enrolled patients|12|||
130454205|NCT00569946|469627465|FG000|Overall Study|Adverse Event|16|||
130454206|NCT00569946|469627465|FG000|Overall Study|Objective Progression or Relapse|42|||
130454207|NCT00569946|469627465|FG000|Overall Study|Global Deterioration of Health Status|1|||
130454208|NCT00762463|469627467|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
130454209|NCT00762463|469627468|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
130704875|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130704876|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
130704877|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130704878|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130704879|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
130704880|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130268607|NCT01713582|468949659|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
130268608|NCT01713582|468949639|FG000|Overall Study|Disease progression and adverse event|0|||
130268609|NCT01713582|468949640|FG001|Overall Study|Disease progression and adverse event|0|||
130268610|NCT01713582|468949641|FG002|Overall Study|Disease progression and adverse event|0|||
130268611|NCT01713582|468949642|FG003|Overall Study|Disease progression and adverse event|0|||
130268612|NCT01713582|468949643|FG004|Overall Study|Disease progression and adverse event|0|||
130268613|NCT01713582|468949644|FG005|Overall Study|Disease progression and adverse event|0|||
130704881|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130268614|NCT01713582|468949645|FG006|Overall Study|Disease progression and adverse event|0|||
130268615|NCT01713582|468949646|FG007|Overall Study|Disease progression and adverse event|0|||
130268616|NCT01713582|468949647|FG008|Overall Study|Disease progression and adverse event|0|||
130454210|NCT00762463|469627469|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
130454211|NCT00762463|469627470|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
130454212|NCT00762463|469627467|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
130454213|NCT00762463|469627468|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
130704882|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
130268617|NCT01713582|468949648|FG009|Overall Study|Disease progression and adverse event|0|||
130268618|NCT01713582|468949649|FG010|Overall Study|Disease progression and adverse event|0|||
130268619|NCT01713582|468949650|FG011|Overall Study|Disease progression and adverse event|0|||
130268620|NCT01713582|468949651|FG012|Overall Study|Disease progression and adverse event|0|||
130268621|NCT01713582|468949652|FG013|Overall Study|Disease progression and adverse event|0|||
130268622|NCT01713582|468949653|FG014|Overall Study|Disease progression and adverse event|0|||
130268623|NCT01713582|468949654|FG015|Overall Study|Disease progression and adverse event|0|||
130454214|NCT00762463|469627469|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
130454215|NCT00762463|469627470|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
130454216|NCT00762463|469627467|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
130454217|NCT00762463|469627468|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
130454218|NCT00762463|469627469|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
130454219|NCT00762463|469627470|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
130454220|NCT00762463|469627467|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
130454221|NCT00762463|469627468|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
130454222|NCT00762463|469627469|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
130454223|NCT00762463|469627470|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
130454224|NCT00762463|469627467|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
130454225|NCT00762463|469627468|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
130454226|NCT00762463|469627469|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
130454227|NCT00762463|469627470|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
130454228|NCT00762463|469627467|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
130454229|NCT00762463|469627468|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
130454230|NCT00762463|469627469|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
130454231|NCT00762463|469627470|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
130454232|NCT00762463|469627467|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
130454233|NCT00762463|469627468|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
130454234|NCT00762463|469627469|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
130454235|NCT00762463|469627470|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
130454236|NCT00762463|469627467|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
130454237|NCT00762463|469627468|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
130454238|NCT00762463|469627469|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
130454239|NCT00762463|469627470|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
130454240|NCT01306331|469627473|FG000|Overall Study|Adverse Event|28|||
130454241|NCT01306331|469627474|FG001|Overall Study|Adverse Event|25|||
130454242|NCT01306331|469627473|FG000|Overall Study|Lost to Follow-up|321|||
130454243|NCT01306331|469627474|FG001|Overall Study|Lost to Follow-up|323|||
130454244|NCT01306331|469627473|FG000|Overall Study|Physician Decision|26|||
130454245|NCT01306331|469627474|FG001|Overall Study|Physician Decision|22|||
130454246|NCT01306331|469627473|FG000|Overall Study|Pregnancy|136|||
130454247|NCT01306331|469627474|FG001|Overall Study|Pregnancy|151|||
130454248|NCT01306331|469627473|FG000|Overall Study|Protocol Violation|154|||
130454249|NCT01306331|469627474|FG001|Overall Study|Protocol Violation|124|||
130454250|NCT01306331|469627473|FG000|Overall Study|Withdrawal by Subject|163|||
130454251|NCT01306331|469627474|FG001|Overall Study|Withdrawal by Subject|152|||
130454252|NCT01306331|469627473|FG000|Overall Study|Not sexually active|29|||
130454253|NCT01306331|469627474|FG001|Overall Study|Not sexually active|28|||
130454254|NCT01306331|469627473|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
130454255|NCT01306331|469627474|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
130454256|NCT01306331|469627473|FG000|Overall Study|Other|34|||
130454257|NCT01306331|469627474|FG001|Overall Study|Other|32|||
130454258|NCT04048135|469627477|FG000|Overall Study|Withdrawal by Subject|1|||
130454259|NCT04048135|469627478|FG001|Overall Study|Withdrawal by Subject|1|||
130454260|NCT04048135|469627479|FG002|Overall Study|Withdrawal by Subject|1|||
130454261|NCT04048135|469627480|FG003|Overall Study|Withdrawal by Subject|2|||
130454262|NCT04048135|469627481|FG004|Overall Study|Withdrawal by Subject|0|||
130454263|NCT04048135|469627482|FG005|Overall Study|Withdrawal by Subject|0|||
130454264|NCT04048135|469627483|FG006|Overall Study|Withdrawal by Subject|1|||
130454265|NCT04048135|469627484|FG007|Overall Study|Withdrawal by Subject|1|||
130454266|NCT04048135|469627477|FG000|Overall Study|Adverse Event|0|||
130454267|NCT04048135|469627478|FG001|Overall Study|Adverse Event|0|||
130454268|NCT04048135|469627479|FG002|Overall Study|Adverse Event|0|||
130454269|NCT04048135|469627480|FG003|Overall Study|Adverse Event|1|||
130454270|NCT04048135|469627481|FG004|Overall Study|Adverse Event|1|||
130454271|NCT04048135|469627482|FG005|Overall Study|Adverse Event|0|||
130454272|NCT04048135|469627483|FG006|Overall Study|Adverse Event|0|||
130454273|NCT04048135|469627484|FG007|Overall Study|Adverse Event|0|||
130454274|NCT04048135|469627477|FG000|Overall Study|Protocol Violation|0|||
130454275|NCT04048135|469627478|FG001|Overall Study|Protocol Violation|0|||
130454276|NCT04048135|469627479|FG002|Overall Study|Protocol Violation|0|||
130454277|NCT04048135|469627480|FG003|Overall Study|Protocol Violation|0|||
130454278|NCT04048135|469627481|FG004|Overall Study|Protocol Violation|0|||
130454279|NCT04048135|469627482|FG005|Overall Study|Protocol Violation|1|||
130454280|NCT04048135|469627483|FG006|Overall Study|Protocol Violation|0|||
130454281|NCT04048135|469627484|FG007|Overall Study|Protocol Violation|0|||
130454282|NCT00172185|469627485|FG000|Overall Study|Adverse Event|0|||
130454283|NCT00172185|469627486|FG001|Overall Study|Adverse Event|1|||
130454284|NCT00172185|469627487|FG002|Overall Study|Adverse Event|3|||
130454285|NCT00172185|469627488|FG003|Overall Study|Adverse Event|4|||
130454286|NCT00172185|469627485|FG000|Overall Study|Physician Decision|0|||
130454287|NCT00172185|469627486|FG001|Overall Study|Physician Decision|0|||
130454288|NCT00172185|469627487|FG002|Overall Study|Physician Decision|1|||
130454289|NCT00172185|469627488|FG003|Overall Study|Physician Decision|0|||
130454290|NCT00172185|469627485|FG000|Overall Study|SPONSOR Decision|0|||
130454291|NCT00172185|469627486|FG001|Overall Study|SPONSOR Decision|1|||
130454292|NCT00172185|469627487|FG002|Overall Study|SPONSOR Decision|0|||
130454293|NCT00172185|469627488|FG003|Overall Study|SPONSOR Decision|0|||
130454294|NCT00172185|469627485|FG000|Overall Study|Withdrawal by Subject|0|||
130454295|NCT00172185|469627486|FG001|Overall Study|Withdrawal by Subject|0|||
130454296|NCT00172185|469627487|FG002|Overall Study|Withdrawal by Subject|1|||
130454297|NCT00172185|469627488|FG003|Overall Study|Withdrawal by Subject|0|||
130454298|NCT01677936|469627489|FG000|Overall Study|Lost to Follow-up|4|||
130454299|NCT01677936|469627490|FG001|Overall Study|Lost to Follow-up|1|||
130454300|NCT01677936|469627489|FG000|Overall Study|Protocol Violation|3|||
130454301|NCT01677936|469627490|FG001|Overall Study|Protocol Violation|0|||
130454302|NCT01677936|469627489|FG000|Overall Study|Adverse Event|1|||
130454303|NCT01677936|469627490|FG001|Overall Study|Adverse Event|0|||
130454304|NCT01677936|469627489|FG000|Overall Study|Lost to Follow-up|1|||
130454305|NCT01677936|469627490|FG001|Overall Study|Lost to Follow-up|0|||
130454306|NCT01677936|469627489|FG000|Overall Study|Protocol Violation|0|||
130454307|NCT01677936|469627490|FG001|Overall Study|Protocol Violation|4|||
130704883|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130704884|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130704885|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
130704886|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130704887|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130704888|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
130704889|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130704890|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130704891|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
130704892|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
130704893|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
130704894|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
130704895|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
130704896|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
130704897|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
130704898|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
130704899|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
130704900|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
130704901|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
130704902|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
130454308|NCT00349908|469627499|FG000|Overall Study|Withdrawal by Subject|0|||
130454309|NCT00349908|469627500|FG001|Overall Study|Withdrawal by Subject|4|||
130454310|NCT04565249|469627501|FG000|Overall Study|Death|0|||
130454311|NCT04565249|469627502|FG001|Overall Study|Death|0|||
130454312|NCT04565249|469627503|FG002|Overall Study|Death|0|||
130454313|NCT04565249|469627504|FG003|Overall Study|Death|1|||
130454314|NCT00151996|469627505|FG000|Overall Study|Adverse Event|3|||
130268624|NCT01713582|468949655|FG016|Overall Study|Disease progression and adverse event|1|||
130268625|NCT01713582|468949656|FG017|Overall Study|Disease progression and adverse event|0|||
130268626|NCT01713582|468949657|FG018|Overall Study|Disease progression and adverse event|0|||
130268627|NCT01713582|468949658|FG019|Overall Study|Disease progression and adverse event|0|||
130268628|NCT01713582|468949659|FG020|Overall Study|Disease progression and adverse event|0|||
130268629|NCT00342628|468949660|FG000|Overall Study|Withdrawal by Subject|19|||
130268630|NCT00342628|468949661|FG001|Overall Study|Withdrawal by Subject|19|||
130268631|NCT00342628|468949662|FG002|Overall Study|Withdrawal by Subject|18|||
130366417|NCT02762578|469311863|FG001|Overall Study|Unclassified|0|||
130366418|NCT00259610|469311864|FG000|Overall Study|Withdrawal by Subject|33|||
130366419|NCT00259610|469311865|FG001|Overall Study|Withdrawal by Subject|25|||
130366420|NCT00259610|469311866|FG002|Overall Study|Withdrawal by Subject|29|||
130366421|NCT00259610|469311867|FG003|Overall Study|Withdrawal by Subject|19|||
130366422|NCT00259610|469311864|FG000|Overall Study|Lost to Follow-up|19|||
130366423|NCT00259610|469311865|FG001|Overall Study|Lost to Follow-up|8|||
130366424|NCT00259610|469311866|FG002|Overall Study|Lost to Follow-up|18|||
130366425|NCT00259610|469311867|FG003|Overall Study|Lost to Follow-up|15|||
130366426|NCT00259610|469311864|FG000|Overall Study|Physician Decision|6|||
130366427|NCT00259610|469311865|FG001|Overall Study|Physician Decision|4|||
130454315|NCT00151996|469627506|FG001|Overall Study|Adverse Event|2|||
130454316|NCT00151996|469627505|FG000|Overall Study|Withdrawal by Subject|1|||
130704903|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
130704904|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
130704905|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
130704906|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
130704907|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
130704908|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
130704909|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
130704910|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
130704911|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
130704912|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
130704913|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
130704914|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
130704915|NCT00442546|470542822|FG000|Overall Study|Adverse Event|11|||
130704916|NCT00442546|470542823|FG001|Overall Study|Adverse Event|17|||
130704917|NCT00442546|470542824|FG002|Overall Study|Adverse Event|13|||
130704918|NCT00442546|470542822|FG000|Overall Study|Lost to Follow-up|1|||
130704919|NCT00442546|470542823|FG001|Overall Study|Lost to Follow-up|2|||
130704920|NCT00442546|470542824|FG002|Overall Study|Lost to Follow-up|1|||
130704921|NCT00442546|470542822|FG000|Overall Study|Other|4|||
130704922|NCT00442546|470542823|FG001|Overall Study|Other|9|||
130704923|NCT00442546|470542824|FG002|Overall Study|Other|6|||
130704924|NCT00442546|470542822|FG000|Overall Study|Withdrawal by Subject|5|||
130704925|NCT00442546|470542823|FG001|Overall Study|Withdrawal by Subject|5|||
130704926|NCT00442546|470542824|FG002|Overall Study|Withdrawal by Subject|7|||
130704927|NCT00442546|470542822|FG000|Overall Study|Randomized But Not Treated|5|||
130704928|NCT00442546|470542823|FG001|Overall Study|Randomized But Not Treated|4|||
130704929|NCT00442546|470542824|FG002|Overall Study|Randomized But Not Treated|6|||
130704930|NCT01557582|470542825|FG000|Overall Study|Protocol Violation|4|||
130704931|NCT01557582|470542825|FG000|Overall Study|Operator error|2|||
130704932|NCT03840382|470542826|FG000|Overall Study|Lost to Follow-up|11|||
130704933|NCT02843659|470542827|FG000|Overall Study|Subject Withdrew Consent|0|||
130704934|NCT02843659|470542828|FG001|Overall Study|Subject Withdrew Consent|0|||
130704935|NCT02843659|470542829|FG002|Overall Study|Subject Withdrew Consent|1|||
130704936|NCT02843659|470542827|FG000|Overall Study|Administrative Reason by Sponsor|4|||
130704937|NCT02843659|470542828|FG001|Overall Study|Administrative Reason by Sponsor|5|||
130704938|NCT02843659|470542829|FG002|Overall Study|Administrative Reason by Sponsor|4|||
130704939|NCT02843659|470542827|FG000|Overall Study|Adverse Event|0|||
130704940|NCT02843659|470542828|FG001|Overall Study|Adverse Event|1|||
130704941|NCT02843659|470542829|FG002|Overall Study|Adverse Event|0|||
130704942|NCT02413294|470542830|FG000|Overall Study|Withdrawal by Subject|1|||
130704943|NCT00831233|470544944|FG000|Overall Study|Adverse Event|0|||
130704944|NCT00831233|470544945|FG001|Overall Study|Adverse Event|1|||
130704945|NCT00831233|470544944|FG000|Overall Study|Protocol Violation|1|||
130704946|NCT00831233|470544945|FG001|Overall Study|Protocol Violation|0|||
130704947|NCT00831233|470544944|FG000|Overall Study|Selection Criteria Not Met|2|||
130704948|NCT00831233|470544945|FG001|Overall Study|Selection Criteria Not Met|0|||
130704949|NCT02211014|470544946|FG000|Overall Study|Adverse Event|0|||
130704950|NCT02211014|470544947|FG001|Overall Study|Adverse Event|2|||
130704951|NCT02211014|470544946|FG000|Overall Study|Physician Decision|1|||
130704952|NCT02211014|470544947|FG001|Overall Study|Physician Decision|2|||
130704953|NCT02211014|470544946|FG000|Overall Study|Started another cancer therapy|1|||
130704954|NCT02211014|470544947|FG001|Overall Study|Started another cancer therapy|0|||
130704955|NCT02211014|470544946|FG000|Overall Study|Withdrawal by Subject|0|||
130704956|NCT02211014|470544947|FG001|Overall Study|Withdrawal by Subject|1|||
130704957|NCT02211014|470544946|FG000|Overall Study|In agreement with patient, no benefit|0|||
130704958|NCT02211014|470544947|FG001|Overall Study|In agreement with patient, no benefit|1|||
130704959|NCT01796964|470544954|FG000|Overall Study|Adverse Event|1|||
130704960|NCT01796964|470544955|FG001|Overall Study|Adverse Event|1|||
130704961|NCT01796964|470544954|FG000|Overall Study|Death|1|||
130704962|NCT01796964|470544955|FG001|Overall Study|Death|0|||
130704963|NCT01796964|470544954|FG000|Overall Study|Protocol Violation|0|||
130704964|NCT01796964|470544955|FG001|Overall Study|Protocol Violation|1|||
130704965|NCT01796964|470544954|FG000|Overall Study|Withdrawal by Subject|1|||
130268632|NCT00342628|468949660|FG000|Overall Study|Death|1|||
130268633|NCT00342628|468949661|FG001|Overall Study|Death|1|||
130268634|NCT00342628|468949662|FG002|Overall Study|Death|0|||
130268635|NCT00342628|468949660|FG000|Overall Study|moved residence|0|||
130268636|NCT00342628|468949661|FG001|Overall Study|moved residence|1|||
130268637|NCT00342628|468949662|FG002|Overall Study|moved residence|1|||
130268638|NCT04551898|468949663|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
130454317|NCT00151996|469627506|FG001|Overall Study|Withdrawal by Subject|1|||
130454318|NCT00151996|469627505|FG000|Overall Study|Protocol Violation|1|||
130454319|NCT00151996|469627506|FG001|Overall Study|Protocol Violation|2|||
130454320|NCT00151996|469627505|FG000|Overall Study|Sponsor's decision|0|||
130454321|NCT00151996|469627506|FG001|Overall Study|Sponsor's decision|2|||
130454322|NCT01649791|469627513|FG000|Overall Study|Disease Progression|2|||
130454323|NCT01649791|469627513|FG000|Overall Study|Adverse Event|1|||
130454324|NCT01801930|469627514|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
130454325|NCT01801930|469627515|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
130454326|NCT01801930|469627516|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
130454327|NCT01801930|469627517|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
130454328|NCT01801930|469627514|FG000|Overall Study|DLT occurs|0|||
130454329|NCT01801930|469627515|FG001|Overall Study|DLT occurs|1|||
130454330|NCT01801930|469627516|FG002|Overall Study|DLT occurs|0|||
130454331|NCT01801930|469627517|FG003|Overall Study|DLT occurs|0|||
130454332|NCT00930813|469627521|FG000|Overall Study|Death|4|||
130268639|NCT04551898|468949664|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
130268640|NCT04551898|468949665|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
130268641|NCT04551898|468949666|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
130268642|NCT04551898|468949663|FG000|Overall Study|Withdrawal by Subject|5|||
130268643|NCT04551898|468949664|FG001|Overall Study|Withdrawal by Subject|1|||
130268644|NCT04551898|468949665|FG002|Overall Study|Withdrawal by Subject|2|||
130268645|NCT04551898|468949666|FG003|Overall Study|Withdrawal by Subject|2|||
130268646|NCT04551898|468949663|FG000|Overall Study|Lost to Follow-up|2|||
130268647|NCT04551898|468949664|FG001|Overall Study|Lost to Follow-up|1|||
130454333|NCT00930813|469627522|FG001|Overall Study|Death|5|||
130704966|NCT01796964|470544955|FG001|Overall Study|Withdrawal by Subject|1|||
130704967|NCT04025684|470544956|FG000|Overall Study|Withdrawal by Subject|1|||
130268648|NCT04551898|468949665|FG002|Overall Study|Lost to Follow-up|2|||
130268649|NCT04551898|468949666|FG003|Overall Study|Lost to Follow-up|2|||
130268650|NCT04551898|468949663|FG000|Overall Study|Death|1|||
130268651|NCT04551898|468949664|FG001|Overall Study|Death|0|||
130268652|NCT04551898|468949665|FG002|Overall Study|Death|0|||
130268653|NCT04551898|468949666|FG003|Overall Study|Death|0|||
130268654|NCT04551898|468949663|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268655|NCT04551898|468949664|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268656|NCT04551898|468949665|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
130268657|NCT04551898|468949666|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268658|NCT03427814|468949667|FG000|Overall Study|Withdrawal by Subject|4|||
130268659|NCT03427814|468949668|FG001|Overall Study|Withdrawal by Subject|4|||
130268660|NCT03427814|468949667|FG000|Overall Study|Lost to Follow-up|0|||
130268661|NCT03427814|468949668|FG001|Overall Study|Lost to Follow-up|2|||
130268662|NCT03427814|468949667|FG000|Overall Study|Death|42|||
130268663|NCT03427814|468949668|FG001|Overall Study|Death|31|||
130268664|NCT03427814|468949667|FG000|Overall Study|Sponsor's Decision|1|||
130268665|NCT03427814|468949668|FG001|Overall Study|Sponsor's Decision|0|||
130268666|NCT03427814|468949667|FG000|Overall Study|Investigator's Decision|1|||
130268667|NCT03427814|468949668|FG001|Overall Study|Investigator's Decision|2|||
130268668|NCT03427814|468949667|FG000|Overall Study|Disease progression|1|||
130268669|NCT03427814|468949668|FG001|Overall Study|Disease progression|0|||
130366428|NCT00259610|469311866|FG002|Overall Study|Physician Decision|7|||
130704968|NCT04025684|470544957|FG001|Overall Study|Withdrawal by Subject|1|||
130704969|NCT04025684|470544958|FG002|Overall Study|Withdrawal by Subject|0|||
130704970|NCT04025684|470544959|FG003|Overall Study|Withdrawal by Subject|0|||
130704971|NCT04025684|470544956|FG000|Overall Study|Multiple reasons|1|||
130704972|NCT04025684|470544957|FG001|Overall Study|Multiple reasons|3|||
130704973|NCT04025684|470544958|FG002|Overall Study|Multiple reasons|0|||
130704974|NCT04025684|470544959|FG003|Overall Study|Multiple reasons|1|||
130704975|NCT02070757|470544960|FG000|Overall Study|Adverse Event|107|||
130268670|NCT03427814|468949667|FG000|Overall Study|Treatment Completed|0|||
130366429|NCT00259610|469311867|FG003|Overall Study|Physician Decision|2|||
130366430|NCT00259610|469311864|FG000|Overall Study|Death|1|||
130268671|NCT03427814|468949668|FG001|Overall Study|Treatment Completed|1|||
130268672|NCT03427814|468949667|FG000|Overall Study|Sponsor's Decision to End study|21|||
130268673|NCT03427814|468949668|FG001|Overall Study|Sponsor's Decision to End study|25|||
130704976|NCT02070757|470544961|FG001|Overall Study|Adverse Event|99|||
130704977|NCT02070757|470544960|FG000|Overall Study|Lost to Follow-up|7|||
130704978|NCT02070757|470544961|FG001|Overall Study|Lost to Follow-up|4|||
130704979|NCT02070757|470544960|FG000|Overall Study|Protocol Violation|0|||
130704980|NCT02070757|470544961|FG001|Overall Study|Protocol Violation|4|||
130704981|NCT02070757|470544960|FG000|Overall Study|Withdrawal by Subject|1|||
130704982|NCT02070757|470544961|FG001|Overall Study|Withdrawal by Subject|3|||
130704983|NCT02070757|470544960|FG000|Overall Study|Investigator Decision|0|||
130704984|NCT02070757|470544961|FG001|Overall Study|Investigator Decision|2|||
130704985|NCT02070757|470544960|FG000|Overall Study|Discharged from Study Hospital|2|||
130704986|NCT02070757|470544961|FG001|Overall Study|Discharged from Study Hospital|2|||
130704987|NCT01546922|470544962|FG000|First Period of 10 Weeks|Protocol Violation|3|||
130704988|NCT01546922|470544963|FG001|First Period of 10 Weeks|Protocol Violation|1|||
130704989|NCT01546922|470544962|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
130704990|NCT01546922|470544963|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
130704991|NCT01546922|470544962|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
130704992|NCT01546922|470544963|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
130704993|NCT01546922|470544962|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
130704994|NCT01546922|470544963|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
130704995|NCT01546922|470544962|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
130704996|NCT01546922|470544963|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
130704997|NCT00792623|470544976|FG000|Overall Study|Adverse Event|2|||
130704998|NCT00792623|470544976|FG000|Overall Study|Withdrawal by Subject|5|||
130704999|NCT02916693|470544977|FG000|Overall Study|Lost to Follow-up|7|||
130705000|NCT02001051|470544982|FG000|Overall Study|Deemed not eligible following enrollment|0|||
130705001|NCT02001051|470544983|FG001|Overall Study|Deemed not eligible following enrollment|1|||
130705002|NCT04205162|470544989|FG000|Overall Study|Lost to Follow-up|1|||
130705003|NCT04205162|470544990|FG001|Overall Study|Lost to Follow-up|0|||
130454334|NCT00930813|469627521|FG000|Overall Study|Withdrawal by Subject|2|||
130454335|NCT00930813|469627522|FG001|Overall Study|Withdrawal by Subject|5|||
130454336|NCT00930813|469627521|FG000|Overall Study|Lost to Follow-up|2|||
130454337|NCT00930813|469627522|FG001|Overall Study|Lost to Follow-up|4|||
130454338|NCT03999554|469627523|FG000|Overall Study|Lost to Follow-up|4|||
130454339|NCT03999554|469627524|FG001|Overall Study|Lost to Follow-up|5|||
130454340|NCT03999554|469627525|FG002|Overall Study|Lost to Follow-up|4|||
130454341|NCT03999554|469627526|FG003|Overall Study|Lost to Follow-up|5|||
130454342|NCT03999554|469627527|FG004|Overall Study|Lost to Follow-up|8|||
130454343|NCT03999554|469627523|FG000|Overall Study|Protocol Violation|0|||
130454344|NCT03999554|469627524|FG001|Overall Study|Protocol Violation|0|||
130454345|NCT03999554|469627525|FG002|Overall Study|Protocol Violation|5|||
130454346|NCT03999554|469627526|FG003|Overall Study|Protocol Violation|0|||
130454347|NCT03999554|469627527|FG004|Overall Study|Protocol Violation|0|||
130454348|NCT03999554|469627523|FG000|Overall Study|Pregnancy|0|||
130454349|NCT03999554|469627524|FG001|Overall Study|Pregnancy|0|||
130454350|NCT03999554|469627525|FG002|Overall Study|Pregnancy|1|||
130454351|NCT03999554|469627526|FG003|Overall Study|Pregnancy|0|||
130454352|NCT03999554|469627527|FG004|Overall Study|Pregnancy|0|||
130454353|NCT03999554|469627523|FG000|Overall Study|Withdrawal by Subject|2|||
130705004|NCT04205162|470544989|FG000|Overall Study|Withdrawal by Subject|2|||
130705005|NCT04205162|470544990|FG001|Overall Study|Withdrawal by Subject|0|||
130454354|NCT03999554|469627524|FG001|Overall Study|Withdrawal by Subject|2|||
130454355|NCT03999554|469627525|FG002|Overall Study|Withdrawal by Subject|2|||
130454356|NCT03999554|469627526|FG003|Overall Study|Withdrawal by Subject|1|||
130454357|NCT03999554|469627527|FG004|Overall Study|Withdrawal by Subject|1|||
130454358|NCT03999554|469627523|FG000|Overall Study|failure to comply with protocol requirements|0|||
130705006|NCT04205162|470544989|FG000|Overall Study|University closure due to COVID-19|1|||
130705007|NCT04205162|470544990|FG001|Overall Study|University closure due to COVID-19|0|||
130705008|NCT01098110|470544994|FG000|Overall Study|Withdrawal by Subject|14|||
130705009|NCT01098110|470544995|FG001|Overall Study|Withdrawal by Subject|24|||
130268674|NCT03427814|468949667|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
130268675|NCT03427814|468949668|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
130268676|NCT03846427|468949669|FG000|Overall Study|Death|13|||
130268677|NCT03846427|468949669|FG000|Overall Study|Withdrawal by Subject|3|||
130268678|NCT03846427|468949669|FG000|Overall Study|Physician Decision|1|||
130268679|NCT04971967|468949672|FG000|Overall Study|Lost to Follow-up|6|||
130268680|NCT04971967|468949673|FG001|Overall Study|Lost to Follow-up|7|||
130268681|NCT00682929|468949676|FG000|Overall Study|Adverse Event|4|||
130268682|NCT00682929|468949677|FG001|Overall Study|Adverse Event|1|||
130268683|NCT00682929|468949678|FG002|Overall Study|Adverse Event|1|||
130268684|NCT00682929|468949676|FG000|Overall Study|Withdrawal by Subject|1|||
130268685|NCT00682929|468949677|FG001|Overall Study|Withdrawal by Subject|2|||
130268686|NCT00682929|468949678|FG002|Overall Study|Withdrawal by Subject|1|||
130268687|NCT00682929|468949676|FG000|Overall Study|dosing compliance < 80%|0|||
130268688|NCT00682929|468949677|FG001|Overall Study|dosing compliance < 80%|2|||
130705010|NCT01098110|470544996|FG002|Overall Study|Withdrawal by Subject|19|||
130705011|NCT01098110|470544994|FG000|Overall Study|Adverse Event|30|||
130705012|NCT01098110|470544995|FG001|Overall Study|Adverse Event|32|||
130705013|NCT01098110|470544996|FG002|Overall Study|Adverse Event|43|||
130705014|NCT01098110|470544994|FG000|Overall Study|Lack of Efficacy|13|||
130705015|NCT01098110|470544995|FG001|Overall Study|Lack of Efficacy|9|||
130705016|NCT01098110|470544996|FG002|Overall Study|Lack of Efficacy|27|||
130705017|NCT01098110|470544994|FG000|Overall Study|Other|4|||
130705018|NCT01098110|470544995|FG001|Overall Study|Other|7|||
130705019|NCT01098110|470544996|FG002|Overall Study|Other|5|||
130705020|NCT01098110|470544994|FG000|Overall Study|Untreated|1|||
130705021|NCT01098110|470544995|FG001|Overall Study|Untreated|1|||
130705022|NCT01098110|470544996|FG002|Overall Study|Untreated|0|||
130705023|NCT02147587|470544997|FG000|Overall Study|Adverse Event|9|||
130705024|NCT02147587|470544998|FG001|Overall Study|Adverse Event|4|||
130705025|NCT02147587|470544997|FG000|Overall Study|Lack of Efficacy|2|||
130705026|NCT02147587|470544998|FG001|Overall Study|Lack of Efficacy|1|||
130705027|NCT00263887|470544999|FG000|Overall Study|Withdrawal by Subject|1|||
130705028|NCT00263887|470545000|FG001|Overall Study|Withdrawal by Subject|1|||
130705029|NCT00263887|470544999|FG000|Overall Study|Lung transplantation|1|||
130705030|NCT00263887|470545000|FG001|Overall Study|Lung transplantation|2|||
130705031|NCT00263887|470544999|FG000|Overall Study|Too ill to attend visit|1|||
130705032|NCT00263887|470545000|FG001|Overall Study|Too ill to attend visit|0|||
130705033|NCT00263887|470544999|FG000|Overall Study|Adverse Event|0|||
130705034|NCT00263887|470545000|FG001|Overall Study|Adverse Event|2|||
130705035|NCT00263887|470544999|FG000|Overall Study|Disease progression|0|||
130705036|NCT00263887|470545000|FG001|Overall Study|Disease progression|1|||
130705037|NCT00263887|470544999|FG000|Overall Study|Lack of Efficacy|0|||
130705038|NCT00263887|470545000|FG001|Overall Study|Lack of Efficacy|1|||
130705039|NCT01519947|470545005|FG000|Overall Study|Death|0|||
130705040|NCT01519947|470545006|FG001|Overall Study|Death|0|||
130705041|NCT01519947|470545007|FG002|Overall Study|Death|0|||
130705042|NCT01519947|470545008|FG003|Overall Study|Death|1|||
130705043|NCT01519947|470545005|FG000|Overall Study|Protocol Violation|0|||
130705044|NCT01519947|470545006|FG001|Overall Study|Protocol Violation|0|||
130705045|NCT01519947|470545007|FG002|Overall Study|Protocol Violation|2|||
130705046|NCT01519947|470545008|FG003|Overall Study|Protocol Violation|1|||
130705047|NCT01519947|470545005|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
130705048|NCT01519947|470545006|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
130705049|NCT01519947|470545007|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
130705050|NCT01519947|470545008|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
130705051|NCT01519947|470545005|FG000|Overall Study|Development of Anemia|0|||
130705052|NCT01519947|470545006|FG001|Overall Study|Development of Anemia|1|||
130705053|NCT01519947|470545007|FG002|Overall Study|Development of Anemia|0|||
130705054|NCT01519947|470545008|FG003|Overall Study|Development of Anemia|1|||
130705055|NCT01519947|470545005|FG000|Overall Study|Blood Transfusion|0|||
130268689|NCT00682929|468949678|FG002|Overall Study|dosing compliance < 80%|0|||
130268690|NCT00682929|468949676|FG000|Overall Study|lag in DEA renewal|1|||
130268691|NCT00682929|468949677|FG001|Overall Study|lag in DEA renewal|0|||
130705056|NCT01519947|470545006|FG001|Overall Study|Blood Transfusion|1|||
130705057|NCT01519947|470545007|FG002|Overall Study|Blood Transfusion|1|||
130705058|NCT01519947|470545008|FG003|Overall Study|Blood Transfusion|0|||
130705059|NCT01519947|470545005|FG000|Overall Study|Withdrawal by Subject|0|||
130705060|NCT01519947|470545006|FG001|Overall Study|Withdrawal by Subject|1|||
130705061|NCT01519947|470545007|FG002|Overall Study|Withdrawal by Subject|0|||
130705062|NCT01519947|470545008|FG003|Overall Study|Withdrawal by Subject|1|||
130705063|NCT01519947|470545005|FG000|Overall Study|Lost to Follow-up|0|||
130705064|NCT01519947|470545006|FG001|Overall Study|Lost to Follow-up|0|||
130705065|NCT01519947|470545007|FG002|Overall Study|Lost to Follow-up|3|||
130705066|NCT01519947|470545008|FG003|Overall Study|Lost to Follow-up|2|||
130705067|NCT01519947|470545005|FG000|Overall Study|Poor Response|1|||
130705068|NCT01519947|470545006|FG001|Overall Study|Poor Response|0|||
130705069|NCT01519947|470545007|FG002|Overall Study|Poor Response|0|||
130705070|NCT01519947|470545008|FG003|Overall Study|Poor Response|1|||
130705071|NCT01519947|470545005|FG000|Overall Study|Adverse Event|1|||
130705072|NCT01519947|470545006|FG001|Overall Study|Adverse Event|0|||
130705073|NCT01519947|470545007|FG002|Overall Study|Adverse Event|1|||
130705074|NCT01519947|470545008|FG003|Overall Study|Adverse Event|1|||
130705075|NCT00530348|470545013|FG000|Overall Study|Adverse Event|5|||
130705076|NCT00530348|470545014|FG001|Overall Study|Adverse Event|1|||
130705077|NCT00530348|470545013|FG000|Overall Study|Death|0|||
130705078|NCT00530348|470545014|FG001|Overall Study|Death|1|||
130705079|NCT00530348|470545013|FG000|Overall Study|Lack of Efficacy|2|||
130705080|NCT00530348|470545014|FG001|Overall Study|Lack of Efficacy|0|||
130705081|NCT00530348|470545013|FG000|Overall Study|Lost to Follow-up|0|||
130705082|NCT00530348|470545014|FG001|Overall Study|Lost to Follow-up|2|||
130705083|NCT00530348|470545013|FG000|Overall Study|Physician Decision|1|||
130705084|NCT00530348|470545014|FG001|Overall Study|Physician Decision|2|||
130705085|NCT00530348|470545013|FG000|Overall Study|Pregnancy|1|||
130705086|NCT00530348|470545014|FG001|Overall Study|Pregnancy|0|||
130705087|NCT00530348|470545013|FG000|Overall Study|Withdrawal by Subject|12|||
130705088|NCT00530348|470545014|FG001|Overall Study|Withdrawal by Subject|12|||
130705089|NCT00530348|470545013|FG000|Overall Study|Randomised in error|1|||
130705090|NCT00530348|470545014|FG001|Overall Study|Randomised in error|0|||
130705091|NCT00530348|470545013|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
130705092|NCT00530348|470545014|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
130705093|NCT04364763|470545015|FG000|Overall Study|Death|1|||
130705094|NCT04364763|470545016|FG001|Overall Study|Death|2|||
130705095|NCT04364763|470545015|FG000|Overall Study|Lost to Follow-up|1|||
130705096|NCT04364763|470545016|FG001|Overall Study|Lost to Follow-up|0|||
130705097|NCT02359864|470545017|FG000|Overall Study|Withdrawal by Subject|1|||
130705098|NCT02359864|470545018|FG001|Overall Study|Withdrawal by Subject|0|||
130705099|NCT02020967|470545019|FG000|Overall Study|Withdrawal by Subject|51|||
130705100|NCT02663882|470545026|FG000|Overall Study|Lost to Follow-up|4|||
130705101|NCT02663882|470545027|FG001|Overall Study|Lost to Follow-up|2|||
130705102|NCT00388037|470545032|FG000|Overall Study|Protocol Violation|1|||
130705103|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
130705104|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
130705105|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
130705106|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
130705107|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
130705108|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
130705109|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
130705110|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
130705111|NCT00602537|470545033|FG000|Follow Up Study Comparison|Adverse Event|1|||
130705112|NCT00602537|470545034|FG001|Follow Up Study Comparison|Adverse Event|0|||
130705113|NCT00602537|470545033|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
130268692|NCT00682929|468949678|FG002|Overall Study|lag in DEA renewal|0|||
130268693|NCT01462929|468949679|FG000|Overall Study|Adverse Event|3|||
130268694|NCT01462929|468949680|FG001|Overall Study|Adverse Event|3|||
130705114|NCT00602537|470545034|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
130705115|NCT00602537|470545033|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
130705116|NCT00602537|470545034|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
130705117|NCT02539368|470545041|FG000|Overall Study|Death|4|||
130705118|NCT02539368|470545042|FG001|Overall Study|Death|2|||
130705119|NCT02539368|470545043|FG002|Overall Study|Death|1|||
130705120|NCT02539368|470545044|FG003|Overall Study|Death|0|||
130705121|NCT02539368|470545045|FG004|Overall Study|Death|0|||
130705122|NCT02539368|470545041|FG000|Overall Study|Withdrawal by Subject|44|||
130705123|NCT02539368|470545042|FG001|Overall Study|Withdrawal by Subject|35|||
130705124|NCT02539368|470545043|FG002|Overall Study|Withdrawal by Subject|9|||
130705125|NCT02539368|470545044|FG003|Overall Study|Withdrawal by Subject|1|||
130705126|NCT02539368|470545045|FG004|Overall Study|Withdrawal by Subject|3|||
130705127|NCT02539368|470545041|FG000|Overall Study|Physician Decision|49|||
130705128|NCT02539368|470545042|FG001|Overall Study|Physician Decision|15|||
130705129|NCT02539368|470545043|FG002|Overall Study|Physician Decision|7|||
130705130|NCT02539368|470545044|FG003|Overall Study|Physician Decision|0|||
130705131|NCT02539368|470545045|FG004|Overall Study|Physician Decision|2|||
130705132|NCT02539368|470545041|FG000|Overall Study|Lost to Follow-up|96|||
130705133|NCT02539368|470545042|FG001|Overall Study|Lost to Follow-up|21|||
130705134|NCT02539368|470545043|FG002|Overall Study|Lost to Follow-up|16|||
130454359|NCT03999554|469627524|FG001|Overall Study|failure to comply with protocol requirements|0|||
130454360|NCT03999554|469627525|FG002|Overall Study|failure to comply with protocol requirements|0|||
130454361|NCT03999554|469627526|FG003|Overall Study|failure to comply with protocol requirements|1|||
130454362|NCT03999554|469627527|FG004|Overall Study|failure to comply with protocol requirements|0|||
130454363|NCT01101165|469627528|FG000|Period 1|Adverse Event|1|||
130454364|NCT01101165|469627529|FG001|Period 1|Adverse Event|2|||
130454365|NCT01101165|469627528|FG000|Period 1|Withdrawal by Subject|0|||
130454366|NCT01101165|469627529|FG001|Period 1|Withdrawal by Subject|2|||
130454367|NCT01101165|469627528|FG000|Period 1|Positive Drug Screen|0|||
130454368|NCT01101165|469627529|FG001|Period 1|Positive Drug Screen|1|||
130454369|NCT01101165|469627528|FG000|Period 1|Lost to Follow-up|1|||
130454370|NCT01101165|469627529|FG001|Period 1|Lost to Follow-up|0|||
130454371|NCT01101165|469627528|FG000|Period 2|Withdrawal by Subject|3|||
130454372|NCT01101165|469627529|FG001|Period 2|Withdrawal by Subject|1|||
130454373|NCT01101165|469627528|FG000|Period 2|Adverse Event|1|||
130454374|NCT01101165|469627529|FG001|Period 2|Adverse Event|0|||
130454375|NCT00015457|469627530|FG000|First Intervention|Adverse Event|0|||
130454376|NCT00015457|469627531|FG001|First Intervention|Adverse Event|2|||
130454377|NCT00015457|469627530|FG000|First Intervention|Lack of Efficacy|0|||
130454378|NCT00015457|469627531|FG001|First Intervention|Lack of Efficacy|1|||
130454379|NCT00015457|469627530|FG000|Second Intervention|Withdrawal by Subject|1|||
130454380|NCT00015457|469627531|FG001|Second Intervention|Withdrawal by Subject|0|||
130454381|NCT03404843|469627533|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
130454382|NCT03404843|469627534|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
130454383|NCT00567164|469627535|FG000|Overall Study|Withdrawal by Subject|171|||
130454384|NCT00567164|469627536|FG001|Overall Study|Withdrawal by Subject|21|||
130454385|NCT00567164|469627537|FG002|Overall Study|Withdrawal by Subject|17|||
130454386|NCT00567164|469627535|FG000|Overall Study|Protocol Violation|23|||
130454387|NCT00567164|469627536|FG001|Overall Study|Protocol Violation|4|||
130454388|NCT00567164|469627537|FG002|Overall Study|Protocol Violation|2|||
130454389|NCT00567164|469627535|FG000|Overall Study|Adverse Event|92|||
130454390|NCT00567164|469627536|FG001|Overall Study|Adverse Event|13|||
130454391|NCT00567164|469627537|FG002|Overall Study|Adverse Event|9|||
130454392|NCT00567164|469627535|FG000|Overall Study|Death|0|||
130454393|NCT00567164|469627536|FG001|Overall Study|Death|0|||
130705135|NCT02539368|470545044|FG003|Overall Study|Lost to Follow-up|4|||
130705136|NCT02539368|470545045|FG004|Overall Study|Lost to Follow-up|3|||
130705137|NCT02539368|470545041|FG000|Overall Study|Adverse Event|44|||
130705138|NCT02539368|470545042|FG001|Overall Study|Adverse Event|5|||
130705139|NCT02539368|470545043|FG002|Overall Study|Adverse Event|9|||
130366431|NCT00259610|469311865|FG001|Overall Study|Death|1|||
130366432|NCT00259610|469311866|FG002|Overall Study|Death|2|||
130366433|NCT00259610|469311867|FG003|Overall Study|Death|0|||
130366434|NCT00259610|469311864|FG000|Overall Study|non medical reason|6|||
130366435|NCT00259610|469311865|FG001|Overall Study|non medical reason|2|||
130366436|NCT00259610|469311866|FG002|Overall Study|non medical reason|10|||
130366437|NCT00259610|469311867|FG003|Overall Study|non medical reason|3|||
130366438|NCT00259610|469311864|FG000|Overall Study|Adverse Event|3|||
130366439|NCT00259610|469311865|FG001|Overall Study|Adverse Event|4|||
130366440|NCT00259610|469311866|FG002|Overall Study|Adverse Event|5|||
130366441|NCT00259610|469311867|FG003|Overall Study|Adverse Event|2|||
130366442|NCT00259610|469311864|FG000|Overall Study|Serious Adverse Event|8|||
130366443|NCT00259610|469311865|FG001|Overall Study|Serious Adverse Event|2|||
130366444|NCT00259610|469311866|FG002|Overall Study|Serious Adverse Event|2|||
130366445|NCT00259610|469311867|FG003|Overall Study|Serious Adverse Event|2|||
130366446|NCT01611155|469311870|FG000|Overall Study|Adverse Event|1|||
130366447|NCT01611155|469311871|FG001|Overall Study|Adverse Event|1|||
130366448|NCT01611155|469311870|FG000|Overall Study|Refused further treatment|6|||
130366449|NCT01611155|469311871|FG001|Overall Study|Refused further treatment|4|||
130366450|NCT01611155|469311870|FG000|Overall Study|Disease progression|1|||
130366451|NCT01611155|469311871|FG001|Overall Study|Disease progression|0|||
130366452|NCT01611155|469311870|FG000|Overall Study|Withdrawal by Subject|1|||
130366453|NCT01611155|469311871|FG001|Overall Study|Withdrawal by Subject|0|||
130366454|NCT01611155|469311870|FG000|Overall Study|Alternative treatment|0|||
130454394|NCT00567164|469627537|FG002|Overall Study|Death|1|||
130454395|NCT00567164|469627535|FG000|Overall Study|Lost to Follow-up|202|||
130705140|NCT02539368|470545044|FG003|Overall Study|Adverse Event|0|||
130366455|NCT01611155|469311871|FG001|Overall Study|Alternative treatment|1|||
130454396|NCT00567164|469627536|FG001|Overall Study|Lost to Follow-up|23|||
130454397|NCT00567164|469627537|FG002|Overall Study|Lost to Follow-up|21|||
130454398|NCT00567164|469627535|FG000|Overall Study|Pregnancy|20|||
130454399|NCT00567164|469627536|FG001|Overall Study|Pregnancy|4|||
130454400|NCT00567164|469627537|FG002|Overall Study|Pregnancy|6|||
130705141|NCT02539368|470545045|FG004|Overall Study|Adverse Event|3|||
130705142|NCT02539368|470545041|FG000|Overall Study|Participant Non-compliant|13|||
130366456|NCT01611155|469311870|FG000|Overall Study|Ineligible patient|0|||
130366457|NCT01611155|469311871|FG001|Overall Study|Ineligible patient|1|||
130366458|NCT02699593|469311872|FG000|Period 1|Unsatisfactory Visual Response|0|||
130366459|NCT02699593|469311873|FG001|Period 1|Unsatisfactory Visual Response|1|||
130705143|NCT02539368|470545042|FG001|Overall Study|Participant Non-compliant|2|||
130705144|NCT02539368|470545043|FG002|Overall Study|Participant Non-compliant|1|||
130705145|NCT02539368|470545044|FG003|Overall Study|Participant Non-compliant|1|||
130705146|NCT02539368|470545045|FG004|Overall Study|Participant Non-compliant|0|||
130454401|NCT00567164|469627535|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
130454402|NCT00567164|469627536|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
130454403|NCT00567164|469627537|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
130454404|NCT00567164|469627535|FG000|Overall Study|Missing|1|||
130454405|NCT00567164|469627536|FG001|Overall Study|Missing|0|||
130454406|NCT00567164|469627537|FG002|Overall Study|Missing|0|||
130454407|NCT02430532|469627548|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
130454408|NCT02430532|469627549|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
130454409|NCT02430532|469627548|FG000|Overall Study|Consent Withdrawn|0|||
130454410|NCT02430532|469627549|FG001|Overall Study|Consent Withdrawn|2|||
130454411|NCT02430532|469627548|FG000|Overall Study|Adverse Event|0|||
130454412|NCT02430532|469627549|FG001|Overall Study|Adverse Event|1|||
130454413|NCT01190150|469627550|FG000|First Treatment|Withdrawal by Subject|1|||
130454414|NCT01190150|469627551|FG001|First Treatment|Withdrawal by Subject|0|||
130454415|NCT01190150|469627550|FG000|Washout|Withdrawal by Subject|0|||
130454416|NCT01190150|469627551|FG001|Washout|Withdrawal by Subject|1|||
130454417|NCT01190150|469627550|FG000|Washout|Difficulty in adherence|0|||
130454418|NCT01190150|469627551|FG001|Washout|Difficulty in adherence|1|||
130454419|NCT03256344|469627552|FG000|Overall Study|Death|6|||
130454420|NCT03256344|469627553|FG001|Overall Study|Death|22|||
130454421|NCT03256344|469627552|FG000|Overall Study|Withdrawal by Subject|3|||
130454422|NCT03256344|469627553|FG001|Overall Study|Withdrawal by Subject|3|||
130454423|NCT03256344|469627552|FG000|Overall Study|Sponsor Decision|1|||
130454424|NCT03256344|469627553|FG001|Overall Study|Sponsor Decision|0|||
130454425|NCT01670019|469627565|FG000|Overall Study|Adverse Event|3|||
130454426|NCT01670019|469627566|FG001|Overall Study|Adverse Event|0|||
130454427|NCT01670019|469627565|FG000|Overall Study|Withdrawal by Subject|6|||
130454428|NCT01670019|469627566|FG001|Overall Study|Withdrawal by Subject|0|||
130454429|NCT00580801|469627567|FG000|Overall Study|Physician Decision|1|||
130454430|NCT00580801|469627568|FG001|Overall Study|Physician Decision|0|||
130454431|NCT00580801|469627569|FG002|Overall Study|Physician Decision|0|||
130454432|NCT00580801|469627567|FG000|Overall Study|Adverse Event|2|||
130454433|NCT00580801|469627568|FG001|Overall Study|Adverse Event|0|||
130454434|NCT00580801|469627569|FG002|Overall Study|Adverse Event|0|||
130454435|NCT00580801|469627567|FG000|Overall Study|Lost to Follow-up|2|||
130454436|NCT00580801|469627568|FG001|Overall Study|Lost to Follow-up|0|||
130454437|NCT00580801|469627569|FG002|Overall Study|Lost to Follow-up|0|||
130454438|NCT00580801|469627567|FG000|Overall Study|Reached a virologic endpoint|0|||
130454439|NCT00580801|469627568|FG001|Overall Study|Reached a virologic endpoint|1|||
130454440|NCT00580801|469627569|FG002|Overall Study|Reached a virologic endpoint|2|||
130454441|NCT00580801|469627567|FG000|Overall Study|Participant non-compliant|0|||
130454442|NCT00580801|469627568|FG001|Overall Study|Participant non-compliant|0|||
130454443|NCT00580801|469627569|FG002|Overall Study|Participant non-compliant|1|||
130454444|NCT00580801|469627567|FG000|Overall Study|Travel|1|||
130454445|NCT00580801|469627568|FG001|Overall Study|Travel|0|||
130454446|NCT00580801|469627569|FG002|Overall Study|Travel|0|||
130454447|NCT00502593|469627570|FG000|Overall Study|Withdrawn unspecified reason|1|||
130454448|NCT00502593|469627571|FG001|Overall Study|Withdrawn unspecified reason|1|||
130454449|NCT00502593|469627572|FG002|Overall Study|Withdrawn unspecified reason|3|||
130454450|NCT00502593|469627573|FG003|Overall Study|Withdrawn unspecified reason|1|||
130454451|NCT00502593|469627574|FG004|Overall Study|Withdrawn unspecified reason|2|||
130705147|NCT02539368|470545041|FG000|Overall Study|Other|145|||
130705148|NCT02539368|470545042|FG001|Overall Study|Other|18|||
130705149|NCT02539368|470545043|FG002|Overall Study|Other|24|||
130705150|NCT02539368|470545044|FG003|Overall Study|Other|1|||
130268695|NCT01462929|468949681|FG002|Overall Study|Adverse Event|4|||
130454452|NCT00502593|469627575|FG005|Overall Study|Withdrawn unspecified reason|0|||
130454453|NCT00502593|469627576|FG006|Overall Study|Withdrawn unspecified reason|2|||
130454454|NCT00502593|469627577|FG007|Overall Study|Withdrawn unspecified reason|0|||
130454455|NCT00502593|469627578|FG008|Overall Study|Withdrawn unspecified reason|0|||
130454456|NCT00502593|469627579|FG009|Overall Study|Withdrawn unspecified reason|0|||
130454457|NCT00502593|469627580|FG010|Overall Study|Withdrawn unspecified reason|0|||
130454458|NCT00502593|469627581|FG011|Overall Study|Withdrawn unspecified reason|0|||
130454459|NCT00502593|469627570|FG000|Overall Study|Withdrawal by Subject|0|||
130454460|NCT00502593|469627571|FG001|Overall Study|Withdrawal by Subject|0|||
130454461|NCT00502593|469627572|FG002|Overall Study|Withdrawal by Subject|6|||
130454462|NCT00502593|469627573|FG003|Overall Study|Withdrawal by Subject|2|||
130454463|NCT00502593|469627574|FG004|Overall Study|Withdrawal by Subject|2|||
130705151|NCT02539368|470545045|FG004|Overall Study|Other|3|||
130705152|NCT02539368|470545041|FG000|Overall Study|Missing|10|||
130454464|NCT00502593|469627575|FG005|Overall Study|Withdrawal by Subject|0|||
130454465|NCT00502593|469627576|FG006|Overall Study|Withdrawal by Subject|3|||
130554191|NCT01372410|469996530|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
130554192|NCT01372410|469996531|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
130554193|NCT01372410|469996532|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
130554194|NCT01372410|469996533|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
130554195|NCT01372410|469996534|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
130554196|NCT01372410|469996535|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
130554197|NCT01372410|469996536|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
130554198|NCT01372410|469996537|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
130554199|NCT01372410|469996530|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
130554200|NCT01372410|469996531|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
130554201|NCT01372410|469996532|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
130554202|NCT01372410|469996533|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
130554203|NCT01372410|469996534|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
130554204|NCT01372410|469996535|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
130554205|NCT01372410|469996536|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
130554206|NCT01372410|469996537|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
130454466|NCT00502593|469627577|FG007|Overall Study|Withdrawal by Subject|0|||
130454467|NCT00502593|469627578|FG008|Overall Study|Withdrawal by Subject|3|||
130454468|NCT00502593|469627579|FG009|Overall Study|Withdrawal by Subject|0|||
130454469|NCT00502593|469627580|FG010|Overall Study|Withdrawal by Subject|1|||
130454470|NCT00502593|469627581|FG011|Overall Study|Withdrawal by Subject|0|||
130454471|NCT00502593|469627570|FG000|Overall Study|Lost to Follow-up|2|||
130454472|NCT00502593|469627571|FG001|Overall Study|Lost to Follow-up|1|||
130454473|NCT00502593|469627572|FG002|Overall Study|Lost to Follow-up|1|||
130454474|NCT00502593|469627573|FG003|Overall Study|Lost to Follow-up|1|||
130554207|NCT01372410|469996530|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130554208|NCT01372410|469996531|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130554209|NCT01372410|469996532|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130454475|NCT00502593|469627574|FG004|Overall Study|Lost to Follow-up|0|||
130454476|NCT00502593|469627575|FG005|Overall Study|Lost to Follow-up|0|||
130454477|NCT00502593|469627576|FG006|Overall Study|Lost to Follow-up|0|||
130454478|NCT00502593|469627577|FG007|Overall Study|Lost to Follow-up|0|||
130705153|NCT02539368|470545042|FG001|Overall Study|Missing|3|||
130705154|NCT02539368|470545043|FG002|Overall Study|Missing|0|||
130705155|NCT02539368|470545044|FG003|Overall Study|Missing|0|||
130705156|NCT02539368|470545045|FG004|Overall Study|Missing|0|||
130705157|NCT03573817|470545047|FG000|Overall Study|Adverse Event|0|||
130705158|NCT03573817|470545048|FG001|Overall Study|Adverse Event|2|||
130705159|NCT03573817|470545047|FG000|Overall Study|Protocol Violation|0|||
130705160|NCT03573817|470545048|FG001|Overall Study|Protocol Violation|1|||
130705161|NCT03573817|470545047|FG000|Overall Study|Withdrawal by Subject|1|||
130705162|NCT03573817|470545048|FG001|Overall Study|Withdrawal by Subject|1|||
130705163|NCT02692482|470545055|FG000|Overall Study|Death|2|||
130705164|NCT02692482|470545056|FG001|Overall Study|Death|2|||
130454479|NCT00502593|469627578|FG008|Overall Study|Lost to Follow-up|3|||
130454480|NCT00502593|469627579|FG009|Overall Study|Lost to Follow-up|0|||
130454481|NCT00502593|469627580|FG010|Overall Study|Lost to Follow-up|1|||
130454482|NCT00502593|469627581|FG011|Overall Study|Lost to Follow-up|0|||
130454483|NCT01664104|469627583|FG000|Overall Study|Adverse Event|6|||
130454484|NCT01664104|469627583|FG000|Overall Study|Lack of Efficacy|2|||
130454485|NCT01664104|469627583|FG000|Overall Study|Withdrawal by Subject|1|||
130554210|NCT01372410|469996533|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130554211|NCT01372410|469996534|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
130554212|NCT01372410|469996535|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130554213|NCT01372410|469996536|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130454486|NCT01664104|469627583|FG000|Overall Study|Lost to Follow-up|4|||
130454487|NCT01664104|469627583|FG000|Overall Study|Other|1|||
130554214|NCT01372410|469996537|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130554215|NCT01372410|469996530|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130705165|NCT02692482|470545055|FG000|Overall Study|Withdrawal by Subject|1|||
130454488|NCT01664104|469627583|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
130454489|NCT00591838|469627585|FG000|Overall Study|Withdrawal by Subject|0|||
130705166|NCT02692482|470545056|FG001|Overall Study|Withdrawal by Subject|2|||
130705167|NCT00613730|470545057|FG000|Overall Study|Disease progression|2|||
130454490|NCT00591838|469627586|FG001|Overall Study|Withdrawal by Subject|0|||
130454491|NCT00591838|469627587|FG002|Overall Study|Withdrawal by Subject|0|||
130454492|NCT00591838|469627588|FG003|Overall Study|Withdrawal by Subject|1|||
130454493|NCT00591838|469627589|FG004|Overall Study|Withdrawal by Subject|0|||
130454494|NCT03586167|469627590|FG000|Overall Study|Other|1|||
130454495|NCT03586167|469627591|FG001|Overall Study|Other|0|||
130454496|NCT04163458|469627595|FG000|Overall Study|Protocol Deviation|7|||
130454497|NCT04163458|469627596|FG001|Overall Study|Protocol Deviation|13|||
130454498|NCT04163458|469627595|FG000|Overall Study|Adverse Event|5|||
130454499|NCT04163458|469627596|FG001|Overall Study|Adverse Event|8|||
130454500|NCT04163458|469627595|FG000|Overall Study|Due to COVID-19 pandemic|4|||
130454501|NCT04163458|469627596|FG001|Overall Study|Due to COVID-19 pandemic|2|||
130454502|NCT04163458|469627595|FG000|Overall Study|Participant withdrew consent|2|||
130454503|NCT04163458|469627596|FG001|Overall Study|Participant withdrew consent|3|||
130454504|NCT04163458|469627595|FG000|Overall Study|Randomization failure|2|||
130454505|NCT04163458|469627596|FG001|Overall Study|Randomization failure|2|||
130454506|NCT04163458|469627595|FG000|Overall Study|Other|4|||
130454507|NCT04163458|469627596|FG001|Overall Study|Other|2|||
130454508|NCT01467700|469627597|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130454509|NCT01467700|469627598|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130454510|NCT01467700|469627599|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
130454511|NCT01467700|469627600|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
130454512|NCT01467700|469627597|FG000|Overall Study|Major Protocol Deviation|3|||
130454513|NCT01467700|469627598|FG001|Overall Study|Major Protocol Deviation|3|||
130454514|NCT01467700|469627599|FG002|Overall Study|Major Protocol Deviation|2|||
130454515|NCT01467700|469627600|FG003|Overall Study|Major Protocol Deviation|3|||
130454516|NCT01467700|469627597|FG000|Overall Study|Lost to Follow-up|6|||
130454517|NCT01467700|469627598|FG001|Overall Study|Lost to Follow-up|5|||
130454518|NCT01467700|469627599|FG002|Overall Study|Lost to Follow-up|2|||
130454519|NCT01467700|469627600|FG003|Overall Study|Lost to Follow-up|3|||
130454520|NCT01467700|469627597|FG000|Overall Study|Voluntary Withdrawal|5|||
130454521|NCT01467700|469627598|FG001|Overall Study|Voluntary Withdrawal|7|||
130454522|NCT01467700|469627599|FG002|Overall Study|Voluntary Withdrawal|6|||
130454523|NCT01467700|469627600|FG003|Overall Study|Voluntary Withdrawal|2|||
130454524|NCT01467700|469627597|FG000|Overall Study|Study Termination|6|||
130454525|NCT01467700|469627598|FG001|Overall Study|Study Termination|5|||
130454526|NCT01467700|469627599|FG002|Overall Study|Study Termination|10|||
130454527|NCT01467700|469627600|FG003|Overall Study|Study Termination|7|||
130454528|NCT01467700|469627597|FG000|Overall Study|Pregnancy|0|||
130454529|NCT01467700|469627598|FG001|Overall Study|Pregnancy|1|||
130454530|NCT01467700|469627599|FG002|Overall Study|Pregnancy|1|||
130454531|NCT01467700|469627600|FG003|Overall Study|Pregnancy|0|||
130454532|NCT01467700|469627597|FG000|Overall Study|Lack of Efficacy|2|||
130454533|NCT01467700|469627598|FG001|Overall Study|Lack of Efficacy|0|||
130454534|NCT01467700|469627599|FG002|Overall Study|Lack of Efficacy|2|||
130454535|NCT01467700|469627600|FG003|Overall Study|Lack of Efficacy|1|||
130454536|NCT01467700|469627597|FG000|Overall Study|Reason not Specified|1|||
130454537|NCT01467700|469627598|FG001|Overall Study|Reason not Specified|3|||
130454538|NCT01467700|469627599|FG002|Overall Study|Reason not Specified|2|||
130454539|NCT01467700|469627600|FG003|Overall Study|Reason not Specified|8|||
130454540|NCT03523962|469627601|FG000|Closed Fractures|Death|86|||
130454541|NCT03523962|469627602|FG001|Closed Fractures|Death|71|||
130454542|NCT03523962|469627603|FG002|Closed Fractures|Death|0|||
130454543|NCT03523962|469627604|FG003|Closed Fractures|Death|0|||
130454544|NCT03523962|469627601|FG000|Closed Fractures|Lost to Follow-up|62|||
130454545|NCT03523962|469627602|FG001|Closed Fractures|Lost to Follow-up|36|||
130454546|NCT03523962|469627603|FG002|Closed Fractures|Lost to Follow-up|0|||
130454547|NCT03523962|469627604|FG003|Closed Fractures|Lost to Follow-up|0|||
130454548|NCT03523962|469627601|FG000|Closed Fractures|Withdrawal by Subject|19|||
130454549|NCT03523962|469627602|FG001|Closed Fractures|Withdrawal by Subject|29|||
130454550|NCT03523962|469627603|FG002|Closed Fractures|Withdrawal by Subject|0|||
130454551|NCT03523962|469627604|FG003|Closed Fractures|Withdrawal by Subject|0|||
130454552|NCT03523962|469627601|FG000|Closed Fractures|Incarceration|1|||
130454553|NCT03523962|469627602|FG001|Closed Fractures|Incarceration|4|||
130454554|NCT03523962|469627603|FG002|Closed Fractures|Incarceration|0|||
130454555|NCT03523962|469627604|FG003|Closed Fractures|Incarceration|0|||
130454556|NCT03523962|469627601|FG000|Open Fractures|Death|0|||
130454557|NCT03523962|469627602|FG001|Open Fractures|Death|0|||
130454558|NCT03523962|469627603|FG002|Open Fractures|Death|11|||
130454559|NCT03523962|469627604|FG003|Open Fractures|Death|6|||
130454560|NCT03523962|469627601|FG000|Open Fractures|Lost to Follow-up|0|||
130705168|NCT00613730|470545057|FG000|Overall Study|Administrative decision|1|||
130705169|NCT00479388|470545058|FG000|Overall Study|Adverse Event|90|||
130705170|NCT00479388|470545059|FG001|Overall Study|Adverse Event|45|||
130705171|NCT00479388|470545058|FG000|Overall Study|Lost to Follow-up|0|||
130705172|NCT00479388|470545059|FG001|Overall Study|Lost to Follow-up|2|||
130705173|NCT00479388|470545058|FG000|Overall Study|Protocol Violation|10|||
130705174|NCT00479388|470545059|FG001|Overall Study|Protocol Violation|9|||
130705175|NCT00479388|470545058|FG000|Overall Study|Withdrawal by Subject|32|||
130705176|NCT00479388|470545059|FG001|Overall Study|Withdrawal by Subject|17|||
130705177|NCT01955044|470545062|FG000|Overall Study|Death|1|||
130705178|NCT01955044|470545063|FG001|Overall Study|Death|1|||
130705179|NCT01955044|470545064|FG002|Overall Study|Death|0|||
130705180|NCT01876368|470545065|FG000|Overall Study|Adverse Event|2|||
130705181|NCT01876368|470545066|FG001|Overall Study|Adverse Event|5|||
130705182|NCT01876368|470545065|FG000|Overall Study|Lack of Efficacy|1|||
130705183|NCT01876368|470545066|FG001|Overall Study|Lack of Efficacy|0|||
130705184|NCT01876368|470545065|FG000|Overall Study|Lost to Follow-up|0|||
130705185|NCT01876368|470545066|FG001|Overall Study|Lost to Follow-up|1|||
130705186|NCT01876368|470545065|FG000|Overall Study|Non-compliance with study treatment|0|||
130705187|NCT01876368|470545066|FG001|Overall Study|Non-compliance with study treatment|1|||
130705188|NCT01876368|470545065|FG000|Overall Study|Physician Decision|0|||
130705189|NCT01876368|470545066|FG001|Overall Study|Physician Decision|2|||
130705190|NCT01876368|470545065|FG000|Overall Study|Protocol deviation|3|||
130705191|NCT01876368|470545066|FG001|Overall Study|Protocol deviation|3|||
130705192|NCT01876368|470545065|FG000|Overall Study|Subject/guardian decision|3|||
130705193|NCT01876368|470545066|FG001|Overall Study|Subject/guardian decision|1|||
130705194|NCT01867606|470545067|FG000|Overall Study|Withdrawal by Subject|10|||
130366460|NCT02699593|469311872|FG000|Period 1|Torn Contact Len|4|||
130366461|NCT02699593|469311873|FG001|Period 1|Torn Contact Len|3|||
130366462|NCT02699593|469311872|FG000|Period 1|Protocol Violation|0|||
130366463|NCT02699593|469311873|FG001|Period 1|Protocol Violation|1|||
130366464|NCT02699593|469311872|FG000|Period 1|Withdrawal by Subject|0|||
130366465|NCT02699593|469311873|FG001|Period 1|Withdrawal by Subject|1|||
130366466|NCT02699593|469311872|FG000|Period 1|Adverse Event|1|||
130366467|NCT02699593|469311873|FG001|Period 1|Adverse Event|1|||
130366468|NCT02699593|469311872|FG000|Period 2|Adverse Event|1|||
130366469|NCT02699593|469311873|FG001|Period 2|Adverse Event|1|||
130366470|NCT02699593|469311872|FG000|Period 2|Lost Contact Lens|0|||
130366471|NCT02699593|469311873|FG001|Period 2|Lost Contact Lens|1|||
130366472|NCT02699593|469311872|FG000|Period 2|Torn Contact Lens|1|||
130366473|NCT02699593|469311873|FG001|Period 2|Torn Contact Lens|0|||
130366474|NCT00868608|469311874|FG000|Overall Study|Withdrawal by Subject|3|||
130366475|NCT00868608|469311875|FG001|Overall Study|Withdrawal by Subject|1|||
130366476|NCT00868608|469311876|FG002|Overall Study|Withdrawal by Subject|0|||
130366477|NCT00868608|469311874|FG000|Overall Study|Lost to Follow-up|3|||
130366478|NCT00868608|469311875|FG001|Overall Study|Lost to Follow-up|0|||
130366479|NCT00868608|469311876|FG002|Overall Study|Lost to Follow-up|1|||
130366480|NCT00868608|469311874|FG000|Overall Study|Death|16|||
130366481|NCT00868608|469311875|FG001|Overall Study|Death|2|||
130366482|NCT00868608|469311876|FG002|Overall Study|Death|4|||
130366483|NCT00868608|469311874|FG000|Overall Study|Other - Unspecified|1|||
130366484|NCT00868608|469311875|FG001|Overall Study|Other - Unspecified|0|||
130366485|NCT00868608|469311876|FG002|Overall Study|Other - Unspecified|0|||
130366486|NCT03344796|469311877|FG000|Overall Study|Lost to Follow-up|0|||
130366487|NCT03344796|469311878|FG001|Overall Study|Lost to Follow-up|0|||
130705195|NCT01867606|470545068|FG001|Overall Study|Withdrawal by Subject|14|||
130705196|NCT01867606|470545067|FG000|Overall Study|Protocol Violation|0|||
130366488|NCT03344796|469311879|FG002|Overall Study|Lost to Follow-up|0|||
130366489|NCT03344796|469311880|FG003|Overall Study|Lost to Follow-up|0|||
130366490|NCT03344796|469311881|FG004|Overall Study|Lost to Follow-up|0|||
130366491|NCT03344796|469311882|FG005|Overall Study|Lost to Follow-up|2|||
130366492|NCT02564796|469311885|FG000|Overall Study|Physician Decision|2|||
130366493|NCT02564796|469311886|FG001|Overall Study|Physician Decision|2|||
130705197|NCT01867606|470545068|FG001|Overall Study|Protocol Violation|1|||
130705198|NCT01378962|470545069|FG000|Overall Study|Death|14|||
130705199|NCT01378962|470545069|FG000|Overall Study|Lost to Follow-up|1|||
130705200|NCT01378962|470545069|FG000|Overall Study|Other|2|||
130705201|NCT00292227|470545072|FG000|Patch Period|Adverse Event|1|||
130705202|NCT00292227|470545073|FG001|Patch Period|Adverse Event|0|||
130705203|NCT00292227|470545074|FG002|Patch Period|Adverse Event|2|||
130454561|NCT03523962|469627602|FG001|Open Fractures|Lost to Follow-up|0|||
130454562|NCT03523962|469627603|FG002|Open Fractures|Lost to Follow-up|15|||
130454563|NCT03523962|469627604|FG003|Open Fractures|Lost to Follow-up|8|||
130454564|NCT03523962|469627601|FG000|Open Fractures|Withdrawal by Subject|0|||
130454565|NCT03523962|469627602|FG001|Open Fractures|Withdrawal by Subject|0|||
130454566|NCT03523962|469627603|FG002|Open Fractures|Withdrawal by Subject|6|||
130554216|NCT01372410|469996531|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130554217|NCT01372410|469996532|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130554218|NCT01372410|469996533|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130554219|NCT01372410|469996534|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130705204|NCT00292227|470545072|FG000|Patch Period|Withdrawal by Subject|0|||
130268696|NCT01462929|468949679|FG000|Overall Study|Withdrawal by Subject|2|||
130268697|NCT01462929|468949680|FG001|Overall Study|Withdrawal by Subject|1|||
130268698|NCT01462929|468949681|FG002|Overall Study|Withdrawal by Subject|0|||
130268699|NCT01462929|468949679|FG000|Overall Study|Lack of Efficacy|0|||
130268700|NCT01462929|468949680|FG001|Overall Study|Lack of Efficacy|0|||
130268701|NCT01462929|468949681|FG002|Overall Study|Lack of Efficacy|1|||
130268702|NCT00399568|468949682|FG000|Overall Study|Adverse Event|1|||
130268703|NCT00399568|468949683|FG001|Overall Study|Adverse Event|2|||
130268704|NCT00399568|468949682|FG000|Overall Study|Withdrawal by Subject|7|||
130268705|NCT00399568|468949683|FG001|Overall Study|Withdrawal by Subject|3|||
130268706|NCT00399568|468949682|FG000|Overall Study|Protocol non-compliance|2|||
130268707|NCT00399568|468949683|FG001|Overall Study|Protocol non-compliance|2|||
130268708|NCT00399568|468949682|FG000|Overall Study|Lost to Follow-up|2|||
130268709|NCT00399568|468949683|FG001|Overall Study|Lost to Follow-up|2|||
130268710|NCT00506779|468949685|FG000|Overall Study|Withdrawal by Subject|1|||
130268711|NCT00506779|468949686|FG001|Overall Study|Withdrawal by Subject|0|||
130268712|NCT00506779|468949687|FG002|Overall Study|Withdrawal by Subject|1|||
130268713|NCT00506779|468949688|FG003|Overall Study|Withdrawal by Subject|0|||
130268714|NCT00506779|468949685|FG000|Overall Study|Adverse Event|0|||
130268715|NCT00506779|468949686|FG001|Overall Study|Adverse Event|1|||
130268716|NCT00506779|468949687|FG002|Overall Study|Adverse Event|1|||
130268717|NCT00506779|468949688|FG003|Overall Study|Adverse Event|1|||
130554220|NCT01372410|469996535|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130554221|NCT01372410|469996536|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
130705205|NCT00292227|470545073|FG001|Patch Period|Withdrawal by Subject|0|||
130705206|NCT00292227|470545074|FG002|Patch Period|Withdrawal by Subject|1|||
130705207|NCT02093923|470545075|FG000|Overall Study|Lost to Follow-up|0|||
130705208|NCT02093923|470545076|FG001|Overall Study|Lost to Follow-up|0|||
130705209|NCT02093923|470545077|FG002|Overall Study|Lost to Follow-up|0|||
130705210|NCT02093923|470545078|FG003|Overall Study|Lost to Follow-up|1|||
130705211|NCT02093923|470545079|FG004|Overall Study|Lost to Follow-up|0|||
130705212|NCT02093923|470545075|FG000|Overall Study|Screen failure after randomization|0|||
130705213|NCT02093923|470545076|FG001|Overall Study|Screen failure after randomization|0|||
130705214|NCT02093923|470545077|FG002|Overall Study|Screen failure after randomization|0|||
130705215|NCT02093923|470545078|FG003|Overall Study|Screen failure after randomization|1|||
130705216|NCT02093923|470545079|FG004|Overall Study|Screen failure after randomization|0|||
130705217|NCT00248170|470545080|FG000|Overall Study|Withdrawal by Subject|71|||
130705218|NCT00248170|470545081|FG001|Overall Study|Withdrawal by Subject|79|||
130268718|NCT02639247|468949691|FG000|Overall Study|Lost to Follow-up|2|||
130705219|NCT00248170|470545080|FG000|Overall Study|Protocol Violation|35|||
130705220|NCT00248170|470545081|FG001|Overall Study|Protocol Violation|30|||
130268719|NCT02639247|468949692|FG001|Overall Study|Lost to Follow-up|1|||
130268720|NCT02639247|468949691|FG000|Overall Study|Death|2|||
130268721|NCT02639247|468949692|FG001|Overall Study|Death|0|||
130268722|NCT02639247|468949691|FG000|Overall Study|Withdrew Consent|0|||
130268723|NCT02639247|468949692|FG001|Overall Study|Withdrew Consent|1|||
130705221|NCT00248170|470545080|FG000|Overall Study|Lost to Follow-up|28|||
130705222|NCT00248170|470545081|FG001|Overall Study|Lost to Follow-up|35|||
130705223|NCT00248170|470545080|FG000|Overall Study|Disease progression|196|||
130268724|NCT02639247|468949691|FG000|Overall Study|Protocol Violation|1|||
130705224|NCT00248170|470545081|FG001|Overall Study|Disease progression|216|||
130705225|NCT00248170|470545080|FG000|Overall Study|Death|28|||
130705226|NCT00248170|470545081|FG001|Overall Study|Death|47|||
130705227|NCT00248170|470545080|FG000|Overall Study|Adverse Event|311|||
130268725|NCT02639247|468949692|FG001|Overall Study|Protocol Violation|0|||
130268726|NCT03462758|468949693|FG000|Overall Study|Chose no or other method of contraception|20|||
130268727|NCT03462758|468949694|FG001|Overall Study|Chose no or other method of contraception|23|||
130268728|NCT03462758|468949693|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
130268729|NCT03462758|468949694|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
130268730|NCT03462758|468949693|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
130268731|NCT03462758|468949694|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
130268732|NCT03462758|468949693|FG000|Overall Study|Medical contraindication|2|||
130366494|NCT00453063|469311887|FG000|Overall Study|Adverse Event|1|||
130705228|NCT00248170|470545081|FG001|Overall Study|Adverse Event|296|||
130705229|NCT00248170|470545080|FG000|Overall Study|Administrative problems|22|||
130705230|NCT00248170|470545081|FG001|Overall Study|Administrative problems|25|||
130705231|NCT00248170|470545080|FG000|Overall Study|Abnormal test procedure(s) result|49|||
130705232|NCT00248170|470545081|FG001|Overall Study|Abnormal test procedure(s) result|61|||
130705233|NCT00248170|470545080|FG000|Overall Study|Abnormal laboratory values|4|||
130705234|NCT00248170|470545081|FG001|Overall Study|Abnormal laboratory values|0|||
130705235|NCT00248170|470545080|FG000|Overall Study|Protocol deviation|17|||
130705236|NCT00248170|470545081|FG001|Overall Study|Protocol deviation|19|||
130705237|NCT01253317|470545093|FG000|Overall Study|Adverse Event|2|||
130705238|NCT00802178|470547186|FG000|Overall Study|Lack of Efficacy|36|||
130705239|NCT00802178|470547186|FG000|Overall Study|Insufficient tolerability (IT)|17|||
130705240|NCT00802178|470547186|FG000|Overall Study|Withdrawal by Subject|18|||
130705241|NCT00802178|470547186|FG000|Overall Study|Other|32|||
130705242|NCT00802178|470547186|FG000|Overall Study|Lack of efficacy and patient wish|1|||
130705243|NCT00802178|470547186|FG000|Overall Study|IT and patient wish|8|||
130705244|NCT00802178|470547186|FG000|Overall Study|Patients wish and other reason|1|||
130705245|NCT04100096|470547187|FG000|Overall Study|Adverse Event|19|||
130705246|NCT04100096|470547188|FG001|Overall Study|Adverse Event|7|||
130705247|NCT04100096|470547187|FG000|Overall Study|Lack of Efficacy|0|||
130705248|NCT04100096|470547188|FG001|Overall Study|Lack of Efficacy|1|||
130705249|NCT04100096|470547187|FG000|Overall Study|Lost to Follow-up|13|||
130705250|NCT04100096|470547188|FG001|Overall Study|Lost to Follow-up|11|||
130705251|NCT04100096|470547187|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130705252|NCT04100096|470547188|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130705253|NCT04100096|470547187|FG000|Overall Study|Protocol Deviation|1|||
130705254|NCT04100096|470547188|FG001|Overall Study|Protocol Deviation|1|||
130705255|NCT04100096|470547187|FG000|Overall Study|Withdrawal by Participant|13|||
130705256|NCT04100096|470547188|FG001|Overall Study|Withdrawal by Participant|15|||
130705257|NCT01613378|470547192|FG000|Overall Study|Lack of Efficacy|13|||
130705258|NCT01613378|470547192|FG000|Overall Study|Adverse Event|11|||
130705259|NCT01613378|470547192|FG000|Overall Study|Withdrawal by Subject|8|||
130705260|NCT01613378|470547192|FG000|Overall Study|Death|2|||
130705261|NCT01613378|470547192|FG000|Overall Study|Lost to Follow-up|1|||
130705262|NCT01613378|470547192|FG000|Overall Study|Other Reason|4|||
130705263|NCT02744755|470547193|FG000|Study Period 1|Protocol Violation|2|||
130705264|NCT02744755|470547194|FG001|Study Period 1|Protocol Violation|1|||
130705265|NCT02744755|470547193|FG000|Study Period 1|not defined|0|||
130705266|NCT02744755|470547194|FG001|Study Period 1|not defined|1|||
130705267|NCT02744755|470547193|FG000|Study Period 1|Pregnancy|1|||
130705268|NCT02744755|470547194|FG001|Study Period 1|Pregnancy|0|||
130705269|NCT02744755|470547193|FG000|Study Period 1|Adverse Event|1|||
130705270|NCT02744755|470547194|FG001|Study Period 1|Adverse Event|1|||
130705271|NCT02744755|470547193|FG000|Study Period 1|Lost to Follow-up|1|||
130705272|NCT02744755|470547194|FG001|Study Period 1|Lost to Follow-up|1|||
130705273|NCT02744755|470547193|FG000|Study Period 1|Lack of Efficacy|1|||
130705274|NCT02744755|470547194|FG001|Study Period 1|Lack of Efficacy|0|||
130705275|NCT02744755|470547193|FG000|Study Period 1|Withdrawal by Subject|8|||
130705276|NCT02744755|470547194|FG001|Study Period 1|Withdrawal by Subject|4|||
130705277|NCT02744755|470547193|FG000|Study Period 2|Adverse Event|5|||
130705278|NCT02744755|470547194|FG001|Study Period 2|Adverse Event|0|||
130705279|NCT02744755|470547193|FG000|Study Period 2|Protocol Violation|1|||
130705280|NCT02744755|470547194|FG001|Study Period 2|Protocol Violation|0|||
130705281|NCT02744755|470547193|FG000|Study Period 2|not defined|3|||
130705282|NCT02744755|470547194|FG001|Study Period 2|not defined|2|||
130705283|NCT02744755|470547193|FG000|Study Period 2|Lost to Follow-up|0|||
130705284|NCT02744755|470547194|FG001|Study Period 2|Lost to Follow-up|2|||
130705285|NCT02744755|470547193|FG000|Study Period 2|Withdrawal by Subject|2|||
130705286|NCT02744755|470547194|FG001|Study Period 2|Withdrawal by Subject|2|||
130705287|NCT02744755|470547193|FG000|Study Period 2|Lack of Efficacy|3|||
130705288|NCT02744755|470547194|FG001|Study Period 2|Lack of Efficacy|2|||
130705289|NCT00880087|470547195|FG000|Overall Study|Lost to Follow-up|0|||
130705290|NCT00880087|470547196|FG001|Overall Study|Lost to Follow-up|2|||
130705291|NCT01011556|470547197|FG000|Overall Study|Adverse Event|1|||
130454567|NCT03523962|469627604|FG003|Open Fractures|Withdrawal by Subject|2|||
130454568|NCT03523962|469627601|FG000|Open Fractures|Incarceration|0|||
130454569|NCT03523962|469627602|FG001|Open Fractures|Incarceration|0|||
130454570|NCT03523962|469627603|FG002|Open Fractures|Incarceration|1|||
130705292|NCT01011556|470547198|FG001|Overall Study|Adverse Event|3|||
130705293|NCT01011556|470547199|FG002|Overall Study|Adverse Event|2|||
130705294|NCT01011556|470547200|FG003|Overall Study|Adverse Event|1|||
130705295|NCT01011556|470547197|FG000|Overall Study|Lost to Follow-up|1|||
130705296|NCT01011556|470547198|FG001|Overall Study|Lost to Follow-up|0|||
130705297|NCT01011556|470547199|FG002|Overall Study|Lost to Follow-up|0|||
130705298|NCT01011556|470547200|FG003|Overall Study|Lost to Follow-up|0|||
130705299|NCT01011556|470547197|FG000|Overall Study|Physician Decision|1|||
130705300|NCT01011556|470547198|FG001|Overall Study|Physician Decision|0|||
130705301|NCT01011556|470547199|FG002|Overall Study|Physician Decision|0|||
130705302|NCT01011556|470547200|FG003|Overall Study|Physician Decision|1|||
130705303|NCT01011556|470547197|FG000|Overall Study|Protocol Violation|0|||
130705304|NCT01011556|470547198|FG001|Overall Study|Protocol Violation|1|||
130705305|NCT01011556|470547199|FG002|Overall Study|Protocol Violation|0|||
130705306|NCT01011556|470547200|FG003|Overall Study|Protocol Violation|0|||
130705307|NCT01011556|470547197|FG000|Overall Study|Withdrawal by Subject|1|||
130705308|NCT01011556|470547198|FG001|Overall Study|Withdrawal by Subject|2|||
130705309|NCT01011556|470547199|FG002|Overall Study|Withdrawal by Subject|4|||
130705310|NCT01011556|470547200|FG003|Overall Study|Withdrawal by Subject|4|||
130705311|NCT01011556|470547197|FG000|Overall Study|Sponsor decision|0|||
130705312|NCT01011556|470547198|FG001|Overall Study|Sponsor decision|1|||
130705313|NCT01011556|470547199|FG002|Overall Study|Sponsor decision|1|||
130454571|NCT03523962|469627604|FG003|Open Fractures|Incarceration|0|||
130454572|NCT03396913|469627607|FG000|Overall Study|Lost to Follow-up|0|||
130454573|NCT03396913|469627608|FG001|Overall Study|Lost to Follow-up|6|||
130454574|NCT00813488|469627609|FG000|Titration Period 1|Adverse Event|6|||
130454575|NCT00813488|469627610|FG001|Titration Period 1|Adverse Event|1|||
130454576|NCT00813488|469627609|FG000|Titration Period 1|Lack of Efficacy|9|||
130454577|NCT00813488|469627610|FG001|Titration Period 1|Lack of Efficacy|7|||
130454578|NCT00813488|469627609|FG000|Titration Period 1|Withdrawal by Subject|2|||
130454579|NCT00813488|469627610|FG001|Titration Period 1|Withdrawal by Subject|2|||
130454580|NCT00813488|469627609|FG000|Titration Period 1|Protocol Violation|4|||
130454581|NCT00813488|469627610|FG001|Titration Period 1|Protocol Violation|3|||
130454582|NCT00813488|469627609|FG000|Titration Period 1|Non-compliance to study medication|4|||
130454583|NCT00813488|469627610|FG001|Titration Period 1|Non-compliance to study medication|1|||
130454584|NCT00813488|469627609|FG000|Titration Period 1|Non-compliance to study procedures|2|||
130454585|NCT00813488|469627610|FG001|Titration Period 1|Non-compliance to study procedures|2|||
130454586|NCT00813488|469627609|FG000|Titration Period 1|Technical Difficulties|0|||
130454587|NCT00813488|469627610|FG001|Titration Period 1|Technical Difficulties|1|||
130454588|NCT00813488|469627609|FG000|Titration Period 2|Adverse Event|2|||
130454589|NCT00813488|469627610|FG001|Titration Period 2|Adverse Event|3|||
130454590|NCT00813488|469627609|FG000|Titration Period 2|Lack of Efficacy|8|||
130705314|NCT01011556|470547200|FG003|Overall Study|Sponsor decision|2|||
130454591|NCT00813488|469627610|FG001|Titration Period 2|Lack of Efficacy|4|||
130454592|NCT00813488|469627609|FG000|Titration Period 2|Protocol Violation|3|||
130454593|NCT00813488|469627610|FG001|Titration Period 2|Protocol Violation|2|||
130454594|NCT00813488|469627609|FG000|Titration Period 2|Lost to Follow-up|1|||
130454595|NCT00813488|469627610|FG001|Titration Period 2|Lost to Follow-up|0|||
130454596|NCT00813488|469627609|FG000|Titration Period 2|Non-compliance with study procedures|2|||
130454597|NCT00813488|469627610|FG001|Titration Period 2|Non-compliance with study procedures|1|||
130454598|NCT00813488|469627609|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
130454599|NCT00813488|469627610|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
130454600|NCT00813488|469627609|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
130454601|NCT00813488|469627610|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
130454602|NCT00813488|469627609|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
130454603|NCT00813488|469627610|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
130454604|NCT00813488|469627609|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
130454605|NCT00813488|469627610|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
130454606|NCT00813488|469627609|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
130454607|NCT00813488|469627610|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
130454608|NCT00813488|469627609|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
130454609|NCT00813488|469627610|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
130454610|NCT00813488|469627609|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
130454611|NCT00813488|469627610|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
130454612|NCT00813488|469627609|FG000|Double-blind Treatment Period 2|Other|1|||
130705315|NCT01011556|470547197|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
130454613|NCT00813488|469627610|FG001|Double-blind Treatment Period 2|Other|0|||
130454614|NCT00813488|469627609|FG000|Open-label Extension|Adverse Event|1|||
130454615|NCT00813488|469627610|FG001|Open-label Extension|Adverse Event|2|||
130454616|NCT00813488|469627609|FG000|Open-label Extension|Lack of Efficacy|3|||
130454617|NCT00813488|469627610|FG001|Open-label Extension|Lack of Efficacy|0|||
130454618|NCT00813488|469627609|FG000|Open-label Extension|Withdrawal by Subject|0|||
130454619|NCT00813488|469627610|FG001|Open-label Extension|Withdrawal by Subject|2|||
130454620|NCT00813488|469627609|FG000|Open-label Extension|Protocol Violation|1|||
130454621|NCT00813488|469627610|FG001|Open-label Extension|Protocol Violation|2|||
130454622|NCT00813488|469627609|FG000|Open-label Extension|Non-compliance study medication|4|||
130454623|NCT00813488|469627610|FG001|Open-label Extension|Non-compliance study medication|0|||
130454624|NCT00813488|469627609|FG000|Open-label Extension|Non-compliance study procedures|2|||
130454625|NCT00813488|469627610|FG001|Open-label Extension|Non-compliance study procedures|1|||
130454626|NCT00813488|469627609|FG000|Open-label Extension|Other|1|||
130454627|NCT00813488|469627610|FG001|Open-label Extension|Other|0|||
130454628|NCT01143077|469627611|FG000|Overall Study|Lack of Efficacy|0|||
130454629|NCT01143077|469627612|FG001|Overall Study|Lack of Efficacy|2|||
130454630|NCT01143077|469627613|FG002|Overall Study|Lack of Efficacy|1|||
130454631|NCT01143077|469627611|FG000|Overall Study|Adverse Event|5|||
130454632|NCT01143077|469627612|FG001|Overall Study|Adverse Event|6|||
130454633|NCT01143077|469627613|FG002|Overall Study|Adverse Event|5|||
130454634|NCT01143077|469627611|FG000|Overall Study|Lost to Follow-up|2|||
130454635|NCT01143077|469627612|FG001|Overall Study|Lost to Follow-up|3|||
130454636|NCT01143077|469627613|FG002|Overall Study|Lost to Follow-up|4|||
130454637|NCT01143077|469627611|FG000|Overall Study|Protocol Violation|2|||
130454638|NCT01143077|469627612|FG001|Overall Study|Protocol Violation|0|||
130454639|NCT01143077|469627613|FG002|Overall Study|Protocol Violation|0|||
130454640|NCT01143077|469627611|FG000|Overall Study|Withdrawal by Subject|4|||
130454641|NCT01143077|469627612|FG001|Overall Study|Withdrawal by Subject|3|||
130454642|NCT01143077|469627613|FG002|Overall Study|Withdrawal by Subject|3|||
130454643|NCT01143077|469627611|FG000|Overall Study|Non-compliance with study drug|0|||
130454644|NCT01143077|469627612|FG001|Overall Study|Non-compliance with study drug|1|||
130454645|NCT01143077|469627613|FG002|Overall Study|Non-compliance with study drug|1|||
130454646|NCT01143077|469627611|FG000|Overall Study|Administrative|1|||
130454647|NCT01143077|469627612|FG001|Overall Study|Administrative|0|||
130454648|NCT01143077|469627613|FG002|Overall Study|Administrative|0|||
130454649|NCT01143077|469627611|FG000|Overall Study|Principal Investigator Decision|2|||
130454650|NCT01143077|469627612|FG001|Overall Study|Principal Investigator Decision|0|||
130454651|NCT01143077|469627613|FG002|Overall Study|Principal Investigator Decision|1|||
130454652|NCT03820986|469627618|FG000|Overall Study|Death|177|||
130454653|NCT03820986|469627619|FG001|Overall Study|Death|156|||
130454654|NCT03820986|469627618|FG000|Overall Study|Lost to Follow-up|0|||
130454655|NCT03820986|469627619|FG001|Overall Study|Lost to Follow-up|1|||
130454656|NCT03820986|469627618|FG000|Overall Study|Withdrawal by Subject|8|||
130454657|NCT03820986|469627619|FG001|Overall Study|Withdrawal by Subject|3|||
130454658|NCT03820986|469627618|FG000|Overall Study|Ongoing|149|||
130268733|NCT03462758|468949694|FG001|Overall Study|Medical contraindication|2|||
130268734|NCT03462758|468949693|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
130366495|NCT00453063|469311888|FG001|Overall Study|Adverse Event|2|||
130366496|NCT00453063|469311887|FG000|Overall Study|Withdrawal by Subject|1|||
130366497|NCT00453063|469311888|FG001|Overall Study|Withdrawal by Subject|1|||
130366498|NCT00453063|469311887|FG000|Overall Study|Protocol Violation|1|||
130366499|NCT00453063|469311888|FG001|Overall Study|Protocol Violation|0|||
130366500|NCT00289783|469311889|FG000|Primary Phase|Adverse Event|10|||
130366501|NCT00289783|469311890|FG001|Primary Phase|Adverse Event|1|||
130366502|NCT00289783|469311889|FG000|Primary Phase|Protocol Violation|27|||
130366503|NCT00289783|469311890|FG001|Primary Phase|Protocol Violation|6|||
130454659|NCT03820986|469627619|FG001|Overall Study|Ongoing|180|||
130454660|NCT00708097|469627621|FG000|Period 1|Protocol Violation|0|||
130454661|NCT00708097|469627622|FG001|Period 1|Protocol Violation|1|||
130454662|NCT00708097|469627623|FG002|Period 1|Protocol Violation|0|||
130268735|NCT03462758|468949694|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
130268736|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
130268737|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
130268738|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268739|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268740|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268741|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268742|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
130268743|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
130268744|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268745|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268746|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268747|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268748|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268749|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
130268750|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268751|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268752|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268753|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268754|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
130366504|NCT00289783|469311889|FG000|Primary Phase|Withdrawal by Subject|93|||
130366505|NCT00289783|469311890|FG001|Primary Phase|Withdrawal by Subject|40|||
130454663|NCT00708097|469627624|FG003|Period 1|Protocol Violation|2|||
130454664|NCT00708097|469627625|FG004|Period 1|Protocol Violation|0|||
130454665|NCT00708097|469627621|FG000|Period 1|Other Reason|0|||
130705316|NCT01011556|470547198|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130705317|NCT01011556|470547199|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
130705318|NCT01011556|470547200|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
130705319|NCT00194792|470547202|FG000|Overall Study|Withdrawal by Subject|1|||
130705320|NCT01714739|470547203|FG000|Overall Study|Disease progression|3|||
130705321|NCT01714739|470547204|FG001|Overall Study|Disease progression|5|||
130705322|NCT01714739|470547205|FG002|Overall Study|Disease progression|5|||
130705323|NCT01714739|470547206|FG003|Overall Study|Disease progression|204|||
130705324|NCT01714739|470547207|FG004|Overall Study|Disease progression|1|||
130705325|NCT01714739|470547208|FG005|Overall Study|Disease progression|3|||
130705326|NCT01714739|470547209|FG006|Overall Study|Disease progression|5|||
130705327|NCT01714739|470547203|FG000|Overall Study|Study drug toxicity|1|||
130705328|NCT01714739|470547204|FG001|Overall Study|Study drug toxicity|1|||
130705329|NCT01714739|470547205|FG002|Overall Study|Study drug toxicity|1|||
130705330|NCT01714739|470547206|FG003|Overall Study|Study drug toxicity|15|||
130705331|NCT01714739|470547207|FG004|Overall Study|Study drug toxicity|0|||
130705332|NCT01714739|470547208|FG005|Overall Study|Study drug toxicity|0|||
130705333|NCT01714739|470547209|FG006|Overall Study|Study drug toxicity|5|||
130705334|NCT01714739|470547203|FG000|Overall Study|Death|0|||
130705335|NCT01714739|470547204|FG001|Overall Study|Death|0|||
130705336|NCT01714739|470547205|FG002|Overall Study|Death|0|||
130705337|NCT01714739|470547206|FG003|Overall Study|Death|1|||
130705338|NCT01714739|470547207|FG004|Overall Study|Death|0|||
130705339|NCT01714739|470547208|FG005|Overall Study|Death|0|||
130705340|NCT01714739|470547209|FG006|Overall Study|Death|0|||
130705341|NCT01714739|470547203|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130705342|NCT01714739|470547204|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130705343|NCT01714739|470547205|FG002|Overall Study|Adverse Event unrelated to drug|3|||
130705344|NCT01714739|470547206|FG003|Overall Study|Adverse Event unrelated to drug|21|||
130705345|NCT01714739|470547207|FG004|Overall Study|Adverse Event unrelated to drug|0|||
130705346|NCT01714739|470547208|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130705347|NCT01714739|470547209|FG006|Overall Study|Adverse Event unrelated to drug|0|||
130705348|NCT01714739|470547203|FG000|Overall Study|Participant request to stop therapy|0|||
130705349|NCT01714739|470547204|FG001|Overall Study|Participant request to stop therapy|1|||
130705350|NCT01714739|470547205|FG002|Overall Study|Participant request to stop therapy|0|||
130705351|NCT01714739|470547206|FG003|Overall Study|Participant request to stop therapy|6|||
130705352|NCT01714739|470547207|FG004|Overall Study|Participant request to stop therapy|0|||
130705353|NCT01714739|470547208|FG005|Overall Study|Participant request to stop therapy|0|||
130705354|NCT01714739|470547209|FG006|Overall Study|Participant request to stop therapy|0|||
130705355|NCT01714739|470547203|FG000|Overall Study|Participant withdrew consent|0|||
130705356|NCT01714739|470547204|FG001|Overall Study|Participant withdrew consent|1|||
130705357|NCT01714739|470547205|FG002|Overall Study|Participant withdrew consent|0|||
130705358|NCT01714739|470547206|FG003|Overall Study|Participant withdrew consent|8|||
130705359|NCT01714739|470547207|FG004|Overall Study|Participant withdrew consent|0|||
130705360|NCT01714739|470547208|FG005|Overall Study|Participant withdrew consent|0|||
130705361|NCT01714739|470547209|FG006|Overall Study|Participant withdrew consent|0|||
130705362|NCT01714739|470547203|FG000|Overall Study|Lost to Follow-up|0|||
130705363|NCT01714739|470547204|FG001|Overall Study|Lost to Follow-up|0|||
130705364|NCT01714739|470547205|FG002|Overall Study|Lost to Follow-up|0|||
130705365|NCT01714739|470547206|FG003|Overall Study|Lost to Follow-up|1|||
130705366|NCT01714739|470547207|FG004|Overall Study|Lost to Follow-up|0|||
130705367|NCT01714739|470547208|FG005|Overall Study|Lost to Follow-up|0|||
130705368|NCT01714739|470547209|FG006|Overall Study|Lost to Follow-up|0|||
130705369|NCT01714739|470547203|FG000|Overall Study|Maximum clinical benefit|0|||
130705370|NCT01714739|470547204|FG001|Overall Study|Maximum clinical benefit|1|||
130705371|NCT01714739|470547205|FG002|Overall Study|Maximum clinical benefit|1|||
130705372|NCT01714739|470547206|FG003|Overall Study|Maximum clinical benefit|3|||
130705373|NCT01714739|470547207|FG004|Overall Study|Maximum clinical benefit|0|||
130705374|NCT01714739|470547208|FG005|Overall Study|Maximum clinical benefit|0|||
130705375|NCT01714739|470547209|FG006|Overall Study|Maximum clinical benefit|0|||
130705376|NCT01714739|470547203|FG000|Overall Study|Poor/non-comliance|0|||
130705377|NCT01714739|470547204|FG001|Overall Study|Poor/non-comliance|1|||
130454666|NCT00708097|469627622|FG001|Period 1|Other Reason|0|||
130454667|NCT00708097|469627623|FG002|Period 1|Other Reason|0|||
130705378|NCT01714739|470547205|FG002|Overall Study|Poor/non-comliance|0|||
130705379|NCT01714739|470547206|FG003|Overall Study|Poor/non-comliance|1|||
130705380|NCT01714739|470547207|FG004|Overall Study|Poor/non-comliance|0|||
130705381|NCT01714739|470547208|FG005|Overall Study|Poor/non-comliance|0|||
130705382|NCT01714739|470547209|FG006|Overall Study|Poor/non-comliance|0|||
130705383|NCT01714739|470547203|FG000|Overall Study|No longer meets study criteria|0|||
130705384|NCT01714739|470547204|FG001|Overall Study|No longer meets study criteria|0|||
130705385|NCT01714739|470547205|FG002|Overall Study|No longer meets study criteria|0|||
130454668|NCT00708097|469627624|FG003|Period 1|Other Reason|0|||
130705386|NCT01714739|470547206|FG003|Overall Study|No longer meets study criteria|1|||
130366506|NCT00289783|469311889|FG000|Primary Phase|Lost to Follow-up|60|||
130366507|NCT00289783|469311890|FG001|Primary Phase|Lost to Follow-up|14|||
130366508|NCT00289783|469311889|FG000|Primary Phase|Migration from the study area|26|||
130366509|NCT00289783|469311890|FG001|Primary Phase|Migration from the study area|10|||
130366510|NCT00289783|469311889|FG000|Primary Phase|Other|32|||
130366511|NCT00289783|469311890|FG001|Primary Phase|Other|12|||
130366512|NCT00289783|469311889|FG000|Fourth Dose Phase|Adverse Event|1|||
130366513|NCT00289783|469311890|FG001|Fourth Dose Phase|Adverse Event|0|||
130366514|NCT00289783|469311889|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
130366515|NCT00289783|469311890|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
130705387|NCT01714739|470547207|FG004|Overall Study|No longer meets study criteria|0|||
130705388|NCT01714739|470547208|FG005|Overall Study|No longer meets study criteria|0|||
130705389|NCT01714739|470547209|FG006|Overall Study|No longer meets study criteria|0|||
130705390|NCT01714739|470547203|FG000|Overall Study|Other reason|0|||
130705391|NCT01714739|470547204|FG001|Overall Study|Other reason|0|||
130705392|NCT01714739|470547205|FG002|Overall Study|Other reason|0|||
130705393|NCT01714739|470547206|FG003|Overall Study|Other reason|3|||
130705394|NCT01714739|470547207|FG004|Overall Study|Other reason|1|||
130705395|NCT01714739|470547208|FG005|Overall Study|Other reason|0|||
130705396|NCT01714739|470547209|FG006|Overall Study|Other reason|0|||
130705397|NCT03585959|470547210|FG000|Overall Study|Physician Decision|1|||
130705398|NCT03585959|470547210|FG000|Overall Study|Unsuccessful Procedure|2|||
130705399|NCT01740791|470547211|FG000|Overall Study|Randomized but never treated|5|||
130705400|NCT01740791|470547212|FG001|Overall Study|Randomized but never treated|3|||
130705401|NCT01740791|470547213|FG002|Overall Study|Randomized but never treated|2|||
130705402|NCT01740791|470547214|FG003|Overall Study|Randomized but never treated|2|||
130705403|NCT01740791|470547215|FG004|Overall Study|Randomized but never treated|1|||
130705404|NCT01740791|470547216|FG005|Overall Study|Randomized but never treated|3|||
130705405|NCT01740791|470547211|FG000|Overall Study|Lost to Follow-up|2|||
130705406|NCT01740791|470547212|FG001|Overall Study|Lost to Follow-up|0|||
130705407|NCT01740791|470547213|FG002|Overall Study|Lost to Follow-up|2|||
130705408|NCT01740791|470547214|FG003|Overall Study|Lost to Follow-up|3|||
130705409|NCT01740791|470547215|FG004|Overall Study|Lost to Follow-up|2|||
130705410|NCT01740791|470547216|FG005|Overall Study|Lost to Follow-up|3|||
130705411|NCT01740791|470547211|FG000|Overall Study|Withdrew Consent|4|||
130705412|NCT01740791|470547212|FG001|Overall Study|Withdrew Consent|0|||
130705413|NCT01740791|470547213|FG002|Overall Study|Withdrew Consent|1|||
130705414|NCT01740791|470547214|FG003|Overall Study|Withdrew Consent|2|||
130705415|NCT01740791|470547215|FG004|Overall Study|Withdrew Consent|0|||
130705416|NCT01740791|470547216|FG005|Overall Study|Withdrew Consent|3|||
130705417|NCT01740791|470547211|FG000|Overall Study|Investigator's discretion|1|||
130705418|NCT01740791|470547212|FG001|Overall Study|Investigator's discretion|0|||
130705419|NCT01740791|470547213|FG002|Overall Study|Investigator's discretion|1|||
130366516|NCT00289783|469311889|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
130366517|NCT00289783|469311890|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
130366518|NCT00289783|469311889|FG000|Fourth Dose Phase|Migration from the study area|1|||
130705420|NCT01740791|470547214|FG003|Overall Study|Investigator's discretion|0|||
130705421|NCT01740791|470547215|FG004|Overall Study|Investigator's discretion|0|||
130705422|NCT01740791|470547216|FG005|Overall Study|Investigator's discretion|1|||
130705423|NCT01740791|470547211|FG000|Overall Study|Adverse Event|0|||
130268755|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
130268756|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268757|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268758|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268759|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268760|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
130268761|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268762|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268763|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268764|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268765|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268766|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268767|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268768|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
130268769|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
130268770|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268771|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268772|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268773|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130454669|NCT00708097|469627625|FG004|Period 1|Other Reason|1|||
130454670|NCT00708097|469627621|FG000|Period 2|Protocol Violation|0|||
130454671|NCT00708097|469627622|FG001|Period 2|Protocol Violation|1|||
130454672|NCT00708097|469627623|FG002|Period 2|Protocol Violation|1|||
130454673|NCT00708097|469627624|FG003|Period 2|Protocol Violation|1|||
130454674|NCT00708097|469627625|FG004|Period 2|Protocol Violation|0|||
130268774|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
130268775|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268776|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268777|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268778|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268779|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268780|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
130268781|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
130268782|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268783|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268784|NCT02820844|468949695|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268785|NCT02820844|468949696|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268786|NCT02820844|468949697|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268787|NCT02820844|468949698|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130705424|NCT01740791|470547212|FG001|Overall Study|Adverse Event|0|||
130705425|NCT01740791|470547213|FG002|Overall Study|Adverse Event|0|||
130705426|NCT01740791|470547214|FG003|Overall Study|Adverse Event|0|||
130705427|NCT01740791|470547215|FG004|Overall Study|Adverse Event|0|||
130705428|NCT01740791|470547216|FG005|Overall Study|Adverse Event|1|||
130705429|NCT01463982|470547217|FG000|Overall Study|Withdrawal by Subject|0|||
130705430|NCT01463982|470547218|FG001|Overall Study|Withdrawal by Subject|1|||
130705431|NCT01463982|470547219|FG002|Overall Study|Withdrawal by Subject|1|||
130705432|NCT01463982|470547220|FG003|Overall Study|Withdrawal by Subject|0|||
130705433|NCT01463982|470547217|FG000|Overall Study|Treatment delay over 5 week|0|||
130705434|NCT01463982|470547218|FG001|Overall Study|Treatment delay over 5 week|0|||
130705435|NCT01463982|470547219|FG002|Overall Study|Treatment delay over 5 week|1|||
130705436|NCT01463982|470547220|FG003|Overall Study|Treatment delay over 5 week|0|||
130705437|NCT04220775|470547223|FG000|Overall Study|Adverse Event|1|||
130705438|NCT04220775|470547224|FG001|Overall Study|Adverse Event|0|||
130705439|NCT04220775|470547223|FG000|Overall Study|Disease Progression|1|||
130705440|NCT04220775|470547224|FG001|Overall Study|Disease Progression|0|||
130705441|NCT00089076|470547225|FG000|Overall Study|Alternate Therapy|1|||
130705442|NCT00089076|470547225|FG000|Overall Study|Withdrawal by Subject|2|||
130705443|NCT00089076|470547225|FG000|Overall Study|Progression|7|||
130705444|NCT00931463|470547226|FG000|Overall Study|Death|8|||
130705445|NCT00931463|470547227|FG001|Overall Study|Death|4|||
130705446|NCT00931463|470547226|FG000|Overall Study|Withdrawal by Subject|5|||
130705447|NCT00931463|470547227|FG001|Overall Study|Withdrawal by Subject|0|||
130705448|NCT00931463|470547226|FG000|Overall Study|Lost to Follow-up|4|||
130705449|NCT00931463|470547227|FG001|Overall Study|Lost to Follow-up|1|||
130705450|NCT03170869|470547228|FG000|Overall Study|Protocol Violation|5|||
130705451|NCT03170869|470547228|FG000|Overall Study|Early study termination|3|||
130705452|NCT01009515|470547229|FG000|Overall Study|Withdrawal by Subject|3|||
130705453|NCT00983476|470547235|FG000|Overall Study|Did not receive intervention|17|||
130705454|NCT00983476|470547236|FG001|Overall Study|Did not receive intervention|22|||
130705455|NCT00983476|470547237|FG002|Overall Study|Did not receive intervention|0|||
130705456|NCT01175473|470547239|FG000|Overall Study|Adverse Event|2|||
130705457|NCT01175473|470547240|FG001|Overall Study|Adverse Event|2|||
130705458|NCT01857206|470547241|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
130705459|NCT01857206|470547242|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
130705460|NCT01857206|470547241|FG000|Overall Study|Lost to Follow-up|9|||
130705461|NCT01857206|470547242|FG001|Overall Study|Lost to Follow-up|6|||
130705462|NCT01857206|470547241|FG000|Overall Study|Unclassified|3|||
130705463|NCT01857206|470547242|FG001|Overall Study|Unclassified|3|||
130705464|NCT01857206|470547241|FG000|Overall Study|Withdrawal by Subject|1|||
130705465|NCT01857206|470547242|FG001|Overall Study|Withdrawal by Subject|0|||
130705466|NCT01857973|470547243|FG000|Overall Study|Subject did not meet required BG range|3|||
130705467|NCT01857973|470547243|FG000|Overall Study|drop out after 3 failed attempts|1|||
130705468|NCT01857973|470547243|FG000|Overall Study|Physician Decision|1|||
130705469|NCT00129116|470547246|FG000|Primary Phase|Lost to Follow-up|1|||
130705470|NCT00129116|470547247|FG001|Primary Phase|Lost to Follow-up|1|||
130705471|NCT00129116|470547248|FG002|Primary Phase|Lost to Follow-up|0|||
130705472|NCT00129116|470547249|FG003|Primary Phase|Lost to Follow-up|1|||
130705473|NCT00129116|470547250|FG004|Primary Phase|Lost to Follow-up|1|||
130705474|NCT00129116|470547246|FG000|Primary Phase|Protocol Violation|0|||
130705475|NCT00129116|470547247|FG001|Primary Phase|Protocol Violation|1|||
130705476|NCT00129116|470547248|FG002|Primary Phase|Protocol Violation|0|||
130705477|NCT00129116|470547249|FG003|Primary Phase|Protocol Violation|0|||
130705478|NCT00129116|470547250|FG004|Primary Phase|Protocol Violation|0|||
130705479|NCT00129116|470547246|FG000|Primary Phase|Adverse Event|1|||
130705480|NCT00129116|470547247|FG001|Primary Phase|Adverse Event|1|||
130705481|NCT00129116|470547248|FG002|Primary Phase|Adverse Event|0|||
130705482|NCT00129116|470547249|FG003|Primary Phase|Adverse Event|0|||
130705483|NCT00129116|470547250|FG004|Primary Phase|Adverse Event|0|||
130268788|NCT02820844|468949699|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
130268789|NCT02820844|468949700|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268790|NCT02820844|468949695|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268791|NCT02820844|468949696|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268792|NCT02820844|468949697|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268793|NCT02820844|468949698|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268794|NCT02820844|468949699|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268795|NCT02820844|468949700|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
130268796|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Physician Decision|0|||
130268797|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Physician Decision|0|||
130366519|NCT00289783|469311890|FG001|Fourth Dose Phase|Migration from the study area|1|||
130366520|NCT00289783|469311889|FG000|Fourth Dose Phase|Other|22|||
130454675|NCT01451814|469629601|FG000|Overall Study|Withdrawal by Subject|1|||
130454676|NCT01451814|469629602|FG001|Overall Study|Withdrawal by Subject|1|||
130454677|NCT01451814|469629601|FG000|Overall Study|Lost to Follow-up|5|||
130454678|NCT01451814|469629602|FG001|Overall Study|Lost to Follow-up|4|||
130454679|NCT02955069|469629604|FG000|Overall Study|Adverse Event|7|||
130454680|NCT02955069|469629605|FG001|Overall Study|Adverse Event|2|||
130454681|NCT02955069|469629604|FG000|Overall Study|Death|7|||
130454682|NCT02955069|469629605|FG001|Overall Study|Death|3|||
130454683|NCT02955069|469629604|FG000|Overall Study|Physician Decision|10|||
130454684|NCT02955069|469629605|FG001|Overall Study|Physician Decision|2|||
130454685|NCT02955069|469629604|FG000|Overall Study|Progressive disease|64|||
130454686|NCT02955069|469629605|FG001|Overall Study|Progressive disease|13|||
130454687|NCT02955069|469629604|FG000|Overall Study|Study terminated by sponsor|4|||
130454688|NCT02955069|469629605|FG001|Overall Study|Study terminated by sponsor|0|||
130454689|NCT02955069|469629604|FG000|Overall Study|Subject/Guardian decision|3|||
130454690|NCT02955069|469629605|FG001|Overall Study|Subject/Guardian decision|1|||
130454691|NCT00943605|469629606|FG000|Overall Study|Study termination|30|||
130454692|NCT00943605|469629607|FG001|Overall Study|Study termination|30|||
130454693|NCT04148937|469629609|FG000|Overall Study|Withdrawal by Subject|0|||
130454694|NCT04148937|469629610|FG001|Overall Study|Withdrawal by Subject|0|||
130454695|NCT04148937|469629611|FG002|Overall Study|Withdrawal by Subject|0|||
130454696|NCT04148937|469629612|FG003|Overall Study|Withdrawal by Subject|1|||
130454697|NCT04148937|469629613|FG004|Overall Study|Withdrawal by Subject|0|||
130454698|NCT04148937|469629614|FG005|Overall Study|Withdrawal by Subject|1|||
130454699|NCT04148937|469629615|FG006|Overall Study|Withdrawal by Subject|1|||
130454700|NCT04148937|469629616|FG007|Overall Study|Withdrawal by Subject|0|||
130454701|NCT04148937|469629609|FG000|Overall Study|Lost to Follow-up|0|||
130454702|NCT04148937|469629610|FG001|Overall Study|Lost to Follow-up|0|||
130454703|NCT04148937|469629611|FG002|Overall Study|Lost to Follow-up|1|||
130454704|NCT04148937|469629612|FG003|Overall Study|Lost to Follow-up|0|||
130454705|NCT04148937|469629613|FG004|Overall Study|Lost to Follow-up|0|||
130454706|NCT04148937|469629614|FG005|Overall Study|Lost to Follow-up|2|||
130454707|NCT04148937|469629615|FG006|Overall Study|Lost to Follow-up|0|||
130454708|NCT04148937|469629616|FG007|Overall Study|Lost to Follow-up|0|||
130454709|NCT03107611|469629618|FG000|Overall Study|Adverse Event|1|||
130454710|NCT03107611|469629619|FG001|Overall Study|Adverse Event|0|||
130454711|NCT03107611|469629620|FG002|Overall Study|Adverse Event|2|||
130454712|NCT03107611|469629618|FG000|Overall Study|Lost to Follow-up|3|||
130454713|NCT03107611|469629619|FG001|Overall Study|Lost to Follow-up|3|||
130454714|NCT03107611|469629620|FG002|Overall Study|Lost to Follow-up|3|||
130454715|NCT03107611|469629618|FG000|Overall Study|Protocol Violation|0|||
130454716|NCT03107611|469629619|FG001|Overall Study|Protocol Violation|0|||
130454717|NCT03107611|469629620|FG002|Overall Study|Protocol Violation|1|||
130454718|NCT03107611|469629618|FG000|Overall Study|Withdrawal by Subject|1|||
130454719|NCT03107611|469629619|FG001|Overall Study|Withdrawal by Subject|0|||
130454720|NCT03107611|469629620|FG002|Overall Study|Withdrawal by Subject|1|||
130454721|NCT03107611|469629618|FG000|Overall Study|Worsening signs/symptoms|2|||
130454722|NCT03107611|469629619|FG001|Overall Study|Worsening signs/symptoms|1|||
130454723|NCT03107611|469629620|FG002|Overall Study|Worsening signs/symptoms|2|||
130454724|NCT01720446|469629621|FG000|Overall Study|Lost to Follow-up|12|||
130454725|NCT01720446|469629622|FG001|Overall Study|Lost to Follow-up|6|||
130454726|NCT01720446|469629623|FG002|Overall Study|Lost to Follow-up|16|||
130454727|NCT01720446|469629624|FG003|Overall Study|Lost to Follow-up|16|||
130454728|NCT01720446|469629621|FG000|Overall Study|Withdrawal by Subject|2|||
130454729|NCT01720446|469629622|FG001|Overall Study|Withdrawal by Subject|5|||
130454730|NCT01720446|469629623|FG002|Overall Study|Withdrawal by Subject|4|||
130454731|NCT01720446|469629624|FG003|Overall Study|Withdrawal by Subject|4|||
130454732|NCT04464421|469629625|FG000|Overall Study|Lost to Follow-up|2|||
130454733|NCT04464421|469629626|FG001|Overall Study|Lost to Follow-up|2|||
130454734|NCT01956669|469629627|FG000|Overall Study|Disease Progression|12|||
130454735|NCT01956669|469629628|FG001|Overall Study|Disease Progression|7|||
130454736|NCT01956669|469629629|FG002|Overall Study|Disease Progression|7|||
130454737|NCT01956669|469629630|FG003|Overall Study|Disease Progression|8|||
130454738|NCT01956669|469629631|FG004|Overall Study|Disease Progression|4|||
130454739|NCT01956669|469629632|FG005|Overall Study|Disease Progression|3|||
130454740|NCT01956669|469629633|FG006|Overall Study|Disease Progression|5|||
130454741|NCT01956669|469629627|FG000|Overall Study|Adverse Event|0|||
130454742|NCT01956669|469629628|FG001|Overall Study|Adverse Event|2|||
130454743|NCT01956669|469629629|FG002|Overall Study|Adverse Event|2|||
130454744|NCT01956669|469629630|FG003|Overall Study|Adverse Event|1|||
130705484|NCT00129116|470547246|FG000|Primary Phase|Withdrawal by Subject|0|||
130705485|NCT00129116|470547247|FG001|Primary Phase|Withdrawal by Subject|1|||
130705486|NCT00129116|470547248|FG002|Primary Phase|Withdrawal by Subject|0|||
130705487|NCT00129116|470547249|FG003|Primary Phase|Withdrawal by Subject|0|||
130705488|NCT00129116|470547250|FG004|Primary Phase|Withdrawal by Subject|0|||
130705489|NCT00129116|470547246|FG000|Primary Phase|Other|0|||
130705490|NCT00129116|470547247|FG001|Primary Phase|Other|0|||
130705491|NCT00129116|470547248|FG002|Primary Phase|Other|1|||
130705492|NCT00129116|470547249|FG003|Primary Phase|Other|0|||
130705493|NCT00129116|470547250|FG004|Primary Phase|Other|0|||
130705494|NCT00129116|470547246|FG000|Booster Phase|Lost to Follow-up|2|||
130705495|NCT00129116|470547247|FG001|Booster Phase|Lost to Follow-up|0|||
130705496|NCT00129116|470547248|FG002|Booster Phase|Lost to Follow-up|0|||
130705497|NCT00129116|470547249|FG003|Booster Phase|Lost to Follow-up|0|||
130705498|NCT00129116|470547250|FG004|Booster Phase|Lost to Follow-up|1|||
130705499|NCT00869440|470547251|FG000|Overall Study|Withdrawal by Subject|1|||
130705500|NCT00869440|470547252|FG001|Overall Study|Withdrawal by Subject|0|||
130705501|NCT00869440|470547253|FG002|Overall Study|Withdrawal by Subject|0|||
130705502|NCT00869440|470547254|FG003|Overall Study|Withdrawal by Subject|0|||
130705503|NCT00869440|470547251|FG000|Overall Study|Physician Decision|1|||
130705504|NCT00869440|470547252|FG001|Overall Study|Physician Decision|1|||
130705505|NCT00869440|470547253|FG002|Overall Study|Physician Decision|0|||
130705506|NCT00869440|470547254|FG003|Overall Study|Physician Decision|0|||
130705507|NCT03558139|470547255|FG000|Overall Study|Consent Withdrawn|1|||
130705508|NCT03558139|470547256|FG001|Overall Study|Consent Withdrawn|1|||
130705509|NCT03558139|470547257|FG002|Overall Study|Consent Withdrawn|4|||
130705510|NCT03558139|470547255|FG000|Overall Study|Death|5|||
130705511|NCT03558139|470547256|FG001|Overall Study|Death|3|||
130705512|NCT03558139|470547257|FG002|Overall Study|Death|8|||
130705513|NCT03558139|470547255|FG000|Overall Study|Lost to Follow-up|0|||
130705514|NCT03558139|470547256|FG001|Overall Study|Lost to Follow-up|0|||
130705515|NCT03558139|470547257|FG002|Overall Study|Lost to Follow-up|3|||
130705516|NCT03558139|470547255|FG000|Overall Study|Study Ended Per Protocol|0|||
130705517|NCT03558139|470547256|FG001|Overall Study|Study Ended Per Protocol|3|||
130705518|NCT03558139|470547257|FG002|Overall Study|Study Ended Per Protocol|6|||
130705519|NCT02752802|470547258|FG000|Overall Study|Contrast Volume Not Collected|1|||
130705520|NCT02752802|470547259|FG001|Overall Study|Contrast Volume Not Collected|0|||
130705521|NCT02808819|470547260|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
130705522|NCT02808819|470547261|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
130705523|NCT02808819|470547260|FG000|Overall Study|Withdrawal by Subject|10|||
130705524|NCT02808819|470547261|FG001|Overall Study|Withdrawal by Subject|13|||
130705525|NCT02808819|470547260|FG000|Overall Study|Site terminated by sponsor|2|||
130705526|NCT02808819|470547261|FG001|Overall Study|Site terminated by sponsor|0|||
130705527|NCT02808819|470547260|FG000|Overall Study|Pregnancy|1|||
130705528|NCT02808819|470547261|FG001|Overall Study|Pregnancy|0|||
130705529|NCT02808819|470547260|FG000|Overall Study|Lost to Follow-up|1|||
130705530|NCT02808819|470547261|FG001|Overall Study|Lost to Follow-up|6|||
130705531|NCT02808819|470547260|FG000|Overall Study|Protocol Violation|0|||
130705532|NCT02808819|470547261|FG001|Overall Study|Protocol Violation|1|||
130705533|NCT02808819|470547260|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
130705534|NCT02808819|470547261|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
130705535|NCT02808819|470547260|FG000|Overall Study|Death|1|||
130705536|NCT02808819|470547261|FG001|Overall Study|Death|0|||
130705537|NCT02808819|470547260|FG000|Overall Study|Adverse Event|3|||
130705538|NCT02808819|470547261|FG001|Overall Study|Adverse Event|4|||
130705539|NCT02013531|470547262|FG000|Overall Study|Lost to Follow-up|3|||
130705540|NCT02013531|470547262|FG000|Overall Study|Met Withdrawal Criteria|1|||
130705541|NCT02013531|470547262|FG000|Overall Study|Withdrawal by Subject|1|||
130705542|NCT03546647|470547263|FG000|Overall Study|Adverse Event|1|||
130705543|NCT03546647|470547264|FG001|Overall Study|Adverse Event|0|||
130705544|NCT02400476|470547265|FG000|Overall Study|Adverse Event|57|||
130705545|NCT02400476|470547266|FG001|Overall Study|Adverse Event|10|||
130705546|NCT02400476|470547267|FG002|Overall Study|Adverse Event|22|||
130705547|NCT02400476|470547268|FG003|Overall Study|Adverse Event|19|||
130366521|NCT00289783|469311890|FG001|Fourth Dose Phase|Other|10|||
130705548|NCT02400476|470547269|FG004|Overall Study|Adverse Event|5|||
130705549|NCT02400476|470547270|FG005|Overall Study|Adverse Event|8|||
130705550|NCT02400476|470547265|FG000|Overall Study|Withdrawal by Subject|4|||
130705551|NCT02400476|470547266|FG001|Overall Study|Withdrawal by Subject|1|||
130705552|NCT02400476|470547267|FG002|Overall Study|Withdrawal by Subject|12|||
130705553|NCT02400476|470547268|FG003|Overall Study|Withdrawal by Subject|7|||
130705554|NCT02400476|470547269|FG004|Overall Study|Withdrawal by Subject|5|||
130705555|NCT02400476|470547270|FG005|Overall Study|Withdrawal by Subject|5|||
130705556|NCT02400476|470547265|FG000|Overall Study|Lost to Follow-up|0|||
130705557|NCT02400476|470547266|FG001|Overall Study|Lost to Follow-up|0|||
130268798|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Physician Decision|1|||
130554222|NCT01372410|469996537|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
130554223|NCT01372410|469996530|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
130554224|NCT01372410|469996531|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554225|NCT01372410|469996532|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554226|NCT01372410|469996533|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554227|NCT01372410|469996534|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554228|NCT01372410|469996535|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554229|NCT01372410|469996536|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130554230|NCT01372410|469996537|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
130554231|NCT01372410|469996530|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554232|NCT01372410|469996531|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554233|NCT01372410|469996532|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554234|NCT01372410|469996533|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554235|NCT01372410|469996534|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
130554236|NCT01372410|469996535|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554237|NCT01372410|469996536|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554238|NCT01372410|469996537|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
130554239|NCT01372410|469996530|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
130554240|NCT01372410|469996531|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
130554241|NCT01372410|469996532|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
130554242|NCT01372410|469996533|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
130554243|NCT01372410|469996534|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
130554244|NCT01372410|469996535|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
130554245|NCT01372410|469996536|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
130554246|NCT01372410|469996537|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
130554247|NCT01372410|469996530|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554248|NCT01372410|469996531|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130705558|NCT02400476|470547267|FG002|Overall Study|Lost to Follow-up|0|||
130705559|NCT02400476|470547268|FG003|Overall Study|Lost to Follow-up|1|||
130705560|NCT02400476|470547269|FG004|Overall Study|Lost to Follow-up|3|||
130705561|NCT02400476|470547270|FG005|Overall Study|Lost to Follow-up|1|||
130705562|NCT02400476|470547265|FG000|Overall Study|Physician Decision|0|||
130705563|NCT02400476|470547266|FG001|Overall Study|Physician Decision|0|||
130705564|NCT02400476|470547267|FG002|Overall Study|Physician Decision|1|||
130705565|NCT02400476|470547268|FG003|Overall Study|Physician Decision|1|||
130705566|NCT02400476|470547269|FG004|Overall Study|Physician Decision|0|||
130705567|NCT02400476|470547270|FG005|Overall Study|Physician Decision|1|||
130705568|NCT02400476|470547265|FG000|Overall Study|Other, Disease Progression|0|||
130705569|NCT02400476|470547266|FG001|Overall Study|Other, Disease Progression|1|||
130705570|NCT02400476|470547267|FG002|Overall Study|Other, Disease Progression|2|||
130705571|NCT02400476|470547268|FG003|Overall Study|Other, Disease Progression|1|||
130705572|NCT02400476|470547269|FG004|Overall Study|Other, Disease Progression|2|||
130705573|NCT02400476|470547270|FG005|Overall Study|Other, Disease Progression|1|||
130705574|NCT02400476|470547265|FG000|Overall Study|Other, Decreased Quality of Life|0|||
130705575|NCT02400476|470547266|FG001|Overall Study|Other, Decreased Quality of Life|0|||
130705576|NCT02400476|470547267|FG002|Overall Study|Other, Decreased Quality of Life|2|||
130705577|NCT02400476|470547268|FG003|Overall Study|Other, Decreased Quality of Life|0|||
130705578|NCT02400476|470547269|FG004|Overall Study|Other, Decreased Quality of Life|0|||
130705579|NCT02400476|470547270|FG005|Overall Study|Other, Decreased Quality of Life|0|||
130705580|NCT02400476|470547265|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705581|NCT02400476|470547266|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705582|NCT02400476|470547267|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
130705583|NCT02400476|470547268|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
130705584|NCT02400476|470547269|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705585|NCT02400476|470547270|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705586|NCT00003531|470547273|FG000|Overall Study|Not evaluable|10|||
130705587|NCT00588731|470547274|FG000|Overall Study|Withdrawal by Subject|3|||
130705588|NCT00588731|470547275|FG001|Overall Study|Withdrawal by Subject|2|||
130705589|NCT00251316|470547276|FG000|Overall Study|Physician Decision|2|||
130705590|NCT00251316|470547277|FG001|Overall Study|Physician Decision|3|||
130705591|NCT00346164|470547278|FG000|Overall Study|Adverse Event|0|||
130705592|NCT00346164|470547279|FG001|Overall Study|Adverse Event|0|||
130705593|NCT00346164|470547280|FG002|Overall Study|Adverse Event|0|||
130705594|NCT00346164|470547281|FG003|Overall Study|Adverse Event|1|||
130705595|NCT00346164|470547278|FG000|Overall Study|Lack of Efficacy|0|||
130705596|NCT00346164|470547279|FG001|Overall Study|Lack of Efficacy|1|||
130705597|NCT00346164|470547280|FG002|Overall Study|Lack of Efficacy|7|||
130705598|NCT00346164|470547281|FG003|Overall Study|Lack of Efficacy|25|||
130705599|NCT00346164|470547278|FG000|Overall Study|Physician Decision|0|||
130705600|NCT00346164|470547279|FG001|Overall Study|Physician Decision|1|||
130705601|NCT00346164|470547280|FG002|Overall Study|Physician Decision|2|||
130705602|NCT00346164|470547281|FG003|Overall Study|Physician Decision|27|||
130705603|NCT00346164|470547278|FG000|Overall Study|Protocol Violation|6|||
130705604|NCT00346164|470547279|FG001|Overall Study|Protocol Violation|2|||
130705605|NCT00346164|470547280|FG002|Overall Study|Protocol Violation|10|||
130705606|NCT00346164|470547281|FG003|Overall Study|Protocol Violation|4|||
130268799|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Physician Decision|0|||
130268800|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
130268801|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
130268802|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
130268803|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
130268804|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130366522|NCT00566995|469311893|FG000|Overall Study|Toxicity|4|||
130366523|NCT00566995|469311893|FG000|Overall Study|Withdrew consent|3|||
130454745|NCT01956669|469629631|FG004|Overall Study|Adverse Event|0|||
130705607|NCT00346164|470547278|FG000|Overall Study|Withdrawal by Subject|0|||
130705608|NCT00346164|470547279|FG001|Overall Study|Withdrawal by Subject|0|||
130705609|NCT00346164|470547280|FG002|Overall Study|Withdrawal by Subject|2|||
130705610|NCT00346164|470547281|FG003|Overall Study|Withdrawal by Subject|0|||
130705611|NCT00346164|470547278|FG000|Overall Study|Ineligible|11|||
130268805|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130268806|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
130268807|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
130268808|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Other|1|||
130268809|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Other|1|||
130705612|NCT00346164|470547279|FG001|Overall Study|Ineligible|2|||
130705613|NCT00346164|470547280|FG002|Overall Study|Ineligible|2|||
130705614|NCT00346164|470547281|FG003|Overall Study|Ineligible|23|||
130705615|NCT00346164|470547278|FG000|Overall Study|Refusal of further protocol therapy|0|||
130705616|NCT00346164|470547279|FG001|Overall Study|Refusal of further protocol therapy|1|||
130705617|NCT00346164|470547280|FG002|Overall Study|Refusal of further protocol therapy|3|||
130705618|NCT00346164|470547281|FG003|Overall Study|Refusal of further protocol therapy|15|||
130705619|NCT00346164|470547278|FG000|Overall Study|Inability to start week 16 tx on time|0|||
130705620|NCT00346164|470547279|FG001|Overall Study|Inability to start week 16 tx on time|0|||
130705621|NCT00346164|470547280|FG002|Overall Study|Inability to start week 16 tx on time|0|||
130705622|NCT00346164|470547281|FG003|Overall Study|Inability to start week 16 tx on time|11|||
130705623|NCT00612677|470547284|FG000|Overall Study|study closed before treatment started|1|||
130705624|NCT03417830|470547285|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
130705625|NCT03417830|470547286|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
130705626|NCT00823199|470547287|FG000|Overall Study|Withdrawal by Subject|2|||
130705627|NCT01998243|470547288|FG000|Overall Study|Pregnancy|0|||
130705628|NCT01998243|470547289|FG001|Overall Study|Pregnancy|1|||
130705629|NCT01998243|470547288|FG000|Overall Study|Protocol Violation|5|||
130705630|NCT01998243|470547289|FG001|Overall Study|Protocol Violation|2|||
130705631|NCT01998243|470547288|FG000|Overall Study|Withdrawal by Subject|3|||
130705632|NCT01998243|470547289|FG001|Overall Study|Withdrawal by Subject|4|||
130705633|NCT04569786|470547292|FG000|Overall Study|Lost to Follow-up|1|||
130705634|NCT04569786|470547293|FG001|Overall Study|Lost to Follow-up|0|||
130705635|NCT04569786|470547294|FG002|Overall Study|Lost to Follow-up|4|||
130705636|NCT04569786|470547295|FG003|Overall Study|Lost to Follow-up|1|||
130705637|NCT04569786|470547296|FG004|Overall Study|Lost to Follow-up|0|||
130705638|NCT04569786|470547292|FG000|Overall Study|Withdrawal by Subject|0|||
130705639|NCT04569786|470547293|FG001|Overall Study|Withdrawal by Subject|0|||
130705640|NCT04569786|470547294|FG002|Overall Study|Withdrawal by Subject|0|||
130705641|NCT04569786|470547295|FG003|Overall Study|Withdrawal by Subject|5|||
130705642|NCT04569786|470547296|FG004|Overall Study|Withdrawal by Subject|1|||
130268810|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Other|0|||
130268811|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Other|0|||
130268812|NCT02266147|468949702|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
130268813|NCT02266147|468949703|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
130268814|NCT02266147|468949704|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
130268815|NCT02266147|468949705|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
130705643|NCT04569786|470547292|FG000|Overall Study|Physician Decision|0|||
130705644|NCT04569786|470547293|FG001|Overall Study|Physician Decision|0|||
130705645|NCT04569786|470547294|FG002|Overall Study|Physician Decision|0|||
130705646|NCT04569786|470547295|FG003|Overall Study|Physician Decision|1|||
130705647|NCT04569786|470547296|FG004|Overall Study|Physician Decision|0|||
130705648|NCT01640184|470547297|FG000|Overall Study|Death|1|||
130705649|NCT01640184|470547298|FG001|Overall Study|Death|0|||
130705650|NCT01640184|470547299|FG002|Overall Study|Death|0|||
130705651|NCT01640184|470547297|FG000|Overall Study|Lost to Follow-up|4|||
130705652|NCT01640184|470547298|FG001|Overall Study|Lost to Follow-up|1|||
130705653|NCT01640184|470547299|FG002|Overall Study|Lost to Follow-up|0|||
130705654|NCT01640184|470547297|FG000|Overall Study|Physician Decision|3|||
130705655|NCT01640184|470547298|FG001|Overall Study|Physician Decision|0|||
130705656|NCT01640184|470547299|FG002|Overall Study|Physician Decision|0|||
130705657|NCT01640184|470547297|FG000|Overall Study|Withdrawal by Subject|0|||
130705658|NCT01640184|470547298|FG001|Overall Study|Withdrawal by Subject|1|||
130268816|NCT02266147|468949702|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
130705659|NCT01640184|470547299|FG002|Overall Study|Withdrawal by Subject|1|||
130705660|NCT01640184|470547297|FG000|Overall Study|Protocol Violation|0|||
130705661|NCT01640184|470547298|FG001|Overall Study|Protocol Violation|0|||
130705662|NCT01640184|470547299|FG002|Overall Study|Protocol Violation|1|||
130705663|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130268817|NCT02266147|468949703|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130454746|NCT01956669|469629632|FG005|Overall Study|Adverse Event|0|||
130454747|NCT01956669|469629633|FG006|Overall Study|Adverse Event|0|||
130454748|NCT01956669|469629627|FG000|Overall Study|Physician Decision|0|||
130454749|NCT01956669|469629628|FG001|Overall Study|Physician Decision|2|||
130705664|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130705665|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130705666|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130705667|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Death|15|||
130705668|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Death|20|||
130268818|NCT02266147|468949704|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130705669|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Death|0|||
130705670|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Death|0|||
130268819|NCT02266147|468949705|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
130268820|NCT01456130|468949706|FG000|Overall Study|Adverse Event|4|||
130454750|NCT01956669|469629629|FG002|Overall Study|Physician Decision|0|||
130705671|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705672|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
130454751|NCT01956669|469629630|FG003|Overall Study|Physician Decision|0|||
130454752|NCT01956669|469629631|FG004|Overall Study|Physician Decision|0|||
130454753|NCT01956669|469629632|FG005|Overall Study|Physician Decision|1|||
130454754|NCT01956669|469629633|FG006|Overall Study|Physician Decision|0|||
130454755|NCT01956669|469629627|FG000|Overall Study|Withdrawal by Subject|0|||
130454756|NCT01956669|469629628|FG001|Overall Study|Withdrawal by Subject|0|||
130454757|NCT01956669|469629629|FG002|Overall Study|Withdrawal by Subject|1|||
130454758|NCT01956669|469629630|FG003|Overall Study|Withdrawal by Subject|1|||
130454759|NCT01956669|469629631|FG004|Overall Study|Withdrawal by Subject|0|||
130454760|NCT01956669|469629632|FG005|Overall Study|Withdrawal by Subject|0|||
130454761|NCT01956669|469629633|FG006|Overall Study|Withdrawal by Subject|1|||
130454762|NCT01072357|469629636|FG000|Overall Study|Lost to Follow-up|0|||
130454763|NCT01072357|469629637|FG001|Overall Study|Lost to Follow-up|1|||
130454764|NCT02131324|469629642|FG000|Overall Study|Withdrawal by Subject|1|||
130454765|NCT02131324|469629643|FG001|Overall Study|Withdrawal by Subject|2|||
130454766|NCT02131324|469629642|FG000|Overall Study|Lost to Follow-up|1|||
130454767|NCT02131324|469629643|FG001|Overall Study|Lost to Follow-up|1|||
130454768|NCT00891618|469629644|FG000|Overall Study|Withdrawal by Subject|1|||
130454769|NCT01693614|469629645|FG000|Overall Study|Adverse Event|7|||
130454770|NCT01693614|469629646|FG001|Overall Study|Adverse Event|11|||
130454771|NCT01693614|469629647|FG002|Overall Study|Adverse Event|5|||
130454772|NCT01693614|469629645|FG000|Overall Study|Disease progression|11|||
130454773|NCT01693614|469629646|FG001|Overall Study|Disease progression|8|||
130454774|NCT01693614|469629647|FG002|Overall Study|Disease progression|7|||
130454775|NCT01693614|469629645|FG000|Overall Study|Protocol Violation|5|||
130454776|NCT01693614|469629646|FG001|Overall Study|Protocol Violation|2|||
130454777|NCT01693614|469629647|FG002|Overall Study|Protocol Violation|1|||
130454778|NCT01693614|469629645|FG000|Overall Study|Death|1|||
130454779|NCT01693614|469629646|FG001|Overall Study|Death|0|||
130454780|NCT01693614|469629647|FG002|Overall Study|Death|0|||
130454781|NCT01693614|469629645|FG000|Overall Study|Physician Decision|1|||
130454782|NCT01693614|469629646|FG001|Overall Study|Physician Decision|1|||
130454783|NCT01693614|469629647|FG002|Overall Study|Physician Decision|4|||
130454784|NCT01693614|469629645|FG000|Overall Study|Withdrawal by subject/guardian|0|||
130454785|NCT01693614|469629646|FG001|Overall Study|Withdrawal by subject/guardian|0|||
130454786|NCT01693614|469629647|FG002|Overall Study|Withdrawal by subject/guardian|2|||
130454787|NCT01693614|469629645|FG000|Overall Study|Withdrawal by Subject|1|||
130454788|NCT01693614|469629646|FG001|Overall Study|Withdrawal by Subject|0|||
130454789|NCT01693614|469629647|FG002|Overall Study|Withdrawal by Subject|5|||
130454790|NCT05790408|469629648|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
130454791|NCT00420316|469629649|FG000|Overall Study|Withdrawal by Subject|0|||
130454792|NCT00420316|469629650|FG001|Overall Study|Withdrawal by Subject|1|||
130454793|NCT00420316|469629649|FG000|Overall Study|Lost to Follow-up|12|||
130454794|NCT00420316|469629650|FG001|Overall Study|Lost to Follow-up|8|||
130454795|NCT02145182|469629651|FG000|Overall Study|Adverse Event|4|||
130454796|NCT02145182|469629652|FG001|Overall Study|Adverse Event|1|||
130454797|NCT02145182|469629651|FG000|Overall Study|Death|7|||
130454798|NCT02145182|469629652|FG001|Overall Study|Death|7|||
130454799|NCT02145182|469629651|FG000|Overall Study|Lost to Follow-up|2|||
130454800|NCT02145182|469629652|FG001|Overall Study|Lost to Follow-up|2|||
130454801|NCT02145182|469629651|FG000|Overall Study|Pre-transplant Withdrawal|0|||
130454802|NCT02145182|469629652|FG001|Overall Study|Pre-transplant Withdrawal|2|||
130454803|NCT02145182|469629651|FG000|Overall Study|Withdrawal by Subject|5|||
130454804|NCT02145182|469629652|FG001|Overall Study|Withdrawal by Subject|4|||
130454805|NCT05419557|469629653|FG000|Overall Study|Lost to Follow-up|11|||
130454806|NCT05419557|469629654|FG001|Overall Study|Lost to Follow-up|4|||
130454807|NCT01196988|469629655|FG000|Overall Study|Adverse Event|1|||
130454808|NCT01196988|469629656|FG001|Overall Study|Adverse Event|2|||
130454809|NCT01196988|469629657|FG002|Overall Study|Adverse Event|0|||
130454810|NCT01196988|469629658|FG003|Overall Study|Adverse Event|0|||
130454811|NCT01196988|469629655|FG000|Overall Study|Withdrawal by Subject|5|||
130454812|NCT01196988|469629656|FG001|Overall Study|Withdrawal by Subject|1|||
130454813|NCT01196988|469629657|FG002|Overall Study|Withdrawal by Subject|4|||
130454814|NCT01196988|469629658|FG003|Overall Study|Withdrawal by Subject|0|||
130454815|NCT01196988|469629655|FG000|Overall Study|Lost to Follow-up|16|||
130454816|NCT01196988|469629656|FG001|Overall Study|Lost to Follow-up|29|||
130454817|NCT01196988|469629657|FG002|Overall Study|Lost to Follow-up|21|||
130454818|NCT01196988|469629658|FG003|Overall Study|Lost to Follow-up|1|||
130454819|NCT01196988|469629655|FG000|Overall Study|Other|2|||
130454820|NCT01196988|469629656|FG001|Overall Study|Other|0|||
130454821|NCT01196988|469629657|FG002|Overall Study|Other|0|||
130454822|NCT01196988|469629658|FG003|Overall Study|Other|0|||
130454823|NCT02274493|469629660|FG000|Overall Study|Withdrawal by Subject|1|||
130454824|NCT00558363|469629661|FG000|Overall Study|Physician Decision|18|||
130454825|NCT00558363|469629662|FG001|Overall Study|Physician Decision|4|||
130454826|NCT00558363|469629661|FG000|Overall Study|Withdrawal by Subject|11|||
130454827|NCT00558363|469629662|FG001|Overall Study|Withdrawal by Subject|4|||
130454828|NCT00558363|469629661|FG000|Overall Study|Adverse Event|5|||
130454829|NCT00558363|469629662|FG001|Overall Study|Adverse Event|5|||
130268821|NCT01456130|468949706|FG000|Overall Study|Voluntary Withdrawal|1|||
130268822|NCT01456130|468949706|FG000|Overall Study|Lack of Efficacy|4|||
130268823|NCT01456130|468949706|FG000|Overall Study|Other|1|||
130268824|NCT00413660|468949711|FG000|Up To Week 12|Adverse Event|1|||
130268825|NCT00413660|468949712|FG001|Up To Week 12|Adverse Event|3|||
130268826|NCT00413660|468949713|FG002|Up To Week 12|Adverse Event|1|||
130454830|NCT00558363|469629661|FG000|Overall Study|Lack of Efficacy|2|||
130454831|NCT00558363|469629662|FG001|Overall Study|Lack of Efficacy|2|||
130454832|NCT00558363|469629661|FG000|Overall Study|Protocol Violation|2|||
130454833|NCT00558363|469629662|FG001|Overall Study|Protocol Violation|1|||
130454834|NCT00558363|469629661|FG000|Overall Study|Lost to Follow-up|0|||
130454835|NCT00558363|469629662|FG001|Overall Study|Lost to Follow-up|1|||
130454836|NCT00558363|469629661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
130454837|NCT00558363|469629662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
130454838|NCT00558363|469629661|FG000|Overall Study|Randomized in Error|1|||
130454839|NCT00558363|469629662|FG001|Overall Study|Randomized in Error|2|||
130454840|NCT00558363|469629661|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
130454841|NCT00558363|469629662|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
130454842|NCT01313182|469629663|FG000|Overall Study|Protocol Violation|66|||
130454843|NCT01313182|469629664|FG001|Overall Study|Protocol Violation|92|||
130454844|NCT01695317|469629665|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
130454845|NCT01695317|469629666|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
130454846|NCT01695317|469629665|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
130454847|NCT01695317|469629666|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
130454848|NCT00606580|469629667|FG000|Overall Study|Lost to Follow-up|1|||
130454849|NCT00606580|469629668|FG001|Overall Study|Lost to Follow-up|1|||
130454850|NCT00606580|469629669|FG002|Overall Study|Lost to Follow-up|4|||
130454851|NCT00606580|469629667|FG000|Overall Study|Clinical failures|1|||
130454852|NCT00606580|469629668|FG001|Overall Study|Clinical failures|0|||
130454853|NCT00606580|469629669|FG002|Overall Study|Clinical failures|12|||
130454854|NCT00606580|469629667|FG000|Overall Study|Withdrawal by investigator|0|||
130454855|NCT00606580|469629668|FG001|Overall Study|Withdrawal by investigator|1|||
130454856|NCT00606580|469629669|FG002|Overall Study|Withdrawal by investigator|6|||
130454857|NCT00606580|469629667|FG000|Overall Study|Withdrawal by Subject|0|||
130454858|NCT00606580|469629668|FG001|Overall Study|Withdrawal by Subject|1|||
130454859|NCT00606580|469629669|FG002|Overall Study|Withdrawal by Subject|0|||
130454860|NCT00927823|469629672|FG000|Continuous Dosing Period|Death|0|||
130454861|NCT00927823|469629673|FG001|Continuous Dosing Period|Death|0|||
130454862|NCT00927823|469629674|FG002|Continuous Dosing Period|Death|6|||
130454863|NCT00927823|469629675|FG003|Continuous Dosing Period|Death|0|||
130454864|NCT00927823|469629672|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
130454865|NCT00927823|469629673|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
130454866|NCT00927823|469629674|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
130454867|NCT00927823|469629675|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
130454868|NCT00927823|469629672|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
130268827|NCT00413660|468949714|FG003|Up To Week 12|Adverse Event|4|||
130454869|NCT00927823|469629673|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
130366524|NCT03298867|469311903|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
130366525|NCT03298867|469311904|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
130554249|NCT01372410|469996532|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554250|NCT01372410|469996533|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554251|NCT01372410|469996534|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554252|NCT01372410|469996535|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554253|NCT01372410|469996536|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
130554254|NCT01372410|469996537|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
130554255|NCT01372410|469996530|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
130554256|NCT01372410|469996531|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
130554257|NCT01372410|469996532|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
130554258|NCT01372410|469996533|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
130366526|NCT03298867|469311903|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
130366527|NCT03298867|469311904|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
130366528|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
130366529|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
130366530|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
130366531|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
130366532|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
130366533|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
130366534|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
130366535|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
130366536|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
130554259|NCT01372410|469996534|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
130554260|NCT01372410|469996535|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
130705673|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705674|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705675|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
130268828|NCT00413660|468949715|FG004|Up To Week 12|Adverse Event|6|||
130268829|NCT00413660|468949716|FG005|Up To Week 12|Adverse Event|4|||
130268830|NCT00413660|468949717|FG006|Up To Week 12|Adverse Event|1|||
130268831|NCT00413660|468949718|FG007|Up To Week 12|Adverse Event|0|||
130268832|NCT00413660|468949719|FG008|Up To Week 12|Adverse Event|0|||
130268833|NCT00413660|468949720|FG009|Up To Week 12|Adverse Event|0|||
130268834|NCT00413660|468949721|FG010|Up To Week 12|Adverse Event|0|||
130268835|NCT00413660|468949711|FG000|Up To Week 12|Lack of Efficacy|2|||
130268836|NCT00413660|468949712|FG001|Up To Week 12|Lack of Efficacy|0|||
130268837|NCT00413660|468949713|FG002|Up To Week 12|Lack of Efficacy|0|||
130268838|NCT00413660|468949714|FG003|Up To Week 12|Lack of Efficacy|0|||
130268839|NCT00413660|468949715|FG004|Up To Week 12|Lack of Efficacy|0|||
130268840|NCT00413660|468949716|FG005|Up To Week 12|Lack of Efficacy|0|||
130705676|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
130705677|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
130705678|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
130705679|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705680|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705681|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
130705682|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705683|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Death|0|||
130705684|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Death|0|||
130454870|NCT00927823|469629674|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
130454871|NCT00927823|469629675|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
130454872|NCT00927823|469629672|FG000|Continuous Dosing Period|Other|1|||
130454873|NCT00927823|469629673|FG001|Continuous Dosing Period|Other|2|||
130454874|NCT00927823|469629674|FG002|Continuous Dosing Period|Other|9|||
130454875|NCT00927823|469629675|FG003|Continuous Dosing Period|Other|3|||
130454876|NCT03736785|469629686|FG000|Overall Study|Adverse Event|1|||
130454877|NCT03736785|469629687|FG001|Overall Study|Adverse Event|1|||
130454878|NCT03736785|469629688|FG002|Overall Study|Adverse Event|1|||
130454879|NCT03736785|469629686|FG000|Overall Study|Death|1|||
130454880|NCT03736785|469629687|FG001|Overall Study|Death|0|||
130454881|NCT03736785|469629688|FG002|Overall Study|Death|1|||
130454882|NCT03736785|469629686|FG000|Overall Study|Lost to Follow-up|0|||
130454883|NCT03736785|469629687|FG001|Overall Study|Lost to Follow-up|2|||
130454884|NCT03736785|469629688|FG002|Overall Study|Lost to Follow-up|3|||
130454885|NCT03736785|469629686|FG000|Overall Study|Non compliance with study drug|1|||
130454886|NCT03736785|469629687|FG001|Overall Study|Non compliance with study drug|1|||
130454887|NCT03736785|469629688|FG002|Overall Study|Non compliance with study drug|0|||
130454888|NCT03736785|469629686|FG000|Overall Study|Physician Decision|0|||
130454889|NCT03736785|469629687|FG001|Overall Study|Physician Decision|1|||
130454890|NCT03736785|469629688|FG002|Overall Study|Physician Decision|1|||
130454891|NCT03736785|469629686|FG000|Overall Study|Protocol Violation|1|||
130454892|NCT03736785|469629687|FG001|Overall Study|Protocol Violation|4|||
130454893|NCT03736785|469629688|FG002|Overall Study|Protocol Violation|3|||
130454894|NCT03736785|469629686|FG000|Overall Study|Sponsor Decision|1|||
130454895|NCT03736785|469629687|FG001|Overall Study|Sponsor Decision|0|||
130454896|NCT03736785|469629688|FG002|Overall Study|Sponsor Decision|0|||
130454897|NCT03736785|469629686|FG000|Overall Study|Unknown/Missing data|3|||
130454898|NCT03736785|469629687|FG001|Overall Study|Unknown/Missing data|2|||
130454899|NCT03736785|469629688|FG002|Overall Study|Unknown/Missing data|1|||
130454900|NCT03736785|469629686|FG000|Overall Study|Withdrawal by Subject|9|||
130454901|NCT03736785|469629687|FG001|Overall Study|Withdrawal by Subject|6|||
130454902|NCT03736785|469629688|FG002|Overall Study|Withdrawal by Subject|4|||
130454903|NCT01744691|469629690|FG000|Overall Study|Progressive Disease|18|||
130454904|NCT01744691|469629690|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
130454905|NCT01744691|469629690|FG000|Overall Study|Withdrawal of consent for treatment|3|||
130454906|NCT01744691|469629690|FG000|Overall Study|Physician Decision|4|||
130454907|NCT02701361|469629692|FG000|Overall Study|Lost to Follow-up|5|||
130454908|NCT02701361|469629693|FG001|Overall Study|Lost to Follow-up|2|||
130454909|NCT02701361|469629694|FG002|Overall Study|Lost to Follow-up|1|||
130454910|NCT02701361|469629692|FG000|Overall Study|Withdrawal by Subject|4|||
130454911|NCT02701361|469629693|FG001|Overall Study|Withdrawal by Subject|0|||
130454912|NCT02701361|469629694|FG002|Overall Study|Withdrawal by Subject|0|||
130454913|NCT02701361|469629692|FG000|Overall Study|timed out in rehab center|0|||
130454914|NCT02701361|469629693|FG001|Overall Study|timed out in rehab center|1|||
130454915|NCT02701361|469629694|FG002|Overall Study|timed out in rehab center|0|||
130454916|NCT02701361|469629692|FG000|Overall Study|incarceration|0|||
130454917|NCT02701361|469629693|FG001|Overall Study|incarceration|0|||
130454918|NCT02701361|469629694|FG002|Overall Study|incarceration|1|||
130454919|NCT04588480|469629695|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
130454920|NCT04588480|469629696|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
130454921|NCT04588480|469629697|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
130454922|NCT04588480|469629695|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
130268841|NCT00413660|468949717|FG006|Up To Week 12|Lack of Efficacy|5|||
130268842|NCT00413660|468949718|FG007|Up To Week 12|Lack of Efficacy|0|||
130268843|NCT00413660|468949719|FG008|Up To Week 12|Lack of Efficacy|0|||
130268844|NCT00413660|468949720|FG009|Up To Week 12|Lack of Efficacy|0|||
130268845|NCT00413660|468949721|FG010|Up To Week 12|Lack of Efficacy|0|||
130268846|NCT00413660|468949711|FG000|Up To Week 12|Lost to Follow-up|0|||
130268847|NCT00413660|468949712|FG001|Up To Week 12|Lost to Follow-up|1|||
130268848|NCT00413660|468949713|FG002|Up To Week 12|Lost to Follow-up|0|||
130268849|NCT00413660|468949714|FG003|Up To Week 12|Lost to Follow-up|0|||
130268850|NCT00413660|468949715|FG004|Up To Week 12|Lost to Follow-up|1|||
130268851|NCT00413660|468949716|FG005|Up To Week 12|Lost to Follow-up|0|||
130268852|NCT00413660|468949717|FG006|Up To Week 12|Lost to Follow-up|0|||
130454923|NCT04588480|469629696|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
130454924|NCT04588480|469629697|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
130454925|NCT00843193|469629700|FG000|Overall Study|Adverse Event|2|||
130454926|NCT00843193|469629701|FG001|Overall Study|Adverse Event|4|||
130454927|NCT00843193|469629700|FG000|Overall Study|Lack of Efficacy|1|||
130454928|NCT00843193|469629701|FG001|Overall Study|Lack of Efficacy|1|||
130454929|NCT00843193|469629700|FG000|Overall Study|Protocol Violation|1|||
130454930|NCT00843193|469629701|FG001|Overall Study|Protocol Violation|2|||
130454931|NCT00843193|469629700|FG000|Overall Study|Lost to Follow-up|1|||
130454932|NCT00843193|469629701|FG001|Overall Study|Lost to Follow-up|0|||
130454933|NCT00843193|469629700|FG000|Overall Study|Physician Decision|0|||
130454934|NCT00843193|469629701|FG001|Overall Study|Physician Decision|1|||
130454935|NCT00843193|469629700|FG000|Overall Study|Withdrawal by Subject|3|||
130454936|NCT00843193|469629701|FG001|Overall Study|Withdrawal by Subject|3|||
130454937|NCT04511650|469629702|FG000|Overall Study|Lost to Follow-up|1|||
130454938|NCT04511650|469629703|FG001|Overall Study|Lost to Follow-up|0|||
130454939|NCT04511650|469629704|FG002|Overall Study|Lost to Follow-up|0|||
130454940|NCT04511650|469629702|FG000|Overall Study|Withdrawal by Subject|1|||
130454941|NCT04511650|469629703|FG001|Overall Study|Withdrawal by Subject|0|||
130454942|NCT04511650|469629704|FG002|Overall Study|Withdrawal by Subject|0|||
130454943|NCT04511650|469629702|FG000|Overall Study|reason not provided|0|||
130454944|NCT04511650|469629703|FG001|Overall Study|reason not provided|0|||
130454945|NCT04511650|469629704|FG002|Overall Study|reason not provided|1|||
130454946|NCT04511650|469629702|FG000|Overall Study|Death|1|||
130454947|NCT04511650|469629703|FG001|Overall Study|Death|1|||
130454948|NCT04511650|469629704|FG002|Overall Study|Death|1|||
130454949|NCT00544440|469629705|FG000|Overall Study|Other|1|||
130454950|NCT00544440|469629705|FG000|Overall Study|Adverse Event|1|||
130454951|NCT00544440|469629705|FG000|Overall Study|Withdrawal by Subject|2|||
130454952|NCT00544440|469629705|FG000|Overall Study|Subject Non-compliance|1|||
130454953|NCT00544440|469629705|FG000|Overall Study|Progressive Disease|47|||
130268853|NCT00413660|468949718|FG007|Up To Week 12|Lost to Follow-up|0|||
130268854|NCT00413660|468949719|FG008|Up To Week 12|Lost to Follow-up|0|||
130268855|NCT00413660|468949720|FG009|Up To Week 12|Lost to Follow-up|0|||
130268856|NCT00413660|468949721|FG010|Up To Week 12|Lost to Follow-up|0|||
130268857|NCT00413660|468949711|FG000|Up To Week 12|Withdrawal by Subject|0|||
130268858|NCT00413660|468949712|FG001|Up To Week 12|Withdrawal by Subject|2|||
130268859|NCT00413660|468949713|FG002|Up To Week 12|Withdrawal by Subject|0|||
130268860|NCT00413660|468949714|FG003|Up To Week 12|Withdrawal by Subject|2|||
130268861|NCT00413660|468949715|FG004|Up To Week 12|Withdrawal by Subject|0|||
130268862|NCT00413660|468949716|FG005|Up To Week 12|Withdrawal by Subject|2|||
130268863|NCT00413660|468949717|FG006|Up To Week 12|Withdrawal by Subject|2|||
130268864|NCT00413660|468949718|FG007|Up To Week 12|Withdrawal by Subject|0|||
130268865|NCT00413660|468949719|FG008|Up To Week 12|Withdrawal by Subject|0|||
130268866|NCT00413660|468949720|FG009|Up To Week 12|Withdrawal by Subject|0|||
130268867|NCT00413660|468949721|FG010|Up To Week 12|Withdrawal by Subject|0|||
130268868|NCT00413660|468949711|FG000|Up To Week 12|Randomized, Not Treated|1|||
130268869|NCT00413660|468949712|FG001|Up To Week 12|Randomized, Not Treated|0|||
130268870|NCT00413660|468949713|FG002|Up To Week 12|Randomized, Not Treated|0|||
130268871|NCT00413660|468949714|FG003|Up To Week 12|Randomized, Not Treated|1|||
130268872|NCT00413660|468949715|FG004|Up To Week 12|Randomized, Not Treated|0|||
130268873|NCT00413660|468949716|FG005|Up To Week 12|Randomized, Not Treated|0|||
130268874|NCT00413660|468949717|FG006|Up To Week 12|Randomized, Not Treated|0|||
130268875|NCT00413660|468949718|FG007|Up To Week 12|Randomized, Not Treated|0|||
130454954|NCT00544440|469629705|FG000|Overall Study|Other|5|||
130268876|NCT00413660|468949719|FG008|Up To Week 12|Randomized, Not Treated|0|||
130268877|NCT00413660|468949720|FG009|Up To Week 12|Randomized, Not Treated|0|||
130268878|NCT00413660|468949721|FG010|Up To Week 12|Randomized, Not Treated|0|||
130268879|NCT00413660|468949711|FG000|Up To Week 12|Other|3|||
130268880|NCT00413660|468949712|FG001|Up To Week 12|Other|1|||
130454955|NCT01081145|469629708|FG000|Open-Label Phase|Lack of Efficacy|56|||
130454956|NCT01081145|469629709|FG001|Open-Label Phase|Lack of Efficacy|0|||
130454957|NCT01081145|469629708|FG000|Open-Label Phase|Response criteria not met|46|||
130268881|NCT00413660|468949713|FG002|Up To Week 12|Other|6|||
130268882|NCT00413660|468949714|FG003|Up To Week 12|Other|1|||
130268883|NCT00413660|468949715|FG004|Up To Week 12|Other|2|||
130268884|NCT00413660|468949716|FG005|Up To Week 12|Other|4|||
130268885|NCT00413660|468949717|FG006|Up To Week 12|Other|3|||
130268886|NCT00413660|468949718|FG007|Up To Week 12|Other|0|||
130268887|NCT00413660|468949719|FG008|Up To Week 12|Other|0|||
130268888|NCT00413660|468949720|FG009|Up To Week 12|Other|0|||
130268889|NCT00413660|468949721|FG010|Up To Week 12|Other|0|||
130454958|NCT01081145|469629709|FG001|Open-Label Phase|Response criteria not met|0|||
130454959|NCT01081145|469629708|FG000|Open-Label Phase|Adverse Event|42|||
130366537|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
130366538|NCT03298867|469311903|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
130366539|NCT03298867|469311904|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
130366540|NCT03298867|469311903|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
130366541|NCT03298867|469311904|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
130366542|NCT00228384|469311905|FG000|Overall Study|Death|9|||
130366543|NCT00228384|469311906|FG001|Overall Study|Death|3|||
130366544|NCT00228384|469311905|FG000|Overall Study|Lost to Follow-up|6|||
130366545|NCT00228384|469311906|FG001|Overall Study|Lost to Follow-up|10|||
130366546|NCT00228384|469311905|FG000|Overall Study|Surgical Intervention (bypass)|5|||
130366547|NCT00228384|469311906|FG001|Overall Study|Surgical Intervention (bypass)|5|||
130366548|NCT00228384|469311905|FG000|Overall Study|Withdrawal by Subject|9|||
130366549|NCT00228384|469311906|FG001|Overall Study|Withdrawal by Subject|10|||
130366550|NCT00228384|469311905|FG000|Overall Study|Physician Decision|0|||
130366551|NCT00228384|469311906|FG001|Overall Study|Physician Decision|1|||
130366552|NCT01785069|469311908|FG000|Overall Study|Implanted with nonstudy device|1|||
130366553|NCT01785069|469311909|FG001|Overall Study|Implanted with nonstudy device|2|||
130366554|NCT01785069|469311910|FG002|Overall Study|Implanted with nonstudy device|1|||
130366555|NCT01785069|469311911|FG003|Overall Study|Implanted with nonstudy device|0|||
130366556|NCT01785069|469311908|FG000|Overall Study|Death|0|||
130366557|NCT01785069|469311909|FG001|Overall Study|Death|0|||
130366558|NCT01785069|469311910|FG002|Overall Study|Death|2|||
130366559|NCT01785069|469311911|FG003|Overall Study|Death|0|||
130366560|NCT01785069|469311908|FG000|Overall Study|Subject choice|2|||
130366561|NCT01785069|469311909|FG001|Overall Study|Subject choice|2|||
130366562|NCT01785069|469311910|FG002|Overall Study|Subject choice|0|||
130366563|NCT01785069|469311911|FG003|Overall Study|Subject choice|1|||
130366564|NCT01785069|469311908|FG000|Overall Study|Lost to Follow-up|1|||
130366565|NCT01785069|469311909|FG001|Overall Study|Lost to Follow-up|2|||
130366566|NCT01785069|469311910|FG002|Overall Study|Lost to Follow-up|4|||
130366567|NCT01785069|469311911|FG003|Overall Study|Lost to Follow-up|1|||
130366568|NCT01785069|469311908|FG000|Overall Study|Reason not Specified|1|||
130366569|NCT01785069|469311909|FG001|Overall Study|Reason not Specified|2|||
130454960|NCT01081145|469629709|FG001|Open-Label Phase|Adverse Event|0|||
130454961|NCT01081145|469629708|FG000|Open-Label Phase|Withdrawal by Subject|41|||
130454962|NCT01081145|469629709|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130454963|NCT01081145|469629708|FG000|Open-Label Phase|Other|12|||
130454964|NCT01081145|469629709|FG001|Open-Label Phase|Other|0|||
130454965|NCT01081145|469629708|FG000|Open-Label Phase|Lost to Follow-up|11|||
130454966|NCT01081145|469629709|FG001|Open-Label Phase|Lost to Follow-up|0|||
130454967|NCT01081145|469629708|FG000|Open-Label Phase|Protocol Violation|4|||
130454968|NCT01081145|469629709|FG001|Open-Label Phase|Protocol Violation|0|||
130454969|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
130454970|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
130454971|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
130454972|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
130454973|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
130454974|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
130454975|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
130454976|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
130454977|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
130454978|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
130454979|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
130454980|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
130454981|NCT01081145|469629708|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
130454982|NCT01081145|469629709|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
130454983|NCT03394027|469629713|FG000|Overall Study|Ineligible|3|||
130454984|NCT03394027|469629714|FG001|Overall Study|Ineligible|1|||
130454985|NCT03394027|469629715|FG002|Overall Study|Ineligible|3|||
130705685|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Death|62|||
130454986|NCT03394027|469629713|FG000|Overall Study|Participant declined to participate before treatment started|0|||
130454987|NCT03394027|469629714|FG001|Overall Study|Participant declined to participate before treatment started|0|||
130454988|NCT03394027|469629715|FG002|Overall Study|Participant declined to participate before treatment started|1|||
130454989|NCT01018511|469629717|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
130705686|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Death|68|||
130366570|NCT01785069|469311910|FG002|Overall Study|Reason not Specified|1|||
130366571|NCT01785069|469311911|FG003|Overall Study|Reason not Specified|4|||
130705687|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
130366572|NCT01785069|469311908|FG000|Overall Study|Not evaluable|7|||
130366573|NCT01785069|469311909|FG001|Overall Study|Not evaluable|4|||
130366574|NCT01785069|469311910|FG002|Overall Study|Not evaluable|5|||
130454990|NCT01018511|469629718|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
130454991|NCT01018511|469629719|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
130454992|NCT01018511|469629720|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
130454993|NCT01018511|469629717|FG000|Overall Study|Adverse Event|5|||
130454994|NCT01018511|469629718|FG001|Overall Study|Adverse Event|9|||
130454995|NCT01018511|469629719|FG002|Overall Study|Adverse Event|13|||
130454996|NCT01018511|469629720|FG003|Overall Study|Adverse Event|10|||
130454997|NCT01018511|469629717|FG000|Overall Study|Lack of Efficacy|4|||
130454998|NCT01018511|469629718|FG001|Overall Study|Lack of Efficacy|1|||
130454999|NCT01018511|469629719|FG002|Overall Study|Lack of Efficacy|1|||
130455000|NCT01018511|469629720|FG003|Overall Study|Lack of Efficacy|2|||
130455001|NCT01018511|469629717|FG000|Overall Study|Withdrawal by Subject|6|||
130455002|NCT01018511|469629718|FG001|Overall Study|Withdrawal by Subject|5|||
130455003|NCT01018511|469629719|FG002|Overall Study|Withdrawal by Subject|11|||
130455004|NCT01018511|469629720|FG003|Overall Study|Withdrawal by Subject|9|||
130455005|NCT01018511|469629717|FG000|Overall Study|Lost to Follow-up|0|||
130455006|NCT01018511|469629718|FG001|Overall Study|Lost to Follow-up|0|||
130455007|NCT01018511|469629719|FG002|Overall Study|Lost to Follow-up|1|||
130455008|NCT01018511|469629720|FG003|Overall Study|Lost to Follow-up|0|||
130455009|NCT01018511|469629717|FG000|Overall Study|Protocol Violation|5|||
130455010|NCT01018511|469629718|FG001|Overall Study|Protocol Violation|8|||
130455011|NCT01018511|469629719|FG002|Overall Study|Protocol Violation|7|||
130455012|NCT01018511|469629720|FG003|Overall Study|Protocol Violation|9|||
130455013|NCT01018511|469629717|FG000|Overall Study|Miscellaneous|0|||
130455014|NCT01018511|469629718|FG001|Overall Study|Miscellaneous|2|||
130455015|NCT01018511|469629719|FG002|Overall Study|Miscellaneous|0|||
130455016|NCT01018511|469629720|FG003|Overall Study|Miscellaneous|0|||
130455017|NCT04523181|469629721|FG000|Overall Study|Withdrawal by Subject|4|||
130455018|NCT04523181|469629722|FG001|Overall Study|Withdrawal by Subject|5|||
130455019|NCT04523181|469629721|FG000|Overall Study|Lost to Follow-up|2|||
130455020|NCT04523181|469629722|FG001|Overall Study|Lost to Follow-up|3|||
130455021|NCT04523181|469629721|FG000|Overall Study|Physician Decision|1|||
130455022|NCT04523181|469629722|FG001|Overall Study|Physician Decision|0|||
130455023|NCT04523181|469629721|FG000|Overall Study|Transferred to external facility.|1|||
130455024|NCT04523181|469629722|FG001|Overall Study|Transferred to external facility.|1|||
130455025|NCT04550039|469629723|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
130455026|NCT04550039|469629724|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
130455027|NCT04550039|469629723|FG000|Overall Study|patient self-withdrew from study|0|||
130455028|NCT04550039|469629724|FG001|Overall Study|patient self-withdrew from study|1|||
130455029|NCT04391309|469629725|FG000|Overall Study|Death|1|||
130455030|NCT04391309|469629726|FG001|Overall Study|Death|1|||
130455031|NCT04391309|469629725|FG000|Overall Study|Lost to Follow-up|3|||
130455032|NCT04391309|469629726|FG001|Overall Study|Lost to Follow-up|2|||
130455033|NCT04391309|469629725|FG000|Overall Study|Withdrawal by Subject|2|||
130455034|NCT04391309|469629726|FG001|Overall Study|Withdrawal by Subject|2|||
130455035|NCT00881335|469629733|FG000|Overall Study|Lost to Follow-up|3|||
130455036|NCT00881335|469629734|FG001|Overall Study|Lost to Follow-up|2|||
130455037|NCT05824351|469629737|FG000|Overall Study|Adverse Event|6|||
130455038|NCT00828945|469629738|FG000|Overall Study|Death|4|||
130455039|NCT00828945|469629738|FG000|Overall Study|Participant was missing|1|||
130455040|NCT00828945|469629738|FG000|Overall Study|Other|36|||
130455041|NCT02482233|469629743|FG000|Overall Study|Lost to Follow-up|1|||
130455042|NCT02482233|469629744|FG001|Overall Study|Lost to Follow-up|1|||
130455043|NCT03822351|469629745|FG000|Overall Study|Death|27|||
130455044|NCT03822351|469629746|FG001|Overall Study|Death|23|||
130455045|NCT03822351|469629747|FG002|Overall Study|Death|24|||
130455046|NCT03822351|469629745|FG000|Overall Study|Lost to Follow-up|6|||
130455047|NCT03822351|469629746|FG001|Overall Study|Lost to Follow-up|2|||
130455048|NCT03822351|469629747|FG002|Overall Study|Lost to Follow-up|1|||
130455049|NCT03822351|469629745|FG000|Overall Study|Withdrawal by Subject|10|||
130455050|NCT03822351|469629746|FG001|Overall Study|Withdrawal by Subject|4|||
130455051|NCT03822351|469629747|FG002|Overall Study|Withdrawal by Subject|6|||
130455052|NCT03822351|469629745|FG000|Overall Study|Progressive Disease|2|||
130455053|NCT03822351|469629746|FG001|Overall Study|Progressive Disease|1|||
130455054|NCT03822351|469629747|FG002|Overall Study|Progressive Disease|0|||
130455055|NCT03822351|469629745|FG000|Overall Study|Not Treated|1|||
130455056|NCT03822351|469629746|FG001|Overall Study|Not Treated|1|||
130455057|NCT03822351|469629747|FG002|Overall Study|Not Treated|1|||
130268890|NCT00413660|468949711|FG000|Post Week 12|Adverse Event|2|||
130455058|NCT00462943|469629748|FG000|Overall Study|Failure to achieve a response|5|||
130455059|NCT00462943|469629749|FG001|Overall Study|Failure to achieve a response|5|||
130455060|NCT00462943|469629750|FG002|Overall Study|Failure to achieve a response|1|||
130455061|NCT00462943|469629748|FG000|Overall Study|Adverse Event|6|||
130455062|NCT00462943|469629749|FG001|Overall Study|Adverse Event|4|||
130455063|NCT00462943|469629750|FG002|Overall Study|Adverse Event|1|||
130455064|NCT00462943|469629748|FG000|Overall Study|Protocol Violation|1|||
130455065|NCT00462943|469629749|FG001|Overall Study|Protocol Violation|0|||
130455066|NCT00462943|469629750|FG002|Overall Study|Protocol Violation|0|||
130268891|NCT00413660|468949712|FG001|Post Week 12|Adverse Event|0|||
130268892|NCT00413660|468949713|FG002|Post Week 12|Adverse Event|2|||
130268893|NCT00413660|468949714|FG003|Post Week 12|Adverse Event|1|||
130268894|NCT00413660|468949715|FG004|Post Week 12|Adverse Event|4|||
130268895|NCT00413660|468949716|FG005|Post Week 12|Adverse Event|2|||
130268896|NCT00413660|468949717|FG006|Post Week 12|Adverse Event|2|||
130268897|NCT00413660|468949718|FG007|Post Week 12|Adverse Event|0|||
130268898|NCT00413660|468949719|FG008|Post Week 12|Adverse Event|0|||
130268899|NCT00413660|468949720|FG009|Post Week 12|Adverse Event|0|||
130268900|NCT00413660|468949721|FG010|Post Week 12|Adverse Event|0|||
130268901|NCT00413660|468949711|FG000|Post Week 12|Lack of Efficacy|0|||
130268902|NCT00413660|468949712|FG001|Post Week 12|Lack of Efficacy|0|||
130268903|NCT00413660|468949713|FG002|Post Week 12|Lack of Efficacy|1|||
130268904|NCT00413660|468949714|FG003|Post Week 12|Lack of Efficacy|0|||
130268905|NCT00413660|468949715|FG004|Post Week 12|Lack of Efficacy|0|||
130268906|NCT00413660|468949716|FG005|Post Week 12|Lack of Efficacy|0|||
130268907|NCT00413660|468949717|FG006|Post Week 12|Lack of Efficacy|0|||
130268908|NCT00413660|468949718|FG007|Post Week 12|Lack of Efficacy|0|||
130268909|NCT00413660|468949719|FG008|Post Week 12|Lack of Efficacy|0|||
130268910|NCT00413660|468949720|FG009|Post Week 12|Lack of Efficacy|1|||
130268911|NCT00413660|468949721|FG010|Post Week 12|Lack of Efficacy|0|||
130268912|NCT00413660|468949711|FG000|Post Week 12|Lost to Follow-up|0|||
130268913|NCT00413660|468949712|FG001|Post Week 12|Lost to Follow-up|1|||
130268914|NCT00413660|468949713|FG002|Post Week 12|Lost to Follow-up|1|||
130268915|NCT00413660|468949714|FG003|Post Week 12|Lost to Follow-up|0|||
130268916|NCT00413660|468949715|FG004|Post Week 12|Lost to Follow-up|0|||
130268917|NCT00413660|468949716|FG005|Post Week 12|Lost to Follow-up|0|||
130268918|NCT00413660|468949717|FG006|Post Week 12|Lost to Follow-up|0|||
130268919|NCT00413660|468949718|FG007|Post Week 12|Lost to Follow-up|0|||
130268920|NCT00413660|468949719|FG008|Post Week 12|Lost to Follow-up|0|||
130268921|NCT00413660|468949720|FG009|Post Week 12|Lost to Follow-up|0|||
130268922|NCT00413660|468949721|FG010|Post Week 12|Lost to Follow-up|0|||
130268923|NCT00413660|468949711|FG000|Post Week 12|Withdrawal by Subject|0|||
130268924|NCT00413660|468949712|FG001|Post Week 12|Withdrawal by Subject|1|||
130268925|NCT00413660|468949713|FG002|Post Week 12|Withdrawal by Subject|1|||
130268926|NCT00413660|468949714|FG003|Post Week 12|Withdrawal by Subject|0|||
130268927|NCT00413660|468949715|FG004|Post Week 12|Withdrawal by Subject|1|||
130268928|NCT00413660|468949716|FG005|Post Week 12|Withdrawal by Subject|0|||
130268929|NCT00413660|468949717|FG006|Post Week 12|Withdrawal by Subject|0|||
130268930|NCT00413660|468949718|FG007|Post Week 12|Withdrawal by Subject|0|||
130268931|NCT00413660|468949719|FG008|Post Week 12|Withdrawal by Subject|0|||
130268932|NCT00413660|468949720|FG009|Post Week 12|Withdrawal by Subject|0|||
130268933|NCT00413660|468949721|FG010|Post Week 12|Withdrawal by Subject|1|||
130268934|NCT00413660|468949711|FG000|Post Week 12|Other|1|||
130268935|NCT00413660|468949712|FG001|Post Week 12|Other|2|||
130268936|NCT00413660|468949713|FG002|Post Week 12|Other|3|||
130268937|NCT00413660|468949714|FG003|Post Week 12|Other|0|||
130268938|NCT00413660|468949715|FG004|Post Week 12|Other|1|||
130268939|NCT00413660|468949716|FG005|Post Week 12|Other|1|||
130268940|NCT00413660|468949717|FG006|Post Week 12|Other|1|||
130268941|NCT00413660|468949718|FG007|Post Week 12|Other|0|||
130268942|NCT00413660|468949719|FG008|Post Week 12|Other|0|||
130268943|NCT00413660|468949720|FG009|Post Week 12|Other|0|||
130268944|NCT00413660|468949721|FG010|Post Week 12|Other|0|||
130268945|NCT00400517|468949723|FG000|Overall Study|Withdrawal by Subject|1|||
130268946|NCT00400517|468949723|FG000|Overall Study|Physician Decision|1|||
130268947|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
130268948|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
130268949|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
130268950|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
130268951|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130268952|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130268953|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
130268954|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268955|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268956|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
130268957|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130268958|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130268959|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
130268960|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130268961|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130268962|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
130268963|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130268964|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130268965|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Other|4|||
130268966|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Other|0|||
130366575|NCT01785069|469311911|FG003|Overall Study|Not evaluable|8|||
130366576|NCT05358444|469311920|FG000|Overall Study|Withdrawal by Subject|0|||
130366577|NCT05358444|469311921|FG001|Overall Study|Withdrawal by Subject|1|||
130366578|NCT05358444|469311920|FG000|Overall Study|Lost to Follow-up|0|||
130366579|NCT05358444|469311921|FG001|Overall Study|Lost to Follow-up|3|||
130366580|NCT04997304|469311924|FG000|Overall Study|Lost to Follow-up|11|||
130366581|NCT04997304|469311924|FG000|Overall Study|Death|1|||
130366582|NCT04997304|469311924|FG000|Overall Study|Withdrawal by Subject|14|||
130366583|NCT01453361|469311925|FG000|Overall Study|Disease Progression|6|||
130366584|NCT01453361|469311925|FG000|Overall Study|Screen-Failures|10|||
130366585|NCT01798004|469313963|FG000|Overall Study|Death|2|||
130366586|NCT01798004|469313963|FG000|Overall Study|Lack of Efficacy|8|||
130366587|NCT01798004|469313963|FG000|Overall Study|Physician Decision|25|||
130366588|NCT01798004|469313963|FG000|Overall Study|Withdrawal by Subject|4|||
130366589|NCT01798004|469313963|FG000|Overall Study|Ineligible|4|||
130366590|NCT01798004|469313963|FG000|Overall Study|Patient/parent refusal|7|||
130366591|NCT01798004|469313963|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
130366592|NCT01798004|469313963|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
130366593|NCT02323113|469313967|FG000|Overall Study|Adverse Event|3|||
130366594|NCT02323113|469313968|FG001|Overall Study|Adverse Event|3|||
130455067|NCT00462943|469629748|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
130455068|NCT00462943|469629749|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
130455069|NCT00462943|469629750|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
130455070|NCT00462943|469629748|FG000|Overall Study|Disease Progression|15|||
130455071|NCT00462943|469629749|FG001|Overall Study|Disease Progression|15|||
130455072|NCT00462943|469629750|FG002|Overall Study|Disease Progression|9|||
130455073|NCT00462943|469629748|FG000|Overall Study|Death|5|||
130455074|NCT00462943|469629749|FG001|Overall Study|Death|2|||
130455075|NCT00462943|469629750|FG002|Overall Study|Death|7|||
130455076|NCT00462943|469629748|FG000|Overall Study|Stem Cell Transplant|1|||
130455077|NCT00462943|469629749|FG001|Overall Study|Stem Cell Transplant|1|||
130455078|NCT00462943|469629750|FG002|Overall Study|Stem Cell Transplant|0|||
130455079|NCT00462943|469629748|FG000|Overall Study|Bone Marrow Transplant|1|||
130455080|NCT00462943|469629749|FG001|Overall Study|Bone Marrow Transplant|0|||
130455081|NCT00462943|469629750|FG002|Overall Study|Bone Marrow Transplant|0|||
130455082|NCT00462943|469629748|FG000|Overall Study|Required Lymphocyte Infusion|1|||
130455083|NCT00462943|469629749|FG001|Overall Study|Required Lymphocyte Infusion|0|||
130455084|NCT00462943|469629750|FG002|Overall Study|Required Lymphocyte Infusion|0|||
130455085|NCT00462943|469629748|FG000|Overall Study|Transplant - not specified|1|||
130455086|NCT00462943|469629749|FG001|Overall Study|Transplant - not specified|0|||
130455087|NCT00462943|469629750|FG002|Overall Study|Transplant - not specified|1|||
130455088|NCT00462943|469629748|FG000|Overall Study|Physician Decision|1|||
130455089|NCT00462943|469629749|FG001|Overall Study|Physician Decision|0|||
130455090|NCT00462943|469629750|FG002|Overall Study|Physician Decision|0|||
130455091|NCT00462943|469629748|FG000|Overall Study|Withdrawal by Subject|0|||
130455092|NCT00462943|469629749|FG001|Overall Study|Withdrawal by Subject|1|||
130455093|NCT00462943|469629750|FG002|Overall Study|Withdrawal by Subject|0|||
130455094|NCT04358549|469631251|FG000|Overall Study|Adverse Event|0|||
130455095|NCT04358549|469631252|FG001|Overall Study|Adverse Event|1|||
130455096|NCT04358549|469631251|FG000|Overall Study|Death|1|||
130455097|NCT04358549|469631252|FG001|Overall Study|Death|0|||
130455098|NCT04358549|469631251|FG000|Overall Study|Lost to Follow-up|2|||
130455099|NCT04358549|469631252|FG001|Overall Study|Lost to Follow-up|1|||
130455100|NCT04358549|469631251|FG000|Overall Study|Withdrawal by Subject|6|||
130455101|NCT04358549|469631252|FG001|Overall Study|Withdrawal by Subject|6|||
130455102|NCT04358549|469631251|FG000|Overall Study|Start remdesivir|1|||
130455103|NCT04358549|469631252|FG001|Overall Study|Start remdesivir|0|||
130455104|NCT03895034|469631253|FG000|Overall Study|Lost to Follow-up|2|||
130455105|NCT01118377|469631254|FG000|Overall Study|Did Not Receive Study Medication|1|||
130366595|NCT02323113|469313969|FG002|Overall Study|Adverse Event|2|||
130366596|NCT02323113|469313970|FG003|Overall Study|Adverse Event|5|||
130366597|NCT02323113|469313971|FG004|Overall Study|Adverse Event|8|||
130366598|NCT02323113|469313972|FG005|Overall Study|Adverse Event|3|||
130366599|NCT02323113|469313973|FG006|Overall Study|Adverse Event|6|||
130366600|NCT02323113|469313974|FG007|Overall Study|Adverse Event|0|||
130366601|NCT02323113|469313967|FG000|Overall Study|Progressive Disease|0|||
130366602|NCT02323113|469313968|FG001|Overall Study|Progressive Disease|1|||
130455106|NCT01118377|469631254|FG000|Overall Study|Death|38|||
130455107|NCT01118377|469631254|FG000|Overall Study|Failure to Return|3|||
130455108|NCT03837028|469631255|FG000|Overall Study|Lost to Follow-up|4|||
130455109|NCT03837028|469631256|FG001|Overall Study|Lost to Follow-up|0|||
130455110|NCT03837028|469631257|FG002|Overall Study|Lost to Follow-up|2|||
130455111|NCT03837028|469631258|FG003|Overall Study|Lost to Follow-up|0|||
130455112|NCT03837028|469631255|FG000|Overall Study|Withdrawal by Subject|12|||
130455113|NCT03837028|469631256|FG001|Overall Study|Withdrawal by Subject|11|||
130366603|NCT02323113|469313969|FG002|Overall Study|Progressive Disease|1|||
130366604|NCT02323113|469313970|FG003|Overall Study|Progressive Disease|0|||
130366605|NCT02323113|469313971|FG004|Overall Study|Progressive Disease|0|||
130366606|NCT02323113|469313972|FG005|Overall Study|Progressive Disease|3|||
130366607|NCT02323113|469313973|FG006|Overall Study|Progressive Disease|0|||
130366608|NCT02323113|469313974|FG007|Overall Study|Progressive Disease|0|||
130366609|NCT02323113|469313967|FG000|Overall Study|Symptomatic Deterioration|0|||
130366610|NCT02323113|469313968|FG001|Overall Study|Symptomatic Deterioration|0|||
130366611|NCT02323113|469313969|FG002|Overall Study|Symptomatic Deterioration|1|||
130366612|NCT02323113|469313970|FG003|Overall Study|Symptomatic Deterioration|0|||
130366613|NCT02323113|469313971|FG004|Overall Study|Symptomatic Deterioration|1|||
130366614|NCT02323113|469313972|FG005|Overall Study|Symptomatic Deterioration|0|||
130366615|NCT02323113|469313973|FG006|Overall Study|Symptomatic Deterioration|0|||
130366616|NCT02323113|469313974|FG007|Overall Study|Symptomatic Deterioration|0|||
130366617|NCT02323113|469313967|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130455114|NCT03837028|469631257|FG002|Overall Study|Withdrawal by Subject|11|||
130455115|NCT03837028|469631258|FG003|Overall Study|Withdrawal by Subject|7|||
130455116|NCT00157014|469631259|FG000|Overall Study|Death|4|||
130455117|NCT00157014|469631260|FG001|Overall Study|Death|2|||
130455118|NCT00157014|469631261|FG002|Overall Study|Death|1|||
130455119|NCT00157014|469631262|FG003|Overall Study|Death|1|||
130455120|NCT00157014|469631259|FG000|Overall Study|Physician Decision|0|||
130455121|NCT00157014|469631260|FG001|Overall Study|Physician Decision|1|||
130455122|NCT00157014|469631261|FG002|Overall Study|Physician Decision|0|||
130455123|NCT00157014|469631262|FG003|Overall Study|Physician Decision|0|||
130455124|NCT00157014|469631259|FG000|Overall Study|Medications withdrawn on family request|0|||
130455125|NCT00157014|469631260|FG001|Overall Study|Medications withdrawn on family request|1|||
130455126|NCT00157014|469631261|FG002|Overall Study|Medications withdrawn on family request|0|||
130455127|NCT00157014|469631262|FG003|Overall Study|Medications withdrawn on family request|0|||
130455128|NCT00157014|469631259|FG000|Overall Study|Patient withdrawn by investigator|1|||
130455129|NCT00157014|469631260|FG001|Overall Study|Patient withdrawn by investigator|0|||
130455130|NCT00157014|469631261|FG002|Overall Study|Patient withdrawn by investigator|0|||
130455131|NCT00157014|469631262|FG003|Overall Study|Patient withdrawn by investigator|0|||
130455132|NCT00157014|469631259|FG000|Overall Study|Patient unable to return in nursing home|1|||
130455133|NCT00157014|469631260|FG001|Overall Study|Patient unable to return in nursing home|0|||
130455134|NCT00157014|469631261|FG002|Overall Study|Patient unable to return in nursing home|0|||
130455135|NCT00157014|469631262|FG003|Overall Study|Patient unable to return in nursing home|0|||
130455136|NCT00157014|469631259|FG000|Overall Study|Patient would not receive transplant|0|||
130455137|NCT00157014|469631260|FG001|Overall Study|Patient would not receive transplant|1|||
130455138|NCT00157014|469631261|FG002|Overall Study|Patient would not receive transplant|0|||
130455139|NCT00157014|469631262|FG003|Overall Study|Patient would not receive transplant|0|||
130455140|NCT00157014|469631259|FG000|Overall Study|Withdrawal by Subject|1|||
130455141|NCT00157014|469631260|FG001|Overall Study|Withdrawal by Subject|0|||
130455142|NCT00157014|469631261|FG002|Overall Study|Withdrawal by Subject|0|||
130455143|NCT00157014|469631262|FG003|Overall Study|Withdrawal by Subject|0|||
130455144|NCT01362491|469631263|FG000|Overall Study|Ineligible|1|||
130455145|NCT01362491|469631264|FG001|Overall Study|Ineligible|0|||
130455146|NCT01362491|469631265|FG002|Overall Study|Ineligible|0|||
130455147|NCT04867902|469631266|FG000|Overall Study|Lost to Follow-up|1|||
130455148|NCT04867902|469631266|FG000|Overall Study|Withdrawal by Subject|2|||
130455149|NCT04867902|469631266|FG000|Overall Study|Protocol Violation|1|||
130455150|NCT05355116|469631267|FG000|Overall Study|Withdrawal by Subject|2|||
130455151|NCT01090024|469631268|FG000|Period 1|Met exclusion criteria|0|||
130455152|NCT01090024|469631269|FG001|Period 1|Met exclusion criteria|0|||
130455153|NCT01090024|469631270|FG002|Period 1|Met exclusion criteria|0|||
130455154|NCT01090024|469631271|FG003|Period 1|Met exclusion criteria|0|||
130366618|NCT02323113|469313968|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
130455155|NCT01090024|469631272|FG004|Period 1|Met exclusion criteria|0|||
130455156|NCT01090024|469631273|FG005|Period 1|Met exclusion criteria|0|||
130455157|NCT01090024|469631274|FG006|Period 1|Met exclusion criteria|0|||
130455158|NCT01090024|469631275|FG007|Period 1|Met exclusion criteria|0|||
130455159|NCT01090024|469631276|FG008|Period 1|Met exclusion criteria|0|||
130455160|NCT01090024|469631277|FG009|Period 1|Met exclusion criteria|0|||
130455161|NCT01090024|469631278|FG010|Period 1|Met exclusion criteria|0|||
130366619|NCT02323113|469313969|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130366620|NCT02323113|469313970|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130455162|NCT01090024|469631279|FG011|Period 1|Met exclusion criteria|0|||
130366621|NCT02323113|469313971|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
130455163|NCT01090024|469631280|FG012|Period 1|Met exclusion criteria|0|||
130455164|NCT01090024|469631281|FG013|Period 1|Met exclusion criteria|0|||
130455165|NCT01090024|469631282|FG014|Period 1|Met exclusion criteria|1|||
130455166|NCT01090024|469631283|FG015|Period 1|Met exclusion criteria|0|||
130455167|NCT01090024|469631284|FG016|Period 1|Met exclusion criteria|0|||
130455168|NCT01090024|469631285|FG017|Period 1|Met exclusion criteria|0|||
130455169|NCT01090024|469631268|FG000|Period 1|Adverse Event|0|||
130268967|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Other|0|||
130268968|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
130268969|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130268970|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130268971|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Death|0|||
130268972|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Death|0|||
130268973|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Death|2|||
130268974|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
130268975|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130268976|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130268977|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130268978|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
130268979|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130268980|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
130268981|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
130268982|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
130268983|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Other|0|||
130268984|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Other|2|||
130268985|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Other|5|||
130268986|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268987|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
130268988|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
130268989|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
130268990|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
130268991|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
130268992|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130268993|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
130268994|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130268995|NCT01722994|468949731|FG000|Overall Study|Missing data|25|||
130268996|NCT01722994|468949732|FG001|Overall Study|Missing data|17|||
130268997|NCT01803880|468949736|FG000|Overall Study|Adverse Event|1|||
130268998|NCT01803880|468949737|FG001|Overall Study|Adverse Event|0|||
130268999|NCT01803880|468949738|FG002|Overall Study|Adverse Event|0|||
130269000|NCT01803880|468949736|FG000|Overall Study|Withdrawal by Subject|1|||
130269001|NCT01803880|468949737|FG001|Overall Study|Withdrawal by Subject|1|||
130269002|NCT01803880|468949738|FG002|Overall Study|Withdrawal by Subject|4|||
130269003|NCT01803880|468949736|FG000|Overall Study|Physician Decision|0|||
130269004|NCT01803880|468949737|FG001|Overall Study|Physician Decision|0|||
130269005|NCT01803880|468949738|FG002|Overall Study|Physician Decision|1|||
130269006|NCT01803880|468949736|FG000|Overall Study|Unable to return for follow-up visits|0|||
130269007|NCT01803880|468949737|FG001|Overall Study|Unable to return for follow-up visits|1|||
130269008|NCT01803880|468949738|FG002|Overall Study|Unable to return for follow-up visits|2|||
130269009|NCT01803880|468949736|FG000|Overall Study|Lost to Follow-up|1|||
130269010|NCT01803880|468949737|FG001|Overall Study|Lost to Follow-up|2|||
130269011|NCT01803880|468949738|FG002|Overall Study|Lost to Follow-up|3|||
130269012|NCT01803880|468949736|FG000|Overall Study|Protocol Violation|1|||
130269013|NCT01803880|468949737|FG001|Overall Study|Protocol Violation|0|||
130269014|NCT01803880|468949738|FG002|Overall Study|Protocol Violation|0|||
130269015|NCT01803880|468949736|FG000|Overall Study|Early study termination|0|||
130269016|NCT01803880|468949737|FG001|Overall Study|Early study termination|6|||
130269017|NCT01803880|468949738|FG002|Overall Study|Early study termination|5|||
130269018|NCT01803880|468949736|FG000|Overall Study|Incomplete data entry by sites|2|||
130269019|NCT01803880|468949737|FG001|Overall Study|Incomplete data entry by sites|0|||
130269020|NCT01803880|468949738|FG002|Overall Study|Incomplete data entry by sites|0|||
130269021|NCT05384834|468949739|FG000|Overall Study|Lost to Follow-up|43|||
130269022|NCT05384834|468949739|FG000|Overall Study|Withdrawal by Subject|5|||
130269023|NCT01881789|468949741|FG000|Overall Study|Withdrawal by Subject|0|||
130269024|NCT01881789|468949742|FG001|Overall Study|Withdrawal by Subject|2|||
130269025|NCT01881789|468949743|FG002|Overall Study|Withdrawal by Subject|1|||
130269026|NCT01881789|468949744|FG003|Overall Study|Withdrawal by Subject|0|||
130269027|NCT01881789|468949745|FG004|Overall Study|Withdrawal by Subject|1|||
130269028|NCT01881789|468949746|FG005|Overall Study|Withdrawal by Subject|1|||
130554261|NCT01372410|469996536|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
130554262|NCT01372410|469996537|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
130554263|NCT01372410|469996530|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130554264|NCT01372410|469996531|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130269029|NCT01881789|468949741|FG000|Overall Study|Study Terminated by Sponsor|0|||
130269030|NCT01881789|468949742|FG001|Overall Study|Study Terminated by Sponsor|0|||
130269031|NCT01881789|468949743|FG002|Overall Study|Study Terminated by Sponsor|0|||
130269032|NCT01881789|468949744|FG003|Overall Study|Study Terminated by Sponsor|0|||
130269033|NCT01881789|468949745|FG004|Overall Study|Study Terminated by Sponsor|0|||
130269034|NCT01881789|468949746|FG005|Overall Study|Study Terminated by Sponsor|1|||
130269035|NCT01881789|468949741|FG000|Overall Study|Other|3|||
130269036|NCT01881789|468949742|FG001|Overall Study|Other|5|||
130269037|NCT01881789|468949743|FG002|Overall Study|Other|2|||
130269038|NCT01881789|468949744|FG003|Overall Study|Other|3|||
130269039|NCT01881789|468949745|FG004|Overall Study|Other|1|||
130269040|NCT01881789|468949746|FG005|Overall Study|Other|1|||
130269041|NCT02041299|468949749|FG000|Overall Study|Adverse Event|9|||
130269042|NCT02041299|468949750|FG001|Overall Study|Adverse Event|3|||
130269043|NCT02041299|468949749|FG000|Overall Study|Lost to Follow-up|4|||
130269044|NCT02041299|468949750|FG001|Overall Study|Lost to Follow-up|1|||
130269045|NCT02041299|468949749|FG000|Overall Study|Physician Decision|1|||
130269046|NCT02041299|468949750|FG001|Overall Study|Physician Decision|1|||
130269047|NCT02041299|468949749|FG000|Overall Study|Withdrawal by Subject|13|||
130269048|NCT02041299|468949750|FG001|Overall Study|Withdrawal by Subject|7|||
130366622|NCT02323113|469313972|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
130366623|NCT02323113|469313973|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130366624|NCT02323113|469313974|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
130366625|NCT02323113|469313967|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366626|NCT02323113|469313968|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
130366627|NCT02323113|469313969|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366628|NCT02323113|469313970|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366629|NCT02323113|469313971|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366630|NCT02323113|469313972|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366631|NCT02323113|469313973|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366632|NCT02323113|469313974|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130366633|NCT01663532|469313975|FG000|Overall Study|Lost to Follow-up|9|||
130366634|NCT01663532|469313976|FG001|Overall Study|Lost to Follow-up|10|||
130366635|NCT01663532|469313975|FG000|Overall Study|Adverse Event|7|||
130366636|NCT01663532|469313976|FG001|Overall Study|Adverse Event|13|||
130366637|NCT01663532|469313975|FG000|Overall Study|Met Withdrawal Criteria|7|||
130366638|NCT01663532|469313976|FG001|Overall Study|Met Withdrawal Criteria|6|||
130366639|NCT01663532|469313975|FG000|Overall Study|Physician Decision|1|||
130366640|NCT01663532|469313976|FG001|Overall Study|Physician Decision|1|||
130366641|NCT01663532|469313975|FG000|Overall Study|Withdrawal by Subject|35|||
130366642|NCT01663532|469313976|FG001|Overall Study|Withdrawal by Subject|17|||
130366643|NCT01663532|469313975|FG000|Overall Study|Lack of Efficacy|15|||
130366644|NCT01663532|469313976|FG001|Overall Study|Lack of Efficacy|60|||
130366645|NCT03539081|469313982|FG000|Overall Study|Withdrawal by Subject|2|||
130366646|NCT03539081|469313983|FG001|Overall Study|Withdrawal by Subject|3|||
130366647|NCT03539081|469313984|FG002|Overall Study|Withdrawal by Subject|0|||
130366648|NCT03539081|469313982|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
130366649|NCT03539081|469313983|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
130366650|NCT03539081|469313984|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
130366651|NCT01673867|469313987|FG000|Randomization|Adverse event unrelated to study drug|1|||
130366652|NCT01673867|469313988|FG001|Randomization|Adverse event unrelated to study drug|0|||
130366653|NCT01673867|469313987|FG000|Randomization|Participant request to discontinue study treatment|0|||
130366654|NCT01673867|469313988|FG001|Randomization|Participant request to discontinue study treatment|4|||
130366655|NCT01673867|469313987|FG000|Randomization|Withdrawal by participant|0|||
130366656|NCT01673867|469313988|FG001|Randomization|Withdrawal by participant|12|||
130366657|NCT01673867|469313987|FG000|Randomization|Lost to Follow-up|0|||
130366658|NCT01673867|469313988|FG001|Randomization|Lost to Follow-up|1|||
130366659|NCT01673867|469313987|FG000|Randomization|Participant no longer meets study criteria|4|||
130366660|NCT01673867|469313988|FG001|Randomization|Participant no longer meets study criteria|5|||
130366661|NCT01673867|469313987|FG000|Treatment|Disease Progression|208|||
130366662|NCT01673867|469313988|FG001|Treatment|Disease Progression|178|||
130366663|NCT01673867|469313987|FG000|Treatment|Study Drug Toxicity|23|||
130366664|NCT01673867|469313988|FG001|Treatment|Study Drug Toxicity|43|||
130366665|NCT01673867|469313987|FG000|Treatment|Death|2|||
130366666|NCT01673867|469313988|FG001|Treatment|Death|3|||
130366667|NCT01673867|469313987|FG000|Treatment|Adverse event unrelated to study drug|23|||
130366668|NCT01673867|469313988|FG001|Treatment|Adverse event unrelated to study drug|10|||
130366669|NCT01673867|469313987|FG000|Treatment|Participant request to discontinue study treatment|7|||
130366670|NCT01673867|469313988|FG001|Treatment|Participant request to discontinue study treatment|17|||
130366671|NCT01673867|469313987|FG000|Treatment|Withdrawal by participant|5|||
130455170|NCT01090024|469631269|FG001|Period 1|Adverse Event|0|||
130455171|NCT01090024|469631270|FG002|Period 1|Adverse Event|0|||
130455172|NCT01090024|469631271|FG003|Period 1|Adverse Event|0|||
130269049|NCT02041299|468949749|FG000|Overall Study|Protocol Violation|11|||
130269050|NCT02041299|468949750|FG001|Overall Study|Protocol Violation|4|||
130269051|NCT02041299|468949749|FG000|Overall Study|Termination of the study|7|||
130269052|NCT02041299|468949750|FG001|Overall Study|Termination of the study|3|||
130269053|NCT02041299|468949749|FG000|Overall Study|Required bone marrow transplant|0|||
130269054|NCT02041299|468949750|FG001|Overall Study|Required bone marrow transplant|1|||
130269055|NCT02041299|468949749|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
130269056|NCT02041299|468949750|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
130269057|NCT01635998|468949751|FG000|Overall Study|Death|1|||
130269058|NCT01635998|468949752|FG001|Overall Study|Death|1|||
130269059|NCT01635998|468949751|FG000|Overall Study|Lost to Follow-up|2|||
130269060|NCT01635998|468949752|FG001|Overall Study|Lost to Follow-up|1|||
130269061|NCT01635998|468949751|FG000|Overall Study|Withdrawal by Subject|1|||
130269062|NCT01635998|468949752|FG001|Overall Study|Withdrawal by Subject|5|||
130269063|NCT01162473|468949756|FG000|Overall Study|Adverse Event|2|||
130269064|NCT01162473|468949757|FG001|Overall Study|Adverse Event|1|||
130269065|NCT01162473|468949756|FG000|Overall Study|Withdrawal by Subject|0|||
130269066|NCT01162473|468949757|FG001|Overall Study|Withdrawal by Subject|4|||
130269067|NCT00943761|468949768|FG000|Overall Study|Lost to Follow-up|2|||
130269068|NCT00943761|468949769|FG001|Overall Study|Lost to Follow-up|0|||
130269069|NCT00943761|468949768|FG000|Overall Study|Withdrawal by Subject|2|||
130269070|NCT00943761|468949769|FG001|Overall Study|Withdrawal by Subject|1|||
130269071|NCT02268383|468949770|FG000|Overall Study|Death|12|||
130269072|NCT02268383|468949770|FG000|Overall Study|Lost to Follow-up|2|||
130269073|NCT02268383|468949770|FG000|Overall Study|Withdrawal by Subject|9|||
130269074|NCT02268383|468949770|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
130269075|NCT02268383|468949770|FG000|Overall Study|Protocol deviation|3|||
130269076|NCT02268383|468949770|FG000|Overall Study|Sponsor decision|22|||
130269077|NCT02268383|468949770|FG000|Overall Study|Not reported|12|||
130269078|NCT02708680|468949771|FG000|Overall Study|Withdrawal by Subject|4|||
130269079|NCT02708680|468949772|FG001|Overall Study|Withdrawal by Subject|12|||
130269080|NCT02708680|468949773|FG002|Overall Study|Withdrawal by Subject|12|||
130269081|NCT02708680|468949771|FG000|Overall Study|Death|4|||
130269082|NCT02708680|468949772|FG001|Overall Study|Death|19|||
130269083|NCT02708680|468949773|FG002|Overall Study|Death|21|||
130269084|NCT02708680|468949771|FG000|Overall Study|Lost to Follow-up|0|||
130269085|NCT02708680|468949772|FG001|Overall Study|Lost to Follow-up|3|||
130269086|NCT02708680|468949773|FG002|Overall Study|Lost to Follow-up|3|||
130269087|NCT02708680|468949771|FG000|Overall Study|Study Terminated By Sponsor|0|||
130269088|NCT02708680|468949772|FG001|Overall Study|Study Terminated By Sponsor|5|||
130269089|NCT02708680|468949773|FG002|Overall Study|Study Terminated By Sponsor|4|||
130269090|NCT02708680|468949771|FG000|Overall Study|Other than Specified|0|||
130269091|NCT02708680|468949772|FG001|Overall Study|Other than Specified|0|||
130269092|NCT02708680|468949773|FG002|Overall Study|Other than Specified|1|||
130269093|NCT02708680|468949771|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130269094|NCT02708680|468949772|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
130269095|NCT02708680|468949773|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130269096|NCT01342926|468949774|FG000|Overall Study|Adverse Event|5|||
130269097|NCT01342926|468949775|FG001|Overall Study|Adverse Event|8|||
130269098|NCT01342926|468949776|FG002|Overall Study|Adverse Event|10|||
130269099|NCT01342926|468949777|FG003|Overall Study|Adverse Event|7|||
130269100|NCT01342926|468949774|FG000|Overall Study|Lost to Follow-up|0|||
130269101|NCT01342926|468949775|FG001|Overall Study|Lost to Follow-up|1|||
130269102|NCT01342926|468949776|FG002|Overall Study|Lost to Follow-up|1|||
130269103|NCT01342926|468949777|FG003|Overall Study|Lost to Follow-up|0|||
130269104|NCT01342926|468949774|FG000|Overall Study|Investigator Discretion|2|||
130269105|NCT01342926|468949775|FG001|Overall Study|Investigator Discretion|2|||
130269106|NCT01342926|468949776|FG002|Overall Study|Investigator Discretion|0|||
130269107|NCT01342926|468949777|FG003|Overall Study|Investigator Discretion|0|||
130269108|NCT01342926|468949774|FG000|Overall Study|Withdrawal by Subject|2|||
130269109|NCT01342926|468949775|FG001|Overall Study|Withdrawal by Subject|4|||
130269110|NCT01342926|468949776|FG002|Overall Study|Withdrawal by Subject|3|||
130269111|NCT01342926|468949777|FG003|Overall Study|Withdrawal by Subject|5|||
130269112|NCT04162470|468949778|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
130269113|NCT01544348|468949785|FG000|Overall Study|Lost to Follow-up|1|||
130269114|NCT01544348|468949786|FG001|Overall Study|Lost to Follow-up|0|||
130269115|NCT01544348|468949787|FG002|Overall Study|Lost to Follow-up|0|||
130269116|NCT01544348|468949788|FG003|Overall Study|Lost to Follow-up|0|||
130269117|NCT01544348|468949789|FG004|Overall Study|Lost to Follow-up|0|||
130269118|NCT01544348|468949790|FG005|Overall Study|Lost to Follow-up|0|||
130269119|NCT01544348|468949791|FG006|Overall Study|Lost to Follow-up|1|||
130269120|NCT01544348|468949792|FG007|Overall Study|Lost to Follow-up|0|||
130269121|NCT01544348|468949785|FG000|Overall Study|Withdrawal by Subject|1|||
130269122|NCT01544348|468949786|FG001|Overall Study|Withdrawal by Subject|0|||
130269123|NCT01544348|468949787|FG002|Overall Study|Withdrawal by Subject|0|||
130269124|NCT01544348|468949788|FG003|Overall Study|Withdrawal by Subject|0|||
130269125|NCT01544348|468949789|FG004|Overall Study|Withdrawal by Subject|1|||
130269126|NCT01544348|468949790|FG005|Overall Study|Withdrawal by Subject|2|||
130269127|NCT01544348|468949791|FG006|Overall Study|Withdrawal by Subject|1|||
130269128|NCT01544348|468949792|FG007|Overall Study|Withdrawal by Subject|0|||
130269129|NCT01544348|468949785|FG000|Overall Study|Physician Decision|0|||
130269130|NCT01544348|468949786|FG001|Overall Study|Physician Decision|0|||
130269131|NCT01544348|468949787|FG002|Overall Study|Physician Decision|0|||
130269132|NCT01544348|468949788|FG003|Overall Study|Physician Decision|0|||
130269133|NCT01544348|468949789|FG004|Overall Study|Physician Decision|0|||
130269134|NCT01544348|468949790|FG005|Overall Study|Physician Decision|1|||
130269135|NCT01544348|468949791|FG006|Overall Study|Physician Decision|0|||
130269136|NCT01544348|468949792|FG007|Overall Study|Physician Decision|0|||
130269137|NCT01445847|468949793|FG000|Overall Study|Protocol Violation|13|||
130269138|NCT01445847|468949794|FG001|Overall Study|Protocol Violation|14|||
130269139|NCT01445847|468949793|FG000|Overall Study|Missed Data|1|||
130269140|NCT01445847|468949794|FG001|Overall Study|Missed Data|0|||
130269141|NCT03008070|468949797|FG000|Overall Study|Adverse Event|3|||
130269142|NCT03008070|468949798|FG001|Overall Study|Adverse Event|3|||
130269143|NCT03008070|468949799|FG002|Overall Study|Adverse Event|3|||
130269144|NCT03008070|468949797|FG000|Overall Study|Lost to Follow-up|1|||
130269145|NCT03008070|468949798|FG001|Overall Study|Lost to Follow-up|1|||
130269146|NCT03008070|468949799|FG002|Overall Study|Lost to Follow-up|0|||
130269147|NCT03008070|468949797|FG000|Overall Study|Non compliance|0|||
130269148|NCT03008070|468949798|FG001|Overall Study|Non compliance|1|||
130269149|NCT03008070|468949799|FG002|Overall Study|Non compliance|1|||
130269150|NCT03008070|468949797|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130269151|NCT03008070|468949798|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
130269152|NCT03008070|468949799|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130269153|NCT03008070|468949797|FG000|Overall Study|Withdrawal by Subject|2|||
130269154|NCT03008070|468949798|FG001|Overall Study|Withdrawal by Subject|0|||
130269155|NCT03008070|468949799|FG002|Overall Study|Withdrawal by Subject|1|||
130269156|NCT03008070|468949797|FG000|Overall Study|Use of prohibited drug|0|||
130269157|NCT03008070|468949798|FG001|Overall Study|Use of prohibited drug|0|||
130269158|NCT03008070|468949799|FG002|Overall Study|Use of prohibited drug|2|||
130269159|NCT04409834|468949802|FG000|Overall Study|Death|55|||
130269160|NCT04409834|468949803|FG001|Overall Study|Death|62|||
130269161|NCT01365455|468949804|FG000|Induction Period|Adverse Event|5|||
130269162|NCT01365455|468949805|FG001|Induction Period|Adverse Event|3|||
130269163|NCT01365455|468949806|FG002|Induction Period|Adverse Event|4|||
130269164|NCT01365455|468949807|FG003|Induction Period|Adverse Event|0|||
130269165|NCT01365455|468949808|FG004|Induction Period|Adverse Event|0|||
130269166|NCT01365455|468949804|FG000|Induction Period|Lack of Efficacy|1|||
130269167|NCT01365455|468949805|FG001|Induction Period|Lack of Efficacy|1|||
130269168|NCT01365455|468949806|FG002|Induction Period|Lack of Efficacy|0|||
130269169|NCT01365455|468949807|FG003|Induction Period|Lack of Efficacy|0|||
130269170|NCT01365455|468949808|FG004|Induction Period|Lack of Efficacy|0|||
130269171|NCT01365455|468949804|FG000|Induction Period|Pregnancy|0|||
130269172|NCT01365455|468949805|FG001|Induction Period|Pregnancy|1|||
130269173|NCT01365455|468949806|FG002|Induction Period|Pregnancy|0|||
130269174|NCT01365455|468949807|FG003|Induction Period|Pregnancy|0|||
130269175|NCT01365455|468949808|FG004|Induction Period|Pregnancy|0|||
130269176|NCT01365455|468949804|FG000|Induction Period|Protocol deviation|0|||
130269177|NCT01365455|468949805|FG001|Induction Period|Protocol deviation|1|||
130269178|NCT01365455|468949806|FG002|Induction Period|Protocol deviation|1|||
130269179|NCT01365455|468949807|FG003|Induction Period|Protocol deviation|0|||
130269180|NCT01365455|468949808|FG004|Induction Period|Protocol deviation|0|||
130269181|NCT01365455|468949804|FG000|Induction Period|Subject/guardian decision|9|||
130269182|NCT01365455|468949805|FG001|Induction Period|Subject/guardian decision|1|||
130269183|NCT01365455|468949806|FG002|Induction Period|Subject/guardian decision|8|||
130269184|NCT01365455|468949807|FG003|Induction Period|Subject/guardian decision|0|||
130269185|NCT01365455|468949808|FG004|Induction Period|Subject/guardian decision|0|||
130269186|NCT01365455|468949804|FG000|Induction Period|Lost to Follow-up|0|||
130269187|NCT01365455|468949805|FG001|Induction Period|Lost to Follow-up|0|||
130269188|NCT01365455|468949806|FG002|Induction Period|Lost to Follow-up|3|||
130269189|NCT01365455|468949807|FG003|Induction Period|Lost to Follow-up|0|||
130269190|NCT01365455|468949808|FG004|Induction Period|Lost to Follow-up|0|||
130269191|NCT01365455|468949804|FG000|Maintenance Period|Adverse Event|12|||
130269192|NCT01365455|468949805|FG001|Maintenance Period|Adverse Event|5|||
130269193|NCT01365455|468949806|FG002|Maintenance Period|Adverse Event|1|||
130269194|NCT01365455|468949807|FG003|Maintenance Period|Adverse Event|2|||
130269195|NCT01365455|468949808|FG004|Maintenance Period|Adverse Event|4|||
130455173|NCT01090024|469631272|FG004|Period 1|Adverse Event|0|||
130269196|NCT01365455|468949804|FG000|Maintenance Period|Lack of Efficacy|10|||
130269197|NCT01365455|468949805|FG001|Maintenance Period|Lack of Efficacy|2|||
130269198|NCT01365455|468949806|FG002|Maintenance Period|Lack of Efficacy|0|||
130269199|NCT01365455|468949807|FG003|Maintenance Period|Lack of Efficacy|2|||
130269200|NCT01365455|468949808|FG004|Maintenance Period|Lack of Efficacy|2|||
130269201|NCT01365455|468949804|FG000|Maintenance Period|Lost to Follow-up|2|||
130269202|NCT01365455|468949805|FG001|Maintenance Period|Lost to Follow-up|4|||
130269203|NCT01365455|468949806|FG002|Maintenance Period|Lost to Follow-up|0|||
130269204|NCT01365455|468949807|FG003|Maintenance Period|Lost to Follow-up|0|||
130455174|NCT01090024|469631273|FG005|Period 1|Adverse Event|0|||
130455175|NCT01090024|469631274|FG006|Period 1|Adverse Event|0|||
130455176|NCT01090024|469631275|FG007|Period 1|Adverse Event|0|||
130455177|NCT01090024|469631276|FG008|Period 1|Adverse Event|0|||
130455178|NCT01090024|469631277|FG009|Period 1|Adverse Event|1|||
130455179|NCT01090024|469631278|FG010|Period 1|Adverse Event|0|||
130455180|NCT01090024|469631279|FG011|Period 1|Adverse Event|1|||
130455181|NCT01090024|469631280|FG012|Period 1|Adverse Event|0|||
130455182|NCT01090024|469631281|FG013|Period 1|Adverse Event|0|||
130455183|NCT01090024|469631282|FG014|Period 1|Adverse Event|0|||
130455184|NCT01090024|469631283|FG015|Period 1|Adverse Event|0|||
130455185|NCT01090024|469631284|FG016|Period 1|Adverse Event|0|||
130554265|NCT01372410|469996532|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130554266|NCT01372410|469996533|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130269205|NCT01365455|468949808|FG004|Maintenance Period|Lost to Follow-up|3|||
130269206|NCT01365455|468949804|FG000|Maintenance Period|Non-compliance with study treatment|0|||
130269207|NCT01365455|468949805|FG001|Maintenance Period|Non-compliance with study treatment|0|||
130269208|NCT01365455|468949806|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130269209|NCT01365455|468949807|FG003|Maintenance Period|Non-compliance with study treatment|1|||
130269210|NCT01365455|468949808|FG004|Maintenance Period|Non-compliance with study treatment|0|||
130269211|NCT01365455|468949804|FG000|Maintenance Period|Physician Decision|0|||
130269212|NCT01365455|468949805|FG001|Maintenance Period|Physician Decision|1|||
130269213|NCT01365455|468949806|FG002|Maintenance Period|Physician Decision|0|||
130269214|NCT01365455|468949807|FG003|Maintenance Period|Physician Decision|0|||
130269215|NCT01365455|468949808|FG004|Maintenance Period|Physician Decision|1|||
130269216|NCT01365455|468949804|FG000|Maintenance Period|Pregnancy|0|||
130269217|NCT01365455|468949805|FG001|Maintenance Period|Pregnancy|4|||
130269218|NCT01365455|468949806|FG002|Maintenance Period|Pregnancy|0|||
130269219|NCT01365455|468949807|FG003|Maintenance Period|Pregnancy|0|||
130269220|NCT01365455|468949808|FG004|Maintenance Period|Pregnancy|2|||
130269221|NCT01365455|468949804|FG000|Maintenance Period|Protocol deviation|1|||
130269222|NCT01365455|468949805|FG001|Maintenance Period|Protocol deviation|1|||
130269223|NCT01365455|468949806|FG002|Maintenance Period|Protocol deviation|0|||
130269224|NCT01365455|468949807|FG003|Maintenance Period|Protocol deviation|0|||
130269225|NCT01365455|468949808|FG004|Maintenance Period|Protocol deviation|0|||
130269226|NCT01365455|468949804|FG000|Maintenance Period|Subject/guardian decision|4|||
130269227|NCT01365455|468949805|FG001|Maintenance Period|Subject/guardian decision|6|||
130269228|NCT01365455|468949806|FG002|Maintenance Period|Subject/guardian decision|2|||
130269229|NCT01365455|468949807|FG003|Maintenance Period|Subject/guardian decision|4|||
130269230|NCT01365455|468949808|FG004|Maintenance Period|Subject/guardian decision|1|||
130269231|NCT00928187|468949809|FG000|Overall Study|Death|1|||
130269232|NCT00928187|468949810|FG001|Overall Study|Death|2|||
130269233|NCT00928187|468949811|FG002|Overall Study|Death|3|||
130269234|NCT00928187|468949809|FG000|Overall Study|Lost to Follow-up|1|||
130269235|NCT00928187|468949810|FG001|Overall Study|Lost to Follow-up|2|||
130269236|NCT00928187|468949811|FG002|Overall Study|Lost to Follow-up|1|||
130269237|NCT00928187|468949809|FG000|Overall Study|Withdrawal by Subject|0|||
130269238|NCT00928187|468949810|FG001|Overall Study|Withdrawal by Subject|1|||
130269239|NCT00928187|468949811|FG002|Overall Study|Withdrawal by Subject|1|||
130269240|NCT00928187|468949809|FG000|Overall Study|Protocol Violation|0|||
130269241|NCT00928187|468949810|FG001|Overall Study|Protocol Violation|1|||
130269242|NCT00928187|468949811|FG002|Overall Study|Protocol Violation|0|||
130269243|NCT04790279|468950846|FG000|Overall Study|Did not meet medication start criteria|27|||
130269244|NCT04790279|468950847|FG001|Overall Study|Did not meet medication start criteria|15|||
130269245|NCT04790279|468950846|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
130269246|NCT04790279|468950847|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
130269247|NCT04790279|468950846|FG000|Overall Study|Protocol Violation|8|||
130269248|NCT04790279|468950847|FG001|Overall Study|Protocol Violation|3|||
130269249|NCT04790279|468950846|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
130269250|NCT04790279|468950847|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
130269251|NCT00810277|468950860|FG000|Overall Study|Adverse Event|1|||
130269252|NCT02079909|468950863|FG000|Overall Study|Adverse Event|23|||
130269253|NCT02079909|468950864|FG001|Overall Study|Adverse Event|23|||
130269254|NCT02079909|468950865|FG002|Overall Study|Adverse Event|7|||
130269255|NCT02079909|468950863|FG000|Overall Study|Withdrawal by Subject|9|||
130455186|NCT01090024|469631285|FG017|Period 1|Adverse Event|1|||
130455187|NCT01090024|469631268|FG000|Period 1|Withdrawal by Subject|0|||
130269256|NCT02079909|468950864|FG001|Overall Study|Withdrawal by Subject|17|||
130269257|NCT02079909|468950865|FG002|Overall Study|Withdrawal by Subject|4|||
130269258|NCT02079909|468950863|FG000|Overall Study|Lost to Follow-up|2|||
130269259|NCT02079909|468950864|FG001|Overall Study|Lost to Follow-up|3|||
130269260|NCT02079909|468950865|FG002|Overall Study|Lost to Follow-up|1|||
130455188|NCT01090024|469631269|FG001|Period 1|Withdrawal by Subject|0|||
130455189|NCT01090024|469631270|FG002|Period 1|Withdrawal by Subject|0|||
130455190|NCT01090024|469631271|FG003|Period 1|Withdrawal by Subject|1|||
130455191|NCT01090024|469631272|FG004|Period 1|Withdrawal by Subject|0|||
130455192|NCT01090024|469631273|FG005|Period 1|Withdrawal by Subject|0|||
130455193|NCT01090024|469631274|FG006|Period 1|Withdrawal by Subject|0|||
130455194|NCT01090024|469631275|FG007|Period 1|Withdrawal by Subject|0|||
130455195|NCT01090024|469631276|FG008|Period 1|Withdrawal by Subject|0|||
130455196|NCT01090024|469631277|FG009|Period 1|Withdrawal by Subject|0|||
130455197|NCT01090024|469631278|FG010|Period 1|Withdrawal by Subject|0|||
130455198|NCT01090024|469631279|FG011|Period 1|Withdrawal by Subject|0|||
130455199|NCT01090024|469631280|FG012|Period 1|Withdrawal by Subject|0|||
130455200|NCT01090024|469631281|FG013|Period 1|Withdrawal by Subject|0|||
130455201|NCT01090024|469631282|FG014|Period 1|Withdrawal by Subject|0|||
130455202|NCT01090024|469631283|FG015|Period 1|Withdrawal by Subject|0|||
130455203|NCT01090024|469631284|FG016|Period 1|Withdrawal by Subject|0|||
130455204|NCT01090024|469631285|FG017|Period 1|Withdrawal by Subject|0|||
130455205|NCT01090024|469631268|FG000|Period 1|Lost to Follow-up|0|||
130455206|NCT01090024|469631269|FG001|Period 1|Lost to Follow-up|1|||
130455207|NCT01090024|469631270|FG002|Period 1|Lost to Follow-up|0|||
130455208|NCT01090024|469631271|FG003|Period 1|Lost to Follow-up|0|||
130455209|NCT01090024|469631272|FG004|Period 1|Lost to Follow-up|0|||
130455210|NCT01090024|469631273|FG005|Period 1|Lost to Follow-up|0|||
130455211|NCT01090024|469631274|FG006|Period 1|Lost to Follow-up|0|||
130455212|NCT01090024|469631275|FG007|Period 1|Lost to Follow-up|0|||
130455213|NCT01090024|469631276|FG008|Period 1|Lost to Follow-up|0|||
130455214|NCT01090024|469631277|FG009|Period 1|Lost to Follow-up|0|||
130455215|NCT01090024|469631278|FG010|Period 1|Lost to Follow-up|0|||
130455216|NCT01090024|469631279|FG011|Period 1|Lost to Follow-up|0|||
130455217|NCT01090024|469631280|FG012|Period 1|Lost to Follow-up|0|||
130455218|NCT01090024|469631281|FG013|Period 1|Lost to Follow-up|0|||
130455219|NCT01090024|469631282|FG014|Period 1|Lost to Follow-up|0|||
130455220|NCT01090024|469631283|FG015|Period 1|Lost to Follow-up|0|||
130455221|NCT01090024|469631284|FG016|Period 1|Lost to Follow-up|0|||
130455222|NCT01090024|469631285|FG017|Period 1|Lost to Follow-up|0|||
130455223|NCT01090024|469631268|FG000|Period 2|Lost to Follow-up|0|||
130455224|NCT01090024|469631269|FG001|Period 2|Lost to Follow-up|0|||
130455225|NCT01090024|469631270|FG002|Period 2|Lost to Follow-up|0|||
130455226|NCT01090024|469631271|FG003|Period 2|Lost to Follow-up|1|||
130455227|NCT01090024|469631272|FG004|Period 2|Lost to Follow-up|0|||
130455228|NCT01090024|469631273|FG005|Period 2|Lost to Follow-up|0|||
130455229|NCT01090024|469631274|FG006|Period 2|Lost to Follow-up|0|||
130455230|NCT01090024|469631275|FG007|Period 2|Lost to Follow-up|0|||
130455231|NCT01090024|469631276|FG008|Period 2|Lost to Follow-up|0|||
130455232|NCT01090024|469631277|FG009|Period 2|Lost to Follow-up|0|||
130455233|NCT01090024|469631278|FG010|Period 2|Lost to Follow-up|0|||
130455234|NCT01090024|469631279|FG011|Period 2|Lost to Follow-up|0|||
130554267|NCT01372410|469996534|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130554268|NCT01372410|469996535|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
130554269|NCT01372410|469996536|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130705688|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
130705689|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
130705690|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
130269261|NCT02079909|468950863|FG000|Overall Study|Death|2|||
130269262|NCT02079909|468950864|FG001|Overall Study|Death|2|||
130269263|NCT02079909|468950865|FG002|Overall Study|Death|0|||
130269264|NCT02079909|468950863|FG000|Overall Study|Lack of Efficacy|0|||
130269265|NCT02079909|468950864|FG001|Overall Study|Lack of Efficacy|0|||
130269266|NCT02079909|468950865|FG002|Overall Study|Lack of Efficacy|1|||
130269267|NCT02079909|468950863|FG000|Overall Study|Protocol Violation|0|||
130269268|NCT02079909|468950864|FG001|Overall Study|Protocol Violation|1|||
130269269|NCT02079909|468950865|FG002|Overall Study|Protocol Violation|1|||
130269270|NCT02079909|468950863|FG000|Overall Study|Physician Decision|0|||
130269271|NCT02079909|468950864|FG001|Overall Study|Physician Decision|1|||
130269272|NCT02079909|468950865|FG002|Overall Study|Physician Decision|1|||
130269273|NCT02079909|468950863|FG000|Overall Study|Relocation etc.|2|||
130705691|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
130705692|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
130705693|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
130705694|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
130269274|NCT02079909|468950864|FG001|Overall Study|Relocation etc.|2|||
130269275|NCT02079909|468950865|FG002|Overall Study|Relocation etc.|3|||
130269276|NCT00720356|468950870|FG000|Registration to Study|Determined to have methylated MGMT|67|||
130269277|NCT00720356|468950870|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130455235|NCT01090024|469631280|FG012|Period 2|Lost to Follow-up|0|||
130455236|NCT01090024|469631281|FG013|Period 2|Lost to Follow-up|0|||
130455237|NCT01090024|469631282|FG014|Period 2|Lost to Follow-up|0|||
130455238|NCT01090024|469631283|FG015|Period 2|Lost to Follow-up|0|||
130455239|NCT01090024|469631284|FG016|Period 2|Lost to Follow-up|0|||
130455240|NCT01090024|469631285|FG017|Period 2|Lost to Follow-up|0|||
130455241|NCT01090024|469631268|FG000|Period 2|Adverse Event|1|||
130455242|NCT01090024|469631269|FG001|Period 2|Adverse Event|0|||
130455243|NCT01090024|469631270|FG002|Period 2|Adverse Event|0|||
130269278|NCT00720356|468950870|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
130269279|NCT00720356|468950870|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
130269280|NCT00720356|468950870|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
130269281|NCT00720356|468950870|FG000|Follow up Until Death|Withdrawal by Subject|1|||
130269282|NCT00720356|468950870|FG000|Follow up Until Death|Alive at last data collection|4|||
130269283|NCT03145064|468950875|FG000|Overall Study|Death|24|||
130269284|NCT03145064|468950875|FG000|Overall Study|Lost to Follow-up|3|||
130269285|NCT03145064|468950875|FG000|Overall Study|Withdrawal by Subject|6|||
130269286|NCT03145064|468950875|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
130269287|NCT03145064|468950875|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
130269288|NCT01693250|468950876|FG000|Overall Study|Lost to Follow-up|2|||
130269289|NCT01693250|468950877|FG001|Overall Study|Lost to Follow-up|2|||
130269290|NCT00628446|468950878|FG000|Overall Study|Lost to Follow-up|3|||
130269291|NCT00628446|468950878|FG000|Overall Study|Withdrawal by Subject|1|||
130269292|NCT00628446|468950878|FG000|Overall Study|Protocol Violation|3|||
130269293|NCT01396187|468950879|FG000|Overall Study|Adverse Event|0|||
130269294|NCT01396187|468950880|FG001|Overall Study|Adverse Event|1|||
130269295|NCT01396187|468950881|FG002|Overall Study|Adverse Event|0|||
130269296|NCT01396187|468950882|FG003|Overall Study|Adverse Event|0|||
130269297|NCT01396187|468950883|FG004|Overall Study|Adverse Event|0|||
130269298|NCT01396187|468950879|FG000|Overall Study|Withdrawal by Subject|0|||
130269299|NCT01396187|468950880|FG001|Overall Study|Withdrawal by Subject|1|||
130455244|NCT01090024|469631271|FG003|Period 2|Adverse Event|0|||
130455245|NCT01090024|469631272|FG004|Period 2|Adverse Event|0|||
130455246|NCT01090024|469631273|FG005|Period 2|Adverse Event|0|||
130455247|NCT01090024|469631274|FG006|Period 2|Adverse Event|0|||
130455248|NCT01090024|469631275|FG007|Period 2|Adverse Event|0|||
130455249|NCT01090024|469631276|FG008|Period 2|Adverse Event|0|||
130455250|NCT01090024|469631277|FG009|Period 2|Adverse Event|0|||
130455251|NCT01090024|469631278|FG010|Period 2|Adverse Event|0|||
130455252|NCT01090024|469631279|FG011|Period 2|Adverse Event|0|||
130455253|NCT01090024|469631280|FG012|Period 2|Adverse Event|0|||
130455254|NCT01090024|469631281|FG013|Period 2|Adverse Event|0|||
130455255|NCT01090024|469631282|FG014|Period 2|Adverse Event|0|||
130455256|NCT01090024|469631283|FG015|Period 2|Adverse Event|0|||
130455257|NCT01090024|469631284|FG016|Period 2|Adverse Event|0|||
130455258|NCT01090024|469631285|FG017|Period 2|Adverse Event|0|||
130455259|NCT01090024|469631268|FG000|Period 3|Withdrawal by Subject|0|||
130455260|NCT01090024|469631269|FG001|Period 3|Withdrawal by Subject|0|||
130455261|NCT01090024|469631270|FG002|Period 3|Withdrawal by Subject|0|||
130455262|NCT01090024|469631271|FG003|Period 3|Withdrawal by Subject|0|||
130455263|NCT01090024|469631272|FG004|Period 3|Withdrawal by Subject|0|||
130455264|NCT01090024|469631273|FG005|Period 3|Withdrawal by Subject|0|||
130455265|NCT01090024|469631274|FG006|Period 3|Withdrawal by Subject|0|||
130455266|NCT01090024|469631275|FG007|Period 3|Withdrawal by Subject|0|||
130455267|NCT01090024|469631276|FG008|Period 3|Withdrawal by Subject|0|||
130455268|NCT01090024|469631277|FG009|Period 3|Withdrawal by Subject|0|||
130455269|NCT01090024|469631278|FG010|Period 3|Withdrawal by Subject|0|||
130455270|NCT01090024|469631279|FG011|Period 3|Withdrawal by Subject|0|||
130455271|NCT01090024|469631280|FG012|Period 3|Withdrawal by Subject|0|||
130455272|NCT01090024|469631281|FG013|Period 3|Withdrawal by Subject|0|||
130455273|NCT01090024|469631282|FG014|Period 3|Withdrawal by Subject|0|||
130455274|NCT01090024|469631283|FG015|Period 3|Withdrawal by Subject|1|||
130455275|NCT01090024|469631284|FG016|Period 3|Withdrawal by Subject|0|||
130455276|NCT01090024|469631285|FG017|Period 3|Withdrawal by Subject|0|||
130455277|NCT01090024|469631268|FG000|Period 3|Protocol Violation|0|||
130455278|NCT01090024|469631269|FG001|Period 3|Protocol Violation|0|||
130455279|NCT01090024|469631270|FG002|Period 3|Protocol Violation|0|||
130554270|NCT01372410|469996537|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
130554271|NCT04585646|469996538|FG000|First Intervention|Physician Decision|1|||
130269300|NCT01396187|468950881|FG002|Overall Study|Withdrawal by Subject|1|||
130269301|NCT01396187|468950882|FG003|Overall Study|Withdrawal by Subject|0|||
130269302|NCT01396187|468950883|FG004|Overall Study|Withdrawal by Subject|0|||
130269303|NCT01396187|468950879|FG000|Overall Study|Other|1|||
130269304|NCT01396187|468950880|FG001|Overall Study|Other|1|||
130269305|NCT01396187|468950881|FG002|Overall Study|Other|0|||
130269306|NCT01396187|468950882|FG003|Overall Study|Other|0|||
130269307|NCT01396187|468950883|FG004|Overall Study|Other|1|||
130269308|NCT01898286|468950884|FG000|Overall Study|Withdrawal by Subject|1|||
130455280|NCT01090024|469631271|FG003|Period 3|Protocol Violation|0|||
130455281|NCT01090024|469631272|FG004|Period 3|Protocol Violation|0|||
130455282|NCT01090024|469631273|FG005|Period 3|Protocol Violation|0|||
130455283|NCT01090024|469631274|FG006|Period 3|Protocol Violation|0|||
130455284|NCT01090024|469631275|FG007|Period 3|Protocol Violation|0|||
130455285|NCT01090024|469631276|FG008|Period 3|Protocol Violation|1|||
130455286|NCT01090024|469631277|FG009|Period 3|Protocol Violation|0|||
130455287|NCT01090024|469631278|FG010|Period 3|Protocol Violation|0|||
130455288|NCT01090024|469631279|FG011|Period 3|Protocol Violation|0|||
130455289|NCT01090024|469631280|FG012|Period 3|Protocol Violation|0|||
130455290|NCT01090024|469631281|FG013|Period 3|Protocol Violation|0|||
130455291|NCT01090024|469631282|FG014|Period 3|Protocol Violation|0|||
130455292|NCT01090024|469631283|FG015|Period 3|Protocol Violation|0|||
130455293|NCT01090024|469631284|FG016|Period 3|Protocol Violation|0|||
130455294|NCT01090024|469631285|FG017|Period 3|Protocol Violation|0|||
130455295|NCT01090024|469631268|FG000|Period 3|Adverse Event|0|||
130455296|NCT01090024|469631269|FG001|Period 3|Adverse Event|0|||
130455297|NCT01090024|469631270|FG002|Period 3|Adverse Event|0|||
130455298|NCT01090024|469631271|FG003|Period 3|Adverse Event|0|||
130455299|NCT01090024|469631272|FG004|Period 3|Adverse Event|0|||
130455300|NCT01090024|469631273|FG005|Period 3|Adverse Event|1|||
130455301|NCT01090024|469631274|FG006|Period 3|Adverse Event|0|||
130455302|NCT01090024|469631275|FG007|Period 3|Adverse Event|0|||
130455303|NCT01090024|469631276|FG008|Period 3|Adverse Event|0|||
130455304|NCT01090024|469631277|FG009|Period 3|Adverse Event|0|||
130455305|NCT01090024|469631278|FG010|Period 3|Adverse Event|0|||
130455306|NCT01090024|469631279|FG011|Period 3|Adverse Event|0|||
130455307|NCT01090024|469631280|FG012|Period 3|Adverse Event|0|||
130455308|NCT01090024|469631281|FG013|Period 3|Adverse Event|0|||
130455309|NCT01090024|469631282|FG014|Period 3|Adverse Event|0|||
130455310|NCT01090024|469631283|FG015|Period 3|Adverse Event|0|||
130455311|NCT01090024|469631284|FG016|Period 3|Adverse Event|0|||
130455312|NCT01090024|469631285|FG017|Period 3|Adverse Event|0|||
130455313|NCT00567879|469631290|FG000|Overall Study|Adverse Event|2|||
130455314|NCT00567879|469631291|FG001|Overall Study|Adverse Event|0|||
130455315|NCT00567879|469631292|FG002|Overall Study|Adverse Event|1|||
130455316|NCT00567879|469631293|FG003|Overall Study|Adverse Event|0|||
130455317|NCT00567879|469631294|FG004|Overall Study|Adverse Event|1|||
130455318|NCT00567879|469631295|FG005|Overall Study|Adverse Event|0|||
130455319|NCT00567879|469631290|FG000|Overall Study|Abnormal test procedure(s)|0|||
130455320|NCT00567879|469631291|FG001|Overall Study|Abnormal test procedure(s)|0|||
130455321|NCT00567879|469631292|FG002|Overall Study|Abnormal test procedure(s)|1|||
130455322|NCT00567879|469631293|FG003|Overall Study|Abnormal test procedure(s)|0|||
130455323|NCT00567879|469631294|FG004|Overall Study|Abnormal test procedure(s)|0|||
130455324|NCT00567879|469631295|FG005|Overall Study|Abnormal test procedure(s)|0|||
130455325|NCT00567879|469631290|FG000|Overall Study|Withdrawal by Subject|0|||
130455326|NCT00567879|469631291|FG001|Overall Study|Withdrawal by Subject|0|||
130455327|NCT00567879|469631292|FG002|Overall Study|Withdrawal by Subject|3|||
130455328|NCT00567879|469631293|FG003|Overall Study|Withdrawal by Subject|1|||
130455329|NCT00567879|469631294|FG004|Overall Study|Withdrawal by Subject|0|||
130455330|NCT00567879|469631295|FG005|Overall Study|Withdrawal by Subject|0|||
130455331|NCT00567879|469631290|FG000|Overall Study|New cancer therapy|0|||
130455332|NCT00567879|469631291|FG001|Overall Study|New cancer therapy|0|||
130455333|NCT00567879|469631292|FG002|Overall Study|New cancer therapy|1|||
130455334|NCT00567879|469631293|FG003|Overall Study|New cancer therapy|0|||
130455335|NCT00567879|469631294|FG004|Overall Study|New cancer therapy|0|||
130455336|NCT00567879|469631295|FG005|Overall Study|New cancer therapy|0|||
130455337|NCT00567879|469631290|FG000|Overall Study|Disease progression|5|||
130455338|NCT00567879|469631291|FG001|Overall Study|Disease progression|7|||
130455339|NCT00567879|469631292|FG002|Overall Study|Disease progression|15|||
130455340|NCT00567879|469631293|FG003|Overall Study|Disease progression|5|||
130455341|NCT00567879|469631294|FG004|Overall Study|Disease progression|11|||
130455342|NCT00567879|469631295|FG005|Overall Study|Disease progression|3|||
130455343|NCT00470626|469631296|FG000|Overall Study|Lost to Follow-up|10|||
130455344|NCT00470626|469631296|FG000|Overall Study|Withdrawal by Subject|7|||
130455345|NCT00777556|469631297|FG000|Overall Study|Inappropriate self-selection|34|||
130269309|NCT01898286|468950884|FG000|Overall Study|Protocol Violation|1|||
130269310|NCT01898286|468950884|FG000|Overall Study|Lost to Follow-up|1|||
130269311|NCT02257242|468950885|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
130269312|NCT02257242|468950886|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269313|NCT02257242|468950887|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269314|NCT02257242|468950888|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130455346|NCT00777556|469631297|FG000|Overall Study|Dispensed but did not use product|12|||
130455347|NCT00777556|469631297|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
130455348|NCT01729819|469631302|FG000|Overall Study|Adverse Event|2|||
130455349|NCT01729819|469631303|FG001|Overall Study|Adverse Event|4|||
130455350|NCT01729819|469631302|FG000|Overall Study|Lack of Efficacy|1|||
130455351|NCT01729819|469631303|FG001|Overall Study|Lack of Efficacy|0|||
130455352|NCT01729819|469631302|FG000|Overall Study|Lost to Follow-up|2|||
130455353|NCT01729819|469631303|FG001|Overall Study|Lost to Follow-up|0|||
130455354|NCT01729819|469631302|FG000|Overall Study|Other reason|1|||
130455355|NCT01729819|469631303|FG001|Overall Study|Other reason|0|||
130455356|NCT01729819|469631302|FG000|Overall Study|Protocol Violation|0|||
130455357|NCT01729819|469631303|FG001|Overall Study|Protocol Violation|1|||
130455358|NCT01729819|469631302|FG000|Overall Study|Withdrawal by Subject|0|||
130455359|NCT01729819|469631303|FG001|Overall Study|Withdrawal by Subject|2|||
130455360|NCT03646669|469631304|FG000|Overall Study|Withdrawal by Subject|5|||
130455361|NCT03646669|469631305|FG001|Overall Study|Withdrawal by Subject|0|||
130455362|NCT03439124|469631310|FG000|Overall Study|Adverse Event|2|||
130455363|NCT03439124|469631311|FG001|Overall Study|Adverse Event|0|||
130455364|NCT03439124|469631310|FG000|Overall Study|Lost to Follow-up|1|||
130455365|NCT03439124|469631311|FG001|Overall Study|Lost to Follow-up|0|||
130455366|NCT03439124|469631310|FG000|Overall Study|Other reasons|1|||
130455367|NCT03439124|469631311|FG001|Overall Study|Other reasons|0|||
130455368|NCT02049866|469631312|FG000|Overall Study|Withdrawal by Subject|1|||
130455369|NCT01117480|469631313|FG000|Overall Study|Protocol Violation|8|||
130455370|NCT01117480|469631313|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
130455371|NCT00920686|469631316|FG000|Overall Study|Lost to Follow-up|2|||
130455372|NCT00920686|469631317|FG001|Overall Study|Lost to Follow-up|3|||
130455373|NCT00920686|469631318|FG002|Overall Study|Lost to Follow-up|1|||
130455374|NCT00920686|469631316|FG000|Overall Study|Study drug dosing criteria not met|17|||
130455375|NCT00920686|469631317|FG001|Overall Study|Study drug dosing criteria not met|19|||
130455376|NCT00920686|469631318|FG002|Overall Study|Study drug dosing criteria not met|12|||
130455377|NCT00464672|469631319|FG000|Overall Study|withdrawal of consent|0|||
130455378|NCT00464672|469631320|FG001|Overall Study|withdrawal of consent|0|||
130455379|NCT00464672|469631321|FG002|Overall Study|withdrawal of consent|0|||
130455380|NCT00464672|469631322|FG003|Overall Study|withdrawal of consent|1|||
130455381|NCT00464672|469631323|FG004|Overall Study|withdrawal of consent|9|||
130455382|NCT00464672|469631324|FG005|Overall Study|withdrawal of consent|4|||
130455383|NCT00464672|469631319|FG000|Overall Study|Lost to Follow-up|25|||
130455384|NCT00464672|469631320|FG001|Overall Study|Lost to Follow-up|10|||
130455385|NCT00464672|469631321|FG002|Overall Study|Lost to Follow-up|0|||
130455386|NCT00464672|469631322|FG003|Overall Study|Lost to Follow-up|0|||
130455387|NCT00464672|469631323|FG004|Overall Study|Lost to Follow-up|1|||
130455388|NCT00464672|469631324|FG005|Overall Study|Lost to Follow-up|0|||
130455389|NCT00957229|469631326|FG000|Study Start|Adverse Event|0|||
130455390|NCT00957229|469631327|FG001|Study Start|Adverse Event|3|||
130455391|NCT00957229|469631326|FG000|Study Start|Disease Progression|1|||
130455392|NCT00957229|469631327|FG001|Study Start|Disease Progression|0|||
130455393|NCT00957229|469631326|FG000|Reallocated to or Continued Vismodegib|Death|1|||
130455394|NCT00957229|469631327|FG001|Reallocated to or Continued Vismodegib|Death|1|||
130455395|NCT00957229|469631326|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
130455396|NCT00957229|469631327|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
130455397|NCT04580303|469631328|FG000|Overall Study|Adverse Event|0|||
130455398|NCT04580303|469631329|FG001|Overall Study|Adverse Event|1|||
130455399|NCT04580303|469631330|FG002|Overall Study|Adverse Event|0|||
130455400|NCT04580303|469631331|FG003|Overall Study|Adverse Event|0|||
130455401|NCT04580303|469631328|FG000|Overall Study|Withdrawal by Subject|0|||
130455402|NCT04580303|469631329|FG001|Overall Study|Withdrawal by Subject|0|||
130455403|NCT04580303|469631330|FG002|Overall Study|Withdrawal by Subject|1|||
130455404|NCT04580303|469631331|FG003|Overall Study|Withdrawal by Subject|0|||
130455405|NCT00828672|469631333|FG000|Study Treatment|Lost to Follow-up|1|||
130455406|NCT00828672|469631334|FG001|Study Treatment|Lost to Follow-up|0|||
130455407|NCT00828672|469631333|FG000|Study Treatment|Adverse Event|0|||
130455408|NCT00828672|469631334|FG001|Study Treatment|Adverse Event|1|||
130455409|NCT00828672|469631333|FG000|Study Treatment|Complete response, no surgery|1|||
130455410|NCT00828672|469631334|FG001|Study Treatment|Complete response, no surgery|1|||
130455411|NCT00828672|469631333|FG000|Post-surgery (<30 Days)|No central review materials|0|||
130455412|NCT00828672|469631334|FG001|Post-surgery (<30 Days)|No central review materials|1|||
130455413|NCT01456936|469631342|FG000|Overall Study|Other reason|41|||
130455414|NCT01456936|469631343|FG001|Overall Study|Other reason|30|||
130455415|NCT01456936|469631344|FG002|Overall Study|Other reason|36|||
130455416|NCT01456936|469631345|FG003|Overall Study|Other reason|33|||
130455417|NCT01456936|469631342|FG000|Overall Study|No longer meets eligibility criteria|4|||
130455418|NCT01456936|469631343|FG001|Overall Study|No longer meets eligibility criteria|8|||
130455419|NCT01456936|469631344|FG002|Overall Study|No longer meets eligibility criteria|6|||
130455420|NCT01456936|469631345|FG003|Overall Study|No longer meets eligibility criteria|5|||
130455421|NCT01456936|469631342|FG000|Overall Study|Protocol Violation|4|||
130554272|NCT04585646|469996539|FG001|First Intervention|Physician Decision|0|||
130554273|NCT04585646|469996538|FG000|First Intervention|Lost to Follow-up|0|||
130554274|NCT04585646|469996539|FG001|First Intervention|Lost to Follow-up|3|||
130554275|NCT04585646|469996538|FG000|First Intervention|Withdrawal by Subject|0|||
130455422|NCT01456936|469631343|FG001|Overall Study|Protocol Violation|2|||
130455423|NCT01456936|469631344|FG002|Overall Study|Protocol Violation|5|||
130455424|NCT01456936|469631345|FG003|Overall Study|Protocol Violation|5|||
130455425|NCT01456936|469631342|FG000|Overall Study|Pregnancy|1|||
130455426|NCT01456936|469631343|FG001|Overall Study|Pregnancy|0|||
130455427|NCT01456936|469631344|FG002|Overall Study|Pregnancy|0|||
130455428|NCT01456936|469631345|FG003|Overall Study|Pregnancy|1|||
130455429|NCT01456936|469631342|FG000|Overall Study|Insufficient clinical response|4|||
130455430|NCT01456936|469631343|FG001|Overall Study|Insufficient clinical response|4|||
130455431|NCT01456936|469631344|FG002|Overall Study|Insufficient clinical response|14|||
130455432|NCT01456936|469631345|FG003|Overall Study|Insufficient clinical response|13|||
130455433|NCT01456936|469631342|FG000|Overall Study|No longer willing to participate|195|||
130455434|NCT01456936|469631343|FG001|Overall Study|No longer willing to participate|218|||
130455435|NCT01456936|469631344|FG002|Overall Study|No longer willing to participate|224|||
130455436|NCT01456936|469631345|FG003|Overall Study|No longer willing to participate|248|||
130455437|NCT01456936|469631342|FG000|Overall Study|Lost to Follow-up|135|||
130455438|NCT01456936|469631343|FG001|Overall Study|Lost to Follow-up|126|||
130455439|NCT01456936|469631344|FG002|Overall Study|Lost to Follow-up|144|||
130455440|NCT01456936|469631345|FG003|Overall Study|Lost to Follow-up|127|||
130455441|NCT01456936|469631342|FG000|Overall Study|Medication error|0|||
130455442|NCT01456936|469631343|FG001|Overall Study|Medication error|1|||
130455443|NCT01456936|469631344|FG002|Overall Study|Medication error|0|||
130455444|NCT01456936|469631345|FG003|Overall Study|Medication error|1|||
130455445|NCT01456936|469631342|FG000|Overall Study|Adverse event (study drug)|25|||
130455446|NCT01456936|469631343|FG001|Overall Study|Adverse event (study drug)|21|||
130455447|NCT01456936|469631344|FG002|Overall Study|Adverse event (study drug)|26|||
130455448|NCT01456936|469631345|FG003|Overall Study|Adverse event (study drug)|17|||
130455449|NCT01456936|469631342|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
130455450|NCT01456936|469631343|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
130455451|NCT01456936|469631344|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
130455452|NCT01456936|469631345|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
130455453|NCT01456936|469631342|FG000|Overall Study|Death|0|||
130455454|NCT01456936|469631343|FG001|Overall Study|Death|3|||
130455455|NCT01456936|469631344|FG002|Overall Study|Death|1|||
130455456|NCT01456936|469631345|FG003|Overall Study|Death|3|||
130269315|NCT02257242|468950889|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269316|NCT02257242|468950890|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269317|NCT02257242|468950891|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130455457|NCT01456936|469631342|FG000|Overall Study|Randomized but not treated|21|||
130455458|NCT01456936|469631343|FG001|Overall Study|Randomized but not treated|28|||
130455459|NCT01456936|469631344|FG002|Overall Study|Randomized but not treated|16|||
130455460|NCT01456936|469631345|FG003|Overall Study|Randomized but not treated|21|||
130455461|NCT01250002|469631346|FG000|Overall Study|Change to open surgical procedure|4|||
130455462|NCT01250002|469631347|FG001|Overall Study|Change to open surgical procedure|3|||
130269318|NCT02257242|468950892|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269319|NCT02257242|468950893|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269320|NCT01650831|468950900|FG000|Overall Study|Screen failure|1|||
130455463|NCT01710514|469631348|FG000|Overall Study|Adverse Event|6|||
130455464|NCT01710514|469631349|FG001|Overall Study|Adverse Event|7|||
130455465|NCT01710514|469631348|FG000|Overall Study|Withdrawal by Subject|1|||
130455466|NCT01710514|469631349|FG001|Overall Study|Withdrawal by Subject|0|||
130455467|NCT04044664|469631354|FG000|Stage 1|Adverse Event|3|||
130455468|NCT04044664|469631355|FG001|Stage 1|Adverse Event|3|||
130455469|NCT04044664|469631356|FG002|Stage 1|Adverse Event|1|||
130455470|NCT04044664|469631354|FG000|Stage 1|Lost to Follow-up|3|||
130455471|NCT04044664|469631355|FG001|Stage 1|Lost to Follow-up|2|||
130455472|NCT04044664|469631356|FG002|Stage 1|Lost to Follow-up|2|||
130455473|NCT04044664|469631354|FG000|Stage 1|Withdrawal by Subject|9|||
130455474|NCT04044664|469631355|FG001|Stage 1|Withdrawal by Subject|1|||
130455475|NCT04044664|469631356|FG002|Stage 1|Withdrawal by Subject|0|||
130455476|NCT04044664|469631354|FG000|Stage 1|noncompliance, personal reason|2|||
130455477|NCT04044664|469631355|FG001|Stage 1|noncompliance, personal reason|0|||
130455478|NCT04044664|469631356|FG002|Stage 1|noncompliance, personal reason|0|||
130455479|NCT04044664|469631354|FG000|Stage 1|randomization error|0|||
130455480|NCT04044664|469631355|FG001|Stage 1|randomization error|1|||
130455481|NCT04044664|469631356|FG002|Stage 1|randomization error|0|||
130455482|NCT04044664|469631354|FG000|Stage 2|Adverse Event|2|||
130455483|NCT04044664|469631355|FG001|Stage 2|Adverse Event|0|||
130269321|NCT01048242|468950903|FG000|Overall Study|See study flow chart|4|||
130269322|NCT01048242|468950904|FG001|Overall Study|See study flow chart|2|||
130455484|NCT04044664|469631356|FG002|Stage 2|Adverse Event|0|||
130269323|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
130455485|NCT04044664|469631354|FG000|Stage 2|Lost to Follow-up|3|||
130455486|NCT04044664|469631355|FG001|Stage 2|Lost to Follow-up|2|||
130455487|NCT04044664|469631356|FG002|Stage 2|Lost to Follow-up|1|||
130455488|NCT04044664|469631354|FG000|Stage 2|Withdrawal by Subject|3|||
130455489|NCT04044664|469631355|FG001|Stage 2|Withdrawal by Subject|0|||
130455490|NCT04044664|469631356|FG002|Stage 2|Withdrawal by Subject|0|||
130455491|NCT04044664|469631354|FG000|Stage 2|protocol deviation|1|||
130455492|NCT04044664|469631355|FG001|Stage 2|protocol deviation|0|||
130455493|NCT04044664|469631356|FG002|Stage 2|protocol deviation|0|||
130455494|NCT00001575|469631360|FG000|Overall Study|Screening failures-Ph I portion|22|||
130455495|NCT00001575|469631360|FG000|Overall Study|Withdrawn/deaths|23|||
130455496|NCT02750709|469631370|FG000|Treatment Period 1|Adverse Event|0|||
130455497|NCT02750709|469631371|FG001|Treatment Period 1|Adverse Event|0|||
130455498|NCT02750709|469631372|FG002|Treatment Period 1|Adverse Event|0|||
130455499|NCT02750709|469631373|FG003|Treatment Period 1|Adverse Event|0|||
130455500|NCT02750709|469631374|FG004|Treatment Period 1|Adverse Event|0|||
130455501|NCT02750709|469631375|FG005|Treatment Period 1|Adverse Event|1|||
130455502|NCT00290732|469631377|FG000|Overall Study|Inability to instill drug intraductally.|0|||
130269324|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130269325|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130455503|NCT00290732|469631378|FG001|Overall Study|Inability to instill drug intraductally.|1|||
130455504|NCT00290732|469631379|FG002|Overall Study|Inability to instill drug intraductally.|1|||
130455505|NCT00290732|469631380|FG003|Overall Study|Inability to instill drug intraductally.|0|||
130455506|NCT00290732|469631381|FG004|Overall Study|Inability to instill drug intraductally.|0|||
130455507|NCT02595398|469631382|FG000|Overall Study|Non-compliance|1|||
130455508|NCT02595398|469631383|FG001|Overall Study|Non-compliance|0|||
130455509|NCT02595398|469631382|FG000|Overall Study|Withdrawal by Subject|2|||
130455510|NCT02595398|469631383|FG001|Overall Study|Withdrawal by Subject|1|||
130455511|NCT02595398|469631382|FG000|Overall Study|Lost to Follow-up|1|||
130455512|NCT02595398|469631383|FG001|Overall Study|Lost to Follow-up|0|||
130455513|NCT00542386|469631384|FG000|Overall Study|Adverse Event|1|||
130455514|NCT00542386|469631385|FG001|Overall Study|Adverse Event|7|||
130455515|NCT00542386|469631386|FG002|Overall Study|Adverse Event|7|||
130455516|NCT00542386|469631387|FG003|Overall Study|Adverse Event|8|||
130455517|NCT00542386|469631388|FG004|Overall Study|Adverse Event|13|||
130455518|NCT00542386|469631389|FG005|Overall Study|Adverse Event|4|||
130455519|NCT00542386|469631384|FG000|Overall Study|Death|0|||
130455520|NCT00542386|469631385|FG001|Overall Study|Death|0|||
130455521|NCT00542386|469631386|FG002|Overall Study|Death|1|||
130455522|NCT00542386|469631387|FG003|Overall Study|Death|2|||
130455523|NCT00542386|469631388|FG004|Overall Study|Death|1|||
130455524|NCT00542386|469631389|FG005|Overall Study|Death|2|||
130455525|NCT00542386|469631384|FG000|Overall Study|Lack of Efficacy|32|||
130455526|NCT00542386|469631385|FG001|Overall Study|Lack of Efficacy|12|||
130455527|NCT00542386|469631386|FG002|Overall Study|Lack of Efficacy|10|||
130455528|NCT00542386|469631387|FG003|Overall Study|Lack of Efficacy|13|||
130455529|NCT00542386|469631388|FG004|Overall Study|Lack of Efficacy|7|||
130455530|NCT00542386|469631389|FG005|Overall Study|Lack of Efficacy|31|||
130455531|NCT00542386|469631384|FG000|Overall Study|Physician Decision|1|||
130455532|NCT00542386|469631385|FG001|Overall Study|Physician Decision|0|||
130455533|NCT00542386|469631386|FG002|Overall Study|Physician Decision|0|||
130455534|NCT00542386|469631387|FG003|Overall Study|Physician Decision|1|||
130455535|NCT00542386|469631388|FG004|Overall Study|Physician Decision|0|||
130455536|NCT00542386|469631389|FG005|Overall Study|Physician Decision|0|||
130455537|NCT00542386|469631384|FG000|Overall Study|Protocol Violation|0|||
130455538|NCT00542386|469631385|FG001|Overall Study|Protocol Violation|0|||
130455539|NCT00542386|469631386|FG002|Overall Study|Protocol Violation|1|||
130455540|NCT00542386|469631387|FG003|Overall Study|Protocol Violation|0|||
130455541|NCT00542386|469631388|FG004|Overall Study|Protocol Violation|0|||
130455542|NCT00542386|469631389|FG005|Overall Study|Protocol Violation|4|||
130455543|NCT00542386|469631384|FG000|Overall Study|Withdrawal by Subject|5|||
130455544|NCT00542386|469631385|FG001|Overall Study|Withdrawal by Subject|8|||
130455545|NCT00542386|469631386|FG002|Overall Study|Withdrawal by Subject|10|||
130455546|NCT00542386|469631387|FG003|Overall Study|Withdrawal by Subject|11|||
130455547|NCT00542386|469631388|FG004|Overall Study|Withdrawal by Subject|15|||
130455548|NCT00542386|469631389|FG005|Overall Study|Withdrawal by Subject|7|||
130455549|NCT00542386|469631384|FG000|Overall Study|Other Reasons|4|||
130554276|NCT04585646|469996539|FG001|First Intervention|Withdrawal by Subject|1|||
130554277|NCT02465463|469996541|FG000|Overall Study|Lost to Follow-up|2|||
130269326|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130269327|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130269328|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
130269329|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130269330|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130455550|NCT00542386|469631385|FG001|Overall Study|Other Reasons|1|||
130455551|NCT00542386|469631386|FG002|Overall Study|Other Reasons|4|||
130455552|NCT00542386|469631387|FG003|Overall Study|Other Reasons|3|||
130455553|NCT00542386|469631388|FG004|Overall Study|Other Reasons|4|||
130455554|NCT00542386|469631389|FG005|Overall Study|Other Reasons|2|||
130455555|NCT00197015|469631390|FG000|Overall Study|Adverse Event|3|||
130455556|NCT00197015|469631391|FG001|Overall Study|Adverse Event|0|||
130455557|NCT00197015|469631392|FG002|Overall Study|Adverse Event|1|||
130455558|NCT00197015|469631390|FG000|Overall Study|Protocol Violation|0|||
130554278|NCT02465463|469996542|FG001|Overall Study|Lost to Follow-up|1|||
130455559|NCT00197015|469631391|FG001|Overall Study|Protocol Violation|3|||
130455560|NCT00197015|469631392|FG002|Overall Study|Protocol Violation|3|||
130455561|NCT00197015|469631390|FG000|Overall Study|Withdrawal by Subject|17|||
130455562|NCT00197015|469631391|FG001|Overall Study|Withdrawal by Subject|37|||
130455563|NCT00197015|469631392|FG002|Overall Study|Withdrawal by Subject|34|||
130455564|NCT00197015|469631390|FG000|Overall Study|Lost to Follow-up|28|||
130455565|NCT00197015|469631391|FG001|Overall Study|Lost to Follow-up|46|||
130554279|NCT02465463|469996541|FG000|Overall Study|Death|1|||
130455566|NCT00197015|469631392|FG002|Overall Study|Lost to Follow-up|37|||
130455567|NCT00197015|469631390|FG000|Overall Study|Other|2|||
130455568|NCT00197015|469631391|FG001|Overall Study|Other|3|||
130455569|NCT00197015|469631392|FG002|Overall Study|Other|2|||
130455570|NCT02982213|469631395|FG000|Overall Study|Did not complete follow up questionnaire|5|||
130455571|NCT02982213|469631396|FG001|Overall Study|Did not complete follow up questionnaire|1|||
130455572|NCT01549652|469631397|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
130455573|NCT01549652|469631398|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
130455574|NCT01549652|469631399|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
130455575|NCT01549652|469631400|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
130455576|NCT01549652|469631397|FG000|Overall Study|Study Drug Titration Failure|5|||
130455577|NCT01549652|469631398|FG001|Overall Study|Study Drug Titration Failure|6|||
130455578|NCT01549652|469631399|FG002|Overall Study|Study Drug Titration Failure|0|||
130455579|NCT01549652|469631400|FG003|Overall Study|Study Drug Titration Failure|0|||
130455580|NCT01549652|469631397|FG000|Overall Study|Withdrawal Effect|0|||
130455581|NCT01549652|469631398|FG001|Overall Study|Withdrawal Effect|2|||
130455582|NCT01549652|469631399|FG002|Overall Study|Withdrawal Effect|0|||
130455583|NCT01549652|469631400|FG003|Overall Study|Withdrawal Effect|0|||
130455584|NCT01549652|469631397|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
130455585|NCT01549652|469631398|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
130455586|NCT01549652|469631399|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
130455587|NCT01549652|469631400|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
130455588|NCT01549652|469631397|FG000|Overall Study|Problem with Infusion|1|||
130455589|NCT01549652|469631398|FG001|Overall Study|Problem with Infusion|0|||
130455590|NCT01549652|469631399|FG002|Overall Study|Problem with Infusion|0|||
130455591|NCT01549652|469631400|FG003|Overall Study|Problem with Infusion|0|||
130455592|NCT01549652|469631397|FG000|Overall Study|Titration Non-Compliance|1|||
130455593|NCT01549652|469631398|FG001|Overall Study|Titration Non-Compliance|3|||
130455594|NCT01549652|469631399|FG002|Overall Study|Titration Non-Compliance|4|||
130455595|NCT01549652|469631400|FG003|Overall Study|Titration Non-Compliance|5|||
130455596|NCT01549652|469631397|FG000|Overall Study|Titration Side Effects|0|||
130455597|NCT01549652|469631398|FG001|Overall Study|Titration Side Effects|0|||
130455598|NCT01549652|469631399|FG002|Overall Study|Titration Side Effects|6|||
130455599|NCT01549652|469631400|FG003|Overall Study|Titration Side Effects|3|||
130455600|NCT01549652|469631397|FG000|Overall Study|Withdrawal by Subject|0|||
130455601|NCT01549652|469631398|FG001|Overall Study|Withdrawal by Subject|0|||
130455602|NCT01549652|469631399|FG002|Overall Study|Withdrawal by Subject|5|||
130455603|NCT01549652|469631400|FG003|Overall Study|Withdrawal by Subject|3|||
130705695|NCT01435031|470547307|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
130705696|NCT01435031|470547307|FG000|ITT at 1 Month|Death|1|||
130705697|NCT01435031|470547307|FG000|ITT at 1 Month|Lost to Follow-up|4|||
130705698|NCT01435031|470547307|FG000|ITT at 6 Months|Death|2|||
130269331|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
130269332|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
130269333|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
130269334|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
130554280|NCT02465463|469996542|FG001|Overall Study|Death|0|||
130554281|NCT02465463|469996541|FG000|Overall Study|Protocol Violation|1|||
130554282|NCT02465463|469996542|FG001|Overall Study|Protocol Violation|0|||
130554283|NCT01067326|469996545|FG000|Overall Study|Adverse Event|0|||
130554284|NCT01067326|469996546|FG001|Overall Study|Adverse Event|2|||
130269335|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269336|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269337|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269338|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
130269339|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
130455604|NCT00988637|469631412|FG000|Overall Study|Lost to Follow-up|2|||
130455605|NCT00988637|469631413|FG001|Overall Study|Lost to Follow-up|1|||
130455606|NCT00988637|469631412|FG000|Overall Study|Withdrawal by Subject|1|||
130455607|NCT00988637|469631413|FG001|Overall Study|Withdrawal by Subject|1|||
130554285|NCT01067326|469996545|FG000|Overall Study|Withdrawal by Subject|1|||
130554286|NCT01067326|469996546|FG001|Overall Study|Withdrawal by Subject|0|||
130455608|NCT00988637|469631412|FG000|Overall Study|non-compliance with study drug|0|||
130455609|NCT00988637|469631413|FG001|Overall Study|non-compliance with study drug|1|||
130455610|NCT03593070|469631414|FG000|Overall Study|administrative withdrawal|1|||
130455611|NCT03593070|469631415|FG001|Overall Study|administrative withdrawal|1|||
130455612|NCT01582945|469631416|FG000|Overall Study|Intolerable side-effects|1|||
130455613|NCT01582945|469631416|FG000|Overall Study|Scheduling conflicts|1|||
130455614|NCT02197234|469631417|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
130554287|NCT01067326|469996545|FG000|Overall Study|Early Study Termination|1|||
130554288|NCT01067326|469996546|FG001|Overall Study|Early Study Termination|1|||
130554289|NCT01230788|469996551|FG000|Overall Study|Prescribed exclusion drug|1|||
130705699|NCT01435031|470547307|FG000|ITT at 6 Months|Lost to Follow-up|3|||
130554290|NCT02411578|469996559|FG000|Crossover Trial Phase|Pregnancy|0|||
130705700|NCT01435031|470547307|FG000|ITT at 1 Year|Death|1|||
130705701|NCT01435031|470547307|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
130705702|NCT01435031|470547307|FG000|ITT at 1 Year|Lost to Follow-up|6|||
130269340|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
130269341|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
130269342|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
130269343|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130269344|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130269345|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
130269346|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
130269347|NCT01453036|468950910|FG000|Overall Study|Lost to Follow-up|26|||
130269348|NCT01453036|468950911|FG001|Overall Study|Lost to Follow-up|115|||
130269349|NCT01453036|468950912|FG002|Overall Study|Lost to Follow-up|31|||
130269350|NCT00559104|468950913|FG000|Overall Study|Lack of Efficacy|9|||
130269351|NCT00559104|468950914|FG001|Overall Study|Lack of Efficacy|0|||
130269352|NCT01336712|468950915|FG000|Overall Study|Death|2|||
130269353|NCT01336712|468950915|FG000|Overall Study|Lack of Efficacy|1|||
130269354|NCT00620373|468950917|FG000|Overall Study|Unverified cancer status|33|||
130269355|NCT03073525|468950918|FG000|Overall Study|Withdrawal by Subject|0|||
130269356|NCT03073525|468950919|FG001|Overall Study|Withdrawal by Subject|0|||
130269357|NCT03073525|468950920|FG002|Overall Study|Withdrawal by Subject|3|||
130269358|NCT01273038|468950921|FG000|Second Intervention (14 Days)|Adverse Event|0|||
130366672|NCT01673867|469313988|FG001|Treatment|Withdrawal by participant|5|||
130366673|NCT01673867|469313987|FG000|Treatment|Maximum clinical benefit|1|||
130366674|NCT01673867|469313988|FG001|Treatment|Maximum clinical benefit|10|||
130366675|NCT01673867|469313987|FG000|Treatment|Participant no longer meets study criteria|2|||
130366676|NCT01673867|469313988|FG001|Treatment|Participant no longer meets study criteria|0|||
130366677|NCT01673867|469313987|FG000|Treatment|Administrative reason by sponsor|3|||
130366678|NCT01673867|469313988|FG001|Treatment|Administrative reason by sponsor|0|||
130366679|NCT01673867|469313987|FG000|Treatment|Other reason|11|||
130366680|NCT01673867|469313988|FG001|Treatment|Other reason|2|||
130366681|NCT00799383|469313993|FG000|Overall Study|Protocol Violation|1|||
130366682|NCT00799383|469313994|FG001|Overall Study|Protocol Violation|1|||
130366683|NCT00799383|469313993|FG000|Overall Study|Adverse Event|0|||
130366684|NCT00799383|469313994|FG001|Overall Study|Adverse Event|1|||
130366685|NCT00799383|469313993|FG000|Overall Study|Lost to Follow-up|1|||
130366686|NCT00799383|469313994|FG001|Overall Study|Lost to Follow-up|2|||
130366687|NCT00799383|469313993|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
130366688|NCT00799383|469313994|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
130366689|NCT00799383|469313993|FG000|Overall Study|Withdrawal by Subject|0|||
130366690|NCT00799383|469313994|FG001|Overall Study|Withdrawal by Subject|1|||
130366691|NCT02165215|469314006|FG000|Induction Phase|Adverse Event|1|||
130366692|NCT02165215|469314007|FG001|Induction Phase|Adverse Event|0|||
130366693|NCT02165215|469314008|FG002|Induction Phase|Adverse Event|0|||
130366694|NCT02165215|469314006|FG000|Induction Phase|Withdrawal by Subject|10|||
130366695|NCT02165215|469314007|FG001|Induction Phase|Withdrawal by Subject|0|||
130366696|NCT02165215|469314008|FG002|Induction Phase|Withdrawal by Subject|0|||
130366697|NCT02165215|469314006|FG000|Induction Phase|Protocol Violation|1|||
130366698|NCT02165215|469314007|FG001|Induction Phase|Protocol Violation|0|||
130366699|NCT02165215|469314008|FG002|Induction Phase|Protocol Violation|0|||
130366700|NCT02165215|469314006|FG000|Induction Phase|Physician Decision|1|||
130366701|NCT02165215|469314007|FG001|Induction Phase|Physician Decision|0|||
130366702|NCT02165215|469314008|FG002|Induction Phase|Physician Decision|0|||
130366703|NCT02165215|469314006|FG000|Induction Phase|Lack of Efficacy|2|||
130366704|NCT02165215|469314007|FG001|Induction Phase|Lack of Efficacy|0|||
130366705|NCT02165215|469314008|FG002|Induction Phase|Lack of Efficacy|0|||
130366706|NCT02165215|469314006|FG000|Induction Phase|Non-Compliance|2|||
130366707|NCT02165215|469314007|FG001|Induction Phase|Non-Compliance|0|||
130366708|NCT02165215|469314008|FG002|Induction Phase|Non-Compliance|0|||
130366709|NCT02165215|469314006|FG000|Induction Phase|Lost to Follow-up|6|||
130366710|NCT02165215|469314007|FG001|Induction Phase|Lost to Follow-up|0|||
130366711|NCT02165215|469314008|FG002|Induction Phase|Lost to Follow-up|0|||
130366712|NCT02165215|469314006|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130366713|NCT02165215|469314007|FG001|Maintenance Phase|Withdrawal by Subject|7|||
130366714|NCT02165215|469314008|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130366715|NCT02165215|469314006|FG000|Maintenance Phase|Multiple reasons|0|||
130366716|NCT02165215|469314007|FG001|Maintenance Phase|Multiple reasons|2|||
130366717|NCT02165215|469314008|FG002|Maintenance Phase|Multiple reasons|1|||
130366718|NCT02165215|469314006|FG000|Maintenance Phase|Lost to Follow-up|0|||
130366719|NCT02165215|469314007|FG001|Maintenance Phase|Lost to Follow-up|2|||
130269359|NCT01273038|468950922|FG001|Second Intervention (14 Days)|Adverse Event|1|||
130269360|NCT01273038|468950921|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130366720|NCT02165215|469314008|FG002|Maintenance Phase|Lost to Follow-up|0|||
130705703|NCT01435031|470547307|FG000|ITT at 2 Years|Death|7|||
130455615|NCT02197234|469631417|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
130455616|NCT02197234|469631417|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
130455617|NCT02197234|469631417|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
130455618|NCT02197234|469631417|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
130455619|NCT02197234|469631417|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
130455620|NCT01543685|469631418|FG000|Overall Study|Lack of Efficacy|1|||
130455621|NCT01543685|469631419|FG001|Overall Study|Lack of Efficacy|2|||
130455622|NCT01543685|469631420|FG002|Overall Study|Lack of Efficacy|2|||
130705704|NCT01435031|470547307|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
130705705|NCT01435031|470547307|FG000|ITT at 2 Years|Lost to Follow-up|4|||
130705706|NCT01435031|470547307|FG000|ITT at 3 Years|Death|5|||
130705707|NCT01435031|470547307|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
130705708|NCT01435031|470547307|FG000|ITT at 3 Years|Lost to Follow-up|4|||
130705709|NCT01435031|470547307|FG000|ITT at 4 Years|Death|4|||
130705710|NCT01435031|470547307|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
130705711|NCT01435031|470547307|FG000|ITT at 4 Years|Lost to Follow-up|1|||
130705712|NCT02927834|470547308|FG000|Overall Study|Lost to Follow-up|1|||
130705713|NCT02927834|470547309|FG001|Overall Study|Lost to Follow-up|2|||
130705714|NCT02927834|470547310|FG002|Overall Study|Lost to Follow-up|2|||
130705715|NCT03234608|470547323|FG000|Overall Study|Lost to Follow-up|23|||
130705716|NCT03234608|470547324|FG001|Overall Study|Lost to Follow-up|21|||
130705717|NCT01662362|470547330|FG000|Overall Study|Lost to Follow-up|38|||
130705718|NCT01181531|470547335|FG000|Overall Study|Other|17|||
130705719|NCT01181531|470547336|FG001|Overall Study|Other|12|||
130705720|NCT01181531|470547335|FG000|Overall Study|Partial consent by subject withdrawn|0|||
130705721|NCT01181531|470547336|FG001|Overall Study|Partial consent by subject withdrawn|1|||
130705722|NCT01181531|470547335|FG000|Overall Study|Physician Decision|3|||
130705723|NCT01181531|470547336|FG001|Overall Study|Physician Decision|1|||
130705724|NCT01181531|470547335|FG000|Overall Study|Noncompliance|2|||
130705725|NCT01181531|470547336|FG001|Overall Study|Noncompliance|2|||
130705726|NCT01181531|470547335|FG000|Overall Study|Ineligibility determined|1|||
130705727|NCT01181531|470547336|FG001|Overall Study|Ineligibility determined|2|||
130705728|NCT01181531|470547335|FG000|Overall Study|Protocol Specified Criteria|15|||
130705729|NCT01181531|470547336|FG001|Overall Study|Protocol Specified Criteria|8|||
130705730|NCT01181531|470547335|FG000|Overall Study|Pregnancy|0|||
130705731|NCT01181531|470547336|FG001|Overall Study|Pregnancy|1|||
130705732|NCT01181531|470547335|FG000|Overall Study|Withdrawal by Subject|8|||
130705733|NCT01181531|470547336|FG001|Overall Study|Withdrawal by Subject|7|||
130705734|NCT01181531|470547335|FG000|Overall Study|Protocol Violation|6|||
130705735|NCT01181531|470547336|FG001|Overall Study|Protocol Violation|6|||
130705736|NCT01181531|470547335|FG000|Overall Study|Death|9|||
130705737|NCT01181531|470547336|FG001|Overall Study|Death|12|||
130705738|NCT01181531|470547335|FG000|Overall Study|Adverse Event|0|||
130705739|NCT01181531|470547336|FG001|Overall Study|Adverse Event|1|||
130705740|NCT00987831|470547337|FG000|Overall Study|Never flared in 12 months|1|||
130705741|NCT00987831|470547338|FG001|Overall Study|Never flared in 12 months|0|||
130705742|NCT00987831|470547339|FG002|Overall Study|Never flared in 12 months|0|||
130705743|NCT00987831|470547337|FG000|Overall Study|Lost to Follow-up|0|||
130705744|NCT00987831|470547338|FG001|Overall Study|Lost to Follow-up|3|||
130705745|NCT00987831|470547339|FG002|Overall Study|Lost to Follow-up|0|||
130705746|NCT02792218|470547341|FG000|Overall Study|Patient/guardian decision|15|||
130705747|NCT02792218|470547342|FG001|Overall Study|Patient/guardian decision|42|||
130705748|NCT02792218|470547341|FG000|Overall Study|Adverse Event|15|||
130705749|NCT02792218|470547342|FG001|Overall Study|Adverse Event|14|||
130269361|NCT01273038|468950922|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130269362|NCT01976299|468950923|FG000|Overall Study|Withdrawal by Subject|3|||
130269363|NCT01976299|468950924|FG001|Overall Study|Withdrawal by Subject|1|||
130269364|NCT01976299|468950923|FG000|Overall Study|Death|4|||
130455623|NCT01543685|469631421|FG003|Overall Study|Lack of Efficacy|0|||
130705750|NCT02792218|470547341|FG000|Overall Study|Lost to Follow-up|10|||
130705751|NCT02792218|470547342|FG001|Overall Study|Lost to Follow-up|5|||
130705752|NCT02792218|470547341|FG000|Overall Study|Lack of Efficacy|1|||
130455624|NCT01543685|469631422|FG004|Overall Study|Lack of Efficacy|2|||
130455625|NCT01543685|469631418|FG000|Overall Study|Adverse Event|2|||
130455626|NCT01543685|469631419|FG001|Overall Study|Adverse Event|1|||
130705753|NCT02792218|470547342|FG001|Overall Study|Lack of Efficacy|12|||
130705754|NCT02792218|470547341|FG000|Overall Study|Physician Decision|4|||
130705755|NCT02792218|470547342|FG001|Overall Study|Physician Decision|4|||
130705756|NCT02792218|470547341|FG000|Overall Study|Protocol deviation|3|||
130705757|NCT02792218|470547342|FG001|Overall Study|Protocol deviation|2|||
130705758|NCT02792218|470547341|FG000|Overall Study|New therapy for study indication|0|||
130269365|NCT01976299|468950924|FG001|Overall Study|Death|2|||
130705759|NCT02792218|470547342|FG001|Overall Study|New therapy for study indication|1|||
130705760|NCT02792218|470547341|FG000|Overall Study|Non-compliance with study treatment|0|||
130705761|NCT02792218|470547342|FG001|Overall Study|Non-compliance with study treatment|1|||
130705762|NCT02792218|470547341|FG000|Overall Study|Pregnancy|1|||
130705763|NCT02792218|470547342|FG001|Overall Study|Pregnancy|0|||
130705764|NCT00810602|470547343|FG000|Overall Study|Withdrawal by Subject|8|||
130269366|NCT01976299|468950923|FG000|Overall Study|Lost to Follow-up|7|||
130269367|NCT01976299|468950924|FG001|Overall Study|Lost to Follow-up|1|||
130269368|NCT01976299|468950923|FG000|Overall Study|See clarification above in comments|9|||
130269369|NCT01976299|468950924|FG001|Overall Study|See clarification above in comments|2|||
130269370|NCT01306643|468950925|FG000|Overall Study|Adverse Event|5|||
130269371|NCT01306643|468950925|FG000|Overall Study|Disease Progression|7|||
130269372|NCT01306643|468950925|FG000|Overall Study|Other: Change in Eligibility Status|1|||
130269373|NCT02071771|468950928|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
130269374|NCT02071771|468950929|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
130269375|NCT02071771|468950928|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
130269376|NCT02071771|468950929|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
130269377|NCT00355368|468950933|FG000|Overall Study|Protocol Violation|8|||
130269378|NCT00355368|468950934|FG001|Overall Study|Protocol Violation|7|||
130269379|NCT00355368|468950933|FG000|Overall Study|cardiac arrest prior to intubation|2|||
130269380|NCT00355368|468950934|FG001|Overall Study|cardiac arrest prior to intubation|2|||
130269381|NCT01152788|468950938|FG000|Overall Study|Withdrawal by Subject|0|||
130269382|NCT01152788|468950939|FG001|Overall Study|Withdrawal by Subject|3|||
130269383|NCT01152788|468950938|FG000|Overall Study|No treatment|0|||
130269384|NCT01152788|468950939|FG001|Overall Study|No treatment|1|||
130269385|NCT01282866|468950940|FG000|Overall Study|Adverse Event|1|||
130269386|NCT01964378|468950945|FG000|Overall Study|Disc. due to death before first dosing|0|||
130269387|NCT01964378|468950946|FG001|Overall Study|Disc. due to death before first dosing|1|||
130269388|NCT01964378|468950945|FG000|Overall Study|Disc. due to AE before first dosing|1|||
130269389|NCT01964378|468950946|FG001|Overall Study|Disc. due to AE before first dosing|0|||
130269390|NCT01964378|468950945|FG000|Overall Study|Death|3|||
130269391|NCT01964378|468950946|FG001|Overall Study|Death|2|||
130269392|NCT01964378|468950945|FG000|Overall Study|Adverse Event|12|||
130269393|NCT01964378|468950946|FG001|Overall Study|Adverse Event|5|||
130269394|NCT01964378|468950945|FG000|Overall Study|Lack of Efficacy|0|||
130269395|NCT01964378|468950946|FG001|Overall Study|Lack of Efficacy|1|||
130269396|NCT01964378|468950945|FG000|Overall Study|Protocol Violation|0|||
130269397|NCT01964378|468950946|FG001|Overall Study|Protocol Violation|1|||
130269398|NCT01964378|468950945|FG000|Overall Study|Lost to Follow-up|0|||
130269399|NCT01964378|468950946|FG001|Overall Study|Lost to Follow-up|1|||
130269400|NCT01964378|468950945|FG000|Overall Study|Withdrawal by Subject|7|||
130269401|NCT01964378|468950946|FG001|Overall Study|Withdrawal by Subject|5|||
130269402|NCT01964378|468950945|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130269403|NCT01964378|468950946|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130269404|NCT01964378|468950945|FG000|Overall Study|Other|1|||
130269405|NCT01964378|468950946|FG001|Overall Study|Other|2|||
130269406|NCT01928433|468950953|FG000|Overall Study|Adverse Event|5|||
130269407|NCT01928433|468950954|FG001|Overall Study|Adverse Event|2|||
130269408|NCT01928433|468950955|FG002|Overall Study|Adverse Event|5|||
130269409|NCT01928433|468950953|FG000|Overall Study|Protocol Violation|0|||
130269410|NCT01928433|468950954|FG001|Overall Study|Protocol Violation|0|||
130269411|NCT01928433|468950955|FG002|Overall Study|Protocol Violation|2|||
130269412|NCT01928433|468950953|FG000|Overall Study|Lack of Efficacy|5|||
130269413|NCT01928433|468950954|FG001|Overall Study|Lack of Efficacy|4|||
130269414|NCT01928433|468950955|FG002|Overall Study|Lack of Efficacy|4|||
130269415|NCT01928433|468950953|FG000|Overall Study|Withdrawal by Subject|0|||
130269416|NCT01928433|468950954|FG001|Overall Study|Withdrawal by Subject|4|||
130269417|NCT01928433|468950955|FG002|Overall Study|Withdrawal by Subject|0|||
130269418|NCT01928433|468950953|FG000|Overall Study|Negative screening urine culture|7|||
130269419|NCT01928433|468950954|FG001|Overall Study|Negative screening urine culture|6|||
130269420|NCT01928433|468950955|FG002|Overall Study|Negative screening urine culture|10|||
130269421|NCT01928433|468950953|FG000|Overall Study|Lost to Follow-up|0|||
130269422|NCT01928433|468950954|FG001|Overall Study|Lost to Follow-up|2|||
130269423|NCT01928433|468950955|FG002|Overall Study|Lost to Follow-up|3|||
130269424|NCT01928433|468950953|FG000|Overall Study|Other reasons|3|||
130269425|NCT01928433|468950954|FG001|Overall Study|Other reasons|3|||
130269426|NCT01928433|468950955|FG002|Overall Study|Other reasons|4|||
130269427|NCT01392573|468950956|FG000|Overall Study|Adverse Event|1|||
130269428|NCT01392573|468950957|FG001|Overall Study|Adverse Event|3|||
130269429|NCT01392573|468950956|FG000|Overall Study|Lack of Efficacy|1|||
130269430|NCT01392573|468950957|FG001|Overall Study|Lack of Efficacy|2|||
130269431|NCT01392573|468950956|FG000|Overall Study|Protocol Violation|0|||
130269432|NCT01392573|468950957|FG001|Overall Study|Protocol Violation|2|||
130366721|NCT02165215|469314006|FG000|Maintenance Phase|Adverse Event|0|||
130366722|NCT02165215|469314007|FG001|Maintenance Phase|Adverse Event|1|||
130269433|NCT01392573|468950956|FG000|Overall Study|Withdrawal Criteria|13|||
130269434|NCT01392573|468950957|FG001|Overall Study|Withdrawal Criteria|15|||
130366723|NCT02165215|469314008|FG002|Maintenance Phase|Adverse Event|1|||
130269435|NCT01392573|468950956|FG000|Overall Study|Site closure|8|||
130269436|NCT01392573|468950957|FG001|Overall Study|Site closure|7|||
130269437|NCT01392573|468950956|FG000|Overall Study|Unclassified|9|||
130269438|NCT01392573|468950957|FG001|Overall Study|Unclassified|6|||
130366724|NCT00612040|469314009|FG000|Overall Study|Adverse Event|0|||
130455627|NCT01543685|469631420|FG002|Overall Study|Adverse Event|0|||
130455628|NCT01543685|469631421|FG003|Overall Study|Adverse Event|0|||
130269439|NCT00436436|468950958|FG000|Overall Study|Progression|4|||
130269440|NCT00436436|468950958|FG000|Overall Study|Adverse Event|2|||
130455629|NCT01543685|469631422|FG004|Overall Study|Adverse Event|2|||
130455630|NCT02163915|469631423|FG000|Overall Study|Withdrawal by Subject|2|||
130455631|NCT02163915|469631424|FG001|Overall Study|Withdrawal by Subject|0|||
130455632|NCT02163915|469631425|FG002|Overall Study|Withdrawal by Subject|2|||
130455633|NCT02163915|469631426|FG003|Overall Study|Withdrawal by Subject|2|||
130455634|NCT02163915|469631427|FG004|Overall Study|Withdrawal by Subject|2|||
130455635|NCT02163915|469631423|FG000|Overall Study|Study termination|1|||
130455636|NCT02163915|469631424|FG001|Overall Study|Study termination|0|||
130455637|NCT02163915|469631425|FG002|Overall Study|Study termination|0|||
130455638|NCT02163915|469631426|FG003|Overall Study|Study termination|0|||
130455639|NCT02163915|469631427|FG004|Overall Study|Study termination|2|||
130455640|NCT02163915|469631423|FG000|Overall Study|Physician Decision|0|||
130455641|NCT02163915|469631424|FG001|Overall Study|Physician Decision|0|||
130455642|NCT02163915|469631425|FG002|Overall Study|Physician Decision|0|||
130455643|NCT02163915|469631426|FG003|Overall Study|Physician Decision|1|||
130269441|NCT00436436|468950958|FG000|Overall Study|Death|6|||
130269442|NCT01102491|468950965|FG000|Overall Study|Protocol Violation|11|||
130269443|NCT01102491|468950966|FG001|Overall Study|Protocol Violation|12|||
130269444|NCT02151786|468950967|FG000|Overall Study|Unavailability of Case Report Form|26|||
130269445|NCT02151786|468950967|FG000|Overall Study|Outside the Contract Period|1|||
130269446|NCT02151786|468950967|FG000|Overall Study|Randomized, not Treated|1|||
130269447|NCT02151786|468950967|FG000|Overall Study|Unavailability of Information|8|||
130269448|NCT03533660|468950968|FG000|Overall Study|Withdrawal by Subject|2|||
130269449|NCT03533660|468950969|FG001|Overall Study|Withdrawal by Subject|2|||
130269450|NCT03533660|468950968|FG000|Overall Study|Death|2|||
130269451|NCT03533660|468950969|FG001|Overall Study|Death|4|||
130269452|NCT03533660|468950968|FG000|Overall Study|Adverse Event|0|||
130269453|NCT03533660|468950969|FG001|Overall Study|Adverse Event|2|||
130269454|NCT00996658|468950970|FG000|Overall Study|Adverse Event|2|||
130269455|NCT00996658|468950971|FG001|Overall Study|Adverse Event|5|||
130269456|NCT00996658|468950970|FG000|Overall Study|Protocol Violation|0|||
130269457|NCT00996658|468950971|FG001|Overall Study|Protocol Violation|1|||
130269458|NCT00996658|468950970|FG000|Overall Study|Lost to Follow-up|2|||
130269459|NCT00996658|468950971|FG001|Overall Study|Lost to Follow-up|5|||
130269460|NCT00996658|468950970|FG000|Overall Study|Non-compliance issues|3|||
130269461|NCT00996658|468950971|FG001|Overall Study|Non-compliance issues|3|||
130269462|NCT00996658|468950970|FG000|Overall Study|Other|9|||
130269463|NCT00996658|468950971|FG001|Overall Study|Other|7|||
130269464|NCT03692403|468953032|FG000|Overall Study|Withdrawal by Subject|1|||
130269465|NCT03692403|468953033|FG001|Overall Study|Withdrawal by Subject|0|||
130269466|NCT03692403|468953034|FG002|Overall Study|Withdrawal by Subject|1|||
130269467|NCT03692403|468953035|FG003|Overall Study|Withdrawal by Subject|0|||
130269468|NCT03692403|468953032|FG000|Overall Study|Adverse Event|0|||
130269469|NCT03692403|468953033|FG001|Overall Study|Adverse Event|0|||
130269470|NCT03692403|468953034|FG002|Overall Study|Adverse Event|0|||
130455644|NCT02163915|469631427|FG004|Overall Study|Physician Decision|0|||
130455645|NCT02931396|469631428|FG000|Overall Study|Lost to Follow-up|3|||
130455646|NCT02931396|469631429|FG001|Overall Study|Lost to Follow-up|0|||
130455647|NCT02931396|469631428|FG000|Overall Study|Withdrawal by Subject|2|||
130455648|NCT02931396|469631429|FG001|Overall Study|Withdrawal by Subject|0|||
130455649|NCT01838200|469631434|FG000|Overall Study|Adverse Event|0|||
130455650|NCT01838200|469631435|FG001|Overall Study|Adverse Event|2|||
130455651|NCT01838200|469631434|FG000|Overall Study|Progressive disease|3|||
130455652|NCT01838200|469631435|FG001|Overall Study|Progressive disease|0|||
130455653|NCT03784963|469632740|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
130455654|NCT03784963|469632741|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
130455655|NCT03784963|469632742|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
130455656|NCT03784963|469632743|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
130455657|NCT03181958|469632744|FG000|Overall Study|Lost to Follow-up|17|||
130455658|NCT03181958|469632745|FG001|Overall Study|Lost to Follow-up|21|||
130455659|NCT03181958|469632746|FG002|Overall Study|Lost to Follow-up|15|||
130269471|NCT03692403|468953035|FG003|Overall Study|Adverse Event|1|||
130269472|NCT03692403|468953032|FG000|Overall Study|Pregnancy|0|||
130269473|NCT03692403|468953033|FG001|Overall Study|Pregnancy|1|||
130269474|NCT03692403|468953034|FG002|Overall Study|Pregnancy|0|||
130269475|NCT03692403|468953035|FG003|Overall Study|Pregnancy|0|||
130269476|NCT03692403|468953032|FG000|Overall Study|Other|0|||
130269477|NCT03692403|468953033|FG001|Overall Study|Other|0|||
130269478|NCT03692403|468953034|FG002|Overall Study|Other|1|||
130269479|NCT03692403|468953035|FG003|Overall Study|Other|0|||
130269480|NCT01147393|468953036|FG000|Dose Level 1|Dose limiting Toxicity|2|||
130269481|NCT01147393|468953036|FG000|Dose Level -1|Dose Limited Toxicity|1|||
130269482|NCT01408277|468953040|FG000|Overall Study|Adverse Event|3|||
130554291|NCT02411578|469996560|FG001|Crossover Trial Phase|Pregnancy|1|||
130554292|NCT01557348|469996563|FG000|Overall Study|Adverse Event|6|||
130554293|NCT01557348|469996564|FG001|Overall Study|Adverse Event|16|||
130554294|NCT01557348|469996563|FG000|Overall Study|Infusion reaction event|5|||
130554295|NCT01557348|469996564|FG001|Overall Study|Infusion reaction event|5|||
130554296|NCT01557348|469996563|FG000|Overall Study|Death|7|||
130554297|NCT01557348|469996564|FG001|Overall Study|Death|4|||
130554298|NCT01557348|469996563|FG000|Overall Study|Insufficient Therapeutic Response|13|||
130554299|NCT01557348|469996564|FG001|Overall Study|Insufficient Therapeutic Response|28|||
130554300|NCT01557348|469996563|FG000|Overall Study|Withdrawal by Subject|5|||
130554301|NCT01557348|469996564|FG001|Overall Study|Withdrawal by Subject|4|||
130554302|NCT01557348|469996563|FG000|Overall Study|Lost to Follow-up|26|||
130554303|NCT01557348|469996564|FG001|Overall Study|Lost to Follow-up|22|||
130554304|NCT01557348|469996563|FG000|Overall Study|Administrative|18|||
130554305|NCT01557348|469996564|FG001|Overall Study|Administrative|11|||
130554306|NCT02000427|469996569|FG000|Overall Study|Death|22|||
130554307|NCT02708095|469996572|FG000|Overall Study|Adverse Event|4|||
130554308|NCT02708095|469996573|FG001|Overall Study|Adverse Event|10|||
130554309|NCT02708095|469996574|FG002|Overall Study|Adverse Event|11|||
130554310|NCT02708095|469996572|FG000|Overall Study|Lack of Efficacy|9|||
130554311|NCT02708095|469996573|FG001|Overall Study|Lack of Efficacy|3|||
130554312|NCT02708095|469996574|FG002|Overall Study|Lack of Efficacy|0|||
130554313|NCT02708095|469996572|FG000|Overall Study|Lost to Follow-up|2|||
130554314|NCT02708095|469996573|FG001|Overall Study|Lost to Follow-up|0|||
130554315|NCT02708095|469996574|FG002|Overall Study|Lost to Follow-up|0|||
130554316|NCT02708095|469996572|FG000|Overall Study|Physician Decision|2|||
130554317|NCT02708095|469996573|FG001|Overall Study|Physician Decision|3|||
130554318|NCT02708095|469996574|FG002|Overall Study|Physician Decision|2|||
130554319|NCT02708095|469996572|FG000|Overall Study|Protocol Violation|0|||
130554320|NCT02708095|469996573|FG001|Overall Study|Protocol Violation|0|||
130554321|NCT02708095|469996574|FG002|Overall Study|Protocol Violation|1|||
130554322|NCT02708095|469996572|FG000|Overall Study|Withdrawal by Subject|5|||
130554323|NCT02708095|469996573|FG001|Overall Study|Withdrawal by Subject|3|||
130554324|NCT02708095|469996574|FG002|Overall Study|Withdrawal by Subject|4|||
130554325|NCT03891524|469996579|FG000|Overall Study|Death|0|||
130554326|NCT03891524|469996580|FG001|Overall Study|Death|0|||
130705765|NCT00810602|470547344|FG001|Overall Study|Withdrawal by Subject|3|||
130705766|NCT00824369|470547348|FG000|Overall Study|Nolonger willing to participate in study|1|||
130705767|NCT00824369|470547349|FG001|Overall Study|Nolonger willing to participate in study|0|||
130705768|NCT00824369|470547350|FG002|Overall Study|Nolonger willing to participate in study|1|||
130705769|NCT00824369|470547351|FG003|Overall Study|Nolonger willing to participate in study|2|||
130705770|NCT00824369|470547352|FG004|Overall Study|Nolonger willing to participate in study|0|||
130705771|NCT00824369|470547353|FG005|Overall Study|Nolonger willing to participate in study|1|||
130705772|NCT00824369|470547348|FG000|Overall Study|Lost to Follow-up|0|||
130705773|NCT00824369|470547349|FG001|Overall Study|Lost to Follow-up|0|||
130705774|NCT00824369|470547350|FG002|Overall Study|Lost to Follow-up|0|||
130705775|NCT00824369|470547351|FG003|Overall Study|Lost to Follow-up|0|||
130705776|NCT00824369|470547352|FG004|Overall Study|Lost to Follow-up|1|||
130705777|NCT00824369|470547353|FG005|Overall Study|Lost to Follow-up|0|||
130705778|NCT01619579|470549549|FG000|Overall Study|Withdrawal by Subject|0|||
130705779|NCT01619579|470549550|FG001|Overall Study|Withdrawal by Subject|3|||
130705780|NCT02012452|470549554|FG000|Overall Study|Lost to Follow-up|2|||
130705781|NCT02012452|470549555|FG001|Overall Study|Lost to Follow-up|1|||
130705782|NCT02012452|470549554|FG000|Overall Study|Withdrawal by Subject|4|||
130705783|NCT02012452|470549555|FG001|Overall Study|Withdrawal by Subject|0|||
130705784|NCT02688387|470549556|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705785|NCT02688387|470549557|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705786|NCT02688387|470549558|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
130705787|NCT02688387|470549559|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705788|NCT02688387|470549560|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705789|NCT02688387|470549561|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705790|NCT02688387|470549562|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705791|NCT02688387|470549563|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705792|NCT02688387|470549564|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705793|NCT02688387|470549565|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705794|NCT02688387|470549566|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705795|NCT02688387|470549567|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705796|NCT02688387|470549568|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705797|NCT02688387|470549569|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705798|NCT02688387|470549570|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705799|NCT02688387|470549571|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130554327|NCT03891524|469996581|FG002|Overall Study|Death|0|||
130554328|NCT03891524|469996582|FG003|Overall Study|Death|0|||
130554329|NCT03891524|469996583|FG004|Overall Study|Death|0|||
130554330|NCT03891524|469996584|FG005|Overall Study|Death|0|||
130554331|NCT03891524|469996585|FG006|Overall Study|Death|0|||
130554332|NCT03891524|469996586|FG007|Overall Study|Death|1|||
130455660|NCT01257503|469632747|FG000|Overall Study|Lost to Follow-up|7|||
130455661|NCT01257503|469632748|FG001|Overall Study|Lost to Follow-up|10|||
130269483|NCT01408277|468953041|FG001|Overall Study|Adverse Event|4|||
130269484|NCT01408277|468953040|FG000|Overall Study|Lost to Follow-up|1|||
130269485|NCT01408277|468953041|FG001|Overall Study|Lost to Follow-up|0|||
130269486|NCT01408277|468953040|FG000|Overall Study|Withdrawal by Subject|2|||
130269487|NCT01408277|468953041|FG001|Overall Study|Withdrawal by Subject|0|||
130269488|NCT01408277|468953040|FG000|Overall Study|Protocol Violation|2|||
130269489|NCT01408277|468953041|FG001|Overall Study|Protocol Violation|0|||
130269490|NCT01349673|468953042|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
130269491|NCT01349673|468953042|FG000|Overall Study|No Longer Qualified For Study|1|||
130269492|NCT01349673|468953042|FG000|Overall Study|Site Closure|10|||
130269493|NCT01349673|468953042|FG000|Overall Study|Withdrawal by Subject|21|||
130269494|NCT01349673|468953042|FG000|Overall Study|Lost to Follow-up|6|||
130269495|NCT01349673|468953042|FG000|Overall Study|Adverse Event|17|||
130269496|NCT01349673|468953042|FG000|Overall Study|Study Terminated By Sponsor|50|||
130269497|NCT01349673|468953042|FG000|Overall Study|Lack of Efficacy|8|||
130269498|NCT04263766|468953045|FG000|Overall Study|Withdrawal by Subject|6|||
130269499|NCT04263766|468953046|FG001|Overall Study|Withdrawal by Subject|4|||
130269500|NCT04263766|468953045|FG000|Overall Study|Lack of Efficacy|1|||
130269501|NCT04263766|468953046|FG001|Overall Study|Lack of Efficacy|3|||
130269502|NCT01891396|468953048|FG000|Overall Study|Withdrawal by Subject|4|||
130269503|NCT01891396|468953049|FG001|Overall Study|Withdrawal by Subject|4|||
130269504|NCT01891396|468953050|FG002|Overall Study|Withdrawal by Subject|3|||
130269505|NCT01891396|468953048|FG000|Overall Study|Lost to Follow-up|0|||
130269506|NCT01891396|468953049|FG001|Overall Study|Lost to Follow-up|1|||
130269507|NCT01891396|468953050|FG002|Overall Study|Lost to Follow-up|0|||
130269508|NCT00540592|468953051|FG000|Overall Study|Adverse Event|0|||
130269509|NCT00540592|468953052|FG001|Overall Study|Adverse Event|1|||
130269510|NCT00540592|468953053|FG002|Overall Study|Adverse Event|0|||
130269511|NCT00540592|468953054|FG003|Overall Study|Adverse Event|0|||
130269512|NCT00540592|468953055|FG004|Overall Study|Adverse Event|1|||
130269513|NCT00540592|468953056|FG005|Overall Study|Adverse Event|0|||
130269514|NCT00540592|468953057|FG006|Overall Study|Adverse Event|0|||
130269515|NCT00540592|468953058|FG007|Overall Study|Adverse Event|1|||
130269516|NCT00540592|468953059|FG008|Overall Study|Adverse Event|1|||
130269517|NCT00540592|468953060|FG009|Overall Study|Adverse Event|2|||
130269518|NCT00540592|468953051|FG000|Overall Study|Lost to Follow-up|2|||
130455662|NCT01257503|469632747|FG000|Overall Study|Over 5 years old at enrollment|0|||
130455663|NCT01257503|469632748|FG001|Overall Study|Over 5 years old at enrollment|1|||
130455664|NCT01257503|469632747|FG000|Overall Study|strep culture positive at enrollment|1|||
130455665|NCT01257503|469632748|FG001|Overall Study|strep culture positive at enrollment|0|||
130455666|NCT02987543|469632751|FG000|Overall Study|Ongoing study at data cut off|49|||
130455667|NCT02987543|469632752|FG001|Overall Study|Ongoing study at data cut off|21|||
130455668|NCT02987543|469632753|FG002|Overall Study|Ongoing study at data cut off|19|||
130455669|NCT02987543|469632754|FG003|Overall Study|Ongoing study at data cut off|12|||
130455670|NCT02987543|469632751|FG000|Overall Study|Death|88|||
130455671|NCT02987543|469632752|FG001|Overall Study|Death|54|||
130554333|NCT03891524|469996579|FG000|Overall Study|Withdrawal by Subject|0|||
130269519|NCT00540592|468953052|FG001|Overall Study|Lost to Follow-up|0|||
130269520|NCT00540592|468953053|FG002|Overall Study|Lost to Follow-up|0|||
130269521|NCT00540592|468953054|FG003|Overall Study|Lost to Follow-up|0|||
130269522|NCT00540592|468953055|FG004|Overall Study|Lost to Follow-up|0|||
130269523|NCT00540592|468953056|FG005|Overall Study|Lost to Follow-up|0|||
130269524|NCT00540592|468953057|FG006|Overall Study|Lost to Follow-up|0|||
130269525|NCT00540592|468953058|FG007|Overall Study|Lost to Follow-up|0|||
130455672|NCT02987543|469632753|FG002|Overall Study|Death|67|||
130269526|NCT00540592|468953059|FG008|Overall Study|Lost to Follow-up|0|||
130269527|NCT00540592|468953060|FG009|Overall Study|Lost to Follow-up|0|||
130269528|NCT00540592|468953051|FG000|Overall Study|Withdrawal by Subject|0|||
130269529|NCT00540592|468953052|FG001|Overall Study|Withdrawal by Subject|0|||
130269530|NCT00540592|468953053|FG002|Overall Study|Withdrawal by Subject|1|||
130269531|NCT00540592|468953054|FG003|Overall Study|Withdrawal by Subject|1|||
130269532|NCT00540592|468953055|FG004|Overall Study|Withdrawal by Subject|0|||
130269533|NCT00540592|468953056|FG005|Overall Study|Withdrawal by Subject|0|||
130269534|NCT00540592|468953057|FG006|Overall Study|Withdrawal by Subject|0|||
130269535|NCT00540592|468953058|FG007|Overall Study|Withdrawal by Subject|0|||
130269536|NCT00540592|468953059|FG008|Overall Study|Withdrawal by Subject|0|||
130269537|NCT00540592|468953060|FG009|Overall Study|Withdrawal by Subject|0|||
130269538|NCT01766037|468953061|FG000|Overall Study|Adverse Event|1|||
130269539|NCT01766037|468953062|FG001|Overall Study|Adverse Event|0|||
130269540|NCT01766037|468953061|FG000|Overall Study|Lack of Efficacy|1|||
130269541|NCT01766037|468953062|FG001|Overall Study|Lack of Efficacy|0|||
130269542|NCT01766037|468953061|FG000|Overall Study|Lost to Follow-up|0|||
130269543|NCT01766037|468953062|FG001|Overall Study|Lost to Follow-up|10|||
130269544|NCT01766037|468953061|FG000|Overall Study|Physician Decision|0|||
130269545|NCT01766037|468953062|FG001|Overall Study|Physician Decision|1|||
130269546|NCT01766037|468953061|FG000|Overall Study|Withdrawal by Subject|18|||
130269547|NCT01766037|468953062|FG001|Overall Study|Withdrawal by Subject|16|||
130269548|NCT01766037|468953061|FG000|Overall Study|Moved from area|5|||
130269549|NCT01766037|468953062|FG001|Overall Study|Moved from area|0|||
130269550|NCT01766037|468953061|FG000|Overall Study|medical - unrelated|1|||
130269551|NCT01766037|468953062|FG001|Overall Study|medical - unrelated|2|||
130269552|NCT01766037|468953061|FG000|Overall Study|nausea / discomfort|3|||
130269553|NCT01766037|468953062|FG001|Overall Study|nausea / discomfort|0|||
130269554|NCT02413996|468953063|FG000|Overall Study|not comfortable with the intervention|9|||
130455673|NCT02987543|469632754|FG003|Overall Study|Death|28|||
130269555|NCT02413996|468953064|FG001|Overall Study|not comfortable with the intervention|2|||
130269556|NCT03810014|468953067|FG000|Overall Study|Pregnancy|2|||
130269557|NCT03810014|468953068|FG001|Overall Study|Pregnancy|2|||
130269558|NCT03810014|468953069|FG002|Overall Study|Pregnancy|0|||
130269559|NCT03810014|468953070|FG003|Overall Study|Pregnancy|2|||
130269560|NCT03606486|468953071|FG000|Overall Study|Unable to collect sample|5|||
130269561|NCT01853462|468953080|FG000|Overall Study|Withdrawal by Subject|1|||
130269562|NCT01853462|468953081|FG001|Overall Study|Withdrawal by Subject|1|||
130455674|NCT02987543|469632751|FG000|Overall Study|Lost to Follow-up|3|||
130455675|NCT02987543|469632752|FG001|Overall Study|Lost to Follow-up|0|||
130455676|NCT02987543|469632753|FG002|Overall Study|Lost to Follow-up|1|||
130455677|NCT02987543|469632754|FG003|Overall Study|Lost to Follow-up|0|||
130455678|NCT02987543|469632751|FG000|Overall Study|Screen failure|0|||
130455679|NCT02987543|469632752|FG001|Overall Study|Screen failure|0|||
130455680|NCT02987543|469632753|FG002|Overall Study|Screen failure|0|||
130455681|NCT02987543|469632754|FG003|Overall Study|Screen failure|1|||
130455682|NCT02987543|469632751|FG000|Overall Study|Withdrawal by Subject|21|||
130455683|NCT02987543|469632752|FG001|Overall Study|Withdrawal by Subject|7|||
130455684|NCT02987543|469632753|FG002|Overall Study|Withdrawal by Subject|7|||
130455685|NCT02987543|469632754|FG003|Overall Study|Withdrawal by Subject|6|||
130455686|NCT02987543|469632751|FG000|Overall Study|Study terminated by sponsor|1|||
130455687|NCT02987543|469632752|FG001|Overall Study|Study terminated by sponsor|0|||
130455688|NCT02987543|469632753|FG002|Overall Study|Study terminated by sponsor|0|||
130455689|NCT02987543|469632754|FG003|Overall Study|Study terminated by sponsor|0|||
130455690|NCT02987543|469632751|FG000|Overall Study|Investigator decision|0|||
130455691|NCT02987543|469632752|FG001|Overall Study|Investigator decision|1|||
130455692|NCT02987543|469632753|FG002|Overall Study|Investigator decision|0|||
130269563|NCT03943290|468953082|FG000|Overall Study|Sponsor Terminated Study|6|||
130269564|NCT03943290|468953083|FG001|Overall Study|Sponsor Terminated Study|1|||
130269565|NCT03943290|468953084|FG002|Overall Study|Sponsor Terminated Study|11|||
130269566|NCT03943290|468953085|FG003|Overall Study|Sponsor Terminated Study|6|||
130269567|NCT03943290|468953086|FG004|Overall Study|Sponsor Terminated Study|7|||
130269568|NCT03943290|468953087|FG005|Overall Study|Sponsor Terminated Study|6|||
130269569|NCT03943290|468953088|FG006|Overall Study|Sponsor Terminated Study|6|||
130269570|NCT03943290|468953089|FG007|Overall Study|Sponsor Terminated Study|7|||
130269571|NCT03943290|468953090|FG008|Overall Study|Sponsor Terminated Study|8|||
130269572|NCT03943290|468953082|FG000|Overall Study|Lost to Follow-up|1|||
130269573|NCT03943290|468953083|FG001|Overall Study|Lost to Follow-up|0|||
130269574|NCT03943290|468953084|FG002|Overall Study|Lost to Follow-up|1|||
130269575|NCT03943290|468953085|FG003|Overall Study|Lost to Follow-up|0|||
130269576|NCT03943290|468953086|FG004|Overall Study|Lost to Follow-up|0|||
130269577|NCT03943290|468953087|FG005|Overall Study|Lost to Follow-up|0|||
130269578|NCT03943290|468953088|FG006|Overall Study|Lost to Follow-up|0|||
130269579|NCT03943290|468953089|FG007|Overall Study|Lost to Follow-up|1|||
130269580|NCT03943290|468953090|FG008|Overall Study|Lost to Follow-up|0|||
130269581|NCT03943290|468953082|FG000|Overall Study|Withdrawal by Subject|0|||
130269582|NCT03943290|468953083|FG001|Overall Study|Withdrawal by Subject|0|||
130269583|NCT03943290|468953084|FG002|Overall Study|Withdrawal by Subject|1|||
130269584|NCT03943290|468953085|FG003|Overall Study|Withdrawal by Subject|0|||
130269585|NCT03943290|468953086|FG004|Overall Study|Withdrawal by Subject|0|||
130269586|NCT03943290|468953087|FG005|Overall Study|Withdrawal by Subject|0|||
130269587|NCT03943290|468953088|FG006|Overall Study|Withdrawal by Subject|0|||
130269588|NCT03943290|468953089|FG007|Overall Study|Withdrawal by Subject|0|||
130269589|NCT03943290|468953090|FG008|Overall Study|Withdrawal by Subject|0|||
130269590|NCT00955474|468953091|FG000|Overall Study|Physician Decision|7|||
130269591|NCT00955474|468953092|FG001|Overall Study|Physician Decision|5|||
130269592|NCT01737762|468953093|FG000|Overall Study|Adverse Event|2|||
130269593|NCT01737762|468953094|FG001|Overall Study|Adverse Event|2|||
130269594|NCT01737762|468953093|FG000|Overall Study|Lost to Follow-up|1|||
130269595|NCT01737762|468953094|FG001|Overall Study|Lost to Follow-up|0|||
130269596|NCT01737762|468953093|FG000|Overall Study|Withdrawal by Subject|2|||
130269597|NCT01737762|468953094|FG001|Overall Study|Withdrawal by Subject|2|||
130269598|NCT01737762|468953093|FG000|Overall Study|Progressive disease|1|||
130269599|NCT01737762|468953094|FG001|Overall Study|Progressive disease|2|||
130269600|NCT01737762|468953093|FG000|Overall Study|Physician Decision|1|||
130269601|NCT01737762|468953094|FG001|Overall Study|Physician Decision|1|||
130269602|NCT01737762|468953093|FG000|Overall Study|Moved from area|2|||
130455693|NCT02987543|469632754|FG003|Overall Study|Investigator decision|0|||
130269603|NCT01737762|468953094|FG001|Overall Study|Moved from area|1|||
130455694|NCT02987543|469632751|FG000|Overall Study|Disease progression|0|||
130455695|NCT02987543|469632752|FG001|Overall Study|Disease progression|0|||
130269604|NCT01737762|468953093|FG000|Overall Study|Trial termination|11|||
130269605|NCT01737762|468953094|FG001|Overall Study|Trial termination|9|||
130269606|NCT02148263|468953095|FG000|Overall Study|Withdrawal by Subject|3|||
130455696|NCT02987543|469632753|FG002|Overall Study|Disease progression|0|||
130455697|NCT02987543|469632754|FG003|Overall Study|Disease progression|1|||
130455698|NCT01977612|469632757|FG000|Overall Study|Lost to Follow-up|1|||
130269607|NCT02148263|468953096|FG001|Overall Study|Withdrawal by Subject|2|||
130269608|NCT03386435|468953097|FG000|Overall Study|Protocol Violation|5|||
130269609|NCT03386435|468953098|FG001|Overall Study|Protocol Violation|7|||
130269610|NCT00625586|468953099|FG000|Overall Study|Adverse Event|1|||
130269611|NCT00625586|468953099|FG000|Overall Study|Progressive disease|1|||
130455699|NCT01977612|469632758|FG001|Overall Study|Lost to Follow-up|1|||
130455700|NCT01883492|469632760|FG000|Overall Study|Lost to Follow-up|3|||
130455701|NCT01883492|469632761|FG001|Overall Study|Lost to Follow-up|4|||
130455702|NCT01883492|469632760|FG000|Overall Study|Surgery on contra-lateral hip|0|||
130455703|NCT01883492|469632761|FG001|Overall Study|Surgery on contra-lateral hip|1|||
130455704|NCT01883492|469632760|FG000|Overall Study|Poor X-ray quality|7|||
130455705|NCT01883492|469632761|FG001|Overall Study|Poor X-ray quality|4|||
130455706|NCT01883492|469632760|FG000|Overall Study|Withdrawal by Subject|1|||
130455707|NCT01883492|469632761|FG001|Overall Study|Withdrawal by Subject|0|||
130455708|NCT01883492|469632760|FG000|Overall Study|inappropriate implant used|1|||
130455709|NCT01883492|469632761|FG001|Overall Study|inappropriate implant used|1|||
130455710|NCT01883492|469632760|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
130455711|NCT01883492|469632761|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
130455712|NCT01259102|469632762|FG000|Overall Study|Adverse Event|1|||
130455713|NCT01259102|469632763|FG001|Overall Study|Adverse Event|0|||
130455714|NCT01259102|469632764|FG002|Overall Study|Adverse Event|1|||
130455715|NCT01259102|469632765|FG003|Overall Study|Adverse Event|1|||
130455716|NCT01259102|469632766|FG004|Overall Study|Adverse Event|0|||
130455717|NCT01259102|469632762|FG000|Overall Study|Other|0|||
130455718|NCT01259102|469632763|FG001|Overall Study|Other|0|||
130455719|NCT01259102|469632764|FG002|Overall Study|Other|1|||
130455720|NCT01259102|469632765|FG003|Overall Study|Other|1|||
130455721|NCT01259102|469632766|FG004|Overall Study|Other|1|||
130554334|NCT03891524|469996580|FG001|Overall Study|Withdrawal by Subject|1|||
130554335|NCT03891524|469996581|FG002|Overall Study|Withdrawal by Subject|2|||
130554336|NCT03891524|469996582|FG003|Overall Study|Withdrawal by Subject|1|||
130554337|NCT03891524|469996583|FG004|Overall Study|Withdrawal by Subject|2|||
130554338|NCT03891524|469996584|FG005|Overall Study|Withdrawal by Subject|2|||
130554339|NCT03891524|469996585|FG006|Overall Study|Withdrawal by Subject|2|||
130554340|NCT03891524|469996586|FG007|Overall Study|Withdrawal by Subject|1|||
130554341|NCT01210118|469996587|FG000|Overall Study|Lost to Follow-up|1|||
130554342|NCT01210118|469996588|FG001|Overall Study|Lost to Follow-up|1|||
130455722|NCT01803646|469632767|FG000|Overall Study|Protocol Violation|1|||
130455723|NCT01803646|469632768|FG001|Overall Study|Protocol Violation|0|||
130455724|NCT01803646|469632767|FG000|Overall Study|Adverse Event|1|||
130455725|NCT01803646|469632768|FG001|Overall Study|Adverse Event|1|||
130455726|NCT01803646|469632767|FG000|Overall Study|Withdrawal by Subject|9|||
130455727|NCT01803646|469632768|FG001|Overall Study|Withdrawal by Subject|6|||
130455728|NCT01803646|469632767|FG000|Overall Study|Randomization error|1|||
130455729|NCT01803646|469632768|FG001|Overall Study|Randomization error|2|||
130455730|NCT01803646|469632767|FG000|Overall Study|Lost to Follow-up|5|||
130455731|NCT01803646|469632768|FG001|Overall Study|Lost to Follow-up|1|||
130455732|NCT01876511|469632772|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
130455733|NCT01876511|469632773|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
130455734|NCT01876511|469632774|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
130455735|NCT01876511|469632772|FG000|Overall Study|Death (unrelated)|3|||
130455736|NCT01876511|469632773|FG001|Overall Study|Death (unrelated)|0|||
130455737|NCT01876511|469632774|FG002|Overall Study|Death (unrelated)|2|||
130455738|NCT01876511|469632772|FG000|Overall Study|Drug-related Toxicity|5|||
130455739|NCT01876511|469632773|FG001|Overall Study|Drug-related Toxicity|1|||
130455740|NCT01876511|469632774|FG002|Overall Study|Drug-related Toxicity|6|||
130455741|NCT01876511|469632772|FG000|Overall Study|Patient Decision|3|||
130455742|NCT01876511|469632773|FG001|Overall Study|Patient Decision|0|||
130455743|NCT01876511|469632774|FG002|Overall Study|Patient Decision|6|||
130554343|NCT01210118|469996587|FG000|Overall Study|Protocol Violation|1|||
130554344|NCT01210118|469996588|FG001|Overall Study|Protocol Violation|1|||
130554345|NCT01210118|469996587|FG000|Overall Study|Spontaneous abortion|1|||
130366725|NCT00612040|469314010|FG001|Overall Study|Adverse Event|2|||
130366726|NCT00612040|469314011|FG002|Overall Study|Adverse Event|1|||
130366727|NCT00612040|469314009|FG000|Overall Study|Protocol Violation|1|||
130366728|NCT00612040|469314010|FG001|Overall Study|Protocol Violation|2|||
130366729|NCT00612040|469314011|FG002|Overall Study|Protocol Violation|1|||
130366730|NCT00612040|469314009|FG000|Overall Study|Lack of Efficacy|2|||
130366731|NCT00612040|469314010|FG001|Overall Study|Lack of Efficacy|1|||
130366732|NCT00612040|469314011|FG002|Overall Study|Lack of Efficacy|0|||
130366733|NCT00612040|469314009|FG000|Overall Study|Unclassified|2|||
130366734|NCT00612040|469314010|FG001|Overall Study|Unclassified|2|||
130366735|NCT00612040|469314011|FG002|Overall Study|Unclassified|5|||
130366736|NCT02021331|469314012|FG000|Overall Study|Adverse Event|0|||
130366737|NCT02021331|469314013|FG001|Overall Study|Adverse Event|2|||
130366738|NCT00319553|469314016|FG000|Overall Study|Protocol Violation|1|||
130366739|NCT00319553|469314017|FG001|Overall Study|Protocol Violation|2|||
130366740|NCT00319553|469314016|FG000|Overall Study|Lost to Follow-up|2|||
130366741|NCT00319553|469314017|FG001|Overall Study|Lost to Follow-up|1|||
130366742|NCT00319553|469314016|FG000|Overall Study|Withdrawal by Subject|1|||
130366743|NCT00319553|469314017|FG001|Overall Study|Withdrawal by Subject|1|||
130366744|NCT01896102|469314018|FG000|Overall Study|Death|1|||
130366745|NCT01896102|469314018|FG000|Overall Study|Participant to receive allogenic transplant|2|||
130366746|NCT01281865|469314023|FG000|Overall Study|Adverse Event|1|||
130366747|NCT01281865|469314024|FG001|Overall Study|Adverse Event|1|||
130366748|NCT01281865|469314023|FG000|Overall Study|Withdrawal by Subject|1|||
130455744|NCT01876511|469632772|FG000|Overall Study|Physician Decision|1|||
130455745|NCT01876511|469632773|FG001|Overall Study|Physician Decision|0|||
130455746|NCT01876511|469632774|FG002|Overall Study|Physician Decision|1|||
130455747|NCT01048788|469632775|FG000|Overall Study|Adverse Event|5|||
130455748|NCT01048788|469632776|FG001|Overall Study|Adverse Event|1|||
130455749|NCT01048788|469632777|FG002|Overall Study|Adverse Event|1|||
130455750|NCT01048788|469632775|FG000|Overall Study|Lack of Efficacy|0|||
130455751|NCT01048788|469632776|FG001|Overall Study|Lack of Efficacy|0|||
130455752|NCT01048788|469632777|FG002|Overall Study|Lack of Efficacy|1|||
130455753|NCT01048788|469632775|FG000|Overall Study|Withdrawal by Subject|0|||
130455754|NCT01048788|469632776|FG001|Overall Study|Withdrawal by Subject|1|||
130455755|NCT01048788|469632777|FG002|Overall Study|Withdrawal by Subject|0|||
130455756|NCT01131494|469632778|FG000|Overall Study|Withdrawal by Subject|2|||
130455757|NCT01233050|469632781|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
130455758|NCT01233050|469632782|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
130455759|NCT01064817|469632784|FG000|Study Completion|Physician Decision|1|||
130455760|NCT01064817|469632785|FG001|Study Completion|Physician Decision|0|||
130455761|NCT01064817|469632784|FG000|Study Completion|Withdrawal by Subject|1|||
130455762|NCT01064817|469632785|FG001|Study Completion|Withdrawal by Subject|0|||
130455763|NCT01368406|469632787|FG000|Overall Study|Lost to Follow-up|8|||
130455764|NCT01368406|469632788|FG001|Overall Study|Lost to Follow-up|4|||
130455765|NCT01368406|469632787|FG000|Overall Study|Withdrawal by Subject|8|||
130455766|NCT01368406|469632788|FG001|Overall Study|Withdrawal by Subject|4|||
130455767|NCT01368406|469632787|FG000|Overall Study|relapse of the disease|3|||
130455768|NCT01368406|469632788|FG001|Overall Study|relapse of the disease|2|||
130455769|NCT01368406|469632787|FG000|Overall Study|started working|2|||
130455770|NCT01368406|469632788|FG001|Overall Study|started working|3|||
130455771|NCT00868192|469632789|FG000|Overall Study|Ineligible|4|||
130455772|NCT04304534|469632790|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
130455773|NCT04304534|469632791|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
130455774|NCT04304534|469632792|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
130455775|NCT04304534|469632793|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
130455776|NCT04304534|469632790|FG000|Overall Study|Non-Compliance with study drug|0|||
130455777|NCT04304534|469632791|FG001|Overall Study|Non-Compliance with study drug|1|||
130455778|NCT04304534|469632792|FG002|Overall Study|Non-Compliance with study drug|1|||
130455779|NCT04304534|469632793|FG003|Overall Study|Non-Compliance with study drug|1|||
130455780|NCT04304534|469632790|FG000|Overall Study|Lost to Follow-up|0|||
130455781|NCT04304534|469632791|FG001|Overall Study|Lost to Follow-up|1|||
130455782|NCT04304534|469632792|FG002|Overall Study|Lost to Follow-up|2|||
130455783|NCT04304534|469632793|FG003|Overall Study|Lost to Follow-up|3|||
130455784|NCT04304534|469632790|FG000|Overall Study|Unspecific|4|||
130455785|NCT04304534|469632791|FG001|Overall Study|Unspecific|2|||
130455786|NCT04304534|469632792|FG002|Overall Study|Unspecific|2|||
130455787|NCT04304534|469632793|FG003|Overall Study|Unspecific|2|||
130455788|NCT04304534|469632790|FG000|Overall Study|Technical Problems|2|||
130455789|NCT04304534|469632791|FG001|Overall Study|Technical Problems|2|||
130455790|NCT04304534|469632792|FG002|Overall Study|Technical Problems|3|||
130455791|NCT04304534|469632793|FG003|Overall Study|Technical Problems|4|||
130455792|NCT04304534|469632790|FG000|Overall Study|Death|7|||
130455793|NCT04304534|469632791|FG001|Overall Study|Death|2|||
130455794|NCT04304534|469632792|FG002|Overall Study|Death|4|||
130269696|NCT01467466|468953108|FG000|Overall Study|Withdrawal by Subject|15|||
130269697|NCT01467466|468953109|FG001|Overall Study|Withdrawal by Subject|18|||
130269698|NCT01467466|468953110|FG002|Overall Study|Withdrawal by Subject|13|||
130269699|NCT01467466|468953111|FG003|Overall Study|Withdrawal by Subject|11|||
130269700|NCT01467466|468953108|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
130269701|NCT01467466|468953109|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
130269702|NCT01467466|468953110|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
130269703|NCT01467466|468953111|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
130269704|NCT01467466|468953108|FG000|Overall Study|Procedure Cancelled|46|||
130269705|NCT01467466|468953109|FG001|Overall Study|Procedure Cancelled|45|||
130269706|NCT01467466|468953110|FG002|Overall Study|Procedure Cancelled|25|||
130269707|NCT01467466|468953111|FG003|Overall Study|Procedure Cancelled|29|||
130269708|NCT01467466|468953108|FG000|Overall Study|No Endpoint Blood Draw|38|||
130455795|NCT04304534|469632793|FG003|Overall Study|Death|3|||
130455796|NCT04304534|469632790|FG000|Overall Study|Withdrawal by Subject|7|||
130455797|NCT04304534|469632791|FG001|Overall Study|Withdrawal by Subject|2|||
130455798|NCT04304534|469632792|FG002|Overall Study|Withdrawal by Subject|7|||
130455799|NCT04304534|469632793|FG003|Overall Study|Withdrawal by Subject|4|||
130455800|NCT04304534|469632790|FG000|Overall Study|Physician Decision|4|||
130455801|NCT04304534|469632791|FG001|Overall Study|Physician Decision|9|||
130455802|NCT04304534|469632792|FG002|Overall Study|Physician Decision|9|||
130455803|NCT04304534|469632793|FG003|Overall Study|Physician Decision|5|||
130455804|NCT04304534|469632790|FG000|Overall Study|Subject Decision|34|||
130455805|NCT04304534|469632791|FG001|Overall Study|Subject Decision|25|||
130455806|NCT04304534|469632792|FG002|Overall Study|Subject Decision|25|||
130455807|NCT04304534|469632793|FG003|Overall Study|Subject Decision|26|||
130455808|NCT04304534|469632790|FG000|Overall Study|Adverse Event|35|||
130269709|NCT01467466|468953109|FG001|Overall Study|No Endpoint Blood Draw|32|||
130269710|NCT01467466|468953110|FG002|Overall Study|No Endpoint Blood Draw|51|||
130269711|NCT01467466|468953111|FG003|Overall Study|No Endpoint Blood Draw|43|||
130269712|NCT01144416|468953116|FG000|Intervention Period|Adverse Event|5|||
130269713|NCT01144416|468953117|FG001|Intervention Period|Adverse Event|6|||
130269714|NCT01144416|468953116|FG000|Intervention Period|Insufficient ovarian response|11|||
130269715|NCT01144416|468953117|FG001|Intervention Period|Insufficient ovarian response|17|||
130269716|NCT01144416|468953116|FG000|Intervention Period|Risk of OHSS|0|||
130269717|NCT01144416|468953117|FG001|Intervention Period|Risk of OHSS|1|||
130269718|NCT01144416|468953116|FG000|Intervention Period|Too high ovarian response|4|||
130269719|NCT01144416|468953117|FG001|Intervention Period|Too high ovarian response|2|||
130269720|NCT01144416|468953116|FG000|Intervention Period|No/too few/bad oocytes|7|||
130269721|NCT01144416|468953117|FG001|Intervention Period|No/too few/bad oocytes|5|||
130269722|NCT01144416|468953116|FG000|Intervention Period|No or abnormal fertilization|25|||
130269723|NCT01144416|468953117|FG001|Intervention Period|No or abnormal fertilization|10|||
130269724|NCT01144416|468953116|FG000|Intervention Period|No/too few/bad quality embryos|3|||
130269725|NCT01144416|468953117|FG001|Intervention Period|No/too few/bad quality embryos|3|||
130269726|NCT01144416|468953116|FG000|Intervention Period|Other|7|||
130269727|NCT01144416|468953117|FG001|Intervention Period|Other|5|||
130269728|NCT00124072|468953118|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
130269729|NCT00124072|468953119|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
130269730|NCT00124072|468953120|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
130269731|NCT00124072|468953121|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
130269732|NCT00124072|468953118|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
130269733|NCT00124072|468953119|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
130269734|NCT00124072|468953120|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
130269735|NCT00124072|468953121|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
130269736|NCT00124072|468953118|FG000|Overall Study|Death|499|||
130269737|NCT00124072|468953119|FG001|Overall Study|Death|484|||
130269738|NCT00124072|468953120|FG002|Overall Study|Death|471|||
130269739|NCT00124072|468953121|FG003|Overall Study|Death|480|||
130269740|NCT02534883|468953122|FG000|Overall Study|Early Termination|8|||
130269741|NCT02534883|468953123|FG001|Overall Study|Early Termination|3|||
130269742|NCT03328832|468953124|FG000|Overall Study|Lost to Follow-up|0|||
130269743|NCT03328832|468953125|FG001|Overall Study|Lost to Follow-up|1|||
130269744|NCT00886769|468953126|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130269745|NCT00886769|468953127|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
130269746|NCT00778336|468953128|FG000|Index Procedure-Discharge|Death|6|||
130269747|NCT00778336|468953129|FG001|Index Procedure-Discharge|Death|3|||
130269748|NCT00778336|468953130|FG002|Index Procedure-Discharge|Death|2|||
130269749|NCT00778336|468953131|FG003|Index Procedure-Discharge|Death|0|||
130269750|NCT00778336|468953128|FG000|3 Month Follow Up|Lost to Follow-up|15|||
130269751|NCT00778336|468953129|FG001|3 Month Follow Up|Lost to Follow-up|20|||
130269752|NCT00778336|468953130|FG002|3 Month Follow Up|Lost to Follow-up|3|||
130269753|NCT00778336|468953131|FG003|3 Month Follow Up|Lost to Follow-up|0|||
130269754|NCT00778336|468953128|FG000|3 Month Follow Up|Death|8|||
130269755|NCT00778336|468953129|FG001|3 Month Follow Up|Death|3|||
130269756|NCT00778336|468953130|FG002|3 Month Follow Up|Death|2|||
130269757|NCT00778336|468953131|FG003|3 Month Follow Up|Death|0|||
130269758|NCT00414076|468953134|FG000|Overall Study|Progression|1|||
130269759|NCT00414076|468953135|FG001|Overall Study|Progression|2|||
130269760|NCT00414076|468953134|FG000|Overall Study|Withdrawal by Subject|1|||
130269761|NCT00414076|468953135|FG001|Overall Study|Withdrawal by Subject|3|||
130705800|NCT02688387|470549572|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705801|NCT02688387|470549573|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705802|NCT02688387|470549574|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130269762|NCT00414076|468953134|FG000|Overall Study|Adverse Event|1|||
130269763|NCT00414076|468953135|FG001|Overall Study|Adverse Event|0|||
130269764|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
130269765|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
130269766|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Death|2|||
130269767|NCT00049257|468953136|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
130269768|NCT04721158|468953137|FG000|Overall Study|Lost to Follow-up|4|||
130269769|NCT04721158|468953137|FG000|Overall Study|Device did not connect|1|||
130269770|NCT03929913|468953138|FG000|Overall Study|Death|4|||
130269771|NCT03929913|468953138|FG000|Overall Study|Lost to Follow-up|1|||
130705803|NCT02688387|470549575|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705804|NCT02688387|470549576|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130269772|NCT03929913|468953138|FG000|Overall Study|Failed Procedure|2|||
130269773|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
130269774|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
130269775|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
130269776|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269777|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269778|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269779|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130705805|NCT02688387|470549577|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705806|NCT02688387|470549556|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705807|NCT02688387|470549557|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705808|NCT02688387|470549558|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130269780|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269781|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269782|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269783|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269784|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269785|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269786|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269787|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269788|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269789|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130269790|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130269791|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269792|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269793|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269794|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269795|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269796|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269797|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269798|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269799|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269800|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269801|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269802|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269803|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269804|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269805|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269806|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269807|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269808|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
130269809|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269810|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269811|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269812|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269813|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269814|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269815|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269816|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269817|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269818|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269819|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269820|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130554346|NCT01210118|469996588|FG001|Overall Study|Spontaneous abortion|3|||
130554347|NCT02958267|469996591|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
130554348|NCT02958267|469996592|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
130554349|NCT02958267|469996591|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
130554350|NCT02958267|469996592|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
130554351|NCT02958267|469996591|FG000|Follow-up Visits|Additional treatment pursued|2|||
130554352|NCT02958267|469996592|FG001|Follow-up Visits|Additional treatment pursued|1|||
130554353|NCT02684357|469996593|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
130554354|NCT02684357|469996594|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
130705809|NCT02688387|470549559|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130269821|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269822|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269823|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
130269824|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269825|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269826|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130705810|NCT02688387|470549560|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705811|NCT02688387|470549561|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130269827|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269828|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269829|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269830|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269831|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269832|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269833|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130705812|NCT02688387|470549562|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705813|NCT02688387|470549563|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130269834|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269835|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269836|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269837|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269838|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269839|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269840|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
130269841|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269842|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269843|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269844|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269845|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269846|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269847|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269848|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269849|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269850|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269851|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269852|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269853|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269854|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269855|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269856|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
130269857|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269858|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269859|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269860|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269861|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269862|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269863|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269864|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269865|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269866|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269867|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269868|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269869|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269870|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269871|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269872|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269873|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269874|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269875|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130269876|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130269877|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
130269878|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
130269879|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269880|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269881|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269882|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269883|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269884|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269885|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269886|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269887|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269888|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269889|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269890|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130269891|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269892|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269893|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269894|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130269895|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269896|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130554355|NCT02684357|469996595|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
130269897|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269898|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269899|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130554356|NCT02684357|469996596|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
130554357|NCT02684357|469996597|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
130269900|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130554358|NCT02684357|469996598|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
130705814|NCT02688387|470549564|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705815|NCT02688387|470549565|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705816|NCT02688387|470549566|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705817|NCT02688387|470549567|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705818|NCT02688387|470549568|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705819|NCT02688387|470549569|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705820|NCT02688387|470549570|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705821|NCT02688387|470549571|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705822|NCT02688387|470549572|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705823|NCT02688387|470549573|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705824|NCT02688387|470549574|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705825|NCT02688387|470549575|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705826|NCT02688387|470549576|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705827|NCT02688387|470549577|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705828|NCT02688387|470549556|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705829|NCT02688387|470549557|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
130705830|NCT02688387|470549558|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705831|NCT02688387|470549559|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705832|NCT02688387|470549560|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705833|NCT02688387|470549561|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705834|NCT02688387|470549562|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705835|NCT02688387|470549563|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705836|NCT02688387|470549564|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705837|NCT02688387|470549565|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705838|NCT02688387|470549566|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705839|NCT02688387|470549567|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705840|NCT02688387|470549568|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705841|NCT02688387|470549569|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705842|NCT02688387|470549570|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705843|NCT02688387|470549571|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705844|NCT02688387|470549572|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130269901|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269902|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269903|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269904|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269905|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269906|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269907|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130269908|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
130269909|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130269910|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
130269911|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269912|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269913|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269914|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269915|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269916|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269917|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269918|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269919|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269920|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269921|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
130269922|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269923|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269924|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269925|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269926|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269927|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269928|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130705845|NCT02688387|470549573|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705846|NCT02688387|470549574|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705847|NCT02688387|470549575|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705848|NCT02688387|470549576|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130269929|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269930|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269931|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130455809|NCT04304534|469632791|FG001|Overall Study|Adverse Event|40|||
130455810|NCT04304534|469632792|FG002|Overall Study|Adverse Event|39|||
130455811|NCT04304534|469632793|FG003|Overall Study|Adverse Event|44|||
130269932|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269933|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269934|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269935|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269936|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269937|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269938|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269939|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
130269940|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269941|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269942|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269943|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269944|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269945|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269946|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269947|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269948|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269949|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269950|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130455812|NCT01466881|469632794|FG000|Overall Study|Ineligible|5|||
130455813|NCT01466881|469632794|FG000|Overall Study|Adverse Event|6|||
130455814|NCT01466881|469632794|FG000|Overall Study|Progression/relapse|20|||
130455815|NCT01466881|469632794|FG000|Overall Study|Death|4|||
130455816|NCT01466881|469632794|FG000|Overall Study|Other reason not protocol specified|5|||
130455817|NCT02299635|469632795|FG000|Overall Study|Adverse Event|2|||
130455818|NCT02299635|469632795|FG000|Overall Study|Death|1|||
130455819|NCT02299635|469632795|FG000|Overall Study|Global deterioration of health status|1|||
130455820|NCT02299635|469632795|FG000|Overall Study|Objective progression or relapse|10|||
130455821|NCT02299635|469632795|FG000|Overall Study|Withdrawal by Subject|2|||
130455822|NCT02299635|469632795|FG000|Overall Study|Other|3|||
130455823|NCT01972152|469632799|FG000|First Treatment Visit|Lost to Follow-up|0|||
130455824|NCT01972152|469632800|FG001|First Treatment Visit|Lost to Follow-up|1|||
130269951|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269952|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269953|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269954|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269955|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269956|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269957|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269958|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269959|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269960|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269961|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269962|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269963|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269964|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269965|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269966|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269967|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269968|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269969|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269970|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269971|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269972|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
130269973|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269974|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130455825|NCT01972152|469632801|FG002|First Treatment Visit|Lost to Follow-up|0|||
130455826|NCT01972152|469632802|FG003|First Treatment Visit|Lost to Follow-up|0|||
130455827|NCT01972152|469632803|FG004|First Treatment Visit|Lost to Follow-up|0|||
130455828|NCT01972152|469632804|FG005|First Treatment Visit|Lost to Follow-up|0|||
130455829|NCT01972152|469632799|FG000|Second Treatment Visit|Protocol Violation|0|||
130455830|NCT01972152|469632800|FG001|Second Treatment Visit|Protocol Violation|1|||
130455831|NCT01972152|469632801|FG002|Second Treatment Visit|Protocol Violation|0|||
130269975|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269976|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269977|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269978|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269979|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269980|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269981|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269982|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269983|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269984|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130455832|NCT01972152|469632802|FG003|Second Treatment Visit|Protocol Violation|0|||
130455833|NCT01972152|469632803|FG004|Second Treatment Visit|Protocol Violation|0|||
130455834|NCT01972152|469632804|FG005|Second Treatment Visit|Protocol Violation|0|||
130455835|NCT02512042|469632805|FG000|Overall Study|Adverse Event|0|||
130455836|NCT02512042|469632806|FG001|Overall Study|Adverse Event|4|||
130455837|NCT02512042|469632805|FG000|Overall Study|Withdrawal by Subject|6|||
130455838|NCT02512042|469632806|FG001|Overall Study|Withdrawal by Subject|6|||
130455839|NCT02512042|469632805|FG000|Overall Study|Non-compliance with study drug|1|||
130455840|NCT02512042|469632806|FG001|Overall Study|Non-compliance with study drug|2|||
130455841|NCT02512042|469632805|FG000|Overall Study|Lost to Follow-up|5|||
130269985|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269986|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269987|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269988|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269989|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
130269990|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269991|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269992|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269993|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269994|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269995|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269996|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269997|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130269998|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130269999|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270000|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270001|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270002|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270003|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270004|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270005|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270006|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
130270007|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130455842|NCT02512042|469632806|FG001|Overall Study|Lost to Follow-up|2|||
130455843|NCT02512042|469632805|FG000|Overall Study|Other|11|||
130455844|NCT02512042|469632806|FG001|Overall Study|Other|11|||
130455845|NCT01194258|469632807|FG000|Titration Period|Withdrawal by Subject|6|||
130455846|NCT01194258|469632808|FG001|Titration Period|Withdrawal by Subject|0|||
130455847|NCT01194258|469632809|FG002|Titration Period|Withdrawal by Subject|0|||
130455848|NCT01194258|469632810|FG003|Titration Period|Withdrawal by Subject|0|||
130455849|NCT01194258|469632811|FG004|Titration Period|Withdrawal by Subject|0|||
130455850|NCT01194258|469632807|FG000|Titration Period|Lost to Follow-up|2|||
130455851|NCT01194258|469632808|FG001|Titration Period|Lost to Follow-up|0|||
130455852|NCT01194258|469632809|FG002|Titration Period|Lost to Follow-up|0|||
130455853|NCT01194258|469632810|FG003|Titration Period|Lost to Follow-up|0|||
130455854|NCT01194258|469632811|FG004|Titration Period|Lost to Follow-up|0|||
130455855|NCT01194258|469632807|FG000|Titration Period|Titration failure|3|||
130455856|NCT01194258|469632808|FG001|Titration Period|Titration failure|0|||
130455857|NCT01194258|469632809|FG002|Titration Period|Titration failure|0|||
130455858|NCT01194258|469632810|FG003|Titration Period|Titration failure|0|||
130455859|NCT01194258|469632811|FG004|Titration Period|Titration failure|0|||
130455860|NCT01194258|469632807|FG000|Period 1 (12 Weeks)|Death|0|||
130455861|NCT01194258|469632808|FG001|Period 1 (12 Weeks)|Death|0|||
130455862|NCT01194258|469632809|FG002|Period 1 (12 Weeks)|Death|0|||
130455863|NCT01194258|469632810|FG003|Period 1 (12 Weeks)|Death|0|||
130270008|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270009|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270010|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270011|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270012|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270013|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270014|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270015|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270016|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270017|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270018|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270019|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270020|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270021|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270022|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
130270023|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270024|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270025|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270026|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270027|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270028|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270029|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270030|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270031|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270032|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270033|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270034|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270035|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270036|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270037|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270038|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270039|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
130270040|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270041|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270042|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270043|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270044|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270045|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270046|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270047|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270048|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270049|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270050|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270051|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270052|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270053|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270054|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270055|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
130270056|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270057|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270058|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270059|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270060|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270061|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270062|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270063|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270064|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270065|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270066|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270067|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270068|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270069|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270070|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270071|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
130270072|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270073|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270074|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270075|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130705849|NCT02688387|470549577|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705850|NCT02688387|470549556|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705851|NCT02688387|470549557|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705852|NCT02688387|470549558|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130705853|NCT02688387|470549559|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705854|NCT02688387|470549560|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130705855|NCT02688387|470549561|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705856|NCT02688387|470549562|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705857|NCT02688387|470549563|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705858|NCT02688387|470549564|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705859|NCT02688387|470549565|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705860|NCT02688387|470549566|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705861|NCT02688387|470549567|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705862|NCT02688387|470549568|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705863|NCT02688387|470549569|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705864|NCT02688387|470549570|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705865|NCT02688387|470549571|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705866|NCT02688387|470549572|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705867|NCT02688387|470549573|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705868|NCT02688387|470549574|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705869|NCT02688387|470549575|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705870|NCT02688387|470549576|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705871|NCT02688387|470549577|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705872|NCT02688387|470549556|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
130705873|NCT02688387|470549557|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705874|NCT02688387|470549558|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705875|NCT02688387|470549559|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705876|NCT02688387|470549560|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705877|NCT02688387|470549561|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705878|NCT02688387|470549562|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705879|NCT02688387|470549563|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705880|NCT02688387|470549564|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705881|NCT02688387|470549565|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705882|NCT02688387|470549566|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705883|NCT02688387|470549567|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705884|NCT02688387|470549568|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705885|NCT02688387|470549569|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130270076|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270077|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270078|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270079|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270080|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270081|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270082|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270083|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270084|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270085|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270086|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270087|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
130270088|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270089|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270090|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270091|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270092|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270093|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270094|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270095|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270096|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270097|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270098|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270099|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270100|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270101|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270102|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270103|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
130270104|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270105|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270106|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270107|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270108|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270109|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270110|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270111|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270112|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270113|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270114|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270115|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270116|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270117|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270118|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270119|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
130270120|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270121|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270122|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270123|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270124|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270125|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270126|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270127|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270128|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270129|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270130|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270131|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270132|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270133|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270134|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270135|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
130270136|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270137|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270138|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130455864|NCT01194258|469632811|FG004|Period 1 (12 Weeks)|Death|1|||
130455865|NCT01194258|469632807|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130455866|NCT01194258|469632808|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130455867|NCT01194258|469632809|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130270139|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270140|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270141|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270142|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270143|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270144|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130705886|NCT02688387|470549570|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705887|NCT02688387|470549571|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705888|NCT02688387|470549572|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705889|NCT02688387|470549573|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130270145|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270146|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270147|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270148|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270149|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270150|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130455868|NCT01194258|469632810|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130455869|NCT01194258|469632811|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
130455870|NCT01194258|469632807|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
130455871|NCT01194258|469632808|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
130455872|NCT01194258|469632809|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
130455873|NCT01194258|469632810|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
130455874|NCT01194258|469632811|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
130455875|NCT01194258|469632807|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130455876|NCT01194258|469632808|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130455877|NCT01194258|469632809|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130455878|NCT01194258|469632810|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130270151|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
130270152|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270153|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270154|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270155|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270156|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270157|NCT02891226|468953139|FG000|Follow-up Period|Withdrawal by Subject|0|||
130270158|NCT02891226|468953140|FG001|Follow-up Period|Withdrawal by Subject|0|||
130270159|NCT02891226|468953141|FG002|Follow-up Period|Withdrawal by Subject|0|||
130270160|NCT02891226|468953142|FG003|Follow-up Period|Withdrawal by Subject|0|||
130270161|NCT02891226|468953143|FG004|Follow-up Period|Withdrawal by Subject|0|||
130270162|NCT02891226|468953144|FG005|Follow-up Period|Withdrawal by Subject|0|||
130270163|NCT02891226|468953145|FG006|Follow-up Period|Withdrawal by Subject|0|||
130270164|NCT02891226|468953146|FG007|Follow-up Period|Withdrawal by Subject|0|||
130270165|NCT02891226|468953147|FG008|Follow-up Period|Withdrawal by Subject|0|||
130270166|NCT02891226|468953148|FG009|Follow-up Period|Withdrawal by Subject|0|||
130270167|NCT02891226|468953149|FG010|Follow-up Period|Withdrawal by Subject|0|||
130270168|NCT02891226|468953150|FG011|Follow-up Period|Withdrawal by Subject|1|||
130455879|NCT01194258|469632811|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130455880|NCT01253226|469632812|FG000|Overall Study|Adverse Event|0|||
130455881|NCT01253226|469632813|FG001|Overall Study|Adverse Event|0|||
130455882|NCT01253226|469632814|FG002|Overall Study|Adverse Event|1|||
130705890|NCT02688387|470549574|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705891|NCT02688387|470549575|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705892|NCT02688387|470549576|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705893|NCT02688387|470549577|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705894|NCT02688387|470549556|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705895|NCT02688387|470549557|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705896|NCT02688387|470549558|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705897|NCT02688387|470549559|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705898|NCT02688387|470549560|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705899|NCT02688387|470549561|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705900|NCT02688387|470549562|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705901|NCT02688387|470549563|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705902|NCT02688387|470549564|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705903|NCT02688387|470549565|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130270169|NCT02891226|468953151|FG012|Follow-up Period|Withdrawal by Subject|0|||
130270170|NCT02891226|468953152|FG013|Follow-up Period|Withdrawal by Subject|0|||
130455883|NCT01253226|469632815|FG003|Overall Study|Adverse Event|0|||
130455884|NCT01253226|469632816|FG004|Overall Study|Adverse Event|0|||
130554359|NCT02684357|469996593|FG000|Part A|Lost to Follow-up|0|||
130455885|NCT01253226|469632812|FG000|Overall Study|Death|0|||
130455886|NCT01253226|469632813|FG001|Overall Study|Death|1|||
130455887|NCT01253226|469632814|FG002|Overall Study|Death|0|||
130270171|NCT02891226|468953153|FG014|Follow-up Period|Withdrawal by Subject|1|||
130270172|NCT02891226|468953154|FG015|Follow-up Period|Withdrawal by Subject|1|||
130270173|NCT00145626|468953155|FG000|Overall Study|Did not have NK infusions|2|||
130270174|NCT00145626|468953155|FG000|Overall Study|Turned 2 years old before treatment|1|||
130270175|NCT00145626|468953155|FG000|Overall Study|Death|1|||
130270176|NCT00145626|468953155|FG000|Overall Study|Withdrawal by Subject|1|||
130270177|NCT03381287|468953156|FG000|Overall Study|Withdrawal by Subject|0|||
130270178|NCT03381287|468953157|FG001|Overall Study|Withdrawal by Subject|1|||
130270179|NCT03381287|468953158|FG002|Overall Study|Withdrawal by Subject|0|||
130270180|NCT03381287|468953159|FG003|Overall Study|Withdrawal by Subject|0|||
130270181|NCT03381287|468953156|FG000|Overall Study|Adverse Event|0|||
130270182|NCT03381287|468953157|FG001|Overall Study|Adverse Event|0|||
130270183|NCT03381287|468953158|FG002|Overall Study|Adverse Event|0|||
130270184|NCT03381287|468953159|FG003|Overall Study|Adverse Event|1|||
130270185|NCT03381287|468953156|FG000|Overall Study|Physician Decision|0|||
130270186|NCT03381287|468953157|FG001|Overall Study|Physician Decision|0|||
130270187|NCT03381287|468953158|FG002|Overall Study|Physician Decision|0|||
130270188|NCT03381287|468953159|FG003|Overall Study|Physician Decision|1|||
130270189|NCT03654274|468953160|FG000|Overall Study|Adverse Event|19|||
130270190|NCT03654274|468953161|FG001|Overall Study|Adverse Event|23|||
130270191|NCT03654274|468953162|FG002|Overall Study|Adverse Event|24|||
130270192|NCT03654274|468953160|FG000|Overall Study|Protocol Deviation|0|||
130270193|NCT03654274|468953161|FG001|Overall Study|Protocol Deviation|2|||
130270194|NCT03654274|468953162|FG002|Overall Study|Protocol Deviation|0|||
130270195|NCT03654274|468953160|FG000|Overall Study|Lost to Follow-up|8|||
130270196|NCT03654274|468953161|FG001|Overall Study|Lost to Follow-up|6|||
130270197|NCT03654274|468953162|FG002|Overall Study|Lost to Follow-up|5|||
130270198|NCT03654274|468953160|FG000|Overall Study|Withdrawal by Subject|46|||
130270199|NCT03654274|468953161|FG001|Overall Study|Withdrawal by Subject|25|||
130270200|NCT03654274|468953162|FG002|Overall Study|Withdrawal by Subject|33|||
130270201|NCT03654274|468953160|FG000|Overall Study|Lack of Efficacy|4|||
130270202|NCT03654274|468953161|FG001|Overall Study|Lack of Efficacy|5|||
130270203|NCT03654274|468953162|FG002|Overall Study|Lack of Efficacy|7|||
130270204|NCT03654274|468953160|FG000|Overall Study|Pregnancy|2|||
130270205|NCT03654274|468953161|FG001|Overall Study|Pregnancy|2|||
130270206|NCT03654274|468953162|FG002|Overall Study|Pregnancy|1|||
130270207|NCT03654274|468953160|FG000|Overall Study|Other|27|||
130270208|NCT03654274|468953161|FG001|Overall Study|Other|29|||
130270209|NCT03654274|468953162|FG002|Overall Study|Other|32|||
130270210|NCT03654274|468953160|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130270211|NCT03654274|468953161|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130270212|NCT03654274|468953162|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
130455888|NCT01253226|469632815|FG003|Overall Study|Death|0|||
130455889|NCT01253226|469632816|FG004|Overall Study|Death|0|||
130455890|NCT01253226|469632812|FG000|Overall Study|Physician Decision|0|||
130455891|NCT01253226|469632813|FG001|Overall Study|Physician Decision|0|||
130455892|NCT01253226|469632814|FG002|Overall Study|Physician Decision|0|||
130455893|NCT01253226|469632815|FG003|Overall Study|Physician Decision|0|||
130455894|NCT01253226|469632816|FG004|Overall Study|Physician Decision|2|||
130455895|NCT01253226|469632812|FG000|Overall Study|Withdrawal by Subject|0|||
130455896|NCT01253226|469632813|FG001|Overall Study|Withdrawal by Subject|0|||
130455897|NCT01253226|469632814|FG002|Overall Study|Withdrawal by Subject|0|||
130455898|NCT01253226|469632815|FG003|Overall Study|Withdrawal by Subject|1|||
130455899|NCT01253226|469632816|FG004|Overall Study|Withdrawal by Subject|0|||
130455900|NCT04858425|469632817|FG000|Overall Study|Adverse Event|2|||
130455901|NCT04858425|469632818|FG001|Overall Study|Adverse Event|2|||
130455902|NCT04858425|469632817|FG000|Overall Study|Withdrawal by Subject|3|||
130270213|NCT01265992|468953163|FG000|Overall Study|Lost to Follow-up|1|||
130270214|NCT01265992|468953163|FG000|Overall Study|Withdrawal by Subject|1|||
130270215|NCT01265992|468953163|FG000|Overall Study|Adverse Event|1|||
130270216|NCT01265992|468953163|FG000|Overall Study|Administrative reasons|2|||
130270217|NCT01265992|468953163|FG000|Overall Study|Stopped treatment|3|||
130270218|NCT01265992|468953163|FG000|Overall Study|Did not receive treatment|1|||
130270219|NCT05005273|468953164|FG000|Overall Study|Study Terminated|1|||
130270220|NCT05005273|468953165|FG001|Overall Study|Study Terminated|0|||
130270221|NCT02685826|468953170|FG000|Overall Study|Adverse Event|2|||
130455903|NCT04858425|469632818|FG001|Overall Study|Withdrawal by Subject|1|||
130455904|NCT04858425|469632817|FG000|Overall Study|Lost to Follow-up|4|||
130455905|NCT04858425|469632818|FG001|Overall Study|Lost to Follow-up|2|||
130455906|NCT04858425|469632817|FG000|Overall Study|Lost to Follow-up|1|||
130455907|NCT04858425|469632818|FG001|Overall Study|Lost to Follow-up|0|||
130455908|NCT03310983|469632819|FG000|Overall Study|Lost to Follow-up|15|||
130455909|NCT03310983|469632820|FG001|Overall Study|Lost to Follow-up|17|||
130270222|NCT02685826|468953171|FG001|Overall Study|Adverse Event|0|||
130270223|NCT02685826|468953172|FG002|Overall Study|Adverse Event|1|||
130455910|NCT04536077|469632821|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
130455911|NCT04536077|469632822|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
130455912|NCT04536077|469632821|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
130455913|NCT04536077|469632822|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
130455914|NCT01656304|469632828|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
130455915|NCT01155869|469632829|FG000|Overall Study|Lost to Follow-up|3|||
130455916|NCT01155869|469632830|FG001|Overall Study|Lost to Follow-up|1|||
130455917|NCT02824432|469632831|FG000|Overall Study|Major Protocol Deviation|1|||
130455918|NCT02824432|469632832|FG001|Overall Study|Major Protocol Deviation|0|||
130455919|NCT05826431|469632834|FG000|Overall Study|Withdrawal by Subject|1|||
130455920|NCT04771273|469632837|FG000|Dose Escalation Period|Not treated with trial medication|0|||
130455921|NCT04771273|469632838|FG001|Dose Escalation Period|Not treated with trial medication|1|||
130455922|NCT04771273|469632839|FG002|Dose Escalation Period|Not treated with trial medication|1|||
130455923|NCT04771273|469632840|FG003|Dose Escalation Period|Not treated with trial medication|0|||
130455924|NCT04771273|469632837|FG000|Dose Escalation Period|Other reasons than listed|2|||
130455925|NCT04771273|469632838|FG001|Dose Escalation Period|Other reasons than listed|0|||
130455926|NCT04771273|469632839|FG002|Dose Escalation Period|Other reasons than listed|2|||
130455927|NCT04771273|469632840|FG003|Dose Escalation Period|Other reasons than listed|1|||
130455928|NCT04771273|469632837|FG000|Dose Escalation Period|Protocol Violation|0|||
130455929|NCT04771273|469632838|FG001|Dose Escalation Period|Protocol Violation|0|||
130455930|NCT04771273|469632839|FG002|Dose Escalation Period|Protocol Violation|3|||
130455931|NCT04771273|469632840|FG003|Dose Escalation Period|Protocol Violation|1|||
130455932|NCT04771273|469632837|FG000|Dose Escalation Period|Burden of study procedures|1|||
130455933|NCT04771273|469632838|FG001|Dose Escalation Period|Burden of study procedures|0|||
130455934|NCT04771273|469632839|FG002|Dose Escalation Period|Burden of study procedures|0|||
130455935|NCT04771273|469632840|FG003|Dose Escalation Period|Burden of study procedures|0|||
130455936|NCT04771273|469632837|FG000|Dose Escalation Period|Change of residence|0|||
130455937|NCT04771273|469632838|FG001|Dose Escalation Period|Change of residence|0|||
130705904|NCT02688387|470549566|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
130270224|NCT02685826|468953170|FG000|Overall Study|Progressive Disease|2|||
130270225|NCT02685826|468953171|FG001|Overall Study|Progressive Disease|1|||
130270226|NCT02685826|468953172|FG002|Overall Study|Progressive Disease|0|||
130270227|NCT02685826|468953170|FG000|Overall Study|Withdrawal by Subject|2|||
130270228|NCT02685826|468953171|FG001|Overall Study|Withdrawal by Subject|0|||
130270229|NCT02685826|468953172|FG002|Overall Study|Withdrawal by Subject|0|||
130270230|NCT02685826|468953170|FG000|Overall Study|Full Clinical Hold by FDA|19|||
130270231|NCT02685826|468953171|FG001|Overall Study|Full Clinical Hold by FDA|9|||
130270232|NCT02685826|468953172|FG002|Overall Study|Full Clinical Hold by FDA|20|||
130270233|NCT03154476|468953173|FG000|Overall Study|Lost to Follow-up|4|||
130270234|NCT03154476|468953174|FG001|Overall Study|Lost to Follow-up|4|||
130270235|NCT00200967|468953175|FG000|First Treatment Period|Withdrawal by Subject|5|||
130270236|NCT00200967|468953176|FG001|First Treatment Period|Withdrawal by Subject|1|||
130270237|NCT00200967|468953175|FG000|First Treatment Period|Pregnancy|1|||
130270238|NCT00200967|468953176|FG001|First Treatment Period|Pregnancy|0|||
130270239|NCT00200967|468953175|FG000|Wash-out Period|Lost to Follow-up|0|||
130270240|NCT00200967|468953176|FG001|Wash-out Period|Lost to Follow-up|1|||
130270241|NCT00200967|468953175|FG000|Second Treatment Period|Withdrawal by Subject|1|||
130270242|NCT00200967|468953176|FG001|Second Treatment Period|Withdrawal by Subject|2|||
130270243|NCT00200967|468953175|FG000|Run-out Period|Lost to Follow-up|1|||
130270244|NCT00200967|468953176|FG001|Run-out Period|Lost to Follow-up|0|||
130270245|NCT01444430|468953179|FG000|Overall Study|Withdrawal by Subject|53|||
130270246|NCT01444430|468953180|FG001|Overall Study|Withdrawal by Subject|72|||
130270247|NCT01444430|468953179|FG000|Overall Study|Death|6|||
130270248|NCT01444430|468953180|FG001|Overall Study|Death|8|||
130270249|NCT01444430|468953179|FG000|Overall Study|Lost to Follow-up|2|||
130270250|NCT01444430|468953180|FG001|Overall Study|Lost to Follow-up|0|||
130270251|NCT01444430|468953179|FG000|Overall Study|CRF termination module not completed.|0|||
130705905|NCT02688387|470549567|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705906|NCT02688387|470549568|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705907|NCT02688387|470549569|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130270252|NCT01444430|468953180|FG001|Overall Study|CRF termination module not completed.|1|||
130270253|NCT04245449|468954534|FG000|Overall Study|COVID shutdown|7|||
130270254|NCT02197572|468954539|FG000|Overall Study|Progressive Disease|28|||
130270255|NCT02197572|468954539|FG000|Overall Study|Withdrawal by Subject|9|||
130270256|NCT02197572|468954539|FG000|Overall Study|Adverse Event|3|||
130270257|NCT02197572|468954539|FG000|Overall Study|Reason Not Specified|4|||
130270258|NCT03801928|468954540|FG000|Overall Study|Adverse Event|1|||
130270259|NCT03801928|468954541|FG001|Overall Study|Adverse Event|0|||
130270260|NCT03801928|468954542|FG002|Overall Study|Adverse Event|1|||
130270261|NCT03801928|468954543|FG003|Overall Study|Adverse Event|2|||
130270262|NCT03801928|468954544|FG004|Overall Study|Adverse Event|0|||
130366749|NCT01281865|469314024|FG001|Overall Study|Withdrawal by Subject|0|||
130366750|NCT01281865|469314023|FG000|Overall Study|Lack of Efficacy|1|||
130366751|NCT01281865|469314024|FG001|Overall Study|Lack of Efficacy|0|||
130366752|NCT02590003|469314025|FG000|Overall Study|Death|1|||
130366753|NCT02590003|469314026|FG001|Overall Study|Death|2|||
130366754|NCT01849783|469314027|FG000|Overall Study|Adverse Event|5|||
130366755|NCT01849783|469314027|FG000|Overall Study|Death|2|||
130366756|NCT01849783|469314027|FG000|Overall Study|Physician Decision|1|||
130366757|NCT01849783|469314027|FG000|Overall Study|Withdrawal by Subject|1|||
130366758|NCT01849783|469314027|FG000|Overall Study|Unable to comply|2|||
130366759|NCT01849783|469314027|FG000|Overall Study|Disease progression|11|||
130366760|NCT03948581|469314028|FG000|Overall Study|Lost to Follow-up|0|||
130366761|NCT03948581|469314029|FG001|Overall Study|Lost to Follow-up|1|||
130366762|NCT04457336|469314032|FG000|Period 2: Part A|Withdrawal by Subject|0|||
130366763|NCT04457336|469314033|FG001|Period 2: Part A|Withdrawal by Subject|1|||
130366764|NCT04457336|469314034|FG002|Period 2: Part A|Withdrawal by Subject|1|||
130366765|NCT04457336|469314035|FG003|Period 2: Part A|Withdrawal by Subject|1|||
130366766|NCT04457336|469314036|FG004|Period 2: Part A|Withdrawal by Subject|0|||
130366767|NCT04457336|469314037|FG005|Period 2: Part A|Withdrawal by Subject|0|||
130366768|NCT04457336|469314038|FG006|Period 2: Part A|Withdrawal by Subject|0|||
130366769|NCT04457336|469314039|FG007|Period 2: Part A|Withdrawal by Subject|0|||
130366770|NCT04457336|469314032|FG000|Period 2: Part A|Adverse Event|0|||
130366771|NCT04457336|469314033|FG001|Period 2: Part A|Adverse Event|0|||
130366772|NCT04457336|469314034|FG002|Period 2: Part A|Adverse Event|1|||
130366773|NCT04457336|469314035|FG003|Period 2: Part A|Adverse Event|1|||
130366774|NCT04457336|469314036|FG004|Period 2: Part A|Adverse Event|0|||
130366775|NCT04457336|469314037|FG005|Period 2: Part A|Adverse Event|0|||
130366776|NCT04457336|469314038|FG006|Period 2: Part A|Adverse Event|0|||
130366777|NCT04457336|469314039|FG007|Period 2: Part A|Adverse Event|0|||
130366778|NCT04457336|469314032|FG000|Period 2: Part A|Study Terminated|0|||
130366779|NCT04457336|469314033|FG001|Period 2: Part A|Study Terminated|0|||
130366780|NCT04457336|469314034|FG002|Period 2: Part A|Study Terminated|1|||
130366781|NCT04457336|469314035|FG003|Period 2: Part A|Study Terminated|0|||
130705908|NCT02688387|470549570|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705909|NCT02688387|470549571|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705910|NCT02688387|470549572|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705911|NCT02688387|470549573|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705912|NCT02688387|470549574|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705913|NCT02688387|470549575|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705914|NCT02688387|470549576|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705915|NCT02688387|470549577|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705916|NCT02688387|470549556|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705917|NCT02688387|470549557|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705918|NCT02688387|470549558|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705919|NCT02688387|470549559|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705920|NCT02688387|470549560|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705921|NCT02688387|470549561|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705922|NCT02688387|470549562|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705923|NCT02688387|470549563|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130366782|NCT04457336|469314036|FG004|Period 2: Part A|Study Terminated|0|||
130366783|NCT04457336|469314037|FG005|Period 2: Part A|Study Terminated|0|||
130366784|NCT04457336|469314038|FG006|Period 2: Part A|Study Terminated|0|||
130366785|NCT04457336|469314039|FG007|Period 2: Part A|Study Terminated|0|||
130366786|NCT04457336|469314032|FG000|Period 2: Part A|Protocol Violation|0|||
130366787|NCT04457336|469314033|FG001|Period 2: Part A|Protocol Violation|1|||
130366788|NCT04457336|469314034|FG002|Period 2: Part A|Protocol Violation|0|||
130366789|NCT04457336|469314035|FG003|Period 2: Part A|Protocol Violation|0|||
130366790|NCT04457336|469314036|FG004|Period 2: Part A|Protocol Violation|0|||
130366791|NCT04457336|469314037|FG005|Period 2: Part A|Protocol Violation|0|||
130366792|NCT04457336|469314038|FG006|Period 2: Part A|Protocol Violation|0|||
130366793|NCT04457336|469314039|FG007|Period 2: Part A|Protocol Violation|0|||
130366794|NCT04457336|469314032|FG000|Period 2: Part A|Lost to Follow-up|0|||
130366795|NCT04457336|469314033|FG001|Period 2: Part A|Lost to Follow-up|1|||
130366796|NCT04457336|469314034|FG002|Period 2: Part A|Lost to Follow-up|0|||
130366797|NCT04457336|469314035|FG003|Period 2: Part A|Lost to Follow-up|0|||
130366798|NCT04457336|469314036|FG004|Period 2: Part A|Lost to Follow-up|0|||
130366799|NCT04457336|469314037|FG005|Period 2: Part A|Lost to Follow-up|0|||
130366800|NCT04457336|469314038|FG006|Period 2: Part A|Lost to Follow-up|0|||
130366801|NCT04457336|469314039|FG007|Period 2: Part A|Lost to Follow-up|0|||
130366802|NCT04457336|469314032|FG000|Period 2: Part A|Other|0|||
130366803|NCT04457336|469314033|FG001|Period 2: Part A|Other|1|||
130366804|NCT04457336|469314034|FG002|Period 2: Part A|Other|0|||
130366805|NCT04457336|469314035|FG003|Period 2: Part A|Other|0|||
130366806|NCT04457336|469314036|FG004|Period 2: Part A|Other|0|||
130366807|NCT04457336|469314037|FG005|Period 2: Part A|Other|0|||
130366808|NCT04457336|469314038|FG006|Period 2: Part A|Other|0|||
130366809|NCT04457336|469314039|FG007|Period 2: Part A|Other|0|||
130366810|NCT04457336|469314032|FG000|Period 2: Part A|Physician Decision|0|||
130455938|NCT04771273|469632839|FG002|Dose Escalation Period|Change of residence|0|||
130455939|NCT04771273|469632840|FG003|Dose Escalation Period|Change of residence|1|||
130366811|NCT04457336|469314033|FG001|Period 2: Part A|Physician Decision|0|||
130366812|NCT04457336|469314034|FG002|Period 2: Part A|Physician Decision|0|||
130366813|NCT04457336|469314035|FG003|Period 2: Part A|Physician Decision|1|||
130366814|NCT04457336|469314036|FG004|Period 2: Part A|Physician Decision|0|||
130366815|NCT04457336|469314037|FG005|Period 2: Part A|Physician Decision|0|||
130366816|NCT04457336|469314038|FG006|Period 2: Part A|Physician Decision|0|||
130366817|NCT04457336|469314039|FG007|Period 2: Part A|Physician Decision|0|||
130366818|NCT04457336|469314032|FG000|Period 3: Part B|Study Terminated|0|||
130366819|NCT04457336|469314033|FG001|Period 3: Part B|Study Terminated|0|||
130455940|NCT04771273|469632837|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
130455941|NCT04771273|469632838|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
130455942|NCT04771273|469632839|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
130455943|NCT04771273|469632840|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
130455944|NCT04771273|469632837|FG000|Dose Escalation Period|Adverse Event|8|||
130455945|NCT04771273|469632838|FG001|Dose Escalation Period|Adverse Event|9|||
130455946|NCT04771273|469632839|FG002|Dose Escalation Period|Adverse Event|12|||
130455947|NCT04771273|469632840|FG003|Dose Escalation Period|Adverse Event|2|||
130455948|NCT04771273|469632837|FG000|Maintenance Period|Other than listed|4|||
130455949|NCT04771273|469632838|FG001|Maintenance Period|Other than listed|2|||
130455950|NCT04771273|469632839|FG002|Maintenance Period|Other than listed|0|||
130455951|NCT04771273|469632840|FG003|Maintenance Period|Other than listed|3|||
130455952|NCT04771273|469632837|FG000|Maintenance Period|Burden of study procedures|1|||
130455953|NCT04771273|469632838|FG001|Maintenance Period|Burden of study procedures|0|||
130455954|NCT04771273|469632839|FG002|Maintenance Period|Burden of study procedures|0|||
130455955|NCT04771273|469632840|FG003|Maintenance Period|Burden of study procedures|0|||
130455956|NCT04771273|469632837|FG000|Maintenance Period|Change of residence|0|||
130455957|NCT04771273|469632838|FG001|Maintenance Period|Change of residence|1|||
130455958|NCT04771273|469632839|FG002|Maintenance Period|Change of residence|3|||
130455959|NCT04771273|469632840|FG003|Maintenance Period|Change of residence|0|||
130455960|NCT04771273|469632837|FG000|Maintenance Period|Perceived lack of efficacy|0|||
130455961|NCT04771273|469632838|FG001|Maintenance Period|Perceived lack of efficacy|0|||
130455962|NCT04771273|469632839|FG002|Maintenance Period|Perceived lack of efficacy|0|||
130366820|NCT04457336|469314034|FG002|Period 3: Part B|Study Terminated|0|||
130366821|NCT04457336|469314035|FG003|Period 3: Part B|Study Terminated|0|||
130366822|NCT04457336|469314036|FG004|Period 3: Part B|Study Terminated|1|||
130366823|NCT04457336|469314037|FG005|Period 3: Part B|Study Terminated|10|||
130366824|NCT04457336|469314038|FG006|Period 3: Part B|Study Terminated|13|||
130455963|NCT04771273|469632840|FG003|Maintenance Period|Perceived lack of efficacy|1|||
130455964|NCT04771273|469632837|FG000|Maintenance Period|Adverse Event|4|||
130455965|NCT04771273|469632838|FG001|Maintenance Period|Adverse Event|5|||
130455966|NCT04771273|469632839|FG002|Maintenance Period|Adverse Event|5|||
130455967|NCT04771273|469632840|FG003|Maintenance Period|Adverse Event|0|||
130366825|NCT04457336|469314039|FG007|Period 3: Part B|Study Terminated|0|||
130366826|NCT04457336|469314032|FG000|Period 3: Part B|Withdrawal by Subject|0|||
130366827|NCT04457336|469314033|FG001|Period 3: Part B|Withdrawal by Subject|0|||
130366828|NCT04457336|469314034|FG002|Period 3: Part B|Withdrawal by Subject|0|||
130366829|NCT04457336|469314035|FG003|Period 3: Part B|Withdrawal by Subject|0|||
130366830|NCT04457336|469314036|FG004|Period 3: Part B|Withdrawal by Subject|0|||
130366831|NCT04457336|469314037|FG005|Period 3: Part B|Withdrawal by Subject|1|||
130366832|NCT04457336|469314038|FG006|Period 3: Part B|Withdrawal by Subject|2|||
130366833|NCT04457336|469314039|FG007|Period 3: Part B|Withdrawal by Subject|0|||
130270263|NCT03801928|468954545|FG005|Overall Study|Adverse Event|2|||
130270264|NCT03801928|468954540|FG000|Overall Study|Lack of Efficacy|0|||
130270265|NCT03801928|468954541|FG001|Overall Study|Lack of Efficacy|0|||
130270266|NCT03801928|468954542|FG002|Overall Study|Lack of Efficacy|1|||
130270267|NCT03801928|468954543|FG003|Overall Study|Lack of Efficacy|0|||
130270268|NCT03801928|468954544|FG004|Overall Study|Lack of Efficacy|0|||
130270269|NCT03801928|468954545|FG005|Overall Study|Lack of Efficacy|0|||
130554360|NCT02684357|469996594|FG001|Part A|Lost to Follow-up|2|||
130554361|NCT02684357|469996595|FG002|Part A|Lost to Follow-up|2|||
130270270|NCT03801928|468954540|FG000|Overall Study|Lost to Follow-up|5|||
130270271|NCT03801928|468954541|FG001|Overall Study|Lost to Follow-up|1|||
130270272|NCT03801928|468954542|FG002|Overall Study|Lost to Follow-up|1|||
130270273|NCT03801928|468954543|FG003|Overall Study|Lost to Follow-up|4|||
130270274|NCT03801928|468954544|FG004|Overall Study|Lost to Follow-up|4|||
130270275|NCT03801928|468954545|FG005|Overall Study|Lost to Follow-up|2|||
130270276|NCT03801928|468954540|FG000|Overall Study|Withdrawal by Subject|0|||
130270277|NCT03801928|468954541|FG001|Overall Study|Withdrawal by Subject|0|||
130270278|NCT03801928|468954542|FG002|Overall Study|Withdrawal by Subject|2|||
130270279|NCT03801928|468954543|FG003|Overall Study|Withdrawal by Subject|1|||
130270280|NCT03801928|468954544|FG004|Overall Study|Withdrawal by Subject|0|||
130270281|NCT03801928|468954545|FG005|Overall Study|Withdrawal by Subject|0|||
130270282|NCT03801928|468954540|FG000|Overall Study|Other|0|||
130270283|NCT03801928|468954541|FG001|Overall Study|Other|2|||
130270284|NCT03801928|468954542|FG002|Overall Study|Other|0|||
130270285|NCT03801928|468954543|FG003|Overall Study|Other|1|||
130270286|NCT03801928|468954544|FG004|Overall Study|Other|0|||
130270287|NCT03801928|468954545|FG005|Overall Study|Other|1|||
130270288|NCT00564733|468954550|FG000|Overall Study|Withdrawal by Subject|4|||
130270289|NCT00564733|468954550|FG000|Overall Study|Ineligible|5|||
130270290|NCT01014767|468954551|FG000|Overall Study|PI left institution, data unavailable|12|||
130270291|NCT01014767|468954552|FG001|Overall Study|PI left institution, data unavailable|1|||
130270292|NCT01014767|468954553|FG002|Overall Study|PI left institution, data unavailable|4|||
130270293|NCT01014767|468954554|FG003|Overall Study|PI left institution, data unavailable|1|||
130270294|NCT01484496|468954555|FG000|Period 1|Protocol Violation|3|||
130270295|NCT01484496|468954556|FG001|Period 1|Protocol Violation|4|||
130270296|NCT01484496|468954557|FG002|Period 1|Protocol Violation|0|||
130270297|NCT01484496|468954558|FG003|Period 1|Protocol Violation|0|||
130270298|NCT01484496|468954555|FG000|Period 1|Physician Decision|5|||
130270299|NCT01484496|468954556|FG001|Period 1|Physician Decision|1|||
130270300|NCT01484496|468954557|FG002|Period 1|Physician Decision|0|||
130270301|NCT01484496|468954558|FG003|Period 1|Physician Decision|0|||
130270302|NCT01484496|468954555|FG000|Period 1|Lack of Efficacy|10|||
130270303|NCT01484496|468954556|FG001|Period 1|Lack of Efficacy|15|||
130270304|NCT01484496|468954557|FG002|Period 1|Lack of Efficacy|0|||
130270305|NCT01484496|468954558|FG003|Period 1|Lack of Efficacy|0|||
130270306|NCT01484496|468954555|FG000|Period 1|Adverse Event|25|||
130270307|NCT01484496|468954556|FG001|Period 1|Adverse Event|40|||
130270308|NCT01484496|468954557|FG002|Period 1|Adverse Event|0|||
130270309|NCT01484496|468954558|FG003|Period 1|Adverse Event|0|||
130270310|NCT01484496|468954555|FG000|Period 1|Withdrawal by Subject|15|||
130270311|NCT01484496|468954556|FG001|Period 1|Withdrawal by Subject|12|||
130270312|NCT01484496|468954557|FG002|Period 1|Withdrawal by Subject|0|||
130270313|NCT01484496|468954558|FG003|Period 1|Withdrawal by Subject|0|||
130270314|NCT01484496|468954555|FG000|Period 1|Lost to Follow-up|2|||
130270315|NCT01484496|468954556|FG001|Period 1|Lost to Follow-up|6|||
130270316|NCT01484496|468954557|FG002|Period 1|Lost to Follow-up|0|||
130270317|NCT01484496|468954558|FG003|Period 1|Lost to Follow-up|0|||
130270318|NCT01484496|468954555|FG000|Period 1|Positive Pregnancy|1|||
130270319|NCT01484496|468954556|FG001|Period 1|Positive Pregnancy|6|||
130270320|NCT01484496|468954557|FG002|Period 1|Positive Pregnancy|0|||
130270321|NCT01484496|468954558|FG003|Period 1|Positive Pregnancy|0|||
130270322|NCT01484496|468954555|FG000|Period 1|Treatment Failure|3|||
130270323|NCT01484496|468954556|FG001|Period 1|Treatment Failure|6|||
130270324|NCT01484496|468954557|FG002|Period 1|Treatment Failure|0|||
130270325|NCT01484496|468954558|FG003|Period 1|Treatment Failure|0|||
130270326|NCT01484496|468954555|FG000|Period 1|Lack of Compliance|2|||
130554362|NCT02684357|469996596|FG003|Part A|Lost to Follow-up|0|||
130270327|NCT01484496|468954556|FG001|Period 1|Lack of Compliance|1|||
130270328|NCT01484496|468954557|FG002|Period 1|Lack of Compliance|0|||
130270329|NCT01484496|468954558|FG003|Period 1|Lack of Compliance|0|||
130270330|NCT01484496|468954555|FG000|Period 1|Unable to Visit Site|0|||
130270331|NCT01484496|468954556|FG001|Period 1|Unable to Visit Site|2|||
130270332|NCT01484496|468954557|FG002|Period 1|Unable to Visit Site|0|||
130270333|NCT01484496|468954558|FG003|Period 1|Unable to Visit Site|0|||
130270334|NCT01484496|468954555|FG000|Period 2|Lack of Efficacy|0|||
130270335|NCT01484496|468954556|FG001|Period 2|Lack of Efficacy|0|||
130270336|NCT01484496|468954557|FG002|Period 2|Lack of Efficacy|1|||
130270337|NCT01484496|468954558|FG003|Period 2|Lack of Efficacy|3|||
130270338|NCT01484496|468954555|FG000|Period 2|Adverse Event|0|||
130270339|NCT01484496|468954556|FG001|Period 2|Adverse Event|0|||
130270340|NCT01484496|468954557|FG002|Period 2|Adverse Event|5|||
130554363|NCT02684357|469996597|FG004|Part A|Lost to Follow-up|0|||
130270341|NCT01484496|468954558|FG003|Period 2|Adverse Event|13|||
130270342|NCT01484496|468954555|FG000|Period 2|Other|0|||
130270343|NCT01484496|468954556|FG001|Period 2|Other|0|||
130270344|NCT01484496|468954557|FG002|Period 2|Other|9|||
130270345|NCT01484496|468954558|FG003|Period 2|Other|6|||
130270346|NCT01645735|468954559|FG000|Overall Study|Physician Decision|2|||
130270347|NCT01645735|468954560|FG001|Overall Study|Physician Decision|0|||
130270348|NCT01645735|468954559|FG000|Overall Study|Withdrawal by Subject|1|||
130270349|NCT01645735|468954560|FG001|Overall Study|Withdrawal by Subject|0|||
130270350|NCT01645735|468954559|FG000|Overall Study|Protocol Violation|1|||
130270351|NCT01645735|468954560|FG001|Overall Study|Protocol Violation|0|||
130270352|NCT01645735|468954559|FG000|Overall Study|Adverse Event|0|||
130270353|NCT01645735|468954560|FG001|Overall Study|Adverse Event|1|||
130270354|NCT00573391|468954563|FG000|Overall Study|study stopped|2|||
130270355|NCT00573391|468954564|FG001|Overall Study|study stopped|2|||
130270356|NCT00573391|468954563|FG000|Overall Study|Death|1|||
130270357|NCT00573391|468954564|FG001|Overall Study|Death|0|||
130270358|NCT03369665|468954565|FG000|Overall Study|Adverse Event|3|||
130270359|NCT03369665|468954565|FG000|Overall Study|Lost to Follow-up|7|||
130270360|NCT03369665|468954565|FG000|Overall Study|Withdrawal by Subject|15|||
130270361|NCT03369665|468954565|FG000|Overall Study|Progression Disease|2|||
130270362|NCT03369665|468954565|FG000|Overall Study|Not classified|3|||
130270363|NCT02553928|468954566|FG000|Overall Study|Adverse Event|2|||
130270364|NCT02553928|468954567|FG001|Overall Study|Adverse Event|1|||
130270365|NCT02553928|468954566|FG000|Overall Study|Lost to Follow-up|0|||
130270366|NCT02553928|468954567|FG001|Overall Study|Lost to Follow-up|1|||
130270367|NCT02553928|468954566|FG000|Overall Study|Administrative reason(s)|0|||
130270368|NCT02553928|468954567|FG001|Overall Study|Administrative reason(s)|1|||
130270369|NCT01206140|468954573|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
130270370|NCT01206140|468954574|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
130270371|NCT02688192|468954575|FG000|Overall Study|Lost to Follow-up|11|||
130270372|NCT02688192|468954576|FG001|Overall Study|Lost to Follow-up|5|||
130270373|NCT02688192|468954575|FG000|Overall Study|Physician Decision|1|||
130270374|NCT02688192|468954576|FG001|Overall Study|Physician Decision|0|||
130270375|NCT00075764|468954577|FG000|Overall Study|Adverse Event|5|||
130270376|NCT00075764|468954578|FG001|Overall Study|Adverse Event|12|||
130270377|NCT00075764|468954577|FG000|Overall Study|Death|4|||
130270378|NCT00075764|468954578|FG001|Overall Study|Death|8|||
130270379|NCT00075764|468954577|FG000|Overall Study|Withdrawal by Subject|28|||
130270380|NCT00075764|468954578|FG001|Overall Study|Withdrawal by Subject|18|||
130270381|NCT00075764|468954577|FG000|Overall Study|Progression|269|||
130270382|NCT00075764|468954578|FG001|Overall Study|Progression|274|||
130270383|NCT00075764|468954577|FG000|Overall Study|Still on treatment|8|||
130270384|NCT00075764|468954578|FG001|Overall Study|Still on treatment|15|||
130270385|NCT00075764|468954577|FG000|Overall Study|Delinquent|4|||
130270386|NCT00075764|468954578|FG001|Overall Study|Delinquent|2|||
130270387|NCT00075764|468954577|FG000|Overall Study|Not protocol specified|27|||
130270388|NCT00075764|468954578|FG001|Overall Study|Not protocol specified|19|||
130270389|NCT00075764|468954577|FG000|Overall Study|Under review|0|||
130270390|NCT00075764|468954578|FG001|Overall Study|Under review|1|||
130270391|NCT02817594|468954579|FG000|Overall Study|Withdrawal by Subject|1|||
130270392|NCT02817594|468954579|FG000|Overall Study|Other|1|||
130270393|NCT02817594|468954579|FG000|Overall Study|Did Not Receive Treatment|1|||
130270394|NCT02010593|468954580|FG000|Overall Study|Lost to Follow-up|1|||
130270395|NCT02010593|468954581|FG001|Overall Study|Lost to Follow-up|0|||
130270396|NCT02010593|468954580|FG000|Overall Study|Physician Decision|1|||
130270397|NCT02010593|468954581|FG001|Overall Study|Physician Decision|0|||
130270398|NCT02010593|468954580|FG000|Overall Study|Unable to adhere to visit schedule|0|||
130270399|NCT02010593|468954581|FG001|Overall Study|Unable to adhere to visit schedule|2|||
130270400|NCT01773967|468954582|FG000|Overall Study|Lost to Follow-up|15|||
130270401|NCT01773967|468954583|FG001|Overall Study|Lost to Follow-up|13|||
130270402|NCT01135459|468954584|FG000|Overall Study|Adverse Event|8|||
130270403|NCT01135459|468954585|FG001|Overall Study|Adverse Event|10|||
130270404|NCT01135459|468954584|FG000|Overall Study|Lack of Efficacy|3|||
130270405|NCT01135459|468954585|FG001|Overall Study|Lack of Efficacy|1|||
130270406|NCT01135459|468954584|FG000|Overall Study|Withdrawal by Subject|2|||
130270407|NCT01135459|468954585|FG001|Overall Study|Withdrawal by Subject|3|||
130270408|NCT01135459|468954584|FG000|Overall Study|Protocol Violation|5|||
130270409|NCT01135459|468954585|FG001|Overall Study|Protocol Violation|3|||
130270410|NCT01135459|468954584|FG000|Overall Study|Lost to Follow-up|2|||
130270411|NCT01135459|468954585|FG001|Overall Study|Lost to Follow-up|1|||
130270412|NCT01135459|468954584|FG000|Overall Study|Non-compliance to study procedures|0|||
130270413|NCT01135459|468954585|FG001|Overall Study|Non-compliance to study procedures|1|||
130270414|NCT01135459|468954584|FG000|Overall Study|Other than specified|1|||
130270415|NCT01135459|468954585|FG001|Overall Study|Other than specified|1|||
130270416|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
130270417|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
130270418|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270419|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270420|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130455968|NCT02698241|469632844|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
130455969|NCT02698241|469632844|FG000|Overall Study|Screening not met|7|||
130455970|NCT02698241|469632844|FG000|Overall Study|Withdrawal by Subject|7|||
130455971|NCT02698241|469632844|FG000|Overall Study|Physician Decision|2|||
130455972|NCT02698241|469632844|FG000|Overall Study|Subject underwent system modification|2|||
130455973|NCT02698241|469632844|FG000|Overall Study|Lost to Follow-up|3|||
130455974|NCT02698241|469632844|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
130455975|NCT02698241|469632844|FG000|Overall Study|geographic and licensing issue|1|||
130455976|NCT02698241|469632844|FG000|Overall Study|Death|2|||
130455977|NCT00906282|469632847|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
130705924|NCT02688387|470549564|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705925|NCT02688387|470549565|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705926|NCT02688387|470549566|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705927|NCT02688387|470549567|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705928|NCT02688387|470549568|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130270421|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270422|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270423|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270424|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270425|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270426|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
130455978|NCT00906282|469632847|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
130455979|NCT00906282|469632847|FG000|Preoperative Chemotherapy|Progressive disease|6|||
130455980|NCT00906282|469632847|FG000|Preoperative Chemotherapy|Toxicity|1|||
130455981|NCT02540213|469632848|FG000|Overall Study|Death/adverse event|18|||
130455982|NCT02540213|469632848|FG000|Overall Study|Administrative reasons|3|||
130455983|NCT02540213|469632848|FG000|Overall Study|Kidney transplant|3|||
130455984|NCT02540213|469632848|FG000|Overall Study|Lack of Efficacy|6|||
130455985|NCT02540213|469632848|FG000|Overall Study|Consent withdrawn|7|||
130455986|NCT02540213|469632848|FG000|Overall Study|Enrolled but not treated|2|||
130455987|NCT00290706|469632855|FG000|Overall Study|Withdrawal by Subject|2|||
130455988|NCT00290706|469632856|FG001|Overall Study|Withdrawal by Subject|0|||
130455989|NCT00290706|469632857|FG002|Overall Study|Withdrawal by Subject|0|||
130455990|NCT00290706|469632858|FG003|Overall Study|Withdrawal by Subject|0|||
130455991|NCT00290706|469632855|FG000|Overall Study|Progressive Disease|3|||
130455992|NCT00290706|469632856|FG001|Overall Study|Progressive Disease|5|||
130455993|NCT00290706|469632857|FG002|Overall Study|Progressive Disease|4|||
130455994|NCT00290706|469632858|FG003|Overall Study|Progressive Disease|10|||
130455995|NCT00290706|469632855|FG000|Overall Study|Adverse Event|0|||
130455996|NCT00290706|469632856|FG001|Overall Study|Adverse Event|1|||
130455997|NCT00290706|469632857|FG002|Overall Study|Adverse Event|2|||
130455998|NCT00290706|469632858|FG003|Overall Study|Adverse Event|0|||
130455999|NCT00290706|469632855|FG000|Overall Study|Receive auto transplant or radiation|0|||
130456000|NCT00290706|469632856|FG001|Overall Study|Receive auto transplant or radiation|0|||
130456001|NCT00290706|469632857|FG002|Overall Study|Receive auto transplant or radiation|0|||
130456002|NCT00290706|469632858|FG003|Overall Study|Receive auto transplant or radiation|1|||
130456003|NCT00290706|469632855|FG000|Overall Study|Physician Decision|0|||
130456004|NCT00290706|469632856|FG001|Overall Study|Physician Decision|0|||
130456005|NCT00290706|469632857|FG002|Overall Study|Physician Decision|0|||
130456006|NCT00290706|469632858|FG003|Overall Study|Physician Decision|1|||
130456007|NCT02465359|469632861|FG000|Overall Study|Lack of Efficacy|1|||
130456008|NCT02465359|469632861|FG000|Overall Study|Withdrawal by Subject|1|||
130456009|NCT02465359|469632861|FG000|Overall Study|Adverse Event|1|||
130456010|NCT01304147|469632862|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
130456011|NCT01304147|469632863|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
130456012|NCT01244828|469632864|FG000|Overall Study|Adverse Event|37|||
130705929|NCT02688387|470549569|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705930|NCT02688387|470549570|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130705931|NCT02688387|470549571|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705932|NCT02688387|470549572|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705933|NCT02688387|470549573|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705934|NCT02688387|470549574|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705935|NCT02688387|470549575|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705936|NCT02688387|470549576|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705937|NCT02688387|470549577|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705938|NCT02688387|470549556|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705939|NCT02688387|470549557|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705940|NCT02688387|470549558|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705941|NCT02688387|470549559|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705942|NCT02688387|470549560|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705943|NCT02688387|470549561|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130554364|NCT02684357|469996598|FG005|Part A|Lost to Follow-up|0|||
130270427|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
130270428|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270429|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270430|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270431|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270432|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270433|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270434|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270435|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270436|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
130270437|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270438|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270439|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270440|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270441|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270442|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270443|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270444|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270445|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270446|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
130270447|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
130270448|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270449|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270450|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270451|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270452|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270453|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270454|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270455|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270456|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270457|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
130270458|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270459|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270460|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270461|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270462|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270463|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270464|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270465|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270466|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
130270467|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
130270468|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270469|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270470|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270471|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270472|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130456013|NCT01244828|469632864|FG000|Overall Study|Withdrawal by Subject|31|||
130705944|NCT02688387|470549562|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705945|NCT02688387|470549563|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705946|NCT02688387|470549564|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705947|NCT02688387|470549565|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705948|NCT02688387|470549566|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705949|NCT02688387|470549567|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705950|NCT02688387|470549568|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705951|NCT02688387|470549569|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705952|NCT02688387|470549570|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705953|NCT02688387|470549571|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705954|NCT02688387|470549572|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705955|NCT02688387|470549573|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705956|NCT02688387|470549574|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705957|NCT02688387|470549575|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130270473|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270474|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270475|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270476|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
130456014|NCT01244828|469632864|FG000|Overall Study|Lack of Efficacy|7|||
130705958|NCT02688387|470549576|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
130705959|NCT02688387|470549577|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705960|NCT02688387|470549556|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705961|NCT02688387|470549557|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705962|NCT02688387|470549558|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705963|NCT02688387|470549559|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705964|NCT02688387|470549560|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705965|NCT02688387|470549561|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705966|NCT02688387|470549562|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705967|NCT02688387|470549563|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705968|NCT02688387|470549564|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705969|NCT02688387|470549565|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705970|NCT02688387|470549566|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705971|NCT02688387|470549567|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705972|NCT02688387|470549568|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705973|NCT02688387|470549569|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705974|NCT02688387|470549570|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705975|NCT02688387|470549571|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705976|NCT02688387|470549572|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705977|NCT02688387|470549573|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705978|NCT02688387|470549574|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130705979|NCT02688387|470549575|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705980|NCT02688387|470549576|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130705981|NCT02688387|470549577|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705982|NCT02688387|470549556|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705983|NCT02688387|470549557|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705984|NCT02688387|470549558|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705985|NCT02688387|470549559|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705986|NCT02688387|470549560|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705987|NCT02688387|470549561|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705988|NCT02688387|470549562|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705989|NCT02688387|470549563|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705990|NCT02688387|470549564|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705991|NCT02688387|470549565|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705992|NCT02688387|470549566|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705993|NCT02688387|470549567|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705994|NCT02688387|470549568|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705995|NCT02688387|470549569|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705996|NCT02688387|470549570|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705997|NCT02688387|470549571|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705998|NCT02688387|470549572|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705999|NCT02688387|470549573|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706000|NCT02688387|470549574|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706001|NCT02688387|470549575|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
130706002|NCT02688387|470549576|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706003|NCT02688387|470549577|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706004|NCT01115855|470549580|FG000|Overall Study|Adverse Event|16|||
130706005|NCT01115855|470549581|FG001|Overall Study|Adverse Event|18|||
130706006|NCT01115855|470549580|FG000|Overall Study|Death|6|||
130706007|NCT01115855|470549581|FG001|Overall Study|Death|5|||
130706008|NCT01115855|470549580|FG000|Overall Study|Lab Abnormality|1|||
130270477|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
130270478|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270479|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270480|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130706009|NCT01115855|470549581|FG001|Overall Study|Lab Abnormality|1|||
130706010|NCT01115855|470549580|FG000|Overall Study|Protocol Violation|0|||
130706011|NCT01115855|470549581|FG001|Overall Study|Protocol Violation|1|||
130270481|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270482|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270483|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130706012|NCT01115855|470549580|FG000|Overall Study|Withdrawal by Subject|5|||
130706013|NCT01115855|470549581|FG001|Overall Study|Withdrawal by Subject|5|||
130706014|NCT01115855|470549580|FG000|Overall Study|Other|8|||
130706015|NCT01115855|470549581|FG001|Overall Study|Other|6|||
130706016|NCT02284347|470549582|FG000|Overall Study|Lost to Follow-up|2|||
130706017|NCT02284347|470549582|FG000|Overall Study|Withdrawn prior to treatment|1|||
130706018|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130706019|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
130270484|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270485|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270486|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130270487|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130270488|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270489|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270490|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270491|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270492|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270493|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270494|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270495|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270496|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270497|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270498|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
130270499|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
130270500|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270501|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270502|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270503|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270504|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270505|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270506|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270507|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270508|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
130270509|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
130270510|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270511|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270512|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270513|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270514|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270515|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270516|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270517|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270518|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
130270519|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
130270520|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270521|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270522|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270523|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270524|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270525|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270526|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270527|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270528|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
130270529|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
130706020|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130706021|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
130706022|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
130706023|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
130706024|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
130270530|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270531|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270532|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270533|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270534|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270535|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270536|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270537|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270538|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
130270539|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270540|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270541|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270542|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130706025|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
130706026|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
130706027|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130270543|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270544|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270545|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270546|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270547|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270548|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270549|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
130270550|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270551|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270552|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270553|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270554|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270555|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270556|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Other|0|||
130270557|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Other|0|||
130270558|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Other|2|||
130270559|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Other|1|||
130270560|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Other|0|||
130270561|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Other|0|||
130270562|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Other|0|||
130270563|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Other|0|||
130270564|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Other|0|||
130270565|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Other|0|||
130270566|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270567|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270568|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270569|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270570|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270571|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
130270572|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
130270573|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
130270574|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270575|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270576|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270577|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270578|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270579|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270580|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130270581|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130270582|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
130270583|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
130270584|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270585|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130456015|NCT01244828|469632864|FG000|Overall Study|Lost to Follow-up|2|||
130456016|NCT01244828|469632864|FG000|Overall Study|Other reason (not specified)|1|||
130456017|NCT01278862|469632865|FG000|Overall Study|Lost to Follow-up|1|||
130456018|NCT01278862|469632866|FG001|Overall Study|Lost to Follow-up|1|||
130456019|NCT02952261|469632868|FG000|Overall Study|Withdrawal by Subject|4|||
130456020|NCT02952261|469632869|FG001|Overall Study|Withdrawal by Subject|5|||
130456021|NCT02952261|469632868|FG000|Overall Study|Protocol Violation|1|||
130456022|NCT02952261|469632869|FG001|Overall Study|Protocol Violation|0|||
130456023|NCT00603447|469632870|FG000|Overall Study|Adverse Event|0|||
130456024|NCT00603447|469632871|FG001|Overall Study|Adverse Event|1|||
130456025|NCT00603447|469632872|FG002|Overall Study|Adverse Event|1|||
130456026|NCT00603447|469632873|FG003|Overall Study|Adverse Event|2|||
130456027|NCT00603447|469632874|FG004|Overall Study|Adverse Event|1|||
130456028|NCT00603447|469632875|FG005|Overall Study|Adverse Event|2|||
130456029|NCT00603447|469632876|FG006|Overall Study|Adverse Event|10|||
130270586|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130456030|NCT00603447|469632870|FG000|Overall Study|Other|0|||
130456031|NCT00603447|469632871|FG001|Overall Study|Other|0|||
130270587|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270588|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270589|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270590|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
130270591|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130456032|NCT00603447|469632872|FG002|Overall Study|Other|1|||
130456033|NCT00603447|469632873|FG003|Overall Study|Other|0|||
130456034|NCT00603447|469632874|FG004|Overall Study|Other|3|||
130456035|NCT00603447|469632875|FG005|Overall Study|Other|0|||
130706028|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130270592|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
130270593|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270594|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270595|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270596|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270597|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270598|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270599|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270600|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
130270601|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270602|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
130270603|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
130270604|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270605|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270606|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270607|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270608|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270609|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270610|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
130270611|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
130270612|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
130270613|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270614|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270615|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270616|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270617|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270618|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270619|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270620|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270621|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270622|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270623|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
130270624|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270625|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130456036|NCT00603447|469632876|FG006|Overall Study|Other|13|||
130456037|NCT00603447|469632870|FG000|Overall Study|Withdrew Consent|0|||
130456038|NCT00603447|469632871|FG001|Overall Study|Withdrew Consent|2|||
130456039|NCT00603447|469632872|FG002|Overall Study|Withdrew Consent|0|||
130456040|NCT00603447|469632873|FG003|Overall Study|Withdrew Consent|0|||
130456041|NCT00603447|469632874|FG004|Overall Study|Withdrew Consent|1|||
130456042|NCT00603447|469632875|FG005|Overall Study|Withdrew Consent|0|||
130456043|NCT00603447|469632876|FG006|Overall Study|Withdrew Consent|1|||
130706029|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130706030|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130706031|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130706032|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130706033|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130706034|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706035|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706036|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
130706037|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706038|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
130706039|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130706040|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
130706041|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130706042|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130706043|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
130706044|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
130706045|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130706046|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706047|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706048|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
130706049|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706050|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706051|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706052|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
130706053|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706054|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130706055|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
130706056|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130706057|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
130706058|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130706059|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130706060|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130706061|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130706062|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
130706063|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
130706064|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
130706065|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
130706066|NCT01647711|470549588|FG000|Overall Study|Progressive disease|6|||
130706067|NCT01647711|470549589|FG001|Overall Study|Progressive disease|2|||
130706068|NCT01647711|470549590|FG002|Overall Study|Progressive disease|6|||
130706069|NCT01647711|470549591|FG003|Overall Study|Progressive disease|8|||
130706070|NCT01647711|470549592|FG004|Overall Study|Progressive disease|2|||
130706071|NCT01647711|470549588|FG000|Overall Study|Other adverse event|0|||
130706072|NCT01647711|470549589|FG001|Overall Study|Other adverse event|0|||
130706073|NCT01647711|470549590|FG002|Overall Study|Other adverse event|2|||
130706074|NCT01647711|470549591|FG003|Overall Study|Other adverse event|0|||
130706075|NCT01647711|470549592|FG004|Overall Study|Other adverse event|2|||
130706076|NCT01647711|470549588|FG000|Overall Study|Protocol Violation|0|||
130706077|NCT01647711|470549589|FG001|Overall Study|Protocol Violation|0|||
130706078|NCT01647711|470549590|FG002|Overall Study|Protocol Violation|0|||
130706079|NCT01647711|470549591|FG003|Overall Study|Protocol Violation|0|||
130706080|NCT01647711|470549592|FG004|Overall Study|Protocol Violation|1|||
130706081|NCT01647711|470549588|FG000|Overall Study|Refused to continue taking medication|0|||
130706082|NCT01647711|470549589|FG001|Overall Study|Refused to continue taking medication|0|||
130706083|NCT01647711|470549590|FG002|Overall Study|Refused to continue taking medication|0|||
130706084|NCT01647711|470549591|FG003|Overall Study|Refused to continue taking medication|2|||
130706085|NCT01647711|470549592|FG004|Overall Study|Refused to continue taking medication|1|||
130706086|NCT01647711|470549588|FG000|Overall Study|Other reason not defined|0|||
130706087|NCT01647711|470549589|FG001|Overall Study|Other reason not defined|1|||
130706088|NCT01647711|470549590|FG002|Overall Study|Other reason not defined|1|||
130706089|NCT01647711|470549591|FG003|Overall Study|Other reason not defined|1|||
130706090|NCT01647711|470549592|FG004|Overall Study|Other reason not defined|0|||
130366834|NCT04457336|469314032|FG000|Period 4: Part C|Study Terminated|0|||
130706091|NCT00754013|470549597|FG000|Overall Study|Lost to Follow-up|1|||
130706092|NCT00754013|470549598|FG001|Overall Study|Lost to Follow-up|1|||
130706093|NCT00754013|470549597|FG000|Overall Study|didn't return after study termed|3|||
130366835|NCT04457336|469314033|FG001|Period 4: Part C|Study Terminated|0|||
130366836|NCT04457336|469314034|FG002|Period 4: Part C|Study Terminated|0|||
130706094|NCT00754013|470549598|FG001|Overall Study|didn't return after study termed|4|||
130706095|NCT04039919|470549599|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130706096|NCT04039919|470549600|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130706097|NCT04039919|470549601|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130706098|NCT04039919|470549602|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130706099|NCT04039919|470549603|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130706100|NCT04039919|470549599|FG000|Treatment Period 1|Sponsor's decision|0|||
130706101|NCT04039919|470549600|FG001|Treatment Period 1|Sponsor's decision|0|||
130706102|NCT04039919|470549601|FG002|Treatment Period 1|Sponsor's decision|0|||
130706103|NCT04039919|470549602|FG003|Treatment Period 1|Sponsor's decision|0|||
130706104|NCT04039919|470549603|FG004|Treatment Period 1|Sponsor's decision|16|||
130706105|NCT04039919|470549599|FG000|Treatment Period 5|Withdrawal by Subject|1|||
130706106|NCT04039919|470549600|FG001|Treatment Period 5|Withdrawal by Subject|0|||
130706107|NCT04039919|470549601|FG002|Treatment Period 5|Withdrawal by Subject|0|||
130706108|NCT04039919|470549602|FG003|Treatment Period 5|Withdrawal by Subject|0|||
130706109|NCT04039919|470549603|FG004|Treatment Period 5|Withdrawal by Subject|0|||
130706110|NCT00983918|470549604|FG000|Overall Study|conversion to open cholecystectomy|0|||
130706111|NCT00983918|470549605|FG001|Overall Study|conversion to open cholecystectomy|2|||
130706112|NCT00983918|470549606|FG002|Overall Study|conversion to open cholecystectomy|2|||
130706113|NCT00983918|470549607|FG003|Overall Study|conversion to open cholecystectomy|2|||
130706114|NCT00794417|470549617|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706115|NCT00794417|470549618|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706116|NCT00794417|470549619|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
130706117|NCT00794417|470549620|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706118|NCT00794417|470549617|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130706119|NCT00794417|470549618|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130706120|NCT00794417|470549619|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
130706121|NCT00794417|470549620|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
130706122|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706123|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706124|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706125|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
130706126|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706127|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706128|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706129|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
130706130|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706131|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706132|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706133|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
130706134|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706135|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706136|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706137|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
130706138|NCT00804141|470549623|FG000|Overall Study|Adverse Event|157|||
130706139|NCT00804141|470549623|FG000|Overall Study|Death|4|||
130706140|NCT00804141|470549623|FG000|Overall Study|Failed to return|96|||
130706141|NCT00804141|470549623|FG000|Overall Study|Investigator request|8|||
130706142|NCT00804141|470549623|FG000|Overall Study|Protocol Violation|85|||
130706143|NCT00804141|470549623|FG000|Overall Study|Withdrawal by Subject|131|||
130706144|NCT00804141|470549623|FG000|Overall Study|Lack of Efficacy|46|||
130706145|NCT00804141|470549623|FG000|Overall Study|Other than specified|30|||
130706146|NCT00804141|470549623|FG000|Overall Study|Enrolled but not treated|6|||
130706147|NCT00572039|470549624|FG000|Overall Study|Withdrawal by Subject|9|||
130706148|NCT00572039|470549625|FG001|Overall Study|Withdrawal by Subject|6|||
130706149|NCT00572039|470549624|FG000|Overall Study|Death|2|||
130706150|NCT00572039|470549625|FG001|Overall Study|Death|3|||
130706151|NCT00572039|470549624|FG000|Overall Study|Ill|5|||
130706152|NCT00572039|470549625|FG001|Overall Study|Ill|1|||
130706153|NCT02973321|470549628|FG000|Overall Study|Other than specified|0|||
130706154|NCT02973321|470549629|FG001|Overall Study|Other than specified|5|||
130706155|NCT02973321|470549630|FG002|Overall Study|Other than specified|3|||
130706156|NCT02973321|470549631|FG003|Overall Study|Other than specified|3|||
130706157|NCT02973321|470549632|FG004|Overall Study|Other than specified|1|||
130706158|NCT02973321|470549628|FG000|Overall Study|Lack of Efficacy|0|||
130706159|NCT02973321|470549629|FG001|Overall Study|Lack of Efficacy|0|||
130706160|NCT02973321|470549630|FG002|Overall Study|Lack of Efficacy|0|||
130706161|NCT02973321|470549631|FG003|Overall Study|Lack of Efficacy|0|||
130706162|NCT02973321|470549632|FG004|Overall Study|Lack of Efficacy|1|||
130706163|NCT02973321|470549628|FG000|Overall Study|Adverse Event|1|||
130706164|NCT02973321|470549629|FG001|Overall Study|Adverse Event|10|||
130706165|NCT02973321|470549630|FG002|Overall Study|Adverse Event|11|||
130366837|NCT04457336|469314035|FG003|Period 4: Part C|Study Terminated|0|||
130554365|NCT02684357|469996593|FG000|Part A|Withdrawal by Subject|3|||
130270626|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270627|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270628|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270629|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270630|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270631|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270632|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
130270633|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130366838|NCT04457336|469314036|FG004|Period 4: Part C|Study Terminated|0|||
130270634|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270635|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270636|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270637|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270638|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270639|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270640|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270641|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270642|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270643|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270644|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
130270645|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
130270646|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270647|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270648|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270649|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270650|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270651|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270652|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270653|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270654|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
130270655|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
130270656|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270657|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270658|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270659|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270660|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270661|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270662|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270663|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270664|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
130270665|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
130270666|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270667|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270668|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270669|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270670|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270671|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270672|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270673|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270674|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
130270675|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
130270676|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
130270677|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
130270678|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
130270679|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
130366839|NCT04457336|469314037|FG005|Period 4: Part C|Study Terminated|0|||
130366840|NCT04457336|469314038|FG006|Period 4: Part C|Study Terminated|0|||
130366841|NCT04457336|469314039|FG007|Period 4: Part C|Study Terminated|30|||
130366842|NCT04457336|469314032|FG000|Period 4: Part C|Adverse Event|0|||
130366843|NCT04457336|469314033|FG001|Period 4: Part C|Adverse Event|0|||
130366844|NCT04457336|469314034|FG002|Period 4: Part C|Adverse Event|0|||
130366845|NCT04457336|469314035|FG003|Period 4: Part C|Adverse Event|0|||
130366846|NCT04457336|469314036|FG004|Period 4: Part C|Adverse Event|0|||
130366847|NCT04457336|469314037|FG005|Period 4: Part C|Adverse Event|0|||
130366848|NCT04457336|469314038|FG006|Period 4: Part C|Adverse Event|0|||
130366849|NCT04457336|469314039|FG007|Period 4: Part C|Adverse Event|2|||
130366850|NCT04457336|469314032|FG000|Period 4: Part C|Site Terminated|0|||
130554366|NCT02684357|469996594|FG001|Part A|Withdrawal by Subject|0|||
130366851|NCT04457336|469314033|FG001|Period 4: Part C|Site Terminated|0|||
130270680|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
130270681|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
130270682|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
130270683|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
130270684|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
130270685|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
130270686|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270687|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270688|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270689|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270690|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270691|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270692|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270693|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270694|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
130270695|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
130270696|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270697|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270698|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270699|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270700|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270701|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270702|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270703|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270704|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
130270705|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270706|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270707|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270708|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270709|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270710|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270711|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270712|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270713|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270714|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
130270715|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
130270716|NCT00292045|468954596|FG000|Core Study (Through Week 13)|Adverse Event|1|||
130270717|NCT00292045|468954596|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
130270718|NCT04474197|468954597|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270719|NCT04474197|468954598|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
130270720|NCT04474197|468954599|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270721|NCT04474197|468954600|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270722|NCT01871545|468954601|FG000|Overall Study|Death|2|||
130270723|NCT01871545|468954602|FG001|Overall Study|Death|0|||
130270724|NCT01871545|468954601|FG000|Overall Study|Lack of Efficacy|11|||
130270725|NCT01871545|468954602|FG001|Overall Study|Lack of Efficacy|2|||
130270726|NCT01871545|468954601|FG000|Overall Study|Physician Decision|4|||
130270727|NCT01871545|468954602|FG001|Overall Study|Physician Decision|0|||
130270728|NCT01871545|468954601|FG000|Overall Study|Withdrawal by Subject|0|||
130270729|NCT01871545|468954602|FG001|Overall Study|Withdrawal by Subject|1|||
130270730|NCT04834726|468954605|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
130270731|NCT04834726|468954606|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
130270732|NCT04834726|468954607|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
130270733|NCT04834726|468954608|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
130270734|NCT04834726|468954609|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
130270735|NCT04834726|468954610|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
130270736|NCT04834726|468954611|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
130270737|NCT04834726|468954612|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
130270738|NCT04834726|468954613|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
130366852|NCT04457336|469314034|FG002|Period 4: Part C|Site Terminated|0|||
130270739|NCT00363142|468954614|FG000|Overall Study|Adverse Event|2|||
130270740|NCT00363142|468954615|FG001|Overall Study|Adverse Event|0|||
130270741|NCT00363142|468954614|FG000|Overall Study|Lack of Efficacy|0|||
130270742|NCT00363142|468954615|FG001|Overall Study|Lack of Efficacy|1|||
130270743|NCT00363142|468954614|FG000|Overall Study|Lost to Follow-up|1|||
130270744|NCT00363142|468954615|FG001|Overall Study|Lost to Follow-up|0|||
130270745|NCT00363142|468954614|FG000|Overall Study|Non-compliance|1|||
130270746|NCT00363142|468954615|FG001|Overall Study|Non-compliance|1|||
130270747|NCT00363142|468954614|FG000|Overall Study|Withdrawal by Subject|3|||
130270748|NCT00363142|468954615|FG001|Overall Study|Withdrawal by Subject|1|||
130270749|NCT00132301|468954622|FG000|Overall Study|Death|7|||
130270750|NCT00132301|468954623|FG001|Overall Study|Death|6|||
130270751|NCT00132301|468954622|FG000|Overall Study|Withdrawal by Subject|5|||
130270752|NCT00132301|468954623|FG001|Overall Study|Withdrawal by Subject|2|||
130270753|NCT00132301|468954622|FG000|Overall Study|Physician Decision|1|||
130270754|NCT00132301|468954623|FG001|Overall Study|Physician Decision|1|||
130270755|NCT00132301|468954622|FG000|Overall Study|Lost to Follow-up|5|||
130270756|NCT00132301|468954623|FG001|Overall Study|Lost to Follow-up|3|||
130270757|NCT00132301|468954622|FG000|Overall Study|Other|1|||
130270758|NCT00132301|468954623|FG001|Overall Study|Other|1|||
130270759|NCT00132301|468954622|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
130270760|NCT00132301|468954623|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
130270761|NCT02012218|468954624|FG000|Overall Study|Withdrawal by Subject|1|||
130270762|NCT02012218|468954625|FG001|Overall Study|Withdrawal by Subject|0|||
130270763|NCT02012218|468954626|FG002|Overall Study|Withdrawal by Subject|1|||
130270764|NCT02012218|468954627|FG003|Overall Study|Withdrawal by Subject|1|||
130270765|NCT02012218|468954628|FG004|Overall Study|Withdrawal by Subject|1|||
130270766|NCT02012218|468954624|FG000|Overall Study|Adverse Event|1|||
130270767|NCT02012218|468954625|FG001|Overall Study|Adverse Event|0|||
130270768|NCT02012218|468954626|FG002|Overall Study|Adverse Event|0|||
130270769|NCT02012218|468954627|FG003|Overall Study|Adverse Event|1|||
130270770|NCT02012218|468954628|FG004|Overall Study|Adverse Event|0|||
130270771|NCT02012218|468954624|FG000|Overall Study|Lost to Follow-up|0|||
130270772|NCT02012218|468954625|FG001|Overall Study|Lost to Follow-up|1|||
130270773|NCT02012218|468954626|FG002|Overall Study|Lost to Follow-up|1|||
130270774|NCT02012218|468954627|FG003|Overall Study|Lost to Follow-up|0|||
130270775|NCT02012218|468954628|FG004|Overall Study|Lost to Follow-up|0|||
130270776|NCT02012218|468954624|FG000|Overall Study|Protocol Specified|1|||
130270777|NCT02012218|468954625|FG001|Overall Study|Protocol Specified|0|||
130270778|NCT02012218|468954626|FG002|Overall Study|Protocol Specified|0|||
130270779|NCT02012218|468954627|FG003|Overall Study|Protocol Specified|0|||
130270780|NCT02012218|468954628|FG004|Overall Study|Protocol Specified|0|||
130270781|NCT02012218|468954624|FG000|Overall Study|Protocol Deviation|1|||
130270782|NCT02012218|468954625|FG001|Overall Study|Protocol Deviation|0|||
130270783|NCT02012218|468954626|FG002|Overall Study|Protocol Deviation|0|||
130270784|NCT02012218|468954627|FG003|Overall Study|Protocol Deviation|0|||
130270785|NCT02012218|468954628|FG004|Overall Study|Protocol Deviation|0|||
130270786|NCT04872569|468954632|FG000|Overall Study|Withdrawal by Subject|2|||
130270787|NCT02382991|468954639|FG000|Overall Study|Adverse Event|1|||
130270788|NCT02382991|468954640|FG001|Overall Study|Adverse Event|2|||
130270789|NCT02382991|468954639|FG000|Overall Study|Lost to Follow-up|1|||
130270790|NCT02382991|468954640|FG001|Overall Study|Lost to Follow-up|0|||
130270791|NCT02382991|468954639|FG000|Overall Study|Withdrawal by Subject|0|||
130270792|NCT02382991|468954640|FG001|Overall Study|Withdrawal by Subject|1|||
130270793|NCT01890265|468954641|FG000|Overall Study|Other (Unspecified reason)|0|||
130270794|NCT01890265|468954642|FG001|Overall Study|Other (Unspecified reason)|1|||
130270795|NCT01890265|468954643|FG002|Overall Study|Other (Unspecified reason)|0|||
130270796|NCT01890265|468954644|FG003|Overall Study|Other (Unspecified reason)|0|||
130270797|NCT01890265|468954645|FG004|Overall Study|Other (Unspecified reason)|0|||
130270798|NCT01890265|468954646|FG005|Overall Study|Other (Unspecified reason)|0|||
130270799|NCT01890265|468954641|FG000|Overall Study|Progressive disease|6|||
130270800|NCT01890265|468954642|FG001|Overall Study|Progressive disease|6|||
130270801|NCT01890265|468954643|FG002|Overall Study|Progressive disease|0|||
130270802|NCT01890265|468954644|FG003|Overall Study|Progressive disease|0|||
130270803|NCT01890265|468954645|FG004|Overall Study|Progressive disease|0|||
130270804|NCT01890265|468954646|FG005|Overall Study|Progressive disease|0|||
130270805|NCT01890265|468954641|FG000|Overall Study|Adverse Event|2|||
130366853|NCT04457336|469314035|FG003|Period 4: Part C|Site Terminated|0|||
130270806|NCT01890265|468954642|FG001|Overall Study|Adverse Event|1|||
130270807|NCT01890265|468954643|FG002|Overall Study|Adverse Event|0|||
130270808|NCT01890265|468954644|FG003|Overall Study|Adverse Event|0|||
130270809|NCT01890265|468954645|FG004|Overall Study|Adverse Event|0|||
130270810|NCT01890265|468954646|FG005|Overall Study|Adverse Event|0|||
130270811|NCT01890265|468954641|FG000|Overall Study|Death|2|||
130270812|NCT01890265|468954642|FG001|Overall Study|Death|3|||
130270813|NCT01890265|468954643|FG002|Overall Study|Death|1|||
130270814|NCT01890265|468954644|FG003|Overall Study|Death|0|||
130366854|NCT04457336|469314036|FG004|Period 4: Part C|Site Terminated|0|||
130366855|NCT04457336|469314037|FG005|Period 4: Part C|Site Terminated|0|||
130270815|NCT01890265|468954645|FG004|Overall Study|Death|0|||
130270816|NCT01890265|468954646|FG005|Overall Study|Death|0|||
130270817|NCT01890265|468954641|FG000|Overall Study|Withdrawal by Subject|0|||
130270818|NCT01890265|468954642|FG001|Overall Study|Withdrawal by Subject|2|||
130270819|NCT01890265|468954643|FG002|Overall Study|Withdrawal by Subject|3|||
130270820|NCT01890265|468954644|FG003|Overall Study|Withdrawal by Subject|0|||
130270821|NCT01890265|468954645|FG004|Overall Study|Withdrawal by Subject|2|||
130270822|NCT01890265|468954646|FG005|Overall Study|Withdrawal by Subject|0|||
130270823|NCT01445613|468954647|FG000|30-day Follow-up|Withdrawal by Subject|6|||
130270824|NCT01445613|468954647|FG000|30-day Follow-up|Physician Decision|3|||
130270825|NCT01445613|468954647|FG000|30-day Follow-up|Missed visit|23|||
130270826|NCT01445613|468954647|FG000|30-day Follow-up|Death|3|||
130270827|NCT01445613|468954647|FG000|1-year Follow-up|Withdrawal by Subject|12|||
130270828|NCT01445613|468954647|FG000|1-year Follow-up|Missed visit|29|||
130270829|NCT01445613|468954647|FG000|1-year Follow-up|Lost to Follow-up|2|||
130270830|NCT01445613|468954647|FG000|1-year Follow-up|Death|30|||
130270831|NCT01445613|468954647|FG000|1-year Follow-up|Physician Decision|2|||
130270832|NCT01445613|468954647|FG000|1-year Follow-up|Received a non-study stent|2|||
130270833|NCT04466384|468954648|FG000|First Phase|Protocol Violation|1|||
130270834|NCT04466384|468954649|FG001|First Phase|Protocol Violation|0|||
130270835|NCT04466384|468954648|FG000|First Phase|Missing data|1|||
130270836|NCT04466384|468954649|FG001|First Phase|Missing data|0|||
130270837|NCT04466384|468954648|FG000|Cross Over Phase|Physician Decision|1|||
130270838|NCT04466384|468954649|FG001|Cross Over Phase|Physician Decision|0|||
130270839|NCT04466384|468954648|FG000|Cross Over Phase|Withdrawal by Subject|0|||
130270840|NCT04466384|468954649|FG001|Cross Over Phase|Withdrawal by Subject|1|||
130270841|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270842|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
130270843|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
130270844|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270845|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270846|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270847|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Other|0|||
130270848|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Other|1|||
130270849|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Other|1|||
130270850|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Other|0|||
130270851|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Other|0|||
130270852|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Other|0|||
130270853|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
130270854|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
130270855|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
130270856|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270857|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270858|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270859|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270860|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270861|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
130270862|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270863|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270864|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270865|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
130270866|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270867|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270868|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270869|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270870|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270871|NCT03554018|468954664|FG000|Overall Study|Lost to Follow-up|3|||
130270872|NCT03554018|468954665|FG001|Overall Study|Lost to Follow-up|7|||
130270873|NCT01402869|468954666|FG000|Overall Study|Required Tooth Extraction|0|||
130270874|NCT01402869|468954667|FG001|Overall Study|Required Tooth Extraction|0|||
130270875|NCT01402869|468954668|FG002|Overall Study|Required Tooth Extraction|1|||
130456044|NCT05233085|469632877|FG000|Overall Study|Adverse Event|1|||
130270876|NCT01154452|468954669|FG000|Phase Ib|Not Treated|1|||
130270877|NCT01154452|468954670|FG001|Phase Ib|Not Treated|0|||
130270878|NCT01154452|468954671|FG002|Phase Ib|Not Treated|0|||
130270879|NCT01154452|468954672|FG003|Phase Ib|Not Treated|0|||
130270880|NCT01154452|468954669|FG000|Phase Ib|Adverse Event|2|||
130270881|NCT01154452|468954670|FG001|Phase Ib|Adverse Event|1|||
130270882|NCT01154452|468954671|FG002|Phase Ib|Adverse Event|0|||
130270883|NCT01154452|468954672|FG003|Phase Ib|Adverse Event|0|||
130270884|NCT01154452|468954669|FG000|Phase II|Withdrawal by Subject|0|||
130270885|NCT01154452|468954670|FG001|Phase II|Withdrawal by Subject|0|||
130456045|NCT05233085|469632878|FG001|Overall Study|Adverse Event|0|||
130456046|NCT05233085|469632879|FG002|Overall Study|Adverse Event|0|||
130706166|NCT02973321|470549631|FG003|Overall Study|Adverse Event|13|||
130270886|NCT01154452|468954671|FG002|Phase II|Withdrawal by Subject|1|||
130270887|NCT01154452|468954672|FG003|Phase II|Withdrawal by Subject|2|||
130270888|NCT01154452|468954669|FG000|Phase II|Adverse Event|0|||
130270889|NCT01154452|468954670|FG001|Phase II|Adverse Event|0|||
130270890|NCT01154452|468954671|FG002|Phase II|Adverse Event|4|||
130270891|NCT01154452|468954672|FG003|Phase II|Adverse Event|4|||
130270892|NCT01837680|468954675|FG000|Overall Study|Lost to Follow-up|2|||
130270893|NCT01837680|468954676|FG001|Overall Study|Lost to Follow-up|2|||
130270894|NCT01837680|468954675|FG000|Overall Study|lack of insurance|0|||
130270895|NCT01837680|468954676|FG001|Overall Study|lack of insurance|2|||
130270896|NCT01837680|468954675|FG000|Overall Study|allergic reaction|6|||
130706167|NCT02973321|470549632|FG004|Overall Study|Adverse Event|3|||
130706168|NCT01790113|470549639|FG000|Overall Study|Adverse Event|2|||
130706169|NCT01790113|470549640|FG001|Overall Study|Adverse Event|7|||
130706170|NCT01790113|470549639|FG000|Overall Study|Study ended due to FDA clearance|1|||
130706171|NCT01790113|470549640|FG001|Overall Study|Study ended due to FDA clearance|68|||
130706172|NCT00865514|470549641|FG000|Overall Study|Infusion cost exceeded funding|2|||
130706173|NCT03920280|470549642|FG000|Overall Study|Adverse Event|2|||
130706174|NCT03920280|470549643|FG001|Overall Study|Adverse Event|3|||
130706175|NCT03920280|470549642|FG000|Overall Study|Lost to Follow-up|0|||
130706176|NCT03920280|470549643|FG001|Overall Study|Lost to Follow-up|1|||
130706177|NCT03920280|470549642|FG000|Overall Study|Withdrawal by Subject|1|||
130706178|NCT03920280|470549643|FG001|Overall Study|Withdrawal by Subject|1|||
130706179|NCT03920280|470549642|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
130706180|NCT03920280|470549643|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
130706181|NCT02487082|470549644|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
130706182|NCT02487082|470549645|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
130706183|NCT02487082|470549644|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
130706184|NCT02487082|470549645|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
130706185|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
130706186|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
130706187|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706188|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706189|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706190|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130706191|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130706192|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706193|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706194|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706195|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
130706196|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
130706197|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706198|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706199|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706200|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130706201|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130706202|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706203|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706204|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706205|NCT03297294|470549646|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706206|NCT03297294|470549647|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706207|NCT03297294|470549648|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706208|NCT03297294|470549649|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
130706209|NCT03297294|470549650|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706210|NCT01198873|470549651|FG000|Overall Study|Adverse Event|4|||
130706211|NCT01198873|470549652|FG001|Overall Study|Adverse Event|7|||
130706212|NCT01198873|470549651|FG000|Overall Study|Study closure|29|||
130706213|NCT01198873|470549652|FG001|Overall Study|Study closure|23|||
130706214|NCT01198873|470549651|FG000|Overall Study|Other than above|4|||
130706215|NCT01198873|470549652|FG001|Overall Study|Other than above|2|||
130706216|NCT03139240|470549653|FG000|Overall Study|Lost to Follow-up|0|||
130706217|NCT03139240|470549654|FG001|Overall Study|Lost to Follow-up|1|||
130706218|NCT03139240|470549655|FG002|Overall Study|Lost to Follow-up|1|||
130706219|NCT03139240|470549656|FG003|Overall Study|Lost to Follow-up|0|||
130706220|NCT00268892|470549657|FG000|Overall Study|Adverse Event|14|||
130706221|NCT00268892|470549658|FG001|Overall Study|Adverse Event|17|||
130706222|NCT00268892|470549659|FG002|Overall Study|Adverse Event|20|||
130706223|NCT00268892|470549657|FG000|Overall Study|Lack of Efficacy|1|||
130706224|NCT00268892|470549658|FG001|Overall Study|Lack of Efficacy|3|||
130706225|NCT00268892|470549659|FG002|Overall Study|Lack of Efficacy|0|||
130706226|NCT00268892|470549657|FG000|Overall Study|Withdrawal by Subject|14|||
130706227|NCT00268892|470549658|FG001|Overall Study|Withdrawal by Subject|15|||
130706228|NCT00268892|470549659|FG002|Overall Study|Withdrawal by Subject|13|||
130706229|NCT00268892|470549657|FG000|Overall Study|Physician Decision|0|||
130706230|NCT00268892|470549658|FG001|Overall Study|Physician Decision|1|||
130706231|NCT00268892|470549659|FG002|Overall Study|Physician Decision|0|||
130706232|NCT00268892|470549657|FG000|Overall Study|Lost to Follow-up|5|||
130706233|NCT00268892|470549658|FG001|Overall Study|Lost to Follow-up|2|||
130706234|NCT00268892|470549659|FG002|Overall Study|Lost to Follow-up|4|||
130706235|NCT00268892|470549657|FG000|Overall Study|Protocol Violation|0|||
130706236|NCT00268892|470549658|FG001|Overall Study|Protocol Violation|1|||
130706237|NCT00268892|470549659|FG002|Overall Study|Protocol Violation|0|||
130270897|NCT01837680|468954676|FG001|Overall Study|allergic reaction|0|||
130270898|NCT01837680|468954675|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
130270899|NCT01837680|468954676|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
130270900|NCT02297815|468955937|FG000|Overall Study|Lost to Follow-up|236|||
130270901|NCT02297815|468955938|FG001|Overall Study|Lost to Follow-up|140|||
130270902|NCT00662831|468955939|FG000|Overall Study|Death|4|||
130270903|NCT00662831|468955940|FG001|Overall Study|Death|1|||
130270904|NCT00662831|468955939|FG000|Overall Study|Lack of Efficacy|6|||
130270905|NCT00662831|468955940|FG001|Overall Study|Lack of Efficacy|6|||
130270906|NCT00662831|468955939|FG000|Overall Study|Lost to Follow-up|1|||
130270907|NCT00662831|468955940|FG001|Overall Study|Lost to Follow-up|0|||
130270908|NCT00662831|468955939|FG000|Overall Study|Withdrawal by Subject|2|||
130270909|NCT00662831|468955940|FG001|Overall Study|Withdrawal by Subject|1|||
130270910|NCT00662831|468955939|FG000|Overall Study|Other|62|||
130270911|NCT00662831|468955940|FG001|Overall Study|Other|31|||
130270912|NCT00662831|468955939|FG000|Overall Study|Protocol Violation|8|||
130270913|NCT00662831|468955940|FG001|Overall Study|Protocol Violation|4|||
130270914|NCT00662831|468955939|FG000|Overall Study|Adverse Event|23|||
130270915|NCT00662831|468955940|FG001|Overall Study|Adverse Event|16|||
130366856|NCT04457336|469314038|FG006|Period 4: Part C|Site Terminated|0|||
130366857|NCT04457336|469314039|FG007|Period 4: Part C|Site Terminated|1|||
130366858|NCT04457336|469314032|FG000|Period 4: Part C|Other|0|||
130366859|NCT04457336|469314033|FG001|Period 4: Part C|Other|0|||
130706238|NCT00268892|470549657|FG000|Overall Study|Disease Progression|1|||
130706239|NCT00268892|470549658|FG001|Overall Study|Disease Progression|1|||
130706240|NCT00268892|470549659|FG002|Overall Study|Disease Progression|0|||
130706241|NCT00268892|470549657|FG000|Overall Study|Trial Site Closed|4|||
130706242|NCT00268892|470549658|FG001|Overall Study|Trial Site Closed|2|||
130366860|NCT04457336|469314034|FG002|Period 4: Part C|Other|0|||
130366861|NCT04457336|469314035|FG003|Period 4: Part C|Other|0|||
130366862|NCT04457336|469314036|FG004|Period 4: Part C|Other|0|||
130706243|NCT00268892|470549659|FG002|Overall Study|Trial Site Closed|2|||
130706244|NCT02492841|470549660|FG000|Overall Study|Lost to Follow-up|34|||
130706245|NCT02492841|470549661|FG001|Overall Study|Lost to Follow-up|31|||
130706246|NCT02492841|470549662|FG002|Overall Study|Lost to Follow-up|35|||
130706247|NCT02563769|470549667|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130706248|NCT02563769|470549668|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130706249|NCT02563769|470549669|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
130706250|NCT00690482|470549670|FG000|Overall Study|Adverse Event|2|||
130706251|NCT00690482|470549671|FG001|Overall Study|Adverse Event|1|||
130706252|NCT00690482|470549670|FG000|Overall Study|Incorrect enrolment|0|||
130706253|NCT00690482|470549671|FG001|Overall Study|Incorrect enrolment|1|||
130270916|NCT00600106|468955941|FG000|Overall Study|Withdrawal by Subject|1|||
130270917|NCT00600106|468955942|FG001|Overall Study|Withdrawal by Subject|1|||
130366863|NCT04457336|469314037|FG005|Period 4: Part C|Other|0|||
130366864|NCT04457336|469314038|FG006|Period 4: Part C|Other|0|||
130366865|NCT04457336|469314039|FG007|Period 4: Part C|Other|2|||
130366866|NCT04457336|469314032|FG000|Period 4: Part C|Withdrawal by Subject|0|||
130366867|NCT04457336|469314033|FG001|Period 4: Part C|Withdrawal by Subject|0|||
130366868|NCT04457336|469314034|FG002|Period 4: Part C|Withdrawal by Subject|0|||
130366869|NCT04457336|469314035|FG003|Period 4: Part C|Withdrawal by Subject|0|||
130270918|NCT01061723|468955945|FG000|Overall Study|Adverse Event|0|||
130270919|NCT01061723|468955946|FG001|Overall Study|Adverse Event|2|||
130270920|NCT01061723|468955947|FG002|Overall Study|Adverse Event|5|||
130366870|NCT04457336|469314036|FG004|Period 4: Part C|Withdrawal by Subject|0|||
130366871|NCT04457336|469314037|FG005|Period 4: Part C|Withdrawal by Subject|0|||
130366872|NCT04457336|469314038|FG006|Period 4: Part C|Withdrawal by Subject|0|||
130456047|NCT05233085|469632880|FG003|Overall Study|Adverse Event|0|||
130456048|NCT00798265|469632881|FG000|Overall Study|Lost to Follow-up|1|||
130706254|NCT00690482|470549670|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130270921|NCT01061723|468955948|FG003|Overall Study|Adverse Event|5|||
130366873|NCT04457336|469314039|FG007|Period 4: Part C|Withdrawal by Subject|3|||
130366874|NCT03330288|469314046|FG000|Overall Study|Other reason|1|||
130706255|NCT00690482|470549671|FG001|Overall Study|Study-specific discontinuation criteria|0|||
130270922|NCT01061723|468955949|FG004|Overall Study|Adverse Event|2|||
130270923|NCT01061723|468955950|FG005|Overall Study|Adverse Event|6|||
130270924|NCT01061723|468955945|FG000|Overall Study|Lack of Efficacy|2|||
130270925|NCT01061723|468955946|FG001|Overall Study|Lack of Efficacy|3|||
130270926|NCT01061723|468955947|FG002|Overall Study|Lack of Efficacy|4|||
130270927|NCT01061723|468955948|FG003|Overall Study|Lack of Efficacy|2|||
130270928|NCT01061723|468955949|FG004|Overall Study|Lack of Efficacy|1|||
130270929|NCT01061723|468955950|FG005|Overall Study|Lack of Efficacy|1|||
130270930|NCT01061723|468955945|FG000|Overall Study|Randomized but not treated|0|||
130270931|NCT01061723|468955946|FG001|Overall Study|Randomized but not treated|0|||
130270932|NCT01061723|468955947|FG002|Overall Study|Randomized but not treated|0|||
130270933|NCT01061723|468955948|FG003|Overall Study|Randomized but not treated|0|||
130270934|NCT01061723|468955949|FG004|Overall Study|Randomized but not treated|0|||
130270935|NCT01061723|468955950|FG005|Overall Study|Randomized but not treated|1|||
130270936|NCT01061723|468955945|FG000|Overall Study|Other than specified above|2|||
130270937|NCT01061723|468955946|FG001|Overall Study|Other than specified above|1|||
130270938|NCT01061723|468955947|FG002|Overall Study|Other than specified above|1|||
130270939|NCT01061723|468955948|FG003|Overall Study|Other than specified above|1|||
130270940|NCT01061723|468955949|FG004|Overall Study|Other than specified above|0|||
130270941|NCT01061723|468955950|FG005|Overall Study|Other than specified above|1|||
130270942|NCT02840253|468955951|FG000|Overall Study|Unsuccessful block|4|||
130270943|NCT03783962|468955952|FG000|Overall Study|Lost to Follow-up|3|||
130270944|NCT03783962|468955953|FG001|Overall Study|Lost to Follow-up|6|||
130270945|NCT03783962|468955952|FG000|Overall Study|Protocol Violation|0|||
130270946|NCT03783962|468955953|FG001|Overall Study|Protocol Violation|1|||
130270947|NCT03458325|468955954|FG000|Overall Study|Withdrawal by Subject|1|||
130270948|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
130270949|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270950|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270951|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270952|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
130270953|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130270954|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130270955|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130366875|NCT03330288|469314047|FG001|Overall Study|Other reason|1|||
130270956|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270957|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
130270958|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270959|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270960|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130270961|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130366876|NCT03330288|469314046|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
130270962|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
130270963|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
130270964|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130270965|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130270966|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
130270967|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
130270968|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270969|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270970|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270971|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
130270972|NCT01724216|468955963|FG000|Overall Study|Scan was not completed|1|||
130270973|NCT00175916|468955964|FG000|Overall Study|Death|19|||
130270974|NCT00175916|468955964|FG000|Overall Study|Adverse Event|81|||
130270975|NCT00175916|468955964|FG000|Overall Study|Lack of Efficacy|354|||
130270976|NCT00175916|468955964|FG000|Overall Study|Lost to Follow-up|17|||
130270977|NCT00175916|468955964|FG000|Overall Study|Subject Choice|98|||
130270978|NCT00175916|468955964|FG000|Overall Study|Lack of compliance|8|||
130270979|NCT00175916|468955964|FG000|Overall Study|Patient cannot record seizures|1|||
130270980|NCT00175916|468955964|FG000|Overall Study|Sponsor decision|17|||
130706256|NCT00690482|470549670|FG000|Overall Study|Intake of prohibited medicine|1|||
130270981|NCT00175916|468955964|FG000|Overall Study|Vigabatrin intake|1|||
130270982|NCT00175916|468955964|FG000|Overall Study|Suicidal behaviour|1|||
130270983|NCT00175916|468955964|FG000|Overall Study|Withdrawal by Subject|1|||
130270984|NCT00175916|468955964|FG000|Overall Study|Seizure - free|4|||
130270985|NCT00175916|468955964|FG000|Overall Study|Administrative reason|1|||
130270986|NCT00175916|468955964|FG000|Overall Study|Pregnancy|1|||
130270987|NCT00175916|468955964|FG000|Overall Study|Patient's request|2|||
130270988|NCT00175916|468955964|FG000|Overall Study|Treating physiciant's choice|1|||
130270989|NCT00175916|468955964|FG000|Overall Study|Moved overseas|1|||
130270990|NCT00175916|468955964|FG000|Overall Study|Loss of job and economic burden|1|||
130270991|NCT00175916|468955964|FG000|Overall Study|Site was closed|9|||
130270992|NCT00175916|468955964|FG000|Overall Study|Patient went to prison|1|||
130270993|NCT03650413|468955965|FG000|Overall Study|Adverse Event|1|||
130270994|NCT03650413|468955965|FG000|Overall Study|Lack of Efficacy|17|||
130270995|NCT03650413|468955965|FG000|Overall Study|Other|9|||
130270996|NCT03650413|468955965|FG000|Overall Study|Physician Decision|2|||
130270997|NCT03650413|468955965|FG000|Overall Study|Study Terminated By Sponsor|16|||
130270998|NCT03650413|468955965|FG000|Overall Study|Withdrawal by Subject|16|||
130270999|NCT03654040|468955966|FG000|Overall Study|Death|1|||
130271000|NCT03654040|468955967|FG001|Overall Study|Death|0|||
130271001|NCT03654040|468955966|FG000|Overall Study|Withdrawal by Subject|1|||
130271002|NCT03654040|468955967|FG001|Overall Study|Withdrawal by Subject|0|||
130271003|NCT03654040|468955966|FG000|Overall Study|Study terminated by sponsor|8|||
130271004|NCT03654040|468955967|FG001|Overall Study|Study terminated by sponsor|2|||
130271005|NCT03654040|468955966|FG000|Overall Study|Failure to initiate study therapy|2|||
130271006|NCT03654040|468955967|FG001|Overall Study|Failure to initiate study therapy|0|||
130271007|NCT03654040|468955966|FG000|Overall Study|Transplanted at another center|2|||
130271008|NCT03654040|468955967|FG001|Overall Study|Transplanted at another center|0|||
130271009|NCT03654040|468955966|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130271010|NCT03654040|468955967|FG001|Overall Study|Failure to meet eligibility criteria|2|||
130271011|NCT03654040|468955966|FG000|Overall Study|No longer transplant candidate|1|||
130271012|NCT03654040|468955967|FG001|Overall Study|No longer transplant candidate|0|||
130271013|NCT03654040|468955966|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
130271014|NCT03654040|468955967|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
130271015|NCT03654040|468955966|FG000|Overall Study|Recipient ineligible|0|||
130271016|NCT03654040|468955967|FG001|Overall Study|Recipient ineligible|2|||
130271017|NCT03654040|468955966|FG000|Overall Study|Received deceased liver|0|||
130271018|NCT03654040|468955967|FG001|Overall Study|Received deceased liver|1|||
130271019|NCT00310375|468955973|FG000|Primary Reporting Phase|Adverse Event|28|||
130271020|NCT00310375|468955974|FG001|Primary Reporting Phase|Adverse Event|22|||
130271021|NCT00310375|468955975|FG002|Primary Reporting Phase|Adverse Event|0|||
130271022|NCT00310375|468955973|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
130271023|NCT00310375|468955974|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
130271024|NCT00310375|468955975|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
130271025|NCT00310375|468955973|FG000|Primary Reporting Phase|Pregnancy|2|||
130271026|NCT00310375|468955974|FG001|Primary Reporting Phase|Pregnancy|2|||
130271027|NCT00310375|468955975|FG002|Primary Reporting Phase|Pregnancy|0|||
130271028|NCT00310375|468955973|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
130271029|NCT00310375|468955974|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
130271030|NCT00310375|468955975|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
130271031|NCT00310375|468955973|FG000|Primary Reporting Phase|Protocol Violation|8|||
130271032|NCT00310375|468955974|FG001|Primary Reporting Phase|Protocol Violation|5|||
130271033|NCT00310375|468955975|FG002|Primary Reporting Phase|Protocol Violation|0|||
130271034|NCT00310375|468955973|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
130271035|NCT00310375|468955974|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
130271036|NCT00310375|468955975|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
130271037|NCT00310375|468955973|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
130271038|NCT00310375|468955974|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
130271039|NCT00310375|468955975|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
130271040|NCT00310375|468955973|FG000|Primary Reporting Phase|Physician Decision|5|||
130271041|NCT00310375|468955974|FG001|Primary Reporting Phase|Physician Decision|3|||
130271042|NCT00310375|468955975|FG002|Primary Reporting Phase|Physician Decision|0|||
130271043|NCT00310375|468955973|FG000|Primary Reporting Phase|Request of the sponsor|2|||
130271044|NCT00310375|468955974|FG001|Primary Reporting Phase|Request of the sponsor|2|||
130271045|NCT00310375|468955975|FG002|Primary Reporting Phase|Request of the sponsor|0|||
130271046|NCT00310375|468955973|FG000|Primary Reporting Phase|Failed to return|1|||
130271047|NCT00310375|468955974|FG001|Primary Reporting Phase|Failed to return|3|||
130271048|NCT00310375|468955975|FG002|Primary Reporting Phase|Failed to return|0|||
130271049|NCT00310375|468955973|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
130271050|NCT00310375|468955974|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
130271051|NCT00310375|468955975|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
130271052|NCT00310375|468955973|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
130271053|NCT00310375|468955974|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
130271054|NCT00310375|468955975|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
130271055|NCT00310375|468955973|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
130271056|NCT00310375|468955974|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
130271057|NCT00310375|468955975|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
130271058|NCT00310375|468955973|FG000|Primary Reporting Phase|Site closure|3|||
130271059|NCT00310375|468955974|FG001|Primary Reporting Phase|Site closure|0|||
130271060|NCT00310375|468955975|FG002|Primary Reporting Phase|Site closure|0|||
130271061|NCT00310375|468955973|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
130271062|NCT00310375|468955974|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
130271063|NCT00310375|468955975|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
130271064|NCT00310375|468955973|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
130271065|NCT00310375|468955974|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
130271066|NCT00310375|468955975|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
130271067|NCT00310375|468955973|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
130271068|NCT00310375|468955974|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
130271069|NCT00310375|468955975|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
130271070|NCT00310375|468955973|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130271071|NCT00310375|468955974|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130271072|NCT00310375|468955975|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
130271073|NCT00131352|468955976|FG000|Initial Treatment Period|Adverse Event|1|||
130271074|NCT00131352|468955977|FG001|Initial Treatment Period|Adverse Event|3|||
130271075|NCT00131352|468955976|FG000|Initial Treatment Period|Non-compliant|1|||
130271076|NCT00131352|468955977|FG001|Initial Treatment Period|Non-compliant|2|||
130271077|NCT00131352|468955976|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130271078|NCT00131352|468955977|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
130271079|NCT00131352|468955976|FG000|Initial Treatment Period|Lack of Efficacy|6|||
130271080|NCT00131352|468955977|FG001|Initial Treatment Period|Lack of Efficacy|4|||
130271081|NCT00131352|468955976|FG000|Initial Treatment Period|Other|0|||
130271082|NCT00131352|468955977|FG001|Initial Treatment Period|Other|2|||
130271083|NCT00131352|468955976|FG000|Repeat Treatment Period|Adverse Event|1|||
130271084|NCT00131352|468955977|FG001|Repeat Treatment Period|Adverse Event|0|||
130271085|NCT00131352|468955976|FG000|Repeat Treatment Period|Other|1|||
130271086|NCT00131352|468955977|FG001|Repeat Treatment Period|Other|0|||
130271087|NCT03230318|468955978|FG000|Overall Study|Radiographic disease progression|72|||
130271088|NCT03230318|468955979|FG001|Overall Study|Radiographic disease progression|19|||
130271089|NCT03230318|468955978|FG000|Overall Study|Clinical progression|17|||
130271090|NCT03230318|468955979|FG001|Overall Study|Clinical progression|7|||
130271091|NCT03230318|468955978|FG000|Overall Study|Adverse Event|5|||
130271092|NCT03230318|468955979|FG001|Overall Study|Adverse Event|3|||
130456049|NCT00798265|469632882|FG001|Overall Study|Lost to Follow-up|10|||
130456050|NCT00798265|469632881|FG000|Overall Study|Study closing|7|||
130456051|NCT00798265|469632882|FG001|Overall Study|Study closing|6|||
130456052|NCT00798265|469632881|FG000|Overall Study|Withdrawal by Subject|0|||
130456053|NCT00798265|469632882|FG001|Overall Study|Withdrawal by Subject|1|||
130456054|NCT00798265|469632881|FG000|Overall Study|Screen failure|0|||
130271093|NCT03230318|468955978|FG000|Overall Study|Physician Decision|2|||
130271094|NCT03230318|468955979|FG001|Overall Study|Physician Decision|3|||
130271095|NCT03230318|468955978|FG000|Overall Study|Death|3|||
130456055|NCT00798265|469632882|FG001|Overall Study|Screen failure|1|||
130271096|NCT03230318|468955979|FG001|Overall Study|Death|2|||
130456056|NCT02738840|469634791|FG000|Overall Study|MRI Scan not Performed|5|||
130456057|NCT02738840|469634791|FG000|Overall Study|Lost to Follow-up|1|||
130554367|NCT02684357|469996595|FG002|Part A|Withdrawal by Subject|0|||
130271097|NCT03230318|468955978|FG000|Overall Study|Lost to Follow-up|1|||
130271098|NCT03230318|468955979|FG001|Overall Study|Lost to Follow-up|0|||
130271099|NCT03230318|468955978|FG000|Overall Study|Withdrawal by Subject|1|||
130271100|NCT03230318|468955979|FG001|Overall Study|Withdrawal by Subject|3|||
130271101|NCT03230318|468955978|FG000|Overall Study|Other|3|||
130271102|NCT03230318|468955979|FG001|Overall Study|Other|7|||
130271103|NCT00211172|468955981|FG000|Overall Study|Died or lost health plan eligibility|39|||
130271104|NCT00211172|468955982|FG001|Overall Study|Died or lost health plan eligibility|32|||
130271105|NCT00770562|468955986|FG000|Overall Study|Did not take treatment|1|||
130271106|NCT00770562|468955987|FG001|Overall Study|Did not take treatment|1|||
130271107|NCT01643408|468955990|FG000|Overall Study|Adverse Event|12|||
130271108|NCT01643408|468955990|FG000|Overall Study|Other|2|||
130271109|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
130271110|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130271111|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130271112|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
130271113|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130271114|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130271115|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
130271116|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130271117|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130271118|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
130271119|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130271120|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130271121|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
130271122|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
130554368|NCT02684357|469996596|FG003|Part A|Withdrawal by Subject|0|||
130271123|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
130271124|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
130271125|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
130271126|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
130271127|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
130271128|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
130271129|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
130271130|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
130271131|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130271132|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130271133|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
130271134|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130271135|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130271136|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
130271137|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130271138|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130271139|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
130271140|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130271141|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130271142|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Other|6|||
130271143|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Other|0|||
130271144|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Other|0|||
130271145|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
130271146|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
130271147|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
130271148|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
130271149|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
130271150|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
130271151|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
130271152|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
130271153|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
130271154|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130271155|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130271156|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
130271157|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
130271158|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
130271159|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
130271160|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130271161|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
130271162|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130271163|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130271164|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130271165|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
130271166|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
130271167|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
130271168|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
130271169|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
130271170|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
130271171|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
130271172|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
130271173|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
130271174|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
130706257|NCT00690482|470549671|FG001|Overall Study|Intake of prohibited medicine|0|||
130271175|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
130706258|NCT00690482|470549670|FG000|Overall Study|withdrew consent at rand.day|0|||
130271176|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
130271177|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
130271178|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
130271179|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130271180|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
130271181|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
130271182|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
130271183|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
130271184|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
130271185|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130271186|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130366877|NCT03330288|469314047|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
130706259|NCT00690482|470549671|FG001|Overall Study|withdrew consent at rand.day|1|||
130706260|NCT01610063|470549672|FG000|Overall Study|Lost to Follow-up|42|||
130706261|NCT01610063|470549673|FG001|Overall Study|Lost to Follow-up|20|||
130706262|NCT04405739|470549674|FG000|Overall Study|Adverse Event|0|||
130706263|NCT04405739|470549675|FG001|Overall Study|Adverse Event|1|||
130706264|NCT04405739|470549676|FG002|Overall Study|Adverse Event|0|||
130706265|NCT04405739|470549677|FG003|Overall Study|Adverse Event|0|||
130706266|NCT04405739|470549674|FG000|Overall Study|Lost to Follow-up|0|||
130706267|NCT04405739|470549675|FG001|Overall Study|Lost to Follow-up|2|||
130706268|NCT04405739|470549676|FG002|Overall Study|Lost to Follow-up|1|||
130706269|NCT04405739|470549677|FG003|Overall Study|Lost to Follow-up|3|||
130706270|NCT04405739|470549674|FG000|Overall Study|Withdrawal by Subject|0|||
130706271|NCT04405739|470549675|FG001|Overall Study|Withdrawal by Subject|2|||
130706272|NCT04405739|470549676|FG002|Overall Study|Withdrawal by Subject|1|||
130706273|NCT04405739|470549677|FG003|Overall Study|Withdrawal by Subject|1|||
130706274|NCT04405739|470549674|FG000|Overall Study|Death|0|||
130706275|NCT04405739|470549675|FG001|Overall Study|Death|0|||
130706276|NCT04405739|470549676|FG002|Overall Study|Death|1|||
130706277|NCT04405739|470549677|FG003|Overall Study|Death|0|||
130706278|NCT04405739|470549674|FG000|Overall Study|Transferred to rehab|0|||
130706279|NCT04405739|470549675|FG001|Overall Study|Transferred to rehab|0|||
130706280|NCT04405739|470549676|FG002|Overall Study|Transferred to rehab|0|||
130706281|NCT04405739|470549677|FG003|Overall Study|Transferred to rehab|1|||
130706282|NCT04405739|470549674|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
130706283|NCT04405739|470549675|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
130706284|NCT04405739|470549676|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
130706285|NCT04405739|470549677|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
130706286|NCT01436643|470549678|FG000|2-week Pre-treatment|Abnormal test result|0|||
130706287|NCT01436643|470549679|FG001|2-week Pre-treatment|Abnormal test result|0|||
130706288|NCT01436643|470549680|FG002|2-week Pre-treatment|Abnormal test result|0|||
130706289|NCT01436643|470549681|FG003|2-week Pre-treatment|Abnormal test result|1|||
130706290|NCT01436643|470549678|FG000|2-week Pre-treatment|Adverse Event|0|||
130706291|NCT01436643|470549679|FG001|2-week Pre-treatment|Adverse Event|0|||
130706292|NCT01436643|470549680|FG002|2-week Pre-treatment|Adverse Event|0|||
130706293|NCT01436643|470549681|FG003|2-week Pre-treatment|Adverse Event|5|||
130706294|NCT01436643|470549678|FG000|2-week Pre-treatment|Protocol Violation|0|||
130706295|NCT01436643|470549679|FG001|2-week Pre-treatment|Protocol Violation|0|||
130706296|NCT01436643|470549680|FG002|2-week Pre-treatment|Protocol Violation|0|||
130706297|NCT01436643|470549681|FG003|2-week Pre-treatment|Protocol Violation|4|||
130706298|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
130706299|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
130706300|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
130706301|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
130706302|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706303|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706304|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
130706305|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706306|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
130706307|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
130706308|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
130706309|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
130706310|NCT03718117|470549682|FG000|Overall Study|Death|12|||
130706311|NCT03718117|470549683|FG001|Overall Study|Death|11|||
130706312|NCT03718117|470549684|FG002|Overall Study|Death|0|||
130706313|NCT03718117|470549682|FG000|Overall Study|Other|0|||
130706314|NCT03718117|470549683|FG001|Overall Study|Other|1|||
130706315|NCT03718117|470549684|FG002|Overall Study|Other|0|||
130706316|NCT03718117|470549682|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
130706317|NCT03718117|470549683|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
130366878|NCT03330288|469314046|FG000|Overall Study|Adverse Event|1|||
130366879|NCT03330288|469314047|FG001|Overall Study|Adverse Event|0|||
130366880|NCT03330288|469314046|FG000|Overall Study|Withdrawal by Subject|1|||
130366881|NCT03330288|469314047|FG001|Overall Study|Withdrawal by Subject|0|||
130366882|NCT03330288|469314046|FG000|Overall Study|Lost to Follow-up|26|||
130706318|NCT03718117|470549684|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
130706319|NCT03718117|470549682|FG000|Overall Study|Participant not met eligibility criteria|0|||
130706320|NCT03718117|470549683|FG001|Overall Study|Participant not met eligibility criteria|0|||
130706321|NCT03718117|470549684|FG002|Overall Study|Participant not met eligibility criteria|2|||
130706322|NCT02056652|470549687|FG000|Overall Study|Withdrawal by Subject|1|||
130706323|NCT02056652|470549688|FG001|Overall Study|Withdrawal by Subject|0|||
130706324|NCT02056652|470549687|FG000|Overall Study|Lost to Follow-up|0|||
130706325|NCT02056652|470549688|FG001|Overall Study|Lost to Follow-up|3|||
130706326|NCT04232540|470549689|FG000|Overall Study|Lost to Follow-up|1|||
130706327|NCT04232540|470549690|FG001|Overall Study|Lost to Follow-up|0|||
130706328|NCT02105701|470549691|FG000|Overall Study|Lost to Follow-up|1|||
130706329|NCT02105701|470549692|FG001|Overall Study|Lost to Follow-up|0|||
130366883|NCT03330288|469314047|FG001|Overall Study|Lost to Follow-up|7|||
130366884|NCT02693119|469314051|FG000|Open-Label Period|Withdrawal by Subject|0|||
130366885|NCT02693119|469314052|FG001|Open-Label Period|Withdrawal by Subject|1|||
130366886|NCT01719783|469314055|FG000|Dose 2|Physician Decision|1|||
130366887|NCT01719783|469314056|FG001|Dose 2|Physician Decision|0|||
130366888|NCT01350492|469314057|FG000|Intervention|Lost to Follow-up|2|||
130366889|NCT01350492|469314058|FG001|Intervention|Lost to Follow-up|5|||
130366890|NCT01350492|469314057|FG000|Intervention|Withdrawal by Subject|3|||
130366891|NCT01350492|469314058|FG001|Intervention|Withdrawal by Subject|1|||
130366892|NCT01350492|469314057|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
130271187|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130271188|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130271189|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
130271190|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
130271191|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
130271192|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
130271193|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
130271194|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
130271195|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
130271196|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
130271197|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130271198|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130271199|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130271200|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130271201|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130271202|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
130271203|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130271204|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130271205|NCT04860869|468956006|FG000|Overall Study|Withdrawal by Subject|1|||
130271206|NCT04860869|468956007|FG001|Overall Study|Withdrawal by Subject|0|||
130271207|NCT03951766|468956008|FG000|Treatment Phase|Lost to Follow-up|1|||
130271208|NCT03951766|468956008|FG000|Follow-up Phase|Lost to Follow-up|10|||
130271209|NCT01541865|468956010|FG000|Overall Study|Lost to Follow-up|11|||
130271210|NCT01541865|468956010|FG000|Overall Study|Withdrawal by Subject|9|||
130271211|NCT01541865|468956010|FG000|Overall Study|Adverse Event|1|||
130271212|NCT01541865|468956010|FG000|Overall Study|Protocol Violation|1|||
130271213|NCT00295646|468956012|FG000|Overall Study|Protocol Violation|18|||
130271214|NCT00295646|468956013|FG001|Overall Study|Protocol Violation|20|||
130271215|NCT00295646|468956014|FG002|Overall Study|Protocol Violation|20|||
130271216|NCT00295646|468956015|FG003|Overall Study|Protocol Violation|18|||
130271217|NCT00295646|468956012|FG000|Overall Study|Withdrawal by Subject|8|||
130271218|NCT00295646|468956013|FG001|Overall Study|Withdrawal by Subject|9|||
130271219|NCT00295646|468956014|FG002|Overall Study|Withdrawal by Subject|11|||
130271220|NCT00295646|468956015|FG003|Overall Study|Withdrawal by Subject|14|||
130271221|NCT00295646|468956012|FG000|Overall Study|Lost to Follow-up|0|||
130271222|NCT00295646|468956013|FG001|Overall Study|Lost to Follow-up|5|||
130271223|NCT00295646|468956014|FG002|Overall Study|Lost to Follow-up|1|||
130271224|NCT00295646|468956015|FG003|Overall Study|Lost to Follow-up|5|||
130271225|NCT00295646|468956012|FG000|Overall Study|Death|9|||
130271226|NCT00295646|468956013|FG001|Overall Study|Death|7|||
130271227|NCT00295646|468956014|FG002|Overall Study|Death|18|||
130271228|NCT00295646|468956015|FG003|Overall Study|Death|8|||
130271229|NCT01232127|468956020|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
130271230|NCT01232127|468956021|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130271231|NCT01232127|468956022|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130271232|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
130366893|NCT01350492|469314058|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
130366894|NCT01350492|469314057|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
130366895|NCT01350492|469314058|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
130706330|NCT02105701|470549693|FG002|Overall Study|Lost to Follow-up|2|||
130271233|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271234|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
130271235|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
130271236|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271237|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271238|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271239|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
130271240|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130366896|NCT00939640|469314059|FG000|Overall Study|Physician Decision|1|||
130366897|NCT00005044|469314064|FG000|Overall Study|Protocol Violation|37|||
130366898|NCT00005044|469314065|FG001|Overall Study|Protocol Violation|46|||
130366899|NCT00005044|469314064|FG000|Overall Study|Withdrawal by Subject|1|||
130554369|NCT02684357|469996597|FG004|Part A|Withdrawal by Subject|0|||
130271241|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271242|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271243|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271244|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271245|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271246|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
130456058|NCT02738840|469634791|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
130456059|NCT02738840|469634791|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
130456060|NCT01311648|469634793|FG000|Main Study|Protocol Violation|0|||
130456061|NCT01311648|469634794|FG001|Main Study|Protocol Violation|1|||
130456062|NCT01311648|469634793|FG000|Main Study|Adverse Event|0|||
130456063|NCT01311648|469634794|FG001|Main Study|Adverse Event|1|||
130456064|NCT01311648|469634793|FG000|Main Study|Inhibitor management|0|||
130456065|NCT01311648|469634794|FG001|Main Study|Inhibitor management|17|||
130456066|NCT01311648|469634793|FG000|Main Study|Withdrawal by Subject|0|||
130271247|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271248|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271249|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271250|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271251|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271252|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271253|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Other|0|||
130271254|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Other|0|||
130271255|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Other|1|||
130271256|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Other|1|||
130271257|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Other|0|||
130271258|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Other|0|||
130271259|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Other|0|||
130271260|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
130271261|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
130271262|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
130366900|NCT00005044|469314065|FG001|Overall Study|Withdrawal by Subject|5|||
130366901|NCT00005044|469314064|FG000|Overall Study|No protocol treatment|0|||
130366902|NCT00005044|469314065|FG001|Overall Study|No protocol treatment|1|||
130366903|NCT03988088|469314066|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130366904|NCT03988088|469314067|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
130366905|NCT03988088|469314068|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130366906|NCT03988088|469314069|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130366907|NCT03988088|469314066|FG000|Open-Label Addendum|Lost to Follow-up|0|||
130366908|NCT03988088|469314067|FG001|Open-Label Addendum|Lost to Follow-up|0|||
130366909|NCT03988088|469314068|FG002|Open-Label Addendum|Lost to Follow-up|1|||
130366910|NCT03988088|469314069|FG003|Open-Label Addendum|Lost to Follow-up|0|||
130366911|NCT04431453|469314070|FG000|Overall Study|Withdrew Consent|0|||
130366912|NCT04431453|469314071|FG001|Overall Study|Withdrew Consent|1|||
130366913|NCT04431453|469314072|FG002|Overall Study|Withdrew Consent|0|||
130366914|NCT04431453|469314073|FG003|Overall Study|Withdrew Consent|2|||
130366915|NCT04431453|469314074|FG004|Overall Study|Withdrew Consent|0|||
130366916|NCT04431453|469314075|FG005|Overall Study|Withdrew Consent|0|||
130366917|NCT04431453|469314076|FG006|Overall Study|Withdrew Consent|0|||
130366918|NCT04431453|469314077|FG007|Overall Study|Withdrew Consent|0|||
130366919|NCT04431453|469314070|FG000|Overall Study|Death|1|||
130366920|NCT04431453|469314071|FG001|Overall Study|Death|0|||
130366921|NCT04431453|469314072|FG002|Overall Study|Death|0|||
130366922|NCT04431453|469314073|FG003|Overall Study|Death|0|||
130366923|NCT04431453|469314074|FG004|Overall Study|Death|0|||
130366924|NCT04431453|469314075|FG005|Overall Study|Death|0|||
130366925|NCT04431453|469314076|FG006|Overall Study|Death|0|||
130366926|NCT04431453|469314077|FG007|Overall Study|Death|1|||
130366927|NCT04431453|469314070|FG000|Overall Study|Lost to Follow-up|0|||
130366928|NCT04431453|469314071|FG001|Overall Study|Lost to Follow-up|0|||
130366929|NCT04431453|469314072|FG002|Overall Study|Lost to Follow-up|1|||
130456067|NCT01311648|469634794|FG001|Main Study|Withdrawal by Subject|2|||
130456068|NCT01311648|469634793|FG000|Extension Study|Physician Decision|0|||
130271263|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
130271264|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
130366930|NCT04431453|469314073|FG003|Overall Study|Lost to Follow-up|1|||
130366931|NCT04431453|469314074|FG004|Overall Study|Lost to Follow-up|0|||
130366932|NCT04431453|469314075|FG005|Overall Study|Lost to Follow-up|0|||
130366933|NCT04431453|469314076|FG006|Overall Study|Lost to Follow-up|0|||
130366934|NCT04431453|469314077|FG007|Overall Study|Lost to Follow-up|0|||
130366935|NCT04431453|469314070|FG000|Overall Study|Enrolled but Never Treated|0|||
130366936|NCT04431453|469314071|FG001|Overall Study|Enrolled but Never Treated|0|||
130366937|NCT04431453|469314072|FG002|Overall Study|Enrolled but Never Treated|0|||
130366938|NCT04431453|469314073|FG003|Overall Study|Enrolled but Never Treated|0|||
130456069|NCT01311648|469634794|FG001|Extension Study|Physician Decision|1|||
130706331|NCT02105701|470549694|FG003|Overall Study|Lost to Follow-up|1|||
130706332|NCT02105701|470549691|FG000|Overall Study|Protocol Violation|0|||
130706333|NCT02105701|470549692|FG001|Overall Study|Protocol Violation|0|||
130706334|NCT02105701|470549693|FG002|Overall Study|Protocol Violation|1|||
130706335|NCT02105701|470549694|FG003|Overall Study|Protocol Violation|0|||
130706336|NCT02105701|470549691|FG000|Overall Study|Withdrawal by Subject|2|||
130706337|NCT02105701|470549692|FG001|Overall Study|Withdrawal by Subject|1|||
130271265|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
130271266|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
130271267|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
130271268|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
130271269|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
130271270|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
130271271|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
130271272|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
130271273|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
130271274|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271275|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271276|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271277|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271278|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
130271279|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130271280|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130271281|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Other|0|||
130271282|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Other|0|||
130271283|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Other|0|||
130271284|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Other|0|||
130271285|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Other|2|||
130271286|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Other|0|||
130271287|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Other|3|||
130271288|NCT01740687|468956036|FG000|Overall Study|Lost to Follow-up|11|||
130271289|NCT01740687|468956036|FG000|Overall Study|Withdrawal by Subject|2|||
130271290|NCT01740687|468956036|FG000|Overall Study|other reason|22|||
130271291|NCT01740687|468956036|FG000|Overall Study|treatment not received|2|||
130271292|NCT00326001|468956040|FG000|Overall Study|Adverse Event|4|||
130271293|NCT00326001|468956041|FG001|Overall Study|Adverse Event|5|||
130271294|NCT00326001|468956040|FG000|Overall Study|Physician Decision|3|||
130271295|NCT00326001|468956041|FG001|Overall Study|Physician Decision|3|||
130271296|NCT00104728|468956042|FG000|Overall Study|screen failures|19|||
130271297|NCT01963767|468956043|FG000|Overall Study|Withdrawal by Subject|4|||
130271298|NCT01963767|468956044|FG001|Overall Study|Withdrawal by Subject|2|||
130271299|NCT01963767|468956043|FG000|Overall Study|Adverse Event|2|||
130706338|NCT02105701|470549693|FG002|Overall Study|Withdrawal by Subject|0|||
130706339|NCT02105701|470549694|FG003|Overall Study|Withdrawal by Subject|1|||
130706340|NCT02105701|470549691|FG000|Overall Study|Death|1|||
130706341|NCT02105701|470549692|FG001|Overall Study|Death|0|||
130706342|NCT02105701|470549693|FG002|Overall Study|Death|0|||
130706343|NCT02105701|470549694|FG003|Overall Study|Death|0|||
130706344|NCT02148445|470549695|FG000|Overall Study|Death|1|||
130706345|NCT02148445|470549696|FG001|Overall Study|Death|3|||
130706346|NCT03450629|470549697|FG000|Overall Study|Adverse Event|15|||
130706347|NCT03450629|470549698|FG001|Overall Study|Adverse Event|14|||
130706348|NCT03450629|470549697|FG000|Overall Study|Physician Decision|2|||
130706349|NCT03450629|470549698|FG001|Overall Study|Physician Decision|2|||
130706350|NCT03450629|470549697|FG000|Overall Study|Lack of Efficacy|2|||
130706351|NCT03450629|470549698|FG001|Overall Study|Lack of Efficacy|0|||
130706352|NCT03450629|470549697|FG000|Overall Study|Lost to Follow-up|4|||
130706353|NCT03450629|470549698|FG001|Overall Study|Lost to Follow-up|2|||
130706354|NCT03450629|470549697|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130706355|NCT03450629|470549698|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130706356|NCT03450629|470549697|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130706357|NCT03450629|470549698|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130271300|NCT01963767|468956044|FG001|Overall Study|Adverse Event|0|||
130271301|NCT03960684|468956045|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
130271302|NCT03941483|468956046|FG000|Overall Study|Miscellaneous|2|||
130271303|NCT03941483|468956047|FG001|Overall Study|Miscellaneous|3|||
130271304|NCT03941483|468956048|FG002|Overall Study|Miscellaneous|0|||
130271305|NCT03941483|468956046|FG000|Overall Study|Study Terminated by Sponsor|1|||
130271306|NCT03941483|468956047|FG001|Overall Study|Study Terminated by Sponsor|0|||
130706358|NCT03450629|470549697|FG000|Overall Study|Protocol Violation|11|||
130706359|NCT03450629|470549698|FG001|Overall Study|Protocol Violation|8|||
130706360|NCT03450629|470549697|FG000|Overall Study|Withdrawal by Subject|12|||
130706361|NCT03450629|470549698|FG001|Overall Study|Withdrawal by Subject|6|||
130706362|NCT04230876|470549699|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130271307|NCT03941483|468956048|FG002|Overall Study|Study Terminated by Sponsor|0|||
130456070|NCT01311648|469634793|FG000|Extension Study|ITI therapy with marketed product|0|||
130456071|NCT01311648|469634794|FG001|Extension Study|ITI therapy with marketed product|1|||
130456072|NCT01311648|469634793|FG000|Extension Study|Incorrect visit planning|0|||
130456073|NCT01311648|469634794|FG001|Extension Study|Incorrect visit planning|1|||
130456074|NCT01311648|469634793|FG000|Extension Study|Family's decision|0|||
130456075|NCT01311648|469634794|FG001|Extension Study|Family's decision|1|||
130456076|NCT01311648|469634793|FG000|Extension Study|Failure of ITI therapy|0|||
130456077|NCT01311648|469634794|FG001|Extension Study|Failure of ITI therapy|3|||
130456078|NCT01311648|469634793|FG000|Extension Study|Long travel|0|||
130456079|NCT01311648|469634794|FG001|Extension Study|Long travel|1|||
130456080|NCT01311648|469634793|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
130271308|NCT03941483|468956046|FG000|Overall Study|Withdrawal by Subject|1|||
130271309|NCT03941483|468956047|FG001|Overall Study|Withdrawal by Subject|4|||
130271310|NCT03941483|468956048|FG002|Overall Study|Withdrawal by Subject|1|||
130271311|NCT03941483|468956046|FG000|Overall Study|Lost to Follow-up|2|||
130271312|NCT03941483|468956047|FG001|Overall Study|Lost to Follow-up|1|||
130271313|NCT03941483|468956048|FG002|Overall Study|Lost to Follow-up|8|||
130271314|NCT03941483|468956046|FG000|Overall Study|Death|3|||
130271315|NCT03941483|468956047|FG001|Overall Study|Death|2|||
130271316|NCT03941483|468956048|FG002|Overall Study|Death|6|||
130271317|NCT01082081|468956049|FG000|Overall Study|Lost to Follow-up|0|||
130271318|NCT01082081|468956050|FG001|Overall Study|Lost to Follow-up|0|||
130271319|NCT01082081|468956051|FG002|Overall Study|Lost to Follow-up|1|||
130271320|NCT01082081|468956049|FG000|Overall Study|Withdrawal by Subject|0|||
130271321|NCT01082081|468956050|FG001|Overall Study|Withdrawal by Subject|0|||
130271322|NCT01082081|468956051|FG002|Overall Study|Withdrawal by Subject|1|||
130271323|NCT01082081|468956049|FG000|Overall Study|Other Reason|0|||
130271324|NCT01082081|468956050|FG001|Overall Study|Other Reason|1|||
130271325|NCT01082081|468956051|FG002|Overall Study|Other Reason|0|||
130271326|NCT00670930|468956054|FG000|Overall Study|Adminstrative Problem|0|||
130271327|NCT00670930|468956055|FG001|Overall Study|Adminstrative Problem|1|||
130271328|NCT00670930|468956054|FG000|Overall Study|Lost to Follow-up|1|||
130271329|NCT00670930|468956055|FG001|Overall Study|Lost to Follow-up|0|||
130271330|NCT03493451|468957262|FG000|Overall Study|Death|11|||
130271331|NCT03493451|468957263|FG001|Overall Study|Death|26|||
130271332|NCT03493451|468957264|FG002|Overall Study|Death|3|||
130271333|NCT03493451|468957262|FG000|Overall Study|Lost to Follow-up|1|||
130271334|NCT03493451|468957263|FG001|Overall Study|Lost to Follow-up|4|||
130271335|NCT03493451|468957264|FG002|Overall Study|Lost to Follow-up|1|||
130271336|NCT03493451|468957262|FG000|Overall Study|Withdrawal by Subject|1|||
130271337|NCT03493451|468957263|FG001|Overall Study|Withdrawal by Subject|1|||
130271338|NCT03493451|468957264|FG002|Overall Study|Withdrawal by Subject|2|||
130271339|NCT03493451|468957262|FG000|Overall Study|Progressive Disease|1|||
130271340|NCT03493451|468957263|FG001|Overall Study|Progressive Disease|0|||
130271341|NCT03493451|468957264|FG002|Overall Study|Progressive Disease|0|||
130271342|NCT03493451|468957262|FG000|Overall Study|Transferred to long term extension study|8|||
130271343|NCT03493451|468957263|FG001|Overall Study|Transferred to long term extension study|13|||
130271344|NCT03493451|468957264|FG002|Overall Study|Transferred to long term extension study|5|||
130271345|NCT01238991|468957265|FG000|Overall Study|Adverse Event|1|||
130271346|NCT01238991|468957266|FG001|Overall Study|Adverse Event|0|||
130271347|NCT01238991|468957267|FG002|Overall Study|Adverse Event|3|||
130271348|NCT01238991|468957268|FG003|Overall Study|Adverse Event|1|||
130271349|NCT01238991|468957269|FG004|Overall Study|Adverse Event|1|||
130271350|NCT01238991|468957270|FG005|Overall Study|Adverse Event|0|||
130271351|NCT01238991|468957271|FG006|Overall Study|Adverse Event|1|||
130271352|NCT01238991|468957272|FG007|Overall Study|Adverse Event|1|||
130271353|NCT01238991|468957273|FG008|Overall Study|Adverse Event|0|||
130271354|NCT01238991|468957274|FG009|Overall Study|Adverse Event|0|||
130271355|NCT01238991|468957265|FG000|Overall Study|Death|0|||
130271356|NCT01238991|468957266|FG001|Overall Study|Death|0|||
130271357|NCT01238991|468957267|FG002|Overall Study|Death|0|||
130271358|NCT01238991|468957268|FG003|Overall Study|Death|1|||
130271359|NCT01238991|468957269|FG004|Overall Study|Death|0|||
130271360|NCT01238991|468957270|FG005|Overall Study|Death|0|||
130456081|NCT01311648|469634794|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
130271361|NCT01238991|468957271|FG006|Overall Study|Death|0|||
130456082|NCT01311648|469634793|FG000|Extension Study|Withdrawal by Subject|0|||
130456083|NCT01311648|469634794|FG001|Extension Study|Withdrawal by Subject|1|||
130456084|NCT01311648|469634793|FG000|Extension Study|Inhibitor management|0|||
130271362|NCT01238991|468957272|FG007|Overall Study|Death|0|||
130271363|NCT01238991|468957273|FG008|Overall Study|Death|0|||
130271364|NCT01238991|468957274|FG009|Overall Study|Death|0|||
130271365|NCT01238991|468957265|FG000|Overall Study|Lack of Efficacy|0|||
130271366|NCT01238991|468957266|FG001|Overall Study|Lack of Efficacy|0|||
130271367|NCT01238991|468957267|FG002|Overall Study|Lack of Efficacy|1|||
130271368|NCT01238991|468957268|FG003|Overall Study|Lack of Efficacy|0|||
130271369|NCT01238991|468957269|FG004|Overall Study|Lack of Efficacy|0|||
130271370|NCT01238991|468957270|FG005|Overall Study|Lack of Efficacy|0|||
130706363|NCT04230876|470549700|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130706364|NCT03438006|470549704|FG000|Overall Study|Adverse Event|1|||
130706365|NCT03438006|470549704|FG000|Overall Study|Lost to Follow-up|67|||
130706366|NCT03438006|470549704|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
130706367|NCT03438006|470549704|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
130706368|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
130706369|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706370|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706371|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706372|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706373|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706374|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706375|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706376|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706377|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
130706378|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706379|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706380|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706381|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706382|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706383|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706384|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706385|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706386|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
130706387|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706388|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706389|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706390|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706391|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706392|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706393|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706394|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706395|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
130706396|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706397|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706398|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706399|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706400|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706401|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706402|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706403|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706404|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
130706405|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706406|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706407|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706408|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706409|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706410|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706411|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706412|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706413|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
130706414|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706415|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706416|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706417|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706418|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706419|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706420|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130366939|NCT04431453|469314074|FG004|Overall Study|Enrolled but Never Treated|1|||
130366940|NCT04431453|469314075|FG005|Overall Study|Enrolled but Never Treated|0|||
130366941|NCT04431453|469314076|FG006|Overall Study|Enrolled but Never Treated|0|||
130366942|NCT04431453|469314077|FG007|Overall Study|Enrolled but Never Treated|0|||
130366943|NCT01768286|469314079|FG000|Overall Study|Randomized But Not Treated|0|||
130366944|NCT01768286|469314080|FG001|Overall Study|Randomized But Not Treated|0|||
130554370|NCT02684357|469996598|FG005|Part A|Withdrawal by Subject|0|||
130554371|NCT02684357|469996593|FG000|Part A|Other|0|||
130554372|NCT02684357|469996594|FG001|Part A|Other|1|||
130554373|NCT02684357|469996595|FG002|Part A|Other|0|||
130554374|NCT02684357|469996596|FG003|Part A|Other|0|||
130554375|NCT02684357|469996597|FG004|Part A|Other|0|||
130554376|NCT02684357|469996598|FG005|Part A|Other|0|||
130554377|NCT02684357|469996593|FG000|Part B|Adverse Event (Other)|0|||
130554378|NCT02684357|469996594|FG001|Part B|Adverse Event (Other)|0|||
130554379|NCT02684357|469996595|FG002|Part B|Adverse Event (Other)|0|||
130554380|NCT02684357|469996596|FG003|Part B|Adverse Event (Other)|1|||
130554381|NCT02684357|469996597|FG004|Part B|Adverse Event (Other)|1|||
130554382|NCT02684357|469996598|FG005|Part B|Adverse Event (Other)|1|||
130554383|NCT02684357|469996593|FG000|Part B|Lost to Follow-up|0|||
130554384|NCT02684357|469996594|FG001|Part B|Lost to Follow-up|0|||
130554385|NCT02684357|469996595|FG002|Part B|Lost to Follow-up|0|||
130456085|NCT01311648|469634794|FG001|Extension Study|Inhibitor management|2|||
130456086|NCT04057196|469634795|FG000|Overall Study|Withdrawal by Subject|3|||
130456087|NCT04057196|469634795|FG000|Overall Study|Death|3|||
130456088|NCT02466516|469634797|FG000|Overall Study|Adverse Event|1|||
130456089|NCT02466516|469634798|FG001|Overall Study|Adverse Event|1|||
130456090|NCT02466516|469634799|FG002|Overall Study|Adverse Event|0|||
130554386|NCT02684357|469996596|FG003|Part B|Lost to Follow-up|1|||
130271371|NCT01238991|468957271|FG006|Overall Study|Lack of Efficacy|0|||
130271372|NCT01238991|468957272|FG007|Overall Study|Lack of Efficacy|0|||
130271373|NCT01238991|468957273|FG008|Overall Study|Lack of Efficacy|1|||
130271374|NCT01238991|468957274|FG009|Overall Study|Lack of Efficacy|0|||
130271375|NCT01238991|468957265|FG000|Overall Study|Withdrawal by Subject|0|||
130271376|NCT01238991|468957266|FG001|Overall Study|Withdrawal by Subject|0|||
130271377|NCT01238991|468957267|FG002|Overall Study|Withdrawal by Subject|1|||
130271378|NCT01238991|468957268|FG003|Overall Study|Withdrawal by Subject|0|||
130271379|NCT01238991|468957269|FG004|Overall Study|Withdrawal by Subject|0|||
130271380|NCT01238991|468957270|FG005|Overall Study|Withdrawal by Subject|0|||
130271381|NCT01238991|468957271|FG006|Overall Study|Withdrawal by Subject|0|||
130271382|NCT01238991|468957272|FG007|Overall Study|Withdrawal by Subject|0|||
130271383|NCT01238991|468957273|FG008|Overall Study|Withdrawal by Subject|0|||
130271384|NCT01238991|468957274|FG009|Overall Study|Withdrawal by Subject|0|||
130271385|NCT01238991|468957265|FG000|Overall Study|Study Terminated by Sponsor|0|||
130271386|NCT01238991|468957266|FG001|Overall Study|Study Terminated by Sponsor|0|||
130271387|NCT01238991|468957267|FG002|Overall Study|Study Terminated by Sponsor|0|||
130271388|NCT01238991|468957268|FG003|Overall Study|Study Terminated by Sponsor|0|||
130271389|NCT01238991|468957269|FG004|Overall Study|Study Terminated by Sponsor|1|||
130271390|NCT01238991|468957270|FG005|Overall Study|Study Terminated by Sponsor|0|||
130271391|NCT01238991|468957271|FG006|Overall Study|Study Terminated by Sponsor|7|||
130271392|NCT01238991|468957272|FG007|Overall Study|Study Terminated by Sponsor|4|||
130271393|NCT01238991|468957273|FG008|Overall Study|Study Terminated by Sponsor|2|||
130271394|NCT01238991|468957274|FG009|Overall Study|Study Terminated by Sponsor|2|||
130271395|NCT01238991|468957265|FG000|Overall Study|Caregiver's request|0|||
130271396|NCT01238991|468957266|FG001|Overall Study|Caregiver's request|0|||
130271397|NCT01238991|468957267|FG002|Overall Study|Caregiver's request|0|||
130271398|NCT01238991|468957268|FG003|Overall Study|Caregiver's request|0|||
130271399|NCT01238991|468957269|FG004|Overall Study|Caregiver's request|0|||
130271400|NCT01238991|468957270|FG005|Overall Study|Caregiver's request|0|||
130271401|NCT01238991|468957271|FG006|Overall Study|Caregiver's request|0|||
130271402|NCT01238991|468957272|FG007|Overall Study|Caregiver's request|0|||
130271403|NCT01238991|468957273|FG008|Overall Study|Caregiver's request|1|||
130271404|NCT01238991|468957274|FG009|Overall Study|Caregiver's request|0|||
130271405|NCT01238991|468957265|FG000|Overall Study|Admission to a nursing home|1|||
130271406|NCT01238991|468957266|FG001|Overall Study|Admission to a nursing home|0|||
130271407|NCT01238991|468957267|FG002|Overall Study|Admission to a nursing home|1|||
130271408|NCT01238991|468957268|FG003|Overall Study|Admission to a nursing home|0|||
130271409|NCT01238991|468957269|FG004|Overall Study|Admission to a nursing home|0|||
130271410|NCT01238991|468957270|FG005|Overall Study|Admission to a nursing home|0|||
130271411|NCT01238991|468957271|FG006|Overall Study|Admission to a nursing home|0|||
130271412|NCT01238991|468957272|FG007|Overall Study|Admission to a nursing home|0|||
130271413|NCT01238991|468957273|FG008|Overall Study|Admission to a nursing home|0|||
130554387|NCT02684357|469996597|FG004|Part B|Lost to Follow-up|1|||
130271414|NCT01238991|468957274|FG009|Overall Study|Admission to a nursing home|0|||
130271415|NCT03370419|468957275|FG000|Overall Study|Lost to Follow-up|16|||
130271416|NCT01897727|468957278|FG000|Overall Study|Exclusion: central sleep apnea|0|||
130456091|NCT02466516|469634800|FG003|Overall Study|Adverse Event|0|||
130456092|NCT02466516|469634801|FG004|Overall Study|Adverse Event|0|||
130456093|NCT02466516|469634797|FG000|Overall Study|Withdrew Consent|1|||
130456094|NCT02466516|469634798|FG001|Overall Study|Withdrew Consent|0|||
130554388|NCT02684357|469996598|FG005|Part B|Lost to Follow-up|7|||
130554389|NCT02684357|469996593|FG000|Part B|Withdrawal by Subject|0|||
130554390|NCT02684357|469996594|FG001|Part B|Withdrawal by Subject|0|||
130554391|NCT02684357|469996595|FG002|Part B|Withdrawal by Subject|0|||
130554392|NCT02684357|469996596|FG003|Part B|Withdrawal by Subject|0|||
130554393|NCT02684357|469996597|FG004|Part B|Withdrawal by Subject|2|||
130271417|NCT01897727|468957279|FG001|Overall Study|Exclusion: central sleep apnea|1|||
130271418|NCT03015363|468957280|FG000|Overall Study|Physician Decision|14|||
130271419|NCT03015363|468957280|FG000|Overall Study|Withdrawal by Subject|3|||
130271420|NCT00078806|468957281|FG000|Part 1A|Adverse Event|2|||
130271421|NCT00078806|468957282|FG001|Part 1A|Adverse Event|0|||
130271422|NCT00078806|468957283|FG002|Part 1A|Adverse Event|0|||
130271423|NCT00078806|468957284|FG003|Part 1A|Adverse Event|0|||
130271424|NCT00078806|468957281|FG000|Part 1A|Lack of Efficacy|7|||
130271425|NCT00078806|468957282|FG001|Part 1A|Lack of Efficacy|0|||
130271426|NCT00078806|468957283|FG002|Part 1A|Lack of Efficacy|0|||
130271427|NCT00078806|468957284|FG003|Part 1A|Lack of Efficacy|0|||
130271428|NCT00078806|468957281|FG000|Part 1A|Other|1|||
130271429|NCT00078806|468957282|FG001|Part 1A|Other|0|||
130271430|NCT00078806|468957283|FG002|Part 1A|Other|0|||
130271431|NCT00078806|468957284|FG003|Part 1A|Other|0|||
130271432|NCT00078806|468957281|FG000|Part 1B|Adverse Event|1|||
130271433|NCT00078806|468957282|FG001|Part 1B|Adverse Event|0|||
130271434|NCT00078806|468957283|FG002|Part 1B|Adverse Event|0|||
130271435|NCT00078806|468957284|FG003|Part 1B|Adverse Event|0|||
130271436|NCT00078806|468957281|FG000|Part 1B|Lack of Efficacy|7|||
130271437|NCT00078806|468957282|FG001|Part 1B|Lack of Efficacy|0|||
130271438|NCT00078806|468957283|FG002|Part 1B|Lack of Efficacy|0|||
130271439|NCT00078806|468957284|FG003|Part 1B|Lack of Efficacy|0|||
130271440|NCT00078806|468957281|FG000|Part 2|Adverse Event|0|||
130271441|NCT00078806|468957282|FG001|Part 2|Adverse Event|1|||
130271442|NCT00078806|468957283|FG002|Part 2|Adverse Event|0|||
130271443|NCT00078806|468957284|FG003|Part 2|Adverse Event|0|||
130271444|NCT01734785|468957287|FG000|Open-Label Period|Adverse Event|0|||
130271445|NCT01734785|468957288|FG001|Open-Label Period|Adverse Event|0|||
130271446|NCT01734785|468957289|FG002|Open-Label Period|Adverse Event|0|||
130271447|NCT01734785|468957290|FG003|Open-Label Period|Adverse Event|9|||
130271448|NCT01734785|468957287|FG000|Open-Label Period|Lack of Efficacy|0|||
130271449|NCT01734785|468957288|FG001|Open-Label Period|Lack of Efficacy|0|||
130271450|NCT01734785|468957289|FG002|Open-Label Period|Lack of Efficacy|0|||
130271451|NCT01734785|468957290|FG003|Open-Label Period|Lack of Efficacy|1|||
130271452|NCT01734785|468957287|FG000|Open-Label Period|Protocol Violation|0|||
130271453|NCT01734785|468957288|FG001|Open-Label Period|Protocol Violation|0|||
130271454|NCT01734785|468957289|FG002|Open-Label Period|Protocol Violation|0|||
130271455|NCT01734785|468957290|FG003|Open-Label Period|Protocol Violation|13|||
130271456|NCT01734785|468957287|FG000|Open-Label Period|Lost to Follow-up|0|||
130271457|NCT01734785|468957288|FG001|Open-Label Period|Lost to Follow-up|0|||
130271458|NCT01734785|468957289|FG002|Open-Label Period|Lost to Follow-up|0|||
130271459|NCT01734785|468957290|FG003|Open-Label Period|Lost to Follow-up|14|||
130271460|NCT01734785|468957287|FG000|Open-Label Period|Withdrawal by Subject|0|||
130271461|NCT01734785|468957288|FG001|Open-Label Period|Withdrawal by Subject|0|||
130271462|NCT01734785|468957289|FG002|Open-Label Period|Withdrawal by Subject|0|||
130271463|NCT01734785|468957290|FG003|Open-Label Period|Withdrawal by Subject|12|||
130271464|NCT01734785|468957287|FG000|Open-Label Period|Other Reasons|0|||
130271465|NCT01734785|468957288|FG001|Open-Label Period|Other Reasons|0|||
130271466|NCT01734785|468957289|FG002|Open-Label Period|Other Reasons|0|||
130271467|NCT01734785|468957290|FG003|Open-Label Period|Other Reasons|224|||
130271468|NCT01734785|468957287|FG000|Double-Blind Period|Adverse Event|0|||
130271469|NCT01734785|468957288|FG001|Double-Blind Period|Adverse Event|3|||
130271470|NCT01734785|468957289|FG002|Double-Blind Period|Adverse Event|2|||
130271471|NCT01734785|468957290|FG003|Double-Blind Period|Adverse Event|0|||
130271472|NCT01734785|468957287|FG000|Double-Blind Period|Lack of Efficacy|0|||
130271473|NCT01734785|468957288|FG001|Double-Blind Period|Lack of Efficacy|1|||
130271474|NCT01734785|468957289|FG002|Double-Blind Period|Lack of Efficacy|0|||
130554394|NCT02684357|469996598|FG005|Part B|Withdrawal by Subject|4|||
130554395|NCT02684357|469996593|FG000|Part B|Other|0|||
130554396|NCT02684357|469996594|FG001|Part B|Other|0|||
130554397|NCT02684357|469996595|FG002|Part B|Other|0|||
130271475|NCT01734785|468957290|FG003|Double-Blind Period|Lack of Efficacy|0|||
130271476|NCT01734785|468957287|FG000|Double-Blind Period|Protocol Violation|0|||
130271477|NCT01734785|468957288|FG001|Double-Blind Period|Protocol Violation|1|||
130271478|NCT01734785|468957289|FG002|Double-Blind Period|Protocol Violation|1|||
130271479|NCT01734785|468957290|FG003|Double-Blind Period|Protocol Violation|0|||
130271480|NCT01734785|468957287|FG000|Double-Blind Period|Lost to Follow-up|2|||
130271481|NCT01734785|468957288|FG001|Double-Blind Period|Lost to Follow-up|4|||
130271482|NCT01734785|468957289|FG002|Double-Blind Period|Lost to Follow-up|2|||
130271483|NCT01734785|468957290|FG003|Double-Blind Period|Lost to Follow-up|0|||
130271484|NCT01734785|468957287|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130271485|NCT01734785|468957288|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130271486|NCT01734785|468957289|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130271487|NCT01734785|468957290|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130271488|NCT01734785|468957287|FG000|Double-Blind Period|Not treated|1|||
130271489|NCT01734785|468957288|FG001|Double-Blind Period|Not treated|0|||
130271490|NCT01734785|468957289|FG002|Double-Blind Period|Not treated|0|||
130271491|NCT01734785|468957290|FG003|Double-Blind Period|Not treated|0|||
130271492|NCT00566982|468957291|FG000|Overall Study|Adverse Event|6|||
130271493|NCT00566982|468957292|FG001|Overall Study|Adverse Event|48|||
130271494|NCT00566982|468957291|FG000|Overall Study|Withdrawal by Subject|1|||
130271495|NCT00566982|468957292|FG001|Overall Study|Withdrawal by Subject|14|||
130271496|NCT00566982|468957291|FG000|Overall Study|Protocol Violation|1|||
130271497|NCT00566982|468957292|FG001|Overall Study|Protocol Violation|4|||
130271498|NCT00566982|468957291|FG000|Overall Study|Lost to Follow-up|0|||
130271499|NCT00566982|468957292|FG001|Overall Study|Lost to Follow-up|1|||
130271500|NCT00566982|468957291|FG000|Overall Study|Other-family problems & doctor's request|0|||
130271501|NCT00566982|468957292|FG001|Overall Study|Other-family problems & doctor's request|2|||
130271502|NCT02013778|468957298|FG000|Overall Study|Death|4|||
130271503|NCT02013778|468957298|FG000|Overall Study|Withdrawal by Subject|1|||
130271504|NCT02013778|468957298|FG000|Overall Study|Physician Decision|1|||
130271505|NCT02013778|468957298|FG000|Overall Study|Adverse Event|1|||
130271506|NCT00293813|468957299|FG000|Overall Study|Physician Decision|0|||
130271507|NCT00293813|468957300|FG001|Overall Study|Physician Decision|1|||
130271508|NCT00293813|468957301|FG002|Overall Study|Physician Decision|0|||
130271509|NCT00293813|468957299|FG000|Overall Study|Adverse Event|3|||
130271510|NCT00293813|468957300|FG001|Overall Study|Adverse Event|1|||
130271511|NCT00293813|468957301|FG002|Overall Study|Adverse Event|1|||
130271512|NCT00293813|468957299|FG000|Overall Study|Withdrawal by Subject|7|||
130271513|NCT00293813|468957300|FG001|Overall Study|Withdrawal by Subject|4|||
130271514|NCT00293813|468957301|FG002|Overall Study|Withdrawal by Subject|4|||
130271515|NCT00293813|468957299|FG000|Overall Study|Lost to Follow-up|3|||
130271516|NCT00293813|468957300|FG001|Overall Study|Lost to Follow-up|2|||
130271517|NCT00293813|468957301|FG002|Overall Study|Lost to Follow-up|3|||
130271518|NCT00293813|468957299|FG000|Overall Study|Noncompliance|0|||
130456095|NCT02466516|469634799|FG002|Overall Study|Withdrew Consent|0|||
130456096|NCT02466516|469634800|FG003|Overall Study|Withdrew Consent|0|||
130456097|NCT02466516|469634801|FG004|Overall Study|Withdrew Consent|0|||
130456098|NCT02466516|469634797|FG000|Overall Study|Lost to Follow-up|2|||
130456099|NCT02466516|469634798|FG001|Overall Study|Lost to Follow-up|0|||
130456100|NCT02466516|469634799|FG002|Overall Study|Lost to Follow-up|1|||
130271519|NCT00293813|468957300|FG001|Overall Study|Noncompliance|1|||
130271520|NCT00293813|468957301|FG002|Overall Study|Noncompliance|0|||
130271521|NCT01465386|468957305|FG000|Overall Study|Lack of Efficacy|3|||
130271522|NCT01465386|468957305|FG000|Overall Study|Adverse Event|1|||
130271523|NCT00473889|468957306|FG000|Overall Study|Did not receive study medication|1|||
130271524|NCT00473889|468957307|FG001|Overall Study|Did not receive study medication|4|||
130271525|NCT00473889|468957306|FG000|Overall Study|Adverse Event|30|||
130271526|NCT00473889|468957307|FG001|Overall Study|Adverse Event|17|||
130271527|NCT00473889|468957306|FG000|Overall Study|Protocol Violation|4|||
130271528|NCT00473889|468957307|FG001|Overall Study|Protocol Violation|2|||
130271529|NCT00473889|468957306|FG000|Overall Study|Lack of Efficacy|28|||
130271530|NCT00473889|468957307|FG001|Overall Study|Lack of Efficacy|29|||
130271531|NCT00473889|468957306|FG000|Overall Study|Lost to Follow-up|2|||
130271532|NCT00473889|468957307|FG001|Overall Study|Lost to Follow-up|1|||
130271533|NCT00473889|468957306|FG000|Overall Study|Physician Decision|10|||
130271534|NCT00473889|468957307|FG001|Overall Study|Physician Decision|5|||
130271535|NCT00473889|468957306|FG000|Overall Study|Trial Terminated|3|||
130271536|NCT00473889|468957307|FG001|Overall Study|Trial Terminated|6|||
130271537|NCT00473889|468957306|FG000|Overall Study|Withdrawal by Subject|5|||
130271538|NCT00473889|468957307|FG001|Overall Study|Withdrawal by Subject|0|||
130271539|NCT00833469|468957308|FG000|Overall Study|Withdrawal by Subject|1|||
130271540|NCT00833469|468957308|FG000|Overall Study|Lost to Follow-up|1|||
130271541|NCT03592771|468957309|FG000|Overall Study|Adverse Event|2|||
130271542|NCT03592771|468957310|FG001|Overall Study|Adverse Event|0|||
130271543|NCT03592771|468957311|FG002|Overall Study|Adverse Event|1|||
130271544|NCT03592771|468957309|FG000|Overall Study|Death|0|||
130271545|NCT03592771|468957310|FG001|Overall Study|Death|1|||
130271546|NCT03592771|468957311|FG002|Overall Study|Death|1|||
130271547|NCT03592771|468957309|FG000|Overall Study|Lost to Follow-up|5|||
130271548|NCT03592771|468957310|FG001|Overall Study|Lost to Follow-up|11|||
130271549|NCT03592771|468957311|FG002|Overall Study|Lost to Follow-up|15|||
130271550|NCT03592771|468957309|FG000|Overall Study|Withdrawal by Subject|0|||
130271551|NCT03592771|468957310|FG001|Overall Study|Withdrawal by Subject|2|||
130271552|NCT03592771|468957311|FG002|Overall Study|Withdrawal by Subject|0|||
130271553|NCT04830215|468957312|FG000|Overall Study|Adverse Event|6|||
130456101|NCT02466516|469634800|FG003|Overall Study|Lost to Follow-up|0|||
130456102|NCT02466516|469634801|FG004|Overall Study|Lost to Follow-up|0|||
130271554|NCT04830215|468957312|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
130271555|NCT04830215|468957312|FG000|Overall Study|Withdrawal by Subject|3|||
130271556|NCT04830215|468957312|FG000|Overall Study|Protocol Deviation|1|||
130271557|NCT02236572|468957313|FG000|Overall Study|Withdrawal by Subject|1|||
130271558|NCT02236572|468957313|FG000|Overall Study|Protocol Violation|1|||
130456103|NCT03712930|469634802|FG000|Overall Study|Death|7|||
130456104|NCT03712930|469634802|FG000|Overall Study|Physician Decision|1|||
130456105|NCT03712930|469634802|FG000|Overall Study|Study Terminated by Sponsor|3|||
130271559|NCT02236572|468957313|FG000|Overall Study|Lost to Follow-up|1|||
130271560|NCT02443337|468957314|FG000|Overall Study|Adverse Event|0|||
130271561|NCT02443337|468957315|FG001|Overall Study|Adverse Event|1|||
130271562|NCT02443337|468957314|FG000|Overall Study|Clinical Progressive Disease|3|||
130271563|NCT02443337|468957315|FG001|Overall Study|Clinical Progressive Disease|0|||
130271564|NCT02443337|468957314|FG000|Overall Study|Withdrawal by Subject|2|||
130271565|NCT02443337|468957315|FG001|Overall Study|Withdrawal by Subject|1|||
130271566|NCT00709319|468957316|FG000|Overall Study|Death|4|||
130271567|NCT00709319|468957316|FG000|Overall Study|Withdrawal by Subject|2|||
130271568|NCT00579553|468957317|FG000|Overall Study|Lost to Follow-up|16|||
130271569|NCT00579553|468957318|FG001|Overall Study|Lost to Follow-up|13|||
130271570|NCT00635349|468957319|FG000|Overall Study|Other|8|||
130271571|NCT00635349|468957320|FG001|Overall Study|Other|6|||
130271572|NCT00635349|468957319|FG000|Overall Study|Protocol Violation|18|||
130271573|NCT00635349|468957320|FG001|Overall Study|Protocol Violation|22|||
130271574|NCT00635349|468957319|FG000|Overall Study|Withdrawal by Subject|3|||
130271575|NCT00635349|468957320|FG001|Overall Study|Withdrawal by Subject|8|||
130271576|NCT00635349|468957319|FG000|Overall Study|Lost to Follow-up|4|||
130271577|NCT00635349|468957320|FG001|Overall Study|Lost to Follow-up|3|||
130271578|NCT00635349|468957319|FG000|Overall Study|Adverse Event|11|||
130271579|NCT00635349|468957320|FG001|Overall Study|Adverse Event|9|||
130271580|NCT00049322|468957322|FG000|Overall Study|disease burden|0|||
130271581|NCT00049322|468957323|FG001|Overall Study|disease burden|3|||
130271582|NCT00049322|468957322|FG000|Overall Study|Adverse Event|1|||
130271583|NCT00049322|468957323|FG001|Overall Study|Adverse Event|0|||
130271584|NCT00049322|468957322|FG000|Overall Study|refused angio|0|||
130271585|NCT00049322|468957323|FG001|Overall Study|refused angio|3|||
130271586|NCT03072043|468957324|FG000|Overall Study|Death|0|||
130271587|NCT03072043|468957325|FG001|Overall Study|Death|0|||
130271588|NCT03072043|468957326|FG002|Overall Study|Death|3|||
130271589|NCT03072043|468957324|FG000|Overall Study|Adverse Event|0|||
130271590|NCT03072043|468957325|FG001|Overall Study|Adverse Event|0|||
130271591|NCT03072043|468957326|FG002|Overall Study|Adverse Event|2|||
130271592|NCT03072043|468957324|FG000|Overall Study|Withdrawal by Subject|0|||
130271593|NCT03072043|468957325|FG001|Overall Study|Withdrawal by Subject|0|||
130271594|NCT03072043|468957326|FG002|Overall Study|Withdrawal by Subject|4|||
130271595|NCT01340664|468957327|FG000|Overall Study|Adverse Event|0|||
130271596|NCT01340664|468957328|FG001|Overall Study|Adverse Event|1|||
130271597|NCT01340664|468957329|FG002|Overall Study|Adverse Event|7|||
130271598|NCT01340664|468957327|FG000|Overall Study|Lost to Follow-up|2|||
130271599|NCT01340664|468957328|FG001|Overall Study|Lost to Follow-up|0|||
130271600|NCT01340664|468957329|FG002|Overall Study|Lost to Follow-up|2|||
130271601|NCT01340664|468957327|FG000|Overall Study|Withdrawal by Subject|2|||
130271602|NCT01340664|468957328|FG001|Overall Study|Withdrawal by Subject|4|||
130271603|NCT01340664|468957329|FG002|Overall Study|Withdrawal by Subject|0|||
130271604|NCT01340664|468957327|FG000|Overall Study|Glycemic withdrawal criteria|2|||
130271605|NCT01340664|468957328|FG001|Overall Study|Glycemic withdrawal criteria|0|||
130271606|NCT01340664|468957329|FG002|Overall Study|Glycemic withdrawal criteria|0|||
130271607|NCT01340664|468957327|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
130271608|NCT01340664|468957328|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
130271609|NCT01340664|468957329|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
130271610|NCT01340664|468957327|FG000|Overall Study|Other|1|||
130271611|NCT01340664|468957328|FG001|Overall Study|Other|2|||
130271612|NCT01340664|468957329|FG002|Overall Study|Other|2|||
130271613|NCT03994211|468957332|FG000|Core Phase|Adverse Event|0|||
130271614|NCT03994211|468957333|FG001|Core Phase|Adverse Event|1|||
130271615|NCT03994211|468957334|FG002|Core Phase|Adverse Event|0|||
130271616|NCT03994211|468957332|FG000|Extension Phase|Adverse Event|0|||
130271617|NCT03994211|468957333|FG001|Extension Phase|Adverse Event|0|||
130271618|NCT03994211|468957334|FG002|Extension Phase|Adverse Event|1|||
130271619|NCT03994211|468957332|FG000|Extension Phase|Physician Decision|0|||
130271620|NCT03994211|468957333|FG001|Extension Phase|Physician Decision|0|||
130271621|NCT03994211|468957334|FG002|Extension Phase|Physician Decision|1|||
130271622|NCT03994211|468957332|FG000|Extension Phase|Progressive Disease|0|||
130271623|NCT03994211|468957333|FG001|Extension Phase|Progressive Disease|0|||
130271624|NCT03994211|468957334|FG002|Extension Phase|Progressive Disease|20|||
130271625|NCT03994211|468957332|FG000|Extension Phase|Withdrawal by Subject|0|||
130271626|NCT03994211|468957333|FG001|Extension Phase|Withdrawal by Subject|0|||
130271627|NCT03994211|468957334|FG002|Extension Phase|Withdrawal by Subject|2|||
130271628|NCT01140867|468957335|FG000|Overall Study|Adverse Event|22|||
130271629|NCT01140867|468957335|FG000|Overall Study|Lack of Efficacy|3|||
130271630|NCT01140867|468957335|FG000|Overall Study|Lost to Follow-up|2|||
130271631|NCT01140867|468957335|FG000|Overall Study|Withdrawal by Subject|1|||
130271632|NCT01140867|468957335|FG000|Overall Study|Protocol Violation|1|||
130271633|NCT01140867|468957335|FG000|Overall Study|Uncooperative patient|2|||
130271634|NCT01140867|468957335|FG000|Overall Study|Medication Noncompliance|2|||
130271635|NCT02997865|468957337|FG000|Overall Study|Death|2|||
130271636|NCT02997865|468957338|FG001|Overall Study|Death|1|||
130271637|NCT02997865|468957337|FG000|Overall Study|Lost to Follow-up|6|||
130271638|NCT02997865|468957338|FG001|Overall Study|Lost to Follow-up|3|||
130554398|NCT02684357|469996596|FG003|Part B|Other|1|||
130554399|NCT02684357|469996597|FG004|Part B|Other|0|||
130366945|NCT01768286|469314081|FG002|Overall Study|Randomized But Not Treated|1|||
130366946|NCT01768286|469314082|FG003|Overall Study|Randomized But Not Treated|0|||
130366947|NCT01768286|469314079|FG000|Overall Study|Lack of Efficacy|7|||
130366948|NCT01768286|469314080|FG001|Overall Study|Lack of Efficacy|4|||
130366949|NCT01768286|469314081|FG002|Overall Study|Lack of Efficacy|0|||
130366950|NCT01768286|469314082|FG003|Overall Study|Lack of Efficacy|1|||
130366951|NCT01768286|469314079|FG000|Overall Study|Withdrew Consent|0|||
130366952|NCT01768286|469314080|FG001|Overall Study|Withdrew Consent|0|||
130366953|NCT01768286|469314081|FG002|Overall Study|Withdrew Consent|1|||
130366954|NCT01768286|469314082|FG003|Overall Study|Withdrew Consent|0|||
130366955|NCT02083965|469314083|FG000|Treatment Period|Other|1|||
130366956|NCT02083965|469314084|FG001|Treatment Period|Other|0|||
130366957|NCT04502433|469314087|FG000|Overall Study|Death|2|||
130366958|NCT04502433|469314088|FG001|Overall Study|Death|4|||
130366959|NCT04502433|469314087|FG000|Overall Study|Lost to Follow-up|1|||
130366960|NCT04502433|469314088|FG001|Overall Study|Lost to Follow-up|0|||
130456106|NCT03712930|469634802|FG000|Overall Study|Progressive Disease|2|||
130456107|NCT00739102|469634807|FG000|Overall Study|Death|5|||
130456108|NCT00739102|469634807|FG000|Overall Study|Withdrawal by Subject|10|||
130456109|NCT01331824|469634808|FG000|Overall Study|Adverse Event|2|||
130366961|NCT04502433|469314087|FG000|Overall Study|Physician Decision|0|||
130456110|NCT01331824|469634808|FG000|Overall Study|Death|1|||
130456111|NCT01331824|469634808|FG000|Overall Study|Disease Progression|9|||
130456112|NCT01331824|469634808|FG000|Overall Study|Withdrawal by Subject|1|||
130456113|NCT01091454|469634811|FG000|Overall Study|Ineligible|1|||
130456114|NCT03179787|469634812|FG000|Overall Study|Lost to Follow-up|15|||
130456115|NCT03179787|469634812|FG000|Overall Study|Case report failures|2|||
130554400|NCT02684357|469996598|FG005|Part B|Other|1|||
130554401|NCT01079130|469996599|FG000|Overall Study|Adverse Event|1|||
130456116|NCT03179787|469634812|FG000|Overall Study|Treatment not administered|1|||
130456117|NCT01510912|469634813|FG000|Overall Study|Adverse Event|99|||
130456118|NCT01510912|469634813|FG000|Overall Study|Lack of Efficacy|12|||
130366962|NCT04502433|469314088|FG001|Overall Study|Physician Decision|1|||
130366963|NCT02935842|469314089|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
130456119|NCT01510912|469634813|FG000|Overall Study|Non-compliance with trial drug|23|||
130554402|NCT01079130|469996600|FG001|Overall Study|Adverse Event|1|||
130271639|NCT02997865|468957337|FG000|Overall Study|Withdrawal by Subject|5|||
130271640|NCT02997865|468957338|FG001|Overall Study|Withdrawal by Subject|0|||
130271641|NCT01926444|468957339|FG000|Overall Study|Colonoscopy not performed|0|||
130271642|NCT01926444|468957340|FG001|Overall Study|Colonoscopy not performed|0|||
130271643|NCT01926444|468957341|FG002|Overall Study|Colonoscopy not performed|4|||
130271644|NCT01926444|468957342|FG003|Overall Study|Colonoscopy not performed|2|||
130271645|NCT02441101|468957349|FG000|Overall Study|Withdrawal by Subject|1|||
130271646|NCT02441101|468957350|FG001|Overall Study|Withdrawal by Subject|0|||
130271647|NCT02441101|468957349|FG000|Overall Study|Lost to Follow-up|1|||
130271648|NCT02441101|468957350|FG001|Overall Study|Lost to Follow-up|0|||
130271649|NCT02441101|468957349|FG000|Overall Study|PI relocated and study terminated|1|||
130271650|NCT02441101|468957350|FG001|Overall Study|PI relocated and study terminated|0|||
130271651|NCT02528942|468957352|FG000|Overall Study|Did not meet imaging criteria|9|||
130271652|NCT02528942|468957352|FG000|Overall Study|Lost to Follow-up|25|||
130271653|NCT00881530|468957353|FG000|Overall Study|Adverse Event|5|||
130271654|NCT00881530|468957354|FG001|Overall Study|Adverse Event|1|||
130271655|NCT00881530|468957355|FG002|Overall Study|Adverse Event|1|||
130271656|NCT00881530|468957356|FG003|Overall Study|Adverse Event|4|||
130271657|NCT00881530|468957357|FG004|Overall Study|Adverse Event|10|||
130271658|NCT00881530|468957358|FG005|Overall Study|Adverse Event|2|||
130271659|NCT00881530|468957353|FG000|Overall Study|Lack of Efficacy|1|||
130271660|NCT00881530|468957354|FG001|Overall Study|Lack of Efficacy|0|||
130271661|NCT00881530|468957355|FG002|Overall Study|Lack of Efficacy|0|||
130271662|NCT00881530|468957356|FG003|Overall Study|Lack of Efficacy|0|||
130271663|NCT00881530|468957357|FG004|Overall Study|Lack of Efficacy|1|||
130271664|NCT00881530|468957358|FG005|Overall Study|Lack of Efficacy|1|||
130271665|NCT00881530|468957353|FG000|Overall Study|Not compliant with the protocol|0|||
130271666|NCT00881530|468957354|FG001|Overall Study|Not compliant with the protocol|0|||
130271667|NCT00881530|468957355|FG002|Overall Study|Not compliant with the protocol|0|||
130271668|NCT00881530|468957356|FG003|Overall Study|Not compliant with the protocol|0|||
130271669|NCT00881530|468957357|FG004|Overall Study|Not compliant with the protocol|2|||
130271670|NCT00881530|468957358|FG005|Overall Study|Not compliant with the protocol|0|||
130271671|NCT00881530|468957353|FG000|Overall Study|Lost to Follow-up|0|||
130271672|NCT00881530|468957354|FG001|Overall Study|Lost to Follow-up|1|||
130271673|NCT00881530|468957355|FG002|Overall Study|Lost to Follow-up|1|||
130271674|NCT00881530|468957356|FG003|Overall Study|Lost to Follow-up|3|||
130271675|NCT00881530|468957357|FG004|Overall Study|Lost to Follow-up|1|||
130271676|NCT00881530|468957358|FG005|Overall Study|Lost to Follow-up|0|||
130271677|NCT00881530|468957353|FG000|Overall Study|Refused to continue medication|7|||
130271678|NCT00881530|468957354|FG001|Overall Study|Refused to continue medication|2|||
130271679|NCT00881530|468957355|FG002|Overall Study|Refused to continue medication|1|||
130271680|NCT00881530|468957356|FG003|Overall Study|Refused to continue medication|2|||
130271681|NCT00881530|468957357|FG004|Overall Study|Refused to continue medication|0|||
130271682|NCT00881530|468957358|FG005|Overall Study|Refused to continue medication|0|||
130271683|NCT00881530|468957353|FG000|Overall Study|Other reason not defined above|1|||
130706421|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706422|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
130706423|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706424|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706425|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706426|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130271684|NCT00881530|468957354|FG001|Overall Study|Other reason not defined above|1|||
130271685|NCT00881530|468957355|FG002|Overall Study|Other reason not defined above|2|||
130366964|NCT02935842|469314090|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130366965|NCT02935842|469314091|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130366966|NCT02935842|469314092|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130366967|NCT02935842|469314089|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
130366968|NCT02935842|469314090|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
130366969|NCT02935842|469314091|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
130554403|NCT01079130|469996601|FG002|Overall Study|Adverse Event|0|||
130706427|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706428|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706429|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706430|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130271686|NCT00881530|468957356|FG003|Overall Study|Other reason not defined above|0|||
130271687|NCT00881530|468957357|FG004|Overall Study|Other reason not defined above|0|||
130271688|NCT00881530|468957358|FG005|Overall Study|Other reason not defined above|2|||
130271689|NCT01509846|468957359|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130271690|NCT01509846|468957360|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130271691|NCT01509846|468957361|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
130271692|NCT01509846|468957362|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130271693|NCT01509846|468957363|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130706431|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130706432|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130271694|NCT01509846|468957359|FG000|Received Vaccination 2|Illness|0|||
130271695|NCT01509846|468957360|FG001|Received Vaccination 2|Illness|0|||
130271696|NCT01509846|468957361|FG002|Received Vaccination 2|Illness|0|||
130271697|NCT01509846|468957362|FG003|Received Vaccination 2|Illness|0|||
130271698|NCT01509846|468957363|FG004|Received Vaccination 2|Illness|1|||
130271699|NCT01509846|468957359|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
130271700|NCT01509846|468957360|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
130271701|NCT01509846|468957361|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
130271702|NCT01509846|468957362|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
130271703|NCT01509846|468957363|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
130271704|NCT01509846|468957359|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
130271705|NCT01509846|468957360|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
130706433|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130706434|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
130706435|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
130706436|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130706437|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130706438|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130706439|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130706440|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706441|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706442|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706443|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706444|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130706445|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706446|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130271706|NCT01509846|468957361|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
130706447|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130706448|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706449|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130706450|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130706451|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706452|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706453|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706454|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706455|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706456|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706457|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706458|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
130706459|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130706460|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130706461|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
130706462|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130720853|NCT04126213|470601550|FG005|Overall Study|Withdrawal by Subject|1|||
130720854|NCT04126213|470601545|FG000|Overall Study|Other|0|||
130720855|NCT04126213|470601546|FG001|Overall Study|Other|0|||
130720856|NCT04126213|470601547|FG002|Overall Study|Other|2|||
130720857|NCT04126213|470601548|FG003|Overall Study|Other|2|||
130720858|NCT04126213|470601549|FG004|Overall Study|Other|0|||
130720859|NCT04126213|470601550|FG005|Overall Study|Other|1|||
130271707|NCT01509846|468957362|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
130271708|NCT01509846|468957363|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
130271709|NCT01509846|468957359|FG000|Received Vaccination 3|Pregnancy|0|||
130271710|NCT01509846|468957360|FG001|Received Vaccination 3|Pregnancy|0|||
130271711|NCT01509846|468957361|FG002|Received Vaccination 3|Pregnancy|0|||
130271712|NCT01509846|468957362|FG003|Received Vaccination 3|Pregnancy|1|||
130271713|NCT01509846|468957363|FG004|Received Vaccination 3|Pregnancy|0|||
130720860|NCT04126213|470601545|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130720861|NCT04126213|470601546|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130720862|NCT04126213|470601547|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130720863|NCT04126213|470601548|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130720864|NCT04126213|470601549|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130720865|NCT04126213|470601550|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130720866|NCT02853370|470601551|FG000|Overall Study|Physician Decision|1|||
130271714|NCT01509846|468957359|FG000|Received Vaccination 3|Lost to Follow-up|0|||
130271715|NCT01509846|468957360|FG001|Received Vaccination 3|Lost to Follow-up|0|||
130271716|NCT01509846|468957361|FG002|Received Vaccination 3|Lost to Follow-up|1|||
130271717|NCT01509846|468957362|FG003|Received Vaccination 3|Lost to Follow-up|0|||
130271718|NCT01509846|468957363|FG004|Received Vaccination 3|Lost to Follow-up|0|||
130271719|NCT01637584|468957364|FG000|Overall Study|Withdrawal by Subject|1|||
130271720|NCT01637584|468957365|FG001|Overall Study|Withdrawal by Subject|3|||
130271721|NCT02969915|468957367|FG000|Overall Study|Death|104|||
130271722|NCT02969915|468957368|FG001|Overall Study|Death|125|||
130271723|NCT02969915|468957367|FG000|Overall Study|Lost to Follow-up|108|||
130271724|NCT02969915|468957368|FG001|Overall Study|Lost to Follow-up|112|||
130271725|NCT02969915|468957367|FG000|Overall Study|Censored due to COVID-19|481|||
130271726|NCT02969915|468957368|FG001|Overall Study|Censored due to COVID-19|471|||
130271727|NCT01393899|468957371|FG000|Overall Study|Study terminated by sponsor|1|||
130271728|NCT01393899|468957372|FG001|Overall Study|Study terminated by sponsor|0|||
130271729|NCT01393899|468957373|FG002|Overall Study|Study terminated by sponsor|1|||
130271730|NCT01393899|468957371|FG000|Overall Study|Other|1|||
130271731|NCT01393899|468957372|FG001|Overall Study|Other|0|||
130271732|NCT01393899|468957373|FG002|Overall Study|Other|0|||
130271733|NCT01393899|468957371|FG000|Overall Study|Withdrawal by Subject|2|||
130271734|NCT01393899|468957372|FG001|Overall Study|Withdrawal by Subject|2|||
130271735|NCT01393899|468957373|FG002|Overall Study|Withdrawal by Subject|1|||
130271736|NCT01393899|468957371|FG000|Overall Study|Lost to Follow-up|0|||
130271737|NCT01393899|468957372|FG001|Overall Study|Lost to Follow-up|0|||
130271738|NCT01393899|468957373|FG002|Overall Study|Lost to Follow-up|1|||
130271739|NCT01393899|468957371|FG000|Overall Study|Does not meet entrance criteria|1|||
130271740|NCT01393899|468957372|FG001|Overall Study|Does not meet entrance criteria|0|||
130271741|NCT01393899|468957373|FG002|Overall Study|Does not meet entrance criteria|1|||
130271742|NCT01393899|468957371|FG000|Overall Study|Lack of Efficacy|26|||
130271743|NCT01393899|468957372|FG001|Overall Study|Lack of Efficacy|21|||
130271744|NCT01393899|468957373|FG002|Overall Study|Lack of Efficacy|16|||
130271745|NCT01393899|468957371|FG000|Overall Study|Adverse Event|1|||
130271746|NCT01393899|468957372|FG001|Overall Study|Adverse Event|5|||
130271747|NCT01393899|468957373|FG002|Overall Study|Adverse Event|3|||
130271748|NCT02503085|468957374|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130271749|NCT02503085|468957375|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130271750|NCT02503085|468957376|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130271751|NCT02503085|468957377|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130271752|NCT00995436|468957378|FG000|Overall Study|Withdrawal by Subject|2|||
130271753|NCT00995436|468957379|FG001|Overall Study|Withdrawal by Subject|5|||
130271754|NCT00995436|468957380|FG002|Overall Study|Withdrawal by Subject|0|||
130271755|NCT02131662|468957381|FG000|Overall Study|Protocol Violation|1|||
130271756|NCT02131662|468957382|FG001|Overall Study|Protocol Violation|0|||
130271757|NCT02131662|468957383|FG002|Overall Study|Protocol Violation|0|||
130271758|NCT02131662|468957384|FG003|Overall Study|Protocol Violation|0|||
130271759|NCT02131662|468957385|FG004|Overall Study|Protocol Violation|0|||
130271760|NCT02131662|468957381|FG000|Overall Study|Other|2|||
130271761|NCT02131662|468957382|FG001|Overall Study|Other|4|||
130271762|NCT02131662|468957383|FG002|Overall Study|Other|3|||
130271763|NCT02131662|468957384|FG003|Overall Study|Other|3|||
130271764|NCT02131662|468957385|FG004|Overall Study|Other|4|||
130271765|NCT02131662|468957381|FG000|Overall Study|Adverse Event|0|||
130271766|NCT02131662|468957382|FG001|Overall Study|Adverse Event|1|||
130271767|NCT02131662|468957383|FG002|Overall Study|Adverse Event|1|||
130271768|NCT02131662|468957384|FG003|Overall Study|Adverse Event|1|||
130271769|NCT02131662|468957385|FG004|Overall Study|Adverse Event|3|||
130271770|NCT02131662|468957381|FG000|Overall Study|Pregnancy|0|||
130271771|NCT02131662|468957382|FG001|Overall Study|Pregnancy|1|||
130271772|NCT02131662|468957383|FG002|Overall Study|Pregnancy|0|||
130271773|NCT02131662|468957384|FG003|Overall Study|Pregnancy|1|||
130271774|NCT02131662|468957385|FG004|Overall Study|Pregnancy|0|||
130271775|NCT02131662|468957381|FG000|Overall Study|Wish for pregnancy|0|||
130271776|NCT02131662|468957382|FG001|Overall Study|Wish for pregnancy|0|||
130271777|NCT02131662|468957383|FG002|Overall Study|Wish for pregnancy|0|||
130271778|NCT02131662|468957384|FG003|Overall Study|Wish for pregnancy|0|||
130271779|NCT02131662|468957385|FG004|Overall Study|Wish for pregnancy|1|||
130271780|NCT02131662|468957381|FG000|Overall Study|Lack of Efficacy|1|||
130271781|NCT02131662|468957382|FG001|Overall Study|Lack of Efficacy|0|||
130271782|NCT02131662|468957383|FG002|Overall Study|Lack of Efficacy|0|||
130271783|NCT02131662|468957384|FG003|Overall Study|Lack of Efficacy|0|||
130271784|NCT02131662|468957385|FG004|Overall Study|Lack of Efficacy|1|||
130271785|NCT02131662|468957381|FG000|Overall Study|Withdrawal by Subject|1|||
130456120|NCT01510912|469634813|FG000|Overall Study|Withdrawal by Subject|49|||
130456121|NCT01510912|469634813|FG000|Overall Study|Physician Decision|1|||
130456122|NCT01510912|469634813|FG000|Overall Study|Protocol Violation|27|||
130456123|NCT01510912|469634813|FG000|Overall Study|Lost to Follow-up|26|||
130456124|NCT01510912|469634813|FG000|Overall Study|Other, including joint replacement|5|||
130456125|NCT02030028|469634814|FG000|Overall Study|Withdrawal by Subject|4|||
130456126|NCT02030028|469634814|FG000|Overall Study|lack of transportation|1|||
130456127|NCT02380742|469634816|FG000|Overall Study|Withdrawal by Subject|1|||
130456128|NCT02380742|469634817|FG001|Overall Study|Withdrawal by Subject|0|||
130456129|NCT02930343|469634819|FG000|Overall Study|Lost to Follow-up|9|||
130456130|NCT02930343|469634820|FG001|Overall Study|Lost to Follow-up|7|||
130456131|NCT01185522|469634821|FG000|Overall Study|Lack of Efficacy|28|||
130456132|NCT01185522|469634821|FG000|Overall Study|Lost to Follow-up|19|||
130456133|NCT01185522|469634821|FG000|Overall Study|Withdrawal by Subject|10|||
130456134|NCT01185522|469634821|FG000|Overall Study|Poor tolerance|39|||
130456135|NCT01185522|469634821|FG000|Overall Study|Other reasons|12|||
130456136|NCT00109967|469634824|FG000|Overall Study|Cancel Prior to Treatment|2|||
130456137|NCT00109967|469634825|FG001|Overall Study|Cancel Prior to Treatment|0|||
130456138|NCT00109967|469634824|FG000|Overall Study|Adverse Event|12|||
130456139|NCT00109967|469634825|FG001|Overall Study|Adverse Event|1|||
130456140|NCT00109967|469634824|FG000|Overall Study|Withdrawal by Subject|5|||
130456141|NCT00109967|469634825|FG001|Overall Study|Withdrawal by Subject|0|||
130456142|NCT00109967|469634824|FG000|Overall Study|Physician Decision|1|||
130456143|NCT00109967|469634825|FG001|Overall Study|Physician Decision|3|||
130456144|NCT00109967|469634824|FG000|Overall Study|Death|0|||
130456145|NCT00109967|469634825|FG001|Overall Study|Death|2|||
130456146|NCT01280591|469634832|FG000|Overall Study|Withdrawal by Subject|0|||
130456147|NCT01280591|469634833|FG001|Overall Study|Withdrawal by Subject|0|||
130456148|NCT01280591|469634834|FG002|Overall Study|Withdrawal by Subject|0|||
130456149|NCT01280591|469634835|FG003|Overall Study|Withdrawal by Subject|2|||
130456150|NCT01280591|469634832|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
130706463|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130706464|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130706465|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130706466|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130706467|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706468|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706469|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
130706470|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706471|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706472|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706473|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706474|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706475|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706476|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706477|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130706478|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706479|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130706480|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706481|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706482|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130706483|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130706484|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706485|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130706486|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706487|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
130706488|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130706489|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706490|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706491|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130706492|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
130706493|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130720867|NCT02853370|470601551|FG000|Overall Study|Lack of Efficacy|2|||
130456151|NCT01280591|469634833|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
130456152|NCT01280591|469634834|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
130456153|NCT01280591|469634835|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
130456154|NCT03357341|469634839|FG000|Overall Study|Withdrawal by Subject|3|||
130554404|NCT01079130|469996602|FG003|Overall Study|Adverse Event|1|||
130554405|NCT01079130|469996603|FG004|Overall Study|Adverse Event|5|||
130554406|NCT01079130|469996604|FG005|Overall Study|Adverse Event|1|||
130554407|NCT01079130|469996599|FG000|Overall Study|Administrative problems|1|||
130554408|NCT01079130|469996600|FG001|Overall Study|Administrative problems|3|||
130554409|NCT01079130|469996601|FG002|Overall Study|Administrative problems|0|||
130554410|NCT01079130|469996602|FG003|Overall Study|Administrative problems|0|||
130554411|NCT01079130|469996603|FG004|Overall Study|Administrative problems|0|||
130554412|NCT01079130|469996604|FG005|Overall Study|Administrative problems|1|||
130554413|NCT01079130|469996599|FG000|Overall Study|Withdrawal by Subject|0|||
130554414|NCT01079130|469996600|FG001|Overall Study|Withdrawal by Subject|1|||
130554415|NCT01079130|469996601|FG002|Overall Study|Withdrawal by Subject|0|||
130554416|NCT01079130|469996602|FG003|Overall Study|Withdrawal by Subject|0|||
130554417|NCT01079130|469996603|FG004|Overall Study|Withdrawal by Subject|1|||
130554418|NCT01079130|469996604|FG005|Overall Study|Withdrawal by Subject|3|||
130554419|NCT01079130|469996599|FG000|Overall Study|Protocol deviation|0|||
130554420|NCT01079130|469996600|FG001|Overall Study|Protocol deviation|2|||
130554421|NCT01079130|469996601|FG002|Overall Study|Protocol deviation|1|||
130554422|NCT01079130|469996602|FG003|Overall Study|Protocol deviation|2|||
130554423|NCT01079130|469996603|FG004|Overall Study|Protocol deviation|0|||
130554424|NCT01079130|469996604|FG005|Overall Study|Protocol deviation|0|||
130554425|NCT01079130|469996599|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130554426|NCT01079130|469996600|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130554427|NCT01079130|469996601|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130554428|NCT01079130|469996602|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130554429|NCT01079130|469996603|FG004|Overall Study|Abnormal test procedure result(s)|1|||
130554430|NCT01079130|469996604|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130554431|NCT01079130|469996599|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130554432|NCT01079130|469996600|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130554433|NCT01079130|469996601|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130554434|NCT01079130|469996602|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
130554435|NCT01079130|469996603|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130554436|NCT01079130|469996604|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130554437|NCT01079130|469996599|FG000|Overall Study|Lost to Follow-up|0|||
130554438|NCT01079130|469996600|FG001|Overall Study|Lost to Follow-up|0|||
130554439|NCT01079130|469996601|FG002|Overall Study|Lost to Follow-up|0|||
130554440|NCT01079130|469996602|FG003|Overall Study|Lost to Follow-up|0|||
130271786|NCT02131662|468957382|FG001|Overall Study|Withdrawal by Subject|5|||
130271787|NCT02131662|468957383|FG002|Overall Study|Withdrawal by Subject|1|||
130271788|NCT02131662|468957384|FG003|Overall Study|Withdrawal by Subject|5|||
130271789|NCT02131662|468957385|FG004|Overall Study|Withdrawal by Subject|6|||
130271790|NCT02131662|468957381|FG000|Overall Study|Lost to Follow-up|1|||
130271791|NCT02131662|468957382|FG001|Overall Study|Lost to Follow-up|3|||
130271792|NCT02131662|468957383|FG002|Overall Study|Lost to Follow-up|0|||
130271793|NCT02131662|468957384|FG003|Overall Study|Lost to Follow-up|9|||
130271794|NCT02131662|468957385|FG004|Overall Study|Lost to Follow-up|0|||
130271795|NCT02131662|468957381|FG000|Overall Study|Not treated|2|||
130271796|NCT02131662|468957382|FG001|Overall Study|Not treated|0|||
130271797|NCT02131662|468957383|FG002|Overall Study|Not treated|2|||
130271798|NCT02131662|468957384|FG003|Overall Study|Not treated|2|||
130271799|NCT02131662|468957385|FG004|Overall Study|Not treated|3|||
130271800|NCT00809926|468957387|FG000|Overall Study|Adverse Event|18|||
130271801|NCT00809926|468957388|FG001|Overall Study|Adverse Event|10|||
130271802|NCT00809926|468957387|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130271803|NCT00809926|468957388|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130271804|NCT00809926|468957387|FG000|Overall Study|Patient withdrew consent|8|||
130554441|NCT01079130|469996603|FG004|Overall Study|Lost to Follow-up|1|||
130271805|NCT00809926|468957388|FG001|Overall Study|Patient withdrew consent|6|||
130554442|NCT01079130|469996604|FG005|Overall Study|Lost to Follow-up|0|||
130554443|NCT01839487|469996605|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
130271806|NCT00809926|468957387|FG000|Overall Study|Lost to Follow-up|2|||
130554444|NCT01839487|469996606|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
130271807|NCT00809926|468957388|FG001|Overall Study|Lost to Follow-up|1|||
130271808|NCT00809926|468957387|FG000|Overall Study|Administrative Problems|0|||
130271809|NCT00809926|468957388|FG001|Overall Study|Administrative Problems|1|||
130271810|NCT00809926|468957387|FG000|Overall Study|Protocol deviation|0|||
130720868|NCT02853370|470601551|FG000|Overall Study|Death|1|||
130720869|NCT02853370|470601551|FG000|Overall Study|Adverse Event|4|||
130720870|NCT02853370|470601551|FG000|Overall Study|Withdrawal by Subject|3|||
130720871|NCT03275064|470601552|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720872|NCT03275064|470601553|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720873|NCT03275064|470601554|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720874|NCT03275064|470601555|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
130720875|NCT03275064|470601556|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130706494|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130271811|NCT00809926|468957388|FG001|Overall Study|Protocol deviation|2|||
130271812|NCT00130039|468957389|FG000|Overall Study|Withdrawal by Subject|15|||
130271813|NCT00130039|468957390|FG001|Overall Study|Withdrawal by Subject|11|||
130271814|NCT00130039|468957389|FG000|Overall Study|Lost to Follow-up|3|||
130271815|NCT00130039|468957390|FG001|Overall Study|Lost to Follow-up|1|||
130271816|NCT00130039|468957389|FG000|Overall Study|Adverse Event|4|||
130271817|NCT00130039|468957390|FG001|Overall Study|Adverse Event|2|||
130271818|NCT00130039|468957389|FG000|Overall Study|Physician Decision|3|||
130271819|NCT00130039|468957390|FG001|Overall Study|Physician Decision|0|||
130271820|NCT00130039|468957389|FG000|Overall Study|clinical events without follow up MRI|5|||
130271821|NCT00130039|468957390|FG001|Overall Study|clinical events without follow up MRI|4|||
130271822|NCT00100802|468957406|FG000|Overall Study|Adverse Event|9|||
130271823|NCT00100802|468957406|FG000|Overall Study|Death|1|||
130271824|NCT00100802|468957406|FG000|Overall Study|Lack of Efficacy|47|||
130271825|NCT00100802|468957406|FG000|Overall Study|Physician Decision|5|||
130271826|NCT00100802|468957406|FG000|Overall Study|Protocol Violation|1|||
130271827|NCT00100802|468957406|FG000|Overall Study|Withdrawal by Subject|5|||
130271828|NCT00100802|468957406|FG000|Overall Study|Ineligible|12|||
130271829|NCT02712996|468957407|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
130271830|NCT02712996|468957408|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
130271831|NCT02709720|468957410|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
130271832|NCT02709720|468957410|FG000|Overall Study|Protocol Violation|1|||
130271833|NCT02709720|468957410|FG000|Overall Study|Not take study medication|1|||
130271834|NCT03265145|468957412|FG000|Overall Study|Protocol Violation|2|||
130271835|NCT03265145|468957413|FG001|Overall Study|Protocol Violation|0|||
130271836|NCT03265145|468957412|FG000|Overall Study|Adverse Event|1|||
130271837|NCT03265145|468957413|FG001|Overall Study|Adverse Event|0|||
130271838|NCT03265145|468957412|FG000|Overall Study|Withdrawal by Subject|23|||
130271839|NCT03265145|468957413|FG001|Overall Study|Withdrawal by Subject|19|||
130271840|NCT03265145|468957412|FG000|Overall Study|Death|12|||
130271841|NCT03265145|468957413|FG001|Overall Study|Death|12|||
130271842|NCT03265145|468957412|FG000|Overall Study|Lost to Follow-up|13|||
130271843|NCT03265145|468957413|FG001|Overall Study|Lost to Follow-up|9|||
130271844|NCT03265145|468957412|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
130271845|NCT03265145|468957413|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
130271846|NCT03265145|468957412|FG000|Overall Study|Switched back to previous medication|1|||
130271847|NCT03265145|468957413|FG001|Overall Study|Switched back to previous medication|0|||
130271848|NCT03265145|468957412|FG000|Overall Study|Did not want to take medication|1|||
130271849|NCT03265145|468957413|FG001|Overall Study|Did not want to take medication|0|||
130271850|NCT03265145|468957412|FG000|Overall Study|Subject could not afford medication|0|||
130271851|NCT03265145|468957413|FG001|Overall Study|Subject could not afford medication|1|||
130271852|NCT03265145|468957412|FG000|Overall Study|Site closed|2|||
130271853|NCT03265145|468957413|FG001|Overall Study|Site closed|3|||
130271854|NCT03265145|468957412|FG000|Overall Study|Incorrectly randomized|16|||
130271855|NCT03265145|468957413|FG001|Overall Study|Incorrectly randomized|6|||
130271856|NCT03265145|468957412|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
130271857|NCT03265145|468957413|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
130271858|NCT03265145|468957412|FG000|Overall Study|Physician Decision|0|||
130271859|NCT03265145|468957413|FG001|Overall Study|Physician Decision|3|||
130271860|NCT03265145|468957412|FG000|Overall Study|Subject transferred to another facility|0|||
130271861|NCT03265145|468957413|FG001|Overall Study|Subject transferred to another facility|1|||
130271862|NCT00283803|468959301|FG000|Overall Study|Physician Decision|9|||
130271863|NCT00283803|468959301|FG000|Overall Study|Withdrawal by Subject|4|||
130271864|NCT01127607|468959302|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
130271865|NCT01127607|468959303|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
130271866|NCT01127607|468959302|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
130271867|NCT01127607|468959303|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
130271868|NCT03640325|468959304|FG000|Overall Study|Withdrawal by Subject|4|||
130271869|NCT03640325|468959305|FG001|Overall Study|Withdrawal by Subject|1|||
130706495|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706496|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706497|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706498|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130271870|NCT03640325|468959306|FG002|Overall Study|Withdrawal by Subject|0|||
130271871|NCT03640325|468959304|FG000|Overall Study|Lost to Follow-up|4|||
130271872|NCT03640325|468959305|FG001|Overall Study|Lost to Follow-up|5|||
130271873|NCT03640325|468959306|FG002|Overall Study|Lost to Follow-up|21|||
130271874|NCT03640325|468959304|FG000|Overall Study|Death|5|||
130271875|NCT03640325|468959305|FG001|Overall Study|Death|5|||
130271876|NCT03640325|468959306|FG002|Overall Study|Death|0|||
130271877|NCT01133756|468959310|FG000|Overall Study|Adverse Event|1|||
130271878|NCT01133756|468959311|FG001|Overall Study|Adverse Event|2|||
130271879|NCT01133756|468959312|FG002|Overall Study|Adverse Event|1|||
130271880|NCT01133756|468959310|FG000|Overall Study|Investigator Decision|1|||
130271881|NCT01133756|468959311|FG001|Overall Study|Investigator Decision|0|||
130554445|NCT01839487|469996607|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
130554446|NCT01839487|469996608|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
130554447|NCT01839487|469996609|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
130554448|NCT01839487|469996610|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
130554449|NCT01839487|469996605|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
130554450|NCT01839487|469996606|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
130554451|NCT01839487|469996607|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
130554452|NCT01839487|469996608|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
130706499|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706500|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
130706501|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706502|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706503|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
130706504|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706505|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130706506|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706507|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706508|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130706509|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706510|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706511|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706512|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706513|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
130706514|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706515|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706516|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706517|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706518|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
130706519|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706520|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706521|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130706522|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130706523|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
130706524|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
130706525|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
130706526|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
130706527|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
130706528|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
130706529|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
130706530|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
130706531|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
130706532|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
130706533|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
130271882|NCT01133756|468959312|FG002|Overall Study|Investigator Decision|0|||
130271883|NCT01133756|468959310|FG000|Overall Study|Withdrawal by Subject|0|||
130271884|NCT01133756|468959311|FG001|Overall Study|Withdrawal by Subject|1|||
130271885|NCT01133756|468959312|FG002|Overall Study|Withdrawal by Subject|0|||
130271886|NCT01133756|468959310|FG000|Overall Study|Progression of Disease|0|||
130271887|NCT01133756|468959311|FG001|Overall Study|Progression of Disease|0|||
130271888|NCT01133756|468959312|FG002|Overall Study|Progression of Disease|1|||
130271889|NCT01566149|468959313|FG000|Overall Study|Adverse Event|0|||
130271890|NCT01566149|468959314|FG001|Overall Study|Adverse Event|1|||
130271891|NCT01566149|468959313|FG000|Overall Study|Non-compliance with study medication|2|||
130271892|NCT01566149|468959314|FG001|Overall Study|Non-compliance with study medication|0|||
130271893|NCT01566149|468959313|FG000|Overall Study|Protocol Violation|0|||
130271894|NCT01566149|468959314|FG001|Overall Study|Protocol Violation|1|||
130271895|NCT01566149|468959313|FG000|Overall Study|Withdrawal by Subject|1|||
130271896|NCT01566149|468959314|FG001|Overall Study|Withdrawal by Subject|0|||
130706534|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
130706535|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
130706536|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
130706537|NCT03253094|470549727|FG000|Overall Study|Adverse Event|2|||
130706538|NCT03253094|470549728|FG001|Overall Study|Adverse Event|0|||
130271897|NCT03276728|468959318|FG000|Overall Study|Lost to Follow-up|0|||
130271898|NCT03276728|468959319|FG001|Overall Study|Lost to Follow-up|0|||
130271899|NCT03276728|468959320|FG002|Overall Study|Lost to Follow-up|2|||
130271900|NCT03276728|468959321|FG003|Overall Study|Lost to Follow-up|2|||
130271901|NCT03276728|468959322|FG004|Overall Study|Lost to Follow-up|0|||
130271902|NCT03276728|468959323|FG005|Overall Study|Lost to Follow-up|0|||
130271903|NCT03276728|468959324|FG006|Overall Study|Lost to Follow-up|0|||
130271904|NCT03276728|468959325|FG007|Overall Study|Lost to Follow-up|0|||
130271905|NCT03276728|468959318|FG000|Overall Study|Withdrawal by Subject|0|||
130271906|NCT03276728|468959319|FG001|Overall Study|Withdrawal by Subject|0|||
130271907|NCT03276728|468959320|FG002|Overall Study|Withdrawal by Subject|0|||
130271908|NCT03276728|468959321|FG003|Overall Study|Withdrawal by Subject|3|||
130271909|NCT03276728|468959322|FG004|Overall Study|Withdrawal by Subject|0|||
130271910|NCT03276728|468959323|FG005|Overall Study|Withdrawal by Subject|0|||
130271911|NCT03276728|468959324|FG006|Overall Study|Withdrawal by Subject|0|||
130271912|NCT03276728|468959325|FG007|Overall Study|Withdrawal by Subject|0|||
130271913|NCT03276728|468959318|FG000|Overall Study|Decision by sponsor|0|||
130271914|NCT03276728|468959319|FG001|Overall Study|Decision by sponsor|0|||
130271915|NCT03276728|468959320|FG002|Overall Study|Decision by sponsor|0|||
130271916|NCT03276728|468959321|FG003|Overall Study|Decision by sponsor|0|||
130271917|NCT03276728|468959322|FG004|Overall Study|Decision by sponsor|1|||
130271918|NCT03276728|468959323|FG005|Overall Study|Decision by sponsor|0|||
130271919|NCT03276728|468959324|FG006|Overall Study|Decision by sponsor|2|||
130271920|NCT03276728|468959325|FG007|Overall Study|Decision by sponsor|1|||
130271921|NCT03941873|468959332|FG000|Overall Study|Death|0|||
130271922|NCT03941873|468959333|FG001|Overall Study|Death|12|||
130271923|NCT03941873|468959334|FG002|Overall Study|Death|2|||
130271924|NCT03941873|468959335|FG003|Overall Study|Death|53|||
130271925|NCT03941873|468959332|FG000|Overall Study|Withdrawal by Subject|1|||
130271926|NCT03941873|468959333|FG001|Overall Study|Withdrawal by Subject|1|||
130271927|NCT03941873|468959334|FG002|Overall Study|Withdrawal by Subject|0|||
130271928|NCT03941873|468959335|FG003|Overall Study|Withdrawal by Subject|5|||
130271929|NCT03941873|468959332|FG000|Overall Study|Lost to Follow-up|1|||
130271930|NCT03941873|468959333|FG001|Overall Study|Lost to Follow-up|2|||
130271931|NCT03941873|468959334|FG002|Overall Study|Lost to Follow-up|0|||
130271932|NCT03941873|468959335|FG003|Overall Study|Lost to Follow-up|0|||
130271933|NCT03941873|468959332|FG000|Overall Study|Sponsor Decision|0|||
130271934|NCT03941873|468959333|FG001|Overall Study|Sponsor Decision|6|||
130271935|NCT03941873|468959334|FG002|Overall Study|Sponsor Decision|0|||
130271936|NCT03941873|468959335|FG003|Overall Study|Sponsor Decision|15|||
130271937|NCT02982772|468959338|FG000|Intervention|Lost to Follow-up|19|||
130271938|NCT02982772|468959339|FG001|Intervention|Lost to Follow-up|13|||
130271939|NCT02982772|468959338|FG000|1M Follow-Up|Lost to Follow-up|21|||
130271940|NCT02982772|468959339|FG001|1M Follow-Up|Lost to Follow-up|18|||
130271941|NCT02982772|468959338|FG000|3M Follow-Up|Lost to Follow-up|17|||
130271942|NCT02982772|468959339|FG001|3M Follow-Up|Lost to Follow-up|11|||
130271943|NCT02982772|468959338|FG000|6M Follow-Up|Lost to Follow-up|11|||
130271944|NCT02982772|468959339|FG001|6M Follow-Up|Lost to Follow-up|9|||
130271945|NCT02982772|468959338|FG000|12M Follow-Up|Lost to Follow-up|11|||
130271946|NCT02982772|468959339|FG001|12M Follow-Up|Lost to Follow-up|5|||
130271947|NCT01234480|468959340|FG000|Overall Study|Pregnancy|88|||
130271948|NCT01234480|468959340|FG000|Overall Study|>36/Normal History|50|||
130271949|NCT01234480|468959340|FG000|Overall Study|Age|3|||
130271950|NCT01234480|468959340|FG000|Overall Study|HPV Vaccine History|28|||
130706539|NCT03253094|470549729|FG002|Overall Study|Adverse Event|0|||
130706540|NCT03253094|470549730|FG003|Overall Study|Adverse Event|0|||
130706541|NCT03253094|470549731|FG004|Overall Study|Adverse Event|0|||
130271951|NCT01234480|468959340|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
130271952|NCT01234480|468959340|FG000|Overall Study|Hysterectomy|2|||
130706542|NCT03253094|470549732|FG005|Overall Study|Adverse Event|0|||
130271953|NCT01234480|468959340|FG000|Overall Study|Hysterectomy post enrollment|1|||
130271954|NCT01234480|468959340|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
130271955|NCT01234480|468959340|FG000|Overall Study|Informed Consent Form Violation|30|||
130271956|NCT01234480|468959340|FG000|Overall Study|Incorrect Visit|3|||
130271957|NCT01234480|468959340|FG000|Overall Study|No Florida Lab License|20|||
130271958|NCT01234480|468959340|FG000|Overall Study|Out of Window|42|||
130271959|NCT01234480|468959340|FG000|Overall Study|Sample Processing/Storage|92|||
130271960|NCT01234480|468959340|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
130271961|NCT01234480|468959340|FG000|Overall Study|Site/Subject non-compliance|44|||
130271962|NCT01234480|468959340|FG000|Overall Study|Missing Sample|9|||
130271963|NCT02974140|468959341|FG000|Overall Study|Adverse Event|2|||
130706543|NCT03253094|470549727|FG000|Overall Study|Lack of Efficacy|0|||
130706544|NCT03253094|470549728|FG001|Overall Study|Lack of Efficacy|0|||
130706545|NCT03253094|470549729|FG002|Overall Study|Lack of Efficacy|2|||
130706546|NCT03253094|470549730|FG003|Overall Study|Lack of Efficacy|1|||
130456155|NCT03357341|469634840|FG001|Overall Study|Withdrawal by Subject|6|||
130456156|NCT03357341|469634839|FG000|Overall Study|Lost to Follow-up|4|||
130456157|NCT03357341|469634840|FG001|Overall Study|Lost to Follow-up|5|||
130456158|NCT03357341|469634839|FG000|Overall Study|Death|0|||
130456159|NCT03357341|469634840|FG001|Overall Study|Death|1|||
130456160|NCT00918957|469634841|FG000|Overall Study|Adverse Event|2|||
130456161|NCT00918957|469634842|FG001|Overall Study|Adverse Event|0|||
130456162|NCT00918957|469634841|FG000|Overall Study|Withdrawal by Subject|1|||
130456163|NCT00918957|469634842|FG001|Overall Study|Withdrawal by Subject|0|||
130456164|NCT03670602|469634851|FG000|Overall Study|Lost to Follow-up|1|||
130456165|NCT03670602|469634852|FG001|Overall Study|Lost to Follow-up|0|||
130456166|NCT03670602|469634851|FG000|Overall Study|Withdrawal by Subject|0|||
130456167|NCT03670602|469634852|FG001|Overall Study|Withdrawal by Subject|3|||
130456168|NCT00543725|469634853|FG000|Overall Study|Adverse Event|18|||
130456169|NCT00543725|469634854|FG001|Overall Study|Adverse Event|27|||
130456170|NCT00543725|469634853|FG000|Overall Study|Sponsor's Decision|0|||
130456171|NCT00543725|469634854|FG001|Overall Study|Sponsor's Decision|1|||
130706547|NCT03253094|470549731|FG004|Overall Study|Lack of Efficacy|2|||
130706548|NCT03253094|470549732|FG005|Overall Study|Lack of Efficacy|1|||
130706549|NCT03253094|470549727|FG000|Overall Study|Lost to Follow-up|0|||
130706550|NCT03253094|470549728|FG001|Overall Study|Lost to Follow-up|0|||
130706551|NCT03253094|470549729|FG002|Overall Study|Lost to Follow-up|1|||
130706552|NCT03253094|470549730|FG003|Overall Study|Lost to Follow-up|1|||
130706553|NCT03253094|470549731|FG004|Overall Study|Lost to Follow-up|0|||
130706554|NCT03253094|470549732|FG005|Overall Study|Lost to Follow-up|1|||
130706555|NCT03253094|470549727|FG000|Overall Study|Physician Decision|1|||
130706556|NCT03253094|470549728|FG001|Overall Study|Physician Decision|0|||
130706557|NCT03253094|470549729|FG002|Overall Study|Physician Decision|0|||
130271964|NCT02974140|468959341|FG000|Overall Study|Lost to Follow-up|1|||
130271965|NCT02974140|468959341|FG000|Overall Study|Study Terminated by Sponsor|36|||
130271966|NCT00617084|468959342|FG000|Overall Study|Withdrawal by Subject|5|||
130271967|NCT00617084|468959343|FG001|Overall Study|Withdrawal by Subject|7|||
130271968|NCT00617084|468959342|FG000|Overall Study|Missed 12 Months visit|16|||
130271969|NCT00617084|468959343|FG001|Overall Study|Missed 12 Months visit|19|||
130271970|NCT02522429|468959344|FG000|Overall Study|Lost to Follow-up|8|||
130271971|NCT02522429|468959344|FG000|Overall Study|Adverse Event|2|||
130271972|NCT02522429|468959344|FG000|Overall Study|Death|1|||
130271973|NCT02522429|468959344|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
130271974|NCT01521923|468959350|FG000|Overall Study|AE, serious fatal|1|||
130271975|NCT01521923|468959351|FG001|Overall Study|AE, serious fatal|0|||
130271976|NCT01521923|468959352|FG002|Overall Study|AE, serious fatal|0|||
130271977|NCT01521923|468959353|FG003|Overall Study|AE, serious fatal|0|||
130271978|NCT01521923|468959350|FG000|Overall Study|SAE, non-fatal|0|||
130271979|NCT01521923|468959351|FG001|Overall Study|SAE, non-fatal|2|||
130271980|NCT01521923|468959352|FG002|Overall Study|SAE, non-fatal|2|||
130271981|NCT01521923|468959353|FG003|Overall Study|SAE, non-fatal|0|||
130271982|NCT01521923|468959350|FG000|Overall Study|AE, non-serious, non-fatal|1|||
130271983|NCT01521923|468959351|FG001|Overall Study|AE, non-serious, non-fatal|3|||
130271984|NCT01521923|468959352|FG002|Overall Study|AE, non-serious, non-fatal|6|||
130271985|NCT01521923|468959353|FG003|Overall Study|AE, non-serious, non-fatal|2|||
130271986|NCT01521923|468959350|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271987|NCT01521923|468959351|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271988|NCT01521923|468959352|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271989|NCT01521923|468959353|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
130271990|NCT01521923|468959350|FG000|Overall Study|Lack of Efficacy|1|||
130456172|NCT00543725|469634853|FG000|Overall Study|Subject Non-Compliant|4|||
130271991|NCT01521923|468959351|FG001|Overall Study|Lack of Efficacy|1|||
130271992|NCT01521923|468959352|FG002|Overall Study|Lack of Efficacy|0|||
130456173|NCT00543725|469634854|FG001|Overall Study|Subject Non-Compliant|4|||
130456174|NCT00543725|469634853|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
130456175|NCT00543725|469634854|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
130706558|NCT03253094|470549730|FG003|Overall Study|Physician Decision|1|||
130271993|NCT01521923|468959353|FG003|Overall Study|Lack of Efficacy|0|||
130271994|NCT01521923|468959350|FG000|Overall Study|Protocol Violation|0|||
130456176|NCT00543725|469634853|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
130706559|NCT03253094|470549731|FG004|Overall Study|Physician Decision|0|||
130706560|NCT03253094|470549732|FG005|Overall Study|Physician Decision|2|||
130706561|NCT03253094|470549727|FG000|Overall Study|Withdrawal by Subject|1|||
130271995|NCT01521923|468959351|FG001|Overall Study|Protocol Violation|0|||
130271996|NCT01521923|468959352|FG002|Overall Study|Protocol Violation|1|||
130706562|NCT03253094|470549728|FG001|Overall Study|Withdrawal by Subject|2|||
130271997|NCT01521923|468959353|FG003|Overall Study|Protocol Violation|0|||
130271998|NCT01521923|468959350|FG000|Overall Study|Lost to Follow-up|1|||
130271999|NCT01521923|468959351|FG001|Overall Study|Lost to Follow-up|0|||
130272000|NCT01521923|468959352|FG002|Overall Study|Lost to Follow-up|2|||
130272001|NCT01521923|468959353|FG003|Overall Study|Lost to Follow-up|1|||
130272002|NCT01521923|468959350|FG000|Overall Study|Withdrawal by Subject|1|||
130272003|NCT01521923|468959351|FG001|Overall Study|Withdrawal by Subject|1|||
130272004|NCT01521923|468959352|FG002|Overall Study|Withdrawal by Subject|1|||
130272005|NCT01521923|468959353|FG003|Overall Study|Withdrawal by Subject|2|||
130272006|NCT01521923|468959350|FG000|Overall Study|Other|2|||
130272007|NCT01521923|468959351|FG001|Overall Study|Other|1|||
130272008|NCT01521923|468959352|FG002|Overall Study|Other|3|||
130272009|NCT01521923|468959353|FG003|Overall Study|Other|6|||
130272010|NCT01521923|468959350|FG000|Overall Study|AE, captured in Period 1|0|||
130272011|NCT01521923|468959351|FG001|Overall Study|AE, captured in Period 1|1|||
130272012|NCT01521923|468959352|FG002|Overall Study|AE, captured in Period 1|0|||
130272013|NCT01521923|468959353|FG003|Overall Study|AE, captured in Period 1|1|||
130272014|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
130272015|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
130272016|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
130272017|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130272018|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
130272019|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130272020|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130272021|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130272022|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
130272023|NCT01582009|468959357|FG000|Overall Study|Withdrawal by Subject|1|||
130272024|NCT01582009|468959357|FG000|Overall Study|Physician Decision|1|||
130272025|NCT01665911|468959358|FG000|Overall Study|Protocol Violation|4|||
130272026|NCT01665911|468959358|FG000|Overall Study|Withdrawal by Subject|1|||
130272027|NCT01665911|468959358|FG000|Overall Study|Adverse Event|1|||
130272028|NCT00735553|468959359|FG000|Overall Study|Study prematurely terminated|77|||
130272029|NCT03726658|468959365|FG000|Overall Study|Lost to Follow-up|0|||
130272030|NCT03726658|468959366|FG001|Overall Study|Lost to Follow-up|0|||
130272031|NCT03726658|468959367|FG002|Overall Study|Lost to Follow-up|2|||
130272032|NCT03726658|468959368|FG003|Overall Study|Lost to Follow-up|0|||
130272033|NCT03726658|468959369|FG004|Overall Study|Lost to Follow-up|0|||
130272034|NCT03726658|468959370|FG005|Overall Study|Lost to Follow-up|1|||
130272035|NCT03726658|468959371|FG006|Overall Study|Lost to Follow-up|1|||
130272036|NCT03726658|468959365|FG000|Overall Study|Withdrawal by Subject|1|||
130272037|NCT03726658|468959366|FG001|Overall Study|Withdrawal by Subject|0|||
130272038|NCT03726658|468959367|FG002|Overall Study|Withdrawal by Subject|0|||
130272039|NCT03726658|468959368|FG003|Overall Study|Withdrawal by Subject|0|||
130272040|NCT03726658|468959369|FG004|Overall Study|Withdrawal by Subject|6|||
130272041|NCT03726658|468959370|FG005|Overall Study|Withdrawal by Subject|4|||
130272042|NCT03726658|468959371|FG006|Overall Study|Withdrawal by Subject|2|||
130272043|NCT03726658|468959365|FG000|Overall Study|Pregnancy|0|||
130272044|NCT03726658|468959366|FG001|Overall Study|Pregnancy|0|||
130272045|NCT03726658|468959367|FG002|Overall Study|Pregnancy|0|||
130272046|NCT03726658|468959368|FG003|Overall Study|Pregnancy|0|||
130272047|NCT03726658|468959369|FG004|Overall Study|Pregnancy|0|||
130272048|NCT03726658|468959370|FG005|Overall Study|Pregnancy|0|||
130272049|NCT03726658|468959371|FG006|Overall Study|Pregnancy|1|||
130272050|NCT03726658|468959365|FG000|Overall Study|Not Reported|0|||
130272051|NCT03726658|468959366|FG001|Overall Study|Not Reported|0|||
130272052|NCT03726658|468959367|FG002|Overall Study|Not Reported|0|||
130272053|NCT03726658|468959368|FG003|Overall Study|Not Reported|0|||
130272054|NCT03726658|468959369|FG004|Overall Study|Not Reported|0|||
130272055|NCT03726658|468959370|FG005|Overall Study|Not Reported|0|||
130272056|NCT03726658|468959371|FG006|Overall Study|Not Reported|1|||
130272057|NCT01318135|468959372|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130272058|NCT01318135|468959373|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272059|NCT01318135|468959374|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272060|NCT01318135|468959375|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130366970|NCT02935842|469314092|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
130366971|NCT02935842|469314089|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
130366972|NCT02935842|469314090|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
130366973|NCT02935842|469314091|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
130366974|NCT02935842|469314092|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
130366975|NCT02935842|469314089|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
130366976|NCT02935842|469314090|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
130366977|NCT02935842|469314091|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
130272061|NCT01318135|468959376|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272062|NCT01318135|468959377|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272063|NCT01318135|468959378|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130706563|NCT03253094|470549729|FG002|Overall Study|Withdrawal by Subject|1|||
130706564|NCT03253094|470549730|FG003|Overall Study|Withdrawal by Subject|0|||
130706565|NCT03253094|470549731|FG004|Overall Study|Withdrawal by Subject|3|||
130706566|NCT03253094|470549732|FG005|Overall Study|Withdrawal by Subject|0|||
130706567|NCT03253094|470549727|FG000|Overall Study|Other|0|||
130706568|NCT03253094|470549728|FG001|Overall Study|Other|1|||
130456177|NCT00543725|469634854|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
130456178|NCT00543725|469634853|FG000|Overall Study|Protocol Violation|0|||
130456179|NCT00543725|469634854|FG001|Overall Study|Protocol Violation|1|||
130706569|NCT03253094|470549729|FG002|Overall Study|Other|2|||
130706570|NCT03253094|470549730|FG003|Overall Study|Other|1|||
130706571|NCT03253094|470549731|FG004|Overall Study|Other|0|||
130706572|NCT03253094|470549732|FG005|Overall Study|Other|0|||
130706573|NCT02339090|470549733|FG000|Overall Study|Adverse Event|1|||
130706574|NCT02339090|470549734|FG001|Overall Study|Adverse Event|0|||
130706575|NCT02339090|470549733|FG000|Overall Study|Lost to Follow-up|0|||
130706576|NCT02339090|470549734|FG001|Overall Study|Lost to Follow-up|1|||
130706577|NCT02339090|470549733|FG000|Overall Study|Non-compliance With Study Drug|0|||
130706578|NCT02339090|470549734|FG001|Overall Study|Non-compliance With Study Drug|1|||
130706579|NCT02339090|470549733|FG000|Overall Study|Withdrawal by Subject|2|||
130706580|NCT02339090|470549734|FG001|Overall Study|Withdrawal by Subject|1|||
130706581|NCT02339090|470549733|FG000|Overall Study|Poor Growth|3|||
130706582|NCT02339090|470549734|FG001|Overall Study|Poor Growth|0|||
130706583|NCT02339090|470549733|FG000|Overall Study|Randomized but not treated|0|||
130706584|NCT02339090|470549734|FG001|Overall Study|Randomized but not treated|2|||
130706585|NCT02737592|470549737|FG000|Overall Study|Withdrawal by Subject|1|||
130456180|NCT00543725|469634853|FG000|Overall Study|Withdrawal by Subject|4|||
130456181|NCT00543725|469634854|FG001|Overall Study|Withdrawal by Subject|13|||
130456182|NCT00543725|469634853|FG000|Overall Study|Lost to Follow-up|15|||
130456183|NCT00543725|469634854|FG001|Overall Study|Lost to Follow-up|11|||
130456184|NCT00543725|469634853|FG000|Overall Study|Other|3|||
130456185|NCT00543725|469634854|FG001|Overall Study|Other|3|||
130456186|NCT00906698|469634855|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
130456187|NCT00906698|469634856|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
130456188|NCT00906698|469634857|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
130706586|NCT00576303|470549738|FG000|Dose Titration Period|Early withdrawal|17|||
130456189|NCT00906698|469634858|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
130706587|NCT00576303|470549738|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
130706588|NCT00576303|470549738|FG000|Long Term Safety Period|Early withdrawal|16|||
130706589|NCT00955721|470549739|FG000|Overall Study|Physician Decision|1|||
130706590|NCT00955721|470549740|FG001|Overall Study|Physician Decision|0|||
130706591|NCT00955721|470549739|FG000|Overall Study|Death|1|||
130706592|NCT00955721|470549740|FG001|Overall Study|Death|0|||
130706593|NCT00955721|470549739|FG000|Overall Study|Withdrawal by Subject|1|||
130272064|NCT01318135|468959379|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272065|NCT01318135|468959372|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
130272066|NCT01318135|468959373|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272067|NCT01318135|468959374|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272068|NCT01318135|468959375|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272069|NCT01318135|468959376|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272070|NCT01318135|468959377|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272071|NCT01318135|468959378|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272072|NCT01318135|468959379|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272073|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
130272074|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
130272075|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
130272076|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
130272077|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
130272078|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
130272079|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
130272080|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
130272081|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272082|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272083|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272084|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272085|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272086|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272087|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272088|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272089|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272090|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272091|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272092|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130272093|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272094|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130272095|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130272096|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130272097|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
130272098|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
130272099|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272100|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
130272101|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272102|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272103|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130272104|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130272105|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272106|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272107|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272108|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272109|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272110|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272111|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272112|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
130272113|NCT00090779|468959380|FG000|Step 1|Withdrawal by Subject|4|||
130272114|NCT00090779|468959381|FG001|Step 1|Withdrawal by Subject|2|||
130272115|NCT00090779|468959380|FG000|Step 1|Lost to Follow-up|3|||
130272116|NCT00090779|468959381|FG001|Step 1|Lost to Follow-up|2|||
130272117|NCT00090779|468959380|FG000|Step 1|Death|0|||
130272118|NCT00090779|468959381|FG001|Step 1|Death|2|||
130272119|NCT00090779|468959380|FG000|Step 1|Physician Decision|1|||
130272120|NCT00090779|468959381|FG001|Step 1|Physician Decision|0|||
130366978|NCT02935842|469314092|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
130272121|NCT00090779|468959380|FG000|Step 1|Pregnancy|1|||
130366979|NCT02935842|469314089|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130366980|NCT02935842|469314090|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130366981|NCT02935842|469314091|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
130366982|NCT02935842|469314092|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130272122|NCT00090779|468959381|FG001|Step 1|Pregnancy|0|||
130272123|NCT00090779|468959380|FG000|Step 1|Non-compliance to study requirements|0|||
130272124|NCT00090779|468959381|FG001|Step 1|Non-compliance to study requirements|1|||
130272125|NCT00090779|468959380|FG000|Step 1|Subject relocated|2|||
130366983|NCT00911547|469314093|FG000|Overall Study|Adverse Event|8|||
130366984|NCT00911547|469314094|FG001|Overall Study|Adverse Event|27|||
130366985|NCT00911547|469314095|FG002|Overall Study|Adverse Event|11|||
130366986|NCT00911547|469314096|FG003|Overall Study|Adverse Event|6|||
130366987|NCT00911547|469314093|FG000|Overall Study|Lost to Follow-up|0|||
130366988|NCT00911547|469314094|FG001|Overall Study|Lost to Follow-up|0|||
130366989|NCT00911547|469314095|FG002|Overall Study|Lost to Follow-up|2|||
130366990|NCT00911547|469314096|FG003|Overall Study|Lost to Follow-up|1|||
130366991|NCT00911547|469314093|FG000|Overall Study|Protocol Violation|0|||
130366992|NCT00911547|469314094|FG001|Overall Study|Protocol Violation|5|||
130456190|NCT00906698|469634859|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
130456191|NCT00906698|469634860|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
130456192|NCT00906698|469634855|FG000|Overall Study|Adverse Event|0|||
130456193|NCT00906698|469634856|FG001|Overall Study|Adverse Event|0|||
130456194|NCT00906698|469634857|FG002|Overall Study|Adverse Event|2|||
130456195|NCT00906698|469634858|FG003|Overall Study|Adverse Event|0|||
130456196|NCT00906698|469634859|FG004|Overall Study|Adverse Event|4|||
130456197|NCT00906698|469634860|FG005|Overall Study|Adverse Event|1|||
130456198|NCT00906698|469634855|FG000|Overall Study|Disease progression|3|||
130456199|NCT00906698|469634856|FG001|Overall Study|Disease progression|12|||
130456200|NCT00906698|469634857|FG002|Overall Study|Disease progression|4|||
130456201|NCT00906698|469634858|FG003|Overall Study|Disease progression|4|||
130456202|NCT00906698|469634859|FG004|Overall Study|Disease progression|12|||
130456203|NCT00906698|469634860|FG005|Overall Study|Disease progression|4|||
130456204|NCT00906698|469634855|FG000|Overall Study|Withdrawal by Subject|0|||
130456205|NCT00906698|469634856|FG001|Overall Study|Withdrawal by Subject|0|||
130456206|NCT00906698|469634857|FG002|Overall Study|Withdrawal by Subject|0|||
130456207|NCT00906698|469634858|FG003|Overall Study|Withdrawal by Subject|0|||
130456208|NCT00906698|469634859|FG004|Overall Study|Withdrawal by Subject|1|||
130456209|NCT00906698|469634860|FG005|Overall Study|Withdrawal by Subject|0|||
130456210|NCT00906698|469634855|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
130456211|NCT00906698|469634856|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
130456212|NCT00906698|469634857|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
130456213|NCT00906698|469634858|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
130706594|NCT00955721|470549740|FG001|Overall Study|Withdrawal by Subject|0|||
130706595|NCT00749411|470549744|FG000|Overall Study|Adverse Event|0|||
130706596|NCT00749411|470549745|FG001|Overall Study|Adverse Event|2|||
130706597|NCT00749411|470549744|FG000|Overall Study|Lack of Efficacy|0|||
130706598|NCT00749411|470549745|FG001|Overall Study|Lack of Efficacy|1|||
130706599|NCT00749411|470549744|FG000|Overall Study|Protocol Violation|1|||
130706600|NCT00749411|470549745|FG001|Overall Study|Protocol Violation|1|||
130706601|NCT00749411|470549744|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130706602|NCT00749411|470549745|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130706603|NCT03183141|470549747|FG000|Overall Study|Withdrawal by Subject|2|||
130706604|NCT03183141|470549748|FG001|Overall Study|Withdrawal by Subject|4|||
130706605|NCT03183141|470549747|FG000|Overall Study|Death|0|||
130706606|NCT03183141|470549748|FG001|Overall Study|Death|8|||
130706607|NCT02756637|470549750|FG000|Overall Study|Not eligible for initial SWOG study|10|||
130706608|NCT02756637|470549751|FG001|Overall Study|Not eligible for initial SWOG study|10|||
130366993|NCT00911547|469314095|FG002|Overall Study|Protocol Violation|5|||
130366994|NCT00911547|469314096|FG003|Overall Study|Protocol Violation|1|||
130456214|NCT00906698|469634859|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
130456215|NCT00906698|469634860|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
130456216|NCT03095508|469634861|FG000|Overall Study|Adverse Event|0|||
130456217|NCT03095508|469634862|FG001|Overall Study|Adverse Event|1|||
130456218|NCT02846415|469634864|FG000|Overall Study|Lost to Follow-up|2|||
130456219|NCT02846415|469634865|FG001|Overall Study|Lost to Follow-up|0|||
130706609|NCT02756637|470549750|FG000|Overall Study|No available NLR value|44|||
130706610|NCT02756637|470549751|FG001|Overall Study|No available NLR value|44|||
130706611|NCT02756637|470549750|FG000|Overall Study|Did not complete curative therapy|33|||
130706612|NCT02756637|470549751|FG001|Overall Study|Did not complete curative therapy|0|||
130706613|NCT04034355|470549752|FG000|Overall Study|Study terminated by Sponsor|10|||
130706614|NCT04034355|470549753|FG001|Overall Study|Study terminated by Sponsor|17|||
130272126|NCT00090779|468959381|FG001|Step 1|Subject relocated|8|||
130272127|NCT00090779|468959380|FG000|Step 2|Off study per study closure|6|||
130272128|NCT00090779|468959381|FG001|Step 2|Off study per study closure|16|||
130272129|NCT00090779|468959380|FG000|Step 2|Subject relocated|0|||
130272130|NCT00090779|468959381|FG001|Step 2|Subject relocated|1|||
130272131|NCT00090779|468959380|FG000|Step 2|Non-compliance to study requirements|0|||
130272132|NCT00090779|468959381|FG001|Step 2|Non-compliance to study requirements|1|||
130272133|NCT00090779|468959380|FG000|Step 3|Initiation of ART and off extended study|3|||
130272134|NCT00090779|468959381|FG001|Step 3|Initiation of ART and off extended study|2|||
130272135|NCT00090779|468959380|FG000|Step 3|Off extended study due to study closure|4|||
130272136|NCT00090779|468959381|FG001|Step 3|Off extended study due to study closure|3|||
130272137|NCT01775553|468959386|FG000|Overall Study|Adverse Event|1|||
130272138|NCT01775553|468959386|FG000|Overall Study|Disease Progression|12|||
130272139|NCT00988052|468959387|FG000|Overall Study|Missing|1|||
130272140|NCT00988052|468959388|FG001|Overall Study|Missing|0|||
130272141|NCT00988052|468959387|FG000|Overall Study|Teva requested subject withdrawal|3|||
130272142|NCT00988052|468959388|FG001|Overall Study|Teva requested subject withdrawal|1|||
130456220|NCT02846415|469634864|FG000|Overall Study|Withdrawal by Subject|1|||
130456221|NCT02846415|469634865|FG001|Overall Study|Withdrawal by Subject|1|||
130456222|NCT03383887|469634866|FG000|Overall Study|Lost to Follow-up|0|||
130456223|NCT03383887|469634867|FG001|Overall Study|Lost to Follow-up|1|||
130456224|NCT00831792|469634868|FG000|Overall Study|Not Eligible|3|||
130456225|NCT00831792|469634868|FG000|Overall Study|Adverse Event|1|||
130456226|NCT00831792|469634868|FG000|Overall Study|Death|1|||
130456227|NCT00831792|469634868|FG000|Overall Study|Lack of Efficacy|1|||
130456228|NCT01242085|469634871|FG000|Overall Study|Withdrawal by Subject|4|||
130456229|NCT01242085|469634872|FG001|Overall Study|Withdrawal by Subject|2|||
130456230|NCT01242085|469634873|FG002|Overall Study|Withdrawal by Subject|0|||
130456231|NCT01242085|469634871|FG000|Overall Study|medically unable to have surgery|4|||
130456232|NCT01242085|469634872|FG001|Overall Study|medically unable to have surgery|5|||
130456233|NCT01242085|469634873|FG002|Overall Study|medically unable to have surgery|0|||
130456234|NCT01651949|469634878|FG000|Overall Study|Unknown status|4|||
130456235|NCT01651949|469634879|FG001|Overall Study|Unknown status|4|||
130456236|NCT01651949|469634880|FG002|Overall Study|Unknown status|0|||
130456237|NCT01651949|469634878|FG000|Overall Study|Lost to Follow-up|30|||
130456238|NCT01651949|469634879|FG001|Overall Study|Lost to Follow-up|56|||
130456239|NCT01651949|469634880|FG002|Overall Study|Lost to Follow-up|20|||
130456240|NCT01651949|469634878|FG000|Overall Study|Protocol Violation|0|||
130456241|NCT01651949|469634879|FG001|Overall Study|Protocol Violation|2|||
130456242|NCT01651949|469634880|FG002|Overall Study|Protocol Violation|1|||
130456243|NCT01651949|469634878|FG000|Overall Study|Physician Decision|0|||
130456244|NCT01651949|469634879|FG001|Overall Study|Physician Decision|2|||
130456245|NCT01651949|469634880|FG002|Overall Study|Physician Decision|0|||
130456246|NCT01651949|469634878|FG000|Overall Study|Adverse Event|0|||
130456247|NCT01651949|469634879|FG001|Overall Study|Adverse Event|2|||
130456248|NCT01651949|469634880|FG002|Overall Study|Adverse Event|1|||
130272143|NCT00988052|468959387|FG000|Overall Study|Death|1|||
130456249|NCT01651949|469634878|FG000|Overall Study|Screen failure|2|||
130456250|NCT01651949|469634879|FG001|Overall Study|Screen failure|2|||
130456251|NCT01651949|469634880|FG002|Overall Study|Screen failure|0|||
130456252|NCT01651949|469634878|FG000|Overall Study|Withdrawal by Subject|17|||
130456253|NCT01651949|469634879|FG001|Overall Study|Withdrawal by Subject|18|||
130456254|NCT01651949|469634880|FG002|Overall Study|Withdrawal by Subject|9|||
130456255|NCT01806714|469634881|FG000|Overall Study|No functioning phone number|200|||
130456256|NCT01806714|469634882|FG001|Overall Study|No functioning phone number|170|||
130456257|NCT02469064|469634883|FG000|Overall Study|Request not to receive intervention.|1|||
130272144|NCT00988052|468959388|FG001|Overall Study|Death|3|||
130272145|NCT00988052|468959387|FG000|Overall Study|Protocol Violation|6|||
130272146|NCT00988052|468959388|FG001|Overall Study|Protocol Violation|5|||
130272147|NCT00988052|468959387|FG000|Overall Study|Pregnancy|6|||
130272148|NCT00988052|468959388|FG001|Overall Study|Pregnancy|6|||
130272149|NCT00988052|468959387|FG000|Overall Study|Lack of Efficacy|8|||
130272150|NCT00988052|468959388|FG001|Overall Study|Lack of Efficacy|7|||
130272151|NCT00988052|468959387|FG000|Overall Study|Lost to Follow-up|6|||
130272152|NCT00988052|468959388|FG001|Overall Study|Lost to Follow-up|11|||
130272153|NCT00988052|468959387|FG000|Overall Study|Physician Decision|27|||
130272154|NCT00988052|468959388|FG001|Overall Study|Physician Decision|28|||
130272155|NCT00988052|468959387|FG000|Overall Study|Adverse Event|35|||
130272156|NCT00988052|468959388|FG001|Overall Study|Adverse Event|28|||
130272157|NCT00988052|468959387|FG000|Overall Study|Withdrawal by Subject|90|||
130272158|NCT00988052|468959388|FG001|Overall Study|Withdrawal by Subject|91|||
130272159|NCT00988052|468959387|FG000|Overall Study|Study terminated by sponsor|240|||
130272160|NCT00988052|468959388|FG001|Overall Study|Study terminated by sponsor|236|||
130272161|NCT01523743|468959389|FG000|Period 1|Adverse Event|1|||
130272162|NCT01523743|468959390|FG001|Period 1|Adverse Event|0|||
130272163|NCT01523743|468959389|FG000|Period 1|Withdrawal by Subject|6|||
130272164|NCT01523743|468959390|FG001|Period 1|Withdrawal by Subject|2|||
130272165|NCT01523743|468959389|FG000|Period 1|Lost to Follow-up|1|||
130272166|NCT01523743|468959390|FG001|Period 1|Lost to Follow-up|0|||
130272167|NCT01523743|468959389|FG000|Period 1|Lack of Efficacy|1|||
130272168|NCT01523743|468959390|FG001|Period 1|Lack of Efficacy|0|||
130366995|NCT00911547|469314093|FG000|Overall Study|Withdrawal by Subject|3|||
130366996|NCT00911547|469314094|FG001|Overall Study|Withdrawal by Subject|10|||
130366997|NCT00911547|469314095|FG002|Overall Study|Withdrawal by Subject|4|||
130366998|NCT00911547|469314096|FG003|Overall Study|Withdrawal by Subject|8|||
130366999|NCT01201785|469314097|FG000|Overall Study|Lost to Follow-up|16|||
130367000|NCT04545385|469314100|FG000|Overall Study|Withdrawal by Subject|2|||
130367001|NCT04545385|469314101|FG001|Overall Study|Withdrawal by Subject|0|||
130367002|NCT04545385|469314100|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
130367003|NCT04545385|469314101|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
130367004|NCT04545385|469314100|FG000|Overall Study|Study termination|10|||
130367005|NCT04545385|469314101|FG001|Overall Study|Study termination|10|||
130367006|NCT04545385|469314100|FG000|Overall Study|Sponsor decision|2|||
130367007|NCT04545385|469314101|FG001|Overall Study|Sponsor decision|2|||
130367008|NCT04545385|469314100|FG000|Overall Study|Other than specified|1|||
130367009|NCT04545385|469314101|FG001|Overall Study|Other than specified|0|||
130367010|NCT00915278|469314102|FG000|Overall Study|Death|1|||
130367011|NCT00915278|469314103|FG001|Overall Study|Death|0|||
130367012|NCT00915278|469314104|FG002|Overall Study|Death|0|||
130367013|NCT00915278|469314105|FG003|Overall Study|Death|0|||
130367014|NCT00915278|469314106|FG004|Overall Study|Death|0|||
130367015|NCT00915278|469314107|FG005|Overall Study|Death|0|||
130367016|NCT00915278|469314102|FG000|Overall Study|Lost to Follow-up|0|||
130367017|NCT00915278|469314103|FG001|Overall Study|Lost to Follow-up|1|||
130367018|NCT00915278|469314104|FG002|Overall Study|Lost to Follow-up|0|||
130367019|NCT00915278|469314105|FG003|Overall Study|Lost to Follow-up|0|||
130367020|NCT00915278|469314106|FG004|Overall Study|Lost to Follow-up|0|||
130367021|NCT00915278|469314107|FG005|Overall Study|Lost to Follow-up|0|||
130367022|NCT00915278|469314102|FG000|Overall Study|Withdrawal by Subject|0|||
130367023|NCT00915278|469314103|FG001|Overall Study|Withdrawal by Subject|1|||
130367024|NCT00915278|469314104|FG002|Overall Study|Withdrawal by Subject|0|||
130367025|NCT00915278|469314105|FG003|Overall Study|Withdrawal by Subject|0|||
130367026|NCT00915278|469314106|FG004|Overall Study|Withdrawal by Subject|1|||
130367027|NCT00915278|469314107|FG005|Overall Study|Withdrawal by Subject|4|||
130367028|NCT00915278|469314102|FG000|Overall Study|Adverse Event|4|||
130456258|NCT02469064|469634884|FG001|Overall Study|Request not to receive intervention.|3|||
130456259|NCT02155829|469634885|FG000|Overall Study|Adverse Event|1|||
130456260|NCT02155829|469634886|FG001|Overall Study|Adverse Event|0|||
130456261|NCT02155829|469634885|FG000|Overall Study|Withdrawal by Subject|3|||
130456262|NCT02155829|469634886|FG001|Overall Study|Withdrawal by Subject|3|||
130272169|NCT01523743|468959389|FG000|Period 1|Felt unable to empty bladder|1|||
130272170|NCT01523743|468959390|FG001|Period 1|Felt unable to empty bladder|0|||
130272171|NCT01523743|468959389|FG000|Period 2|Withdrawal by Subject|0|||
130367029|NCT00915278|469314103|FG001|Overall Study|Adverse Event|1|||
130367030|NCT00915278|469314104|FG002|Overall Study|Adverse Event|0|||
130456263|NCT02155829|469634885|FG000|Overall Study|Protocol Violation|2|||
130272172|NCT01523743|468959390|FG001|Period 2|Withdrawal by Subject|2|||
130367031|NCT00915278|469314105|FG003|Overall Study|Adverse Event|0|||
130367032|NCT00915278|469314106|FG004|Overall Study|Adverse Event|0|||
130367033|NCT00915278|469314107|FG005|Overall Study|Adverse Event|0|||
130554453|NCT01839487|469996609|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
130272173|NCT01523743|468959389|FG000|Period 2|Adverse Event|1|||
130272174|NCT01523743|468959390|FG001|Period 2|Adverse Event|0|||
130272175|NCT02569476|468959391|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
130272176|NCT02569476|468959391|FG000|Overall Study|Death|33|||
130272177|NCT02569476|468959391|FG000|Overall Study|Withdrawal by Subject|9|||
130272178|NCT02569476|468959391|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
130706615|NCT04034355|470549752|FG000|Overall Study|Withdrawal by Subject|12|||
130706616|NCT04034355|470549753|FG001|Overall Study|Withdrawal by Subject|11|||
130706617|NCT04034355|470549752|FG000|Overall Study|Site terminated by Sponsor|4|||
130706618|NCT04034355|470549753|FG001|Overall Study|Site terminated by Sponsor|5|||
130706619|NCT04034355|470549752|FG000|Overall Study|Adverse Event|2|||
130706620|NCT04034355|470549753|FG001|Overall Study|Adverse Event|0|||
130706621|NCT04034355|470549752|FG000|Overall Study|Death|1|||
130706622|NCT04034355|470549753|FG001|Overall Study|Death|1|||
130272179|NCT02569476|468959391|FG000|Overall Study|Palliative care|1|||
130272180|NCT02569476|468959391|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
130272181|NCT02569476|468959391|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
130272182|NCT01434654|468959392|FG000|Overall Study|Withdrawal by Subject|1|||
130272183|NCT01434654|468959393|FG001|Overall Study|Withdrawal by Subject|0|||
130272184|NCT01434654|468959392|FG000|Overall Study|Lost to Follow-up|1|||
130272185|NCT01434654|468959393|FG001|Overall Study|Lost to Follow-up|0|||
130272186|NCT03782064|468959394|FG000|Overall Study|Lack of Efficacy|2|||
130272187|NCT03782064|468959394|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
130272188|NCT02446769|468959397|FG000|Screening Period|Screen Failure|11|||
130272189|NCT02446769|468959398|FG001|Screening Period|Screen Failure|0|||
130272190|NCT02446769|468959399|FG002|Screening Period|Screen Failure|0|||
130272191|NCT02446769|468959397|FG000|Study Period|Randomized in Error|0|||
130272192|NCT02446769|468959398|FG001|Study Period|Randomized in Error|2|||
130272193|NCT02446769|468959399|FG002|Study Period|Randomized in Error|0|||
130272194|NCT00703963|468959400|FG000|Overall Study|Withdrawal by Subject|7|||
130272195|NCT00703963|468959401|FG001|Overall Study|Withdrawal by Subject|13|||
130272196|NCT00703963|468959400|FG000|Overall Study|Physician Decision|0|||
130272197|NCT00703963|468959401|FG001|Overall Study|Physician Decision|1|||
130272198|NCT00645840|468959402|FG000|Overall Study|Protocol Violation|3|||
130272199|NCT00402324|468959403|FG000|Overall Study|Lost to Follow-up|11|||
130272200|NCT00402324|468959404|FG001|Overall Study|Lost to Follow-up|11|||
130272201|NCT00402324|468959403|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
130272202|NCT00402324|468959404|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
130272203|NCT00402324|468959403|FG000|Overall Study|Protocol Violation|8|||
130272204|NCT00402324|468959404|FG001|Overall Study|Protocol Violation|7|||
130272205|NCT00402324|468959403|FG000|Overall Study|Withdrawal by Subject|5|||
130272206|NCT00402324|468959404|FG001|Overall Study|Withdrawal by Subject|2|||
130272207|NCT00402324|468959403|FG000|Overall Study|Physician Decision|2|||
130272208|NCT00402324|468959404|FG001|Overall Study|Physician Decision|4|||
130272209|NCT00402324|468959403|FG000|Overall Study|Sponsor Decision|4|||
130272210|NCT00402324|468959404|FG001|Overall Study|Sponsor Decision|5|||
130272211|NCT00402324|468959403|FG000|Overall Study|Lack of Efficacy|1|||
130272212|NCT00402324|468959404|FG001|Overall Study|Lack of Efficacy|4|||
130272213|NCT00402324|468959403|FG000|Overall Study|Adverse Event|6|||
130272214|NCT00402324|468959404|FG001|Overall Study|Adverse Event|4|||
130272215|NCT00402324|468959403|FG000|Overall Study|Death|1|||
130367034|NCT00915278|469314102|FG000|Overall Study|Progressive disease/clinical progression|0|||
130367035|NCT00915278|469314103|FG001|Overall Study|Progressive disease/clinical progression|0|||
130367036|NCT00915278|469314104|FG002|Overall Study|Progressive disease/clinical progression|0|||
130367037|NCT00915278|469314105|FG003|Overall Study|Progressive disease/clinical progression|3|||
130367038|NCT00915278|469314106|FG004|Overall Study|Progressive disease/clinical progression|1|||
130367039|NCT00915278|469314107|FG005|Overall Study|Progressive disease/clinical progression|2|||
130367040|NCT00915278|469314102|FG000|Overall Study|Infusion related AEs|0|||
130367041|NCT00915278|469314103|FG001|Overall Study|Infusion related AEs|0|||
130367042|NCT00915278|469314104|FG002|Overall Study|Infusion related AEs|0|||
130367043|NCT00915278|469314105|FG003|Overall Study|Infusion related AEs|0|||
130367044|NCT00915278|469314106|FG004|Overall Study|Infusion related AEs|0|||
130367045|NCT00915278|469314107|FG005|Overall Study|Infusion related AEs|2|||
130367046|NCT00915278|469314102|FG000|Overall Study|Admission to hospice|0|||
130554454|NCT01839487|469996610|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
130706623|NCT04034355|470549752|FG000|Overall Study|Not reported|2|||
130706624|NCT04034355|470549753|FG001|Overall Study|Not reported|0|||
130706625|NCT04034355|470549752|FG000|Overall Study|Lost to Follow-up|1|||
130272216|NCT00402324|468959404|FG001|Overall Study|Death|0|||
130272217|NCT02625220|468959405|FG000|Overall Study|Adverse Event|2|||
130272218|NCT02625220|468959405|FG000|Overall Study|Lost to Follow-up|2|||
130272219|NCT02625220|468959405|FG000|Overall Study|Protocol Violation|1|||
130272220|NCT02625220|468959405|FG000|Overall Study|Study discontinued at site|2|||
130706626|NCT04034355|470549753|FG001|Overall Study|Lost to Follow-up|0|||
130706627|NCT04034355|470549752|FG000|Overall Study|Physician Decision|1|||
130272221|NCT04599803|468959408|FG000|Overall Study|Withdrawal by Subject|5|||
130272222|NCT04599803|468959408|FG000|Overall Study|Lost to Follow-up|26|||
130272223|NCT02484443|468959409|FG000|Overall Study|Lack of Efficacy|28|||
130272224|NCT02484443|468959409|FG000|Overall Study|Physician Decision|2|||
130272225|NCT02484443|468959409|FG000|Overall Study|Ineligible|2|||
130272226|NCT04677543|468959410|FG000|Overall Study|Withdrawal by Subject|4|||
130272227|NCT04677543|468959411|FG001|Overall Study|Withdrawal by Subject|1|||
130272228|NCT04677543|468959410|FG000|Overall Study|Physician Decision|0|||
130272229|NCT04677543|468959411|FG001|Overall Study|Physician Decision|1|||
130272230|NCT04677543|468959410|FG000|Overall Study|Adverse Event|0|||
130272231|NCT04677543|468959411|FG001|Overall Study|Adverse Event|1|||
130272232|NCT03799952|468959412|FG000|Overall Study|Program was too easy, discontinued|1|||
130272233|NCT03799952|468959413|FG001|Overall Study|Program was too easy, discontinued|0|||
130272234|NCT03799952|468959412|FG000|Overall Study|Lost to Follow-up|0|||
130272235|NCT03799952|468959413|FG001|Overall Study|Lost to Follow-up|2|||
130272236|NCT02595866|468959414|FG000|Overall Study|Adverse Event|2|||
130272237|NCT02595866|468959415|FG001|Overall Study|Adverse Event|5|||
130272238|NCT02595866|468959414|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130272239|NCT02595866|468959415|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130272240|NCT02595866|468959414|FG000|Overall Study|Death|0|||
130272241|NCT02595866|468959415|FG001|Overall Study|Death|1|||
130272242|NCT02595866|468959414|FG000|Overall Study|Incarceration|1|||
130272243|NCT02595866|468959415|FG001|Overall Study|Incarceration|0|||
130272244|NCT02595866|468959414|FG000|Overall Study|Lack of Efficacy|17|||
130272245|NCT02595866|468959415|FG001|Overall Study|Lack of Efficacy|7|||
130272246|NCT02595866|468959414|FG000|Overall Study|Physician Decision|4|||
130272247|NCT02595866|468959415|FG001|Overall Study|Physician Decision|3|||
130272248|NCT02595866|468959414|FG000|Overall Study|Switched to Alternative Treatment|1|||
130272249|NCT02595866|468959415|FG001|Overall Study|Switched to Alternative Treatment|0|||
130272250|NCT02595866|468959414|FG000|Overall Study|Study Terminated|0|||
130272251|NCT02595866|468959415|FG001|Overall Study|Study Terminated|4|||
130272252|NCT02595866|468959414|FG000|Overall Study|Withdrawal by Subject|6|||
130272253|NCT02595866|468959415|FG001|Overall Study|Withdrawal by Subject|1|||
130272254|NCT02520388|468959416|FG000|Overall Study|Physician Decision|1|||
130272255|NCT02520388|468959417|FG001|Overall Study|Physician Decision|0|||
130272256|NCT02520388|468959416|FG000|Overall Study|Subject or parent/guardian request|0|||
130272257|NCT02520388|468959417|FG001|Overall Study|Subject or parent/guardian request|6|||
130272258|NCT02520388|468959416|FG000|Overall Study|Adverse Event|1|||
130272259|NCT02520388|468959417|FG001|Overall Study|Adverse Event|4|||
130272260|NCT02520388|468959416|FG000|Overall Study|Lost to Follow-up|3|||
130272261|NCT02520388|468959417|FG001|Overall Study|Lost to Follow-up|2|||
130272262|NCT02520388|468959416|FG000|Overall Study|Other (reason not defined)|4|||
130272263|NCT02520388|468959417|FG001|Overall Study|Other (reason not defined)|4|||
130272264|NCT03035864|468959421|FG000|Treatment Period|Adverse Event|1|||
130272265|NCT03035864|468959422|FG001|Treatment Period|Adverse Event|0|||
130272266|NCT03035864|468959421|FG000|Treatment Period|Other|3|||
130272267|NCT03035864|468959422|FG001|Treatment Period|Other|1|||
130272268|NCT03035864|468959421|FG000|Follow-up Period|Adverse Event|1|||
130272269|NCT03035864|468959422|FG001|Follow-up Period|Adverse Event|0|||
130272270|NCT03035864|468959421|FG000|Follow-up Period|Lost to Follow-up|6|||
130272271|NCT03035864|468959422|FG001|Follow-up Period|Lost to Follow-up|2|||
130272272|NCT03035864|468959421|FG000|Follow-up Period|Physician Decision|1|||
130272273|NCT03035864|468959422|FG001|Follow-up Period|Physician Decision|0|||
130272274|NCT03035864|468959421|FG000|Follow-up Period|Other|3|||
130272275|NCT03035864|468959422|FG001|Follow-up Period|Other|2|||
130272276|NCT02375373|468959423|FG000|Overall Study|Withdrawal by Subject|11|||
130272277|NCT00577707|468959424|FG000|Overall Study|Withdrawal by Subject|3|||
130272278|NCT03299244|468959425|FG000|Overall Study|Withdrawal by Subject|34|||
130272279|NCT03299244|468959426|FG001|Overall Study|Withdrawal by Subject|29|||
130272280|NCT03299244|468959425|FG000|Overall Study|Decision by Sponsor|4|||
130272281|NCT03299244|468959426|FG001|Overall Study|Decision by Sponsor|5|||
130272282|NCT03299244|468959425|FG000|Overall Study|Death|9|||
130272283|NCT03299244|468959426|FG001|Overall Study|Death|4|||
130272284|NCT00431444|468959427|FG000|Overall Study|Protocol Violation|1|||
130272285|NCT00431444|468959428|FG001|Overall Study|Protocol Violation|4|||
130272286|NCT00431444|468959427|FG000|Overall Study|Adverse Event|2|||
130272287|NCT00431444|468959428|FG001|Overall Study|Adverse Event|1|||
130272288|NCT00431444|468959427|FG000|Overall Study|Withdrawal by Subject|1|||
130272289|NCT00431444|468959428|FG001|Overall Study|Withdrawal by Subject|1|||
130272290|NCT00431444|468959427|FG000|Overall Study|Lost to Follow-up|1|||
130272291|NCT00431444|468959428|FG001|Overall Study|Lost to Follow-up|0|||
130272292|NCT00431444|468959427|FG000|Overall Study|Administrative Problems|0|||
130272293|NCT00431444|468959428|FG001|Overall Study|Administrative Problems|1|||
130272294|NCT01603043|468959429|FG000|Overall Study|Study Futility|7|||
130272295|NCT01603043|468959430|FG001|Overall Study|Study Futility|3|||
130272296|NCT00642707|468959445|FG000|Overall Study|Adverse Event|0|||
130272297|NCT00642707|468959446|FG001|Overall Study|Adverse Event|0|||
130272298|NCT00642707|468959447|FG002|Overall Study|Adverse Event|0|||
130272299|NCT00642707|468959448|FG003|Overall Study|Adverse Event|2|||
130272300|NCT00642707|468959445|FG000|Overall Study|Withdrawal by Subject|1|||
130272301|NCT00642707|468959446|FG001|Overall Study|Withdrawal by Subject|0|||
130272302|NCT00642707|468959447|FG002|Overall Study|Withdrawal by Subject|0|||
130272303|NCT00642707|468959448|FG003|Overall Study|Withdrawal by Subject|0|||
130272304|NCT01016132|468959449|FG000|Overall Study|Discomfort|1|||
130272305|NCT01451749|468959452|FG000|Overall Study|Protocol Violation|14|||
130272306|NCT01451749|468959453|FG001|Overall Study|Protocol Violation|7|||
130272307|NCT01451749|468959452|FG000|Overall Study|Lost to Follow-up|15|||
130272308|NCT01451749|468959453|FG001|Overall Study|Lost to Follow-up|5|||
130272309|NCT01451749|468959452|FG000|Overall Study|Meet the exclusion criteria,and|1|||
130272310|NCT01451749|468959453|FG001|Overall Study|Meet the exclusion criteria,and|1|||
130272311|NCT01451749|468959452|FG000|Overall Study|Adverse Event|2|||
130272312|NCT01451749|468959453|FG001|Overall Study|Adverse Event|0|||
130272313|NCT01451749|468959452|FG000|Overall Study|Withdrawal by Subject|0|||
130272314|NCT01451749|468959453|FG001|Overall Study|Withdrawal by Subject|1|||
130272315|NCT01198574|468959461|FG000|Overall Study|Resigned from schools|4|||
130272316|NCT01198574|468959462|FG001|Overall Study|Resigned from schools|1|||
130272317|NCT01198574|468959463|FG002|Overall Study|Resigned from schools|1|||
130706628|NCT04034355|470549753|FG001|Overall Study|Physician Decision|0|||
130272318|NCT01198574|468959464|FG003|Overall Study|Resigned from schools|4|||
130272319|NCT00556439|468959494|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
130272320|NCT00556439|468959495|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
130272321|NCT00556439|468959496|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
130272322|NCT00556439|468959497|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
130272323|NCT00556439|468959494|FG000|Study Entry to Week 12|Physician Decision|1|||
130272324|NCT00556439|468959495|FG001|Study Entry to Week 12|Physician Decision|0|||
130272325|NCT00556439|468959496|FG002|Study Entry to Week 12|Physician Decision|0|||
130272326|NCT00556439|468959497|FG003|Study Entry to Week 12|Physician Decision|0|||
130272327|NCT00556439|468959494|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
130272328|NCT00556439|468959495|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
130272329|NCT00556439|468959496|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
130272330|NCT00556439|468959497|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
130272331|NCT00556439|468959494|FG000|Study Entry to Week 12|Recurrent infection|1|||
130272332|NCT00556439|468959495|FG001|Study Entry to Week 12|Recurrent infection|0|||
130272333|NCT00556439|468959496|FG002|Study Entry to Week 12|Recurrent infection|0|||
130272334|NCT00556439|468959497|FG003|Study Entry to Week 12|Recurrent infection|0|||
130272335|NCT00556439|468959494|FG000|Study Entry to Week 12|Malignancy|0|||
130272336|NCT00556439|468959495|FG001|Study Entry to Week 12|Malignancy|0|||
130272337|NCT00556439|468959496|FG002|Study Entry to Week 12|Malignancy|1|||
130272338|NCT00556439|468959497|FG003|Study Entry to Week 12|Malignancy|0|||
130272339|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
130272340|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
130272341|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130272342|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130272343|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
130272344|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272345|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272346|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272347|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
130272348|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
130272349|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
130272350|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
130272351|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
130272352|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272353|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272354|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272355|NCT02100423|468959498|FG000|Overall Study|Death|1|||
130272356|NCT02100423|468959498|FG000|Overall Study|Withdrawal by Subject|3|||
130272357|NCT02100423|468959498|FG000|Overall Study|Adverse Event|1|||
130272358|NCT02100423|468959498|FG000|Overall Study|Physician Decision|1|||
130272359|NCT02454530|468959499|FG000|Overall Study|Other|8|||
130272360|NCT02454530|468959500|FG001|Overall Study|Other|13|||
130272361|NCT02454530|468959499|FG000|Overall Study|Missing information|56|||
130456264|NCT02155829|469634886|FG001|Overall Study|Protocol Violation|0|||
130456265|NCT01585038|469634887|FG000|Overall Study|Adverse Event|2|||
130456266|NCT01585038|469634888|FG001|Overall Study|Adverse Event|2|||
130456267|NCT00678795|469634889|FG000|Overall Study|Adverse Event|7|||
130706629|NCT04034355|470549752|FG000|Overall Study|Protocol Violation|0|||
130272362|NCT02454530|468959500|FG001|Overall Study|Missing information|69|||
130272363|NCT02454530|468959499|FG000|Overall Study|Death|2|||
130272364|NCT02454530|468959500|FG001|Overall Study|Death|41|||
130272365|NCT02454530|468959499|FG000|Overall Study|Lost to Follow-up|4|||
130272366|NCT02454530|468959500|FG001|Overall Study|Lost to Follow-up|4|||
130272367|NCT00325130|468959501|FG000|Overall Study|Lost to Follow-up|6|||
130456268|NCT00678795|469634890|FG001|Overall Study|Adverse Event|3|||
130272368|NCT00325130|468959502|FG001|Overall Study|Lost to Follow-up|14|||
130272369|NCT00325130|468959501|FG000|Overall Study|Withdrawal by Subject|12|||
130272370|NCT00325130|468959502|FG001|Overall Study|Withdrawal by Subject|14|||
130272371|NCT00325130|468959501|FG000|Overall Study|Protocol Deviation|0|||
130272372|NCT00325130|468959502|FG001|Overall Study|Protocol Deviation|1|||
130272373|NCT00325130|468959501|FG000|Overall Study|Moved|0|||
130272374|NCT00325130|468959502|FG001|Overall Study|Moved|1|||
130272375|NCT00325130|468959501|FG000|Overall Study|Patient Discontinued for Other|1|||
130272376|NCT00325130|468959502|FG001|Overall Study|Patient Discontinued for Other|0|||
130272377|NCT02949024|468959505|FG000|Overall Study|Withdrawal by Subject|0|||
130272378|NCT02949024|468959506|FG001|Overall Study|Withdrawal by Subject|1|||
130272379|NCT03159468|468959507|FG000|Overall Study|Withdrawal by Subject|0|||
130272380|NCT03159468|468959508|FG001|Overall Study|Withdrawal by Subject|0|||
130272381|NCT03159468|468959509|FG002|Overall Study|Withdrawal by Subject|3|||
130272382|NCT03159468|468959510|FG003|Overall Study|Withdrawal by Subject|0|||
130272383|NCT03159468|468959511|FG004|Overall Study|Withdrawal by Subject|0|||
130272384|NCT03159468|468959512|FG005|Overall Study|Withdrawal by Subject|0|||
130272385|NCT02524145|468959513|FG000|Overall Study|Withdrawal by Subject|2|||
130272386|NCT02524145|468959514|FG001|Overall Study|Withdrawal by Subject|2|||
130272387|NCT02524145|468959515|FG002|Overall Study|Withdrawal by Subject|3|||
130272388|NCT00500357|468961187|FG000|Overall Study|Death|1|||
130272389|NCT00161616|468961188|FG000|Overall Study|Withdrawal by Subject|6|||
130272390|NCT00161616|468961189|FG001|Overall Study|Withdrawal by Subject|5|||
130272391|NCT00161616|468961188|FG000|Overall Study|Physician Decision|1|||
130272392|NCT00161616|468961189|FG001|Overall Study|Physician Decision|0|||
130272393|NCT00161616|468961188|FG000|Overall Study|Death|1|||
130272394|NCT00161616|468961189|FG001|Overall Study|Death|1|||
130272395|NCT00161616|468961188|FG000|Overall Study|Lost to Follow-up|17|||
130272396|NCT00161616|468961189|FG001|Overall Study|Lost to Follow-up|13|||
130272397|NCT00161616|468961188|FG000|Overall Study|Protocol deviation|1|||
130272398|NCT00161616|468961189|FG001|Overall Study|Protocol deviation|0|||
130272399|NCT00854724|468961190|FG000|First Intervention|Withdrawal by Subject|1|||
130272400|NCT00854724|468961191|FG001|First Intervention|Withdrawal by Subject|1|||
130272401|NCT00854724|468961190|FG000|Washout|Protocol Violation|1|||
130272402|NCT00854724|468961191|FG001|Washout|Protocol Violation|0|||
130272403|NCT00854724|468961190|FG000|Washout|Withdrawal by Subject|0|||
130272404|NCT00854724|468961191|FG001|Washout|Withdrawal by Subject|1|||
130272405|NCT00854724|468961190|FG000|Second Intervention|Protocol Violation|1|||
130272406|NCT00854724|468961191|FG001|Second Intervention|Protocol Violation|0|||
130272407|NCT00854724|468961190|FG000|Second Intervention|Physician Decision|0|||
130272408|NCT00854724|468961191|FG001|Second Intervention|Physician Decision|1|||
130272409|NCT02141633|468961192|FG000|Overall Study|Physician Decision|1|||
130272410|NCT02141633|468961193|FG001|Overall Study|Physician Decision|0|||
130272411|NCT02140970|468961203|FG000|Overall Study|Lost to Follow-up|1|||
130272412|NCT02140970|468961204|FG001|Overall Study|Lost to Follow-up|2|||
130272413|NCT02140970|468961203|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
130272414|NCT02140970|468961204|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
130272415|NCT02140970|468961203|FG000|Overall Study|Did not meet inclusion criteria|0|||
130272416|NCT02140970|468961204|FG001|Overall Study|Did not meet inclusion criteria|1|||
130272417|NCT01947283|468961208|FG000|Overall Study|Death|1|||
130272418|NCT01947283|468961209|FG001|Overall Study|Death|1|||
130272419|NCT01947283|468961210|FG002|Overall Study|Death|1|||
130272420|NCT01947283|468961211|FG003|Overall Study|Death|0|||
130272421|NCT01947283|468961212|FG004|Overall Study|Death|0|||
130272422|NCT01947283|468961213|FG005|Overall Study|Death|0|||
130272423|NCT01947283|468961214|FG006|Overall Study|Death|0|||
130272424|NCT01947283|468961208|FG000|Overall Study|Lost to Follow-up|4|||
130456269|NCT00678795|469634889|FG000|Overall Study|Withdrawal by Subject|3|||
130456270|NCT00678795|469634890|FG001|Overall Study|Withdrawal by Subject|0|||
130456271|NCT00678795|469634889|FG000|Overall Study|Protocol Violation|0|||
130456272|NCT00678795|469634890|FG001|Overall Study|Protocol Violation|1|||
130272425|NCT01947283|468961209|FG001|Overall Study|Lost to Follow-up|6|||
130272426|NCT01947283|468961210|FG002|Overall Study|Lost to Follow-up|5|||
130272427|NCT01947283|468961211|FG003|Overall Study|Lost to Follow-up|5|||
130272428|NCT01947283|468961212|FG004|Overall Study|Lost to Follow-up|0|||
130272429|NCT01947283|468961213|FG005|Overall Study|Lost to Follow-up|2|||
130272430|NCT01947283|468961214|FG006|Overall Study|Lost to Follow-up|5|||
130272431|NCT01947283|468961208|FG000|Overall Study|Withdrawal by Subject|10|||
130272432|NCT01947283|468961209|FG001|Overall Study|Withdrawal by Subject|8|||
130272433|NCT01947283|468961210|FG002|Overall Study|Withdrawal by Subject|4|||
130272434|NCT01947283|468961211|FG003|Overall Study|Withdrawal by Subject|1|||
130272435|NCT01947283|468961212|FG004|Overall Study|Withdrawal by Subject|0|||
130272436|NCT01947283|468961213|FG005|Overall Study|Withdrawal by Subject|0|||
130272437|NCT01947283|468961214|FG006|Overall Study|Withdrawal by Subject|2|||
130272438|NCT01947283|468961208|FG000|Overall Study|No Clinical Recording|12|||
130272439|NCT01947283|468961209|FG001|Overall Study|No Clinical Recording|6|||
130456273|NCT00678795|469634889|FG000|Overall Study|Lost to Follow-up|0|||
130456274|NCT00678795|469634890|FG001|Overall Study|Lost to Follow-up|1|||
130456275|NCT00678795|469634889|FG000|Overall Study|Lack of Efficacy|1|||
130272440|NCT01947283|468961210|FG002|Overall Study|No Clinical Recording|8|||
130272441|NCT01947283|468961211|FG003|Overall Study|No Clinical Recording|10|||
130272442|NCT01947283|468961212|FG004|Overall Study|No Clinical Recording|0|||
130272443|NCT01947283|468961213|FG005|Overall Study|No Clinical Recording|0|||
130272444|NCT01947283|468961214|FG006|Overall Study|No Clinical Recording|0|||
130272445|NCT01947283|468961208|FG000|Overall Study|Non-coding Clinical Recording language|0|||
130272446|NCT01947283|468961209|FG001|Overall Study|Non-coding Clinical Recording language|0|||
130272447|NCT01947283|468961210|FG002|Overall Study|Non-coding Clinical Recording language|0|||
130272448|NCT01947283|468961211|FG003|Overall Study|Non-coding Clinical Recording language|1|||
130272449|NCT01947283|468961212|FG004|Overall Study|Non-coding Clinical Recording language|0|||
130272450|NCT01947283|468961213|FG005|Overall Study|Non-coding Clinical Recording language|0|||
130272451|NCT01947283|468961214|FG006|Overall Study|Non-coding Clinical Recording language|0|||
130272452|NCT01947283|468961208|FG000|Overall Study|Missing Follow-up Assessment|2|||
130272453|NCT01947283|468961209|FG001|Overall Study|Missing Follow-up Assessment|2|||
130272454|NCT01947283|468961210|FG002|Overall Study|Missing Follow-up Assessment|3|||
130272455|NCT01947283|468961211|FG003|Overall Study|Missing Follow-up Assessment|0|||
130272456|NCT01947283|468961212|FG004|Overall Study|Missing Follow-up Assessment|0|||
130272457|NCT01947283|468961213|FG005|Overall Study|Missing Follow-up Assessment|2|||
130272458|NCT01947283|468961214|FG006|Overall Study|Missing Follow-up Assessment|0|||
130272459|NCT01947283|468961208|FG000|Overall Study|No patients were enrolled in study|0|||
130272460|NCT01947283|468961209|FG001|Overall Study|No patients were enrolled in study|0|||
130272461|NCT01947283|468961210|FG002|Overall Study|No patients were enrolled in study|0|||
130272462|NCT01947283|468961211|FG003|Overall Study|No patients were enrolled in study|0|||
130272463|NCT01947283|468961212|FG004|Overall Study|No patients were enrolled in study|0|||
130272464|NCT01947283|468961213|FG005|Overall Study|No patients were enrolled in study|3|||
130272465|NCT01947283|468961214|FG006|Overall Study|No patients were enrolled in study|1|||
130272466|NCT03782259|468961215|FG000|Overall Study|Lost to Follow-up|1|||
130272467|NCT03782259|468961216|FG001|Overall Study|Lost to Follow-up|1|||
130272468|NCT03782259|468961215|FG000|Overall Study|Moved out of state|0|||
130272469|NCT03782259|468961216|FG001|Overall Study|Moved out of state|2|||
130272470|NCT03782259|468961215|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
130272471|NCT03782259|468961216|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
130272472|NCT03782259|468961215|FG000|Overall Study|Subject discontinued intervention|1|||
130272473|NCT03782259|468961216|FG001|Overall Study|Subject discontinued intervention|0|||
130272474|NCT00603941|468961220|FG000|Overall Study|Disease progression|6|||
130272475|NCT00603941|468961221|FG001|Overall Study|Disease progression|7|||
130272476|NCT00603941|468961222|FG002|Overall Study|Disease progression|1|||
130272477|NCT00603941|468961220|FG000|Overall Study|Adverse Event|1|||
130272478|NCT00603941|468961221|FG001|Overall Study|Adverse Event|0|||
130272479|NCT00603941|468961222|FG002|Overall Study|Adverse Event|1|||
130272480|NCT00603941|468961220|FG000|Overall Study|Physician Decision|0|||
130272481|NCT00603941|468961221|FG001|Overall Study|Physician Decision|1|||
130272482|NCT00603941|468961222|FG002|Overall Study|Physician Decision|0|||
130272483|NCT00603941|468961220|FG000|Overall Study|Withdrawal by Subject|0|||
130272484|NCT00603941|468961221|FG001|Overall Study|Withdrawal by Subject|2|||
130272485|NCT00603941|468961222|FG002|Overall Study|Withdrawal by Subject|0|||
130272486|NCT05069597|468961223|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130272487|NCT05069597|468961224|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
130272488|NCT02705105|468961225|FG000|Treatment|Objective Disease Progression|1|||
130272489|NCT02705105|468961226|FG001|Treatment|Objective Disease Progression|50|||
130272490|NCT02705105|468961225|FG000|Treatment|Withdrawal by Subject|3|||
130272491|NCT02705105|468961226|FG001|Treatment|Withdrawal by Subject|5|||
130272492|NCT02705105|468961225|FG000|Treatment|Adverse Event|0|||
130272493|NCT02705105|468961226|FG001|Treatment|Adverse Event|17|||
130272494|NCT02705105|468961225|FG000|Treatment|Clinical Disease Progression|0|||
130272495|NCT02705105|468961226|FG001|Treatment|Clinical Disease Progression|32|||
130272496|NCT02705105|468961225|FG000|Treatment|Physician Decision|0|||
130272497|NCT02705105|468961226|FG001|Treatment|Physician Decision|3|||
130456276|NCT00678795|469634890|FG001|Overall Study|Lack of Efficacy|1|||
130456277|NCT04107805|469634891|FG000|Overall Study|Adverse Event|0|||
130272498|NCT02705105|468961225|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
130272499|NCT02705105|468961226|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
130272500|NCT02705105|468961225|FG000|Follow-Up|Death|3|||
130272501|NCT02705105|468961226|FG001|Follow-Up|Death|68|||
130272502|NCT02705105|468961225|FG000|Follow-Up|Withdrawal by Subject|1|||
130272503|NCT02705105|468961226|FG001|Follow-Up|Withdrawal by Subject|14|||
130706630|NCT04034355|470549753|FG001|Overall Study|Protocol Violation|1|||
130272504|NCT02705105|468961225|FG000|Follow-Up|Study Terminated|0|||
130706631|NCT04034355|470549752|FG000|Overall Study|Progressive disease|1|||
130706632|NCT04034355|470549753|FG001|Overall Study|Progressive disease|0|||
130272505|NCT02705105|468961226|FG001|Follow-Up|Study Terminated|26|||
130272506|NCT02705105|468961225|FG000|Follow-Up|Discontinued per Amendment 3|0|||
130272507|NCT02705105|468961226|FG001|Follow-Up|Discontinued per Amendment 3|2|||
130272508|NCT01709110|468961227|FG000|Overall Study|Adverse Event|56|||
130272509|NCT01709110|468961228|FG001|Overall Study|Adverse Event|48|||
130272510|NCT01709110|468961227|FG000|Overall Study|Death|14|||
130272511|NCT01709110|468961228|FG001|Overall Study|Death|6|||
130272512|NCT01709110|468961227|FG000|Overall Study|Lost to Follow-up|7|||
130272513|NCT01709110|468961228|FG001|Overall Study|Lost to Follow-up|5|||
130272514|NCT01709110|468961227|FG000|Overall Study|Protocol Violation|4|||
130272515|NCT01709110|468961228|FG001|Overall Study|Protocol Violation|6|||
130272516|NCT01709110|468961227|FG000|Overall Study|Withdrawal by Subject|96|||
130272517|NCT01709110|468961228|FG001|Overall Study|Withdrawal by Subject|89|||
130272518|NCT01709110|468961227|FG000|Overall Study|Physician Decision|4|||
130272519|NCT01709110|468961228|FG001|Overall Study|Physician Decision|10|||
130272520|NCT01709110|468961227|FG000|Overall Study|Sponsor Decision|2|||
130272521|NCT01709110|468961228|FG001|Overall Study|Sponsor Decision|2|||
130272522|NCT01709110|468961227|FG000|Overall Study|Lack of Efficacy|1|||
130272523|NCT01709110|468961228|FG001|Overall Study|Lack of Efficacy|1|||
130272524|NCT01709110|468961227|FG000|Overall Study|Caregiver Decision|1|||
130272525|NCT01709110|468961228|FG001|Overall Study|Caregiver Decision|1|||
130272526|NCT04556591|468961229|FG000|Overall Study|Lost to Follow-up|1|||
130272527|NCT04556591|468961230|FG001|Overall Study|Lost to Follow-up|0|||
130272528|NCT04556591|468961229|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
130272529|NCT04556591|468961230|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
130272530|NCT03332173|468961231|FG000|Overall Study|Death|7|||
130272531|NCT03332173|468961231|FG000|Overall Study|Withdrawal by Subject|6|||
130272532|NCT03332173|468961231|FG000|Overall Study|Lost to Follow-up|2|||
130272533|NCT03332173|468961231|FG000|Overall Study|Transferred to long-term extension study|29|||
130272534|NCT02168101|468961232|FG000|Overall Study|Death|2|||
130272535|NCT02168101|468961233|FG001|Overall Study|Death|2|||
130272536|NCT02168101|468961234|FG002|Overall Study|Death|1|||
130272537|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130272538|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130272539|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
130272540|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
130272541|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
130272542|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
130272543|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
130272544|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130272545|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130272546|NCT05507567|468961235|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130272547|NCT05507567|468961236|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
130272548|NCT05507567|468961237|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130272549|NCT00910910|468961238|FG000|Overall Study|Adverse Event|63|||
130272550|NCT00910910|468961239|FG001|Overall Study|Adverse Event|35|||
130272551|NCT00910910|468961238|FG000|Overall Study|PD without histologic change|27|||
130272552|NCT00910910|468961239|FG001|Overall Study|PD without histologic change|23|||
130272553|NCT00910910|468961238|FG000|Overall Study|PD with histologic change|0|||
130272554|NCT00910910|468961239|FG001|Overall Study|PD with histologic change|2|||
130272555|NCT00910910|468961238|FG000|Overall Study|Withdrawal by Subject|7|||
130272556|NCT00910910|468961239|FG001|Overall Study|Withdrawal by Subject|5|||
130272557|NCT00910910|468961238|FG000|Overall Study|Lost to Follow-up|2|||
130272558|NCT00910910|468961239|FG001|Overall Study|Lost to Follow-up|2|||
130272559|NCT00910910|468961238|FG000|Overall Study|Death|9|||
130272560|NCT00910910|468961239|FG001|Overall Study|Death|3|||
130272561|NCT00910910|468961238|FG000|Overall Study|Protocol Violation|2|||
130272562|NCT00910910|468961239|FG001|Overall Study|Protocol Violation|2|||
130272563|NCT00910910|468961238|FG000|Overall Study|Completed 13 cycles of treatment|0|||
130272564|NCT00910910|468961239|FG001|Overall Study|Completed 13 cycles of treatment|118|||
130272565|NCT00910910|468961238|FG000|Overall Study|Other|114|||
130272566|NCT00910910|468961239|FG001|Overall Study|Other|32|||
130272567|NCT00910910|468961238|FG000|Overall Study|Untreated before cycle 1|1|||
130272568|NCT00910910|468961239|FG001|Overall Study|Untreated before cycle 1|2|||
130272569|NCT01973231|468961240|FG000|Overall Study|Protocol Violation|1|||
130272570|NCT01973231|468961241|FG001|Overall Study|Protocol Violation|1|||
130272571|NCT01973231|468961240|FG000|Overall Study|Lost to Follow-up|1|||
130272572|NCT01973231|468961241|FG001|Overall Study|Lost to Follow-up|1|||
130272573|NCT01973231|468961240|FG000|Overall Study|unclassified|2|||
130272574|NCT01973231|468961241|FG001|Overall Study|unclassified|1|||
130272575|NCT01973231|468961240|FG000|Overall Study|Withdrawal by Subject|7|||
130272576|NCT01973231|468961241|FG001|Overall Study|Withdrawal by Subject|9|||
130272577|NCT01277822|468961246|FG000|Overall Study|Adverse Event|2|||
130272578|NCT01277822|468961247|FG001|Overall Study|Adverse Event|1|||
130272579|NCT01277822|468961246|FG000|Overall Study|Withdrawal by Subject|6|||
130272580|NCT01277822|468961247|FG001|Overall Study|Withdrawal by Subject|7|||
130272581|NCT01277822|468961246|FG000|Overall Study|Physician Decision|1|||
130272582|NCT01277822|468961247|FG001|Overall Study|Physician Decision|1|||
130272583|NCT01277822|468961246|FG000|Overall Study|Protocol Violation|1|||
130272584|NCT01277822|468961247|FG001|Overall Study|Protocol Violation|0|||
130272585|NCT01277822|468961246|FG000|Overall Study|Lost to Follow-up|2|||
130272586|NCT01277822|468961247|FG001|Overall Study|Lost to Follow-up|1|||
130272587|NCT01277822|468961246|FG000|Overall Study|Contraindicated medication used|2|||
130272588|NCT01277822|468961247|FG001|Overall Study|Contraindicated medication used|1|||
130272589|NCT01277822|468961246|FG000|Overall Study|Participant moved|1|||
130272590|NCT01277822|468961247|FG001|Overall Study|Participant moved|0|||
130272591|NCT02923531|468961248|FG000|Overall Study|Adverse Event|4|||
130272592|NCT02923531|468961248|FG000|Overall Study|Clinical Deterioration|1|||
130272593|NCT02923531|468961248|FG000|Overall Study|Disease Progression|3|||
130272594|NCT02923531|468961248|FG000|Overall Study|Study Termination|1|||
130272595|NCT00997984|468961249|FG000|Overall Study|Adverse Event|1|||
130272596|NCT00997984|468961250|FG001|Overall Study|Adverse Event|8|||
130272597|NCT00997984|468961251|FG002|Overall Study|Adverse Event|8|||
130272598|NCT00997984|468961249|FG000|Overall Study|Protocol Violation|1|||
130272599|NCT00997984|468961250|FG001|Overall Study|Protocol Violation|3|||
130272600|NCT00997984|468961251|FG002|Overall Study|Protocol Violation|0|||
130272601|NCT00997984|468961249|FG000|Overall Study|Withdrawal by Subject|6|||
130272602|NCT00997984|468961250|FG001|Overall Study|Withdrawal by Subject|9|||
130272603|NCT00997984|468961251|FG002|Overall Study|Withdrawal by Subject|5|||
130272604|NCT00997984|468961249|FG000|Overall Study|Lost to Follow-up|8|||
130272605|NCT00997984|468961250|FG001|Overall Study|Lost to Follow-up|5|||
130272606|NCT00997984|468961251|FG002|Overall Study|Lost to Follow-up|4|||
130272607|NCT00997984|468961249|FG000|Overall Study|Lack of Efficacy|20|||
130272608|NCT00997984|468961250|FG001|Overall Study|Lack of Efficacy|6|||
130272609|NCT00997984|468961251|FG002|Overall Study|Lack of Efficacy|3|||
130272610|NCT00997984|468961249|FG000|Overall Study|Met exclusion criteria|1|||
130272611|NCT00997984|468961250|FG001|Overall Study|Met exclusion criteria|0|||
130272612|NCT00997984|468961251|FG002|Overall Study|Met exclusion criteria|0|||
130272613|NCT00997984|468961249|FG000|Overall Study|non-compliance|0|||
130272614|NCT00997984|468961250|FG001|Overall Study|non-compliance|2|||
130272615|NCT00997984|468961251|FG002|Overall Study|non-compliance|3|||
130272616|NCT00997984|468961249|FG000|Overall Study|Wrong medication dispensed|0|||
130272617|NCT00997984|468961250|FG001|Overall Study|Wrong medication dispensed|1|||
130272618|NCT00997984|468961251|FG002|Overall Study|Wrong medication dispensed|0|||
130272619|NCT00997984|468961249|FG000|Overall Study|Suicidal ideation|0|||
130272620|NCT00997984|468961250|FG001|Overall Study|Suicidal ideation|0|||
130272621|NCT00997984|468961251|FG002|Overall Study|Suicidal ideation|1|||
130272622|NCT00997984|468961249|FG000|Overall Study|Work schedule|0|||
130272623|NCT00997984|468961250|FG001|Overall Study|Work schedule|0|||
130272624|NCT00997984|468961251|FG002|Overall Study|Work schedule|2|||
130272625|NCT01119066|468961253|FG000|Overall Study|Withdrawal by Subject|4|||
130272626|NCT01119066|468961254|FG001|Overall Study|Withdrawal by Subject|6|||
130272627|NCT01119066|468961255|FG002|Overall Study|Withdrawal by Subject|0|||
130272628|NCT01119066|468961256|FG003|Overall Study|Withdrawal by Subject|0|||
130272629|NCT01119066|468961253|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
130272630|NCT01119066|468961254|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
130272631|NCT01119066|468961255|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130272632|NCT01119066|468961256|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130272633|NCT01119066|468961253|FG000|Overall Study|Relapse identified before transplant|1|||
130272634|NCT01119066|468961254|FG001|Overall Study|Relapse identified before transplant|0|||
130272635|NCT01119066|468961255|FG002|Overall Study|Relapse identified before transplant|0|||
130272636|NCT01119066|468961256|FG003|Overall Study|Relapse identified before transplant|0|||
130272637|NCT01119066|468961253|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272638|NCT01119066|468961254|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
130272639|NCT01119066|468961255|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272640|NCT01119066|468961256|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272641|NCT01119066|468961253|FG000|Overall Study|Relapse identified before transplant|0|||
130272642|NCT01119066|468961254|FG001|Overall Study|Relapse identified before transplant|4|||
130272643|NCT01119066|468961255|FG002|Overall Study|Relapse identified before transplant|0|||
130272644|NCT01119066|468961256|FG003|Overall Study|Relapse identified before transplant|0|||
130272645|NCT00271856|468961259|FG000|Overall Study|Withdrawal by Subject|1|||
130272646|NCT00271856|468961260|FG001|Overall Study|Withdrawal by Subject|7|||
130367047|NCT00915278|469314103|FG001|Overall Study|Admission to hospice|0|||
130367048|NCT00915278|469314104|FG002|Overall Study|Admission to hospice|1|||
130367049|NCT00915278|469314105|FG003|Overall Study|Admission to hospice|0|||
130367050|NCT00915278|469314106|FG004|Overall Study|Admission to hospice|0|||
130367051|NCT00915278|469314107|FG005|Overall Study|Admission to hospice|0|||
130367052|NCT02151110|469314108|FG000|Overall Study|Withdrawal by Subject|0|||
130367053|NCT02151110|469314109|FG001|Overall Study|Withdrawal by Subject|0|||
130272647|NCT00271856|468961259|FG000|Overall Study|Lost to Follow-up|10|||
130367054|NCT02151110|469314110|FG002|Overall Study|Withdrawal by Subject|0|||
130272648|NCT00271856|468961260|FG001|Overall Study|Lost to Follow-up|11|||
130272649|NCT02366923|468961261|FG000|Overall Study|Withdrawal by Subject|1|||
130272650|NCT02366923|468961261|FG000|Overall Study|Positive Slit Lamp Findings|2|||
130272651|NCT02366923|468961261|FG000|Overall Study|High Astigmatism|3|||
130272652|NCT01437111|468961267|FG000|Overall Study|Adverse Event|2|||
130272653|NCT01437111|468961267|FG000|Overall Study|Withdrawal by Subject|4|||
130272654|NCT01437111|468961267|FG000|Overall Study|Not reported|5|||
130272655|NCT01437111|468961267|FG000|Overall Study|Physician Decision|1|||
130272656|NCT01437111|468961267|FG000|Overall Study|Lost to Follow-up|5|||
130272657|NCT01437111|468961267|FG000|Overall Study|Protocol Violation|1|||
130272658|NCT02131311|468961268|FG000|Overall Study|Adverse Event|2|||
130272659|NCT02131311|468961268|FG000|Overall Study|Protocol Violation|1|||
130272660|NCT02131311|468961268|FG000|Overall Study|Lost to Follow-up|1|||
130272661|NCT02623205|468961270|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
130272662|NCT02623205|468961271|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
130272663|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
130272664|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
130272665|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
130272666|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
130272667|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130272668|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130272669|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
130272670|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
130272671|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
130272672|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130272673|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130272674|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130272675|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
130272676|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130272677|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130272678|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
130272679|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130272680|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130272681|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
130272682|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
130272683|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
130272684|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130272685|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130272686|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130272687|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130272688|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130272689|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
130272690|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130272691|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
130272692|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130272693|NCT03162796|468961272|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130272694|NCT03162796|468961273|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
130272695|NCT03162796|468961274|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130272696|NCT02342288|468961275|FG000|Overall Study|no protocol anesthesiologist available|3|||
130272697|NCT02342288|468961276|FG001|Overall Study|no protocol anesthesiologist available|2|||
130272698|NCT02342288|468961275|FG000|Overall Study|anesthesia leak in system|1|||
130272699|NCT02342288|468961276|FG001|Overall Study|anesthesia leak in system|0|||
130272700|NCT02342288|468961275|FG000|Overall Study|Withdrawal by Subject|1|||
130272701|NCT02342288|468961276|FG001|Overall Study|Withdrawal by Subject|0|||
130272702|NCT02342288|468961275|FG000|Overall Study|coordinator contaminated with blood|0|||
130272703|NCT02342288|468961276|FG001|Overall Study|coordinator contaminated with blood|1|||
130272704|NCT02342288|468961275|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
130272705|NCT02342288|468961276|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
130272706|NCT02342288|468961275|FG000|Overall Study|coordinator not available|0|||
130272707|NCT02342288|468961276|FG001|Overall Study|coordinator not available|2|||
130272708|NCT03082677|468961277|FG000|Overall Study|Not Treated|2|||
130272709|NCT01916824|468961284|FG000|Overall Study|Lost to Follow-up|3|||
130272710|NCT01916824|468961285|FG001|Overall Study|Lost to Follow-up|6|||
130272711|NCT01916824|468961284|FG000|Overall Study|Physician Decision|2|||
130272712|NCT01916824|468961285|FG001|Overall Study|Physician Decision|0|||
130272713|NCT01916824|468961284|FG000|Overall Study|Withdrawal by Subject|2|||
130272714|NCT01916824|468961285|FG001|Overall Study|Withdrawal by Subject|3|||
130272715|NCT00771927|468961286|FG000|Overall Study|Adverse Event|100|||
130272716|NCT00771927|468961287|FG001|Overall Study|Adverse Event|105|||
130367055|NCT02151110|469314111|FG003|Overall Study|Withdrawal by Subject|0|||
130272717|NCT00771927|468961286|FG000|Overall Study|Lack of Efficacy|70|||
130272718|NCT00771927|468961287|FG001|Overall Study|Lack of Efficacy|42|||
130272719|NCT00771927|468961286|FG000|Overall Study|Lost to Follow-up|46|||
130272720|NCT00771927|468961287|FG001|Overall Study|Lost to Follow-up|46|||
130272721|NCT00771927|468961286|FG000|Overall Study|Withdrawal by Subject|16|||
130272722|NCT00771927|468961287|FG001|Overall Study|Withdrawal by Subject|17|||
130272723|NCT00771927|468961286|FG000|Overall Study|Other reason|23|||
130272724|NCT00771927|468961287|FG001|Overall Study|Other reason|27|||
130272725|NCT03711370|468961288|FG000|Overall Study|Lost to Follow-up|16|||
130272726|NCT03711370|468961289|FG001|Overall Study|Lost to Follow-up|10|||
130272727|NCT03711370|468961288|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
130272728|NCT03711370|468961289|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
130272729|NCT00407602|468961290|FG000|Overall Study|Death - unrelated to device|1|||
130272730|NCT00407602|468961290|FG000|Overall Study|Device explanted|5|||
130272731|NCT00407602|468961290|FG000|Overall Study|Withdrawal by Subject|1|||
130272732|NCT02063984|468961291|FG000|Overall Study|Lost to Follow-up|6|||
130272733|NCT02063984|468961292|FG001|Overall Study|Lost to Follow-up|5|||
130272734|NCT02517398|468961293|FG000|Overall Study|Death|2|||
130272735|NCT02517398|468961294|FG001|Overall Study|Death|3|||
130272736|NCT02517398|468961295|FG002|Overall Study|Death|4|||
130272737|NCT02517398|468961296|FG003|Overall Study|Death|2|||
130272738|NCT02517398|468961297|FG004|Overall Study|Death|3|||
130272739|NCT02517398|468961298|FG005|Overall Study|Death|8|||
130272740|NCT02517398|468961299|FG006|Overall Study|Death|3|||
130272741|NCT02517398|468961300|FG007|Overall Study|Death|2|||
130272742|NCT02517398|468961301|FG008|Overall Study|Death|6|||
130272743|NCT02517398|468961302|FG009|Overall Study|Death|24|||
130272744|NCT02517398|468961303|FG010|Overall Study|Death|53|||
130272745|NCT02517398|468961304|FG011|Overall Study|Death|25|||
130272746|NCT02517398|468961305|FG012|Overall Study|Death|73|||
130272747|NCT02517398|468961306|FG013|Overall Study|Death|29|||
130272748|NCT02517398|468961307|FG014|Overall Study|Death|26|||
130272749|NCT02517398|468961308|FG015|Overall Study|Death|23|||
130272750|NCT02517398|468961309|FG016|Overall Study|Death|26|||
130272751|NCT02517398|468961310|FG017|Overall Study|Death|25|||
130272752|NCT02517398|468961311|FG018|Overall Study|Death|22|||
130272753|NCT02517398|468961312|FG019|Overall Study|Death|7|||
130272754|NCT02517398|468961313|FG020|Overall Study|Death|26|||
130272755|NCT02517398|468961314|FG021|Overall Study|Death|30|||
130272756|NCT02517398|468961315|FG022|Overall Study|Death|20|||
130272757|NCT02517398|468961293|FG000|Overall Study|Other|0|||
130272758|NCT02517398|468961294|FG001|Overall Study|Other|0|||
130272759|NCT02517398|468961295|FG002|Overall Study|Other|0|||
130272760|NCT02517398|468961296|FG003|Overall Study|Other|1|||
130272761|NCT02517398|468961297|FG004|Overall Study|Other|0|||
130272762|NCT02517398|468961298|FG005|Overall Study|Other|0|||
130272763|NCT02517398|468961299|FG006|Overall Study|Other|0|||
130272764|NCT02517398|468961300|FG007|Overall Study|Other|0|||
130272765|NCT02517398|468961301|FG008|Overall Study|Other|0|||
130272766|NCT02517398|468961302|FG009|Overall Study|Other|1|||
130272767|NCT02517398|468961303|FG010|Overall Study|Other|0|||
130272768|NCT02517398|468961304|FG011|Overall Study|Other|0|||
130272769|NCT02517398|468961305|FG012|Overall Study|Other|0|||
130272770|NCT02517398|468961306|FG013|Overall Study|Other|1|||
130272771|NCT02517398|468961307|FG014|Overall Study|Other|0|||
130272772|NCT02517398|468961308|FG015|Overall Study|Other|1|||
130272773|NCT02517398|468961309|FG016|Overall Study|Other|1|||
130272774|NCT02517398|468961310|FG017|Overall Study|Other|0|||
130272775|NCT02517398|468961311|FG018|Overall Study|Other|0|||
130272776|NCT02517398|468961312|FG019|Overall Study|Other|1|||
130272777|NCT02517398|468961313|FG020|Overall Study|Other|0|||
130272778|NCT02517398|468961314|FG021|Overall Study|Other|0|||
130272779|NCT02517398|468961315|FG022|Overall Study|Other|0|||
130272780|NCT02517398|468961293|FG000|Overall Study|Lost to Follow-up|0|||
130272781|NCT02517398|468961294|FG001|Overall Study|Lost to Follow-up|0|||
130272782|NCT02517398|468961295|FG002|Overall Study|Lost to Follow-up|0|||
130272783|NCT02517398|468961296|FG003|Overall Study|Lost to Follow-up|0|||
130272784|NCT02517398|468961297|FG004|Overall Study|Lost to Follow-up|0|||
130272785|NCT02517398|468961298|FG005|Overall Study|Lost to Follow-up|0|||
130272786|NCT02517398|468961299|FG006|Overall Study|Lost to Follow-up|0|||
130272787|NCT02517398|468961300|FG007|Overall Study|Lost to Follow-up|0|||
130272788|NCT02517398|468961301|FG008|Overall Study|Lost to Follow-up|0|||
130272789|NCT02517398|468961302|FG009|Overall Study|Lost to Follow-up|1|||
130272790|NCT02517398|468961303|FG010|Overall Study|Lost to Follow-up|0|||
130272791|NCT02517398|468961304|FG011|Overall Study|Lost to Follow-up|2|||
130272792|NCT02517398|468961305|FG012|Overall Study|Lost to Follow-up|2|||
130272793|NCT02517398|468961306|FG013|Overall Study|Lost to Follow-up|0|||
130272794|NCT02517398|468961307|FG014|Overall Study|Lost to Follow-up|1|||
130272795|NCT02517398|468961308|FG015|Overall Study|Lost to Follow-up|1|||
130272796|NCT02517398|468961309|FG016|Overall Study|Lost to Follow-up|0|||
130272797|NCT02517398|468961310|FG017|Overall Study|Lost to Follow-up|3|||
130272798|NCT02517398|468961311|FG018|Overall Study|Lost to Follow-up|1|||
130272799|NCT02517398|468961312|FG019|Overall Study|Lost to Follow-up|0|||
130367056|NCT02151110|469314112|FG004|Overall Study|Withdrawal by Subject|0|||
130367057|NCT02151110|469314113|FG005|Overall Study|Withdrawal by Subject|0|||
130367058|NCT02151110|469314114|FG006|Overall Study|Withdrawal by Subject|0|||
130367059|NCT02151110|469314115|FG007|Overall Study|Withdrawal by Subject|1|||
130367060|NCT02151110|469314108|FG000|Overall Study|Lost to Follow-up|0|||
130367061|NCT02151110|469314109|FG001|Overall Study|Lost to Follow-up|0|||
130367062|NCT02151110|469314110|FG002|Overall Study|Lost to Follow-up|0|||
130367063|NCT02151110|469314111|FG003|Overall Study|Lost to Follow-up|0|||
130367064|NCT02151110|469314112|FG004|Overall Study|Lost to Follow-up|0|||
130367065|NCT02151110|469314113|FG005|Overall Study|Lost to Follow-up|0|||
130367066|NCT02151110|469314114|FG006|Overall Study|Lost to Follow-up|0|||
130367067|NCT02151110|469314115|FG007|Overall Study|Lost to Follow-up|2|||
130367068|NCT02369016|469314116|FG000|Overall Study|AE associated with clinical disease progression|2|||
130367069|NCT02369016|469314117|FG001|Overall Study|AE associated with clinical disease progression|1|||
130367070|NCT02369016|469314116|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
130367071|NCT02369016|469314117|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
130367072|NCT02369016|469314116|FG000|Overall Study|Progressive disease - clinical progression|1|||
130367073|NCT02369016|469314117|FG001|Overall Study|Progressive disease - clinical progression|4|||
130367074|NCT02369016|469314116|FG000|Overall Study|withdrawal by patient|4|||
130367075|NCT02369016|469314117|FG001|Overall Study|withdrawal by patient|0|||
130367076|NCT02369016|469314116|FG000|Overall Study|Progressive disease - radiological progression|6|||
130367077|NCT02369016|469314117|FG001|Overall Study|Progressive disease - radiological progression|2|||
130367078|NCT02229383|469314118|FG000|Overall Study|Adverse Event|7|||
130367079|NCT02229383|469314119|FG001|Overall Study|Adverse Event|4|||
130367080|NCT02229383|469314118|FG000|Overall Study|Death|0|||
130367081|NCT02229383|469314119|FG001|Overall Study|Death|1|||
130367082|NCT02229383|469314118|FG000|Overall Study|Lost to Follow-up|5|||
130367083|NCT02229383|469314119|FG001|Overall Study|Lost to Follow-up|3|||
130367084|NCT02229383|469314118|FG000|Overall Study|Withdrawal by Subject|4|||
130367085|NCT02229383|469314119|FG001|Overall Study|Withdrawal by Subject|6|||
130367086|NCT02229383|469314118|FG000|Overall Study|Did not receive treatment|1|||
130367087|NCT02229383|469314119|FG001|Overall Study|Did not receive treatment|0|||
130367088|NCT02229383|469314118|FG000|Overall Study|Other|3|||
130367089|NCT02229383|469314119|FG001|Overall Study|Other|8|||
130367090|NCT01201850|469314124|FG000|Overall Study|Tumor progression|4|||
130367091|NCT01817530|469314129|FG000|Overall Study|Exclusionary Medication Received|0|||
130367092|NCT01817530|469314130|FG001|Overall Study|Exclusionary Medication Received|0|||
130367093|NCT01817530|469314131|FG002|Overall Study|Exclusionary Medication Received|0|||
130367094|NCT01817530|469314132|FG003|Overall Study|Exclusionary Medication Received|0|||
130367095|NCT01817530|469314133|FG004|Overall Study|Exclusionary Medication Received|1|||
130367096|NCT01817530|469314134|FG005|Overall Study|Exclusionary Medication Received|0|||
130367097|NCT01817530|469314135|FG006|Overall Study|Exclusionary Medication Received|0|||
130367098|NCT01817530|469314136|FG007|Overall Study|Exclusionary Medication Received|0|||
130367099|NCT01817530|469314129|FG000|Overall Study|Adverse Event|6|||
130367100|NCT01817530|469314130|FG001|Overall Study|Adverse Event|3|||
130367101|NCT01817530|469314131|FG002|Overall Study|Adverse Event|2|||
130367102|NCT01817530|469314132|FG003|Overall Study|Adverse Event|5|||
130367103|NCT01817530|469314133|FG004|Overall Study|Adverse Event|0|||
130367104|NCT01817530|469314134|FG005|Overall Study|Adverse Event|10|||
130367105|NCT01817530|469314135|FG006|Overall Study|Adverse Event|5|||
130367106|NCT01817530|469314136|FG007|Overall Study|Adverse Event|8|||
130367107|NCT01817530|469314129|FG000|Overall Study|Subject Noncompliant|3|||
130367108|NCT01817530|469314130|FG001|Overall Study|Subject Noncompliant|1|||
130367109|NCT01817530|469314131|FG002|Overall Study|Subject Noncompliant|0|||
130367110|NCT01817530|469314132|FG003|Overall Study|Subject Noncompliant|4|||
130367111|NCT01817530|469314133|FG004|Overall Study|Subject Noncompliant|0|||
130367112|NCT01817530|469314134|FG005|Overall Study|Subject Noncompliant|1|||
130367113|NCT01817530|469314135|FG006|Overall Study|Subject Noncompliant|1|||
130706633|NCT03581188|470551508|FG000|Overall Study|Inclusion criteria not met|3|||
130706634|NCT03581188|470551509|FG001|Overall Study|Inclusion criteria not met|2|||
130706635|NCT03581188|470551508|FG000|Overall Study|Lost to Follow-up|5|||
130706636|NCT03581188|470551509|FG001|Overall Study|Lost to Follow-up|5|||
130367114|NCT01817530|469314136|FG007|Overall Study|Subject Noncompliant|1|||
130367115|NCT01817530|469314129|FG000|Overall Study|Lack of Efficacy|1|||
130367116|NCT01817530|469314130|FG001|Overall Study|Lack of Efficacy|0|||
130456278|NCT04107805|469634892|FG001|Overall Study|Adverse Event|0|||
130456279|NCT04107805|469634893|FG002|Overall Study|Adverse Event|0|||
130456280|NCT04107805|469634894|FG003|Overall Study|Adverse Event|1|||
130456281|NCT04107805|469634895|FG004|Overall Study|Adverse Event|0|||
130367117|NCT01817530|469314131|FG002|Overall Study|Lack of Efficacy|0|||
130367118|NCT01817530|469314132|FG003|Overall Study|Lack of Efficacy|0|||
130367119|NCT01817530|469314133|FG004|Overall Study|Lack of Efficacy|0|||
130367120|NCT01817530|469314134|FG005|Overall Study|Lack of Efficacy|1|||
130706637|NCT03581188|470551508|FG000|Overall Study|Discontinued intervention|11|||
130706638|NCT03581188|470551509|FG001|Overall Study|Discontinued intervention|8|||
130367121|NCT01817530|469314135|FG006|Overall Study|Lack of Efficacy|0|||
130456282|NCT04107805|469634896|FG005|Overall Study|Adverse Event|1|||
130456283|NCT04107805|469634897|FG006|Overall Study|Adverse Event|0|||
130456284|NCT04107805|469634898|FG007|Overall Study|Adverse Event|0|||
130456285|NCT04107805|469634899|FG008|Overall Study|Adverse Event|1|||
130456286|NCT00404079|469634900|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
130456287|NCT00404079|469634901|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
130456288|NCT01120275|469634902|FG000|Overall Study|Adverse Event|3|||
130272800|NCT02517398|468961313|FG020|Overall Study|Lost to Follow-up|1|||
130272801|NCT02517398|468961314|FG021|Overall Study|Lost to Follow-up|0|||
130272802|NCT02517398|468961315|FG022|Overall Study|Lost to Follow-up|2|||
130272803|NCT02517398|468961293|FG000|Overall Study|Withdrew Consent|0|||
130272804|NCT02517398|468961294|FG001|Overall Study|Withdrew Consent|0|||
130272805|NCT02517398|468961295|FG002|Overall Study|Withdrew Consent|0|||
130272806|NCT02517398|468961296|FG003|Overall Study|Withdrew Consent|0|||
130272807|NCT02517398|468961297|FG004|Overall Study|Withdrew Consent|0|||
130272808|NCT02517398|468961298|FG005|Overall Study|Withdrew Consent|0|||
130272809|NCT02517398|468961299|FG006|Overall Study|Withdrew Consent|1|||
130272810|NCT02517398|468961300|FG007|Overall Study|Withdrew Consent|0|||
130272811|NCT02517398|468961301|FG008|Overall Study|Withdrew Consent|0|||
130272812|NCT02517398|468961302|FG009|Overall Study|Withdrew Consent|2|||
130272813|NCT02517398|468961303|FG010|Overall Study|Withdrew Consent|7|||
130272814|NCT02517398|468961304|FG011|Overall Study|Withdrew Consent|1|||
130272815|NCT02517398|468961305|FG012|Overall Study|Withdrew Consent|5|||
130272816|NCT02517398|468961306|FG013|Overall Study|Withdrew Consent|4|||
130272817|NCT02517398|468961307|FG014|Overall Study|Withdrew Consent|2|||
130272818|NCT02517398|468961308|FG015|Overall Study|Withdrew Consent|5|||
130272819|NCT02517398|468961309|FG016|Overall Study|Withdrew Consent|4|||
130272820|NCT02517398|468961310|FG017|Overall Study|Withdrew Consent|2|||
130272821|NCT02517398|468961311|FG018|Overall Study|Withdrew Consent|3|||
130272822|NCT02517398|468961312|FG019|Overall Study|Withdrew Consent|2|||
130272823|NCT02517398|468961313|FG020|Overall Study|Withdrew Consent|9|||
130272824|NCT02517398|468961314|FG021|Overall Study|Withdrew Consent|3|||
130272825|NCT02517398|468961315|FG022|Overall Study|Withdrew Consent|1|||
130272826|NCT00005947|468961317|FG000|Overall Study|Death|54|||
130272827|NCT00005947|468961318|FG001|Overall Study|Death|40|||
130272828|NCT00005947|468961317|FG000|Overall Study|Patient Refused to Continue|2|||
130272829|NCT00005947|468961318|FG001|Overall Study|Patient Refused to Continue|1|||
130272830|NCT00005947|468961317|FG000|Overall Study|Site Closure|1|||
130272831|NCT00005947|468961318|FG001|Overall Study|Site Closure|0|||
130272832|NCT00429182|468961319|FG000|Overall Study|Not evaluable, Disease Progression|2|||
130272833|NCT00429182|468961319|FG000|Overall Study|Not eligible|5|||
130272834|NCT00790582|468961321|FG000|Overall Study|Death|14|||
130272835|NCT00790582|468961322|FG001|Overall Study|Death|32|||
130272836|NCT00790582|468961321|FG000|Overall Study|Physician Decision|7|||
130272837|NCT00790582|468961322|FG001|Overall Study|Physician Decision|1|||
130272838|NCT00790582|468961321|FG000|Overall Study|Lost to Follow-up|3|||
130272839|NCT00790582|468961322|FG001|Overall Study|Lost to Follow-up|3|||
130272840|NCT00790582|468961321|FG000|Overall Study|Withdrawal by Subject|7|||
130272841|NCT00790582|468961322|FG001|Overall Study|Withdrawal by Subject|51|||
130272842|NCT02195700|468961324|FG000|Overall Study|Protocol Violation|0|||
130272843|NCT02195700|468961325|FG001|Overall Study|Protocol Violation|2|||
130272844|NCT02195700|468961324|FG000|Overall Study|Noncompliance|1|||
130272845|NCT02195700|468961325|FG001|Overall Study|Noncompliance|0|||
130272846|NCT02195700|468961324|FG000|Overall Study|Adverse Event|1|||
130272847|NCT02195700|468961325|FG001|Overall Study|Adverse Event|2|||
130272848|NCT02195700|468961324|FG000|Overall Study|Withdrawal by Subject|3|||
130272849|NCT02195700|468961325|FG001|Overall Study|Withdrawal by Subject|2|||
130272850|NCT02195700|468961324|FG000|Overall Study|Lost to Follow-up|1|||
130272851|NCT02195700|468961325|FG001|Overall Study|Lost to Follow-up|1|||
130272852|NCT02931838|468961326|FG000|Overall Study|Reason not provided by investigator|1|||
130272853|NCT02931838|468961327|FG001|Overall Study|Reason not provided by investigator|0|||
130272854|NCT02931838|468961328|FG002|Overall Study|Reason not provided by investigator|1|||
130272855|NCT02931838|468961329|FG003|Overall Study|Reason not provided by investigator|0|||
130272856|NCT02931838|468961330|FG004|Overall Study|Reason not provided by investigator|0|||
130272857|NCT02931838|468961331|FG005|Overall Study|Reason not provided by investigator|0|||
130272858|NCT02931838|468961326|FG000|Overall Study|Poor/non-compliance|0|||
130272859|NCT02931838|468961327|FG001|Overall Study|Poor/non-compliance|0|||
130272860|NCT02931838|468961328|FG002|Overall Study|Poor/non-compliance|1|||
130272861|NCT02931838|468961329|FG003|Overall Study|Poor/non-compliance|0|||
130272862|NCT02931838|468961330|FG004|Overall Study|Poor/non-compliance|0|||
130456289|NCT01120275|469634902|FG000|Overall Study|Progression|27|||
130272863|NCT02931838|468961331|FG005|Overall Study|Poor/non-compliance|0|||
130272864|NCT02931838|468961326|FG000|Overall Study|Lack of Efficacy|5|||
130272865|NCT02931838|468961327|FG001|Overall Study|Lack of Efficacy|4|||
130272866|NCT02931838|468961328|FG002|Overall Study|Lack of Efficacy|0|||
130272867|NCT02931838|468961329|FG003|Overall Study|Lack of Efficacy|0|||
130272868|NCT02931838|468961330|FG004|Overall Study|Lack of Efficacy|0|||
130272869|NCT02931838|468961331|FG005|Overall Study|Lack of Efficacy|1|||
130272870|NCT02931838|468961326|FG000|Overall Study|Lost to Follow-up|1|||
130456290|NCT01120275|469634902|FG000|Overall Study|Ineligible|3|||
130367122|NCT01817530|469314136|FG007|Overall Study|Lack of Efficacy|1|||
130367123|NCT01817530|469314129|FG000|Overall Study|Pregnancy|0|||
130367124|NCT01817530|469314130|FG001|Overall Study|Pregnancy|0|||
130367125|NCT01817530|469314131|FG002|Overall Study|Pregnancy|0|||
130367126|NCT01817530|469314132|FG003|Overall Study|Pregnancy|0|||
130367127|NCT01817530|469314133|FG004|Overall Study|Pregnancy|0|||
130367128|NCT01817530|469314134|FG005|Overall Study|Pregnancy|1|||
130367129|NCT01817530|469314135|FG006|Overall Study|Pregnancy|0|||
130367130|NCT01817530|469314136|FG007|Overall Study|Pregnancy|0|||
130367131|NCT01817530|469314129|FG000|Overall Study|Other|0|||
130367132|NCT01817530|469314130|FG001|Overall Study|Other|1|||
130367133|NCT01817530|469314131|FG002|Overall Study|Other|0|||
130367134|NCT01817530|469314132|FG003|Overall Study|Other|0|||
130367135|NCT01817530|469314133|FG004|Overall Study|Other|1|||
130272871|NCT02931838|468961327|FG001|Overall Study|Lost to Follow-up|0|||
130272872|NCT02931838|468961328|FG002|Overall Study|Lost to Follow-up|1|||
130272873|NCT02931838|468961329|FG003|Overall Study|Lost to Follow-up|1|||
130272874|NCT02931838|468961330|FG004|Overall Study|Lost to Follow-up|2|||
130272875|NCT02931838|468961331|FG005|Overall Study|Lost to Follow-up|0|||
130272876|NCT02931838|468961326|FG000|Overall Study|Subject request to discontinue treatment|4|||
130272877|NCT02931838|468961327|FG001|Overall Study|Subject request to discontinue treatment|3|||
130272878|NCT02931838|468961328|FG002|Overall Study|Subject request to discontinue treatment|3|||
130272879|NCT02931838|468961329|FG003|Overall Study|Subject request to discontinue treatment|0|||
130272880|NCT02931838|468961330|FG004|Overall Study|Subject request to discontinue treatment|1|||
130272881|NCT02931838|468961331|FG005|Overall Study|Subject request to discontinue treatment|0|||
130272882|NCT02931838|468961326|FG000|Overall Study|Withdrawal by Subject|1|||
130272883|NCT02931838|468961327|FG001|Overall Study|Withdrawal by Subject|2|||
130272884|NCT02931838|468961328|FG002|Overall Study|Withdrawal by Subject|0|||
130272885|NCT02931838|468961329|FG003|Overall Study|Withdrawal by Subject|1|||
130272886|NCT02931838|468961330|FG004|Overall Study|Withdrawal by Subject|0|||
130272887|NCT02931838|468961331|FG005|Overall Study|Withdrawal by Subject|0|||
130272888|NCT02931838|468961326|FG000|Overall Study|Adverse Event|2|||
130272889|NCT02931838|468961327|FG001|Overall Study|Adverse Event|1|||
130272890|NCT02931838|468961328|FG002|Overall Study|Adverse Event|2|||
130272891|NCT02931838|468961329|FG003|Overall Study|Adverse Event|1|||
130272892|NCT02931838|468961330|FG004|Overall Study|Adverse Event|3|||
130272893|NCT02931838|468961331|FG005|Overall Study|Adverse Event|1|||
130272894|NCT03110029|468961332|FG000|Overall Study|Withdrawal by Subject|1|||
130272895|NCT03110029|468961333|FG001|Overall Study|Withdrawal by Subject|1|||
130272896|NCT01042158|468961334|FG000|Overall Study|Physician Decision|1|||
130272897|NCT05823974|468963646|FG000|Overall Study|Lost to Follow-up|0|||
130272898|NCT05823974|468963647|FG001|Overall Study|Lost to Follow-up|3|||
130272899|NCT05823974|468963648|FG002|Overall Study|Lost to Follow-up|1|||
130272900|NCT05823974|468963649|FG003|Overall Study|Lost to Follow-up|0|||
130272901|NCT05823974|468963650|FG004|Overall Study|Lost to Follow-up|1|||
130272902|NCT05823974|468963651|FG005|Overall Study|Lost to Follow-up|0|||
130272903|NCT05823974|468963652|FG006|Overall Study|Lost to Follow-up|1|||
130272904|NCT05823974|468963653|FG007|Overall Study|Lost to Follow-up|0|||
130272905|NCT05823974|468963654|FG008|Overall Study|Lost to Follow-up|0|||
130272906|NCT05823974|468963655|FG009|Overall Study|Lost to Follow-up|1|||
130367136|NCT01817530|469314134|FG005|Overall Study|Other|0|||
130367137|NCT01817530|469314135|FG006|Overall Study|Other|5|||
130367138|NCT01817530|469314136|FG007|Overall Study|Other|0|||
130456291|NCT01120275|469634902|FG000|Overall Study|Withdrawal by Subject|1|||
130456292|NCT01120275|469634902|FG000|Overall Study|Refusal|1|||
130456293|NCT01120275|469634902|FG000|Overall Study|Not specific|1|||
130456294|NCT00880906|469634903|FG000|Overall Study|Lost to Follow-up|0|||
130272907|NCT05823974|468963656|FG010|Overall Study|Lost to Follow-up|1|||
130272908|NCT05823974|468963657|FG011|Overall Study|Lost to Follow-up|0|||
130272909|NCT05823974|468963658|FG012|Overall Study|Lost to Follow-up|1|||
130272910|NCT05823974|468963659|FG013|Overall Study|Lost to Follow-up|2|||
130272911|NCT05823974|468963660|FG014|Overall Study|Lost to Follow-up|1|||
130272912|NCT05823974|468963661|FG015|Overall Study|Lost to Follow-up|1|||
130272913|NCT05823974|468963662|FG016|Overall Study|Lost to Follow-up|1|||
130272914|NCT05823974|468963663|FG017|Overall Study|Lost to Follow-up|0|||
130272915|NCT05823974|468963664|FG018|Overall Study|Lost to Follow-up|0|||
130272916|NCT05823974|468963665|FG019|Overall Study|Lost to Follow-up|2|||
130272917|NCT05823974|468963666|FG020|Overall Study|Lost to Follow-up|0|||
130272918|NCT05823974|468963646|FG000|Overall Study|Physician Decision|0|||
130272919|NCT05823974|468963647|FG001|Overall Study|Physician Decision|0|||
130272920|NCT05823974|468963648|FG002|Overall Study|Physician Decision|0|||
130272921|NCT05823974|468963649|FG003|Overall Study|Physician Decision|0|||
130272922|NCT05823974|468963650|FG004|Overall Study|Physician Decision|0|||
130367139|NCT01817530|469314129|FG000|Overall Study|Surgery or Invasive Intervention|1|||
130367140|NCT01817530|469314130|FG001|Overall Study|Surgery or Invasive Intervention|0|||
130367141|NCT01817530|469314131|FG002|Overall Study|Surgery or Invasive Intervention|0|||
130367142|NCT01817530|469314132|FG003|Overall Study|Surgery or Invasive Intervention|0|||
130272923|NCT05823974|468963651|FG005|Overall Study|Physician Decision|0|||
130367143|NCT01817530|469314133|FG004|Overall Study|Surgery or Invasive Intervention|1|||
130456295|NCT00880906|469634904|FG001|Overall Study|Lost to Follow-up|1|||
130367144|NCT01817530|469314134|FG005|Overall Study|Surgery or Invasive Intervention|1|||
130367145|NCT01817530|469314135|FG006|Overall Study|Surgery or Invasive Intervention|1|||
130367146|NCT01817530|469314136|FG007|Overall Study|Surgery or Invasive Intervention|0|||
130367147|NCT01817530|469314129|FG000|Overall Study|Consent Withdrawn by Subject|3|||
130367148|NCT01817530|469314130|FG001|Overall Study|Consent Withdrawn by Subject|4|||
130367149|NCT01817530|469314131|FG002|Overall Study|Consent Withdrawn by Subject|7|||
130367150|NCT01817530|469314132|FG003|Overall Study|Consent Withdrawn by Subject|3|||
130367151|NCT01817530|469314133|FG004|Overall Study|Consent Withdrawn by Subject|5|||
130367152|NCT01817530|469314134|FG005|Overall Study|Consent Withdrawn by Subject|3|||
130367153|NCT01817530|469314135|FG006|Overall Study|Consent Withdrawn by Subject|3|||
130367154|NCT01817530|469314136|FG007|Overall Study|Consent Withdrawn by Subject|10|||
130367155|NCT01817530|469314129|FG000|Overall Study|Lost to Follow-up|1|||
130367156|NCT01817530|469314130|FG001|Overall Study|Lost to Follow-up|4|||
130367157|NCT01817530|469314131|FG002|Overall Study|Lost to Follow-up|2|||
130367158|NCT01817530|469314132|FG003|Overall Study|Lost to Follow-up|1|||
130367159|NCT01817530|469314133|FG004|Overall Study|Lost to Follow-up|3|||
130367160|NCT01817530|469314134|FG005|Overall Study|Lost to Follow-up|2|||
130367161|NCT01817530|469314135|FG006|Overall Study|Lost to Follow-up|8|||
130367162|NCT01817530|469314136|FG007|Overall Study|Lost to Follow-up|4|||
130367163|NCT00404235|469314138|FG000|Overall Study|Withdrawal by Subject|1|||
130367164|NCT00404235|469314139|FG001|Overall Study|Withdrawal by Subject|2|||
130367165|NCT00594659|469314140|FG000|Overall Study|Lost to Follow-up|13|||
130367166|NCT00594659|469314141|FG001|Overall Study|Lost to Follow-up|9|||
130272924|NCT05823974|468963652|FG006|Overall Study|Physician Decision|0|||
130272925|NCT05823974|468963653|FG007|Overall Study|Physician Decision|0|||
130272926|NCT05823974|468963654|FG008|Overall Study|Physician Decision|0|||
130272927|NCT05823974|468963655|FG009|Overall Study|Physician Decision|0|||
130272928|NCT05823974|468963656|FG010|Overall Study|Physician Decision|0|||
130272929|NCT05823974|468963657|FG011|Overall Study|Physician Decision|0|||
130272930|NCT05823974|468963658|FG012|Overall Study|Physician Decision|0|||
130272931|NCT05823974|468963659|FG013|Overall Study|Physician Decision|0|||
130272932|NCT05823974|468963660|FG014|Overall Study|Physician Decision|0|||
130272933|NCT05823974|468963661|FG015|Overall Study|Physician Decision|1|||
130272934|NCT05823974|468963662|FG016|Overall Study|Physician Decision|0|||
130272935|NCT05823974|468963663|FG017|Overall Study|Physician Decision|1|||
130272936|NCT05823974|468963664|FG018|Overall Study|Physician Decision|1|||
130272937|NCT05823974|468963665|FG019|Overall Study|Physician Decision|0|||
130272938|NCT05823974|468963666|FG020|Overall Study|Physician Decision|0|||
130272939|NCT05823974|468963646|FG000|Overall Study|Withdrawal by Subject|1|||
130272940|NCT05823974|468963647|FG001|Overall Study|Withdrawal by Subject|1|||
130272941|NCT05823974|468963648|FG002|Overall Study|Withdrawal by Subject|2|||
130272942|NCT05823974|468963649|FG003|Overall Study|Withdrawal by Subject|0|||
130272943|NCT05823974|468963650|FG004|Overall Study|Withdrawal by Subject|2|||
130272944|NCT05823974|468963651|FG005|Overall Study|Withdrawal by Subject|3|||
130272945|NCT05823974|468963652|FG006|Overall Study|Withdrawal by Subject|1|||
130272946|NCT05823974|468963653|FG007|Overall Study|Withdrawal by Subject|1|||
130272947|NCT05823974|468963654|FG008|Overall Study|Withdrawal by Subject|2|||
130272948|NCT05823974|468963655|FG009|Overall Study|Withdrawal by Subject|1|||
130272949|NCT05823974|468963656|FG010|Overall Study|Withdrawal by Subject|1|||
130272950|NCT05823974|468963657|FG011|Overall Study|Withdrawal by Subject|0|||
130272951|NCT05823974|468963658|FG012|Overall Study|Withdrawal by Subject|0|||
130272952|NCT05823974|468963659|FG013|Overall Study|Withdrawal by Subject|1|||
130272953|NCT05823974|468963660|FG014|Overall Study|Withdrawal by Subject|1|||
130272954|NCT05823974|468963661|FG015|Overall Study|Withdrawal by Subject|3|||
130272955|NCT05823974|468963662|FG016|Overall Study|Withdrawal by Subject|0|||
130272956|NCT05823974|468963663|FG017|Overall Study|Withdrawal by Subject|2|||
130272957|NCT05823974|468963664|FG018|Overall Study|Withdrawal by Subject|2|||
130272958|NCT05823974|468963665|FG019|Overall Study|Withdrawal by Subject|0|||
130272959|NCT05823974|468963666|FG020|Overall Study|Withdrawal by Subject|1|||
130456296|NCT00880906|469634903|FG000|Overall Study|Did not meet criteria following patholog|12|||
130456297|NCT00880906|469634904|FG001|Overall Study|Did not meet criteria following patholog|6|||
130456298|NCT00559949|469634907|FG000|Overall Study|Progressive Disease during cycle 1|1|||
130456299|NCT00559949|469634907|FG000|Overall Study|Adverse Event|1|||
130456300|NCT00559949|469634907|FG000|Overall Study|Withdrawal by Subject|4|||
130456301|NCT00559949|469634907|FG000|Overall Study|No disease evaluation per protocol|1|||
130456302|NCT01235949|469634910|FG000|Primary Phase|Migrated/moved from study area|1|||
130272960|NCT05823974|468963646|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272961|NCT05823974|468963647|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272962|NCT05823974|468963648|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130272963|NCT05823974|468963649|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272964|NCT05823974|468963650|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130367167|NCT00594659|469314142|FG002|Overall Study|Lost to Follow-up|7|||
130367168|NCT04560998|469314148|FG000|Overall Study|Withdrawal by Subject|18|||
130367169|NCT04560998|469314149|FG001|Overall Study|Withdrawal by Subject|12|||
130367170|NCT04560998|469314148|FG000|Overall Study|Lost to Follow-up|8|||
130272965|NCT05823974|468963651|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272966|NCT05823974|468963652|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272967|NCT05823974|468963653|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272968|NCT05823974|468963654|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272969|NCT05823974|468963655|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272970|NCT05823974|468963656|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272971|NCT05823974|468963657|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272972|NCT05823974|468963658|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272973|NCT05823974|468963659|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272974|NCT05823974|468963660|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130272975|NCT05823974|468963661|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272976|NCT05823974|468963662|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272977|NCT05823974|468963663|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272978|NCT05823974|468963664|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272979|NCT05823974|468963665|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272980|NCT05823974|468963666|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272981|NCT05823974|468963646|FG000|Overall Study|Other|0|||
130272982|NCT05823974|468963647|FG001|Overall Study|Other|1|||
130272983|NCT05823974|468963648|FG002|Overall Study|Other|1|||
130272984|NCT05823974|468963649|FG003|Overall Study|Other|1|||
130272985|NCT05823974|468963650|FG004|Overall Study|Other|0|||
130272986|NCT05823974|468963651|FG005|Overall Study|Other|1|||
130272987|NCT05823974|468963652|FG006|Overall Study|Other|1|||
130272988|NCT05823974|468963653|FG007|Overall Study|Other|1|||
130272989|NCT05823974|468963654|FG008|Overall Study|Other|1|||
130272990|NCT05823974|468963655|FG009|Overall Study|Other|0|||
130272991|NCT05823974|468963656|FG010|Overall Study|Other|0|||
130272992|NCT05823974|468963657|FG011|Overall Study|Other|0|||
130272993|NCT05823974|468963658|FG012|Overall Study|Other|2|||
130272994|NCT05823974|468963659|FG013|Overall Study|Other|1|||
130272995|NCT05823974|468963660|FG014|Overall Study|Other|0|||
130272996|NCT05823974|468963661|FG015|Overall Study|Other|1|||
130272997|NCT05823974|468963662|FG016|Overall Study|Other|0|||
130272998|NCT05823974|468963663|FG017|Overall Study|Other|0|||
130272999|NCT05823974|468963664|FG018|Overall Study|Other|0|||
130273000|NCT05823974|468963665|FG019|Overall Study|Other|0|||
130273001|NCT05823974|468963666|FG020|Overall Study|Other|0|||
130273002|NCT00316706|468963667|FG000|Overall Study|Lost to Follow-up|38|||
130273003|NCT00316706|468963668|FG001|Overall Study|Lost to Follow-up|48|||
130273004|NCT02220855|468963669|FG000|Overall Study|Adverse Event|8|||
130273005|NCT02220855|468963669|FG000|Overall Study|Disease Progression|5|||
130273006|NCT02220855|468963669|FG000|Overall Study|Withdrawal by Subject|1|||
130273007|NCT03280303|468963670|FG000|Overall Study|Death|505|||
130273008|NCT03280303|468963670|FG000|Overall Study|Study terminated by sponsor|383|||
130273009|NCT03280303|468963670|FG000|Overall Study|Other|148|||
130273010|NCT03280303|468963670|FG000|Overall Study|No longer willing to participate in study|101|||
130273011|NCT03280303|468963670|FG000|Overall Study|Lost to follow up|39|||
130273012|NCT03280303|468963670|FG000|Overall Study|Adverse Event|20|||
130273013|NCT03419897|468963671|FG000|Overall Study|Death|180|||
130273014|NCT03419897|468963671|FG000|Overall Study|Lost to Follow-up|1|||
130273015|NCT03419897|468963671|FG000|Overall Study|Withdrawal by Subject|6|||
130273016|NCT03419897|468963671|FG000|Overall Study|Sponsor Decision|61|||
130456303|NCT01235949|469634911|FG001|Primary Phase|Migrated/moved from study area|1|||
130456304|NCT01235949|469634912|FG002|Primary Phase|Migrated/moved from study area|0|||
130456305|NCT01235949|469634913|FG003|Primary Phase|Migrated/moved from study area|0|||
130456306|NCT01235949|469634914|FG004|Primary Phase|Migrated/moved from study area|1|||
130456307|NCT01235949|469634915|FG005|Primary Phase|Migrated/moved from study area|2|||
130456308|NCT01235949|469634916|FG006|Primary Phase|Migrated/moved from study area|0|||
130456309|NCT01235949|469634917|FG007|Primary Phase|Migrated/moved from study area|0|||
130706639|NCT02124902|470551512|FG000|Overall Study|Adverse Event|7|||
130706640|NCT02124902|470551513|FG001|Overall Study|Adverse Event|2|||
130706641|NCT02124902|470551512|FG000|Overall Study|Went to alternative treatment|4|||
130273017|NCT03419897|468963671|FG000|Overall Study|Physician Decision|1|||
130273018|NCT02222688|468963684|FG000|Overall Study|Withdrawal by Subject|0|||
130456310|NCT01235949|469634918|FG008|Primary Phase|Migrated/moved from study area|0|||
130273019|NCT02222688|468963685|FG001|Overall Study|Withdrawal by Subject|0|||
130273020|NCT02222688|468963686|FG002|Overall Study|Withdrawal by Subject|0|||
130273021|NCT02222688|468963687|FG003|Overall Study|Withdrawal by Subject|2|||
130273022|NCT02222688|468963688|FG004|Overall Study|Withdrawal by Subject|1|||
130273023|NCT02222688|468963689|FG005|Overall Study|Withdrawal by Subject|0|||
130273024|NCT02222688|468963690|FG006|Overall Study|Withdrawal by Subject|1|||
130273025|NCT02222688|468963684|FG000|Overall Study|Disease progression|1|||
130273026|NCT02222688|468963685|FG001|Overall Study|Disease progression|0|||
130273027|NCT02222688|468963686|FG002|Overall Study|Disease progression|0|||
130273028|NCT02222688|468963687|FG003|Overall Study|Disease progression|0|||
130273029|NCT02222688|468963688|FG004|Overall Study|Disease progression|0|||
130273030|NCT02222688|468963689|FG005|Overall Study|Disease progression|0|||
130273031|NCT02222688|468963690|FG006|Overall Study|Disease progression|0|||
130273032|NCT00958360|468963700|FG000|Overall Study|Withdrawal by Subject|3|||
130273033|NCT00958360|468963701|FG001|Overall Study|Withdrawal by Subject|1|||
130273034|NCT00958360|468963700|FG000|Overall Study|Death|6|||
130273035|NCT00958360|468963701|FG001|Overall Study|Death|7|||
130273036|NCT00958360|468963700|FG000|Overall Study|Physician Decision|2|||
130273037|NCT00958360|468963701|FG001|Overall Study|Physician Decision|1|||
130273038|NCT00958360|468963700|FG000|Overall Study|Lost to Follow-up|0|||
130273039|NCT00958360|468963701|FG001|Overall Study|Lost to Follow-up|1|||
130273040|NCT03107052|468963702|FG000|Overall Study|Adverse Event|6|||
130273041|NCT03107052|468963703|FG001|Overall Study|Adverse Event|1|||
130273042|NCT03107052|468963704|FG002|Overall Study|Adverse Event|2|||
130273043|NCT03107052|468963702|FG000|Overall Study|Withdrawal by Subject|9|||
130273044|NCT03107052|468963703|FG001|Overall Study|Withdrawal by Subject|5|||
130273045|NCT03107052|468963704|FG002|Overall Study|Withdrawal by Subject|8|||
130273046|NCT03107052|468963702|FG000|Overall Study|Protocol Violation|6|||
130273047|NCT03107052|468963703|FG001|Overall Study|Protocol Violation|0|||
130273048|NCT03107052|468963704|FG002|Overall Study|Protocol Violation|3|||
130273049|NCT03107052|468963702|FG000|Overall Study|Lost to Follow-up|4|||
130273050|NCT03107052|468963703|FG001|Overall Study|Lost to Follow-up|0|||
130273051|NCT03107052|468963704|FG002|Overall Study|Lost to Follow-up|1|||
130273052|NCT03107052|468963702|FG000|Overall Study|Lack of Efficacy|23|||
130273053|NCT03107052|468963703|FG001|Overall Study|Lack of Efficacy|7|||
130273054|NCT03107052|468963704|FG002|Overall Study|Lack of Efficacy|4|||
130273055|NCT03107052|468963702|FG000|Overall Study|Other than specified|4|||
130273056|NCT03107052|468963703|FG001|Overall Study|Other than specified|2|||
130273057|NCT03107052|468963704|FG002|Overall Study|Other than specified|0|||
130273058|NCT03107052|468963702|FG000|Overall Study|Study terminated due to futility|67|||
130273059|NCT03107052|468963703|FG001|Overall Study|Study terminated due to futility|31|||
130273060|NCT03107052|468963704|FG002|Overall Study|Study terminated due to futility|23|||
130273061|NCT02719691|468963706|FG000|Overall Study|Physician Decision|0|||
130273062|NCT02719691|468963707|FG001|Overall Study|Physician Decision|0|||
130273063|NCT02719691|468963708|FG002|Overall Study|Physician Decision|1|||
130273064|NCT02719691|468963709|FG003|Overall Study|Physician Decision|0|||
130273065|NCT02719691|468963710|FG004|Overall Study|Physician Decision|0|||
130273066|NCT02719691|468963711|FG005|Overall Study|Physician Decision|0|||
130273067|NCT02719691|468963712|FG006|Overall Study|Physician Decision|0|||
130273068|NCT02719691|468963706|FG000|Overall Study|Withdrawal by Subject|0|||
130273069|NCT02719691|468963707|FG001|Overall Study|Withdrawal by Subject|0|||
130273070|NCT02719691|468963708|FG002|Overall Study|Withdrawal by Subject|0|||
130273071|NCT02719691|468963709|FG003|Overall Study|Withdrawal by Subject|0|||
130273072|NCT02719691|468963710|FG004|Overall Study|Withdrawal by Subject|0|||
130273073|NCT02719691|468963711|FG005|Overall Study|Withdrawal by Subject|1|||
130273074|NCT02719691|468963712|FG006|Overall Study|Withdrawal by Subject|0|||
130273075|NCT00336284|468963715|FG000|Overall Study|Death|52|||
130273076|NCT00336284|468963716|FG001|Overall Study|Death|26|||
130273077|NCT00336284|468963715|FG000|Overall Study|Lost to Follow-up|82|||
130273078|NCT00336284|468963716|FG001|Overall Study|Lost to Follow-up|61|||
130273079|NCT00336284|468963715|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
130273080|NCT00336284|468963716|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
130273081|NCT00861757|468963719|FG000|Overall Study|Adverse Event|1|||
130273082|NCT00861757|468963720|FG001|Overall Study|Adverse Event|5|||
130273083|NCT00861757|468963721|FG002|Overall Study|Adverse Event|7|||
130273084|NCT00861757|468963722|FG003|Overall Study|Adverse Event|2|||
130273085|NCT00861757|468963719|FG000|Overall Study|Entry Criteria Not Met|1|||
130273086|NCT00861757|468963720|FG001|Overall Study|Entry Criteria Not Met|2|||
130273087|NCT00861757|468963721|FG002|Overall Study|Entry Criteria Not Met|1|||
130273088|NCT00861757|468963722|FG003|Overall Study|Entry Criteria Not Met|1|||
130273089|NCT00861757|468963719|FG000|Overall Study|Lack of Efficacy|3|||
130273090|NCT00861757|468963720|FG001|Overall Study|Lack of Efficacy|1|||
130273091|NCT00861757|468963721|FG002|Overall Study|Lack of Efficacy|0|||
130273092|NCT00861757|468963722|FG003|Overall Study|Lack of Efficacy|1|||
130273093|NCT00861757|468963719|FG000|Overall Study|Lost to Follow-up|1|||
130273094|NCT00861757|468963720|FG001|Overall Study|Lost to Follow-up|0|||
130273095|NCT00861757|468963721|FG002|Overall Study|Lost to Follow-up|1|||
130273096|NCT00861757|468963722|FG003|Overall Study|Lost to Follow-up|1|||
130273097|NCT00861757|468963719|FG000|Overall Study|Physician Decision|0|||
130456311|NCT01235949|469634919|FG009|Primary Phase|Migrated/moved from study area|0|||
130456312|NCT01235949|469634920|FG010|Primary Phase|Migrated/moved from study area|0|||
130273098|NCT00861757|468963720|FG001|Overall Study|Physician Decision|0|||
130273099|NCT00861757|468963721|FG002|Overall Study|Physician Decision|0|||
130273100|NCT00861757|468963722|FG003|Overall Study|Physician Decision|1|||
130273101|NCT00861757|468963719|FG000|Overall Study|Protocol Violation|2|||
130273102|NCT00861757|468963720|FG001|Overall Study|Protocol Violation|2|||
130273103|NCT00861757|468963721|FG002|Overall Study|Protocol Violation|4|||
130273104|NCT00861757|468963722|FG003|Overall Study|Protocol Violation|1|||
130273105|NCT00861757|468963719|FG000|Overall Study|Withdrawal by Subject|1|||
130273106|NCT00861757|468963720|FG001|Overall Study|Withdrawal by Subject|5|||
130273107|NCT00861757|468963721|FG002|Overall Study|Withdrawal by Subject|5|||
130273108|NCT00861757|468963722|FG003|Overall Study|Withdrawal by Subject|2|||
130273109|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
130273110|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
130273111|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
130273112|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130273113|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130273114|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
130273115|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
130273116|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
130273117|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
130273118|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130273119|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130273120|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
130273121|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
130273122|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130273123|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130273124|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130273125|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130273126|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
130273127|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
130273128|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
130273129|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
130273130|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
130273131|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
130273132|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
130273133|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
130273134|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
130273135|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
130273136|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130273137|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130273138|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
130273139|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
130273140|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130273141|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130273142|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130273143|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130273144|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
130273145|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
130273146|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130273147|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130273148|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
130273149|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
130273150|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
130273151|NCT01961297|468963731|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
130273152|NCT01961297|468963732|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
130273153|NCT02482298|468963733|FG000|Overall Study|Withdrawal by Subject|2|||
130273154|NCT02482298|468963734|FG001|Overall Study|Withdrawal by Subject|1|||
130273155|NCT02482298|468963735|FG002|Overall Study|Withdrawal by Subject|2|||
130273156|NCT02482298|468963733|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130273157|NCT02482298|468963734|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
130273158|NCT02482298|468963735|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130273159|NCT02482298|468963733|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130273160|NCT02482298|468963734|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130273161|NCT02482298|468963735|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
130273162|NCT02482298|468963733|FG000|Overall Study|Lost to Follow-up|0|||
130273163|NCT02482298|468963734|FG001|Overall Study|Lost to Follow-up|1|||
130273164|NCT02482298|468963735|FG002|Overall Study|Lost to Follow-up|0|||
130273165|NCT01188551|468963736|FG000|Overall Study|Pharmacy issues|1|||
130273166|NCT01188551|468963737|FG001|Overall Study|Pharmacy issues|0|||
130273167|NCT01188551|468963738|FG002|Overall Study|Pharmacy issues|0|||
130273168|NCT01188551|468963739|FG003|Overall Study|Pharmacy issues|0|||
130367171|NCT04560998|469314149|FG001|Overall Study|Lost to Follow-up|5|||
130367172|NCT04560998|469314148|FG000|Overall Study|Physician Decision|4|||
130367173|NCT04560998|469314149|FG001|Overall Study|Physician Decision|0|||
130367174|NCT03281577|469315868|FG000|Overall Study|Adverse Event|0|||
130367175|NCT03281577|469315869|FG001|Overall Study|Adverse Event|0|||
130367176|NCT03281577|469315870|FG002|Overall Study|Adverse Event|0|||
130367177|NCT03281577|469315871|FG003|Overall Study|Adverse Event|1|||
130367178|NCT03281577|469315868|FG000|Overall Study|Withdrawal by Subject|1|||
130367179|NCT03281577|469315869|FG001|Overall Study|Withdrawal by Subject|0|||
130273169|NCT03012828|468963748|FG000|Overall Study|Lost to Follow-up|1|||
130273170|NCT03012828|468963749|FG001|Overall Study|Lost to Follow-up|0|||
130273171|NCT03012828|468963750|FG002|Overall Study|Lost to Follow-up|1|||
130273172|NCT03012828|468963751|FG003|Overall Study|Lost to Follow-up|0|||
130273173|NCT03012828|468963752|FG004|Overall Study|Lost to Follow-up|1|||
130273174|NCT03012828|468963753|FG005|Overall Study|Lost to Follow-up|0|||
130273175|NCT03012828|468963748|FG000|Overall Study|Withdrawal by Subject|0|||
130273176|NCT03012828|468963749|FG001|Overall Study|Withdrawal by Subject|0|||
130273177|NCT03012828|468963750|FG002|Overall Study|Withdrawal by Subject|1|||
130273178|NCT03012828|468963751|FG003|Overall Study|Withdrawal by Subject|0|||
130273179|NCT03012828|468963752|FG004|Overall Study|Withdrawal by Subject|0|||
130273180|NCT03012828|468963753|FG005|Overall Study|Withdrawal by Subject|1|||
130273181|NCT03012828|468963748|FG000|Overall Study|Non-compliance with protocol|0|||
130273182|NCT03012828|468963749|FG001|Overall Study|Non-compliance with protocol|0|||
130273183|NCT03012828|468963750|FG002|Overall Study|Non-compliance with protocol|0|||
130273184|NCT03012828|468963751|FG003|Overall Study|Non-compliance with protocol|0|||
130273185|NCT03012828|468963752|FG004|Overall Study|Non-compliance with protocol|1|||
130273186|NCT03012828|468963753|FG005|Overall Study|Non-compliance with protocol|0|||
130273187|NCT03012828|468963748|FG000|Overall Study|Delay to last visit would delay DBL|0|||
130273188|NCT03012828|468963749|FG001|Overall Study|Delay to last visit would delay DBL|0|||
130273189|NCT03012828|468963750|FG002|Overall Study|Delay to last visit would delay DBL|0|||
130273190|NCT03012828|468963751|FG003|Overall Study|Delay to last visit would delay DBL|0|||
130273191|NCT03012828|468963752|FG004|Overall Study|Delay to last visit would delay DBL|0|||
130273192|NCT03012828|468963753|FG005|Overall Study|Delay to last visit would delay DBL|1|||
130273193|NCT03900728|468963754|FG000|Overall Study|No text responses|0|||
130273194|NCT03900728|468963755|FG001|Overall Study|No text responses|0|||
130273195|NCT03900728|468963756|FG002|Overall Study|No text responses|4|||
130273196|NCT00763256|468963758|FG000|Overall Study|Didn't return for appointments|7|||
130273197|NCT00763256|468963759|FG001|Overall Study|Didn't return for appointments|10|||
130273198|NCT02544750|468963761|FG000|Overall Study|Physician Decision|3|||
130273199|NCT02544750|468963762|FG001|Overall Study|Physician Decision|1|||
130273200|NCT02544750|468963761|FG000|Overall Study|Other reasons|69|||
130273201|NCT02544750|468963762|FG001|Overall Study|Other reasons|39|||
130273202|NCT02544750|468963761|FG000|Overall Study|Met withdrawal criteria|2|||
130273203|NCT02544750|468963762|FG001|Overall Study|Met withdrawal criteria|2|||
130273204|NCT02544750|468963761|FG000|Overall Study|Transition To Commercial Product|1|||
130273205|NCT02544750|468963762|FG001|Overall Study|Transition To Commercial Product|0|||
130273206|NCT02544750|468963761|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
130273207|NCT02544750|468963762|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
130273208|NCT02544750|468963761|FG000|Overall Study|Adverse Event|8|||
130273209|NCT02544750|468963762|FG001|Overall Study|Adverse Event|10|||
130273210|NCT02544750|468963761|FG000|Overall Study|Withdrawal by Subject|10|||
130273211|NCT02544750|468963762|FG001|Overall Study|Withdrawal by Subject|4|||
130273212|NCT02544750|468963761|FG000|Overall Study|Lost to Follow-up|1|||
130273213|NCT02544750|468963762|FG001|Overall Study|Lost to Follow-up|0|||
130273214|NCT04396795|468963765|FG000|Month 1|Lost to Follow-up|2|||
130273215|NCT04396795|468963766|FG001|Month 1|Lost to Follow-up|3|||
130273216|NCT04396795|468963765|FG000|Month 3|Lost to Follow-up|1|||
130273217|NCT04396795|468963766|FG001|Month 3|Lost to Follow-up|3|||
130273218|NCT04396795|468963765|FG000|Month 6|Lost to Follow-up|3|||
130273219|NCT04396795|468963766|FG001|Month 6|Lost to Follow-up|3|||
130273220|NCT03902392|468963770|FG000|Overall Study|Lost to Follow-up|7|||
130273221|NCT03902392|468963771|FG001|Overall Study|Lost to Follow-up|7|||
130273222|NCT00244725|468963772|FG000|Overall Study|Lost to Follow-up|3|||
130706642|NCT02124902|470551513|FG001|Overall Study|Went to alternative treatment|0|||
130273223|NCT00244725|468963773|FG001|Overall Study|Lost to Follow-up|4|||
130273224|NCT00244725|468963774|FG002|Overall Study|Lost to Follow-up|9|||
130273225|NCT00244725|468963775|FG003|Overall Study|Lost to Follow-up|2|||
130273226|NCT00244725|468963772|FG000|Overall Study|Withdrawal by Subject|9|||
130273227|NCT00244725|468963773|FG001|Overall Study|Withdrawal by Subject|7|||
130273228|NCT00244725|468963774|FG002|Overall Study|Withdrawal by Subject|7|||
130273229|NCT00244725|468963775|FG003|Overall Study|Withdrawal by Subject|8|||
130273230|NCT00244725|468963772|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
130273231|NCT00244725|468963773|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
130273232|NCT00244725|468963774|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
130273233|NCT00244725|468963775|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
130273234|NCT00244725|468963772|FG000|Overall Study|Physician Decision|3|||
130273235|NCT00244725|468963773|FG001|Overall Study|Physician Decision|0|||
130273236|NCT00244725|468963774|FG002|Overall Study|Physician Decision|1|||
130273237|NCT00244725|468963775|FG003|Overall Study|Physician Decision|2|||
130273238|NCT00244725|468963772|FG000|Overall Study|Adverse Events|3|||
130706643|NCT02124902|470551512|FG000|Overall Study|Withdrawal by Subject|2|||
130273239|NCT00244725|468963773|FG001|Overall Study|Adverse Events|1|||
130273240|NCT00244725|468963774|FG002|Overall Study|Adverse Events|4|||
130273241|NCT00244725|468963775|FG003|Overall Study|Adverse Events|4|||
130273242|NCT00244725|468963772|FG000|Overall Study|Withdrwal by participant|1|||
130273243|NCT00244725|468963773|FG001|Overall Study|Withdrwal by participant|0|||
130273244|NCT00244725|468963774|FG002|Overall Study|Withdrwal by participant|0|||
130273245|NCT00244725|468963775|FG003|Overall Study|Withdrwal by participant|1|||
130273246|NCT00244725|468963772|FG000|Overall Study|Liver function test abnormality|2|||
130273247|NCT00244725|468963773|FG001|Overall Study|Liver function test abnormality|0|||
130273248|NCT00244725|468963774|FG002|Overall Study|Liver function test abnormality|0|||
130273249|NCT00244725|468963775|FG003|Overall Study|Liver function test abnormality|1|||
130273250|NCT00244725|468963772|FG000|Overall Study|Sponsor withdrew the participant|1|||
130273251|NCT00244725|468963773|FG001|Overall Study|Sponsor withdrew the participant|0|||
130273252|NCT00244725|468963774|FG002|Overall Study|Sponsor withdrew the participant|0|||
130273253|NCT00244725|468963775|FG003|Overall Study|Sponsor withdrew the participant|1|||
130273254|NCT00244725|468963772|FG000|Overall Study|Mediciation Error|0|||
130273255|NCT00244725|468963773|FG001|Overall Study|Mediciation Error|1|||
130273256|NCT00244725|468963774|FG002|Overall Study|Mediciation Error|0|||
130273257|NCT00244725|468963775|FG003|Overall Study|Mediciation Error|0|||
130273258|NCT00244725|468963772|FG000|Overall Study|Rehab Refused to allow participantion|0|||
130273259|NCT00244725|468963773|FG001|Overall Study|Rehab Refused to allow participantion|1|||
130273260|NCT00244725|468963774|FG002|Overall Study|Rehab Refused to allow participantion|0|||
130273261|NCT00244725|468963775|FG003|Overall Study|Rehab Refused to allow participantion|0|||
130273262|NCT00244725|468963772|FG000|Overall Study|Headache|0|||
130273263|NCT00244725|468963773|FG001|Overall Study|Headache|1|||
130273264|NCT00244725|468963774|FG002|Overall Study|Headache|0|||
130273265|NCT00244725|468963775|FG003|Overall Study|Headache|0|||
130273266|NCT00244725|468963772|FG000|Overall Study|Received prohibited medication|0|||
130273267|NCT00244725|468963773|FG001|Overall Study|Received prohibited medication|1|||
130273268|NCT00244725|468963774|FG002|Overall Study|Received prohibited medication|0|||
130273269|NCT00244725|468963775|FG003|Overall Study|Received prohibited medication|1|||
130273270|NCT00244725|468963772|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273271|NCT00244725|468963773|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
130273272|NCT00244725|468963774|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273273|NCT00244725|468963775|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273274|NCT00244725|468963772|FG000|Overall Study|Administrative reason|0|||
130273275|NCT00244725|468963773|FG001|Overall Study|Administrative reason|0|||
130273276|NCT00244725|468963774|FG002|Overall Study|Administrative reason|1|||
130273277|NCT00244725|468963775|FG003|Overall Study|Administrative reason|0|||
130273278|NCT00244725|468963772|FG000|Overall Study|Vomit|0|||
130273279|NCT00244725|468963773|FG001|Overall Study|Vomit|0|||
130273280|NCT00244725|468963774|FG002|Overall Study|Vomit|1|||
130273281|NCT00244725|468963775|FG003|Overall Study|Vomit|0|||
130273282|NCT00244725|468963772|FG000|Overall Study|Failed to follow-up|0|||
130273283|NCT00244725|468963773|FG001|Overall Study|Failed to follow-up|0|||
130273284|NCT00244725|468963774|FG002|Overall Study|Failed to follow-up|1|||
130273285|NCT00244725|468963775|FG003|Overall Study|Failed to follow-up|1|||
130273286|NCT03248167|468963776|FG000|Overall Study|Withdrawal by Subject|2|||
130273287|NCT03248167|468963777|FG001|Overall Study|Withdrawal by Subject|2|||
130273288|NCT03248167|468963776|FG000|Overall Study|Physician Decision|0|||
130273289|NCT03248167|468963777|FG001|Overall Study|Physician Decision|1|||
130273290|NCT03248167|468963776|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
130273291|NCT03248167|468963777|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
130273292|NCT03248167|468963776|FG000|Overall Study|Lost to Follow-up|1|||
130273293|NCT03248167|468963777|FG001|Overall Study|Lost to Follow-up|0|||
130273294|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Death|0|||
130273295|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Death|1|||
130273296|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Death|1|||
130273297|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Death|0|||
130273298|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Death|0|||
130273299|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Death|0|||
130273300|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Death|0|||
130273301|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Death|0|||
130273302|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273303|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273304|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
130273305|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130706644|NCT02124902|470551513|FG001|Overall Study|Withdrawal by Subject|1|||
130706645|NCT02124902|470551512|FG000|Overall Study|Physician Decision|2|||
130273306|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
130273307|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273308|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273309|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273310|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273311|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273312|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273313|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130706646|NCT02124902|470551513|FG001|Overall Study|Physician Decision|0|||
130273314|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273315|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273316|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273317|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273318|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Other|1|||
130273319|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Other|0|||
130273320|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Other|0|||
130273321|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Other|0|||
130273322|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Other|0|||
130273323|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Other|1|||
130273324|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Other|1|||
130273325|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Other|2|||
130273326|NCT03472495|468963786|FG000|Overall Study|Treatment no longer indicated|1|||
130273327|NCT03472495|468963787|FG001|Overall Study|Treatment no longer indicated|2|||
130273328|NCT03472495|468963786|FG000|Overall Study|Physician Decision|0|||
130273329|NCT03472495|468963787|FG001|Overall Study|Physician Decision|2|||
130273330|NCT01107392|468963789|FG000|Overall Study|Adverse Event|2|||
130273331|NCT01107392|468963790|FG001|Overall Study|Adverse Event|0|||
130273332|NCT01107392|468963789|FG000|Overall Study|Personal Reasons|2|||
130273333|NCT01107392|468963790|FG001|Overall Study|Personal Reasons|3|||
130273334|NCT01107392|468963789|FG000|Overall Study|Administrative decision|1|||
130273335|NCT01107392|468963790|FG001|Overall Study|Administrative decision|0|||
130273336|NCT02998671|468963793|FG000|Period 1|Study Terminated By Sponsor|2|||
130273337|NCT02998671|468963794|FG001|Period 1|Study Terminated By Sponsor|1|||
130273338|NCT02998671|468963795|FG002|Period 1|Study Terminated By Sponsor|0|||
130273339|NCT02998671|468963796|FG003|Period 1|Study Terminated By Sponsor|0|||
130273340|NCT02998671|468963797|FG004|Period 1|Study Terminated By Sponsor|1|||
130273341|NCT02998671|468963793|FG000|Period 1|Withdrawal by Subject|1|||
130273342|NCT02998671|468963794|FG001|Period 1|Withdrawal by Subject|2|||
130273343|NCT02998671|468963795|FG002|Period 1|Withdrawal by Subject|0|||
130273344|NCT02998671|468963796|FG003|Period 1|Withdrawal by Subject|0|||
130273345|NCT02998671|468963797|FG004|Period 1|Withdrawal by Subject|2|||
130273346|NCT02998671|468963793|FG000|Period 1|Pregnancy|1|||
130273347|NCT02998671|468963794|FG001|Period 1|Pregnancy|0|||
130273348|NCT02998671|468963795|FG002|Period 1|Pregnancy|0|||
130273349|NCT02998671|468963796|FG003|Period 1|Pregnancy|0|||
130273350|NCT02998671|468963797|FG004|Period 1|Pregnancy|0|||
130273351|NCT02998671|468963793|FG000|Period 1|Adverse Event|0|||
130273352|NCT02998671|468963794|FG001|Period 1|Adverse Event|0|||
130273353|NCT02998671|468963795|FG002|Period 1|Adverse Event|0|||
130273354|NCT02998671|468963796|FG003|Period 1|Adverse Event|0|||
130273355|NCT02998671|468963797|FG004|Period 1|Adverse Event|1|||
130273356|NCT02998671|468963793|FG000|Period 2|Adverse Event|0|||
130273357|NCT02998671|468963794|FG001|Period 2|Adverse Event|1|||
130273358|NCT02998671|468963795|FG002|Period 2|Adverse Event|0|||
130273359|NCT02998671|468963796|FG003|Period 2|Adverse Event|0|||
130273360|NCT02998671|468963797|FG004|Period 2|Adverse Event|0|||
130273361|NCT02998671|468963793|FG000|Period 2|Study Terminated By Sponsor|3|||
130273362|NCT02998671|468963794|FG001|Period 2|Study Terminated By Sponsor|5|||
130273363|NCT02998671|468963795|FG002|Period 2|Study Terminated By Sponsor|1|||
130273364|NCT02998671|468963796|FG003|Period 2|Study Terminated By Sponsor|3|||
130273365|NCT02998671|468963797|FG004|Period 2|Study Terminated By Sponsor|0|||
130273366|NCT02998671|468963793|FG000|Period 2|Withdrawal by Subject|0|||
130273367|NCT02998671|468963794|FG001|Period 2|Withdrawal by Subject|1|||
130273368|NCT02998671|468963795|FG002|Period 2|Withdrawal by Subject|0|||
130273369|NCT02998671|468963796|FG003|Period 2|Withdrawal by Subject|0|||
130273370|NCT02998671|468963797|FG004|Period 2|Withdrawal by Subject|0|||
130273371|NCT02998671|468963793|FG000|Period 2|Lost to Follow-up|0|||
130273372|NCT02998671|468963794|FG001|Period 2|Lost to Follow-up|0|||
130273373|NCT02998671|468963795|FG002|Period 2|Lost to Follow-up|0|||
130273374|NCT02998671|468963796|FG003|Period 2|Lost to Follow-up|1|||
130273375|NCT02998671|468963797|FG004|Period 2|Lost to Follow-up|0|||
130273376|NCT02038946|468963799|FG000|Overall Study|Death|5|||
130273377|NCT02038946|468963799|FG000|Overall Study|Withdrawal by Subject|3|||
130273378|NCT02038946|468963799|FG000|Overall Study|Lost to Follow-up|2|||
130273379|NCT02038946|468963799|FG000|Overall Study|Other reasons|2|||
130273380|NCT02473471|468963800|FG000|Overall Study|poor oral hygiene|2|||
130273381|NCT02473471|468963800|FG000|Overall Study|Lost to Follow-up|1|||
130273382|NCT02725476|468963803|FG000|Overall Study|Physician Decision|2|||
130273383|NCT02725476|468963804|FG001|Overall Study|Physician Decision|0|||
130273384|NCT02725476|468963803|FG000|Overall Study|Adverse Event|1|||
130273385|NCT02725476|468963804|FG001|Overall Study|Adverse Event|1|||
130273386|NCT02455336|468963809|FG000|Overall Study|Withdrawal by Subject|0|||
130273387|NCT02455336|468963810|FG001|Overall Study|Withdrawal by Subject|2|||
130273388|NCT02455336|468963809|FG000|Overall Study|Adverse Event|3|||
130273389|NCT02455336|468963810|FG001|Overall Study|Adverse Event|0|||
130273390|NCT02455336|468963809|FG000|Overall Study|Non-responder to treatment|2|||
130273391|NCT02455336|468963810|FG001|Overall Study|Non-responder to treatment|0|||
130273392|NCT00391430|468963811|FG000|Overall Study|Withdrawal by Subject|3|||
130273393|NCT00391430|468963812|FG001|Overall Study|Withdrawal by Subject|0|||
130273394|NCT00391430|468963813|FG002|Overall Study|Withdrawal by Subject|12|||
130273395|NCT02467192|468963814|FG000|Overall Study|Death|1|||
130273396|NCT02467192|468963814|FG000|Overall Study|revealed to have pneumonia before|2|||
130273397|NCT03146663|468963818|FG000|Overall Study|Did not receive study treatment|1|||
130273398|NCT03146663|468963819|FG001|Overall Study|Did not receive study treatment|1|||
130273399|NCT03089047|468963820|FG000|Overall Study|Lost to Follow-up|1|||
130273400|NCT03089047|468963821|FG001|Overall Study|Lost to Follow-up|0|||
130273401|NCT03599518|468963822|FG000|Overall Study|Clinical progression|0|||
130273402|NCT03599518|468963823|FG001|Overall Study|Clinical progression|0|||
130273403|NCT03599518|468963824|FG002|Overall Study|Clinical progression|0|||
130273404|NCT03599518|468963825|FG003|Overall Study|Clinical progression|0|||
130273405|NCT03599518|468963826|FG004|Overall Study|Clinical progression|1|||
130273406|NCT03599518|468963822|FG000|Overall Study|Adverse Event|0|||
130273407|NCT03599518|468963823|FG001|Overall Study|Adverse Event|0|||
130273408|NCT03599518|468963824|FG002|Overall Study|Adverse Event|0|||
130273409|NCT03599518|468963825|FG003|Overall Study|Adverse Event|0|||
130273410|NCT03599518|468963826|FG004|Overall Study|Adverse Event|1|||
130273411|NCT03599518|468963822|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
130273412|NCT03599518|468963823|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
130273413|NCT03599518|468963824|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
130273414|NCT03599518|468963825|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
130273415|NCT03599518|468963826|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
130273416|NCT03599518|468963822|FG000|Overall Study|Participant withdrawal from study treatment|0|||
130273417|NCT03599518|468963823|FG001|Overall Study|Participant withdrawal from study treatment|0|||
130273418|NCT03599518|468963824|FG002|Overall Study|Participant withdrawal from study treatment|1|||
130273419|NCT03599518|468963825|FG003|Overall Study|Participant withdrawal from study treatment|0|||
130273420|NCT03599518|468963826|FG004|Overall Study|Participant withdrawal from study treatment|0|||
130273421|NCT02701764|468963831|FG000|Overall Study|Lost to Follow-up|0|||
130273422|NCT02701764|468963832|FG001|Overall Study|Lost to Follow-up|1|||
130273423|NCT01027650|468963833|FG000|Overall Study|Personal Reasons|0|||
130273424|NCT01027650|468963834|FG001|Overall Study|Personal Reasons|0|||
130273425|NCT01027650|468963835|FG002|Overall Study|Personal Reasons|0|||
130273426|NCT01027650|468963836|FG003|Overall Study|Personal Reasons|0|||
130273427|NCT01027650|468963837|FG004|Overall Study|Personal Reasons|2|||
130273428|NCT01027650|468963838|FG005|Overall Study|Personal Reasons|1|||
130273429|NCT01027650|468963839|FG006|Overall Study|Personal Reasons|0|||
130273430|NCT01027650|468963840|FG007|Overall Study|Personal Reasons|0|||
130273431|NCT01027650|468963833|FG000|Overall Study|Lost to Follow-up|0|||
130273432|NCT01027650|468963834|FG001|Overall Study|Lost to Follow-up|0|||
130273433|NCT01027650|468963835|FG002|Overall Study|Lost to Follow-up|0|||
130273434|NCT01027650|468963836|FG003|Overall Study|Lost to Follow-up|0|||
130273435|NCT01027650|468963837|FG004|Overall Study|Lost to Follow-up|0|||
130273436|NCT01027650|468963838|FG005|Overall Study|Lost to Follow-up|0|||
130273437|NCT01027650|468963839|FG006|Overall Study|Lost to Follow-up|1|||
130273438|NCT01027650|468963840|FG007|Overall Study|Lost to Follow-up|0|||
130273439|NCT01027650|468963833|FG000|Overall Study|Lack of Efficacy|0|||
130273440|NCT01027650|468963834|FG001|Overall Study|Lack of Efficacy|0|||
130273441|NCT01027650|468963835|FG002|Overall Study|Lack of Efficacy|0|||
130273442|NCT01027650|468963836|FG003|Overall Study|Lack of Efficacy|0|||
130273443|NCT01027650|468963837|FG004|Overall Study|Lack of Efficacy|0|||
130273444|NCT01027650|468963838|FG005|Overall Study|Lack of Efficacy|1|||
130273445|NCT01027650|468963839|FG006|Overall Study|Lack of Efficacy|0|||
130273446|NCT01027650|468963840|FG007|Overall Study|Lack of Efficacy|0|||
130273447|NCT00912782|468963841|FG000|Overall Study|Death|2|||
130273448|NCT00912782|468963842|FG001|Overall Study|Death|1|||
130273449|NCT00912782|468963841|FG000|Overall Study|Lost to Follow-up|0|||
130273450|NCT00912782|468963842|FG001|Overall Study|Lost to Follow-up|1|||
130273451|NCT00912782|468963841|FG000|Overall Study|Did not receive vascular access type|1|||
130273452|NCT00912782|468963842|FG001|Overall Study|Did not receive vascular access type|2|||
130273453|NCT00912782|468963841|FG000|Overall Study|Relocated before study completion|0|||
130273454|NCT00912782|468963842|FG001|Overall Study|Relocated before study completion|1|||
130273455|NCT00294671|468965552|FG000|Overall Study|Lack of Efficacy|11|||
130273456|NCT00294671|468965553|FG001|Overall Study|Lack of Efficacy|23|||
130273457|NCT00294671|468965552|FG000|Overall Study|Liver transplant|7|||
130273458|NCT00294671|468965553|FG001|Overall Study|Liver transplant|9|||
130456313|NCT01235949|469634921|FG011|Primary Phase|Migrated/moved from study area|0|||
130456314|NCT01235949|469634922|FG012|Primary Phase|Migrated/moved from study area|0|||
130456315|NCT01235949|469634923|FG013|Primary Phase|Migrated/moved from study area|0|||
130456316|NCT01235949|469634924|FG014|Primary Phase|Migrated/moved from study area|0|||
130273459|NCT00294671|468965552|FG000|Overall Study|Drug related adverse event (AE)|4|||
130273460|NCT00294671|468965553|FG001|Overall Study|Drug related adverse event (AE)|2|||
130273461|NCT00294671|468965552|FG000|Overall Study|Non-drug related AE|3|||
130273462|NCT00294671|468965553|FG001|Overall Study|Non-drug related AE|2|||
130273463|NCT00294671|468965552|FG000|Overall Study|Lost to Follow-up|1|||
130273464|NCT00294671|468965553|FG001|Overall Study|Lost to Follow-up|3|||
130273465|NCT00294671|468965552|FG000|Overall Study|Non-compliance|1|||
130273466|NCT00294671|468965553|FG001|Overall Study|Non-compliance|0|||
130273467|NCT00294671|468965552|FG000|Overall Study|Death|0|||
130273468|NCT00294671|468965553|FG001|Overall Study|Death|1|||
130273469|NCT02263326|468965560|FG000|Overall Study|Lost to Follow-up|1|||
130273470|NCT02263326|468965561|FG001|Overall Study|Lost to Follow-up|1|||
130273471|NCT01893411|468965562|FG000|Overall Study|Protocol Violation|1|||
130273472|NCT01893411|468965563|FG001|Overall Study|Protocol Violation|0|||
130273473|NCT01893411|468965564|FG002|Overall Study|Protocol Violation|0|||
130273474|NCT01893411|468965562|FG000|Overall Study|Physician Decision|1|||
130273475|NCT01893411|468965563|FG001|Overall Study|Physician Decision|1|||
130273476|NCT01893411|468965564|FG002|Overall Study|Physician Decision|2|||
130273477|NCT01893411|468965562|FG000|Overall Study|Lack of Efficacy|2|||
130273478|NCT01893411|468965563|FG001|Overall Study|Lack of Efficacy|1|||
130273479|NCT01893411|468965564|FG002|Overall Study|Lack of Efficacy|0|||
130273480|NCT01893411|468965562|FG000|Overall Study|Other|3|||
130273481|NCT01893411|468965563|FG001|Overall Study|Other|1|||
130273482|NCT01893411|468965564|FG002|Overall Study|Other|3|||
130273483|NCT01893411|468965562|FG000|Overall Study|Adverse Event|1|||
130273484|NCT01893411|468965563|FG001|Overall Study|Adverse Event|0|||
130273485|NCT01893411|468965564|FG002|Overall Study|Adverse Event|0|||
130273486|NCT01893411|468965562|FG000|Overall Study|Withdrawal by Subject|7|||
130273487|NCT01893411|468965563|FG001|Overall Study|Withdrawal by Subject|4|||
130273488|NCT01893411|468965564|FG002|Overall Study|Withdrawal by Subject|3|||
130273489|NCT01893411|468965562|FG000|Overall Study|Lost to Follow-up|2|||
130273490|NCT01893411|468965563|FG001|Overall Study|Lost to Follow-up|0|||
130273491|NCT01893411|468965564|FG002|Overall Study|Lost to Follow-up|1|||
130273492|NCT02397915|468965565|FG000|Period 1|Protocol Violation|0|||
130273493|NCT02397915|468965566|FG001|Period 1|Protocol Violation|1|||
130273494|NCT02397915|468965567|FG002|Period 1|Protocol Violation|0|||
130273495|NCT02397915|468965568|FG003|Period 1|Protocol Violation|0|||
130273496|NCT02397915|468965565|FG000|Period 1|Physician Decision|1|||
130273497|NCT02397915|468965566|FG001|Period 1|Physician Decision|0|||
130273498|NCT02397915|468965567|FG002|Period 1|Physician Decision|0|||
130273499|NCT02397915|468965568|FG003|Period 1|Physician Decision|0|||
130273500|NCT03292874|468965569|FG000|Overall Study|Due to pandemic|5|||
130273501|NCT00933608|468965570|FG000|Overall Study|Adverse Event|4|||
130273502|NCT00933608|468965571|FG001|Overall Study|Adverse Event|2|||
130273503|NCT00933608|468965570|FG000|Overall Study|Physician Decision|1|||
130273504|NCT00933608|468965571|FG001|Overall Study|Physician Decision|0|||
130273505|NCT03053440|468965574|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
130273506|NCT03053440|468965575|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
130273507|NCT03053440|468965574|FG000|Overall Study|Death|18|||
130273508|NCT03053440|468965575|FG001|Overall Study|Death|14|||
130273509|NCT03053440|468965574|FG000|Overall Study|Withdrawal by Subject|9|||
130273510|NCT03053440|468965575|FG001|Overall Study|Withdrawal by Subject|8|||
130273511|NCT03053440|468965574|FG000|Overall Study|Lost to Follow-up|1|||
130273512|NCT03053440|468965575|FG001|Overall Study|Lost to Follow-up|0|||
130273513|NCT03053440|468965574|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
130273514|NCT03053440|468965575|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
130273515|NCT03053440|468965574|FG000|Overall Study|Physician Decision|2|||
130273516|NCT03053440|468965575|FG001|Overall Study|Physician Decision|1|||
130273517|NCT03053440|468965574|FG000|Overall Study|Participant Randomized but died before dosing|1|||
130273518|NCT03053440|468965575|FG001|Overall Study|Participant Randomized but died before dosing|0|||
130273519|NCT00391053|468965576|FG000|Overall Study|Serious Adverse Events|1|||
130273520|NCT00391053|468965577|FG001|Overall Study|Serious Adverse Events|0|||
130273521|NCT00391053|468965578|FG002|Overall Study|Serious Adverse Events|1|||
130273522|NCT00391053|468965579|FG003|Overall Study|Serious Adverse Events|4|||
130273523|NCT00391053|468965576|FG000|Overall Study|Protocol Violation|2|||
130273524|NCT00391053|468965577|FG001|Overall Study|Protocol Violation|0|||
130273525|NCT00391053|468965578|FG002|Overall Study|Protocol Violation|0|||
130273526|NCT00391053|468965579|FG003|Overall Study|Protocol Violation|0|||
130273527|NCT00391053|468965576|FG000|Overall Study|Lost to Follow-up|1|||
130273528|NCT00391053|468965577|FG001|Overall Study|Lost to Follow-up|0|||
130273529|NCT00391053|468965578|FG002|Overall Study|Lost to Follow-up|0|||
130273530|NCT00391053|468965579|FG003|Overall Study|Lost to Follow-up|5|||
130273531|NCT00391053|468965576|FG000|Overall Study|Withdrawal by Subject|5|||
130273532|NCT00391053|468965577|FG001|Overall Study|Withdrawal by Subject|1|||
130273533|NCT00391053|468965578|FG002|Overall Study|Withdrawal by Subject|1|||
130273534|NCT00391053|468965579|FG003|Overall Study|Withdrawal by Subject|1|||
130273535|NCT05002985|468965580|FG000|Overall Study|Withdrawal by Subject|1|||
130273536|NCT02943070|468965581|FG000|Overall Study|Physician Decision|1|||
130273537|NCT02943070|468965581|FG000|Overall Study|Adverse Event|2|||
130273538|NCT02943070|468965581|FG000|Overall Study|Death|2|||
130273539|NCT02943070|468965581|FG000|Overall Study|Withdrawal by Subject|3|||
130273540|NCT02943070|468965581|FG000|Overall Study|Lost to Follow-up|4|||
130273541|NCT02943070|468965581|FG000|Overall Study|Retreatment or TURP|13|||
130273542|NCT02943070|468965581|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
130273543|NCT04123093|468965582|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
130273544|NCT04123093|468965583|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
130273545|NCT04123093|468965582|FG000|Phase 2|Physician Decision|0|||
130273546|NCT04123093|468965583|FG001|Phase 2|Physician Decision|1|||
130273547|NCT04123093|468965582|FG000|Phase 2|Withdrawal by Subject|0|||
130273548|NCT04123093|468965583|FG001|Phase 2|Withdrawal by Subject|1|||
130273549|NCT01485796|468965585|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
130273550|NCT01485796|468965585|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
130273551|NCT01485796|468965585|FG000|Period 2: Epoch 2|Adverse Event|3|||
130273552|NCT01485796|468965585|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
130273553|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
130273554|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
130273555|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
130273556|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
130273557|NCT00606411|468965595|FG000|Overall Study|Adverse Event|1|||
130273558|NCT00606411|468965596|FG001|Overall Study|Adverse Event|2|||
130273559|NCT00606411|468965595|FG000|Overall Study|Lack of Adherence|1|||
130273560|NCT00606411|468965596|FG001|Overall Study|Lack of Adherence|1|||
130273561|NCT00606411|468965595|FG000|Overall Study|Lack of Efficacy|1|||
130273562|NCT00606411|468965596|FG001|Overall Study|Lack of Efficacy|1|||
130273563|NCT00606411|468965595|FG000|Overall Study|Withdrawal by Subject|2|||
130273564|NCT00606411|468965596|FG001|Overall Study|Withdrawal by Subject|0|||
130273565|NCT00606411|468965595|FG000|Overall Study|Lost to Follow-up|1|||
130273566|NCT00606411|468965596|FG001|Overall Study|Lost to Follow-up|2|||
130367180|NCT03281577|469315870|FG002|Overall Study|Withdrawal by Subject|0|||
130367181|NCT03281577|469315871|FG003|Overall Study|Withdrawal by Subject|0|||
130367182|NCT00443261|469315872|FG000|Overall Study|Death|1|||
130367183|NCT01433991|469315874|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
130706647|NCT02124902|470551512|FG000|Overall Study|Not eligible|1|||
130706648|NCT02124902|470551513|FG001|Overall Study|Not eligible|0|||
130706649|NCT02124902|470551512|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
130706650|NCT02124902|470551513|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
130706651|NCT02190279|470551514|FG000|Overall Study|Withdrawal consent|1|||
130706652|NCT02190279|470551515|FG001|Overall Study|Withdrawal consent|0|||
130273567|NCT00606411|468965595|FG000|Overall Study|Move out of state|0|||
130273568|NCT00606411|468965596|FG001|Overall Study|Move out of state|1|||
130367184|NCT01433991|469315875|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130706653|NCT02190279|470551516|FG002|Overall Study|Withdrawal consent|1|||
130706654|NCT02190279|470551514|FG000|Overall Study|Lost to Follow-up|2|||
130706655|NCT02190279|470551515|FG001|Overall Study|Lost to Follow-up|0|||
130706656|NCT02190279|470551516|FG002|Overall Study|Lost to Follow-up|0|||
130706657|NCT02190279|470551514|FG000|Overall Study|Refused further treatment|0|||
130706658|NCT02190279|470551515|FG001|Overall Study|Refused further treatment|0|||
130706659|NCT02190279|470551516|FG002|Overall Study|Refused further treatment|1|||
130706660|NCT02190279|470551514|FG000|Overall Study|Screening failure|0|||
130706661|NCT02190279|470551515|FG001|Overall Study|Screening failure|0|||
130706662|NCT02190279|470551516|FG002|Overall Study|Screening failure|1|||
130706663|NCT02938442|470551517|FG000|Overall Study|Death|0|||
130706664|NCT02938442|470551518|FG001|Overall Study|Death|1|||
130706665|NCT02938442|470551517|FG000|Overall Study|Lost to Follow-up|0|||
130706666|NCT02938442|470551518|FG001|Overall Study|Lost to Follow-up|1|||
130706667|NCT02938442|470551517|FG000|Overall Study|Physician Decision|0|||
130706668|NCT02938442|470551518|FG001|Overall Study|Physician Decision|1|||
130706669|NCT02938442|470551517|FG000|Overall Study|Withdrawal by Subject|2|||
130706670|NCT02938442|470551518|FG001|Overall Study|Withdrawal by Subject|0|||
130706671|NCT04403399|470551519|FG000|Period 2|Physician Decision|0|||
130706672|NCT04403399|470551520|FG001|Period 2|Physician Decision|1|||
130706673|NCT01606228|470551522|FG000|Overall Study|Lost to Follow-up|20|||
130706674|NCT01606228|470551522|FG000|Overall Study|Withdrawal by Subject|3|||
130706675|NCT01606228|470551522|FG000|Overall Study|Non-compliant|3|||
130706676|NCT01606228|470551522|FG000|Overall Study|Lack of Efficacy|2|||
130706677|NCT01606228|470551522|FG000|Overall Study|Adverse Event|1|||
130706678|NCT00546910|470551523|FG000|Overall Study|Adverse Event|2|||
130706679|NCT00546910|470551524|FG001|Overall Study|Adverse Event|3|||
130706680|NCT00546910|470551523|FG000|Overall Study|Lack of Efficacy|5|||
130706681|NCT00546910|470551524|FG001|Overall Study|Lack of Efficacy|7|||
130706682|NCT00546910|470551523|FG000|Overall Study|Physician Decision|0|||
130706683|NCT00546910|470551524|FG001|Overall Study|Physician Decision|1|||
130706684|NCT00546910|470551523|FG000|Overall Study|Withdrawal by Subject|2|||
130706685|NCT00546910|470551524|FG001|Overall Study|Withdrawal by Subject|0|||
130706686|NCT01316419|470551530|FG000|Overall Study|Not treated|103|||
130706687|NCT01316419|470551530|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
130706688|NCT01316419|470551530|FG000|Overall Study|Lost to Follow-up|19|||
130706689|NCT02310789|470551533|FG000|Overall Study|Adverse Event|1|||
130706690|NCT01197417|470551534|FG000|Overall Study|Physician Decision|3|||
130706691|NCT01197417|470551535|FG001|Overall Study|Physician Decision|2|||
130706692|NCT01197417|470551534|FG000|Overall Study|Withdrawal by Subject|2|||
130706693|NCT01197417|470551535|FG001|Overall Study|Withdrawal by Subject|4|||
130706694|NCT01197417|470551534|FG000|Overall Study|Site miscommunication|0|||
130706695|NCT01197417|470551535|FG001|Overall Study|Site miscommunication|1|||
130706696|NCT01197417|470551534|FG000|Overall Study|Subject transferred to intensive care|0|||
130706697|NCT01197417|470551535|FG001|Overall Study|Subject transferred to intensive care|1|||
130706698|NCT01197417|470551534|FG000|Overall Study|Not consented in time to receive drug|0|||
130706699|NCT01197417|470551535|FG001|Overall Study|Not consented in time to receive drug|1|||
130706700|NCT01197417|470551534|FG000|Overall Study|Hypotension|1|||
130706701|NCT01197417|470551535|FG001|Overall Study|Hypotension|2|||
130706702|NCT01197417|470551534|FG000|Overall Study|Found to be ineligible|2|||
130706703|NCT01197417|470551535|FG001|Overall Study|Found to be ineligible|5|||
130706704|NCT01197417|470551534|FG000|Overall Study|No 25-hour magnesium level|0|||
130706705|NCT01197417|470551535|FG001|Overall Study|No 25-hour magnesium level|2|||
130706706|NCT03919448|470551536|FG000|Overall Study|Withdrawal by Subject|1|||
130706707|NCT03919448|470551537|FG001|Overall Study|Withdrawal by Subject|0|||
130706708|NCT03919448|470551538|FG002|Overall Study|Withdrawal by Subject|0|||
130706709|NCT01652729|470551539|FG000|Overall Study|Withdrawal by Subject|14|||
130706710|NCT01652729|470551540|FG001|Overall Study|Withdrawal by Subject|7|||
130706711|NCT01652729|470551541|FG002|Overall Study|Withdrawal by Subject|7|||
130706712|NCT01652729|470551539|FG000|Overall Study|Adverse Event|4|||
130706713|NCT01652729|470551540|FG001|Overall Study|Adverse Event|0|||
130706714|NCT01652729|470551541|FG002|Overall Study|Adverse Event|3|||
130706715|NCT01652729|470551539|FG000|Overall Study|Physician Decision|1|||
130706716|NCT01652729|470551540|FG001|Overall Study|Physician Decision|0|||
130706717|NCT01652729|470551541|FG002|Overall Study|Physician Decision|1|||
130706718|NCT01652729|470551539|FG000|Overall Study|Protocol Violation|1|||
130706719|NCT01652729|470551540|FG001|Overall Study|Protocol Violation|0|||
130706720|NCT01652729|470551541|FG002|Overall Study|Protocol Violation|0|||
130706721|NCT01652729|470551539|FG000|Overall Study|Lost to Follow-up|6|||
130706722|NCT01652729|470551540|FG001|Overall Study|Lost to Follow-up|6|||
130706723|NCT01652729|470551541|FG002|Overall Study|Lost to Follow-up|3|||
130706724|NCT01652729|470551539|FG000|Overall Study|Administrative|1|||
130706725|NCT01652729|470551540|FG001|Overall Study|Administrative|0|||
130706726|NCT01652729|470551541|FG002|Overall Study|Administrative|0|||
130706727|NCT04364737|470551542|FG000|Overall Study|Withdrawal by Subject|4|||
130706728|NCT04364737|470551543|FG001|Overall Study|Withdrawal by Subject|9|||
130706729|NCT04364737|470551542|FG000|Overall Study|Lost to Follow-up|1|||
130706730|NCT04364737|470551543|FG001|Overall Study|Lost to Follow-up|1|||
130706731|NCT01220609|470551544|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
130706732|NCT01220609|470551544|FG000|Overall Study|Ineligible- Wrong cell type|1|||
130706733|NCT01220609|470551544|FG000|Overall Study|Ineligible-Never treated|1|||
130706734|NCT02225665|470551545|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
130706735|NCT02225665|470551546|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
130706736|NCT02225665|470551545|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
130706737|NCT02225665|470551546|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
130706738|NCT01311557|470551547|FG000|Overall Study|Serious adverse event|0|||
130706739|NCT01311557|470551548|FG001|Overall Study|Serious adverse event|1|||
130706740|NCT01311557|470551547|FG000|Overall Study|Protocol Violation|4|||
130706741|NCT01311557|470551548|FG001|Overall Study|Protocol Violation|2|||
130706742|NCT01311557|470551547|FG000|Overall Study|Lost to Follow-up|0|||
130706743|NCT01311557|470551548|FG001|Overall Study|Lost to Follow-up|1|||
130706744|NCT01311557|470551547|FG000|Overall Study|Withdrawal by Subject|1|||
130706745|NCT01311557|470551548|FG001|Overall Study|Withdrawal by Subject|2|||
130706746|NCT01470417|470551551|FG000|Overall Study|Disease progression|0|||
130367185|NCT01433991|469315876|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130706747|NCT01470417|470551552|FG001|Overall Study|Disease progression|2|||
130706748|NCT02418455|470551553|FG000|48-Week Treatment Period|Other- Not Specified|1|||
130706749|NCT02418455|470551553|FG000|Continuation Period|Sponsor Decision|7|||
130706750|NCT00614822|470551557|FG000|Overall Study|Adverse Event|3|||
130706751|NCT01557920|470551558|FG000|Overall Study|Withdrawal by Subject|2|||
130706752|NCT01557920|470551559|FG001|Overall Study|Withdrawal by Subject|3|||
130706753|NCT01557920|470551558|FG000|Overall Study|Lack of Efficacy|1|||
130706754|NCT01557920|470551559|FG001|Overall Study|Lack of Efficacy|0|||
130706755|NCT02075606|470551562|FG000|Overall Study|Adverse Event|5|||
130706756|NCT02075606|470551562|FG000|Overall Study|Withdrawal by Subject|1|||
130706757|NCT02075606|470551562|FG000|Overall Study|Death|1|||
130706758|NCT02075606|470551562|FG000|Overall Study|Investigator's decision|1|||
130706759|NCT02075606|470551562|FG000|Overall Study|Symptom management|1|||
130706760|NCT02075606|470551562|FG000|Overall Study|Increasing Symptoms|1|||
130706761|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706762|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706763|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706764|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
130706765|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130706766|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130706767|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
130706768|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130706769|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130706770|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
130706771|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130706772|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130706773|NCT02310763|470551567|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706774|NCT02310763|470551568|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706775|NCT02310763|470551569|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706776|NCT00271024|470551575|FG000|Overall Study|Lost Interest|3|||
130706777|NCT00271024|470551576|FG001|Overall Study|Lost Interest|4|||
130706778|NCT00271024|470551577|FG002|Overall Study|Lost Interest|2|||
130706779|NCT00271024|470551578|FG003|Overall Study|Lost Interest|3|||
130706780|NCT00271024|470551575|FG000|Overall Study|Unknown/Unspecified|11|||
130706781|NCT00271024|470551576|FG001|Overall Study|Unknown/Unspecified|11|||
130706782|NCT00271024|470551577|FG002|Overall Study|Unknown/Unspecified|8|||
130706783|NCT00271024|470551578|FG003|Overall Study|Unknown/Unspecified|4|||
130706784|NCT00271024|470551575|FG000|Overall Study|Protocol Violation|1|||
130706785|NCT00271024|470551576|FG001|Overall Study|Protocol Violation|6|||
130706786|NCT00271024|470551577|FG002|Overall Study|Protocol Violation|5|||
130706787|NCT00271024|470551578|FG003|Overall Study|Protocol Violation|11|||
130706788|NCT00271024|470551575|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
130706789|NCT00271024|470551576|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
130706790|NCT00271024|470551577|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
130706791|NCT00271024|470551578|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
130706792|NCT00271024|470551575|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
130706793|NCT00271024|470551576|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
130706794|NCT00271024|470551577|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130706795|NCT00271024|470551578|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130706796|NCT01040793|470551582|FG000|Overall Study|Adverse Event|5|||
130706797|NCT01040793|470551583|FG001|Overall Study|Adverse Event|3|||
130706798|NCT01040793|470551584|FG002|Overall Study|Adverse Event|0|||
130706799|NCT01040793|470551585|FG003|Overall Study|Adverse Event|2|||
130706800|NCT01040793|470551586|FG004|Overall Study|Adverse Event|2|||
130706801|NCT01040793|470551587|FG005|Overall Study|Adverse Event|1|||
130706802|NCT01040793|470551582|FG000|Overall Study|Protocol Violation|1|||
130706803|NCT01040793|470551583|FG001|Overall Study|Protocol Violation|1|||
130706804|NCT01040793|470551584|FG002|Overall Study|Protocol Violation|1|||
130706805|NCT01040793|470551585|FG003|Overall Study|Protocol Violation|0|||
130706806|NCT01040793|470551586|FG004|Overall Study|Protocol Violation|1|||
130706807|NCT01040793|470551587|FG005|Overall Study|Protocol Violation|0|||
130706808|NCT01040793|470551582|FG000|Overall Study|Lost to Follow-up|0|||
130706809|NCT01040793|470551583|FG001|Overall Study|Lost to Follow-up|1|||
130706810|NCT01040793|470551584|FG002|Overall Study|Lost to Follow-up|1|||
130706811|NCT01040793|470551585|FG003|Overall Study|Lost to Follow-up|0|||
130706812|NCT01040793|470551586|FG004|Overall Study|Lost to Follow-up|0|||
130706813|NCT01040793|470551587|FG005|Overall Study|Lost to Follow-up|0|||
130706814|NCT01040793|470551582|FG000|Overall Study|Withdrawal by Subject|0|||
130706815|NCT01040793|470551583|FG001|Overall Study|Withdrawal by Subject|0|||
130706816|NCT01040793|470551584|FG002|Overall Study|Withdrawal by Subject|0|||
130706817|NCT01040793|470551585|FG003|Overall Study|Withdrawal by Subject|2|||
130706818|NCT01040793|470551586|FG004|Overall Study|Withdrawal by Subject|0|||
130706819|NCT01040793|470551587|FG005|Overall Study|Withdrawal by Subject|0|||
130706820|NCT01040793|470551582|FG000|Overall Study|Other reasons not listed above|0|||
130273569|NCT02526212|468965597|FG000|Overall Study|Incarceration|1|||
130273570|NCT02526212|468965598|FG001|Overall Study|Incarceration|0|||
130273571|NCT02526212|468965597|FG000|Overall Study|Lost to Follow-up|1|||
130706821|NCT01040793|470551583|FG001|Overall Study|Other reasons not listed above|0|||
130706822|NCT01040793|470551584|FG002|Overall Study|Other reasons not listed above|1|||
130706823|NCT01040793|470551585|FG003|Overall Study|Other reasons not listed above|0|||
130706824|NCT01040793|470551586|FG004|Overall Study|Other reasons not listed above|1|||
130273572|NCT02526212|468965598|FG001|Overall Study|Lost to Follow-up|0|||
130273573|NCT02526212|468965597|FG000|Overall Study|Death|0|||
130706825|NCT01040793|470551587|FG005|Overall Study|Other reasons not listed above|0|||
130706826|NCT00939627|470551590|FG000|Overall Study|Disease Progression|16|||
130706827|NCT00939627|470551591|FG001|Overall Study|Disease Progression|12|||
130706828|NCT00939627|470551592|FG002|Overall Study|Disease Progression|0|||
130706829|NCT00939627|470551590|FG000|Overall Study|Adverse Event|6|||
130706830|NCT00939627|470551591|FG001|Overall Study|Adverse Event|7|||
130706831|NCT00939627|470551592|FG002|Overall Study|Adverse Event|0|||
130706832|NCT00939627|470551590|FG000|Overall Study|Death|0|||
130706833|NCT00939627|470551591|FG001|Overall Study|Death|2|||
130706834|NCT00939627|470551592|FG002|Overall Study|Death|0|||
130706835|NCT00939627|470551590|FG000|Overall Study|Withdrawal by Subject|2|||
130706836|NCT00939627|470551591|FG001|Overall Study|Withdrawal by Subject|4|||
130706837|NCT00939627|470551592|FG002|Overall Study|Withdrawal by Subject|0|||
130706838|NCT00939627|470551590|FG000|Overall Study|Other complicating disease|1|||
130706839|NCT00939627|470551591|FG001|Overall Study|Other complicating disease|1|||
130706840|NCT00939627|470551592|FG002|Overall Study|Other complicating disease|0|||
130706841|NCT00939627|470551590|FG000|Overall Study|Not compliant|2|||
130706842|NCT00939627|470551591|FG001|Overall Study|Not compliant|0|||
130706843|NCT00939627|470551592|FG002|Overall Study|Not compliant|0|||
130706844|NCT00939627|470551590|FG000|Overall Study|No off-tx reason given|0|||
130706845|NCT00939627|470551591|FG001|Overall Study|No off-tx reason given|2|||
130706846|NCT00939627|470551592|FG002|Overall Study|No off-tx reason given|0|||
130706847|NCT00124462|470551593|FG000|Overall Study|Lost to Follow-up|3|||
130706848|NCT00124462|470551594|FG001|Overall Study|Lost to Follow-up|3|||
130706849|NCT00124462|470551593|FG000|Overall Study|Physician Decision|3|||
130706850|NCT00124462|470551594|FG001|Overall Study|Physician Decision|4|||
130706851|NCT00124462|470551593|FG000|Overall Study|Withdrawal by Subject|4|||
130706852|NCT00124462|470551594|FG001|Overall Study|Withdrawal by Subject|5|||
130706853|NCT00124462|470551593|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
130706854|NCT00124462|470551594|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
130706855|NCT02039063|470551596|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
130706856|NCT02039063|470551597|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
130706857|NCT02039063|470551598|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
130706858|NCT02039063|470551599|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
130706859|NCT02039063|470551596|FG000|Treatment Phase|Progression of disease|0|||
130706860|NCT02039063|470551597|FG001|Treatment Phase|Progression of disease|0|||
130706861|NCT02039063|470551598|FG002|Treatment Phase|Progression of disease|1|||
130706862|NCT02039063|470551599|FG003|Treatment Phase|Progression of disease|1|||
130706863|NCT02039063|470551596|FG000|Extension Phase|Inadequate therapeutic effect|0|||
130554455|NCT01839487|469996605|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130554456|NCT01839487|469996606|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
130554457|NCT01839487|469996607|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130554458|NCT01839487|469996608|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130554459|NCT01839487|469996609|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130554460|NCT01839487|469996610|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130554461|NCT01839487|469996605|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
130554462|NCT01839487|469996606|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130554463|NCT01839487|469996607|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130554464|NCT01839487|469996608|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130554465|NCT01839487|469996609|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130554466|NCT01839487|469996610|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130554467|NCT01839487|469996605|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
130554468|NCT01839487|469996606|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
130554469|NCT01839487|469996607|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
130554470|NCT01839487|469996608|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
130554471|NCT01839487|469996609|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
130554472|NCT01839487|469996610|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
130706864|NCT02039063|470551597|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130706865|NCT02039063|470551598|FG002|Extension Phase|Inadequate therapeutic effect|2|||
130706866|NCT02039063|470551599|FG003|Extension Phase|Inadequate therapeutic effect|0|||
130706867|NCT02039063|470551596|FG000|Extension Phase|Progression of disease|0|||
130706868|NCT02039063|470551597|FG001|Extension Phase|Progression of disease|0|||
130706869|NCT02039063|470551598|FG002|Extension Phase|Progression of disease|0|||
130706870|NCT02039063|470551599|FG003|Extension Phase|Progression of disease|1|||
130273574|NCT02526212|468965598|FG001|Overall Study|Death|1|||
130273575|NCT01390298|468965599|FG000|Overall Study|Death|1|||
130273576|NCT01390298|468965599|FG000|Overall Study|long term ICU admission|1|||
130273577|NCT01390298|468965599|FG000|Overall Study|Withdrawal by Subject|14|||
130706871|NCT02039063|470551596|FG000|Extension Phase|Adverse Event|0|||
130706872|NCT02039063|470551597|FG001|Extension Phase|Adverse Event|0|||
130706873|NCT02039063|470551598|FG002|Extension Phase|Adverse Event|1|||
130706874|NCT02039063|470551599|FG003|Extension Phase|Adverse Event|0|||
130273578|NCT01390298|468965599|FG000|Overall Study|Lost to Follow-up|7|||
130706875|NCT02260258|470551605|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
130706876|NCT02260258|470551606|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
130706877|NCT03314662|470551614|FG000|Overall Study|Withdrawal by Subject|1|||
130554473|NCT01839487|469996605|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
130456317|NCT01235949|469634925|FG015|Primary Phase|Migrated/moved from study area|0|||
130456318|NCT01235949|469634926|FG016|Primary Phase|Migrated/moved from study area|0|||
130456319|NCT01235949|469634927|FG017|Primary Phase|Migrated/moved from study area|0|||
130456320|NCT01235949|469634910|FG000|Primary Phase|Adverse Event|0|||
130456321|NCT01235949|469634911|FG001|Primary Phase|Adverse Event|0|||
130456322|NCT01235949|469634912|FG002|Primary Phase|Adverse Event|0|||
130456323|NCT01235949|469634913|FG003|Primary Phase|Adverse Event|1|||
130456324|NCT01235949|469634914|FG004|Primary Phase|Adverse Event|0|||
130456325|NCT01235949|469634915|FG005|Primary Phase|Adverse Event|0|||
130456326|NCT01235949|469634916|FG006|Primary Phase|Adverse Event|0|||
130456327|NCT01235949|469634917|FG007|Primary Phase|Adverse Event|0|||
130456328|NCT01235949|469634918|FG008|Primary Phase|Adverse Event|0|||
130456329|NCT01235949|469634919|FG009|Primary Phase|Adverse Event|0|||
130456330|NCT01235949|469634920|FG010|Primary Phase|Adverse Event|0|||
130456331|NCT01235949|469634921|FG011|Primary Phase|Adverse Event|0|||
130456332|NCT01235949|469634922|FG012|Primary Phase|Adverse Event|0|||
130456333|NCT01235949|469634923|FG013|Primary Phase|Adverse Event|0|||
130456334|NCT01235949|469634924|FG014|Primary Phase|Adverse Event|0|||
130456335|NCT01235949|469634925|FG015|Primary Phase|Adverse Event|0|||
130456336|NCT01235949|469634926|FG016|Primary Phase|Adverse Event|0|||
130456337|NCT01235949|469634927|FG017|Primary Phase|Adverse Event|0|||
130456338|NCT01235949|469634910|FG000|Primary Phase|Withdrawal by Subject|3|||
130456339|NCT01235949|469634911|FG001|Primary Phase|Withdrawal by Subject|2|||
130456340|NCT01235949|469634912|FG002|Primary Phase|Withdrawal by Subject|2|||
130456341|NCT01235949|469634913|FG003|Primary Phase|Withdrawal by Subject|0|||
130456342|NCT01235949|469634914|FG004|Primary Phase|Withdrawal by Subject|0|||
130456343|NCT01235949|469634915|FG005|Primary Phase|Withdrawal by Subject|3|||
130456344|NCT01235949|469634916|FG006|Primary Phase|Withdrawal by Subject|0|||
130456345|NCT01235949|469634917|FG007|Primary Phase|Withdrawal by Subject|0|||
130456346|NCT01235949|469634918|FG008|Primary Phase|Withdrawal by Subject|0|||
130456347|NCT01235949|469634919|FG009|Primary Phase|Withdrawal by Subject|0|||
130456348|NCT01235949|469634920|FG010|Primary Phase|Withdrawal by Subject|0|||
130456349|NCT01235949|469634921|FG011|Primary Phase|Withdrawal by Subject|0|||
130456350|NCT01235949|469634922|FG012|Primary Phase|Withdrawal by Subject|0|||
130456351|NCT01235949|469634923|FG013|Primary Phase|Withdrawal by Subject|0|||
130456352|NCT01235949|469634924|FG014|Primary Phase|Withdrawal by Subject|0|||
130456353|NCT01235949|469634925|FG015|Primary Phase|Withdrawal by Subject|0|||
130456354|NCT01235949|469634926|FG016|Primary Phase|Withdrawal by Subject|0|||
130456355|NCT01235949|469634927|FG017|Primary Phase|Withdrawal by Subject|0|||
130456356|NCT01235949|469634910|FG000|Primary Phase|Lost to Follow-up|0|||
130456357|NCT01235949|469634911|FG001|Primary Phase|Lost to Follow-up|0|||
130456358|NCT01235949|469634912|FG002|Primary Phase|Lost to Follow-up|1|||
130456359|NCT01235949|469634913|FG003|Primary Phase|Lost to Follow-up|1|||
130456360|NCT01235949|469634914|FG004|Primary Phase|Lost to Follow-up|0|||
130456361|NCT01235949|469634915|FG005|Primary Phase|Lost to Follow-up|2|||
130456362|NCT01235949|469634916|FG006|Primary Phase|Lost to Follow-up|0|||
130456363|NCT01235949|469634917|FG007|Primary Phase|Lost to Follow-up|0|||
130456364|NCT01235949|469634918|FG008|Primary Phase|Lost to Follow-up|0|||
130456365|NCT01235949|469634919|FG009|Primary Phase|Lost to Follow-up|0|||
130554474|NCT01839487|469996606|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
130554475|NCT01839487|469996607|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
130554476|NCT01839487|469996608|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
130706878|NCT03314662|470551615|FG001|Overall Study|Withdrawal by Subject|1|||
130706879|NCT03314662|470551616|FG002|Overall Study|Withdrawal by Subject|1|||
130706880|NCT03314662|470551614|FG000|Overall Study|Lost to Follow-up|5|||
130706881|NCT03314662|470551615|FG001|Overall Study|Lost to Follow-up|4|||
130706882|NCT03314662|470551616|FG002|Overall Study|Lost to Follow-up|4|||
130273579|NCT01390298|468965599|FG000|Overall Study|Surgery cancelled|1|||
130273580|NCT00040742|468965606|FG000|Overall Study|Death|0|||
130273581|NCT00040742|468965607|FG001|Overall Study|Death|0|||
130456366|NCT01235949|469634920|FG010|Primary Phase|Lost to Follow-up|0|||
130456367|NCT01235949|469634921|FG011|Primary Phase|Lost to Follow-up|0|||
130456368|NCT01235949|469634922|FG012|Primary Phase|Lost to Follow-up|0|||
130456369|NCT01235949|469634923|FG013|Primary Phase|Lost to Follow-up|0|||
130456370|NCT01235949|469634924|FG014|Primary Phase|Lost to Follow-up|0|||
130456371|NCT01235949|469634925|FG015|Primary Phase|Lost to Follow-up|0|||
130456372|NCT01235949|469634926|FG016|Primary Phase|Lost to Follow-up|0|||
130456373|NCT01235949|469634927|FG017|Primary Phase|Lost to Follow-up|0|||
130456374|NCT01235949|469634910|FG000|Booster Phase|Migrated/moved from study area|0|||
130456375|NCT01235949|469634911|FG001|Booster Phase|Migrated/moved from study area|0|||
130706883|NCT03314662|470551614|FG000|Overall Study|Death|2|||
130273582|NCT00040742|468965608|FG002|Overall Study|Death|1|||
130456376|NCT01235949|469634912|FG002|Booster Phase|Migrated/moved from study area|0|||
130706884|NCT03314662|470551615|FG001|Overall Study|Death|0|||
130706885|NCT03314662|470551616|FG002|Overall Study|Death|0|||
130706886|NCT00925301|470551619|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706887|NCT00925301|470551620|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
130706888|NCT00925301|470551621|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706889|NCT00925301|470551622|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706890|NCT00925301|470551619|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706891|NCT00925301|470551620|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
130706892|NCT00925301|470551621|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706893|NCT00925301|470551622|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706894|NCT00925301|470551619|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706895|NCT00925301|470551620|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706896|NCT00925301|470551621|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
130706897|NCT00925301|470551622|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706898|NCT00925301|470551619|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706899|NCT00925301|470551620|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706900|NCT00925301|470551621|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
130706901|NCT00925301|470551622|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706902|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706903|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706904|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706905|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
130706906|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706907|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706908|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706909|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
130706910|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706911|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706912|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706913|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
130706914|NCT01117766|470551623|FG000|First Intervention|Adverse Event|0|||
130706915|NCT01117766|470551624|FG001|First Intervention|Adverse Event|1|||
130706916|NCT01117766|470551623|FG000|First Intervention|Protocol Violation|1|||
130706917|NCT01117766|470551624|FG001|First Intervention|Protocol Violation|0|||
130706918|NCT01117766|470551623|FG000|Washout Period|Protocol Violation|0|||
130706919|NCT01117766|470551624|FG001|Washout Period|Protocol Violation|2|||
130706920|NCT01117766|470551623|FG000|Second Intervention|Lost to Follow-up|1|||
130706921|NCT01117766|470551624|FG001|Second Intervention|Lost to Follow-up|0|||
130706922|NCT01117766|470551623|FG000|Second Intervention|Other|1|||
130706923|NCT01117766|470551624|FG001|Second Intervention|Other|2|||
130706924|NCT01117766|470551623|FG000|Second Intervention|Adverse Event|0|||
130706925|NCT01117766|470551624|FG001|Second Intervention|Adverse Event|2|||
130706926|NCT01117766|470551623|FG000|Second Intervention|Withdrawal by Subject|0|||
130706927|NCT01117766|470551624|FG001|Second Intervention|Withdrawal by Subject|1|||
130706928|NCT00438659|470551625|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
130706929|NCT00438659|470551626|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
130706930|NCT00438659|470551625|FG000|Overall Study|Cancel|5|||
130706931|NCT00438659|470551626|FG001|Overall Study|Cancel|2|||
130706932|NCT01117987|470551627|FG000|Overall Study|Protocol deviation|0|||
130706933|NCT01117987|470551628|FG001|Overall Study|Protocol deviation|1|||
130706934|NCT01117987|470551627|FG000|Overall Study|Subject no longer requires study drug|1|||
130706935|NCT01117987|470551628|FG001|Overall Study|Subject no longer requires study drug|0|||
130706936|NCT01117987|470551627|FG000|Overall Study|Lost to Follow-up|1|||
130706937|NCT01117987|470551628|FG001|Overall Study|Lost to Follow-up|1|||
130706938|NCT01117987|470551627|FG000|Overall Study|Abnormal test procedure result|2|||
130706939|NCT01117987|470551628|FG001|Overall Study|Abnormal test procedure result|0|||
130706940|NCT01117987|470551627|FG000|Overall Study|Lack of Efficacy|3|||
130706941|NCT01117987|470551628|FG001|Overall Study|Lack of Efficacy|4|||
130706942|NCT01117987|470551627|FG000|Overall Study|Death|5|||
130706943|NCT01117987|470551628|FG001|Overall Study|Death|10|||
130706944|NCT01117987|470551627|FG000|Overall Study|Withdrawal by Subject|5|||
130706945|NCT01117987|470551628|FG001|Overall Study|Withdrawal by Subject|10|||
130706946|NCT01117987|470551627|FG000|Overall Study|Adverse Event|19|||
130706947|NCT01117987|470551628|FG001|Overall Study|Adverse Event|26|||
130706948|NCT01117987|470551627|FG000|Overall Study|Administrative problems|25|||
130706949|NCT01117987|470551628|FG001|Overall Study|Administrative problems|22|||
130706950|NCT00440115|470551629|FG000|Overall Study|Death|7|||
130706951|NCT00440115|470551630|FG001|Overall Study|Death|9|||
130706952|NCT00440115|470551631|FG002|Overall Study|Death|5|||
130706953|NCT00440115|470551629|FG000|Overall Study|Incarceration|0|||
130706954|NCT00440115|470551630|FG001|Overall Study|Incarceration|2|||
130706955|NCT00440115|470551631|FG002|Overall Study|Incarceration|1|||
130706956|NCT03069417|470551633|FG000|Overall Study|Lost to Follow-up|2|||
130706957|NCT03069417|470551634|FG001|Overall Study|Lost to Follow-up|0|||
130706958|NCT03069417|470551633|FG000|Overall Study|Reason Unknown|4|||
130706959|NCT03069417|470551634|FG001|Overall Study|Reason Unknown|7|||
130706960|NCT02244424|470551635|FG000|Overall Study|Lost to Follow-up|20|||
130706961|NCT02244424|470551636|FG001|Overall Study|Lost to Follow-up|10|||
130706962|NCT00206102|470551637|FG000|Overall Study|Adverse Event|119|||
130706963|NCT00206102|470551638|FG001|Overall Study|Adverse Event|82|||
130706964|NCT00206102|470551637|FG000|Overall Study|Protocol Violation|0|||
130706965|NCT00206102|470551638|FG001|Overall Study|Protocol Violation|2|||
130706966|NCT00206102|470551637|FG000|Overall Study|Lack of therapeutic response|16|||
130706967|NCT00206102|470551638|FG001|Overall Study|Lack of therapeutic response|11|||
130706968|NCT00206102|470551637|FG000|Overall Study|Lost to Follow-up|95|||
130706969|NCT00206102|470551638|FG001|Overall Study|Lost to Follow-up|66|||
130706970|NCT00206102|470551637|FG000|Overall Study|Withdrawal by Subject|118|||
130706971|NCT00206102|470551638|FG001|Overall Study|Withdrawal by Subject|101|||
130706972|NCT00206102|470551637|FG000|Overall Study|Study-specific discontinuation criteria|18|||
130706973|NCT00206102|470551638|FG001|Overall Study|Study-specific discontinuation criteria|17|||
130706974|NCT00206102|470551637|FG000|Overall Study|None of those categories|42|||
130706975|NCT00206102|470551638|FG001|Overall Study|None of those categories|36|||
130706976|NCT04117945|470551639|FG000|Overall Study|Death|1|||
130706977|NCT04117945|470551640|FG001|Overall Study|Death|0|||
130706978|NCT04117945|470551639|FG000|Overall Study|Withdrawal by Subject|3|||
130706979|NCT04117945|470551640|FG001|Overall Study|Withdrawal by Subject|1|||
130706980|NCT04117945|470551639|FG000|Overall Study|Disease Progression|0|||
130706981|NCT04117945|470551640|FG001|Overall Study|Disease Progression|2|||
130706982|NCT04117945|470551639|FG000|Overall Study|Ineligible|8|||
130706983|NCT04117945|470551640|FG001|Overall Study|Ineligible|7|||
130706984|NCT00402025|470551642|FG000|Overall Study|Adverse Event|0|||
130273583|NCT00040742|468965609|FG003|Overall Study|Death|0|||
130273584|NCT00040742|468965606|FG000|Overall Study|Adverse Event|15|||
130273585|NCT00040742|468965607|FG001|Overall Study|Adverse Event|16|||
130273586|NCT00040742|468965608|FG002|Overall Study|Adverse Event|21|||
130273587|NCT00040742|468965609|FG003|Overall Study|Adverse Event|9|||
130273588|NCT00040742|468965606|FG000|Overall Study|Withdrawal by Subject|7|||
130273589|NCT00040742|468965607|FG001|Overall Study|Withdrawal by Subject|15|||
130273590|NCT00040742|468965608|FG002|Overall Study|Withdrawal by Subject|10|||
130273591|NCT00040742|468965609|FG003|Overall Study|Withdrawal by Subject|13|||
130273592|NCT00040742|468965606|FG000|Overall Study|Chemotoxicity|4|||
130273593|NCT00040742|468965607|FG001|Overall Study|Chemotoxicity|3|||
130273594|NCT00040742|468965608|FG002|Overall Study|Chemotoxicity|5|||
130273595|NCT00040742|468965609|FG003|Overall Study|Chemotoxicity|2|||
130273596|NCT00040742|468965606|FG000|Overall Study|Incomplete Forms|6|||
130273597|NCT00040742|468965607|FG001|Overall Study|Incomplete Forms|10|||
130273598|NCT00040742|468965608|FG002|Overall Study|Incomplete Forms|4|||
130273599|NCT00040742|468965609|FG003|Overall Study|Incomplete Forms|5|||
130273600|NCT00040742|468965606|FG000|Overall Study|Other medical|7|||
130273601|NCT00040742|468965607|FG001|Overall Study|Other medical|5|||
130273602|NCT00040742|468965608|FG002|Overall Study|Other medical|5|||
130273603|NCT00040742|468965609|FG003|Overall Study|Other medical|5|||
130273604|NCT03520920|468965612|FG000|Overall Study|Death|13|||
130273605|NCT03520920|468965613|FG001|Overall Study|Death|1|||
130273606|NCT03520920|468965614|FG002|Overall Study|Death|0|||
130273607|NCT03520920|468965612|FG000|Overall Study|Withdrawal by Subject|2|||
130273608|NCT03520920|468965613|FG001|Overall Study|Withdrawal by Subject|1|||
130273609|NCT03520920|468965614|FG002|Overall Study|Withdrawal by Subject|0|||
130273610|NCT03520920|468965612|FG000|Overall Study|Study Terminated by the Sponsor|5|||
130273611|NCT03520920|468965613|FG001|Overall Study|Study Terminated by the Sponsor|14|||
130273612|NCT03520920|468965614|FG002|Overall Study|Study Terminated by the Sponsor|5|||
130273613|NCT00405392|468965615|FG000|Overall Study|Adverse Event|15|||
130273614|NCT00405392|468965616|FG001|Overall Study|Adverse Event|14|||
130273615|NCT00405392|468965615|FG000|Overall Study|Did not meet Eligibility criteria|7|||
130273616|NCT00405392|468965616|FG001|Overall Study|Did not meet Eligibility criteria|2|||
130273617|NCT00405392|468965615|FG000|Overall Study|Withdrawal by Subject|4|||
130273618|NCT00405392|468965616|FG001|Overall Study|Withdrawal by Subject|3|||
130456377|NCT01235949|469634913|FG003|Booster Phase|Migrated/moved from study area|0|||
130456378|NCT01235949|469634914|FG004|Booster Phase|Migrated/moved from study area|0|||
130456379|NCT01235949|469634915|FG005|Booster Phase|Migrated/moved from study area|0|||
130456380|NCT01235949|469634916|FG006|Booster Phase|Migrated/moved from study area|0|||
130456381|NCT01235949|469634917|FG007|Booster Phase|Migrated/moved from study area|0|||
130456382|NCT01235949|469634918|FG008|Booster Phase|Migrated/moved from study area|0|||
130456383|NCT01235949|469634919|FG009|Booster Phase|Migrated/moved from study area|0|||
130456384|NCT01235949|469634920|FG010|Booster Phase|Migrated/moved from study area|0|||
130456385|NCT01235949|469634921|FG011|Booster Phase|Migrated/moved from study area|1|||
130456386|NCT01235949|469634922|FG012|Booster Phase|Migrated/moved from study area|1|||
130456387|NCT01235949|469634923|FG013|Booster Phase|Migrated/moved from study area|0|||
130706985|NCT00402025|470551643|FG001|Overall Study|Adverse Event|0|||
130706986|NCT00402025|470551644|FG002|Overall Study|Adverse Event|2|||
130706987|NCT00402025|470551642|FG000|Overall Study|Death|0|||
130706988|NCT00402025|470551643|FG001|Overall Study|Death|1|||
130706989|NCT00402025|470551644|FG002|Overall Study|Death|5|||
130706990|NCT00402025|470551642|FG000|Overall Study|Disease Progression|1|||
130706991|NCT00402025|470551643|FG001|Overall Study|Disease Progression|1|||
130706992|NCT00402025|470551644|FG002|Overall Study|Disease Progression|2|||
130706993|NCT00402025|470551642|FG000|Overall Study|Physician Decision|1|||
130706994|NCT00402025|470551643|FG001|Overall Study|Physician Decision|1|||
130706995|NCT00402025|470551644|FG002|Overall Study|Physician Decision|0|||
130706996|NCT00402025|470551642|FG000|Overall Study|Participant Decision|0|||
130706997|NCT00402025|470551643|FG001|Overall Study|Participant Decision|0|||
130706998|NCT00402025|470551644|FG002|Overall Study|Participant Decision|1|||
130706999|NCT01917968|470551645|FG000|Overall Study|Death|3|||
130707000|NCT01917968|470551646|FG001|Overall Study|Death|2|||
130707001|NCT01917968|470551645|FG000|Overall Study|Lost to Follow-up|21|||
130707002|NCT01917968|470551646|FG001|Overall Study|Lost to Follow-up|39|||
130707003|NCT01917968|470551645|FG000|Overall Study|Physician Decision|1|||
130707004|NCT01917968|470551646|FG001|Overall Study|Physician Decision|2|||
130707005|NCT01917968|470551645|FG000|Overall Study|Withdrawal by Subject|20|||
130707006|NCT01917968|470551646|FG001|Overall Study|Withdrawal by Subject|35|||
130707007|NCT01917968|470551645|FG000|Overall Study|Subject Relocation|5|||
130707008|NCT01917968|470551646|FG001|Overall Study|Subject Relocation|1|||
130707009|NCT01917968|470551645|FG000|Overall Study|36M Missed Visit|3|||
130707010|NCT01917968|470551646|FG001|Overall Study|36M Missed Visit|2|||
130707011|NCT01917968|470551645|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
130707012|NCT01917968|470551646|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
130707013|NCT01917968|470551645|FG000|Overall Study|Change in Family Circumstances|0|||
130707014|NCT01917968|470551646|FG001|Overall Study|Change in Family Circumstances|1|||
130707015|NCT01917968|470551645|FG000|Overall Study|No Data Available|0|||
130707016|NCT01917968|470551646|FG001|Overall Study|No Data Available|2|||
130707017|NCT01507090|470551649|FG000|Overall Study|incomplete dataset|18|||
130707018|NCT04678817|470553223|FG000|Overall Study|Lost to Follow-up|28|||
130707019|NCT04678817|470553224|FG001|Overall Study|Lost to Follow-up|0|||
130707020|NCT04678817|470553225|FG002|Overall Study|Lost to Follow-up|0|||
130707021|NCT03064438|470553228|FG000|Overall Study|Lost to Follow-up|1|||
130707022|NCT03064438|470553229|FG001|Overall Study|Lost to Follow-up|0|||
130707023|NCT03064438|470553228|FG000|Overall Study|Withdrawal by Subject|0|||
130707024|NCT03064438|470553229|FG001|Overall Study|Withdrawal by Subject|1|||
130707025|NCT01937351|470553230|FG000|Overall Study|Withdrawal by Subject|4|||
130707026|NCT01937351|470553231|FG001|Overall Study|Withdrawal by Subject|2|||
130707027|NCT01937351|470553230|FG000|Overall Study|Death|1|||
130707028|NCT01937351|470553231|FG001|Overall Study|Death|0|||
130707029|NCT01937351|470553230|FG000|Overall Study|Not treated w device, per protocol fail|4|||
130707030|NCT01937351|470553231|FG001|Overall Study|Not treated w device, per protocol fail|0|||
130707031|NCT01961687|470553232|FG000|Overall Study|Lost to Follow-up|19|||
130707032|NCT01961687|470553232|FG000|Overall Study|Re-operation|17|||
130707033|NCT01961687|470553232|FG000|Overall Study|Death|7|||
130707034|NCT01961687|470553232|FG000|Overall Study|Withdrawal by Subject|6|||
130707035|NCT01961687|470553232|FG000|Overall Study|Adverse Event|6|||
130707036|NCT01961687|470553232|FG000|Overall Study|Moved to area without study site|2|||
130707037|NCT01961687|470553232|FG000|Overall Study|Sponsor decision|2|||
130707038|NCT01961687|470553232|FG000|Overall Study|Physician Decision|1|||
130456388|NCT01235949|469634924|FG014|Booster Phase|Migrated/moved from study area|0|||
130456389|NCT01235949|469634925|FG015|Booster Phase|Migrated/moved from study area|0|||
130456390|NCT01235949|469634926|FG016|Booster Phase|Migrated/moved from study area|0|||
130456391|NCT01235949|469634927|FG017|Booster Phase|Migrated/moved from study area|1|||
130707039|NCT01961687|470553232|FG000|Overall Study|Unable to meet follow-up requirements|1|||
130707040|NCT01467479|470553233|FG000|Overall Study|No Study Medication|1|||
130707041|NCT01467479|470553234|FG001|Overall Study|No Study Medication|0|||
130707042|NCT01467479|470553235|FG002|Overall Study|No Study Medication|2|||
130707043|NCT01467479|470553233|FG000|Overall Study|Adverse Event|1|||
130707044|NCT01467479|470553234|FG001|Overall Study|Adverse Event|2|||
130707045|NCT01467479|470553235|FG002|Overall Study|Adverse Event|0|||
130707046|NCT01467479|470553233|FG000|Overall Study|Death|0|||
130707047|NCT01467479|470553234|FG001|Overall Study|Death|0|||
130707048|NCT01467479|470553235|FG002|Overall Study|Death|1|||
130707049|NCT01467479|470553233|FG000|Overall Study|Lost to Follow-up|2|||
130707050|NCT01467479|470553234|FG001|Overall Study|Lost to Follow-up|5|||
130707051|NCT01467479|470553235|FG002|Overall Study|Lost to Follow-up|3|||
130707052|NCT01467479|470553233|FG000|Overall Study|Withdrawal of Consent|3|||
130707053|NCT01467479|470553234|FG001|Overall Study|Withdrawal of Consent|7|||
130707054|NCT01467479|470553235|FG002|Overall Study|Withdrawal of Consent|7|||
130707055|NCT01467479|470553233|FG000|Overall Study|Study Terminated by Sponsor|1|||
130707056|NCT01467479|470553234|FG001|Overall Study|Study Terminated by Sponsor|3|||
130707057|NCT01467479|470553235|FG002|Overall Study|Study Terminated by Sponsor|3|||
130707058|NCT01467479|470553233|FG000|Overall Study|Other|1|||
130707059|NCT01467479|470553234|FG001|Overall Study|Other|0|||
130707060|NCT01467479|470553235|FG002|Overall Study|Other|0|||
130707061|NCT01915940|470553247|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
130707062|NCT01915940|470553248|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130707063|NCT01915940|470553249|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130707064|NCT01915940|470553247|FG000|Treatment Period|Decision of Participant|0|||
130707065|NCT01915940|470553248|FG001|Treatment Period|Decision of Participant|1|||
130707066|NCT01915940|470553249|FG002|Treatment Period|Decision of Participant|3|||
130707067|NCT01915940|470553247|FG000|Treatment Period|Adverse Event|0|||
130707068|NCT01915940|470553248|FG001|Treatment Period|Adverse Event|9|||
130707069|NCT01915940|470553249|FG002|Treatment Period|Adverse Event|1|||
130707070|NCT01915940|470553247|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130707071|NCT01915940|470553248|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
130707072|NCT01915940|470553249|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130707073|NCT02999984|470553250|FG000|Overall Study|Treatment Failure|1|||
130707074|NCT04086641|470553251|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
130707075|NCT04086641|470553252|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
130707076|NCT01042535|470553253|FG000|Overall Study|disease progression prior to treatment|3|||
130707077|NCT01042535|470553253|FG000|Overall Study|disease progression during treatment|3|||
130707078|NCT01042535|470553253|FG000|Overall Study|complications from other disease|2|||
130707079|NCT03438539|470553262|FG000|Overall Study|Lost to Follow-up|8|||
130707080|NCT03438539|470553263|FG001|Overall Study|Lost to Follow-up|4|||
130707081|NCT03438539|470553264|FG002|Overall Study|Lost to Follow-up|10|||
130707082|NCT03438539|470553265|FG003|Overall Study|Lost to Follow-up|9|||
130707083|NCT03438539|470553266|FG004|Overall Study|Lost to Follow-up|3|||
130707084|NCT03438539|470553267|FG005|Overall Study|Lost to Follow-up|8|||
130707085|NCT04213209|470553268|FG000|Overall Study|Protocol Violation|1|||
130707086|NCT04213209|470553269|FG001|Overall Study|Protocol Violation|0|||
130707087|NCT04213209|470553270|FG002|Overall Study|Protocol Violation|0|||
130707088|NCT04213209|470553271|FG003|Overall Study|Protocol Violation|0|||
130707089|NCT04213209|470553272|FG004|Overall Study|Protocol Violation|0|||
130707090|NCT04213209|470553273|FG005|Overall Study|Protocol Violation|0|||
130707091|NCT00743509|470553274|FG000|Overall Study|Withdrawal by Subject|2|||
130707092|NCT02065713|470553280|FG000|Overall Study|Adverse Event|0|||
130707093|NCT02065713|470553281|FG001|Overall Study|Adverse Event|1|||
130707094|NCT02065713|470553280|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130707095|NCT02065713|470553281|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130707096|NCT00418522|470553284|FG000|Overall Study|Adverse Event|7|||
130707097|NCT00418522|470553285|FG001|Overall Study|Adverse Event|1|||
130707098|NCT00418522|470553284|FG000|Overall Study|Lack of Efficacy|1|||
130707099|NCT00418522|470553285|FG001|Overall Study|Lack of Efficacy|3|||
130707100|NCT00418522|470553284|FG000|Overall Study|Lost to Follow-up|10|||
130707101|NCT00418522|470553285|FG001|Overall Study|Lost to Follow-up|4|||
130707102|NCT00418522|470553284|FG000|Overall Study|Withdrawal by Subject|31|||
130707103|NCT00418522|470553285|FG001|Overall Study|Withdrawal by Subject|7|||
130707104|NCT00418522|470553284|FG000|Overall Study|Other|27|||
130707105|NCT00418522|470553285|FG001|Overall Study|Other|23|||
130707106|NCT00418522|470553284|FG000|Overall Study|Randomized but did not receive treatment|7|||
130456392|NCT01235949|469634910|FG000|Booster Phase|Adverse Event|0|||
130456393|NCT01235949|469634911|FG001|Booster Phase|Adverse Event|0|||
130456394|NCT01235949|469634912|FG002|Booster Phase|Adverse Event|0|||
130707107|NCT00418522|470553285|FG001|Overall Study|Randomized but did not receive treatment|4|||
130456395|NCT01235949|469634913|FG003|Booster Phase|Adverse Event|0|||
130456396|NCT01235949|469634914|FG004|Booster Phase|Adverse Event|0|||
130707108|NCT02695719|470553286|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
130707109|NCT02695719|470553287|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
130707110|NCT02695719|470553286|FG000|Overall Study|Significant Protocol Deviation|0|||
130707111|NCT02695719|470553287|FG001|Overall Study|Significant Protocol Deviation|1|||
130707112|NCT02695719|470553286|FG000|Overall Study|Voluntary Withdrawal|1|||
130707113|NCT02695719|470553287|FG001|Overall Study|Voluntary Withdrawal|0|||
130707114|NCT00483548|470553288|FG000|Overall Study|Randomized; not treated with study drug|1|||
130707115|NCT00483548|470553289|FG001|Overall Study|Randomized; not treated with study drug|3|||
130707116|NCT00483548|470553288|FG000|Overall Study|Adverse Event|25|||
130456397|NCT01235949|469634915|FG005|Booster Phase|Adverse Event|0|||
130707117|NCT00483548|470553289|FG001|Overall Study|Adverse Event|14|||
130707118|NCT00483548|470553288|FG000|Overall Study|Laboratory abnormality|1|||
130707119|NCT00483548|470553289|FG001|Overall Study|Laboratory abnormality|2|||
130707120|NCT00483548|470553288|FG000|Overall Study|Lack of Efficacy|4|||
130707121|NCT00483548|470553289|FG001|Overall Study|Lack of Efficacy|8|||
130707122|NCT00483548|470553288|FG000|Overall Study|Protocol Violation|11|||
130707123|NCT00483548|470553289|FG001|Overall Study|Protocol Violation|7|||
130707124|NCT00483548|470553288|FG000|Overall Study|Pregnancy|1|||
130707125|NCT00483548|470553289|FG001|Overall Study|Pregnancy|0|||
130707126|NCT00483548|470553288|FG000|Overall Study|Protocol required discontinuation|6|||
130707127|NCT00483548|470553289|FG001|Overall Study|Protocol required discontinuation|6|||
130707128|NCT00483548|470553288|FG000|Overall Study|Unable to comply with protocol schedule|1|||
130707129|NCT00483548|470553289|FG001|Overall Study|Unable to comply with protocol schedule|0|||
130707130|NCT00483548|470553288|FG000|Overall Study|Non-compliance with medication|2|||
130707131|NCT00483548|470553289|FG001|Overall Study|Non-compliance with medication|0|||
130707132|NCT00483548|470553288|FG000|Overall Study|Lost to Follow-up|3|||
130707133|NCT00483548|470553289|FG001|Overall Study|Lost to Follow-up|4|||
130707134|NCT00483548|470553288|FG000|Overall Study|Withdrawal by Subject|5|||
130707135|NCT00483548|470553289|FG001|Overall Study|Withdrawal by Subject|2|||
130707136|NCT00126126|470553290|FG000|Overall Study|Lost to Follow-up|0|||
130707137|NCT00126126|470553291|FG001|Overall Study|Lost to Follow-up|2|||
130707138|NCT02694549|470553292|FG000|Overall Study|screen failures|2|||
130707139|NCT01534078|470553293|FG000|Overall Study|Death|1|||
130707140|NCT01534078|470553293|FG000|Overall Study|Withdrawal by Subject|1|||
130707141|NCT02459665|470553294|FG000|Overall Study|Withdrawal by Subject|0|||
130707142|NCT02459665|470553295|FG001|Overall Study|Withdrawal by Subject|1|||
130707143|NCT02459665|470553296|FG002|Overall Study|Withdrawal by Subject|1|||
130707144|NCT02459665|470553297|FG003|Overall Study|Withdrawal by Subject|2|||
130707145|NCT01223235|470553298|FG000|Overall Study|Withdrawal by Subject|1|||
130707146|NCT00868296|470553303|FG000|Overall Study|Adverse Event|0|||
130707147|NCT00868296|470553304|FG001|Overall Study|Adverse Event|2|||
130707148|NCT00868296|470553303|FG000|Overall Study|Withdrawal by Subject|0|||
130707149|NCT00868296|470553304|FG001|Overall Study|Withdrawal by Subject|1|||
130707150|NCT00573170|470553309|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
130707151|NCT00573170|470553310|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
130707152|NCT00573170|470553311|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
130707153|NCT00573170|470553312|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
130707154|NCT00573170|470553313|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
130707155|NCT00573170|470553314|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
130707156|NCT00573170|470553309|FG000|First Washout Period|Adverse Event|1|||
130707157|NCT00573170|470553310|FG001|First Washout Period|Adverse Event|1|||
130707158|NCT00573170|470553311|FG002|First Washout Period|Adverse Event|0|||
130707159|NCT00573170|470553312|FG003|First Washout Period|Adverse Event|0|||
130707160|NCT00573170|470553313|FG004|First Washout Period|Adverse Event|0|||
130707161|NCT00573170|470553314|FG005|First Washout Period|Adverse Event|1|||
130707162|NCT00573170|470553309|FG000|First Washout Period|Lack of Efficacy|0|||
130707163|NCT00573170|470553310|FG001|First Washout Period|Lack of Efficacy|0|||
130456398|NCT01235949|469634916|FG006|Booster Phase|Adverse Event|0|||
130707164|NCT00573170|470553311|FG002|First Washout Period|Lack of Efficacy|0|||
130707165|NCT00573170|470553312|FG003|First Washout Period|Lack of Efficacy|0|||
130707166|NCT00573170|470553313|FG004|First Washout Period|Lack of Efficacy|0|||
130707167|NCT00573170|470553314|FG005|First Washout Period|Lack of Efficacy|1|||
130707168|NCT00573170|470553309|FG000|First Washout Period|Lost to Follow-up|1|||
130707169|NCT00573170|470553310|FG001|First Washout Period|Lost to Follow-up|1|||
130707170|NCT00573170|470553311|FG002|First Washout Period|Lost to Follow-up|0|||
130707171|NCT00573170|470553312|FG003|First Washout Period|Lost to Follow-up|2|||
130707172|NCT00573170|470553313|FG004|First Washout Period|Lost to Follow-up|0|||
130707173|NCT00573170|470553314|FG005|First Washout Period|Lost to Follow-up|2|||
130707174|NCT00573170|470553309|FG000|First Washout Period|Withdrawal by Subject|2|||
130707175|NCT00573170|470553310|FG001|First Washout Period|Withdrawal by Subject|0|||
130707176|NCT00573170|470553311|FG002|First Washout Period|Withdrawal by Subject|0|||
130456399|NCT01235949|469634917|FG007|Booster Phase|Adverse Event|0|||
130456400|NCT01235949|469634918|FG008|Booster Phase|Adverse Event|0|||
130707177|NCT00573170|470553312|FG003|First Washout Period|Withdrawal by Subject|2|||
130707178|NCT00573170|470553313|FG004|First Washout Period|Withdrawal by Subject|3|||
130707179|NCT00573170|470553314|FG005|First Washout Period|Withdrawal by Subject|3|||
130707180|NCT00573170|470553309|FG000|First Washout Period|Other|4|||
130707181|NCT00573170|470553310|FG001|First Washout Period|Other|0|||
130707182|NCT00573170|470553311|FG002|First Washout Period|Other|1|||
130707183|NCT00573170|470553312|FG003|First Washout Period|Other|1|||
130707184|NCT00573170|470553313|FG004|First Washout Period|Other|0|||
130707185|NCT00573170|470553314|FG005|First Washout Period|Other|0|||
130707186|NCT00573170|470553309|FG000|Second Washout Period|Adverse Event|1|||
130707187|NCT00573170|470553310|FG001|Second Washout Period|Adverse Event|0|||
130707188|NCT00573170|470553311|FG002|Second Washout Period|Adverse Event|0|||
130456401|NCT01235949|469634919|FG009|Booster Phase|Adverse Event|0|||
130707189|NCT00573170|470553312|FG003|Second Washout Period|Adverse Event|0|||
130707190|NCT00573170|470553313|FG004|Second Washout Period|Adverse Event|1|||
130707191|NCT00573170|470553314|FG005|Second Washout Period|Adverse Event|0|||
130707192|NCT00573170|470553309|FG000|Second Washout Period|Protocol Violation|2|||
130707193|NCT00573170|470553310|FG001|Second Washout Period|Protocol Violation|1|||
130707194|NCT00573170|470553311|FG002|Second Washout Period|Protocol Violation|1|||
130707195|NCT00573170|470553312|FG003|Second Washout Period|Protocol Violation|0|||
130707196|NCT00573170|470553313|FG004|Second Washout Period|Protocol Violation|0|||
130707197|NCT00573170|470553314|FG005|Second Washout Period|Protocol Violation|0|||
130707198|NCT00573170|470553309|FG000|Second Washout Period|Withdrawal by Subject|1|||
130707199|NCT00573170|470553310|FG001|Second Washout Period|Withdrawal by Subject|1|||
130707200|NCT00573170|470553311|FG002|Second Washout Period|Withdrawal by Subject|2|||
130707201|NCT00573170|470553312|FG003|Second Washout Period|Withdrawal by Subject|0|||
130707202|NCT00573170|470553313|FG004|Second Washout Period|Withdrawal by Subject|1|||
130707203|NCT00573170|470553314|FG005|Second Washout Period|Withdrawal by Subject|0|||
130707204|NCT00573170|470553309|FG000|Second Washout Period|Lost to Follow-up|0|||
130707205|NCT00573170|470553310|FG001|Second Washout Period|Lost to Follow-up|0|||
130707206|NCT00573170|470553311|FG002|Second Washout Period|Lost to Follow-up|0|||
130707207|NCT00573170|470553312|FG003|Second Washout Period|Lost to Follow-up|1|||
130707208|NCT00573170|470553313|FG004|Second Washout Period|Lost to Follow-up|0|||
130707209|NCT00573170|470553314|FG005|Second Washout Period|Lost to Follow-up|0|||
130707210|NCT00573170|470553309|FG000|Second Washout Period|Other|1|||
130707211|NCT00573170|470553310|FG001|Second Washout Period|Other|2|||
130707212|NCT00573170|470553311|FG002|Second Washout Period|Other|1|||
130707213|NCT00573170|470553312|FG003|Second Washout Period|Other|4|||
130707214|NCT00573170|470553313|FG004|Second Washout Period|Other|6|||
130707215|NCT00573170|470553314|FG005|Second Washout Period|Other|2|||
130707216|NCT00573170|470553309|FG000|Third Treatment Period|Withdrawal by Subject|1|||
130707217|NCT00573170|470553310|FG001|Third Treatment Period|Withdrawal by Subject|0|||
130707218|NCT00573170|470553311|FG002|Third Treatment Period|Withdrawal by Subject|0|||
130707219|NCT00573170|470553312|FG003|Third Treatment Period|Withdrawal by Subject|0|||
130707220|NCT00573170|470553313|FG004|Third Treatment Period|Withdrawal by Subject|0|||
130707221|NCT00573170|470553314|FG005|Third Treatment Period|Withdrawal by Subject|0|||
130707222|NCT00573170|470553309|FG000|Third Treatment Period|Lost to Follow-up|0|||
130707223|NCT00573170|470553310|FG001|Third Treatment Period|Lost to Follow-up|0|||
130707224|NCT00573170|470553311|FG002|Third Treatment Period|Lost to Follow-up|0|||
130707225|NCT00573170|470553312|FG003|Third Treatment Period|Lost to Follow-up|0|||
130707226|NCT00573170|470553313|FG004|Third Treatment Period|Lost to Follow-up|0|||
130707227|NCT00573170|470553314|FG005|Third Treatment Period|Lost to Follow-up|2|||
130707228|NCT00986570|470553315|FG000|Overall Study|Lost to Follow-up|6|||
130707229|NCT00986570|470553315|FG000|Overall Study|Potential bias for objective assessment|1|||
130707230|NCT00493454|470553317|FG000|Overall Study|Withdrawal by Subject|1|||
130707231|NCT00103038|470553318|FG000|Overall Study|Withdrawal by Subject|8|||
130707232|NCT00103038|470553318|FG000|Overall Study|Screen failure|3|||
130707233|NCT00103038|470553318|FG000|Overall Study|Death|1|||
130707234|NCT00103038|470553318|FG000|Overall Study|Physician Decision|1|||
130707235|NCT03649412|470553325|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
130707236|NCT03649412|470553326|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
130707237|NCT03649412|470553325|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
130707238|NCT03649412|470553326|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
130707239|NCT03649412|470553325|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
130707240|NCT03649412|470553326|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130707241|NCT03649412|470553325|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
130707242|NCT03649412|470553326|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
130456402|NCT01235949|469634920|FG010|Booster Phase|Adverse Event|0|||
130456403|NCT01235949|469634921|FG011|Booster Phase|Adverse Event|0|||
130456404|NCT01235949|469634922|FG012|Booster Phase|Adverse Event|0|||
130707243|NCT03649412|470553325|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
130707244|NCT03649412|470553326|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
130456405|NCT01235949|469634923|FG013|Booster Phase|Adverse Event|0|||
130456406|NCT01235949|469634924|FG014|Booster Phase|Adverse Event|0|||
130456407|NCT01235949|469634925|FG015|Booster Phase|Adverse Event|1|||
130456408|NCT01235949|469634926|FG016|Booster Phase|Adverse Event|0|||
130707245|NCT03649412|470553325|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
130707246|NCT03649412|470553326|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
130707247|NCT02865395|470553327|FG000|Overall Study|Physician Decision|6|||
130707248|NCT02865395|470553328|FG001|Overall Study|Physician Decision|10|||
130707249|NCT02865395|470553329|FG002|Overall Study|Physician Decision|7|||
130707250|NCT01439724|470553330|FG000|Overall Study|missing consultation|9|||
130707251|NCT01439724|470553331|FG001|Overall Study|missing consultation|8|||
130707252|NCT04019054|470553333|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
130707253|NCT04019054|470553334|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
130456409|NCT01235949|469634927|FG017|Booster Phase|Adverse Event|0|||
130707254|NCT04019054|470553333|FG000|Overall Study|Withdrawal by Subject|3|||
130707255|NCT04019054|470553334|FG001|Overall Study|Withdrawal by Subject|1|||
130707256|NCT01731886|470553335|FG000|Overall Study|Death|1|||
130707257|NCT01731886|470553336|FG001|Overall Study|Death|0|||
130707258|NCT01731886|470553335|FG000|Overall Study|Never started treatment|0|||
130707259|NCT01731886|470553336|FG001|Overall Study|Never started treatment|1|||
130707260|NCT01731886|470553335|FG000|Overall Study|Non-compliant|1|||
130707261|NCT01731886|470553336|FG001|Overall Study|Non-compliant|0|||
130707262|NCT03877926|470553342|FG000|Overall Study|Adverse Event|1|||
130707263|NCT03877926|470553343|FG001|Overall Study|Adverse Event|0|||
130707264|NCT03877926|470553344|FG002|Overall Study|Adverse Event|0|||
130367186|NCT01433991|469315877|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130367187|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
130367188|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
130367189|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
130367190|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
130367191|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
130367192|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
130707265|NCT03877926|470553345|FG003|Overall Study|Adverse Event|0|||
130707266|NCT03877926|470553342|FG000|Overall Study|Death|2|||
130707267|NCT03877926|470553343|FG001|Overall Study|Death|2|||
130707268|NCT03877926|470553344|FG002|Overall Study|Death|2|||
130707269|NCT03877926|470553345|FG003|Overall Study|Death|0|||
130707270|NCT03877926|470553342|FG000|Overall Study|Lost to Follow-up|41|||
130707271|NCT03877926|470553343|FG001|Overall Study|Lost to Follow-up|52|||
130707272|NCT03877926|470553344|FG002|Overall Study|Lost to Follow-up|45|||
130707273|NCT03877926|470553345|FG003|Overall Study|Lost to Follow-up|17|||
130707274|NCT03877926|470553342|FG000|Overall Study|Physician Decision|2|||
130707275|NCT03877926|470553343|FG001|Overall Study|Physician Decision|0|||
130707276|NCT03877926|470553344|FG002|Overall Study|Physician Decision|2|||
130707277|NCT03877926|470553345|FG003|Overall Study|Physician Decision|0|||
130707278|NCT03877926|470553342|FG000|Overall Study|Withdrawal by Subject|18|||
130707279|NCT03877926|470553343|FG001|Overall Study|Withdrawal by Subject|21|||
130707280|NCT03877926|470553344|FG002|Overall Study|Withdrawal by Subject|12|||
130707281|NCT03877926|470553345|FG003|Overall Study|Withdrawal by Subject|4|||
130707282|NCT03877926|470553342|FG000|Overall Study|Other - Various|4|||
130707283|NCT03877926|470553343|FG001|Overall Study|Other - Various|1|||
130707284|NCT03877926|470553344|FG002|Overall Study|Other - Various|1|||
130707285|NCT03877926|470553345|FG003|Overall Study|Other - Various|0|||
130707286|NCT03877926|470553342|FG000|Overall Study|Not Treated|3|||
130707287|NCT03877926|470553343|FG001|Overall Study|Not Treated|1|||
130707288|NCT03877926|470553344|FG002|Overall Study|Not Treated|1|||
130707289|NCT03877926|470553345|FG003|Overall Study|Not Treated|0|||
130707290|NCT00467831|470553349|FG000|Overall Study|Death|2|||
130707291|NCT00467831|470553349|FG000|Overall Study|Withdrawal by Subject|1|||
130707292|NCT00860743|470553352|FG000|Overall Study|Withdrawal by Subject|3|||
130707293|NCT00860743|470553353|FG001|Overall Study|Withdrawal by Subject|0|||
130707294|NCT02776553|470553357|FG000|Overall Study|Lost to Follow-up|1|||
130707295|NCT02776553|470553358|FG001|Overall Study|Lost to Follow-up|0|||
130707296|NCT02776553|470553357|FG000|Overall Study|got liver transplant|1|||
130707297|NCT02776553|470553358|FG001|Overall Study|got liver transplant|2|||
130707298|NCT02776553|470553357|FG000|Overall Study|had other surgery|1|||
130707299|NCT02776553|470553358|FG001|Overall Study|had other surgery|0|||
130707300|NCT02776553|470553357|FG000|Overall Study|Protocol Violation|0|||
130707301|NCT02776553|470553358|FG001|Overall Study|Protocol Violation|1|||
130707302|NCT00171340|470553360|FG000|Overall Study|Adverse Event|46|||
130707303|NCT00171340|470553361|FG001|Overall Study|Adverse Event|42|||
130707304|NCT00171340|470553360|FG000|Overall Study|Lack of Efficacy|29|||
130707305|NCT00171340|470553361|FG001|Overall Study|Lack of Efficacy|41|||
130707306|NCT00171340|470553360|FG000|Overall Study|Protocol Violation|7|||
130707307|NCT00171340|470553361|FG001|Overall Study|Protocol Violation|8|||
130707308|NCT00171340|470553360|FG000|Overall Study|Withdrawal by Subject|22|||
130707309|NCT00171340|470553361|FG001|Overall Study|Withdrawal by Subject|19|||
130707310|NCT00171340|470553360|FG000|Overall Study|Lost to Follow-up|0|||
130707311|NCT00171340|470553361|FG001|Overall Study|Lost to Follow-up|5|||
130707312|NCT00171340|470553360|FG000|Overall Study|Abnormal Laboratory Results|2|||
130707313|NCT00171340|470553361|FG001|Overall Study|Abnormal Laboratory Results|0|||
130707314|NCT00171340|470553360|FG000|Overall Study|Abnormal Test Procedure Results|6|||
130707315|NCT00171340|470553361|FG001|Overall Study|Abnormal Test Procedure Results|11|||
130707316|NCT00171340|470553360|FG000|Overall Study|No Longer Required Study Drug|1|||
130707317|NCT00171340|470553361|FG001|Overall Study|No Longer Required Study Drug|1|||
130707318|NCT00171340|470553360|FG000|Overall Study|Administrative Problems|5|||
130707319|NCT00171340|470553361|FG001|Overall Study|Administrative Problems|2|||
130707320|NCT00171340|470553360|FG000|Overall Study|Death|6|||
130707321|NCT00171340|470553361|FG001|Overall Study|Death|6|||
130707322|NCT01056640|470553362|FG000|Overall Study|Withdrawal by Subject|11|||
130707323|NCT01056640|470553363|FG001|Overall Study|Withdrawal by Subject|8|||
130707324|NCT01056640|470553362|FG000|Overall Study|Death|15|||
130707325|NCT01056640|470553363|FG001|Overall Study|Death|4|||
130707326|NCT03648879|470553364|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
130707327|NCT03812991|470553365|FG000|Overall Study|Lost to Follow-up|3|||
130707328|NCT03812991|470553366|FG001|Overall Study|Lost to Follow-up|1|||
130707329|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130707330|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
130707331|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130707332|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
130707333|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
130707334|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
130707335|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
130707336|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
130707337|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130707338|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130707339|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130707340|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
130707341|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
130707342|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
130707343|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130707344|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
130707345|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130707346|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130707347|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
130707348|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
130707349|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130707350|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130707351|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
130707352|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
130707353|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
130707354|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
130707355|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
130707356|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
130707357|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
130707358|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
130707359|NCT00895037|470553371|FG000|Overall Study|Death|0|||
130707360|NCT00895037|470553372|FG001|Overall Study|Death|2|||
130707361|NCT00895037|470553373|FG002|Overall Study|Death|1|||
130707362|NCT00104247|470553389|FG000|Overall Study|Withdrawal by Subject|1|||
130707363|NCT00104247|470553390|FG001|Overall Study|Withdrawal by Subject|0|||
130707364|NCT00104247|470553389|FG000|Overall Study|Noncompliant with dosing|0|||
130707365|NCT00104247|470553390|FG001|Overall Study|Noncompliant with dosing|1|||
130707366|NCT04798482|470553393|FG000|Overall Study|Physician Decision|1|||
130707367|NCT04798482|470553393|FG000|Overall Study|Lost eligibility|1|||
130707368|NCT01192399|470553396|FG000|Overall Study|Lack of Efficacy|2|||
130707369|NCT01930175|470553397|FG000|Core Study|Lost to Follow-up|0|||
130707370|NCT01930175|470553398|FG001|Core Study|Lost to Follow-up|1|||
130707371|NCT01930175|470553399|FG002|Core Study|Lost to Follow-up|0|||
130707372|NCT01930175|470553397|FG000|Core Study|Adverse Event|0|||
130707373|NCT01930175|470553398|FG001|Core Study|Adverse Event|0|||
130707374|NCT01930175|470553399|FG002|Core Study|Adverse Event|1|||
130707375|NCT02820740|470553400|FG000|Overall Study|Did not have procedure|2|||
130707376|NCT01684215|470554905|FG000|Phase 1, Part 1|Adverse Event|1|||
130707377|NCT01684215|470554906|FG001|Phase 1, Part 1|Adverse Event|0|||
130707378|NCT01684215|470554907|FG002|Phase 1, Part 1|Adverse Event|0|||
130707379|NCT01684215|470554908|FG003|Phase 1, Part 1|Adverse Event|0|||
130707380|NCT01684215|470554905|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
130707381|NCT01684215|470554906|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
130707382|NCT01684215|470554907|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
130707383|NCT01684215|470554908|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
130707384|NCT01684215|470554905|FG000|Phase 1, Part 2|Adverse Event|0|||
130707385|NCT01684215|470554906|FG001|Phase 1, Part 2|Adverse Event|0|||
130707386|NCT01684215|470554907|FG002|Phase 1, Part 2|Adverse Event|1|||
130707387|NCT01684215|470554908|FG003|Phase 1, Part 2|Adverse Event|0|||
130707388|NCT01684215|470554905|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707389|NCT01684215|470554906|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707390|NCT01684215|470554907|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
130707391|NCT01684215|470554908|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707392|NCT01684215|470554905|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
130707393|NCT01684215|470554906|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
130707394|NCT01684215|470554907|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
130707395|NCT01684215|470554908|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
130707396|NCT01684215|470554905|FG000|Phase 2|Death|0|||
130707397|NCT01684215|470554906|FG001|Phase 2|Death|0|||
130707398|NCT01684215|470554907|FG002|Phase 2|Death|0|||
130707399|NCT01684215|470554908|FG003|Phase 2|Death|8|||
130707400|NCT01684215|470554905|FG000|Phase 2|Study terminated by sponsor|0|||
130707401|NCT01684215|470554906|FG001|Phase 2|Study terminated by sponsor|0|||
130707402|NCT01684215|470554907|FG002|Phase 2|Study terminated by sponsor|0|||
130707403|NCT01684215|470554908|FG003|Phase 2|Study terminated by sponsor|30|||
130707404|NCT01684215|470554905|FG000|Phase 2|Enrolled but not treated|0|||
130707405|NCT01684215|470554906|FG001|Phase 2|Enrolled but not treated|0|||
130707406|NCT01684215|470554907|FG002|Phase 2|Enrolled but not treated|0|||
130707407|NCT01684215|470554908|FG003|Phase 2|Enrolled but not treated|1|||
130707408|NCT01684215|470554905|FG000|Phase 2|Lost to Follow-up|0|||
130707409|NCT01684215|470554906|FG001|Phase 2|Lost to Follow-up|0|||
130707410|NCT01684215|470554907|FG002|Phase 2|Lost to Follow-up|0|||
130707411|NCT01684215|470554908|FG003|Phase 2|Lost to Follow-up|4|||
130707412|NCT01301482|470554909|FG000|Overall Study|Withdrawal by Subject|1|||
130707413|NCT00480324|470554910|FG000|Overall Study|Adverse Event|1|||
130707414|NCT00480324|470554911|FG001|Overall Study|Adverse Event|1|||
130707415|NCT00480324|470554910|FG000|Overall Study|Protocol Violation|0|||
130707416|NCT00480324|470554911|FG001|Overall Study|Protocol Violation|1|||
130707417|NCT00480324|470554910|FG000|Overall Study|Withdrawal by Subject|14|||
130707418|NCT00480324|470554911|FG001|Overall Study|Withdrawal by Subject|5|||
130707419|NCT00480324|470554910|FG000|Overall Study|Lost to Follow-up|17|||
130707420|NCT00480324|470554911|FG001|Overall Study|Lost to Follow-up|8|||
130707421|NCT00480324|470554910|FG000|Overall Study|Subject's mother pregnant|0|||
130707422|NCT00480324|470554911|FG001|Overall Study|Subject's mother pregnant|1|||
130707423|NCT00784134|470554912|FG000|Overall Study|Lost to Follow-up|3|||
130707424|NCT00784134|470554913|FG001|Overall Study|Lost to Follow-up|6|||
130707425|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
130707426|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
130707427|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
130707428|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
130707429|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130707430|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130707431|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
130707432|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
130707433|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
130707434|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
130707435|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
130707436|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
130707437|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
130707438|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
130707439|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
130707440|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
130707441|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
130707442|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
130707443|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
130707444|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
130707445|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
130707446|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
130707447|NCT03250299|470554917|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
130707448|NCT03250299|470554918|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
130707449|NCT03250299|470554919|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
130707450|NCT03250299|470554920|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
130707451|NCT03250299|470554921|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
130707452|NCT03250299|470554917|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
130707453|NCT03250299|470554918|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
130707454|NCT03250299|470554919|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
130707455|NCT03250299|470554920|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
130707456|NCT03250299|470554921|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
130707457|NCT03250299|470554917|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707458|NCT03250299|470554918|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707459|NCT03250299|470554919|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
130707460|NCT03250299|470554920|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707461|NCT03250299|470554921|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707462|NCT03250299|470554917|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
130707463|NCT03250299|470554918|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
130707464|NCT03250299|470554919|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
130707465|NCT03250299|470554920|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
130707466|NCT03250299|470554921|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
130707467|NCT03346070|470554926|FG000|Overall Study|Death|0|||
130707468|NCT03346070|470554927|FG001|Overall Study|Death|0|||
130273619|NCT00405392|468965615|FG000|Overall Study|Lost to Follow-up|1|||
130707469|NCT03346070|470554928|FG002|Overall Study|Death|0|||
130707470|NCT03346070|470554929|FG003|Overall Study|Death|0|||
130707471|NCT03346070|470554930|FG004|Overall Study|Death|1|||
130707472|NCT03346070|470554926|FG000|Overall Study|Lost to Follow-up|0|||
130707473|NCT03346070|470554927|FG001|Overall Study|Lost to Follow-up|1|||
130707474|NCT03346070|470554928|FG002|Overall Study|Lost to Follow-up|2|||
130707475|NCT03346070|470554929|FG003|Overall Study|Lost to Follow-up|0|||
130707476|NCT03346070|470554930|FG004|Overall Study|Lost to Follow-up|0|||
130707477|NCT03346070|470554926|FG000|Overall Study|Physician Decision|0|||
130707478|NCT03346070|470554927|FG001|Overall Study|Physician Decision|0|||
130554477|NCT01839487|469996609|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
130707479|NCT03346070|470554928|FG002|Overall Study|Physician Decision|0|||
130707480|NCT03346070|470554929|FG003|Overall Study|Physician Decision|1|||
130707481|NCT03346070|470554930|FG004|Overall Study|Physician Decision|1|||
130707482|NCT03346070|470554926|FG000|Overall Study|Withdrawal by Subject|1|||
130707483|NCT03346070|470554927|FG001|Overall Study|Withdrawal by Subject|0|||
130707484|NCT03346070|470554928|FG002|Overall Study|Withdrawal by Subject|0|||
130707485|NCT03346070|470554929|FG003|Overall Study|Withdrawal by Subject|1|||
130707486|NCT03346070|470554930|FG004|Overall Study|Withdrawal by Subject|0|||
130707487|NCT03346070|470554926|FG000|Overall Study|Study medication not received as planned|2|||
130707488|NCT03346070|470554927|FG001|Overall Study|Study medication not received as planned|3|||
130707489|NCT03346070|470554928|FG002|Overall Study|Study medication not received as planned|2|||
130707490|NCT03346070|470554929|FG003|Overall Study|Study medication not received as planned|3|||
130707491|NCT03346070|470554930|FG004|Overall Study|Study medication not received as planned|2|||
130707492|NCT03346070|470554926|FG000|Overall Study|Screen Failure|0|||
130707493|NCT03346070|470554927|FG001|Overall Study|Screen Failure|0|||
130707494|NCT03346070|470554928|FG002|Overall Study|Screen Failure|0|||
130707495|NCT03346070|470554929|FG003|Overall Study|Screen Failure|1|||
130707496|NCT03346070|470554930|FG004|Overall Study|Screen Failure|1|||
130707497|NCT00977548|470554931|FG000|Overall Study|Ineligible|4|||
130707498|NCT00977548|470554931|FG000|Overall Study|Adverse Event|8|||
130707499|NCT00977548|470554931|FG000|Overall Study|Withdrawal by Subject|1|||
130707500|NCT01546142|470554935|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130707501|NCT01546142|470554936|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130707502|NCT01546142|470554935|FG000|Overall Study|Subject Noncompliance|1|||
130707503|NCT01546142|470554936|FG001|Overall Study|Subject Noncompliance|1|||
130707504|NCT01546142|470554935|FG000|Overall Study|Adverse Event|6|||
130707505|NCT01546142|470554936|FG001|Overall Study|Adverse Event|3|||
130707506|NCT01546142|470554935|FG000|Overall Study|Lost to Follow-up|20|||
130707507|NCT01546142|470554936|FG001|Overall Study|Lost to Follow-up|15|||
130707508|NCT01546142|470554935|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
130707509|NCT01546142|470554936|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
130707510|NCT01546142|470554935|FG000|Overall Study|Subject Randomized but Not Treated|1|||
130707511|NCT01546142|470554936|FG001|Overall Study|Subject Randomized but Not Treated|0|||
130707512|NCT00440466|470554939|FG000|Overall Study|Death|3|||
130707513|NCT00440466|470554940|FG001|Overall Study|Death|2|||
130707514|NCT00440466|470554941|FG002|Overall Study|Death|9|||
130707515|NCT00440466|470554939|FG000|Overall Study|Adverse Event|3|||
130707516|NCT00440466|470554940|FG001|Overall Study|Adverse Event|4|||
130707517|NCT00440466|470554941|FG002|Overall Study|Adverse Event|11|||
130707518|NCT00440466|470554939|FG000|Overall Study|Lost to Follow-up|1|||
130707519|NCT00440466|470554940|FG001|Overall Study|Lost to Follow-up|0|||
130707520|NCT00440466|470554941|FG002|Overall Study|Lost to Follow-up|2|||
130707521|NCT00440466|470554939|FG000|Overall Study|Physician Decision|2|||
130707522|NCT00440466|470554940|FG001|Overall Study|Physician Decision|0|||
130707523|NCT00440466|470554941|FG002|Overall Study|Physician Decision|1|||
130707524|NCT00440466|470554939|FG000|Overall Study|Protocol Violation|2|||
130707525|NCT00440466|470554940|FG001|Overall Study|Protocol Violation|0|||
130707526|NCT00440466|470554941|FG002|Overall Study|Protocol Violation|4|||
130707527|NCT00440466|470554939|FG000|Overall Study|Withdrawal by Subject|2|||
130707528|NCT00440466|470554940|FG001|Overall Study|Withdrawal by Subject|5|||
130707529|NCT00440466|470554941|FG002|Overall Study|Withdrawal by Subject|9|||
130707530|NCT00440466|470554939|FG000|Overall Study|Began Dialysis|0|||
130707531|NCT00440466|470554940|FG001|Overall Study|Began Dialysis|0|||
130707532|NCT00440466|470554941|FG002|Overall Study|Began Dialysis|1|||
130707533|NCT00440466|470554939|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
130707534|NCT00440466|470554940|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130707535|NCT00440466|470554941|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130707536|NCT01005329|470554944|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
130707537|NCT00608517|470554945|FG000|Overall Study|Death|1|||
130707538|NCT00608517|470554946|FG001|Overall Study|Death|0|||
130707539|NCT00608517|470554947|FG002|Overall Study|Death|0|||
130707540|NCT01501110|470554948|FG000|Overall Study|Death|0|||
130707541|NCT01501110|470554949|FG001|Overall Study|Death|1|||
130707542|NCT02674386|470554952|FG000|Overall Study|Lost to Follow-up|0|||
130707543|NCT02674386|470554953|FG001|Overall Study|Lost to Follow-up|1|||
130707544|NCT02674386|470554954|FG002|Overall Study|Lost to Follow-up|1|||
130707545|NCT02674386|470554952|FG000|Overall Study|Withdrawal by Subject|0|||
130707546|NCT02674386|470554953|FG001|Overall Study|Withdrawal by Subject|4|||
130707547|NCT02674386|470554954|FG002|Overall Study|Withdrawal by Subject|0|||
130707548|NCT02674386|470554952|FG000|Overall Study|Other|0|||
130707549|NCT02674386|470554953|FG001|Overall Study|Other|1|||
130707550|NCT02674386|470554954|FG002|Overall Study|Other|0|||
130707551|NCT02674386|470554952|FG000|Overall Study|Enrolled but not evaluated|0|||
130707552|NCT02674386|470554953|FG001|Overall Study|Enrolled but not evaluated|4|||
130707553|NCT02674386|470554954|FG002|Overall Study|Enrolled but not evaluated|0|||
130707554|NCT02462486|470554959|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130707555|NCT02462486|470554960|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130707556|NCT02462486|470554961|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
130707557|NCT02462486|470554959|FG000|Overall Study|Adverse Event|53|||
130707558|NCT02462486|470554960|FG001|Overall Study|Adverse Event|48|||
130707559|NCT02462486|470554961|FG002|Overall Study|Adverse Event|21|||
130707560|NCT02462486|470554959|FG000|Overall Study|Lack of Efficacy|6|||
130707561|NCT02462486|470554960|FG001|Overall Study|Lack of Efficacy|12|||
130707562|NCT02462486|470554961|FG002|Overall Study|Lack of Efficacy|3|||
130707563|NCT02462486|470554959|FG000|Overall Study|Lost to Follow-up|3|||
130707564|NCT02462486|470554960|FG001|Overall Study|Lost to Follow-up|4|||
130707565|NCT02462486|470554961|FG002|Overall Study|Lost to Follow-up|2|||
130707566|NCT02462486|470554959|FG000|Overall Study|Withdrawal by Subject|25|||
130707567|NCT02462486|470554960|FG001|Overall Study|Withdrawal by Subject|22|||
130707568|NCT02462486|470554961|FG002|Overall Study|Withdrawal by Subject|19|||
130707569|NCT02462486|470554959|FG000|Overall Study|Protocol Violation|3|||
130707570|NCT02462486|470554960|FG001|Overall Study|Protocol Violation|1|||
130707571|NCT02462486|470554961|FG002|Overall Study|Protocol Violation|1|||
130707572|NCT02462486|470554959|FG000|Overall Study|Reason not Specified|3|||
130707573|NCT02462486|470554960|FG001|Overall Study|Reason not Specified|4|||
130707574|NCT02462486|470554961|FG002|Overall Study|Reason not Specified|3|||
130707575|NCT01261624|470554962|FG000|Week 0 to Week 12|Disease Progression|1|||
130707576|NCT01261624|470554963|FG001|Week 0 to Week 12|Disease Progression|1|||
130707577|NCT01261624|470554962|FG000|Week 0 to Week 12|Insufficient Response|0|||
130707578|NCT01261624|470554963|FG001|Week 0 to Week 12|Insufficient Response|2|||
130707579|NCT01261624|470554962|FG000|Week 13 to Week 24|Insufficient Response|0|||
130707580|NCT01261624|470554963|FG001|Week 13 to Week 24|Insufficient Response|1|||
130707581|NCT02094261|470554966|FG000|Overall Study|Death|24|||
130707582|NCT02094261|470554966|FG000|Overall Study|Lost to Follow-up|1|||
130707583|NCT02094261|470554966|FG000|Overall Study|Withdrawal by Subject|4|||
130707584|NCT02094261|470554966|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
130707585|NCT02363439|470554969|FG000|Overall Study|Lack of Efficacy|4|||
130707586|NCT01719562|470554970|FG000|Overall Study|Lost to Follow-up|1|||
130707587|NCT01719562|470554971|FG001|Overall Study|Lost to Follow-up|0|||
130707588|NCT01719562|470554970|FG000|Overall Study|Death|1|||
130707589|NCT01719562|470554971|FG001|Overall Study|Death|0|||
130707590|NCT01719562|470554970|FG000|Overall Study|New cancer diagnosis|1|||
130707591|NCT01719562|470554971|FG001|Overall Study|New cancer diagnosis|0|||
130707592|NCT00508027|470554972|FG000|Dose Level 1|Lost to Follow-up|4|||
130707593|NCT00508027|470554972|FG000|Dose Level 1|Withdrawal by Subject|2|||
130707594|NCT00508027|470554972|FG000|Dose Level 1|Physician Decision|2|||
130707595|NCT00508027|470554972|FG000|Dose Level 2|Lost to Follow-up|2|||
130707596|NCT00508027|470554972|FG000|Dose Level 2|Withdrawal by Subject|2|||
130707597|NCT03554317|470554973|FG000|Overall Study|Withdrawal by Subject|1|||
130707598|NCT03554317|470554973|FG000|Overall Study|PSA Progression|3|||
130707599|NCT03554317|470554973|FG000|Overall Study|Radiographic Progression|4|||
130707600|NCT00537199|470554974|FG000|Overall Study|Study Terminated|1|||
130707601|NCT03827018|470554981|FG000|Overall Study|Adverse Event|1|||
130707602|NCT03827018|470554982|FG001|Overall Study|Adverse Event|0|||
130707603|NCT03827018|470554981|FG000|Overall Study|Withdrawal by Subject|2|||
130707604|NCT03827018|470554982|FG001|Overall Study|Withdrawal by Subject|2|||
130707605|NCT03827018|470554981|FG000|Overall Study|Lack of Efficacy|0|||
130707606|NCT03827018|470554982|FG001|Overall Study|Lack of Efficacy|1|||
130707607|NCT00775528|470554984|FG000|Overall Study|Protocol Violation|1|||
130707608|NCT02087176|470554985|FG000|Overall Study|Withdrawal by Subject|1|||
130707609|NCT02087176|470554985|FG000|Overall Study|Death|10|||
130707610|NCT02087176|470554985|FG000|Overall Study|Censored|19|||
130707611|NCT02087176|470554985|FG000|Overall Study|Study Terminated by Sponsor|2|||
130707612|NCT04099641|470554988|FG000|Overall Study|Death|46|||
130707613|NCT04099641|470554989|FG001|Overall Study|Death|12|||
130707614|NCT04099641|470554988|FG000|Overall Study|Lost to Follow-up|1|||
130707615|NCT04099641|470554989|FG001|Overall Study|Lost to Follow-up|0|||
130707616|NCT04099641|470554988|FG000|Overall Study|Withdrawal by Subject|2|||
130707617|NCT04099641|470554989|FG001|Overall Study|Withdrawal by Subject|0|||
130707618|NCT00834899|470554990|FG000|Overall Study|Withdrawal by Subject|1|||
130707619|NCT00834899|470554991|FG001|Overall Study|Withdrawal by Subject|1|||
130707620|NCT01534637|470554992|FG000|Overall Study|Physician Decision|3|||
130707621|NCT01534637|470554992|FG000|Overall Study|Lack of Efficacy|3|||
130707622|NCT01534637|470554992|FG000|Overall Study|Withdrawal by Subject|1|||
130707623|NCT01534637|470554992|FG000|Overall Study|Adverse Event|1|||
130707624|NCT01534637|470554992|FG000|Overall Study|Liver Mets before treatment|1|||
130707625|NCT00605917|470554993|FG000|Overall Study|Protocol Violation|79|||
130707626|NCT00890552|470554994|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
130707627|NCT00890552|470554994|FG000|On-treatment|Early prog disease/ death|10|||
130707628|NCT04965389|470554996|FG000|Overall Study|Other reasons|1|||
130707629|NCT04965389|470554997|FG001|Overall Study|Other reasons|0|||
130707630|NCT04965389|470554998|FG002|Overall Study|Other reasons|0|||
130707631|NCT04965389|470554999|FG003|Overall Study|Other reasons|0|||
130707632|NCT04965389|470554996|FG000|Overall Study|Participant withdrew consent|0|||
130707633|NCT04965389|470554997|FG001|Overall Study|Participant withdrew consent|1|||
130707634|NCT04965389|470554998|FG002|Overall Study|Participant withdrew consent|0|||
130707635|NCT04965389|470554999|FG003|Overall Study|Participant withdrew consent|0|||
130707636|NCT04965389|470554996|FG000|Overall Study|Poor/Non-compliance|0|||
130707637|NCT04965389|470554997|FG001|Overall Study|Poor/Non-compliance|1|||
130707638|NCT04965389|470554998|FG002|Overall Study|Poor/Non-compliance|0|||
130707639|NCT04965389|470554999|FG003|Overall Study|Poor/Non-compliance|0|||
130707640|NCT03903159|470555002|FG000|Overall Study|Discharged with Staff Approval|2|||
130707641|NCT03903159|470555002|FG000|Overall Study|Discharged at Staff Request|2|||
130707642|NCT03903159|470555002|FG000|Overall Study|Discharged Against Staff Advice|1|||
130707643|NCT02443545|470555003|FG000|Overall Study|Adverse Event|1|||
130707644|NCT02443545|470555004|FG001|Overall Study|Adverse Event|1|||
130707645|NCT02443545|470555003|FG000|Overall Study|Lost to Follow-up|0|||
130707646|NCT02443545|470555004|FG001|Overall Study|Lost to Follow-up|2|||
130707647|NCT02443545|470555003|FG000|Overall Study|Physician Decision|3|||
130707648|NCT02443545|470555004|FG001|Overall Study|Physician Decision|0|||
130707649|NCT02443545|470555003|FG000|Overall Study|Protocol Violation|8|||
130707650|NCT02443545|470555004|FG001|Overall Study|Protocol Violation|1|||
130707651|NCT02443545|470555003|FG000|Overall Study|Pregnancy|1|||
130707652|NCT02443545|470555004|FG001|Overall Study|Pregnancy|1|||
130707653|NCT02443545|470555003|FG000|Overall Study|Withdrawal by Subject|6|||
130707654|NCT02443545|470555004|FG001|Overall Study|Withdrawal by Subject|3|||
130707655|NCT02443545|470555003|FG000|Overall Study|Termination of study|20|||
130707656|NCT02443545|470555004|FG001|Overall Study|Termination of study|11|||
130707657|NCT00724373|470555005|FG000|Overall Study|Adverse Event|41|||
130707658|NCT00724373|470555005|FG000|Overall Study|Lack of Efficacy|82|||
130707659|NCT00724373|470555005|FG000|Overall Study|Lost to Follow-up|7|||
130707660|NCT00724373|470555005|FG000|Overall Study|Non-compliance|2|||
130707661|NCT00724373|470555005|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
130707662|NCT00724373|470555005|FG000|Overall Study|Participant moved away|1|||
130707663|NCT00724373|470555005|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
130707664|NCT00724373|470555005|FG000|Overall Study|Only to have 24 week regimen|1|||
130707665|NCT00724373|470555005|FG000|Overall Study|Viral Relapse|1|||
130707666|NCT00724373|470555005|FG000|Overall Study|Acute HCV infection|1|||
130707667|NCT00724373|470555005|FG000|Overall Study|Drug Relapse|1|||
130707668|NCT00724373|470555005|FG000|Overall Study|Tolerability|23|||
130707669|NCT00536484|470555006|FG000|Overall Study|Adverse Event|21|||
130707670|NCT00536484|470555007|FG001|Overall Study|Adverse Event|34|||
130707671|NCT00536484|470555006|FG000|Overall Study|Withdrawal by Subject|11|||
130707672|NCT00536484|470555007|FG001|Overall Study|Withdrawal by Subject|11|||
130707673|NCT00536484|470555006|FG000|Overall Study|Lost to Follow-up|8|||
130707674|NCT00536484|470555007|FG001|Overall Study|Lost to Follow-up|6|||
130707675|NCT00536484|470555006|FG000|Overall Study|Lack of Efficacy|16|||
130707676|NCT00536484|470555007|FG001|Overall Study|Lack of Efficacy|5|||
130707677|NCT00536484|470555006|FG000|Overall Study|Other|4|||
130707678|NCT00536484|470555007|FG001|Overall Study|Other|0|||
130456410|NCT01235949|469634910|FG000|Booster Phase|Withdrawal by Subject|0|||
130456411|NCT01235949|469634911|FG001|Booster Phase|Withdrawal by Subject|0|||
130707679|NCT01506908|470555008|FG000|Overall Study|Adverse Event|1|||
130707680|NCT01506908|470555009|FG001|Overall Study|Adverse Event|0|||
130707681|NCT03043560|470555013|FG000|Overall Study|Discontinued Intervention|1|||
130707682|NCT03043560|470555014|FG001|Overall Study|Discontinued Intervention|2|||
130707683|NCT03043560|470555013|FG000|Overall Study|Lost to Follow-up|0|||
130707684|NCT03043560|470555014|FG001|Overall Study|Lost to Follow-up|1|||
130707685|NCT01382251|470555015|FG000|Overall Study|Surgeries cancelled or delayed|16|||
130707686|NCT01382251|470555016|FG001|Overall Study|Surgeries cancelled or delayed|16|||
130456412|NCT01235949|469634912|FG002|Booster Phase|Withdrawal by Subject|0|||
130707687|NCT01382251|470555015|FG000|Overall Study|Lost to Follow-up|4|||
130707688|NCT01382251|470555016|FG001|Overall Study|Lost to Follow-up|4|||
130707689|NCT01382251|470555015|FG000|Overall Study|Contacted after study closed|1|||
130707690|NCT01382251|470555016|FG001|Overall Study|Contacted after study closed|1|||
130707691|NCT00562120|470555017|FG000|First Intervention Period|Adverse Event|1|||
130707692|NCT00562120|470555018|FG001|First Intervention Period|Adverse Event|0|||
130707693|NCT00562120|470555019|FG002|First Intervention Period|Adverse Event|0|||
130707694|NCT00562120|470555020|FG003|First Intervention Period|Adverse Event|0|||
130707695|NCT00562120|470555017|FG000|First Intervention Period|Randomized but not Treated|1|||
130707696|NCT00562120|470555018|FG001|First Intervention Period|Randomized but not Treated|0|||
130707697|NCT00562120|470555019|FG002|First Intervention Period|Randomized but not Treated|0|||
130707698|NCT00562120|470555020|FG003|First Intervention Period|Randomized but not Treated|0|||
130707699|NCT03366194|470555024|FG000|Overall Study|Lost to Follow-up|2|||
130707700|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707701|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
130707702|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707703|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707704|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707705|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707706|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
130707707|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707708|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
130707709|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707710|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707711|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707712|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Death|0|||
130707713|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Death|1|||
130707714|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Death|0|||
130707715|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Death|0|||
130707716|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
130707717|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
130707718|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
130707719|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
130456413|NCT01235949|469634913|FG003|Booster Phase|Withdrawal by Subject|0|||
130456414|NCT01235949|469634914|FG004|Booster Phase|Withdrawal by Subject|0|||
130456415|NCT01235949|469634915|FG005|Booster Phase|Withdrawal by Subject|0|||
130456416|NCT01235949|469634916|FG006|Booster Phase|Withdrawal by Subject|0|||
130456417|NCT01235949|469634917|FG007|Booster Phase|Withdrawal by Subject|1|||
130456418|NCT01235949|469634918|FG008|Booster Phase|Withdrawal by Subject|1|||
130456419|NCT01235949|469634919|FG009|Booster Phase|Withdrawal by Subject|0|||
130456420|NCT01235949|469634920|FG010|Booster Phase|Withdrawal by Subject|1|||
130456421|NCT01235949|469634921|FG011|Booster Phase|Withdrawal by Subject|1|||
130456422|NCT01235949|469634922|FG012|Booster Phase|Withdrawal by Subject|2|||
130456423|NCT01235949|469634923|FG013|Booster Phase|Withdrawal by Subject|0|||
130456424|NCT01235949|469634924|FG014|Booster Phase|Withdrawal by Subject|2|||
130456425|NCT01235949|469634925|FG015|Booster Phase|Withdrawal by Subject|0|||
130456426|NCT01235949|469634926|FG016|Booster Phase|Withdrawal by Subject|0|||
130456427|NCT01235949|469634927|FG017|Booster Phase|Withdrawal by Subject|0|||
130456428|NCT01235949|469634910|FG000|Booster Phase|Lost to Follow-up|0|||
130456429|NCT01235949|469634911|FG001|Booster Phase|Lost to Follow-up|0|||
130456430|NCT01235949|469634912|FG002|Booster Phase|Lost to Follow-up|0|||
130456431|NCT01235949|469634913|FG003|Booster Phase|Lost to Follow-up|0|||
130456432|NCT01235949|469634914|FG004|Booster Phase|Lost to Follow-up|0|||
130456433|NCT01235949|469634915|FG005|Booster Phase|Lost to Follow-up|0|||
130456434|NCT01235949|469634916|FG006|Booster Phase|Lost to Follow-up|0|||
130456435|NCT01235949|469634917|FG007|Booster Phase|Lost to Follow-up|0|||
130456436|NCT01235949|469634918|FG008|Booster Phase|Lost to Follow-up|1|||
130456437|NCT01235949|469634919|FG009|Booster Phase|Lost to Follow-up|1|||
130456438|NCT01235949|469634920|FG010|Booster Phase|Lost to Follow-up|1|||
130456439|NCT01235949|469634921|FG011|Booster Phase|Lost to Follow-up|1|||
130456440|NCT01235949|469634922|FG012|Booster Phase|Lost to Follow-up|0|||
130456441|NCT01235949|469634923|FG013|Booster Phase|Lost to Follow-up|0|||
130456442|NCT01235949|469634924|FG014|Booster Phase|Lost to Follow-up|0|||
130456443|NCT01235949|469634925|FG015|Booster Phase|Lost to Follow-up|0|||
130456444|NCT01235949|469634926|FG016|Booster Phase|Lost to Follow-up|0|||
130456445|NCT01235949|469634927|FG017|Booster Phase|Lost to Follow-up|1|||
130456446|NCT00383188|469634928|FG000|Overall Study|Adverse Event|4|||
130456447|NCT00383188|469634929|FG001|Overall Study|Adverse Event|7|||
130707720|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
130707721|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130707722|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130707723|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130456448|NCT00383188|469634930|FG002|Overall Study|Adverse Event|9|||
130456449|NCT00383188|469634931|FG003|Overall Study|Adverse Event|8|||
130456450|NCT00383188|469634932|FG004|Overall Study|Adverse Event|8|||
130456451|NCT00383188|469634928|FG000|Overall Study|Lack of Efficacy|9|||
130456452|NCT00383188|469634929|FG001|Overall Study|Lack of Efficacy|3|||
130456453|NCT00383188|469634930|FG002|Overall Study|Lack of Efficacy|3|||
130456454|NCT00383188|469634931|FG003|Overall Study|Lack of Efficacy|2|||
130456455|NCT00383188|469634932|FG004|Overall Study|Lack of Efficacy|6|||
130456456|NCT00383188|469634928|FG000|Overall Study|Other|3|||
130456457|NCT00383188|469634929|FG001|Overall Study|Other|1|||
130456458|NCT00383188|469634930|FG002|Overall Study|Other|0|||
130456459|NCT00383188|469634931|FG003|Overall Study|Other|2|||
130456460|NCT00383188|469634932|FG004|Overall Study|Other|6|||
130456461|NCT00383188|469634928|FG000|Overall Study|No longer willing to participate|1|||
130707724|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130707725|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130707726|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130707727|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130707728|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Disease Progression|3|||
130707729|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Disease Progression|3|||
130707730|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Disease Progression|0|||
130707731|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Disease Progression|7|||
130707732|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
130707733|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
130707734|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
130707735|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
130707736|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
130707737|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
130707738|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
130707739|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
130707740|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Adverse Event|0|||
130707741|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Adverse Event|3|||
130707742|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Adverse Event|2|||
130707743|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Adverse Event|2|||
130707744|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
130707745|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
130707746|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
130707747|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
130707748|NCT00545688|470555027|FG000|Follow-Up Period|Death|4|||
130707749|NCT00545688|470555028|FG001|Follow-Up Period|Death|2|||
130707750|NCT00545688|470555029|FG002|Follow-Up Period|Death|2|||
130707751|NCT00545688|470555030|FG003|Follow-Up Period|Death|6|||
130707752|NCT00545688|470555027|FG000|Follow-Up Period|Disease Progression|6|||
130707753|NCT00545688|470555028|FG001|Follow-Up Period|Disease Progression|5|||
130707754|NCT00545688|470555029|FG002|Follow-Up Period|Disease Progression|9|||
130707755|NCT00545688|470555030|FG003|Follow-Up Period|Disease Progression|9|||
130707756|NCT00545688|470555027|FG000|Follow-Up Period|Refused Treatment|6|||
130707757|NCT00545688|470555028|FG001|Follow-Up Period|Refused Treatment|2|||
130707758|NCT00545688|470555029|FG002|Follow-Up Period|Refused Treatment|0|||
130707759|NCT00545688|470555030|FG003|Follow-Up Period|Refused Treatment|2|||
130707760|NCT00545688|470555027|FG000|Follow-Up Period|Lost to Follow-up|3|||
130707761|NCT00545688|470555028|FG001|Follow-Up Period|Lost to Follow-up|3|||
130707762|NCT00545688|470555029|FG002|Follow-Up Period|Lost to Follow-up|3|||
130707763|NCT00545688|470555030|FG003|Follow-Up Period|Lost to Follow-up|1|||
130707764|NCT00545688|470555027|FG000|Follow-Up Period|Unspecified Reason|2|||
130707765|NCT00545688|470555028|FG001|Follow-Up Period|Unspecified Reason|5|||
130707766|NCT00545688|470555029|FG002|Follow-Up Period|Unspecified Reason|6|||
130707767|NCT00545688|470555030|FG003|Follow-Up Period|Unspecified Reason|8|||
130707768|NCT00545688|470555027|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130707769|NCT00545688|470555028|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
130707770|NCT00545688|470555029|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130707771|NCT00545688|470555030|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
130707772|NCT03123783|470555031|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707773|NCT03123783|470555032|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
130707774|NCT03123783|470555033|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707775|NCT03123783|470555034|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707776|NCT03123783|470555035|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707777|NCT03123783|470555036|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707778|NCT03123783|470555037|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707779|NCT03123783|470555031|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
130707780|NCT03123783|470555032|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
130707781|NCT03123783|470555033|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
130707782|NCT03123783|470555034|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
130707783|NCT03123783|470555035|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
130707784|NCT03123783|470555036|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
130707785|NCT03123783|470555037|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
130707786|NCT03123783|470555031|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707787|NCT03123783|470555032|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707788|NCT03123783|470555033|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707789|NCT03123783|470555034|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
130707790|NCT03123783|470555035|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
130707791|NCT03123783|470555036|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
130707792|NCT03123783|470555037|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
130707793|NCT03123783|470555031|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707794|NCT03123783|470555032|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707795|NCT03123783|470555033|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707796|NCT03123783|470555034|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707797|NCT03123783|470555035|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
130707798|NCT03123783|470555036|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707799|NCT03123783|470555037|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707800|NCT02953678|470555043|FG000|Overall Study|Adverse Event|20|||
130707801|NCT02953678|470555043|FG000|Overall Study|Death|7|||
130707802|NCT02953678|470555043|FG000|Overall Study|Physician Decision|23|||
130707803|NCT02953678|470555043|FG000|Overall Study|Progressive Disease of GVHD|7|||
130707804|NCT02953678|470555043|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
130707805|NCT02953678|470555043|FG000|Overall Study|Withdrawal by participant|3|||
130707806|NCT02953678|470555043|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
130707807|NCT02953678|470555043|FG000|Overall Study|Participants were transferred to commercial product.|3|||
130707808|NCT00952276|470555044|FG000|Overall Study|Withdrawal by Subject|1|||
130707809|NCT00952276|470555045|FG001|Overall Study|Withdrawal by Subject|0|||
130707810|NCT00952276|470555046|FG002|Overall Study|Withdrawal by Subject|0|||
130707811|NCT00952276|470555047|FG003|Overall Study|Withdrawal by Subject|1|||
130707812|NCT00952276|470555048|FG004|Overall Study|Withdrawal by Subject|0|||
130707813|NCT01730040|470556562|FG000|Overall Study|Randomized but not treated|0|||
130707814|NCT01730040|470556563|FG001|Overall Study|Randomized but not treated|0|||
130707815|NCT01730040|470556564|FG002|Overall Study|Randomized but not treated|0|||
130707816|NCT01730040|470556565|FG003|Overall Study|Randomized but not treated|0|||
130707817|NCT01730040|470556566|FG004|Overall Study|Randomized but not treated|0|||
130707818|NCT01730040|470556567|FG005|Overall Study|Randomized but not treated|1|||
130707819|NCT01730040|470556568|FG006|Overall Study|Randomized but not treated|0|||
130707820|NCT01730040|470556562|FG000|Overall Study|Subject moved|0|||
130707821|NCT01730040|470556563|FG001|Overall Study|Subject moved|0|||
130707822|NCT01730040|470556564|FG002|Overall Study|Subject moved|1|||
130707823|NCT01730040|470556565|FG003|Overall Study|Subject moved|0|||
130707824|NCT01730040|470556566|FG004|Overall Study|Subject moved|0|||
130707825|NCT01730040|470556567|FG005|Overall Study|Subject moved|0|||
130707826|NCT01730040|470556568|FG006|Overall Study|Subject moved|1|||
130707827|NCT01730040|470556562|FG000|Overall Study|Physician Decision|0|||
130707828|NCT01730040|470556563|FG001|Overall Study|Physician Decision|0|||
130707829|NCT01730040|470556564|FG002|Overall Study|Physician Decision|0|||
130707830|NCT01730040|470556565|FG003|Overall Study|Physician Decision|0|||
130707831|NCT01730040|470556566|FG004|Overall Study|Physician Decision|0|||
130707832|NCT01730040|470556567|FG005|Overall Study|Physician Decision|1|||
130707833|NCT01730040|470556568|FG006|Overall Study|Physician Decision|1|||
130707834|NCT01730040|470556562|FG000|Overall Study|Other than specified|7|||
130707835|NCT01730040|470556563|FG001|Overall Study|Other than specified|8|||
130707836|NCT01730040|470556564|FG002|Overall Study|Other than specified|5|||
130707837|NCT01730040|470556565|FG003|Overall Study|Other than specified|5|||
130707838|NCT01730040|470556566|FG004|Overall Study|Other than specified|5|||
130707839|NCT01730040|470556567|FG005|Overall Study|Other than specified|4|||
130707840|NCT01730040|470556568|FG006|Overall Study|Other than specified|4|||
130707841|NCT01730040|470556562|FG000|Overall Study|Adverse Event|4|||
130707842|NCT01730040|470556563|FG001|Overall Study|Adverse Event|3|||
130707843|NCT01730040|470556564|FG002|Overall Study|Adverse Event|5|||
130707844|NCT01730040|470556565|FG003|Overall Study|Adverse Event|3|||
130707845|NCT01730040|470556566|FG004|Overall Study|Adverse Event|1|||
130707846|NCT01730040|470556567|FG005|Overall Study|Adverse Event|1|||
130707847|NCT01730040|470556568|FG006|Overall Study|Adverse Event|2|||
130707848|NCT01730040|470556562|FG000|Overall Study|Poor compliance to protocol|2|||
130707849|NCT01730040|470556563|FG001|Overall Study|Poor compliance to protocol|4|||
130707850|NCT01730040|470556564|FG002|Overall Study|Poor compliance to protocol|0|||
130707851|NCT01730040|470556565|FG003|Overall Study|Poor compliance to protocol|0|||
130707852|NCT01730040|470556566|FG004|Overall Study|Poor compliance to protocol|0|||
130707853|NCT01730040|470556567|FG005|Overall Study|Poor compliance to protocol|0|||
130707854|NCT01730040|470556568|FG006|Overall Study|Poor compliance to protocol|1|||
130707855|NCT01552369|470556569|FG000|Overall Study|Did not consent to extended follow up|8|||
130707856|NCT01552369|470556570|FG001|Overall Study|Did not consent to extended follow up|9|||
130707857|NCT04776746|470556576|FG000|Overall Study|Study terminated by sponsor|61|||
130707858|NCT04776746|470556576|FG000|Overall Study|Adverse Event|5|||
130707859|NCT04776746|470556576|FG000|Overall Study|Death|4|||
130707860|NCT04776746|470556576|FG000|Overall Study|Lack of Efficacy|3|||
130707861|NCT04776746|470556576|FG000|Overall Study|Noncompliance with study drug|2|||
130707862|NCT04776746|470556576|FG000|Overall Study|Not related to COVID-19|2|||
130707863|NCT04109313|470556585|FG000|Overall Study|Pregnancy|1|||
130707864|NCT04109313|470556585|FG000|Overall Study|Adverse Event|11|||
130367193|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
130707865|NCT04109313|470556585|FG000|Overall Study|Lack of Efficacy|11|||
130707866|NCT04109313|470556585|FG000|Overall Study|Lost to Follow-up|1|||
130707867|NCT04109313|470556585|FG000|Overall Study|Physician Decision|2|||
130707868|NCT04109313|470556585|FG000|Overall Study|Subject Decision|13|||
130707869|NCT04109313|470556585|FG000|Overall Study|Covid-19 situation|2|||
130707870|NCT01132664|470556586|FG000|Phase lb|Adverse Event|0|||
130707871|NCT01132664|470556587|FG001|Phase lb|Adverse Event|1|||
130707872|NCT01132664|470556588|FG002|Phase lb|Adverse Event|0|||
130707873|NCT01132664|470556589|FG003|Phase lb|Adverse Event|0|||
130707874|NCT01132664|470556590|FG004|Phase lb|Adverse Event|0|||
130707875|NCT01132664|470556586|FG000|Phase lb|Withdrawal by Subject|1|||
130707876|NCT01132664|470556587|FG001|Phase lb|Withdrawal by Subject|2|||
130707877|NCT01132664|470556588|FG002|Phase lb|Withdrawal by Subject|0|||
130707878|NCT01132664|470556589|FG003|Phase lb|Withdrawal by Subject|0|||
130707879|NCT01132664|470556590|FG004|Phase lb|Withdrawal by Subject|0|||
130707880|NCT01132664|470556586|FG000|Phase lb|Disease Progression|4|||
130707881|NCT01132664|470556587|FG001|Phase lb|Disease Progression|9|||
130707882|NCT01132664|470556588|FG002|Phase lb|Disease Progression|0|||
130707883|NCT01132664|470556589|FG003|Phase lb|Disease Progression|0|||
130707884|NCT01132664|470556590|FG004|Phase lb|Disease Progression|0|||
130707885|NCT01132664|470556586|FG000|Phase ll|Death|0|||
130707886|NCT01132664|470556587|FG001|Phase ll|Death|0|||
130707887|NCT01132664|470556588|FG002|Phase ll|Death|2|||
130707888|NCT01132664|470556589|FG003|Phase ll|Death|0|||
130707889|NCT01132664|470556590|FG004|Phase ll|Death|0|||
130707890|NCT01132664|470556586|FG000|Phase ll|Adverse Event|0|||
130707891|NCT01132664|470556587|FG001|Phase ll|Adverse Event|0|||
130707892|NCT01132664|470556588|FG002|Phase ll|Adverse Event|10|||
130707893|NCT01132664|470556589|FG003|Phase ll|Adverse Event|0|||
130707894|NCT01132664|470556590|FG004|Phase ll|Adverse Event|0|||
130707895|NCT01132664|470556586|FG000|Phase ll|Withdrawal by Subject|0|||
130707896|NCT01132664|470556587|FG001|Phase ll|Withdrawal by Subject|0|||
130707897|NCT01132664|470556588|FG002|Phase ll|Withdrawal by Subject|3|||
130707898|NCT01132664|470556589|FG003|Phase ll|Withdrawal by Subject|0|||
130707899|NCT01132664|470556590|FG004|Phase ll|Withdrawal by Subject|0|||
130707900|NCT01132664|470556586|FG000|Phase ll|Disease progression|0|||
130707901|NCT01132664|470556587|FG001|Phase ll|Disease progression|0|||
130707902|NCT01132664|470556588|FG002|Phase ll|Disease progression|35|||
130707903|NCT01132664|470556589|FG003|Phase ll|Disease progression|0|||
130707904|NCT01132664|470556590|FG004|Phase ll|Disease progression|0|||
130707905|NCT01132664|470556586|FG000|BM Cohort|Disease progression|0|||
130707906|NCT01132664|470556587|FG001|BM Cohort|Disease progression|0|||
130707907|NCT01132664|470556588|FG002|BM Cohort|Disease progression|0|||
130707908|NCT01132664|470556589|FG003|BM Cohort|Disease progression|3|||
130707909|NCT01132664|470556590|FG004|BM Cohort|Disease progression|4|||
130707910|NCT01132664|470556586|FG000|BM Cohort|Adverse Event|0|||
130707911|NCT01132664|470556587|FG001|BM Cohort|Adverse Event|0|||
130707912|NCT01132664|470556588|FG002|BM Cohort|Adverse Event|0|||
130707913|NCT01132664|470556589|FG003|BM Cohort|Adverse Event|0|||
130707914|NCT01132664|470556590|FG004|BM Cohort|Adverse Event|1|||
130707915|NCT01132664|470556586|FG000|BM Cohort|Withdrawal by Subject|0|||
130707916|NCT01132664|470556587|FG001|BM Cohort|Withdrawal by Subject|0|||
130707917|NCT01132664|470556588|FG002|BM Cohort|Withdrawal by Subject|0|||
130707918|NCT01132664|470556589|FG003|BM Cohort|Withdrawal by Subject|0|||
130707919|NCT01132664|470556590|FG004|BM Cohort|Withdrawal by Subject|1|||
130707920|NCT00655850|470556593|FG000|Overall Study|Death|2|||
130707921|NCT00655850|470556593|FG000|Overall Study|Withdrawal by Subject|1|||
130707922|NCT01567826|470556596|FG000|Overall Study|Lost to Follow-up|3|||
130707923|NCT01567826|470556597|FG001|Overall Study|Lost to Follow-up|2|||
130707924|NCT01360866|470556611|FG000|Overall Study|Lost to Follow-up|11|||
130707925|NCT01360866|470556612|FG001|Overall Study|Lost to Follow-up|28|||
130707926|NCT01360866|470556613|FG002|Overall Study|Lost to Follow-up|41|||
130707927|NCT01360866|470556614|FG003|Overall Study|Lost to Follow-up|0|||
130707928|NCT01360866|470556611|FG000|Overall Study|Adverse Event|56|||
130707929|NCT01360866|470556612|FG001|Overall Study|Adverse Event|61|||
130707930|NCT01360866|470556613|FG002|Overall Study|Adverse Event|134|||
130707931|NCT01360866|470556614|FG003|Overall Study|Adverse Event|6|||
130707932|NCT01360866|470556611|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
130707933|NCT01360866|470556612|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
130707934|NCT01360866|470556613|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
130707935|NCT01360866|470556614|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
130707936|NCT01360866|470556611|FG000|Overall Study|Withdrawn by Investigator|9|||
130707937|NCT01360866|470556612|FG001|Overall Study|Withdrawn by Investigator|8|||
130707938|NCT01360866|470556613|FG002|Overall Study|Withdrawn by Investigator|31|||
130707939|NCT01360866|470556614|FG003|Overall Study|Withdrawn by Investigator|2|||
130707940|NCT01360866|470556611|FG000|Overall Study|Withdrawal by participant|79|||
130707941|NCT01360866|470556612|FG001|Overall Study|Withdrawal by participant|89|||
130707942|NCT01360866|470556613|FG002|Overall Study|Withdrawal by participant|168|||
130707943|NCT01360866|470556614|FG003|Overall Study|Withdrawal by participant|8|||
130707944|NCT01360866|470556611|FG000|Overall Study|Protocol Deviation|25|||
130707945|NCT01360866|470556612|FG001|Overall Study|Protocol Deviation|33|||
130707946|NCT01360866|470556613|FG002|Overall Study|Protocol Deviation|61|||
130707947|NCT01360866|470556614|FG003|Overall Study|Protocol Deviation|2|||
130707948|NCT01360866|470556611|FG000|Overall Study|Lack of Efficacy|30|||
130707949|NCT01360866|470556612|FG001|Overall Study|Lack of Efficacy|40|||
130707950|NCT01360866|470556613|FG002|Overall Study|Lack of Efficacy|30|||
130707951|NCT01360866|470556614|FG003|Overall Study|Lack of Efficacy|4|||
130707952|NCT03702049|470556618|FG000|Overall Study|Lost to Follow-up|4|||
130707953|NCT03702049|470556618|FG000|Overall Study|Physician Decision|1|||
130707954|NCT01715896|470556619|FG000|Overall Study|Lost to Follow-up|0|||
130707955|NCT01715896|470556620|FG001|Overall Study|Lost to Follow-up|2|||
130707956|NCT01715896|470556619|FG000|Overall Study|Withdrawal by Subject|1|||
130707957|NCT01715896|470556620|FG001|Overall Study|Withdrawal by Subject|4|||
130707958|NCT01715896|470556619|FG000|Overall Study|Other|2|||
130707959|NCT01715896|470556620|FG001|Overall Study|Other|5|||
130707960|NCT01048502|470556622|FG000|Overall Study|Lost to Follow-up|2|||
130707961|NCT01048502|470556623|FG001|Overall Study|Lost to Follow-up|0|||
130707962|NCT01048502|470556624|FG002|Overall Study|Lost to Follow-up|0|||
130707963|NCT01048502|470556625|FG003|Overall Study|Lost to Follow-up|0|||
130707964|NCT01048502|470556622|FG000|Overall Study|Adverse Event|1|||
130707965|NCT01048502|470556623|FG001|Overall Study|Adverse Event|0|||
130707966|NCT01048502|470556624|FG002|Overall Study|Adverse Event|0|||
130707967|NCT01048502|470556625|FG003|Overall Study|Adverse Event|0|||
130707968|NCT01048502|470556622|FG000|Overall Study|Withdrawal by Subject|1|||
130707969|NCT01048502|470556623|FG001|Overall Study|Withdrawal by Subject|4|||
130707970|NCT01048502|470556624|FG002|Overall Study|Withdrawal by Subject|5|||
130707971|NCT01048502|470556625|FG003|Overall Study|Withdrawal by Subject|3|||
130707972|NCT01048502|470556622|FG000|Overall Study|Physician Decision|0|||
130707973|NCT01048502|470556623|FG001|Overall Study|Physician Decision|3|||
130707974|NCT01048502|470556624|FG002|Overall Study|Physician Decision|0|||
130707975|NCT01048502|470556625|FG003|Overall Study|Physician Decision|1|||
130707976|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
130707977|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130707978|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130707979|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
130707980|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130707981|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130707982|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
130707983|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130707984|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130707985|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
130707986|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130707987|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130707988|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
130707989|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130707990|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130707991|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
130707992|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130707993|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130707994|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
130707995|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130707996|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130707997|NCT00384293|470556626|FG000|Post-randomization Period|Adverse Event|0|||
130554478|NCT01839487|469996610|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
130707998|NCT00384293|470556627|FG001|Post-randomization Period|Adverse Event|23|||
130707999|NCT00384293|470556628|FG002|Post-randomization Period|Adverse Event|7|||
130708000|NCT00384293|470556626|FG000|Post-randomization Period|Lost to Follow-up|0|||
130708001|NCT00384293|470556627|FG001|Post-randomization Period|Lost to Follow-up|2|||
130708002|NCT00384293|470556628|FG002|Post-randomization Period|Lost to Follow-up|1|||
130708003|NCT00384293|470556626|FG000|Post-randomization Period|Protocol Violation|0|||
130708004|NCT00384293|470556627|FG001|Post-randomization Period|Protocol Violation|1|||
130708005|NCT00384293|470556628|FG002|Post-randomization Period|Protocol Violation|0|||
130708006|NCT00384293|470556626|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130708007|NCT00384293|470556627|FG001|Post-randomization Period|Withdrawal by Subject|8|||
130708008|NCT00384293|470556628|FG002|Post-randomization Period|Withdrawal by Subject|6|||
130708009|NCT00384293|470556626|FG000|Post-randomization Period|Trial Termination|0|||
130708010|NCT00384293|470556627|FG001|Post-randomization Period|Trial Termination|180|||
130708011|NCT00384293|470556628|FG002|Post-randomization Period|Trial Termination|204|||
130708012|NCT00384293|470556626|FG000|Post-randomization Period|Patient Randomized in Error|0|||
130708013|NCT00384293|470556627|FG001|Post-randomization Period|Patient Randomized in Error|0|||
130554479|NCT01839487|469996605|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
130708014|NCT00384293|470556628|FG002|Post-randomization Period|Patient Randomized in Error|1|||
130708015|NCT05212883|470556629|FG000|Overall Study|Invalid test result|125|||
130708016|NCT02502734|470556630|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
130708017|NCT02502734|470556631|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
130708018|NCT02502734|470556630|FG000|Washout Period|Adverse Event|1|||
130708019|NCT02502734|470556631|FG001|Washout Period|Adverse Event|0|||
130708020|NCT01483625|470556634|FG000|Overall Study|Adverse Event|1|||
130708021|NCT01483625|470556635|FG001|Overall Study|Adverse Event|1|||
130708022|NCT01483625|470556634|FG000|Overall Study|Refused to continue medication|2|||
130708023|NCT01483625|470556635|FG001|Overall Study|Refused to continue medication|1|||
130708024|NCT01483625|470556634|FG000|Overall Study|Due to other reason|1|||
130708025|NCT01483625|470556635|FG001|Overall Study|Due to other reason|0|||
130708026|NCT05444543|470556639|FG000|Overall Study|Withdrawal by Subject|1|||
130708027|NCT05444543|470556640|FG001|Overall Study|Withdrawal by Subject|0|||
130708028|NCT05444543|470556639|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
130708029|NCT05444543|470556640|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
130708030|NCT05444543|470556639|FG000|Overall Study|Adverse Event|0|||
130708031|NCT05444543|470556640|FG001|Overall Study|Adverse Event|1|||
130708032|NCT05444543|470556639|FG000|Overall Study|Family relocating at a distance from study site|0|||
130708033|NCT05444543|470556640|FG001|Overall Study|Family relocating at a distance from study site|1|||
130708034|NCT02280187|470556641|FG000|Overall Study|Lost to Follow-up|218|||
130708035|NCT04668274|470556642|FG000|Part 1 Study Period 1|Adverse Event|3|||
130708036|NCT04668274|470556643|FG001|Part 1 Study Period 1|Adverse Event|0|||
130708037|NCT04668274|470556644|FG002|Part 1 Study Period 1|Adverse Event|0|||
130708038|NCT04668274|470556645|FG003|Part 1 Study Period 1|Adverse Event|0|||
130708039|NCT04668274|470556642|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
130708040|NCT04668274|470556643|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708041|NCT04668274|470556644|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708042|NCT04668274|470556645|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708043|NCT04668274|470556642|FG000|Part 1 Study Period 2|Other|0|||
130708044|NCT04668274|470556643|FG001|Part 1 Study Period 2|Other|1|||
130708045|NCT04668274|470556644|FG002|Part 1 Study Period 2|Other|0|||
130708046|NCT04668274|470556645|FG003|Part 1 Study Period 2|Other|0|||
130708047|NCT04668274|470556642|FG000|Part 1 Study Period 3|Adverse Event|0|||
130708048|NCT04668274|470556643|FG001|Part 1 Study Period 3|Adverse Event|0|||
130708049|NCT04668274|470556644|FG002|Part 1 Study Period 3|Adverse Event|1|||
130708050|NCT04668274|470556645|FG003|Part 1 Study Period 3|Adverse Event|0|||
130708051|NCT04668274|470556642|FG000|Part 1 Study Period 3|Other|0|||
130708052|NCT04668274|470556643|FG001|Part 1 Study Period 3|Other|0|||
130708053|NCT04668274|470556644|FG002|Part 1 Study Period 3|Other|2|||
130708054|NCT04668274|470556645|FG003|Part 1 Study Period 3|Other|0|||
130708055|NCT04668274|470556642|FG000|Part 2 Study Period 4|Other|0|||
130708056|NCT04668274|470556643|FG001|Part 2 Study Period 4|Other|0|||
130708057|NCT04668274|470556644|FG002|Part 2 Study Period 4|Other|0|||
130708058|NCT04668274|470556645|FG003|Part 2 Study Period 4|Other|1|||
130708059|NCT01832402|470556648|FG000|Overall Study|Lost to Follow-up|2|||
130708060|NCT01832402|470556649|FG001|Overall Study|Lost to Follow-up|0|||
130708061|NCT01832402|470556648|FG000|Overall Study|Withdrawal by Subject|3|||
130708062|NCT01832402|470556649|FG001|Overall Study|Withdrawal by Subject|3|||
130708063|NCT01832402|470556648|FG000|Overall Study|Declining Performance status|2|||
130273620|NCT00405392|468965616|FG001|Overall Study|Lost to Follow-up|2|||
130708064|NCT01832402|470556649|FG001|Overall Study|Declining Performance status|1|||
130708065|NCT00941720|470556650|FG000|Overall Study|Withdrawal by Subject|1|||
130708066|NCT00941720|470556650|FG000|Overall Study|Insurance denied participation|11|||
130708067|NCT00941720|470556650|FG000|Overall Study|ineligible|2|||
130708068|NCT01682148|470556651|FG000|Overall Study|Withdrawal by Subject|2|||
130708069|NCT01682148|470556652|FG001|Overall Study|Withdrawal by Subject|0|||
130273621|NCT00405392|468965615|FG000|Overall Study|Data missing|2|||
130273622|NCT00405392|468965616|FG001|Overall Study|Data missing|0|||
130273623|NCT00405392|468965615|FG000|Overall Study|Non-compliance|0|||
130273624|NCT00405392|468965616|FG001|Overall Study|Non-compliance|1|||
130273625|NCT00405392|468965615|FG000|Overall Study|Other|1|||
130273626|NCT00405392|468965616|FG001|Overall Study|Other|5|||
130273627|NCT00412958|468965617|FG000|Overall Study|Withdrawal by Subject|3|||
130273628|NCT00412958|468965618|FG001|Overall Study|Withdrawal by Subject|0|||
130273629|NCT00412958|468965619|FG002|Overall Study|Withdrawal by Subject|0|||
130273630|NCT00412958|468965620|FG003|Overall Study|Withdrawal by Subject|1|||
130273631|NCT00412958|468965617|FG000|Overall Study|Adverse Event|0|||
130273632|NCT00412958|468965618|FG001|Overall Study|Adverse Event|1|||
130273633|NCT00412958|468965619|FG002|Overall Study|Adverse Event|0|||
130708070|NCT01682148|470556651|FG000|Overall Study|Lost to Follow-up|1|||
130708071|NCT01682148|470556652|FG001|Overall Study|Lost to Follow-up|2|||
130708072|NCT01682148|470556651|FG000|Overall Study|Protocol Violation|1|||
130708073|NCT01682148|470556652|FG001|Overall Study|Protocol Violation|1|||
130273634|NCT00412958|468965620|FG003|Overall Study|Adverse Event|0|||
130273635|NCT00412958|468965617|FG000|Overall Study|Lost to Follow-up|0|||
130456462|NCT00383188|469634929|FG001|Overall Study|No longer willing to participate|0|||
130456463|NCT00383188|469634930|FG002|Overall Study|No longer willing to participate|1|||
130708074|NCT01803269|470556655|FG000|Overall Study|Withdrawal by Subject|3|||
130708075|NCT01803269|470556656|FG001|Overall Study|Withdrawal by Subject|0|||
130708076|NCT01803269|470556657|FG002|Overall Study|Withdrawal by Subject|0|||
130708077|NCT01202877|470556658|FG000|Overall Study|Disease Progression|0|||
130708078|NCT01202877|470556659|FG001|Overall Study|Disease Progression|1|||
130708079|NCT01202877|470556660|FG002|Overall Study|Disease Progression|2|||
130708080|NCT01202877|470556658|FG000|Overall Study|Adverse Event|0|||
130708081|NCT01202877|470556659|FG001|Overall Study|Adverse Event|0|||
130708082|NCT01202877|470556660|FG002|Overall Study|Adverse Event|2|||
130708083|NCT01202877|470556658|FG000|Overall Study|Withdrawal by Subject|0|||
130708084|NCT01202877|470556659|FG001|Overall Study|Withdrawal by Subject|0|||
130708085|NCT01202877|470556660|FG002|Overall Study|Withdrawal by Subject|1|||
130708086|NCT01202877|470556658|FG000|Overall Study|Death|0|||
130708087|NCT01202877|470556659|FG001|Overall Study|Death|0|||
130708088|NCT01202877|470556660|FG002|Overall Study|Death|1|||
130708089|NCT00396331|470556661|FG000|Overall Study|Failed to mobilize - no transplant|8|||
130708090|NCT00396331|470556661|FG000|Overall Study|Did not go on to transplant|5|||
130708091|NCT00396331|470556661|FG000|Overall Study|Lost to Follow-up|3|||
130708092|NCT00396331|470556661|FG000|Overall Study|Death|16|||
130708093|NCT00350402|470556662|FG000|Overall Study|Lost to Follow-up|1|||
130708094|NCT00350402|470556663|FG001|Overall Study|Lost to Follow-up|1|||
130708095|NCT01884688|470556664|FG000|Overall Study|Screen Failure|2|||
130708096|NCT01029392|470556674|FG000|Overall Study|Withdrawal by Subject|18|||
130708097|NCT01029392|470556675|FG001|Overall Study|Withdrawal by Subject|11|||
130708098|NCT01029392|470556674|FG000|Overall Study|Physician Decision|2|||
130708099|NCT01029392|470556675|FG001|Overall Study|Physician Decision|0|||
130708100|NCT00063882|470556676|FG000|Overall Study|Protocol Violation|3|||
130708101|NCT00063882|470556677|FG001|Overall Study|Protocol Violation|3|||
130708102|NCT00063882|470556676|FG000|Overall Study|Withdrawal by Subject|2|||
130708103|NCT00063882|470556677|FG001|Overall Study|Withdrawal by Subject|1|||
130708104|NCT01103479|470556678|FG000|Overall Study|Up to date with CRC screening|1|||
130708105|NCT01103479|470556679|FG001|Overall Study|Up to date with CRC screening|9|||
130708106|NCT01103479|470556680|FG002|Overall Study|Up to date with CRC screening|12|||
130708107|NCT01103479|470556678|FG000|Overall Study|Family history of CRC|1|||
130708108|NCT01103479|470556679|FG001|Overall Study|Family history of CRC|0|||
130708109|NCT01103479|470556680|FG002|Overall Study|Family history of CRC|2|||
130708110|NCT01103479|470556678|FG000|Overall Study|Active cancer|1|||
130708111|NCT01103479|470556679|FG001|Overall Study|Active cancer|0|||
130708112|NCT01103479|470556680|FG002|Overall Study|Active cancer|0|||
130708113|NCT01103479|470556678|FG000|Overall Study|Saw non-study physician|2|||
130708114|NCT01103479|470556679|FG001|Overall Study|Saw non-study physician|0|||
130708115|NCT01103479|470556680|FG002|Overall Study|Saw non-study physician|0|||
130708116|NCT02709486|470556681|FG000|Overall Study|Adverse Event|2|||
130708117|NCT02709486|470556682|FG001|Overall Study|Adverse Event|5|||
130708118|NCT02709486|470556683|FG002|Overall Study|Adverse Event|3|||
130708119|NCT02709486|470556681|FG000|Overall Study|Death|0|||
130708120|NCT02709486|470556682|FG001|Overall Study|Death|0|||
130708121|NCT02709486|470556683|FG002|Overall Study|Death|2|||
130708122|NCT02709486|470556681|FG000|Overall Study|Insufficient clinical response|7|||
130708123|NCT02709486|470556682|FG001|Overall Study|Insufficient clinical response|3|||
130708124|NCT02709486|470556683|FG002|Overall Study|Insufficient clinical response|3|||
130708125|NCT02709486|470556681|FG000|Overall Study|Lost to Follow-up|3|||
130456464|NCT00383188|469634931|FG003|Overall Study|No longer willing to participate|0|||
130456465|NCT00383188|469634932|FG004|Overall Study|No longer willing to participate|2|||
130456466|NCT00383188|469634928|FG000|Overall Study|Lost to Follow-up|0|||
130456467|NCT00383188|469634929|FG001|Overall Study|Lost to Follow-up|0|||
130456468|NCT00383188|469634930|FG002|Overall Study|Lost to Follow-up|0|||
130456469|NCT00383188|469634931|FG003|Overall Study|Lost to Follow-up|0|||
130456470|NCT00383188|469634932|FG004|Overall Study|Lost to Follow-up|1|||
130456471|NCT02341625|469634937|FG000|Overall Study|Disease Progression|2|||
130456472|NCT02341625|469634938|FG001|Overall Study|Disease Progression|2|||
130456473|NCT02341625|469634939|FG002|Overall Study|Disease Progression|3|||
130456474|NCT02341625|469634940|FG003|Overall Study|Disease Progression|6|||
130708126|NCT02709486|470556682|FG001|Overall Study|Lost to Follow-up|2|||
130708127|NCT02709486|470556683|FG002|Overall Study|Lost to Follow-up|2|||
130708128|NCT02709486|470556681|FG000|Overall Study|Other|0|||
130456475|NCT02341625|469634941|FG004|Overall Study|Disease Progression|7|||
130456476|NCT02341625|469634942|FG005|Overall Study|Disease Progression|7|||
130456477|NCT02341625|469634943|FG006|Overall Study|Disease Progression|28|||
130708129|NCT02709486|470556682|FG001|Overall Study|Other|2|||
130708130|NCT02709486|470556683|FG002|Overall Study|Other|3|||
130708131|NCT02709486|470556681|FG000|Overall Study|Withdrawal by Subject|32|||
130708132|NCT02709486|470556682|FG001|Overall Study|Withdrawal by Subject|22|||
130708133|NCT02709486|470556683|FG002|Overall Study|Withdrawal by Subject|32|||
130708134|NCT02377921|470556687|FG000|Overall Study|Subject non-compliance|1|||
130708135|NCT02377921|470556688|FG001|Overall Study|Subject non-compliance|1|||
130554480|NCT01839487|469996606|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
130554481|NCT01839487|469996607|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
130554482|NCT01839487|469996608|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
130554483|NCT01839487|469996609|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
130554484|NCT01839487|469996610|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
130554485|NCT01839487|469996605|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
130554486|NCT01839487|469996606|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
130554487|NCT01839487|469996607|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
130554488|NCT01839487|469996608|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
130554489|NCT01839487|469996609|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
130554490|NCT01839487|469996610|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
130554491|NCT01839487|469996605|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
130554492|NCT01839487|469996606|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
130554493|NCT01839487|469996607|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
130554494|NCT01839487|469996608|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
130554495|NCT01839487|469996609|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
130554496|NCT01839487|469996610|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
130554497|NCT03471871|469996611|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
130554498|NCT03471871|469996612|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
130554499|NCT03471871|469996613|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
130554500|NCT03471871|469996614|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
130554501|NCT03471871|469996615|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
130554502|NCT03471871|469996611|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
130554503|NCT03471871|469996612|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
130554504|NCT03471871|469996613|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
130554505|NCT03471871|469996614|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
130554506|NCT03471871|469996615|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
130554507|NCT03471871|469996611|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
130554508|NCT03471871|469996612|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
130554509|NCT03471871|469996613|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
130554510|NCT03471871|469996614|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
130554511|NCT03471871|469996615|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
130554512|NCT03471871|469996611|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
130554513|NCT03471871|469996612|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
130554514|NCT03471871|469996613|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
130554515|NCT03471871|469996614|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
130554516|NCT03471871|469996615|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
130554517|NCT03471871|469996611|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
130554518|NCT03471871|469996612|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
130554519|NCT03471871|469996613|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
130554520|NCT03471871|469996614|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
130554521|NCT03471871|469996615|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
130554522|NCT03971422|469998003|FG000|Overall Study|Lost to Follow-up|0|||
130554523|NCT03971422|469998004|FG001|Overall Study|Lost to Follow-up|1|||
130554524|NCT03971422|469998005|FG002|Overall Study|Lost to Follow-up|0|||
130554525|NCT03971422|469998003|FG000|Overall Study|Lack of Efficacy|5|||
130554526|NCT03971422|469998004|FG001|Overall Study|Lack of Efficacy|1|||
130554527|NCT03971422|469998005|FG002|Overall Study|Lack of Efficacy|1|||
130554528|NCT03971422|469998003|FG000|Overall Study|Adverse event, not fatal|2|||
130554529|NCT03971422|469998004|FG001|Overall Study|Adverse event, not fatal|2|||
130554530|NCT03971422|469998005|FG002|Overall Study|Adverse event, not fatal|5|||
130554531|NCT03971422|469998003|FG000|Overall Study|Worsening of MG Symptoms|1|||
130554532|NCT03971422|469998004|FG001|Overall Study|Worsening of MG Symptoms|4|||
130554533|NCT03971422|469998005|FG002|Overall Study|Worsening of MG Symptoms|2|||
130554534|NCT03971422|469998003|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
130554535|NCT03971422|469998004|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
130554536|NCT03971422|469998005|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
130554537|NCT03971422|469998003|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
130554538|NCT03971422|469998004|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
130554539|NCT03971422|469998005|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
130554540|NCT03971422|469998003|FG000|Overall Study|Due to COVID-19 pandemic|0|||
130554541|NCT03971422|469998004|FG001|Overall Study|Due to COVID-19 pandemic|1|||
130554542|NCT03971422|469998005|FG002|Overall Study|Due to COVID-19 pandemic|1|||
130554543|NCT04751656|469998008|FG000|Overall Study|Lost to Follow-up|1|||
130554544|NCT03566810|469998009|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
130708136|NCT02549573|470556693|FG000|Overall Study|Withdrawal by Subject|0|||
130708137|NCT02549573|470556694|FG001|Overall Study|Withdrawal by Subject|2|||
130708138|NCT02549573|470556693|FG000|Overall Study|Protocol Violation|0|||
130708139|NCT02549573|470556694|FG001|Overall Study|Protocol Violation|1|||
130708140|NCT01010126|470558279|FG000|Overall Study|Withdrawal by Subject|1|||
130708141|NCT01010126|470558280|FG001|Overall Study|Withdrawal by Subject|0|||
130708142|NCT01010126|470558281|FG002|Overall Study|Withdrawal by Subject|1|||
130708143|NCT01010126|470558282|FG003|Overall Study|Withdrawal by Subject|0|||
130708144|NCT01010126|470558283|FG004|Overall Study|Withdrawal by Subject|3|||
130708145|NCT01010126|470558284|FG005|Overall Study|Withdrawal by Subject|0|||
130708146|NCT00595335|470558287|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
130708147|NCT00595335|470558288|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
130708148|NCT00595335|470558287|FG000|Baseline to Six Months|Disease Progression|1|||
130708149|NCT00595335|470558288|FG001|Baseline to Six Months|Disease Progression|1|||
130708150|NCT00595335|470558287|FG000|Baseline to Six Months|Adverse Event|1|||
130708151|NCT00595335|470558288|FG001|Baseline to Six Months|Adverse Event|0|||
130708152|NCT00595335|470558287|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
130708153|NCT00595335|470558288|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
130708154|NCT00595335|470558287|FG000|Six Months to Twelve Months|Disease Progression|1|||
130708155|NCT00595335|470558288|FG001|Six Months to Twelve Months|Disease Progression|0|||
130708156|NCT02658487|470558294|FG000|Overall Study|Death|2|||
130708157|NCT02658487|470558294|FG000|Overall Study|Disease progression|10|||
130708158|NCT02658487|470558294|FG000|Overall Study|Alternative therapy|1|||
130708159|NCT02658487|470558294|FG000|Overall Study|Adverse Event|1|||
130708160|NCT02658487|470558294|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
130708161|NCT02658487|470558294|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
130708162|NCT01647958|470558295|FG000|Initial Study|Lost to Follow-up|2|||
130708163|NCT01647958|470558296|FG001|Initial Study|Lost to Follow-up|3|||
130708164|NCT01647958|470558295|FG000|Continuation Phase|treatment received during Overall Study|39|||
130708165|NCT01647958|470558296|FG001|Continuation Phase|treatment received during Overall Study|0|||
130708166|NCT01647958|470558295|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
130708167|NCT01647958|470558296|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
130708168|NCT00544817|470558297|FG000|Combined Modality|Lack of Efficacy|2|||
130708169|NCT00544817|470558297|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
130708170|NCT00544817|470558297|FG000|Combined Modality|Adverse Event|2|||
130708171|NCT00544817|470558297|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
130708172|NCT00544817|470558297|FG000|No Treatment Interval|Lack of Efficacy|8|||
130708173|NCT00544817|470558297|FG000|No Treatment Interval|Physician Decision|3|||
130708174|NCT00544817|470558297|FG000|No Treatment Interval|Adverse Event|1|||
130708175|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
130708176|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
130708177|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
130708178|NCT01131299|470558298|FG000|Overall Study|Withdrawal by Subject|4|||
130708179|NCT01131299|470558299|FG001|Overall Study|Withdrawal by Subject|7|||
130708180|NCT03686150|470558306|FG000|Overall Study|Withdrawal by Subject|1|||
130708181|NCT03686150|470558307|FG001|Overall Study|Withdrawal by Subject|1|||
130708182|NCT03686150|470558308|FG002|Overall Study|Withdrawal by Subject|1|||
130708183|NCT03686150|470558309|FG003|Overall Study|Withdrawal by Subject|0|||
130708184|NCT03686150|470558310|FG004|Overall Study|Withdrawal by Subject|1|||
130708185|NCT03686150|470558311|FG005|Overall Study|Withdrawal by Subject|2|||
130708186|NCT03686150|470558306|FG000|Overall Study|Physician Decision|1|||
130273636|NCT00412958|468965618|FG001|Overall Study|Lost to Follow-up|1|||
130456478|NCT02341625|469634944|FG007|Overall Study|Disease Progression|5|||
130456479|NCT02341625|469634945|FG008|Overall Study|Disease Progression|4|||
130456480|NCT02341625|469634946|FG009|Overall Study|Disease Progression|19|||
130456481|NCT02341625|469634937|FG000|Overall Study|Study Drug Toxicity|0|||
130456482|NCT02341625|469634938|FG001|Overall Study|Study Drug Toxicity|0|||
130456483|NCT02341625|469634939|FG002|Overall Study|Study Drug Toxicity|0|||
130456484|NCT02341625|469634940|FG003|Overall Study|Study Drug Toxicity|1|||
130456485|NCT02341625|469634941|FG004|Overall Study|Study Drug Toxicity|0|||
130456486|NCT02341625|469634942|FG005|Overall Study|Study Drug Toxicity|3|||
130456487|NCT02341625|469634943|FG006|Overall Study|Study Drug Toxicity|10|||
130456488|NCT02341625|469634944|FG007|Overall Study|Study Drug Toxicity|0|||
130708187|NCT03686150|470558307|FG001|Overall Study|Physician Decision|0|||
130708188|NCT03686150|470558308|FG002|Overall Study|Physician Decision|0|||
130708189|NCT03686150|470558309|FG003|Overall Study|Physician Decision|0|||
130708190|NCT03686150|470558310|FG004|Overall Study|Physician Decision|0|||
130708191|NCT03686150|470558311|FG005|Overall Study|Physician Decision|1|||
130708192|NCT03686150|470558306|FG000|Overall Study|Lost to Follow-up|0|||
130708193|NCT03686150|470558307|FG001|Overall Study|Lost to Follow-up|1|||
130708194|NCT03686150|470558308|FG002|Overall Study|Lost to Follow-up|0|||
130456489|NCT02341625|469634945|FG008|Overall Study|Study Drug Toxicity|0|||
130456490|NCT02341625|469634946|FG009|Overall Study|Study Drug Toxicity|3|||
130456491|NCT02341625|469634937|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130456492|NCT02341625|469634938|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130708195|NCT03686150|470558309|FG003|Overall Study|Lost to Follow-up|0|||
130708196|NCT03686150|470558310|FG004|Overall Study|Lost to Follow-up|0|||
130708197|NCT03686150|470558311|FG005|Overall Study|Lost to Follow-up|0|||
130708198|NCT00614926|470558312|FG000|Overall Study|Burden of travel|1|||
130708199|NCT00614926|470558313|FG001|Overall Study|Burden of travel|0|||
130708200|NCT00614926|470558312|FG000|Overall Study|Adverse Event|3|||
130708201|NCT00614926|470558313|FG001|Overall Study|Adverse Event|0|||
130708202|NCT03341000|470558316|FG000|Overall Study|Adverse Event|1|||
130708203|NCT02813421|470558319|FG000|Overall Study|Withdrawal by Subject|1|||
130708204|NCT02813421|470558320|FG001|Overall Study|Withdrawal by Subject|2|||
130708205|NCT02813421|470558319|FG000|Overall Study|Lost to Follow-up|1|||
130708206|NCT02813421|470558320|FG001|Overall Study|Lost to Follow-up|1|||
130708207|NCT01213836|470558335|FG000|Period 1, First Intervention|Adverse Event|2|||
130708208|NCT01213836|470558336|FG001|Period 1, First Intervention|Adverse Event|1|||
130708209|NCT01213836|470558335|FG000|Period 1, First Intervention|Protocol Violation|0|||
130708210|NCT01213836|470558336|FG001|Period 1, First Intervention|Protocol Violation|1|||
130708211|NCT01213836|470558335|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
130708212|NCT01213836|470558336|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
130708213|NCT00255151|470558337|FG000|Overall Study|Adverse Event|10|||
130708214|NCT00255151|470558338|FG001|Overall Study|Adverse Event|6|||
130708215|NCT00255151|470558339|FG002|Overall Study|Adverse Event|9|||
130708216|NCT00255151|470558337|FG000|Overall Study|Lost to Follow-up|4|||
130708217|NCT00255151|470558338|FG001|Overall Study|Lost to Follow-up|3|||
130708218|NCT00255151|470558339|FG002|Overall Study|Lost to Follow-up|4|||
130708219|NCT00255151|470558337|FG000|Overall Study|Withdrawal by Subject|18|||
130708220|NCT00255151|470558338|FG001|Overall Study|Withdrawal by Subject|17|||
130708221|NCT00255151|470558339|FG002|Overall Study|Withdrawal by Subject|8|||
130708222|NCT00255151|470558337|FG000|Overall Study|Noncompliance|0|||
130708223|NCT00255151|470558338|FG001|Overall Study|Noncompliance|1|||
130708224|NCT00255151|470558339|FG002|Overall Study|Noncompliance|2|||
130708225|NCT00255151|470558337|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130708226|NCT00255151|470558338|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130708227|NCT00255151|470558339|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130708228|NCT00255151|470558337|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130708229|NCT00255151|470558338|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130708230|NCT00255151|470558339|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130708231|NCT00255151|470558337|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130708232|NCT00255151|470558338|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130708233|NCT00255151|470558339|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130708234|NCT00255151|470558337|FG000|Overall Study|Esophageal Stricture|0|||
130708235|NCT00255151|470558338|FG001|Overall Study|Esophageal Stricture|0|||
130708236|NCT00255151|470558339|FG002|Overall Study|Esophageal Stricture|1|||
130708237|NCT00255151|470558337|FG000|Overall Study|Therapeutic Failure|11|||
130708238|NCT00255151|470558338|FG001|Overall Study|Therapeutic Failure|2|||
130708239|NCT00255151|470558339|FG002|Overall Study|Therapeutic Failure|3|||
130708240|NCT00706095|470558340|FG000|Overall Study|Progressive Disease|4|||
130708241|NCT00706095|470558341|FG001|Overall Study|Progressive Disease|5|||
130708242|NCT00706095|470558342|FG002|Overall Study|Progressive Disease|3|||
130708243|NCT00706095|470558340|FG000|Overall Study|Clinical Progression|1|||
130708244|NCT00706095|470558341|FG001|Overall Study|Clinical Progression|2|||
130708245|NCT00706095|470558342|FG002|Overall Study|Clinical Progression|2|||
130708246|NCT00706095|470558340|FG000|Overall Study|Withdrawal by Subject|1|||
130708247|NCT00706095|470558341|FG001|Overall Study|Withdrawal by Subject|0|||
130708248|NCT00706095|470558342|FG002|Overall Study|Withdrawal by Subject|0|||
130708249|NCT02676284|470558343|FG000|Overall Study|Withdrawal by Subject|1|||
130708250|NCT01685073|470558344|FG000|Overall Study|Lost to Follow-up|6|||
130708251|NCT01685073|470558345|FG001|Overall Study|Lost to Follow-up|8|||
130708252|NCT01685073|470558344|FG000|Overall Study|Withdrawal by Subject|24|||
130708253|NCT01685073|470558345|FG001|Overall Study|Withdrawal by Subject|24|||
130708254|NCT00107042|470558350|FG000|Overall Study|Lost to Follow-up|9|||
130708255|NCT00107042|470558351|FG001|Overall Study|Lost to Follow-up|7|||
130708256|NCT00107042|470558350|FG000|Overall Study|Withdrawal by Subject|6|||
130708257|NCT00107042|470558351|FG001|Overall Study|Withdrawal by Subject|1|||
130708258|NCT00107042|470558350|FG000|Overall Study|Moved out of area|5|||
130708259|NCT00107042|470558351|FG001|Overall Study|Moved out of area|3|||
130708260|NCT00107042|470558350|FG000|Overall Study|Pregnancy|1|||
130708261|NCT00107042|470558351|FG001|Overall Study|Pregnancy|1|||
130708262|NCT00107042|470558350|FG000|Overall Study|Inadvertent enrollment|0|||
130708263|NCT00107042|470558351|FG001|Overall Study|Inadvertent enrollment|1|||
130708264|NCT00107042|470558350|FG000|Overall Study|vaccinated outside window|1|||
130708265|NCT00107042|470558351|FG001|Overall Study|vaccinated outside window|1|||
130708266|NCT00107042|470558350|FG000|Overall Study|Disallowed medications|0|||
130708267|NCT00107042|470558351|FG001|Overall Study|Disallowed medications|2|||
130273637|NCT00412958|468965619|FG002|Overall Study|Lost to Follow-up|0|||
130708268|NCT01221090|470558352|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
130708269|NCT01221090|470558353|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
130708270|NCT01221090|470558354|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
130708271|NCT01221090|470558355|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
130708272|NCT01221090|470558352|FG000|Overall Study|Withdrawal by Subject|0|||
130708273|NCT01221090|470558353|FG001|Overall Study|Withdrawal by Subject|22|||
130708274|NCT01221090|470558354|FG002|Overall Study|Withdrawal by Subject|27|||
130708275|NCT01221090|470558355|FG003|Overall Study|Withdrawal by Subject|2|||
130708276|NCT00708708|470558356|FG000|Overall Study|Another therapy instead of Enbrel|141|||
130708277|NCT00708708|470558356|FG000|Overall Study|Lost to Follow-up|52|||
130708278|NCT00708708|470558356|FG000|Overall Study|Withdrawal by Subject|51|||
130708279|NCT00708708|470558356|FG000|Overall Study|Intolerance|42|||
130708280|NCT00708708|470558356|FG000|Overall Study|Another therapy along with Enbrel|15|||
130708281|NCT00708708|470558356|FG000|Overall Study|Other unspecified|11|||
130708282|NCT00708708|470558356|FG000|Overall Study|Good effectiveness|9|||
130708283|NCT00708708|470558356|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
130708284|NCT00708708|470558356|FG000|Overall Study|Administrative reasons|7|||
130708285|NCT00708708|470558356|FG000|Overall Study|Lack of effectiveness|4|||
130708286|NCT00708708|470558356|FG000|Overall Study|Lack of compliance|3|||
130708287|NCT00708708|470558356|FG000|Overall Study|Pregnancy|3|||
130708288|NCT00708708|470558356|FG000|Overall Study|Adverse Event|3|||
130708289|NCT00708708|470558356|FG000|Overall Study|Missing values|392|||
130708290|NCT03768726|470558360|FG000|Treatment Phase|Adverse Event|2|||
130708291|NCT03768726|470558361|FG001|Treatment Phase|Adverse Event|2|||
130708292|NCT03768726|470558360|FG000|Treatment Phase|Lost to Follow-up|1|||
130708293|NCT03768726|470558361|FG001|Treatment Phase|Lost to Follow-up|0|||
130708294|NCT03768726|470558360|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
130708295|NCT03768726|470558361|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
130708296|NCT03768726|470558360|FG000|Treatment Phase|Withdrawal by Subject|3|||
130708297|NCT03768726|470558361|FG001|Treatment Phase|Withdrawal by Subject|1|||
130708298|NCT03768726|470558360|FG000|Follow-Up|Adverse Event|2|||
130708299|NCT03768726|470558361|FG001|Follow-Up|Adverse Event|2|||
130708300|NCT03768726|470558360|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
130708301|NCT03768726|470558361|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
130708302|NCT03768726|470558360|FG000|Follow-Up|Withdrawal by Subject|2|||
130708303|NCT03768726|470558361|FG001|Follow-Up|Withdrawal by Subject|0|||
130708304|NCT03768726|470558360|FG000|Follow-Up|Other|1|||
130708305|NCT03768726|470558361|FG001|Follow-Up|Other|0|||
130708306|NCT01286558|470558362|FG000|Overall Study|Adverse Event|1|||
130708307|NCT01286558|470558363|FG001|Overall Study|Adverse Event|1|||
130708308|NCT01286558|470558362|FG000|Overall Study|Withdrawal by Subject|0|||
130708309|NCT01286558|470558363|FG001|Overall Study|Withdrawal by Subject|1|||
130708310|NCT01787279|470558365|FG000|Overall Study|Lost to Follow-up|2|||
130708311|NCT01787279|470558365|FG000|Overall Study|Lack of Efficacy|1|||
130708312|NCT01272921|470558367|FG000|Overall Study|Protocol Violation|2|||
130708313|NCT01272921|470558368|FG001|Overall Study|Protocol Violation|1|||
130708314|NCT00892281|470558370|FG000|Overall Study|Adverse Event|65|||
130708315|NCT00892281|470558371|FG001|Overall Study|Adverse Event|8|||
130708316|NCT00892281|470558370|FG000|Overall Study|Lost to Follow-up|81|||
130708317|NCT00892281|470558371|FG001|Overall Study|Lost to Follow-up|8|||
130708318|NCT00892281|470558370|FG000|Overall Study|Pregnancy|1|||
130708319|NCT00892281|470558371|FG001|Overall Study|Pregnancy|0|||
130708320|NCT00892281|470558370|FG000|Overall Study|Protocol Violation|7|||
130708321|NCT00892281|470558371|FG001|Overall Study|Protocol Violation|2|||
130708322|NCT00892281|470558370|FG000|Overall Study|Withdrawal by Subject|86|||
130708323|NCT00892281|470558371|FG001|Overall Study|Withdrawal by Subject|14|||
130708324|NCT00892281|470558370|FG000|Overall Study|Subject failed to return for final visit|2|||
130708325|NCT00892281|470558371|FG001|Overall Study|Subject failed to return for final visit|0|||
130708326|NCT00892281|470558370|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
130708327|NCT00892281|470558371|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
130708328|NCT00892281|470558370|FG000|Overall Study|Final visit completed 4 weeks late|0|||
130708329|NCT00892281|470558371|FG001|Overall Study|Final visit completed 4 weeks late|1|||
130456493|NCT02341625|469634939|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130456494|NCT02341625|469634940|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130456495|NCT02341625|469634941|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130456496|NCT02341625|469634942|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130708330|NCT00892281|470558370|FG000|Overall Study|Subject completed day after study closed|1|||
130708331|NCT00892281|470558371|FG001|Overall Study|Subject completed day after study closed|0|||
130708332|NCT00892281|470558370|FG000|Overall Study|Family emergency|1|||
130708333|NCT00892281|470558371|FG001|Overall Study|Family emergency|0|||
130708334|NCT00892281|470558370|FG000|Overall Study|Last visit not done - death in family|1|||
130708335|NCT00892281|470558371|FG001|Overall Study|Last visit not done - death in family|0|||
130708336|NCT00892281|470558370|FG000|Overall Study|Did not meet incl/excl criteria|1|||
130708337|NCT00892281|470558371|FG001|Overall Study|Did not meet incl/excl criteria|0|||
130708338|NCT00892281|470558370|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
130708339|NCT00892281|470558371|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
130708340|NCT00892281|470558370|FG000|Overall Study|Unable to redeem the drug voucher|1|||
130708341|NCT00892281|470558371|FG001|Overall Study|Unable to redeem the drug voucher|0|||
130708342|NCT00892281|470558370|FG000|Overall Study|Subject not good candidate for study|1|||
130708343|NCT00892281|470558371|FG001|Overall Study|Subject not good candidate for study|0|||
130708344|NCT00892281|470558370|FG000|Overall Study|Subject did not return for any visits|1|||
130708345|NCT00892281|470558371|FG001|Overall Study|Subject did not return for any visits|0|||
130708346|NCT00892281|470558370|FG000|Overall Study|Subject missed several visits/lost meds|1|||
130708347|NCT00892281|470558371|FG001|Overall Study|Subject missed several visits/lost meds|0|||
130708348|NCT00892281|470558370|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130708349|NCT00892281|470558371|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130708350|NCT00892281|470558370|FG000|Overall Study|Scheduled for knee replacement|0|||
130708351|NCT00892281|470558371|FG001|Overall Study|Scheduled for knee replacement|1|||
130708352|NCT00892281|470558370|FG000|Overall Study|PI complained of inadequate compensation|3|||
130708353|NCT00892281|470558371|FG001|Overall Study|PI complained of inadequate compensation|0|||
130708354|NCT00892281|470558370|FG000|Overall Study|Subject lost interest in program|0|||
130708355|NCT00892281|470558371|FG001|Overall Study|Subject lost interest in program|1|||
130708356|NCT00892281|470558370|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
130708357|NCT00892281|470558371|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
130708358|NCT00892281|470558370|FG000|Overall Study|Death in family|1|||
130708359|NCT00892281|470558371|FG001|Overall Study|Death in family|0|||
130708360|NCT00892281|470558370|FG000|Overall Study|Lack of efficacy of study product|2|||
130708361|NCT00892281|470558371|FG001|Overall Study|Lack of efficacy of study product|0|||
130708362|NCT00892281|470558370|FG000|Overall Study|Subject not seen by PI at final visit|1|||
130708363|NCT00892281|470558371|FG001|Overall Study|Subject not seen by PI at final visit|0|||
130708364|NCT00892281|470558370|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
130708365|NCT00892281|470558371|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
130708366|NCT00892281|470558370|FG000|Overall Study|Missed multiple visits|1|||
130708367|NCT00892281|470558371|FG001|Overall Study|Missed multiple visits|0|||
130708368|NCT00892281|470558370|FG000|Overall Study|Missed visits rescheduled out of window|1|||
130708369|NCT00892281|470558371|FG001|Overall Study|Missed visits rescheduled out of window|0|||
130708370|NCT00892281|470558370|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
130708371|NCT00892281|470558371|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
130708372|NCT00892281|470558370|FG000|Overall Study|Subject had history of drug abuse|1|||
130708373|NCT00892281|470558371|FG001|Overall Study|Subject had history of drug abuse|0|||
130708374|NCT00892281|470558370|FG000|Overall Study|Rash on hand|1|||
130708375|NCT00892281|470558371|FG001|Overall Study|Rash on hand|0|||
130708376|NCT00892281|470558370|FG000|Overall Study|Visit 4 date out of window|1|||
130708377|NCT00892281|470558371|FG001|Overall Study|Visit 4 date out of window|0|||
130708378|NCT00140413|470558372|FG000|Overall Study|Lost to Follow-up|1|||
130708379|NCT00140413|470558373|FG001|Overall Study|Lost to Follow-up|0|||
130708380|NCT00140413|470558372|FG000|Overall Study|Withdrawal by Subject|2|||
130708381|NCT00140413|470558373|FG001|Overall Study|Withdrawal by Subject|0|||
130708382|NCT00865098|470558374|FG000|Overall Study|Progressive disease|1|||
130708383|NCT01304693|470558375|FG000|Overall Study|Adverse Event|0|||
130708384|NCT01304693|470558376|FG001|Overall Study|Adverse Event|0|||
130708385|NCT01304693|470558377|FG002|Overall Study|Adverse Event|0|||
130708386|NCT01304693|470558378|FG003|Overall Study|Adverse Event|0|||
130708387|NCT01304693|470558379|FG004|Overall Study|Adverse Event|1|||
130708388|NCT01304693|470558375|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708389|NCT01304693|470558376|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708390|NCT01304693|470558377|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
130708391|NCT01304693|470558378|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
130708392|NCT01304693|470558379|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708393|NCT02129647|470558380|FG000|Overall Study|Adverse Event|2|||
130708394|NCT02129647|470558380|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
130708395|NCT01833533|470558388|FG000|Overall Study|Adverse Event|0|||
130708396|NCT01833533|470558389|FG001|Overall Study|Adverse Event|1|||
130708397|NCT01833533|470558388|FG000|Overall Study|Lost to Follow-up|4|||
130708398|NCT01833533|470558389|FG001|Overall Study|Lost to Follow-up|9|||
130708399|NCT01833533|470558388|FG000|Overall Study|To Enter an Extension Study|0|||
130708400|NCT01833533|470558389|FG001|Overall Study|To Enter an Extension Study|4|||
130708401|NCT01833533|470558388|FG000|Overall Study|Other|2|||
130708402|NCT01833533|470558389|FG001|Overall Study|Other|7|||
130708403|NCT01138826|470558393|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130708404|NCT01138826|470558394|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130708405|NCT01138826|470558395|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708406|NCT01138826|470558396|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708407|NCT01138826|470558397|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130708408|NCT01138826|470558398|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708409|NCT01333072|470558402|FG000|Overall Study|Lost to Follow-up|3|||
130708410|NCT01333072|470558403|FG001|Overall Study|Lost to Follow-up|0|||
130708411|NCT01333072|470558402|FG000|Overall Study|Adverse Event|2|||
130708412|NCT01333072|470558403|FG001|Overall Study|Adverse Event|4|||
130708413|NCT01333072|470558402|FG000|Overall Study|Physician Decision|1|||
130708414|NCT01333072|470558403|FG001|Overall Study|Physician Decision|0|||
130708415|NCT01557842|470558404|FG000|Overall Study|Lost to Follow-up|0|||
130708416|NCT01557842|470558405|FG001|Overall Study|Lost to Follow-up|1|||
130708417|NCT01557842|470558404|FG000|Overall Study|Death|1|||
130708418|NCT01557842|470558405|FG001|Overall Study|Death|0|||
130708419|NCT01557842|470558404|FG000|Overall Study|Lack of Efficacy|0|||
130708420|NCT01557842|470558405|FG001|Overall Study|Lack of Efficacy|1|||
130708421|NCT01557842|470558404|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
130708422|NCT01557842|470558405|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
130708423|NCT01557842|470558404|FG000|Overall Study|Study Terminated by Sponsor|3|||
130708424|NCT01557842|470558405|FG001|Overall Study|Study Terminated by Sponsor|4|||
130708425|NCT01557842|470558404|FG000|Overall Study|Not Ablated|2|||
130708426|NCT01557842|470558405|FG001|Overall Study|Not Ablated|0|||
130708427|NCT02457611|470558409|FG000|Overall Study|Lost to Follow-up|3|||
130708428|NCT03005067|470558410|FG000|Overall Study|Withdrawal by Subject|3|||
130708429|NCT03005067|470558411|FG001|Overall Study|Withdrawal by Subject|2|||
130708430|NCT03005067|470558410|FG000|Overall Study|Adverse Event|4|||
130708431|NCT03005067|470558411|FG001|Overall Study|Adverse Event|3|||
130708432|NCT03005067|470558410|FG000|Overall Study|Other (reason not specified)|3|||
130708433|NCT03005067|470558411|FG001|Overall Study|Other (reason not specified)|1|||
130708434|NCT03005067|470558410|FG000|Overall Study|Protocol Violation|0|||
130708435|NCT03005067|470558411|FG001|Overall Study|Protocol Violation|1|||
130708436|NCT00619359|470558414|FG000|Overall Study|Adverse Event|32|||
130708437|NCT00619359|470558415|FG001|Overall Study|Adverse Event|36|||
130708438|NCT00619359|470558414|FG000|Overall Study|Lost to Follow-up|12|||
130708439|NCT00619359|470558415|FG001|Overall Study|Lost to Follow-up|16|||
130708440|NCT00619359|470558414|FG000|Overall Study|Physician Decision|0|||
130708441|NCT00619359|470558415|FG001|Overall Study|Physician Decision|7|||
130708442|NCT00619359|470558414|FG000|Overall Study|Protocol Violation|1|||
130708443|NCT00619359|470558415|FG001|Overall Study|Protocol Violation|1|||
130708444|NCT00619359|470558414|FG000|Overall Study|Withdrawal by Subject|19|||
130708445|NCT00619359|470558415|FG001|Overall Study|Withdrawal by Subject|20|||
130708446|NCT00619359|470558414|FG000|Overall Study|Progressive Disease|3|||
130708447|NCT00619359|470558415|FG001|Overall Study|Progressive Disease|1|||
130708448|NCT03891329|470558431|FG000|Overall Study|Death|5|||
130708449|NCT03891329|470558431|FG000|Overall Study|Lost to Follow-up|4|||
130708450|NCT03891329|470558431|FG000|Overall Study|Physician Decision|4|||
130708451|NCT03891329|470558431|FG000|Overall Study|Device explanted|3|||
130708452|NCT03891329|470558431|FG000|Overall Study|No study device implanted|3|||
130456497|NCT02341625|469634943|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130456498|NCT02341625|469634944|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130456499|NCT02341625|469634945|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130456500|NCT02341625|469634946|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130456501|NCT02341625|469634937|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456502|NCT02341625|469634938|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456503|NCT02341625|469634939|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456504|NCT02341625|469634940|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456505|NCT02341625|469634941|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456506|NCT02341625|469634942|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456507|NCT02341625|469634943|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
130456508|NCT02341625|469634944|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
130456509|NCT02341625|469634945|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456510|NCT02341625|469634946|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
130456511|NCT02341625|469634937|FG000|Overall Study|Participant Withdrew Consent|0|||
130456512|NCT02341625|469634938|FG001|Overall Study|Participant Withdrew Consent|0|||
130456513|NCT02341625|469634939|FG002|Overall Study|Participant Withdrew Consent|0|||
130456514|NCT02341625|469634940|FG003|Overall Study|Participant Withdrew Consent|1|||
130708453|NCT03176784|470558432|FG000|Overall Study|Lost to Follow-up|77|||
130708454|NCT03176784|470558433|FG001|Overall Study|Lost to Follow-up|79|||
130273638|NCT00412958|468965620|FG003|Overall Study|Lost to Follow-up|0|||
130708455|NCT03176784|470558434|FG002|Overall Study|Lost to Follow-up|79|||
130708456|NCT03176784|470558435|FG003|Overall Study|Lost to Follow-up|49|||
130708457|NCT03176784|470558432|FG000|Overall Study|Withdrawal by Subject|28|||
130708458|NCT03176784|470558433|FG001|Overall Study|Withdrawal by Subject|34|||
130708459|NCT03176784|470558434|FG002|Overall Study|Withdrawal by Subject|34|||
130708460|NCT03176784|470558435|FG003|Overall Study|Withdrawal by Subject|21|||
130708461|NCT01351350|470558436|FG000|Overall Study|Disease Progression|5|||
130708462|NCT01351350|470558437|FG001|Overall Study|Disease Progression|13|||
130708463|NCT01351350|470558438|FG002|Overall Study|Disease Progression|6|||
130554545|NCT03566810|469998010|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
130554546|NCT03566810|469998011|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
130554547|NCT03566810|469998012|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
130554548|NCT01955122|469998020|FG000|Overall Study|Physician Decision|5|||
130554549|NCT01955122|469998021|FG001|Overall Study|Physician Decision|5|||
130554550|NCT00826111|469998022|FG000|Overall Study|Lost to Follow-up|0|||
130554551|NCT00826111|469998023|FG001|Overall Study|Lost to Follow-up|1|||
130554552|NCT00826111|469998022|FG000|Overall Study|Protocol Violation|1|||
130554553|NCT00826111|469998023|FG001|Overall Study|Protocol Violation|0|||
130554554|NCT00826111|469998022|FG000|Overall Study|Withdrawal by Subject|5|||
130708464|NCT01351350|470558439|FG003|Overall Study|Disease Progression|8|||
130708465|NCT01351350|470558440|FG004|Overall Study|Disease Progression|5|||
130708466|NCT01351350|470558436|FG000|Overall Study|Adverse Event|1|||
130708467|NCT01351350|470558437|FG001|Overall Study|Adverse Event|10|||
130708468|NCT01351350|470558438|FG002|Overall Study|Adverse Event|1|||
130708469|NCT01351350|470558439|FG003|Overall Study|Adverse Event|2|||
130708470|NCT01351350|470558440|FG004|Overall Study|Adverse Event|0|||
130708471|NCT01351350|470558436|FG000|Overall Study|Participant Decision|2|||
130708472|NCT01351350|470558437|FG001|Overall Study|Participant Decision|6|||
130708473|NCT01351350|470558438|FG002|Overall Study|Participant Decision|3|||
130708474|NCT01351350|470558439|FG003|Overall Study|Participant Decision|3|||
130708475|NCT01351350|470558440|FG004|Overall Study|Participant Decision|2|||
130708476|NCT01351350|470558436|FG000|Overall Study|Enrolled but not Treated|0|||
130708477|NCT01351350|470558437|FG001|Overall Study|Enrolled but not Treated|0|||
130708478|NCT01351350|470558438|FG002|Overall Study|Enrolled but not Treated|1|||
130708479|NCT01351350|470558439|FG003|Overall Study|Enrolled but not Treated|0|||
130708480|NCT01351350|470558440|FG004|Overall Study|Enrolled but not Treated|0|||
130708481|NCT01258101|470558441|FG000|Overall Study|Adverse Event|5|||
130708482|NCT01258101|470558442|FG001|Overall Study|Adverse Event|6|||
130708483|NCT01258101|470558443|FG002|Overall Study|Adverse Event|0|||
130708484|NCT01258101|470558444|FG003|Overall Study|Adverse Event|0|||
130708485|NCT01258101|470558441|FG000|Overall Study|Extra exclusion criterion amended|2|||
130708486|NCT01258101|470558442|FG001|Overall Study|Extra exclusion criterion amended|1|||
130708487|NCT01258101|470558443|FG002|Overall Study|Extra exclusion criterion amended|1|||
130708488|NCT01258101|470558444|FG003|Overall Study|Extra exclusion criterion amended|1|||
130708489|NCT01258101|470558441|FG000|Overall Study|Informed consent has been withdrawn|2|||
130708490|NCT01258101|470558442|FG001|Overall Study|Informed consent has been withdrawn|2|||
130708491|NCT01258101|470558443|FG002|Overall Study|Informed consent has been withdrawn|1|||
130708492|NCT01258101|470558444|FG003|Overall Study|Informed consent has been withdrawn|1|||
130708493|NCT01258101|470558441|FG000|Overall Study|Patient is not able to attend visits|8|||
130708494|NCT01258101|470558442|FG001|Overall Study|Patient is not able to attend visits|9|||
130708495|NCT01258101|470558443|FG002|Overall Study|Patient is not able to attend visits|7|||
130708496|NCT01258101|470558444|FG003|Overall Study|Patient is not able to attend visits|6|||
130708497|NCT01258101|470558441|FG000|Overall Study|Patient´s compliance|4|||
130708498|NCT01258101|470558442|FG001|Overall Study|Patient´s compliance|3|||
130708499|NCT01258101|470558443|FG002|Overall Study|Patient´s compliance|1|||
130708500|NCT01258101|470558444|FG003|Overall Study|Patient´s compliance|2|||
130708501|NCT01258101|470558441|FG000|Overall Study|Lost to Follow-up|5|||
130708502|NCT01258101|470558442|FG001|Overall Study|Lost to Follow-up|5|||
130708503|NCT01258101|470558443|FG002|Overall Study|Lost to Follow-up|0|||
130708504|NCT01258101|470558444|FG003|Overall Study|Lost to Follow-up|6|||
130708505|NCT01258101|470558441|FG000|Overall Study|PCR positive at week 24|0|||
130708506|NCT01258101|470558442|FG001|Overall Study|PCR positive at week 24|0|||
130708507|NCT01258101|470558443|FG002|Overall Study|PCR positive at week 24|0|||
130708508|NCT01258101|470558444|FG003|Overall Study|PCR positive at week 24|1|||
130708509|NCT01258101|470558441|FG000|Overall Study|Other reason|7|||
130708510|NCT01258101|470558442|FG001|Overall Study|Other reason|8|||
130708511|NCT01258101|470558443|FG002|Overall Study|Other reason|1|||
130708512|NCT01258101|470558444|FG003|Overall Study|Other reason|8|||
130456515|NCT02341625|469634941|FG004|Overall Study|Participant Withdrew Consent|0|||
130456516|NCT02341625|469634942|FG005|Overall Study|Participant Withdrew Consent|0|||
130456517|NCT02341625|469634943|FG006|Overall Study|Participant Withdrew Consent|0|||
130456518|NCT02341625|469634944|FG007|Overall Study|Participant Withdrew Consent|0|||
130456519|NCT02341625|469634945|FG008|Overall Study|Participant Withdrew Consent|0|||
130456520|NCT02341625|469634946|FG009|Overall Study|Participant Withdrew Consent|0|||
130456521|NCT02341625|469634937|FG000|Overall Study|Completed Treatment as per Protocol|0|||
130456522|NCT02341625|469634938|FG001|Overall Study|Completed Treatment as per Protocol|0|||
130456523|NCT02341625|469634939|FG002|Overall Study|Completed Treatment as per Protocol|0|||
130456524|NCT02341625|469634940|FG003|Overall Study|Completed Treatment as per Protocol|0|||
130456525|NCT02341625|469634941|FG004|Overall Study|Completed Treatment as per Protocol|0|||
130708513|NCT00303667|470558446|FG000|Overall Study|Death|0|||
130554555|NCT00826111|469998023|FG001|Overall Study|Withdrawal by Subject|0|||
130708514|NCT00303667|470558447|FG001|Overall Study|Death|4|||
130708515|NCT01807117|470558448|FG000|Overall Study|Physician Decision|2|||
130708516|NCT01807117|470558448|FG000|Overall Study|Disease diagnosis not a study disease|1|||
130708517|NCT00706355|470558449|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
130708518|NCT00706355|470558450|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708519|NCT00706355|470558451|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708520|NCT00706355|470558452|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708521|NCT00706355|470558449|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
130708522|NCT00706355|470558450|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708523|NCT00706355|470558451|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708524|NCT00706355|470558452|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708525|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708526|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
130708527|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708528|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708529|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708530|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
130708531|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708532|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708533|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708534|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
130708535|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708536|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708537|NCT00706355|470558449|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708538|NCT00706355|470558450|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708539|NCT00706355|470558451|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
130708540|NCT00706355|470558452|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708541|NCT00706355|470558449|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708542|NCT00706355|470558450|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708543|NCT00706355|470558451|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
130708544|NCT00706355|470558452|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708545|NCT00706355|470558449|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708546|NCT00706355|470558450|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708547|NCT00706355|470558451|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708548|NCT00706355|470558452|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
130708549|NCT00706355|470558449|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708550|NCT00706355|470558450|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708551|NCT00706355|470558451|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708552|NCT00706355|470558452|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
130708553|NCT04179019|470558453|FG000|Overall Study|Lost to Follow-up|2|||
130708554|NCT04179019|470558453|FG000|Overall Study|Physician Decision|2|||
130708555|NCT04179019|470558453|FG000|Overall Study|Withdrawal by Subject|5|||
130708556|NCT04179019|470558453|FG000|Overall Study|Adverse Event|4|||
130708557|NCT03465436|470558454|FG000|Period 1|Protocol Violation|0|||
130708558|NCT03465436|470558455|FG001|Period 1|Protocol Violation|0|||
130708559|NCT03465436|470558456|FG002|Period 1|Protocol Violation|1|||
130708560|NCT03465436|470558457|FG003|Period 1|Protocol Violation|0|||
130708561|NCT03465436|470558454|FG000|Period 2|Protocol Violation|0|||
130708562|NCT03465436|470558455|FG001|Period 2|Protocol Violation|1|||
130708563|NCT03465436|470558456|FG002|Period 2|Protocol Violation|0|||
130708564|NCT03465436|470558457|FG003|Period 2|Protocol Violation|0|||
130708565|NCT03465436|470558454|FG000|Period 3|Protocol Violation|1|||
130708566|NCT03465436|470558455|FG001|Period 3|Protocol Violation|1|||
130708567|NCT03465436|470558456|FG002|Period 3|Protocol Violation|0|||
130708568|NCT03465436|470558457|FG003|Period 3|Protocol Violation|0|||
130708569|NCT03465436|470558454|FG000|Period 4|Protocol Violation|0|||
130708570|NCT03465436|470558455|FG001|Period 4|Protocol Violation|0|||
130708571|NCT03465436|470558456|FG002|Period 4|Protocol Violation|1|||
130708572|NCT03465436|470558457|FG003|Period 4|Protocol Violation|0|||
130708573|NCT02243293|470558458|FG000|Overall Study|Adverse Event|1|||
130708574|NCT02243293|470558459|FG001|Overall Study|Adverse Event|0|||
130708575|NCT02243293|470558460|FG002|Overall Study|Adverse Event|0|||
130708576|NCT02243293|470558461|FG003|Overall Study|Adverse Event|0|||
130456526|NCT02341625|469634942|FG005|Overall Study|Completed Treatment as per Protocol|0|||
130456527|NCT02341625|469634943|FG006|Overall Study|Completed Treatment as per Protocol|0|||
130456528|NCT02341625|469634944|FG007|Overall Study|Completed Treatment as per Protocol|0|||
130708577|NCT02243293|470558462|FG004|Overall Study|Adverse Event|0|||
130708578|NCT02243293|470558463|FG005|Overall Study|Adverse Event|0|||
130708579|NCT02243293|470558464|FG006|Overall Study|Adverse Event|0|||
130708580|NCT02243293|470558465|FG007|Overall Study|Adverse Event|0|||
130708581|NCT02243293|470558466|FG008|Overall Study|Adverse Event|0|||
130554556|NCT00826111|469998022|FG000|Overall Study|Physician Decision|1|||
130554557|NCT00826111|469998023|FG001|Overall Study|Physician Decision|1|||
130554558|NCT01672788|469998024|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
130554559|NCT01672788|469998025|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
130554560|NCT01672788|469998026|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
130554561|NCT01672788|469998027|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
130554562|NCT03511053|469998030|FG000|Overall Study|Withdrawal by Subject|1|||
130554563|NCT01128361|469998031|FG000|Overall Study|Lost to Follow-up|0|||
130554564|NCT01128361|469998032|FG001|Overall Study|Lost to Follow-up|1|||
130554565|NCT01128361|469998031|FG000|Overall Study|Withdrawal by Subject|5|||
130554566|NCT01128361|469998032|FG001|Overall Study|Withdrawal by Subject|2|||
130554567|NCT01929980|469998033|FG000|Overall Study|Physician Decision|1|||
130554568|NCT00985166|469998034|FG000|Overall Study|Lost to Follow-up|3|||
130554569|NCT00985166|469998035|FG001|Overall Study|Lost to Follow-up|2|||
130554570|NCT00985166|469998036|FG002|Overall Study|Lost to Follow-up|2|||
130554571|NCT00985166|469998034|FG000|Overall Study|Withdrawal by Subject|3|||
130554572|NCT00985166|469998035|FG001|Overall Study|Withdrawal by Subject|2|||
130554573|NCT00985166|469998036|FG002|Overall Study|Withdrawal by Subject|0|||
130554574|NCT00985166|469998034|FG000|Overall Study|Test not done|2|||
130554575|NCT00985166|469998035|FG001|Overall Study|Test not done|0|||
130554576|NCT00985166|469998036|FG002|Overall Study|Test not done|4|||
130554577|NCT00985166|469998034|FG000|Overall Study|Other|1|||
130554578|NCT00985166|469998035|FG001|Overall Study|Other|0|||
130554579|NCT00985166|469998036|FG002|Overall Study|Other|1|||
130554580|NCT01028222|469998037|FG000|Overall Study|Protocol deviation|1|||
130554581|NCT01028222|469998038|FG001|Overall Study|Protocol deviation|0|||
130554582|NCT01028222|469998037|FG000|Overall Study|Disease progression|33|||
130554583|NCT01028222|469998038|FG001|Overall Study|Disease progression|9|||
130554584|NCT01028222|469998037|FG000|Overall Study|Administrative problems|1|||
130554585|NCT01028222|469998038|FG001|Overall Study|Administrative problems|1|||
130554586|NCT01028222|469998037|FG000|Overall Study|Lost to Follow-up|0|||
130554587|NCT01028222|469998038|FG001|Overall Study|Lost to Follow-up|1|||
130554588|NCT01028222|469998037|FG000|Overall Study|Withdrawal by Subject|1|||
130554589|NCT01028222|469998038|FG001|Overall Study|Withdrawal by Subject|0|||
130554590|NCT01028222|469998037|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
130554591|NCT01028222|469998038|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
130456529|NCT02341625|469634945|FG008|Overall Study|Completed Treatment as per Protocol|0|||
130456530|NCT02341625|469634946|FG009|Overall Study|Completed Treatment as per Protocol|1|||
130456531|NCT02341625|469634937|FG000|Overall Study|Other Reasons|0|||
130456532|NCT02341625|469634938|FG001|Overall Study|Other Reasons|0|||
130456533|NCT02341625|469634939|FG002|Overall Study|Other Reasons|0|||
130456534|NCT02341625|469634940|FG003|Overall Study|Other Reasons|0|||
130456535|NCT02341625|469634941|FG004|Overall Study|Other Reasons|1|||
130456536|NCT02341625|469634942|FG005|Overall Study|Other Reasons|0|||
130456537|NCT02341625|469634943|FG006|Overall Study|Other Reasons|5|||
130456538|NCT02341625|469634944|FG007|Overall Study|Other Reasons|0|||
130456539|NCT02341625|469634945|FG008|Overall Study|Other Reasons|0|||
130456540|NCT02341625|469634946|FG009|Overall Study|Other Reasons|2|||
130456541|NCT02341625|469634937|FG000|Overall Study|Not Reported|0|||
130456542|NCT02341625|469634938|FG001|Overall Study|Not Reported|0|||
130456543|NCT02341625|469634939|FG002|Overall Study|Not Reported|0|||
130456544|NCT02341625|469634940|FG003|Overall Study|Not Reported|0|||
130456545|NCT02341625|469634941|FG004|Overall Study|Not Reported|0|||
130456546|NCT02341625|469634942|FG005|Overall Study|Not Reported|0|||
130456547|NCT02341625|469634943|FG006|Overall Study|Not Reported|0|||
130554592|NCT01028222|469998037|FG000|Overall Study|Adverse Event|2|||
130554593|NCT01028222|469998038|FG001|Overall Study|Adverse Event|0|||
130708582|NCT02243293|470558467|FG009|Overall Study|Adverse Event|0|||
130708583|NCT02243293|470558468|FG010|Overall Study|Adverse Event|0|||
130708584|NCT02243293|470558469|FG011|Overall Study|Adverse Event|0|||
130708585|NCT02243293|470558470|FG012|Overall Study|Adverse Event|0|||
130708586|NCT02243293|470558471|FG013|Overall Study|Adverse Event|0|||
130708587|NCT02243293|470558472|FG014|Overall Study|Adverse Event|0|||
130456548|NCT02341625|469634944|FG007|Overall Study|Not Reported|0|||
130456549|NCT02341625|469634945|FG008|Overall Study|Not Reported|0|||
130708588|NCT02243293|470558473|FG015|Overall Study|Adverse Event|1|||
130456550|NCT02341625|469634946|FG009|Overall Study|Not Reported|3|||
130456551|NCT01726023|469634951|FG000|Overall Study|Death|1|||
130554594|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
130554595|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
130554596|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
130554597|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
130554598|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
130708589|NCT02243293|470558474|FG016|Overall Study|Adverse Event|0|||
130708590|NCT02243293|470558475|FG017|Overall Study|Adverse Event|0|||
130456552|NCT01726023|469634952|FG001|Overall Study|Death|1|||
130708591|NCT02243293|470558476|FG018|Overall Study|Adverse Event|0|||
130456553|NCT01726023|469634951|FG000|Overall Study|Lost to Follow-up|5|||
130456554|NCT01726023|469634952|FG001|Overall Study|Lost to Follow-up|10|||
130708592|NCT02243293|470558477|FG019|Overall Study|Adverse Event|0|||
130708593|NCT02243293|470558478|FG020|Overall Study|Adverse Event|1|||
130708594|NCT02243293|470558479|FG021|Overall Study|Adverse Event|0|||
130708595|NCT02243293|470558458|FG000|Overall Study|Withdrawal by Subject|1|||
130708596|NCT02243293|470558459|FG001|Overall Study|Withdrawal by Subject|0|||
130708597|NCT02243293|470558460|FG002|Overall Study|Withdrawal by Subject|0|||
130708598|NCT02243293|470558461|FG003|Overall Study|Withdrawal by Subject|0|||
130708599|NCT02243293|470558462|FG004|Overall Study|Withdrawal by Subject|0|||
130708600|NCT02243293|470558463|FG005|Overall Study|Withdrawal by Subject|0|||
130708601|NCT02243293|470558464|FG006|Overall Study|Withdrawal by Subject|0|||
130708602|NCT02243293|470558465|FG007|Overall Study|Withdrawal by Subject|0|||
130708603|NCT02243293|470558466|FG008|Overall Study|Withdrawal by Subject|0|||
130708604|NCT02243293|470558467|FG009|Overall Study|Withdrawal by Subject|1|||
130708605|NCT02243293|470558468|FG010|Overall Study|Withdrawal by Subject|0|||
130708606|NCT02243293|470558469|FG011|Overall Study|Withdrawal by Subject|1|||
130708607|NCT02243293|470558470|FG012|Overall Study|Withdrawal by Subject|0|||
130708608|NCT02243293|470558471|FG013|Overall Study|Withdrawal by Subject|0|||
130708609|NCT02243293|470558472|FG014|Overall Study|Withdrawal by Subject|0|||
130708610|NCT02243293|470558473|FG015|Overall Study|Withdrawal by Subject|0|||
130708611|NCT02243293|470558474|FG016|Overall Study|Withdrawal by Subject|0|||
130708612|NCT02243293|470558475|FG017|Overall Study|Withdrawal by Subject|0|||
130708613|NCT02243293|470558476|FG018|Overall Study|Withdrawal by Subject|0|||
130708614|NCT02243293|470558477|FG019|Overall Study|Withdrawal by Subject|0|||
130708615|NCT02243293|470558478|FG020|Overall Study|Withdrawal by Subject|0|||
130708616|NCT02243293|470558479|FG021|Overall Study|Withdrawal by Subject|1|||
130708617|NCT02243293|470558458|FG000|Overall Study|Lost to Follow-up|0|||
130708618|NCT02243293|470558459|FG001|Overall Study|Lost to Follow-up|1|||
130708619|NCT02243293|470558460|FG002|Overall Study|Lost to Follow-up|1|||
130708620|NCT02243293|470558461|FG003|Overall Study|Lost to Follow-up|1|||
130708621|NCT02243293|470558462|FG004|Overall Study|Lost to Follow-up|0|||
130708622|NCT02243293|470558463|FG005|Overall Study|Lost to Follow-up|0|||
130708623|NCT02243293|470558464|FG006|Overall Study|Lost to Follow-up|3|||
130708624|NCT02243293|470558465|FG007|Overall Study|Lost to Follow-up|0|||
130708625|NCT02243293|470558466|FG008|Overall Study|Lost to Follow-up|0|||
130708626|NCT02243293|470558467|FG009|Overall Study|Lost to Follow-up|0|||
130708627|NCT02243293|470558468|FG010|Overall Study|Lost to Follow-up|0|||
130708628|NCT02243293|470558469|FG011|Overall Study|Lost to Follow-up|2|||
130708629|NCT02243293|470558470|FG012|Overall Study|Lost to Follow-up|0|||
130708630|NCT02243293|470558471|FG013|Overall Study|Lost to Follow-up|0|||
130708631|NCT02243293|470558472|FG014|Overall Study|Lost to Follow-up|0|||
130456555|NCT01726023|469634951|FG000|Overall Study|Other Eligibility criteria|7|||
130456556|NCT01726023|469634952|FG001|Overall Study|Other Eligibility criteria|7|||
130456557|NCT01726023|469634951|FG000|Overall Study|Withdrawal by Subject|16|||
130456558|NCT01726023|469634952|FG001|Overall Study|Withdrawal by Subject|8|||
130456559|NCT03227757|469636233|FG000|Overall Study|Death|25|||
130456560|NCT03227757|469636233|FG000|Overall Study|Withdrawal|10|||
130456561|NCT03227757|469636233|FG000|Overall Study|Missed visits|1|||
130456562|NCT03227757|469636233|FG000|Overall Study|Lost to Follow-up|2|||
130456563|NCT02960659|469636234|FG000|Overall Study|Withdrawal by Subject|1|||
130456564|NCT02960659|469636235|FG001|Overall Study|Withdrawal by Subject|0|||
130456565|NCT02960659|469636234|FG000|Overall Study|Poor compliance|0|||
130456566|NCT02960659|469636235|FG001|Overall Study|Poor compliance|1|||
130456567|NCT01645111|469636237|FG000|Overall Study|Did not require Clevidipine|15|||
130456568|NCT03068468|469636243|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
130456569|NCT03068468|469636244|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
130456570|NCT03068468|469636245|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
130456571|NCT03068468|469636246|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
130456572|NCT03068468|469636243|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
130456573|NCT03068468|469636244|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
130708632|NCT02243293|470558473|FG015|Overall Study|Lost to Follow-up|0|||
130456574|NCT03068468|469636245|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
130708633|NCT02243293|470558474|FG016|Overall Study|Lost to Follow-up|3|||
130456575|NCT03068468|469636246|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
130456576|NCT03068468|469636243|FG000|Placebo-Controlled Period|Adverse Event|16|||
130456577|NCT03068468|469636244|FG001|Placebo-Controlled Period|Adverse Event|21|||
130708634|NCT02243293|470558475|FG017|Overall Study|Lost to Follow-up|1|||
130708635|NCT02243293|470558476|FG018|Overall Study|Lost to Follow-up|0|||
130708636|NCT02243293|470558477|FG019|Overall Study|Lost to Follow-up|0|||
130708637|NCT02243293|470558478|FG020|Overall Study|Lost to Follow-up|1|||
130708638|NCT02243293|470558479|FG021|Overall Study|Lost to Follow-up|2|||
130708639|NCT02243293|470558458|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
130708640|NCT02243293|470558459|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
130456578|NCT03068468|469636245|FG002|Placebo-Controlled Period|Adverse Event|0|||
130456579|NCT03068468|469636246|FG003|Placebo-Controlled Period|Adverse Event|0|||
130456580|NCT03068468|469636243|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
130708641|NCT02243293|470558460|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
130456581|NCT03068468|469636244|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
130456582|NCT03068468|469636245|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
130456583|NCT03068468|469636246|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
130456584|NCT03068468|469636243|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
130456585|NCT03068468|469636244|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
130456586|NCT03068468|469636245|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130456587|NCT03068468|469636246|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130456588|NCT03068468|469636243|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
130456589|NCT03068468|469636244|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
130456590|NCT03068468|469636245|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
130456591|NCT03068468|469636246|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
130456592|NCT03068468|469636243|FG000|Placebo-Controlled Period|Death|0|||
130456593|NCT03068468|469636244|FG001|Placebo-Controlled Period|Death|1|||
130456594|NCT03068468|469636245|FG002|Placebo-Controlled Period|Death|0|||
130456595|NCT03068468|469636246|FG003|Placebo-Controlled Period|Death|0|||
130456596|NCT03068468|469636243|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
130456597|NCT03068468|469636244|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
130456598|NCT03068468|469636245|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
130456599|NCT03068468|469636246|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
130456600|NCT03068468|469636243|FG000|Open-Label Extension Period|Adverse Event|0|||
130456601|NCT03068468|469636244|FG001|Open-Label Extension Period|Adverse Event|0|||
130456602|NCT03068468|469636245|FG002|Open-Label Extension Period|Adverse Event|13|||
130456603|NCT03068468|469636246|FG003|Open-Label Extension Period|Adverse Event|17|||
130456604|NCT03068468|469636243|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
130456605|NCT03068468|469636244|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
130456606|NCT03068468|469636245|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
130456607|NCT03068468|469636246|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
130456608|NCT03068468|469636243|FG000|Open-Label Extension Period|Death|0|||
130456609|NCT03068468|469636244|FG001|Open-Label Extension Period|Death|0|||
130456610|NCT03068468|469636245|FG002|Open-Label Extension Period|Death|0|||
130456611|NCT03068468|469636246|FG003|Open-Label Extension Period|Death|1|||
130456612|NCT03068468|469636243|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
130456613|NCT03068468|469636244|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
130456614|NCT03068468|469636245|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
130456615|NCT03068468|469636246|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
130456616|NCT03068468|469636243|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
130456617|NCT03068468|469636244|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
130456618|NCT03068468|469636245|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
130456619|NCT03068468|469636246|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
130456620|NCT03068468|469636243|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
130456621|NCT03068468|469636244|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
130456622|NCT03068468|469636245|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
130456623|NCT03068468|469636246|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
130456624|NCT03068468|469636243|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
130456625|NCT03068468|469636244|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
130456626|NCT03068468|469636245|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
130456627|NCT03068468|469636246|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
130456628|NCT03068468|469636243|FG000|Open-Label Extension Period|Reason not Specified|0|||
130456629|NCT03068468|469636244|FG001|Open-Label Extension Period|Reason not Specified|0|||
130456630|NCT03068468|469636245|FG002|Open-Label Extension Period|Reason not Specified|1|||
130456631|NCT03068468|469636246|FG003|Open-Label Extension Period|Reason not Specified|4|||
130456632|NCT01062126|469636248|FG000|Overall Study|Death|209|||
130456633|NCT01062126|469636248|FG000|Overall Study|All Withdrawals|324|||
130456634|NCT00646451|469636249|FG000|Overall Study|Adverse Event|3|||
130456635|NCT00646451|469636250|FG001|Overall Study|Adverse Event|0|||
130456636|NCT00646451|469636249|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
130456637|NCT00646451|469636250|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
130456638|NCT01249092|469636254|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
130456639|NCT01249092|469636254|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
130456640|NCT00486759|469636255|FG000|Treatment|Adverse event/intercurrent illness|86|||
130456641|NCT00486759|469636256|FG001|Treatment|Adverse event/intercurrent illness|39|||
130456642|NCT00486759|469636255|FG000|Treatment|Insufficient therapeutic response|37|||
130456643|NCT00486759|469636256|FG001|Treatment|Insufficient therapeutic response|39|||
130456644|NCT00486759|469636255|FG000|Treatment|Death|17|||
130456645|NCT00486759|469636256|FG001|Treatment|Death|10|||
130456646|NCT00486759|469636255|FG000|Treatment|Withdrew consent|15|||
130456647|NCT00486759|469636256|FG001|Treatment|Withdrew consent|12|||
130456648|NCT00486759|469636255|FG000|Treatment|Administrative/reason not specified|17|||
130456649|NCT00486759|469636256|FG001|Treatment|Administrative/reason not specified|21|||
130456650|NCT00486759|469636255|FG000|Treatment|Refused treatment|10|||
130456651|NCT00486759|469636256|FG001|Treatment|Refused treatment|7|||
130708642|NCT02243293|470558461|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
130456652|NCT00486759|469636255|FG000|Treatment|Violation of selection criteria at entry|3|||
130456653|NCT00486759|469636256|FG001|Treatment|Violation of selection criteria at entry|3|||
130456654|NCT00486759|469636255|FG000|Treatment|Other protocol violation|1|||
130456655|NCT00486759|469636256|FG001|Treatment|Other protocol violation|5|||
130456656|NCT00486759|469636255|FG000|Treatment|Failure to return|1|||
130456657|NCT00486759|469636256|FG001|Treatment|Failure to return|1|||
130456658|NCT00486759|469636255|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
130456659|NCT00486759|469636256|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
130456660|NCT00486759|469636255|FG000|Safety Follow-up|Death|40|||
130456661|NCT00486759|469636256|FG001|Safety Follow-up|Death|29|||
130456662|NCT00486759|469636255|FG000|Safety Follow-up|Withdrew consent|32|||
130456663|NCT00486759|469636256|FG001|Safety Follow-up|Withdrew consent|23|||
130456664|NCT00486759|469636255|FG000|Safety Follow-up|Failure to return|9|||
130456665|NCT00486759|469636256|FG001|Safety Follow-up|Failure to return|6|||
130456666|NCT00486759|469636255|FG000|Safety Follow-up|Administrative/not specified|8|||
130456667|NCT00486759|469636256|FG001|Safety Follow-up|Administrative/not specified|6|||
130456668|NCT00486759|469636255|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
130456669|NCT00486759|469636256|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
130456670|NCT00486759|469636255|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
130456671|NCT00486759|469636256|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
130456672|NCT02715258|469636257|FG000|Overall Study|Withdrawal by Subject|6|||
130708643|NCT02243293|470558462|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
130708644|NCT02243293|470558463|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
130456673|NCT02715258|469636258|FG001|Overall Study|Withdrawal by Subject|1|||
130456674|NCT02715258|469636257|FG000|Overall Study|Lost to Follow-up|7|||
130456675|NCT02715258|469636258|FG001|Overall Study|Lost to Follow-up|1|||
130456676|NCT02715258|469636257|FG000|Overall Study|Terminated by Sponsor|0|||
130456677|NCT02715258|469636258|FG001|Overall Study|Terminated by Sponsor|1|||
130456678|NCT02715258|469636257|FG000|Overall Study|Death|0|||
130456679|NCT02715258|469636258|FG001|Overall Study|Death|1|||
130456680|NCT02715258|469636257|FG000|Overall Study|Subject non-compliant|1|||
130456681|NCT02715258|469636258|FG001|Overall Study|Subject non-compliant|1|||
130456682|NCT02715258|469636257|FG000|Overall Study|GCP violation|2|||
130456683|NCT02715258|469636258|FG001|Overall Study|GCP violation|1|||
130456684|NCT02814643|469636259|FG000|Overall Study|Lost to Follow-up|0|||
130456685|NCT02814643|469636260|FG001|Overall Study|Lost to Follow-up|1|||
130456686|NCT02814643|469636259|FG000|Overall Study|Withdrawal by Subject|1|||
130456687|NCT02814643|469636260|FG001|Overall Study|Withdrawal by Subject|2|||
130456688|NCT02263508|469636261|FG000|Overall Study|Withdrawal by Subject|1|||
130456689|NCT02263508|469636262|FG001|Overall Study|Withdrawal by Subject|23|||
130456690|NCT02263508|469636263|FG002|Overall Study|Withdrawal by Subject|17|||
130456691|NCT02263508|469636261|FG000|Overall Study|Sponsor Decision|12|||
130456692|NCT02263508|469636262|FG001|Overall Study|Sponsor Decision|165|||
130456693|NCT02263508|469636263|FG002|Overall Study|Sponsor Decision|182|||
130456694|NCT02263508|469636261|FG000|Overall Study|Lost to Follow-up|2|||
130456695|NCT02263508|469636262|FG001|Overall Study|Lost to Follow-up|7|||
130456696|NCT02263508|469636263|FG002|Overall Study|Lost to Follow-up|7|||
130456697|NCT02263508|469636261|FG000|Overall Study|Death|6|||
130456698|NCT02263508|469636262|FG001|Overall Study|Death|151|||
130456699|NCT02263508|469636263|FG002|Overall Study|Death|140|||
130456700|NCT03265210|469636266|FG000|Overall Study|Withdrawal by Subject|7|||
130456701|NCT03265210|469636267|FG001|Overall Study|Withdrawal by Subject|9|||
130456702|NCT03265210|469636266|FG000|Overall Study|Lost to Follow-up|2|||
130456703|NCT03265210|469636267|FG001|Overall Study|Lost to Follow-up|0|||
130456704|NCT03265210|469636266|FG000|Overall Study|Physician Decision|2|||
130456705|NCT03265210|469636267|FG001|Overall Study|Physician Decision|0|||
130456706|NCT03265210|469636266|FG000|Overall Study|Adverse Event|1|||
130456707|NCT03265210|469636267|FG001|Overall Study|Adverse Event|0|||
130456708|NCT00686517|469636268|FG000|Treatment|Serious Adverse Event|1|||
130456709|NCT00686517|469636269|FG001|Treatment|Serious Adverse Event|2|||
130456710|NCT00686517|469636270|FG002|Treatment|Serious Adverse Event|1|||
130554599|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
130708645|NCT02243293|470558464|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
130456711|NCT00686517|469636268|FG000|Treatment|Adverse Event|2|||
130456712|NCT00686517|469636269|FG001|Treatment|Adverse Event|0|||
130456713|NCT00686517|469636270|FG002|Treatment|Adverse Event|0|||
130456714|NCT00686517|469636268|FG000|Treatment|Poor Protocol Compliance|1|||
130456715|NCT00686517|469636269|FG001|Treatment|Poor Protocol Compliance|0|||
130456716|NCT00686517|469636270|FG002|Treatment|Poor Protocol Compliance|0|||
130456717|NCT00686517|469636268|FG000|Treatment|Protocol Violation|2|||
130456718|NCT00686517|469636269|FG001|Treatment|Protocol Violation|1|||
130456719|NCT00686517|469636270|FG002|Treatment|Protocol Violation|0|||
130456720|NCT02281318|469636271|FG000|Overall Study|Adverse Event|2|||
130456721|NCT02281318|469636272|FG001|Overall Study|Adverse Event|2|||
130456722|NCT02281318|469636271|FG000|Overall Study|Lack of Efficacy|2|||
130456723|NCT02281318|469636272|FG001|Overall Study|Lack of Efficacy|0|||
130708646|NCT02243293|470558465|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
130708647|NCT02243293|470558466|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
130708648|NCT02243293|470558467|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
130708649|NCT02243293|470558468|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
130708650|NCT02243293|470558469|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
130708651|NCT02243293|470558470|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
130708652|NCT02243293|470558471|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
130708653|NCT02243293|470558472|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
130708654|NCT02243293|470558473|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
130708655|NCT02243293|470558474|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
130708656|NCT02243293|470558475|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
130708657|NCT02243293|470558476|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
130708658|NCT02243293|470558477|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
130708659|NCT02243293|470558478|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
130708660|NCT02243293|470558479|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
130708661|NCT02243293|470558458|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
130708662|NCT02243293|470558459|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
130708663|NCT02243293|470558460|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
130708664|NCT02243293|470558461|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
130708665|NCT02243293|470558462|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
130708666|NCT02243293|470558463|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
130708667|NCT02243293|470558464|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
130708668|NCT02243293|470558465|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
130708669|NCT02243293|470558466|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
130708670|NCT02243293|470558467|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
130708671|NCT02243293|470558468|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
130708672|NCT02243293|470558469|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
130708673|NCT02243293|470558470|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
130708674|NCT02243293|470558471|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
130708675|NCT02243293|470558472|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
130708676|NCT02243293|470558473|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
130708677|NCT02243293|470558474|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
130708678|NCT02243293|470558475|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
130708679|NCT02243293|470558476|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
130708680|NCT02243293|470558477|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
130708681|NCT02243293|470558478|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
130708682|NCT02243293|470558479|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
130720876|NCT03275064|470601552|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
130720877|NCT03275064|470601553|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720878|NCT03275064|470601554|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720879|NCT03275064|470601555|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720880|NCT03275064|470601556|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720881|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
130720882|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130720883|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
130720884|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130720885|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
130720886|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720887|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720888|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720889|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
130720890|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720891|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130720892|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130720893|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130720894|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130720895|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130367194|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
130720896|NCT01341782|470601557|FG000|Overall Study|Adverse Event|1|||
130720897|NCT01341782|470601558|FG001|Overall Study|Adverse Event|1|||
130720898|NCT01341782|470601557|FG000|Overall Study|Withdrawal by Subject|6|||
130367195|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
130273639|NCT00412958|468965617|FG000|Overall Study|Death|0|||
130273640|NCT00412958|468965618|FG001|Overall Study|Death|1|||
130273641|NCT00412958|468965619|FG002|Overall Study|Death|0|||
130273642|NCT00412958|468965620|FG003|Overall Study|Death|0|||
130273643|NCT00412958|468965617|FG000|Overall Study|Transport issue|0|||
130554600|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
130554601|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
130554602|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
130554603|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
130554604|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
130554605|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
130554606|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Death|3|||
130554607|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Death|1|||
130708683|NCT01475253|470560446|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
130708684|NCT01475253|470560447|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
130708685|NCT01475253|470560448|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
130708686|NCT01475253|470560449|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
130708687|NCT01475253|470560446|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
130708688|NCT01475253|470560447|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
130708689|NCT01475253|470560448|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
130708690|NCT01475253|470560449|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
130708691|NCT03135899|470560450|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708692|NCT03135899|470560451|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708693|NCT03135899|470560452|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708694|NCT03135899|470560453|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708695|NCT03135899|470560454|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708696|NCT03135899|470560455|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708697|NCT03135899|470560456|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
130708698|NCT03135899|470560457|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708699|NCT03135899|470560450|FG000|Overall Study|Withdrawal by Subject|0|||
130708700|NCT03135899|470560451|FG001|Overall Study|Withdrawal by Subject|0|||
130708701|NCT03135899|470560452|FG002|Overall Study|Withdrawal by Subject|0|||
130708702|NCT03135899|470560453|FG003|Overall Study|Withdrawal by Subject|0|||
130708703|NCT03135899|470560454|FG004|Overall Study|Withdrawal by Subject|0|||
130708704|NCT03135899|470560455|FG005|Overall Study|Withdrawal by Subject|2|||
130708705|NCT03135899|470560456|FG006|Overall Study|Withdrawal by Subject|0|||
130708706|NCT03135899|470560457|FG007|Overall Study|Withdrawal by Subject|0|||
130708707|NCT00856830|470560462|FG000|Irinotecan & Bendamustine|Death|0|||
130708708|NCT00856830|470560463|FG001|Irinotecan & Bendamustine|Death|0|||
130708709|NCT00856830|470560464|FG002|Irinotecan & Bendamustine|Death|0|||
130708710|NCT00856830|470560465|FG003|Irinotecan & Bendamustine|Death|2|||
130708711|NCT00856830|470560462|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
130708712|NCT00856830|470560463|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
130708713|NCT00856830|470560464|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
130708714|NCT00856830|470560465|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
130708715|NCT01744093|470560466|FG000|Overall Study|Withdrawal by Subject|6|||
130708716|NCT01744093|470560467|FG001|Overall Study|Withdrawal by Subject|1|||
130708717|NCT01570283|470560468|FG000|Cohort 1: Dose Level 1|Death|0|||
130708718|NCT01570283|470560469|FG001|Cohort 1: Dose Level 1|Death|1|||
130708719|NCT01570283|470560470|FG002|Cohort 1: Dose Level 1|Death|0|||
130708720|NCT01570283|470560471|FG003|Cohort 1: Dose Level 1|Death|0|||
130708721|NCT01570283|470560472|FG004|Cohort 1: Dose Level 1|Death|0|||
130708722|NCT01570283|470560473|FG005|Cohort 1: Dose Level 1|Death|0|||
130708723|NCT01570283|470560468|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708724|NCT01570283|470560469|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
130708725|NCT01570283|470560470|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708726|NCT01570283|470560471|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708727|NCT01570283|470560472|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708728|NCT01570283|470560473|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130554608|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
130708729|NCT01570283|470560468|FG000|Cohort 2: Dose Level 2|Death|0|||
130708730|NCT01570283|470560469|FG001|Cohort 2: Dose Level 2|Death|0|||
130708731|NCT01570283|470560470|FG002|Cohort 2: Dose Level 2|Death|1|||
130708732|NCT01570283|470560471|FG003|Cohort 2: Dose Level 2|Death|0|||
130708733|NCT01570283|470560472|FG004|Cohort 2: Dose Level 2|Death|0|||
130708734|NCT01570283|470560473|FG005|Cohort 2: Dose Level 2|Death|0|||
130708735|NCT01570283|470560468|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708736|NCT01570283|470560469|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708737|NCT01570283|470560470|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708738|NCT01570283|470560471|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
130273644|NCT00412958|468965618|FG001|Overall Study|Transport issue|1|||
130708739|NCT01570283|470560472|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708740|NCT01570283|470560473|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708741|NCT01570283|470560468|FG000|Cohort 3: Dose Level 3|Death|0|||
130273645|NCT00412958|468965619|FG002|Overall Study|Transport issue|0|||
130273646|NCT00412958|468965620|FG003|Overall Study|Transport issue|0|||
130554609|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
130554610|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Adverse Event|7|||
130554611|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Adverse Event|8|||
130554612|NCT03236246|469998041|FG000|24-Week Dose Titration Period|Captured as Other|1|||
130554613|NCT03236246|469998042|FG001|24-Week Dose Titration Period|Captured as Other|2|||
130554614|NCT03236246|469998041|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
130554615|NCT03236246|469998042|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
130554616|NCT03236246|469998041|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
130554617|NCT03236246|469998042|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
130554618|NCT03236246|469998041|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
130554619|NCT03236246|469998042|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
130554620|NCT03236246|469998041|FG000|24-Week Dose Maintenance Period|Death|0|||
130554621|NCT03236246|469998042|FG001|24-Week Dose Maintenance Period|Death|1|||
130554622|NCT03236246|469998041|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
130554623|NCT03236246|469998042|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
130554624|NCT04263909|469998043|FG000|Overall Study|Physician Decision|1|||
130554625|NCT04263909|469998044|FG001|Overall Study|Physician Decision|0|||
130554626|NCT04263909|469998045|FG002|Overall Study|Physician Decision|0|||
130554627|NCT04263909|469998043|FG000|Overall Study|Adverse Event|3|||
130554628|NCT04263909|469998044|FG001|Overall Study|Adverse Event|0|||
130708742|NCT01570283|470560469|FG001|Cohort 3: Dose Level 3|Death|0|||
130708743|NCT01570283|470560470|FG002|Cohort 3: Dose Level 3|Death|0|||
130708744|NCT01570283|470560471|FG003|Cohort 3: Dose Level 3|Death|0|||
130708745|NCT01570283|470560472|FG004|Cohort 3: Dose Level 3|Death|0|||
130708746|NCT01570283|470560473|FG005|Cohort 3: Dose Level 3|Death|1|||
130708747|NCT01570283|470560468|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708748|NCT01570283|470560469|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708749|NCT01570283|470560470|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708750|NCT01570283|470560471|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708751|NCT01570283|470560472|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708752|NCT01570283|470560473|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
130708753|NCT03028740|470560476|FG000|Overall Study|Did not Receive Study Drug|4|||
130708754|NCT03028740|470560477|FG001|Overall Study|Did not Receive Study Drug|5|||
130708755|NCT03028740|470560476|FG000|Overall Study|Adverse Event|8|||
130708756|NCT03028740|470560477|FG001|Overall Study|Adverse Event|26|||
130708757|NCT03028740|470560476|FG000|Overall Study|Lack of Efficacy|0|||
130708758|NCT03028740|470560477|FG001|Overall Study|Lack of Efficacy|1|||
130708759|NCT03028740|470560476|FG000|Overall Study|Withdrawal by Subject|48|||
130708760|NCT03028740|470560477|FG001|Overall Study|Withdrawal by Subject|101|||
130708761|NCT03028740|470560476|FG000|Overall Study|Lost to Follow-up|30|||
130708762|NCT03028740|470560477|FG001|Overall Study|Lost to Follow-up|54|||
130708763|NCT03028740|470560476|FG000|Overall Study|Physician Decision|4|||
130708764|NCT03028740|470560477|FG001|Overall Study|Physician Decision|11|||
130708765|NCT03028740|470560476|FG000|Overall Study|Protocol Violation|4|||
130708766|NCT03028740|470560477|FG001|Overall Study|Protocol Violation|8|||
130708767|NCT03028740|470560476|FG000|Overall Study|Non-compliance with Study Drug|0|||
130708768|NCT03028740|470560477|FG001|Overall Study|Non-compliance with Study Drug|2|||
130708769|NCT03028740|470560476|FG000|Overall Study|Study Terminated by Sponsor|467|||
130708770|NCT03028740|470560477|FG001|Overall Study|Study Terminated by Sponsor|917|||
130708771|NCT03028740|470560476|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
130708772|NCT03028740|470560477|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
130708773|NCT03028740|470560476|FG000|Overall Study|Reason not Specified|1|||
130708774|NCT03028740|470560477|FG001|Overall Study|Reason not Specified|5|||
130708775|NCT00685802|470560483|FG000|Washout Period of 7 Days|Protocol Violation|2|||
130708776|NCT00685802|470560484|FG001|Washout Period of 7 Days|Protocol Violation|0|||
130708777|NCT00685802|470560483|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130708778|NCT00685802|470560484|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130708779|NCT03336242|470560488|FG000|Overall Study|Adverse Event|0|||
130708780|NCT03336242|470560489|FG001|Overall Study|Adverse Event|1|||
130708781|NCT02224573|470560492|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
130554629|NCT04263909|469998045|FG002|Overall Study|Adverse Event|0|||
130708782|NCT02224573|470560493|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
130708783|NCT02224573|470560492|FG000|Treatment Phase|Started on Other IMP|1|||
130708784|NCT02224573|470560493|FG001|Treatment Phase|Started on Other IMP|0|||
130708785|NCT02224573|470560492|FG000|Treatment Phase|Participant Discontinued IMP|0|||
130708786|NCT02224573|470560493|FG001|Treatment Phase|Participant Discontinued IMP|1|||
130708787|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficacy|15|||
130708788|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficacy|8|||
130708789|NCT02224573|470560492|FG000|Treatment Phase|Began Commercial Product|1|||
130273647|NCT01703091|468965631|FG000|Overall Study|Adverse Event|5|||
130554630|NCT04263909|469998043|FG000|Overall Study|Protocol Violation|5|||
130554631|NCT04263909|469998044|FG001|Overall Study|Protocol Violation|0|||
130708790|NCT02224573|470560493|FG001|Treatment Phase|Began Commercial Product|0|||
130708791|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130708792|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130708793|NCT02224573|470560492|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
130708794|NCT02224573|470560493|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
130708795|NCT02224573|470560492|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
130708796|NCT02224573|470560493|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
130708797|NCT02224573|470560492|FG000|Treatment Phase|Continued Compassionate Use|1|||
130708798|NCT02224573|470560493|FG001|Treatment Phase|Continued Compassionate Use|0|||
130708799|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficiency|2|||
130708800|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficiency|1|||
130708801|NCT02224573|470560492|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
130708802|NCT02224573|470560493|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
130708803|NCT02224573|470560492|FG000|Treatment Phase|Participant Moved|2|||
130708804|NCT02224573|470560493|FG001|Treatment Phase|Participant Moved|0|||
130708805|NCT02224573|470560492|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
130708806|NCT02224573|470560493|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
130708807|NCT02224573|470560492|FG000|Treatment Phase|Refused Medication|1|||
130708808|NCT02224573|470560493|FG001|Treatment Phase|Refused Medication|1|||
130708809|NCT02224573|470560492|FG000|Treatment Phase|Adverse Event|26|||
130708810|NCT02224573|470560493|FG001|Treatment Phase|Adverse Event|38|||
130708811|NCT02224573|470560492|FG000|Treatment Phase|Placed in Group Home|0|||
130708812|NCT02224573|470560493|FG001|Treatment Phase|Placed in Group Home|1|||
130708813|NCT02224573|470560492|FG000|Treatment Phase|Pursued Other Trials|1|||
130708814|NCT02224573|470560493|FG001|Treatment Phase|Pursued Other Trials|0|||
130708815|NCT02224573|470560492|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
130708816|NCT02224573|470560493|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
130708817|NCT02224573|470560492|FG000|Treatment Phase|Lost to Follow-up|2|||
130273648|NCT01703091|468965632|FG001|Overall Study|Adverse Event|3|||
130273649|NCT01703091|468965631|FG000|Overall Study|Physician Decision|2|||
130273650|NCT01703091|468965632|FG001|Overall Study|Physician Decision|1|||
130273651|NCT01703091|468965631|FG000|Overall Study|Withdrawal by Subject|1|||
130273652|NCT01703091|468965632|FG001|Overall Study|Withdrawal by Subject|0|||
130273653|NCT01703091|468965631|FG000|Overall Study|Sponsor Decision|1|||
130273654|NCT01703091|468965632|FG001|Overall Study|Sponsor Decision|0|||
130273655|NCT02819297|468965638|FG000|Overall Study|Withdrawal by Subject|25|||
130273656|NCT02819297|468965639|FG001|Overall Study|Withdrawal by Subject|13|||
130273657|NCT02819297|468965638|FG000|Overall Study|Lost to Follow-up|12|||
130273658|NCT02819297|468965639|FG001|Overall Study|Lost to Follow-up|14|||
130273659|NCT02819297|468965638|FG000|Overall Study|Adverse Event|12|||
130273660|NCT02819297|468965639|FG001|Overall Study|Adverse Event|10|||
130273661|NCT02819297|468965638|FG000|Overall Study|Physician Decision|5|||
130273662|NCT02819297|468965639|FG001|Overall Study|Physician Decision|5|||
130273663|NCT02819297|468965638|FG000|Overall Study|Lack of Efficacy|5|||
130273664|NCT02819297|468965639|FG001|Overall Study|Lack of Efficacy|8|||
130273665|NCT02819297|468965638|FG000|Overall Study|Protocol Violation|1|||
130273666|NCT02819297|468965639|FG001|Overall Study|Protocol Violation|2|||
130273667|NCT02858440|468965640|FG000|Overall Study|Lost to Follow-up|3|||
130273668|NCT02858440|468965640|FG000|Overall Study|Protocol Violation|2|||
130273669|NCT02858440|468965640|FG000|Overall Study|Consent withdrawal|3|||
130273670|NCT02858440|468965640|FG000|Overall Study|Migrated/moved from study area|4|||
130273671|NCT01670279|468965641|FG000|Overall Study|Adverse Event|0|||
130273672|NCT01670279|468965642|FG001|Overall Study|Adverse Event|1|||
130273673|NCT01670279|468965643|FG002|Overall Study|Adverse Event|0|||
130273674|NCT01670279|468965644|FG003|Overall Study|Adverse Event|0|||
130273675|NCT01670279|468965641|FG000|Overall Study|Physician Decision|0|||
130273676|NCT01670279|468965642|FG001|Overall Study|Physician Decision|1|||
130273677|NCT01670279|468965643|FG002|Overall Study|Physician Decision|0|||
130367196|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
130367197|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
130367198|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
130367199|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
130367200|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
130367201|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
130367202|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
130708818|NCT02224573|470560493|FG001|Treatment Phase|Lost to Follow-up|1|||
130708819|NCT02224573|470560492|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
130708820|NCT02224573|470560493|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
130708821|NCT02224573|470560492|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
130708822|NCT02224573|470560493|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
130708823|NCT02224573|470560492|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
130708824|NCT02224573|470560493|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
130708825|NCT02224573|470560492|FG000|Taper Phase|Adverse Event|1|||
130456724|NCT02281318|469636271|FG000|Overall Study|Lost to Follow-up|2|||
130456725|NCT02281318|469636272|FG001|Overall Study|Lost to Follow-up|1|||
130456726|NCT02281318|469636271|FG000|Overall Study|Physician Decision|2|||
130456727|NCT02281318|469636272|FG001|Overall Study|Physician Decision|0|||
130456728|NCT02281318|469636271|FG000|Overall Study|Withdrawal by Subject|6|||
130456729|NCT02281318|469636272|FG001|Overall Study|Withdrawal by Subject|2|||
130456730|NCT02614560|469636275|FG000|Overall Study|Death|6|||
130456731|NCT02614560|469636276|FG001|Overall Study|Death|2|||
130273678|NCT01670279|468965644|FG003|Overall Study|Physician Decision|0|||
130273679|NCT01670279|468965641|FG000|Overall Study|Participant met withdrawal criteria|0|||
130273680|NCT01670279|468965642|FG001|Overall Study|Participant met withdrawal criteria|0|||
130273681|NCT01670279|468965643|FG002|Overall Study|Participant met withdrawal criteria|0|||
130273682|NCT01670279|468965644|FG003|Overall Study|Participant met withdrawal criteria|1|||
130273683|NCT01901614|468965645|FG000|Overall Study|Adverse Event|0|||
130273684|NCT01901614|468965646|FG001|Overall Study|Adverse Event|1|||
130273685|NCT01901614|468965645|FG000|Overall Study|Lost to Follow-up|1|||
130273686|NCT01901614|468965646|FG001|Overall Study|Lost to Follow-up|0|||
130273687|NCT01901614|468965645|FG000|Overall Study|Screen Fail|1|||
130273688|NCT01901614|468965646|FG001|Overall Study|Screen Fail|0|||
130273689|NCT01823198|468965648|FG000|Overall Study|Physician Decision|0|||
130273690|NCT01823198|468965649|FG001|Overall Study|Physician Decision|1|||
130273691|NCT01823198|468965650|FG002|Overall Study|Physician Decision|0|||
130273692|NCT01823198|468965651|FG003|Overall Study|Physician Decision|0|||
130273693|NCT01823198|468965652|FG004|Overall Study|Physician Decision|0|||
130273694|NCT01823198|468965653|FG005|Overall Study|Physician Decision|3|||
130273695|NCT01823198|468965654|FG006|Overall Study|Physician Decision|3|||
130273696|NCT01262638|468965655|FG000|Overall Study|Adverse Event|3|||
130273697|NCT01262638|468965656|FG001|Overall Study|Adverse Event|4|||
130273698|NCT01262638|468965657|FG002|Overall Study|Adverse Event|3|||
130273699|NCT01262638|468965658|FG003|Overall Study|Adverse Event|4|||
130273700|NCT01262638|468965655|FG000|Overall Study|Protocol Violation|1|||
130273701|NCT01262638|468965656|FG001|Overall Study|Protocol Violation|0|||
130273702|NCT01262638|468965657|FG002|Overall Study|Protocol Violation|0|||
130273703|NCT01262638|468965658|FG003|Overall Study|Protocol Violation|1|||
130273704|NCT01262638|468965655|FG000|Overall Study|Withdrawal by Subject|2|||
130273705|NCT01262638|468965656|FG001|Overall Study|Withdrawal by Subject|1|||
130273706|NCT01262638|468965657|FG002|Overall Study|Withdrawal by Subject|0|||
130273707|NCT01262638|468965658|FG003|Overall Study|Withdrawal by Subject|1|||
130273708|NCT01262638|468965655|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273709|NCT01262638|468965656|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273710|NCT01262638|468965657|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130273711|NCT01262638|468965658|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273712|NCT01262638|468965655|FG000|Overall Study|Lost to Follow-up|1|||
130273713|NCT01262638|468965656|FG001|Overall Study|Lost to Follow-up|1|||
130273714|NCT01262638|468965657|FG002|Overall Study|Lost to Follow-up|1|||
130273715|NCT01262638|468965658|FG003|Overall Study|Lost to Follow-up|1|||
130273716|NCT01262638|468965655|FG000|Overall Study|Participant Went Out of Town|0|||
130273717|NCT01262638|468965656|FG001|Overall Study|Participant Went Out of Town|0|||
130273718|NCT01262638|468965657|FG002|Overall Study|Participant Went Out of Town|1|||
130273719|NCT01262638|468965658|FG003|Overall Study|Participant Went Out of Town|0|||
130273720|NCT02243371|468965663|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
130273721|NCT02243371|468965664|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
130273722|NCT02243371|468965663|FG000|Overall Study|Death (unrelated)|2|||
130273723|NCT02243371|468965664|FG001|Overall Study|Death (unrelated)|4|||
130273724|NCT02243371|468965663|FG000|Overall Study|Adverse Event (unrelated)|0|||
130273725|NCT02243371|468965664|FG001|Overall Study|Adverse Event (unrelated)|1|||
130273726|NCT02243371|468965663|FG000|Overall Study|Lack of Clinical Benefit|0|||
130273727|NCT02243371|468965664|FG001|Overall Study|Lack of Clinical Benefit|1|||
130273728|NCT02243371|468965663|FG000|Overall Study|Withdrawal by Subject|0|||
130273729|NCT02243371|468965664|FG001|Overall Study|Withdrawal by Subject|2|||
130273730|NCT01369199|468965665|FG000|Overall Study|Withdrawal by Subject|1|||
130273731|NCT01369199|468965665|FG000|Overall Study|Lost to Follow-up|2|||
130273732|NCT01071252|468965666|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
130273733|NCT01071252|468965667|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
130273734|NCT01071252|468965668|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
130456732|NCT00703911|469636277|FG000|Overall Study|Death|1|||
130273735|NCT01071252|468965669|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
130456733|NCT00703911|469636277|FG000|Overall Study|Physician Decision|6|||
130273736|NCT01071252|468965670|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
130273737|NCT01071252|468965666|FG000|Overall Study|Withdrawal by Subject|8|||
130273738|NCT01071252|468965667|FG001|Overall Study|Withdrawal by Subject|2|||
130273739|NCT01071252|468965668|FG002|Overall Study|Withdrawal by Subject|1|||
130273740|NCT01071252|468965669|FG003|Overall Study|Withdrawal by Subject|2|||
130273741|NCT01071252|468965670|FG004|Overall Study|Withdrawal by Subject|3|||
130273742|NCT01071252|468965666|FG000|Overall Study|administrative problems|1|||
130273743|NCT01071252|468965667|FG001|Overall Study|administrative problems|1|||
130273744|NCT01071252|468965668|FG002|Overall Study|administrative problems|0|||
130273745|NCT01071252|468965669|FG003|Overall Study|administrative problems|2|||
130273746|NCT01071252|468965670|FG004|Overall Study|administrative problems|1|||
130273747|NCT01071252|468965666|FG000|Overall Study|Lost to Follow-up|1|||
130273748|NCT01071252|468965667|FG001|Overall Study|Lost to Follow-up|0|||
130273749|NCT01071252|468965668|FG002|Overall Study|Lost to Follow-up|1|||
130273750|NCT01071252|468965669|FG003|Overall Study|Lost to Follow-up|2|||
130273751|NCT01071252|468965670|FG004|Overall Study|Lost to Follow-up|0|||
130273752|NCT01071252|468965666|FG000|Overall Study|Adverse Event|1|||
130273753|NCT01071252|468965667|FG001|Overall Study|Adverse Event|1|||
130273754|NCT01071252|468965668|FG002|Overall Study|Adverse Event|0|||
130273755|NCT01071252|468965669|FG003|Overall Study|Adverse Event|1|||
130273756|NCT01071252|468965670|FG004|Overall Study|Adverse Event|0|||
130273757|NCT01071252|468965666|FG000|Overall Study|Death|0|||
130273758|NCT01071252|468965667|FG001|Overall Study|Death|0|||
130273759|NCT01071252|468965668|FG002|Overall Study|Death|0|||
130273760|NCT01071252|468965669|FG003|Overall Study|Death|0|||
130273761|NCT01071252|468965670|FG004|Overall Study|Death|1|||
130273762|NCT03928418|468965671|FG000|Overall Study|Lost to Follow-up|5|||
130273763|NCT03928418|468965672|FG001|Overall Study|Lost to Follow-up|3|||
130273764|NCT03928418|468965673|FG002|Overall Study|Lost to Follow-up|5|||
130273765|NCT03928418|468965671|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
130273766|NCT03928418|468965672|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
130273767|NCT03928418|468965673|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
130273768|NCT00470262|468965674|FG000|Overall Study|Withdrawal by Subject|2|||
130273769|NCT00470262|468965675|FG001|Overall Study|Withdrawal by Subject|0|||
130273770|NCT00553436|468965678|FG000|Overall Study|Conversion to another procedure|1|||
130273771|NCT04188834|468965679|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
130273772|NCT01030952|468965680|FG000|Overall Study|Protocol Violation|0|||
130273773|NCT01030952|468965681|FG001|Overall Study|Protocol Violation|1|||
130273774|NCT01030952|468965680|FG000|Overall Study|Informed consent withdrawal|1|||
130273775|NCT01030952|468965681|FG001|Overall Study|Informed consent withdrawal|0|||
130273776|NCT01030952|468965680|FG000|Overall Study|Lost to Follow-up|0|||
130273777|NCT01030952|468965681|FG001|Overall Study|Lost to Follow-up|1|||
130273778|NCT01030952|468965680|FG000|Overall Study|Unexplained|1|||
130273779|NCT01030952|468965681|FG001|Overall Study|Unexplained|1|||
130273780|NCT01814046|468965686|FG000|Drug Administration|Death due to complications of RSV|1|||
130273781|NCT01814046|468965687|FG001|Drug Administration|Death due to complications of RSV|0|||
130273782|NCT01814046|468965688|FG002|Drug Administration|Death due to complications of RSV|0|||
130273783|NCT00958347|468965689|FG000|Overall Study|Death|43|||
130273784|NCT00958347|468965689|FG000|Overall Study|Withdrawal by Subject|23|||
130273785|NCT00958347|468965689|FG000|Overall Study|Lost to Follow-up|15|||
130273786|NCT00958347|468965689|FG000|Overall Study|revision/removal|10|||
130273787|NCT00958347|468965689|FG000|Overall Study|study termination|135|||
130273788|NCT01831466|468965699|FG000|Overall Study|Protocol Violation|1|||
130273789|NCT01831466|468965700|FG001|Overall Study|Protocol Violation|1|||
130273790|NCT01831466|468965701|FG002|Overall Study|Protocol Violation|2|||
130456734|NCT00703911|469636277|FG000|Overall Study|Lost to Follow-up|1|||
130456735|NCT00703911|469636277|FG000|Overall Study|Withdrawal by Subject|2|||
130456736|NCT01178762|469636280|FG000|Overall Study|Lost to Follow-up|15|||
130456737|NCT02377362|469636281|FG000|Part A Second Treatment|Protocol Violation|0|||
130456738|NCT02377362|469636282|FG001|Part A Second Treatment|Protocol Violation|0|||
130456739|NCT02377362|469636283|FG002|Part A Second Treatment|Protocol Violation|0|||
130273791|NCT01831466|468965702|FG003|Overall Study|Protocol Violation|0|||
130273792|NCT01831466|468965703|FG004|Overall Study|Protocol Violation|0|||
130273793|NCT01831466|468965704|FG005|Overall Study|Protocol Violation|1|||
130273794|NCT01831466|468965705|FG006|Overall Study|Protocol Violation|0|||
130273795|NCT01831466|468965706|FG007|Overall Study|Protocol Violation|0|||
130273796|NCT01831466|468965707|FG008|Overall Study|Protocol Violation|0|||
130273797|NCT01831466|468965708|FG009|Overall Study|Protocol Violation|0|||
130456740|NCT02377362|469636284|FG003|Part A Second Treatment|Protocol Violation|0|||
130273798|NCT01831466|468965709|FG010|Overall Study|Protocol Violation|0|||
130273799|NCT01831466|468965710|FG011|Overall Study|Protocol Violation|0|||
130273800|NCT01831466|468965699|FG000|Overall Study|Other|2|||
130273801|NCT01831466|468965700|FG001|Overall Study|Other|3|||
130273802|NCT01831466|468965701|FG002|Overall Study|Other|2|||
130273803|NCT01831466|468965702|FG003|Overall Study|Other|2|||
130273804|NCT01831466|468965703|FG004|Overall Study|Other|2|||
130273805|NCT01831466|468965704|FG005|Overall Study|Other|1|||
130456741|NCT02377362|469636285|FG004|Part A Second Treatment|Protocol Violation|1|||
130273806|NCT01831466|468965705|FG006|Overall Study|Other|0|||
130273807|NCT01831466|468965706|FG007|Overall Study|Other|0|||
130273808|NCT01831466|468965707|FG008|Overall Study|Other|0|||
130273809|NCT01831466|468965708|FG009|Overall Study|Other|0|||
130273810|NCT01831466|468965709|FG010|Overall Study|Other|0|||
130273811|NCT01831466|468965710|FG011|Overall Study|Other|0|||
130273812|NCT01831466|468965699|FG000|Overall Study|Non-compliance with study treatment|2|||
130273813|NCT01831466|468965700|FG001|Overall Study|Non-compliance with study treatment|1|||
130273814|NCT01831466|468965701|FG002|Overall Study|Non-compliance with study treatment|1|||
130273815|NCT01831466|468965702|FG003|Overall Study|Non-compliance with study treatment|0|||
130273816|NCT01831466|468965703|FG004|Overall Study|Non-compliance with study treatment|0|||
130273817|NCT01831466|468965704|FG005|Overall Study|Non-compliance with study treatment|1|||
130273818|NCT01831466|468965705|FG006|Overall Study|Non-compliance with study treatment|0|||
130273819|NCT01831466|468965706|FG007|Overall Study|Non-compliance with study treatment|0|||
130273820|NCT01831466|468965707|FG008|Overall Study|Non-compliance with study treatment|0|||
130273821|NCT01831466|468965708|FG009|Overall Study|Non-compliance with study treatment|0|||
130273822|NCT01831466|468965709|FG010|Overall Study|Non-compliance with study treatment|0|||
130273823|NCT01831466|468965710|FG011|Overall Study|Non-compliance with study treatment|0|||
130273824|NCT01831466|468965699|FG000|Overall Study|Death|0|||
130273825|NCT01831466|468965700|FG001|Overall Study|Death|1|||
130273826|NCT01831466|468965701|FG002|Overall Study|Death|0|||
130273827|NCT01831466|468965702|FG003|Overall Study|Death|0|||
130273828|NCT01831466|468965703|FG004|Overall Study|Death|0|||
130273829|NCT01831466|468965704|FG005|Overall Study|Death|0|||
130273830|NCT01831466|468965705|FG006|Overall Study|Death|0|||
130273831|NCT01831466|468965706|FG007|Overall Study|Death|0|||
130273832|NCT01831466|468965707|FG008|Overall Study|Death|0|||
130273833|NCT01831466|468965708|FG009|Overall Study|Death|0|||
130273834|NCT01831466|468965709|FG010|Overall Study|Death|0|||
130273835|NCT01831466|468965710|FG011|Overall Study|Death|0|||
130273836|NCT01831466|468965699|FG000|Overall Study|Withdrawal by Subject|6|||
130273837|NCT01831466|468965700|FG001|Overall Study|Withdrawal by Subject|3|||
130273838|NCT01831466|468965701|FG002|Overall Study|Withdrawal by Subject|3|||
130273839|NCT01831466|468965702|FG003|Overall Study|Withdrawal by Subject|3|||
130273840|NCT01831466|468965703|FG004|Overall Study|Withdrawal by Subject|3|||
130273841|NCT01831466|468965704|FG005|Overall Study|Withdrawal by Subject|5|||
130273842|NCT01831466|468965705|FG006|Overall Study|Withdrawal by Subject|0|||
130273843|NCT01831466|468965706|FG007|Overall Study|Withdrawal by Subject|0|||
130273844|NCT01831466|468965707|FG008|Overall Study|Withdrawal by Subject|0|||
130273845|NCT01831466|468965708|FG009|Overall Study|Withdrawal by Subject|1|||
130273846|NCT01831466|468965709|FG010|Overall Study|Withdrawal by Subject|0|||
130273847|NCT01831466|468965710|FG011|Overall Study|Withdrawal by Subject|1|||
130273848|NCT01831466|468965699|FG000|Overall Study|Lost to Follow-up|0|||
130273849|NCT01831466|468965700|FG001|Overall Study|Lost to Follow-up|1|||
130273850|NCT01831466|468965701|FG002|Overall Study|Lost to Follow-up|4|||
130273851|NCT01831466|468965702|FG003|Overall Study|Lost to Follow-up|2|||
130273852|NCT01831466|468965703|FG004|Overall Study|Lost to Follow-up|0|||
130273853|NCT01831466|468965704|FG005|Overall Study|Lost to Follow-up|3|||
130273854|NCT01831466|468965705|FG006|Overall Study|Lost to Follow-up|0|||
130273855|NCT01831466|468965706|FG007|Overall Study|Lost to Follow-up|0|||
130273856|NCT01831466|468965707|FG008|Overall Study|Lost to Follow-up|0|||
130273857|NCT01831466|468965708|FG009|Overall Study|Lost to Follow-up|1|||
130273858|NCT01831466|468965709|FG010|Overall Study|Lost to Follow-up|0|||
130273859|NCT01831466|468965710|FG011|Overall Study|Lost to Follow-up|1|||
130273860|NCT01831466|468965699|FG000|Overall Study|Lack of Efficacy|5|||
130273861|NCT01831466|468965700|FG001|Overall Study|Lack of Efficacy|8|||
130273862|NCT01831466|468965701|FG002|Overall Study|Lack of Efficacy|7|||
130273863|NCT01831466|468965702|FG003|Overall Study|Lack of Efficacy|6|||
130273864|NCT01831466|468965703|FG004|Overall Study|Lack of Efficacy|9|||
130273865|NCT01831466|468965704|FG005|Overall Study|Lack of Efficacy|8|||
130273866|NCT01831466|468965705|FG006|Overall Study|Lack of Efficacy|1|||
130273867|NCT01831466|468965706|FG007|Overall Study|Lack of Efficacy|1|||
130273868|NCT01831466|468965707|FG008|Overall Study|Lack of Efficacy|2|||
130273869|NCT01831466|468965708|FG009|Overall Study|Lack of Efficacy|2|||
130273870|NCT01831466|468965709|FG010|Overall Study|Lack of Efficacy|2|||
130273871|NCT01831466|468965710|FG011|Overall Study|Lack of Efficacy|0|||
130273872|NCT01831466|468965699|FG000|Overall Study|Adverse Event|0|||
130273873|NCT01831466|468965700|FG001|Overall Study|Adverse Event|0|||
130273874|NCT01831466|468965701|FG002|Overall Study|Adverse Event|4|||
130273875|NCT01831466|468965702|FG003|Overall Study|Adverse Event|6|||
130273876|NCT01831466|468965703|FG004|Overall Study|Adverse Event|3|||
130273877|NCT01831466|468965704|FG005|Overall Study|Adverse Event|7|||
130273878|NCT01831466|468965705|FG006|Overall Study|Adverse Event|0|||
130273879|NCT01831466|468965706|FG007|Overall Study|Adverse Event|1|||
130273880|NCT01831466|468965707|FG008|Overall Study|Adverse Event|1|||
130273881|NCT01831466|468965708|FG009|Overall Study|Adverse Event|1|||
130273882|NCT01831466|468965709|FG010|Overall Study|Adverse Event|0|||
130273883|NCT01831466|468965710|FG011|Overall Study|Adverse Event|2|||
130273884|NCT02311881|468965725|FG000|Overall Study|Did not meet the study criteria|2|||
130554632|NCT04263909|469998045|FG002|Overall Study|Protocol Violation|0|||
130273885|NCT02311881|468965726|FG001|Overall Study|Did not meet the study criteria|2|||
130273886|NCT02311881|468965727|FG002|Overall Study|Did not meet the study criteria|0|||
130273887|NCT02311881|468965725|FG000|Overall Study|Adverse Event|7|||
130273888|NCT02311881|468965726|FG001|Overall Study|Adverse Event|15|||
130273889|NCT02311881|468965727|FG002|Overall Study|Adverse Event|8|||
130273890|NCT02311881|468965725|FG000|Overall Study|Lost to Follow-up|3|||
130273891|NCT02311881|468965726|FG001|Overall Study|Lost to Follow-up|3|||
130273892|NCT02311881|468965727|FG002|Overall Study|Lost to Follow-up|2|||
130273893|NCT02311881|468965725|FG000|Overall Study|Protocol Violation|1|||
130273894|NCT02311881|468965726|FG001|Overall Study|Protocol Violation|2|||
130273895|NCT02311881|468965727|FG002|Overall Study|Protocol Violation|3|||
130273896|NCT02311881|468965725|FG000|Overall Study|Withdrawal of consent|14|||
130273897|NCT02311881|468965726|FG001|Overall Study|Withdrawal of consent|16|||
130273898|NCT02311881|468965727|FG002|Overall Study|Withdrawal of consent|17|||
130273899|NCT02311881|468965725|FG000|Overall Study|Other|0|||
130273900|NCT02311881|468965726|FG001|Overall Study|Other|0|||
130273901|NCT02311881|468965727|FG002|Overall Study|Other|1|||
130273902|NCT02311881|468965725|FG000|Overall Study|Lack of Efficacy|1|||
130273903|NCT02311881|468965726|FG001|Overall Study|Lack of Efficacy|2|||
130273904|NCT02311881|468965727|FG002|Overall Study|Lack of Efficacy|0|||
130273905|NCT02311881|468965725|FG000|Overall Study|Subject has border line pregnancy test|1|||
130273906|NCT02311881|468965726|FG001|Overall Study|Subject has border line pregnancy test|0|||
130273907|NCT02311881|468965727|FG002|Overall Study|Subject has border line pregnancy test|0|||
130273908|NCT02311881|468965725|FG000|Overall Study|Withdrawal by Subject|3|||
130273909|NCT02311881|468965726|FG001|Overall Study|Withdrawal by Subject|1|||
130273910|NCT02311881|468965727|FG002|Overall Study|Withdrawal by Subject|4|||
130273911|NCT02311881|468965725|FG000|Overall Study|Sponsor Decision|1|||
130367203|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
130367204|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
130367205|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
130367206|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
130367207|NCT01433991|469315874|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130367208|NCT01433991|469315875|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130367209|NCT01433991|469315876|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
130273912|NCT02311881|468965726|FG001|Overall Study|Sponsor Decision|1|||
130273913|NCT02311881|468965727|FG002|Overall Study|Sponsor Decision|1|||
130273914|NCT02311881|468965725|FG000|Overall Study|Protocol Deviation|1|||
130273915|NCT02311881|468965726|FG001|Overall Study|Protocol Deviation|0|||
130273916|NCT02311881|468965727|FG002|Overall Study|Protocol Deviation|0|||
130273917|NCT02311881|468965725|FG000|Overall Study|Non-Compliance|1|||
130273918|NCT02311881|468965726|FG001|Overall Study|Non-Compliance|0|||
130273919|NCT02311881|468965727|FG002|Overall Study|Non-Compliance|2|||
130273920|NCT02311881|468965725|FG000|Overall Study|Physician Decision|0|||
130273921|NCT02311881|468965726|FG001|Overall Study|Physician Decision|0|||
130273922|NCT02311881|468965727|FG002|Overall Study|Physician Decision|1|||
130273923|NCT02311881|468965725|FG000|Overall Study|Medical Monitor Discretion|0|||
130273924|NCT02311881|468965726|FG001|Overall Study|Medical Monitor Discretion|0|||
130273925|NCT02311881|468965727|FG002|Overall Study|Medical Monitor Discretion|1|||
130273926|NCT02311881|468965725|FG000|Overall Study|Participant taking another medication|0|||
130273927|NCT02311881|468965726|FG001|Overall Study|Participant taking another medication|0|||
130273928|NCT02311881|468965727|FG002|Overall Study|Participant taking another medication|1|||
130273929|NCT02311881|468965725|FG000|Overall Study|Serious Adverse Event|0|||
130273930|NCT02311881|468965726|FG001|Overall Study|Serious Adverse Event|1|||
130273931|NCT02311881|468965727|FG002|Overall Study|Serious Adverse Event|0|||
130273932|NCT00819156|468965728|FG000|Overall Study|Adverse Event|1|||
130273933|NCT00819156|468965729|FG001|Overall Study|Adverse Event|4|||
130273934|NCT00819156|468965730|FG002|Overall Study|Adverse Event|2|||
130273935|NCT00819156|468965731|FG003|Overall Study|Adverse Event|1|||
130273936|NCT00819156|468965732|FG004|Overall Study|Adverse Event|2|||
130273937|NCT00819156|468965733|FG005|Overall Study|Adverse Event|3|||
130273938|NCT00819156|468965728|FG000|Overall Study|Withdrawal by Subject|0|||
130273939|NCT00819156|468965729|FG001|Overall Study|Withdrawal by Subject|3|||
130273940|NCT00819156|468965730|FG002|Overall Study|Withdrawal by Subject|2|||
130708826|NCT02224573|470560493|FG001|Taper Phase|Adverse Event|1|||
130708827|NCT02546362|470560494|FG000|4-week Treatment Period|Lost to Follow-up|1|||
130708828|NCT02546362|470560494|FG000|4-week Treatment Period|Change in medication|2|||
130273941|NCT00819156|468965731|FG003|Overall Study|Withdrawal by Subject|0|||
130273942|NCT00819156|468965732|FG004|Overall Study|Withdrawal by Subject|1|||
130273943|NCT00819156|468965733|FG005|Overall Study|Withdrawal by Subject|0|||
130273944|NCT00819156|468965728|FG000|Overall Study|Protocol Violation|1|||
130273945|NCT00819156|468965729|FG001|Overall Study|Protocol Violation|0|||
130273946|NCT00819156|468965730|FG002|Overall Study|Protocol Violation|1|||
130273947|NCT00819156|468965731|FG003|Overall Study|Protocol Violation|0|||
130273948|NCT00819156|468965732|FG004|Overall Study|Protocol Violation|0|||
130273949|NCT00819156|468965733|FG005|Overall Study|Protocol Violation|1|||
130273950|NCT00819156|468965728|FG000|Overall Study|Lost to Follow-up|0|||
130273951|NCT00819156|468965729|FG001|Overall Study|Lost to Follow-up|1|||
130273952|NCT00819156|468965730|FG002|Overall Study|Lost to Follow-up|0|||
130273953|NCT00819156|468965731|FG003|Overall Study|Lost to Follow-up|0|||
130273954|NCT00819156|468965732|FG004|Overall Study|Lost to Follow-up|0|||
130273955|NCT00819156|468965733|FG005|Overall Study|Lost to Follow-up|2|||
130273956|NCT00819156|468965728|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
130273957|NCT00819156|468965729|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130273958|NCT00819156|468965730|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273959|NCT00819156|468965731|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273960|NCT00819156|468965732|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273961|NCT00819156|468965733|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130456742|NCT02377362|469636286|FG005|Part A Second Treatment|Protocol Violation|0|||
130456743|NCT02377362|469636287|FG006|Part A Second Treatment|Protocol Violation|0|||
130456744|NCT02377362|469636288|FG007|Part A Second Treatment|Protocol Violation|0|||
130456745|NCT02377362|469636289|FG008|Part A Second Treatment|Protocol Violation|0|||
130456746|NCT02377362|469636290|FG009|Part A Second Treatment|Protocol Violation|0|||
130456747|NCT02377362|469636291|FG010|Part A Second Treatment|Protocol Violation|0|||
130456748|NCT02377362|469636292|FG011|Part A Second Treatment|Protocol Violation|0|||
130456749|NCT02377362|469636293|FG012|Part A Second Treatment|Protocol Violation|0|||
130456750|NCT02377362|469636281|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456751|NCT02377362|469636282|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456752|NCT02377362|469636283|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456753|NCT02377362|469636284|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
130456754|NCT02377362|469636285|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
130456755|NCT02377362|469636286|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
130456756|NCT02377362|469636287|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456757|NCT02377362|469636288|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456758|NCT02377362|469636289|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456759|NCT02377362|469636290|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456760|NCT02377362|469636291|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456761|NCT02377362|469636292|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456762|NCT02377362|469636293|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
130456763|NCT02377362|469636281|FG000|Part B Overall|Protocol Violation|0|||
130273962|NCT00819156|468965728|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
130273963|NCT00819156|468965729|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273964|NCT00819156|468965730|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273965|NCT00819156|468965731|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273966|NCT00819156|468965732|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
130273967|NCT00819156|468965733|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273968|NCT00819156|468965728|FG000|Overall Study|Prostate-specific antigen progression|0|||
130273969|NCT00819156|468965729|FG001|Overall Study|Prostate-specific antigen progression|0|||
130273970|NCT00819156|468965730|FG002|Overall Study|Prostate-specific antigen progression|0|||
130273971|NCT00819156|468965731|FG003|Overall Study|Prostate-specific antigen progression|0|||
130273972|NCT00819156|468965732|FG004|Overall Study|Prostate-specific antigen progression|1|||
130273973|NCT00819156|468965733|FG005|Overall Study|Prostate-specific antigen progression|0|||
130273974|NCT00803595|468965734|FG000|Overall Study|Adverse Event|3|||
130273975|NCT00803595|468965735|FG001|Overall Study|Adverse Event|4|||
130273976|NCT00803595|468965736|FG002|Overall Study|Adverse Event|1|||
130273977|NCT00803595|468965734|FG000|Overall Study|Protocol Violation|7|||
130273978|NCT00803595|468965735|FG001|Overall Study|Protocol Violation|2|||
130273979|NCT00803595|468965736|FG002|Overall Study|Protocol Violation|12|||
130273980|NCT00803595|468965734|FG000|Overall Study|Withdrawal by Subject|5|||
130273981|NCT00803595|468965735|FG001|Overall Study|Withdrawal by Subject|2|||
130273982|NCT00803595|468965736|FG002|Overall Study|Withdrawal by Subject|3|||
130273983|NCT01575808|468965739|FG000|Overall Study|Death|2|||
130273984|NCT01575808|468965740|FG001|Overall Study|Death|0|||
130273985|NCT01575808|468965739|FG000|Overall Study|Withdrawal by Subject|1|||
130273986|NCT01575808|468965740|FG001|Overall Study|Withdrawal by Subject|0|||
130273987|NCT02403817|468967302|FG000|Overall Study|Withdrawal by Subject|5|||
130273988|NCT02403817|468967303|FG001|Overall Study|Withdrawal by Subject|0|||
130273989|NCT04908384|468967304|FG000|Overall Study|Lost to Follow-up|4|||
130273990|NCT04908384|468967305|FG001|Overall Study|Lost to Follow-up|4|||
130273991|NCT04908384|468967306|FG002|Overall Study|Lost to Follow-up|0|||
130273992|NCT04908384|468967307|FG003|Overall Study|Lost to Follow-up|0|||
130273993|NCT00430989|468967308|FG000|Overall Study|Lost to Follow-up|2|||
130456764|NCT02377362|469636282|FG001|Part B Overall|Protocol Violation|0|||
130456765|NCT02377362|469636283|FG002|Part B Overall|Protocol Violation|0|||
130456766|NCT02377362|469636284|FG003|Part B Overall|Protocol Violation|0|||
130456767|NCT02377362|469636285|FG004|Part B Overall|Protocol Violation|0|||
130456768|NCT02377362|469636286|FG005|Part B Overall|Protocol Violation|0|||
130456769|NCT02377362|469636287|FG006|Part B Overall|Protocol Violation|0|||
130456770|NCT02377362|469636288|FG007|Part B Overall|Protocol Violation|0|||
130456771|NCT02377362|469636289|FG008|Part B Overall|Protocol Violation|0|||
130456772|NCT02377362|469636290|FG009|Part B Overall|Protocol Violation|1|||
130456773|NCT02377362|469636291|FG010|Part B Overall|Protocol Violation|0|||
130456774|NCT02377362|469636292|FG011|Part B Overall|Protocol Violation|0|||
130456775|NCT02377362|469636293|FG012|Part B Overall|Protocol Violation|0|||
130456776|NCT02377362|469636281|FG000|Part B Overall|Adverse Event|0|||
130456777|NCT02377362|469636282|FG001|Part B Overall|Adverse Event|0|||
130456778|NCT02377362|469636283|FG002|Part B Overall|Adverse Event|0|||
130456779|NCT02377362|469636284|FG003|Part B Overall|Adverse Event|0|||
130456780|NCT02377362|469636285|FG004|Part B Overall|Adverse Event|0|||
130456781|NCT02377362|469636286|FG005|Part B Overall|Adverse Event|0|||
130456782|NCT02377362|469636287|FG006|Part B Overall|Adverse Event|1|||
130456783|NCT02377362|469636288|FG007|Part B Overall|Adverse Event|1|||
130456784|NCT02377362|469636289|FG008|Part B Overall|Adverse Event|0|||
130456785|NCT02377362|469636290|FG009|Part B Overall|Adverse Event|0|||
130456786|NCT02377362|469636291|FG010|Part B Overall|Adverse Event|0|||
130456787|NCT02377362|469636292|FG011|Part B Overall|Adverse Event|0|||
130456788|NCT02377362|469636293|FG012|Part B Overall|Adverse Event|0|||
130456789|NCT02377362|469636281|FG000|Part B Overall|Withdrawal by Subject|0|||
130456790|NCT02377362|469636282|FG001|Part B Overall|Withdrawal by Subject|0|||
130456791|NCT02377362|469636283|FG002|Part B Overall|Withdrawal by Subject|0|||
130456792|NCT02377362|469636284|FG003|Part B Overall|Withdrawal by Subject|0|||
130456793|NCT02377362|469636285|FG004|Part B Overall|Withdrawal by Subject|0|||
130456794|NCT02377362|469636286|FG005|Part B Overall|Withdrawal by Subject|0|||
130456795|NCT02377362|469636287|FG006|Part B Overall|Withdrawal by Subject|1|||
130456796|NCT02377362|469636288|FG007|Part B Overall|Withdrawal by Subject|0|||
130456797|NCT02377362|469636289|FG008|Part B Overall|Withdrawal by Subject|0|||
130456798|NCT02377362|469636290|FG009|Part B Overall|Withdrawal by Subject|0|||
130456799|NCT02377362|469636291|FG010|Part B Overall|Withdrawal by Subject|0|||
130456800|NCT02377362|469636292|FG011|Part B Overall|Withdrawal by Subject|1|||
130456801|NCT02377362|469636293|FG012|Part B Overall|Withdrawal by Subject|0|||
130456802|NCT04889664|469636294|FG000|Screen|Lost to Follow-up|1|||
130456803|NCT04889664|469636294|FG000|Screen|Failed to meet screening criteria|1|||
130273994|NCT00430989|468967309|FG001|Overall Study|Lost to Follow-up|3|||
130273995|NCT00430989|468967308|FG000|Overall Study|Withdrawal by Subject|15|||
130273996|NCT00430989|468967309|FG001|Overall Study|Withdrawal by Subject|14|||
130456804|NCT04889664|469636294|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
130456805|NCT02322216|469636295|FG000|Overall Study|Adverse Event|1|||
130456806|NCT02322216|469636296|FG001|Overall Study|Adverse Event|0|||
130708829|NCT02546362|470560494|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
130708830|NCT02546362|470560494|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130708831|NCT02546362|470560494|FG000|12-week Treatment Period|Change in medication|1|||
130708832|NCT05206448|470560495|FG000|Overall Study|Lost to Follow-up|2|||
130708833|NCT05206448|470560496|FG001|Overall Study|Lost to Follow-up|2|||
130708834|NCT05206448|470560495|FG000|Overall Study|Withdrawal by Subject|2|||
130708835|NCT05206448|470560496|FG001|Overall Study|Withdrawal by Subject|0|||
130273997|NCT00430989|468967308|FG000|Overall Study|Protocol Violation|30|||
130273998|NCT00430989|468967309|FG001|Overall Study|Protocol Violation|37|||
130273999|NCT00430989|468967308|FG000|Overall Study|Not eligible|13|||
130274000|NCT00430989|468967309|FG001|Overall Study|Not eligible|6|||
130274001|NCT03050450|468967310|FG000|Overall Study|Physician Decision|1|||
130274002|NCT03050450|468967311|FG001|Overall Study|Physician Decision|0|||
130274003|NCT03050450|468967312|FG002|Overall Study|Physician Decision|0|||
130274004|NCT03050450|468967313|FG003|Overall Study|Physician Decision|0|||
130274005|NCT03050450|468967314|FG004|Overall Study|Physician Decision|0|||
130367210|NCT01433991|469315877|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130367211|NCT02550106|469315879|FG000|Overall Study|Adverse Event|1|||
130367212|NCT02550106|469315879|FG000|Overall Study|Lack of Efficacy|3|||
130367213|NCT02550106|469315879|FG000|Overall Study|Protocol Violation|6|||
130367214|NCT02550106|469315879|FG000|Overall Study|Withdrawal by Subject|2|||
130367215|NCT00354744|469315880|FG000|Overall Study|Adverse Event|2|||
130367216|NCT00354744|469315880|FG000|Overall Study|Death|2|||
130367217|NCT00354744|469315880|FG000|Overall Study|Lack of Efficacy|11|||
130367218|NCT00354744|469315880|FG000|Overall Study|Lost to Follow-up|2|||
130367219|NCT00354744|469315880|FG000|Overall Study|Physician Decision|11|||
130367220|NCT00354744|469315880|FG000|Overall Study|Withdrawal by Subject|14|||
130367221|NCT01193530|469315881|FG000|Overall Study|Withdrawal by Subject|2|||
130367222|NCT01193530|469315882|FG001|Overall Study|Withdrawal by Subject|2|||
130367223|NCT01193530|469315881|FG000|Overall Study|Began Contraindicated Therapy|1|||
130367224|NCT01193530|469315882|FG001|Overall Study|Began Contraindicated Therapy|0|||
130367225|NCT01193530|469315881|FG000|Overall Study|Lost Light Box|0|||
130367226|NCT01193530|469315882|FG001|Overall Study|Lost Light Box|1|||
130367227|NCT01193530|469315881|FG000|Overall Study|Returned home - out of state|0|||
130367228|NCT01193530|469315882|FG001|Overall Study|Returned home - out of state|1|||
130367229|NCT01193530|469315881|FG000|Overall Study|Non-Compliance|0|||
130367230|NCT01193530|469315882|FG001|Overall Study|Non-Compliance|1|||
130367231|NCT00926328|469315883|FG000|Overall Study|Lost to Follow-up|12|||
130367232|NCT00926328|469315884|FG001|Overall Study|Lost to Follow-up|14|||
130367233|NCT00289133|469315887|FG000|Overall Study|Non-study device implanted|12|||
130367234|NCT00289133|469315888|FG001|Overall Study|Non-study device implanted|0|||
130367235|NCT00289133|469315887|FG000|Overall Study|Protocol Violation|32|||
130367236|NCT00289133|469315888|FG001|Overall Study|Protocol Violation|38|||
130367237|NCT00289133|469315887|FG000|Overall Study|Withdrawal by Subject|9|||
130367238|NCT00289133|469315888|FG001|Overall Study|Withdrawal by Subject|10|||
130367239|NCT00289133|469315887|FG000|Overall Study|Death|5|||
130367240|NCT00289133|469315888|FG001|Overall Study|Death|10|||
130367241|NCT00289133|469315887|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
130367242|NCT00289133|469315888|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
130367243|NCT00289133|469315887|FG000|Overall Study|Physician Decision|41|||
130367244|NCT00289133|469315888|FG001|Overall Study|Physician Decision|45|||
130367245|NCT00289133|469315887|FG000|Overall Study|Revision|8|||
130367246|NCT00289133|469315888|FG001|Overall Study|Revision|6|||
130367247|NCT00289133|469315887|FG000|Overall Study|Lost to Follow-up|92|||
130367248|NCT00289133|469315888|FG001|Overall Study|Lost to Follow-up|115|||
130367249|NCT00726986|469315889|FG000|Induction Phase|Adverse Event|4|||
130367250|NCT00726986|469315889|FG000|Induction Phase|Withdrawal by Subject|2|||
130367251|NCT00726986|469315889|FG000|Induction Phase|Death|2|||
130367252|NCT00726986|469315889|FG000|Induction Phase|Lack of Efficacy|5|||
130367253|NCT00726986|469315889|FG000|Induction Phase|Secondary Disease|2|||
130367254|NCT00726986|469315889|FG000|Maintenance Phase|Adverse Event|1|||
130367255|NCT00726986|469315889|FG000|Maintenance Phase|Lack of Efficacy|2|||
130367256|NCT01513343|469315892|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
130367257|NCT01513343|469315893|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
130367258|NCT01513343|469315892|FG000|Post Data Collection|Dropped/withdrew from study|7|||
130367259|NCT01513343|469315893|FG001|Post Data Collection|Dropped/withdrew from study|1|||
130456807|NCT02322216|469636295|FG000|Overall Study|Withdrawal by Subject|1|||
130456808|NCT02322216|469636296|FG001|Overall Study|Withdrawal by Subject|4|||
130456809|NCT01191086|469636315|FG000|Overall Study|Adverse Event|20|||
130456810|NCT01191086|469636315|FG000|Overall Study|Lack of Efficacy|10|||
130456811|NCT01191086|469636315|FG000|Overall Study|Lost to Follow-up|4|||
130456812|NCT01191086|469636315|FG000|Overall Study|Physician Decision|2|||
130456813|NCT01191086|469636315|FG000|Overall Study|Withdrawal by Subject|24|||
130274006|NCT01642901|468967315|FG000|12-month Follow-up|Withdrawal by Subject|1|||
130367260|NCT01513343|469315892|FG000|Post Data Collection|Lost to Follow-up|10|||
130367261|NCT01513343|469315893|FG001|Post Data Collection|Lost to Follow-up|23|||
130274007|NCT01642901|468967316|FG001|12-month Follow-up|Withdrawal by Subject|0|||
130274008|NCT01701362|468967318|FG000|Overall Study|Adverse events not related to study drug|1|||
130274009|NCT01701362|468967319|FG001|Overall Study|Adverse events not related to study drug|6|||
130274010|NCT01701362|468967318|FG000|Overall Study|Adverse events related to study drug|12|||
130274011|NCT01701362|468967319|FG001|Overall Study|Adverse events related to study drug|10|||
130274012|NCT01701362|468967318|FG000|Overall Study|Protocol Violation|5|||
130274013|NCT01701362|468967319|FG001|Overall Study|Protocol Violation|3|||
130274014|NCT01701362|468967318|FG000|Overall Study|No longer willing to participate|8|||
130274015|NCT01701362|468967319|FG001|Overall Study|No longer willing to participate|14|||
130274016|NCT01701362|468967318|FG000|Overall Study|Lost to Follow-up|6|||
130274017|NCT01701362|468967319|FG001|Overall Study|Lost to Follow-up|9|||
130274018|NCT01701362|468967318|FG000|Overall Study|Insufficient clinical response|6|||
130274019|NCT01701362|468967319|FG001|Overall Study|Insufficient clinical response|6|||
130274020|NCT01701362|468967318|FG000|Overall Study|Death|0|||
130274021|NCT01701362|468967319|FG001|Overall Study|Death|1|||
130274022|NCT01701362|468967318|FG000|Overall Study|Randomized but not treated|1|||
130274023|NCT01701362|468967319|FG001|Overall Study|Randomized but not treated|2|||
130274024|NCT01701362|468967318|FG000|Overall Study|Reasons other than those mentioned above|3|||
130274025|NCT01701362|468967319|FG001|Overall Study|Reasons other than those mentioned above|5|||
130274026|NCT00570778|468967320|FG000|Overall Study|Protocol deviation|2|||
130274027|NCT00570778|468967321|FG001|Overall Study|Protocol deviation|1|||
130274028|NCT00570778|468967322|FG002|Overall Study|Protocol deviation|2|||
130274029|NCT00570778|468967323|FG003|Overall Study|Protocol deviation|2|||
130274030|NCT00570778|468967320|FG000|Overall Study|Adverse Event|0|||
130274031|NCT00570778|468967321|FG001|Overall Study|Adverse Event|1|||
130274032|NCT00570778|468967322|FG002|Overall Study|Adverse Event|4|||
130274033|NCT00570778|468967323|FG003|Overall Study|Adverse Event|1|||
130274034|NCT00570778|468967320|FG000|Overall Study|Subject withdrew consent|0|||
130274035|NCT00570778|468967321|FG001|Overall Study|Subject withdrew consent|1|||
130274036|NCT00570778|468967322|FG002|Overall Study|Subject withdrew consent|0|||
130274037|NCT00570778|468967323|FG003|Overall Study|Subject withdrew consent|1|||
130274038|NCT00570778|468967320|FG000|Overall Study|Abnormal test procedure|1|||
130274039|NCT00570778|468967321|FG001|Overall Study|Abnormal test procedure|0|||
130274040|NCT00570778|468967322|FG002|Overall Study|Abnormal test procedure|0|||
130274041|NCT00570778|468967323|FG003|Overall Study|Abnormal test procedure|0|||
130274042|NCT00570778|468967320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130274043|NCT00570778|468967321|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130274044|NCT00570778|468967322|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130274045|NCT00570778|468967323|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130274046|NCT00570778|468967320|FG000|Overall Study|Lost to Follow-up|0|||
130274047|NCT00570778|468967321|FG001|Overall Study|Lost to Follow-up|0|||
130274048|NCT00570778|468967322|FG002|Overall Study|Lost to Follow-up|1|||
130274049|NCT00570778|468967323|FG003|Overall Study|Lost to Follow-up|0|||
130456814|NCT01191086|469636315|FG000|Overall Study|Discontinuation criterion met|1|||
130456815|NCT01191086|469636315|FG000|Overall Study|Other|1|||
130456816|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Other|4|||
130456817|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Other|0|||
130456818|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
130456819|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
130456820|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
130456821|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
130456822|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
130456823|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
130456824|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
130456825|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
130456826|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
130456827|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
130456828|NCT00853827|469636316|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
130708836|NCT05206448|470560495|FG000|Overall Study|found ineligible after randomization|1|||
130708837|NCT05206448|470560496|FG001|Overall Study|found ineligible after randomization|1|||
130708838|NCT05206448|470560495|FG000|Overall Study|unable to complete study due to personal constraints|1|||
130274050|NCT00570778|468967320|FG000|Overall Study|Subject no longer requires study drug|0|||
130274051|NCT00570778|468967321|FG001|Overall Study|Subject no longer requires study drug|1|||
130274052|NCT00570778|468967322|FG002|Overall Study|Subject no longer requires study drug|0|||
130274053|NCT00570778|468967323|FG003|Overall Study|Subject no longer requires study drug|0|||
130274054|NCT00711594|468967324|FG000|Overall Study|Progressive disease|2|||
130274055|NCT00711594|468967325|FG001|Overall Study|Progressive disease|2|||
130274056|NCT00711594|468967326|FG002|Overall Study|Progressive disease|6|||
130456829|NCT00853827|469636317|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
130456830|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
130274057|NCT00711594|468967327|FG003|Overall Study|Progressive disease|44|||
130456831|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
130274058|NCT00711594|468967324|FG000|Overall Study|Other Adverse Event|1|||
130274059|NCT00711594|468967325|FG001|Overall Study|Other Adverse Event|0|||
130274060|NCT00711594|468967326|FG002|Overall Study|Other Adverse Event|0|||
130274061|NCT00711594|468967327|FG003|Overall Study|Other Adverse Event|16|||
130274062|NCT00711594|468967324|FG000|Overall Study|Withdrawal by Subject|0|||
130274063|NCT00711594|468967325|FG001|Overall Study|Withdrawal by Subject|1|||
130274064|NCT00711594|468967326|FG002|Overall Study|Withdrawal by Subject|0|||
130274065|NCT00711594|468967327|FG003|Overall Study|Withdrawal by Subject|2|||
130274066|NCT00443872|468967328|FG000|Overall Study|Protocol Violation|7|||
130274067|NCT00443872|468967328|FG000|Overall Study|Lost to Follow-up|2|||
130274068|NCT00443872|468967328|FG000|Overall Study|Adverse Event|8|||
130274069|NCT00485758|468967334|FG000|Overall Study|Adverse Event|102|||
130274070|NCT00485758|468967335|FG001|Overall Study|Adverse Event|31|||
130274071|NCT00485758|468967334|FG000|Overall Study|Death|0|||
130274072|NCT00485758|468967335|FG001|Overall Study|Death|1|||
130274073|NCT00485758|468967334|FG000|Overall Study|Lost to Follow-up|5|||
130274074|NCT00485758|468967335|FG001|Overall Study|Lost to Follow-up|1|||
130274075|NCT00485758|468967334|FG000|Overall Study|Physician Decision|3|||
130274076|NCT00485758|468967335|FG001|Overall Study|Physician Decision|3|||
130274077|NCT00485758|468967334|FG000|Overall Study|Protocol Violation|11|||
130274078|NCT00485758|468967335|FG001|Overall Study|Protocol Violation|2|||
130274079|NCT00485758|468967334|FG000|Overall Study|Withdrawal by Subject|32|||
130274080|NCT00485758|468967335|FG001|Overall Study|Withdrawal by Subject|27|||
130274081|NCT00485758|468967334|FG000|Overall Study|Study Terminated by Sponsor|3|||
130274082|NCT00485758|468967335|FG001|Overall Study|Study Terminated by Sponsor|0|||
130274083|NCT04551963|468967336|FG000|Overall Study|Physician Decision|1|||
130274084|NCT04551963|468967337|FG001|Overall Study|Physician Decision|1|||
130274085|NCT04551963|468967336|FG000|Overall Study|Death|1|||
130274086|NCT04551963|468967337|FG001|Overall Study|Death|0|||
130274087|NCT03379259|468967338|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
130274088|NCT03379259|468967339|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
130274089|NCT03379259|468967340|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
130274090|NCT03379259|468967341|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
130274091|NCT03379259|468967342|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
130274092|NCT03379259|468967343|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
130274093|NCT03379259|468967338|FG000|Overall Study|Death|0|||
130274094|NCT03379259|468967339|FG001|Overall Study|Death|1|||
130274095|NCT03379259|468967340|FG002|Overall Study|Death|2|||
130274096|NCT03379259|468967341|FG003|Overall Study|Death|1|||
130274097|NCT03379259|468967342|FG004|Overall Study|Death|4|||
130274098|NCT03379259|468967343|FG005|Overall Study|Death|2|||
130274099|NCT03379259|468967338|FG000|Overall Study|Withdrawal by Subject|0|||
130274100|NCT03379259|468967339|FG001|Overall Study|Withdrawal by Subject|0|||
130274101|NCT03379259|468967340|FG002|Overall Study|Withdrawal by Subject|1|||
130274102|NCT03379259|468967341|FG003|Overall Study|Withdrawal by Subject|0|||
130274103|NCT03379259|468967342|FG004|Overall Study|Withdrawal by Subject|2|||
130274104|NCT03379259|468967343|FG005|Overall Study|Withdrawal by Subject|0|||
130274105|NCT03379259|468967338|FG000|Overall Study|Study terminated by sponsor|0|||
130274106|NCT03379259|468967339|FG001|Overall Study|Study terminated by sponsor|0|||
130274107|NCT03379259|468967340|FG002|Overall Study|Study terminated by sponsor|0|||
130274108|NCT03379259|468967341|FG003|Overall Study|Study terminated by sponsor|1|||
130274109|NCT03379259|468967342|FG004|Overall Study|Study terminated by sponsor|1|||
130274110|NCT03379259|468967343|FG005|Overall Study|Study terminated by sponsor|4|||
130274111|NCT03379259|468967338|FG000|Overall Study|Disease progression|0|||
130274112|NCT03379259|468967339|FG001|Overall Study|Disease progression|0|||
130274113|NCT03379259|468967340|FG002|Overall Study|Disease progression|0|||
130274114|NCT03379259|468967341|FG003|Overall Study|Disease progression|1|||
130456832|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
130274115|NCT03379259|468967342|FG004|Overall Study|Disease progression|0|||
130274116|NCT03379259|468967343|FG005|Overall Study|Disease progression|1|||
130274117|NCT03379259|468967338|FG000|Overall Study|Lost to Follow-up|0|||
130274118|NCT03379259|468967339|FG001|Overall Study|Lost to Follow-up|0|||
130274119|NCT03379259|468967340|FG002|Overall Study|Lost to Follow-up|0|||
130274120|NCT03379259|468967341|FG003|Overall Study|Lost to Follow-up|0|||
130274121|NCT03379259|468967342|FG004|Overall Study|Lost to Follow-up|1|||
130274122|NCT03379259|468967343|FG005|Overall Study|Lost to Follow-up|0|||
130456833|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
130274123|NCT03379259|468967338|FG000|Overall Study|Deteriorating condition|0|||
130274124|NCT03379259|468967339|FG001|Overall Study|Deteriorating condition|0|||
130274125|NCT03379259|468967340|FG002|Overall Study|Deteriorating condition|0|||
130274126|NCT03379259|468967341|FG003|Overall Study|Deteriorating condition|0|||
130274127|NCT03379259|468967342|FG004|Overall Study|Deteriorating condition|1|||
130274128|NCT03379259|468967343|FG005|Overall Study|Deteriorating condition|0|||
130274129|NCT00700622|468967344|FG000|Overall Study|Adverse Event|4|||
130274130|NCT00700622|468967345|FG001|Overall Study|Adverse Event|0|||
130274131|NCT00700622|468967344|FG000|Overall Study|Lost to Follow-up|0|||
130274132|NCT00700622|468967345|FG001|Overall Study|Lost to Follow-up|1|||
130274133|NCT00700622|468967344|FG000|Overall Study|Physician Decision|2|||
130274134|NCT00700622|468967345|FG001|Overall Study|Physician Decision|1|||
130274135|NCT00700622|468967344|FG000|Overall Study|Protocol Violation|0|||
130274136|NCT00700622|468967345|FG001|Overall Study|Protocol Violation|1|||
130274137|NCT00700622|468967344|FG000|Overall Study|Withdrawal by Subject|4|||
130274138|NCT00700622|468967345|FG001|Overall Study|Withdrawal by Subject|1|||
130274139|NCT00700622|468967344|FG000|Overall Study|Other|3|||
130274140|NCT00700622|468967345|FG001|Overall Study|Other|1|||
130274141|NCT00383331|468967346|FG000|Overall Study|Protocol Violation|0|||
130274142|NCT00383331|468967347|FG001|Overall Study|Protocol Violation|1|||
130274143|NCT00375427|468967348|FG000|Overall Study|Adverse Event|21|||
130274144|NCT00375427|468967349|FG001|Overall Study|Adverse Event|27|||
130274145|NCT00375427|468967348|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130274146|NCT00375427|468967349|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130274147|NCT00375427|468967348|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130274148|NCT00375427|468967349|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130274149|NCT00375427|468967348|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130274150|NCT00375427|468967349|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130274151|NCT00375427|468967348|FG000|Overall Study|Patient no longer requires study drug|3|||
130274152|NCT00375427|468967349|FG001|Overall Study|Patient no longer requires study drug|7|||
130274153|NCT00375427|468967348|FG000|Overall Study|Protocol Violation|10|||
130274154|NCT00375427|468967349|FG001|Overall Study|Protocol Violation|8|||
130274155|NCT00375427|468967348|FG000|Overall Study|Withdrawal by Subject|9|||
130274156|NCT00375427|468967349|FG001|Overall Study|Withdrawal by Subject|13|||
130274157|NCT00375427|468967348|FG000|Overall Study|Lost to Follow-up|1|||
130274158|NCT00375427|468967349|FG001|Overall Study|Lost to Follow-up|1|||
130274159|NCT00375427|468967348|FG000|Overall Study|Administrative reasons|0|||
130274160|NCT00375427|468967349|FG001|Overall Study|Administrative reasons|1|||
130274161|NCT00375427|468967348|FG000|Overall Study|Death|11|||
130274162|NCT00375427|468967349|FG001|Overall Study|Death|10|||
130274163|NCT03850093|468967350|FG000|Overall Study|Withdrawal by Subject|1|||
130274164|NCT03850093|468967351|FG001|Overall Study|Withdrawal by Subject|0|||
130274165|NCT03850093|468967352|FG002|Overall Study|Withdrawal by Subject|2|||
130274166|NCT03226249|468967358|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
130274167|NCT03226249|468967358|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
130274168|NCT03226249|468967358|FG000|Survival Follow-up|Patients still in follow-up.|30|||
130274169|NCT01532921|468967359|FG000|Overall Study|Death|3|||
130274170|NCT01532921|468967359|FG000|Overall Study|Withdrawal by Subject|2|||
130274171|NCT01532921|468967359|FG000|Overall Study|Lost to Follow-up|3|||
130274172|NCT01532921|468967359|FG000|Overall Study|Physician Decision|7|||
130274173|NCT01532921|468967359|FG000|Overall Study|Device was explanted during procedure|1|||
130274174|NCT00070109|468967360|FG000|Overall Study|Death|1|||
130274175|NCT00070109|468967361|FG001|Overall Study|Death|1|||
130274176|NCT00070109|468967362|FG002|Overall Study|Death|0|||
130274177|NCT00070109|468967363|FG003|Overall Study|Death|0|||
130274178|NCT00070109|468967364|FG004|Overall Study|Death|1|||
130274179|NCT00070109|468967360|FG000|Overall Study|Lack of Efficacy|6|||
130274180|NCT00070109|468967361|FG001|Overall Study|Lack of Efficacy|4|||
130274181|NCT00070109|468967362|FG002|Overall Study|Lack of Efficacy|5|||
130274182|NCT00070109|468967363|FG003|Overall Study|Lack of Efficacy|15|||
130274183|NCT00070109|468967364|FG004|Overall Study|Lack of Efficacy|5|||
130274184|NCT00070109|468967360|FG000|Overall Study|Physician Decision|1|||
130274185|NCT00070109|468967361|FG001|Overall Study|Physician Decision|0|||
130274186|NCT00070109|468967362|FG002|Overall Study|Physician Decision|0|||
130274187|NCT00070109|468967363|FG003|Overall Study|Physician Decision|0|||
130274188|NCT00070109|468967364|FG004|Overall Study|Physician Decision|0|||
130274189|NCT00070109|468967360|FG000|Overall Study|Withdrawal by Subject|0|||
130274190|NCT00070109|468967361|FG001|Overall Study|Withdrawal by Subject|1|||
130274191|NCT00070109|468967362|FG002|Overall Study|Withdrawal by Subject|1|||
130274192|NCT00070109|468967363|FG003|Overall Study|Withdrawal by Subject|0|||
130274193|NCT00070109|468967364|FG004|Overall Study|Withdrawal by Subject|0|||
130274194|NCT00070109|468967360|FG000|Overall Study|Adverse Event|0|||
130274195|NCT00070109|468967361|FG001|Overall Study|Adverse Event|0|||
130274196|NCT00070109|468967362|FG002|Overall Study|Adverse Event|2|||
130274197|NCT00070109|468967363|FG003|Overall Study|Adverse Event|4|||
130274198|NCT00070109|468967364|FG004|Overall Study|Adverse Event|2|||
130274199|NCT00070109|468967360|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
130274200|NCT00070109|468967361|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
130274201|NCT00070109|468967362|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
130274202|NCT00070109|468967363|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
130274203|NCT00070109|468967364|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
130274204|NCT00624468|468967367|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
130274205|NCT00624468|468967368|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
130274206|NCT00624468|468967369|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130274207|NCT00624468|468967370|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130274208|NCT00624468|468967367|FG000|Double-blind Period|Withdrew Prematurely|1|||
130274209|NCT00624468|468967368|FG001|Double-blind Period|Withdrew Prematurely|1|||
130274210|NCT00624468|468967369|FG002|Double-blind Period|Withdrew Prematurely|0|||
130274211|NCT00624468|468967370|FG003|Double-blind Period|Withdrew Prematurely|0|||
130274212|NCT00624468|468967367|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130274213|NCT00624468|468967368|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130274214|NCT00624468|468967369|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
130274215|NCT00624468|468967370|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
130274216|NCT00624468|468967367|FG000|Safety Follow-up (SFU) Period|Other|0|||
130274217|NCT00624468|468967368|FG001|Safety Follow-up (SFU) Period|Other|0|||
130274218|NCT00624468|468967369|FG002|Safety Follow-up (SFU) Period|Other|1|||
130274219|NCT00624468|468967370|FG003|Safety Follow-up (SFU) Period|Other|1|||
130274220|NCT02550288|468967371|FG000|Overall Study|Adverse Event|0|||
130274221|NCT02550288|468967372|FG001|Overall Study|Adverse Event|1|||
130274222|NCT02550288|468967373|FG002|Overall Study|Adverse Event|0|||
130274223|NCT02550288|468967374|FG003|Overall Study|Adverse Event|0|||
130274224|NCT02550288|468967375|FG004|Overall Study|Adverse Event|0|||
130274225|NCT02550288|468967371|FG000|Overall Study|Physician Decision|0|||
130274226|NCT02550288|468967372|FG001|Overall Study|Physician Decision|0|||
130274227|NCT02550288|468967373|FG002|Overall Study|Physician Decision|0|||
130274228|NCT02550288|468967374|FG003|Overall Study|Physician Decision|1|||
130274229|NCT02550288|468967375|FG004|Overall Study|Physician Decision|0|||
130274230|NCT02550288|468967371|FG000|Overall Study|Protocol Violation|2|||
130274231|NCT02550288|468967372|FG001|Overall Study|Protocol Violation|2|||
130274232|NCT02550288|468967373|FG002|Overall Study|Protocol Violation|1|||
130274233|NCT02550288|468967374|FG003|Overall Study|Protocol Violation|0|||
130274234|NCT02550288|468967375|FG004|Overall Study|Protocol Violation|3|||
130274235|NCT02550288|468967371|FG000|Overall Study|Participant moved|0|||
130274236|NCT02550288|468967372|FG001|Overall Study|Participant moved|0|||
130274237|NCT02550288|468967373|FG002|Overall Study|Participant moved|0|||
130274238|NCT02550288|468967374|FG003|Overall Study|Participant moved|1|||
130274239|NCT02550288|468967375|FG004|Overall Study|Participant moved|0|||
130274240|NCT02550288|468967371|FG000|Overall Study|Withdrawal by Subject|0|||
130274241|NCT02550288|468967372|FG001|Overall Study|Withdrawal by Subject|0|||
130274242|NCT02550288|468967373|FG002|Overall Study|Withdrawal by Subject|0|||
130274243|NCT02550288|468967374|FG003|Overall Study|Withdrawal by Subject|1|||
130274244|NCT02550288|468967375|FG004|Overall Study|Withdrawal by Subject|0|||
130274245|NCT00803361|468967377|FG000|Overall Study|Adverse Event|13|||
130274246|NCT00803361|468967378|FG001|Overall Study|Adverse Event|3|||
130274247|NCT00803361|468967377|FG000|Overall Study|Lack of Efficacy|4|||
130274248|NCT00803361|468967378|FG001|Overall Study|Lack of Efficacy|13|||
130274249|NCT00803361|468967377|FG000|Overall Study|Lost to Follow-up|1|||
130274250|NCT00803361|468967378|FG001|Overall Study|Lost to Follow-up|2|||
130274251|NCT00803361|468967377|FG000|Overall Study|Physician Decision|1|||
130274252|NCT00803361|468967378|FG001|Overall Study|Physician Decision|0|||
130274253|NCT00803361|468967377|FG000|Overall Study|Protocol Violation|2|||
130274254|NCT00803361|468967378|FG001|Overall Study|Protocol Violation|4|||
130274255|NCT00803361|468967377|FG000|Overall Study|Withdrawal by Subject|5|||
130274256|NCT00803361|468967378|FG001|Overall Study|Withdrawal by Subject|6|||
130274257|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
130708839|NCT05206448|470560496|FG001|Overall Study|unable to complete study due to personal constraints|0|||
130708840|NCT05206448|470560495|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
130708841|NCT05206448|470560496|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
130708842|NCT02025010|470560497|FG000|Overall Study|Symptomatic or radiographic progression|36|||
130708843|NCT02025010|470560497|FG000|Overall Study|Adverse Event|6|||
130708844|NCT02025010|470560497|FG000|Overall Study|Physician Decision|7|||
130708845|NCT02025010|470560497|FG000|Overall Study|Withdrawal by Subject|3|||
130708846|NCT02025010|470560497|FG000|Overall Study|Intercurrent illness|3|||
130274258|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274259|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
130708847|NCT02025010|470560497|FG000|Overall Study|Patients still on treatment|3|||
130274260|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
130274261|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274262|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274263|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274264|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274265|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274266|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
130274267|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274268|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274269|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274270|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
130274271|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274272|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274273|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274274|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274275|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274276|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
130274277|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274278|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274279|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274280|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274281|NCT03629223|468967379|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
130274282|NCT03629223|468967380|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274283|NCT03629223|468967381|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274284|NCT03629223|468967382|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274285|NCT03629223|468967383|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274286|NCT03629223|468967384|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274287|NCT01534351|468967385|FG000|Overall Study|Study Terminated Early|1|||
130274288|NCT01534351|468967386|FG001|Overall Study|Study Terminated Early|0|||
130274289|NCT01534351|468967387|FG002|Overall Study|Study Terminated Early|0|||
130274290|NCT02702609|468967388|FG000|Overall Study|Lost to Follow-up|8|||
130274291|NCT02702609|468967389|FG001|Overall Study|Lost to Follow-up|4|||
130274292|NCT02702609|468967388|FG000|Overall Study|Physician Decision|1|||
130274293|NCT02702609|468967389|FG001|Overall Study|Physician Decision|0|||
130274294|NCT02674464|468967390|FG000|Overall Study|Death|10|||
130274295|NCT02674464|468967391|FG001|Overall Study|Death|21|||
130274296|NCT02674464|468967390|FG000|Overall Study|Withdrawal by Subject|24|||
130274297|NCT02674464|468967391|FG001|Overall Study|Withdrawal by Subject|44|||
130274298|NCT02674464|468967390|FG000|Overall Study|Lost to Follow-up|97|||
130274299|NCT02674464|468967391|FG001|Overall Study|Lost to Follow-up|92|||
130274300|NCT02674464|468967390|FG000|Overall Study|Outside survey window|6|||
130274301|NCT02674464|468967391|FG001|Overall Study|Outside survey window|3|||
130274302|NCT00783835|468967392|FG000|Overall Study|Adverse Event|3|||
130274303|NCT00783835|468967392|FG000|Overall Study|Medical Criteria|1|||
130274304|NCT00783835|468967392|FG000|Overall Study|Withdrawal by Subject|2|||
130274305|NCT00783835|468967392|FG000|Overall Study|Lost to Follow-up|1|||
130274306|NCT00783835|468967392|FG000|Overall Study|Participant not Adherent|3|||
130274307|NCT03835481|468967393|FG000|Double-blind Period|Other not stated below|0|||
130274308|NCT03835481|468967394|FG001|Double-blind Period|Other not stated below|0|||
130274309|NCT03835481|468967395|FG002|Double-blind Period|Other not stated below|0|||
130274310|NCT03835481|468967396|FG003|Double-blind Period|Other not stated below|1|||
130274311|NCT03835481|468967397|FG004|Double-blind Period|Other not stated below|1|||
130274312|NCT03835481|468967393|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
130274313|NCT03835481|468967394|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
130274314|NCT03835481|468967395|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
130274315|NCT03835481|468967396|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
130274316|NCT03835481|468967397|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
130274317|NCT03835481|468967393|FG000|Double-blind Period|Withdrawal by Subject|0|||
130274318|NCT03835481|468967394|FG001|Double-blind Period|Withdrawal by Subject|0|||
130274319|NCT03835481|468967395|FG002|Double-blind Period|Withdrawal by Subject|1|||
130274320|NCT03835481|468967396|FG003|Double-blind Period|Withdrawal by Subject|0|||
130274321|NCT03835481|468967397|FG004|Double-blind Period|Withdrawal by Subject|5|||
130274322|NCT03835481|468967393|FG000|Double-blind Period|Lost to Follow-up|0|||
130274323|NCT03835481|468967394|FG001|Double-blind Period|Lost to Follow-up|0|||
130274324|NCT03835481|468967395|FG002|Double-blind Period|Lost to Follow-up|0|||
130367262|NCT01513343|469315892|FG000|6-month Follow-up|Lost to Follow-up|28|||
130367263|NCT01513343|469315893|FG001|6-month Follow-up|Lost to Follow-up|17|||
130274325|NCT03835481|468967396|FG003|Double-blind Period|Lost to Follow-up|1|||
130274326|NCT03835481|468967397|FG004|Double-blind Period|Lost to Follow-up|0|||
130274327|NCT03835481|468967393|FG000|Double-blind Period|Protocol Violation|0|||
130274328|NCT03835481|468967394|FG001|Double-blind Period|Protocol Violation|2|||
130274329|NCT03835481|468967395|FG002|Double-blind Period|Protocol Violation|0|||
130274330|NCT03835481|468967396|FG003|Double-blind Period|Protocol Violation|1|||
130274331|NCT03835481|468967397|FG004|Double-blind Period|Protocol Violation|0|||
130274332|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130367264|NCT01513343|469315892|FG000|12-month Follow-up|Lost to Follow-up|10|||
130367265|NCT01513343|469315893|FG001|12-month Follow-up|Lost to Follow-up|3|||
130456834|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
130456835|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
130456836|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
130456837|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
130456838|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
130456839|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
130274333|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130274334|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
130274335|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
130456840|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
130274336|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
130274337|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130274338|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130274339|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
130274340|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
130274341|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
130274342|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274343|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274344|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
130274345|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
130367266|NCT00064337|469315894|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
130367267|NCT00064337|469315894|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
130367268|NCT00064337|469315894|FG000|PBSCC or Induction/PBSCC|Progression|3|||
130367269|NCT00064337|469315894|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
130367270|NCT00064337|469315894|FG000|PBSCC or Induction/PBSCC|Death|2|||
130367271|NCT00064337|469315894|FG000|Transplant|Adverse Event|9|||
130367272|NCT00064337|469315894|FG000|Transplant|Not protocol-specified|5|||
130367273|NCT00064337|469315894|FG000|Transplant|Death|3|||
130367274|NCT00064337|469315894|FG000|Transplant|Patient Refusal|2|||
130367275|NCT00064337|469315894|FG000|Transplant|Progression|2|||
130367276|NCT00064337|469315894|FG000|Maintenance|Adverse Event|3|||
130367277|NCT00064337|469315894|FG000|Maintenance|Progression|2|||
130367278|NCT00064337|469315894|FG000|Maintenance|On treatment at time of analysis|2|||
130367279|NCT00064337|469315894|FG000|Maintenance|Not protocol-specified|2|||
130367280|NCT00064337|469315894|FG000|Maintenance|Death|1|||
130367281|NCT01397890|469315895|FG000|Overall Study|Withdrawal by Subject|7|||
130367282|NCT01397890|469315896|FG001|Overall Study|Withdrawal by Subject|11|||
130367283|NCT01397890|469315895|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
130367284|NCT01397890|469315896|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
130367285|NCT01397890|469315895|FG000|Overall Study|Death|2|||
130367286|NCT01397890|469315896|FG001|Overall Study|Death|3|||
130367287|NCT01397890|469315895|FG000|Overall Study|Lost to Follow-up|1|||
130367288|NCT01397890|469315896|FG001|Overall Study|Lost to Follow-up|4|||
130367289|NCT01397890|469315895|FG000|Overall Study|Condition under Investigation Worsened|1|||
130367290|NCT01397890|469315896|FG001|Overall Study|Condition under Investigation Worsened|3|||
130367291|NCT01397890|469315895|FG000|Overall Study|Adverse Event|1|||
130367292|NCT01397890|469315896|FG001|Overall Study|Adverse Event|2|||
130367293|NCT01397890|469315895|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
130367294|NCT01397890|469315896|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
130367295|NCT01397890|469315895|FG000|Overall Study|Others|2|||
130367296|NCT01397890|469315896|FG001|Overall Study|Others|1|||
130367297|NCT00002651|469315897|FG000|Induction|Adverse Event|44|||
130367298|NCT00002651|469315898|FG001|Induction|Adverse Event|0|||
130367299|NCT00002651|469315899|FG002|Induction|Adverse Event|0|||
130367300|NCT00002651|469315897|FG000|Induction|Refusal unrelated to adverse event|50|||
130367301|NCT00002651|469315898|FG001|Induction|Refusal unrelated to adverse event|0|||
130708848|NCT02025010|470560497|FG000|Overall Study|Never initiate the treatment|2|||
130708849|NCT01661881|470560499|FG000|Overall Study|Disease Progression|1|||
130708850|NCT00949988|470560504|FG000|Overall Study|Withdrawal by Subject|3|||
130708851|NCT00484419|470560511|FG000|Overall Study|Adverse Event|3|||
130708852|NCT00484419|470560512|FG001|Overall Study|Adverse Event|0|||
130708853|NCT00484419|470560513|FG002|Overall Study|Adverse Event|0|||
130708854|NCT00484419|470560511|FG000|Overall Study|Lost to Follow-up|1|||
130708855|NCT00484419|470560512|FG001|Overall Study|Lost to Follow-up|0|||
130708856|NCT00484419|470560513|FG002|Overall Study|Lost to Follow-up|2|||
130708857|NCT00484419|470560511|FG000|Overall Study|Withdrawal by Subject|3|||
130708858|NCT00484419|470560512|FG001|Overall Study|Withdrawal by Subject|1|||
130708859|NCT00484419|470560513|FG002|Overall Study|Withdrawal by Subject|1|||
130708860|NCT00484419|470560511|FG000|Overall Study|subject met discontinuation criteria|2|||
130708861|NCT00484419|470560512|FG001|Overall Study|subject met discontinuation criteria|2|||
130708862|NCT00484419|470560513|FG002|Overall Study|subject met discontinuation criteria|4|||
130708863|NCT00484419|470560511|FG000|Overall Study|required restricted medication|1|||
130708864|NCT00484419|470560512|FG001|Overall Study|required restricted medication|0|||
130708865|NCT00484419|470560513|FG002|Overall Study|required restricted medication|1|||
130708866|NCT00484419|470560511|FG000|Overall Study|Physician Decision|1|||
130708867|NCT00484419|470560512|FG001|Overall Study|Physician Decision|1|||
130708868|NCT00484419|470560513|FG002|Overall Study|Physician Decision|1|||
130708869|NCT00484419|470560511|FG000|Overall Study|subject unable to receive medication|1|||
130708870|NCT00484419|470560512|FG001|Overall Study|subject unable to receive medication|0|||
130708871|NCT00484419|470560513|FG002|Overall Study|subject unable to receive medication|0|||
130708872|NCT00484419|470560511|FG000|Overall Study|subject relocated|0|||
130708873|NCT00484419|470560512|FG001|Overall Study|subject relocated|1|||
130708874|NCT00484419|470560513|FG002|Overall Study|subject relocated|0|||
130708875|NCT00484419|470560511|FG000|Overall Study|sponsor decision, randomized in error|0|||
130708876|NCT00484419|470560512|FG001|Overall Study|sponsor decision, randomized in error|0|||
130708877|NCT00484419|470560513|FG002|Overall Study|sponsor decision, randomized in error|2|||
130708878|NCT00355472|470560516|FG000|Overall Study|Physician Decision|1|||
130708879|NCT03095118|470560517|FG000|Overall Study|Adverse Event|1|||
130708880|NCT03095118|470560517|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
130367302|NCT00002651|469315899|FG002|Induction|Refusal unrelated to adverse event|0|||
130367303|NCT00002651|469315897|FG000|Induction|Progression/relapse|274|||
130367304|NCT00002651|469315898|FG001|Induction|Progression/relapse|0|||
130367305|NCT00002651|469315899|FG002|Induction|Progression/relapse|0|||
130367306|NCT00002651|469315897|FG000|Induction|Death|62|||
130367307|NCT00002651|469315898|FG001|Induction|Death|0|||
130367308|NCT00002651|469315899|FG002|Induction|Death|0|||
130367309|NCT00002651|469315897|FG000|Induction|Other|823|||
130554633|NCT04288778|469998046|FG000|Overall Study|Withdrawal by Subject|2|||
130554634|NCT04288778|469998046|FG000|Overall Study|Adverse Event|5|||
130274346|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274347|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
130274348|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
130274349|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
130274350|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
130274351|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
130274352|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274353|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274354|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274355|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
130274356|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274357|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
130274358|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
130274359|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
130274360|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
130274361|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
130274362|NCT00255723|468967400|FG000|Overall Study|Adverse Event|1|||
130274363|NCT00255723|468967401|FG001|Overall Study|Adverse Event|1|||
130274364|NCT00255723|468967400|FG000|Overall Study|Death|0|||
130274365|NCT00255723|468967401|FG001|Overall Study|Death|1|||
130274366|NCT00255723|468967400|FG000|Overall Study|Response Data Not Available|1|||
130274367|NCT00255723|468967401|FG001|Overall Study|Response Data Not Available|0|||
130274368|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
130274369|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
130274370|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
130274371|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
130274372|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
130274373|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
130274374|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
130274375|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
130274376|NCT01169701|468967417|FG000|Overall Study|Lost to Follow-up|1|||
130274377|NCT01169701|468967418|FG001|Overall Study|Lost to Follow-up|1|||
130274378|NCT01169701|468967417|FG000|Overall Study|Withdrawal by Subject|1|||
130274379|NCT01169701|468967418|FG001|Overall Study|Withdrawal by Subject|3|||
130274380|NCT01169701|468967417|FG000|Overall Study|Adverse Event|1|||
130274381|NCT01169701|468967418|FG001|Overall Study|Adverse Event|2|||
130274382|NCT01169701|468967417|FG000|Overall Study|Exclusion criteria|2|||
130274383|NCT01169701|468967418|FG001|Overall Study|Exclusion criteria|0|||
130274384|NCT01169701|468967417|FG000|Overall Study|Death|0|||
130274385|NCT01169701|468967418|FG001|Overall Study|Death|1|||
130274386|NCT01169701|468967417|FG000|Overall Study|Administrative problems|0|||
130274387|NCT01169701|468967418|FG001|Overall Study|Administrative problems|1|||
130274388|NCT01169701|468967417|FG000|Overall Study|Serious adverse event|0|||
130274389|NCT01169701|468967418|FG001|Overall Study|Serious adverse event|1|||
130274390|NCT01169701|468967417|FG000|Overall Study|Sponsor decision|0|||
130274391|NCT01169701|468967418|FG001|Overall Study|Sponsor decision|1|||
130274392|NCT00564902|468967419|FG000|Overall Study|Withdrawal by Subject|0|||
130367310|NCT00002651|469315898|FG001|Induction|Other|0|||
130274393|NCT00564902|468967420|FG001|Overall Study|Withdrawal by Subject|3|||
130274394|NCT00564902|468967421|FG002|Overall Study|Withdrawal by Subject|4|||
130274395|NCT00564902|468967419|FG000|Overall Study|Death|1|||
130274396|NCT00564902|468967420|FG001|Overall Study|Death|1|||
130274397|NCT00564902|468967421|FG002|Overall Study|Death|0|||
130367311|NCT00002651|469315899|FG002|Induction|Other|0|||
130367312|NCT00002651|469315897|FG000|Induction|not eligible|90|||
130274398|NCT03583359|468967424|FG000|Overall Study|Withdrawal by Subject|15|||
130274399|NCT03583359|468967425|FG001|Overall Study|Withdrawal by Subject|6|||
130367313|NCT00002651|469315898|FG001|Induction|not eligible|0|||
130554635|NCT04288778|469998046|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130274400|NCT03583359|468967424|FG000|Overall Study|Lost to Follow-up|12|||
130274401|NCT03583359|468967425|FG001|Overall Study|Lost to Follow-up|3|||
130274402|NCT03583359|468967424|FG000|Overall Study|Adverse Event|0|||
130274403|NCT03583359|468967425|FG001|Overall Study|Adverse Event|1|||
130274404|NCT03583359|468967424|FG000|Overall Study|Protocol Violation|0|||
130274405|NCT03583359|468967425|FG001|Overall Study|Protocol Violation|1|||
130708881|NCT03847194|470560520|FG000|Overall Study|Lost to Follow-up|2|||
130708882|NCT03847194|470560521|FG001|Overall Study|Lost to Follow-up|5|||
130708883|NCT03847194|470560520|FG000|Overall Study|Withdrawal by Subject|1|||
130708884|NCT03847194|470560521|FG001|Overall Study|Withdrawal by Subject|2|||
130708885|NCT03847194|470560520|FG000|Overall Study|Death|0|||
130708886|NCT03847194|470560521|FG001|Overall Study|Death|1|||
130708887|NCT02408120|470560522|FG000|Overall Study|Withdrawal by Subject|0|||
130708888|NCT02408120|470560523|FG001|Overall Study|Withdrawal by Subject|1|||
130708889|NCT02408120|470560522|FG000|Overall Study|Treatment Refusal|1|||
130708890|NCT02408120|470560523|FG001|Overall Study|Treatment Refusal|0|||
130708891|NCT02408120|470560522|FG000|Overall Study|Received Steroids|1|||
130708892|NCT02408120|470560523|FG001|Overall Study|Received Steroids|1|||
130708893|NCT02408120|470560522|FG000|Overall Study|Discharged same day|1|||
130708894|NCT02408120|470560523|FG001|Overall Study|Discharged same day|1|||
130708895|NCT02408120|470560522|FG000|Overall Study|Did not receive insulin|1|||
130708896|NCT02408120|470560523|FG001|Overall Study|Did not receive insulin|2|||
130708897|NCT01144403|470560524|FG000|Overall Study|Lost to Follow-up|3|||
130708898|NCT01144403|470560524|FG000|Overall Study|Death|1|||
130708899|NCT01144403|470560524|FG000|Overall Study|Adverse Event|1|||
130708900|NCT00680186|470560529|FG000|Overall Study|Adverse Event|47|||
130708901|NCT00680186|470560530|FG001|Overall Study|Adverse Event|44|||
130708902|NCT00680186|470560529|FG000|Overall Study|Protocol Violation|31|||
130708903|NCT00680186|470560530|FG001|Overall Study|Protocol Violation|26|||
130708904|NCT00680186|470560529|FG000|Overall Study|Lost to Follow-up|11|||
130708905|NCT00680186|470560530|FG001|Overall Study|Lost to Follow-up|6|||
130708906|NCT00680186|470560529|FG000|Overall Study|Withdrawal by Subject|32|||
130708907|NCT00680186|470560530|FG001|Overall Study|Withdrawal by Subject|39|||
130708908|NCT00680186|470560529|FG000|Overall Study|Other|4|||
130708909|NCT00680186|470560530|FG001|Overall Study|Other|1|||
130274406|NCT03583359|468967424|FG000|Overall Study|Other|2|||
130274407|NCT03583359|468967425|FG001|Overall Study|Other|1|||
130274408|NCT00375505|468967426|FG000|Overall Study|Adverse Event|1|||
130274409|NCT00375505|468967427|FG001|Overall Study|Adverse Event|2|||
130274410|NCT02470585|468967428|FG000|Overall Study|Death|224|||
130274411|NCT02470585|468967429|FG001|Overall Study|Death|227|||
130274412|NCT02470585|468967430|FG002|Overall Study|Death|199|||
130274413|NCT02470585|468967428|FG000|Overall Study|Withdrew consent|21|||
130274414|NCT02470585|468967429|FG001|Overall Study|Withdrew consent|22|||
130274415|NCT02470585|468967430|FG002|Overall Study|Withdrew consent|31|||
130274416|NCT02470585|468967428|FG000|Overall Study|Lost to Follow-up|8|||
130274417|NCT02470585|468967429|FG001|Overall Study|Lost to Follow-up|15|||
130274418|NCT02470585|468967430|FG002|Overall Study|Lost to Follow-up|13|||
130274419|NCT02470585|468967428|FG000|Overall Study|Sponsor discontinued study|117|||
130274420|NCT02470585|468967429|FG001|Overall Study|Sponsor discontinued study|110|||
130274421|NCT02470585|468967430|FG002|Overall Study|Sponsor discontinued study|122|||
130274422|NCT02470585|468967428|FG000|Overall Study|Other, not specified|5|||
130274423|NCT02470585|468967429|FG001|Overall Study|Other, not specified|7|||
130274424|NCT02470585|468967430|FG002|Overall Study|Other, not specified|14|||
130274425|NCT02470585|468967428|FG000|Overall Study|Missing due to site non-compliance|0|||
130274426|NCT02470585|468967429|FG001|Overall Study|Missing due to site non-compliance|2|||
130274427|NCT02470585|468967430|FG002|Overall Study|Missing due to site non-compliance|3|||
130274428|NCT03497039|468967431|FG000|Overall Study|Withdrawal by Subject|1|||
130274429|NCT03497039|468967432|FG001|Overall Study|Withdrawal by Subject|0|||
130274430|NCT03497039|468967431|FG000|Overall Study|Protocol Violation|0|||
130274431|NCT03497039|468967432|FG001|Overall Study|Protocol Violation|1|||
130274432|NCT02146131|468967433|FG000|Overall Study|Physician Decision|61|||
130274433|NCT02146131|468967434|FG001|Overall Study|Physician Decision|56|||
130367314|NCT00002651|469315899|FG002|Induction|not eligible|0|||
130554636|NCT04288778|469998046|FG000|Overall Study|Other|1|||
130708910|NCT04647383|470560535|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
130708911|NCT04647383|470560536|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
130554637|NCT04288778|469998046|FG000|Overall Study|Started but not treated|2|||
130554638|NCT01324323|469998047|FG000|Overall Study|Withdrawal by Subject|1|||
130708912|NCT04647383|470560537|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
130274434|NCT00465972|468967437|FG000|Overall Study|Withdrawal by Subject|2|||
130274435|NCT00465972|468967438|FG001|Overall Study|Withdrawal by Subject|1|||
130274436|NCT00861692|468967439|FG000|Overall Study|Death|6|||
130708913|NCT04647383|470560538|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
130708914|NCT00873119|470560546|FG000|Overall Study|Patient request|4|||
130708915|NCT00873119|470560547|FG001|Overall Study|Patient request|2|||
130708916|NCT00873119|470560546|FG000|Overall Study|Adverse Event|8|||
130274437|NCT03292640|468967440|FG000|Overall Study|Withdrawal by Subject|17|||
130274438|NCT03292640|468967441|FG001|Overall Study|Withdrawal by Subject|16|||
130274439|NCT03292640|468967440|FG000|Overall Study|Adverse Event|20|||
130274440|NCT03292640|468967441|FG001|Overall Study|Adverse Event|2|||
130708917|NCT00873119|470560547|FG001|Overall Study|Adverse Event|0|||
130708918|NCT00873119|470560546|FG000|Overall Study|Progressive disease|26|||
130274441|NCT03292640|468967440|FG000|Overall Study|Lost to Follow-up|24|||
130274442|NCT03292640|468967441|FG001|Overall Study|Lost to Follow-up|24|||
130274443|NCT02218697|468967442|FG000|Overall Study|Adverse Event|0|||
130274444|NCT02218697|468967443|FG001|Overall Study|Adverse Event|2|||
130274445|NCT02218697|468967442|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
130274446|NCT02218697|468967443|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
130274447|NCT02218697|468967442|FG000|Overall Study|Withdrawal by Subject|2|||
130274448|NCT02218697|468967443|FG001|Overall Study|Withdrawal by Subject|3|||
130274449|NCT04380753|468967444|FG000|Overall Study|Participants continuing study|4|||
130274450|NCT04380753|468967444|FG000|Overall Study|Death|2|||
130274451|NCT03306433|468967447|FG000|Overall Study|Lost to Follow-up|3|||
130274452|NCT03306433|468967447|FG000|Overall Study|Patient did not have teeth extracted|1|||
130274453|NCT03306433|468967447|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
130274454|NCT01597908|468967448|FG000|Randomized Phase|Death|217|||
130274455|NCT01597908|468967449|FG001|Randomized Phase|Death|238|||
130274456|NCT01597908|468967450|FG002|Randomized Phase|Death|0|||
130274457|NCT01597908|468967448|FG000|Randomized Phase|Sponsor Decision|93|||
130274458|NCT01597908|468967449|FG001|Randomized Phase|Sponsor Decision|39|||
130274459|NCT01597908|468967450|FG002|Randomized Phase|Sponsor Decision|0|||
130274460|NCT01597908|468967448|FG000|Randomized Phase|Lost to Follow-up|9|||
130274461|NCT01597908|468967449|FG001|Randomized Phase|Lost to Follow-up|16|||
130274462|NCT01597908|468967450|FG002|Randomized Phase|Lost to Follow-up|0|||
130274463|NCT01597908|468967448|FG000|Randomized Phase|Physician Decision|6|||
130274464|NCT01597908|468967449|FG001|Randomized Phase|Physician Decision|3|||
130274465|NCT01597908|468967450|FG002|Randomized Phase|Physician Decision|0|||
130274466|NCT01597908|468967448|FG000|Randomized Phase|Withdrawal by Subject|26|||
130274467|NCT01597908|468967449|FG001|Randomized Phase|Withdrawal by Subject|22|||
130274468|NCT01597908|468967450|FG002|Randomized Phase|Withdrawal by Subject|0|||
130274469|NCT01597908|468967448|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130708919|NCT00873119|470560547|FG001|Overall Study|Progressive disease|18|||
130708920|NCT00873119|470560546|FG000|Overall Study|Death|2|||
130708921|NCT00873119|470560547|FG001|Overall Study|Death|1|||
130708922|NCT00873119|470560546|FG000|Overall Study|Other|2|||
130708923|NCT00873119|470560547|FG001|Overall Study|Other|5|||
130708924|NCT00873119|470560546|FG000|Overall Study|Not treated|2|||
130708925|NCT00873119|470560547|FG001|Overall Study|Not treated|0|||
130708926|NCT00285584|470560548|FG000|Month 3|Lost to Follow-up|3|||
130708927|NCT00285584|470560549|FG001|Month 3|Lost to Follow-up|3|||
130708928|NCT00285584|470560548|FG000|Month 3|Withdrawal by Subject|1|||
130708929|NCT00285584|470560549|FG001|Month 3|Withdrawal by Subject|0|||
130708930|NCT00285584|470560548|FG000|Month 6|Lost to Follow-up|0|||
130708931|NCT00285584|470560549|FG001|Month 6|Lost to Follow-up|1|||
130274470|NCT01597908|468967449|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
130274471|NCT01597908|468967450|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130274472|NCT01597908|468967448|FG000|Crossover Phase|Death|0|||
130274473|NCT01597908|468967449|FG001|Crossover Phase|Death|0|||
130274474|NCT01597908|468967450|FG002|Crossover Phase|Death|11|||
130274475|NCT01597908|468967448|FG000|Crossover Phase|Withdrawal by Subject|0|||
130274476|NCT01597908|468967449|FG001|Crossover Phase|Withdrawal by Subject|0|||
130274477|NCT01597908|468967450|FG002|Crossover Phase|Withdrawal by Subject|3|||
130274478|NCT01597908|468967448|FG000|Crossover Phase|Sponsor Decision|0|||
130274479|NCT01597908|468967449|FG001|Crossover Phase|Sponsor Decision|0|||
130274480|NCT01597908|468967450|FG002|Crossover Phase|Sponsor Decision|20|||
130274481|NCT02709577|468967451|FG000|Overall Study|non-accommodating anatomy|0|||
130274482|NCT02709577|468967452|FG001|Overall Study|non-accommodating anatomy|1|||
130274483|NCT02709577|468967453|FG002|Overall Study|non-accommodating anatomy|0|||
130274484|NCT02709577|468967454|FG003|Overall Study|non-accommodating anatomy|0|||
130274485|NCT02709577|468967451|FG000|Overall Study|procedural complication|0|||
130274486|NCT02709577|468967452|FG001|Overall Study|procedural complication|1|||
130274487|NCT02709577|468967453|FG002|Overall Study|procedural complication|0|||
130274488|NCT02709577|468967454|FG003|Overall Study|procedural complication|0|||
130274489|NCT02709577|468967451|FG000|Overall Study|Withdrawal by Subject|2|||
130274490|NCT02709577|468967452|FG001|Overall Study|Withdrawal by Subject|3|||
130708932|NCT00645944|470560550|FG000|Randomized|Withdrawal by Subject|1|||
130708933|NCT00645944|470560551|FG001|Randomized|Withdrawal by Subject|2|||
130274491|NCT02709577|468967453|FG002|Overall Study|Withdrawal by Subject|2|||
130274492|NCT02709577|468967454|FG003|Overall Study|Withdrawal by Subject|0|||
130274493|NCT00948857|468969196|FG000|Overall Study|Lost to Follow-up|1|||
130274494|NCT00948857|468969197|FG001|Overall Study|Lost to Follow-up|0|||
130274495|NCT02120781|468969202|FG000|Overall Study|Physician Decision|2|||
130274496|NCT02120781|468969203|FG001|Overall Study|Physician Decision|0|||
130274497|NCT02120781|468969202|FG000|Overall Study|Completion not documented|2|||
130274498|NCT02120781|468969203|FG001|Overall Study|Completion not documented|1|||
130274499|NCT00654745|468969206|FG000|Overall Study|Adverse Event|12|||
130708934|NCT00645944|470560550|FG000|Received Medication|Adverse Event|2|||
130708935|NCT00645944|470560551|FG001|Received Medication|Adverse Event|1|||
130708936|NCT00645944|470560550|FG000|Received Medication|Withdrawal by Subject|1|||
130708937|NCT00645944|470560551|FG001|Received Medication|Withdrawal by Subject|1|||
130708938|NCT00645944|470560550|FG000|Received Medication|Lost to Follow-up|1|||
130708939|NCT00645944|470560551|FG001|Received Medication|Lost to Follow-up|0|||
130708940|NCT00645944|470560550|FG000|Received Medication|Protocol Violation|2|||
130708941|NCT00645944|470560551|FG001|Received Medication|Protocol Violation|1|||
130708942|NCT02096588|470560552|FG000|Overall Study|Lack of Efficacy|2|||
130708943|NCT02096588|470560553|FG001|Overall Study|Lack of Efficacy|0|||
130708944|NCT02096588|470560552|FG000|Overall Study|Withdrawal by Subject|0|||
130708945|NCT02096588|470560553|FG001|Overall Study|Withdrawal by Subject|1|||
130708946|NCT02470091|470560554|FG000|Overall Study|Withdrawal by Subject|1|||
130708947|NCT02470091|470560555|FG001|Overall Study|Withdrawal by Subject|0|||
130708948|NCT02470091|470560554|FG000|Overall Study|Ineligible|0|||
130708949|NCT02470091|470560555|FG001|Overall Study|Ineligible|2|||
130708950|NCT01523587|470560557|FG000|Overall Study|Other than listed|5|||
130708951|NCT01523587|470560558|FG001|Overall Study|Other than listed|5|||
130708952|NCT01523587|470560557|FG000|Overall Study|Worsening of underlying cancer disease|19|||
130708953|NCT01523587|470560558|FG001|Overall Study|Worsening of underlying cancer disease|34|||
130708954|NCT01523587|470560557|FG000|Overall Study|Adverse Event|68|||
130708955|NCT01523587|470560558|FG001|Overall Study|Adverse Event|52|||
130708956|NCT01523587|470560557|FG000|Overall Study|Protocol Violation|5|||
130708957|NCT01523587|470560558|FG001|Overall Study|Protocol Violation|3|||
130708958|NCT01523587|470560557|FG000|Overall Study|Lost to Follow-up|2|||
130274500|NCT00654745|468969206|FG000|Overall Study|Lost to Follow-up|7|||
130274501|NCT00654745|468969206|FG000|Overall Study|Protocol Violation|11|||
130708959|NCT01523587|470560558|FG001|Overall Study|Lost to Follow-up|2|||
130708960|NCT01523587|470560557|FG000|Overall Study|Withdrawal by Subject|28|||
130708961|NCT01523587|470560558|FG001|Overall Study|Withdrawal by Subject|20|||
130708962|NCT01523587|470560557|FG000|Overall Study|Withdrew due to Progressive disease|265|||
130708963|NCT01523587|470560558|FG001|Overall Study|Withdrew due to Progressive disease|279|||
130708964|NCT01523587|470560557|FG000|Overall Study|Randomised but bot treated|6|||
130708965|NCT01523587|470560558|FG001|Overall Study|Randomised but bot treated|2|||
130274502|NCT00654745|468969206|FG000|Overall Study|Withdrawal by Subject|10|||
130274503|NCT00654745|468969206|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
130274504|NCT00984165|468969207|FG000|Overall Study|Death on study|2|||
130274505|NCT00984165|468969208|FG001|Overall Study|Death on study|0|||
130274506|NCT00984165|468969209|FG002|Overall Study|Death on study|0|||
130274507|NCT00984165|468969210|FG003|Overall Study|Death on study|0|||
130274508|NCT00984165|468969207|FG000|Overall Study|Disease progression on study|5|||
130274509|NCT00984165|468969208|FG001|Overall Study|Disease progression on study|1|||
130274510|NCT00984165|468969209|FG002|Overall Study|Disease progression on study|0|||
130708966|NCT01298778|470560559|FG000|Overall Study|Lost to Follow-up|2|||
130708967|NCT01298778|470560560|FG001|Overall Study|Lost to Follow-up|3|||
130708968|NCT01298778|470560559|FG000|Overall Study|Incorrect use of VAS|1|||
130708969|NCT01298778|470560560|FG001|Overall Study|Incorrect use of VAS|0|||
130708970|NCT01298778|470560559|FG000|Overall Study|Withdrawal by Subject|0|||
130708971|NCT01298778|470560560|FG001|Overall Study|Withdrawal by Subject|1|||
130708972|NCT01298778|470560559|FG000|Overall Study|Protocol Violation|0|||
130708973|NCT01298778|470560560|FG001|Overall Study|Protocol Violation|1|||
130708974|NCT01298778|470560559|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
130708975|NCT01298778|470560560|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
130708976|NCT01020799|470560579|FG000|Overall Study|Adverse Event|4|||
130708977|NCT01020799|470560580|FG001|Overall Study|Adverse Event|3|||
130708978|NCT01020799|470560581|FG002|Overall Study|Adverse Event|2|||
130708979|NCT01020799|470560579|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
130708980|NCT01020799|470560580|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
130708981|NCT01020799|470560581|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
130708982|NCT01020799|470560579|FG000|Overall Study|Protocol Violation|3|||
130708983|NCT01020799|470560580|FG001|Overall Study|Protocol Violation|2|||
130708984|NCT01020799|470560581|FG002|Overall Study|Protocol Violation|0|||
130708985|NCT01020799|470560579|FG000|Overall Study|Withdrawal by Subject|2|||
130708986|NCT01020799|470560580|FG001|Overall Study|Withdrawal by Subject|2|||
130708987|NCT01020799|470560581|FG002|Overall Study|Withdrawal by Subject|3|||
130708988|NCT01020799|470560579|FG000|Overall Study|Lost to Follow-up|6|||
130708989|NCT01020799|470560580|FG001|Overall Study|Lost to Follow-up|4|||
130708990|NCT01020799|470560581|FG002|Overall Study|Lost to Follow-up|2|||
130708991|NCT02610816|470560582|FG000|Phase 1|Withdrawal by Subject|2|||
130708992|NCT02610816|470560583|FG001|Phase 1|Withdrawal by Subject|6|||
130708993|NCT02610816|470560584|FG002|Phase 1|Withdrawal by Subject|0|||
130274511|NCT00984165|468969210|FG003|Overall Study|Disease progression on study|0|||
130274512|NCT00984165|468969207|FG000|Overall Study|Death of recipient|0|||
130274513|NCT00984165|468969208|FG001|Overall Study|Death of recipient|0|||
130274514|NCT00984165|468969209|FG002|Overall Study|Death of recipient|0|||
130708994|NCT02610816|470560585|FG003|Phase 1|Withdrawal by Subject|0|||
130708995|NCT02610816|470560582|FG000|Phase 1|Lost to Follow-up|2|||
130367315|NCT00002651|469315897|FG000|Consolidation and Randomization|Adverse Event|0|||
130367316|NCT00002651|469315898|FG001|Consolidation and Randomization|Adverse Event|36|||
130367317|NCT00002651|469315899|FG002|Consolidation and Randomization|Adverse Event|14|||
130367318|NCT00002651|469315897|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
130367319|NCT00002651|469315898|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
130367320|NCT00002651|469315899|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
130367321|NCT00002651|469315897|FG000|Consolidation and Randomization|Progression/relapse|0|||
130367322|NCT00002651|469315898|FG001|Consolidation and Randomization|Progression/relapse|295|||
130367323|NCT00002651|469315899|FG002|Consolidation and Randomization|Progression/relapse|298|||
130367324|NCT00002651|469315897|FG000|Consolidation and Randomization|Death|0|||
130367325|NCT00002651|469315898|FG001|Consolidation and Randomization|Death|38|||
130367326|NCT00002651|469315899|FG002|Consolidation and Randomization|Death|48|||
130367327|NCT00002651|469315897|FG000|Consolidation and Randomization|Other|0|||
130367328|NCT00002651|469315898|FG001|Consolidation and Randomization|Other|314|||
130367329|NCT00002651|469315899|FG002|Consolidation and Randomization|Other|313|||
130367330|NCT00002651|469315897|FG000|Consolidation and Randomization|not eligible|0|||
130367331|NCT00002651|469315898|FG001|Consolidation and Randomization|not eligible|102|||
130367332|NCT00002651|469315899|FG002|Consolidation and Randomization|not eligible|112|||
130554639|NCT03153137|469998048|FG000|Overall Study|Lost to Follow-up|1|||
130554640|NCT03153137|469998049|FG001|Overall Study|Lost to Follow-up|0|||
130554641|NCT03153137|469998048|FG000|Overall Study|Withdrawal by Subject|2|||
130554642|NCT03153137|469998049|FG001|Overall Study|Withdrawal by Subject|1|||
130554643|NCT03153137|469998048|FG000|Overall Study|Physician Decision|0|||
130554644|NCT03153137|469998049|FG001|Overall Study|Physician Decision|3|||
130554645|NCT00993915|469998056|FG000|Overall Study|Insufficient clinical response|3|||
130554646|NCT00993915|469998056|FG000|Overall Study|Withdrawal by Subject|2|||
130554647|NCT00993915|469998056|FG000|Overall Study|Other|1|||
130554648|NCT00993915|469998056|FG000|Overall Study|Ongoing|3|||
130554649|NCT00769860|469998057|FG000|Overall Study|Withdrawal by Subject|2|||
130554650|NCT00769860|469998058|FG001|Overall Study|Withdrawal by Subject|0|||
130554651|NCT01603082|469998059|FG000|Overall Study|Adverse Event|0|||
130554652|NCT01603082|469998060|FG001|Overall Study|Adverse Event|1|||
130554653|NCT01603082|469998059|FG000|Overall Study|Withdrawal by Subject|1|||
130554654|NCT01603082|469998060|FG001|Overall Study|Withdrawal by Subject|0|||
130554655|NCT01603082|469998059|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
130554656|NCT01603082|469998060|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
130554657|NCT01019317|469998064|FG000|Overall Study|Not Eligible|4|||
130554658|NCT03294109|469998066|FG000|Overall Study|Withdrawal by Subject|6|||
130554659|NCT03294109|469998067|FG001|Overall Study|Withdrawal by Subject|5|||
130554660|NCT04744285|469998068|FG000|Overall Study|Withdrawal by Subject|1|||
130554661|NCT04744285|469998069|FG001|Overall Study|Withdrawal by Subject|1|||
130554662|NCT04744285|469998070|FG002|Overall Study|Withdrawal by Subject|2|||
130367333|NCT03741062|469315902|FG000|Overall Study|Protocol Violation|1|||
130367334|NCT03741062|469315903|FG001|Overall Study|Protocol Violation|0|||
130367335|NCT02763462|469315906|FG000|Overall Study|Protocol Violation|6|||
130367336|NCT03417219|469315907|FG000|Overall Study|Lost to Follow-up|0|||
130367337|NCT03417219|469315908|FG001|Overall Study|Lost to Follow-up|3|||
130367338|NCT00261807|469315909|FG000|Overall Study|Lost to Follow-up|2|||
130367339|NCT00261807|469315909|FG000|Overall Study|Adverse Event|2|||
130367340|NCT00261807|469315909|FG000|Overall Study|Death|1|||
130367341|NCT00261807|469315909|FG000|Overall Study|Protocol Violation|2|||
130367342|NCT02527161|469315912|FG000|Overall Study|Failed MRI|52|||
130367343|NCT02527161|469315912|FG000|Overall Study|Withdrawal by Subject|19|||
130367344|NCT02527161|469315912|FG000|Overall Study|Delay in or unfit for surgery|16|||
130554663|NCT04744285|469998071|FG003|Overall Study|Withdrawal by Subject|1|||
130554664|NCT01774084|469998072|FG000|Overall Study|Personal reasons|1|||
130554665|NCT01774084|469998073|FG001|Overall Study|Personal reasons|0|||
130554666|NCT00821431|469998074|FG000|Overall Study|Adverse Event|6|||
130367345|NCT02527161|469315912|FG000|Overall Study|MRI contraindication|6|||
130554667|NCT00821431|469998075|FG001|Overall Study|Adverse Event|3|||
130367346|NCT02527161|469315912|FG000|Overall Study|Consent violation|4|||
130367347|NCT02527161|469315912|FG000|Overall Study|Only Recruited to Part A|27|||
130367348|NCT02527161|469315912|FG000|Overall Study|Physician Decision|1|||
130367349|NCT02527161|469315912|FG000|Overall Study|Adverse Event|1|||
130367350|NCT02527161|469315912|FG000|Overall Study|Lost to Follow-up|6|||
130554668|NCT00821431|469998074|FG000|Overall Study|Withdrawal by Subject|5|||
130708996|NCT02610816|470560583|FG001|Phase 1|Lost to Follow-up|1|||
130708997|NCT02610816|470560584|FG002|Phase 1|Lost to Follow-up|0|||
130708998|NCT02610816|470560585|FG003|Phase 1|Lost to Follow-up|0|||
130708999|NCT02610816|470560582|FG000|Phase 1|Physician Decision|0|||
130709000|NCT02610816|470560583|FG001|Phase 1|Physician Decision|1|||
130709001|NCT02610816|470560584|FG002|Phase 1|Physician Decision|0|||
130709002|NCT02610816|470560585|FG003|Phase 1|Physician Decision|0|||
130709003|NCT02610816|470560582|FG000|Phase 2|Withdrawal by Subject|0|||
130709004|NCT02610816|470560583|FG001|Phase 2|Withdrawal by Subject|0|||
130709005|NCT02610816|470560584|FG002|Phase 2|Withdrawal by Subject|9|||
130709006|NCT02610816|470560585|FG003|Phase 2|Withdrawal by Subject|3|||
130709007|NCT02610816|470560582|FG000|Phase 2|Lost to Follow-up|0|||
130709008|NCT02610816|470560583|FG001|Phase 2|Lost to Follow-up|0|||
130709009|NCT02610816|470560584|FG002|Phase 2|Lost to Follow-up|2|||
130709010|NCT02610816|470560585|FG003|Phase 2|Lost to Follow-up|0|||
130709011|NCT02610816|470560582|FG000|Phase 2|Physician Decision|0|||
130709012|NCT02610816|470560583|FG001|Phase 2|Physician Decision|0|||
130709013|NCT02610816|470560584|FG002|Phase 2|Physician Decision|0|||
130709014|NCT02610816|470560585|FG003|Phase 2|Physician Decision|2|||
130709015|NCT02610816|470560582|FG000|Phase 2|Pregnancy|0|||
130709016|NCT02610816|470560583|FG001|Phase 2|Pregnancy|0|||
130709017|NCT02610816|470560584|FG002|Phase 2|Pregnancy|0|||
130709018|NCT02610816|470560585|FG003|Phase 2|Pregnancy|1|||
130709019|NCT03438227|470560588|FG000|Overall Study|Withdrawal by Subject|10|||
130709020|NCT03438227|470560589|FG001|Overall Study|Withdrawal by Subject|5|||
130709021|NCT01855048|470560590|FG000|Overall Study|Withdrawal by Subject|0|||
130709022|NCT01855048|470560591|FG001|Overall Study|Withdrawal by Subject|1|||
130709023|NCT01855048|470560592|FG002|Overall Study|Withdrawal by Subject|0|||
130709024|NCT01855048|470560593|FG003|Overall Study|Withdrawal by Subject|0|||
130709025|NCT01855048|470560594|FG004|Overall Study|Withdrawal by Subject|1|||
130709026|NCT01855048|470560595|FG005|Overall Study|Withdrawal by Subject|0|||
130709027|NCT02691741|470560596|FG000|Overall Study|Adverse Event|0|||
130709028|NCT02691741|470560597|FG001|Overall Study|Adverse Event|2|||
130709029|NCT02691741|470560596|FG000|Overall Study|Lost to Follow-up|1|||
130709030|NCT02691741|470560597|FG001|Overall Study|Lost to Follow-up|0|||
130274515|NCT00984165|468969210|FG003|Overall Study|Death of recipient|1|||
130274516|NCT00984165|468969207|FG000|Overall Study|New protocol|0|||
130274517|NCT00984165|468969208|FG001|Overall Study|New protocol|0|||
130274518|NCT00984165|468969209|FG002|Overall Study|New protocol|0|||
130274519|NCT00984165|468969210|FG003|Overall Study|New protocol|1|||
130274520|NCT00984165|468969207|FG000|Overall Study|P+/donor pair removed from protocol|0|||
130274521|NCT00984165|468969208|FG001|Overall Study|P+/donor pair removed from protocol|0|||
130709031|NCT02691741|470560596|FG000|Overall Study|Physician Decision|0|||
130709032|NCT02691741|470560597|FG001|Overall Study|Physician Decision|1|||
130456841|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
130456842|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
130709033|NCT02691741|470560596|FG000|Overall Study|Withdrawal by Subject|0|||
130709034|NCT02691741|470560597|FG001|Overall Study|Withdrawal by Subject|4|||
130274522|NCT00984165|468969209|FG002|Overall Study|P+/donor pair removed from protocol|0|||
130274523|NCT00984165|468969210|FG003|Overall Study|P+/donor pair removed from protocol|1|||
130274524|NCT00984165|468969207|FG000|Overall Study|removed with a pair recipient|0|||
130274525|NCT00984165|468969208|FG001|Overall Study|removed with a pair recipient|0|||
130456843|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
130456844|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
130456845|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
130709035|NCT02139124|470560598|FG000|Overall Study|Adverse Event|2|||
130709036|NCT02139124|470560599|FG001|Overall Study|Adverse Event|0|||
130274526|NCT00984165|468969209|FG002|Overall Study|removed with a pair recipient|0|||
130274527|NCT00984165|468969210|FG003|Overall Study|removed with a pair recipient|1|||
130274528|NCT00466947|468969211|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
130274529|NCT00466947|468969212|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
130274530|NCT00466947|468969211|FG000|Study End Analysis Period|Adverse Event|35|||
130274531|NCT00466947|468969212|FG001|Study End Analysis Period|Adverse Event|43|||
130274532|NCT00466947|468969211|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
130274533|NCT00466947|468969212|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
130274534|NCT00466947|468969211|FG000|Study End Analysis Period|Physician Decision|29|||
130274535|NCT00466947|468969212|FG001|Study End Analysis Period|Physician Decision|29|||
130274536|NCT00466947|468969211|FG000|Study End Analysis Period|Protocol Violation|9|||
130274537|NCT00466947|468969212|FG001|Study End Analysis Period|Protocol Violation|17|||
130274538|NCT00466947|468969211|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
130274539|NCT00466947|468969212|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
130274540|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
130274541|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
130274542|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
130274543|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
130709037|NCT02139124|470560600|FG002|Overall Study|Adverse Event|1|||
130709038|NCT02139124|470560601|FG003|Overall Study|Adverse Event|2|||
130709039|NCT02139124|470560602|FG004|Overall Study|Adverse Event|5|||
130709040|NCT02139124|470560598|FG000|Overall Study|Withdrawal by Subject|2|||
130709041|NCT02139124|470560599|FG001|Overall Study|Withdrawal by Subject|2|||
130709042|NCT02139124|470560600|FG002|Overall Study|Withdrawal by Subject|2|||
130709043|NCT02139124|470560601|FG003|Overall Study|Withdrawal by Subject|2|||
130709044|NCT02139124|470560602|FG004|Overall Study|Withdrawal by Subject|3|||
130709045|NCT02139124|470560598|FG000|Overall Study|Protocol Violation|0|||
130709046|NCT02139124|470560599|FG001|Overall Study|Protocol Violation|0|||
130709047|NCT02139124|470560600|FG002|Overall Study|Protocol Violation|0|||
130709048|NCT02139124|470560601|FG003|Overall Study|Protocol Violation|1|||
130709049|NCT02139124|470560602|FG004|Overall Study|Protocol Violation|1|||
130709050|NCT02139124|470560598|FG000|Overall Study|non-compliant|1|||
130709051|NCT02139124|470560599|FG001|Overall Study|non-compliant|0|||
130709052|NCT02139124|470560600|FG002|Overall Study|non-compliant|0|||
130709053|NCT02139124|470560601|FG003|Overall Study|non-compliant|2|||
130709054|NCT02139124|470560602|FG004|Overall Study|non-compliant|0|||
130709055|NCT02139124|470560598|FG000|Overall Study|incarceration|0|||
130709056|NCT02139124|470560599|FG001|Overall Study|incarceration|0|||
130709057|NCT02139124|470560600|FG002|Overall Study|incarceration|1|||
130709058|NCT02139124|470560601|FG003|Overall Study|incarceration|0|||
130709059|NCT02139124|470560602|FG004|Overall Study|incarceration|0|||
130709060|NCT02139124|470560598|FG000|Overall Study|subject moved|1|||
130709061|NCT02139124|470560599|FG001|Overall Study|subject moved|0|||
130709062|NCT02139124|470560600|FG002|Overall Study|subject moved|0|||
130709063|NCT02139124|470560601|FG003|Overall Study|subject moved|0|||
130709064|NCT02139124|470560602|FG004|Overall Study|subject moved|0|||
130709065|NCT02139124|470560598|FG000|Overall Study|Lost to Follow-up|3|||
130709066|NCT02139124|470560599|FG001|Overall Study|Lost to Follow-up|2|||
130709067|NCT02139124|470560600|FG002|Overall Study|Lost to Follow-up|0|||
130709068|NCT02139124|470560601|FG003|Overall Study|Lost to Follow-up|5|||
130709069|NCT02139124|470560602|FG004|Overall Study|Lost to Follow-up|4|||
130709070|NCT01813071|470560603|FG000|Overall Study|Protocol Violation|0|||
130709071|NCT01813071|470560604|FG001|Overall Study|Protocol Violation|0|||
130709072|NCT01813071|470560605|FG002|Overall Study|Protocol Violation|0|||
130709073|NCT01813071|470560606|FG003|Overall Study|Protocol Violation|0|||
130709074|NCT01813071|470560607|FG004|Overall Study|Protocol Violation|1|||
130709075|NCT01813071|470560608|FG005|Overall Study|Protocol Violation|4|||
130709076|NCT01813071|470560609|FG006|Overall Study|Protocol Violation|2|||
130709077|NCT01813071|470560610|FG007|Overall Study|Protocol Violation|4|||
130709078|NCT01813071|470560611|FG008|Overall Study|Protocol Violation|2|||
130709079|NCT01813071|470560603|FG000|Overall Study|Withdrawal by Subject|0|||
130709080|NCT01813071|470560604|FG001|Overall Study|Withdrawal by Subject|0|||
130709081|NCT01813071|470560605|FG002|Overall Study|Withdrawal by Subject|0|||
130709082|NCT01813071|470560606|FG003|Overall Study|Withdrawal by Subject|0|||
130709083|NCT01813071|470560607|FG004|Overall Study|Withdrawal by Subject|0|||
130709084|NCT01813071|470560608|FG005|Overall Study|Withdrawal by Subject|1|||
130709085|NCT01813071|470560609|FG006|Overall Study|Withdrawal by Subject|0|||
130709086|NCT01813071|470560610|FG007|Overall Study|Withdrawal by Subject|0|||
130709087|NCT01813071|470560611|FG008|Overall Study|Withdrawal by Subject|0|||
130709088|NCT01813071|470560603|FG000|Overall Study|Adverse Event|0|||
130709089|NCT01813071|470560604|FG001|Overall Study|Adverse Event|0|||
130709090|NCT01813071|470560605|FG002|Overall Study|Adverse Event|0|||
130709091|NCT01813071|470560606|FG003|Overall Study|Adverse Event|0|||
130709092|NCT01813071|470560607|FG004|Overall Study|Adverse Event|0|||
130709093|NCT01813071|470560608|FG005|Overall Study|Adverse Event|1|||
130709094|NCT01813071|470560609|FG006|Overall Study|Adverse Event|0|||
130709095|NCT01813071|470560610|FG007|Overall Study|Adverse Event|0|||
130274544|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
130456846|NCT00853827|469636316|FG000|Double Blind Period (103 Weeks)|Death|1|||
130456847|NCT00853827|469636317|FG001|Double Blind Period (103 Weeks)|Death|6|||
130456848|NCT02596035|469636329|FG000|Overall Study|Disease Progression|64|||
130274545|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
130274546|NCT01995526|468969213|FG000|Overall Study|Physician Decision|1|||
130709096|NCT01813071|470560611|FG008|Overall Study|Adverse Event|0|||
130709097|NCT01813071|470560603|FG000|Overall Study|Physician Decision|0|||
130709098|NCT01813071|470560604|FG001|Overall Study|Physician Decision|0|||
130709099|NCT01813071|470560605|FG002|Overall Study|Physician Decision|0|||
130709100|NCT01813071|470560606|FG003|Overall Study|Physician Decision|0|||
130709101|NCT01813071|470560607|FG004|Overall Study|Physician Decision|0|||
130709102|NCT01813071|470560608|FG005|Overall Study|Physician Decision|0|||
130709103|NCT01813071|470560609|FG006|Overall Study|Physician Decision|1|||
130709104|NCT01813071|470560610|FG007|Overall Study|Physician Decision|0|||
130709105|NCT01813071|470560611|FG008|Overall Study|Physician Decision|0|||
130709106|NCT01813071|470560603|FG000|Overall Study|Met inc/exc criteria|0|||
130709107|NCT01813071|470560604|FG001|Overall Study|Met inc/exc criteria|0|||
130274547|NCT02229825|468969219|FG000|Overall Study|Personal Reasons|0|||
130709108|NCT01813071|470560605|FG002|Overall Study|Met inc/exc criteria|0|||
130709109|NCT01813071|470560606|FG003|Overall Study|Met inc/exc criteria|0|||
130554669|NCT00821431|469998075|FG001|Overall Study|Withdrawal by Subject|0|||
130554670|NCT00821431|469998074|FG000|Overall Study|Lost to Follow-up|1|||
130554671|NCT00821431|469998075|FG001|Overall Study|Lost to Follow-up|0|||
130554672|NCT00821431|469998074|FG000|Overall Study|Protocol Violation|3|||
130554673|NCT00821431|469998075|FG001|Overall Study|Protocol Violation|1|||
130554674|NCT00821431|469998074|FG000|Overall Study|Physician Decision|0|||
130554675|NCT00821431|469998075|FG001|Overall Study|Physician Decision|1|||
130554676|NCT04526197|469998078|FG000|Period 1|Adverse Event|0|||
130554677|NCT04526197|469998079|FG001|Period 1|Adverse Event|1|||
130554678|NCT04526197|469998078|FG000|Period 1|Withdrawal by Subject|1|||
130554679|NCT04526197|469998079|FG001|Period 1|Withdrawal by Subject|0|||
130274548|NCT02229825|468969220|FG001|Overall Study|Personal Reasons|1|||
130274549|NCT02229825|468969219|FG000|Overall Study|Refused continuing medication|7|||
130274550|NCT02229825|468969220|FG001|Overall Study|Refused continuing medication|6|||
130274551|NCT02229825|468969219|FG000|Overall Study|Lost to Follow-up|1|||
130274552|NCT02229825|468969220|FG001|Overall Study|Lost to Follow-up|2|||
130274553|NCT02229825|468969219|FG000|Overall Study|Protocol Violation|1|||
130274554|NCT02229825|468969220|FG001|Overall Study|Protocol Violation|1|||
130274555|NCT02229825|468969219|FG000|Overall Study|Lack of Efficacy|4|||
130274556|NCT02229825|468969220|FG001|Overall Study|Lack of Efficacy|10|||
130274557|NCT02229825|468969219|FG000|Overall Study|Adverse Event|11|||
130274558|NCT02229825|468969220|FG001|Overall Study|Adverse Event|9|||
130274559|NCT02229825|468969219|FG000|Overall Study|Not treated|0|||
130274560|NCT02229825|468969220|FG001|Overall Study|Not treated|1|||
130367351|NCT05209360|469315913|FG000|Overall Study|Withdrawal by Subject|0|||
130554680|NCT04526197|469998078|FG000|Period 2|Adverse Event|0|||
130554681|NCT04526197|469998079|FG001|Period 2|Adverse Event|1|||
130554682|NCT04526197|469998078|FG000|Period 2|Withdrawal by Subject|0|||
130367352|NCT05209360|469315914|FG001|Overall Study|Withdrawal by Subject|0|||
130367353|NCT05209360|469315915|FG002|Overall Study|Withdrawal by Subject|1|||
130367354|NCT05209360|469315916|FG003|Overall Study|Withdrawal by Subject|0|||
130367355|NCT05209360|469315917|FG004|Overall Study|Withdrawal by Subject|0|||
130367356|NCT05209360|469315918|FG005|Overall Study|Withdrawal by Subject|0|||
130554683|NCT04526197|469998079|FG001|Period 2|Withdrawal by Subject|1|||
130554684|NCT00372385|469998080|FG000|Overall Study|Adverse Event|6|||
130554685|NCT00372385|469998081|FG001|Overall Study|Adverse Event|11|||
130554686|NCT00372385|469998082|FG002|Overall Study|Adverse Event|9|||
130554687|NCT00372385|469998083|FG003|Overall Study|Adverse Event|7|||
130554688|NCT00372385|469998080|FG000|Overall Study|Noncompliance|0|||
130554689|NCT00372385|469998081|FG001|Overall Study|Noncompliance|1|||
130554690|NCT00372385|469998082|FG002|Overall Study|Noncompliance|1|||
130554691|NCT00372385|469998083|FG003|Overall Study|Noncompliance|1|||
130554692|NCT00372385|469998080|FG000|Overall Study|Physician Decision|1|||
130709110|NCT01813071|470560607|FG004|Overall Study|Met inc/exc criteria|0|||
130709111|NCT01813071|470560608|FG005|Overall Study|Met inc/exc criteria|1|||
130709112|NCT01813071|470560609|FG006|Overall Study|Met inc/exc criteria|0|||
130709113|NCT01813071|470560610|FG007|Overall Study|Met inc/exc criteria|1|||
130709114|NCT01813071|470560611|FG008|Overall Study|Met inc/exc criteria|1|||
130709115|NCT01425528|470560612|FG000|Overall Study|Withdrawal by Subject|1|||
130709116|NCT01425528|470560613|FG001|Overall Study|Withdrawal by Subject|1|||
130709117|NCT00842530|470560614|FG000|Overall Study|Serious adverse event|0|||
130709118|NCT00842530|470560615|FG001|Overall Study|Serious adverse event|6|||
130709119|NCT00842530|470560614|FG000|Overall Study|Other adverse event|6|||
130709120|NCT00842530|470560615|FG001|Overall Study|Other adverse event|1|||
130709121|NCT00842530|470560614|FG000|Overall Study|Protocol Violation|32|||
130709122|NCT00842530|470560615|FG001|Overall Study|Protocol Violation|14|||
130709123|NCT00842530|470560614|FG000|Overall Study|Lost to Follow-up|6|||
130709124|NCT00842530|470560615|FG001|Overall Study|Lost to Follow-up|8|||
130709125|NCT00842530|470560614|FG000|Overall Study|Withdrawal by Subject|73|||
130709126|NCT00842530|470560615|FG001|Overall Study|Withdrawal by Subject|28|||
130709127|NCT02939950|470560616|FG000|Overall Study|Lost to Follow-up|13|||
130709128|NCT02939950|470560617|FG001|Overall Study|Lost to Follow-up|16|||
130709129|NCT02939950|470560616|FG000|Overall Study|Positive slit lamp findings|0|||
130709130|NCT02939950|470560617|FG001|Overall Study|Positive slit lamp findings|1|||
130367357|NCT02100514|469315919|FG000|Treatment Period|Adverse Event|0|||
130554693|NCT00372385|469998081|FG001|Overall Study|Physician Decision|0|||
130709131|NCT02939950|470560616|FG000|Overall Study|Chalazion upper lid|0|||
130709132|NCT02939950|470560617|FG001|Overall Study|Chalazion upper lid|1|||
130709133|NCT02939950|470560616|FG000|Overall Study|Lack of motivation|0|||
130709134|NCT02939950|470560617|FG001|Overall Study|Lack of motivation|2|||
130554694|NCT00372385|469998082|FG002|Overall Study|Physician Decision|0|||
130554695|NCT00372385|469998083|FG003|Overall Study|Physician Decision|0|||
130709135|NCT02939950|470560616|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
130274561|NCT00104416|468969221|FG000|Double-Blind Phase|Adverse Event|2|||
130274562|NCT00104416|468969222|FG001|Double-Blind Phase|Adverse Event|1|||
130274563|NCT00104416|468969223|FG002|Double-Blind Phase|Adverse Event|0|||
130274564|NCT00104416|468969224|FG003|Double-Blind Phase|Adverse Event|0|||
130274565|NCT00104416|468969225|FG004|Double-Blind Phase|Adverse Event|0|||
130709136|NCT02939950|470560617|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
130274566|NCT00104416|468969221|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130274567|NCT00104416|468969222|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130274568|NCT00104416|468969223|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130274569|NCT00104416|468969224|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130274570|NCT00104416|468969225|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130274571|NCT00104416|468969221|FG000|Double-Blind Phase|Protocol Violation|0|||
130274572|NCT00104416|468969222|FG001|Double-Blind Phase|Protocol Violation|1|||
130274573|NCT00104416|468969223|FG002|Double-Blind Phase|Protocol Violation|0|||
130274574|NCT00104416|468969224|FG003|Double-Blind Phase|Protocol Violation|0|||
130274575|NCT00104416|468969225|FG004|Double-Blind Phase|Protocol Violation|0|||
130274576|NCT00104416|468969221|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130274577|NCT00104416|468969222|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
130274578|NCT00104416|468969223|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130274579|NCT00104416|468969224|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130274580|NCT00104416|468969225|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130274581|NCT00104416|468969221|FG000|Double-Blind Phase|Pregnancy|1|||
130274582|NCT00104416|468969222|FG001|Double-Blind Phase|Pregnancy|0|||
130274583|NCT00104416|468969223|FG002|Double-Blind Phase|Pregnancy|0|||
130274584|NCT00104416|468969224|FG003|Double-Blind Phase|Pregnancy|0|||
130274585|NCT00104416|468969225|FG004|Double-Blind Phase|Pregnancy|0|||
130274586|NCT00104416|468969221|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
130274587|NCT00104416|468969222|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
130274588|NCT00104416|468969223|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274589|NCT00104416|468969224|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274590|NCT00104416|468969225|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274591|NCT00104416|468969221|FG000|Continuation Phase|Adverse Event|0|||
130274592|NCT00104416|468969222|FG001|Continuation Phase|Adverse Event|0|||
130274593|NCT00104416|468969223|FG002|Continuation Phase|Adverse Event|2|||
130274594|NCT00104416|468969224|FG003|Continuation Phase|Adverse Event|0|||
130274595|NCT00104416|468969225|FG004|Continuation Phase|Adverse Event|2|||
130274596|NCT00104416|468969221|FG000|Continuation Phase|Lost to Follow-up|0|||
130274597|NCT00104416|468969222|FG001|Continuation Phase|Lost to Follow-up|0|||
130274598|NCT00104416|468969223|FG002|Continuation Phase|Lost to Follow-up|1|||
130274599|NCT00104416|468969224|FG003|Continuation Phase|Lost to Follow-up|0|||
130274600|NCT00104416|468969225|FG004|Continuation Phase|Lost to Follow-up|1|||
130274601|NCT00104416|468969221|FG000|Continuation Phase|Withdrawal by Subject|0|||
130274602|NCT00104416|468969222|FG001|Continuation Phase|Withdrawal by Subject|0|||
130274603|NCT00104416|468969223|FG002|Continuation Phase|Withdrawal by Subject|2|||
130274604|NCT00104416|468969224|FG003|Continuation Phase|Withdrawal by Subject|1|||
130274605|NCT00104416|468969225|FG004|Continuation Phase|Withdrawal by Subject|1|||
130274606|NCT00104416|468969221|FG000|Continuation Phase|Pregnancy|0|||
130456849|NCT02596035|469636330|FG001|Overall Study|Disease Progression|32|||
130456850|NCT02596035|469636331|FG002|Overall Study|Disease Progression|1|||
130456851|NCT02596035|469636329|FG000|Overall Study|study drug toxicity|12|||
130456852|NCT02596035|469636330|FG001|Overall Study|study drug toxicity|3|||
130456853|NCT02596035|469636331|FG002|Overall Study|study drug toxicity|0|||
130456854|NCT02596035|469636329|FG000|Overall Study|AE unrelated to study drug|5|||
130709137|NCT02939950|470560616|FG000|Overall Study|Military orders|1|||
130709138|NCT02939950|470560617|FG001|Overall Study|Military orders|0|||
130709139|NCT02939950|470560616|FG000|Overall Study|Participant Relocated|5|||
130709140|NCT02939950|470560617|FG001|Overall Study|Participant Relocated|3|||
130709141|NCT02939950|470560616|FG000|Overall Study|Study related symptoms|8|||
130709142|NCT02939950|470560617|FG001|Overall Study|Study related symptoms|8|||
130709143|NCT02939950|470560616|FG000|Overall Study|Unacceptable lens movement|2|||
130709144|NCT02939950|470560617|FG001|Overall Study|Unacceptable lens movement|0|||
130709145|NCT02939950|470560616|FG000|Overall Study|Protocol Violation|6|||
130709146|NCT02939950|470560617|FG001|Overall Study|Protocol Violation|3|||
130709147|NCT02939950|470560616|FG000|Overall Study|Physician Decision|2|||
130709148|NCT02939950|470560617|FG001|Overall Study|Physician Decision|0|||
130709149|NCT02939950|470560616|FG000|Overall Study|Pregnancy|6|||
130709150|NCT02939950|470560617|FG001|Overall Study|Pregnancy|7|||
130709151|NCT02939950|470560616|FG000|Overall Study|Withdrawal by Subject|12|||
130456855|NCT02596035|469636330|FG001|Overall Study|AE unrelated to study drug|2|||
130456856|NCT02596035|469636331|FG002|Overall Study|AE unrelated to study drug|0|||
130274607|NCT00104416|468969222|FG001|Continuation Phase|Pregnancy|0|||
130554696|NCT00372385|469998080|FG000|Overall Study|Lost to Follow-up|2|||
130709152|NCT02939950|470560617|FG001|Overall Study|Withdrawal by Subject|28|||
130709153|NCT02939950|470560616|FG000|Overall Study|Adverse Event|7|||
130274608|NCT00104416|468969223|FG002|Continuation Phase|Pregnancy|1|||
130274609|NCT00104416|468969224|FG003|Continuation Phase|Pregnancy|1|||
130274610|NCT00104416|468969225|FG004|Continuation Phase|Pregnancy|0|||
130274611|NCT00104416|468969221|FG000|Continuation Phase|Non-compliance|0|||
130274612|NCT00104416|468969222|FG001|Continuation Phase|Non-compliance|0|||
130274613|NCT00104416|468969223|FG002|Continuation Phase|Non-compliance|0|||
130274614|NCT00104416|468969224|FG003|Continuation Phase|Non-compliance|0|||
130274615|NCT00104416|468969225|FG004|Continuation Phase|Non-compliance|1|||
130709154|NCT02939950|470560617|FG001|Overall Study|Adverse Event|3|||
130709155|NCT02939950|470560616|FG000|Overall Study|Randomized, not dispensed|1|||
130367358|NCT02100514|469315920|FG001|Treatment Period|Adverse Event|5|||
130367359|NCT02100514|469315921|FG002|Treatment Period|Adverse Event|0|||
130367360|NCT02100514|469315922|FG003|Treatment Period|Adverse Event|0|||
130367361|NCT02100514|469315923|FG004|Treatment Period|Adverse Event|0|||
130367362|NCT02100514|469315919|FG000|Treatment Period|Death|2|||
130367363|NCT02100514|469315920|FG001|Treatment Period|Death|2|||
130367364|NCT02100514|469315921|FG002|Treatment Period|Death|0|||
130367365|NCT02100514|469315922|FG003|Treatment Period|Death|0|||
130367366|NCT02100514|469315923|FG004|Treatment Period|Death|0|||
130456857|NCT02596035|469636329|FG000|Overall Study|participant request to discontinue study treatment|2|||
130456858|NCT02596035|469636330|FG001|Overall Study|participant request to discontinue study treatment|0|||
130456859|NCT02596035|469636331|FG002|Overall Study|participant request to discontinue study treatment|0|||
130456860|NCT02596035|469636329|FG000|Overall Study|participant withdrew consent|2|||
130456861|NCT02596035|469636330|FG001|Overall Study|participant withdrew consent|2|||
130456862|NCT02596035|469636331|FG002|Overall Study|participant withdrew consent|0|||
130456863|NCT02596035|469636329|FG000|Overall Study|Poor/Non Comlpiance|0|||
130456864|NCT02596035|469636330|FG001|Overall Study|Poor/Non Comlpiance|1|||
130456865|NCT02596035|469636331|FG002|Overall Study|Poor/Non Comlpiance|0|||
130367367|NCT02100514|469315919|FG000|Treatment Period|Lost to Follow-up|5|||
130367368|NCT02100514|469315920|FG001|Treatment Period|Lost to Follow-up|17|||
130367369|NCT02100514|469315921|FG002|Treatment Period|Lost to Follow-up|0|||
130456866|NCT02596035|469636329|FG000|Overall Study|participant no longer meets study criteria|1|||
130554697|NCT00372385|469998081|FG001|Overall Study|Lost to Follow-up|0|||
130367370|NCT02100514|469315922|FG003|Treatment Period|Lost to Follow-up|0|||
130367371|NCT02100514|469315923|FG004|Treatment Period|Lost to Follow-up|0|||
130274616|NCT01309997|468969226|FG000|Overall Study|Adverse Event|1|||
130274617|NCT01309997|468969227|FG001|Overall Study|Adverse Event|0|||
130274618|NCT01309997|468969226|FG000|Overall Study|Death|1|||
130274619|NCT01309997|468969227|FG001|Overall Study|Death|3|||
130274620|NCT01309997|468969226|FG000|Overall Study|Lack of Efficacy|2|||
130274621|NCT01309997|468969227|FG001|Overall Study|Lack of Efficacy|2|||
130274622|NCT01309997|468969226|FG000|Overall Study|Withdrawal by Subject|1|||
130274623|NCT01309997|468969227|FG001|Overall Study|Withdrawal by Subject|1|||
130274624|NCT03462641|468969230|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
130274625|NCT03462641|468969231|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
130274626|NCT03462641|468969230|FG000|Visit 2|Withdrawal by Subject|0|||
130274627|NCT03462641|468969231|FG001|Visit 2|Withdrawal by Subject|1|||
130274628|NCT02096952|468969235|FG000|Overall Study|Adverse Event|1|||
130274629|NCT02684617|468969236|FG000|Overall Study|Adverse Event|1|||
130274630|NCT02684617|468969237|FG001|Overall Study|Adverse Event|0|||
130274631|NCT02684617|468969238|FG002|Overall Study|Adverse Event|1|||
130274632|NCT02684617|468969236|FG000|Overall Study|Death|8|||
130274633|NCT02684617|468969237|FG001|Overall Study|Death|16|||
130274634|NCT02684617|468969238|FG002|Overall Study|Death|28|||
130274635|NCT02684617|468969236|FG000|Overall Study|Withdrawal by Subject|2|||
130274636|NCT02684617|468969237|FG001|Overall Study|Withdrawal by Subject|0|||
130274637|NCT02684617|468969238|FG002|Overall Study|Withdrawal by Subject|4|||
130274638|NCT02684617|468969236|FG000|Overall Study|Screen Failure|1|||
130274639|NCT02684617|468969237|FG001|Overall Study|Screen Failure|0|||
130274640|NCT02684617|468969238|FG002|Overall Study|Screen Failure|2|||
130274641|NCT02684617|468969236|FG000|Overall Study|Study Terminated by Sponsor|6|||
130274642|NCT02684617|468969237|FG001|Overall Study|Study Terminated by Sponsor|1|||
130274643|NCT02684617|468969238|FG002|Overall Study|Study Terminated by Sponsor|5|||
130274644|NCT04482439|468969247|FG000|Overall Study|Lost to Follow-up|1|||
130274645|NCT04482439|468969247|FG000|Overall Study|Unrelated illness|1|||
130274646|NCT02318368|468969248|FG000|Overall Study|Withdrawal by Subject|2|||
130274647|NCT02318368|468969249|FG001|Overall Study|Withdrawal by Subject|0|||
130274648|NCT02318368|468969248|FG000|Overall Study|Study terminated by the sponsor|5|||
130274649|NCT02318368|468969249|FG001|Overall Study|Study terminated by the sponsor|2|||
130274650|NCT02318368|468969248|FG000|Overall Study|Death|0|||
130274651|NCT02318368|468969249|FG001|Overall Study|Death|1|||
130274652|NCT02201329|468969250|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
130274653|NCT02201329|468969250|FG000|Overall Study|Withdrawal by Subject|2|||
130274654|NCT01945996|468969251|FG000|Overall Study|Lost to Follow-up|3|||
130274655|NCT01945996|468969252|FG001|Overall Study|Lost to Follow-up|5|||
130274656|NCT01066104|468969253|FG000|Overall Study|Adverse Event|1|||
130274657|NCT01066104|468969254|FG001|Overall Study|Adverse Event|1|||
130274658|NCT01066104|468969253|FG000|Overall Study|Protocol Violation|1|||
130274659|NCT01066104|468969254|FG001|Overall Study|Protocol Violation|0|||
130274660|NCT04660552|468969255|FG000|Overall Study|Withdrawal by Subject|3|||
130367372|NCT02100514|469315919|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
130367373|NCT02100514|469315920|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
130367374|NCT02100514|469315921|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
130367375|NCT02100514|469315922|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
130367376|NCT02100514|469315923|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
130367377|NCT02100514|469315919|FG000|Treatment Period|Protocol Violation|1|||
130367378|NCT02100514|469315920|FG001|Treatment Period|Protocol Violation|1|||
130367379|NCT02100514|469315921|FG002|Treatment Period|Protocol Violation|0|||
130367380|NCT02100514|469315922|FG003|Treatment Period|Protocol Violation|0|||
130367381|NCT02100514|469315923|FG004|Treatment Period|Protocol Violation|0|||
130367382|NCT02100514|469315919|FG000|Treatment Period|Withdrawal by Subject|12|||
130367383|NCT02100514|469315920|FG001|Treatment Period|Withdrawal by Subject|37|||
130367384|NCT02100514|469315921|FG002|Treatment Period|Withdrawal by Subject|0|||
130367385|NCT02100514|469315922|FG003|Treatment Period|Withdrawal by Subject|0|||
130367386|NCT02100514|469315923|FG004|Treatment Period|Withdrawal by Subject|0|||
130367387|NCT02100514|469315919|FG000|Treatment Period|Other|9|||
130367388|NCT02100514|469315920|FG001|Treatment Period|Other|11|||
130367389|NCT02100514|469315921|FG002|Treatment Period|Other|0|||
130367390|NCT02100514|469315922|FG003|Treatment Period|Other|0|||
130367391|NCT02100514|469315923|FG004|Treatment Period|Other|0|||
130367392|NCT02100514|469315919|FG000|Extension Period|Withdrew consent|0|||
130367393|NCT02100514|469315920|FG001|Extension Period|Withdrew consent|0|||
130367394|NCT02100514|469315921|FG002|Extension Period|Withdrew consent|2|||
130367395|NCT02100514|469315922|FG003|Extension Period|Withdrew consent|0|||
130367396|NCT02100514|469315923|FG004|Extension Period|Withdrew consent|0|||
130367397|NCT00724932|469315924|FG000|Overall Study|Lost to Follow-up|1|||
130367398|NCT00724932|469315925|FG001|Overall Study|Lost to Follow-up|0|||
130367399|NCT00724932|469315924|FG000|Overall Study|Not treated|4|||
130274661|NCT04660552|468969256|FG001|Overall Study|Withdrawal by Subject|1|||
130274662|NCT02091362|468969264|FG000|Period 1|Protocol Violation|1|||
130274663|NCT02091362|468969265|FG001|Period 1|Protocol Violation|0|||
130274664|NCT02091362|468969264|FG000|Period 1|Withdrawal by Subject|2|||
130274665|NCT02091362|468969265|FG001|Period 1|Withdrawal by Subject|3|||
130274666|NCT02091362|468969264|FG000|Period 1|Lost to Follow-up|0|||
130274667|NCT02091362|468969265|FG001|Period 1|Lost to Follow-up|1|||
130274668|NCT02091362|468969264|FG000|Period 1|Adverse Event|2|||
130274669|NCT02091362|468969265|FG001|Period 1|Adverse Event|0|||
130274670|NCT02091362|468969264|FG000|Wash-out|Lost to Follow-up|1|||
130274671|NCT02091362|468969265|FG001|Wash-out|Lost to Follow-up|1|||
130274672|NCT02091362|468969264|FG000|Wash-out|Withdrawal by Subject|0|||
130274673|NCT02091362|468969265|FG001|Wash-out|Withdrawal by Subject|2|||
130274674|NCT02091362|468969264|FG000|Period 2|Adverse Event|1|||
130274675|NCT02091362|468969265|FG001|Period 2|Adverse Event|0|||
130274676|NCT02091362|468969264|FG000|Period 2|Lost to Follow-up|0|||
130274677|NCT02091362|468969265|FG001|Period 2|Lost to Follow-up|1|||
130274678|NCT02091362|468969264|FG000|Period 2|Withdrawal by Subject|1|||
130274679|NCT02091362|468969265|FG001|Period 2|Withdrawal by Subject|1|||
130274680|NCT00690430|468969266|FG000|Core Phase|Abnormal Laboratory value|0|||
130274681|NCT00690430|468969267|FG001|Core Phase|Abnormal Laboratory value|1|||
130274682|NCT00690430|468969268|FG002|Core Phase|Abnormal Laboratory value|0|||
130274683|NCT00690430|468969266|FG000|Core Phase|Adverse Event|5|||
130274684|NCT00690430|468969267|FG001|Core Phase|Adverse Event|1|||
130274685|NCT00690430|468969268|FG002|Core Phase|Adverse Event|0|||
130274686|NCT00690430|468969266|FG000|Core Phase|Death|0|||
130274687|NCT00690430|468969267|FG001|Core Phase|Death|2|||
130456867|NCT02596035|469636330|FG001|Overall Study|participant no longer meets study criteria|0|||
130456868|NCT02596035|469636331|FG002|Overall Study|participant no longer meets study criteria|0|||
130456869|NCT02596035|469636329|FG000|Overall Study|other reasons|11|||
130456870|NCT02596035|469636330|FG001|Overall Study|other reasons|4|||
130709156|NCT02939950|470560617|FG001|Overall Study|Randomized, not dispensed|0|||
130709157|NCT02939950|470560616|FG000|Overall Study|Ineligible at Baseline|2|||
130709158|NCT02939950|470560617|FG001|Overall Study|Ineligible at Baseline|8|||
130709159|NCT02985879|470560625|FG000|Overall Study|Adverse Event|7|||
130709160|NCT02985879|470560626|FG001|Overall Study|Adverse Event|9|||
130709161|NCT02985879|470560627|FG002|Overall Study|Adverse Event|7|||
130709162|NCT02985879|470560625|FG000|Overall Study|Withdrew consent|6|||
130709163|NCT02985879|470560626|FG001|Overall Study|Withdrew consent|8|||
130709164|NCT02985879|470560627|FG002|Overall Study|Withdrew consent|10|||
130709165|NCT02985879|470560625|FG000|Overall Study|Lost to Follow-up|1|||
130709166|NCT02985879|470560626|FG001|Overall Study|Lost to Follow-up|0|||
130709167|NCT02985879|470560627|FG002|Overall Study|Lost to Follow-up|2|||
130709168|NCT02985879|470560625|FG000|Overall Study|Other, not specified|62|||
130709169|NCT02985879|470560626|FG001|Overall Study|Other, not specified|58|||
130709170|NCT02985879|470560627|FG002|Overall Study|Other, not specified|58|||
130709171|NCT04974619|470562277|FG000|Overall Study|Lost to Follow-up|0|||
130709172|NCT04974619|470562278|FG001|Overall Study|Lost to Follow-up|0|||
130709173|NCT04974619|470562279|FG002|Overall Study|Lost to Follow-up|1|||
130709174|NCT04974619|470562277|FG000|Overall Study|Withdrawal by Subject|0|||
130709175|NCT04974619|470562278|FG001|Overall Study|Withdrawal by Subject|0|||
130709176|NCT04974619|470562279|FG002|Overall Study|Withdrawal by Subject|1|||
130709177|NCT04974619|470562277|FG000|Overall Study|Protocol Violation|0|||
130709178|NCT04974619|470562278|FG001|Overall Study|Protocol Violation|1|||
130709179|NCT04974619|470562279|FG002|Overall Study|Protocol Violation|0|||
130709180|NCT00493779|470562286|FG000|Overall Study|Logistical issue at site|1|||
130709181|NCT01885182|470562288|FG000|Overall Study|Adverse Event|11|||
130709182|NCT01885182|470562289|FG001|Overall Study|Adverse Event|13|||
130709183|NCT01885182|470562288|FG000|Overall Study|Withdrawal by Subject|13|||
130709184|NCT01885182|470562289|FG001|Overall Study|Withdrawal by Subject|6|||
130709185|NCT01885182|470562288|FG000|Overall Study|Lost to Follow-up|2|||
130709186|NCT01885182|470562289|FG001|Overall Study|Lost to Follow-up|2|||
130709187|NCT01885182|470562288|FG000|Overall Study|Lack of Efficacy|8|||
130709188|NCT01885182|470562289|FG001|Overall Study|Lack of Efficacy|1|||
130709189|NCT01207440|470562296|FG000|Overall Study|Adverse Event|46|||
130709190|NCT01207440|470562297|FG001|Overall Study|Adverse Event|11|||
130709191|NCT01207440|470562298|FG002|Overall Study|Adverse Event|7|||
130709192|NCT01207440|470562299|FG003|Overall Study|Adverse Event|2|||
130709193|NCT01207440|470562300|FG004|Overall Study|Adverse Event|6|||
130709194|NCT01207440|470562301|FG005|Overall Study|Adverse Event|6|||
130709195|NCT01207440|470562302|FG006|Overall Study|Adverse Event|2|||
130709196|NCT01207440|470562296|FG000|Overall Study|Death|6|||
130456871|NCT02596035|469636331|FG002|Overall Study|other reasons|0|||
130709197|NCT01207440|470562297|FG001|Overall Study|Death|3|||
130709198|NCT01207440|470562298|FG002|Overall Study|Death|2|||
130709199|NCT01207440|470562299|FG003|Overall Study|Death|2|||
130709200|NCT01207440|470562300|FG004|Overall Study|Death|7|||
130709201|NCT01207440|470562301|FG005|Overall Study|Death|5|||
130709202|NCT01207440|470562302|FG006|Overall Study|Death|1|||
130709203|NCT01207440|470562296|FG000|Overall Study|Lack of Efficacy|13|||
130709204|NCT01207440|470562297|FG001|Overall Study|Lack of Efficacy|2|||
130274688|NCT00690430|468969268|FG002|Core Phase|Death|0|||
130274689|NCT00690430|468969266|FG000|Core Phase|Protocol Violation|1|||
130274690|NCT00690430|468969267|FG001|Core Phase|Protocol Violation|0|||
130274691|NCT00690430|468969268|FG002|Core Phase|Protocol Violation|0|||
130274692|NCT00690430|468969266|FG000|Core Phase|Withdrawal by Subject|3|||
130274693|NCT00690430|468969267|FG001|Core Phase|Withdrawal by Subject|3|||
130709205|NCT01207440|470562298|FG002|Overall Study|Lack of Efficacy|5|||
130709206|NCT01207440|470562299|FG003|Overall Study|Lack of Efficacy|1|||
130709207|NCT01207440|470562300|FG004|Overall Study|Lack of Efficacy|2|||
130709208|NCT01207440|470562301|FG005|Overall Study|Lack of Efficacy|3|||
130709209|NCT01207440|470562302|FG006|Overall Study|Lack of Efficacy|0|||
130709210|NCT01207440|470562296|FG000|Overall Study|Lost to Follow-up|0|||
130709211|NCT01207440|470562297|FG001|Overall Study|Lost to Follow-up|0|||
130709212|NCT01207440|470562298|FG002|Overall Study|Lost to Follow-up|2|||
130709213|NCT01207440|470562299|FG003|Overall Study|Lost to Follow-up|1|||
130709214|NCT01207440|470562300|FG004|Overall Study|Lost to Follow-up|0|||
130709215|NCT01207440|470562301|FG005|Overall Study|Lost to Follow-up|0|||
130709216|NCT01207440|470562302|FG006|Overall Study|Lost to Follow-up|0|||
130709217|NCT01207440|470562296|FG000|Overall Study|Non-compliance with Study Drug|3|||
130709218|NCT01207440|470562297|FG001|Overall Study|Non-compliance with Study Drug|0|||
130709219|NCT01207440|470562298|FG002|Overall Study|Non-compliance with Study Drug|1|||
130709220|NCT01207440|470562299|FG003|Overall Study|Non-compliance with Study Drug|0|||
130709221|NCT01207440|470562300|FG004|Overall Study|Non-compliance with Study Drug|0|||
130709222|NCT01207440|470562301|FG005|Overall Study|Non-compliance with Study Drug|0|||
130709223|NCT01207440|470562302|FG006|Overall Study|Non-compliance with Study Drug|0|||
130709224|NCT01207440|470562296|FG000|Overall Study|Physician Decision|6|||
130709225|NCT01207440|470562297|FG001|Overall Study|Physician Decision|5|||
130709226|NCT01207440|470562298|FG002|Overall Study|Physician Decision|5|||
130709227|NCT01207440|470562299|FG003|Overall Study|Physician Decision|0|||
130709228|NCT01207440|470562300|FG004|Overall Study|Physician Decision|1|||
130709229|NCT01207440|470562301|FG005|Overall Study|Physician Decision|0|||
130709230|NCT01207440|470562302|FG006|Overall Study|Physician Decision|0|||
130709231|NCT01207440|470562296|FG000|Overall Study|Progressive Disease|19|||
130709232|NCT01207440|470562297|FG001|Overall Study|Progressive Disease|10|||
130709233|NCT01207440|470562298|FG002|Overall Study|Progressive Disease|19|||
130709234|NCT01207440|470562299|FG003|Overall Study|Progressive Disease|7|||
130709235|NCT01207440|470562300|FG004|Overall Study|Progressive Disease|23|||
130709236|NCT01207440|470562301|FG005|Overall Study|Progressive Disease|27|||
130709237|NCT01207440|470562302|FG006|Overall Study|Progressive Disease|0|||
130709238|NCT01207440|470562296|FG000|Overall Study|Protocol Violation|2|||
130709239|NCT01207440|470562297|FG001|Overall Study|Protocol Violation|0|||
130709240|NCT01207440|470562298|FG002|Overall Study|Protocol Violation|0|||
130709241|NCT01207440|470562299|FG003|Overall Study|Protocol Violation|0|||
130709242|NCT01207440|470562300|FG004|Overall Study|Protocol Violation|0|||
130709243|NCT01207440|470562301|FG005|Overall Study|Protocol Violation|0|||
130709244|NCT01207440|470562302|FG006|Overall Study|Protocol Violation|0|||
130709245|NCT01207440|470562296|FG000|Overall Study|Site Terminated by Sponsor|69|||
130709246|NCT01207440|470562297|FG001|Overall Study|Site Terminated by Sponsor|19|||
130709247|NCT01207440|470562298|FG002|Overall Study|Site Terminated by Sponsor|12|||
130709248|NCT01207440|470562299|FG003|Overall Study|Site Terminated by Sponsor|2|||
130709249|NCT01207440|470562300|FG004|Overall Study|Site Terminated by Sponsor|3|||
130709250|NCT01207440|470562301|FG005|Overall Study|Site Terminated by Sponsor|0|||
130709251|NCT01207440|470562302|FG006|Overall Study|Site Terminated by Sponsor|2|||
130709252|NCT01207440|470562296|FG000|Overall Study|Withdrawal by Subject|29|||
130709253|NCT01207440|470562297|FG001|Overall Study|Withdrawal by Subject|4|||
130709254|NCT01207440|470562298|FG002|Overall Study|Withdrawal by Subject|5|||
130709255|NCT01207440|470562299|FG003|Overall Study|Withdrawal by Subject|3|||
130709256|NCT01207440|470562300|FG004|Overall Study|Withdrawal by Subject|2|||
130709257|NCT01207440|470562301|FG005|Overall Study|Withdrawal by Subject|2|||
130709258|NCT01207440|470562302|FG006|Overall Study|Withdrawal by Subject|0|||
130367400|NCT00724932|469315925|FG001|Overall Study|Not treated|3|||
130367401|NCT00762229|469315926|FG000|Overall Study|Lost to Follow-up|1|||
130367402|NCT00762229|469315927|FG001|Overall Study|Lost to Follow-up|1|||
130367403|NCT00762229|469315926|FG000|Overall Study|did not recveive intervention|0|||
130367404|NCT00762229|469315927|FG001|Overall Study|did not recveive intervention|1|||
130367405|NCT04203498|469315930|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
130367406|NCT04203498|469315931|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
130367407|NCT04203498|469315930|FG000|Overall Study|Withdrawal of patient consent|7|||
130367408|NCT04203498|469315931|FG001|Overall Study|Withdrawal of patient consent|2|||
130456872|NCT00414648|469636332|FG000|Overall Study|Adverse Event|5|||
130456873|NCT00414648|469636333|FG001|Overall Study|Adverse Event|5|||
130456874|NCT00414648|469636332|FG000|Overall Study|Death|0|||
130367409|NCT04203498|469315930|FG000|Overall Study|Adverse Event|4|||
130367410|NCT04203498|469315931|FG001|Overall Study|Adverse Event|1|||
130367411|NCT04203498|469315930|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
130709259|NCT01207440|470562296|FG000|Overall Study|Reason Not Specified|10|||
130709260|NCT01207440|470562297|FG001|Overall Study|Reason Not Specified|10|||
130709261|NCT01207440|470562298|FG002|Overall Study|Reason Not Specified|7|||
130709262|NCT01207440|470562299|FG003|Overall Study|Reason Not Specified|0|||
130709263|NCT01207440|470562300|FG004|Overall Study|Reason Not Specified|4|||
130709264|NCT01207440|470562301|FG005|Overall Study|Reason Not Specified|3|||
130709265|NCT01207440|470562302|FG006|Overall Study|Reason Not Specified|0|||
130709266|NCT01592721|470562303|FG000|Long-term Follow-up|Death|1|||
130554698|NCT00372385|469998082|FG002|Overall Study|Lost to Follow-up|0|||
130274694|NCT00690430|468969268|FG002|Core Phase|Withdrawal by Subject|0|||
130554699|NCT00372385|469998083|FG003|Overall Study|Lost to Follow-up|0|||
130274695|NCT00690430|468969266|FG000|Core Phase|Subject no longer requires study drug|1|||
130274696|NCT00690430|468969267|FG001|Core Phase|Subject no longer requires study drug|0|||
130274697|NCT00690430|468969268|FG002|Core Phase|Subject no longer requires study drug|0|||
130274698|NCT00690430|468969266|FG000|Core Phase|Lack of Efficacy|8|||
130274699|NCT00690430|468969267|FG001|Core Phase|Lack of Efficacy|10|||
130274700|NCT00690430|468969268|FG002|Core Phase|Lack of Efficacy|0|||
130274701|NCT00690430|468969266|FG000|Core Phase|Administrative Problems|0|||
130274702|NCT00690430|468969267|FG001|Core Phase|Administrative Problems|1|||
130274703|NCT00690430|468969268|FG002|Core Phase|Administrative Problems|0|||
130274704|NCT00690430|468969266|FG000|Core Phase|Early Termination|0|||
130274705|NCT00690430|468969267|FG001|Core Phase|Early Termination|5|||
130274706|NCT00690430|468969268|FG002|Core Phase|Early Termination|0|||
130274707|NCT00690430|468969266|FG000|Extension Phase|Lack of Efficacy|3|||
130274708|NCT00690430|468969267|FG001|Extension Phase|Lack of Efficacy|1|||
130274709|NCT00690430|468969268|FG002|Extension Phase|Lack of Efficacy|4|||
130274710|NCT00690430|468969266|FG000|Extension Phase|Abnormal Lab Values|1|||
130274711|NCT00690430|468969267|FG001|Extension Phase|Abnormal Lab Values|0|||
130274712|NCT00690430|468969268|FG002|Extension Phase|Abnormal Lab Values|0|||
130274713|NCT00690430|468969266|FG000|Extension Phase|Abnormal test procedure results|1|||
130274714|NCT00690430|468969267|FG001|Extension Phase|Abnormal test procedure results|0|||
130274715|NCT00690430|468969268|FG002|Extension Phase|Abnormal test procedure results|0|||
130274716|NCT00690430|468969266|FG000|Extension Phase|Administrative Problems|0|||
130274717|NCT00690430|468969267|FG001|Extension Phase|Administrative Problems|1|||
130274718|NCT00690430|468969268|FG002|Extension Phase|Administrative Problems|1|||
130274719|NCT00690430|468969266|FG000|Extension Phase|Adverse Event|2|||
130274720|NCT00690430|468969267|FG001|Extension Phase|Adverse Event|1|||
130274721|NCT00690430|468969268|FG002|Extension Phase|Adverse Event|2|||
130274722|NCT00690430|468969266|FG000|Extension Phase|Death|1|||
130274723|NCT00690430|468969267|FG001|Extension Phase|Death|1|||
130274724|NCT00690430|468969268|FG002|Extension Phase|Death|1|||
130274725|NCT00690430|468969266|FG000|Extension Phase|Withdrawal by Subject|0|||
130274726|NCT00690430|468969267|FG001|Extension Phase|Withdrawal by Subject|0|||
130274727|NCT00690430|468969268|FG002|Extension Phase|Withdrawal by Subject|2|||
130274728|NCT00690430|468969266|FG000|Extension Phase|Early Termination|10|||
130274729|NCT00690430|468969267|FG001|Extension Phase|Early Termination|1|||
130274730|NCT00690430|468969268|FG002|Extension Phase|Early Termination|3|||
130274731|NCT02125838|468969277|FG000|Overall Study|Lost to Follow-up|4|||
130274732|NCT02125838|468969278|FG001|Overall Study|Lost to Follow-up|4|||
130274733|NCT00787839|468969279|FG000|Overall Study|Failure to have the OGTT was most common|404|||
130274734|NCT01970241|468969284|FG000|Overall Study|Withdrawal by Subject|2|||
130274735|NCT01970241|468969285|FG001|Overall Study|Withdrawal by Subject|0|||
130274736|NCT01970241|468969284|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
130274737|NCT01970241|468969285|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
130274738|NCT01001767|468969288|FG000|Overall Study|no baseline study performed|1|||
130274739|NCT01001767|468969289|FG001|Overall Study|no baseline study performed|0|||
130274740|NCT01001767|468969288|FG000|Overall Study|Protocol Violation|1|||
130274741|NCT01001767|468969289|FG001|Overall Study|Protocol Violation|0|||
130274742|NCT01001767|468969288|FG000|Overall Study|Lost to Follow-up|1|||
130274743|NCT01001767|468969289|FG001|Overall Study|Lost to Follow-up|0|||
130274744|NCT01001767|468969288|FG000|Overall Study|Physician Decision|1|||
130274745|NCT01001767|468969289|FG001|Overall Study|Physician Decision|0|||
130274746|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
130274747|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
130274748|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
130274749|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
130274750|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
130274751|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
130274752|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
130274753|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
130274754|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
130274755|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
130274756|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
130274757|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
130274758|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274759|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130456875|NCT00414648|469636333|FG001|Overall Study|Death|1|||
130456876|NCT00414648|469636332|FG000|Overall Study|Lack of Efficacy|0|||
130274760|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
130274761|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274762|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274763|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130709267|NCT02516410|470562304|FG000|Overall Study|Adverse Event|0|||
130709268|NCT02516410|470562305|FG001|Overall Study|Adverse Event|1|||
130709269|NCT02516410|470562304|FG000|Overall Study|Withdrawal by Subject|0|||
130709270|NCT02516410|470562305|FG001|Overall Study|Withdrawal by Subject|1|||
130709271|NCT01432574|470562306|FG000|Overall Study|Moved|2|||
130709272|NCT01432574|470562306|FG000|Overall Study|Not interested|1|||
130709273|NCT04146363|470562312|FG000|Induction Period|Adverse Event|1|||
130709274|NCT04146363|470562313|FG001|Induction Period|Adverse Event|2|||
130367412|NCT04203498|469315931|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
130709275|NCT04146363|470562314|FG002|Induction Period|Adverse Event|0|||
130709276|NCT04146363|470562315|FG003|Induction Period|Adverse Event|0|||
130709277|NCT04146363|470562316|FG004|Induction Period|Adverse Event|0|||
130709278|NCT04146363|470562317|FG005|Induction Period|Adverse Event|0|||
130709279|NCT04146363|470562318|FG006|Induction Period|Adverse Event|0|||
130709280|NCT04146363|470562319|FG007|Induction Period|Adverse Event|0|||
130709281|NCT04146363|470562320|FG008|Induction Period|Adverse Event|0|||
130709282|NCT04146363|470562321|FG009|Induction Period|Adverse Event|0|||
130709283|NCT04146363|470562322|FG010|Induction Period|Adverse Event|0|||
130709284|NCT04146363|470562312|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
130709285|NCT04146363|470562313|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
130709286|NCT04146363|470562314|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
130709287|NCT04146363|470562315|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
130709288|NCT04146363|470562316|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
130709289|NCT04146363|470562317|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
130709290|NCT04146363|470562318|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130709291|NCT04146363|470562319|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
130709292|NCT04146363|470562320|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130709293|NCT04146363|470562321|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
130709294|NCT04146363|470562322|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
130367413|NCT04203498|469315930|FG000|Overall Study|Did not receive IMP|2|||
130367414|NCT04203498|469315931|FG001|Overall Study|Did not receive IMP|0|||
130367415|NCT01235689|469315933|FG000|Overall Study|Adverse Event|12|||
130367416|NCT01235689|469315934|FG001|Overall Study|Adverse Event|16|||
130367417|NCT01235689|469315933|FG000|Overall Study|Lack of Efficacy|12|||
130367418|NCT01235689|469315934|FG001|Overall Study|Lack of Efficacy|5|||
130367419|NCT01235689|469315933|FG000|Overall Study|Withdrawal by Subject|3|||
130367420|NCT01235689|469315934|FG001|Overall Study|Withdrawal by Subject|4|||
130367421|NCT01235689|469315933|FG000|Overall Study|Lost to Follow-up|1|||
130367422|NCT01235689|469315934|FG001|Overall Study|Lost to Follow-up|2|||
130367423|NCT01235689|469315933|FG000|Overall Study|Miscellaneous|1|||
130367424|NCT01235689|469315934|FG001|Overall Study|Miscellaneous|5|||
130367425|NCT01443078|469315935|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
130367426|NCT01443078|469315935|FG000|Overall Study|Withdrawal by Subject|1|||
130367427|NCT01443078|469315935|FG000|Overall Study|Patient had brain mets|1|||
130367428|NCT00389597|469315940|FG000|Overall Study|Lost to Follow-up|8|||
130367429|NCT00389597|469315941|FG001|Overall Study|Lost to Follow-up|6|||
130367430|NCT00389597|469315942|FG002|Overall Study|Lost to Follow-up|4|||
130367431|NCT00389597|469315943|FG003|Overall Study|Lost to Follow-up|6|||
130367432|NCT02106975|469315944|FG000|Overall Study|Death|25|||
130367433|NCT02106975|469315945|FG001|Overall Study|Death|39|||
130367434|NCT03546062|469315948|FG000|Overall Study|Adverse Event|6|||
130367435|NCT03546062|469315949|FG001|Overall Study|Adverse Event|5|||
130367436|NCT03546062|469315950|FG002|Overall Study|Adverse Event|8|||
130367437|NCT00087607|469315951|FG000|Overall Study|Adverse Event|14|||
130367438|NCT00087607|469315952|FG001|Overall Study|Adverse Event|24|||
130367439|NCT00087607|469315951|FG000|Overall Study|Death|0|||
130367440|NCT00087607|469315952|FG001|Overall Study|Death|1|||
130367441|NCT00087607|469315951|FG000|Overall Study|Insufficient Therapeutic Response|53|||
130367442|NCT00087607|469315952|FG001|Overall Study|Insufficient Therapeutic Response|42|||
130367443|NCT00087607|469315951|FG000|Overall Study|Failure to return|21|||
130367444|NCT00087607|469315952|FG001|Overall Study|Failure to return|17|||
130367445|NCT00087607|469315951|FG000|Overall Study|Withdrew Consent|12|||
130367446|NCT00087607|469315952|FG001|Overall Study|Withdrew Consent|16|||
130367447|NCT00087607|469315951|FG000|Overall Study|Administrative|12|||
130367448|NCT00087607|469315952|FG001|Overall Study|Administrative|12|||
130367449|NCT00087607|469315951|FG000|Overall Study|Refused Treatment|5|||
130367450|NCT00087607|469315952|FG001|Overall Study|Refused Treatment|7|||
130367451|NCT00087607|469315951|FG000|Overall Study|Other Protocol Violation|5|||
130367452|NCT00087607|469315952|FG001|Overall Study|Other Protocol Violation|2|||
130367453|NCT00087607|469315951|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130367454|NCT00087607|469315952|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130367455|NCT02015754|469315953|FG000|Overall Study|Disease progression|5|||
130709295|NCT04146363|470562312|FG000|Induction Period|Lack of Efficacy|7|||
130456877|NCT00414648|469636333|FG001|Overall Study|Lack of Efficacy|2|||
130709296|NCT04146363|470562313|FG001|Induction Period|Lack of Efficacy|2|||
130709297|NCT04146363|470562314|FG002|Induction Period|Lack of Efficacy|0|||
130709298|NCT04146363|470562315|FG003|Induction Period|Lack of Efficacy|0|||
130709299|NCT04146363|470562316|FG004|Induction Period|Lack of Efficacy|0|||
130709300|NCT04146363|470562317|FG005|Induction Period|Lack of Efficacy|0|||
130274764|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274765|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274766|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274767|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274768|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274769|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274770|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
130274771|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
130274772|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
130274773|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
130456878|NCT00414648|469636332|FG000|Overall Study|Withdrawal by Subject|0|||
130274774|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
130456879|NCT00414648|469636333|FG001|Overall Study|Withdrawal by Subject|1|||
130456880|NCT04173572|469636336|FG000|Overall Study|Withdrawal by Subject|1|||
130709301|NCT04146363|470562318|FG006|Induction Period|Lack of Efficacy|0|||
130709302|NCT04146363|470562319|FG007|Induction Period|Lack of Efficacy|0|||
130709303|NCT04146363|470562320|FG008|Induction Period|Lack of Efficacy|0|||
130709304|NCT04146363|470562321|FG009|Induction Period|Lack of Efficacy|0|||
130709305|NCT04146363|470562322|FG010|Induction Period|Lack of Efficacy|0|||
130709306|NCT04146363|470562312|FG000|Induction Period|Lost to Follow-up|1|||
130709307|NCT04146363|470562313|FG001|Induction Period|Lost to Follow-up|4|||
130709308|NCT04146363|470562314|FG002|Induction Period|Lost to Follow-up|0|||
130709309|NCT04146363|470562315|FG003|Induction Period|Lost to Follow-up|0|||
130709310|NCT04146363|470562316|FG004|Induction Period|Lost to Follow-up|0|||
130709311|NCT04146363|470562317|FG005|Induction Period|Lost to Follow-up|0|||
130709312|NCT04146363|470562318|FG006|Induction Period|Lost to Follow-up|0|||
130709313|NCT04146363|470562319|FG007|Induction Period|Lost to Follow-up|0|||
130709314|NCT04146363|470562320|FG008|Induction Period|Lost to Follow-up|0|||
130709315|NCT04146363|470562321|FG009|Induction Period|Lost to Follow-up|0|||
130709316|NCT04146363|470562322|FG010|Induction Period|Lost to Follow-up|0|||
130709317|NCT04146363|470562312|FG000|Induction Period|Positive quantiferon test|0|||
130709318|NCT04146363|470562313|FG001|Induction Period|Positive quantiferon test|1|||
130709319|NCT04146363|470562314|FG002|Induction Period|Positive quantiferon test|0|||
130709320|NCT04146363|470562315|FG003|Induction Period|Positive quantiferon test|0|||
130709321|NCT04146363|470562316|FG004|Induction Period|Positive quantiferon test|0|||
130709322|NCT04146363|470562317|FG005|Induction Period|Positive quantiferon test|0|||
130709323|NCT04146363|470562318|FG006|Induction Period|Positive quantiferon test|0|||
130709324|NCT04146363|470562319|FG007|Induction Period|Positive quantiferon test|0|||
130709325|NCT04146363|470562320|FG008|Induction Period|Positive quantiferon test|0|||
130709326|NCT04146363|470562321|FG009|Induction Period|Positive quantiferon test|0|||
130709327|NCT04146363|470562322|FG010|Induction Period|Positive quantiferon test|0|||
130709328|NCT04146363|470562312|FG000|Induction Period|Protocol Deviation|5|||
130709329|NCT04146363|470562313|FG001|Induction Period|Protocol Deviation|6|||
130709330|NCT04146363|470562314|FG002|Induction Period|Protocol Deviation|0|||
130709331|NCT04146363|470562315|FG003|Induction Period|Protocol Deviation|0|||
130709332|NCT04146363|470562316|FG004|Induction Period|Protocol Deviation|0|||
130709333|NCT04146363|470562317|FG005|Induction Period|Protocol Deviation|0|||
130709334|NCT04146363|470562318|FG006|Induction Period|Protocol Deviation|0|||
130709335|NCT04146363|470562319|FG007|Induction Period|Protocol Deviation|0|||
130709336|NCT04146363|470562320|FG008|Induction Period|Protocol Deviation|0|||
130709337|NCT04146363|470562321|FG009|Induction Period|Protocol Deviation|0|||
130709338|NCT04146363|470562322|FG010|Induction Period|Protocol Deviation|0|||
130709339|NCT04146363|470562312|FG000|Induction Period|Withdrawal by Subject|6|||
130709340|NCT04146363|470562313|FG001|Induction Period|Withdrawal by Subject|3|||
130709341|NCT04146363|470562314|FG002|Induction Period|Withdrawal by Subject|0|||
130709342|NCT04146363|470562315|FG003|Induction Period|Withdrawal by Subject|0|||
130709343|NCT04146363|470562316|FG004|Induction Period|Withdrawal by Subject|0|||
130709344|NCT04146363|470562317|FG005|Induction Period|Withdrawal by Subject|0|||
130709345|NCT04146363|470562318|FG006|Induction Period|Withdrawal by Subject|0|||
130709346|NCT04146363|470562319|FG007|Induction Period|Withdrawal by Subject|0|||
130709347|NCT04146363|470562320|FG008|Induction Period|Withdrawal by Subject|0|||
130709348|NCT04146363|470562321|FG009|Induction Period|Withdrawal by Subject|0|||
130709349|NCT04146363|470562322|FG010|Induction Period|Withdrawal by Subject|0|||
130709350|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709351|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709352|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709353|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709354|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709355|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709356|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
130709357|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
130709358|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709359|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709360|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709361|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709362|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709363|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709364|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709365|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709366|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709367|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709368|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
130709369|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709370|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709371|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709372|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709373|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709374|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709375|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709376|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709377|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709378|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130709379|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130709380|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709381|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709382|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130367456|NCT02015754|469315953|FG000|Overall Study|Change in treatment modality|5|||
130367457|NCT02015754|469315953|FG000|Overall Study|Lost to Follow-up|1|||
130367458|NCT00939770|469315957|FG000|Overall Study|Adverse Event|1|||
130367459|NCT00939770|469315958|FG001|Overall Study|Adverse Event|1|||
130367460|NCT00939770|469315959|FG002|Overall Study|Adverse Event|0|||
130367461|NCT00939770|469315960|FG003|Overall Study|Adverse Event|0|||
130367462|NCT00939770|469315961|FG004|Overall Study|Adverse Event|6|||
130367463|NCT00939770|469315962|FG005|Overall Study|Adverse Event|2|||
130367464|NCT00939770|469315963|FG006|Overall Study|Adverse Event|1|||
130367465|NCT00939770|469315964|FG007|Overall Study|Adverse Event|1|||
130367466|NCT00939770|469315957|FG000|Overall Study|Lack of Efficacy|4|||
130367467|NCT00939770|469315958|FG001|Overall Study|Lack of Efficacy|6|||
130367468|NCT00939770|469315959|FG002|Overall Study|Lack of Efficacy|13|||
130367469|NCT00939770|469315960|FG003|Overall Study|Lack of Efficacy|9|||
130367470|NCT00939770|469315961|FG004|Overall Study|Lack of Efficacy|16|||
130367471|NCT00939770|469315962|FG005|Overall Study|Lack of Efficacy|8|||
130367472|NCT00939770|469315963|FG006|Overall Study|Lack of Efficacy|11|||
130367473|NCT00939770|469315964|FG007|Overall Study|Lack of Efficacy|1|||
130274775|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
130709383|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709384|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709385|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
130709386|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709387|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709388|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
130709389|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
130274776|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
130456881|NCT04173572|469636337|FG001|Overall Study|Withdrawal by Subject|5|||
130456882|NCT04173572|469636336|FG000|Overall Study|Lost to Follow-up|3|||
130456883|NCT04173572|469636337|FG001|Overall Study|Lost to Follow-up|1|||
130456884|NCT00835380|469636342|FG000|Overall Study|Withdrawal by Subject|2|||
130456885|NCT03247543|469636343|FG000|Overall Study|Adverse Event|3|||
130456886|NCT03247543|469636344|FG001|Overall Study|Adverse Event|6|||
130456887|NCT03247543|469636345|FG002|Overall Study|Adverse Event|4|||
130456888|NCT03247543|469636343|FG000|Overall Study|Lost to Follow-up|10|||
130456889|NCT03247543|469636344|FG001|Overall Study|Lost to Follow-up|7|||
130456890|NCT03247543|469636345|FG002|Overall Study|Lost to Follow-up|8|||
130456891|NCT03247543|469636343|FG000|Overall Study|Consent withdrawn by caregiver|2|||
130456892|NCT03247543|469636344|FG001|Overall Study|Consent withdrawn by caregiver|2|||
130456893|NCT03247543|469636345|FG002|Overall Study|Consent withdrawn by caregiver|9|||
130456894|NCT03247543|469636343|FG000|Overall Study|Withdrawal by Subject|0|||
130456895|NCT03247543|469636344|FG001|Overall Study|Withdrawal by Subject|0|||
130709390|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709391|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709392|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709393|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709394|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709395|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709396|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709397|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709398|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130709399|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
130709400|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
130709401|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
130709402|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709403|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709404|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709405|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709406|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709407|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130709408|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709409|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709410|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
130709411|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
130709412|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
130709413|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709414|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709415|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709416|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709417|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709418|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709419|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709420|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709421|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709422|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709423|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709424|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
130709425|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
130709426|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709427|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709428|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130456896|NCT03247543|469636345|FG002|Overall Study|Withdrawal by Subject|1|||
130456897|NCT03247543|469636343|FG000|Overall Study|Failure to Follow study procedures|1|||
130456898|NCT03247543|469636344|FG001|Overall Study|Failure to Follow study procedures|3|||
130456899|NCT03247543|469636345|FG002|Overall Study|Failure to Follow study procedures|1|||
130456900|NCT03247543|469636343|FG000|Overall Study|Lack of Efficacy|1|||
130456901|NCT03247543|469636344|FG001|Overall Study|Lack of Efficacy|0|||
130456902|NCT03247543|469636345|FG002|Overall Study|Lack of Efficacy|0|||
130456903|NCT03247543|469636343|FG000|Overall Study|Non-compliance with study visits|0|||
130456904|NCT03247543|469636344|FG001|Overall Study|Non-compliance with study visits|1|||
130456905|NCT03247543|469636345|FG002|Overall Study|Non-compliance with study visits|0|||
130456906|NCT02059980|469636348|FG000|Overall Study|Lost to Follow-up|2|||
130456907|NCT02059980|469636349|FG001|Overall Study|Lost to Follow-up|1|||
130456908|NCT01104415|469636350|FG000|Core Phase|Consent withdrawn by subjects|1|||
130456909|NCT01104415|469636351|FG001|Core Phase|Consent withdrawn by subjects|0|||
130456910|NCT01104415|469636350|FG000|Extension Period|Progressive disease|0|||
130456911|NCT01104415|469636351|FG001|Extension Period|Progressive disease|4|||
130456912|NCT01104415|469636350|FG000|Extension Period|Death|0|||
130456913|NCT01104415|469636351|FG001|Extension Period|Death|1|||
130456914|NCT01104415|469636350|FG000|Extension Period|Physician Decision|0|||
130456915|NCT01104415|469636351|FG001|Extension Period|Physician Decision|1|||
130456916|NCT01104415|469636350|FG000|Extension Period|Transition to Study LX1606.302|0|||
130456917|NCT01104415|469636351|FG001|Extension Period|Transition to Study LX1606.302|4|||
130456918|NCT01104415|469636350|FG000|Extension Period|Heart surgery/feeling miserable|0|||
130456919|NCT01104415|469636351|FG001|Extension Period|Heart surgery/feeling miserable|1|||
130456920|NCT01839877|469636354|FG000|Overall Study|Protocol Violation|1|||
130456921|NCT03098030|469636355|FG000|Overall Study|Death|10|||
130456922|NCT03098030|469636356|FG001|Overall Study|Death|156|||
130456923|NCT03098030|469636357|FG002|Overall Study|Death|156|||
130456924|NCT03098030|469636358|FG003|Overall Study|Death|82|||
130456925|NCT03098030|469636355|FG000|Overall Study|Withdrawal by Subject|0|||
130456926|NCT03098030|469636356|FG001|Overall Study|Withdrawal by Subject|7|||
130456927|NCT03098030|469636357|FG002|Overall Study|Withdrawal by Subject|8|||
130456928|NCT03098030|469636358|FG003|Overall Study|Withdrawal by Subject|2|||
130709429|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709430|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709431|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709432|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709433|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709434|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709435|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
130709436|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
130709437|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
130709438|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709439|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709440|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709441|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709442|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709443|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709444|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709445|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709446|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
130709447|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
130709448|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709449|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709450|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709451|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709452|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709453|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709454|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709455|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709456|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709457|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
130709458|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
130709459|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709460|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709461|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709462|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709463|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709464|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709465|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709466|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709467|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130456929|NCT03098030|469636355|FG000|Overall Study|Lost to Follow-up|0|||
130456930|NCT03098030|469636356|FG001|Overall Study|Lost to Follow-up|0|||
130456931|NCT03098030|469636357|FG002|Overall Study|Lost to Follow-up|2|||
130709468|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
130709469|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130709470|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130709471|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709472|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709473|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709474|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709475|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709476|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709477|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709478|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709479|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709480|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
130709481|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709482|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709483|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709484|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709485|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709486|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709487|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709488|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709489|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709490|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709491|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
130709492|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709493|NCT02914236|470562324|FG000|Overall Study|Lost to Follow-up|1|||
130709494|NCT02148913|470562329|FG000|Overall Study|Death|0|||
130709495|NCT02148913|470562330|FG001|Overall Study|Death|1|||
130709496|NCT02148913|470562331|FG002|Overall Study|Death|0|||
130709497|NCT02148913|470562332|FG003|Overall Study|Death|0|||
130709498|NCT00918463|470562336|FG000|Overall Study|Death|1|||
130709499|NCT00918463|470562336|FG000|Overall Study|Lack of Efficacy|1|||
130709500|NCT01014624|470562341|FG000|Overall Study|Adverse Event|0|||
130709501|NCT01014624|470562342|FG001|Overall Study|Adverse Event|1|||
130709502|NCT01014624|470562341|FG000|Overall Study|Protocol Violation|1|||
130709503|NCT01014624|470562342|FG001|Overall Study|Protocol Violation|0|||
130709504|NCT01014624|470562341|FG000|Overall Study|Withdrawal by Subject|1|||
130709505|NCT01014624|470562342|FG001|Overall Study|Withdrawal by Subject|0|||
130709506|NCT02954159|470562344|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
130709507|NCT02954159|470562345|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
130709508|NCT02954159|470562344|FG000|Overall Study|Withdrawal by Subject|0|||
130709509|NCT02954159|470562345|FG001|Overall Study|Withdrawal by Subject|1|||
130709510|NCT01117337|470562350|FG000|Overall Study|Lost to Follow-up|4|||
130709511|NCT01117337|470562351|FG001|Overall Study|Lost to Follow-up|0|||
130709512|NCT03575871|470562352|FG000|Overall Study|Adverse Event|5|||
130709513|NCT03575871|470562353|FG001|Overall Study|Adverse Event|5|||
130709514|NCT03575871|470562354|FG002|Overall Study|Adverse Event|8|||
130367474|NCT00939770|469315957|FG000|Overall Study|Lost to Follow-up|0|||
130367475|NCT00939770|469315958|FG001|Overall Study|Lost to Follow-up|0|||
130367476|NCT00939770|469315959|FG002|Overall Study|Lost to Follow-up|0|||
130367477|NCT00939770|469315960|FG003|Overall Study|Lost to Follow-up|0|||
130367478|NCT00939770|469315961|FG004|Overall Study|Lost to Follow-up|1|||
130367479|NCT00939770|469315962|FG005|Overall Study|Lost to Follow-up|0|||
130367480|NCT00939770|469315963|FG006|Overall Study|Lost to Follow-up|0|||
130367481|NCT00939770|469315964|FG007|Overall Study|Lost to Follow-up|0|||
130367482|NCT00939770|469315957|FG000|Overall Study|Physician Decision|0|||
130367483|NCT00939770|469315958|FG001|Overall Study|Physician Decision|0|||
130367484|NCT00939770|469315959|FG002|Overall Study|Physician Decision|2|||
130367485|NCT00939770|469315960|FG003|Overall Study|Physician Decision|0|||
130367486|NCT00939770|469315961|FG004|Overall Study|Physician Decision|7|||
130367487|NCT00939770|469315962|FG005|Overall Study|Physician Decision|1|||
130367488|NCT00939770|469315963|FG006|Overall Study|Physician Decision|0|||
130367489|NCT00939770|469315964|FG007|Overall Study|Physician Decision|6|||
130367490|NCT00939770|469315957|FG000|Overall Study|Protocol Violation|0|||
130367491|NCT00939770|469315958|FG001|Overall Study|Protocol Violation|0|||
130367492|NCT00939770|469315959|FG002|Overall Study|Protocol Violation|0|||
130367493|NCT00939770|469315960|FG003|Overall Study|Protocol Violation|0|||
130367494|NCT00939770|469315961|FG004|Overall Study|Protocol Violation|1|||
130367495|NCT00939770|469315962|FG005|Overall Study|Protocol Violation|0|||
130367496|NCT00939770|469315963|FG006|Overall Study|Protocol Violation|0|||
130367497|NCT00939770|469315964|FG007|Overall Study|Protocol Violation|0|||
130709515|NCT03575871|470562352|FG000|Overall Study|Death|1|||
130367498|NCT00939770|469315957|FG000|Overall Study|Withdrawal by Subject|0|||
130367499|NCT00939770|469315958|FG001|Overall Study|Withdrawal by Subject|1|||
130367500|NCT00939770|469315959|FG002|Overall Study|Withdrawal by Subject|5|||
130554700|NCT00372385|469998080|FG000|Overall Study|Withdrawal by Subject|2|||
130554701|NCT00372385|469998081|FG001|Overall Study|Withdrawal by Subject|1|||
130367501|NCT00939770|469315960|FG003|Overall Study|Withdrawal by Subject|2|||
130367502|NCT00939770|469315961|FG004|Overall Study|Withdrawal by Subject|6|||
130367503|NCT00939770|469315962|FG005|Overall Study|Withdrawal by Subject|0|||
130367504|NCT00939770|469315963|FG006|Overall Study|Withdrawal by Subject|2|||
130367505|NCT00939770|469315964|FG007|Overall Study|Withdrawal by Subject|2|||
130367506|NCT03137537|469315965|FG000|Overall Study|Adverse Event|0|||
130367507|NCT03137537|469315966|FG001|Overall Study|Adverse Event|1|||
130367508|NCT03338010|469315967|FG000|Overall Study|Withdrawal by Subject|14|||
130367509|NCT03338010|469315968|FG001|Overall Study|Withdrawal by Subject|8|||
130367510|NCT03338010|469315967|FG000|Overall Study|Lost to Follow-up|4|||
130367511|NCT03338010|469315968|FG001|Overall Study|Lost to Follow-up|2|||
130367512|NCT03338010|469315967|FG000|Overall Study|Adverse Event|3|||
130554702|NCT00372385|469998082|FG002|Overall Study|Withdrawal by Subject|0|||
130367513|NCT03338010|469315968|FG001|Overall Study|Adverse Event|2|||
130709516|NCT03575871|470562353|FG001|Overall Study|Death|0|||
130709517|NCT03575871|470562354|FG002|Overall Study|Death|0|||
130709518|NCT03575871|470562352|FG000|Overall Study|Lack of Efficacy|5|||
130709519|NCT03575871|470562353|FG001|Overall Study|Lack of Efficacy|4|||
130709520|NCT03575871|470562354|FG002|Overall Study|Lack of Efficacy|7|||
130709521|NCT03575871|470562352|FG000|Overall Study|Lost to Follow-up|1|||
130709522|NCT03575871|470562353|FG001|Overall Study|Lost to Follow-up|1|||
130709523|NCT03575871|470562354|FG002|Overall Study|Lost to Follow-up|1|||
130709524|NCT03575871|470562352|FG000|Overall Study|Protocol Deviation|1|||
130709525|NCT03575871|470562353|FG001|Overall Study|Protocol Deviation|1|||
130709526|NCT03575871|470562354|FG002|Overall Study|Protocol Deviation|1|||
130709527|NCT03575871|470562352|FG000|Overall Study|Withdrawal by Subject|6|||
130709528|NCT03575871|470562353|FG001|Overall Study|Withdrawal by Subject|1|||
130709529|NCT03575871|470562354|FG002|Overall Study|Withdrawal by Subject|9|||
130709530|NCT03575871|470562352|FG000|Overall Study|Other than specified|2|||
130709531|NCT03575871|470562353|FG001|Overall Study|Other than specified|2|||
130709532|NCT03575871|470562354|FG002|Overall Study|Other than specified|0|||
130709533|NCT01045993|470562355|FG000|Overall Study|Treated-later found eligibility not met|0|||
130709534|NCT01045993|470562356|FG001|Overall Study|Treated-later found eligibility not met|1|||
130709535|NCT01045993|470562357|FG002|Overall Study|Treated-later found eligibility not met|0|||
130709536|NCT01045993|470562358|FG003|Overall Study|Treated-later found eligibility not met|0|||
130709537|NCT05506358|470562359|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
130709538|NCT05506358|470562360|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130274777|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
130274778|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
130709539|NCT05506358|470562361|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709540|NCT05506358|470562362|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709541|NCT05506358|470562363|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709542|NCT05506358|470562359|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
130709543|NCT05506358|470562360|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709544|NCT05506358|470562361|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709545|NCT05506358|470562362|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709546|NCT05506358|470562363|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709547|NCT05506358|470562359|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709548|NCT05506358|470562360|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709549|NCT05506358|470562361|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709550|NCT05506358|470562362|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
130709551|NCT05506358|470562363|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709552|NCT05506358|470562359|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
130709553|NCT05506358|470562360|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
130709554|NCT05506358|470562361|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
130709555|NCT05506358|470562362|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
130709556|NCT05506358|470562363|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
130709557|NCT05506358|470562359|FG000|Overall Study|HbE trait|0|||
130709558|NCT05506358|470562360|FG001|Overall Study|HbE trait|0|||
130709559|NCT05506358|470562361|FG002|Overall Study|HbE trait|0|||
130709560|NCT05506358|470562362|FG003|Overall Study|HbE trait|1|||
130709561|NCT05506358|470562363|FG004|Overall Study|HbE trait|0|||
130709562|NCT01659736|470562364|FG000|Treatment Period|Adverse Event|1|||
130709563|NCT01659736|470562365|FG001|Treatment Period|Adverse Event|1|||
130709564|NCT01659736|470562364|FG000|Treatment Period|Protocol Violation|3|||
130709565|NCT01659736|470562365|FG001|Treatment Period|Protocol Violation|1|||
130709566|NCT01659736|470562364|FG000|Treatment Period|Withdrawal by Subject|1|||
130709567|NCT01659736|470562365|FG001|Treatment Period|Withdrawal by Subject|0|||
130709568|NCT01659736|470562364|FG000|3-month Follow-up|Lost to Follow-up|0|||
130709569|NCT01659736|470562365|FG001|3-month Follow-up|Lost to Follow-up|1|||
130709570|NCT01173471|470562374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130709571|NCT01173471|470562375|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130709572|NCT01173471|470562376|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130709573|NCT01173471|470562377|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130274779|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
130274780|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
130274781|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
130274782|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274783|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274784|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274785|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
130709574|NCT01173471|470562374|FG000|Overall Study|Condition under investigation worsened|2|||
130709575|NCT01173471|470562375|FG001|Overall Study|Condition under investigation worsened|0|||
130456932|NCT03098030|469636358|FG003|Overall Study|Lost to Follow-up|1|||
130456933|NCT03643211|469636359|FG000|Overall Study|Contract violation/deficiency|12|||
130456934|NCT03643211|469636359|FG000|Overall Study|Invalid registration|3|||
130456935|NCT03643211|469636359|FG000|Overall Study|No treatment information|2|||
130456936|NCT03643211|469636359|FG000|Overall Study|No adverse event information - No revisit|4|||
130456937|NCT03368001|469636360|FG000|Allocation|Lost to Pretest|16|||
130456938|NCT03368001|469636361|FG001|Allocation|Lost to Pretest|25|||
130456939|NCT03368001|469636360|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
130456940|NCT03368001|469636361|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
130456941|NCT03368001|469636360|FG000|Posttest|Lost to Posttest|7|||
130456942|NCT03368001|469636361|FG001|Posttest|Lost to Posttest|11|||
130456943|NCT03368001|469636360|FG000|Posttest|Discontinued Intervention|6|||
130554703|NCT00372385|469998083|FG003|Overall Study|Withdrawal by Subject|0|||
130709576|NCT01173471|470562376|FG002|Overall Study|Condition under investigation worsened|0|||
130709577|NCT01173471|470562377|FG003|Overall Study|Condition under investigation worsened|0|||
130709578|NCT01173471|470562374|FG000|Overall Study|Lost to Follow-up|0|||
130709579|NCT01173471|470562375|FG001|Overall Study|Lost to Follow-up|0|||
130709580|NCT01173471|470562376|FG002|Overall Study|Lost to Follow-up|1|||
130709581|NCT01173471|470562377|FG003|Overall Study|Lost to Follow-up|0|||
130709582|NCT01173471|470562374|FG000|Overall Study|Reason given as Other|0|||
130709583|NCT01173471|470562375|FG001|Overall Study|Reason given as Other|0|||
130709584|NCT01173471|470562376|FG002|Overall Study|Reason given as Other|1|||
130709585|NCT01173471|470562377|FG003|Overall Study|Reason given as Other|0|||
130709586|NCT00252174|470562378|FG000|Overall Study|Withdrawal by Subject|0|||
130709587|NCT00252174|470562379|FG001|Overall Study|Withdrawal by Subject|1|||
130709588|NCT00252174|470562380|FG002|Overall Study|Withdrawal by Subject|0|||
130709589|NCT00102687|470562382|FG000|Initial Period|Withdrawal by Subject|6|||
130709590|NCT00102687|470562383|FG001|Initial Period|Withdrawal by Subject|3|||
130709591|NCT00102687|470562384|FG002|Initial Period|Withdrawal by Subject|5|||
130709592|NCT00102687|470562385|FG003|Initial Period|Withdrawal by Subject|0|||
130709593|NCT00102687|470562386|FG004|Initial Period|Withdrawal by Subject|0|||
130709594|NCT00102687|470562382|FG000|Initial Period|Adverse Event|4|||
130709595|NCT00102687|470562383|FG001|Initial Period|Adverse Event|7|||
130709596|NCT00102687|470562384|FG002|Initial Period|Adverse Event|9|||
130709597|NCT00102687|470562385|FG003|Initial Period|Adverse Event|0|||
130709598|NCT00102687|470562386|FG004|Initial Period|Adverse Event|0|||
130709599|NCT00102687|470562382|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
130709600|NCT00102687|470562383|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
130709601|NCT00102687|470562384|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
130709602|NCT00102687|470562385|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
130709603|NCT00102687|470562386|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
130709604|NCT00102687|470562382|FG000|Initial Period|Protocol Violation|0|||
130709605|NCT00102687|470562383|FG001|Initial Period|Protocol Violation|0|||
130709606|NCT00102687|470562384|FG002|Initial Period|Protocol Violation|2|||
130709607|NCT00102687|470562385|FG003|Initial Period|Protocol Violation|0|||
130709608|NCT00102687|470562386|FG004|Initial Period|Protocol Violation|0|||
130709609|NCT00102687|470562382|FG000|Initial Period|Physician Decision|2|||
130709610|NCT00102687|470562383|FG001|Initial Period|Physician Decision|9|||
130709611|NCT00102687|470562384|FG002|Initial Period|Physician Decision|6|||
130709612|NCT00102687|470562385|FG003|Initial Period|Physician Decision|0|||
130709613|NCT00102687|470562386|FG004|Initial Period|Physician Decision|0|||
130709614|NCT00102687|470562382|FG000|Initial Period|Sponsor's decision|0|||
130709615|NCT00102687|470562383|FG001|Initial Period|Sponsor's decision|1|||
130709616|NCT00102687|470562384|FG002|Initial Period|Sponsor's decision|1|||
130709617|NCT00102687|470562385|FG003|Initial Period|Sponsor's decision|0|||
130709618|NCT00102687|470562386|FG004|Initial Period|Sponsor's decision|0|||
130709619|NCT00102687|470562382|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130709620|NCT00102687|470562383|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130709621|NCT00102687|470562384|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
130709622|NCT00102687|470562385|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130709623|NCT00102687|470562386|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130709624|NCT00102687|470562382|FG000|Initial Period|Death|1|||
130709625|NCT00102687|470562383|FG001|Initial Period|Death|1|||
130709626|NCT00102687|470562384|FG002|Initial Period|Death|1|||
130554704|NCT00372385|469998080|FG000|Overall Study|Refusal of Treatment|3|||
130709627|NCT00102687|470562385|FG003|Initial Period|Death|0|||
130709628|NCT00102687|470562386|FG004|Initial Period|Death|0|||
130709629|NCT00102687|470562382|FG000|Maintenance Period|Withdrawal by Subject|4|||
130709630|NCT00102687|470562383|FG001|Maintenance Period|Withdrawal by Subject|0|||
130709631|NCT00102687|470562384|FG002|Maintenance Period|Withdrawal by Subject|2|||
130456944|NCT03368001|469636361|FG001|Posttest|Discontinued Intervention|19|||
130709632|NCT00102687|470562385|FG003|Maintenance Period|Withdrawal by Subject|3|||
130709633|NCT00102687|470562386|FG004|Maintenance Period|Withdrawal by Subject|1|||
130709634|NCT00102687|470562382|FG000|Maintenance Period|Adverse Event|1|||
130709635|NCT00102687|470562383|FG001|Maintenance Period|Adverse Event|0|||
130709636|NCT00102687|470562384|FG002|Maintenance Period|Adverse Event|0|||
130709637|NCT00102687|470562385|FG003|Maintenance Period|Adverse Event|1|||
130709638|NCT00102687|470562386|FG004|Maintenance Period|Adverse Event|3|||
130709639|NCT00102687|470562382|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709640|NCT00102687|470562383|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
130709641|NCT00102687|470562384|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709642|NCT00102687|470562385|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
130709643|NCT00102687|470562386|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709644|NCT00102687|470562382|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709645|NCT00102687|470562383|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709646|NCT00102687|470562384|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709647|NCT00102687|470562385|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
130709648|NCT00102687|470562386|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
130709649|NCT00102687|470562382|FG000|Maintenance Period|Death|0|||
130709650|NCT00102687|470562383|FG001|Maintenance Period|Death|0|||
130274786|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274787|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274788|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274789|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274790|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274791|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274792|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274793|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274794|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
130274795|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
130274796|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
130274797|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
130274798|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
130274799|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
130274800|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
130274801|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
130274802|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
130274803|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
130274804|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
130274805|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
130274806|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274807|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274808|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274809|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274810|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274811|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274812|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130367514|NCT03338010|469315967|FG000|Overall Study|Physician Decision|2|||
130367515|NCT03338010|469315968|FG001|Overall Study|Physician Decision|2|||
130367516|NCT03338010|469315967|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130367517|NCT03338010|469315968|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130367518|NCT03338010|469315967|FG000|Overall Study|Protocol Violation|0|||
130367519|NCT03338010|469315968|FG001|Overall Study|Protocol Violation|1|||
130367520|NCT01146665|469315971|FG000|Overall Study|Withdrawal by Subject|10|||
130367521|NCT01146665|469315972|FG001|Overall Study|Withdrawal by Subject|16|||
130367522|NCT00816595|469315973|FG000|Overall Study|Withdrawal by Subject|2|||
130367523|NCT00816595|469315974|FG001|Overall Study|Withdrawal by Subject|0|||
130367524|NCT00293033|469315975|FG000|Open-label Titration Period|Adverse Event|10|||
130367525|NCT00293033|469315975|FG000|Open-label Titration Period|Death|3|||
130367526|NCT00293033|469315975|FG000|Open-label Titration Period|Lack of Efficacy|5|||
130367527|NCT00293033|469315975|FG000|Open-label Titration Period|Protocol Violation|2|||
130367528|NCT00293033|469315975|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
130367529|NCT00293033|469315975|FG000|Open-label Titration Period|Noncompliance and other|27|||
130367530|NCT00293033|469315975|FG000|Double-blind Treatment Period|Adverse Event|3|||
130367531|NCT00293033|469315975|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
130367532|NCT00293033|469315975|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
130367533|NCT00293033|469315975|FG000|Double-blind Treatment Period|Noncompliance|4|||
130709651|NCT00102687|470562384|FG002|Maintenance Period|Death|0|||
130274813|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274814|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130456945|NCT03368001|469636360|FG000|Follow-up|Lost to Follow-up|6|||
130456946|NCT03368001|469636361|FG001|Follow-up|Lost to Follow-up|3|||
130456947|NCT00554801|469636362|FG000|Overall Study|left area before completion|5|||
130456948|NCT00554801|469636363|FG001|Overall Study|left area before completion|0|||
130456949|NCT00554801|469636362|FG000|Overall Study|Withdrawal by Subject|14|||
130456950|NCT00554801|469636363|FG001|Overall Study|Withdrawal by Subject|0|||
130456951|NCT04436120|469636364|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
130456952|NCT04436120|469636365|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
130456953|NCT04436120|469636366|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
130456954|NCT04436120|469636367|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
130456955|NCT04436120|469636368|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
130456956|NCT04436120|469636369|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
130554705|NCT00372385|469998081|FG001|Overall Study|Refusal of Treatment|6|||
130554706|NCT00372385|469998082|FG002|Overall Study|Refusal of Treatment|0|||
130554707|NCT00372385|469998083|FG003|Overall Study|Refusal of Treatment|0|||
130554708|NCT00372385|469998080|FG000|Overall Study|No Response|1|||
130554709|NCT00372385|469998081|FG001|Overall Study|No Response|1|||
130456957|NCT04436120|469636370|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
130709652|NCT00102687|470562385|FG003|Maintenance Period|Death|1|||
130709653|NCT00102687|470562386|FG004|Maintenance Period|Death|1|||
130709654|NCT00102687|470562382|FG000|Maintenance Period|Physician Decision|1|||
130709655|NCT00102687|470562383|FG001|Maintenance Period|Physician Decision|2|||
130709656|NCT00102687|470562384|FG002|Maintenance Period|Physician Decision|3|||
130709657|NCT00102687|470562385|FG003|Maintenance Period|Physician Decision|0|||
130709658|NCT00102687|470562386|FG004|Maintenance Period|Physician Decision|4|||
130709659|NCT00351351|470562387|FG000|Overall Study|surgical access pbs; device issues|9|||
130709660|NCT00351351|470562388|FG001|Overall Study|surgical access pbs; device issues|4|||
130709661|NCT00466726|470562389|FG000|Overall Study|Not evaluable for response|14|||
130709662|NCT04403763|470562390|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
130709663|NCT04403763|470562391|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
130709664|NCT04403763|470562392|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709665|NCT04403763|470562393|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709666|NCT04403763|470562394|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709667|NCT04403763|470562395|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709668|NCT04403763|470562396|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709669|NCT04403763|470562390|FG000|Stage 1|Early termination due to PK tube failure|0|||
130709670|NCT04403763|470562391|FG001|Stage 1|Early termination due to PK tube failure|0|||
130709671|NCT04403763|470562392|FG002|Stage 1|Early termination due to PK tube failure|1|||
130709672|NCT04403763|470562393|FG003|Stage 1|Early termination due to PK tube failure|0|||
130709673|NCT04403763|470562394|FG004|Stage 1|Early termination due to PK tube failure|0|||
130709674|NCT04403763|470562395|FG005|Stage 1|Early termination due to PK tube failure|0|||
130709675|NCT04403763|470562396|FG006|Stage 1|Early termination due to PK tube failure|0|||
130709676|NCT04403763|470562390|FG000|Stage 2A|Adverse Event|0|||
130709677|NCT04403763|470562391|FG001|Stage 2A|Adverse Event|0|||
130709678|NCT04403763|470562392|FG002|Stage 2A|Adverse Event|0|||
130709679|NCT04403763|470562393|FG003|Stage 2A|Adverse Event|0|||
130709680|NCT04403763|470562394|FG004|Stage 2A|Adverse Event|0|||
130709681|NCT04403763|470562395|FG005|Stage 2A|Adverse Event|0|||
130709682|NCT04403763|470562396|FG006|Stage 2A|Adverse Event|1|||
130709683|NCT01376310|470562397|FG000|Overall Study|Study closed/terminated|1|||
130709684|NCT01376310|470562398|FG001|Overall Study|Study closed/terminated|2|||
130709685|NCT01376310|470562397|FG000|Overall Study|Withdrawal by Subject|8|||
130709686|NCT01376310|470562398|FG001|Overall Study|Withdrawal by Subject|2|||
130709687|NCT01376310|470562397|FG000|Overall Study|Physician Decision|26|||
130709688|NCT01376310|470562398|FG001|Overall Study|Physician Decision|7|||
130709689|NCT01376310|470562397|FG000|Overall Study|Lost to Follow-up|1|||
130709690|NCT01376310|470562398|FG001|Overall Study|Lost to Follow-up|0|||
130709691|NCT02339740|470562401|FG000|Overall Study|Death|1|||
130709692|NCT02339740|470562402|FG001|Overall Study|Death|0|||
130709693|NCT02339740|470562401|FG000|Overall Study|Physician Decision|0|||
130709694|NCT02339740|470562402|FG001|Overall Study|Physician Decision|2|||
130709695|NCT02339740|470562401|FG000|Overall Study|Withdrawal by Subject|5|||
130274815|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
130274816|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274817|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274818|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
130456958|NCT02357784|469636371|FG000|Overall Study|Withdrawal by Subject|1|||
130709696|NCT02339740|470562402|FG001|Overall Study|Withdrawal by Subject|1|||
130709697|NCT02339740|470562401|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
130709698|NCT02339740|470562402|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
130709699|NCT00606502|470562403|FG000|Randomization|Randomized but not treated|3|||
130709700|NCT00606502|470562404|FG001|Randomization|Randomized but not treated|0|||
130709701|NCT00606502|470562403|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
130709702|NCT00606502|470562404|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
130709703|NCT02083926|470562407|FG000|Overall Study|Withdrawal by Subject|1|||
130709704|NCT02083926|470562408|FG001|Overall Study|Withdrawal by Subject|0|||
130709705|NCT00384176|470562409|FG000|Overall Study|Death|239|||
130709706|NCT00384176|470562410|FG001|Overall Study|Death|247|||
130709707|NCT00384176|470562411|FG002|Overall Study|Death|105|||
130709708|NCT00384176|470562409|FG000|Overall Study|Withdrawal by Subject|52|||
130709709|NCT00384176|470562410|FG001|Overall Study|Withdrawal by Subject|48|||
130709710|NCT00384176|470562411|FG002|Overall Study|Withdrawal by Subject|22|||
130709711|NCT00384176|470562409|FG000|Overall Study|Lost to Follow-up|16|||
130709712|NCT00384176|470562410|FG001|Overall Study|Lost to Follow-up|18|||
130709713|NCT00384176|470562411|FG002|Overall Study|Lost to Follow-up|4|||
130709714|NCT00384176|470562409|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
130709715|NCT00384176|470562410|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
130709716|NCT00384176|470562411|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
130709717|NCT00384176|470562409|FG000|Overall Study|Longer QTC as Visit 1|1|||
130709718|NCT00384176|470562410|FG001|Overall Study|Longer QTC as Visit 1|0|||
130709719|NCT00384176|470562411|FG002|Overall Study|Longer QTC as Visit 1|0|||
130709720|NCT00384176|470562409|FG000|Overall Study|Toxicity of treatment|1|||
130709721|NCT00384176|470562410|FG001|Overall Study|Toxicity of treatment|0|||
130274819|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
130274820|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
130274821|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
130274822|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
130274823|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
130274824|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
130274825|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
130274826|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
130274827|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
130274828|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
130274829|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
130274830|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274831|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274832|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274833|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274834|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274835|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274836|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274837|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274838|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274839|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
130274840|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274841|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274842|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Death|0|||
130274843|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Death|0|||
130709722|NCT00384176|470562411|FG002|Overall Study|Toxicity of treatment|0|||
130709723|NCT00384176|470562409|FG000|Overall Study|Did not receive study treatment|0|||
130709724|NCT00384176|470562410|FG001|Overall Study|Did not receive study treatment|1|||
130709725|NCT00384176|470562411|FG002|Overall Study|Did not receive study treatment|1|||
130709726|NCT00384176|470562409|FG000|Overall Study|Physician Decision|0|||
130709727|NCT00384176|470562410|FG001|Overall Study|Physician Decision|2|||
130709728|NCT00384176|470562411|FG002|Overall Study|Physician Decision|0|||
130709729|NCT00384176|470562409|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
130709730|NCT00384176|470562410|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
130709731|NCT00384176|470562411|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
130709732|NCT02697773|470562412|FG000|Overall Study|Adverse Event|2|||
130709733|NCT02697773|470562413|FG001|Overall Study|Adverse Event|1|||
130709734|NCT02697773|470562414|FG002|Overall Study|Adverse Event|2|||
130709735|NCT02697773|470562412|FG000|Overall Study|Death|0|||
130709736|NCT02697773|470562413|FG001|Overall Study|Death|0|||
130709737|NCT02697773|470562414|FG002|Overall Study|Death|2|||
130709738|NCT02697773|470562412|FG000|Overall Study|Lack of Efficacy|4|||
130709739|NCT02697773|470562413|FG001|Overall Study|Lack of Efficacy|6|||
130709740|NCT02697773|470562414|FG002|Overall Study|Lack of Efficacy|6|||
130709741|NCT02697773|470562412|FG000|Overall Study|Lost to Follow-up|5|||
130709742|NCT02697773|470562413|FG001|Overall Study|Lost to Follow-up|5|||
130709743|NCT02697773|470562414|FG002|Overall Study|Lost to Follow-up|7|||
130709744|NCT02697773|470562412|FG000|Overall Study|Other|15|||
130709745|NCT02697773|470562413|FG001|Overall Study|Other|11|||
130274844|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Death|0|||
130274845|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Death|0|||
130274846|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Death|0|||
130274847|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Death|0|||
130274848|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Death|0|||
130274849|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Death|0|||
130274850|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Death|0|||
130274851|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Death|1|||
130274852|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Death|0|||
130274853|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Death|0|||
130709746|NCT02697773|470562414|FG002|Overall Study|Other|10|||
130709747|NCT02697773|470562412|FG000|Overall Study|Protocol Violation|1|||
130709748|NCT02697773|470562413|FG001|Overall Study|Protocol Violation|1|||
130709749|NCT02697773|470562414|FG002|Overall Study|Protocol Violation|0|||
130709750|NCT02697773|470562412|FG000|Overall Study|Withdrawal by Subject|10|||
130709751|NCT02697773|470562413|FG001|Overall Study|Withdrawal by Subject|13|||
130274854|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Other|0|||
130274855|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Other|0|||
130274856|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Other|0|||
130274857|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Other|0|||
130274858|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Other|0|||
130274859|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Other|0|||
130274860|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Other|0|||
130274861|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Other|0|||
130274862|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Other|0|||
130274863|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Other|0|||
130274864|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Other|0|||
130709752|NCT02697773|470562414|FG002|Overall Study|Withdrawal by Subject|13|||
130709753|NCT02697773|470562412|FG000|Overall Study|Randomized but not treated|1|||
130709754|NCT02697773|470562413|FG001|Overall Study|Randomized but not treated|1|||
130709755|NCT02697773|470562414|FG002|Overall Study|Randomized but not treated|0|||
130709756|NCT00613834|470562415|FG000|Overall Study|Withdrawal by Subject|0|||
130709757|NCT00613834|470562416|FG001|Overall Study|Withdrawal by Subject|3|||
130709758|NCT01660022|470562417|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709759|NCT01660022|470562418|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
130709760|NCT01660022|470562419|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709761|NCT01660022|470562420|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
130709762|NCT01660022|470562421|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709763|NCT01660022|470562422|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709764|NCT01660022|470562417|FG000|First Sequence (7 Days)|Adverse Event|0|||
130709765|NCT01660022|470562418|FG001|First Sequence (7 Days)|Adverse Event|0|||
130709766|NCT01660022|470562419|FG002|First Sequence (7 Days)|Adverse Event|0|||
130709767|NCT01660022|470562420|FG003|First Sequence (7 Days)|Adverse Event|0|||
130709768|NCT01660022|470562421|FG004|First Sequence (7 Days)|Adverse Event|1|||
130709769|NCT01660022|470562422|FG005|First Sequence (7 Days)|Adverse Event|3|||
130709770|NCT01660022|470562417|FG000|First Sequence (7 Days)|Protocol Violation|0|||
130709771|NCT01660022|470562418|FG001|First Sequence (7 Days)|Protocol Violation|0|||
130709772|NCT01660022|470562419|FG002|First Sequence (7 Days)|Protocol Violation|0|||
130274865|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Other|1|||
130274866|NCT00289289|468969307|FG000|Overall Study|Withdrawal by Subject|5|||
130274867|NCT00289289|468969308|FG001|Overall Study|Withdrawal by Subject|3|||
130274868|NCT00289289|468969309|FG002|Overall Study|Withdrawal by Subject|15|||
130274869|NCT00289289|468969307|FG000|Overall Study|Lost to Follow-up|1|||
130274870|NCT00289289|468969308|FG001|Overall Study|Lost to Follow-up|0|||
130274871|NCT00289289|468969309|FG002|Overall Study|Lost to Follow-up|1|||
130274872|NCT00289289|468969307|FG000|Overall Study|Death|4|||
130274873|NCT00289289|468969308|FG001|Overall Study|Death|2|||
130274874|NCT00289289|468969309|FG002|Overall Study|Death|5|||
130274875|NCT00289289|468969307|FG000|Overall Study|No implant attempted|0|||
130274876|NCT00289289|468969308|FG001|Overall Study|No implant attempted|0|||
130274877|NCT00289289|468969309|FG002|Overall Study|No implant attempted|1|||
130274878|NCT00289289|468969307|FG000|Overall Study|Physician Decision|1|||
130274879|NCT00289289|468969308|FG001|Overall Study|Physician Decision|0|||
130274880|NCT00289289|468969309|FG002|Overall Study|Physician Decision|6|||
130274881|NCT00289289|468969307|FG000|Overall Study|Non-study device implanted|2|||
130274882|NCT00289289|468969308|FG001|Overall Study|Non-study device implanted|1|||
130274883|NCT00289289|468969309|FG002|Overall Study|Non-study device implanted|3|||
130274884|NCT00289289|468969307|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
130274885|NCT00289289|468969308|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
130274886|NCT00289289|468969309|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
130274887|NCT00289289|468969307|FG000|Overall Study|Other Exit Reason|6|||
130274888|NCT00289289|468969308|FG001|Overall Study|Other Exit Reason|4|||
130709773|NCT01660022|470562420|FG003|First Sequence (7 Days)|Protocol Violation|0|||
130709774|NCT01660022|470562421|FG004|First Sequence (7 Days)|Protocol Violation|0|||
130709775|NCT01660022|470562422|FG005|First Sequence (7 Days)|Protocol Violation|1|||
130709776|NCT02149121|470562428|FG000|Main Study Period|Lack of Efficacy|2|||
130709777|NCT02149121|470562429|FG001|Main Study Period|Lack of Efficacy|2|||
130709778|NCT02149121|470562430|FG002|Main Study Period|Lack of Efficacy|1|||
130709779|NCT02149121|470562431|FG003|Main Study Period|Lack of Efficacy|0|||
130709780|NCT02149121|470562432|FG004|Main Study Period|Lack of Efficacy|0|||
130709781|NCT02149121|470562433|FG005|Main Study Period|Lack of Efficacy|0|||
130274889|NCT00289289|468969309|FG002|Overall Study|Other Exit Reason|12|||
130274890|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Death|1|||
130274891|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Death|0|||
130274892|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Death|0|||
130274893|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
130274894|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
130274895|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
130274896|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
130709782|NCT02149121|470562434|FG006|Main Study Period|Lack of Efficacy|0|||
130709783|NCT02149121|470562428|FG000|Main Study Period|Withdrawal by Subject|9|||
130709784|NCT02149121|470562429|FG001|Main Study Period|Withdrawal by Subject|5|||
130709785|NCT02149121|470562430|FG002|Main Study Period|Withdrawal by Subject|1|||
130709786|NCT02149121|470562431|FG003|Main Study Period|Withdrawal by Subject|0|||
130274897|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
130274898|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
130274899|NCT02567799|468969310|FG000|Follow-up|Death|1|||
130274900|NCT02567799|468969311|FG001|Follow-up|Death|0|||
130274901|NCT02567799|468969312|FG002|Follow-up|Death|1|||
130274902|NCT02567799|468969310|FG000|Follow-up|Progressive Disease|1|||
130274903|NCT02567799|468969311|FG001|Follow-up|Progressive Disease|1|||
130709787|NCT02149121|470562432|FG004|Main Study Period|Withdrawal by Subject|0|||
130709788|NCT02149121|470562433|FG005|Main Study Period|Withdrawal by Subject|0|||
130709789|NCT02149121|470562434|FG006|Main Study Period|Withdrawal by Subject|0|||
130709790|NCT02149121|470562428|FG000|Main Study Period|Adverse Event|2|||
130709791|NCT02149121|470562429|FG001|Main Study Period|Adverse Event|5|||
130709792|NCT02149121|470562430|FG002|Main Study Period|Adverse Event|1|||
130709793|NCT02149121|470562431|FG003|Main Study Period|Adverse Event|0|||
130274904|NCT02567799|468969312|FG002|Follow-up|Progressive Disease|3|||
130274905|NCT00349349|468969314|FG000|Overall Study|Adverse Event|5|||
130274906|NCT00349349|468969315|FG001|Overall Study|Adverse Event|6|||
130274907|NCT00349349|468969316|FG002|Overall Study|Adverse Event|2|||
130274908|NCT00349349|468969314|FG000|Overall Study|Withdrawal by Subject|5|||
130274909|NCT00349349|468969315|FG001|Overall Study|Withdrawal by Subject|2|||
130274910|NCT00349349|468969316|FG002|Overall Study|Withdrawal by Subject|1|||
130274911|NCT00349349|468969314|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
130274912|NCT00349349|468969315|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
130274913|NCT00349349|468969316|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
130367534|NCT00365508|469315979|FG000|Overall Study|Lost to Follow-up|139|||
130367535|NCT00365508|469315980|FG001|Overall Study|Lost to Follow-up|154|||
130367536|NCT00751933|469315981|FG000|Overall Study|Withdrawal by Subject|0|||
130367537|NCT00751933|469315982|FG001|Overall Study|Withdrawal by Subject|1|||
130367538|NCT00751933|469315983|FG002|Overall Study|Withdrawal by Subject|0|||
130367539|NCT00751933|469315984|FG003|Overall Study|Withdrawal by Subject|0|||
130367540|NCT00751933|469315981|FG000|Overall Study|Physician Decision|0|||
130367541|NCT00751933|469315982|FG001|Overall Study|Physician Decision|0|||
130367542|NCT00751933|469315983|FG002|Overall Study|Physician Decision|1|||
130367543|NCT00751933|469315984|FG003|Overall Study|Physician Decision|1|||
130367544|NCT05248867|469315986|FG000|Double-blind Period|Lost to Follow-up|0|||
130367545|NCT05248867|469315987|FG001|Double-blind Period|Lost to Follow-up|3|||
130367546|NCT05248867|469315988|FG002|Double-blind Period|Lost to Follow-up|0|||
130367547|NCT05248867|469315989|FG003|Double-blind Period|Lost to Follow-up|0|||
130367548|NCT05248867|469315990|FG004|Double-blind Period|Lost to Follow-up|0|||
130709794|NCT02149121|470562432|FG004|Main Study Period|Adverse Event|0|||
130709795|NCT02149121|470562433|FG005|Main Study Period|Adverse Event|0|||
130274914|NCT00349349|468969314|FG000|Overall Study|Death|13|||
130274915|NCT00349349|468969315|FG001|Overall Study|Death|10|||
130274916|NCT00349349|468969316|FG002|Overall Study|Death|1|||
130274917|NCT00349349|468969314|FG000|Overall Study|Other Treatment Selected|2|||
130274918|NCT00349349|468969315|FG001|Overall Study|Other Treatment Selected|0|||
130274919|NCT00349349|468969316|FG002|Overall Study|Other Treatment Selected|0|||
130274920|NCT00349349|468969314|FG000|Overall Study|Participant Reduced General Condition|0|||
130274921|NCT00349349|468969315|FG001|Overall Study|Participant Reduced General Condition|1|||
130274922|NCT00349349|468969316|FG002|Overall Study|Participant Reduced General Condition|0|||
130274923|NCT00349349|468969314|FG000|Overall Study|Physician Decision|1|||
130274924|NCT00349349|468969315|FG001|Overall Study|Physician Decision|2|||
130274925|NCT00349349|468969316|FG002|Overall Study|Physician Decision|1|||
130274926|NCT00349349|468969314|FG000|Overall Study|No Response|0|||
130274927|NCT00349349|468969315|FG001|Overall Study|No Response|3|||
130274928|NCT00349349|468969316|FG002|Overall Study|No Response|0|||
130274929|NCT00349349|468969314|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
130274930|NCT00349349|468969315|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
130709796|NCT02149121|470562434|FG006|Main Study Period|Adverse Event|0|||
130709797|NCT02149121|470562428|FG000|Main Study Period|Protocol Violation|2|||
130709798|NCT02149121|470562429|FG001|Main Study Period|Protocol Violation|0|||
130709799|NCT02149121|470562430|FG002|Main Study Period|Protocol Violation|0|||
130709800|NCT02149121|470562431|FG003|Main Study Period|Protocol Violation|0|||
130709801|NCT02149121|470562432|FG004|Main Study Period|Protocol Violation|0|||
130709802|NCT02149121|470562433|FG005|Main Study Period|Protocol Violation|0|||
130709803|NCT02149121|470562434|FG006|Main Study Period|Protocol Violation|0|||
130709804|NCT02149121|470562428|FG000|Main Study Period|Lost to Follow-up|2|||
130709805|NCT02149121|470562429|FG001|Main Study Period|Lost to Follow-up|1|||
130709806|NCT02149121|470562430|FG002|Main Study Period|Lost to Follow-up|0|||
130709807|NCT02149121|470562431|FG003|Main Study Period|Lost to Follow-up|0|||
130709808|NCT02149121|470562432|FG004|Main Study Period|Lost to Follow-up|0|||
130709809|NCT02149121|470562433|FG005|Main Study Period|Lost to Follow-up|0|||
130709810|NCT02149121|470562434|FG006|Main Study Period|Lost to Follow-up|0|||
130709811|NCT02149121|470562428|FG000|Main Study Period|Death|1|||
130709812|NCT02149121|470562429|FG001|Main Study Period|Death|0|||
130709813|NCT02149121|470562430|FG002|Main Study Period|Death|0|||
130709814|NCT02149121|470562431|FG003|Main Study Period|Death|0|||
130709815|NCT02149121|470562432|FG004|Main Study Period|Death|0|||
130709816|NCT02149121|470562433|FG005|Main Study Period|Death|0|||
130709817|NCT02149121|470562434|FG006|Main Study Period|Death|0|||
130709818|NCT02149121|470562428|FG000|Main Study Period|Physician Decision|1|||
130709819|NCT02149121|470562429|FG001|Main Study Period|Physician Decision|0|||
130709820|NCT02149121|470562430|FG002|Main Study Period|Physician Decision|0|||
130709821|NCT02149121|470562431|FG003|Main Study Period|Physician Decision|0|||
130709822|NCT02149121|470562432|FG004|Main Study Period|Physician Decision|0|||
130709823|NCT02149121|470562433|FG005|Main Study Period|Physician Decision|0|||
130709824|NCT02149121|470562434|FG006|Main Study Period|Physician Decision|0|||
130709825|NCT02149121|470562428|FG000|Main Study Period|Developed any malignancy|0|||
130709826|NCT02149121|470562429|FG001|Main Study Period|Developed any malignancy|1|||
130709827|NCT02149121|470562430|FG002|Main Study Period|Developed any malignancy|1|||
130709828|NCT02149121|470562431|FG003|Main Study Period|Developed any malignancy|0|||
130709829|NCT02149121|470562432|FG004|Main Study Period|Developed any malignancy|0|||
130709830|NCT02149121|470562433|FG005|Main Study Period|Developed any malignancy|0|||
130709831|NCT02149121|470562434|FG006|Main Study Period|Developed any malignancy|0|||
130709832|NCT02149121|470562428|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
130709833|NCT02149121|470562429|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
130709834|NCT02149121|470562430|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
130709835|NCT02149121|470562431|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
130709836|NCT02149121|470562432|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
130274931|NCT00349349|468969316|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
130274932|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
130274933|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
130554710|NCT00372385|469998082|FG002|Overall Study|No Response|0|||
130709837|NCT02149121|470562433|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
130709838|NCT02149121|470562434|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
130709839|NCT02149121|470562428|FG000|Main Study Period|Disease progression|0|||
130709840|NCT02149121|470562429|FG001|Main Study Period|Disease progression|1|||
130709841|NCT02149121|470562430|FG002|Main Study Period|Disease progression|0|||
130274934|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
130274935|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
130274936|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130709842|NCT02149121|470562431|FG003|Main Study Period|Disease progression|0|||
130709843|NCT02149121|470562432|FG004|Main Study Period|Disease progression|0|||
130709844|NCT02149121|470562433|FG005|Main Study Period|Disease progression|0|||
130709845|NCT02149121|470562434|FG006|Main Study Period|Disease progression|0|||
130709846|NCT02149121|470562428|FG000|Extension Study Period|Withdrawal by Subject|0|||
130709847|NCT02149121|470562429|FG001|Extension Study Period|Withdrawal by Subject|0|||
130709848|NCT02149121|470562430|FG002|Extension Study Period|Withdrawal by Subject|0|||
130709849|NCT02149121|470562431|FG003|Extension Study Period|Withdrawal by Subject|1|||
130709850|NCT02149121|470562432|FG004|Extension Study Period|Withdrawal by Subject|0|||
130709851|NCT02149121|470562433|FG005|Extension Study Period|Withdrawal by Subject|2|||
130709852|NCT02149121|470562434|FG006|Extension Study Period|Withdrawal by Subject|0|||
130709853|NCT03166124|470562435|FG000|Treatment Period 1|Adverse Event|0|||
130709854|NCT03166124|470562436|FG001|Treatment Period 1|Adverse Event|0|||
130709855|NCT03166124|470562437|FG002|Treatment Period 1|Adverse Event|1|||
130709856|NCT03166124|470562438|FG003|Treatment Period 1|Adverse Event|0|||
130709857|NCT03166124|470562435|FG000|Wash-out Period|Withdrawal by Subject|0|||
130709858|NCT03166124|470562436|FG001|Wash-out Period|Withdrawal by Subject|1|||
130456959|NCT04776213|469636373|FG000|Overall Study|Other|1|||
130456960|NCT04776213|469636373|FG000|Overall Study|Withdrawal by Subject|7|||
130709859|NCT03166124|470562437|FG002|Wash-out Period|Withdrawal by Subject|0|||
130709860|NCT03166124|470562438|FG003|Wash-out Period|Withdrawal by Subject|1|||
130709861|NCT03166124|470562435|FG000|Wash-out Period|Adverse Event|0|||
130709862|NCT03166124|470562436|FG001|Wash-out Period|Adverse Event|1|||
130456961|NCT04776213|469636373|FG000|Overall Study|Protocol Violation|1|||
130456962|NCT04776213|469636373|FG000|Overall Study|Lost to Follow-up|2|||
130456963|NCT01838551|469636374|FG000|Overall Study|Adverse Event|16|||
130456964|NCT01838551|469636374|FG000|Overall Study|Death|1|||
130456965|NCT01838551|469636374|FG000|Overall Study|Lack of Efficacy|10|||
130456966|NCT01838551|469636374|FG000|Overall Study|Physician Decision|4|||
130456967|NCT01838551|469636374|FG000|Overall Study|Withdrawal by Subject|10|||
130456968|NCT01838551|469636374|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
130709863|NCT03166124|470562437|FG002|Wash-out Period|Adverse Event|1|||
130709864|NCT03166124|470562438|FG003|Wash-out Period|Adverse Event|0|||
130709865|NCT00766831|470562439|FG000|Overall Study|Withdrawal by Subject|4|||
130709866|NCT00766831|470562439|FG000|Overall Study|Lost to Follow-up|3|||
130709867|NCT00766831|470562439|FG000|Overall Study|Adverse Event|20|||
130709868|NCT00766831|470562439|FG000|Overall Study|Protocol Violation|15|||
130709869|NCT00766831|470562439|FG000|Overall Study|Physician Decision|5|||
130709870|NCT00766831|470562439|FG000|Overall Study|Withdrawal of consent|26|||
130709871|NCT00766831|470562439|FG000|Overall Study|Non cooperation by participants|14|||
130709872|NCT00766831|470562439|FG000|Overall Study|Other|28|||
130709873|NCT01172821|470562442|FG000|Overall Study|Adverse Event|5|||
130709874|NCT01172821|470562443|FG001|Overall Study|Adverse Event|2|||
130709875|NCT01172821|470562444|FG002|Overall Study|Adverse Event|2|||
130709876|NCT01172821|470562445|FG003|Overall Study|Adverse Event|7|||
130709877|NCT01172821|470562442|FG000|Overall Study|Protocol Violation|0|||
130709878|NCT01172821|470562443|FG001|Overall Study|Protocol Violation|2|||
130709879|NCT01172821|470562444|FG002|Overall Study|Protocol Violation|1|||
130709880|NCT01172821|470562445|FG003|Overall Study|Protocol Violation|2|||
130709881|NCT01172821|470562442|FG000|Overall Study|Lost to Follow-up|4|||
130709882|NCT01172821|470562443|FG001|Overall Study|Lost to Follow-up|1|||
130709883|NCT01172821|470562444|FG002|Overall Study|Lost to Follow-up|2|||
130709884|NCT01172821|470562445|FG003|Overall Study|Lost to Follow-up|2|||
130709885|NCT01172821|470562442|FG000|Overall Study|Withdrawal by Subject|2|||
130709886|NCT01172821|470562443|FG001|Overall Study|Withdrawal by Subject|3|||
130709887|NCT01172821|470562444|FG002|Overall Study|Withdrawal by Subject|3|||
130709888|NCT01172821|470562445|FG003|Overall Study|Withdrawal by Subject|3|||
130709889|NCT01172821|470562442|FG000|Overall Study|Other|3|||
130709890|NCT01172821|470562443|FG001|Overall Study|Other|4|||
130709891|NCT01172821|470562444|FG002|Overall Study|Other|5|||
130709892|NCT01172821|470562445|FG003|Overall Study|Other|3|||
130709893|NCT00094094|470562446|FG000|Overall Study|Death|2|||
130709894|NCT00094094|470562446|FG000|Overall Study|Lack of Efficacy|23|||
130709895|NCT00094094|470562446|FG000|Overall Study|Adverse Event|7|||
130709896|NCT00710749|470562447|FG000|First Intervention|Withdrawal by Subject|1|||
130709897|NCT00710749|470562448|FG001|First Intervention|Withdrawal by Subject|0|||
130709898|NCT05626803|470564733|FG000|Overall Study|Lost to Follow-up|0|||
130709899|NCT05626803|470564734|FG001|Overall Study|Lost to Follow-up|1|||
130709900|NCT05626803|470564735|FG002|Overall Study|Lost to Follow-up|0|||
130709901|NCT05626803|470564736|FG003|Overall Study|Lost to Follow-up|0|||
130709902|NCT01000610|470564741|FG000|Overall Study|Adverse Event|1|||
130709903|NCT01000610|470564741|FG000|Overall Study|Lost to Follow-up|4|||
130709904|NCT01000610|470564741|FG000|Overall Study|Treatment failure|1|||
130709905|NCT00493246|470564742|FG000|Overall Study|Withdrawal by Subject|0|||
130709906|NCT00493246|470564743|FG001|Overall Study|Withdrawal by Subject|0|||
130709907|NCT00493246|470564744|FG002|Overall Study|Withdrawal by Subject|0|||
130709908|NCT00493246|470564745|FG003|Overall Study|Withdrawal by Subject|0|||
130709909|NCT00493246|470564746|FG004|Overall Study|Withdrawal by Subject|1|||
130709910|NCT00493246|470564747|FG005|Overall Study|Withdrawal by Subject|0|||
130709911|NCT00493246|470564748|FG006|Overall Study|Withdrawal by Subject|0|||
130709912|NCT00493246|470564749|FG007|Overall Study|Withdrawal by Subject|0|||
130709913|NCT00493246|470564742|FG000|Overall Study|No access to draw blood|0|||
130709914|NCT00493246|470564743|FG001|Overall Study|No access to draw blood|0|||
130709915|NCT00493246|470564744|FG002|Overall Study|No access to draw blood|0|||
130709916|NCT00493246|470564745|FG003|Overall Study|No access to draw blood|0|||
130709917|NCT00493246|470564746|FG004|Overall Study|No access to draw blood|0|||
130456969|NCT02289560|469636375|FG000|Overall Study|Lost to Follow-up|6|||
130456970|NCT02289560|469636375|FG000|Overall Study|Alternative Treatment|4|||
130456971|NCT02289560|469636375|FG000|Overall Study|Inadequate Treatment|2|||
130456972|NCT02289560|469636375|FG000|Overall Study|Withdrawal by Subject|23|||
130456973|NCT01981356|469636378|FG000|Overall Study|Lost to Follow-up|4|||
130709918|NCT00493246|470564747|FG005|Overall Study|No access to draw blood|1|||
130709919|NCT00493246|470564748|FG006|Overall Study|No access to draw blood|0|||
130709920|NCT00493246|470564749|FG007|Overall Study|No access to draw blood|0|||
130709921|NCT00493246|470564742|FG000|Overall Study|Lost to Follow-up|0|||
130709922|NCT00493246|470564743|FG001|Overall Study|Lost to Follow-up|0|||
130709923|NCT00493246|470564744|FG002|Overall Study|Lost to Follow-up|0|||
130709924|NCT00493246|470564745|FG003|Overall Study|Lost to Follow-up|0|||
130709925|NCT00493246|470564746|FG004|Overall Study|Lost to Follow-up|0|||
130709926|NCT00493246|470564747|FG005|Overall Study|Lost to Follow-up|0|||
130709927|NCT00493246|470564748|FG006|Overall Study|Lost to Follow-up|1|||
130709928|NCT00493246|470564749|FG007|Overall Study|Lost to Follow-up|0|||
130274937|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130456974|NCT01981356|469636379|FG001|Overall Study|Lost to Follow-up|1|||
130456975|NCT01981356|469636378|FG000|Overall Study|Withdrawal by Subject|1|||
130456976|NCT01981356|469636379|FG001|Overall Study|Withdrawal by Subject|1|||
130456977|NCT01981356|469636378|FG000|Overall Study|Protocol Violation|2|||
130456978|NCT01981356|469636379|FG001|Overall Study|Protocol Violation|0|||
130456979|NCT02685033|469636380|FG000|Overall Study|Withdrawal of Consent|0|||
130456980|NCT02685033|469636381|FG001|Overall Study|Withdrawal of Consent|1|||
130456981|NCT02685033|469636380|FG000|Overall Study|Lost to Follow-up|2|||
130456982|NCT02685033|469636381|FG001|Overall Study|Lost to Follow-up|1|||
130456983|NCT02685033|469636380|FG000|Overall Study|Adverse Event|1|||
130456984|NCT02685033|469636381|FG001|Overall Study|Adverse Event|0|||
130456985|NCT02013037|469636382|FG000|Overall Study|Death|6|||
130456986|NCT02013037|469636382|FG000|Overall Study|Withdrawal by Subject|1|||
130456987|NCT02013037|469636382|FG000|Overall Study|Awaiting Transplantation|7|||
130456988|NCT02013037|469636382|FG000|Overall Study|Transplanted without DSA|2|||
130456989|NCT01875250|469638233|FG000|Overall Study|Adverse Event|2|||
130456990|NCT01875250|469638234|FG001|Overall Study|Adverse Event|0|||
130456991|NCT03140176|469638238|FG000|Overall Study|Reason missing|23|||
130456992|NCT03140176|469638238|FG000|Overall Study|Death|33|||
130456993|NCT03140176|469638238|FG000|Overall Study|Disease progression|1|||
130456994|NCT03140176|469638238|FG000|Overall Study|Physician Decision|1|||
130456995|NCT03140176|469638238|FG000|Overall Study|Withdrawal by Subject|1|||
130456996|NCT03140176|469638238|FG000|Overall Study|Lost to Follow-up|15|||
130456997|NCT00149630|469638242|FG000|Overall Study|Incarceration|2|||
130456998|NCT00149630|469638243|FG001|Overall Study|Incarceration|0|||
130456999|NCT00149630|469638242|FG000|Overall Study|Treatment Programs|4|||
130457000|NCT00149630|469638243|FG001|Overall Study|Treatment Programs|5|||
130709929|NCT02698865|470564751|FG000|Overall Study|Other|11|||
130709930|NCT02698865|470564752|FG001|Overall Study|Other|11|||
130709931|NCT02698865|470564751|FG000|Overall Study|Withdrawal by Subject|20|||
130709932|NCT02698865|470564752|FG001|Overall Study|Withdrawal by Subject|16|||
130709933|NCT02698865|470564751|FG000|Overall Study|Physician Decision|0|||
130709934|NCT02698865|470564752|FG001|Overall Study|Physician Decision|4|||
130709935|NCT02698865|470564751|FG000|Overall Study|Lost to Follow-up|4|||
130709936|NCT02698865|470564752|FG001|Overall Study|Lost to Follow-up|2|||
130709937|NCT03861481|470564753|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
130709938|NCT03861481|470564754|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
130709939|NCT03861481|470564753|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
130709940|NCT03861481|470564754|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
130709941|NCT03861481|470564753|FG000|Overall Study|Relapse|1|||
130709942|NCT03861481|470564754|FG001|Overall Study|Relapse|0|||
130709943|NCT03861481|470564753|FG000|Overall Study|Withdrawal by Subject|0|||
130709944|NCT03861481|470564754|FG001|Overall Study|Withdrawal by Subject|1|||
130709945|NCT03861481|470564753|FG000|Overall Study|Lack of Efficacy|4|||
130709946|NCT03861481|470564754|FG001|Overall Study|Lack of Efficacy|5|||
130709947|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
130274938|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130274939|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130274940|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
130274941|NCT01854775|468969321|FG000|Extension Phase|Pregnancy|3|||
130274942|NCT01854775|468969322|FG001|Extension Phase|Pregnancy|0|||
130274943|NCT01854775|468969323|FG002|Extension Phase|Pregnancy|0|||
130274944|NCT01854775|468969321|FG000|Extension Phase|Investigator's Discretion|1|||
130274945|NCT01854775|468969322|FG001|Extension Phase|Investigator's Discretion|0|||
130274946|NCT01854775|468969323|FG002|Extension Phase|Investigator's Discretion|0|||
130274947|NCT01854775|468969321|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
130274948|NCT01854775|468969322|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
130367549|NCT05248867|469315991|FG005|Double-blind Period|Lost to Follow-up|0|||
130367550|NCT05248867|469315986|FG000|Double-blind Period|Withdrawal by Subject|5|||
130367551|NCT05248867|469315987|FG001|Double-blind Period|Withdrawal by Subject|14|||
130367552|NCT05248867|469315988|FG002|Double-blind Period|Withdrawal by Subject|0|||
130367553|NCT05248867|469315989|FG003|Double-blind Period|Withdrawal by Subject|0|||
130367554|NCT05248867|469315990|FG004|Double-blind Period|Withdrawal by Subject|0|||
130367555|NCT05248867|469315991|FG005|Double-blind Period|Withdrawal by Subject|0|||
130367556|NCT05248867|469315986|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130457001|NCT00149630|469638242|FG000|Overall Study|Adverse Event|2|||
130457002|NCT00149630|469638243|FG001|Overall Study|Adverse Event|0|||
130457003|NCT05298111|469638246|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
130457004|NCT05298111|469638247|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
130709948|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
130709949|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
130709950|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
130709951|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130367557|NCT05248867|469315987|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
130367558|NCT05248867|469315988|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130367559|NCT05248867|469315989|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130367560|NCT05248867|469315990|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130457005|NCT02689349|469638248|FG000|Overall Study|Not implanted|4|||
130457006|NCT02689349|469638249|FG001|Overall Study|Not implanted|0|||
130457007|NCT02689349|469638248|FG000|Overall Study|Withdrawal by Subject|9|||
130457008|NCT02689349|469638249|FG001|Overall Study|Withdrawal by Subject|0|||
130457009|NCT03518112|469638250|FG000|Overall Study|Withdrawal by Subject|1|||
130709952|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130709953|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
130709954|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
130457010|NCT00954707|469638252|FG000|Overall Study|Death|34|||
130457011|NCT00954707|469638252|FG000|Overall Study|Withdrawal by Subject|100|||
130457012|NCT00954707|469638252|FG000|Overall Study|Lost to Follow-up|33|||
130457013|NCT02001623|469638253|FG000|Overall Study|Disease Progression|2|||
130457014|NCT02001623|469638254|FG001|Overall Study|Disease Progression|2|||
130709955|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130709956|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130709957|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130709958|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130709959|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130709960|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130709961|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
130709962|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
130709963|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130367561|NCT05248867|469315991|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130367562|NCT05248867|469315986|FG000|Double-blind Period|Other, not specified|3|||
130367563|NCT05248867|469315987|FG001|Double-blind Period|Other, not specified|8|||
130367564|NCT05248867|469315988|FG002|Double-blind Period|Other, not specified|0|||
130367565|NCT05248867|469315989|FG003|Double-blind Period|Other, not specified|0|||
130367566|NCT05248867|469315990|FG004|Double-blind Period|Other, not specified|0|||
130367567|NCT05248867|469315991|FG005|Double-blind Period|Other, not specified|0|||
130367568|NCT05248867|469315986|FG000|Open-label Period|Withdrawal by Subject|0|||
130367569|NCT05248867|469315987|FG001|Open-label Period|Withdrawal by Subject|0|||
130367570|NCT05248867|469315988|FG002|Open-label Period|Withdrawal by Subject|3|||
130367571|NCT05248867|469315989|FG003|Open-label Period|Withdrawal by Subject|1|||
130367572|NCT05248867|469315990|FG004|Open-label Period|Withdrawal by Subject|7|||
130367573|NCT05248867|469315991|FG005|Open-label Period|Withdrawal by Subject|9|||
130367574|NCT05248867|469315986|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130367575|NCT05248867|469315987|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130367576|NCT05248867|469315988|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130367577|NCT05248867|469315989|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
130367578|NCT05248867|469315990|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130457015|NCT02001623|469638255|FG002|Overall Study|Disease Progression|3|||
130457016|NCT02001623|469638256|FG003|Overall Study|Disease Progression|2|||
130457017|NCT02001623|469638257|FG004|Overall Study|Disease Progression|3|||
130709964|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130457018|NCT02001623|469638258|FG005|Overall Study|Disease Progression|2|||
130709965|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
130709966|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709967|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709968|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709969|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709970|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709971|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
130709972|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709973|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709974|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
130709975|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709976|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709977|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
130709978|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
130709979|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
130709980|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709981|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709982|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709983|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709984|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709985|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709986|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709987|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130709988|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130709989|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709990|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
130709991|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709992|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709993|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
130709994|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
130709995|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130709996|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130709997|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130709998|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
130709999|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130710000|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130710001|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710002|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130710003|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130710004|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710005|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710006|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
130710007|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710008|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130710009|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130710010|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710011|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710012|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710013|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130710014|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130274949|NCT01854775|468969323|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
130274950|NCT01854775|468969321|FG000|Extension Phase|Lost to Follow-up|2|||
130274951|NCT01854775|468969322|FG001|Extension Phase|Lost to Follow-up|0|||
130274952|NCT01854775|468969323|FG002|Extension Phase|Lost to Follow-up|0|||
130274953|NCT01854775|468969321|FG000|Extension Phase|Still on Study|32|||
130274954|NCT01854775|468969322|FG001|Extension Phase|Still on Study|47|||
130274955|NCT01854775|468969323|FG002|Extension Phase|Still on Study|18|||
130274956|NCT05111002|468969324|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
130274957|NCT05111002|468969325|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
130274958|NCT05111002|468969324|FG000|Secondary Outcome|Lost to Follow-up|1|||
130457019|NCT02001623|469638259|FG006|Overall Study|Disease Progression|3|||
130274959|NCT05111002|468969325|FG001|Secondary Outcome|Lost to Follow-up|0|||
130274960|NCT04776720|468969328|FG000|Overall Study|COVID Related|4|||
130457020|NCT02001623|469638260|FG007|Overall Study|Disease Progression|3|||
130274961|NCT04776720|468969329|FG001|Overall Study|COVID Related|2|||
130710015|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710016|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710017|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130710018|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710019|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
130710020|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
130710021|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
130710022|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
130710023|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
130710024|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
130710025|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710026|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710027|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710028|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710029|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
130710030|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
130710031|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
130710032|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
130710033|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
130710034|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
130710035|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
130710036|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
130710037|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
130710038|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130710039|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
130710040|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
130710041|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
130710042|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130710043|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130710044|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
130710045|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
130710046|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
130710047|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130710048|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
130710049|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Other|0|||
130710050|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Other|0|||
130710051|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Other|1|||
130710052|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Other|2|||
130710053|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Other|0|||
130710054|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Other|1|||
130710055|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710056|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710057|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710058|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
130710059|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710060|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710061|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710062|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710063|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
130710064|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
130710065|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710066|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710067|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710068|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710069|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
130710070|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
130710071|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710072|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710073|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710074|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710075|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130710076|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130710077|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710078|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710079|NCT01220297|470564763|FG000|Overall Study|Death|2|||
130710080|NCT01220297|470564763|FG000|Overall Study|Lost to Follow-up|1|||
130710081|NCT01287039|470564764|FG000|Overall Study|Noncompliance with study procedures|0|||
130710082|NCT01287039|470564765|FG001|Overall Study|Noncompliance with study procedures|1|||
130710083|NCT01287039|470564764|FG000|Overall Study|Change of location/residence|0|||
130710084|NCT01287039|470564765|FG001|Overall Study|Change of location/residence|3|||
130710085|NCT01287039|470564764|FG000|Overall Study|Elective surgery|0|||
130710086|NCT01287039|470564765|FG001|Overall Study|Elective surgery|1|||
130710087|NCT01287039|470564764|FG000|Overall Study|Protocol Violation|2|||
130710088|NCT01287039|470564765|FG001|Overall Study|Protocol Violation|3|||
130710089|NCT01287039|470564764|FG000|Overall Study|Excluded medication taken|1|||
130710090|NCT01287039|470564765|FG001|Overall Study|Excluded medication taken|0|||
130710091|NCT01287039|470564764|FG000|Overall Study|Noncompliance with study medication|0|||
130710092|NCT01287039|470564765|FG001|Overall Study|Noncompliance with study medication|1|||
130367579|NCT05248867|469315991|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130710093|NCT01287039|470564764|FG000|Overall Study|Problem with travel|0|||
130710094|NCT01287039|470564765|FG001|Overall Study|Problem with travel|1|||
130710095|NCT01287039|470564764|FG000|Overall Study|Death|1|||
130710096|NCT01287039|470564765|FG001|Overall Study|Death|0|||
130710097|NCT01287039|470564764|FG000|Overall Study|Change of residence|1|||
130710098|NCT01287039|470564765|FG001|Overall Study|Change of residence|0|||
130710099|NCT01287039|470564764|FG000|Overall Study|Adverse Event|7|||
130710100|NCT01287039|470564765|FG001|Overall Study|Adverse Event|4|||
130710101|NCT01287039|470564764|FG000|Overall Study|Withdrawal by Subject|14|||
130710102|NCT01287039|470564765|FG001|Overall Study|Withdrawal by Subject|11|||
130710103|NCT01287039|470564764|FG000|Overall Study|Lost to Follow-up|3|||
130710104|NCT01287039|470564765|FG001|Overall Study|Lost to Follow-up|2|||
130710105|NCT05016622|470564766|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
130710106|NCT05016622|470564766|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
130710107|NCT02581163|470564769|FG000|Overall Study|Failure to return|15|||
130710108|NCT02581163|470564769|FG000|Overall Study|Insufficient virological response|3|||
130710109|NCT02581163|470564769|FG000|Overall Study|Withdrew consent|1|||
130710110|NCT02581163|470564769|FG000|Overall Study|Death|1|||
130710111|NCT02581163|470564769|FG000|Overall Study|Other, not specified|9|||
130710112|NCT02791893|470564770|FG000|Blinded Phase|Lost to Follow-up|2|||
130710113|NCT02791893|470564771|FG001|Blinded Phase|Lost to Follow-up|2|||
130710114|NCT02791893|470564770|FG000|Blinded Phase|Withdrawal by Subject|1|||
130367580|NCT05248867|469315986|FG000|Open-label Period|Lost to Follow-up|0|||
130554711|NCT00372385|469998083|FG003|Overall Study|No Response|0|||
130554712|NCT00372385|469998080|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
130554713|NCT00372385|469998081|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
130554714|NCT00372385|469998082|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
130554715|NCT00372385|469998083|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
130554716|NCT00372385|469998080|FG000|Overall Study|Virologic Stopping Rule|17|||
130554717|NCT00372385|469998081|FG001|Overall Study|Virologic Stopping Rule|0|||
130554718|NCT00372385|469998082|FG002|Overall Study|Virologic Stopping Rule|0|||
130554719|NCT00372385|469998083|FG003|Overall Study|Virologic Stopping Rule|0|||
130554720|NCT01699789|469998084|FG000|Overall Study|Withdrawal by Subject|18|||
130554721|NCT01699789|469998085|FG001|Overall Study|Withdrawal by Subject|23|||
130554722|NCT01699789|469998084|FG000|Overall Study|Death|1|||
130554723|NCT01699789|469998085|FG001|Overall Study|Death|2|||
130554724|NCT01699789|469998084|FG000|Overall Study|Lost to Follow-up|83|||
130554725|NCT01699789|469998085|FG001|Overall Study|Lost to Follow-up|101|||
130554726|NCT01906346|469998086|FG000|Overall Study|AEs|1|||
130554727|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
130554728|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
130554729|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
130554730|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
130554731|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
130554732|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
130554733|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
130554734|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
130554735|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
130554736|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
130554737|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
130554738|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
130554739|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
130554740|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
130554741|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
130554742|NCT01323621|469998089|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
130554743|NCT01323621|469998090|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
130554744|NCT01323621|469998091|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
130554745|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
130554746|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
130554747|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
130274962|NCT04776720|468969328|FG000|Overall Study|Adverse Event|2|||
130274963|NCT04776720|468969329|FG001|Overall Study|Adverse Event|0|||
130274964|NCT04776720|468969328|FG000|Overall Study|Serious Adverse Event|0|||
130274965|NCT04776720|468969329|FG001|Overall Study|Serious Adverse Event|1|||
130274966|NCT04776720|468969328|FG000|Overall Study|Too Busy|3|||
130274967|NCT04776720|468969329|FG001|Overall Study|Too Busy|1|||
130274968|NCT04776720|468969328|FG000|Overall Study|Lost to Follow-up|1|||
130274969|NCT04776720|468969329|FG001|Overall Study|Lost to Follow-up|2|||
130274970|NCT04776720|468969328|FG000|Overall Study|Family|2|||
130274971|NCT04776720|468969329|FG001|Overall Study|Family|2|||
130274972|NCT04776720|468969328|FG000|Overall Study|No remote technology access|0|||
130274973|NCT04776720|468969329|FG001|Overall Study|No remote technology access|1|||
130274974|NCT04776720|468969328|FG000|Overall Study|Withdrawal by Subject|1|||
130274975|NCT04776720|468969329|FG001|Overall Study|Withdrawal by Subject|0|||
130274976|NCT04776720|468969328|FG000|Overall Study|Cannot tolerate intervention|1|||
130457021|NCT02001623|469638261|FG008|Overall Study|Disease Progression|7|||
130274977|NCT04776720|468969329|FG001|Overall Study|Cannot tolerate intervention|0|||
130274978|NCT04776720|468969328|FG000|Overall Study|Incomplete outcome data|6|||
130274979|NCT04776720|468969329|FG001|Overall Study|Incomplete outcome data|1|||
130274980|NCT05356910|468969330|FG000|Overall Study|Lost to Follow-up|10|||
130274981|NCT05356910|468969331|FG001|Overall Study|Lost to Follow-up|19|||
130274982|NCT05356910|468969332|FG002|Overall Study|Lost to Follow-up|0|||
130274983|NCT05356910|468969333|FG003|Overall Study|Lost to Follow-up|0|||
130274984|NCT05356910|468969330|FG000|Overall Study|Withdrawal by Subject|4|||
130274985|NCT05356910|468969331|FG001|Overall Study|Withdrawal by Subject|2|||
130274986|NCT05356910|468969332|FG002|Overall Study|Withdrawal by Subject|0|||
130274987|NCT05356910|468969333|FG003|Overall Study|Withdrawal by Subject|0|||
130274988|NCT03122145|468969335|FG000|Overall Study|Concurrent respiratory disease|3|||
130274989|NCT03122145|468969336|FG001|Overall Study|Concurrent respiratory disease|0|||
130274990|NCT00837161|468969337|FG000|Overall Study|refused hysterectomy|2|||
130274991|NCT01659996|468969340|FG000|Overall Study|Protocol Violation|3|||
130274992|NCT01659996|468969341|FG001|Overall Study|Protocol Violation|3|||
130274993|NCT01659996|468969342|FG002|Overall Study|Protocol Violation|3|||
130274994|NCT01659996|468969340|FG000|Overall Study|Lost to Follow-up|1|||
130274995|NCT01659996|468969341|FG001|Overall Study|Lost to Follow-up|3|||
130274996|NCT01659996|468969342|FG002|Overall Study|Lost to Follow-up|2|||
130274997|NCT01659996|468969340|FG000|Overall Study|Adverse Event|0|||
130274998|NCT01659996|468969341|FG001|Overall Study|Adverse Event|0|||
130274999|NCT01659996|468969342|FG002|Overall Study|Adverse Event|1|||
130275000|NCT01659996|468969340|FG000|Overall Study|Withdrawal by Subject|4|||
130275001|NCT01659996|468969341|FG001|Overall Study|Withdrawal by Subject|1|||
130554748|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130554749|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
130554750|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
130554751|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
130554752|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
130554753|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
130554754|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130554755|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130554756|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130554757|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
130554758|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
130554759|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
130554760|NCT01323621|469998089|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130554761|NCT01323621|469998090|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
130554762|NCT01323621|469998091|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
130554763|NCT04226833|469998092|FG000|Overall Study|Death|0|||
130554764|NCT04226833|469998093|FG001|Overall Study|Death|0|||
130554765|NCT04226833|469998094|FG002|Overall Study|Death|1|||
130554766|NCT04226833|469998095|FG003|Overall Study|Death|0|||
130554767|NCT02876835|469998098|FG000|Treatment Period (51.1 Month)|Other|1|||
130554768|NCT02876835|469998099|FG001|Treatment Period (51.1 Month)|Other|0|||
130554769|NCT02876835|469998098|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
130554770|NCT02876835|469998099|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
130554771|NCT02876835|469998098|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
130554772|NCT02876835|469998099|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
130554773|NCT02876835|469998098|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
130554774|NCT02876835|469998099|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
130554775|NCT02540538|469998101|FG000|Overall Study|Pregnancy|0|||
130554776|NCT02540538|469998102|FG001|Overall Study|Pregnancy|1|||
130554777|NCT02540538|469998103|FG002|Overall Study|Pregnancy|0|||
130554778|NCT00364156|469998107|FG000|Overall Study|Withdrawal by Subject|73|||
130554779|NCT00364156|469998108|FG001|Overall Study|Withdrawal by Subject|80|||
130554780|NCT00364156|469998107|FG000|Overall Study|Protocol Violation|6|||
130554781|NCT00364156|469998108|FG001|Overall Study|Protocol Violation|1|||
130554782|NCT01891721|469998109|FG000|Overall Study|Lost to Follow-up|10|||
130554783|NCT01891721|469998110|FG001|Overall Study|Lost to Follow-up|5|||
130554784|NCT01891721|469998111|FG002|Overall Study|Lost to Follow-up|1|||
130554785|NCT04343248|469998112|FG000|Overall Study|Withdrawal by Subject|5|||
130554786|NCT04343248|469998113|FG001|Overall Study|Withdrawal by Subject|6|||
130554787|NCT04343248|469998112|FG000|Overall Study|Death|1|||
130554788|NCT04343248|469998113|FG001|Overall Study|Death|2|||
130554789|NCT04343248|469998112|FG000|Overall Study|Lost to Follow-up|9|||
130554790|NCT04343248|469998113|FG001|Overall Study|Lost to Follow-up|6|||
130275002|NCT01659996|468969342|FG002|Overall Study|Withdrawal by Subject|5|||
130275003|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Adverse Event|21|||
130275004|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Adverse Event|34|||
130275005|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Adverse Event|14|||
130275006|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Adverse Event|17|||
130275007|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Adverse Event|0|||
130275008|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
130554791|NCT04343248|469998112|FG000|Overall Study|Physician Decision|0|||
130554792|NCT04343248|469998113|FG001|Overall Study|Physician Decision|1|||
130554793|NCT04343248|469998112|FG000|Overall Study|Adverse Event|1|||
130457022|NCT02001623|469638262|FG009|Overall Study|Disease Progression|40|||
130457023|NCT02001623|469638263|FG010|Overall Study|Disease Progression|5|||
130457024|NCT02001623|469638264|FG011|Overall Study|Disease Progression|9|||
130457025|NCT02001623|469638265|FG012|Overall Study|Disease Progression|9|||
130457026|NCT02001623|469638266|FG013|Overall Study|Disease Progression|20|||
130457027|NCT02001623|469638267|FG014|Overall Study|Disease Progression|9|||
130457028|NCT02001623|469638253|FG000|Overall Study|Physician Decision|0|||
130457029|NCT02001623|469638254|FG001|Overall Study|Physician Decision|0|||
130457030|NCT02001623|469638255|FG002|Overall Study|Physician Decision|0|||
130457031|NCT02001623|469638256|FG003|Overall Study|Physician Decision|0|||
130457032|NCT02001623|469638257|FG004|Overall Study|Physician Decision|0|||
130457033|NCT02001623|469638258|FG005|Overall Study|Physician Decision|0|||
130554794|NCT04343248|469998113|FG001|Overall Study|Adverse Event|0|||
130275009|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
130275010|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
130275011|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
130275012|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
130275013|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
130275014|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
130275015|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
130275016|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
130275017|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
130275018|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Physician Decision|2|||
130275019|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Physician Decision|4|||
130275020|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Physician Decision|4|||
130275021|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Physician Decision|4|||
130275022|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Physician Decision|0|||
130275023|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
130275024|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130275025|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130275026|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
130275027|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
130275028|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
130275029|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
130275030|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
130275031|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
130275032|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
130275033|NCT03108521|468969350|FG000|Overall Study|Lost to Follow-up|3|||
130275034|NCT03108521|468969351|FG001|Overall Study|Lost to Follow-up|0|||
130275035|NCT03108521|468969350|FG000|Overall Study|Lack of Efficacy|2|||
130275036|NCT03108521|468969351|FG001|Overall Study|Lack of Efficacy|0|||
130275037|NCT03108521|468969350|FG000|Overall Study|Physician Decision|4|||
130275038|NCT03108521|468969351|FG001|Overall Study|Physician Decision|0|||
130275039|NCT03108521|468969350|FG000|Overall Study|Adverse Event|3|||
130554795|NCT01313650|469998116|FG000|Overall Study|Adverse Event|9|||
130554796|NCT01313650|469998117|FG001|Overall Study|Adverse Event|34|||
130554797|NCT01313650|469998118|FG002|Overall Study|Adverse Event|24|||
130554798|NCT01313650|469998119|FG003|Overall Study|Adverse Event|23|||
130554799|NCT01313650|469998116|FG000|Overall Study|Lack of Efficacy|37|||
130554800|NCT01313650|469998117|FG001|Overall Study|Lack of Efficacy|20|||
130554801|NCT01313650|469998118|FG002|Overall Study|Lack of Efficacy|32|||
130554802|NCT01313650|469998119|FG003|Overall Study|Lack of Efficacy|20|||
130554803|NCT01313650|469998116|FG000|Overall Study|Lost to Follow-up|1|||
130554804|NCT01313650|469998117|FG001|Overall Study|Lost to Follow-up|0|||
130554805|NCT01313650|469998118|FG002|Overall Study|Lost to Follow-up|3|||
130554806|NCT01313650|469998119|FG003|Overall Study|Lost to Follow-up|2|||
130554807|NCT01313650|469998116|FG000|Overall Study|Withdrawal by Subject|16|||
130554808|NCT01313650|469998117|FG001|Overall Study|Withdrawal by Subject|20|||
130554809|NCT01313650|469998118|FG002|Overall Study|Withdrawal by Subject|15|||
130275040|NCT03108521|468969351|FG001|Overall Study|Adverse Event|0|||
130275041|NCT06899737|468969356|FG000|Overall Study|Lost to Follow-up|19|||
130275042|NCT06899737|468969357|FG001|Overall Study|Lost to Follow-up|7|||
130275043|NCT03281629|468969359|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
130275044|NCT03281629|468969360|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
130275045|NCT03281629|468969359|FG000|Overall Study|Death|0|||
130275046|NCT03281629|468969360|FG001|Overall Study|Death|1|||
130457034|NCT02001623|469638259|FG006|Overall Study|Physician Decision|0|||
130457035|NCT02001623|469638260|FG007|Overall Study|Physician Decision|0|||
130457036|NCT02001623|469638261|FG008|Overall Study|Physician Decision|3|||
130457037|NCT02001623|469638262|FG009|Overall Study|Physician Decision|2|||
130457038|NCT02001623|469638263|FG010|Overall Study|Physician Decision|3|||
130554810|NCT01313650|469998119|FG003|Overall Study|Withdrawal by Subject|15|||
130554811|NCT01313650|469998116|FG000|Overall Study|Protocol Violation|4|||
130554812|NCT01313650|469998117|FG001|Overall Study|Protocol Violation|7|||
130554813|NCT01313650|469998118|FG002|Overall Study|Protocol Violation|5|||
130554814|NCT01313650|469998119|FG003|Overall Study|Protocol Violation|6|||
130554815|NCT01313650|469998116|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
130554816|NCT01313650|469998117|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
130554817|NCT01313650|469998118|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
130554818|NCT01313650|469998119|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
130554819|NCT05393037|469998120|FG000|Part A|Death|1|||
130554820|NCT05393037|469998121|FG001|Part A|Death|0|||
130554821|NCT05393037|469998120|FG000|Part A|Lost to Follow-up|1|||
130554822|NCT05393037|469998121|FG001|Part A|Lost to Follow-up|1|||
130554823|NCT05393037|469998120|FG000|Part A|Withdrawal by Subject|2|||
130554824|NCT05393037|469998121|FG001|Part A|Withdrawal by Subject|4|||
130554825|NCT05393037|469998120|FG000|Part B|Lost to Follow-up|1|||
130554826|NCT05393037|469998121|FG001|Part B|Lost to Follow-up|0|||
130554827|NCT04540133|469998122|FG000|Overall Study|Lost to Follow-up|1|||
130554828|NCT04540133|469998123|FG001|Overall Study|Lost to Follow-up|0|||
130554829|NCT03153111|469998124|FG000|Overall Study|Death|2|||
130554830|NCT03153111|469998125|FG001|Overall Study|Death|5|||
130554831|NCT03153111|469998124|FG000|Overall Study|Lost to Follow-up|1|||
130554832|NCT03153111|469998125|FG001|Overall Study|Lost to Follow-up|0|||
130554833|NCT03153111|469998124|FG000|Overall Study|Physician Decision|5|||
130554834|NCT03153111|469998125|FG001|Overall Study|Physician Decision|1|||
130554835|NCT03153111|469998124|FG000|Overall Study|Withdrawal by Subject|3|||
130554836|NCT03153111|469998125|FG001|Overall Study|Withdrawal by Subject|3|||
130554837|NCT00174265|469998129|FG000|Overall Study|Adverse Event|7|||
130554838|NCT00174265|469998130|FG001|Overall Study|Adverse Event|4|||
130554839|NCT00174265|469998129|FG000|Overall Study|Lack of Efficacy|2|||
130554840|NCT00174265|469998130|FG001|Overall Study|Lack of Efficacy|2|||
130554841|NCT00174265|469998129|FG000|Overall Study|Withdrawal by Subject|3|||
130554842|NCT00174265|469998130|FG001|Overall Study|Withdrawal by Subject|5|||
130554843|NCT00174265|469998129|FG000|Overall Study|Lost to Follow-up|1|||
130554844|NCT00174265|469998130|FG001|Overall Study|Lost to Follow-up|0|||
130554845|NCT00174265|469998129|FG000|Overall Study|Other (Not specified)|16|||
130554846|NCT00174265|469998130|FG001|Overall Study|Other (Not specified)|10|||
130554847|NCT03040622|469998132|FG000|Overall Study|unable to implant device|3|||
130554848|NCT01572922|469998133|FG000|Overall Study|Adverse Event|1|||
130554849|NCT01572922|469998133|FG000|Overall Study|Protocol Violation|1|||
130554850|NCT01572922|469998133|FG000|Overall Study|Death|1|||
130554851|NCT00445068|469998134|FG000|Overall Study|Disease progression|26|||
130554852|NCT00445068|469998134|FG000|Overall Study|Adverse Event|5|||
130554853|NCT00445068|469998134|FG000|Overall Study|Abnormal laboratory value|2|||
130554854|NCT00445068|469998134|FG000|Overall Study|Withdrawal by Subject|2|||
130554855|NCT00445068|469998134|FG000|Overall Study|Death|1|||
130554856|NCT03144804|469998137|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
130554857|NCT04091451|469998140|FG000|Overall Study|Adverse Event|15|||
130554858|NCT04091451|469998141|FG001|Overall Study|Adverse Event|10|||
130554859|NCT04091451|469998140|FG000|Overall Study|Lost to Follow-up|8|||
130554860|NCT04091451|469998141|FG001|Overall Study|Lost to Follow-up|8|||
130554861|NCT04091451|469998140|FG000|Overall Study|Protocol Violation|5|||
130554862|NCT04091451|469998141|FG001|Overall Study|Protocol Violation|4|||
130554863|NCT04091451|469998140|FG000|Overall Study|Withdrawal by Subject|21|||
130554864|NCT04091451|469998141|FG001|Overall Study|Withdrawal by Subject|27|||
130554865|NCT04091451|469998140|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
130275047|NCT03281629|468969359|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
130275048|NCT03281629|468969360|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
130275049|NCT02175277|468969362|FG000|Overall Study|Protocol-specified Criteria|1|||
130275050|NCT00375674|468969367|FG000|Overall Study|Other|26|||
130275051|NCT00375674|468969368|FG001|Overall Study|Other|18|||
130275052|NCT00375674|468969367|FG000|Overall Study|Death|67|||
130275053|NCT00375674|468969368|FG001|Overall Study|Death|76|||
130275054|NCT00375674|468969367|FG000|Overall Study|Participants refused further follow-up|31|||
130275055|NCT00375674|468969368|FG001|Overall Study|Participants refused further follow-up|30|||
130275056|NCT00375674|468969367|FG000|Overall Study|Lost to Follow-up|17|||
130554866|NCT04091451|469998141|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
130554867|NCT04091451|469998140|FG000|Overall Study|Migrated/moved from the study area|3|||
130554868|NCT04091451|469998141|FG001|Overall Study|Migrated/moved from the study area|5|||
130554869|NCT04091451|469998140|FG000|Overall Study|Suspected HZ episode|1|||
130275057|NCT00375674|468969368|FG001|Overall Study|Lost to Follow-up|15|||
130275058|NCT00375674|468969367|FG000|Overall Study|Enrolled but not treated|3|||
130554870|NCT04091451|469998141|FG001|Overall Study|Suspected HZ episode|0|||
130554871|NCT02598557|469999722|FG000|Overall Study|Withdrawal by Subject|1|||
130554872|NCT02598557|469999723|FG001|Overall Study|Withdrawal by Subject|0|||
130554873|NCT02598557|469999724|FG002|Overall Study|Withdrawal by Subject|1|||
130275059|NCT00375674|468969368|FG001|Overall Study|Enrolled but not treated|2|||
130554874|NCT02598557|469999722|FG000|Overall Study|Participant did not start treatment|2|||
130554875|NCT02598557|469999723|FG001|Overall Study|Participant did not start treatment|1|||
130554876|NCT02598557|469999724|FG002|Overall Study|Participant did not start treatment|1|||
130554877|NCT02598557|469999722|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
130275060|NCT03744910|468971892|FG000|Overall Study|Withdrew Consent|1|||
130554878|NCT02598557|469999723|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
130275061|NCT03744910|468971893|FG001|Overall Study|Withdrew Consent|8|||
130275062|NCT03744910|468971892|FG000|Overall Study|Physician Decision|5|||
130275063|NCT03744910|468971893|FG001|Overall Study|Physician Decision|4|||
130275064|NCT03744910|468971892|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
130275065|NCT03744910|468971893|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
130275066|NCT03744910|468971892|FG000|Overall Study|Lost to Follow-up|0|||
130275067|NCT03744910|468971893|FG001|Overall Study|Lost to Follow-up|1|||
130275068|NCT03744910|468971892|FG000|Overall Study|Other-unspecified|4|||
130275069|NCT03744910|468971893|FG001|Overall Study|Other-unspecified|1|||
130275070|NCT00064259|468971894|FG000|Overall Study|Adverse Event|1|||
130275071|NCT00064259|468971895|FG001|Overall Study|Adverse Event|0|||
130275072|NCT00064259|468971896|FG002|Overall Study|Adverse Event|0|||
130275073|NCT00064259|468971897|FG003|Overall Study|Adverse Event|1|||
130275074|NCT01132651|468971900|FG000|Overall Study|Lost to Follow-up|1|||
130275075|NCT01132651|468971901|FG001|Overall Study|Lost to Follow-up|1|||
130275076|NCT03430843|468971904|FG000|Overall Study|Death|233|||
130275077|NCT03430843|468971905|FG001|Overall Study|Death|233|||
130275078|NCT03430843|468971904|FG000|Overall Study|Sponsor Decision|17|||
130275079|NCT03430843|468971905|FG001|Overall Study|Sponsor Decision|6|||
130275080|NCT03430843|468971904|FG000|Overall Study|Withdrawal by Subject|5|||
130275081|NCT03430843|468971905|FG001|Overall Study|Withdrawal by Subject|14|||
130275082|NCT03430843|468971904|FG000|Overall Study|Lost to Follow-up|1|||
130275083|NCT03430843|468971905|FG001|Overall Study|Lost to Follow-up|3|||
130275084|NCT01905943|468971912|FG000|Overall Study|Withdrawal of consent|90|||
130275085|NCT01905943|468971912|FG000|Overall Study|Lost to Follow-up|16|||
130275086|NCT01905943|468971912|FG000|Overall Study|Investigator discretion|7|||
130275087|NCT01905943|468971912|FG000|Overall Study|Death|186|||
130275088|NCT01905943|468971912|FG000|Overall Study|Adverse Event|3|||
130275089|NCT01905943|468971912|FG000|Overall Study|Other|12|||
130275090|NCT02574078|468971913|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275091|NCT02574078|468971914|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275092|NCT02574078|468971915|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275093|NCT02574078|468971916|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275094|NCT02574078|468971917|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275095|NCT02574078|468971918|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130275096|NCT02574078|468971919|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
130275097|NCT02574078|468971920|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275098|NCT02574078|468971921|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130275099|NCT02574078|468971922|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275100|NCT02574078|468971923|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275101|NCT02574078|468971924|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275102|NCT02574078|468971925|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275103|NCT02574078|468971913|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130275104|NCT02574078|468971914|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130275105|NCT02574078|468971915|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
130275106|NCT02574078|468971916|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
130275107|NCT02574078|468971917|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
130275108|NCT02574078|468971918|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
130275109|NCT02574078|468971919|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
130275110|NCT02574078|468971920|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
130275111|NCT02574078|468971921|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
130275112|NCT02574078|468971922|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
130275113|NCT02574078|468971923|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
130554879|NCT02598557|469999724|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
130554880|NCT02598557|469999722|FG000|Overall Study|Adverse Event|1|||
130554881|NCT02598557|469999723|FG001|Overall Study|Adverse Event|1|||
130554882|NCT02598557|469999724|FG002|Overall Study|Adverse Event|0|||
130554883|NCT01117454|469999725|FG000|Overall Study|Pregnancy|0|||
130554884|NCT01117454|469999726|FG001|Overall Study|Pregnancy|1|||
130554885|NCT00888433|469999729|FG000|Overall Study|Withdrawal by Subject|1|||
130275114|NCT02574078|468971924|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
130275115|NCT02574078|468971925|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
130275116|NCT02574078|468971913|FG000|Pre-Treatment Period|Other reasons|0|||
130275117|NCT02574078|468971914|FG001|Pre-Treatment Period|Other reasons|0|||
130554886|NCT00888433|469999730|FG001|Overall Study|Withdrawal by Subject|2|||
130554887|NCT00888433|469999729|FG000|Overall Study|Missed Visit|2|||
130275118|NCT02574078|468971915|FG002|Pre-Treatment Period|Other reasons|0|||
130275119|NCT02574078|468971916|FG003|Pre-Treatment Period|Other reasons|0|||
130275120|NCT02574078|468971917|FG004|Pre-Treatment Period|Other reasons|0|||
130275121|NCT02574078|468971918|FG005|Pre-Treatment Period|Other reasons|0|||
130367581|NCT05248867|469315987|FG001|Open-label Period|Lost to Follow-up|0|||
130367582|NCT05248867|469315988|FG002|Open-label Period|Lost to Follow-up|0|||
130367583|NCT05248867|469315989|FG003|Open-label Period|Lost to Follow-up|0|||
130554888|NCT00888433|469999730|FG001|Overall Study|Missed Visit|1|||
130367584|NCT05248867|469315990|FG004|Open-label Period|Lost to Follow-up|5|||
130367585|NCT05248867|469315991|FG005|Open-label Period|Lost to Follow-up|2|||
130367586|NCT05248867|469315986|FG000|Open-label Period|COVID-19 Infection|0|||
130367587|NCT05248867|469315987|FG001|Open-label Period|COVID-19 Infection|0|||
130367588|NCT05248867|469315988|FG002|Open-label Period|COVID-19 Infection|0|||
130367589|NCT05248867|469315989|FG003|Open-label Period|COVID-19 Infection|0|||
130367590|NCT05248867|469315990|FG004|Open-label Period|COVID-19 Infection|1|||
130367591|NCT05248867|469315991|FG005|Open-label Period|COVID-19 Infection|0|||
130367592|NCT05248867|469315986|FG000|Open-label Period|Other, not specified|0|||
130554889|NCT01681628|469999731|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
130554890|NCT01681628|469999732|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
130554891|NCT01681628|469999731|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
130554892|NCT01681628|469999732|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
130554893|NCT01681628|469999731|FG000|19 Months Follow-up|Death|1|||
130554894|NCT01681628|469999732|FG001|19 Months Follow-up|Death|0|||
130554895|NCT01681628|469999731|FG000|19 Months Follow-up|Lost to Follow-up|61|||
130554896|NCT01681628|469999732|FG001|19 Months Follow-up|Lost to Follow-up|43|||
130554897|NCT01637623|469999741|FG000|Overall Study|Lost to Follow-up|0|||
130367593|NCT05248867|469315987|FG001|Open-label Period|Other, not specified|0|||
130275122|NCT02574078|468971919|FG006|Pre-Treatment Period|Other reasons|2|||
130275123|NCT02574078|468971920|FG007|Pre-Treatment Period|Other reasons|0|||
130275124|NCT02574078|468971921|FG008|Pre-Treatment Period|Other reasons|0|||
130275125|NCT02574078|468971922|FG009|Pre-Treatment Period|Other reasons|0|||
130275126|NCT02574078|468971923|FG010|Pre-Treatment Period|Other reasons|2|||
130275127|NCT02574078|468971924|FG011|Pre-Treatment Period|Other reasons|0|||
130275128|NCT02574078|468971925|FG012|Pre-Treatment Period|Other reasons|0|||
130275129|NCT02574078|468971913|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130275130|NCT02574078|468971914|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
130275131|NCT02574078|468971915|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
130275132|NCT02574078|468971916|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
130275133|NCT02574078|468971917|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
130275134|NCT02574078|468971918|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
130275135|NCT02574078|468971919|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
130275136|NCT02574078|468971920|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
130275137|NCT02574078|468971921|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
130275138|NCT02574078|468971922|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
130275139|NCT02574078|468971923|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
130275140|NCT02574078|468971924|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
130554898|NCT01637623|469999742|FG001|Overall Study|Lost to Follow-up|0|||
130554899|NCT01637623|469999743|FG002|Overall Study|Lost to Follow-up|2|||
130554900|NCT01637623|469999741|FG000|Overall Study|Physician Decision|1|||
130554901|NCT01637623|469999742|FG001|Overall Study|Physician Decision|0|||
130554902|NCT01637623|469999743|FG002|Overall Study|Physician Decision|1|||
130554903|NCT02170389|469999746|FG000|Overall Study|Study terminated prior to start of treat|1|||
130554904|NCT01008696|469999748|FG000|Overall Study|Participant's evasion of hospital visit|5|||
130554905|NCT01008696|469999749|FG001|Overall Study|Participant's evasion of hospital visit|4|||
130554906|NCT01008696|469999748|FG000|Overall Study|Withdrawal by Subject|2|||
130554907|NCT01008696|469999749|FG001|Overall Study|Withdrawal by Subject|4|||
130554908|NCT01008696|469999748|FG000|Overall Study|Physician Decision|5|||
130554909|NCT01008696|469999749|FG001|Overall Study|Physician Decision|1|||
130554910|NCT01008696|469999748|FG000|Overall Study|Adverse Event|1|||
130554911|NCT01008696|469999749|FG001|Overall Study|Adverse Event|0|||
130554912|NCT01008696|469999748|FG000|Overall Study|Participants' non-cooperation|2|||
130554913|NCT01008696|469999749|FG001|Overall Study|Participants' non-cooperation|3|||
130554914|NCT01008696|469999748|FG000|Overall Study|Other|2|||
130554915|NCT01008696|469999749|FG001|Overall Study|Other|3|||
130554916|NCT01008696|469999748|FG000|Overall Study|Other|0|||
130554917|NCT01008696|469999749|FG001|Overall Study|Other|2|||
130554918|NCT02076113|469999752|FG000|Overall Study|Lost to Follow-up|4|||
130554919|NCT02076113|469999753|FG001|Overall Study|Lost to Follow-up|1|||
130554920|NCT02076113|469999752|FG000|Overall Study|Withdrawal by Subject|2|||
130554921|NCT02076113|469999753|FG001|Overall Study|Withdrawal by Subject|3|||
130554922|NCT02076113|469999752|FG000|Overall Study|Death|1|||
130554923|NCT02076113|469999753|FG001|Overall Study|Death|3|||
130554924|NCT01054144|469999756|FG000|Overall Study|Death|2|||
130554925|NCT03801902|469999758|FG000|Overall Study|Did not receive protocol treatment.|1|||
130554926|NCT03801902|469999759|FG001|Overall Study|Did not receive protocol treatment.|0|||
130554927|NCT03801902|469999760|FG002|Overall Study|Did not receive protocol treatment.|0|||
130554928|NCT03801902|469999761|FG003|Overall Study|Did not receive protocol treatment.|0|||
130554929|NCT02993523|469999764|FG000|Overall Study|Withdrew Consent|0|||
130554930|NCT02993523|469999765|FG001|Overall Study|Withdrew Consent|0|||
130554931|NCT02993523|469999766|FG002|Overall Study|Withdrew Consent|2|||
130554932|NCT02993523|469999767|FG003|Overall Study|Withdrew Consent|9|||
130554933|NCT02993523|469999768|FG004|Overall Study|Withdrew Consent|0|||
130554934|NCT02993523|469999764|FG000|Overall Study|Lost to Follow-up|0|||
130554935|NCT02993523|469999765|FG001|Overall Study|Lost to Follow-up|0|||
130554936|NCT02993523|469999766|FG002|Overall Study|Lost to Follow-up|3|||
130554937|NCT02993523|469999767|FG003|Overall Study|Lost to Follow-up|6|||
130554938|NCT02993523|469999768|FG004|Overall Study|Lost to Follow-up|0|||
130554939|NCT02993523|469999764|FG000|Overall Study|Death|1|||
130554940|NCT02993523|469999765|FG001|Overall Study|Death|1|||
130554941|NCT02993523|469999766|FG002|Overall Study|Death|138|||
130554942|NCT02993523|469999767|FG003|Overall Study|Death|222|||
130554943|NCT02993523|469999768|FG004|Overall Study|Death|6|||
130554944|NCT02993523|469999764|FG000|Overall Study|Reason not Specified|0|||
130554945|NCT02993523|469999765|FG001|Overall Study|Reason not Specified|0|||
130275141|NCT02574078|468971925|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
130275142|NCT02574078|468971913|FG000|Treatment Period|Disease progression|6|||
130554946|NCT02993523|469999766|FG002|Overall Study|Reason not Specified|1|||
130554947|NCT02993523|469999767|FG003|Overall Study|Reason not Specified|1|||
130554948|NCT02993523|469999768|FG004|Overall Study|Reason not Specified|0|||
130554949|NCT03118674|469999769|FG000|Overall Study|Lost to Follow-up|2|||
130554950|NCT03118674|469999769|FG000|Overall Study|Screen Faliure|8|||
130554951|NCT03118674|469999769|FG000|Overall Study|Withdrawal by Subject|5|||
130554952|NCT00528866|469999770|FG000|Overall Study|Protocol Violation|6|||
130554953|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
130275143|NCT02574078|468971914|FG001|Treatment Period|Disease progression|4|||
130457039|NCT02001623|469638264|FG011|Overall Study|Physician Decision|3|||
130457040|NCT02001623|469638265|FG012|Overall Study|Physician Decision|1|||
130457041|NCT02001623|469638266|FG013|Overall Study|Physician Decision|2|||
130457042|NCT02001623|469638267|FG014|Overall Study|Physician Decision|1|||
130457043|NCT02001623|469638253|FG000|Overall Study|Death|0|||
130457044|NCT02001623|469638254|FG001|Overall Study|Death|1|||
130457045|NCT02001623|469638255|FG002|Overall Study|Death|0|||
130457046|NCT02001623|469638256|FG003|Overall Study|Death|0|||
130457047|NCT02001623|469638257|FG004|Overall Study|Death|0|||
130457048|NCT02001623|469638258|FG005|Overall Study|Death|0|||
130457049|NCT02001623|469638259|FG006|Overall Study|Death|0|||
130457050|NCT02001623|469638260|FG007|Overall Study|Death|0|||
130457051|NCT02001623|469638261|FG008|Overall Study|Death|0|||
130457052|NCT02001623|469638262|FG009|Overall Study|Death|0|||
130457053|NCT02001623|469638263|FG010|Overall Study|Death|0|||
130457054|NCT02001623|469638264|FG011|Overall Study|Death|0|||
130457055|NCT02001623|469638265|FG012|Overall Study|Death|0|||
130457056|NCT02001623|469638266|FG013|Overall Study|Death|0|||
130457057|NCT02001623|469638267|FG014|Overall Study|Death|0|||
130457058|NCT02001623|469638253|FG000|Overall Study|Adverse Event|0|||
130457059|NCT02001623|469638254|FG001|Overall Study|Adverse Event|0|||
130457060|NCT02001623|469638255|FG002|Overall Study|Adverse Event|0|||
130457061|NCT02001623|469638256|FG003|Overall Study|Adverse Event|0|||
130457062|NCT02001623|469638257|FG004|Overall Study|Adverse Event|0|||
130457063|NCT02001623|469638258|FG005|Overall Study|Adverse Event|1|||
130457064|NCT02001623|469638259|FG006|Overall Study|Adverse Event|0|||
130457065|NCT02001623|469638260|FG007|Overall Study|Adverse Event|3|||
130457066|NCT02001623|469638261|FG008|Overall Study|Adverse Event|4|||
130457067|NCT02001623|469638262|FG009|Overall Study|Adverse Event|6|||
130457068|NCT02001623|469638263|FG010|Overall Study|Adverse Event|4|||
130457069|NCT02001623|469638264|FG011|Overall Study|Adverse Event|0|||
130457070|NCT02001623|469638265|FG012|Overall Study|Adverse Event|3|||
130457071|NCT02001623|469638266|FG013|Overall Study|Adverse Event|5|||
130457072|NCT02001623|469638267|FG014|Overall Study|Adverse Event|6|||
130457073|NCT02001623|469638253|FG000|Overall Study|Other - Miscellaneous|0|||
130457074|NCT02001623|469638254|FG001|Overall Study|Other - Miscellaneous|0|||
130457075|NCT02001623|469638255|FG002|Overall Study|Other - Miscellaneous|0|||
130457076|NCT02001623|469638256|FG003|Overall Study|Other - Miscellaneous|0|||
130457077|NCT02001623|469638257|FG004|Overall Study|Other - Miscellaneous|0|||
130457078|NCT02001623|469638258|FG005|Overall Study|Other - Miscellaneous|0|||
130457079|NCT02001623|469638259|FG006|Overall Study|Other - Miscellaneous|0|||
130275144|NCT02574078|468971915|FG002|Treatment Period|Disease progression|7|||
130457080|NCT02001623|469638260|FG007|Overall Study|Other - Miscellaneous|0|||
130457081|NCT02001623|469638261|FG008|Overall Study|Other - Miscellaneous|0|||
130457082|NCT02001623|469638262|FG009|Overall Study|Other - Miscellaneous|1|||
130457083|NCT02001623|469638263|FG010|Overall Study|Other - Miscellaneous|0|||
130457084|NCT02001623|469638264|FG011|Overall Study|Other - Miscellaneous|0|||
130275145|NCT02574078|468971916|FG003|Treatment Period|Disease progression|18|||
130275146|NCT02574078|468971917|FG004|Treatment Period|Disease progression|16|||
130275147|NCT02574078|468971918|FG005|Treatment Period|Disease progression|26|||
130275148|NCT02574078|468971919|FG006|Treatment Period|Disease progression|5|||
130275149|NCT02574078|468971920|FG007|Treatment Period|Disease progression|9|||
130275150|NCT02574078|468971921|FG008|Treatment Period|Disease progression|8|||
130275151|NCT02574078|468971922|FG009|Treatment Period|Disease progression|5|||
130275152|NCT02574078|468971923|FG010|Treatment Period|Disease progression|20|||
130275153|NCT02574078|468971924|FG011|Treatment Period|Disease progression|29|||
130275154|NCT02574078|468971925|FG012|Treatment Period|Disease progression|2|||
130275155|NCT02574078|468971913|FG000|Treatment Period|Study drug toxicity|1|||
130275156|NCT02574078|468971914|FG001|Treatment Period|Study drug toxicity|1|||
130275157|NCT02574078|468971915|FG002|Treatment Period|Study drug toxicity|0|||
130275158|NCT02574078|468971916|FG003|Treatment Period|Study drug toxicity|5|||
130275159|NCT02574078|468971917|FG004|Treatment Period|Study drug toxicity|3|||
130275160|NCT02574078|468971918|FG005|Treatment Period|Study drug toxicity|1|||
130275161|NCT02574078|468971919|FG006|Treatment Period|Study drug toxicity|2|||
130275162|NCT02574078|468971920|FG007|Treatment Period|Study drug toxicity|0|||
130275163|NCT02574078|468971921|FG008|Treatment Period|Study drug toxicity|2|||
130275164|NCT02574078|468971922|FG009|Treatment Period|Study drug toxicity|1|||
130275165|NCT02574078|468971923|FG010|Treatment Period|Study drug toxicity|16|||
130275166|NCT02574078|468971924|FG011|Treatment Period|Study drug toxicity|2|||
130275167|NCT02574078|468971925|FG012|Treatment Period|Study drug toxicity|4|||
130275168|NCT02574078|468971913|FG000|Treatment Period|Death|2|||
130275169|NCT02574078|468971914|FG001|Treatment Period|Death|0|||
130275170|NCT02574078|468971915|FG002|Treatment Period|Death|0|||
130275171|NCT02574078|468971916|FG003|Treatment Period|Death|0|||
130275172|NCT02574078|468971917|FG004|Treatment Period|Death|1|||
130275173|NCT02574078|468971918|FG005|Treatment Period|Death|1|||
130275174|NCT02574078|468971919|FG006|Treatment Period|Death|1|||
130275175|NCT02574078|468971920|FG007|Treatment Period|Death|1|||
130275176|NCT02574078|468971921|FG008|Treatment Period|Death|7|||
130275177|NCT02574078|468971922|FG009|Treatment Period|Death|1|||
130275178|NCT02574078|468971923|FG010|Treatment Period|Death|0|||
130275179|NCT02574078|468971924|FG011|Treatment Period|Death|2|||
130275180|NCT02574078|468971925|FG012|Treatment Period|Death|1|||
130275181|NCT02574078|468971913|FG000|Treatment Period|Adverse event unrelated to drug|0|||
130275182|NCT02574078|468971914|FG001|Treatment Period|Adverse event unrelated to drug|0|||
130275183|NCT02574078|468971915|FG002|Treatment Period|Adverse event unrelated to drug|1|||
130275184|NCT02574078|468971916|FG003|Treatment Period|Adverse event unrelated to drug|0|||
130275185|NCT02574078|468971917|FG004|Treatment Period|Adverse event unrelated to drug|2|||
130275186|NCT02574078|468971918|FG005|Treatment Period|Adverse event unrelated to drug|3|||
130275187|NCT02574078|468971919|FG006|Treatment Period|Adverse event unrelated to drug|0|||
130275188|NCT02574078|468971920|FG007|Treatment Period|Adverse event unrelated to drug|0|||
130275189|NCT02574078|468971921|FG008|Treatment Period|Adverse event unrelated to drug|1|||
130275190|NCT02574078|468971922|FG009|Treatment Period|Adverse event unrelated to drug|2|||
130275191|NCT02574078|468971923|FG010|Treatment Period|Adverse event unrelated to drug|4|||
130275192|NCT02574078|468971924|FG011|Treatment Period|Adverse event unrelated to drug|1|||
130275193|NCT02574078|468971925|FG012|Treatment Period|Adverse event unrelated to drug|0|||
130275194|NCT02574078|468971913|FG000|Treatment Period|Administrative reason by Sponsor|0|||
130275195|NCT02574078|468971914|FG001|Treatment Period|Administrative reason by Sponsor|1|||
130275196|NCT02574078|468971915|FG002|Treatment Period|Administrative reason by Sponsor|0|||
130275197|NCT02574078|468971916|FG003|Treatment Period|Administrative reason by Sponsor|0|||
130275198|NCT02574078|468971917|FG004|Treatment Period|Administrative reason by Sponsor|0|||
130275199|NCT02574078|468971918|FG005|Treatment Period|Administrative reason by Sponsor|0|||
130275200|NCT02574078|468971919|FG006|Treatment Period|Administrative reason by Sponsor|1|||
130367594|NCT05248867|469315988|FG002|Open-label Period|Other, not specified|0|||
130275201|NCT02574078|468971920|FG007|Treatment Period|Administrative reason by Sponsor|0|||
130554954|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
130554955|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
130554956|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
130275202|NCT02574078|468971921|FG008|Treatment Period|Administrative reason by Sponsor|0|||
130275203|NCT02574078|468971922|FG009|Treatment Period|Administrative reason by Sponsor|0|||
130275204|NCT02574078|468971923|FG010|Treatment Period|Administrative reason by Sponsor|0|||
130275205|NCT02574078|468971924|FG011|Treatment Period|Administrative reason by Sponsor|0|||
130275206|NCT02574078|468971925|FG012|Treatment Period|Administrative reason by Sponsor|3|||
130275207|NCT02574078|468971913|FG000|Treatment Period|Other reasons|1|||
130275208|NCT02574078|468971914|FG001|Treatment Period|Other reasons|0|||
130275209|NCT02574078|468971915|FG002|Treatment Period|Other reasons|1|||
130275210|NCT02574078|468971916|FG003|Treatment Period|Other reasons|3|||
130275211|NCT02574078|468971917|FG004|Treatment Period|Other reasons|3|||
130275212|NCT02574078|468971918|FG005|Treatment Period|Other reasons|1|||
130275213|NCT02574078|468971919|FG006|Treatment Period|Other reasons|2|||
130275214|NCT02574078|468971920|FG007|Treatment Period|Other reasons|1|||
130275215|NCT02574078|468971921|FG008|Treatment Period|Other reasons|3|||
130275216|NCT02574078|468971922|FG009|Treatment Period|Other reasons|1|||
130275217|NCT02574078|468971923|FG010|Treatment Period|Other reasons|1|||
130275218|NCT02574078|468971924|FG011|Treatment Period|Other reasons|3|||
130275219|NCT02574078|468971925|FG012|Treatment Period|Other reasons|1|||
130275220|NCT02574078|468971913|FG000|Treatment Period|Participant request to stop drug|0|||
130275221|NCT02574078|468971914|FG001|Treatment Period|Participant request to stop drug|0|||
130275222|NCT02574078|468971915|FG002|Treatment Period|Participant request to stop drug|0|||
130275223|NCT02574078|468971916|FG003|Treatment Period|Participant request to stop drug|2|||
130275224|NCT02574078|468971917|FG004|Treatment Period|Participant request to stop drug|4|||
130275225|NCT02574078|468971918|FG005|Treatment Period|Participant request to stop drug|0|||
130275226|NCT02574078|468971919|FG006|Treatment Period|Participant request to stop drug|1|||
130275227|NCT02574078|468971920|FG007|Treatment Period|Participant request to stop drug|0|||
130275228|NCT02574078|468971921|FG008|Treatment Period|Participant request to stop drug|3|||
130275229|NCT02574078|468971922|FG009|Treatment Period|Participant request to stop drug|2|||
130275230|NCT02574078|468971923|FG010|Treatment Period|Participant request to stop drug|2|||
130554957|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
130275231|NCT02574078|468971924|FG011|Treatment Period|Participant request to stop drug|4|||
130275232|NCT02574078|468971925|FG012|Treatment Period|Participant request to stop drug|1|||
130275233|NCT02574078|468971913|FG000|Treatment Period|Participant withdrew consent|0|||
130275234|NCT02574078|468971914|FG001|Treatment Period|Participant withdrew consent|0|||
130275235|NCT02574078|468971915|FG002|Treatment Period|Participant withdrew consent|0|||
130275236|NCT02574078|468971916|FG003|Treatment Period|Participant withdrew consent|0|||
130275237|NCT02574078|468971917|FG004|Treatment Period|Participant withdrew consent|1|||
130275238|NCT02574078|468971918|FG005|Treatment Period|Participant withdrew consent|1|||
130275239|NCT02574078|468971919|FG006|Treatment Period|Participant withdrew consent|0|||
130275240|NCT02574078|468971920|FG007|Treatment Period|Participant withdrew consent|1|||
130275241|NCT02574078|468971921|FG008|Treatment Period|Participant withdrew consent|0|||
130275242|NCT02574078|468971922|FG009|Treatment Period|Participant withdrew consent|2|||
130275243|NCT02574078|468971923|FG010|Treatment Period|Participant withdrew consent|1|||
130275244|NCT02574078|468971924|FG011|Treatment Period|Participant withdrew consent|4|||
130275245|NCT02574078|468971925|FG012|Treatment Period|Participant withdrew consent|1|||
130275246|NCT02574078|468971913|FG000|Treatment Period|Participant no longer meets criteria|0|||
130275247|NCT02574078|468971914|FG001|Treatment Period|Participant no longer meets criteria|0|||
130275248|NCT02574078|468971915|FG002|Treatment Period|Participant no longer meets criteria|0|||
130275249|NCT02574078|468971916|FG003|Treatment Period|Participant no longer meets criteria|0|||
130275250|NCT02574078|468971917|FG004|Treatment Period|Participant no longer meets criteria|1|||
130275251|NCT02574078|468971918|FG005|Treatment Period|Participant no longer meets criteria|0|||
130275252|NCT02574078|468971919|FG006|Treatment Period|Participant no longer meets criteria|0|||
130275253|NCT02574078|468971920|FG007|Treatment Period|Participant no longer meets criteria|0|||
130275254|NCT02574078|468971921|FG008|Treatment Period|Participant no longer meets criteria|0|||
130275255|NCT02574078|468971922|FG009|Treatment Period|Participant no longer meets criteria|1|||
130275256|NCT02574078|468971923|FG010|Treatment Period|Participant no longer meets criteria|1|||
130275257|NCT02574078|468971924|FG011|Treatment Period|Participant no longer meets criteria|1|||
130275258|NCT02574078|468971925|FG012|Treatment Period|Participant no longer meets criteria|0|||
130275259|NCT02574078|468971913|FG000|Treatment Period|Lost to Follow-up|0|||
130275260|NCT02574078|468971914|FG001|Treatment Period|Lost to Follow-up|0|||
130275261|NCT02574078|468971915|FG002|Treatment Period|Lost to Follow-up|0|||
130275262|NCT02574078|468971916|FG003|Treatment Period|Lost to Follow-up|0|||
130275263|NCT02574078|468971917|FG004|Treatment Period|Lost to Follow-up|0|||
130275264|NCT02574078|468971918|FG005|Treatment Period|Lost to Follow-up|0|||
130275265|NCT02574078|468971919|FG006|Treatment Period|Lost to Follow-up|0|||
130275266|NCT02574078|468971920|FG007|Treatment Period|Lost to Follow-up|0|||
130275267|NCT02574078|468971921|FG008|Treatment Period|Lost to Follow-up|0|||
130275268|NCT02574078|468971922|FG009|Treatment Period|Lost to Follow-up|1|||
130275269|NCT02574078|468971923|FG010|Treatment Period|Lost to Follow-up|0|||
130275270|NCT02574078|468971924|FG011|Treatment Period|Lost to Follow-up|1|||
130275271|NCT02574078|468971925|FG012|Treatment Period|Lost to Follow-up|0|||
130275272|NCT02574078|468971913|FG000|Treatment Period|Maximum clinical benefit|0|||
130275273|NCT02574078|468971914|FG001|Treatment Period|Maximum clinical benefit|0|||
130275274|NCT02574078|468971915|FG002|Treatment Period|Maximum clinical benefit|0|||
130275275|NCT02574078|468971916|FG003|Treatment Period|Maximum clinical benefit|0|||
130275276|NCT02574078|468971917|FG004|Treatment Period|Maximum clinical benefit|0|||
130275277|NCT02574078|468971918|FG005|Treatment Period|Maximum clinical benefit|0|||
130275278|NCT02574078|468971919|FG006|Treatment Period|Maximum clinical benefit|0|||
130275279|NCT02574078|468971920|FG007|Treatment Period|Maximum clinical benefit|0|||
130275280|NCT02574078|468971921|FG008|Treatment Period|Maximum clinical benefit|0|||
130275281|NCT02574078|468971922|FG009|Treatment Period|Maximum clinical benefit|1|||
130275282|NCT02574078|468971923|FG010|Treatment Period|Maximum clinical benefit|0|||
130275283|NCT02574078|468971924|FG011|Treatment Period|Maximum clinical benefit|0|||
130275284|NCT02574078|468971925|FG012|Treatment Period|Maximum clinical benefit|0|||
130275285|NCT03037476|468971926|FG000|Overall Study|Lost to Follow-up|63|||
130275286|NCT03037476|468971927|FG001|Overall Study|Lost to Follow-up|46|||
130275287|NCT01498692|468971935|FG000|Overall Study|Death|4|||
130275288|NCT01498692|468971935|FG000|Overall Study|Withdrawal by Subject|1|||
130275289|NCT01498692|468971935|FG000|Overall Study|Missed 12-month visit|3|||
130275290|NCT00590122|468971936|FG000|Overall Study|swallowed oral dissolving dose|1|||
130275291|NCT00590122|468971937|FG001|Overall Study|swallowed oral dissolving dose|0|||
130275292|NCT01208324|468971938|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
130275293|NCT01208324|468971939|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
130275294|NCT01208324|468971940|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
130367595|NCT05248867|469315989|FG003|Open-label Period|Other, not specified|0|||
130367596|NCT05248867|469315990|FG004|Open-label Period|Other, not specified|4|||
130275295|NCT01208324|468971941|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
130275296|NCT02707965|468971942|FG000|Overall Study|Withdrawal by Subject|0|||
130275297|NCT02707965|468971943|FG001|Overall Study|Withdrawal by Subject|0|||
130275298|NCT02707965|468971944|FG002|Overall Study|Withdrawal by Subject|1|||
130275299|NCT02707965|468971945|FG003|Overall Study|Withdrawal by Subject|0|||
130275300|NCT02707965|468971946|FG004|Overall Study|Withdrawal by Subject|0|||
130275301|NCT02707965|468971947|FG005|Overall Study|Withdrawal by Subject|0|||
130275302|NCT02707965|468971948|FG006|Overall Study|Withdrawal by Subject|0|||
130275303|NCT02707965|468971949|FG007|Overall Study|Withdrawal by Subject|2|||
130275304|NCT02707965|468971950|FG008|Overall Study|Withdrawal by Subject|0|||
130275305|NCT02707965|468971951|FG009|Overall Study|Withdrawal by Subject|0|||
130275306|NCT02707965|468971952|FG010|Overall Study|Withdrawal by Subject|0|||
130275307|NCT02707965|468971953|FG011|Overall Study|Withdrawal by Subject|0|||
130275308|NCT02707965|468971954|FG012|Overall Study|Withdrawal by Subject|0|||
130275309|NCT02707965|468971955|FG013|Overall Study|Withdrawal by Subject|0|||
130275310|NCT02707965|468971956|FG014|Overall Study|Withdrawal by Subject|0|||
130275311|NCT02707965|468971957|FG015|Overall Study|Withdrawal by Subject|0|||
130275312|NCT02707965|468971942|FG000|Overall Study|PI decisions|0|||
130275313|NCT02707965|468971943|FG001|Overall Study|PI decisions|0|||
130275314|NCT02707965|468971944|FG002|Overall Study|PI decisions|0|||
130275315|NCT02707965|468971945|FG003|Overall Study|PI decisions|0|||
130275316|NCT02707965|468971946|FG004|Overall Study|PI decisions|0|||
130275317|NCT02707965|468971947|FG005|Overall Study|PI decisions|0|||
130275318|NCT02707965|468971948|FG006|Overall Study|PI decisions|0|||
130275319|NCT02707965|468971949|FG007|Overall Study|PI decisions|0|||
130275320|NCT02707965|468971950|FG008|Overall Study|PI decisions|0|||
130275321|NCT02707965|468971951|FG009|Overall Study|PI decisions|0|||
130275322|NCT02707965|468971952|FG010|Overall Study|PI decisions|0|||
130367597|NCT05248867|469315991|FG005|Open-label Period|Other, not specified|0|||
130367598|NCT00743483|469315999|FG000|Baseline Period|Physician Decision|1|||
130275323|NCT02707965|468971953|FG011|Overall Study|PI decisions|0|||
130275324|NCT02707965|468971954|FG012|Overall Study|PI decisions|0|||
130275325|NCT02707965|468971955|FG013|Overall Study|PI decisions|0|||
130275326|NCT02707965|468971956|FG014|Overall Study|PI decisions|2|||
130275327|NCT02707965|468971957|FG015|Overall Study|PI decisions|0|||
130275328|NCT02707965|468971942|FG000|Overall Study|Protocol deviation|1|||
130367599|NCT00743483|469315999|FG000|Treatment Period|Adverse Event|1|||
130367600|NCT00873912|469316001|FG000|Overall Study|Withdrawal by Subject|1|||
130367601|NCT00873912|469316002|FG001|Overall Study|Withdrawal by Subject|0|||
130367602|NCT00873912|469316001|FG000|Overall Study|Lost to Follow-up|2|||
130367603|NCT00873912|469316002|FG001|Overall Study|Lost to Follow-up|0|||
130367604|NCT01466153|469316003|FG000|Overall Study|Disease Progression|2|||
130367605|NCT01466153|469316004|FG001|Overall Study|Disease Progression|2|||
130275329|NCT02707965|468971943|FG001|Overall Study|Protocol deviation|1|||
130275330|NCT02707965|468971944|FG002|Overall Study|Protocol deviation|0|||
130275331|NCT02707965|468971945|FG003|Overall Study|Protocol deviation|0|||
130275332|NCT02707965|468971946|FG004|Overall Study|Protocol deviation|0|||
130275333|NCT02707965|468971947|FG005|Overall Study|Protocol deviation|0|||
130275334|NCT02707965|468971948|FG006|Overall Study|Protocol deviation|0|||
130275335|NCT02707965|468971949|FG007|Overall Study|Protocol deviation|1|||
130275336|NCT02707965|468971950|FG008|Overall Study|Protocol deviation|0|||
130275337|NCT02707965|468971951|FG009|Overall Study|Protocol deviation|0|||
130275338|NCT02707965|468971952|FG010|Overall Study|Protocol deviation|0|||
130275339|NCT02707965|468971953|FG011|Overall Study|Protocol deviation|0|||
130275340|NCT02707965|468971954|FG012|Overall Study|Protocol deviation|0|||
130275341|NCT02707965|468971955|FG013|Overall Study|Protocol deviation|0|||
130275342|NCT02707965|468971956|FG014|Overall Study|Protocol deviation|0|||
130275343|NCT02707965|468971957|FG015|Overall Study|Protocol deviation|0|||
130275344|NCT00249808|468971958|FG000|Overall Study|Other|27|||
130275345|NCT00249808|468971958|FG000|Overall Study|Protocol Violation|3|||
130275346|NCT00249808|468971958|FG000|Overall Study|Lost to Follow-up|8|||
130275347|NCT00249808|468971958|FG000|Overall Study|Adverse Event|81|||
130367606|NCT01466153|469316005|FG002|Overall Study|Disease Progression|0|||
130367607|NCT01466153|469316003|FG000|Overall Study|Adverse Event|14|||
130367608|NCT01466153|469316004|FG001|Overall Study|Adverse Event|13|||
130367609|NCT01466153|469316005|FG002|Overall Study|Adverse Event|17|||
130367610|NCT01466153|469316003|FG000|Overall Study|Withdrawal of Consent|2|||
130367611|NCT01466153|469316004|FG001|Overall Study|Withdrawal of Consent|0|||
130367612|NCT01466153|469316005|FG002|Overall Study|Withdrawal of Consent|0|||
130367613|NCT01466153|469316003|FG000|Overall Study|Investigator Discretion|3|||
130367614|NCT01466153|469316004|FG001|Overall Study|Investigator Discretion|2|||
130554958|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
130554959|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
130554960|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
130554961|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Death|1|||
130554962|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Death|1|||
130554963|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
130554964|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
130554965|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
130554966|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
130554967|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
130554968|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
130554969|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
130554970|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
130554971|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
130554972|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
130554973|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
130554974|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
130554975|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
130554976|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
130554977|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
130554978|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
130554979|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
130554980|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
130554981|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
130275348|NCT00249808|468971958|FG000|Overall Study|Lack of Efficacy|52|||
130275349|NCT00249808|468971958|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
130275350|NCT02789345|468971959|FG000|Overall Study|Adverse Event|0|||
130367615|NCT01466153|469316005|FG002|Overall Study|Investigator Discretion|2|||
130367616|NCT01466153|469316003|FG000|Overall Study|Randomized-Not Treated|2|||
130367617|NCT01466153|469316004|FG001|Overall Study|Randomized-Not Treated|3|||
130367618|NCT01466153|469316005|FG002|Overall Study|Randomized-Not Treated|4|||
130275351|NCT02789345|468971960|FG001|Overall Study|Adverse Event|0|||
130275352|NCT02789345|468971961|FG002|Overall Study|Adverse Event|1|||
130275353|NCT02789345|468971959|FG000|Overall Study|Death|0|||
130275354|NCT02789345|468971960|FG001|Overall Study|Death|0|||
130275355|NCT02789345|468971961|FG002|Overall Study|Death|1|||
130275356|NCT02789345|468971959|FG000|Overall Study|Physician Decision|2|||
130367619|NCT01466153|469316003|FG000|Overall Study|Other-Unspecified|6|||
130275357|NCT02789345|468971960|FG001|Overall Study|Physician Decision|0|||
130275358|NCT02789345|468971961|FG002|Overall Study|Physician Decision|1|||
130275359|NCT02789345|468971959|FG000|Overall Study|Progressive Disease|1|||
130275360|NCT02789345|468971960|FG001|Overall Study|Progressive Disease|3|||
130275361|NCT02789345|468971961|FG002|Overall Study|Progressive Disease|14|||
130275362|NCT00135330|468971963|FG000|Overall Study|Adverse Event|2|||
130275363|NCT00135330|468971964|FG001|Overall Study|Adverse Event|5|||
130275364|NCT00135330|468971965|FG002|Overall Study|Adverse Event|1|||
130275365|NCT00135330|468971963|FG000|Overall Study|Lost to Follow-up|0|||
130275366|NCT00135330|468971964|FG001|Overall Study|Lost to Follow-up|2|||
130275367|NCT00135330|468971965|FG002|Overall Study|Lost to Follow-up|3|||
130275368|NCT00135330|468971963|FG000|Overall Study|Physician Decision|1|||
130275369|NCT00135330|468971964|FG001|Overall Study|Physician Decision|1|||
130275370|NCT00135330|468971965|FG002|Overall Study|Physician Decision|0|||
130275371|NCT00135330|468971963|FG000|Overall Study|Protocol Violation|4|||
130275372|NCT00135330|468971964|FG001|Overall Study|Protocol Violation|3|||
130275373|NCT00135330|468971965|FG002|Overall Study|Protocol Violation|3|||
130275374|NCT00135330|468971963|FG000|Overall Study|Patient Decision|5|||
130275375|NCT00135330|468971964|FG001|Overall Study|Patient Decision|1|||
130275376|NCT00135330|468971965|FG002|Overall Study|Patient Decision|4|||
130275377|NCT00135330|468971963|FG000|Overall Study|Sponsor Decision|0|||
130275378|NCT00135330|468971964|FG001|Overall Study|Sponsor Decision|1|||
130275379|NCT00135330|468971965|FG002|Overall Study|Sponsor Decision|0|||
130275380|NCT00372619|468971966|FG000|Overall Study|Ineligible|0|||
130275381|NCT00372619|468971967|FG001|Overall Study|Ineligible|0|||
130275382|NCT00372619|468971968|FG002|Overall Study|Ineligible|0|||
130275383|NCT00372619|468971969|FG003|Overall Study|Ineligible|0|||
130275384|NCT00372619|468971970|FG004|Overall Study|Ineligible|0|||
130275385|NCT00372619|468971971|FG005|Overall Study|Ineligible|2|||
130275386|NCT00372619|468971972|FG006|Overall Study|Ineligible|0|||
130275387|NCT00372619|468971966|FG000|Overall Study|Inevaluable|0|||
130275388|NCT00372619|468971967|FG001|Overall Study|Inevaluable|0|||
130275389|NCT00372619|468971968|FG002|Overall Study|Inevaluable|0|||
130275390|NCT00372619|468971969|FG003|Overall Study|Inevaluable|0|||
130275391|NCT00372619|468971970|FG004|Overall Study|Inevaluable|0|||
130275392|NCT00372619|468971971|FG005|Overall Study|Inevaluable|1|||
130275393|NCT00372619|468971972|FG006|Overall Study|Inevaluable|0|||
130275394|NCT00066222|468971973|FG000|Overall Study|No protocol treatment received|1|||
130275395|NCT01524224|468971980|FG000|Overall Study|Progressive Disease|1|||
130275396|NCT01524224|468971981|FG001|Overall Study|Progressive Disease|0|||
130275397|NCT01524224|468971982|FG002|Overall Study|Progressive Disease|2|||
130275398|NCT01524224|468971983|FG003|Overall Study|Progressive Disease|1|||
130275399|NCT01524224|468971984|FG004|Overall Study|Progressive Disease|2|||
130275400|NCT01524224|468971985|FG005|Overall Study|Progressive Disease|1|||
130275401|NCT01524224|468971986|FG006|Overall Study|Progressive Disease|1|||
130275402|NCT01524224|468971987|FG007|Overall Study|Progressive Disease|5|||
130275403|NCT01524224|468971980|FG000|Overall Study|Withdrawal by Subject|2|||
130275404|NCT01524224|468971981|FG001|Overall Study|Withdrawal by Subject|0|||
130275405|NCT01524224|468971982|FG002|Overall Study|Withdrawal by Subject|0|||
130275406|NCT01524224|468971983|FG003|Overall Study|Withdrawal by Subject|0|||
130275407|NCT01524224|468971984|FG004|Overall Study|Withdrawal by Subject|0|||
130275408|NCT01524224|468971985|FG005|Overall Study|Withdrawal by Subject|0|||
130275409|NCT01524224|468971986|FG006|Overall Study|Withdrawal by Subject|2|||
130275410|NCT01524224|468971987|FG007|Overall Study|Withdrawal by Subject|0|||
130275411|NCT01524224|468971980|FG000|Overall Study|Adverse Event|0|||
130275412|NCT01524224|468971981|FG001|Overall Study|Adverse Event|1|||
130275413|NCT01524224|468971982|FG002|Overall Study|Adverse Event|0|||
130275414|NCT01524224|468971983|FG003|Overall Study|Adverse Event|0|||
130275415|NCT01524224|468971984|FG004|Overall Study|Adverse Event|0|||
130275416|NCT01524224|468971985|FG005|Overall Study|Adverse Event|1|||
130275417|NCT01524224|468971986|FG006|Overall Study|Adverse Event|0|||
130275418|NCT01524224|468971987|FG007|Overall Study|Adverse Event|0|||
130275419|NCT01524224|468971980|FG000|Overall Study|Physician Decision|0|||
130275420|NCT01524224|468971981|FG001|Overall Study|Physician Decision|0|||
130275421|NCT01524224|468971982|FG002|Overall Study|Physician Decision|0|||
130275422|NCT01524224|468971983|FG003|Overall Study|Physician Decision|1|||
130275423|NCT01524224|468971984|FG004|Overall Study|Physician Decision|1|||
130275424|NCT01524224|468971985|FG005|Overall Study|Physician Decision|0|||
130275425|NCT01524224|468971986|FG006|Overall Study|Physician Decision|0|||
130275426|NCT01524224|468971987|FG007|Overall Study|Physician Decision|1|||
130275427|NCT01524224|468971980|FG000|Overall Study|Sponsor Decision|0|||
130275428|NCT01524224|468971981|FG001|Overall Study|Sponsor Decision|0|||
130275429|NCT01524224|468971982|FG002|Overall Study|Sponsor Decision|0|||
130275430|NCT01524224|468971983|FG003|Overall Study|Sponsor Decision|0|||
130275431|NCT01524224|468971984|FG004|Overall Study|Sponsor Decision|1|||
130275432|NCT01524224|468971985|FG005|Overall Study|Sponsor Decision|0|||
130275433|NCT01524224|468971986|FG006|Overall Study|Sponsor Decision|0|||
130554982|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
130554983|NCT00559585|469999771|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
130554984|NCT00559585|469999772|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
130554985|NCT00559585|469999771|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
130554986|NCT00559585|469999772|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
130554987|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
130554988|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
130554989|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
130554990|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
130554991|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
130554992|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
130554993|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
130554994|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
130554995|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
130554996|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
130554997|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
130554998|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
130554999|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
130555000|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
130555001|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
130555002|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
130555003|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
130555004|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
130555005|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
130555006|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
130555007|NCT00559585|469999771|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
130555008|NCT00559585|469999772|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
130555009|NCT04614662|469999773|FG000|Overall Study|Withdrawal by Subject|0|||
130555010|NCT04614662|469999774|FG001|Overall Study|Withdrawal by Subject|1|||
130555011|NCT04195581|469999785|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
130555012|NCT04195581|469999785|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
130555013|NCT04195581|469999785|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
130555014|NCT04195581|469999785|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
130555015|NCT04195581|469999785|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
130555016|NCT04195581|469999785|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
130555017|NCT01237340|469999788|FG000|Overall Study|Adverse Event|3|||
130555018|NCT01237340|469999788|FG000|Overall Study|Withdrawal by Subject|1|||
130555019|NCT01237340|469999788|FG000|Overall Study|Early termination of the trial|36|||
130555020|NCT01843218|469999789|FG000|Overall Study|Withdrawal by Subject|5|||
130555021|NCT01136811|469999790|FG000|Overall Study|Physician Decision|11|||
130555022|NCT03829319|469999793|FG000|Overall Study|Sponsor's Decision|4|||
130555023|NCT03829319|469999794|FG001|Overall Study|Sponsor's Decision|90|||
130555024|NCT03829319|469999795|FG002|Overall Study|Sponsor's Decision|102|||
130555025|NCT03829319|469999793|FG000|Overall Study|Withdrawal by Subject|1|||
130555026|NCT03829319|469999794|FG001|Overall Study|Withdrawal by Subject|5|||
130555027|NCT03829319|469999795|FG002|Overall Study|Withdrawal by Subject|4|||
130555028|NCT03829319|469999793|FG000|Overall Study|Physician Decision|0|||
130555029|NCT03829319|469999794|FG001|Overall Study|Physician Decision|3|||
130555030|NCT03829319|469999795|FG002|Overall Study|Physician Decision|0|||
130555031|NCT03829319|469999793|FG000|Overall Study|Lost to Follow-up|0|||
130555032|NCT03829319|469999794|FG001|Overall Study|Lost to Follow-up|0|||
130555033|NCT03829319|469999795|FG002|Overall Study|Lost to Follow-up|1|||
130555034|NCT03829319|469999793|FG000|Overall Study|Death|8|||
130555035|NCT03829319|469999794|FG001|Overall Study|Death|277|||
130555036|NCT03829319|469999795|FG002|Overall Study|Death|266|||
130555037|NCT04498832|469999796|FG000|Overall Study|Adverse Event|1|||
130555038|NCT04498832|469999797|FG001|Overall Study|Adverse Event|3|||
130555039|NCT04498832|469999796|FG000|Overall Study|Withdrawal by Subject|0|||
130555040|NCT04498832|469999797|FG001|Overall Study|Withdrawal by Subject|1|||
130555041|NCT01012739|469999798|FG000|Treatment Period 1|Adverse Event|0|||
130555042|NCT01012739|469999799|FG001|Treatment Period 1|Adverse Event|0|||
130555043|NCT01012739|469999800|FG002|Treatment Period 1|Adverse Event|0|||
130555044|NCT01012739|469999801|FG003|Treatment Period 1|Adverse Event|1|||
130555045|NCT01012739|469999798|FG000|Treatment Period 2|Abnormal test procedure results|0|||
130555046|NCT01012739|469999799|FG001|Treatment Period 2|Abnormal test procedure results|0|||
130275434|NCT01524224|468971987|FG007|Overall Study|Sponsor Decision|0|||
130367620|NCT01466153|469316004|FG001|Overall Study|Other-Unspecified|4|||
130367621|NCT01466153|469316005|FG002|Overall Study|Other-Unspecified|2|||
130367622|NCT01088997|469316010|FG000|Overall Study|Physician Decision|1|||
130367623|NCT01088997|469316011|FG001|Overall Study|Physician Decision|1|||
130367624|NCT01088997|469316010|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
130367625|NCT01088997|469316011|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
130367626|NCT01088997|469316010|FG000|Overall Study|Excluded prior to receiving drug|1|||
130367627|NCT01088997|469316011|FG001|Overall Study|Excluded prior to receiving drug|1|||
130367628|NCT05695209|469316015|FG000|3-months|Withdrawal by Subject|2|||
130367629|NCT05695209|469316016|FG001|3-months|Withdrawal by Subject|0|||
130367630|NCT05695209|469316015|FG000|3-months|Unable to contact for 3-month data collection|0|||
130367631|NCT05695209|469316016|FG001|3-months|Unable to contact for 3-month data collection|1|||
130367632|NCT05695209|469316015|FG000|6-months|Lost to Follow-up|1|||
130367633|NCT05695209|469316016|FG001|6-months|Lost to Follow-up|1|||
130367634|NCT03749447|469317258|FG000|Overall Study|Adverse Event|11|||
130275435|NCT00615719|468971989|FG000|Overall Study|Physician Decision|5|||
130275436|NCT03517371|468971990|FG000|Overall Study|Adverse Event|8|||
130275437|NCT03517371|468971991|FG001|Overall Study|Adverse Event|9|||
130367635|NCT03749447|469317259|FG001|Overall Study|Adverse Event|3|||
130367636|NCT03749447|469317258|FG000|Overall Study|Death|1|||
130555047|NCT01012739|469999800|FG002|Treatment Period 2|Abnormal test procedure results|0|||
130555048|NCT01012739|469999801|FG003|Treatment Period 2|Abnormal test procedure results|1|||
130275438|NCT03517371|468971990|FG000|Overall Study|Lost to Follow-up|1|||
130275439|NCT03517371|468971991|FG001|Overall Study|Lost to Follow-up|2|||
130275440|NCT03517371|468971990|FG000|Overall Study|Withdrawal by Subject|4|||
130275441|NCT03517371|468971991|FG001|Overall Study|Withdrawal by Subject|4|||
130275442|NCT03517371|468971990|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
130275443|NCT03517371|468971991|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
130275444|NCT03517371|468971990|FG000|Overall Study|COVID restrictions|2|||
130275445|NCT03517371|468971991|FG001|Overall Study|COVID restrictions|0|||
130275446|NCT03517371|468971990|FG000|Overall Study|Receiving DBS Surgery|0|||
130275447|NCT03517371|468971991|FG001|Overall Study|Receiving DBS Surgery|1|||
130275448|NCT05420961|468971992|FG000|Overall Study|Withdrawal by Subject|2|||
130275449|NCT05420961|468971993|FG001|Overall Study|Withdrawal by Subject|1|||
130275450|NCT05420961|468971994|FG002|Overall Study|Withdrawal by Subject|1|||
130275451|NCT05420961|468971995|FG003|Overall Study|Withdrawal by Subject|0|||
130275452|NCT05420961|468971996|FG004|Overall Study|Withdrawal by Subject|0|||
130275453|NCT05420961|468971992|FG000|Overall Study|Lost to Follow-up|0|||
130275454|NCT05420961|468971993|FG001|Overall Study|Lost to Follow-up|0|||
130275455|NCT05420961|468971994|FG002|Overall Study|Lost to Follow-up|1|||
130275456|NCT05420961|468971995|FG003|Overall Study|Lost to Follow-up|0|||
130275457|NCT05420961|468971996|FG004|Overall Study|Lost to Follow-up|0|||
130275458|NCT05420961|468971992|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130275459|NCT05420961|468971993|FG001|Overall Study|Randomized by mistake without study treatment|0|||
130275460|NCT05420961|468971994|FG002|Overall Study|Randomized by mistake without study treatment|1|||
130275461|NCT05420961|468971995|FG003|Overall Study|Randomized by mistake without study treatment|0|||
130275462|NCT05420961|468971996|FG004|Overall Study|Randomized by mistake without study treatment|1|||
130275463|NCT04283656|468971997|FG000|Overall Study|Adverse Event|1|||
130275464|NCT04283656|468971998|FG001|Overall Study|Adverse Event|0|||
130275465|NCT04283656|468971997|FG000|Overall Study|Lost to Follow-up|0|||
130275466|NCT04283656|468971998|FG001|Overall Study|Lost to Follow-up|1|||
130275467|NCT00935493|468972003|FG000|Overall Study|Lost to Follow-up|1|||
130275468|NCT00935493|468972004|FG001|Overall Study|Lost to Follow-up|1|||
130275469|NCT00935493|468972005|FG002|Overall Study|Lost to Follow-up|1|||
130275470|NCT00935493|468972003|FG000|Overall Study|Treatment Discontinued|0|||
130275471|NCT00935493|468972004|FG001|Overall Study|Treatment Discontinued|1|||
130275472|NCT00935493|468972005|FG002|Overall Study|Treatment Discontinued|0|||
130275473|NCT01555073|468972006|FG000|Overall Study|Lost to Follow-up|1|||
130275474|NCT01555073|468972007|FG001|Overall Study|Lost to Follow-up|2|||
130275475|NCT01555073|468972008|FG002|Overall Study|Lost to Follow-up|0|||
130275476|NCT01555073|468972009|FG003|Overall Study|Lost to Follow-up|5|||
130275477|NCT02565147|468972017|FG000|Overall Study|Withdrawal by Subject|5|||
130275478|NCT02565147|468972018|FG001|Overall Study|Withdrawal by Subject|1|||
130275479|NCT02565147|468972017|FG000|Overall Study|Lost to Follow-up|0|||
130555049|NCT03049735|469999804|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
130555050|NCT03049735|469999805|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
130555051|NCT03049735|469999806|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
130555052|NCT03049735|469999804|FG000|Overall Study|Other|5|||
130555053|NCT03049735|469999805|FG001|Overall Study|Other|3|||
130555054|NCT03049735|469999806|FG002|Overall Study|Other|1|||
130555055|NCT03049735|469999804|FG000|Overall Study|Lack of Efficacy|4|||
130555056|NCT03049735|469999805|FG001|Overall Study|Lack of Efficacy|0|||
130555057|NCT03049735|469999806|FG002|Overall Study|Lack of Efficacy|3|||
130555058|NCT03049735|469999804|FG000|Overall Study|Protocol deviation|1|||
130555059|NCT03049735|469999805|FG001|Overall Study|Protocol deviation|0|||
130555060|NCT03049735|469999806|FG002|Overall Study|Protocol deviation|0|||
130555061|NCT03049735|469999804|FG000|Overall Study|Pregnancy|0|||
130555062|NCT03049735|469999805|FG001|Overall Study|Pregnancy|0|||
130555063|NCT03049735|469999806|FG002|Overall Study|Pregnancy|1|||
130555064|NCT03049735|469999804|FG000|Overall Study|Adverse Event|7|||
130555065|NCT03049735|469999805|FG001|Overall Study|Adverse Event|18|||
130275480|NCT02565147|468972018|FG001|Overall Study|Lost to Follow-up|1|||
130275481|NCT02565147|468972017|FG000|Overall Study|Death|1|||
130275482|NCT02565147|468972018|FG001|Overall Study|Death|1|||
130275483|NCT02936869|468972025|FG000|Overall Study|Lost to Follow-up|1|||
130275484|NCT02936869|468972026|FG001|Overall Study|Lost to Follow-up|3|||
130275485|NCT02936869|468972025|FG000|Overall Study|Death|0|||
130275486|NCT02936869|468972026|FG001|Overall Study|Death|1|||
130275487|NCT02936869|468972025|FG000|Overall Study|Legal Case|0|||
130275488|NCT02936869|468972026|FG001|Overall Study|Legal Case|1|||
130275489|NCT02936869|468972025|FG000|Overall Study|Protocol Violation|1|||
130555066|NCT03049735|469999806|FG002|Overall Study|Adverse Event|5|||
130555067|NCT03049735|469999804|FG000|Overall Study|Withdrawal by Subject|10|||
130275490|NCT02936869|468972026|FG001|Overall Study|Protocol Violation|0|||
130275491|NCT00335738|468972027|FG000|Overall Study|Physician Decision|6|||
130275492|NCT00335738|468972028|FG001|Overall Study|Physician Decision|0|||
130275493|NCT00335738|468972027|FG000|Overall Study|Withdrawal by Subject|2|||
130275494|NCT00335738|468972028|FG001|Overall Study|Withdrawal by Subject|0|||
130275495|NCT00335738|468972027|FG000|Overall Study|Ineligible|3|||
130275496|NCT00335738|468972028|FG001|Overall Study|Ineligible|4|||
130275497|NCT03423238|468972035|FG000|Overall Study|Lost to Follow-up|1|||
130275498|NCT03423238|468972036|FG001|Overall Study|Lost to Follow-up|0|||
130275499|NCT03423238|468972035|FG000|Overall Study|Withdrawal by Subject|1|||
130275500|NCT03423238|468972036|FG001|Overall Study|Withdrawal by Subject|0|||
130275501|NCT00992056|468972037|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
130275502|NCT00992056|468972038|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
130275503|NCT00992056|468972037|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
130275504|NCT00992056|468972038|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
130275505|NCT00902850|468972039|FG000|Overall Study|Physician Decision|2|||
130275506|NCT00902850|468972040|FG001|Overall Study|Physician Decision|2|||
130275507|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
130275508|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
130275509|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
130275510|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275511|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275512|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275513|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275514|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130275515|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275516|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275517|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275518|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275519|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275520|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130555068|NCT03049735|469999805|FG001|Overall Study|Withdrawal by Subject|3|||
130555069|NCT03049735|469999806|FG002|Overall Study|Withdrawal by Subject|7|||
130555070|NCT03049735|469999804|FG000|Overall Study|Lost to Follow-up|1|||
130555071|NCT03049735|469999805|FG001|Overall Study|Lost to Follow-up|5|||
130555072|NCT03049735|469999806|FG002|Overall Study|Lost to Follow-up|5|||
130555073|NCT00390910|469999807|FG000|Overall Study|Adverse Event|1|||
130555074|NCT00390910|469999808|FG001|Overall Study|Adverse Event|0|||
130555075|NCT00390910|469999809|FG002|Overall Study|Adverse Event|0|||
130555076|NCT00390910|469999807|FG000|Overall Study|Lost to Follow-up|0|||
130555077|NCT00390910|469999808|FG001|Overall Study|Lost to Follow-up|1|||
130555078|NCT00390910|469999809|FG002|Overall Study|Lost to Follow-up|5|||
130555079|NCT00390910|469999807|FG000|Overall Study|Withdrawal by Subject|1|||
130555080|NCT00390910|469999808|FG001|Overall Study|Withdrawal by Subject|3|||
130555081|NCT00390910|469999809|FG002|Overall Study|Withdrawal by Subject|2|||
130555082|NCT00390910|469999807|FG000|Overall Study|Migrated/moved from study area|0|||
130555083|NCT00390910|469999808|FG001|Overall Study|Migrated/moved from study area|0|||
130555084|NCT00390910|469999809|FG002|Overall Study|Migrated/moved from study area|3|||
130555085|NCT03231943|469999814|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555086|NCT03231943|469999815|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
130555087|NCT03231943|469999816|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
130555088|NCT03231943|469999817|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555089|NCT03231943|469999818|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555090|NCT03231943|469999819|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555091|NCT03231943|469999820|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555092|NCT03231943|469999821|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555093|NCT03231943|469999822|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555094|NCT03231943|469999823|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555095|NCT03231943|469999824|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555096|NCT03231943|469999825|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555097|NCT03231943|469999826|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
130555098|NCT03231943|469999814|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555099|NCT03231943|469999815|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
130555100|NCT03231943|469999816|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555101|NCT03231943|469999817|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555102|NCT03231943|469999818|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555103|NCT03231943|469999819|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555104|NCT03231943|469999820|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555105|NCT03231943|469999821|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555106|NCT03231943|469999822|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555107|NCT03231943|469999823|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555108|NCT03231943|469999824|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555109|NCT03231943|469999825|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555110|NCT03231943|469999826|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
130555111|NCT03231943|469999814|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
130555112|NCT03231943|469999815|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555113|NCT03231943|469999816|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555114|NCT03231943|469999817|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555115|NCT03231943|469999818|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555116|NCT03231943|469999819|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555117|NCT03231943|469999820|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555118|NCT03231943|469999821|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555119|NCT03231943|469999822|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555120|NCT03231943|469999823|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555121|NCT03231943|469999824|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555122|NCT03231943|469999825|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555123|NCT03231943|469999826|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130555124|NCT03231943|469999814|FG000|Part 2|Adverse Event|0|||
130555125|NCT03231943|469999815|FG001|Part 2|Adverse Event|0|||
130555126|NCT03231943|469999816|FG002|Part 2|Adverse Event|0|||
130555127|NCT03231943|469999817|FG003|Part 2|Adverse Event|0|||
130555128|NCT03231943|469999818|FG004|Part 2|Adverse Event|0|||
130555129|NCT03231943|469999819|FG005|Part 2|Adverse Event|0|||
130555130|NCT03231943|469999820|FG006|Part 2|Adverse Event|0|||
130555131|NCT03231943|469999821|FG007|Part 2|Adverse Event|0|||
130555132|NCT03231943|469999822|FG008|Part 2|Adverse Event|0|||
130555133|NCT03231943|469999823|FG009|Part 2|Adverse Event|0|||
130275521|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130275522|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
130275523|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
130275524|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275525|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275526|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275527|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275528|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130275529|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130457085|NCT02001623|469638265|FG012|Overall Study|Other - Miscellaneous|0|||
130457086|NCT02001623|469638266|FG013|Overall Study|Other - Miscellaneous|1|||
130457087|NCT02001623|469638267|FG014|Overall Study|Other - Miscellaneous|0|||
130457088|NCT02001623|469638253|FG000|Overall Study|Withdrawal by Subject|1|||
130275530|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275531|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275532|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275533|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275534|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275535|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
130275536|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275537|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130457089|NCT02001623|469638254|FG001|Overall Study|Withdrawal by Subject|0|||
130275538|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275539|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275540|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275541|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275542|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275543|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
130457090|NCT02001623|469638255|FG002|Overall Study|Withdrawal by Subject|0|||
130457091|NCT02001623|469638256|FG003|Overall Study|Withdrawal by Subject|0|||
130457092|NCT02001623|469638257|FG004|Overall Study|Withdrawal by Subject|0|||
130457093|NCT02001623|469638258|FG005|Overall Study|Withdrawal by Subject|0|||
130457094|NCT02001623|469638259|FG006|Overall Study|Withdrawal by Subject|0|||
130457095|NCT02001623|469638260|FG007|Overall Study|Withdrawal by Subject|0|||
130457096|NCT02001623|469638261|FG008|Overall Study|Withdrawal by Subject|1|||
130457097|NCT02001623|469638262|FG009|Overall Study|Withdrawal by Subject|3|||
130457098|NCT02001623|469638263|FG010|Overall Study|Withdrawal by Subject|2|||
130457099|NCT02001623|469638264|FG011|Overall Study|Withdrawal by Subject|2|||
130457100|NCT02001623|469638265|FG012|Overall Study|Withdrawal by Subject|1|||
130457101|NCT02001623|469638266|FG013|Overall Study|Withdrawal by Subject|5|||
130457102|NCT02001623|469638267|FG014|Overall Study|Withdrawal by Subject|2|||
130457103|NCT02001623|469638253|FG000|Overall Study|Lost to Follow-up|0|||
130457104|NCT02001623|469638254|FG001|Overall Study|Lost to Follow-up|0|||
130457105|NCT02001623|469638255|FG002|Overall Study|Lost to Follow-up|0|||
130457106|NCT02001623|469638256|FG003|Overall Study|Lost to Follow-up|0|||
130457107|NCT02001623|469638257|FG004|Overall Study|Lost to Follow-up|0|||
130457108|NCT02001623|469638258|FG005|Overall Study|Lost to Follow-up|0|||
130457109|NCT02001623|469638259|FG006|Overall Study|Lost to Follow-up|0|||
130457110|NCT02001623|469638260|FG007|Overall Study|Lost to Follow-up|0|||
130457111|NCT02001623|469638261|FG008|Overall Study|Lost to Follow-up|0|||
130457112|NCT02001623|469638262|FG009|Overall Study|Lost to Follow-up|1|||
130457113|NCT02001623|469638263|FG010|Overall Study|Lost to Follow-up|0|||
130457114|NCT02001623|469638264|FG011|Overall Study|Lost to Follow-up|0|||
130457115|NCT02001623|469638265|FG012|Overall Study|Lost to Follow-up|0|||
130457116|NCT02001623|469638266|FG013|Overall Study|Lost to Follow-up|0|||
130457117|NCT02001623|469638267|FG014|Overall Study|Lost to Follow-up|0|||
130457118|NCT02001623|469638253|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
130457119|NCT02001623|469638254|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
130457120|NCT02001623|469638255|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
130457121|NCT02001623|469638256|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
130457122|NCT02001623|469638257|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
130457123|NCT02001623|469638258|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
130457124|NCT02001623|469638259|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
130457125|NCT02001623|469638260|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
130457126|NCT02001623|469638261|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
130457127|NCT02001623|469638262|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
130457128|NCT02001623|469638263|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
130457129|NCT02001623|469638264|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
130457130|NCT02001623|469638265|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
130457131|NCT02001623|469638266|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
130457132|NCT02001623|469638267|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
130457133|NCT02001623|469638253|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
130457134|NCT02001623|469638254|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
130457135|NCT02001623|469638255|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
130457136|NCT02001623|469638256|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
130457137|NCT02001623|469638257|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
130457138|NCT02001623|469638258|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
130457139|NCT02001623|469638259|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
130457140|NCT02001623|469638260|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
130457141|NCT02001623|469638261|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
130457142|NCT02001623|469638262|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
130457143|NCT02001623|469638263|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
130275544|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275545|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275546|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275547|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275548|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275549|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
130275550|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
130275551|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
130275552|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275553|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275554|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275555|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275556|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
130275557|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
130275558|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275559|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275560|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275561|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275562|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275563|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275564|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275565|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275566|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275567|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275568|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
130275569|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
130275570|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275571|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275572|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275573|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130275574|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275575|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130555134|NCT03231943|469999824|FG010|Part 2|Adverse Event|1|||
130555135|NCT03231943|469999825|FG011|Part 2|Adverse Event|0|||
130555136|NCT03231943|469999826|FG012|Part 2|Adverse Event|0|||
130555137|NCT03231943|469999814|FG000|Part 2|Withdrawal by Subject|0|||
130555138|NCT03231943|469999815|FG001|Part 2|Withdrawal by Subject|0|||
130555139|NCT03231943|469999816|FG002|Part 2|Withdrawal by Subject|0|||
130555140|NCT03231943|469999817|FG003|Part 2|Withdrawal by Subject|0|||
130555141|NCT03231943|469999818|FG004|Part 2|Withdrawal by Subject|0|||
130555142|NCT03231943|469999819|FG005|Part 2|Withdrawal by Subject|0|||
130555143|NCT03231943|469999820|FG006|Part 2|Withdrawal by Subject|0|||
130555144|NCT03231943|469999821|FG007|Part 2|Withdrawal by Subject|0|||
130275576|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130275577|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275578|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275579|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275580|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
130275581|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
130275582|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
130555145|NCT03231943|469999822|FG008|Part 2|Withdrawal by Subject|0|||
130555146|NCT03231943|469999823|FG009|Part 2|Withdrawal by Subject|0|||
130555147|NCT03231943|469999824|FG010|Part 2|Withdrawal by Subject|0|||
130555148|NCT03231943|469999825|FG011|Part 2|Withdrawal by Subject|1|||
130555149|NCT03231943|469999826|FG012|Part 2|Withdrawal by Subject|0|||
130555150|NCT02906787|469999828|FG000|Overall Study|Withdrawal by Subject|12|||
130555151|NCT02906787|469999829|FG001|Overall Study|Withdrawal by Subject|10|||
130275583|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
130367637|NCT03749447|469317259|FG001|Overall Study|Death|1|||
130367638|NCT03749447|469317258|FG000|Overall Study|Lost to Follow-up|2|||
130367639|NCT03749447|469317259|FG001|Overall Study|Lost to Follow-up|2|||
130367640|NCT03749447|469317258|FG000|Overall Study|Reason Not Specified|0|||
130555152|NCT02906787|469999828|FG000|Overall Study|Missed|24|||
130555153|NCT02906787|469999829|FG001|Overall Study|Missed|22|||
130555154|NCT02818920|469999830|FG000|Overall Study|Unresectable|4|||
130555155|NCT02818920|469999830|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
130555156|NCT02818920|469999830|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
130555157|NCT02818920|469999830|FG000|Overall Study|Adverse Event|3|||
130367641|NCT03749447|469317259|FG001|Overall Study|Reason Not Specified|3|||
130555158|NCT02818920|469999830|FG000|Overall Study|Developed Other Disease|1|||
130275584|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275585|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275586|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275587|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275588|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
130275589|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
130275590|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275591|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275592|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275593|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275594|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275595|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275596|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
130275597|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275598|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275599|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275600|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275601|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
130275602|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
130275603|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
130275604|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
130275605|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275606|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275607|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275608|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275609|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275610|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
130275611|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
130275612|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130275613|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130275614|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130275615|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Adverse Event|1|||
130275616|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Adverse Event|0|||
130275617|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Adverse Event|0|||
130275618|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Adverse Event|0|||
130275619|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275620|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275621|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275622|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275623|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
130275624|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275625|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275626|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
130275627|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
130275628|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130275629|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130275630|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130275631|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
130275632|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
130275633|NCT03604172|468972056|FG000|Overall Study|Lost to Follow-up|1|||
130275634|NCT03604172|468972057|FG001|Overall Study|Lost to Follow-up|2|||
130457144|NCT02001623|469638264|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
130457145|NCT02001623|469638265|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
130457146|NCT02001623|469638266|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
130275635|NCT02676895|468972058|FG000|Overall Study|Administrative reason|1|||
130275636|NCT02676895|468972059|FG001|Overall Study|Administrative reason|0|||
130275637|NCT02676895|468972060|FG002|Overall Study|Administrative reason|0|||
130275638|NCT02676895|468972058|FG000|Overall Study|Protocol Violation|1|||
130275639|NCT02676895|468972059|FG001|Overall Study|Protocol Violation|0|||
130275640|NCT02676895|468972060|FG002|Overall Study|Protocol Violation|0|||
130275641|NCT02676895|468972058|FG000|Overall Study|Adverse Event|0|||
130275642|NCT02676895|468972059|FG001|Overall Study|Adverse Event|3|||
130275643|NCT02676895|468972060|FG002|Overall Study|Adverse Event|1|||
130275644|NCT02676895|468972058|FG000|Overall Study|Lost to Follow-up|0|||
130457147|NCT02001623|469638267|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
130275645|NCT02676895|468972059|FG001|Overall Study|Lost to Follow-up|0|||
130275646|NCT02676895|468972060|FG002|Overall Study|Lost to Follow-up|1|||
130275647|NCT02676895|468972058|FG000|Overall Study|Withdrawal by Subject|0|||
130275648|NCT02676895|468972059|FG001|Overall Study|Withdrawal by Subject|0|||
130275649|NCT02676895|468972060|FG002|Overall Study|Withdrawal by Subject|1|||
130275650|NCT00976716|468972066|FG000|Overall Study|Adverse Event|1|||
130275651|NCT03028129|468972072|FG000|Overall Study|Adverse Event|13|||
130275652|NCT03028129|468972073|FG001|Overall Study|Adverse Event|2|||
130275653|NCT03028129|468972072|FG000|Overall Study|Lost to Follow-up|50|||
130275654|NCT03028129|468972073|FG001|Overall Study|Lost to Follow-up|38|||
130275655|NCT03028129|468972072|FG000|Overall Study|Physician Decision|0|||
130275656|NCT03028129|468972073|FG001|Overall Study|Physician Decision|1|||
130275657|NCT03028129|468972072|FG000|Overall Study|Protocol Violation|1|||
130275658|NCT03028129|468972073|FG001|Overall Study|Protocol Violation|1|||
130367642|NCT03749447|469317258|FG000|Overall Study|Physician Decision|4|||
130367643|NCT03749447|469317259|FG001|Overall Study|Physician Decision|3|||
130367644|NCT03749447|469317258|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
130367645|NCT03749447|469317259|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
130367646|NCT03749447|469317258|FG000|Overall Study|Study Terminated By Sponsor|112|||
130367647|NCT03749447|469317259|FG001|Overall Study|Study Terminated By Sponsor|105|||
130367648|NCT03749447|469317258|FG000|Overall Study|Withdrawal by Subject|12|||
130367649|NCT03749447|469317259|FG001|Overall Study|Withdrawal by Subject|6|||
130367650|NCT03749447|469317258|FG000|Overall Study|Non-compliance With Study Drug|0|||
130367651|NCT03749447|469317259|FG001|Overall Study|Non-compliance With Study Drug|1|||
130367652|NCT03486223|469317268|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
130367653|NCT03486223|469317269|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
130367654|NCT01819831|469317270|FG000|Overall Study|Withdrawal by Subject|1|||
130367655|NCT02279420|469317271|FG000|Overall Study|Lost to Follow-up|23|||
130367656|NCT01153347|469317274|FG000|Overall Study|Withdrawal by Subject|7|||
130367657|NCT01153347|469317275|FG001|Overall Study|Withdrawal by Subject|7|||
130367658|NCT01153347|469317276|FG002|Overall Study|Withdrawal by Subject|7|||
130367659|NCT01153347|469317277|FG003|Overall Study|Withdrawal by Subject|7|||
130367660|NCT01153347|469317274|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130367661|NCT01153347|469317275|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130367662|NCT01153347|469317276|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130367663|NCT01153347|469317277|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130367664|NCT01153347|469317274|FG000|Overall Study|Adverse Event|3|||
130367665|NCT01153347|469317275|FG001|Overall Study|Adverse Event|9|||
130367666|NCT01153347|469317276|FG002|Overall Study|Adverse Event|21|||
130367667|NCT01153347|469317277|FG003|Overall Study|Adverse Event|7|||
130367668|NCT01153347|469317274|FG000|Overall Study|Severe non-compliance to protocol|6|||
130367669|NCT01153347|469317275|FG001|Overall Study|Severe non-compliance to protocol|7|||
130367670|NCT01153347|469317276|FG002|Overall Study|Severe non-compliance to protocol|4|||
130367671|NCT01153347|469317277|FG003|Overall Study|Severe non-compliance to protocol|3|||
130367672|NCT01153347|469317274|FG000|Overall Study|Condition under investigation worsened|1|||
130367673|NCT01153347|469317275|FG001|Overall Study|Condition under investigation worsened|1|||
130367674|NCT01153347|469317276|FG002|Overall Study|Condition under investigation worsened|0|||
130367675|NCT01153347|469317277|FG003|Overall Study|Condition under investigation worsened|0|||
130367676|NCT01153347|469317274|FG000|Overall Study|Lack of Efficacy|2|||
130367677|NCT01153347|469317275|FG001|Overall Study|Lack of Efficacy|2|||
130367678|NCT01153347|469317276|FG002|Overall Study|Lack of Efficacy|0|||
130367679|NCT01153347|469317277|FG003|Overall Study|Lack of Efficacy|4|||
130367680|NCT01153347|469317274|FG000|Overall Study|Study-specific withdrawal criteria|4|||
130367681|NCT01153347|469317275|FG001|Overall Study|Study-specific withdrawal criteria|3|||
130367682|NCT01153347|469317276|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130367683|NCT01153347|469317277|FG003|Overall Study|Study-specific withdrawal criteria|2|||
130367684|NCT01153347|469317274|FG000|Overall Study|Lost to Follow-up|4|||
130367685|NCT01153347|469317275|FG001|Overall Study|Lost to Follow-up|9|||
130367686|NCT01153347|469317276|FG002|Overall Study|Lost to Follow-up|11|||
130367687|NCT01153347|469317277|FG003|Overall Study|Lost to Follow-up|8|||
130367688|NCT01153347|469317274|FG000|Overall Study|Other|5|||
130367689|NCT01153347|469317275|FG001|Overall Study|Other|5|||
130367690|NCT01153347|469317276|FG002|Overall Study|Other|4|||
130367691|NCT01153347|469317277|FG003|Overall Study|Other|0|||
130367692|NCT01153347|469317274|FG000|Overall Study|Death|1|||
130367693|NCT01153347|469317275|FG001|Overall Study|Death|0|||
130367694|NCT01153347|469317276|FG002|Overall Study|Death|0|||
130367695|NCT01153347|469317277|FG003|Overall Study|Death|0|||
130367696|NCT00297830|469317278|FG000|6 Month Visit|Death|1|||
130367697|NCT00297830|469317279|FG001|6 Month Visit|Death|0|||
130367698|NCT00297830|469317280|FG002|6 Month Visit|Death|2|||
130367699|NCT00297830|469317278|FG000|6 Month Visit|Withdrawal by Subject|2|||
130367700|NCT00297830|469317279|FG001|6 Month Visit|Withdrawal by Subject|1|||
130367701|NCT00297830|469317280|FG002|6 Month Visit|Withdrawal by Subject|1|||
130367702|NCT00297830|469317278|FG000|6 Month Visit|Adverse Event|0|||
130367703|NCT00297830|469317279|FG001|6 Month Visit|Adverse Event|1|||
130457148|NCT00309452|469638268|FG000|Overall Study|Withdrawal by Subject|3|||
130457149|NCT00309452|469638269|FG001|Overall Study|Withdrawal by Subject|0|||
130275659|NCT03028129|468972072|FG000|Overall Study|Withdrawal by Subject|62|||
130275660|NCT03028129|468972073|FG001|Overall Study|Withdrawal by Subject|45|||
130367704|NCT00297830|469317280|FG002|6 Month Visit|Adverse Event|0|||
130367705|NCT00297830|469317278|FG000|12 Month Visit|Lost to Follow-up|1|||
130367706|NCT00297830|469317279|FG001|12 Month Visit|Lost to Follow-up|0|||
130555159|NCT02818920|469999830|FG000|Overall Study|Refused Further Treatment|1|||
130555160|NCT03769181|470001475|FG000|Overall Study|Adverse Event|1|||
130555161|NCT03769181|470001476|FG001|Overall Study|Adverse Event|0|||
130555162|NCT03769181|470001477|FG002|Overall Study|Adverse Event|2|||
130555163|NCT03769181|470001478|FG003|Overall Study|Adverse Event|4|||
130555164|NCT03769181|470001475|FG000|Overall Study|Withdrawal by Subject|1|||
130555165|NCT03769181|470001476|FG001|Overall Study|Withdrawal by Subject|0|||
130555166|NCT03769181|470001477|FG002|Overall Study|Withdrawal by Subject|2|||
130555167|NCT03769181|470001478|FG003|Overall Study|Withdrawal by Subject|1|||
130555168|NCT03769181|470001475|FG000|Overall Study|Progressive disease|9|||
130555169|NCT03769181|470001476|FG001|Overall Study|Progressive disease|7|||
130555170|NCT03769181|470001477|FG002|Overall Study|Progressive disease|13|||
130555171|NCT03769181|470001478|FG003|Overall Study|Progressive disease|6|||
130555172|NCT03769181|470001475|FG000|Overall Study|Other - Unspecified|2|||
130555173|NCT03769181|470001476|FG001|Overall Study|Other - Unspecified|1|||
130555174|NCT03769181|470001477|FG002|Overall Study|Other - Unspecified|0|||
130555175|NCT03769181|470001478|FG003|Overall Study|Other - Unspecified|0|||
130555176|NCT03078907|470001481|FG000|Overall Study|Adverse Event|2|||
130555177|NCT03078907|470001482|FG001|Overall Study|Adverse Event|0|||
130555178|NCT03078907|470001481|FG000|Overall Study|Other|1|||
130555179|NCT03078907|470001482|FG001|Overall Study|Other|0|||
130555180|NCT03078907|470001481|FG000|Overall Study|Protocol Violation|0|||
130555181|NCT03078907|470001482|FG001|Overall Study|Protocol Violation|1|||
130555182|NCT03338192|470001483|FG000|Year One to Year Two|High Blood Pressure|7|||
130555183|NCT03338192|470001484|FG001|Year One to Year Two|High Blood Pressure|1|||
130555184|NCT03338192|470001483|FG000|Year One to Year Two|HIV +|1|||
130555185|NCT03338192|470001484|FG001|Year One to Year Two|HIV +|0|||
130555186|NCT03338192|470001483|FG000|Year Two to Year Four|High Blood Pressure|1|||
130555187|NCT03338192|470001484|FG001|Year Two to Year Four|High Blood Pressure|0|||
130555188|NCT03338192|470001483|FG000|Year Two to Year Four|HIV +|2|||
130555189|NCT03338192|470001484|FG001|Year Two to Year Four|HIV +|0|||
130555190|NCT03338192|470001483|FG000|Year Four to Year Six|High Blood Pressure|2|||
130555191|NCT03338192|470001484|FG001|Year Four to Year Six|High Blood Pressure|1|||
130555192|NCT03808688|470001485|FG000|Overall Study|Adverse Event|13|||
130555193|NCT03808688|470001486|FG001|Overall Study|Adverse Event|17|||
130555194|NCT03808688|470001485|FG000|Overall Study|Lack of Efficacy|2|||
130555195|NCT03808688|470001486|FG001|Overall Study|Lack of Efficacy|0|||
130555196|NCT03808688|470001485|FG000|Overall Study|Lost to Follow-up|0|||
130555197|NCT03808688|470001486|FG001|Overall Study|Lost to Follow-up|2|||
130555198|NCT03808688|470001485|FG000|Overall Study|Withdrawal by Subject|1|||
130555199|NCT03808688|470001486|FG001|Overall Study|Withdrawal by Subject|0|||
130555200|NCT03808688|470001485|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
130555201|NCT03808688|470001486|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
130555202|NCT03808688|470001485|FG000|Overall Study|IOP Too High|1|||
130555203|NCT03808688|470001486|FG001|Overall Study|IOP Too High|1|||
130555204|NCT03808688|470001485|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
130555205|NCT03808688|470001486|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
130555206|NCT03808688|470001485|FG000|Overall Study|Visit Out of Window|0|||
130555207|NCT03808688|470001486|FG001|Overall Study|Visit Out of Window|1|||
130555208|NCT03808688|470001485|FG000|Overall Study|Medication Non-Compliance|0|||
130555209|NCT03808688|470001486|FG001|Overall Study|Medication Non-Compliance|1|||
130555210|NCT03329196|470001487|FG000|Overall Study|Adverse Event|10|||
130555211|NCT03329196|470001488|FG001|Overall Study|Adverse Event|5|||
130555212|NCT03329196|470001487|FG000|Overall Study|Physician Decision|2|||
130555213|NCT03329196|470001488|FG001|Overall Study|Physician Decision|2|||
130555214|NCT03329196|470001487|FG000|Overall Study|Withdrawal by Subject|11|||
130555215|NCT03329196|470001488|FG001|Overall Study|Withdrawal by Subject|3|||
130555216|NCT03329196|470001487|FG000|Overall Study|Hepatic function abnormalities|0|||
130555217|NCT03329196|470001488|FG001|Overall Study|Hepatic function abnormalities|1|||
130555218|NCT03329196|470001487|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
130555219|NCT03329196|470001488|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
130555220|NCT03329196|470001487|FG000|Overall Study|Difficult to control Hb|2|||
130555221|NCT03329196|470001488|FG001|Overall Study|Difficult to control Hb|3|||
130555222|NCT03329196|470001487|FG000|Overall Study|Dialysis or renal transplant|13|||
130275661|NCT04222699|468972074|FG000|Overall Study|Lost to Follow-up|2|||
130275662|NCT00923351|468972075|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
130555223|NCT03329196|470001488|FG001|Overall Study|Dialysis or renal transplant|15|||
130555224|NCT03434353|470001495|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
130555225|NCT03434353|470001496|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
130555226|NCT03434353|470001497|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
130555227|NCT03434353|470001498|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
130555228|NCT03434353|470001499|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
130555229|NCT03434353|470001495|FG000|Overall Study|Withdrew consent|1|||
130275663|NCT00923351|468972076|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
130555230|NCT03434353|470001496|FG001|Overall Study|Withdrew consent|0|||
130555231|NCT03434353|470001497|FG002|Overall Study|Withdrew consent|3|||
130275664|NCT00923351|468972077|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
130275665|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
130275666|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
130275667|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130275668|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
130275669|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
130275670|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
130275671|NCT00972517|468972085|FG000|Overall Study|Adverse Event|0|||
130275672|NCT00972517|468972086|FG001|Overall Study|Adverse Event|0|||
130275673|NCT00972517|468972087|FG002|Overall Study|Adverse Event|0|||
130275674|NCT00972517|468972088|FG003|Overall Study|Adverse Event|1|||
130275675|NCT00972517|468972089|FG004|Overall Study|Adverse Event|0|||
130367707|NCT00297830|469317280|FG002|12 Month Visit|Lost to Follow-up|0|||
130367708|NCT00297830|469317278|FG000|12 Month Visit|Adverse Event|0|||
130367709|NCT00297830|469317279|FG001|12 Month Visit|Adverse Event|3|||
130367710|NCT00297830|469317280|FG002|12 Month Visit|Adverse Event|0|||
130367711|NCT00297830|469317278|FG000|12 Month Visit|Withdrawal by Subject|0|||
130367712|NCT00297830|469317279|FG001|12 Month Visit|Withdrawal by Subject|3|||
130367713|NCT00297830|469317280|FG002|12 Month Visit|Withdrawal by Subject|0|||
130367714|NCT05096221|469317283|FG000|Part 2|Physician Decision|0|||
130367715|NCT05096221|469317284|FG001|Part 2|Physician Decision|1|||
130367716|NCT04678661|469317286|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
130367717|NCT04678661|469317287|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
130367718|NCT04678661|469317286|FG000|Overall Study|Protocol Violation|2|||
130457150|NCT00771667|469638270|FG000|Induction Phase|Adverse Event|5|||
130275676|NCT00972517|468972090|FG005|Overall Study|Adverse Event|0|||
130275677|NCT00972517|468972085|FG000|Overall Study|Withdrawal by Subject|0|||
130367719|NCT04678661|469317287|FG001|Overall Study|Protocol Violation|0|||
130367720|NCT04678661|469317286|FG000|Overall Study|Withdrawal by Subject|1|||
130367721|NCT04678661|469317287|FG001|Overall Study|Withdrawal by Subject|0|||
130367722|NCT04678661|469317286|FG000|Overall Study|Lost to Follow-up|2|||
130367723|NCT04678661|469317287|FG001|Overall Study|Lost to Follow-up|0|||
130367724|NCT04678661|469317286|FG000|Overall Study|Death|2|||
130367725|NCT04678661|469317287|FG001|Overall Study|Death|0|||
130367726|NCT03094169|469317288|FG000|Overall Study|Lack of Efficacy|0|||
130367727|NCT03094169|469317289|FG001|Overall Study|Lack of Efficacy|0|||
130275678|NCT00972517|468972086|FG001|Overall Study|Withdrawal by Subject|1|||
130275679|NCT00972517|468972087|FG002|Overall Study|Withdrawal by Subject|0|||
130275680|NCT00972517|468972088|FG003|Overall Study|Withdrawal by Subject|2|||
130275681|NCT00972517|468972089|FG004|Overall Study|Withdrawal by Subject|1|||
130275682|NCT00972517|468972090|FG005|Overall Study|Withdrawal by Subject|0|||
130275683|NCT00984594|468972091|FG000|Overall Study|Lost to Follow-up|1|||
130275684|NCT00984594|468972092|FG001|Overall Study|Lost to Follow-up|0|||
130275685|NCT00984594|468972091|FG000|Overall Study|Withdrawal by Subject|0|||
130275686|NCT00984594|468972092|FG001|Overall Study|Withdrawal by Subject|1|||
130275687|NCT00851890|468972093|FG000|Overall Study|Lost to Follow-up|0|||
130275688|NCT00851890|468972094|FG001|Overall Study|Lost to Follow-up|1|||
130275689|NCT00851890|468972095|FG002|Overall Study|Lost to Follow-up|0|||
130275690|NCT00851890|468972096|FG003|Overall Study|Lost to Follow-up|1|||
130457151|NCT00771667|469638271|FG001|Induction Phase|Adverse Event|2|||
130457152|NCT00771667|469638272|FG002|Induction Phase|Adverse Event|4|||
130457153|NCT00771667|469638273|FG003|Induction Phase|Adverse Event|1|||
130457154|NCT00771667|469638274|FG004|Induction Phase|Adverse Event|0|||
130457155|NCT00771667|469638275|FG005|Induction Phase|Adverse Event|0|||
130457156|NCT00771667|469638276|FG006|Induction Phase|Adverse Event|0|||
130457157|NCT00771667|469638277|FG007|Induction Phase|Adverse Event|0|||
130457158|NCT00771667|469638278|FG008|Induction Phase|Adverse Event|0|||
130457159|NCT00771667|469638279|FG009|Induction Phase|Adverse Event|0|||
130457160|NCT00771667|469638270|FG000|Induction Phase|Lack of Efficacy|9|||
130457161|NCT00771667|469638271|FG001|Induction Phase|Lack of Efficacy|2|||
130457162|NCT00771667|469638272|FG002|Induction Phase|Lack of Efficacy|4|||
130457163|NCT00771667|469638273|FG003|Induction Phase|Lack of Efficacy|3|||
130457164|NCT00771667|469638274|FG004|Induction Phase|Lack of Efficacy|0|||
130457165|NCT00771667|469638275|FG005|Induction Phase|Lack of Efficacy|0|||
130457166|NCT00771667|469638276|FG006|Induction Phase|Lack of Efficacy|0|||
130457167|NCT00771667|469638277|FG007|Induction Phase|Lack of Efficacy|0|||
130457168|NCT00771667|469638278|FG008|Induction Phase|Lack of Efficacy|0|||
130457169|NCT00771667|469638279|FG009|Induction Phase|Lack of Efficacy|0|||
130457170|NCT00771667|469638270|FG000|Induction Phase|Lost to Follow-up|1|||
130457171|NCT00771667|469638271|FG001|Induction Phase|Lost to Follow-up|0|||
130457172|NCT00771667|469638272|FG002|Induction Phase|Lost to Follow-up|1|||
130457173|NCT00771667|469638273|FG003|Induction Phase|Lost to Follow-up|0|||
130457174|NCT00771667|469638274|FG004|Induction Phase|Lost to Follow-up|0|||
130457175|NCT00771667|469638275|FG005|Induction Phase|Lost to Follow-up|0|||
130457176|NCT00771667|469638276|FG006|Induction Phase|Lost to Follow-up|0|||
130457177|NCT00771667|469638277|FG007|Induction Phase|Lost to Follow-up|0|||
130457178|NCT00771667|469638278|FG008|Induction Phase|Lost to Follow-up|0|||
130457179|NCT00771667|469638279|FG009|Induction Phase|Lost to Follow-up|0|||
130457180|NCT00771667|469638270|FG000|Induction Phase|Other|4|||
130457181|NCT00771667|469638271|FG001|Induction Phase|Other|6|||
130457182|NCT00771667|469638272|FG002|Induction Phase|Other|3|||
130457183|NCT00771667|469638273|FG003|Induction Phase|Other|4|||
130457184|NCT00771667|469638274|FG004|Induction Phase|Other|0|||
130457185|NCT00771667|469638275|FG005|Induction Phase|Other|0|||
130457186|NCT00771667|469638276|FG006|Induction Phase|Other|0|||
130457187|NCT00771667|469638277|FG007|Induction Phase|Other|0|||
130457188|NCT00771667|469638278|FG008|Induction Phase|Other|0|||
130457189|NCT00771667|469638279|FG009|Induction Phase|Other|0|||
130457190|NCT00771667|469638270|FG000|Maintenance Phase|Adverse Event|0|||
130457191|NCT00771667|469638271|FG001|Maintenance Phase|Adverse Event|0|||
130457192|NCT00771667|469638272|FG002|Maintenance Phase|Adverse Event|0|||
130457193|NCT00771667|469638273|FG003|Maintenance Phase|Adverse Event|0|||
130457194|NCT00771667|469638274|FG004|Maintenance Phase|Adverse Event|1|||
130457195|NCT00771667|469638275|FG005|Maintenance Phase|Adverse Event|3|||
130457196|NCT00771667|469638276|FG006|Maintenance Phase|Adverse Event|5|||
130457197|NCT00771667|469638277|FG007|Maintenance Phase|Adverse Event|1|||
130457198|NCT00771667|469638278|FG008|Maintenance Phase|Adverse Event|8|||
130457199|NCT00771667|469638279|FG009|Maintenance Phase|Adverse Event|7|||
130457200|NCT00771667|469638270|FG000|Maintenance Phase|Lack of Efficacy|0|||
130457201|NCT00771667|469638271|FG001|Maintenance Phase|Lack of Efficacy|0|||
130457202|NCT00771667|469638272|FG002|Maintenance Phase|Lack of Efficacy|0|||
130457203|NCT00771667|469638273|FG003|Maintenance Phase|Lack of Efficacy|0|||
130457204|NCT00771667|469638274|FG004|Maintenance Phase|Lack of Efficacy|1|||
130457205|NCT00771667|469638275|FG005|Maintenance Phase|Lack of Efficacy|3|||
130275691|NCT03135431|468972097|FG000|Overall Study|Study Surgeon not available|2|||
130275692|NCT03135431|468972098|FG001|Overall Study|Study Surgeon not available|0|||
130275693|NCT00281099|468972101|FG000|Overall Study|Death|46|||
130275694|NCT00281099|468972102|FG001|Overall Study|Death|57|||
130457206|NCT00771667|469638276|FG006|Maintenance Phase|Lack of Efficacy|3|||
130457207|NCT00771667|469638277|FG007|Maintenance Phase|Lack of Efficacy|2|||
130457208|NCT00771667|469638278|FG008|Maintenance Phase|Lack of Efficacy|11|||
130457209|NCT00771667|469638279|FG009|Maintenance Phase|Lack of Efficacy|7|||
130457210|NCT00771667|469638270|FG000|Maintenance Phase|Other|0|||
130457211|NCT00771667|469638271|FG001|Maintenance Phase|Other|0|||
130457212|NCT00771667|469638272|FG002|Maintenance Phase|Other|0|||
130457213|NCT00771667|469638273|FG003|Maintenance Phase|Other|0|||
130457214|NCT00771667|469638274|FG004|Maintenance Phase|Other|0|||
130457215|NCT00771667|469638275|FG005|Maintenance Phase|Other|1|||
130275695|NCT00281099|468972101|FG000|Overall Study|Lost to Follow-up|10|||
130275696|NCT00281099|468972102|FG001|Overall Study|Lost to Follow-up|19|||
130275697|NCT00281099|468972101|FG000|Overall Study|Withdrawal by Subject|65|||
130457216|NCT00771667|469638276|FG006|Maintenance Phase|Other|2|||
130457217|NCT00771667|469638277|FG007|Maintenance Phase|Other|2|||
130275698|NCT00281099|468972102|FG001|Overall Study|Withdrawal by Subject|70|||
130275699|NCT00281099|468972101|FG000|Overall Study|Physician Decision|79|||
130457218|NCT00771667|469638278|FG008|Maintenance Phase|Other|3|||
130275700|NCT00281099|468972102|FG001|Overall Study|Physician Decision|72|||
130275701|NCT00281099|468972101|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
130275702|NCT00281099|468972102|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
130275703|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Adverse Event|7|||
130275704|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Adverse Event|0|||
130275705|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Adverse Event|0|||
130275706|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
130275707|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
130275708|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
130275709|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
130275710|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
130275711|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
130275712|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
130275713|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130275714|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130275715|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
130275716|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
130275717|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
130275718|NCT01059864|468972107|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130275719|NCT01059864|468972108|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130275720|NCT01059864|468972109|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
130275721|NCT00962741|468974119|FG000|Overall Study|Failed to return|3|||
130457219|NCT00771667|469638279|FG009|Maintenance Phase|Other|3|||
130457220|NCT00628862|469638280|FG000|Overall Study|Adverse Event|6|||
130457221|NCT00628862|469638281|FG001|Overall Study|Adverse Event|8|||
130457222|NCT00628862|469638282|FG002|Overall Study|Adverse Event|10|||
130457223|NCT00628862|469638280|FG000|Overall Study|Withdrawal by Subject|4|||
130457224|NCT00628862|469638281|FG001|Overall Study|Withdrawal by Subject|6|||
130457225|NCT00628862|469638282|FG002|Overall Study|Withdrawal by Subject|11|||
130457226|NCT00628862|469638280|FG000|Overall Study|Lost to Follow-up|0|||
130457227|NCT00628862|469638281|FG001|Overall Study|Lost to Follow-up|2|||
130457228|NCT00628862|469638282|FG002|Overall Study|Lost to Follow-up|1|||
130555232|NCT03434353|470001498|FG003|Overall Study|Withdrew consent|0|||
130275722|NCT00962741|468974119|FG000|Overall Study|Lost to Follow-up|2|||
130275723|NCT00962741|468974119|FG000|Overall Study|Withdrawal by Subject|1|||
130275724|NCT00962741|468974119|FG000|Overall Study|Lack of Efficacy|1|||
130275725|NCT00962741|468974119|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
130275726|NCT01814878|468974122|FG000|Overall Study|Adverse Event|16|||
130275727|NCT01814878|468974123|FG001|Overall Study|Adverse Event|5|||
130275728|NCT01814878|468974122|FG000|Overall Study|Withdrawal by Subject|20|||
130275729|NCT01814878|468974123|FG001|Overall Study|Withdrawal by Subject|16|||
130457229|NCT00628862|469638280|FG000|Overall Study|Protocol Violation|1|||
130457230|NCT00628862|469638281|FG001|Overall Study|Protocol Violation|0|||
130555233|NCT03434353|470001499|FG004|Overall Study|Withdrew consent|0|||
130555234|NCT03434353|470001495|FG000|Overall Study|Adverse Event|1|||
130555235|NCT03434353|470001496|FG001|Overall Study|Adverse Event|0|||
130555236|NCT03434353|470001497|FG002|Overall Study|Adverse Event|0|||
130555237|NCT03434353|470001498|FG003|Overall Study|Adverse Event|0|||
130555238|NCT03434353|470001499|FG004|Overall Study|Adverse Event|1|||
130555239|NCT03434353|470001495|FG000|Overall Study|Lost to Follow-up|2|||
130555240|NCT03434353|470001496|FG001|Overall Study|Lost to Follow-up|0|||
130555241|NCT03434353|470001497|FG002|Overall Study|Lost to Follow-up|0|||
130555242|NCT03434353|470001498|FG003|Overall Study|Lost to Follow-up|0|||
130555243|NCT03434353|470001499|FG004|Overall Study|Lost to Follow-up|0|||
130555244|NCT01990534|470001502|FG000|Overall Study|Death|22|||
130555245|NCT01990534|470001502|FG000|Overall Study|Progressive disease|3|||
130555246|NCT01990534|470001502|FG000|Overall Study|Protocol Violation|1|||
130555247|NCT01990534|470001502|FG000|Overall Study|Withdrawal of Informed Consent|2|||
130555248|NCT01990534|470001502|FG000|Overall Study|Symptomatic Deterioration|1|||
130275730|NCT01814878|468974122|FG000|Overall Study|Protocol Violation|5|||
130275731|NCT01814878|468974123|FG001|Overall Study|Protocol Violation|5|||
130457231|NCT00628862|469638282|FG002|Overall Study|Protocol Violation|0|||
130275732|NCT01814878|468974122|FG000|Overall Study|Physician Decision|3|||
130457232|NCT00628862|469638280|FG000|Overall Study|COPD Exacerbation|0|||
130457233|NCT00628862|469638281|FG001|Overall Study|COPD Exacerbation|1|||
130275733|NCT01814878|468974123|FG001|Overall Study|Physician Decision|1|||
130275734|NCT01814878|468974122|FG000|Overall Study|Screening failure (drop-out)|0|||
130457234|NCT00628862|469638282|FG002|Overall Study|COPD Exacerbation|0|||
130555249|NCT01990534|470001502|FG000|Overall Study|Withdrawal by Subject|3|||
130555250|NCT01990534|470001502|FG000|Overall Study|Reason not Specified|2|||
130555251|NCT01990534|470001502|FG000|Overall Study|Lost to Follow-up|1|||
130555252|NCT00234494|470001503|FG000|Overall Study|Protocol Violation|2|||
130457235|NCT01063036|469638283|FG000|Participants Treated With Study Drug|Adverse Event|1|||
130457236|NCT01063036|469638283|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
130555253|NCT01831544|470001506|FG000|Overall Study|Death|1|||
130555254|NCT01831544|470001506|FG000|Overall Study|Still on original MVAD device|2|||
130555255|NCT04175808|470001509|FG000|Part A|Miscellaneous|2|||
130555256|NCT04175808|470001510|FG001|Part A|Miscellaneous|0|||
130555257|NCT04175808|470001511|FG002|Part A|Miscellaneous|0|||
130555258|NCT04175808|470001512|FG003|Part A|Miscellaneous|0|||
130555259|NCT04175808|470001513|FG004|Part A|Miscellaneous|0|||
130555260|NCT04175808|470001514|FG005|Part A|Miscellaneous|0|||
130555261|NCT04175808|470001515|FG006|Part A|Miscellaneous|0|||
130555262|NCT02021292|470001519|FG000|Overall Study|Physician Decision|0|||
130555263|NCT02021292|470001520|FG001|Overall Study|Physician Decision|1|||
130555264|NCT02021292|470001519|FG000|Overall Study|Lost to Follow-up|0|||
130555265|NCT02021292|470001520|FG001|Overall Study|Lost to Follow-up|1|||
130555266|NCT02021292|470001519|FG000|Overall Study|Death|0|||
130555267|NCT02021292|470001520|FG001|Overall Study|Death|1|||
130555268|NCT05972733|470001521|FG000|Overall Study|Lost to Follow-up|2|||
130555269|NCT05972733|470001521|FG000|Overall Study|Withdrawal by Subject|1|||
130555270|NCT04982588|470001524|FG000|Overall Study|Withdrawal by Subject|2|||
130555271|NCT02366728|470001525|FG000|Overall Study|Death|0|||
130555272|NCT02366728|470001526|FG001|Overall Study|Death|0|||
130555273|NCT02366728|470001527|FG002|Overall Study|Death|1|||
130555274|NCT02366728|470001525|FG000|Overall Study|Adverse Event|1|||
130555275|NCT02366728|470001526|FG001|Overall Study|Adverse Event|0|||
130555276|NCT02366728|470001527|FG002|Overall Study|Adverse Event|0|||
130555277|NCT02366728|470001525|FG000|Overall Study|Screen Failure|2|||
130555278|NCT02366728|470001526|FG001|Overall Study|Screen Failure|1|||
130555279|NCT02366728|470001527|FG002|Overall Study|Screen Failure|0|||
130555280|NCT02366728|470001525|FG000|Overall Study|Only yielded 2 vaccines|1|||
130555281|NCT02366728|470001526|FG001|Overall Study|Only yielded 2 vaccines|0|||
130555282|NCT02366728|470001527|FG002|Overall Study|Only yielded 2 vaccines|0|||
130555283|NCT00992511|470001529|FG000|Overall Study|Migrated/moved from study area|1|||
130555284|NCT00992511|470001530|FG001|Overall Study|Migrated/moved from study area|0|||
130457237|NCT01063036|469638283|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
130457238|NCT01063036|469638283|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
130457239|NCT01063036|469638283|FG000|Participants Treated With Study Drug|Pregnancy|1|||
130457240|NCT01063036|469638283|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
130457241|NCT01063036|469638283|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
130457242|NCT01063036|469638283|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
130457243|NCT02174562|469638288|FG000|Overall Study|Withdrawal by Subject|7|||
130457244|NCT02174562|469638289|FG001|Overall Study|Withdrawal by Subject|2|||
130457245|NCT02174562|469638288|FG000|Overall Study|Death|2|||
130457246|NCT02174562|469638289|FG001|Overall Study|Death|0|||
130457247|NCT02174562|469638288|FG000|Overall Study|Lost to Follow-up|0|||
130457248|NCT02174562|469638289|FG001|Overall Study|Lost to Follow-up|3|||
130457249|NCT05193318|469638290|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
130457250|NCT05193318|469638290|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
130457251|NCT00798096|469638291|FG000|Overall Study|Ongoing|2|||
130457252|NCT01833065|469638292|FG000|Overall Study|Adverse Event|6|||
130457253|NCT01833065|469638293|FG001|Overall Study|Adverse Event|1|||
130457254|NCT01833065|469638294|FG002|Overall Study|Adverse Event|0|||
130457255|NCT01833065|469638295|FG003|Overall Study|Adverse Event|2|||
130457256|NCT01833065|469638296|FG004|Overall Study|Adverse Event|3|||
130457257|NCT01833065|469638292|FG000|Overall Study|Protocol Violation|1|||
130457258|NCT01833065|469638293|FG001|Overall Study|Protocol Violation|0|||
130457259|NCT01833065|469638294|FG002|Overall Study|Protocol Violation|0|||
130457260|NCT01833065|469638295|FG003|Overall Study|Protocol Violation|0|||
130457261|NCT01833065|469638296|FG004|Overall Study|Protocol Violation|2|||
130457262|NCT01833065|469638292|FG000|Overall Study|Lost to Follow-up|1|||
130457263|NCT01833065|469638293|FG001|Overall Study|Lost to Follow-up|0|||
130457264|NCT01833065|469638294|FG002|Overall Study|Lost to Follow-up|0|||
130457265|NCT01833065|469638295|FG003|Overall Study|Lost to Follow-up|0|||
130457266|NCT01833065|469638296|FG004|Overall Study|Lost to Follow-up|3|||
130457267|NCT01833065|469638292|FG000|Overall Study|Withdrawal by Subject|6|||
130457268|NCT01833065|469638293|FG001|Overall Study|Withdrawal by Subject|2|||
130457269|NCT01833065|469638294|FG002|Overall Study|Withdrawal by Subject|4|||
130457270|NCT01833065|469638295|FG003|Overall Study|Withdrawal by Subject|3|||
130457271|NCT01833065|469638296|FG004|Overall Study|Withdrawal by Subject|11|||
130457272|NCT01833065|469638292|FG000|Overall Study|Subject's substantial non-compliance|0|||
130457273|NCT01833065|469638293|FG001|Overall Study|Subject's substantial non-compliance|1|||
130555285|NCT00992511|470001531|FG002|Overall Study|Migrated/moved from study area|1|||
130555286|NCT00992511|470001532|FG003|Overall Study|Migrated/moved from study area|2|||
130555287|NCT00992511|470001529|FG000|Overall Study|Lost to Follow-up|1|||
130555288|NCT00992511|470001530|FG001|Overall Study|Lost to Follow-up|0|||
130555289|NCT00992511|470001531|FG002|Overall Study|Lost to Follow-up|0|||
130555290|NCT00992511|470001532|FG003|Overall Study|Lost to Follow-up|2|||
130457274|NCT01833065|469638294|FG002|Overall Study|Subject's substantial non-compliance|0|||
130457275|NCT01833065|469638295|FG003|Overall Study|Subject's substantial non-compliance|0|||
130457276|NCT01833065|469638296|FG004|Overall Study|Subject's substantial non-compliance|0|||
130457277|NCT01833065|469638292|FG000|Overall Study|Trial terminated by sponsor|8|||
130457278|NCT01833065|469638293|FG001|Overall Study|Trial terminated by sponsor|8|||
130457279|NCT01833065|469638294|FG002|Overall Study|Trial terminated by sponsor|7|||
130457280|NCT01833065|469638295|FG003|Overall Study|Trial terminated by sponsor|3|||
130457281|NCT01833065|469638296|FG004|Overall Study|Trial terminated by sponsor|13|||
130457282|NCT01833065|469638292|FG000|Overall Study|Others|2|||
130457283|NCT01833065|469638293|FG001|Overall Study|Others|1|||
130457284|NCT01833065|469638294|FG002|Overall Study|Others|1|||
130457285|NCT01833065|469638295|FG003|Overall Study|Others|1|||
130457286|NCT01833065|469638296|FG004|Overall Study|Others|4|||
130457287|NCT03201809|469638300|FG000|Overall Study|Lost to Follow-up|2|||
130457288|NCT03201809|469638301|FG001|Overall Study|Lost to Follow-up|0|||
130457289|NCT00864682|469638303|FG000|Overall Study|Protocol Violation|2|||
130457290|NCT00864682|469638304|FG001|Overall Study|Protocol Violation|1|||
130457291|NCT00864682|469638305|FG002|Overall Study|Protocol Violation|2|||
130457292|NCT00957658|469638306|FG000|Overall Study|Death|1|||
130457293|NCT00957658|469638306|FG000|Overall Study|Lost to Follow-up|4|||
130457294|NCT00957658|469638306|FG000|Overall Study|Withdrawal by Subject|12|||
130457295|NCT00957658|469638306|FG000|Overall Study|Revision|1|||
130457296|NCT00957658|469638306|FG000|Overall Study|Incomplete 2 yr data|28|||
130457297|NCT00957658|469638306|FG000|Overall Study|Site termination|10|||
130457298|NCT00957658|469638306|FG000|Overall Study|unwilling/unable to return|2|||
130457299|NCT00957658|469638306|FG000|Overall Study|surgery cancelled|2|||
130457300|NCT00957658|469638306|FG000|Overall Study|Protocol Violation|5|||
130457301|NCT00975806|469638307|FG000|Overall Study|Adverse Event|2|||
130457302|NCT00975806|469638308|FG001|Overall Study|Adverse Event|1|||
130457303|NCT00975806|469638309|FG002|Overall Study|Adverse Event|2|||
130457304|NCT00975806|469638307|FG000|Overall Study|Disease Progression|1|||
130457305|NCT00975806|469638308|FG001|Overall Study|Disease Progression|5|||
130457306|NCT00975806|469638309|FG002|Overall Study|Disease Progression|1|||
130457307|NCT00975806|469638307|FG000|Overall Study|Withdrawal by Subject|1|||
130457308|NCT00975806|469638308|FG001|Overall Study|Withdrawal by Subject|0|||
130457309|NCT00975806|469638309|FG002|Overall Study|Withdrawal by Subject|0|||
130457310|NCT00975806|469638307|FG000|Overall Study|Death|0|||
130457311|NCT00975806|469638308|FG001|Overall Study|Death|1|||
130457312|NCT00975806|469638309|FG002|Overall Study|Death|0|||
130457313|NCT00975806|469638307|FG000|Overall Study|Physician decision and disease related|1|||
130457314|NCT00975806|469638308|FG001|Overall Study|Physician decision and disease related|0|||
130555291|NCT00992511|470001529|FG000|Overall Study|Withdrawal by Subject|0|||
130555292|NCT00992511|470001530|FG001|Overall Study|Withdrawal by Subject|0|||
130555293|NCT00992511|470001531|FG002|Overall Study|Withdrawal by Subject|1|||
130555294|NCT00992511|470001532|FG003|Overall Study|Withdrawal by Subject|1|||
130555295|NCT04498169|470001533|FG000|Study Completion|Adverse Event|1|||
130555296|NCT04498169|470001534|FG001|Study Completion|Adverse Event|1|||
130555297|NCT04615247|470001535|FG000|Overall Study|Adverse Event|0|||
130555298|NCT04615247|470001536|FG001|Overall Study|Adverse Event|2|||
130555299|NCT04615247|470001535|FG000|Overall Study|Withdrawal by Subject|1|||
130710115|NCT02791893|470564771|FG001|Blinded Phase|Withdrawal by Subject|2|||
130710116|NCT02791893|470564770|FG000|Open Label Phase|Lost to Follow-up|3|||
130710117|NCT02791893|470564771|FG001|Open Label Phase|Lost to Follow-up|0|||
130710118|NCT02791893|470564770|FG000|Open Label Phase|Withdrawal by Subject|0|||
130710119|NCT02791893|470564771|FG001|Open Label Phase|Withdrawal by Subject|2|||
130710120|NCT03438396|470564772|FG000|Overall Study|Reason Not Specified|9|||
130710121|NCT03438396|470564772|FG000|Overall Study|Withdrawal by Subject|5|||
130710122|NCT03438396|470564772|FG000|Overall Study|Lost to Follow-up|2|||
130710123|NCT03438396|470564772|FG000|Overall Study|Death|85|||
130710124|NCT03438396|470564772|FG000|Overall Study|Not treated|1|||
130710125|NCT02017860|470564775|FG000|Overall Study|Adverse Event|1|||
130710126|NCT02017860|470564775|FG000|Overall Study|Withdrawal by Subject|1|||
130710127|NCT02488330|470564776|FG000|Overall Study|Adverse Event|1|||
130710128|NCT02488330|470564776|FG000|Overall Study|Physician Decision|2|||
130457315|NCT00975806|469638309|FG002|Overall Study|Physician decision and disease related|1|||
130457316|NCT00246012|469638310|FG000|Overall Study|Adverse Event|0|||
130457317|NCT00246012|469638311|FG001|Overall Study|Adverse Event|0|||
130710129|NCT02488330|470564776|FG000|Overall Study|Death|2|||
130457318|NCT00246012|469638312|FG002|Overall Study|Adverse Event|0|||
130457319|NCT00246012|469638313|FG003|Overall Study|Adverse Event|0|||
130457320|NCT00246012|469638314|FG004|Overall Study|Adverse Event|0|||
130457321|NCT00246012|469638315|FG005|Overall Study|Adverse Event|1|||
130457322|NCT00246012|469638316|FG006|Overall Study|Adverse Event|0|||
130457323|NCT00246012|469638317|FG007|Overall Study|Adverse Event|0|||
130457324|NCT00246012|469638318|FG008|Overall Study|Adverse Event|2|||
130457325|NCT00246012|469638310|FG000|Overall Study|Withdrawal by Subject|0|||
130555300|NCT04615247|470001536|FG001|Overall Study|Withdrawal by Subject|1|||
130555301|NCT01383161|470001541|FG000|Overall Study|Adverse Event|5|||
130710130|NCT02488330|470564776|FG000|Overall Study|Disease Progression|3|||
130710131|NCT02488330|470564776|FG000|Overall Study|Study Termination by Sponsor|4|||
130710132|NCT01206816|470564780|FG000|Overall Study|Protocol Violation|0|||
130710133|NCT01206816|470564781|FG001|Overall Study|Protocol Violation|0|||
130710134|NCT01206816|470564782|FG002|Overall Study|Protocol Violation|1|||
130710135|NCT01206816|470564783|FG003|Overall Study|Protocol Violation|0|||
130710136|NCT01206816|470564784|FG004|Overall Study|Protocol Violation|0|||
130710137|NCT01206816|470564785|FG005|Overall Study|Protocol Violation|0|||
130710138|NCT01206816|470564786|FG006|Overall Study|Protocol Violation|0|||
130710139|NCT01206816|470564780|FG000|Overall Study|Withdrawal by Subject|0|||
130710140|NCT01206816|470564781|FG001|Overall Study|Withdrawal by Subject|0|||
130710141|NCT01206816|470564782|FG002|Overall Study|Withdrawal by Subject|1|||
130710142|NCT01206816|470564783|FG003|Overall Study|Withdrawal by Subject|0|||
130710143|NCT01206816|470564784|FG004|Overall Study|Withdrawal by Subject|0|||
130710144|NCT01206816|470564785|FG005|Overall Study|Withdrawal by Subject|0|||
130710145|NCT01206816|470564786|FG006|Overall Study|Withdrawal by Subject|0|||
130710146|NCT01206816|470564780|FG000|Overall Study|Progressive disease|3|||
130710147|NCT01206816|470564781|FG001|Overall Study|Progressive disease|3|||
130710148|NCT01206816|470564782|FG002|Overall Study|Progressive disease|13|||
130710149|NCT01206816|470564783|FG003|Overall Study|Progressive disease|3|||
130710150|NCT01206816|470564784|FG004|Overall Study|Progressive disease|3|||
130710151|NCT01206816|470564785|FG005|Overall Study|Progressive disease|16|||
130710152|NCT01206816|470564786|FG006|Overall Study|Progressive disease|3|||
130710153|NCT01206816|470564780|FG000|Overall Study|Other AE|0|||
130710154|NCT01206816|470564781|FG001|Overall Study|Other AE|0|||
130710155|NCT01206816|470564782|FG002|Overall Study|Other AE|4|||
130710156|NCT01206816|470564783|FG003|Overall Study|Other AE|0|||
130710157|NCT01206816|470564784|FG004|Overall Study|Other AE|0|||
130710158|NCT01206816|470564785|FG005|Overall Study|Other AE|3|||
130710159|NCT01206816|470564786|FG006|Overall Study|Other AE|2|||
130710160|NCT01206816|470564780|FG000|Overall Study|other than stated above|0|||
130710161|NCT01206816|470564781|FG001|Overall Study|other than stated above|0|||
130710162|NCT01206816|470564782|FG002|Overall Study|other than stated above|1|||
130710163|NCT01206816|470564783|FG003|Overall Study|other than stated above|0|||
130710164|NCT01206816|470564784|FG004|Overall Study|other than stated above|0|||
130710165|NCT01206816|470564785|FG005|Overall Study|other than stated above|0|||
130710166|NCT01206816|470564786|FG006|Overall Study|other than stated above|1|||
130710167|NCT02384941|470564789|FG000|Overall Study|Adverse Event|11|||
130710168|NCT02384941|470564790|FG001|Overall Study|Adverse Event|13|||
130710169|NCT02384941|470564791|FG002|Overall Study|Adverse Event|17|||
130367728|NCT03094169|469317290|FG002|Overall Study|Lack of Efficacy|0|||
130367729|NCT03094169|469317291|FG003|Overall Study|Lack of Efficacy|0|||
130367730|NCT03094169|469317292|FG004|Overall Study|Lack of Efficacy|0|||
130367731|NCT03094169|469317293|FG005|Overall Study|Lack of Efficacy|0|||
130367732|NCT03094169|469317294|FG006|Overall Study|Lack of Efficacy|0|||
130367733|NCT03094169|469317295|FG007|Overall Study|Lack of Efficacy|21|||
130367734|NCT03094169|469317288|FG000|Overall Study|Adverse Event|0|||
130367735|NCT03094169|469317289|FG001|Overall Study|Adverse Event|0|||
130367736|NCT03094169|469317290|FG002|Overall Study|Adverse Event|0|||
130457326|NCT00246012|469638311|FG001|Overall Study|Withdrawal by Subject|0|||
130710170|NCT02384941|470564789|FG000|Overall Study|Lost to Follow-up|3|||
130710171|NCT02384941|470564790|FG001|Overall Study|Lost to Follow-up|2|||
130710172|NCT02384941|470564791|FG002|Overall Study|Lost to Follow-up|1|||
130710173|NCT02384941|470564789|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130710174|NCT02384941|470564790|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130710175|NCT02384941|470564791|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130710176|NCT02384941|470564789|FG000|Overall Study|Physician Decision|1|||
130710177|NCT02384941|470564790|FG001|Overall Study|Physician Decision|1|||
130710178|NCT02384941|470564791|FG002|Overall Study|Physician Decision|0|||
130710179|NCT02384941|470564789|FG000|Overall Study|Protocol Violation|3|||
130710180|NCT02384941|470564790|FG001|Overall Study|Protocol Violation|0|||
130710181|NCT02384941|470564791|FG002|Overall Study|Protocol Violation|0|||
130710182|NCT02384941|470564789|FG000|Overall Study|Withdrawal by Subject|26|||
130710183|NCT02384941|470564790|FG001|Overall Study|Withdrawal by Subject|19|||
130710184|NCT02384941|470564791|FG002|Overall Study|Withdrawal by Subject|20|||
130457327|NCT00246012|469638312|FG002|Overall Study|Withdrawal by Subject|0|||
130367737|NCT03094169|469317291|FG003|Overall Study|Adverse Event|0|||
130367738|NCT03094169|469317292|FG004|Overall Study|Adverse Event|0|||
130367739|NCT03094169|469317293|FG005|Overall Study|Adverse Event|0|||
130710185|NCT02384941|470564789|FG000|Overall Study|Pregnancy|0|||
130710186|NCT02384941|470564790|FG001|Overall Study|Pregnancy|0|||
130367740|NCT03094169|469317294|FG006|Overall Study|Adverse Event|0|||
130367741|NCT03094169|469317295|FG007|Overall Study|Adverse Event|2|||
130367742|NCT03094169|469317288|FG000|Overall Study|Withdrawal by Subject|0|||
130367743|NCT03094169|469317289|FG001|Overall Study|Withdrawal by Subject|0|||
130710187|NCT02384941|470564791|FG002|Overall Study|Pregnancy|1|||
130710188|NCT02384941|470564789|FG000|Overall Study|Other than specified above|4|||
130710189|NCT02384941|470564790|FG001|Overall Study|Other than specified above|0|||
130710190|NCT02384941|470564791|FG002|Overall Study|Other than specified above|1|||
130710191|NCT02493777|470564792|FG000|Overall Study|Lost to Follow-up|0|||
130710192|NCT02493777|470564793|FG001|Overall Study|Lost to Follow-up|1|||
130710193|NCT01705236|470564794|FG000|Overall Study|Lost to Follow-up|1|||
130710194|NCT01705236|470564794|FG000|Overall Study|Administrative problems|2|||
130710195|NCT01705236|470564794|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130710196|NCT01705236|470564794|FG000|Overall Study|Protocol Violation|3|||
130710197|NCT01705236|470564794|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130555302|NCT01383161|470001542|FG001|Overall Study|Adverse Event|1|||
130555303|NCT01383161|470001541|FG000|Overall Study|Withdrawal by Subject|0|||
130555304|NCT01383161|470001542|FG001|Overall Study|Withdrawal by Subject|2|||
130555305|NCT01383161|470001541|FG000|Overall Study|Lack of Efficacy|0|||
130555306|NCT01383161|470001542|FG001|Overall Study|Lack of Efficacy|1|||
130555307|NCT03942406|470001549|FG000|Overall Study|Lost to Follow-up|4|||
130555308|NCT03942406|470001550|FG001|Overall Study|Lost to Follow-up|5|||
130555309|NCT03942406|470001551|FG002|Overall Study|Lost to Follow-up|3|||
130710198|NCT01705236|470564794|FG000|Overall Study|Abnormal laboratory value(s)|4|||
130710199|NCT01705236|470564794|FG000|Overall Study|Withdrawal by Subject|5|||
130710200|NCT01705236|470564794|FG000|Overall Study|Adverse Event|5|||
130710201|NCT02370914|470564795|FG000|Overall Study|Protocol Violation|2|||
130710202|NCT01341587|470564796|FG000|Overall Study|Lost to Follow-up|2|||
130710203|NCT01341587|470564797|FG001|Overall Study|Lost to Follow-up|0|||
130710204|NCT01341587|470564796|FG000|Overall Study|stopped using the meters|2|||
130710205|NCT01341587|470564797|FG001|Overall Study|stopped using the meters|10|||
130555310|NCT03942406|470001552|FG003|Overall Study|Lost to Follow-up|7|||
130555311|NCT03942406|470001553|FG004|Overall Study|Lost to Follow-up|1|||
130710206|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
130710207|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
130555312|NCT03942406|470001554|FG005|Overall Study|Lost to Follow-up|0|||
130555313|NCT03942406|470001555|FG006|Overall Study|Lost to Follow-up|0|||
130275735|NCT01814878|468974123|FG001|Overall Study|Screening failure (drop-out)|3|||
130275736|NCT01814878|468974122|FG000|Overall Study|Other|2|||
130275737|NCT01814878|468974123|FG001|Overall Study|Other|0|||
130275738|NCT03645421|468974124|FG000|Overall Study|Adverse Event|0|||
130275739|NCT03645421|468974125|FG001|Overall Study|Adverse Event|0|||
130275740|NCT03645421|468974126|FG002|Overall Study|Adverse Event|4|||
130275741|NCT03645421|468974127|FG003|Overall Study|Adverse Event|1|||
130275742|NCT03645421|468974124|FG000|Overall Study|Withdrawal by patient|0|||
130275743|NCT03645421|468974125|FG001|Overall Study|Withdrawal by patient|0|||
130275744|NCT03645421|468974126|FG002|Overall Study|Withdrawal by patient|0|||
130275745|NCT03645421|468974127|FG003|Overall Study|Withdrawal by patient|3|||
130275746|NCT03645421|468974124|FG000|Overall Study|Study specific withdrawal criteria|0|||
130275747|NCT03645421|468974125|FG001|Overall Study|Study specific withdrawal criteria|0|||
130275748|NCT03645421|468974126|FG002|Overall Study|Study specific withdrawal criteria|1|||
130275749|NCT03645421|468974127|FG003|Overall Study|Study specific withdrawal criteria|0|||
130710208|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
130710209|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
130710210|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
130710211|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
130710212|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
130710213|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
130710214|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130710215|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130710216|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130710217|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130710218|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710219|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710220|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710221|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710222|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130710223|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130710224|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130710225|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130710226|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
130710227|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
130710228|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130710229|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130710230|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
130710231|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
130710232|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130710233|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130710234|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Death|0|||
130710235|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Death|1|||
130710236|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Death|0|||
130710237|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Death|0|||
130710238|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710239|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
130710240|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710241|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710242|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710243|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
130710244|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710245|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710246|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Other|1|||
130710247|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Other|3|||
130710248|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Other|0|||
130710249|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Other|0|||
130710250|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
130710251|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
130710252|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
130710253|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
130275750|NCT00748618|468974130|FG000|Overall Study|Adverse Event|1|||
130275751|NCT00748618|468974131|FG001|Overall Study|Adverse Event|0|||
130275752|NCT02854436|468974135|FG000|Overall Study|Adverse Event|1|||
130275753|NCT02854436|468974135|FG000|Overall Study|Death|208|||
130275754|NCT02854436|468974135|FG000|Overall Study|Lost to Follow-up|5|||
130275755|NCT02854436|468974135|FG000|Overall Study|Withdrawal by Subject|24|||
130275756|NCT02854436|468974135|FG000|Overall Study|Other|45|||
130275757|NCT02854436|468974135|FG000|Overall Study|Physician Decision|6|||
130710254|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Death|1|||
130710255|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Death|0|||
130710256|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Death|0|||
130275758|NCT01977729|468974137|FG000|Overall Study|Study terminated|1|||
130275759|NCT01268046|468974138|FG000|Overall Study|Withdrawal by Subject|1|||
130275760|NCT01268046|468974139|FG001|Overall Study|Withdrawal by Subject|0|||
130275761|NCT01268046|468974140|FG002|Overall Study|Withdrawal by Subject|0|||
130275762|NCT01268046|468974141|FG003|Overall Study|Withdrawal by Subject|1|||
130275763|NCT01268046|468974138|FG000|Overall Study|Lost to Follow-up|0|||
130275764|NCT01268046|468974139|FG001|Overall Study|Lost to Follow-up|0|||
130275765|NCT01268046|468974140|FG002|Overall Study|Lost to Follow-up|1|||
130275766|NCT01268046|468974141|FG003|Overall Study|Lost to Follow-up|0|||
130275767|NCT02253433|468974142|FG000|Overall Study|Unable to Contact|9|||
130275768|NCT02253433|468974143|FG001|Overall Study|Unable to Contact|16|||
130275769|NCT02253433|468974142|FG000|Overall Study|Death|1|||
130275770|NCT02253433|468974143|FG001|Overall Study|Death|1|||
130275771|NCT02253433|468974142|FG000|Overall Study|No Longer Interested|3|||
130275772|NCT02253433|468974143|FG001|Overall Study|No Longer Interested|15|||
130275773|NCT02253433|468974142|FG000|Overall Study|Out of Study Area|2|||
130275774|NCT02253433|468974143|FG001|Overall Study|Out of Study Area|7|||
130275775|NCT02253433|468974142|FG000|Overall Study|Uncomfortable with home visitors|0|||
130275776|NCT02253433|468974143|FG001|Overall Study|Uncomfortable with home visitors|3|||
130275777|NCT02253433|468974142|FG000|Overall Study|Unstable Housing/Homeless|0|||
130275778|NCT02253433|468974143|FG001|Overall Study|Unstable Housing/Homeless|7|||
130275779|NCT02253433|468974142|FG000|Overall Study|Too Busy|0|||
130275780|NCT02253433|468974143|FG001|Overall Study|Too Busy|4|||
130275781|NCT02253433|468974142|FG000|Overall Study|Medical or Other Concerns|1|||
130275782|NCT02253433|468974143|FG001|Overall Study|Medical or Other Concerns|2|||
130275783|NCT02836717|468974146|FG000|Test Phase|Lack of Efficacy|14|||
130275784|NCT02836717|468974147|FG001|Test Phase|Lack of Efficacy|8|||
130275785|NCT02836717|468974148|FG002|Test Phase|Lack of Efficacy|0|||
130275786|NCT02836717|468974146|FG000|Study Phase|Adverse Event|2|||
130275787|NCT02836717|468974147|FG001|Study Phase|Adverse Event|0|||
130275788|NCT02836717|468974148|FG002|Study Phase|Adverse Event|0|||
130275789|NCT02836717|468974146|FG000|Study Phase|Lack of Efficacy|8|||
130275790|NCT02836717|468974147|FG001|Study Phase|Lack of Efficacy|6|||
130275791|NCT02836717|468974148|FG002|Study Phase|Lack of Efficacy|1|||
130275792|NCT02836717|468974146|FG000|Study Phase|Withdrawal by Subject|1|||
130275793|NCT02836717|468974147|FG001|Study Phase|Withdrawal by Subject|0|||
130275794|NCT02836717|468974148|FG002|Study Phase|Withdrawal by Subject|0|||
130275795|NCT02836717|468974146|FG000|Study Phase|Death|1|||
130275796|NCT02836717|468974147|FG001|Study Phase|Death|0|||
130275797|NCT02836717|468974148|FG002|Study Phase|Death|0|||
130275798|NCT02836717|468974146|FG000|Study Phase|abdominal surgeries|2|||
130275799|NCT02836717|468974147|FG001|Study Phase|abdominal surgeries|1|||
130275800|NCT02836717|468974148|FG002|Study Phase|abdominal surgeries|0|||
130275801|NCT00224120|468974149|FG000|Overall Study|Adverse Event|10|||
130275802|NCT00224120|468974150|FG001|Overall Study|Adverse Event|4|||
130275803|NCT00224120|468974149|FG000|Overall Study|Protocol Violation|1|||
130275804|NCT00224120|468974150|FG001|Overall Study|Protocol Violation|0|||
130275805|NCT00224120|468974149|FG000|Overall Study|Withdrawal by Subject|5|||
130275806|NCT00224120|468974150|FG001|Overall Study|Withdrawal by Subject|10|||
130275807|NCT00224120|468974149|FG000|Overall Study|Lack of Efficacy|0|||
130275808|NCT00224120|468974150|FG001|Overall Study|Lack of Efficacy|2|||
130275809|NCT00224120|468974149|FG000|Overall Study|Lost to Follow-up|2|||
130275810|NCT00224120|468974150|FG001|Overall Study|Lost to Follow-up|3|||
130275811|NCT00224120|468974149|FG000|Overall Study|Other|4|||
130275812|NCT00224120|468974150|FG001|Overall Study|Other|5|||
130275813|NCT00438360|468974151|FG000|Overall Study|Adverse Event|6|||
130710257|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Death|0|||
130710258|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
130710259|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
130710260|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
130710261|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
130710262|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130275814|NCT00438360|468974152|FG001|Overall Study|Adverse Event|1|||
130275815|NCT00438360|468974151|FG000|Overall Study|Lack of Efficacy|42|||
130275816|NCT00438360|468974152|FG001|Overall Study|Lack of Efficacy|27|||
130275817|NCT00438360|468974151|FG000|Overall Study|Other|24|||
130275818|NCT00438360|468974152|FG001|Overall Study|Other|15|||
130275819|NCT00282087|468974153|FG000|Overall Study|Death|1|||
130457328|NCT00246012|469638313|FG003|Overall Study|Withdrawal by Subject|0|||
130710263|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130275820|NCT01147250|468974158|FG000|Overall Study|Lost to Follow-up|14|||
130275821|NCT01147250|468974159|FG001|Overall Study|Lost to Follow-up|11|||
130275822|NCT01147250|468974158|FG000|Overall Study|Withdrawal by Subject|83|||
130275823|NCT01147250|468974159|FG001|Overall Study|Withdrawal by Subject|88|||
130710264|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130275824|NCT01147250|468974158|FG000|Overall Study|Site termination by sponsor|13|||
130275825|NCT01147250|468974159|FG001|Overall Study|Site termination by sponsor|5|||
130275826|NCT01147250|468974158|FG000|Overall Study|Other than specified|0|||
130275827|NCT01147250|468974159|FG001|Overall Study|Other than specified|1|||
130275828|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130710265|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130710266|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130710267|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
130275829|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
130275830|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275831|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275832|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275833|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275834|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
130275835|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
130275836|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275837|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275838|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275839|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275840|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130275841|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130275842|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275843|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275844|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275845|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275846|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
130275847|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
130275848|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275849|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275850|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275851|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275852|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275853|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
130275854|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275855|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275856|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275857|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275858|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
130275859|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
130275860|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275861|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275862|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275863|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275864|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275865|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
130275866|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275867|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275868|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275869|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275870|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275871|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
130275872|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275873|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275874|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275875|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275876|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130275877|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130275878|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130275879|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130275880|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
130275881|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130275882|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130275883|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130275884|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275885|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130710268|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130710269|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130710270|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
130710271|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130710272|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130710273|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
130710274|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710275|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710276|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
130710277|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
130275886|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275887|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275888|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130275889|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130275890|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
130275891|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
130275892|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
130275893|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
130275894|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275895|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275896|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275897|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275898|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275899|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275900|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275901|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275902|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130275903|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275904|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130275905|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275906|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130275907|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130275908|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130275909|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130275910|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130275911|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130275912|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130275913|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130275914|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
130275915|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
130275916|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
130275917|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
130275918|NCT00338286|468974168|FG000|Overall Study|Withdrawal by Subject|50|||
130275919|NCT00338286|468974169|FG001|Overall Study|Withdrawal by Subject|54|||
130275920|NCT00338286|468974168|FG000|Overall Study|Lost to Follow-up|80|||
130275921|NCT00338286|468974169|FG001|Overall Study|Lost to Follow-up|66|||
130275922|NCT00338286|468974168|FG000|Overall Study|Other|103|||
130275923|NCT00338286|468974169|FG001|Overall Study|Other|93|||
130275924|NCT00022763|468974173|FG000|Overall Study|Adverse Event|1|||
130275925|NCT00022763|468974174|FG001|Overall Study|Adverse Event|2|||
130275926|NCT00022763|468974173|FG000|Overall Study|Injection Site Reactions|0|||
130275927|NCT00022763|468974174|FG001|Overall Study|Injection Site Reactions|2|||
130275928|NCT00022763|468974173|FG000|Overall Study|Death|0|||
130275929|NCT00022763|468974174|FG001|Overall Study|Death|1|||
130275930|NCT00022763|468974173|FG000|Overall Study|Lost to Follow-up|0|||
130275931|NCT00022763|468974174|FG001|Overall Study|Lost to Follow-up|3|||
130710278|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130710279|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
130710280|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130275932|NCT00022763|468974173|FG000|Overall Study|Withdrawal by Subject|4|||
130275933|NCT00022763|468974174|FG001|Overall Study|Withdrawal by Subject|7|||
130275934|NCT00022763|468974173|FG000|Overall Study|Insufficient Therapy|1|||
130275935|NCT00022763|468974174|FG001|Overall Study|Insufficient Therapy|0|||
130275936|NCT00022763|468974173|FG000|Overall Study|Admin|3|||
130275937|NCT00022763|468974174|FG001|Overall Study|Admin|2|||
130275938|NCT00716482|468974175|FG000|Overall Study|Lost to Follow-up|6|||
130710281|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
130710282|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
130710283|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
130710284|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
130710285|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
130710286|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
130710287|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
130710288|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
130710289|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
130710290|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
130710291|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
130710292|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
130710293|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
130710294|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Other|3|||
130710295|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Other|0|||
130710296|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Other|4|||
130275939|NCT00716482|468974175|FG000|Overall Study|Inadequate acquisition or analysis|50|||
130275940|NCT00716482|468974175|FG000|Overall Study|no pathology obtained|10|||
130275941|NCT00716482|468974175|FG000|Overall Study|technical/machine error|28|||
130275942|NCT00716482|468974175|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
130275943|NCT03248531|468974176|FG000|Overall Study|Adverse Event|0|||
130275944|NCT03248531|468974177|FG001|Overall Study|Adverse Event|0|||
130275945|NCT03248531|468974178|FG002|Overall Study|Adverse Event|1|||
130275946|NCT03248531|468974176|FG000|Overall Study|Lost to Follow-up|1|||
130275947|NCT03248531|468974177|FG001|Overall Study|Lost to Follow-up|0|||
130275948|NCT03248531|468974178|FG002|Overall Study|Lost to Follow-up|5|||
130275949|NCT03248531|468974176|FG000|Overall Study|Withdrawal by Subject|3|||
130275950|NCT03248531|468974177|FG001|Overall Study|Withdrawal by Subject|3|||
130275951|NCT03248531|468974178|FG002|Overall Study|Withdrawal by Subject|2|||
130275952|NCT03248531|468974176|FG000|Overall Study|Sponsor Request|0|||
130275953|NCT03248531|468974177|FG001|Overall Study|Sponsor Request|2|||
130275954|NCT03248531|468974178|FG002|Overall Study|Sponsor Request|0|||
130275955|NCT04075513|468974179|FG000|Overall Study|Withdrawal by Subject|2|||
130275956|NCT04075513|468974180|FG001|Overall Study|Withdrawal by Subject|2|||
130275957|NCT04075513|468974179|FG000|Overall Study|Lack of Efficacy|1|||
130275958|NCT04075513|468974180|FG001|Overall Study|Lack of Efficacy|0|||
130275959|NCT04075513|468974179|FG000|Overall Study|Lost to Follow-up|4|||
130275960|NCT04075513|468974180|FG001|Overall Study|Lost to Follow-up|2|||
130275961|NCT04075513|468974179|FG000|Overall Study|Switch to insulin pump|1|||
130275962|NCT04075513|468974180|FG001|Overall Study|Switch to insulin pump|0|||
130275963|NCT03748706|468974182|FG000|Overall Study|Lost to Follow-up|1|||
130275964|NCT04153981|468974185|FG000|Overall Study|Death|1|||
130275965|NCT04153981|468974185|FG000|Overall Study|Withdrawal by Subject|24|||
130275966|NCT04153981|468974185|FG000|Overall Study|Lost to Follow-up|1|||
130275967|NCT04153981|468974185|FG000|Overall Study|Physician Decision|1|||
130275968|NCT04153981|468974185|FG000|Overall Study|Due to Unavailable Glucometer|1|||
130275969|NCT04153981|468974185|FG000|Overall Study|Covid 19|52|||
130275970|NCT04153981|468974185|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
130275971|NCT04153981|468974185|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
130275972|NCT01355679|468974186|FG000|Overall Study|benign tumor types found at biopsy|2|||
130275973|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
130275974|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
130457329|NCT00246012|469638314|FG004|Overall Study|Withdrawal by Subject|0|||
130710297|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Other|1|||
130710298|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710299|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710300|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710301|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
130710302|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
130710303|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
130710304|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
130710305|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
130710306|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130710307|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
130710308|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130275975|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
130275976|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
130275977|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
130275978|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
130275979|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
130275980|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
130275981|NCT03490292|468974187|FG000|1 Year Follow Up Post Last Dose|Death|1|||
130275982|NCT03490292|468974188|FG001|1 Year Follow Up Post Last Dose|Death|1|||
130275983|NCT00964002|468974189|FG000|Overall Study|Protocol Violation|8|||
130275984|NCT00904670|468974190|FG000|Open Label Phase|Withdrawal by Subject|2|||
130275985|NCT00904670|468974191|FG001|Open Label Phase|Withdrawal by Subject|0|||
130275986|NCT00904670|468974190|FG000|Open Label Phase|Adverse Event|2|||
130275987|NCT00904670|468974191|FG001|Open Label Phase|Adverse Event|0|||
130275988|NCT00904670|468974190|FG000|Open Label Phase|Lack of Efficacy|1|||
130275989|NCT00904670|468974191|FG001|Open Label Phase|Lack of Efficacy|0|||
130275990|NCT00904670|468974190|FG000|Open Label Phase|Lost to Follow-up|1|||
130275991|NCT00904670|468974191|FG001|Open Label Phase|Lost to Follow-up|0|||
130275992|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
130275993|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
130275994|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
130275995|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
130275996|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Death|58|||
130275997|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Death|65|||
130275998|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Adverse Event|28|||
130275999|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Adverse Event|40|||
130276000|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Disease Progression|22|||
130276001|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Disease Progression|35|||
130276002|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Other|25|||
130276003|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Other|33|||
130276004|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
130276005|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
130276006|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Noncompliance|8|||
130276007|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Noncompliance|8|||
130276008|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
130276009|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
130276010|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
130276011|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
130276012|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
130276013|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
130276014|NCT00286091|468974192|FG000|Open-label Treatment Phase|Physician Decision|24|||
130276015|NCT00286091|468974193|FG001|Open-label Treatment Phase|Physician Decision|21|||
130276016|NCT00286091|468974192|FG000|Open-label Treatment Phase|Adverse Event|5|||
130276017|NCT00286091|468974193|FG001|Open-label Treatment Phase|Adverse Event|16|||
130276018|NCT00286091|468974192|FG000|Open-label Treatment Phase|Other|11|||
130276019|NCT00286091|468974193|FG001|Open-label Treatment Phase|Other|11|||
130276020|NCT00286091|468974192|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
130276021|NCT00286091|468974193|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
130276022|NCT00286091|468974192|FG000|Open-label Treatment Phase|Death|10|||
130276023|NCT00286091|468974193|FG001|Open-label Treatment Phase|Death|7|||
130276024|NCT00286091|468974192|FG000|Open-label Treatment Phase|Disease Progression|9|||
130276025|NCT00286091|468974193|FG001|Open-label Treatment Phase|Disease Progression|3|||
130276026|NCT00286091|468974192|FG000|Open-label Treatment Phase|Noncompliance|3|||
130276027|NCT00286091|468974193|FG001|Open-label Treatment Phase|Noncompliance|1|||
130276028|NCT00286091|468974192|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130276029|NCT00286091|468974193|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
130276030|NCT00286091|468974192|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
130276031|NCT00286091|468974193|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
130276032|NCT00286091|468974192|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
130276033|NCT00286091|468974193|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
130276034|NCT04004221|468974194|FG000|Overall Study|Death|89|||
130276035|NCT04004221|468974194|FG000|Overall Study|Withdrawal by Subject|5|||
130276036|NCT04004221|468974194|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
130276037|NCT04004221|468974194|FG000|Overall Study|Sponsor Decision|9|||
130276038|NCT04004221|468974194|FG000|Overall Study|Participant refused to enter LTE|1|||
130710309|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130276039|NCT02036580|468974195|FG000|Overall Study|Withdrawal by Subject|0|||
130276040|NCT02036580|468974196|FG001|Overall Study|Withdrawal by Subject|1|||
130276041|NCT02036580|468974197|FG002|Overall Study|Withdrawal by Subject|0|||
130276042|NCT02036580|468974195|FG000|Overall Study|Adverse Event|1|||
130276043|NCT02036580|468974196|FG001|Overall Study|Adverse Event|0|||
130457330|NCT00246012|469638315|FG005|Overall Study|Withdrawal by Subject|1|||
130720899|NCT01341782|470601558|FG001|Overall Study|Withdrawal by Subject|5|||
130276044|NCT02036580|468974197|FG002|Overall Study|Adverse Event|0|||
130276045|NCT00506454|468974198|FG000|Overall Study|Withdrawal by Subject|1|||
130276046|NCT00506454|468974199|FG001|Overall Study|Withdrawal by Subject|1|||
130457331|NCT00246012|469638316|FG006|Overall Study|Withdrawal by Subject|0|||
130457332|NCT00246012|469638317|FG007|Overall Study|Withdrawal by Subject|0|||
130457333|NCT00246012|469638318|FG008|Overall Study|Withdrawal by Subject|0|||
130457334|NCT00246012|469638310|FG000|Overall Study|Disease progression|3|||
130457335|NCT00246012|469638311|FG001|Overall Study|Disease progression|1|||
130457336|NCT00246012|469638312|FG002|Overall Study|Disease progression|2|||
130276047|NCT02584452|468974202|FG000|Overall Study|Physician Decision|1|||
130276048|NCT02584452|468974203|FG001|Overall Study|Physician Decision|1|||
130276049|NCT02584452|468974202|FG000|Overall Study|Lost to Follow-up|1|||
130276050|NCT02584452|468974203|FG001|Overall Study|Lost to Follow-up|1|||
130276051|NCT02689206|468974204|FG000|Overall Study|Adverse Event|0|||
130276052|NCT02689206|468974205|FG001|Overall Study|Adverse Event|0|||
130276053|NCT02689206|468974206|FG002|Overall Study|Adverse Event|1|||
130276054|NCT02689206|468974207|FG003|Overall Study|Adverse Event|0|||
130276055|NCT02689206|468974208|FG004|Overall Study|Adverse Event|2|||
130276056|NCT02689206|468974204|FG000|Overall Study|Protocol Violation|1|||
130276057|NCT02689206|468974205|FG001|Overall Study|Protocol Violation|0|||
130276058|NCT02689206|468974206|FG002|Overall Study|Protocol Violation|0|||
130276059|NCT02689206|468974207|FG003|Overall Study|Protocol Violation|1|||
130276060|NCT02689206|468974208|FG004|Overall Study|Protocol Violation|2|||
130276061|NCT02689206|468974204|FG000|Overall Study|Other: Reached stopping criteria|0|||
130276062|NCT02689206|468974205|FG001|Overall Study|Other: Reached stopping criteria|1|||
130276063|NCT02689206|468974206|FG002|Overall Study|Other: Reached stopping criteria|2|||
130276064|NCT02689206|468974207|FG003|Overall Study|Other: Reached stopping criteria|3|||
130276065|NCT02689206|468974208|FG004|Overall Study|Other: Reached stopping criteria|4|||
130276066|NCT02689206|468974204|FG000|Overall Study|Physician Decision|1|||
130276067|NCT02689206|468974205|FG001|Overall Study|Physician Decision|0|||
130276068|NCT02689206|468974206|FG002|Overall Study|Physician Decision|0|||
130276069|NCT02689206|468974207|FG003|Overall Study|Physician Decision|0|||
130276070|NCT02689206|468974208|FG004|Overall Study|Physician Decision|0|||
130276071|NCT02689206|468974204|FG000|Overall Study|Withdrawal by Subject|1|||
130276072|NCT02689206|468974205|FG001|Overall Study|Withdrawal by Subject|0|||
130276073|NCT02689206|468974206|FG002|Overall Study|Withdrawal by Subject|1|||
130276074|NCT02689206|468974207|FG003|Overall Study|Withdrawal by Subject|0|||
130276075|NCT02689206|468974208|FG004|Overall Study|Withdrawal by Subject|0|||
130276076|NCT01558596|468974211|FG000|Overall Study|Withdrawal by Subject|1|||
130276077|NCT01558596|468974212|FG001|Overall Study|Withdrawal by Subject|0|||
130276078|NCT01558596|468974211|FG000|Overall Study|surgery elsewhere or cancelled|1|||
130276079|NCT01558596|468974212|FG001|Overall Study|surgery elsewhere or cancelled|1|||
130276080|NCT01558596|468974211|FG000|Overall Study|Protocol Violation|1|||
130276081|NCT01558596|468974212|FG001|Overall Study|Protocol Violation|0|||
130276082|NCT01479764|468974214|FG000|Randomized|Adverse Event|1|||
130276083|NCT01479764|468974215|FG001|Randomized|Adverse Event|1|||
130276084|NCT01479764|468974214|FG000|Randomized|Withdrawal by Subject|1|||
130276085|NCT01479764|468974215|FG001|Randomized|Withdrawal by Subject|0|||
130276086|NCT01479764|468974214|FG000|Treated|Lost to Follow-up|0|||
130276087|NCT01479764|468974215|FG001|Treated|Lost to Follow-up|2|||
130276088|NCT00260832|468974217|FG000|Overall Study|Adverse Event|26|||
130276089|NCT00260832|468974218|FG001|Overall Study|Adverse Event|19|||
130276090|NCT00260832|468974217|FG000|Overall Study|Progression|116|||
130276091|NCT00260832|468974218|FG001|Overall Study|Progression|96|||
130276092|NCT00260832|468974217|FG000|Overall Study|Withdrawal by Subject|15|||
130276093|NCT00260832|468974218|FG001|Overall Study|Withdrawal by Subject|17|||
130276094|NCT00260832|468974217|FG000|Overall Study|Physician Decision|15|||
130276095|NCT00260832|468974218|FG001|Overall Study|Physician Decision|9|||
130276096|NCT00260832|468974217|FG000|Overall Study|Death|43|||
130276097|NCT00260832|468974218|FG001|Overall Study|Death|62|||
130276098|NCT00260832|468974217|FG000|Overall Study|Other|10|||
130276099|NCT00260832|468974218|FG001|Overall Study|Other|7|||
130276100|NCT00260832|468974217|FG000|Overall Study|Protocol Violation|3|||
130276101|NCT00260832|468974218|FG001|Overall Study|Protocol Violation|1|||
130276102|NCT03098433|468974221|FG000|Overall Study|Withdrawal by Subject|10|||
130276103|NCT01104545|468974222|FG000|Overall Study|Adverse Event|0|||
130276104|NCT01104545|468974223|FG001|Overall Study|Adverse Event|1|||
130276105|NCT01104545|468974224|FG002|Overall Study|Adverse Event|2|||
130276106|NCT03585764|468974227|FG000|Overall Study|Death|3|||
130276107|NCT03585764|468974228|FG001|Overall Study|Death|2|||
130276108|NCT03585764|468974229|FG002|Overall Study|Death|3|||
130457337|NCT00246012|469638313|FG003|Overall Study|Disease progression|3|||
130457338|NCT00246012|469638314|FG004|Overall Study|Disease progression|3|||
130457339|NCT00246012|469638315|FG005|Overall Study|Disease progression|25|||
130276109|NCT03585764|468974230|FG003|Overall Study|Death|0|||
130276110|NCT03585764|468974227|FG000|Overall Study|Lost to Follow-up|0|||
130276111|NCT03585764|468974228|FG001|Overall Study|Lost to Follow-up|1|||
130276112|NCT03585764|468974229|FG002|Overall Study|Lost to Follow-up|0|||
130276113|NCT03585764|468974230|FG003|Overall Study|Lost to Follow-up|0|||
130276114|NCT03585764|468974227|FG000|Overall Study|Physician Decision|0|||
130276115|NCT03585764|468974228|FG001|Overall Study|Physician Decision|0|||
130276116|NCT03585764|468974229|FG002|Overall Study|Physician Decision|2|||
130276117|NCT03585764|468974230|FG003|Overall Study|Physician Decision|0|||
130276118|NCT03640507|468974231|FG000|Overall Study|Withdrawal by Subject|0|||
130276119|NCT03640507|468974232|FG001|Overall Study|Withdrawal by Subject|0|||
130276120|NCT03640507|468974233|FG002|Overall Study|Withdrawal by Subject|1|||
130276121|NCT02993822|468974234|FG000|Overall Study|Lack of Efficacy|1|||
130276122|NCT02993822|468974235|FG001|Overall Study|Lack of Efficacy|1|||
130276123|NCT02993822|468974236|FG002|Overall Study|Lack of Efficacy|0|||
130276124|NCT02993822|468974237|FG003|Overall Study|Lack of Efficacy|0|||
130276125|NCT02993822|468974234|FG000|Overall Study|Protocol Violation|1|||
130276126|NCT02993822|468974235|FG001|Overall Study|Protocol Violation|0|||
130276127|NCT02993822|468974236|FG002|Overall Study|Protocol Violation|0|||
130276128|NCT02993822|468974237|FG003|Overall Study|Protocol Violation|0|||
130276129|NCT02993822|468974234|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
130276130|NCT02993822|468974235|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
130276131|NCT02993822|468974236|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
130276132|NCT02993822|468974237|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
130276133|NCT02993822|468974234|FG000|Overall Study|Adverse Event|3|||
130276134|NCT02993822|468974235|FG001|Overall Study|Adverse Event|1|||
130276135|NCT02993822|468974236|FG002|Overall Study|Adverse Event|7|||
130276136|NCT02993822|468974237|FG003|Overall Study|Adverse Event|0|||
130276137|NCT02993822|468974234|FG000|Overall Study|Withdrawal by Subject|4|||
130276138|NCT02993822|468974235|FG001|Overall Study|Withdrawal by Subject|2|||
130276139|NCT02993822|468974236|FG002|Overall Study|Withdrawal by Subject|2|||
130276140|NCT02993822|468974237|FG003|Overall Study|Withdrawal by Subject|3|||
130276141|NCT02993822|468974234|FG000|Overall Study|Lost to Follow-up|1|||
130276142|NCT02993822|468974235|FG001|Overall Study|Lost to Follow-up|0|||
130276143|NCT02993822|468974236|FG002|Overall Study|Lost to Follow-up|1|||
130276144|NCT02993822|468974237|FG003|Overall Study|Lost to Follow-up|0|||
130276145|NCT01221753|468974238|FG000|Overall Study|Adverse Event|1|||
130276146|NCT01939977|468974242|FG000|Overall Study|Adverse Event|4|||
130276147|NCT01939977|468974243|FG001|Overall Study|Adverse Event|3|||
130276148|NCT01939977|468974242|FG000|Overall Study|Lack of Efficacy|3|||
130276149|NCT01939977|468974243|FG001|Overall Study|Lack of Efficacy|0|||
130276150|NCT01939977|468974242|FG000|Overall Study|Physician Decision|1|||
130276151|NCT01939977|468974243|FG001|Overall Study|Physician Decision|1|||
130276152|NCT01939977|468974242|FG000|Overall Study|Withdrawal by Subject|0|||
130276153|NCT01939977|468974243|FG001|Overall Study|Withdrawal by Subject|2|||
130276154|NCT01939977|468974242|FG000|Overall Study|Did not meet inclusion criteria|1|||
130276155|NCT01939977|468974243|FG001|Overall Study|Did not meet inclusion criteria|0|||
130276156|NCT01939977|468974242|FG000|Overall Study|Did not receive study medication|0|||
130276157|NCT01939977|468974243|FG001|Overall Study|Did not receive study medication|1|||
130276158|NCT04552288|468974247|FG000|Overall Study|Death|3|||
130276159|NCT04552288|468974247|FG000|Overall Study|Lost to Follow-up|6|||
130276160|NCT04552288|468974247|FG000|Overall Study|Physician Decision|3|||
130276161|NCT04552288|468974247|FG000|Overall Study|Protocol Violation|9|||
130276162|NCT04552288|468974247|FG000|Overall Study|Withdrawal by Subject|6|||
130276163|NCT04552288|468974247|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
130276164|NCT05285644|468974248|FG000|Overall Study|Adverse Event|3|||
130276165|NCT05285644|468974249|FG001|Overall Study|Adverse Event|3|||
130276166|NCT05285644|468974248|FG000|Overall Study|Withdrawal of Consent|2|||
130276167|NCT05285644|468974249|FG001|Overall Study|Withdrawal of Consent|5|||
130276168|NCT05285644|468974248|FG000|Overall Study|Noncompliance|0|||
130276169|NCT05285644|468974249|FG001|Overall Study|Noncompliance|4|||
130276170|NCT05285644|468974248|FG000|Overall Study|Lost to Follow-up|4|||
130457340|NCT00246012|469638316|FG006|Overall Study|Disease progression|30|||
130457341|NCT00246012|469638317|FG007|Overall Study|Disease progression|27|||
130457342|NCT00246012|469638318|FG008|Overall Study|Disease progression|26|||
130457343|NCT00246012|469638310|FG000|Overall Study|Other|0|||
130457344|NCT00246012|469638311|FG001|Overall Study|Other|0|||
130710310|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710311|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130457345|NCT00246012|469638312|FG002|Overall Study|Other|0|||
130276171|NCT05285644|468974249|FG001|Overall Study|Lost to Follow-up|6|||
130276172|NCT05285644|468974248|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130276173|NCT05285644|468974249|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130276174|NCT05285644|468974248|FG000|Overall Study|Investigator Decision|2|||
130276175|NCT05285644|468974249|FG001|Overall Study|Investigator Decision|0|||
130276176|NCT05285644|468974248|FG000|Overall Study|Protocol Deviation|1|||
130276177|NCT05285644|468974249|FG001|Overall Study|Protocol Deviation|0|||
130276178|NCT05285644|468974248|FG000|Overall Study|As specified in the Clinical Study Report|7|||
130276179|NCT05285644|468974249|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130276180|NCT04532294|468974250|FG000|Overall Study|Withdrawal by Subject|0|||
130276181|NCT04532294|468974251|FG001|Overall Study|Withdrawal by Subject|0|||
130276182|NCT04532294|468974252|FG002|Overall Study|Withdrawal by Subject|1|||
130276183|NCT04532294|468974250|FG000|Overall Study|Participants Not Dosed|0|||
130457346|NCT00246012|469638313|FG003|Overall Study|Other|0|||
130457347|NCT00246012|469638314|FG004|Overall Study|Other|0|||
130276184|NCT04532294|468974251|FG001|Overall Study|Participants Not Dosed|0|||
130276185|NCT04532294|468974252|FG002|Overall Study|Participants Not Dosed|2|||
130276186|NCT04295759|468974253|FG000|Overall Study|Lack of Efficacy|9|||
130276187|NCT04295759|468974253|FG000|Overall Study|Death|1|||
130276188|NCT04295759|468974253|FG000|Overall Study|Withdrawal by Subject|2|||
130276189|NCT04295759|468974253|FG000|Overall Study|Deemed ineligible|1|||
130276190|NCT01696981|468974254|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
130276191|NCT01696981|468974255|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
130276192|NCT01696981|468974254|FG000|Overall Study|Died Before Randomization|3|||
130276193|NCT01696981|468974255|FG001|Overall Study|Died Before Randomization|8|||
130276194|NCT01696981|468974254|FG000|Overall Study|Died Before ASU (Control)|278|||
130276195|NCT01696981|468974255|FG001|Overall Study|Died Before ASU (Control)|0|||
130276196|NCT01696981|468974254|FG000|Overall Study|Refused ASU (Control)|920|||
130276197|NCT01696981|468974255|FG001|Overall Study|Refused ASU (Control)|0|||
130276198|NCT01696981|468974254|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
130276199|NCT01696981|468974255|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
130276200|NCT02798315|468974256|FG000|Overall Study|Failure to return|1|||
130276201|NCT03335150|468974258|FG000|Overall Study|Withdrawal by Subject|10|||
130276202|NCT03335150|468974259|FG001|Overall Study|Withdrawal by Subject|4|||
130276203|NCT03335150|468974258|FG000|Overall Study|Adverse Event|0|||
130276204|NCT03335150|468974259|FG001|Overall Study|Adverse Event|1|||
130276205|NCT02097719|468974260|FG000|Overall Study|Subject Withdrew Consent|1|||
130276206|NCT02097719|468974261|FG001|Overall Study|Subject Withdrew Consent|0|||
130276207|NCT02097719|468974260|FG000|Overall Study|Lost to Follow-up|0|||
130276208|NCT02097719|468974261|FG001|Overall Study|Lost to Follow-up|1|||
130276209|NCT02097719|468974260|FG000|Overall Study|Adverse Event|2|||
130276210|NCT02097719|468974261|FG001|Overall Study|Adverse Event|0|||
130276211|NCT04601532|468974262|FG000|Overall Study|Lost to Follow-up|1|||
130276212|NCT04601532|468974263|FG001|Overall Study|Lost to Follow-up|2|||
130276213|NCT04601532|468974262|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
130276214|NCT04601532|468974263|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
130276215|NCT03823287|468974264|FG000|Overall Study|Withdrawal by Subject|25|||
130276216|NCT03823287|468974265|FG001|Overall Study|Withdrawal by Subject|17|||
130276217|NCT03823287|468974264|FG000|Overall Study|Death|13|||
130276218|NCT03823287|468974265|FG001|Overall Study|Death|7|||
130276219|NCT03823287|468974264|FG000|Overall Study|Lost to Follow-up|7|||
130276220|NCT03823287|468974265|FG001|Overall Study|Lost to Follow-up|8|||
130276221|NCT03823287|468974264|FG000|Overall Study|Adverse Event|6|||
130276222|NCT03823287|468974265|FG001|Overall Study|Adverse Event|8|||
130276223|NCT03823287|468974264|FG000|Overall Study|Physician Decision|5|||
130276224|NCT03823287|468974265|FG001|Overall Study|Physician Decision|2|||
130276225|NCT03823287|468974264|FG000|Overall Study|Lack of Efficacy|2|||
130276226|NCT03823287|468974265|FG001|Overall Study|Lack of Efficacy|0|||
130276227|NCT03823287|468974264|FG000|Overall Study|Other|2|||
130276228|NCT03823287|468974265|FG001|Overall Study|Other|4|||
130276229|NCT02744612|468976194|FG000|Overall Study|Withdrawal by Subject|0|||
130276230|NCT02744612|468976195|FG001|Overall Study|Withdrawal by Subject|2|||
130276231|NCT02712983|468976197|FG000|Treatment Phase|Adverse Event|3|||
130276232|NCT02712983|468976198|FG001|Treatment Phase|Adverse Event|1|||
130276233|NCT02712983|468976199|FG002|Treatment Phase|Adverse Event|1|||
130276234|NCT02712983|468976200|FG003|Treatment Phase|Adverse Event|4|||
130276235|NCT02712983|468976201|FG004|Treatment Phase|Adverse Event|3|||
130276236|NCT02712983|468976202|FG005|Treatment Phase|Adverse Event|0|||
130276237|NCT02712983|468976203|FG006|Treatment Phase|Adverse Event|6|||
130367744|NCT03094169|469317290|FG002|Overall Study|Withdrawal by Subject|0|||
130367745|NCT03094169|469317291|FG003|Overall Study|Withdrawal by Subject|0|||
130367746|NCT03094169|469317292|FG004|Overall Study|Withdrawal by Subject|0|||
130367747|NCT03094169|469317293|FG005|Overall Study|Withdrawal by Subject|0|||
130367748|NCT03094169|469317294|FG006|Overall Study|Withdrawal by Subject|1|||
130367749|NCT03094169|469317295|FG007|Overall Study|Withdrawal by Subject|1|||
130367750|NCT03094169|469317288|FG000|Overall Study|Trial Termination|0|||
130367751|NCT03094169|469317289|FG001|Overall Study|Trial Termination|0|||
130367752|NCT03094169|469317290|FG002|Overall Study|Trial Termination|0|||
130367753|NCT03094169|469317291|FG003|Overall Study|Trial Termination|0|||
130367754|NCT03094169|469317292|FG004|Overall Study|Trial Termination|0|||
130367755|NCT03094169|469317293|FG005|Overall Study|Trial Termination|0|||
130276238|NCT02712983|468976204|FG007|Treatment Phase|Adverse Event|6|||
130276239|NCT02712983|468976205|FG008|Treatment Phase|Adverse Event|1|||
130276240|NCT02712983|468976197|FG000|Treatment Phase|Protocol Deviation|0|||
130276241|NCT02712983|468976198|FG001|Treatment Phase|Protocol Deviation|0|||
130276242|NCT02712983|468976199|FG002|Treatment Phase|Protocol Deviation|0|||
130276243|NCT02712983|468976200|FG003|Treatment Phase|Protocol Deviation|2|||
130276244|NCT02712983|468976201|FG004|Treatment Phase|Protocol Deviation|0|||
130276245|NCT02712983|468976202|FG005|Treatment Phase|Protocol Deviation|0|||
130276246|NCT02712983|468976203|FG006|Treatment Phase|Protocol Deviation|1|||
130276247|NCT02712983|468976204|FG007|Treatment Phase|Protocol Deviation|0|||
130276248|NCT02712983|468976205|FG008|Treatment Phase|Protocol Deviation|0|||
130457348|NCT00246012|469638315|FG005|Overall Study|Other|0|||
130457349|NCT00246012|469638316|FG006|Overall Study|Other|0|||
130457350|NCT00246012|469638317|FG007|Overall Study|Other|1|||
130457351|NCT00246012|469638318|FG008|Overall Study|Other|0|||
130457352|NCT00246012|469638310|FG000|Overall Study|Randomly assigned but not treated|0|||
130276249|NCT02712983|468976197|FG000|Treatment Phase|Technical Problems|0|||
130276250|NCT02712983|468976198|FG001|Treatment Phase|Technical Problems|0|||
130276251|NCT02712983|468976199|FG002|Treatment Phase|Technical Problems|0|||
130457353|NCT00246012|469638311|FG001|Overall Study|Randomly assigned but not treated|0|||
130457354|NCT00246012|469638312|FG002|Overall Study|Randomly assigned but not treated|0|||
130457355|NCT00246012|469638313|FG003|Overall Study|Randomly assigned but not treated|0|||
130457356|NCT00246012|469638314|FG004|Overall Study|Randomly assigned but not treated|0|||
130457357|NCT00246012|469638315|FG005|Overall Study|Randomly assigned but not treated|1|||
130457358|NCT00246012|469638316|FG006|Overall Study|Randomly assigned but not treated|1|||
130457359|NCT00246012|469638317|FG007|Overall Study|Randomly assigned but not treated|0|||
130457360|NCT00246012|469638318|FG008|Overall Study|Randomly assigned but not treated|0|||
130457361|NCT00094809|469638319|FG000|Overall Study|Protocol deviation|2|||
130457362|NCT00094809|469638320|FG001|Overall Study|Protocol deviation|2|||
130276252|NCT02712983|468976200|FG003|Treatment Phase|Technical Problems|0|||
130276253|NCT02712983|468976201|FG004|Treatment Phase|Technical Problems|0|||
130276254|NCT02712983|468976202|FG005|Treatment Phase|Technical Problems|0|||
130276255|NCT02712983|468976203|FG006|Treatment Phase|Technical Problems|1|||
130276256|NCT02712983|468976204|FG007|Treatment Phase|Technical Problems|0|||
130276257|NCT02712983|468976205|FG008|Treatment Phase|Technical Problems|0|||
130276258|NCT02712983|468976197|FG000|Treatment Phase|Physician Decision|0|||
130276259|NCT02712983|468976198|FG001|Treatment Phase|Physician Decision|0|||
130276260|NCT02712983|468976199|FG002|Treatment Phase|Physician Decision|0|||
130276261|NCT02712983|468976200|FG003|Treatment Phase|Physician Decision|0|||
130276262|NCT02712983|468976201|FG004|Treatment Phase|Physician Decision|0|||
130276263|NCT02712983|468976202|FG005|Treatment Phase|Physician Decision|0|||
130276264|NCT02712983|468976203|FG006|Treatment Phase|Physician Decision|0|||
130276265|NCT02712983|468976204|FG007|Treatment Phase|Physician Decision|1|||
130276266|NCT02712983|468976205|FG008|Treatment Phase|Physician Decision|1|||
130276267|NCT02712983|468976197|FG000|Treatment Phase|Subject Decision|2|||
130276268|NCT02712983|468976198|FG001|Treatment Phase|Subject Decision|0|||
130276269|NCT02712983|468976199|FG002|Treatment Phase|Subject Decision|0|||
130276270|NCT02712983|468976200|FG003|Treatment Phase|Subject Decision|2|||
130276271|NCT02712983|468976201|FG004|Treatment Phase|Subject Decision|1|||
130276272|NCT02712983|468976202|FG005|Treatment Phase|Subject Decision|0|||
130276273|NCT02712983|468976203|FG006|Treatment Phase|Subject Decision|1|||
130276274|NCT02712983|468976204|FG007|Treatment Phase|Subject Decision|2|||
130276275|NCT02712983|468976205|FG008|Treatment Phase|Subject Decision|0|||
130276276|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276277|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276278|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276279|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276280|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276281|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276282|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276283|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276284|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276285|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276286|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276287|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276288|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
130276289|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276290|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276291|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276292|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276293|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130457363|NCT00094809|469638319|FG000|Overall Study|Noncompliance|1|||
130457364|NCT00094809|469638320|FG001|Overall Study|Noncompliance|0|||
130457365|NCT00094809|469638319|FG000|Overall Study|Adverse Event|3|||
130457366|NCT00094809|469638320|FG001|Overall Study|Adverse Event|1|||
130457367|NCT00094809|469638319|FG000|Overall Study|Withdrawal by Subject|8|||
130457368|NCT00094809|469638320|FG001|Overall Study|Withdrawal by Subject|9|||
130457369|NCT00094809|469638319|FG000|Overall Study|Disease progression|3|||
130276294|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276295|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276296|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276297|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130457370|NCT00094809|469638320|FG001|Overall Study|Disease progression|3|||
130457371|NCT00094809|469638319|FG000|Overall Study|Physician Decision|3|||
130276298|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130276299|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130276300|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130276301|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130276302|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276303|NCT01945216|468976206|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
130276304|NCT01945216|468976206|FG000|Overall Study|Protocol Violation|42|||
130276305|NCT01945216|468976206|FG000|Overall Study|CRF not assured by investigators|5|||
130276306|NCT05360966|468976210|FG000|Overall Study|Adverse Event|5|||
130276307|NCT05360966|468976211|FG001|Overall Study|Adverse Event|5|||
130276308|NCT05360966|468976210|FG000|Overall Study|Withdrawal of Consent|5|||
130276309|NCT05360966|468976211|FG001|Overall Study|Withdrawal of Consent|3|||
130276310|NCT05360966|468976210|FG000|Overall Study|Noncompliance|2|||
130276311|NCT05360966|468976211|FG001|Overall Study|Noncompliance|1|||
130276312|NCT05360966|468976210|FG000|Overall Study|Lost to Follow-up|2|||
130276313|NCT05360966|468976211|FG001|Overall Study|Lost to Follow-up|3|||
130276314|NCT05360966|468976210|FG000|Overall Study|Protocol Deviation|2|||
130276315|NCT05360966|468976211|FG001|Overall Study|Protocol Deviation|1|||
130276316|NCT05360966|468976210|FG000|Overall Study|As specified in the Clinical Study Report|1|||
130276317|NCT05360966|468976211|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130276318|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
130276319|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276320|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276321|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276322|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276323|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276324|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276325|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276326|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276327|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276328|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276329|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276330|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276331|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
130276332|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276333|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276334|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276335|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276336|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276337|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276338|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276339|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276340|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276341|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276342|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276343|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276344|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130276345|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276346|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276347|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276348|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276349|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276350|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276351|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276352|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276353|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276354|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276355|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276356|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276357|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130276358|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276359|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276360|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276361|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
130276362|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276363|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276364|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276365|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276366|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276367|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276368|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276369|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276370|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276371|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276372|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276373|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276374|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130276375|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276376|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276377|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276378|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276379|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130457372|NCT00094809|469638320|FG001|Overall Study|Physician Decision|5|||
130457373|NCT00094809|469638319|FG000|Overall Study|Lost to Follow-up|6|||
130457374|NCT00094809|469638320|FG001|Overall Study|Lost to Follow-up|6|||
130457375|NCT00094809|469638319|FG000|Overall Study|Death|19|||
130457376|NCT00094809|469638320|FG001|Overall Study|Death|25|||
130457377|NCT00094809|469638319|FG000|Overall Study|Protocol-specified criteria|1|||
130457378|NCT00094809|469638320|FG001|Overall Study|Protocol-specified criteria|1|||
130457379|NCT00094809|469638319|FG000|Overall Study|Other|2|||
130457380|NCT00094809|469638320|FG001|Overall Study|Other|4|||
130457381|NCT00094809|469638319|FG000|Overall Study|Informed consent signed after treatment|1|||
130457382|NCT00094809|469638320|FG001|Overall Study|Informed consent signed after treatment|0|||
130457383|NCT00094809|469638319|FG000|Overall Study|Study drug not received|2|||
130457384|NCT00094809|469638320|FG001|Overall Study|Study drug not received|8|||
130457385|NCT00094809|469638319|FG000|Overall Study|Other|1|||
130457386|NCT00094809|469638320|FG001|Overall Study|Other|1|||
130457387|NCT00771849|469638324|FG000|Overall Study|Lost to Follow-up|1|||
130457388|NCT00771849|469638325|FG001|Overall Study|Lost to Follow-up|2|||
130457389|NCT00771849|469638324|FG000|Overall Study|Withdrawal by Subject|1|||
130457390|NCT00771849|469638325|FG001|Overall Study|Withdrawal by Subject|1|||
130457391|NCT00771849|469638324|FG000|Overall Study|Not vaccinated|0|||
130457392|NCT00771849|469638325|FG001|Overall Study|Not vaccinated|1|||
130457393|NCT02046616|469638328|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
130457394|NCT02046616|469638328|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
130457395|NCT02046616|469638328|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
130457396|NCT02046616|469638328|FG000|24-Week Treatment Period|Physician Decision|3|||
130457397|NCT02046616|469638328|FG000|24-Week Treatment Period|Other|1|||
130457398|NCT02046616|469638328|FG000|8-Week FU Period|Lost to Follow-up|1|||
130457399|NCT02736799|469638329|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
130457400|NCT02736799|469638330|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
130457401|NCT02736799|469638331|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
130457402|NCT02736799|469638332|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
130457403|NCT01833832|469638334|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
130457404|NCT01156116|469638336|FG000|Overall Study|Withdrawal by Subject|3|||
130457405|NCT01156116|469638337|FG001|Overall Study|Withdrawal by Subject|1|||
130457406|NCT01156116|469638336|FG000|Overall Study|CPAP intolerance|2|||
130457407|NCT01156116|469638337|FG001|Overall Study|CPAP intolerance|0|||
130457408|NCT00344019|469638338|FG000|Overall Study|did not meet final inclusion criteria|0|||
130457409|NCT00344019|469638339|FG001|Overall Study|did not meet final inclusion criteria|0|||
130457410|NCT00344019|469638340|FG002|Overall Study|did not meet final inclusion criteria|74|||
130457411|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
130457412|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
130457413|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
130457414|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
130457415|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
130457416|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
130457417|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
130457418|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
130457419|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
130457420|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
130457421|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
130457422|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
130457423|NCT02057718|469638341|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
130457424|NCT02057718|469638342|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
130457425|NCT02057718|469638341|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
130457426|NCT02057718|469638342|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
130457427|NCT02057718|469638341|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
130457428|NCT02057718|469638342|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
130457429|NCT02057718|469638341|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
130457430|NCT02057718|469638342|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
130457431|NCT02057718|469638341|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
130457432|NCT02057718|469638342|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
130457433|NCT02503202|469638343|FG000|Base Study: Up to Month 6|Death|1|||
130457434|NCT02503202|469638344|FG001|Base Study: Up to Month 6|Death|1|||
130457435|NCT02503202|469638345|FG002|Base Study: Up to Month 6|Death|0|||
130457436|NCT02503202|469638346|FG003|Base Study: Up to Month 6|Death|0|||
130457437|NCT02503202|469638347|FG004|Base Study: Up to Month 6|Death|0|||
130457438|NCT02503202|469638343|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
130457439|NCT02503202|469638344|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
130457440|NCT02503202|469638345|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
130457441|NCT02503202|469638346|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
130457442|NCT02503202|469638347|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
130457443|NCT02503202|469638343|FG000|Base Study: Up to Month 6|Physician Decision|0|||
130457444|NCT02503202|469638344|FG001|Base Study: Up to Month 6|Physician Decision|0|||
130457445|NCT02503202|469638345|FG002|Base Study: Up to Month 6|Physician Decision|0|||
130457446|NCT02503202|469638346|FG003|Base Study: Up to Month 6|Physician Decision|0|||
130457447|NCT02503202|469638347|FG004|Base Study: Up to Month 6|Physician Decision|1|||
130276380|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276381|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276382|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276383|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276384|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276385|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276386|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276387|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130276388|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276389|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276390|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276391|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276392|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276393|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276394|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276395|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276396|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276397|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276398|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130457448|NCT02503202|469638343|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
130276399|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130457449|NCT02503202|469638344|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
130555314|NCT03942406|470001549|FG000|Overall Study|Withdrawal by Subject|3|||
130555315|NCT03942406|470001550|FG001|Overall Study|Withdrawal by Subject|1|||
130276400|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
130276401|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130457450|NCT02503202|469638345|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
130457451|NCT02503202|469638346|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
130457452|NCT02503202|469638347|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
130367756|NCT03094169|469317294|FG006|Overall Study|Trial Termination|0|||
130367757|NCT03094169|469317295|FG007|Overall Study|Trial Termination|1|||
130367758|NCT04645953|469317296|FG000|Overall Study|Lost to Follow-up|2|||
130367759|NCT04645953|469317297|FG001|Overall Study|Lost to Follow-up|1|||
130367760|NCT04645953|469317298|FG002|Overall Study|Lost to Follow-up|1|||
130367761|NCT04645953|469317296|FG000|Overall Study|Withdrawal by Subject|0|||
130367762|NCT04645953|469317297|FG001|Overall Study|Withdrawal by Subject|1|||
130367763|NCT04645953|469317298|FG002|Overall Study|Withdrawal by Subject|0|||
130367764|NCT04645953|469317296|FG000|Overall Study|Physician Decision|0|||
130367765|NCT04645953|469317297|FG001|Overall Study|Physician Decision|1|||
130367766|NCT04645953|469317298|FG002|Overall Study|Physician Decision|0|||
130367767|NCT04645953|469317296|FG000|Overall Study|Discontinued Prior to Dosing|0|||
130457453|NCT02503202|469638343|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
130457454|NCT02503202|469638344|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
130457455|NCT02503202|469638345|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
130457456|NCT02503202|469638346|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
130457457|NCT02503202|469638347|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
130457458|NCT02503202|469638343|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
130457459|NCT02503202|469638344|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
130457460|NCT02503202|469638345|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
130710312|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710313|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710314|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130710315|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130710316|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130710317|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130710318|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130710319|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130710320|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
130710321|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
130710322|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710323|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710324|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
130710325|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710326|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710327|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710328|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710329|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
130710330|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710331|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710332|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
130710333|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710334|NCT00977431|470564805|FG000|Overall Study|Other than listed|1|||
130710335|NCT00977431|470564806|FG001|Overall Study|Other than listed|0|||
130710336|NCT00977431|470564807|FG002|Overall Study|Other than listed|0|||
130710337|NCT00977431|470564808|FG003|Overall Study|Other than listed|0|||
130710338|NCT00977431|470564809|FG004|Overall Study|Other than listed|2|||
130710339|NCT00977431|470564805|FG000|Overall Study|Protocol Violation|0|||
130710340|NCT00977431|470564806|FG001|Overall Study|Protocol Violation|0|||
130710341|NCT00977431|470564807|FG002|Overall Study|Protocol Violation|1|||
130710342|NCT00977431|470564808|FG003|Overall Study|Protocol Violation|0|||
130710343|NCT00977431|470564809|FG004|Overall Study|Protocol Violation|0|||
130710344|NCT00977431|470564805|FG000|Overall Study|Adverse Event|3|||
130710345|NCT00977431|470564806|FG001|Overall Study|Adverse Event|0|||
130710346|NCT00977431|470564807|FG002|Overall Study|Adverse Event|4|||
130710347|NCT00977431|470564808|FG003|Overall Study|Adverse Event|0|||
130710348|NCT00977431|470564809|FG004|Overall Study|Adverse Event|6|||
130710349|NCT00977431|470564805|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
130710350|NCT00977431|470564806|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
130710351|NCT00977431|470564807|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
130710352|NCT00977431|470564808|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
130710353|NCT00977431|470564809|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
130367768|NCT04645953|469317297|FG001|Overall Study|Discontinued Prior to Dosing|0|||
130710354|NCT00977431|470564805|FG000|Overall Study|Progressive disease|2|||
130710355|NCT00977431|470564806|FG001|Overall Study|Progressive disease|6|||
130367769|NCT04645953|469317298|FG002|Overall Study|Discontinued Prior to Dosing|2|||
130367770|NCT04613375|469317299|FG000|Overall Study|Death|198|||
130367771|NCT04613375|469317299|FG000|Overall Study|Withdrawal by Subject|3|||
130367772|NCT01921387|469317300|FG000|Overall Study|Adverse Event|1|||
130367773|NCT01706146|469317303|FG000|Overall Study|Withdrawal by Subject|1|||
130367774|NCT01706146|469317303|FG000|Overall Study|Adverse Event|3|||
130276402|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276403|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276404|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276405|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276406|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276407|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276408|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276409|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276410|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276411|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276412|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276413|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276414|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276415|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276416|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276417|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276418|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276419|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276420|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276421|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276422|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276423|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276424|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276425|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276426|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276427|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276428|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276429|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276430|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276431|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276432|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276433|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276434|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276435|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276436|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276437|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276438|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276439|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276440|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276441|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276442|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276443|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
130276444|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276445|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276446|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276447|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276448|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276449|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276450|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276451|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276452|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276453|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276454|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276455|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276456|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276457|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276458|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130457461|NCT02503202|469638346|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
130457462|NCT02503202|469638347|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
130710356|NCT00977431|470564807|FG002|Overall Study|Progressive disease|1|||
130276459|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276460|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276461|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276462|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276463|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276464|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276465|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276466|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130710357|NCT00977431|470564808|FG003|Overall Study|Progressive disease|3|||
130457463|NCT02503202|469638343|FG000|Extension: Month 6 to 24|Death|1|||
130276467|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276468|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276469|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276470|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276471|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276472|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276473|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130276474|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276475|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276476|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276477|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276478|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276479|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276480|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276481|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276482|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276483|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276484|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276485|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276486|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130276487|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276488|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276489|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276490|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276491|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276492|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276493|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276494|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276495|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276496|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276497|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276498|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276499|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276500|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276501|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276502|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276503|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276504|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276505|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276506|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276507|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276508|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276509|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276510|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276511|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276512|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276513|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276514|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276515|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276516|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
130276517|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276518|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276519|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276520|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276521|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276522|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276523|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276524|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276525|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276526|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276527|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130457464|NCT02503202|469638344|FG001|Extension: Month 6 to 24|Death|0|||
130457465|NCT02503202|469638345|FG002|Extension: Month 6 to 24|Death|0|||
130457466|NCT02503202|469638346|FG003|Extension: Month 6 to 24|Death|0|||
130457467|NCT02503202|469638347|FG004|Extension: Month 6 to 24|Death|0|||
130710358|NCT00977431|470564809|FG004|Overall Study|Progressive disease|5|||
130276528|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276529|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276530|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276531|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276532|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276533|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276534|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276535|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276536|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276537|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276538|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276539|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276540|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276541|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276542|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276543|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276544|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276545|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276546|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
130276547|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276548|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276549|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276550|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276551|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276552|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276553|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276554|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276555|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276556|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276557|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276558|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276559|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276560|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276561|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276562|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276563|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276564|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276565|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276566|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276567|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276568|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276569|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276570|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276571|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276572|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276573|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276574|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276575|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276576|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130276577|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276578|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276579|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276580|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276581|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276582|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276583|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130457468|NCT02503202|469638343|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
130457469|NCT02503202|469638344|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
130457470|NCT02503202|469638345|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
130457471|NCT02503202|469638346|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
130457472|NCT02503202|469638347|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
130276584|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276585|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276586|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276587|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276588|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276589|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130276590|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276591|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276592|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276593|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276594|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276595|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276596|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276597|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276598|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276599|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276600|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276601|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276602|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276603|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276604|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276605|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276606|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276607|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276608|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276609|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276610|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276611|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276612|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276613|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276614|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276615|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
130276616|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276617|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276618|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276619|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130276620|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276621|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276622|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276623|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276624|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276625|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276626|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276627|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276628|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276629|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276630|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276631|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276632|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276633|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276634|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276635|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276636|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276637|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276638|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276639|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276640|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276641|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276642|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276643|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130367775|NCT01706146|469317303|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
130276644|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130367776|NCT00675948|469317304|FG000|Overall Study|Adverse Event|23|||
130367777|NCT00675948|469317305|FG001|Overall Study|Adverse Event|1|||
130276645|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130276646|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276647|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276648|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276649|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276650|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276651|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276652|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276653|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276654|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276655|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276656|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276657|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276658|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276659|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276660|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276661|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276662|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276663|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276664|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276665|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276666|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276667|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276668|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276669|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276670|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276671|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276672|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276673|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276674|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276675|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
130276676|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276677|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276678|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276679|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276680|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276681|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276682|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276683|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276684|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276685|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276686|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276687|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276688|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276689|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276690|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276691|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276692|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276693|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276694|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276695|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276696|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276697|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276698|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276699|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276700|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276701|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276702|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276703|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276704|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276705|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276706|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276707|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276708|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130457473|NCT02503202|469638343|FG000|Extension: Month 6 to 24|Physician Decision|1|||
130457474|NCT02503202|469638344|FG001|Extension: Month 6 to 24|Physician Decision|0|||
130367778|NCT00675948|469317304|FG000|Overall Study|Lack of Efficacy|3|||
130367779|NCT00675948|469317305|FG001|Overall Study|Lack of Efficacy|0|||
130367780|NCT00675948|469317304|FG000|Overall Study|Withdrawal by Subject|7|||
130367781|NCT00675948|469317305|FG001|Overall Study|Withdrawal by Subject|0|||
130367782|NCT00675948|469317304|FG000|Overall Study|Lost to Follow-up|2|||
130367783|NCT00675948|469317305|FG001|Overall Study|Lost to Follow-up|0|||
130367784|NCT00675948|469317304|FG000|Overall Study|Protocol Violation|1|||
130367785|NCT00675948|469317305|FG001|Overall Study|Protocol Violation|0|||
130367786|NCT00675948|469317304|FG000|Overall Study|Pain under control|1|||
130367787|NCT00675948|469317305|FG001|Overall Study|Pain under control|0|||
130367788|NCT00675948|469317304|FG000|Overall Study|Sponsor decision|0|||
130367789|NCT00675948|469317305|FG001|Overall Study|Sponsor decision|1|||
130367790|NCT00675948|469317304|FG000|Overall Study|Patient died|1|||
130367791|NCT00675948|469317305|FG001|Overall Study|Patient died|0|||
130367792|NCT00675948|469317304|FG000|Overall Study|Patient unable to comply with diaries|1|||
130367793|NCT00675948|469317305|FG001|Overall Study|Patient unable to comply with diaries|0|||
130367794|NCT00675948|469317304|FG000|Overall Study|Patient feels unable to take medication|0|||
130276709|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276710|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276711|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276712|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276713|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276714|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276715|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276716|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276717|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276718|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276719|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276720|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276721|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276722|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276723|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276724|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276725|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276726|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276727|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276728|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276729|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276730|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276731|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276732|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276733|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276734|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276735|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276736|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276737|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276738|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276739|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276740|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276741|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276742|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276743|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276744|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276745|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
130276746|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276747|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276748|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276749|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276750|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130367795|NCT00675948|469317305|FG001|Overall Study|Patient feels unable to take medication|1|||
130367796|NCT02582983|469317306|FG000|Overall Study|Death|3|||
130367797|NCT02582983|469317306|FG000|Overall Study|Withdrawal by Subject|2|||
130367798|NCT02582983|469317306|FG000|Overall Study|Adverse Event|1|||
130367799|NCT01081678|469317312|FG000|Overall Study|Ineligibility Determined|0|||
130367800|NCT01081678|469317313|FG001|Overall Study|Ineligibility Determined|0|||
130367801|NCT01081678|469317314|FG002|Overall Study|Ineligibility Determined|1|||
130367802|NCT01081678|469317315|FG003|Overall Study|Ineligibility Determined|1|||
130367803|NCT01081678|469317312|FG000|Overall Study|Noncompliance|3|||
130367804|NCT01081678|469317313|FG001|Overall Study|Noncompliance|4|||
130367805|NCT01081678|469317314|FG002|Overall Study|Noncompliance|5|||
130276751|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276752|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276753|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276754|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276755|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276756|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276757|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276758|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276759|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276760|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276761|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276762|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276763|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276764|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276765|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276766|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276767|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276768|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276769|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276770|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276771|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276772|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276773|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276774|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276775|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276776|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276777|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276778|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276779|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276780|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276781|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276782|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276783|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276784|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276785|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276786|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276787|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276788|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276789|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
130276790|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276791|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276792|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276793|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276794|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276795|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276796|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276797|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276798|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276799|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276800|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276801|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276802|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276803|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276804|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276805|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276806|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276807|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276808|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276809|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276810|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276811|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276812|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276813|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276814|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276815|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276816|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276817|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276818|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276819|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276820|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276821|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276822|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276823|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276824|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276825|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276826|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276827|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276828|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276829|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276830|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276831|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276832|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276833|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276834|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276835|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276836|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276837|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276838|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276839|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276840|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276841|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276842|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276843|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276844|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276845|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130367806|NCT01081678|469317315|FG003|Overall Study|Noncompliance|2|||
130367807|NCT01081678|469317312|FG000|Overall Study|Adverse Event|2|||
130367808|NCT01081678|469317313|FG001|Overall Study|Adverse Event|1|||
130367809|NCT01081678|469317314|FG002|Overall Study|Adverse Event|2|||
130367810|NCT01081678|469317315|FG003|Overall Study|Adverse Event|2|||
130367811|NCT01081678|469317312|FG000|Overall Study|Withdrawal by Subject|15|||
130367812|NCT01081678|469317313|FG001|Overall Study|Withdrawal by Subject|7|||
130367813|NCT01081678|469317314|FG002|Overall Study|Withdrawal by Subject|17|||
130367814|NCT01081678|469317315|FG003|Overall Study|Withdrawal by Subject|14|||
130367815|NCT01081678|469317312|FG000|Overall Study|Administrative Decision|1|||
130367816|NCT01081678|469317313|FG001|Overall Study|Administrative Decision|0|||
130367817|NCT01081678|469317314|FG002|Overall Study|Administrative Decision|0|||
130367818|NCT01081678|469317315|FG003|Overall Study|Administrative Decision|1|||
130367819|NCT01081678|469317312|FG000|Overall Study|Lost to Follow-up|4|||
130367820|NCT01081678|469317313|FG001|Overall Study|Lost to Follow-up|1|||
130367821|NCT01081678|469317314|FG002|Overall Study|Lost to Follow-up|4|||
130367822|NCT01081678|469317315|FG003|Overall Study|Lost to Follow-up|3|||
130367823|NCT01081678|469317312|FG000|Overall Study|Death|2|||
130367824|NCT01081678|469317313|FG001|Overall Study|Death|2|||
130367825|NCT01081678|469317314|FG002|Overall Study|Death|2|||
130367826|NCT01081678|469317315|FG003|Overall Study|Death|6|||
130367827|NCT01081678|469317312|FG000|Overall Study|Other|0|||
130367828|NCT01081678|469317313|FG001|Overall Study|Other|1|||
130367829|NCT01081678|469317314|FG002|Overall Study|Other|0|||
130367830|NCT01081678|469317315|FG003|Overall Study|Other|0|||
130367831|NCT00444912|469317323|FG000|Overall Study|Death|1|||
130367832|NCT00444912|469317324|FG001|Overall Study|Death|2|||
130367833|NCT00444912|469317323|FG000|Overall Study|Lost to Follow-up|1|||
130367834|NCT00444912|469317324|FG001|Overall Study|Lost to Follow-up|0|||
130367835|NCT00444912|469317323|FG000|Overall Study|Participant Failed Mobilization|1|||
130367836|NCT00444912|469317324|FG001|Overall Study|Participant Failed Mobilization|0|||
130367837|NCT01007812|469317327|FG000|Period 1, One Week|Lost to Follow-up|0|||
130367838|NCT01007812|469317328|FG001|Period 1, One Week|Lost to Follow-up|1|||
130367839|NCT01007812|469317327|FG000|Period 1, One Week|Discomfort|1|||
130367840|NCT01007812|469317328|FG001|Period 1, One Week|Discomfort|0|||
130367841|NCT01091974|469317329|FG000|Overall Study|Did not start intervention|3|||
130367842|NCT01091974|469317330|FG001|Overall Study|Did not start intervention|1|||
130367843|NCT01091974|469317331|FG002|Overall Study|Did not start intervention|3|||
130367844|NCT01091974|469317332|FG003|Overall Study|Did not start intervention|1|||
130367845|NCT01091974|469317329|FG000|Overall Study|resumed sleep medication|0|||
130367846|NCT01091974|469317330|FG001|Overall Study|resumed sleep medication|0|||
130367847|NCT01091974|469317331|FG002|Overall Study|resumed sleep medication|1|||
130367848|NCT01091974|469317332|FG003|Overall Study|resumed sleep medication|2|||
130367849|NCT01091974|469317329|FG000|Overall Study|Withdrawal by Subject|1|||
130367850|NCT01091974|469317330|FG001|Overall Study|Withdrawal by Subject|3|||
130367851|NCT01091974|469317331|FG002|Overall Study|Withdrawal by Subject|2|||
130710359|NCT01010750|470564810|FG000|Second Intervention|Adverse Event|0|||
130367852|NCT01091974|469317332|FG003|Overall Study|Withdrawal by Subject|2|||
130367853|NCT01091974|469317329|FG000|Overall Study|side-effects|1|||
130367854|NCT01091974|469317330|FG001|Overall Study|side-effects|1|||
130367855|NCT01091974|469317331|FG002|Overall Study|side-effects|0|||
130367856|NCT01091974|469317332|FG003|Overall Study|side-effects|2|||
130367857|NCT02499783|469317333|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
130367858|NCT02499783|469317334|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
130367859|NCT02499783|469317335|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
130367860|NCT02499783|469317333|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
130367861|NCT02499783|469317334|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
130367862|NCT02499783|469317335|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
130367863|NCT02499783|469317333|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
130367864|NCT02499783|469317334|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
130367865|NCT02499783|469317335|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
130367866|NCT02499783|469317333|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
130367867|NCT02499783|469317334|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
130367868|NCT02499783|469317335|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
130276846|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276847|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276848|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276849|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276850|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276851|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276852|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276853|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276854|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276855|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276856|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276857|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276858|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276859|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276860|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
130276861|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276862|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276863|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276864|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276865|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276866|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276867|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276868|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276869|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276870|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276871|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276872|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276873|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276874|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276875|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276876|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276877|NCT03062280|468976255|FG000|Overall Study|Adverse Event|1|||
130276878|NCT03062280|468976255|FG000|Overall Study|Death|1|||
130276879|NCT03062280|468976255|FG000|Overall Study|Fertility Treatment|2|||
130276880|NCT03062280|468976255|FG000|Overall Study|Physician Decision|2|||
130276881|NCT03062280|468976255|FG000|Overall Study|Pregnancy|5|||
130276882|NCT03062280|468976255|FG000|Overall Study|Withdrawal by Subject|11|||
130367869|NCT02499783|469317333|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
130367870|NCT02499783|469317334|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
130367871|NCT02499783|469317335|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
130367872|NCT02499783|469317333|FG000|DB Period: Weeks 0-8|Other|1|||
130367873|NCT02499783|469317334|FG001|DB Period: Weeks 0-8|Other|1|||
130367874|NCT02499783|469317335|FG002|DB Period: Weeks 0-8|Other|0|||
130367875|NCT02499783|469317333|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
130367876|NCT02499783|469317334|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
130367877|NCT02499783|469317335|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
130457475|NCT02503202|469638345|FG002|Extension: Month 6 to 24|Physician Decision|1|||
130710360|NCT01010750|470564811|FG001|Second Intervention|Adverse Event|1|||
130276883|NCT04299308|468976256|FG000|Overall Study|Withdrawal by Subject|1|||
130276884|NCT04299308|468976257|FG001|Overall Study|Withdrawal by Subject|0|||
130276885|NCT04299308|468976256|FG000|Overall Study|issue with PET image (1)|1|||
130276886|NCT04299308|468976257|FG001|Overall Study|issue with PET image (1)|0|||
130367878|NCT02499783|469317333|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
130276887|NCT05258890|468976258|FG000|Overall Study|Patient withdrawal|6|||
130276888|NCT05258890|468976259|FG001|Overall Study|Patient withdrawal|7|||
130276889|NCT05258890|468976258|FG000|Overall Study|Patient lost to follow-up|10|||
130276890|NCT05258890|468976259|FG001|Overall Study|Patient lost to follow-up|3|||
130276891|NCT05258890|468976258|FG000|Overall Study|Social network member withdrawal|1|||
130276892|NCT05258890|468976259|FG001|Overall Study|Social network member withdrawal|0|||
130276893|NCT05258890|468976258|FG000|Overall Study|Social network member lost to follow-up|5|||
130276894|NCT05258890|468976259|FG001|Overall Study|Social network member lost to follow-up|0|||
130276895|NCT04493424|468976260|FG000|Overall Study|Termination of the trial by the sponsor|89|||
130276896|NCT04493424|468976260|FG000|Overall Study|Withdrawal by Subject|9|||
130276897|NCT04493424|468976260|FG000|Overall Study|Lost to Follow-up|2|||
130276898|NCT04493424|468976260|FG000|Overall Study|Lack of Efficacy|3|||
130276899|NCT04493424|468976260|FG000|Overall Study|Adverse Event|5|||
130276900|NCT00516893|468976263|FG000|Overall Study|Lost to Follow-up|4|||
130276901|NCT00516893|468976263|FG000|Overall Study|Adverse Event|3|||
130276902|NCT00516893|468976263|FG000|Overall Study|Withdrawal by Subject|2|||
130276903|NCT00516893|468976263|FG000|Overall Study|Noncompliance|2|||
130276904|NCT00516893|468976263|FG000|Overall Study|Death|1|||
130276905|NCT00516893|468976263|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
130276906|NCT00516893|468976263|FG000|Overall Study|Relocated|1|||
130276907|NCT00516893|468976263|FG000|Overall Study|Pregnancy|1|||
130276908|NCT00516893|468976263|FG000|Overall Study|Received Medication From Another Study|1|||
130457476|NCT02503202|469638346|FG003|Extension: Month 6 to 24|Physician Decision|3|||
130457477|NCT02503202|469638347|FG004|Extension: Month 6 to 24|Physician Decision|0|||
130457478|NCT02503202|469638343|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
130457479|NCT02503202|469638344|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
130457480|NCT02503202|469638345|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
130457481|NCT02503202|469638346|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
130457482|NCT02503202|469638347|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
130457483|NCT00608907|469638351|FG000|Overall Study|Adverse Event|6|||
130457484|NCT00608907|469638352|FG001|Overall Study|Adverse Event|0|||
130276909|NCT05935878|468976269|FG000|Overall Study|Death|1|||
130276910|NCT05935878|468976270|FG001|Overall Study|Death|2|||
130276911|NCT05935878|468976269|FG000|Overall Study|Withdrawal by Subject|5|||
130276912|NCT05935878|468976270|FG001|Overall Study|Withdrawal by Subject|5|||
130276913|NCT05935878|468976269|FG000|Overall Study|Revision of implant|1|||
130276914|NCT05935878|468976270|FG001|Overall Study|Revision of implant|1|||
130276915|NCT05935878|468976269|FG000|Overall Study|Mobile bearing dislocation|0|||
130276916|NCT05935878|468976270|FG001|Overall Study|Mobile bearing dislocation|1|||
130276917|NCT05924165|468976271|FG000|Overall Study|Physician Decision|2|||
130276918|NCT05924165|468976272|FG001|Overall Study|Physician Decision|3|||
130276919|NCT05959447|468976273|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
130276920|NCT05959447|468976274|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
130276921|NCT05959447|468976273|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
130276922|NCT05959447|468976274|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
130276923|NCT05959447|468976273|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
130276924|NCT05959447|468976274|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
130276925|NCT05959447|468976273|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130276926|NCT05959447|468976274|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130276927|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Adverse Event|1|||
130276928|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Adverse Event|0|||
130276929|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
130276930|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
130276931|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
130276932|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
130276933|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130276934|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130276935|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Other|1|||
130276936|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Other|4|||
130276937|NCT00301262|468976275|FG000|Open Label Phase (OL)|Adverse Event|1|||
130276938|NCT00301262|468976276|FG001|Open Label Phase (OL)|Adverse Event|0|||
130276939|NCT00301262|468976275|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
130276940|NCT00301262|468976276|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
130276941|NCT00301262|468976275|FG000|Open Label Phase (OL)|Other|2|||
130276942|NCT00301262|468976276|FG001|Open Label Phase (OL)|Other|0|||
130276943|NCT00368745|468976277|FG000|Double-blind Treatment Period|Adverse Event|6|||
130276944|NCT00368745|468976278|FG001|Double-blind Treatment Period|Adverse Event|6|||
130276945|NCT00368745|468976277|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
130276946|NCT00368745|468976278|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
130276947|NCT00368745|468976277|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130457485|NCT00608907|469638353|FG002|Overall Study|Adverse Event|1|||
130276948|NCT00368745|468976278|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130276949|NCT00368745|468976277|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
130367879|NCT02499783|469317334|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
130367880|NCT02499783|469317335|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
130367881|NCT02499783|469317333|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
130367882|NCT02499783|469317334|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
130367883|NCT02499783|469317335|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
130276950|NCT00368745|468976278|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
130276951|NCT00368745|468976277|FG000|Double-blind Treatment Period|Other|7|||
130276952|NCT00368745|468976278|FG001|Double-blind Treatment Period|Other|6|||
130276953|NCT01436656|468976279|FG000|Dose Escalation|Death|1|||
130276954|NCT01436656|468976280|FG001|Dose Escalation|Death|3|||
130276955|NCT01436656|468976281|FG002|Dose Escalation|Death|1|||
130276956|NCT01436656|468976282|FG003|Dose Escalation|Death|0|||
130276957|NCT01436656|468976283|FG004|Dose Escalation|Death|2|||
130276958|NCT01436656|468976284|FG005|Dose Escalation|Death|1|||
130276959|NCT01436656|468976285|FG006|Dose Escalation|Death|1|||
130276960|NCT01436656|468976286|FG007|Dose Escalation|Death|1|||
130276961|NCT01436656|468976287|FG008|Dose Escalation|Death|1|||
130276962|NCT01436656|468976288|FG009|Dose Escalation|Death|0|||
130276963|NCT01436656|468976289|FG010|Dose Escalation|Death|0|||
130276964|NCT01436656|468976290|FG011|Dose Escalation|Death|0|||
130276965|NCT01436656|468976291|FG012|Dose Escalation|Death|0|||
130276966|NCT01436656|468976292|FG013|Dose Escalation|Death|0|||
130276967|NCT01436656|468976293|FG014|Dose Escalation|Death|0|||
130276968|NCT01436656|468976294|FG015|Dose Escalation|Death|0|||
130276969|NCT01436656|468976295|FG016|Dose Escalation|Death|0|||
130276970|NCT01436656|468976296|FG017|Dose Escalation|Death|0|||
130276971|NCT01436656|468976279|FG000|Dose Escalation|Protocol Violation|0|||
130276972|NCT01436656|468976280|FG001|Dose Escalation|Protocol Violation|0|||
130276973|NCT01436656|468976281|FG002|Dose Escalation|Protocol Violation|0|||
130276974|NCT01436656|468976282|FG003|Dose Escalation|Protocol Violation|0|||
130276975|NCT01436656|468976283|FG004|Dose Escalation|Protocol Violation|0|||
130276976|NCT01436656|468976284|FG005|Dose Escalation|Protocol Violation|1|||
130276977|NCT01436656|468976285|FG006|Dose Escalation|Protocol Violation|0|||
130276978|NCT01436656|468976286|FG007|Dose Escalation|Protocol Violation|0|||
130276979|NCT01436656|468976287|FG008|Dose Escalation|Protocol Violation|0|||
130276980|NCT01436656|468976288|FG009|Dose Escalation|Protocol Violation|0|||
130276981|NCT01436656|468976289|FG010|Dose Escalation|Protocol Violation|0|||
130276982|NCT01436656|468976290|FG011|Dose Escalation|Protocol Violation|0|||
130276983|NCT01436656|468976291|FG012|Dose Escalation|Protocol Violation|0|||
130276984|NCT01436656|468976292|FG013|Dose Escalation|Protocol Violation|0|||
130276985|NCT01436656|468976293|FG014|Dose Escalation|Protocol Violation|0|||
130276986|NCT01436656|468976294|FG015|Dose Escalation|Protocol Violation|0|||
130276987|NCT01436656|468976295|FG016|Dose Escalation|Protocol Violation|0|||
130276988|NCT01436656|468976296|FG017|Dose Escalation|Protocol Violation|0|||
130276989|NCT01436656|468976279|FG000|Dose Escalation|Withdrawal by Subject|0|||
130276990|NCT01436656|468976280|FG001|Dose Escalation|Withdrawal by Subject|0|||
130276991|NCT01436656|468976281|FG002|Dose Escalation|Withdrawal by Subject|0|||
130276992|NCT01436656|468976282|FG003|Dose Escalation|Withdrawal by Subject|0|||
130276993|NCT01436656|468976283|FG004|Dose Escalation|Withdrawal by Subject|1|||
130276994|NCT01436656|468976284|FG005|Dose Escalation|Withdrawal by Subject|0|||
130276995|NCT01436656|468976285|FG006|Dose Escalation|Withdrawal by Subject|0|||
130276996|NCT01436656|468976286|FG007|Dose Escalation|Withdrawal by Subject|2|||
130276997|NCT01436656|468976287|FG008|Dose Escalation|Withdrawal by Subject|0|||
130276998|NCT01436656|468976288|FG009|Dose Escalation|Withdrawal by Subject|1|||
130276999|NCT01436656|468976289|FG010|Dose Escalation|Withdrawal by Subject|1|||
130277000|NCT01436656|468976290|FG011|Dose Escalation|Withdrawal by Subject|0|||
130277001|NCT01436656|468976291|FG012|Dose Escalation|Withdrawal by Subject|0|||
130277002|NCT01436656|468976292|FG013|Dose Escalation|Withdrawal by Subject|0|||
130277003|NCT01436656|468976293|FG014|Dose Escalation|Withdrawal by Subject|0|||
130277004|NCT01436656|468976294|FG015|Dose Escalation|Withdrawal by Subject|0|||
130277005|NCT01436656|468976295|FG016|Dose Escalation|Withdrawal by Subject|0|||
130277006|NCT01436656|468976296|FG017|Dose Escalation|Withdrawal by Subject|0|||
130277007|NCT01436656|468976279|FG000|Dose Escalation|Administrative problems|0|||
130367884|NCT02499783|469317333|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
130367885|NCT02499783|469317334|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
130367886|NCT02499783|469317335|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
130367887|NCT01866293|469317336|FG000|Overall Study|Adverse Event|2|||
130367888|NCT00555971|469317338|FG000|Overall Study|Adverse Event|1|||
130367889|NCT00555971|469317339|FG001|Overall Study|Adverse Event|1|||
130367890|NCT00518284|469317340|FG000|Overall Study|Adverse Event|0|||
130367891|NCT00518284|469317341|FG001|Overall Study|Adverse Event|1|||
130277008|NCT01436656|468976280|FG001|Dose Escalation|Administrative problems|1|||
130277009|NCT01436656|468976281|FG002|Dose Escalation|Administrative problems|0|||
130277010|NCT01436656|468976282|FG003|Dose Escalation|Administrative problems|0|||
130367892|NCT00518284|469317342|FG002|Overall Study|Adverse Event|0|||
130367893|NCT00518284|469317343|FG003|Overall Study|Adverse Event|0|||
130277011|NCT01436656|468976283|FG004|Dose Escalation|Administrative problems|0|||
130277012|NCT01436656|468976284|FG005|Dose Escalation|Administrative problems|0|||
130277013|NCT01436656|468976285|FG006|Dose Escalation|Administrative problems|0|||
130277014|NCT01436656|468976286|FG007|Dose Escalation|Administrative problems|0|||
130277015|NCT01436656|468976287|FG008|Dose Escalation|Administrative problems|0|||
130277016|NCT01436656|468976288|FG009|Dose Escalation|Administrative problems|0|||
130277017|NCT01436656|468976289|FG010|Dose Escalation|Administrative problems|0|||
130277018|NCT01436656|468976290|FG011|Dose Escalation|Administrative problems|0|||
130277019|NCT01436656|468976291|FG012|Dose Escalation|Administrative problems|0|||
130277020|NCT01436656|468976292|FG013|Dose Escalation|Administrative problems|0|||
130277021|NCT01436656|468976293|FG014|Dose Escalation|Administrative problems|0|||
130277022|NCT01436656|468976294|FG015|Dose Escalation|Administrative problems|0|||
130277023|NCT01436656|468976295|FG016|Dose Escalation|Administrative problems|0|||
130277024|NCT01436656|468976296|FG017|Dose Escalation|Administrative problems|0|||
130277025|NCT01436656|468976279|FG000|Dose Escalation|Lost to Follow-up|1|||
130277026|NCT01436656|468976280|FG001|Dose Escalation|Lost to Follow-up|0|||
130277027|NCT01436656|468976281|FG002|Dose Escalation|Lost to Follow-up|0|||
130277028|NCT01436656|468976282|FG003|Dose Escalation|Lost to Follow-up|0|||
130277029|NCT01436656|468976283|FG004|Dose Escalation|Lost to Follow-up|1|||
130277030|NCT01436656|468976284|FG005|Dose Escalation|Lost to Follow-up|0|||
130277031|NCT01436656|468976285|FG006|Dose Escalation|Lost to Follow-up|0|||
130277032|NCT01436656|468976286|FG007|Dose Escalation|Lost to Follow-up|0|||
130277033|NCT01436656|468976287|FG008|Dose Escalation|Lost to Follow-up|0|||
130277034|NCT01436656|468976288|FG009|Dose Escalation|Lost to Follow-up|0|||
130277035|NCT01436656|468976289|FG010|Dose Escalation|Lost to Follow-up|0|||
130277036|NCT01436656|468976290|FG011|Dose Escalation|Lost to Follow-up|0|||
130277037|NCT01436656|468976291|FG012|Dose Escalation|Lost to Follow-up|0|||
130277038|NCT01436656|468976292|FG013|Dose Escalation|Lost to Follow-up|0|||
130277039|NCT01436656|468976293|FG014|Dose Escalation|Lost to Follow-up|0|||
130277040|NCT01436656|468976294|FG015|Dose Escalation|Lost to Follow-up|0|||
130277041|NCT01436656|468976295|FG016|Dose Escalation|Lost to Follow-up|0|||
130277042|NCT01436656|468976296|FG017|Dose Escalation|Lost to Follow-up|0|||
130277043|NCT01436656|468976279|FG000|Dose Escalation|New anti-cancer therapy|1|||
130277044|NCT01436656|468976280|FG001|Dose Escalation|New anti-cancer therapy|0|||
130277045|NCT01436656|468976281|FG002|Dose Escalation|New anti-cancer therapy|0|||
130277046|NCT01436656|468976282|FG003|Dose Escalation|New anti-cancer therapy|0|||
130277047|NCT01436656|468976283|FG004|Dose Escalation|New anti-cancer therapy|0|||
130277048|NCT01436656|468976284|FG005|Dose Escalation|New anti-cancer therapy|0|||
130277049|NCT01436656|468976285|FG006|Dose Escalation|New anti-cancer therapy|0|||
130367894|NCT00518284|469317340|FG000|Overall Study|Study Termination|0|||
130367895|NCT00518284|469317341|FG001|Overall Study|Study Termination|2|||
130367896|NCT00518284|469317342|FG002|Overall Study|Study Termination|1|||
130367897|NCT00518284|469317343|FG003|Overall Study|Study Termination|2|||
130367898|NCT00801632|469317344|FG000|Overall Study|Re-transplant|1|||
130277050|NCT01436656|468976286|FG007|Dose Escalation|New anti-cancer therapy|0|||
130277051|NCT01436656|468976287|FG008|Dose Escalation|New anti-cancer therapy|1|||
130277052|NCT01436656|468976288|FG009|Dose Escalation|New anti-cancer therapy|1|||
130277053|NCT01436656|468976289|FG010|Dose Escalation|New anti-cancer therapy|0|||
130277054|NCT01436656|468976290|FG011|Dose Escalation|New anti-cancer therapy|0|||
130277055|NCT01436656|468976291|FG012|Dose Escalation|New anti-cancer therapy|0|||
130367899|NCT00621582|469317345|FG000|Overall Study|Adverse Event|7|||
130277056|NCT01436656|468976292|FG013|Dose Escalation|New anti-cancer therapy|0|||
130457486|NCT00608907|469638351|FG000|Overall Study|Death|1|||
130277057|NCT01436656|468976293|FG014|Dose Escalation|New anti-cancer therapy|0|||
130277058|NCT01436656|468976294|FG015|Dose Escalation|New anti-cancer therapy|0|||
130277059|NCT01436656|468976295|FG016|Dose Escalation|New anti-cancer therapy|0|||
130277060|NCT01436656|468976296|FG017|Dose Escalation|New anti-cancer therapy|0|||
130277061|NCT01436656|468976279|FG000|Dose Expansion|Adverse Event|0|||
130277062|NCT01436656|468976280|FG001|Dose Expansion|Adverse Event|0|||
130277063|NCT01436656|468976281|FG002|Dose Expansion|Adverse Event|0|||
130277064|NCT01436656|468976282|FG003|Dose Expansion|Adverse Event|0|||
130277065|NCT01436656|468976283|FG004|Dose Expansion|Adverse Event|0|||
130277066|NCT01436656|468976284|FG005|Dose Expansion|Adverse Event|0|||
130277067|NCT01436656|468976285|FG006|Dose Expansion|Adverse Event|0|||
130277068|NCT01436656|468976286|FG007|Dose Expansion|Adverse Event|0|||
130277069|NCT01436656|468976287|FG008|Dose Expansion|Adverse Event|0|||
130277070|NCT01436656|468976288|FG009|Dose Expansion|Adverse Event|0|||
130277071|NCT01436656|468976289|FG010|Dose Expansion|Adverse Event|0|||
130277072|NCT01436656|468976290|FG011|Dose Expansion|Adverse Event|1|||
130277073|NCT01436656|468976291|FG012|Dose Expansion|Adverse Event|0|||
130277074|NCT01436656|468976292|FG013|Dose Expansion|Adverse Event|0|||
130277075|NCT01436656|468976293|FG014|Dose Expansion|Adverse Event|0|||
130277076|NCT01436656|468976294|FG015|Dose Expansion|Adverse Event|0|||
130277077|NCT01436656|468976295|FG016|Dose Expansion|Adverse Event|0|||
130277078|NCT01436656|468976296|FG017|Dose Expansion|Adverse Event|0|||
130277079|NCT01436656|468976279|FG000|Dose Expansion|Withdrawal by Subject|0|||
130277080|NCT01436656|468976280|FG001|Dose Expansion|Withdrawal by Subject|0|||
130277081|NCT01436656|468976281|FG002|Dose Expansion|Withdrawal by Subject|0|||
130277082|NCT01436656|468976282|FG003|Dose Expansion|Withdrawal by Subject|0|||
130277083|NCT01436656|468976283|FG004|Dose Expansion|Withdrawal by Subject|0|||
130277084|NCT01436656|468976284|FG005|Dose Expansion|Withdrawal by Subject|0|||
130277085|NCT01436656|468976285|FG006|Dose Expansion|Withdrawal by Subject|0|||
130277086|NCT01436656|468976286|FG007|Dose Expansion|Withdrawal by Subject|0|||
130277087|NCT01436656|468976287|FG008|Dose Expansion|Withdrawal by Subject|0|||
130277088|NCT01436656|468976288|FG009|Dose Expansion|Withdrawal by Subject|0|||
130277089|NCT01436656|468976289|FG010|Dose Expansion|Withdrawal by Subject|0|||
130277090|NCT01436656|468976290|FG011|Dose Expansion|Withdrawal by Subject|1|||
130277091|NCT01436656|468976291|FG012|Dose Expansion|Withdrawal by Subject|3|||
130277092|NCT01436656|468976292|FG013|Dose Expansion|Withdrawal by Subject|1|||
130277093|NCT01436656|468976293|FG014|Dose Expansion|Withdrawal by Subject|2|||
130277094|NCT01436656|468976294|FG015|Dose Expansion|Withdrawal by Subject|0|||
130277095|NCT01436656|468976295|FG016|Dose Expansion|Withdrawal by Subject|1|||
130277096|NCT01436656|468976296|FG017|Dose Expansion|Withdrawal by Subject|1|||
130277097|NCT01436656|468976279|FG000|Dose Expansion|Death|0|||
130277098|NCT01436656|468976280|FG001|Dose Expansion|Death|0|||
130277099|NCT01436656|468976281|FG002|Dose Expansion|Death|0|||
130277100|NCT01436656|468976282|FG003|Dose Expansion|Death|0|||
130277101|NCT01436656|468976283|FG004|Dose Expansion|Death|0|||
130277102|NCT01436656|468976284|FG005|Dose Expansion|Death|0|||
130277103|NCT01436656|468976285|FG006|Dose Expansion|Death|0|||
130277104|NCT01436656|468976286|FG007|Dose Expansion|Death|0|||
130277105|NCT01436656|468976287|FG008|Dose Expansion|Death|0|||
130277106|NCT01436656|468976288|FG009|Dose Expansion|Death|0|||
130277107|NCT01436656|468976289|FG010|Dose Expansion|Death|0|||
130277108|NCT01436656|468976290|FG011|Dose Expansion|Death|0|||
130277109|NCT01436656|468976291|FG012|Dose Expansion|Death|1|||
130277110|NCT01436656|468976292|FG013|Dose Expansion|Death|0|||
130277111|NCT01436656|468976293|FG014|Dose Expansion|Death|3|||
130277112|NCT01436656|468976294|FG015|Dose Expansion|Death|0|||
130277113|NCT01436656|468976295|FG016|Dose Expansion|Death|3|||
130277114|NCT01436656|468976296|FG017|Dose Expansion|Death|3|||
130277115|NCT01436656|468976279|FG000|Dose Expansion|Lost to Follow-up|0|||
130277116|NCT01436656|468976280|FG001|Dose Expansion|Lost to Follow-up|0|||
130277117|NCT01436656|468976281|FG002|Dose Expansion|Lost to Follow-up|0|||
130277118|NCT01436656|468976282|FG003|Dose Expansion|Lost to Follow-up|0|||
130277119|NCT01436656|468976283|FG004|Dose Expansion|Lost to Follow-up|0|||
130277120|NCT01436656|468976284|FG005|Dose Expansion|Lost to Follow-up|0|||
130277121|NCT01436656|468976285|FG006|Dose Expansion|Lost to Follow-up|0|||
130277122|NCT01436656|468976286|FG007|Dose Expansion|Lost to Follow-up|0|||
130277123|NCT01436656|468976287|FG008|Dose Expansion|Lost to Follow-up|0|||
130277124|NCT01436656|468976288|FG009|Dose Expansion|Lost to Follow-up|0|||
130277125|NCT01436656|468976289|FG010|Dose Expansion|Lost to Follow-up|0|||
130277126|NCT01436656|468976290|FG011|Dose Expansion|Lost to Follow-up|0|||
130277127|NCT01436656|468976291|FG012|Dose Expansion|Lost to Follow-up|0|||
130277128|NCT01436656|468976292|FG013|Dose Expansion|Lost to Follow-up|0|||
130277129|NCT01436656|468976293|FG014|Dose Expansion|Lost to Follow-up|0|||
130277130|NCT01436656|468976294|FG015|Dose Expansion|Lost to Follow-up|0|||
130277131|NCT01436656|468976295|FG016|Dose Expansion|Lost to Follow-up|0|||
130277132|NCT01436656|468976296|FG017|Dose Expansion|Lost to Follow-up|3|||
130277133|NCT01436656|468976279|FG000|Dose Expansion|Disease progression|0|||
130367900|NCT00621582|469317345|FG000|Overall Study|Protocol Violation|57|||
130367901|NCT00621582|469317345|FG000|Overall Study|Lost to Follow-up|24|||
130277134|NCT01436656|468976280|FG001|Dose Expansion|Disease progression|0|||
130277135|NCT01436656|468976281|FG002|Dose Expansion|Disease progression|0|||
130277136|NCT01436656|468976282|FG003|Dose Expansion|Disease progression|0|||
130277137|NCT01436656|468976283|FG004|Dose Expansion|Disease progression|0|||
130277138|NCT01436656|468976284|FG005|Dose Expansion|Disease progression|0|||
130277139|NCT01436656|468976285|FG006|Dose Expansion|Disease progression|0|||
130277140|NCT01436656|468976286|FG007|Dose Expansion|Disease progression|0|||
130277141|NCT01436656|468976287|FG008|Dose Expansion|Disease progression|0|||
130277142|NCT01436656|468976288|FG009|Dose Expansion|Disease progression|0|||
130277143|NCT01436656|468976289|FG010|Dose Expansion|Disease progression|0|||
130277144|NCT01436656|468976290|FG011|Dose Expansion|Disease progression|3|||
130277145|NCT01436656|468976291|FG012|Dose Expansion|Disease progression|1|||
130277146|NCT01436656|468976292|FG013|Dose Expansion|Disease progression|0|||
130277147|NCT01436656|468976293|FG014|Dose Expansion|Disease progression|1|||
130277148|NCT01436656|468976294|FG015|Dose Expansion|Disease progression|0|||
130277149|NCT01436656|468976295|FG016|Dose Expansion|Disease progression|0|||
130277150|NCT01436656|468976296|FG017|Dose Expansion|Disease progression|1|||
130277151|NCT01436656|468976279|FG000|Dose Expansion|New cancer therapy|0|||
130457487|NCT00608907|469638352|FG001|Overall Study|Death|0|||
130457488|NCT00608907|469638353|FG002|Overall Study|Death|0|||
130457489|NCT00608907|469638351|FG000|Overall Study|Withdrawal by Subject|4|||
130277152|NCT01436656|468976280|FG001|Dose Expansion|New cancer therapy|0|||
130277153|NCT01436656|468976281|FG002|Dose Expansion|New cancer therapy|0|||
130277154|NCT01436656|468976282|FG003|Dose Expansion|New cancer therapy|0|||
130277155|NCT01436656|468976283|FG004|Dose Expansion|New cancer therapy|0|||
130277156|NCT01436656|468976284|FG005|Dose Expansion|New cancer therapy|0|||
130277157|NCT01436656|468976285|FG006|Dose Expansion|New cancer therapy|0|||
130277158|NCT01436656|468976286|FG007|Dose Expansion|New cancer therapy|0|||
130277159|NCT01436656|468976287|FG008|Dose Expansion|New cancer therapy|0|||
130277160|NCT01436656|468976288|FG009|Dose Expansion|New cancer therapy|0|||
130277161|NCT01436656|468976289|FG010|Dose Expansion|New cancer therapy|0|||
130277162|NCT01436656|468976290|FG011|Dose Expansion|New cancer therapy|1|||
130277163|NCT01436656|468976291|FG012|Dose Expansion|New cancer therapy|1|||
130277164|NCT01436656|468976292|FG013|Dose Expansion|New cancer therapy|0|||
130277165|NCT01436656|468976293|FG014|Dose Expansion|New cancer therapy|2|||
130277166|NCT01436656|468976294|FG015|Dose Expansion|New cancer therapy|0|||
130277167|NCT01436656|468976295|FG016|Dose Expansion|New cancer therapy|0|||
130277168|NCT01436656|468976296|FG017|Dose Expansion|New cancer therapy|0|||
130277169|NCT04729972|468976297|FG000|Overall Study|Adverse Event|1|||
130277170|NCT00576628|468976299|FG000|Overall Study|Adverse Event|11|||
130277171|NCT00576628|468976299|FG000|Overall Study|Death|2|||
130277172|NCT00576628|468976299|FG000|Overall Study|Failure to return|1|||
130277173|NCT00576628|468976299|FG000|Overall Study|Refused Treatment|8|||
130277174|NCT00576628|468976299|FG000|Overall Study|Pregnancy|1|||
130277175|NCT00576628|468976299|FG000|Overall Study|RBC transfusion|1|||
130277176|NCT00576628|468976299|FG000|Overall Study|Progression of Kidney Disease|1|||
130277177|NCT00576628|468976299|FG000|Overall Study|Progression of Renal Failure|1|||
130277178|NCT00576628|468976299|FG000|Overall Study|The patient move into other town|1|||
130277179|NCT00576628|468976299|FG000|Overall Study|Transplantation|1|||
130277180|NCT00576628|468976299|FG000|Overall Study|Dialysis|15|||
130277181|NCT03206970|468976300|FG000|Overall Study|Death|21|||
130277182|NCT03206970|468976300|FG000|Overall Study|Withdrawal by Subject|13|||
130277183|NCT03206970|468976300|FG000|Overall Study|Lost to Follow-up|3|||
130277184|NCT03206970|468976300|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
130277185|NCT02516982|468976301|FG000|Overall Study|Called in to antenatal appointment|32|||
130277186|NCT02516982|468976302|FG001|Overall Study|Called in to antenatal appointment|35|||
130277187|NCT02516982|468976303|FG002|Overall Study|Called in to antenatal appointment|0|||
130277188|NCT02516982|468976304|FG003|Overall Study|Called in to antenatal appointment|0|||
130277189|NCT02516982|468976301|FG000|Overall Study|Withdrawal by Subject|0|||
130277190|NCT02516982|468976302|FG001|Overall Study|Withdrawal by Subject|0|||
130277191|NCT02516982|468976303|FG002|Overall Study|Withdrawal by Subject|1|||
130277192|NCT02516982|468976304|FG003|Overall Study|Withdrawal by Subject|2|||
130277193|NCT02516982|468976301|FG000|Overall Study|Protocol Violation|0|||
130277194|NCT02516982|468976302|FG001|Overall Study|Protocol Violation|0|||
130277195|NCT02516982|468976303|FG002|Overall Study|Protocol Violation|1|||
130277196|NCT02516982|468976304|FG003|Overall Study|Protocol Violation|1|||
130277197|NCT02516982|468976301|FG000|Overall Study|Did not install the app|0|||
130277198|NCT02516982|468976302|FG001|Overall Study|Did not install the app|0|||
130277199|NCT02516982|468976303|FG002|Overall Study|Did not install the app|46|||
130277200|NCT02516982|468976304|FG003|Overall Study|Did not install the app|47|||
130277201|NCT01804049|468976312|FG000|Overall Study|Adverse Event|2|||
130277202|NCT01804049|468976313|FG001|Overall Study|Adverse Event|10|||
130277203|NCT01804049|468976312|FG000|Overall Study|Lost to Follow-up|2|||
130277204|NCT01804049|468976313|FG001|Overall Study|Lost to Follow-up|1|||
130457490|NCT00608907|469638352|FG001|Overall Study|Withdrawal by Subject|0|||
130457491|NCT00608907|469638353|FG002|Overall Study|Withdrawal by Subject|0|||
130457492|NCT00608907|469638351|FG000|Overall Study|Progressive Disease|1|||
130710361|NCT01010750|470564812|FG002|Second Intervention|Adverse Event|0|||
130710362|NCT01010750|470564813|FG003|Second Intervention|Adverse Event|0|||
130710363|NCT01010750|470564814|FG004|Second Intervention|Adverse Event|0|||
130277205|NCT01804049|468976312|FG000|Overall Study|Decreased interest/personal|4|||
130277206|NCT01804049|468976313|FG001|Overall Study|Decreased interest/personal|5|||
130277207|NCT01804049|468976312|FG000|Overall Study|Other health concerns|2|||
130277208|NCT01804049|468976313|FG001|Overall Study|Other health concerns|7|||
130277209|NCT01804049|468976312|FG000|Overall Study|Moved out of area|0|||
130277210|NCT01804049|468976313|FG001|Overall Study|Moved out of area|7|||
130277211|NCT01804049|468976312|FG000|Overall Study|other MD recommended|1|||
130277212|NCT01804049|468976313|FG001|Overall Study|other MD recommended|1|||
130277213|NCT01804049|468976312|FG000|Overall Study|Enrollment in dual studies|0|||
130277214|NCT01804049|468976313|FG001|Overall Study|Enrollment in dual studies|1|||
130277215|NCT03249909|468976315|FG000|Overall Study|Withdrawal by Subject|3|||
130277216|NCT03249909|468976316|FG001|Overall Study|Withdrawal by Subject|0|||
130277217|NCT03249909|468976317|FG002|Overall Study|Withdrawal by Subject|0|||
130277218|NCT03249909|468976315|FG000|Overall Study|Adverse Event|3|||
130277219|NCT03249909|468976316|FG001|Overall Study|Adverse Event|0|||
130277220|NCT03249909|468976317|FG002|Overall Study|Adverse Event|0|||
130277221|NCT03249909|468976315|FG000|Overall Study|Lost to Follow-up|0|||
130277222|NCT03249909|468976316|FG001|Overall Study|Lost to Follow-up|1|||
130277223|NCT03249909|468976317|FG002|Overall Study|Lost to Follow-up|0|||
130277224|NCT05286658|468976318|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
130277225|NCT05286658|468976318|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
130277226|NCT01035463|468976319|FG000|Overall Study|Adverse Event|0|||
130277227|NCT01035463|468976320|FG001|Overall Study|Adverse Event|0|||
130277228|NCT01035463|468976321|FG002|Overall Study|Adverse Event|4|||
130277229|NCT01035463|468976322|FG003|Overall Study|Adverse Event|1|||
130277230|NCT01035463|468976323|FG004|Overall Study|Adverse Event|5|||
130277231|NCT01035463|468976324|FG005|Overall Study|Adverse Event|7|||
130277232|NCT01035463|468976319|FG000|Overall Study|Withdrawal by Subject|0|||
130277233|NCT01035463|468976320|FG001|Overall Study|Withdrawal by Subject|2|||
130277234|NCT01035463|468976321|FG002|Overall Study|Withdrawal by Subject|1|||
130277235|NCT01035463|468976322|FG003|Overall Study|Withdrawal by Subject|0|||
130277236|NCT01035463|468976323|FG004|Overall Study|Withdrawal by Subject|1|||
130277237|NCT01035463|468976324|FG005|Overall Study|Withdrawal by Subject|4|||
130277238|NCT01035463|468976319|FG000|Overall Study|Disease progression|0|||
130277239|NCT01035463|468976320|FG001|Overall Study|Disease progression|0|||
130277240|NCT01035463|468976321|FG002|Overall Study|Disease progression|0|||
130277241|NCT01035463|468976322|FG003|Overall Study|Disease progression|0|||
130277242|NCT01035463|468976323|FG004|Overall Study|Disease progression|0|||
130277243|NCT01035463|468976324|FG005|Overall Study|Disease progression|3|||
130277244|NCT01035463|468976319|FG000|Overall Study|Other Malignancy|0|||
130277245|NCT01035463|468976320|FG001|Overall Study|Other Malignancy|0|||
130277246|NCT01035463|468976321|FG002|Overall Study|Other Malignancy|0|||
130277247|NCT01035463|468976322|FG003|Overall Study|Other Malignancy|0|||
130277248|NCT01035463|468976323|FG004|Overall Study|Other Malignancy|0|||
130277249|NCT01035463|468976324|FG005|Overall Study|Other Malignancy|2|||
130277250|NCT01035463|468976319|FG000|Overall Study|Other|0|||
130277251|NCT01035463|468976320|FG001|Overall Study|Other|0|||
130277252|NCT01035463|468976321|FG002|Overall Study|Other|0|||
130277253|NCT01035463|468976322|FG003|Overall Study|Other|1|||
130277254|NCT01035463|468976323|FG004|Overall Study|Other|0|||
130277255|NCT01035463|468976324|FG005|Overall Study|Other|2|||
130277256|NCT01092780|468976325|FG000|Washout Period 1|Adverse Event|0|||
130277257|NCT01092780|468976326|FG001|Washout Period 1|Adverse Event|1|||
130277258|NCT01092780|468976327|FG002|Washout Period 1|Adverse Event|0|||
130277259|NCT01092780|468976328|FG003|Washout Period 1|Adverse Event|0|||
130277260|NCT01092780|468976325|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
130277261|NCT01092780|468976326|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
130277262|NCT01092780|468976327|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
130710364|NCT01010750|470564815|FG005|Second Intervention|Adverse Event|0|||
130710365|NCT03739138|470564817|FG000|Overall Study|Death|0|||
130277263|NCT01092780|468976328|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
130277264|NCT01092780|468976325|FG000|Washout Period 2|Adverse Event|0|||
130277265|NCT01092780|468976326|FG001|Washout Period 2|Adverse Event|1|||
130277266|NCT01092780|468976327|FG002|Washout Period 2|Adverse Event|1|||
130277267|NCT01092780|468976328|FG003|Washout Period 2|Adverse Event|0|||
130277268|NCT00851552|468976338|FG000|Overall Study|Death|2|||
130277269|NCT00851552|468976338|FG000|Overall Study|Adverse Event|1|||
130277270|NCT00851552|468976338|FG000|Overall Study|Disease Progression|4|||
130277271|NCT01270880|468976340|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
130277272|NCT00182078|468976341|FG000|Overall Study|Withdrawal by Subject|1|||
130277273|NCT00182078|468976342|FG001|Overall Study|Withdrawal by Subject|0|||
130277274|NCT01606176|468976343|FG000|Overall Study|Adverse Event|2|||
130277275|NCT01606176|468976344|FG001|Overall Study|Adverse Event|3|||
130277276|NCT01606176|468976343|FG000|Overall Study|Disease progression|1|||
130710366|NCT03739138|470564818|FG001|Overall Study|Death|7|||
130277277|NCT01606176|468976344|FG001|Overall Study|Disease progression|0|||
130277278|NCT01606176|468976343|FG000|Overall Study|Withdrawal by Subject|1|||
130277279|NCT01606176|468976344|FG001|Overall Study|Withdrawal by Subject|0|||
130277280|NCT01076205|468976345|FG000|Overall Study|Adverse Drug Reaction|299|||
130277281|NCT01076205|468976345|FG000|Overall Study|Lack of Effectiveness|1423|||
130277282|NCT01076205|468976345|FG000|Overall Study|Other Reason|1075|||
130277283|NCT01076205|468976345|FG000|Overall Study|Unknown Reason|71|||
130277284|NCT01076205|468976345|FG000|Overall Study|Lost to Follow-up|3151|||
130277285|NCT01832493|468976347|FG000|Overall Study|Physician Decision|2|||
130277286|NCT01832493|468976347|FG000|Overall Study|Protocol Violation|4|||
130277287|NCT01832493|468976347|FG000|Overall Study|Unable to place LV lead|2|||
130277288|NCT01732510|468976348|FG000|Overall Study|Adverse Event|0|||
130277289|NCT01732510|468976349|FG001|Overall Study|Adverse Event|1|||
130277290|NCT01732510|468976350|FG002|Overall Study|Adverse Event|1|||
130277291|NCT01732510|468976351|FG003|Overall Study|Adverse Event|0|||
130277292|NCT01732510|468976352|FG004|Overall Study|Adverse Event|0|||
130277293|NCT01732510|468976353|FG005|Overall Study|Adverse Event|0|||
130277294|NCT01732510|468976354|FG006|Overall Study|Adverse Event|1|||
130555316|NCT03942406|470001551|FG002|Overall Study|Withdrawal by Subject|1|||
130555317|NCT03942406|470001552|FG003|Overall Study|Withdrawal by Subject|3|||
130277295|NCT01732510|468976348|FG000|Overall Study|Protocol Violation|0|||
130277296|NCT01732510|468976349|FG001|Overall Study|Protocol Violation|0|||
130277297|NCT01732510|468976350|FG002|Overall Study|Protocol Violation|0|||
130277298|NCT01732510|468976351|FG003|Overall Study|Protocol Violation|1|||
130277299|NCT01732510|468976352|FG004|Overall Study|Protocol Violation|0|||
130277300|NCT01732510|468976353|FG005|Overall Study|Protocol Violation|0|||
130277301|NCT01732510|468976354|FG006|Overall Study|Protocol Violation|0|||
130277302|NCT01732510|468976348|FG000|Overall Study|Withdrawal by Subject|1|||
130277303|NCT01732510|468976349|FG001|Overall Study|Withdrawal by Subject|3|||
130277304|NCT01732510|468976350|FG002|Overall Study|Withdrawal by Subject|2|||
130277305|NCT01732510|468976351|FG003|Overall Study|Withdrawal by Subject|1|||
130277306|NCT01732510|468976352|FG004|Overall Study|Withdrawal by Subject|5|||
130277307|NCT01732510|468976353|FG005|Overall Study|Withdrawal by Subject|0|||
130277308|NCT01732510|468976354|FG006|Overall Study|Withdrawal by Subject|1|||
130277309|NCT01732510|468976348|FG000|Overall Study|Lost to Follow-up|0|||
130277310|NCT01732510|468976349|FG001|Overall Study|Lost to Follow-up|0|||
130277311|NCT01732510|468976350|FG002|Overall Study|Lost to Follow-up|1|||
130277312|NCT01732510|468976351|FG003|Overall Study|Lost to Follow-up|1|||
130277313|NCT01732510|468976352|FG004|Overall Study|Lost to Follow-up|0|||
130277314|NCT01732510|468976353|FG005|Overall Study|Lost to Follow-up|1|||
130277315|NCT01732510|468976354|FG006|Overall Study|Lost to Follow-up|0|||
130277316|NCT01732510|468976348|FG000|Overall Study|Physician Decision|0|||
130277317|NCT01732510|468976349|FG001|Overall Study|Physician Decision|1|||
130277318|NCT01732510|468976350|FG002|Overall Study|Physician Decision|0|||
130277319|NCT01732510|468976351|FG003|Overall Study|Physician Decision|0|||
130277320|NCT01732510|468976352|FG004|Overall Study|Physician Decision|0|||
130277321|NCT01732510|468976353|FG005|Overall Study|Physician Decision|0|||
130277322|NCT01732510|468976354|FG006|Overall Study|Physician Decision|0|||
130277323|NCT01732510|468976348|FG000|Overall Study|Pregnancy|0|||
130277324|NCT01732510|468976349|FG001|Overall Study|Pregnancy|0|||
130277325|NCT01732510|468976350|FG002|Overall Study|Pregnancy|0|||
130277326|NCT01732510|468976351|FG003|Overall Study|Pregnancy|1|||
130277327|NCT01732510|468976352|FG004|Overall Study|Pregnancy|0|||
130277328|NCT01732510|468976353|FG005|Overall Study|Pregnancy|0|||
130277329|NCT01732510|468976354|FG006|Overall Study|Pregnancy|0|||
130277330|NCT01732510|468976348|FG000|Overall Study|Study Terminated By Sponsor|0|||
130277331|NCT01732510|468976349|FG001|Overall Study|Study Terminated By Sponsor|0|||
130277332|NCT01732510|468976350|FG002|Overall Study|Study Terminated By Sponsor|0|||
130277333|NCT01732510|468976351|FG003|Overall Study|Study Terminated By Sponsor|1|||
130277334|NCT01732510|468976352|FG004|Overall Study|Study Terminated By Sponsor|0|||
130277335|NCT01732510|468976353|FG005|Overall Study|Study Terminated By Sponsor|12|||
130277336|NCT01732510|468976354|FG006|Overall Study|Study Terminated By Sponsor|6|||
130367902|NCT00621582|469317345|FG000|Overall Study|issues not identified by investigators|18|||
130277337|NCT01262560|468976358|FG000|Overall Study|Protocol Violation|0|||
130277338|NCT01262560|468976359|FG001|Overall Study|Protocol Violation|1|||
130277339|NCT01262560|468976360|FG002|Overall Study|Protocol Violation|2|||
130277340|NCT03213938|468976361|FG000|Overall Study|Lost to Follow-up|4|||
130277341|NCT03213938|468976362|FG001|Overall Study|Lost to Follow-up|3|||
130277342|NCT03213938|468976361|FG000|Overall Study|Lack of Efficacy|1|||
130277343|NCT03213938|468976362|FG001|Overall Study|Lack of Efficacy|0|||
130457493|NCT00608907|469638352|FG001|Overall Study|Progressive Disease|0|||
130457494|NCT00608907|469638353|FG002|Overall Study|Progressive Disease|0|||
130457495|NCT00906035|469638356|FG000|Overall Study|Withdrawal by Subject|2|||
130457496|NCT00906035|469638357|FG001|Overall Study|Withdrawal by Subject|3|||
130457497|NCT00906035|469638358|FG002|Overall Study|Withdrawal by Subject|0|||
130457498|NCT01191788|469638359|FG000|Overall Study|Lost to Follow-up|21|||
130457499|NCT01191788|469638360|FG001|Overall Study|Lost to Follow-up|22|||
130457500|NCT05046132|469638362|FG000|Overall Study|Adverse Event|4|||
130457501|NCT05046132|469638363|FG001|Overall Study|Adverse Event|0|||
130277344|NCT03213938|468976361|FG000|Overall Study|Decline to participate|5|||
130277345|NCT03213938|468976362|FG001|Overall Study|Decline to participate|4|||
130277346|NCT03213938|468976361|FG000|Overall Study|Without reason|4|||
130277347|NCT03213938|468976362|FG001|Overall Study|Without reason|5|||
130277348|NCT04238481|468976363|FG000|Overall Study|Miscellaneous|0|||
130277349|NCT04238481|468976364|FG001|Overall Study|Miscellaneous|1|||
130277350|NCT04238481|468976365|FG002|Overall Study|Miscellaneous|0|||
130277351|NCT04238481|468976366|FG003|Overall Study|Miscellaneous|0|||
130277352|NCT00673231|468976367|FG000|Overall Study|Withdrawal by Subject|14|||
130277353|NCT00673231|468976368|FG001|Overall Study|Withdrawal by Subject|10|||
130277354|NCT00673231|468976369|FG002|Overall Study|Withdrawal by Subject|8|||
130277355|NCT00673231|468976370|FG003|Overall Study|Withdrawal by Subject|6|||
130277356|NCT00673231|468976367|FG000|Overall Study|Adverse Event|6|||
130277357|NCT00673231|468976368|FG001|Overall Study|Adverse Event|5|||
130277358|NCT00673231|468976369|FG002|Overall Study|Adverse Event|9|||
130277359|NCT00673231|468976370|FG003|Overall Study|Adverse Event|6|||
130277360|NCT00673231|468976367|FG000|Overall Study|Lost to Follow-up|1|||
130277361|NCT00673231|468976368|FG001|Overall Study|Lost to Follow-up|2|||
130277362|NCT00673231|468976369|FG002|Overall Study|Lost to Follow-up|1|||
130277363|NCT00673231|468976370|FG003|Overall Study|Lost to Follow-up|2|||
130277364|NCT00673231|468976367|FG000|Overall Study|Death|0|||
130277365|NCT00673231|468976368|FG001|Overall Study|Death|0|||
130277366|NCT00673231|468976369|FG002|Overall Study|Death|1|||
130277367|NCT00673231|468976370|FG003|Overall Study|Death|0|||
130277368|NCT00673231|468976367|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
130277369|NCT00673231|468976368|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
130277370|NCT00673231|468976369|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
130277371|NCT00673231|468976370|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
130277372|NCT02952313|468976371|FG000|Primary Endpoint|Lost to Follow-up|4|||
130367903|NCT01387932|469317347|FG000|Randomized and Treated|Physician Decision|3|||
130367904|NCT01387932|469317348|FG001|Randomized and Treated|Physician Decision|2|||
130367905|NCT01387932|469317347|FG000|Randomized and Treated|Withdrawal by Subject|4|||
130367906|NCT01387932|469317348|FG001|Randomized and Treated|Withdrawal by Subject|2|||
130367907|NCT01387932|469317347|FG000|Survival Follow-up|Liver Transplant|24|||
130367908|NCT01387932|469317348|FG001|Survival Follow-up|Liver Transplant|28|||
130367909|NCT01387932|469317347|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
130367910|NCT01387932|469317348|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
130367911|NCT01387932|469317347|FG000|Survival Follow-up|Withdrawal by Subject|2|||
130367912|NCT01387932|469317348|FG001|Survival Follow-up|Withdrawal by Subject|4|||
130367913|NCT01387932|469317347|FG000|Survival Follow-up|Lost to Follow-up|6|||
130367914|NCT01387932|469317348|FG001|Survival Follow-up|Lost to Follow-up|5|||
130367915|NCT00205881|469317349|FG000|Overall Study|Withdrawal by Subject|16|||
130367916|NCT02217878|469317355|FG000|Overall Study|required morphine due to chest pain|1|||
130367917|NCT02217878|469317356|FG001|Overall Study|required morphine due to chest pain|2|||
130367918|NCT02217878|469317355|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
130367919|NCT02217878|469317356|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
130367920|NCT00334958|469317357|FG000|Overall Study|Medication Noncompliance|0|||
130367921|NCT00334958|469317358|FG001|Overall Study|Medication Noncompliance|3|||
130367922|NCT00334958|469317357|FG000|Overall Study|Protocol Violation|2|||
130367923|NCT00334958|469317358|FG001|Overall Study|Protocol Violation|2|||
130367924|NCT00334958|469317357|FG000|Overall Study|Request of the investigator or sponsor|0|||
130367925|NCT00334958|469317358|FG001|Overall Study|Request of the investigator or sponsor|1|||
130367926|NCT00334958|469317357|FG000|Overall Study|Withdrawal by Subject|7|||
130367927|NCT00334958|469317358|FG001|Overall Study|Withdrawal by Subject|4|||
130457502|NCT05046132|469638364|FG002|Overall Study|Adverse Event|0|||
130457503|NCT05046132|469638362|FG000|Overall Study|Withdrawal by Subject|3|||
130367928|NCT00334958|469317357|FG000|Overall Study|Adverse Event|27|||
130457504|NCT05046132|469638363|FG001|Overall Study|Withdrawal by Subject|0|||
130710367|NCT03739138|470564819|FG002|Overall Study|Death|4|||
130710368|NCT03739138|470564820|FG003|Overall Study|Death|13|||
130710369|NCT03739138|470564821|FG004|Overall Study|Death|0|||
130710370|NCT03739138|470564817|FG000|Overall Study|Lost to Follow-up|0|||
130710371|NCT03739138|470564818|FG001|Overall Study|Lost to Follow-up|0|||
130710372|NCT03739138|470564819|FG002|Overall Study|Lost to Follow-up|1|||
130710373|NCT03739138|470564820|FG003|Overall Study|Lost to Follow-up|0|||
130367929|NCT00334958|469317358|FG001|Overall Study|Adverse Event|12|||
130710374|NCT03739138|470564821|FG004|Overall Study|Lost to Follow-up|0|||
130367930|NCT00334958|469317357|FG000|Overall Study|Other|1|||
130367931|NCT00334958|469317358|FG001|Overall Study|Other|2|||
130367932|NCT00622401|469317359|FG000|Overall Study|Disease progression prior to treatment|3|||
130367933|NCT00622401|469317360|FG001|Overall Study|Disease progression prior to treatment|2|||
130367934|NCT00622401|469317361|FG002|Overall Study|Disease progression prior to treatment|0|||
130367935|NCT00781274|469317365|FG000|Overall Study|Withdrawal by Subject|2|||
130367936|NCT02021773|469317369|FG000|Overall Study|Adverse Event|1|||
130367937|NCT02021773|469317370|FG001|Overall Study|Adverse Event|4|||
130367938|NCT02021773|469317371|FG002|Overall Study|Adverse Event|3|||
130367939|NCT02021773|469317369|FG000|Overall Study|Lack of Efficacy|2|||
130367940|NCT02021773|469317370|FG001|Overall Study|Lack of Efficacy|2|||
130367941|NCT02021773|469317371|FG002|Overall Study|Lack of Efficacy|2|||
130367942|NCT02021773|469317369|FG000|Overall Study|Protocol Violation|2|||
130367943|NCT02021773|469317370|FG001|Overall Study|Protocol Violation|3|||
130367944|NCT02021773|469317371|FG002|Overall Study|Protocol Violation|1|||
130367945|NCT02021773|469317369|FG000|Overall Study|Withdrawal by Subject|3|||
130367946|NCT02021773|469317370|FG001|Overall Study|Withdrawal by Subject|4|||
130367947|NCT02021773|469317371|FG002|Overall Study|Withdrawal by Subject|5|||
130367948|NCT02021773|469317369|FG000|Overall Study|Lost to Follow-up|1|||
130367949|NCT02021773|469317370|FG001|Overall Study|Lost to Follow-up|3|||
130367950|NCT02021773|469317371|FG002|Overall Study|Lost to Follow-up|0|||
130367951|NCT02021773|469317369|FG000|Overall Study|Reason not specified|3|||
130367952|NCT02021773|469317370|FG001|Overall Study|Reason not specified|0|||
130367953|NCT02021773|469317371|FG002|Overall Study|Reason not specified|0|||
130367954|NCT01534962|469317372|FG000|Overall Study|Randomized but did not start treatment|2|||
130367955|NCT01534962|469317373|FG001|Overall Study|Randomized but did not start treatment|0|||
130367956|NCT01534962|469317374|FG002|Overall Study|Randomized but did not start treatment|0|||
130367957|NCT01534962|469317375|FG003|Overall Study|Randomized but did not start treatment|1|||
130367958|NCT01534962|469317372|FG000|Overall Study|Discontinued at AF recurrence|35|||
130367959|NCT01534962|469317373|FG001|Overall Study|Discontinued at AF recurrence|26|||
130367960|NCT01534962|469317374|FG002|Overall Study|Discontinued at AF recurrence|24|||
130367961|NCT01534962|469317375|FG003|Overall Study|Discontinued at AF recurrence|31|||
130367962|NCT02243696|469317376|FG000|Overall Study|Death|282|||
130367963|NCT02243696|469317376|FG000|Overall Study|Withdrawal by Subject|79|||
130367964|NCT02243696|469317376|FG000|Overall Study|Lost to Follow-up|57|||
130367965|NCT02243696|469317376|FG000|Overall Study|Subject No Longer has Study System|42|||
130367966|NCT02243696|469317376|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
130367967|NCT02243696|469317376|FG000|Overall Study|Study Terminated for EP PASSION|961|||
130367968|NCT00190671|469317377|FG000|Overall Study|Satisfactory Response|4|||
130367969|NCT00190671|469317378|FG001|Overall Study|Satisfactory Response|7|||
130367970|NCT00190671|469317377|FG000|Overall Study|Lack of Efficacy|19|||
130367971|NCT00190671|469317378|FG001|Overall Study|Lack of Efficacy|24|||
130367972|NCT00190671|469317377|FG000|Overall Study|Death from Study Disease|1|||
130367973|NCT00190671|469317378|FG001|Overall Study|Death from Study Disease|1|||
130367974|NCT00190671|469317377|FG000|Overall Study|Adverse Event|3|||
130367975|NCT00190671|469317378|FG001|Overall Study|Adverse Event|2|||
130367976|NCT00190671|469317377|FG000|Overall Study|Clinical Relapse|0|||
130367977|NCT00190671|469317378|FG001|Overall Study|Clinical Relapse|1|||
130367978|NCT00190671|469317377|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
130367979|NCT00190671|469317378|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
130367980|NCT00190671|469317377|FG000|Overall Study|Death from Other Causes|0|||
130367981|NCT00190671|469317378|FG001|Overall Study|Death from Other Causes|2|||
130367982|NCT00190671|469317377|FG000|Overall Study|Protocol Violation|0|||
130367983|NCT00190671|469317378|FG001|Overall Study|Protocol Violation|1|||
130367984|NCT00190671|469317377|FG000|Overall Study|Withdrawal by Subject|0|||
130367985|NCT00190671|469317378|FG001|Overall Study|Withdrawal by Subject|2|||
130367986|NCT00191269|469317379|FG000|Overall Study|Protocol Violation|0|||
130367987|NCT00191269|469317380|FG001|Overall Study|Protocol Violation|2|||
130367988|NCT00191269|469317379|FG000|Overall Study|Adverse Event|1|||
130367989|NCT00191269|469317380|FG001|Overall Study|Adverse Event|4|||
130367990|NCT00191269|469317379|FG000|Overall Study|Progression of Disease|4|||
130367991|NCT00191269|469317380|FG001|Overall Study|Progression of Disease|42|||
130367992|NCT00191269|469317379|FG000|Overall Study|Lack of Efficacy|1|||
130367993|NCT00191269|469317380|FG001|Overall Study|Lack of Efficacy|5|||
130367994|NCT00191269|469317379|FG000|Overall Study|Withdrawal by Subject|0|||
130367995|NCT00191269|469317380|FG001|Overall Study|Withdrawal by Subject|1|||
130367996|NCT00191269|469317379|FG000|Overall Study|Pathologic Aggrevation|0|||
130367997|NCT00191269|469317380|FG001|Overall Study|Pathologic Aggrevation|1|||
130367998|NCT00191269|469317379|FG000|Overall Study|Physician Decision|0|||
130367999|NCT00191269|469317380|FG001|Overall Study|Physician Decision|3|||
130368000|NCT00668707|469317386|FG000|Overall Study|Cancer Recurrence|58|||
130368001|NCT00668707|469317387|FG001|Overall Study|Cancer Recurrence|58|||
130368002|NCT00668707|469317386|FG000|Overall Study|Withdrawal by Subject|117|||
130368003|NCT00668707|469317387|FG001|Overall Study|Withdrawal by Subject|100|||
130368004|NCT00668707|469317386|FG000|Overall Study|Lost to Follow-up|3|||
130368005|NCT00668707|469317387|FG001|Overall Study|Lost to Follow-up|6|||
130368006|NCT00668707|469317386|FG000|Overall Study|Protocol Violation|10|||
130368007|NCT00668707|469317387|FG001|Overall Study|Protocol Violation|12|||
130368008|NCT00668707|469317386|FG000|Overall Study|Death|11|||
130368009|NCT00668707|469317387|FG001|Overall Study|Death|4|||
130368010|NCT00191139|469317389|FG000|Overall Study|Adverse Event|2|||
130368011|NCT00191139|469317390|FG001|Overall Study|Adverse Event|6|||
130277373|NCT02952313|468976371|FG000|Primary Endpoint|Withdrawal by Subject|1|||
130277374|NCT02952313|468976371|FG000|Primary Endpoint|Lack of Efficacy|1|||
130277375|NCT02952313|468976371|FG000|Primary Endpoint|Missed visit|1|||
130277376|NCT02952313|468976371|FG000|Long-term Follow-up|Lost to Follow-up|12|||
130277377|NCT02952313|468976371|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
130277378|NCT02952313|468976371|FG000|Long-term Follow-up|Lack of Efficacy|6|||
130277379|NCT02952313|468976371|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
130277380|NCT02952313|468976371|FG000|Long-term Follow-up|Physician Decision|1|||
130277381|NCT02952313|468976371|FG000|Long-term Follow-up|Death|1|||
130277382|NCT03594747|468976372|FG000|Overall Study|Death|78|||
130277383|NCT03594747|468976373|FG001|Overall Study|Death|86|||
130277384|NCT03594747|468976374|FG002|Overall Study|Death|87|||
130277385|NCT03594747|468976372|FG000|Overall Study|Withdrawal by Subject|5|||
130277386|NCT03594747|468976373|FG001|Overall Study|Withdrawal by Subject|2|||
130277387|NCT03594747|468976374|FG002|Overall Study|Withdrawal by Subject|11|||
130277388|NCT03594747|468976372|FG000|Overall Study|Lost to Follow-up|4|||
130277389|NCT03594747|468976373|FG001|Overall Study|Lost to Follow-up|1|||
130277390|NCT03594747|468976374|FG002|Overall Study|Lost to Follow-up|1|||
130277391|NCT03594747|468976372|FG000|Overall Study|Physician Decision|0|||
130277392|NCT03594747|468976373|FG001|Overall Study|Physician Decision|1|||
130277393|NCT03594747|468976374|FG002|Overall Study|Physician Decision|0|||
130277394|NCT03594747|468976372|FG000|Overall Study|Sponsor decision|23|||
130368012|NCT00191139|469317389|FG000|Overall Study|Death|2|||
130368013|NCT00191139|469317390|FG001|Overall Study|Death|0|||
130368014|NCT00191139|469317389|FG000|Overall Study|Withdrawal by Subject|0|||
130368015|NCT00191139|469317390|FG001|Overall Study|Withdrawal by Subject|3|||
130368016|NCT00191139|469317389|FG000|Overall Study|Disease Progression|0|||
130368017|NCT00191139|469317390|FG001|Overall Study|Disease Progression|1|||
130368018|NCT00191139|469317389|FG000|Overall Study|Other|1|||
130368019|NCT00191139|469317390|FG001|Overall Study|Other|2|||
130368020|NCT02465515|469317391|FG000|Overall Study|Investigator site closed|4|||
130368021|NCT02465515|469317392|FG001|Overall Study|Investigator site closed|5|||
130368022|NCT02465515|469317391|FG000|Overall Study|Withdrawal by Subject|74|||
130368023|NCT02465515|469317392|FG001|Overall Study|Withdrawal by Subject|43|||
130368024|NCT02465515|469317391|FG000|Overall Study|Physician Decision|8|||
130368025|NCT02465515|469317392|FG001|Overall Study|Physician Decision|12|||
130368026|NCT02465515|469317391|FG000|Overall Study|Lost to Follow-up|68|||
130368027|NCT02465515|469317392|FG001|Overall Study|Lost to Follow-up|51|||
130368028|NCT03846804|469317393|FG000|Overall Study|Refused blood draw|1|||
130368029|NCT03846804|469317393|FG000|Overall Study|Protocol Violation|1|||
130277395|NCT03594747|468976373|FG001|Overall Study|Sponsor decision|17|||
130368030|NCT00345839|469317396|FG000|Overall Study|Withdrawal by Subject|91|||
130368031|NCT00345839|469317397|FG001|Overall Study|Withdrawal by Subject|98|||
130368032|NCT00345839|469317396|FG000|Overall Study|Lost to Follow-up|58|||
130368033|NCT00345839|469317397|FG001|Overall Study|Lost to Follow-up|61|||
130277396|NCT03594747|468976374|FG002|Overall Study|Sponsor decision|16|||
130277397|NCT03594747|468976372|FG000|Overall Study|Did not meet inclusion criteria|0|||
130277398|NCT03594747|468976373|FG001|Overall Study|Did not meet inclusion criteria|0|||
130277399|NCT03594747|468976374|FG002|Overall Study|Did not meet inclusion criteria|1|||
130277400|NCT03594747|468976372|FG000|Overall Study|Transfer to long term extension study|10|||
130368034|NCT01084083|469317400|FG000|Overall Study|Adverse Event|5|||
130368035|NCT01084083|469317400|FG000|Overall Study|Death|1|||
130368036|NCT01084083|469317400|FG000|Overall Study|Withdrawal by Subject|2|||
130368037|NCT01084083|469317400|FG000|Overall Study|Complicating disease|1|||
130368038|NCT01084083|469317400|FG000|Overall Study|Other|2|||
130368039|NCT01084083|469317400|FG000|Overall Study|Never started assigned therapy|1|||
130368040|NCT01218113|469319526|FG000|Overall Study|Withdrawal by Subject|1|||
130368041|NCT01218113|469319527|FG001|Overall Study|Withdrawal by Subject|0|||
130368042|NCT01218113|469319528|FG002|Overall Study|Withdrawal by Subject|1|||
130368043|NCT01218113|469319526|FG000|Overall Study|Lost to Follow-up|4|||
130368044|NCT01218113|469319527|FG001|Overall Study|Lost to Follow-up|1|||
130368045|NCT01218113|469319528|FG002|Overall Study|Lost to Follow-up|4|||
130368046|NCT01218113|469319526|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
130368047|NCT01218113|469319527|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
130368048|NCT01218113|469319528|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
130368049|NCT04840615|469319529|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
130710375|NCT03739138|470564817|FG000|Overall Study|Study Terminated By Sponsor|0|||
130710376|NCT03739138|470564818|FG001|Overall Study|Study Terminated By Sponsor|0|||
130277401|NCT03594747|468976373|FG001|Overall Study|Transfer to long term extension study|12|||
130277402|NCT03594747|468976374|FG002|Overall Study|Transfer to long term extension study|5|||
130277403|NCT02095873|468976375|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130277404|NCT02095873|468976376|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130277405|NCT02095873|468976375|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130277406|NCT02095873|468976376|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130277407|NCT02095873|468976375|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
130277408|NCT02095873|468976376|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
130277409|NCT00792740|468976377|FG000|Overall Study|Disease Worsening|3|||
130277410|NCT00792740|468976378|FG001|Overall Study|Disease Worsening|2|||
130277411|NCT00792740|468976377|FG000|Overall Study|Personal Reason|1|||
130277412|NCT00792740|468976378|FG001|Overall Study|Personal Reason|0|||
130277413|NCT00792740|468976377|FG000|Overall Study|Adverse Event|1|||
130277414|NCT00792740|468976378|FG001|Overall Study|Adverse Event|3|||
130277415|NCT00792740|468976377|FG000|Overall Study|Patient's withdrawal of consent|0|||
130277416|NCT00792740|468976378|FG001|Overall Study|Patient's withdrawal of consent|1|||
130277417|NCT00792740|468976377|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
130277418|NCT00792740|468976378|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
130277419|NCT00792740|468976377|FG000|Overall Study|Other reasons|0|||
130277420|NCT00792740|468976378|FG001|Overall Study|Other reasons|1|||
130277421|NCT00703846|468976379|FG000|Overall Study|Adverse Event|8|||
130277422|NCT00703846|468976379|FG000|Overall Study|Lost to Follow-up|55|||
130277423|NCT00703846|468976379|FG000|Overall Study|Lack of Efficacy|15|||
130277424|NCT00703846|468976379|FG000|Overall Study|Noncompliance with Study Treatment|2|||
130277425|NCT00703846|468976379|FG000|Overall Study|Withdrawal by Subject|40|||
130277426|NCT00703846|468976379|FG000|Overall Study|Death|1|||
130277427|NCT00703846|468976379|FG000|Overall Study|Other|14|||
130277428|NCT00703846|468976379|FG000|Overall Study|Did Not Receive Study Drug|2|||
130710377|NCT03739138|470564819|FG002|Overall Study|Study Terminated By Sponsor|0|||
130710378|NCT03739138|470564820|FG003|Overall Study|Study Terminated By Sponsor|4|||
130277429|NCT02485639|468976382|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
130277430|NCT02485639|468976382|FG000|Overall Study|Early termination|4|||
130277431|NCT02485639|468976382|FG000|Overall Study|Withdrawal by Subject|4|||
130277432|NCT02015481|468976383|FG000|Overall Study|Death|1|||
130277433|NCT02566785|468976384|FG000|Overall Study|Lost to Follow-up|0|||
130277434|NCT02566785|468976385|FG001|Overall Study|Lost to Follow-up|2|||
130277435|NCT02566785|468976384|FG000|Overall Study|Worsening condition|1|||
130277436|NCT02566785|468976385|FG001|Overall Study|Worsening condition|1|||
130277437|NCT01170273|468976389|FG000|Overall Study|Lost to Follow-up|6|||
130277438|NCT01170273|468976390|FG001|Overall Study|Lost to Follow-up|8|||
130277439|NCT01170273|468976389|FG000|Overall Study|Protocol Violation|1|||
130277440|NCT01170273|468976390|FG001|Overall Study|Protocol Violation|0|||
130277441|NCT01170273|468976389|FG000|Overall Study|Death|1|||
130277442|NCT01170273|468976390|FG001|Overall Study|Death|0|||
130277443|NCT01170273|468976389|FG000|Overall Study|Adverse Event|0|||
130277444|NCT01170273|468976390|FG001|Overall Study|Adverse Event|1|||
130277445|NCT00334737|468976391|FG000|Hospital Phase|Death|1|||
130277446|NCT00334737|468976392|FG001|Hospital Phase|Death|2|||
130555318|NCT03942406|470001553|FG004|Overall Study|Withdrawal by Subject|0|||
130277447|NCT00334737|468976393|FG002|Hospital Phase|Death|3|||
130277448|NCT00334737|468976391|FG000|Hospital Phase|Withdrawal by Subject|0|||
130277449|NCT00334737|468976392|FG001|Hospital Phase|Withdrawal by Subject|0|||
130277450|NCT00334737|468976393|FG002|Hospital Phase|Withdrawal by Subject|1|||
130277451|NCT00334737|468976391|FG000|Hospital Phase|Did not receive study drug|1|||
130277452|NCT00334737|468976392|FG001|Hospital Phase|Did not receive study drug|0|||
130277453|NCT00334737|468976393|FG002|Hospital Phase|Did not receive study drug|0|||
130277454|NCT00334737|468976391|FG000|Follow up Phase|Lost to Follow-up|5|||
130277455|NCT00334737|468976392|FG001|Follow up Phase|Lost to Follow-up|3|||
130277456|NCT00334737|468976393|FG002|Follow up Phase|Lost to Follow-up|6|||
130277457|NCT00583752|468976394|FG000|Overall Study|Lost to Follow-up|5|||
130277458|NCT00583752|468976395|FG001|Overall Study|Lost to Follow-up|5|||
130277459|NCT02316353|468976396|FG000|Overall Study|Pregnancy|1|||
130277460|NCT02316353|468976397|FG001|Overall Study|Pregnancy|3|||
130277461|NCT02316353|468976396|FG000|Overall Study|Adverse Event|1|||
130277462|NCT02316353|468976397|FG001|Overall Study|Adverse Event|3|||
130277463|NCT02316353|468976396|FG000|Overall Study|Withdrawal by Subject|6|||
130277464|NCT02316353|468976397|FG001|Overall Study|Withdrawal by Subject|2|||
130277465|NCT02147197|468976398|FG000|Overall Study|Adverse Event|1|||
130277466|NCT02147197|468976399|FG001|Overall Study|Adverse Event|0|||
130277467|NCT02147197|468976400|FG002|Overall Study|Adverse Event|0|||
130277468|NCT02147197|468976398|FG000|Overall Study|Withdrawal of Consent|4|||
130277469|NCT02147197|468976399|FG001|Overall Study|Withdrawal of Consent|3|||
130277470|NCT02147197|468976400|FG002|Overall Study|Withdrawal of Consent|2|||
130710379|NCT03739138|470564821|FG004|Overall Study|Study Terminated By Sponsor|0|||
130710380|NCT03739138|470564817|FG000|Overall Study|Withdrawal by Subject|0|||
130277471|NCT02147197|468976398|FG000|Overall Study|Lost to Follow-up|2|||
130277472|NCT02147197|468976399|FG001|Overall Study|Lost to Follow-up|3|||
130277473|NCT02147197|468976400|FG002|Overall Study|Lost to Follow-up|1|||
130277474|NCT02147197|468976398|FG000|Overall Study|Protocol Violation|1|||
130277475|NCT02147197|468976399|FG001|Overall Study|Protocol Violation|0|||
130277476|NCT02147197|468976400|FG002|Overall Study|Protocol Violation|3|||
130277477|NCT02147197|468976398|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130277478|NCT02147197|468976399|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130277479|NCT02147197|468976400|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130277480|NCT03522246|468978160|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
130277481|NCT03522246|468978161|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
130277482|NCT03522246|468978162|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
130277483|NCT03522246|468978163|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
130277484|NCT03522246|468978164|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
130277485|NCT04683029|468978165|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
130277486|NCT04683029|468978166|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277487|NCT04683029|468978167|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277488|NCT04683029|468978168|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277489|NCT04683029|468978165|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277490|NCT04683029|468978166|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277491|NCT04683029|468978167|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277492|NCT04683029|468978168|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
130277493|NCT04683029|468978165|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277494|NCT04683029|468978166|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277495|NCT04683029|468978167|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
130277496|NCT04683029|468978168|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277497|NCT00814580|468978169|FG000|Overall Study|Adverse Event|6|||
130277498|NCT00814580|468978170|FG001|Overall Study|Adverse Event|15|||
130277499|NCT00814580|468978169|FG000|Overall Study|Lack of Efficacy|18|||
130277500|NCT00814580|468978170|FG001|Overall Study|Lack of Efficacy|25|||
130277501|NCT00814580|468978169|FG000|Overall Study|Protocol Violation|2|||
130277502|NCT00814580|468978170|FG001|Overall Study|Protocol Violation|0|||
130277503|NCT00814580|468978169|FG000|Overall Study|Withdrawal by Subject|2|||
130277504|NCT00814580|468978170|FG001|Overall Study|Withdrawal by Subject|2|||
130277505|NCT00814580|468978169|FG000|Overall Study|Other|1|||
130277506|NCT00814580|468978170|FG001|Overall Study|Other|3|||
130277507|NCT00814580|468978169|FG000|Overall Study|Did Not Take Drug|2|||
130277508|NCT00814580|468978170|FG001|Overall Study|Did Not Take Drug|2|||
130277509|NCT02482428|468978171|FG000|Overall Study|Lost to Follow-up|4|||
130277510|NCT02482428|468978172|FG001|Overall Study|Lost to Follow-up|9|||
130277511|NCT02482428|468978173|FG002|Overall Study|Lost to Follow-up|1|||
130277512|NCT02482428|468978174|FG003|Overall Study|Lost to Follow-up|2|||
130277513|NCT02482428|468978175|FG004|Overall Study|Lost to Follow-up|4|||
130277514|NCT02482428|468978171|FG000|Overall Study|Physician Decision|0|||
130277515|NCT02482428|468978172|FG001|Overall Study|Physician Decision|0|||
130277516|NCT02482428|468978173|FG002|Overall Study|Physician Decision|0|||
130277517|NCT02482428|468978174|FG003|Overall Study|Physician Decision|0|||
130277518|NCT02482428|468978175|FG004|Overall Study|Physician Decision|1|||
130277519|NCT02482428|468978171|FG000|Overall Study|protocol deviation|1|||
130277520|NCT02482428|468978172|FG001|Overall Study|protocol deviation|1|||
130277521|NCT02482428|468978173|FG002|Overall Study|protocol deviation|0|||
130277522|NCT02482428|468978174|FG003|Overall Study|protocol deviation|0|||
130277523|NCT02482428|468978175|FG004|Overall Study|protocol deviation|0|||
130277524|NCT02482428|468978171|FG000|Overall Study|subject/guardian decision|4|||
130277525|NCT02482428|468978172|FG001|Overall Study|subject/guardian decision|2|||
130277526|NCT02482428|468978173|FG002|Overall Study|subject/guardian decision|0|||
130277527|NCT02482428|468978174|FG003|Overall Study|subject/guardian decision|0|||
130277528|NCT02482428|468978175|FG004|Overall Study|subject/guardian decision|2|||
130277529|NCT00459875|468978178|FG000|Overall Study|Ineligible participant|1|||
130277530|NCT00459875|468978178|FG000|Overall Study|Adverse Event|2|||
130277531|NCT01406938|468978181|FG000|Induction Period|Subject/guardian decision|6|||
130277532|NCT01406938|468978182|FG001|Induction Period|Subject/guardian decision|8|||
130277533|NCT01406938|468978183|FG002|Induction Period|Subject/guardian decision|0|||
130277534|NCT01406938|468978184|FG003|Induction Period|Subject/guardian decision|0|||
130277535|NCT01406938|468978185|FG004|Induction Period|Subject/guardian decision|0|||
130277536|NCT01406938|468978186|FG005|Induction Period|Subject/guardian decision|0|||
130277537|NCT01406938|468978181|FG000|Induction Period|Protocol deviation|1|||
130277538|NCT01406938|468978182|FG001|Induction Period|Protocol deviation|0|||
130277539|NCT01406938|468978183|FG002|Induction Period|Protocol deviation|0|||
130277540|NCT01406938|468978184|FG003|Induction Period|Protocol deviation|0|||
130277541|NCT01406938|468978185|FG004|Induction Period|Protocol deviation|0|||
130277542|NCT01406938|468978186|FG005|Induction Period|Protocol deviation|0|||
130277543|NCT01406938|468978181|FG000|Induction Period|Adverse Event|8|||
130277544|NCT01406938|468978182|FG001|Induction Period|Adverse Event|9|||
130277545|NCT01406938|468978183|FG002|Induction Period|Adverse Event|0|||
130277546|NCT01406938|468978184|FG003|Induction Period|Adverse Event|0|||
130277547|NCT01406938|468978185|FG004|Induction Period|Adverse Event|0|||
130277548|NCT01406938|468978186|FG005|Induction Period|Adverse Event|0|||
130277549|NCT01406938|468978181|FG000|Induction Period|Lack of Efficacy|1|||
130277550|NCT01406938|468978182|FG001|Induction Period|Lack of Efficacy|0|||
130277551|NCT01406938|468978183|FG002|Induction Period|Lack of Efficacy|0|||
130277552|NCT01406938|468978184|FG003|Induction Period|Lack of Efficacy|0|||
130277553|NCT01406938|468978185|FG004|Induction Period|Lack of Efficacy|0|||
130277554|NCT01406938|468978186|FG005|Induction Period|Lack of Efficacy|0|||
130277555|NCT01406938|468978181|FG000|Induction Period|Lost to Follow-up|2|||
130277556|NCT01406938|468978182|FG001|Induction Period|Lost to Follow-up|3|||
130277557|NCT01406938|468978183|FG002|Induction Period|Lost to Follow-up|0|||
130277558|NCT01406938|468978184|FG003|Induction Period|Lost to Follow-up|0|||
130277559|NCT01406938|468978185|FG004|Induction Period|Lost to Follow-up|0|||
130277560|NCT01406938|468978186|FG005|Induction Period|Lost to Follow-up|0|||
130277561|NCT01406938|468978181|FG000|Maintenance Period|Adverse Event|0|||
130277562|NCT01406938|468978182|FG001|Maintenance Period|Adverse Event|0|||
130277563|NCT01406938|468978183|FG002|Maintenance Period|Adverse Event|2|||
130277564|NCT01406938|468978184|FG003|Maintenance Period|Adverse Event|8|||
130277565|NCT01406938|468978185|FG004|Maintenance Period|Adverse Event|4|||
130277566|NCT01406938|468978186|FG005|Maintenance Period|Adverse Event|2|||
130277567|NCT01406938|468978181|FG000|Maintenance Period|Death|0|||
130277568|NCT01406938|468978182|FG001|Maintenance Period|Death|0|||
130277569|NCT01406938|468978183|FG002|Maintenance Period|Death|0|||
130277570|NCT01406938|468978184|FG003|Maintenance Period|Death|0|||
130277571|NCT01406938|468978185|FG004|Maintenance Period|Death|1|||
130277572|NCT01406938|468978186|FG005|Maintenance Period|Death|0|||
130277573|NCT01406938|468978181|FG000|Maintenance Period|Subject/guardian decision|0|||
130277574|NCT01406938|468978182|FG001|Maintenance Period|Subject/guardian decision|0|||
130277575|NCT01406938|468978183|FG002|Maintenance Period|Subject/guardian decision|11|||
130277576|NCT01406938|468978184|FG003|Maintenance Period|Subject/guardian decision|7|||
130277577|NCT01406938|468978185|FG004|Maintenance Period|Subject/guardian decision|10|||
130277578|NCT01406938|468978186|FG005|Maintenance Period|Subject/guardian decision|7|||
130277579|NCT01406938|468978181|FG000|Maintenance Period|Protocol Violation|0|||
130277580|NCT01406938|468978182|FG001|Maintenance Period|Protocol Violation|0|||
130277581|NCT01406938|468978183|FG002|Maintenance Period|Protocol Violation|2|||
130277582|NCT01406938|468978184|FG003|Maintenance Period|Protocol Violation|2|||
130277583|NCT01406938|468978185|FG004|Maintenance Period|Protocol Violation|2|||
130277584|NCT01406938|468978186|FG005|Maintenance Period|Protocol Violation|2|||
130277585|NCT01406938|468978181|FG000|Maintenance Period|Pregnancy|0|||
130277586|NCT01406938|468978182|FG001|Maintenance Period|Pregnancy|0|||
130277587|NCT01406938|468978183|FG002|Maintenance Period|Pregnancy|0|||
130277588|NCT01406938|468978184|FG003|Maintenance Period|Pregnancy|0|||
130277589|NCT01406938|468978185|FG004|Maintenance Period|Pregnancy|1|||
130277590|NCT01406938|468978186|FG005|Maintenance Period|Pregnancy|0|||
130277591|NCT01406938|468978181|FG000|Maintenance Period|Lost to Follow-up|0|||
130277592|NCT01406938|468978182|FG001|Maintenance Period|Lost to Follow-up|0|||
130277593|NCT01406938|468978183|FG002|Maintenance Period|Lost to Follow-up|0|||
130277594|NCT01406938|468978184|FG003|Maintenance Period|Lost to Follow-up|0|||
130277595|NCT01406938|468978185|FG004|Maintenance Period|Lost to Follow-up|4|||
130368050|NCT04840615|469319530|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
130368051|NCT04840615|469319531|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
130368052|NCT00967668|469319532|FG000|Overall Study|Withdrawal by Subject|13|||
130368053|NCT00967668|469319533|FG001|Overall Study|Withdrawal by Subject|8|||
130368054|NCT00967668|469319534|FG002|Overall Study|Withdrawal by Subject|8|||
130368055|NCT00967668|469319532|FG000|Overall Study|Death|0|||
130368056|NCT00967668|469319533|FG001|Overall Study|Death|2|||
130368057|NCT00967668|469319534|FG002|Overall Study|Death|4|||
130368058|NCT00967668|469319532|FG000|Overall Study|Removed due to behavior|1|||
130277596|NCT01406938|468978186|FG005|Maintenance Period|Lost to Follow-up|0|||
130277597|NCT01406938|468978181|FG000|Maintenance Period|Lack of Efficacy|0|||
130277598|NCT01406938|468978182|FG001|Maintenance Period|Lack of Efficacy|0|||
130277599|NCT01406938|468978183|FG002|Maintenance Period|Lack of Efficacy|2|||
130277600|NCT01406938|468978184|FG003|Maintenance Period|Lack of Efficacy|1|||
130368059|NCT00967668|469319533|FG001|Overall Study|Removed due to behavior|1|||
130457505|NCT05046132|469638364|FG002|Overall Study|Withdrawal by Subject|0|||
130277601|NCT01406938|468978185|FG004|Maintenance Period|Lack of Efficacy|3|||
130277602|NCT01406938|468978186|FG005|Maintenance Period|Lack of Efficacy|5|||
130277603|NCT01406938|468978181|FG000|Follow up|Lack of Efficacy|3|||
130277604|NCT01406938|468978182|FG001|Follow up|Lack of Efficacy|2|||
130277605|NCT01406938|468978183|FG002|Follow up|Lack of Efficacy|1|||
130277606|NCT01406938|468978184|FG003|Follow up|Lack of Efficacy|0|||
130277607|NCT01406938|468978185|FG004|Follow up|Lack of Efficacy|0|||
130277608|NCT01406938|468978186|FG005|Follow up|Lack of Efficacy|0|||
130277609|NCT01406938|468978181|FG000|Follow up|Patient/guardian decision|4|||
130277610|NCT01406938|468978182|FG001|Follow up|Patient/guardian decision|2|||
130277611|NCT01406938|468978183|FG002|Follow up|Patient/guardian decision|4|||
130277612|NCT01406938|468978184|FG003|Follow up|Patient/guardian decision|2|||
130277613|NCT01406938|468978185|FG004|Follow up|Patient/guardian decision|4|||
130277614|NCT01406938|468978186|FG005|Follow up|Patient/guardian decision|1|||
130277615|NCT01406938|468978181|FG000|Follow up|Protocol Violation|0|||
130277616|NCT01406938|468978182|FG001|Follow up|Protocol Violation|0|||
130277617|NCT01406938|468978183|FG002|Follow up|Protocol Violation|1|||
130277618|NCT01406938|468978184|FG003|Follow up|Protocol Violation|0|||
130277619|NCT01406938|468978185|FG004|Follow up|Protocol Violation|0|||
130277620|NCT01406938|468978186|FG005|Follow up|Protocol Violation|0|||
130277621|NCT01406938|468978181|FG000|Follow up|Physician Decision|0|||
130277622|NCT01406938|468978182|FG001|Follow up|Physician Decision|0|||
130277623|NCT01406938|468978183|FG002|Follow up|Physician Decision|2|||
130277624|NCT01406938|468978184|FG003|Follow up|Physician Decision|0|||
130277625|NCT01406938|468978185|FG004|Follow up|Physician Decision|3|||
130277626|NCT01406938|468978186|FG005|Follow up|Physician Decision|1|||
130277627|NCT01406938|468978181|FG000|Follow up|Lost to Follow-up|1|||
130277628|NCT01406938|468978182|FG001|Follow up|Lost to Follow-up|1|||
130277629|NCT01406938|468978183|FG002|Follow up|Lost to Follow-up|0|||
130277630|NCT01406938|468978184|FG003|Follow up|Lost to Follow-up|1|||
130277631|NCT01406938|468978185|FG004|Follow up|Lost to Follow-up|2|||
130277632|NCT01406938|468978186|FG005|Follow up|Lost to Follow-up|1|||
130277633|NCT01951586|468978194|FG000|Overall Study|Death|61|||
130277634|NCT01951586|468978195|FG001|Overall Study|Death|120|||
130277635|NCT01951586|468978194|FG000|Overall Study|Withdrawal by Subject|8|||
130277636|NCT01951586|468978195|FG001|Overall Study|Withdrawal by Subject|17|||
130277637|NCT01951586|468978194|FG000|Overall Study|Lost to Follow-up|0|||
130277638|NCT01951586|468978195|FG001|Overall Study|Lost to Follow-up|1|||
130277639|NCT01951586|468978194|FG000|Overall Study|Sponsor Decision|9|||
130277640|NCT01951586|468978195|FG001|Overall Study|Sponsor Decision|10|||
130277641|NCT00878254|468978197|FG000|Overall Study|Physician Decision|1|||
130277642|NCT00878254|468978197|FG000|Overall Study|Death|1|||
130277643|NCT00878254|468978197|FG000|Overall Study|Withdrawal by Subject|1|||
130277644|NCT04560816|468978199|FG000|Overall Study|Withdrawal by Subject|1|||
130277645|NCT04560816|468978200|FG001|Overall Study|Withdrawal by Subject|1|||
130277646|NCT04560816|468978201|FG002|Overall Study|Withdrawal by Subject|1|||
130277647|NCT04560816|468978202|FG003|Overall Study|Withdrawal by Subject|0|||
130277648|NCT04560816|468978203|FG004|Overall Study|Withdrawal by Subject|3|||
130277649|NCT04560816|468978204|FG005|Overall Study|Withdrawal by Subject|0|||
130277650|NCT04560816|468978199|FG000|Overall Study|Lost to Follow-up|1|||
130277651|NCT04560816|468978200|FG001|Overall Study|Lost to Follow-up|0|||
130277652|NCT04560816|468978201|FG002|Overall Study|Lost to Follow-up|0|||
130277653|NCT04560816|468978202|FG003|Overall Study|Lost to Follow-up|0|||
130277654|NCT04560816|468978203|FG004|Overall Study|Lost to Follow-up|0|||
130277655|NCT04560816|468978204|FG005|Overall Study|Lost to Follow-up|0|||
130277656|NCT04560816|468978199|FG000|Overall Study|Protocol Violation|1|||
130277657|NCT04560816|468978200|FG001|Overall Study|Protocol Violation|0|||
130277658|NCT04560816|468978201|FG002|Overall Study|Protocol Violation|0|||
130277659|NCT04560816|468978202|FG003|Overall Study|Protocol Violation|0|||
130277660|NCT04560816|468978203|FG004|Overall Study|Protocol Violation|0|||
130277661|NCT04560816|468978204|FG005|Overall Study|Protocol Violation|0|||
130277662|NCT02277691|468978205|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
130277663|NCT02277691|468978205|FG000|Overall Study|Voluntary Withdrawal|7|||
130277664|NCT02277691|468978205|FG000|Overall Study|Lack of Efficacy|5|||
130277665|NCT02277691|468978205|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
130277666|NCT00441142|468978207|FG000|Overall Study|Adverse Event|2|||
130277667|NCT00441142|468978208|FG001|Overall Study|Adverse Event|3|||
130277668|NCT00441142|468978209|FG002|Overall Study|Adverse Event|3|||
130277669|NCT00441142|468978210|FG003|Overall Study|Adverse Event|22|||
130277670|NCT00441142|468978207|FG000|Overall Study|Lack of Efficacy|3|||
130277671|NCT00441142|468978208|FG001|Overall Study|Lack of Efficacy|3|||
130277672|NCT00441142|468978209|FG002|Overall Study|Lack of Efficacy|17|||
130277673|NCT00441142|468978210|FG003|Overall Study|Lack of Efficacy|32|||
130277674|NCT00441142|468978207|FG000|Overall Study|Withdrawal by Subject|0|||
130277675|NCT00441142|468978208|FG001|Overall Study|Withdrawal by Subject|0|||
130277676|NCT00441142|468978209|FG002|Overall Study|Withdrawal by Subject|2|||
130277677|NCT00441142|468978210|FG003|Overall Study|Withdrawal by Subject|10|||
130277678|NCT00441142|468978207|FG000|Overall Study|Patient still receiving active study tx|1|||
130277679|NCT00441142|468978208|FG001|Overall Study|Patient still receiving active study tx|0|||
130277680|NCT00441142|468978209|FG002|Overall Study|Patient still receiving active study tx|0|||
130277681|NCT00441142|468978210|FG003|Overall Study|Patient still receiving active study tx|2|||
130277682|NCT00441142|468978207|FG000|Overall Study|Physician Decision|0|||
130277683|NCT00441142|468978208|FG001|Overall Study|Physician Decision|1|||
130277684|NCT00441142|468978209|FG002|Overall Study|Physician Decision|0|||
130277685|NCT00441142|468978210|FG003|Overall Study|Physician Decision|1|||
130277686|NCT00441142|468978207|FG000|Overall Study|Death|0|||
130277687|NCT00441142|468978208|FG001|Overall Study|Death|0|||
130277688|NCT00441142|468978209|FG002|Overall Study|Death|0|||
130277689|NCT00441142|468978210|FG003|Overall Study|Death|1|||
130277690|NCT04952597|468978211|FG000|Overall Study|Death|12|||
130277691|NCT04952597|468978212|FG001|Overall Study|Death|13|||
130277692|NCT04952597|468978213|FG002|Overall Study|Death|14|||
130277693|NCT04952597|468978211|FG000|Overall Study|Withdrawal by Subject|1|||
130368060|NCT00967668|469319534|FG002|Overall Study|Removed due to behavior|2|||
130368061|NCT00967668|469319532|FG000|Overall Study|Refused Year 2|11|||
130368062|NCT00967668|469319533|FG001|Overall Study|Refused Year 2|6|||
130368063|NCT00967668|469319534|FG002|Overall Study|Refused Year 2|4|||
130368064|NCT00967668|469319532|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
130368065|NCT00967668|469319533|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
130368066|NCT00967668|469319534|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
130368067|NCT00967668|469319532|FG000|Overall Study|Lost to Follow-up|15|||
130457506|NCT05046132|469638362|FG000|Overall Study|Positive Covid19 Result.|0|||
130457507|NCT05046132|469638363|FG001|Overall Study|Positive Covid19 Result.|1|||
130457508|NCT05046132|469638364|FG002|Overall Study|Positive Covid19 Result.|0|||
130457509|NCT01959412|469638365|FG000|Overall Study|Protocol deviation|1|||
130457510|NCT01959412|469638366|FG001|Overall Study|Protocol deviation|1|||
130457511|NCT01959412|469638367|FG002|Overall Study|Protocol deviation|0|||
130457512|NCT01959412|469638368|FG003|Overall Study|Protocol deviation|1|||
130277694|NCT04952597|468978212|FG001|Overall Study|Withdrawal by Subject|0|||
130277695|NCT04952597|468978213|FG002|Overall Study|Withdrawal by Subject|3|||
130277696|NCT04952597|468978211|FG000|Overall Study|Lost to Follow-up|0|||
130277697|NCT04952597|468978212|FG001|Overall Study|Lost to Follow-up|1|||
130277698|NCT04952597|468978213|FG002|Overall Study|Lost to Follow-up|1|||
130277699|NCT01265563|468978214|FG000|Overall Study|Withdrawal by Subject|0|||
130277700|NCT01265563|468978215|FG001|Overall Study|Withdrawal by Subject|1|||
130277701|NCT01265563|468978216|FG002|Overall Study|Withdrawal by Subject|1|||
130277702|NCT01265563|468978217|FG003|Overall Study|Withdrawal by Subject|0|||
130277703|NCT01265563|468978218|FG004|Overall Study|Withdrawal by Subject|2|||
130277704|NCT04908865|468978223|FG000|Overall Study|Adverse Event|2|||
130277705|NCT04908865|468978223|FG000|Overall Study|Lack of Efficacy|5|||
130277706|NCT04908865|468978223|FG000|Overall Study|Lost to Follow-up|1|||
130277707|NCT02141399|468978226|FG000|Overall Study|Adverse Event|158|||
130277708|NCT02141399|468978226|FG000|Overall Study|Lack of Efficacy|62|||
130277709|NCT02141399|468978226|FG000|Overall Study|Lost to Follow-up|151|||
130277710|NCT02141399|468978226|FG000|Overall Study|Non-compliance with study drug|18|||
130277711|NCT02141399|468978226|FG000|Overall Study|Other|45|||
130277712|NCT02141399|468978226|FG000|Overall Study|Physician Decision|17|||
130277713|NCT02141399|468978226|FG000|Overall Study|Pregnancy|3|||
130277714|NCT02141399|468978226|FG000|Overall Study|Protocol Violation|38|||
130277715|NCT02141399|468978226|FG000|Overall Study|Withdrawal by Subject|238|||
130277716|NCT02141399|468978226|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130368068|NCT00967668|469319533|FG001|Overall Study|Lost to Follow-up|9|||
130368069|NCT00967668|469319534|FG002|Overall Study|Lost to Follow-up|16|||
130277717|NCT05730335|468978227|FG000|Overall Study|Lost to Follow-up|8|||
130710381|NCT03739138|470564818|FG001|Overall Study|Withdrawal by Subject|0|||
130710382|NCT03739138|470564819|FG002|Overall Study|Withdrawal by Subject|0|||
130710383|NCT03739138|470564820|FG003|Overall Study|Withdrawal by Subject|1|||
130710384|NCT03739138|470564821|FG004|Overall Study|Withdrawal by Subject|0|||
130710385|NCT02654587|470564822|FG000|Overall Study|patient alive at end of study|22|||
130710386|NCT02654587|470564823|FG001|Overall Study|patient alive at end of study|8|||
130710387|NCT02654587|470564822|FG000|Overall Study|Withdrawal by Subject|1|||
130710388|NCT02654587|470564823|FG001|Overall Study|Withdrawal by Subject|7|||
130710389|NCT01825837|470564824|FG000|PART I|Withdrawal by Subject|0|||
130710390|NCT01825837|470564825|FG001|PART I|Withdrawal by Subject|0|||
130277718|NCT05730335|468978227|FG000|Overall Study|Withdrawal by Subject|6|||
130277719|NCT01296711|468978228|FG000|Overall Study|Adverse Event|3|||
130710391|NCT01825837|470564826|FG002|PART I|Withdrawal by Subject|0|||
130277720|NCT01296711|468978229|FG001|Overall Study|Adverse Event|1|||
130277721|NCT01296711|468978230|FG002|Overall Study|Adverse Event|4|||
130277722|NCT01296711|468978231|FG003|Overall Study|Adverse Event|3|||
130277723|NCT01296711|468978232|FG004|Overall Study|Adverse Event|1|||
130277724|NCT01296711|468978233|FG005|Overall Study|Adverse Event|6|||
130277725|NCT01296711|468978234|FG006|Overall Study|Adverse Event|11|||
130277726|NCT01296711|468978235|FG007|Overall Study|Adverse Event|3|||
130277727|NCT01296711|468978228|FG000|Overall Study|Lack of Efficacy|1|||
130277728|NCT01296711|468978229|FG001|Overall Study|Lack of Efficacy|4|||
130277729|NCT01296711|468978230|FG002|Overall Study|Lack of Efficacy|1|||
130277730|NCT01296711|468978231|FG003|Overall Study|Lack of Efficacy|1|||
130277731|NCT01296711|468978232|FG004|Overall Study|Lack of Efficacy|1|||
130277732|NCT01296711|468978233|FG005|Overall Study|Lack of Efficacy|0|||
130277733|NCT01296711|468978234|FG006|Overall Study|Lack of Efficacy|2|||
130277734|NCT01296711|468978235|FG007|Overall Study|Lack of Efficacy|3|||
130277735|NCT01296711|468978228|FG000|Overall Study|Lost to Follow-up|0|||
130277736|NCT01296711|468978229|FG001|Overall Study|Lost to Follow-up|0|||
130277737|NCT01296711|468978230|FG002|Overall Study|Lost to Follow-up|1|||
130277738|NCT01296711|468978231|FG003|Overall Study|Lost to Follow-up|1|||
130277739|NCT01296711|468978232|FG004|Overall Study|Lost to Follow-up|2|||
130277740|NCT01296711|468978233|FG005|Overall Study|Lost to Follow-up|0|||
130277741|NCT01296711|468978234|FG006|Overall Study|Lost to Follow-up|4|||
130277742|NCT01296711|468978235|FG007|Overall Study|Lost to Follow-up|2|||
130277743|NCT01296711|468978228|FG000|Overall Study|Protocol Violation|0|||
130710392|NCT01825837|470564827|FG003|PART I|Withdrawal by Subject|6|||
130710393|NCT01825837|470564824|FG000|PART I|Patient non-compliance|0|||
130277744|NCT01296711|468978229|FG001|Overall Study|Protocol Violation|0|||
130277745|NCT01296711|468978230|FG002|Overall Study|Protocol Violation|0|||
130277746|NCT01296711|468978231|FG003|Overall Study|Protocol Violation|1|||
130277747|NCT01296711|468978232|FG004|Overall Study|Protocol Violation|1|||
130277748|NCT01296711|468978233|FG005|Overall Study|Protocol Violation|0|||
130277749|NCT01296711|468978234|FG006|Overall Study|Protocol Violation|0|||
130277750|NCT01296711|468978235|FG007|Overall Study|Protocol Violation|0|||
130277751|NCT01296711|468978228|FG000|Overall Study|Withdrawal by Subject|4|||
130277752|NCT01296711|468978229|FG001|Overall Study|Withdrawal by Subject|2|||
130277753|NCT01296711|468978230|FG002|Overall Study|Withdrawal by Subject|2|||
130277754|NCT01296711|468978231|FG003|Overall Study|Withdrawal by Subject|1|||
130277755|NCT01296711|468978232|FG004|Overall Study|Withdrawal by Subject|1|||
130277756|NCT01296711|468978233|FG005|Overall Study|Withdrawal by Subject|1|||
130277757|NCT01296711|468978234|FG006|Overall Study|Withdrawal by Subject|2|||
130277758|NCT01296711|468978235|FG007|Overall Study|Withdrawal by Subject|1|||
130277759|NCT01296711|468978228|FG000|Overall Study|Study termination|8|||
130277760|NCT01296711|468978229|FG001|Overall Study|Study termination|1|||
130277761|NCT01296711|468978230|FG002|Overall Study|Study termination|5|||
130277762|NCT01296711|468978231|FG003|Overall Study|Study termination|4|||
130277763|NCT01296711|468978232|FG004|Overall Study|Study termination|4|||
130277764|NCT01296711|468978233|FG005|Overall Study|Study termination|4|||
130277765|NCT01296711|468978234|FG006|Overall Study|Study termination|8|||
130277766|NCT01296711|468978235|FG007|Overall Study|Study termination|10|||
130277767|NCT01296711|468978228|FG000|Overall Study|Continued elevated liver enzymes|0|||
130277768|NCT01296711|468978229|FG001|Overall Study|Continued elevated liver enzymes|0|||
130277769|NCT01296711|468978230|FG002|Overall Study|Continued elevated liver enzymes|0|||
130277770|NCT01296711|468978231|FG003|Overall Study|Continued elevated liver enzymes|1|||
130277771|NCT01296711|468978232|FG004|Overall Study|Continued elevated liver enzymes|0|||
130277772|NCT01296711|468978233|FG005|Overall Study|Continued elevated liver enzymes|0|||
130457513|NCT01959412|469638369|FG004|Overall Study|Protocol deviation|3|||
130710394|NCT01825837|470564825|FG001|PART I|Patient non-compliance|0|||
130710395|NCT01825837|470564826|FG002|PART I|Patient non-compliance|0|||
130710396|NCT01825837|470564827|FG003|PART I|Patient non-compliance|1|||
130710397|NCT01825837|470564824|FG000|PART I|Treatment failure|0|||
130710398|NCT01825837|470564825|FG001|PART I|Treatment failure|0|||
130710399|NCT01825837|470564826|FG002|PART I|Treatment failure|0|||
130710400|NCT01825837|470564827|FG003|PART I|Treatment failure|7|||
130710401|NCT01825837|470564824|FG000|PART I|reason unspecified|0|||
130710402|NCT01825837|470564825|FG001|PART I|reason unspecified|0|||
130710403|NCT01825837|470564826|FG002|PART I|reason unspecified|0|||
130710404|NCT01825837|470564827|FG003|PART I|reason unspecified|3|||
130710405|NCT01825837|470564824|FG000|PART II|Withdrawal by Subject|3|||
130710406|NCT01825837|470564825|FG001|PART II|Withdrawal by Subject|3|||
130710407|NCT01825837|470564826|FG002|PART II|Withdrawal by Subject|7|||
130710408|NCT01825837|470564827|FG003|PART II|Withdrawal by Subject|0|||
130710409|NCT01825837|470564824|FG000|PART II|Patient non-compliance|5|||
130710410|NCT01825837|470564825|FG001|PART II|Patient non-compliance|2|||
130710411|NCT01825837|470564826|FG002|PART II|Patient non-compliance|4|||
130710412|NCT01825837|470564827|FG003|PART II|Patient non-compliance|0|||
130710413|NCT01825837|470564824|FG000|PART II|Adverse Event|3|||
130710414|NCT01825837|470564825|FG001|PART II|Adverse Event|3|||
130710415|NCT01825837|470564826|FG002|PART II|Adverse Event|1|||
130710416|NCT01825837|470564827|FG003|PART II|Adverse Event|0|||
130710417|NCT01825837|470564824|FG000|PART II|Treatment failure|6|||
130710418|NCT01825837|470564825|FG001|PART II|Treatment failure|4|||
130710419|NCT01825837|470564826|FG002|PART II|Treatment failure|5|||
130710420|NCT01825837|470564827|FG003|PART II|Treatment failure|0|||
130710421|NCT01825837|470564824|FG000|PART II|reason unspecified|2|||
130710422|NCT01825837|470564825|FG001|PART II|reason unspecified|2|||
130710423|NCT01825837|470564826|FG002|PART II|reason unspecified|2|||
130710424|NCT01825837|470564827|FG003|PART II|reason unspecified|0|||
130710425|NCT00904748|470564828|FG000|Overall Study|Withdrawal by Subject|1|||
130710426|NCT00904748|470564829|FG001|Overall Study|Withdrawal by Subject|1|||
130710427|NCT00904748|470564830|FG002|Overall Study|Withdrawal by Subject|1|||
130710428|NCT00904748|470564831|FG003|Overall Study|Withdrawal by Subject|2|||
130710429|NCT00904748|470564832|FG004|Overall Study|Withdrawal by Subject|0|||
130710430|NCT00904748|470564833|FG005|Overall Study|Withdrawal by Subject|0|||
130710431|NCT00904748|470564828|FG000|Overall Study|Adverse Event|0|||
130710432|NCT00904748|470564829|FG001|Overall Study|Adverse Event|0|||
130710433|NCT00904748|470564830|FG002|Overall Study|Adverse Event|0|||
130710434|NCT00904748|470564831|FG003|Overall Study|Adverse Event|0|||
130710435|NCT00904748|470564832|FG004|Overall Study|Adverse Event|1|||
130710436|NCT00904748|470564833|FG005|Overall Study|Adverse Event|0|||
130710437|NCT02903238|470564840|FG000|Overall Study|Lost to Follow-up|4|||
130710438|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
130710439|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
130277773|NCT01296711|468978234|FG006|Overall Study|Continued elevated liver enzymes|0|||
130710440|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
130710441|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
130710442|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
130277774|NCT01296711|468978235|FG007|Overall Study|Continued elevated liver enzymes|0|||
130277775|NCT01296711|468978228|FG000|Overall Study|Methotrexate discontinued|0|||
130277776|NCT01296711|468978229|FG001|Overall Study|Methotrexate discontinued|0|||
130277777|NCT01296711|468978230|FG002|Overall Study|Methotrexate discontinued|0|||
130277778|NCT01296711|468978231|FG003|Overall Study|Methotrexate discontinued|1|||
130277779|NCT01296711|468978232|FG004|Overall Study|Methotrexate discontinued|0|||
130277780|NCT01296711|468978233|FG005|Overall Study|Methotrexate discontinued|0|||
130710443|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130710444|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710445|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130710446|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710447|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710448|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
130710449|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
130710450|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
130710451|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
130710452|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
130710453|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
130710454|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
130710455|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
130710456|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130710457|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130710458|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Unclassified|14|||
130710459|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Unclassified|4|||
130710460|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Unclassified|8|||
130710461|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Unclassified|0|||
130710462|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Unclassified|0|||
130710463|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
130710464|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
130710465|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
130710466|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130710467|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130710468|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
130710469|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130710470|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130710471|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130710472|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130710473|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
130710474|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
130710475|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
130710476|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130710477|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130710478|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
130710479|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
130710480|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
130710481|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130710482|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130710483|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
130710484|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
130710485|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
130710486|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
130710487|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
130710488|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710489|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
130710490|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710491|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
130710492|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710493|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710494|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
130710495|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
130710496|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710497|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710498|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130710499|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130710500|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710501|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710502|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710503|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
130710504|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130710505|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
130277781|NCT01296711|468978234|FG006|Overall Study|Methotrexate discontinued|0|||
130277782|NCT01296711|468978235|FG007|Overall Study|Methotrexate discontinued|0|||
130277783|NCT01296711|468978228|FG000|Overall Study|Investigator discretion|0|||
130277784|NCT01296711|468978229|FG001|Overall Study|Investigator discretion|0|||
130277785|NCT01296711|468978230|FG002|Overall Study|Investigator discretion|0|||
130277786|NCT01296711|468978231|FG003|Overall Study|Investigator discretion|0|||
130277787|NCT01296711|468978232|FG004|Overall Study|Investigator discretion|0|||
130277788|NCT01296711|468978233|FG005|Overall Study|Investigator discretion|0|||
130277789|NCT01296711|468978234|FG006|Overall Study|Investigator discretion|1|||
130277790|NCT01296711|468978235|FG007|Overall Study|Investigator discretion|0|||
130277791|NCT01296711|468978228|FG000|Overall Study|Other|0|||
130277792|NCT01296711|468978229|FG001|Overall Study|Other|0|||
130277793|NCT01296711|468978230|FG002|Overall Study|Other|0|||
130277794|NCT01296711|468978231|FG003|Overall Study|Other|0|||
130277795|NCT01296711|468978232|FG004|Overall Study|Other|0|||
130277796|NCT01296711|468978233|FG005|Overall Study|Other|0|||
130277797|NCT01296711|468978234|FG006|Overall Study|Other|1|||
130277798|NCT01296711|468978235|FG007|Overall Study|Other|0|||
130277799|NCT01296711|468978228|FG000|Overall Study|Required restricted steroid injections|0|||
130277800|NCT01296711|468978229|FG001|Overall Study|Required restricted steroid injections|0|||
130277801|NCT01296711|468978230|FG002|Overall Study|Required restricted steroid injections|0|||
130277802|NCT01296711|468978231|FG003|Overall Study|Required restricted steroid injections|0|||
130277803|NCT01296711|468978232|FG004|Overall Study|Required restricted steroid injections|0|||
130277804|NCT01296711|468978233|FG005|Overall Study|Required restricted steroid injections|0|||
130277805|NCT01296711|468978234|FG006|Overall Study|Required restricted steroid injections|1|||
130277806|NCT01296711|468978235|FG007|Overall Study|Required restricted steroid injections|0|||
130277807|NCT01296711|468978228|FG000|Overall Study|Ongoing missed appointments|0|||
130277808|NCT01296711|468978229|FG001|Overall Study|Ongoing missed appointments|0|||
130277809|NCT01296711|468978230|FG002|Overall Study|Ongoing missed appointments|0|||
130277810|NCT01296711|468978231|FG003|Overall Study|Ongoing missed appointments|0|||
130277811|NCT01296711|468978232|FG004|Overall Study|Ongoing missed appointments|0|||
130277812|NCT01296711|468978233|FG005|Overall Study|Ongoing missed appointments|0|||
130277813|NCT01296711|468978234|FG006|Overall Study|Ongoing missed appointments|1|||
130277814|NCT01296711|468978235|FG007|Overall Study|Ongoing missed appointments|0|||
130277815|NCT01296711|468978228|FG000|Overall Study|Failure to comply with visits|0|||
130277816|NCT01296711|468978229|FG001|Overall Study|Failure to comply with visits|0|||
130277817|NCT01296711|468978230|FG002|Overall Study|Failure to comply with visits|0|||
130368070|NCT00967668|469319532|FG000|Overall Study|Refused 12-mo assessment|3|||
130368071|NCT00967668|469319533|FG001|Overall Study|Refused 12-mo assessment|1|||
130368072|NCT00967668|469319534|FG002|Overall Study|Refused 12-mo assessment|9|||
130368073|NCT00967668|469319532|FG000|Overall Study|Pregnancy|1|||
130710506|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
130710507|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130710508|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
130710509|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
130710510|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
130710511|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
130710512|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
130710513|NCT00049842|470564860|FG000|Treatment Phase|Adverse Event|47|||
130710514|NCT00049842|470564861|FG001|Treatment Phase|Adverse Event|12|||
130710515|NCT00049842|470564860|FG000|Treatment Phase|Withdrawal by Subject|35|||
130710516|NCT00049842|470564861|FG001|Treatment Phase|Withdrawal by Subject|46|||
130710517|NCT00049842|470564860|FG000|Treatment Phase|Non-compliance with protocol|7|||
130710518|NCT00049842|470564861|FG001|Treatment Phase|Non-compliance with protocol|8|||
130710519|NCT00049842|470564860|FG000|Treatment Phase|Lost to Follow-up|4|||
130710520|NCT00049842|470564861|FG001|Treatment Phase|Lost to Follow-up|8|||
130710521|NCT00049842|470564860|FG000|Treatment Phase|Administrative|0|||
130710522|NCT00049842|470564861|FG001|Treatment Phase|Administrative|3|||
130710523|NCT00049842|470564860|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
130710524|NCT00049842|470564861|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
130710525|NCT00049842|470564860|FG000|Follow-up Phase|Adverse Event|6|||
130710526|NCT00049842|470564861|FG001|Follow-up Phase|Adverse Event|1|||
130710527|NCT00049842|470564860|FG000|Follow-up Phase|Other|1|||
130710528|NCT00049842|470564861|FG001|Follow-up Phase|Other|4|||
130710529|NCT00307931|470564862|FG000|Overall Study|Adverse Event|1|||
130710530|NCT00854373|470564863|FG000|Overall Study|Withdrawal by Subject|1|||
130710531|NCT00854373|470564864|FG001|Overall Study|Withdrawal by Subject|3|||
130710532|NCT00854373|470564863|FG000|Overall Study|Forgot to take study drug|1|||
130710533|NCT00854373|470564864|FG001|Overall Study|Forgot to take study drug|1|||
130710534|NCT00293202|470564865|FG000|Overall Study|Withdrawal by Subject|1|||
130710535|NCT00293202|470564866|FG001|Overall Study|Withdrawal by Subject|2|||
130710536|NCT00293202|470564865|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
130710537|NCT00293202|470564866|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
130710538|NCT00293202|470564865|FG000|Overall Study|on-hold due to fistula maturation time|1|||
130368074|NCT00967668|469319533|FG001|Overall Study|Pregnancy|0|||
130277818|NCT01296711|468978231|FG003|Overall Study|Failure to comply with visits|0|||
130277819|NCT01296711|468978232|FG004|Overall Study|Failure to comply with visits|0|||
130277820|NCT01296711|468978233|FG005|Overall Study|Failure to comply with visits|0|||
130277821|NCT01296711|468978234|FG006|Overall Study|Failure to comply with visits|0|||
130277822|NCT01296711|468978235|FG007|Overall Study|Failure to comply with visits|1|||
130277823|NCT01296711|468978228|FG000|Overall Study|Patient decision due to transport|0|||
130277824|NCT01296711|468978229|FG001|Overall Study|Patient decision due to transport|0|||
130277825|NCT01296711|468978230|FG002|Overall Study|Patient decision due to transport|0|||
130277826|NCT01296711|468978231|FG003|Overall Study|Patient decision due to transport|0|||
130277827|NCT01296711|468978232|FG004|Overall Study|Patient decision due to transport|0|||
130277828|NCT01296711|468978233|FG005|Overall Study|Patient decision due to transport|0|||
130277829|NCT01296711|468978234|FG006|Overall Study|Patient decision due to transport|0|||
130277830|NCT01296711|468978235|FG007|Overall Study|Patient decision due to transport|1|||
130277831|NCT05411822|468978241|FG000|Overall Study|Withdrawal by Subject|2|||
130277832|NCT05411822|468978242|FG001|Overall Study|Withdrawal by Subject|1|||
130277833|NCT01864148|468978244|FG000|Overall Study|Other|2|||
130277834|NCT01864148|468978245|FG001|Overall Study|Other|1|||
130277835|NCT01864148|468978246|FG002|Overall Study|Other|1|||
130277836|NCT01864148|468978247|FG003|Overall Study|Other|3|||
130277837|NCT01864148|468978248|FG004|Overall Study|Other|1|||
130277838|NCT01864148|468978244|FG000|Overall Study|Death|0|||
130277839|NCT01864148|468978245|FG001|Overall Study|Death|0|||
130277840|NCT01864148|468978246|FG002|Overall Study|Death|0|||
130277841|NCT01864148|468978247|FG003|Overall Study|Death|1|||
130277842|NCT01864148|468978248|FG004|Overall Study|Death|0|||
130277843|NCT01864148|468978244|FG000|Overall Study|Investigator Decision|5|||
130277844|NCT01864148|468978245|FG001|Overall Study|Investigator Decision|0|||
130277845|NCT01864148|468978246|FG002|Overall Study|Investigator Decision|0|||
130277846|NCT01864148|468978247|FG003|Overall Study|Investigator Decision|4|||
130277847|NCT01864148|468978248|FG004|Overall Study|Investigator Decision|6|||
130277848|NCT01864148|468978244|FG000|Overall Study|Withdrawal by Subject|9|||
130277849|NCT01864148|468978245|FG001|Overall Study|Withdrawal by Subject|2|||
130277850|NCT01864148|468978246|FG002|Overall Study|Withdrawal by Subject|6|||
130277851|NCT01864148|468978247|FG003|Overall Study|Withdrawal by Subject|8|||
130277852|NCT01864148|468978248|FG004|Overall Study|Withdrawal by Subject|8|||
130277853|NCT01864148|468978244|FG000|Overall Study|Lost to Follow-up|0|||
130277854|NCT01864148|468978245|FG001|Overall Study|Lost to Follow-up|0|||
130277855|NCT01864148|468978246|FG002|Overall Study|Lost to Follow-up|0|||
130277856|NCT01864148|468978247|FG003|Overall Study|Lost to Follow-up|2|||
130277857|NCT01864148|468978248|FG004|Overall Study|Lost to Follow-up|1|||
130277858|NCT01864148|468978244|FG000|Overall Study|Adverse Event|4|||
130277859|NCT01864148|468978245|FG001|Overall Study|Adverse Event|2|||
130277860|NCT01864148|468978246|FG002|Overall Study|Adverse Event|4|||
130277861|NCT01864148|468978247|FG003|Overall Study|Adverse Event|7|||
130277862|NCT01864148|468978248|FG004|Overall Study|Adverse Event|7|||
130277863|NCT01864148|468978244|FG000|Overall Study|Not Dosed|0|||
130277864|NCT01864148|468978245|FG001|Overall Study|Not Dosed|0|||
130277865|NCT01864148|468978246|FG002|Overall Study|Not Dosed|0|||
130277866|NCT01864148|468978247|FG003|Overall Study|Not Dosed|1|||
130277867|NCT01864148|468978248|FG004|Overall Study|Not Dosed|0|||
130277868|NCT02027311|468978249|FG000|Overall Study|Protocol Violation|3|||
130277869|NCT02027311|468978250|FG001|Overall Study|Protocol Violation|2|||
130277870|NCT02466425|468978253|FG000|Overall Study|Adverse Event|3|||
130277871|NCT02466425|468978254|FG001|Overall Study|Adverse Event|11|||
130277872|NCT02466425|468978253|FG000|Overall Study|Lack of Efficacy|4|||
130277873|NCT02466425|468978254|FG001|Overall Study|Lack of Efficacy|1|||
130277874|NCT02466425|468978253|FG000|Overall Study|Lost to Follow-up|3|||
130710539|NCT00293202|470564866|FG001|Overall Study|on-hold due to fistula maturation time|0|||
130457514|NCT01959412|469638370|FG005|Overall Study|Protocol deviation|0|||
130457515|NCT01959412|469638365|FG000|Overall Study|Adverse Event|0|||
130457516|NCT01959412|469638366|FG001|Overall Study|Adverse Event|0|||
130457517|NCT01959412|469638367|FG002|Overall Study|Adverse Event|0|||
130457518|NCT01959412|469638368|FG003|Overall Study|Adverse Event|1|||
130457519|NCT01959412|469638369|FG004|Overall Study|Adverse Event|0|||
130457520|NCT01959412|469638370|FG005|Overall Study|Adverse Event|0|||
130457521|NCT00509769|469638373|FG000|Overall Study|Progressive disease|77|||
130457522|NCT00509769|469638373|FG000|Overall Study|Adverse Event|4|||
130457523|NCT00509769|469638373|FG000|Overall Study|Patient's decision|1|||
130457524|NCT00509769|469638373|FG000|Overall Study|Physician Decision|8|||
130457525|NCT00509769|469638373|FG000|Overall Study|Use of prohibited therapies during study|1|||
130457526|NCT00754936|469638374|FG000|Overall Study|Lost to Follow-up|3|||
130457527|NCT00754936|469638374|FG000|Overall Study|Physician Decision|1|||
130457528|NCT00754936|469638374|FG000|Overall Study|Withdrawal by Subject|2|||
130457529|NCT00754936|469638374|FG000|Overall Study|Side Effects|3|||
130457530|NCT00754936|469638374|FG000|Overall Study|Inter-current medical events|3|||
130457531|NCT00604721|469638380|FG000|Overall Study|Physician Decision|1|||
130457532|NCT00604721|469638380|FG000|Overall Study|Withdrawal by Subject|1|||
130457533|NCT01144182|469638385|FG000|Overall Study|Death|5|||
130457534|NCT01144182|469638386|FG001|Overall Study|Death|6|||
130457535|NCT01144182|469638385|FG000|Overall Study|Withdrawal by Subject|3|||
130457536|NCT01144182|469638386|FG001|Overall Study|Withdrawal by Subject|6|||
130457537|NCT01144182|469638385|FG000|Overall Study|Lost to Follow-up|9|||
130457538|NCT01144182|469638386|FG001|Overall Study|Lost to Follow-up|9|||
130457539|NCT02317016|469638387|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
130457540|NCT02317016|469638387|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
130457541|NCT02317016|469638387|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
130457542|NCT02317016|469638387|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
130457543|NCT02317016|469638387|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
130457544|NCT02317016|469638387|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
130457545|NCT02317016|469638387|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
130457546|NCT00536380|469638388|FG000|Overall Study|Adverse Event|0|||
130457547|NCT00536380|469638389|FG001|Overall Study|Adverse Event|2|||
130457548|NCT00536380|469638390|FG002|Overall Study|Adverse Event|2|||
130457549|NCT00536380|469638388|FG000|Overall Study|Lost to Follow-up|0|||
130457550|NCT00536380|469638389|FG001|Overall Study|Lost to Follow-up|0|||
130457551|NCT00536380|469638390|FG002|Overall Study|Lost to Follow-up|1|||
130457552|NCT00536380|469638388|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
130457553|NCT00536380|469638389|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
130457554|NCT00536380|469638390|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
130710540|NCT02442271|470564869|FG000|Overall Study|Adverse Event|1|||
130710541|NCT02442271|470564869|FG000|Overall Study|Withdrew Consent|1|||
130277875|NCT02466425|468978254|FG001|Overall Study|Lost to Follow-up|0|||
130277876|NCT02466425|468978253|FG000|Overall Study|Protocol Violation|1|||
130277877|NCT02466425|468978254|FG001|Overall Study|Protocol Violation|0|||
130277878|NCT02466425|468978253|FG000|Overall Study|Withdrawal by Subject|0|||
130277879|NCT02466425|468978254|FG001|Overall Study|Withdrawal by Subject|1|||
130277880|NCT02466425|468978253|FG000|Overall Study|Other|1|||
130277881|NCT02466425|468978254|FG001|Overall Study|Other|3|||
130277882|NCT02466425|468978253|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130277883|NCT02466425|468978254|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130277884|NCT01721486|468978259|FG000|Overall Study|Protocol Violation|1|||
130277885|NCT01721486|468978260|FG001|Overall Study|Protocol Violation|0|||
130277886|NCT01721486|468978259|FG000|Overall Study|Physician Decision|0|||
130277887|NCT01721486|468978260|FG001|Overall Study|Physician Decision|1|||
130277888|NCT00582712|468978261|FG000|Overall Study|Adverse Event|1|||
130277889|NCT00582712|468978261|FG000|Overall Study|Lack of Efficacy|1|||
130277890|NCT00582712|468978261|FG000|Overall Study|Withdrawal by Subject|1|||
130277891|NCT00582712|468978261|FG000|Overall Study|Complicating disease requiring treatment|1|||
130277892|NCT01901289|468978263|FG000|Overall Study|Death|32|||
130277893|NCT01901289|468978263|FG000|Overall Study|Lost to Follow-up|16|||
130277894|NCT01901289|468978263|FG000|Overall Study|Withdrawal by Subject|35|||
130277895|NCT01901289|468978263|FG000|Overall Study|Other type of endpoint met|2|||
130277896|NCT01813058|468978264|FG000|Overall Study|Withdrawal by Subject|5|||
130277897|NCT01813058|468978265|FG001|Overall Study|Withdrawal by Subject|4|||
130277898|NCT00395486|468978266|FG000|Overall Study|Adverse Event|1|||
130277899|NCT00395486|468978267|FG001|Overall Study|Adverse Event|2|||
130277900|NCT00395486|468978266|FG000|Overall Study|Withdrawal by Subject|5|||
130457555|NCT00536380|469638388|FG000|Overall Study|Withdrawal related to study drug|7|||
130457556|NCT00536380|469638389|FG001|Overall Study|Withdrawal related to study drug|5|||
130457557|NCT00536380|469638390|FG002|Overall Study|Withdrawal related to study drug|2|||
130457558|NCT00536380|469638388|FG000|Overall Study|Noncompliance with protocol|3|||
130710542|NCT02442271|470564869|FG000|Overall Study|Lost to Follow-up|1|||
130277901|NCT00395486|468978267|FG001|Overall Study|Withdrawal by Subject|2|||
130457559|NCT00536380|469638389|FG001|Overall Study|Noncompliance with protocol|2|||
130457560|NCT00536380|469638390|FG002|Overall Study|Noncompliance with protocol|2|||
130457561|NCT00536380|469638388|FG000|Overall Study|Did not meet protocol eligibility|0|||
130710543|NCT02442271|470564869|FG000|Overall Study|Other|1|||
130710544|NCT02080832|470564870|FG000|Overall Study|Excluded from analysis by MRI|9|||
130710545|NCT02080832|470564871|FG001|Overall Study|Excluded from analysis by MRI|10|||
130710546|NCT02080832|470564872|FG002|Overall Study|Excluded from analysis by MRI|14|||
130710547|NCT02080832|470564870|FG000|Overall Study|Lost to Follow-up|0|||
130710548|NCT02080832|470564871|FG001|Overall Study|Lost to Follow-up|2|||
130710549|NCT02080832|470564872|FG002|Overall Study|Lost to Follow-up|2|||
130277902|NCT00395486|468978266|FG000|Overall Study|Lost to Follow-up|0|||
130277903|NCT00395486|468978267|FG001|Overall Study|Lost to Follow-up|1|||
130277904|NCT00361231|468978272|FG000|Overall Study|Physician Decision|3|||
130277905|NCT00361231|468978272|FG000|Overall Study|Symptomatic deterioration|5|||
130277906|NCT00361231|468978272|FG000|Overall Study|Radiographic disease progression|16|||
130277907|NCT00361231|468978272|FG000|Overall Study|Withdrawal by Subject|4|||
130277908|NCT00361231|468978272|FG000|Overall Study|Adverse Event|6|||
130277909|NCT01814397|468978275|FG000|Overall Study|Adverse Event|7|||
130277910|NCT01814397|468978275|FG000|Overall Study|Withdrawal by Subject|7|||
130277911|NCT00313144|468978276|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
130277912|NCT00313144|468978276|FG000|Overall Study|Death|7|||
130277913|NCT00313144|468978276|FG000|Overall Study|Lost to Follow-up|5|||
130277914|NCT00313144|468978276|FG000|Overall Study|Withdrawal by Subject|4|||
130277915|NCT00313144|468978276|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
130277916|NCT00313144|468978276|FG000|Overall Study|Physician Decision|4|||
130277917|NCT00313144|468978276|FG000|Overall Study|Adverse event - transient|5|||
130277918|NCT00313144|468978276|FG000|Overall Study|Liver transplant|1|||
130277919|NCT00313144|468978276|FG000|Overall Study|Insurance (homecare provider) change|1|||
130277920|NCT00313144|468978276|FG000|Overall Study|Change to different product|1|||
130277921|NCT00313144|468978276|FG000|Overall Study|Due to termination of the study|66|||
130277922|NCT01932372|468978290|FG000|Overall Study|Not meeting eligibility criteria|33|||
130277923|NCT01932372|468978291|FG001|Overall Study|Not meeting eligibility criteria|179|||
130277924|NCT01917929|468978292|FG000|Overall Study|Death|8|||
130277925|NCT01917929|468978292|FG000|Overall Study|Lost to Follow-up|19|||
130277926|NCT01917929|468978292|FG000|Overall Study|Withdrawal by Subject|33|||
130277927|NCT01917929|468978292|FG000|Overall Study|Adverse Event|6|||
130277928|NCT01917929|468978292|FG000|Overall Study|Investigative Site Terminated|35|||
130277929|NCT01917929|468978292|FG000|Overall Study|Censored because study device not implanted|6|||
130277930|NCT01917929|468978292|FG000|Overall Study|Censored because surgery not performed|3|||
130277931|NCT01917929|468978292|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
130277932|NCT01917929|468978292|FG000|Overall Study|Sponsor terminated study|175|||
130277933|NCT03028415|468978293|FG000|Overall Study|Lost to Follow-up|6|||
130277934|NCT03028415|468978294|FG001|Overall Study|Lost to Follow-up|3|||
130277935|NCT03028415|468978293|FG000|Overall Study|Withdrawal by Subject|1|||
130277936|NCT03028415|468978294|FG001|Overall Study|Withdrawal by Subject|0|||
130277937|NCT03028415|468978293|FG000|Overall Study|Discontinued due to COVID-19|1|||
130277938|NCT03028415|468978294|FG001|Overall Study|Discontinued due to COVID-19|0|||
130277939|NCT02907216|468978295|FG000|Overall Study|No benefit to be obtained by continuing|0|||
130277940|NCT02907216|468978296|FG001|Overall Study|No benefit to be obtained by continuing|1|||
130277941|NCT02907216|468978295|FG000|Overall Study|Withdrawal by Subject|1|||
130277942|NCT02907216|468978296|FG001|Overall Study|Withdrawal by Subject|0|||
130277943|NCT02241733|468978299|FG000|Overall Study|Lost to Follow-up|9|||
130277944|NCT02241733|468978300|FG001|Overall Study|Lost to Follow-up|4|||
130277945|NCT02241733|468978299|FG000|Overall Study|Physician Decision|6|||
130277946|NCT02241733|468978300|FG001|Overall Study|Physician Decision|2|||
130277947|NCT02241733|468978299|FG000|Overall Study|Withdrawal by Subject|0|||
130277948|NCT02241733|468978300|FG001|Overall Study|Withdrawal by Subject|2|||
130277949|NCT02241733|468978299|FG000|Overall Study|Death|0|||
130277950|NCT02241733|468978300|FG001|Overall Study|Death|2|||
130277951|NCT01063062|468978311|FG000|Overall Study|Patient withdrew consent|0|||
130277952|NCT01063062|468978312|FG001|Overall Study|Patient withdrew consent|1|||
130277953|NCT01063062|468978311|FG000|Overall Study|Adverse Event|2|||
130277954|NCT01063062|468978312|FG001|Overall Study|Adverse Event|4|||
130277955|NCT01063062|468978311|FG000|Overall Study|Protocol Violation|5|||
130710550|NCT01560507|470564873|FG000|Overall Study|Lost to Follow-up|3|||
130277956|NCT01063062|468978312|FG001|Overall Study|Protocol Violation|4|||
130277957|NCT01063062|468978311|FG000|Overall Study|Investigator's request|1|||
130277958|NCT01063062|468978312|FG001|Overall Study|Investigator's request|0|||
130277959|NCT01063062|468978311|FG000|Overall Study|Lost to Follow-up|0|||
130277960|NCT01063062|468978312|FG001|Overall Study|Lost to Follow-up|2|||
130710551|NCT01560507|470564874|FG001|Overall Study|Lost to Follow-up|1|||
130277961|NCT01063062|468978311|FG000|Overall Study|Miscellaneous reason|0|||
130277962|NCT01063062|468978312|FG001|Overall Study|Miscellaneous reason|1|||
130277963|NCT02597452|468978315|FG000|Overall Study|testing incomplete|30|||
130277964|NCT04621240|468978322|FG000|Overall Study|Withdrawal by Subject|36|||
130277965|NCT03206918|468978323|FG000|Overall Study|Death|11|||
130277966|NCT03206918|468978323|FG000|Overall Study|Withdrawal by Subject|5|||
130277967|NCT03206918|468978323|FG000|Overall Study|Study terminated by sponsor|12|||
130277968|NCT03206918|468978323|FG000|Overall Study|Lost to Follow-up|3|||
130277969|NCT03206918|468978323|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
130277970|NCT02954406|468979498|FG000|Overall Study|Adverse Event|0|||
130277971|NCT02954406|468979499|FG001|Overall Study|Adverse Event|1|||
130277972|NCT02954406|468979500|FG002|Overall Study|Adverse Event|0|||
130277973|NCT02954406|468979501|FG003|Overall Study|Adverse Event|0|||
130277974|NCT02954406|468979502|FG004|Overall Study|Adverse Event|1|||
130277975|NCT02954406|468979503|FG005|Overall Study|Adverse Event|0|||
130277976|NCT02954406|468979504|FG006|Overall Study|Adverse Event|0|||
130277977|NCT02954406|468979505|FG007|Overall Study|Adverse Event|0|||
130277978|NCT02954406|468979506|FG008|Overall Study|Adverse Event|1|||
130277979|NCT02954406|468979507|FG009|Overall Study|Adverse Event|1|||
130277980|NCT02954406|468979508|FG010|Overall Study|Adverse Event|0|||
130277981|NCT02954406|468979498|FG000|Overall Study|Progressive Disease|3|||
130277982|NCT02954406|468979499|FG001|Overall Study|Progressive Disease|4|||
130277983|NCT02954406|468979500|FG002|Overall Study|Progressive Disease|3|||
130277984|NCT02954406|468979501|FG003|Overall Study|Progressive Disease|4|||
130277985|NCT02954406|468979502|FG004|Overall Study|Progressive Disease|3|||
130277986|NCT02954406|468979503|FG005|Overall Study|Progressive Disease|3|||
130277987|NCT02954406|468979504|FG006|Overall Study|Progressive Disease|2|||
130277988|NCT02954406|468979505|FG007|Overall Study|Progressive Disease|2|||
130277989|NCT02954406|468979506|FG008|Overall Study|Progressive Disease|1|||
130277990|NCT02954406|468979507|FG009|Overall Study|Progressive Disease|1|||
130277991|NCT02954406|468979508|FG010|Overall Study|Progressive Disease|0|||
130277992|NCT02954406|468979498|FG000|Overall Study|Symptomatic Deterioration|0|||
130277993|NCT02954406|468979499|FG001|Overall Study|Symptomatic Deterioration|1|||
130277994|NCT02954406|468979500|FG002|Overall Study|Symptomatic Deterioration|0|||
130277995|NCT02954406|468979501|FG003|Overall Study|Symptomatic Deterioration|0|||
130277996|NCT02954406|468979502|FG004|Overall Study|Symptomatic Deterioration|0|||
130277997|NCT02954406|468979503|FG005|Overall Study|Symptomatic Deterioration|0|||
130277998|NCT02954406|468979504|FG006|Overall Study|Symptomatic Deterioration|0|||
130277999|NCT02954406|468979505|FG007|Overall Study|Symptomatic Deterioration|0|||
130278000|NCT02954406|468979506|FG008|Overall Study|Symptomatic Deterioration|0|||
130278001|NCT02954406|468979507|FG009|Overall Study|Symptomatic Deterioration|0|||
130278002|NCT02954406|468979508|FG010|Overall Study|Symptomatic Deterioration|0|||
130457562|NCT00536380|469638389|FG001|Overall Study|Did not meet protocol eligibility|0|||
130457563|NCT00536380|469638390|FG002|Overall Study|Did not meet protocol eligibility|1|||
130457564|NCT00536380|469638388|FG000|Overall Study|Administrative|0|||
130457565|NCT00536380|469638389|FG001|Overall Study|Administrative|0|||
130278003|NCT02954406|468979498|FG000|Overall Study|Death|0|||
130278004|NCT02954406|468979499|FG001|Overall Study|Death|0|||
130278005|NCT02954406|468979500|FG002|Overall Study|Death|0|||
130278006|NCT02954406|468979501|FG003|Overall Study|Death|0|||
130278007|NCT02954406|468979502|FG004|Overall Study|Death|1|||
130278008|NCT02954406|468979503|FG005|Overall Study|Death|0|||
130278009|NCT02954406|468979504|FG006|Overall Study|Death|0|||
130457566|NCT00536380|469638390|FG002|Overall Study|Administrative|1|||
130278010|NCT02954406|468979505|FG007|Overall Study|Death|0|||
130278011|NCT02954406|468979506|FG008|Overall Study|Death|1|||
130278012|NCT02954406|468979507|FG009|Overall Study|Death|1|||
130278013|NCT02954406|468979508|FG010|Overall Study|Death|0|||
130457567|NCT01768676|469638395|FG000|Overall Study|Adverse Event|3|||
130278014|NCT02954406|468979498|FG000|Overall Study|Reason Not Specified|0|||
130278015|NCT02954406|468979499|FG001|Overall Study|Reason Not Specified|0|||
130278016|NCT02954406|468979500|FG002|Overall Study|Reason Not Specified|3|||
130278017|NCT02954406|468979501|FG003|Overall Study|Reason Not Specified|2|||
130278018|NCT02954406|468979502|FG004|Overall Study|Reason Not Specified|2|||
130278019|NCT02954406|468979503|FG005|Overall Study|Reason Not Specified|0|||
130278020|NCT02954406|468979504|FG006|Overall Study|Reason Not Specified|1|||
130278021|NCT02954406|468979505|FG007|Overall Study|Reason Not Specified|0|||
130278022|NCT02954406|468979506|FG008|Overall Study|Reason Not Specified|1|||
130278023|NCT02954406|468979507|FG009|Overall Study|Reason Not Specified|0|||
130278024|NCT02954406|468979508|FG010|Overall Study|Reason Not Specified|0|||
130278025|NCT00782171|468979509|FG000|Overall Study|Lost to Follow-up|2|||
130278026|NCT00782171|468979510|FG001|Overall Study|Lost to Follow-up|2|||
130278027|NCT00782171|468979509|FG000|Overall Study|Withdrawal by Subject|2|||
130278028|NCT00782171|468979510|FG001|Overall Study|Withdrawal by Subject|1|||
130278029|NCT00782171|468979509|FG000|Overall Study|complications|3|||
130278030|NCT00782171|468979510|FG001|Overall Study|complications|1|||
130278031|NCT00782171|468979509|FG000|Overall Study|others|7|||
130278032|NCT00782171|468979510|FG001|Overall Study|others|9|||
130278033|NCT00782171|468979509|FG000|Overall Study|not eligible|8|||
130278034|NCT00782171|468979510|FG001|Overall Study|not eligible|6|||
130278035|NCT04075292|468979515|FG000|Overall Study|Withdrawal by Subject|1|||
130278036|NCT04075292|468979516|FG001|Overall Study|Withdrawal by Subject|9|||
130278037|NCT04075292|468979515|FG000|Overall Study|Death|2|||
130278038|NCT04075292|468979516|FG001|Overall Study|Death|5|||
130278039|NCT04075292|468979515|FG000|Overall Study|Remained on study at time of DCO|74|||
130278040|NCT04075292|468979516|FG001|Overall Study|Remained on study at time of DCO|64|||
130278041|NCT04308239|468979517|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
130710552|NCT01560507|470564875|FG002|Overall Study|Lost to Follow-up|2|||
130710553|NCT01560507|470564873|FG000|Overall Study|Withdrawal by Subject|1|||
130710554|NCT01560507|470564874|FG001|Overall Study|Withdrawal by Subject|1|||
130710555|NCT01560507|470564875|FG002|Overall Study|Withdrawal by Subject|0|||
130710556|NCT01118117|470564876|FG000|Overall Study|Death|8|||
130710557|NCT01118117|470564877|FG001|Overall Study|Death|0|||
130710558|NCT01118117|470564876|FG000|Overall Study|Lost to Follow-up|6|||
130710559|NCT01118117|470564877|FG001|Overall Study|Lost to Follow-up|0|||
130710560|NCT01118117|470564876|FG000|Overall Study|Missed 12 Month Visit|7|||
130710561|NCT01118117|470564877|FG001|Overall Study|Missed 12 Month Visit|0|||
130710562|NCT03545191|470564878|FG000|Overall Study|Death|1|||
130710563|NCT03545191|470564879|FG001|Overall Study|Death|0|||
130710564|NCT03545191|470564880|FG002|Overall Study|Death|0|||
130710565|NCT03545191|470564878|FG000|Overall Study|Adverse Event|4|||
130710566|NCT03545191|470564879|FG001|Overall Study|Adverse Event|2|||
130278042|NCT04308239|468979518|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
130278043|NCT04308239|468979517|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
130278044|NCT04308239|468979518|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130278045|NCT04308239|468979517|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
130278046|NCT04308239|468979518|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
130278047|NCT04308239|468979517|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
130278048|NCT04308239|468979518|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130278049|NCT01443364|468979519|FG000|Overall Study|Lack of Efficacy|14|||
130278050|NCT01443364|468979519|FG000|Overall Study|Lost to Follow-up|3|||
130278051|NCT01443364|468979519|FG000|Overall Study|Withdrawal by Subject|5|||
130278052|NCT01443364|468979519|FG000|Overall Study|Other Reason|4|||
130278053|NCT01443364|468979519|FG000|Overall Study|SAE, non-fatal|6|||
130278054|NCT01443364|468979519|FG000|Overall Study|AE, non-serious non-fatal|8|||
130278055|NCT01443364|468979519|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130278056|NCT00559845|468979522|FG000|Overall Study|Withdrew Consent|1|||
130278057|NCT00559845|468979522|FG000|Overall Study|Disease Progression|1|||
130278058|NCT00559845|468979522|FG000|Overall Study|Adverse Event|3|||
130278059|NCT00559845|468979522|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
130278060|NCT00559845|468979522|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
130278061|NCT03367403|468979525|FG000|Overall Study|Adverse Event|20|||
130278062|NCT03367403|468979526|FG001|Overall Study|Adverse Event|6|||
130278063|NCT03367403|468979527|FG002|Overall Study|Adverse Event|2|||
130278064|NCT03367403|468979525|FG000|Overall Study|Withdrawal by Subject|12|||
130278065|NCT03367403|468979526|FG001|Overall Study|Withdrawal by Subject|13|||
130278066|NCT03367403|468979527|FG002|Overall Study|Withdrawal by Subject|1|||
130368075|NCT00967668|469319534|FG002|Overall Study|Pregnancy|0|||
130368076|NCT00115739|469319535|FG000|Overall Study|Lost to Follow-up|3|||
130368077|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
130368078|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
130368079|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
130368080|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
130368081|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
130368082|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
130368083|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
130278067|NCT03367403|468979525|FG000|Overall Study|Death|1|||
130710567|NCT03545191|470564880|FG002|Overall Study|Adverse Event|7|||
130710568|NCT03545191|470564878|FG000|Overall Study|Other reasons|3|||
130278068|NCT03367403|468979526|FG001|Overall Study|Death|2|||
130278069|NCT03367403|468979527|FG002|Overall Study|Death|0|||
130278070|NCT03367403|468979525|FG000|Overall Study|Physician Decision|0|||
130278071|NCT03367403|468979526|FG001|Overall Study|Physician Decision|1|||
130278072|NCT03367403|468979527|FG002|Overall Study|Physician Decision|0|||
130278073|NCT03367403|468979525|FG000|Overall Study|Protocol Violation|1|||
130278074|NCT03367403|468979526|FG001|Overall Study|Protocol Violation|1|||
130278075|NCT03367403|468979527|FG002|Overall Study|Protocol Violation|0|||
130278076|NCT03367403|468979525|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130278077|NCT03367403|468979526|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
130278078|NCT03367403|468979527|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130278079|NCT03367403|468979525|FG000|Overall Study|COVID-19|3|||
130278080|NCT03367403|468979526|FG001|Overall Study|COVID-19|6|||
130278081|NCT03367403|468979527|FG002|Overall Study|COVID-19|0|||
130278082|NCT03367403|468979525|FG000|Overall Study|Abuse of Alcohol Intake|0|||
130278083|NCT03367403|468979526|FG001|Overall Study|Abuse of Alcohol Intake|1|||
130278084|NCT03367403|468979527|FG002|Overall Study|Abuse of Alcohol Intake|0|||
130278085|NCT03367403|468979525|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130457568|NCT01768676|469638396|FG001|Overall Study|Adverse Event|3|||
130457569|NCT01768676|469638395|FG000|Overall Study|Lost to Follow-up|13|||
130457570|NCT01768676|469638396|FG001|Overall Study|Lost to Follow-up|16|||
130457571|NCT01768676|469638395|FG000|Overall Study|Protocol Violation|1|||
130457572|NCT01768676|469638396|FG001|Overall Study|Protocol Violation|1|||
130457573|NCT01768676|469638395|FG000|Overall Study|Physician Decision|4|||
130457574|NCT01768676|469638396|FG001|Overall Study|Physician Decision|1|||
130457575|NCT01768676|469638395|FG000|Overall Study|Withdrawal by Subject|3|||
130457576|NCT01768676|469638396|FG001|Overall Study|Withdrawal by Subject|10|||
130457577|NCT03395353|469638398|FG000|Overall Study|Adverse Event|20|||
130457578|NCT03395353|469638398|FG000|Overall Study|Protocol Violation|1|||
130457579|NCT03395353|469638398|FG000|Overall Study|Lack of Efficacy|3|||
130457580|NCT03395353|469638398|FG000|Overall Study|Withdrawal by Subject|24|||
130457581|NCT03395353|469638398|FG000|Overall Study|Discontinued visit|1|||
130278086|NCT03367403|468979526|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
130278087|NCT03367403|468979527|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130278088|NCT00194077|468979528|FG000|Overall Study|Lack of Efficacy|22|||
130278089|NCT00194077|468979529|FG001|Overall Study|Lack of Efficacy|29|||
130278090|NCT00194077|468979528|FG000|Overall Study|Study nonadherence|1|||
130278091|NCT00194077|468979529|FG001|Overall Study|Study nonadherence|0|||
130278092|NCT00194077|468979528|FG000|Overall Study|Withdrawal by Subject|1|||
130278093|NCT00194077|468979529|FG001|Overall Study|Withdrawal by Subject|1|||
130278094|NCT03470194|468979532|FG000|Overall Study|Lost to Follow-up|11|||
130278095|NCT03470194|468979533|FG001|Overall Study|Lost to Follow-up|17|||
130278096|NCT03286543|468979534|FG000|Consented|Screen failure before randomization|2|||
130278097|NCT03286543|468979535|FG001|Consented|Screen failure before randomization|0|||
130278098|NCT03286543|468979536|FG002|Consented|Screen failure before randomization|0|||
130278099|NCT03286543|468979534|FG000|Consented|Screen failure before enrollment|4|||
130278100|NCT03286543|468979535|FG001|Consented|Screen failure before enrollment|0|||
130278101|NCT03286543|468979536|FG002|Consented|Screen failure before enrollment|0|||
130278102|NCT03286543|468979534|FG000|Consented|TKA cancelled after enrollment|1|||
130278103|NCT03286543|468979535|FG001|Consented|TKA cancelled after enrollment|0|||
130278104|NCT03286543|468979536|FG002|Consented|TKA cancelled after enrollment|0|||
130278105|NCT03286543|468979534|FG000|Consented|Withdrawn from study|12|||
130278106|NCT03286543|468979535|FG001|Consented|Withdrawn from study|0|||
130278107|NCT03286543|468979536|FG002|Consented|Withdrawn from study|0|||
130278108|NCT03286543|468979534|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
130278109|NCT03286543|468979535|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
130278110|NCT03286543|468979536|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
130278111|NCT03286543|468979534|FG000|Study Enrollment|Withdrawn from study|0|||
130278112|NCT03286543|468979535|FG001|Study Enrollment|Withdrawn from study|6|||
130278113|NCT03286543|468979536|FG002|Study Enrollment|Withdrawn from study|6|||
130278114|NCT01822899|468979537|FG000|Overall Study|Adverse Event|6|||
130278115|NCT01822899|468979538|FG001|Overall Study|Adverse Event|5|||
130278116|NCT01822899|468979537|FG000|Overall Study|Lack of Efficacy|6|||
130278117|NCT01822899|468979538|FG001|Overall Study|Lack of Efficacy|3|||
130278118|NCT01822899|468979537|FG000|Overall Study|Protocol Violation|6|||
130278119|NCT01822899|468979538|FG001|Overall Study|Protocol Violation|3|||
130278120|NCT01822899|468979537|FG000|Overall Study|Lost to Follow-up|1|||
130278121|NCT01822899|468979538|FG001|Overall Study|Lost to Follow-up|0|||
130278122|NCT01822899|468979537|FG000|Overall Study|Withdrawal by Subject|5|||
130457582|NCT03395353|469638398|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
130278123|NCT01822899|468979538|FG001|Overall Study|Withdrawal by Subject|7|||
130278124|NCT05332392|468979539|FG000|Overall Study|Did not meet inclusion criteria|25|||
130278125|NCT05332392|468979539|FG000|Overall Study|Principal Investigator's decision|17|||
130457583|NCT03395353|469638398|FG000|Overall Study|Physician Decision|4|||
130457584|NCT03395353|469638398|FG000|Overall Study|Early termination of overall study|33|||
130278126|NCT05332392|468979539|FG000|Overall Study|Adverse Event|1|||
130278127|NCT05332392|468979539|FG000|Overall Study|Subject's decision|1|||
130278128|NCT00759876|468979543|FG000|Overall Study|Sponsor terminated study early|36|||
130278129|NCT03636893|468979544|FG000|Overall Study|Death|0|||
130278130|NCT03636893|468979545|FG001|Overall Study|Death|1|||
130278131|NCT03636893|468979544|FG000|Overall Study|Protocol Violation|0|||
130278132|NCT03636893|468979545|FG001|Overall Study|Protocol Violation|3|||
130278133|NCT03636893|468979544|FG000|Overall Study|Withdrawal by Subject|1|||
130278134|NCT03636893|468979545|FG001|Overall Study|Withdrawal by Subject|2|||
130278135|NCT03636893|468979544|FG000|Overall Study|Refusal to surgery|4|||
130278136|NCT03636893|468979545|FG001|Overall Study|Refusal to surgery|3|||
130278137|NCT03636893|468979544|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
130278138|NCT03636893|468979545|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
130278139|NCT03636893|468979544|FG000|Overall Study|Adverse Event|1|||
130278140|NCT03636893|468979545|FG001|Overall Study|Adverse Event|1|||
130278141|NCT00758069|468979546|FG000|Overall Study|Lack of Efficacy|0|||
130278142|NCT00758069|468979547|FG001|Overall Study|Lack of Efficacy|0|||
130278143|NCT00758069|468979548|FG002|Overall Study|Lack of Efficacy|1|||
130278144|NCT00758069|468979546|FG000|Overall Study|Incorrect Study Drug|1|||
130278145|NCT00758069|468979547|FG001|Overall Study|Incorrect Study Drug|0|||
130278146|NCT00758069|468979548|FG002|Overall Study|Incorrect Study Drug|0|||
130278147|NCT03818607|468979550|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
130278148|NCT03818607|468979551|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
130278149|NCT03818607|468979550|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
130278150|NCT03818607|468979551|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
130278151|NCT03818607|468979550|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
130278152|NCT03818607|468979551|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
130278153|NCT00588237|468979552|FG000|Overall Study|Evaluable for toxicity only|3|||
130278154|NCT00588237|468979552|FG000|Overall Study|Patien not treated|1|||
130555319|NCT03942406|470001554|FG005|Overall Study|Withdrawal by Subject|0|||
130278155|NCT05059301|468979553|FG000|Overall Study|Adverse Event|0|||
130278156|NCT05059301|468979554|FG001|Overall Study|Adverse Event|2|||
130278157|NCT05059301|468979555|FG002|Overall Study|Adverse Event|2|||
130278158|NCT05059301|468979553|FG000|Overall Study|Lost to Follow-up|2|||
130278159|NCT05059301|468979554|FG001|Overall Study|Lost to Follow-up|3|||
130278160|NCT05059301|468979555|FG002|Overall Study|Lost to Follow-up|3|||
130278161|NCT01164891|468979559|FG000|Overall Study|Disease Progression|5|||
130278162|NCT01164891|468979559|FG000|Overall Study|Adverse Event|1|||
130278163|NCT00606034|468979562|FG000|Overall Study|incarceration|1|||
130710569|NCT03545191|470564879|FG001|Overall Study|Other reasons|11|||
130710570|NCT03545191|470564880|FG002|Overall Study|Other reasons|8|||
130710571|NCT03545191|470564878|FG000|Overall Study|Withdrawal by Subject|13|||
130368084|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
130368085|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
130368086|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
130368087|NCT00787891|469319542|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
130368088|NCT00787891|469319543|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
130368089|NCT00787891|469319542|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
130368090|NCT00787891|469319543|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
130368091|NCT00787891|469319542|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
130368092|NCT00787891|469319543|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
130368093|NCT00787891|469319542|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
130368094|NCT00787891|469319543|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
130368095|NCT00787891|469319542|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
130368096|NCT00787891|469319543|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
130368097|NCT00395304|469319548|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130710572|NCT03545191|470564879|FG001|Overall Study|Withdrawal by Subject|10|||
130710573|NCT03545191|470564880|FG002|Overall Study|Withdrawal by Subject|12|||
130710574|NCT03545191|470564878|FG000|Overall Study|Lost to Follow-up|1|||
130368098|NCT00395304|469319549|FG001|Treatment Period 1|Withdrawal by Subject|3|||
130368099|NCT00395304|469319550|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130457585|NCT01196429|469638399|FG000|Overall Study|Ineligible - inadequate pathology|1|||
130457586|NCT01196429|469638400|FG001|Overall Study|Ineligible - inadequate pathology|0|||
130457587|NCT01196429|469638399|FG000|Overall Study|Ineligible - wrong cell type|1|||
130457588|NCT01196429|469638400|FG001|Overall Study|Ineligible - wrong cell type|0|||
130457589|NCT01196429|469638399|FG000|Overall Study|Refused - Never Treated|1|||
130457590|NCT01196429|469638400|FG001|Overall Study|Refused - Never Treated|0|||
130457591|NCT02486588|469638401|FG000|Overall Study|Randomized in error- ineligible|738|||
130457592|NCT02486588|469638402|FG001|Overall Study|Randomized in error- ineligible|750|||
130457593|NCT02486588|469638403|FG002|Overall Study|Randomized in error- ineligible|755|||
130457594|NCT02486588|469638404|FG003|Overall Study|Randomized in error- ineligible|738|||
130457595|NCT02486588|469638405|FG004|Overall Study|Randomized in error- ineligible|746|||
130457596|NCT02486588|469638406|FG005|Overall Study|Randomized in error- ineligible|746|||
130457597|NCT04248829|469638407|FG000|Overall Study|Disease progression|44|||
130457598|NCT04248829|469638408|FG001|Overall Study|Disease progression|109|||
130457599|NCT04248829|469638407|FG000|Overall Study|Adverse Event|19|||
130457600|NCT04248829|469638408|FG001|Overall Study|Adverse Event|18|||
130457601|NCT04248829|469638407|FG000|Overall Study|Withdrawal by Subject|11|||
130457602|NCT04248829|469638408|FG001|Overall Study|Withdrawal by Subject|2|||
130457603|NCT04248829|469638407|FG000|Overall Study|Lost to Follow-up|0|||
130457604|NCT04248829|469638408|FG001|Overall Study|Lost to Follow-up|1|||
130457605|NCT04248829|469638407|FG000|Overall Study|Death|12|||
130457606|NCT04248829|469638408|FG001|Overall Study|Death|14|||
130457607|NCT04248829|469638407|FG000|Overall Study|Physician Decision|2|||
130457608|NCT04248829|469638408|FG001|Overall Study|Physician Decision|4|||
130457609|NCT04248829|469638407|FG000|Overall Study|Any reason not specifically recorded|0|||
130457610|NCT04248829|469638408|FG001|Overall Study|Any reason not specifically recorded|2|||
130457611|NCT02132702|469638409|FG000|Overall Study|Protocol Violation|2|||
130457612|NCT02132702|469638409|FG000|Overall Study|Adverse Event|3|||
130710575|NCT03545191|470564879|FG001|Overall Study|Lost to Follow-up|2|||
130710576|NCT03545191|470564880|FG002|Overall Study|Lost to Follow-up|3|||
130710577|NCT01277718|470564882|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
130710578|NCT01277718|470564883|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
130710579|NCT01277718|470564882|FG000|Period 2 - Second Intervention|Physician Decision|0|||
130710580|NCT01277718|470564883|FG001|Period 2 - Second Intervention|Physician Decision|2|||
130457613|NCT02132702|469638409|FG000|Overall Study|Withdrawal by Subject|3|||
130457614|NCT03354390|469638410|FG000|Level 1|Death|2|||
130457615|NCT03354390|469638411|FG001|Level 1|Death|0|||
130457616|NCT03354390|469638412|FG002|Level 1|Death|0|||
130457617|NCT03354390|469638413|FG003|Level 1|Death|0|||
130457618|NCT03354390|469638410|FG000|Level 1|Physician Decision|1|||
130457619|NCT03354390|469638411|FG001|Level 1|Physician Decision|0|||
130457620|NCT03354390|469638412|FG002|Level 1|Physician Decision|0|||
130368100|NCT00395304|469319551|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130368101|NCT00395304|469319552|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130368102|NCT00395304|469319553|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130457621|NCT03354390|469638413|FG003|Level 1|Physician Decision|0|||
130457622|NCT03354390|469638410|FG000|Level 2|Physician Decision|0|||
130710581|NCT01524913|470564884|FG000|Overall Study|Lost to Follow-up|4|||
130710582|NCT01524913|470564885|FG001|Overall Study|Lost to Follow-up|0|||
130710583|NCT01524913|470564886|FG002|Overall Study|Lost to Follow-up|0|||
130457623|NCT03354390|469638411|FG001|Level 2|Physician Decision|2|||
130457624|NCT03354390|469638412|FG002|Level 2|Physician Decision|0|||
130457625|NCT03354390|469638413|FG003|Level 2|Physician Decision|0|||
130710584|NCT02181296|470564887|FG000|Overall Study|Lost to Follow-up|7|||
130710585|NCT02181296|470564888|FG001|Overall Study|Lost to Follow-up|6|||
130710586|NCT00788593|470564891|FG000|Placebo Run-in Phase|Adverse Event|2|||
130710587|NCT00788593|470564892|FG001|Placebo Run-in Phase|Adverse Event|0|||
130710588|NCT00788593|470564893|FG002|Placebo Run-in Phase|Adverse Event|0|||
130710589|NCT00788593|470564891|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
130710590|NCT00788593|470564892|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
130710591|NCT00788593|470564893|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
130710592|NCT00788593|470564891|FG000|Placebo Run-in Phase|Protocol Violation|2|||
130710593|NCT00788593|470564892|FG001|Placebo Run-in Phase|Protocol Violation|0|||
130710594|NCT00788593|470564893|FG002|Placebo Run-in Phase|Protocol Violation|0|||
130278164|NCT01126268|468979565|FG000|Overall Study|Adverse Event|1|||
130278165|NCT01988662|468979566|FG000|Overall Study|Subject/guardian decision|1|||
130278166|NCT01988662|468979567|FG001|Overall Study|Subject/guardian decision|1|||
130278167|NCT01988662|468979566|FG000|Overall Study|Adverse Event|3|||
130278168|NCT01988662|468979567|FG001|Overall Study|Adverse Event|1|||
130278169|NCT00842153|468979571|FG000|Overall Study|Adverse Event|0|||
130278170|NCT00842153|468979572|FG001|Overall Study|Adverse Event|1|||
130278171|NCT00842153|468979571|FG000|Overall Study|Lost to Follow-up|1|||
130278172|NCT00842153|468979572|FG001|Overall Study|Lost to Follow-up|2|||
130278173|NCT00002540|468979573|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
130278174|NCT00002540|468979574|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
130278175|NCT00002540|468979573|FG000|Overall Study|Died Before Randomization|2|||
130278176|NCT00002540|468979574|FG001|Overall Study|Died Before Randomization|6|||
130278177|NCT00002540|468979573|FG000|Overall Study|Died Before ASU (Control)|202|||
130278178|NCT00002540|468979574|FG001|Overall Study|Died Before ASU (Control)|0|||
130278179|NCT00002540|468979573|FG000|Overall Study|Refused ASU (Control)|597|||
130278180|NCT00002540|468979574|FG001|Overall Study|Refused ASU (Control)|0|||
130278181|NCT00002540|468979573|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
130278182|NCT00002540|468979574|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
130278183|NCT05312697|468979575|FG000|Overall Study|Sponsor Terminated Trial|2|||
130278184|NCT04445519|468979576|FG000|Overall Study|Due to adaptive design|3|||
130368103|NCT00395304|469319548|FG000|Treatment Period 1|Lost to Follow-up|1|||
130368104|NCT00395304|469319549|FG001|Treatment Period 1|Lost to Follow-up|0|||
130368105|NCT00395304|469319550|FG002|Treatment Period 1|Lost to Follow-up|0|||
130368106|NCT00395304|469319551|FG003|Treatment Period 1|Lost to Follow-up|1|||
130368107|NCT00395304|469319552|FG004|Treatment Period 1|Lost to Follow-up|0|||
130368108|NCT00395304|469319553|FG005|Treatment Period 1|Lost to Follow-up|1|||
130368109|NCT00395304|469319548|FG000|Treatment Period 1|Physician Decision|0|||
130368110|NCT00395304|469319549|FG001|Treatment Period 1|Physician Decision|1|||
130278185|NCT04445519|468979577|FG001|Overall Study|Due to adaptive design|0|||
130278186|NCT04445519|468979578|FG002|Overall Study|Due to adaptive design|0|||
130278187|NCT04445519|468979576|FG000|Overall Study|Lost to Follow-up|0|||
130278188|NCT04445519|468979577|FG001|Overall Study|Lost to Follow-up|1|||
130278189|NCT04445519|468979578|FG002|Overall Study|Lost to Follow-up|4|||
130368111|NCT00395304|469319550|FG002|Treatment Period 1|Physician Decision|0|||
130368112|NCT00395304|469319551|FG003|Treatment Period 1|Physician Decision|0|||
130368113|NCT00395304|469319552|FG004|Treatment Period 1|Physician Decision|0|||
130368114|NCT00395304|469319553|FG005|Treatment Period 1|Physician Decision|0|||
130368115|NCT00395304|469319548|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130368116|NCT00395304|469319549|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130368117|NCT00395304|469319550|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130368118|NCT00395304|469319551|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130368119|NCT00395304|469319552|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130368120|NCT00395304|469319553|FG005|Treatment Period 2|Withdrawal by Subject|2|||
130368121|NCT00395304|469319548|FG000|Treatment Period 2|Lost to Follow-up|0|||
130368122|NCT00395304|469319549|FG001|Treatment Period 2|Lost to Follow-up|3|||
130368123|NCT00395304|469319550|FG002|Treatment Period 2|Lost to Follow-up|0|||
130368124|NCT00395304|469319551|FG003|Treatment Period 2|Lost to Follow-up|0|||
130368125|NCT00395304|469319552|FG004|Treatment Period 2|Lost to Follow-up|0|||
130368126|NCT00395304|469319553|FG005|Treatment Period 2|Lost to Follow-up|0|||
130368127|NCT00395304|469319548|FG000|Treatment Period 2|Physician Decision|0|||
130368128|NCT00395304|469319549|FG001|Treatment Period 2|Physician Decision|0|||
130368129|NCT00395304|469319550|FG002|Treatment Period 2|Physician Decision|1|||
130368130|NCT00395304|469319551|FG003|Treatment Period 2|Physician Decision|0|||
130368131|NCT00395304|469319552|FG004|Treatment Period 2|Physician Decision|0|||
130368132|NCT00395304|469319553|FG005|Treatment Period 2|Physician Decision|0|||
130368133|NCT00395304|469319548|FG000|Treatment Period 2|Other|0|||
130368134|NCT00395304|469319549|FG001|Treatment Period 2|Other|1|||
130368135|NCT00395304|469319550|FG002|Treatment Period 2|Other|0|||
130368136|NCT00395304|469319551|FG003|Treatment Period 2|Other|0|||
130368137|NCT00395304|469319552|FG004|Treatment Period 2|Other|0|||
130368138|NCT00395304|469319553|FG005|Treatment Period 2|Other|0|||
130368139|NCT00395304|469319548|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130368140|NCT00395304|469319549|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130368141|NCT00395304|469319550|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130368142|NCT00395304|469319551|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130368143|NCT00395304|469319552|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130368144|NCT00395304|469319553|FG005|Treatment Period 3|Withdrawal by Subject|1|||
130368145|NCT00395304|469319548|FG000|Treatment Period 3|Lost to Follow-up|1|||
130368146|NCT00395304|469319549|FG001|Treatment Period 3|Lost to Follow-up|1|||
130368147|NCT00395304|469319550|FG002|Treatment Period 3|Lost to Follow-up|0|||
130368148|NCT00395304|469319551|FG003|Treatment Period 3|Lost to Follow-up|0|||
130368149|NCT00395304|469319552|FG004|Treatment Period 3|Lost to Follow-up|0|||
130368150|NCT00395304|469319553|FG005|Treatment Period 3|Lost to Follow-up|0|||
130368151|NCT00395304|469319548|FG000|Treatment Period 3|Physician Decision|0|||
130368152|NCT00395304|469319549|FG001|Treatment Period 3|Physician Decision|1|||
130368153|NCT00395304|469319550|FG002|Treatment Period 3|Physician Decision|0|||
130368154|NCT00395304|469319551|FG003|Treatment Period 3|Physician Decision|0|||
130368155|NCT00395304|469319552|FG004|Treatment Period 3|Physician Decision|0|||
130368156|NCT00395304|469319553|FG005|Treatment Period 3|Physician Decision|0|||
130368157|NCT00395304|469319548|FG000|Treatment Period 3|Other|0|||
130368158|NCT00395304|469319549|FG001|Treatment Period 3|Other|0|||
130368159|NCT00395304|469319550|FG002|Treatment Period 3|Other|0|||
130368160|NCT00395304|469319551|FG003|Treatment Period 3|Other|1|||
130368161|NCT00395304|469319552|FG004|Treatment Period 3|Other|0|||
130368162|NCT00395304|469319553|FG005|Treatment Period 3|Other|0|||
130368163|NCT01970397|469319554|FG000|Overall Study|Adverse Event|0|||
130368164|NCT01970397|469319555|FG001|Overall Study|Adverse Event|1|||
130368165|NCT01970397|469319554|FG000|Overall Study|Lost to Follow-up|0|||
130368166|NCT01970397|469319555|FG001|Overall Study|Lost to Follow-up|1|||
130368167|NCT01970397|469319554|FG000|Overall Study|Personal Reasons|1|||
130368168|NCT01970397|469319555|FG001|Overall Study|Personal Reasons|2|||
130368169|NCT01970397|469319554|FG000|Overall Study|Protocol Violation|1|||
130368170|NCT01970397|469319555|FG001|Overall Study|Protocol Violation|1|||
130368171|NCT03305575|469319558|FG000|Overall Study|Physician Decision|1|||
130368172|NCT03305575|469319559|FG001|Overall Study|Physician Decision|0|||
130368173|NCT01434667|469319570|FG000|Overall Study|Lost to Follow-up|5|||
130368174|NCT01434667|469319571|FG001|Overall Study|Lost to Follow-up|10|||
130368175|NCT02034110|469319580|FG000|Overall Study|Physician Decision|0|||
130368176|NCT02034110|469319581|FG001|Overall Study|Physician Decision|0|||
130368177|NCT02034110|469319582|FG002|Overall Study|Physician Decision|0|||
130368178|NCT02034110|469319583|FG003|Overall Study|Physician Decision|0|||
130368179|NCT02034110|469319584|FG004|Overall Study|Physician Decision|2|||
130457626|NCT03354390|469638410|FG000|Level 2|Lack of Efficacy|0|||
130368180|NCT02034110|469319585|FG005|Overall Study|Physician Decision|0|||
130368181|NCT02034110|469319586|FG006|Overall Study|Physician Decision|1|||
130368182|NCT02034110|469319587|FG007|Overall Study|Physician Decision|0|||
130368183|NCT02034110|469319580|FG000|Overall Study|Lost to Follow-up|1|||
130368184|NCT02034110|469319581|FG001|Overall Study|Lost to Follow-up|0|||
130368185|NCT02034110|469319582|FG002|Overall Study|Lost to Follow-up|0|||
130368186|NCT02034110|469319583|FG003|Overall Study|Lost to Follow-up|0|||
130368187|NCT02034110|469319584|FG004|Overall Study|Lost to Follow-up|1|||
130368188|NCT02034110|469319585|FG005|Overall Study|Lost to Follow-up|0|||
130710595|NCT00788593|470564891|FG000|First Intervention Period|Adverse Event|0|||
130710596|NCT00788593|470564892|FG001|First Intervention Period|Adverse Event|1|||
130710597|NCT00788593|470564893|FG002|First Intervention Period|Adverse Event|0|||
130710598|NCT00788593|470564891|FG000|Second Intervention Period|Lost to Follow-up|0|||
130710599|NCT00788593|470564892|FG001|Second Intervention Period|Lost to Follow-up|1|||
130710600|NCT00788593|470564893|FG002|Second Intervention Period|Lost to Follow-up|0|||
130710601|NCT00788593|470564891|FG000|Second Intervention Period|Other|0|||
130710602|NCT00788593|470564892|FG001|Second Intervention Period|Other|0|||
130710603|NCT00788593|470564893|FG002|Second Intervention Period|Other|1|||
130710604|NCT00515034|470564894|FG000|Overall Study|Adverse Event|2|||
130710605|NCT00515034|470564895|FG001|Overall Study|Adverse Event|0|||
130710606|NCT00515034|470564896|FG002|Overall Study|Adverse Event|1|||
130710607|NCT00515034|470564897|FG003|Overall Study|Adverse Event|0|||
130710608|NCT00515034|470564894|FG000|Overall Study|Death|4|||
130710609|NCT00515034|470564895|FG001|Overall Study|Death|2|||
130710610|NCT00515034|470564896|FG002|Overall Study|Death|1|||
130710611|NCT00515034|470564897|FG003|Overall Study|Death|3|||
130710612|NCT00515034|470564894|FG000|Overall Study|Withdrawal by Subject|1|||
130710613|NCT00515034|470564895|FG001|Overall Study|Withdrawal by Subject|0|||
130710614|NCT00515034|470564896|FG002|Overall Study|Withdrawal by Subject|3|||
130710615|NCT00515034|470564897|FG003|Overall Study|Withdrawal by Subject|0|||
130710616|NCT00515034|470564894|FG000|Overall Study|Physician Decision|0|||
130710617|NCT00515034|470564895|FG001|Overall Study|Physician Decision|0|||
130710618|NCT00515034|470564896|FG002|Overall Study|Physician Decision|1|||
130710619|NCT00515034|470564897|FG003|Overall Study|Physician Decision|1|||
130710620|NCT00515034|470564894|FG000|Overall Study|Other|1|||
130368189|NCT02034110|469319586|FG006|Overall Study|Lost to Follow-up|1|||
130368190|NCT02034110|469319587|FG007|Overall Study|Lost to Follow-up|0|||
130368191|NCT02034110|469319580|FG000|Overall Study|Withdrawal by Subject|5|||
130368192|NCT02034110|469319581|FG001|Overall Study|Withdrawal by Subject|7|||
130710621|NCT00515034|470564895|FG001|Overall Study|Other|0|||
130710622|NCT00515034|470564896|FG002|Overall Study|Other|2|||
130710623|NCT00515034|470564897|FG003|Overall Study|Other|1|||
130710624|NCT01688726|470564902|FG000|Overall Study|Adverse Event|1|||
130710625|NCT01688726|470564903|FG001|Overall Study|Adverse Event|0|||
130368193|NCT02034110|469319582|FG002|Overall Study|Withdrawal by Subject|0|||
130710626|NCT01688726|470564902|FG000|Overall Study|Relocated abroad|0|||
130710627|NCT01688726|470564903|FG001|Overall Study|Relocated abroad|1|||
130368194|NCT02034110|469319583|FG003|Overall Study|Withdrawal by Subject|3|||
130368195|NCT02034110|469319584|FG004|Overall Study|Withdrawal by Subject|7|||
130368196|NCT02034110|469319585|FG005|Overall Study|Withdrawal by Subject|0|||
130368197|NCT02034110|469319586|FG006|Overall Study|Withdrawal by Subject|3|||
130368198|NCT02034110|469319587|FG007|Overall Study|Withdrawal by Subject|1|||
130368199|NCT02034110|469319580|FG000|Overall Study|Study closed by sponsor|6|||
130368200|NCT02034110|469319581|FG001|Overall Study|Study closed by sponsor|2|||
130368201|NCT02034110|469319582|FG002|Overall Study|Study closed by sponsor|0|||
130368202|NCT02034110|469319583|FG003|Overall Study|Study closed by sponsor|6|||
130368203|NCT02034110|469319584|FG004|Overall Study|Study closed by sponsor|7|||
130368204|NCT02034110|469319585|FG005|Overall Study|Study closed by sponsor|0|||
130368205|NCT02034110|469319586|FG006|Overall Study|Study closed by sponsor|42|||
130368206|NCT02034110|469319587|FG007|Overall Study|Study closed by sponsor|0|||
130368207|NCT02835820|469319590|FG000|Overall Study|Baseline Screen Failure|0|||
130368208|NCT02835820|469319591|FG001|Overall Study|Baseline Screen Failure|3|||
130368209|NCT01867424|469319595|FG000|Overall Study|Patient noncompliance|2|||
130368210|NCT01867424|469319596|FG001|Overall Study|Patient noncompliance|1|||
130368211|NCT01056653|469319597|FG000|Overall Study|Lost to Follow-up|0|||
130368212|NCT01056653|469319598|FG001|Overall Study|Lost to Follow-up|0|||
130368213|NCT01056653|469319599|FG002|Overall Study|Lost to Follow-up|2|||
130368214|NCT01751178|469319600|FG000|Overall Study|Adverse Event|2|||
130368215|NCT01751178|469319601|FG001|Overall Study|Adverse Event|0|||
130368216|NCT01751178|469319602|FG002|Overall Study|Adverse Event|0|||
130368217|NCT01751178|469319600|FG000|Overall Study|Other Reason (unknown)|1|||
130368218|NCT01751178|469319601|FG001|Overall Study|Other Reason (unknown)|0|||
130368219|NCT01751178|469319602|FG002|Overall Study|Other Reason (unknown)|2|||
130368220|NCT00288054|469319603|FG000|Overall Study|Protocol Violation|2|||
130368221|NCT00288054|469319603|FG000|Overall Study|Lack of Efficacy|16|||
130368222|NCT00288054|469319603|FG000|Overall Study|Adverse Event|3|||
130368223|NCT00288054|469319603|FG000|Overall Study|Withdrawal by Subject|1|||
130368224|NCT00288054|469319603|FG000|Overall Study|Not protocol specified|2|||
130368225|NCT03733470|469319609|FG000|Overall Study|PI Decision|1|||
130710628|NCT03499119|470564904|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710629|NCT03499119|470564905|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710630|NCT03499119|470564906|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710631|NCT03499119|470564907|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
130710632|NCT03499119|470564904|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
130710633|NCT03499119|470564905|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
130710634|NCT03499119|470564906|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
130368226|NCT03733470|469319610|FG001|Overall Study|PI Decision|1|||
130368227|NCT01010061|469319611|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
130368228|NCT01010061|469319612|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
130368229|NCT01010061|469319611|FG000|Overall Study|Disease Progression|2|||
130368230|NCT01010061|469319612|FG001|Overall Study|Disease Progression|8|||
130368231|NCT01010061|469319611|FG000|Overall Study|Withdrew Consent|5|||
130368232|NCT01010061|469319612|FG001|Overall Study|Withdrew Consent|1|||
130368233|NCT01010061|469319611|FG000|Overall Study|Death|3|||
130368234|NCT01010061|469319612|FG001|Overall Study|Death|6|||
130368235|NCT01010061|469319611|FG000|Overall Study|Administrative/Other|0|||
130368236|NCT01010061|469319612|FG001|Overall Study|Administrative/Other|1|||
130368237|NCT01010061|469319611|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
130368238|NCT01010061|469319612|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130368239|NCT01010061|469319611|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130368240|NCT01010061|469319612|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130368241|NCT01010061|469319611|FG000|Overall Study|Violation of Selection Criteria|0|||
130368242|NCT01010061|469319612|FG001|Overall Study|Violation of Selection Criteria|1|||
130368243|NCT01010061|469319611|FG000|Overall Study|Did Not Receive Treatment|2|||
130368244|NCT01010061|469319612|FG001|Overall Study|Did Not Receive Treatment|2|||
130368245|NCT03470441|469319613|FG000|Overall Study|Death|0|||
130368246|NCT03470441|469319614|FG001|Overall Study|Death|1|||
130368247|NCT03470441|469319615|FG002|Overall Study|Death|1|||
130368248|NCT03470441|469319616|FG003|Overall Study|Death|0|||
130368249|NCT03470441|469319613|FG000|Overall Study|Adverse Event|0|||
130368250|NCT03470441|469319614|FG001|Overall Study|Adverse Event|0|||
130368251|NCT03470441|469319615|FG002|Overall Study|Adverse Event|0|||
130368252|NCT03470441|469319616|FG003|Overall Study|Adverse Event|1|||
130368253|NCT03470441|469319613|FG000|Overall Study|Withdrawal by Subject|1|||
130368254|NCT03470441|469319614|FG001|Overall Study|Withdrawal by Subject|4|||
130710635|NCT03499119|470564907|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
130368255|NCT03470441|469319615|FG002|Overall Study|Withdrawal by Subject|1|||
130368256|NCT03470441|469319616|FG003|Overall Study|Withdrawal by Subject|3|||
130368257|NCT03768414|469319617|FG000|Overall Study|Adverse Event or side effects|72|||
130368258|NCT03768414|469319618|FG001|Overall Study|Adverse Event or side effects|28|||
130368259|NCT03768414|469319617|FG000|Overall Study|Refusal unrelated to adverse event|33|||
130368260|NCT03768414|469319618|FG001|Overall Study|Refusal unrelated to adverse event|33|||
130368261|NCT03768414|469319617|FG000|Overall Study|Progression/relapse|132|||
130368262|NCT03768414|469319618|FG001|Overall Study|Progression/relapse|60|||
130368263|NCT03768414|469319617|FG000|Overall Study|Death|9|||
130368264|NCT03768414|469319618|FG001|Overall Study|Death|6|||
130368265|NCT03768414|469319617|FG000|Overall Study|Other - not protocol specified|45|||
130710636|NCT03499119|470564904|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
130710637|NCT03499119|470564905|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
130278190|NCT04445519|468979576|FG000|Overall Study|Sponsor or IRB Decision|0|||
130278191|NCT04445519|468979577|FG001|Overall Study|Sponsor or IRB Decision|1|||
130278192|NCT04445519|468979578|FG002|Overall Study|Sponsor or IRB Decision|2|||
130278193|NCT04445519|468979576|FG000|Overall Study|Withdrawal by Subject|0|||
130278194|NCT04445519|468979577|FG001|Overall Study|Withdrawal by Subject|3|||
130278195|NCT04445519|468979578|FG002|Overall Study|Withdrawal by Subject|3|||
130278196|NCT04445519|468979576|FG000|Overall Study|Adverse Event|0|||
130278197|NCT04445519|468979577|FG001|Overall Study|Adverse Event|8|||
130278198|NCT04445519|468979578|FG002|Overall Study|Adverse Event|6|||
130278199|NCT04445519|468979576|FG000|Overall Study|Other Reason|0|||
130278200|NCT04445519|468979577|FG001|Overall Study|Other Reason|1|||
130278201|NCT04445519|468979578|FG002|Overall Study|Other Reason|1|||
130278202|NCT04445519|468979576|FG000|Overall Study|Protocol Violation|0|||
130278203|NCT04445519|468979577|FG001|Overall Study|Protocol Violation|0|||
130278204|NCT04445519|468979578|FG002|Overall Study|Protocol Violation|1|||
130278205|NCT01345929|468979579|FG000|Overall Study|Withdrawal by Subject|9|||
130278206|NCT01345929|468979580|FG001|Overall Study|Withdrawal by Subject|8|||
130278207|NCT01345929|468979579|FG000|Overall Study|Lost to Follow-up|9|||
130278208|NCT01345929|468979580|FG001|Overall Study|Lost to Follow-up|9|||
130278209|NCT01345929|468979579|FG000|Overall Study|Adverse Event|0|||
130278210|NCT01345929|468979580|FG001|Overall Study|Adverse Event|1|||
130278211|NCT01345929|468979579|FG000|Overall Study|Didn't meet eligibility criteria|2|||
130555320|NCT03942406|470001555|FG006|Overall Study|Withdrawal by Subject|0|||
130555321|NCT03942406|470001549|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
130710638|NCT03499119|470564906|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
130710639|NCT03499119|470564907|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
130710640|NCT03499119|470564904|FG000|Optional Extension Phase|Lost to Follow-up|0|||
130710641|NCT03499119|470564905|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130710642|NCT03499119|470564906|FG002|Optional Extension Phase|Lost to Follow-up|0|||
130710643|NCT03499119|470564907|FG003|Optional Extension Phase|Lost to Follow-up|1|||
130710644|NCT03499119|470564904|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
130710645|NCT03499119|470564905|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
130710646|NCT03499119|470564906|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
130710647|NCT03499119|470564907|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
130710648|NCT03499119|470564904|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
130710649|NCT03499119|470564905|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
130710650|NCT03499119|470564906|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
130710651|NCT03499119|470564907|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
130710652|NCT04553913|470564908|FG000|Overall Study|patient's block resolved prior to PACU|1|||
130710653|NCT04553913|470564908|FG000|Overall Study|did not use the device properly|5|||
130710654|NCT01481324|470564909|FG000|Overall Study|Missing Data|0|||
130710655|NCT01481324|470564910|FG001|Overall Study|Missing Data|2|||
130710656|NCT01481324|470564911|FG002|Overall Study|Missing Data|2|||
130710657|NCT02427984|470564913|FG000|Overall Study|Lost to Follow-up|13|||
130710658|NCT02427984|470564914|FG001|Overall Study|Lost to Follow-up|5|||
130710659|NCT02427984|470564915|FG002|Overall Study|Lost to Follow-up|18|||
130710660|NCT04189445|470567004|FG000|Overall Study|Withdrawal of consent|8|||
130710661|NCT04189445|470567005|FG001|Overall Study|Withdrawal of consent|1|||
130710662|NCT04189445|470567006|FG002|Overall Study|Withdrawal of consent|0|||
130710663|NCT04189445|470567004|FG000|Overall Study|Study Terminated by Sponsor|25|||
130710664|NCT04189445|470567005|FG001|Overall Study|Study Terminated by Sponsor|3|||
130710665|NCT04189445|470567006|FG002|Overall Study|Study Terminated by Sponsor|0|||
130710666|NCT04189445|470567004|FG000|Overall Study|Death|54|||
130710667|NCT04189445|470567005|FG001|Overall Study|Death|24|||
130710668|NCT04189445|470567006|FG002|Overall Study|Death|0|||
130710669|NCT03959527|470567007|FG000|Overall Study|Withdrawal by Subject|8|||
130710670|NCT03959527|470567008|FG001|Overall Study|Withdrawal by Subject|3|||
130710671|NCT03959527|470567007|FG000|Overall Study|Lost to Follow-up|31|||
130710672|NCT03959527|470567008|FG001|Overall Study|Lost to Follow-up|15|||
130710673|NCT03959527|470567007|FG000|Overall Study|Did not meet eligibility criteria|1|||
130710674|NCT03959527|470567008|FG001|Overall Study|Did not meet eligibility criteria|1|||
130710675|NCT03959527|470567007|FG000|Overall Study|Protocol Violation|10|||
130710676|NCT03959527|470567008|FG001|Overall Study|Protocol Violation|5|||
130710677|NCT06029959|470567009|FG000|Overall Study|Physician Decision|6|||
130710678|NCT00099268|470567012|FG000|Overall Study|Withdrawal by Subject|46|||
130710679|NCT00099268|470567013|FG001|Overall Study|Withdrawal by Subject|28|||
130710680|NCT00099268|470567012|FG000|Overall Study|Adverse Event|19|||
130710681|NCT00099268|470567013|FG001|Overall Study|Adverse Event|19|||
130278212|NCT01345929|468979580|FG001|Overall Study|Didn't meet eligibility criteria|0|||
130278213|NCT01345929|468979579|FG000|Overall Study|40,000 CFU/ML|1|||
130278214|NCT01345929|468979580|FG001|Overall Study|40,000 CFU/ML|0|||
130278215|NCT01345929|468979579|FG000|Overall Study|Patient withdrawal|0|||
130278216|NCT01345929|468979580|FG001|Overall Study|Patient withdrawal|1|||
130710682|NCT00099268|470567012|FG000|Overall Study|Protocol Violation|9|||
130278217|NCT02151903|468979581|FG000|Overall Study|Withdrawal by Subject|1|||
130278218|NCT02151903|468979582|FG001|Overall Study|Withdrawal by Subject|0|||
130278219|NCT02151903|468979581|FG000|Overall Study|Progressive disease|2|||
130278220|NCT02151903|468979582|FG001|Overall Study|Progressive disease|1|||
130278221|NCT03768089|468979583|FG000|Part A|Lost to Follow-up|0|||
130278222|NCT03768089|468979584|FG001|Part A|Lost to Follow-up|0|||
130278223|NCT03768089|468979585|FG002|Part A|Lost to Follow-up|0|||
130278224|NCT03768089|468979586|FG003|Part A|Lost to Follow-up|0|||
130278225|NCT03768089|468979587|FG004|Part A|Lost to Follow-up|1|||
130278226|NCT03768089|468979588|FG005|Part A|Lost to Follow-up|0|||
130278227|NCT03768089|468979589|FG006|Part A|Lost to Follow-up|0|||
130278228|NCT03768089|468979590|FG007|Part A|Lost to Follow-up|0|||
130278229|NCT03768089|468979591|FG008|Part A|Lost to Follow-up|0|||
130278230|NCT03768089|468979592|FG009|Part A|Lost to Follow-up|0|||
130278231|NCT03768089|468979593|FG010|Part A|Lost to Follow-up|0|||
130278232|NCT03768089|468979594|FG011|Part A|Lost to Follow-up|0|||
130278233|NCT03768089|468979595|FG012|Part A|Lost to Follow-up|0|||
130278234|NCT03768089|468979596|FG013|Part A|Lost to Follow-up|0|||
130278235|NCT03768089|468979597|FG014|Part A|Lost to Follow-up|0|||
130457627|NCT03354390|469638411|FG001|Level 2|Lack of Efficacy|1|||
130457628|NCT03354390|469638412|FG002|Level 2|Lack of Efficacy|0|||
130457629|NCT03354390|469638413|FG003|Level 2|Lack of Efficacy|0|||
130457630|NCT03354390|469638410|FG000|Level 2|Lost to Follow-up|0|||
130457631|NCT03354390|469638411|FG001|Level 2|Lost to Follow-up|1|||
130457632|NCT03354390|469638412|FG002|Level 2|Lost to Follow-up|0|||
130457633|NCT03354390|469638413|FG003|Level 2|Lost to Follow-up|0|||
130710683|NCT00099268|470567013|FG001|Overall Study|Protocol Violation|8|||
130710684|NCT00099268|470567012|FG000|Overall Study|Lost to Follow-up|6|||
130710685|NCT00099268|470567013|FG001|Overall Study|Lost to Follow-up|4|||
130710686|NCT00099268|470567012|FG000|Overall Study|Lack of Efficacy|5|||
130710687|NCT00099268|470567013|FG001|Overall Study|Lack of Efficacy|18|||
130710688|NCT00099268|470567012|FG000|Overall Study|Administrative problems|4|||
130710689|NCT00099268|470567013|FG001|Overall Study|Administrative problems|4|||
130710690|NCT00099268|470567012|FG000|Overall Study|Death|3|||
130710691|NCT00099268|470567013|FG001|Overall Study|Death|1|||
130710692|NCT02006628|470567015|FG000|Overall Study|Adverse Event|1|||
130710693|NCT02006628|470567016|FG001|Overall Study|Adverse Event|1|||
130710694|NCT02006628|470567015|FG000|Overall Study|Withdrawal by Subject|2|||
130710695|NCT02006628|470567016|FG001|Overall Study|Withdrawal by Subject|1|||
130710696|NCT00262041|470567017|FG000|Overall Study|Withdrawal by Subject|0|||
130710697|NCT00262041|470567018|FG001|Overall Study|Withdrawal by Subject|3|||
130710698|NCT00262041|470567019|FG002|Overall Study|Withdrawal by Subject|1|||
130710699|NCT00262041|470567017|FG000|Overall Study|Lost to Follow-up|1|||
130710700|NCT00262041|470567018|FG001|Overall Study|Lost to Follow-up|1|||
130710701|NCT00262041|470567019|FG002|Overall Study|Lost to Follow-up|5|||
130710702|NCT00262041|470567017|FG000|Overall Study|Unable to classify|1|||
130710703|NCT00262041|470567018|FG001|Overall Study|Unable to classify|0|||
130710704|NCT00262041|470567019|FG002|Overall Study|Unable to classify|0|||
130710705|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
130710706|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
130710707|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
130710708|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
130710709|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
130710710|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
130710711|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
130710712|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
130710713|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
130710714|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
130710715|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
130710716|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
130710717|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
130710718|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
130710719|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
130710720|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
130710721|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
130710722|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
130710723|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
130710724|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
130710725|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
130710726|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130710727|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
130278236|NCT03768089|468979598|FG015|Part A|Lost to Follow-up|0|||
130278237|NCT03768089|468979599|FG016|Part A|Lost to Follow-up|0|||
130278238|NCT03768089|468979600|FG017|Part A|Lost to Follow-up|0|||
130278239|NCT03768089|468979583|FG000|Part C|Randomized, Never Dosed|0|||
130278240|NCT03768089|468979584|FG001|Part C|Randomized, Never Dosed|0|||
130278241|NCT03768089|468979585|FG002|Part C|Randomized, Never Dosed|0|||
130278242|NCT03768089|468979586|FG003|Part C|Randomized, Never Dosed|0|||
130278243|NCT03768089|468979587|FG004|Part C|Randomized, Never Dosed|0|||
130278244|NCT03768089|468979588|FG005|Part C|Randomized, Never Dosed|0|||
130278245|NCT03768089|468979589|FG006|Part C|Randomized, Never Dosed|0|||
130278246|NCT03768089|468979590|FG007|Part C|Randomized, Never Dosed|0|||
130278247|NCT03768089|468979591|FG008|Part C|Randomized, Never Dosed|0|||
130278248|NCT03768089|468979592|FG009|Part C|Randomized, Never Dosed|0|||
130278249|NCT03768089|468979593|FG010|Part C|Randomized, Never Dosed|0|||
130278250|NCT03768089|468979594|FG011|Part C|Randomized, Never Dosed|0|||
130278251|NCT03768089|468979595|FG012|Part C|Randomized, Never Dosed|0|||
130278252|NCT03768089|468979596|FG013|Part C|Randomized, Never Dosed|0|||
130278253|NCT03768089|468979597|FG014|Part C|Randomized, Never Dosed|1|||
130278254|NCT03768089|468979598|FG015|Part C|Randomized, Never Dosed|0|||
130278255|NCT03768089|468979599|FG016|Part C|Randomized, Never Dosed|0|||
130278256|NCT03768089|468979600|FG017|Part C|Randomized, Never Dosed|0|||
130278257|NCT05141175|468979605|FG000|Overall Study|Withdrawal by Subject|1|||
130278258|NCT00177294|468979606|FG000|Overall Study|Withdrawal by Subject|7|||
130278259|NCT00177294|468979607|FG001|Overall Study|Withdrawal by Subject|5|||
130278260|NCT02443116|468979608|FG000|Part 1|Adverse Event|2|||
130278261|NCT02443116|468979609|FG001|Part 1|Adverse Event|3|||
130278262|NCT02443116|468979610|FG002|Part 1|Adverse Event|0|||
130278263|NCT02443116|468979611|FG003|Part 1|Adverse Event|0|||
130278264|NCT02443116|468979612|FG004|Part 1|Adverse Event|0|||
130278265|NCT02443116|468979613|FG005|Part 1|Adverse Event|0|||
130278266|NCT02443116|468979614|FG006|Part 1|Adverse Event|0|||
130278267|NCT02443116|468979615|FG007|Part 1|Adverse Event|0|||
130278268|NCT02443116|468979616|FG008|Part 1|Adverse Event|0|||
130278269|NCT02443116|468979608|FG000|Part 1|Withdrew informed consent|0|||
130278270|NCT02443116|468979609|FG001|Part 1|Withdrew informed consent|1|||
130278271|NCT02443116|468979610|FG002|Part 1|Withdrew informed consent|0|||
130278272|NCT02443116|468979611|FG003|Part 1|Withdrew informed consent|0|||
130278273|NCT02443116|468979612|FG004|Part 1|Withdrew informed consent|0|||
130278274|NCT02443116|468979613|FG005|Part 1|Withdrew informed consent|0|||
130278275|NCT02443116|468979614|FG006|Part 1|Withdrew informed consent|0|||
130278276|NCT02443116|468979615|FG007|Part 1|Withdrew informed consent|0|||
130278277|NCT02443116|468979616|FG008|Part 1|Withdrew informed consent|0|||
130278278|NCT02443116|468979608|FG000|Part 1|Lost to Follow-up|0|||
130278279|NCT02443116|468979609|FG001|Part 1|Lost to Follow-up|0|||
130278280|NCT02443116|468979610|FG002|Part 1|Lost to Follow-up|2|||
130278281|NCT02443116|468979611|FG003|Part 1|Lost to Follow-up|0|||
130278282|NCT02443116|468979612|FG004|Part 1|Lost to Follow-up|0|||
130278283|NCT02443116|468979613|FG005|Part 1|Lost to Follow-up|0|||
130278284|NCT02443116|468979614|FG006|Part 1|Lost to Follow-up|0|||
130278285|NCT02443116|468979615|FG007|Part 1|Lost to Follow-up|0|||
130278286|NCT02443116|468979616|FG008|Part 1|Lost to Follow-up|0|||
130278287|NCT02443116|468979608|FG000|Part 1|Participant moved out of state|0|||
130278288|NCT02443116|468979609|FG001|Part 1|Participant moved out of state|0|||
130278289|NCT02443116|468979610|FG002|Part 1|Participant moved out of state|1|||
130278290|NCT02443116|468979611|FG003|Part 1|Participant moved out of state|0|||
130278291|NCT02443116|468979612|FG004|Part 1|Participant moved out of state|0|||
130278292|NCT02443116|468979613|FG005|Part 1|Participant moved out of state|0|||
130278293|NCT02443116|468979614|FG006|Part 1|Participant moved out of state|0|||
130278294|NCT02443116|468979615|FG007|Part 1|Participant moved out of state|0|||
130278295|NCT02443116|468979616|FG008|Part 1|Participant moved out of state|0|||
130278296|NCT02443116|468979608|FG000|Part 1|Participant enrolled in another clinical trial|0|||
130368266|NCT03768414|469319618|FG001|Overall Study|Other - not protocol specified|18|||
130710728|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130710729|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
130710730|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
130710731|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
130710732|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
130278297|NCT02443116|468979609|FG001|Part 1|Participant enrolled in another clinical trial|0|||
130278298|NCT02443116|468979610|FG002|Part 1|Participant enrolled in another clinical trial|1|||
130278299|NCT02443116|468979611|FG003|Part 1|Participant enrolled in another clinical trial|0|||
130278300|NCT02443116|468979612|FG004|Part 1|Participant enrolled in another clinical trial|0|||
130278301|NCT02443116|468979613|FG005|Part 1|Participant enrolled in another clinical trial|0|||
130278302|NCT02443116|468979614|FG006|Part 1|Participant enrolled in another clinical trial|0|||
130278303|NCT02443116|468979615|FG007|Part 1|Participant enrolled in another clinical trial|0|||
130278304|NCT02443116|468979616|FG008|Part 1|Participant enrolled in another clinical trial|0|||
130278305|NCT02443116|468979608|FG000|Part 2|Adverse Event|0|||
130278306|NCT02443116|468979609|FG001|Part 2|Adverse Event|0|||
130368267|NCT03768414|469319617|FG000|Overall Study|Reason under review|3|||
130368268|NCT03768414|469319618|FG001|Overall Study|Reason under review|2|||
130278307|NCT02443116|468979610|FG002|Part 2|Adverse Event|0|||
130278308|NCT02443116|468979611|FG003|Part 2|Adverse Event|0|||
130278309|NCT02443116|468979612|FG004|Part 2|Adverse Event|1|||
130278310|NCT02443116|468979613|FG005|Part 2|Adverse Event|1|||
130278311|NCT02443116|468979614|FG006|Part 2|Adverse Event|2|||
130278312|NCT02443116|468979615|FG007|Part 2|Adverse Event|0|||
130278313|NCT02443116|468979616|FG008|Part 2|Adverse Event|0|||
130278314|NCT02443116|468979608|FG000|Part 2|Withdrew informed consent|0|||
130278315|NCT02443116|468979609|FG001|Part 2|Withdrew informed consent|0|||
130278316|NCT02443116|468979610|FG002|Part 2|Withdrew informed consent|0|||
130278317|NCT02443116|468979611|FG003|Part 2|Withdrew informed consent|0|||
130278318|NCT02443116|468979612|FG004|Part 2|Withdrew informed consent|0|||
130278319|NCT02443116|468979613|FG005|Part 2|Withdrew informed consent|1|||
130278320|NCT02443116|468979614|FG006|Part 2|Withdrew informed consent|1|||
130278321|NCT02443116|468979615|FG007|Part 2|Withdrew informed consent|0|||
130278322|NCT02443116|468979616|FG008|Part 2|Withdrew informed consent|0|||
130278323|NCT02443116|468979608|FG000|Part 2|Inability to comply with protocol|0|||
130278324|NCT02443116|468979609|FG001|Part 2|Inability to comply with protocol|0|||
130278325|NCT02443116|468979610|FG002|Part 2|Inability to comply with protocol|0|||
130278326|NCT02443116|468979611|FG003|Part 2|Inability to comply with protocol|1|||
130278327|NCT02443116|468979612|FG004|Part 2|Inability to comply with protocol|0|||
130278328|NCT02443116|468979613|FG005|Part 2|Inability to comply with protocol|0|||
130278329|NCT02443116|468979614|FG006|Part 2|Inability to comply with protocol|0|||
130278330|NCT02443116|468979615|FG007|Part 2|Inability to comply with protocol|0|||
130278331|NCT02443116|468979616|FG008|Part 2|Inability to comply with protocol|0|||
130278332|NCT02443116|468979608|FG000|Part 2|Lost to Follow-up|0|||
130278333|NCT02443116|468979609|FG001|Part 2|Lost to Follow-up|0|||
130278334|NCT02443116|468979610|FG002|Part 2|Lost to Follow-up|0|||
130278335|NCT02443116|468979611|FG003|Part 2|Lost to Follow-up|1|||
130278336|NCT02443116|468979612|FG004|Part 2|Lost to Follow-up|0|||
130278337|NCT02443116|468979613|FG005|Part 2|Lost to Follow-up|0|||
130278338|NCT02443116|468979614|FG006|Part 2|Lost to Follow-up|0|||
130278339|NCT02443116|468979615|FG007|Part 2|Lost to Follow-up|0|||
130278340|NCT02443116|468979616|FG008|Part 2|Lost to Follow-up|0|||
130278341|NCT02443116|468979608|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278342|NCT02443116|468979609|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278343|NCT02443116|468979610|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278344|NCT02443116|468979611|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278345|NCT02443116|468979612|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278346|NCT02443116|468979613|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
130278347|NCT02443116|468979614|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278348|NCT02443116|468979615|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278349|NCT02443116|468979616|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278350|NCT02443116|468979608|FG000|Part 3|Adverse Event|0|||
130278351|NCT02443116|468979609|FG001|Part 3|Adverse Event|0|||
130278352|NCT02443116|468979610|FG002|Part 3|Adverse Event|0|||
130278353|NCT02443116|468979611|FG003|Part 3|Adverse Event|0|||
130278354|NCT02443116|468979612|FG004|Part 3|Adverse Event|0|||
130278355|NCT02443116|468979613|FG005|Part 3|Adverse Event|0|||
130278356|NCT02443116|468979614|FG006|Part 3|Adverse Event|0|||
130278357|NCT02443116|468979615|FG007|Part 3|Adverse Event|0|||
130278358|NCT02443116|468979616|FG008|Part 3|Adverse Event|1|||
130278359|NCT02443116|468979608|FG000|Part 3|Withdrew informed consent|0|||
130278360|NCT02443116|468979609|FG001|Part 3|Withdrew informed consent|0|||
130278361|NCT02443116|468979610|FG002|Part 3|Withdrew informed consent|0|||
130278362|NCT02443116|468979611|FG003|Part 3|Withdrew informed consent|0|||
130278363|NCT02443116|468979612|FG004|Part 3|Withdrew informed consent|0|||
130278364|NCT02443116|468979613|FG005|Part 3|Withdrew informed consent|0|||
130278365|NCT02443116|468979614|FG006|Part 3|Withdrew informed consent|0|||
130278366|NCT02443116|468979615|FG007|Part 3|Withdrew informed consent|3|||
130278367|NCT02443116|468979616|FG008|Part 3|Withdrew informed consent|2|||
130278368|NCT02443116|468979608|FG000|Part 3|Lost to Follow-up|0|||
130278369|NCT02443116|468979609|FG001|Part 3|Lost to Follow-up|0|||
130278370|NCT02443116|468979610|FG002|Part 3|Lost to Follow-up|0|||
130278371|NCT02443116|468979611|FG003|Part 3|Lost to Follow-up|0|||
130278372|NCT02443116|468979612|FG004|Part 3|Lost to Follow-up|0|||
130278373|NCT02443116|468979613|FG005|Part 3|Lost to Follow-up|0|||
130278374|NCT02443116|468979614|FG006|Part 3|Lost to Follow-up|0|||
130278375|NCT02443116|468979615|FG007|Part 3|Lost to Follow-up|1|||
130278376|NCT02443116|468979616|FG008|Part 3|Lost to Follow-up|2|||
130278377|NCT03100539|468981314|FG000|Overall Study|Lost to Follow-up|60|||
130278378|NCT03100539|468981315|FG001|Overall Study|Lost to Follow-up|54|||
130278379|NCT03100539|468981316|FG002|Overall Study|Lost to Follow-up|17|||
130278380|NCT03100539|468981314|FG000|Overall Study|Uncollected|8|||
130278381|NCT03100539|468981315|FG001|Overall Study|Uncollected|8|||
130278382|NCT03100539|468981316|FG002|Overall Study|Uncollected|0|||
130278383|NCT03100539|468981314|FG000|Overall Study|Ally Health|0|||
130278384|NCT03100539|468981315|FG001|Overall Study|Ally Health|0|||
130278385|NCT03100539|468981316|FG002|Overall Study|Ally Health|3|||
130278386|NCT03100539|468981314|FG000|Overall Study|Disinterest|0|||
130278387|NCT03100539|468981315|FG001|Overall Study|Disinterest|0|||
130278388|NCT03100539|468981316|FG002|Overall Study|Disinterest|22|||
130278389|NCT03100539|468981314|FG000|Overall Study|Veteran Health|0|||
130278390|NCT03100539|468981315|FG001|Overall Study|Veteran Health|0|||
130710733|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
130710734|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
130710735|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
130710736|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
130710737|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
130710738|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
130710739|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
130278391|NCT03100539|468981316|FG002|Overall Study|Veteran Health|8|||
130278392|NCT03100539|468981314|FG000|Overall Study|Moved|0|||
130278393|NCT03100539|468981315|FG001|Overall Study|Moved|0|||
130278394|NCT03100539|468981316|FG002|Overall Study|Moved|1|||
130278395|NCT03100539|468981314|FG000|Overall Study|Scheduling Conflicts|0|||
130278396|NCT03100539|468981315|FG001|Overall Study|Scheduling Conflicts|0|||
130278397|NCT03100539|468981316|FG002|Overall Study|Scheduling Conflicts|12|||
130278398|NCT00809835|468981319|FG000|Overall Study|Lost to Follow-up|7|||
130278399|NCT00809835|468981320|FG001|Overall Study|Lost to Follow-up|6|||
130278400|NCT00809835|468981321|FG002|Overall Study|Lost to Follow-up|10|||
130278401|NCT00809835|468981322|FG003|Overall Study|Lost to Follow-up|2|||
130278402|NCT00809835|468981319|FG000|Overall Study|Withdrawal by Subject|1|||
130278403|NCT00809835|468981320|FG001|Overall Study|Withdrawal by Subject|1|||
130278404|NCT00809835|468981321|FG002|Overall Study|Withdrawal by Subject|1|||
130278405|NCT00809835|468981322|FG003|Overall Study|Withdrawal by Subject|0|||
130278406|NCT05659719|468981323|FG000|Overall Study|At sponsor's request|0|||
130278407|NCT05659719|468981324|FG001|Overall Study|At sponsor's request|0|||
130278408|NCT05659719|468981325|FG002|Overall Study|At sponsor's request|0|||
130278409|NCT05659719|468981326|FG003|Overall Study|At sponsor's request|95|||
130278410|NCT05659719|468981323|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278411|NCT05659719|468981324|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278412|NCT05659719|468981325|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278413|NCT05659719|468981326|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
130278414|NCT05659719|468981323|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
130278415|NCT05659719|468981324|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
130278416|NCT05659719|468981325|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
130278417|NCT05659719|468981326|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
130278418|NCT05659719|468981323|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278419|NCT05659719|468981324|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278420|NCT05659719|468981325|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278421|NCT05659719|468981326|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
130278422|NCT05659719|468981323|FG000|Overall Study|Lost to Follow-up|0|||
130278423|NCT05659719|468981324|FG001|Overall Study|Lost to Follow-up|0|||
130278424|NCT05659719|468981325|FG002|Overall Study|Lost to Follow-up|0|||
130278425|NCT05659719|468981326|FG003|Overall Study|Lost to Follow-up|2|||
130278426|NCT05659719|468981323|FG000|Overall Study|Moved to another observational study|0|||
130278427|NCT05659719|468981324|FG001|Overall Study|Moved to another observational study|0|||
130278428|NCT05659719|468981325|FG002|Overall Study|Moved to another observational study|0|||
130278429|NCT05659719|468981326|FG003|Overall Study|Moved to another observational study|1|||
130278430|NCT05659719|468981323|FG000|Overall Study|The child was enrolled in an interventional study|0|||
130368269|NCT02571777|469319619|FG000|Overall Study|Subject/guardian decision|34|||
130368270|NCT02571777|469319620|FG001|Overall Study|Subject/guardian decision|26|||
130368271|NCT02571777|469319621|FG002|Overall Study|Subject/guardian decision|26|||
130368272|NCT02571777|469319622|FG003|Overall Study|Subject/guardian decision|25|||
130368273|NCT02571777|469319623|FG004|Overall Study|Subject/guardian decision|27|||
130368274|NCT02571777|469319619|FG000|Overall Study|Protocol Deviation|2|||
130368275|NCT02571777|469319620|FG001|Overall Study|Protocol Deviation|3|||
130368276|NCT02571777|469319621|FG002|Overall Study|Protocol Deviation|4|||
130278431|NCT05659719|468981324|FG001|Overall Study|The child was enrolled in an interventional study|0|||
130278432|NCT05659719|468981325|FG002|Overall Study|The child was enrolled in an interventional study|0|||
130278433|NCT05659719|468981326|FG003|Overall Study|The child was enrolled in an interventional study|55|||
130368277|NCT02571777|469319622|FG003|Overall Study|Protocol Deviation|8|||
130368278|NCT02571777|469319623|FG004|Overall Study|Protocol Deviation|4|||
130368279|NCT02571777|469319619|FG000|Overall Study|Death|1|||
130368280|NCT02571777|469319620|FG001|Overall Study|Death|1|||
130368281|NCT02571777|469319621|FG002|Overall Study|Death|4|||
130278434|NCT05659719|468981323|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130368282|NCT02571777|469319622|FG003|Overall Study|Death|0|||
130278435|NCT05659719|468981324|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130278436|NCT05659719|468981325|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130278437|NCT05659719|468981326|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
130278438|NCT05659719|468981323|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278439|NCT05659719|468981324|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278440|NCT05659719|468981325|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278441|NCT05659719|468981326|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
130278442|NCT01681186|468981327|FG000|Washout Period From Second Intervention|Adverse Event|0|||
130278443|NCT01681186|468981328|FG001|Washout Period From Second Intervention|Adverse Event|0|||
130278444|NCT01681186|468981329|FG002|Washout Period From Second Intervention|Adverse Event|0|||
130278445|NCT01681186|468981330|FG003|Washout Period From Second Intervention|Adverse Event|0|||
130278446|NCT01681186|468981331|FG004|Washout Period From Second Intervention|Adverse Event|0|||
130278447|NCT01681186|468981332|FG005|Washout Period From Second Intervention|Adverse Event|0|||
130278448|NCT01681186|468981333|FG006|Washout Period From Second Intervention|Adverse Event|1|||
130278449|NCT01681186|468981334|FG007|Washout Period From Second Intervention|Adverse Event|0|||
130278450|NCT01681186|468981327|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
130278451|NCT01681186|468981328|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
130278452|NCT01681186|468981329|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
130278453|NCT01681186|468981330|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
130278454|NCT01681186|468981331|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
130278455|NCT01681186|468981332|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
130278456|NCT01681186|468981333|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
130278457|NCT01681186|468981334|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
130278458|NCT01681186|468981327|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278459|NCT01681186|468981328|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278460|NCT01681186|468981329|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278461|NCT01681186|468981330|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278462|NCT01681186|468981331|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278463|NCT01681186|468981332|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278464|NCT01681186|468981333|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
130278465|NCT01681186|468981334|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278466|NCT01681186|468981327|FG000|Fourth Intervention|Protocol Violation|0|||
130278467|NCT01681186|468981328|FG001|Fourth Intervention|Protocol Violation|0|||
130278468|NCT01681186|468981329|FG002|Fourth Intervention|Protocol Violation|0|||
130278469|NCT01681186|468981330|FG003|Fourth Intervention|Protocol Violation|0|||
130278470|NCT01681186|468981331|FG004|Fourth Intervention|Protocol Violation|0|||
130278471|NCT01681186|468981332|FG005|Fourth Intervention|Protocol Violation|0|||
130278472|NCT01681186|468981333|FG006|Fourth Intervention|Protocol Violation|0|||
130278473|NCT01681186|468981334|FG007|Fourth Intervention|Protocol Violation|1|||
130278474|NCT05160415|468981335|FG000|Overall Study|Withdrawal by Subject|3|||
130278475|NCT02582814|468981336|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130278476|NCT02582814|468981337|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130278477|NCT02582814|468981336|FG000|Overall Study|Withdrawal by Subject|4|||
130278478|NCT02582814|468981337|FG001|Overall Study|Withdrawal by Subject|3|||
130278479|NCT02582814|468981336|FG000|Overall Study|Adverse Event|4|||
130278480|NCT02582814|468981337|FG001|Overall Study|Adverse Event|4|||
130278481|NCT03530995|468981338|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
130278482|NCT03530995|468981339|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
130278483|NCT03530995|468981338|FG000|Part 1 Period 3|Protocol Violation|1|||
130278484|NCT03530995|468981339|FG001|Part 1 Period 3|Protocol Violation|0|||
130278485|NCT03530995|468981338|FG000|Part 1 Period 4|Physician Decision|1|||
130278486|NCT03530995|468981339|FG001|Part 1 Period 4|Physician Decision|0|||
130278487|NCT03530995|468981338|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
130278488|NCT03530995|468981339|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
130278489|NCT01986231|468981343|FG000|Overall Study|Adverse Event|1|||
130278490|NCT00623233|468981344|FG000|Overall Study|Adverse Event|10|||
130278491|NCT00623233|468981344|FG000|Overall Study|Physician Decision|10|||
130278492|NCT00623233|468981344|FG000|Overall Study|Lost to Follow-up|1|||
130368283|NCT02571777|469319623|FG004|Overall Study|Death|0|||
130368284|NCT02571777|469319619|FG000|Overall Study|Lost to Follow-up|1|||
130368285|NCT02571777|469319620|FG001|Overall Study|Lost to Follow-up|1|||
130368286|NCT02571777|469319621|FG002|Overall Study|Lost to Follow-up|2|||
130368287|NCT02571777|469319622|FG003|Overall Study|Lost to Follow-up|0|||
130368288|NCT02571777|469319623|FG004|Overall Study|Lost to Follow-up|1|||
130368289|NCT02571777|469319619|FG000|Overall Study|Physician Decision|1|||
130368290|NCT02571777|469319620|FG001|Overall Study|Physician Decision|7|||
130368291|NCT02571777|469319621|FG002|Overall Study|Physician Decision|5|||
130368292|NCT02571777|469319622|FG003|Overall Study|Physician Decision|2|||
130368293|NCT02571777|469319623|FG004|Overall Study|Physician Decision|4|||
130710740|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
130710741|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
130710742|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
130710743|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
130710744|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
130278493|NCT00623233|468981344|FG000|Overall Study|Withdrawal by Subject|3|||
130278494|NCT01751906|468981345|FG000|Overall Study|Lost to Follow-up|151|||
130278495|NCT01751906|468981346|FG001|Overall Study|Lost to Follow-up|68|||
130278496|NCT01751906|468981345|FG000|Overall Study|Withdrawal by Subject|22|||
130278497|NCT01751906|468981346|FG001|Overall Study|Withdrawal by Subject|18|||
130278498|NCT01751906|468981345|FG000|Overall Study|Physician Decision|5|||
130278499|NCT01751906|468981346|FG001|Overall Study|Physician Decision|2|||
130278500|NCT01751906|468981345|FG000|Overall Study|Death|84|||
130278501|NCT01751906|468981346|FG001|Overall Study|Death|43|||
130278502|NCT01751906|468981345|FG000|Overall Study|Denied on premises for follow-up by law|1|||
130278503|NCT01751906|468981346|FG001|Overall Study|Denied on premises for follow-up by law|0|||
130278504|NCT01110330|468981347|FG000|Overall Study|Adverse Event|0|||
130278505|NCT01110330|468981348|FG001|Overall Study|Adverse Event|4|||
130278506|NCT01110330|468981349|FG002|Overall Study|Adverse Event|3|||
130278507|NCT01110330|468981347|FG000|Overall Study|Lack of Efficacy|3|||
130278508|NCT01110330|468981348|FG001|Overall Study|Lack of Efficacy|1|||
130278509|NCT01110330|468981349|FG002|Overall Study|Lack of Efficacy|1|||
130278510|NCT01110330|468981347|FG000|Overall Study|Lost to Follow-up|9|||
130278511|NCT01110330|468981348|FG001|Overall Study|Lost to Follow-up|10|||
130278512|NCT01110330|468981349|FG002|Overall Study|Lost to Follow-up|15|||
130278513|NCT01110330|468981347|FG000|Overall Study|Physician Decision|0|||
130278514|NCT01110330|468981348|FG001|Overall Study|Physician Decision|1|||
130278515|NCT01110330|468981349|FG002|Overall Study|Physician Decision|0|||
130278516|NCT01110330|468981347|FG000|Overall Study|Protocol Violation|2|||
130278517|NCT01110330|468981348|FG001|Overall Study|Protocol Violation|0|||
130278518|NCT01110330|468981349|FG002|Overall Study|Protocol Violation|4|||
130278519|NCT01110330|468981347|FG000|Overall Study|Withdrawal by Subject|0|||
130278520|NCT01110330|468981348|FG001|Overall Study|Withdrawal by Subject|6|||
130278521|NCT01110330|468981349|FG002|Overall Study|Withdrawal by Subject|2|||
130278522|NCT01110330|468981347|FG000|Overall Study|Other|1|||
130278523|NCT01110330|468981348|FG001|Overall Study|Other|1|||
130278524|NCT01110330|468981349|FG002|Overall Study|Other|1|||
130278525|NCT02557100|468981350|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
130278526|NCT02557100|468981351|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
130278527|NCT02557100|468981352|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
130278528|NCT02557100|468981350|FG000|Single Blind Treatment Period|Death|0|||
130278529|NCT02557100|468981351|FG001|Single Blind Treatment Period|Death|1|||
130278530|NCT02557100|468981352|FG002|Single Blind Treatment Period|Death|0|||
130278531|NCT02557100|468981350|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
130278532|NCT02557100|468981351|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
130278533|NCT02557100|468981352|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
130278534|NCT02557100|468981350|FG000|Single Blind Treatment Period|Adverse Event|0|||
130278535|NCT02557100|468981351|FG001|Single Blind Treatment Period|Adverse Event|1|||
130278536|NCT02557100|468981352|FG002|Single Blind Treatment Period|Adverse Event|0|||
130278537|NCT02557100|468981350|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
130278538|NCT02557100|468981351|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
130278539|NCT02557100|468981352|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
130278540|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Other Reasons|0|||
130278541|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Other Reasons|0|||
130278542|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Other Reasons|1|||
130278543|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
130278544|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
130278545|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
130278546|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
130278547|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
130278548|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
130278549|NCT04644276|468981354|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130278550|NCT04644276|468981355|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130278551|NCT04644276|468981356|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
130278552|NCT01667224|468981358|FG000|Overall Study|Withdrawal by Subject|3|||
130368294|NCT02571777|469319619|FG000|Overall Study|Pregnancy|0|||
130368295|NCT02571777|469319620|FG001|Overall Study|Pregnancy|0|||
130368296|NCT02571777|469319621|FG002|Overall Study|Pregnancy|0|||
130368297|NCT02571777|469319622|FG003|Overall Study|Pregnancy|2|||
130278553|NCT01667224|468981359|FG001|Overall Study|Withdrawal by Subject|1|||
130278554|NCT01667224|468981358|FG000|Overall Study|Protocol Violation|1|||
130278555|NCT01667224|468981359|FG001|Overall Study|Protocol Violation|1|||
130368298|NCT02571777|469319623|FG004|Overall Study|Pregnancy|0|||
130278556|NCT02314156|468981367|FG000|Overall Study|Adverse Event|1|||
130278557|NCT02314156|468981368|FG001|Overall Study|Adverse Event|0|||
130278558|NCT02314156|468981367|FG000|Overall Study|Withdrawal by Subject|1|||
130278559|NCT02314156|468981368|FG001|Overall Study|Withdrawal by Subject|0|||
130278560|NCT02752633|468981369|FG000|Overall Study|Withdrawal by Subject|1|||
130278561|NCT02846389|468981370|FG000|Overall Study|Withdrawal by Subject|1|||
130278562|NCT02846389|468981371|FG001|Overall Study|Withdrawal by Subject|1|||
130278563|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
130278564|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
130278565|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130278566|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130278567|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
130278568|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
130278569|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130278570|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130278571|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
130278572|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
130278573|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130278574|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130278575|NCT00433966|468981374|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130278576|NCT00433966|468981375|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130278577|NCT00433966|468981376|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
130278578|NCT00433966|468981377|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
130278579|NCT00433966|468981374|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
130278580|NCT00433966|468981375|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
130278581|NCT00433966|468981376|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
130278582|NCT00433966|468981377|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
130278583|NCT00853242|468981379|FG000|Overall Study|Adverse Event|0|||
130278584|NCT00853242|468981380|FG001|Overall Study|Adverse Event|1|||
130278585|NCT00853242|468981381|FG002|Overall Study|Adverse Event|1|||
130278586|NCT00853242|468981382|FG003|Overall Study|Adverse Event|0|||
130278587|NCT00853242|468981383|FG004|Overall Study|Adverse Event|3|||
130278588|NCT00853242|468981384|FG005|Overall Study|Adverse Event|1|||
130278589|NCT00853242|468981385|FG006|Overall Study|Adverse Event|1|||
130278590|NCT00853242|468981379|FG000|Overall Study|Noncompliant|0|||
130278591|NCT00853242|468981380|FG001|Overall Study|Noncompliant|0|||
130278592|NCT00853242|468981381|FG002|Overall Study|Noncompliant|0|||
130278593|NCT00853242|468981382|FG003|Overall Study|Noncompliant|0|||
130278594|NCT00853242|468981383|FG004|Overall Study|Noncompliant|1|||
130278595|NCT00853242|468981384|FG005|Overall Study|Noncompliant|0|||
130278596|NCT00853242|468981385|FG006|Overall Study|Noncompliant|0|||
130278597|NCT00853242|468981379|FG000|Overall Study|Withdrawal by Subject|1|||
130278598|NCT00853242|468981380|FG001|Overall Study|Withdrawal by Subject|2|||
130278599|NCT00853242|468981381|FG002|Overall Study|Withdrawal by Subject|0|||
130278600|NCT00853242|468981382|FG003|Overall Study|Withdrawal by Subject|4|||
130278601|NCT00853242|468981383|FG004|Overall Study|Withdrawal by Subject|0|||
130278602|NCT00853242|468981384|FG005|Overall Study|Withdrawal by Subject|0|||
130278603|NCT00853242|468981385|FG006|Overall Study|Withdrawal by Subject|2|||
130278604|NCT00853242|468981379|FG000|Overall Study|Other|2|||
130278605|NCT00853242|468981380|FG001|Overall Study|Other|0|||
130278606|NCT00853242|468981381|FG002|Overall Study|Other|2|||
130457634|NCT03354390|469638410|FG000|Level 3|Death|0|||
130457635|NCT03354390|469638411|FG001|Level 3|Death|0|||
130278607|NCT00853242|468981382|FG003|Overall Study|Other|0|||
130278608|NCT00853242|468981383|FG004|Overall Study|Other|0|||
130457636|NCT03354390|469638412|FG002|Level 3|Death|1|||
130457637|NCT03354390|469638413|FG003|Level 3|Death|0|||
130457638|NCT03354390|469638410|FG000|Level 3|Physician Decision|0|||
130278609|NCT00853242|468981384|FG005|Overall Study|Other|1|||
130278610|NCT00853242|468981385|FG006|Overall Study|Other|2|||
130278611|NCT03497975|468981386|FG000|Overall Study|Withdrew Consent|34|||
130278612|NCT03497975|468981387|FG001|Overall Study|Withdrew Consent|35|||
130457639|NCT03354390|469638411|FG001|Level 3|Physician Decision|0|||
130368299|NCT03095612|469319631|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368300|NCT03095612|469319632|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
130368301|NCT03095612|469319633|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368302|NCT03095612|469319634|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368303|NCT03095612|469319635|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368304|NCT03095612|469319636|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368305|NCT03095612|469319637|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130368306|NCT04447794|469319638|FG000|Overall Study|Lost to Follow-up|2|||
130368307|NCT04447794|469319639|FG001|Overall Study|Lost to Follow-up|3|||
130368308|NCT04447794|469319640|FG002|Overall Study|Lost to Follow-up|8|||
130368309|NCT04447794|469319638|FG000|Overall Study|Withdrawal by Subject|1|||
130368310|NCT04447794|469319639|FG001|Overall Study|Withdrawal by Subject|1|||
130368311|NCT04447794|469319640|FG002|Overall Study|Withdrawal by Subject|0|||
130368312|NCT02571075|469319643|FG000|Overall Study|Lost to Follow-up|20|||
130368313|NCT02571075|469319644|FG001|Overall Study|Lost to Follow-up|24|||
130368314|NCT00963937|469319647|FG000|Overall Study|Protocol Violation|1|||
130368315|NCT00963937|469319648|FG001|Overall Study|Protocol Violation|1|||
130368316|NCT00963937|469319649|FG002|Overall Study|Protocol Violation|0|||
130368317|NCT00963937|469319647|FG000|Overall Study|Physician Decision|18|||
130368318|NCT00963937|469319648|FG001|Overall Study|Physician Decision|10|||
130368319|NCT00963937|469319649|FG002|Overall Study|Physician Decision|4|||
130368320|NCT02197520|469319653|FG000|Period 1|Withdrawal by Subject|1|||
130368321|NCT02197520|469319654|FG001|Period 1|Withdrawal by Subject|0|||
130368322|NCT02197520|469319653|FG000|Period 2|Adverse Event|0|||
130368323|NCT02197520|469319654|FG001|Period 2|Adverse Event|2|||
130368324|NCT02197520|469319653|FG000|Period 2|Withdrawal by Subject|1|||
130368325|NCT02197520|469319654|FG001|Period 2|Withdrawal by Subject|0|||
130368326|NCT00369824|469319655|FG000|Overall Study|Adverse Event|0|||
130368327|NCT00369824|469319656|FG001|Overall Study|Adverse Event|2|||
130368328|NCT00369824|469319657|FG002|Overall Study|Adverse Event|0|||
130368329|NCT00369824|469319658|FG003|Overall Study|Adverse Event|0|||
130368330|NCT00369824|469319659|FG004|Overall Study|Adverse Event|1|||
130368331|NCT00369824|469319660|FG005|Overall Study|Adverse Event|0|||
130368332|NCT00369824|469319655|FG000|Overall Study|Protocol Violation|0|||
130368333|NCT00369824|469319656|FG001|Overall Study|Protocol Violation|1|||
130368334|NCT00369824|469319657|FG002|Overall Study|Protocol Violation|0|||
130368335|NCT00369824|469319658|FG003|Overall Study|Protocol Violation|1|||
130368336|NCT00369824|469319659|FG004|Overall Study|Protocol Violation|1|||
130368337|NCT00369824|469319660|FG005|Overall Study|Protocol Violation|0|||
130368338|NCT00369824|469319655|FG000|Overall Study|Withdrawal by Subject|9|||
130368339|NCT00369824|469319656|FG001|Overall Study|Withdrawal by Subject|5|||
130368340|NCT00369824|469319657|FG002|Overall Study|Withdrawal by Subject|5|||
130368341|NCT00369824|469319658|FG003|Overall Study|Withdrawal by Subject|4|||
130368342|NCT00369824|469319659|FG004|Overall Study|Withdrawal by Subject|6|||
130368343|NCT00369824|469319660|FG005|Overall Study|Withdrawal by Subject|2|||
130368344|NCT00369824|469319655|FG000|Overall Study|Lost to Follow-up|6|||
130368345|NCT00369824|469319656|FG001|Overall Study|Lost to Follow-up|11|||
130368346|NCT00369824|469319657|FG002|Overall Study|Lost to Follow-up|7|||
130368347|NCT00369824|469319658|FG003|Overall Study|Lost to Follow-up|8|||
130368348|NCT00369824|469319659|FG004|Overall Study|Lost to Follow-up|9|||
130368349|NCT00369824|469319660|FG005|Overall Study|Lost to Follow-up|6|||
130368350|NCT00369824|469319655|FG000|Overall Study|Other|0|||
130368351|NCT00369824|469319656|FG001|Overall Study|Other|0|||
130368352|NCT00369824|469319657|FG002|Overall Study|Other|0|||
130368353|NCT00369824|469319658|FG003|Overall Study|Other|2|||
130368354|NCT00369824|469319659|FG004|Overall Study|Other|1|||
130368355|NCT00369824|469319660|FG005|Overall Study|Other|3|||
130368356|NCT04528732|469319667|FG000|Overall Study|Death|1|||
130710745|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
130710746|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
130368357|NCT04528732|469319668|FG001|Overall Study|Death|0|||
130368358|NCT04528732|469319669|FG002|Overall Study|Death|1|||
130368359|NCT04528732|469319667|FG000|Overall Study|Lost to Follow-up|0|||
130368360|NCT04528732|469319668|FG001|Overall Study|Lost to Follow-up|1|||
130368361|NCT04528732|469319669|FG002|Overall Study|Lost to Follow-up|2|||
130368362|NCT02094677|469319670|FG000|Overall Study|Screening|3|||
130368363|NCT02094677|469319671|FG001|Overall Study|Screening|1|||
130368364|NCT05399641|469319672|FG000|Overall Study|Adverse Event|0|||
130368365|NCT05399641|469319673|FG001|Overall Study|Adverse Event|1|||
130368366|NCT05399641|469319674|FG002|Overall Study|Adverse Event|1|||
130368367|NCT05399641|469319672|FG000|Overall Study|Lost to Follow-up|1|||
130368368|NCT05399641|469319673|FG001|Overall Study|Lost to Follow-up|2|||
130368369|NCT05399641|469319674|FG002|Overall Study|Lost to Follow-up|2|||
130368370|NCT05399641|469319672|FG000|Overall Study|Physician Decision|1|||
130368371|NCT05399641|469319673|FG001|Overall Study|Physician Decision|3|||
130368372|NCT05399641|469319674|FG002|Overall Study|Physician Decision|3|||
130368373|NCT05399641|469319672|FG000|Overall Study|Withdrawal by Subject|4|||
130278613|NCT03497975|468981386|FG000|Overall Study|Lost to Follow-up|7|||
130278614|NCT03497975|468981387|FG001|Overall Study|Lost to Follow-up|7|||
130278615|NCT03497975|468981386|FG000|Overall Study|Physician Decision|4|||
130278616|NCT03497975|468981387|FG001|Overall Study|Physician Decision|5|||
130278617|NCT03497975|468981386|FG000|Overall Study|Discontinued|42|||
130278618|NCT03497975|468981387|FG001|Overall Study|Discontinued|39|||
130278619|NCT03497975|468981386|FG000|Overall Study|Reason Not Specified|15|||
130278620|NCT03497975|468981387|FG001|Overall Study|Reason Not Specified|14|||
130278621|NCT04026009|468981388|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130278622|NCT04026009|468981389|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130278623|NCT04026009|468981390|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130278624|NCT04026009|468981391|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130278625|NCT04026009|468981392|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130278626|NCT04026009|468981388|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278627|NCT04026009|468981389|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278628|NCT04026009|468981390|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278629|NCT04026009|468981391|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278630|NCT04026009|468981392|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
130278631|NCT01500252|468981396|FG000|Overall Study|Death|4|||
130278632|NCT01500252|468981397|FG001|Overall Study|Death|2|||
130278633|NCT01500252|468981396|FG000|Overall Study|Lost to Follow-up|5|||
130278634|NCT01500252|468981397|FG001|Overall Study|Lost to Follow-up|4|||
130278635|NCT05319600|468981399|FG000|Overall Study|Withdrawal by Subject|1|||
130278636|NCT05319600|468981400|FG001|Overall Study|Withdrawal by Subject|0|||
130278637|NCT05319600|468981399|FG000|Overall Study|Lost to Follow-up|0|||
130278638|NCT05319600|468981400|FG001|Overall Study|Lost to Follow-up|4|||
130278639|NCT02120300|468981404|FG000|Overall Study|Enrolled but Never Treated|2|||
130278640|NCT02120300|468981405|FG001|Overall Study|Enrolled but Never Treated|0|||
130278641|NCT02120300|468981406|FG002|Overall Study|Enrolled but Never Treated|0|||
130278642|NCT02120300|468981407|FG003|Overall Study|Enrolled but Never Treated|0|||
130278643|NCT02120300|468981404|FG000|Overall Study|Lack of Efficacy|0|||
130278644|NCT02120300|468981405|FG001|Overall Study|Lack of Efficacy|0|||
130278645|NCT02120300|468981406|FG002|Overall Study|Lack of Efficacy|0|||
130278646|NCT02120300|468981407|FG003|Overall Study|Lack of Efficacy|1|||
130278647|NCT02120300|468981404|FG000|Overall Study|Lost to Follow-up|1|||
130278648|NCT02120300|468981405|FG001|Overall Study|Lost to Follow-up|0|||
130278649|NCT02120300|468981406|FG002|Overall Study|Lost to Follow-up|0|||
130278650|NCT02120300|468981407|FG003|Overall Study|Lost to Follow-up|0|||
130278651|NCT02059499|468981416|FG000|Upto Week 20|Lost to Follow-up|2|||
130278652|NCT02059499|468981417|FG001|Upto Week 20|Lost to Follow-up|6|||
130278653|NCT02059499|468981418|FG002|Upto Week 20|Lost to Follow-up|0|||
130278654|NCT02059499|468981416|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
130278655|NCT02059499|468981417|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
130278656|NCT02059499|468981418|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
130278657|NCT02059499|468981416|FG000|Upto Week 20|Withdrawal by Subject|1|||
130278658|NCT02059499|468981417|FG001|Upto Week 20|Withdrawal by Subject|1|||
130278659|NCT02059499|468981418|FG002|Upto Week 20|Withdrawal by Subject|0|||
130278660|NCT02059499|468981416|FG000|Upto Week 20|No treatment per protocol criteria|0|||
130278661|NCT02059499|468981417|FG001|Upto Week 20|No treatment per protocol criteria|0|||
130278662|NCT02059499|468981418|FG002|Upto Week 20|No treatment per protocol criteria|5|||
130278663|NCT02059499|468981416|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
130278664|NCT02059499|468981417|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
130278665|NCT02059499|468981418|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
130278666|NCT02059499|468981416|FG000|Post-week 20|Lost to Follow-up|0|||
130278667|NCT02059499|468981417|FG001|Post-week 20|Lost to Follow-up|2|||
130278668|NCT02059499|468981418|FG002|Post-week 20|Lost to Follow-up|0|||
130278669|NCT02059499|468981416|FG000|Post-week 20|Withdrawal by Subject|0|||
130278670|NCT02059499|468981417|FG001|Post-week 20|Withdrawal by Subject|1|||
130278671|NCT02059499|468981418|FG002|Post-week 20|Withdrawal by Subject|0|||
130368374|NCT05399641|469319673|FG001|Overall Study|Withdrawal by Subject|11|||
130368375|NCT05399641|469319674|FG002|Overall Study|Withdrawal by Subject|7|||
130368376|NCT05399641|469319672|FG000|Overall Study|Reason not defined|3|||
130368377|NCT05399641|469319673|FG001|Overall Study|Reason not defined|5|||
130278672|NCT02059499|468981416|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130278673|NCT02059499|468981417|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
130278674|NCT02059499|468981418|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130278675|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
130278676|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130368378|NCT05399641|469319674|FG002|Overall Study|Reason not defined|6|||
130278677|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278678|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130368379|NCT03408483|469319675|FG000|Overall Study|Physician Decision|3|||
130368380|NCT03408483|469319676|FG001|Overall Study|Physician Decision|3|||
130368381|NCT03408483|469319675|FG000|Overall Study|Lost to Follow-up|3|||
130368382|NCT03408483|469319676|FG001|Overall Study|Lost to Follow-up|0|||
130368383|NCT01300650|469319677|FG000|Overall Study|Adverse Event|1|||
130368384|NCT01702961|469319678|FG000|Overall Study|Additional treatment|3|||
130368385|NCT01702961|469319678|FG000|Overall Study|Progressive disease|5|||
130368386|NCT01702961|469319678|FG000|Overall Study|Relapse|20|||
130368387|NCT01702961|469319678|FG000|Overall Study|Death|6|||
130368388|NCT01702961|469319678|FG000|Overall Study|Lost to Follow-up|2|||
130368389|NCT01702961|469319678|FG000|Overall Study|Ongoing|11|||
130368390|NCT00674362|469319681|FG000|Double Blind|Adverse Event|6|||
130368391|NCT00674362|469319682|FG001|Double Blind|Adverse Event|6|||
130368392|NCT00674362|469319681|FG000|Double Blind|Lack of Efficacy|2|||
130368393|NCT00674362|469319682|FG001|Double Blind|Lack of Efficacy|6|||
130368394|NCT00674362|469319681|FG000|Double Blind|Loss of efficacy|0|||
130368395|NCT00674362|469319682|FG001|Double Blind|Loss of efficacy|1|||
130368396|NCT00674362|469319681|FG000|Double Blind|Withdrawal by Subject|4|||
130368397|NCT00674362|469319682|FG001|Double Blind|Withdrawal by Subject|3|||
130368398|NCT00674362|469319681|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
130368399|NCT00674362|469319682|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
130368400|NCT00674362|469319681|FG000|Double Blind|Other: Surgery|0|||
130368401|NCT00674362|469319682|FG001|Double Blind|Other: Surgery|1|||
130368402|NCT00674362|469319681|FG000|Open Label|Adverse Event|1|||
130368403|NCT00674362|469319682|FG001|Open Label|Adverse Event|0|||
130368404|NCT00674362|469319681|FG000|Open Label|Other: Subject moved to extension study|1|||
130368405|NCT00674362|469319682|FG001|Open Label|Other: Subject moved to extension study|0|||
130368406|NCT00923156|469319683|FG000|Overall Study|Adverse Event|0|||
130368407|NCT00923156|469319684|FG001|Overall Study|Adverse Event|2|||
130368408|NCT00923156|469319685|FG002|Overall Study|Adverse Event|1|||
130368409|NCT00923156|469319683|FG000|Overall Study|Abnormal laboratory values|0|||
130368410|NCT00923156|469319684|FG001|Overall Study|Abnormal laboratory values|0|||
130368411|NCT00923156|469319685|FG002|Overall Study|Abnormal laboratory values|1|||
130368412|NCT00923156|469319683|FG000|Overall Study|Withdrawal by Subject|0|||
130368413|NCT00923156|469319684|FG001|Overall Study|Withdrawal by Subject|1|||
130368414|NCT00923156|469319685|FG002|Overall Study|Withdrawal by Subject|0|||
130368415|NCT00923156|469319683|FG000|Overall Study|Death|0|||
130368416|NCT00923156|469319684|FG001|Overall Study|Death|1|||
130368417|NCT00923156|469319685|FG002|Overall Study|Death|0|||
130368418|NCT00923156|469319683|FG000|Overall Study|Lack of Efficacy|0|||
130368419|NCT00923156|469319684|FG001|Overall Study|Lack of Efficacy|0|||
130368420|NCT00923156|469319685|FG002|Overall Study|Lack of Efficacy|1|||
130368421|NCT04066023|469319687|FG000|Overall Study|Adverse Event|0|||
130368422|NCT04066023|469319688|FG001|Overall Study|Adverse Event|0|||
130368423|NCT04066023|469319689|FG002|Overall Study|Adverse Event|1|||
130368424|NCT04066023|469319687|FG000|Overall Study|Sponsor decision|3|||
130368425|NCT04066023|469319688|FG001|Overall Study|Sponsor decision|6|||
130368426|NCT04066023|469319689|FG002|Overall Study|Sponsor decision|2|||
130368427|NCT04066023|469319687|FG000|Overall Study|Physician Decision|0|||
130368428|NCT04066023|469319688|FG001|Overall Study|Physician Decision|0|||
130368429|NCT04066023|469319689|FG002|Overall Study|Physician Decision|1|||
130368430|NCT04066023|469319687|FG000|Overall Study|Lost to Follow-up|0|||
130368431|NCT04066023|469319688|FG001|Overall Study|Lost to Follow-up|1|||
130368432|NCT04066023|469319689|FG002|Overall Study|Lost to Follow-up|1|||
130368433|NCT04066023|469319687|FG000|Overall Study|Noncompliance|0|||
130368434|NCT04066023|469319688|FG001|Overall Study|Noncompliance|1|||
130368435|NCT04066023|469319689|FG002|Overall Study|Noncompliance|1|||
130368436|NCT03386448|469319690|FG000|Overall Study|Adverse Event|0|||
130368437|NCT03386448|469319691|FG001|Overall Study|Adverse Event|2|||
130368438|NCT03583697|469319692|FG000|Overall Study|Withdrawal by Subject|0|||
130368439|NCT03583697|469319693|FG001|Overall Study|Withdrawal by Subject|0|||
130710747|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130710748|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
130710749|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130710750|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
130368440|NCT03583697|469319694|FG002|Overall Study|Withdrawal by Subject|1|||
130368441|NCT03583697|469319692|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
130368442|NCT03583697|469319693|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
130368443|NCT03583697|469319694|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
130710751|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
130368444|NCT00114530|469319695|FG000|Overall Study|Death|3|||
130368445|NCT00114530|469319696|FG001|Overall Study|Death|11|||
130368446|NCT00114530|469319695|FG000|Overall Study|Lost to Follow-up|1|||
130368447|NCT00114530|469319696|FG001|Overall Study|Lost to Follow-up|1|||
130368448|NCT00114530|469319695|FG000|Overall Study|Physician Decision|1|||
130368449|NCT00114530|469319696|FG001|Overall Study|Physician Decision|1|||
130368450|NCT00114530|469319695|FG000|Overall Study|Withdrawal by Subject|2|||
130368451|NCT00114530|469319696|FG001|Overall Study|Withdrawal by Subject|6|||
130368452|NCT00114530|469319695|FG000|Overall Study|Breast Cancer|1|||
130368453|NCT00114530|469319696|FG001|Overall Study|Breast Cancer|0|||
130278679|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278680|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278681|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
130278682|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
130278683|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278684|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278685|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278686|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278687|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
130278688|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
130278689|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278690|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278691|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278692|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278693|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130278694|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130278695|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278696|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278697|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278698|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278699|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
130278700|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
130278701|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278702|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278703|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278704|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278705|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
130278706|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278707|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278708|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278709|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278710|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278711|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
130278712|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
130278713|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278714|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278715|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278716|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278717|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130278718|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130278719|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130278720|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130278721|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130278722|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130368454|NCT00114530|469319695|FG000|Overall Study|Subject decision after endpoint failure|0|||
130368455|NCT00114530|469319696|FG001|Overall Study|Subject decision after endpoint failure|1|||
130368456|NCT00114530|469319695|FG000|Overall Study|Ineligible|1|||
130368457|NCT00114530|469319696|FG001|Overall Study|Ineligible|0|||
130368458|NCT02538029|469319697|FG000|Overall Study|unable to complete cognitive assessments|1|||
130368459|NCT02538029|469319698|FG001|Overall Study|unable to complete cognitive assessments|0|||
130368460|NCT02538029|469319699|FG002|Overall Study|unable to complete cognitive assessments|1|||
130368461|NCT01064310|469319700|FG000|Period 1|Adverse Event|7|||
130368462|NCT01064310|469319701|FG001|Period 1|Adverse Event|10|||
130368463|NCT01064310|469319702|FG002|Period 1|Adverse Event|0|||
130368464|NCT01064310|469319700|FG000|Period 1|Physician Decision|1|||
130368465|NCT01064310|469319701|FG001|Period 1|Physician Decision|0|||
130368466|NCT01064310|469319702|FG002|Period 1|Physician Decision|0|||
130368467|NCT01064310|469319700|FG000|Period 1|Withdrawal by Subject|2|||
130368468|NCT01064310|469319701|FG001|Period 1|Withdrawal by Subject|2|||
130368469|NCT01064310|469319702|FG002|Period 1|Withdrawal by Subject|0|||
130368470|NCT01064310|469319700|FG000|Period 1|Lack of Efficacy|3|||
130368471|NCT01064310|469319701|FG001|Period 1|Lack of Efficacy|5|||
130368472|NCT01064310|469319702|FG002|Period 1|Lack of Efficacy|0|||
130368473|NCT01064310|469319700|FG000|Period 1|Entered Open-label Period|1|||
130368474|NCT01064310|469319701|FG001|Period 1|Entered Open-label Period|1|||
130368475|NCT01064310|469319702|FG002|Period 1|Entered Open-label Period|0|||
130278723|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130278724|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130278725|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130278726|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130278727|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130278728|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130278729|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130278730|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130278731|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
130278732|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
130278733|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
130278734|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
130278735|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278736|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278737|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130278738|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278739|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
130278740|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278741|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278742|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278743|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278744|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278745|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278746|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278747|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130278748|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130278749|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
130278750|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
130278751|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
130278752|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
130278753|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278754|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278755|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278756|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278757|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278758|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278759|NCT01352221|468981425|FG000|Double-blind Phase|Adverse Event|6|||
130278760|NCT01352221|468981426|FG001|Double-blind Phase|Adverse Event|4|||
130278761|NCT01352221|468981427|FG002|Double-blind Phase|Adverse Event|0|||
130278762|NCT01352221|468981428|FG003|Double-blind Phase|Adverse Event|0|||
130278763|NCT01352221|468981425|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130278764|NCT01352221|468981426|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130278765|NCT01352221|468981427|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130278766|NCT01352221|468981428|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130278767|NCT01352221|468981425|FG000|Double-blind Phase|Lost to Follow-up|0|||
130278768|NCT01352221|468981426|FG001|Double-blind Phase|Lost to Follow-up|1|||
130278769|NCT01352221|468981427|FG002|Double-blind Phase|Lost to Follow-up|0|||
130278770|NCT01352221|468981428|FG003|Double-blind Phase|Lost to Follow-up|0|||
130278771|NCT01352221|468981425|FG000|Double-blind Phase|Protocol Violation|0|||
130278772|NCT01352221|468981426|FG001|Double-blind Phase|Protocol Violation|1|||
130278773|NCT01352221|468981427|FG002|Double-blind Phase|Protocol Violation|0|||
130278774|NCT01352221|468981428|FG003|Double-blind Phase|Protocol Violation|0|||
130278775|NCT01352221|468981425|FG000|Open-label Phase|Physician Decision|0|||
130278776|NCT01352221|468981426|FG001|Open-label Phase|Physician Decision|0|||
130278777|NCT01352221|468981427|FG002|Open-label Phase|Physician Decision|2|||
130278778|NCT01352221|468981428|FG003|Open-label Phase|Physician Decision|1|||
130278779|NCT01352221|468981425|FG000|Open-label Phase|Pregnancy|0|||
130278780|NCT01352221|468981426|FG001|Open-label Phase|Pregnancy|0|||
130278781|NCT01352221|468981427|FG002|Open-label Phase|Pregnancy|1|||
130278782|NCT01352221|468981428|FG003|Open-label Phase|Pregnancy|0|||
130368476|NCT01064310|469319700|FG000|Period 2|Adverse Event|2|||
130368477|NCT01064310|469319701|FG001|Period 2|Adverse Event|1|||
130368478|NCT01064310|469319702|FG002|Period 2|Adverse Event|0|||
130368479|NCT01064310|469319700|FG000|Period 2|Physician Decision|0|||
130368480|NCT01064310|469319701|FG001|Period 2|Physician Decision|1|||
130278783|NCT01352221|468981425|FG000|Open-label Phase|Adverse Event|0|||
130278784|NCT01352221|468981426|FG001|Open-label Phase|Adverse Event|0|||
130278785|NCT01352221|468981427|FG002|Open-label Phase|Adverse Event|8|||
130278786|NCT01352221|468981428|FG003|Open-label Phase|Adverse Event|4|||
130278787|NCT01352221|468981425|FG000|Open-label Phase|Withdrawal by Subject|0|||
130278788|NCT01352221|468981426|FG001|Open-label Phase|Withdrawal by Subject|0|||
130278789|NCT01352221|468981427|FG002|Open-label Phase|Withdrawal by Subject|1|||
130278790|NCT01352221|468981428|FG003|Open-label Phase|Withdrawal by Subject|6|||
130278791|NCT01352221|468981425|FG000|Open-label Phase|Worsening of IBD|0|||
130278792|NCT01352221|468981426|FG001|Open-label Phase|Worsening of IBD|0|||
130278793|NCT01352221|468981427|FG002|Open-label Phase|Worsening of IBD|1|||
130278794|NCT01352221|468981428|FG003|Open-label Phase|Worsening of IBD|0|||
130278795|NCT02016716|468981429|FG000|Overall Study|Withdrawal by Subject|5|||
130278796|NCT02016716|468981430|FG001|Overall Study|Withdrawal by Subject|5|||
130278797|NCT02016716|468981431|FG002|Overall Study|Withdrawal by Subject|5|||
130278798|NCT02016716|468981429|FG000|Overall Study|Protocol-specified Criteria|0|||
130278799|NCT02016716|468981430|FG001|Overall Study|Protocol-specified Criteria|1|||
130278800|NCT02016716|468981431|FG002|Overall Study|Protocol-specified Criteria|0|||
130278801|NCT02016716|468981429|FG000|Overall Study|Lost to Follow-up|1|||
130278802|NCT02016716|468981430|FG001|Overall Study|Lost to Follow-up|2|||
130278803|NCT02016716|468981431|FG002|Overall Study|Lost to Follow-up|1|||
130278804|NCT02248649|468981432|FG000|Overall Study|Death|7|||
130278805|NCT02248649|468981433|FG001|Overall Study|Death|11|||
130278806|NCT02248649|468981432|FG000|Overall Study|Lost to Follow-up|14|||
130278807|NCT02248649|468981433|FG001|Overall Study|Lost to Follow-up|10|||
130278808|NCT01439971|468981434|FG000|Overall Study|Required number in cohort dosed|0|||
130278809|NCT01439971|468981435|FG001|Overall Study|Required number in cohort dosed|1|||
130278810|NCT01439971|468981436|FG002|Overall Study|Required number in cohort dosed|2|||
130278811|NCT01439971|468981437|FG003|Overall Study|Required number in cohort dosed|0|||
130278812|NCT01439971|468981438|FG004|Overall Study|Required number in cohort dosed|1|||
130278813|NCT01221623|468981442|FG000|Overall Study|Withdrawal by Subject|19|||
130278814|NCT01221623|468981443|FG001|Overall Study|Withdrawal by Subject|8|||
130278815|NCT01221623|468981442|FG000|Overall Study|Lost to Follow-up|7|||
130278816|NCT01221623|468981443|FG001|Overall Study|Lost to Follow-up|1|||
130278817|NCT01221623|468981442|FG000|Overall Study|Adverse Event|6|||
130278818|NCT01221623|468981443|FG001|Overall Study|Adverse Event|3|||
130278819|NCT01221623|468981442|FG000|Overall Study|Death|1|||
130278820|NCT01221623|468981443|FG001|Overall Study|Death|0|||
130278821|NCT01221623|468981442|FG000|Overall Study|Other|5|||
130278822|NCT01221623|468981443|FG001|Overall Study|Other|2|||
130368481|NCT01064310|469319702|FG002|Period 2|Physician Decision|0|||
130457640|NCT03354390|469638412|FG002|Level 3|Physician Decision|2|||
130457641|NCT03354390|469638413|FG003|Level 3|Physician Decision|0|||
130457642|NCT03354390|469638410|FG000|Level 4|Death|0|||
130457643|NCT03354390|469638411|FG001|Level 4|Death|0|||
130457644|NCT03354390|469638412|FG002|Level 4|Death|0|||
130457645|NCT03354390|469638413|FG003|Level 4|Death|3|||
130457646|NCT01066923|469638414|FG000|Overall Study|Withdrawal by Subject|3|||
130457647|NCT01066923|469638415|FG001|Overall Study|Withdrawal by Subject|3|||
130457648|NCT01066923|469638416|FG002|Overall Study|Withdrawal by Subject|8|||
130457649|NCT01066923|469638417|FG003|Overall Study|Withdrawal by Subject|8|||
130457650|NCT01144468|469639892|FG000|Overall Study|Lost to Follow-up|4|||
130457651|NCT01144468|469639893|FG001|Overall Study|Lost to Follow-up|7|||
130457652|NCT01144468|469639892|FG000|Overall Study|Adverse Event|3|||
130457653|NCT01144468|469639893|FG001|Overall Study|Adverse Event|2|||
130457654|NCT01144468|469639892|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
130457655|NCT01144468|469639893|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
130457656|NCT01546155|469639896|FG000|Overall Study|could not tolerate long scan duration|3|||
130457657|NCT01025843|469639899|FG000|Washout 4|Withdrawal by Subject|0|||
130457658|NCT01025843|469639900|FG001|Washout 4|Withdrawal by Subject|0|||
130457659|NCT01025843|469639901|FG002|Washout 4|Withdrawal by Subject|1|||
130457660|NCT01025843|469639902|FG003|Washout 4|Withdrawal by Subject|1|||
130457661|NCT01025843|469639903|FG004|Washout 4|Withdrawal by Subject|0|||
130457662|NCT01025843|469639904|FG005|Washout 4|Withdrawal by Subject|0|||
130457663|NCT01025843|469639905|FG006|Washout 4|Withdrawal by Subject|0|||
130457664|NCT01025843|469639906|FG007|Washout 4|Withdrawal by Subject|0|||
130457665|NCT01025843|469639907|FG008|Washout 4|Withdrawal by Subject|0|||
130457666|NCT01025843|469639908|FG009|Washout 4|Withdrawal by Subject|0|||
130457667|NCT00377455|469639911|FG000|Overall Study|Withdrawal by Subject|1|||
130457668|NCT01897233|469639914|FG000|Part B (24 Weeks)|Adverse Event|1|||
130457669|NCT01897233|469639914|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
130457670|NCT01897233|469639914|FG000|Part B (24 Weeks)|Physician Decision|1|||
130457671|NCT03546907|469639923|FG000|Overall Study|Lack of Efficacy|1|||
130457672|NCT03546907|469639924|FG001|Overall Study|Lack of Efficacy|1|||
130457673|NCT03546907|469639923|FG000|Overall Study|Withdrawal by Subject|8|||
130457674|NCT03546907|469639924|FG001|Overall Study|Withdrawal by Subject|9|||
130457675|NCT03546907|469639923|FG000|Overall Study|Adverse events (AEs)|7|||
130457676|NCT03546907|469639924|FG001|Overall Study|Adverse events (AEs)|10|||
130457677|NCT03546907|469639923|FG000|Overall Study|Other-unspecified|1|||
130457678|NCT03546907|469639924|FG001|Overall Study|Other-unspecified|1|||
130457679|NCT01281813|469639925|FG000|Overall Study|Adverse Event|0|||
130457680|NCT01281813|469639926|FG001|Overall Study|Adverse Event|0|||
130368482|NCT01064310|469319700|FG000|Period 2|Entered Open-label Period|1|||
130368483|NCT01064310|469319701|FG001|Period 2|Entered Open-label Period|0|||
130368484|NCT01064310|469319702|FG002|Period 2|Entered Open-label Period|0|||
130368485|NCT01064310|469319700|FG000|Period 2|Lack of Efficacy|1|||
130368486|NCT01064310|469319701|FG001|Period 2|Lack of Efficacy|4|||
130368487|NCT01064310|469319702|FG002|Period 2|Lack of Efficacy|0|||
130368488|NCT01064310|469319700|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
130368489|NCT01064310|469319701|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
130368490|NCT01064310|469319702|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
130368491|NCT01064310|469319700|FG000|Open Label Pazopinib|Adverse Event|0|||
130368492|NCT01064310|469319701|FG001|Open Label Pazopinib|Adverse Event|0|||
130457681|NCT01281813|469639927|FG002|Overall Study|Adverse Event|10|||
130457682|NCT01281813|469639925|FG000|Overall Study|Lost to Follow-up|0|||
130457683|NCT01281813|469639926|FG001|Overall Study|Lost to Follow-up|0|||
130457684|NCT01281813|469639927|FG002|Overall Study|Lost to Follow-up|31|||
130457685|NCT01281813|469639925|FG000|Overall Study|Withdrawal by Subject|0|||
130278823|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
130278824|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
130278825|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
130278826|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
130278827|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
130278828|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
130278829|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130278830|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130278831|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
130278832|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
130278833|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130278834|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130278835|NCT03479541|468981444|FG000|Home Monitoring|Lost to Follow-up|0|||
130278836|NCT03479541|468981445|FG001|Home Monitoring|Lost to Follow-up|0|||
130278837|NCT03479541|468981446|FG002|Home Monitoring|Lost to Follow-up|8|||
130278838|NCT03479541|468981447|FG003|Home Monitoring|Lost to Follow-up|12|||
130278839|NCT03479541|468981444|FG000|Home Monitoring|Withdrawal by Subject|0|||
130278840|NCT03479541|468981445|FG001|Home Monitoring|Withdrawal by Subject|0|||
130278841|NCT03479541|468981446|FG002|Home Monitoring|Withdrawal by Subject|17|||
130278842|NCT03479541|468981447|FG003|Home Monitoring|Withdrawal by Subject|30|||
130278843|NCT03479541|468981444|FG000|Home Monitoring|Early Termination - PI Decision|0|||
130278844|NCT03479541|468981445|FG001|Home Monitoring|Early Termination - PI Decision|0|||
130278845|NCT03479541|468981446|FG002|Home Monitoring|Early Termination - PI Decision|4|||
130278846|NCT03479541|468981447|FG003|Home Monitoring|Early Termination - PI Decision|6|||
130278847|NCT00661726|468981448|FG000|Overall Study|Adverse Event|1|||
130278848|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
130278849|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
130278850|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
130278851|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
130278852|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
130278853|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
130278854|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
130278855|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
130278856|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
130278857|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
130278858|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
130278859|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
130278860|NCT00107900|468981452|FG000|Overall Study|Adverse Event|3|||
130278861|NCT00107900|468981453|FG001|Overall Study|Adverse Event|2|||
130278862|NCT00107900|468981454|FG002|Overall Study|Adverse Event|10|||
130278863|NCT00107900|468981455|FG003|Overall Study|Adverse Event|3|||
130278864|NCT00107900|468981456|FG004|Overall Study|Adverse Event|5|||
130278865|NCT00107900|468981457|FG005|Overall Study|Adverse Event|3|||
130278866|NCT00107900|468981452|FG000|Overall Study|Death|0|||
130278867|NCT00107900|468981453|FG001|Overall Study|Death|0|||
130368493|NCT01064310|469319702|FG002|Open Label Pazopinib|Adverse Event|12|||
130457686|NCT01281813|469639926|FG001|Overall Study|Withdrawal by Subject|0|||
130457687|NCT01281813|469639927|FG002|Overall Study|Withdrawal by Subject|13|||
130278868|NCT00107900|468981454|FG002|Overall Study|Death|0|||
130457688|NCT01281813|469639925|FG000|Overall Study|Subject Non-Compliant|0|||
130368494|NCT01064310|469319700|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
130368495|NCT01064310|469319701|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
130457689|NCT01281813|469639926|FG001|Overall Study|Subject Non-Compliant|0|||
130457690|NCT01281813|469639927|FG002|Overall Study|Subject Non-Compliant|6|||
130278869|NCT00107900|468981455|FG003|Overall Study|Death|0|||
130278870|NCT00107900|468981456|FG004|Overall Study|Death|1|||
130368496|NCT01064310|469319702|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
130278871|NCT00107900|468981457|FG005|Overall Study|Death|0|||
130278872|NCT00107900|468981452|FG000|Overall Study|Lost to Follow-up|4|||
130278873|NCT00107900|468981453|FG001|Overall Study|Lost to Follow-up|1|||
130278874|NCT00107900|468981454|FG002|Overall Study|Lost to Follow-up|3|||
130278875|NCT00107900|468981455|FG003|Overall Study|Lost to Follow-up|2|||
130278876|NCT00107900|468981456|FG004|Overall Study|Lost to Follow-up|5|||
130278877|NCT00107900|468981457|FG005|Overall Study|Lost to Follow-up|5|||
130278878|NCT00107900|468981452|FG000|Overall Study|Protocol Violation|1|||
130278879|NCT00107900|468981453|FG001|Overall Study|Protocol Violation|0|||
130278880|NCT00107900|468981454|FG002|Overall Study|Protocol Violation|5|||
130278881|NCT00107900|468981455|FG003|Overall Study|Protocol Violation|5|||
130278882|NCT00107900|468981456|FG004|Overall Study|Protocol Violation|7|||
130278883|NCT00107900|468981457|FG005|Overall Study|Protocol Violation|0|||
130278884|NCT00107900|468981452|FG000|Overall Study|Withdrawal by Subject|1|||
130278885|NCT00107900|468981453|FG001|Overall Study|Withdrawal by Subject|0|||
130278886|NCT00107900|468981454|FG002|Overall Study|Withdrawal by Subject|5|||
130278887|NCT00107900|468981455|FG003|Overall Study|Withdrawal by Subject|0|||
130278888|NCT00107900|468981456|FG004|Overall Study|Withdrawal by Subject|1|||
130278889|NCT00107900|468981457|FG005|Overall Study|Withdrawal by Subject|1|||
130278890|NCT00107900|468981452|FG000|Overall Study|Administrative Reasons|1|||
130278891|NCT00107900|468981453|FG001|Overall Study|Administrative Reasons|0|||
130278892|NCT00107900|468981454|FG002|Overall Study|Administrative Reasons|2|||
130278893|NCT00107900|468981455|FG003|Overall Study|Administrative Reasons|2|||
130278894|NCT00107900|468981456|FG004|Overall Study|Administrative Reasons|2|||
130278895|NCT00107900|468981457|FG005|Overall Study|Administrative Reasons|0|||
130278896|NCT01700959|468981461|FG000|Overall Study|Adverse Event|0|||
130278897|NCT01700959|468981462|FG001|Overall Study|Adverse Event|1|||
130278898|NCT01700959|468981463|FG002|Overall Study|Adverse Event|1|||
130278899|NCT01700959|468981464|FG003|Overall Study|Adverse Event|2|||
130278900|NCT01700959|468981465|FG004|Overall Study|Adverse Event|0|||
130278901|NCT01700959|468981466|FG005|Overall Study|Adverse Event|2|||
130278902|NCT01700959|468981461|FG000|Overall Study|Withdrawal by Subject|15|||
130278903|NCT01700959|468981462|FG001|Overall Study|Withdrawal by Subject|9|||
130278904|NCT01700959|468981463|FG002|Overall Study|Withdrawal by Subject|12|||
130278905|NCT01700959|468981464|FG003|Overall Study|Withdrawal by Subject|11|||
130278906|NCT01700959|468981465|FG004|Overall Study|Withdrawal by Subject|8|||
130278907|NCT01700959|468981466|FG005|Overall Study|Withdrawal by Subject|12|||
130278908|NCT01700959|468981461|FG000|Overall Study|Ineligible|2|||
130278909|NCT01700959|468981462|FG001|Overall Study|Ineligible|1|||
130278910|NCT01700959|468981463|FG002|Overall Study|Ineligible|2|||
130278911|NCT01700959|468981464|FG003|Overall Study|Ineligible|0|||
130278912|NCT01700959|468981465|FG004|Overall Study|Ineligible|0|||
130457691|NCT01281813|469639925|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
130457692|NCT01281813|469639926|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
130457693|NCT01281813|469639927|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
130457694|NCT01281813|469639925|FG000|Overall Study|Sponsor's Decision|4|||
130457695|NCT01281813|469639926|FG001|Overall Study|Sponsor's Decision|3|||
130457696|NCT01281813|469639927|FG002|Overall Study|Sponsor's Decision|7|||
130457697|NCT01281813|469639925|FG000|Overall Study|Switched to Commercially Available Medication|0|||
130457698|NCT01281813|469639926|FG001|Overall Study|Switched to Commercially Available Medication|0|||
130457699|NCT01281813|469639927|FG002|Overall Study|Switched to Commercially Available Medication|26|||
130457700|NCT01281813|469639925|FG000|Overall Study|Other|0|||
130457701|NCT01281813|469639926|FG001|Overall Study|Other|1|||
130457702|NCT01281813|469639927|FG002|Overall Study|Other|39|||
130457703|NCT02034916|469639934|FG000|Overall Study|Death|39|||
130457704|NCT02034916|469639935|FG001|Overall Study|Death|28|||
130457705|NCT02034916|469639934|FG000|Overall Study|Withdrawal by Subject|2|||
130457706|NCT02034916|469639935|FG001|Overall Study|Withdrawal by Subject|1|||
130457707|NCT02034916|469639934|FG000|Overall Study|Lost to Follow-up|4|||
130457708|NCT02034916|469639935|FG001|Overall Study|Lost to Follow-up|1|||
130457709|NCT02034916|469639934|FG000|Overall Study|Study terminated by sponsor|4|||
130278913|NCT01700959|468981466|FG005|Overall Study|Ineligible|1|||
130278914|NCT01700959|468981461|FG000|Overall Study|Noncompliant|9|||
130278915|NCT01700959|468981462|FG001|Overall Study|Noncompliant|9|||
130278916|NCT01700959|468981463|FG002|Overall Study|Noncompliant|17|||
130278917|NCT01700959|468981464|FG003|Overall Study|Noncompliant|18|||
130278918|NCT01700959|468981465|FG004|Overall Study|Noncompliant|15|||
130278919|NCT01700959|468981466|FG005|Overall Study|Noncompliant|9|||
130457710|NCT02034916|469639935|FG001|Overall Study|Study terminated by sponsor|5|||
130278920|NCT01700959|468981461|FG000|Overall Study|Side effects|1|||
130457711|NCT01616654|469639940|FG000|Overall Study|Lack of Efficacy|1|||
130457712|NCT01616654|469639941|FG001|Overall Study|Lack of Efficacy|0|||
130457713|NCT01616654|469639942|FG002|Overall Study|Lack of Efficacy|0|||
130278921|NCT01700959|468981462|FG001|Overall Study|Side effects|4|||
130278922|NCT01700959|468981463|FG002|Overall Study|Side effects|8|||
130278923|NCT01700959|468981464|FG003|Overall Study|Side effects|4|||
130278924|NCT01700959|468981465|FG004|Overall Study|Side effects|4|||
130278925|NCT01700959|468981466|FG005|Overall Study|Side effects|1|||
130278926|NCT00830375|468981467|FG000|Overall Study|Lost to Follow-up|1|||
130278927|NCT00875485|468984271|FG000|Challenge Dose Epoch|Pregnancy|1|||
130278928|NCT00875485|468984272|FG001|Challenge Dose Epoch|Pregnancy|0|||
130278929|NCT01271010|468984273|FG000|Overall Study|Reason not specified|11|||
130278930|NCT01271010|468984273|FG000|Overall Study|Start of new CLL therapy|1|||
130278931|NCT01271010|468984273|FG000|Overall Study|Protocol Violation|1|||
130278932|NCT01271010|468984273|FG000|Overall Study|Death|2|||
130278933|NCT01271010|468984273|FG000|Overall Study|Progression and relapse of disease|1|||
130278934|NCT01271010|468984273|FG000|Overall Study|Withdrawal by Subject|18|||
130278935|NCT01271010|468984273|FG000|Overall Study|Disease progression|27|||
130278936|NCT01631747|468984274|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
130278937|NCT01631747|468984275|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
130278938|NCT01631747|468984274|FG000|Live Birth|Pregnancy Termination|1|||
130278939|NCT01631747|468984275|FG001|Live Birth|Pregnancy Termination|0|||
130278940|NCT01631747|468984274|FG000|Live Birth|MIscarriage|2|||
130278941|NCT01631747|468984275|FG001|Live Birth|MIscarriage|0|||
130278942|NCT01631747|468984274|FG000|Live Birth|Stillbirth|1|||
130278943|NCT01631747|468984275|FG001|Live Birth|Stillbirth|1|||
130278944|NCT01631747|468984274|FG000|One Year Infant Outcomes|Patient Refused|13|||
130278945|NCT01631747|468984275|FG001|One Year Infant Outcomes|Patient Refused|9|||
130278946|NCT01456195|468984276|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130278947|NCT01456195|468984277|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
130278948|NCT01456195|468984278|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130278949|NCT01456195|468984276|FG000|Overall Study|Lost to Follow-up|3|||
130278950|NCT01456195|468984277|FG001|Overall Study|Lost to Follow-up|1|||
130278951|NCT01456195|468984278|FG002|Overall Study|Lost to Follow-up|3|||
130278952|NCT01456195|468984276|FG000|Overall Study|Voluntary Withdrawal|5|||
130278953|NCT01456195|468984277|FG001|Overall Study|Voluntary Withdrawal|3|||
130278954|NCT01456195|468984278|FG002|Overall Study|Voluntary Withdrawal|7|||
130278955|NCT01456195|468984276|FG000|Overall Study|Lack of Efficacy|0|||
130278956|NCT01456195|468984277|FG001|Overall Study|Lack of Efficacy|1|||
130278957|NCT01456195|468984278|FG002|Overall Study|Lack of Efficacy|0|||
130278958|NCT01456195|468984276|FG000|Overall Study|Other Reasons|2|||
130278959|NCT01456195|468984277|FG001|Overall Study|Other Reasons|1|||
130278960|NCT01456195|468984278|FG002|Overall Study|Other Reasons|3|||
130278961|NCT04848220|468984281|FG000|Overall Study|Unable to proceed to study procedure|0|||
130278962|NCT04848220|468984282|FG001|Overall Study|Unable to proceed to study procedure|1|||
130278963|NCT04848220|468984283|FG002|Overall Study|Unable to proceed to study procedure|0|||
130278964|NCT04848220|468984281|FG000|Overall Study|Fractional flow not significant|0|||
130278965|NCT04848220|468984282|FG001|Overall Study|Fractional flow not significant|1|||
130278966|NCT04848220|468984283|FG002|Overall Study|Fractional flow not significant|0|||
130278967|NCT02923830|468984284|FG000|Overall Study|Physician Decision|13|||
130278968|NCT02923830|468984285|FG001|Overall Study|Physician Decision|15|||
130278969|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
130278970|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
130278971|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
130278972|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
130278973|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
130278974|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
130278975|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
130278976|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
130278977|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
130278978|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
130278979|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
130278980|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
130278981|NCT02150057|468984296|FG000|Overall Study|Lost to Follow-up|6|||
130278982|NCT02150057|468984297|FG001|Overall Study|Lost to Follow-up|4|||
130278983|NCT00489424|468984298|FG000|Overall Study|Adverse Event|3|||
130278984|NCT00489424|468984299|FG001|Overall Study|Adverse Event|3|||
130278985|NCT00489424|468984300|FG002|Overall Study|Adverse Event|4|||
130278986|NCT00489424|468984298|FG000|Overall Study|Lack of Efficacy|1|||
130278987|NCT00489424|468984299|FG001|Overall Study|Lack of Efficacy|0|||
130278988|NCT00489424|468984300|FG002|Overall Study|Lack of Efficacy|0|||
130278989|NCT00489424|468984298|FG000|Overall Study|Administrative problems|0|||
130278990|NCT00489424|468984299|FG001|Overall Study|Administrative problems|2|||
130278991|NCT00489424|468984300|FG002|Overall Study|Administrative problems|1|||
130278992|NCT00394251|468984301|FG000|Overall Study|Adverse Event|7|||
130278993|NCT00394251|468984302|FG001|Overall Study|Adverse Event|5|||
130278994|NCT00394251|468984301|FG000|Overall Study|Unacceptable Toxicity|20|||
130278995|NCT00394251|468984302|FG001|Overall Study|Unacceptable Toxicity|18|||
130278996|NCT00394251|468984301|FG000|Overall Study|Physician Decision|1|||
130368497|NCT01064310|469319700|FG000|Open Label Pazopinib|Physician Decision|0|||
130278997|NCT00394251|468984302|FG001|Overall Study|Physician Decision|1|||
130278998|NCT00394251|468984301|FG000|Overall Study|Protocol Violation|0|||
130278999|NCT00394251|468984302|FG001|Overall Study|Protocol Violation|1|||
130279000|NCT00394251|468984301|FG000|Overall Study|Withdrawal by Subject|7|||
130368498|NCT01064310|469319701|FG001|Open Label Pazopinib|Physician Decision|0|||
130368499|NCT01064310|469319702|FG002|Open Label Pazopinib|Physician Decision|20|||
130368500|NCT00679432|469319703|FG000|Overall Study|Adverse Event|5|||
130368501|NCT00679432|469319704|FG001|Overall Study|Adverse Event|6|||
130368502|NCT00679432|469319705|FG002|Overall Study|Adverse Event|10|||
130368503|NCT00679432|469319706|FG003|Overall Study|Adverse Event|7|||
130368504|NCT00679432|469319703|FG000|Overall Study|Protocol Violation|1|||
130368505|NCT00679432|469319704|FG001|Overall Study|Protocol Violation|1|||
130368506|NCT00679432|469319705|FG002|Overall Study|Protocol Violation|2|||
130368507|NCT00679432|469319706|FG003|Overall Study|Protocol Violation|1|||
130368508|NCT00679432|469319703|FG000|Overall Study|Withdrawal by Subject|8|||
130368509|NCT00679432|469319704|FG001|Overall Study|Withdrawal by Subject|11|||
130368510|NCT00679432|469319705|FG002|Overall Study|Withdrawal by Subject|10|||
130368511|NCT00679432|469319706|FG003|Overall Study|Withdrawal by Subject|9|||
130368512|NCT00679432|469319703|FG000|Overall Study|Lost to Follow-up|1|||
130368513|NCT00679432|469319704|FG001|Overall Study|Lost to Follow-up|5|||
130368514|NCT00679432|469319705|FG002|Overall Study|Lost to Follow-up|4|||
130710752|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
130710753|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
130710754|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130710755|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130279001|NCT00394251|468984302|FG001|Overall Study|Withdrawal by Subject|11|||
130279002|NCT00394251|468984301|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130279003|NCT00394251|468984302|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130279004|NCT05791565|468984303|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
130279005|NCT05791565|468984304|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
130279006|NCT01558115|468984305|FG000|Overall Study|Withdrawal by Subject|3|||
130279007|NCT01558115|468984305|FG000|Overall Study|Study closed due to poor enrollment|4|||
130279008|NCT01696994|468984306|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
130279009|NCT01696994|468984307|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
130279010|NCT01696994|468984306|FG000|Overall Study|Died Before Randomization|1|||
130279011|NCT01696994|468984307|FG001|Overall Study|Died Before Randomization|2|||
130279012|NCT01696994|468984306|FG000|Overall Study|Died Before ASU (Control)|73|||
130279013|NCT01696994|468984307|FG001|Overall Study|Died Before ASU (Control)|0|||
130279014|NCT01696994|468984306|FG000|Overall Study|No Ovaries at Baseline|4807|||
130279015|NCT01696994|468984307|FG001|Overall Study|No Ovaries at Baseline|4851|||
130279016|NCT01696994|468984306|FG000|Overall Study|Refused ASU (Control)|311|||
130279017|NCT01696994|468984307|FG001|Overall Study|Refused ASU (Control)|0|||
130279018|NCT01696994|468984306|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
130279019|NCT01696994|468984307|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
130279020|NCT02388165|468984308|FG000|Overall Study|Study terminated by sponsor|5|||
130279021|NCT02388165|468984309|FG001|Overall Study|Study terminated by sponsor|5|||
130279022|NCT02388165|468984308|FG000|Overall Study|Other|11|||
130279023|NCT02388165|468984309|FG001|Overall Study|Other|13|||
130279024|NCT02388165|468984308|FG000|Overall Study|No longer meet eligibility criteria|40|||
130279025|NCT02388165|468984309|FG001|Overall Study|No longer meet eligibility criteria|43|||
130279026|NCT02388165|468984308|FG000|Overall Study|Withdrawal of consent|31|||
130279027|NCT02388165|468984309|FG001|Overall Study|Withdrawal of consent|32|||
130279028|NCT02388165|468984308|FG000|Overall Study|Lost to Follow-up|19|||
130279029|NCT02388165|468984309|FG001|Overall Study|Lost to Follow-up|20|||
130279030|NCT02388165|468984308|FG000|Overall Study|Death|13|||
130279031|NCT02388165|468984309|FG001|Overall Study|Death|10|||
130279032|NCT02388165|468984308|FG000|Overall Study|Adverse Event|3|||
130279033|NCT02388165|468984309|FG001|Overall Study|Adverse Event|5|||
130279034|NCT02388165|468984308|FG000|Overall Study|Did not meet entrance criteria|5|||
130279035|NCT02388165|468984309|FG001|Overall Study|Did not meet entrance criteria|2|||
130279036|NCT00705250|468984310|FG000|Overall Study|Withdrawal by Subject|1|||
130279037|NCT00705250|468984310|FG000|Overall Study|Patient died in car accident|1|||
130279038|NCT00880269|468984311|FG000|Overall Study|Protocol Violation|1|||
130279039|NCT00880269|468984312|FG001|Overall Study|Protocol Violation|0|||
130279040|NCT00880269|468984311|FG000|Overall Study|Disease Progression|13|||
130279041|NCT00880269|468984312|FG001|Overall Study|Disease Progression|11|||
130279042|NCT00880269|468984311|FG000|Overall Study|New Cancer Therapy|1|||
130279043|NCT00880269|468984312|FG001|Overall Study|New Cancer Therapy|0|||
130279044|NCT00880269|468984311|FG000|Overall Study|Death|4|||
130279045|NCT00880269|468984312|FG001|Overall Study|Death|2|||
130368515|NCT00679432|469319706|FG003|Overall Study|Lost to Follow-up|2|||
130368516|NCT00679432|469319703|FG000|Overall Study|Physician Decision|3|||
130368517|NCT00679432|469319704|FG001|Overall Study|Physician Decision|2|||
130710756|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130279046|NCT00880269|468984311|FG000|Overall Study|Lost to Follow-up|0|||
130279047|NCT00880269|468984312|FG001|Overall Study|Lost to Follow-up|1|||
130279048|NCT00880269|468984311|FG000|Overall Study|Withdrawal by Subject|3|||
130279049|NCT00880269|468984312|FG001|Overall Study|Withdrawal by Subject|4|||
130279050|NCT00880269|468984311|FG000|Overall Study|Adverse Event|10|||
130279051|NCT00880269|468984312|FG001|Overall Study|Adverse Event|9|||
130279052|NCT01576146|468984313|FG000|Extension Period 1|Adverse Event|2|||
130279053|NCT01576146|468984313|FG000|Extension Period 1|Death|2|||
130279054|NCT01576146|468984313|FG000|Extension Period 1|Physician Decision|2|||
130279055|NCT01576146|468984313|FG000|Extension Period 1|Withdrawal by Subject|1|||
130279056|NCT01576146|468984313|FG000|Extension Period 1|Lost to Follow-up|1|||
130279057|NCT01576146|468984313|FG000|Extension Period 1|Parathyroidectomy|1|||
130279058|NCT01576146|468984313|FG000|Extension Period 1|Renal Transplant|1|||
130279059|NCT01576146|468984313|FG000|Extension Period 2|Sponsor Decision|13|||
130279060|NCT01576146|468984313|FG000|Extension Period 2|Death|1|||
130279061|NCT01576146|468984313|FG000|Extension Period 2|Adverse Event|1|||
130279062|NCT01576146|468984313|FG000|Extension Period 2|Renal Transplant|1|||
130279063|NCT01576146|468984313|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
130279064|NCT00316225|468984314|FG000|Overall Study|Adverse Event|2|||
130279065|NCT00316225|468984314|FG000|Overall Study|Physician Decision|3|||
130279066|NCT00316225|468984314|FG000|Overall Study|Progressive Disease|15|||
130279067|NCT00316225|468984314|FG000|Overall Study|Withdrawal by Subject|3|||
130279068|NCT00316225|468984314|FG000|Overall Study|Death|2|||
130279069|NCT01811485|468984315|FG000|Overall Study|Adverse Event|1|||
130279070|NCT01811485|468984316|FG001|Overall Study|Adverse Event|3|||
130279071|NCT01811485|468984317|FG002|Overall Study|Adverse Event|2|||
130279072|NCT01811485|468984315|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130279073|NCT01811485|468984316|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130279074|NCT01811485|468984317|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130279075|NCT01811485|468984315|FG000|Overall Study|Administrative problems|1|||
130279076|NCT01811485|468984316|FG001|Overall Study|Administrative problems|0|||
130279077|NCT01811485|468984317|FG002|Overall Study|Administrative problems|0|||
130279078|NCT01811485|468984315|FG000|Overall Study|Protocol Deviation|0|||
130279079|NCT01811485|468984316|FG001|Overall Study|Protocol Deviation|1|||
130279080|NCT01811485|468984317|FG002|Overall Study|Protocol Deviation|0|||
130279081|NCT01545934|468984318|FG000|Overall Study|Withdrawal by Subject|4|||
130279082|NCT01545934|468984319|FG001|Overall Study|Withdrawal by Subject|3|||
130279083|NCT01545934|468984318|FG000|Overall Study|Lost to Follow-up|1|||
130279084|NCT01545934|468984319|FG001|Overall Study|Lost to Follow-up|0|||
130279085|NCT03654404|468984320|FG000|Overall Study|Death|1|||
130279086|NCT03654404|468984320|FG000|Overall Study|Lost to Follow-up|2|||
130279087|NCT03654404|468984320|FG000|Overall Study|Withdrawal by Subject|5|||
130279088|NCT03215758|468984323|FG000|Overall Study|Technical Problems|1|||
130279089|NCT03215758|468984324|FG001|Overall Study|Technical Problems|0|||
130279090|NCT03215758|468984323|FG000|Overall Study|Protocol deviation|0|||
130279091|NCT03215758|468984324|FG001|Overall Study|Protocol deviation|1|||
130279092|NCT03215758|468984323|FG000|Overall Study|Physician Decision|0|||
130279093|NCT03215758|468984324|FG001|Overall Study|Physician Decision|1|||
130279094|NCT03215758|468984323|FG000|Overall Study|Death|0|||
130279095|NCT03215758|468984324|FG001|Overall Study|Death|1|||
130279096|NCT03215758|468984323|FG000|Overall Study|Adverse Event|1|||
130279097|NCT03215758|468984324|FG001|Overall Study|Adverse Event|2|||
130279098|NCT03215758|468984323|FG000|Overall Study|Subject/Guardian Decision|3|||
130279099|NCT03215758|468984324|FG001|Overall Study|Subject/Guardian Decision|3|||
130279100|NCT02003638|468984325|FG000|Overall Study|Withdrawal by Subject|1|||
130279101|NCT02003638|468984326|FG001|Overall Study|Withdrawal by Subject|0|||
130279102|NCT04115748|468984332|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130279103|NCT04115748|468984333|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
130279104|NCT04115748|468984334|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
130279105|NCT04115748|468984335|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130279106|NCT04115748|468984336|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279107|NCT04115748|468984337|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279108|NCT04115748|468984338|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279109|NCT04115748|468984339|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279110|NCT04115748|468984340|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279111|NCT04115748|468984341|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279112|NCT04115748|468984332|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279113|NCT04115748|468984333|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279114|NCT04115748|468984334|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279115|NCT04115748|468984335|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
130279116|NCT04115748|468984336|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279117|NCT04115748|468984337|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279118|NCT04115748|468984338|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279119|NCT04115748|468984339|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279120|NCT04115748|468984340|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279121|NCT04115748|468984341|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279122|NCT04115748|468984332|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130368518|NCT00679432|469319705|FG002|Overall Study|Physician Decision|2|||
130368519|NCT00679432|469319706|FG003|Overall Study|Physician Decision|2|||
130368520|NCT00679432|469319703|FG000|Overall Study|Sponsor decision|1|||
130368521|NCT00679432|469319704|FG001|Overall Study|Sponsor decision|0|||
130368522|NCT00679432|469319705|FG002|Overall Study|Sponsor decision|0|||
130368523|NCT00679432|469319706|FG003|Overall Study|Sponsor decision|0|||
130368524|NCT00679432|469319703|FG000|Overall Study|Lack of Efficacy|13|||
130368525|NCT00679432|469319704|FG001|Overall Study|Lack of Efficacy|9|||
130368526|NCT00679432|469319705|FG002|Overall Study|Lack of Efficacy|14|||
130368527|NCT00679432|469319706|FG003|Overall Study|Lack of Efficacy|8|||
130368528|NCT00679432|469319703|FG000|Overall Study|Infectious colitis, normal histology|5|||
130368529|NCT00679432|469319704|FG001|Overall Study|Infectious colitis, normal histology|4|||
130368530|NCT00679432|469319705|FG002|Overall Study|Infectious colitis, normal histology|8|||
130368531|NCT00679432|469319706|FG003|Overall Study|Infectious colitis, normal histology|3|||
130368532|NCT00679432|469319703|FG000|Overall Study|Randomization error, return to prior Rx|0|||
130368533|NCT00679432|469319704|FG001|Overall Study|Randomization error, return to prior Rx|0|||
130457714|NCT01616654|469639943|FG003|Overall Study|Lack of Efficacy|0|||
130457715|NCT01616654|469639944|FG004|Overall Study|Lack of Efficacy|1|||
130457716|NCT01616654|469639940|FG000|Overall Study|Adverse Event|0|||
130457717|NCT01616654|469639941|FG001|Overall Study|Adverse Event|1|||
130279123|NCT04115748|468984333|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279124|NCT04115748|468984334|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279125|NCT04115748|468984335|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279126|NCT04115748|468984336|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
130279127|NCT04115748|468984337|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
130279128|NCT04115748|468984338|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279129|NCT04115748|468984339|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279130|NCT04115748|468984340|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279131|NCT04115748|468984341|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
130279132|NCT04115748|468984332|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279133|NCT04115748|468984333|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279134|NCT04115748|468984334|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279135|NCT04115748|468984335|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279136|NCT04115748|468984336|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279137|NCT04115748|468984337|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279138|NCT04115748|468984338|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279139|NCT04115748|468984339|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279140|NCT04115748|468984340|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
130279141|NCT04115748|468984341|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279142|NCT00713349|468984342|FG000|Overall Study|Protocol Violation|1|||
130279143|NCT03764631|468984343|FG000|Overall Study|Personal Reasons|3|||
130279144|NCT03764631|468984344|FG001|Overall Study|Personal Reasons|2|||
130279145|NCT03764631|468984343|FG000|Overall Study|Switching Therapy|3|||
130279146|NCT03764631|468984344|FG001|Overall Study|Switching Therapy|3|||
130279147|NCT03764631|468984343|FG000|Overall Study|Adverse Event|0|||
130279148|NCT03764631|468984344|FG001|Overall Study|Adverse Event|1|||
130279149|NCT03764631|468984343|FG000|Overall Study|Lost to Follow-up|33|||
130279150|NCT03764631|468984344|FG001|Overall Study|Lost to Follow-up|41|||
130279151|NCT03764631|468984343|FG000|Overall Study|No data as study site was closed|2|||
130279152|NCT03764631|468984344|FG001|Overall Study|No data as study site was closed|6|||
130279153|NCT01200407|468984345|FG000|Overall Study|Lost to Follow-up|56|||
130279154|NCT01200407|468984345|FG000|Overall Study|Adverse Event|3|||
130279155|NCT01200407|468984345|FG000|Overall Study|Withdrawal by Subject|4|||
130279156|NCT01200407|468984345|FG000|Overall Study|Other|19|||
130279157|NCT03299881|468984346|FG000|Overall Study|Study Termination|17|||
130279158|NCT03299881|468984347|FG001|Overall Study|Study Termination|13|||
130279159|NCT01450696|468984348|FG000|Overall Study|Never Treated|1|||
130279160|NCT01450696|468984349|FG001|Overall Study|Never Treated|1|||
130279161|NCT01450696|468984348|FG000|Overall Study|Death|77|||
130279162|NCT01450696|468984349|FG001|Overall Study|Death|84|||
130279163|NCT01450696|468984348|FG000|Overall Study|Lost to Follow-up|3|||
130457718|NCT01616654|469639942|FG002|Overall Study|Adverse Event|2|||
130457719|NCT01616654|469639943|FG003|Overall Study|Adverse Event|1|||
130368534|NCT00679432|469319705|FG002|Overall Study|Randomization error, return to prior Rx|3|||
130457720|NCT01616654|469639944|FG004|Overall Study|Adverse Event|0|||
130279164|NCT01450696|468984349|FG001|Overall Study|Lost to Follow-up|3|||
130368535|NCT00679432|469319706|FG003|Overall Study|Randomization error, return to prior Rx|0|||
130368536|NCT02339584|469319707|FG000|Overall Study|Adverse Event|11|||
130279165|NCT01450696|468984348|FG000|Overall Study|Non-Compliance|1|||
130279166|NCT01450696|468984349|FG001|Overall Study|Non-Compliance|0|||
130368537|NCT02339584|469319708|FG001|Overall Study|Adverse Event|7|||
130368538|NCT02339584|469319707|FG000|Overall Study|Lack of Efficacy|0|||
130457721|NCT01616654|469639940|FG000|Overall Study|Withdrawal by Subject|2|||
130555322|NCT03942406|470001550|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
130279167|NCT01450696|468984348|FG000|Overall Study|Withdrawal by Subject|13|||
130279168|NCT01450696|468984349|FG001|Overall Study|Withdrawal by Subject|2|||
130279169|NCT01450696|468984348|FG000|Overall Study|Study Terminated by Sponsor|53|||
130279170|NCT01450696|468984349|FG001|Overall Study|Study Terminated by Sponsor|58|||
130279171|NCT01843673|468984350|FG000|Overall Study|Lack of Efficacy|2|||
130279172|NCT01843673|468984350|FG000|Overall Study|Withdrawal by Subject|4|||
130279173|NCT02321319|468984351|FG000|Overall Study|Product discontinued|5|||
130279174|NCT02249091|468984352|FG000|Overall Study|Lack of Efficacy|8|||
130279175|NCT02249091|468984353|FG001|Overall Study|Lack of Efficacy|3|||
130279176|NCT02249091|468984352|FG000|Overall Study|Physician Decision|4|||
130279177|NCT02249091|468984353|FG001|Overall Study|Physician Decision|1|||
130279178|NCT02249091|468984352|FG000|Overall Study|Withdrawal by Subject|2|||
130279179|NCT02249091|468984353|FG001|Overall Study|Withdrawal by Subject|2|||
130279180|NCT02249091|468984352|FG000|Overall Study|Death|3|||
130279181|NCT02249091|468984353|FG001|Overall Study|Death|4|||
130279182|NCT02249091|468984352|FG000|Overall Study|Adverse Event|1|||
130279183|NCT02249091|468984353|FG001|Overall Study|Adverse Event|0|||
130279184|NCT02249091|468984352|FG000|Overall Study|Stable disease with following SCT|0|||
130279185|NCT02249091|468984353|FG001|Overall Study|Stable disease with following SCT|1|||
130279186|NCT02249091|468984352|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
130279187|NCT02249091|468984353|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
130279188|NCT02249091|468984352|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
130279189|NCT02249091|468984353|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
130279190|NCT02249091|468984352|FG000|Overall Study|Refractory AML|1|||
130279191|NCT02249091|468984353|FG001|Overall Study|Refractory AML|1|||
130279192|NCT01257230|468984356|FG000|Overall Study|Not Treated|0|||
130279193|NCT01257230|468984357|FG001|Overall Study|Not Treated|0|||
130279194|NCT01257230|468984358|FG002|Overall Study|Not Treated|1|||
130279195|NCT01257230|468984356|FG000|Overall Study|Adverse Event|2|||
130279196|NCT01257230|468984357|FG001|Overall Study|Adverse Event|0|||
130279197|NCT01257230|468984358|FG002|Overall Study|Adverse Event|0|||
130279198|NCT01257230|468984356|FG000|Overall Study|Lack of Efficacy|0|||
130279199|NCT01257230|468984357|FG001|Overall Study|Lack of Efficacy|1|||
130279200|NCT01257230|468984358|FG002|Overall Study|Lack of Efficacy|0|||
130279201|NCT01257230|468984356|FG000|Overall Study|Protocol Violation|3|||
130279202|NCT01257230|468984357|FG001|Overall Study|Protocol Violation|0|||
130279203|NCT01257230|468984358|FG002|Overall Study|Protocol Violation|1|||
130279204|NCT01257230|468984356|FG000|Overall Study|Withdrawal by Subject|0|||
130279205|NCT01257230|468984357|FG001|Overall Study|Withdrawal by Subject|4|||
130279206|NCT01257230|468984358|FG002|Overall Study|Withdrawal by Subject|1|||
130279207|NCT01257230|468984356|FG000|Overall Study|Other reason not defined above|1|||
130279208|NCT01257230|468984357|FG001|Overall Study|Other reason not defined above|5|||
130279209|NCT01257230|468984358|FG002|Overall Study|Other reason not defined above|3|||
130279210|NCT01205061|468984361|FG000|Overall Study|Adverse Event|4|||
130279211|NCT01205061|468984361|FG000|Overall Study|Withdrawal by Subject|11|||
130279212|NCT01205061|468984361|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
130279213|NCT01205061|468984361|FG000|Overall Study|Lost to Follow-up|9|||
130279214|NCT01205061|468984361|FG000|Overall Study|Other|1|||
130279215|NCT00765037|468984362|FG000|Overall Study|Lost to Follow-up|5|||
130279216|NCT00765037|468984362|FG000|Overall Study|Adverse Event|1|||
130279217|NCT03070171|468984369|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
130279218|NCT03070171|468984370|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
130279219|NCT03070171|468984369|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
130279220|NCT03070171|468984370|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
130279221|NCT01471028|468984374|FG000|VTI-208|Adverse Event|39|||
130279222|NCT01471028|468984375|FG001|VTI-208|Adverse Event|41|||
130279223|NCT01471028|468984374|FG000|VTI-208|Withdrawal by Subject|0|||
130279224|NCT01471028|468984375|FG001|VTI-208|Withdrawal by Subject|2|||
130279225|NCT01471028|468984374|FG000|VTI-208|Lost to Follow-up|1|||
130368539|NCT02339584|469319708|FG001|Overall Study|Lack of Efficacy|1|||
130279226|NCT01471028|468984375|FG001|VTI-208|Lost to Follow-up|1|||
130279227|NCT01471028|468984374|FG000|VTI-208E|Death|7|||
130279228|NCT01471028|468984375|FG001|VTI-208E|Death|10|||
130279229|NCT01471028|468984374|FG000|VTI-208E|Withdrawal by Subject|1|||
130279230|NCT01471028|468984375|FG001|VTI-208E|Withdrawal by Subject|0|||
130279231|NCT01471028|468984374|FG000|VTI-208E|Lost to Follow-up|0|||
130279232|NCT01471028|468984375|FG001|VTI-208E|Lost to Follow-up|2|||
130368540|NCT02339584|469319707|FG000|Overall Study|Physician Decision|1|||
130368541|NCT02339584|469319708|FG001|Overall Study|Physician Decision|2|||
130279233|NCT00610857|468984377|FG000|Overall Study|Not evaluable for response|2|||
130279234|NCT01626118|468984378|FG000|Overall Study|Lack of Efficacy|1|||
130279235|NCT01626118|468984379|FG001|Overall Study|Lack of Efficacy|0|||
130279236|NCT01626118|468984380|FG002|Overall Study|Lack of Efficacy|1|||
130279237|NCT01626118|468984381|FG003|Overall Study|Lack of Efficacy|3|||
130279238|NCT01626118|468984378|FG000|Overall Study|Lost to Follow-up|1|||
130279239|NCT01626118|468984379|FG001|Overall Study|Lost to Follow-up|0|||
130279240|NCT01626118|468984380|FG002|Overall Study|Lost to Follow-up|0|||
130279241|NCT01626118|468984381|FG003|Overall Study|Lost to Follow-up|0|||
130279242|NCT01626118|468984378|FG000|Overall Study|Adverse Event|0|||
130279243|NCT01626118|468984379|FG001|Overall Study|Adverse Event|1|||
130279244|NCT01626118|468984380|FG002|Overall Study|Adverse Event|1|||
130279245|NCT01626118|468984381|FG003|Overall Study|Adverse Event|0|||
130279246|NCT01626118|468984378|FG000|Overall Study|Investigator Decision|0|||
130279247|NCT01626118|468984379|FG001|Overall Study|Investigator Decision|1|||
130279248|NCT01626118|468984380|FG002|Overall Study|Investigator Decision|0|||
130279249|NCT01626118|468984381|FG003|Overall Study|Investigator Decision|0|||
130279250|NCT04826094|468984382|FG000|Overall Study|Lost to Follow-up|2|||
130279251|NCT04826094|468984383|FG001|Overall Study|Lost to Follow-up|1|||
130279252|NCT04826094|468984384|FG002|Overall Study|Lost to Follow-up|0|||
130279253|NCT04826094|468984385|FG003|Overall Study|Lost to Follow-up|0|||
130279254|NCT04826094|468984386|FG004|Overall Study|Lost to Follow-up|1|||
130279255|NCT04826094|468984387|FG005|Overall Study|Lost to Follow-up|3|||
130279256|NCT04826094|468984388|FG006|Overall Study|Lost to Follow-up|1|||
130279257|NCT04826094|468984389|FG007|Overall Study|Lost to Follow-up|1|||
130279258|NCT04826094|468984382|FG000|Overall Study|Participant withdrew consent|1|||
130279259|NCT04826094|468984383|FG001|Overall Study|Participant withdrew consent|0|||
130279260|NCT04826094|468984384|FG002|Overall Study|Participant withdrew consent|0|||
130279261|NCT04826094|468984385|FG003|Overall Study|Participant withdrew consent|1|||
130279262|NCT04826094|468984386|FG004|Overall Study|Participant withdrew consent|1|||
130279263|NCT04826094|468984387|FG005|Overall Study|Participant withdrew consent|1|||
130279264|NCT04826094|468984388|FG006|Overall Study|Participant withdrew consent|0|||
130279265|NCT04826094|468984389|FG007|Overall Study|Participant withdrew consent|1|||
130279266|NCT04826094|468984382|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
130279267|NCT04826094|468984383|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
130279268|NCT04826094|468984384|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
130279269|NCT04826094|468984385|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
130279270|NCT04826094|468984386|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
130279271|NCT04826094|468984387|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
130279272|NCT04826094|468984388|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
130279273|NCT04826094|468984389|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
130279274|NCT04826094|468984382|FG000|Overall Study|Withdrawn by Investigator|0|||
130279275|NCT04826094|468984383|FG001|Overall Study|Withdrawn by Investigator|0|||
130279276|NCT04826094|468984384|FG002|Overall Study|Withdrawn by Investigator|0|||
130279277|NCT04826094|468984385|FG003|Overall Study|Withdrawn by Investigator|0|||
130279278|NCT04826094|468984386|FG004|Overall Study|Withdrawn by Investigator|0|||
130279279|NCT04826094|468984387|FG005|Overall Study|Withdrawn by Investigator|1|||
130279280|NCT04826094|468984388|FG006|Overall Study|Withdrawn by Investigator|0|||
130279281|NCT04826094|468984389|FG007|Overall Study|Withdrawn by Investigator|1|||
130279282|NCT04826094|468984382|FG000|Overall Study|Other: Moved from area|1|||
130279283|NCT04826094|468984383|FG001|Overall Study|Other: Moved from area|1|||
130279284|NCT04826094|468984384|FG002|Overall Study|Other: Moved from area|1|||
130279285|NCT04826094|468984385|FG003|Overall Study|Other: Moved from area|0|||
130279286|NCT04826094|468984386|FG004|Overall Study|Other: Moved from area|0|||
130279287|NCT04826094|468984387|FG005|Overall Study|Other: Moved from area|0|||
130279288|NCT04826094|468984388|FG006|Overall Study|Other: Moved from area|0|||
130279289|NCT04826094|468984389|FG007|Overall Study|Other: Moved from area|0|||
130279290|NCT04826094|468984382|FG000|Overall Study|Other: Declined|0|||
130279291|NCT04826094|468984383|FG001|Overall Study|Other: Declined|0|||
130279292|NCT04826094|468984384|FG002|Overall Study|Other: Declined|0|||
130279293|NCT04826094|468984385|FG003|Overall Study|Other: Declined|0|||
130279294|NCT04826094|468984386|FG004|Overall Study|Other: Declined|1|||
130279295|NCT04826094|468984387|FG005|Overall Study|Other: Declined|0|||
130279296|NCT04826094|468984388|FG006|Overall Study|Other: Declined|0|||
130279297|NCT04826094|468984389|FG007|Overall Study|Other: Declined|0|||
130279298|NCT04826094|468984382|FG000|Overall Study|Other: Vaccine not administered|0|||
130279299|NCT04826094|468984383|FG001|Overall Study|Other: Vaccine not administered|0|||
130279300|NCT04826094|468984384|FG002|Overall Study|Other: Vaccine not administered|1|||
130279301|NCT04826094|468984385|FG003|Overall Study|Other: Vaccine not administered|0|||
130279302|NCT04826094|468984386|FG004|Overall Study|Other: Vaccine not administered|0|||
130279303|NCT04826094|468984387|FG005|Overall Study|Other: Vaccine not administered|1|||
130279304|NCT04826094|468984388|FG006|Overall Study|Other: Vaccine not administered|1|||
130279305|NCT04826094|468984389|FG007|Overall Study|Other: Vaccine not administered|3|||
130279306|NCT00700882|468984392|FG000|Overall Study|Never received treatment|6|||
130279307|NCT00700882|468984392|FG000|Overall Study|Ineligible|2|||
130279308|NCT00700882|468984392|FG000|Overall Study|No KIT mutation|51|||
130279309|NCT04154293|468984396|FG000|Overall Study|Withdrawal by Subject|2|||
130279310|NCT04154293|468984397|FG001|Overall Study|Withdrawal by Subject|3|||
130279311|NCT04154293|468984398|FG002|Overall Study|Withdrawal by Subject|1|||
130279312|NCT04154293|468984396|FG000|Overall Study|Physician Decision|0|||
130279313|NCT04154293|468984397|FG001|Overall Study|Physician Decision|0|||
130279314|NCT04154293|468984398|FG002|Overall Study|Physician Decision|1|||
130279315|NCT04731298|468984399|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
130279316|NCT04731298|468984400|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
130279317|NCT01208961|468984401|FG000|High-Fat Period III|Protocol Violation|1|||
130279318|NCT01208961|468984402|FG001|High-Fat Period III|Protocol Violation|0|||
130279319|NCT03403361|468984403|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
130279320|NCT02152371|468984405|FG000|Overall Study|Adverse Event|6|||
130279321|NCT02152371|468984406|FG001|Overall Study|Adverse Event|2|||
130279322|NCT02152371|468984405|FG000|Overall Study|Withdrawal by Subject|3|||
130279323|NCT02152371|468984406|FG001|Overall Study|Withdrawal by Subject|7|||
130279324|NCT02152371|468984405|FG000|Overall Study|Protocol Violation|2|||
130279325|NCT02152371|468984406|FG001|Overall Study|Protocol Violation|3|||
130279326|NCT02152371|468984405|FG000|Overall Study|Lost to Follow-up|1|||
130279327|NCT02152371|468984406|FG001|Overall Study|Lost to Follow-up|0|||
130279328|NCT02152371|468984405|FG000|Overall Study|Lack of Efficacy|0|||
130279329|NCT02152371|468984406|FG001|Overall Study|Lack of Efficacy|1|||
130279330|NCT02152371|468984405|FG000|Overall Study|Physician Decision|0|||
130279331|NCT02152371|468984406|FG001|Overall Study|Physician Decision|2|||
130279332|NCT02152371|468984405|FG000|Overall Study|Reason Not Given|0|||
130279333|NCT02152371|468984406|FG001|Overall Study|Reason Not Given|1|||
130279334|NCT04382586|468984411|FG000|Overall Study|Death|3|||
130279335|NCT04382586|468984412|FG001|Overall Study|Death|4|||
130279336|NCT04382586|468984411|FG000|Overall Study|Lost to Follow-up|11|||
130279337|NCT04382586|468984412|FG001|Overall Study|Lost to Follow-up|8|||
130279338|NCT04382586|468984411|FG000|Overall Study|Withdrawal by Subject|3|||
130279339|NCT04382586|468984412|FG001|Overall Study|Withdrawal by Subject|1|||
130279340|NCT04382586|468984411|FG000|Overall Study|Physician Decision|0|||
130279341|NCT04382586|468984412|FG001|Overall Study|Physician Decision|3|||
130279342|NCT06099223|468984418|FG000|Overall Study|Preoperative surveys missed|0|||
130279343|NCT06099223|468984419|FG001|Overall Study|Preoperative surveys missed|1|||
130279344|NCT00079391|468984420|FG000|Overall Study|Withdrawal by Subject|1|||
130279345|NCT02628600|468984424|FG000|Overall Study|Death|2|||
130279346|NCT02628600|468984425|FG001|Overall Study|Death|1|||
130279347|NCT02628600|468984424|FG000|Overall Study|Adverse Event|3|||
130279348|NCT02628600|468984425|FG001|Overall Study|Adverse Event|20|||
130279349|NCT02628600|468984424|FG000|Overall Study|Protocol Violation|0|||
130279350|NCT02628600|468984425|FG001|Overall Study|Protocol Violation|1|||
130279351|NCT02628600|468984424|FG000|Overall Study|Lack of Efficacy|2|||
130279352|NCT02628600|468984425|FG001|Overall Study|Lack of Efficacy|0|||
130279353|NCT02628600|468984424|FG000|Overall Study|Withdrawal by Subject|13|||
130279354|NCT02628600|468984425|FG001|Overall Study|Withdrawal by Subject|8|||
130279355|NCT02628600|468984424|FG000|Overall Study|Lost to Follow-up|1|||
130279356|NCT02628600|468984425|FG001|Overall Study|Lost to Follow-up|0|||
130279357|NCT02628600|468984424|FG000|Overall Study|Physician Decision|2|||
130279358|NCT02628600|468984425|FG001|Overall Study|Physician Decision|2|||
130279359|NCT02628600|468984424|FG000|Overall Study|Other not specified|1|||
130279360|NCT02628600|468984425|FG001|Overall Study|Other not specified|0|||
130279361|NCT02644096|468984426|FG000|Overall Study|Withdrawal by Subject|28|||
130279362|NCT02644096|468984427|FG001|Overall Study|Withdrawal by Subject|25|||
130279363|NCT02461290|468984428|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
130279364|NCT02461290|468984428|FG000|Overall Study|Lost to Follow-up|3|||
130279365|NCT00526656|468984429|FG000|Overall Study|Death|1|||
130279366|NCT00526656|468984429|FG000|Overall Study|Refused surgery|1|||
130279367|NCT02109432|468986650|FG000|Overall Study|Withdrawal by Subject|1|||
130279368|NCT02908685|468986651|FG000|Part 1 OLE|Withdrawal by Subject|0|||
130279369|NCT02908685|468986652|FG001|Part 1 OLE|Withdrawal by Subject|0|||
130279370|NCT02908685|468986653|FG002|Part 1 OLE|Withdrawal by Subject|0|||
130279371|NCT02908685|468986654|FG003|Part 1 OLE|Withdrawal by Subject|0|||
130279372|NCT02908685|468986655|FG004|Part 1 OLE|Withdrawal by Subject|0|||
130279373|NCT02908685|468986656|FG005|Part 1 OLE|Withdrawal by Subject|0|||
130279374|NCT02908685|468986657|FG006|Part 1 OLE|Withdrawal by Subject|0|||
130279375|NCT02908685|468986658|FG007|Part 1 OLE|Withdrawal by Subject|0|||
130279376|NCT02908685|468986659|FG008|Part 1 OLE|Withdrawal by Subject|0|||
130710757|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130710758|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
130279377|NCT02908685|468986660|FG009|Part 1 OLE|Withdrawal by Subject|0|||
130279378|NCT02908685|468986661|FG010|Part 1 OLE|Withdrawal by Subject|2|||
130279379|NCT02908685|468986662|FG011|Part 1 OLE|Withdrawal by Subject|1|||
130279380|NCT02908685|468986663|FG012|Part 1 OLE|Withdrawal by Subject|0|||
130279381|NCT02908685|468986664|FG013|Part 1 OLE|Withdrawal by Subject|0|||
130279382|NCT02908685|468986651|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279383|NCT02908685|468986652|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279384|NCT02908685|468986653|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279385|NCT02908685|468986654|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279386|NCT02908685|468986655|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279387|NCT02908685|468986656|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279388|NCT02908685|468986657|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279389|NCT02908685|468986658|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279390|NCT02908685|468986659|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279391|NCT02908685|468986660|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279392|NCT02908685|468986661|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279393|NCT02908685|468986662|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279394|NCT02908685|468986663|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
130279395|NCT02908685|468986664|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
130279396|NCT02908685|468986651|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279397|NCT02908685|468986652|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279398|NCT02908685|468986653|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279399|NCT02908685|468986654|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279400|NCT02908685|468986655|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279401|NCT02908685|468986656|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279402|NCT02908685|468986657|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279403|NCT02908685|468986658|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279404|NCT02908685|468986659|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279405|NCT02908685|468986660|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279406|NCT02908685|468986661|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279407|NCT02908685|468986662|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279408|NCT02908685|468986663|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
130279409|NCT02908685|468986664|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279410|NCT02908685|468986651|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279411|NCT02908685|468986652|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279412|NCT02908685|468986653|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279413|NCT02908685|468986654|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279414|NCT02908685|468986655|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279415|NCT02908685|468986656|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279416|NCT02908685|468986657|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279417|NCT02908685|468986658|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279418|NCT02908685|468986659|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279419|NCT02908685|468986660|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279420|NCT02908685|468986661|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279421|NCT02908685|468986662|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279422|NCT02908685|468986663|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
130279423|NCT02908685|468986664|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279424|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Death|0|||
130279425|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Death|0|||
130279426|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Death|0|||
130279427|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Death|0|||
130279428|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Death|0|||
130279429|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Death|0|||
130279430|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Death|0|||
130279431|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Death|0|||
130279432|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Death|0|||
130279433|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Death|0|||
130279434|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Death|0|||
130279435|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Death|0|||
130279436|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Death|1|||
130279437|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Death|0|||
130279438|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
130279439|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
130279440|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
130279441|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
130279442|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
130279443|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
130279444|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
130279445|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
130279446|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
130279447|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
130279448|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
130279449|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
130279450|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
130279451|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
130279452|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279453|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279454|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279455|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130457722|NCT01616654|469639941|FG001|Overall Study|Withdrawal by Subject|2|||
130457723|NCT01616654|469639942|FG002|Overall Study|Withdrawal by Subject|3|||
130457724|NCT01616654|469639943|FG003|Overall Study|Withdrawal by Subject|1|||
130457725|NCT01616654|469639944|FG004|Overall Study|Withdrawal by Subject|5|||
130457726|NCT01616654|469639940|FG000|Overall Study|Protocol Violation|0|||
130457727|NCT01616654|469639941|FG001|Overall Study|Protocol Violation|5|||
130368542|NCT02339584|469319707|FG000|Overall Study|Protocol Violation|1|||
130368543|NCT02339584|469319708|FG001|Overall Study|Protocol Violation|1|||
130368544|NCT02339584|469319707|FG000|Overall Study|Withdrawal by Subject|2|||
130368545|NCT02339584|469319708|FG001|Overall Study|Withdrawal by Subject|4|||
130368546|NCT01980940|469319709|FG000|Overall Study|Protocol Violation|0|||
130368547|NCT01980940|469319710|FG001|Overall Study|Protocol Violation|0|||
130368548|NCT01980940|469319711|FG002|Overall Study|Protocol Violation|0|||
130368549|NCT01980940|469319712|FG003|Overall Study|Protocol Violation|0|||
130368550|NCT01980940|469319713|FG004|Overall Study|Protocol Violation|0|||
130368551|NCT01980940|469319714|FG005|Overall Study|Protocol Violation|2|||
130368552|NCT01980940|469319715|FG006|Overall Study|Protocol Violation|0|||
130368553|NCT01980940|469319716|FG007|Overall Study|Protocol Violation|0|||
130368554|NCT05996718|469321146|FG000|Overall Study|Lost to Follow-up|3|||
130368555|NCT01713686|469321147|FG000|Overall Study|Lost to Follow-up|9|||
130368556|NCT01713686|469321147|FG000|Overall Study|Withdrawal by Subject|6|||
130368557|NCT00709761|469321151|FG000|Overall Study|Withdrawal by Subject|8|||
130368558|NCT00709761|469321151|FG000|Overall Study|study closed/terminated|17|||
130368559|NCT00709761|469321151|FG000|Overall Study|Lost to Follow-up|2|||
130368560|NCT01918774|469321152|FG000|Overall Study|Lost prior to first CBTw session|4|||
130368561|NCT01918774|469321152|FG000|Overall Study|Lost to Follow-up|1|||
130368562|NCT01606800|469321153|FG000|Overall Study|Adverse Event|3|||
130368563|NCT01606800|469321154|FG001|Overall Study|Adverse Event|1|||
130368564|NCT01606800|469321153|FG000|Overall Study|Participant withdrew consent|0|||
130368565|NCT01606800|469321154|FG001|Overall Study|Participant withdrew consent|1|||
130368566|NCT01606800|469321153|FG000|Overall Study|Missing completion status|2|||
130368567|NCT01606800|469321154|FG001|Overall Study|Missing completion status|0|||
130368568|NCT01687998|469321155|FG000|Overall Study|Withdrawal by Subject|49|||
130368569|NCT01687998|469321156|FG001|Overall Study|Withdrawal by Subject|51|||
130368570|NCT01687998|469321155|FG000|Overall Study|Known to be Alive at Study End|54|||
130368571|NCT01687998|469321156|FG001|Overall Study|Known to be Alive at Study End|62|||
130368572|NCT01687998|469321155|FG000|Overall Study|Lost to Follow-up|9|||
130368573|NCT01687998|469321156|FG001|Overall Study|Lost to Follow-up|7|||
130368574|NCT00717197|469321163|FG000|Overall Study|Unable to purchase study drug|5|||
130368575|NCT00717197|469321163|FG000|Overall Study|Tumor Progression|1|||
130368576|NCT00717197|469321163|FG000|Overall Study|Physician Decision|1|||
130368577|NCT00982137|469321164|FG000|Overall Study|Lost to Follow-up|0|||
130368578|NCT00982137|469321165|FG001|Overall Study|Lost to Follow-up|0|||
130368579|NCT00982137|469321166|FG002|Overall Study|Lost to Follow-up|0|||
130368580|NCT00982137|469321167|FG003|Overall Study|Lost to Follow-up|1|||
130368581|NCT00982137|469321164|FG000|Overall Study|Withdrawal by Subject|0|||
130368582|NCT00982137|469321165|FG001|Overall Study|Withdrawal by Subject|1|||
130368583|NCT00982137|469321166|FG002|Overall Study|Withdrawal by Subject|0|||
130368584|NCT00982137|469321167|FG003|Overall Study|Withdrawal by Subject|0|||
130368585|NCT01648101|469321168|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
130368586|NCT01648101|469321169|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
130368587|NCT01648101|469321170|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
130368588|NCT01648101|469321168|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
130368589|NCT01648101|469321169|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
130368590|NCT01648101|469321170|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
130368591|NCT01648101|469321168|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
130368592|NCT01648101|469321169|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
130710759|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130710760|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130710761|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
130279456|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279457|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279458|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279459|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279460|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279461|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279462|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279463|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130368593|NCT01648101|469321170|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
130368594|NCT01648101|469321168|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
130368595|NCT01648101|469321169|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
130368596|NCT01648101|469321170|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
130368597|NCT01648101|469321168|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
130368598|NCT01648101|469321169|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
130368599|NCT01648101|469321170|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
130368600|NCT01648101|469321168|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
130368601|NCT01648101|469321169|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
130710762|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
130368602|NCT01648101|469321170|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
130457728|NCT01616654|469639942|FG002|Overall Study|Protocol Violation|2|||
130279464|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
130279465|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
130279466|NCT01691014|468986666|FG000|Overall Study|Premature Termination|1|||
130279467|NCT01691014|468986667|FG001|Overall Study|Premature Termination|6|||
130279468|NCT01691014|468986668|FG002|Overall Study|Premature Termination|0|||
130279469|NCT01691014|468986669|FG003|Overall Study|Premature Termination|3|||
130279470|NCT01691014|468986666|FG000|Overall Study|Other|0|||
130279471|NCT01691014|468986667|FG001|Overall Study|Other|0|||
130279472|NCT01691014|468986668|FG002|Overall Study|Other|2|||
130279473|NCT01691014|468986669|FG003|Overall Study|Other|0|||
130279474|NCT01691014|468986666|FG000|Overall Study|Withdrawal by Subject|0|||
130279475|NCT01691014|468986667|FG001|Overall Study|Withdrawal by Subject|1|||
130279476|NCT01691014|468986668|FG002|Overall Study|Withdrawal by Subject|1|||
130279477|NCT01691014|468986669|FG003|Overall Study|Withdrawal by Subject|1|||
130279478|NCT01691014|468986666|FG000|Overall Study|Adverse Event|0|||
130279479|NCT01691014|468986667|FG001|Overall Study|Adverse Event|5|||
130279480|NCT01691014|468986668|FG002|Overall Study|Adverse Event|1|||
130279481|NCT01691014|468986669|FG003|Overall Study|Adverse Event|1|||
130279482|NCT01691014|468986666|FG000|Overall Study|Lack of Efficacy|2|||
130279483|NCT01691014|468986667|FG001|Overall Study|Lack of Efficacy|3|||
130279484|NCT01691014|468986668|FG002|Overall Study|Lack of Efficacy|7|||
130279485|NCT01691014|468986669|FG003|Overall Study|Lack of Efficacy|0|||
130279486|NCT02370537|468986670|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130279487|NCT02370537|468986671|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
130279488|NCT02370537|468986672|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130279489|NCT02370537|468986670|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
130279490|NCT02370537|468986671|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
130279491|NCT02370537|468986672|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
130279492|NCT02370537|468986670|FG000|Part B|Not randomised to receive treatment|1|||
130279493|NCT02370537|468986671|FG001|Part B|Not randomised to receive treatment|2|||
130279494|NCT02370537|468986672|FG002|Part B|Not randomised to receive treatment|259|||
130279495|NCT02370537|468986670|FG000|Part B|Withdrawal by Subject|0|||
130279496|NCT02370537|468986671|FG001|Part B|Withdrawal by Subject|1|||
130279497|NCT02370537|468986672|FG002|Part B|Withdrawal by Subject|0|||
130279498|NCT05897242|468986673|FG000|Overall Study|Lost to Follow-up|6|||
130279499|NCT05897242|468986674|FG001|Overall Study|Lost to Follow-up|1|||
130279500|NCT05897242|468986673|FG000|Overall Study|Incomplete|1|||
130279501|NCT05897242|468986674|FG001|Overall Study|Incomplete|0|||
130279502|NCT05897242|468986673|FG000|Overall Study|Withdrawal by Subject|1|||
130279503|NCT05897242|468986674|FG001|Overall Study|Withdrawal by Subject|0|||
130279504|NCT04439539|468986678|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
130279505|NCT04439539|468986679|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
130279506|NCT04439539|468986680|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
130279507|NCT04439539|468986678|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130279508|NCT04439539|468986679|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
130279509|NCT04439539|468986680|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130279510|NCT04439539|468986678|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130279511|NCT04439539|468986679|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
130279512|NCT04439539|468986680|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130279513|NCT02920528|468986681|FG000|Overall Study|Incomplete Data|1|||
130279514|NCT02920528|468986682|FG001|Overall Study|Incomplete Data|1|||
130279515|NCT02920528|468986683|FG002|Overall Study|Incomplete Data|1|||
130279516|NCT02920528|468986681|FG000|Overall Study|Adverse Event|0|||
130279517|NCT02920528|468986682|FG001|Overall Study|Adverse Event|0|||
130279518|NCT02920528|468986683|FG002|Overall Study|Adverse Event|3|||
130279519|NCT02920528|468986681|FG000|Overall Study|Did not meet inclusion criteria|2|||
130279520|NCT02920528|468986682|FG001|Overall Study|Did not meet inclusion criteria|0|||
130279521|NCT02920528|468986683|FG002|Overall Study|Did not meet inclusion criteria|1|||
130279522|NCT02547038|468986684|FG000|Overall Study|Lost to Follow-up|3|||
130279523|NCT02547038|468986685|FG001|Overall Study|Lost to Follow-up|2|||
130279524|NCT01340625|468986686|FG000|First Intervention|Adverse Event|1|||
130279525|NCT01340625|468986687|FG001|First Intervention|Adverse Event|0|||
130710763|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
130279526|NCT01340625|468986686|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
130279527|NCT01340625|468986687|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
130279528|NCT00066703|468986688|FG000|Overall Study|Adverse Event|80|||
130279529|NCT00066703|468986689|FG001|Overall Study|Adverse Event|111|||
130279530|NCT00066703|468986688|FG000|Overall Study|Death|3|||
130279531|NCT00066703|468986689|FG001|Overall Study|Death|0|||
130279532|NCT00066703|468986688|FG000|Overall Study|Lack of Efficacy|114|||
130279533|NCT00066703|468986689|FG001|Overall Study|Lack of Efficacy|69|||
130279534|NCT00066703|468986688|FG000|Overall Study|Lost to Follow-up|31|||
130279535|NCT00066703|468986689|FG001|Overall Study|Lost to Follow-up|28|||
130279536|NCT00066703|468986688|FG000|Overall Study|Withdrawal by Subject|38|||
130279537|NCT00066703|468986689|FG001|Overall Study|Withdrawal by Subject|63|||
130279538|NCT00066703|468986688|FG000|Overall Study|Treatment ongoing|346|||
130279539|NCT00066703|468986689|FG001|Overall Study|Treatment ongoing|311|||
130279540|NCT01696968|468986690|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
130279541|NCT01696968|468986691|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
130279542|NCT01696968|468986690|FG000|Overall Study|Died Before Randomization|3|||
130279543|NCT01696968|468986691|FG001|Overall Study|Died Before Randomization|8|||
130279544|NCT01696968|468986690|FG000|Overall Study|Died Before ASU (Control)|278|||
130279545|NCT01696968|468986691|FG001|Overall Study|Died Before ASU (Control)|0|||
130279546|NCT01696968|468986690|FG000|Overall Study|Refused ASU (Control)|920|||
130279547|NCT01696968|468986691|FG001|Overall Study|Refused ASU (Control)|0|||
130279548|NCT01696968|468986690|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
130279549|NCT01696968|468986691|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
130279550|NCT01519791|468986704|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
130279551|NCT01519791|468986705|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
130279552|NCT01519791|468986704|FG000|Overall Study|Protocol Violation|6|||
130279553|NCT01519791|468986705|FG001|Overall Study|Protocol Violation|19|||
130279554|NCT01519791|468986704|FG000|Overall Study|Other Reason|87|||
130279555|NCT01519791|468986705|FG001|Overall Study|Other Reason|222|||
130279556|NCT01519791|468986704|FG000|Overall Study|subjects randomized in error|2|||
130279557|NCT01519791|468986705|FG001|Overall Study|subjects randomized in error|0|||
130279558|NCT01519791|468986704|FG000|Overall Study|Lack of Efficacy|16|||
130279559|NCT01519791|468986705|FG001|Overall Study|Lack of Efficacy|20|||
130279560|NCT01519791|468986704|FG000|Overall Study|SAE, non-fatal|6|||
130279561|NCT01519791|468986705|FG001|Overall Study|SAE, non-fatal|22|||
130279562|NCT01519791|468986704|FG000|Overall Study|AE, serious fatal|0|||
130279563|NCT01519791|468986705|FG001|Overall Study|AE, serious fatal|1|||
130279564|NCT01519791|468986704|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130279565|NCT01519791|468986705|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130279566|NCT01519791|468986704|FG000|Overall Study|AE, non-serious non-fatal|12|||
130279567|NCT01519791|468986705|FG001|Overall Study|AE, non-serious non-fatal|31|||
130279568|NCT01519791|468986704|FG000|Overall Study|Withdrawal by Subject|15|||
130279569|NCT01519791|468986705|FG001|Overall Study|Withdrawal by Subject|37|||
130279570|NCT01519791|468986704|FG000|Overall Study|Lost to Follow-up|6|||
130279571|NCT01519791|468986705|FG001|Overall Study|Lost to Follow-up|14|||
130279572|NCT01289353|468986723|FG000|Overall Study|Lost to Follow-up|2|||
130279573|NCT01549886|468986724|FG000|Overall Study|Sponsor's decision|2|||
130279574|NCT01549886|468986725|FG001|Overall Study|Sponsor's decision|3|||
130279575|NCT06004895|468986726|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
130279576|NCT06004895|468986726|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
130279577|NCT00967694|468986727|FG000|Overall Study|Withdrawal by Subject|6|||
130279578|NCT02957747|468986728|FG000|Overall Study|Withdrawal by Subject|0|||
130279579|NCT02957747|468986729|FG001|Overall Study|Withdrawal by Subject|3|||
130279580|NCT02957747|468986728|FG000|Overall Study|Lost to Follow-up|10|||
130279581|NCT02957747|468986729|FG001|Overall Study|Lost to Follow-up|5|||
130279582|NCT00632827|468986730|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
130279583|NCT00632827|468986730|FG000|Overall Study|Death|2|||
130279584|NCT00632827|468986730|FG000|Overall Study|Adverse Event|5|||
130279585|NCT00632827|468986730|FG000|Overall Study|Lost to Follow-up|1|||
130279586|NCT03425006|468986733|FG000|Overall Study|Withdrawal by Subject|1|||
130279587|NCT03425006|468986733|FG000|Overall Study|Physician Decision|1|||
130279588|NCT03425006|468986733|FG000|Overall Study|Death|1|||
130279589|NCT00888329|468986737|FG000|Overall Study|Physician Decision|6|||
130279590|NCT00888329|468986738|FG001|Overall Study|Physician Decision|9|||
130279591|NCT03931382|468986739|FG000|Overall Study|Equipment malfunction|2|||
130279592|NCT03931382|468986740|FG001|Overall Study|Equipment malfunction|0|||
130279593|NCT03931382|468986741|FG002|Overall Study|Equipment malfunction|2|||
130279594|NCT03931382|468986739|FG000|Overall Study|Withdrawal by Subject|0|||
130279595|NCT03931382|468986740|FG001|Overall Study|Withdrawal by Subject|1|||
130279596|NCT03931382|468986741|FG002|Overall Study|Withdrawal by Subject|0|||
130279597|NCT00778375|468986747|FG000|Overall Study|Ineligible|3|||
130279598|NCT00939029|468986748|FG000|Overall Study|Withdrawal by Subject|3|||
130279599|NCT00939029|468986749|FG001|Overall Study|Withdrawal by Subject|7|||
130279600|NCT00939029|468986748|FG000|Overall Study|Lost to Follow-up|3|||
130279601|NCT00939029|468986749|FG001|Overall Study|Lost to Follow-up|4|||
130279602|NCT00939029|468986748|FG000|Overall Study|Adverse Event|0|||
130279603|NCT00939029|468986749|FG001|Overall Study|Adverse Event|1|||
130279604|NCT01421303|468986750|FG000|Overall Study|Lost to Follow-up|13|||
130279605|NCT01421303|468986750|FG000|Overall Study|Non compliance with study procedure|1|||
130279606|NCT01421303|468986750|FG000|Overall Study|Other|7|||
130279607|NCT01421303|468986750|FG000|Overall Study|Withdrawal by Subject|1|||
130279608|NCT06003777|468986752|FG000|Period 1|Adverse Event|0|||
130368603|NCT01648101|469321168|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
130368604|NCT01648101|469321169|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
130279609|NCT06003777|468986753|FG001|Period 1|Adverse Event|0|||
130279610|NCT06003777|468986754|FG002|Period 1|Adverse Event|1|||
130279611|NCT06003777|468986755|FG003|Period 1|Adverse Event|0|||
130279612|NCT06003777|468986756|FG004|Period 1|Adverse Event|0|||
130279613|NCT06003777|468986757|FG005|Period 1|Adverse Event|0|||
130279614|NCT06003777|468986758|FG006|Period 1|Adverse Event|0|||
130279615|NCT06003777|468986759|FG007|Period 1|Adverse Event|0|||
130279616|NCT06003777|468986760|FG008|Period 1|Adverse Event|0|||
130279617|NCT06003777|468986761|FG009|Period 1|Adverse Event|0|||
130279618|NCT06003777|468986762|FG010|Period 1|Adverse Event|0|||
130279619|NCT06003777|468986763|FG011|Period 1|Adverse Event|0|||
130279620|NCT06003777|468986752|FG000|Period 1|Withdrawal by Subject|0|||
130279621|NCT06003777|468986753|FG001|Period 1|Withdrawal by Subject|0|||
130279622|NCT06003777|468986754|FG002|Period 1|Withdrawal by Subject|0|||
130279623|NCT06003777|468986755|FG003|Period 1|Withdrawal by Subject|0|||
130279624|NCT06003777|468986756|FG004|Period 1|Withdrawal by Subject|1|||
130279625|NCT06003777|468986757|FG005|Period 1|Withdrawal by Subject|0|||
130279626|NCT06003777|468986758|FG006|Period 1|Withdrawal by Subject|0|||
130279627|NCT06003777|468986759|FG007|Period 1|Withdrawal by Subject|0|||
130279628|NCT06003777|468986760|FG008|Period 1|Withdrawal by Subject|0|||
130279629|NCT06003777|468986761|FG009|Period 1|Withdrawal by Subject|0|||
130279630|NCT06003777|468986762|FG010|Period 1|Withdrawal by Subject|0|||
130279631|NCT06003777|468986763|FG011|Period 1|Withdrawal by Subject|0|||
130279632|NCT06003777|468986752|FG000|Period 2|Withdrawal by Subject|0|||
130279633|NCT06003777|468986753|FG001|Period 2|Withdrawal by Subject|0|||
130279634|NCT06003777|468986754|FG002|Period 2|Withdrawal by Subject|0|||
130279635|NCT06003777|468986755|FG003|Period 2|Withdrawal by Subject|0|||
130279636|NCT06003777|468986756|FG004|Period 2|Withdrawal by Subject|0|||
130279637|NCT06003777|468986757|FG005|Period 2|Withdrawal by Subject|0|||
130279638|NCT06003777|468986758|FG006|Period 2|Withdrawal by Subject|0|||
130279639|NCT06003777|468986759|FG007|Period 2|Withdrawal by Subject|0|||
130279640|NCT06003777|468986760|FG008|Period 2|Withdrawal by Subject|1|||
130279641|NCT06003777|468986761|FG009|Period 2|Withdrawal by Subject|0|||
130279642|NCT06003777|468986762|FG010|Period 2|Withdrawal by Subject|0|||
130279643|NCT06003777|468986763|FG011|Period 2|Withdrawal by Subject|0|||
130279644|NCT06003777|468986752|FG000|Period 3|Adverse Event|0|||
130279645|NCT06003777|468986753|FG001|Period 3|Adverse Event|0|||
130279646|NCT06003777|468986754|FG002|Period 3|Adverse Event|0|||
130279647|NCT06003777|468986755|FG003|Period 3|Adverse Event|0|||
130279648|NCT06003777|468986756|FG004|Period 3|Adverse Event|0|||
130279649|NCT06003777|468986757|FG005|Period 3|Adverse Event|0|||
130279650|NCT06003777|468986758|FG006|Period 3|Adverse Event|1|||
130279651|NCT06003777|468986759|FG007|Period 3|Adverse Event|0|||
130279652|NCT06003777|468986760|FG008|Period 3|Adverse Event|0|||
130279653|NCT06003777|468986761|FG009|Period 3|Adverse Event|0|||
130279654|NCT06003777|468986762|FG010|Period 3|Adverse Event|0|||
130279655|NCT06003777|468986763|FG011|Period 3|Adverse Event|0|||
130279656|NCT06003777|468986752|FG000|Period 4|No longer met eligibility criteria|0|||
130279657|NCT06003777|468986753|FG001|Period 4|No longer met eligibility criteria|0|||
130279658|NCT06003777|468986754|FG002|Period 4|No longer met eligibility criteria|1|||
130279659|NCT06003777|468986755|FG003|Period 4|No longer met eligibility criteria|0|||
130279660|NCT06003777|468986756|FG004|Period 4|No longer met eligibility criteria|0|||
130279661|NCT06003777|468986757|FG005|Period 4|No longer met eligibility criteria|0|||
130279662|NCT06003777|468986758|FG006|Period 4|No longer met eligibility criteria|0|||
130279663|NCT06003777|468986759|FG007|Period 4|No longer met eligibility criteria|0|||
130279664|NCT06003777|468986760|FG008|Period 4|No longer met eligibility criteria|0|||
130279665|NCT06003777|468986761|FG009|Period 4|No longer met eligibility criteria|0|||
130279666|NCT06003777|468986762|FG010|Period 4|No longer met eligibility criteria|0|||
130279667|NCT06003777|468986763|FG011|Period 4|No longer met eligibility criteria|0|||
130279668|NCT06003777|468986752|FG000|Period 4|Withdrawal by Subject|0|||
130279669|NCT06003777|468986753|FG001|Period 4|Withdrawal by Subject|1|||
130279670|NCT06003777|468986754|FG002|Period 4|Withdrawal by Subject|0|||
130279671|NCT06003777|468986755|FG003|Period 4|Withdrawal by Subject|0|||
130279672|NCT06003777|468986756|FG004|Period 4|Withdrawal by Subject|0|||
130457729|NCT01616654|469639943|FG003|Overall Study|Protocol Violation|4|||
130279673|NCT06003777|468986757|FG005|Period 4|Withdrawal by Subject|0|||
130279674|NCT06003777|468986758|FG006|Period 4|Withdrawal by Subject|0|||
130279675|NCT06003777|468986759|FG007|Period 4|Withdrawal by Subject|0|||
130279676|NCT06003777|468986760|FG008|Period 4|Withdrawal by Subject|0|||
130279677|NCT06003777|468986761|FG009|Period 4|Withdrawal by Subject|0|||
130279678|NCT06003777|468986762|FG010|Period 4|Withdrawal by Subject|0|||
130279679|NCT06003777|468986763|FG011|Period 4|Withdrawal by Subject|0|||
130279680|NCT04154605|468986766|FG000|Overall Study|Procedure Canceled|1|||
130279681|NCT04154605|468986767|FG001|Overall Study|Procedure Canceled|1|||
130279682|NCT04154605|468986766|FG000|Overall Study|Missed follow up|1|||
130279683|NCT04154605|468986767|FG001|Overall Study|Missed follow up|1|||
130279684|NCT04154605|468986766|FG000|Overall Study|Withdrawal by Subject|1|||
130279685|NCT04154605|468986767|FG001|Overall Study|Withdrawal by Subject|0|||
130279686|NCT00675441|468986768|FG000|Overall Study|Withdrawal by Subject|2|||
130279687|NCT00675441|468986768|FG000|Overall Study|Death|1|||
130279688|NCT00344318|468986772|FG000|Overall Study|Adverse Event|0|||
130279689|NCT00344318|468986773|FG001|Overall Study|Adverse Event|3|||
130279690|NCT00344318|468986774|FG002|Overall Study|Adverse Event|0|||
130279691|NCT00344318|468986775|FG003|Overall Study|Adverse Event|1|||
130368605|NCT01648101|469321170|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
130368606|NCT01648101|469321168|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
130368607|NCT01648101|469321169|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
130368608|NCT01648101|469321170|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
130368609|NCT01648101|469321168|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
130368610|NCT01648101|469321169|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
130368611|NCT01648101|469321170|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
130368612|NCT01648101|469321168|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
130368613|NCT01648101|469321169|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
130368614|NCT01648101|469321170|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
130368615|NCT01648101|469321168|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
130368616|NCT01648101|469321169|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
130368617|NCT01648101|469321170|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
130368618|NCT03003390|469321171|FG000|Overall Study|Physician Decision|2|||
130368619|NCT03003390|469321172|FG001|Overall Study|Physician Decision|0|||
130368620|NCT03003390|469321171|FG000|Overall Study|Parent refused intervention|2|||
130368621|NCT03003390|469321172|FG001|Overall Study|Parent refused intervention|0|||
130368622|NCT03311724|469321173|FG000|Overall Study|Physician Decision|0|||
130368623|NCT03311724|469321174|FG001|Overall Study|Physician Decision|0|||
130368624|NCT03311724|469321175|FG002|Overall Study|Physician Decision|0|||
130368625|NCT03311724|469321176|FG003|Overall Study|Physician Decision|1|||
130368626|NCT03311724|469321173|FG000|Overall Study|Protocol Violation|1|||
130368627|NCT03311724|469321174|FG001|Overall Study|Protocol Violation|0|||
130368628|NCT03311724|469321175|FG002|Overall Study|Protocol Violation|1|||
130368629|NCT03311724|469321176|FG003|Overall Study|Protocol Violation|0|||
130368630|NCT03311724|469321173|FG000|Overall Study|Withdrawal by Subject|1|||
130368631|NCT03311724|469321174|FG001|Overall Study|Withdrawal by Subject|1|||
130368632|NCT03311724|469321175|FG002|Overall Study|Withdrawal by Subject|0|||
130368633|NCT03311724|469321176|FG003|Overall Study|Withdrawal by Subject|0|||
130368634|NCT03311724|469321173|FG000|Overall Study|Lost to Follow-up|1|||
130368635|NCT03311724|469321174|FG001|Overall Study|Lost to Follow-up|0|||
130368636|NCT03311724|469321175|FG002|Overall Study|Lost to Follow-up|0|||
130368637|NCT03311724|469321176|FG003|Overall Study|Lost to Follow-up|0|||
130279692|NCT00344318|468986772|FG000|Overall Study|Withdrawal by Subject|2|||
130279693|NCT00344318|468986773|FG001|Overall Study|Withdrawal by Subject|2|||
130279694|NCT00344318|468986774|FG002|Overall Study|Withdrawal by Subject|0|||
130279695|NCT00344318|468986775|FG003|Overall Study|Withdrawal by Subject|2|||
130279696|NCT00344318|468986772|FG000|Overall Study|Lost to Follow-up|2|||
130279697|NCT00344318|468986773|FG001|Overall Study|Lost to Follow-up|0|||
130279698|NCT00344318|468986774|FG002|Overall Study|Lost to Follow-up|1|||
130279699|NCT00344318|468986775|FG003|Overall Study|Lost to Follow-up|0|||
130279700|NCT01923363|468986776|FG000|Overall Study|Protocol Violation|1|||
130279701|NCT00656058|468986780|FG000|Overall Study|Withdrawal by Subject|2|||
130279702|NCT00656058|468986780|FG000|Overall Study|Withdrawal by Subject|4|||
130279703|NCT06359028|468986781|FG000|Overall Study|Adverse Event|1|||
130279704|NCT06359028|468986782|FG001|Overall Study|Adverse Event|0|||
130279705|NCT06359028|468986781|FG000|Overall Study|Withdrawal by Subject|1|||
130368638|NCT03311724|469321173|FG000|Overall Study|Sponsor Decision|0|||
130368639|NCT03311724|469321174|FG001|Overall Study|Sponsor Decision|0|||
130368640|NCT03311724|469321175|FG002|Overall Study|Sponsor Decision|1|||
130368641|NCT03311724|469321176|FG003|Overall Study|Sponsor Decision|0|||
130368642|NCT01389817|469321178|FG000|Overall Study|Physician Decision|1|||
130368643|NCT01389817|469321179|FG001|Overall Study|Physician Decision|0|||
130368644|NCT01389817|469321178|FG000|Overall Study|Lost to Follow-up|1|||
130368645|NCT01389817|469321179|FG001|Overall Study|Lost to Follow-up|0|||
130368646|NCT01389817|469321178|FG000|Overall Study|Withdrawal by Subject|2|||
130368647|NCT01389817|469321179|FG001|Overall Study|Withdrawal by Subject|0|||
130368648|NCT01749137|469321180|FG000|Overall Study|Adverse Event|4|||
130368649|NCT01749137|469321181|FG001|Overall Study|Adverse Event|4|||
130368650|NCT01749137|469321180|FG000|Overall Study|Lost to Follow-up|2|||
130368651|NCT01749137|469321181|FG001|Overall Study|Lost to Follow-up|3|||
130368652|NCT01749137|469321180|FG000|Overall Study|Physician Decision|1|||
130368653|NCT01749137|469321181|FG001|Overall Study|Physician Decision|0|||
130368654|NCT01749137|469321180|FG000|Overall Study|Withdrawal by Subject|8|||
130368655|NCT01749137|469321181|FG001|Overall Study|Withdrawal by Subject|4|||
130368656|NCT00621985|469321189|FG000|Dexamethasone Admission|Adverse Event|1|||
130368657|NCT02587234|469321190|FG000|Overall Study|Withdrawal by Subject|1|||
130368658|NCT02587234|469321191|FG001|Overall Study|Withdrawal by Subject|1|||
130279706|NCT06359028|468986782|FG001|Overall Study|Withdrawal by Subject|0|||
130279707|NCT03515551|468986783|FG000|Overall Study|Death|4|||
130279708|NCT03515551|468986784|FG001|Overall Study|Death|1|||
130279709|NCT03515551|468986785|FG002|Overall Study|Death|2|||
130368659|NCT02587234|469321190|FG000|Overall Study|Lost to Follow-up|0|||
130279710|NCT03515551|468986786|FG003|Overall Study|Death|2|||
130279711|NCT03515551|468986787|FG004|Overall Study|Death|2|||
130368660|NCT02587234|469321191|FG001|Overall Study|Lost to Follow-up|2|||
130368661|NCT01877265|469321192|FG000|Treatment Period 1|Sponsor Decision|0|||
130279712|NCT03515551|468986788|FG005|Overall Study|Death|4|||
130279713|NCT03515551|468986789|FG006|Overall Study|Death|1|||
130279714|NCT03515551|468986783|FG000|Overall Study|Lost to Follow-up|0|||
130279715|NCT03515551|468986784|FG001|Overall Study|Lost to Follow-up|0|||
130279716|NCT03515551|468986785|FG002|Overall Study|Lost to Follow-up|1|||
130279717|NCT03515551|468986786|FG003|Overall Study|Lost to Follow-up|0|||
130279718|NCT03515551|468986787|FG004|Overall Study|Lost to Follow-up|0|||
130279719|NCT03515551|468986788|FG005|Overall Study|Lost to Follow-up|0|||
130279720|NCT03515551|468986789|FG006|Overall Study|Lost to Follow-up|0|||
130279721|NCT03515551|468986783|FG000|Overall Study|Withdrawal by Subject|0|||
130279722|NCT03515551|468986784|FG001|Overall Study|Withdrawal by Subject|1|||
130279723|NCT03515551|468986785|FG002|Overall Study|Withdrawal by Subject|0|||
130279724|NCT03515551|468986786|FG003|Overall Study|Withdrawal by Subject|0|||
130279725|NCT03515551|468986787|FG004|Overall Study|Withdrawal by Subject|0|||
130279726|NCT03515551|468986788|FG005|Overall Study|Withdrawal by Subject|0|||
130279727|NCT03515551|468986789|FG006|Overall Study|Withdrawal by Subject|1|||
130279728|NCT03515551|468986783|FG000|Overall Study|Study ended by sponsor|0|||
130279729|NCT03515551|468986784|FG001|Overall Study|Study ended by sponsor|0|||
130279730|NCT03515551|468986785|FG002|Overall Study|Study ended by sponsor|2|||
130279731|NCT03515551|468986786|FG003|Overall Study|Study ended by sponsor|1|||
130279732|NCT03515551|468986787|FG004|Overall Study|Study ended by sponsor|3|||
130279733|NCT03515551|468986788|FG005|Overall Study|Study ended by sponsor|0|||
130279734|NCT03515551|468986789|FG006|Overall Study|Study ended by sponsor|3|||
130279735|NCT03515551|468986783|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279736|NCT03515551|468986784|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
130279737|NCT03515551|468986785|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279738|NCT03515551|468986786|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279739|NCT03515551|468986787|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279740|NCT03515551|468986788|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279741|NCT03515551|468986789|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279742|NCT00920387|468986790|FG000|Stage 1|Adverse Event|1|||
130279743|NCT00920387|468986791|FG001|Stage 1|Adverse Event|0|||
130279744|NCT00920387|468986792|FG002|Stage 1|Adverse Event|0|||
130279745|NCT02265536|468986793|FG000|Overall Study|Adverse Event|1|||
130279746|NCT02265536|468986794|FG001|Overall Study|Adverse Event|0|||
130279747|NCT02265536|468986795|FG002|Overall Study|Adverse Event|0|||
130279748|NCT02265536|468986796|FG003|Overall Study|Adverse Event|0|||
130279749|NCT02265536|468986797|FG004|Overall Study|Adverse Event|1|||
130279750|NCT02265536|468986798|FG005|Overall Study|Adverse Event|0|||
130279751|NCT02265536|468986793|FG000|Overall Study|Physician Decision|0|||
130279752|NCT02265536|468986794|FG001|Overall Study|Physician Decision|0|||
130279753|NCT02265536|468986795|FG002|Overall Study|Physician Decision|0|||
130279754|NCT02265536|468986796|FG003|Overall Study|Physician Decision|0|||
130279755|NCT02265536|468986797|FG004|Overall Study|Physician Decision|2|||
130279756|NCT02265536|468986798|FG005|Overall Study|Physician Decision|0|||
130279757|NCT02265536|468986793|FG000|Overall Study|Withdrawal by Subject|0|||
130279758|NCT02265536|468986794|FG001|Overall Study|Withdrawal by Subject|3|||
130279759|NCT02265536|468986795|FG002|Overall Study|Withdrawal by Subject|0|||
130279760|NCT02265536|468986796|FG003|Overall Study|Withdrawal by Subject|0|||
130279761|NCT02265536|468986797|FG004|Overall Study|Withdrawal by Subject|0|||
130279762|NCT02265536|468986798|FG005|Overall Study|Withdrawal by Subject|0|||
130279763|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
130279764|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
130279765|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
130279766|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
130279767|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
130279768|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
130279769|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
130279770|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
130279771|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130279772|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130279773|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130279774|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130279775|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130279776|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130279777|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130279778|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130279779|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279780|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279781|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279782|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
130279783|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
130279784|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279785|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279786|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279787|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
130279788|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130279789|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130279790|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
130279791|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
130279792|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130279793|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130279794|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
130279795|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
130279796|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
130279797|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
130279798|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
130279799|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
130279800|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130279801|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130279802|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
130279803|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
130279804|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130279805|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130279806|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
130279807|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Death|1|||
130279808|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Death|1|||
130279809|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Death|3|||
130279810|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Death|2|||
130279811|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
130279812|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
130279813|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
130279814|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
130279815|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
130279816|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
130279817|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
130279818|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
130279819|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279820|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279821|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
130279822|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279823|NCT05596734|468986803|FG000|Substudy A|Withdrawal by Subject|1|||
130279824|NCT05596734|468986804|FG001|Substudy A|Withdrawal by Subject|0|||
130279825|NCT05596734|468986805|FG002|Substudy A|Withdrawal by Subject|0|||
130279826|NCT05596734|468986806|FG003|Substudy A|Withdrawal by Subject|0|||
130279827|NCT05596734|468986807|FG004|Substudy A|Withdrawal by Subject|0|||
130279828|NCT05596734|468986808|FG005|Substudy A|Withdrawal by Subject|0|||
130279829|NCT05596734|468986809|FG006|Substudy A|Withdrawal by Subject|1|||
130279830|NCT05596734|468986810|FG007|Substudy A|Withdrawal by Subject|0|||
130279831|NCT05596734|468986811|FG008|Substudy A|Withdrawal by Subject|0|||
130279832|NCT05596734|468986812|FG009|Substudy A|Withdrawal by Subject|0|||
130279833|NCT05596734|468986813|FG010|Substudy A|Withdrawal by Subject|0|||
130279834|NCT05596734|468986814|FG011|Substudy A|Withdrawal by Subject|0|||
130279835|NCT05596734|468986815|FG012|Substudy A|Withdrawal by Subject|0|||
130279836|NCT05596734|468986816|FG013|Substudy A|Withdrawal by Subject|0|||
130279837|NCT05596734|468986817|FG014|Substudy A|Withdrawal by Subject|0|||
130279838|NCT05596734|468986818|FG015|Substudy A|Withdrawal by Subject|0|||
130279839|NCT05596734|468986819|FG016|Substudy A|Withdrawal by Subject|0|||
130279840|NCT05596734|468986820|FG017|Substudy A|Withdrawal by Subject|0|||
130279841|NCT05596734|468986821|FG018|Substudy A|Withdrawal by Subject|0|||
130279842|NCT05596734|468986822|FG019|Substudy A|Withdrawal by Subject|0|||
130279843|NCT05596734|468986823|FG020|Substudy A|Withdrawal by Subject|0|||
130279844|NCT05596734|468986824|FG021|Substudy A|Withdrawal by Subject|0|||
130279845|NCT05596734|468986825|FG022|Substudy A|Withdrawal by Subject|0|||
130279846|NCT05596734|468986826|FG023|Substudy A|Withdrawal by Subject|0|||
130279847|NCT05596734|468986803|FG000|Substudy A|Lost to Follow-up|1|||
130279848|NCT05596734|468986804|FG001|Substudy A|Lost to Follow-up|0|||
130279849|NCT05596734|468986805|FG002|Substudy A|Lost to Follow-up|1|||
130457730|NCT01616654|469639944|FG004|Overall Study|Protocol Violation|4|||
130457731|NCT01616654|469639940|FG000|Overall Study|Lost to Follow-up|1|||
130279850|NCT05596734|468986806|FG003|Substudy A|Lost to Follow-up|0|||
130279851|NCT05596734|468986807|FG004|Substudy A|Lost to Follow-up|0|||
130710764|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
130368662|NCT01877265|469321193|FG001|Treatment Period 1|Sponsor Decision|0|||
130368663|NCT01877265|469321194|FG002|Treatment Period 1|Sponsor Decision|1|||
130368664|NCT01877265|469321195|FG003|Treatment Period 1|Sponsor Decision|0|||
130368665|NCT01877265|469321196|FG004|Treatment Period 1|Sponsor Decision|0|||
130368666|NCT01877265|469321197|FG005|Treatment Period 1|Sponsor Decision|0|||
130368667|NCT01877265|469321192|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130368668|NCT01877265|469321193|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130368669|NCT01877265|469321194|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130368670|NCT01877265|469321195|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130368671|NCT01877265|469321196|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130368672|NCT01877265|469321197|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
130368673|NCT01877265|469321192|FG000|Treatment Period 3|Lost to Follow-up|1|||
130368674|NCT01877265|469321193|FG001|Treatment Period 3|Lost to Follow-up|0|||
130368675|NCT01877265|469321194|FG002|Treatment Period 3|Lost to Follow-up|0|||
130368676|NCT01877265|469321195|FG003|Treatment Period 3|Lost to Follow-up|0|||
130368677|NCT01877265|469321196|FG004|Treatment Period 3|Lost to Follow-up|0|||
130368678|NCT01877265|469321197|FG005|Treatment Period 3|Lost to Follow-up|0|||
130368679|NCT03068130|469321200|FG000|Overall Study|Adverse Event|19|||
130368680|NCT03068130|469321200|FG000|Overall Study|Death|14|||
130368681|NCT03068130|469321200|FG000|Overall Study|Lost to Follow-up|4|||
130368682|NCT03068130|469321200|FG000|Overall Study|Withdrawal by Subject|26|||
130368683|NCT03068130|469321200|FG000|Overall Study|Administrative Reasons|3|||
130368684|NCT03068130|469321200|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
130368685|NCT03068130|469321200|FG000|Overall Study|Study terminated by sponsor|194|||
130368686|NCT03535844|469321205|FG000|Overall Study|Withdrawal by Subject|0|||
130368687|NCT03535844|469321206|FG001|Overall Study|Withdrawal by Subject|1|||
130368688|NCT03130257|469321207|FG000|Overall Study|Withdrawal by Subject|1|||
130368689|NCT03130257|469321208|FG001|Overall Study|Withdrawal by Subject|0|||
130368690|NCT03130257|469321209|FG002|Overall Study|Withdrawal by Subject|2|||
130368691|NCT00160693|469321210|FG000|Overall Study|Adverse Event|97|||
130368692|NCT00160693|469321210|FG000|Overall Study|Lack of Efficacy|30|||
130368693|NCT00160693|469321210|FG000|Overall Study|Protocol Violation|24|||
130368694|NCT00160693|469321210|FG000|Overall Study|Lost to Follow-up|15|||
130368695|NCT00160693|469321210|FG000|Overall Study|Withdrawal by Subject|54|||
130368696|NCT00160693|469321210|FG000|Overall Study|Study terminated by sponsor|15|||
130368697|NCT03039283|469321213|FG000|Overall Study|Protocol Violation|2|||
130368698|NCT05386680|469321214|FG000|Overall Study|Guardian decision|2|||
130368699|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
130368700|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
130368701|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
130368702|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
130368703|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368704|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368705|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368706|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368707|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368708|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368709|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130368710|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
130368711|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
130368712|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
130368713|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
130368714|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368715|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368716|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368717|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368718|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368719|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368720|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130368721|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
130368722|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
130368723|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
130368724|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
130368725|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368726|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368727|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368728|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368729|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368730|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368731|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130368732|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368733|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368734|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368735|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
130368736|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368737|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368738|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368739|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368740|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368741|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368742|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130368743|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
130368744|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
130368745|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
130368746|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
130368747|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368748|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368749|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368750|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368751|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368752|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368753|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130368754|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
130368755|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
130368756|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
130368757|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
130368758|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368759|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368760|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368761|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368762|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368763|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368764|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130368765|NCT01847274|469321215|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
130368766|NCT01847274|469321216|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
130368767|NCT01847274|469321217|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
130368768|NCT01847274|469321218|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
130368769|NCT01847274|469321219|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368770|NCT01847274|469321220|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368771|NCT01847274|469321221|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368772|NCT01847274|469321222|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368773|NCT01847274|469321223|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368774|NCT01847274|469321224|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368775|NCT01847274|469321225|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130368776|NCT01847274|469321215|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368777|NCT01847274|469321216|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368778|NCT01847274|469321217|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368779|NCT01847274|469321218|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368780|NCT01847274|469321219|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368781|NCT01847274|469321220|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
130368782|NCT01847274|469321221|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368783|NCT01847274|469321222|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130368784|NCT01847274|469321223|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130457732|NCT01616654|469639941|FG001|Overall Study|Lost to Follow-up|0|||
130457733|NCT01616654|469639942|FG002|Overall Study|Lost to Follow-up|3|||
130457734|NCT01616654|469639943|FG003|Overall Study|Lost to Follow-up|2|||
130457735|NCT01616654|469639944|FG004|Overall Study|Lost to Follow-up|1|||
130368785|NCT01847274|469321224|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130457736|NCT01616654|469639940|FG000|Overall Study|Pregnancy|1|||
130457737|NCT01616654|469639941|FG001|Overall Study|Pregnancy|0|||
130457738|NCT01616654|469639942|FG002|Overall Study|Pregnancy|0|||
130457739|NCT01616654|469639943|FG003|Overall Study|Pregnancy|0|||
130457740|NCT01616654|469639944|FG004|Overall Study|Pregnancy|1|||
130457741|NCT02057692|469639946|FG000|Overall Study|Adverse Event|1|||
130457742|NCT02057692|469639947|FG001|Overall Study|Adverse Event|0|||
130279852|NCT05596734|468986808|FG005|Substudy A|Lost to Follow-up|0|||
130279853|NCT05596734|468986809|FG006|Substudy A|Lost to Follow-up|0|||
130279854|NCT05596734|468986810|FG007|Substudy A|Lost to Follow-up|0|||
130279855|NCT05596734|468986811|FG008|Substudy A|Lost to Follow-up|0|||
130279856|NCT05596734|468986812|FG009|Substudy A|Lost to Follow-up|0|||
130279857|NCT05596734|468986813|FG010|Substudy A|Lost to Follow-up|0|||
130279858|NCT05596734|468986814|FG011|Substudy A|Lost to Follow-up|0|||
130279859|NCT05596734|468986815|FG012|Substudy A|Lost to Follow-up|0|||
130279860|NCT05596734|468986816|FG013|Substudy A|Lost to Follow-up|0|||
130279861|NCT05596734|468986817|FG014|Substudy A|Lost to Follow-up|0|||
130279862|NCT05596734|468986818|FG015|Substudy A|Lost to Follow-up|0|||
130279863|NCT05596734|468986819|FG016|Substudy A|Lost to Follow-up|0|||
130279864|NCT05596734|468986820|FG017|Substudy A|Lost to Follow-up|0|||
130279865|NCT05596734|468986821|FG018|Substudy A|Lost to Follow-up|0|||
130279866|NCT05596734|468986822|FG019|Substudy A|Lost to Follow-up|0|||
130279867|NCT05596734|468986823|FG020|Substudy A|Lost to Follow-up|0|||
130279868|NCT05596734|468986824|FG021|Substudy A|Lost to Follow-up|0|||
130279869|NCT05596734|468986825|FG022|Substudy A|Lost to Follow-up|0|||
130279870|NCT05596734|468986826|FG023|Substudy A|Lost to Follow-up|0|||
130279871|NCT05596734|468986803|FG000|Substudy B|Withdrawal by Subject|0|||
130279872|NCT05596734|468986804|FG001|Substudy B|Withdrawal by Subject|0|||
130279873|NCT05596734|468986805|FG002|Substudy B|Withdrawal by Subject|0|||
130279874|NCT05596734|468986806|FG003|Substudy B|Withdrawal by Subject|0|||
130279875|NCT05596734|468986807|FG004|Substudy B|Withdrawal by Subject|0|||
130279876|NCT05596734|468986808|FG005|Substudy B|Withdrawal by Subject|0|||
130279877|NCT05596734|468986809|FG006|Substudy B|Withdrawal by Subject|0|||
130279878|NCT05596734|468986810|FG007|Substudy B|Withdrawal by Subject|0|||
130279879|NCT05596734|468986811|FG008|Substudy B|Withdrawal by Subject|0|||
130279880|NCT05596734|468986812|FG009|Substudy B|Withdrawal by Subject|0|||
130279881|NCT05596734|468986813|FG010|Substudy B|Withdrawal by Subject|0|||
130279882|NCT05596734|468986814|FG011|Substudy B|Withdrawal by Subject|0|||
130279883|NCT05596734|468986815|FG012|Substudy B|Withdrawal by Subject|1|||
130279884|NCT05596734|468986816|FG013|Substudy B|Withdrawal by Subject|0|||
130279885|NCT05596734|468986817|FG014|Substudy B|Withdrawal by Subject|1|||
130279886|NCT05596734|468986818|FG015|Substudy B|Withdrawal by Subject|2|||
130279887|NCT05596734|468986819|FG016|Substudy B|Withdrawal by Subject|2|||
130279888|NCT05596734|468986820|FG017|Substudy B|Withdrawal by Subject|1|||
130279889|NCT05596734|468986821|FG018|Substudy B|Withdrawal by Subject|2|||
130279890|NCT05596734|468986822|FG019|Substudy B|Withdrawal by Subject|0|||
130279891|NCT05596734|468986823|FG020|Substudy B|Withdrawal by Subject|0|||
130279892|NCT05596734|468986824|FG021|Substudy B|Withdrawal by Subject|0|||
130279893|NCT05596734|468986825|FG022|Substudy B|Withdrawal by Subject|0|||
130279894|NCT05596734|468986826|FG023|Substudy B|Withdrawal by Subject|1|||
130279895|NCT05596734|468986803|FG000|Substudy B|Physician Decision|0|||
130279896|NCT05596734|468986804|FG001|Substudy B|Physician Decision|0|||
130279897|NCT05596734|468986805|FG002|Substudy B|Physician Decision|0|||
130279898|NCT05596734|468986806|FG003|Substudy B|Physician Decision|0|||
130279899|NCT05596734|468986807|FG004|Substudy B|Physician Decision|0|||
130279900|NCT05596734|468986808|FG005|Substudy B|Physician Decision|0|||
130279901|NCT05596734|468986809|FG006|Substudy B|Physician Decision|0|||
130279902|NCT05596734|468986810|FG007|Substudy B|Physician Decision|0|||
130279903|NCT05596734|468986811|FG008|Substudy B|Physician Decision|0|||
130279904|NCT05596734|468986812|FG009|Substudy B|Physician Decision|0|||
130279905|NCT05596734|468986813|FG010|Substudy B|Physician Decision|0|||
130279906|NCT05596734|468986814|FG011|Substudy B|Physician Decision|0|||
130279907|NCT05596734|468986815|FG012|Substudy B|Physician Decision|0|||
130279908|NCT05596734|468986816|FG013|Substudy B|Physician Decision|0|||
130279909|NCT05596734|468986817|FG014|Substudy B|Physician Decision|0|||
130279910|NCT05596734|468986818|FG015|Substudy B|Physician Decision|1|||
130279911|NCT05596734|468986819|FG016|Substudy B|Physician Decision|0|||
130279912|NCT05596734|468986820|FG017|Substudy B|Physician Decision|0|||
130279913|NCT05596734|468986821|FG018|Substudy B|Physician Decision|0|||
130279914|NCT05596734|468986822|FG019|Substudy B|Physician Decision|0|||
130279915|NCT05596734|468986823|FG020|Substudy B|Physician Decision|0|||
130368786|NCT01847274|469321225|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130279916|NCT05596734|468986824|FG021|Substudy B|Physician Decision|0|||
130368787|NCT01847274|469321215|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130279917|NCT05596734|468986825|FG022|Substudy B|Physician Decision|0|||
130279918|NCT05596734|468986826|FG023|Substudy B|Physician Decision|0|||
130279919|NCT05596734|468986803|FG000|Substudy B|Lost to Follow-up|0|||
130279920|NCT05596734|468986804|FG001|Substudy B|Lost to Follow-up|0|||
130279921|NCT05596734|468986805|FG002|Substudy B|Lost to Follow-up|0|||
130279922|NCT05596734|468986806|FG003|Substudy B|Lost to Follow-up|0|||
130279923|NCT05596734|468986807|FG004|Substudy B|Lost to Follow-up|0|||
130279924|NCT05596734|468986808|FG005|Substudy B|Lost to Follow-up|0|||
130279925|NCT05596734|468986809|FG006|Substudy B|Lost to Follow-up|0|||
130279926|NCT05596734|468986810|FG007|Substudy B|Lost to Follow-up|0|||
130279927|NCT05596734|468986811|FG008|Substudy B|Lost to Follow-up|0|||
130279928|NCT05596734|468986812|FG009|Substudy B|Lost to Follow-up|0|||
130279929|NCT05596734|468986813|FG010|Substudy B|Lost to Follow-up|0|||
130279930|NCT05596734|468986814|FG011|Substudy B|Lost to Follow-up|0|||
130279931|NCT05596734|468986815|FG012|Substudy B|Lost to Follow-up|1|||
130279932|NCT05596734|468986816|FG013|Substudy B|Lost to Follow-up|0|||
130279933|NCT05596734|468986817|FG014|Substudy B|Lost to Follow-up|1|||
130279934|NCT05596734|468986818|FG015|Substudy B|Lost to Follow-up|1|||
130279935|NCT05596734|468986819|FG016|Substudy B|Lost to Follow-up|0|||
130279936|NCT05596734|468986820|FG017|Substudy B|Lost to Follow-up|0|||
130279937|NCT05596734|468986821|FG018|Substudy B|Lost to Follow-up|0|||
130279938|NCT05596734|468986822|FG019|Substudy B|Lost to Follow-up|0|||
130279939|NCT05596734|468986823|FG020|Substudy B|Lost to Follow-up|0|||
130279940|NCT05596734|468986824|FG021|Substudy B|Lost to Follow-up|0|||
130279941|NCT05596734|468986825|FG022|Substudy B|Lost to Follow-up|0|||
130279942|NCT05596734|468986826|FG023|Substudy B|Lost to Follow-up|0|||
130279943|NCT04113018|468986827|FG000|Overall Study|Death|2|||
130279944|NCT04113018|468986827|FG000|Overall Study|Lost to Follow-up|1|||
130279945|NCT04113018|468986827|FG000|Overall Study|Still On Study (on study treatment)|24|||
130279946|NCT04113018|468986827|FG000|Overall Study|Still On Study (in follow up)|12|||
130279947|NCT05005013|468986828|FG000|Overall Study|Withdrawal by Subject|5|||
130279948|NCT05005013|468986829|FG001|Overall Study|Withdrawal by Subject|1|||
130279949|NCT05005013|468986828|FG000|Overall Study|Lost to Follow-up|3|||
130279950|NCT05005013|468986829|FG001|Overall Study|Lost to Follow-up|1|||
130279951|NCT05005013|468986828|FG000|Overall Study|Ineligibility|1|||
130279952|NCT05005013|468986829|FG001|Overall Study|Ineligibility|1|||
130279953|NCT01802580|468986830|FG000|Overall Study|Physician Decision|1|||
130279954|NCT01802580|468986831|FG001|Overall Study|Physician Decision|0|||
130279955|NCT01802580|468986830|FG000|Overall Study|Protocol Violation|2|||
130279956|NCT01802580|468986831|FG001|Overall Study|Protocol Violation|0|||
130279957|NCT01802580|468986830|FG000|Overall Study|Withdrawal by Subject|5|||
130279958|NCT01802580|468986831|FG001|Overall Study|Withdrawal by Subject|6|||
130279959|NCT01802580|468986830|FG000|Overall Study|Other|1|||
130279960|NCT01802580|468986831|FG001|Overall Study|Other|3|||
130279961|NCT01802580|468986830|FG000|Overall Study|Lack of Efficacy|0|||
130279962|NCT01802580|468986831|FG001|Overall Study|Lack of Efficacy|2|||
130279963|NCT02791516|468986832|FG000|Overall Study|Withdrawal by Subject|1|||
130279964|NCT02791516|468986833|FG001|Overall Study|Withdrawal by Subject|1|||
130279965|NCT00211757|468986839|FG000|Overall Study|Withdrawal by Subject|1|||
130279966|NCT00211757|468986840|FG001|Overall Study|Withdrawal by Subject|1|||
130279967|NCT00211757|468986839|FG000|Overall Study|Lack of Efficacy|0|||
130279968|NCT00211757|468986840|FG001|Overall Study|Lack of Efficacy|1|||
130279969|NCT00322452|468986841|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130279970|NCT00322452|468986842|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130279971|NCT00322452|468986841|FG000|Overall Study|Lost to Follow-up|5|||
130279972|NCT00322452|468986842|FG001|Overall Study|Lost to Follow-up|2|||
130279973|NCT00322452|468986841|FG000|Overall Study|Withdrawal by Subject|19|||
130279974|NCT00322452|468986842|FG001|Overall Study|Withdrawal by Subject|46|||
130279975|NCT00322452|468986841|FG000|Overall Study|Death|223|||
130279976|NCT00322452|468986842|FG001|Overall Study|Death|227|||
130279977|NCT04091581|468986843|FG000|Overall Study|Lost to Follow-up|0|||
130279978|NCT04091581|468986844|FG001|Overall Study|Lost to Follow-up|1|||
130279979|NCT03372551|468988637|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
130279980|NCT03372551|468988638|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
130279981|NCT03727646|468988639|FG000|Overall Study|Adverse Event|1|||
130279982|NCT03727646|468988640|FG001|Overall Study|Adverse Event|0|||
130279983|NCT00327015|468988643|FG000|Overall Study|Lack of Efficacy|18|||
130279984|NCT00327015|468988644|FG001|Overall Study|Lack of Efficacy|18|||
130279985|NCT00327015|468988645|FG002|Overall Study|Lack of Efficacy|35|||
130279986|NCT00327015|468988646|FG003|Overall Study|Lack of Efficacy|29|||
130279987|NCT00327015|468988643|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
130279988|NCT00327015|468988644|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
130279989|NCT00327015|468988645|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
130279990|NCT00327015|468988646|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
130279991|NCT00327015|468988643|FG000|Overall Study|Lost to Follow-up|22|||
130279992|NCT00327015|468988644|FG001|Overall Study|Lost to Follow-up|23|||
130279993|NCT00327015|468988645|FG002|Overall Study|Lost to Follow-up|29|||
130279994|NCT00327015|468988646|FG003|Overall Study|Lost to Follow-up|22|||
130279995|NCT00327015|468988643|FG000|Overall Study|Adverse Event|14|||
130279996|NCT00327015|468988644|FG001|Overall Study|Adverse Event|10|||
130279997|NCT00327015|468988645|FG002|Overall Study|Adverse Event|14|||
130279998|NCT00327015|468988646|FG003|Overall Study|Adverse Event|14|||
130279999|NCT00327015|468988643|FG000|Overall Study|Subject no longer meets study criteria|4|||
130280000|NCT00327015|468988644|FG001|Overall Study|Subject no longer meets study criteria|2|||
130280001|NCT00327015|468988645|FG002|Overall Study|Subject no longer meets study criteria|8|||
130280002|NCT00327015|468988646|FG003|Overall Study|Subject no longer meets study criteria|7|||
130280003|NCT00327015|468988643|FG000|Overall Study|Poor/Noncompliance|11|||
130280004|NCT00327015|468988644|FG001|Overall Study|Poor/Noncompliance|8|||
130280005|NCT00327015|468988645|FG002|Overall Study|Poor/Noncompliance|4|||
130280006|NCT00327015|468988646|FG003|Overall Study|Poor/Noncompliance|5|||
130280007|NCT00327015|468988643|FG000|Overall Study|Physician Decision|0|||
130280008|NCT00327015|468988644|FG001|Overall Study|Physician Decision|1|||
130280009|NCT00327015|468988645|FG002|Overall Study|Physician Decision|3|||
130280010|NCT00327015|468988646|FG003|Overall Study|Physician Decision|2|||
130280011|NCT00327015|468988643|FG000|Overall Study|Death|1|||
130280012|NCT00327015|468988644|FG001|Overall Study|Death|2|||
130280013|NCT00327015|468988645|FG002|Overall Study|Death|2|||
130280014|NCT00327015|468988646|FG003|Overall Study|Death|3|||
130280015|NCT00327015|468988643|FG000|Overall Study|Pregnancy|0|||
130280016|NCT00327015|468988644|FG001|Overall Study|Pregnancy|2|||
130280017|NCT00327015|468988645|FG002|Overall Study|Pregnancy|1|||
130280018|NCT00327015|468988646|FG003|Overall Study|Pregnancy|1|||
130280019|NCT00327015|468988643|FG000|Overall Study|Administrative Reason by Sponsor|1|||
130280020|NCT00327015|468988644|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130280021|NCT00327015|468988645|FG002|Overall Study|Administrative Reason by Sponsor|2|||
130280022|NCT00327015|468988646|FG003|Overall Study|Administrative Reason by Sponsor|1|||
130280023|NCT00837265|468988647|FG000|Pilot Phase|Withdrawal by Subject|0|||
130280024|NCT00837265|468988648|FG001|Pilot Phase|Withdrawal by Subject|2|||
130280025|NCT00837265|468988649|FG002|Pilot Phase|Withdrawal by Subject|3|||
130280026|NCT00837265|468988650|FG003|Pilot Phase|Withdrawal by Subject|2|||
130280027|NCT00837265|468988651|FG004|Pilot Phase|Withdrawal by Subject|0|||
130280028|NCT00837265|468988652|FG005|Pilot Phase|Withdrawal by Subject|0|||
130280029|NCT00837265|468988653|FG006|Pilot Phase|Withdrawal by Subject|0|||
130280030|NCT00837265|468988647|FG000|Pilot Phase|Decision of the investigator|2|||
130280031|NCT00837265|468988648|FG001|Pilot Phase|Decision of the investigator|1|||
130280032|NCT00837265|468988649|FG002|Pilot Phase|Decision of the investigator|0|||
130280033|NCT00837265|468988650|FG003|Pilot Phase|Decision of the investigator|0|||
130280034|NCT00837265|468988651|FG004|Pilot Phase|Decision of the investigator|0|||
130280035|NCT00837265|468988652|FG005|Pilot Phase|Decision of the investigator|0|||
130280036|NCT00837265|468988653|FG006|Pilot Phase|Decision of the investigator|0|||
130280037|NCT00837265|468988647|FG000|Pilot Phase|Adverse Event|1|||
130280038|NCT00837265|468988648|FG001|Pilot Phase|Adverse Event|0|||
130280039|NCT00837265|468988649|FG002|Pilot Phase|Adverse Event|0|||
130280040|NCT00837265|468988650|FG003|Pilot Phase|Adverse Event|0|||
130280041|NCT00837265|468988651|FG004|Pilot Phase|Adverse Event|0|||
130280042|NCT00837265|468988652|FG005|Pilot Phase|Adverse Event|0|||
130280043|NCT00837265|468988653|FG006|Pilot Phase|Adverse Event|0|||
130280044|NCT00837265|468988647|FG000|Pilot Phase|Disease progression|0|||
130280045|NCT00837265|468988648|FG001|Pilot Phase|Disease progression|0|||
130280046|NCT00837265|468988649|FG002|Pilot Phase|Disease progression|0|||
130280047|NCT00837265|468988650|FG003|Pilot Phase|Disease progression|1|||
130280048|NCT00837265|468988651|FG004|Pilot Phase|Disease progression|0|||
130280049|NCT00837265|468988652|FG005|Pilot Phase|Disease progression|0|||
130280050|NCT00837265|468988653|FG006|Pilot Phase|Disease progression|0|||
130280051|NCT00837265|468988647|FG000|Pilot Phase|Participant left the city|0|||
130280052|NCT00837265|468988648|FG001|Pilot Phase|Participant left the city|0|||
130280053|NCT00837265|468988649|FG002|Pilot Phase|Participant left the city|0|||
130280054|NCT00837265|468988650|FG003|Pilot Phase|Participant left the city|1|||
130280055|NCT00837265|468988651|FG004|Pilot Phase|Participant left the city|0|||
130280056|NCT00837265|468988652|FG005|Pilot Phase|Participant left the city|0|||
130280057|NCT00837265|468988653|FG006|Pilot Phase|Participant left the city|0|||
130280058|NCT00837265|468988647|FG000|Main Phase|Withdrawal by Subject|0|||
130280059|NCT00837265|468988648|FG001|Main Phase|Withdrawal by Subject|0|||
130280060|NCT00837265|468988649|FG002|Main Phase|Withdrawal by Subject|0|||
130280061|NCT00837265|468988650|FG003|Main Phase|Withdrawal by Subject|0|||
130710765|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
130710766|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
130710767|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
130710768|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
130710769|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
130710770|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
130710771|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
130710772|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
130710773|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
130710774|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
130710775|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
130710776|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
130710777|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
130710778|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
130280062|NCT00837265|468988651|FG004|Main Phase|Withdrawal by Subject|4|||
130280063|NCT00837265|468988652|FG005|Main Phase|Withdrawal by Subject|2|||
130280064|NCT00837265|468988653|FG006|Main Phase|Withdrawal by Subject|1|||
130280065|NCT00837265|468988647|FG000|Main Phase|Decision of the investigator|0|||
130280066|NCT00837265|468988648|FG001|Main Phase|Decision of the investigator|0|||
130280067|NCT00837265|468988649|FG002|Main Phase|Decision of the investigator|0|||
130280068|NCT00837265|468988650|FG003|Main Phase|Decision of the investigator|0|||
130280069|NCT00837265|468988651|FG004|Main Phase|Decision of the investigator|0|||
130280070|NCT00837265|468988652|FG005|Main Phase|Decision of the investigator|2|||
130710779|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
130710780|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
130710781|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
130280071|NCT00837265|468988653|FG006|Main Phase|Decision of the investigator|1|||
130280072|NCT00837265|468988647|FG000|Main Phase|Adverse Event|0|||
130280073|NCT00837265|468988648|FG001|Main Phase|Adverse Event|0|||
130280074|NCT00837265|468988649|FG002|Main Phase|Adverse Event|0|||
130280075|NCT00837265|468988650|FG003|Main Phase|Adverse Event|0|||
130280076|NCT00837265|468988651|FG004|Main Phase|Adverse Event|0|||
130280077|NCT00837265|468988652|FG005|Main Phase|Adverse Event|1|||
130280078|NCT00837265|468988653|FG006|Main Phase|Adverse Event|0|||
130280079|NCT00837265|468988647|FG000|Main Phase|Death|0|||
130280080|NCT00837265|468988648|FG001|Main Phase|Death|0|||
130280081|NCT00837265|468988649|FG002|Main Phase|Death|0|||
130280082|NCT00837265|468988650|FG003|Main Phase|Death|0|||
130280083|NCT00837265|468988651|FG004|Main Phase|Death|2|||
130280084|NCT00837265|468988652|FG005|Main Phase|Death|0|||
130280085|NCT00837265|468988653|FG006|Main Phase|Death|1|||
130280086|NCT00837265|468988647|FG000|Main Phase|Lost to Follow-up|0|||
130280087|NCT00837265|468988648|FG001|Main Phase|Lost to Follow-up|0|||
130280088|NCT00837265|468988649|FG002|Main Phase|Lost to Follow-up|0|||
130280089|NCT00837265|468988650|FG003|Main Phase|Lost to Follow-up|0|||
130280090|NCT00837265|468988651|FG004|Main Phase|Lost to Follow-up|1|||
130280091|NCT00837265|468988652|FG005|Main Phase|Lost to Follow-up|0|||
130280092|NCT00837265|468988653|FG006|Main Phase|Lost to Follow-up|0|||
130280093|NCT00837265|468988647|FG000|Main Phase|Principal investigator resignation|0|||
130280094|NCT00837265|468988648|FG001|Main Phase|Principal investigator resignation|0|||
130280095|NCT00837265|468988649|FG002|Main Phase|Principal investigator resignation|0|||
130280096|NCT00837265|468988650|FG003|Main Phase|Principal investigator resignation|0|||
130280097|NCT00837265|468988651|FG004|Main Phase|Principal investigator resignation|2|||
130280098|NCT00837265|468988652|FG005|Main Phase|Principal investigator resignation|0|||
130280099|NCT00837265|468988653|FG006|Main Phase|Principal investigator resignation|0|||
130280100|NCT00837265|468988647|FG000|Main Phase|Participant's personal reason|0|||
130280101|NCT00837265|468988648|FG001|Main Phase|Participant's personal reason|0|||
130280102|NCT00837265|468988649|FG002|Main Phase|Participant's personal reason|0|||
130280103|NCT00837265|468988650|FG003|Main Phase|Participant's personal reason|0|||
130280104|NCT00837265|468988651|FG004|Main Phase|Participant's personal reason|1|||
130280105|NCT00837265|468988652|FG005|Main Phase|Participant's personal reason|0|||
130280106|NCT00837265|468988653|FG006|Main Phase|Participant's personal reason|0|||
130280107|NCT00473668|468988656|FG000|Overall Study|Withdrawal by Subject|0|||
130280108|NCT00473668|468988657|FG001|Overall Study|Withdrawal by Subject|2|||
130280109|NCT00473668|468988658|FG002|Overall Study|Withdrawal by Subject|0|||
130280110|NCT00473668|468988656|FG000|Overall Study|Migrated/moved from study area|3|||
130280111|NCT00473668|468988657|FG001|Overall Study|Migrated/moved from study area|2|||
130280112|NCT00473668|468988658|FG002|Overall Study|Migrated/moved from study area|0|||
130280113|NCT00473668|468988656|FG000|Overall Study|Lost to Follow-up|0|||
130280114|NCT00473668|468988657|FG001|Overall Study|Lost to Follow-up|4|||
130280115|NCT00473668|468988658|FG002|Overall Study|Lost to Follow-up|6|||
130280116|NCT00473668|468988656|FG000|Overall Study|Other|2|||
130280117|NCT00473668|468988657|FG001|Overall Study|Other|3|||
130280118|NCT00473668|468988658|FG002|Overall Study|Other|4|||
130280119|NCT02226562|468988659|FG000|Overall Study|Lost to Follow-up|0|||
130280120|NCT02226562|468988660|FG001|Overall Study|Lost to Follow-up|1|||
130280121|NCT01474772|468988662|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
130280122|NCT01474772|468988663|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
130280123|NCT01474772|468988662|FG000|Period 1|AE not Related to Study Drug|1|||
130280124|NCT01474772|468988663|FG001|Period 1|AE not Related to Study Drug|0|||
130280125|NCT01474772|468988662|FG000|Period 1|Withdrawal by Subject|3|||
130280126|NCT01474772|468988663|FG001|Period 1|Withdrawal by Subject|1|||
130710782|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
130710783|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130710784|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130280127|NCT01474772|468988662|FG000|Period 1|Lost to Follow-up|1|||
130280128|NCT01474772|468988663|FG001|Period 1|Lost to Follow-up|0|||
130280129|NCT01474772|468988662|FG000|Period 1|Reason not Specified|1|||
130280130|NCT01474772|468988663|FG001|Period 1|Reason not Specified|1|||
130280131|NCT01474772|468988662|FG000|Washout|AE not Related to Study Drug|2|||
130280132|NCT01474772|468988663|FG001|Washout|AE not Related to Study Drug|0|||
130280133|NCT01474772|468988662|FG000|Washout|Withdrawal by Subject|1|||
130280134|NCT01474772|468988663|FG001|Washout|Withdrawal by Subject|0|||
130280135|NCT01474772|468988662|FG000|Washout|Lost to Follow-up|0|||
130280136|NCT01474772|468988663|FG001|Washout|Lost to Follow-up|1|||
130280137|NCT01474772|468988662|FG000|Washout|Reason not Specified|0|||
130280138|NCT01474772|468988663|FG001|Washout|Reason not Specified|1|||
130280139|NCT01474772|468988662|FG000|Period 2|Death|0|||
130280140|NCT01474772|468988663|FG001|Period 2|Death|1|||
130280141|NCT01474772|468988662|FG000|Period 2|AE Related to Study Drug|0|||
130280142|NCT01474772|468988663|FG001|Period 2|AE Related to Study Drug|1|||
130280143|NCT01474772|468988662|FG000|Period 2|AE not Related to Study Drug|4|||
130280144|NCT01474772|468988663|FG001|Period 2|AE not Related to Study Drug|1|||
130280145|NCT01474772|468988662|FG000|Period 2|Lack of Efficacy|1|||
130280146|NCT01474772|468988663|FG001|Period 2|Lack of Efficacy|0|||
130280147|NCT01474772|468988662|FG000|Period 2|Withdrawal by Subject|3|||
130280148|NCT01474772|468988663|FG001|Period 2|Withdrawal by Subject|4|||
130280149|NCT01474772|468988662|FG000|Period 2|Lost to Follow-up|1|||
130280150|NCT01474772|468988663|FG001|Period 2|Lost to Follow-up|1|||
130280151|NCT01474772|468988662|FG000|Period 2|Reason not Specified|0|||
130280152|NCT01474772|468988663|FG001|Period 2|Reason not Specified|2|||
130280153|NCT01474772|468988662|FG000|Follow-up|AE not Related to Study Drug|0|||
130280154|NCT01474772|468988663|FG001|Follow-up|AE not Related to Study Drug|1|||
130280155|NCT00223808|468988664|FG000|Overall Study|<5 hrs therapy before discharge|3|||
130280156|NCT00223808|468988665|FG001|Overall Study|<5 hrs therapy before discharge|5|||
130280157|NCT00223808|468988666|FG002|Overall Study|<5 hrs therapy before discharge|5|||
130280158|NCT03195660|468988667|FG000|Overall Study|The study was terminated|2|||
130280159|NCT05260073|468988669|FG000|Overall Study|Physician Decision|1|||
130280160|NCT05260073|468988669|FG000|Overall Study|Withdrawal by Subject|6|||
130280161|NCT05260073|468988669|FG000|Overall Study|Lost to Follow-up|14|||
130280162|NCT03458910|468988670|FG000|Overall Study|Withdrawal by Subject|7|||
130280163|NCT03458910|468988671|FG001|Overall Study|Withdrawal by Subject|8|||
130280164|NCT03458910|468988672|FG002|Overall Study|Withdrawal by Subject|6|||
130280165|NCT03458910|468988673|FG003|Overall Study|Withdrawal by Subject|4|||
130280166|NCT03458910|468988670|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
130280167|NCT03458910|468988671|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
130280168|NCT03458910|468988672|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
130280169|NCT03458910|468988673|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
130280170|NCT04484649|468988674|FG000|Overall Study|Lost to Follow-up|2|||
130280171|NCT04484649|468988675|FG001|Overall Study|Lost to Follow-up|1|||
130280172|NCT04484649|468988674|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
130280173|NCT04484649|468988675|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
130280174|NCT00152477|468988680|FG000|Chemotherapy Period|Adverse Event|9|||
130280175|NCT00152477|468988681|FG001|Chemotherapy Period|Adverse Event|4|||
130280176|NCT00152477|468988682|FG002|Chemotherapy Period|Adverse Event|5|||
130280177|NCT00152477|468988680|FG000|Chemotherapy Period|Death|1|||
130280178|NCT00152477|468988681|FG001|Chemotherapy Period|Death|3|||
130280179|NCT00152477|468988682|FG002|Chemotherapy Period|Death|3|||
130280180|NCT00152477|468988680|FG000|Chemotherapy Period|Lack of Efficacy|4|||
130280181|NCT00152477|468988681|FG001|Chemotherapy Period|Lack of Efficacy|5|||
130280182|NCT00152477|468988682|FG002|Chemotherapy Period|Lack of Efficacy|6|||
130280183|NCT00152477|468988680|FG000|Chemotherapy Period|Lost to Follow-up|1|||
130280184|NCT00152477|468988681|FG001|Chemotherapy Period|Lost to Follow-up|0|||
130280185|NCT00152477|468988682|FG002|Chemotherapy Period|Lost to Follow-up|1|||
130280186|NCT00152477|468988680|FG000|Chemotherapy Period|Protocol Violation|1|||
130280187|NCT00152477|468988681|FG001|Chemotherapy Period|Protocol Violation|1|||
130280188|NCT00152477|468988682|FG002|Chemotherapy Period|Protocol Violation|0|||
130280189|NCT00152477|468988680|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
130280190|NCT00152477|468988681|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
130280191|NCT00152477|468988682|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
130280192|NCT00152477|468988680|FG000|Chemotherapy Period|Progression of Disease|6|||
130280193|NCT00152477|468988681|FG001|Chemotherapy Period|Progression of Disease|8|||
130280194|NCT00152477|468988682|FG002|Chemotherapy Period|Progression of Disease|4|||
130280195|NCT00152477|468988680|FG000|Chemotherapy Period|Investigator decision|0|||
130280196|NCT00152477|468988681|FG001|Chemotherapy Period|Investigator decision|0|||
130280197|NCT00152477|468988682|FG002|Chemotherapy Period|Investigator decision|1|||
130280198|NCT00152477|468988680|FG000|Chemotherapy Period|Patient condition worsened|1|||
130280199|NCT00152477|468988681|FG001|Chemotherapy Period|Patient condition worsened|0|||
130280200|NCT00152477|468988682|FG002|Chemotherapy Period|Patient condition worsened|0|||
130280201|NCT00152477|468988680|FG000|Monotherapy Period|Adverse Event|1|||
130280202|NCT00152477|468988681|FG001|Monotherapy Period|Adverse Event|0|||
130280203|NCT00152477|468988682|FG002|Monotherapy Period|Adverse Event|5|||
130280204|NCT00152477|468988680|FG000|Monotherapy Period|Death|2|||
130280205|NCT00152477|468988681|FG001|Monotherapy Period|Death|0|||
130280206|NCT00152477|468988682|FG002|Monotherapy Period|Death|1|||
130280207|NCT00152477|468988680|FG000|Monotherapy Period|Lack of Efficacy|7|||
130710785|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130280208|NCT00152477|468988681|FG001|Monotherapy Period|Lack of Efficacy|16|||
130280209|NCT00152477|468988682|FG002|Monotherapy Period|Lack of Efficacy|10|||
130280210|NCT00152477|468988680|FG000|Monotherapy Period|Protocol Violation|0|||
130280211|NCT00152477|468988681|FG001|Monotherapy Period|Protocol Violation|1|||
130280212|NCT00152477|468988682|FG002|Monotherapy Period|Protocol Violation|0|||
130280213|NCT00152477|468988680|FG000|Monotherapy Period|Withdrawal by Subject|0|||
130280214|NCT00152477|468988681|FG001|Monotherapy Period|Withdrawal by Subject|0|||
130280215|NCT00152477|468988682|FG002|Monotherapy Period|Withdrawal by Subject|4|||
130280216|NCT00152477|468988680|FG000|Monotherapy Period|Progression of Disease|5|||
130280217|NCT00152477|468988681|FG001|Monotherapy Period|Progression of Disease|11|||
130280218|NCT00152477|468988682|FG002|Monotherapy Period|Progression of Disease|12|||
130280219|NCT00152477|468988680|FG000|Monotherapy Period|Patient decision|0|||
130280220|NCT00152477|468988681|FG001|Monotherapy Period|Patient decision|1|||
130280221|NCT00152477|468988682|FG002|Monotherapy Period|Patient decision|1|||
130280222|NCT00152477|468988680|FG000|Monotherapy Period|Study personel decision|0|||
130280223|NCT00152477|468988681|FG001|Monotherapy Period|Study personel decision|0|||
130280224|NCT00152477|468988682|FG002|Monotherapy Period|Study personel decision|1|||
130280225|NCT02570152|468988683|FG000|Overall Study|Protocol Violation|2|||
130280226|NCT02570152|468988683|FG000|Overall Study|Migrated/moved from study area|13|||
130280227|NCT00923975|468988685|FG000|Overall Study|Did not meet inclusion criteria|1|||
130280228|NCT01328535|468988686|FG000|Overall Study|Ineligible|1|||
130280229|NCT01005316|468988687|FG000|Overall Study|Adverse Event|0|||
130280230|NCT01005316|468988688|FG001|Overall Study|Adverse Event|0|||
130280231|NCT01005316|468988689|FG002|Overall Study|Adverse Event|0|||
130280232|NCT01005316|468988690|FG003|Overall Study|Adverse Event|1|||
130280233|NCT01005316|468988687|FG000|Overall Study|Death|20|||
130280234|NCT01005316|468988688|FG001|Overall Study|Death|5|||
130280235|NCT01005316|468988689|FG002|Overall Study|Death|1|||
130280236|NCT01005316|468988690|FG003|Overall Study|Death|15|||
130280237|NCT01005316|468988687|FG000|Overall Study|Study Termination|5|||
130280238|NCT01005316|468988688|FG001|Overall Study|Study Termination|63|||
130280239|NCT01005316|468988689|FG002|Overall Study|Study Termination|9|||
130280240|NCT01005316|468988690|FG003|Overall Study|Study Termination|85|||
130280241|NCT01005316|468988687|FG000|Overall Study|Lost to Follow-up|1|||
130280242|NCT01005316|468988688|FG001|Overall Study|Lost to Follow-up|3|||
130280243|NCT01005316|468988689|FG002|Overall Study|Lost to Follow-up|0|||
130280244|NCT01005316|468988690|FG003|Overall Study|Lost to Follow-up|2|||
130280245|NCT01005316|468988687|FG000|Overall Study|Physician Decision|6|||
130280246|NCT01005316|468988688|FG001|Overall Study|Physician Decision|0|||
130280247|NCT01005316|468988689|FG002|Overall Study|Physician Decision|0|||
130280248|NCT01005316|468988690|FG003|Overall Study|Physician Decision|0|||
130280249|NCT01005316|468988687|FG000|Overall Study|Sponsor Decision|6|||
130280250|NCT01005316|468988688|FG001|Overall Study|Sponsor Decision|3|||
130280251|NCT01005316|468988689|FG002|Overall Study|Sponsor Decision|0|||
130280252|NCT01005316|468988690|FG003|Overall Study|Sponsor Decision|0|||
130280253|NCT01005316|468988687|FG000|Overall Study|Withdrawal by Subject|1|||
130280254|NCT01005316|468988688|FG001|Overall Study|Withdrawal by Subject|1|||
130280255|NCT01005316|468988689|FG002|Overall Study|Withdrawal by Subject|0|||
130280256|NCT01005316|468988690|FG003|Overall Study|Withdrawal by Subject|2|||
130280257|NCT01005316|468988687|FG000|Overall Study|Consented to Another Study|2|||
130280258|NCT01005316|468988688|FG001|Overall Study|Consented to Another Study|0|||
130280259|NCT01005316|468988689|FG002|Overall Study|Consented to Another Study|0|||
130280260|NCT01005316|468988690|FG003|Overall Study|Consented to Another Study|0|||
130280261|NCT01005316|468988687|FG000|Overall Study|Delisted|8|||
130280262|NCT01005316|468988688|FG001|Overall Study|Delisted|0|||
130280263|NCT01005316|468988689|FG002|Overall Study|Delisted|0|||
130280264|NCT01005316|468988690|FG003|Overall Study|Delisted|0|||
130280265|NCT01005316|468988687|FG000|Overall Study|Transferred Care|1|||
130280266|NCT01005316|468988688|FG001|Overall Study|Transferred Care|0|||
130280267|NCT01005316|468988689|FG002|Overall Study|Transferred Care|1|||
130280268|NCT01005316|468988690|FG003|Overall Study|Transferred Care|3|||
130280269|NCT01005316|468988687|FG000|Overall Study|Retransplanted|0|||
130280270|NCT01005316|468988688|FG001|Overall Study|Retransplanted|1|||
130280271|NCT01005316|468988689|FG002|Overall Study|Retransplanted|0|||
130280272|NCT01005316|468988690|FG003|Overall Study|Retransplanted|0|||
130280273|NCT00960011|468988691|FG000|Overall Study|Death|5|||
130280274|NCT00960011|468988692|FG001|Overall Study|Death|0|||
130280275|NCT00960011|468988691|FG000|Overall Study|Lost to Follow-up|6|||
130280276|NCT00960011|468988692|FG001|Overall Study|Lost to Follow-up|2|||
130280277|NCT04417218|468988693|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
130280278|NCT04417218|468988694|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
130280279|NCT01734395|468988697|FG000|Overall Study|Other|65|||
130280280|NCT01734395|468988697|FG000|Overall Study|Lost to Follow-up|287|||
130280281|NCT01734395|468988697|FG000|Overall Study|Lack of Efficacy|5|||
130280282|NCT01734395|468988697|FG000|Overall Study|Adverse Event|40|||
130280283|NCT01734395|468988697|FG000|Overall Study|Withdrawal by Subject|10|||
130280284|NCT01734395|468988697|FG000|Overall Study|Missing the reasons for not completed|3|||
130457743|NCT02057692|469639948|FG002|Overall Study|Adverse Event|0|||
130280285|NCT01032291|468988698|FG000|Safety Lead-in|Adverse Event|1|||
130280286|NCT01032291|468988699|FG001|Safety Lead-in|Adverse Event|0|||
130280287|NCT01032291|468988700|FG002|Safety Lead-in|Adverse Event|0|||
130280288|NCT01032291|468988698|FG000|Safety Lead-in|Death|1|||
130280289|NCT01032291|468988699|FG001|Safety Lead-in|Death|0|||
130280290|NCT01032291|468988700|FG002|Safety Lead-in|Death|0|||
130280291|NCT01032291|468988698|FG000|Proof of Concept|Adverse Event|0|||
130280292|NCT01032291|468988699|FG001|Proof of Concept|Adverse Event|5|||
130280293|NCT01032291|468988700|FG002|Proof of Concept|Adverse Event|1|||
130280294|NCT01032291|468988698|FG000|Proof of Concept|Death|0|||
130280295|NCT01032291|468988699|FG001|Proof of Concept|Death|1|||
130280296|NCT01032291|468988700|FG002|Proof of Concept|Death|2|||
130280297|NCT01032291|468988698|FG000|Proof of Concept|Lack of Efficacy|0|||
130280298|NCT01032291|468988699|FG001|Proof of Concept|Lack of Efficacy|1|||
130280299|NCT01032291|468988700|FG002|Proof of Concept|Lack of Efficacy|0|||
130280300|NCT01032291|468988698|FG000|Proof of Concept|Never Received Study Drug|0|||
130280301|NCT01032291|468988699|FG001|Proof of Concept|Never Received Study Drug|1|||
130280302|NCT01032291|468988700|FG002|Proof of Concept|Never Received Study Drug|0|||
130280303|NCT00313313|468988701|FG000|Overall Study|Lack of Efficacy|14|||
130280304|NCT00313313|468988702|FG001|Overall Study|Lack of Efficacy|9|||
130280305|NCT00313313|468988703|FG002|Overall Study|Lack of Efficacy|20|||
130280306|NCT00313313|468988701|FG000|Overall Study|Withdrawal of consent by subject|18|||
130280307|NCT00313313|468988702|FG001|Overall Study|Withdrawal of consent by subject|17|||
130280308|NCT00313313|468988703|FG002|Overall Study|Withdrawal of consent by subject|31|||
130280309|NCT00313313|468988701|FG000|Overall Study|Lost to Follow-up|10|||
130280310|NCT00313313|468988702|FG001|Overall Study|Lost to Follow-up|7|||
130280311|NCT00313313|468988703|FG002|Overall Study|Lost to Follow-up|9|||
130280312|NCT00313313|468988701|FG000|Overall Study|Adverse Event|15|||
130280313|NCT00313313|468988702|FG001|Overall Study|Adverse Event|16|||
130280314|NCT00313313|468988703|FG002|Overall Study|Adverse Event|12|||
130280315|NCT00313313|468988701|FG000|Overall Study|Physician Decision|2|||
130280316|NCT00313313|468988702|FG001|Overall Study|Physician Decision|6|||
130280317|NCT00313313|468988703|FG002|Overall Study|Physician Decision|4|||
130280318|NCT00313313|468988701|FG000|Overall Study|Poor/Noncompliance|3|||
130280319|NCT00313313|468988702|FG001|Overall Study|Poor/Noncompliance|6|||
130280320|NCT00313313|468988703|FG002|Overall Study|Poor/Noncompliance|2|||
130280321|NCT00313313|468988701|FG000|Overall Study|Pregnancy|1|||
130280322|NCT00313313|468988702|FG001|Overall Study|Pregnancy|2|||
130280323|NCT00313313|468988703|FG002|Overall Study|Pregnancy|0|||
130280324|NCT00313313|468988701|FG000|Overall Study|Death|0|||
130280325|NCT00313313|468988702|FG001|Overall Study|Death|0|||
130280326|NCT00313313|468988703|FG002|Overall Study|Death|2|||
130280327|NCT00313313|468988701|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130280328|NCT00313313|468988702|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
130280329|NCT00313313|468988703|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
130280330|NCT00758264|468988704|FG000|Active Phase|Withdrawal by Subject|0|||
130280331|NCT00758264|468988705|FG001|Active Phase|Withdrawal by Subject|0|||
130280332|NCT00758264|468988706|FG002|Active Phase|Withdrawal by Subject|1|||
130280333|NCT00758264|468988704|FG000|Active Phase|Lost to Follow-up|1|||
130280334|NCT00758264|468988705|FG001|Active Phase|Lost to Follow-up|0|||
130280335|NCT00758264|468988706|FG002|Active Phase|Lost to Follow-up|0|||
130280336|NCT00758264|468988704|FG000|Active Phase|Other|0|||
130280337|NCT00758264|468988705|FG001|Active Phase|Other|0|||
130280338|NCT00758264|468988706|FG002|Active Phase|Other|4|||
130280339|NCT01177553|468988707|FG000|Overall Study|babies not yet 6 months of age|1|||
130280340|NCT01177553|468988708|FG001|Overall Study|babies not yet 6 months of age|0|||
130280341|NCT00695955|468988712|FG000|Cohort 1|Adverse Event|26|||
130280342|NCT00695955|468988712|FG000|Cohort 1|Protocol Violation|2|||
130280343|NCT00695955|468988712|FG000|Cohort 1|Lost to Follow-up|30|||
130280344|NCT00695955|468988712|FG000|Cohort 1|Withdrawal by Subject|25|||
130280345|NCT00695955|468988712|FG000|Cohort 1|Lack of Efficacy|3|||
130280346|NCT00695955|468988712|FG000|Cohort 1|Other|16|||
130280347|NCT00695955|468988712|FG000|Cohort 2|Adverse Event|24|||
130280348|NCT00695955|468988712|FG000|Cohort 2|Protocol Violation|5|||
130280349|NCT00695955|468988712|FG000|Cohort 2|Lost to Follow-up|38|||
130280350|NCT00695955|468988712|FG000|Cohort 2|Withdrawal by Subject|28|||
130280351|NCT00695955|468988712|FG000|Cohort 2|Lack of Efficacy|4|||
130280352|NCT00695955|468988712|FG000|Cohort 2|Other|5|||
130280353|NCT01106651|468988713|FG000|Overall Study|Adverse Event|17|||
130710786|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
130710787|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
130710788|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
130710789|NCT01642914|470567027|FG000|Overall Study|Adverse Event|11|||
130710790|NCT01642914|470567028|FG001|Overall Study|Adverse Event|7|||
130280354|NCT01106651|468988714|FG001|Overall Study|Adverse Event|9|||
130280355|NCT01106651|468988715|FG002|Overall Study|Adverse Event|23|||
130280356|NCT01106651|468988713|FG000|Overall Study|Lost to Follow-up|8|||
130280357|NCT01106651|468988714|FG001|Overall Study|Lost to Follow-up|2|||
130368788|NCT01847274|469321216|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130710791|NCT01642914|470567029|FG002|Overall Study|Adverse Event|15|||
130280358|NCT01106651|468988715|FG002|Overall Study|Lost to Follow-up|6|||
130280359|NCT01106651|468988713|FG000|Overall Study|Physician Decision|4|||
130280360|NCT01106651|468988714|FG001|Overall Study|Physician Decision|3|||
130280361|NCT01106651|468988715|FG002|Overall Study|Physician Decision|1|||
130280362|NCT01106651|468988713|FG000|Overall Study|Protocol Violation|1|||
130710792|NCT01642914|470567027|FG000|Overall Study|Lack of Efficacy|9|||
130280363|NCT01106651|468988714|FG001|Overall Study|Protocol Violation|2|||
130280364|NCT01106651|468988715|FG002|Overall Study|Protocol Violation|1|||
130280365|NCT01106651|468988713|FG000|Overall Study|Withdrawal by Subject|14|||
130280366|NCT01106651|468988714|FG001|Overall Study|Withdrawal by Subject|7|||
130280367|NCT01106651|468988715|FG002|Overall Study|Withdrawal by Subject|4|||
130280368|NCT01106651|468988713|FG000|Overall Study|Noncompliance with study drug|1|||
130280369|NCT01106651|468988714|FG001|Overall Study|Noncompliance with study drug|0|||
130280370|NCT01106651|468988715|FG002|Overall Study|Noncompliance with study drug|2|||
130280371|NCT01106651|468988713|FG000|Overall Study|Other|34|||
130280372|NCT01106651|468988714|FG001|Overall Study|Other|31|||
130280373|NCT01106651|468988715|FG002|Overall Study|Other|21|||
130280374|NCT01106651|468988713|FG000|Overall Study|Death|0|||
130280375|NCT01106651|468988714|FG001|Overall Study|Death|3|||
130280376|NCT01106651|468988715|FG002|Overall Study|Death|0|||
130280377|NCT04590404|468988716|FG000|Overall Study|Death|16|||
130280378|NCT04590404|468988717|FG001|Overall Study|Death|17|||
130280379|NCT04590404|468988716|FG000|Overall Study|Withdrawal by Subject|7|||
130280380|NCT04590404|468988717|FG001|Overall Study|Withdrawal by Subject|2|||
130280381|NCT01581021|468988719|FG000|Overall Study|Lost to Follow-up|4|||
130280382|NCT01581021|468988720|FG001|Overall Study|Lost to Follow-up|6|||
130280383|NCT01581021|468988719|FG000|Overall Study|More than 2 hooks in thoracic|3|||
130280384|NCT01581021|468988720|FG001|Overall Study|More than 2 hooks in thoracic|0|||
130280385|NCT01581021|468988719|FG000|Overall Study|Neuromuscular|2|||
130280386|NCT01581021|468988720|FG001|Overall Study|Neuromuscular|1|||
130280387|NCT01581021|468988719|FG000|Overall Study|Not Randomized|1|||
130280388|NCT01581021|468988720|FG001|Overall Study|Not Randomized|2|||
130280389|NCT01581021|468988719|FG000|Overall Study|Lenke 6 Classification|0|||
130280390|NCT01581021|468988720|FG001|Overall Study|Lenke 6 Classification|1|||
130280391|NCT01581021|468988719|FG000|Overall Study|Lack of Efficacy|0|||
130280392|NCT01581021|468988720|FG001|Overall Study|Lack of Efficacy|1|||
130280393|NCT00054327|468988723|FG000|Overall Study|Engraftment failure|1|||
130280394|NCT00054327|468988724|FG001|Overall Study|Engraftment failure|0|||
130280395|NCT00054327|468988725|FG002|Overall Study|Engraftment failure|0|||
130280396|NCT00054327|468988726|FG003|Overall Study|Engraftment failure|0|||
130280397|NCT00054327|468988727|FG004|Overall Study|Engraftment failure|0|||
130280398|NCT00054327|468988728|FG005|Overall Study|Engraftment failure|0|||
130280399|NCT00290771|468988735|FG000|Overall Study|Disease progression|95|||
130280400|NCT00290771|468988736|FG001|Overall Study|Disease progression|73|||
130280401|NCT00290771|468988735|FG000|Overall Study|Death|11|||
130280402|NCT00290771|468988736|FG001|Overall Study|Death|10|||
130280403|NCT00290771|468988735|FG000|Overall Study|Adverse Event|12|||
130280404|NCT00290771|468988736|FG001|Overall Study|Adverse Event|6|||
130280405|NCT00290771|468988735|FG000|Overall Study|Withdrawal by Subject|5|||
130280406|NCT00290771|468988736|FG001|Overall Study|Withdrawal by Subject|6|||
130280407|NCT00290771|468988735|FG000|Overall Study|Administrative problems|2|||
130280408|NCT00290771|468988736|FG001|Overall Study|Administrative problems|1|||
130280409|NCT00290771|468988735|FG000|Overall Study|Protocol Violation|2|||
130280410|NCT00290771|468988736|FG001|Overall Study|Protocol Violation|0|||
130280411|NCT00290771|468988735|FG000|Overall Study|Lost to Follow-up|0|||
130280412|NCT00290771|468988736|FG001|Overall Study|Lost to Follow-up|1|||
130280413|NCT00244933|468988739|FG000|Overall Study|Not response evaluable|2|||
130280414|NCT02487654|468988741|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
130280415|NCT02487654|468988742|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
130280416|NCT02487654|468988741|FG000|Overall Study|Withdrawal by Subject|3|||
130280417|NCT02487654|468988742|FG001|Overall Study|Withdrawal by Subject|7|||
130280418|NCT02247011|468988743|FG000|Overall Study|Poor quality of radiological results|125|||
130280419|NCT00616018|468988744|FG000|Overall Study|Protocol Violation|3|||
130280420|NCT03718884|468988745|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
130280421|NCT03718884|468988746|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
130368789|NCT01847274|469321217|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368790|NCT01847274|469321218|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368791|NCT01847274|469321219|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
130368792|NCT01847274|469321220|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368793|NCT01847274|469321221|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368794|NCT01847274|469321222|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368795|NCT01847274|469321223|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368796|NCT01847274|469321224|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368797|NCT01847274|469321225|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130368798|NCT01847274|469321215|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368799|NCT01847274|469321216|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368800|NCT01847274|469321217|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368801|NCT01847274|469321218|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368802|NCT01847274|469321219|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368803|NCT01847274|469321220|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368804|NCT01847274|469321221|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
130457744|NCT02057692|469639949|FG003|Overall Study|Adverse Event|0|||
130710793|NCT01642914|470567028|FG001|Overall Study|Lack of Efficacy|4|||
130710794|NCT01642914|470567029|FG002|Overall Study|Lack of Efficacy|2|||
130710795|NCT01642914|470567027|FG000|Overall Study|Protocol Violation|15|||
130710796|NCT01642914|470567028|FG001|Overall Study|Protocol Violation|13|||
130710797|NCT01642914|470567029|FG002|Overall Study|Protocol Violation|6|||
130710798|NCT01642914|470567027|FG000|Overall Study|Withdrawal by Subject|5|||
130710799|NCT01642914|470567028|FG001|Overall Study|Withdrawal by Subject|5|||
130710800|NCT01642914|470567029|FG002|Overall Study|Withdrawal by Subject|10|||
130710801|NCT01642914|470567027|FG000|Overall Study|Lost to Follow-up|5|||
130710802|NCT01642914|470567028|FG001|Overall Study|Lost to Follow-up|3|||
130710803|NCT01642914|470567029|FG002|Overall Study|Lost to Follow-up|7|||
130710804|NCT01642914|470567027|FG000|Overall Study|Other Reason|1|||
130710805|NCT01642914|470567028|FG001|Overall Study|Other Reason|0|||
130710806|NCT01642914|470567029|FG002|Overall Study|Other Reason|0|||
130710807|NCT06005597|470567030|FG000|Overall Study|Lost to Follow-up|1|||
130710808|NCT06005597|470567031|FG001|Overall Study|Lost to Follow-up|2|||
130710809|NCT06005597|470567032|FG002|Overall Study|Lost to Follow-up|1|||
130710810|NCT06005597|470567033|FG003|Overall Study|Lost to Follow-up|2|||
130710811|NCT06005597|470567030|FG000|Overall Study|Death|1|||
130710812|NCT06005597|470567031|FG001|Overall Study|Death|1|||
130710813|NCT06005597|470567032|FG002|Overall Study|Death|1|||
130710814|NCT06005597|470567033|FG003|Overall Study|Death|0|||
130710815|NCT00754442|470567034|FG000|Overall Study|Withdrawal by Subject|5|||
130710816|NCT00754442|470567035|FG001|Overall Study|Withdrawal by Subject|3|||
130280422|NCT03718884|468988745|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
130280423|NCT03718884|468988746|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
130280424|NCT00349921|468988747|FG000|First Spinal Injection|Physician Decision|1|||
130280425|NCT00349921|468988748|FG001|First Spinal Injection|Physician Decision|0|||
130280426|NCT00349921|468988749|FG002|First Spinal Injection|Physician Decision|0|||
130280427|NCT00349921|468988750|FG003|First Spinal Injection|Physician Decision|0|||
130280428|NCT00349921|468988747|FG000|First Spinal Injection|Adverse Event|0|||
130280429|NCT00349921|468988748|FG001|First Spinal Injection|Adverse Event|0|||
130280430|NCT00349921|468988749|FG002|First Spinal Injection|Adverse Event|1|||
130280431|NCT00349921|468988750|FG003|First Spinal Injection|Adverse Event|0|||
130280432|NCT04700540|468988751|FG000|Overall Study|Withdrawal by Subject|12|||
130280433|NCT04700540|468988752|FG001|Overall Study|Withdrawal by Subject|8|||
130280434|NCT04700540|468988751|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
130280435|NCT04700540|468988752|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
130280436|NCT02602275|468988771|FG000|Day 1|Physician Decision|0|||
130280437|NCT02602275|468988772|FG001|Day 1|Physician Decision|1|||
130280438|NCT03802630|468988775|FG000|Overall Study|Study terminated by sponsor|130|||
130280439|NCT03802630|468988776|FG001|Overall Study|Study terminated by sponsor|134|||
130280440|NCT03802630|468988775|FG000|Overall Study|Subject decision|16|||
130280441|NCT03802630|468988776|FG001|Overall Study|Subject decision|9|||
130280442|NCT03802630|468988775|FG000|Overall Study|Adverse Event|3|||
130280443|NCT03802630|468988776|FG001|Overall Study|Adverse Event|1|||
130280444|NCT03802630|468988775|FG000|Overall Study|Lost to Follow-up|2|||
130280445|NCT03802630|468988776|FG001|Overall Study|Lost to Follow-up|2|||
130280446|NCT03802630|468988775|FG000|Overall Study|Physician Decision|2|||
130280447|NCT03802630|468988776|FG001|Overall Study|Physician Decision|0|||
130280448|NCT03802630|468988775|FG000|Overall Study|Death|0|||
130280449|NCT03802630|468988776|FG001|Overall Study|Death|2|||
130280450|NCT01108731|468988777|FG000|Overall Study|Withdrawal by Subject|1|||
130280451|NCT01108731|468988778|FG001|Overall Study|Withdrawal by Subject|1|||
130280452|NCT01108731|468988777|FG000|Overall Study|Adverse Event|3|||
130710817|NCT04479475|470567036|FG000|Overall Study|Withdrawal by Subject|7|||
130710818|NCT00296491|470567037|FG000|Overall Study|Low Pollen Counts|18|||
130710819|NCT00296491|470567038|FG001|Overall Study|Low Pollen Counts|26|||
130710820|NCT00296491|470567039|FG002|Overall Study|Low Pollen Counts|25|||
130710821|NCT00296491|470567040|FG003|Overall Study|Low Pollen Counts|16|||
130710822|NCT00296491|470567037|FG000|Overall Study|Protocol Violation|4|||
130710823|NCT00296491|470567038|FG001|Overall Study|Protocol Violation|6|||
130710824|NCT00296491|470567039|FG002|Overall Study|Protocol Violation|2|||
130710825|NCT00296491|470567040|FG003|Overall Study|Protocol Violation|3|||
130710826|NCT00296491|470567037|FG000|Overall Study|Adverse Event|1|||
130710827|NCT00296491|470567038|FG001|Overall Study|Adverse Event|3|||
130710828|NCT00296491|470567039|FG002|Overall Study|Adverse Event|1|||
130280453|NCT01108731|468988778|FG001|Overall Study|Adverse Event|3|||
130368805|NCT01847274|469321222|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130280454|NCT00157196|468988779|FG000|Overall Study|Ongoing at data cut-off|9|||
130710829|NCT00296491|470567040|FG003|Overall Study|Adverse Event|4|||
130710830|NCT00296491|470567037|FG000|Overall Study|Withdrawn due to Asthma|0|||
130710831|NCT00296491|470567038|FG001|Overall Study|Withdrawn due to Asthma|0|||
130710832|NCT00296491|470567039|FG002|Overall Study|Withdrawn due to Asthma|0|||
130710833|NCT00296491|470567040|FG003|Overall Study|Withdrawn due to Asthma|4|||
130710834|NCT00296491|470567037|FG000|Overall Study|Withdrawal by Subject|7|||
130710835|NCT00296491|470567038|FG001|Overall Study|Withdrawal by Subject|3|||
130710836|NCT00296491|470567039|FG002|Overall Study|Withdrawal by Subject|3|||
130710837|NCT00296491|470567040|FG003|Overall Study|Withdrawal by Subject|2|||
130710838|NCT00296491|470567037|FG000|Overall Study|Non-Compliance|12|||
130710839|NCT00296491|470567038|FG001|Overall Study|Non-Compliance|13|||
130710840|NCT00296491|470567039|FG002|Overall Study|Non-Compliance|10|||
130710841|NCT00296491|470567040|FG003|Overall Study|Non-Compliance|14|||
130710842|NCT00296491|470567037|FG000|Overall Study|Lost to Follow-up|0|||
130710843|NCT00296491|470567038|FG001|Overall Study|Lost to Follow-up|2|||
130280455|NCT04210245|468988780|FG000|Overall Study|Adverse Event|0|||
130280456|NCT04210245|468988781|FG001|Overall Study|Adverse Event|3|||
130280457|NCT04210245|468988782|FG002|Overall Study|Adverse Event|6|||
130280458|NCT04210245|468988783|FG003|Overall Study|Adverse Event|0|||
130280459|NCT04210245|468988780|FG000|Overall Study|Withdrawal by Subject|0|||
130280460|NCT04210245|468988781|FG001|Overall Study|Withdrawal by Subject|1|||
130280461|NCT04210245|468988782|FG002|Overall Study|Withdrawal by Subject|4|||
130280462|NCT04210245|468988783|FG003|Overall Study|Withdrawal by Subject|4|||
130280463|NCT04210245|468988780|FG000|Overall Study|Lost to Follow-up|0|||
130280464|NCT04210245|468988781|FG001|Overall Study|Lost to Follow-up|1|||
130280465|NCT04210245|468988782|FG002|Overall Study|Lost to Follow-up|1|||
130280466|NCT04210245|468988783|FG003|Overall Study|Lost to Follow-up|1|||
130280467|NCT04210245|468988780|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280468|NCT04210245|468988781|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280469|NCT04210245|468988782|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280470|NCT04210245|468988783|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
130457745|NCT02057692|469639946|FG000|Overall Study|Lost to Follow-up|0|||
130457746|NCT02057692|469639947|FG001|Overall Study|Lost to Follow-up|0|||
130457747|NCT02057692|469639948|FG002|Overall Study|Lost to Follow-up|0|||
130457748|NCT02057692|469639949|FG003|Overall Study|Lost to Follow-up|1|||
130457749|NCT00545844|469639950|FG000|Overall Study|Lost to Follow-up|9|||
130457750|NCT00545844|469639950|FG000|Overall Study|Protocol Violation|1|||
130457751|NCT00545844|469639950|FG000|Overall Study|Withdrawal by Subject|2|||
130457752|NCT03058991|469639954|FG000|Overall Study|Lost to Follow-up|17|||
130457753|NCT03058991|469639955|FG001|Overall Study|Lost to Follow-up|12|||
130457754|NCT03058991|469639956|FG002|Overall Study|Lost to Follow-up|12|||
130457755|NCT03058991|469639954|FG000|Overall Study|Withdrawal by Subject|1|||
130457756|NCT03058991|469639955|FG001|Overall Study|Withdrawal by Subject|0|||
130457757|NCT03058991|469639956|FG002|Overall Study|Withdrawal by Subject|0|||
130457758|NCT00130637|469639957|FG000|Overall Study|Adverse Event|2|||
130280485|NCT01252186|468988788|FG000|Overall Study|Adverse Event|9|||
130280486|NCT01252186|468988789|FG001|Overall Study|Adverse Event|6|||
130280487|NCT01252186|468988790|FG002|Overall Study|Adverse Event|8|||
130280488|NCT01252186|468988788|FG000|Overall Study|Withdrawal by Subject|2|||
130280489|NCT01252186|468988789|FG001|Overall Study|Withdrawal by Subject|5|||
130280490|NCT01252186|468988790|FG002|Overall Study|Withdrawal by Subject|2|||
130280491|NCT01252186|468988788|FG000|Overall Study|Physician Decision|0|||
130280492|NCT01252186|468988789|FG001|Overall Study|Physician Decision|0|||
130280493|NCT01252186|468988790|FG002|Overall Study|Physician Decision|1|||
130280494|NCT01252186|468988788|FG000|Overall Study|Non-compliance|0|||
130280495|NCT01252186|468988789|FG001|Overall Study|Non-compliance|3|||
130280496|NCT01252186|468988790|FG002|Overall Study|Non-compliance|4|||
130280497|NCT01252186|468988788|FG000|Overall Study|Protocol Violation|0|||
130280498|NCT01252186|468988789|FG001|Overall Study|Protocol Violation|0|||
130457759|NCT00130637|469639957|FG000|Overall Study|Withdrawal by Subject|1|||
130710844|NCT00296491|470567039|FG002|Overall Study|Lost to Follow-up|2|||
130710845|NCT00296491|470567040|FG003|Overall Study|Lost to Follow-up|0|||
130280499|NCT01252186|468988790|FG002|Overall Study|Protocol Violation|1|||
130280500|NCT01252186|468988788|FG000|Overall Study|Pregnancy|2|||
130280501|NCT01252186|468988789|FG001|Overall Study|Pregnancy|2|||
130280502|NCT01252186|468988790|FG002|Overall Study|Pregnancy|0|||
130710846|NCT01300052|470567041|FG000|Overall Study|Adverse Event|3|||
130710847|NCT01300052|470567042|FG001|Overall Study|Adverse Event|0|||
130710848|NCT01300052|470567041|FG000|Overall Study|Withdrawal by Subject|2|||
130280503|NCT01252186|468988788|FG000|Overall Study|Sponsor Request|2|||
130280504|NCT01252186|468988789|FG001|Overall Study|Sponsor Request|1|||
130280505|NCT01252186|468988790|FG002|Overall Study|Sponsor Request|0|||
130280506|NCT01252186|468988788|FG000|Overall Study|Lost to Follow-up|10|||
130280507|NCT01252186|468988789|FG001|Overall Study|Lost to Follow-up|10|||
130280508|NCT01252186|468988790|FG002|Overall Study|Lost to Follow-up|11|||
130710849|NCT01300052|470567042|FG001|Overall Study|Withdrawal by Subject|2|||
130710850|NCT01300052|470567041|FG000|Overall Study|Protocol Violation|1|||
130710851|NCT01300052|470567042|FG001|Overall Study|Protocol Violation|1|||
130710852|NCT06972251|470567043|FG000|Overall Study|Withdrawal by Subject|1|||
130710853|NCT06972251|470567044|FG001|Overall Study|Withdrawal by Subject|0|||
130710854|NCT06972251|470567043|FG000|Overall Study|Lost to Follow-up|10|||
130710855|NCT06972251|470567044|FG001|Overall Study|Lost to Follow-up|2|||
130710856|NCT01231373|470567045|FG000|Overall Study|Withdrew consent prior to randomization|2|||
130710857|NCT01231373|470567046|FG001|Overall Study|Withdrew consent prior to randomization|1|||
130710858|NCT01231373|470567047|FG002|Overall Study|Withdrew consent prior to randomization|0|||
130710859|NCT01231373|470567048|FG003|Overall Study|Withdrew consent prior to randomization|0|||
130710860|NCT01231373|470567045|FG000|Overall Study|Lost to Follow-up|0|||
130710861|NCT01231373|470567046|FG001|Overall Study|Lost to Follow-up|0|||
130710862|NCT01231373|470567047|FG002|Overall Study|Lost to Follow-up|0|||
130710863|NCT01231373|470567048|FG003|Overall Study|Lost to Follow-up|1|||
130710864|NCT01231373|470567045|FG000|Overall Study|Withdrew Consent|1|||
130710865|NCT01231373|470567046|FG001|Overall Study|Withdrew Consent|0|||
130280509|NCT01252186|468988788|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
130280510|NCT01252186|468988789|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
130280511|NCT01252186|468988790|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
130280512|NCT02524275|468988791|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
130280513|NCT04283994|468988792|FG000|Overall Study|Death|11|||
130280514|NCT04283994|468988793|FG001|Overall Study|Death|20|||
130280515|NCT04283994|468988794|FG002|Overall Study|Death|11|||
130280516|NCT04283994|468988795|FG003|Overall Study|Death|0|||
130280517|NCT04283994|468988796|FG004|Overall Study|Death|0|||
130280518|NCT04283994|468988797|FG005|Overall Study|Death|0|||
130280519|NCT04283994|468988798|FG006|Overall Study|Death|0|||
130280520|NCT04283994|468988792|FG000|Overall Study|Withdrawal by Subject|16|||
130280521|NCT04283994|468988793|FG001|Overall Study|Withdrawal by Subject|4|||
130280522|NCT04283994|468988794|FG002|Overall Study|Withdrawal by Subject|6|||
130280523|NCT04283994|468988795|FG003|Overall Study|Withdrawal by Subject|1|||
130280524|NCT04283994|468988796|FG004|Overall Study|Withdrawal by Subject|0|||
130280525|NCT04283994|468988797|FG005|Overall Study|Withdrawal by Subject|1|||
130280526|NCT04283994|468988798|FG006|Overall Study|Withdrawal by Subject|0|||
130280527|NCT03763656|468988799|FG000|Overall Study|Physician Decision|1|||
130280528|NCT03763656|468988799|FG000|Overall Study|Protocol Violation|1|||
130280529|NCT03763656|468988799|FG000|Overall Study|Withdrawal by Subject|7|||
130280530|NCT01795495|468988802|FG000|Overall Study|Protocol Violation|1|||
130280531|NCT01795495|468988803|FG001|Overall Study|Protocol Violation|0|||
130280532|NCT01795495|468988804|FG002|Overall Study|Protocol Violation|1|||
130280533|NCT01795495|468988802|FG000|Overall Study|Physician Decision|0|||
130280534|NCT01795495|468988803|FG001|Overall Study|Physician Decision|0|||
130280535|NCT01795495|468988804|FG002|Overall Study|Physician Decision|1|||
130280536|NCT01331837|468988805|FG000|Overall Study|Death|30|||
130280537|NCT01331837|468988806|FG001|Overall Study|Death|34|||
130280538|NCT01331837|468988805|FG000|Overall Study|Lost to Follow-up|3|||
130280539|NCT01331837|468988806|FG001|Overall Study|Lost to Follow-up|1|||
130280540|NCT01331837|468988805|FG000|Overall Study|Info not recorded|10|||
130280541|NCT01331837|468988806|FG001|Overall Study|Info not recorded|16|||
130280542|NCT01331837|468988805|FG000|Overall Study|Withdrawal by Subject|13|||
130280543|NCT01331837|468988806|FG001|Overall Study|Withdrawal by Subject|16|||
130280544|NCT03724981|468990365|FG000|First Device|Protocol Violation|1|||
130280545|NCT03724981|468990366|FG001|First Device|Protocol Violation|1|||
130280546|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130280547|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130280548|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
130280549|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
130710866|NCT01231373|470567047|FG002|Overall Study|Withdrew Consent|0|||
130710867|NCT01231373|470567048|FG003|Overall Study|Withdrew Consent|0|||
130710868|NCT03451006|470567049|FG000|Overall Study|Withdrawal by Subject|2|||
130710869|NCT03451006|470567050|FG001|Overall Study|Withdrawal by Subject|2|||
130710870|NCT01929395|470567051|FG000|Overall Study|Did not complete - non-related toxicity|1|||
130710871|NCT01929395|470567052|FG001|Overall Study|Did not complete - non-related toxicity|0|||
130710872|NCT01929395|470567053|FG002|Overall Study|Did not complete - non-related toxicity|0|||
130280550|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Other|2|||
130280551|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Other|2|||
130280552|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
130280553|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
130280554|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
130280555|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
130280556|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
130280557|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
130280558|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
130710873|NCT01929395|470567051|FG000|Overall Study|Withdrawal by Subject|0|||
130710874|NCT01929395|470567052|FG001|Overall Study|Withdrawal by Subject|1|||
130710875|NCT01929395|470567053|FG002|Overall Study|Withdrawal by Subject|0|||
130710876|NCT01929395|470567051|FG000|Overall Study|Screen Fail|0|||
130710877|NCT01929395|470567052|FG001|Overall Study|Screen Fail|0|||
130710878|NCT01929395|470567053|FG002|Overall Study|Screen Fail|1|||
130710879|NCT02547766|470567054|FG000|Overall Study|Withdrawal by Subject|1|||
130710880|NCT03604341|470567055|FG000|Overall Study|Withdrawal by Subject|1|||
130710881|NCT03604341|470567056|FG001|Overall Study|Withdrawal by Subject|1|||
130710882|NCT03604341|470567055|FG000|Overall Study|Adverse Event|1|||
130710883|NCT03604341|470567056|FG001|Overall Study|Adverse Event|0|||
130710884|NCT03604341|470567055|FG000|Overall Study|Protocol Violation|0|||
130710885|NCT03604341|470567056|FG001|Overall Study|Protocol Violation|1|||
130710886|NCT01829113|470567060|FG000|Overall Study|Disease Progression|37|||
130710887|NCT01829113|470567061|FG001|Overall Study|Disease Progression|48|||
130710888|NCT01829113|470567060|FG000|Overall Study|Adverse Event|14|||
130710889|NCT01829113|470567061|FG001|Overall Study|Adverse Event|10|||
130710890|NCT01829113|470567060|FG000|Overall Study|Withdrawal by Subject|17|||
130710891|NCT01829113|470567061|FG001|Overall Study|Withdrawal by Subject|10|||
130710892|NCT01829113|470567060|FG000|Overall Study|Death|4|||
130710893|NCT01829113|470567061|FG001|Overall Study|Death|6|||
130710894|NCT01829113|470567060|FG000|Overall Study|Sponsor Decision|1|||
130710895|NCT01829113|470567061|FG001|Overall Study|Sponsor Decision|1|||
130710896|NCT01829113|470567060|FG000|Overall Study|No Study Treatment Received|3|||
130710897|NCT01829113|470567061|FG001|Overall Study|No Study Treatment Received|2|||
130710898|NCT01829113|470567060|FG000|Overall Study|Physician Decision|1|||
130710899|NCT01829113|470567061|FG001|Overall Study|Physician Decision|1|||
130710900|NCT04134845|470567066|FG000|Overall Study|withdrawl by PI|5|||
130710901|NCT04134845|470567067|FG001|Overall Study|withdrawl by PI|12|||
130710902|NCT02010255|470567068|FG000|Overall Study|Death|0|||
130710903|NCT02010255|470567069|FG001|Overall Study|Death|1|||
130710904|NCT02010255|470567070|FG002|Overall Study|Death|4|||
130710905|NCT02010255|470567071|FG003|Overall Study|Death|4|||
130710906|NCT02010255|470567072|FG004|Overall Study|Death|2|||
130710907|NCT02010255|470567073|FG005|Overall Study|Death|0|||
130710908|NCT02010255|470567074|FG006|Overall Study|Death|1|||
130710909|NCT02010255|470567075|FG007|Overall Study|Death|1|||
130710910|NCT02010255|470567076|FG008|Overall Study|Death|1|||
130710911|NCT02010255|470567077|FG009|Overall Study|Death|0|||
130710912|NCT02010255|470567078|FG010|Overall Study|Death|1|||
130710913|NCT02010255|470567079|FG011|Overall Study|Death|1|||
130710914|NCT02010255|470567080|FG012|Overall Study|Death|0|||
130710915|NCT02010255|470567081|FG013|Overall Study|Death|0|||
130710916|NCT02010255|470567068|FG000|Overall Study|Lack of Efficacy|4|||
130710917|NCT02010255|470567069|FG001|Overall Study|Lack of Efficacy|1|||
130710918|NCT02010255|470567070|FG002|Overall Study|Lack of Efficacy|2|||
130710919|NCT02010255|470567071|FG003|Overall Study|Lack of Efficacy|1|||
130710920|NCT02010255|470567072|FG004|Overall Study|Lack of Efficacy|1|||
130710921|NCT02010255|470567073|FG005|Overall Study|Lack of Efficacy|0|||
130710922|NCT02010255|470567074|FG006|Overall Study|Lack of Efficacy|0|||
130710923|NCT02010255|470567075|FG007|Overall Study|Lack of Efficacy|0|||
130710924|NCT02010255|470567076|FG008|Overall Study|Lack of Efficacy|0|||
130710925|NCT02010255|470567077|FG009|Overall Study|Lack of Efficacy|0|||
130280559|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
130280560|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Other|1|||
130280561|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Other|0|||
130280562|NCT02578680|468990371|FG000|Overall Study|Death|329|||
130280563|NCT02578680|468990372|FG001|Overall Study|Death|181|||
130280564|NCT02578680|468990371|FG000|Overall Study|Lost to Follow-up|3|||
130280565|NCT02578680|468990372|FG001|Overall Study|Lost to Follow-up|1|||
130280566|NCT02578680|468990371|FG000|Overall Study|Physician Decision|0|||
130280567|NCT02578680|468990372|FG001|Overall Study|Physician Decision|1|||
130280568|NCT02578680|468990371|FG000|Overall Study|Protocol Violation|1|||
130457760|NCT01460342|469639959|FG000|Overall Study|Adverse Event|5|||
130710926|NCT02010255|470567078|FG010|Overall Study|Lack of Efficacy|1|||
130710927|NCT02010255|470567079|FG011|Overall Study|Lack of Efficacy|0|||
130710928|NCT02010255|470567080|FG012|Overall Study|Lack of Efficacy|0|||
130710929|NCT02010255|470567081|FG013|Overall Study|Lack of Efficacy|0|||
130710930|NCT02010255|470567068|FG000|Overall Study|Withdrew Consent|1|||
130710931|NCT02010255|470567069|FG001|Overall Study|Withdrew Consent|0|||
130710932|NCT02010255|470567070|FG002|Overall Study|Withdrew Consent|0|||
130280569|NCT02578680|468990372|FG001|Overall Study|Protocol Violation|1|||
130710933|NCT02010255|470567071|FG003|Overall Study|Withdrew Consent|1|||
130710934|NCT02010255|470567072|FG004|Overall Study|Withdrew Consent|0|||
130710935|NCT02010255|470567073|FG005|Overall Study|Withdrew Consent|0|||
130710936|NCT02010255|470567074|FG006|Overall Study|Withdrew Consent|0|||
130710937|NCT02010255|470567075|FG007|Overall Study|Withdrew Consent|0|||
130280570|NCT02578680|468990371|FG000|Overall Study|Sponsor Decision|64|||
130710938|NCT02010255|470567076|FG008|Overall Study|Withdrew Consent|0|||
130710939|NCT02010255|470567077|FG009|Overall Study|Withdrew Consent|0|||
130710940|NCT02010255|470567078|FG010|Overall Study|Withdrew Consent|0|||
130710941|NCT02010255|470567079|FG011|Overall Study|Withdrew Consent|0|||
130710942|NCT02010255|470567080|FG012|Overall Study|Withdrew Consent|0|||
130710943|NCT02010255|470567081|FG013|Overall Study|Withdrew Consent|0|||
130710944|NCT02010255|470567068|FG000|Overall Study|Adverse Event|1|||
130710945|NCT02010255|470567069|FG001|Overall Study|Adverse Event|0|||
130710946|NCT02010255|470567070|FG002|Overall Study|Adverse Event|0|||
130710947|NCT02010255|470567071|FG003|Overall Study|Adverse Event|0|||
130710948|NCT02010255|470567072|FG004|Overall Study|Adverse Event|0|||
130710949|NCT02010255|470567073|FG005|Overall Study|Adverse Event|0|||
130710950|NCT02010255|470567074|FG006|Overall Study|Adverse Event|0|||
130710951|NCT02010255|470567075|FG007|Overall Study|Adverse Event|0|||
130710952|NCT02010255|470567076|FG008|Overall Study|Adverse Event|0|||
130710953|NCT02010255|470567077|FG009|Overall Study|Adverse Event|0|||
130710954|NCT02010255|470567078|FG010|Overall Study|Adverse Event|0|||
130710955|NCT02010255|470567079|FG011|Overall Study|Adverse Event|0|||
130710956|NCT02010255|470567080|FG012|Overall Study|Adverse Event|0|||
130710957|NCT02010255|470567081|FG013|Overall Study|Adverse Event|0|||
130710958|NCT02010255|470567068|FG000|Overall Study|Lost to Follow-up|0|||
130710959|NCT02010255|470567069|FG001|Overall Study|Lost to Follow-up|0|||
130710960|NCT02010255|470567070|FG002|Overall Study|Lost to Follow-up|1|||
130710961|NCT02010255|470567071|FG003|Overall Study|Lost to Follow-up|0|||
130710962|NCT02010255|470567072|FG004|Overall Study|Lost to Follow-up|1|||
130710963|NCT02010255|470567073|FG005|Overall Study|Lost to Follow-up|0|||
130710964|NCT02010255|470567074|FG006|Overall Study|Lost to Follow-up|0|||
130710965|NCT02010255|470567075|FG007|Overall Study|Lost to Follow-up|0|||
130710966|NCT02010255|470567076|FG008|Overall Study|Lost to Follow-up|0|||
130710967|NCT02010255|470567077|FG009|Overall Study|Lost to Follow-up|0|||
130710968|NCT02010255|470567078|FG010|Overall Study|Lost to Follow-up|0|||
130710969|NCT02010255|470567079|FG011|Overall Study|Lost to Follow-up|0|||
130710970|NCT02010255|470567080|FG012|Overall Study|Lost to Follow-up|0|||
130710971|NCT02010255|470567081|FG013|Overall Study|Lost to Follow-up|0|||
130710972|NCT02010255|470567068|FG000|Overall Study|Randomized but Not Treated|0|||
130710973|NCT02010255|470567069|FG001|Overall Study|Randomized but Not Treated|0|||
130710974|NCT02010255|470567070|FG002|Overall Study|Randomized but Not Treated|0|||
130710975|NCT02010255|470567071|FG003|Overall Study|Randomized but Not Treated|0|||
130710976|NCT02010255|470567072|FG004|Overall Study|Randomized but Not Treated|0|||
130710977|NCT02010255|470567073|FG005|Overall Study|Randomized but Not Treated|0|||
130710978|NCT02010255|470567074|FG006|Overall Study|Randomized but Not Treated|0|||
130710979|NCT02010255|470567075|FG007|Overall Study|Randomized but Not Treated|0|||
130710980|NCT02010255|470567076|FG008|Overall Study|Randomized but Not Treated|0|||
130710981|NCT02010255|470567077|FG009|Overall Study|Randomized but Not Treated|0|||
130710982|NCT02010255|470567078|FG010|Overall Study|Randomized but Not Treated|0|||
130710983|NCT02010255|470567079|FG011|Overall Study|Randomized but Not Treated|0|||
130710984|NCT02010255|470567080|FG012|Overall Study|Randomized but Not Treated|0|||
130710985|NCT02010255|470567081|FG013|Overall Study|Randomized but Not Treated|1|||
130710986|NCT00767520|470567085|FG000|Overall Study|Participants still on treatment|11|||
130710987|NCT00767520|470567086|FG001|Overall Study|Participants still on treatment|15|||
130710988|NCT00767520|470567085|FG000|Overall Study|Randomized in error and Never treated|0|||
130280571|NCT02578680|468990372|FG001|Overall Study|Sponsor Decision|13|||
130280572|NCT02578680|468990371|FG000|Overall Study|Withdrawal by Subject|13|||
130280573|NCT02578680|468990372|FG001|Overall Study|Withdrawal by Subject|9|||
130280574|NCT03596047|468990373|FG000|Overall Study|Withdrawal by Subject|7|||
130280575|NCT03596047|468990374|FG001|Overall Study|Withdrawal by Subject|4|||
130280576|NCT03596047|468990373|FG000|Overall Study|Lost to Follow-up|0|||
130280577|NCT03596047|468990374|FG001|Overall Study|Lost to Follow-up|2|||
130280578|NCT02290691|468990375|FG000|Overall Study|Noncompliance|0|||
130280579|NCT02290691|468990376|FG001|Overall Study|Noncompliance|1|||
130280580|NCT02290691|468990375|FG000|Overall Study|Withdrawal by Subject|1|||
130280581|NCT02290691|468990376|FG001|Overall Study|Withdrawal by Subject|1|||
130280582|NCT02290691|468990375|FG000|Overall Study|Lost to Follow-up|7|||
130710989|NCT00767520|470567086|FG001|Overall Study|Randomized in error and Never treated|2|||
130280583|NCT02290691|468990376|FG001|Overall Study|Lost to Follow-up|7|||
130457761|NCT01460342|469639960|FG001|Overall Study|Adverse Event|4|||
130710990|NCT02777918|470567087|FG000|Overall Study|Medical reasons|1|||
130710991|NCT02777918|470567088|FG001|Overall Study|Medical reasons|2|||
130710992|NCT02777918|470567087|FG000|Overall Study|Too busy / stressed|1|||
130710993|NCT02777918|470567088|FG001|Overall Study|Too busy / stressed|1|||
130710994|NCT02777918|470567087|FG000|Overall Study|Withdrawal by Subject|1|||
130710995|NCT02777918|470567088|FG001|Overall Study|Withdrawal by Subject|1|||
130710996|NCT01338987|470567089|FG000|Overall Study|enrolled on new protocol|0|||
130710997|NCT01338987|470567090|FG001|Overall Study|enrolled on new protocol|0|||
130280584|NCT00734604|468990381|FG000|Overall Study|Adverse Event|0|||
130280585|NCT00734604|468990382|FG001|Overall Study|Adverse Event|2|||
130280586|NCT00734604|468990383|FG002|Overall Study|Adverse Event|0|||
130710998|NCT01338987|470567091|FG002|Overall Study|enrolled on new protocol|1|||
130710999|NCT01338987|470567092|FG003|Overall Study|enrolled on new protocol|0|||
130711000|NCT01338987|470567093|FG004|Overall Study|enrolled on new protocol|0|||
130711001|NCT01338987|470567089|FG000|Overall Study|Disease progression on study|2|||
130711002|NCT01338987|470567090|FG001|Overall Study|Disease progression on study|1|||
130368806|NCT01847274|469321223|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368807|NCT01847274|469321224|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368808|NCT01847274|469321225|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130368809|NCT01847274|469321215|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368810|NCT01847274|469321216|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368811|NCT01847274|469321217|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368812|NCT01847274|469321218|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368813|NCT01847274|469321219|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368814|NCT01847274|469321220|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368815|NCT01847274|469321221|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
130368816|NCT01847274|469321222|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368817|NCT01847274|469321223|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130711003|NCT01338987|470567091|FG002|Overall Study|Disease progression on study|1|||
130711004|NCT01338987|470567092|FG003|Overall Study|Disease progression on study|0|||
130711005|NCT01338987|470567093|FG004|Overall Study|Disease progression on study|0|||
130711006|NCT00757848|470567094|FG000|Overall Study|Voluntary discontinuation|1|||
130711007|NCT00757848|470567095|FG001|Overall Study|Voluntary discontinuation|0|||
130711008|NCT00757848|470567094|FG000|Overall Study|Adverse Event|1|||
130711009|NCT00757848|470567095|FG001|Overall Study|Adverse Event|2|||
130711010|NCT00757848|470567094|FG000|Overall Study|Incorrect enrolment|1|||
130280587|NCT00734604|468990384|FG003|Overall Study|Adverse Event|2|||
130280588|NCT00734604|468990385|FG004|Overall Study|Adverse Event|1|||
130280589|NCT00734604|468990386|FG005|Overall Study|Adverse Event|1|||
130280590|NCT00734604|468990381|FG000|Overall Study|Serious Adverse Event|1|||
130280591|NCT00734604|468990382|FG001|Overall Study|Serious Adverse Event|0|||
130280592|NCT00734604|468990383|FG002|Overall Study|Serious Adverse Event|1|||
130280593|NCT00734604|468990384|FG003|Overall Study|Serious Adverse Event|2|||
130280594|NCT00734604|468990385|FG004|Overall Study|Serious Adverse Event|0|||
130280595|NCT00734604|468990386|FG005|Overall Study|Serious Adverse Event|1|||
130280596|NCT00734604|468990381|FG000|Overall Study|Lost to Follow-up|1|||
130280597|NCT00734604|468990382|FG001|Overall Study|Lost to Follow-up|2|||
130280598|NCT00734604|468990383|FG002|Overall Study|Lost to Follow-up|2|||
130280599|NCT00734604|468990384|FG003|Overall Study|Lost to Follow-up|4|||
130280600|NCT00734604|468990385|FG004|Overall Study|Lost to Follow-up|2|||
130280601|NCT00734604|468990386|FG005|Overall Study|Lost to Follow-up|3|||
130280602|NCT00734604|468990381|FG000|Overall Study|Physician Decision|0|||
130280603|NCT00734604|468990382|FG001|Overall Study|Physician Decision|1|||
130280604|NCT00734604|468990383|FG002|Overall Study|Physician Decision|1|||
130280605|NCT00734604|468990384|FG003|Overall Study|Physician Decision|0|||
130280606|NCT00734604|468990385|FG004|Overall Study|Physician Decision|0|||
130280607|NCT00734604|468990386|FG005|Overall Study|Physician Decision|0|||
130280608|NCT00734604|468990381|FG000|Overall Study|Protocol Violation|0|||
130280609|NCT00734604|468990382|FG001|Overall Study|Protocol Violation|2|||
130280610|NCT00734604|468990383|FG002|Overall Study|Protocol Violation|0|||
130280611|NCT00734604|468990384|FG003|Overall Study|Protocol Violation|0|||
130280612|NCT00734604|468990385|FG004|Overall Study|Protocol Violation|1|||
130280613|NCT00734604|468990386|FG005|Overall Study|Protocol Violation|0|||
130280614|NCT00734604|468990381|FG000|Overall Study|Sponsor Decision|1|||
130280615|NCT00734604|468990382|FG001|Overall Study|Sponsor Decision|2|||
130280616|NCT00734604|468990383|FG002|Overall Study|Sponsor Decision|1|||
130280617|NCT00734604|468990384|FG003|Overall Study|Sponsor Decision|0|||
130280618|NCT00734604|468990385|FG004|Overall Study|Sponsor Decision|2|||
130280619|NCT00734604|468990386|FG005|Overall Study|Sponsor Decision|0|||
130280620|NCT00734604|468990381|FG000|Overall Study|Withdrawal by Subject|0|||
130280621|NCT00734604|468990382|FG001|Overall Study|Withdrawal by Subject|2|||
130280622|NCT00734604|468990383|FG002|Overall Study|Withdrawal by Subject|0|||
130280623|NCT00734604|468990384|FG003|Overall Study|Withdrawal by Subject|1|||
130280624|NCT00734604|468990385|FG004|Overall Study|Withdrawal by Subject|2|||
130280625|NCT00734604|468990386|FG005|Overall Study|Withdrawal by Subject|1|||
130280626|NCT00734604|468990381|FG000|Overall Study|Lack of Efficacy|0|||
130280627|NCT00734604|468990382|FG001|Overall Study|Lack of Efficacy|1|||
130368818|NCT01847274|469321224|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130711011|NCT00757848|470567095|FG001|Overall Study|Incorrect enrolment|0|||
130711012|NCT00058214|470567098|FG000|Overall Study|Adverse Event|1|||
130280628|NCT00734604|468990383|FG002|Overall Study|Lack of Efficacy|1|||
130280629|NCT00734604|468990384|FG003|Overall Study|Lack of Efficacy|0|||
130280630|NCT00734604|468990385|FG004|Overall Study|Lack of Efficacy|0|||
130280631|NCT00734604|468990386|FG005|Overall Study|Lack of Efficacy|0|||
130280632|NCT02589665|468990387|FG000|Induction Period|Did not receive drug|0|||
130280633|NCT02589665|468990388|FG001|Induction Period|Did not receive drug|0|||
130280634|NCT02589665|468990389|FG002|Induction Period|Did not receive drug|0|||
130280635|NCT02589665|468990390|FG003|Induction Period|Did not receive drug|1|||
130280636|NCT02589665|468990391|FG004|Induction Period|Did not receive drug|0|||
130280637|NCT02589665|468990392|FG005|Induction Period|Did not receive drug|0|||
130711013|NCT00958126|470567106|FG000|Overall Study|Serious Adverse Event|0|||
130711014|NCT00958126|470567107|FG001|Overall Study|Serious Adverse Event|2|||
130711015|NCT00958126|470567108|FG002|Overall Study|Serious Adverse Event|0|||
130711016|NCT00958126|470567109|FG003|Overall Study|Serious Adverse Event|0|||
130711017|NCT00958126|470567110|FG004|Overall Study|Serious Adverse Event|0|||
130711018|NCT00958126|470567111|FG005|Overall Study|Serious Adverse Event|0|||
130711019|NCT00958126|470567112|FG006|Overall Study|Serious Adverse Event|1|||
130711020|NCT00958126|470567113|FG007|Overall Study|Serious Adverse Event|0|||
130711021|NCT00958126|470567106|FG000|Overall Study|Withdrawal by Subject|0|||
130280638|NCT02589665|468990393|FG006|Induction Period|Did not receive drug|0|||
130280639|NCT02589665|468990394|FG007|Induction Period|Did not receive drug|0|||
130280640|NCT02589665|468990395|FG008|Induction Period|Did not receive drug|0|||
130280641|NCT02589665|468990396|FG009|Induction Period|Did not receive drug|0|||
130280642|NCT02589665|468990387|FG000|Induction Period|Adverse Event|3|||
130280643|NCT02589665|468990388|FG001|Induction Period|Adverse Event|0|||
130280644|NCT02589665|468990389|FG002|Induction Period|Adverse Event|2|||
130280645|NCT02589665|468990390|FG003|Induction Period|Adverse Event|2|||
130280646|NCT02589665|468990391|FG004|Induction Period|Adverse Event|0|||
130280647|NCT02589665|468990392|FG005|Induction Period|Adverse Event|0|||
130280648|NCT02589665|468990393|FG006|Induction Period|Adverse Event|0|||
130280649|NCT02589665|468990394|FG007|Induction Period|Adverse Event|0|||
130280650|NCT02589665|468990395|FG008|Induction Period|Adverse Event|0|||
130280651|NCT02589665|468990396|FG009|Induction Period|Adverse Event|0|||
130280652|NCT02589665|468990387|FG000|Induction Period|Withdrawal by Subject|0|||
130280653|NCT02589665|468990388|FG001|Induction Period|Withdrawal by Subject|1|||
130280654|NCT02589665|468990389|FG002|Induction Period|Withdrawal by Subject|0|||
130280655|NCT02589665|468990390|FG003|Induction Period|Withdrawal by Subject|1|||
130280656|NCT02589665|468990391|FG004|Induction Period|Withdrawal by Subject|0|||
130280657|NCT02589665|468990392|FG005|Induction Period|Withdrawal by Subject|0|||
130280658|NCT02589665|468990393|FG006|Induction Period|Withdrawal by Subject|0|||
130280659|NCT02589665|468990394|FG007|Induction Period|Withdrawal by Subject|0|||
130280660|NCT02589665|468990395|FG008|Induction Period|Withdrawal by Subject|0|||
130280661|NCT02589665|468990396|FG009|Induction Period|Withdrawal by Subject|0|||
130280662|NCT02589665|468990387|FG000|Induction Period|Protocol Violation|0|||
130280663|NCT02589665|468990388|FG001|Induction Period|Protocol Violation|1|||
130280664|NCT02589665|468990389|FG002|Induction Period|Protocol Violation|0|||
130280665|NCT02589665|468990390|FG003|Induction Period|Protocol Violation|0|||
130280666|NCT02589665|468990391|FG004|Induction Period|Protocol Violation|0|||
130280667|NCT02589665|468990392|FG005|Induction Period|Protocol Violation|0|||
130280668|NCT02589665|468990393|FG006|Induction Period|Protocol Violation|0|||
130280669|NCT02589665|468990394|FG007|Induction Period|Protocol Violation|0|||
130280670|NCT02589665|468990395|FG008|Induction Period|Protocol Violation|0|||
130280671|NCT02589665|468990396|FG009|Induction Period|Protocol Violation|0|||
130280672|NCT02589665|468990387|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280673|NCT02589665|468990388|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280674|NCT02589665|468990389|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280675|NCT02589665|468990390|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280676|NCT02589665|468990391|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
130280677|NCT02589665|468990392|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
130280678|NCT02589665|468990393|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
130280679|NCT02589665|468990394|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280680|NCT02589665|468990395|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280681|NCT02589665|468990396|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280682|NCT02589665|468990387|FG000|Maintenance Period|Withdrawal by Subject|0|||
130280683|NCT02589665|468990388|FG001|Maintenance Period|Withdrawal by Subject|0|||
130280684|NCT02589665|468990389|FG002|Maintenance Period|Withdrawal by Subject|0|||
130280685|NCT02589665|468990390|FG003|Maintenance Period|Withdrawal by Subject|0|||
130280686|NCT02589665|468990391|FG004|Maintenance Period|Withdrawal by Subject|4|||
130280687|NCT02589665|468990392|FG005|Maintenance Period|Withdrawal by Subject|2|||
130280688|NCT02589665|468990393|FG006|Maintenance Period|Withdrawal by Subject|4|||
130280689|NCT02589665|468990394|FG007|Maintenance Period|Withdrawal by Subject|0|||
130280690|NCT02589665|468990395|FG008|Maintenance Period|Withdrawal by Subject|0|||
130711022|NCT00958126|470567107|FG001|Overall Study|Withdrawal by Subject|2|||
130711023|NCT00958126|470567108|FG002|Overall Study|Withdrawal by Subject|0|||
130711024|NCT00958126|470567109|FG003|Overall Study|Withdrawal by Subject|0|||
130280691|NCT02589665|468990396|FG009|Maintenance Period|Withdrawal by Subject|0|||
130280692|NCT02589665|468990387|FG000|Maintenance Period|Lack of Efficacy|0|||
130280693|NCT02589665|468990388|FG001|Maintenance Period|Lack of Efficacy|0|||
130280694|NCT02589665|468990389|FG002|Maintenance Period|Lack of Efficacy|0|||
130280695|NCT02589665|468990390|FG003|Maintenance Period|Lack of Efficacy|0|||
130280696|NCT02589665|468990391|FG004|Maintenance Period|Lack of Efficacy|2|||
130280697|NCT02589665|468990392|FG005|Maintenance Period|Lack of Efficacy|1|||
130280698|NCT02589665|468990393|FG006|Maintenance Period|Lack of Efficacy|0|||
130711025|NCT00958126|470567110|FG004|Overall Study|Withdrawal by Subject|0|||
130711026|NCT00958126|470567111|FG005|Overall Study|Withdrawal by Subject|0|||
130711027|NCT00958126|470567112|FG006|Overall Study|Withdrawal by Subject|0|||
130711028|NCT00958126|470567113|FG007|Overall Study|Withdrawal by Subject|0|||
130280699|NCT02589665|468990394|FG007|Maintenance Period|Lack of Efficacy|0|||
130280700|NCT02589665|468990395|FG008|Maintenance Period|Lack of Efficacy|0|||
130280701|NCT02589665|468990396|FG009|Maintenance Period|Lack of Efficacy|0|||
130280702|NCT02589665|468990387|FG000|Maintenance Period|Adverse Event|0|||
130280703|NCT02589665|468990388|FG001|Maintenance Period|Adverse Event|0|||
130280704|NCT02589665|468990389|FG002|Maintenance Period|Adverse Event|0|||
130280705|NCT02589665|468990390|FG003|Maintenance Period|Adverse Event|0|||
130280706|NCT02589665|468990391|FG004|Maintenance Period|Adverse Event|0|||
130280707|NCT02589665|468990392|FG005|Maintenance Period|Adverse Event|0|||
130280708|NCT02589665|468990393|FG006|Maintenance Period|Adverse Event|2|||
130280709|NCT02589665|468990394|FG007|Maintenance Period|Adverse Event|0|||
130280710|NCT02589665|468990395|FG008|Maintenance Period|Adverse Event|0|||
130280711|NCT02589665|468990396|FG009|Maintenance Period|Adverse Event|0|||
130280712|NCT02589665|468990387|FG000|Maintenance Period|Lost to Follow-up|0|||
130280713|NCT02589665|468990388|FG001|Maintenance Period|Lost to Follow-up|0|||
130280714|NCT02589665|468990389|FG002|Maintenance Period|Lost to Follow-up|0|||
130280715|NCT02589665|468990390|FG003|Maintenance Period|Lost to Follow-up|0|||
130280716|NCT02589665|468990391|FG004|Maintenance Period|Lost to Follow-up|0|||
130280717|NCT02589665|468990392|FG005|Maintenance Period|Lost to Follow-up|1|||
130280718|NCT02589665|468990393|FG006|Maintenance Period|Lost to Follow-up|0|||
130280719|NCT02589665|468990394|FG007|Maintenance Period|Lost to Follow-up|0|||
130280720|NCT02589665|468990395|FG008|Maintenance Period|Lost to Follow-up|0|||
130280721|NCT02589665|468990396|FG009|Maintenance Period|Lost to Follow-up|0|||
130280722|NCT02589665|468990387|FG000|Maintenance Period|Physician Decision|0|||
130280723|NCT02589665|468990388|FG001|Maintenance Period|Physician Decision|0|||
130280724|NCT02589665|468990389|FG002|Maintenance Period|Physician Decision|0|||
130280725|NCT02589665|468990390|FG003|Maintenance Period|Physician Decision|0|||
130280726|NCT02589665|468990391|FG004|Maintenance Period|Physician Decision|0|||
130280727|NCT02589665|468990392|FG005|Maintenance Period|Physician Decision|1|||
130280728|NCT02589665|468990393|FG006|Maintenance Period|Physician Decision|0|||
130280729|NCT02589665|468990394|FG007|Maintenance Period|Physician Decision|0|||
130280730|NCT02589665|468990395|FG008|Maintenance Period|Physician Decision|0|||
130280731|NCT02589665|468990396|FG009|Maintenance Period|Physician Decision|0|||
130280732|NCT02589665|468990387|FG000|Maintenance Period|Reason Not Collected|0|||
130280733|NCT02589665|468990388|FG001|Maintenance Period|Reason Not Collected|0|||
130280734|NCT02589665|468990389|FG002|Maintenance Period|Reason Not Collected|0|||
130280735|NCT02589665|468990390|FG003|Maintenance Period|Reason Not Collected|0|||
130280736|NCT02589665|468990391|FG004|Maintenance Period|Reason Not Collected|0|||
130280737|NCT02589665|468990392|FG005|Maintenance Period|Reason Not Collected|1|||
130280738|NCT02589665|468990393|FG006|Maintenance Period|Reason Not Collected|1|||
130280739|NCT02589665|468990394|FG007|Maintenance Period|Reason Not Collected|0|||
130280740|NCT02589665|468990395|FG008|Maintenance Period|Reason Not Collected|0|||
130280741|NCT02589665|468990396|FG009|Maintenance Period|Reason Not Collected|0|||
130280742|NCT02589665|468990387|FG000|Induction Extension Period|Adverse Event|0|||
130280743|NCT02589665|468990388|FG001|Induction Extension Period|Adverse Event|0|||
130280744|NCT02589665|468990389|FG002|Induction Extension Period|Adverse Event|0|||
130280745|NCT02589665|468990390|FG003|Induction Extension Period|Adverse Event|0|||
130280746|NCT02589665|468990391|FG004|Induction Extension Period|Adverse Event|0|||
130280747|NCT02589665|468990392|FG005|Induction Extension Period|Adverse Event|0|||
130280748|NCT02589665|468990393|FG006|Induction Extension Period|Adverse Event|0|||
130280749|NCT02589665|468990394|FG007|Induction Extension Period|Adverse Event|0|||
130280750|NCT02589665|468990395|FG008|Induction Extension Period|Adverse Event|4|||
130280751|NCT02589665|468990396|FG009|Induction Extension Period|Adverse Event|0|||
130280752|NCT02589665|468990387|FG000|Induction Extension Period|Lack of Efficacy|0|||
130280753|NCT02589665|468990388|FG001|Induction Extension Period|Lack of Efficacy|0|||
130280754|NCT02589665|468990389|FG002|Induction Extension Period|Lack of Efficacy|0|||
130280755|NCT02589665|468990390|FG003|Induction Extension Period|Lack of Efficacy|0|||
130280756|NCT02589665|468990391|FG004|Induction Extension Period|Lack of Efficacy|0|||
130280757|NCT02589665|468990392|FG005|Induction Extension Period|Lack of Efficacy|0|||
130280758|NCT02589665|468990393|FG006|Induction Extension Period|Lack of Efficacy|0|||
130280759|NCT02589665|468990394|FG007|Induction Extension Period|Lack of Efficacy|0|||
130280760|NCT02589665|468990395|FG008|Induction Extension Period|Lack of Efficacy|3|||
130280761|NCT02589665|468990396|FG009|Induction Extension Period|Lack of Efficacy|0|||
130280762|NCT02589665|468990387|FG000|Induction Extension Period|Withdrawal by Subject|0|||
130280763|NCT02589665|468990388|FG001|Induction Extension Period|Withdrawal by Subject|0|||
130280764|NCT02589665|468990389|FG002|Induction Extension Period|Withdrawal by Subject|0|||
130280765|NCT02589665|468990390|FG003|Induction Extension Period|Withdrawal by Subject|0|||
130280766|NCT02589665|468990391|FG004|Induction Extension Period|Withdrawal by Subject|0|||
130280767|NCT02589665|468990392|FG005|Induction Extension Period|Withdrawal by Subject|0|||
130280768|NCT02589665|468990393|FG006|Induction Extension Period|Withdrawal by Subject|0|||
130280769|NCT02589665|468990394|FG007|Induction Extension Period|Withdrawal by Subject|2|||
130280770|NCT02589665|468990395|FG008|Induction Extension Period|Withdrawal by Subject|3|||
130280771|NCT02589665|468990396|FG009|Induction Extension Period|Withdrawal by Subject|0|||
130711029|NCT00958126|470567106|FG000|Overall Study|Moved away from study area|0|||
130711030|NCT00958126|470567107|FG001|Overall Study|Moved away from study area|0|||
130711031|NCT00958126|470567108|FG002|Overall Study|Moved away from study area|1|||
130711032|NCT00958126|470567109|FG003|Overall Study|Moved away from study area|1|||
130711033|NCT00958126|470567110|FG004|Overall Study|Moved away from study area|0|||
130711034|NCT00958126|470567111|FG005|Overall Study|Moved away from study area|0|||
130711035|NCT00958126|470567112|FG006|Overall Study|Moved away from study area|0|||
130711036|NCT00958126|470567113|FG007|Overall Study|Moved away from study area|0|||
130711037|NCT00958126|470567106|FG000|Overall Study|Lost to Follow-up|1|||
130711038|NCT00958126|470567107|FG001|Overall Study|Lost to Follow-up|5|||
130711039|NCT00958126|470567108|FG002|Overall Study|Lost to Follow-up|9|||
130711040|NCT00958126|470567109|FG003|Overall Study|Lost to Follow-up|8|||
130280772|NCT02589665|468990387|FG000|Induction Extension Period|Physician Decision|0|||
130280773|NCT02589665|468990388|FG001|Induction Extension Period|Physician Decision|0|||
130280774|NCT02589665|468990389|FG002|Induction Extension Period|Physician Decision|0|||
130280775|NCT02589665|468990390|FG003|Induction Extension Period|Physician Decision|0|||
130280776|NCT02589665|468990391|FG004|Induction Extension Period|Physician Decision|0|||
130280777|NCT02589665|468990392|FG005|Induction Extension Period|Physician Decision|0|||
130280778|NCT02589665|468990393|FG006|Induction Extension Period|Physician Decision|0|||
130280779|NCT02589665|468990394|FG007|Induction Extension Period|Physician Decision|0|||
130280780|NCT02589665|468990395|FG008|Induction Extension Period|Physician Decision|1|||
130280781|NCT02589665|468990396|FG009|Induction Extension Period|Physician Decision|0|||
130280782|NCT02589665|468990387|FG000|Induction Extension Period|Reason Not Collected|0|||
130280783|NCT02589665|468990388|FG001|Induction Extension Period|Reason Not Collected|0|||
130280784|NCT02589665|468990389|FG002|Induction Extension Period|Reason Not Collected|0|||
130280785|NCT02589665|468990390|FG003|Induction Extension Period|Reason Not Collected|0|||
130280786|NCT02589665|468990391|FG004|Induction Extension Period|Reason Not Collected|0|||
130280787|NCT02589665|468990392|FG005|Induction Extension Period|Reason Not Collected|0|||
130280788|NCT02589665|468990393|FG006|Induction Extension Period|Reason Not Collected|0|||
130280789|NCT02589665|468990394|FG007|Induction Extension Period|Reason Not Collected|0|||
130280790|NCT02589665|468990395|FG008|Induction Extension Period|Reason Not Collected|1|||
130280791|NCT02589665|468990396|FG009|Induction Extension Period|Reason Not Collected|0|||
130280792|NCT02589665|468990387|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280793|NCT02589665|468990388|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280794|NCT02589665|468990389|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280795|NCT02589665|468990390|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280796|NCT02589665|468990391|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280797|NCT02589665|468990392|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280798|NCT02589665|468990393|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280799|NCT02589665|468990394|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280800|NCT02589665|468990395|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280801|NCT02589665|468990396|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
130280802|NCT02589665|468990387|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
130280803|NCT02589665|468990388|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
130280804|NCT02589665|468990389|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
130280805|NCT02589665|468990390|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
130280806|NCT02589665|468990391|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
130280807|NCT02589665|468990392|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
130280808|NCT02589665|468990393|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
130280809|NCT02589665|468990394|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
130280810|NCT02589665|468990395|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
130280811|NCT02589665|468990396|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
130280812|NCT02589665|468990387|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
130280813|NCT02589665|468990388|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
130280814|NCT02589665|468990389|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
130280815|NCT02589665|468990390|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
130280816|NCT02589665|468990391|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
130280817|NCT02589665|468990392|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
130711041|NCT00958126|470567110|FG004|Overall Study|Lost to Follow-up|0|||
130711042|NCT00958126|470567111|FG005|Overall Study|Lost to Follow-up|0|||
130711043|NCT00958126|470567112|FG006|Overall Study|Lost to Follow-up|0|||
130711044|NCT00958126|470567113|FG007|Overall Study|Lost to Follow-up|0|||
130711045|NCT00958126|470567106|FG000|Overall Study|Sponsor/Investigator decision|0|||
130280818|NCT02589665|468990393|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
130280819|NCT02589665|468990394|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
130280820|NCT02589665|468990395|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
130280821|NCT02589665|468990396|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
130280822|NCT02589665|468990387|FG000|Maintenance Extension Period|Adverse Event|0|||
130280823|NCT02589665|468990388|FG001|Maintenance Extension Period|Adverse Event|0|||
130280824|NCT02589665|468990389|FG002|Maintenance Extension Period|Adverse Event|0|||
130280825|NCT02589665|468990390|FG003|Maintenance Extension Period|Adverse Event|0|||
130280826|NCT02589665|468990391|FG004|Maintenance Extension Period|Adverse Event|0|||
130280827|NCT02589665|468990392|FG005|Maintenance Extension Period|Adverse Event|0|||
130280828|NCT02589665|468990393|FG006|Maintenance Extension Period|Adverse Event|0|||
130280829|NCT02589665|468990394|FG007|Maintenance Extension Period|Adverse Event|0|||
130280830|NCT02589665|468990395|FG008|Maintenance Extension Period|Adverse Event|0|||
130280831|NCT02589665|468990396|FG009|Maintenance Extension Period|Adverse Event|2|||
130280832|NCT02589665|468990387|FG000|Maintenance Extension Period|Non-responder|0|||
130280833|NCT02589665|468990388|FG001|Maintenance Extension Period|Non-responder|0|||
130280834|NCT02589665|468990389|FG002|Maintenance Extension Period|Non-responder|0|||
130280835|NCT02589665|468990390|FG003|Maintenance Extension Period|Non-responder|0|||
130280836|NCT02589665|468990391|FG004|Maintenance Extension Period|Non-responder|0|||
130280837|NCT02589665|468990392|FG005|Maintenance Extension Period|Non-responder|0|||
130280838|NCT02589665|468990393|FG006|Maintenance Extension Period|Non-responder|0|||
130280839|NCT02589665|468990394|FG007|Maintenance Extension Period|Non-responder|0|||
130280840|NCT02589665|468990395|FG008|Maintenance Extension Period|Non-responder|0|||
130280841|NCT02589665|468990396|FG009|Maintenance Extension Period|Non-responder|1|||
130280842|NCT00978380|468990397|FG000|Overall Study|Protocol Violation|2|||
130280843|NCT00978380|468990397|FG000|Overall Study|Withdrawal criteria|9|||
130280844|NCT00978380|468990397|FG000|Overall Study|Unclassified|8|||
130280845|NCT01681069|468990405|FG000|Overall Study|Withdrawal by Subject|4|||
130280846|NCT01681069|468990406|FG001|Overall Study|Withdrawal by Subject|5|||
130280847|NCT01681069|468990405|FG000|Overall Study|Protocol Violation|1|||
130280848|NCT01681069|468990406|FG001|Overall Study|Protocol Violation|1|||
130280849|NCT01681069|468990405|FG000|Overall Study|Adverse Event|0|||
130280850|NCT01681069|468990406|FG001|Overall Study|Adverse Event|1|||
130280851|NCT03883165|468990407|FG000|Overall Study|Withdrawal by Subject|4|||
130280852|NCT03883165|468990408|FG001|Overall Study|Withdrawal by Subject|3|||
130280853|NCT00245050|468990412|FG000|Overall Study|Adverse Event|3|||
130280854|NCT00245050|468990413|FG001|Overall Study|Adverse Event|2|||
130280855|NCT00425698|468990414|FG000|Overall Study|Adverse Event|3|||
130280856|NCT00425698|468990415|FG001|Overall Study|Adverse Event|1|||
130280857|NCT00425698|468990414|FG000|Overall Study|Withdrawal by Subject|0|||
130280858|NCT00425698|468990415|FG001|Overall Study|Withdrawal by Subject|1|||
130280859|NCT03275246|468990422|FG000|Overall Study|Protocol Violation|5|||
130280860|NCT03275246|468990422|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
130280861|NCT02516098|468990431|FG000|Period 1|Protocol Violation|1|||
130280862|NCT02516098|468990432|FG001|Period 1|Protocol Violation|0|||
130280863|NCT02516098|468990431|FG000|Washout After Period 1|Adverse Event|0|||
130280864|NCT02516098|468990432|FG001|Washout After Period 1|Adverse Event|1|||
130280865|NCT02516098|468990431|FG000|Period 2|Withdrawal by Subject|0|||
130280866|NCT02516098|468990432|FG001|Period 2|Withdrawal by Subject|1|||
130280867|NCT00873041|468990433|FG000|Core Study|Adverse Event|2|||
130280868|NCT00873041|468990434|FG001|Core Study|Adverse Event|3|||
130280869|NCT00873041|468990435|FG002|Core Study|Adverse Event|1|||
130280870|NCT00873041|468990433|FG000|Core Study|Withdrawal by Subject|1|||
130280871|NCT00873041|468990434|FG001|Core Study|Withdrawal by Subject|2|||
130280872|NCT00873041|468990435|FG002|Core Study|Withdrawal by Subject|2|||
130280873|NCT00873041|468990433|FG000|Core Study|Lost to Follow-up|3|||
130280874|NCT00873041|468990434|FG001|Core Study|Lost to Follow-up|1|||
130280875|NCT00873041|468990435|FG002|Core Study|Lost to Follow-up|0|||
130280876|NCT00873041|468990433|FG000|Core Study|Abnormal laboratory value|0|||
130280877|NCT00873041|468990434|FG001|Core Study|Abnormal laboratory value|0|||
130368819|NCT01847274|469321225|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130368820|NCT01847274|469321215|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130280878|NCT00873041|468990435|FG002|Core Study|Abnormal laboratory value|1|||
130280879|NCT00873041|468990433|FG000|Core Study|Protocol deviation|1|||
130280880|NCT00873041|468990434|FG001|Core Study|Protocol deviation|0|||
130280881|NCT00873041|468990435|FG002|Core Study|Protocol deviation|1|||
130280882|NCT00873041|468990433|FG000|Extension Study|Adverse Event|1|||
130280883|NCT00873041|468990434|FG001|Extension Study|Adverse Event|0|||
130280884|NCT00873041|468990435|FG002|Extension Study|Adverse Event|1|||
130280885|NCT00873041|468990433|FG000|Extension Study|Administrative reasons|0|||
130280886|NCT00873041|468990434|FG001|Extension Study|Administrative reasons|0|||
130280887|NCT00873041|468990435|FG002|Extension Study|Administrative reasons|1|||
130280888|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
130280889|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
130711046|NCT00958126|470567107|FG001|Overall Study|Sponsor/Investigator decision|0|||
130711047|NCT00958126|470567108|FG002|Overall Study|Sponsor/Investigator decision|0|||
130711048|NCT00958126|470567109|FG003|Overall Study|Sponsor/Investigator decision|1|||
130711049|NCT00958126|470567110|FG004|Overall Study|Sponsor/Investigator decision|0|||
130280890|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
130280891|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
130280892|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130280893|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130280894|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130280895|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
130280896|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
130280897|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
130280898|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
130280899|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
130280900|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
130280901|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
130280902|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
130280903|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
130280904|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
130280905|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280906|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280907|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280908|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280909|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280910|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280911|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280912|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280913|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280914|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280915|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280916|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280917|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280918|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
130280919|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
130280920|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
130280921|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
130280922|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
130280923|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
130280924|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
130280925|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
130280926|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
130280927|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
130280928|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
130280929|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
130280930|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
130280931|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
130280932|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
130280933|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
130280934|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
130280935|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
130280936|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
130280937|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
130280938|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
130280939|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
130280940|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
130280941|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
130280942|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
130280943|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
130280944|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
130280945|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
130280946|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
130280947|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
130280948|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
130280949|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130280950|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
130280951|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
130280952|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280953|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280954|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280955|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130457762|NCT01460342|469639959|FG000|Overall Study|Lost to Follow-up|1|||
130711050|NCT00958126|470567111|FG005|Overall Study|Sponsor/Investigator decision|0|||
130280956|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280957|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280958|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280959|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280960|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280961|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280962|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280963|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
130280964|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
130280965|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
130280966|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
130280967|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280968|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280969|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280970|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280971|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280972|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280973|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280974|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280975|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280976|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280977|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280978|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280979|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280980|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280981|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
130280982|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280983|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280984|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280985|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280986|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280987|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280988|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280989|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280990|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280991|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280992|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280993|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280994|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280995|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280996|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280997|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130368821|NCT01847274|469321216|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368822|NCT01847274|469321217|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130280998|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
130368823|NCT01847274|469321218|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368824|NCT01847274|469321219|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368825|NCT01847274|469321220|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368826|NCT01847274|469321221|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
130368827|NCT01847274|469321222|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368828|NCT01847274|469321223|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368829|NCT01847274|469321224|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368830|NCT01847274|469321225|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130368831|NCT01847274|469321215|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368832|NCT01847274|469321216|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368833|NCT01847274|469321217|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368834|NCT01847274|469321218|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368835|NCT01847274|469321219|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368836|NCT01847274|469321220|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368837|NCT01847274|469321221|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130368838|NCT01847274|469321222|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
130368839|NCT01847274|469321223|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
130368840|NCT01847274|469321224|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
130280999|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
130368841|NCT01847274|469321225|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
130457763|NCT01460342|469639960|FG001|Overall Study|Lost to Follow-up|2|||
130368842|NCT01847274|469321215|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368843|NCT01847274|469321216|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368844|NCT01847274|469321217|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368845|NCT01847274|469321218|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368846|NCT01847274|469321219|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368847|NCT01847274|469321220|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130457764|NCT01460342|469639959|FG000|Overall Study|Protocol Violation|0|||
130457765|NCT01460342|469639960|FG001|Overall Study|Protocol Violation|1|||
130457766|NCT01460342|469639959|FG000|Overall Study|Withdrawal by Subject|3|||
130457767|NCT01460342|469639960|FG001|Overall Study|Withdrawal by Subject|4|||
130457768|NCT01460342|469639959|FG000|Overall Study|Physician Decision|1|||
130457769|NCT01460342|469639960|FG001|Overall Study|Physician Decision|3|||
130457770|NCT01460342|469639959|FG000|Overall Study|Lack of Efficacy|1|||
130457771|NCT01460342|469639960|FG001|Overall Study|Lack of Efficacy|0|||
130457772|NCT01689519|469639961|FG000|Intent to Treat|Death|157|||
130457773|NCT01689519|469639962|FG001|Intent to Treat|Death|167|||
130457774|NCT01689519|469639961|FG000|Intent to Treat|Lost to Follow-up|4|||
130457775|NCT01689519|469639962|FG001|Intent to Treat|Lost to Follow-up|8|||
130457776|NCT01689519|469639961|FG000|Intent to Treat|Other|2|||
130457777|NCT01689519|469639962|FG001|Intent to Treat|Other|4|||
130457778|NCT01689519|469639961|FG000|Intent to Treat|Physician Decision|4|||
130457779|NCT01689519|469639962|FG001|Intent to Treat|Physician Decision|1|||
130457780|NCT01689519|469639961|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
130457781|NCT01689519|469639962|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
130457782|NCT01689519|469639961|FG000|Intent to Treat|Withdrawal by Subject|21|||
130457783|NCT01689519|469639962|FG001|Intent to Treat|Withdrawal by Subject|20|||
130457784|NCT01689519|469639961|FG000|Safety Population|Death|158|||
130457785|NCT01689519|469639962|FG001|Safety Population|Death|165|||
130457786|NCT01689519|469639961|FG000|Safety Population|Lost to Follow-up|4|||
130711051|NCT00958126|470567112|FG006|Overall Study|Sponsor/Investigator decision|0|||
130711052|NCT00958126|470567113|FG007|Overall Study|Sponsor/Investigator decision|0|||
130711053|NCT00958126|470567106|FG000|Overall Study|Other Reason|0|||
130711054|NCT00958126|470567107|FG001|Overall Study|Other Reason|0|||
130711055|NCT00958126|470567108|FG002|Overall Study|Other Reason|0|||
130711056|NCT00958126|470567109|FG003|Overall Study|Other Reason|1|||
130368848|NCT01847274|469321221|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368849|NCT01847274|469321222|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
130368850|NCT01847274|469321223|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368851|NCT01847274|469321224|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
130368852|NCT01847274|469321225|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130368853|NCT01847274|469321215|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368854|NCT01847274|469321216|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368855|NCT01847274|469321217|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368856|NCT01847274|469321218|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368857|NCT01847274|469321219|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368858|NCT01847274|469321220|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368859|NCT01847274|469321221|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368860|NCT01847274|469321222|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
130368861|NCT01847274|469321223|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130368862|NCT01847274|469321224|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
130368863|NCT01847274|469321225|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
130368864|NCT01847274|469321215|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368865|NCT01847274|469321216|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368866|NCT01847274|469321217|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368867|NCT01847274|469321218|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368868|NCT01847274|469321219|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368869|NCT01847274|469321220|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368870|NCT01847274|469321221|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368871|NCT01847274|469321222|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368872|NCT01847274|469321223|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368873|NCT01847274|469321224|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
130368874|NCT01847274|469321225|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130368875|NCT03727230|469321226|FG000|Overall Study|Lost to Follow-up|12|||
130368876|NCT04377620|469321228|FG000|Overall Study|Death|42|||
130368877|NCT04377620|469321229|FG001|Overall Study|Death|48|||
130368878|NCT04377620|469321230|FG002|Overall Study|Death|36|||
130368879|NCT04377620|469321228|FG000|Overall Study|Withdrawal by Subject|0|||
130711057|NCT00958126|470567110|FG004|Overall Study|Other Reason|0|||
130711058|NCT00958126|470567111|FG005|Overall Study|Other Reason|1|||
130711059|NCT00958126|470567112|FG006|Overall Study|Other Reason|0|||
130711060|NCT00958126|470567113|FG007|Overall Study|Other Reason|0|||
130711061|NCT00720226|470567114|FG000|Overall Study|Withdrawal by Subject|7|||
130711062|NCT00720226|470567115|FG001|Overall Study|Withdrawal by Subject|4|||
130711063|NCT03401073|470567116|FG000|Overall Study|Lost to Follow-up|1|||
130711064|NCT03401073|470567117|FG001|Overall Study|Lost to Follow-up|2|||
130711065|NCT00733369|470567118|FG000|Overall Study|Lost to Follow-up|2|||
130711066|NCT00733369|470567119|FG001|Overall Study|Lost to Follow-up|1|||
130711067|NCT00733369|470567118|FG000|Overall Study|Adverse Event|4|||
130711068|NCT00733369|470567119|FG001|Overall Study|Adverse Event|4|||
130711069|NCT00733369|470567118|FG000|Overall Study|Protocol Violation|4|||
130711070|NCT00733369|470567119|FG001|Overall Study|Protocol Violation|4|||
130711071|NCT01470612|470567120|FG000|Overall Study|Adverse Event|20|||
130711072|NCT01470612|470567121|FG001|Overall Study|Adverse Event|80|||
130711073|NCT01470612|470567120|FG000|Overall Study|Death|0|||
130711074|NCT01470612|470567121|FG001|Overall Study|Death|1|||
130711075|NCT01470612|470567120|FG000|Overall Study|Lack of Efficacy|20|||
130711076|NCT01470612|470567121|FG001|Overall Study|Lack of Efficacy|326|||
130711077|NCT01470612|470567120|FG000|Overall Study|Lost to Follow-up|2|||
130711078|NCT01470612|470567121|FG001|Overall Study|Lost to Follow-up|5|||
130711079|NCT01470612|470567120|FG000|Overall Study|Did not meet entrance criteria|0|||
130711080|NCT01470612|470567121|FG001|Overall Study|Did not meet entrance criteria|1|||
130711081|NCT01470612|470567120|FG000|Overall Study|Pregnancy|2|||
130711082|NCT01470612|470567121|FG001|Overall Study|Pregnancy|10|||
130711083|NCT01470612|470567120|FG000|Overall Study|Protocol Violation|2|||
130711084|NCT01470612|470567121|FG001|Overall Study|Protocol Violation|7|||
130711085|NCT01470612|470567120|FG000|Overall Study|Withdrawal by Subject|24|||
130711086|NCT01470612|470567121|FG001|Overall Study|Withdrawal by Subject|79|||
130711087|NCT01470612|470567120|FG000|Overall Study|Other|14|||
130711088|NCT01470612|470567121|FG001|Overall Study|Other|156|||
130711089|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130711090|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130711091|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
130711092|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
130711093|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
130711094|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
130711095|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
130711096|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
130711097|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
130711098|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
130711099|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
130711100|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
130711101|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
130711102|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
130711103|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
130711104|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
130711105|NCT02510014|470567125|FG000|Treatment Period|Adverse Event|11|||
130711106|NCT02510014|470567126|FG001|Treatment Period|Adverse Event|4|||
130711107|NCT02510014|470567125|FG000|Treatment Period|Withdrawal symptoms|3|||
130711108|NCT02510014|470567126|FG001|Treatment Period|Withdrawal symptoms|0|||
130711109|NCT02510014|470567125|FG000|Treatment Period|Lost to Follow-up|80|||
130711110|NCT02510014|470567126|FG001|Treatment Period|Lost to Follow-up|19|||
130711111|NCT02510014|470567125|FG000|Treatment Period|Physician Decision|5|||
130711112|NCT02510014|470567126|FG001|Treatment Period|Physician Decision|0|||
130711113|NCT02510014|470567125|FG000|Treatment Period|Withdrawal by Subject|67|||
130711114|NCT02510014|470567126|FG001|Treatment Period|Withdrawal by Subject|24|||
130711115|NCT02510014|470567125|FG000|Treatment Period|Withdrawn by the investigator|7|||
130457787|NCT01689519|469639962|FG001|Safety Population|Lost to Follow-up|8|||
130457788|NCT01689519|469639961|FG000|Safety Population|Other|2|||
130711116|NCT02510014|470567126|FG001|Treatment Period|Withdrawn by the investigator|1|||
130711117|NCT02510014|470567125|FG000|Treatment Period|Protocol Violation|4|||
130711118|NCT02510014|470567126|FG001|Treatment Period|Protocol Violation|4|||
130457789|NCT01689519|469639962|FG001|Safety Population|Other|4|||
130711119|NCT02510014|470567125|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
130281000|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130457790|NCT01689519|469639961|FG000|Safety Population|Physician Decision|4|||
130457791|NCT01689519|469639962|FG001|Safety Population|Physician Decision|1|||
130711120|NCT02510014|470567126|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
130711121|NCT02556307|470567128|FG000|Overall Study|Premature treatment interruption|11|||
130711122|NCT02556307|470567128|FG000|Overall Study|Lost to Follow-up|36|||
130711123|NCT02556307|470567128|FG000|Overall Study|Change to triple therapy|4|||
130711124|NCT02556307|470567128|FG000|Overall Study|Enrolled but not treated|2|||
130711125|NCT00706992|470567134|FG000|Overall Study|Study termination|5|||
130711126|NCT00706992|470567135|FG001|Overall Study|Study termination|5|||
130281001|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
130281002|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281003|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130281004|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
130281005|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281006|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281007|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
130281008|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281009|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281010|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281011|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281012|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281013|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281014|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281015|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281016|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281017|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281018|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281019|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281020|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281021|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281022|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130281023|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281024|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281025|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281026|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281027|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281028|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281029|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281030|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281031|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281032|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281033|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281034|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281035|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130368880|NCT04377620|469321229|FG001|Overall Study|Withdrawal by Subject|2|||
130368881|NCT04377620|469321230|FG002|Overall Study|Withdrawal by Subject|0|||
130368882|NCT02849678|469321231|FG000|Overall Study|Protocol Violation|3|||
130368883|NCT02849678|469321232|FG001|Overall Study|Protocol Violation|6|||
130368884|NCT00289991|469321233|FG000|Overall Study|Death|35|||
130368885|NCT00289991|469321234|FG001|Overall Study|Death|38|||
130281036|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281037|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
130281038|NCT02300558|468990451|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
130281039|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
130281040|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
130281041|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
130281042|NCT01054560|468990454|FG000|Overall Study|Death|10|||
130281043|NCT01054560|468990455|FG001|Overall Study|Death|21|||
130281044|NCT01054560|468990454|FG000|Overall Study|Lost to Follow-up|2|||
130281045|NCT01054560|468990455|FG001|Overall Study|Lost to Follow-up|5|||
130281046|NCT01054560|468990454|FG000|Overall Study|Withdrawal by Subject|0|||
130281047|NCT01054560|468990455|FG001|Overall Study|Withdrawal by Subject|2|||
130281048|NCT01054560|468990454|FG000|Overall Study|Physician Decision|1|||
130281049|NCT01054560|468990455|FG001|Overall Study|Physician Decision|0|||
130281050|NCT02135029|468990459|FG000|Overall Study|Adverse Event|2|||
130281051|NCT02135029|468990460|FG001|Overall Study|Adverse Event|2|||
130281052|NCT02135029|468990461|FG002|Overall Study|Adverse Event|2|||
130281053|NCT02135029|468990459|FG000|Overall Study|Lost to Follow-up|0|||
130281054|NCT02135029|468990460|FG001|Overall Study|Lost to Follow-up|1|||
130281055|NCT02135029|468990461|FG002|Overall Study|Lost to Follow-up|0|||
130281056|NCT02135029|468990459|FG000|Overall Study|Withdrawal by Subject|2|||
130281057|NCT02135029|468990460|FG001|Overall Study|Withdrawal by Subject|0|||
130281058|NCT02135029|468990461|FG002|Overall Study|Withdrawal by Subject|1|||
130368886|NCT00289991|469321233|FG000|Overall Study|Adverse Event|15|||
130368887|NCT00289991|469321234|FG001|Overall Study|Adverse Event|13|||
130281059|NCT02135029|468990459|FG000|Overall Study|Other|0|||
130281060|NCT02135029|468990460|FG001|Overall Study|Other|1|||
130281061|NCT02135029|468990461|FG002|Overall Study|Other|0|||
130281062|NCT02135029|468990459|FG000|Overall Study|Death|0|||
130368888|NCT00289991|469321233|FG000|Overall Study|Failure of prophylaxis|1|||
130368889|NCT00289991|469321234|FG001|Overall Study|Failure of prophylaxis|1|||
130281063|NCT02135029|468990460|FG001|Overall Study|Death|1|||
130711127|NCT00706992|470567136|FG002|Overall Study|Study termination|6|||
130711128|NCT00706992|470567137|FG003|Overall Study|Study termination|2|||
130711129|NCT00706992|470567138|FG004|Overall Study|Study termination|3|||
130711130|NCT00706992|470567139|FG005|Overall Study|Study termination|2|||
130711131|NCT00706992|470567140|FG006|Overall Study|Study termination|3|||
130711132|NCT00706992|470567134|FG000|Overall Study|Disease progression before treatment|0|||
130711133|NCT00706992|470567135|FG001|Overall Study|Disease progression before treatment|0|||
130711134|NCT00706992|470567136|FG002|Overall Study|Disease progression before treatment|0|||
130711135|NCT00706992|470567137|FG003|Overall Study|Disease progression before treatment|0|||
130711136|NCT00706992|470567138|FG004|Overall Study|Disease progression before treatment|1|||
130711137|NCT00706992|470567139|FG005|Overall Study|Disease progression before treatment|0|||
130711138|NCT00706992|470567140|FG006|Overall Study|Disease progression before treatment|0|||
130711139|NCT02377063|470567144|FG000|Overall Study|Non-compliance|5|||
130711140|NCT00702208|470567145|FG000|Overall Study|Lost to Follow-up|28|||
130711141|NCT00702208|470567145|FG000|Overall Study|Did not self-lavage|1|||
130281064|NCT02135029|468990461|FG002|Overall Study|Death|0|||
130281065|NCT00712725|468990462|FG000|Overall Study|Adverse Event|1|||
130281066|NCT00712725|468990463|FG001|Overall Study|Adverse Event|0|||
130281067|NCT00712725|468990464|FG002|Overall Study|Adverse Event|0|||
130281068|NCT00712725|468990465|FG003|Overall Study|Adverse Event|1|||
130281069|NCT00712725|468990466|FG004|Overall Study|Adverse Event|0|||
130281070|NCT00712725|468990467|FG005|Overall Study|Adverse Event|0|||
130281071|NCT00712725|468990468|FG006|Overall Study|Adverse Event|0|||
130281072|NCT00712725|468990469|FG007|Overall Study|Adverse Event|0|||
130281073|NCT00712725|468990462|FG000|Overall Study|Lost to Follow-up|3|||
130281074|NCT00712725|468990463|FG001|Overall Study|Lost to Follow-up|2|||
130281075|NCT00712725|468990464|FG002|Overall Study|Lost to Follow-up|1|||
130281076|NCT00712725|468990465|FG003|Overall Study|Lost to Follow-up|1|||
130281077|NCT00712725|468990466|FG004|Overall Study|Lost to Follow-up|2|||
130281078|NCT00712725|468990467|FG005|Overall Study|Lost to Follow-up|2|||
130281079|NCT00712725|468990468|FG006|Overall Study|Lost to Follow-up|3|||
130281080|NCT00712725|468990469|FG007|Overall Study|Lost to Follow-up|1|||
130281081|NCT00712725|468990462|FG000|Overall Study|Physician Decision|2|||
130281082|NCT00712725|468990463|FG001|Overall Study|Physician Decision|0|||
130281083|NCT00712725|468990464|FG002|Overall Study|Physician Decision|0|||
130281084|NCT00712725|468990465|FG003|Overall Study|Physician Decision|0|||
130281085|NCT00712725|468990466|FG004|Overall Study|Physician Decision|1|||
130281086|NCT00712725|468990467|FG005|Overall Study|Physician Decision|0|||
130281087|NCT00712725|468990468|FG006|Overall Study|Physician Decision|2|||
130281088|NCT00712725|468990469|FG007|Overall Study|Physician Decision|0|||
130281089|NCT00712725|468990462|FG000|Overall Study|Pregnancy|0|||
130281090|NCT00712725|468990463|FG001|Overall Study|Pregnancy|1|||
130281091|NCT00712725|468990464|FG002|Overall Study|Pregnancy|0|||
130281092|NCT00712725|468990465|FG003|Overall Study|Pregnancy|0|||
130281093|NCT00712725|468990466|FG004|Overall Study|Pregnancy|1|||
130281094|NCT00712725|468990467|FG005|Overall Study|Pregnancy|0|||
130281095|NCT00712725|468990468|FG006|Overall Study|Pregnancy|2|||
130281096|NCT00712725|468990469|FG007|Overall Study|Pregnancy|0|||
130281097|NCT00712725|468990462|FG000|Overall Study|Protocol Violation|2|||
130281098|NCT00712725|468990463|FG001|Overall Study|Protocol Violation|0|||
130281099|NCT00712725|468990464|FG002|Overall Study|Protocol Violation|1|||
130281100|NCT00712725|468990465|FG003|Overall Study|Protocol Violation|3|||
130281101|NCT00712725|468990466|FG004|Overall Study|Protocol Violation|2|||
130281102|NCT00712725|468990467|FG005|Overall Study|Protocol Violation|0|||
130711142|NCT00702208|470567145|FG000|Overall Study|Unsatisfactory colposcopy|2|||
130711143|NCT02746627|470567146|FG000|Overall Study|Withdrawal by Subject|1|||
130711144|NCT02746627|470567147|FG001|Overall Study|Withdrawal by Subject|1|||
130281103|NCT00712725|468990468|FG006|Overall Study|Protocol Violation|1|||
130281104|NCT00712725|468990469|FG007|Overall Study|Protocol Violation|1|||
130281105|NCT00712725|468990462|FG000|Overall Study|Withdrawal by Subject|2|||
130281106|NCT00712725|468990463|FG001|Overall Study|Withdrawal by Subject|1|||
130368890|NCT00289991|469321233|FG000|Overall Study|Fungal breakthrough infection|0|||
130281107|NCT00712725|468990464|FG002|Overall Study|Withdrawal by Subject|1|||
130281108|NCT00712725|468990465|FG003|Overall Study|Withdrawal by Subject|2|||
130281109|NCT00712725|468990466|FG004|Overall Study|Withdrawal by Subject|1|||
130281110|NCT00712725|468990467|FG005|Overall Study|Withdrawal by Subject|1|||
130281111|NCT00712725|468990468|FG006|Overall Study|Withdrawal by Subject|1|||
130281112|NCT00712725|468990469|FG007|Overall Study|Withdrawal by Subject|2|||
130711145|NCT02746627|470567148|FG002|Overall Study|Withdrawal by Subject|1|||
130711146|NCT01392326|470567153|FG000|Overall Study|Death|2|||
130711147|NCT01392326|470567154|FG001|Overall Study|Death|0|||
130711148|NCT01392326|470567155|FG002|Overall Study|Death|0|||
130281113|NCT00712725|468990462|FG000|Overall Study|Lack of Qualifying Event|16|||
130281114|NCT00712725|468990463|FG001|Overall Study|Lack of Qualifying Event|2|||
130281115|NCT00712725|468990464|FG002|Overall Study|Lack of Qualifying Event|6|||
130711149|NCT01392326|470567153|FG000|Overall Study|Withdrawal by Subject|12|||
130711150|NCT01392326|470567154|FG001|Overall Study|Withdrawal by Subject|11|||
130711151|NCT01392326|470567155|FG002|Overall Study|Withdrawal by Subject|15|||
130711152|NCT01392326|470567153|FG000|Overall Study|Protocol Violation|2|||
130711153|NCT01392326|470567154|FG001|Overall Study|Protocol Violation|0|||
130711154|NCT01392326|470567155|FG002|Overall Study|Protocol Violation|0|||
130711155|NCT01392326|470567153|FG000|Overall Study|Pregnancy|0|||
130711156|NCT01392326|470567154|FG001|Overall Study|Pregnancy|0|||
130711157|NCT01392326|470567155|FG002|Overall Study|Pregnancy|1|||
130711158|NCT01392326|470567153|FG000|Overall Study|Physician Decision|7|||
130711159|NCT01392326|470567154|FG001|Overall Study|Physician Decision|5|||
130711160|NCT01392326|470567155|FG002|Overall Study|Physician Decision|2|||
130711161|NCT01392326|470567153|FG000|Overall Study|Lost to Follow-up|1|||
130711162|NCT01392326|470567154|FG001|Overall Study|Lost to Follow-up|3|||
130711163|NCT01392326|470567155|FG002|Overall Study|Lost to Follow-up|4|||
130711164|NCT01392326|470567153|FG000|Overall Study|Lack of Efficacy|14|||
130711165|NCT01392326|470567154|FG001|Overall Study|Lack of Efficacy|10|||
130711166|NCT01392326|470567155|FG002|Overall Study|Lack of Efficacy|15|||
130711167|NCT01392326|470567153|FG000|Overall Study|Adverse Event|9|||
130711168|NCT01392326|470567154|FG001|Overall Study|Adverse Event|6|||
130711169|NCT01392326|470567155|FG002|Overall Study|Adverse Event|11|||
130711170|NCT00233987|470567158|FG000|Overall Study|Withdrawal by Subject|1|||
130711171|NCT00233987|470567158|FG000|Overall Study|Lack of Efficacy|2|||
130711172|NCT00233987|470567158|FG000|Overall Study|Reason Under Review|1|||
130711173|NCT00233987|470567158|FG000|Overall Study|Other - Not Protocol Specified|5|||
130711174|NCT00233987|470567158|FG000|Overall Study|Eligible but No Treatment Received|2|||
130711175|NCT00233987|470567158|FG000|Overall Study|Ineligible|4|||
130711176|NCT00518622|470567161|FG000|Overall Study|Lost to Follow-up|0|||
130711177|NCT00518622|470567162|FG001|Overall Study|Lost to Follow-up|0|||
130711178|NCT00518622|470567163|FG002|Overall Study|Lost to Follow-up|1|||
130711179|NCT00518622|470567164|FG003|Overall Study|Lost to Follow-up|0|||
130711180|NCT00518622|470567165|FG004|Overall Study|Lost to Follow-up|0|||
130711181|NCT00518622|470567166|FG005|Overall Study|Lost to Follow-up|0|||
130711182|NCT00518622|470567167|FG006|Overall Study|Lost to Follow-up|0|||
130711183|NCT00518622|470567168|FG007|Overall Study|Lost to Follow-up|0|||
130281116|NCT00712725|468990465|FG003|Overall Study|Lack of Qualifying Event|8|||
130281117|NCT00712725|468990466|FG004|Overall Study|Lack of Qualifying Event|11|||
130281118|NCT00712725|468990467|FG005|Overall Study|Lack of Qualifying Event|13|||
130281119|NCT00712725|468990468|FG006|Overall Study|Lack of Qualifying Event|11|||
130281120|NCT00712725|468990469|FG007|Overall Study|Lack of Qualifying Event|6|||
130281121|NCT00712725|468990462|FG000|Overall Study|Protocol Specified Criteria|3|||
130281122|NCT00712725|468990463|FG001|Overall Study|Protocol Specified Criteria|0|||
130281123|NCT00712725|468990464|FG002|Overall Study|Protocol Specified Criteria|1|||
130281124|NCT00712725|468990465|FG003|Overall Study|Protocol Specified Criteria|2|||
130281125|NCT00712725|468990466|FG004|Overall Study|Protocol Specified Criteria|1|||
130281126|NCT00712725|468990467|FG005|Overall Study|Protocol Specified Criteria|0|||
130281127|NCT00712725|468990468|FG006|Overall Study|Protocol Specified Criteria|2|||
130281128|NCT00712725|468990469|FG007|Overall Study|Protocol Specified Criteria|1|||
130281129|NCT03466099|468990470|FG000|Overall Study|Adverse Event|1|||
130281130|NCT03466099|468990471|FG001|Overall Study|Adverse Event|1|||
130281131|NCT03466099|468990472|FG002|Overall Study|Adverse Event|1|||
130281132|NCT03466099|468990470|FG000|Overall Study|Withdrawal by Subject|2|||
130281133|NCT03466099|468990471|FG001|Overall Study|Withdrawal by Subject|3|||
130281134|NCT03466099|468990472|FG002|Overall Study|Withdrawal by Subject|1|||
130281135|NCT03466099|468990470|FG000|Overall Study|Use of rescue medication|8|||
130368891|NCT00289991|469321234|FG001|Overall Study|Fungal breakthrough infection|1|||
130368892|NCT00289991|469321233|FG000|Overall Study|Lost to Follow-up|0|||
130368893|NCT00289991|469321234|FG001|Overall Study|Lost to Follow-up|1|||
130711184|NCT00518622|470567161|FG000|Overall Study|Study medication taken incorrectly|0|||
130711185|NCT00518622|470567162|FG001|Overall Study|Study medication taken incorrectly|1|||
130711186|NCT00518622|470567163|FG002|Overall Study|Study medication taken incorrectly|0|||
130711187|NCT00518622|470567164|FG003|Overall Study|Study medication taken incorrectly|0|||
130711188|NCT00518622|470567165|FG004|Overall Study|Study medication taken incorrectly|0|||
130711189|NCT00518622|470567166|FG005|Overall Study|Study medication taken incorrectly|0|||
130711190|NCT00518622|470567167|FG006|Overall Study|Study medication taken incorrectly|0|||
130711191|NCT00518622|470567168|FG007|Overall Study|Study medication taken incorrectly|0|||
130711192|NCT03821272|470567929|FG000|Overall Study|Death|1|||
130711193|NCT03821272|470567930|FG001|Overall Study|Death|0|||
130711194|NCT03821272|470567929|FG000|Overall Study|Physician Decision|1|||
130711195|NCT03821272|470567930|FG001|Overall Study|Physician Decision|0|||
130711196|NCT03821272|470567929|FG000|Overall Study|Withdrawal by Subject|1|||
130711197|NCT03821272|470567930|FG001|Overall Study|Withdrawal by Subject|0|||
130281136|NCT03466099|468990471|FG001|Overall Study|Use of rescue medication|9|||
130281137|NCT03466099|468990472|FG002|Overall Study|Use of rescue medication|13|||
130281138|NCT03466099|468990470|FG000|Overall Study|Rescued without meeting criteria|4|||
130281139|NCT03466099|468990471|FG001|Overall Study|Rescued without meeting criteria|1|||
130281140|NCT03466099|468990472|FG002|Overall Study|Rescued without meeting criteria|1|||
130281141|NCT03466099|468990470|FG000|Overall Study|Subject compliance|2|||
130281142|NCT03466099|468990471|FG001|Overall Study|Subject compliance|0|||
130281143|NCT03466099|468990472|FG002|Overall Study|Subject compliance|0|||
130281144|NCT03466099|468990470|FG000|Overall Study|Worsening disease|0|||
130281145|NCT03466099|468990471|FG001|Overall Study|Worsening disease|0|||
130281146|NCT03466099|468990472|FG002|Overall Study|Worsening disease|1|||
130281147|NCT00613327|468990475|FG000|Overall Study|Adverse Event|38|||
130281148|NCT00613327|468990475|FG000|Overall Study|Lost to Follow-up|8|||
130457792|NCT01689519|469639961|FG000|Safety Population|Study Terminated By Sponsor|60|||
130281149|NCT00613327|468990475|FG000|Overall Study|Withdrawal by Subject|6|||
130281150|NCT00613327|468990475|FG000|Overall Study|Protocol Violation|2|||
130281151|NCT00613327|468990475|FG000|Overall Study|Other|47|||
130281152|NCT03832322|468990478|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
130281153|NCT03832322|468990479|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
130281154|NCT00404755|468990480|FG000|Phase I (Bupropion)|Adverse Event|3|||
130281155|NCT00404755|468990480|FG000|Phase I (Bupropion)|Other|1|||
130281156|NCT00404755|468990480|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
130281157|NCT00350870|468990481|FG000|Overall Study|Withdrawal by Subject|21|||
130281158|NCT00350870|468990482|FG001|Overall Study|Withdrawal by Subject|17|||
130281159|NCT00350870|468990483|FG002|Overall Study|Withdrawal by Subject|15|||
130281160|NCT00350870|468990484|FG003|Overall Study|Withdrawal by Subject|14|||
130281161|NCT00350870|468990481|FG000|Overall Study|Physician Decision|1|||
130281162|NCT00350870|468990482|FG001|Overall Study|Physician Decision|0|||
130281163|NCT00350870|468990483|FG002|Overall Study|Physician Decision|1|||
130281164|NCT00350870|468990484|FG003|Overall Study|Physician Decision|1|||
130281165|NCT03194568|468990485|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
130281166|NCT01453205|468990486|FG000|Overall Study|Lost to Follow-up|3|||
130281167|NCT01453205|468990487|FG001|Overall Study|Lost to Follow-up|0|||
130281168|NCT01453205|468990488|FG002|Overall Study|Lost to Follow-up|1|||
130281169|NCT01453205|468990486|FG000|Overall Study|Withdrawal by Subject|8|||
130281170|NCT01453205|468990487|FG001|Overall Study|Withdrawal by Subject|3|||
130281171|NCT01453205|468990488|FG002|Overall Study|Withdrawal by Subject|0|||
130281172|NCT01453205|468990486|FG000|Overall Study|Death|24|||
130281173|NCT01453205|468990487|FG001|Overall Study|Death|22|||
130281174|NCT01453205|468990488|FG002|Overall Study|Death|18|||
130281175|NCT01453205|468990486|FG000|Overall Study|Other|45|||
130281176|NCT01453205|468990487|FG001|Overall Study|Other|27|||
130281177|NCT01453205|468990488|FG002|Overall Study|Other|35|||
130281178|NCT00487942|468990496|FG000|Overall Study|Adverse Event|1|||
130281179|NCT00487942|468990497|FG001|Overall Study|Adverse Event|1|||
130281180|NCT00487942|468990498|FG002|Overall Study|Adverse Event|1|||
130281181|NCT00487942|468990499|FG003|Overall Study|Adverse Event|1|||
130281182|NCT00487942|468990496|FG000|Overall Study|Lost to Follow-up|1|||
130281183|NCT00487942|468990497|FG001|Overall Study|Lost to Follow-up|0|||
130281184|NCT00487942|468990498|FG002|Overall Study|Lost to Follow-up|0|||
130281185|NCT00487942|468990499|FG003|Overall Study|Lost to Follow-up|1|||
130281186|NCT00487942|468990496|FG000|Overall Study|Protocol Violation|1|||
130281187|NCT00487942|468990497|FG001|Overall Study|Protocol Violation|1|||
130457793|NCT01689519|469639962|FG001|Safety Population|Study Terminated By Sponsor|47|||
130457794|NCT01689519|469639961|FG000|Safety Population|Withdrawal by Subject|20|||
130457795|NCT01689519|469639962|FG001|Safety Population|Withdrawal by Subject|20|||
130457796|NCT01713530|469639966|FG000|Overall Study|Adverse Event|0|||
130457797|NCT01713530|469639967|FG001|Overall Study|Adverse Event|5|||
130457798|NCT01713530|469639966|FG000|Overall Study|Withdrawal criteria|21|||
130457799|NCT01713530|469639967|FG001|Overall Study|Withdrawal criteria|12|||
130457800|NCT01713530|469639966|FG000|Overall Study|Unclassified|4|||
130457801|NCT01713530|469639967|FG001|Overall Study|Unclassified|2|||
130281188|NCT00487942|468990498|FG002|Overall Study|Protocol Violation|0|||
130281189|NCT00487942|468990499|FG003|Overall Study|Protocol Violation|0|||
130457802|NCT03525119|469639968|FG000|Overall Study|Adverse Event|0|||
130457803|NCT03525119|469639969|FG001|Overall Study|Adverse Event|1|||
130457804|NCT03525119|469639970|FG002|Overall Study|Adverse Event|0|||
130457805|NCT03525119|469639968|FG000|Overall Study|Lost to Follow-up|32|||
130457806|NCT03525119|469639969|FG001|Overall Study|Lost to Follow-up|33|||
130457807|NCT03525119|469639970|FG002|Overall Study|Lost to Follow-up|37|||
130457808|NCT03525119|469639968|FG000|Overall Study|Withdrawal by Subject|5|||
130457809|NCT03525119|469639969|FG001|Overall Study|Withdrawal by Subject|4|||
130457810|NCT03525119|469639970|FG002|Overall Study|Withdrawal by Subject|2|||
130457811|NCT03525119|469639968|FG000|Overall Study|Reason not Specified|2|||
130555323|NCT03942406|470001551|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
130555324|NCT03942406|470001552|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
130711198|NCT05904769|470567931|FG000|Overall Study|Physician Decision|0|||
130281190|NCT00487942|468990496|FG000|Overall Study|Withdrawal by Subject|0|||
130281191|NCT00487942|468990497|FG001|Overall Study|Withdrawal by Subject|1|||
130281192|NCT00487942|468990498|FG002|Overall Study|Withdrawal by Subject|2|||
130281193|NCT00487942|468990499|FG003|Overall Study|Withdrawal by Subject|0|||
130281194|NCT00082368|468990500|FG000|Overall Study|Not treated-pt had poor IV access|1|||
130281195|NCT03319953|468990503|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
130711199|NCT05904769|470567932|FG001|Overall Study|Physician Decision|6|||
130711200|NCT01688466|470567933|FG000|Overall Study|Withdrawal by Subject|2|||
130281196|NCT03319953|468990504|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281197|NCT03319953|468990505|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281198|NCT03319953|468990506|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281199|NCT03319953|468990503|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130281200|NCT03319953|468990504|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130281201|NCT03319953|468990505|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130281202|NCT03319953|468990506|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130281203|NCT00790868|468992453|FG000|Overall Study|Withdrawal by Subject|4|||
130281204|NCT00790868|468992454|FG001|Overall Study|Withdrawal by Subject|5|||
130281205|NCT00790868|468992453|FG000|Overall Study|Lost to Follow-up|2|||
130281206|NCT00790868|468992454|FG001|Overall Study|Lost to Follow-up|12|||
130281207|NCT01380535|468992455|FG000|Overall Study|Adverse Event|3|||
130281208|NCT01380535|468992456|FG001|Overall Study|Adverse Event|3|||
130281209|NCT01380535|468992455|FG000|Overall Study|Death|3|||
130281210|NCT01380535|468992456|FG001|Overall Study|Death|0|||
130281211|NCT01380535|468992455|FG000|Overall Study|Study site closed|0|||
130281212|NCT01380535|468992456|FG001|Overall Study|Study site closed|5|||
130281213|NCT01380535|468992455|FG000|Overall Study|Withdrawal by Subject|1|||
130281214|NCT01380535|468992456|FG001|Overall Study|Withdrawal by Subject|2|||
130281215|NCT01380535|468992455|FG000|Overall Study|Protocol Violation|0|||
130281216|NCT01380535|468992456|FG001|Overall Study|Protocol Violation|2|||
130281217|NCT01380535|468992455|FG000|Overall Study|Lack of Efficacy|0|||
130281218|NCT01380535|468992456|FG001|Overall Study|Lack of Efficacy|3|||
130281219|NCT04753658|468992462|FG000|Overall Study|Progressive disease|7|||
130281220|NCT04753658|468992462|FG000|Overall Study|Other|7|||
130281221|NCT04753658|468992462|FG000|Overall Study|Adverse Event|1|||
130281222|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
130281223|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
130281224|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
130281225|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
130281226|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130281227|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130281228|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130281229|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130281230|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
130281231|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
130281232|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
130281233|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
130281234|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
130281235|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
130281236|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
130281237|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
130281238|NCT00218634|468992465|FG000|Overall Study|Lost to Follow-up|8|||
130281239|NCT00218634|468992466|FG001|Overall Study|Lost to Follow-up|15|||
130281240|NCT05243745|468992467|FG000|Overall Study|Withdrawal by Subject|0|||
130281241|NCT05243745|468992468|FG001|Overall Study|Withdrawal by Subject|0|||
130281242|NCT05243745|468992469|FG002|Overall Study|Withdrawal by Subject|0|||
130281243|NCT05243745|468992470|FG003|Overall Study|Withdrawal by Subject|1|||
130281244|NCT05243745|468992467|FG000|Overall Study|Unable to Attend Visit 6|0|||
130281245|NCT05243745|468992468|FG001|Overall Study|Unable to Attend Visit 6|0|||
130281246|NCT05243745|468992469|FG002|Overall Study|Unable to Attend Visit 6|1|||
130281247|NCT05243745|468992470|FG003|Overall Study|Unable to Attend Visit 6|0|||
130281248|NCT00420004|468992481|FG000|Overall Study|Adverse Event|4|||
130281249|NCT00420004|468992482|FG001|Overall Study|Adverse Event|1|||
130281250|NCT00420004|468992483|FG002|Overall Study|Adverse Event|1|||
130281251|NCT00420004|468992481|FG000|Overall Study|Lack of Efficacy|5|||
130281252|NCT00420004|468992482|FG001|Overall Study|Lack of Efficacy|4|||
130281253|NCT00420004|468992483|FG002|Overall Study|Lack of Efficacy|1|||
130711201|NCT01688466|470567934|FG001|Overall Study|Withdrawal by Subject|1|||
130711202|NCT01688466|470567933|FG000|Overall Study|Death|0|||
130711203|NCT01688466|470567934|FG001|Overall Study|Death|1|||
130711204|NCT01688466|470567933|FG000|Overall Study|Adverse Event|0|||
130711205|NCT01688466|470567934|FG001|Overall Study|Adverse Event|4|||
130711206|NCT01688466|470567933|FG000|Overall Study|Not evaluable|0|||
130711207|NCT01688466|470567934|FG001|Overall Study|Not evaluable|1|||
130711208|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
130281254|NCT00420004|468992481|FG000|Overall Study|Lost to Follow-up|31|||
130281255|NCT00420004|468992482|FG001|Overall Study|Lost to Follow-up|12|||
130281256|NCT00420004|468992483|FG002|Overall Study|Lost to Follow-up|10|||
130281257|NCT00420004|468992481|FG000|Overall Study|Entry Criteria Not Met|0|||
130281258|NCT00420004|468992482|FG001|Overall Study|Entry Criteria Not Met|1|||
130281259|NCT00420004|468992483|FG002|Overall Study|Entry Criteria Not Met|0|||
130281260|NCT00420004|468992481|FG000|Overall Study|Physician Decision|14|||
130368894|NCT00289991|469321233|FG000|Overall Study|Withdrawal by Subject|2|||
130368895|NCT00289991|469321234|FG001|Overall Study|Withdrawal by Subject|12|||
130368896|NCT00289991|469321233|FG000|Overall Study|Other|5|||
130368897|NCT00289991|469321234|FG001|Overall Study|Other|14|||
130368898|NCT01606007|469321237|FG000|Overall Study|Reason 'Other' in the protocol|0|||
130368899|NCT01606007|469321238|FG001|Overall Study|Reason 'Other' in the protocol|1|||
130368900|NCT01606007|469321239|FG002|Overall Study|Reason 'Other' in the protocol|1|||
130368901|NCT01606007|469321237|FG000|Overall Study|Pregnancy|0|||
130368902|NCT01606007|469321238|FG001|Overall Study|Pregnancy|1|||
130368903|NCT01606007|469321239|FG002|Overall Study|Pregnancy|1|||
130368904|NCT01606007|469321237|FG000|Overall Study|Withdrawal by Subject|8|||
130368905|NCT01606007|469321238|FG001|Overall Study|Withdrawal by Subject|6|||
130368906|NCT01606007|469321239|FG002|Overall Study|Withdrawal by Subject|1|||
130368907|NCT01606007|469321237|FG000|Overall Study|Adverse Event|0|||
130368908|NCT01606007|469321238|FG001|Overall Study|Adverse Event|1|||
130368909|NCT01606007|469321239|FG002|Overall Study|Adverse Event|1|||
130368910|NCT01606007|469321237|FG000|Overall Study|discontinue study treatment|0|||
130368911|NCT01606007|469321238|FG001|Overall Study|discontinue study treatment|2|||
130368912|NCT01606007|469321239|FG002|Overall Study|discontinue study treatment|1|||
130368913|NCT01606007|469321237|FG000|Overall Study|Lost to Follow-up|6|||
130368914|NCT01606007|469321238|FG001|Overall Study|Lost to Follow-up|8|||
130368915|NCT01606007|469321239|FG002|Overall Study|Lost to Follow-up|5|||
130368916|NCT01606007|469321237|FG000|Overall Study|Poor/Non-compliance|1|||
130368917|NCT01606007|469321238|FG001|Overall Study|Poor/Non-compliance|0|||
130368918|NCT01606007|469321239|FG002|Overall Study|Poor/Non-compliance|0|||
130368919|NCT03706079|469321240|FG000|Predecessor Study|Death|0|||
130368920|NCT03706079|469321241|FG001|Predecessor Study|Death|2|||
130368921|NCT03706079|469321242|FG002|Predecessor Study|Death|0|||
130368922|NCT03706079|469321243|FG003|Predecessor Study|Death|1|||
130368923|NCT03706079|469321244|FG004|Predecessor Study|Death|0|||
130368924|NCT03706079|469321245|FG005|Predecessor Study|Death|0|||
130368925|NCT03706079|469321240|FG000|Predecessor Study|Lost to Follow-up|5|||
130368926|NCT03706079|469321241|FG001|Predecessor Study|Lost to Follow-up|2|||
130368927|NCT03706079|469321242|FG002|Predecessor Study|Lost to Follow-up|0|||
130368928|NCT03706079|469321243|FG003|Predecessor Study|Lost to Follow-up|0|||
130368929|NCT03706079|469321244|FG004|Predecessor Study|Lost to Follow-up|1|||
130368930|NCT03706079|469321245|FG005|Predecessor Study|Lost to Follow-up|0|||
130368931|NCT03706079|469321240|FG000|Predecessor Study|Withdrawal by Subject|8|||
130368932|NCT03706079|469321241|FG001|Predecessor Study|Withdrawal by Subject|15|||
130368933|NCT03706079|469321242|FG002|Predecessor Study|Withdrawal by Subject|0|||
130368934|NCT03706079|469321243|FG003|Predecessor Study|Withdrawal by Subject|5|||
130368935|NCT03706079|469321244|FG004|Predecessor Study|Withdrawal by Subject|2|||
130368936|NCT03706079|469321245|FG005|Predecessor Study|Withdrawal by Subject|0|||
130368937|NCT03706079|469321240|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
130368938|NCT03706079|469321241|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
130368939|NCT03706079|469321242|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130368940|NCT03706079|469321243|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130368941|NCT03706079|469321244|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130368942|NCT03706079|469321245|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130368943|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130368944|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130368945|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130368946|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130368947|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130368948|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
130368949|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
130368950|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130368951|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
130368952|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130368953|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130368954|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130368955|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
130368956|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
130368957|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
130368958|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
130368959|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
130368960|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
130368961|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130368962|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130368963|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130368964|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
130368965|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130368966|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
130368967|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
130368968|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130368969|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130368970|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
130368971|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130368972|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
130368973|NCT03706079|469321240|FG000|Long Term Extension (DESTINATION)|Death|8|||
130368974|NCT03706079|469321241|FG001|Long Term Extension (DESTINATION)|Death|2|||
130368975|NCT03706079|469321242|FG002|Long Term Extension (DESTINATION)|Death|2|||
130368976|NCT03706079|469321243|FG003|Long Term Extension (DESTINATION)|Death|1|||
130368977|NCT03706079|469321244|FG004|Long Term Extension (DESTINATION)|Death|0|||
130368978|NCT03706079|469321245|FG005|Long Term Extension (DESTINATION)|Death|0|||
130368979|NCT00968513|469321246|FG000|Overall Study|Death|4|||
130368980|NCT00968513|469321247|FG001|Overall Study|Death|10|||
130368981|NCT00968513|469321248|FG002|Overall Study|Death|15|||
130281261|NCT00420004|468992482|FG001|Overall Study|Physician Decision|4|||
130281262|NCT00420004|468992483|FG002|Overall Study|Physician Decision|2|||
130281263|NCT00420004|468992481|FG000|Overall Study|Protocol Violation|5|||
130281264|NCT00420004|468992482|FG001|Overall Study|Protocol Violation|4|||
130281265|NCT00420004|468992483|FG002|Overall Study|Protocol Violation|3|||
130281266|NCT00420004|468992481|FG000|Overall Study|Withdrawal by Subject|67|||
130281267|NCT00420004|468992482|FG001|Overall Study|Withdrawal by Subject|42|||
130281268|NCT00420004|468992483|FG002|Overall Study|Withdrawal by Subject|14|||
130281269|NCT00420004|468992481|FG000|Overall Study|Sponsor Decision|3|||
130281270|NCT00420004|468992482|FG001|Overall Study|Sponsor Decision|3|||
130281271|NCT00420004|468992483|FG002|Overall Study|Sponsor Decision|1|||
130281272|NCT00591149|468992485|FG000|Overall Study|Adverse Event|4|||
130281273|NCT00591149|468992485|FG000|Overall Study|Withdrawal by Subject|1|||
130281274|NCT00470093|468992486|FG000|Overall Study|Adverse Event|2|||
130281275|NCT00664560|468992487|FG000|Overall Study|Adverse Event|19|||
130281276|NCT00664560|468992488|FG001|Overall Study|Adverse Event|16|||
130281277|NCT00664560|468992489|FG002|Overall Study|Adverse Event|7|||
130281278|NCT00664560|468992487|FG000|Overall Study|Withdrawal by Subject|9|||
130281279|NCT00664560|468992488|FG001|Overall Study|Withdrawal by Subject|13|||
130281280|NCT00664560|468992489|FG002|Overall Study|Withdrawal by Subject|7|||
130281281|NCT00664560|468992487|FG000|Overall Study|Lost to Follow-up|0|||
130281282|NCT00664560|468992488|FG001|Overall Study|Lost to Follow-up|2|||
130281283|NCT00664560|468992489|FG002|Overall Study|Lost to Follow-up|0|||
130281284|NCT00664560|468992487|FG000|Overall Study|Other|11|||
130281285|NCT00664560|468992488|FG001|Overall Study|Other|4|||
130281286|NCT00664560|468992489|FG002|Overall Study|Other|5|||
130281287|NCT02456636|468992490|FG000|Overall Study|Death|0|||
130281288|NCT02456636|468992491|FG001|Overall Study|Death|3|||
130281289|NCT02456636|468992492|FG002|Overall Study|Death|0|||
130281290|NCT02456636|468992490|FG000|Overall Study|Pregnancy|1|||
130281291|NCT02456636|468992491|FG001|Overall Study|Pregnancy|3|||
130281292|NCT02456636|468992492|FG002|Overall Study|Pregnancy|5|||
130281293|NCT02456636|468992490|FG000|Overall Study|Physician Decision|4|||
130281294|NCT02456636|468992491|FG001|Overall Study|Physician Decision|5|||
130281295|NCT02456636|468992492|FG002|Overall Study|Physician Decision|4|||
130281296|NCT02456636|468992490|FG000|Overall Study|Withdrawal by Subject|13|||
130368982|NCT05379231|469321249|FG000|Home Visit|Withdrawal by Subject|2|||
130368983|NCT05379231|469321249|FG000|In-lab Visit|Withdrawal by Subject|2|||
130368984|NCT01203098|469321256|FG000|Overall Study|Adverse Event|3|||
130368985|NCT01203098|469321257|FG001|Overall Study|Adverse Event|1|||
130368986|NCT01203098|469321258|FG002|Overall Study|Adverse Event|7|||
130368987|NCT01203098|469321256|FG000|Overall Study|Lost to Follow-up|0|||
130368988|NCT01203098|469321257|FG001|Overall Study|Lost to Follow-up|0|||
130711209|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
130711210|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
130711211|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
130281297|NCT02456636|468992491|FG001|Overall Study|Withdrawal by Subject|14|||
130281298|NCT02456636|468992492|FG002|Overall Study|Withdrawal by Subject|16|||
130281299|NCT02456636|468992490|FG000|Overall Study|Lost to Follow-up|50|||
130281300|NCT02456636|468992491|FG001|Overall Study|Lost to Follow-up|44|||
130368989|NCT01203098|469321258|FG002|Overall Study|Lost to Follow-up|1|||
130368990|NCT01203098|469321256|FG000|Overall Study|Physician Decision|2|||
130281301|NCT02456636|468992492|FG002|Overall Study|Lost to Follow-up|50|||
130281302|NCT03350035|468992493|FG000|Overall Study|Lack of Efficacy|2|||
130281303|NCT03350035|468992494|FG001|Overall Study|Lack of Efficacy|0|||
130281304|NCT03350035|468992495|FG002|Overall Study|Lack of Efficacy|0|||
130281305|NCT03350035|468992493|FG000|Overall Study|Subject discharged to hospice|0|||
130281306|NCT03350035|468992494|FG001|Overall Study|Subject discharged to hospice|0|||
130281307|NCT03350035|468992495|FG002|Overall Study|Subject discharged to hospice|1|||
130281308|NCT01610557|468992496|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281309|NCT01610557|468992497|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
130281310|NCT01610557|468992498|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281311|NCT01610557|468992499|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281312|NCT01610557|468992500|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281313|NCT01610557|468992496|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281314|NCT01610557|468992497|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281315|NCT01610557|468992498|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281316|NCT01610557|468992499|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281317|NCT01610557|468992500|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
130281318|NCT02039219|468992501|FG000|Treatment|Withdrawal by Subject|1|||
130281319|NCT02039219|468992502|FG001|Treatment|Withdrawal by Subject|0|||
130281320|NCT02039219|468992501|FG000|Treatment|Adverse Event|0|||
130281321|NCT02039219|468992502|FG001|Treatment|Adverse Event|1|||
130281322|NCT02039219|468992501|FG000|Treatment|Physician Decision|1|||
130281323|NCT02039219|468992502|FG001|Treatment|Physician Decision|0|||
130281324|NCT02039219|468992501|FG000|Treatment|Lost to Follow-up|0|||
130281325|NCT02039219|468992502|FG001|Treatment|Lost to Follow-up|1|||
130281326|NCT02039219|468992501|FG000|Treatment|Protocol Violation|1|||
130281327|NCT02039219|468992502|FG001|Treatment|Protocol Violation|0|||
130281328|NCT02039219|468992501|FG000|Treatment|Death|1|||
130281329|NCT02039219|468992502|FG001|Treatment|Death|0|||
130281330|NCT02039219|468992501|FG000|Follow up|Adverse Event|0|||
130281331|NCT02039219|468992502|FG001|Follow up|Adverse Event|1|||
130281332|NCT02974855|468992503|FG000|Overall Study|Adverse Event|0|||
130281333|NCT02974855|468992504|FG001|Overall Study|Adverse Event|1|||
130281334|NCT02974855|468992505|FG002|Overall Study|Adverse Event|0|||
130281335|NCT02974855|468992506|FG003|Overall Study|Adverse Event|1|||
130281336|NCT00129701|468992507|FG000|Overall Study|Withdrawal by Subject|33|||
130281337|NCT03576066|468992508|FG000|Overall Study|Noncompliance with study drug|0|||
130281338|NCT03576066|468992509|FG001|Overall Study|Noncompliance with study drug|1|||
130281339|NCT02750345|468992510|FG000|Intervention 1|Adverse Event|0|||
130281340|NCT02750345|468992511|FG001|Intervention 1|Adverse Event|0|||
130281341|NCT02750345|468992512|FG002|Intervention 1|Adverse Event|0|||
130281342|NCT02750345|468992513|FG003|Intervention 1|Adverse Event|0|||
130281343|NCT02750345|468992514|FG004|Intervention 1|Adverse Event|1|||
130281344|NCT02750345|468992515|FG005|Intervention 1|Adverse Event|0|||
130281345|NCT00006164|468992516|FG000|Overall Study|Withdrew or lost to follow-up|70|||
130281346|NCT00006164|468992517|FG001|Overall Study|Withdrew or lost to follow-up|81|||
130281347|NCT00633074|468992520|FG000|Overall Study|Adverse Event|1|||
130281348|NCT00633074|468992521|FG001|Overall Study|Adverse Event|0|||
130281349|NCT00365105|468992522|FG000|Overall Study|Protocol Violation|5|||
130281350|NCT00365105|468992523|FG001|Overall Study|Protocol Violation|8|||
130281351|NCT00608023|468992524|FG000|Overall Study|Withdrawal by Subject|8|||
130281352|NCT00608023|468992525|FG001|Overall Study|Withdrawal by Subject|10|||
130281353|NCT00608023|468992526|FG002|Overall Study|Withdrawal by Subject|7|||
130281354|NCT00608023|468992524|FG000|Overall Study|Adverse Event|1|||
130281355|NCT00608023|468992525|FG001|Overall Study|Adverse Event|4|||
130457812|NCT03525119|469639969|FG001|Overall Study|Reason not Specified|1|||
130281356|NCT00608023|468992526|FG002|Overall Study|Adverse Event|5|||
130281357|NCT00608023|468992524|FG000|Overall Study|Lost to Follow-up|2|||
130281358|NCT00608023|468992525|FG001|Overall Study|Lost to Follow-up|2|||
130281359|NCT00608023|468992526|FG002|Overall Study|Lost to Follow-up|1|||
130281360|NCT00608023|468992524|FG000|Overall Study|Protocol Violation|1|||
130281361|NCT00608023|468992525|FG001|Overall Study|Protocol Violation|3|||
130281362|NCT00608023|468992526|FG002|Overall Study|Protocol Violation|1|||
130281363|NCT00608023|468992524|FG000|Overall Study|Unknown reason|0|||
130281364|NCT00608023|468992525|FG001|Overall Study|Unknown reason|3|||
130281365|NCT00608023|468992526|FG002|Overall Study|Unknown reason|0|||
130281366|NCT06422364|468992527|FG000|Overall Study|Withdrawn due to study closure|0|||
130281367|NCT06422364|468992528|FG001|Overall Study|Withdrawn due to study closure|2|||
130281368|NCT01463696|468992533|FG000|Overall Study|Adverse Event|0|||
130281369|NCT01463696|468992534|FG001|Overall Study|Adverse Event|1|||
130368991|NCT01203098|469321257|FG001|Overall Study|Physician Decision|2|||
130368992|NCT01203098|469321258|FG002|Overall Study|Physician Decision|0|||
130368993|NCT01203098|469321256|FG000|Overall Study|Withdrawal by Subject|1|||
130368994|NCT01203098|469321257|FG001|Overall Study|Withdrawal by Subject|1|||
130368995|NCT01203098|469321258|FG002|Overall Study|Withdrawal by Subject|3|||
130368996|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
130368997|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
130368998|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
130368999|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
130369000|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
130369001|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130369002|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
130369003|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
130369004|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130369005|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130369006|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
130369007|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
130369008|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
130369009|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
130369010|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
130369011|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
130369012|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
130369013|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
130369014|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
130369015|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
130369016|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
130369017|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
130369018|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
130369019|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
130369020|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
130369021|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130369022|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130369023|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
130369024|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130369025|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130369026|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
130369027|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130369028|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130369029|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130369030|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130369031|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130369032|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
130369033|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130369034|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130369035|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130369036|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130369037|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
130369038|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130369039|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130369040|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
130369041|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130369042|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130369043|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
130369044|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130369045|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130369046|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
130369047|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
130369048|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
130369049|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
130369050|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
130711212|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
130711213|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
130711214|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
130369051|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
130369052|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
130281370|NCT01463696|468992535|FG002|Overall Study|Adverse Event|0|||
130281371|NCT01463696|468992536|FG003|Overall Study|Adverse Event|2|||
130281372|NCT01463696|468992537|FG004|Overall Study|Adverse Event|0|||
130281373|NCT01463696|468992538|FG005|Overall Study|Adverse Event|1|||
130281374|NCT01463696|468992539|FG006|Overall Study|Adverse Event|3|||
130281375|NCT01463696|468992540|FG007|Overall Study|Adverse Event|2|||
130281376|NCT01463696|468992533|FG000|Overall Study|Lost to Follow-up|0|||
130281377|NCT01463696|468992534|FG001|Overall Study|Lost to Follow-up|0|||
130281378|NCT01463696|468992535|FG002|Overall Study|Lost to Follow-up|1|||
130281379|NCT01463696|468992536|FG003|Overall Study|Lost to Follow-up|0|||
130281380|NCT01463696|468992537|FG004|Overall Study|Lost to Follow-up|0|||
130281381|NCT01463696|468992538|FG005|Overall Study|Lost to Follow-up|0|||
130281382|NCT01463696|468992539|FG006|Overall Study|Lost to Follow-up|0|||
130281383|NCT01463696|468992540|FG007|Overall Study|Lost to Follow-up|0|||
130281384|NCT01463696|468992533|FG000|Overall Study|Progressive Disease|0|||
130281385|NCT01463696|468992534|FG001|Overall Study|Progressive Disease|1|||
130281386|NCT01463696|468992535|FG002|Overall Study|Progressive Disease|0|||
130281387|NCT01463696|468992536|FG003|Overall Study|Progressive Disease|1|||
130281388|NCT01463696|468992537|FG004|Overall Study|Progressive Disease|0|||
130281389|NCT01463696|468992538|FG005|Overall Study|Progressive Disease|1|||
130281390|NCT01463696|468992539|FG006|Overall Study|Progressive Disease|4|||
130281391|NCT01463696|468992540|FG007|Overall Study|Progressive Disease|2|||
130281392|NCT01463696|468992533|FG000|Overall Study|Withdrawal by Subject|0|||
130281393|NCT01463696|468992534|FG001|Overall Study|Withdrawal by Subject|0|||
130281394|NCT01463696|468992535|FG002|Overall Study|Withdrawal by Subject|0|||
130281395|NCT01463696|468992536|FG003|Overall Study|Withdrawal by Subject|1|||
130281396|NCT01463696|468992537|FG004|Overall Study|Withdrawal by Subject|1|||
130281397|NCT01463696|468992538|FG005|Overall Study|Withdrawal by Subject|1|||
130281398|NCT01463696|468992539|FG006|Overall Study|Withdrawal by Subject|2|||
130281399|NCT01463696|468992540|FG007|Overall Study|Withdrawal by Subject|0|||
130281400|NCT01463696|468992533|FG000|Overall Study|Not Treated|0|||
130281401|NCT01463696|468992534|FG001|Overall Study|Not Treated|0|||
130281402|NCT01463696|468992535|FG002|Overall Study|Not Treated|0|||
130281403|NCT01463696|468992536|FG003|Overall Study|Not Treated|0|||
130281404|NCT01463696|468992537|FG004|Overall Study|Not Treated|0|||
130281405|NCT01463696|468992538|FG005|Overall Study|Not Treated|0|||
130281406|NCT01463696|468992539|FG006|Overall Study|Not Treated|1|||
130281407|NCT01463696|468992540|FG007|Overall Study|Not Treated|0|||
130281408|NCT03905265|468992542|FG000|Overall Study|Withdrawal by Subject|1|||
130281409|NCT03905265|468992543|FG001|Overall Study|Withdrawal by Subject|1|||
130281410|NCT03905265|468992544|FG002|Overall Study|Withdrawal by Subject|0|||
130281411|NCT03905265|468992545|FG003|Overall Study|Withdrawal by Subject|0|||
130281412|NCT01973387|468992549|FG000|Overall Study|Adverse Event|14|||
130281413|NCT01973387|468992550|FG001|Overall Study|Adverse Event|4|||
130281414|NCT01973387|468992549|FG000|Overall Study|Withdrawal by Subject|7|||
130281415|NCT01973387|468992550|FG001|Overall Study|Withdrawal by Subject|4|||
130281416|NCT01973387|468992549|FG000|Overall Study|Study terminated by sponsor|63|||
130281417|NCT01973387|468992550|FG001|Overall Study|Study terminated by sponsor|0|||
130281418|NCT01973387|468992549|FG000|Overall Study|Progressive disease or relapse|16|||
130281419|NCT01973387|468992550|FG001|Overall Study|Progressive disease or relapse|5|||
130281420|NCT01973387|468992549|FG000|Overall Study|Death|4|||
130281421|NCT01973387|468992550|FG001|Overall Study|Death|3|||
130281422|NCT01973387|468992549|FG000|Overall Study|Randomized, not treated|2|||
130281423|NCT01973387|468992550|FG001|Overall Study|Randomized, not treated|2|||
130281424|NCT03888235|468992559|FG000|Overall Study|Lost to Follow-up|1|||
130281425|NCT03888235|468992560|FG001|Overall Study|Lost to Follow-up|1|||
130281426|NCT03888235|468992561|FG002|Overall Study|Lost to Follow-up|0|||
130281427|NCT03525600|468992566|FG000|Overall Study|Adverse Event|9|||
130281428|NCT03525600|468992567|FG001|Overall Study|Adverse Event|6|||
130281429|NCT03525600|468992568|FG002|Overall Study|Adverse Event|5|||
130281430|NCT03525600|468992569|FG003|Overall Study|Adverse Event|3|||
130281431|NCT03525600|468992566|FG000|Overall Study|Lost to Follow-up|2|||
130281432|NCT03525600|468992567|FG001|Overall Study|Lost to Follow-up|4|||
130281433|NCT03525600|468992568|FG002|Overall Study|Lost to Follow-up|4|||
130281434|NCT03525600|468992569|FG003|Overall Study|Lost to Follow-up|0|||
130281435|NCT03525600|468992566|FG000|Overall Study|Physician Decision|1|||
130281436|NCT03525600|468992567|FG001|Overall Study|Physician Decision|0|||
130281437|NCT03525600|468992568|FG002|Overall Study|Physician Decision|2|||
130281438|NCT03525600|468992569|FG003|Overall Study|Physician Decision|0|||
130281439|NCT03525600|468992566|FG000|Overall Study|Consent withdrawal|36|||
130281440|NCT03525600|468992567|FG001|Overall Study|Consent withdrawal|20|||
130281441|NCT03525600|468992568|FG002|Overall Study|Consent withdrawal|6|||
130281442|NCT03525600|468992569|FG003|Overall Study|Consent withdrawal|13|||
130281443|NCT03525600|468992566|FG000|Overall Study|Death|7|||
130281444|NCT03525600|468992567|FG001|Overall Study|Death|6|||
130281445|NCT03525600|468992568|FG002|Overall Study|Death|4|||
130281446|NCT03525600|468992569|FG003|Overall Study|Death|3|||
130281447|NCT03525600|468992566|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
130281448|NCT03525600|468992567|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
130281449|NCT03525600|468992568|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130711215|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
130711216|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130711217|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
130711218|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130711219|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130281450|NCT03525600|468992569|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130281451|NCT03525600|468992566|FG000|Overall Study|Other|0|||
130281452|NCT03525600|468992567|FG001|Overall Study|Other|1|||
130281453|NCT03525600|468992568|FG002|Overall Study|Other|0|||
130281454|NCT03525600|468992569|FG003|Overall Study|Other|0|||
130281455|NCT03703817|468992579|FG000|Overall Study|Not meeting eligibility criteria|7|||
130281456|NCT03703817|468992580|FG001|Overall Study|Not meeting eligibility criteria|4|||
130281457|NCT05248997|468992584|FG000|Overall Study|Lost to Follow-up|1|||
130281458|NCT05248997|468992585|FG001|Overall Study|Lost to Follow-up|1|||
130281459|NCT05248997|468992584|FG000|Overall Study|Randomized but not treated|32|||
130281460|NCT05248997|468992585|FG001|Overall Study|Randomized but not treated|25|||
130281461|NCT04262882|468992587|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
130281462|NCT04262882|468992588|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
130281463|NCT04262882|468992587|FG000|Overall Study|Lost to Follow-up|1|||
130281464|NCT04262882|468992588|FG001|Overall Study|Lost to Follow-up|0|||
130281465|NCT01301066|468992589|FG000|Overall Study|Lost to Follow-up|5|||
130281466|NCT01301066|468992590|FG001|Overall Study|Lost to Follow-up|11|||
130281467|NCT01301066|468992589|FG000|Overall Study|Protocol Violation|8|||
130281468|NCT01301066|468992590|FG001|Overall Study|Protocol Violation|7|||
130281469|NCT01301066|468992589|FG000|Overall Study|Withdrawal by Subject|4|||
130281470|NCT01301066|468992590|FG001|Overall Study|Withdrawal by Subject|9|||
130281471|NCT01301066|468992589|FG000|Overall Study|Adverse Event|6|||
130281472|NCT01301066|468992590|FG001|Overall Study|Adverse Event|6|||
130281473|NCT01301066|468992589|FG000|Overall Study|Sponsor Decision|2|||
130281474|NCT01301066|468992590|FG001|Overall Study|Sponsor Decision|1|||
130281475|NCT01301066|468992589|FG000|Overall Study|Physician Decision|0|||
130281476|NCT01301066|468992590|FG001|Overall Study|Physician Decision|1|||
130281477|NCT01301066|468992589|FG000|Overall Study|Other|2|||
130281478|NCT01301066|468992590|FG001|Overall Study|Other|0|||
130281479|NCT03268954|468992595|FG000|Overall Study|Ongoing|23|||
130281480|NCT03268954|468992596|FG001|Overall Study|Ongoing|31|||
130281481|NCT03268954|468992595|FG000|Overall Study|Adverse Event|53|||
130281482|NCT03268954|468992596|FG001|Overall Study|Adverse Event|62|||
130281483|NCT03268954|468992595|FG000|Overall Study|Withdrawal by Subject|25|||
130281484|NCT03268954|468992596|FG001|Overall Study|Withdrawal by Subject|16|||
130281485|NCT03268954|468992595|FG000|Overall Study|Progressive Disease|61|||
130281486|NCT03268954|468992596|FG001|Overall Study|Progressive Disease|48|||
130281487|NCT03268954|468992595|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
130281488|NCT03268954|468992596|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
130281489|NCT03268954|468992595|FG000|Overall Study|Reason not Specified|40|||
130281490|NCT03268954|468992596|FG001|Overall Study|Reason not Specified|40|||
130281491|NCT03255967|468992597|FG000|Overall Study|Adverse Event|26|||
130281492|NCT03255967|468992598|FG001|Overall Study|Adverse Event|30|||
130281493|NCT03255967|468992597|FG000|Overall Study|Withdrawal by Subject|6|||
130281494|NCT03255967|468992598|FG001|Overall Study|Withdrawal by Subject|6|||
130281495|NCT03255967|468992597|FG000|Overall Study|Schedule conflict|6|||
130281496|NCT03255967|468992598|FG001|Overall Study|Schedule conflict|4|||
130281497|NCT03255967|468992597|FG000|Overall Study|POA did not sign consent form|2|||
130281498|NCT03255967|468992598|FG001|Overall Study|POA did not sign consent form|0|||
130281499|NCT00778258|468992599|FG000|Overall Study|Adverse Event|1|||
130281500|NCT00778258|468992600|FG001|Overall Study|Adverse Event|0|||
130281501|NCT00778258|468992601|FG002|Overall Study|Adverse Event|0|||
130281502|NCT00778258|468992602|FG003|Overall Study|Adverse Event|0|||
130281503|NCT00778258|468992603|FG004|Overall Study|Adverse Event|0|||
130711220|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130711221|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130281504|NCT00778258|468992604|FG005|Overall Study|Adverse Event|1|||
130281505|NCT00778258|468992605|FG006|Overall Study|Adverse Event|0|||
130281506|NCT00778258|468992606|FG007|Overall Study|Adverse Event|0|||
130281507|NCT00778258|468992607|FG008|Overall Study|Adverse Event|0|||
130281508|NCT00778258|468992599|FG000|Overall Study|Lost to Follow-up|0|||
130281509|NCT00778258|468992600|FG001|Overall Study|Lost to Follow-up|0|||
130711222|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130281510|NCT00778258|468992601|FG002|Overall Study|Lost to Follow-up|2|||
130281511|NCT00778258|468992602|FG003|Overall Study|Lost to Follow-up|0|||
130281512|NCT00778258|468992603|FG004|Overall Study|Lost to Follow-up|0|||
130281513|NCT00778258|468992604|FG005|Overall Study|Lost to Follow-up|3|||
130281514|NCT00778258|468992605|FG006|Overall Study|Lost to Follow-up|2|||
130281515|NCT00778258|468992606|FG007|Overall Study|Lost to Follow-up|2|||
130281516|NCT00778258|468992607|FG008|Overall Study|Lost to Follow-up|0|||
130281517|NCT00778258|468992599|FG000|Overall Study|Withdrawal by Subject|6|||
130281518|NCT00778258|468992600|FG001|Overall Study|Withdrawal by Subject|2|||
130281519|NCT00778258|468992601|FG002|Overall Study|Withdrawal by Subject|8|||
130281520|NCT00778258|468992602|FG003|Overall Study|Withdrawal by Subject|2|||
130281521|NCT00778258|468992603|FG004|Overall Study|Withdrawal by Subject|0|||
130281522|NCT00778258|468992604|FG005|Overall Study|Withdrawal by Subject|6|||
130281523|NCT00778258|468992605|FG006|Overall Study|Withdrawal by Subject|12|||
130281524|NCT00778258|468992606|FG007|Overall Study|Withdrawal by Subject|12|||
130281525|NCT00778258|468992607|FG008|Overall Study|Withdrawal by Subject|4|||
130281526|NCT00778258|468992599|FG000|Overall Study|New Contraindication|0|||
130281527|NCT00778258|468992600|FG001|Overall Study|New Contraindication|0|||
130281528|NCT00778258|468992601|FG002|Overall Study|New Contraindication|0|||
130281529|NCT00778258|468992602|FG003|Overall Study|New Contraindication|0|||
130281530|NCT00778258|468992603|FG004|Overall Study|New Contraindication|0|||
130281531|NCT00778258|468992604|FG005|Overall Study|New Contraindication|0|||
130281532|NCT00778258|468992605|FG006|Overall Study|New Contraindication|0|||
130281533|NCT00778258|468992606|FG007|Overall Study|New Contraindication|1|||
130281534|NCT00778258|468992607|FG008|Overall Study|New Contraindication|0|||
130281535|NCT00778258|468992599|FG000|Overall Study|Non-compliance|0|||
130281536|NCT00778258|468992600|FG001|Overall Study|Non-compliance|0|||
130281537|NCT00778258|468992601|FG002|Overall Study|Non-compliance|0|||
130281538|NCT00778258|468992602|FG003|Overall Study|Non-compliance|1|||
130281539|NCT00778258|468992603|FG004|Overall Study|Non-compliance|0|||
130281540|NCT00778258|468992604|FG005|Overall Study|Non-compliance|0|||
130281541|NCT00778258|468992605|FG006|Overall Study|Non-compliance|0|||
130281542|NCT00778258|468992606|FG007|Overall Study|Non-compliance|0|||
130281543|NCT00778258|468992607|FG008|Overall Study|Non-compliance|0|||
130281544|NCT00778258|468992599|FG000|Overall Study|Other|0|||
130281545|NCT00778258|468992600|FG001|Overall Study|Other|0|||
130281546|NCT00778258|468992601|FG002|Overall Study|Other|0|||
130281547|NCT00778258|468992602|FG003|Overall Study|Other|0|||
130281548|NCT00778258|468992603|FG004|Overall Study|Other|0|||
130281549|NCT00778258|468992604|FG005|Overall Study|Other|0|||
130281550|NCT00778258|468992605|FG006|Overall Study|Other|1|||
130281551|NCT00778258|468992606|FG007|Overall Study|Other|0|||
130281552|NCT00778258|468992607|FG008|Overall Study|Other|0|||
130281553|NCT01202188|468992611|FG000|Overall Study|Protocol deviation|14|||
130281554|NCT01202188|468992612|FG001|Overall Study|Protocol deviation|8|||
130281555|NCT01202188|468992613|FG002|Overall Study|Protocol deviation|12|||
130281556|NCT01202188|468992614|FG003|Overall Study|Protocol deviation|10|||
130281557|NCT01202188|468992615|FG004|Overall Study|Protocol deviation|11|||
130281558|NCT01202188|468992611|FG000|Overall Study|Subject withdrew consent|12|||
130281559|NCT01202188|468992612|FG001|Overall Study|Subject withdrew consent|13|||
130281560|NCT01202188|468992613|FG002|Overall Study|Subject withdrew consent|22|||
130281561|NCT01202188|468992614|FG003|Overall Study|Subject withdrew consent|11|||
130281562|NCT01202188|468992615|FG004|Overall Study|Subject withdrew consent|13|||
130281563|NCT01202188|468992611|FG000|Overall Study|Adverse Event|5|||
130281564|NCT01202188|468992612|FG001|Overall Study|Adverse Event|23|||
130281565|NCT01202188|468992613|FG002|Overall Study|Adverse Event|13|||
130281566|NCT01202188|468992614|FG003|Overall Study|Adverse Event|10|||
130281567|NCT01202188|468992615|FG004|Overall Study|Adverse Event|10|||
130281568|NCT01202188|468992611|FG000|Overall Study|Administrative problems|3|||
130281569|NCT01202188|468992612|FG001|Overall Study|Administrative problems|2|||
130281570|NCT01202188|468992613|FG002|Overall Study|Administrative problems|1|||
130281571|NCT01202188|468992614|FG003|Overall Study|Administrative problems|1|||
130281572|NCT01202188|468992615|FG004|Overall Study|Administrative problems|2|||
130281573|NCT01202188|468992611|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130281574|NCT01202188|468992612|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130281575|NCT01202188|468992613|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130281576|NCT01202188|468992614|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
130281577|NCT01202188|468992615|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
130281578|NCT01202188|468992611|FG000|Overall Study|Lost to Follow-up|1|||
130281579|NCT01202188|468992612|FG001|Overall Study|Lost to Follow-up|1|||
130369053|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
130281580|NCT01202188|468992613|FG002|Overall Study|Lost to Follow-up|0|||
130281581|NCT01202188|468992614|FG003|Overall Study|Lost to Follow-up|4|||
130281582|NCT01202188|468992615|FG004|Overall Study|Lost to Follow-up|1|||
130281583|NCT01202188|468992611|FG000|Overall Study|Death|1|||
130281584|NCT01202188|468992612|FG001|Overall Study|Death|1|||
130369054|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
130281585|NCT01202188|468992613|FG002|Overall Study|Death|1|||
130281586|NCT01202188|468992614|FG003|Overall Study|Death|1|||
130281587|NCT01202188|468992615|FG004|Overall Study|Death|0|||
130281588|NCT01202188|468992611|FG000|Overall Study|Abnormal test procedure result (s)|0|||
130369055|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
130281589|NCT01202188|468992612|FG001|Overall Study|Abnormal test procedure result (s)|0|||
130281590|NCT01202188|468992613|FG002|Overall Study|Abnormal test procedure result (s)|2|||
130281591|NCT01202188|468992614|FG003|Overall Study|Abnormal test procedure result (s)|0|||
130281592|NCT01202188|468992615|FG004|Overall Study|Abnormal test procedure result (s)|0|||
130281593|NCT00780143|468992622|FG000|Overall Study|Progressive disease|1|||
130281594|NCT00780143|468992622|FG000|Overall Study|Toxicity|1|||
130281595|NCT00780143|468992622|FG000|Overall Study|Adverse Event|1|||
130281596|NCT02438384|468992623|FG000|Overall Study|Lost to Follow-up|8|||
130281597|NCT02438384|468992624|FG001|Overall Study|Lost to Follow-up|6|||
130281598|NCT02438384|468992625|FG002|Overall Study|Lost to Follow-up|4|||
130281599|NCT02640625|468994449|FG000|Overall Study|Adverse Event|1|||
130281600|NCT00511433|468994450|FG000|Overall Study|Adverse Event|5|||
130281601|NCT00511433|468994451|FG001|Overall Study|Adverse Event|0|||
130281602|NCT00511433|468994450|FG000|Overall Study|Other Reason|1|||
130281603|NCT00511433|468994451|FG001|Overall Study|Other Reason|1|||
130281604|NCT01740089|468994452|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
130281605|NCT01740089|468994453|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
130281606|NCT01740089|468994454|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
130281607|NCT01740089|468994452|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130281608|NCT01740089|468994453|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
130281609|NCT01740089|468994454|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130281610|NCT01740089|468994452|FG000|After 12 Weeks|Lack of Efficacy|3|||
130281611|NCT01740089|468994453|FG001|After 12 Weeks|Lack of Efficacy|1|||
130281612|NCT01740089|468994454|FG002|After 12 Weeks|Lack of Efficacy|4|||
130281613|NCT01740089|468994452|FG000|After 12 Weeks|Adverse Event|2|||
130281614|NCT01740089|468994453|FG001|After 12 Weeks|Adverse Event|0|||
130281615|NCT01740089|468994454|FG002|After 12 Weeks|Adverse Event|5|||
130281616|NCT01740089|468994452|FG000|After 12 Weeks|Protocol Violation|1|||
130281617|NCT01740089|468994453|FG001|After 12 Weeks|Protocol Violation|1|||
130281618|NCT01740089|468994454|FG002|After 12 Weeks|Protocol Violation|1|||
130281619|NCT01740089|468994452|FG000|After 12 Weeks|Withdrawal by Subject|1|||
130281620|NCT01740089|468994453|FG001|After 12 Weeks|Withdrawal by Subject|1|||
130281621|NCT01740089|468994454|FG002|After 12 Weeks|Withdrawal by Subject|1|||
130281622|NCT01579565|468994457|FG000|Randomized|Adverse Event|1|||
130281623|NCT01579565|468994458|FG001|Randomized|Adverse Event|3|||
130281624|NCT01579565|468994457|FG000|Randomized|Withdrawal by Subject|3|||
130281625|NCT01579565|468994458|FG001|Randomized|Withdrawal by Subject|0|||
130281626|NCT01579565|468994457|FG000|Randomized|inadequate preoperative pupil dilation|0|||
130281627|NCT01579565|468994458|FG001|Randomized|inadequate preoperative pupil dilation|1|||
130281628|NCT01579565|468994457|FG000|Randomized|prohibited preoperative eating|1|||
130281629|NCT01579565|468994458|FG001|Randomized|prohibited preoperative eating|0|||
130281630|NCT01579565|468994457|FG000|Randomized|prohibited preoperative medication|0|||
130281631|NCT01579565|468994458|FG001|Randomized|prohibited preoperative medication|1|||
130281632|NCT01579565|468994457|FG000|Treated|Physician Decision|0|||
130281633|NCT01579565|468994458|FG001|Treated|Physician Decision|1|||
130281634|NCT01579565|468994457|FG000|Treated|Lost to Follow-up|2|||
130281635|NCT01579565|468994458|FG001|Treated|Lost to Follow-up|1|||
130281636|NCT01579565|468994457|FG000|Treated|declined to return for final visit|0|||
130281637|NCT01579565|468994458|FG001|Treated|declined to return for final visit|1|||
130281638|NCT02867813|468994462|FG000|Overall Study|Withdrawal by Subject|57|||
130281639|NCT02867813|468994463|FG001|Overall Study|Withdrawal by Subject|56|||
130281640|NCT02867813|468994462|FG000|Overall Study|Decision by Sponsor|7|||
130281641|NCT02867813|468994463|FG001|Overall Study|Decision by Sponsor|7|||
130281642|NCT02867813|468994462|FG000|Overall Study|Lost to Follow-up|91|||
130281643|NCT02867813|468994463|FG001|Overall Study|Lost to Follow-up|78|||
130457813|NCT03525119|469639970|FG002|Overall Study|Reason not Specified|2|||
130457814|NCT03525119|469639968|FG000|Overall Study|Randomized but not Vaccinated|1|||
130457815|NCT03525119|469639969|FG001|Overall Study|Randomized but not Vaccinated|0|||
130457816|NCT03525119|469639970|FG002|Overall Study|Randomized but not Vaccinated|2|||
130457817|NCT01186848|469639971|FG000|Overall Study|Lost to Follow-up|4|||
130457818|NCT01186848|469639971|FG000|Overall Study|Withdrawal by Subject|2|||
130457819|NCT01186848|469639971|FG000|Overall Study|Adverse Event|2|||
130457820|NCT02148133|469639984|FG000|Overall Study|Investigator discretion|1|||
130457821|NCT02148133|469639984|FG000|Overall Study|Lack of Efficacy|1|||
130457822|NCT02148133|469639984|FG000|Overall Study|Protocol deviation|1|||
130281644|NCT02867813|468994462|FG000|Overall Study|Missing|2|||
130281645|NCT02867813|468994463|FG001|Overall Study|Missing|1|||
130281646|NCT02867813|468994462|FG000|Overall Study|Death|294|||
130281647|NCT02867813|468994463|FG001|Overall Study|Death|268|||
130281648|NCT01463111|468994467|FG000|Overall Study|Withdrawal by Subject|2|||
130281649|NCT01463111|468994467|FG000|Overall Study|Lost to Follow-up|5|||
130281650|NCT01463111|468994467|FG000|Overall Study|Physician Decision|2|||
130281651|NCT03285958|468994468|FG000|Overall Study|Lost to Follow-up|1|||
130281652|NCT03285958|468994469|FG001|Overall Study|Lost to Follow-up|1|||
130281653|NCT03285958|468994468|FG000|Overall Study|Withdrawal by Subject|1|||
130281654|NCT03285958|468994469|FG001|Overall Study|Withdrawal by Subject|0|||
130281655|NCT03285958|468994468|FG000|Overall Study|Not able to attend required orientation|3|||
130281656|NCT03285958|468994469|FG001|Overall Study|Not able to attend required orientation|0|||
130281657|NCT03116828|468994472|FG000|Overall Study|Adverse Event|1|||
130281658|NCT03116828|468994473|FG001|Overall Study|Adverse Event|10|||
130281659|NCT03116828|468994472|FG000|Overall Study|Withdrawal by Subject|4|||
130281660|NCT03116828|468994473|FG001|Overall Study|Withdrawal by Subject|8|||
130281661|NCT03116828|468994472|FG000|Overall Study|OTHER|3|||
130281662|NCT03116828|468994473|FG001|Overall Study|OTHER|3|||
130281663|NCT00882583|468994474|FG000|Overall Study|Physician Decision|1|||
130281664|NCT00882583|468994475|FG001|Overall Study|Physician Decision|0|||
130281665|NCT00882583|468994474|FG000|Overall Study|Adverse Event|0|||
130281666|NCT00882583|468994475|FG001|Overall Study|Adverse Event|1|||
130281667|NCT00176488|468994492|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
130281668|NCT01044745|468994493|FG000|Overall Study|Ineiligible|2|||
130281669|NCT01159171|468994498|FG000|Overall Study|Adverse Event|11|||
130281670|NCT01159171|468994498|FG000|Overall Study|Progression of Disease|28|||
130281671|NCT01159171|468994498|FG000|Overall Study|Protocol Violation|1|||
130281672|NCT01159171|468994498|FG000|Overall Study|Need for Surgery|5|||
130281673|NCT01159171|468994498|FG000|Overall Study|Medical Decision|4|||
130281674|NCT01159171|468994498|FG000|Overall Study|Death|1|||
130281675|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Adverse Event|76|||
130281676|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Adverse Event|0|||
130281677|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Adverse Event|0|||
130281678|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Death|3|||
130281679|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Death|0|||
130281680|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Death|0|||
130281681|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
130281682|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
130281683|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
130281684|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Physician Decision|9|||
130281685|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Physician Decision|0|||
130281686|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Physician Decision|0|||
130281687|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
130281688|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130281689|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130281690|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Disease progression|45|||
130281691|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Disease progression|0|||
130281692|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Disease progression|0|||
130281693|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
130281694|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130281695|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130281696|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
130281697|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130281698|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130281699|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
130281700|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
130281701|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
130281702|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
130281703|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130281704|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130281705|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
130281706|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130281707|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130281708|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
130281709|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
130281710|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
130281711|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
130281712|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
130281713|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
130281714|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
130281715|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130281716|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130281717|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
130281718|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130281719|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130281720|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Promotor request|1|||
130281721|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Promotor request|0|||
130369056|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130369057|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130369058|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130369059|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
130369060|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130281722|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Promotor request|0|||
130281723|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
130369061|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130711223|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130281724|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130281725|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130281726|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
130281727|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
130281728|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
130281729|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Death|3|||
130281730|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Death|0|||
130281731|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Death|0|||
130281732|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
130281733|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130281734|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130281735|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
130281736|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
130281737|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
130281738|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Diseases progression|91|||
130281739|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Diseases progression|0|||
130281740|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Diseases progression|0|||
130281741|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Adverse Event|70|||
130281742|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Adverse Event|0|||
130281743|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Adverse Event|0|||
130281744|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Physician Decision|9|||
130281745|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Physician Decision|0|||
130281746|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Physician Decision|0|||
130281747|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
130281748|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130281749|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130281750|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
130281751|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130281752|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130281753|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
130281754|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130281755|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130281756|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Not compliant|1|||
130281757|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Not compliant|0|||
130281758|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Not compliant|0|||
130281759|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
130281760|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
130281761|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
130281762|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Adverse Event|0|||
130281763|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Adverse Event|2|||
130281764|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Adverse Event|0|||
130281765|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Death|0|||
130281766|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Death|10|||
130281767|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Death|8|||
130281768|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Physician Decision|0|||
130281769|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Physician Decision|0|||
130281770|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Physician Decision|4|||
130281771|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
130281772|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
130281773|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
130281774|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Moved to another town|0|||
130281775|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Moved to another town|1|||
130281776|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Moved to another town|0|||
130281777|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Disease progression|0|||
130281778|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Disease progression|0|||
130281779|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Disease progression|3|||
130281780|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
130281781|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
130281782|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
130281783|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130281784|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130281785|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
130281786|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130281787|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130281788|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
130281789|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
130281790|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
130457823|NCT02148133|469639984|FG000|Overall Study|Protocol-defined stopping criteria|2|||
130711224|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
130711225|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
130711226|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
130711227|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
130711228|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130281791|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
130281792|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130281793|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130281794|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
130281795|NCT02242435|468994510|FG000|Overall Study|Lost to Follow-up|3|||
130281796|NCT02242435|468994511|FG001|Overall Study|Lost to Follow-up|4|||
130281797|NCT02242435|468994510|FG000|Overall Study|Adverse Event|3|||
130281798|NCT02242435|468994511|FG001|Overall Study|Adverse Event|2|||
130281799|NCT02242435|468994510|FG000|Overall Study|Withdrawal by Subject|13|||
130281800|NCT02242435|468994511|FG001|Overall Study|Withdrawal by Subject|8|||
130281801|NCT02242435|468994510|FG000|Overall Study|Death|0|||
130281802|NCT02242435|468994511|FG001|Overall Study|Death|1|||
130281803|NCT02242435|468994510|FG000|Overall Study|Protocol Violation|1|||
130281804|NCT02242435|468994511|FG001|Overall Study|Protocol Violation|0|||
130281805|NCT02242435|468994510|FG000|Overall Study|Physician Decision|0|||
130281806|NCT02242435|468994511|FG001|Overall Study|Physician Decision|1|||
130281807|NCT03895086|468994514|FG000|Overall Study|Early termination study|1|||
130281808|NCT03895086|468994515|FG001|Overall Study|Early termination study|0|||
130281809|NCT01089413|468994519|FG000|Overall Study|Lost to Follow-up|1|||
130281810|NCT01089413|468994519|FG000|Overall Study|Progressive Disease|93|||
130281811|NCT01089413|468994519|FG000|Overall Study|Participant Withdrew Consent|1|||
130281812|NCT01089413|468994519|FG000|Overall Study|Unacceptable Toxicity|12|||
130281813|NCT01089413|468994519|FG000|Overall Study|Death|10|||
130281814|NCT01089413|468994519|FG000|Overall Study|Metastasectomy|13|||
130281815|NCT01089413|468994519|FG000|Overall Study|Other|71|||
130281816|NCT02513485|468994523|FG000|Overall Study|Adverse Event|1|||
130281817|NCT02513485|468994524|FG001|Overall Study|Adverse Event|0|||
130281818|NCT02526524|468994531|FG000|Overall Study|Withdrawal by Subject|3|||
130281819|NCT02526524|468994532|FG001|Overall Study|Withdrawal by Subject|3|||
130281820|NCT02526524|468994533|FG002|Overall Study|Withdrawal by Subject|6|||
130281821|NCT02526524|468994534|FG003|Overall Study|Withdrawal by Subject|1|||
130281822|NCT02526524|468994535|FG004|Overall Study|Withdrawal by Subject|9|||
130281823|NCT02526524|468994536|FG005|Overall Study|Withdrawal by Subject|5|||
130281824|NCT02526524|468994531|FG000|Overall Study|Adverse Event|3|||
130281825|NCT02526524|468994532|FG001|Overall Study|Adverse Event|2|||
130281826|NCT02526524|468994533|FG002|Overall Study|Adverse Event|4|||
130281827|NCT02526524|468994534|FG003|Overall Study|Adverse Event|2|||
130281828|NCT02526524|468994535|FG004|Overall Study|Adverse Event|6|||
130281829|NCT02526524|468994536|FG005|Overall Study|Adverse Event|8|||
130281830|NCT02526524|468994531|FG000|Overall Study|Lost to Follow-up|2|||
130281831|NCT02526524|468994532|FG001|Overall Study|Lost to Follow-up|3|||
130281832|NCT02526524|468994533|FG002|Overall Study|Lost to Follow-up|8|||
130281833|NCT02526524|468994534|FG003|Overall Study|Lost to Follow-up|1|||
130281834|NCT02526524|468994535|FG004|Overall Study|Lost to Follow-up|2|||
130281835|NCT02526524|468994536|FG005|Overall Study|Lost to Follow-up|5|||
130281836|NCT02526524|468994531|FG000|Overall Study|Protocol Violation|3|||
130281837|NCT02526524|468994532|FG001|Overall Study|Protocol Violation|1|||
130281838|NCT02526524|468994533|FG002|Overall Study|Protocol Violation|5|||
130281839|NCT02526524|468994534|FG003|Overall Study|Protocol Violation|3|||
130281840|NCT02526524|468994535|FG004|Overall Study|Protocol Violation|4|||
130281841|NCT02526524|468994536|FG005|Overall Study|Protocol Violation|3|||
130281842|NCT02526524|468994531|FG000|Overall Study|Loss of Glucose Control|0|||
130281843|NCT02526524|468994532|FG001|Overall Study|Loss of Glucose Control|0|||
130281844|NCT02526524|468994533|FG002|Overall Study|Loss of Glucose Control|3|||
130281845|NCT02526524|468994534|FG003|Overall Study|Loss of Glucose Control|0|||
130281846|NCT02526524|468994535|FG004|Overall Study|Loss of Glucose Control|2|||
130281847|NCT02526524|468994536|FG005|Overall Study|Loss of Glucose Control|0|||
130281848|NCT02526524|468994531|FG000|Overall Study|Physician Decision|0|||
130711229|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130711230|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130711231|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130281849|NCT02526524|468994532|FG001|Overall Study|Physician Decision|0|||
130369062|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130369063|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
130369064|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130281850|NCT02526524|468994533|FG002|Overall Study|Physician Decision|0|||
130281851|NCT02526524|468994534|FG003|Overall Study|Physician Decision|0|||
130281852|NCT02526524|468994535|FG004|Overall Study|Physician Decision|1|||
130281853|NCT02526524|468994536|FG005|Overall Study|Physician Decision|0|||
130281854|NCT02526524|468994531|FG000|Overall Study|Sponsor Decision|1|||
130369065|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130369066|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Change of location|0|||
130369067|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Change of location|0|||
130369068|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Change of location|0|||
130369069|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Change of location|1|||
130369070|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Change of location|0|||
130369071|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
130369072|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
130369073|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
130369074|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
130369075|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
130369076|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130369077|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130369078|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130369079|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130369080|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
130369081|NCT00730405|469321259|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
130369082|NCT00730405|469321260|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130369083|NCT00730405|469321261|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130369084|NCT00730405|469321262|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130369085|NCT00730405|469321263|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130369086|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
130369087|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
130369088|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
130369089|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
130369090|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
130369091|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
130369092|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
130369093|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
130369094|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
130369095|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
130369096|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
130369097|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
130369098|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
130369099|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
130369100|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
130369101|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Death|0|||
130369102|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Death|1|||
130369103|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Death|0|||
130369104|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Death|1|||
130369105|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Death|0|||
130369106|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Change of location|1|||
130369107|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Change of location|1|||
130369108|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Change of location|0|||
130369109|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Change of location|1|||
130369110|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Change of location|0|||
130369111|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
130369112|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
130369113|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
130369114|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
130369115|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
130369116|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130369117|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130369118|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
130369119|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130369120|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130457824|NCT00158054|469639986|FG000|Overall Study|Refused to continue|3|||
130457825|NCT00158054|469639987|FG001|Overall Study|Refused to continue|0|||
130457826|NCT00158054|469639986|FG000|Overall Study|Unavailable for follow up|7|||
130457827|NCT00158054|469639987|FG001|Overall Study|Unavailable for follow up|3|||
130457828|NCT00855465|469639990|FG000|Treatment Period|Adverse Event|4|||
130369121|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130369122|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130369123|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
130369124|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130369125|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130457829|NCT00855465|469639991|FG001|Treatment Period|Adverse Event|2|||
130457830|NCT00855465|469639990|FG000|Treatment Period|Death|2|||
130711232|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130711233|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130711234|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
130711235|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
130711236|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130711237|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130711238|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
130711239|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
130711240|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130711241|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130711242|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
130711243|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
130711244|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130711245|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130711246|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
130711247|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
130711248|NCT01013649|470567943|FG000|First Step|Withdrawal by Subject|36|||
130711249|NCT01013649|470567944|FG001|First Step|Withdrawal by Subject|19|||
130711250|NCT01013649|470567945|FG002|First Step|Withdrawal by Subject|0|||
130711251|NCT01013649|470567946|FG003|First Step|Withdrawal by Subject|0|||
130711252|NCT01013649|470567943|FG000|First Step|Progression|58|||
130711253|NCT01013649|470567944|FG001|First Step|Progression|23|||
130711254|NCT01013649|470567945|FG002|First Step|Progression|0|||
130711255|NCT01013649|470567946|FG003|First Step|Progression|0|||
130711256|NCT01013649|470567943|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
130711257|NCT01013649|470567944|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
130711258|NCT01013649|470567945|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
130711259|NCT01013649|470567946|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
130711260|NCT01013649|470567943|FG000|First Step|Death|3|||
130711261|NCT01013649|470567944|FG001|First Step|Death|4|||
130711262|NCT01013649|470567945|FG002|First Step|Death|0|||
130711263|NCT01013649|470567946|FG003|First Step|Death|0|||
130711264|NCT01013649|470567943|FG000|First Step|Adverse Event|9|||
130711265|NCT01013649|470567944|FG001|First Step|Adverse Event|5|||
130711266|NCT01013649|470567945|FG002|First Step|Adverse Event|0|||
130711267|NCT01013649|470567946|FG003|First Step|Adverse Event|0|||
130711268|NCT01013649|470567943|FG000|First Step|Other|4|||
130711269|NCT01013649|470567944|FG001|First Step|Other|6|||
130711270|NCT01013649|470567945|FG002|First Step|Other|0|||
130711271|NCT01013649|470567946|FG003|First Step|Other|0|||
130711272|NCT04285567|470567947|FG000|Overall Study|Death|3|||
130711273|NCT04285567|470567948|FG001|Overall Study|Death|3|||
130281855|NCT02526524|468994532|FG001|Overall Study|Sponsor Decision|0|||
130281856|NCT02526524|468994533|FG002|Overall Study|Sponsor Decision|0|||
130281857|NCT02526524|468994534|FG003|Overall Study|Sponsor Decision|0|||
130281858|NCT02526524|468994535|FG004|Overall Study|Sponsor Decision|0|||
130281859|NCT02526524|468994536|FG005|Overall Study|Sponsor Decision|0|||
130281860|NCT05312632|468994540|FG000|Overall Study|Adverse Event|12|||
130281861|NCT05312632|468994540|FG000|Overall Study|Withdrawal by Subject|10|||
130281862|NCT05312632|468994540|FG000|Overall Study|Lack of Efficacy|4|||
130281863|NCT05312632|468994540|FG000|Overall Study|Non-compliance with study procedures|9|||
130281864|NCT05312632|468994540|FG000|Overall Study|Other|4|||
130281865|NCT02379221|468994541|FG000|Overall Study|Lost to Follow-up|1|||
130281866|NCT00519376|468994544|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281867|NCT00519376|468994545|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281868|NCT00519376|468994546|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130711274|NCT04285567|470567947|FG000|Overall Study|Lost to Follow-up|1|||
130711275|NCT04285567|470567948|FG001|Overall Study|Lost to Follow-up|1|||
130711276|NCT04285567|470567947|FG000|Overall Study|Reason Not Specified|1|||
130711277|NCT04285567|470567948|FG001|Overall Study|Reason Not Specified|1|||
130281869|NCT00519376|468994547|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281870|NCT00519376|468994548|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281871|NCT00519376|468994549|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281872|NCT00519376|468994550|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281873|NCT00519376|468994551|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281874|NCT00519376|468994552|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130711278|NCT04285567|470567947|FG000|Overall Study|Physician Decision|2|||
130711279|NCT04285567|470567948|FG001|Overall Study|Physician Decision|1|||
130711280|NCT04285567|470567947|FG000|Overall Study|Withdrawal by Subject|2|||
130711281|NCT04285567|470567948|FG001|Overall Study|Withdrawal by Subject|6|||
130711282|NCT04285567|470567947|FG000|Overall Study|Adverse Event|1|||
130711283|NCT04285567|470567948|FG001|Overall Study|Adverse Event|0|||
130711284|NCT04285567|470567947|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
130711285|NCT04285567|470567948|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
130457831|NCT00855465|469639991|FG001|Treatment Period|Death|2|||
130457832|NCT00855465|469639990|FG000|Treatment Period|Lack of Efficacy|2|||
130457833|NCT00855465|469639991|FG001|Treatment Period|Lack of Efficacy|1|||
130457834|NCT00855465|469639990|FG000|Treatment Period|Non-compliance|1|||
130457835|NCT00855465|469639991|FG001|Treatment Period|Non-compliance|0|||
130457836|NCT00855465|469639990|FG000|Treatment Period|Protocol Violation|2|||
130457837|NCT00855465|469639991|FG001|Treatment Period|Protocol Violation|0|||
130457838|NCT00855465|469639990|FG000|Treatment Period|Withdrawal by Subject|2|||
130457839|NCT00855465|469639991|FG001|Treatment Period|Withdrawal by Subject|0|||
130457840|NCT00855465|469639990|FG000|Treatment Period|Not treated|1|||
130457841|NCT00855465|469639991|FG001|Treatment Period|Not treated|0|||
130457842|NCT00855465|469639990|FG000|Follow-up Period (FUP)|Adverse Event|0|||
130457843|NCT00855465|469639991|FG001|Follow-up Period (FUP)|Adverse Event|1|||
130457844|NCT00855465|469639990|FG000|Follow-up Period (FUP)|Death|0|||
130457845|NCT00855465|469639991|FG001|Follow-up Period (FUP)|Death|1|||
130457846|NCT00855465|469639990|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
130457847|NCT00855465|469639991|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
130457848|NCT00855465|469639990|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
130457849|NCT00855465|469639991|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
130457850|NCT00855465|469639990|FG000|Follow-up Period (FUP)|Missing|1|||
130457851|NCT00855465|469639991|FG001|Follow-up Period (FUP)|Missing|0|||
130457852|NCT00079183|469639995|FG000|Overall Study|Withdrawal by Subject|4|||
130457853|NCT00079183|469639995|FG000|Overall Study|Study medication non-compliance|2|||
130457854|NCT00079183|469639995|FG000|Overall Study|Specimen collection non-compliance|1|||
130457855|NCT04567888|469639996|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
130457856|NCT04567888|469639997|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
130457857|NCT04567888|469639996|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
130711286|NCT03578237|470567955|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
130711287|NCT03578237|470567956|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
130281875|NCT00519376|468994553|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281876|NCT00519376|468994554|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281877|NCT00519376|468994555|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281878|NCT00519376|468994556|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
130281879|NCT00519376|468994557|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281880|NCT00519376|468994558|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281881|NCT00519376|468994559|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281882|NCT00519376|468994544|FG000|Treatment Period 4|Lost to Follow-up|0|||
130281883|NCT00519376|468994545|FG001|Treatment Period 4|Lost to Follow-up|0|||
130281884|NCT00519376|468994546|FG002|Treatment Period 4|Lost to Follow-up|1|||
130281885|NCT00519376|468994547|FG003|Treatment Period 4|Lost to Follow-up|0|||
130281886|NCT00519376|468994548|FG004|Treatment Period 4|Lost to Follow-up|0|||
130281887|NCT00519376|468994549|FG005|Treatment Period 4|Lost to Follow-up|0|||
130281888|NCT00519376|468994550|FG006|Treatment Period 4|Lost to Follow-up|0|||
130281889|NCT00519376|468994551|FG007|Treatment Period 4|Lost to Follow-up|0|||
130281890|NCT00519376|468994552|FG008|Treatment Period 4|Lost to Follow-up|0|||
130281891|NCT00519376|468994553|FG009|Treatment Period 4|Lost to Follow-up|0|||
130281892|NCT00519376|468994554|FG010|Treatment Period 4|Lost to Follow-up|0|||
130281893|NCT00519376|468994555|FG011|Treatment Period 4|Lost to Follow-up|0|||
130281894|NCT00519376|468994556|FG012|Treatment Period 4|Lost to Follow-up|0|||
130281895|NCT00519376|468994557|FG013|Treatment Period 4|Lost to Follow-up|0|||
130281896|NCT00519376|468994558|FG014|Treatment Period 4|Lost to Follow-up|0|||
130281897|NCT00519376|468994559|FG015|Treatment Period 4|Lost to Follow-up|0|||
130281898|NCT02650128|468994560|FG000|Overall Study|Death|2|||
130281899|NCT01801436|468994574|FG000|Overall Study|Withdrawal by Subject|3|||
130281900|NCT01801436|468994574|FG000|Overall Study|Adverse Event|2|||
130281901|NCT01801436|468994574|FG000|Overall Study|Progressive disease|4|||
130281902|NCT01885208|468994575|FG000|Overall Study|Unclassified|32|||
130281903|NCT01885208|468994576|FG001|Overall Study|Unclassified|38|||
130281904|NCT01498575|468994577|FG000|Overall Sample|Withdrawal by Subject|60|||
130281905|NCT01498575|468994578|FG001|Overall Sample|Withdrawal by Subject|14|||
130281906|NCT01498575|468994577|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
130281907|NCT01498575|468994578|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
130281908|NCT01498575|468994577|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
130281909|NCT01498575|468994578|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
130281910|NCT01126437|468994584|FG000|Overall Study|Not treated|11|||
130281911|NCT01126437|468994585|FG001|Overall Study|Not treated|18|||
130457858|NCT04567888|469639997|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
130457859|NCT04567888|469639996|FG000|Overall Study|Reported Unusual Birth Year|2|||
130457860|NCT04567888|469639997|FG001|Overall Study|Reported Unusual Birth Year|3|||
130457861|NCT04567888|469639996|FG000|Overall Study|Duplicate Responses|0|||
130457862|NCT04567888|469639997|FG001|Overall Study|Duplicate Responses|1|||
130281912|NCT01126437|468994586|FG002|Overall Study|Not treated|19|||
130281913|NCT01126437|468994584|FG000|Overall Study|Sites with data irregularities/fraud|6|||
130281914|NCT01126437|468994585|FG001|Overall Study|Sites with data irregularities/fraud|6|||
130281915|NCT01126437|468994586|FG002|Overall Study|Sites with data irregularities/fraud|7|||
130281916|NCT01126437|468994584|FG000|Overall Study|Adverse Event|602|||
130281917|NCT01126437|468994585|FG001|Overall Study|Adverse Event|606|||
130281918|NCT01126437|468994586|FG002|Overall Study|Adverse Event|635|||
130281919|NCT01126437|468994584|FG000|Overall Study|Lack of Efficacy|65|||
130281920|NCT01126437|468994585|FG001|Overall Study|Lack of Efficacy|60|||
130281921|NCT01126437|468994586|FG002|Overall Study|Lack of Efficacy|59|||
130281922|NCT01126437|468994584|FG000|Overall Study|Protocol Violation|64|||
130281923|NCT01126437|468994585|FG001|Overall Study|Protocol Violation|66|||
130281924|NCT01126437|468994586|FG002|Overall Study|Protocol Violation|41|||
130281925|NCT01126437|468994584|FG000|Overall Study|Lost to Follow-up|52|||
130281926|NCT01126437|468994585|FG001|Overall Study|Lost to Follow-up|63|||
130281927|NCT01126437|468994586|FG002|Overall Study|Lost to Follow-up|55|||
130281928|NCT01126437|468994584|FG000|Overall Study|Withdrawal by Subject|331|||
130281929|NCT01126437|468994585|FG001|Overall Study|Withdrawal by Subject|335|||
130281930|NCT01126437|468994586|FG002|Overall Study|Withdrawal by Subject|319|||
130281931|NCT01126437|468994584|FG000|Overall Study|Other reason not specified|210|||
130281932|NCT01126437|468994585|FG001|Overall Study|Other reason not specified|176|||
130281933|NCT01126437|468994586|FG002|Overall Study|Other reason not specified|178|||
130281934|NCT01972308|468994593|FG000|Overall Study|Withdrawal by Subject|0|||
130281935|NCT01972308|468994594|FG001|Overall Study|Withdrawal by Subject|1|||
130281936|NCT01972308|468994593|FG000|Overall Study|Lost to Follow-up|4|||
130281937|NCT01972308|468994594|FG001|Overall Study|Lost to Follow-up|6|||
130281938|NCT01972308|468994593|FG000|Overall Study|Death|4|||
130281939|NCT01972308|468994594|FG001|Overall Study|Death|1|||
130281940|NCT01846663|468994599|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
130281941|NCT01846663|468994600|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
130281942|NCT01846663|468994599|FG000|Overall Study|Withdrawal by Subject|1|||
130281943|NCT01846663|468994600|FG001|Overall Study|Withdrawal by Subject|0|||
130281944|NCT01846663|468994599|FG000|Overall Study|Adverse Event|1|||
130281945|NCT01846663|468994600|FG001|Overall Study|Adverse Event|2|||
130281946|NCT01562314|468994601|FG000|Overall Study|Adverse Event|10|||
130281947|NCT01562314|468994602|FG001|Overall Study|Adverse Event|5|||
130281948|NCT01562314|468994601|FG000|Overall Study|Met Withdrawal Criteria|3|||
130281949|NCT01562314|468994602|FG001|Overall Study|Met Withdrawal Criteria|2|||
130281950|NCT01562314|468994601|FG000|Overall Study|Withdrawal by Subject|0|||
130281951|NCT01562314|468994602|FG001|Overall Study|Withdrawal by Subject|1|||
130281952|NCT02851797|468994603|FG000|Overall Study|Withdrawal by Subject|4|||
130281953|NCT02851797|468994604|FG001|Overall Study|Withdrawal by Subject|2|||
130281954|NCT02851797|468994603|FG000|Overall Study|Adverse Event|3|||
130281955|NCT02851797|468994604|FG001|Overall Study|Adverse Event|0|||
130281956|NCT03655054|468994605|FG000|Overall Study|Lost to Follow-up|1|||
130281957|NCT00813865|468994609|FG000|Overall Study|Failure to Respond|3|||
130281958|NCT00813865|468994609|FG000|Overall Study|Lost to Follow-up|3|||
130281959|NCT00813865|468994609|FG000|Overall Study|Withdrawal by Subject|1|||
130281960|NCT00543803|468994610|FG000|Overall Study|Adverse Event|14|||
130281961|NCT00543803|468994610|FG000|Overall Study|Lack of Efficacy|22|||
130281962|NCT00543803|468994610|FG000|Overall Study|Lost to Follow-up|20|||
130281963|NCT00543803|468994610|FG000|Overall Study|Other|86|||
130281964|NCT02256384|468994626|FG000|Overall Study|Withdrawal by Subject|12|||
130281965|NCT02256384|468994626|FG000|Overall Study|Equipment not capturing data|2|||
130281966|NCT04295681|468994628|FG000|Overall Study|Eligibility error|1|||
130281967|NCT04295681|468994629|FG001|Overall Study|Eligibility error|3|||
130281968|NCT03070223|468994641|FG000|Overall Study|Lost to Follow-up|34|||
130281969|NCT03070223|468994642|FG001|Overall Study|Lost to Follow-up|27|||
130281970|NCT03070223|468994641|FG000|Overall Study|Withdrawal by Subject|12|||
130281971|NCT03070223|468994642|FG001|Overall Study|Withdrawal by Subject|22|||
130281972|NCT03070223|468994641|FG000|Overall Study|Protocol Violation|0|||
130281973|NCT03070223|468994642|FG001|Overall Study|Protocol Violation|1|||
130281974|NCT03219034|468994643|FG000|Overall Study|Lost to Follow-up|9|||
130281975|NCT03219034|468994644|FG001|Overall Study|Lost to Follow-up|13|||
130369126|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130369127|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130369128|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130369129|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130457863|NCT00436644|469639999|FG000|Overall Study|Adverse Event|2|||
130281976|NCT03219034|468994643|FG000|Overall Study|Additional dental work needed|1|||
130281977|NCT03219034|468994644|FG001|Overall Study|Additional dental work needed|0|||
130281978|NCT03219034|468994643|FG000|Overall Study|UPPP Surgery|1|||
130281979|NCT03219034|468994644|FG001|Overall Study|UPPP Surgery|0|||
130281980|NCT03219034|468994643|FG000|Overall Study|Dental sensitivity|0|||
130281981|NCT03219034|468994644|FG001|Overall Study|Dental sensitivity|1|||
130281982|NCT03219034|468994643|FG000|Overall Study|Death in family|0|||
130281983|NCT03219034|468994644|FG001|Overall Study|Death in family|1|||
130281984|NCT02438683|468994645|FG000|Overall Study|Adverse Event|1|||
130711288|NCT00973765|470567957|FG000|Overall Study|Lost to Follow-up|8|||
130281985|NCT02438683|468994646|FG001|Overall Study|Adverse Event|0|||
130281986|NCT02438683|468994647|FG002|Overall Study|Adverse Event|0|||
130281987|NCT02438683|468994648|FG003|Overall Study|Adverse Event|0|||
130281988|NCT02438683|468994649|FG004|Overall Study|Adverse Event|0|||
130281989|NCT02438683|468994650|FG005|Overall Study|Adverse Event|0|||
130281990|NCT03315793|468994651|FG000|Overall Study|Adverse Event|4|||
130281991|NCT03315793|468994652|FG001|Overall Study|Adverse Event|2|||
130281992|NCT03315793|468994651|FG000|Overall Study|Protocol Deviation|1|||
130281993|NCT03315793|468994652|FG001|Overall Study|Protocol Deviation|0|||
130281994|NCT03315793|468994651|FG000|Overall Study|Difficult for regular visit|0|||
130281995|NCT03315793|468994652|FG001|Overall Study|Difficult for regular visit|1|||
130281996|NCT01952665|468996513|FG000|Overall Study|Physician Decision|3|||
130281997|NCT01952665|468996514|FG001|Overall Study|Physician Decision|2|||
130281998|NCT01952665|468996513|FG000|Overall Study|Lost to Follow-up|1|||
130281999|NCT01952665|468996514|FG001|Overall Study|Lost to Follow-up|2|||
130282000|NCT01952665|468996513|FG000|Overall Study|Adverse Event|2|||
130282001|NCT01952665|468996514|FG001|Overall Study|Adverse Event|1|||
130282002|NCT01952665|468996513|FG000|Overall Study|Protocol Violation|0|||
130282003|NCT01952665|468996514|FG001|Overall Study|Protocol Violation|1|||
130282004|NCT01537081|468996515|FG000|Overall Study|Adverse Event|5|||
130282005|NCT01537081|468996516|FG001|Overall Study|Adverse Event|2|||
130282006|NCT01537081|468996517|FG002|Overall Study|Adverse Event|2|||
130282007|NCT01537081|468996515|FG000|Overall Study|Lack of Efficacy|2|||
130282008|NCT01537081|468996516|FG001|Overall Study|Lack of Efficacy|1|||
130282009|NCT01537081|468996517|FG002|Overall Study|Lack of Efficacy|0|||
130282010|NCT01537081|468996515|FG000|Overall Study|Lost to Follow-up|17|||
130282011|NCT01537081|468996516|FG001|Overall Study|Lost to Follow-up|15|||
130282012|NCT01537081|468996517|FG002|Overall Study|Lost to Follow-up|9|||
130282013|NCT01537081|468996515|FG000|Overall Study|Protocol Violation|3|||
130282014|NCT01537081|468996516|FG001|Overall Study|Protocol Violation|2|||
130282015|NCT01537081|468996517|FG002|Overall Study|Protocol Violation|2|||
130282016|NCT01537081|468996515|FG000|Overall Study|Withdrawal by Subject|6|||
130282017|NCT01537081|468996516|FG001|Overall Study|Withdrawal by Subject|11|||
130282018|NCT01537081|468996517|FG002|Overall Study|Withdrawal by Subject|3|||
130282019|NCT01537081|468996515|FG000|Overall Study|Physician Decision|5|||
130282020|NCT01537081|468996516|FG001|Overall Study|Physician Decision|6|||
130282021|NCT01537081|468996517|FG002|Overall Study|Physician Decision|0|||
130282022|NCT01537081|468996515|FG000|Overall Study|Sponsor decision|0|||
130282023|NCT01537081|468996516|FG001|Overall Study|Sponsor decision|1|||
130282024|NCT01537081|468996517|FG002|Overall Study|Sponsor decision|0|||
130282025|NCT01537081|468996515|FG000|Overall Study|Assigned but never dosed|1|||
130282026|NCT01537081|468996516|FG001|Overall Study|Assigned but never dosed|0|||
130282027|NCT01537081|468996517|FG002|Overall Study|Assigned but never dosed|0|||
130282028|NCT02596958|468996520|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
130282029|NCT02596958|468996520|FG000|Overall Study|Cancer Progression|441|||
130282030|NCT02596958|468996520|FG000|Overall Study|Death From Cancer|112|||
130282031|NCT02596958|468996520|FG000|Overall Study|Death From Other Cause|33|||
130282032|NCT02596958|468996520|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
130282033|NCT02596958|468996520|FG000|Overall Study|Administrative Reasons/Other|231|||
130282034|NCT02596958|468996520|FG000|Overall Study|Lost to Follow-up|33|||
130282035|NCT02596958|468996520|FG000|Overall Study|Missing|32|||
130282036|NCT02596958|468996520|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
130282037|NCT01559259|468996521|FG000|Overall Study|Withdrawal by Subject|0|||
130282038|NCT01559259|468996522|FG001|Overall Study|Withdrawal by Subject|0|||
130282039|NCT01559259|468996523|FG002|Overall Study|Withdrawal by Subject|0|||
130282040|NCT01559259|468996524|FG003|Overall Study|Withdrawal by Subject|1|||
130282041|NCT01559259|468996525|FG004|Overall Study|Withdrawal by Subject|0|||
130282042|NCT01559259|468996521|FG000|Overall Study|Adverse Event|0|||
130457864|NCT00436644|469639999|FG000|Overall Study|Death|1|||
130711289|NCT00973765|470567958|FG001|Overall Study|Lost to Follow-up|14|||
130711290|NCT02011113|470567959|FG000|Overall Study|Adverse Event|4|||
130282043|NCT01559259|468996522|FG001|Overall Study|Adverse Event|1|||
130282044|NCT01559259|468996523|FG002|Overall Study|Adverse Event|1|||
130282045|NCT01559259|468996524|FG003|Overall Study|Adverse Event|0|||
130282046|NCT01559259|468996525|FG004|Overall Study|Adverse Event|0|||
130282047|NCT00185380|468996527|FG000|Overall Study|Adverse Event|41|||
130282048|NCT00185380|468996528|FG001|Overall Study|Adverse Event|43|||
130282049|NCT00185380|468996529|FG002|Overall Study|Adverse Event|48|||
130282050|NCT00185380|468996527|FG000|Overall Study|Lost to Follow-up|0|||
130457865|NCT00619645|469640000|FG000|Overall Study|Adverse Event|1|||
130457866|NCT04364269|469640001|FG000|Overall Study|Adverse Event|1|||
130282051|NCT00185380|468996528|FG001|Overall Study|Lost to Follow-up|4|||
130282052|NCT00185380|468996529|FG002|Overall Study|Lost to Follow-up|3|||
130282053|NCT00185380|468996527|FG000|Overall Study|Pregnancy|1|||
130457867|NCT04364269|469640002|FG001|Overall Study|Adverse Event|0|||
130457868|NCT04364269|469640003|FG002|Overall Study|Adverse Event|0|||
130282054|NCT00185380|468996528|FG001|Overall Study|Pregnancy|4|||
130282055|NCT00185380|468996529|FG002|Overall Study|Pregnancy|0|||
130711291|NCT02011113|470567959|FG000|Overall Study|Disease Progression (DP)|16|||
130369130|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
130369131|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
130369132|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130369133|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130369134|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130369135|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130369136|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130369137|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130369138|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130369139|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
130369140|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130369141|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130369142|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
130369143|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
130369144|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130369145|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130369146|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
130369147|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
130369148|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130369149|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130369150|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130369151|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
130369152|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
130369153|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
130369154|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
130369155|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
130369156|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
130369157|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
130369158|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
130369159|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
130369160|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
130369161|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Missing|0|||
130369162|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Missing|0|||
130369163|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Missing|2|||
130369164|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Missing|0|||
130369165|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Missing|0|||
130369166|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130369167|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130369168|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130369169|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130369170|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
130369171|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130369172|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130369173|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
130369174|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130369175|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130369176|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
130369177|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
130369178|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
130369179|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
130369180|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
130369181|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
130369182|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
130369183|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
130369184|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
130369185|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
130369186|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130369187|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130369188|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130369189|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
130369190|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130369191|NCT00730405|469321259|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
130369192|NCT00730405|469321260|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130711292|NCT02011113|470567959|FG000|Overall Study|Death|1|||
130711293|NCT02011113|470567959|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
130711294|NCT02011113|470567959|FG000|Overall Study|Investigator's judgement- DP|3|||
130711295|NCT02011113|470567959|FG000|Overall Study|Study terminated by sponsor|11|||
130711296|NCT00171301|470567960|FG000|Overall Study|Death|1|||
130711297|NCT00171301|470567961|FG001|Overall Study|Death|2|||
130711298|NCT00171301|470567960|FG000|Overall Study|Adverse Event|1|||
130711299|NCT00171301|470567961|FG001|Overall Study|Adverse Event|2|||
130711300|NCT00171301|470567960|FG000|Overall Study|Lost to Follow-up|6|||
130711301|NCT00171301|470567961|FG001|Overall Study|Lost to Follow-up|2|||
130711302|NCT00171301|470567960|FG000|Overall Study|Protocol Violation|0|||
130711303|NCT00171301|470567961|FG001|Overall Study|Protocol Violation|2|||
130711304|NCT00171301|470567960|FG000|Overall Study|Withdrawal by Subject|0|||
130711305|NCT00171301|470567961|FG001|Overall Study|Withdrawal by Subject|1|||
130711306|NCT04319159|470567962|FG000|Overall Study|Screening failure|13|||
130711307|NCT04319159|470567962|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
130711308|NCT04319159|470567962|FG000|Overall Study|Withdrawal by Subject|1|||
130711309|NCT02100319|470567963|FG000|Overall Study|Case Report Forms Uncollected|11|||
130711310|NCT02100319|470567963|FG000|Overall Study|Protocol Deviation|5|||
130711311|NCT03375320|470567964|FG000|Overall Study|Adverse Event|34|||
130711312|NCT03375320|470567965|FG001|Overall Study|Adverse Event|9|||
130711313|NCT03375320|470567966|FG002|Overall Study|Adverse Event|10|||
130711314|NCT03375320|470567967|FG003|Overall Study|Adverse Event|0|||
130711315|NCT03375320|470567964|FG000|Overall Study|Death|6|||
130711316|NCT03375320|470567965|FG001|Overall Study|Death|3|||
130711317|NCT03375320|470567966|FG002|Overall Study|Death|0|||
130711318|NCT03375320|470567967|FG003|Overall Study|Death|0|||
130282056|NCT00185380|468996527|FG000|Overall Study|Protocol Violation|2|||
130282057|NCT00185380|468996528|FG001|Overall Study|Protocol Violation|2|||
130282058|NCT00185380|468996529|FG002|Overall Study|Protocol Violation|1|||
130282059|NCT00185380|468996527|FG000|Overall Study|Withdrawal by Subject|1|||
130282060|NCT00185380|468996528|FG001|Overall Study|Withdrawal by Subject|2|||
130282061|NCT00185380|468996529|FG002|Overall Study|Withdrawal by Subject|0|||
130282062|NCT00185380|468996527|FG000|Overall Study|Failed insertion|1|||
130282063|NCT00185380|468996528|FG001|Overall Study|Failed insertion|1|||
130282064|NCT00185380|468996529|FG002|Overall Study|Failed insertion|2|||
130282065|NCT00185380|468996527|FG000|Overall Study|Planned pregnancy|9|||
130282066|NCT00185380|468996528|FG001|Overall Study|Planned pregnancy|12|||
130282067|NCT00185380|468996529|FG002|Overall Study|Planned pregnancy|12|||
130282068|NCT00185380|468996527|FG000|Overall Study|No need for contraception|3|||
130282069|NCT00185380|468996528|FG001|Overall Study|No need for contraception|3|||
130282070|NCT00185380|468996529|FG002|Overall Study|No need for contraception|3|||
130282071|NCT00185380|468996527|FG000|Overall Study|Could not attend visits|2|||
130282072|NCT00185380|468996528|FG001|Overall Study|Could not attend visits|0|||
130282073|NCT00185380|468996529|FG002|Overall Study|Could not attend visits|4|||
130282074|NCT00185380|468996527|FG000|Overall Study|personal reason|6|||
130282075|NCT00185380|468996528|FG001|Overall Study|personal reason|1|||
130282076|NCT00185380|468996529|FG002|Overall Study|personal reason|1|||
130282077|NCT02199314|468996530|FG000|Overall Study|Withdrawal by Subject|6|||
130282078|NCT02199314|468996530|FG000|Overall Study|Physician Decision|10|||
130282079|NCT03842969|468996531|FG000|Overall Study|Participant declined follow-up visit|0|||
130282080|NCT03842969|468996532|FG001|Overall Study|Participant declined follow-up visit|1|||
130282081|NCT03842969|468996533|FG002|Overall Study|Participant declined follow-up visit|0|||
130282082|NCT03842969|468996531|FG000|Overall Study|Sponsor's decision|12|||
130282083|NCT03842969|468996532|FG001|Overall Study|Sponsor's decision|99|||
130282084|NCT03842969|468996533|FG002|Overall Study|Sponsor's decision|61|||
130282085|NCT03842969|468996531|FG000|Overall Study|Pregnancy|0|||
130282086|NCT03842969|468996532|FG001|Overall Study|Pregnancy|0|||
130282087|NCT03842969|468996533|FG002|Overall Study|Pregnancy|1|||
130282088|NCT03842969|468996531|FG000|Overall Study|Death|1|||
130282089|NCT03842969|468996532|FG001|Overall Study|Death|0|||
130282090|NCT03842969|468996533|FG002|Overall Study|Death|1|||
130282091|NCT03842969|468996531|FG000|Overall Study|Withdrawal by Subject|3|||
130282092|NCT03842969|468996532|FG001|Overall Study|Withdrawal by Subject|30|||
130282093|NCT03842969|468996533|FG002|Overall Study|Withdrawal by Subject|18|||
130282094|NCT03842969|468996531|FG000|Overall Study|Protocol Violation|1|||
130282095|NCT03842969|468996532|FG001|Overall Study|Protocol Violation|1|||
130282096|NCT03842969|468996533|FG002|Overall Study|Protocol Violation|0|||
130282097|NCT03842969|468996531|FG000|Overall Study|Physician Decision|0|||
130282098|NCT03842969|468996532|FG001|Overall Study|Physician Decision|3|||
130282099|NCT03842969|468996533|FG002|Overall Study|Physician Decision|0|||
130282100|NCT03842969|468996531|FG000|Overall Study|Lost to Follow-up|0|||
130711319|NCT03375320|470567964|FG000|Overall Study|Withdrawal by Subject|7|||
130711320|NCT03375320|470567965|FG001|Overall Study|Withdrawal by Subject|4|||
130711321|NCT03375320|470567966|FG002|Overall Study|Withdrawal by Subject|5|||
130711322|NCT03375320|470567967|FG003|Overall Study|Withdrawal by Subject|4|||
130711323|NCT03375320|470567964|FG000|Overall Study|Progressive disease|55|||
130711324|NCT03375320|470567965|FG001|Overall Study|Progressive disease|41|||
130711325|NCT03375320|470567966|FG002|Overall Study|Progressive disease|29|||
130282101|NCT03842969|468996532|FG001|Overall Study|Lost to Follow-up|2|||
130282102|NCT03842969|468996533|FG002|Overall Study|Lost to Follow-up|0|||
130282103|NCT03842969|468996531|FG000|Overall Study|Adverse Event|0|||
130282104|NCT03842969|468996532|FG001|Overall Study|Adverse Event|2|||
130711326|NCT03375320|470567967|FG003|Overall Study|Progressive disease|24|||
130282105|NCT03842969|468996533|FG002|Overall Study|Adverse Event|0|||
130282106|NCT01892436|468996534|FG000|Overall Study|Withdrawal by Subject|8|||
130282107|NCT01892436|468996535|FG001|Overall Study|Withdrawal by Subject|15|||
130282108|NCT01892436|468996536|FG002|Overall Study|Withdrawal by Subject|4|||
130282109|NCT01892436|468996537|FG003|Overall Study|Withdrawal by Subject|4|||
130282110|NCT01892436|468996534|FG000|Overall Study|Death|1|||
130282111|NCT01892436|468996535|FG001|Overall Study|Death|1|||
130282112|NCT01892436|468996536|FG002|Overall Study|Death|0|||
130282113|NCT01892436|468996537|FG003|Overall Study|Death|0|||
130282114|NCT01892436|468996534|FG000|Overall Study|Physician Decision|2|||
130282115|NCT01892436|468996535|FG001|Overall Study|Physician Decision|1|||
130282116|NCT01892436|468996536|FG002|Overall Study|Physician Decision|0|||
130282117|NCT01892436|468996537|FG003|Overall Study|Physician Decision|1|||
130282118|NCT01892436|468996534|FG000|Overall Study|Pregnancy|0|||
130282119|NCT01892436|468996535|FG001|Overall Study|Pregnancy|2|||
130282120|NCT01892436|468996536|FG002|Overall Study|Pregnancy|1|||
130282121|NCT01892436|468996537|FG003|Overall Study|Pregnancy|0|||
130282122|NCT01892436|468996534|FG000|Overall Study|Technical problems|2|||
130282123|NCT01892436|468996535|FG001|Overall Study|Technical problems|1|||
130282124|NCT01892436|468996536|FG002|Overall Study|Technical problems|1|||
130282125|NCT01892436|468996537|FG003|Overall Study|Technical problems|1|||
130282126|NCT01892436|468996534|FG000|Overall Study|Lack of Efficacy|1|||
130282127|NCT01892436|468996535|FG001|Overall Study|Lack of Efficacy|2|||
130282128|NCT01892436|468996536|FG002|Overall Study|Lack of Efficacy|2|||
130282129|NCT01892436|468996537|FG003|Overall Study|Lack of Efficacy|2|||
130282130|NCT01892436|468996534|FG000|Overall Study|Lost to Follow-up|1|||
130282131|NCT01892436|468996535|FG001|Overall Study|Lost to Follow-up|1|||
130282132|NCT01892436|468996536|FG002|Overall Study|Lost to Follow-up|1|||
130282133|NCT01892436|468996537|FG003|Overall Study|Lost to Follow-up|3|||
130282134|NCT01892436|468996534|FG000|Overall Study|non-compliance with treatment|1|||
130282135|NCT01892436|468996535|FG001|Overall Study|non-compliance with treatment|0|||
130282136|NCT01892436|468996536|FG002|Overall Study|non-compliance with treatment|0|||
130282137|NCT01892436|468996537|FG003|Overall Study|non-compliance with treatment|0|||
130282138|NCT01892436|468996534|FG000|Overall Study|Adverse Event|7|||
130282139|NCT01892436|468996535|FG001|Overall Study|Adverse Event|6|||
130282140|NCT01892436|468996536|FG002|Overall Study|Adverse Event|2|||
130282141|NCT01892436|468996537|FG003|Overall Study|Adverse Event|3|||
130282142|NCT00733291|468996539|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
130282143|NCT00733291|468996540|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282144|NCT00733291|468996541|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282145|NCT00733291|468996542|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282146|NCT02759107|468996544|FG000|Overall Study|Adverse Event|0|||
130282147|NCT02759107|468996545|FG001|Overall Study|Adverse Event|0|||
130282148|NCT02759107|468996546|FG002|Overall Study|Adverse Event|0|||
130282149|NCT02759107|468996547|FG003|Overall Study|Adverse Event|0|||
130282150|NCT02759107|468996548|FG004|Overall Study|Adverse Event|0|||
130282151|NCT02759107|468996549|FG005|Overall Study|Adverse Event|0|||
130282152|NCT02759107|468996550|FG006|Overall Study|Adverse Event|0|||
130282153|NCT02759107|468996551|FG007|Overall Study|Adverse Event|0|||
130282154|NCT02759107|468996552|FG008|Overall Study|Adverse Event|0|||
130369193|NCT00730405|469321261|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130369194|NCT00730405|469321262|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130369195|NCT00730405|469321263|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130369196|NCT03851705|469321267|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
130369197|NCT03851705|469321268|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130711327|NCT03375320|470567964|FG000|Overall Study|Alternative treatment|6|||
130282155|NCT02759107|468996553|FG009|Overall Study|Adverse Event|0|||
130282156|NCT02759107|468996554|FG010|Overall Study|Adverse Event|0|||
130282157|NCT02759107|468996555|FG011|Overall Study|Adverse Event|0|||
130369198|NCT03851705|469321269|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130711328|NCT03375320|470567965|FG001|Overall Study|Alternative treatment|1|||
130282158|NCT02759107|468996556|FG012|Overall Study|Adverse Event|2|||
130282159|NCT02759107|468996557|FG013|Overall Study|Adverse Event|0|||
130282160|NCT02759107|468996558|FG014|Overall Study|Adverse Event|0|||
130282161|NCT02759107|468996559|FG015|Overall Study|Adverse Event|1|||
130711329|NCT03375320|470567966|FG002|Overall Study|Alternative treatment|1|||
130369199|NCT03851705|469321270|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130369200|NCT03851705|469321267|FG000|Part 1: Double-Blind Period|Other reason|1|||
130369201|NCT03851705|469321268|FG001|Part 1: Double-Blind Period|Other reason|0|||
130369202|NCT03851705|469321269|FG002|Part 1: Double-Blind Period|Other reason|0|||
130369203|NCT03851705|469321270|FG003|Part 1: Double-Blind Period|Other reason|0|||
130369204|NCT03851705|469321267|FG000|Part 2: Open-Label Period|Other reason|0|||
130369205|NCT03851705|469321268|FG001|Part 2: Open-Label Period|Other reason|0|||
130369206|NCT03851705|469321269|FG002|Part 2: Open-Label Period|Other reason|0|||
130369207|NCT03851705|469321270|FG003|Part 2: Open-Label Period|Other reason|1|||
130369208|NCT03851705|469321267|FG000|Part 2: Open-Label Period|Death|0|||
130711330|NCT03375320|470567967|FG003|Overall Study|Alternative treatment|0|||
130711331|NCT03375320|470567964|FG000|Overall Study|Other disease|1|||
130711332|NCT03375320|470567965|FG001|Overall Study|Other disease|1|||
130711333|NCT03375320|470567966|FG002|Overall Study|Other disease|3|||
130369209|NCT03851705|469321268|FG001|Part 2: Open-Label Period|Death|0|||
130369210|NCT03851705|469321269|FG002|Part 2: Open-Label Period|Death|3|||
130369211|NCT03851705|469321270|FG003|Part 2: Open-Label Period|Death|0|||
130369212|NCT03851705|469321267|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130369213|NCT03851705|469321268|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130369214|NCT03851705|469321269|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
130369215|NCT03851705|469321270|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130369216|NCT01496807|469321271|FG000|Overall Study|Progressive Disease|21|||
130369217|NCT01496807|469321271|FG000|Overall Study|Participant preference/toxicity|8|||
130369218|NCT01496807|469321271|FG000|Overall Study|Change in diagnosis|1|||
130369219|NCT02591290|469321278|FG000|Overall Study|Withdrawal by Subject|2|||
130369220|NCT01306942|469321279|FG000|Phase I|Adverse Event|2|||
130369221|NCT01306942|469321280|FG001|Phase I|Adverse Event|2|||
130369222|NCT01306942|469321281|FG002|Phase I|Adverse Event|0|||
130369223|NCT01306942|469321282|FG003|Phase I|Adverse Event|0|||
130369224|NCT01306942|469321279|FG000|Phase I|Physician Decision|3|||
130369225|NCT01306942|469321280|FG001|Phase I|Physician Decision|1|||
130369226|NCT01306942|469321281|FG002|Phase I|Physician Decision|0|||
130369227|NCT01306942|469321282|FG003|Phase I|Physician Decision|0|||
130369228|NCT01306942|469321279|FG000|Phase II|Adverse Event|0|||
130369229|NCT01306942|469321280|FG001|Phase II|Adverse Event|0|||
130369230|NCT01306942|469321281|FG002|Phase II|Adverse Event|0|||
130369231|NCT01306942|469321282|FG003|Phase II|Adverse Event|6|||
130369232|NCT01306942|469321279|FG000|Phase II|Physician Decision|2|||
130369233|NCT01306942|469321280|FG001|Phase II|Physician Decision|0|||
130369234|NCT01306942|469321281|FG002|Phase II|Physician Decision|0|||
130369235|NCT01306942|469321282|FG003|Phase II|Physician Decision|5|||
130369236|NCT01306942|469321279|FG000|Phase II|Withdrawal by Subject|0|||
130369237|NCT01306942|469321280|FG001|Phase II|Withdrawal by Subject|0|||
130711334|NCT03375320|470567967|FG003|Overall Study|Other disease|0|||
130282162|NCT02759107|468996560|FG016|Overall Study|Adverse Event|0|||
130282163|NCT02759107|468996561|FG017|Overall Study|Adverse Event|2|||
130282164|NCT02759107|468996544|FG000|Overall Study|Scheduling Conflict|0|||
130282165|NCT02759107|468996545|FG001|Overall Study|Scheduling Conflict|0|||
130282166|NCT02759107|468996546|FG002|Overall Study|Scheduling Conflict|0|||
130282167|NCT02759107|468996547|FG003|Overall Study|Scheduling Conflict|0|||
130282168|NCT02759107|468996548|FG004|Overall Study|Scheduling Conflict|0|||
130282169|NCT02759107|468996549|FG005|Overall Study|Scheduling Conflict|0|||
130282170|NCT02759107|468996550|FG006|Overall Study|Scheduling Conflict|0|||
130282171|NCT02759107|468996551|FG007|Overall Study|Scheduling Conflict|0|||
130282172|NCT02759107|468996552|FG008|Overall Study|Scheduling Conflict|0|||
130282173|NCT02759107|468996553|FG009|Overall Study|Scheduling Conflict|1|||
130282174|NCT02759107|468996554|FG010|Overall Study|Scheduling Conflict|0|||
130282175|NCT02759107|468996555|FG011|Overall Study|Scheduling Conflict|0|||
130369238|NCT01306942|469321281|FG002|Phase II|Withdrawal by Subject|0|||
130369239|NCT01306942|469321282|FG003|Phase II|Withdrawal by Subject|2|||
130369240|NCT01306942|469321279|FG000|Phase II|Death|0|||
130369241|NCT01306942|469321280|FG001|Phase II|Death|0|||
130369242|NCT01306942|469321281|FG002|Phase II|Death|0|||
130369243|NCT01306942|469321282|FG003|Phase II|Death|1|||
130282176|NCT02759107|468996556|FG012|Overall Study|Scheduling Conflict|0|||
130282177|NCT02759107|468996557|FG013|Overall Study|Scheduling Conflict|0|||
130282178|NCT02759107|468996558|FG014|Overall Study|Scheduling Conflict|0|||
130369244|NCT01306942|469321279|FG000|Phase II|Not finished treatment|0|||
130369245|NCT01306942|469321280|FG001|Phase II|Not finished treatment|0|||
130457869|NCT04364269|469640001|FG000|Overall Study|Withdrawal by Subject|0|||
130457870|NCT04364269|469640002|FG001|Overall Study|Withdrawal by Subject|1|||
130369246|NCT01306942|469321281|FG002|Phase II|Not finished treatment|0|||
130369247|NCT01306942|469321282|FG003|Phase II|Not finished treatment|1|||
130369248|NCT01306942|469321279|FG000|Phase II|Protocol Violation|0|||
130369249|NCT01306942|469321280|FG001|Phase II|Protocol Violation|0|||
130711335|NCT03375320|470567964|FG000|Overall Study|Withdrawal prior to initiation|2|||
130369250|NCT01306942|469321281|FG002|Phase II|Protocol Violation|0|||
130369251|NCT01306942|469321282|FG003|Phase II|Protocol Violation|1|||
130369252|NCT01390649|469321289|FG000|Overall Study|Physician Decision|1|||
130369253|NCT00282984|469321290|FG000|Overall Study|Death|2|||
130457871|NCT04364269|469640003|FG002|Overall Study|Withdrawal by Subject|0|||
130457872|NCT01490580|469640004|FG000|Overall Study|Parents withdrew consent|0|||
130282179|NCT02759107|468996559|FG015|Overall Study|Scheduling Conflict|0|||
130282180|NCT02759107|468996560|FG016|Overall Study|Scheduling Conflict|0|||
130282181|NCT02759107|468996561|FG017|Overall Study|Scheduling Conflict|0|||
130282182|NCT02019108|468996564|FG000|Overall Study|Lost to Follow-up|5|||
130282183|NCT02019108|468996565|FG001|Overall Study|Lost to Follow-up|7|||
130282184|NCT04569136|468996571|FG000|Overall Study|Lost to Follow-up|2|||
130282185|NCT04569136|468996572|FG001|Overall Study|Lost to Follow-up|0|||
130282186|NCT04569136|468996573|FG002|Overall Study|Lost to Follow-up|1|||
130282187|NCT01466660|468996578|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
130282188|NCT01466660|468996579|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
130282189|NCT01466660|468996578|FG000|Overall Study|Worsening of underlying cancer disease|5|||
130282190|NCT01466660|468996579|FG001|Overall Study|Worsening of underlying cancer disease|2|||
130282191|NCT01466660|468996578|FG000|Overall Study|Other adverse event|19|||
130282192|NCT01466660|468996579|FG001|Overall Study|Other adverse event|18|||
130282193|NCT01466660|468996578|FG000|Overall Study|Protocol Violation|2|||
130282194|NCT01466660|468996579|FG001|Overall Study|Protocol Violation|1|||
130282195|NCT01466660|468996578|FG000|Overall Study|Refused continuation of trial medication|4|||
130282196|NCT01466660|468996579|FG001|Overall Study|Refused continuation of trial medication|3|||
130282197|NCT01466660|468996578|FG000|Overall Study|Other reason not defined above|10|||
130282198|NCT01466660|468996579|FG001|Overall Study|Other reason not defined above|8|||
130282199|NCT00191724|468996580|FG000|Overall Study|Adverse Event|0|||
130282200|NCT00191724|468996581|FG001|Overall Study|Adverse Event|0|||
130282201|NCT00191724|468996582|FG002|Overall Study|Adverse Event|1|||
130282202|NCT00191724|468996583|FG003|Overall Study|Adverse Event|0|||
130282203|NCT00191724|468996584|FG004|Overall Study|Adverse Event|0|||
130282204|NCT00191724|468996580|FG000|Overall Study|Lost to Follow-up|1|||
130282205|NCT00191724|468996581|FG001|Overall Study|Lost to Follow-up|1|||
130282206|NCT00191724|468996582|FG002|Overall Study|Lost to Follow-up|0|||
130282207|NCT00191724|468996583|FG003|Overall Study|Lost to Follow-up|2|||
130282208|NCT00191724|468996584|FG004|Overall Study|Lost to Follow-up|3|||
130282209|NCT00191724|468996580|FG000|Overall Study|Withdrawal by Subject|0|||
130282210|NCT00191724|468996581|FG001|Overall Study|Withdrawal by Subject|0|||
130282211|NCT00191724|468996582|FG002|Overall Study|Withdrawal by Subject|0|||
130282212|NCT00191724|468996583|FG003|Overall Study|Withdrawal by Subject|1|||
130282213|NCT00191724|468996584|FG004|Overall Study|Withdrawal by Subject|0|||
130282214|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
130282215|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
130282216|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
130282217|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
130282218|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
130282219|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
130282220|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130282221|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130282222|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
130282223|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
130282224|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
130282225|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
130282226|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
130282227|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
130282228|NCT04085458|468996593|FG000|Overall Study|Other|1|||
130282229|NCT04085458|468996593|FG000|Overall Study|Withdrawal by Subject|2|||
130282230|NCT04085458|468996593|FG000|Overall Study|Adverse Event|2|||
130282231|NCT02447250|468996594|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
130282232|NCT02447250|468996594|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
130282233|NCT02447250|468996594|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
130282234|NCT03632993|468996595|FG000|Overall Study|Withdrawal by Subject|1|||
130282235|NCT03632993|468996596|FG001|Overall Study|Withdrawal by Subject|0|||
130282236|NCT03632993|468996597|FG002|Overall Study|Withdrawal by Subject|0|||
130282237|NCT03632993|468996598|FG003|Overall Study|Withdrawal by Subject|0|||
130457873|NCT01490580|469640005|FG001|Overall Study|Parents withdrew consent|2|||
130282238|NCT03632993|468996599|FG004|Overall Study|Withdrawal by Subject|0|||
130282239|NCT03632993|468996600|FG005|Overall Study|Withdrawal by Subject|0|||
130282240|NCT03632993|468996601|FG006|Overall Study|Withdrawal by Subject|0|||
130282241|NCT03632993|468996602|FG007|Overall Study|Withdrawal by Subject|0|||
130282242|NCT03632993|468996603|FG008|Overall Study|Withdrawal by Subject|0|||
130457874|NCT00371566|469640006|FG000|Treatment Phase|Withdrawal by Subject|0|||
130457875|NCT00371566|469640007|FG001|Treatment Phase|Withdrawal by Subject|1|||
130282243|NCT03632993|468996604|FG009|Overall Study|Withdrawal by Subject|1|||
130282244|NCT03632993|468996595|FG000|Overall Study|Protocol Non-compliance|0|||
130282245|NCT03632993|468996596|FG001|Overall Study|Protocol Non-compliance|1|||
130282246|NCT03632993|468996597|FG002|Overall Study|Protocol Non-compliance|0|||
130457876|NCT00371566|469640006|FG000|Treatment Phase|Adverse Event|0|||
130711336|NCT03375320|470567965|FG001|Overall Study|Withdrawal prior to initiation|2|||
130711337|NCT03375320|470567966|FG002|Overall Study|Withdrawal prior to initiation|1|||
130282247|NCT03632993|468996598|FG003|Overall Study|Protocol Non-compliance|0|||
130282248|NCT03632993|468996599|FG004|Overall Study|Protocol Non-compliance|0|||
130282249|NCT03632993|468996600|FG005|Overall Study|Protocol Non-compliance|0|||
130282250|NCT03632993|468996601|FG006|Overall Study|Protocol Non-compliance|0|||
130282251|NCT03632993|468996602|FG007|Overall Study|Protocol Non-compliance|0|||
130282252|NCT03632993|468996603|FG008|Overall Study|Protocol Non-compliance|0|||
130282253|NCT03632993|468996604|FG009|Overall Study|Protocol Non-compliance|0|||
130282254|NCT03632993|468996595|FG000|Overall Study|Lost to Follow-up|0|||
130282255|NCT03632993|468996596|FG001|Overall Study|Lost to Follow-up|0|||
130282256|NCT03632993|468996597|FG002|Overall Study|Lost to Follow-up|0|||
130282257|NCT03632993|468996598|FG003|Overall Study|Lost to Follow-up|0|||
130282258|NCT03632993|468996599|FG004|Overall Study|Lost to Follow-up|0|||
130282259|NCT03632993|468996600|FG005|Overall Study|Lost to Follow-up|1|||
130282260|NCT03632993|468996601|FG006|Overall Study|Lost to Follow-up|0|||
130282261|NCT03632993|468996602|FG007|Overall Study|Lost to Follow-up|1|||
130282262|NCT03632993|468996603|FG008|Overall Study|Lost to Follow-up|0|||
130282263|NCT03632993|468996604|FG009|Overall Study|Lost to Follow-up|0|||
130282264|NCT03632993|468996595|FG000|Overall Study|Adverse Event|0|||
130282265|NCT03632993|468996596|FG001|Overall Study|Adverse Event|0|||
130282266|NCT03632993|468996597|FG002|Overall Study|Adverse Event|0|||
130282267|NCT03632993|468996598|FG003|Overall Study|Adverse Event|0|||
130282268|NCT03632993|468996599|FG004|Overall Study|Adverse Event|0|||
130282269|NCT03632993|468996600|FG005|Overall Study|Adverse Event|1|||
130282270|NCT03632993|468996601|FG006|Overall Study|Adverse Event|0|||
130282271|NCT03632993|468996602|FG007|Overall Study|Adverse Event|1|||
130282272|NCT03632993|468996603|FG008|Overall Study|Adverse Event|0|||
130282273|NCT03632993|468996604|FG009|Overall Study|Adverse Event|0|||
130282274|NCT03224507|468996605|FG000|Overall Study|Death|3|||
130282275|NCT03224507|468996606|FG001|Overall Study|Death|0|||
130282276|NCT03224507|468996605|FG000|Overall Study|Lack of Efficacy|6|||
130282277|NCT03224507|468996606|FG001|Overall Study|Lack of Efficacy|0|||
130282278|NCT03224507|468996605|FG000|Overall Study|Withdrawal by Subject|6|||
130282279|NCT03224507|468996606|FG001|Overall Study|Withdrawal by Subject|0|||
130282280|NCT00075946|468996609|FG000|Overall Study|Path ineligible: undetermined histology|0|||
130282281|NCT00075946|468996610|FG001|Overall Study|Path ineligible: undetermined histology|0|||
130282282|NCT00075946|468996611|FG002|Overall Study|Path ineligible: undetermined histology|0|||
130282283|NCT00075946|468996612|FG003|Overall Study|Path ineligible: undetermined histology|0|||
130282284|NCT00075946|468996613|FG004|Overall Study|Path ineligible: undetermined histology|6|||
130282285|NCT00075946|468996609|FG000|Overall Study|Did not achieve response after induction|0|||
130282286|NCT00075946|468996610|FG001|Overall Study|Did not achieve response after induction|0|||
130282287|NCT00075946|468996611|FG002|Overall Study|Did not achieve response after induction|0|||
130282288|NCT00075946|468996612|FG003|Overall Study|Did not achieve response after induction|0|||
130282289|NCT00075946|468996613|FG004|Overall Study|Did not achieve response after induction|182|||
130282290|NCT00075946|468996609|FG000|Overall Study|Incorrectly randomized (no response)|5|||
130282291|NCT00075946|468996610|FG001|Overall Study|Incorrectly randomized (no response)|5|||
130282292|NCT00075946|468996611|FG002|Overall Study|Incorrectly randomized (no response)|5|||
130282293|NCT00075946|468996612|FG003|Overall Study|Incorrectly randomized (no response)|1|||
130282294|NCT00075946|468996613|FG004|Overall Study|Incorrectly randomized (no response)|0|||
130282295|NCT00075946|468996609|FG000|Overall Study|Adverse Event|2|||
130282296|NCT00075946|468996610|FG001|Overall Study|Adverse Event|10|||
130555325|NCT03942406|470001553|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
130711338|NCT03375320|470567967|FG003|Overall Study|Withdrawal prior to initiation|0|||
130711339|NCT03375320|470567964|FG000|Overall Study|Physician Decision|1|||
130711340|NCT03375320|470567965|FG001|Overall Study|Physician Decision|1|||
130711341|NCT03375320|470567966|FG002|Overall Study|Physician Decision|1|||
130282297|NCT00075946|468996611|FG002|Overall Study|Adverse Event|0|||
130282298|NCT00075946|468996612|FG003|Overall Study|Adverse Event|2|||
130282299|NCT00075946|468996613|FG004|Overall Study|Adverse Event|0|||
130282300|NCT00075946|468996609|FG000|Overall Study|Death|0|||
130282301|NCT00075946|468996610|FG001|Overall Study|Death|1|||
130282302|NCT00075946|468996611|FG002|Overall Study|Death|0|||
130282303|NCT00075946|468996612|FG003|Overall Study|Death|0|||
130282304|NCT00075946|468996613|FG004|Overall Study|Death|0|||
130282305|NCT00075946|468996609|FG000|Overall Study|Withdrawal by Subject|23|||
130282306|NCT00075946|468996610|FG001|Overall Study|Withdrawal by Subject|58|||
130282307|NCT00075946|468996611|FG002|Overall Study|Withdrawal by Subject|4|||
130555326|NCT03942406|470001554|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
130711342|NCT03375320|470567967|FG003|Overall Study|Physician Decision|1|||
130711343|NCT03375320|470567964|FG000|Overall Study|Non-compliance|1|||
130282308|NCT00075946|468996612|FG003|Overall Study|Withdrawal by Subject|9|||
130282309|NCT00075946|468996613|FG004|Overall Study|Withdrawal by Subject|0|||
130282310|NCT00075946|468996609|FG000|Overall Study|Alternative therapy|16|||
130282311|NCT00075946|468996610|FG001|Overall Study|Alternative therapy|2|||
130282312|NCT00075946|468996611|FG002|Overall Study|Alternative therapy|5|||
130282313|NCT00075946|468996612|FG003|Overall Study|Alternative therapy|0|||
130282314|NCT00075946|468996613|FG004|Overall Study|Alternative therapy|0|||
130282315|NCT00075946|468996609|FG000|Overall Study|Other complicating disease|7|||
130282316|NCT00075946|468996610|FG001|Overall Study|Other complicating disease|13|||
130282317|NCT00075946|468996611|FG002|Overall Study|Other complicating disease|1|||
130282318|NCT00075946|468996612|FG003|Overall Study|Other complicating disease|4|||
130282319|NCT00075946|468996613|FG004|Overall Study|Other complicating disease|0|||
130282320|NCT00075946|468996609|FG000|Overall Study|No response to retreatment|23|||
130282321|NCT00075946|468996610|FG001|Overall Study|No response to retreatment|0|||
130282322|NCT00075946|468996611|FG002|Overall Study|No response to retreatment|2|||
130282323|NCT00075946|468996612|FG003|Overall Study|No response to retreatment|0|||
130282324|NCT00075946|468996613|FG004|Overall Study|No response to retreatment|0|||
130282325|NCT00075946|468996609|FG000|Overall Study|Time to progression less than 6 months|15|||
130282326|NCT00075946|468996610|FG001|Overall Study|Time to progression less than 6 months|30|||
130282327|NCT00075946|468996611|FG002|Overall Study|Time to progression less than 6 months|8|||
130282328|NCT00075946|468996612|FG003|Overall Study|Time to progression less than 6 months|3|||
130282329|NCT00075946|468996613|FG004|Overall Study|Time to progression less than 6 months|0|||
130282330|NCT00075946|468996609|FG000|Overall Study|Other|57|||
130282331|NCT00075946|468996610|FG001|Overall Study|Other|32|||
130282332|NCT00075946|468996611|FG002|Overall Study|Other|3|||
130282333|NCT00075946|468996612|FG003|Overall Study|Other|11|||
130282334|NCT00075946|468996613|FG004|Overall Study|Other|0|||
130282335|NCT01229254|468996616|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
130282336|NCT01229254|468996617|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
130282337|NCT01229254|468996618|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
130282338|NCT01229254|468996616|FG000|Overall Study|Adverse Event|4|||
130282339|NCT01229254|468996617|FG001|Overall Study|Adverse Event|5|||
130282340|NCT01229254|468996618|FG002|Overall Study|Adverse Event|3|||
130282341|NCT01229254|468996616|FG000|Overall Study|Lost to Follow-up|3|||
130282342|NCT01229254|468996617|FG001|Overall Study|Lost to Follow-up|0|||
130282343|NCT01229254|468996618|FG002|Overall Study|Lost to Follow-up|1|||
130282344|NCT01229254|468996616|FG000|Overall Study|Physician Decision|0|||
130282345|NCT01229254|468996617|FG001|Overall Study|Physician Decision|3|||
130282346|NCT01229254|468996618|FG002|Overall Study|Physician Decision|0|||
130282347|NCT01229254|468996616|FG000|Overall Study|Protocol Violation|4|||
130282348|NCT01229254|468996617|FG001|Overall Study|Protocol Violation|6|||
130282349|NCT01229254|468996618|FG002|Overall Study|Protocol Violation|5|||
130282350|NCT01229254|468996616|FG000|Overall Study|Withdrawal by Subject|1|||
130282351|NCT01229254|468996617|FG001|Overall Study|Withdrawal by Subject|0|||
130282352|NCT01229254|468996618|FG002|Overall Study|Withdrawal by Subject|1|||
130282353|NCT01229254|468996616|FG000|Overall Study|Non-compliance with Study Drug|0|||
130282354|NCT01229254|468996617|FG001|Overall Study|Non-compliance with Study Drug|1|||
130282355|NCT01229254|468996618|FG002|Overall Study|Non-compliance with Study Drug|1|||
130282356|NCT02231892|468996619|FG000|Overall Study|Lost to Follow-up|1|||
130282357|NCT02231892|468996620|FG001|Overall Study|Lost to Follow-up|0|||
130282358|NCT02231892|468996621|FG002|Overall Study|Lost to Follow-up|3|||
130282359|NCT02231892|468996619|FG000|Overall Study|Withdrawal by Subject|4|||
130282360|NCT02231892|468996620|FG001|Overall Study|Withdrawal by Subject|3|||
130282361|NCT02231892|468996621|FG002|Overall Study|Withdrawal by Subject|15|||
130282362|NCT02231892|468996619|FG000|Overall Study|Physician Decision|0|||
130457877|NCT00371566|469640007|FG001|Treatment Phase|Adverse Event|1|||
130457878|NCT00371566|469640006|FG000|Treatment Phase|Protocol Violation|0|||
130457879|NCT00371566|469640007|FG001|Treatment Phase|Protocol Violation|1|||
130457880|NCT00371566|469640006|FG000|Chemoradiation Phase|Physician Decision|2|||
130282363|NCT02231892|468996620|FG001|Overall Study|Physician Decision|2|||
130282364|NCT02231892|468996621|FG002|Overall Study|Physician Decision|4|||
130282365|NCT02231892|468996619|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
130282366|NCT02231892|468996620|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
130282367|NCT02231892|468996621|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
130282368|NCT02231892|468996619|FG000|Overall Study|Participant motor threshold was >83%|0|||
130282369|NCT02231892|468996620|FG001|Overall Study|Participant motor threshold was >83%|0|||
130282370|NCT02231892|468996621|FG002|Overall Study|Participant motor threshold was >83%|9|||
130282371|NCT02231892|468996619|FG000|Overall Study|Could not find motor threshold|2|||
130282372|NCT02231892|468996620|FG001|Overall Study|Could not find motor threshold|0|||
130282373|NCT02231892|468996621|FG002|Overall Study|Could not find motor threshold|1|||
130457881|NCT00371566|469640007|FG001|Chemoradiation Phase|Physician Decision|0|||
130282374|NCT02231892|468996619|FG000|Overall Study|Could not find reliable motor hotspot|0|||
130282375|NCT02231892|468996620|FG001|Overall Study|Could not find reliable motor hotspot|0|||
130282376|NCT02231892|468996621|FG002|Overall Study|Could not find reliable motor hotspot|1|||
130282377|NCT02680041|468996623|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
130282378|NCT02680041|468996623|FG000|Overall Study|Lost to Follow-up|2|||
130282379|NCT02186652|468996624|FG000|Overall Study|Lost to Follow-up|2|||
130282380|NCT02186652|468996625|FG001|Overall Study|Lost to Follow-up|0|||
130282381|NCT00744978|468996626|FG000|Period 1|Lost to Follow-up|1|||
130282382|NCT00744978|468996627|FG001|Period 1|Lost to Follow-up|0|||
130282383|NCT00744978|468996626|FG000|Period 1|Withdrawal by Subject|0|||
130282384|NCT00744978|468996627|FG001|Period 1|Withdrawal by Subject|2|||
130282385|NCT00744978|468996626|FG000|Period 1|Other|0|||
130282386|NCT00744978|468996627|FG001|Period 1|Other|2|||
130282387|NCT00744978|468996626|FG000|Period 1|Adverse Event|4|||
130282388|NCT00744978|468996627|FG001|Period 1|Adverse Event|0|||
130282389|NCT00744978|468996626|FG000|Period 1|Randomized but not Treated|1|||
130282390|NCT00744978|468996627|FG001|Period 1|Randomized but not Treated|1|||
130282391|NCT00744978|468996626|FG000|Period 2|Adverse Event|0|||
130282392|NCT00744978|468996627|FG001|Period 2|Adverse Event|1|||
130282393|NCT00515294|468996631|FG000|Overall Study|Lost to Follow-up|3|||
130282394|NCT00515294|468996632|FG001|Overall Study|Lost to Follow-up|2|||
130282395|NCT00515294|468996633|FG002|Overall Study|Lost to Follow-up|3|||
130282396|NCT00515294|468996634|FG003|Overall Study|Lost to Follow-up|1|||
130282397|NCT00515294|468996631|FG000|Overall Study|Driver simulator problems|1|||
130282398|NCT00515294|468996632|FG001|Overall Study|Driver simulator problems|1|||
130282399|NCT00515294|468996633|FG002|Overall Study|Driver simulator problems|1|||
130282400|NCT00515294|468996634|FG003|Overall Study|Driver simulator problems|3|||
130282401|NCT00515294|468996631|FG000|Overall Study|Caffeine amount inaccurate|5|||
130282402|NCT00515294|468996632|FG001|Overall Study|Caffeine amount inaccurate|0|||
130282403|NCT00515294|468996633|FG002|Overall Study|Caffeine amount inaccurate|7|||
130282404|NCT00515294|468996634|FG003|Overall Study|Caffeine amount inaccurate|0|||
130282405|NCT03943550|468996641|FG000|Overall Study|Adverse Event|0|||
130282406|NCT03943550|468996642|FG001|Overall Study|Adverse Event|0|||
130282407|NCT03943550|468996643|FG002|Overall Study|Adverse Event|1|||
130282408|NCT03943550|468996641|FG000|Overall Study|Lost to Follow-up|0|||
130282409|NCT03943550|468996642|FG001|Overall Study|Lost to Follow-up|0|||
130282410|NCT03943550|468996643|FG002|Overall Study|Lost to Follow-up|1|||
130282411|NCT03943550|468996641|FG000|Overall Study|Progressive Disease|0|||
130282412|NCT03943550|468996642|FG001|Overall Study|Progressive Disease|0|||
130282413|NCT03943550|468996643|FG002|Overall Study|Progressive Disease|2|||
130282414|NCT03943550|468996641|FG000|Overall Study|Participant Moved Out of the Country|0|||
130282415|NCT03943550|468996642|FG001|Overall Study|Participant Moved Out of the Country|1|||
130282416|NCT03943550|468996643|FG002|Overall Study|Participant Moved Out of the Country|0|||
130282417|NCT03359785|468996644|FG000|Overall Study|Protocol Violation|0|||
130282418|NCT03359785|468996645|FG001|Overall Study|Protocol Violation|1|||
130282419|NCT03359785|468996646|FG002|Overall Study|Protocol Violation|0|||
130282420|NCT03359785|468996647|FG003|Overall Study|Protocol Violation|0|||
130282421|NCT03359785|468996644|FG000|Overall Study|Early study termination due to study pause|0|||
130282422|NCT03359785|468996645|FG001|Overall Study|Early study termination due to study pause|0|||
130282423|NCT03359785|468996646|FG002|Overall Study|Early study termination due to study pause|2|||
130282424|NCT03359785|468996647|FG003|Overall Study|Early study termination due to study pause|0|||
130282425|NCT03359785|468996644|FG000|Overall Study|Withdrawal by Subject|2|||
130282426|NCT03359785|468996645|FG001|Overall Study|Withdrawal by Subject|2|||
130282427|NCT03359785|468996646|FG002|Overall Study|Withdrawal by Subject|0|||
130282428|NCT03359785|468996647|FG003|Overall Study|Withdrawal by Subject|0|||
130282429|NCT02099344|468996653|FG000|Overall Study|Physician Decision|1|||
130282430|NCT02099344|468996654|FG001|Overall Study|Physician Decision|0|||
130282431|NCT02839720|468996655|FG000|Overall Study|Adverse Event|2|||
130282432|NCT02839720|468996655|FG000|Overall Study|Non-compliance|2|||
130282433|NCT02839720|468996655|FG000|Overall Study|Intercurrent Illness|1|||
130282434|NCT02839720|468996655|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
130282435|NCT02649218|468996656|FG000|Overall Study|Adverse Event|8|||
130369254|NCT00282984|469321291|FG001|Overall Study|Death|5|||
130369255|NCT00282984|469321290|FG000|Overall Study|Adverse Event|8|||
130369256|NCT00282984|469321291|FG001|Overall Study|Adverse Event|5|||
130282436|NCT02649218|468996656|FG000|Overall Study|Lack of Efficacy|8|||
130282437|NCT02649218|468996656|FG000|Overall Study|Pregnancy|3|||
130282438|NCT02649218|468996656|FG000|Overall Study|Protocol Violation|3|||
130282439|NCT02649218|468996656|FG000|Overall Study|Physician Decision|1|||
130282440|NCT02649218|468996656|FG000|Overall Study|Withdrawal by Subject|2|||
130282441|NCT00503581|468996657|FG000|Overall Study|Study closed|3|||
130282442|NCT00503581|468996658|FG001|Overall Study|Study closed|4|||
130282443|NCT00503581|468996659|FG002|Overall Study|Study closed|2|||
130282444|NCT06107803|468996661|FG000|Overall Study|Adverse Event|1|||
130282445|NCT06107803|468996661|FG000|Overall Study|Withdrawal by Subject|2|||
130282446|NCT06107803|468996661|FG000|Overall Study|Protocol Violation|1|||
130282447|NCT04730635|468996663|FG000|Overall Study|Lost to Follow-up|1|||
130282448|NCT04730635|468996664|FG001|Overall Study|Lost to Follow-up|0|||
130282449|NCT04730635|468996663|FG000|Overall Study|Withdrawal by Subject|0|||
130282450|NCT04730635|468996664|FG001|Overall Study|Withdrawal by Subject|1|||
130282451|NCT01096368|468996665|FG000|Overall Study|Death|0|||
130369257|NCT00282984|469321290|FG000|Overall Study|Lack of Efficacy|0|||
130369258|NCT00282984|469321291|FG001|Overall Study|Lack of Efficacy|2|||
130282452|NCT01096368|468996666|FG001|Overall Study|Death|1|||
130282453|NCT01096368|468996667|FG002|Overall Study|Death|0|||
130282454|NCT01096368|468996668|FG003|Overall Study|Death|0|||
130282455|NCT01096368|468996669|FG004|Overall Study|Death|0|||
130282456|NCT01096368|468996665|FG000|Overall Study|Physician Decision|0|||
130282457|NCT01096368|468996666|FG001|Overall Study|Physician Decision|13|||
130282458|NCT01096368|468996667|FG002|Overall Study|Physician Decision|2|||
130282459|NCT01096368|468996668|FG003|Overall Study|Physician Decision|4|||
130282460|NCT01096368|468996669|FG004|Overall Study|Physician Decision|6|||
130282461|NCT01096368|468996665|FG000|Overall Study|Withdrawal by Subject|0|||
130282462|NCT01096368|468996666|FG001|Overall Study|Withdrawal by Subject|52|||
130282463|NCT01096368|468996667|FG002|Overall Study|Withdrawal by Subject|0|||
130282464|NCT01096368|468996668|FG003|Overall Study|Withdrawal by Subject|10|||
130282465|NCT01096368|468996669|FG004|Overall Study|Withdrawal by Subject|14|||
130282466|NCT01096368|468996665|FG000|Overall Study|Ineligible|0|||
130282467|NCT01096368|468996666|FG001|Overall Study|Ineligible|3|||
130282468|NCT01096368|468996667|FG002|Overall Study|Ineligible|2|||
130282469|NCT01096368|468996668|FG003|Overall Study|Ineligible|0|||
130282470|NCT01096368|468996669|FG004|Overall Study|Ineligible|25|||
130282471|NCT01096368|468996665|FG000|Overall Study|Did not start treatment|0|||
130282472|NCT01096368|468996666|FG001|Overall Study|Did not start treatment|4|||
130282473|NCT01096368|468996667|FG002|Overall Study|Did not start treatment|4|||
130282474|NCT01096368|468996668|FG003|Overall Study|Did not start treatment|0|||
130282475|NCT01096368|468996669|FG004|Overall Study|Did not start treatment|0|||
130282476|NCT01096368|468996665|FG000|Overall Study|Progressive disease|0|||
130282477|NCT01096368|468996666|FG001|Overall Study|Progressive disease|6|||
130282478|NCT01096368|468996667|FG002|Overall Study|Progressive disease|0|||
130282479|NCT01096368|468996668|FG003|Overall Study|Progressive disease|10|||
130282480|NCT01096368|468996669|FG004|Overall Study|Progressive disease|3|||
130282481|NCT01096368|468996665|FG000|Overall Study|Other|0|||
130282482|NCT01096368|468996666|FG001|Overall Study|Other|0|||
130282483|NCT01096368|468996667|FG002|Overall Study|Other|1|||
130282484|NCT01096368|468996668|FG003|Overall Study|Other|0|||
130282485|NCT01096368|468996669|FG004|Overall Study|Other|0|||
130282486|NCT01096368|468996665|FG000|Overall Study|Treated with institutional review|0|||
130282487|NCT01096368|468996666|FG001|Overall Study|Treated with institutional review|0|||
130282488|NCT01096368|468996667|FG002|Overall Study|Treated with institutional review|0|||
130282489|NCT01096368|468996668|FG003|Overall Study|Treated with institutional review|0|||
130282490|NCT01096368|468996669|FG004|Overall Study|Treated with institutional review|1|||
130282491|NCT04934800|468996670|FG000|Overall Study|Other|1|||
130282492|NCT04934800|468996670|FG000|Overall Study|Withdrawal by Subject|5|||
130282493|NCT04934800|468996670|FG000|Overall Study|Lack of Efficacy|1|||
130282494|NCT04934800|468996670|FG000|Overall Study|Adverse Event|9|||
130282495|NCT04934800|468996670|FG000|Overall Study|Lost to Follow-up|5|||
130282496|NCT04934800|468996670|FG000|Overall Study|Enrolled but not treated|1|||
130282497|NCT00516906|468996671|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
130282498|NCT00516906|468996672|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
130282499|NCT01974206|468996675|FG000|Overall Study|Did Not Take Study Drug|0|||
130282500|NCT01974206|468996676|FG001|Overall Study|Did Not Take Study Drug|1|||
130282501|NCT01974206|468996675|FG000|Overall Study|Physician Decision|1|||
130282502|NCT01974206|468996676|FG001|Overall Study|Physician Decision|0|||
130282503|NCT01974206|468996675|FG000|Overall Study|Withdrawal by Subject|3|||
130282504|NCT01974206|468996676|FG001|Overall Study|Withdrawal by Subject|0|||
130282505|NCT01974206|468996675|FG000|Overall Study|Lost to Follow-up|1|||
130282506|NCT01974206|468996676|FG001|Overall Study|Lost to Follow-up|0|||
130282507|NCT01974206|468996675|FG000|Overall Study|Death|1|||
130282508|NCT01974206|468996676|FG001|Overall Study|Death|0|||
130282509|NCT02118766|468996681|FG000|Overall Study|Adverse Event|7|||
130282510|NCT02118766|468996682|FG001|Overall Study|Adverse Event|2|||
130282511|NCT02118766|468996681|FG000|Overall Study|Withdrawal by Subject|3|||
130282512|NCT02118766|468996682|FG001|Overall Study|Withdrawal by Subject|6|||
130282513|NCT02118766|468996681|FG000|Overall Study|Lost to Follow-up|5|||
130282514|NCT02118766|468996682|FG001|Overall Study|Lost to Follow-up|4|||
130282515|NCT02118766|468996681|FG000|Overall Study|Withdrawal by parent/guardian|12|||
130282516|NCT02118766|468996682|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130282517|NCT02118766|468996681|FG000|Overall Study|Other|3|||
130282518|NCT02118766|468996682|FG001|Overall Study|Other|1|||
130282519|NCT04669262|468996700|FG000|Overall Study|Withdrawal by Subject|0|||
130282520|NCT04669262|468996701|FG001|Overall Study|Withdrawal by Subject|0|||
130282521|NCT04669262|468996702|FG002|Overall Study|Withdrawal by Subject|0|||
130282522|NCT04669262|468996703|FG003|Overall Study|Withdrawal by Subject|1|||
130282523|NCT04669262|468996700|FG000|Overall Study|Randomized but Not Treated|0|||
130282524|NCT04669262|468996701|FG001|Overall Study|Randomized but Not Treated|1|||
130282525|NCT04669262|468996702|FG002|Overall Study|Randomized but Not Treated|0|||
130282526|NCT04669262|468996703|FG003|Overall Study|Randomized but Not Treated|0|||
130282527|NCT01638013|468996704|FG000|Overall Study|Adverse Event|36|||
130282528|NCT01638013|468996705|FG001|Overall Study|Adverse Event|29|||
130282529|NCT01638013|468996706|FG002|Overall Study|Adverse Event|48|||
130282530|NCT01638013|468996704|FG000|Overall Study|Lack of Efficacy|39|||
130711344|NCT03375320|470567965|FG001|Overall Study|Non-compliance|0|||
130711345|NCT03375320|470567966|FG002|Overall Study|Non-compliance|0|||
130711346|NCT03375320|470567967|FG003|Overall Study|Non-compliance|0|||
130711347|NCT02589522|470567969|FG000|Overall Study|Physician Decision|1|||
130711348|NCT02589522|470567970|FG001|Overall Study|Physician Decision|2|||
130711349|NCT02589522|470567971|FG002|Overall Study|Physician Decision|0|||
130711350|NCT02589522|470567969|FG000|Overall Study|Did not start treatment|1|||
130711351|NCT02589522|470567970|FG001|Overall Study|Did not start treatment|0|||
130711352|NCT02589522|470567971|FG002|Overall Study|Did not start treatment|0|||
130711353|NCT05611996|470567972|FG000|Overall Study|Ineligible|1|||
130711354|NCT05611996|470567972|FG000|Overall Study|Withdrawal by Subject|9|||
130711355|NCT05560763|470567973|FG000|Overall Study|Withdrawal by Subject|4|||
130711356|NCT03228537|470567974|FG000|Neoadjuvant|Adverse Event|2|||
130711357|NCT03228537|470567974|FG000|Neoadjuvant|Progression/Relapse|4|||
130711358|NCT03228537|470567974|FG000|Neoadjuvant|Death|1|||
130711359|NCT03228537|470567974|FG000|Surgery|Death|1|||
130711360|NCT03228537|470567974|FG000|Surgery|Other - Not Protocol Specified|2|||
130457882|NCT00371566|469640006|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
130457883|NCT00371566|469640007|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
130711361|NCT03228537|470567974|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
130711362|NCT03228537|470567974|FG000|Maintenance|Progression/Relapse|10|||
130711363|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Adverse Event|1|||
130711364|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Adverse Event|2|||
130711365|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Adverse Event|0|||
130282531|NCT01638013|468996705|FG001|Overall Study|Lack of Efficacy|11|||
130457884|NCT00371566|469640006|FG000|Chemoradiation Phase|Non compliant|0|||
130457885|NCT00371566|469640007|FG001|Chemoradiation Phase|Non compliant|1|||
130457886|NCT00371566|469640006|FG000|Chemoradiation Phase|Progressive Disease|1|||
130457887|NCT00371566|469640007|FG001|Chemoradiation Phase|Progressive Disease|1|||
130457888|NCT00371566|469640006|FG000|Chemoradiation Phase|Death|2|||
130457889|NCT00371566|469640007|FG001|Chemoradiation Phase|Death|0|||
130457890|NCT00371566|469640006|FG000|Follow Up Phase|Death|0|||
130457891|NCT00371566|469640007|FG001|Follow Up Phase|Death|5|||
130457892|NCT00371566|469640006|FG000|Follow Up Phase|Disease progression|1|||
130555327|NCT03942406|470001555|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
130711366|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Adverse Event|0|||
130711367|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Subject choice|0|||
130711368|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Subject choice|2|||
130711369|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Subject choice|0|||
130282532|NCT01638013|468996706|FG002|Overall Study|Lack of Efficacy|14|||
130282533|NCT01638013|468996704|FG000|Overall Study|Protocol Violation|10|||
130282534|NCT01638013|468996705|FG001|Overall Study|Protocol Violation|7|||
130282535|NCT01638013|468996706|FG002|Overall Study|Protocol Violation|11|||
130282536|NCT01638013|468996704|FG000|Overall Study|Met discontinuation criteria|4|||
130282537|NCT01638013|468996705|FG001|Overall Study|Met discontinuation criteria|0|||
130282538|NCT01638013|468996706|FG002|Overall Study|Met discontinuation criteria|7|||
130282539|NCT01638013|468996704|FG000|Overall Study|Subject Lost to Follow up|1|||
130282540|NCT01638013|468996705|FG001|Overall Study|Subject Lost to Follow up|0|||
130282541|NCT01638013|468996706|FG002|Overall Study|Subject Lost to Follow up|1|||
130282542|NCT01638013|468996704|FG000|Overall Study|Miscellaneous|25|||
130282543|NCT01638013|468996705|FG001|Overall Study|Miscellaneous|19|||
130282544|NCT01638013|468996706|FG002|Overall Study|Miscellaneous|23|||
130282545|NCT01638013|468996704|FG000|Overall Study|Withdrawal of Consent|16|||
130282546|NCT01638013|468996705|FG001|Overall Study|Withdrawal of Consent|12|||
130282547|NCT01638013|468996706|FG002|Overall Study|Withdrawal of Consent|16|||
130282548|NCT01638013|468996704|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
130282549|NCT01638013|468996705|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
130282550|NCT01638013|468996706|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
130282551|NCT01846299|468996709|FG000|Overall Study|Physician Decision|4|||
130282552|NCT01846299|468996710|FG001|Overall Study|Physician Decision|2|||
130282553|NCT01846299|468996709|FG000|Overall Study|Protocol deviation|1|||
130282554|NCT01846299|468996710|FG001|Overall Study|Protocol deviation|0|||
130282555|NCT01846299|468996709|FG000|Overall Study|Death|1|||
130282556|NCT01846299|468996710|FG001|Overall Study|Death|2|||
130282557|NCT01846299|468996709|FG000|Overall Study|Lost to Follow-up|3|||
130282558|NCT01846299|468996710|FG001|Overall Study|Lost to Follow-up|0|||
130282559|NCT01846299|468996709|FG000|Overall Study|Withdrawal by Subject|1|||
130282560|NCT01846299|468996710|FG001|Overall Study|Withdrawal by Subject|6|||
130282561|NCT01846299|468996709|FG000|Overall Study|Adverse Event|2|||
130457893|NCT00371566|469640007|FG001|Follow Up Phase|Disease progression|0|||
130711370|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Subject choice|0|||
130711371|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
130711372|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711373|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711374|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711375|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
130711376|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
130282562|NCT01846299|468996710|FG001|Overall Study|Adverse Event|0|||
130282563|NCT03559517|468996711|FG000|Overall Study|Withdrawal by Subject|1|||
130282564|NCT03559517|468996712|FG001|Overall Study|Withdrawal by Subject|0|||
130282565|NCT03559517|468996713|FG002|Overall Study|Withdrawal by Subject|0|||
130282566|NCT01330628|468996715|FG000|Overall Study|Death|2|||
130282567|NCT01330628|468996716|FG001|Overall Study|Death|3|||
130282568|NCT01330628|468996715|FG000|Overall Study|Lost to Follow-up|5|||
130282569|NCT01330628|468996716|FG001|Overall Study|Lost to Follow-up|6|||
130282570|NCT01330628|468996715|FG000|Overall Study|Adverse Event|44|||
130282571|NCT01330628|468996716|FG001|Overall Study|Adverse Event|25|||
130282572|NCT01330628|468996715|FG000|Overall Study|Withdrawn|18|||
130282573|NCT01330628|468996716|FG001|Overall Study|Withdrawn|6|||
130282574|NCT01330628|468996715|FG000|Overall Study|Didn't receive study treatment|1|||
130282575|NCT01330628|468996716|FG001|Overall Study|Didn't receive study treatment|0|||
130282576|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Death|5|||
130282577|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Death|0|||
130282578|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Death|0|||
130282579|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
130282580|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130282581|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130282582|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
130282583|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
130282584|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
130282585|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
130282586|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130282587|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130282588|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
130282589|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130282590|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130282591|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
130282592|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
130282593|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
130282594|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
130282595|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
130282596|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
130282597|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
130282598|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
130282599|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
130282600|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
130282601|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
130282602|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
130282603|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
130282604|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
130282605|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
130282606|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
130282607|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
130282608|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
130282609|NCT02013206|468998552|FG000|Overall Study|Progressive disease (PD)|14|||
130282610|NCT02013206|468998553|FG001|Overall Study|Progressive disease (PD)|17|||
130282611|NCT02013206|468998552|FG000|Overall Study|Symptomatic deterioration|3|||
130282612|NCT02013206|468998553|FG001|Overall Study|Symptomatic deterioration|1|||
130282613|NCT02013206|468998552|FG000|Overall Study|Adverse Event|1|||
130282614|NCT02013206|468998553|FG001|Overall Study|Adverse Event|0|||
130282615|NCT02013206|468998552|FG000|Overall Study|Patient refusal|2|||
130282616|NCT02013206|468998553|FG001|Overall Study|Patient refusal|0|||
130282617|NCT02013206|468998552|FG000|Overall Study|Patient non-compliance|1|||
130282618|NCT02013206|468998553|FG001|Overall Study|Patient non-compliance|0|||
130282619|NCT02013206|468998552|FG000|Overall Study|Death|1|||
130282620|NCT02013206|468998553|FG001|Overall Study|Death|2|||
130282621|NCT02013206|468998552|FG000|Overall Study|Other reasons off treatment|5|||
130282622|NCT02013206|468998553|FG001|Overall Study|Other reasons off treatment|2|||
130282623|NCT02791191|468998554|FG000|Overall Study|Adverse Event|2|||
130282624|NCT02791191|468998555|FG001|Overall Study|Adverse Event|4|||
130555328|NCT05628285|470001556|FG000|Overall Study|Lost to Follow-up|1|||
130282625|NCT02791191|468998556|FG002|Overall Study|Adverse Event|5|||
130282626|NCT02791191|468998554|FG000|Overall Study|Lack of Efficacy|0|||
130282627|NCT02791191|468998555|FG001|Overall Study|Lack of Efficacy|1|||
130282628|NCT02791191|468998556|FG002|Overall Study|Lack of Efficacy|0|||
130282629|NCT02791191|468998554|FG000|Overall Study|Study Drug Non-Compliance|0|||
130282630|NCT02791191|468998555|FG001|Overall Study|Study Drug Non-Compliance|2|||
130711377|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
130711378|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
130282631|NCT02791191|468998556|FG002|Overall Study|Study Drug Non-Compliance|0|||
130711379|NCT05420012|470567979|FG000|Overall Study|Lost to Follow-up|0|||
130555329|NCT03694418|470001557|FG000|Overall Study|Lost to Follow-up|115|||
130711380|NCT05420012|470567980|FG001|Overall Study|Lost to Follow-up|1|||
130711381|NCT03253744|470567982|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
130711382|NCT03253744|470567983|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
130711383|NCT03253744|470567984|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
130711384|NCT03253744|470567985|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
130711385|NCT03856593|470567988|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
130711386|NCT03856593|470567989|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
130282632|NCT02791191|468998554|FG000|Overall Study|Site Closed by Sponsor|1|||
130282633|NCT02791191|468998555|FG001|Overall Study|Site Closed by Sponsor|1|||
130282634|NCT02791191|468998556|FG002|Overall Study|Site Closed by Sponsor|3|||
130282635|NCT02791191|468998554|FG000|Overall Study|Progressive Disease|1|||
130282636|NCT02791191|468998555|FG001|Overall Study|Progressive Disease|0|||
130282637|NCT02791191|468998556|FG002|Overall Study|Progressive Disease|0|||
130282638|NCT02791191|468998554|FG000|Overall Study|Study Terminated by Sponsor|29|||
130282639|NCT02791191|468998555|FG001|Overall Study|Study Terminated by Sponsor|101|||
130282640|NCT02791191|468998556|FG002|Overall Study|Study Terminated by Sponsor|109|||
130282641|NCT02791191|468998554|FG000|Overall Study|Withdrawal by Subject|3|||
130282642|NCT02791191|468998555|FG001|Overall Study|Withdrawal by Subject|1|||
130282643|NCT02791191|468998556|FG002|Overall Study|Withdrawal by Subject|3|||
130282644|NCT02791191|468998554|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
130282645|NCT02791191|468998555|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
130282646|NCT02791191|468998556|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
130282647|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282648|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282649|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282650|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282651|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282652|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282653|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
130282654|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282655|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282656|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282657|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282658|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130282659|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
130282660|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130282661|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282662|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282663|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282664|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282665|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282666|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282667|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282668|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
130282669|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282670|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282671|NCT01448824|468998557|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
130282672|NCT01448824|468998558|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
130282673|NCT01448824|468998559|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
130282674|NCT01448824|468998560|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
130282675|NCT01448824|468998561|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
130282676|NCT01448824|468998562|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
130282677|NCT01448824|468998563|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
130282678|NCT01448824|468998564|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
130282679|NCT01448824|468998557|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282680|NCT01448824|468998558|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282681|NCT01448824|468998559|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282682|NCT01448824|468998560|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282683|NCT01448824|468998561|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282684|NCT01448824|468998562|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282685|NCT01448824|468998563|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282686|NCT01448824|468998564|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
130282687|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282688|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282689|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282690|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282691|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282692|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282693|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282694|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
130282695|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282696|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282697|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282698|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282699|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282700|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282701|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282702|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
130282703|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282704|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282705|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282706|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282707|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282708|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282709|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282710|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
130282711|NCT01995669|468998567|FG000|Overall Study|Progression|2|||
130282712|NCT01995669|468998568|FG001|Overall Study|Progression|1|||
130282713|NCT01995669|468998569|FG002|Overall Study|Progression|1|||
130282714|NCT01995669|468998570|FG003|Overall Study|Progression|13|||
130282715|NCT01995669|468998567|FG000|Overall Study|Adverse Event|0|||
130282716|NCT01995669|468998568|FG001|Overall Study|Adverse Event|0|||
130282717|NCT01995669|468998569|FG002|Overall Study|Adverse Event|0|||
130282718|NCT01995669|468998570|FG003|Overall Study|Adverse Event|3|||
130282719|NCT01995669|468998567|FG000|Overall Study|Death|0|||
130282720|NCT01995669|468998568|FG001|Overall Study|Death|0|||
130282721|NCT01995669|468998569|FG002|Overall Study|Death|0|||
130282722|NCT01995669|468998570|FG003|Overall Study|Death|6|||
130282723|NCT01995669|468998567|FG000|Overall Study|Withdrawal by Subject|0|||
130282724|NCT01995669|468998568|FG001|Overall Study|Withdrawal by Subject|0|||
130282725|NCT01995669|468998569|FG002|Overall Study|Withdrawal by Subject|0|||
130282726|NCT01995669|468998570|FG003|Overall Study|Withdrawal by Subject|6|||
130282727|NCT01995669|468998567|FG000|Overall Study|Insurance Expired|0|||
130282728|NCT01995669|468998568|FG001|Overall Study|Insurance Expired|0|||
130282729|NCT01995669|468998569|FG002|Overall Study|Insurance Expired|0|||
130282730|NCT01995669|468998570|FG003|Overall Study|Insurance Expired|1|||
130282731|NCT05425732|468998571|FG000|Overall Study|Death|4|||
130282732|NCT05425732|468998572|FG001|Overall Study|Death|2|||
130282733|NCT05425732|468998573|FG002|Overall Study|Death|0|||
130282734|NCT05425732|468998574|FG003|Overall Study|Death|0|||
130282735|NCT05425732|468998571|FG000|Overall Study|Lost to Follow-up|10|||
130282736|NCT05425732|468998572|FG001|Overall Study|Lost to Follow-up|15|||
130282737|NCT05425732|468998573|FG002|Overall Study|Lost to Follow-up|5|||
130282738|NCT05425732|468998574|FG003|Overall Study|Lost to Follow-up|3|||
130282739|NCT05425732|468998571|FG000|Overall Study|Physician Decision|0|||
130282740|NCT05425732|468998572|FG001|Overall Study|Physician Decision|2|||
130369259|NCT00282984|469321290|FG000|Overall Study|Lost to Follow-up|14|||
130369260|NCT00282984|469321291|FG001|Overall Study|Lost to Follow-up|10|||
130369261|NCT00282984|469321290|FG000|Overall Study|Withdrawal by Participant|22|||
130369262|NCT00282984|469321291|FG001|Overall Study|Withdrawal by Participant|34|||
130369263|NCT00282984|469321290|FG000|Overall Study|Participant stopped study medication|2|||
130369264|NCT00282984|469321291|FG001|Overall Study|Participant stopped study medication|2|||
130369265|NCT00282984|469321290|FG000|Overall Study|Participant only allowed phone follow-up|0|||
130369266|NCT00282984|469321291|FG001|Overall Study|Participant only allowed phone follow-up|1|||
130369267|NCT00282984|469321290|FG000|Overall Study|Participant used antipsychosis meds|0|||
130369268|NCT00282984|469321291|FG001|Overall Study|Participant used antipsychosis meds|1|||
130369269|NCT00282984|469321290|FG000|Overall Study|lack of motivation|1|||
130369270|NCT00282984|469321291|FG001|Overall Study|lack of motivation|0|||
130369271|NCT00282984|469321290|FG000|Overall Study|in prison|0|||
130369272|NCT00282984|469321291|FG001|Overall Study|in prison|1|||
130282741|NCT05425732|468998573|FG002|Overall Study|Physician Decision|0|||
130369273|NCT00282984|469321290|FG000|Overall Study|Protocol Violation|2|||
130369274|NCT00282984|469321291|FG001|Overall Study|Protocol Violation|0|||
130369275|NCT01128842|469321296|FG000|Overall Study|Adverse Event|1|||
130369276|NCT01128842|469321296|FG000|Overall Study|Disease Progression|6|||
130369277|NCT00824720|469321297|FG000|Overall Study|failed plug insertion|3|||
130555330|NCT03694418|470001558|FG001|Overall Study|Lost to Follow-up|23|||
130282742|NCT05425732|468998574|FG003|Overall Study|Physician Decision|0|||
130282743|NCT05425732|468998571|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130369278|NCT00824720|469321298|FG001|Overall Study|failed plug insertion|1|||
130369279|NCT00824720|469321299|FG002|Overall Study|failed plug insertion|0|||
130369280|NCT00824720|469321297|FG000|Overall Study|Protocol Violation|0|||
130369281|NCT00824720|469321298|FG001|Overall Study|Protocol Violation|0|||
130369282|NCT00824720|469321299|FG002|Overall Study|Protocol Violation|1|||
130369283|NCT04731363|469321308|FG000|Overall Study|Could not obtain samples|0|||
130369284|NCT04731363|469321309|FG001|Overall Study|Could not obtain samples|1|||
130369285|NCT04731363|469321310|FG002|Overall Study|Could not obtain samples|0|||
130369286|NCT04731363|469321311|FG003|Overall Study|Could not obtain samples|0|||
130369287|NCT04731363|469321308|FG000|Overall Study|Physician Decision|0|||
130369288|NCT04731363|469321309|FG001|Overall Study|Physician Decision|1|||
130369289|NCT04731363|469321310|FG002|Overall Study|Physician Decision|0|||
130369290|NCT04731363|469321311|FG003|Overall Study|Physician Decision|0|||
130369291|NCT00688753|469323061|FG000|Overall Study|Disease progression|55|||
130369292|NCT00688753|469323061|FG000|Overall Study|Missing|1|||
130369293|NCT00688753|469323061|FG000|Overall Study|Death|9|||
130369294|NCT00688753|469323061|FG000|Overall Study|Withdrawal by Subject|3|||
130369295|NCT00688753|469323061|FG000|Overall Study|Adverse Event|20|||
130369296|NCT00688753|469323061|FG000|Overall Study|Protocol Violation|1|||
130369297|NCT00688753|469323061|FG000|Overall Study|Lost to Follow-up|3|||
130369298|NCT03187197|469323062|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
130369299|NCT03187197|469323063|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
130369300|NCT03187197|469323064|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
130369301|NCT03187197|469323062|FG000|Overall Study|Withdrawal by Subject|8|||
130369302|NCT03187197|469323063|FG001|Overall Study|Withdrawal by Subject|63|||
130369303|NCT03187197|469323064|FG002|Overall Study|Withdrawal by Subject|4|||
130369304|NCT03187197|469323062|FG000|Overall Study|Lost to Follow-up|1|||
130369305|NCT03187197|469323063|FG001|Overall Study|Lost to Follow-up|60|||
130369306|NCT03187197|469323064|FG002|Overall Study|Lost to Follow-up|7|||
130369307|NCT03187197|469323062|FG000|Overall Study|Adverse Event|6|||
130369308|NCT03187197|469323063|FG001|Overall Study|Adverse Event|29|||
130369309|NCT03187197|469323064|FG002|Overall Study|Adverse Event|0|||
130369310|NCT03187197|469323062|FG000|Overall Study|Death|0|||
130369311|NCT03187197|469323063|FG001|Overall Study|Death|11|||
130369312|NCT03187197|469323064|FG002|Overall Study|Death|0|||
130369313|NCT03187197|469323062|FG000|Overall Study|Administrative problem|1|||
130369314|NCT03187197|469323063|FG001|Overall Study|Administrative problem|1|||
130369315|NCT03187197|469323064|FG002|Overall Study|Administrative problem|0|||
130369316|NCT03187197|469323062|FG000|Overall Study|Reason not listed|2|||
130369317|NCT03187197|469323063|FG001|Overall Study|Reason not listed|54|||
130369318|NCT03187197|469323064|FG002|Overall Study|Reason not listed|1|||
130369319|NCT03187197|469323062|FG000|Overall Study|Missing|1|||
130369320|NCT03187197|469323063|FG001|Overall Study|Missing|32|||
130369321|NCT03187197|469323064|FG002|Overall Study|Missing|3|||
130369322|NCT03187197|469323062|FG000|Overall Study|Status missing|2|||
130369323|NCT03187197|469323063|FG001|Overall Study|Status missing|33|||
130369324|NCT03187197|469323064|FG002|Overall Study|Status missing|3|||
130369325|NCT03187197|469323062|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
130369326|NCT03187197|469323063|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
130369327|NCT03187197|469323064|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
130369328|NCT00259649|469323065|FG000|Overall Study|Lost to Follow-up|7|||
130369329|NCT00259649|469323065|FG000|Overall Study|irregular menses|3|||
130369330|NCT02200211|469323068|FG000|Overall Study|Lost to Follow-up|7|||
130369331|NCT02200211|469323069|FG001|Overall Study|Lost to Follow-up|7|||
130369332|NCT02200211|469323070|FG002|Overall Study|Lost to Follow-up|1|||
130369333|NCT02200211|469323071|FG003|Overall Study|Lost to Follow-up|2|||
130369334|NCT02200211|469323068|FG000|Overall Study|Withdrawal by Subject|1|||
130369335|NCT02200211|469323069|FG001|Overall Study|Withdrawal by Subject|0|||
130369336|NCT02200211|469323070|FG002|Overall Study|Withdrawal by Subject|0|||
130369337|NCT02200211|469323071|FG003|Overall Study|Withdrawal by Subject|0|||
130457894|NCT00371566|469640006|FG000|Follow Up Phase|Withdrawal by Subject|0|||
130711387|NCT01949116|470567990|FG000|Overall Study|Death|2|||
130711388|NCT01949116|470567991|FG001|Overall Study|Death|0|||
130711389|NCT01949116|470567990|FG000|Overall Study|Lost to Follow-up|1|||
130457895|NCT00371566|469640007|FG001|Follow Up Phase|Withdrawal by Subject|1|||
130457896|NCT00371566|469640006|FG000|Follow Up Phase|Physician Decision|1|||
130711390|NCT01949116|470567991|FG001|Overall Study|Lost to Follow-up|3|||
130711391|NCT01949116|470567990|FG000|Overall Study|Withdrawal by Subject|5|||
130369338|NCT00381485|469323072|FG000|Open-Label Run-In Period|Adverse Event|9|||
130369339|NCT00381485|469323073|FG001|Open-Label Run-In Period|Adverse Event|0|||
130457897|NCT00371566|469640007|FG001|Follow Up Phase|Physician Decision|1|||
130369340|NCT00381485|469323074|FG002|Open-Label Run-In Period|Adverse Event|0|||
130369341|NCT00381485|469323075|FG003|Open-Label Run-In Period|Adverse Event|0|||
130369342|NCT00381485|469323072|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
130369343|NCT00381485|469323073|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130369344|NCT00381485|469323074|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130711392|NCT01949116|470567991|FG001|Overall Study|Withdrawal by Subject|3|||
130369345|NCT00381485|469323075|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130369346|NCT00381485|469323072|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
130369347|NCT00381485|469323073|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130369348|NCT00381485|469323074|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130369349|NCT00381485|469323075|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130369350|NCT00381485|469323072|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
130369351|NCT00381485|469323073|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130369352|NCT00381485|469323074|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130369353|NCT00381485|469323075|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130369354|NCT00381485|469323072|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
130369355|NCT00381485|469323073|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
130369356|NCT00381485|469323074|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
130369357|NCT00381485|469323075|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
130369358|NCT00381485|469323072|FG000|Open-Label Run-In Period|Treatment failure|1|||
130369359|NCT00381485|469323073|FG001|Open-Label Run-In Period|Treatment failure|0|||
130369360|NCT00381485|469323074|FG002|Open-Label Run-In Period|Treatment failure|0|||
130369361|NCT00381485|469323075|FG003|Open-Label Run-In Period|Treatment failure|0|||
130369362|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130369363|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130369364|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Adverse Event|2|||
130369365|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Adverse Event|5|||
130369366|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130369367|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
130369368|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
130369369|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
130369370|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130369371|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130369372|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
130369373|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130369374|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
130369375|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
130369376|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
130369377|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
130369378|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
130369379|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130369380|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
130369381|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130282744|NCT05425732|468998572|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130282745|NCT05425732|468998573|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130282746|NCT05425732|468998574|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130282747|NCT05425732|468998571|FG000|Overall Study|Withdrawal by Subject|4|||
130282748|NCT05425732|468998572|FG001|Overall Study|Withdrawal by Subject|8|||
130282749|NCT05425732|468998573|FG002|Overall Study|Withdrawal by Subject|1|||
130282750|NCT05425732|468998574|FG003|Overall Study|Withdrawal by Subject|1|||
130282751|NCT05425732|468998571|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
130282752|NCT05425732|468998572|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282753|NCT05425732|468998573|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282754|NCT05425732|468998574|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282755|NCT02998203|468998575|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
130282756|NCT02998203|468998576|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
130282757|NCT02998203|468998575|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
130282758|NCT02998203|468998576|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
130282759|NCT04187144|468998577|FG000|Overall Study|Lost to Follow-up|12|||
130282760|NCT04187144|468998578|FG001|Overall Study|Lost to Follow-up|11|||
130282761|NCT04187144|468998577|FG000|Overall Study|Withdrawal by Subject|20|||
130282762|NCT04187144|468998578|FG001|Overall Study|Withdrawal by Subject|18|||
130282763|NCT04187144|468998577|FG000|Overall Study|Adverse Event|19|||
130282764|NCT04187144|468998578|FG001|Overall Study|Adverse Event|4|||
130282765|NCT04187144|468998577|FG000|Overall Study|Physician Decision|5|||
130282766|NCT04187144|468998578|FG001|Overall Study|Physician Decision|3|||
130282767|NCT04187144|468998577|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
130282768|NCT04187144|468998578|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
130282769|NCT04187144|468998577|FG000|Overall Study|Protocol Deviation|1|||
130369382|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
130376671|NCT01327885|469345895|FG000|Overall Study|Withdrawal of consent from study|3|||
130376672|NCT01327885|469345896|FG001|Overall Study|Withdrawal of consent from study|4|||
130376673|NCT01327885|469345895|FG000|Overall Study|Not treated|1|||
130376674|NCT01327885|469345896|FG001|Overall Study|Not treated|1|||
130282770|NCT04187144|468998578|FG001|Overall Study|Protocol Deviation|4|||
130282771|NCT02650804|468998579|FG000|Overall Study|Adverse Event|3|||
130282772|NCT02650804|468998580|FG001|Overall Study|Adverse Event|2|||
130282773|NCT02650804|468998579|FG000|Overall Study|Death|1|||
130282774|NCT02650804|468998580|FG001|Overall Study|Death|2|||
130282775|NCT02650804|468998579|FG000|Overall Study|Progressive Disease|7|||
130282776|NCT02650804|468998580|FG001|Overall Study|Progressive Disease|10|||
130282777|NCT02650804|468998579|FG000|Overall Study|Physician Decision|0|||
130282778|NCT02650804|468998580|FG001|Overall Study|Physician Decision|2|||
130282779|NCT02650804|468998579|FG000|Overall Study|Withdrawal by Subject|1|||
130282780|NCT02650804|468998580|FG001|Overall Study|Withdrawal by Subject|4|||
130282781|NCT02650804|468998579|FG000|Overall Study|Symptomatic deterioration|5|||
130282782|NCT02650804|468998580|FG001|Overall Study|Symptomatic deterioration|7|||
130282783|NCT02650804|468998579|FG000|Overall Study|Protocol Violation|0|||
130282784|NCT02650804|468998580|FG001|Overall Study|Protocol Violation|1|||
130282785|NCT02743949|468998581|FG000|Overall Study|Adverse Event|0|||
130282786|NCT02743949|468998582|FG001|Overall Study|Adverse Event|0|||
130282787|NCT02743949|468998583|FG002|Overall Study|Adverse Event|2|||
130282788|NCT02743949|468998581|FG000|Overall Study|Significant Protocol Deviation|2|||
130282789|NCT02743949|468998582|FG001|Overall Study|Significant Protocol Deviation|0|||
130282790|NCT02743949|468998583|FG002|Overall Study|Significant Protocol Deviation|1|||
130282791|NCT02743949|468998581|FG000|Overall Study|Voluntary Withdrawal|2|||
130282792|NCT02743949|468998582|FG001|Overall Study|Voluntary Withdrawal|1|||
130282793|NCT02743949|468998583|FG002|Overall Study|Voluntary Withdrawal|0|||
130282794|NCT03389555|468998584|FG000|Overall Study|Protocol Violation|1|||
130282795|NCT03389555|468998585|FG001|Overall Study|Protocol Violation|3|||
130282796|NCT03389555|468998584|FG000|Overall Study|Death|1|||
130282797|NCT03389555|468998585|FG001|Overall Study|Death|0|||
130282798|NCT00920218|468998586|FG000|Overall Study|Serious Adverse Event|2|||
130282799|NCT00920218|468998587|FG001|Overall Study|Serious Adverse Event|0|||
130282800|NCT00920218|468998588|FG002|Overall Study|Serious Adverse Event|2|||
130282801|NCT00920218|468998589|FG003|Overall Study|Serious Adverse Event|1|||
130282802|NCT00920218|468998586|FG000|Overall Study|Withdrawal by Subject|0|||
130282803|NCT00920218|468998587|FG001|Overall Study|Withdrawal by Subject|3|||
130282804|NCT00920218|468998588|FG002|Overall Study|Withdrawal by Subject|2|||
130282805|NCT00920218|468998589|FG003|Overall Study|Withdrawal by Subject|0|||
130282806|NCT00920218|468998586|FG000|Overall Study|Migrated/moved from study area|0|||
130282807|NCT00920218|468998587|FG001|Overall Study|Migrated/moved from study area|0|||
130282808|NCT00920218|468998588|FG002|Overall Study|Migrated/moved from study area|1|||
130282809|NCT00920218|468998589|FG003|Overall Study|Migrated/moved from study area|0|||
130282810|NCT00920218|468998586|FG000|Overall Study|Lost to Follow-up|0|||
130282811|NCT00920218|468998587|FG001|Overall Study|Lost to Follow-up|1|||
130282812|NCT00920218|468998588|FG002|Overall Study|Lost to Follow-up|0|||
130282813|NCT00920218|468998589|FG003|Overall Study|Lost to Follow-up|3|||
130282814|NCT00920218|468998586|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
130282815|NCT00920218|468998587|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
130282816|NCT00920218|468998588|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
130282817|NCT00920218|468998589|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
130282818|NCT00920218|468998586|FG000|Overall Study|Other|0|||
130282819|NCT00920218|468998587|FG001|Overall Study|Other|0|||
130282820|NCT00920218|468998588|FG002|Overall Study|Other|1|||
130282821|NCT00920218|468998589|FG003|Overall Study|Other|0|||
130282822|NCT01007435|468998590|FG000|Overall Study|Adverse Event|16|||
130282823|NCT01007435|468998591|FG001|Overall Study|Adverse Event|25|||
130282824|NCT01007435|468998592|FG002|Overall Study|Adverse Event|47|||
130282825|NCT01007435|468998593|FG003|Overall Study|Adverse Event|31|||
130282826|NCT01007435|468998590|FG000|Overall Study|Death|2|||
130282827|NCT01007435|468998591|FG001|Overall Study|Death|4|||
130282828|NCT01007435|468998592|FG002|Overall Study|Death|2|||
130282829|NCT01007435|468998593|FG003|Overall Study|Death|1|||
130282830|NCT01007435|468998590|FG000|Overall Study|Insufficient Therapeutic Response|21|||
130282831|NCT01007435|468998591|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130282832|NCT01007435|468998592|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130282833|NCT01007435|468998593|FG003|Overall Study|Insufficient Therapeutic Response|9|||
130282834|NCT01007435|468998590|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
130711393|NCT02858726|470567992|FG000|Overall Study|Adverse Event|4|||
130282835|NCT01007435|468998591|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
130282836|NCT01007435|468998592|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
130282837|NCT01007435|468998593|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
130282838|NCT01007435|468998590|FG000|Overall Study|Other Protocol Violation|2|||
130282839|NCT01007435|468998591|FG001|Overall Study|Other Protocol Violation|0|||
130282840|NCT01007435|468998592|FG002|Overall Study|Other Protocol Violation|1|||
130282841|NCT01007435|468998593|FG003|Overall Study|Other Protocol Violation|0|||
130282842|NCT01007435|468998590|FG000|Overall Study|Refused Treatment|13|||
130282843|NCT01007435|468998591|FG001|Overall Study|Refused Treatment|13|||
130282844|NCT01007435|468998592|FG002|Overall Study|Refused Treatment|5|||
130282845|NCT01007435|468998593|FG003|Overall Study|Refused Treatment|8|||
130282846|NCT01007435|468998590|FG000|Overall Study|Failure to Return|5|||
130282847|NCT01007435|468998591|FG001|Overall Study|Failure to Return|4|||
130282848|NCT01007435|468998592|FG002|Overall Study|Failure to Return|3|||
130282849|NCT01007435|468998593|FG003|Overall Study|Failure to Return|6|||
130282850|NCT01007435|468998590|FG000|Overall Study|Reason not Specified|1|||
130282851|NCT01007435|468998591|FG001|Overall Study|Reason not Specified|1|||
130282852|NCT01007435|468998592|FG002|Overall Study|Reason not Specified|2|||
130282853|NCT01007435|468998593|FG003|Overall Study|Reason not Specified|1|||
130282854|NCT01345591|468998596|FG000|Overall Study|Lost to Follow-up|1|||
130282855|NCT00847665|468998603|FG000|Overall Study|Withdrawal by Subject|1|||
130282856|NCT00847665|468998604|FG001|Overall Study|Withdrawal by Subject|0|||
130282857|NCT03077438|468998611|FG000|Overall Study|Protocol Violation|3|||
130282858|NCT03077438|468998612|FG001|Overall Study|Protocol Violation|5|||
130282859|NCT03077438|468998611|FG000|Overall Study|Withdrawal by Subject|3|||
130282860|NCT03077438|468998612|FG001|Overall Study|Withdrawal by Subject|6|||
130282861|NCT03077438|468998611|FG000|Overall Study|Lost to Follow-up|6|||
130282862|NCT03077438|468998612|FG001|Overall Study|Lost to Follow-up|3|||
130282863|NCT01190475|468998613|FG000|Overall Study|Withdrawal by Subject|0|||
130282864|NCT01190475|468998614|FG001|Overall Study|Withdrawal by Subject|0|||
130282865|NCT01190475|468998615|FG002|Overall Study|Withdrawal by Subject|1|||
130282866|NCT00624585|468998616|FG000|Overall Study|Death|3|||
130282867|NCT00624585|468998616|FG000|Overall Study|Disease Progression|6|||
130282868|NCT00624585|468998616|FG000|Overall Study|Adverse Event|3|||
130282869|NCT00676520|468998620|FG000|Overall Study|Withdrawal by Subject|163|||
130282870|NCT00676520|468998620|FG000|Overall Study|Lost to Follow-up|162|||
130282871|NCT00676520|468998620|FG000|Overall Study|Death|159|||
130457898|NCT00371566|469640006|FG000|Follow Up Phase|Lost to Follow-up|1|||
130457899|NCT00371566|469640007|FG001|Follow Up Phase|Lost to Follow-up|0|||
130457900|NCT00972504|469640008|FG000|Overall Study|Adverse Event|2|||
130457901|NCT00972504|469640008|FG000|Overall Study|Investigator discretion|1|||
130457902|NCT04246762|469640009|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
130457903|NCT00597519|469640010|FG000|Overall Study|Death|1|||
130457904|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
130457905|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
130457906|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
130457907|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
130457908|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
130457909|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
130457910|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
130457911|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
130457912|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
130457913|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
130457914|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
130457915|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
130457916|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Death|7|||
130457917|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Death|4|||
130457918|NCT00410124|469640011|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
130457919|NCT00410124|469640012|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
130711394|NCT02858726|470567993|FG001|Overall Study|Adverse Event|4|||
130711395|NCT02858726|470567994|FG002|Overall Study|Adverse Event|9|||
130711396|NCT02858726|470567995|FG003|Overall Study|Adverse Event|1|||
130711397|NCT02858726|470567992|FG000|Overall Study|Physician Decision|0|||
130282872|NCT00676520|468998620|FG000|Overall Study|Physician Decision|20|||
130282873|NCT00676520|468998620|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
130282874|NCT00676520|468998620|FG000|Overall Study|Other Reason|18|||
130457920|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
130457921|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
130457922|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
130457923|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
130457924|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
130457925|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
130457926|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
130282875|NCT01425359|468998621|FG000|Overall Study|Randomized but Not Treated|2|||
130282876|NCT01425359|468998622|FG001|Overall Study|Randomized but Not Treated|3|||
130457927|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
130711398|NCT02858726|470567993|FG001|Overall Study|Physician Decision|0|||
130457928|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
130282877|NCT01425359|468998621|FG000|Overall Study|Adverse Event|9|||
130282878|NCT01425359|468998622|FG001|Overall Study|Adverse Event|8|||
130282879|NCT01425359|468998621|FG000|Overall Study|Revascularization|0|||
130282880|NCT01425359|468998622|FG001|Overall Study|Revascularization|1|||
130282881|NCT01425359|468998621|FG000|Overall Study|Death|0|||
130282882|NCT01425359|468998622|FG001|Overall Study|Death|1|||
130282883|NCT01425359|468998621|FG000|Overall Study|Unsatisfactory Response|1|||
130282884|NCT01425359|468998622|FG001|Overall Study|Unsatisfactory Response|0|||
130282885|NCT01425359|468998621|FG000|Overall Study|Protocol Violation|1|||
130282886|NCT01425359|468998622|FG001|Overall Study|Protocol Violation|2|||
130282887|NCT01425359|468998621|FG000|Overall Study|Subject Withdrew Consent|1|||
130282888|NCT01425359|468998622|FG001|Overall Study|Subject Withdrew Consent|2|||
130282889|NCT01425359|468998621|FG000|Overall Study|Investigator's Discretion|2|||
130282890|NCT01425359|468998622|FG001|Overall Study|Investigator's Discretion|0|||
130282891|NCT01425359|468998621|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
130282892|NCT01425359|468998622|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
130282893|NCT03172325|468998623|FG000|Overall Study|Adverse Event|2|||
130282894|NCT03172325|468998624|FG001|Overall Study|Adverse Event|3|||
130282895|NCT03172325|468998623|FG000|Overall Study|Positive PPD|1|||
130282896|NCT03172325|468998624|FG001|Overall Study|Positive PPD|0|||
130282897|NCT03172325|468998623|FG000|Overall Study|Poor Compliance|1|||
130282898|NCT03172325|468998624|FG001|Overall Study|Poor Compliance|1|||
130282899|NCT03305419|468998640|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282900|NCT03305419|468998641|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
130282901|NCT03305419|468998642|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282902|NCT03305419|468998643|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282903|NCT03305419|468998644|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282904|NCT03305419|468998645|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282905|NCT03305419|468998646|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282906|NCT03305419|468998647|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282907|NCT03305419|468998640|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
130282908|NCT03305419|468998641|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282909|NCT03305419|468998642|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282910|NCT03305419|468998643|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282911|NCT03305419|468998644|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282912|NCT03305419|468998645|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282913|NCT03305419|468998646|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282914|NCT03305419|468998647|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282915|NCT03305419|468998640|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
130282916|NCT03305419|468998641|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282917|NCT03305419|468998642|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282918|NCT03305419|468998643|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282919|NCT03305419|468998644|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282920|NCT03305419|468998645|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282921|NCT03305419|468998646|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282922|NCT03305419|468998647|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282923|NCT03305419|468998640|FG000|Part B (14 Days)|Adverse Event|0|||
130282924|NCT03305419|468998641|FG001|Part B (14 Days)|Adverse Event|0|||
130282925|NCT03305419|468998642|FG002|Part B (14 Days)|Adverse Event|0|||
130282926|NCT03305419|468998643|FG003|Part B (14 Days)|Adverse Event|0|||
130282927|NCT03305419|468998644|FG004|Part B (14 Days)|Adverse Event|1|||
130282928|NCT03305419|468998645|FG005|Part B (14 Days)|Adverse Event|2|||
130282929|NCT03305419|468998646|FG006|Part B (14 Days)|Adverse Event|4|||
130282930|NCT03305419|468998647|FG007|Part B (14 Days)|Adverse Event|0|||
130282931|NCT03305419|468998640|FG000|Part B (14 Days)|Physician Decision|0|||
130282932|NCT03305419|468998641|FG001|Part B (14 Days)|Physician Decision|0|||
130282933|NCT03305419|468998642|FG002|Part B (14 Days)|Physician Decision|0|||
130282934|NCT03305419|468998643|FG003|Part B (14 Days)|Physician Decision|0|||
130282935|NCT03305419|468998644|FG004|Part B (14 Days)|Physician Decision|2|||
130282936|NCT03305419|468998645|FG005|Part B (14 Days)|Physician Decision|8|||
130282937|NCT03305419|468998646|FG006|Part B (14 Days)|Physician Decision|1|||
130282938|NCT03305419|468998647|FG007|Part B (14 Days)|Physician Decision|0|||
130282939|NCT00889603|468998649|FG000|Overall Study|Adverse Event|7|||
130282940|NCT00889603|468998649|FG000|Overall Study|Death|3|||
130282941|NCT00889603|468998649|FG000|Overall Study|Lost to Follow-up|19|||
130282942|NCT00889603|468998649|FG000|Overall Study|No longer willing to participant in stud|4|||
130282943|NCT00889603|468998649|FG000|Overall Study|Other|4|||
130282944|NCT01895543|468998650|FG000|Overall Study|Withdrawal by Subject|43|||
130282945|NCT01895543|468998650|FG000|Overall Study|Lost to Follow-up|25|||
130282946|NCT01895543|468998650|FG000|Overall Study|Adverse Event|28|||
130282947|NCT01895543|468998650|FG000|Overall Study|Subject's substantial non-compliance|6|||
130282948|NCT01895543|468998650|FG000|Overall Study|Protocol Violation|1|||
130282949|NCT01895543|468998650|FG000|Overall Study|Physician Decision|2|||
130282950|NCT01895543|468998650|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
130282951|NCT04659174|468998655|FG000|Overall Study|Sponsor decision to discontinue study|0|||
130282952|NCT04659174|468998656|FG001|Overall Study|Sponsor decision to discontinue study|2|||
130282953|NCT04659174|468998655|FG000|Overall Study|Lost to Follow-up|9|||
130282954|NCT04659174|468998656|FG001|Overall Study|Lost to Follow-up|11|||
130282955|NCT04659174|468998655|FG000|Overall Study|Adverse Event|8|||
130282956|NCT04659174|468998656|FG001|Overall Study|Adverse Event|5|||
130282957|NCT04659174|468998655|FG000|Overall Study|Withdrawal by Subject|17|||
130282958|NCT04659174|468998656|FG001|Overall Study|Withdrawal by Subject|33|||
130282959|NCT04659174|468998655|FG000|Overall Study|Progressive disease|0|||
130282960|NCT04659174|468998656|FG001|Overall Study|Progressive disease|2|||
130282961|NCT04659174|468998655|FG000|Overall Study|Other reasons|0|||
130282962|NCT04659174|468998656|FG001|Overall Study|Other reasons|2|||
130282963|NCT04659174|468998655|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
130282964|NCT04659174|468998656|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
130282965|NCT04659174|468998655|FG000|Overall Study|Alcohol or illegal drug use|0|||
130282966|NCT04659174|468998656|FG001|Overall Study|Alcohol or illegal drug use|3|||
130282967|NCT04659174|468998655|FG000|Overall Study|Violation of entry criteria|1|||
130282968|NCT04659174|468998656|FG001|Overall Study|Violation of entry criteria|0|||
130282969|NCT04659174|468998655|FG000|Overall Study|Death|0|||
130282970|NCT04659174|468998656|FG001|Overall Study|Death|1|||
130282971|NCT05129449|468998657|FG000|Overall Study|Protocol Violation|1|||
130282972|NCT03650803|468998659|FG000|Overall Study|Lost to Follow-up|6|||
130282973|NCT02901054|468998660|FG000|Overall Study|Physician Decision|1|||
130282974|NCT02901054|468998660|FG000|Overall Study|Withdrawal by Subject|3|||
130282975|NCT01534260|468998661|FG000|Overall Study|Adverse Event|1|||
130282976|NCT01534260|468998662|FG001|Overall Study|Adverse Event|8|||
130282977|NCT01534260|468998661|FG000|Overall Study|Death|2|||
130282978|NCT01534260|468998662|FG001|Overall Study|Death|0|||
130282979|NCT01534260|468998661|FG000|Overall Study|Lack of Efficacy|1|||
130282980|NCT01534260|468998662|FG001|Overall Study|Lack of Efficacy|1|||
130282981|NCT01534260|468998661|FG000|Overall Study|Withdrawal by Subject|1|||
130282982|NCT01534260|468998662|FG001|Overall Study|Withdrawal by Subject|3|||
130282983|NCT01534260|468998661|FG000|Overall Study|Disease Progression|8|||
130282984|NCT01534260|468998662|FG001|Overall Study|Disease Progression|6|||
130282985|NCT01534260|468998661|FG000|Overall Study|Physician Decision|3|||
130282986|NCT01534260|468998662|FG001|Overall Study|Physician Decision|1|||
130282987|NCT01534260|468998661|FG000|Overall Study|No treatment, per protocol|0|||
130282988|NCT01534260|468998662|FG001|Overall Study|No treatment, per protocol|1|||
130282989|NCT01818258|468998665|FG000|Overall Study|Death|3|||
130282990|NCT01818258|468998666|FG001|Overall Study|Death|0|||
130282991|NCT01818258|468998665|FG000|Overall Study|Withdrawal by Subject|0|||
130282992|NCT01818258|468998666|FG001|Overall Study|Withdrawal by Subject|1|||
130282993|NCT01818258|468998665|FG000|Overall Study|Lost to Follow-up|0|||
130282994|NCT01818258|468998666|FG001|Overall Study|Lost to Follow-up|1|||
130282995|NCT01818258|468998665|FG000|Overall Study|Unable to Travel to Clinic|0|||
130282996|NCT01818258|468998666|FG001|Overall Study|Unable to Travel to Clinic|1|||
130282997|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
130282998|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
130282999|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
130283000|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
130283001|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
130283002|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
130283003|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
130283004|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
130283005|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
130283006|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
130283007|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
130283008|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
130283009|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
130283010|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
130283011|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
130283012|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
130283013|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
130711399|NCT02858726|470567994|FG002|Overall Study|Physician Decision|1|||
130711400|NCT02858726|470567995|FG003|Overall Study|Physician Decision|0|||
130283014|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
130283015|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
130283016|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
130283017|NCT05145322|468998676|FG000|Overall Study|Lost to Follow-up|4|||
130711401|NCT02858726|470567992|FG000|Overall Study|Protocol Violation|0|||
130711402|NCT02858726|470567993|FG001|Overall Study|Protocol Violation|0|||
130283018|NCT05145322|468998677|FG001|Overall Study|Lost to Follow-up|5|||
130283019|NCT03022097|468998678|FG000|Overall Study|Adverse Event|3|||
130283020|NCT03022097|468998679|FG001|Overall Study|Adverse Event|4|||
130283021|NCT03022097|468998680|FG002|Overall Study|Adverse Event|1|||
130283022|NCT03022097|468998681|FG003|Overall Study|Adverse Event|3|||
130283023|NCT03022097|468998678|FG000|Overall Study|Progressive Disease|2|||
130283024|NCT03022097|468998679|FG001|Overall Study|Progressive Disease|0|||
130283025|NCT03022097|468998680|FG002|Overall Study|Progressive Disease|5|||
130369383|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
130369384|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
130369385|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
130369386|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130369387|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130369388|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130369389|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
130369390|NCT00381485|469323072|FG000|Double-Blind Treatment Period|Administrative|0|||
130369391|NCT00381485|469323073|FG001|Double-Blind Treatment Period|Administrative|1|||
130369392|NCT00381485|469323074|FG002|Double-Blind Treatment Period|Administrative|0|||
130369393|NCT00381485|469323075|FG003|Double-Blind Treatment Period|Administrative|1|||
130369394|NCT01235351|469323076|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
130369395|NCT01235351|469323077|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
130369396|NCT00126191|469323080|FG000|Overall Study|Physician Decision|0|||
130369397|NCT00126191|469323081|FG001|Overall Study|Physician Decision|1|||
130369398|NCT00126191|469323080|FG000|Overall Study|Death|0|||
130369399|NCT00126191|469323081|FG001|Overall Study|Death|1|||
130369400|NCT01898806|469323082|FG000|Overall Study|Withdrawal by Subject|2|||
130369401|NCT01898806|469323082|FG000|Overall Study|Physician Decision|1|||
130369402|NCT00307294|469323095|FG000|Overall Study|Withdrawal by Subject|1|||
130369403|NCT00612690|469323096|FG000|Overall Study|Lost to Follow-up|72|||
130369404|NCT00612690|469323097|FG001|Overall Study|Lost to Follow-up|98|||
130369405|NCT00612690|469323096|FG000|Overall Study|Withdrawal by Subject|32|||
130555331|NCT03694418|470001559|FG002|Overall Study|Lost to Follow-up|12|||
130283026|NCT03022097|468998681|FG003|Overall Study|Progressive Disease|2|||
130283027|NCT03022097|468998678|FG000|Overall Study|Lack of Efficacy|0|||
130283028|NCT03022097|468998679|FG001|Overall Study|Lack of Efficacy|0|||
130283029|NCT03022097|468998680|FG002|Overall Study|Lack of Efficacy|3|||
130283030|NCT03022097|468998681|FG003|Overall Study|Lack of Efficacy|3|||
130283031|NCT03022097|468998678|FG000|Overall Study|Protocol Violation|1|||
130283032|NCT03022097|468998679|FG001|Overall Study|Protocol Violation|0|||
130283033|NCT03022097|468998680|FG002|Overall Study|Protocol Violation|1|||
130283034|NCT03022097|468998681|FG003|Overall Study|Protocol Violation|0|||
130283035|NCT03022097|468998678|FG000|Overall Study|Withdrawal by Subject|11|||
130283036|NCT03022097|468998679|FG001|Overall Study|Withdrawal by Subject|13|||
130283037|NCT03022097|468998680|FG002|Overall Study|Withdrawal by Subject|15|||
130283038|NCT03022097|468998681|FG003|Overall Study|Withdrawal by Subject|21|||
130283039|NCT03022097|468998678|FG000|Overall Study|Lost to Follow-up|0|||
130283040|NCT03022097|468998679|FG001|Overall Study|Lost to Follow-up|0|||
130283041|NCT03022097|468998680|FG002|Overall Study|Lost to Follow-up|1|||
130283042|NCT03022097|468998681|FG003|Overall Study|Lost to Follow-up|1|||
130283043|NCT03022097|468998678|FG000|Overall Study|Other|4|||
130283044|NCT03022097|468998679|FG001|Overall Study|Other|1|||
130283045|NCT03022097|468998680|FG002|Overall Study|Other|6|||
130283046|NCT03022097|468998681|FG003|Overall Study|Other|4|||
130283047|NCT03022097|468998678|FG000|Overall Study|Due to COVID-19 pandemic|0|||
130283048|NCT03022097|468998679|FG001|Overall Study|Due to COVID-19 pandemic|1|||
130283049|NCT03022097|468998680|FG002|Overall Study|Due to COVID-19 pandemic|0|||
130283050|NCT03022097|468998681|FG003|Overall Study|Due to COVID-19 pandemic|0|||
130283051|NCT01349322|468998684|FG000|Overall Study|Protocol Violation|45|||
130283052|NCT01349322|468998685|FG001|Overall Study|Protocol Violation|47|||
130283053|NCT05593913|468998690|FG000|Overall Study|Insufficient image quality|39|||
130283054|NCT04470908|468998691|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
130283055|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
130283056|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
130283057|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130283058|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130283059|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
130283060|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
130283061|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
130283062|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
130283063|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
130283064|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
130283065|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
130283066|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
130283067|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
130283068|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
130283069|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130283070|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130283071|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130283072|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130283073|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130283074|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130283075|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
130283076|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
130283077|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
130283078|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
130283079|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130283080|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130283081|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
130283082|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
130283083|NCT02136680|468998698|FG000|Overall Study|No Longer Interested|1|||
130283084|NCT02136680|468998699|FG001|Overall Study|No Longer Interested|1|||
130283085|NCT02136680|468998698|FG000|Overall Study|No longer receiving care at clinic|3|||
130283086|NCT02136680|468998699|FG001|Overall Study|No longer receiving care at clinic|5|||
130283087|NCT02136680|468998698|FG000|Overall Study|Moved away|5|||
130283088|NCT02136680|468998699|FG001|Overall Study|Moved away|4|||
130283089|NCT02136680|468998698|FG000|Overall Study|Unable to schedule|17|||
130283090|NCT02136680|468998699|FG001|Overall Study|Unable to schedule|16|||
130283091|NCT02136680|468998698|FG000|Overall Study|Study ended before interview due|6|||
130283092|NCT02136680|468998699|FG001|Overall Study|Study ended before interview due|3|||
130283093|NCT05151445|468998700|FG000|Overall Study|Withdrawal by Subject|3|||
130283094|NCT01457014|468998701|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
130283095|NCT01457014|468998702|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283096|NCT01457014|468998703|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283097|NCT01457014|468998704|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283098|NCT01457014|468998701|FG000|First Night|Withdrawal by Subject|3|||
130283099|NCT01457014|468998702|FG001|First Night|Withdrawal by Subject|0|||
130283100|NCT01457014|468998703|FG002|First Night|Withdrawal by Subject|0|||
130283101|NCT01457014|468998704|FG003|First Night|Withdrawal by Subject|0|||
130283102|NCT05463744|468998705|FG000|Treatment Period|Withdrawal by Subject|19|||
130283103|NCT05463744|468998706|FG001|Treatment Period|Withdrawal by Subject|16|||
130283104|NCT05463744|468998705|FG000|Treatment Period|Adverse Event|4|||
130283105|NCT05463744|468998706|FG001|Treatment Period|Adverse Event|4|||
130283106|NCT05463744|468998705|FG000|Treatment Period|Pregnancy|0|||
130283107|NCT05463744|468998706|FG001|Treatment Period|Pregnancy|3|||
130283108|NCT05463744|468998705|FG000|Treatment Period|Lost to Follow-up|1|||
130283109|NCT05463744|468998706|FG001|Treatment Period|Lost to Follow-up|3|||
130283110|NCT05463744|468998705|FG000|Treatment Period|Inadvertent enrollment|2|||
130283111|NCT05463744|468998706|FG001|Treatment Period|Inadvertent enrollment|1|||
130283112|NCT05463744|468998705|FG000|Treatment Period|Death|0|||
130283113|NCT05463744|468998706|FG001|Treatment Period|Death|1|||
130283114|NCT05463744|468998705|FG000|Treatment Period|Non-compliance with Study Drug|1|||
130283115|NCT05463744|468998706|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130283116|NCT05463744|468998705|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
130283117|NCT05463744|468998706|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
130283118|NCT05463744|468998705|FG000|Treatment Period|Physician Decision|0|||
130283119|NCT05463744|468998706|FG001|Treatment Period|Physician Decision|1|||
130283120|NCT05463744|468998705|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130283121|NCT05463744|468998706|FG001|Follow-Up Period|Withdrawal by Subject|1|||
130283122|NCT05463744|468998705|FG000|Follow-Up Period|Lost to Follow-up|1|||
130283123|NCT05463744|468998706|FG001|Follow-Up Period|Lost to Follow-up|1|||
130283124|NCT02825420|468998709|FG000|Overall Study|Death|30|||
130283125|NCT02825420|468998710|FG001|Overall Study|Death|12|||
130283126|NCT02825420|468998709|FG000|Overall Study|Progressive disease|6|||
130283127|NCT02825420|468998710|FG001|Overall Study|Progressive disease|1|||
130283128|NCT02825420|468998709|FG000|Overall Study|Lost to Follow-up|2|||
130283129|NCT02825420|468998710|FG001|Overall Study|Lost to Follow-up|2|||
130283130|NCT02825420|468998709|FG000|Overall Study|Withdrawal by Subject|1|||
130283131|NCT02825420|468998710|FG001|Overall Study|Withdrawal by Subject|1|||
130457929|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
130457930|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
130283132|NCT02825420|468998709|FG000|Overall Study|Protocol amendment not signed|1|||
130283133|NCT02825420|468998710|FG001|Overall Study|Protocol amendment not signed|1|||
130457931|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
130457932|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
130283134|NCT02825420|468998709|FG000|Overall Study|Physician Decision|1|||
130283135|NCT02825420|468998710|FG001|Overall Study|Physician Decision|0|||
130283136|NCT02825420|468998709|FG000|Overall Study|Did not receive PLD|2|||
130283137|NCT02825420|468998710|FG001|Overall Study|Did not receive PLD|0|||
130283138|NCT04027049|468998711|FG000|Overall Study|Withdrawn by family|1|||
130283139|NCT04027049|468998712|FG001|Overall Study|Withdrawn by family|0|||
130283140|NCT04027049|468998711|FG000|Overall Study|Participant safety|1|||
130283141|NCT04027049|468998712|FG001|Overall Study|Participant safety|0|||
130283142|NCT02264665|469000398|FG000|Overall Study|Other|0|||
130283143|NCT02264665|469000399|FG001|Overall Study|Other|0|||
130283144|NCT02264665|469000400|FG002|Overall Study|Other|3|||
130283145|NCT02264665|469000401|FG003|Overall Study|Other|0|||
130283146|NCT02264665|469000402|FG004|Overall Study|Other|0|||
130283147|NCT02264665|469000403|FG005|Overall Study|Other|0|||
130711403|NCT02858726|470567994|FG002|Overall Study|Protocol Violation|0|||
130283148|NCT02264665|469000404|FG006|Overall Study|Other|0|||
130283149|NCT02264665|469000398|FG000|Overall Study|Death|9|||
130283150|NCT02264665|469000399|FG001|Overall Study|Death|8|||
130283151|NCT02264665|469000400|FG002|Overall Study|Death|13|||
130283152|NCT02264665|469000401|FG003|Overall Study|Death|5|||
130283153|NCT02264665|469000402|FG004|Overall Study|Death|0|||
130283154|NCT02264665|469000403|FG005|Overall Study|Death|0|||
130283155|NCT02264665|469000404|FG006|Overall Study|Death|1|||
130283156|NCT02264665|469000398|FG000|Overall Study|Lost to Follow-up|1|||
130283157|NCT02264665|469000399|FG001|Overall Study|Lost to Follow-up|0|||
130283158|NCT02264665|469000400|FG002|Overall Study|Lost to Follow-up|2|||
130283159|NCT02264665|469000401|FG003|Overall Study|Lost to Follow-up|1|||
130283160|NCT02264665|469000402|FG004|Overall Study|Lost to Follow-up|0|||
130283161|NCT02264665|469000403|FG005|Overall Study|Lost to Follow-up|0|||
130283162|NCT02264665|469000404|FG006|Overall Study|Lost to Follow-up|0|||
130283163|NCT02264665|469000398|FG000|Overall Study|Participant decision|0|||
130283164|NCT02264665|469000399|FG001|Overall Study|Participant decision|0|||
130283165|NCT02264665|469000400|FG002|Overall Study|Participant decision|0|||
130283166|NCT02264665|469000401|FG003|Overall Study|Participant decision|1|||
130283167|NCT02264665|469000402|FG004|Overall Study|Participant decision|0|||
130283168|NCT02264665|469000403|FG005|Overall Study|Participant decision|0|||
130283169|NCT02264665|469000404|FG006|Overall Study|Participant decision|0|||
130283170|NCT02264665|469000398|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
130283171|NCT02264665|469000399|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283172|NCT02264665|469000400|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283173|NCT02264665|469000401|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283174|NCT02264665|469000402|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283175|NCT02264665|469000403|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283176|NCT02264665|469000404|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283177|NCT02264665|469000398|FG000|Overall Study|Data Missing|0|||
130283178|NCT02264665|469000399|FG001|Overall Study|Data Missing|0|||
130283179|NCT02264665|469000400|FG002|Overall Study|Data Missing|1|||
130283180|NCT02264665|469000401|FG003|Overall Study|Data Missing|0|||
130283181|NCT02264665|469000402|FG004|Overall Study|Data Missing|0|||
130283182|NCT02264665|469000403|FG005|Overall Study|Data Missing|0|||
130283183|NCT02264665|469000404|FG006|Overall Study|Data Missing|0|||
130283184|NCT00789581|469000410|FG000|AC Therapy|Adverse Event|2|||
130283185|NCT00789581|469000411|FG001|AC Therapy|Adverse Event|3|||
130283186|NCT00789581|469000410|FG000|AC Therapy|Withdrawal by Subject|4|||
130283187|NCT00789581|469000411|FG001|AC Therapy|Withdrawal by Subject|7|||
130283188|NCT00789581|469000410|FG000|AC Therapy|Disease recurrence|3|||
130283189|NCT00789581|469000411|FG001|AC Therapy|Disease recurrence|1|||
130283190|NCT00789581|469000410|FG000|AC Therapy|Intercurrent Illness|1|||
130283191|NCT00789581|469000411|FG001|AC Therapy|Intercurrent Illness|0|||
130283192|NCT00789581|469000410|FG000|AC Therapy|Never Treated|1|||
130283193|NCT00789581|469000411|FG001|AC Therapy|Never Treated|4|||
130283194|NCT00789581|469000410|FG000|AC Therapy|Other|0|||
130283195|NCT00789581|469000411|FG001|AC Therapy|Other|2|||
130283196|NCT00789581|469000410|FG000|Adjuvant Therapy|Never treated|2|||
130283197|NCT00789581|469000411|FG001|Adjuvant Therapy|Never treated|2|||
130283198|NCT00789581|469000410|FG000|Adjuvant Therapy|Adverse Event|20|||
130283199|NCT00789581|469000411|FG001|Adjuvant Therapy|Adverse Event|44|||
130283200|NCT00789581|469000410|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
130283201|NCT00789581|469000411|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
130283202|NCT00789581|469000410|FG000|Adjuvant Therapy|Disease recurrence|2|||
130283203|NCT00789581|469000411|FG001|Adjuvant Therapy|Disease recurrence|1|||
130283204|NCT00789581|469000410|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
130283205|NCT00789581|469000411|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
130283206|NCT00789581|469000410|FG000|Adjuvant Therapy|Protocol Violation|1|||
130283207|NCT00789581|469000411|FG001|Adjuvant Therapy|Protocol Violation|1|||
130283208|NCT00789581|469000410|FG000|Adjuvant Therapy|Other|0|||
130283209|NCT00789581|469000411|FG001|Adjuvant Therapy|Other|1|||
130711404|NCT02858726|470567995|FG003|Overall Study|Protocol Violation|1|||
130283210|NCT01468207|469000412|FG000|Treatment Period 1|Adverse Event|1|||
130457933|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
130457934|NCT00410124|469640011|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
130457935|NCT00410124|469640012|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
130283211|NCT01468207|469000413|FG001|Treatment Period 1|Adverse Event|0|||
130283212|NCT01468207|469000414|FG002|Treatment Period 1|Adverse Event|0|||
130283213|NCT01468207|469000415|FG003|Treatment Period 1|Adverse Event|0|||
130283214|NCT01468207|469000416|FG004|Treatment Period 1|Adverse Event|0|||
130283215|NCT01468207|469000417|FG005|Treatment Period 1|Adverse Event|0|||
130457936|NCT01227707|469640013|FG000|Overall Study|Adverse Event|10|||
130283216|NCT01468207|469000412|FG000|Treatment Period 1|Protocol Violation|1|||
130283217|NCT01468207|469000413|FG001|Treatment Period 1|Protocol Violation|1|||
130283218|NCT01468207|469000414|FG002|Treatment Period 1|Protocol Violation|0|||
130283219|NCT01468207|469000415|FG003|Treatment Period 1|Protocol Violation|0|||
130283220|NCT01468207|469000416|FG004|Treatment Period 1|Protocol Violation|0|||
130283221|NCT01468207|469000417|FG005|Treatment Period 1|Protocol Violation|0|||
130283222|NCT01468207|469000412|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130283223|NCT01468207|469000413|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130283224|NCT01468207|469000414|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130283225|NCT01468207|469000415|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130283226|NCT01468207|469000416|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130283227|NCT01468207|469000417|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130283228|NCT01468207|469000412|FG000|Treatment Period 1|Lost to Follow-up|2|||
130283229|NCT01468207|469000413|FG001|Treatment Period 1|Lost to Follow-up|1|||
130283230|NCT01468207|469000414|FG002|Treatment Period 1|Lost to Follow-up|0|||
130283231|NCT01468207|469000415|FG003|Treatment Period 1|Lost to Follow-up|0|||
130283232|NCT01468207|469000416|FG004|Treatment Period 1|Lost to Follow-up|0|||
130283233|NCT01468207|469000417|FG005|Treatment Period 1|Lost to Follow-up|0|||
130283234|NCT01468207|469000412|FG000|Treatment Period 1|Other|0|||
130283235|NCT01468207|469000413|FG001|Treatment Period 1|Other|2|||
130283236|NCT01468207|469000414|FG002|Treatment Period 1|Other|0|||
130283237|NCT01468207|469000415|FG003|Treatment Period 1|Other|0|||
130283238|NCT01468207|469000416|FG004|Treatment Period 1|Other|0|||
130283239|NCT01468207|469000417|FG005|Treatment Period 1|Other|0|||
130283240|NCT01468207|469000412|FG000|Treatment Period 2|Adverse Event|0|||
130283241|NCT01468207|469000413|FG001|Treatment Period 2|Adverse Event|0|||
130283242|NCT01468207|469000414|FG002|Treatment Period 2|Adverse Event|6|||
130283243|NCT01468207|469000415|FG003|Treatment Period 2|Adverse Event|1|||
130283244|NCT01468207|469000416|FG004|Treatment Period 2|Adverse Event|2|||
130283245|NCT01468207|469000417|FG005|Treatment Period 2|Adverse Event|1|||
130283246|NCT01468207|469000412|FG000|Treatment Period 2|Lack of Efficacy|0|||
130283247|NCT01468207|469000413|FG001|Treatment Period 2|Lack of Efficacy|0|||
130283248|NCT01468207|469000414|FG002|Treatment Period 2|Lack of Efficacy|1|||
130283249|NCT01468207|469000415|FG003|Treatment Period 2|Lack of Efficacy|1|||
130283250|NCT01468207|469000416|FG004|Treatment Period 2|Lack of Efficacy|0|||
130283251|NCT01468207|469000417|FG005|Treatment Period 2|Lack of Efficacy|2|||
130283252|NCT01468207|469000412|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130283253|NCT01468207|469000413|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130283254|NCT01468207|469000414|FG002|Treatment Period 2|Withdrawal by Subject|5|||
130283255|NCT01468207|469000415|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130283256|NCT01468207|469000416|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130283257|NCT01468207|469000417|FG005|Treatment Period 2|Withdrawal by Subject|2|||
130283258|NCT01468207|469000412|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130283259|NCT01468207|469000413|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130283260|NCT01468207|469000414|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
130283261|NCT01468207|469000415|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
130283262|NCT01468207|469000416|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
130283263|NCT01468207|469000417|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
130283264|NCT01468207|469000412|FG000|Treatment Period 2|Lost to Follow-up|0|||
130283265|NCT01468207|469000413|FG001|Treatment Period 2|Lost to Follow-up|0|||
130283266|NCT01468207|469000414|FG002|Treatment Period 2|Lost to Follow-up|5|||
130283267|NCT01468207|469000415|FG003|Treatment Period 2|Lost to Follow-up|1|||
130283268|NCT01468207|469000416|FG004|Treatment Period 2|Lost to Follow-up|0|||
130283269|NCT01468207|469000417|FG005|Treatment Period 2|Lost to Follow-up|0|||
130283270|NCT01468207|469000412|FG000|Treatment Period 2|Other|0|||
130283271|NCT01468207|469000413|FG001|Treatment Period 2|Other|0|||
130283272|NCT01468207|469000414|FG002|Treatment Period 2|Other|5|||
130283273|NCT01468207|469000415|FG003|Treatment Period 2|Other|1|||
130283274|NCT01468207|469000416|FG004|Treatment Period 2|Other|1|||
130283275|NCT01468207|469000417|FG005|Treatment Period 2|Other|2|||
130283276|NCT00539513|469000420|FG000|Overall Study|Withdrawal by Subject|2|||
130283277|NCT00539513|469000421|FG001|Overall Study|Withdrawal by Subject|1|||
130283278|NCT00539513|469000420|FG000|Overall Study|Lost to Follow-up|0|||
130283279|NCT00539513|469000421|FG001|Overall Study|Lost to Follow-up|1|||
130283280|NCT01328041|469000422|FG000|Overall Study|Adverse Event|7|||
130283281|NCT01328041|469000422|FG000|Overall Study|Lack of Efficacy|27|||
130283282|NCT01328041|469000422|FG000|Overall Study|Protocol Violation|7|||
130711405|NCT02858726|470567992|FG000|Overall Study|Study Terminated by Sponsor|0|||
130711406|NCT02858726|470567993|FG001|Overall Study|Study Terminated by Sponsor|0|||
130283283|NCT01328041|469000422|FG000|Overall Study|Lost to Follow-up|7|||
130283284|NCT01328041|469000422|FG000|Overall Study|Physician Decision|2|||
130283285|NCT01328041|469000422|FG000|Overall Study|Withdrawal by Subject|7|||
130283286|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283287|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
130283288|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283289|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283290|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283291|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283292|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
130711407|NCT02858726|470567994|FG002|Overall Study|Study Terminated by Sponsor|0|||
130283293|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283294|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283295|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283296|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283297|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
130283298|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283299|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283300|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283301|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283302|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
130283303|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283304|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283305|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283306|NCT02688088|469000426|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283307|NCT02688088|469000427|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283308|NCT02688088|469000428|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
130283309|NCT02688088|469000429|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283310|NCT02688088|469000430|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283311|NCT02688088|469000426|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283312|NCT02688088|469000427|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283313|NCT02688088|469000428|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
130283314|NCT02688088|469000429|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283315|NCT02688088|469000430|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283316|NCT02688088|469000426|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283317|NCT02688088|469000427|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283318|NCT02688088|469000428|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283319|NCT02688088|469000429|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
130283320|NCT02688088|469000430|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283321|NCT02688088|469000426|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283322|NCT02688088|469000427|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283323|NCT02688088|469000428|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283324|NCT02688088|469000429|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
130283325|NCT02688088|469000430|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283326|NCT02688088|469000426|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283327|NCT02688088|469000427|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283328|NCT02688088|469000428|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283329|NCT02688088|469000429|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283330|NCT02688088|469000430|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
130283331|NCT04021524|469000433|FG000|Overall Study|Change in surgical intervention|0|||
130283332|NCT04021524|469000434|FG001|Overall Study|Change in surgical intervention|1|||
130283333|NCT05275010|469000435|FG000|Overall Study|Reason Not Specified|4|||
130283334|NCT05275010|469000436|FG001|Overall Study|Reason Not Specified|1|||
130283335|NCT05275010|469000435|FG000|Overall Study|Withdrawal by Subject|1|||
130283336|NCT05275010|469000436|FG001|Overall Study|Withdrawal by Subject|0|||
130283337|NCT05275010|469000435|FG000|Overall Study|Lost to Follow-up|0|||
130283338|NCT05275010|469000436|FG001|Overall Study|Lost to Follow-up|1|||
130283339|NCT00730041|469000437|FG000|Overall Study|Lost to Follow-up|0|||
130283340|NCT00730041|469000438|FG001|Overall Study|Lost to Follow-up|2|||
130283341|NCT05526781|469000439|FG000|Overall Study|Lost to Follow-up|1|||
130283342|NCT01921218|469000440|FG000|Overall Study|Death|2|||
130283343|NCT01921218|469000441|FG001|Overall Study|Death|1|||
130283344|NCT01921218|469000440|FG000|Overall Study|Withdrawal by Subject|0|||
130283345|NCT01921218|469000441|FG001|Overall Study|Withdrawal by Subject|2|||
130283346|NCT01921218|469000440|FG000|Overall Study|Kidney transplant|1|||
130283347|NCT01921218|469000441|FG001|Overall Study|Kidney transplant|1|||
130283348|NCT02449889|469000442|FG000|Overall Study|Adverse Event|1|||
130283349|NCT02449889|469000443|FG001|Overall Study|Adverse Event|2|||
130283350|NCT02449889|469000444|FG002|Overall Study|Adverse Event|0|||
130283351|NCT02449889|469000442|FG000|Overall Study|Protocol Violation|0|||
130283352|NCT02449889|469000443|FG001|Overall Study|Protocol Violation|4|||
130283353|NCT02449889|469000444|FG002|Overall Study|Protocol Violation|1|||
130283354|NCT03327220|469000445|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
130283355|NCT03327220|469000446|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
130283356|NCT03327220|469000445|FG000|Overall Study|Investigator Decision|2|||
130283357|NCT03327220|469000446|FG001|Overall Study|Investigator Decision|0|||
130283358|NCT03327220|469000445|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
130283359|NCT03327220|469000446|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
130283360|NCT03327220|469000445|FG000|Overall Study|Fungal infection|1|||
130283361|NCT03327220|469000446|FG001|Overall Study|Fungal infection|0|||
130283362|NCT03327220|469000445|FG000|Overall Study|Discharged to Rehabilitation|0|||
130283363|NCT03327220|469000446|FG001|Overall Study|Discharged to Rehabilitation|1|||
130283364|NCT03327220|469000445|FG000|Overall Study|Missing|1|||
130283365|NCT03327220|469000446|FG001|Overall Study|Missing|0|||
130283366|NCT00368836|469000449|FG000|Phase II|Screen Failure|1|||
130283367|NCT00368836|469000449|FG000|Phase II|Withdrawal by Subject|1|||
130283368|NCT00368836|469000449|FG000|Phase II|unable to collect blood and/or breath|17|||
130283369|NCT00368836|469000449|FG000|Phase II|Protocol Violation|2|||
130283370|NCT01082874|469000451|FG000|Overall Study|Lost to Follow-up|10|||
130283371|NCT01082874|469000452|FG001|Overall Study|Lost to Follow-up|10|||
130283372|NCT01082874|469000453|FG002|Overall Study|Lost to Follow-up|6|||
130283373|NCT01082874|469000454|FG003|Overall Study|Lost to Follow-up|10|||
130283374|NCT01082874|469000451|FG000|Overall Study|Withdrawal by Subject|1|||
130283375|NCT01082874|469000452|FG001|Overall Study|Withdrawal by Subject|2|||
130283376|NCT01082874|469000453|FG002|Overall Study|Withdrawal by Subject|5|||
130283377|NCT01082874|469000454|FG003|Overall Study|Withdrawal by Subject|3|||
130283378|NCT00090142|469000455|FG000|Treatment Period I|Lost to Follow-up|1|||
130283379|NCT00090142|469000456|FG001|Treatment Period I|Lost to Follow-up|2|||
130283380|NCT00090142|469000455|FG000|Treatment Period I|Protocol Violation|2|||
130283381|NCT00090142|469000456|FG001|Treatment Period I|Protocol Violation|0|||
130283382|NCT00090142|469000455|FG000|Treatment Period I|Withdrawal by Subject|2|||
130283383|NCT00090142|469000456|FG001|Treatment Period I|Withdrawal by Subject|0|||
130283384|NCT00090142|469000455|FG000|Treatment Period I|Other|0|||
130283385|NCT00090142|469000456|FG001|Treatment Period I|Other|1|||
130283386|NCT00090142|469000455|FG000|Treatment Period II|Other|1|||
130283387|NCT00090142|469000456|FG001|Treatment Period II|Other|0|||
130283388|NCT02442310|469000457|FG000|Overall Study|Adverse Event|2|||
130283389|NCT02442310|469000457|FG000|Overall Study|Withdrawal by Subject|1|||
130283390|NCT00688324|469000458|FG000|Overall Study|Withdrawal by Subject|2|||
130283391|NCT00688324|469000458|FG000|Overall Study|Physician Decision|5|||
130283392|NCT00688324|469000458|FG000|Overall Study|Lost to Follow-up|1|||
130283393|NCT00006046|469000459|FG000|Overall Study|Adverse Event|3|||
130283394|NCT00006046|469000460|FG001|Overall Study|Adverse Event|0|||
130283395|NCT00006046|469000461|FG002|Overall Study|Adverse Event|0|||
130283396|NCT00006046|469000462|FG003|Overall Study|Adverse Event|0|||
130283397|NCT00006046|469000463|FG004|Overall Study|Adverse Event|0|||
130283398|NCT00006046|469000459|FG000|Overall Study|Disease Progression|2|||
130283399|NCT00006046|469000460|FG001|Overall Study|Disease Progression|0|||
130283400|NCT00006046|469000461|FG002|Overall Study|Disease Progression|0|||
130283401|NCT00006046|469000462|FG003|Overall Study|Disease Progression|0|||
130283402|NCT00006046|469000463|FG004|Overall Study|Disease Progression|0|||
130283403|NCT03176472|469000464|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
130283404|NCT03176472|469000465|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
130283405|NCT03176472|469000464|FG000|Double Blind Treatment Period|Adverse Event|0|||
130283406|NCT03176472|469000465|FG001|Double Blind Treatment Period|Adverse Event|5|||
130283407|NCT03176472|469000464|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
130283408|NCT03176472|469000465|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130283409|NCT03176472|469000464|FG000|Double Blind Treatment Period|Physician Decision|0|||
130283410|NCT03176472|469000465|FG001|Double Blind Treatment Period|Physician Decision|1|||
130283411|NCT03176472|469000464|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130283412|NCT03176472|469000465|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130283413|NCT03176472|469000464|FG000|Double Blind Treatment Period|Not Provided|1|||
130283414|NCT03176472|469000465|FG001|Double Blind Treatment Period|Not Provided|0|||
130283415|NCT03176472|469000464|FG000|Open Label Extension|Withdrawal by Subject|3|||
130283416|NCT03176472|469000465|FG001|Open Label Extension|Withdrawal by Subject|4|||
130283417|NCT03176472|469000464|FG000|Open Label Extension|Adverse Event|2|||
130283418|NCT03176472|469000465|FG001|Open Label Extension|Adverse Event|4|||
130283419|NCT03176472|469000464|FG000|Open Label Extension|Lost to Follow-up|1|||
130283420|NCT03176472|469000465|FG001|Open Label Extension|Lost to Follow-up|2|||
130283421|NCT03176472|469000464|FG000|Open Label Extension|Protocol Violation|0|||
130283422|NCT03176472|469000465|FG001|Open Label Extension|Protocol Violation|1|||
130283423|NCT03176472|469000464|FG000|Open Label Extension|Not Provided|2|||
130283424|NCT03176472|469000465|FG001|Open Label Extension|Not Provided|1|||
130283425|NCT00596154|469000466|FG000|Overall Study|Not Evaluable|2|||
130283426|NCT00642369|469000467|FG000|Overall Study|Adverse Event|2|||
130283427|NCT00642369|469000468|FG001|Overall Study|Adverse Event|3|||
130283428|NCT00642369|469000467|FG000|Overall Study|Withdrawal by Subject|1|||
130283429|NCT00642369|469000468|FG001|Overall Study|Withdrawal by Subject|0|||
130283430|NCT00642369|469000467|FG000|Overall Study|misdiagnosis|0|||
130283431|NCT00642369|469000468|FG001|Overall Study|misdiagnosis|1|||
130283432|NCT00642369|469000467|FG000|Overall Study|Lack of Efficacy|2|||
130283433|NCT00642369|469000468|FG001|Overall Study|Lack of Efficacy|2|||
130283434|NCT00585546|469000469|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
130283435|NCT00585546|469000469|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
130283436|NCT04154345|469000470|FG000|Overall Study|Covid-19 pandemic|4|||
130283437|NCT03622112|469000473|FG000|Overall Study|Withdrawal by Subject|6|||
130283438|NCT03622112|469000474|FG001|Overall Study|Withdrawal by Subject|2|||
130283439|NCT03622112|469000475|FG002|Overall Study|Withdrawal by Subject|4|||
130283440|NCT03622112|469000476|FG003|Overall Study|Withdrawal by Subject|2|||
130283441|NCT03622112|469000477|FG004|Overall Study|Withdrawal by Subject|1|||
130283442|NCT03622112|469000478|FG005|Overall Study|Withdrawal by Subject|2|||
130283443|NCT03622112|469000479|FG006|Overall Study|Withdrawal by Subject|2|||
130283444|NCT03622112|469000473|FG000|Overall Study|Death|0|||
130283445|NCT03622112|469000474|FG001|Overall Study|Death|0|||
130283446|NCT03622112|469000475|FG002|Overall Study|Death|0|||
130283447|NCT03622112|469000476|FG003|Overall Study|Death|1|||
130283448|NCT03622112|469000477|FG004|Overall Study|Death|0|||
130283449|NCT03622112|469000478|FG005|Overall Study|Death|0|||
130283450|NCT03622112|469000479|FG006|Overall Study|Death|0|||
130283451|NCT03622112|469000473|FG000|Overall Study|Lost to Follow-up|1|||
130283452|NCT03622112|469000474|FG001|Overall Study|Lost to Follow-up|1|||
130283453|NCT03622112|469000475|FG002|Overall Study|Lost to Follow-up|0|||
130283454|NCT03622112|469000476|FG003|Overall Study|Lost to Follow-up|0|||
130283455|NCT03622112|469000477|FG004|Overall Study|Lost to Follow-up|0|||
130283456|NCT03622112|469000478|FG005|Overall Study|Lost to Follow-up|0|||
130283457|NCT03622112|469000479|FG006|Overall Study|Lost to Follow-up|0|||
130711408|NCT02858726|470567995|FG003|Overall Study|Study Terminated by Sponsor|1|||
130711409|NCT02858726|470567992|FG000|Overall Study|Withdrawal by Subject|1|||
130711410|NCT02858726|470567993|FG001|Overall Study|Withdrawal by Subject|2|||
130711411|NCT02858726|470567994|FG002|Overall Study|Withdrawal by Subject|1|||
130711412|NCT02858726|470567995|FG003|Overall Study|Withdrawal by Subject|0|||
130711413|NCT02858726|470567992|FG000|Overall Study|Noncompliance|0|||
130711414|NCT02858726|470567993|FG001|Overall Study|Noncompliance|1|||
130283458|NCT03622112|469000473|FG000|Overall Study|Study-specific withdrawal criteria|10|||
130283459|NCT03622112|469000474|FG001|Overall Study|Study-specific withdrawal criteria|8|||
130283460|NCT03622112|469000475|FG002|Overall Study|Study-specific withdrawal criteria|7|||
130283461|NCT03622112|469000476|FG003|Overall Study|Study-specific withdrawal criteria|6|||
130283462|NCT03622112|469000477|FG004|Overall Study|Study-specific withdrawal criteria|4|||
130283463|NCT03622112|469000478|FG005|Overall Study|Study-specific withdrawal criteria|18|||
130283464|NCT03622112|469000479|FG006|Overall Study|Study-specific withdrawal criteria|4|||
130283465|NCT03622112|469000473|FG000|Overall Study|Protocol Violation|2|||
130283466|NCT03622112|469000474|FG001|Overall Study|Protocol Violation|0|||
130283467|NCT03622112|469000475|FG002|Overall Study|Protocol Violation|1|||
130283468|NCT03622112|469000476|FG003|Overall Study|Protocol Violation|1|||
130283469|NCT03622112|469000477|FG004|Overall Study|Protocol Violation|0|||
130283470|NCT03622112|469000478|FG005|Overall Study|Protocol Violation|0|||
130283471|NCT03622112|469000479|FG006|Overall Study|Protocol Violation|0|||
130283472|NCT03622112|469000473|FG000|Overall Study|Adverse Event|6|||
130283473|NCT03622112|469000474|FG001|Overall Study|Adverse Event|8|||
130283474|NCT03622112|469000475|FG002|Overall Study|Adverse Event|4|||
130283475|NCT03622112|469000476|FG003|Overall Study|Adverse Event|11|||
130283476|NCT03622112|469000477|FG004|Overall Study|Adverse Event|4|||
130283477|NCT03622112|469000478|FG005|Overall Study|Adverse Event|20|||
130283478|NCT03622112|469000479|FG006|Overall Study|Adverse Event|2|||
130283479|NCT03622112|469000473|FG000|Overall Study|Reason not specified|0|||
130283480|NCT03622112|469000474|FG001|Overall Study|Reason not specified|1|||
130283481|NCT03622112|469000475|FG002|Overall Study|Reason not specified|0|||
130283482|NCT03622112|469000476|FG003|Overall Study|Reason not specified|1|||
130283483|NCT03622112|469000477|FG004|Overall Study|Reason not specified|1|||
130283484|NCT03622112|469000478|FG005|Overall Study|Reason not specified|2|||
130283485|NCT03622112|469000479|FG006|Overall Study|Reason not specified|1|||
130283486|NCT02210689|469000480|FG000|Overall Study|Withdrawal by Subject|7|||
130283487|NCT02210689|469000481|FG001|Overall Study|Withdrawal by Subject|4|||
130283488|NCT02210689|469000482|FG002|Overall Study|Withdrawal by Subject|2|||
130711415|NCT02858726|470567994|FG002|Overall Study|Noncompliance|0|||
130711416|NCT02858726|470567995|FG003|Overall Study|Noncompliance|0|||
130711417|NCT02655016|470567996|FG000|Overall Study|Disease progression|6|||
130283489|NCT02210689|469000480|FG000|Overall Study|Adverse Event|0|||
130283490|NCT02210689|469000481|FG001|Overall Study|Adverse Event|1|||
130711418|NCT02655016|470567997|FG001|Overall Study|Disease progression|4|||
130711419|NCT02655016|470567996|FG000|Overall Study|Site closed|0|||
130711420|NCT02655016|470567997|FG001|Overall Study|Site closed|1|||
130711421|NCT02655016|470567996|FG000|Overall Study|Death|30|||
130711422|NCT02655016|470567997|FG001|Overall Study|Death|48|||
130711423|NCT02655016|470567996|FG000|Overall Study|Lost to Follow-up|1|||
130711424|NCT02655016|470567997|FG001|Overall Study|Lost to Follow-up|1|||
130711425|NCT02655016|470567996|FG000|Overall Study|Withdrawal by Subject|18|||
130711426|NCT02655016|470567997|FG001|Overall Study|Withdrawal by Subject|36|||
130711427|NCT04459715|470567998|FG000|Overall Study|Adverse Event|3|||
130711428|NCT04459715|470567999|FG001|Overall Study|Adverse Event|3|||
130711429|NCT04459715|470567998|FG000|Overall Study|Death|111|||
130283491|NCT02210689|469000482|FG002|Overall Study|Adverse Event|0|||
130283492|NCT02210689|469000480|FG000|Overall Study|Protocol Violation|1|||
130283493|NCT02210689|469000481|FG001|Overall Study|Protocol Violation|0|||
130283494|NCT02210689|469000482|FG002|Overall Study|Protocol Violation|0|||
130283495|NCT02210689|469000480|FG000|Overall Study|Lost to Follow-up|11|||
130283496|NCT02210689|469000481|FG001|Overall Study|Lost to Follow-up|9|||
130283497|NCT02210689|469000482|FG002|Overall Study|Lost to Follow-up|5|||
130283498|NCT02210689|469000480|FG000|Overall Study|Pregnancy|0|||
130283499|NCT02210689|469000481|FG001|Overall Study|Pregnancy|1|||
130283500|NCT02210689|469000482|FG002|Overall Study|Pregnancy|0|||
130283501|NCT02210689|469000480|FG000|Overall Study|Lack of Efficacy|0|||
130283502|NCT02210689|469000481|FG001|Overall Study|Lack of Efficacy|1|||
130283503|NCT02210689|469000482|FG002|Overall Study|Lack of Efficacy|5|||
130283504|NCT02210689|469000480|FG000|Overall Study|Prohibited medication|2|||
130283505|NCT02210689|469000481|FG001|Overall Study|Prohibited medication|8|||
130283506|NCT02210689|469000482|FG002|Overall Study|Prohibited medication|1|||
130283507|NCT02210689|469000480|FG000|Overall Study|Negative Nugent score at baseline|6|||
130283508|NCT02210689|469000481|FG001|Overall Study|Negative Nugent score at baseline|2|||
130283509|NCT02210689|469000482|FG002|Overall Study|Negative Nugent score at baseline|2|||
130283510|NCT02210689|469000480|FG000|Overall Study|Other|25|||
130283511|NCT02210689|469000481|FG001|Overall Study|Other|21|||
130283512|NCT02210689|469000482|FG002|Overall Study|Other|8|||
130283513|NCT01694121|469000484|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
130283514|NCT01694121|469000485|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
130283515|NCT00521599|469000486|FG000|Overall Study|Adverse Event|5|||
130283516|NCT00521599|469000487|FG001|Overall Study|Adverse Event|7|||
130283517|NCT00521599|469000488|FG002|Overall Study|Adverse Event|6|||
130283518|NCT00521599|469000486|FG000|Overall Study|Treatment Failure|8|||
130283519|NCT00521599|469000487|FG001|Overall Study|Treatment Failure|9|||
130283520|NCT00521599|469000488|FG002|Overall Study|Treatment Failure|22|||
130283521|NCT00521599|469000486|FG000|Overall Study|Lost to Follow-up|2|||
130283522|NCT00521599|469000487|FG001|Overall Study|Lost to Follow-up|1|||
130283523|NCT00521599|469000488|FG002|Overall Study|Lost to Follow-up|2|||
130283524|NCT00521599|469000486|FG000|Overall Study|Withdrawal by Subject|3|||
130283525|NCT00521599|469000487|FG001|Overall Study|Withdrawal by Subject|5|||
130283526|NCT00521599|469000488|FG002|Overall Study|Withdrawal by Subject|1|||
130283527|NCT00521599|469000486|FG000|Overall Study|Withdrawal by subject treatment related|3|||
130283528|NCT00521599|469000487|FG001|Overall Study|Withdrawal by subject treatment related|1|||
130283529|NCT00521599|469000488|FG002|Overall Study|Withdrawal by subject treatment related|2|||
130283530|NCT00521599|469000486|FG000|Overall Study|Protocol Violation|2|||
130283531|NCT00521599|469000487|FG001|Overall Study|Protocol Violation|4|||
130283532|NCT00521599|469000488|FG002|Overall Study|Protocol Violation|2|||
130283533|NCT00521599|469000486|FG000|Overall Study|Did not meet protocol eligibility|2|||
130283534|NCT00521599|469000487|FG001|Overall Study|Did not meet protocol eligibility|2|||
130283535|NCT00521599|469000488|FG002|Overall Study|Did not meet protocol eligibility|1|||
130283536|NCT00866047|469000489|FG000|Treatment Period|Progressive disease|13|||
130283537|NCT00866047|469000489|FG000|Treatment Period|Adverse Event|16|||
130283538|NCT00866047|469000489|FG000|Treatment Period|Physician Decision|14|||
130283539|NCT00866047|469000489|FG000|Treatment Period|Withdrawal by Subject|5|||
130283540|NCT00866047|469000489|FG000|Follow-up Period|Lost to Follow-up|5|||
130283541|NCT02928029|469000490|FG000|Overall Study|Withdrawal by Subject|0|||
130283542|NCT02928029|469000491|FG001|Overall Study|Withdrawal by Subject|1|||
130283543|NCT02928029|469000490|FG000|Overall Study|Radiological progression|1|||
130283544|NCT02928029|469000491|FG001|Overall Study|Radiological progression|0|||
130283545|NCT02928029|469000490|FG000|Overall Study|Clinical progression|1|||
130283546|NCT02928029|469000491|FG001|Overall Study|Clinical progression|2|||
130283547|NCT02928029|469000490|FG000|Overall Study|AE not related to clinical progression|1|||
130283548|NCT02928029|469000491|FG001|Overall Study|AE not related to clinical progression|1|||
130711430|NCT04459715|470567999|FG001|Overall Study|Death|93|||
130711431|NCT04459715|470567998|FG000|Overall Study|Lost to Follow-up|10|||
130711432|NCT04459715|470567999|FG001|Overall Study|Lost to Follow-up|9|||
130711433|NCT04459715|470567998|FG000|Overall Study|Other Reasons|4|||
130711434|NCT04459715|470567999|FG001|Overall Study|Other Reasons|5|||
130711435|NCT04459715|470567998|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130711436|NCT04459715|470567999|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130711437|NCT04459715|470567998|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
130711438|NCT04459715|470567999|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
130711439|NCT04459715|470567998|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
130711440|NCT04459715|470567999|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
130711441|NCT04459715|470567998|FG000|Overall Study|Withdrawal by Subject|22|||
130711442|NCT04459715|470567999|FG001|Overall Study|Withdrawal by Subject|22|||
130711443|NCT02631876|470569842|FG000|Overall Study|Death|96|||
130711444|NCT02631876|470569843|FG001|Overall Study|Death|50|||
130711445|NCT02631876|470569842|FG000|Overall Study|Investigator's discretion|1|||
130711446|NCT02631876|470569843|FG001|Overall Study|Investigator's discretion|0|||
130711447|NCT02631876|470569842|FG000|Overall Study|Lost to Follow-up|2|||
130711448|NCT02631876|470569843|FG001|Overall Study|Lost to Follow-up|0|||
130711449|NCT02631876|470569842|FG000|Overall Study|Withdrawal by Subject|16|||
130711450|NCT02631876|470569843|FG001|Overall Study|Withdrawal by Subject|9|||
130283549|NCT01610713|469000492|FG000|Overall Study|Adverse Event|3|||
130283550|NCT01610713|469000493|FG001|Overall Study|Adverse Event|0|||
130283551|NCT01610713|469000492|FG000|Overall Study|Lack of Efficacy|1|||
130283552|NCT01610713|469000493|FG001|Overall Study|Lack of Efficacy|0|||
130283553|NCT01610713|469000492|FG000|Overall Study|low mood and poor motivation|1|||
130283554|NCT01610713|469000493|FG001|Overall Study|low mood and poor motivation|0|||
130283555|NCT01610713|469000492|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
130283556|NCT01610713|469000493|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
130283557|NCT01610713|469000492|FG000|Overall Study|Lost to Follow-up|0|||
130283558|NCT01610713|469000493|FG001|Overall Study|Lost to Follow-up|1|||
130283559|NCT03770728|469000498|FG000|Overall Study|Adverse Event|1|||
130283560|NCT03770728|469000499|FG001|Overall Study|Adverse Event|0|||
130283561|NCT03770728|469000500|FG002|Overall Study|Adverse Event|1|||
130283562|NCT03770728|469000501|FG003|Overall Study|Adverse Event|0|||
130283563|NCT03770728|469000498|FG000|Overall Study|Poor compliance to protocol|0|||
130283564|NCT03770728|469000499|FG001|Overall Study|Poor compliance to protocol|0|||
130283565|NCT03770728|469000500|FG002|Overall Study|Poor compliance to protocol|1|||
130283566|NCT03770728|469000501|FG003|Overall Study|Poor compliance to protocol|0|||
130283567|NCT03770728|469000498|FG000|Overall Study|Withdrawal by Subject|13|||
130283568|NCT03770728|469000499|FG001|Overall Study|Withdrawal by Subject|8|||
130283569|NCT03770728|469000500|FG002|Overall Study|Withdrawal by Subject|9|||
130283570|NCT03770728|469000501|FG003|Overall Study|Withdrawal by Subject|13|||
130283571|NCT03770728|469000498|FG000|Overall Study|Other than specified|24|||
130283572|NCT03770728|469000499|FG001|Overall Study|Other than specified|23|||
130283573|NCT03770728|469000500|FG002|Overall Study|Other than specified|21|||
130283574|NCT03770728|469000501|FG003|Overall Study|Other than specified|22|||
130283575|NCT00503776|469000502|FG000|Overall Study|Withdrawal by Subject|1|||
130283576|NCT00503776|469000503|FG001|Overall Study|Withdrawal by Subject|0|||
130283577|NCT00503776|469000504|FG002|Overall Study|Withdrawal by Subject|1|||
130283578|NCT00503776|469000505|FG003|Overall Study|Withdrawal by Subject|1|||
130283579|NCT00503776|469000502|FG000|Overall Study|Physician Decision|0|||
130283580|NCT00503776|469000503|FG001|Overall Study|Physician Decision|0|||
130283581|NCT00503776|469000504|FG002|Overall Study|Physician Decision|1|||
130283582|NCT00503776|469000505|FG003|Overall Study|Physician Decision|1|||
130283583|NCT02778555|469000506|FG000|Overall Study|Withdrawal by Subject|55|||
130283584|NCT02778555|469000507|FG001|Overall Study|Withdrawal by Subject|32|||
130283585|NCT02778555|469000508|FG002|Overall Study|Withdrawal by Subject|107|||
130283586|NCT02379988|469000509|FG000|Overall Study|Not eligible|1|||
130283587|NCT05427539|469000514|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130283588|NCT05427539|469000515|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130283589|NCT05427539|469000514|FG000|Period 1|Withdrawal by Subject|1|||
130283590|NCT05427539|469000515|FG001|Period 1|Withdrawal by Subject|0|||
130283591|NCT00223977|469000516|FG000|Overall Study|Adverse Event|7|||
130283592|NCT00223977|469000517|FG001|Overall Study|Adverse Event|10|||
130283593|NCT00223977|469000518|FG002|Overall Study|Adverse Event|0|||
130283594|NCT00223977|469000516|FG000|Overall Study|Protocol Violation|0|||
130283595|NCT00223977|469000517|FG001|Overall Study|Protocol Violation|0|||
130283596|NCT00223977|469000518|FG002|Overall Study|Protocol Violation|1|||
130283597|NCT00223977|469000516|FG000|Overall Study|Withdrawal by Subject|1|||
130283598|NCT00223977|469000517|FG001|Overall Study|Withdrawal by Subject|1|||
130283599|NCT00223977|469000518|FG002|Overall Study|Withdrawal by Subject|2|||
130283600|NCT00223977|469000516|FG000|Overall Study|Other|1|||
130283601|NCT00223977|469000517|FG001|Overall Study|Other|0|||
130283602|NCT00223977|469000518|FG002|Overall Study|Other|0|||
130283603|NCT00934947|469000519|FG000|Overall Study|Adverse Event|0|||
130283604|NCT00934947|469000520|FG001|Overall Study|Adverse Event|2|||
130283605|NCT01451931|469000526|FG000|Overall Study|Lost to Follow-up|17|||
130283606|NCT01451931|469000527|FG001|Overall Study|Lost to Follow-up|36|||
130711451|NCT02631876|470569842|FG000|Overall Study|Other than specified|4|||
130711452|NCT02631876|470569843|FG001|Overall Study|Other than specified|4|||
130711453|NCT01408563|470569848|FG000|Overall Study|Ineligible after consent/ registration|2|||
130711454|NCT00380692|470569849|FG000|Study Period II - Double Blind|Adverse Event|1|||
130283607|NCT01451931|469000528|FG002|Overall Study|Lost to Follow-up|21|||
130283608|NCT01451931|469000526|FG000|Overall Study|Withdrawal by Subject|16|||
130283609|NCT01451931|469000527|FG001|Overall Study|Withdrawal by Subject|22|||
130283610|NCT01451931|469000528|FG002|Overall Study|Withdrawal by Subject|22|||
130283611|NCT02979093|469000531|FG000|First Scan Session|Scanning data problems|1|||
130283612|NCT02979093|469000532|FG001|First Scan Session|Scanning data problems|2|||
130283613|NCT02979093|469000533|FG002|First Scan Session|Scanning data problems|2|||
130283614|NCT02979093|469000534|FG003|First Scan Session|Scanning data problems|0|||
130283615|NCT02979093|469000531|FG000|Second Scan Session|Scanning data problems|3|||
130283616|NCT02979093|469000532|FG001|Second Scan Session|Scanning data problems|0|||
130283617|NCT02979093|469000533|FG002|Second Scan Session|Scanning data problems|1|||
130283618|NCT02979093|469000534|FG003|Second Scan Session|Scanning data problems|3|||
130283619|NCT03099174|469000535|FG000|Overall Study|Withdrawal by Subject|0|||
130283620|NCT03099174|469000536|FG001|Overall Study|Withdrawal by Subject|0|||
130283621|NCT03099174|469000537|FG002|Overall Study|Withdrawal by Subject|1|||
130283622|NCT03099174|469000538|FG003|Overall Study|Withdrawal by Subject|0|||
130283623|NCT03099174|469000539|FG004|Overall Study|Withdrawal by Subject|2|||
130283624|NCT03099174|469000540|FG005|Overall Study|Withdrawal by Subject|2|||
130283625|NCT03099174|469000541|FG006|Overall Study|Withdrawal by Subject|1|||
130283626|NCT03099174|469000542|FG007|Overall Study|Withdrawal by Subject|4|||
130283627|NCT03099174|469000535|FG000|Overall Study|Adverse Event|0|||
130283628|NCT03099174|469000536|FG001|Overall Study|Adverse Event|1|||
130283629|NCT03099174|469000537|FG002|Overall Study|Adverse Event|1|||
130283630|NCT03099174|469000538|FG003|Overall Study|Adverse Event|2|||
130283631|NCT03099174|469000539|FG004|Overall Study|Adverse Event|5|||
130283632|NCT03099174|469000540|FG005|Overall Study|Adverse Event|3|||
130283633|NCT03099174|469000541|FG006|Overall Study|Adverse Event|6|||
130283634|NCT03099174|469000542|FG007|Overall Study|Adverse Event|4|||
130283635|NCT03099174|469000535|FG000|Overall Study|Other than listed|6|||
130283636|NCT03099174|469000536|FG001|Overall Study|Other than listed|6|||
130283637|NCT03099174|469000537|FG002|Overall Study|Other than listed|5|||
130283638|NCT03099174|469000538|FG003|Overall Study|Other than listed|6|||
130283639|NCT03099174|469000539|FG004|Overall Study|Other than listed|19|||
130283640|NCT03099174|469000540|FG005|Overall Study|Other than listed|10|||
130283641|NCT03099174|469000541|FG006|Overall Study|Other than listed|26|||
130283642|NCT03099174|469000542|FG007|Overall Study|Other than listed|23|||
130283643|NCT02378298|469000543|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130283644|NCT02378298|469000544|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
130283645|NCT02378298|469000545|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130283646|NCT02378298|469000543|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130283647|NCT02378298|469000544|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130283648|NCT02378298|469000545|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
130283649|NCT02378298|469000543|FG000|Surveillance (19-68 Weeks)|Death|1|||
130283650|NCT02378298|469000544|FG001|Surveillance (19-68 Weeks)|Death|0|||
130283651|NCT02378298|469000545|FG002|Surveillance (19-68 Weeks)|Death|0|||
130283652|NCT04173260|469000546|FG000|Overall Study|Early termination|4|||
130283653|NCT02308163|469000547|FG000|Overall Study|Not fulfill eligible criteria|1|||
130555332|NCT03694418|470001560|FG003|Overall Study|Lost to Follow-up|12|||
130711455|NCT00380692|470569850|FG001|Study Period II - Double Blind|Adverse Event|0|||
130711456|NCT00380692|470569849|FG000|Study Period II - Double Blind|Protocol Violation|2|||
130711457|NCT00380692|470569850|FG001|Study Period II - Double Blind|Protocol Violation|2|||
130711458|NCT00380692|470569849|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
130711459|NCT00380692|470569850|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
130711460|NCT00380692|470569849|FG000|Study Period II - Double Blind|Physician Decision|0|||
130711461|NCT00380692|470569850|FG001|Study Period II - Double Blind|Physician Decision|1|||
130711462|NCT00380692|470569849|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
130711463|NCT00380692|470569850|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
130711464|NCT00380692|470569849|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
130711465|NCT00380692|470569850|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
130711466|NCT00380692|470569849|FG000|Study Period III - Open Label|Adverse Event|5|||
130711467|NCT00380692|470569850|FG001|Study Period III - Open Label|Adverse Event|3|||
130283654|NCT02308163|469000548|FG001|Overall Study|Not fulfill eligible criteria|2|||
130283655|NCT02308163|469000549|FG002|Overall Study|Not fulfill eligible criteria|0|||
130283656|NCT02308163|469000550|FG003|Overall Study|Not fulfill eligible criteria|1|||
130283657|NCT02308163|469000551|FG004|Overall Study|Not fulfill eligible criteria|1|||
130283658|NCT02308163|469000547|FG000|Overall Study|Adverse Event|9|||
130283659|NCT02308163|469000548|FG001|Overall Study|Adverse Event|5|||
130283660|NCT02308163|469000549|FG002|Overall Study|Adverse Event|2|||
130283661|NCT02308163|469000550|FG003|Overall Study|Adverse Event|2|||
130283662|NCT02308163|469000551|FG004|Overall Study|Adverse Event|11|||
130283663|NCT02308163|469000547|FG000|Overall Study|Lack of Efficacy|11|||
130283664|NCT02308163|469000548|FG001|Overall Study|Lack of Efficacy|3|||
130283665|NCT02308163|469000549|FG002|Overall Study|Lack of Efficacy|8|||
130283666|NCT02308163|469000550|FG003|Overall Study|Lack of Efficacy|4|||
130283667|NCT02308163|469000551|FG004|Overall Study|Lack of Efficacy|6|||
130283668|NCT02308163|469000547|FG000|Overall Study|Withdrawal of consent|2|||
130283669|NCT02308163|469000548|FG001|Overall Study|Withdrawal of consent|3|||
130283670|NCT02308163|469000549|FG002|Overall Study|Withdrawal of consent|0|||
130283671|NCT02308163|469000550|FG003|Overall Study|Withdrawal of consent|2|||
130283672|NCT02308163|469000551|FG004|Overall Study|Withdrawal of consent|6|||
130283673|NCT02308163|469000547|FG000|Overall Study|Protocol Violation|3|||
130283674|NCT02308163|469000548|FG001|Overall Study|Protocol Violation|3|||
130283675|NCT02308163|469000549|FG002|Overall Study|Protocol Violation|3|||
130283676|NCT02308163|469000550|FG003|Overall Study|Protocol Violation|2|||
130283677|NCT02308163|469000551|FG004|Overall Study|Protocol Violation|5|||
130283678|NCT02308163|469000547|FG000|Overall Study|Lab data met discontinuation criteria|3|||
130283679|NCT02308163|469000548|FG001|Overall Study|Lab data met discontinuation criteria|0|||
130283680|NCT02308163|469000549|FG002|Overall Study|Lab data met discontinuation criteria|0|||
130283681|NCT02308163|469000550|FG003|Overall Study|Lab data met discontinuation criteria|2|||
130283682|NCT02308163|469000551|FG004|Overall Study|Lab data met discontinuation criteria|0|||
130283683|NCT02308163|469000547|FG000|Overall Study|Miscellaneous|2|||
130283684|NCT02308163|469000548|FG001|Overall Study|Miscellaneous|2|||
130283685|NCT02308163|469000549|FG002|Overall Study|Miscellaneous|1|||
130283686|NCT02308163|469000550|FG003|Overall Study|Miscellaneous|0|||
130283687|NCT02308163|469000551|FG004|Overall Study|Miscellaneous|5|||
130283688|NCT02684058|469000552|FG000|Treatment Period|Progressive disease|4|||
130283689|NCT02684058|469000553|FG001|Treatment Period|Progressive disease|10|||
130283690|NCT02684058|469000554|FG002|Treatment Period|Progressive disease|19|||
130283691|NCT02684058|469000552|FG000|Treatment Period|Adverse Event|3|||
130283692|NCT02684058|469000553|FG001|Treatment Period|Adverse Event|8|||
130283693|NCT02684058|469000554|FG002|Treatment Period|Adverse Event|1|||
130283694|NCT02684058|469000552|FG000|Treatment Period|Physician Decision|5|||
130283695|NCT02684058|469000553|FG001|Treatment Period|Physician Decision|1|||
130283696|NCT02684058|469000554|FG002|Treatment Period|Physician Decision|2|||
130283697|NCT02684058|469000552|FG000|Treatment Period|New therapy for study indication|1|||
130283698|NCT02684058|469000553|FG001|Treatment Period|New therapy for study indication|0|||
130283699|NCT02684058|469000554|FG002|Treatment Period|New therapy for study indication|0|||
130283700|NCT02684058|469000552|FG000|Treatment Period|Protocol deviation|0|||
130283701|NCT02684058|469000553|FG001|Treatment Period|Protocol deviation|1|||
130283702|NCT02684058|469000554|FG002|Treatment Period|Protocol deviation|0|||
130283703|NCT02684058|469000552|FG000|Treatment Period|Subject/guardian decision|4|||
130283704|NCT02684058|469000553|FG001|Treatment Period|Subject/guardian decision|3|||
130283705|NCT02684058|469000554|FG002|Treatment Period|Subject/guardian decision|0|||
130283706|NCT02684058|469000552|FG000|Treatment Period|Death|0|||
130283707|NCT02684058|469000553|FG001|Treatment Period|Death|0|||
130283708|NCT02684058|469000554|FG002|Treatment Period|Death|2|||
130283709|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130283710|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130283711|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130283712|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
130283713|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130283714|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
130283715|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130283716|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130457937|NCT01227707|469640013|FG000|Overall Study|Progression of disease|3|||
130711468|NCT00380692|470569849|FG000|Study Period III - Open Label|Protocol Violation|0|||
130711469|NCT00380692|470569850|FG001|Study Period III - Open Label|Protocol Violation|0|||
130711470|NCT00380692|470569849|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
130711471|NCT00380692|470569850|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
130711472|NCT00380692|470569849|FG000|Study Period III - Open Label|Physician Decision|0|||
130711473|NCT00380692|470569850|FG001|Study Period III - Open Label|Physician Decision|3|||
130711474|NCT00380692|470569849|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
130283717|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130283718|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130283719|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130283720|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Death|3|||
130283721|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130283722|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
130283723|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130283724|NCT02684058|469000552|FG000|Post-treatment Survival Follow-up|Death|0|||
130283725|NCT02684058|469000553|FG001|Post-treatment Survival Follow-up|Death|0|||
130711475|NCT00380692|470569850|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
130283726|NCT02684058|469000554|FG002|Post-treatment Survival Follow-up|Death|7|||
130283727|NCT02684058|469000552|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
130283728|NCT02684058|469000553|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130283729|NCT02684058|469000554|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130283730|NCT02684058|469000552|FG000|Crossover Treatment Period|Progressive disease|0|||
130283731|NCT02684058|469000553|FG001|Crossover Treatment Period|Progressive disease|1|||
130283732|NCT02684058|469000554|FG002|Crossover Treatment Period|Progressive disease|0|||
130457938|NCT01227707|469640013|FG000|Overall Study|Withdrawal by Subject|1|||
130457939|NCT01227707|469640013|FG000|Overall Study|Patient non-compliance|3|||
130457940|NCT01227707|469640013|FG000|Overall Study|Medical decision|6|||
130457941|NCT01227707|469640013|FG000|Overall Study|Death|1|||
130457942|NCT05484726|469640016|FG000|Overall Study|Protocol Violation|3|||
130457943|NCT05484726|469640017|FG001|Overall Study|Protocol Violation|3|||
130457944|NCT05484726|469640016|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
130457945|NCT05484726|469640017|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
130457946|NCT05484726|469640016|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
130457947|NCT05484726|469640017|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
130457948|NCT05484726|469640016|FG000|Overall Study|continued need of mechanical ventilation|2|||
130457949|NCT05484726|469640017|FG001|Overall Study|continued need of mechanical ventilation|3|||
130457950|NCT05484726|469640016|FG000|Overall Study|Withdrawal by Subject|2|||
130457951|NCT05484726|469640017|FG001|Overall Study|Withdrawal by Subject|3|||
130457952|NCT05484726|469640016|FG000|Overall Study|IVH (G III & IV)|2|||
130457953|NCT05484726|469640017|FG001|Overall Study|IVH (G III & IV)|1|||
130457954|NCT05484726|469640016|FG000|Overall Study|NEC (stage II & III)|2|||
130457955|NCT05484726|469640017|FG001|Overall Study|NEC (stage II & III)|3|||
130457956|NCT01093534|469640020|FG000|Overall Study|Adverse Event|2|||
130457957|NCT01093534|469640021|FG001|Overall Study|Adverse Event|5|||
130457958|NCT01093534|469640022|FG002|Overall Study|Adverse Event|2|||
130457959|NCT01093534|469640020|FG000|Overall Study|Lack of Efficacy|2|||
130457960|NCT01093534|469640021|FG001|Overall Study|Lack of Efficacy|1|||
130457961|NCT01093534|469640022|FG002|Overall Study|Lack of Efficacy|1|||
130457962|NCT01093534|469640020|FG000|Overall Study|Withdrawal by Subject|5|||
130457963|NCT01093534|469640021|FG001|Overall Study|Withdrawal by Subject|7|||
130457964|NCT01093534|469640022|FG002|Overall Study|Withdrawal by Subject|2|||
130457965|NCT01093534|469640020|FG000|Overall Study|Other|1|||
130457966|NCT01093534|469640021|FG001|Overall Study|Other|3|||
130457967|NCT01093534|469640022|FG002|Overall Study|Other|4|||
130457968|NCT01837641|469640029|FG000|Overall Study|Sponsor decision|1|||
130457969|NCT01837641|469640030|FG001|Overall Study|Sponsor decision|0|||
130457970|NCT01837641|469640031|FG002|Overall Study|Sponsor decision|0|||
130457971|NCT01837641|469640032|FG003|Overall Study|Sponsor decision|0|||
130457972|NCT01837641|469640033|FG004|Overall Study|Sponsor decision|0|||
130457973|NCT01837641|469640034|FG005|Overall Study|Sponsor decision|1|||
130457974|NCT01837641|469640035|FG006|Overall Study|Sponsor decision|0|||
130457975|NCT01837641|469640036|FG007|Overall Study|Sponsor decision|0|||
130457976|NCT01837641|469640029|FG000|Overall Study|Adverse Event|0|||
130457977|NCT01837641|469640030|FG001|Overall Study|Adverse Event|0|||
130457978|NCT01837641|469640031|FG002|Overall Study|Adverse Event|0|||
130457979|NCT01837641|469640032|FG003|Overall Study|Adverse Event|0|||
130457980|NCT01837641|469640033|FG004|Overall Study|Adverse Event|0|||
130457981|NCT01837641|469640034|FG005|Overall Study|Adverse Event|1|||
130457982|NCT01837641|469640035|FG006|Overall Study|Adverse Event|0|||
130457983|NCT01837641|469640036|FG007|Overall Study|Adverse Event|0|||
130457984|NCT01837641|469640029|FG000|Overall Study|Withdrawal by Subject|0|||
130457985|NCT01837641|469640030|FG001|Overall Study|Withdrawal by Subject|0|||
130457986|NCT01837641|469640031|FG002|Overall Study|Withdrawal by Subject|0|||
130457987|NCT01837641|469640032|FG003|Overall Study|Withdrawal by Subject|0|||
130457988|NCT01837641|469640033|FG004|Overall Study|Withdrawal by Subject|1|||
130457989|NCT01837641|469640034|FG005|Overall Study|Withdrawal by Subject|0|||
130457990|NCT01837641|469640035|FG006|Overall Study|Withdrawal by Subject|1|||
130457991|NCT01837641|469640036|FG007|Overall Study|Withdrawal by Subject|0|||
130457992|NCT01769391|469640041|FG000|Overall Study|Death|10|||
130457993|NCT01769391|469640042|FG001|Overall Study|Death|1|||
130457994|NCT01769391|469640041|FG000|Overall Study|Adverse Event|0|||
130457995|NCT01769391|469640042|FG001|Overall Study|Adverse Event|3|||
130457996|NCT01769391|469640041|FG000|Overall Study|Progressive Disease|1|||
130457997|NCT01769391|469640042|FG001|Overall Study|Progressive Disease|2|||
130457998|NCT01769391|469640041|FG000|Overall Study|Withdrawal by Subject|4|||
130457999|NCT01769391|469640042|FG001|Overall Study|Withdrawal by Subject|3|||
130458000|NCT01769391|469640041|FG000|Overall Study|Investigator Decision|2|||
130458001|NCT01769391|469640042|FG001|Overall Study|Investigator Decision|0|||
130458002|NCT02351180|469640045|FG000|Overall Study|Withdrawal by Subject|1|||
130458003|NCT02351180|469640046|FG001|Overall Study|Withdrawal by Subject|0|||
130283733|NCT01730339|469002001|FG000|Overall Study|Withdrawal by Subject|3|||
130458004|NCT01123083|469640047|FG000|Overall Study|Investigator recommendation|1|||
130555333|NCT03694418|470001561|FG004|Overall Study|Lost to Follow-up|13|||
130283734|NCT01730339|469002002|FG001|Overall Study|Withdrawal by Subject|2|||
130283735|NCT01730339|469002001|FG000|Overall Study|Lost to Follow-up|1|||
130283736|NCT01730339|469002002|FG001|Overall Study|Lost to Follow-up|1|||
130283737|NCT01730339|469002001|FG000|Overall Study|Un-specified|1|||
130283738|NCT01730339|469002002|FG001|Overall Study|Un-specified|0|||
130283739|NCT03095027|469002003|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
130283740|NCT03095027|469002004|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
130283741|NCT04143217|469002005|FG000|Overall Study|Withdrawal by Subject|42|||
130283742|NCT04143217|469002005|FG000|Overall Study|Adverse Event|29|||
130283743|NCT04143217|469002005|FG000|Overall Study|Lost to Follow-up|29|||
130283744|NCT04143217|469002005|FG000|Overall Study|Lack of Efficacy|15|||
130283745|NCT04143217|469002005|FG000|Overall Study|Physician Decision|1|||
130283746|NCT04143217|469002005|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130283747|NCT04143217|469002005|FG000|Overall Study|Other, Multiple Categories|11|||
130283748|NCT01962987|469002008|FG000|Overall Study|Adverse Event|4|||
130283749|NCT01962987|469002009|FG001|Overall Study|Adverse Event|4|||
130283750|NCT01962987|469002010|FG002|Overall Study|Adverse Event|0|||
130283751|NCT01962987|469002008|FG000|Overall Study|Lost to Follow-up|0|||
130283752|NCT01962987|469002009|FG001|Overall Study|Lost to Follow-up|0|||
130283753|NCT01962987|469002010|FG002|Overall Study|Lost to Follow-up|1|||
130283754|NCT01962987|469002008|FG000|Overall Study|Non compliance with dosing requirements|4|||
130283755|NCT01962987|469002009|FG001|Overall Study|Non compliance with dosing requirements|2|||
130283756|NCT01962987|469002010|FG002|Overall Study|Non compliance with dosing requirements|0|||
130283757|NCT01962987|469002008|FG000|Overall Study|Miscellaneous|1|||
130283758|NCT01962987|469002009|FG001|Overall Study|Miscellaneous|9|||
130283759|NCT01962987|469002010|FG002|Overall Study|Miscellaneous|2|||
130283760|NCT01962987|469002008|FG000|Overall Study|Restricted medication|5|||
130283761|NCT01962987|469002009|FG001|Overall Study|Restricted medication|1|||
130283762|NCT01962987|469002010|FG002|Overall Study|Restricted medication|1|||
130283763|NCT01962987|469002008|FG000|Overall Study|Serious Adverse Event|1|||
130283764|NCT01962987|469002009|FG001|Overall Study|Serious Adverse Event|0|||
130283765|NCT01962987|469002010|FG002|Overall Study|Serious Adverse Event|0|||
130283766|NCT01962987|469002008|FG000|Overall Study|Withdrawal by Subject|11|||
130283767|NCT01962987|469002009|FG001|Overall Study|Withdrawal by Subject|10|||
130283768|NCT01962987|469002010|FG002|Overall Study|Withdrawal by Subject|6|||
130283769|NCT01962987|469002008|FG000|Overall Study|Randomized in Error|4|||
130283770|NCT01962987|469002009|FG001|Overall Study|Randomized in Error|2|||
130283771|NCT01962987|469002010|FG002|Overall Study|Randomized in Error|2|||
130283772|NCT00347438|469002013|FG000|Overall Study|Withdrawal by Subject|1|||
130283773|NCT00347438|469002013|FG000|Overall Study|Physician Decision|1|||
130283774|NCT00322023|469002014|FG000|Overall Study|various|0|||
130283775|NCT00322023|469002015|FG001|Overall Study|various|2|||
130283776|NCT00322023|469002016|FG002|Overall Study|various|6|||
130283777|NCT00523705|469002017|FG000|Overall Study|No time for study.|0|||
130283778|NCT00523705|469002018|FG001|Overall Study|No time for study.|1|||
130283779|NCT00693017|469002019|FG000|Overall Study|Sponsor Decision|2|||
130283780|NCT00693017|469002020|FG001|Overall Study|Sponsor Decision|1|||
130283781|NCT00693017|469002019|FG000|Overall Study|Death|0|||
130283782|NCT00693017|469002020|FG001|Overall Study|Death|1|||
130283783|NCT00113399|469002032|FG000|Overall Study|Death|1|||
130283784|NCT00113399|469002033|FG001|Overall Study|Death|1|||
130283785|NCT00113399|469002032|FG000|Overall Study|Withdrawal by Subject|1|||
130283786|NCT00113399|469002033|FG001|Overall Study|Withdrawal by Subject|2|||
130283787|NCT00113399|469002032|FG000|Overall Study|Complete Response|0|||
130283788|NCT00113399|469002033|FG001|Overall Study|Complete Response|1|||
130283789|NCT00113399|469002032|FG000|Overall Study|Other|0|||
130283790|NCT00113399|469002033|FG001|Overall Study|Other|1|||
130283791|NCT01779856|469002035|FG000|Overall Study|Withdrawal by Subject|15|||
130283792|NCT01779856|469002035|FG000|Overall Study|Death|3|||
130283793|NCT01779856|469002035|FG000|Overall Study|Physician Decision|1|||
130283794|NCT01779856|469002035|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
130283795|NCT01779856|469002035|FG000|Overall Study|Delays in scheduling implant|1|||
130283796|NCT01779856|469002035|FG000|Overall Study|Subject ineligible for Implant|2|||
130283797|NCT01535599|469002036|FG000|Overall Study|Adverse Event|6|||
130283798|NCT01535599|469002037|FG001|Overall Study|Adverse Event|15|||
130283799|NCT01535599|469002036|FG000|Overall Study|Lost to Follow-up|3|||
130283800|NCT01535599|469002037|FG001|Overall Study|Lost to Follow-up|4|||
130283801|NCT01535599|469002036|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
130283802|NCT01535599|469002037|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
130283803|NCT01535599|469002036|FG000|Overall Study|Treatment Failure|33|||
130283804|NCT01535599|469002037|FG001|Overall Study|Treatment Failure|66|||
130283805|NCT01535599|469002036|FG000|Overall Study|BL Culture + for Group A Strep|0|||
130283806|NCT01535599|469002037|FG001|Overall Study|BL Culture + for Group A Strep|1|||
130283807|NCT01535599|469002036|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
130283808|NCT01535599|469002037|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
130283809|NCT01535599|469002036|FG000|Overall Study|Randomized in Error|2|||
130283810|NCT01535599|469002037|FG001|Overall Study|Randomized in Error|4|||
130283811|NCT01535599|469002036|FG000|Overall Study|Did not use product|1|||
130283812|NCT01535599|469002037|FG001|Overall Study|Did not use product|0|||
130283813|NCT01535599|469002036|FG000|Overall Study|Other|1|||
130283814|NCT01535599|469002037|FG001|Overall Study|Other|0|||
130283815|NCT01535599|469002036|FG000|Overall Study|Stopped medication|0|||
130283816|NCT01535599|469002037|FG001|Overall Study|Stopped medication|1|||
130283817|NCT01535599|469002036|FG000|Overall Study|Noncompliance|0|||
130283818|NCT01535599|469002037|FG001|Overall Study|Noncompliance|1|||
130283819|NCT04043234|469002038|FG000|Overall Study|Lost to Follow-up|1|||
130283820|NCT04043234|469002038|FG000|Overall Study|Withdrawal by Subject|1|||
130283821|NCT01165320|469002039|FG000|Overall Study|Clinical adverse experience|2|||
130283822|NCT01165320|469002040|FG001|Overall Study|Clinical adverse experience|1|||
130283823|NCT01165320|469002041|FG002|Overall Study|Clinical adverse experience|0|||
130283824|NCT01165320|469002039|FG000|Overall Study|Laboratory adverse experience|1|||
130283825|NCT01165320|469002040|FG001|Overall Study|Laboratory adverse experience|0|||
130283826|NCT01165320|469002041|FG002|Overall Study|Laboratory adverse experience|0|||
130283827|NCT01165320|469002039|FG000|Overall Study|Lack of Efficacy|0|||
130283828|NCT01165320|469002040|FG001|Overall Study|Lack of Efficacy|2|||
130283829|NCT01165320|469002041|FG002|Overall Study|Lack of Efficacy|0|||
130283830|NCT01165320|469002039|FG000|Overall Study|Reason unknown|0|||
130283831|NCT01165320|469002040|FG001|Overall Study|Reason unknown|1|||
130283832|NCT01165320|469002041|FG002|Overall Study|Reason unknown|0|||
130283833|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Physician Decision|1|||
130283834|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Physician Decision|0|||
130283835|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Physician Decision|0|||
130283836|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130283837|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
130283838|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130283839|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
130283840|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130283841|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130283842|NCT00385944|469002045|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
130283843|NCT00385944|469002046|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
130283844|NCT00385944|469002047|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
130283845|NCT01155466|469002048|FG000|Overall Study|Adverse Event|13|||
130283846|NCT01155466|469002049|FG001|Overall Study|Adverse Event|15|||
130283847|NCT01155466|469002050|FG002|Overall Study|Adverse Event|6|||
130283848|NCT01155466|469002051|FG003|Overall Study|Adverse Event|17|||
130283849|NCT01155466|469002052|FG004|Overall Study|Adverse Event|18|||
130283850|NCT01155466|469002048|FG000|Overall Study|Lost to Follow-up|0|||
130283851|NCT01155466|469002049|FG001|Overall Study|Lost to Follow-up|0|||
130369406|NCT00612690|469323097|FG001|Overall Study|Withdrawal by Subject|20|||
130369407|NCT00612690|469323096|FG000|Overall Study|Withdrawal by Site|11|||
130283852|NCT01155466|469002050|FG002|Overall Study|Lost to Follow-up|0|||
130283853|NCT01155466|469002051|FG003|Overall Study|Lost to Follow-up|0|||
130283854|NCT01155466|469002052|FG004|Overall Study|Lost to Follow-up|2|||
130711476|NCT00380692|470569849|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130711477|NCT00380692|470569850|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130711478|NCT02177136|470569856|FG000|DB Phase|Withdrawal by Subject|2|||
130711479|NCT02177136|470569857|FG001|DB Phase|Withdrawal by Subject|0|||
130711480|NCT02177136|470569858|FG002|DB Phase|Withdrawal by Subject|0|||
130711481|NCT02177136|470569859|FG003|DB Phase|Withdrawal by Subject|0|||
130711482|NCT02177136|470569856|FG000|DB Phase|Discontinued Due to Pruritus|1|||
130283855|NCT01155466|469002048|FG000|Overall Study|Withdrawal by Subject|7|||
130283856|NCT01155466|469002049|FG001|Overall Study|Withdrawal by Subject|5|||
130283857|NCT01155466|469002050|FG002|Overall Study|Withdrawal by Subject|9|||
130283858|NCT01155466|469002051|FG003|Overall Study|Withdrawal by Subject|4|||
130283859|NCT01155466|469002052|FG004|Overall Study|Withdrawal by Subject|4|||
130283860|NCT01155466|469002048|FG000|Overall Study|Protocol Violation|0|||
130283861|NCT01155466|469002049|FG001|Overall Study|Protocol Violation|0|||
130711483|NCT02177136|470569857|FG001|DB Phase|Discontinued Due to Pruritus|3|||
130711484|NCT02177136|470569858|FG002|DB Phase|Discontinued Due to Pruritus|0|||
130283862|NCT01155466|469002050|FG002|Overall Study|Protocol Violation|2|||
130283863|NCT01155466|469002051|FG003|Overall Study|Protocol Violation|0|||
130283864|NCT01155466|469002052|FG004|Overall Study|Protocol Violation|1|||
130283865|NCT01155466|469002048|FG000|Overall Study|Administrative|0|||
130283866|NCT01155466|469002049|FG001|Overall Study|Administrative|3|||
130283867|NCT01155466|469002050|FG002|Overall Study|Administrative|0|||
130283868|NCT01155466|469002051|FG003|Overall Study|Administrative|0|||
130283869|NCT01155466|469002052|FG004|Overall Study|Administrative|0|||
130283870|NCT01155466|469002048|FG000|Overall Study|Randomized not treated|2|||
130283871|NCT01155466|469002049|FG001|Overall Study|Randomized not treated|2|||
130283872|NCT01155466|469002050|FG002|Overall Study|Randomized not treated|3|||
130283873|NCT01155466|469002051|FG003|Overall Study|Randomized not treated|0|||
130283874|NCT01155466|469002052|FG004|Overall Study|Randomized not treated|2|||
130283875|NCT00590824|469002053|FG000|Overall Study|Disease could not be resected|0|||
130283876|NCT00590824|469002054|FG001|Overall Study|Disease could not be resected|2|||
130283877|NCT00590824|469002055|FG002|Overall Study|Disease could not be resected|1|||
130283878|NCT00590824|469002056|FG003|Overall Study|Disease could not be resected|0|||
130283879|NCT00590824|469002053|FG000|Overall Study|Adverse Event|0|||
130283880|NCT00590824|469002054|FG001|Overall Study|Adverse Event|0|||
130283881|NCT00590824|469002055|FG002|Overall Study|Adverse Event|0|||
130283882|NCT00590824|469002056|FG003|Overall Study|Adverse Event|1|||
130283883|NCT00791479|469002062|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283884|NCT00791479|469002063|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283885|NCT00791479|469002064|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283886|NCT00791479|469002065|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283887|NCT00791479|469002066|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
130283888|NCT00791479|469002067|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283889|NCT00791479|469002062|FG000|Overall Study|Adverse Event|0|||
130283890|NCT00791479|469002063|FG001|Overall Study|Adverse Event|1|||
130283891|NCT00791479|469002064|FG002|Overall Study|Adverse Event|0|||
130283892|NCT00791479|469002065|FG003|Overall Study|Adverse Event|2|||
130283893|NCT00791479|469002066|FG004|Overall Study|Adverse Event|0|||
130283894|NCT00791479|469002067|FG005|Overall Study|Adverse Event|1|||
130283895|NCT00791479|469002062|FG000|Overall Study|Lost to Follow-up|0|||
130283896|NCT00791479|469002063|FG001|Overall Study|Lost to Follow-up|1|||
130283897|NCT00791479|469002064|FG002|Overall Study|Lost to Follow-up|0|||
130283898|NCT00791479|469002065|FG003|Overall Study|Lost to Follow-up|0|||
130283899|NCT00791479|469002066|FG004|Overall Study|Lost to Follow-up|0|||
130283900|NCT00791479|469002067|FG005|Overall Study|Lost to Follow-up|1|||
130283901|NCT00791479|469002062|FG000|Overall Study|Protocol Violation|2|||
130283902|NCT00791479|469002063|FG001|Overall Study|Protocol Violation|1|||
130283903|NCT00791479|469002064|FG002|Overall Study|Protocol Violation|0|||
130283904|NCT00791479|469002065|FG003|Overall Study|Protocol Violation|1|||
130283905|NCT00791479|469002066|FG004|Overall Study|Protocol Violation|0|||
130283906|NCT00791479|469002067|FG005|Overall Study|Protocol Violation|0|||
130283907|NCT00791479|469002062|FG000|Overall Study|Withdrawal by Subject|0|||
130283908|NCT00791479|469002063|FG001|Overall Study|Withdrawal by Subject|0|||
130283909|NCT00791479|469002064|FG002|Overall Study|Withdrawal by Subject|0|||
130283910|NCT00791479|469002065|FG003|Overall Study|Withdrawal by Subject|1|||
130283911|NCT00791479|469002066|FG004|Overall Study|Withdrawal by Subject|0|||
130283912|NCT00791479|469002067|FG005|Overall Study|Withdrawal by Subject|1|||
130283913|NCT01778049|469002068|FG000|Open Label Treatment Period|Adverse Event|5|||
130283914|NCT01778049|469002069|FG001|Open Label Treatment Period|Adverse Event|15|||
130283915|NCT01778049|469002070|FG002|Open Label Treatment Period|Adverse Event|0|||
130458005|NCT01123083|469640048|FG001|Overall Study|Investigator recommendation|1|||
130458006|NCT01123083|469640047|FG000|Overall Study|Administrative reasons|0|||
130458007|NCT01123083|469640048|FG001|Overall Study|Administrative reasons|4|||
130711485|NCT02177136|470569859|FG003|DB Phase|Discontinued Due to Pruritus|0|||
130711486|NCT02177136|470569856|FG000|DB Phase|Adverse Event|3|||
130711487|NCT02177136|470569857|FG001|DB Phase|Adverse Event|2|||
130711488|NCT02177136|470569858|FG002|DB Phase|Adverse Event|3|||
130283916|NCT01778049|469002071|FG003|Open Label Treatment Period|Adverse Event|0|||
130283917|NCT01778049|469002072|FG004|Open Label Treatment Period|Adverse Event|0|||
130283918|NCT01778049|469002073|FG005|Open Label Treatment Period|Adverse Event|0|||
130283919|NCT01778049|469002068|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
130283920|NCT01778049|469002069|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
130283921|NCT01778049|469002070|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130283922|NCT01778049|469002071|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130283923|NCT01778049|469002072|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
130283924|NCT01778049|469002073|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
130711489|NCT02177136|470569859|FG003|DB Phase|Adverse Event|0|||
130711490|NCT02177136|470569856|FG000|DB Phase|Protocol Violation|0|||
130283925|NCT01778049|469002068|FG000|Open Label Treatment Period|Protocol Violation|5|||
130283926|NCT01778049|469002069|FG001|Open Label Treatment Period|Protocol Violation|5|||
130283927|NCT01778049|469002070|FG002|Open Label Treatment Period|Protocol Violation|0|||
130711491|NCT02177136|470569857|FG001|DB Phase|Protocol Violation|0|||
130283928|NCT01778049|469002071|FG003|Open Label Treatment Period|Protocol Violation|0|||
130283929|NCT01778049|469002072|FG004|Open Label Treatment Period|Protocol Violation|0|||
130283930|NCT01778049|469002073|FG005|Open Label Treatment Period|Protocol Violation|0|||
130283931|NCT01778049|469002068|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
130283932|NCT01778049|469002069|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
130283933|NCT01778049|469002070|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130283934|NCT01778049|469002071|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130283935|NCT01778049|469002072|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
130283936|NCT01778049|469002073|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
130283937|NCT01778049|469002068|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
130283938|NCT01778049|469002069|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
130283939|NCT01778049|469002070|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130283940|NCT01778049|469002071|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130283941|NCT01778049|469002072|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
130283942|NCT01778049|469002073|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
130283943|NCT01778049|469002068|FG000|Open Label Treatment Period|Not treated|2|||
130283944|NCT01778049|469002069|FG001|Open Label Treatment Period|Not treated|1|||
130283945|NCT01778049|469002070|FG002|Open Label Treatment Period|Not treated|0|||
130283946|NCT01778049|469002071|FG003|Open Label Treatment Period|Not treated|0|||
130283947|NCT01778049|469002072|FG004|Open Label Treatment Period|Not treated|0|||
130283948|NCT01778049|469002073|FG005|Open Label Treatment Period|Not treated|0|||
130283949|NCT01778049|469002068|FG000|Open Label Treatment Period|Other reason not defined above|77|||
130283950|NCT01778049|469002069|FG001|Open Label Treatment Period|Other reason not defined above|94|||
130283951|NCT01778049|469002070|FG002|Open Label Treatment Period|Other reason not defined above|0|||
130283952|NCT01778049|469002071|FG003|Open Label Treatment Period|Other reason not defined above|0|||
130283953|NCT01778049|469002072|FG004|Open Label Treatment Period|Other reason not defined above|0|||
130283954|NCT01778049|469002073|FG005|Open Label Treatment Period|Other reason not defined above|0|||
130283955|NCT01778049|469002068|FG000|Double Blind Treatment Period|Adverse Event|0|||
130283956|NCT01778049|469002069|FG001|Double Blind Treatment Period|Adverse Event|0|||
130283957|NCT01778049|469002070|FG002|Double Blind Treatment Period|Adverse Event|4|||
130283958|NCT01778049|469002071|FG003|Double Blind Treatment Period|Adverse Event|5|||
130283959|NCT01778049|469002072|FG004|Double Blind Treatment Period|Adverse Event|3|||
130283960|NCT01778049|469002073|FG005|Double Blind Treatment Period|Adverse Event|2|||
130283961|NCT01778049|469002068|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
130283962|NCT01778049|469002069|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130283963|NCT01778049|469002070|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130283964|NCT01778049|469002071|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130283965|NCT01778049|469002072|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130283966|NCT01778049|469002073|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
130283967|NCT01778049|469002068|FG000|Double Blind Treatment Period|Protocol Violation|0|||
130283968|NCT01778049|469002069|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130283969|NCT01778049|469002070|FG002|Double Blind Treatment Period|Protocol Violation|2|||
130283970|NCT01778049|469002071|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130283971|NCT01778049|469002072|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130283972|NCT01778049|469002073|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130283973|NCT01778049|469002068|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130283974|NCT01778049|469002069|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130283975|NCT01778049|469002070|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
130283976|NCT01778049|469002071|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
130283977|NCT01778049|469002072|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
130283978|NCT01778049|469002073|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
130283979|NCT01778049|469002068|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283980|NCT01778049|469002069|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283981|NCT01778049|469002070|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
130283982|NCT01778049|469002071|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
130283983|NCT01778049|469002072|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283984|NCT01778049|469002073|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
130283985|NCT01778049|469002068|FG000|Double Blind Treatment Period|Not treated|0|||
130283986|NCT01778049|469002069|FG001|Double Blind Treatment Period|Not treated|0|||
130283987|NCT01778049|469002070|FG002|Double Blind Treatment Period|Not treated|0|||
130283988|NCT01778049|469002071|FG003|Double Blind Treatment Period|Not treated|2|||
130283989|NCT01778049|469002072|FG004|Double Blind Treatment Period|Not treated|2|||
130283990|NCT01778049|469002073|FG005|Double Blind Treatment Period|Not treated|0|||
130283991|NCT01778049|469002068|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
130283992|NCT01778049|469002069|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
130283993|NCT01778049|469002070|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
130283994|NCT01778049|469002071|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
130283995|NCT01778049|469002072|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
130283996|NCT01778049|469002073|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
130711492|NCT02177136|470569858|FG002|DB Phase|Protocol Violation|1|||
130711493|NCT02177136|470569859|FG003|DB Phase|Protocol Violation|0|||
130283997|NCT03773133|469002074|FG000|Overall Study|Screen Failure|8|||
130283998|NCT00107315|469002078|FG000|Overall Study|Disease Progression|9|||
130283999|NCT00107315|469002078|FG000|Overall Study|Adverse Event|4|||
130284000|NCT00107315|469002078|FG000|Overall Study|Withdrawal by Subject|2|||
130284001|NCT02509039|469002081|FG000|Overall Study|Adverse Event|0|||
130284002|NCT02509039|469002082|FG001|Overall Study|Adverse Event|1|||
130284003|NCT02509039|469002083|FG002|Overall Study|Adverse Event|1|||
130284004|NCT02509039|469002084|FG003|Overall Study|Adverse Event|1|||
130284005|NCT02509039|469002081|FG000|Overall Study|Withdrawal by Subject|0|||
130284006|NCT02509039|469002082|FG001|Overall Study|Withdrawal by Subject|0|||
130284007|NCT02509039|469002083|FG002|Overall Study|Withdrawal by Subject|1|||
130284008|NCT02509039|469002084|FG003|Overall Study|Withdrawal by Subject|0|||
130284009|NCT02509039|469002081|FG000|Overall Study|Progressive disease|2|||
130284010|NCT02509039|469002082|FG001|Overall Study|Progressive disease|2|||
130284011|NCT02509039|469002083|FG002|Overall Study|Progressive disease|1|||
130284012|NCT02509039|469002084|FG003|Overall Study|Progressive disease|5|||
130284013|NCT02509039|469002081|FG000|Overall Study|Study terminated by Sponsor|1|||
130555334|NCT02310672|470001562|FG000|Overall Study|Death|1|||
130284014|NCT02509039|469002082|FG001|Overall Study|Study terminated by Sponsor|0|||
130284015|NCT02509039|469002083|FG002|Overall Study|Study terminated by Sponsor|0|||
130284016|NCT02509039|469002084|FG003|Overall Study|Study terminated by Sponsor|0|||
130555335|NCT02310672|470001562|FG000|Overall Study|Lost to Follow-up|1|||
130711494|NCT02177136|470569856|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
130711495|NCT02177136|470569857|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711496|NCT02177136|470569858|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711497|NCT02177136|470569859|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711498|NCT02177136|470569856|FG000|LTSE Phase|Withdrawal by Subject|0|||
130711499|NCT02177136|470569857|FG001|LTSE Phase|Withdrawal by Subject|0|||
130711500|NCT02177136|470569858|FG002|LTSE Phase|Withdrawal by Subject|0|||
130711501|NCT02177136|470569859|FG003|LTSE Phase|Withdrawal by Subject|6|||
130711502|NCT02177136|470569856|FG000|LTSE Phase|Adverse Event|0|||
130284017|NCT03136497|469002085|FG000|Overall Study|Screen Failure|1|||
130284018|NCT03136497|469002086|FG001|Overall Study|Screen Failure|0|||
130284019|NCT03136497|469002087|FG002|Overall Study|Screen Failure|0|||
130284020|NCT00543296|469002088|FG000|Overall Study|Physician Decision|7|||
130284021|NCT00557310|469002089|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
130284022|NCT00557310|469002089|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
130369408|NCT00612690|469323097|FG001|Overall Study|Withdrawal by Site|0|||
130369409|NCT02980601|469323098|FG000|Overall Study|Lost to Follow-up|2|||
130369410|NCT02980601|469323099|FG001|Overall Study|Lost to Follow-up|2|||
130369411|NCT02980601|469323098|FG000|Overall Study|Death|0|||
130369412|NCT02980601|469323099|FG001|Overall Study|Death|1|||
130369413|NCT02980601|469323098|FG000|Overall Study|Graft loss|1|||
130369414|NCT02980601|469323099|FG001|Overall Study|Graft loss|0|||
130369415|NCT02980601|469323098|FG000|Overall Study|Failed to sign consent|2|||
130369416|NCT02980601|469323099|FG001|Overall Study|Failed to sign consent|0|||
130369417|NCT01575769|469323100|FG000|Overall Study|Adverse Event|1|||
130369418|NCT01575769|469323100|FG000|Overall Study|Study terminated by sponsor|40|||
130369419|NCT00844831|469323101|FG000|Overall Study|Withdrawal by Subject|4|||
130369420|NCT00844831|469323101|FG000|Overall Study|Adverse Event|1|||
130369421|NCT00844831|469323101|FG000|Overall Study|Physician Decision|1|||
130369422|NCT01581931|469323109|FG000|Washout|Adverse Event|0|||
130369423|NCT01581931|469323110|FG001|Washout|Adverse Event|1|||
130369424|NCT03156543|469323111|FG000|Overall Study|Withdrawal by Subject|1|||
130369425|NCT03156543|469323112|FG001|Overall Study|Withdrawal by Subject|0|||
130369426|NCT00674700|469323113|FG000|Year 1|Adverse Event|17|||
130369427|NCT00674700|469323114|FG001|Year 1|Adverse Event|20|||
130369428|NCT00674700|469323115|FG002|Year 1|Adverse Event|5|||
130369429|NCT00674700|469323113|FG000|Year 1|Withdrawal by Subject|7|||
130369430|NCT00674700|469323114|FG001|Year 1|Withdrawal by Subject|7|||
130369431|NCT00674700|469323115|FG002|Year 1|Withdrawal by Subject|6|||
130369432|NCT00674700|469323113|FG000|Year 1|Any other reason not above-mentioned|7|||
130369433|NCT00674700|469323114|FG001|Year 1|Any other reason not above-mentioned|7|||
130369434|NCT00674700|469323115|FG002|Year 1|Any other reason not above-mentioned|6|||
130555336|NCT02310672|470001562|FG000|Overall Study|Withdrawal by Subject|1|||
130711503|NCT02177136|470569857|FG001|LTSE Phase|Adverse Event|0|||
130711504|NCT02177136|470569858|FG002|LTSE Phase|Adverse Event|0|||
130711505|NCT02177136|470569859|FG003|LTSE Phase|Adverse Event|10|||
130284023|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
130369435|NCT00674700|469323113|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
130369436|NCT00674700|469323114|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
130711506|NCT02177136|470569856|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
130369437|NCT00674700|469323115|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
130369438|NCT00674700|469323113|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
130711507|NCT02177136|470569857|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
130711508|NCT02177136|470569858|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
130711509|NCT02177136|470569859|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
130284024|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
130284025|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
130284026|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
130284027|NCT03276026|469002092|FG000|Overall Study|Protocol Violation|1|||
130284028|NCT03276026|469002093|FG001|Overall Study|Protocol Violation|0|||
130711510|NCT02177136|470569856|FG000|LTSE Phase|Physician Decision|0|||
130711511|NCT02177136|470569857|FG001|LTSE Phase|Physician Decision|0|||
130711512|NCT02177136|470569858|FG002|LTSE Phase|Physician Decision|0|||
130711513|NCT02177136|470569859|FG003|LTSE Phase|Physician Decision|2|||
130284029|NCT04049266|469002097|FG000|Overall Study|Adverse Event|16|||
130284030|NCT04049266|469002098|FG001|Overall Study|Adverse Event|9|||
130284031|NCT04049266|469002097|FG000|Overall Study|Non-compliance with study drug|0|||
130284032|NCT04049266|469002098|FG001|Overall Study|Non-compliance with study drug|3|||
130284033|NCT04049266|469002097|FG000|Overall Study|Withdrawal by Subject|6|||
130284034|NCT04049266|469002098|FG001|Overall Study|Withdrawal by Subject|10|||
130284035|NCT04049266|469002097|FG000|Overall Study|Lost to Follow-up|2|||
130284036|NCT04049266|469002098|FG001|Overall Study|Lost to Follow-up|2|||
130284037|NCT04049266|469002097|FG000|Overall Study|Progressive disease|11|||
130284038|NCT04049266|469002098|FG001|Overall Study|Progressive disease|2|||
130284039|NCT04049266|469002097|FG000|Overall Study|Physician Decision|1|||
130284040|NCT04049266|469002098|FG001|Overall Study|Physician Decision|0|||
130284041|NCT04049266|469002097|FG000|Overall Study|Patient moved out of state|1|||
130284042|NCT04049266|469002098|FG001|Overall Study|Patient moved out of state|0|||
130284043|NCT01703208|469002099|FG000|Overall Study|Death|61|||
130284044|NCT01703208|469002100|FG001|Overall Study|Death|48|||
130284045|NCT01703208|469002099|FG000|Overall Study|Lack of Efficacy|1|||
130284046|NCT01703208|469002100|FG001|Overall Study|Lack of Efficacy|2|||
130284047|NCT01703208|469002099|FG000|Overall Study|Lost to Follow-up|68|||
130284048|NCT01703208|469002100|FG001|Overall Study|Lost to Follow-up|62|||
130284049|NCT01703208|469002099|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130284050|NCT01703208|469002100|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130284051|NCT01703208|469002099|FG000|Overall Study|Excluded Medication|1|||
130284052|NCT01703208|469002100|FG001|Overall Study|Excluded Medication|2|||
130284053|NCT01703208|469002099|FG000|Overall Study|Site Discontinued Study Participation|23|||
130284054|NCT01703208|469002100|FG001|Overall Study|Site Discontinued Study Participation|27|||
130284055|NCT01703208|469002099|FG000|Overall Study|Physician Decision|11|||
130284056|NCT01703208|469002100|FG001|Overall Study|Physician Decision|13|||
130284057|NCT01703208|469002099|FG000|Overall Study|Progressive disease|2|||
130284058|NCT01703208|469002100|FG001|Overall Study|Progressive disease|2|||
130284059|NCT01703208|469002099|FG000|Overall Study|Protocol Violation|1|||
130284060|NCT01703208|469002100|FG001|Overall Study|Protocol Violation|1|||
130284061|NCT01703208|469002099|FG000|Overall Study|Study Terminated by Sponsor|1710|||
130284062|NCT01703208|469002100|FG001|Overall Study|Study Terminated by Sponsor|1716|||
130284063|NCT01703208|469002099|FG000|Overall Study|Withdrawal by Subject|205|||
130284064|NCT01703208|469002100|FG001|Overall Study|Withdrawal by Subject|209|||
130284065|NCT01703208|469002099|FG000|Overall Study|Adverse Event|14|||
130284066|NCT01703208|469002100|FG001|Overall Study|Adverse Event|19|||
130284067|NCT01703208|469002099|FG000|Overall Study|Technical Problems|0|||
130284068|NCT01703208|469002100|FG001|Overall Study|Technical Problems|1|||
130284069|NCT01703208|469002099|FG000|Overall Study|Protocol Deviation|2|||
130284070|NCT01703208|469002100|FG001|Overall Study|Protocol Deviation|0|||
130284071|NCT00367744|469002104|FG000|Overall Study|Lost to Follow-up|4|||
130284072|NCT00367744|469002105|FG001|Overall Study|Lost to Follow-up|5|||
130284073|NCT04003207|469002112|FG000|Overall Study|Protocol Violation|1|||
130284074|NCT03941964|469002119|FG000|Overall Study|Adverse Event|1|||
130284075|NCT03941964|469002120|FG001|Overall Study|Adverse Event|8|||
130284076|NCT03941964|469002119|FG000|Overall Study|Progressive disease|7|||
130284077|NCT03941964|469002120|FG001|Overall Study|Progressive disease|3|||
130284078|NCT03941964|469002119|FG000|Overall Study|Lack of Efficacy|0|||
130284079|NCT03941964|469002120|FG001|Overall Study|Lack of Efficacy|1|||
130284080|NCT03941964|469002119|FG000|Overall Study|Death|3|||
130284081|NCT03941964|469002120|FG001|Overall Study|Death|1|||
130711514|NCT02177136|470569856|FG000|LTSE Phase|Lost to Follow-up|0|||
130711515|NCT02177136|470569857|FG001|LTSE Phase|Lost to Follow-up|0|||
130284082|NCT03941964|469002119|FG000|Overall Study|Withdrew consent|1|||
130284083|NCT03941964|469002120|FG001|Overall Study|Withdrew consent|3|||
130284084|NCT03941964|469002119|FG000|Overall Study|Physician Decision|9|||
130284085|NCT03941964|469002120|FG001|Overall Study|Physician Decision|2|||
130284086|NCT03941964|469002119|FG000|Overall Study|Other, not specified|2|||
130284087|NCT03941964|469002120|FG001|Overall Study|Other, not specified|1|||
130284088|NCT02298179|469002121|FG000|Overall Study|Lost to Follow-up|0|||
130284089|NCT02298179|469002122|FG001|Overall Study|Lost to Follow-up|0|||
130284090|NCT02298179|469002123|FG002|Overall Study|Lost to Follow-up|1|||
130284091|NCT02298179|469002124|FG003|Overall Study|Lost to Follow-up|0|||
130284092|NCT02298179|469002125|FG004|Overall Study|Lost to Follow-up|0|||
130284093|NCT02298179|469002126|FG005|Overall Study|Lost to Follow-up|0|||
130284094|NCT02298179|469002127|FG006|Overall Study|Lost to Follow-up|0|||
130711516|NCT02177136|470569858|FG002|LTSE Phase|Lost to Follow-up|0|||
130711517|NCT02177136|470569859|FG003|LTSE Phase|Lost to Follow-up|1|||
130284095|NCT02298179|469002128|FG007|Overall Study|Lost to Follow-up|1|||
130284096|NCT02298179|469002129|FG008|Overall Study|Lost to Follow-up|0|||
130284097|NCT02298179|469002130|FG009|Overall Study|Lost to Follow-up|0|||
130284098|NCT02298179|469002131|FG010|Overall Study|Lost to Follow-up|0|||
130284099|NCT02298179|469002132|FG011|Overall Study|Lost to Follow-up|0|||
130284100|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
130284101|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
130284102|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Death|0|||
130284103|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Death|0|||
130284104|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130284105|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130284106|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
130284107|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
130284108|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
130284109|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
130284110|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
130284111|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
130284112|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
130284113|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
130284114|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130284115|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130284116|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
130284117|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
130284118|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
130284119|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
130284120|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
130284121|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
130284122|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
130284123|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
130284124|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
130284125|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
130284126|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
130284127|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
130284128|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
130284129|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
130284130|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
130284131|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
130284132|NCT02226198|469003980|FG000|Lead-in Phase|Protocol Violation|1|||
130284133|NCT02226198|469003981|FG001|Lead-in Phase|Protocol Violation|0|||
130284134|NCT02226198|469003982|FG002|Lead-in Phase|Protocol Violation|0|||
130284135|NCT02226198|469003980|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130284136|NCT02226198|469003981|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
130284137|NCT02226198|469003982|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130284138|NCT01440517|469003984|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
130284139|NCT01288612|469003986|FG000|Overall Study|Unable to contact|11|||
130284140|NCT01288612|469003987|FG001|Overall Study|Unable to contact|16|||
130284141|NCT01288612|469003988|FG002|Overall Study|Unable to contact|20|||
130284142|NCT01288612|469003986|FG000|Overall Study|Declined|78|||
130284143|NCT01288612|469003987|FG001|Overall Study|Declined|63|||
130284144|NCT01288612|469003988|FG002|Overall Study|Declined|62|||
130284145|NCT01288612|469003986|FG000|Overall Study|Unable to intubate|0|||
130284146|NCT01288612|469003987|FG001|Overall Study|Unable to intubate|3|||
130284147|NCT01288612|469003988|FG002|Overall Study|Unable to intubate|0|||
130284148|NCT05599451|469003989|FG000|Overall Study|Not randomized|11|||
130284149|NCT05599451|469003990|FG001|Overall Study|Not randomized|0|||
130284150|NCT05599451|469003991|FG002|Overall Study|Not randomized|0|||
130284151|NCT05599451|469003992|FG003|Overall Study|Not randomized|0|||
130284152|NCT05599451|469003993|FG004|Overall Study|Not randomized|0|||
130284153|NCT05599451|469003989|FG000|Overall Study|Physician Decision|0|||
130284154|NCT05599451|469003990|FG001|Overall Study|Physician Decision|0|||
130711518|NCT02177136|470569856|FG000|LTSE Phase|Participant Moved|0|||
130711519|NCT02177136|470569857|FG001|LTSE Phase|Participant Moved|0|||
130284155|NCT05599451|469003991|FG002|Overall Study|Physician Decision|0|||
130284156|NCT05599451|469003992|FG003|Overall Study|Physician Decision|1|||
130711520|NCT02177136|470569858|FG002|LTSE Phase|Participant Moved|0|||
130284157|NCT05599451|469003993|FG004|Overall Study|Physician Decision|0|||
130284158|NCT00496483|469003994|FG000|Overall Study|Not dosed|9|||
130284159|NCT00496483|469003994|FG000|Overall Study|Adverse Event|2|||
130284160|NCT00496483|469003994|FG000|Overall Study|Lack of Efficacy|1|||
130284161|NCT00983515|469003996|FG000|Ritonavir Alone|liver panel out of range|6|||
130284162|NCT00983515|469003996|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
130284163|NCT01145352|469004007|FG000|Overall Study|Found to have been registered twice|6|||
130711521|NCT02177136|470569859|FG003|LTSE Phase|Participant Moved|1|||
130369439|NCT00674700|469323114|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
130369440|NCT00674700|469323115|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
130369441|NCT00674700|469323113|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
130369442|NCT00674700|469323114|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
130369443|NCT00674700|469323115|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
130369444|NCT02954237|469323116|FG000|Overall Study|Withdrawal by Subject|25|||
130369445|NCT02954237|469323116|FG000|Overall Study|Missed visit|16|||
130369446|NCT02954237|469323116|FG000|Overall Study|Death|2|||
130369447|NCT03797014|469323118|FG000|Overall Study|Withdrawal by Subject|1|||
130369448|NCT03797014|469323118|FG000|Overall Study|Lost to Follow-up|1|||
130369449|NCT03797014|469323118|FG000|Overall Study|Protocol Violation|1|||
130369450|NCT02871297|469323119|FG000|Overall Study|Adverse Event|34|||
130369451|NCT02871297|469323119|FG000|Overall Study|Lack of Efficacy|10|||
130369452|NCT02871297|469323119|FG000|Overall Study|Non-compliance with study drug|15|||
130369453|NCT02871297|469323119|FG000|Overall Study|Protocol Violation|3|||
130369454|NCT02871297|469323119|FG000|Overall Study|Withdrawal by Subject|20|||
130369455|NCT02871297|469323119|FG000|Overall Study|Lost to Follow-up|13|||
130369456|NCT02871297|469323119|FG000|Overall Study|Rolled over to 13546A|2|||
130369457|NCT02871297|469323119|FG000|Overall Study|Other than specified|39|||
130369458|NCT02966028|469323123|FG000|Overall Study|Adverse Event|7|||
130369459|NCT02966028|469323124|FG001|Overall Study|Adverse Event|13|||
130369460|NCT02966028|469323125|FG002|Overall Study|Adverse Event|10|||
130369461|NCT02966028|469323123|FG000|Overall Study|Physician Decision|1|||
130369462|NCT02966028|469323124|FG001|Overall Study|Physician Decision|0|||
130369463|NCT02966028|469323125|FG002|Overall Study|Physician Decision|2|||
130369464|NCT02966028|469323123|FG000|Overall Study|Withdrawal by Subject|7|||
130369465|NCT02966028|469323124|FG001|Overall Study|Withdrawal by Subject|5|||
130369466|NCT02966028|469323125|FG002|Overall Study|Withdrawal by Subject|5|||
130369467|NCT02966028|469323123|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
130369468|NCT02966028|469323124|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
130369469|NCT02966028|469323125|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
130369470|NCT04115839|469323126|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
130369471|NCT04115839|469323127|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
130369472|NCT04115839|469323128|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
130369473|NCT04115839|469323129|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130369474|NCT04115839|469323130|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130369475|NCT04115839|469323131|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130369476|NCT04115839|469323132|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130555337|NCT02310672|470001562|FG000|Overall Study|Sponsor's decision|12|||
130555338|NCT01601847|470001570|FG000|Overall Study|Death|1|||
130369477|NCT04115839|469323126|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
130369478|NCT04115839|469323127|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
130369479|NCT04115839|469323128|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
130369480|NCT04115839|469323129|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130369481|NCT04115839|469323130|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130369482|NCT04115839|469323131|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130369483|NCT04115839|469323132|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130369484|NCT04115839|469323126|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
130369485|NCT04115839|469323127|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369486|NCT04115839|469323128|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369487|NCT04115839|469323129|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369488|NCT04115839|469323130|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369489|NCT04115839|469323131|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369490|NCT04115839|469323132|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130369491|NCT04115839|469323126|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369492|NCT04115839|469323127|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369493|NCT04115839|469323128|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
130369494|NCT04115839|469323129|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369495|NCT04115839|469323130|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369496|NCT04115839|469323131|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369497|NCT04115839|469323132|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130369498|NCT04115839|469323126|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130369499|NCT04115839|469323127|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130458008|NCT01123083|469640047|FG000|Overall Study|Lost to Follow-up|2|||
130458009|NCT01123083|469640048|FG001|Overall Study|Lost to Follow-up|6|||
130458010|NCT01123083|469640047|FG000|Overall Study|Adverse Event|1|||
130458011|NCT01123083|469640048|FG001|Overall Study|Adverse Event|0|||
130458012|NCT01123083|469640047|FG000|Overall Study|Withdrew for another reason not covered|0|||
130458013|NCT01123083|469640048|FG001|Overall Study|Withdrew for another reason not covered|1|||
130458014|NCT01123083|469640047|FG000|Overall Study|Participant/legal representative request|7|||
130458015|NCT01123083|469640048|FG001|Overall Study|Participant/legal representative request|3|||
130284164|NCT01145352|469004007|FG000|Overall Study|Treated before marketing approval|4|||
130284165|NCT01145352|469004007|FG000|Overall Study|Syringe formulation was used|1|||
130284166|NCT01967823|469004008|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
130284167|NCT05289271|469004014|FG000|Overall Study|Mistakenly allocated, untreated|1|||
130284168|NCT05289271|469004015|FG001|Overall Study|Mistakenly allocated, untreated|0|||
130284169|NCT01257568|469004017|FG000|Overall Study|Lost to Follow-up|2|||
130284170|NCT01257568|469004017|FG000|Overall Study|Withdrawal by Subject|6|||
130284171|NCT01257568|469004017|FG000|Overall Study|Terminated|1|||
130284172|NCT01257568|469004017|FG000|Overall Study|Component Revision|24|||
130555339|NCT01601847|470001571|FG001|Overall Study|Death|0|||
130555340|NCT01601847|470001570|FG000|Overall Study|Withdrawal by Subject|11|||
130555341|NCT01601847|470001571|FG001|Overall Study|Withdrawal by Subject|7|||
130555342|NCT01601847|470001570|FG000|Overall Study|Lost to Follow-up|1|||
130284173|NCT03392883|469004018|FG000|Overall Study|Lost to Follow-up|122|||
130284174|NCT03392883|469004019|FG001|Overall Study|Lost to Follow-up|13|||
130555343|NCT01601847|470001571|FG001|Overall Study|Lost to Follow-up|3|||
130555344|NCT01284062|470001572|FG000|Overall Study|Adverse Event|4|||
130555345|NCT01284062|470001573|FG001|Overall Study|Adverse Event|5|||
130555346|NCT01284062|470001574|FG002|Overall Study|Adverse Event|0|||
130555347|NCT01284062|470001575|FG003|Overall Study|Adverse Event|5|||
130555348|NCT01284062|470001572|FG000|Overall Study|Lack of Efficacy|3|||
130555349|NCT01284062|470001573|FG001|Overall Study|Lack of Efficacy|2|||
130555350|NCT01284062|470001574|FG002|Overall Study|Lack of Efficacy|2|||
130555351|NCT01284062|470001575|FG003|Overall Study|Lack of Efficacy|1|||
130555352|NCT01284062|470001572|FG000|Overall Study|Medication error without adverse event|0|||
130555353|NCT01284062|470001573|FG001|Overall Study|Medication error without adverse event|0|||
130555354|NCT01284062|470001574|FG002|Overall Study|Medication error without adverse event|1|||
130284175|NCT03392883|469004020|FG002|Overall Study|Lost to Follow-up|9|||
130284176|NCT03392883|469004018|FG000|Overall Study|Death|4|||
130284177|NCT03392883|469004019|FG001|Overall Study|Death|0|||
130284178|NCT03392883|469004020|FG002|Overall Study|Death|0|||
130284179|NCT03392883|469004018|FG000|Overall Study|Lack of Efficacy|29|||
130284180|NCT03392883|469004019|FG001|Overall Study|Lack of Efficacy|0|||
130284181|NCT03392883|469004020|FG002|Overall Study|Lack of Efficacy|0|||
130284182|NCT03392883|469004018|FG000|Overall Study|Withdrawal by Subject|180|||
130284183|NCT03392883|469004019|FG001|Overall Study|Withdrawal by Subject|0|||
130284184|NCT03392883|469004020|FG002|Overall Study|Withdrawal by Subject|0|||
130284185|NCT03392883|469004018|FG000|Overall Study|Adverse Event|1|||
130284186|NCT03392883|469004019|FG001|Overall Study|Adverse Event|0|||
130284187|NCT03392883|469004020|FG002|Overall Study|Adverse Event|0|||
130284188|NCT00132691|469004030|FG000|Overall Study|Lost to Follow-up|5|||
130284189|NCT00132691|469004031|FG001|Overall Study|Lost to Follow-up|8|||
130284190|NCT00132691|469004030|FG000|Overall Study|Missed 2-year visit|4|||
130284191|NCT00132691|469004031|FG001|Overall Study|Missed 2-year visit|4|||
130284192|NCT00132691|469004030|FG000|Overall Study|Death|2|||
130284193|NCT00132691|469004031|FG001|Overall Study|Death|0|||
130284194|NCT01739933|469004032|FG000|Overall Study|Death|89|||
130284195|NCT01739933|469004033|FG001|Overall Study|Death|86|||
130284196|NCT01739933|469004032|FG000|Overall Study|Withdrawal by Subject|10|||
130284197|NCT01739933|469004033|FG001|Overall Study|Withdrawal by Subject|8|||
130284198|NCT01739933|469004032|FG000|Overall Study|Lost to Follow-up|3|||
130284199|NCT01739933|469004033|FG001|Overall Study|Lost to Follow-up|10|||
130284200|NCT01739933|469004032|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
130284201|NCT01739933|469004033|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
130284202|NCT04098367|469004034|FG000|Overall Study|Adverse Event|0|||
130284203|NCT04098367|469004035|FG001|Overall Study|Adverse Event|0|||
130284204|NCT04098367|469004036|FG002|Overall Study|Adverse Event|1|||
130284205|NCT04098367|469004034|FG000|Overall Study|Lost to Follow-up|1|||
130284206|NCT04098367|469004035|FG001|Overall Study|Lost to Follow-up|5|||
130284207|NCT04098367|469004036|FG002|Overall Study|Lost to Follow-up|2|||
130369500|NCT04115839|469323128|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130369501|NCT04115839|469323129|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
130555355|NCT01284062|470001575|FG003|Overall Study|Medication error without adverse event|0|||
130555356|NCT01284062|470001572|FG000|Overall Study|Protocol Violation|1|||
130555357|NCT01284062|470001573|FG001|Overall Study|Protocol Violation|0|||
130555358|NCT01284062|470001574|FG002|Overall Study|Protocol Violation|0|||
130555359|NCT01284062|470001575|FG003|Overall Study|Protocol Violation|2|||
130284208|NCT04098367|469004034|FG000|Overall Study|Withdrawal by Subject|0|||
130284209|NCT04098367|469004035|FG001|Overall Study|Withdrawal by Subject|0|||
130284210|NCT04098367|469004036|FG002|Overall Study|Withdrawal by Subject|1|||
130555360|NCT01284062|470001572|FG000|Overall Study|Withdrawal by Subject|3|||
130555361|NCT01284062|470001573|FG001|Overall Study|Withdrawal by Subject|1|||
130555362|NCT01284062|470001574|FG002|Overall Study|Withdrawal by Subject|2|||
130284211|NCT04098367|469004034|FG000|Overall Study|Sick . Could not attend visit|1|||
130284212|NCT04098367|469004035|FG001|Overall Study|Sick . Could not attend visit|0|||
130284213|NCT04098367|469004036|FG002|Overall Study|Sick . Could not attend visit|0|||
130284214|NCT01231321|469004042|FG000|Overall Study|Adverse Event|3|||
130284215|NCT01231321|469004042|FG000|Overall Study|Lack of Efficacy|2|||
130284216|NCT00908115|469004043|FG000|Overall Study|Other|14|||
130284217|NCT01728077|469004044|FG000|Overall Study|Lack of Efficacy|3|||
130284218|NCT01728077|469004045|FG001|Overall Study|Lack of Efficacy|1|||
130284219|NCT01728077|469004044|FG000|Overall Study|Lost to Follow-up|1|||
130284220|NCT01728077|469004045|FG001|Overall Study|Lost to Follow-up|0|||
130284221|NCT01728077|469004044|FG000|Overall Study|Subject choice|2|||
130284222|NCT01728077|469004045|FG001|Overall Study|Subject choice|3|||
130284223|NCT01728077|469004044|FG000|Overall Study|Death|0|||
130284224|NCT01728077|469004045|FG001|Overall Study|Death|1|||
130284225|NCT01728077|469004044|FG000|Overall Study|Patient moving|1|||
130284226|NCT01728077|469004045|FG001|Overall Study|Patient moving|0|||
130284227|NCT01728077|469004044|FG000|Overall Study|Non compliance|1|||
130284228|NCT01728077|469004045|FG001|Overall Study|Non compliance|0|||
130284229|NCT00396136|469004051|FG000|Overall Study|Death|43|||
130284230|NCT00396136|469004051|FG000|Overall Study|Withdrawal by Subject|59|||
130284231|NCT00396136|469004051|FG000|Overall Study|Lost to Follow-up|15|||
130284232|NCT00396136|469004051|FG000|Overall Study|Study device explanted|8|||
130284233|NCT03960580|469004052|FG000|Overall Study|Adverse Event|2|||
130284234|NCT03960580|469004053|FG001|Overall Study|Adverse Event|1|||
130284235|NCT03960580|469004054|FG002|Overall Study|Adverse Event|1|||
130284236|NCT03960580|469004052|FG000|Overall Study|Lost to Follow-up|1|||
130284237|NCT03960580|469004053|FG001|Overall Study|Lost to Follow-up|0|||
130284238|NCT03960580|469004054|FG002|Overall Study|Lost to Follow-up|0|||
130284239|NCT03960580|469004052|FG000|Overall Study|Lack of Efficacy|2|||
130284240|NCT03960580|469004053|FG001|Overall Study|Lack of Efficacy|1|||
130284241|NCT03960580|469004054|FG002|Overall Study|Lack of Efficacy|0|||
130284242|NCT03960580|469004052|FG000|Overall Study|Protocol Violation|0|||
130284243|NCT03960580|469004053|FG001|Overall Study|Protocol Violation|0|||
130284244|NCT03960580|469004054|FG002|Overall Study|Protocol Violation|1|||
130284245|NCT03960580|469004052|FG000|Overall Study|Withdrawal by Subject|1|||
130284246|NCT03960580|469004053|FG001|Overall Study|Withdrawal by Subject|1|||
130458016|NCT01751724|469640049|FG000|Overall Study|extubated bef.start assigned treatment|1|||
130458017|NCT01751724|469640050|FG001|Overall Study|extubated bef.start assigned treatment|0|||
130458018|NCT01751724|469640049|FG000|Overall Study|withdrawn by parent|0|||
130458019|NCT01751724|469640050|FG001|Overall Study|withdrawn by parent|2|||
130458020|NCT00605033|469640051|FG000|Overall Study|Adverse Event|2|||
130458021|NCT00605033|469640052|FG001|Overall Study|Adverse Event|2|||
130458022|NCT00605033|469640051|FG000|Overall Study|Lost to Follow-up|1|||
130458023|NCT00605033|469640052|FG001|Overall Study|Lost to Follow-up|1|||
130458024|NCT00605033|469640051|FG000|Overall Study|Withdrawal by Subject|3|||
130458025|NCT00605033|469640052|FG001|Overall Study|Withdrawal by Subject|4|||
130458026|NCT00605033|469640051|FG000|Overall Study|Protocol Violation|1|||
130458027|NCT00605033|469640052|FG001|Overall Study|Protocol Violation|1|||
130458028|NCT03121950|469640054|FG000|Overall Study|Withdrawal by Subject|11|||
130458029|NCT03121950|469640055|FG001|Overall Study|Withdrawal by Subject|2|||
130458030|NCT01867580|469640056|FG000|Overall Study|Withdrawal by Subject|2|||
130458031|NCT01867580|469640057|FG001|Overall Study|Withdrawal by Subject|3|||
130458032|NCT01867580|469640056|FG000|Overall Study|Physician Decision|17|||
130458033|NCT01867580|469640057|FG001|Overall Study|Physician Decision|12|||
130458034|NCT01867580|469640056|FG000|Overall Study|Lost to Follow-up|3|||
130458035|NCT01867580|469640057|FG001|Overall Study|Lost to Follow-up|5|||
130458036|NCT01867580|469640056|FG000|Overall Study|Sponsor terminated study|1|||
130458037|NCT01867580|469640057|FG001|Overall Study|Sponsor terminated study|0|||
130458038|NCT01867580|469640056|FG000|Overall Study|Missed follow-up assessment|2|||
130458039|NCT01867580|469640057|FG001|Overall Study|Missed follow-up assessment|1|||
130458040|NCT01867580|469640056|FG000|Overall Study|Interruption to therapy|3|||
130458041|NCT01867580|469640057|FG001|Overall Study|Interruption to therapy|0|||
130458042|NCT01867580|469640056|FG000|Overall Study|Osteomyelitis|0|||
130458043|NCT01867580|469640057|FG001|Overall Study|Osteomyelitis|1|||
130284247|NCT03960580|469004054|FG002|Overall Study|Withdrawal by Subject|1|||
130284248|NCT03960580|469004052|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130284249|NCT03960580|469004053|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
130284250|NCT03960580|469004054|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130284251|NCT02359045|469004059|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
130284252|NCT02359045|469004060|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130458044|NCT01867580|469640056|FG000|Overall Study|Continuation of therapy|0|||
130458045|NCT01867580|469640057|FG001|Overall Study|Continuation of therapy|1|||
130458046|NCT01867580|469640056|FG000|Overall Study|Wound recurrence|0|||
130284253|NCT02359045|469004059|FG000|Overall Study|Lost to Follow-up|1|||
130284254|NCT02359045|469004060|FG001|Overall Study|Lost to Follow-up|1|||
130284255|NCT02359045|469004059|FG000|Overall Study|Adverse Event|0|||
130284256|NCT02359045|469004060|FG001|Overall Study|Adverse Event|1|||
130284257|NCT01271712|469004066|FG000|Double Blind Treatment|Death|2|||
130284258|NCT01271712|469004067|FG001|Double Blind Treatment|Death|0|||
130458047|NCT01867580|469640057|FG001|Overall Study|Wound recurrence|1|||
130458048|NCT03141788|469640058|FG000|Overall Study|Lost to Follow-up|1|||
130458049|NCT03141788|469640058|FG000|Overall Study|Protocol Violation|3|||
130284259|NCT01271712|469004066|FG000|Double Blind Treatment|Lack of Efficacy|1|||
130284260|NCT01271712|469004067|FG001|Double Blind Treatment|Lack of Efficacy|0|||
130284261|NCT01271712|469004066|FG000|Double Blind Treatment|Adverse Event|9|||
130284262|NCT01271712|469004067|FG001|Double Blind Treatment|Adverse Event|4|||
130284263|NCT01271712|469004066|FG000|Double Blind Treatment|Progressive disease|23|||
130284264|NCT01271712|469004067|FG001|Double Blind Treatment|Progressive disease|3|||
130284265|NCT01271712|469004066|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
130284266|NCT01271712|469004067|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
130284267|NCT01271712|469004066|FG000|Double Blind Treatment|Non compliance with study drug|2|||
130284268|NCT01271712|469004067|FG001|Double Blind Treatment|Non compliance with study drug|0|||
130284269|NCT01271712|469004066|FG000|Double Blind Treatment|receive no study drug|1|||
130284270|NCT01271712|469004067|FG001|Double Blind Treatment|receive no study drug|0|||
130284271|NCT01271712|469004066|FG000|Open Label Treatment|Death|6|||
130284272|NCT01271712|469004067|FG001|Open Label Treatment|Death|5|||
130284273|NCT01271712|469004066|FG000|Open Label Treatment|Withdrawal by Subject|6|||
130284274|NCT01271712|469004067|FG001|Open Label Treatment|Withdrawal by Subject|11|||
130284275|NCT01271712|469004066|FG000|Open Label Treatment|Physician Decision|2|||
130284276|NCT01271712|469004067|FG001|Open Label Treatment|Physician Decision|0|||
130284277|NCT01271712|469004066|FG000|Open Label Treatment|Adverse Event|14|||
130284278|NCT01271712|469004067|FG001|Open Label Treatment|Adverse Event|8|||
130284279|NCT01271712|469004066|FG000|Open Label Treatment|Progressive disease|59|||
130284280|NCT01271712|469004067|FG001|Open Label Treatment|Progressive disease|32|||
130284281|NCT01271712|469004066|FG000|Open Label Treatment|transferred to rollover study|1|||
130284282|NCT01271712|469004067|FG001|Open Label Treatment|transferred to rollover study|0|||
130284283|NCT01271712|469004066|FG000|Open Label Treatment|Non-compliance with study drug|1|||
130284284|NCT01271712|469004067|FG001|Open Label Treatment|Non-compliance with study drug|0|||
130284285|NCT01271712|469004066|FG000|Open Label Treatment|Protocol Violation|0|||
130284286|NCT01271712|469004067|FG001|Open Label Treatment|Protocol Violation|1|||
130284287|NCT01271712|469004066|FG000|Open Label Treatment|Switching to other therapy|2|||
130284288|NCT01271712|469004067|FG001|Open Label Treatment|Switching to other therapy|1|||
130284289|NCT01271712|469004066|FG000|Safety Follow-up|Death|11|||
130284290|NCT01271712|469004067|FG001|Safety Follow-up|Death|7|||
130458050|NCT03141788|469640058|FG000|Overall Study|Withdrawal by Subject|4|||
130466713|NCT02544074|469676366|FG004|Overall Study|Withdrawal by Subject|0|||
130466714|NCT02544074|469676367|FG005|Overall Study|Withdrawal by Subject|0|||
130466715|NCT02544074|469676368|FG006|Overall Study|Withdrawal by Subject|0|||
130466716|NCT02544074|469676369|FG007|Overall Study|Withdrawal by Subject|0|||
130466717|NCT02544074|469676370|FG008|Overall Study|Withdrawal by Subject|0|||
130466718|NCT02544074|469676371|FG009|Overall Study|Withdrawal by Subject|0|||
130466719|NCT02544074|469676372|FG010|Overall Study|Withdrawal by Subject|0|||
130466720|NCT02544074|469676373|FG011|Overall Study|Withdrawal by Subject|0|||
130466721|NCT02544074|469676374|FG012|Overall Study|Withdrawal by Subject|0|||
130466722|NCT02544074|469676375|FG013|Overall Study|Withdrawal by Subject|0|||
130466723|NCT02544074|469676376|FG014|Overall Study|Withdrawal by Subject|0|||
130466724|NCT02544074|469676377|FG015|Overall Study|Withdrawal by Subject|0|||
130466725|NCT02544074|469676378|FG016|Overall Study|Withdrawal by Subject|0|||
130466726|NCT02544074|469676379|FG017|Overall Study|Withdrawal by Subject|0|||
130466727|NCT02544074|469676380|FG018|Overall Study|Withdrawal by Subject|0|||
130466728|NCT02544074|469676381|FG019|Overall Study|Withdrawal by Subject|0|||
130466729|NCT02544074|469676382|FG020|Overall Study|Withdrawal by Subject|0|||
130466730|NCT02544074|469676362|FG000|Overall Study|Tablet error|0|||
130466731|NCT02544074|469676363|FG001|Overall Study|Tablet error|0|||
130466732|NCT02544074|469676364|FG002|Overall Study|Tablet error|0|||
130466733|NCT02544074|469676365|FG003|Overall Study|Tablet error|0|||
130466734|NCT02544074|469676366|FG004|Overall Study|Tablet error|0|||
130466735|NCT02544074|469676367|FG005|Overall Study|Tablet error|1|||
130466736|NCT02544074|469676368|FG006|Overall Study|Tablet error|0|||
130466737|NCT02544074|469676369|FG007|Overall Study|Tablet error|0|||
130466738|NCT02544074|469676370|FG008|Overall Study|Tablet error|0|||
130466739|NCT02544074|469676371|FG009|Overall Study|Tablet error|1|||
130466740|NCT02544074|469676372|FG010|Overall Study|Tablet error|0|||
130284291|NCT01271712|469004066|FG000|Safety Follow-up|Withdrawal by Subject|4|||
130466741|NCT02544074|469676373|FG011|Overall Study|Tablet error|0|||
130466742|NCT02544074|469676374|FG012|Overall Study|Tablet error|0|||
130555363|NCT01284062|470001575|FG003|Overall Study|Withdrawal by Subject|5|||
130555364|NCT01284062|470001572|FG000|Overall Study|Other|0|||
130555365|NCT01284062|470001573|FG001|Overall Study|Other|0|||
130284292|NCT01271712|469004067|FG001|Safety Follow-up|Withdrawal by Subject|2|||
130284293|NCT01271712|469004066|FG000|Safety Follow-up|Protocol Violation|1|||
130466743|NCT02544074|469676375|FG013|Overall Study|Tablet error|0|||
130466744|NCT02544074|469676376|FG014|Overall Study|Tablet error|0|||
130466745|NCT02544074|469676377|FG015|Overall Study|Tablet error|0|||
130466746|NCT02544074|469676378|FG016|Overall Study|Tablet error|0|||
130284294|NCT01271712|469004067|FG001|Safety Follow-up|Protocol Violation|1|||
130466747|NCT02544074|469676379|FG017|Overall Study|Tablet error|0|||
130284295|NCT01271712|469004066|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
130284296|NCT01271712|469004067|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
130284297|NCT01271712|469004066|FG000|Safety Follow-up|No follow-up|1|||
130284298|NCT01271712|469004067|FG001|Safety Follow-up|No follow-up|1|||
130284299|NCT01271712|469004066|FG000|Safety Follow-up|Progressive disease|1|||
130284300|NCT01271712|469004067|FG001|Safety Follow-up|Progressive disease|0|||
130284301|NCT01271712|469004066|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
130284302|NCT01271712|469004067|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
130284303|NCT00096226|469004070|FG000|Overall Study|Ineligible|2|||
130284304|NCT00096226|469004070|FG000|Overall Study|Protocol treatment not started|1|||
130458051|NCT04257058|469641521|FG000|Overall Study|Lost to Follow-up|31|||
130458052|NCT00661778|469641524|FG000|Overall Study|Disease Progression|23|||
130458053|NCT00661778|469641524|FG000|Overall Study|Adverse Event|18|||
130458054|NCT00661778|469641524|FG000|Overall Study|Reason not Specified|6|||
130458055|NCT00661778|469641524|FG000|Overall Study|Protocol Violation|2|||
130458056|NCT00661778|469641524|FG000|Overall Study|Withdrawal of Consent|1|||
130458057|NCT02810080|469641525|FG000|Overall Study|Adverse Event|3|||
130458058|NCT02810080|469641526|FG001|Overall Study|Adverse Event|0|||
130458059|NCT02810080|469641525|FG000|Overall Study|Death|0|||
130458060|NCT02810080|469641526|FG001|Overall Study|Death|2|||
130458061|NCT02810080|469641525|FG000|Overall Study|Physician Decision|4|||
130458062|NCT02810080|469641526|FG001|Overall Study|Physician Decision|0|||
130458063|NCT02810080|469641525|FG000|Overall Study|Withdrawal by Subject|0|||
130458064|NCT02810080|469641526|FG001|Overall Study|Withdrawal by Subject|2|||
130458065|NCT03939819|469641534|FG000|Overall Study|Death|2|||
130458066|NCT03939819|469641535|FG001|Overall Study|Death|0|||
130458067|NCT01183780|469641536|FG000|Overall Study|Withdrawal by Subject|25|||
130458068|NCT01183780|469641537|FG001|Overall Study|Withdrawal by Subject|14|||
130458069|NCT01183780|469641536|FG000|Overall Study|Lost to Follow-up|6|||
130458070|NCT01183780|469641537|FG001|Overall Study|Lost to Follow-up|11|||
130458071|NCT03808883|469641539|FG000|Overall Study|Withdrawal by Subject|2|||
130458072|NCT03808883|469641540|FG001|Overall Study|Withdrawal by Subject|0|||
130458073|NCT03808883|469641539|FG000|Overall Study|Did not complete pre test or post test survey|4|||
130458074|NCT03808883|469641540|FG001|Overall Study|Did not complete pre test or post test survey|3|||
130458075|NCT02371746|469641551|FG000|Overall Study|Consent withdrawn|0|||
130458076|NCT02371746|469641552|FG001|Overall Study|Consent withdrawn|0|||
130458077|NCT02371746|469641553|FG002|Overall Study|Consent withdrawn|0|||
130458078|NCT02371746|469641554|FG003|Overall Study|Consent withdrawn|0|||
130458079|NCT02371746|469641555|FG004|Overall Study|Consent withdrawn|0|||
130458080|NCT02371746|469641556|FG005|Overall Study|Consent withdrawn|0|||
130458081|NCT02371746|469641557|FG006|Overall Study|Consent withdrawn|1|||
130458082|NCT02613364|469641558|FG000|Overall Study|Other|19|||
130458083|NCT02613364|469641559|FG001|Overall Study|Other|29|||
130458084|NCT02613364|469641560|FG002|Overall Study|Other|17|||
130458085|NCT02613364|469641558|FG000|Overall Study|Too time consuming|21|||
130458086|NCT02613364|469641559|FG001|Overall Study|Too time consuming|26|||
130458087|NCT02613364|469641560|FG002|Overall Study|Too time consuming|26|||
130458088|NCT02613364|469641558|FG000|Overall Study|Withdrawal by Subject|13|||
130458089|NCT02613364|469641559|FG001|Overall Study|Withdrawal by Subject|18|||
130458090|NCT02613364|469641560|FG002|Overall Study|Withdrawal by Subject|17|||
130458091|NCT02613364|469641558|FG000|Overall Study|Medical|12|||
130458092|NCT02613364|469641559|FG001|Overall Study|Medical|13|||
130458093|NCT02613364|469641560|FG002|Overall Study|Medical|9|||
130458094|NCT02613364|469641558|FG000|Overall Study|Disliked Study Procedure|1|||
130458095|NCT02613364|469641559|FG001|Overall Study|Disliked Study Procedure|1|||
130458096|NCT02613364|469641560|FG002|Overall Study|Disliked Study Procedure|4|||
130458097|NCT02613364|469641558|FG000|Overall Study|Disliked Intervention|0|||
130458098|NCT02613364|469641559|FG001|Overall Study|Disliked Intervention|3|||
130458099|NCT02613364|469641560|FG002|Overall Study|Disliked Intervention|3|||
130458100|NCT00878722|469641567|FG000|Overall Study|Progressive disease|3|||
130458101|NCT00878722|469641568|FG001|Overall Study|Progressive disease|3|||
130284305|NCT01666119|469004071|FG000|Overall Study|Adverse Event|6|||
130284306|NCT01666119|469004071|FG000|Overall Study|Withdrawal by Subject|16|||
130284307|NCT01666119|469004071|FG000|Overall Study|Lost to Follow-up|7|||
130284308|NCT01666119|469004071|FG000|Overall Study|non compliance with study medication, pa|18|||
130284309|NCT01666119|469004071|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
130458102|NCT00878722|469641569|FG002|Overall Study|Progressive disease|3|||
130458103|NCT00878722|469641570|FG003|Overall Study|Progressive disease|7|||
130458104|NCT00878722|469641571|FG004|Overall Study|Progressive disease|7|||
130458105|NCT00878722|469641572|FG005|Overall Study|Progressive disease|1|||
130284310|NCT05479097|469004074|FG000|Overall Study|Withdrawal by Subject|2|||
130458106|NCT00878722|469641573|FG006|Overall Study|Progressive disease|4|||
130458107|NCT00878722|469641574|FG007|Overall Study|Progressive disease|3|||
130458108|NCT00878722|469641567|FG000|Overall Study|Death|0|||
130458109|NCT00878722|469641568|FG001|Overall Study|Death|0|||
130458110|NCT00878722|469641569|FG002|Overall Study|Death|0|||
130458111|NCT00878722|469641570|FG003|Overall Study|Death|1|||
130555366|NCT01284062|470001574|FG002|Overall Study|Other|0|||
130555367|NCT01284062|470001575|FG003|Overall Study|Other|1|||
130555368|NCT01284062|470001572|FG000|Overall Study|Site Closed|0|||
130555369|NCT01284062|470001573|FG001|Overall Study|Site Closed|0|||
130555370|NCT01284062|470001574|FG002|Overall Study|Site Closed|1|||
130555371|NCT01284062|470001575|FG003|Overall Study|Site Closed|0|||
130555372|NCT02234323|470001576|FG000|All Enrolled|Not Treated: Completed study in database|2|||
130555373|NCT02234323|470001576|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
130555374|NCT02234323|470001576|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
130555375|NCT02234323|470001576|FG000|All Treated|Death|1|||
130555376|NCT02234323|470001576|FG000|All Treated|Physician Decision|5|||
130555377|NCT02234323|470001576|FG000|All Treated|Lack of Efficacy|3|||
130555378|NCT02234323|470001576|FG000|All Treated|Exceeded lab value limit|2|||
130555379|NCT02234323|470001576|FG000|All Treated|Other|7|||
130555380|NCT02644941|470001577|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
130555381|NCT02644941|470001578|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
130284311|NCT03894969|469004080|FG000|Overall Study|Adverse Event|0|||
130555382|NCT01717768|470001580|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555383|NCT01717768|470001581|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
130555384|NCT01717768|470001582|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555385|NCT01717768|470001583|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555386|NCT01717768|470001584|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555387|NCT01717768|470001585|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130284312|NCT03894969|469004081|FG001|Overall Study|Adverse Event|2|||
130284313|NCT03894969|469004082|FG002|Overall Study|Adverse Event|0|||
130284314|NCT03894969|469004083|FG003|Overall Study|Adverse Event|1|||
130284315|NCT03894969|469004084|FG004|Overall Study|Adverse Event|2|||
130284316|NCT03894969|469004080|FG000|Overall Study|Lost to Follow-up|3|||
130284317|NCT03894969|469004081|FG001|Overall Study|Lost to Follow-up|1|||
130284318|NCT03894969|469004082|FG002|Overall Study|Lost to Follow-up|1|||
130284319|NCT03894969|469004083|FG003|Overall Study|Lost to Follow-up|0|||
130284320|NCT03894969|469004084|FG004|Overall Study|Lost to Follow-up|0|||
130284321|NCT03894969|469004080|FG000|Overall Study|Withdrawal by Subject|2|||
130284322|NCT03894969|469004081|FG001|Overall Study|Withdrawal by Subject|1|||
130284323|NCT03894969|469004082|FG002|Overall Study|Withdrawal by Subject|3|||
130284324|NCT03894969|469004083|FG003|Overall Study|Withdrawal by Subject|4|||
130284325|NCT03894969|469004084|FG004|Overall Study|Withdrawal by Subject|8|||
130284326|NCT03894969|469004080|FG000|Overall Study|Other|0|||
130284327|NCT03894969|469004081|FG001|Overall Study|Other|0|||
130284328|NCT03894969|469004082|FG002|Overall Study|Other|0|||
130284329|NCT03894969|469004083|FG003|Overall Study|Other|0|||
130284330|NCT03894969|469004084|FG004|Overall Study|Other|3|||
130284331|NCT03894969|469004080|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284332|NCT03894969|469004081|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284333|NCT03894969|469004082|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284334|NCT03894969|469004083|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
130284335|NCT03894969|469004084|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
130284336|NCT03894969|469004080|FG000|Overall Study|Solicited Adverse Event|0|||
130555388|NCT01717768|470001586|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555389|NCT01717768|470001587|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555390|NCT01717768|470001588|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130284337|NCT03894969|469004081|FG001|Overall Study|Solicited Adverse Event|1|||
130284338|NCT03894969|469004082|FG002|Overall Study|Solicited Adverse Event|0|||
130369502|NCT04115839|469323130|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
130369503|NCT04115839|469323131|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
130369504|NCT04115839|469323132|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
130369505|NCT04115839|469323126|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130369506|NCT04115839|469323127|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130369507|NCT04115839|469323128|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130369508|NCT04115839|469323129|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
130369509|NCT04115839|469323130|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
130369510|NCT04115839|469323131|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130369511|NCT04115839|469323132|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130369512|NCT00691015|469323136|FG000|Overall Study|Refused further treatment|1|||
130369513|NCT04160195|469323139|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
130369514|NCT04160195|469323140|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
130369515|NCT00590720|469323143|FG000|Overall Study|Lost to Follow-up|1|||
130369516|NCT00590720|469323144|FG001|Overall Study|Lost to Follow-up|0|||
130369517|NCT00590720|469323143|FG000|Overall Study|Withdrawal by Subject|0|||
130555391|NCT01717768|470001589|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130284339|NCT03894969|469004083|FG003|Overall Study|Solicited Adverse Event|0|||
130369518|NCT00590720|469323144|FG001|Overall Study|Withdrawal by Subject|1|||
130284340|NCT03894969|469004084|FG004|Overall Study|Solicited Adverse Event|0|||
130458112|NCT00878722|469641571|FG004|Overall Study|Death|0|||
130458113|NCT00878722|469641572|FG005|Overall Study|Death|1|||
130458114|NCT00878722|469641573|FG006|Overall Study|Death|0|||
130458115|NCT00878722|469641574|FG007|Overall Study|Death|2|||
130458116|NCT00878722|469641567|FG000|Overall Study|Adverse Event|0|||
130458117|NCT00878722|469641568|FG001|Overall Study|Adverse Event|0|||
130458118|NCT00878722|469641569|FG002|Overall Study|Adverse Event|0|||
130711522|NCT02054130|470569863|FG000|Overall Study|Withdrawal by Subject|4|||
130711523|NCT02054130|470569864|FG001|Overall Study|Withdrawal by Subject|4|||
130711524|NCT02054130|470569865|FG002|Overall Study|Withdrawal by Subject|7|||
130711525|NCT02054130|470569866|FG003|Overall Study|Withdrawal by Subject|10|||
130711526|NCT02054130|470569863|FG000|Overall Study|Death|0|||
130711527|NCT02054130|470569864|FG001|Overall Study|Death|1|||
130711528|NCT02054130|470569865|FG002|Overall Study|Death|0|||
130711529|NCT02054130|470569866|FG003|Overall Study|Death|0|||
130711530|NCT02054130|470569863|FG000|Overall Study|Lost to Follow-up|0|||
130711531|NCT02054130|470569864|FG001|Overall Study|Lost to Follow-up|0|||
130711532|NCT02054130|470569865|FG002|Overall Study|Lost to Follow-up|1|||
130711533|NCT02054130|470569866|FG003|Overall Study|Lost to Follow-up|2|||
130711534|NCT02054130|470569863|FG000|Overall Study|Missed dose|4|||
130711535|NCT02054130|470569864|FG001|Overall Study|Missed dose|6|||
130711536|NCT02054130|470569865|FG002|Overall Study|Missed dose|7|||
130711537|NCT02054130|470569866|FG003|Overall Study|Missed dose|10|||
130711538|NCT01386684|470569867|FG000|Overall Study|Lost to Follow-up|51|||
130711539|NCT01386684|470569867|FG000|Overall Study|Other|51|||
130711540|NCT01386684|470569867|FG000|Overall Study|Death|47|||
130711541|NCT01386684|470569867|FG000|Overall Study|Withdrawal of Consent|44|||
130711542|NCT01386684|470569867|FG000|Overall Study|Alternative Therapy Required|37|||
130711543|NCT01386684|470569867|FG000|Overall Study|Disease Progression|28|||
130711544|NCT01386684|470569867|FG000|Overall Study|Adverse Event|20|||
130711545|NCT01386684|470569867|FG000|Overall Study|Noncompliance|8|||
130711546|NCT01386684|470569867|FG000|Overall Study|Protocol Violation|4|||
130711547|NCT01386684|470569867|FG000|Overall Study|Missing|3|||
130711548|NCT00094458|470569868|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
130711549|NCT00094458|470569869|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
130711550|NCT00094458|470569870|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
130711551|NCT00094458|470569871|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711552|NCT00094458|470569872|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711553|NCT00094458|470569873|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711554|NCT00094458|470569868|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
130711555|NCT00094458|470569869|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
130711556|NCT00094458|470569870|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
130711557|NCT00094458|470569871|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
130284341|NCT00468676|469004085|FG000|Overall Study|Lost to Follow-up|14|||
130284342|NCT00468676|469004086|FG001|Overall Study|Lost to Follow-up|11|||
130284343|NCT00468676|469004085|FG000|Overall Study|Death|2|||
130284344|NCT00468676|469004086|FG001|Overall Study|Death|1|||
130284345|NCT00118846|469004090|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
130458119|NCT00878722|469641570|FG003|Overall Study|Adverse Event|0|||
130458120|NCT00878722|469641571|FG004|Overall Study|Adverse Event|0|||
130458121|NCT00878722|469641572|FG005|Overall Study|Adverse Event|0|||
130458122|NCT00878722|469641573|FG006|Overall Study|Adverse Event|2|||
130458123|NCT00878722|469641574|FG007|Overall Study|Adverse Event|0|||
130458124|NCT00878722|469641567|FG000|Overall Study|Withdrawal by Subject|0|||
130458125|NCT00878722|469641568|FG001|Overall Study|Withdrawal by Subject|0|||
130458126|NCT00878722|469641569|FG002|Overall Study|Withdrawal by Subject|0|||
130458127|NCT00878722|469641570|FG003|Overall Study|Withdrawal by Subject|0|||
130458128|NCT00878722|469641571|FG004|Overall Study|Withdrawal by Subject|0|||
130458129|NCT00878722|469641572|FG005|Overall Study|Withdrawal by Subject|0|||
130458130|NCT00878722|469641573|FG006|Overall Study|Withdrawal by Subject|0|||
130458131|NCT00878722|469641574|FG007|Overall Study|Withdrawal by Subject|2|||
130458132|NCT00878722|469641567|FG000|Overall Study|Relapse|0|||
130458133|NCT00878722|469641568|FG001|Overall Study|Relapse|0|||
130458134|NCT00878722|469641569|FG002|Overall Study|Relapse|0|||
130284346|NCT00118846|469004091|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
130284347|NCT00118846|469004090|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
130458135|NCT00878722|469641570|FG003|Overall Study|Relapse|1|||
130458136|NCT00878722|469641571|FG004|Overall Study|Relapse|0|||
130458137|NCT00878722|469641572|FG005|Overall Study|Relapse|0|||
130458138|NCT00878722|469641573|FG006|Overall Study|Relapse|0|||
130458139|NCT00878722|469641574|FG007|Overall Study|Relapse|0|||
130458140|NCT02873754|469641575|FG000|Overall Study|Lost to Follow-up|5|||
130711558|NCT00094458|470569872|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
130711559|NCT00094458|470569873|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
130711560|NCT00094458|470569868|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
130711561|NCT00094458|470569869|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
130711562|NCT00094458|470569870|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
130711563|NCT00094458|470569871|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
130284348|NCT00118846|469004091|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
130284349|NCT00118846|469004090|FG000|Overall Study|Physician Decision|1|||
130284350|NCT00118846|469004091|FG001|Overall Study|Physician Decision|0|||
130284351|NCT00118846|469004090|FG000|Overall Study|Medical condition|2|||
130284352|NCT00118846|469004091|FG001|Overall Study|Medical condition|2|||
130284353|NCT00118846|469004090|FG000|Overall Study|Lost to Follow-up|0|||
130284354|NCT00118846|469004091|FG001|Overall Study|Lost to Follow-up|2|||
130284355|NCT00118846|469004090|FG000|Overall Study|Personal reason|4|||
130284356|NCT00118846|469004091|FG001|Overall Study|Personal reason|5|||
130284357|NCT00443053|469004092|FG000|Overall Study|Adverse Event|2|||
130284358|NCT00443053|469004093|FG001|Overall Study|Adverse Event|1|||
130284359|NCT00443053|469004092|FG000|Overall Study|Withdrawal by Subject|9|||
130284360|NCT00443053|469004093|FG001|Overall Study|Withdrawal by Subject|18|||
130284361|NCT00443053|469004092|FG000|Overall Study|Lost to Follow-up|4|||
130284362|NCT00443053|469004093|FG001|Overall Study|Lost to Follow-up|5|||
130284363|NCT00443053|469004092|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130284364|NCT00443053|469004093|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130284365|NCT00443053|469004092|FG000|Overall Study|Noncompliance|2|||
130284366|NCT00443053|469004093|FG001|Overall Study|Noncompliance|1|||
130284367|NCT00443053|469004092|FG000|Overall Study|Other|3|||
130284368|NCT00443053|469004093|FG001|Overall Study|Other|4|||
130284369|NCT00443053|469004092|FG000|Overall Study|Physician Decision|0|||
130284370|NCT00443053|469004093|FG001|Overall Study|Physician Decision|4|||
130284371|NCT00541866|469004094|FG000|Overall Study|Adverse Event|3|||
130284372|NCT00541866|469004095|FG001|Overall Study|Adverse Event|0|||
130284373|NCT00541866|469004096|FG002|Overall Study|Adverse Event|0|||
130284374|NCT00541866|469004097|FG003|Overall Study|Adverse Event|0|||
130284375|NCT00541866|469004098|FG004|Overall Study|Adverse Event|0|||
130284376|NCT00541866|469004094|FG000|Overall Study|Death|1|||
130284377|NCT00541866|469004095|FG001|Overall Study|Death|0|||
130284378|NCT00541866|469004096|FG002|Overall Study|Death|0|||
130284379|NCT00541866|469004097|FG003|Overall Study|Death|0|||
130284380|NCT00541866|469004098|FG004|Overall Study|Death|0|||
130284381|NCT00541866|469004094|FG000|Overall Study|Lack of Efficacy|19|||
130284382|NCT00541866|469004095|FG001|Overall Study|Lack of Efficacy|15|||
130284383|NCT00541866|469004096|FG002|Overall Study|Lack of Efficacy|10|||
130284384|NCT00541866|469004097|FG003|Overall Study|Lack of Efficacy|12|||
130284385|NCT00541866|469004098|FG004|Overall Study|Lack of Efficacy|14|||
130284386|NCT00541866|469004094|FG000|Overall Study|Not Reported or Other|11|||
130284387|NCT00541866|469004095|FG001|Overall Study|Not Reported or Other|3|||
130284388|NCT00541866|469004096|FG002|Overall Study|Not Reported or Other|3|||
130284389|NCT00541866|469004097|FG003|Overall Study|Not Reported or Other|3|||
130284390|NCT00541866|469004098|FG004|Overall Study|Not Reported or Other|1|||
130284391|NCT00541866|469004094|FG000|Overall Study|Physician Decision|0|||
130284392|NCT00541866|469004095|FG001|Overall Study|Physician Decision|0|||
130284393|NCT00541866|469004096|FG002|Overall Study|Physician Decision|2|||
130284394|NCT00541866|469004097|FG003|Overall Study|Physician Decision|1|||
130284395|NCT00541866|469004098|FG004|Overall Study|Physician Decision|0|||
130284396|NCT01327053|469004099|FG000|Overall Study|Adverse Event|23|||
130284397|NCT01327053|469004100|FG001|Overall Study|Adverse Event|57|||
130284398|NCT01327053|469004099|FG000|Overall Study|Patient/guardian decision|11|||
130284399|NCT01327053|469004100|FG001|Overall Study|Patient/guardian decision|35|||
130284400|NCT01327053|469004099|FG000|Overall Study|Physician Decision|10|||
130284401|NCT01327053|469004100|FG001|Overall Study|Physician Decision|14|||
130284402|NCT01327053|469004099|FG000|Overall Study|Death|1|||
130284403|NCT01327053|469004100|FG001|Overall Study|Death|5|||
130284404|NCT01327053|469004099|FG000|Overall Study|Lost to Follow-up|2|||
130284405|NCT01327053|469004100|FG001|Overall Study|Lost to Follow-up|4|||
130284406|NCT01327053|469004099|FG000|Overall Study|Non-compliance with study treatment|0|||
130284407|NCT01327053|469004100|FG001|Overall Study|Non-compliance with study treatment|5|||
130284408|NCT01327053|469004099|FG000|Overall Study|Study terminated by Sponsor|1|||
130284409|NCT01327053|469004100|FG001|Overall Study|Study terminated by Sponsor|3|||
130284410|NCT01327053|469004099|FG000|Overall Study|Progressive disease|31|||
130284411|NCT01327053|469004100|FG001|Overall Study|Progressive disease|26|||
130284412|NCT01327053|469004099|FG000|Overall Study|Protocol Violation|0|||
130284413|NCT01327053|469004100|FG001|Overall Study|Protocol Violation|1|||
130284414|NCT01327053|469004099|FG000|Overall Study|Untreated|0|||
130369519|NCT04189081|469323146|FG000|Overall Study|Lost to Follow-up|1|||
130369520|NCT04189081|469323147|FG001|Overall Study|Lost to Follow-up|0|||
130369521|NCT04189081|469323148|FG002|Overall Study|Lost to Follow-up|0|||
130369522|NCT04189081|469323146|FG000|Overall Study|Withdrawal by Subject|0|||
130369523|NCT04189081|469323147|FG001|Overall Study|Withdrawal by Subject|0|||
130369524|NCT04189081|469323148|FG002|Overall Study|Withdrawal by Subject|1|||
130284415|NCT01327053|469004100|FG001|Overall Study|Untreated|1|||
130284416|NCT01574157|469004101|FG000|Overall Study|Withdrawal by Subject|4|||
130284417|NCT01574157|469004102|FG001|Overall Study|Withdrawal by Subject|5|||
130284418|NCT01574157|469004101|FG000|Overall Study|Lost to Follow-up|0|||
130369525|NCT01619423|469323149|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
130369526|NCT01619423|469323150|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
130369527|NCT01619423|469323151|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
130711564|NCT00094458|470569872|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
130711565|NCT00094458|470569873|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
130711566|NCT00094458|470569868|FG000|Main Study: Through Week 30|Adverse Event|38|||
130711567|NCT00094458|470569869|FG001|Main Study: Through Week 30|Adverse Event|20|||
130711568|NCT00094458|470569870|FG002|Main Study: Through Week 30|Adverse Event|28|||
130711569|NCT00094458|470569871|FG003|Main Study: Through Week 30|Adverse Event|0|||
130711570|NCT00094458|470569872|FG004|Main Study: Through Week 30|Adverse Event|0|||
130711571|NCT00094458|470569873|FG005|Main Study: Through Week 30|Adverse Event|0|||
130711572|NCT00094458|470569868|FG000|Main Study: Through Week 30|Death|1|||
130711573|NCT00094458|470569869|FG001|Main Study: Through Week 30|Death|0|||
130711574|NCT00094458|470569870|FG002|Main Study: Through Week 30|Death|0|||
130711575|NCT00094458|470569871|FG003|Main Study: Through Week 30|Death|0|||
130711576|NCT00094458|470569872|FG004|Main Study: Through Week 30|Death|0|||
130711577|NCT00094458|470569873|FG005|Main Study: Through Week 30|Death|0|||
130711578|NCT00094458|470569868|FG000|Main Study: Through Week 30|Other|19|||
130711579|NCT00094458|470569869|FG001|Main Study: Through Week 30|Other|16|||
130711580|NCT00094458|470569870|FG002|Main Study: Through Week 30|Other|9|||
130711581|NCT00094458|470569871|FG003|Main Study: Through Week 30|Other|0|||
130711582|NCT00094458|470569872|FG004|Main Study: Through Week 30|Other|0|||
130711583|NCT00094458|470569873|FG005|Main Study: Through Week 30|Other|0|||
130711584|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
130711585|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
130711586|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
130711587|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130711588|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130711589|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130555392|NCT01717768|470001590|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555393|NCT01717768|470001591|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130555394|NCT01717768|470001580|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555395|NCT01717768|470001581|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130711590|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
130711591|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130711592|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
130284419|NCT01574157|469004102|FG001|Overall Study|Lost to Follow-up|3|||
130284420|NCT00721578|469004103|FG000|Overall Study|Death|1|||
130284421|NCT00721578|469004104|FG001|Overall Study|Death|1|||
130284422|NCT00721578|469004103|FG000|Overall Study|Withdrawal by Subject|1|||
130284423|NCT00721578|469004104|FG001|Overall Study|Withdrawal by Subject|1|||
130284424|NCT01944098|469004105|FG000|Overall Study|Physician Decision|1|||
130458141|NCT02873754|469641575|FG000|Overall Study|Couldn't complete study procedures|1|||
130458142|NCT00082810|469641576|FG000|Overall Study|Adverse Event|3|||
130458143|NCT00082810|469641576|FG000|Overall Study|Progressive disease|24|||
130458144|NCT00082810|469641576|FG000|Overall Study|Withdrawal by Subject|4|||
130458145|NCT02807493|469641581|FG000|Overall Study|Adverse Event|5|||
130458146|NCT02807493|469641582|FG001|Overall Study|Adverse Event|2|||
130458147|NCT02807493|469641581|FG000|Overall Study|Lost to Follow-up|6|||
130458148|NCT02807493|469641582|FG001|Overall Study|Lost to Follow-up|0|||
130458149|NCT02807493|469641581|FG000|Overall Study|Physician Decision|4|||
130458150|NCT02807493|469641582|FG001|Overall Study|Physician Decision|1|||
130458151|NCT02807493|469641581|FG000|Overall Study|Protocol Violation|7|||
130458152|NCT02807493|469641582|FG001|Overall Study|Protocol Violation|0|||
130555396|NCT01717768|470001582|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130711593|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130284425|NCT01944098|469004106|FG001|Overall Study|Physician Decision|0|||
130284426|NCT05032690|469004107|FG000|Period 1|Adverse Event|0|||
130458153|NCT02807493|469641581|FG000|Overall Study|Withdrawal by Subject|17|||
130458154|NCT02807493|469641582|FG001|Overall Study|Withdrawal by Subject|10|||
130458155|NCT02807493|469641581|FG000|Overall Study|Other withdrawal|17|||
130369528|NCT01619423|469323152|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
130369529|NCT00913497|469323155|FG000|Overall Study|Adverse Event|1|||
130369530|NCT00913497|469323155|FG000|Overall Study|Withdrawal by Subject|2|||
130369531|NCT02002091|469323156|FG000|Screening|Lost to Follow-up|10|||
130369532|NCT02002091|469323157|FG001|Screening|Lost to Follow-up|12|||
130369533|NCT02002091|469323156|FG000|Screening|Death|3|||
130369534|NCT02002091|469323157|FG001|Screening|Death|2|||
130369535|NCT03385564|469323159|FG000|Overall Study|Adverse Event|0|||
130369536|NCT03385564|469323160|FG001|Overall Study|Adverse Event|0|||
130369537|NCT03385564|469323161|FG002|Overall Study|Adverse Event|3|||
130369538|NCT03385564|469323162|FG003|Overall Study|Adverse Event|3|||
130369539|NCT03385564|469323159|FG000|Overall Study|Other than listed|0|||
130369540|NCT03385564|469323160|FG001|Overall Study|Other than listed|0|||
130369541|NCT03385564|469323161|FG002|Overall Study|Other than listed|0|||
130369542|NCT03385564|469323162|FG003|Overall Study|Other than listed|5|||
130369543|NCT03385564|469323159|FG000|Overall Study|Withdrawal by Subject|0|||
130369544|NCT03385564|469323160|FG001|Overall Study|Withdrawal by Subject|1|||
130555397|NCT01717768|470001583|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555398|NCT01717768|470001584|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555399|NCT01717768|470001585|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555400|NCT01717768|470001586|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555401|NCT01717768|470001587|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555402|NCT01717768|470001588|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555403|NCT01717768|470001589|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555404|NCT01717768|470001590|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
130555405|NCT01717768|470001591|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
130555406|NCT01717768|470001580|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555407|NCT01717768|470001581|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555408|NCT01717768|470001582|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555409|NCT01717768|470001583|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555410|NCT01717768|470001584|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555411|NCT01717768|470001585|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555412|NCT01717768|470001586|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555413|NCT01717768|470001587|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
130555414|NCT01717768|470001588|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555415|NCT01717768|470001589|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555416|NCT01717768|470001590|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555417|NCT01717768|470001591|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
130555418|NCT01717768|470001580|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555419|NCT01717768|470001581|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130284427|NCT05032690|469004108|FG001|Period 1|Adverse Event|1|||
130284428|NCT05032690|469004109|FG002|Period 1|Adverse Event|0|||
130284429|NCT05032690|469004110|FG003|Period 1|Adverse Event|0|||
130284430|NCT05032690|469004107|FG000|Period 1|Withdrawal by Subject|1|||
130284431|NCT05032690|469004108|FG001|Period 1|Withdrawal by Subject|0|||
130284432|NCT05032690|469004109|FG002|Period 1|Withdrawal by Subject|0|||
130284433|NCT05032690|469004110|FG003|Period 1|Withdrawal by Subject|0|||
130284434|NCT05032690|469004107|FG000|Period 1|No longer meets eligibility criteria|0|||
130284435|NCT05032690|469004108|FG001|Period 1|No longer meets eligibility criteria|1|||
130284436|NCT05032690|469004109|FG002|Period 1|No longer meets eligibility criteria|0|||
130284437|NCT05032690|469004110|FG003|Period 1|No longer meets eligibility criteria|0|||
130284438|NCT05032690|469004107|FG000|Period 2|Adverse Event|1|||
130284439|NCT05032690|469004108|FG001|Period 2|Adverse Event|0|||
130284440|NCT05032690|469004109|FG002|Period 2|Adverse Event|0|||
130284441|NCT05032690|469004110|FG003|Period 2|Adverse Event|0|||
130284442|NCT05032690|469004107|FG000|Period 2|Withdrawal by Subject|0|||
130284443|NCT05032690|469004108|FG001|Period 2|Withdrawal by Subject|1|||
130284444|NCT05032690|469004109|FG002|Period 2|Withdrawal by Subject|0|||
130284445|NCT05032690|469004110|FG003|Period 2|Withdrawal by Subject|0|||
130284446|NCT05032690|469004107|FG000|Period 2|No longer meets eligibility criteria|0|||
130284447|NCT05032690|469004108|FG001|Period 2|No longer meets eligibility criteria|1|||
130284448|NCT05032690|469004109|FG002|Period 2|No longer meets eligibility criteria|0|||
130369545|NCT03385564|469323161|FG002|Overall Study|Withdrawal by Subject|1|||
130284449|NCT05032690|469004110|FG003|Period 2|No longer meets eligibility criteria|0|||
130284450|NCT05032690|469004107|FG000|Period 3|Adverse Event|0|||
130369546|NCT03385564|469323162|FG003|Overall Study|Withdrawal by Subject|0|||
130369547|NCT03385564|469323159|FG000|Overall Study|Lack of Efficacy|0|||
130284451|NCT05032690|469004108|FG001|Period 3|Adverse Event|1|||
130369548|NCT03385564|469323160|FG001|Overall Study|Lack of Efficacy|0|||
130369549|NCT03385564|469323161|FG002|Overall Study|Lack of Efficacy|0|||
130369550|NCT03385564|469323162|FG003|Overall Study|Lack of Efficacy|1|||
130369551|NCT03385564|469323159|FG000|Overall Study|Death|0|||
130369552|NCT03385564|469323160|FG001|Overall Study|Death|0|||
130555420|NCT01717768|470001582|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555421|NCT01717768|470001583|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555422|NCT01717768|470001584|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555423|NCT01717768|470001585|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555424|NCT01717768|470001586|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555425|NCT01717768|470001587|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555426|NCT01717768|470001588|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555427|NCT01717768|470001589|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
130555428|NCT01717768|470001590|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555429|NCT01717768|470001591|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
130555430|NCT00448435|470001592|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
130555431|NCT00448435|470001593|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130555432|NCT01387230|470001594|FG000|Overall Study|Adverse Event|0|||
130555433|NCT01387230|470001595|FG001|Overall Study|Adverse Event|1|||
130555434|NCT01387230|470001596|FG002|Overall Study|Adverse Event|3|||
130555435|NCT01387230|470001594|FG000|Overall Study|Lack of Efficacy|8|||
130555436|NCT01387230|470001595|FG001|Overall Study|Lack of Efficacy|5|||
130555437|NCT01387230|470001596|FG002|Overall Study|Lack of Efficacy|4|||
130555438|NCT01387230|470001594|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
130555439|NCT01387230|470001595|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
130555440|NCT01387230|470001596|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
130555441|NCT01387230|470001594|FG000|Overall Study|Lost to Follow-up|0|||
130555442|NCT01387230|470001595|FG001|Overall Study|Lost to Follow-up|0|||
130555443|NCT01387230|470001596|FG002|Overall Study|Lost to Follow-up|1|||
130555444|NCT01387230|470001594|FG000|Overall Study|Withdrawal by Subject|4|||
130555445|NCT01387230|470001595|FG001|Overall Study|Withdrawal by Subject|1|||
130555446|NCT01387230|470001596|FG002|Overall Study|Withdrawal by Subject|0|||
130555447|NCT00403754|470001597|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
130555448|NCT00403754|470001598|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
130284452|NCT05032690|469004109|FG002|Period 3|Adverse Event|0|||
130284453|NCT05032690|469004110|FG003|Period 3|Adverse Event|0|||
130284454|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
130284455|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
130284456|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Death|1|||
130284457|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Death|0|||
130284458|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
130284459|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
130284460|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
130284461|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
130284462|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
130284463|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
130284464|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
130284465|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
130284466|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
130284467|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
130284468|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
130284469|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
130284470|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
130284471|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
130284472|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
130284473|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
130369553|NCT03385564|469323161|FG002|Overall Study|Death|1|||
130369554|NCT03385564|469323162|FG003|Overall Study|Death|0|||
130369555|NCT00457301|469323173|FG000|Overall Study|Withdrawal by Subject|3|||
130369556|NCT00457301|469323174|FG001|Overall Study|Withdrawal by Subject|3|||
130369557|NCT00457301|469323173|FG000|Overall Study|Censored out of the study|15|||
130369558|NCT00457301|469323174|FG001|Overall Study|Censored out of the study|14|||
130369559|NCT00457301|469323173|FG000|Overall Study|Death|5|||
130369560|NCT00457301|469323174|FG001|Overall Study|Death|7|||
130369561|NCT00478231|469323175|FG000|Overall Study|Death|7|||
130369562|NCT00478231|469323175|FG000|Overall Study|Lack of Efficacy|47|||
130369563|NCT00478231|469323175|FG000|Overall Study|Lost to Follow-up|7|||
130369564|NCT00478231|469323175|FG000|Overall Study|Withdrawal by Subject|6|||
130555449|NCT00403754|470001599|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
130555450|NCT00403754|470001600|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
130284474|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
130284475|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
130369565|NCT00478231|469323175|FG000|Overall Study|Other|9|||
130369566|NCT00478231|469323175|FG000|Overall Study|Adverse Event|5|||
130369567|NCT00478231|469323175|FG000|Overall Study|Randomized, not treated|3|||
130458156|NCT02807493|469641582|FG001|Overall Study|Other withdrawal|0|||
130458157|NCT02807493|469641581|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
130458158|NCT02807493|469641582|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
130458159|NCT03612804|469641584|FG000|Overall Study|Death|0|||
130458160|NCT03612804|469641585|FG001|Overall Study|Death|7|||
130458161|NCT03612804|469641586|FG002|Overall Study|Death|0|||
130458162|NCT03612804|469641587|FG003|Overall Study|Death|8|||
130458163|NCT03612804|469641584|FG000|Overall Study|Medication copay coverage issues|0|||
130458164|NCT03612804|469641585|FG001|Overall Study|Medication copay coverage issues|0|||
130458165|NCT03612804|469641586|FG002|Overall Study|Medication copay coverage issues|0|||
130458166|NCT03612804|469641587|FG003|Overall Study|Medication copay coverage issues|17|||
130458167|NCT03612804|469641584|FG000|Overall Study|Not current smoker at time of screening|0|||
130458168|NCT03612804|469641585|FG001|Overall Study|Not current smoker at time of screening|1|||
130458169|NCT03612804|469641586|FG002|Overall Study|Not current smoker at time of screening|0|||
130458170|NCT03612804|469641587|FG003|Overall Study|Not current smoker at time of screening|3|||
130458171|NCT03612804|469641584|FG000|Overall Study|Non-veteran status|0|||
130458172|NCT03612804|469641585|FG001|Overall Study|Non-veteran status|1|||
130458173|NCT03612804|469641586|FG002|Overall Study|Non-veteran status|0|||
130458174|NCT03612804|469641587|FG003|Overall Study|Non-veteran status|0|||
130458175|NCT03612804|469641584|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
130458176|NCT03612804|469641585|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
130458177|NCT03612804|469641586|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
130458178|NCT03612804|469641587|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
130458179|NCT03612804|469641584|FG000|Overall Study|Provider retired from VA|0|||
130458180|NCT03612804|469641585|FG001|Overall Study|Provider retired from VA|0|||
130458181|NCT03612804|469641586|FG002|Overall Study|Provider retired from VA|2|||
130284476|NCT02910401|469004113|FG000|Overall Study|Study closure Study closure|0|||
130284477|NCT02910401|469004114|FG001|Overall Study|Study closure Study closure|0|||
130284478|NCT02910401|469004115|FG002|Overall Study|Study closure Study closure|2|||
130284479|NCT02910401|469004113|FG000|Overall Study|Physician Decision|1|||
130284480|NCT02910401|469004114|FG001|Overall Study|Physician Decision|0|||
130284481|NCT02910401|469004115|FG002|Overall Study|Physician Decision|0|||
130284482|NCT03300024|469004116|FG000|Overall Study|Physician Decision|4|||
130284483|NCT03300024|469004117|FG001|Overall Study|Physician Decision|6|||
130284484|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
130284485|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284486|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284487|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284488|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130284489|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130284490|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130284491|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130284492|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
130284493|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
130284494|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130284495|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130284496|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
130284497|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
130284498|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
130284499|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
130284500|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284501|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
130284502|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284503|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284504|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
130284505|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
130284506|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
130284507|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
130284508|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284509|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284510|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
130284511|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284512|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130284513|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130284514|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
130284515|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
130284516|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130284517|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130284518|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
130458182|NCT03612804|469641587|FG003|Overall Study|Provider retired from VA|0|||
130458183|NCT03612804|469641584|FG000|Overall Study|Withdrawal by Subject|0|||
130458184|NCT03612804|469641585|FG001|Overall Study|Withdrawal by Subject|0|||
130458185|NCT03612804|469641586|FG002|Overall Study|Withdrawal by Subject|7|||
130458186|NCT03612804|469641587|FG003|Overall Study|Withdrawal by Subject|0|||
130284519|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
130284520|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130284521|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130284522|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
130284523|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
130284524|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
130284525|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
130284526|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
130284527|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
130284528|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284529|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284530|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
130284531|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284532|NCT02080481|469004122|FG000|Overall Study|Never received a block.|1|||
130284533|NCT02080481|469004123|FG001|Overall Study|Never received a block.|0|||
130284534|NCT00840060|469005818|FG000|Overall Study|Withdrawal by Subject|1|||
130284535|NCT00840060|469005819|FG001|Overall Study|Withdrawal by Subject|0|||
130284536|NCT00840060|469005818|FG000|Overall Study|Change in emotional/behavioral status|0|||
130284537|NCT00840060|469005819|FG001|Overall Study|Change in emotional/behavioral status|1|||
130284538|NCT00871923|469005820|FG000|Overall Study|Death|1|||
130284539|NCT00871923|469005820|FG000|Overall Study|Withdrawal by Subject|1|||
130284540|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
130284541|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
130284542|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
130284543|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
130284544|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
130284545|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
130284546|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
130284547|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
130284548|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
130284549|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
130284550|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
130284551|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
130284552|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
130284553|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
130284554|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
130284555|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
130284556|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
130284557|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
130284558|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130284559|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130284560|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
130284561|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
130284562|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
130284563|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
130284564|NCT02723006|469005827|FG000|Overall Study|Withdrawal by Subject|0|||
130284565|NCT02723006|469005828|FG001|Overall Study|Withdrawal by Subject|1|||
130284566|NCT02723006|469005829|FG002|Overall Study|Withdrawal by Subject|1|||
130284567|NCT02723006|469005827|FG000|Overall Study|Study Terminated by Sponsor|1|||
130284568|NCT02723006|469005828|FG001|Overall Study|Study Terminated by Sponsor|6|||
130284569|NCT02723006|469005829|FG002|Overall Study|Study Terminated by Sponsor|6|||
130284570|NCT00303446|469005830|FG000|Overall Study|Withdrawal by Subject|2|||
130284571|NCT00303446|469005831|FG001|Overall Study|Withdrawal by Subject|2|||
130284572|NCT00303446|469005830|FG000|Overall Study|Death|0|||
130284573|NCT00303446|469005831|FG001|Overall Study|Death|1|||
130284574|NCT00303446|469005830|FG000|Overall Study|Physician Decision|0|||
130284575|NCT00303446|469005831|FG001|Overall Study|Physician Decision|1|||
130284576|NCT04258995|469005832|FG000|Overall Study|Lost to Follow-up|1|||
130284577|NCT04258995|469005833|FG001|Overall Study|Lost to Follow-up|1|||
130284578|NCT00642174|469005835|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
130284579|NCT00642174|469005836|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
130284580|NCT00896363|469005837|FG000|Overall Study|Adverse Event|3|||
130284581|NCT00896363|469005838|FG001|Overall Study|Adverse Event|4|||
130284582|NCT00896363|469005839|FG002|Overall Study|Adverse Event|2|||
130284583|NCT00896363|469005837|FG000|Overall Study|Lack of Efficacy|0|||
130284584|NCT00896363|469005838|FG001|Overall Study|Lack of Efficacy|2|||
130284585|NCT00896363|469005839|FG002|Overall Study|Lack of Efficacy|1|||
130284586|NCT00896363|469005837|FG000|Overall Study|Withdrawal by Subject|3|||
130284587|NCT00896363|469005838|FG001|Overall Study|Withdrawal by Subject|5|||
130284588|NCT00896363|469005839|FG002|Overall Study|Withdrawal by Subject|5|||
130284589|NCT00316693|469005842|FG000|Overall Study|Adverse Event|6|||
130284590|NCT00316693|469005843|FG001|Overall Study|Adverse Event|1|||
130555451|NCT00403754|470001597|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
130555452|NCT00403754|470001598|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
130555453|NCT00403754|470001599|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
130555454|NCT00403754|470001600|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
130555455|NCT02499770|470001605|FG000|Overall Study|Death|17|||
130555456|NCT02499770|470001606|FG001|Overall Study|Death|56|||
130555457|NCT02499770|470001605|FG000|Overall Study|Study completion|1|||
130555458|NCT02499770|470001606|FG001|Overall Study|Study completion|10|||
130555459|NCT02499770|470001605|FG000|Overall Study|Withdrawal by Subject|0|||
130555460|NCT02499770|470001606|FG001|Overall Study|Withdrawal by Subject|7|||
130555461|NCT02499770|470001605|FG000|Overall Study|Lost to Follow-up|0|||
130555462|NCT02499770|470001606|FG001|Overall Study|Lost to Follow-up|2|||
130555463|NCT02499770|470001605|FG000|Overall Study|Subject declined further treatment|1|||
130555464|NCT02499770|470001606|FG001|Overall Study|Subject declined further treatment|0|||
130555465|NCT02499770|470001605|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
130555466|NCT02499770|470001606|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
130555467|NCT02499770|470001605|FG000|Overall Study|Randomized but not enrolled|0|||
130555468|NCT02499770|470001606|FG001|Overall Study|Randomized but not enrolled|1|||
130555469|NCT00047320|470001607|FG000|Overall Study|Lack of Efficacy|8|||
130555470|NCT00047320|470001607|FG000|Overall Study|Lost to Follow-up|1|||
130555471|NCT00047320|470001607|FG000|Overall Study|Physician Decision|8|||
130555472|NCT00047320|470001607|FG000|Overall Study|Withdrawal by Subject|9|||
130555473|NCT00047320|470001607|FG000|Overall Study|Ineligible|2|||
130555474|NCT04824521|470001610|FG000|Overall Study|Lost to Follow-up|1|||
130555475|NCT00447382|470001611|FG000|Overall Study|Adverse Event|1|||
130555476|NCT00447382|470001612|FG001|Overall Study|Adverse Event|1|||
130555477|NCT00447382|470001611|FG000|Overall Study|Lack of Efficacy|1|||
130284591|NCT00316693|469005842|FG000|Overall Study|Protocol Violation|1|||
130284592|NCT00316693|469005843|FG001|Overall Study|Protocol Violation|0|||
130284593|NCT00316693|469005842|FG000|Overall Study|Withdrawal by Subject|6|||
130284594|NCT00316693|469005843|FG001|Overall Study|Withdrawal by Subject|6|||
130284595|NCT00316693|469005842|FG000|Overall Study|Lost to Follow-up|26|||
130284596|NCT00316693|469005843|FG001|Overall Study|Lost to Follow-up|34|||
130284597|NCT00316693|469005842|FG000|Overall Study|Other|38|||
130284598|NCT00316693|469005843|FG001|Overall Study|Other|44|||
130284599|NCT03002818|469005847|FG000|Overall Study|Decision of the investigator|1|||
130284600|NCT00711113|469005848|FG000|Overall Study|Lost to Follow-up|9|||
130284601|NCT00711113|469005848|FG000|Overall Study|Implant lost|2|||
130284602|NCT01606787|469005856|FG000|Overall Study|Withdrawal by Subject|4|||
130284603|NCT01606787|469005857|FG001|Overall Study|Withdrawal by Subject|5|||
130284604|NCT01606787|469005856|FG000|Overall Study|Surgery canceled|0|||
130284605|NCT01606787|469005857|FG001|Overall Study|Surgery canceled|2|||
130284606|NCT04225676|469005858|FG000|Overall Study|Physician Decision|1|||
130284607|NCT04225676|469005858|FG000|Overall Study|Lack of Efficacy|1|||
130284608|NCT04225676|469005858|FG000|Overall Study|Study terminated by sponsor|3|||
130284609|NCT03245736|469005859|FG000|Overall Study|Adverse Event|1|||
130284610|NCT03245736|469005859|FG000|Overall Study|Progressive Disease|4|||
130284611|NCT00354107|469005865|FG000|Overall Study|Adverse Event|2|||
130284612|NCT00354107|469005865|FG000|Overall Study|Physician Decision|2|||
130284613|NCT00354107|469005865|FG000|Overall Study|Withdrawal by Subject|1|||
130284614|NCT01685801|469005868|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284615|NCT01685801|469005869|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284616|NCT01685801|469005870|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284617|NCT01685801|469005871|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
130284618|NCT01685801|469005868|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130284619|NCT01685801|469005869|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
130284620|NCT01685801|469005870|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130284621|NCT01685801|469005871|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
130555478|NCT00447382|470001612|FG001|Overall Study|Lack of Efficacy|0|||
130555479|NCT00447382|470001611|FG000|Overall Study|Protocol Violation|2|||
130555480|NCT00447382|470001612|FG001|Overall Study|Protocol Violation|0|||
130555481|NCT00447382|470001611|FG000|Overall Study|Unclassified|2|||
130555482|NCT00447382|470001612|FG001|Overall Study|Unclassified|5|||
130555483|NCT02673619|470001613|FG000|Overall Study|Lost to Follow-up|1|||
130284622|NCT04686084|469005872|FG000|Overall Study|Lost to Follow-up|1|||
130555484|NCT02673619|470001614|FG001|Overall Study|Lost to Follow-up|0|||
130555485|NCT02673619|470001615|FG002|Overall Study|Lost to Follow-up|0|||
130555486|NCT02673619|470001616|FG003|Overall Study|Lost to Follow-up|0|||
130555487|NCT02673619|470001613|FG000|Overall Study|Withdrawal by Subject|1|||
130284623|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
130284624|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
130284625|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284626|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130284627|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
130555488|NCT02673619|470001614|FG001|Overall Study|Withdrawal by Subject|1|||
130555489|NCT02673619|470001615|FG002|Overall Study|Withdrawal by Subject|1|||
130555490|NCT02673619|470001616|FG003|Overall Study|Withdrawal by Subject|0|||
130458187|NCT03612804|469641584|FG000|Overall Study|Provider involved with study activities|1|||
130458188|NCT03612804|469641585|FG001|Overall Study|Provider involved with study activities|0|||
130458189|NCT03612804|469641586|FG002|Overall Study|Provider involved with study activities|0|||
130458190|NCT03612804|469641587|FG003|Overall Study|Provider involved with study activities|0|||
130458191|NCT00741988|469641595|FG000|Overall Study|Adverse Event|2|||
130458192|NCT00741988|469641596|FG001|Overall Study|Adverse Event|4|||
130458193|NCT00741988|469641595|FG000|Overall Study|Lack of Efficacy|2|||
130458194|NCT00741988|469641596|FG001|Overall Study|Lack of Efficacy|0|||
130284628|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284629|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
130284630|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284631|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284632|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284633|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284634|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130284635|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284636|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284637|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130711594|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130711595|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130284638|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284639|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284640|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284641|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284642|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284643|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284644|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284645|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284646|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284647|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284648|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284649|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284650|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284651|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284652|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284653|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284654|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284655|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284656|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284657|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284658|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284659|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284660|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284661|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
130284662|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284663|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284664|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284665|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284666|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284667|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284668|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284669|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130458195|NCT00811057|469641597|FG000|Overall Study|Protocol Violation|5|||
130458196|NCT00811057|469641598|FG001|Overall Study|Protocol Violation|10|||
130458197|NCT00811057|469641599|FG002|Overall Study|Protocol Violation|10|||
130458198|NCT00768651|469641604|FG000|Overall Study|Withdrawal by Subject|1|||
130711596|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
130711597|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
130711598|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
130711599|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711600|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711601|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711602|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
130711603|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
130711604|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
130711605|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
130711606|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
130284670|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284671|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284672|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284673|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284674|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284675|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284676|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284677|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284678|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284679|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
130284680|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284681|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284682|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284683|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284684|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284685|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284686|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284687|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284688|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284689|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284690|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284691|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284692|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284693|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284694|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284695|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284696|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284697|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284698|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284699|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130316226|NCT04319198|469124334|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
130458199|NCT02104765|469641605|FG000|Overall Study|Lost to Follow-up|0|||
130458200|NCT02104765|469641606|FG001|Overall Study|Lost to Follow-up|0|||
130458201|NCT02104765|469641607|FG002|Overall Study|Lost to Follow-up|1|||
130458202|NCT02104765|469641608|FG003|Overall Study|Lost to Follow-up|0|||
130458203|NCT02104765|469641609|FG004|Overall Study|Lost to Follow-up|0|||
130458204|NCT02104765|469641610|FG005|Overall Study|Lost to Follow-up|0|||
130458205|NCT02104765|469641611|FG006|Overall Study|Lost to Follow-up|0|||
130458206|NCT02104765|469641605|FG000|Overall Study|Withdrawal by Subject|0|||
130458207|NCT02104765|469641606|FG001|Overall Study|Withdrawal by Subject|0|||
130458208|NCT02104765|469641607|FG002|Overall Study|Withdrawal by Subject|0|||
130458209|NCT02104765|469641608|FG003|Overall Study|Withdrawal by Subject|1|||
130458210|NCT02104765|469641609|FG004|Overall Study|Withdrawal by Subject|1|||
130458211|NCT02104765|469641610|FG005|Overall Study|Withdrawal by Subject|0|||
130458212|NCT02104765|469641611|FG006|Overall Study|Withdrawal by Subject|1|||
130458213|NCT00995709|469641616|FG000|Overall Study|Adverse Event|4|||
130458214|NCT00995709|469641617|FG001|Overall Study|Adverse Event|2|||
130458215|NCT00995709|469641618|FG002|Overall Study|Adverse Event|0|||
130458216|NCT00995709|469641616|FG000|Overall Study|Lack of Efficacy|0|||
130458217|NCT00995709|469641617|FG001|Overall Study|Lack of Efficacy|1|||
130458218|NCT00995709|469641618|FG002|Overall Study|Lack of Efficacy|4|||
130458219|NCT00995709|469641616|FG000|Overall Study|Withdrawal by Subject|0|||
130458220|NCT00995709|469641617|FG001|Overall Study|Withdrawal by Subject|4|||
130458221|NCT00995709|469641618|FG002|Overall Study|Withdrawal by Subject|1|||
130458222|NCT00995709|469641616|FG000|Overall Study|Lost to Follow-up|1|||
130458223|NCT00995709|469641617|FG001|Overall Study|Lost to Follow-up|0|||
130458224|NCT00995709|469641618|FG002|Overall Study|Lost to Follow-up|0|||
130458225|NCT00995709|469641616|FG000|Overall Study|Death|0|||
130458226|NCT00995709|469641617|FG001|Overall Study|Death|1|||
130458227|NCT00995709|469641618|FG002|Overall Study|Death|0|||
130458228|NCT00995709|469641616|FG000|Overall Study|Protocol Violation|2|||
130458229|NCT00995709|469641617|FG001|Overall Study|Protocol Violation|1|||
130458230|NCT00995709|469641618|FG002|Overall Study|Protocol Violation|0|||
130458231|NCT01697319|469641619|FG000|Primary Phase|Withdrawal by Subject|1|||
130458232|NCT01697319|469641619|FG000|Extension Phase|Terminated by Sponsor|15|||
130458233|NCT04222959|469641620|FG000|Overall Study|Lost to Follow-up|76|||
130458234|NCT04222959|469641621|FG001|Overall Study|Lost to Follow-up|28|||
130458235|NCT03008915|469641622|FG000|Treatment 1|Withdrawal by Subject|0|||
130458236|NCT03008915|469641623|FG001|Treatment 1|Withdrawal by Subject|1|||
130458237|NCT00712166|469641626|FG000|Overall Study|Noncompliance|0|||
130458238|NCT00712166|469641627|FG001|Overall Study|Noncompliance|1|||
130284700|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284701|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284702|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284703|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284704|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284705|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
130284706|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284707|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284708|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284709|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284710|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284711|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284712|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284713|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284714|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284715|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284716|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130284717|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284718|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130284719|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284720|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284721|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284722|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284723|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130458239|NCT01773122|469641628|FG000|Overall Study|Due to amended age eligibility criteria|3|||
130458240|NCT01773122|469641629|FG001|Overall Study|Due to amended age eligibility criteria|1|||
130458241|NCT01773122|469641630|FG002|Overall Study|Due to amended age eligibility criteria|0|||
130458242|NCT01773122|469641631|FG003|Overall Study|Due to amended age eligibility criteria|1|||
130458243|NCT01264718|469641632|FG000|Overall Study|Lost to Follow-up|3|||
130458244|NCT01264718|469641633|FG001|Overall Study|Lost to Follow-up|2|||
130458245|NCT01264718|469641632|FG000|Overall Study|Withdrawal by Subject|9|||
130458246|NCT01264718|469641633|FG001|Overall Study|Withdrawal by Subject|15|||
130458247|NCT01264718|469641632|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
130458248|NCT01264718|469641633|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
130458249|NCT03386929|469641636|FG000|Overall Study|Death|0|||
130458250|NCT03386929|469641637|FG001|Overall Study|Death|0|||
130458251|NCT03386929|469641638|FG002|Overall Study|Death|1|||
130458252|NCT03386929|469641636|FG000|Overall Study|Withdrawal by Subject|0|||
130458253|NCT03386929|469641637|FG001|Overall Study|Withdrawal by Subject|1|||
130458254|NCT03386929|469641638|FG002|Overall Study|Withdrawal by Subject|0|||
130458255|NCT03386929|469641636|FG000|Overall Study|Physician Decision|0|||
130458256|NCT03386929|469641637|FG001|Overall Study|Physician Decision|0|||
130458257|NCT03386929|469641638|FG002|Overall Study|Physician Decision|1|||
130458258|NCT03386929|469641636|FG000|Overall Study|Progression|4|||
130458259|NCT03386929|469641637|FG001|Overall Study|Progression|4|||
130458260|NCT03386929|469641638|FG002|Overall Study|Progression|0|||
130458261|NCT03386929|469641636|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
130458262|NCT03386929|469641637|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
130458263|NCT03386929|469641638|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
130458264|NCT03386929|469641636|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
130458265|NCT03386929|469641637|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
130458266|NCT03386929|469641638|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
130458267|NCT03264456|469641645|FG000|Overall Study|Withdrawal by Subject|3|||
130458268|NCT03264456|469641645|FG000|Overall Study|Lost to Follow-up|1|||
130458269|NCT03538054|469641646|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
130458270|NCT03538054|469641646|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
130458271|NCT03538054|469641646|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
130458272|NCT03254394|469641647|FG000|Overall Study|Withdrawal by Subject|0|||
130458273|NCT03254394|469641648|FG001|Overall Study|Withdrawal by Subject|2|||
130458274|NCT00387465|469641655|FG000|Overall Study|Withdrawal by Subject|0|||
130458275|NCT00387465|469641656|FG001|Overall Study|Withdrawal by Subject|1|||
130458276|NCT00387465|469641657|FG002|Overall Study|Withdrawal by Subject|0|||
130555491|NCT02673619|470001613|FG000|Overall Study|Adverse Event|0|||
130555492|NCT02673619|470001614|FG001|Overall Study|Adverse Event|0|||
130555493|NCT02673619|470001615|FG002|Overall Study|Adverse Event|1|||
130555494|NCT02673619|470001616|FG003|Overall Study|Adverse Event|0|||
130555495|NCT02673619|470001613|FG000|Overall Study|Lack of Efficacy|0|||
130555496|NCT02673619|470001614|FG001|Overall Study|Lack of Efficacy|0|||
130555497|NCT02673619|470001615|FG002|Overall Study|Lack of Efficacy|1|||
130555498|NCT02673619|470001616|FG003|Overall Study|Lack of Efficacy|0|||
130555499|NCT04600336|470001619|FG000|Initial Treatment|Withdrawal by Subject|1|||
130555500|NCT04600336|470001620|FG001|Initial Treatment|Withdrawal by Subject|2|||
130711607|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
130711608|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Adverse Event|0|||
130711609|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Adverse Event|0|||
130711610|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Adverse Event|0|||
130284724|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284725|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284726|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284727|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284728|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284729|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284730|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284731|NCT04600076|469005894|FG000|Overall Study|Lost to Follow-up|3|||
130284732|NCT02891681|469005895|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130284733|NCT02891681|469005896|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130284734|NCT02891681|469005897|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
130284735|NCT02891681|469005895|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
130284736|NCT02891681|469005896|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130284737|NCT02891681|469005897|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130284738|NCT02891681|469005895|FG000|Overall Study|Taken off study after first imaging appointment|1|||
130284739|NCT02891681|469005896|FG001|Overall Study|Taken off study after first imaging appointment|0|||
130284740|NCT02891681|469005897|FG002|Overall Study|Taken off study after first imaging appointment|0|||
130284741|NCT00957944|469005901|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
130284742|NCT00957944|469005902|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
130284743|NCT01482169|469005903|FG000|Overall Study|Physician Decision|2|||
130284744|NCT00522418|469005904|FG000|Overall Study|Local IRB Consent Violation|5|||
130284745|NCT00522418|469005905|FG001|Overall Study|Local IRB Consent Violation|5|||
130284746|NCT00522418|469005904|FG000|Overall Study|Early Study Termination|46|||
130284747|NCT00522418|469005905|FG001|Overall Study|Early Study Termination|47|||
130284748|NCT00522418|469005904|FG000|Overall Study|Noncompliance|2|||
130284749|NCT00522418|469005905|FG001|Overall Study|Noncompliance|2|||
130284750|NCT00522418|469005904|FG000|Overall Study|Reason Not Specified|3|||
130284751|NCT00522418|469005905|FG001|Overall Study|Reason Not Specified|1|||
130284752|NCT00522418|469005904|FG000|Overall Study|Consent Withdraw|1|||
130284753|NCT00522418|469005905|FG001|Overall Study|Consent Withdraw|2|||
130284754|NCT00522418|469005904|FG000|Overall Study|Lack of Efficacy|0|||
130284755|NCT00522418|469005905|FG001|Overall Study|Lack of Efficacy|1|||
130284756|NCT00578877|469005908|FG000|Overall Study|Lost to Follow-up|8|||
130284757|NCT00578877|469005909|FG001|Overall Study|Lost to Follow-up|10|||
130284758|NCT00578877|469005908|FG000|Overall Study|early discontinue|61|||
130284759|NCT00578877|469005909|FG001|Overall Study|early discontinue|101|||
130284760|NCT00578877|469005908|FG000|Overall Study|did not provide follow-up data|12|||
130284761|NCT00578877|469005909|FG001|Overall Study|did not provide follow-up data|17|||
130284762|NCT02437409|469005914|FG000|Overall Study|Withdrawal by Subject|3|||
130284763|NCT02437409|469005914|FG000|Overall Study|Screening failure|12|||
130284764|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
130284765|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
130284766|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
130284767|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
130284768|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
130284769|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
130284770|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
130284771|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
130284772|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
130711611|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Adverse Event|0|||
130711612|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Adverse Event|3|||
130284773|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
130284774|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
130555501|NCT04600336|470001621|FG002|Initial Treatment|Withdrawal by Subject|0|||
130555502|NCT04600336|470001622|FG003|Initial Treatment|Withdrawal by Subject|0|||
130555503|NCT04600336|470001619|FG000|Initial Treatment|Adverse Event|0|||
130369568|NCT03035409|469323178|FG000|Overall Study|Adverse Event|5|||
130369569|NCT03035409|469323178|FG000|Overall Study|Death|2|||
130555504|NCT04600336|470001620|FG001|Initial Treatment|Adverse Event|2|||
130369570|NCT03035409|469323178|FG000|Overall Study|Withdrawal by Subject|2|||
130369571|NCT03035409|469323178|FG000|Overall Study|Non compliance|4|||
130369572|NCT03035409|469323178|FG000|Overall Study|Patient was jittery|1|||
130369573|NCT03035409|469323178|FG000|Overall Study|Did not like Questionnaire|1|||
130369574|NCT03035409|469323178|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
130369575|NCT03035409|469323178|FG000|Overall Study|Did not like taking drugs|1|||
130369576|NCT01552694|469323181|FG000|Overall Study|Lost to Follow-up|0|||
130369577|NCT01552694|469323182|FG001|Overall Study|Lost to Follow-up|1|||
130369578|NCT01552694|469323181|FG000|Overall Study|Protocol Violation|0|||
130369579|NCT01552694|469323182|FG001|Overall Study|Protocol Violation|1|||
130369580|NCT03724032|469323184|FG000|Overall Study|Physician Decision|1|||
130369581|NCT03724032|469323185|FG001|Overall Study|Physician Decision|0|||
130369582|NCT03724032|469323186|FG002|Overall Study|Physician Decision|0|||
130369583|NCT03724032|469323184|FG000|Overall Study|Protocol Violation|2|||
130369584|NCT03724032|469323185|FG001|Overall Study|Protocol Violation|2|||
130369585|NCT03724032|469323186|FG002|Overall Study|Protocol Violation|1|||
130369586|NCT00001880|469323187|FG000|Overall Study|Death|14|||
130369587|NCT00873015|469323188|FG000|Overall Study|Withdrawal by Subject|0|||
130369588|NCT00873015|469323189|FG001|Overall Study|Withdrawal by Subject|1|||
130369589|NCT00873015|469323190|FG002|Overall Study|Withdrawal by Subject|0|||
130369590|NCT00873015|469323191|FG003|Overall Study|Withdrawal by Subject|0|||
130369591|NCT04094883|469323192|FG000|Overall Study|Withdrawal by Subject|1|||
130369592|NCT01382212|469323194|FG000|Overall Study|Kidney transplant|1|||
130369593|NCT01382212|469323194|FG000|Overall Study|Withdrew consent|1|||
130369594|NCT01273597|469323195|FG000|Overall Study|Adverse Event|5|||
130369595|NCT01273597|469323195|FG000|Overall Study|Underwent Kidney Transplantation|2|||
130369596|NCT01273597|469323195|FG000|Overall Study|Reason Not Reported|1|||
130369597|NCT03329573|469323198|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130369598|NCT03329573|469323199|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
130555505|NCT04600336|470001621|FG002|Initial Treatment|Adverse Event|0|||
130555506|NCT04600336|470001622|FG003|Initial Treatment|Adverse Event|0|||
130555507|NCT04600336|470001619|FG000|Initial Treatment|Other complicating disease|0|||
130555508|NCT04600336|470001620|FG001|Initial Treatment|Other complicating disease|0|||
130555509|NCT04600336|470001621|FG002|Initial Treatment|Other complicating disease|1|||
130555510|NCT04600336|470001622|FG003|Initial Treatment|Other complicating disease|0|||
130555511|NCT04600336|470001619|FG000|Crossover Treatment|Withdrawal by Subject|0|||
130555512|NCT04600336|470001620|FG001|Crossover Treatment|Withdrawal by Subject|0|||
130555513|NCT04600336|470001621|FG002|Crossover Treatment|Withdrawal by Subject|2|||
130555514|NCT04600336|470001622|FG003|Crossover Treatment|Withdrawal by Subject|1|||
130555515|NCT04600336|470001619|FG000|Crossover Treatment|Adverse Event|0|||
130555516|NCT04600336|470001620|FG001|Crossover Treatment|Adverse Event|0|||
130555517|NCT04600336|470001621|FG002|Crossover Treatment|Adverse Event|1|||
130555518|NCT04600336|470001622|FG003|Crossover Treatment|Adverse Event|1|||
130555519|NCT01521897|470003220|FG000|Overall Study|Protocol Violation|18|||
130555520|NCT01521897|470003220|FG000|Overall Study|Lost to Follow-up|5|||
130369599|NCT03329573|469323200|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130555521|NCT02194062|470003227|FG000|Overall Study|Lost to Follow-up|2|||
130555522|NCT02194062|470003228|FG001|Overall Study|Lost to Follow-up|2|||
130555523|NCT02194062|470003229|FG002|Overall Study|Lost to Follow-up|5|||
130555524|NCT02276872|470003230|FG000|Overall Study|Adverse Event|1|||
130555525|NCT02276872|470003231|FG001|Overall Study|Adverse Event|0|||
130555526|NCT02276872|470003232|FG002|Overall Study|Adverse Event|0|||
130555527|NCT04147234|470003233|FG000|Overall Study|Clinical deterioration|0|||
130555528|NCT04147234|470003234|FG001|Overall Study|Clinical deterioration|0|||
130369600|NCT03329573|469323201|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130369601|NCT03329573|469323198|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
130369602|NCT03329573|469323199|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
130369603|NCT03329573|469323200|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130369604|NCT03329573|469323201|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130555529|NCT04147234|470003235|FG002|Overall Study|Clinical deterioration|1|||
130555530|NCT04147234|470003236|FG003|Overall Study|Clinical deterioration|0|||
130369605|NCT03329573|469323198|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
130284775|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
130284776|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
130284777|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
130284778|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
130284779|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
130284780|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
130284781|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
130284782|NCT00855933|469005919|FG000|Overall Study|Withdrawal by Subject|0|||
130284783|NCT00855933|469005920|FG001|Overall Study|Withdrawal by Subject|1|||
130284784|NCT00951080|469005921|FG000|Overall Study|Adverse Event|3|||
130284785|NCT00951080|469005922|FG001|Overall Study|Adverse Event|3|||
130284786|NCT00951080|469005921|FG000|Overall Study|Lost to Follow-up|0|||
130284787|NCT00951080|469005922|FG001|Overall Study|Lost to Follow-up|1|||
130284788|NCT00951080|469005921|FG000|Overall Study|Physician Decision|4|||
130284789|NCT00951080|469005922|FG001|Overall Study|Physician Decision|1|||
130284790|NCT00951080|469005921|FG000|Overall Study|Other|19|||
130284791|NCT00951080|469005922|FG001|Overall Study|Other|22|||
130284792|NCT01960998|469005923|FG000|Overall Study|Lost to Follow-up|3|||
130284793|NCT01960998|469005924|FG001|Overall Study|Lost to Follow-up|7|||
130369606|NCT03329573|469323199|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130369607|NCT03329573|469323200|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130369608|NCT03329573|469323201|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130369609|NCT03329573|469323198|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130369610|NCT03329573|469323199|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
130369611|NCT03329573|469323200|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130369612|NCT03329573|469323201|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130369613|NCT02777333|469323204|FG000|Overall Study|Withdrawal by Subject|0|||
130369614|NCT02777333|469323205|FG001|Overall Study|Withdrawal by Subject|1|||
130369615|NCT02777333|469323204|FG000|Overall Study|Lost to Follow-up|0|||
130369616|NCT02777333|469323205|FG001|Overall Study|Lost to Follow-up|1|||
130369617|NCT00837811|469323206|FG000|Overall Study|Adverse Event|4|||
130369618|NCT00837811|469323207|FG001|Overall Study|Adverse Event|6|||
130369619|NCT00837811|469323208|FG002|Overall Study|Adverse Event|0|||
130369620|NCT00837811|469323206|FG000|Overall Study|Death|1|||
130369621|NCT00837811|469323207|FG001|Overall Study|Death|1|||
130369622|NCT00837811|469323208|FG002|Overall Study|Death|0|||
130369623|NCT00837811|469323206|FG000|Overall Study|Lack of Efficacy|0|||
130369624|NCT00837811|469323207|FG001|Overall Study|Lack of Efficacy|11|||
130369625|NCT00837811|469323208|FG002|Overall Study|Lack of Efficacy|0|||
130369626|NCT00837811|469323206|FG000|Overall Study|Lost to Follow-up|1|||
130369627|NCT00837811|469323207|FG001|Overall Study|Lost to Follow-up|3|||
130369628|NCT00837811|469323208|FG002|Overall Study|Lost to Follow-up|0|||
130369629|NCT00837811|469323206|FG000|Overall Study|Physician Decision|0|||
130369630|NCT00837811|469323207|FG001|Overall Study|Physician Decision|2|||
130369631|NCT00837811|469323208|FG002|Overall Study|Physician Decision|1|||
130369632|NCT00837811|469323206|FG000|Overall Study|Withdrawal by Subject|1|||
130369633|NCT00837811|469323207|FG001|Overall Study|Withdrawal by Subject|9|||
130369634|NCT00837811|469323208|FG002|Overall Study|Withdrawal by Subject|0|||
130369635|NCT00837811|469323206|FG000|Overall Study|Sponsor Decision|0|||
130369636|NCT00837811|469323207|FG001|Overall Study|Sponsor Decision|2|||
130369637|NCT00837811|469323208|FG002|Overall Study|Sponsor Decision|0|||
130369638|NCT03307967|469323209|FG000|Overall Study|Lost to Follow-up|4|||
130369639|NCT02578316|469323210|FG000|Extension Phase|Progression of disease|6|||
130369640|NCT05372419|469323211|FG000|Overall Study|Protocol Deviation|1|||
130369641|NCT05372419|469323211|FG000|Overall Study|Withdrawal by Subject|5|||
130369642|NCT05372419|469323211|FG000|Overall Study|Lost to Follow-up|7|||
130369643|NCT04362072|469323215|FG000|Treatment|Adverse Event|1|||
130369644|NCT04362072|469323215|FG000|Treatment|Death|9|||
130369645|NCT04362072|469323215|FG000|Treatment|Physician Decision|2|||
130369646|NCT04362072|469323215|FG000|Treatment|Progressive disease|27|||
130369647|NCT04362072|469323215|FG000|Treatment|Withdrawal by Subject|4|||
130369648|NCT04362072|469323215|FG000|Treatment|Global deterioration of health status|1|||
130369649|NCT04362072|469323215|FG000|Treatment|Switched to commercial Lorlatinib|13|||
130369650|NCT04362072|469323215|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
130369651|NCT04362072|469323215|FG000|Treatment|Other|3|||
130369652|NCT04362072|469323215|FG000|Follow up|Death|2|||
130369653|NCT04362072|469323215|FG000|Follow up|Other|2|||
130284794|NCT01960998|469005923|FG000|Overall Study|Death|0|||
130284795|NCT01960998|469005924|FG001|Overall Study|Death|1|||
130284796|NCT01960998|469005923|FG000|Overall Study|Withdrawal by Subject|8|||
130284797|NCT01960998|469005924|FG001|Overall Study|Withdrawal by Subject|2|||
130369654|NCT01133522|469323216|FG000|Overall Study|Withdrawal by Subject|0|||
130369655|NCT01133522|469323217|FG001|Overall Study|Withdrawal by Subject|1|||
130369656|NCT01133522|469323218|FG002|Overall Study|Withdrawal by Subject|0|||
130369657|NCT01133522|469323219|FG003|Overall Study|Withdrawal by Subject|1|||
130369658|NCT01133522|469323220|FG004|Overall Study|Withdrawal by Subject|0|||
130369659|NCT01133522|469323221|FG005|Overall Study|Withdrawal by Subject|0|||
130284798|NCT01960998|469005923|FG000|Overall Study|lost computer access|0|||
130284799|NCT01960998|469005924|FG001|Overall Study|lost computer access|1|||
130284800|NCT00759356|469005925|FG000|Overall Study|Adverse Event|0|||
130284801|NCT00759356|469005926|FG001|Overall Study|Adverse Event|1|||
130284802|NCT00759356|469005925|FG000|Overall Study|Withdrawal by Subject|0|||
130284803|NCT00759356|469005926|FG001|Overall Study|Withdrawal by Subject|2|||
130284804|NCT00759356|469005925|FG000|Overall Study|Subject was unable to return|1|||
130284805|NCT00759356|469005926|FG001|Overall Study|Subject was unable to return|0|||
130284806|NCT01713283|469005930|FG000|Overall Study|Lack of Efficacy|10|||
130284807|NCT01713283|469005931|FG001|Overall Study|Lack of Efficacy|2|||
130284808|NCT01713283|469005930|FG000|Overall Study|Lost to Follow-up|1|||
130284809|NCT01713283|469005931|FG001|Overall Study|Lost to Follow-up|1|||
130284810|NCT01904149|469005937|FG000|Overall Study|Adverse Event|3|||
130284811|NCT01904149|469005938|FG001|Overall Study|Adverse Event|4|||
130284812|NCT01904149|469005939|FG002|Overall Study|Adverse Event|0|||
130284813|NCT01904149|469005940|FG003|Overall Study|Adverse Event|1|||
130284814|NCT01904149|469005941|FG004|Overall Study|Adverse Event|1|||
130284815|NCT01904149|469005942|FG005|Overall Study|Adverse Event|2|||
130284816|NCT01904149|469005937|FG000|Overall Study|Lack of Efficacy|0|||
130284817|NCT01904149|469005938|FG001|Overall Study|Lack of Efficacy|3|||
130284818|NCT01904149|469005939|FG002|Overall Study|Lack of Efficacy|1|||
130284819|NCT01904149|469005940|FG003|Overall Study|Lack of Efficacy|3|||
130284820|NCT01904149|469005941|FG004|Overall Study|Lack of Efficacy|3|||
130284821|NCT01904149|469005942|FG005|Overall Study|Lack of Efficacy|1|||
130284822|NCT01904149|469005937|FG000|Overall Study|Withdrawal by Subject|1|||
130284823|NCT01904149|469005938|FG001|Overall Study|Withdrawal by Subject|3|||
130284824|NCT01904149|469005939|FG002|Overall Study|Withdrawal by Subject|1|||
130284825|NCT01904149|469005940|FG003|Overall Study|Withdrawal by Subject|0|||
130284826|NCT01904149|469005941|FG004|Overall Study|Withdrawal by Subject|1|||
130284827|NCT01904149|469005942|FG005|Overall Study|Withdrawal by Subject|0|||
130284828|NCT01904149|469005937|FG000|Overall Study|Protocol Violation|0|||
130284829|NCT01904149|469005938|FG001|Overall Study|Protocol Violation|1|||
130284830|NCT01904149|469005939|FG002|Overall Study|Protocol Violation|0|||
130284831|NCT01904149|469005940|FG003|Overall Study|Protocol Violation|0|||
130284832|NCT01904149|469005941|FG004|Overall Study|Protocol Violation|0|||
130284833|NCT01904149|469005942|FG005|Overall Study|Protocol Violation|0|||
130284834|NCT01904149|469005937|FG000|Overall Study|non compliance with study drug|1|||
130284835|NCT01904149|469005938|FG001|Overall Study|non compliance with study drug|0|||
130284836|NCT01904149|469005939|FG002|Overall Study|non compliance with study drug|0|||
130284837|NCT01904149|469005940|FG003|Overall Study|non compliance with study drug|0|||
130284838|NCT01904149|469005941|FG004|Overall Study|non compliance with study drug|0|||
130284839|NCT01904149|469005942|FG005|Overall Study|non compliance with study drug|0|||
130284840|NCT00812006|469005943|FG000|Overall Study|Lost to Follow-up|0|||
130369660|NCT01133522|469323222|FG006|Overall Study|Withdrawal by Subject|0|||
130458277|NCT03418324|469641658|FG000|Overall Study|Death|0|||
130458278|NCT03418324|469641659|FG001|Overall Study|Death|1|||
130458279|NCT03418324|469641658|FG000|Overall Study|Physician Decision|1|||
130458280|NCT03418324|469641659|FG001|Overall Study|Physician Decision|1|||
130458281|NCT05052983|469641665|FG000|Overall Study|Lack of Efficacy|3|||
130458282|NCT05052983|469641666|FG001|Overall Study|Lack of Efficacy|12|||
130458283|NCT05052983|469641665|FG000|Overall Study|Adverse Event|1|||
130458284|NCT05052983|469641666|FG001|Overall Study|Adverse Event|0|||
130555531|NCT04147234|470003237|FG004|Overall Study|Clinical deterioration|0|||
130555532|NCT04147234|470003238|FG005|Overall Study|Clinical deterioration|0|||
130555533|NCT04147234|470003239|FG006|Overall Study|Clinical deterioration|0|||
130711613|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Adverse Event|4|||
130284841|NCT00812006|469005944|FG001|Overall Study|Lost to Follow-up|0|||
130369661|NCT01133522|469323223|FG007|Overall Study|Withdrawal by Subject|0|||
130369662|NCT01133522|469323224|FG008|Overall Study|Withdrawal by Subject|0|||
130369663|NCT01133522|469323225|FG009|Overall Study|Withdrawal by Subject|0|||
130369664|NCT01133522|469323216|FG000|Overall Study|Physician Decision|0|||
130369665|NCT01133522|469323217|FG001|Overall Study|Physician Decision|0|||
130369666|NCT01133522|469323218|FG002|Overall Study|Physician Decision|0|||
130369667|NCT01133522|469323219|FG003|Overall Study|Physician Decision|0|||
130284842|NCT00812006|469005945|FG002|Overall Study|Lost to Follow-up|2|||
130284843|NCT00812006|469005943|FG000|Overall Study|Physician Decision|0|||
130284844|NCT00812006|469005944|FG001|Overall Study|Physician Decision|0|||
130284845|NCT00812006|469005945|FG002|Overall Study|Physician Decision|1|||
130284846|NCT00812006|469005943|FG000|Overall Study|Withdrawal by Subject|2|||
130284847|NCT00812006|469005944|FG001|Overall Study|Withdrawal by Subject|1|||
130284848|NCT00812006|469005945|FG002|Overall Study|Withdrawal by Subject|1|||
130284849|NCT00812006|469005943|FG000|Overall Study|Lack of Qualifying Event|4|||
130284850|NCT00812006|469005944|FG001|Overall Study|Lack of Qualifying Event|2|||
130284851|NCT00812006|469005945|FG002|Overall Study|Lack of Qualifying Event|2|||
130369668|NCT01133522|469323220|FG004|Overall Study|Physician Decision|1|||
130369669|NCT01133522|469323221|FG005|Overall Study|Physician Decision|0|||
130458285|NCT03425643|469641667|FG000|Overall Study|Withdrawal by Subject|10|||
130458286|NCT03425643|469641668|FG001|Overall Study|Withdrawal by Subject|12|||
130369670|NCT01133522|469323222|FG006|Overall Study|Physician Decision|0|||
130369671|NCT01133522|469323223|FG007|Overall Study|Physician Decision|0|||
130369672|NCT01133522|469323224|FG008|Overall Study|Physician Decision|0|||
130369673|NCT01133522|469323225|FG009|Overall Study|Physician Decision|0|||
130369674|NCT02513394|469323228|FG000|Overall Study|Withdrawal by Subject|11|||
130369675|NCT02513394|469323229|FG001|Overall Study|Withdrawal by Subject|23|||
130711614|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711615|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711616|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711617|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130711618|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130711619|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711620|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Patient decision|0|||
130711621|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Patient decision|0|||
130711622|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Patient decision|0|||
130711623|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Patient decision|0|||
130711624|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Patient decision|1|||
130711625|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Patient decision|0|||
130369676|NCT02513394|469323228|FG000|Overall Study|Ineligible|1|||
130369677|NCT02513394|469323229|FG001|Overall Study|Ineligible|0|||
130369678|NCT04292743|469323230|FG000|Overall Study|Physician Decision|1|||
130369679|NCT04292743|469323231|FG001|Overall Study|Physician Decision|3|||
130369680|NCT04292743|469323232|FG002|Overall Study|Physician Decision|0|||
130369681|NCT04292743|469323233|FG003|Overall Study|Physician Decision|0|||
130369682|NCT04292743|469323230|FG000|Overall Study|Withdrawal by Subject|0|||
130369683|NCT04292743|469323231|FG001|Overall Study|Withdrawal by Subject|5|||
130369684|NCT04292743|469323232|FG002|Overall Study|Withdrawal by Subject|0|||
130369685|NCT04292743|469323233|FG003|Overall Study|Withdrawal by Subject|0|||
130711626|NCT03265288|470569874|FG000|Overall Study|Adverse Event|0|||
130711627|NCT03265288|470569875|FG001|Overall Study|Adverse Event|1|||
130369686|NCT04292743|469323230|FG000|Overall Study|Death|0|||
130369687|NCT04292743|469323231|FG001|Overall Study|Death|1|||
130369688|NCT04292743|469323232|FG002|Overall Study|Death|0|||
130369689|NCT04292743|469323233|FG003|Overall Study|Death|0|||
130369690|NCT04292743|469323230|FG000|Overall Study|Progression of Disease|2|||
130369691|NCT04292743|469323231|FG001|Overall Study|Progression of Disease|5|||
130369692|NCT04292743|469323232|FG002|Overall Study|Progression of Disease|0|||
130369693|NCT04292743|469323233|FG003|Overall Study|Progression of Disease|0|||
130369694|NCT04292743|469323230|FG000|Overall Study|No Treatment per protocol|0|||
130369695|NCT04292743|469323231|FG001|Overall Study|No Treatment per protocol|2|||
130369696|NCT04292743|469323232|FG002|Overall Study|No Treatment per protocol|0|||
130369697|NCT04292743|469323233|FG003|Overall Study|No Treatment per protocol|0|||
130369698|NCT05766423|469323234|FG000|Overall Study|Withdrawal by Subject|1|||
130369699|NCT05766423|469323235|FG001|Overall Study|Withdrawal by Subject|0|||
130369700|NCT05766423|469323234|FG000|Overall Study|Consented, not scheduled|3|||
130369701|NCT05766423|469323235|FG001|Overall Study|Consented, not scheduled|5|||
130369702|NCT02385045|469325071|FG000|Overall Study|Endoscopy could not be completed|4|||
130369703|NCT00042289|469325073|FG000|Overall Study|Lost to Follow-up|3|||
130369704|NCT00042289|469325074|FG001|Overall Study|Lost to Follow-up|0|||
130369705|NCT00042289|469325075|FG002|Overall Study|Lost to Follow-up|0|||
130369706|NCT00042289|469325076|FG003|Overall Study|Lost to Follow-up|1|||
130555534|NCT04147234|470003233|FG000|Overall Study|Withdrawal by Subject|0|||
130555535|NCT04147234|470003234|FG001|Overall Study|Withdrawal by Subject|1|||
130555536|NCT04147234|470003235|FG002|Overall Study|Withdrawal by Subject|1|||
130555537|NCT04147234|470003236|FG003|Overall Study|Withdrawal by Subject|0|||
130369707|NCT00042289|469325077|FG004|Overall Study|Lost to Follow-up|3|||
130369708|NCT00042289|469325078|FG005|Overall Study|Lost to Follow-up|3|||
130369709|NCT00042289|469325079|FG006|Overall Study|Lost to Follow-up|6|||
130369710|NCT00042289|469325080|FG007|Overall Study|Lost to Follow-up|1|||
130369711|NCT00042289|469325081|FG008|Overall Study|Lost to Follow-up|1|||
130369712|NCT00042289|469325082|FG009|Overall Study|Lost to Follow-up|0|||
130369713|NCT00042289|469325083|FG010|Overall Study|Lost to Follow-up|0|||
130369714|NCT00042289|469325084|FG011|Overall Study|Lost to Follow-up|0|||
130369715|NCT00042289|469325085|FG012|Overall Study|Lost to Follow-up|0|||
130369716|NCT00042289|469325086|FG013|Overall Study|Lost to Follow-up|0|||
130369717|NCT00042289|469325087|FG014|Overall Study|Lost to Follow-up|0|||
130369718|NCT00042289|469325088|FG015|Overall Study|Lost to Follow-up|1|||
130369719|NCT00042289|469325089|FG016|Overall Study|Lost to Follow-up|1|||
130369720|NCT00042289|469325090|FG017|Overall Study|Lost to Follow-up|0|||
130369721|NCT00042289|469325091|FG018|Overall Study|Lost to Follow-up|3|||
130369722|NCT00042289|469325092|FG019|Overall Study|Lost to Follow-up|2|||
130369723|NCT00042289|469325093|FG020|Overall Study|Lost to Follow-up|0|||
130369724|NCT00042289|469325094|FG021|Overall Study|Lost to Follow-up|0|||
130369725|NCT00042289|469325095|FG022|Overall Study|Lost to Follow-up|0|||
130369726|NCT00042289|469325096|FG023|Overall Study|Lost to Follow-up|0|||
130369727|NCT00042289|469325097|FG024|Overall Study|Lost to Follow-up|0|||
130369728|NCT00042289|469325098|FG025|Overall Study|Lost to Follow-up|0|||
130711628|NCT03265288|470569874|FG000|Overall Study|Withdrawal by Subject|13|||
130711629|NCT03265288|470569875|FG001|Overall Study|Withdrawal by Subject|5|||
130711630|NCT03265288|470569874|FG000|Overall Study|Drug Withdrawn|3|||
130711631|NCT03265288|470569875|FG001|Overall Study|Drug Withdrawn|3|||
130711632|NCT03265288|470569874|FG000|Overall Study|Any Other Reason|7|||
130711633|NCT03265288|470569875|FG001|Overall Study|Any Other Reason|3|||
130711634|NCT03197558|470569876|FG000|Overall Study|Tubes not placed|1|||
130711635|NCT00468728|470569879|FG000|Treatment|criteria for mITT population|4|||
130711636|NCT00468728|470569880|FG001|Treatment|criteria for mITT population|11|||
130711637|NCT00468728|470569879|FG000|Follow-up|mITT failure|34|||
130711638|NCT00468728|470569880|FG001|Follow-up|mITT failure|31|||
130711639|NCT03463993|470569882|FG000|Overall Study|Lost to Follow-up|7|||
130711640|NCT03463993|470569883|FG001|Overall Study|Lost to Follow-up|8|||
130711641|NCT03463993|470569882|FG000|Overall Study|Withdrawal by Subject|2|||
130711642|NCT03463993|470569883|FG001|Overall Study|Withdrawal by Subject|0|||
130711643|NCT03463993|470569882|FG000|Overall Study|Protocol Violation|4|||
130711644|NCT03463993|470569883|FG001|Overall Study|Protocol Violation|1|||
130711645|NCT03463993|470569882|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
130711646|NCT03463993|470569883|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
130711647|NCT03463993|470569882|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
130711648|NCT03463993|470569883|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
130284852|NCT00235391|469005946|FG000|Overall Study|Adverse Event|4|||
130284853|NCT00235391|469005947|FG001|Overall Study|Adverse Event|5|||
130284854|NCT00235391|469005948|FG002|Overall Study|Adverse Event|10|||
130284855|NCT00235391|469005949|FG003|Overall Study|Adverse Event|72|||
130284856|NCT00235391|469005950|FG004|Overall Study|Adverse Event|5|||
130284857|NCT00235391|469005951|FG005|Overall Study|Adverse Event|2|||
130284858|NCT00235391|469005946|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130284859|NCT00235391|469005947|FG001|Overall Study|Abnormal laboratory value(s)|5|||
130284860|NCT00235391|469005948|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130284861|NCT00235391|469005949|FG003|Overall Study|Abnormal laboratory value(s)|27|||
130284862|NCT00235391|469005950|FG004|Overall Study|Abnormal laboratory value(s)|1|||
130284863|NCT00235391|469005951|FG005|Overall Study|Abnormal laboratory value(s)|2|||
130284864|NCT00235391|469005946|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130284865|NCT00235391|469005947|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130284866|NCT00235391|469005948|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130284867|NCT00235391|469005949|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
130284868|NCT00235391|469005950|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130284869|NCT00235391|469005951|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130284870|NCT00235391|469005946|FG000|Overall Study|Condition no longer requires treatment|3|||
130284871|NCT00235391|469005947|FG001|Overall Study|Condition no longer requires treatment|0|||
130284872|NCT00235391|469005948|FG002|Overall Study|Condition no longer requires treatment|0|||
130284873|NCT00235391|469005949|FG003|Overall Study|Condition no longer requires treatment|11|||
130284874|NCT00235391|469005950|FG004|Overall Study|Condition no longer requires treatment|1|||
130284875|NCT00235391|469005951|FG005|Overall Study|Condition no longer requires treatment|0|||
130284876|NCT00235391|469005946|FG000|Overall Study|Protocol deviation|0|||
130284877|NCT00235391|469005947|FG001|Overall Study|Protocol deviation|0|||
130284878|NCT00235391|469005948|FG002|Overall Study|Protocol deviation|1|||
130284879|NCT00235391|469005949|FG003|Overall Study|Protocol deviation|11|||
130284880|NCT00235391|469005950|FG004|Overall Study|Protocol deviation|0|||
130284881|NCT00235391|469005951|FG005|Overall Study|Protocol deviation|0|||
130284882|NCT00235391|469005946|FG000|Overall Study|Withdrawal by Subject|2|||
130284883|NCT00235391|469005947|FG001|Overall Study|Withdrawal by Subject|3|||
130284884|NCT00235391|469005948|FG002|Overall Study|Withdrawal by Subject|3|||
130284885|NCT00235391|469005949|FG003|Overall Study|Withdrawal by Subject|61|||
130284886|NCT00235391|469005950|FG004|Overall Study|Withdrawal by Subject|5|||
130284887|NCT00235391|469005951|FG005|Overall Study|Withdrawal by Subject|0|||
130711649|NCT01478828|470569885|FG000|Overall Study|Adverse Event|1|||
130284888|NCT00235391|469005946|FG000|Overall Study|Lost to Follow-up|0|||
130284889|NCT00235391|469005947|FG001|Overall Study|Lost to Follow-up|3|||
130284890|NCT00235391|469005948|FG002|Overall Study|Lost to Follow-up|3|||
130284891|NCT00235391|469005949|FG003|Overall Study|Lost to Follow-up|16|||
130284892|NCT00235391|469005950|FG004|Overall Study|Lost to Follow-up|0|||
130284893|NCT00235391|469005951|FG005|Overall Study|Lost to Follow-up|0|||
130284894|NCT00235391|469005946|FG000|Overall Study|Administrative problems|0|||
130284895|NCT00235391|469005947|FG001|Overall Study|Administrative problems|0|||
130284896|NCT00235391|469005948|FG002|Overall Study|Administrative problems|0|||
130284897|NCT00235391|469005949|FG003|Overall Study|Administrative problems|1|||
130284898|NCT00235391|469005950|FG004|Overall Study|Administrative problems|0|||
130711650|NCT02278718|470569886|FG000|Overall Study|Adverse Event|1|||
130711651|NCT02278718|470569887|FG001|Overall Study|Adverse Event|0|||
130711652|NCT02278718|470569886|FG000|Overall Study|Lost to Follow-up|2|||
130711653|NCT02278718|470569887|FG001|Overall Study|Lost to Follow-up|4|||
130711654|NCT02278718|470569886|FG000|Overall Study|Withdrawal by Subject|1|||
130711655|NCT02278718|470569887|FG001|Overall Study|Withdrawal by Subject|4|||
130284899|NCT00235391|469005951|FG005|Overall Study|Administrative problems|0|||
130284900|NCT00235391|469005946|FG000|Overall Study|Death|0|||
130284901|NCT00235391|469005947|FG001|Overall Study|Death|0|||
130284902|NCT00235391|469005948|FG002|Overall Study|Death|1|||
130284903|NCT00235391|469005949|FG003|Overall Study|Death|4|||
130284904|NCT00235391|469005950|FG004|Overall Study|Death|0|||
130284905|NCT00235391|469005951|FG005|Overall Study|Death|0|||
130284906|NCT00098748|469005955|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
130284907|NCT00098748|469005956|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
130284908|NCT00098748|469005957|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
130284909|NCT00098748|469005955|FG000|Received Study Treatment|Death|2|||
130284910|NCT00098748|469005956|FG001|Received Study Treatment|Death|1|||
130284911|NCT00098748|469005957|FG002|Received Study Treatment|Death|2|||
130284912|NCT00098748|469005955|FG000|Received Study Treatment|Adverse Event|1|||
130284913|NCT00098748|469005956|FG001|Received Study Treatment|Adverse Event|2|||
130284914|NCT00098748|469005957|FG002|Received Study Treatment|Adverse Event|5|||
130284915|NCT00098748|469005955|FG000|Received Study Treatment|Lack of Efficacy|40|||
130284916|NCT00098748|469005956|FG001|Received Study Treatment|Lack of Efficacy|27|||
130284917|NCT00098748|469005957|FG002|Received Study Treatment|Lack of Efficacy|27|||
130284918|NCT00098748|469005955|FG000|Received Study Treatment|Other|2|||
130284919|NCT00098748|469005956|FG001|Received Study Treatment|Other|2|||
130284920|NCT00098748|469005957|FG002|Received Study Treatment|Other|6|||
130284921|NCT00098748|469005955|FG000|Received Study Treatment|Subject defaulted|3|||
130284922|NCT00098748|469005956|FG001|Received Study Treatment|Subject defaulted|4|||
130284923|NCT00098748|469005957|FG002|Received Study Treatment|Subject defaulted|4|||
130284924|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
130284925|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
130284926|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
130284927|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
130284928|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
130284929|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
130284930|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
130284931|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
130284932|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
130284933|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130284934|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130284935|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
130284936|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130369729|NCT00042289|469325099|FG026|Overall Study|Lost to Follow-up|2|||
130369730|NCT00042289|469325100|FG027|Overall Study|Lost to Follow-up|2|||
130369731|NCT00042289|469325101|FG028|Overall Study|Lost to Follow-up|2|||
130369732|NCT00042289|469325102|FG029|Overall Study|Lost to Follow-up|0|||
130369733|NCT00042289|469325103|FG030|Overall Study|Lost to Follow-up|0|||
130369734|NCT00042289|469325104|FG031|Overall Study|Lost to Follow-up|2|||
130369735|NCT00042289|469325105|FG032|Overall Study|Lost to Follow-up|1|||
130369736|NCT00042289|469325106|FG033|Overall Study|Lost to Follow-up|1|||
130369737|NCT00042289|469325107|FG034|Overall Study|Lost to Follow-up|1|||
130369738|NCT00042289|469325108|FG035|Overall Study|Lost to Follow-up|2|||
130369739|NCT00042289|469325109|FG036|Overall Study|Lost to Follow-up|1|||
130369740|NCT00042289|469325110|FG037|Overall Study|Lost to Follow-up|1|||
130369741|NCT00042289|469325111|FG038|Overall Study|Lost to Follow-up|0|||
130369742|NCT00042289|469325112|FG039|Overall Study|Lost to Follow-up|5|||
130369743|NCT00042289|469325113|FG040|Overall Study|Lost to Follow-up|0|||
130369744|NCT00042289|469325114|FG041|Overall Study|Lost to Follow-up|2|||
130369745|NCT00042289|469325115|FG042|Overall Study|Lost to Follow-up|2|||
130369746|NCT00042289|469325116|FG043|Overall Study|Lost to Follow-up|0|||
130369747|NCT00042289|469325117|FG044|Overall Study|Lost to Follow-up|0|||
130369748|NCT00042289|469325118|FG045|Overall Study|Lost to Follow-up|1|||
130369749|NCT00042289|469325119|FG046|Overall Study|Lost to Follow-up|0|||
130369750|NCT00042289|469325073|FG000|Overall Study|Other reason|0|||
130369751|NCT00042289|469325074|FG001|Overall Study|Other reason|0|||
130369752|NCT00042289|469325075|FG002|Overall Study|Other reason|0|||
130369753|NCT00042289|469325076|FG003|Overall Study|Other reason|2|||
130369754|NCT00042289|469325077|FG004|Overall Study|Other reason|0|||
130369755|NCT00042289|469325078|FG005|Overall Study|Other reason|0|||
130369756|NCT00042289|469325079|FG006|Overall Study|Other reason|0|||
130369757|NCT00042289|469325080|FG007|Overall Study|Other reason|0|||
130369758|NCT00042289|469325081|FG008|Overall Study|Other reason|0|||
130369759|NCT00042289|469325082|FG009|Overall Study|Other reason|0|||
130369760|NCT00042289|469325083|FG010|Overall Study|Other reason|0|||
130369761|NCT00042289|469325084|FG011|Overall Study|Other reason|0|||
130369762|NCT00042289|469325085|FG012|Overall Study|Other reason|0|||
130369763|NCT00042289|469325086|FG013|Overall Study|Other reason|0|||
130369764|NCT00042289|469325087|FG014|Overall Study|Other reason|0|||
130369765|NCT00042289|469325088|FG015|Overall Study|Other reason|0|||
130369766|NCT00042289|469325089|FG016|Overall Study|Other reason|0|||
130284937|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
130284938|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130284939|NCT00570037|469005958|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
130284940|NCT00570037|469005959|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
130284941|NCT01081301|469005962|FG000|Overall Study|Bereaved|3|||
130284942|NCT01081301|469005962|FG000|Overall Study|Too busy|5|||
130284943|NCT01081301|469005962|FG000|Overall Study|Patient too ill|2|||
130284944|NCT01081301|469005962|FG000|Overall Study|Lost to Follow-up|4|||
130284945|NCT03551665|469005963|FG000|Overall Study|Lost to Follow-up|11|||
130284946|NCT03551665|469005964|FG001|Overall Study|Lost to Follow-up|2|||
130284947|NCT00413894|469007950|FG000|Overall Study|Withdrawal by Subject|10|||
130284948|NCT00413894|469007950|FG000|Overall Study|Administrative Reasons|1|||
130284949|NCT00413894|469007950|FG000|Overall Study|Hb <10 grams/deciliter|12|||
130284950|NCT00413894|469007950|FG000|Overall Study|Adverse Event|28|||
130284951|NCT00413894|469007950|FG000|Overall Study|Protocol Violation|11|||
130284952|NCT00413894|469007950|FG000|Overall Study|Other|18|||
130284953|NCT01942161|469007951|FG000|Overall Study|Adverse Event|1|||
130284954|NCT01942161|469007952|FG001|Overall Study|Adverse Event|2|||
130284955|NCT01942161|469007953|FG002|Overall Study|Adverse Event|5|||
130284956|NCT01942161|469007951|FG000|Overall Study|Physician Decision|3|||
130284957|NCT01942161|469007952|FG001|Overall Study|Physician Decision|1|||
130284958|NCT01942161|469007953|FG002|Overall Study|Physician Decision|0|||
130284959|NCT01942161|469007951|FG000|Overall Study|Protocol Violation|1|||
130284960|NCT01942161|469007952|FG001|Overall Study|Protocol Violation|0|||
130284961|NCT01942161|469007953|FG002|Overall Study|Protocol Violation|0|||
130284962|NCT01942161|469007951|FG000|Overall Study|Withdrawal by Subject|3|||
130284963|NCT01942161|469007952|FG001|Overall Study|Withdrawal by Subject|3|||
130284964|NCT01942161|469007953|FG002|Overall Study|Withdrawal by Subject|1|||
130284965|NCT02251717|469007957|FG000|Overall Study|Adverse Event|0|||
130284966|NCT02251717|469007958|FG001|Overall Study|Adverse Event|1|||
130284967|NCT02251717|469007957|FG000|Overall Study|Withdrew Consent|1|||
130284968|NCT02251717|469007958|FG001|Overall Study|Withdrew Consent|0|||
130284969|NCT03356977|469007959|FG000|Overall Study|Lost to Follow-up|3|||
130284970|NCT03356977|469007959|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130284971|NCT00445939|469007963|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
130284972|NCT00445939|469007964|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
130284973|NCT00445939|469007965|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
130284974|NCT00445939|469007966|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
130284975|NCT00445939|469007963|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
130284976|NCT00445939|469007964|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
130284977|NCT00445939|469007965|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
130284978|NCT00445939|469007966|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
130284979|NCT00378599|469007970|FG000|Overall Study|Adverse Event|38|||
130284980|NCT00378599|469007970|FG000|Overall Study|Protocol Violation|2|||
130284981|NCT00378599|469007970|FG000|Overall Study|Treatment failure|7|||
130284982|NCT00378599|469007970|FG000|Overall Study|Withdrawal by Subject|5|||
130284983|NCT00489736|469007971|FG000|Overall Study|Lack of Efficacy|53|||
130458287|NCT03425643|469641667|FG000|Overall Study|Lost to Follow-up|2|||
130458288|NCT03425643|469641668|FG001|Overall Study|Lost to Follow-up|0|||
130458289|NCT03425643|469641667|FG000|Overall Study|Death|109|||
130458290|NCT03425643|469641668|FG001|Overall Study|Death|141|||
130458291|NCT03425643|469641667|FG000|Overall Study|Ongoing in study|276|||
130458292|NCT03425643|469641668|FG001|Overall Study|Ongoing in study|247|||
130458293|NCT04133363|469641669|FG000|Overall Study|Lost to Follow-up|2|||
130458294|NCT04133363|469641670|FG001|Overall Study|Lost to Follow-up|1|||
130458295|NCT04133363|469641671|FG002|Overall Study|Lost to Follow-up|4|||
130458296|NCT04199728|469643412|FG000|Overall Study|Adverse Event|1|||
130458297|NCT04199728|469643413|FG001|Overall Study|Adverse Event|0|||
130458298|NCT04199728|469643412|FG000|Overall Study|Withdrawal by Subject|8|||
130458299|NCT04199728|469643413|FG001|Overall Study|Withdrawal by Subject|3|||
130458300|NCT04199728|469643412|FG000|Overall Study|Screen fail after consent|0|||
130458301|NCT04199728|469643413|FG001|Overall Study|Screen fail after consent|1|||
130458302|NCT04199728|469643412|FG000|Overall Study|Early withdraw criteria met|0|||
130458303|NCT04199728|469643413|FG001|Overall Study|Early withdraw criteria met|1|||
130458304|NCT04199728|469643412|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
130458305|NCT04199728|469643413|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
130458306|NCT00482729|469643414|FG000|Overall Study|Adverse Event|29|||
130458307|NCT00482729|469643415|FG001|Overall Study|Adverse Event|33|||
130458308|NCT00482729|469643414|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
130555538|NCT04147234|470003237|FG004|Overall Study|Withdrawal by Subject|0|||
130458309|NCT00482729|469643415|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
130284984|NCT00489736|469007972|FG001|Overall Study|Lack of Efficacy|14|||
130284985|NCT00489736|469007971|FG000|Overall Study|Adverse Event|32|||
130284986|NCT00489736|469007972|FG001|Overall Study|Adverse Event|45|||
130284987|NCT00489736|469007971|FG000|Overall Study|Poor compliance|6|||
130458310|NCT00482729|469643414|FG000|Overall Study|Hyperglycemia Criteria|7|||
130711656|NCT02278718|470569886|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
130711657|NCT02278718|470569887|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
130711658|NCT02278718|470569886|FG000|Overall Study|Missing|0|||
130711659|NCT02278718|470569887|FG001|Overall Study|Missing|1|||
130711660|NCT04440449|470569888|FG000|Overall Study|Lost to Follow-up|2|||
130711661|NCT04440449|470569889|FG001|Overall Study|Lost to Follow-up|0|||
130711662|NCT00897949|470569890|FG000|Overall Study|Adverse Event|1|||
130711663|NCT00897949|470569891|FG001|Overall Study|Adverse Event|1|||
130711664|NCT00897949|470569892|FG002|Overall Study|Adverse Event|0|||
130711665|NCT00897949|470569890|FG000|Overall Study|Lost to Follow-up|0|||
130711666|NCT00897949|470569891|FG001|Overall Study|Lost to Follow-up|2|||
130711667|NCT00897949|470569892|FG002|Overall Study|Lost to Follow-up|1|||
130711668|NCT00897949|470569890|FG000|Overall Study|Protocol Violation|6|||
130711669|NCT00897949|470569891|FG001|Overall Study|Protocol Violation|3|||
130711670|NCT00897949|470569892|FG002|Overall Study|Protocol Violation|1|||
130711671|NCT00897949|470569890|FG000|Overall Study|Withdrawal by Subject|1|||
130711672|NCT00897949|470569891|FG001|Overall Study|Withdrawal by Subject|2|||
130711673|NCT00897949|470569892|FG002|Overall Study|Withdrawal by Subject|0|||
130711674|NCT00897949|470569890|FG000|Overall Study|Patient Uncoorperative|0|||
130711675|NCT00897949|470569891|FG001|Overall Study|Patient Uncoorperative|2|||
130711676|NCT00897949|470569892|FG002|Overall Study|Patient Uncoorperative|1|||
130711677|NCT00897949|470569890|FG000|Overall Study|Lost to Follow-up|30|||
130711678|NCT00897949|470569891|FG001|Overall Study|Lost to Follow-up|23|||
130711679|NCT00897949|470569892|FG002|Overall Study|Lost to Follow-up|17|||
130711680|NCT00897949|470569890|FG000|Overall Study|Withdrawal by Subject|24|||
130711681|NCT00897949|470569891|FG001|Overall Study|Withdrawal by Subject|31|||
130711682|NCT00897949|470569892|FG002|Overall Study|Withdrawal by Subject|17|||
130711683|NCT00897949|470569890|FG000|Overall Study|Abnormal Prestudy Labs|2|||
130711684|NCT00897949|470569891|FG001|Overall Study|Abnormal Prestudy Labs|3|||
130711685|NCT00897949|470569892|FG002|Overall Study|Abnormal Prestudy Labs|4|||
130284988|NCT00489736|469007972|FG001|Overall Study|Poor compliance|2|||
130284989|NCT00489736|469007971|FG000|Overall Study|Not coded/ Not pre-specified|5|||
130284990|NCT00489736|469007972|FG001|Overall Study|Not coded/ Not pre-specified|8|||
130284991|NCT03812185|469007976|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
130284992|NCT02576535|469007979|FG000|Overall Study|Withdrawal by Subject|2|||
130284993|NCT01529515|469007982|FG000|TRANSITION PHASE|Adverse Event|16|||
130284994|NCT01529515|469007983|FG001|TRANSITION PHASE|Adverse Event|0|||
130284995|NCT01529515|469007984|FG002|TRANSITION PHASE|Adverse Event|0|||
130284996|NCT01529515|469007985|FG003|TRANSITION PHASE|Adverse Event|0|||
130284997|NCT01529515|469007982|FG000|TRANSITION PHASE|Death|1|||
130284998|NCT01529515|469007983|FG001|TRANSITION PHASE|Death|0|||
130284999|NCT01529515|469007984|FG002|TRANSITION PHASE|Death|0|||
130285000|NCT01529515|469007985|FG003|TRANSITION PHASE|Death|0|||
130285001|NCT01529515|469007982|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
130285002|NCT01529515|469007983|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
130285003|NCT01529515|469007984|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
130285004|NCT01529515|469007985|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
130285005|NCT01529515|469007982|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
130285006|NCT01529515|469007983|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
130285007|NCT01529515|469007984|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
130285008|NCT01529515|469007985|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
130285009|NCT01529515|469007982|FG000|TRANSITION PHASE|Protocol Violation|4|||
130285010|NCT01529515|469007983|FG001|TRANSITION PHASE|Protocol Violation|0|||
130285011|NCT01529515|469007984|FG002|TRANSITION PHASE|Protocol Violation|0|||
130285012|NCT01529515|469007985|FG003|TRANSITION PHASE|Protocol Violation|0|||
130285013|NCT01529515|469007982|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
130285014|NCT01529515|469007983|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
130285015|NCT01529515|469007984|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
130285016|NCT01529515|469007985|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
130285017|NCT01529515|469007982|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
130458311|NCT00482729|469643415|FG001|Overall Study|Hyperglycemia Criteria|5|||
130458312|NCT00482729|469643414|FG000|Overall Study|Lack of Efficacy|4|||
130711686|NCT00897949|470569890|FG000|Overall Study|Abnormal Baseline ECG|2|||
130711687|NCT00897949|470569891|FG001|Overall Study|Abnormal Baseline ECG|2|||
130458313|NCT00482729|469643415|FG001|Overall Study|Lack of Efficacy|16|||
130458314|NCT00482729|469643414|FG000|Overall Study|Lost to Follow-up|86|||
130711688|NCT00897949|470569892|FG002|Overall Study|Abnormal Baseline ECG|4|||
130711689|NCT00897949|470569890|FG000|Overall Study|Need for Concom. Med.|0|||
130711690|NCT00897949|470569891|FG001|Overall Study|Need for Concom. Med.|1|||
130711691|NCT00897949|470569892|FG002|Overall Study|Need for Concom. Med.|1|||
130711692|NCT00897949|470569890|FG000|Overall Study|Lack of Migraine Attack|29|||
130285018|NCT01529515|469007983|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285019|NCT01529515|469007984|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285020|NCT01529515|469007985|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285021|NCT01529515|469007982|FG000|TRANSITION PHASE|Other|9|||
130285022|NCT01529515|469007983|FG001|TRANSITION PHASE|Other|0|||
130711693|NCT00897949|470569891|FG001|Overall Study|Lack of Migraine Attack|30|||
130369767|NCT00042289|469325090|FG017|Overall Study|Other reason|0|||
130369768|NCT00042289|469325091|FG018|Overall Study|Other reason|1|||
130369769|NCT00042289|469325092|FG019|Overall Study|Other reason|0|||
130369770|NCT00042289|469325093|FG020|Overall Study|Other reason|0|||
130369771|NCT00042289|469325094|FG021|Overall Study|Other reason|0|||
130369772|NCT00042289|469325095|FG022|Overall Study|Other reason|0|||
130369773|NCT00042289|469325096|FG023|Overall Study|Other reason|1|||
130369774|NCT00042289|469325097|FG024|Overall Study|Other reason|0|||
130369775|NCT00042289|469325098|FG025|Overall Study|Other reason|0|||
130369776|NCT00042289|469325099|FG026|Overall Study|Other reason|1|||
130369777|NCT00042289|469325100|FG027|Overall Study|Other reason|0|||
130369778|NCT00042289|469325101|FG028|Overall Study|Other reason|3|||
130369779|NCT00042289|469325102|FG029|Overall Study|Other reason|0|||
130369780|NCT00042289|469325103|FG030|Overall Study|Other reason|0|||
130285023|NCT01529515|469007984|FG002|TRANSITION PHASE|Other|0|||
130285024|NCT01529515|469007985|FG003|TRANSITION PHASE|Other|0|||
130285025|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Adverse Event|0|||
130285026|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Adverse Event|10|||
130285027|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Adverse Event|0|||
130285028|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Adverse Event|0|||
130285029|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285030|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
130285031|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285032|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285033|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285034|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
130285035|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285036|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285037|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
130285038|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
130285039|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
130285040|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
130285041|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285042|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
130285043|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285044|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285045|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285046|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
130285047|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285048|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285049|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Other|0|||
130285050|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Other|10|||
130285051|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Other|0|||
130285052|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Other|0|||
130285053|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
130285054|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
130285055|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
130285056|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
130369781|NCT00042289|469325104|FG031|Overall Study|Other reason|1|||
130369782|NCT00042289|469325105|FG032|Overall Study|Other reason|0|||
130369783|NCT00042289|469325106|FG033|Overall Study|Other reason|1|||
130369784|NCT00042289|469325107|FG034|Overall Study|Other reason|0|||
130369785|NCT00042289|469325108|FG035|Overall Study|Other reason|2|||
130369786|NCT00042289|469325109|FG036|Overall Study|Other reason|0|||
130369787|NCT00042289|469325110|FG037|Overall Study|Other reason|0|||
130369788|NCT00042289|469325111|FG038|Overall Study|Other reason|0|||
130369789|NCT00042289|469325112|FG039|Overall Study|Other reason|0|||
130369790|NCT00042289|469325113|FG040|Overall Study|Other reason|0|||
130369791|NCT00042289|469325114|FG041|Overall Study|Other reason|0|||
130369792|NCT00042289|469325115|FG042|Overall Study|Other reason|0|||
130369793|NCT00042289|469325116|FG043|Overall Study|Other reason|1|||
130369794|NCT00042289|469325117|FG044|Overall Study|Other reason|0|||
130369795|NCT00042289|469325118|FG045|Overall Study|Other reason|0|||
130369796|NCT00042289|469325119|FG046|Overall Study|Other reason|0|||
130369797|NCT00042289|469325073|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130369798|NCT00042289|469325074|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130369799|NCT00042289|469325075|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130369800|NCT00042289|469325076|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130369801|NCT00042289|469325077|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130369802|NCT00042289|469325078|FG005|Overall Study|Severe debilitation, unable to continue|0|||
130369803|NCT00042289|469325079|FG006|Overall Study|Severe debilitation, unable to continue|0|||
130285057|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130285058|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130285059|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
130285060|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
130285061|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
130369804|NCT00042289|469325080|FG007|Overall Study|Severe debilitation, unable to continue|0|||
130458315|NCT00482729|469643415|FG001|Overall Study|Lost to Follow-up|66|||
130458316|NCT00482729|469643414|FG000|Overall Study|Physician Decision|10|||
130458317|NCT00482729|469643415|FG001|Overall Study|Physician Decision|7|||
130458318|NCT00482729|469643414|FG000|Overall Study|Pregnancy|4|||
130458319|NCT00482729|469643415|FG001|Overall Study|Pregnancy|2|||
130458320|NCT00482729|469643414|FG000|Overall Study|Protocol Violation|10|||
130458321|NCT00482729|469643415|FG001|Overall Study|Protocol Violation|18|||
130458322|NCT00482729|469643414|FG000|Overall Study|Withdrawal by Subject|67|||
130458323|NCT00482729|469643415|FG001|Overall Study|Withdrawal by Subject|69|||
130458324|NCT02631148|469643421|FG000|Overall Study|8 were ineligible|8|||
130458325|NCT02631148|469643422|FG001|Overall Study|8 were ineligible|0|||
130285062|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
130285063|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
130285064|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
130285065|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130285066|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130285067|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
130285068|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
130285069|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285070|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285071|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
130285072|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285073|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Other|0|||
130285074|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Other|0|||
130285075|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Other|9|||
130285076|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Other|2|||
130285077|NCT03334851|469007987|FG000|Overall Study|Other|0|||
130285078|NCT03334851|469007988|FG001|Overall Study|Other|0|||
130285079|NCT03334851|469007989|FG002|Overall Study|Other|0|||
130285080|NCT03334851|469007990|FG003|Overall Study|Other|0|||
130285081|NCT03334851|469007991|FG004|Overall Study|Other|0|||
130285082|NCT03334851|469007992|FG005|Overall Study|Other|0|||
130285083|NCT03334851|469007993|FG006|Overall Study|Other|0|||
130285084|NCT03334851|469007994|FG007|Overall Study|Other|1|||
130285085|NCT03334851|469007995|FG008|Overall Study|Other|0|||
130285086|NCT03334851|469007996|FG009|Overall Study|Other|0|||
130285087|NCT03334851|469007997|FG010|Overall Study|Other|0|||
130285088|NCT03334851|469007998|FG011|Overall Study|Other|0|||
130285089|NCT03334851|469007999|FG012|Overall Study|Other|0|||
130285090|NCT03334851|469007987|FG000|Overall Study|Adverse Event|0|||
130285091|NCT03334851|469007988|FG001|Overall Study|Adverse Event|0|||
130285092|NCT03334851|469007989|FG002|Overall Study|Adverse Event|0|||
130285093|NCT03334851|469007990|FG003|Overall Study|Adverse Event|0|||
130285094|NCT03334851|469007991|FG004|Overall Study|Adverse Event|0|||
130285095|NCT03334851|469007992|FG005|Overall Study|Adverse Event|0|||
130285096|NCT03334851|469007993|FG006|Overall Study|Adverse Event|0|||
130285097|NCT03334851|469007994|FG007|Overall Study|Adverse Event|1|||
130285098|NCT03334851|469007995|FG008|Overall Study|Adverse Event|0|||
130285099|NCT03334851|469007996|FG009|Overall Study|Adverse Event|0|||
130285100|NCT03334851|469007997|FG010|Overall Study|Adverse Event|0|||
130285101|NCT03334851|469007998|FG011|Overall Study|Adverse Event|0|||
130285102|NCT03334851|469007999|FG012|Overall Study|Adverse Event|0|||
130285103|NCT03334851|469007987|FG000|Overall Study|Withdrawal by Subject|0|||
130285104|NCT03334851|469007988|FG001|Overall Study|Withdrawal by Subject|0|||
130285105|NCT03334851|469007989|FG002|Overall Study|Withdrawal by Subject|0|||
130285106|NCT03334851|469007990|FG003|Overall Study|Withdrawal by Subject|0|||
130285107|NCT03334851|469007991|FG004|Overall Study|Withdrawal by Subject|0|||
130285108|NCT03334851|469007992|FG005|Overall Study|Withdrawal by Subject|0|||
130285109|NCT03334851|469007993|FG006|Overall Study|Withdrawal by Subject|0|||
130285110|NCT03334851|469007994|FG007|Overall Study|Withdrawal by Subject|0|||
130285111|NCT03334851|469007995|FG008|Overall Study|Withdrawal by Subject|0|||
130285112|NCT03334851|469007996|FG009|Overall Study|Withdrawal by Subject|0|||
130285113|NCT03334851|469007997|FG010|Overall Study|Withdrawal by Subject|1|||
130285114|NCT03334851|469007998|FG011|Overall Study|Withdrawal by Subject|0|||
130458326|NCT02631148|469643421|FG000|Overall Study|Withdrawal by Subject|1|||
130458327|NCT02631148|469643422|FG001|Overall Study|Withdrawal by Subject|0|||
130458328|NCT02631148|469643421|FG000|Overall Study|PAH not available to study participant|1|||
130458329|NCT02631148|469643422|FG001|Overall Study|PAH not available to study participant|0|||
130458330|NCT00487578|469643424|FG000|Overall Study|Adverse Event|1|||
130285115|NCT03334851|469007999|FG012|Overall Study|Withdrawal by Subject|1|||
130285116|NCT03334851|469007987|FG000|Overall Study|Lost to Follow-up|0|||
130285117|NCT03334851|469007988|FG001|Overall Study|Lost to Follow-up|0|||
130285118|NCT03334851|469007989|FG002|Overall Study|Lost to Follow-up|0|||
130285119|NCT03334851|469007990|FG003|Overall Study|Lost to Follow-up|0|||
130285120|NCT03334851|469007991|FG004|Overall Study|Lost to Follow-up|0|||
130285121|NCT03334851|469007992|FG005|Overall Study|Lost to Follow-up|0|||
130285122|NCT03334851|469007993|FG006|Overall Study|Lost to Follow-up|0|||
130458331|NCT00487578|469643425|FG001|Overall Study|Adverse Event|2|||
130458332|NCT00487578|469643424|FG000|Overall Study|Lack of Efficacy|0|||
130285123|NCT03334851|469007994|FG007|Overall Study|Lost to Follow-up|0|||
130285124|NCT03334851|469007995|FG008|Overall Study|Lost to Follow-up|0|||
130285125|NCT03334851|469007996|FG009|Overall Study|Lost to Follow-up|0|||
130285126|NCT03334851|469007997|FG010|Overall Study|Lost to Follow-up|2|||
130285127|NCT03334851|469007998|FG011|Overall Study|Lost to Follow-up|1|||
130285128|NCT03334851|469007999|FG012|Overall Study|Lost to Follow-up|0|||
130285129|NCT03920293|469008000|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
130285130|NCT03920293|469008001|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
130285131|NCT03920293|469008000|FG000|Randomized-Controlled Period|Physician Decision|1|||
130285132|NCT03920293|469008001|FG001|Randomized-Controlled Period|Physician Decision|2|||
130285133|NCT03920293|469008000|FG000|Randomized-Controlled Period|Adverse Event|0|||
130285134|NCT03920293|469008001|FG001|Randomized-Controlled Period|Adverse Event|2|||
130285135|NCT03920293|469008000|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
130285136|NCT03920293|469008001|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
130285137|NCT03920293|469008000|FG000|Randomized-Controlled Period|Death|2|||
130285138|NCT03920293|469008001|FG001|Randomized-Controlled Period|Death|0|||
130285139|NCT03920293|469008000|FG000|Randomized-Controlled Period|Protocol Violation|1|||
130285140|NCT03920293|469008001|FG001|Randomized-Controlled Period|Protocol Violation|0|||
130285141|NCT03920293|469008000|FG000|Randomized-Controlled Period|Noncompliance|1|||
130285142|NCT03920293|469008001|FG001|Randomized-Controlled Period|Noncompliance|0|||
130285143|NCT03920293|469008000|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
130285144|NCT03920293|469008001|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
130285145|NCT03920293|469008000|FG000|Open- Label Extension Period|Death|3|||
130285146|NCT03920293|469008001|FG001|Open- Label Extension Period|Death|3|||
130285147|NCT03920293|469008000|FG000|Open- Label Extension Period|Physician Decision|5|||
130285148|NCT03920293|469008001|FG001|Open- Label Extension Period|Physician Decision|3|||
130285149|NCT03920293|469008000|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
130285150|NCT03920293|469008001|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
130285151|NCT01691885|469008003|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130285152|NCT01691885|469008004|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130285153|NCT01691885|469008003|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
130285154|NCT01691885|469008004|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
130285155|NCT03555981|469008005|FG000|Overall Study|Lost to Follow-up|0|||
130285156|NCT03555981|469008006|FG001|Overall Study|Lost to Follow-up|2|||
130285157|NCT03272828|469008009|FG000|Overall Study|Lost to Follow-up|7|||
130285158|NCT03272828|469008010|FG001|Overall Study|Lost to Follow-up|7|||
130285159|NCT03272828|469008009|FG000|Overall Study|Withdrawal by Subject|2|||
130285160|NCT03272828|469008010|FG001|Overall Study|Withdrawal by Subject|0|||
130555539|NCT04147234|470003238|FG005|Overall Study|Withdrawal by Subject|0|||
130555540|NCT04147234|470003239|FG006|Overall Study|Withdrawal by Subject|0|||
130285161|NCT03272828|469008009|FG000|Overall Study|Deceased|1|||
130285162|NCT03272828|469008010|FG001|Overall Study|Deceased|1|||
130285163|NCT03272828|469008009|FG000|Overall Study|Failed implant|1|||
130285164|NCT03272828|469008010|FG001|Overall Study|Failed implant|2|||
130285165|NCT03575065|469008014|FG000|Overall Study|Death|31|||
130285166|NCT03575065|469008015|FG001|Overall Study|Death|12|||
130285167|NCT03575065|469008014|FG000|Overall Study|Sponsor's Decision|28|||
130285168|NCT03575065|469008015|FG001|Overall Study|Sponsor's Decision|13|||
130285169|NCT03575065|469008014|FG000|Overall Study|Withdrawal by Subject|2|||
130285170|NCT03575065|469008015|FG001|Overall Study|Withdrawal by Subject|1|||
130285171|NCT03575065|469008014|FG000|Overall Study|Lost to Follow-up|1|||
130285172|NCT03575065|469008015|FG001|Overall Study|Lost to Follow-up|0|||
130285173|NCT02323126|469008020|FG000|Overall Study|Patient / guardian decision|0|||
130285174|NCT02323126|469008021|FG001|Overall Study|Patient / guardian decision|1|||
130285175|NCT02323126|469008022|FG002|Overall Study|Patient / guardian decision|2|||
130285176|NCT02323126|469008020|FG000|Overall Study|Progressive disease|14|||
130285177|NCT02323126|469008021|FG001|Overall Study|Progressive disease|8|||
130285178|NCT02323126|469008022|FG002|Overall Study|Progressive disease|14|||
130711694|NCT00897949|470569892|FG002|Overall Study|Lack of Migraine Attack|19|||
130285179|NCT02323126|469008020|FG000|Overall Study|Physician Decision|0|||
130285180|NCT02323126|469008021|FG001|Overall Study|Physician Decision|1|||
130285181|NCT02323126|469008022|FG002|Overall Study|Physician Decision|3|||
130711695|NCT00897949|470569890|FG000|Overall Study|Did not take study drug|9|||
130711696|NCT00897949|470569891|FG001|Overall Study|Did not take study drug|3|||
130711697|NCT00897949|470569892|FG002|Overall Study|Did not take study drug|4|||
130711698|NCT01763918|470569893|FG000|Overall Study|Withdrawal by Subject|2|||
130711699|NCT01763918|470569894|FG001|Overall Study|Withdrawal by Subject|1|||
130711700|NCT01763918|470569895|FG002|Overall Study|Withdrawal by Subject|1|||
130711701|NCT01763918|470569896|FG003|Overall Study|Withdrawal by Subject|2|||
130285182|NCT02323126|469008020|FG000|Overall Study|Death|1|||
130285183|NCT02323126|469008021|FG001|Overall Study|Death|1|||
130285184|NCT02323126|469008022|FG002|Overall Study|Death|4|||
130285185|NCT02323126|469008020|FG000|Overall Study|Adverse Event|3|||
130285186|NCT02323126|469008021|FG001|Overall Study|Adverse Event|5|||
130285187|NCT02323126|469008022|FG002|Overall Study|Adverse Event|7|||
130285188|NCT03350256|469008023|FG000|Overall Study|Inclusion/exclusion violation|4|||
130285189|NCT03350256|469008023|FG000|Overall Study|Recommended for other therapies|2|||
130285190|NCT03350256|469008023|FG000|Overall Study|Protocol Violation|3|||
130285191|NCT03350256|469008023|FG000|Overall Study|Non compliance|2|||
130285192|NCT03350256|469008023|FG000|Overall Study|Denial by insurance|1|||
130285193|NCT03350256|469008023|FG000|Overall Study|Adverse Event|2|||
130285194|NCT03350256|469008023|FG000|Overall Study|Trial failure|12|||
130285195|NCT03350256|469008023|FG000|Overall Study|Did not proceed to permanent implant|3|||
130285196|NCT03350256|469008023|FG000|Overall Study|Withdrawal by Subject|3|||
130285197|NCT03350256|469008023|FG000|Overall Study|Subject moving out of state|1|||
130285198|NCT03350256|469008023|FG000|Overall Study|Lost to Follow-up|1|||
130285199|NCT03350256|469008023|FG000|Overall Study|Lack of Efficacy|2|||
130285200|NCT02324205|469008024|FG000|Overall Study|Withdrawal by Subject|37|||
130285201|NCT03664674|469008032|FG000|Overall Study|Adverse Event|1|||
130285202|NCT03664674|469008033|FG001|Overall Study|Adverse Event|1|||
130285203|NCT03664674|469008032|FG000|Overall Study|Physician Decision|0|||
130285204|NCT03664674|469008033|FG001|Overall Study|Physician Decision|1|||
130285205|NCT03664674|469008032|FG000|Overall Study|Withdrawal by Subject|2|||
130285206|NCT03664674|469008033|FG001|Overall Study|Withdrawal by Subject|0|||
130285207|NCT02174523|469008034|FG000|Overall Study|Withdrawal by Subject|1|||
130285208|NCT02174523|469008035|FG001|Overall Study|Withdrawal by Subject|0|||
130285209|NCT00856206|469008036|FG000|Overall Study|Protocol Violation|6|||
130285210|NCT00856206|469008037|FG001|Overall Study|Protocol Violation|18|||
130285211|NCT00856206|469008036|FG000|Overall Study|Adverse Event|10|||
130285212|NCT00856206|469008037|FG001|Overall Study|Adverse Event|46|||
130285213|NCT00856206|469008036|FG000|Overall Study|Lack of Efficacy|1|||
130285214|NCT00856206|469008037|FG001|Overall Study|Lack of Efficacy|2|||
130285215|NCT00856206|469008036|FG000|Overall Study|Withdrawal by Subject|15|||
130285216|NCT00856206|469008037|FG001|Overall Study|Withdrawal by Subject|36|||
130285217|NCT00856206|469008036|FG000|Overall Study|Lost to Follow-up|13|||
130285218|NCT00856206|469008037|FG001|Overall Study|Lost to Follow-up|39|||
130285219|NCT00856206|469008036|FG000|Overall Study|Death|2|||
130285220|NCT00856206|469008037|FG001|Overall Study|Death|2|||
130285221|NCT00856206|469008036|FG000|Overall Study|Decision by the Sponsor|4|||
130285222|NCT00856206|469008037|FG001|Overall Study|Decision by the Sponsor|8|||
130285223|NCT00856206|469008036|FG000|Overall Study|Other than specified above|3|||
130285224|NCT00856206|469008037|FG001|Overall Study|Other than specified above|10|||
130285225|NCT02780856|469008042|FG000|Overall Study|Lost to Follow-up|1|||
130285226|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
130285227|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
130285228|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
130285229|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
130285230|NCT03006458|469008047|FG000|First Intervention|Unsatisfied Vision|0|||
130285231|NCT03006458|469008048|FG001|First Intervention|Unsatisfied Vision|3|||
130285232|NCT01468233|469008054|FG000|Treatment Period 1|Adverse Event|5|||
130285233|NCT01468233|469008055|FG001|Treatment Period 1|Adverse Event|3|||
130285234|NCT01468233|469008056|FG002|Treatment Period 1|Adverse Event|0|||
130285235|NCT01468233|469008057|FG003|Treatment Period 1|Adverse Event|0|||
130285236|NCT01468233|469008058|FG004|Treatment Period 1|Adverse Event|0|||
130285237|NCT01468233|469008059|FG005|Treatment Period 1|Adverse Event|0|||
130285238|NCT01468233|469008054|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130285239|NCT01468233|469008055|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130285240|NCT01468233|469008056|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130285241|NCT01468233|469008057|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130711702|NCT01763918|470569893|FG000|Overall Study|Sponsor Decision|4|||
130711703|NCT01763918|470569894|FG001|Overall Study|Sponsor Decision|0|||
130711704|NCT01763918|470569895|FG002|Overall Study|Sponsor Decision|9|||
130711705|NCT01763918|470569896|FG003|Overall Study|Sponsor Decision|0|||
130711706|NCT01553747|470569897|FG000|Overall Study|Protocol Violation|0|||
130711707|NCT01553747|470569898|FG001|Overall Study|Protocol Violation|2|||
130711708|NCT01553747|470569899|FG002|Overall Study|Protocol Violation|0|||
130711709|NCT01553747|470569897|FG000|Overall Study|Voluntarily withdrew|70|||
130711710|NCT01553747|470569898|FG001|Overall Study|Voluntarily withdrew|66|||
130711711|NCT01553747|470569899|FG002|Overall Study|Voluntarily withdrew|74|||
130711712|NCT01553747|470569897|FG000|Overall Study|Adverse event or SAE|32|||
130285242|NCT01468233|469008058|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130285243|NCT01468233|469008059|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130285244|NCT01468233|469008054|FG000|Treatment Period 1|Lost to Follow-up|3|||
130285245|NCT01468233|469008055|FG001|Treatment Period 1|Lost to Follow-up|0|||
130285246|NCT01468233|469008056|FG002|Treatment Period 1|Lost to Follow-up|0|||
130285247|NCT01468233|469008057|FG003|Treatment Period 1|Lost to Follow-up|0|||
130285248|NCT01468233|469008058|FG004|Treatment Period 1|Lost to Follow-up|0|||
130285249|NCT01468233|469008059|FG005|Treatment Period 1|Lost to Follow-up|0|||
130285250|NCT01468233|469008054|FG000|Treatment Period 1|Other|1|||
130285251|NCT01468233|469008055|FG001|Treatment Period 1|Other|1|||
130711713|NCT01553747|470569898|FG001|Overall Study|Adverse event or SAE|28|||
130285252|NCT01468233|469008056|FG002|Treatment Period 1|Other|0|||
130285253|NCT01468233|469008057|FG003|Treatment Period 1|Other|0|||
130285254|NCT01468233|469008058|FG004|Treatment Period 1|Other|0|||
130285255|NCT01468233|469008059|FG005|Treatment Period 1|Other|0|||
130285256|NCT01468233|469008054|FG000|Treatment Period 2|Adverse Event|0|||
130285257|NCT01468233|469008055|FG001|Treatment Period 2|Adverse Event|0|||
130285258|NCT01468233|469008056|FG002|Treatment Period 2|Adverse Event|3|||
130285259|NCT01468233|469008057|FG003|Treatment Period 2|Adverse Event|0|||
130285260|NCT01468233|469008058|FG004|Treatment Period 2|Adverse Event|2|||
130458333|NCT00487578|469643425|FG001|Overall Study|Lack of Efficacy|1|||
130458334|NCT00487578|469643424|FG000|Overall Study|Lost to Follow-up|0|||
130458335|NCT00487578|469643425|FG001|Overall Study|Lost to Follow-up|1|||
130458336|NCT02525796|469643430|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
130458337|NCT02525796|469643431|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
130458338|NCT02525796|469643432|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
130458339|NCT02525796|469643430|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
130458340|NCT02525796|469643431|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
130458341|NCT02525796|469643432|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
130458342|NCT02525796|469643430|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
130458343|NCT02525796|469643431|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
130458344|NCT02525796|469643432|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
130458345|NCT02525796|469643430|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
130458346|NCT02525796|469643431|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
130458347|NCT02525796|469643432|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
130458348|NCT02525796|469643430|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
130458349|NCT02525796|469643431|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
130458350|NCT02525796|469643432|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
130458351|NCT01499134|469643433|FG000|Overall Study|Withdrawal by Subject|0|||
130458352|NCT01499134|469643434|FG001|Overall Study|Withdrawal by Subject|1|||
130458353|NCT01198275|469643435|FG000|Overall Study|Adverse Event|2|||
130458354|NCT01198275|469643436|FG001|Overall Study|Adverse Event|3|||
130458355|NCT01198275|469643435|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
130458356|NCT01198275|469643436|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
130458357|NCT00150176|469643437|FG000|Overall Study|Adverse Event|16|||
130458358|NCT00150176|469643438|FG001|Overall Study|Adverse Event|53|||
130458359|NCT00150176|469643437|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
130458360|NCT00150176|469643438|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
130458361|NCT00150176|469643437|FG000|Overall Study|Withdrawal by Subject|19|||
130458362|NCT00150176|469643438|FG001|Overall Study|Withdrawal by Subject|12|||
130458363|NCT00150176|469643437|FG000|Overall Study|Lost to Follow-up|3|||
130458364|NCT00150176|469643438|FG001|Overall Study|Lost to Follow-up|3|||
130458365|NCT00150176|469643437|FG000|Overall Study|OTHER|11|||
130458366|NCT00150176|469643438|FG001|Overall Study|OTHER|13|||
130458367|NCT02385669|469643442|FG000|Overall Study|Adverse Event|2|||
130458368|NCT00970307|469643443|FG000|Overall Study|Serious Adverse Event|1|||
130458369|NCT00970307|469643444|FG001|Overall Study|Serious Adverse Event|0|||
130458370|NCT00970307|469643445|FG002|Overall Study|Serious Adverse Event|0|||
130458371|NCT00970307|469643443|FG000|Overall Study|Withdrawal by Subject|2|||
130458372|NCT00970307|469643444|FG001|Overall Study|Withdrawal by Subject|3|||
130285261|NCT01468233|469008059|FG005|Treatment Period 2|Adverse Event|1|||
130285262|NCT01468233|469008054|FG000|Treatment Period 2|Lack of Efficacy|0|||
130285263|NCT01468233|469008055|FG001|Treatment Period 2|Lack of Efficacy|0|||
130285264|NCT01468233|469008056|FG002|Treatment Period 2|Lack of Efficacy|9|||
130285265|NCT01468233|469008057|FG003|Treatment Period 2|Lack of Efficacy|2|||
130285266|NCT01468233|469008058|FG004|Treatment Period 2|Lack of Efficacy|0|||
130285267|NCT01468233|469008059|FG005|Treatment Period 2|Lack of Efficacy|1|||
130285268|NCT01468233|469008054|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130285269|NCT01468233|469008055|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130285270|NCT01468233|469008056|FG002|Treatment Period 2|Withdrawal by Subject|9|||
130285271|NCT01468233|469008057|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130285272|NCT01468233|469008058|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130285273|NCT01468233|469008059|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130285274|NCT01468233|469008054|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130285275|NCT01468233|469008055|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130458373|NCT00970307|469643445|FG002|Overall Study|Withdrawal by Subject|2|||
130458374|NCT05257798|469643446|FG000|Follow-up Phase|Lost to Follow-up|1|||
130458375|NCT05257798|469643447|FG001|Follow-up Phase|Lost to Follow-up|0|||
130458376|NCT04033432|469643450|FG000|Overall Study|Progressive Disease|8|||
130458377|NCT04033432|469643450|FG000|Overall Study|Adverse Event|4|||
130458378|NCT04033432|469643450|FG000|Overall Study|Death|1|||
130458379|NCT00393848|469643451|FG000|Overall Study|Surgical schedule|0|||
130458380|NCT00393848|469643452|FG001|Overall Study|Surgical schedule|0|||
130285276|NCT01468233|469008056|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
130285277|NCT01468233|469008057|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
130711714|NCT01553747|470569899|FG002|Overall Study|Adverse event or SAE|19|||
130711715|NCT01553747|470569897|FG000|Overall Study|Physician decision: other|10|||
130711716|NCT01553747|470569898|FG001|Overall Study|Physician decision: other|8|||
130711717|NCT01553747|470569899|FG002|Overall Study|Physician decision: other|7|||
130285278|NCT01468233|469008058|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
130285279|NCT01468233|469008059|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
130285280|NCT01468233|469008054|FG000|Treatment Period 2|Lost to Follow-up|0|||
130285281|NCT01468233|469008055|FG001|Treatment Period 2|Lost to Follow-up|0|||
130285282|NCT01468233|469008056|FG002|Treatment Period 2|Lost to Follow-up|3|||
130285283|NCT01468233|469008057|FG003|Treatment Period 2|Lost to Follow-up|0|||
130285284|NCT01468233|469008058|FG004|Treatment Period 2|Lost to Follow-up|2|||
130285285|NCT01468233|469008059|FG005|Treatment Period 2|Lost to Follow-up|0|||
130285286|NCT01468233|469008054|FG000|Treatment Period 2|Other|0|||
130285287|NCT01468233|469008055|FG001|Treatment Period 2|Other|0|||
130285288|NCT01468233|469008056|FG002|Treatment Period 2|Other|3|||
130285289|NCT01468233|469008057|FG003|Treatment Period 2|Other|0|||
130285290|NCT01468233|469008058|FG004|Treatment Period 2|Other|1|||
130285291|NCT01468233|469008059|FG005|Treatment Period 2|Other|0|||
130285292|NCT00457821|469008067|FG000|Part 2|Withdrawal by Subject|0|||
130285293|NCT00457821|469008068|FG001|Part 2|Withdrawal by Subject|0|||
130285294|NCT00457821|469008069|FG002|Part 2|Withdrawal by Subject|0|||
130285295|NCT00457821|469008070|FG003|Part 2|Withdrawal by Subject|0|||
130285296|NCT00457821|469008071|FG004|Part 2|Withdrawal by Subject|0|||
130285297|NCT00457821|469008072|FG005|Part 2|Withdrawal by Subject|0|||
130285298|NCT00457821|469008073|FG006|Part 2|Withdrawal by Subject|0|||
130285299|NCT00457821|469008074|FG007|Part 2|Withdrawal by Subject|1|||
130285300|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
130285301|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
130285302|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
130285303|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
130285304|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
130285305|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
130285306|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
130285307|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
130285308|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
130285309|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
130285310|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
130285311|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
130285312|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
130285313|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
130285314|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
130285315|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
130285316|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
130285317|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
130285318|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
130285319|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
130285320|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
130285321|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
130285322|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
130285323|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
130285324|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
130285325|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
130285326|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
130285327|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
130285328|NCT02851407|469008086|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130285329|NCT02851407|469008087|FG001|Overall Study|Withdrawal by parent/guardian|7|||
130285330|NCT02851407|469008086|FG000|Overall Study|Protocol deviation|0|||
130285331|NCT02851407|469008087|FG001|Overall Study|Protocol deviation|1|||
130285332|NCT02851407|469008086|FG000|Overall Study|Transferred to another hospital to continue|1|||
130285333|NCT02851407|469008087|FG001|Overall Study|Transferred to another hospital to continue|0|||
130369805|NCT00042289|469325081|FG008|Overall Study|Severe debilitation, unable to continue|0|||
130711718|NCT01553747|470569897|FG000|Overall Study|Lost to Follow-up|11|||
130711719|NCT01553747|470569898|FG001|Overall Study|Lost to Follow-up|5|||
130711720|NCT01553747|470569899|FG002|Overall Study|Lost to Follow-up|6|||
130285334|NCT02851407|469008086|FG000|Overall Study|Other Death|30|||
130285335|NCT02851407|469008087|FG001|Overall Study|Other Death|20|||
130285336|NCT02851407|469008086|FG000|Overall Study|Adverse event, serious fatal|6|||
130285337|NCT02851407|469008087|FG001|Overall Study|Adverse event, serious fatal|8|||
130285338|NCT02851407|469008086|FG000|Overall Study|Consent withdrawn by participant|5|||
130285339|NCT02851407|469008087|FG001|Overall Study|Consent withdrawn by participant|3|||
130285340|NCT02851407|469008086|FG000|Overall Study|Screen failure|2|||
130285341|NCT02851407|469008087|FG001|Overall Study|Screen failure|1|||
130285342|NCT02851407|469008086|FG000|Overall Study|Disease relapse|9|||
130711721|NCT01553747|470569897|FG000|Overall Study|Sponsor decision, specify|7|||
130458381|NCT00393848|469643453|FG002|Overall Study|Surgical schedule|0|||
130458382|NCT00393848|469643454|FG003|Overall Study|Surgical schedule|1|||
130458383|NCT00393848|469643451|FG000|Overall Study|Personal reasons|0|||
130285343|NCT02851407|469008087|FG001|Overall Study|Disease relapse|6|||
130285344|NCT02851407|469008086|FG000|Overall Study|Physician Decision|7|||
130285345|NCT02851407|469008087|FG001|Overall Study|Physician Decision|6|||
130285346|NCT02851407|469008086|FG000|Overall Study|Transferred to hospital closer to home|0|||
130285347|NCT02851407|469008087|FG001|Overall Study|Transferred to hospital closer to home|1|||
130285348|NCT02851407|469008086|FG000|Overall Study|Enrolled in an investigational study|0|||
130285349|NCT02851407|469008087|FG001|Overall Study|Enrolled in an investigational study|1|||
130285350|NCT02851407|469008086|FG000|Overall Study|Early recovery|1|||
130285351|NCT02851407|469008087|FG001|Overall Study|Early recovery|0|||
130285352|NCT02851407|469008086|FG000|Overall Study|Adverse event, non-fatal|7|||
130285353|NCT02851407|469008087|FG001|Overall Study|Adverse event, non-fatal|5|||
130458384|NCT00393848|469643452|FG001|Overall Study|Personal reasons|0|||
130458385|NCT00393848|469643453|FG002|Overall Study|Personal reasons|2|||
130458386|NCT00393848|469643454|FG003|Overall Study|Personal reasons|0|||
130458387|NCT02082158|469643457|FG000|Overall Study|Withdrawal by Subject|0|||
130458388|NCT02082158|469643458|FG001|Overall Study|Withdrawal by Subject|0|||
130458389|NCT02082158|469643459|FG002|Overall Study|Withdrawal by Subject|0|||
130458390|NCT02082158|469643460|FG003|Overall Study|Withdrawal by Subject|0|||
130458391|NCT02082158|469643461|FG004|Overall Study|Withdrawal by Subject|1|||
130458392|NCT02082158|469643462|FG005|Overall Study|Withdrawal by Subject|0|||
130458393|NCT02082158|469643457|FG000|Overall Study|Failed Fit-testing|8|||
130458394|NCT02082158|469643458|FG001|Overall Study|Failed Fit-testing|8|||
130458395|NCT02082158|469643459|FG002|Overall Study|Failed Fit-testing|14|||
130458396|NCT02082158|469643460|FG003|Overall Study|Failed Fit-testing|4|||
130458397|NCT02082158|469643461|FG004|Overall Study|Failed Fit-testing|3|||
130458398|NCT02082158|469643462|FG005|Overall Study|Failed Fit-testing|7|||
130458399|NCT02192606|469643463|FG000|Overall Study|surgery type was changed|1|||
130458400|NCT02192606|469643464|FG001|Overall Study|surgery type was changed|1|||
130458401|NCT02192606|469643463|FG000|Overall Study|Physician Decision|1|||
130458402|NCT02192606|469643464|FG001|Overall Study|Physician Decision|2|||
130458403|NCT02192606|469643463|FG000|Overall Study|3D equipment rep unable to join|0|||
130458404|NCT02192606|469643464|FG001|Overall Study|3D equipment rep unable to join|1|||
130458405|NCT01458210|469643470|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
130458406|NCT01458210|469643470|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
130458407|NCT01458210|469643470|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
130458408|NCT01458210|469643470|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
130458409|NCT03923491|469643471|FG000|Overall Study|Lost to Follow-up|5|||
130458410|NCT03923491|469643472|FG001|Overall Study|Lost to Follow-up|8|||
130458411|NCT03923491|469643471|FG000|Overall Study|Withdrawal by Subject|4|||
130458412|NCT03923491|469643472|FG001|Overall Study|Withdrawal by Subject|6|||
130458413|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
130458414|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
130458415|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
130458416|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
130458417|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
130458418|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
130458419|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
130458420|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
130458421|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
130458422|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
130458423|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
130458424|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
130458425|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
130458426|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
130458427|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
130458428|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
130458429|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
130285354|NCT02851407|469008086|FG000|Overall Study|Lost to Follow-up|0|||
130285355|NCT02851407|469008087|FG001|Overall Study|Lost to Follow-up|2|||
130285356|NCT02403635|469008088|FG000|Overall Study|Not eligible|9|||
130285357|NCT00835640|469008089|FG000|Second Intervention|Protocol Violation|1|||
130285358|NCT00835640|469008090|FG001|Second Intervention|Protocol Violation|0|||
130458430|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
130458431|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
130458432|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
130285359|NCT00068250|469008091|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
130285360|NCT00068250|469008092|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
130285361|NCT00068250|469008093|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
130458433|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
130458434|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
130466748|NCT02544074|469676380|FG018|Overall Study|Tablet error|0|||
130711722|NCT01553747|470569898|FG001|Overall Study|Sponsor decision, specify|5|||
130711723|NCT01553747|470569899|FG002|Overall Study|Sponsor decision, specify|0|||
130711724|NCT01553747|470569897|FG000|Overall Study|Physician decision: lack of efficacy|1|||
130711725|NCT01553747|470569898|FG001|Overall Study|Physician decision: lack of efficacy|5|||
130711726|NCT01553747|470569899|FG002|Overall Study|Physician decision: lack of efficacy|3|||
130711727|NCT01875471|470569906|FG000|Overall Study|Adverse Event|0|||
130711728|NCT01875471|470569907|FG001|Overall Study|Adverse Event|1|||
130711729|NCT01875471|470569906|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130711730|NCT01875471|470569907|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130711731|NCT03407118|470569911|FG000|Period 2|Withdrawal by Subject|1|||
130711732|NCT03407118|470569912|FG001|Period 2|Withdrawal by Subject|0|||
130711733|NCT02972502|470569916|FG000|Overall Study|Lost to Follow-up|3|||
130711734|NCT02972502|470569917|FG001|Overall Study|Lost to Follow-up|1|||
130711735|NCT02972502|470569916|FG000|Overall Study|Withdrawal by Subject|1|||
130711736|NCT02972502|470569917|FG001|Overall Study|Withdrawal by Subject|1|||
130711737|NCT03832738|470569918|FG000|Overall Study|Withdrawal by Subject|6|||
130711738|NCT03832738|470569919|FG001|Overall Study|Withdrawal by Subject|7|||
130711739|NCT03832738|470569920|FG002|Overall Study|Withdrawal by Subject|16|||
130711740|NCT03832738|470569918|FG000|Overall Study|Physician Decision|0|||
130711741|NCT03832738|470569919|FG001|Overall Study|Physician Decision|1|||
130711742|NCT03832738|470569920|FG002|Overall Study|Physician Decision|2|||
130711743|NCT03832738|470569918|FG000|Overall Study|Adverse Event|2|||
130711744|NCT03832738|470569919|FG001|Overall Study|Adverse Event|3|||
130711745|NCT03832738|470569920|FG002|Overall Study|Adverse Event|1|||
130711746|NCT03832738|470569918|FG000|Overall Study|Pregnancy|0|||
130711747|NCT03832738|470569919|FG001|Overall Study|Pregnancy|1|||
130285362|NCT00068250|469008094|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
130285363|NCT03349645|469008095|FG000|Overall Study|Sponsor Terminated Study|75|||
130285364|NCT03349645|469008095|FG000|Overall Study|Withdrawal by Subject|4|||
130285365|NCT03349645|469008095|FG000|Overall Study|Protocol Violation|1|||
130285366|NCT03349645|469008095|FG000|Overall Study|Other|2|||
130285367|NCT00580034|469008098|FG000|Overall Study|Toxicity|10|||
130285368|NCT00580034|469008099|FG001|Overall Study|Toxicity|0|||
130285369|NCT01939002|469008100|FG000|Overall Study|Adverse Event|13|||
130285370|NCT01939002|469008101|FG001|Overall Study|Adverse Event|13|||
130285371|NCT01939002|469008100|FG000|Overall Study|Withdrawal by Subject|5|||
130285372|NCT01939002|469008101|FG001|Overall Study|Withdrawal by Subject|3|||
130458435|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
130458436|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
130458437|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
130458438|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
130458439|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
130458440|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
130458441|NCT00241644|469643476|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
130458442|NCT00241644|469643477|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
130458443|NCT00241644|469643478|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
130458444|NCT00241644|469643479|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
130458445|NCT00241644|469643476|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
130458446|NCT00241644|469643477|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
130458447|NCT00241644|469643478|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
130458448|NCT00241644|469643479|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
130458449|NCT00241644|469643476|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
130458450|NCT00241644|469643477|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
130458451|NCT00241644|469643478|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
130458452|NCT00241644|469643479|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
130458453|NCT00241644|469643476|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
130458454|NCT00241644|469643477|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
130458455|NCT00241644|469643478|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
130458456|NCT00241644|469643479|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
130458457|NCT00241644|469643476|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
130285373|NCT01939002|469008100|FG000|Overall Study|Other|1|||
130285374|NCT01939002|469008101|FG001|Overall Study|Other|2|||
130466749|NCT02544074|469676381|FG019|Overall Study|Tablet error|0|||
130711748|NCT03832738|470569920|FG002|Overall Study|Pregnancy|0|||
130285375|NCT03372460|469008105|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
130285376|NCT03372460|469008106|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
130711749|NCT01347866|470569923|FG000|Overall Study|Death|0|||
130711750|NCT01347866|470569924|FG001|Overall Study|Death|0|||
130711751|NCT01347866|470569925|FG002|Overall Study|Death|0|||
130711752|NCT01347866|470569926|FG003|Overall Study|Death|1|||
130555541|NCT04147234|470003233|FG000|Overall Study|Clinical disease progression|1|||
130555542|NCT04147234|470003234|FG001|Overall Study|Clinical disease progression|3|||
130555543|NCT04147234|470003235|FG002|Overall Study|Clinical disease progression|1|||
130555544|NCT04147234|470003236|FG003|Overall Study|Clinical disease progression|1|||
130555545|NCT04147234|470003237|FG004|Overall Study|Clinical disease progression|0|||
130555546|NCT04147234|470003238|FG005|Overall Study|Clinical disease progression|1|||
130555547|NCT04147234|470003239|FG006|Overall Study|Clinical disease progression|0|||
130555548|NCT04147234|470003233|FG000|Overall Study|Objective disease progression|6|||
130555549|NCT04147234|470003234|FG001|Overall Study|Objective disease progression|4|||
130555550|NCT04147234|470003235|FG002|Overall Study|Objective disease progression|3|||
130555551|NCT04147234|470003236|FG003|Overall Study|Objective disease progression|3|||
130555552|NCT04147234|470003237|FG004|Overall Study|Objective disease progression|5|||
130555553|NCT04147234|470003238|FG005|Overall Study|Objective disease progression|2|||
130555554|NCT04147234|470003239|FG006|Overall Study|Objective disease progression|3|||
130555555|NCT04147234|470003233|FG000|Overall Study|Adverse Event|0|||
130555556|NCT04147234|470003234|FG001|Overall Study|Adverse Event|0|||
130555557|NCT04147234|470003235|FG002|Overall Study|Adverse Event|0|||
130555558|NCT04147234|470003236|FG003|Overall Study|Adverse Event|0|||
130555559|NCT04147234|470003237|FG004|Overall Study|Adverse Event|1|||
130555560|NCT04147234|470003238|FG005|Overall Study|Adverse Event|0|||
130555561|NCT04147234|470003239|FG006|Overall Study|Adverse Event|0|||
130555562|NCT02596620|470003240|FG000|Overall Study|Lost to Follow-up|1|||
130555563|NCT02596620|470003241|FG001|Overall Study|Lost to Follow-up|1|||
130555564|NCT00867113|470003242|FG000|Treatment Period|Adverse Event|15|||
130555565|NCT00867113|470003242|FG000|Treatment Period|Death|2|||
130555566|NCT00867113|470003242|FG000|Treatment Period|Withdrawal by Subject|19|||
130555567|NCT00867113|470003242|FG000|Treatment Period|Lost to Follow-up|3|||
130555568|NCT00867113|470003242|FG000|Treatment Period|Administrative problems|1|||
130555569|NCT00867113|470003242|FG000|Treatment Period|Disease progression/relapse|1|||
130555570|NCT00867113|470003242|FG000|Treatment Period|Protocol Violation|4|||
130555571|NCT00867113|470003242|FG000|Post Treatment After Survival Follow-up|Death|1|||
130555572|NCT00867113|470003242|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
130555573|NCT00867113|470003242|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
130555574|NCT00867113|470003242|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
130555575|NCT01886313|470003243|FG000|Overall Study|Adverse Event|1|||
130555576|NCT01886313|470003244|FG001|Overall Study|Adverse Event|1|||
130555577|NCT00634010|470003248|FG000|Overall Study|Adverse Event|2|||
130555578|NCT00634010|470003249|FG001|Overall Study|Adverse Event|5|||
130555579|NCT00634010|470003248|FG000|Overall Study|Withdrawal by Subject|5|||
130555580|NCT00634010|470003249|FG001|Overall Study|Withdrawal by Subject|6|||
130555581|NCT00634010|470003248|FG000|Overall Study|Physician Decision|1|||
130555582|NCT00634010|470003249|FG001|Overall Study|Physician Decision|1|||
130555583|NCT00634010|470003248|FG000|Overall Study|Disease Progression|1|||
130555584|NCT00634010|470003249|FG001|Overall Study|Disease Progression|1|||
130555585|NCT00634010|470003248|FG000|Overall Study|Non-Compliant|1|||
130555586|NCT00634010|470003249|FG001|Overall Study|Non-Compliant|1|||
130555587|NCT02066051|470003253|FG000|Overall Study|Subject developed active GVHD|1|||
130555588|NCT03027557|470003259|FG000|Overall Study|Adverse Event|1|||
130555589|NCT03027557|470003260|FG001|Overall Study|Adverse Event|0|||
130555590|NCT03027557|470003261|FG002|Overall Study|Adverse Event|0|||
130555591|NCT01610687|470003266|FG000|Overall Study|Lack of Efficacy|26|||
130555592|NCT01610687|470003266|FG000|Overall Study|Adverse Event|18|||
130458458|NCT00241644|469643477|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
130458459|NCT00241644|469643478|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
130458460|NCT00241644|469643479|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
130458461|NCT00241644|469643476|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
130458462|NCT00241644|469643477|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
130458463|NCT00241644|469643478|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
130458464|NCT00241644|469643479|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
130458465|NCT01027286|469643480|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
130458466|NCT01027286|469643481|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
130458467|NCT01027286|469643480|FG000|Overall Study|Lost to Follow-up|0|||
130555593|NCT01610687|470003266|FG000|Overall Study|Moved out of area|6|||
130555594|NCT01610687|470003266|FG000|Overall Study|Withdrawal by Subject|7|||
130555595|NCT01610687|470003266|FG000|Overall Study|Lost to Follow-up|4|||
130555596|NCT01610687|470003266|FG000|Overall Study|Symptom control without study medication|2|||
130711753|NCT01347866|470569927|FG004|Overall Study|Death|2|||
130555597|NCT01610687|470003266|FG000|Overall Study|Unable to make journey|1|||
130555598|NCT01610687|470003266|FG000|Overall Study|Death|1|||
130711754|NCT01347866|470569928|FG005|Overall Study|Death|2|||
130711755|NCT01347866|470569929|FG006|Overall Study|Death|1|||
130555599|NCT01610687|470003266|FG000|Overall Study|Cannabis affecting job|1|||
130555600|NCT01610687|470003266|FG000|Overall Study|Felt more alter without study medication|1|||
130555601|NCT03836807|470003267|FG000|Overall Study|Physician Decision|1|||
130711756|NCT01347866|470569930|FG007|Overall Study|Death|0|||
130285377|NCT02499900|469008107|FG000|Core Study Period|Other|1|||
130285378|NCT02499900|469008108|FG001|Core Study Period|Other|4|||
130285379|NCT02499900|469008107|FG000|Core Study Period|Lost to Follow-up|1|||
130285380|NCT02499900|469008108|FG001|Core Study Period|Lost to Follow-up|2|||
130285381|NCT02499900|469008107|FG000|Core Study Period|Per sponsor request|0|||
130285382|NCT02499900|469008108|FG001|Core Study Period|Per sponsor request|1|||
130285383|NCT02499900|469008107|FG000|Core Study Period|Pregnancy|1|||
130285384|NCT02499900|469008108|FG001|Core Study Period|Pregnancy|0|||
130555602|NCT03836807|470003268|FG001|Overall Study|Physician Decision|0|||
130555603|NCT02430051|470003269|FG000|Overall Study|Withdrawal by Subject|6|||
130555604|NCT02430051|470003270|FG001|Overall Study|Withdrawal by Subject|3|||
130555605|NCT02430051|470003269|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
130555606|NCT02430051|470003270|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
130555607|NCT02430051|470003269|FG000|Overall Study|Protocol Violation|1|||
130555608|NCT02430051|470003270|FG001|Overall Study|Protocol Violation|0|||
130555609|NCT01272947|470003271|FG000|Overall Study|Abnormal Laboratory Value|2|||
130555610|NCT01272947|470003272|FG001|Overall Study|Abnormal Laboratory Value|2|||
130555611|NCT02019420|470003274|FG000|Overall Study|Did not receive study drug|2|||
130555612|NCT02019420|470003275|FG001|Overall Study|Did not receive study drug|2|||
130555613|NCT02019420|470003274|FG000|Overall Study|Withdrawal by Subject|1|||
130555614|NCT02019420|470003275|FG001|Overall Study|Withdrawal by Subject|3|||
130555615|NCT02019420|470003274|FG000|Overall Study|At request of sponsor or investigator|0|||
130555616|NCT02019420|470003275|FG001|Overall Study|At request of sponsor or investigator|1|||
130555617|NCT02019420|470003274|FG000|Overall Study|Death|104|||
130555618|NCT02019420|470003275|FG001|Overall Study|Death|99|||
130555619|NCT02019420|470003274|FG000|Overall Study|Transferred to other care facility|1|||
130555620|NCT02019420|470003275|FG001|Overall Study|Transferred to other care facility|1|||
130555621|NCT02510560|470003276|FG000|Overall Study|Discontinued from Treatment|27|||
130555622|NCT02510560|470003277|FG001|Overall Study|Discontinued from Treatment|18|||
130555623|NCT02510560|470003278|FG002|Overall Study|Discontinued from Treatment|19|||
130555624|NCT02510560|470003276|FG000|Overall Study|Other|4|||
130555625|NCT02510560|470003277|FG001|Overall Study|Other|4|||
130555626|NCT02510560|470003278|FG002|Overall Study|Other|3|||
130555627|NCT00132496|470003279|FG000|Overall Study|Withdrawal by Subject|1|||
130555628|NCT00132496|470003280|FG001|Overall Study|Withdrawal by Subject|2|||
130555629|NCT00132496|470003279|FG000|Overall Study|Physician Decision|1|||
130555630|NCT00132496|470003280|FG001|Overall Study|Physician Decision|0|||
130285385|NCT02499900|469008107|FG000|Core Study Period|Protocol Violation|3|||
130285386|NCT02499900|469008108|FG001|Core Study Period|Protocol Violation|0|||
130285387|NCT02499900|469008107|FG000|Core Study Period|Withdrawal by Subject|11|||
130285388|NCT02499900|469008108|FG001|Core Study Period|Withdrawal by Subject|10|||
130285389|NCT02499900|469008107|FG000|Core Study Period|Adverse Event|18|||
130285390|NCT02499900|469008108|FG001|Core Study Period|Adverse Event|14|||
130285391|NCT02499900|469008107|FG000|Core Study Period|Death|0|||
130285392|NCT02499900|469008108|FG001|Core Study Period|Death|1|||
130285393|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
130285394|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
130285395|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
130285396|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
130285397|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
130285398|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
130285399|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
130285400|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
130285401|NCT02499900|469008107|FG000|Extension Study Period|Adverse Event|2|||
130285402|NCT02499900|469008108|FG001|Extension Study Period|Adverse Event|4|||
130285403|NCT02499900|469008107|FG000|Extension Study Period|Withdrawal by Subject|5|||
130285404|NCT02499900|469008108|FG001|Extension Study Period|Withdrawal by Subject|2|||
130285405|NCT02499900|469008107|FG000|Extension Study Period|Physician Decision|2|||
130458468|NCT01027286|469643481|FG001|Overall Study|Lost to Follow-up|1|||
130458469|NCT01563354|469643483|FG000|Core Phase|Adverse Event|5|||
130458470|NCT01563354|469643484|FG001|Core Phase|Adverse Event|15|||
130458471|NCT01563354|469643485|FG002|Core Phase|Adverse Event|13|||
130458472|NCT01563354|469643483|FG000|Core Phase|Withdrawal by Subject|1|||
130458473|NCT01563354|469643484|FG001|Core Phase|Withdrawal by Subject|0|||
130458474|NCT01563354|469643485|FG002|Core Phase|Withdrawal by Subject|3|||
130458475|NCT01563354|469643483|FG000|Core Phase|Lost to Follow-up|1|||
130555631|NCT01093625|470003285|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
130555632|NCT01093625|470003286|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
130555633|NCT01093625|470003285|FG000|2-Week Visit|Withdrawal by Subject|1|||
130285406|NCT02499900|469008108|FG001|Extension Study Period|Physician Decision|5|||
130285407|NCT02499900|469008107|FG000|Extension Study Period|Pregnancy|1|||
130285408|NCT02499900|469008108|FG001|Extension Study Period|Pregnancy|2|||
130285409|NCT02499900|469008107|FG000|Extension Study Period|Lost to Follow-up|2|||
130316227|NCT04319198|469124332|FG000|Overall Study|Death|0|||
130458476|NCT01563354|469643484|FG001|Core Phase|Lost to Follow-up|0|||
130711757|NCT01347866|470569931|FG008|Overall Study|Death|4|||
130711758|NCT01347866|470569932|FG009|Overall Study|Death|1|||
130711759|NCT01347866|470569933|FG010|Overall Study|Death|3|||
130711760|NCT01347866|470569934|FG011|Overall Study|Death|1|||
130285410|NCT02499900|469008108|FG001|Extension Study Period|Lost to Follow-up|5|||
130285411|NCT02499900|469008107|FG000|Extension Study Period|Other|0|||
130285412|NCT02499900|469008108|FG001|Extension Study Period|Other|2|||
130285413|NCT03385265|469008109|FG000|Overall Study|Withdrawal by Subject|5|||
130285414|NCT03385265|469008110|FG001|Overall Study|Withdrawal by Subject|2|||
130711761|NCT01347866|470569935|FG012|Overall Study|Death|2|||
130711762|NCT01347866|470569936|FG013|Overall Study|Death|0|||
130711763|NCT01347866|470569937|FG014|Overall Study|Death|0|||
130711764|NCT01347866|470569938|FG015|Overall Study|Death|1|||
130711765|NCT01347866|470569939|FG016|Overall Study|Death|0|||
130711766|NCT01347866|470569923|FG000|Overall Study|Lost to Follow-up|0|||
130711767|NCT01347866|470569924|FG001|Overall Study|Lost to Follow-up|0|||
130711768|NCT01347866|470569925|FG002|Overall Study|Lost to Follow-up|0|||
130711769|NCT01347866|470569926|FG003|Overall Study|Lost to Follow-up|0|||
130711770|NCT01347866|470569927|FG004|Overall Study|Lost to Follow-up|0|||
130711771|NCT01347866|470569928|FG005|Overall Study|Lost to Follow-up|0|||
130711772|NCT01347866|470569929|FG006|Overall Study|Lost to Follow-up|0|||
130711773|NCT01347866|470569930|FG007|Overall Study|Lost to Follow-up|1|||
130711774|NCT01347866|470569931|FG008|Overall Study|Lost to Follow-up|1|||
130285415|NCT03385265|469008111|FG002|Overall Study|Withdrawal by Subject|5|||
130285416|NCT03385265|469008112|FG003|Overall Study|Withdrawal by Subject|2|||
130285417|NCT02439450|469008114|FG000|Overall Study|Adverse Event|4|||
130285418|NCT02439450|469008115|FG001|Overall Study|Adverse Event|1|||
130285419|NCT02439450|469008116|FG002|Overall Study|Adverse Event|0|||
130285420|NCT02439450|469008117|FG003|Overall Study|Adverse Event|0|||
130285421|NCT02439450|469008114|FG000|Overall Study|Withdrawal by Subject|1|||
130285422|NCT02439450|469008115|FG001|Overall Study|Withdrawal by Subject|2|||
130285423|NCT02439450|469008116|FG002|Overall Study|Withdrawal by Subject|0|||
130285424|NCT02439450|469008117|FG003|Overall Study|Withdrawal by Subject|0|||
130285425|NCT02439450|469008114|FG000|Overall Study|Death|3|||
130285426|NCT02439450|469008115|FG001|Overall Study|Death|0|||
130285427|NCT02439450|469008116|FG002|Overall Study|Death|0|||
130285428|NCT02439450|469008117|FG003|Overall Study|Death|1|||
130285429|NCT02439450|469008114|FG000|Overall Study|Progressive Disease|18|||
130285430|NCT02439450|469008115|FG001|Overall Study|Progressive Disease|41|||
130285431|NCT02439450|469008116|FG002|Overall Study|Progressive Disease|2|||
130285432|NCT02439450|469008117|FG003|Overall Study|Progressive Disease|3|||
130285433|NCT01170065|469008120|FG000|Overall Study|Adverse Event|17|||
130285434|NCT01170065|469008121|FG001|Overall Study|Adverse Event|50|||
130285435|NCT01170065|469008122|FG002|Overall Study|Adverse Event|10|||
130285436|NCT01170065|469008120|FG000|Overall Study|Lost to Follow-up|1|||
130285437|NCT01170065|469008121|FG001|Overall Study|Lost to Follow-up|4|||
130285438|NCT01170065|469008122|FG002|Overall Study|Lost to Follow-up|1|||
130285439|NCT01170065|469008120|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
130285440|NCT01170065|469008121|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
130285441|NCT01170065|469008122|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
130285442|NCT01170065|469008120|FG000|Overall Study|Reason other than specified|3|||
130285443|NCT01170065|469008121|FG001|Overall Study|Reason other than specified|8|||
130285444|NCT01170065|469008122|FG002|Overall Study|Reason other than specified|3|||
130285445|NCT01170065|469008120|FG000|Overall Study|Ongoing after planned observation time|5|||
130285446|NCT01170065|469008121|FG001|Overall Study|Ongoing after planned observation time|26|||
130285447|NCT01170065|469008122|FG002|Overall Study|Ongoing after planned observation time|10|||
130285448|NCT00853125|469008129|FG000|Overall Study|Study participant's donor was CMV +|1|||
130285449|NCT03023826|469008131|FG000|Period 1|Withdrawal by Subject|0|||
130285450|NCT03023826|469008132|FG001|Period 1|Withdrawal by Subject|0|||
130285451|NCT03023826|469008133|FG002|Period 1|Withdrawal by Subject|0|||
130285452|NCT03023826|469008134|FG003|Period 1|Withdrawal by Subject|0|||
130285453|NCT03023826|469008135|FG004|Period 1|Withdrawal by Subject|1|||
130285454|NCT03023826|469008136|FG005|Period 1|Withdrawal by Subject|0|||
130285455|NCT00428220|469010121|FG000|Overall Study|Participant died|8|||
130285456|NCT00428220|469010121|FG000|Overall Study|Global deterioration of health status|7|||
130711775|NCT01347866|470569932|FG009|Overall Study|Lost to Follow-up|0|||
130711776|NCT01347866|470569933|FG010|Overall Study|Lost to Follow-up|0|||
130285457|NCT00428220|469010121|FG000|Overall Study|Lost to Follow-up|4|||
130285458|NCT00428220|469010121|FG000|Overall Study|Objective progression or relapse|123|||
130285459|NCT00428220|469010121|FG000|Overall Study|Participant refused continued treatment|7|||
130285460|NCT00428220|469010121|FG000|Overall Study|Adverse Event|51|||
130285461|NCT00428220|469010121|FG000|Overall Study|Other|23|||
130285462|NCT00549900|469010123|FG000|Overall Study|Adverse Event|1|||
130711777|NCT01347866|470569934|FG011|Overall Study|Lost to Follow-up|0|||
130711778|NCT01347866|470569935|FG012|Overall Study|Lost to Follow-up|0|||
130711779|NCT01347866|470569936|FG013|Overall Study|Lost to Follow-up|0|||
130711780|NCT01347866|470569937|FG014|Overall Study|Lost to Follow-up|0|||
130711781|NCT01347866|470569938|FG015|Overall Study|Lost to Follow-up|0|||
130711782|NCT01347866|470569939|FG016|Overall Study|Lost to Follow-up|0|||
130711783|NCT01347866|470569923|FG000|Overall Study|Other|3|||
130711784|NCT01347866|470569924|FG001|Overall Study|Other|1|||
130711785|NCT01347866|470569925|FG002|Overall Study|Other|1|||
130711786|NCT01347866|470569926|FG003|Overall Study|Other|4|||
130711787|NCT01347866|470569927|FG004|Overall Study|Other|5|||
130711788|NCT01347866|470569928|FG005|Overall Study|Other|0|||
130711789|NCT01347866|470569929|FG006|Overall Study|Other|5|||
130711790|NCT01347866|470569930|FG007|Overall Study|Other|3|||
130711791|NCT01347866|470569931|FG008|Overall Study|Other|22|||
130711792|NCT01347866|470569932|FG009|Overall Study|Other|5|||
130711793|NCT01347866|470569933|FG010|Overall Study|Other|0|||
130711794|NCT01347866|470569934|FG011|Overall Study|Other|3|||
130711795|NCT01347866|470569935|FG012|Overall Study|Other|4|||
130711796|NCT01347866|470569936|FG013|Overall Study|Other|4|||
130711797|NCT01347866|470569937|FG014|Overall Study|Other|2|||
130711798|NCT01347866|470569938|FG015|Overall Study|Other|3|||
130711799|NCT01347866|470569939|FG016|Overall Study|Other|0|||
130711800|NCT01347866|470569923|FG000|Overall Study|Subject refused further follow-up|2|||
130711801|NCT01347866|470569924|FG001|Overall Study|Subject refused further follow-up|0|||
130711802|NCT01347866|470569925|FG002|Overall Study|Subject refused further follow-up|0|||
130711803|NCT01347866|470569926|FG003|Overall Study|Subject refused further follow-up|2|||
130711804|NCT01347866|470569927|FG004|Overall Study|Subject refused further follow-up|0|||
130285463|NCT02982018|469010124|FG000|Overall Study|Incorrect Lens Dispensed|1|||
130285464|NCT02982018|469010125|FG001|Overall Study|Incorrect Lens Dispensed|0|||
130285465|NCT02982018|469010124|FG000|Overall Study|Protocol Violation|1|||
130285466|NCT02982018|469010125|FG001|Overall Study|Protocol Violation|1|||
130285467|NCT02982018|469010124|FG000|Overall Study|Adverse Event|1|||
130285468|NCT02982018|469010125|FG001|Overall Study|Adverse Event|1|||
130285469|NCT02982018|469010124|FG000|Overall Study|Lens Discomfort|2|||
130285470|NCT02982018|469010125|FG001|Overall Study|Lens Discomfort|0|||
130285471|NCT02982018|469010124|FG000|Overall Study|Withdrawal by Subject|0|||
130285472|NCT02982018|469010125|FG001|Overall Study|Withdrawal by Subject|1|||
130285473|NCT03283098|469010126|FG000|Overall Study|Withdrawal by Subject|0|||
130285474|NCT03283098|469010127|FG001|Overall Study|Withdrawal by Subject|1|||
130285475|NCT00798317|469010128|FG000|Overall Study|Physician Decision|0|||
130285476|NCT00798317|469010129|FG001|Overall Study|Physician Decision|1|||
130285477|NCT00798317|469010128|FG000|Overall Study|Withdrawal by Subject|5|||
130285478|NCT00798317|469010129|FG001|Overall Study|Withdrawal by Subject|4|||
130285479|NCT00798317|469010128|FG000|Overall Study|Lost to Follow-up|2|||
130285480|NCT00798317|469010129|FG001|Overall Study|Lost to Follow-up|2|||
130285481|NCT00798317|469010128|FG000|Overall Study|Adverse Event|2|||
130285482|NCT00798317|469010129|FG001|Overall Study|Adverse Event|0|||
130285483|NCT00798317|469010128|FG000|Overall Study|Death|1|||
130285484|NCT00798317|469010129|FG001|Overall Study|Death|0|||
130285485|NCT00416715|469010130|FG000|Overall Study|Not evaluable for joint aches|7|||
130285486|NCT00416715|469010130|FG000|Overall Study|Vitamin D levels not evaluable|8|||
130285487|NCT02545517|469010141|FG000|Overall Study|Death|2|||
130285488|NCT02545517|469010142|FG001|Overall Study|Death|2|||
130285489|NCT02545517|469010143|FG002|Overall Study|Death|1|||
130711805|NCT01347866|470569928|FG005|Overall Study|Subject refused further follow-up|1|||
130711806|NCT01347866|470569929|FG006|Overall Study|Subject refused further follow-up|0|||
130711807|NCT01347866|470569930|FG007|Overall Study|Subject refused further follow-up|0|||
130285490|NCT02545517|469010141|FG000|Overall Study|Lost to Follow-up|14|||
130285491|NCT02545517|469010142|FG001|Overall Study|Lost to Follow-up|13|||
130285492|NCT02545517|469010143|FG002|Overall Study|Lost to Follow-up|17|||
130285493|NCT02545517|469010141|FG000|Overall Study|Protocol Violation|0|||
130711808|NCT01347866|470569931|FG008|Overall Study|Subject refused further follow-up|4|||
130369806|NCT00042289|469325082|FG009|Overall Study|Severe debilitation, unable to continue|0|||
130369807|NCT00042289|469325083|FG010|Overall Study|Severe debilitation, unable to continue|0|||
130369808|NCT00042289|469325084|FG011|Overall Study|Severe debilitation, unable to continue|0|||
130711809|NCT01347866|470569932|FG009|Overall Study|Subject refused further follow-up|1|||
130711810|NCT01347866|470569933|FG010|Overall Study|Subject refused further follow-up|0|||
130369809|NCT00042289|469325085|FG012|Overall Study|Severe debilitation, unable to continue|0|||
130369810|NCT00042289|469325086|FG013|Overall Study|Severe debilitation, unable to continue|0|||
130369811|NCT00042289|469325087|FG014|Overall Study|Severe debilitation, unable to continue|0|||
130369812|NCT00042289|469325088|FG015|Overall Study|Severe debilitation, unable to continue|0|||
130369813|NCT00042289|469325089|FG016|Overall Study|Severe debilitation, unable to continue|0|||
130711811|NCT01347866|470569934|FG011|Overall Study|Subject refused further follow-up|0|||
130711812|NCT01347866|470569935|FG012|Overall Study|Subject refused further follow-up|1|||
130711813|NCT01347866|470569936|FG013|Overall Study|Subject refused further follow-up|3|||
130285494|NCT02545517|469010142|FG001|Overall Study|Protocol Violation|1|||
130285495|NCT02545517|469010143|FG002|Overall Study|Protocol Violation|1|||
130285496|NCT02545517|469010141|FG000|Overall Study|Withdrawal by Subject|5|||
130285497|NCT02545517|469010142|FG001|Overall Study|Withdrawal by Subject|8|||
130285498|NCT02545517|469010143|FG002|Overall Study|Withdrawal by Subject|9|||
130285499|NCT02545517|469010141|FG000|Overall Study|Administrative reason|5|||
130711814|NCT01347866|470569937|FG014|Overall Study|Subject refused further follow-up|1|||
130711815|NCT01347866|470569938|FG015|Overall Study|Subject refused further follow-up|0|||
130711816|NCT01347866|470569939|FG016|Overall Study|Subject refused further follow-up|2|||
130711817|NCT00430950|470569940|FG000|Overall Study|Adverse Event|7|||
130711818|NCT00430950|470569941|FG001|Overall Study|Adverse Event|6|||
130711819|NCT00430950|470569940|FG000|Overall Study|Withdrawal by Subject|1|||
130711820|NCT00430950|470569941|FG001|Overall Study|Withdrawal by Subject|0|||
130711821|NCT00430950|470569940|FG000|Overall Study|concomitant medication,etc.|5|||
130711822|NCT00430950|470569941|FG001|Overall Study|concomitant medication,etc.|7|||
130711823|NCT02429934|470569942|FG000|Overall Study|Withdrawal by Subject|0|||
130711824|NCT02429934|470569943|FG001|Overall Study|Withdrawal by Subject|2|||
130285500|NCT02545517|469010142|FG001|Overall Study|Administrative reason|6|||
130285501|NCT02545517|469010143|FG002|Overall Study|Administrative reason|10|||
130285502|NCT02545517|469010141|FG000|Overall Study|Other|2|||
130285503|NCT02545517|469010142|FG001|Overall Study|Other|4|||
130285504|NCT02545517|469010143|FG002|Overall Study|Other|3|||
130285505|NCT01069861|469010144|FG000|Overall Study|Death|1|||
130285506|NCT01069861|469010144|FG000|Overall Study|Adverse Event|1|||
130285507|NCT01069861|469010144|FG000|Overall Study|Did not meet entrance criteria|1|||
130285508|NCT04035564|469010145|FG000|Overall Study|Protocol Violation|1|||
130285509|NCT04035564|469010146|FG001|Overall Study|Protocol Violation|2|||
130285510|NCT04035564|469010145|FG000|Overall Study|No laboratory available|2|||
130285511|NCT04035564|469010146|FG001|Overall Study|No laboratory available|2|||
130285512|NCT04035564|469010145|FG000|Overall Study|Guardian declined consent|1|||
130285513|NCT04035564|469010146|FG001|Overall Study|Guardian declined consent|2|||
130285514|NCT00996281|469010148|FG000|Overall Study|Adverse Event|75|||
130285515|NCT00996281|469010149|FG001|Overall Study|Adverse Event|37|||
130285516|NCT00996281|469010148|FG000|Overall Study|Major Protocol Deviation|6|||
130285517|NCT00996281|469010149|FG001|Overall Study|Major Protocol Deviation|7|||
130285518|NCT00996281|469010148|FG000|Overall Study|Lost to Follow-up|14|||
130285519|NCT00996281|469010149|FG001|Overall Study|Lost to Follow-up|16|||
130285520|NCT00996281|469010148|FG000|Overall Study|Withdrawal by Subject|31|||
130285521|NCT00996281|469010149|FG001|Overall Study|Withdrawal by Subject|20|||
130285522|NCT00996281|469010148|FG000|Overall Study|Lack of Efficacy|0|||
130285523|NCT00996281|469010149|FG001|Overall Study|Lack of Efficacy|2|||
130285524|NCT00996281|469010148|FG000|Overall Study|Other|5|||
130285525|NCT00996281|469010149|FG001|Overall Study|Other|7|||
130285526|NCT02754141|469010150|FG000|Overall Study|Disease progression|11|||
130285527|NCT02754141|469010151|FG001|Overall Study|Disease progression|7|||
130285528|NCT02754141|469010152|FG002|Overall Study|Disease progression|8|||
130285529|NCT02754141|469010153|FG003|Overall Study|Disease progression|5|||
130458477|NCT01563354|469643485|FG002|Core Phase|Lost to Follow-up|0|||
130458478|NCT01563354|469643483|FG000|Core Phase|Death|1|||
130458479|NCT01563354|469643484|FG001|Core Phase|Death|5|||
130458480|NCT01563354|469643485|FG002|Core Phase|Death|2|||
130458481|NCT01563354|469643483|FG000|Core Phase|Diseasse progression|18|||
130458482|NCT01563354|469643484|FG001|Core Phase|Diseasse progression|7|||
130458483|NCT01563354|469643485|FG002|Core Phase|Diseasse progression|8|||
130458484|NCT01563354|469643483|FG000|Core Phase|Protocol deviation|2|||
130458485|NCT01563354|469643484|FG001|Core Phase|Protocol deviation|0|||
130458486|NCT01563354|469643485|FG002|Core Phase|Protocol deviation|0|||
130458487|NCT01563354|469643483|FG000|Core Phase|PI decision - did not enter extension|0|||
130458488|NCT01563354|469643484|FG001|Core Phase|PI decision - did not enter extension|1|||
130458489|NCT01563354|469643485|FG002|Core Phase|PI decision - did not enter extension|0|||
130458490|NCT01563354|469643483|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
130458491|NCT01563354|469643484|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
130458492|NCT01563354|469643485|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
130458493|NCT01563354|469643483|FG000|Extension Phase|Adverse Event|0|||
130458494|NCT01563354|469643484|FG001|Extension Phase|Adverse Event|3|||
130458495|NCT01563354|469643485|FG002|Extension Phase|Adverse Event|2|||
130458496|NCT01563354|469643483|FG000|Extension Phase|Withdrawal by Subject|0|||
130458497|NCT01563354|469643484|FG001|Extension Phase|Withdrawal by Subject|1|||
130458498|NCT01563354|469643485|FG002|Extension Phase|Withdrawal by Subject|0|||
130458499|NCT01563354|469643483|FG000|Extension Phase|Administration problems|3|||
130458500|NCT01563354|469643484|FG001|Extension Phase|Administration problems|2|||
130458501|NCT01563354|469643485|FG002|Extension Phase|Administration problems|3|||
130711825|NCT02429934|470569942|FG000|Overall Study|Adverse Event|2|||
130711826|NCT02429934|470569943|FG001|Overall Study|Adverse Event|0|||
130285530|NCT02754141|469010154|FG004|Overall Study|Disease progression|7|||
130285531|NCT02754141|469010155|FG005|Overall Study|Disease progression|7|||
130285532|NCT02754141|469010156|FG006|Overall Study|Disease progression|7|||
130285533|NCT02754141|469010157|FG007|Overall Study|Disease progression|6|||
130285534|NCT02754141|469010158|FG008|Overall Study|Disease progression|11|||
130285535|NCT02754141|469010159|FG009|Overall Study|Disease progression|16|||
130285536|NCT02754141|469010160|FG010|Overall Study|Disease progression|18|||
130458502|NCT01563354|469643483|FG000|Extension Phase|Disease progression|9|||
130711827|NCT02429934|470569942|FG000|Overall Study|Lost to Follow-up|1|||
130285537|NCT02754141|469010161|FG011|Overall Study|Disease progression|13|||
130285538|NCT02754141|469010162|FG012|Overall Study|Disease progression|10|||
130285539|NCT02754141|469010163|FG013|Overall Study|Disease progression|12|||
130285540|NCT02754141|469010164|FG014|Overall Study|Disease progression|12|||
130285541|NCT02754141|469010165|FG015|Overall Study|Disease progression|14|||
130285542|NCT02754141|469010166|FG016|Overall Study|Disease progression|0|||
130285543|NCT02754141|469010167|FG017|Overall Study|Disease progression|1|||
130285544|NCT02754141|469010150|FG000|Overall Study|Study drug toxicity|1|||
130285545|NCT02754141|469010151|FG001|Overall Study|Study drug toxicity|1|||
130285546|NCT02754141|469010152|FG002|Overall Study|Study drug toxicity|0|||
130285547|NCT02754141|469010153|FG003|Overall Study|Study drug toxicity|0|||
130285548|NCT02754141|469010154|FG004|Overall Study|Study drug toxicity|0|||
130285549|NCT02754141|469010155|FG005|Overall Study|Study drug toxicity|0|||
130285550|NCT02754141|469010156|FG006|Overall Study|Study drug toxicity|0|||
130285551|NCT02754141|469010157|FG007|Overall Study|Study drug toxicity|0|||
130285552|NCT02754141|469010158|FG008|Overall Study|Study drug toxicity|0|||
130285553|NCT02754141|469010159|FG009|Overall Study|Study drug toxicity|0|||
130285554|NCT02754141|469010160|FG010|Overall Study|Study drug toxicity|2|||
130285555|NCT02754141|469010161|FG011|Overall Study|Study drug toxicity|1|||
130285556|NCT02754141|469010162|FG012|Overall Study|Study drug toxicity|1|||
130285557|NCT02754141|469010163|FG013|Overall Study|Study drug toxicity|0|||
130285558|NCT02754141|469010164|FG014|Overall Study|Study drug toxicity|0|||
130285559|NCT02754141|469010165|FG015|Overall Study|Study drug toxicity|0|||
130285560|NCT02754141|469010166|FG016|Overall Study|Study drug toxicity|0|||
130285561|NCT02754141|469010167|FG017|Overall Study|Study drug toxicity|0|||
130285562|NCT02754141|469010150|FG000|Overall Study|AE unrelated to study drug|1|||
130285563|NCT02754141|469010151|FG001|Overall Study|AE unrelated to study drug|1|||
130285564|NCT02754141|469010152|FG002|Overall Study|AE unrelated to study drug|0|||
130285565|NCT02754141|469010153|FG003|Overall Study|AE unrelated to study drug|1|||
130285566|NCT02754141|469010154|FG004|Overall Study|AE unrelated to study drug|3|||
130285567|NCT02754141|469010155|FG005|Overall Study|AE unrelated to study drug|2|||
130285568|NCT02754141|469010156|FG006|Overall Study|AE unrelated to study drug|1|||
130285569|NCT02754141|469010157|FG007|Overall Study|AE unrelated to study drug|0|||
130285570|NCT02754141|469010158|FG008|Overall Study|AE unrelated to study drug|0|||
130285571|NCT02754141|469010159|FG009|Overall Study|AE unrelated to study drug|0|||
130285572|NCT02754141|469010160|FG010|Overall Study|AE unrelated to study drug|0|||
130285573|NCT02754141|469010161|FG011|Overall Study|AE unrelated to study drug|0|||
130555634|NCT01093625|470003286|FG001|2-Week Visit|Withdrawal by Subject|0|||
130555635|NCT01093625|470003285|FG000|1-Month Visit|Lost to Follow-up|2|||
130285574|NCT02754141|469010162|FG012|Overall Study|AE unrelated to study drug|0|||
130285575|NCT02754141|469010163|FG013|Overall Study|AE unrelated to study drug|0|||
130285576|NCT02754141|469010164|FG014|Overall Study|AE unrelated to study drug|0|||
130285577|NCT02754141|469010165|FG015|Overall Study|AE unrelated to study drug|0|||
130285578|NCT02754141|469010166|FG016|Overall Study|AE unrelated to study drug|0|||
130285579|NCT02754141|469010167|FG017|Overall Study|AE unrelated to study drug|0|||
130285580|NCT02754141|469010150|FG000|Overall Study|Request to discontinue|0|||
130369814|NCT00042289|469325090|FG017|Overall Study|Severe debilitation, unable to continue|0|||
130369815|NCT00042289|469325091|FG018|Overall Study|Severe debilitation, unable to continue|0|||
130369816|NCT00042289|469325092|FG019|Overall Study|Severe debilitation, unable to continue|0|||
130369817|NCT00042289|469325093|FG020|Overall Study|Severe debilitation, unable to continue|0|||
130369818|NCT00042289|469325094|FG021|Overall Study|Severe debilitation, unable to continue|1|||
130369819|NCT00042289|469325095|FG022|Overall Study|Severe debilitation, unable to continue|0|||
130369820|NCT00042289|469325096|FG023|Overall Study|Severe debilitation, unable to continue|1|||
130369821|NCT00042289|469325097|FG024|Overall Study|Severe debilitation, unable to continue|0|||
130369822|NCT00042289|469325098|FG025|Overall Study|Severe debilitation, unable to continue|0|||
130369823|NCT00042289|469325099|FG026|Overall Study|Severe debilitation, unable to continue|0|||
130369824|NCT00042289|469325100|FG027|Overall Study|Severe debilitation, unable to continue|1|||
130369825|NCT00042289|469325101|FG028|Overall Study|Severe debilitation, unable to continue|0|||
130369826|NCT00042289|469325102|FG029|Overall Study|Severe debilitation, unable to continue|0|||
130369827|NCT00042289|469325103|FG030|Overall Study|Severe debilitation, unable to continue|0|||
130369828|NCT00042289|469325104|FG031|Overall Study|Severe debilitation, unable to continue|1|||
130369829|NCT00042289|469325105|FG032|Overall Study|Severe debilitation, unable to continue|1|||
130369830|NCT00042289|469325106|FG033|Overall Study|Severe debilitation, unable to continue|0|||
130369831|NCT00042289|469325107|FG034|Overall Study|Severe debilitation, unable to continue|0|||
130369832|NCT00042289|469325108|FG035|Overall Study|Severe debilitation, unable to continue|0|||
130369833|NCT00042289|469325109|FG036|Overall Study|Severe debilitation, unable to continue|0|||
130369834|NCT00042289|469325110|FG037|Overall Study|Severe debilitation, unable to continue|0|||
130369835|NCT00042289|469325111|FG038|Overall Study|Severe debilitation, unable to continue|0|||
130369836|NCT00042289|469325112|FG039|Overall Study|Severe debilitation, unable to continue|0|||
130369837|NCT00042289|469325113|FG040|Overall Study|Severe debilitation, unable to continue|0|||
130369838|NCT00042289|469325114|FG041|Overall Study|Severe debilitation, unable to continue|0|||
130369839|NCT00042289|469325115|FG042|Overall Study|Severe debilitation, unable to continue|0|||
130369840|NCT00042289|469325116|FG043|Overall Study|Severe debilitation, unable to continue|0|||
130285581|NCT02754141|469010151|FG001|Overall Study|Request to discontinue|0|||
130285582|NCT02754141|469010152|FG002|Overall Study|Request to discontinue|0|||
130285583|NCT02754141|469010153|FG003|Overall Study|Request to discontinue|0|||
130285584|NCT02754141|469010154|FG004|Overall Study|Request to discontinue|0|||
130285585|NCT02754141|469010155|FG005|Overall Study|Request to discontinue|0|||
130285586|NCT02754141|469010156|FG006|Overall Study|Request to discontinue|0|||
130285587|NCT02754141|469010157|FG007|Overall Study|Request to discontinue|0|||
130285588|NCT02754141|469010158|FG008|Overall Study|Request to discontinue|1|||
130285589|NCT02754141|469010159|FG009|Overall Study|Request to discontinue|0|||
130285590|NCT02754141|469010160|FG010|Overall Study|Request to discontinue|0|||
130285591|NCT02754141|469010161|FG011|Overall Study|Request to discontinue|0|||
130458503|NCT01563354|469643484|FG001|Extension Phase|Disease progression|8|||
130458504|NCT01563354|469643485|FG002|Extension Phase|Disease progression|10|||
130711828|NCT02429934|470569943|FG001|Overall Study|Lost to Follow-up|1|||
130711829|NCT02429934|470569942|FG000|Overall Study|Physician Decision|1|||
130711830|NCT02429934|470569943|FG001|Overall Study|Physician Decision|0|||
130711831|NCT01564459|470569944|FG000|Run-In|Adverse Event|7|||
130711832|NCT01564459|470569945|FG001|Run-In|Adverse Event|0|||
130711833|NCT01564459|470569946|FG002|Run-In|Adverse Event|0|||
130711834|NCT01564459|470569944|FG000|Run-In|Lost to Follow-up|1|||
130711835|NCT01564459|470569945|FG001|Run-In|Lost to Follow-up|0|||
130711836|NCT01564459|470569946|FG002|Run-In|Lost to Follow-up|0|||
130711837|NCT01564459|470569944|FG000|Run-In|Non-compliance with study drug|2|||
130458505|NCT01565928|469643486|FG000|Overall Study|Adverse Event|3|||
130711838|NCT01564459|470569945|FG001|Run-In|Non-compliance with study drug|0|||
130711839|NCT01564459|470569946|FG002|Run-In|Non-compliance with study drug|0|||
130711840|NCT01564459|470569944|FG000|Run-In|Protocol Violation|1|||
130458506|NCT01565928|469643486|FG000|Overall Study|Other|3|||
130458507|NCT01565928|469643486|FG000|Overall Study|Progressive Disease|13|||
130458508|NCT01565928|469643486|FG000|Overall Study|Withdrawal by Subject|1|||
130458509|NCT01565928|469643486|FG000|Overall Study|Death|2|||
130458510|NCT01119950|469643487|FG000|Overall Study|Adverse Event|25|||
130458511|NCT01119950|469643487|FG000|Overall Study|Withdrawal by Subject|9|||
130458512|NCT01119950|469643487|FG000|Overall Study|Protocol Violation|5|||
130458513|NCT01119950|469643487|FG000|Overall Study|Lost to Follow-up|4|||
130458514|NCT01119950|469643487|FG000|Overall Study|Administrative|2|||
130458515|NCT01119950|469643487|FG000|Overall Study|Abnormal lab value|1|||
130458516|NCT01119950|469643487|FG000|Overall Study|Death|1|||
130458517|NCT01988233|469643490|FG000|Overall Study|Lost to Follow-up|64|||
130458518|NCT01988233|469643491|FG001|Overall Study|Lost to Follow-up|51|||
130458519|NCT03621761|469643496|FG000|Overall Study|Lost to Follow-up|1|||
130458520|NCT03621761|469643497|FG001|Overall Study|Lost to Follow-up|1|||
130458521|NCT03621761|469643498|FG002|Overall Study|Lost to Follow-up|2|||
130458522|NCT03621761|469643496|FG000|Overall Study|Withdrawal by Subject|2|||
130458523|NCT03621761|469643497|FG001|Overall Study|Withdrawal by Subject|1|||
130458524|NCT03621761|469643498|FG002|Overall Study|Withdrawal by Subject|1|||
130458525|NCT03621761|469643496|FG000|Overall Study|Became Ineligible|0|||
130458526|NCT03621761|469643497|FG001|Overall Study|Became Ineligible|2|||
130458527|NCT03621761|469643498|FG002|Overall Study|Became Ineligible|0|||
130458528|NCT00217672|469643499|FG000|Allocation|Ineligible|2|||
130458529|NCT00217672|469643500|FG001|Allocation|Ineligible|0|||
130458530|NCT00217672|469643499|FG000|Treatment|disease progression|33|||
130458531|NCT00217672|469643500|FG001|Treatment|disease progression|4|||
130458532|NCT00217672|469643499|FG000|Treatment|Adverse Event|18|||
130458533|NCT00217672|469643500|FG001|Treatment|Adverse Event|2|||
130711841|NCT01564459|470569945|FG001|Run-In|Protocol Violation|0|||
130711842|NCT01564459|470569946|FG002|Run-In|Protocol Violation|0|||
130711843|NCT01564459|470569944|FG000|Run-In|Withdrawal by Subject|1|||
130711844|NCT01564459|470569945|FG001|Run-In|Withdrawal by Subject|0|||
130711845|NCT01564459|470569946|FG002|Run-In|Withdrawal by Subject|0|||
130458534|NCT00217672|469643499|FG000|Treatment|reqd treatment not permitted by protocol|6|||
130458535|NCT00217672|469643500|FG001|Treatment|reqd treatment not permitted by protocol|0|||
130458536|NCT00217672|469643499|FG000|Treatment|Physician Decision|6|||
130458537|NCT00217672|469643500|FG001|Treatment|Physician Decision|0|||
130458538|NCT00217672|469643499|FG000|Treatment|insurance issues|1|||
130711846|NCT01564459|470569944|FG000|Double-blind Treatment|Adverse Event|0|||
130711847|NCT01564459|470569945|FG001|Double-blind Treatment|Adverse Event|0|||
130711848|NCT01564459|470569946|FG002|Double-blind Treatment|Adverse Event|1|||
130285592|NCT02754141|469010162|FG012|Overall Study|Request to discontinue|0|||
130458539|NCT00217672|469643500|FG001|Treatment|insurance issues|1|||
130458540|NCT00217672|469643499|FG000|Treatment|Death|2|||
130458541|NCT00217672|469643500|FG001|Treatment|Death|0|||
130458542|NCT00217672|469643499|FG000|Treatment|secondary malignancy|1|||
130458543|NCT00217672|469643500|FG001|Treatment|secondary malignancy|0|||
130458544|NCT00217672|469643499|FG000|Follow-up|Withdrawal by Subject|4|||
130458545|NCT00217672|469643500|FG001|Follow-up|Withdrawal by Subject|0|||
130458546|NCT00217672|469643499|FG000|Follow-up|Lost to Follow-up|1|||
130711849|NCT01138111|470569952|FG000|Overall Study|Withdrawal by Subject|5|||
130711850|NCT01138111|470569952|FG000|Overall Study|Adverse Event|1|||
130711851|NCT01138111|470569952|FG000|Overall Study|Death|1|||
130458547|NCT00217672|469643500|FG001|Follow-up|Lost to Follow-up|0|||
130458548|NCT01050569|469643501|FG000|Overall Study|Lost to Follow-up|20|||
130555636|NCT01093625|470003286|FG001|1-Month Visit|Lost to Follow-up|0|||
130555637|NCT01093625|470003285|FG000|3-Month Visit|Lost to Follow-up|2|||
130555638|NCT01093625|470003286|FG001|3-Month Visit|Lost to Follow-up|0|||
130711852|NCT01138111|470569952|FG000|Overall Study|Lost to Follow-up|2|||
130711853|NCT01491035|470569953|FG000|Overall Study|Lost to Follow-up|0|||
130711854|NCT01491035|470569954|FG001|Overall Study|Lost to Follow-up|0|||
130711855|NCT01491035|470569955|FG002|Overall Study|Lost to Follow-up|0|||
130711856|NCT01491035|470569956|FG003|Overall Study|Lost to Follow-up|0|||
130711857|NCT01491035|470569957|FG004|Overall Study|Lost to Follow-up|1|||
130711858|NCT01491035|470569958|FG005|Overall Study|Lost to Follow-up|0|||
130711859|NCT01491035|470569959|FG006|Overall Study|Lost to Follow-up|0|||
130458549|NCT01050569|469643502|FG001|Overall Study|Lost to Follow-up|14|||
130458550|NCT01050569|469643503|FG002|Overall Study|Lost to Follow-up|16|||
130458551|NCT01050569|469643501|FG000|Overall Study|Withdrawal by Subject|9|||
130458552|NCT01050569|469643502|FG001|Overall Study|Withdrawal by Subject|3|||
130458553|NCT01050569|469643503|FG002|Overall Study|Withdrawal by Subject|11|||
130458554|NCT01050569|469643501|FG000|Overall Study|Lack of Efficacy|5|||
130458555|NCT01050569|469643502|FG001|Overall Study|Lack of Efficacy|4|||
130458556|NCT01050569|469643503|FG002|Overall Study|Lack of Efficacy|3|||
130458557|NCT01050569|469643501|FG000|Overall Study|Adverse Event|1|||
130458558|NCT01050569|469643502|FG001|Overall Study|Adverse Event|0|||
130458559|NCT01050569|469643503|FG002|Overall Study|Adverse Event|0|||
130458560|NCT01050569|469643501|FG000|Overall Study|Physician Decision|3|||
130458561|NCT01050569|469643502|FG001|Overall Study|Physician Decision|3|||
130458562|NCT01050569|469643503|FG002|Overall Study|Physician Decision|3|||
130458563|NCT01591616|469643508|FG000|Overall Study|Withdrawal by Subject|1|||
130458564|NCT00758602|469643509|FG000|Overall Study|Adverse Event|11|||
130458565|NCT00758602|469643510|FG001|Overall Study|Adverse Event|10|||
130458566|NCT00758602|469643509|FG000|Overall Study|Lost to Follow-up|4|||
130458567|NCT00758602|469643510|FG001|Overall Study|Lost to Follow-up|3|||
130458568|NCT00758602|469643509|FG000|Overall Study|Withdrawal by Subject|1|||
130458569|NCT00758602|469643510|FG001|Overall Study|Withdrawal by Subject|3|||
130458570|NCT00758602|469643509|FG000|Overall Study|Protocol Violation|0|||
130458571|NCT00758602|469643510|FG001|Overall Study|Protocol Violation|2|||
130711860|NCT01491035|470569960|FG007|Overall Study|Lost to Follow-up|0|||
130711861|NCT02999477|470569968|FG000|Overall Study|found ineligible after first dose|0|||
130711862|NCT02999477|470569969|FG001|Overall Study|found ineligible after first dose|1|||
130711863|NCT02999477|470569968|FG000|Overall Study|Withdrawal by Subject|1|||
130711864|NCT02999477|470569969|FG001|Overall Study|Withdrawal by Subject|1|||
130711865|NCT04266795|470569982|FG000|Overall Study|Adverse Event|10|||
130711866|NCT04266795|470569983|FG001|Overall Study|Adverse Event|19|||
130711867|NCT04266795|470569982|FG000|Overall Study|Death|7|||
130711868|NCT04266795|470569983|FG001|Overall Study|Death|8|||
130711869|NCT04266795|470569982|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
130711870|NCT04266795|470569983|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
130711871|NCT04266795|470569982|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130711872|NCT04266795|470569983|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130711873|NCT04266795|470569982|FG000|Overall Study|Progressive Disease|12|||
130711874|NCT04266795|470569983|FG001|Overall Study|Progressive Disease|9|||
130711875|NCT04266795|470569982|FG000|Overall Study|Withdrawal by Patient|5|||
130711876|NCT04266795|470569983|FG001|Overall Study|Withdrawal by Patient|6|||
130711877|NCT04266795|470569982|FG000|Overall Study|Disease Relapse|3|||
130711878|NCT04266795|470569983|FG001|Overall Study|Disease Relapse|6|||
130285593|NCT02754141|469010163|FG013|Overall Study|Request to discontinue|1|||
130458572|NCT00758602|469643509|FG000|Overall Study|Death|0|||
130458573|NCT00758602|469643510|FG001|Overall Study|Death|1|||
130458574|NCT00758602|469643509|FG000|Overall Study|Reason not specified|3|||
130458575|NCT00758602|469643510|FG001|Overall Study|Reason not specified|3|||
130458576|NCT04379713|469643511|FG000|Overall Study|Adverse Event|2|||
130458577|NCT04379713|469643512|FG001|Overall Study|Adverse Event|0|||
130458578|NCT04379713|469643511|FG000|Overall Study|Physician Decision|2|||
130458579|NCT04379713|469643512|FG001|Overall Study|Physician Decision|1|||
130555639|NCT01093625|470003285|FG000|6-Month Visit|Withdrawal by Subject|6|||
130711879|NCT04266795|470569982|FG000|Overall Study|Reason not Specified|12|||
130711880|NCT04266795|470569983|FG001|Overall Study|Reason not Specified|10|||
130711881|NCT04266795|470569982|FG000|Overall Study|Participants Ongoing on Treatment|25|||
130711882|NCT04266795|470569983|FG001|Overall Study|Participants Ongoing on Treatment|23|||
130458580|NCT04379713|469643511|FG000|Overall Study|Protocol Violation|11|||
130458581|NCT04379713|469643512|FG001|Overall Study|Protocol Violation|6|||
130458582|NCT04379713|469643511|FG000|Overall Study|No longer met eligibility criteria|14|||
130458583|NCT04379713|469643512|FG001|Overall Study|No longer met eligibility criteria|11|||
130458584|NCT04379713|469643511|FG000|Overall Study|Withdrawal by parent/guardian|36|||
130711883|NCT03351231|470569984|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
130711884|NCT03351231|470569984|FG000|Combination Therapy Period|Disease progression|2|||
130316228|NCT04319198|469124333|FG001|Overall Study|Death|3|||
130711885|NCT03351231|470569984|FG000|Combination Therapy Period|Study drug toxicity|1|||
130711886|NCT03351231|470569984|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
130285594|NCT02754141|469010164|FG014|Overall Study|Request to discontinue|1|||
130285595|NCT02754141|469010165|FG015|Overall Study|Request to discontinue|0|||
130285596|NCT02754141|469010166|FG016|Overall Study|Request to discontinue|0|||
130285597|NCT02754141|469010167|FG017|Overall Study|Request to discontinue|0|||
130285598|NCT02754141|469010150|FG000|Overall Study|Withdrew consent|0|||
130285599|NCT02754141|469010151|FG001|Overall Study|Withdrew consent|0|||
130285600|NCT02754141|469010152|FG002|Overall Study|Withdrew consent|0|||
130285601|NCT02754141|469010153|FG003|Overall Study|Withdrew consent|0|||
130285602|NCT02754141|469010154|FG004|Overall Study|Withdrew consent|0|||
130285603|NCT02754141|469010155|FG005|Overall Study|Withdrew consent|0|||
130285604|NCT02754141|469010156|FG006|Overall Study|Withdrew consent|0|||
130285605|NCT02754141|469010157|FG007|Overall Study|Withdrew consent|0|||
130285606|NCT02754141|469010158|FG008|Overall Study|Withdrew consent|0|||
130285607|NCT02754141|469010159|FG009|Overall Study|Withdrew consent|1|||
130285608|NCT02754141|469010160|FG010|Overall Study|Withdrew consent|0|||
130285609|NCT02754141|469010161|FG011|Overall Study|Withdrew consent|0|||
130285610|NCT02754141|469010162|FG012|Overall Study|Withdrew consent|0|||
130285611|NCT02754141|469010163|FG013|Overall Study|Withdrew consent|0|||
130285612|NCT02754141|469010164|FG014|Overall Study|Withdrew consent|0|||
130285613|NCT02754141|469010165|FG015|Overall Study|Withdrew consent|0|||
130285614|NCT02754141|469010166|FG016|Overall Study|Withdrew consent|0|||
130285615|NCT02754141|469010167|FG017|Overall Study|Withdrew consent|0|||
130285616|NCT02754141|469010150|FG000|Overall Study|Maximum clinical benefit|0|||
130285617|NCT02754141|469010151|FG001|Overall Study|Maximum clinical benefit|0|||
130285618|NCT02754141|469010152|FG002|Overall Study|Maximum clinical benefit|0|||
130285619|NCT02754141|469010153|FG003|Overall Study|Maximum clinical benefit|1|||
130285620|NCT02754141|469010154|FG004|Overall Study|Maximum clinical benefit|0|||
130285621|NCT02754141|469010155|FG005|Overall Study|Maximum clinical benefit|0|||
130285622|NCT02754141|469010156|FG006|Overall Study|Maximum clinical benefit|0|||
130285623|NCT02754141|469010157|FG007|Overall Study|Maximum clinical benefit|0|||
130285624|NCT02754141|469010158|FG008|Overall Study|Maximum clinical benefit|0|||
130285625|NCT02754141|469010159|FG009|Overall Study|Maximum clinical benefit|0|||
130285626|NCT02754141|469010160|FG010|Overall Study|Maximum clinical benefit|0|||
130285627|NCT02754141|469010161|FG011|Overall Study|Maximum clinical benefit|0|||
130285628|NCT02754141|469010162|FG012|Overall Study|Maximum clinical benefit|0|||
130285629|NCT02754141|469010163|FG013|Overall Study|Maximum clinical benefit|0|||
130285630|NCT02754141|469010164|FG014|Overall Study|Maximum clinical benefit|0|||
130285631|NCT02754141|469010165|FG015|Overall Study|Maximum clinical benefit|0|||
130285632|NCT02754141|469010166|FG016|Overall Study|Maximum clinical benefit|0|||
130285633|NCT02754141|469010167|FG017|Overall Study|Maximum clinical benefit|0|||
130285634|NCT02754141|469010150|FG000|Overall Study|No longer meets study criteria|0|||
130285635|NCT02754141|469010151|FG001|Overall Study|No longer meets study criteria|0|||
130285636|NCT02754141|469010152|FG002|Overall Study|No longer meets study criteria|0|||
130285637|NCT02754141|469010153|FG003|Overall Study|No longer meets study criteria|1|||
130285638|NCT02754141|469010154|FG004|Overall Study|No longer meets study criteria|0|||
130285639|NCT02754141|469010155|FG005|Overall Study|No longer meets study criteria|0|||
130285640|NCT02754141|469010156|FG006|Overall Study|No longer meets study criteria|0|||
130285641|NCT02754141|469010157|FG007|Overall Study|No longer meets study criteria|0|||
130285642|NCT02754141|469010158|FG008|Overall Study|No longer meets study criteria|0|||
130285643|NCT02754141|469010159|FG009|Overall Study|No longer meets study criteria|0|||
130285644|NCT02754141|469010160|FG010|Overall Study|No longer meets study criteria|0|||
130285645|NCT02754141|469010161|FG011|Overall Study|No longer meets study criteria|0|||
130285646|NCT02754141|469010162|FG012|Overall Study|No longer meets study criteria|0|||
130458585|NCT04379713|469643512|FG001|Overall Study|Withdrawal by parent/guardian|15|||
130458586|NCT04379713|469643511|FG000|Overall Study|Lost to Follow-up|31|||
130458587|NCT04379713|469643512|FG001|Overall Study|Lost to Follow-up|21|||
130458588|NCT02781584|469643514|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
130458589|NCT02781584|469643515|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
130458590|NCT02781584|469643516|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
130458591|NCT02781584|469643517|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
130458592|NCT02781584|469643518|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
130711887|NCT03351231|470569984|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
130711888|NCT03351231|470569984|FG000|Safety Follow-Up Period|Other reason|2|||
130711889|NCT03487848|470569985|FG000|Overall Study|Lost to Follow-up|1|||
130458593|NCT02781584|469643519|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
130458594|NCT02781584|469643520|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
130458595|NCT02781584|469643521|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
130285647|NCT02754141|469010163|FG013|Overall Study|No longer meets study criteria|0|||
130285648|NCT02754141|469010164|FG014|Overall Study|No longer meets study criteria|0|||
130285649|NCT02754141|469010165|FG015|Overall Study|No longer meets study criteria|0|||
130466750|NCT02544074|469676382|FG020|Overall Study|Tablet error|0|||
130285650|NCT02754141|469010166|FG016|Overall Study|No longer meets study criteria|0|||
130711890|NCT00731549|470569986|FG000|Overall Study|Lost to Follow-up|19|||
130711891|NCT00731549|470569986|FG000|Overall Study|Met withdrawal criteria|24|||
130711892|NCT00731549|470569986|FG000|Overall Study|Physician Decision|16|||
130711893|NCT00731549|470569986|FG000|Overall Study|Withdrawal by Subject|89|||
130285651|NCT02754141|469010167|FG017|Overall Study|No longer meets study criteria|0|||
130285652|NCT02754141|469010150|FG000|Overall Study|Other reasons|0|||
130285653|NCT02754141|469010151|FG001|Overall Study|Other reasons|0|||
130285654|NCT02754141|469010152|FG002|Overall Study|Other reasons|0|||
130285655|NCT02754141|469010153|FG003|Overall Study|Other reasons|0|||
130285656|NCT02754141|469010154|FG004|Overall Study|Other reasons|0|||
130285657|NCT02754141|469010155|FG005|Overall Study|Other reasons|0|||
130285658|NCT02754141|469010156|FG006|Overall Study|Other reasons|0|||
130285659|NCT02754141|469010157|FG007|Overall Study|Other reasons|1|||
130285660|NCT02754141|469010158|FG008|Overall Study|Other reasons|0|||
130285661|NCT02754141|469010159|FG009|Overall Study|Other reasons|0|||
130285662|NCT02754141|469010160|FG010|Overall Study|Other reasons|0|||
130285663|NCT02754141|469010161|FG011|Overall Study|Other reasons|0|||
130285664|NCT02754141|469010162|FG012|Overall Study|Other reasons|2|||
130285665|NCT02754141|469010163|FG013|Overall Study|Other reasons|0|||
130285666|NCT02754141|469010164|FG014|Overall Study|Other reasons|0|||
130285667|NCT02754141|469010165|FG015|Overall Study|Other reasons|0|||
130285668|NCT02754141|469010166|FG016|Overall Study|Other reasons|0|||
130285669|NCT02754141|469010167|FG017|Overall Study|Other reasons|0|||
130285670|NCT02754141|469010150|FG000|Overall Study|Completed treatment as per protocol|0|||
130285671|NCT02754141|469010151|FG001|Overall Study|Completed treatment as per protocol|1|||
130285672|NCT02754141|469010152|FG002|Overall Study|Completed treatment as per protocol|0|||
130285673|NCT02754141|469010153|FG003|Overall Study|Completed treatment as per protocol|0|||
130285674|NCT02754141|469010154|FG004|Overall Study|Completed treatment as per protocol|0|||
130285675|NCT02754141|469010155|FG005|Overall Study|Completed treatment as per protocol|0|||
130285676|NCT02754141|469010156|FG006|Overall Study|Completed treatment as per protocol|0|||
130285677|NCT02754141|469010157|FG007|Overall Study|Completed treatment as per protocol|0|||
130458596|NCT02781584|469643522|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
130458597|NCT02781584|469643523|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
130458598|NCT02781584|469643524|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
130458599|NCT02781584|469643525|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
130458600|NCT02781584|469643526|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
130458601|NCT02781584|469643514|FG000|Pre-treatment Phase|Adverse Event|0|||
130458602|NCT02781584|469643515|FG001|Pre-treatment Phase|Adverse Event|0|||
130458603|NCT02781584|469643516|FG002|Pre-treatment Phase|Adverse Event|0|||
130458604|NCT02781584|469643517|FG003|Pre-treatment Phase|Adverse Event|0|||
130458605|NCT02781584|469643518|FG004|Pre-treatment Phase|Adverse Event|0|||
130458606|NCT02781584|469643519|FG005|Pre-treatment Phase|Adverse Event|0|||
130458607|NCT02781584|469643520|FG006|Pre-treatment Phase|Adverse Event|0|||
130458608|NCT02781584|469643521|FG007|Pre-treatment Phase|Adverse Event|0|||
130458609|NCT02781584|469643522|FG008|Pre-treatment Phase|Adverse Event|0|||
130458610|NCT02781584|469643523|FG009|Pre-treatment Phase|Adverse Event|0|||
130458611|NCT02781584|469643524|FG010|Pre-treatment Phase|Adverse Event|0|||
130458612|NCT02781584|469643525|FG011|Pre-treatment Phase|Adverse Event|1|||
130458613|NCT02781584|469643526|FG012|Pre-treatment Phase|Adverse Event|0|||
130458614|NCT02781584|469643514|FG000|Treatment Phase|Withdrew Consent|0|||
130458615|NCT02781584|469643515|FG001|Treatment Phase|Withdrew Consent|0|||
130458616|NCT02781584|469643516|FG002|Treatment Phase|Withdrew Consent|0|||
130458617|NCT02781584|469643517|FG003|Treatment Phase|Withdrew Consent|0|||
130458618|NCT02781584|469643518|FG004|Treatment Phase|Withdrew Consent|0|||
130458619|NCT02781584|469643519|FG005|Treatment Phase|Withdrew Consent|1|||
130458620|NCT02781584|469643520|FG006|Treatment Phase|Withdrew Consent|0|||
130458621|NCT02781584|469643521|FG007|Treatment Phase|Withdrew Consent|0|||
130458622|NCT02781584|469643522|FG008|Treatment Phase|Withdrew Consent|0|||
130458623|NCT02781584|469643523|FG009|Treatment Phase|Withdrew Consent|0|||
130458624|NCT02781584|469643524|FG010|Treatment Phase|Withdrew Consent|1|||
130458625|NCT02781584|469643525|FG011|Treatment Phase|Withdrew Consent|2|||
130458626|NCT02781584|469643526|FG012|Treatment Phase|Withdrew Consent|0|||
130458627|NCT02781584|469643514|FG000|Treatment Phase|Adverse Event|0|||
130458628|NCT02781584|469643515|FG001|Treatment Phase|Adverse Event|0|||
130711894|NCT00731549|470569986|FG000|Overall Study|Protocol deviation|1|||
130285678|NCT02754141|469010158|FG008|Overall Study|Completed treatment as per protocol|0|||
130285679|NCT02754141|469010159|FG009|Overall Study|Completed treatment as per protocol|0|||
130285680|NCT02754141|469010160|FG010|Overall Study|Completed treatment as per protocol|0|||
130285681|NCT02754141|469010161|FG011|Overall Study|Completed treatment as per protocol|0|||
130458629|NCT02781584|469643516|FG002|Treatment Phase|Adverse Event|0|||
130458630|NCT02781584|469643517|FG003|Treatment Phase|Adverse Event|0|||
130458631|NCT02781584|469643518|FG004|Treatment Phase|Adverse Event|0|||
130458632|NCT02781584|469643519|FG005|Treatment Phase|Adverse Event|0|||
130458633|NCT02781584|469643520|FG006|Treatment Phase|Adverse Event|0|||
130458634|NCT02781584|469643521|FG007|Treatment Phase|Adverse Event|1|||
130711895|NCT00731549|470569986|FG000|Overall Study|Adverse Event|31|||
130711896|NCT00731549|470569986|FG000|Overall Study|Lack of efficacy with AE|37|||
130458635|NCT02781584|469643522|FG008|Treatment Phase|Adverse Event|0|||
130458636|NCT02781584|469643523|FG009|Treatment Phase|Adverse Event|0|||
130458637|NCT02781584|469643524|FG010|Treatment Phase|Adverse Event|0|||
130458638|NCT02781584|469643525|FG011|Treatment Phase|Adverse Event|0|||
130458639|NCT02781584|469643526|FG012|Treatment Phase|Adverse Event|0|||
130458640|NCT00038103|469643531|FG000|Overall Study|Adverse Event|5|||
130458641|NCT00038103|469643532|FG001|Overall Study|Adverse Event|6|||
130458642|NCT00038103|469643531|FG000|Overall Study|Lack of Efficacy|48|||
130458643|NCT00038103|469643532|FG001|Overall Study|Lack of Efficacy|41|||
130458644|NCT00038103|469643531|FG000|Overall Study|Withdrawal by Subject|0|||
130458645|NCT00038103|469643532|FG001|Overall Study|Withdrawal by Subject|3|||
130458646|NCT00038103|469643531|FG000|Overall Study|Lost to Follow-up|0|||
130458647|NCT00038103|469643532|FG001|Overall Study|Lost to Follow-up|3|||
130458648|NCT00038103|469643531|FG000|Overall Study|Protocol Violation|0|||
130458649|NCT00038103|469643532|FG001|Overall Study|Protocol Violation|2|||
130458650|NCT00038103|469643531|FG000|Overall Study|Sponsor Decision|0|||
130458651|NCT00038103|469643532|FG001|Overall Study|Sponsor Decision|1|||
130458652|NCT00038103|469643531|FG000|Overall Study|Randomized/never treated|2|||
130458653|NCT00038103|469643532|FG001|Overall Study|Randomized/never treated|0|||
130458654|NCT00208767|469643535|FG000|Overall Study|Adverse Event|9|||
130458655|NCT00208767|469643536|FG001|Overall Study|Adverse Event|1|||
130458656|NCT00208767|469643535|FG000|Overall Study|Withdrawal by Subject|14|||
130285682|NCT02754141|469010162|FG012|Overall Study|Completed treatment as per protocol|1|||
130285683|NCT02754141|469010163|FG013|Overall Study|Completed treatment as per protocol|0|||
130285684|NCT02754141|469010164|FG014|Overall Study|Completed treatment as per protocol|0|||
130285685|NCT02754141|469010165|FG015|Overall Study|Completed treatment as per protocol|0|||
130285686|NCT02754141|469010166|FG016|Overall Study|Completed treatment as per protocol|0|||
130285687|NCT02754141|469010167|FG017|Overall Study|Completed treatment as per protocol|0|||
130285688|NCT02754141|469010150|FG000|Overall Study|Not completing monotherapy|0|||
130285689|NCT02754141|469010151|FG001|Overall Study|Not completing monotherapy|0|||
130285690|NCT02754141|469010152|FG002|Overall Study|Not completing monotherapy|0|||
130285691|NCT02754141|469010153|FG003|Overall Study|Not completing monotherapy|0|||
130285692|NCT02754141|469010154|FG004|Overall Study|Not completing monotherapy|0|||
130285693|NCT02754141|469010155|FG005|Overall Study|Not completing monotherapy|0|||
130285694|NCT02754141|469010156|FG006|Overall Study|Not completing monotherapy|0|||
130285695|NCT02754141|469010157|FG007|Overall Study|Not completing monotherapy|0|||
130285696|NCT02754141|469010158|FG008|Overall Study|Not completing monotherapy|0|||
130285697|NCT02754141|469010159|FG009|Overall Study|Not completing monotherapy|0|||
130285698|NCT02754141|469010160|FG010|Overall Study|Not completing monotherapy|0|||
130285699|NCT02754141|469010161|FG011|Overall Study|Not completing monotherapy|0|||
130285700|NCT02754141|469010162|FG012|Overall Study|Not completing monotherapy|0|||
130285701|NCT02754141|469010163|FG013|Overall Study|Not completing monotherapy|1|||
130285702|NCT02754141|469010164|FG014|Overall Study|Not completing monotherapy|0|||
130285703|NCT02754141|469010165|FG015|Overall Study|Not completing monotherapy|0|||
130285704|NCT02754141|469010166|FG016|Overall Study|Not completing monotherapy|0|||
130285705|NCT02754141|469010167|FG017|Overall Study|Not completing monotherapy|0|||
130285706|NCT03361189|469010168|FG000|Overall Study|Received heart transplant|1|||
130285707|NCT03361189|469010169|FG001|Overall Study|Received heart transplant|0|||
130285708|NCT03361189|469010168|FG000|Overall Study|Pacemake replacement|0|||
130285709|NCT03361189|469010169|FG001|Overall Study|Pacemake replacement|1|||
130285710|NCT03505788|469010170|FG000|Overall Study|Lost to Follow-up|2|||
130285711|NCT03505788|469010171|FG001|Overall Study|Lost to Follow-up|1|||
130285712|NCT03505788|469010170|FG000|Overall Study|Withdrawal by Subject|1|||
130285713|NCT03505788|469010171|FG001|Overall Study|Withdrawal by Subject|3|||
130285714|NCT03505788|469010170|FG000|Overall Study|Physician Decision|0|||
130285715|NCT03505788|469010171|FG001|Overall Study|Physician Decision|1|||
130285716|NCT03344549|469010172|FG000|Overall Study|Withdrawal by Subject|3|||
130285717|NCT03344549|469010173|FG001|Overall Study|Withdrawal by Subject|2|||
130285718|NCT03344549|469010172|FG000|Overall Study|Dialysis|2|||
130458657|NCT00208767|469643536|FG001|Overall Study|Withdrawal by Subject|3|||
130458658|NCT00208767|469643535|FG000|Overall Study|Death|1|||
130458659|NCT00208767|469643536|FG001|Overall Study|Death|0|||
130458660|NCT00208767|469643535|FG000|Overall Study|Lost to Follow-up|3|||
130458661|NCT00208767|469643536|FG001|Overall Study|Lost to Follow-up|3|||
130458662|NCT03545984|469643537|FG000|Overall Study|CSF cases not present during rotation|11|||
130458663|NCT03545984|469643538|FG001|Overall Study|CSF cases not present during rotation|9|||
130458664|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130458665|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
130285719|NCT03344549|469010173|FG001|Overall Study|Dialysis|0|||
130285720|NCT03344549|469010172|FG000|Overall Study|Cancer|1|||
130285721|NCT03344549|469010173|FG001|Overall Study|Cancer|0|||
130285722|NCT03344549|469010172|FG000|Overall Study|Lack of electronic device|1|||
130285723|NCT03344549|469010173|FG001|Overall Study|Lack of electronic device|0|||
130285724|NCT03344549|469010172|FG000|Overall Study|Transportation difficulty|0|||
130285725|NCT03344549|469010173|FG001|Overall Study|Transportation difficulty|13|||
130285726|NCT03333252|469010174|FG000|Overall Study|Adverse Event|10|||
130458666|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
130285727|NCT03333252|469010175|FG001|Overall Study|Adverse Event|6|||
130285728|NCT03333252|469010176|FG002|Overall Study|Adverse Event|5|||
130285729|NCT03333252|469010177|FG003|Overall Study|Adverse Event|2|||
130285730|NCT03333252|469010174|FG000|Overall Study|Death|1|||
130285731|NCT03333252|469010175|FG001|Overall Study|Death|3|||
130285732|NCT03333252|469010176|FG002|Overall Study|Death|0|||
130285733|NCT03333252|469010177|FG003|Overall Study|Death|0|||
130285734|NCT03333252|469010174|FG000|Overall Study|Lack of Efficacy|8|||
130285735|NCT03333252|469010175|FG001|Overall Study|Lack of Efficacy|4|||
130285736|NCT03333252|469010176|FG002|Overall Study|Lack of Efficacy|0|||
130285737|NCT03333252|469010177|FG003|Overall Study|Lack of Efficacy|7|||
130285738|NCT03333252|469010174|FG000|Overall Study|Lost to Follow-up|0|||
130285739|NCT03333252|469010175|FG001|Overall Study|Lost to Follow-up|5|||
130285740|NCT03333252|469010176|FG002|Overall Study|Lost to Follow-up|9|||
130285741|NCT03333252|469010177|FG003|Overall Study|Lost to Follow-up|3|||
130285742|NCT03333252|469010174|FG000|Overall Study|Withdrawal by Subject|14|||
130285743|NCT03333252|469010175|FG001|Overall Study|Withdrawal by Subject|24|||
130285744|NCT03333252|469010176|FG002|Overall Study|Withdrawal by Subject|11|||
130285745|NCT03333252|469010177|FG003|Overall Study|Withdrawal by Subject|17|||
130285746|NCT00666588|469010181|FG000|Overall Study|ineligible|2|||
130285747|NCT00666588|469010182|FG001|Overall Study|ineligible|0|||
130285748|NCT00666588|469010183|FG002|Overall Study|ineligible|0|||
130285749|NCT00666588|469010184|FG003|Overall Study|ineligible|2|||
130285750|NCT00666588|469010181|FG000|Overall Study|inevaluable|2|||
130285751|NCT00666588|469010182|FG001|Overall Study|inevaluable|0|||
130285752|NCT00666588|469010183|FG002|Overall Study|inevaluable|0|||
130285753|NCT00666588|469010184|FG003|Overall Study|inevaluable|0|||
130285754|NCT01007123|469010189|FG000|Overall Study|Adverse Event|3|||
130285755|NCT01007123|469010190|FG001|Overall Study|Adverse Event|4|||
130285756|NCT01007123|469010191|FG002|Overall Study|Adverse Event|7|||
130285757|NCT01007123|469010192|FG003|Overall Study|Adverse Event|1|||
130285758|NCT01007123|469010189|FG000|Overall Study|Lack of Efficacy|1|||
130285759|NCT01007123|469010190|FG001|Overall Study|Lack of Efficacy|0|||
130285760|NCT01007123|469010191|FG002|Overall Study|Lack of Efficacy|1|||
130285761|NCT01007123|469010192|FG003|Overall Study|Lack of Efficacy|4|||
130285762|NCT01007123|469010189|FG000|Overall Study|Protocol Violation|1|||
130285763|NCT01007123|469010190|FG001|Overall Study|Protocol Violation|1|||
130369841|NCT00042289|469325117|FG044|Overall Study|Severe debilitation, unable to continue|0|||
130369842|NCT00042289|469325118|FG045|Overall Study|Severe debilitation, unable to continue|0|||
130369843|NCT00042289|469325119|FG046|Overall Study|Severe debilitation, unable to continue|0|||
130369844|NCT00042289|469325073|FG000|Overall Study|Site closed|0|||
130369845|NCT00042289|469325074|FG001|Overall Study|Site closed|0|||
130369846|NCT00042289|469325075|FG002|Overall Study|Site closed|0|||
130369847|NCT00042289|469325076|FG003|Overall Study|Site closed|0|||
130369848|NCT00042289|469325077|FG004|Overall Study|Site closed|0|||
130369849|NCT00042289|469325078|FG005|Overall Study|Site closed|0|||
130369850|NCT00042289|469325079|FG006|Overall Study|Site closed|0|||
130369851|NCT00042289|469325080|FG007|Overall Study|Site closed|0|||
130369852|NCT00042289|469325081|FG008|Overall Study|Site closed|0|||
130369853|NCT00042289|469325082|FG009|Overall Study|Site closed|0|||
130369854|NCT00042289|469325083|FG010|Overall Study|Site closed|0|||
130369855|NCT00042289|469325084|FG011|Overall Study|Site closed|0|||
130369856|NCT00042289|469325085|FG012|Overall Study|Site closed|0|||
130369857|NCT00042289|469325086|FG013|Overall Study|Site closed|0|||
130369858|NCT00042289|469325087|FG014|Overall Study|Site closed|0|||
130369859|NCT00042289|469325088|FG015|Overall Study|Site closed|0|||
130369860|NCT00042289|469325089|FG016|Overall Study|Site closed|0|||
130369861|NCT00042289|469325090|FG017|Overall Study|Site closed|0|||
130369862|NCT00042289|469325091|FG018|Overall Study|Site closed|0|||
130369863|NCT00042289|469325092|FG019|Overall Study|Site closed|0|||
130369864|NCT00042289|469325093|FG020|Overall Study|Site closed|0|||
130369865|NCT00042289|469325094|FG021|Overall Study|Site closed|0|||
130711897|NCT00731549|470569986|FG000|Overall Study|Lack of efficacy without AE|6|||
130285764|NCT01007123|469010191|FG002|Overall Study|Protocol Violation|2|||
130285765|NCT01007123|469010192|FG003|Overall Study|Protocol Violation|1|||
130369866|NCT00042289|469325095|FG022|Overall Study|Site closed|0|||
130369867|NCT00042289|469325096|FG023|Overall Study|Site closed|0|||
130711898|NCT00588640|470569987|FG000|Overall Study|Physician Decision|1|||
130711899|NCT00588640|470569987|FG000|Overall Study|Ineligible Patient|1|||
130711900|NCT00003138|470571736|FG000|Step 1|Reasons off treatment not documented|60|||
130285766|NCT01007123|469010189|FG000|Overall Study|Withdrawal by Subject|1|||
130285767|NCT01007123|469010190|FG001|Overall Study|Withdrawal by Subject|0|||
130285768|NCT01007123|469010191|FG002|Overall Study|Withdrawal by Subject|1|||
130285769|NCT01007123|469010192|FG003|Overall Study|Withdrawal by Subject|0|||
130285770|NCT01007123|469010189|FG000|Overall Study|Lost to Follow-up|0|||
130285771|NCT01007123|469010190|FG001|Overall Study|Lost to Follow-up|1|||
130285772|NCT01007123|469010191|FG002|Overall Study|Lost to Follow-up|0|||
130285773|NCT01007123|469010192|FG003|Overall Study|Lost to Follow-up|0|||
130285774|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
130369868|NCT00042289|469325097|FG024|Overall Study|Site closed|0|||
130369869|NCT00042289|469325098|FG025|Overall Study|Site closed|0|||
130369870|NCT00042289|469325099|FG026|Overall Study|Site closed|0|||
130369871|NCT00042289|469325100|FG027|Overall Study|Site closed|0|||
130711901|NCT00003138|470571737|FG001|Step 1|Reasons off treatment not documented|57|||
130711902|NCT00003138|470571736|FG000|Step 1|Never started treatment|1|||
130711903|NCT00003138|470571737|FG001|Step 1|Never started treatment|0|||
130711904|NCT00003138|470571736|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
130711905|NCT00003138|470571737|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
130711906|NCT00003138|470571736|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
130285775|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
130285776|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130285777|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130285778|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
130285779|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130285780|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
130285781|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
130285782|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
130285783|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
130285784|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Other|1|||
130285785|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Other|1|||
130285786|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
130285787|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
130285788|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
130285789|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
130285790|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130285791|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130285792|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
130285793|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
130285794|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
130285795|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
130285796|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
130285797|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
130285798|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Other|1|||
130285799|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Other|2|||
130285800|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
130285801|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
130285802|NCT04195438|469010201|FG000|Overall Study|Withdrawal by Subject|1|||
130285803|NCT01774097|469010202|FG000|Overall Study|Withdrawal by Subject|1|||
130285804|NCT01774097|469010203|FG001|Overall Study|Withdrawal by Subject|1|||
130285805|NCT01774097|469010202|FG000|Overall Study|Adverse Event|1|||
130285806|NCT01774097|469010203|FG001|Overall Study|Adverse Event|1|||
130285807|NCT00613925|469010204|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
130285808|NCT00613925|469010205|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
130285809|NCT01920568|469010212|FG000|Overall Study|Adverse Event|27|||
130285810|NCT01920568|469010213|FG001|Overall Study|Adverse Event|8|||
130285811|NCT01920568|469010212|FG000|Overall Study|Protocol Violation|5|||
130285812|NCT01920568|469010213|FG001|Overall Study|Protocol Violation|3|||
130285813|NCT01920568|469010212|FG000|Overall Study|Lost to Follow-up|2|||
130285814|NCT01920568|469010213|FG001|Overall Study|Lost to Follow-up|2|||
130285815|NCT01920568|469010212|FG000|Overall Study|Physician Decision|13|||
130285816|NCT01920568|469010213|FG001|Overall Study|Physician Decision|4|||
130285817|NCT01920568|469010212|FG000|Overall Study|Withdrawal by Subject|79|||
130285818|NCT01920568|469010213|FG001|Overall Study|Withdrawal by Subject|55|||
130285819|NCT01920568|469010212|FG000|Overall Study|Death due to disease progression|25|||
130458667|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458668|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458669|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458670|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458671|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458672|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130458673|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130458674|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
130458675|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
130458676|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130285820|NCT01920568|469010213|FG001|Overall Study|Death due to disease progression|12|||
130285821|NCT00252694|469010215|FG000|Overall Study|Withdrawal by Subject|83|||
130458677|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130458678|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130458679|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130285822|NCT00252694|469010216|FG001|Overall Study|Withdrawal by Subject|91|||
130285823|NCT00252694|469010215|FG000|Overall Study|Death|36|||
130458680|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130285824|NCT00252694|469010216|FG001|Overall Study|Death|34|||
130285825|NCT00252694|469010215|FG000|Overall Study|Mostly Lost to Follow Up|8|||
130285826|NCT00252694|469010216|FG001|Overall Study|Mostly Lost to Follow Up|13|||
130285827|NCT00252694|469010215|FG000|Overall Study|Patient Moving|17|||
130285828|NCT00252694|469010216|FG001|Overall Study|Patient Moving|16|||
130285829|NCT00794365|469010217|FG000|Overall Study|Lost to Follow-up|38|||
130285830|NCT00794365|469010217|FG000|Overall Study|Other|17|||
130285831|NCT00794365|469010217|FG000|Overall Study|Poor Compliance|11|||
130285832|NCT00794365|469010217|FG000|Overall Study|Adverse Event|10|||
130285833|NCT00794365|469010217|FG000|Overall Study|Lack of Efficacy|3|||
130285834|NCT04584346|469010218|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
130285835|NCT04584346|469010219|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
130285836|NCT04239222|469010220|FG000|Baseline|Withdrawal by Subject|0|||
130285837|NCT04239222|469010221|FG001|Baseline|Withdrawal by Subject|0|||
130285838|NCT04239222|469010222|FG002|Baseline|Withdrawal by Subject|1|||
130285839|NCT04239222|469010223|FG003|Baseline|Withdrawal by Subject|1|||
130285840|NCT04239222|469010220|FG000|First Foot Assignment|Withdrawal by Subject|0|||
130285841|NCT04239222|469010221|FG001|First Foot Assignment|Withdrawal by Subject|0|||
130285842|NCT04239222|469010222|FG002|First Foot Assignment|Withdrawal by Subject|1|||
130285843|NCT04239222|469010223|FG003|First Foot Assignment|Withdrawal by Subject|0|||
130285844|NCT04239222|469010220|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285845|NCT04239222|469010221|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285846|NCT04239222|469010222|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
130285847|NCT04239222|469010223|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285848|NCT02701777|469010227|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
130285849|NCT02701777|469010228|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
130285850|NCT02701777|469010229|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
130285851|NCT02701777|469010230|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
130285852|NCT02701777|469010227|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
130285853|NCT02701777|469010228|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
130285854|NCT02701777|469010229|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
130369872|NCT00042289|469325101|FG028|Overall Study|Site closed|0|||
130555640|NCT01093625|470003286|FG001|6-Month Visit|Withdrawal by Subject|7|||
130555641|NCT01093625|470003285|FG000|6-Month Visit|Lost to Follow-up|2|||
130555642|NCT01093625|470003286|FG001|6-Month Visit|Lost to Follow-up|2|||
130555643|NCT01093625|470003285|FG000|1-Year Visit|Lost to Follow-up|5|||
130555644|NCT01093625|470003286|FG001|1-Year Visit|Lost to Follow-up|3|||
130555645|NCT01431534|470003289|FG000|Treatment Phase|Adverse Event|0|||
130555646|NCT01431534|470003290|FG001|Treatment Phase|Adverse Event|0|||
130555647|NCT01431534|470003291|FG002|Treatment Phase|Adverse Event|1|||
130555648|NCT01431534|470003289|FG000|Treatment Phase|Progressive Disease|4|||
130555649|NCT01431534|470003290|FG001|Treatment Phase|Progressive Disease|3|||
130555650|NCT01431534|470003291|FG002|Treatment Phase|Progressive Disease|10|||
130555651|NCT01009554|470003294|FG000|Overall Study|Adverse Event|1|||
130555652|NCT01009554|470003295|FG001|Overall Study|Adverse Event|1|||
130555653|NCT01009554|470003294|FG000|Overall Study|Withdrawal by Subject|1|||
130555654|NCT01009554|470003295|FG001|Overall Study|Withdrawal by Subject|3|||
130555655|NCT01009554|470003294|FG000|Overall Study|Noncompliant with Study Product|0|||
130555656|NCT01009554|470003295|FG001|Overall Study|Noncompliant with Study Product|3|||
130555657|NCT01605253|470003296|FG000|Overall Study|Physician Decision|3|||
130555658|NCT01605253|470003297|FG001|Overall Study|Physician Decision|2|||
130555659|NCT01605253|470003296|FG000|Overall Study|Lost to Follow-up|3|||
130555660|NCT01605253|470003297|FG001|Overall Study|Lost to Follow-up|1|||
130555661|NCT02554903|470003300|FG000|Overall Study|Death|1|||
130555662|NCT02554903|470003301|FG001|Overall Study|Death|1|||
130555663|NCT02554903|470003300|FG000|Overall Study|Physician Decision|2|||
130555664|NCT02554903|470003301|FG001|Overall Study|Physician Decision|2|||
130555665|NCT02554903|470003300|FG000|Overall Study|Heart Transplant|1|||
130555666|NCT02554903|470003301|FG001|Overall Study|Heart Transplant|2|||
130555667|NCT03951220|470003307|FG000|Overall Study|Withdrawal by Subject|9|||
130555668|NCT03951220|470003308|FG001|Overall Study|Withdrawal by Subject|2|||
130711907|NCT00003138|470571737|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
130285855|NCT02701777|469010230|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
130285856|NCT00075725|469010231|FG000|Overall Study|Adverse Event|6|||
130285857|NCT00075725|469010232|FG001|Overall Study|Adverse Event|6|||
130555669|NCT03951220|470003309|FG002|Overall Study|Withdrawal by Subject|0|||
130555670|NCT04598477|470003311|FG000|Overall Study|Adverse Event|2|||
130555671|NCT04598477|470003312|FG001|Overall Study|Adverse Event|0|||
130555672|NCT04598477|470003311|FG000|Overall Study|Death|0|||
130555673|NCT04598477|470003312|FG001|Overall Study|Death|1|||
130555674|NCT04598477|470003311|FG000|Overall Study|Lost to Follow-up|1|||
130285858|NCT00075725|469010233|FG002|Overall Study|Adverse Event|20|||
130555675|NCT04598477|470003312|FG001|Overall Study|Lost to Follow-up|0|||
130555676|NCT04598477|470003311|FG000|Overall Study|Physician Decision|7|||
130555677|NCT04598477|470003312|FG001|Overall Study|Physician Decision|2|||
130555678|NCT04598477|470003311|FG000|Overall Study|Pregnancy|0|||
130555679|NCT04598477|470003312|FG001|Overall Study|Pregnancy|1|||
130711908|NCT00003138|470571736|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
130711909|NCT00003138|470571737|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
130711910|NCT00003138|470571736|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
130711911|NCT00003138|470571737|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
130711912|NCT04495283|470571739|FG000|Overall Study|Physician Decision|0|||
130711913|NCT04495283|470571740|FG001|Overall Study|Physician Decision|0|||
130711914|NCT04495283|470571741|FG002|Overall Study|Physician Decision|1|||
130711915|NCT04495283|470571739|FG000|Overall Study|Withdrawal by Subject|0|||
130711916|NCT04495283|470571740|FG001|Overall Study|Withdrawal by Subject|1|||
130711917|NCT04495283|470571741|FG002|Overall Study|Withdrawal by Subject|1|||
130285859|NCT00075725|469010234|FG003|Overall Study|Adverse Event|8|||
130285860|NCT00075725|469010235|FG004|Overall Study|Adverse Event|4|||
130285861|NCT00075725|469010236|FG005|Overall Study|Adverse Event|38|||
130285862|NCT00075725|469010237|FG006|Overall Study|Adverse Event|3|||
130285863|NCT00075725|469010238|FG007|Overall Study|Adverse Event|51|||
130285864|NCT00075725|469010239|FG008|Overall Study|Adverse Event|15|||
130285865|NCT00075725|469010240|FG009|Overall Study|Adverse Event|4|||
130285866|NCT00075725|469010241|FG010|Overall Study|Adverse Event|2|||
130285867|NCT00075725|469010242|FG011|Overall Study|Adverse Event|2|||
130285868|NCT00075725|469010231|FG000|Overall Study|Death|3|||
130285869|NCT00075725|469010232|FG001|Overall Study|Death|5|||
130285870|NCT00075725|469010233|FG002|Overall Study|Death|10|||
130285871|NCT00075725|469010234|FG003|Overall Study|Death|2|||
130285872|NCT00075725|469010235|FG004|Overall Study|Death|3|||
130285873|NCT00075725|469010236|FG005|Overall Study|Death|25|||
130285874|NCT00075725|469010237|FG006|Overall Study|Death|4|||
130285875|NCT00075725|469010238|FG007|Overall Study|Death|22|||
130285876|NCT00075725|469010239|FG008|Overall Study|Death|14|||
130285877|NCT00075725|469010240|FG009|Overall Study|Death|4|||
130285878|NCT00075725|469010241|FG010|Overall Study|Death|3|||
130285879|NCT00075725|469010242|FG011|Overall Study|Death|0|||
130285880|NCT00075725|469010231|FG000|Overall Study|Lost to Follow-up|1|||
130285881|NCT00075725|469010232|FG001|Overall Study|Lost to Follow-up|1|||
130285882|NCT00075725|469010233|FG002|Overall Study|Lost to Follow-up|4|||
130285883|NCT00075725|469010234|FG003|Overall Study|Lost to Follow-up|1|||
130285884|NCT00075725|469010235|FG004|Overall Study|Lost to Follow-up|0|||
130285885|NCT00075725|469010236|FG005|Overall Study|Lost to Follow-up|13|||
130285886|NCT00075725|469010237|FG006|Overall Study|Lost to Follow-up|2|||
130285887|NCT00075725|469010238|FG007|Overall Study|Lost to Follow-up|4|||
130285888|NCT00075725|469010239|FG008|Overall Study|Lost to Follow-up|1|||
130285889|NCT00075725|469010240|FG009|Overall Study|Lost to Follow-up|0|||
130285890|NCT00075725|469010241|FG010|Overall Study|Lost to Follow-up|0|||
130285891|NCT00075725|469010242|FG011|Overall Study|Lost to Follow-up|0|||
130285892|NCT00075725|469010231|FG000|Overall Study|Physician Decision|2|||
130285893|NCT00075725|469010232|FG001|Overall Study|Physician Decision|6|||
130285894|NCT00075725|469010233|FG002|Overall Study|Physician Decision|5|||
130285895|NCT00075725|469010234|FG003|Overall Study|Physician Decision|8|||
130285896|NCT00075725|469010235|FG004|Overall Study|Physician Decision|4|||
130285897|NCT00075725|469010236|FG005|Overall Study|Physician Decision|19|||
130285898|NCT00075725|469010237|FG006|Overall Study|Physician Decision|3|||
130285899|NCT00075725|469010238|FG007|Overall Study|Physician Decision|17|||
130285900|NCT00075725|469010239|FG008|Overall Study|Physician Decision|5|||
130285901|NCT00075725|469010240|FG009|Overall Study|Physician Decision|0|||
130285902|NCT00075725|469010241|FG010|Overall Study|Physician Decision|1|||
130285903|NCT00075725|469010242|FG011|Overall Study|Physician Decision|0|||
130285904|NCT00075725|469010231|FG000|Overall Study|Pregnancy|0|||
130285905|NCT00075725|469010232|FG001|Overall Study|Pregnancy|0|||
130285906|NCT00075725|469010233|FG002|Overall Study|Pregnancy|0|||
130285907|NCT00075725|469010234|FG003|Overall Study|Pregnancy|0|||
130285908|NCT00075725|469010235|FG004|Overall Study|Pregnancy|0|||
130285909|NCT00075725|469010236|FG005|Overall Study|Pregnancy|1|||
130285910|NCT00075725|469010237|FG006|Overall Study|Pregnancy|0|||
130285911|NCT00075725|469010238|FG007|Overall Study|Pregnancy|1|||
130285912|NCT00075725|469010239|FG008|Overall Study|Pregnancy|0|||
130285913|NCT00075725|469010240|FG009|Overall Study|Pregnancy|0|||
130285914|NCT00075725|469010241|FG010|Overall Study|Pregnancy|0|||
130285915|NCT00075725|469010242|FG011|Overall Study|Pregnancy|0|||
130285916|NCT00075725|469010231|FG000|Overall Study|Protocol Violation|1|||
130285917|NCT00075725|469010232|FG001|Overall Study|Protocol Violation|1|||
130285918|NCT00075725|469010233|FG002|Overall Study|Protocol Violation|0|||
130285919|NCT00075725|469010234|FG003|Overall Study|Protocol Violation|3|||
130711918|NCT04495283|470571739|FG000|Overall Study|Other|1|||
130711919|NCT04495283|470571740|FG001|Overall Study|Other|0|||
130285920|NCT00075725|469010235|FG004|Overall Study|Protocol Violation|3|||
130285921|NCT00075725|469010236|FG005|Overall Study|Protocol Violation|2|||
130285922|NCT00075725|469010237|FG006|Overall Study|Protocol Violation|1|||
130285923|NCT00075725|469010238|FG007|Overall Study|Protocol Violation|2|||
130285924|NCT00075725|469010239|FG008|Overall Study|Protocol Violation|3|||
130285925|NCT00075725|469010240|FG009|Overall Study|Protocol Violation|0|||
130285926|NCT00075725|469010241|FG010|Overall Study|Protocol Violation|0|||
130285927|NCT00075725|469010242|FG011|Overall Study|Protocol Violation|1|||
130316229|NCT04319198|469124334|FG002|Overall Study|Death|3|||
130285928|NCT00075725|469010231|FG000|Overall Study|Withdrawal by Subject|12|||
130285929|NCT00075725|469010232|FG001|Overall Study|Withdrawal by Subject|3|||
130285930|NCT00075725|469010233|FG002|Overall Study|Withdrawal by Subject|6|||
130285931|NCT00075725|469010234|FG003|Overall Study|Withdrawal by Subject|10|||
130285932|NCT00075725|469010235|FG004|Overall Study|Withdrawal by Subject|6|||
130285933|NCT00075725|469010236|FG005|Overall Study|Withdrawal by Subject|27|||
130285934|NCT00075725|469010237|FG006|Overall Study|Withdrawal by Subject|7|||
130285935|NCT00075725|469010238|FG007|Overall Study|Withdrawal by Subject|31|||
130285936|NCT00075725|469010239|FG008|Overall Study|Withdrawal by Subject|10|||
130285937|NCT00075725|469010240|FG009|Overall Study|Withdrawal by Subject|2|||
130285938|NCT00075725|469010241|FG010|Overall Study|Withdrawal by Subject|0|||
130285939|NCT00075725|469010242|FG011|Overall Study|Withdrawal by Subject|0|||
130285940|NCT00075725|469010231|FG000|Overall Study|Disease Progression, all other reasons|17|||
130285941|NCT00075725|469010232|FG001|Overall Study|Disease Progression, all other reasons|5|||
130285942|NCT00075725|469010233|FG002|Overall Study|Disease Progression, all other reasons|33|||
130285943|NCT00075725|469010234|FG003|Overall Study|Disease Progression, all other reasons|6|||
130285944|NCT00075725|469010235|FG004|Overall Study|Disease Progression, all other reasons|21|||
130285945|NCT00075725|469010236|FG005|Overall Study|Disease Progression, all other reasons|59|||
130285946|NCT00075725|469010237|FG006|Overall Study|Disease Progression, all other reasons|20|||
130285947|NCT00075725|469010238|FG007|Overall Study|Disease Progression, all other reasons|46|||
130285948|NCT00075725|469010239|FG008|Overall Study|Disease Progression, all other reasons|21|||
130285949|NCT00075725|469010240|FG009|Overall Study|Disease Progression, all other reasons|4|||
130285950|NCT00075725|469010241|FG010|Overall Study|Disease Progression, all other reasons|0|||
130285951|NCT00075725|469010242|FG011|Overall Study|Disease Progression, all other reasons|5|||
130285952|NCT00075725|469010231|FG000|Overall Study|Patient off treatment|0|||
130285953|NCT00075725|469010232|FG001|Overall Study|Patient off treatment|0|||
130285954|NCT00075725|469010233|FG002|Overall Study|Patient off treatment|1|||
130285955|NCT00075725|469010234|FG003|Overall Study|Patient off treatment|2|||
130285956|NCT00075725|469010235|FG004|Overall Study|Patient off treatment|1|||
130285957|NCT00075725|469010236|FG005|Overall Study|Patient off treatment|0|||
130285958|NCT00075725|469010237|FG006|Overall Study|Patient off treatment|0|||
130285959|NCT00075725|469010238|FG007|Overall Study|Patient off treatment|2|||
130285960|NCT00075725|469010239|FG008|Overall Study|Patient off treatment|1|||
130285961|NCT00075725|469010240|FG009|Overall Study|Patient off treatment|0|||
130285962|NCT00075725|469010241|FG010|Overall Study|Patient off treatment|0|||
130285963|NCT00075725|469010242|FG011|Overall Study|Patient off treatment|0|||
130285964|NCT00075725|469010231|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
130285965|NCT00075725|469010232|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
130285966|NCT00075725|469010233|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
130285967|NCT00075725|469010234|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
130285968|NCT00075725|469010235|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
130285969|NCT00075725|469010236|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
130285970|NCT00075725|469010237|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
130285971|NCT00075725|469010238|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
130458681|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130458682|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
130458683|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
130458684|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
130458685|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458686|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458687|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458688|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458689|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458690|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130458691|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
130458692|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458693|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
130458694|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130555680|NCT04598477|470003311|FG000|Overall Study|Requires Prohibited Medication|0|||
130555681|NCT04598477|470003312|FG001|Overall Study|Requires Prohibited Medication|1|||
130555682|NCT04598477|470003311|FG000|Overall Study|Study Terminated by Sponsor|18|||
130285972|NCT00075725|469010239|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
130285973|NCT00075725|469010240|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
130285974|NCT00075725|469010241|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
130285975|NCT00075725|469010242|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
130285976|NCT00075725|469010231|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
130285977|NCT00075725|469010232|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
130285978|NCT00075725|469010233|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
130285979|NCT00075725|469010234|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
130711920|NCT04495283|470571741|FG002|Overall Study|Other|1|||
130285980|NCT00075725|469010235|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
130285981|NCT00075725|469010236|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
130285982|NCT00075725|469010237|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
130285983|NCT00075725|469010238|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
130285984|NCT00075725|469010239|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
130285985|NCT00075725|469010240|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
130285986|NCT00075725|469010241|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
130285987|NCT00075725|469010242|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
130285988|NCT00075725|469010231|FG000|Overall Study|Pt non compliant with therapy|2|||
130285989|NCT00075725|469010232|FG001|Overall Study|Pt non compliant with therapy|1|||
130285990|NCT00075725|469010233|FG002|Overall Study|Pt non compliant with therapy|1|||
130285991|NCT00075725|469010234|FG003|Overall Study|Pt non compliant with therapy|0|||
130285992|NCT00075725|469010235|FG004|Overall Study|Pt non compliant with therapy|2|||
130285993|NCT00075725|469010236|FG005|Overall Study|Pt non compliant with therapy|14|||
130285994|NCT00075725|469010237|FG006|Overall Study|Pt non compliant with therapy|2|||
130285995|NCT00075725|469010238|FG007|Overall Study|Pt non compliant with therapy|5|||
130285996|NCT00075725|469010239|FG008|Overall Study|Pt non compliant with therapy|3|||
130285997|NCT00075725|469010240|FG009|Overall Study|Pt non compliant with therapy|0|||
130285998|NCT00075725|469010241|FG010|Overall Study|Pt non compliant with therapy|0|||
130285999|NCT00075725|469010242|FG011|Overall Study|Pt non compliant with therapy|0|||
130286000|NCT00075725|469010231|FG000|Overall Study|Pt age out of range for treatment|0|||
130286001|NCT00075725|469010232|FG001|Overall Study|Pt age out of range for treatment|1|||
130286002|NCT00075725|469010233|FG002|Overall Study|Pt age out of range for treatment|0|||
130286003|NCT00075725|469010234|FG003|Overall Study|Pt age out of range for treatment|0|||
130286004|NCT00075725|469010235|FG004|Overall Study|Pt age out of range for treatment|0|||
130286005|NCT00075725|469010236|FG005|Overall Study|Pt age out of range for treatment|1|||
130286006|NCT00075725|469010237|FG006|Overall Study|Pt age out of range for treatment|0|||
130286007|NCT00075725|469010238|FG007|Overall Study|Pt age out of range for treatment|1|||
130286008|NCT00075725|469010239|FG008|Overall Study|Pt age out of range for treatment|0|||
130286009|NCT00075725|469010240|FG009|Overall Study|Pt age out of range for treatment|0|||
130286010|NCT00075725|469010241|FG010|Overall Study|Pt age out of range for treatment|0|||
130286011|NCT00075725|469010242|FG011|Overall Study|Pt age out of range for treatment|0|||
130286012|NCT00075725|469010231|FG000|Overall Study|Insurance issues|0|||
130286013|NCT00075725|469010232|FG001|Overall Study|Insurance issues|1|||
130286014|NCT00075725|469010233|FG002|Overall Study|Insurance issues|0|||
130286015|NCT00075725|469010234|FG003|Overall Study|Insurance issues|1|||
130286016|NCT00075725|469010235|FG004|Overall Study|Insurance issues|1|||
130286017|NCT00075725|469010236|FG005|Overall Study|Insurance issues|1|||
130286018|NCT00075725|469010237|FG006|Overall Study|Insurance issues|0|||
130286019|NCT00075725|469010238|FG007|Overall Study|Insurance issues|1|||
130286020|NCT00075725|469010239|FG008|Overall Study|Insurance issues|0|||
130286021|NCT00075725|469010240|FG009|Overall Study|Insurance issues|0|||
130286022|NCT00075725|469010241|FG010|Overall Study|Insurance issues|0|||
130286023|NCT00075725|469010242|FG011|Overall Study|Insurance issues|0|||
130286024|NCT00075725|469010231|FG000|Overall Study|MRD positive after extended ind|0|||
130286025|NCT00075725|469010232|FG001|Overall Study|MRD positive after extended ind|1|||
130286026|NCT00075725|469010233|FG002|Overall Study|MRD positive after extended ind|1|||
130286027|NCT00075725|469010234|FG003|Overall Study|MRD positive after extended ind|0|||
130286028|NCT00075725|469010235|FG004|Overall Study|MRD positive after extended ind|1|||
130286029|NCT00075725|469010236|FG005|Overall Study|MRD positive after extended ind|2|||
130458695|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458696|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458697|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458698|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458699|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130458700|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130711921|NCT05142566|470571744|FG000|Overall Study|Protocol Violation|1|||
130711922|NCT01032018|470571749|FG000|Overall Study|Lost to Follow-up|6|||
130286030|NCT00075725|469010237|FG006|Overall Study|MRD positive after extended ind|0|||
130286031|NCT00075725|469010238|FG007|Overall Study|MRD positive after extended ind|1|||
130286032|NCT00075725|469010239|FG008|Overall Study|MRD positive after extended ind|0|||
130458701|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130286033|NCT00075725|469010240|FG009|Overall Study|MRD positive after extended ind|0|||
130286034|NCT00075725|469010241|FG010|Overall Study|MRD positive after extended ind|0|||
130458702|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
130458703|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130458704|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130711923|NCT01032018|470571750|FG001|Overall Study|Lost to Follow-up|5|||
130286035|NCT00075725|469010242|FG011|Overall Study|MRD positive after extended ind|0|||
130711924|NCT01032018|470571749|FG000|Overall Study|Death|0|||
130711925|NCT01032018|470571750|FG001|Overall Study|Death|1|||
130711926|NCT02072148|470571761|FG000|Overall Study|withdrew prior to surgery|23|||
130711927|NCT02072148|470571762|FG001|Overall Study|withdrew prior to surgery|0|||
130711928|NCT02072148|470571763|FG002|Overall Study|withdrew prior to surgery|0|||
130711929|NCT02072148|470571761|FG000|Overall Study|Death|0|||
130711930|NCT02072148|470571762|FG001|Overall Study|Death|0|||
130711931|NCT02072148|470571763|FG002|Overall Study|Death|1|||
130711932|NCT02072148|470571761|FG000|Overall Study|Withdrawal by Subject|0|||
130711933|NCT02072148|470571762|FG001|Overall Study|Withdrawal by Subject|13|||
130286036|NCT00075725|469010231|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
130286037|NCT00075725|469010232|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
130286038|NCT00075725|469010233|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
130286039|NCT00075725|469010234|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
130286040|NCT00075725|469010235|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
130286041|NCT00075725|469010236|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
130286042|NCT00075725|469010237|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
130286043|NCT00075725|469010238|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
130286044|NCT00075725|469010239|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
130286045|NCT00075725|469010240|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
130286046|NCT00075725|469010241|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
130286047|NCT00075725|469010242|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
130286048|NCT00075725|469010231|FG000|Overall Study|Inevaluable|1|||
130286049|NCT00075725|469010232|FG001|Overall Study|Inevaluable|1|||
130286050|NCT00075725|469010233|FG002|Overall Study|Inevaluable|4|||
130286051|NCT00075725|469010234|FG003|Overall Study|Inevaluable|2|||
130286052|NCT00075725|469010235|FG004|Overall Study|Inevaluable|2|||
130286053|NCT00075725|469010236|FG005|Overall Study|Inevaluable|9|||
130286054|NCT00075725|469010237|FG006|Overall Study|Inevaluable|1|||
130286055|NCT00075725|469010238|FG007|Overall Study|Inevaluable|11|||
130286056|NCT00075725|469010239|FG008|Overall Study|Inevaluable|2|||
130286057|NCT00075725|469010240|FG009|Overall Study|Inevaluable|0|||
130286058|NCT00075725|469010241|FG010|Overall Study|Inevaluable|1|||
130286059|NCT00075725|469010242|FG011|Overall Study|Inevaluable|0|||
130286060|NCT00075725|469010231|FG000|Overall Study|Other|4|||
130286061|NCT00075725|469010232|FG001|Overall Study|Other|2|||
130286062|NCT00075725|469010233|FG002|Overall Study|Other|1|||
130286063|NCT00075725|469010234|FG003|Overall Study|Other|1|||
130286064|NCT00075725|469010235|FG004|Overall Study|Other|1|||
130286065|NCT00075725|469010236|FG005|Overall Study|Other|4|||
130286066|NCT00075725|469010237|FG006|Overall Study|Other|2|||
130286067|NCT00075725|469010238|FG007|Overall Study|Other|9|||
130286068|NCT00075725|469010239|FG008|Overall Study|Other|2|||
130286069|NCT00075725|469010240|FG009|Overall Study|Other|1|||
130286070|NCT00075725|469010241|FG010|Overall Study|Other|0|||
130286071|NCT00075725|469010242|FG011|Overall Study|Other|3|||
130458705|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130458706|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130458707|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130458708|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130458709|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458710|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130458711|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130458712|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458713|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458714|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458715|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458716|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458717|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130458718|NCT01212757|469643540|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
130458719|NCT01212757|469643541|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
130458720|NCT01212757|469643542|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130458721|NCT01212757|469643543|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130458722|NCT01212757|469643544|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130458723|NCT01212757|469643545|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130458724|NCT01212757|469643546|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130458725|NCT01212757|469643547|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130711934|NCT02072148|470571763|FG002|Overall Study|Withdrawal by Subject|12|||
130286072|NCT00075725|469010231|FG000|Overall Study|Pt trying to find a BM donor|0|||
130286073|NCT00075725|469010232|FG001|Overall Study|Pt trying to find a BM donor|1|||
130286074|NCT00075725|469010233|FG002|Overall Study|Pt trying to find a BM donor|0|||
130286075|NCT00075725|469010234|FG003|Overall Study|Pt trying to find a BM donor|0|||
130286076|NCT00075725|469010235|FG004|Overall Study|Pt trying to find a BM donor|0|||
130286077|NCT00075725|469010236|FG005|Overall Study|Pt trying to find a BM donor|0|||
130458726|NCT01212757|469643548|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130711935|NCT02145026|470571765|FG000|Overall Study|Adverse Event|2|||
130711936|NCT02145026|470571765|FG000|Overall Study|Death|4|||
130711937|NCT02145026|470571765|FG000|Overall Study|Withdrawal by Subject|2|||
130711938|NCT02145026|470571765|FG000|Overall Study|Physician Decision|4|||
130711939|NCT04132336|470571766|FG000|Overall Study|Investigator Decision|0|||
130711940|NCT04132336|470571767|FG001|Overall Study|Investigator Decision|1|||
130711941|NCT04132336|470571768|FG002|Overall Study|Investigator Decision|0|||
130711942|NCT04132336|470571769|FG003|Overall Study|Investigator Decision|0|||
130711943|NCT04132336|470571770|FG004|Overall Study|Investigator Decision|0|||
130711944|NCT04132336|470571771|FG005|Overall Study|Investigator Decision|0|||
130711945|NCT04132336|470571772|FG006|Overall Study|Investigator Decision|0|||
130711946|NCT00584844|470571773|FG000|Overall Study|Withdrawal by Subject|59|||
130711947|NCT00584844|470571773|FG000|Overall Study|Screen Failure|20|||
130711948|NCT01939496|470571774|FG000|Overall Study|Adverse Event|2|||
130711949|NCT01939496|470571775|FG001|Overall Study|Adverse Event|0|||
130711950|NCT01939496|470571776|FG002|Overall Study|Adverse Event|0|||
130711951|NCT01939496|470571774|FG000|Overall Study|Lost to Follow-up|1|||
130711952|NCT01939496|470571775|FG001|Overall Study|Lost to Follow-up|1|||
130711953|NCT01939496|470571776|FG002|Overall Study|Lost to Follow-up|0|||
130711954|NCT01939496|470571774|FG000|Overall Study|Physician Decision|1|||
130711955|NCT01939496|470571775|FG001|Overall Study|Physician Decision|0|||
130711956|NCT01939496|470571776|FG002|Overall Study|Physician Decision|0|||
130711957|NCT01939496|470571774|FG000|Overall Study|Protocol Violation|3|||
130711958|NCT01939496|470571775|FG001|Overall Study|Protocol Violation|0|||
130711959|NCT01939496|470571776|FG002|Overall Study|Protocol Violation|0|||
130711960|NCT01939496|470571774|FG000|Overall Study|Withdrawal by Subject|0|||
130711961|NCT01939496|470571775|FG001|Overall Study|Withdrawal by Subject|1|||
130711962|NCT01939496|470571776|FG002|Overall Study|Withdrawal by Subject|1|||
130711963|NCT01939496|470571774|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130711964|NCT01939496|470571775|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
130711965|NCT01939496|470571776|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130711966|NCT01939496|470571774|FG000|Overall Study|Other|2|||
130711967|NCT01939496|470571775|FG001|Overall Study|Other|0|||
130711968|NCT01939496|470571776|FG002|Overall Study|Other|1|||
130711969|NCT03052322|470571777|FG000|Overall Study|Other un-specified|1|||
130711970|NCT03052322|470571778|FG001|Overall Study|Other un-specified|2|||
130711971|NCT03052322|470571777|FG000|Overall Study|Withdrawal by Subject|10|||
130711972|NCT03052322|470571778|FG001|Overall Study|Withdrawal by Subject|9|||
130711973|NCT03052322|470571777|FG000|Overall Study|Death|0|||
130711974|NCT03052322|470571778|FG001|Overall Study|Death|2|||
130711975|NCT03052322|470571777|FG000|Overall Study|Lack of Efficacy|1|||
130711976|NCT03052322|470571778|FG001|Overall Study|Lack of Efficacy|2|||
130711977|NCT03052322|470571777|FG000|Overall Study|Protocol Violation|1|||
130711978|NCT03052322|470571778|FG001|Overall Study|Protocol Violation|0|||
130711979|NCT03052322|470571777|FG000|Overall Study|Lost to Follow-up|2|||
130711980|NCT03052322|470571778|FG001|Overall Study|Lost to Follow-up|4|||
130711981|NCT03052322|470571777|FG000|Overall Study|Adverse Event|6|||
130711982|NCT03052322|470571778|FG001|Overall Study|Adverse Event|13|||
130711983|NCT04920916|470571779|FG000|Phase IIa 60 Day Study|Death|2|||
130711984|NCT04920916|470571780|FG001|Phase IIa 60 Day Study|Death|5|||
130711985|NCT04920916|470571779|FG000|1 Year Follow up (Phone Call)|Death|1|||
130286078|NCT00075725|469010237|FG006|Overall Study|Pt trying to find a BM donor|0|||
130286079|NCT00075725|469010238|FG007|Overall Study|Pt trying to find a BM donor|0|||
130286080|NCT00075725|469010239|FG008|Overall Study|Pt trying to find a BM donor|0|||
130286081|NCT00075725|469010240|FG009|Overall Study|Pt trying to find a BM donor|0|||
130286082|NCT00075725|469010241|FG010|Overall Study|Pt trying to find a BM donor|0|||
130286083|NCT00075725|469010242|FG011|Overall Study|Pt trying to find a BM donor|0|||
130286084|NCT00075725|469010231|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
130286085|NCT00075725|469010232|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
130286086|NCT00075725|469010233|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
130286087|NCT00075725|469010234|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
130286088|NCT00075725|469010235|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
130286089|NCT00075725|469010236|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
130711986|NCT04920916|470571780|FG001|1 Year Follow up (Phone Call)|Death|3|||
130711987|NCT04920916|470571779|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
130711988|NCT04920916|470571780|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
130458727|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
130711989|NCT01892657|470571783|FG000|Overall Study|Withdrawal by Subject|6|||
130711990|NCT01892657|470571783|FG000|Overall Study|Protocol Violation|12|||
130711991|NCT02712333|470571784|FG000|First Period|Withdrawal by Subject|3|||
130711992|NCT02712333|470571785|FG001|First Period|Withdrawal by Subject|2|||
130711993|NCT00136318|470571786|FG000|Overall Study|Adverse Event|5|||
130711994|NCT00136318|470571787|FG001|Overall Study|Adverse Event|5|||
130711995|NCT00136318|470571786|FG000|Overall Study|Withdrawal by Subject|2|||
130711996|NCT00136318|470571787|FG001|Overall Study|Withdrawal by Subject|2|||
130711997|NCT01546649|470571792|FG000|Overall Study|Adverse Event|4|||
130711998|NCT01546649|470571793|FG001|Overall Study|Adverse Event|5|||
130711999|NCT01546649|470571792|FG000|Overall Study|Protocol Violation|1|||
130712000|NCT01546649|470571793|FG001|Overall Study|Protocol Violation|0|||
130712001|NCT01546649|470571792|FG000|Overall Study|Lack of Efficacy|1|||
130712002|NCT01546649|470571793|FG001|Overall Study|Lack of Efficacy|0|||
130286090|NCT00075725|469010237|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
130712003|NCT01546649|470571792|FG000|Overall Study|Recurrence|1|||
130712004|NCT01546649|470571793|FG001|Overall Study|Recurrence|1|||
130712005|NCT01546649|470571792|FG000|Overall Study|Discovery of secondary cancer|0|||
130712006|NCT01546649|470571793|FG001|Overall Study|Discovery of secondary cancer|1|||
130712007|NCT01546649|470571792|FG000|Overall Study|Withdrawal by Subject|1|||
130712008|NCT01546649|470571793|FG001|Overall Study|Withdrawal by Subject|2|||
130712009|NCT01134627|470571798|FG000|Overall Study|Adverse Event|47|||
130712010|NCT01134627|470571799|FG001|Overall Study|Adverse Event|31|||
130712011|NCT01134627|470571798|FG000|Overall Study|Lost to Follow-up|1|||
130712012|NCT01134627|470571799|FG001|Overall Study|Lost to Follow-up|2|||
130712013|NCT01134627|470571798|FG000|Overall Study|Protocol Violation|3|||
130712014|NCT01134627|470571799|FG001|Overall Study|Protocol Violation|5|||
130712015|NCT01134627|470571798|FG000|Overall Study|Lack of Efficacy|2|||
130712016|NCT01134627|470571799|FG001|Overall Study|Lack of Efficacy|12|||
130712017|NCT01134627|470571798|FG000|Overall Study|Withdrawal by Subject|4|||
130712018|NCT01134627|470571799|FG001|Overall Study|Withdrawal by Subject|3|||
130712019|NCT01134627|470571798|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
130712020|NCT01134627|470571799|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
130712021|NCT01134627|470571798|FG000|Overall Study|Other|11|||
130712022|NCT01134627|470571799|FG001|Overall Study|Other|14|||
130712023|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
130712024|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
130286091|NCT00075725|469010238|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
130286092|NCT00075725|469010239|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
130286093|NCT00075725|469010240|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
130286094|NCT00075725|469010241|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
130286095|NCT00075725|469010242|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
130286096|NCT00075725|469010231|FG000|Overall Study|Unsuccessful institutional transfer|0|||
130286097|NCT00075725|469010232|FG001|Overall Study|Unsuccessful institutional transfer|0|||
130286098|NCT00075725|469010233|FG002|Overall Study|Unsuccessful institutional transfer|2|||
130286099|NCT00075725|469010234|FG003|Overall Study|Unsuccessful institutional transfer|0|||
130286100|NCT00075725|469010235|FG004|Overall Study|Unsuccessful institutional transfer|0|||
130286101|NCT00075725|469010236|FG005|Overall Study|Unsuccessful institutional transfer|0|||
130286102|NCT00075725|469010237|FG006|Overall Study|Unsuccessful institutional transfer|0|||
130286103|NCT00075725|469010238|FG007|Overall Study|Unsuccessful institutional transfer|0|||
130286104|NCT00075725|469010239|FG008|Overall Study|Unsuccessful institutional transfer|0|||
130286105|NCT00075725|469010240|FG009|Overall Study|Unsuccessful institutional transfer|1|||
130286106|NCT00075725|469010241|FG010|Overall Study|Unsuccessful institutional transfer|0|||
130286107|NCT00075725|469010242|FG011|Overall Study|Unsuccessful institutional transfer|0|||
130286108|NCT00075725|469010231|FG000|Overall Study|specimen(s) not submitted|0|||
130286109|NCT00075725|469010232|FG001|Overall Study|specimen(s) not submitted|0|||
130286110|NCT00075725|469010233|FG002|Overall Study|specimen(s) not submitted|2|||
130286111|NCT00075725|469010234|FG003|Overall Study|specimen(s) not submitted|0|||
130286112|NCT00075725|469010235|FG004|Overall Study|specimen(s) not submitted|0|||
130286113|NCT00075725|469010236|FG005|Overall Study|specimen(s) not submitted|0|||
130286114|NCT00075725|469010237|FG006|Overall Study|specimen(s) not submitted|0|||
130286115|NCT00075725|469010238|FG007|Overall Study|specimen(s) not submitted|0|||
130286116|NCT00075725|469010239|FG008|Overall Study|specimen(s) not submitted|0|||
130286117|NCT00075725|469010240|FG009|Overall Study|specimen(s) not submitted|0|||
130286118|NCT00075725|469010241|FG010|Overall Study|specimen(s) not submitted|0|||
130286119|NCT00075725|469010242|FG011|Overall Study|specimen(s) not submitted|0|||
130286120|NCT00075725|469010231|FG000|Overall Study|Pt went to transplant|0|||
130286121|NCT00075725|469010232|FG001|Overall Study|Pt went to transplant|0|||
130286122|NCT00075725|469010233|FG002|Overall Study|Pt went to transplant|0|||
130286123|NCT00075725|469010234|FG003|Overall Study|Pt went to transplant|1|||
130286124|NCT00075725|469010235|FG004|Overall Study|Pt went to transplant|0|||
130286125|NCT00075725|469010236|FG005|Overall Study|Pt went to transplant|1|||
130286126|NCT00075725|469010237|FG006|Overall Study|Pt went to transplant|0|||
130458728|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
130458729|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
130712025|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
130286127|NCT00075725|469010238|FG007|Overall Study|Pt went to transplant|0|||
130286128|NCT00075725|469010239|FG008|Overall Study|Pt went to transplant|0|||
130286129|NCT00075725|469010240|FG009|Overall Study|Pt went to transplant|0|||
130458730|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
130712026|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
130286130|NCT00075725|469010241|FG010|Overall Study|Pt went to transplant|0|||
130286131|NCT00075725|469010242|FG011|Overall Study|Pt went to transplant|0|||
130712027|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
130712028|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
130712029|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130286132|NCT00075725|469010231|FG000|Overall Study|Pt received additional steroids|0|||
130286133|NCT00075725|469010232|FG001|Overall Study|Pt received additional steroids|0|||
130286134|NCT00075725|469010233|FG002|Overall Study|Pt received additional steroids|0|||
130286135|NCT00075725|469010234|FG003|Overall Study|Pt received additional steroids|1|||
130286136|NCT00075725|469010235|FG004|Overall Study|Pt received additional steroids|0|||
130286137|NCT00075725|469010236|FG005|Overall Study|Pt received additional steroids|0|||
130286138|NCT00075725|469010237|FG006|Overall Study|Pt received additional steroids|0|||
130286139|NCT00075725|469010238|FG007|Overall Study|Pt received additional steroids|0|||
130286140|NCT00075725|469010239|FG008|Overall Study|Pt received additional steroids|0|||
130286141|NCT00075725|469010240|FG009|Overall Study|Pt received additional steroids|0|||
130286142|NCT00075725|469010241|FG010|Overall Study|Pt received additional steroids|0|||
130286143|NCT00075725|469010242|FG011|Overall Study|Pt received additional steroids|0|||
130286144|NCT00075725|469010231|FG000|Overall Study|Pt relocated|0|||
130286145|NCT00075725|469010232|FG001|Overall Study|Pt relocated|0|||
130286146|NCT00075725|469010233|FG002|Overall Study|Pt relocated|0|||
130286147|NCT00075725|469010234|FG003|Overall Study|Pt relocated|2|||
130286148|NCT00075725|469010235|FG004|Overall Study|Pt relocated|0|||
130286149|NCT00075725|469010236|FG005|Overall Study|Pt relocated|1|||
130286150|NCT00075725|469010237|FG006|Overall Study|Pt relocated|1|||
130286151|NCT00075725|469010238|FG007|Overall Study|Pt relocated|2|||
130286152|NCT00075725|469010239|FG008|Overall Study|Pt relocated|1|||
130286153|NCT00075725|469010240|FG009|Overall Study|Pt relocated|0|||
130286154|NCT00075725|469010241|FG010|Overall Study|Pt relocated|0|||
130286155|NCT00075725|469010242|FG011|Overall Study|Pt relocated|0|||
130286156|NCT00075725|469010231|FG000|Overall Study|Institution Terminated|0|||
130286157|NCT00075725|469010232|FG001|Overall Study|Institution Terminated|0|||
130286158|NCT00075725|469010233|FG002|Overall Study|Institution Terminated|0|||
130286159|NCT00075725|469010234|FG003|Overall Study|Institution Terminated|0|||
130286160|NCT00075725|469010235|FG004|Overall Study|Institution Terminated|1|||
130286161|NCT00075725|469010236|FG005|Overall Study|Institution Terminated|0|||
130286162|NCT00075725|469010237|FG006|Overall Study|Institution Terminated|0|||
130286163|NCT00075725|469010238|FG007|Overall Study|Institution Terminated|3|||
130286164|NCT00075725|469010239|FG008|Overall Study|Institution Terminated|0|||
130286165|NCT00075725|469010240|FG009|Overall Study|Institution Terminated|0|||
130286166|NCT00075725|469010241|FG010|Overall Study|Institution Terminated|0|||
130286167|NCT00075725|469010242|FG011|Overall Study|Institution Terminated|0|||
130286168|NCT00075725|469010231|FG000|Overall Study|Study Closure|1|||
130286169|NCT00075725|469010232|FG001|Overall Study|Study Closure|0|||
130286170|NCT00075725|469010233|FG002|Overall Study|Study Closure|0|||
130286171|NCT00075725|469010234|FG003|Overall Study|Study Closure|0|||
130286172|NCT00075725|469010235|FG004|Overall Study|Study Closure|1|||
130286173|NCT00075725|469010236|FG005|Overall Study|Study Closure|3|||
130286174|NCT00075725|469010237|FG006|Overall Study|Study Closure|0|||
130286175|NCT00075725|469010238|FG007|Overall Study|Study Closure|1|||
130286176|NCT00075725|469010239|FG008|Overall Study|Study Closure|0|||
130286177|NCT00075725|469010240|FG009|Overall Study|Study Closure|0|||
130286178|NCT00075725|469010241|FG010|Overall Study|Study Closure|0|||
130286179|NCT00075725|469010242|FG011|Overall Study|Study Closure|0|||
130286180|NCT00075725|469010231|FG000|Overall Study|Other complications|0|||
130286181|NCT00075725|469010232|FG001|Overall Study|Other complications|0|||
130286182|NCT00075725|469010233|FG002|Overall Study|Other complications|0|||
130286183|NCT00075725|469010234|FG003|Overall Study|Other complications|0|||
130286184|NCT00075725|469010235|FG004|Overall Study|Other complications|0|||
130286185|NCT00075725|469010236|FG005|Overall Study|Other complications|1|||
130286186|NCT00075725|469010237|FG006|Overall Study|Other complications|0|||
130286187|NCT00075725|469010238|FG007|Overall Study|Other complications|0|||
130286188|NCT00075725|469010239|FG008|Overall Study|Other complications|0|||
130286189|NCT00075725|469010240|FG009|Overall Study|Other complications|0|||
130286190|NCT00075725|469010241|FG010|Overall Study|Other complications|0|||
130286191|NCT00075725|469010242|FG011|Overall Study|Other complications|0|||
130286192|NCT00075725|469010231|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
130286193|NCT00075725|469010232|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
130369873|NCT00042289|469325102|FG029|Overall Study|Site closed|0|||
130369874|NCT00042289|469325103|FG030|Overall Study|Site closed|0|||
130286194|NCT00075725|469010233|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
130286195|NCT00075725|469010234|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
130286196|NCT00075725|469010235|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
130286197|NCT00075725|469010236|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
130286198|NCT00075725|469010237|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
130286199|NCT00075725|469010238|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
130286200|NCT00075725|469010239|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
130286201|NCT00075725|469010240|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
130286202|NCT00075725|469010241|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
130286203|NCT00075725|469010242|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
130286204|NCT00075725|469010231|FG000|Overall Study|Pt incarcerated|0|||
130369875|NCT00042289|469325104|FG031|Overall Study|Site closed|3|||
130286205|NCT00075725|469010232|FG001|Overall Study|Pt incarcerated|0|||
130286206|NCT00075725|469010233|FG002|Overall Study|Pt incarcerated|0|||
130286207|NCT00075725|469010234|FG003|Overall Study|Pt incarcerated|0|||
130286208|NCT00075725|469010235|FG004|Overall Study|Pt incarcerated|0|||
130286209|NCT00075725|469010236|FG005|Overall Study|Pt incarcerated|0|||
130286210|NCT00075725|469010237|FG006|Overall Study|Pt incarcerated|0|||
130286211|NCT00075725|469010238|FG007|Overall Study|Pt incarcerated|1|||
130286212|NCT00075725|469010239|FG008|Overall Study|Pt incarcerated|0|||
130286213|NCT00075725|469010240|FG009|Overall Study|Pt incarcerated|0|||
130286214|NCT00075725|469010241|FG010|Overall Study|Pt incarcerated|0|||
130286215|NCT00075725|469010242|FG011|Overall Study|Pt incarcerated|0|||
130286216|NCT02240368|469010243|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
130286217|NCT02240368|469010244|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
130286218|NCT02240368|469010245|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
130286219|NCT02240368|469010243|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
130286220|NCT02240368|469010244|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
130286221|NCT02240368|469010245|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
130286222|NCT02752958|469010251|FG000|Overall Study|Adverse Event|3|||
130286223|NCT02752958|469010251|FG000|Overall Study|Lost to Follow-up|1|||
130286224|NCT02752958|469010251|FG000|Overall Study|Protocol Violation|1|||
130286225|NCT02752958|469010251|FG000|Overall Study|Withdrawal by Subject|2|||
130286226|NCT02752958|469010251|FG000|Overall Study|Other (Reason not specified)|2|||
130286227|NCT03746600|469010252|FG000|Overall Study|Withdrawal by Subject|3|||
130286228|NCT03746600|469010253|FG001|Overall Study|Withdrawal by Subject|3|||
130286229|NCT03746600|469010252|FG000|Overall Study|dismissed from study|1|||
130286230|NCT03746600|469010253|FG001|Overall Study|dismissed from study|0|||
130286231|NCT03746600|469010252|FG000|Overall Study|Lost to Follow-up|1|||
130286232|NCT03746600|469010253|FG001|Overall Study|Lost to Follow-up|0|||
130286233|NCT00717522|469010254|FG000|Overall Study|Disease Progression|5|||
130286234|NCT00717522|469010254|FG000|Overall Study|Adverse Event|1|||
130286235|NCT00717522|469010254|FG000|Overall Study|Death|1|||
130286236|NCT02182440|469010255|FG000|Overall Study|Adverse Event|0|||
130286237|NCT02182440|469010256|FG001|Overall Study|Adverse Event|1|||
130286238|NCT02182440|469010257|FG002|Overall Study|Adverse Event|0|||
130458731|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
130458732|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
130458733|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
130458734|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
130458735|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
130458736|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
130458737|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
130458738|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
130458739|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
130458740|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
130458741|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
130458742|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
130458743|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
130458744|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
130458745|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458746|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458747|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
130458748|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458749|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130286239|NCT02182440|469010258|FG003|Overall Study|Adverse Event|0|||
130286240|NCT02182440|469010255|FG000|Overall Study|Death|31|||
130286241|NCT02182440|469010256|FG001|Overall Study|Death|8|||
130286242|NCT02182440|469010257|FG002|Overall Study|Death|5|||
130286243|NCT02182440|469010258|FG003|Overall Study|Death|16|||
130286244|NCT02182440|469010255|FG000|Overall Study|Protocol Violation|0|||
130286245|NCT02182440|469010256|FG001|Overall Study|Protocol Violation|1|||
130286246|NCT02182440|469010257|FG002|Overall Study|Protocol Violation|0|||
130458750|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130286247|NCT02182440|469010258|FG003|Overall Study|Protocol Violation|0|||
130286248|NCT02182440|469010255|FG000|Overall Study|Physician Decision|1|||
130458751|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458752|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458753|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
130458754|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130458755|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
130286249|NCT02182440|469010256|FG001|Overall Study|Physician Decision|0|||
130286250|NCT02182440|469010257|FG002|Overall Study|Physician Decision|0|||
130286251|NCT02182440|469010258|FG003|Overall Study|Physician Decision|0|||
130712030|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130712031|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
130712032|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
130286252|NCT02182440|469010255|FG000|Overall Study|Withdrawal by Subject|1|||
130286253|NCT02182440|469010256|FG001|Overall Study|Withdrawal by Subject|1|||
130286254|NCT02182440|469010257|FG002|Overall Study|Withdrawal by Subject|3|||
130458756|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
130458757|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
130458758|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
130458759|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
130458760|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130458761|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130458762|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130458763|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458764|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
130286255|NCT02182440|469010258|FG003|Overall Study|Withdrawal by Subject|4|||
130286256|NCT02182440|469010255|FG000|Overall Study|different, e.g adm other hospital|12|||
130286257|NCT02182440|469010256|FG001|Overall Study|different, e.g adm other hospital|3|||
130286258|NCT02182440|469010257|FG002|Overall Study|different, e.g adm other hospital|3|||
130286259|NCT02182440|469010258|FG003|Overall Study|different, e.g adm other hospital|10|||
130286260|NCT00072293|469010259|FG000|Overall Study|Lost to Follow-up|1|||
130286261|NCT00072293|469010260|FG001|Overall Study|Lost to Follow-up|1|||
130286262|NCT00072293|469010259|FG000|Overall Study|Withdrawal by Subject|0|||
130286263|NCT00072293|469010260|FG001|Overall Study|Withdrawal by Subject|1|||
130286264|NCT01166958|469010261|FG000|Overall Study|Withdrawal by Subject|1|||
130286265|NCT01166958|469010262|FG001|Overall Study|Withdrawal by Subject|0|||
130286266|NCT04209114|469010263|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130286267|NCT04209114|469010264|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130286268|NCT04209114|469010265|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
130286269|NCT04209114|469010263|FG000|Pre-Treatment Phase|Other reasons|0|||
130286270|NCT04209114|469010264|FG001|Pre-Treatment Phase|Other reasons|0|||
130286271|NCT04209114|469010265|FG002|Pre-Treatment Phase|Other reasons|1|||
130286272|NCT04209114|469010263|FG000|Pre-Treatment Phase|Death|0|||
130286273|NCT04209114|469010264|FG001|Pre-Treatment Phase|Death|0|||
130286274|NCT04209114|469010265|FG002|Pre-Treatment Phase|Death|1|||
130286275|NCT04209114|469010263|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
130286276|NCT04209114|469010264|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
130286277|NCT04209114|469010265|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
130286278|NCT04209114|469010263|FG000|Treatment Phase|Other reasons|5|||
130286279|NCT04209114|469010264|FG001|Treatment Phase|Other reasons|3|||
130286280|NCT04209114|469010265|FG002|Treatment Phase|Other reasons|0|||
130286281|NCT04209114|469010263|FG000|Treatment Phase|Lost to Follow-up|1|||
130286282|NCT04209114|469010264|FG001|Treatment Phase|Lost to Follow-up|0|||
130286283|NCT04209114|469010265|FG002|Treatment Phase|Lost to Follow-up|0|||
130286284|NCT04209114|469010263|FG000|Treatment Phase|Participant withdrew consent|1|||
130286285|NCT04209114|469010264|FG001|Treatment Phase|Participant withdrew consent|0|||
130286286|NCT04209114|469010265|FG002|Treatment Phase|Participant withdrew consent|0|||
130458765|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458766|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458767|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
130712033|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Subject decision|1|||
130712034|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Subject decision|1|||
130712035|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
130286287|NCT04209114|469010263|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
130286288|NCT04209114|469010264|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
130458768|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458769|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130712036|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
130712037|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
130286289|NCT04209114|469010265|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
130286290|NCT04209114|469010263|FG000|Treatment Phase|Death|4|||
130712038|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
130286291|NCT04209114|469010264|FG001|Treatment Phase|Death|1|||
130286292|NCT04209114|469010265|FG002|Treatment Phase|Death|0|||
130286293|NCT04209114|469010263|FG000|Treatment Phase|Study drug toxicity|4|||
130286294|NCT04209114|469010264|FG001|Treatment Phase|Study drug toxicity|6|||
130286295|NCT04209114|469010265|FG002|Treatment Phase|Study drug toxicity|0|||
130286296|NCT04209114|469010263|FG000|Treatment Phase|Disease progression|6|||
130286297|NCT04209114|469010264|FG001|Treatment Phase|Disease progression|9|||
130286298|NCT04209114|469010265|FG002|Treatment Phase|Disease progression|0|||
130286299|NCT01444027|469010273|FG000|Overall Study|Withdrawal by Subject|4|||
130286300|NCT01444027|469010274|FG001|Overall Study|Withdrawal by Subject|10|||
130458770|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458771|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130458772|NCT01212757|469643540|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130458773|NCT01212757|469643541|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
130458774|NCT01212757|469643542|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
130286301|NCT01444027|469010275|FG002|Overall Study|Withdrawal by Subject|24|||
130286302|NCT01444027|469010273|FG000|Overall Study|Lost to Follow-up|26|||
130286303|NCT01444027|469010274|FG001|Overall Study|Lost to Follow-up|20|||
130286304|NCT01444027|469010275|FG002|Overall Study|Lost to Follow-up|14|||
130286305|NCT01416441|469010277|FG000|Overall Study|Lost to Follow-up|5|||
130286306|NCT01416441|469010277|FG000|Overall Study|Adverse Event|6|||
130286307|NCT01416441|469010277|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
130286308|NCT01416441|469010277|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
130286309|NCT01416441|469010277|FG000|Overall Study|Investigator Withdrew Subject|2|||
130286310|NCT01416441|469010277|FG000|Overall Study|Subject Withdrew Consent|12|||
130286311|NCT01416441|469010277|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
130286312|NCT02653495|469010282|FG000|Overall Study|Lost to Follow-up|2|||
130286313|NCT02653495|469010283|FG001|Overall Study|Lost to Follow-up|0|||
130286314|NCT02653495|469010282|FG000|Overall Study|Screening Failure|10|||
130286315|NCT02653495|469010283|FG001|Overall Study|Screening Failure|0|||
130286316|NCT00953680|469010284|FG000|Period 1|Withdrawal by Subject|0|||
130286317|NCT00953680|469010285|FG001|Period 1|Withdrawal by Subject|1|||
130286318|NCT01360398|469010286|FG000|Overall Study|Withdrawal by Subject|14|||
130286319|NCT01360398|469010286|FG000|Overall Study|Other|7|||
130286320|NCT01360398|469010286|FG000|Overall Study|Migrated/moved from study area|1|||
130286321|NCT00737711|469010287|FG000|Overall Study|Adverse Event|2|||
130286322|NCT00737711|469010287|FG000|Overall Study|Death|8|||
130286323|NCT00737711|469010287|FG000|Overall Study|Failure to return|4|||
130286324|NCT00737711|469010287|FG000|Overall Study|Protocol Violation|1|||
130286325|NCT00737711|469010287|FG000|Overall Study|Withdrawal by Subject|5|||
130286326|NCT00737711|469010287|FG000|Overall Study|Blood transfusion|6|||
130286327|NCT00737711|469010287|FG000|Overall Study|Other|5|||
130286328|NCT01514240|469012106|FG000|Overall Study|Adverse Event|4|||
130286329|NCT01514240|469012107|FG001|Overall Study|Adverse Event|4|||
130286330|NCT01514240|469012106|FG000|Overall Study|Subject Decision|2|||
130286331|NCT01514240|469012107|FG001|Overall Study|Subject Decision|7|||
130286332|NCT01103063|469012108|FG000|Overall Study|Adverse Event|3|||
130286333|NCT01103063|469012109|FG001|Overall Study|Adverse Event|1|||
130286334|NCT01103063|469012108|FG000|Overall Study|Lost to Follow-up|68|||
130286335|NCT01103063|469012109|FG001|Overall Study|Lost to Follow-up|51|||
130286336|NCT01103063|469012108|FG000|Overall Study|Withdrawal by Subject|60|||
130286337|NCT01103063|469012109|FG001|Overall Study|Withdrawal by Subject|15|||
130286338|NCT01103063|469012108|FG000|Overall Study|Other|16|||
130286339|NCT01103063|469012109|FG001|Overall Study|Other|11|||
130286340|NCT01103063|469012108|FG000|Overall Study|Protocol Violation|1|||
130286341|NCT01103063|469012109|FG001|Overall Study|Protocol Violation|0|||
130286342|NCT01103063|469012108|FG000|Overall Study|Study terminated by Sponsor|326|||
130286343|NCT01103063|469012109|FG001|Overall Study|Study terminated by Sponsor|342|||
130286344|NCT01103063|469012108|FG000|Overall Study|Death|3|||
130286345|NCT01103063|469012109|FG001|Overall Study|Death|1|||
130286346|NCT01187446|469012112|FG000|Overall Study|Patient started non-protocol therapy|0|||
130286347|NCT01187446|469012113|FG001|Overall Study|Patient started non-protocol therapy|1|||
130286348|NCT00149994|469012114|FG000|Overall Study|Administrative problems:|1|||
130286349|NCT00149994|469012115|FG001|Overall Study|Administrative problems:|0|||
130286350|NCT00149994|469012114|FG000|Overall Study|Protocol Violation|0|||
130286351|NCT00149994|469012115|FG001|Overall Study|Protocol Violation|1|||
130286352|NCT01342965|469012116|FG000|Overall Study|Death|58|||
130286353|NCT01342965|469012117|FG001|Overall Study|Death|57|||
130458775|NCT01212757|469643543|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130458776|NCT01212757|469643544|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130458777|NCT01212757|469643545|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130458778|NCT01212757|469643546|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130458779|NCT01212757|469643547|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130555683|NCT04598477|470003312|FG001|Overall Study|Study Terminated by Sponsor|12|||
130712039|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
130286354|NCT01342965|469012116|FG000|Overall Study|Lost to Follow-up|5|||
130286355|NCT01342965|469012117|FG001|Overall Study|Lost to Follow-up|3|||
130286356|NCT01342965|469012116|FG000|Overall Study|Other Reasons- Unspecified|44|||
130286357|NCT01342965|469012117|FG001|Overall Study|Other Reasons- Unspecified|38|||
130286358|NCT01342965|469012116|FG000|Overall Study|Withdrawal by Subject|2|||
130286359|NCT01342965|469012117|FG001|Overall Study|Withdrawal by Subject|9|||
130286360|NCT03538444|469012128|FG000|Overall Study|opioid withdrawal|1|||
130286361|NCT03538444|469012129|FG001|Overall Study|opioid withdrawal|0|||
130286362|NCT03640052|469012132|FG000|Overall Study|Lost to Follow-up|0|||
130286363|NCT03640052|469012133|FG001|Overall Study|Lost to Follow-up|1|||
130286364|NCT03640052|469012134|FG002|Overall Study|Lost to Follow-up|0|||
130286365|NCT03640052|469012135|FG003|Overall Study|Lost to Follow-up|0|||
130286366|NCT03640052|469012136|FG004|Overall Study|Lost to Follow-up|0|||
130286367|NCT04422561|469012137|FG000|Overall Study|Lost to Follow-up|25|||
130286368|NCT04422561|469012138|FG001|Overall Study|Lost to Follow-up|11|||
130286369|NCT00790647|469012145|FG000|Overall Study|Adverse Event|1|||
130286370|NCT04926831|469012146|FG000|Overall Study|Withdrawal by Subject|2|||
130286371|NCT04926831|469012146|FG000|Overall Study|Adverse Event|2|||
130286372|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
130286373|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
130286374|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
130286375|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
130286376|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
130286377|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
130286378|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
130286379|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
130286380|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
130286381|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
130286382|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
130286383|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
130286384|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
130286385|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
130286386|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
130286387|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
130286388|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
130286389|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
130286390|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
130286391|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
130286392|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
130286393|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
130286394|NCT01133626|469012154|FG000|Overall Study|Adverse Event|0|||
130286395|NCT01133626|469012155|FG001|Overall Study|Adverse Event|1|||
130286396|NCT01133626|469012156|FG002|Overall Study|Adverse Event|0|||
130286397|NCT01133626|469012154|FG000|Overall Study|Withdrawal by Subject|1|||
130286398|NCT01133626|469012155|FG001|Overall Study|Withdrawal by Subject|2|||
130286399|NCT01133626|469012156|FG002|Overall Study|Withdrawal by Subject|2|||
130286400|NCT01133626|469012154|FG000|Overall Study|Other|0|||
130286401|NCT01133626|469012155|FG001|Overall Study|Other|2|||
130286402|NCT01133626|469012156|FG002|Overall Study|Other|0|||
130286403|NCT03298984|469012159|FG000|Overall Study|Physician Decision|1|||
130286404|NCT03298984|469012160|FG001|Overall Study|Physician Decision|0|||
130286405|NCT03298984|469012161|FG002|Overall Study|Physician Decision|0|||
130286406|NCT03298984|469012162|FG003|Overall Study|Physician Decision|6|||
130286407|NCT03298984|469012159|FG000|Overall Study|Lack of Efficacy|0|||
130286408|NCT03298984|469012160|FG001|Overall Study|Lack of Efficacy|1|||
130286409|NCT03298984|469012161|FG002|Overall Study|Lack of Efficacy|1|||
130286410|NCT03298984|469012162|FG003|Overall Study|Lack of Efficacy|4|||
130286411|NCT03298984|469012159|FG000|Overall Study|Relapsed disease (following remission)|0|||
130286412|NCT03298984|469012160|FG001|Overall Study|Relapsed disease (following remission)|0|||
130286413|NCT03298984|469012161|FG002|Overall Study|Relapsed disease (following remission)|1|||
130286414|NCT03298984|469012162|FG003|Overall Study|Relapsed disease (following remission)|1|||
130286415|NCT03298984|469012159|FG000|Overall Study|Adverse Event|0|||
130286416|NCT03298984|469012160|FG001|Overall Study|Adverse Event|0|||
130286417|NCT03298984|469012161|FG002|Overall Study|Adverse Event|0|||
130458780|NCT01212757|469643548|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
130712040|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
130286418|NCT03298984|469012162|FG003|Overall Study|Adverse Event|1|||
130286419|NCT03298984|469012159|FG000|Overall Study|Death|0|||
130286420|NCT03298984|469012160|FG001|Overall Study|Death|0|||
130286421|NCT03298984|469012161|FG002|Overall Study|Death|0|||
130286422|NCT03298984|469012162|FG003|Overall Study|Death|2|||
130286423|NCT03298984|469012159|FG000|Overall Study|Insurance Company Decision|0|||
130286424|NCT03298984|469012160|FG001|Overall Study|Insurance Company Decision|0|||
130286425|NCT03298984|469012161|FG002|Overall Study|Insurance Company Decision|0|||
130286426|NCT03298984|469012162|FG003|Overall Study|Insurance Company Decision|1|||
130286427|NCT00294645|469012163|FG000|Overall Study|Death|10|||
130286428|NCT00294645|469012164|FG001|Overall Study|Death|18|||
130286429|NCT00294645|469012163|FG000|Overall Study|Lost to Follow-up|1|||
130286430|NCT00294645|469012164|FG001|Overall Study|Lost to Follow-up|10|||
130286431|NCT00294645|469012163|FG000|Overall Study|Withdrawal by Subject|18|||
130286432|NCT00294645|469012164|FG001|Overall Study|Withdrawal by Subject|34|||
130286433|NCT00294645|469012163|FG000|Overall Study|Physician Decision|15|||
130286434|NCT00294645|469012164|FG001|Overall Study|Physician Decision|20|||
130286435|NCT00294645|469012163|FG000|Overall Study|Other|4|||
130369876|NCT00042289|469325105|FG032|Overall Study|Site closed|0|||
130286436|NCT00294645|469012164|FG001|Overall Study|Other|10|||
130286437|NCT03263923|469012165|FG000|Overall Study|Withdrawal by Subject|10|||
130286438|NCT03263923|469012166|FG001|Overall Study|Withdrawal by Subject|8|||
130286439|NCT03263923|469012165|FG000|Overall Study|Lost to Follow-up|15|||
130286440|NCT03263923|469012166|FG001|Overall Study|Lost to Follow-up|13|||
130286441|NCT03305081|469012179|FG000|Overall Study|Lost to Follow-up|10|||
130286442|NCT03305081|469012180|FG001|Overall Study|Lost to Follow-up|15|||
130286443|NCT00772369|469012181|FG000|Overall Study|Did not return record release form|1|||
130286444|NCT01774253|469012182|FG000|Overall Study|Lack of Efficacy|4|||
130286445|NCT01774253|469012182|FG000|Overall Study|Physician Decision|2|||
130286446|NCT01774253|469012182|FG000|Overall Study|Withdrawal by Subject|2|||
130286447|NCT01774253|469012182|FG000|Overall Study|Death|1|||
130286448|NCT00554619|469012183|FG000|Overall Study|Adverse Event|1|||
130286449|NCT00554619|469012183|FG000|Overall Study|Physician Decision|1|||
130286450|NCT00554619|469012183|FG000|Overall Study|Liver Function Test Abnormality|1|||
130286451|NCT01571284|469012186|FG000|Overall Study|Participant's decision|84|||
130286452|NCT01571284|469012186|FG000|Overall Study|Lost to Follow-up|3|||
130286453|NCT01571284|469012186|FG000|Overall Study|Enrolled but not treated|2|||
130286454|NCT01571284|469012186|FG000|Overall Study|Other than specified above|80|||
130286455|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Death|1|||
130286456|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Death|1|||
130286457|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Death|0|||
130286458|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Death|0|||
130286459|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Death|1|||
130286460|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Death|0|||
130286461|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Death|0|||
130286462|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Death|0|||
130286463|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Death|0|||
130286464|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Death|0|||
130286465|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
130286466|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
130286467|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
130286468|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286469|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
130286470|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286471|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286472|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286473|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286474|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286475|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286476|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286477|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130369877|NCT00042289|469325106|FG033|Overall Study|Site closed|0|||
130369878|NCT00042289|469325107|FG034|Overall Study|Site closed|0|||
130369879|NCT00042289|469325108|FG035|Overall Study|Site closed|0|||
130369880|NCT00042289|469325109|FG036|Overall Study|Site closed|1|||
130369881|NCT00042289|469325110|FG037|Overall Study|Site closed|0|||
130369882|NCT00042289|469325111|FG038|Overall Study|Site closed|0|||
130369883|NCT00042289|469325112|FG039|Overall Study|Site closed|0|||
130369884|NCT00042289|469325113|FG040|Overall Study|Site closed|0|||
130369885|NCT00042289|469325114|FG041|Overall Study|Site closed|0|||
130369886|NCT00042289|469325115|FG042|Overall Study|Site closed|1|||
130369887|NCT00042289|469325116|FG043|Overall Study|Site closed|0|||
130369888|NCT00042289|469325117|FG044|Overall Study|Site closed|0|||
130458781|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458782|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458783|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458784|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458785|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458786|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458787|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458788|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
130458789|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
130458790|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
130458791|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
130458792|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
130458793|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
130458794|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
130286478|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130369889|NCT00042289|469325118|FG045|Overall Study|Site closed|0|||
130369890|NCT00042289|469325119|FG046|Overall Study|Site closed|0|||
130286479|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
130286480|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286481|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130369891|NCT00042289|469325073|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
130286482|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286483|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286484|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286485|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
130286486|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286487|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286488|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286489|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286490|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286491|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286492|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286493|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286494|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286495|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130286496|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286497|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286498|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130286499|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
130286500|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286501|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286502|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286503|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286504|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286505|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
130286506|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286507|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286508|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
130286509|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130712041|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
130286510|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286511|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286512|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286513|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286514|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286515|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130286516|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286517|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286518|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286519|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130286520|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286521|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286522|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286523|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286524|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286525|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
130286526|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286527|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286528|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286529|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130286530|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286531|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286532|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130712042|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
130286533|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286534|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130369892|NCT00042289|469325074|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
130369893|NCT00042289|469325075|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
130369894|NCT00042289|469325076|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
130369895|NCT00042289|469325077|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
130369896|NCT00042289|469325078|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
130369897|NCT00042289|469325079|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
130369898|NCT00042289|469325080|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
130369899|NCT00042289|469325081|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
130712043|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
130286535|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130286536|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286537|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286538|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130286539|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
130286540|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286541|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286542|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286543|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286544|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286545|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286546|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286547|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286548|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286549|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286550|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286551|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286552|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286553|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286554|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286555|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286556|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286557|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286558|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286559|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286560|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286561|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286562|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286563|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286564|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286565|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
130369900|NCT00042289|469325082|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
130369901|NCT00042289|469325083|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
130369902|NCT00042289|469325084|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
130369903|NCT00042289|469325085|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
130369904|NCT00042289|469325086|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
130369905|NCT00042289|469325087|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
130369906|NCT00042289|469325088|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
130369907|NCT00042289|469325089|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
130369908|NCT00042289|469325090|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
130369909|NCT00042289|469325091|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
130369910|NCT00042289|469325092|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
130369911|NCT00042289|469325093|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
130369912|NCT00042289|469325094|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
130369913|NCT00042289|469325095|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
130369914|NCT00042289|469325096|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
130369915|NCT00042289|469325097|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
130369916|NCT00042289|469325098|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
130458795|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
130458796|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
130458797|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
130458798|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
130458799|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458800|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
130369917|NCT00042289|469325099|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
130369918|NCT00042289|469325100|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
130369919|NCT00042289|469325101|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
130369920|NCT00042289|469325102|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
130369921|NCT00042289|469325103|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
130369922|NCT00042289|469325104|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
130369923|NCT00042289|469325105|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
130369924|NCT00042289|469325106|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
130369925|NCT00042289|469325107|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
130369926|NCT00042289|469325108|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
130369927|NCT00042289|469325109|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
130369928|NCT00042289|469325110|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
130369929|NCT00042289|469325111|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
130458801|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
130458802|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458803|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458804|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458805|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458806|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
130458807|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
130458808|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130458809|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
130458810|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
130458811|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130458812|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130458813|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130458814|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130458815|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
130458816|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
130458817|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458818|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458819|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
130458820|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458821|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458822|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458823|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458824|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458825|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130458826|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458827|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
130458828|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
130458829|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458830|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458831|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458832|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458833|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
130458834|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
130458835|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
130458836|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
130458837|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
130458838|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
130458839|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
130458840|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
130458841|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
130458842|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
130458843|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
130458844|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458845|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458846|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
130458847|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130369930|NCT00042289|469325112|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
130369931|NCT00042289|469325113|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
130458848|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458849|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458850|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458851|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130286566|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130286567|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130286568|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
130286569|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
130286570|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286571|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286572|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286573|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286574|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286575|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286576|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286577|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286578|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130286579|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
130286580|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286581|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286582|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286583|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286584|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286585|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286586|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286587|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286588|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286589|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286590|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286591|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286592|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286593|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286594|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286595|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286596|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286597|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286598|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286599|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286600|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286601|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286602|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286603|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286604|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286605|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286606|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286607|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286608|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286609|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130286610|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286611|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286612|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286613|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130458852|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
130458853|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130458854|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
130458855|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130458856|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130458857|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130458858|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130712044|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
130712045|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
130712046|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
130712047|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
130712048|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
130712049|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
130712050|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
130712051|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
130712052|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
130712053|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
130712054|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
130712055|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130712056|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130712057|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
130712058|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
130712059|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
130712060|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
130712061|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
130712062|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
130712063|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
130712064|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
130712065|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
130712066|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
130712067|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
130712068|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
130712069|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
130712070|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
130712071|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130712072|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130712073|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
130712074|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
130712075|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130712076|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130712077|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130720900|NCT01341782|470601557|FG000|Overall Study|Missed 3 consecutive doses|0|||
130286614|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286615|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286616|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
130286617|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286618|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286619|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
130286620|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286621|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286622|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286623|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286624|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286625|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
130286626|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286627|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286628|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286629|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
130286630|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286631|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130369932|NCT00042289|469325114|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
130369933|NCT00042289|469325115|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
130369934|NCT00042289|469325116|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
130369935|NCT00042289|469325117|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
130369936|NCT00042289|469325118|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
130369937|NCT00042289|469325119|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
130369938|NCT00042289|469325073|FG000|Overall Study|Protocol Violation|0|||
130369939|NCT00042289|469325074|FG001|Overall Study|Protocol Violation|0|||
130369940|NCT00042289|469325075|FG002|Overall Study|Protocol Violation|0|||
130369941|NCT00042289|469325076|FG003|Overall Study|Protocol Violation|0|||
130369942|NCT00042289|469325077|FG004|Overall Study|Protocol Violation|0|||
130369943|NCT00042289|469325078|FG005|Overall Study|Protocol Violation|1|||
130369944|NCT00042289|469325079|FG006|Overall Study|Protocol Violation|0|||
130286632|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286633|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286634|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286635|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130286636|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286637|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130286638|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286639|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
130286640|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286641|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286642|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286643|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286644|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286645|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Other|5|||
130286646|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Other|1|||
130286647|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Other|0|||
130286648|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Other|3|||
130286649|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Other|0|||
130286650|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Other|0|||
130286651|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Other|0|||
130286652|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Other|0|||
130286653|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Other|0|||
130286654|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Other|0|||
130286655|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286656|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286657|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286658|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286659|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
130286660|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286661|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286662|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286663|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286664|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286665|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Death|0|||
130286666|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Death|0|||
130286667|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Death|0|||
130286668|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Death|0|||
130286669|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Death|0|||
130286670|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Death|1|||
130286671|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Death|0|||
130286672|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Death|1|||
130286673|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Death|1|||
130286674|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Death|1|||
130286675|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286676|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286677|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286678|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286679|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286680|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
130286681|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286682|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286683|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286684|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286685|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286686|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286687|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286688|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286689|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286690|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286691|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286692|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286693|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
130286694|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286695|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286696|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286697|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286698|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286699|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286700|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
130286701|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
130286702|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
130286703|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
130286704|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
130286705|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286706|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286707|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286708|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286709|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286710|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286711|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286712|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130286713|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130286714|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130286715|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286716|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286717|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286718|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286719|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286720|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286721|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286722|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286723|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286724|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286725|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286726|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286727|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286728|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286729|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286730|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286731|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286732|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286733|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286734|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
130286735|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286736|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286737|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286738|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286739|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130458859|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130458860|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130458861|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130458862|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458863|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458864|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458865|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458866|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458867|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458868|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458869|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
130458870|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
130458871|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458872|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
130555684|NCT04598477|470003311|FG000|Overall Study|Withdrawal by Subject|16|||
130555685|NCT04598477|470003312|FG001|Overall Study|Withdrawal by Subject|12|||
130555686|NCT04598477|470003311|FG000|Overall Study|Other|15|||
130555687|NCT04598477|470003312|FG001|Overall Study|Other|8|||
130555688|NCT05579990|470003315|FG000|Overall Study|Lost to Follow-up|3|||
130555689|NCT02038920|470003326|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
130555690|NCT02038920|470003327|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
130286740|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286741|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286742|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286743|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
130286744|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130286745|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286746|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286747|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286748|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286749|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286750|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286751|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286752|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286753|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286754|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286755|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286756|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286757|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286758|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286759|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286760|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286761|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286762|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
130286763|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286764|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286765|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286766|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286767|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286768|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130369945|NCT00042289|469325080|FG007|Overall Study|Protocol Violation|1|||
130369946|NCT00042289|469325081|FG008|Overall Study|Protocol Violation|0|||
130369947|NCT00042289|469325082|FG009|Overall Study|Protocol Violation|0|||
130369948|NCT00042289|469325083|FG010|Overall Study|Protocol Violation|0|||
130369949|NCT00042289|469325084|FG011|Overall Study|Protocol Violation|0|||
130369950|NCT00042289|469325085|FG012|Overall Study|Protocol Violation|0|||
130369951|NCT00042289|469325086|FG013|Overall Study|Protocol Violation|0|||
130369952|NCT00042289|469325087|FG014|Overall Study|Protocol Violation|0|||
130369953|NCT00042289|469325088|FG015|Overall Study|Protocol Violation|0|||
130369954|NCT00042289|469325089|FG016|Overall Study|Protocol Violation|0|||
130369955|NCT00042289|469325090|FG017|Overall Study|Protocol Violation|0|||
130369956|NCT00042289|469325091|FG018|Overall Study|Protocol Violation|0|||
130369957|NCT00042289|469325092|FG019|Overall Study|Protocol Violation|0|||
130369958|NCT00042289|469325093|FG020|Overall Study|Protocol Violation|0|||
130369959|NCT00042289|469325094|FG021|Overall Study|Protocol Violation|0|||
130369960|NCT00042289|469325095|FG022|Overall Study|Protocol Violation|0|||
130369961|NCT00042289|469325096|FG023|Overall Study|Protocol Violation|1|||
130369962|NCT00042289|469325097|FG024|Overall Study|Protocol Violation|1|||
130369963|NCT00042289|469325098|FG025|Overall Study|Protocol Violation|0|||
130369964|NCT00042289|469325099|FG026|Overall Study|Protocol Violation|2|||
130369965|NCT00042289|469325100|FG027|Overall Study|Protocol Violation|0|||
130369966|NCT00042289|469325101|FG028|Overall Study|Protocol Violation|0|||
130369967|NCT00042289|469325102|FG029|Overall Study|Protocol Violation|0|||
130369968|NCT00042289|469325103|FG030|Overall Study|Protocol Violation|1|||
130369969|NCT00042289|469325104|FG031|Overall Study|Protocol Violation|0|||
130369970|NCT00042289|469325105|FG032|Overall Study|Protocol Violation|0|||
130369971|NCT00042289|469325106|FG033|Overall Study|Protocol Violation|0|||
130369972|NCT00042289|469325107|FG034|Overall Study|Protocol Violation|0|||
130369973|NCT00042289|469325108|FG035|Overall Study|Protocol Violation|0|||
130369974|NCT00042289|469325109|FG036|Overall Study|Protocol Violation|0|||
130458873|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458874|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458875|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458876|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458877|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130712078|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
130712079|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130712080|NCT03395639|470571807|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
130712081|NCT03395639|470571808|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
130712082|NCT03395639|470571809|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
130712083|NCT03395639|470571807|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130712084|NCT03395639|470571808|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130712085|NCT03395639|470571809|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
130712086|NCT00942331|470571810|FG000|Overall Study|Did not start treatment|15|||
130712087|NCT00942331|470571811|FG001|Overall Study|Did not start treatment|22|||
130712088|NCT00567476|470571816|FG000|Overall Study|Adverse Event|2|||
130712089|NCT00567476|470571817|FG001|Overall Study|Adverse Event|0|||
130712090|NCT00567476|470571816|FG000|Overall Study|Pregnancy|1|||
130712091|NCT00567476|470571817|FG001|Overall Study|Pregnancy|0|||
130712092|NCT00567476|470571816|FG000|Overall Study|Protocol Violation|4|||
130712093|NCT00567476|470571817|FG001|Overall Study|Protocol Violation|1|||
130712094|NCT00567476|470571816|FG000|Overall Study|Lost to Follow-up|0|||
130712095|NCT00567476|470571817|FG001|Overall Study|Lost to Follow-up|1|||
130712096|NCT00567476|470571816|FG000|Overall Study|Administrative issues|1|||
130712097|NCT00567476|470571817|FG001|Overall Study|Administrative issues|0|||
130712098|NCT00567476|470571816|FG000|Overall Study|Medical Decision|0|||
130712099|NCT00567476|470571817|FG001|Overall Study|Medical Decision|1|||
130712100|NCT00567476|470571816|FG000|Overall Study|Non-adherence to protocol|0|||
130712101|NCT00567476|470571817|FG001|Overall Study|Non-adherence to protocol|1|||
130712102|NCT02696031|470571818|FG000|Up to Week 24|Adverse Event|2|||
130712103|NCT02696031|470571819|FG001|Up to Week 24|Adverse Event|4|||
130712104|NCT02696031|470571820|FG002|Up to Week 24|Adverse Event|2|||
130712105|NCT02696031|470571821|FG003|Up to Week 24|Adverse Event|0|||
130712106|NCT02696031|470571822|FG004|Up to Week 24|Adverse Event|0|||
130712107|NCT02696031|470571823|FG005|Up to Week 24|Adverse Event|0|||
130712108|NCT02696031|470571818|FG000|Up to Week 24|Lack of Efficacy|2|||
130712109|NCT02696031|470571819|FG001|Up to Week 24|Lack of Efficacy|1|||
130712110|NCT02696031|470571820|FG002|Up to Week 24|Lack of Efficacy|2|||
130712111|NCT02696031|470571821|FG003|Up to Week 24|Lack of Efficacy|0|||
130712112|NCT02696031|470571822|FG004|Up to Week 24|Lack of Efficacy|0|||
130712113|NCT02696031|470571823|FG005|Up to Week 24|Lack of Efficacy|0|||
130712114|NCT02696031|470571818|FG000|Up to Week 24|Lost to Follow-up|0|||
130712115|NCT02696031|470571819|FG001|Up to Week 24|Lost to Follow-up|1|||
130712116|NCT02696031|470571820|FG002|Up to Week 24|Lost to Follow-up|1|||
130712117|NCT02696031|470571821|FG003|Up to Week 24|Lost to Follow-up|0|||
130712118|NCT02696031|470571822|FG004|Up to Week 24|Lost to Follow-up|0|||
130712119|NCT02696031|470571823|FG005|Up to Week 24|Lost to Follow-up|0|||
130712120|NCT02696031|470571818|FG000|Up to Week 24|Physician Decision|1|||
130712121|NCT02696031|470571819|FG001|Up to Week 24|Physician Decision|0|||
130712122|NCT02696031|470571820|FG002|Up to Week 24|Physician Decision|1|||
130712123|NCT02696031|470571821|FG003|Up to Week 24|Physician Decision|0|||
130712124|NCT02696031|470571822|FG004|Up to Week 24|Physician Decision|0|||
130712125|NCT02696031|470571823|FG005|Up to Week 24|Physician Decision|0|||
130712126|NCT02696031|470571818|FG000|Up to Week 24|Protocol Violation|1|||
130286769|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286770|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286771|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286772|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
130286773|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130286774|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286775|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130369975|NCT00042289|469325110|FG037|Overall Study|Protocol Violation|0|||
130369976|NCT00042289|469325111|FG038|Overall Study|Protocol Violation|0|||
130369977|NCT00042289|469325112|FG039|Overall Study|Protocol Violation|0|||
130712127|NCT02696031|470571819|FG001|Up to Week 24|Protocol Violation|0|||
130712128|NCT02696031|470571820|FG002|Up to Week 24|Protocol Violation|0|||
130712129|NCT02696031|470571821|FG003|Up to Week 24|Protocol Violation|0|||
130712130|NCT02696031|470571822|FG004|Up to Week 24|Protocol Violation|0|||
130712131|NCT02696031|470571823|FG005|Up to Week 24|Protocol Violation|0|||
130712132|NCT02696031|470571818|FG000|Up to Week 24|Withdrawal by Subject|4|||
130712133|NCT02696031|470571819|FG001|Up to Week 24|Withdrawal by Subject|1|||
130712134|NCT02696031|470571820|FG002|Up to Week 24|Withdrawal by Subject|5|||
130712135|NCT02696031|470571821|FG003|Up to Week 24|Withdrawal by Subject|0|||
130712136|NCT02696031|470571822|FG004|Up to Week 24|Withdrawal by Subject|0|||
130712137|NCT02696031|470571823|FG005|Up to Week 24|Withdrawal by Subject|0|||
130712138|NCT02696031|470571818|FG000|Up to Week 52|Adverse Event|4|||
130712139|NCT02696031|470571819|FG001|Up to Week 52|Adverse Event|5|||
130712140|NCT02696031|470571820|FG002|Up to Week 52|Adverse Event|3|||
130712141|NCT02696031|470571821|FG003|Up to Week 52|Adverse Event|0|||
130712142|NCT02696031|470571822|FG004|Up to Week 52|Adverse Event|0|||
130286776|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286777|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286778|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286779|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286780|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
130286781|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286782|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286783|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
130286784|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286785|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286786|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286787|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286788|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286789|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286790|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130369978|NCT00042289|469325113|FG040|Overall Study|Protocol Violation|0|||
130712143|NCT02696031|470571823|FG005|Up to Week 52|Adverse Event|0|||
130712144|NCT02696031|470571818|FG000|Up to Week 52|Lack of Efficacy|10|||
130286791|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286792|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286793|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130369979|NCT00042289|469325114|FG041|Overall Study|Protocol Violation|1|||
130369980|NCT00042289|469325115|FG042|Overall Study|Protocol Violation|1|||
130369981|NCT00042289|469325116|FG043|Overall Study|Protocol Violation|1|||
130369982|NCT00042289|469325117|FG044|Overall Study|Protocol Violation|0|||
130369983|NCT00042289|469325118|FG045|Overall Study|Protocol Violation|0|||
130369984|NCT00042289|469325119|FG046|Overall Study|Protocol Violation|0|||
130369985|NCT00042289|469325073|FG000|Overall Study|Withdrawal by Subject|4|||
130369986|NCT00042289|469325074|FG001|Overall Study|Withdrawal by Subject|1|||
130369987|NCT00042289|469325075|FG002|Overall Study|Withdrawal by Subject|0|||
130369988|NCT00042289|469325076|FG003|Overall Study|Withdrawal by Subject|2|||
130369989|NCT00042289|469325077|FG004|Overall Study|Withdrawal by Subject|0|||
130369990|NCT00042289|469325078|FG005|Overall Study|Withdrawal by Subject|2|||
130369991|NCT00042289|469325079|FG006|Overall Study|Withdrawal by Subject|0|||
130369992|NCT00042289|469325080|FG007|Overall Study|Withdrawal by Subject|0|||
130369993|NCT00042289|469325081|FG008|Overall Study|Withdrawal by Subject|0|||
130369994|NCT00042289|469325082|FG009|Overall Study|Withdrawal by Subject|1|||
130369995|NCT00042289|469325083|FG010|Overall Study|Withdrawal by Subject|0|||
130369996|NCT00042289|469325084|FG011|Overall Study|Withdrawal by Subject|0|||
130369997|NCT00042289|469325085|FG012|Overall Study|Withdrawal by Subject|2|||
130369998|NCT00042289|469325086|FG013|Overall Study|Withdrawal by Subject|0|||
130369999|NCT00042289|469325087|FG014|Overall Study|Withdrawal by Subject|0|||
130370000|NCT00042289|469325088|FG015|Overall Study|Withdrawal by Subject|0|||
130370001|NCT00042289|469325089|FG016|Overall Study|Withdrawal by Subject|0|||
130370002|NCT00042289|469325090|FG017|Overall Study|Withdrawal by Subject|0|||
130370003|NCT00042289|469325091|FG018|Overall Study|Withdrawal by Subject|0|||
130370004|NCT00042289|469325092|FG019|Overall Study|Withdrawal by Subject|0|||
130370005|NCT00042289|469325093|FG020|Overall Study|Withdrawal by Subject|0|||
130370006|NCT00042289|469325094|FG021|Overall Study|Withdrawal by Subject|1|||
130370007|NCT00042289|469325095|FG022|Overall Study|Withdrawal by Subject|1|||
130370008|NCT00042289|469325096|FG023|Overall Study|Withdrawal by Subject|1|||
130370009|NCT00042289|469325097|FG024|Overall Study|Withdrawal by Subject|0|||
130370010|NCT00042289|469325098|FG025|Overall Study|Withdrawal by Subject|0|||
130370011|NCT00042289|469325099|FG026|Overall Study|Withdrawal by Subject|1|||
130370012|NCT00042289|469325100|FG027|Overall Study|Withdrawal by Subject|0|||
130370013|NCT00042289|469325101|FG028|Overall Study|Withdrawal by Subject|2|||
130458878|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130370014|NCT00042289|469325102|FG029|Overall Study|Withdrawal by Subject|0|||
130370015|NCT00042289|469325103|FG030|Overall Study|Withdrawal by Subject|0|||
130370016|NCT00042289|469325104|FG031|Overall Study|Withdrawal by Subject|1|||
130370017|NCT00042289|469325105|FG032|Overall Study|Withdrawal by Subject|2|||
130370018|NCT00042289|469325106|FG033|Overall Study|Withdrawal by Subject|1|||
130370019|NCT00042289|469325107|FG034|Overall Study|Withdrawal by Subject|0|||
130370020|NCT00042289|469325108|FG035|Overall Study|Withdrawal by Subject|0|||
130370021|NCT00042289|469325109|FG036|Overall Study|Withdrawal by Subject|0|||
130712145|NCT02696031|470571819|FG001|Up to Week 52|Lack of Efficacy|7|||
130712146|NCT02696031|470571820|FG002|Up to Week 52|Lack of Efficacy|11|||
130286794|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
130286795|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286796|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286797|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286798|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286799|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130458879|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
130458880|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458881|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458882|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
130458883|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458884|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458885|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458886|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458887|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
130458888|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
130458889|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458890|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
130458891|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458892|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458893|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458894|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458895|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458896|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
130458897|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
130458898|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
130458899|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
130458900|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
130458901|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
130458902|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
130458903|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
130458904|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
130458905|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
130458906|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
130458907|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
130458908|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
130458909|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
130458910|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
130458911|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
130458912|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
130458913|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
130458914|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
130458915|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
130458916|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130458917|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
130458918|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
130458919|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130458920|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130458921|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130458922|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130458923|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
130458924|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
130458925|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
130458926|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
130458927|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
130458928|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
130458929|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
130458930|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
130458931|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
130458932|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
130458933|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
130458934|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458935|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458936|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458937|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458938|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130286800|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286801|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130458939|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130286802|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130555691|NCT02038920|470003328|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
130555692|NCT02038920|470003329|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
130555693|NCT02038920|470003330|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
130555694|NCT02038920|470003331|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
130555695|NCT02038920|470003326|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
130555696|NCT02038920|470003327|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
130555697|NCT02038920|470003328|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
130555698|NCT02038920|470003329|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
130555699|NCT02038920|470003330|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
130555700|NCT02038920|470003331|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
130555701|NCT02038920|470003326|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
130555702|NCT02038920|470003327|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
130555703|NCT02038920|470003328|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
130555704|NCT02038920|470003329|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
130555705|NCT02038920|470003330|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
130555706|NCT02038920|470003331|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
130555707|NCT02038920|470003326|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
130555708|NCT02038920|470003327|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
130555709|NCT02038920|470003328|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
130555710|NCT02038920|470003329|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
130555711|NCT02038920|470003330|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
130555712|NCT02038920|470003331|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
130555713|NCT02038920|470003326|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
130555714|NCT02038920|470003327|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
130555715|NCT02038920|470003328|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
130555716|NCT02038920|470003329|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
130555717|NCT02038920|470003330|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
130555718|NCT02038920|470003331|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
130555719|NCT02038920|470003326|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
130555720|NCT02038920|470003327|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
130555721|NCT02038920|470003328|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
130555722|NCT02038920|470003329|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
130555723|NCT02038920|470003330|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
130555724|NCT02038920|470003331|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
130555725|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
130555726|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
130555727|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
130555728|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
130555729|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
130555730|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
130555731|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
130555732|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
130555733|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
130555734|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
130555735|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
130555736|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
130555737|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
130555738|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
130555739|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
130555740|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
130555741|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
130555742|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
130555743|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130555744|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130555745|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130555746|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130555747|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130555748|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
130555749|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
130555750|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
130286803|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
130286804|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
130286805|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130712147|NCT02696031|470571821|FG003|Up to Week 52|Lack of Efficacy|0|||
130555751|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
130555752|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
130555753|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
130555754|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
130555755|NCT02038920|470003326|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130555756|NCT02038920|470003327|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130555757|NCT02038920|470003328|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130555758|NCT02038920|470003329|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130555759|NCT02038920|470003330|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130712148|NCT02696031|470571822|FG004|Up to Week 52|Lack of Efficacy|0|||
130712149|NCT02696031|470571823|FG005|Up to Week 52|Lack of Efficacy|0|||
130712150|NCT02696031|470571818|FG000|Up to Week 52|Lost to Follow-up|1|||
130712151|NCT02696031|470571819|FG001|Up to Week 52|Lost to Follow-up|1|||
130712152|NCT02696031|470571820|FG002|Up to Week 52|Lost to Follow-up|1|||
130712153|NCT02696031|470571821|FG003|Up to Week 52|Lost to Follow-up|0|||
130712154|NCT02696031|470571822|FG004|Up to Week 52|Lost to Follow-up|0|||
130712155|NCT02696031|470571823|FG005|Up to Week 52|Lost to Follow-up|0|||
130712156|NCT02696031|470571818|FG000|Up to Week 52|Physician Decision|1|||
130712157|NCT02696031|470571819|FG001|Up to Week 52|Physician Decision|1|||
130712158|NCT02696031|470571820|FG002|Up to Week 52|Physician Decision|2|||
130712159|NCT02696031|470571821|FG003|Up to Week 52|Physician Decision|0|||
130712160|NCT02696031|470571822|FG004|Up to Week 52|Physician Decision|0|||
130712161|NCT02696031|470571823|FG005|Up to Week 52|Physician Decision|0|||
130712162|NCT02696031|470571818|FG000|Up to Week 52|Pregnancy|0|||
130712163|NCT02696031|470571819|FG001|Up to Week 52|Pregnancy|2|||
130712164|NCT02696031|470571820|FG002|Up to Week 52|Pregnancy|0|||
130712165|NCT02696031|470571821|FG003|Up to Week 52|Pregnancy|0|||
130712166|NCT02696031|470571822|FG004|Up to Week 52|Pregnancy|0|||
130712167|NCT02696031|470571823|FG005|Up to Week 52|Pregnancy|0|||
130712168|NCT02696031|470571818|FG000|Up to Week 52|Protocol Violation|1|||
130712169|NCT02696031|470571819|FG001|Up to Week 52|Protocol Violation|0|||
130712170|NCT02696031|470571820|FG002|Up to Week 52|Protocol Violation|0|||
130712171|NCT02696031|470571821|FG003|Up to Week 52|Protocol Violation|0|||
130712172|NCT02696031|470571822|FG004|Up to Week 52|Protocol Violation|0|||
130712173|NCT02696031|470571823|FG005|Up to Week 52|Protocol Violation|0|||
130712174|NCT02696031|470571818|FG000|Up to Week 52|Withdrawal by Subject|12|||
130712175|NCT02696031|470571819|FG001|Up to Week 52|Withdrawal by Subject|3|||
130712176|NCT02696031|470571820|FG002|Up to Week 52|Withdrawal by Subject|9|||
130712177|NCT02696031|470571821|FG003|Up to Week 52|Withdrawal by Subject|0|||
130712178|NCT02696031|470571822|FG004|Up to Week 52|Withdrawal by Subject|0|||
130712179|NCT02696031|470571823|FG005|Up to Week 52|Withdrawal by Subject|0|||
130712180|NCT02696031|470571818|FG000|Up to Week 104|Pregnancy|0|||
130712181|NCT02696031|470571819|FG001|Up to Week 104|Pregnancy|2|||
130712182|NCT02696031|470571820|FG002|Up to Week 104|Pregnancy|1|||
130712183|NCT02696031|470571821|FG003|Up to Week 104|Pregnancy|0|||
130712184|NCT02696031|470571822|FG004|Up to Week 104|Pregnancy|0|||
130712185|NCT02696031|470571823|FG005|Up to Week 104|Pregnancy|0|||
130712186|NCT02696031|470571818|FG000|Up to Week 104|Withdrawal by Subject|15|||
130712187|NCT02696031|470571819|FG001|Up to Week 104|Withdrawal by Subject|10|||
130712188|NCT02696031|470571820|FG002|Up to Week 104|Withdrawal by Subject|16|||
130712189|NCT02696031|470571821|FG003|Up to Week 104|Withdrawal by Subject|0|||
130712190|NCT02696031|470571822|FG004|Up to Week 104|Withdrawal by Subject|0|||
130712191|NCT02696031|470571823|FG005|Up to Week 104|Withdrawal by Subject|0|||
130712192|NCT02696031|470571818|FG000|Up to Week 104|Protocol Violation|1|||
130712193|NCT02696031|470571819|FG001|Up to Week 104|Protocol Violation|0|||
130712194|NCT02696031|470571820|FG002|Up to Week 104|Protocol Violation|0|||
130712195|NCT02696031|470571821|FG003|Up to Week 104|Protocol Violation|0|||
130286806|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286807|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286808|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286809|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130555760|NCT02038920|470003331|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
130555761|NCT00866697|470003332|FG000|Overall Study|Study closed/terminated|156|||
130712196|NCT02696031|470571822|FG004|Up to Week 104|Protocol Violation|0|||
130712197|NCT02696031|470571823|FG005|Up to Week 104|Protocol Violation|0|||
130712198|NCT02696031|470571818|FG000|Up to Week 104|Physician Decision|1|||
130712199|NCT02696031|470571819|FG001|Up to Week 104|Physician Decision|2|||
130712200|NCT02696031|470571820|FG002|Up to Week 104|Physician Decision|3|||
130712201|NCT02696031|470571821|FG003|Up to Week 104|Physician Decision|0|||
130712202|NCT02696031|470571822|FG004|Up to Week 104|Physician Decision|0|||
130712203|NCT02696031|470571823|FG005|Up to Week 104|Physician Decision|0|||
130712204|NCT02696031|470571818|FG000|Up to Week 104|Lost to Follow-up|2|||
130712205|NCT02696031|470571819|FG001|Up to Week 104|Lost to Follow-up|3|||
130712206|NCT02696031|470571820|FG002|Up to Week 104|Lost to Follow-up|1|||
130712207|NCT02696031|470571821|FG003|Up to Week 104|Lost to Follow-up|0|||
130712208|NCT02696031|470571822|FG004|Up to Week 104|Lost to Follow-up|0|||
130286810|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286811|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286812|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
130286813|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
130286814|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286815|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Other|0|||
130286816|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Other|0|||
130286817|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Other|0|||
130286818|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Other|0|||
130286819|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Other|0|||
130286820|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Other|0|||
130286821|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Other|0|||
130286822|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Other|1|||
130286823|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Other|0|||
130286824|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Other|0|||
130286825|NCT04065074|469012197|FG000|Overall Study|Adverse Event|1|||
130286826|NCT04065074|469012197|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
130286827|NCT00916058|469012198|FG000|Phase 1|Screen Failure|0|||
130286828|NCT00916058|469012199|FG001|Phase 1|Screen Failure|0|||
130286829|NCT00916058|469012200|FG002|Phase 1|Screen Failure|0|||
130458940|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458941|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
130458942|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
130458943|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130458944|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
130458945|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
130458946|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130458947|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130458948|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130458949|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130458950|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130458951|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130458952|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458953|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
130458954|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
130458955|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458956|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458957|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458958|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458959|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
130458960|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
130458961|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
130458962|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
130458963|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
130458964|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
130458965|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
130458966|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
130458967|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
130458968|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
130458969|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
130458970|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458971|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
130458972|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458973|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458974|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458975|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458976|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458977|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458978|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
130458979|NCT01212757|469643540|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130458980|NCT01212757|469643541|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
130458981|NCT01212757|469643542|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
130458982|NCT01212757|469643543|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130286830|NCT00916058|469012201|FG003|Phase 1|Screen Failure|0|||
130286831|NCT00916058|469012202|FG004|Phase 1|Screen Failure|0|||
130458983|NCT01212757|469643544|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130458984|NCT01212757|469643545|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130458985|NCT01212757|469643546|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130286832|NCT00916058|469012203|FG005|Phase 1|Screen Failure|1|||
130286833|NCT00916058|469012204|FG006|Phase 1|Screen Failure|0|||
130370022|NCT00042289|469325110|FG037|Overall Study|Withdrawal by Subject|1|||
130370023|NCT00042289|469325111|FG038|Overall Study|Withdrawal by Subject|0|||
130370024|NCT00042289|469325112|FG039|Overall Study|Withdrawal by Subject|0|||
130370025|NCT00042289|469325113|FG040|Overall Study|Withdrawal by Subject|0|||
130370026|NCT00042289|469325114|FG041|Overall Study|Withdrawal by Subject|0|||
130370027|NCT00042289|469325115|FG042|Overall Study|Withdrawal by Subject|1|||
130370028|NCT00042289|469325116|FG043|Overall Study|Withdrawal by Subject|0|||
130370029|NCT00042289|469325117|FG044|Overall Study|Withdrawal by Subject|0|||
130370030|NCT00042289|469325118|FG045|Overall Study|Withdrawal by Subject|0|||
130370031|NCT00042289|469325119|FG046|Overall Study|Withdrawal by Subject|0|||
130370032|NCT00745823|469325121|FG000|Overall Study|Adverse Event|5|||
130370033|NCT00745823|469325122|FG001|Overall Study|Adverse Event|3|||
130370034|NCT00745823|469325121|FG000|Overall Study|Lack of Efficacy|20|||
130370035|NCT00745823|469325122|FG001|Overall Study|Lack of Efficacy|6|||
130370036|NCT00745823|469325121|FG000|Overall Study|Lost to Follow-up|10|||
130370037|NCT00745823|469325122|FG001|Overall Study|Lost to Follow-up|11|||
130370038|NCT00745823|469325121|FG000|Overall Study|Physician Decision|10|||
130370039|NCT00745823|469325122|FG001|Overall Study|Physician Decision|5|||
130370040|NCT00745823|469325121|FG000|Overall Study|Pregnancy|0|||
130370041|NCT00745823|469325122|FG001|Overall Study|Pregnancy|4|||
130370042|NCT00745823|469325121|FG000|Overall Study|Withdrawal by Subject|14|||
130370043|NCT00745823|469325122|FG001|Overall Study|Withdrawal by Subject|8|||
130370044|NCT00745823|469325121|FG000|Overall Study|Study Terminated by Sponsor|326|||
130370045|NCT00745823|469325122|FG001|Overall Study|Study Terminated by Sponsor|349|||
130370046|NCT02955602|469325128|FG000|Overall Study|Adverse Event|0|||
130370047|NCT02955602|469325129|FG001|Overall Study|Adverse Event|3|||
130370048|NCT02955602|469325130|FG002|Overall Study|Adverse Event|0|||
130370049|NCT02955602|469325128|FG000|Overall Study|Withdrawal of informed consent|1|||
130370050|NCT02955602|469325129|FG001|Overall Study|Withdrawal of informed consent|3|||
130370051|NCT02955602|469325130|FG002|Overall Study|Withdrawal of informed consent|2|||
130370052|NCT02955602|469325128|FG000|Overall Study|Lost to Follow-up|0|||
130370053|NCT02955602|469325129|FG001|Overall Study|Lost to Follow-up|0|||
130370054|NCT02955602|469325130|FG002|Overall Study|Lost to Follow-up|1|||
130370055|NCT02955602|469325128|FG000|Overall Study|Other|0|||
130370056|NCT02955602|469325129|FG001|Overall Study|Other|1|||
130370057|NCT02955602|469325130|FG002|Overall Study|Other|3|||
130370058|NCT03000439|469325131|FG000|Open Label Part 1|Adverse Event|6|||
130370059|NCT03000439|469325132|FG001|Open Label Part 1|Adverse Event|0|||
130370060|NCT03000439|469325133|FG002|Open Label Part 1|Adverse Event|0|||
130370061|NCT03000439|469325134|FG003|Open Label Part 1|Adverse Event|0|||
130370062|NCT03000439|469325131|FG000|Open Label Part 1|Other|2|||
130370063|NCT03000439|469325132|FG001|Open Label Part 1|Other|0|||
130370064|NCT03000439|469325133|FG002|Open Label Part 1|Other|0|||
130370065|NCT03000439|469325134|FG003|Open Label Part 1|Other|0|||
130370066|NCT03000439|469325131|FG000|Open Label Part 1|Insufficient clinical response|16|||
130370067|NCT03000439|469325132|FG001|Open Label Part 1|Insufficient clinical response|0|||
130370068|NCT03000439|469325133|FG002|Open Label Part 1|Insufficient clinical response|0|||
130370069|NCT03000439|469325134|FG003|Open Label Part 1|Insufficient clinical response|0|||
130370070|NCT03000439|469325131|FG000|Open Label Part 2|Other|0|||
130370071|NCT03000439|469325132|FG001|Open Label Part 2|Other|5|||
130370072|NCT03000439|469325133|FG002|Open Label Part 2|Other|0|||
130370073|NCT03000439|469325134|FG003|Open Label Part 2|Other|0|||
130370074|NCT03000439|469325131|FG000|Open Label Part 2|Insufficient clinical response|0|||
130370075|NCT03000439|469325132|FG001|Open Label Part 2|Insufficient clinical response|12|||
130370076|NCT03000439|469325133|FG002|Open Label Part 2|Insufficient clinical response|0|||
130370077|NCT03000439|469325134|FG003|Open Label Part 2|Insufficient clinical response|0|||
130370078|NCT03000439|469325131|FG000|Double Blind Phase|Adverse Event|0|||
130370079|NCT03000439|469325132|FG001|Double Blind Phase|Adverse Event|0|||
130458986|NCT01212757|469643547|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130370080|NCT03000439|469325133|FG002|Double Blind Phase|Adverse Event|2|||
130370081|NCT03000439|469325134|FG003|Double Blind Phase|Adverse Event|1|||
130370082|NCT03000439|469325131|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
130370083|NCT03000439|469325132|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
130370084|NCT03000439|469325133|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
130370085|NCT03000439|469325134|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
130370086|NCT03000439|469325131|FG000|Double Blind Phase|Other|0|||
130370087|NCT03000439|469325132|FG001|Double Blind Phase|Other|0|||
130370088|NCT03000439|469325133|FG002|Double Blind Phase|Other|10|||
130370089|NCT03000439|469325134|FG003|Double Blind Phase|Other|11|||
130370090|NCT03000439|469325131|FG000|Double Blind Phase|Insufficient clinical response|0|||
130370091|NCT03000439|469325132|FG001|Double Blind Phase|Insufficient clinical response|0|||
130370092|NCT03000439|469325133|FG002|Double Blind Phase|Insufficient clinical response|0|||
130370093|NCT03000439|469325134|FG003|Double Blind Phase|Insufficient clinical response|2|||
130370094|NCT02370160|469325135|FG000|Overall Study|Death|3|||
130370095|NCT02370160|469325136|FG001|Overall Study|Death|4|||
130370096|NCT02370160|469325137|FG002|Overall Study|Death|1|||
130370097|NCT00592384|469325138|FG000|Overall Study|Withdrawal by Subject|5|||
130370098|NCT00592384|469325139|FG001|Overall Study|Withdrawal by Subject|6|||
130370099|NCT02151591|469325141|FG000|Overall Study|Lost to Follow-up|6|||
130555762|NCT00866697|470003333|FG001|Overall Study|Study closed/terminated|138|||
130555763|NCT00866697|470003332|FG000|Overall Study|Lost to Follow-up|22|||
130555764|NCT00866697|470003333|FG001|Overall Study|Lost to Follow-up|28|||
130555765|NCT00866697|470003332|FG000|Overall Study|Physician Decision|3|||
130555766|NCT00866697|470003333|FG001|Overall Study|Physician Decision|5|||
130555767|NCT00866697|470003332|FG000|Overall Study|Withdrawal by Subject|33|||
130555768|NCT00866697|470003333|FG001|Overall Study|Withdrawal by Subject|57|||
130555769|NCT04376060|470003334|FG000|Overall Study|Physician Decision|1|||
130555770|NCT04275297|470003335|FG000|Overall Study|Lost to Follow-up|1|||
130555771|NCT04275297|470003336|FG001|Overall Study|Lost to Follow-up|1|||
130555772|NCT01423812|470004428|FG000|Overall Study|Lost to Follow-up|2|||
130555773|NCT01423812|470004429|FG001|Overall Study|Lost to Follow-up|2|||
130555774|NCT01423812|470004428|FG000|Overall Study|Withdrawal by Subject|1|||
130555775|NCT01423812|470004429|FG001|Overall Study|Withdrawal by Subject|2|||
130555776|NCT02748018|470004430|FG000|Study Period|Adverse Event|1|||
130555777|NCT02748018|470004431|FG001|Study Period|Adverse Event|3|||
130555778|NCT02748018|470004432|FG002|Study Period|Adverse Event|4|||
130555779|NCT02748018|470004433|FG003|Study Period|Adverse Event|0|||
130555780|NCT02748018|470004434|FG004|Study Period|Adverse Event|3|||
130555781|NCT02748018|470004435|FG005|Study Period|Adverse Event|3|||
130555782|NCT02748018|470004430|FG000|Study Period|Withdrawal by Subject|7|||
130555783|NCT02748018|470004431|FG001|Study Period|Withdrawal by Subject|4|||
130555784|NCT02748018|470004432|FG002|Study Period|Withdrawal by Subject|4|||
130555785|NCT02748018|470004433|FG003|Study Period|Withdrawal by Subject|11|||
130555786|NCT02748018|470004434|FG004|Study Period|Withdrawal by Subject|12|||
130555787|NCT02748018|470004435|FG005|Study Period|Withdrawal by Subject|10|||
130555788|NCT02748018|470004430|FG000|Study Period|Pregnancy|0|||
130555789|NCT02748018|470004431|FG001|Study Period|Pregnancy|1|||
130555790|NCT02748018|470004432|FG002|Study Period|Pregnancy|0|||
130555791|NCT02748018|470004433|FG003|Study Period|Pregnancy|0|||
130555792|NCT02748018|470004434|FG004|Study Period|Pregnancy|1|||
130555793|NCT02748018|470004435|FG005|Study Period|Pregnancy|0|||
130555794|NCT02748018|470004430|FG000|Study Period|Physician Decision|2|||
130555795|NCT02748018|470004431|FG001|Study Period|Physician Decision|2|||
130555796|NCT02748018|470004432|FG002|Study Period|Physician Decision|1|||
130555797|NCT02748018|470004433|FG003|Study Period|Physician Decision|0|||
130555798|NCT02748018|470004434|FG004|Study Period|Physician Decision|2|||
130555799|NCT02748018|470004435|FG005|Study Period|Physician Decision|0|||
130555800|NCT02748018|470004430|FG000|Study Period|Lost to Follow-up|0|||
130555801|NCT02748018|470004431|FG001|Study Period|Lost to Follow-up|0|||
130555802|NCT02748018|470004432|FG002|Study Period|Lost to Follow-up|0|||
130555803|NCT02748018|470004433|FG003|Study Period|Lost to Follow-up|2|||
130712209|NCT02696031|470571823|FG005|Up to Week 104|Lost to Follow-up|0|||
130712210|NCT02696031|470571818|FG000|Up to Week 104|Lack of Efficacy|13|||
130712211|NCT02696031|470571819|FG001|Up to Week 104|Lack of Efficacy|12|||
130712212|NCT02696031|470571820|FG002|Up to Week 104|Lack of Efficacy|11|||
130555804|NCT02748018|470004434|FG004|Study Period|Lost to Follow-up|0|||
130712213|NCT02696031|470571821|FG003|Up to Week 104|Lack of Efficacy|0|||
130712214|NCT02696031|470571822|FG004|Up to Week 104|Lack of Efficacy|0|||
130370100|NCT02151591|469325142|FG001|Overall Study|Lost to Follow-up|3|||
130370101|NCT00684593|469325148|FG000|Overall Study|Adverse Event|0|||
130370102|NCT00684593|469325149|FG001|Overall Study|Adverse Event|2|||
130370103|NCT01001377|469325150|FG000|Overall Study|Ineligibility determined|2|||
130370104|NCT01001377|469325151|FG001|Overall Study|Ineligibility determined|0|||
130370105|NCT01001377|469325150|FG000|Overall Study|Withdrawal by Subject|19|||
130370106|NCT01001377|469325151|FG001|Overall Study|Withdrawal by Subject|20|||
130370107|NCT01001377|469325150|FG000|Overall Study|Lost to Follow-up|14|||
130370108|NCT01001377|469325151|FG001|Overall Study|Lost to Follow-up|17|||
130370109|NCT01001377|469325150|FG000|Overall Study|Death|391|||
130370110|NCT01001377|469325151|FG001|Overall Study|Death|384|||
130370111|NCT02193867|469325155|FG000|Overall Study|Death|2|||
130370112|NCT02193867|469325155|FG000|Overall Study|Sponsor Study Termination|2|||
130370113|NCT00964860|469325156|FG000|Overall Study|Withdrawal by Subject|0|||
130370114|NCT00964860|469325157|FG001|Overall Study|Withdrawal by Subject|1|||
130555805|NCT02748018|470004435|FG005|Study Period|Lost to Follow-up|1|||
130555806|NCT02748018|470004430|FG000|Continuation Period|Adverse Event|2|||
130555807|NCT02748018|470004431|FG001|Continuation Period|Adverse Event|0|||
130555808|NCT02748018|470004432|FG002|Continuation Period|Adverse Event|1|||
130712215|NCT02696031|470571823|FG005|Up to Week 104|Lack of Efficacy|0|||
130370115|NCT03716024|469325158|FG000|Overall Study|Randomized, not Treated|7|||
130370116|NCT03716024|469325159|FG001|Overall Study|Randomized, not Treated|8|||
130555809|NCT02748018|470004433|FG003|Continuation Period|Adverse Event|1|||
130555810|NCT02748018|470004434|FG004|Continuation Period|Adverse Event|1|||
130555811|NCT02748018|470004435|FG005|Continuation Period|Adverse Event|4|||
130555812|NCT02748018|470004430|FG000|Continuation Period|Withdrawal by Subject|3|||
130555813|NCT02748018|470004431|FG001|Continuation Period|Withdrawal by Subject|5|||
130555814|NCT02748018|470004432|FG002|Continuation Period|Withdrawal by Subject|3|||
130712216|NCT02696031|470571818|FG000|Up to Week 104|Adverse Event|7|||
130712217|NCT02696031|470571819|FG001|Up to Week 104|Adverse Event|11|||
130712218|NCT02696031|470571820|FG002|Up to Week 104|Adverse Event|5|||
130712219|NCT02696031|470571821|FG003|Up to Week 104|Adverse Event|0|||
130712220|NCT02696031|470571822|FG004|Up to Week 104|Adverse Event|0|||
130712221|NCT02696031|470571823|FG005|Up to Week 104|Adverse Event|0|||
130712222|NCT02696031|470571818|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712223|NCT02696031|470571819|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
130712224|NCT02696031|470571820|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712225|NCT02696031|470571821|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712226|NCT02696031|470571822|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712227|NCT02696031|470571823|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712228|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712229|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712230|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712231|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
130712232|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
130712233|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
130712234|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712235|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712236|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712237|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130712238|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130712239|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712240|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712241|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712242|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712243|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
130712244|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712245|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712246|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712247|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712248|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712249|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712250|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
130712251|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712252|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712253|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712254|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712255|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130712256|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130712257|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
130712258|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712259|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712260|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712261|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130712262|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
130712263|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130712264|NCT01901874|470571826|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
130712265|NCT01901874|470571826|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
130712266|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
130712267|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
130712268|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
130712269|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
130712270|NCT02595008|470571828|FG000|Overall Study|Enrolled In Error|1|||
130712271|NCT02595008|470571829|FG001|Overall Study|Enrolled In Error|0|||
130712272|NCT03078582|470571836|FG000|Overall Study|Adverse Event|0|||
130712273|NCT03078582|470571837|FG001|Overall Study|Adverse Event|8|||
130286834|NCT00916058|469012198|FG000|Phase 2|Screen Failure|0|||
130286835|NCT00916058|469012199|FG001|Phase 2|Screen Failure|0|||
130286836|NCT00916058|469012200|FG002|Phase 2|Screen Failure|0|||
130286837|NCT00916058|469012201|FG003|Phase 2|Screen Failure|0|||
130286838|NCT00916058|469012202|FG004|Phase 2|Screen Failure|0|||
130286839|NCT00916058|469012203|FG005|Phase 2|Screen Failure|0|||
130286840|NCT00916058|469012204|FG006|Phase 2|Screen Failure|3|||
130712274|NCT01843348|470571840|FG000|Overall Study|Withdrawal by Subject|4|||
130712275|NCT01843348|470571841|FG001|Overall Study|Withdrawal by Subject|16|||
130286841|NCT00871117|469012205|FG000|Overall Study|Lost to Follow-up|5|||
130286842|NCT00871117|469012206|FG001|Overall Study|Lost to Follow-up|6|||
130286843|NCT00871117|469012205|FG000|Overall Study|Other|0|||
130286844|NCT00871117|469012206|FG001|Overall Study|Other|4|||
130286845|NCT03444766|469012207|FG000|Overall Study|Other Reasons|2|||
130286846|NCT03444766|469012207|FG000|Overall Study|Participant Withdrew Consent|5|||
130286847|NCT03444766|469012207|FG000|Overall Study|Lost to Follow-up|2|||
130286848|NCT03444766|469012207|FG000|Overall Study|Death|2|||
130286849|NCT03444766|469012207|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
130286850|NCT03444766|469012207|FG000|Overall Study|Disease Progression|49|||
130286851|NCT01767493|469012208|FG000|Overall Study|screen failures|3|||
130286852|NCT02275117|469012209|FG000|Overall Study|Adverse Event|0|||
130286853|NCT02275117|469012210|FG001|Overall Study|Adverse Event|0|||
130286854|NCT02275117|469012211|FG002|Overall Study|Adverse Event|0|||
130286855|NCT02275117|469012212|FG003|Overall Study|Adverse Event|0|||
130286856|NCT02275117|469012213|FG004|Overall Study|Adverse Event|1|||
130286857|NCT02275117|469012209|FG000|Overall Study|Lack of Efficacy|6|||
130286858|NCT02275117|469012210|FG001|Overall Study|Lack of Efficacy|7|||
130370117|NCT03716024|469325158|FG000|Overall Study|Adverse Event|1|||
130286859|NCT02275117|469012211|FG002|Overall Study|Lack of Efficacy|5|||
130286860|NCT02275117|469012212|FG003|Overall Study|Lack of Efficacy|2|||
130286861|NCT02275117|469012213|FG004|Overall Study|Lack of Efficacy|10|||
130370118|NCT03716024|469325159|FG001|Overall Study|Adverse Event|2|||
130370119|NCT03716024|469325158|FG000|Overall Study|Treatment Failure|1|||
130370120|NCT03716024|469325159|FG001|Overall Study|Treatment Failure|0|||
130370121|NCT03716024|469325158|FG000|Overall Study|Lost to Follow-up|2|||
130370122|NCT03716024|469325159|FG001|Overall Study|Lost to Follow-up|6|||
130370123|NCT03716024|469325158|FG000|Overall Study|Withdrawal by Subject|0|||
130370124|NCT03716024|469325159|FG001|Overall Study|Withdrawal by Subject|1|||
130370125|NCT03716024|469325158|FG000|Overall Study|Missing Reason|0|||
130370126|NCT03716024|469325159|FG001|Overall Study|Missing Reason|1|||
130370127|NCT00867568|469325160|FG000|Overall Study|Lack of Efficacy|10|||
130370128|NCT00867568|469325160|FG000|Overall Study|Adverse Event|4|||
130370129|NCT00867568|469325160|FG000|Overall Study|Withdrawal by Subject|1|||
130370130|NCT03648541|469325165|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
130370131|NCT03648541|469325166|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
130370132|NCT03648541|469325165|FG000|Re-induction Period Only|Lack of Efficacy|7|||
130370133|NCT03648541|469325166|FG001|Re-induction Period Only|Lack of Efficacy|0|||
130370134|NCT03648541|469325165|FG000|Maintenance Period Only|Missing|0|||
130370135|NCT03648541|469325166|FG001|Maintenance Period Only|Missing|1|||
130370136|NCT03648541|469325165|FG000|Maintenance Period Only|Other not listed below|0|||
130370137|NCT03648541|469325166|FG001|Maintenance Period Only|Other not listed below|4|||
130370138|NCT03648541|469325165|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
130370139|NCT03648541|469325166|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
130370140|NCT03648541|469325165|FG000|Maintenance Period Only|Protocol Violation|0|||
130370141|NCT03648541|469325166|FG001|Maintenance Period Only|Protocol Violation|1|||
130370142|NCT03648541|469325165|FG000|Maintenance Period Only|Lack of Efficacy|0|||
130370143|NCT03648541|469325166|FG001|Maintenance Period Only|Lack of Efficacy|18|||
130370144|NCT03648541|469325165|FG000|Maintenance Period Only|Adverse Event|0|||
130370145|NCT03648541|469325166|FG001|Maintenance Period Only|Adverse Event|4|||
130370146|NCT03648541|469325165|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
130370147|NCT03648541|469325166|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
130370148|NCT04623216|469325169|FG000|Overall Study|Death|5|||
130370149|NCT04623216|469325170|FG001|Overall Study|Death|2|||
130370150|NCT04623216|469325171|FG002|Overall Study|Death|0|||
130370151|NCT04623216|469325172|FG003|Overall Study|Death|0|||
130370152|NCT04623216|469325169|FG000|Overall Study|Terminated by Sponsor|3|||
130370153|NCT04623216|469325170|FG001|Overall Study|Terminated by Sponsor|2|||
130370154|NCT04623216|469325171|FG002|Overall Study|Terminated by Sponsor|2|||
130370155|NCT04623216|469325172|FG003|Overall Study|Terminated by Sponsor|0|||
130370156|NCT04623216|469325169|FG000|Overall Study|Physician Decision|1|||
130370157|NCT04623216|469325170|FG001|Overall Study|Physician Decision|0|||
130370158|NCT04623216|469325171|FG002|Overall Study|Physician Decision|0|||
130370159|NCT04623216|469325172|FG003|Overall Study|Physician Decision|0|||
130370160|NCT03600818|469325173|FG000|Overall Study|Adverse Event|4|||
130370161|NCT03600818|469325174|FG001|Overall Study|Adverse Event|7|||
130370162|NCT03600818|469325173|FG000|Overall Study|Lack of Efficacy|9|||
130370163|NCT03600818|469325174|FG001|Overall Study|Lack of Efficacy|4|||
130370164|NCT03600818|469325173|FG000|Overall Study|Withdrawal by Subject|4|||
130370165|NCT03600818|469325174|FG001|Overall Study|Withdrawal by Subject|3|||
130370166|NCT03600818|469325173|FG000|Overall Study|Other-unspecified|5|||
130370167|NCT03600818|469325174|FG001|Overall Study|Other-unspecified|3|||
130370168|NCT03600818|469325173|FG000|Overall Study|Randomized and not treated|0|||
130370169|NCT03600818|469325174|FG001|Overall Study|Randomized and not treated|1|||
130286862|NCT02275117|469012209|FG000|Overall Study|Lost to Follow-up|11|||
130286863|NCT02275117|469012210|FG001|Overall Study|Lost to Follow-up|16|||
130286864|NCT02275117|469012211|FG002|Overall Study|Lost to Follow-up|15|||
130370170|NCT04930965|469325178|FG000|Overall Study|Lost to Follow-up|7|||
130370171|NCT04930965|469325179|FG001|Overall Study|Lost to Follow-up|5|||
130370172|NCT01471171|469325182|FG000|Treatment Period 1|Adverse Event|4|||
130370173|NCT01471171|469325183|FG001|Treatment Period 1|Adverse Event|1|||
130286865|NCT02275117|469012212|FG003|Overall Study|Lost to Follow-up|16|||
130286866|NCT02275117|469012213|FG004|Overall Study|Lost to Follow-up|8|||
130286867|NCT02275117|469012209|FG000|Overall Study|Physician Decision|0|||
130286868|NCT02275117|469012210|FG001|Overall Study|Physician Decision|1|||
130286869|NCT02275117|469012211|FG002|Overall Study|Physician Decision|1|||
130286870|NCT02275117|469012212|FG003|Overall Study|Physician Decision|0|||
130286871|NCT02275117|469012213|FG004|Overall Study|Physician Decision|1|||
130286872|NCT02275117|469012209|FG000|Overall Study|Protocol Violation|1|||
130286873|NCT02275117|469012210|FG001|Overall Study|Protocol Violation|0|||
130286874|NCT02275117|469012211|FG002|Overall Study|Protocol Violation|1|||
130286875|NCT02275117|469012212|FG003|Overall Study|Protocol Violation|1|||
130286876|NCT02275117|469012213|FG004|Overall Study|Protocol Violation|0|||
130286877|NCT02275117|469012209|FG000|Overall Study|Withdrawal by Subject|6|||
130286878|NCT02275117|469012210|FG001|Overall Study|Withdrawal by Subject|4|||
130286879|NCT02275117|469012211|FG002|Overall Study|Withdrawal by Subject|7|||
130286880|NCT02275117|469012212|FG003|Overall Study|Withdrawal by Subject|3|||
130286881|NCT02275117|469012213|FG004|Overall Study|Withdrawal by Subject|3|||
130286882|NCT02275117|469012209|FG000|Overall Study|Terminated by Sponsor|4|||
130286883|NCT02275117|469012210|FG001|Overall Study|Terminated by Sponsor|4|||
130286884|NCT02275117|469012211|FG002|Overall Study|Terminated by Sponsor|4|||
130286885|NCT02275117|469012212|FG003|Overall Study|Terminated by Sponsor|6|||
130286886|NCT02275117|469012213|FG004|Overall Study|Terminated by Sponsor|4|||
130286887|NCT02275117|469012209|FG000|Overall Study|Worsening of Study Indication|0|||
130286888|NCT02275117|469012210|FG001|Overall Study|Worsening of Study Indication|1|||
130458987|NCT01212757|469643548|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
130458988|NCT02812966|469643549|FG000|Overall Study|Death|1|||
130458989|NCT02812966|469643550|FG001|Overall Study|Death|0|||
130458990|NCT00849147|469643551|FG000|Overall Study|Withdrawal by Subject|1|||
130458991|NCT00849147|469643551|FG000|Overall Study|Protocol Violation|2|||
130458992|NCT00849147|469643551|FG000|Overall Study|Disease Relapse/Progression|2|||
130458993|NCT01070888|469645174|FG000|First Intervention (14 Days)|Adverse Event|0|||
130458994|NCT01070888|469645175|FG001|First Intervention (14 Days)|Adverse Event|1|||
130458995|NCT01070888|469645174|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
130458996|NCT01070888|469645175|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
130458997|NCT01070888|469645174|FG000|Washout (14 Days)|Physician Decision|1|||
130458998|NCT01070888|469645175|FG001|Washout (14 Days)|Physician Decision|0|||
130458999|NCT02577523|469645179|FG000|Overall Study|Adverse Event|1|||
130459000|NCT02577523|469645180|FG001|Overall Study|Adverse Event|1|||
130459001|NCT02577523|469645179|FG000|Overall Study|Lack of Efficacy|1|||
130459002|NCT02577523|469645180|FG001|Overall Study|Lack of Efficacy|1|||
130459003|NCT02577523|469645179|FG000|Overall Study|Withdrawal by Subject|1|||
130459004|NCT02577523|469645180|FG001|Overall Study|Withdrawal by Subject|0|||
130459005|NCT00726999|469645182|FG000|Overall Study|Physician Decision|0|||
130459006|NCT00726999|469645183|FG001|Overall Study|Physician Decision|1|||
130459007|NCT00726999|469645182|FG000|Overall Study|Withdrawal by Subject|2|||
130459008|NCT00726999|469645183|FG001|Overall Study|Withdrawal by Subject|0|||
130459009|NCT00726999|469645182|FG000|Overall Study|Protocol Violation|1|||
130459010|NCT00726999|469645183|FG001|Overall Study|Protocol Violation|0|||
130459011|NCT00955825|469645184|FG000|Overall Study|Adverse Event|15|||
130459012|NCT00955825|469645185|FG001|Overall Study|Adverse Event|2|||
130459013|NCT00955825|469645184|FG000|Overall Study|Withdrawal by Subject|4|||
130459014|NCT00955825|469645185|FG001|Overall Study|Withdrawal by Subject|6|||
130459015|NCT00955825|469645184|FG000|Overall Study|Any other reason not above-mentioned|7|||
130459016|NCT00955825|469645185|FG001|Overall Study|Any other reason not above-mentioned|9|||
130459017|NCT02488980|469645186|FG000|Overall Study|Protocol Violation|2|||
130459018|NCT02488980|469645187|FG001|Overall Study|Protocol Violation|2|||
130459019|NCT02488980|469645188|FG002|Overall Study|Protocol Violation|2|||
130459020|NCT00738699|469645190|FG000|Overall Study|Withdrawal by Subject|5|||
130459021|NCT00738699|469645191|FG001|Overall Study|Withdrawal by Subject|0|||
130459022|NCT00738699|469645190|FG000|Overall Study|Lost to Follow-up|1|||
130459023|NCT00738699|469645191|FG001|Overall Study|Lost to Follow-up|0|||
130459024|NCT00738699|469645190|FG000|Overall Study|Death|144|||
130459025|NCT00738699|469645191|FG001|Overall Study|Death|68|||
130459026|NCT00738699|469645190|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
130286889|NCT02275117|469012211|FG002|Overall Study|Worsening of Study Indication|2|||
130286890|NCT02275117|469012212|FG003|Overall Study|Worsening of Study Indication|0|||
130286891|NCT02275117|469012213|FG004|Overall Study|Worsening of Study Indication|0|||
130286892|NCT02275117|469012209|FG000|Overall Study|Study Burden|5|||
130459027|NCT00738699|469645191|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
130459028|NCT00738699|469645190|FG000|Overall Study|Other|2|||
130459029|NCT00738699|469645191|FG001|Overall Study|Other|0|||
130459030|NCT00549848|469645192|FG000|Overall Study|Death|1|||
130459031|NCT00549848|469645193|FG001|Overall Study|Death|4|||
130459032|NCT00549848|469645194|FG002|Overall Study|Death|13|||
130459033|NCT00549848|469645192|FG000|Overall Study|Physician Decision|0|||
130459034|NCT00549848|469645193|FG001|Overall Study|Physician Decision|0|||
130286893|NCT02275117|469012210|FG001|Overall Study|Study Burden|4|||
130286894|NCT02275117|469012211|FG002|Overall Study|Study Burden|7|||
130555815|NCT02748018|470004433|FG003|Continuation Period|Withdrawal by Subject|9|||
130286895|NCT02275117|469012212|FG003|Overall Study|Study Burden|5|||
130286896|NCT02275117|469012213|FG004|Overall Study|Study Burden|7|||
130286897|NCT02275117|469012209|FG000|Overall Study|Other|1|||
130286898|NCT02275117|469012210|FG001|Overall Study|Other|0|||
130286899|NCT02275117|469012211|FG002|Overall Study|Other|0|||
130286900|NCT02275117|469012212|FG003|Overall Study|Other|0|||
130286901|NCT02275117|469012213|FG004|Overall Study|Other|2|||
130286902|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
130286903|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
130286904|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
130286905|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
130286906|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
130286907|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
130286908|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
130286909|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
130286910|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
130286911|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
130286912|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
130286913|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
130286914|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
130286915|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
130286916|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
130286917|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
130286918|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
130286919|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
130286920|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
130286921|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
130286922|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
130286923|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
130286924|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
130286925|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
130555816|NCT02748018|470004434|FG004|Continuation Period|Withdrawal by Subject|11|||
130555817|NCT02748018|470004435|FG005|Continuation Period|Withdrawal by Subject|1|||
130555818|NCT02748018|470004430|FG000|Continuation Period|Lost to Follow-up|0|||
130555819|NCT02748018|470004431|FG001|Continuation Period|Lost to Follow-up|2|||
130555820|NCT02748018|470004432|FG002|Continuation Period|Lost to Follow-up|1|||
130555821|NCT02748018|470004433|FG003|Continuation Period|Lost to Follow-up|0|||
130286926|NCT02142283|469012224|FG000|Overall Study|Death|20|||
130286927|NCT02142283|469012225|FG001|Overall Study|Death|18|||
130286928|NCT02142283|469012224|FG000|Overall Study|Withdrawal by Subject|1|||
130286929|NCT02142283|469012225|FG001|Overall Study|Withdrawal by Subject|3|||
130286930|NCT02460783|469012228|FG000|Overall Study|Withdrawal by Subject|1|||
130555822|NCT02748018|470004434|FG004|Continuation Period|Lost to Follow-up|1|||
130555823|NCT02748018|470004435|FG005|Continuation Period|Lost to Follow-up|0|||
130555824|NCT02748018|470004430|FG000|Continuation Period|Pregnancy|1|||
130555825|NCT02748018|470004431|FG001|Continuation Period|Pregnancy|2|||
130555826|NCT02748018|470004432|FG002|Continuation Period|Pregnancy|0|||
130555827|NCT02748018|470004433|FG003|Continuation Period|Pregnancy|0|||
130555828|NCT02748018|470004434|FG004|Continuation Period|Pregnancy|0|||
130555829|NCT02748018|470004435|FG005|Continuation Period|Pregnancy|0|||
130286931|NCT02460783|469012229|FG001|Overall Study|Withdrawal by Subject|3|||
130286932|NCT02460783|469012228|FG000|Overall Study|Lost to Follow-up|1|||
130286933|NCT02460783|469012229|FG001|Overall Study|Lost to Follow-up|1|||
130286934|NCT01646645|469012230|FG000|Overall Study|No Treated|1|||
130286935|NCT01646645|469012230|FG000|Overall Study|Inevaluable Donor|29|||
130286936|NCT02374814|469012236|FG000|Overall Study|Lost to Follow-up|1|||
130286937|NCT02374814|469012237|FG001|Overall Study|Lost to Follow-up|1|||
130286938|NCT02374814|469012238|FG002|Overall Study|Lost to Follow-up|0|||
130286939|NCT02374814|469012239|FG003|Overall Study|Lost to Follow-up|1|||
130286940|NCT02374814|469012240|FG004|Overall Study|Lost to Follow-up|0|||
130286941|NCT02374814|469012241|FG005|Overall Study|Lost to Follow-up|0|||
130286942|NCT02374814|469012236|FG000|Overall Study|Withdrawal by Subject|0|||
130286943|NCT02374814|469012237|FG001|Overall Study|Withdrawal by Subject|0|||
130286944|NCT02374814|469012238|FG002|Overall Study|Withdrawal by Subject|1|||
130286945|NCT02374814|469012239|FG003|Overall Study|Withdrawal by Subject|1|||
130555830|NCT02748018|470004430|FG000|Continuation Period|Physician Decision|0|||
130555831|NCT02748018|470004431|FG001|Continuation Period|Physician Decision|1|||
130555832|NCT02748018|470004432|FG002|Continuation Period|Physician Decision|2|||
130286946|NCT02374814|469012240|FG004|Overall Study|Withdrawal by Subject|0|||
130286947|NCT02374814|469012241|FG005|Overall Study|Withdrawal by Subject|0|||
130286948|NCT00884039|469012245|FG000|Overall Study|Withdrawal by Subject|0|||
130555833|NCT02748018|470004433|FG003|Continuation Period|Physician Decision|0|||
130555834|NCT02748018|470004434|FG004|Continuation Period|Physician Decision|2|||
130555835|NCT02748018|470004435|FG005|Continuation Period|Physician Decision|1|||
130555836|NCT02748018|470004430|FG000|Continuation Period|Protocol Violation|0|||
130555837|NCT02748018|470004431|FG001|Continuation Period|Protocol Violation|1|||
130555838|NCT02748018|470004432|FG002|Continuation Period|Protocol Violation|0|||
130555839|NCT02748018|470004433|FG003|Continuation Period|Protocol Violation|0|||
130555840|NCT02748018|470004434|FG004|Continuation Period|Protocol Violation|0|||
130555841|NCT02748018|470004435|FG005|Continuation Period|Protocol Violation|0|||
130555842|NCT00537485|470004436|FG000|Overall Study|Adverse Event|10|||
130555843|NCT00537485|470004437|FG001|Overall Study|Adverse Event|5|||
130555844|NCT00537485|470004436|FG000|Overall Study|Withdrawal by Subject|3|||
130555845|NCT00537485|470004437|FG001|Overall Study|Withdrawal by Subject|2|||
130555846|NCT00537485|470004436|FG000|Overall Study|Withdrawal by Subject|1|||
130555847|NCT00537485|470004437|FG001|Overall Study|Withdrawal by Subject|3|||
130555848|NCT00537485|470004436|FG000|Overall Study|Physician Decision|1|||
130555849|NCT00537485|470004437|FG001|Overall Study|Physician Decision|0|||
130555850|NCT00312221|470004440|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
130555851|NCT00312221|470004441|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130555852|NCT00312221|470004442|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130555853|NCT00312221|470004443|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
130555854|NCT00312221|470004440|FG000|Open-label Run-in Period|Adverse Event|74|||
130555855|NCT00312221|470004441|FG001|Open-label Run-in Period|Adverse Event|0|||
130555856|NCT00312221|470004442|FG002|Open-label Run-in Period|Adverse Event|0|||
130555857|NCT00312221|470004443|FG003|Open-label Run-in Period|Adverse Event|0|||
130555858|NCT00312221|470004440|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
130555859|NCT00312221|470004441|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130555860|NCT00312221|470004442|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130555861|NCT00312221|470004443|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
130555862|NCT00312221|470004440|FG000|Open-label Run-in Period|Administrative|42|||
130555863|NCT00312221|470004441|FG001|Open-label Run-in Period|Administrative|0|||
130555864|NCT00312221|470004442|FG002|Open-label Run-in Period|Administrative|0|||
130555865|NCT00312221|470004443|FG003|Open-label Run-in Period|Administrative|0|||
130555866|NCT00312221|470004440|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
130555867|NCT00312221|470004441|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130555868|NCT00312221|470004442|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130555869|NCT00312221|470004443|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
130555870|NCT00312221|470004440|FG000|Open-label Run-in Period|Did not qualify|5|||
130555871|NCT00312221|470004441|FG001|Open-label Run-in Period|Did not qualify|0|||
130555872|NCT00312221|470004442|FG002|Open-label Run-in Period|Did not qualify|0|||
130555873|NCT00312221|470004443|FG003|Open-label Run-in Period|Did not qualify|0|||
130555874|NCT00312221|470004440|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130555875|NCT00312221|470004441|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130555876|NCT00312221|470004442|FG002|Double-blind Phase|Withdrawal by Subject|8|||
130555877|NCT00312221|470004443|FG003|Double-blind Phase|Withdrawal by Subject|7|||
130555878|NCT00312221|470004440|FG000|Double-blind Phase|Adverse Event|0|||
130555879|NCT00312221|470004441|FG001|Double-blind Phase|Adverse Event|10|||
130555880|NCT00312221|470004442|FG002|Double-blind Phase|Adverse Event|19|||
130555881|NCT00312221|470004443|FG003|Double-blind Phase|Adverse Event|18|||
130555882|NCT00312221|470004440|FG000|Double-blind Phase|Lost to Follow-up|0|||
130555883|NCT00312221|470004441|FG001|Double-blind Phase|Lost to Follow-up|0|||
130555884|NCT00312221|470004442|FG002|Double-blind Phase|Lost to Follow-up|2|||
130555885|NCT00312221|470004443|FG003|Double-blind Phase|Lost to Follow-up|2|||
130555886|NCT00312221|470004440|FG000|Double-blind Phase|Administrative|0|||
130555887|NCT00312221|470004441|FG001|Double-blind Phase|Administrative|26|||
130555888|NCT00312221|470004442|FG002|Double-blind Phase|Administrative|37|||
130555889|NCT00312221|470004443|FG003|Double-blind Phase|Administrative|33|||
130555890|NCT00312221|470004440|FG000|Double-blind Phase|Lack of Efficacy|0|||
130555891|NCT00312221|470004441|FG001|Double-blind Phase|Lack of Efficacy|17|||
130555892|NCT00312221|470004442|FG002|Double-blind Phase|Lack of Efficacy|6|||
130555893|NCT00312221|470004443|FG003|Double-blind Phase|Lack of Efficacy|10|||
130555894|NCT01003990|470004444|FG000|Overall Study|Adverse Event|8|||
130555895|NCT01003990|470004445|FG001|Overall Study|Adverse Event|5|||
130555896|NCT01003990|470004446|FG002|Overall Study|Adverse Event|11|||
130555897|NCT01003990|470004444|FG000|Overall Study|Death|0|||
130555898|NCT01003990|470004445|FG001|Overall Study|Death|8|||
130555899|NCT01003990|470004446|FG002|Overall Study|Death|1|||
130555900|NCT01003990|470004444|FG000|Overall Study|Lack of Efficacy|10|||
130555901|NCT01003990|470004445|FG001|Overall Study|Lack of Efficacy|2|||
130555902|NCT01003990|470004446|FG002|Overall Study|Lack of Efficacy|3|||
130555903|NCT01003990|470004444|FG000|Overall Study|Lost to Follow-up|30|||
130555904|NCT01003990|470004445|FG001|Overall Study|Lost to Follow-up|12|||
130555905|NCT01003990|470004446|FG002|Overall Study|Lost to Follow-up|7|||
130555906|NCT01003990|470004444|FG000|Overall Study|Reasons Not Identified|14|||
130555907|NCT01003990|470004445|FG001|Overall Study|Reasons Not Identified|13|||
130555908|NCT01003990|470004446|FG002|Overall Study|Reasons Not Identified|8|||
130555909|NCT01003990|470004444|FG000|Overall Study|Poor/Non-compliance|4|||
130286949|NCT00884039|469012246|FG001|Overall Study|Withdrawal by Subject|1|||
130286950|NCT00884039|469012245|FG000|Overall Study|Lack of Efficacy|2|||
130286951|NCT00884039|469012246|FG001|Overall Study|Lack of Efficacy|0|||
130286952|NCT00624819|469012249|FG000|Follow-up Period: Year 4|Parents decision|0|||
130286953|NCT00624819|469012250|FG001|Follow-up Period: Year 4|Parents decision|0|||
130286954|NCT00624819|469012251|FG002|Follow-up Period: Year 4|Parents decision|1|||
130286955|NCT00624819|469012252|FG003|Follow-up Period: Year 4|Parents decision|0|||
130286956|NCT00624819|469012249|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
130286957|NCT00624819|469012250|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
130286958|NCT00624819|469012251|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
130286959|NCT00624819|469012252|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
130286960|NCT00405964|469012257|FG000|Overall Study|Treatment Failure|17|||
130370174|NCT01471171|469325182|FG000|Treatment Period 2|Adverse Event|1|||
130370175|NCT01471171|469325183|FG001|Treatment Period 2|Adverse Event|0|||
130370176|NCT03478930|469325184|FG000|Overall Study|Adverse Event|0|||
130370177|NCT03478930|469325185|FG001|Overall Study|Adverse Event|1|||
130370178|NCT03478930|469325184|FG000|Overall Study|Lack of Efficacy|3|||
130370179|NCT03478930|469325185|FG001|Overall Study|Lack of Efficacy|3|||
130370180|NCT03478930|469325184|FG000|Overall Study|Withdrawal by Subject|6|||
130370181|NCT03478930|469325185|FG001|Overall Study|Withdrawal by Subject|5|||
130370182|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
130370183|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
130370184|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
130370185|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
130370186|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
130370187|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
130370188|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
130370189|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
130370190|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
130370191|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
130370192|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
130370193|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
130370194|NCT00044083|469325186|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
130370195|NCT00044083|469325187|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
130370196|NCT00044083|469325186|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
130370197|NCT00044083|469325187|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
130370198|NCT00044083|469325186|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
130370199|NCT00044083|469325187|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
130370200|NCT00044083|469325186|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
130370201|NCT00044083|469325187|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
130370202|NCT00705484|469325192|FG000|Overall Study|Adverse Event|28|||
130370203|NCT00705484|469325193|FG001|Overall Study|Adverse Event|27|||
130370204|NCT00705484|469325192|FG000|Overall Study|Lost to Follow-up|169|||
130370205|NCT00705484|469325193|FG001|Overall Study|Lost to Follow-up|250|||
130370206|NCT00705484|469325192|FG000|Overall Study|Withdrawal by Subject|96|||
130370207|NCT00705484|469325193|FG001|Overall Study|Withdrawal by Subject|72|||
130370208|NCT00705484|469325192|FG000|Overall Study|Administrative|89|||
130370209|NCT00705484|469325193|FG001|Overall Study|Administrative|59|||
130370210|NCT02340975|469325195|FG000|Overall Study|Death|6|||
130370211|NCT02340975|469325196|FG001|Overall Study|Death|23|||
130370212|NCT02340975|469325197|FG002|Overall Study|Death|21|||
130370213|NCT02340975|469325198|FG003|Overall Study|Death|7|||
130370214|NCT02340975|469325199|FG004|Overall Study|Death|21|||
130370215|NCT02340975|469325200|FG005|Overall Study|Death|13|||
130370216|NCT02340975|469325195|FG000|Overall Study|Lost to Follow-up|0|||
130370217|NCT02340975|469325196|FG001|Overall Study|Lost to Follow-up|0|||
130370218|NCT02340975|469325197|FG002|Overall Study|Lost to Follow-up|0|||
130370219|NCT02340975|469325198|FG003|Overall Study|Lost to Follow-up|0|||
130370220|NCT02340975|469325199|FG004|Overall Study|Lost to Follow-up|2|||
130370221|NCT02340975|469325200|FG005|Overall Study|Lost to Follow-up|0|||
130370222|NCT02340975|469325195|FG000|Overall Study|Withdrawal by Subject|0|||
130370223|NCT02340975|469325196|FG001|Overall Study|Withdrawal by Subject|0|||
130370224|NCT02340975|469325197|FG002|Overall Study|Withdrawal by Subject|3|||
130370225|NCT02340975|469325198|FG003|Overall Study|Withdrawal by Subject|3|||
130370226|NCT02340975|469325199|FG004|Overall Study|Withdrawal by Subject|2|||
130370227|NCT02340975|469325200|FG005|Overall Study|Withdrawal by Subject|0|||
130370228|NCT02340975|469325195|FG000|Overall Study|Other|0|||
130370229|NCT02340975|469325196|FG001|Overall Study|Other|4|||
130370230|NCT02340975|469325197|FG002|Overall Study|Other|0|||
130370231|NCT02340975|469325198|FG003|Overall Study|Other|2|||
130370232|NCT02340975|469325199|FG004|Overall Study|Other|0|||
130370233|NCT02340975|469325200|FG005|Overall Study|Other|6|||
130459035|NCT00549848|469645194|FG002|Overall Study|Physician Decision|4|||
130459036|NCT00549848|469645192|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
130370234|NCT02228460|469325203|FG000|Overall Study|Adverse Event|1|||
130370235|NCT02228460|469325203|FG000|Overall Study|Lost to Follow-up|1|||
130370236|NCT01243892|469325204|FG000|Overall Study|Did not meet eligibility criteria|2|||
130370237|NCT01243892|469325205|FG001|Overall Study|Did not meet eligibility criteria|0|||
130370238|NCT00119106|469325206|FG000|Overall Study|HIV infected at baseline|179|||
130370239|NCT00119106|469325207|FG001|Overall Study|HIV infected at baseline|178|||
130459037|NCT00549848|469645193|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
130459038|NCT00549848|469645194|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
130459039|NCT00549848|469645192|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
130459040|NCT00549848|469645193|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
130459041|NCT00549848|469645194|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
130459042|NCT00549848|469645192|FG000|Overall Study|Participant/Family Withdraw|2|||
130459043|NCT00549848|469645193|FG001|Overall Study|Participant/Family Withdraw|3|||
130459044|NCT00549848|469645194|FG002|Overall Study|Participant/Family Withdraw|5|||
130459045|NCT00549848|469645192|FG000|Overall Study|Second Malignancy|1|||
130459046|NCT00549848|469645193|FG001|Overall Study|Second Malignancy|0|||
130459047|NCT00549848|469645194|FG002|Overall Study|Second Malignancy|0|||
130459048|NCT00549848|469645192|FG000|Overall Study|Transplant|3|||
130459049|NCT00549848|469645193|FG001|Overall Study|Transplant|3|||
130459050|NCT00549848|469645194|FG002|Overall Study|Transplant|18|||
130459051|NCT00549848|469645192|FG000|Overall Study|Unacceptable Toxicity|1|||
130459052|NCT00549848|469645193|FG001|Overall Study|Unacceptable Toxicity|6|||
130459053|NCT00549848|469645194|FG002|Overall Study|Unacceptable Toxicity|6|||
130459054|NCT00419094|469645197|FG000|Overall Study|Adverse Event|3|||
130459055|NCT00419094|469645198|FG001|Overall Study|Adverse Event|7|||
130459056|NCT00419094|469645197|FG000|Overall Study|Lack of Efficacy|1|||
130459057|NCT00419094|469645198|FG001|Overall Study|Lack of Efficacy|0|||
130459058|NCT00419094|469645197|FG000|Overall Study|Lost to Follow-up|0|||
130459059|NCT00419094|469645198|FG001|Overall Study|Lost to Follow-up|2|||
130459060|NCT00419094|469645197|FG000|Overall Study|Protocol Violation|1|||
130459061|NCT00419094|469645198|FG001|Overall Study|Protocol Violation|14|||
130459062|NCT00419094|469645197|FG000|Overall Study|Withdrawal of consent|1|||
130459063|NCT00419094|469645198|FG001|Overall Study|Withdrawal of consent|5|||
130459064|NCT00419094|469645197|FG000|Overall Study|Other: Error determining exit criteria|1|||
130459065|NCT00419094|469645198|FG001|Overall Study|Other: Error determining exit criteria|0|||
130459066|NCT00419094|469645197|FG000|Overall Study|Other: Patient non-compliant|0|||
130459067|NCT00419094|469645198|FG001|Overall Study|Other: Patient non-compliant|1|||
130459068|NCT00419094|469645197|FG000|Overall Study|Other: No contact for extended period|0|||
130459069|NCT00419094|469645198|FG001|Overall Study|Other: No contact for extended period|1|||
130459070|NCT03262935|469645199|FG000|Overall Study|Withdrawal by Subject|6|||
130459071|NCT03262935|469645200|FG001|Overall Study|Withdrawal by Subject|7|||
130459072|NCT03262935|469645199|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
130459073|NCT03262935|469645200|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
130459074|NCT03262935|469645199|FG000|Overall Study|Death|181|||
130459075|NCT03262935|469645200|FG001|Overall Study|Death|94|||
130459076|NCT03262935|469645199|FG000|Overall Study|Lost to Follow-up|9|||
130370240|NCT03066804|469325208|FG000|Overall Study|Physician Decision|0|||
130370241|NCT03066804|469325209|FG001|Overall Study|Physician Decision|4|||
130370242|NCT03066804|469325208|FG000|Overall Study|Death|23|||
130370243|NCT03066804|469325209|FG001|Overall Study|Death|17|||
130370244|NCT03066804|469325208|FG000|Overall Study|Withdrawal by Subject|19|||
130370245|NCT03066804|469325209|FG001|Overall Study|Withdrawal by Subject|25|||
130370246|NCT03066804|469325208|FG000|Overall Study|Lost to Follow-up|2|||
130370247|NCT03066804|469325209|FG001|Overall Study|Lost to Follow-up|0|||
130370248|NCT03066804|469325208|FG000|Overall Study|Adverse Event|2|||
130370249|NCT03066804|469325209|FG001|Overall Study|Adverse Event|3|||
130370250|NCT03066804|469325208|FG000|Overall Study|Technical problems|5|||
130370251|NCT03066804|469325209|FG001|Overall Study|Technical problems|1|||
130370252|NCT03982368|469325217|FG000|Overall Study|Adverse Event|6|||
130370253|NCT03982368|469325218|FG001|Overall Study|Adverse Event|4|||
130459077|NCT03262935|469645200|FG001|Overall Study|Lost to Follow-up|4|||
130459078|NCT03262935|469645199|FG000|Overall Study|Other reason|5|||
130370254|NCT03982368|469325219|FG002|Overall Study|Adverse Event|3|||
130370255|NCT03982368|469325217|FG000|Overall Study|Lost to Follow-up|2|||
130370256|NCT03982368|469325218|FG001|Overall Study|Lost to Follow-up|1|||
130459079|NCT03262935|469645200|FG001|Overall Study|Other reason|0|||
130459080|NCT01811706|469645201|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
130459081|NCT01811706|469645202|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
130370257|NCT03982368|469325219|FG002|Overall Study|Lost to Follow-up|0|||
130370258|NCT03982368|469325217|FG000|Overall Study|Withdrawal by Subject|1|||
130370259|NCT03982368|469325218|FG001|Overall Study|Withdrawal by Subject|2|||
130370260|NCT03982368|469325219|FG002|Overall Study|Withdrawal by Subject|0|||
130370261|NCT03982368|469325217|FG000|Overall Study|unknow|4|||
130370262|NCT03982368|469325218|FG001|Overall Study|unknow|0|||
130370263|NCT03982368|469325219|FG002|Overall Study|unknow|2|||
130370264|NCT00329238|469325220|FG000|Overall Study|Adverse Event|147|||
130370265|NCT00329238|469325221|FG001|Overall Study|Adverse Event|129|||
130370266|NCT00329238|469325220|FG000|Overall Study|Protocol Violation|23|||
130370267|NCT00329238|469325221|FG001|Overall Study|Protocol Violation|34|||
130370268|NCT00329238|469325220|FG000|Overall Study|Lost to Follow-up|2|||
130370269|NCT00329238|469325221|FG001|Overall Study|Lost to Follow-up|6|||
130370270|NCT00329238|469325220|FG000|Overall Study|Withdrawal by Subject|64|||
130370271|NCT00329238|469325221|FG001|Overall Study|Withdrawal by Subject|58|||
130370272|NCT00329238|469325220|FG000|Overall Study|Other reason (not specified)|40|||
130370273|NCT00329238|469325221|FG001|Overall Study|Other reason (not specified)|54|||
130370274|NCT03087643|469325224|FG000|Overall Study|Withdrawal by Subject|2|||
130370275|NCT03087643|469325225|FG001|Overall Study|Withdrawal by Subject|4|||
130370276|NCT03087643|469325224|FG000|Overall Study|Death|2|||
130370277|NCT03087643|469325225|FG001|Overall Study|Death|2|||
130370278|NCT02083783|469325226|FG000|Overall Study|Withdrawal by Subject|1|||
130370279|NCT02083783|469325227|FG001|Overall Study|Withdrawal by Subject|0|||
130370280|NCT01546883|469325228|FG000|Overall Study|Withdrawal by Subject|3|||
130370281|NCT01546883|469325228|FG000|Overall Study|Adverse Event|4|||
130370282|NCT01546883|469325228|FG000|Overall Study|Lost to Follow-up|2|||
130370283|NCT01546883|469325228|FG000|Overall Study|early closure of study|2|||
130370284|NCT01546883|469325228|FG000|Overall Study|other unrelated illness|1|||
130370285|NCT02256631|469325232|FG000|Overall Study|Lost to Follow-up|1|||
130370286|NCT02256631|469325233|FG001|Overall Study|Lost to Follow-up|1|||
130370287|NCT02256631|469325234|FG002|Overall Study|Lost to Follow-up|0|||
130370288|NCT02256631|469325235|FG003|Overall Study|Lost to Follow-up|2|||
130370289|NCT02256631|469325236|FG004|Overall Study|Lost to Follow-up|0|||
130370290|NCT02256631|469325237|FG005|Overall Study|Lost to Follow-up|4|||
130370291|NCT02256631|469325238|FG006|Overall Study|Lost to Follow-up|1|||
130370292|NCT02256631|469325232|FG000|Overall Study|Withdrawal by Subject|0|||
130370293|NCT02256631|469325233|FG001|Overall Study|Withdrawal by Subject|0|||
130370294|NCT02256631|469325234|FG002|Overall Study|Withdrawal by Subject|0|||
130370295|NCT02256631|469325235|FG003|Overall Study|Withdrawal by Subject|1|||
130370296|NCT02256631|469325236|FG004|Overall Study|Withdrawal by Subject|1|||
130370297|NCT02256631|469325237|FG005|Overall Study|Withdrawal by Subject|0|||
130370298|NCT02256631|469325238|FG006|Overall Study|Withdrawal by Subject|1|||
130370299|NCT02256631|469325232|FG000|Overall Study|Unable to get to clinic|0|||
130370300|NCT02256631|469325233|FG001|Overall Study|Unable to get to clinic|2|||
130370301|NCT02256631|469325234|FG002|Overall Study|Unable to get to clinic|0|||
130370302|NCT02256631|469325235|FG003|Overall Study|Unable to get to clinic|1|||
130370303|NCT02256631|469325236|FG004|Overall Study|Unable to get to clinic|0|||
130370304|NCT02256631|469325237|FG005|Overall Study|Unable to get to clinic|1|||
130370305|NCT02256631|469325238|FG006|Overall Study|Unable to get to clinic|2|||
130370306|NCT00361569|469325242|FG000|Overall Study|Protocol Violation|3|||
130370307|NCT00361569|469325243|FG001|Overall Study|Protocol Violation|2|||
130370308|NCT00361569|469325244|FG002|Overall Study|Protocol Violation|4|||
130370309|NCT00361569|469325245|FG003|Overall Study|Protocol Violation|2|||
130370310|NCT00361569|469325242|FG000|Overall Study|Withdrawal by Subject|2|||
130370311|NCT00361569|469325243|FG001|Overall Study|Withdrawal by Subject|1|||
130370312|NCT00361569|469325244|FG002|Overall Study|Withdrawal by Subject|9|||
130370313|NCT00361569|469325245|FG003|Overall Study|Withdrawal by Subject|14|||
130370314|NCT00361569|469325242|FG000|Overall Study|Adverse Event|3|||
130370315|NCT00361569|469325243|FG001|Overall Study|Adverse Event|5|||
130370316|NCT00361569|469325244|FG002|Overall Study|Adverse Event|2|||
130370317|NCT00361569|469325245|FG003|Overall Study|Adverse Event|2|||
130370318|NCT00361569|469325242|FG000|Overall Study|Lost to Follow-up|2|||
130370319|NCT00361569|469325243|FG001|Overall Study|Lost to Follow-up|3|||
130370320|NCT00361569|469325244|FG002|Overall Study|Lost to Follow-up|3|||
130370321|NCT00361569|469325245|FG003|Overall Study|Lost to Follow-up|2|||
130370322|NCT00361569|469325242|FG000|Overall Study|Not specified by investigator|2|||
130370323|NCT00361569|469325243|FG001|Overall Study|Not specified by investigator|0|||
130370324|NCT00361569|469325244|FG002|Overall Study|Not specified by investigator|0|||
130370325|NCT00361569|469325245|FG003|Overall Study|Not specified by investigator|1|||
130370326|NCT02639065|469325246|FG000|Study Treatment|Disease Progression|13|||
130712276|NCT01843348|470571842|FG002|Overall Study|Withdrawal by Subject|18|||
130712277|NCT01843348|470571840|FG000|Overall Study|Lost to Follow-up|5|||
130712278|NCT01843348|470571841|FG001|Overall Study|Lost to Follow-up|4|||
130370327|NCT02639065|469325246|FG000|Study Treatment|Adverse Event|9|||
130370328|NCT02639065|469325246|FG000|Study Treatment|Withdrawal by Subject|1|||
130370329|NCT02639065|469325246|FG000|Follow up|Subject refused to follow up|1|||
130555910|NCT01003990|470004445|FG001|Overall Study|Poor/Non-compliance|3|||
130370330|NCT02639065|469325246|FG000|Follow up|Symptomatic Deterioration|2|||
130370331|NCT02639065|469325246|FG000|Follow up|Death|2|||
130370332|NCT02639065|469325246|FG000|Follow up|Study Terminated|1|||
130712279|NCT01843348|470571842|FG002|Overall Study|Lost to Follow-up|2|||
130712280|NCT01843348|470571840|FG000|Overall Study|Death|5|||
130286961|NCT00405964|469012258|FG001|Overall Study|Treatment Failure|45|||
130286962|NCT00405964|469012257|FG000|Overall Study|Adverse Event|7|||
130286963|NCT00405964|469012258|FG001|Overall Study|Adverse Event|16|||
130286964|NCT00405964|469012257|FG000|Overall Study|Lost to Follow-up|5|||
130286965|NCT00405964|469012258|FG001|Overall Study|Lost to Follow-up|5|||
130286966|NCT00405964|469012257|FG000|Overall Study|Withdrawal by Subject|19|||
130286967|NCT00405964|469012258|FG001|Overall Study|Withdrawal by Subject|23|||
130286968|NCT00405964|469012257|FG000|Overall Study|Protocol Violation|11|||
130286969|NCT00405964|469012258|FG001|Overall Study|Protocol Violation|6|||
130286970|NCT02981407|469012264|FG000|Overall Study|Withdrawal by Subject|2|||
130286971|NCT02981407|469012265|FG001|Overall Study|Withdrawal by Subject|0|||
130712281|NCT01843348|470571841|FG001|Overall Study|Death|3|||
130712282|NCT01843348|470571842|FG002|Overall Study|Death|4|||
130286972|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
130286973|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130286974|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
130286975|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
130459082|NCT02224924|469645203|FG000|Overall Study|Withdrawal by Subject|7|||
130712283|NCT01843348|470571840|FG000|Overall Study|Graft loss/retransplantation|5|||
130712284|NCT01843348|470571841|FG001|Overall Study|Graft loss/retransplantation|8|||
130712285|NCT01843348|470571842|FG002|Overall Study|Graft loss/retransplantation|11|||
130712286|NCT01843348|470571840|FG000|Overall Study|Various reasons|4|||
130712287|NCT01843348|470571841|FG001|Overall Study|Various reasons|9|||
130712288|NCT01843348|470571842|FG002|Overall Study|Various reasons|6|||
130712289|NCT02039414|470571849|FG000|Overall Study|Delivered|1|||
130712290|NCT02039414|470571850|FG001|Overall Study|Delivered|1|||
130712291|NCT02039414|470571849|FG000|Overall Study|Lost to Follow-up|2|||
130712292|NCT02039414|470571850|FG001|Overall Study|Lost to Follow-up|0|||
130712293|NCT02039414|470571849|FG000|Overall Study|Protocol Violation|3|||
130712294|NCT02039414|470571850|FG001|Overall Study|Protocol Violation|1|||
130712295|NCT03977701|470571853|FG000|Overall Study|COVID-19 pandemic|0|||
130712296|NCT03977701|470571854|FG001|Overall Study|COVID-19 pandemic|0|||
130712297|NCT03977701|470571855|FG002|Overall Study|COVID-19 pandemic|0|||
130712298|NCT03977701|470571856|FG003|Overall Study|COVID-19 pandemic|0|||
130712299|NCT03977701|470571857|FG004|Overall Study|COVID-19 pandemic|0|||
130712300|NCT03977701|470571858|FG005|Overall Study|COVID-19 pandemic|1|||
130712301|NCT03977701|470571859|FG006|Overall Study|COVID-19 pandemic|0|||
130712302|NCT03977701|470571860|FG007|Overall Study|COVID-19 pandemic|1|||
130286976|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
130286977|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130286978|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130286979|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
130286980|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
130286981|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130286982|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
130286983|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
130286984|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130286985|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130286986|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130286987|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130286988|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130286989|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130286990|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130286991|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
130286992|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
130286993|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130286994|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130286995|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130286996|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
130286997|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
130286998|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
130286999|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
130287000|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
130287001|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
130287002|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130712303|NCT03977701|470571861|FG008|Overall Study|COVID-19 pandemic|0|||
130712304|NCT03977701|470571862|FG009|Overall Study|COVID-19 pandemic|0|||
130712305|NCT00869024|470571863|FG000|Overall Study|Death|2|||
130712306|NCT00869024|470571864|FG001|Overall Study|Death|3|||
130712307|NCT00869024|470571863|FG000|Overall Study|Lost to Follow-up|0|||
130712308|NCT00869024|470571864|FG001|Overall Study|Lost to Follow-up|1|||
130712309|NCT00869024|470571863|FG000|Overall Study|Protocol Violation|0|||
130712310|NCT00869024|470571864|FG001|Overall Study|Protocol Violation|1|||
130712311|NCT00831623|470571869|FG000|Overall Study|Withdrawal by Subject|9|||
130712312|NCT00831623|470571869|FG000|Overall Study|Lost to Follow-up|1|||
130712313|NCT00831623|470571869|FG000|Overall Study|Not 2 years post-treatment|12|||
130712314|NCT00653991|470571872|FG000|3 Month Follow-up|Participant would not respond|150|||
130712315|NCT00653991|470571873|FG001|3 Month Follow-up|Participant would not respond|157|||
130712316|NCT00653991|470571872|FG000|6 Month Follow-up|Participant would not respond|133|||
130459083|NCT02224924|469645204|FG001|Overall Study|Withdrawal by Subject|6|||
130459084|NCT02224924|469645203|FG000|Overall Study|Biopsy cancelled|20|||
130459085|NCT02224924|469645204|FG001|Overall Study|Biopsy cancelled|14|||
130459086|NCT02224924|469645203|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
130459087|NCT02224924|469645204|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
130459088|NCT02224924|469645203|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
130459089|NCT02224924|469645204|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
130459090|NCT03020745|469645205|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459091|NCT03020745|469645206|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459092|NCT03020745|469645207|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459093|NCT03020745|469645208|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459094|NCT03020745|469645209|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459095|NCT03020745|469645210|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459096|NCT03020745|469645211|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459097|NCT03020745|469645212|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459098|NCT03020745|469645213|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
130459099|NCT03020745|469645214|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
130459100|NCT03020745|469645205|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459101|NCT03020745|469645206|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459102|NCT03020745|469645207|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459103|NCT03020745|469645208|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459104|NCT03020745|469645209|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459105|NCT03020745|469645210|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459106|NCT03020745|469645211|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459107|NCT03020745|469645212|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
130459108|NCT03020745|469645213|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459109|NCT03020745|469645214|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
130459110|NCT03020745|469645205|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459111|NCT03020745|469645206|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459112|NCT03020745|469645207|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459113|NCT03020745|469645208|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459114|NCT03020745|469645209|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459115|NCT03020745|469645210|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
130459116|NCT03020745|469645211|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459117|NCT03020745|469645212|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459118|NCT03020745|469645213|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
130459119|NCT03020745|469645214|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
130459120|NCT03020745|469645205|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459121|NCT03020745|469645206|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130712317|NCT00653991|470571873|FG001|6 Month Follow-up|Participant would not respond|141|||
130712318|NCT02939014|470571876|FG000|Overall Study|Lost to Follow-up|1|||
130459122|NCT03020745|469645207|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459123|NCT03020745|469645208|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459124|NCT03020745|469645209|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459125|NCT03020745|469645210|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459126|NCT03020745|469645211|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459127|NCT03020745|469645212|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459128|NCT03020745|469645213|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
130459129|NCT03020745|469645214|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
130459130|NCT03823300|469645219|FG000|Overall Study|Withdrawal by Subject|16|||
130459131|NCT03823300|469645220|FG001|Overall Study|Withdrawal by Subject|22|||
130459132|NCT03823300|469645219|FG000|Overall Study|Death|10|||
130459133|NCT03823300|469645220|FG001|Overall Study|Death|14|||
130459134|NCT03823300|469645219|FG000|Overall Study|Adverse Event|3|||
130555911|NCT01003990|470004446|FG002|Overall Study|Poor/Non-compliance|2|||
130555912|NCT01003990|470004444|FG000|Overall Study|Pregnancy|10|||
130555913|NCT01003990|470004445|FG001|Overall Study|Pregnancy|2|||
130555914|NCT01003990|470004446|FG002|Overall Study|Pregnancy|4|||
130712319|NCT02939014|470571877|FG001|Overall Study|Lost to Follow-up|0|||
130712320|NCT02939014|470571876|FG000|Overall Study|Death|4|||
130712321|NCT02939014|470571877|FG001|Overall Study|Death|3|||
130712322|NCT03864042|470571878|FG000|DDI Phase|Adverse Event|2|||
130555915|NCT01003990|470004444|FG000|Overall Study|No Longer Met Study Criteria|4|||
130712323|NCT03864042|470571879|FG001|DDI Phase|Adverse Event|0|||
130712324|NCT03864042|470571880|FG002|DDI Phase|Adverse Event|0|||
130712325|NCT03864042|470571878|FG000|DDI Phase|Physician Decision|1|||
130712326|NCT03864042|470571879|FG001|DDI Phase|Physician Decision|0|||
130712327|NCT03864042|470571880|FG002|DDI Phase|Physician Decision|0|||
130712328|NCT03864042|470571878|FG000|DDI Phase|Progressive Disease|1|||
130712329|NCT03864042|470571879|FG001|DDI Phase|Progressive Disease|0|||
130712330|NCT03864042|470571880|FG002|DDI Phase|Progressive Disease|0|||
130712331|NCT03864042|470571878|FG000|Post-DDI Phase|Adverse Event|5|||
130712332|NCT03864042|470571879|FG001|Post-DDI Phase|Adverse Event|3|||
130712333|NCT03864042|470571880|FG002|Post-DDI Phase|Adverse Event|2|||
130712334|NCT03864042|470571878|FG000|Post-DDI Phase|Progressive Disease|11|||
130712335|NCT03864042|470571879|FG001|Post-DDI Phase|Progressive Disease|6|||
130712336|NCT03864042|470571880|FG002|Post-DDI Phase|Progressive Disease|13|||
130712337|NCT03864042|470571878|FG000|Post-DDI Phase|Discretion of investigator|1|||
130712338|NCT03864042|470571879|FG001|Post-DDI Phase|Discretion of investigator|1|||
130712339|NCT03864042|470571880|FG002|Post-DDI Phase|Discretion of investigator|0|||
130712340|NCT03864042|470571878|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
130712341|NCT03864042|470571879|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
130712342|NCT03864042|470571880|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
130712343|NCT03864042|470571878|FG000|Post-DDI Phase|Withdrawal of consent|1|||
130712344|NCT03864042|470571879|FG001|Post-DDI Phase|Withdrawal of consent|2|||
130712345|NCT03864042|470571880|FG002|Post-DDI Phase|Withdrawal of consent|0|||
130712346|NCT02220725|470571881|FG000|Overall Study|Lost to Follow-up|0|||
130712347|NCT02220725|470571882|FG001|Overall Study|Lost to Follow-up|0|||
130712348|NCT02220725|470571883|FG002|Overall Study|Lost to Follow-up|0|||
130712349|NCT02220725|470571884|FG003|Overall Study|Lost to Follow-up|1|||
130712350|NCT02220725|470571881|FG000|Overall Study|Withdrawal by Subject|0|||
130712351|NCT02220725|470571882|FG001|Overall Study|Withdrawal by Subject|0|||
130712352|NCT02220725|470571883|FG002|Overall Study|Withdrawal by Subject|0|||
130555916|NCT01003990|470004445|FG001|Overall Study|No Longer Met Study Criteria|1|||
130555917|NCT01003990|470004446|FG002|Overall Study|No Longer Met Study Criteria|0|||
130555918|NCT01003990|470004444|FG000|Overall Study|Subject Withdrew Consent|12|||
130712353|NCT02220725|470571884|FG003|Overall Study|Withdrawal by Subject|1|||
130712354|NCT02340221|470571887|FG000|Overall Study|Death|100|||
130555919|NCT01003990|470004445|FG001|Overall Study|Subject Withdrew Consent|5|||
130555920|NCT01003990|470004446|FG002|Overall Study|Subject Withdrew Consent|7|||
130555921|NCT03690141|470004447|FG000|Overall Study|Adverse Event|5|||
130555922|NCT03690141|470004447|FG000|Overall Study|Withdrawal by Subject|3|||
130555923|NCT03690141|470004447|FG000|Overall Study|Physician Decision|4|||
130555924|NCT03690141|470004447|FG000|Overall Study|Disease progression|4|||
130555925|NCT01807923|470004448|FG000|Overall Study|Adverse Event|2|||
130555926|NCT01807923|470004449|FG001|Overall Study|Adverse Event|1|||
130555927|NCT01807923|470004450|FG002|Overall Study|Adverse Event|2|||
130555928|NCT01807923|470004448|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130555929|NCT01807923|470004449|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130555930|NCT01807923|470004450|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130555931|NCT01807923|470004448|FG000|Overall Study|Physician Decision|0|||
130555932|NCT01807923|470004449|FG001|Overall Study|Physician Decision|0|||
130555933|NCT01807923|470004450|FG002|Overall Study|Physician Decision|1|||
130555934|NCT01807923|470004448|FG000|Overall Study|Not Eligible (Genotype)|0|||
130555935|NCT01807923|470004449|FG001|Overall Study|Not Eligible (Genotype)|0|||
130555936|NCT01807923|470004450|FG002|Overall Study|Not Eligible (Genotype)|1|||
130555937|NCT01807923|470004448|FG000|Overall Study|Randomized But Not Treated|3|||
130555938|NCT01807923|470004449|FG001|Overall Study|Randomized But Not Treated|2|||
130555939|NCT01807923|470004450|FG002|Overall Study|Randomized But Not Treated|5|||
130555940|NCT02014740|470004454|FG000|Overall Study|Lost to Follow-up|4|||
130555941|NCT02014740|470004455|FG001|Overall Study|Lost to Follow-up|4|||
130555942|NCT02014740|470004454|FG000|Overall Study|Withdrawal by Subject|2|||
130555943|NCT02014740|470004455|FG001|Overall Study|Withdrawal by Subject|1|||
130555944|NCT02742766|470004456|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130712355|NCT02340221|470571888|FG001|Overall Study|Death|197|||
130555945|NCT02742766|470004457|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130712356|NCT02340221|470571887|FG000|Overall Study|Withdrawal by Participant|24|||
130555946|NCT02742766|470004458|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555947|NCT02742766|470004459|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555948|NCT02742766|470004460|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555949|NCT02742766|470004461|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555950|NCT02742766|470004462|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130712357|NCT02340221|470571888|FG001|Overall Study|Withdrawal by Participant|37|||
130712358|NCT02340221|470571887|FG000|Overall Study|Lost to Follow-up|4|||
130712359|NCT02340221|470571888|FG001|Overall Study|Lost to Follow-up|15|||
130712360|NCT02340221|470571887|FG000|Overall Study|Reason Not Specified|85|||
130712361|NCT02340221|470571888|FG001|Overall Study|Reason Not Specified|165|||
130712362|NCT02340221|470571887|FG000|Overall Study|Study Terminated by Sponsor|1|||
130712363|NCT02340221|470571888|FG001|Overall Study|Study Terminated by Sponsor|3|||
130712364|NCT00103402|470571889|FG000|Overall Study|Adverse Event|3|||
130712365|NCT00103402|470571890|FG001|Overall Study|Adverse Event|4|||
130712366|NCT00103402|470571889|FG000|Overall Study|Lost to Follow-up|8|||
130712367|NCT00103402|470571890|FG001|Overall Study|Lost to Follow-up|7|||
130712368|NCT00103402|470571889|FG000|Overall Study|Dissatisfied/No longer interested|6|||
130712369|NCT00103402|470571890|FG001|Overall Study|Dissatisfied/No longer interested|6|||
130712370|NCT00103402|470571889|FG000|Overall Study|Personal constraints/Other|5|||
130712371|NCT00103402|470571890|FG001|Overall Study|Personal constraints/Other|0|||
130712372|NCT01393730|470571891|FG000|Overall Study|Withdrawal by Subject|3|||
130712373|NCT01393730|470571891|FG000|Overall Study|Other|2|||
130712374|NCT01393730|470571891|FG000|Overall Study|Adverse Event|1|||
130712375|NCT02333487|470571892|FG000|Overall Study|Adverse Event|0|||
130712376|NCT02333487|470571893|FG001|Overall Study|Adverse Event|2|||
130712377|NCT02333487|470571894|FG002|Overall Study|Adverse Event|0|||
130712378|NCT01297322|470571895|FG000|Overall Study|Lost to Follow-up|1|||
130712379|NCT01297322|470571896|FG001|Overall Study|Lost to Follow-up|0|||
130712380|NCT01297322|470571895|FG000|Overall Study|Withdrawal by Subject|0|||
130712381|NCT01297322|470571896|FG001|Overall Study|Withdrawal by Subject|1|||
130712382|NCT01297322|470571895|FG000|Overall Study|Protocol Violation|0|||
130712383|NCT01297322|470571896|FG001|Overall Study|Protocol Violation|3|||
130712384|NCT01111019|470571897|FG000|Overall Study|Withdrew Prematurely|2|||
130712385|NCT01111019|470571897|FG000|Overall Study|Other|1|||
130712386|NCT01583218|470571901|FG000|Overall Study|Withdrawal by Subject|43|||
130712387|NCT01583218|470571902|FG001|Overall Study|Withdrawal by Subject|29|||
130712388|NCT01583218|470571901|FG000|Overall Study|Death|206|||
130712389|NCT01583218|470571902|FG001|Overall Study|Death|211|||
130712390|NCT01583218|470571901|FG000|Overall Study|Lost to Follow-up|11|||
130712391|NCT01583218|470571902|FG001|Overall Study|Lost to Follow-up|17|||
130712392|NCT01583218|470571901|FG000|Overall Study|Adverse event or serious adverse event|3|||
130712393|NCT01583218|470571902|FG001|Overall Study|Adverse event or serious adverse event|3|||
130459135|NCT03823300|469645220|FG001|Overall Study|Adverse Event|5|||
130459136|NCT03823300|469645219|FG000|Overall Study|Physician Decision|1|||
130459137|NCT03823300|469645220|FG001|Overall Study|Physician Decision|7|||
130459138|NCT03823300|469645219|FG000|Overall Study|Lost to Follow-up|1|||
130459139|NCT03823300|469645220|FG001|Overall Study|Lost to Follow-up|3|||
130459140|NCT03823300|469645219|FG000|Overall Study|Protocol Violation|1|||
130459141|NCT03823300|469645220|FG001|Overall Study|Protocol Violation|1|||
130459142|NCT03823300|469645219|FG000|Overall Study|Lack of Efficacy|1|||
130459143|NCT03823300|469645220|FG001|Overall Study|Lack of Efficacy|1|||
130459144|NCT03823300|469645219|FG000|Overall Study|Not Eligible|0|||
130459145|NCT03823300|469645220|FG001|Overall Study|Not Eligible|1|||
130459146|NCT03823300|469645219|FG000|Overall Study|Other|1|||
130459147|NCT03823300|469645220|FG001|Overall Study|Other|0|||
130459148|NCT00753012|469645222|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
130459149|NCT00753012|469645223|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
130459150|NCT00753012|469645222|FG000|Overall Study|Adverse Event|2|||
130459151|NCT00753012|469645223|FG001|Overall Study|Adverse Event|0|||
130459152|NCT00753012|469645222|FG000|Overall Study|Withdrawal by Subject|0|||
130459153|NCT00753012|469645223|FG001|Overall Study|Withdrawal by Subject|1|||
130459154|NCT00753012|469645222|FG000|Overall Study|Lost to Follow-up|4|||
130459155|NCT00753012|469645223|FG001|Overall Study|Lost to Follow-up|0|||
130459156|NCT00753012|469645222|FG000|Overall Study|Confounded endpoint data|1|||
130459157|NCT00753012|469645223|FG001|Overall Study|Confounded endpoint data|0|||
130459158|NCT00943735|469645226|FG000|Overall Study|Adverse Event|12|||
130459159|NCT00943735|469645226|FG000|Overall Study|Withdrawal by Subject|8|||
130459160|NCT00943735|469645226|FG000|Overall Study|Death|1|||
130459161|NCT00943735|469645226|FG000|Overall Study|Other|8|||
130459162|NCT00943735|469645226|FG000|Overall Study|Other|3|||
130459163|NCT03804918|469645227|FG000|Overall Study|Participant did not use the app|1|||
130459164|NCT01329328|469645228|FG000|Overall Study|Withdrawal by Subject|2|||
130459165|NCT01329328|469645229|FG001|Overall Study|Withdrawal by Subject|4|||
130459166|NCT01329328|469645230|FG002|Overall Study|Withdrawal by Subject|3|||
130459167|NCT00964366|469645231|FG000|Overall Study|Did not qualify at Day 1|1|||
130459168|NCT00964366|469645232|FG001|Overall Study|Did not qualify at Day 1|0|||
130459169|NCT00964366|469645231|FG000|Overall Study|Withdrawal by Subject|0|||
130459170|NCT00964366|469645232|FG001|Overall Study|Withdrawal by Subject|1|||
130459171|NCT01370694|469645233|FG000|Overall Study|Switched to rituximab|4|||
130459172|NCT01370694|469645233|FG000|Overall Study|Progressive disease|2|||
130459173|NCT02393716|469645234|FG000|Overall Study|Death|29|||
130712394|NCT01583218|470571901|FG000|Overall Study|Patient /Family decision|3|||
130712395|NCT01583218|470571902|FG001|Overall Study|Patient /Family decision|0|||
130712396|NCT01583218|470571901|FG000|Overall Study|Cannot contact patient directly|1|||
130712397|NCT01583218|470571902|FG001|Overall Study|Cannot contact patient directly|2|||
130712398|NCT01583218|470571901|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
130712399|NCT01583218|470571902|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
130712400|NCT01583218|470571901|FG000|Overall Study|Patient did not wish to attend visits|0|||
130712401|NCT01583218|470571902|FG001|Overall Study|Patient did not wish to attend visits|1|||
130712402|NCT01583218|470571901|FG000|Overall Study|Patient randomized but not dosed|17|||
130287003|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
130287004|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130287005|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
130287006|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
130287007|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
130287008|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287009|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
130287010|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287011|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130287012|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130287013|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287014|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287015|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
130287016|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287017|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
130459174|NCT02393716|469645234|FG000|Overall Study|Withdrawal by Subject|8|||
130459175|NCT02393716|469645234|FG000|Overall Study|Device Explanted|8|||
130712403|NCT01583218|470571902|FG001|Overall Study|Patient randomized but not dosed|16|||
130712404|NCT01583218|470571901|FG000|Overall Study|Patient was assessed via phone in person|1|||
130712405|NCT01583218|470571902|FG001|Overall Study|Patient was assessed via phone in person|0|||
130712406|NCT01583218|470571901|FG000|Overall Study|Patient deemed ineligible after random|2|||
130712407|NCT01583218|470571902|FG001|Overall Study|Patient deemed ineligible after random|0|||
130712408|NCT01583218|470571901|FG000|Overall Study|Patient was early terminated from study|0|||
130712409|NCT01583218|470571902|FG001|Overall Study|Patient was early terminated from study|1|||
130712410|NCT01583218|470571901|FG000|Overall Study|Patient was randomized due to mistake|1|||
130712411|NCT01583218|470571902|FG001|Overall Study|Patient was randomized due to mistake|0|||
130712412|NCT01583218|470571901|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
130712413|NCT01583218|470571902|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
130712414|NCT01583218|470571901|FG000|Overall Study|Withdraw of consent on day of random|1|||
130712415|NCT01583218|470571902|FG001|Overall Study|Withdraw of consent on day of random|0|||
130712416|NCT03334721|470571905|FG000|Overall Study|Withdrawal by Subject|1|||
130712417|NCT03334721|470571906|FG001|Overall Study|Withdrawal by Subject|0|||
130712418|NCT03334721|470571905|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
130712419|NCT03334721|470571906|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
130712420|NCT02091141|470573371|FG000|Overall Study|Death|280|||
130712421|NCT02091141|470573372|FG001|Overall Study|Death|118|||
130712422|NCT02091141|470573373|FG002|Overall Study|Death|46|||
130712423|NCT02091141|470573374|FG003|Overall Study|Death|13|||
130459176|NCT02393716|469645234|FG000|Overall Study|Missed visit|16|||
130459177|NCT02957539|469645235|FG000|Baseline to Week 16|Lost to Follow-up|8|||
130459178|NCT02957539|469645236|FG001|Baseline to Week 16|Lost to Follow-up|10|||
130459179|NCT02957539|469645237|FG002|Baseline to Week 16|Lost to Follow-up|16|||
130459180|NCT02957539|469645235|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
130459181|NCT02957539|469645236|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
130459182|NCT02957539|469645237|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
130459183|NCT02957539|469645235|FG000|Week 16 to 32|Withdrawal by Subject|3|||
130459184|NCT02957539|469645236|FG001|Week 16 to 32|Withdrawal by Subject|3|||
130459185|NCT02957539|469645237|FG002|Week 16 to 32|Withdrawal by Subject|1|||
130459186|NCT02957539|469645235|FG000|Week 16 to 32|Lost to Follow-up|8|||
130459187|NCT02957539|469645236|FG001|Week 16 to 32|Lost to Follow-up|7|||
130459188|NCT02957539|469645237|FG002|Week 16 to 32|Lost to Follow-up|5|||
130459189|NCT02957539|469645235|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
130459190|NCT02957539|469645236|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
130459191|NCT02957539|469645237|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
130459192|NCT02957539|469645235|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
130459193|NCT02957539|469645236|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
130459194|NCT02957539|469645237|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
130459195|NCT04842604|469645240|FG000|Overall Study|Death|1|||
130459196|NCT04842604|469645241|FG001|Overall Study|Death|0|||
130459197|NCT04842604|469645240|FG000|Overall Study|Other|4|||
130555951|NCT02742766|470004463|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130712424|NCT02091141|470573375|FG004|Overall Study|Death|31|||
130712425|NCT02091141|470573376|FG005|Overall Study|Death|16|||
130712426|NCT02091141|470573377|FG006|Overall Study|Death|12|||
130287018|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287019|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130459198|NCT04842604|469645241|FG001|Overall Study|Other|4|||
130459199|NCT04842604|469645240|FG000|Overall Study|Randomized but not treated|1|||
130712427|NCT02091141|470573371|FG000|Overall Study|Withdrawal by Subject|21|||
130459200|NCT04842604|469645241|FG001|Overall Study|Randomized but not treated|0|||
130712428|NCT02091141|470573372|FG001|Overall Study|Withdrawal by Subject|13|||
130712429|NCT02091141|470573373|FG002|Overall Study|Withdrawal by Subject|3|||
130712430|NCT02091141|470573374|FG003|Overall Study|Withdrawal by Subject|2|||
130712431|NCT02091141|470573375|FG004|Overall Study|Withdrawal by Subject|2|||
130712432|NCT02091141|470573376|FG005|Overall Study|Withdrawal by Subject|3|||
130712433|NCT02091141|470573377|FG006|Overall Study|Withdrawal by Subject|0|||
130712434|NCT02091141|470573371|FG000|Overall Study|Lost to Follow-up|21|||
130712435|NCT02091141|470573372|FG001|Overall Study|Lost to Follow-up|5|||
130712436|NCT02091141|470573373|FG002|Overall Study|Lost to Follow-up|1|||
130712437|NCT02091141|470573374|FG003|Overall Study|Lost to Follow-up|0|||
130712438|NCT02091141|470573375|FG004|Overall Study|Lost to Follow-up|1|||
130712439|NCT02091141|470573376|FG005|Overall Study|Lost to Follow-up|2|||
130712440|NCT02091141|470573377|FG006|Overall Study|Lost to Follow-up|0|||
130712441|NCT02091141|470573371|FG000|Overall Study|Reason Not Specified|6|||
130712442|NCT02091141|470573372|FG001|Overall Study|Reason Not Specified|5|||
130712443|NCT02091141|470573373|FG002|Overall Study|Reason Not Specified|2|||
130712444|NCT02091141|470573374|FG003|Overall Study|Reason Not Specified|0|||
130712445|NCT02091141|470573375|FG004|Overall Study|Reason Not Specified|0|||
130712446|NCT02091141|470573376|FG005|Overall Study|Reason Not Specified|0|||
130712447|NCT02091141|470573377|FG006|Overall Study|Reason Not Specified|1|||
130712448|NCT02091141|470573371|FG000|Overall Study|Study Ended by Sponsor|1|||
130712449|NCT02091141|470573372|FG001|Overall Study|Study Ended by Sponsor|9|||
130712450|NCT02091141|470573373|FG002|Overall Study|Study Ended by Sponsor|0|||
130712451|NCT02091141|470573374|FG003|Overall Study|Study Ended by Sponsor|0|||
130712452|NCT02091141|470573375|FG004|Overall Study|Study Ended by Sponsor|0|||
130712453|NCT02091141|470573376|FG005|Overall Study|Study Ended by Sponsor|0|||
130712454|NCT02091141|470573377|FG006|Overall Study|Study Ended by Sponsor|0|||
130712455|NCT02091141|470573371|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712456|NCT02091141|470573372|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
130712457|NCT02091141|470573373|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712458|NCT02091141|470573374|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712459|NCT02091141|470573375|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712460|NCT02091141|470573376|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
130287020|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130287021|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130287022|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130287023|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130287024|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130287025|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130287026|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
130287027|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130287028|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130287029|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
130287030|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130287031|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130287032|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287033|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130287034|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
130287035|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287036|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130287037|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287038|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
130287039|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287040|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287041|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287042|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287043|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287044|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287045|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287046|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
130287047|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287048|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287049|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287050|NCT00624780|469012269|FG000|Follow-up (Week 26)|Death|0|||
130287051|NCT00624780|469012270|FG001|Follow-up (Week 26)|Death|0|||
130287052|NCT00624780|469012271|FG002|Follow-up (Week 26)|Death|1|||
130287053|NCT00624780|469012272|FG003|Follow-up (Week 26)|Death|0|||
130712461|NCT02091141|470573377|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712462|NCT02246439|470573378|FG000|Overall Study|Adverse Event|3|||
130712463|NCT02246439|470573379|FG001|Overall Study|Adverse Event|0|||
130712464|NCT02246439|470573378|FG000|Overall Study|Lost to Follow-up|7|||
130370333|NCT02639065|469325246|FG000|Follow up|Disease Progression|3|||
130370334|NCT00481078|469325247|FG000|Overall Study|Progression of disease|11|||
130370335|NCT00481078|469325248|FG001|Overall Study|Progression of disease|11|||
130370336|NCT00481078|469325247|FG000|Overall Study|Adverse Event|15|||
130370337|NCT00481078|469325248|FG001|Overall Study|Adverse Event|3|||
130370338|NCT00481078|469325247|FG000|Overall Study|Death|5|||
130370339|NCT00481078|469325248|FG001|Overall Study|Death|3|||
130370340|NCT00481078|469325247|FG000|Overall Study|Intercurrent illness|1|||
130370341|NCT00481078|469325248|FG001|Overall Study|Intercurrent illness|0|||
130370342|NCT00481078|469325247|FG000|Overall Study|Withdrawal by Subject|7|||
130370343|NCT00481078|469325248|FG001|Overall Study|Withdrawal by Subject|1|||
130370344|NCT00481078|469325247|FG000|Overall Study|Information not available|1|||
130370345|NCT00481078|469325248|FG001|Overall Study|Information not available|0|||
130370346|NCT00481078|469325247|FG000|Overall Study|Received other treatment|2|||
130370347|NCT00481078|469325248|FG001|Overall Study|Received other treatment|1|||
130370348|NCT00481078|469325247|FG000|Overall Study|Brain metastasis|0|||
130370349|NCT00481078|469325248|FG001|Overall Study|Brain metastasis|1|||
130370350|NCT01558271|469325249|FG000|Overall Study|Adverse Event|6|||
130370351|NCT01558271|469325250|FG001|Overall Study|Adverse Event|3|||
130370352|NCT01558271|469325251|FG002|Overall Study|Adverse Event|4|||
130370353|NCT01558271|469325249|FG000|Overall Study|Lost to Follow-up|1|||
130370354|NCT01558271|469325250|FG001|Overall Study|Lost to Follow-up|0|||
130370355|NCT01558271|469325251|FG002|Overall Study|Lost to Follow-up|0|||
130370356|NCT01558271|469325249|FG000|Overall Study|Protocol Violation|1|||
130370357|NCT01558271|469325250|FG001|Overall Study|Protocol Violation|0|||
130370358|NCT01558271|469325251|FG002|Overall Study|Protocol Violation|0|||
130370359|NCT01558271|469325249|FG000|Overall Study|Withdrawal by Subject|10|||
130370360|NCT01558271|469325250|FG001|Overall Study|Withdrawal by Subject|6|||
130370361|NCT01558271|469325251|FG002|Overall Study|Withdrawal by Subject|12|||
130370362|NCT01558271|469325249|FG000|Overall Study|Physician Decision|0|||
130370363|NCT01558271|469325250|FG001|Overall Study|Physician Decision|2|||
130370364|NCT01558271|469325251|FG002|Overall Study|Physician Decision|1|||
130370365|NCT01845831|469325252|FG000|Inpatient Phase|Withdrawal by Subject|1|||
130370366|NCT01845831|469325253|FG001|Inpatient Phase|Withdrawal by Subject|1|||
130370367|NCT01845831|469325254|FG002|Inpatient Phase|Withdrawal by Subject|0|||
130370368|NCT01845831|469325255|FG003|Inpatient Phase|Withdrawal by Subject|0|||
130370369|NCT01845831|469325256|FG004|Inpatient Phase|Withdrawal by Subject|0|||
130370370|NCT00221403|469325257|FG000|Overall Study|Protocol Violation|1|||
130370371|NCT00221403|469325258|FG001|Overall Study|Protocol Violation|0|||
130370372|NCT00221403|469325259|FG002|Overall Study|Protocol Violation|0|||
130370373|NCT00221403|469325257|FG000|Overall Study|Physician Decision|1|||
130370374|NCT00221403|469325258|FG001|Overall Study|Physician Decision|0|||
130370375|NCT00221403|469325259|FG002|Overall Study|Physician Decision|0|||
130370376|NCT00221403|469325257|FG000|Overall Study|Withdrawal by Subject|0|||
130370377|NCT00221403|469325258|FG001|Overall Study|Withdrawal by Subject|3|||
130370378|NCT00221403|469325259|FG002|Overall Study|Withdrawal by Subject|0|||
130370379|NCT00221403|469325257|FG000|Overall Study|Lack of Efficacy|0|||
130370380|NCT00221403|469325258|FG001|Overall Study|Lack of Efficacy|1|||
130370381|NCT00221403|469325259|FG002|Overall Study|Lack of Efficacy|0|||
130370382|NCT00221403|469325257|FG000|Overall Study|Adverse Event|0|||
130370383|NCT00221403|469325258|FG001|Overall Study|Adverse Event|1|||
130370384|NCT00221403|469325259|FG002|Overall Study|Adverse Event|0|||
130370385|NCT02610725|469325260|FG000|Overall Study|Lost to Follow-up|197|||
130370386|NCT02610725|469325260|FG000|Overall Study|self-reported contraindication|9|||
130370387|NCT00826943|469325261|FG000|Overall Study|Withdrawal by Subject|0|||
130370388|NCT00826943|469325262|FG001|Overall Study|Withdrawal by Subject|0|||
130370389|NCT00826943|469325263|FG002|Overall Study|Withdrawal by Subject|0|||
130370390|NCT00826943|469325264|FG003|Overall Study|Withdrawal by Subject|0|||
130370391|NCT00826943|469325265|FG004|Overall Study|Withdrawal by Subject|1|||
130370392|NCT00826943|469325266|FG005|Overall Study|Withdrawal by Subject|0|||
130370393|NCT01348165|469325267|FG000|Overall Study|Adverse Event|0|||
130370394|NCT01348165|469325268|FG001|Overall Study|Adverse Event|0|||
130370395|NCT01348165|469325269|FG002|Overall Study|Adverse Event|0|||
130370396|NCT01348165|469325270|FG003|Overall Study|Adverse Event|0|||
130370397|NCT01348165|469325271|FG004|Overall Study|Adverse Event|0|||
130370398|NCT01348165|469325272|FG005|Overall Study|Adverse Event|0|||
130370399|NCT01348165|469325273|FG006|Overall Study|Adverse Event|1|||
130712465|NCT02246439|470573379|FG001|Overall Study|Lost to Follow-up|5|||
130712466|NCT02246439|470573378|FG000|Overall Study|Protocol Violation|0|||
130370400|NCT00074152|469325274|FG000|Overall Study|Death|21|||
130370401|NCT00074152|469325275|FG001|Overall Study|Death|9|||
130370402|NCT00074152|469325274|FG000|Overall Study|Lack of Efficacy|34|||
130370403|NCT00074152|469325275|FG001|Overall Study|Lack of Efficacy|24|||
130370404|NCT01063868|469325276|FG000|Overall Study|Adverse Event|9|||
130370405|NCT01063868|469325277|FG001|Overall Study|Adverse Event|7|||
130370406|NCT01063868|469325276|FG000|Overall Study|Withdrawal by Subject|3|||
130370407|NCT01063868|469325277|FG001|Overall Study|Withdrawal by Subject|1|||
130370408|NCT01063868|469325276|FG000|Overall Study|Study Terminated By Sponsor|23|||
130712467|NCT02246439|470573379|FG001|Overall Study|Protocol Violation|2|||
130459201|NCT01193153|469645242|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
130459202|NCT01193153|469645243|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
130712468|NCT02246439|470573378|FG000|Overall Study|Physician Decision|0|||
130712469|NCT02246439|470573379|FG001|Overall Study|Physician Decision|1|||
130459203|NCT01193153|469645242|FG000|Open-label Lead in Period|Pregnancy|1|||
130459204|NCT01193153|469645243|FG001|Open-label Lead in Period|Pregnancy|0|||
130459205|NCT01193153|469645242|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
130459206|NCT01193153|469645243|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
130459207|NCT01193153|469645242|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
130459208|NCT01193153|469645243|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
130712470|NCT02246439|470573378|FG000|Overall Study|Unkonwn|1|||
130712471|NCT02246439|470573379|FG001|Overall Study|Unkonwn|3|||
130712472|NCT02246439|470573378|FG000|Overall Study|Withdrawal by Subject|1|||
130712473|NCT02246439|470573379|FG001|Overall Study|Withdrawal by Subject|0|||
130712474|NCT03439852|470573380|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
130712475|NCT03439852|470573381|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
130712476|NCT03439852|470573380|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
130712477|NCT03439852|470573381|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
130712478|NCT03439852|470573380|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
130712479|NCT03439852|470573381|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
130712480|NCT03247517|470573388|FG000|Overall Study|Adverse Event|0|||
130712481|NCT03247517|470573389|FG001|Overall Study|Adverse Event|4|||
130712482|NCT03247517|470573390|FG002|Overall Study|Adverse Event|2|||
130712483|NCT03247517|470573388|FG000|Overall Study|Lost to Follow-up|2|||
130712484|NCT03247517|470573389|FG001|Overall Study|Lost to Follow-up|6|||
130712485|NCT03247517|470573390|FG002|Overall Study|Lost to Follow-up|4|||
130712486|NCT03247517|470573388|FG000|Overall Study|Consent withdrawn by caregiver|1|||
130712487|NCT03247517|470573389|FG001|Overall Study|Consent withdrawn by caregiver|4|||
130712488|NCT03247517|470573390|FG002|Overall Study|Consent withdrawn by caregiver|7|||
130712489|NCT03247517|470573388|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
130712490|NCT03247517|470573389|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
130712491|NCT03247517|470573390|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
130712492|NCT03247517|470573388|FG000|Overall Study|Protocol Violation|0|||
130712493|NCT03247517|470573389|FG001|Overall Study|Protocol Violation|2|||
130712494|NCT03247517|470573390|FG002|Overall Study|Protocol Violation|0|||
130712495|NCT03247517|470573388|FG000|Overall Study|Multiple reasons|3|||
130712496|NCT03247517|470573389|FG001|Overall Study|Multiple reasons|1|||
130712497|NCT03247517|470573390|FG002|Overall Study|Multiple reasons|0|||
130712498|NCT01996332|470573391|FG000|Overall Study|Adverse Event|117|||
130712499|NCT01996332|470573391|FG000|Overall Study|Lack of Efficacy|1245|||
130712500|NCT01996332|470573391|FG000|Overall Study|Death|264|||
130712501|NCT01996332|470573391|FG000|Overall Study|Protocol Violation|9|||
130712502|NCT01996332|470573391|FG000|Overall Study|Withdrawal by Subject|71|||
130712503|NCT01996332|470573391|FG000|Overall Study|Other|20|||
130712504|NCT01996332|470573391|FG000|Overall Study|Clinical Deterioration|28|||
130712505|NCT01996332|470573391|FG000|Overall Study|Physician Decision|17|||
130712506|NCT01996332|470573391|FG000|Overall Study|Lost to Follow-up|34|||
130712507|NCT02113189|470573392|FG000|Overall Study|Lost to follow up|2|||
130712508|NCT02113189|470573393|FG001|Overall Study|Lost to follow up|1|||
130712509|NCT02113189|470573394|FG002|Overall Study|Lost to follow up|3|||
130287054|NCT00624780|469012273|FG004|Follow-up (Week 26)|Death|0|||
130287055|NCT00624780|469012274|FG005|Follow-up (Week 26)|Death|0|||
130287056|NCT00624780|469012269|FG000|Follow-up (Week 26)|Adverse Event|0|||
130287057|NCT00624780|469012270|FG001|Follow-up (Week 26)|Adverse Event|0|||
130287058|NCT00624780|469012271|FG002|Follow-up (Week 26)|Adverse Event|0|||
130287059|NCT00624780|469012272|FG003|Follow-up (Week 26)|Adverse Event|0|||
130287060|NCT00624780|469012273|FG004|Follow-up (Week 26)|Adverse Event|1|||
130287061|NCT00624780|469012274|FG005|Follow-up (Week 26)|Adverse Event|0|||
130712510|NCT00931268|470573395|FG000|Overall Study|Lost to Follow-up|6|||
130712511|NCT01388166|470573396|FG000|Overall Study|Adverse Event|16|||
130712512|NCT01388166|470573396|FG000|Overall Study|Lost to Follow-up|30|||
130712513|NCT01388166|470573396|FG000|Overall Study|Others than specified above|13|||
130712514|NCT00430495|470573397|FG000|Overall Study|Adverse Event|2|||
130287062|NCT00624780|469012269|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
130287063|NCT00624780|469012270|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
130459209|NCT01193153|469645242|FG000|Open-label Lead in Period|Other|14|||
130459210|NCT01193153|469645243|FG001|Open-label Lead in Period|Other|0|||
130459211|NCT01193153|469645242|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
130712515|NCT00430495|470573398|FG001|Overall Study|Adverse Event|3|||
130712516|NCT00430495|470573399|FG002|Overall Study|Adverse Event|2|||
130712517|NCT00430495|470573400|FG003|Overall Study|Adverse Event|0|||
130712518|NCT00430495|470573397|FG000|Overall Study|Death|0|||
130712519|NCT00430495|470573398|FG001|Overall Study|Death|0|||
130712520|NCT00430495|470573399|FG002|Overall Study|Death|1|||
130712521|NCT00430495|470573400|FG003|Overall Study|Death|0|||
130712522|NCT00430495|470573397|FG000|Overall Study|Lost to Follow-up|0|||
130712523|NCT00430495|470573398|FG001|Overall Study|Lost to Follow-up|1|||
130712524|NCT00430495|470573399|FG002|Overall Study|Lost to Follow-up|4|||
130712525|NCT00430495|470573400|FG003|Overall Study|Lost to Follow-up|0|||
130712526|NCT00430495|470573397|FG000|Overall Study|Protocol Violation|1|||
130712527|NCT00430495|470573398|FG001|Overall Study|Protocol Violation|0|||
130712528|NCT00430495|470573399|FG002|Overall Study|Protocol Violation|1|||
130370409|NCT01063868|469325277|FG001|Overall Study|Study Terminated By Sponsor|4|||
130712529|NCT00430495|470573400|FG003|Overall Study|Protocol Violation|0|||
130712530|NCT00430495|470573397|FG000|Overall Study|Disease Progression|1|||
130712531|NCT00430495|470573398|FG001|Overall Study|Disease Progression|1|||
130712532|NCT00430495|470573399|FG002|Overall Study|Disease Progression|0|||
130712533|NCT00430495|470573400|FG003|Overall Study|Disease Progression|0|||
130712534|NCT00430495|470573397|FG000|Overall Study|Other|8|||
130712535|NCT00430495|470573398|FG001|Overall Study|Other|2|||
130712536|NCT00430495|470573399|FG002|Overall Study|Other|5|||
130712537|NCT00430495|470573400|FG003|Overall Study|Other|4|||
130712538|NCT00430495|470573397|FG000|Overall Study|Randomized but not Treated|2|||
130712539|NCT00430495|470573398|FG001|Overall Study|Randomized but not Treated|0|||
130712540|NCT00430495|470573399|FG002|Overall Study|Randomized but not Treated|0|||
130712541|NCT00430495|470573400|FG003|Overall Study|Randomized but not Treated|0|||
130712542|NCT00158756|470573405|FG000|Overall Study|Withdrawal by Subject|5|||
130712543|NCT00158756|470573406|FG001|Overall Study|Withdrawal by Subject|0|||
130712544|NCT00158756|470573407|FG002|Overall Study|Withdrawal by Subject|6|||
130712545|NCT00158756|470573408|FG003|Overall Study|Withdrawal by Subject|1|||
130712546|NCT00158756|470573409|FG004|Overall Study|Withdrawal by Subject|3|||
130712547|NCT00158756|470573405|FG000|Overall Study|Adverse Event|0|||
130712548|NCT00158756|470573406|FG001|Overall Study|Adverse Event|0|||
130712549|NCT00158756|470573407|FG002|Overall Study|Adverse Event|1|||
130712550|NCT00158756|470573408|FG003|Overall Study|Adverse Event|0|||
130712551|NCT00158756|470573409|FG004|Overall Study|Adverse Event|0|||
130712552|NCT00158756|470573405|FG000|Overall Study|Serious adverse event|0|||
130712553|NCT00158756|470573406|FG001|Overall Study|Serious adverse event|0|||
130712554|NCT00158756|470573407|FG002|Overall Study|Serious adverse event|1|||
130712555|NCT00158756|470573408|FG003|Overall Study|Serious adverse event|0|||
130712556|NCT00158756|470573409|FG004|Overall Study|Serious adverse event|0|||
130712557|NCT03656874|470573411|FG000|Overall Study|Lost to Follow-up|3|||
130712558|NCT03656874|470573412|FG001|Overall Study|Lost to Follow-up|17|||
130712559|NCT00857792|470573413|FG000|Overall Study|inadequate image quality for analysis|12|||
130712560|NCT03251963|470573424|FG000|Overall Study|inappropriate Xa level timing|6|||
130712561|NCT03251963|470573425|FG001|Overall Study|inappropriate Xa level timing|3|||
130712562|NCT03251963|470573424|FG000|Overall Study|no peak Xa level drawn|2|||
130712563|NCT03251963|470573425|FG001|Overall Study|no peak Xa level drawn|0|||
130712564|NCT03251963|470573424|FG000|Overall Study|bled prior to Xa level|1|||
130712565|NCT03251963|470573425|FG001|Overall Study|bled prior to Xa level|2|||
130712566|NCT04505293|470573426|FG000|Overall Study|Lost to Follow-up|2|||
130712567|NCT04505293|470573426|FG000|Overall Study|Withdrawal by Subject|6|||
130712568|NCT04505293|470573426|FG000|Overall Study|CT scan unreadable|277|||
130712569|NCT04295135|470573427|FG000|Overall Study|Withdrawal by Subject|2|||
130712570|NCT04295135|470573428|FG001|Overall Study|Withdrawal by Subject|1|||
130712571|NCT04295135|470573427|FG000|Overall Study|Subject left organization|8|||
130712572|NCT04295135|470573428|FG001|Overall Study|Subject left organization|4|||
130712573|NCT03484117|470573430|FG000|Overall Study|Lost to Follow-up|1|||
130712574|NCT03484117|470573431|FG001|Overall Study|Lost to Follow-up|3|||
130712575|NCT03484117|470573430|FG000|Overall Study|Declined participation in exit assess|1|||
130712576|NCT03484117|470573431|FG001|Overall Study|Declined participation in exit assess|1|||
130712577|NCT00289874|470573432|FG000|Overall Study|Adverse Event|1|||
130712578|NCT00289874|470573433|FG001|Overall Study|Adverse Event|5|||
130712579|NCT00289874|470573432|FG000|Overall Study|Lost to Follow-up|1|||
130712580|NCT00289874|470573433|FG001|Overall Study|Lost to Follow-up|1|||
130712581|NCT00289874|470573432|FG000|Overall Study|Protocol Violation|3|||
130712582|NCT00289874|470573433|FG001|Overall Study|Protocol Violation|2|||
130712583|NCT00289874|470573432|FG000|Overall Study|Did not meet eligibility|1|||
130370410|NCT02469298|469327086|FG000|Overall Study|Protocol Violation|0|||
130370411|NCT02469298|469327087|FG001|Overall Study|Protocol Violation|1|||
130370412|NCT02469298|469327088|FG002|Overall Study|Protocol Violation|1|||
130370413|NCT02469298|469327089|FG003|Overall Study|Protocol Violation|0|||
130370414|NCT02469298|469327086|FG000|Overall Study|Lost to Follow-up|1|||
130370415|NCT02469298|469327087|FG001|Overall Study|Lost to Follow-up|0|||
130370416|NCT02469298|469327088|FG002|Overall Study|Lost to Follow-up|1|||
130370417|NCT02469298|469327089|FG003|Overall Study|Lost to Follow-up|0|||
130712584|NCT00289874|470573433|FG001|Overall Study|Did not meet eligibility|0|||
130712585|NCT03835325|470573434|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
130712586|NCT03835325|470573434|FG000|Overall Study|Selection failure|1|||
130712587|NCT00775606|470573435|FG000|Overall Study|Study sponsor terminated funding|3|||
130712588|NCT00775606|470573436|FG001|Overall Study|Study sponsor terminated funding|0|||
130720901|NCT01341782|470601558|FG001|Overall Study|Missed 3 consecutive doses|4|||
130712589|NCT03212794|470573437|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
130712590|NCT03212794|470573438|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
130712591|NCT03212794|470573437|FG000|Overall Study|Lost to Follow-up|5|||
130712592|NCT03212794|470573438|FG001|Overall Study|Lost to Follow-up|6|||
130712593|NCT03212794|470573437|FG000|Overall Study|Incarcerated; unable to participate|2|||
130712594|NCT03212794|470573438|FG001|Overall Study|Incarcerated; unable to participate|0|||
130712595|NCT03212794|470573437|FG000|Overall Study|Withdrawal by Subject|1|||
130712596|NCT03212794|470573438|FG001|Overall Study|Withdrawal by Subject|0|||
130712597|NCT03212794|470573437|FG000|Overall Study|Death|0|||
130712598|NCT03212794|470573438|FG001|Overall Study|Death|1|||
130712599|NCT03212794|470573437|FG000|Overall Study|Found to be ineligible after allocation|0|||
130712600|NCT03212794|470573438|FG001|Overall Study|Found to be ineligible after allocation|1|||
130712601|NCT03212794|470573437|FG000|Overall Study|Relocated out of area|2|||
130712602|NCT03212794|470573438|FG001|Overall Study|Relocated out of area|0|||
130712603|NCT00597116|470573440|FG000|Overall Study|Adverse Event|2|||
130712604|NCT00597116|470573441|FG001|Overall Study|Adverse Event|1|||
130712605|NCT00597116|470573440|FG000|Overall Study|Withdrawal by Subject|0|||
130712606|NCT00597116|470573441|FG001|Overall Study|Withdrawal by Subject|2|||
130712607|NCT00597116|470573440|FG000|Overall Study|Physician Decision|0|||
130712608|NCT00597116|470573441|FG001|Overall Study|Physician Decision|1|||
130712609|NCT00597116|470573440|FG000|Overall Study|Death|0|||
130712610|NCT00597116|470573441|FG001|Overall Study|Death|1|||
130712611|NCT00597116|470573440|FG000|Overall Study|Lost to Follow-up|1|||
130712612|NCT00597116|470573441|FG001|Overall Study|Lost to Follow-up|0|||
130712613|NCT00597116|470573440|FG000|Overall Study|Progressive disease|11|||
130712614|NCT00597116|470573441|FG001|Overall Study|Progressive disease|6|||
130712615|NCT03978091|470573442|FG000|Overall Study|Lost to Follow-up|0|||
130712616|NCT03978091|470573443|FG001|Overall Study|Lost to Follow-up|0|||
130712617|NCT03978091|470573444|FG002|Overall Study|Lost to Follow-up|1|||
130712618|NCT03978091|470573445|FG003|Overall Study|Lost to Follow-up|0|||
130712619|NCT03978091|470573446|FG004|Overall Study|Lost to Follow-up|0|||
130712620|NCT03978091|470573447|FG005|Overall Study|Lost to Follow-up|0|||
130712621|NCT03978091|470573442|FG000|Overall Study|Withdrawal by Subject|0|||
130712622|NCT03978091|470573443|FG001|Overall Study|Withdrawal by Subject|0|||
130712623|NCT03978091|470573444|FG002|Overall Study|Withdrawal by Subject|0|||
130712624|NCT03978091|470573445|FG003|Overall Study|Withdrawal by Subject|1|||
130712625|NCT03978091|470573446|FG004|Overall Study|Withdrawal by Subject|1|||
130712626|NCT03978091|470573447|FG005|Overall Study|Withdrawal by Subject|0|||
130712627|NCT00257920|470573452|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
130712628|NCT00257920|470573453|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
130712629|NCT00257920|470573452|FG000|Period: Second Intervention|Other|2|||
130712630|NCT00257920|470573453|FG001|Period: Second Intervention|Other|1|||
130712631|NCT00770692|470573456|FG000|Overall Study|Withdrawal by Subject|7|||
130712632|NCT00770692|470573457|FG001|Overall Study|Withdrawal by Subject|9|||
130712633|NCT00770692|470573458|FG002|Overall Study|Withdrawal by Subject|9|||
130712634|NCT00770692|470573459|FG003|Overall Study|Withdrawal by Subject|6|||
130712635|NCT00770692|470573456|FG000|Overall Study|Adverse Event|3|||
130287064|NCT00624780|469012271|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
130287065|NCT00624780|469012272|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
130287066|NCT00624780|469012273|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
130287067|NCT00624780|469012274|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
130287068|NCT00624780|469012269|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
130712636|NCT00770692|470573457|FG001|Overall Study|Adverse Event|0|||
130712637|NCT00770692|470573458|FG002|Overall Study|Adverse Event|4|||
130712638|NCT00770692|470573459|FG003|Overall Study|Adverse Event|4|||
130712639|NCT00770692|470573456|FG000|Overall Study|Investigator judgment|2|||
130712640|NCT00770692|470573457|FG001|Overall Study|Investigator judgment|0|||
130712641|NCT00770692|470573458|FG002|Overall Study|Investigator judgment|1|||
130712642|NCT00770692|470573459|FG003|Overall Study|Investigator judgment|1|||
130712643|NCT00560937|470573461|FG000|Overall Study|Withdrawal by Subject|0|||
130712644|NCT00560937|470573462|FG001|Overall Study|Withdrawal by Subject|1|||
130712645|NCT00560937|470573461|FG000|Overall Study|Physician Decision|1|||
130712646|NCT00560937|470573462|FG001|Overall Study|Physician Decision|1|||
130712647|NCT02025751|470573467|FG000|Overall Study|Lost to Follow-up|1|||
130712648|NCT02025751|470573468|FG001|Overall Study|Lost to Follow-up|0|||
130712649|NCT02025751|470573467|FG000|Overall Study|Adverse Event|0|||
130712650|NCT02025751|470573468|FG001|Overall Study|Adverse Event|1|||
130712651|NCT02025751|470573467|FG000|Overall Study|Physician Decision|0|||
130712652|NCT02025751|470573468|FG001|Overall Study|Physician Decision|1|||
130287069|NCT00624780|469012270|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287070|NCT00624780|469012271|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
130712653|NCT02025751|470573467|FG000|Overall Study|Withdrawal by Subject|0|||
130712654|NCT02025751|470573468|FG001|Overall Study|Withdrawal by Subject|1|||
130712655|NCT01846273|470573469|FG000|Overall Study|Adverse Event|9|||
130712656|NCT01846273|470573470|FG001|Overall Study|Adverse Event|7|||
130712657|NCT01846273|470573471|FG002|Overall Study|Adverse Event|0|||
130712658|NCT01846273|470573469|FG000|Overall Study|Subject withdrew consent|5|||
130712659|NCT01846273|470573470|FG001|Overall Study|Subject withdrew consent|8|||
130712660|NCT01846273|470573471|FG002|Overall Study|Subject withdrew consent|0|||
130712661|NCT01846273|470573469|FG000|Overall Study|Lost to Follow-up|2|||
130712662|NCT01846273|470573470|FG001|Overall Study|Lost to Follow-up|1|||
130712663|NCT01846273|470573471|FG002|Overall Study|Lost to Follow-up|0|||
130712664|NCT01846273|470573469|FG000|Overall Study|Administrative problems|1|||
130712665|NCT01846273|470573470|FG001|Overall Study|Administrative problems|0|||
130712666|NCT01846273|470573471|FG002|Overall Study|Administrative problems|0|||
130712667|NCT01846273|470573469|FG000|Overall Study|Death|2|||
130712668|NCT01846273|470573470|FG001|Overall Study|Death|1|||
130287071|NCT00624780|469012272|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287072|NCT00624780|469012273|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287073|NCT00624780|469012274|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287074|NCT00624780|469012269|FG000|Follow-up (Week 26)|Other|1|||
130287075|NCT00624780|469012270|FG001|Follow-up (Week 26)|Other|1|||
130287076|NCT00624780|469012271|FG002|Follow-up (Week 26)|Other|0|||
130287077|NCT00624780|469012272|FG003|Follow-up (Week 26)|Other|0|||
130287078|NCT00624780|469012273|FG004|Follow-up (Week 26)|Other|0|||
130287079|NCT00624780|469012274|FG005|Follow-up (Week 26)|Other|0|||
130287080|NCT00496197|469014620|FG000|Overall Study|Discontinued study due to death|43|||
130287081|NCT00496197|469014620|FG000|Overall Study|Adverse Event|13|||
130287082|NCT00496197|469014620|FG000|Overall Study|Does not meet entrance criteria|5|||
130287083|NCT00496197|469014620|FG000|Overall Study|Insufficient clinical response|3|||
130287084|NCT00496197|469014620|FG000|Overall Study|Insufficient bacteriological response|10|||
130287085|NCT00496197|469014620|FG000|Overall Study|Lost to Follow-up|11|||
130287086|NCT00496197|469014620|FG000|Overall Study|Withdrawal by Subject|11|||
130287087|NCT00496197|469014620|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
130287088|NCT00496197|469014620|FG000|Overall Study|Other|14|||
130370418|NCT02469298|469327086|FG000|Overall Study|Physician Decision|0|||
130370419|NCT02469298|469327087|FG001|Overall Study|Physician Decision|0|||
130370420|NCT02469298|469327088|FG002|Overall Study|Physician Decision|0|||
130370421|NCT02469298|469327089|FG003|Overall Study|Physician Decision|1|||
130370422|NCT02469298|469327086|FG000|Overall Study|Withdrawal by Subject|0|||
130370423|NCT02469298|469327087|FG001|Overall Study|Withdrawal by Subject|0|||
130370424|NCT02469298|469327088|FG002|Overall Study|Withdrawal by Subject|0|||
130370425|NCT02469298|469327089|FG003|Overall Study|Withdrawal by Subject|1|||
130370426|NCT01664533|469327092|FG000|Overall Study|Death|42|||
130370427|NCT01664533|469327092|FG000|Overall Study|Lost to Follow-up|3|||
130370428|NCT01664533|469327092|FG000|Overall Study|Study termination|9|||
130370429|NCT01664533|469327092|FG000|Overall Study|Protocol Violation|3|||
130370430|NCT00290888|469327093|FG000|Overall Study|Physician Decision|3|||
130370431|NCT00290888|469327094|FG001|Overall Study|Physician Decision|1|||
130370432|NCT02397278|469327101|FG000|Overall Study|Withdrawal by Subject|0|||
130370433|NCT02397278|469327102|FG001|Overall Study|Withdrawal by Subject|2|||
130370434|NCT02397278|469327101|FG000|Overall Study|Deemed ineligible following surgery|1|||
130370435|NCT02397278|469327102|FG001|Overall Study|Deemed ineligible following surgery|1|||
130370436|NCT01397084|469327107|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130370437|NCT01397084|469327107|FG000|Overall Study|Protocol Violation|2|||
130370438|NCT01397084|469327107|FG000|Overall Study|Adverse Event|2|||
130370439|NCT01397084|469327107|FG000|Overall Study|Withdrawal by Subject|1|||
130370440|NCT01397084|469327107|FG000|Overall Study|Lost to Follow-up|1|||
130370441|NCT01397084|469327107|FG000|Overall Study|Used other proton pump inhibitor|1|||
130370442|NCT02853604|469327108|FG000|Overall Study|Withdrawal by Subject|12|||
130370443|NCT02853604|469327109|FG001|Overall Study|Withdrawal by Subject|35|||
130370444|NCT02853604|469327108|FG000|Overall Study|Lost to Follow-up|4|||
130370445|NCT02853604|469327109|FG001|Overall Study|Lost to Follow-up|8|||
130370446|NCT02853604|469327108|FG000|Overall Study|Death|1|||
130370447|NCT02853604|469327109|FG001|Overall Study|Death|5|||
130370448|NCT02853604|469327108|FG000|Overall Study|Miscellaneous|11|||
130370449|NCT02853604|469327109|FG001|Overall Study|Miscellaneous|2|||
130370450|NCT02853604|469327108|FG000|Overall Study|Progressive Disease|0|||
130370451|NCT02853604|469327109|FG001|Overall Study|Progressive Disease|2|||
130370452|NCT04213079|469327110|FG000|Overall Study|Lost to Follow-up|0|||
130370453|NCT04213079|469327111|FG001|Overall Study|Lost to Follow-up|2|||
130370454|NCT04343261|469327112|FG000|Overall Study|Adverse Event|1|||
130370455|NCT04343261|469327112|FG000|Overall Study|received inadequate amount of antibodies|7|||
130287089|NCT00496197|469014620|FG000|Overall Study|Protocol Violation|8|||
130287090|NCT00683917|469014624|FG000|Overall Study|Study prematurely terminated|10|||
130287091|NCT01170598|469014631|FG000|Overall Study|Withdrawal by Subject|1|||
130712669|NCT01846273|470573471|FG002|Overall Study|Death|0|||
130287092|NCT01170598|469014631|FG000|Overall Study|Death|3|||
130287093|NCT01170598|469014631|FG000|Overall Study|Lost to Follow-up|1|||
130287094|NCT01170598|469014631|FG000|Overall Study|Refused|1|||
130287095|NCT01779869|469014632|FG000|Overall Study|Physician Decision|2|||
130370456|NCT05275400|469327116|FG000|Treatment Period|Adverse Event|7|||
130370457|NCT05275400|469327117|FG001|Treatment Period|Adverse Event|1|||
130712670|NCT01846273|470573469|FG000|Overall Study|Disease Progression|0|||
130712671|NCT01846273|470573470|FG001|Overall Study|Disease Progression|4|||
130712672|NCT01846273|470573471|FG002|Overall Study|Disease Progression|0|||
130712673|NCT01846273|470573469|FG000|Overall Study|Protocol Deviation|2|||
130712674|NCT01846273|470573470|FG001|Overall Study|Protocol Deviation|3|||
130712675|NCT01846273|470573471|FG002|Overall Study|Protocol Deviation|0|||
130712676|NCT01846273|470573469|FG000|Overall Study|Physician Decision|1|||
130712677|NCT01846273|470573470|FG001|Overall Study|Physician Decision|2|||
130712678|NCT01846273|470573471|FG002|Overall Study|Physician Decision|0|||
130712679|NCT00891839|470573472|FG000|Overall Study|Adverse Event|2|||
130287096|NCT00027378|469014633|FG000|Overall Study|Physician Decision|0|||
130287097|NCT00027378|469014634|FG001|Overall Study|Physician Decision|3|||
130287098|NCT05605691|469014635|FG000|Overall Study|Lost to Follow-up|1|||
130287099|NCT02098369|469014636|FG000|Overall Study|Withdrawal by Subject|1|||
130287100|NCT02098369|469014637|FG001|Overall Study|Withdrawal by Subject|5|||
130287101|NCT02098369|469014638|FG002|Overall Study|Withdrawal by Subject|0|||
130287102|NCT02098369|469014636|FG000|Overall Study|Lost to Follow-up|5|||
130287103|NCT02098369|469014637|FG001|Overall Study|Lost to Follow-up|1|||
130287104|NCT02098369|469014638|FG002|Overall Study|Lost to Follow-up|3|||
130555952|NCT02742766|470004464|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555953|NCT02742766|470004465|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555954|NCT02742766|470004466|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555955|NCT02742766|470004467|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555956|NCT02742766|470004468|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555957|NCT02742766|470004469|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
130555958|NCT02742766|470004470|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555959|NCT02742766|470004471|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555960|NCT02742766|470004472|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555961|NCT02742766|470004473|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555962|NCT02742766|470004474|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130555963|NCT02742766|470004456|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555964|NCT02742766|470004457|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555965|NCT02742766|470004458|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555966|NCT02742766|470004459|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555967|NCT02742766|470004460|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555968|NCT02742766|470004461|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555969|NCT02742766|470004462|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555970|NCT02742766|470004463|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555971|NCT02742766|470004464|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555972|NCT02742766|470004465|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555973|NCT02742766|470004466|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555974|NCT02742766|470004467|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555975|NCT02742766|470004468|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
130555976|NCT02742766|470004469|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
130555977|NCT02742766|470004470|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555978|NCT02742766|470004471|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
130555979|NCT02742766|470004472|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555980|NCT02742766|470004473|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555981|NCT02742766|470004474|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
130555982|NCT04427501|470004475|FG000|Overall Study|Death|0|||
130555983|NCT04427501|470004476|FG001|Overall Study|Death|0|||
130555984|NCT04427501|470004477|FG002|Overall Study|Death|0|||
130555985|NCT04427501|470004478|FG003|Overall Study|Death|0|||
130555986|NCT04427501|470004479|FG004|Overall Study|Death|0|||
130555987|NCT04427501|470004480|FG005|Overall Study|Death|15|||
130555988|NCT04427501|470004481|FG006|Overall Study|Death|0|||
130287105|NCT02098369|469014636|FG000|Overall Study|Death|1|||
130287106|NCT02098369|469014637|FG001|Overall Study|Death|1|||
130287107|NCT02098369|469014638|FG002|Overall Study|Death|1|||
130287108|NCT02098369|469014636|FG000|Overall Study|Other|0|||
130287109|NCT02098369|469014637|FG001|Overall Study|Other|2|||
130370458|NCT05275400|469327116|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
130287110|NCT02098369|469014638|FG002|Overall Study|Other|1|||
130287111|NCT02927925|469014646|FG000|Overall Study|Death|16|||
130370459|NCT05275400|469327117|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
130555989|NCT04427501|470004482|FG007|Overall Study|Death|0|||
130555990|NCT04427501|470004483|FG008|Overall Study|Death|0|||
130712680|NCT00891839|470573472|FG000|Overall Study|Withdrawal by Subject|2|||
130712681|NCT00891839|470573472|FG000|Overall Study|Disease progression|3|||
130287112|NCT02927925|469014646|FG000|Overall Study|Physician Decision|1|||
130555991|NCT04427501|470004484|FG009|Overall Study|Death|0|||
130712682|NCT05069155|470573473|FG000|Overall Study|Withdrawal by Subject|1|||
130555992|NCT04427501|470004485|FG010|Overall Study|Death|0|||
130287113|NCT02927925|469014646|FG000|Overall Study|Withdrawal by Subject|11|||
130555993|NCT04427501|470004486|FG011|Overall Study|Death|0|||
130555994|NCT04427501|470004475|FG000|Overall Study|Lost to Follow-up|5|||
130555995|NCT04427501|470004476|FG001|Overall Study|Lost to Follow-up|1|||
130555996|NCT04427501|470004477|FG002|Overall Study|Lost to Follow-up|2|||
130555997|NCT04427501|470004478|FG003|Overall Study|Lost to Follow-up|0|||
130712683|NCT05069155|470573474|FG001|Overall Study|Withdrawal by Subject|3|||
130287114|NCT02927925|469014646|FG000|Overall Study|Other|3|||
130287115|NCT02927925|469014646|FG000|Overall Study|Disease progression at clinical cutoff|1|||
130287116|NCT02229214|469014653|FG000|Overall Study|Adverse Event|2|||
130287117|NCT02229214|469014654|FG001|Overall Study|Adverse Event|0|||
130712684|NCT00712985|470573475|FG000|Overall Study|1 withdrew prior to start of drug|1|||
130712685|NCT00712985|470573475|FG000|Overall Study|1 patient moved out of state|1|||
130712686|NCT00712985|470573475|FG000|Overall Study|Lack of Efficacy|3|||
130712687|NCT02674061|470573476|FG000|Overall Study|Death|229|||
130712688|NCT02674061|470573477|FG001|Overall Study|Death|77|||
130712689|NCT02674061|470573476|FG000|Overall Study|Lost to Follow-up|3|||
130712690|NCT02674061|470573477|FG001|Overall Study|Lost to Follow-up|3|||
130712691|NCT02674061|470573476|FG000|Overall Study|Withdrawal by Subject|9|||
130712692|NCT02674061|470573477|FG001|Overall Study|Withdrawal by Subject|1|||
130712693|NCT02674061|470573476|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
130712694|NCT02674061|470573477|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
130712695|NCT01299805|470573480|FG000|Overall Study|Adverse Event|2|||
130712696|NCT01299805|470573481|FG001|Overall Study|Adverse Event|0|||
130287118|NCT02229214|469014653|FG000|Overall Study|Withdrawal by Subject|4|||
130287119|NCT02229214|469014654|FG001|Overall Study|Withdrawal by Subject|0|||
130287120|NCT00246025|469014655|FG000|Overall Study|Adverse Event|7|||
130287121|NCT00246025|469014656|FG001|Overall Study|Adverse Event|9|||
130287122|NCT00246025|469014657|FG002|Overall Study|Adverse Event|9|||
130287123|NCT00246025|469014658|FG003|Overall Study|Adverse Event|10|||
130287124|NCT00246025|469014655|FG000|Overall Study|Withdrawal by Subject|3|||
130287125|NCT00246025|469014656|FG001|Overall Study|Withdrawal by Subject|0|||
130287126|NCT00246025|469014657|FG002|Overall Study|Withdrawal by Subject|1|||
130287127|NCT00246025|469014658|FG003|Overall Study|Withdrawal by Subject|2|||
130287128|NCT00246025|469014655|FG000|Overall Study|unsuitable medical history was found|0|||
130287129|NCT00246025|469014656|FG001|Overall Study|unsuitable medical history was found|0|||
130287130|NCT00246025|469014657|FG002|Overall Study|unsuitable medical history was found|0|||
130287131|NCT00246025|469014658|FG003|Overall Study|unsuitable medical history was found|1|||
130287132|NCT01238835|469014661|FG000|Overall Study|Death|124|||
130287133|NCT01238835|469014661|FG000|Overall Study|Withdrawal by Subject|9|||
130287134|NCT01238835|469014661|FG000|Overall Study|Lost to Follow-up|1|||
130287135|NCT01238835|469014661|FG000|Overall Study|Site early discontinuation|2|||
130287136|NCT00907803|469014663|FG000|Overall Study|Withdrawal of consent - long commute|1|||
130287137|NCT00907803|469014664|FG001|Overall Study|Withdrawal of consent - long commute|0|||
130287138|NCT00907803|469014665|FG002|Overall Study|Withdrawal of consent - long commute|0|||
130287139|NCT00907803|469014663|FG000|Overall Study|Adverse Event|2|||
130287140|NCT00907803|469014664|FG001|Overall Study|Adverse Event|0|||
130287141|NCT00907803|469014665|FG002|Overall Study|Adverse Event|0|||
130287142|NCT00907803|469014663|FG000|Overall Study|Withdrawal by Subject|0|||
130287143|NCT00907803|469014664|FG001|Overall Study|Withdrawal by Subject|1|||
130287144|NCT00907803|469014665|FG002|Overall Study|Withdrawal by Subject|0|||
130287145|NCT00907803|469014663|FG000|Overall Study|Lost to Follow-up|0|||
130287146|NCT00907803|469014664|FG001|Overall Study|Lost to Follow-up|1|||
130287147|NCT00907803|469014665|FG002|Overall Study|Lost to Follow-up|0|||
130287148|NCT00907803|469014663|FG000|Overall Study|Protocol Violation|0|||
130287149|NCT00907803|469014664|FG001|Overall Study|Protocol Violation|1|||
130287150|NCT00907803|469014665|FG002|Overall Study|Protocol Violation|0|||
130287151|NCT03510468|469014666|FG000|Overall Study|Lost to Follow-up|1|||
130287152|NCT03510468|469014666|FG000|Overall Study|Adverse Event|5|||
130287153|NCT03510468|469014666|FG000|Overall Study|Physician Decision|1|||
130287154|NCT03510468|469014666|FG000|Overall Study|non-compliant with treatment|2|||
130287155|NCT03510468|469014666|FG000|Overall Study|Missed visit|1|||
130287156|NCT04612842|469014667|FG000|Overall Study|Lost to Follow-up|20|||
130287157|NCT04612842|469014668|FG001|Overall Study|Lost to Follow-up|11|||
130287158|NCT04612842|469014667|FG000|Overall Study|Withdrawal by Subject|26|||
130287159|NCT04612842|469014668|FG001|Overall Study|Withdrawal by Subject|15|||
130287160|NCT04612842|469014667|FG000|Overall Study|Death|2|||
130287161|NCT04612842|469014668|FG001|Overall Study|Death|2|||
130287162|NCT02419131|469014669|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
130287163|NCT02419131|469014670|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
130287164|NCT02419131|469014671|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
130287165|NCT02419131|469014669|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
130555998|NCT04427501|470004479|FG004|Overall Study|Lost to Follow-up|2|||
130287166|NCT02419131|469014670|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
130370460|NCT05275400|469327116|FG000|Treatment Period|Death|5|||
130712697|NCT00123955|470573485|FG000|Overall Study|Adverse Event|1|||
130712698|NCT00123955|470573486|FG001|Overall Study|Adverse Event|0|||
130712699|NCT00123955|470573485|FG000|Overall Study|Withdrawal by Subject|4|||
130712700|NCT00123955|470573486|FG001|Overall Study|Withdrawal by Subject|3|||
130712701|NCT00123955|470573485|FG000|Overall Study|Death|0|||
130712702|NCT00123955|470573486|FG001|Overall Study|Death|1|||
130712703|NCT04969861|470573489|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
130712704|NCT04969861|470573490|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
130712705|NCT04718194|470575165|FG000|Overall Study|Withdrawal by Subject|3|||
130712706|NCT04718194|470575166|FG001|Overall Study|Withdrawal by Subject|0|||
130712707|NCT04718194|470575165|FG000|Overall Study|Lost to Follow-up|3|||
130712708|NCT04718194|470575166|FG001|Overall Study|Lost to Follow-up|0|||
130712709|NCT04556552|470575168|FG000|Overall Study|Lost to Follow-up|1|||
130712710|NCT04556552|470575169|FG001|Overall Study|Lost to Follow-up|0|||
130712711|NCT04556552|470575168|FG000|Overall Study|Claustrophobia|0|||
130712712|NCT04556552|470575169|FG001|Overall Study|Claustrophobia|1|||
130712713|NCT04556552|470575168|FG000|Overall Study|Inability to continue|0|||
130712714|NCT04556552|470575169|FG001|Overall Study|Inability to continue|1|||
130712715|NCT01215513|470575170|FG000|Overall Study|Not completed CS42|9|||
130712716|NCT01215513|470575170|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
130712717|NCT01215513|470575170|FG000|Overall Study|Adverse event (CS42A)|2|||
130712718|NCT01215513|470575170|FG000|Overall Study|Physician decision (CS42A)|6|||
130712719|NCT01215513|470575170|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
130712720|NCT01215513|470575170|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
130712721|NCT01553279|470575171|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
130712722|NCT01553279|470575172|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
130712723|NCT01553279|470575171|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130712724|NCT01553279|470575172|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130712725|NCT01553279|470575171|FG000|Interim Period|Withdrawal by Subject|2|||
130712726|NCT01553279|470575172|FG001|Interim Period|Withdrawal by Subject|2|||
130712727|NCT01553279|470575171|FG000|Interim Period|Lost to Follow-up|1|||
130712728|NCT01553279|470575172|FG001|Interim Period|Lost to Follow-up|0|||
130712729|NCT01553279|470575171|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
130712730|NCT01553279|470575172|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
130712731|NCT01553279|470575171|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
130712732|NCT01553279|470575172|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
130459212|NCT01193153|469645243|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
130459213|NCT01193153|469645242|FG000|Open-label Lead in Period|Adverse Event|41|||
130712733|NCT00605865|470575173|FG000|Overall Study|Protocol Violation|115|||
130712734|NCT03955471|470575174|FG000|Overall Study|Death|22|||
130712735|NCT03955471|470575174|FG000|Overall Study|Lost to Follow-up|1|||
130712736|NCT03955471|470575174|FG000|Overall Study|Withdrawal by Subject|6|||
130712737|NCT03955471|470575174|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
130712738|NCT00793780|470575183|FG000|Overall Study|Withdrawal by Subject|2|||
130712739|NCT00793780|470575184|FG001|Overall Study|Withdrawal by Subject|1|||
130712740|NCT02858492|470575185|FG000|Overall Study|Withdrawal by Subject|0|||
130712741|NCT02858492|470575186|FG001|Overall Study|Withdrawal by Subject|1|||
130712742|NCT02858492|470575187|FG002|Overall Study|Withdrawal by Subject|0|||
130712743|NCT02858492|470575188|FG003|Overall Study|Withdrawal by Subject|1|||
130712744|NCT02858492|470575185|FG000|Overall Study|Adverse Event|0|||
130712745|NCT02858492|470575186|FG001|Overall Study|Adverse Event|0|||
130712746|NCT02858492|470575187|FG002|Overall Study|Adverse Event|0|||
130712747|NCT02858492|470575188|FG003|Overall Study|Adverse Event|3|||
130712748|NCT02858492|470575185|FG000|Overall Study|Lack of Efficacy|0|||
130712749|NCT02858492|470575186|FG001|Overall Study|Lack of Efficacy|0|||
130712750|NCT02858492|470575187|FG002|Overall Study|Lack of Efficacy|0|||
130459214|NCT01193153|469645243|FG001|Open-label Lead in Period|Adverse Event|0|||
130459215|NCT01193153|469645242|FG000|Open-label Lead in Period|Death|1|||
130459216|NCT01193153|469645243|FG001|Open-label Lead in Period|Death|0|||
130459217|NCT01193153|469645242|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
130555999|NCT04427501|470004480|FG005|Overall Study|Lost to Follow-up|11|||
130712751|NCT02858492|470575188|FG003|Overall Study|Lack of Efficacy|1|||
130712752|NCT02858492|470575185|FG000|Overall Study|Protocol defined stopping criteria|0|||
130712753|NCT02858492|470575186|FG001|Overall Study|Protocol defined stopping criteria|0|||
130712754|NCT02858492|470575187|FG002|Overall Study|Protocol defined stopping criteria|0|||
130712755|NCT02858492|470575188|FG003|Overall Study|Protocol defined stopping criteria|1|||
130459218|NCT01193153|469645243|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
130459219|NCT01193153|469645242|FG000|Open-label Stabilization Period|Adverse Event|9|||
130459220|NCT01193153|469645243|FG001|Open-label Stabilization Period|Adverse Event|0|||
130712756|NCT02119286|470575195|FG000|Overall Study|Adverse Event|9|||
130712757|NCT02119286|470575196|FG001|Overall Study|Adverse Event|7|||
130712758|NCT02119286|470575197|FG002|Overall Study|Adverse Event|2|||
130712759|NCT02119286|470575195|FG000|Overall Study|Lack of Efficacy|11|||
130712760|NCT02119286|470575196|FG001|Overall Study|Lack of Efficacy|3|||
130712761|NCT02119286|470575197|FG002|Overall Study|Lack of Efficacy|4|||
130556000|NCT04427501|470004481|FG006|Overall Study|Lost to Follow-up|10|||
130556001|NCT04427501|470004482|FG007|Overall Study|Lost to Follow-up|10|||
130556002|NCT04427501|470004483|FG008|Overall Study|Lost to Follow-up|2|||
130556003|NCT04427501|470004484|FG009|Overall Study|Lost to Follow-up|5|||
130556004|NCT04427501|470004485|FG010|Overall Study|Lost to Follow-up|2|||
130556005|NCT04427501|470004486|FG011|Overall Study|Lost to Follow-up|0|||
130556006|NCT04427501|470004475|FG000|Overall Study|Physician Decision|0|||
130556007|NCT04427501|470004476|FG001|Overall Study|Physician Decision|3|||
130556008|NCT04427501|470004477|FG002|Overall Study|Physician Decision|0|||
130556009|NCT04427501|470004478|FG003|Overall Study|Physician Decision|0|||
130556010|NCT04427501|470004479|FG004|Overall Study|Physician Decision|0|||
130556011|NCT04427501|470004480|FG005|Overall Study|Physician Decision|0|||
130556012|NCT04427501|470004481|FG006|Overall Study|Physician Decision|2|||
130556013|NCT04427501|470004482|FG007|Overall Study|Physician Decision|0|||
130556014|NCT04427501|470004483|FG008|Overall Study|Physician Decision|0|||
130556015|NCT04427501|470004484|FG009|Overall Study|Physician Decision|0|||
130556016|NCT04427501|470004485|FG010|Overall Study|Physician Decision|0|||
130556017|NCT04427501|470004486|FG011|Overall Study|Physician Decision|0|||
130556018|NCT04427501|470004475|FG000|Overall Study|Withdrawal by Subject|9|||
130556019|NCT04427501|470004476|FG001|Overall Study|Withdrawal by Subject|2|||
130556020|NCT04427501|470004477|FG002|Overall Study|Withdrawal by Subject|2|||
130556021|NCT04427501|470004478|FG003|Overall Study|Withdrawal by Subject|3|||
130556022|NCT04427501|470004479|FG004|Overall Study|Withdrawal by Subject|7|||
130556023|NCT04427501|470004480|FG005|Overall Study|Withdrawal by Subject|25|||
130556024|NCT04427501|470004481|FG006|Overall Study|Withdrawal by Subject|15|||
130556025|NCT04427501|470004482|FG007|Overall Study|Withdrawal by Subject|7|||
130556026|NCT04427501|470004483|FG008|Overall Study|Withdrawal by Subject|4|||
130556027|NCT04427501|470004484|FG009|Overall Study|Withdrawal by Subject|1|||
130556028|NCT04427501|470004485|FG010|Overall Study|Withdrawal by Subject|4|||
130556029|NCT04427501|470004486|FG011|Overall Study|Withdrawal by Subject|0|||
130556030|NCT04427501|470004475|FG000|Overall Study|Other - as reported by the investigator|1|||
130556031|NCT04427501|470004476|FG001|Overall Study|Other - as reported by the investigator|0|||
130556032|NCT04427501|470004477|FG002|Overall Study|Other - as reported by the investigator|0|||
130556033|NCT04427501|470004478|FG003|Overall Study|Other - as reported by the investigator|0|||
130556034|NCT04427501|470004479|FG004|Overall Study|Other - as reported by the investigator|0|||
130556035|NCT04427501|470004480|FG005|Overall Study|Other - as reported by the investigator|6|||
130556036|NCT04427501|470004481|FG006|Overall Study|Other - as reported by the investigator|6|||
130556037|NCT04427501|470004482|FG007|Overall Study|Other - as reported by the investigator|0|||
130556038|NCT04427501|470004483|FG008|Overall Study|Other - as reported by the investigator|0|||
130556039|NCT04427501|470004484|FG009|Overall Study|Other - as reported by the investigator|0|||
130556040|NCT04427501|470004485|FG010|Overall Study|Other - as reported by the investigator|0|||
130370461|NCT05275400|469327117|FG001|Treatment Period|Death|2|||
130556041|NCT04427501|470004486|FG011|Overall Study|Other - as reported by the investigator|0|||
130556042|NCT04427501|470004475|FG000|Overall Study|Other|0|||
130556043|NCT04427501|470004476|FG001|Overall Study|Other|0|||
130556044|NCT04427501|470004477|FG002|Overall Study|Other|0|||
130556045|NCT04427501|470004478|FG003|Overall Study|Other|0|||
130556046|NCT04427501|470004479|FG004|Overall Study|Other|0|||
130556047|NCT04427501|470004480|FG005|Overall Study|Other|0|||
130556048|NCT04427501|470004481|FG006|Overall Study|Other|0|||
130556049|NCT04427501|470004482|FG007|Overall Study|Other|0|||
130556050|NCT04427501|470004483|FG008|Overall Study|Other|0|||
130556051|NCT04427501|470004484|FG009|Overall Study|Other|0|||
130556052|NCT04427501|470004485|FG010|Overall Study|Other|0|||
130370462|NCT05275400|469327116|FG000|Treatment Period|Protocol Violation|1|||
130370463|NCT05275400|469327117|FG001|Treatment Period|Protocol Violation|0|||
130370464|NCT05275400|469327116|FG000|Treatment Period|Physician Decision|5|||
130370465|NCT05275400|469327117|FG001|Treatment Period|Physician Decision|4|||
130370466|NCT05275400|469327116|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
130370467|NCT05275400|469327117|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
130370468|NCT05275400|469327116|FG000|Treatment Period|Withdrawal by Subject|30|||
130370469|NCT05275400|469327117|FG001|Treatment Period|Withdrawal by Subject|12|||
130370470|NCT05275400|469327116|FG000|Treatment Period|Lost to Follow-up|1|||
130370471|NCT05275400|469327117|FG001|Treatment Period|Lost to Follow-up|5|||
130370472|NCT05275400|469327116|FG000|Treatment Period|Lack of Efficacy|1|||
130370473|NCT05275400|469327117|FG001|Treatment Period|Lack of Efficacy|0|||
130370474|NCT05275400|469327116|FG000|Treatment Period|Sponsor Decision|1|||
130556053|NCT04427501|470004486|FG011|Overall Study|Other|1|||
130556054|NCT00999713|470004487|FG000|Overall Study|Physician Decision|2|||
130556055|NCT00999713|470004488|FG001|Overall Study|Physician Decision|0|||
130370475|NCT05275400|469327117|FG001|Treatment Period|Sponsor Decision|0|||
130370476|NCT05275400|469327116|FG000|Follow-Up Period|Death|2|||
130370477|NCT05275400|469327117|FG001|Follow-Up Period|Death|0|||
130556056|NCT00639223|470004489|FG000|Overall Study|Lost to Follow-up|0|||
130556057|NCT00639223|470004490|FG001|Overall Study|Lost to Follow-up|2|||
130556058|NCT04936841|470004491|FG000|Overall Study|Death|1|||
130556059|NCT03739437|470004493|FG000|Overall Study|Lost to Follow-up|2|||
130556060|NCT03739437|470004494|FG001|Overall Study|Lost to Follow-up|5|||
130712762|NCT02119286|470575195|FG000|Overall Study|Lost to Follow-up|2|||
130712763|NCT02119286|470575196|FG001|Overall Study|Lost to Follow-up|0|||
130712764|NCT02119286|470575197|FG002|Overall Study|Lost to Follow-up|1|||
130712765|NCT02119286|470575195|FG000|Overall Study|Withdrawal by Subject|4|||
130712766|NCT02119286|470575196|FG001|Overall Study|Withdrawal by Subject|1|||
130712767|NCT02119286|470575197|FG002|Overall Study|Withdrawal by Subject|0|||
130712768|NCT03310411|470575198|FG000|Period 1|Adverse Event|0|||
130712769|NCT03310411|470575199|FG001|Period 1|Adverse Event|0|||
130712770|NCT03310411|470575200|FG002|Period 1|Adverse Event|0|||
130712771|NCT03310411|470575201|FG003|Period 1|Adverse Event|1|||
130287167|NCT02419131|469014671|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
130287168|NCT05426031|469014672|FG000|Overall Study|Circulatory Arrest|3|||
130287169|NCT05426031|469014673|FG001|Overall Study|Circulatory Arrest|2|||
130287170|NCT04677660|469014674|FG000|Overall Study|Lost to Follow-up|0|||
130287171|NCT04677660|469014675|FG001|Overall Study|Lost to Follow-up|2|||
130287172|NCT04677660|469014674|FG000|Overall Study|Withdrawal by Subject|0|||
130287173|NCT04677660|469014675|FG001|Overall Study|Withdrawal by Subject|1|||
130712772|NCT00619112|470575202|FG000|Overall Study|Adverse Event|1|||
130712773|NCT00619112|470575203|FG001|Overall Study|Adverse Event|2|||
130712774|NCT03623386|470575206|FG000|Overall Study|Protocol Violation|3|||
130712775|NCT03623386|470575207|FG001|Overall Study|Protocol Violation|2|||
130712776|NCT03623386|470575208|FG002|Overall Study|Protocol Violation|0|||
130712777|NCT03623386|470575206|FG000|Overall Study|Physician Decision|1|||
130712778|NCT03623386|470575207|FG001|Overall Study|Physician Decision|1|||
130712779|NCT03623386|470575208|FG002|Overall Study|Physician Decision|0|||
130712780|NCT03623386|470575206|FG000|Overall Study|Lost to Follow-up|0|||
130712781|NCT03623386|470575207|FG001|Overall Study|Lost to Follow-up|2|||
130287174|NCT04677660|469014674|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
130287175|NCT04677660|469014675|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
130712782|NCT03623386|470575208|FG002|Overall Study|Lost to Follow-up|0|||
130712783|NCT03623386|470575206|FG000|Overall Study|COVID-19|0|||
130712784|NCT03623386|470575207|FG001|Overall Study|COVID-19|1|||
130712785|NCT03623386|470575208|FG002|Overall Study|COVID-19|0|||
130712786|NCT04271735|470575213|FG000|Overall Study|Physician Decision|2|||
130712787|NCT04271735|470575214|FG001|Overall Study|Physician Decision|0|||
130712788|NCT00515541|470575215|FG000|Overall Study|Physician Decision|0|||
130712789|NCT00515541|470575216|FG001|Overall Study|Physician Decision|2|||
130712790|NCT00515541|470575217|FG002|Overall Study|Physician Decision|0|||
130712791|NCT00515541|470575218|FG003|Overall Study|Physician Decision|1|||
130712792|NCT00515541|470575215|FG000|Overall Study|No show for appointments|0|||
130712793|NCT00515541|470575216|FG001|Overall Study|No show for appointments|1|||
130712794|NCT00515541|470575217|FG002|Overall Study|No show for appointments|0|||
130712795|NCT00515541|470575218|FG003|Overall Study|No show for appointments|2|||
130712796|NCT00515541|470575215|FG000|Overall Study|Withdrawal by Subject|0|||
130712797|NCT00515541|470575216|FG001|Overall Study|Withdrawal by Subject|2|||
130287176|NCT02437305|469014679|FG000|Overall Study|Lost to Follow-up|18|||
130287177|NCT02437305|469014680|FG001|Overall Study|Lost to Follow-up|12|||
130287178|NCT01560637|469014697|FG000|Overall Study|Adverse Event|63|||
130287179|NCT01560637|469014697|FG000|Overall Study|Death|69|||
130287180|NCT01560637|469014697|FG000|Overall Study|Lost to Follow-up|8|||
130287181|NCT01560637|469014697|FG000|Overall Study|Protocol Violation|8|||
130287182|NCT01560637|469014697|FG000|Overall Study|Withdrawal by Subject|24|||
130287183|NCT01560637|469014697|FG000|Overall Study|Progressive Disease|20|||
130287184|NCT01560637|469014697|FG000|Overall Study|Other Reason Not Specified|6|||
130287185|NCT01071200|469014698|FG000|Overall Study|Lack of ovarian response|1|||
130287186|NCT01071200|469014699|FG001|Overall Study|Lack of ovarian response|1|||
130287187|NCT01071200|469014698|FG000|Overall Study|No fertilization|4|||
130287188|NCT01071200|469014699|FG001|Overall Study|No fertilization|0|||
130287189|NCT01071200|469014698|FG000|Overall Study|No oocytes retrieved|1|||
130287190|NCT01071200|469014699|FG001|Overall Study|No oocytes retrieved|1|||
130287191|NCT01071200|469014698|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
130712798|NCT00515541|470575217|FG002|Overall Study|Withdrawal by Subject|0|||
130712799|NCT00515541|470575218|FG003|Overall Study|Withdrawal by Subject|2|||
130712800|NCT02040779|470575220|FG000|Overall Study|Adverse Event|1|||
130712801|NCT02040779|470575221|FG001|Overall Study|Adverse Event|0|||
130712802|NCT02040779|470575222|FG002|Overall Study|Adverse Event|0|||
130712803|NCT02040779|470575220|FG000|Overall Study|Withdrawal by Subject|4|||
130712804|NCT02040779|470575221|FG001|Overall Study|Withdrawal by Subject|1|||
130712805|NCT02040779|470575222|FG002|Overall Study|Withdrawal by Subject|3|||
130712806|NCT02040779|470575220|FG000|Overall Study|Non-compliance|0|||
130712807|NCT02040779|470575221|FG001|Overall Study|Non-compliance|1|||
130712808|NCT02040779|470575222|FG002|Overall Study|Non-compliance|0|||
130712809|NCT02040779|470575220|FG000|Overall Study|Protocol Violation|2|||
130712810|NCT02040779|470575221|FG001|Overall Study|Protocol Violation|1|||
130287192|NCT01071200|469014699|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
130287193|NCT01071200|469014698|FG000|Overall Study|No viable embryos|0|||
130287194|NCT01071200|469014699|FG001|Overall Study|No viable embryos|1|||
130287195|NCT00413920|469014700|FG000|Overall Study|Adverse Event|9|||
130287196|NCT00413920|469014701|FG001|Overall Study|Adverse Event|11|||
130556061|NCT01395316|470004497|FG000|Overall Study|Lost to Follow-up|2|||
130556062|NCT01395316|470004497|FG000|Overall Study|poor MRI quality|1|||
130556063|NCT03359590|470004498|FG000|First Intervention|Withdrawal by Subject|1|||
130556064|NCT03359590|470004499|FG001|First Intervention|Withdrawal by Subject|1|||
130556065|NCT03359590|470004498|FG000|First Intervention|Protocol Violation|0|||
130556066|NCT03359590|470004499|FG001|First Intervention|Protocol Violation|1|||
130556067|NCT02846532|470004500|FG000|Overall Study|Lost to Follow-up|0|||
130556068|NCT02846532|470004501|FG001|Overall Study|Lost to Follow-up|1|||
130556069|NCT02846532|470004502|FG002|Overall Study|Lost to Follow-up|1|||
130556070|NCT02846532|470004500|FG000|Overall Study|Withdrawal by Subject|1|||
130556071|NCT02846532|470004501|FG001|Overall Study|Withdrawal by Subject|2|||
130556072|NCT02846532|470004502|FG002|Overall Study|Withdrawal by Subject|0|||
130556073|NCT06132425|470004503|FG000|Overall Study|Withdrawal by Subject|3|||
130556074|NCT06132425|470004504|FG001|Overall Study|Withdrawal by Subject|0|||
130556075|NCT06132425|470004503|FG000|Overall Study|Did not follow study instructions|0|||
130556076|NCT06132425|470004504|FG001|Overall Study|Did not follow study instructions|2|||
130556077|NCT06132425|470004503|FG000|Overall Study|Lost to Follow-up|3|||
130556078|NCT06132425|470004504|FG001|Overall Study|Lost to Follow-up|5|||
130556079|NCT01019980|470004510|FG000|Overall Study|Drug not available.|2|||
130712811|NCT02040779|470575222|FG002|Overall Study|Protocol Violation|0|||
130712812|NCT02040779|470575220|FG000|Overall Study|Lost to Follow-up|1|||
130712813|NCT02040779|470575221|FG001|Overall Study|Lost to Follow-up|2|||
130287197|NCT00413920|469014700|FG000|Overall Study|Lack of Efficacy|11|||
130287198|NCT00413920|469014701|FG001|Overall Study|Lack of Efficacy|9|||
130287199|NCT00413920|469014700|FG000|Overall Study|Death|3|||
130287200|NCT00413920|469014701|FG001|Overall Study|Death|5|||
130287201|NCT00413920|469014700|FG000|Overall Study|Graft Loss|5|||
130712814|NCT02040779|470575222|FG002|Overall Study|Lost to Follow-up|1|||
130712815|NCT02040779|470575220|FG000|Overall Study|Lack of Efficacy|4|||
130287202|NCT00413920|469014701|FG001|Overall Study|Graft Loss|3|||
130287203|NCT03730961|469014702|FG000|Overall Study|Adverse Event|0|||
130287204|NCT03730961|469014703|FG001|Overall Study|Adverse Event|1|||
130287205|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
130287206|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
130287207|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
130287208|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
130370478|NCT05275400|469327116|FG000|Follow-Up Period|Protocol Violation|1|||
130712816|NCT02040779|470575221|FG001|Overall Study|Lack of Efficacy|2|||
130712817|NCT02040779|470575222|FG002|Overall Study|Lack of Efficacy|0|||
130712818|NCT02132637|470575223|FG000|Study Period 1|Withdrawal by Subject|0|||
130712819|NCT02132637|470575224|FG001|Study Period 1|Withdrawal by Subject|4|||
130712820|NCT02132637|470575223|FG000|Study Period 1|Physician Decision|1|||
130712821|NCT02132637|470575224|FG001|Study Period 1|Physician Decision|0|||
130712822|NCT02132637|470575223|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
130712823|NCT02132637|470575224|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
130712824|NCT02132637|470575223|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
130712825|NCT02132637|470575224|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
130712826|NCT00922272|470575227|FG000|Open-label Phase|Adverse Event|5|||
130712827|NCT00922272|470575228|FG001|Open-label Phase|Adverse Event|0|||
130712828|NCT00922272|470575227|FG000|Open-label Phase|Protocol Violation|1|||
130712829|NCT00922272|470575228|FG001|Open-label Phase|Protocol Violation|0|||
130712830|NCT00922272|470575227|FG000|Open-label Phase|Withdrawal by Subject|11|||
130712831|NCT00922272|470575228|FG001|Open-label Phase|Withdrawal by Subject|0|||
130712832|NCT00922272|470575227|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
130712833|NCT00922272|470575228|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
130712834|NCT00922272|470575227|FG000|Open-label Phase|Withdrawal criteria met|5|||
130712835|NCT00922272|470575228|FG001|Open-label Phase|Withdrawal criteria met|0|||
130712836|NCT00922272|470575227|FG000|Double-blind Phase|Adverse Event|1|||
130712837|NCT00922272|470575228|FG001|Double-blind Phase|Adverse Event|1|||
130712838|NCT00922272|470575227|FG000|Double-blind Phase|Withdrawal by Subject|1|||
130712839|NCT00922272|470575228|FG001|Double-blind Phase|Withdrawal by Subject|1|||
130370479|NCT05275400|469327117|FG001|Follow-Up Period|Protocol Violation|0|||
130556080|NCT01019980|470004511|FG001|Overall Study|Drug not available.|0|||
130712840|NCT00922272|470575227|FG000|Double-blind Phase|Lost to Follow-up|2|||
130712841|NCT00922272|470575228|FG001|Double-blind Phase|Lost to Follow-up|1|||
130712842|NCT00922272|470575227|FG000|Double-blind Phase|Withdrawal criteria met|1|||
130712843|NCT00922272|470575228|FG001|Double-blind Phase|Withdrawal criteria met|1|||
130287209|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
130556081|NCT02383589|470004521|FG000|Treatment Period|Adverse Event|1|||
130556082|NCT02383589|470004522|FG001|Treatment Period|Adverse Event|3|||
130556083|NCT02383589|470004521|FG000|Treatment Period|Lost to Follow-up|0|||
130712844|NCT00922272|470575227|FG000|Double-blind Phase|Noncompliance|1|||
130712845|NCT00922272|470575228|FG001|Double-blind Phase|Noncompliance|1|||
130712846|NCT00922272|470575227|FG000|Double-blind Phase|Positive urine drug screen|1|||
130287210|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
130370480|NCT05275400|469327116|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130556084|NCT02383589|470004522|FG001|Treatment Period|Lost to Follow-up|1|||
130712847|NCT00922272|470575228|FG001|Double-blind Phase|Positive urine drug screen|1|||
130712848|NCT02588950|470575229|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
130712849|NCT02588950|470575230|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
130712850|NCT02588950|470575231|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
130712851|NCT02588950|470575232|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
130712852|NCT02588950|470575229|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
130712853|NCT02588950|470575230|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
130712854|NCT02588950|470575231|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
130712855|NCT02588950|470575232|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
130712856|NCT00652028|470575235|FG000|Overall Study|Adverse Event|1|||
130712857|NCT00652028|470575236|FG001|Overall Study|Adverse Event|0|||
130712858|NCT00652028|470575237|FG002|Overall Study|Adverse Event|0|||
130712859|NCT00652028|470575238|FG003|Overall Study|Adverse Event|0|||
130712860|NCT00652028|470575235|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
130712861|NCT00652028|470575236|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
130712862|NCT00652028|470575237|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
130712863|NCT00652028|470575238|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
130712864|NCT00652028|470575235|FG000|Overall Study|Physician Decision|0|||
130712865|NCT00652028|470575236|FG001|Overall Study|Physician Decision|0|||
130712866|NCT00652028|470575237|FG002|Overall Study|Physician Decision|1|||
130712867|NCT00652028|470575238|FG003|Overall Study|Physician Decision|0|||
130712868|NCT02400671|470575242|FG000|Overall Study|Death|5|||
130370481|NCT05275400|469327117|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130370482|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Physician Decision|0|||
130370483|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Physician Decision|1|||
130370484|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Physician Decision|0|||
130370485|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
130370486|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
130370487|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
130370488|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
130370489|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
130370490|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
130370491|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Other|4|||
130370492|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Other|4|||
130370493|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Other|0|||
130370494|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
130370495|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
130370496|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
130370497|NCT02585960|469327118|FG000|PK/Safety Assessment Period|Screen Failure|0|||
130370498|NCT02585960|469327119|FG001|PK/Safety Assessment Period|Screen Failure|0|||
130370499|NCT02585960|469327120|FG002|PK/Safety Assessment Period|Screen Failure|1|||
130370500|NCT02585960|469327118|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
130370501|NCT02585960|469327119|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
130370502|NCT02585960|469327120|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
130370503|NCT02585960|469327118|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
130370504|NCT02585960|469327119|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
130370505|NCT02585960|469327120|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
130370506|NCT03639935|469327121|FG000|Overall Study|Death|3|||
130370507|NCT03639935|469327121|FG000|Overall Study|Adverse Event|1|||
130370508|NCT06333613|469327123|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
130370509|NCT03616600|469327125|FG000|Overall Study|Withdrawal by Subject|1|||
130370510|NCT03616600|469327126|FG001|Overall Study|Withdrawal by Subject|0|||
130370511|NCT01651039|469327128|FG000|Overall Study|Non-evaluables|5|||
130370512|NCT01651039|469327128|FG000|Overall Study|Physician Decision|2|||
130370513|NCT01651039|469327128|FG000|Overall Study|Withdrawal by Subject|1|||
130370514|NCT01651039|469327128|FG000|Overall Study|Progressive Disease|22|||
130370515|NCT02059395|469327129|FG000|Overall Study|Lost to Follow-up|2|||
130370516|NCT02059395|469327130|FG001|Overall Study|Lost to Follow-up|4|||
130370517|NCT00134082|469327131|FG000|Overall Study|Adverse Event|2|||
130370518|NCT00134082|469327131|FG000|Overall Study|Death|1|||
130370519|NCT01488370|469327132|FG000|Overall Study|Protocol Violation|0|||
130370520|NCT01488370|469327133|FG001|Overall Study|Protocol Violation|1|||
130370521|NCT01488370|469327134|FG002|Overall Study|Protocol Violation|1|||
130370522|NCT05393895|469327143|FG000|Overall Study|Adverse Event|2|||
130370523|NCT05393895|469327144|FG001|Overall Study|Adverse Event|3|||
130370524|NCT05393895|469327143|FG000|Overall Study|Lost to Follow-up|4|||
130370525|NCT05393895|469327144|FG001|Overall Study|Lost to Follow-up|3|||
130712869|NCT02400671|470575243|FG001|Overall Study|Death|3|||
130712870|NCT02400671|470575244|FG002|Overall Study|Death|4|||
130370526|NCT05393895|469327143|FG000|Overall Study|Protocol Violation|1|||
130712871|NCT02400671|470575242|FG000|Overall Study|Lost to Follow-up|20|||
130712872|NCT02400671|470575243|FG001|Overall Study|Lost to Follow-up|27|||
130712873|NCT02400671|470575244|FG002|Overall Study|Lost to Follow-up|24|||
130712874|NCT02400671|470575242|FG000|Overall Study|Withdrawal by Subject|2|||
130712875|NCT02400671|470575243|FG001|Overall Study|Withdrawal by Subject|2|||
130459221|NCT01193153|469645242|FG000|Open-label Stabilization Period|Death|2|||
130459222|NCT01193153|469645243|FG001|Open-label Stabilization Period|Death|0|||
130459223|NCT01193153|469645242|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
130459224|NCT01193153|469645243|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
130459225|NCT01193153|469645242|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
130459226|NCT01193153|469645243|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
130459227|NCT01193153|469645242|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
130459228|NCT01193153|469645243|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
130459229|NCT01193153|469645242|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
130459230|NCT01193153|469645243|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
130459231|NCT01193153|469645242|FG000|Open-label Stabilization Period|Other|8|||
130459232|NCT01193153|469645243|FG001|Open-label Stabilization Period|Other|0|||
130459233|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Other|2|||
130712876|NCT02400671|470575244|FG002|Overall Study|Withdrawal by Subject|0|||
130459234|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Other|3|||
130459235|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
130459236|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
130459237|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Death|2|||
130459238|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Death|0|||
130459239|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
130459240|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
130459241|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
130459242|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
130459243|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
130459244|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
130459245|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
130459246|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
130459247|NCT01193153|469645242|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
130459248|NCT01193153|469645243|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
130459249|NCT01648140|469645244|FG000|Overall Study|Physician Decision|1|||
130459250|NCT01648140|469645245|FG001|Overall Study|Physician Decision|0|||
130459251|NCT01648140|469645246|FG002|Overall Study|Physician Decision|0|||
130459252|NCT01648140|469645247|FG003|Overall Study|Physician Decision|0|||
130459253|NCT01648140|469645244|FG000|Overall Study|Lack of Efficacy|4|||
130459254|NCT01648140|469645245|FG001|Overall Study|Lack of Efficacy|7|||
130459255|NCT01648140|469645246|FG002|Overall Study|Lack of Efficacy|1|||
130459256|NCT01648140|469645247|FG003|Overall Study|Lack of Efficacy|0|||
130459257|NCT01648140|469645244|FG000|Overall Study|Adverse Event|3|||
130459258|NCT01648140|469645245|FG001|Overall Study|Adverse Event|1|||
130459259|NCT01648140|469645246|FG002|Overall Study|Adverse Event|2|||
130459260|NCT01648140|469645247|FG003|Overall Study|Adverse Event|0|||
130459261|NCT01648140|469645244|FG000|Overall Study|Withdrawal by Subject|2|||
130556085|NCT02383589|470004521|FG000|Treatment Period|Withdrawal by Subject|0|||
130712877|NCT01429051|470575250|FG000|Titration Phase|Death|1|||
130712878|NCT01429051|470575250|FG000|Titration Phase|Withdrawal by Subject|7|||
130712879|NCT01429051|470575250|FG000|Titration Phase|Physician Decision|1|||
130712880|NCT01429051|470575250|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
130712881|NCT01429051|470575250|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
130712882|NCT01429051|470575250|FG000|Efficacy Phase|Adverse Event|1|||
130712883|NCT01429051|470575250|FG000|Efficacy Phase|Death|1|||
130712884|NCT01429051|470575250|FG000|Tolerability Phase|Death|5|||
130712885|NCT01429051|470575250|FG000|Tolerability Phase|Adverse Event|2|||
130712886|NCT01429051|470575250|FG000|Tolerability Phase|Withdrawal by Subject|5|||
130712887|NCT01429051|470575250|FG000|Tolerability Phase|Physician Decision|1|||
130712888|NCT01429051|470575250|FG000|Tolerability Phase|Other|2|||
130712889|NCT01797835|470575255|FG000|Overall Study|Lost to Follow-up|31|||
130712890|NCT01797835|470575256|FG001|Overall Study|Lost to Follow-up|27|||
130459262|NCT01648140|469645245|FG001|Overall Study|Withdrawal by Subject|3|||
130459263|NCT01648140|469645246|FG002|Overall Study|Withdrawal by Subject|3|||
130459264|NCT01648140|469645247|FG003|Overall Study|Withdrawal by Subject|2|||
130459265|NCT01648140|469645244|FG000|Overall Study|Lost to Follow-up|2|||
130459266|NCT01648140|469645245|FG001|Overall Study|Lost to Follow-up|1|||
130459267|NCT01648140|469645246|FG002|Overall Study|Lost to Follow-up|2|||
130459268|NCT01648140|469645247|FG003|Overall Study|Lost to Follow-up|0|||
130459269|NCT01909336|469645256|FG000|Overall Study|Lost to Follow-up|4|||
130459270|NCT01909336|469645257|FG001|Overall Study|Lost to Follow-up|2|||
130712891|NCT03001219|470575257|FG000|Proof of Concept|Study Termination by Sponsor|0|||
130712892|NCT03001219|470575258|FG001|Proof of Concept|Study Termination by Sponsor|1|||
130712893|NCT03001219|470575257|FG000|Proof of Concept|Withdrawal by Subject|0|||
130459271|NCT01909336|469645258|FG002|Overall Study|Lost to Follow-up|2|||
130459272|NCT01909336|469645256|FG000|Overall Study|Physician Decision|0|||
130712894|NCT03001219|470575258|FG001|Proof of Concept|Withdrawal by Subject|4|||
130712895|NCT03001219|470575257|FG000|Proof of Concept|Protocol Deviation|0|||
130712896|NCT03001219|470575258|FG001|Proof of Concept|Protocol Deviation|1|||
130712897|NCT03001219|470575257|FG000|Proof of Concept|Adverse Event|1|||
130712898|NCT03001219|470575258|FG001|Proof of Concept|Adverse Event|1|||
130712899|NCT03001219|470575257|FG000|Proof of Concept|Physician Decision|1|||
130712900|NCT03001219|470575258|FG001|Proof of Concept|Physician Decision|0|||
130712901|NCT03001219|470575257|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
130712902|NCT03001219|470575258|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
130712903|NCT03001219|470575257|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
130712904|NCT03001219|470575258|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
130712905|NCT03001219|470575257|FG000|Extension Period Analysis|Physician Decision|0|||
130712906|NCT03001219|470575258|FG001|Extension Period Analysis|Physician Decision|1|||
130712907|NCT03001219|470575257|FG000|Extension Period Analysis|Adverse Event|1|||
130712908|NCT03001219|470575258|FG001|Extension Period Analysis|Adverse Event|1|||
130712909|NCT03001219|470575257|FG000|Extension Period Analysis|Protocol Deviation|0|||
130712910|NCT03001219|470575258|FG001|Extension Period Analysis|Protocol Deviation|1|||
130712911|NCT03001219|470575257|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
130712912|NCT03001219|470575258|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
130712913|NCT01195103|470575259|FG000|Overall Study|Withdrawal by Subject|1|||
130712914|NCT01195103|470575260|FG001|Overall Study|Withdrawal by Subject|0|||
130712915|NCT01195103|470575261|FG002|Overall Study|Withdrawal by Subject|0|||
130712916|NCT02528123|470575262|FG000|Overall Study|Lost to Follow-up|1|||
130712917|NCT03733210|470575263|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
130712918|NCT03733210|470575264|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
130712919|NCT03760250|470575265|FG000|Overall Study|Withdrawal by Subject|1|||
130712920|NCT03760250|470575265|FG000|Overall Study|Physician Decision|1|||
130712921|NCT04421586|470575272|FG000|Overall Study|Death|0|||
130712922|NCT04421586|470575273|FG001|Overall Study|Death|1|||
130712923|NCT04421586|470575272|FG000|Overall Study|Lost to Follow-up|2|||
130712924|NCT04421586|470575273|FG001|Overall Study|Lost to Follow-up|2|||
130712925|NCT04421586|470575272|FG000|Overall Study|Withdrawn by PI|1|||
130712926|NCT04421586|470575273|FG001|Overall Study|Withdrawn by PI|0|||
130712927|NCT04421586|470575272|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
130712928|NCT04421586|470575273|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
130712929|NCT02963441|470575274|FG000|Overall Study|Protocol violation or withdrawn|8|||
130712930|NCT02963441|470575274|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
130712931|NCT02963441|470575274|FG000|Overall Study|IDx-DR insufficient quality|33|||
130712932|NCT02669940|470575277|FG000|Overall Study|Failure to return|0|||
130712933|NCT02669940|470575278|FG001|Overall Study|Failure to return|3|||
130712934|NCT02669940|470575277|FG000|Overall Study|Insufficient follow-up data|1|||
130712935|NCT02669940|470575278|FG001|Overall Study|Insufficient follow-up data|0|||
130712936|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Adverse Event|9|||
130712937|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Adverse Event|4|||
130712938|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Adverse Event|5|||
130712939|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Adverse Event|9|||
130712940|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Adverse Event|8|||
130712941|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Adverse Event|0|||
130712942|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Adverse Event|0|||
130712943|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
130712944|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712945|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712946|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
130712947|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
130712948|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712949|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712950|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Death|1|||
130712951|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Death|1|||
130712952|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Death|1|||
130712953|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Death|1|||
130712954|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Death|0|||
130712955|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Death|0|||
130287211|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
130287212|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
130287213|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287214|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287215|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
130287216|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287217|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Adverse Event|1|||
130287218|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Adverse Event|0|||
130712956|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Death|0|||
130712957|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130712958|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130712959|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130712960|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130556086|NCT02383589|470004522|FG001|Treatment Period|Withdrawal by Subject|5|||
130556087|NCT02383589|470004521|FG000|Treatment Period|Non-compliance with study drug|0|||
130556088|NCT02383589|470004522|FG001|Treatment Period|Non-compliance with study drug|1|||
130556089|NCT02383589|470004521|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
130556090|NCT02383589|470004522|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
130556091|NCT02383589|470004521|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
130556092|NCT02383589|470004522|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
130556093|NCT02383589|470004521|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
130556094|NCT02383589|470004522|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
130556095|NCT04225806|470004523|FG000|Overall Study|Trial termination|15|||
130556096|NCT02408861|470004526|FG000|Overall Study|Death|0|||
130556097|NCT02408861|470004527|FG001|Overall Study|Death|3|||
130556098|NCT02408861|470004528|FG002|Overall Study|Death|1|||
130556099|NCT02408861|470004529|FG003|Overall Study|Death|2|||
130556100|NCT02408861|470004530|FG004|Overall Study|Death|4|||
130556101|NCT02408861|470004531|FG005|Overall Study|Death|1|||
130556102|NCT02408861|470004532|FG006|Overall Study|Death|0|||
130556103|NCT02408861|470004526|FG000|Overall Study|Lost to Follow-up|0|||
130556104|NCT02408861|470004527|FG001|Overall Study|Lost to Follow-up|0|||
130556105|NCT02408861|470004528|FG002|Overall Study|Lost to Follow-up|1|||
130556106|NCT02408861|470004529|FG003|Overall Study|Lost to Follow-up|1|||
130556107|NCT02408861|470004530|FG004|Overall Study|Lost to Follow-up|4|||
130556108|NCT02408861|470004531|FG005|Overall Study|Lost to Follow-up|2|||
130556109|NCT02408861|470004532|FG006|Overall Study|Lost to Follow-up|1|||
130556110|NCT02408861|470004526|FG000|Overall Study|Disease Progression|0|||
130556111|NCT02408861|470004527|FG001|Overall Study|Disease Progression|0|||
130556112|NCT02408861|470004528|FG002|Overall Study|Disease Progression|1|||
130556113|NCT02408861|470004529|FG003|Overall Study|Disease Progression|0|||
130556114|NCT02408861|470004530|FG004|Overall Study|Disease Progression|3|||
130556115|NCT02408861|470004531|FG005|Overall Study|Disease Progression|1|||
130556116|NCT02408861|470004532|FG006|Overall Study|Disease Progression|1|||
130556117|NCT02408861|470004526|FG000|Overall Study|Adverse Event|1|||
130556118|NCT02408861|470004527|FG001|Overall Study|Adverse Event|0|||
130556119|NCT02408861|470004528|FG002|Overall Study|Adverse Event|1|||
130556120|NCT02408861|470004529|FG003|Overall Study|Adverse Event|0|||
130556121|NCT02408861|470004530|FG004|Overall Study|Adverse Event|2|||
130556122|NCT02408861|470004531|FG005|Overall Study|Adverse Event|0|||
130556123|NCT02408861|470004532|FG006|Overall Study|Adverse Event|0|||
130556124|NCT02408861|470004526|FG000|Overall Study|Physician Decision|1|||
130556125|NCT02408861|470004527|FG001|Overall Study|Physician Decision|1|||
130556126|NCT02408861|470004528|FG002|Overall Study|Physician Decision|1|||
130556127|NCT02408861|470004529|FG003|Overall Study|Physician Decision|0|||
130556128|NCT02408861|470004530|FG004|Overall Study|Physician Decision|0|||
130556129|NCT02408861|470004531|FG005|Overall Study|Physician Decision|1|||
130556130|NCT02408861|470004532|FG006|Overall Study|Physician Decision|0|||
130556131|NCT02408861|470004526|FG000|Overall Study|Protocol Violation|1|||
130556132|NCT02408861|470004527|FG001|Overall Study|Protocol Violation|0|||
130556133|NCT02408861|470004528|FG002|Overall Study|Protocol Violation|0|||
130556134|NCT02408861|470004529|FG003|Overall Study|Protocol Violation|0|||
130556135|NCT02408861|470004530|FG004|Overall Study|Protocol Violation|0|||
130556136|NCT02408861|470004531|FG005|Overall Study|Protocol Violation|0|||
130556137|NCT02408861|470004532|FG006|Overall Study|Protocol Violation|0|||
130556138|NCT02408861|470004526|FG000|Overall Study|Withdrawal by Subject|0|||
130556139|NCT02408861|470004527|FG001|Overall Study|Withdrawal by Subject|0|||
130556140|NCT02408861|470004528|FG002|Overall Study|Withdrawal by Subject|0|||
130556141|NCT02408861|470004529|FG003|Overall Study|Withdrawal by Subject|0|||
130556142|NCT02408861|470004530|FG004|Overall Study|Withdrawal by Subject|1|||
130556143|NCT02408861|470004531|FG005|Overall Study|Withdrawal by Subject|1|||
130556144|NCT02408861|470004532|FG006|Overall Study|Withdrawal by Subject|0|||
130556145|NCT02408861|470004526|FG000|Overall Study|Other Treatment|0|||
130712961|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130712962|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
130712963|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
130556146|NCT02408861|470004527|FG001|Overall Study|Other Treatment|0|||
130556147|NCT02408861|470004528|FG002|Overall Study|Other Treatment|0|||
130556148|NCT02408861|470004529|FG003|Overall Study|Other Treatment|0|||
130556149|NCT02408861|470004530|FG004|Overall Study|Other Treatment|0|||
130556150|NCT02408861|470004531|FG005|Overall Study|Other Treatment|1|||
130556151|NCT02408861|470004532|FG006|Overall Study|Other Treatment|1|||
130556152|NCT05460273|470004533|FG000|Overall Study|Death|43|||
130556153|NCT05460273|470004534|FG001|Overall Study|Death|9|||
130556154|NCT05460273|470004533|FG000|Overall Study|Lost to Follow-up|7|||
130556155|NCT05460273|470004534|FG001|Overall Study|Lost to Follow-up|0|||
130556156|NCT05460273|470004533|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
130556157|NCT05460273|470004534|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
130556158|NCT04124614|470004535|FG000|Placebo Run-in Period|Not Randomized|34|||
130556159|NCT04124614|470004536|FG001|Placebo Run-in Period|Not Randomized|0|||
130556160|NCT04124614|470004537|FG002|Placebo Run-in Period|Not Randomized|0|||
130459273|NCT01909336|469645257|FG001|Overall Study|Physician Decision|1|||
130459274|NCT01909336|469645258|FG002|Overall Study|Physician Decision|1|||
130459275|NCT01157182|469645259|FG000|Washout of 28 Days|Adverse Event|2|||
130459276|NCT01157182|469645260|FG001|Washout of 28 Days|Adverse Event|0|||
130459277|NCT00716144|469645261|FG000|Overall Study|Withdrawal by Subject|4|||
130459278|NCT00716144|469645262|FG001|Overall Study|Withdrawal by Subject|2|||
130459279|NCT00716144|469645263|FG002|Overall Study|Withdrawal by Subject|6|||
130459280|NCT00716144|469645264|FG003|Overall Study|Withdrawal by Subject|6|||
130459281|NCT00716144|469645261|FG000|Overall Study|Lost to Follow-up|2|||
130459282|NCT00716144|469645262|FG001|Overall Study|Lost to Follow-up|2|||
130459283|NCT00716144|469645263|FG002|Overall Study|Lost to Follow-up|1|||
130459284|NCT00716144|469645264|FG003|Overall Study|Lost to Follow-up|2|||
130459285|NCT00716144|469645261|FG000|Overall Study|Adverse Event|0|||
130459286|NCT00716144|469645262|FG001|Overall Study|Adverse Event|0|||
130459287|NCT00716144|469645263|FG002|Overall Study|Adverse Event|0|||
130459288|NCT00716144|469645264|FG003|Overall Study|Adverse Event|2|||
130459289|NCT00716144|469645261|FG000|Overall Study|Non-compliance|1|||
130459290|NCT00716144|469645262|FG001|Overall Study|Non-compliance|0|||
130459291|NCT00716144|469645263|FG002|Overall Study|Non-compliance|0|||
130459292|NCT00716144|469645264|FG003|Overall Study|Non-compliance|0|||
130459293|NCT00716144|469645261|FG000|Overall Study|Protocol Violation|2|||
130459294|NCT00716144|469645262|FG001|Overall Study|Protocol Violation|0|||
130459295|NCT00716144|469645263|FG002|Overall Study|Protocol Violation|1|||
130459296|NCT00716144|469645264|FG003|Overall Study|Protocol Violation|0|||
130459297|NCT00716144|469645261|FG000|Overall Study|Physician Decision|0|||
130459298|NCT00716144|469645262|FG001|Overall Study|Physician Decision|1|||
130459299|NCT00716144|469645263|FG002|Overall Study|Physician Decision|2|||
130459300|NCT00716144|469645264|FG003|Overall Study|Physician Decision|2|||
130459301|NCT00716144|469645261|FG000|Overall Study|Intercurrent illness|0|||
130459302|NCT00716144|469645262|FG001|Overall Study|Intercurrent illness|0|||
130459303|NCT00716144|469645263|FG002|Overall Study|Intercurrent illness|1|||
130459304|NCT00716144|469645264|FG003|Overall Study|Intercurrent illness|0|||
130459305|NCT00716144|469645261|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
130459306|NCT00716144|469645262|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
130459307|NCT00716144|469645263|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
130459308|NCT00716144|469645264|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
130459309|NCT00716144|469645261|FG000|Overall Study|Adverse event: left foot pain|0|||
130459310|NCT00716144|469645262|FG001|Overall Study|Adverse event: left foot pain|1|||
130459311|NCT00716144|469645263|FG002|Overall Study|Adverse event: left foot pain|0|||
130459312|NCT00716144|469645264|FG003|Overall Study|Adverse event: left foot pain|0|||
130459313|NCT00716144|469645261|FG000|Overall Study|Clinical Depression|0|||
130459314|NCT00716144|469645262|FG001|Overall Study|Clinical Depression|1|||
130459315|NCT00716144|469645263|FG002|Overall Study|Clinical Depression|0|||
130459316|NCT00716144|469645264|FG003|Overall Study|Clinical Depression|0|||
130459317|NCT02950558|469645265|FG000|Overall Study|Lost to Follow-up|2|||
130459318|NCT02950558|469645266|FG001|Overall Study|Lost to Follow-up|0|||
130459319|NCT01321606|469645269|FG000|Overall Study|Lost to Follow-up|0|||
130459320|NCT01321606|469645270|FG001|Overall Study|Lost to Follow-up|0|||
130459321|NCT01321606|469645271|FG002|Overall Study|Lost to Follow-up|0|||
130459322|NCT01321606|469645272|FG003|Overall Study|Lost to Follow-up|1|||
130459323|NCT00756730|469645277|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
130459324|NCT00756730|469645278|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
130459325|NCT00756730|469645277|FG000|Overall Study|persistent low-level viremmia|0|||
130459326|NCT00756730|469645278|FG001|Overall Study|persistent low-level viremmia|1|||
130459327|NCT01161498|469645280|FG000|Overall Study|Disease Progression|0|||
130459328|NCT01161498|469645281|FG001|Overall Study|Disease Progression|1|||
130459329|NCT05686421|469645282|FG000|Overall Study|Screen failure|22|||
130459330|NCT05686421|469645283|FG001|Overall Study|Screen failure|0|||
130459331|NCT05686421|469645284|FG002|Overall Study|Screen failure|0|||
130459332|NCT05686421|469645285|FG003|Overall Study|Screen failure|0|||
130459333|NCT00367055|469645289|FG000|Overall Study|Adverse Event|6|||
130459334|NCT00367055|469645290|FG001|Overall Study|Adverse Event|3|||
130459335|NCT00367055|469645289|FG000|Overall Study|Patient's Willing|3|||
130459336|NCT00367055|469645290|FG001|Overall Study|Patient's Willing|2|||
130459337|NCT00367055|469645289|FG000|Overall Study|Lack of Efficacy|1|||
130459338|NCT00367055|469645290|FG001|Overall Study|Lack of Efficacy|2|||
130459339|NCT00367055|469645289|FG000|Overall Study|Lost to Follow-up|1|||
130459340|NCT00367055|469645290|FG001|Overall Study|Lost to Follow-up|1|||
130459341|NCT00367055|469645289|FG000|Overall Study|Protocol Violation|0|||
130459342|NCT00367055|469645290|FG001|Overall Study|Protocol Violation|1|||
130459343|NCT00367055|469645289|FG000|Overall Study|Stopping Criterion Met|0|||
130459344|NCT00367055|469645290|FG001|Overall Study|Stopping Criterion Met|1|||
130459345|NCT00367055|469645289|FG000|Overall Study|Participant Living too Far from Hospital|0|||
130459346|NCT00367055|469645290|FG001|Overall Study|Participant Living too Far from Hospital|1|||
130459347|NCT02517307|469645305|FG000|Overall Study|Withdrawal by Subject|1|||
130459348|NCT02517307|469645306|FG001|Overall Study|Withdrawal by Subject|0|||
130459349|NCT02517307|469645307|FG002|Overall Study|Withdrawal by Subject|1|||
130459350|NCT02517307|469645308|FG003|Overall Study|Withdrawal by Subject|0|||
130459351|NCT02517307|469645305|FG000|Overall Study|Protocol Violation|0|||
130459352|NCT02517307|469645306|FG001|Overall Study|Protocol Violation|0|||
130459353|NCT02517307|469645307|FG002|Overall Study|Protocol Violation|1|||
130459354|NCT02517307|469645308|FG003|Overall Study|Protocol Violation|1|||
130459355|NCT00823979|469645309|FG000|Overall Study|Lack of Efficacy|13|||
130459356|NCT00823979|469645310|FG001|Overall Study|Lack of Efficacy|16|||
130459357|NCT00823979|469645311|FG002|Overall Study|Lack of Efficacy|9|||
130459358|NCT00823979|469645309|FG000|Overall Study|Lost to Follow-up|2|||
130459359|NCT00823979|469645310|FG001|Overall Study|Lost to Follow-up|1|||
130459360|NCT00823979|469645311|FG002|Overall Study|Lost to Follow-up|0|||
130459361|NCT00823979|469645309|FG000|Overall Study|Withdrawal by Subject|2|||
130459362|NCT00823979|469645310|FG001|Overall Study|Withdrawal by Subject|3|||
130459363|NCT00823979|469645311|FG002|Overall Study|Withdrawal by Subject|2|||
130459364|NCT00823979|469645309|FG000|Overall Study|Protocol Violation|1|||
130459365|NCT00823979|469645310|FG001|Overall Study|Protocol Violation|1|||
130459366|NCT00823979|469645311|FG002|Overall Study|Protocol Violation|0|||
130459367|NCT00823979|469645309|FG000|Overall Study|Pregnancy|0|||
130459368|NCT00823979|469645310|FG001|Overall Study|Pregnancy|1|||
130459369|NCT00823979|469645311|FG002|Overall Study|Pregnancy|0|||
130459370|NCT00823979|469645309|FG000|Overall Study|Adverse Event|0|||
130459371|NCT00823979|469645310|FG001|Overall Study|Adverse Event|2|||
130459372|NCT00823979|469645311|FG002|Overall Study|Adverse Event|4|||
130459373|NCT00823979|469645309|FG000|Overall Study|Other|2|||
130459374|NCT00823979|469645310|FG001|Overall Study|Other|0|||
130459375|NCT00823979|469645311|FG002|Overall Study|Other|1|||
130459376|NCT00823979|469645309|FG000|Overall Study|Randomized but not Treated|4|||
130459377|NCT00823979|469645310|FG001|Overall Study|Randomized but not Treated|3|||
130459378|NCT00823979|469645311|FG002|Overall Study|Randomized but not Treated|1|||
130459379|NCT00823979|469645309|FG000|Overall Study|Study Terminated by Sponsor|5|||
130459380|NCT00823979|469645310|FG001|Overall Study|Study Terminated by Sponsor|5|||
130459381|NCT00823979|469645311|FG002|Overall Study|Study Terminated by Sponsor|7|||
130459382|NCT05019729|469645312|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130459383|NCT05019729|469645313|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130459384|NCT05019729|469645314|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130459385|NCT05019729|469645315|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130459386|NCT05019729|469645316|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
130459387|NCT05019729|469645317|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130287219|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Adverse Event|2|||
130287220|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Adverse Event|0|||
130287221|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130287222|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130287223|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130287224|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130287225|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287226|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287227|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287228|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
130287229|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287230|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287231|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287232|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
130287233|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287234|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287235|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287236|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
130287237|NCT01920893|469014713|FG000|Overall Study|Adverse Event|5|||
130287238|NCT01920893|469014714|FG001|Overall Study|Adverse Event|2|||
130287239|NCT01920893|469014713|FG000|Overall Study|Lack of Efficacy|2|||
130287240|NCT01920893|469014714|FG001|Overall Study|Lack of Efficacy|0|||
130287241|NCT03762616|469014715|FG000|Overall Study|Protocol Violation|2|||
130287242|NCT04465877|469014716|FG000|Overall Study|Noncompliant with study requirements|0|||
130287243|NCT04465877|469014717|FG001|Overall Study|Noncompliant with study requirements|0|||
130287244|NCT04465877|469014718|FG002|Overall Study|Noncompliant with study requirements|1|||
130287245|NCT04465877|469014719|FG003|Overall Study|Noncompliant with study requirements|0|||
130287246|NCT02323204|469014723|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
130287247|NCT02323204|469014724|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
130287248|NCT02323204|469014725|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
130287249|NCT02323204|469014726|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
130459388|NCT00361283|469645326|FG000|Overall Study|Lost to Follow-up|27|||
130459389|NCT05147233|469647485|FG000|Overall Study|Adverse Event|0|||
130370527|NCT05393895|469327144|FG001|Overall Study|Protocol Violation|0|||
130370528|NCT05393895|469327143|FG000|Overall Study|Withdrawal by Subject|1|||
130370529|NCT05393895|469327144|FG001|Overall Study|Withdrawal by Subject|4|||
130370530|NCT05537883|469327147|FG000|Overall Study|revisional surgery|4|||
130370531|NCT05537883|469327148|FG001|Overall Study|revisional surgery|2|||
130370532|NCT05537883|469327147|FG000|Overall Study|surgeries were cancelled|0|||
130370533|NCT05537883|469327148|FG001|Overall Study|surgeries were cancelled|2|||
130370534|NCT05537883|469327147|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
130370535|NCT05537883|469327148|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
130370536|NCT01328431|469327149|FG000|Baseline|Protocol Violation|0|||
130370537|NCT01328431|469327150|FG001|Baseline|Protocol Violation|2|||
130370538|NCT01328431|469327149|FG000|1 Month (1M)|Lost to Follow-up|55|||
130370539|NCT01328431|469327150|FG001|1 Month (1M)|Lost to Follow-up|58|||
130370540|NCT01328431|469327149|FG000|3 Month (3M)|Death|2|||
130370541|NCT01328431|469327150|FG001|3 Month (3M)|Death|2|||
130370542|NCT01328431|469327149|FG000|3 Month (3M)|Lost to Follow-up|75|||
130370543|NCT01328431|469327150|FG001|3 Month (3M)|Lost to Follow-up|70|||
130370544|NCT01328431|469327149|FG000|12 Month (12M)|Death|2|||
130370545|NCT01328431|469327150|FG001|12 Month (12M)|Death|6|||
130370546|NCT01328431|469327149|FG000|12 Month (12M)|Lost to Follow-up|82|||
130459390|NCT05147233|469647486|FG001|Overall Study|Adverse Event|1|||
130459391|NCT05147233|469647485|FG000|Overall Study|Lost to Follow-up|1|||
130459392|NCT05147233|469647486|FG001|Overall Study|Lost to Follow-up|1|||
130459393|NCT05147233|469647485|FG000|Overall Study|Protocol Violation|0|||
130459394|NCT05147233|469647486|FG001|Overall Study|Protocol Violation|1|||
130459395|NCT05147233|469647485|FG000|Overall Study|Withdrawal by Subject|2|||
130459396|NCT05147233|469647486|FG001|Overall Study|Withdrawal by Subject|1|||
130459397|NCT04517864|469647489|FG000|Placebo-Controlled Phase|Adverse Event|1|||
130459398|NCT04517864|469647490|FG001|Placebo-Controlled Phase|Adverse Event|0|||
130459399|NCT04517864|469647491|FG002|Placebo-Controlled Phase|Adverse Event|0|||
130459400|NCT04517864|469647489|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
130459401|NCT04517864|469647490|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
130459402|NCT04517864|469647491|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
130459403|NCT04517864|469647489|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
130459404|NCT04517864|469647490|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
130459405|NCT04517864|469647491|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
130459406|NCT04517864|469647489|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
130459407|NCT04517864|469647490|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
130459408|NCT04517864|469647491|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
130459409|NCT04517864|469647489|FG000|Active Therapy Extension Phase|Adverse Event|1|||
130459410|NCT04517864|469647490|FG001|Active Therapy Extension Phase|Adverse Event|0|||
130459411|NCT04517864|469647491|FG002|Active Therapy Extension Phase|Adverse Event|0|||
130459412|NCT04517864|469647489|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
130459413|NCT04517864|469647490|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
130459414|NCT04517864|469647491|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
130459415|NCT04517864|469647489|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
130459416|NCT04517864|469647490|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
130459417|NCT04517864|469647491|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
130459418|NCT04517864|469647489|FG000|Active Therapy Extension Phase|Physician Decision|1|||
130459419|NCT04517864|469647490|FG001|Active Therapy Extension Phase|Physician Decision|0|||
130459420|NCT04517864|469647491|FG002|Active Therapy Extension Phase|Physician Decision|0|||
130459421|NCT04517864|469647489|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
130459422|NCT04517864|469647490|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
130459423|NCT04517864|469647491|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
130459424|NCT04517864|469647489|FG000|Extension Phase|Adverse Event|0|||
130459425|NCT04517864|469647490|FG001|Extension Phase|Adverse Event|0|||
130459426|NCT04517864|469647491|FG002|Extension Phase|Adverse Event|1|||
130459427|NCT04517864|469647489|FG000|Extension Phase|Lack of Efficacy|0|||
130459428|NCT04517864|469647490|FG001|Extension Phase|Lack of Efficacy|0|||
130459429|NCT04517864|469647491|FG002|Extension Phase|Lack of Efficacy|2|||
130459430|NCT04517864|469647489|FG000|Extension Phase|Study Terminated By Sponsor|0|||
130459431|NCT04517864|469647490|FG001|Extension Phase|Study Terminated By Sponsor|0|||
130459432|NCT04517864|469647491|FG002|Extension Phase|Study Terminated By Sponsor|32|||
130370547|NCT01328431|469327150|FG001|12 Month (12M)|Lost to Follow-up|91|||
130370548|NCT02296320|469327157|FG000|Overall Study|Withdrawal by Subject|4|||
130370549|NCT02296320|469327158|FG001|Overall Study|Withdrawal by Subject|0|||
130370550|NCT02296320|469327159|FG002|Overall Study|Withdrawal by Subject|2|||
130370551|NCT02296320|469327157|FG000|Overall Study|Death|24|||
130370552|NCT02296320|469327158|FG001|Overall Study|Death|3|||
130370553|NCT02296320|469327159|FG002|Overall Study|Death|27|||
130459433|NCT04517864|469647489|FG000|Extension Phase|Withdrawal by Subject|0|||
130459434|NCT04517864|469647490|FG001|Extension Phase|Withdrawal by Subject|0|||
130370554|NCT02296320|469327157|FG000|Overall Study|Lost to Follow-up|5|||
130459435|NCT04517864|469647491|FG002|Extension Phase|Withdrawal by Subject|3|||
130459436|NCT04517864|469647489|FG000|Extension Phase|Approved Drug Available for Indication|0|||
130556161|NCT04124614|470004535|FG000|Double Blind Treatment Period|Adverse Event|0|||
130556162|NCT04124614|470004536|FG001|Double Blind Treatment Period|Adverse Event|7|||
130556163|NCT04124614|470004537|FG002|Double Blind Treatment Period|Adverse Event|22|||
130556164|NCT04124614|470004535|FG000|Double Blind Treatment Period|Death|0|||
130556165|NCT04124614|470004536|FG001|Double Blind Treatment Period|Death|0|||
130556166|NCT04124614|470004537|FG002|Double Blind Treatment Period|Death|1|||
130556167|NCT04124614|470004535|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130556168|NCT04124614|470004536|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
130556169|NCT04124614|470004537|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
130556170|NCT04124614|470004535|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
130556171|NCT04124614|470004536|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
130556172|NCT04124614|470004537|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
130556173|NCT04124614|470004535|FG000|Double Blind Treatment Period|Physician Decision|0|||
130556174|NCT04124614|470004536|FG001|Double Blind Treatment Period|Physician Decision|0|||
130556175|NCT04124614|470004537|FG002|Double Blind Treatment Period|Physician Decision|3|||
130556176|NCT04124614|470004535|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
130556177|NCT04124614|470004536|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
130556178|NCT04124614|470004537|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
130556179|NCT04124614|470004535|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130556180|NCT04124614|470004536|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
130556181|NCT04124614|470004537|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
130556182|NCT04124614|470004535|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
130556183|NCT04124614|470004536|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
130556184|NCT04124614|470004537|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
130556185|NCT04890054|470006049|FG000|Overall Study|Lost to Follow-up|202|||
130556186|NCT04890054|470006050|FG001|Overall Study|Lost to Follow-up|219|||
130556187|NCT01310803|470006054|FG000|Overall Study|Subject terminated by Sponsor|1|||
130556188|NCT01310803|470006055|FG001|Overall Study|Subject terminated by Sponsor|0|||
130556189|NCT01306890|470006056|FG000|Overall Study|Adverse Event|2|||
130556190|NCT01306890|470006056|FG000|Overall Study|Death|1223|||
130556191|NCT01306890|470006056|FG000|Overall Study|Lost to Follow-up|58|||
130556192|NCT01306890|470006056|FG000|Overall Study|Withdrawal by Subject|88|||
130556193|NCT01306890|470006056|FG000|Overall Study|Unspecified reasons|104|||
130556194|NCT01306890|470006056|FG000|Overall Study|Study Termination|3|||
130556195|NCT01306890|470006056|FG000|Overall Study|No discontinuation documentation|41|||
130556196|NCT03047551|470006061|FG000|Overall Study|Did not receive TAS|1|||
130556197|NCT03047551|470006062|FG001|Overall Study|Did not receive TAS|0|||
130556198|NCT03047551|470006061|FG000|Overall Study|Physician Decision|1|||
130556199|NCT03047551|470006062|FG001|Overall Study|Physician Decision|0|||
130556200|NCT03047551|470006061|FG000|Overall Study|Withdrawal by Subject|0|||
130556201|NCT03047551|470006062|FG001|Overall Study|Withdrawal by Subject|1|||
130556202|NCT03047551|470006061|FG000|Overall Study|Probe malfunction|0|||
130556203|NCT03047551|470006062|FG001|Overall Study|Probe malfunction|1|||
130556204|NCT03047551|470006061|FG000|Overall Study|Ineligible|0|||
130556205|NCT03047551|470006062|FG001|Overall Study|Ineligible|1|||
130556206|NCT00726622|470006063|FG000|Overall Study|Withdrawal by Subject|16|||
130556207|NCT00726622|470006064|FG001|Overall Study|Withdrawal by Subject|2|||
130556208|NCT00726622|470006063|FG000|Overall Study|Physician Decision|0|||
130556209|NCT00726622|470006064|FG001|Overall Study|Physician Decision|1|||
130556210|NCT00726622|470006063|FG000|Overall Study|Metastasis|2|||
130556211|NCT00726622|470006064|FG001|Overall Study|Metastasis|0|||
130556212|NCT01940354|470006065|FG000|Overall Study|Withdrawal by Subject|4|||
130556213|NCT01940354|470006066|FG001|Overall Study|Withdrawal by Subject|2|||
130556214|NCT03872453|470006067|FG000|Overall Study|Adverse Event|1|||
130556215|NCT03872453|470006068|FG001|Overall Study|Adverse Event|1|||
130556216|NCT03872453|470006069|FG002|Overall Study|Adverse Event|0|||
130556217|NCT03872453|470006070|FG003|Overall Study|Adverse Event|0|||
130712964|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712965|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712966|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
130712967|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130287250|NCT02323204|469014723|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
130287251|NCT02323204|469014724|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
130287252|NCT02323204|469014725|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
130287253|NCT02323204|469014726|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
130287254|NCT02323204|469014723|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
130287255|NCT02323204|469014724|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
130287256|NCT02323204|469014725|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
130556218|NCT03872453|470006067|FG000|Overall Study|Lost to Follow-up|8|||
130556219|NCT03872453|470006068|FG001|Overall Study|Lost to Follow-up|7|||
130556220|NCT03872453|470006069|FG002|Overall Study|Lost to Follow-up|4|||
130556221|NCT03872453|470006070|FG003|Overall Study|Lost to Follow-up|4|||
130556222|NCT03872453|470006067|FG000|Overall Study|Never Treated Migraine|19|||
130712968|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712969|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712970|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712971|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
130712972|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
130712973|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
130712974|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
130712975|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
130712976|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
130712977|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
130712978|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Other|2|||
130712979|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Other|9|||
130712980|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Other|9|||
130712981|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Other|3|||
130712982|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Other|2|||
130712983|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Other|0|||
130712984|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Other|0|||
130712985|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
130712986|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
130712987|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
130712988|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
130712989|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
130712990|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
130712991|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
130712992|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712993|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712994|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
130712995|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712996|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712997|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712998|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712999|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713000|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713001|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713002|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713003|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713004|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713005|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713006|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Death|0|||
130713007|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Death|0|||
130713008|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Death|0|||
130713009|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Death|0|||
130287257|NCT02323204|469014726|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
130287258|NCT02323204|469014723|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130287259|NCT02323204|469014724|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
130287260|NCT02323204|469014725|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130287261|NCT02323204|469014726|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
130287262|NCT02323204|469014723|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130287263|NCT02323204|469014724|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
130370555|NCT02296320|469327158|FG001|Overall Study|Lost to Follow-up|2|||
130370556|NCT02296320|469327159|FG002|Overall Study|Lost to Follow-up|7|||
130370557|NCT02296320|469327157|FG000|Overall Study|Not treated|2|||
130370558|NCT02296320|469327158|FG001|Overall Study|Not treated|0|||
130370559|NCT02296320|469327159|FG002|Overall Study|Not treated|0|||
130370560|NCT02296320|469327157|FG000|Overall Study|Not - specified|0|||
130370561|NCT02296320|469327158|FG001|Overall Study|Not - specified|0|||
130370562|NCT02296320|469327159|FG002|Overall Study|Not - specified|1|||
130370563|NCT03310021|469327163|FG000|Overall Study|Withdrawal by Subject|0|||
130370564|NCT03310021|469327164|FG001|Overall Study|Withdrawal by Subject|0|||
130370565|NCT03310021|469327165|FG002|Overall Study|Withdrawal by Subject|0|||
130370566|NCT03310021|469327166|FG003|Overall Study|Withdrawal by Subject|0|||
130370567|NCT03310021|469327167|FG004|Overall Study|Withdrawal by Subject|0|||
130370568|NCT03310021|469327168|FG005|Overall Study|Withdrawal by Subject|0|||
130713010|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Death|0|||
130287264|NCT02323204|469014725|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130713011|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Death|0|||
130370569|NCT03310021|469327169|FG006|Overall Study|Withdrawal by Subject|1|||
130370570|NCT03310021|469327170|FG007|Overall Study|Withdrawal by Subject|0|||
130370571|NCT03310021|469327171|FG008|Overall Study|Withdrawal by Subject|0|||
130713012|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Death|1|||
130713013|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713014|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713015|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713016|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713017|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713018|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713019|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130287265|NCT02323204|469014726|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
130287266|NCT02323204|469014723|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
130287267|NCT02323204|469014724|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
130287268|NCT02323204|469014725|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
130287269|NCT02323204|469014726|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
130287270|NCT02323204|469014723|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287271|NCT02323204|469014724|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130287272|NCT02323204|469014725|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287273|NCT02323204|469014726|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130287274|NCT02323204|469014723|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
130287275|NCT02323204|469014724|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
130287276|NCT02323204|469014725|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
130287277|NCT02323204|469014726|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
130287278|NCT02323204|469014723|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287279|NCT02323204|469014724|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287280|NCT02323204|469014725|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
130287281|NCT02323204|469014726|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
130287282|NCT03440918|469014732|FG000|Overall Study|Protocol Violation|0|||
130287283|NCT03440918|469014733|FG001|Overall Study|Protocol Violation|16|||
130287284|NCT03576755|469014745|FG000|Overall Study|Withdrawal by Subject|1|||
130713020|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Other|1|||
130713021|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Other|0|||
130713022|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Other|0|||
130713023|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Other|1|||
130459437|NCT04517864|469647490|FG001|Extension Phase|Approved Drug Available for Indication|0|||
130713024|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Other|0|||
130459438|NCT04517864|469647491|FG002|Extension Phase|Approved Drug Available for Indication|7|||
130459439|NCT04722003|469647492|FG000|Overall Study|Lost to Follow-up|2|||
130459440|NCT04722003|469647493|FG001|Overall Study|Lost to Follow-up|0|||
130459441|NCT04722003|469647492|FG000|Overall Study|Physician Decision|1|||
130459442|NCT04722003|469647493|FG001|Overall Study|Physician Decision|0|||
130459443|NCT04860258|469647497|FG000|Overall Study|Withdrawal by Subject|0|||
130459444|NCT04860258|469647498|FG001|Overall Study|Withdrawal by Subject|0|||
130459445|NCT04860258|469647499|FG002|Overall Study|Withdrawal by Subject|4|||
130459446|NCT04860258|469647500|FG003|Overall Study|Withdrawal by Subject|1|||
130459447|NCT04860258|469647501|FG004|Overall Study|Withdrawal by Subject|4|||
130459448|NCT04860258|469647502|FG005|Overall Study|Withdrawal by Subject|1|||
130459449|NCT04860258|469647503|FG006|Overall Study|Withdrawal by Subject|0|||
130459450|NCT00357396|469647504|FG000|Overall Study|Adverse Event|1|||
130459451|NCT00357396|469647505|FG001|Overall Study|Adverse Event|0|||
130459452|NCT02496702|469647506|FG000|Overall Study|Lost to Follow-up|8|||
130459453|NCT02496702|469647507|FG001|Overall Study|Lost to Follow-up|6|||
130459454|NCT02496702|469647506|FG000|Overall Study|Only partially tested|0|||
130459455|NCT02496702|469647507|FG001|Overall Study|Only partially tested|2|||
130459456|NCT00391846|469647510|FG000|Overall Study|Adverse Event|4|||
130459457|NCT00391846|469647511|FG001|Overall Study|Adverse Event|1|||
130459458|NCT00391846|469647510|FG000|Overall Study|Did not meet the required elig. crit|2|||
130459459|NCT00391846|469647511|FG001|Overall Study|Did not meet the required elig. crit|2|||
130459460|NCT00391846|469647510|FG000|Overall Study|Withdrawal by Subject|2|||
130459461|NCT00391846|469647511|FG001|Overall Study|Withdrawal by Subject|3|||
130459462|NCT00391846|469647510|FG000|Overall Study|Developed study specific DC criteria|0|||
130459463|NCT00391846|469647511|FG001|Overall Study|Developed study specific DC criteria|1|||
130459464|NCT01227278|469647512|FG000|Overall Study|Withdrawal by Subject|4|||
130556223|NCT03872453|470006068|FG001|Overall Study|Never Treated Migraine|17|||
130556224|NCT03872453|470006069|FG002|Overall Study|Never Treated Migraine|13|||
130713025|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Other|1|||
130713026|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Other|2|||
130713027|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713028|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130459465|NCT01227278|469647513|FG001|Overall Study|Withdrawal by Subject|4|||
130459466|NCT01227278|469647512|FG000|Overall Study|Death|0|||
130459467|NCT01227278|469647513|FG001|Overall Study|Death|2|||
130459468|NCT01227278|469647512|FG000|Overall Study|Other|1|||
130459469|NCT01227278|469647513|FG001|Overall Study|Other|2|||
130713029|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
130459470|NCT04035668|469647514|FG000|Overall Study|Adverse Event|3|||
130459471|NCT04035668|469647515|FG001|Overall Study|Adverse Event|4|||
130459472|NCT04035668|469647516|FG002|Overall Study|Adverse Event|2|||
130459473|NCT04035668|469647514|FG000|Overall Study|Lost to Follow-up|0|||
130713030|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713031|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713032|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713033|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
130713034|NCT05065983|470575287|FG000|Overall Study|Lost to Follow-up|2|||
130287285|NCT03576755|469014746|FG001|Overall Study|Withdrawal by Subject|0|||
130287286|NCT03576755|469014747|FG002|Overall Study|Withdrawal by Subject|0|||
130287287|NCT03576755|469014748|FG003|Overall Study|Withdrawal by Subject|0|||
130287288|NCT04962230|469014749|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
130287289|NCT04962230|469014749|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
130287290|NCT01396265|469014750|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
130287291|NCT03958656|469014753|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287292|NCT03958656|469014754|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
130287293|NCT03958656|469014755|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287294|NCT03958656|469014756|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287295|NCT03958656|469014753|FG000|Overall Study|No longer meets eligibility criteria|0|||
130287296|NCT03958656|469014754|FG001|Overall Study|No longer meets eligibility criteria|0|||
130287297|NCT03958656|469014755|FG002|Overall Study|No longer meets eligibility criteria|1|||
130287298|NCT03958656|469014756|FG003|Overall Study|No longer meets eligibility criteria|0|||
130287299|NCT03958656|469014753|FG000|Overall Study|Started anti-cancer treatment|0|||
130287300|NCT03958656|469014754|FG001|Overall Study|Started anti-cancer treatment|0|||
130287301|NCT03958656|469014755|FG002|Overall Study|Started anti-cancer treatment|1|||
130287302|NCT03958656|469014756|FG003|Overall Study|Started anti-cancer treatment|0|||
130287303|NCT03831880|469014757|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
130287304|NCT03831880|469014758|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
130287305|NCT03831880|469014757|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
130287306|NCT03831880|469014758|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
130287307|NCT04346108|469014761|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130287308|NCT04346108|469014762|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
130287309|NCT04346108|469014763|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130287310|NCT04346108|469014761|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130287311|NCT04346108|469014762|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
130287312|NCT04346108|469014763|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130287313|NCT03158012|469014764|FG000|Overall Study|Withdrawal by Subject|0|||
130287314|NCT03158012|469014765|FG001|Overall Study|Withdrawal by Subject|1|||
130287315|NCT01598753|469014766|FG000|Overall Study|Adverse Event|1|||
130287316|NCT01598753|469014767|FG001|Overall Study|Adverse Event|9|||
130287317|NCT01598753|469014768|FG002|Overall Study|Adverse Event|1|||
130287318|NCT01598753|469014769|FG003|Overall Study|Adverse Event|7|||
130287319|NCT01598753|469014766|FG000|Overall Study|Lost to Follow-up|4|||
130287320|NCT01598753|469014767|FG001|Overall Study|Lost to Follow-up|3|||
130287321|NCT01598753|469014768|FG002|Overall Study|Lost to Follow-up|7|||
130287322|NCT01598753|469014769|FG003|Overall Study|Lost to Follow-up|5|||
130287323|NCT01598753|469014766|FG000|Overall Study|Physician Decision|0|||
130287324|NCT01598753|469014767|FG001|Overall Study|Physician Decision|1|||
130287325|NCT01598753|469014768|FG002|Overall Study|Physician Decision|0|||
130287326|NCT01598753|469014769|FG003|Overall Study|Physician Decision|2|||
130287327|NCT01598753|469014766|FG000|Overall Study|Withdrawal by Subject|7|||
130287328|NCT01598753|469014767|FG001|Overall Study|Withdrawal by Subject|2|||
130287329|NCT01598753|469014768|FG002|Overall Study|Withdrawal by Subject|0|||
130287330|NCT01598753|469014769|FG003|Overall Study|Withdrawal by Subject|1|||
130287331|NCT02788201|469014770|FG000|Overall Study|Death|1|||
130287332|NCT02788201|469014771|FG001|Overall Study|Death|1|||
130287333|NCT02788201|469014772|FG002|Overall Study|Death|1|||
130287334|NCT02788201|469014773|FG003|Overall Study|Death|1|||
130287335|NCT02788201|469014774|FG004|Overall Study|Death|0|||
130287336|NCT02788201|469014775|FG005|Overall Study|Death|1|||
130287337|NCT02788201|469014770|FG000|Overall Study|Ineligible|0|||
130287338|NCT02788201|469014771|FG001|Overall Study|Ineligible|0|||
130287339|NCT02788201|469014772|FG002|Overall Study|Ineligible|0|||
130287340|NCT02788201|469014773|FG003|Overall Study|Ineligible|0|||
130287341|NCT02788201|469014774|FG004|Overall Study|Ineligible|0|||
130287342|NCT02788201|469014775|FG005|Overall Study|Ineligible|1|||
130287343|NCT02788201|469014770|FG000|Overall Study|Withdrawal by Subject|0|||
130287344|NCT02788201|469014771|FG001|Overall Study|Withdrawal by Subject|0|||
130287345|NCT02788201|469014772|FG002|Overall Study|Withdrawal by Subject|0|||
130287346|NCT02788201|469014773|FG003|Overall Study|Withdrawal by Subject|0|||
130287347|NCT02788201|469014774|FG004|Overall Study|Withdrawal by Subject|0|||
130287348|NCT02788201|469014775|FG005|Overall Study|Withdrawal by Subject|1|||
130370572|NCT03310021|469327172|FG009|Overall Study|Withdrawal by Subject|0|||
130370573|NCT03310021|469327173|FG010|Overall Study|Withdrawal by Subject|0|||
130713035|NCT01765582|470575288|FG000|Overall Study|Other|3|||
130287349|NCT01852825|469014776|FG000|Overall Study|Withdrawal by Subject|2|||
130287350|NCT01852825|469014777|FG001|Overall Study|Withdrawal by Subject|0|||
130287351|NCT01852825|469014778|FG002|Overall Study|Withdrawal by Subject|0|||
130370574|NCT03310021|469327174|FG011|Overall Study|Withdrawal by Subject|0|||
130370575|NCT03310021|469327175|FG012|Overall Study|Withdrawal by Subject|0|||
130370576|NCT03310021|469327176|FG013|Overall Study|Withdrawal by Subject|0|||
130370577|NCT03310021|469327177|FG014|Overall Study|Withdrawal by Subject|0|||
130370578|NCT03310021|469327178|FG015|Overall Study|Withdrawal by Subject|0|||
130370579|NCT03310021|469327179|FG016|Overall Study|Withdrawal by Subject|0|||
130370580|NCT03310021|469327180|FG017|Overall Study|Withdrawal by Subject|0|||
130370581|NCT03310021|469327181|FG018|Overall Study|Withdrawal by Subject|0|||
130370582|NCT03310021|469327182|FG019|Overall Study|Withdrawal by Subject|0|||
130370583|NCT03310021|469327163|FG000|Overall Study|Lost to Follow-up|0|||
130370584|NCT03310021|469327164|FG001|Overall Study|Lost to Follow-up|0|||
130370585|NCT03310021|469327165|FG002|Overall Study|Lost to Follow-up|0|||
130370586|NCT03310021|469327166|FG003|Overall Study|Lost to Follow-up|0|||
130370587|NCT03310021|469327167|FG004|Overall Study|Lost to Follow-up|0|||
130370588|NCT03310021|469327168|FG005|Overall Study|Lost to Follow-up|0|||
130370589|NCT03310021|469327169|FG006|Overall Study|Lost to Follow-up|0|||
130370590|NCT03310021|469327170|FG007|Overall Study|Lost to Follow-up|0|||
130370591|NCT03310021|469327171|FG008|Overall Study|Lost to Follow-up|0|||
130370592|NCT03310021|469327172|FG009|Overall Study|Lost to Follow-up|0|||
130370593|NCT03310021|469327173|FG010|Overall Study|Lost to Follow-up|1|||
130370594|NCT03310021|469327174|FG011|Overall Study|Lost to Follow-up|0|||
130370595|NCT03310021|469327175|FG012|Overall Study|Lost to Follow-up|0|||
130370596|NCT03310021|469327176|FG013|Overall Study|Lost to Follow-up|0|||
130370597|NCT03310021|469327177|FG014|Overall Study|Lost to Follow-up|0|||
130370598|NCT03310021|469327178|FG015|Overall Study|Lost to Follow-up|0|||
130370599|NCT03310021|469327179|FG016|Overall Study|Lost to Follow-up|0|||
130370600|NCT03310021|469327180|FG017|Overall Study|Lost to Follow-up|0|||
130370601|NCT03310021|469327181|FG018|Overall Study|Lost to Follow-up|0|||
130370602|NCT03310021|469327182|FG019|Overall Study|Lost to Follow-up|0|||
130370603|NCT01427972|469327193|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370604|NCT01427972|469327194|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370605|NCT01427972|469327195|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370606|NCT01427972|469327196|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370607|NCT01427972|469327197|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370608|NCT01427972|469327198|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370609|NCT01427972|469327199|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130287352|NCT04508751|469014782|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
130287353|NCT04508751|469014783|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
130287354|NCT04508751|469014784|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
130287355|NCT00724854|469014785|FG000|Overall Study|Lack of Efficacy|187|||
130287356|NCT00724854|469014786|FG001|Overall Study|Lack of Efficacy|13|||
130287357|NCT00724854|469014785|FG000|Overall Study|Lost to Follow-up|87|||
130713036|NCT01765582|470575289|FG001|Overall Study|Other|6|||
130713037|NCT01765582|470575290|FG002|Overall Study|Other|9|||
130713038|NCT01765582|470575288|FG000|Overall Study|Lost to Follow-up|2|||
130713039|NCT01765582|470575289|FG001|Overall Study|Lost to Follow-up|2|||
130713040|NCT01765582|470575290|FG002|Overall Study|Lost to Follow-up|1|||
130713041|NCT01765582|470575288|FG000|Overall Study|Death|31|||
130713042|NCT01765582|470575289|FG001|Overall Study|Death|36|||
130713043|NCT01765582|470575290|FG002|Overall Study|Death|33|||
130287358|NCT00724854|469014786|FG001|Overall Study|Lost to Follow-up|10|||
130287359|NCT00724854|469014785|FG000|Overall Study|Adverse Event|62|||
130287360|NCT00724854|469014786|FG001|Overall Study|Adverse Event|4|||
130287361|NCT00724854|469014785|FG000|Overall Study|Other|42|||
130287362|NCT00724854|469014786|FG001|Overall Study|Other|3|||
130287363|NCT00724854|469014785|FG000|Overall Study|Death|11|||
130287364|NCT00724854|469014786|FG001|Overall Study|Death|0|||
130287365|NCT00724854|469014785|FG000|Overall Study|Change of treatment|7|||
130287366|NCT00724854|469014786|FG001|Overall Study|Change of treatment|0|||
130287367|NCT00724854|469014785|FG000|Overall Study|Withdrawal by Subject|5|||
130287368|NCT00724854|469014786|FG001|Overall Study|Withdrawal by Subject|0|||
130287369|NCT00724854|469014785|FG000|Overall Study|Adverse event + lack of efficacy|2|||
130287370|NCT00724854|469014786|FG001|Overall Study|Adverse event + lack of efficacy|1|||
130370610|NCT01427972|469327200|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
130370611|NCT01427972|469327201|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370612|NCT01427972|469327202|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370613|NCT01427972|469327203|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130370614|NCT01427972|469327204|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130459474|NCT04035668|469647515|FG001|Overall Study|Lost to Follow-up|1|||
130370615|NCT01427972|469327193|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370616|NCT01427972|469327194|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370617|NCT01427972|469327195|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130459475|NCT04035668|469647516|FG002|Overall Study|Lost to Follow-up|0|||
130713044|NCT01765582|470575288|FG000|Overall Study|Sponsor Decision|46|||
130713045|NCT01765582|470575289|FG001|Overall Study|Sponsor Decision|42|||
130713046|NCT01765582|470575290|FG002|Overall Study|Sponsor Decision|42|||
130287371|NCT01865812|469014787|FG000|Primary Treatment Phase|Adverse Event|2|||
130287372|NCT01865812|469014788|FG001|Primary Treatment Phase|Adverse Event|0|||
130287373|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
130287374|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
130287375|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Pruritus|0|||
130287376|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Pruritus|3|||
130287377|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
130287378|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
130287379|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
130287380|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
130287381|NCT01338610|469014789|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130287382|NCT01338610|469014790|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130287383|NCT01338610|469014791|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
130287384|NCT01338610|469014789|FG000|Overall Study|Protocol Violation|1|||
130287385|NCT01338610|469014790|FG001|Overall Study|Protocol Violation|0|||
130287386|NCT01338610|469014791|FG002|Overall Study|Protocol Violation|1|||
130287387|NCT01338610|469014789|FG000|Overall Study|Adverse Event|3|||
130287388|NCT01338610|469014790|FG001|Overall Study|Adverse Event|0|||
130287389|NCT01338610|469014791|FG002|Overall Study|Adverse Event|0|||
130287390|NCT01095653|469014792|FG000|Overall Study|Lack of Efficacy|3|||
130287391|NCT01095653|469014793|FG001|Overall Study|Lack of Efficacy|0|||
130287392|NCT01095653|469014794|FG002|Overall Study|Lack of Efficacy|0|||
130287393|NCT01095653|469014792|FG000|Overall Study|Adverse Event|1|||
130287394|NCT01095653|469014793|FG001|Overall Study|Adverse Event|4|||
130287395|NCT01095653|469014794|FG002|Overall Study|Adverse Event|4|||
130287396|NCT01095653|469014792|FG000|Overall Study|Lost to Follow-up|1|||
130287397|NCT01095653|469014793|FG001|Overall Study|Lost to Follow-up|0|||
130287398|NCT01095653|469014794|FG002|Overall Study|Lost to Follow-up|4|||
130287399|NCT01095653|469014792|FG000|Overall Study|Withdrawal by Subject|4|||
130287400|NCT01095653|469014793|FG001|Overall Study|Withdrawal by Subject|5|||
130287401|NCT01095653|469014794|FG002|Overall Study|Withdrawal by Subject|3|||
130287402|NCT01095653|469014792|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
130287403|NCT01095653|469014793|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
130287404|NCT01095653|469014794|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
130287405|NCT02046226|469014795|FG000|Overall Study|Lost to Follow-up|7|||
130287406|NCT00171925|469014796|FG000|Overall Study|Adverse Event|10|||
130287407|NCT00171925|469014797|FG001|Overall Study|Adverse Event|6|||
130287408|NCT00171925|469014796|FG000|Overall Study|Protocol Violation|1|||
130287409|NCT00171925|469014797|FG001|Overall Study|Protocol Violation|1|||
130287410|NCT00171925|469014796|FG000|Overall Study|Withdrawal by Subject|6|||
130287411|NCT00171925|469014797|FG001|Overall Study|Withdrawal by Subject|9|||
130287412|NCT00171925|469014796|FG000|Overall Study|Lost to Follow-up|2|||
130287413|NCT00171925|469014797|FG001|Overall Study|Lost to Follow-up|2|||
130287414|NCT00171925|469014796|FG000|Overall Study|Administrative problems|10|||
130713047|NCT01765582|470575288|FG000|Overall Study|Withdrawal of Consent|11|||
130713048|NCT01765582|470575289|FG001|Overall Study|Withdrawal of Consent|6|||
130713049|NCT01765582|470575290|FG002|Overall Study|Withdrawal of Consent|10|||
130713050|NCT00986180|470575291|FG000|Overall Study|Adverse Event|21|||
130713051|NCT00986180|470575292|FG001|Overall Study|Adverse Event|23|||
130713052|NCT00986180|470575291|FG000|Overall Study|Lack of Efficacy|4|||
130713053|NCT00986180|470575292|FG001|Overall Study|Lack of Efficacy|3|||
130713054|NCT00986180|470575291|FG000|Overall Study|Lost to Follow-up|5|||
130713055|NCT00986180|470575292|FG001|Overall Study|Lost to Follow-up|7|||
130713056|NCT00986180|470575291|FG000|Overall Study|Physician Decision|1|||
130713057|NCT00986180|470575292|FG001|Overall Study|Physician Decision|3|||
130713058|NCT00986180|470575291|FG000|Overall Study|Protocol Violation|2|||
130713059|NCT00986180|470575292|FG001|Overall Study|Protocol Violation|0|||
130713060|NCT00986180|470575291|FG000|Overall Study|Withdrawal by Subject|1|||
130713061|NCT00986180|470575292|FG001|Overall Study|Withdrawal by Subject|9|||
130713062|NCT00986180|470575291|FG000|Overall Study|Miscellanies|10|||
130713063|NCT00986180|470575292|FG001|Overall Study|Miscellanies|11|||
130713064|NCT01691820|470575293|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
130713065|NCT01691820|470575294|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
130713066|NCT01691820|470575293|FG000|Overall Study|Migrated/moved from study area|7|||
130713067|NCT01691820|470575294|FG001|Overall Study|Migrated/moved from study area|4|||
130713068|NCT01691820|470575293|FG000|Overall Study|Lost to Follow-up|6|||
130287415|NCT00171925|469014797|FG001|Overall Study|Administrative problems|11|||
130287416|NCT00171925|469014796|FG000|Overall Study|Death|1|||
130556225|NCT03872453|470006070|FG003|Overall Study|Never Treated Migraine|12|||
130713069|NCT01691820|470575294|FG001|Overall Study|Lost to Follow-up|17|||
130287417|NCT00171925|469014797|FG001|Overall Study|Death|2|||
130287418|NCT02692040|469014798|FG000|Overall Study|Protocol Violation|0|||
130713070|NCT01691820|470575293|FG000|Overall Study|Other (unspecified)|4|||
130713071|NCT01691820|470575294|FG001|Overall Study|Other (unspecified)|1|||
130713072|NCT00076804|470575299|FG000|Overall Study|Death|9|||
130713073|NCT00076804|470575300|FG001|Overall Study|Death|20|||
130713074|NCT00076804|470575299|FG000|Overall Study|Lost to Follow-up|9|||
130713075|NCT00076804|470575300|FG001|Overall Study|Lost to Follow-up|9|||
130713076|NCT00076804|470575299|FG000|Overall Study|Withdrawal by Subject|10|||
130713077|NCT00076804|470575300|FG001|Overall Study|Withdrawal by Subject|8|||
130713078|NCT00076804|470575299|FG000|Overall Study|Early study Closure|32|||
130713079|NCT00076804|470575300|FG001|Overall Study|Early study Closure|32|||
130713080|NCT02408068|470575302|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713081|NCT02408068|470575303|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
130287419|NCT02692040|469014799|FG001|Overall Study|Protocol Violation|0|||
130287420|NCT02692040|469014800|FG002|Overall Study|Protocol Violation|0|||
130287421|NCT02692040|469014801|FG003|Overall Study|Protocol Violation|0|||
130287422|NCT02692040|469014802|FG004|Overall Study|Protocol Violation|0|||
130287423|NCT02692040|469014803|FG005|Overall Study|Protocol Violation|0|||
130287424|NCT02692040|469014804|FG006|Overall Study|Protocol Violation|0|||
130287425|NCT02692040|469014805|FG007|Overall Study|Protocol Violation|0|||
130287426|NCT02692040|469014806|FG008|Overall Study|Protocol Violation|0|||
130287427|NCT02692040|469014807|FG009|Overall Study|Protocol Violation|0|||
130287428|NCT02692040|469014808|FG010|Overall Study|Protocol Violation|0|||
130287429|NCT02692040|469014809|FG011|Overall Study|Protocol Violation|0|||
130713082|NCT02408068|470575304|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
130713083|NCT02408068|470575305|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713084|NCT02408068|470575306|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713085|NCT02408068|470575307|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713086|NCT02303041|470575308|FG000|Overall Study|Adverse Event|1|||
130713087|NCT02303041|470575309|FG001|Overall Study|Adverse Event|2|||
130713088|NCT02458092|470575315|FG000|Overall Study|Withdrawal by Subject|1|||
130713089|NCT02458092|470575316|FG001|Overall Study|Withdrawal by Subject|0|||
130287430|NCT02692040|469014810|FG012|Overall Study|Protocol Violation|1|||
130287431|NCT02692040|469014811|FG013|Overall Study|Protocol Violation|0|||
130287432|NCT02692040|469014812|FG014|Overall Study|Protocol Violation|0|||
130287433|NCT02692040|469014813|FG015|Overall Study|Protocol Violation|0|||
130287434|NCT02692040|469014814|FG016|Overall Study|Protocol Violation|0|||
130287435|NCT02692040|469014798|FG000|Overall Study|Adverse Event|0|||
130287436|NCT02692040|469014799|FG001|Overall Study|Adverse Event|0|||
130713090|NCT03852459|470575319|FG000|Overall Study|Adverse Event|2|||
130713091|NCT03852459|470575320|FG001|Overall Study|Adverse Event|2|||
130713092|NCT03852459|470575319|FG000|Overall Study|Withdrawal by Subject|1|||
130713093|NCT03852459|470575320|FG001|Overall Study|Withdrawal by Subject|1|||
130713094|NCT03629028|470575321|FG000|Overall Study|Lost to Follow-up|26|||
130713095|NCT03629028|470575322|FG001|Overall Study|Lost to Follow-up|23|||
130713096|NCT03629028|470575321|FG000|Overall Study|Pregnancy|4|||
130713097|NCT03629028|470575322|FG001|Overall Study|Pregnancy|2|||
130713098|NCT03629028|470575321|FG000|Overall Study|intolerance to examination|2|||
130713099|NCT03629028|470575322|FG001|Overall Study|intolerance to examination|0|||
130713100|NCT02687360|470575323|FG000|Overall Study|Withdrawal by Subject|3|||
130713101|NCT02687360|470575324|FG001|Overall Study|Withdrawal by Subject|0|||
130713102|NCT02522403|470576853|FG000|Overall Study|Lost to Follow-up|2|||
130713103|NCT02522403|470576854|FG001|Overall Study|Lost to Follow-up|2|||
130713104|NCT02522403|470576853|FG000|Overall Study|Withdrawal by Subject|2|||
130713105|NCT02522403|470576854|FG001|Overall Study|Withdrawal by Subject|4|||
130713106|NCT03340064|470576855|FG000|First Period|Adverse Event, non-fatal|2|||
130287437|NCT02692040|469014800|FG002|Overall Study|Adverse Event|0|||
130287438|NCT02692040|469014801|FG003|Overall Study|Adverse Event|0|||
130287439|NCT02692040|469014802|FG004|Overall Study|Adverse Event|0|||
130370618|NCT01427972|469327196|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370619|NCT01427972|469327197|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370620|NCT01427972|469327198|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
130370621|NCT01427972|469327199|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370622|NCT01427972|469327200|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370623|NCT01427972|469327201|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370624|NCT01427972|469327202|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370625|NCT01427972|469327203|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370626|NCT01427972|469327204|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130370627|NCT01427972|469327193|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370628|NCT01427972|469327194|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
130370629|NCT01427972|469327195|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130459476|NCT04035668|469647514|FG000|Overall Study|Physician Decision|2|||
130459477|NCT04035668|469647515|FG001|Overall Study|Physician Decision|1|||
130459478|NCT04035668|469647516|FG002|Overall Study|Physician Decision|1|||
130459479|NCT04035668|469647514|FG000|Overall Study|Subject Decision|2|||
130459480|NCT04035668|469647515|FG001|Overall Study|Subject Decision|2|||
130459481|NCT04035668|469647516|FG002|Overall Study|Subject Decision|0|||
130459482|NCT02320123|469647517|FG000|Overall Study|Lost to Follow-up|4|||
130713107|NCT03340064|470576856|FG001|First Period|Adverse Event, non-fatal|0|||
130713108|NCT03340064|470576855|FG000|First Period|Lack of Efficacy|3|||
130287440|NCT02692040|469014803|FG005|Overall Study|Adverse Event|0|||
130459483|NCT02320123|469647518|FG001|Overall Study|Lost to Follow-up|6|||
130713109|NCT03340064|470576856|FG001|First Period|Lack of Efficacy|0|||
130713110|NCT03340064|470576855|FG000|Second Period|Adverse Event, non-fatal|1|||
130287441|NCT02692040|469014804|FG006|Overall Study|Adverse Event|0|||
130287442|NCT02692040|469014805|FG007|Overall Study|Adverse Event|0|||
130287443|NCT02692040|469014806|FG008|Overall Study|Adverse Event|0|||
130287444|NCT02692040|469014807|FG009|Overall Study|Adverse Event|0|||
130287445|NCT02692040|469014808|FG010|Overall Study|Adverse Event|0|||
130287446|NCT02692040|469014809|FG011|Overall Study|Adverse Event|0|||
130287447|NCT02692040|469014810|FG012|Overall Study|Adverse Event|0|||
130287448|NCT02692040|469014811|FG013|Overall Study|Adverse Event|3|||
130287449|NCT02692040|469014812|FG014|Overall Study|Adverse Event|1|||
130287450|NCT02692040|469014813|FG015|Overall Study|Adverse Event|1|||
130287451|NCT02692040|469014814|FG016|Overall Study|Adverse Event|0|||
130287452|NCT02826421|469014822|FG000|Overall Study|Adverse Event|1|||
130287453|NCT02826421|469014823|FG001|Overall Study|Adverse Event|0|||
130287454|NCT02826421|469014824|FG002|Overall Study|Adverse Event|0|||
130287455|NCT02826421|469014825|FG003|Overall Study|Adverse Event|1|||
130287456|NCT02826421|469014822|FG000|Overall Study|Withdrawal by Subject|1|||
130287457|NCT02826421|469014823|FG001|Overall Study|Withdrawal by Subject|3|||
130287458|NCT02826421|469014824|FG002|Overall Study|Withdrawal by Subject|1|||
130287459|NCT02826421|469014825|FG003|Overall Study|Withdrawal by Subject|1|||
130287460|NCT02826421|469014822|FG000|Overall Study|Reason not given|1|||
130287461|NCT02826421|469014823|FG001|Overall Study|Reason not given|0|||
130459484|NCT02320123|469647517|FG000|Overall Study|Death|6|||
130459485|NCT02320123|469647518|FG001|Overall Study|Death|5|||
130459486|NCT00516386|469647525|FG000|Overall Study|not interested in the study|4|||
130459487|NCT00516386|469647525|FG000|Overall Study|Lost to Follow-up|2|||
130459488|NCT01376089|469647530|FG000|Overall Study|Patient received no contrast media|3|||
130459489|NCT01376089|469647531|FG001|Overall Study|Patient received no contrast media|4|||
130459490|NCT03743246|469647536|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
130459491|NCT03743246|469647537|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
130459492|NCT03743246|469647538|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
130459493|NCT03743246|469647539|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
130287462|NCT02826421|469014824|FG002|Overall Study|Reason not given|1|||
130287463|NCT02826421|469014825|FG003|Overall Study|Reason not given|0|||
130287464|NCT02210221|469014828|FG000|Overall Study|Lack of Efficacy|7|||
130287465|NCT02210221|469014828|FG000|Overall Study|Withdrawal by Subject|43|||
130287466|NCT02141490|469014831|FG000|Overall Study|Screening failures|4|||
130287467|NCT02141490|469014832|FG001|Overall Study|Screening failures|0|||
130287468|NCT02141490|469014833|FG002|Overall Study|Screening failures|0|||
130287469|NCT00355342|469014838|FG000|Overall Study|Adverse Event|13|||
130287470|NCT00355342|469014839|FG001|Overall Study|Adverse Event|15|||
130287471|NCT00355342|469014838|FG000|Overall Study|Lost to Follow-up|4|||
130287472|NCT00355342|469014839|FG001|Overall Study|Lost to Follow-up|2|||
130287473|NCT00355342|469014838|FG000|Overall Study|Withdrawal by Subject|14|||
130287474|NCT00355342|469014839|FG001|Overall Study|Withdrawal by Subject|11|||
130287475|NCT00355342|469014838|FG000|Overall Study|Sponsor terminated study|2|||
130287476|NCT00355342|469014839|FG001|Overall Study|Sponsor terminated study|2|||
130287477|NCT00355342|469014838|FG000|Overall Study|Overcompliant-PI discretion|1|||
130287478|NCT00355342|469014839|FG001|Overall Study|Overcompliant-PI discretion|0|||
130287479|NCT00355342|469014838|FG000|Overall Study|Use of prohibited medication|1|||
130287480|NCT00355342|469014839|FG001|Overall Study|Use of prohibited medication|0|||
130287481|NCT00355342|469014838|FG000|Overall Study|COPD exacerbation|1|||
130287482|NCT00355342|469014839|FG001|Overall Study|COPD exacerbation|1|||
130287483|NCT00355342|469014838|FG000|Overall Study|Dispensed wrong study drug kit|1|||
130287484|NCT00355342|469014839|FG001|Overall Study|Dispensed wrong study drug kit|0|||
130287485|NCT00355342|469014838|FG000|Overall Study|Non-compliance with Dexa scans|1|||
130287486|NCT00355342|469014839|FG001|Overall Study|Non-compliance with Dexa scans|0|||
130287487|NCT00355342|469014838|FG000|Overall Study|Withdrawal by participant and physician|1|||
130287488|NCT00355342|469014839|FG001|Overall Study|Withdrawal by participant and physician|0|||
130287489|NCT00355342|469014838|FG000|Overall Study|Participant relocated|0|||
130287490|NCT00355342|469014839|FG001|Overall Study|Participant relocated|1|||
130287491|NCT00355342|469014838|FG000|Overall Study|Participant discontinued study drug|0|||
130287492|NCT00355342|469014839|FG001|Overall Study|Participant discontinued study drug|1|||
130287493|NCT00355342|469014838|FG000|Overall Study|Study management|0|||
130287494|NCT00355342|469014839|FG001|Overall Study|Study management|1|||
130287495|NCT00355342|469014838|FG000|Overall Study|Protocol Violation|0|||
130287496|NCT00355342|469014839|FG001|Overall Study|Protocol Violation|1|||
130287497|NCT00355342|469014838|FG000|Overall Study|Use of protocol excluded medication|0|||
130287498|NCT00355342|469014839|FG001|Overall Study|Use of protocol excluded medication|1|||
130459494|NCT03743246|469647536|FG000|Pre-Treatment Period|Death|0|||
130459495|NCT03743246|469647537|FG001|Pre-Treatment Period|Death|1|||
130459496|NCT03743246|469647538|FG002|Pre-Treatment Period|Death|0|||
130459497|NCT03743246|469647539|FG003|Pre-Treatment Period|Death|1|||
130459498|NCT03743246|469647536|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
130459499|NCT03743246|469647537|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
130287499|NCT00434759|469014840|FG000|Overall Study|Lack of Efficacy|5|||
130287500|NCT00434759|469014841|FG001|Overall Study|Lack of Efficacy|4|||
130287501|NCT00434759|469014840|FG000|Overall Study|Withdrawal by Subject|17|||
130287502|NCT00434759|469014841|FG001|Overall Study|Withdrawal by Subject|1|||
130287503|NCT00434759|469014840|FG000|Overall Study|family affairs|2|||
130287504|NCT00434759|469014841|FG001|Overall Study|family affairs|0|||
130713111|NCT03340064|470576856|FG001|Second Period|Adverse Event, non-fatal|1|||
130713112|NCT03340064|470576855|FG000|Second Period|Lack of Efficacy|11|||
130713113|NCT03340064|470576856|FG001|Second Period|Lack of Efficacy|0|||
130713114|NCT03340064|470576855|FG000|Second Period|Physician Decision|3|||
130713115|NCT03340064|470576856|FG001|Second Period|Physician Decision|0|||
130713116|NCT03340064|470576855|FG000|Second Period|Withdrawal by Subject|2|||
130713117|NCT03340064|470576856|FG001|Second Period|Withdrawal by Subject|1|||
130713118|NCT03340064|470576855|FG000|Second Period|Approved Drug Available For Indication|1|||
130713119|NCT03340064|470576856|FG001|Second Period|Approved Drug Available For Indication|0|||
130713120|NCT03340064|470576855|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
130713121|NCT03340064|470576856|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
130713122|NCT00856973|470576857|FG000|Overall Study|Adverse Event|5|||
130713123|NCT00856973|470576858|FG001|Overall Study|Adverse Event|5|||
130713124|NCT00856973|470576859|FG002|Overall Study|Adverse Event|3|||
130713125|NCT00856973|470576857|FG000|Overall Study|Lost to Follow-up|6|||
130713126|NCT00856973|470576858|FG001|Overall Study|Lost to Follow-up|3|||
130713127|NCT00856973|470576859|FG002|Overall Study|Lost to Follow-up|5|||
130713128|NCT00856973|470576857|FG000|Overall Study|Physician Decision|0|||
130713129|NCT00856973|470576858|FG001|Overall Study|Physician Decision|3|||
130713130|NCT00856973|470576859|FG002|Overall Study|Physician Decision|1|||
130713131|NCT00856973|470576857|FG000|Overall Study|Protocol Violation|1|||
130713132|NCT00856973|470576858|FG001|Overall Study|Protocol Violation|2|||
130713133|NCT00856973|470576859|FG002|Overall Study|Protocol Violation|1|||
130713134|NCT00856973|470576857|FG000|Overall Study|Withdrawal by Subject|13|||
130713135|NCT00856973|470576858|FG001|Overall Study|Withdrawal by Subject|16|||
130713136|NCT00856973|470576859|FG002|Overall Study|Withdrawal by Subject|15|||
130713137|NCT00856973|470576857|FG000|Overall Study|Other|11|||
130713138|NCT00856973|470576858|FG001|Overall Study|Other|12|||
130713139|NCT00856973|470576859|FG002|Overall Study|Other|13|||
130713140|NCT02751359|470576861|FG000|Overall Study|Lost to Follow-up|1|||
130713141|NCT00912093|470576862|FG000|The Controlled Phase|Death|0|||
130713142|NCT00912093|470576863|FG001|The Controlled Phase|Death|1|||
130713143|NCT00912093|470576864|FG002|The Controlled Phase|Death|0|||
130713144|NCT00912093|470576865|FG003|The Controlled Phase|Death|0|||
130713145|NCT00912093|470576866|FG004|The Controlled Phase|Death|0|||
130713146|NCT00912093|470576862|FG000|The Controlled Phase|Medical Condition|0|||
130713147|NCT00912093|470576863|FG001|The Controlled Phase|Medical Condition|1|||
130287505|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130713148|NCT00912093|470576864|FG002|The Controlled Phase|Medical Condition|0|||
130713149|NCT00912093|470576865|FG003|The Controlled Phase|Medical Condition|0|||
130713150|NCT00912093|470576866|FG004|The Controlled Phase|Medical Condition|0|||
130713151|NCT00912093|470576862|FG000|The Controlled Phase|Lost to Follow-up|0|||
130713152|NCT00912093|470576863|FG001|The Controlled Phase|Lost to Follow-up|0|||
130713153|NCT00912093|470576864|FG002|The Controlled Phase|Lost to Follow-up|0|||
130713154|NCT00912093|470576865|FG003|The Controlled Phase|Lost to Follow-up|0|||
130713155|NCT00912093|470576866|FG004|The Controlled Phase|Lost to Follow-up|1|||
130713156|NCT04397445|470576869|FG000|Overall Study|Withdrawal by Subject|1|||
130713157|NCT04397445|470576870|FG001|Overall Study|Withdrawal by Subject|0|||
130713158|NCT04397445|470576871|FG002|Overall Study|Withdrawal by Subject|0|||
130713159|NCT04397445|470576872|FG003|Overall Study|Withdrawal by Subject|0|||
130713160|NCT03921151|470576873|FG000|Overall Study|Withdrawal by Subject|11|||
130713161|NCT03921151|470576874|FG001|Overall Study|Withdrawal by Subject|16|||
130713162|NCT00616941|470576875|FG000|Overall Study|Progressive Disease|1|||
130713163|NCT00616941|470576876|FG001|Overall Study|Progressive Disease|2|||
130713164|NCT00616941|470576877|FG002|Overall Study|Progressive Disease|1|||
130713165|NCT00616941|470576875|FG000|Overall Study|Adverse Event|0|||
130713166|NCT00616941|470576876|FG001|Overall Study|Adverse Event|1|||
130713167|NCT00616941|470576877|FG002|Overall Study|Adverse Event|1|||
130713168|NCT00616941|470576875|FG000|Overall Study|Subject Non-compliance|0|||
130713169|NCT00616941|470576876|FG001|Overall Study|Subject Non-compliance|0|||
130713170|NCT00616941|470576877|FG002|Overall Study|Subject Non-compliance|1|||
130713171|NCT00616941|470576875|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
130713172|NCT00616941|470576876|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
130713173|NCT00616941|470576877|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
130713174|NCT00616941|470576875|FG000|Overall Study|Vaccination Suspended|0|||
130713175|NCT00616941|470576876|FG001|Overall Study|Vaccination Suspended|0|||
130713176|NCT00616941|470576877|FG002|Overall Study|Vaccination Suspended|3|||
130713177|NCT00354341|470576885|FG000|Overall Study|Adverse Event|1|||
130713178|NCT00354341|470576886|FG001|Overall Study|Adverse Event|0|||
130713179|NCT00354341|470576885|FG000|Overall Study|Death|0|||
130713180|NCT00354341|470576886|FG001|Overall Study|Death|2|||
130713181|NCT00354341|470576885|FG000|Overall Study|Refused treatment|1|||
130287506|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287507|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130459500|NCT03743246|469647538|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
130713182|NCT00354341|470576886|FG001|Overall Study|Refused treatment|2|||
130287508|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287509|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287510|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287511|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287512|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130459501|NCT03743246|469647539|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
130713183|NCT00354341|470576885|FG000|Overall Study|Failure to return|0|||
130713184|NCT00354341|470576886|FG001|Overall Study|Failure to return|1|||
130287513|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287514|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287515|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287516|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287517|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287518|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287519|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
130287520|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287521|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287522|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287523|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287524|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287525|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287526|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287527|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287528|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287529|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287530|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287531|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
130287532|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287533|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287534|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287535|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287536|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287537|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287538|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287539|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287540|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287541|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130459502|NCT03743246|469647536|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
130459503|NCT03743246|469647537|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
130459504|NCT03743246|469647538|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
130459505|NCT03743246|469647539|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
130459506|NCT03743246|469647536|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
130459507|NCT03743246|469647537|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
130459508|NCT03743246|469647538|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
130459509|NCT03743246|469647539|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
130459510|NCT03743246|469647536|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
130459511|NCT03743246|469647537|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
130459512|NCT03743246|469647538|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
130459513|NCT03743246|469647539|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
130459514|NCT03743246|469647536|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
130459515|NCT03743246|469647537|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
130459516|NCT03743246|469647538|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
130459517|NCT03743246|469647539|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
130459518|NCT03743246|469647536|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
130459519|NCT03743246|469647537|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
130459520|NCT03743246|469647538|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
130459521|NCT03743246|469647539|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
130459522|NCT03743246|469647536|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
130459523|NCT03743246|469647537|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
130459524|NCT03743246|469647538|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
130459525|NCT03743246|469647539|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
130459526|NCT01901276|469647540|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
130459527|NCT01901276|469647541|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
130459528|NCT01596504|469647542|FG000|Overall Study|Participant's Private Reason|0|||
130459529|NCT01596504|469647543|FG001|Overall Study|Participant's Private Reason|1|||
130459530|NCT01596504|469647544|FG002|Overall Study|Participant's Private Reason|0|||
130459531|NCT01596504|469647542|FG000|Overall Study|Adverse Event|1|||
130459532|NCT01596504|469647543|FG001|Overall Study|Adverse Event|2|||
130459533|NCT01596504|469647544|FG002|Overall Study|Adverse Event|1|||
130459534|NCT01596504|469647542|FG000|Overall Study|Withdrawal by Subject|1|||
130459535|NCT01596504|469647543|FG001|Overall Study|Withdrawal by Subject|0|||
130459536|NCT01596504|469647544|FG002|Overall Study|Withdrawal by Subject|0|||
130459537|NCT02026258|469647545|FG000|Randomized|Did not start treatment|2|||
130287542|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287543|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287544|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287545|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287546|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287547|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287548|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287549|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
130287550|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287551|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287552|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287553|NCT00969761|469014845|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287554|NCT00969761|469014846|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287555|NCT00969761|469014847|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
130287556|NCT00969761|469014848|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287557|NCT00969761|469014849|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287558|NCT00969761|469014850|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287559|NCT00969761|469014851|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287560|NCT00969761|469014852|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
130287561|NCT00969761|469014853|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
130287562|NCT00969761|469014854|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287563|NCT00969761|469014855|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287564|NCT00969761|469014856|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287565|NCT00969761|469014845|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287566|NCT00969761|469014846|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287567|NCT00969761|469014847|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287568|NCT00969761|469014848|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130287569|NCT00969761|469014849|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
130287570|NCT00969761|469014850|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287571|NCT00969761|469014851|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287572|NCT00969761|469014852|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287573|NCT00969761|469014853|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130287574|NCT00969761|469014854|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287575|NCT00969761|469014855|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287576|NCT00969761|469014856|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287577|NCT04030247|469017450|FG000|Overall Study|Withdrawal by Subject|4|||
130287578|NCT04030247|469017450|FG000|Overall Study|Lost to Follow-up|13|||
130287579|NCT00509093|469017451|FG000|Overall Study|Adverse Event|10|||
130287580|NCT00509093|469017451|FG000|Overall Study|Disease Progression|9|||
130287581|NCT00509093|469017451|FG000|Overall Study|Transformed into MDS|1|||
130459538|NCT02026258|469647546|FG001|Randomized|Did not start treatment|1|||
130459539|NCT02026258|469647545|FG000|Randomized|Change in treatment plan|1|||
130459540|NCT02026258|469647546|FG001|Randomized|Change in treatment plan|0|||
130370630|NCT01427972|469327196|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370631|NCT01427972|469327197|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370632|NCT01427972|469327198|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370633|NCT01427972|469327199|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370634|NCT01427972|469327200|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130556226|NCT03872453|470006067|FG000|Overall Study|Pregnancy|1|||
130556227|NCT03872453|470006068|FG001|Overall Study|Pregnancy|0|||
130556228|NCT03872453|470006069|FG002|Overall Study|Pregnancy|0|||
130556229|NCT03872453|470006070|FG003|Overall Study|Pregnancy|0|||
130556230|NCT03872453|470006067|FG000|Overall Study|Protocol Deviation|2|||
130556231|NCT03872453|470006068|FG001|Overall Study|Protocol Deviation|0|||
130556232|NCT03872453|470006069|FG002|Overall Study|Protocol Deviation|0|||
130556233|NCT03872453|470006070|FG003|Overall Study|Protocol Deviation|2|||
130556234|NCT03872453|470006067|FG000|Overall Study|Withdrawal by Subject|0|||
130556235|NCT03872453|470006068|FG001|Overall Study|Withdrawal by Subject|1|||
130556236|NCT03872453|470006069|FG002|Overall Study|Withdrawal by Subject|2|||
130556237|NCT03872453|470006070|FG003|Overall Study|Withdrawal by Subject|0|||
130556238|NCT03872453|470006067|FG000|Overall Study|Other Than Specified|1|||
130556239|NCT03872453|470006068|FG001|Overall Study|Other Than Specified|0|||
130556240|NCT03872453|470006069|FG002|Overall Study|Other Than Specified|0|||
130556241|NCT03872453|470006070|FG003|Overall Study|Other Than Specified|0|||
130556242|NCT00352885|470006071|FG000|Overall Study|Withdrawal by Subject|0|||
130556243|NCT00352885|470006072|FG001|Overall Study|Withdrawal by Subject|3|||
130287582|NCT00509093|469017451|FG000|Overall Study|Withdrawal by Subject|3|||
130287583|NCT00509093|469017451|FG000|Overall Study|Physician Decision|1|||
130287584|NCT03187834|469017452|FG000|Overall Study|Lost to Follow-up|0|||
130287585|NCT03187834|469017453|FG001|Overall Study|Lost to Follow-up|1|||
130287586|NCT03187834|469017454|FG002|Overall Study|Lost to Follow-up|2|||
130287587|NCT03187834|469017455|FG003|Overall Study|Lost to Follow-up|2|||
130287588|NCT03187834|469017452|FG000|Overall Study|Had invalid anthropometric measurements|5|||
130287589|NCT03187834|469017453|FG001|Overall Study|Had invalid anthropometric measurements|3|||
130287590|NCT03187834|469017454|FG002|Overall Study|Had invalid anthropometric measurements|4|||
130370635|NCT01427972|469327201|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370636|NCT01427972|469327202|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130287591|NCT03187834|469017455|FG003|Overall Study|Had invalid anthropometric measurements|2|||
130287592|NCT00823212|469017456|FG000|Overall Study|Death|8|||
130287593|NCT00823212|469017457|FG001|Overall Study|Death|10|||
130287594|NCT00823212|469017456|FG000|Overall Study|Withdrawal by Subject|6|||
130287595|NCT00823212|469017457|FG001|Overall Study|Withdrawal by Subject|1|||
130287596|NCT00823212|469017456|FG000|Overall Study|Incarcerated|0|||
130287597|NCT00823212|469017457|FG001|Overall Study|Incarcerated|1|||
130287598|NCT00823212|469017456|FG000|Overall Study|Missed 12-month visit|21|||
130287599|NCT00823212|469017457|FG001|Overall Study|Missed 12-month visit|21|||
130287600|NCT01344538|469017458|FG000|Overall Study|Adverse Event|1|||
130287601|NCT01344538|469017459|FG001|Overall Study|Adverse Event|1|||
130287602|NCT01344538|469017458|FG000|Overall Study|Lost to Follow-up|1|||
130287603|NCT01344538|469017459|FG001|Overall Study|Lost to Follow-up|0|||
130287604|NCT01655381|469017460|FG000|Overall Study|Investigator Decision|1|||
130287605|NCT01655381|469017460|FG000|Overall Study|Moved to Another City|1|||
130287606|NCT01655381|469017460|FG000|Overall Study|Insufficient Treatment Response|1|||
130287607|NCT00320255|469017461|FG000|Overall Study|Lack of Efficacy|1|||
130287608|NCT00320255|469017462|FG001|Overall Study|Lack of Efficacy|0|||
130287609|NCT00320255|469017463|FG002|Overall Study|Lack of Efficacy|0|||
130287610|NCT00320255|469017464|FG003|Overall Study|Lack of Efficacy|0|||
130287611|NCT00320255|469017465|FG004|Overall Study|Lack of Efficacy|0|||
130287612|NCT00320255|469017466|FG005|Overall Study|Lack of Efficacy|0|||
130287613|NCT00320255|469017461|FG000|Overall Study|Adverse Event|5|||
130287614|NCT00320255|469017462|FG001|Overall Study|Adverse Event|2|||
130287615|NCT00320255|469017463|FG002|Overall Study|Adverse Event|3|||
130370637|NCT01427972|469327203|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130370638|NCT01427972|469327204|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130713185|NCT00354341|470576885|FG000|Overall Study|Other|1|||
130370639|NCT00799422|469327208|FG000|First Week of Wear|Lost to Follow-up|0|||
130370640|NCT00799422|469327209|FG001|First Week of Wear|Lost to Follow-up|0|||
130370641|NCT00799422|469327210|FG002|First Week of Wear|Lost to Follow-up|1|||
130370642|NCT00799422|469327211|FG003|First Week of Wear|Lost to Follow-up|0|||
130370643|NCT00799422|469327212|FG004|First Week of Wear|Lost to Follow-up|0|||
130370644|NCT00799422|469327213|FG005|First Week of Wear|Lost to Follow-up|0|||
130370645|NCT00799422|469327208|FG000|First Week of Wear|Adverse Event|0|||
130370646|NCT00799422|469327209|FG001|First Week of Wear|Adverse Event|0|||
130370647|NCT00799422|469327210|FG002|First Week of Wear|Adverse Event|0|||
130370648|NCT00799422|469327211|FG003|First Week of Wear|Adverse Event|1|||
130370649|NCT00799422|469327212|FG004|First Week of Wear|Adverse Event|0|||
130370650|NCT00799422|469327213|FG005|First Week of Wear|Adverse Event|0|||
130370651|NCT00530946|469327214|FG000|Overall Study|Adverse Event|1|||
130370652|NCT00530946|469327215|FG001|Overall Study|Adverse Event|2|||
130370653|NCT00530946|469327216|FG002|Overall Study|Adverse Event|1|||
130713186|NCT00354341|470576886|FG001|Overall Study|Other|2|||
130713187|NCT01732874|470576887|FG000|Overall Study|Withdrawal by Subject|5|||
130713188|NCT01732874|470576888|FG001|Overall Study|Withdrawal by Subject|1|||
130713189|NCT01732874|470576887|FG000|Overall Study|Death of Infant|3|||
130713190|NCT01732874|470576888|FG001|Overall Study|Death of Infant|2|||
130713191|NCT00557076|470576889|FG000|Overall Study|Unblinding|0|||
130713192|NCT00557076|470576890|FG001|Overall Study|Unblinding|1|||
130713193|NCT01370213|470576891|FG000|Overall Study|Early Death|1|||
130713194|NCT01370213|470576892|FG001|Overall Study|Early Death|0|||
130713195|NCT01370213|470576893|FG002|Overall Study|Early Death|0|||
130713196|NCT01370213|470576891|FG000|Overall Study|Not evaluable|0|||
130713197|NCT01370213|470576892|FG001|Overall Study|Not evaluable|2|||
130713198|NCT01370213|470576893|FG002|Overall Study|Not evaluable|0|||
130713199|NCT03097588|470576914|FG000|Overall Study|Adverse Event|1|||
130713200|NCT03456960|470576915|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713201|NCT03456960|470576916|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713202|NCT03456960|470576917|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
130713203|NCT03456960|470576918|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
130713204|NCT03456960|470576919|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713205|NCT03456960|470576920|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713206|NCT03456960|470576915|FG000|Period 2 (1 Day)|Adverse Event|1|||
130713207|NCT03456960|470576916|FG001|Period 2 (1 Day)|Adverse Event|0|||
130713208|NCT03456960|470576917|FG002|Period 2 (1 Day)|Adverse Event|0|||
130713209|NCT03456960|470576918|FG003|Period 2 (1 Day)|Adverse Event|1|||
130713210|NCT03456960|470576919|FG004|Period 2 (1 Day)|Adverse Event|0|||
130713211|NCT03456960|470576920|FG005|Period 2 (1 Day)|Adverse Event|0|||
130287616|NCT00320255|469017464|FG003|Overall Study|Adverse Event|2|||
130287617|NCT00320255|469017465|FG004|Overall Study|Adverse Event|0|||
130287618|NCT00320255|469017466|FG005|Overall Study|Adverse Event|0|||
130287619|NCT00320255|469017461|FG000|Overall Study|Withdrawal by Subject|1|||
130287620|NCT00320255|469017462|FG001|Overall Study|Withdrawal by Subject|2|||
130287621|NCT00320255|469017463|FG002|Overall Study|Withdrawal by Subject|2|||
130287622|NCT00320255|469017464|FG003|Overall Study|Withdrawal by Subject|4|||
130287623|NCT00320255|469017465|FG004|Overall Study|Withdrawal by Subject|0|||
130287624|NCT00320255|469017466|FG005|Overall Study|Withdrawal by Subject|0|||
130287625|NCT00320255|469017461|FG000|Overall Study|Poor compliance/noncompliance|1|||
130287626|NCT00320255|469017462|FG001|Overall Study|Poor compliance/noncompliance|1|||
130287627|NCT00320255|469017463|FG002|Overall Study|Poor compliance/noncompliance|0|||
130287628|NCT00320255|469017464|FG003|Overall Study|Poor compliance/noncompliance|1|||
130287629|NCT00320255|469017465|FG004|Overall Study|Poor compliance/noncompliance|0|||
130287630|NCT00320255|469017466|FG005|Overall Study|Poor compliance/noncompliance|0|||
130287631|NCT00320255|469017461|FG000|Overall Study|No longer meets study criteria|0|||
130287632|NCT00320255|469017462|FG001|Overall Study|No longer meets study criteria|0|||
130287633|NCT00320255|469017463|FG002|Overall Study|No longer meets study criteria|0|||
130287634|NCT00320255|469017464|FG003|Overall Study|No longer meets study criteria|1|||
130287635|NCT00320255|469017465|FG004|Overall Study|No longer meets study criteria|0|||
130287636|NCT00320255|469017466|FG005|Overall Study|No longer meets study criteria|0|||
130287637|NCT00320255|469017461|FG000|Overall Study|Other|3|||
130287638|NCT00320255|469017462|FG001|Overall Study|Other|2|||
130287639|NCT00320255|469017463|FG002|Overall Study|Other|1|||
130287640|NCT00320255|469017464|FG003|Overall Study|Other|0|||
130370654|NCT00530946|469327217|FG003|Overall Study|Adverse Event|1|||
130713212|NCT02989168|470576921|FG000|Overall Study|Withdrawal by Subject|2|||
130713213|NCT02989168|470576922|FG001|Overall Study|Withdrawal by Subject|0|||
130713214|NCT02989168|470576921|FG000|Overall Study|Physician Decision|0|||
130713215|NCT02989168|470576922|FG001|Overall Study|Physician Decision|1|||
130713216|NCT02989168|470576921|FG000|Overall Study|Adverse Event|1|||
130713217|NCT02989168|470576922|FG001|Overall Study|Adverse Event|2|||
130713218|NCT02989168|470576921|FG000|Overall Study|Sponsor stopped study.|1|||
130713219|NCT02989168|470576922|FG001|Overall Study|Sponsor stopped study.|0|||
130713220|NCT03828448|470576923|FG000|Overall Study|Sponsor's Discretion|34|||
130713221|NCT02037165|470576924|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130287641|NCT00320255|469017465|FG004|Overall Study|Other|0|||
130287642|NCT00320255|469017466|FG005|Overall Study|Other|0|||
130287643|NCT03405935|469017468|FG000|Overall Study|Adverse Event|3|||
130287644|NCT03405935|469017468|FG000|Overall Study|Death|2|||
130287645|NCT03405935|469017468|FG000|Overall Study|Withdrawal by Subject|1|||
130713222|NCT02037165|470576925|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130713223|NCT02037165|470576926|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130713224|NCT02037165|470576927|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130713225|NCT02037165|470576928|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
130713226|NCT00532935|470576929|FG000|Overall Study|Adverse Event|11|||
130287646|NCT03405935|469017468|FG000|Overall Study|Lost to Follow-up|2|||
130287647|NCT04979897|469017469|FG000|Overall Study|Death|1|||
130556244|NCT00352885|470006071|FG000|Overall Study|Development of major depression|0|||
130556245|NCT00352885|470006072|FG001|Overall Study|Development of major depression|1|||
130556246|NCT00352885|470006071|FG000|Overall Study|Progression of metastatic melanoma|5|||
130556247|NCT00352885|470006072|FG001|Overall Study|Progression of metastatic melanoma|3|||
130556248|NCT00352885|470006071|FG000|Overall Study|Side effects of IL-2 administration|1|||
130556249|NCT00352885|470006072|FG001|Overall Study|Side effects of IL-2 administration|0|||
130556250|NCT03873493|470006073|FG000|Overall Study|Withdrawal by Subject|1|||
130556251|NCT03873493|470006073|FG000|Overall Study|Death|9|||
130556252|NCT03873493|470006073|FG000|Overall Study|Lost to Follow-up|1|||
130556253|NCT03873493|470006073|FG000|Overall Study|Study Terminated by Sponsor|1|||
130556254|NCT03873493|470006073|FG000|Overall Study|Other|2|||
130556255|NCT03756350|470006075|FG000|Overall Study|Lost to Follow-up|1|||
130556256|NCT00440700|470006078|FG000|Overall Study|Withdrawal by Subject|8|||
130556257|NCT00440700|470006079|FG001|Overall Study|Withdrawal by Subject|8|||
130556258|NCT00440700|470006080|FG002|Overall Study|Withdrawal by Subject|4|||
130556259|NCT01096342|470006081|FG000|Overall Study|Protocol Violation|1|||
130556260|NCT04906616|470006082|FG000|Overall Study|Divorce|3|||
130556261|NCT04906616|470006083|FG001|Overall Study|Divorce|2|||
130556262|NCT03739762|470006084|FG000|Overall Study|Lost to Follow-up|1|||
130556263|NCT03739762|470006085|FG001|Overall Study|Lost to Follow-up|1|||
130556264|NCT03739762|470006084|FG000|Overall Study|Withdrawal by Subject|2|||
130556265|NCT03739762|470006085|FG001|Overall Study|Withdrawal by Subject|6|||
130556266|NCT02464228|470006088|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
130556267|NCT02464228|470006089|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
130556268|NCT02464228|470006090|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
130556269|NCT02464228|470006091|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
130556270|NCT02464228|470006088|FG000|Overall Study|Physician Decision|2|||
130556271|NCT02464228|470006089|FG001|Overall Study|Physician Decision|0|||
130556272|NCT02464228|470006090|FG002|Overall Study|Physician Decision|1|||
130556273|NCT02464228|470006091|FG003|Overall Study|Physician Decision|0|||
130556274|NCT02464228|470006088|FG000|Overall Study|Miscellaneous|1|||
130556275|NCT02464228|470006089|FG001|Overall Study|Miscellaneous|0|||
130556276|NCT02464228|470006090|FG002|Overall Study|Miscellaneous|1|||
130556277|NCT02464228|470006091|FG003|Overall Study|Miscellaneous|0|||
130556278|NCT02464228|470006088|FG000|Overall Study|Adverse Event|9|||
130556279|NCT02464228|470006089|FG001|Overall Study|Adverse Event|0|||
130556280|NCT02464228|470006090|FG002|Overall Study|Adverse Event|3|||
130556281|NCT02464228|470006091|FG003|Overall Study|Adverse Event|0|||
130556282|NCT02464228|470006088|FG000|Overall Study|Withdrawal by Subject|1|||
130556283|NCT02464228|470006089|FG001|Overall Study|Withdrawal by Subject|1|||
130556284|NCT02464228|470006090|FG002|Overall Study|Withdrawal by Subject|1|||
130556285|NCT02464228|470006091|FG003|Overall Study|Withdrawal by Subject|0|||
130556286|NCT02464228|470006088|FG000|Overall Study|Disease Progression|22|||
130556287|NCT02464228|470006089|FG001|Overall Study|Disease Progression|12|||
130556288|NCT02464228|470006090|FG002|Overall Study|Disease Progression|5|||
130556289|NCT02464228|470006091|FG003|Overall Study|Disease Progression|2|||
130556290|NCT00385203|470006094|FG000|Overall Study|Adverse Event|5|||
130556291|NCT00385203|470006095|FG001|Overall Study|Adverse Event|4|||
130556292|NCT00385203|470006094|FG000|Overall Study|Death|1|||
130556293|NCT00385203|470006095|FG001|Overall Study|Death|0|||
130556294|NCT00385203|470006094|FG000|Overall Study|Condition under investigation worsened|18|||
130556295|NCT00385203|470006095|FG001|Overall Study|Condition under investigation worsened|3|||
130556296|NCT00385203|470006094|FG000|Overall Study|Incorrect enrollment|2|||
130556297|NCT00385203|470006095|FG001|Overall Study|Incorrect enrollment|0|||
130556298|NCT03308942|470006096|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
130556299|NCT03308942|470006097|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
130556300|NCT03308942|470006098|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
130556301|NCT03308942|470006099|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
130556302|NCT03308942|470006100|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
130556303|NCT03308942|470006096|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
130556304|NCT03308942|470006097|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
130556305|NCT03308942|470006098|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
130556306|NCT03308942|470006099|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
130556307|NCT03308942|470006100|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
130556308|NCT03308942|470006096|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130556309|NCT03308942|470006097|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
130287648|NCT04979897|469017470|FG001|Overall Study|Death|8|||
130556310|NCT03308942|470006098|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130556311|NCT03308942|470006099|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130556312|NCT03308942|470006100|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130556313|NCT03308942|470006096|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
130556314|NCT03308942|470006097|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
130556315|NCT03308942|470006098|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130556316|NCT03308942|470006099|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130287649|NCT04979897|469017469|FG000|Overall Study|Lost to Follow-up|111|||
130287650|NCT04979897|469017470|FG001|Overall Study|Lost to Follow-up|56|||
130287651|NCT04979897|469017469|FG000|Overall Study|Withdrawal by Subject|7|||
130287652|NCT04979897|469017470|FG001|Overall Study|Withdrawal by Subject|2|||
130287653|NCT02781792|469017477|FG000|Overall Study|Adverse Event|1|||
130287654|NCT02781792|469017478|FG001|Overall Study|Adverse Event|2|||
130287655|NCT02781792|469017477|FG000|Overall Study|Withdrawal by Subject|3|||
130287656|NCT02781792|469017478|FG001|Overall Study|Withdrawal by Subject|1|||
130287657|NCT02781792|469017477|FG000|Overall Study|Lack of Efficacy|1|||
130287658|NCT02781792|469017478|FG001|Overall Study|Lack of Efficacy|1|||
130287659|NCT02781792|469017477|FG000|Overall Study|Hospice|0|||
130287660|NCT02781792|469017478|FG001|Overall Study|Hospice|1|||
130287661|NCT01703117|469017479|FG000|Overall Study|Adverse Event|4|||
130287662|NCT01703117|469017480|FG001|Overall Study|Adverse Event|3|||
130287663|NCT01703117|469017479|FG000|Overall Study|Withdrawal by Subject|0|||
130287664|NCT01703117|469017480|FG001|Overall Study|Withdrawal by Subject|1|||
130287665|NCT00937404|469017492|FG000|Overall Study|Protocol Violation|1|||
130287666|NCT00937404|469017492|FG000|Overall Study|Withdrawal by Subject|1|||
130287667|NCT04644237|469017493|FG000|Overall Study|Death|3|||
130287668|NCT04644237|469017494|FG001|Overall Study|Death|2|||
130287669|NCT04644237|469017493|FG000|Overall Study|Adverse Event|15|||
130287670|NCT04644237|469017494|FG001|Overall Study|Adverse Event|12|||
130287671|NCT04644237|469017493|FG000|Overall Study|Progressive Disease|47|||
130287672|NCT04644237|469017494|FG001|Overall Study|Progressive Disease|19|||
130556317|NCT03308942|470006100|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130556318|NCT03308942|470006096|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130556319|NCT03308942|470006097|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130556320|NCT03308942|470006098|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130556321|NCT03308942|470006099|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
130556322|NCT03308942|470006100|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130556323|NCT03308942|470006096|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130556324|NCT03308942|470006097|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130556325|NCT03308942|470006098|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130556326|NCT03308942|470006099|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
130556327|NCT03308942|470006100|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130556328|NCT03308942|470006096|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130556329|NCT03308942|470006097|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130556330|NCT03308942|470006098|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130556331|NCT03308942|470006099|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
130287673|NCT04644237|469017493|FG000|Overall Study|Clinical Progression|4|||
130556332|NCT03308942|470006100|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130287674|NCT04644237|469017494|FG001|Overall Study|Clinical Progression|1|||
130287675|NCT04644237|469017493|FG000|Overall Study|Withdrawal by Subject|1|||
130287676|NCT04644237|469017494|FG001|Overall Study|Withdrawal by Subject|2|||
130287677|NCT04644237|469017493|FG000|Overall Study|Physician Decision|3|||
130287678|NCT04644237|469017494|FG001|Overall Study|Physician Decision|0|||
130287679|NCT04644237|469017493|FG000|Overall Study|Other|1|||
130287680|NCT04644237|469017494|FG001|Overall Study|Other|0|||
130287681|NCT04644237|469017493|FG000|Overall Study|Randomized but not Treated|1|||
130287682|NCT04644237|469017494|FG001|Overall Study|Randomized but not Treated|0|||
130287683|NCT00090233|469017495|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
130287684|NCT00090233|469017496|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
130287685|NCT00090233|469017495|FG000|Overall Study|Adverse Event|214|||
130287686|NCT00090233|469017496|FG001|Overall Study|Adverse Event|198|||
130287687|NCT00090233|469017495|FG000|Overall Study|Lost to Follow-up|68|||
130287688|NCT00090233|469017496|FG001|Overall Study|Lost to Follow-up|95|||
130287689|NCT00090233|469017495|FG000|Overall Study|Protocol Violation|960|||
130287690|NCT00090233|469017496|FG001|Overall Study|Protocol Violation|1022|||
130287691|NCT00090233|469017495|FG000|Overall Study|Withdrawal by Subject|182|||
130287692|NCT00090233|469017496|FG001|Overall Study|Withdrawal by Subject|211|||
130556333|NCT01131351|470006101|FG000|Overall Study|Adverse Event|0|||
130556334|NCT01131351|470006102|FG001|Overall Study|Adverse Event|2|||
130287693|NCT00090233|469017495|FG000|Overall Study|Moved|203|||
130287694|NCT00090233|469017496|FG001|Overall Study|Moved|189|||
130287695|NCT00090233|469017495|FG000|Overall Study|Other|1211|||
130287696|NCT00090233|469017496|FG001|Overall Study|Other|1160|||
130287697|NCT00090233|469017495|FG000|Overall Study|Data not available at data cut-off point|1552|||
130287698|NCT00090233|469017496|FG001|Overall Study|Data not available at data cut-off point|1563|||
130287699|NCT04863248|469017497|FG000|Overall Study|Sponsor Terminated|4|||
130287700|NCT04863248|469017498|FG001|Overall Study|Sponsor Terminated|1|||
130287701|NCT04863248|469017497|FG000|Overall Study|Death|0|||
130287702|NCT04863248|469017498|FG001|Overall Study|Death|1|||
130287703|NCT04863248|469017497|FG000|Overall Study|Withdrawal by Subject|0|||
130287704|NCT04863248|469017498|FG001|Overall Study|Withdrawal by Subject|1|||
130287705|NCT02536300|469017499|FG000|Overall Study|Investigator's Discretion|17|||
130287706|NCT02536300|469017500|FG001|Overall Study|Investigator's Discretion|11|||
130287707|NCT02536300|469017501|FG002|Overall Study|Investigator's Discretion|2|||
130287708|NCT02536300|469017499|FG000|Overall Study|Progressive Disease|11|||
130287709|NCT02536300|469017500|FG001|Overall Study|Progressive Disease|7|||
130287710|NCT02536300|469017501|FG002|Overall Study|Progressive Disease|6|||
130287711|NCT02536300|469017499|FG000|Overall Study|Study Terminated by Sponsor|6|||
130287712|NCT02536300|469017500|FG001|Overall Study|Study Terminated by Sponsor|4|||
130287713|NCT02536300|469017501|FG002|Overall Study|Study Terminated by Sponsor|7|||
130287714|NCT02536300|469017499|FG000|Overall Study|Death|7|||
130287715|NCT02536300|469017500|FG001|Overall Study|Death|0|||
130287716|NCT02536300|469017501|FG002|Overall Study|Death|5|||
130287717|NCT02536300|469017499|FG000|Overall Study|Withdrew Consent|4|||
130287718|NCT02536300|469017500|FG001|Overall Study|Withdrew Consent|2|||
130287719|NCT02536300|469017501|FG002|Overall Study|Withdrew Consent|0|||
130287720|NCT02536300|469017499|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130287721|NCT02536300|469017500|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
130287722|NCT02536300|469017501|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130287723|NCT02536300|469017499|FG000|Overall Study|Enrolled but Never Treated|0|||
130287724|NCT02536300|469017500|FG001|Overall Study|Enrolled but Never Treated|0|||
130287725|NCT02536300|469017501|FG002|Overall Study|Enrolled but Never Treated|1|||
130287726|NCT02536300|469017499|FG000|Overall Study|Non-compliance With Study Drug|1|||
130287727|NCT02536300|469017500|FG001|Overall Study|Non-compliance With Study Drug|0|||
130287728|NCT02536300|469017501|FG002|Overall Study|Non-compliance With Study Drug|0|||
130287729|NCT02536300|469017499|FG000|Overall Study|Protocol Violation|0|||
130287730|NCT02536300|469017500|FG001|Overall Study|Protocol Violation|1|||
130287731|NCT02536300|469017501|FG002|Overall Study|Protocol Violation|0|||
130287732|NCT01691105|469017508|FG000|1 Month Follow-up|Lost to Follow-up|41|||
130287733|NCT01691105|469017509|FG001|1 Month Follow-up|Lost to Follow-up|38|||
130287734|NCT01691105|469017508|FG000|1 Month Follow-up|Death|2|||
130287735|NCT01691105|469017509|FG001|1 Month Follow-up|Death|3|||
130287736|NCT01691105|469017508|FG000|6 Month Follow-up|Lost to Follow-up|39|||
130287737|NCT01691105|469017509|FG001|6 Month Follow-up|Lost to Follow-up|58|||
130287738|NCT01691105|469017508|FG000|6 Month Follow-up|Death|13|||
130287739|NCT01691105|469017509|FG001|6 Month Follow-up|Death|13|||
130287740|NCT01691105|469017508|FG000|12 Month Follow-up|Lost to Follow-up|50|||
130287741|NCT01691105|469017509|FG001|12 Month Follow-up|Lost to Follow-up|71|||
130287742|NCT01691105|469017508|FG000|12 Month Follow-up|Death|22|||
130287743|NCT01691105|469017509|FG001|12 Month Follow-up|Death|30|||
130287744|NCT01691105|469017508|FG000|12 Month Biochemical Verification|Death|22|||
130287745|NCT01691105|469017509|FG001|12 Month Biochemical Verification|Death|30|||
130287746|NCT01691105|469017508|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
130287747|NCT01691105|469017509|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
130287748|NCT01691105|469017508|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
130287749|NCT01691105|469017509|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
130287750|NCT02233738|469017510|FG000|Overall Study|Lost to Follow-up|5|||
130287751|NCT02233738|469017511|FG001|Overall Study|Lost to Follow-up|12|||
130287752|NCT02233738|469017510|FG000|Overall Study|Death|0|||
130287753|NCT02233738|469017511|FG001|Overall Study|Death|1|||
130287754|NCT02233738|469017510|FG000|Overall Study|Withdrawal by Subject|0|||
130287755|NCT02233738|469017511|FG001|Overall Study|Withdrawal by Subject|1|||
130287756|NCT02233738|469017510|FG000|Overall Study|Did not return after Baseline|3|||
130287757|NCT02233738|469017511|FG001|Overall Study|Did not return after Baseline|2|||
130287758|NCT00096174|469017512|FG000|Overall Study|Lack of Efficacy|9|||
130287759|NCT00096174|469017512|FG000|Overall Study|Adverse Event|15|||
130287760|NCT00096174|469017512|FG000|Overall Study|Death|6|||
130287761|NCT00096174|469017512|FG000|Overall Study|Withdrawal by Subject|15|||
130287762|NCT00096174|469017512|FG000|Overall Study|Not started protocol therapy|3|||
130287763|NCT00096174|469017512|FG000|Overall Study|Ineligible|6|||
130287764|NCT00096174|469017512|FG000|Overall Study|other reason|8|||
130287765|NCT00445848|469017516|FG000|Overall Study|Adverse Event|14|||
130287766|NCT00445848|469017516|FG000|Overall Study|Withdrawal by Subject|4|||
130287767|NCT00445848|469017516|FG000|Overall Study|Progression|62|||
130287768|NCT00445848|469017516|FG000|Overall Study|Other-Not protocol specified|5|||
130287769|NCT04706273|469017517|FG000|Overall Study|Withdrawal by Subject|27|||
130287770|NCT04706273|469017517|FG000|Overall Study|Physician Decision|1|||
130287771|NCT04706273|469017517|FG000|Overall Study|Lost to Follow-up|42|||
130287772|NCT04706273|469017517|FG000|Overall Study|Death|85|||
130370655|NCT00530946|469327214|FG000|Overall Study|Protocol Violation|0|||
130370656|NCT00530946|469327215|FG001|Overall Study|Protocol Violation|0|||
130556335|NCT01131351|470006101|FG000|Overall Study|Protocol Deviation|0|||
130287773|NCT04706273|469017517|FG000|Overall Study|Amputation that removes study device|2|||
130287774|NCT04706273|469017517|FG000|Overall Study|Surgical bypass|3|||
130287775|NCT04706273|469017517|FG000|Overall Study|Changing hospital|23|||
130287776|NCT04706273|469017517|FG000|Overall Study|Unable to attend hospital|2|||
130287777|NCT03199053|469017520|FG000|ST Period|Withdrawal by Subject|2|||
130287778|NCT03199053|469017521|FG001|ST Period|Withdrawal by Subject|4|||
130556336|NCT01131351|470006102|FG001|Overall Study|Protocol Deviation|1|||
130713227|NCT00532935|470576930|FG001|Overall Study|Adverse Event|12|||
130713228|NCT00532935|470576929|FG000|Overall Study|Lack of Efficacy|0|||
130713229|NCT00532935|470576930|FG001|Overall Study|Lack of Efficacy|3|||
130713230|NCT00532935|470576929|FG000|Overall Study|Lost to Follow-up|10|||
130713231|NCT00532935|470576930|FG001|Overall Study|Lost to Follow-up|6|||
130713232|NCT00532935|470576929|FG000|Overall Study|Physician Decision|4|||
130713233|NCT00532935|470576930|FG001|Overall Study|Physician Decision|5|||
130713234|NCT00532935|470576929|FG000|Overall Study|Pregnancy|1|||
130713235|NCT00532935|470576930|FG001|Overall Study|Pregnancy|0|||
130713236|NCT00532935|470576929|FG000|Overall Study|Protocol Violation|4|||
130713237|NCT00532935|470576930|FG001|Overall Study|Protocol Violation|2|||
130713238|NCT00532935|470576929|FG000|Overall Study|Withdrawal by Subject|10|||
130713239|NCT00532935|470576930|FG001|Overall Study|Withdrawal by Subject|9|||
130713240|NCT00532935|470576929|FG000|Overall Study|Protocol Specific Criteria|11|||
130287779|NCT03199053|469017522|FG002|ST Period|Withdrawal by Subject|6|||
130287780|NCT03199053|469017520|FG000|ST Period|Withdrawal by parent/guardian|1|||
130287781|NCT03199053|469017521|FG001|ST Period|Withdrawal by parent/guardian|1|||
130287782|NCT03199053|469017522|FG002|ST Period|Withdrawal by parent/guardian|1|||
130287783|NCT03199053|469017520|FG000|ST Period|Lost to Follow-up|2|||
130287784|NCT03199053|469017521|FG001|ST Period|Lost to Follow-up|0|||
130287785|NCT03199053|469017522|FG002|ST Period|Lost to Follow-up|1|||
130287786|NCT03199053|469017520|FG000|LT Period|Withdrawal by Subject|1|||
130287787|NCT03199053|469017521|FG001|LT Period|Withdrawal by Subject|3|||
130287788|NCT03199053|469017522|FG002|LT Period|Withdrawal by Subject|3|||
130287789|NCT03199053|469017520|FG000|LT Period|Withdrawal by parent/guardian|0|||
130287790|NCT03199053|469017521|FG001|LT Period|Withdrawal by parent/guardian|0|||
130287791|NCT03199053|469017522|FG002|LT Period|Withdrawal by parent/guardian|1|||
130287792|NCT03199053|469017520|FG000|LT Period|Lost to Follow-up|0|||
130287793|NCT03199053|469017521|FG001|LT Period|Lost to Follow-up|1|||
130287794|NCT03199053|469017522|FG002|LT Period|Lost to Follow-up|1|||
130287795|NCT03199053|469017520|FG000|LT Period|Miscellaneous|0|||
130287796|NCT03199053|469017521|FG001|LT Period|Miscellaneous|0|||
130287797|NCT03199053|469017522|FG002|LT Period|Miscellaneous|2|||
130287798|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
130287799|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
130287800|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
130287801|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130287802|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
130287803|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130287804|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
130287805|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
130287806|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
130287807|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
130287808|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
130287809|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
130287810|NCT02509052|469017525|FG000|Overall Study|Non compliance|0|||
130287811|NCT02509052|469017526|FG001|Overall Study|Non compliance|0|||
130287812|NCT02509052|469017527|FG002|Overall Study|Non compliance|1|||
130287813|NCT01824823|469017528|FG000|Overall Study|Lack of Efficacy|1|||
130287814|NCT01824823|469017529|FG001|Overall Study|Lack of Efficacy|1|||
130287815|NCT01824823|469017528|FG000|Overall Study|Off-treatment reason not submitted|1|||
130287816|NCT01824823|469017529|FG001|Overall Study|Off-treatment reason not submitted|0|||
130287817|NCT03362931|469017532|FG000|Overall Study|Adverse Event|1|||
130287818|NCT03362931|469017532|FG000|Overall Study|Death|2|||
130287819|NCT01323270|469017533|FG000|Overall Study|Withdrawal by Subject|19|||
130287820|NCT01323270|469017534|FG001|Overall Study|Withdrawal by Subject|10|||
130713241|NCT00532935|470576930|FG001|Overall Study|Protocol Specific Criteria|15|||
130713242|NCT00456495|470576931|FG000|Overall Study|Physician Decision|2|||
130713243|NCT02192164|470576932|FG000|Overall Study|Other|8|||
130287821|NCT01323270|469017533|FG000|Overall Study|Protocol Violation|9|||
130287822|NCT01323270|469017534|FG001|Overall Study|Protocol Violation|7|||
130287823|NCT01323270|469017533|FG000|Overall Study|Lost to Follow-up|4|||
130287824|NCT01323270|469017534|FG001|Overall Study|Lost to Follow-up|6|||
130287825|NCT01323270|469017533|FG000|Overall Study|Adverse Event|8|||
130287826|NCT01323270|469017534|FG001|Overall Study|Adverse Event|0|||
130287827|NCT01323270|469017533|FG000|Overall Study|Other|0|||
130287828|NCT01323270|469017534|FG001|Overall Study|Other|3|||
130287829|NCT01323270|469017533|FG000|Overall Study|Physician Decision|0|||
130556337|NCT02294682|470006103|FG000|Overall Study|Could not swallow pills|1|||
130713244|NCT02192164|470576932|FG000|Overall Study|Withdrawal by Subject|1|||
130287830|NCT01323270|469017534|FG001|Overall Study|Physician Decision|2|||
130287831|NCT01323270|469017533|FG000|Overall Study|Not eligible|1|||
130287832|NCT01323270|469017534|FG001|Overall Study|Not eligible|1|||
130287833|NCT01323270|469017533|FG000|Overall Study|Death|1|||
130287834|NCT01323270|469017534|FG001|Overall Study|Death|0|||
130713245|NCT02192164|470576932|FG000|Overall Study|Physician Decision|4|||
130713246|NCT02192164|470576932|FG000|Overall Study|Did not meet the exclusion criteria|1|||
130713247|NCT01300923|470576933|FG000|Overall Study|Physician Decision|0|||
130713248|NCT01300923|470576934|FG001|Overall Study|Physician Decision|2|||
130713249|NCT01568866|470576935|FG000|Overall Study|Disease Progression|208|||
130713250|NCT01568866|470576936|FG001|Overall Study|Disease Progression|183|||
130713251|NCT01568866|470576935|FG000|Overall Study|Adverse Event|94|||
130713252|NCT01568866|470576936|FG001|Overall Study|Adverse Event|96|||
130713253|NCT01568866|470576935|FG000|Overall Study|Patient Request|55|||
130713254|NCT01568866|470576936|FG001|Overall Study|Patient Request|71|||
130713255|NCT01568866|470576935|FG000|Overall Study|Physician Decision|40|||
130713256|NCT01568866|470576936|FG001|Overall Study|Physician Decision|32|||
130713257|NCT01568866|470576935|FG000|Overall Study|Withdrawal by Subject|19|||
130713258|NCT01568866|470576936|FG001|Overall Study|Withdrawal by Subject|11|||
130713259|NCT01568866|470576935|FG000|Overall Study|Death|10|||
130713260|NCT01568866|470576936|FG001|Overall Study|Death|18|||
130713261|NCT01568866|470576935|FG000|Overall Study|Protocol Non-compliance|2|||
130287835|NCT01323270|469017533|FG000|Overall Study|Randomized, but not vaccinated|1|||
130287836|NCT01323270|469017534|FG001|Overall Study|Randomized, but not vaccinated|0|||
130287837|NCT03761394|469017536|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287838|NCT03761394|469017537|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
130287839|NCT03761394|469017538|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287840|NCT03761394|469017539|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287841|NCT03761394|469017536|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
130287842|NCT03761394|469017537|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
130287843|NCT03761394|469017538|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130287844|NCT03761394|469017539|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130287845|NCT03761394|469017536|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287846|NCT03761394|469017537|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287847|NCT03761394|469017538|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
130287848|NCT03761394|469017539|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287849|NCT03761394|469017536|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130287850|NCT03761394|469017537|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130287851|NCT03761394|469017538|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130287852|NCT03761394|469017539|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
130287853|NCT01080768|469017548|FG000|Overall Study|Protocol Deviation|2|||
130287854|NCT01080768|469017549|FG001|Overall Study|Protocol Deviation|1|||
130287855|NCT00931723|469017554|FG000|Overall Study|Withdrawal by Subject|11|||
130459541|NCT02026258|469647545|FG000|Randomized|Presence of periodontal disease|1|||
130713262|NCT01568866|470576936|FG001|Overall Study|Protocol Non-compliance|4|||
130713263|NCT01568866|470576935|FG000|Overall Study|Lost to Follow-up|1|||
130459542|NCT02026258|469647546|FG001|Randomized|Presence of periodontal disease|1|||
130713264|NCT01568866|470576936|FG001|Overall Study|Lost to Follow-up|0|||
130713265|NCT01568866|470576935|FG000|Overall Study|Randomized but Not Dosed|9|||
130713266|NCT01568866|470576936|FG001|Overall Study|Randomized but Not Dosed|1|||
130713267|NCT01698775|470576939|FG000|Phase A|Adverse Event|2|||
130713268|NCT01698775|470576940|FG001|Phase A|Adverse Event|1|||
130713269|NCT01698775|470576939|FG000|Phase A|Death|1|||
130287856|NCT00931723|469017555|FG001|Overall Study|Withdrawal by Subject|13|||
130287857|NCT00931723|469017554|FG000|Overall Study|Adverse Event|6|||
130287858|NCT00931723|469017555|FG001|Overall Study|Adverse Event|13|||
130287859|NCT00931723|469017554|FG000|Overall Study|Lithium found in blood|0|||
130287860|NCT00931723|469017555|FG001|Overall Study|Lithium found in blood|1|||
130287861|NCT00931723|469017554|FG000|Overall Study|Condition under investigation worsened|1|||
130287862|NCT00931723|469017555|FG001|Overall Study|Condition under investigation worsened|2|||
130287863|NCT00931723|469017554|FG000|Overall Study|Lost to Follow-up|1|||
130287864|NCT00931723|469017555|FG001|Overall Study|Lost to Follow-up|2|||
130287865|NCT00931723|469017554|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130287866|NCT00931723|469017555|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130287867|NCT00931723|469017554|FG000|Overall Study|Severe non-compliance to protocol|2|||
130287868|NCT00931723|469017555|FG001|Overall Study|Severe non-compliance to protocol|0|||
130287869|NCT00931723|469017554|FG000|Overall Study|Safety reasons|0|||
130287870|NCT00931723|469017555|FG001|Overall Study|Safety reasons|1|||
130287871|NCT00931723|469017554|FG000|Overall Study|Took prohibited concomitant medication|0|||
130287872|NCT00931723|469017555|FG001|Overall Study|Took prohibited concomitant medication|1|||
130287873|NCT00931723|469017554|FG000|Overall Study|Lack or insufficient theraputic response|2|||
130287874|NCT00931723|469017555|FG001|Overall Study|Lack or insufficient theraputic response|5|||
130287875|NCT00931723|469017554|FG000|Overall Study|Sponsor decision|1|||
130287876|NCT00931723|469017555|FG001|Overall Study|Sponsor decision|0|||
130287877|NCT00931723|469017554|FG000|Overall Study|Late hospital discharge|1|||
130287878|NCT00931723|469017555|FG001|Overall Study|Late hospital discharge|0|||
130287879|NCT01643850|469017559|FG000|Overall Study|Withdrawal by Subject|0|||
130287880|NCT01643850|469017560|FG001|Overall Study|Withdrawal by Subject|0|||
130287881|NCT01643850|469017561|FG002|Overall Study|Withdrawal by Subject|0|||
130287882|NCT01643850|469017562|FG003|Overall Study|Withdrawal by Subject|0|||
130287883|NCT01643850|469017563|FG004|Overall Study|Withdrawal by Subject|1|||
130287884|NCT01643850|469017564|FG005|Overall Study|Withdrawal by Subject|0|||
130287885|NCT01643850|469017565|FG006|Overall Study|Withdrawal by Subject|0|||
130287886|NCT01643850|469017566|FG007|Overall Study|Withdrawal by Subject|0|||
130287887|NCT01643850|469017567|FG008|Overall Study|Withdrawal by Subject|0|||
130287888|NCT01643850|469017559|FG000|Overall Study|Lost to Follow-up|0|||
130287889|NCT01643850|469017560|FG001|Overall Study|Lost to Follow-up|0|||
130287890|NCT01643850|469017561|FG002|Overall Study|Lost to Follow-up|0|||
130287891|NCT01643850|469017562|FG003|Overall Study|Lost to Follow-up|0|||
130287892|NCT01643850|469017563|FG004|Overall Study|Lost to Follow-up|0|||
130287893|NCT01643850|469017564|FG005|Overall Study|Lost to Follow-up|0|||
130287894|NCT01643850|469017565|FG006|Overall Study|Lost to Follow-up|1|||
130287895|NCT01643850|469017566|FG007|Overall Study|Lost to Follow-up|0|||
130287896|NCT01643850|469017567|FG008|Overall Study|Lost to Follow-up|1|||
130287897|NCT01643850|469017559|FG000|Overall Study|Adverse Event|0|||
130287898|NCT01643850|469017560|FG001|Overall Study|Adverse Event|0|||
130287899|NCT01643850|469017561|FG002|Overall Study|Adverse Event|0|||
130287900|NCT01643850|469017562|FG003|Overall Study|Adverse Event|0|||
130287901|NCT01643850|469017563|FG004|Overall Study|Adverse Event|1|||
130287902|NCT01643850|469017564|FG005|Overall Study|Adverse Event|0|||
130287903|NCT01643850|469017565|FG006|Overall Study|Adverse Event|0|||
130287904|NCT01643850|469017566|FG007|Overall Study|Adverse Event|0|||
130287905|NCT01643850|469017567|FG008|Overall Study|Adverse Event|0|||
130287906|NCT01643850|469017559|FG000|Overall Study|Administrative Problems|0|||
130287907|NCT01643850|469017560|FG001|Overall Study|Administrative Problems|0|||
130287908|NCT01643850|469017561|FG002|Overall Study|Administrative Problems|1|||
130287909|NCT01643850|469017562|FG003|Overall Study|Administrative Problems|0|||
130287910|NCT01643850|469017563|FG004|Overall Study|Administrative Problems|1|||
130287911|NCT01643850|469017564|FG005|Overall Study|Administrative Problems|0|||
130287912|NCT01643850|469017565|FG006|Overall Study|Administrative Problems|0|||
130287913|NCT01643850|469017566|FG007|Overall Study|Administrative Problems|0|||
130370657|NCT00530946|469327216|FG002|Overall Study|Protocol Violation|0|||
130370658|NCT00530946|469327217|FG003|Overall Study|Protocol Violation|1|||
130370659|NCT00530946|469327214|FG000|Overall Study|Noncompliance|1|||
130287914|NCT01643850|469017567|FG008|Overall Study|Administrative Problems|0|||
130287915|NCT03054350|469017568|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130287916|NCT03054350|469017569|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130287917|NCT03054350|469017570|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
130287918|NCT03054350|469017571|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130370660|NCT00530946|469327215|FG001|Overall Study|Noncompliance|0|||
130287919|NCT03054350|469017572|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130287920|NCT03054350|469017573|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
130287921|NCT03054350|469017568|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130370661|NCT00530946|469327216|FG002|Overall Study|Noncompliance|0|||
130370662|NCT00530946|469327217|FG003|Overall Study|Noncompliance|0|||
130370663|NCT00622284|469327218|FG000|Overall Study|Lack of Efficacy|45|||
130370664|NCT00622284|469327219|FG001|Overall Study|Lack of Efficacy|15|||
130287922|NCT03054350|469017569|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130556338|NCT02294682|470006104|FG001|Overall Study|Could not swallow pills|0|||
130556339|NCT03422172|470006107|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
130556340|NCT03422172|470006107|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
130556341|NCT03422172|470006107|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
130556342|NCT00404066|470006111|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
130556343|NCT00404066|470006111|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
130556344|NCT01179672|470006112|FG000|Overall Study|Adverse Event|17|||
130556345|NCT01179672|470006113|FG001|Overall Study|Adverse Event|8|||
130556346|NCT01179672|470006112|FG000|Overall Study|Withdrawal by Subject|10|||
130556347|NCT01179672|470006113|FG001|Overall Study|Withdrawal by Subject|12|||
130556348|NCT01179672|470006112|FG000|Overall Study|Entry Criteria Not Met|0|||
130556349|NCT01179672|470006113|FG001|Overall Study|Entry Criteria Not Met|2|||
130556350|NCT01179672|470006112|FG000|Overall Study|Lost to Follow-up|0|||
130556351|NCT01179672|470006113|FG001|Overall Study|Lost to Follow-up|1|||
130556352|NCT01179672|470006112|FG000|Overall Study|Protocol Violation|2|||
130556353|NCT01179672|470006113|FG001|Overall Study|Protocol Violation|2|||
130287923|NCT03054350|469017570|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
130287924|NCT03054350|469017571|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287925|NCT03054350|469017572|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287926|NCT03054350|469017573|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287927|NCT03054350|469017568|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130287928|NCT03054350|469017569|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287929|NCT03054350|469017570|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287930|NCT03054350|469017571|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130287931|NCT03054350|469017572|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287932|NCT03054350|469017573|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287933|NCT03054350|469017568|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287934|NCT03054350|469017569|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287935|NCT03054350|469017570|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
130713270|NCT01698775|470576940|FG001|Phase A|Death|1|||
130713271|NCT01698775|470576939|FG000|Phase A|Lack of Efficacy|1|||
130713272|NCT01698775|470576940|FG001|Phase A|Lack of Efficacy|0|||
130713273|NCT01698775|470576939|FG000|Phase A|Lost to Follow-up|1|||
130713274|NCT01698775|470576940|FG001|Phase A|Lost to Follow-up|2|||
130713275|NCT01698775|470576939|FG000|Phase A|Protocol Violation|1|||
130713276|NCT01698775|470576940|FG001|Phase A|Protocol Violation|0|||
130713277|NCT01698775|470576939|FG000|Phase A|Withdrawal by Subject|3|||
130713278|NCT01698775|470576940|FG001|Phase A|Withdrawal by Subject|4|||
130713279|NCT01698775|470576939|FG000|Phase A|Kidney [transplant]|0|||
130713280|NCT01698775|470576940|FG001|Phase A|Kidney [transplant]|1|||
130713281|NCT01698775|470576939|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
130713282|NCT01698775|470576940|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
130713283|NCT01698775|470576939|FG000|Phase B|Adverse Event|6|||
130713284|NCT01698775|470576940|FG001|Phase B|Adverse Event|3|||
130713285|NCT01698775|470576939|FG000|Phase B|Death|0|||
130713286|NCT01698775|470576940|FG001|Phase B|Death|1|||
130713287|NCT01698775|470576939|FG000|Phase B|Lack of Efficacy|0|||
130713288|NCT01698775|470576940|FG001|Phase B|Lack of Efficacy|1|||
130713289|NCT01698775|470576939|FG000|Phase B|Lost to Follow-up|0|||
130713290|NCT01698775|470576940|FG001|Phase B|Lost to Follow-up|1|||
130713291|NCT01698775|470576939|FG000|Phase B|Physician Decision|1|||
130713292|NCT01698775|470576940|FG001|Phase B|Physician Decision|1|||
130713293|NCT01698775|470576939|FG000|Phase B|Protocol Violation|1|||
130713294|NCT01698775|470576940|FG001|Phase B|Protocol Violation|1|||
130713295|NCT01698775|470576939|FG000|Phase B|Withdrawal by Subject|6|||
130713296|NCT01698775|470576940|FG001|Phase B|Withdrawal by Subject|2|||
130713297|NCT00359788|470576941|FG000|Overall Study|Adverse Event|11|||
130713298|NCT00359788|470576942|FG001|Overall Study|Adverse Event|10|||
130713299|NCT00359788|470576941|FG000|Overall Study|Lack of Efficacy|1|||
130713300|NCT00359788|470576942|FG001|Overall Study|Lack of Efficacy|2|||
130713301|NCT00359788|470576941|FG000|Overall Study|Lost to Follow-up|3|||
130287936|NCT03054350|469017571|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287937|NCT03054350|469017572|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130370665|NCT00622284|469327218|FG000|Overall Study|Adverse Event|61|||
130556354|NCT01179672|470006112|FG000|Overall Study|Physician Decision|1|||
130556355|NCT01179672|470006113|FG001|Overall Study|Physician Decision|1|||
130556356|NCT01187550|470006116|FG000|Overall Study|Protocol Violation|3|||
130713302|NCT00359788|470576942|FG001|Overall Study|Lost to Follow-up|2|||
130713303|NCT00359788|470576941|FG000|Overall Study|Withdrawal by Subject|4|||
130713304|NCT00359788|470576942|FG001|Overall Study|Withdrawal by Subject|1|||
130713305|NCT00359788|470576941|FG000|Overall Study|Protocol Violation|4|||
130713306|NCT00359788|470576942|FG001|Overall Study|Protocol Violation|2|||
130713307|NCT00673933|470576945|FG000|Overall Study|Withdrawal by Subject|2|||
130713308|NCT00673933|470576945|FG000|Overall Study|Lost to Follow-up|1|||
130713309|NCT04932941|470576948|FG000|Overall Study|Lost to Follow-up|3|||
130713310|NCT04932941|470576949|FG001|Overall Study|Lost to Follow-up|1|||
130713311|NCT04932941|470576948|FG000|Overall Study|Withdrawal by Subject|7|||
130713312|NCT04932941|470576949|FG001|Overall Study|Withdrawal by Subject|4|||
130713313|NCT04932941|470576948|FG000|Overall Study|Other|4|||
130713314|NCT04932941|470576949|FG001|Overall Study|Other|2|||
130713315|NCT01366443|470576950|FG000|Overall Study|Lost to Follow-up|2|||
130713316|NCT01366443|470576950|FG000|Overall Study|Under 18 yo|1|||
130713317|NCT02394730|470576956|FG000|Overall Study|Lost to Follow-up|1|||
130713318|NCT02394730|470576957|FG001|Overall Study|Lost to Follow-up|0|||
130713319|NCT02394730|470576956|FG000|Overall Study|Withdrawal by Subject|0|||
130713320|NCT02394730|470576957|FG001|Overall Study|Withdrawal by Subject|1|||
130713321|NCT02384850|470576958|FG000|Overall Study|Withdrawal by Subject|2|||
130713322|NCT02384850|470576959|FG001|Overall Study|Withdrawal by Subject|2|||
130713323|NCT01673698|470576960|FG000|Overall Study|Lost to Follow-up|51|||
130713324|NCT01673698|470576961|FG001|Overall Study|Lost to Follow-up|13|||
130713325|NCT00507546|470576962|FG000|Overall Study|Withdrawal by Subject|1|||
130713326|NCT00507546|470576963|FG001|Overall Study|Withdrawal by Subject|0|||
130713327|NCT00507546|470576962|FG000|Overall Study|Protocol Violation|1|||
130713328|NCT00507546|470576963|FG001|Overall Study|Protocol Violation|0|||
130713329|NCT00507546|470576962|FG000|Overall Study|Physician Decision|0|||
130713330|NCT00507546|470576963|FG001|Overall Study|Physician Decision|1|||
130713331|NCT00448136|470576964|FG000|Overall Study|Death|3|||
130713332|NCT00448136|470576965|FG001|Overall Study|Death|8|||
130713333|NCT00448136|470576964|FG000|Overall Study|Investigator's decision (progression)|1|||
130713334|NCT00448136|470576965|FG001|Overall Study|Investigator's decision (progression)|0|||
130713335|NCT02013375|470576966|FG000|Overall Study|Did not engraft|1|||
130713336|NCT02013375|470576966|FG000|Overall Study|Did not engraft|1|||
130713337|NCT03510182|470576969|FG000|Overall Study|Withdrawal by Subject|2|||
130713338|NCT01334710|470576976|FG000|Overall Study|Trial was terminated|3|||
130713339|NCT01558297|470576977|FG000|Overall Study|Withdrawal by Subject|2|||
130713340|NCT01558297|470576978|FG001|Overall Study|Withdrawal by Subject|2|||
130713341|NCT01558297|470576979|FG002|Overall Study|Withdrawal by Subject|1|||
130713342|NCT00375492|470576980|FG000|Overall Study|Adverse Event|4|||
130713343|NCT00375492|470576981|FG001|Overall Study|Adverse Event|5|||
130713344|NCT00375492|470576980|FG000|Overall Study|Entry Criteria Not Met|0|||
130713345|NCT00375492|470576981|FG001|Overall Study|Entry Criteria Not Met|1|||
130713346|NCT00375492|470576980|FG000|Overall Study|Loss of Glucose Control|0|||
130713347|NCT00375492|470576981|FG001|Overall Study|Loss of Glucose Control|1|||
130713348|NCT00375492|470576980|FG000|Overall Study|Lost to Follow-up|10|||
130713349|NCT00375492|470576981|FG001|Overall Study|Lost to Follow-up|5|||
130713350|NCT00375492|470576980|FG000|Overall Study|Physician Decision|0|||
130713351|NCT00375492|470576981|FG001|Overall Study|Physician Decision|4|||
130713352|NCT00375492|470576980|FG000|Overall Study|Protocol Violation|6|||
130713353|NCT00375492|470576981|FG001|Overall Study|Protocol Violation|3|||
130370666|NCT00622284|469327219|FG001|Overall Study|Adverse Event|90|||
130713354|NCT00375492|470576980|FG000|Overall Study|Sponsor Decision|0|||
130713355|NCT00375492|470576981|FG001|Overall Study|Sponsor Decision|1|||
130713356|NCT00375492|470576980|FG000|Overall Study|Withdrawal by Subject|6|||
130713357|NCT00375492|470576981|FG001|Overall Study|Withdrawal by Subject|6|||
130713358|NCT01663727|470576982|FG000|Overall Study|Death|161|||
130713359|NCT01663727|470576983|FG001|Overall Study|Death|155|||
130713360|NCT01663727|470576982|FG000|Overall Study|Lost to Follow-up|10|||
130713361|NCT01663727|470576983|FG001|Overall Study|Lost to Follow-up|8|||
130713362|NCT01663727|470576982|FG000|Overall Study|Withdrawal by Subject|18|||
130713363|NCT01663727|470576983|FG001|Overall Study|Withdrawal by Subject|25|||
130713364|NCT01663727|470576982|FG000|Overall Study|Study Terminated|51|||
130713365|NCT01663727|470576983|FG001|Overall Study|Study Terminated|50|||
130713366|NCT01663727|470576982|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
130713367|NCT01663727|470576983|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
130713368|NCT01663727|470576982|FG000|Overall Study|Withdrawal prior to dosing.|1|||
130713369|NCT01663727|470576983|FG001|Overall Study|Withdrawal prior to dosing.|0|||
130713370|NCT01902628|470576984|FG000|Overall Study|Withdrawal of participant's consent|7|||
130713371|NCT01902628|470576984|FG000|Overall Study|Adverse Event|41|||
130713372|NCT01902628|470576984|FG000|Overall Study|Lost to Follow-up|35|||
130713373|NCT01232491|470576985|FG000|Overall Study|Adverse Event|13|||
130713374|NCT01232491|470576986|FG001|Overall Study|Adverse Event|8|||
130713375|NCT01232491|470576985|FG000|Overall Study|Lack of Efficacy|1|||
130713376|NCT01232491|470576986|FG001|Overall Study|Lack of Efficacy|5|||
130713377|NCT01232491|470576985|FG000|Overall Study|Protocol Violation|13|||
130713378|NCT01232491|470576986|FG001|Overall Study|Protocol Violation|11|||
130713379|NCT01232491|470576985|FG000|Overall Study|Withdrawal Criteria|12|||
130713380|NCT01232491|470576986|FG001|Overall Study|Withdrawal Criteria|21|||
130713381|NCT01232491|470576985|FG000|Overall Study|Other|21|||
130713382|NCT01232491|470576986|FG001|Overall Study|Other|18|||
130713383|NCT02932228|470576991|FG000|Overall Study|Death|8|||
130713384|NCT02932228|470576992|FG001|Overall Study|Death|23|||
130287938|NCT03054350|469017573|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287939|NCT01133405|469017574|FG000|Period 1|Withdrawal by Subject|0|||
130287940|NCT01133405|469017575|FG001|Period 1|Withdrawal by Subject|1|||
130287941|NCT01133405|469017576|FG002|Period 1|Withdrawal by Subject|0|||
130287942|NCT01133405|469017577|FG003|Period 1|Withdrawal by Subject|1|||
130287943|NCT01133405|469017578|FG004|Period 1|Withdrawal by Subject|0|||
130287944|NCT01133405|469017579|FG005|Period 1|Withdrawal by Subject|1|||
130287945|NCT01133405|469017580|FG006|Period 1|Withdrawal by Subject|0|||
130287946|NCT01133405|469017581|FG007|Period 1|Withdrawal by Subject|0|||
130287947|NCT01133405|469017582|FG008|Period 1|Withdrawal by Subject|0|||
130287948|NCT01133405|469017583|FG009|Period 1|Withdrawal by Subject|0|||
130287949|NCT01133405|469017574|FG000|Period 1|Physician Decision|0|||
130287950|NCT01133405|469017575|FG001|Period 1|Physician Decision|0|||
130287951|NCT01133405|469017576|FG002|Period 1|Physician Decision|0|||
130287952|NCT01133405|469017577|FG003|Period 1|Physician Decision|1|||
130287953|NCT01133405|469017578|FG004|Period 1|Physician Decision|0|||
130287954|NCT01133405|469017579|FG005|Period 1|Physician Decision|0|||
130287955|NCT01133405|469017580|FG006|Period 1|Physician Decision|0|||
130287956|NCT01133405|469017581|FG007|Period 1|Physician Decision|0|||
130287957|NCT01133405|469017582|FG008|Period 1|Physician Decision|0|||
130287958|NCT01133405|469017583|FG009|Period 1|Physician Decision|0|||
130287959|NCT01133405|469017574|FG000|Period 1|Discontinued after randomization|1|||
130287960|NCT01133405|469017575|FG001|Period 1|Discontinued after randomization|0|||
130287961|NCT01133405|469017576|FG002|Period 1|Discontinued after randomization|0|||
130287962|NCT01133405|469017577|FG003|Period 1|Discontinued after randomization|0|||
130287963|NCT01133405|469017578|FG004|Period 1|Discontinued after randomization|0|||
130287964|NCT01133405|469017579|FG005|Period 1|Discontinued after randomization|0|||
130287965|NCT01133405|469017580|FG006|Period 1|Discontinued after randomization|1|||
130287966|NCT01133405|469017581|FG007|Period 1|Discontinued after randomization|0|||
130287967|NCT01133405|469017582|FG008|Period 1|Discontinued after randomization|0|||
130287968|NCT01133405|469017583|FG009|Period 1|Discontinued after randomization|0|||
130287969|NCT01133405|469017574|FG000|Period 1|Received drug only in period 2|0|||
130287970|NCT01133405|469017575|FG001|Period 1|Received drug only in period 2|1|||
130287971|NCT01133405|469017576|FG002|Period 1|Received drug only in period 2|0|||
130287972|NCT01133405|469017577|FG003|Period 1|Received drug only in period 2|2|||
130287973|NCT01133405|469017578|FG004|Period 1|Received drug only in period 2|0|||
130287974|NCT01133405|469017579|FG005|Period 1|Received drug only in period 2|1|||
130287975|NCT01133405|469017580|FG006|Period 1|Received drug only in period 2|0|||
130287976|NCT01133405|469017581|FG007|Period 1|Received drug only in period 2|0|||
130287977|NCT01133405|469017582|FG008|Period 1|Received drug only in period 2|0|||
130287978|NCT01133405|469017583|FG009|Period 1|Received drug only in period 2|0|||
130287979|NCT01133405|469017574|FG000|Period 1|Received drug only in period 3|0|||
130287980|NCT01133405|469017575|FG001|Period 1|Received drug only in period 3|1|||
130287981|NCT01133405|469017576|FG002|Period 1|Received drug only in period 3|1|||
130287982|NCT01133405|469017577|FG003|Period 1|Received drug only in period 3|0|||
130287983|NCT01133405|469017578|FG004|Period 1|Received drug only in period 3|0|||
130287984|NCT01133405|469017579|FG005|Period 1|Received drug only in period 3|0|||
130287985|NCT01133405|469017580|FG006|Period 1|Received drug only in period 3|0|||
130287986|NCT01133405|469017581|FG007|Period 1|Received drug only in period 3|0|||
130287987|NCT01133405|469017582|FG008|Period 1|Received drug only in period 3|0|||
130287988|NCT01133405|469017583|FG009|Period 1|Received drug only in period 3|0|||
130287989|NCT01133405|469017574|FG000|Period 2|Adverse Event|0|||
130287990|NCT01133405|469017575|FG001|Period 2|Adverse Event|0|||
130287991|NCT01133405|469017576|FG002|Period 2|Adverse Event|1|||
130287992|NCT01133405|469017577|FG003|Period 2|Adverse Event|0|||
130287993|NCT01133405|469017578|FG004|Period 2|Adverse Event|0|||
130287994|NCT01133405|469017579|FG005|Period 2|Adverse Event|0|||
130287995|NCT01133405|469017580|FG006|Period 2|Adverse Event|0|||
130287996|NCT01133405|469017581|FG007|Period 2|Adverse Event|0|||
130287997|NCT01133405|469017582|FG008|Period 2|Adverse Event|0|||
130287998|NCT01133405|469017583|FG009|Period 2|Adverse Event|0|||
130287999|NCT01133405|469017574|FG000|Period 2|Withdrawal by Subject|0|||
130288000|NCT01133405|469017575|FG001|Period 2|Withdrawal by Subject|0|||
130288001|NCT01133405|469017576|FG002|Period 2|Withdrawal by Subject|0|||
130288002|NCT01133405|469017577|FG003|Period 2|Withdrawal by Subject|1|||
130459543|NCT02026258|469647545|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
130288003|NCT01133405|469017578|FG004|Period 2|Withdrawal by Subject|0|||
130288004|NCT01133405|469017579|FG005|Period 2|Withdrawal by Subject|1|||
130288005|NCT01133405|469017580|FG006|Period 2|Withdrawal by Subject|0|||
130288006|NCT01133405|469017581|FG007|Period 2|Withdrawal by Subject|0|||
130288007|NCT01133405|469017582|FG008|Period 2|Withdrawal by Subject|0|||
130288008|NCT01133405|469017583|FG009|Period 2|Withdrawal by Subject|0|||
130288009|NCT01133405|469017574|FG000|Period 2|Entry Criteria Not Met|0|||
130459544|NCT02026258|469647546|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
130459545|NCT02026258|469647545|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
130459546|NCT02026258|469647546|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
130459547|NCT00530842|469647547|FG000|Overall Study|Adverse Event|10|||
130459548|NCT00530842|469647548|FG001|Overall Study|Adverse Event|6|||
130459549|NCT00530842|469647547|FG000|Overall Study|Lack of Efficacy|2|||
130713385|NCT02932228|470576991|FG000|Overall Study|not eligible upon chart review|2|||
130713386|NCT02932228|470576992|FG001|Overall Study|not eligible upon chart review|5|||
130713387|NCT04905290|470578345|FG000|Overall Study|Adverse Event|4|||
130713388|NCT04905290|470578345|FG000|Overall Study|Death|2|||
130288010|NCT01133405|469017575|FG001|Period 2|Entry Criteria Not Met|1|||
130288011|NCT01133405|469017576|FG002|Period 2|Entry Criteria Not Met|0|||
130288012|NCT01133405|469017577|FG003|Period 2|Entry Criteria Not Met|0|||
130288013|NCT01133405|469017578|FG004|Period 2|Entry Criteria Not Met|0|||
130288014|NCT01133405|469017579|FG005|Period 2|Entry Criteria Not Met|0|||
130288015|NCT01133405|469017580|FG006|Period 2|Entry Criteria Not Met|0|||
130288016|NCT01133405|469017581|FG007|Period 2|Entry Criteria Not Met|0|||
130288017|NCT01133405|469017582|FG008|Period 2|Entry Criteria Not Met|0|||
130288018|NCT01133405|469017583|FG009|Period 2|Entry Criteria Not Met|0|||
130288019|NCT01133405|469017574|FG000|Period 2|Physician Decision|0|||
130288020|NCT01133405|469017575|FG001|Period 2|Physician Decision|0|||
130288021|NCT01133405|469017576|FG002|Period 2|Physician Decision|0|||
130288022|NCT01133405|469017577|FG003|Period 2|Physician Decision|0|||
130288023|NCT01133405|469017578|FG004|Period 2|Physician Decision|0|||
130288024|NCT01133405|469017579|FG005|Period 2|Physician Decision|1|||
130288025|NCT01133405|469017580|FG006|Period 2|Physician Decision|0|||
130288026|NCT01133405|469017581|FG007|Period 2|Physician Decision|0|||
130288027|NCT01133405|469017582|FG008|Period 2|Physician Decision|0|||
130288028|NCT01133405|469017583|FG009|Period 2|Physician Decision|0|||
130288029|NCT03242772|469017584|FG000|Overall Study|Lost to Follow-up|2|||
130288030|NCT03242772|469017585|FG001|Overall Study|Lost to Follow-up|0|||
130288031|NCT03242772|469017584|FG000|Overall Study|Physician Decision|0|||
130288032|NCT03242772|469017585|FG001|Overall Study|Physician Decision|1|||
130288033|NCT03242772|469017584|FG000|Overall Study|Withdrawal by Subject|1|||
130288034|NCT03242772|469017585|FG001|Overall Study|Withdrawal by Subject|0|||
130288035|NCT00089986|469017586|FG000|Overall Study|Adverse Event|6|||
130288036|NCT00089986|469017587|FG001|Overall Study|Adverse Event|9|||
130288037|NCT00089986|469017588|FG002|Overall Study|Adverse Event|6|||
130288038|NCT00089986|469017586|FG000|Overall Study|Lost to Follow-up|3|||
130288039|NCT00089986|469017587|FG001|Overall Study|Lost to Follow-up|1|||
130288040|NCT00089986|469017588|FG002|Overall Study|Lost to Follow-up|1|||
130288041|NCT00089986|469017586|FG000|Overall Study|Protocol Violation|0|||
130288042|NCT00089986|469017587|FG001|Overall Study|Protocol Violation|1|||
130288043|NCT00089986|469017588|FG002|Overall Study|Protocol Violation|0|||
130288044|NCT00089986|469017586|FG000|Overall Study|Patient transferred to another hospital|2|||
130288045|NCT00089986|469017587|FG001|Overall Study|Patient transferred to another hospital|1|||
130288046|NCT00089986|469017588|FG002|Overall Study|Patient transferred to another hospital|0|||
130288047|NCT00089986|469017586|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
130288048|NCT00089986|469017587|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
130288049|NCT00089986|469017588|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
130288050|NCT00089986|469017586|FG000|Overall Study|Hemohlobin stopping rule|0|||
130288051|NCT00089986|469017587|FG001|Overall Study|Hemohlobin stopping rule|1|||
130288052|NCT00089986|469017588|FG002|Overall Study|Hemohlobin stopping rule|0|||
130288053|NCT00089986|469017586|FG000|Overall Study|Investigator decision to withdrew|0|||
130288054|NCT00089986|469017587|FG001|Overall Study|Investigator decision to withdrew|1|||
130288055|NCT00089986|469017588|FG002|Overall Study|Investigator decision to withdrew|0|||
130288056|NCT00089986|469017586|FG000|Overall Study|Enrollment in another study|0|||
130288057|NCT00089986|469017587|FG001|Overall Study|Enrollment in another study|1|||
130288058|NCT00089986|469017588|FG002|Overall Study|Enrollment in another study|0|||
130288059|NCT00089986|469017586|FG000|Overall Study|Family decision|0|||
130288060|NCT00089986|469017587|FG001|Overall Study|Family decision|1|||
130288061|NCT00089986|469017588|FG002|Overall Study|Family decision|0|||
130288062|NCT00089986|469017586|FG000|Overall Study|Do not resuscitate (DNR)|0|||
130288063|NCT00089986|469017587|FG001|Overall Study|Do not resuscitate (DNR)|0|||
130288064|NCT00089986|469017588|FG002|Overall Study|Do not resuscitate (DNR)|1|||
130713389|NCT04905290|470578345|FG000|Overall Study|Withdrawal by Subject|4|||
130713390|NCT04905290|470578345|FG000|Overall Study|Physician Decision|2|||
130288065|NCT00089986|469017586|FG000|Overall Study|Withdrawal by Subject|3|||
130288066|NCT00089986|469017587|FG001|Overall Study|Withdrawal by Subject|6|||
130288067|NCT00089986|469017588|FG002|Overall Study|Withdrawal by Subject|2|||
130288068|NCT02334683|469017595|FG000|First 12 Week Period|Lost to Follow-up|1|||
130370667|NCT00622284|469327218|FG000|Overall Study|Protocol Violation|12|||
130288069|NCT02334683|469017596|FG001|First 12 Week Period|Lost to Follow-up|0|||
130288070|NCT02334683|469017595|FG000|Second 12 Week Period|Adverse Event|0|||
130288071|NCT02334683|469017596|FG001|Second 12 Week Period|Adverse Event|1|||
130288072|NCT01062841|469017597|FG000|Overall Study|Indwelling Device Removed|41|||
130288073|NCT01062841|469017598|FG001|Overall Study|Indwelling Device Removed|48|||
130288074|NCT01062841|469017597|FG000|Overall Study|Death|3|||
130288075|NCT01062841|469017598|FG001|Overall Study|Death|5|||
130288076|NCT01062841|469017597|FG000|Overall Study|Withdrawal by Subject|2|||
130288077|NCT01062841|469017598|FG001|Overall Study|Withdrawal by Subject|0|||
130288078|NCT01062841|469017597|FG000|Overall Study|Withdrawal by Study|3|||
130370668|NCT00622284|469327219|FG001|Overall Study|Protocol Violation|5|||
130288079|NCT01062841|469017598|FG001|Overall Study|Withdrawal by Study|0|||
130288080|NCT01218100|469017599|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288081|NCT01218100|469017600|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288082|NCT01218100|469017601|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288083|NCT01218100|469017602|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
130288084|NCT01218100|469017599|FG000|Overall Study|Adverse Event|4|||
130288085|NCT01218100|469017600|FG001|Overall Study|Adverse Event|6|||
130288086|NCT01218100|469017601|FG002|Overall Study|Adverse Event|6|||
130288087|NCT01218100|469017602|FG003|Overall Study|Adverse Event|7|||
130288088|NCT01218100|469017599|FG000|Overall Study|Lack of Efficacy|9|||
130288089|NCT01218100|469017600|FG001|Overall Study|Lack of Efficacy|6|||
130288090|NCT01218100|469017601|FG002|Overall Study|Lack of Efficacy|5|||
130288091|NCT01218100|469017602|FG003|Overall Study|Lack of Efficacy|12|||
130288092|NCT01218100|469017599|FG000|Overall Study|Protocol Violation|0|||
130556357|NCT01187550|470006117|FG001|Overall Study|Protocol Violation|1|||
130556358|NCT01187550|470006116|FG000|Overall Study|Other|3|||
130556359|NCT01187550|470006117|FG001|Overall Study|Other|0|||
130556360|NCT01187550|470006116|FG000|Overall Study|Randomized but not treated|8|||
130556361|NCT01187550|470006117|FG001|Overall Study|Randomized but not treated|0|||
130556362|NCT00129623|470006118|FG000|Overall Study|Adverse Event|3|||
130556363|NCT00129623|470006119|FG001|Overall Study|Adverse Event|7|||
130556364|NCT00129623|470006118|FG000|Overall Study|Refused Treatment|5|||
130556365|NCT00129623|470006119|FG001|Overall Study|Refused Treatment|3|||
130556366|NCT00129623|470006118|FG000|Overall Study|Failure to Return|1|||
130556367|NCT00129623|470006119|FG001|Overall Study|Failure to Return|1|||
130556368|NCT00129623|470006118|FG000|Overall Study|Relocated job out of state|1|||
130556369|NCT00129623|470006119|FG001|Overall Study|Relocated job out of state|0|||
130556370|NCT00129623|470006118|FG000|Overall Study|Uncertainty to return|0|||
130556371|NCT00129623|470006119|FG001|Overall Study|Uncertainty to return|1|||
130556372|NCT02616614|470006120|FG000|Overall Study|Withdrawal by Subject|10|||
130556373|NCT02616614|470006121|FG001|Overall Study|Withdrawal by Subject|5|||
130556374|NCT02616614|470006122|FG002|Overall Study|Withdrawal by Subject|6|||
130556375|NCT02616614|470006120|FG000|Overall Study|Physician Decision|2|||
130556376|NCT02616614|470006121|FG001|Overall Study|Physician Decision|1|||
130556377|NCT02616614|470006122|FG002|Overall Study|Physician Decision|0|||
130556378|NCT02616614|470006120|FG000|Overall Study|Adverse Event|1|||
130556379|NCT02616614|470006121|FG001|Overall Study|Adverse Event|4|||
130556380|NCT02616614|470006122|FG002|Overall Study|Adverse Event|1|||
130556381|NCT02616614|470006120|FG000|Overall Study|Protocol Violation|0|||
130556382|NCT02616614|470006121|FG001|Overall Study|Protocol Violation|3|||
130556383|NCT02616614|470006122|FG002|Overall Study|Protocol Violation|1|||
130556384|NCT02616614|470006120|FG000|Overall Study|Prohibited Medication|12|||
130556385|NCT02616614|470006121|FG001|Overall Study|Prohibited Medication|9|||
130556386|NCT02616614|470006122|FG002|Overall Study|Prohibited Medication|5|||
130556387|NCT02616614|470006120|FG000|Overall Study|More than 3 applications missed|6|||
130556388|NCT02616614|470006121|FG001|Overall Study|More than 3 applications missed|8|||
130556389|NCT02616614|470006122|FG002|Overall Study|More than 3 applications missed|1|||
130556390|NCT02616614|470006120|FG000|Overall Study|Lost to Follow-up|31|||
130556391|NCT02616614|470006121|FG001|Overall Study|Lost to Follow-up|28|||
130556392|NCT02616614|470006122|FG002|Overall Study|Lost to Follow-up|13|||
130556393|NCT02616614|470006120|FG000|Overall Study|Pregnancy|2|||
130556394|NCT02616614|470006121|FG001|Overall Study|Pregnancy|0|||
130556395|NCT02616614|470006122|FG002|Overall Study|Pregnancy|1|||
130556396|NCT02616614|470006120|FG000|Overall Study|Other|1|||
130556397|NCT02616614|470006121|FG001|Overall Study|Other|2|||
130556398|NCT02616614|470006122|FG002|Overall Study|Other|1|||
130556399|NCT02315898|470006123|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
130556400|NCT02315898|470006124|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
130556401|NCT02315898|470006125|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
130556402|NCT02315898|470006126|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
130556403|NCT02445755|470006127|FG000|Overall Study|Withdrawal by Subject|2|||
130556404|NCT02445755|470006127|FG000|Overall Study|Protocol Violation|6|||
130556405|NCT02445755|470006127|FG000|Overall Study|Screen Failure|5|||
130556406|NCT03239483|470006128|FG000|Overall Study|Lost to Follow-up|1|||
130288093|NCT01218100|469017600|FG001|Overall Study|Protocol Violation|0|||
130288094|NCT01218100|469017601|FG002|Overall Study|Protocol Violation|1|||
130288095|NCT01218100|469017602|FG003|Overall Study|Protocol Violation|1|||
130288096|NCT01218100|469017599|FG000|Overall Study|Withdrawal by Subject|5|||
130288097|NCT01218100|469017600|FG001|Overall Study|Withdrawal by Subject|2|||
130288098|NCT01218100|469017601|FG002|Overall Study|Withdrawal by Subject|6|||
130556407|NCT03239483|470006129|FG001|Overall Study|Lost to Follow-up|0|||
130556408|NCT03239483|470006128|FG000|Overall Study|Withdrawal by Subject|1|||
130556409|NCT03239483|470006129|FG001|Overall Study|Withdrawal by Subject|0|||
130556410|NCT05352048|470006130|FG000|Overall Study|Lost to Follow-up|1|||
130556411|NCT05352048|470006130|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
130713391|NCT04905290|470578345|FG000|Overall Study|Lost to Follow-up|2|||
130713392|NCT04905290|470578345|FG000|Overall Study|Screen Failure|2|||
130288099|NCT01218100|469017602|FG003|Overall Study|Withdrawal by Subject|7|||
130288100|NCT01218100|469017599|FG000|Overall Study|Lost to Follow-up|3|||
130288101|NCT01218100|469017600|FG001|Overall Study|Lost to Follow-up|8|||
130288102|NCT01218100|469017601|FG002|Overall Study|Lost to Follow-up|2|||
130288103|NCT01218100|469017602|FG003|Overall Study|Lost to Follow-up|1|||
130288104|NCT01218100|469017599|FG000|Overall Study|Other Reason|2|||
130288105|NCT01218100|469017600|FG001|Overall Study|Other Reason|2|||
130288106|NCT01218100|469017601|FG002|Overall Study|Other Reason|6|||
130288107|NCT01218100|469017602|FG003|Overall Study|Other Reason|4|||
130288108|NCT02434354|469017609|FG000|Overall Study|screen fail|3|||
130288109|NCT02446418|469017610|FG000|Overall Study|Adverse Event|4|||
130288110|NCT02446418|469017611|FG001|Overall Study|Adverse Event|8|||
130288111|NCT02446418|469017610|FG000|Overall Study|Physician Decision|5|||
130288112|NCT02446418|469017611|FG001|Overall Study|Physician Decision|1|||
130288113|NCT02446418|469017610|FG000|Overall Study|Withdrawal by Subject|3|||
130288114|NCT02446418|469017611|FG001|Overall Study|Withdrawal by Subject|3|||
130288115|NCT02446418|469017610|FG000|Overall Study|Lost to Follow-up|2|||
130288116|NCT02446418|469017611|FG001|Overall Study|Lost to Follow-up|2|||
130288117|NCT02446418|469017610|FG000|Overall Study|Protocol Violation|1|||
130288118|NCT02446418|469017611|FG001|Overall Study|Protocol Violation|2|||
130288119|NCT02446418|469017610|FG000|Overall Study|Lack of Efficacy|2|||
130288120|NCT02446418|469017611|FG001|Overall Study|Lack of Efficacy|0|||
130288121|NCT02446418|469017610|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
130288122|NCT02446418|469017611|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
130288123|NCT02014480|469017614|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288124|NCT02014480|469017615|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288125|NCT02014480|469017616|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130288126|NCT02014480|469017617|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288127|NCT02014480|469017618|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288128|NCT02014480|469017619|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288129|NCT02014480|469017614|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288130|NCT02014480|469017615|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130288131|NCT02014480|469017616|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288132|NCT02014480|469017617|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
130288133|NCT02014480|469017618|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130288134|NCT02014480|469017619|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288135|NCT02014480|469017614|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288136|NCT02014480|469017615|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288137|NCT02014480|469017616|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130288138|NCT02014480|469017617|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288139|NCT02014480|469017618|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288140|NCT02014480|469017619|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288141|NCT02014480|469017614|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288142|NCT02014480|469017615|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288143|NCT02014480|469017616|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
130288144|NCT02014480|469017617|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288145|NCT02014480|469017618|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130288146|NCT02014480|469017619|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130713393|NCT04905290|470578345|FG000|Overall Study|Unsuccessful Procedure|2|||
130713394|NCT06204887|470578346|FG000|Overall Study|Lost to Follow-up|3|||
130713395|NCT06204887|470578347|FG001|Overall Study|Lost to Follow-up|4|||
130713396|NCT06204887|470578348|FG002|Overall Study|Lost to Follow-up|1|||
130713397|NCT06204887|470578349|FG003|Overall Study|Lost to Follow-up|6|||
130713398|NCT00821873|470578354|FG000|Overall Study|Lost to Follow-up|4|||
130713399|NCT01995266|470578356|FG000|Overall Study|Death|1|||
130713400|NCT01995266|470578356|FG000|Overall Study|Lack of Efficacy|6|||
130713401|NCT01995266|470578356|FG000|Overall Study|Adverse Event|2|||
130288147|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288148|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130288149|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130459550|NCT00530842|469647548|FG001|Overall Study|Lack of Efficacy|1|||
130288150|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288151|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288152|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130459551|NCT00530842|469647547|FG000|Overall Study|Lost to Follow-up|0|||
130459552|NCT00530842|469647548|FG001|Overall Study|Lost to Follow-up|4|||
130713402|NCT00729248|470578357|FG000|Overall Study|Physician Decision|2|||
130713403|NCT04032158|470578369|FG000|Overall Study|Study Termination|2|||
130713404|NCT04032158|470578370|FG001|Overall Study|Study Termination|1|||
130713405|NCT02072824|470578371|FG000|Overall Study|Insufficient clinical response|1|||
130288153|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288154|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288155|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
130288156|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288157|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288158|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
130288159|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288160|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288161|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288162|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288163|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288164|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130288165|NCT01414205|469017622|FG000|Overall Study|Death|5|||
130288166|NCT01414205|469017623|FG001|Overall Study|Death|1|||
130288167|NCT01414205|469017622|FG000|Overall Study|Lost to Follow-up|1|||
130288168|NCT01414205|469017623|FG001|Overall Study|Lost to Follow-up|4|||
130288169|NCT01414205|469017622|FG000|Overall Study|Physician Decision|0|||
130288170|NCT01414205|469017623|FG001|Overall Study|Physician Decision|1|||
130288171|NCT01414205|469017622|FG000|Overall Study|Randomized but not Treated|1|||
130288172|NCT01414205|469017623|FG001|Overall Study|Randomized but not Treated|1|||
130288173|NCT02305849|469017627|FG000|Overall Study|Adverse Event|10|||
130288174|NCT02305849|469017628|FG001|Overall Study|Adverse Event|12|||
130288175|NCT02305849|469017629|FG002|Overall Study|Adverse Event|7|||
130288176|NCT02305849|469017630|FG003|Overall Study|Adverse Event|3|||
130288177|NCT02305849|469017627|FG000|Overall Study|Lack of Efficacy|10|||
130288178|NCT02305849|469017628|FG001|Overall Study|Lack of Efficacy|6|||
130288179|NCT02305849|469017629|FG002|Overall Study|Lack of Efficacy|3|||
130288180|NCT02305849|469017630|FG003|Overall Study|Lack of Efficacy|9|||
130288181|NCT02305849|469017627|FG000|Overall Study|Withdrawal by Subject|2|||
130288182|NCT02305849|469017628|FG001|Overall Study|Withdrawal by Subject|2|||
130288183|NCT02305849|469017629|FG002|Overall Study|Withdrawal by Subject|1|||
130288184|NCT02305849|469017630|FG003|Overall Study|Withdrawal by Subject|4|||
130288185|NCT02305849|469017627|FG000|Overall Study|Lost to Follow-up|0|||
130288186|NCT02305849|469017628|FG001|Overall Study|Lost to Follow-up|2|||
130370669|NCT00622284|469327218|FG000|Overall Study|Lost to Follow-up|11|||
130556412|NCT01233869|470006140|FG000|Initial Treatment Period (24 Months)|Death|1|||
130556413|NCT01233869|470006141|FG001|Initial Treatment Period (24 Months)|Death|0|||
130288187|NCT02305849|469017629|FG002|Overall Study|Lost to Follow-up|0|||
130288188|NCT02305849|469017630|FG003|Overall Study|Lost to Follow-up|0|||
130288189|NCT02305849|469017627|FG000|Overall Study|Protocol Violation|3|||
130288190|NCT02305849|469017628|FG001|Overall Study|Protocol Violation|2|||
130288191|NCT02305849|469017629|FG002|Overall Study|Protocol Violation|1|||
130288192|NCT02305849|469017630|FG003|Overall Study|Protocol Violation|1|||
130288193|NCT02305849|469017627|FG000|Overall Study|Lab data met discontinuation criteria|0|||
130288194|NCT02305849|469017628|FG001|Overall Study|Lab data met discontinuation criteria|1|||
130288195|NCT02305849|469017629|FG002|Overall Study|Lab data met discontinuation criteria|2|||
130288196|NCT02305849|469017630|FG003|Overall Study|Lab data met discontinuation criteria|1|||
130288197|NCT02305849|469017627|FG000|Overall Study|Miscellaneous|1|||
130288198|NCT02305849|469017628|FG001|Overall Study|Miscellaneous|2|||
130288199|NCT02305849|469017629|FG002|Overall Study|Miscellaneous|4|||
130288200|NCT02305849|469017630|FG003|Overall Study|Miscellaneous|1|||
130288201|NCT02305849|469017627|FG000|Overall Study|Not fulfill eligibility criteria|1|||
130288202|NCT02305849|469017628|FG001|Overall Study|Not fulfill eligibility criteria|1|||
130288203|NCT02305849|469017629|FG002|Overall Study|Not fulfill eligibility criteria|0|||
130288204|NCT02305849|469017630|FG003|Overall Study|Not fulfill eligibility criteria|0|||
130288205|NCT00495521|469017636|FG000|Overall Study|Physician Decision|0|||
130288206|NCT00495521|469017637|FG001|Overall Study|Physician Decision|1|||
130288207|NCT01300819|469017638|FG000|Overall Study|Adverse Event|9|||
130288208|NCT01300819|469017639|FG001|Overall Study|Adverse Event|27|||
130556414|NCT01233869|470006142|FG002|Initial Treatment Period (24 Months)|Death|0|||
130556415|NCT01233869|470006143|FG003|Initial Treatment Period (24 Months)|Death|0|||
130288209|NCT01300819|469017638|FG000|Overall Study|Lack of Efficacy|2|||
130288210|NCT01300819|469017639|FG001|Overall Study|Lack of Efficacy|1|||
130288211|NCT01300819|469017638|FG000|Overall Study|Withdrawal by Subject|10|||
130288212|NCT01300819|469017639|FG001|Overall Study|Withdrawal by Subject|12|||
130288213|NCT01300819|469017638|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
130288214|NCT01300819|469017639|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
130288215|NCT01300819|469017638|FG000|Overall Study|Refusal to down titrate study drug|0|||
130370670|NCT00622284|469327219|FG001|Overall Study|Lost to Follow-up|13|||
130556416|NCT01233869|470006140|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
130556417|NCT01233869|470006141|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
130556418|NCT01233869|470006142|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
130556419|NCT01233869|470006143|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
130556420|NCT01233869|470006140|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
130556421|NCT01233869|470006141|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
130556422|NCT01233869|470006142|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
130556423|NCT01233869|470006143|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
130556424|NCT01233869|470006140|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130556425|NCT01233869|470006141|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130556426|NCT01233869|470006142|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130556427|NCT01233869|470006143|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
130556428|NCT01233869|470006140|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
130556429|NCT01233869|470006141|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
130556430|NCT01233869|470006142|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
130556431|NCT01233869|470006143|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
130556432|NCT01233869|470006140|FG000|Extended Treatment Period (46 Months)|Other|3|||
130288216|NCT01300819|469017639|FG001|Overall Study|Refusal to down titrate study drug|1|||
130288217|NCT01300819|469017638|FG000|Overall Study|Administrative reason|0|||
130288218|NCT01300819|469017639|FG001|Overall Study|Administrative reason|1|||
130288219|NCT01300819|469017638|FG000|Overall Study|Safety follow up not done by mistake|0|||
130288220|NCT01300819|469017639|FG001|Overall Study|Safety follow up not done by mistake|1|||
130288221|NCT01300819|469017638|FG000|Overall Study|Follow up call was not done|1|||
130288222|NCT01300819|469017639|FG001|Overall Study|Follow up call was not done|0|||
130288223|NCT00432744|469017640|FG000|Months 0-6|Withdrawal by Subject|4|||
130288224|NCT00432744|469017641|FG001|Months 0-6|Withdrawal by Subject|4|||
130288225|NCT00432744|469017640|FG000|Months 0-6|Too disabled to score|1|||
130288226|NCT00432744|469017641|FG001|Months 0-6|Too disabled to score|0|||
130288227|NCT00432744|469017640|FG000|Months 7 - 12|Withdrawal by Subject|1|||
130288228|NCT00432744|469017641|FG001|Months 7 - 12|Withdrawal by Subject|0|||
130288229|NCT00432744|469017640|FG000|Months 7 - 12|Too disabled to score|0|||
130288230|NCT00432744|469017641|FG001|Months 7 - 12|Too disabled to score|1|||
130288231|NCT01319721|469017642|FG000|Overall Study|Lost to Follow-up|1|||
130288232|NCT01319721|469017643|FG001|Overall Study|Lost to Follow-up|6|||
130288233|NCT00461305|469017645|FG000|Treatment|Adverse Event|26|||
130288234|NCT00461305|469017646|FG001|Treatment|Adverse Event|3|||
130288235|NCT00461305|469017645|FG000|Treatment|Lost to Follow-up|4|||
130288236|NCT00461305|469017646|FG001|Treatment|Lost to Follow-up|2|||
130288237|NCT00461305|469017645|FG000|Treatment|Protocol Violation|13|||
130288238|NCT00461305|469017646|FG001|Treatment|Protocol Violation|2|||
130288239|NCT00461305|469017645|FG000|Treatment|Withdrawal by Subject|48|||
130288240|NCT00461305|469017646|FG001|Treatment|Withdrawal by Subject|2|||
130288241|NCT00461305|469017645|FG000|Treatment|Never dispensed|5|||
130288242|NCT00461305|469017646|FG001|Treatment|Never dispensed|0|||
130288243|NCT00461305|469017645|FG000|Treatment|Study drug not taken|1|||
130288244|NCT00461305|469017646|FG001|Treatment|Study drug not taken|0|||
130288245|NCT00461305|469017645|FG000|Treatment|Partially missing diary|2|||
130288246|NCT00461305|469017646|FG001|Treatment|Partially missing diary|0|||
130288247|NCT00461305|469017645|FG000|Treatment|Other (missing drug etc)|2|||
130288248|NCT00461305|469017646|FG001|Treatment|Other (missing drug etc)|0|||
130556433|NCT01233869|470006141|FG001|Extended Treatment Period (46 Months)|Other|0|||
130288249|NCT00461305|469017645|FG000|Continued Treatment|Adverse Event|26|||
130556434|NCT01233869|470006142|FG002|Extended Treatment Period (46 Months)|Other|0|||
130556435|NCT01233869|470006143|FG003|Extended Treatment Period (46 Months)|Other|3|||
130288250|NCT00461305|469017646|FG001|Continued Treatment|Adverse Event|0|||
130288251|NCT00461305|469017645|FG000|Continued Treatment|Lost to Follow-up|4|||
130288252|NCT00461305|469017646|FG001|Continued Treatment|Lost to Follow-up|0|||
130288253|NCT00461305|469017645|FG000|Continued Treatment|Protocol Violation|13|||
130288254|NCT00461305|469017646|FG001|Continued Treatment|Protocol Violation|0|||
130288255|NCT00461305|469017645|FG000|Continued Treatment|Withdrawal by Subject|48|||
130288256|NCT00461305|469017646|FG001|Continued Treatment|Withdrawal by Subject|0|||
130288257|NCT00461305|469017645|FG000|Continued Treatment|Partially missing diary|2|||
130288258|NCT00461305|469017646|FG001|Continued Treatment|Partially missing diary|0|||
130288259|NCT00461305|469017645|FG000|Continued Treatment|Other (missing drug etc)|2|||
130288260|NCT00461305|469017646|FG001|Continued Treatment|Other (missing drug etc)|0|||
130713406|NCT02072824|470578372|FG001|Overall Study|Insufficient clinical response|0|||
130713407|NCT02072824|470578373|FG002|Overall Study|Insufficient clinical response|1|||
130713408|NCT02072824|470578371|FG000|Overall Study|No longer willing to participate|1|||
130713409|NCT02072824|470578372|FG001|Overall Study|No longer willing to participate|0|||
130713410|NCT02072824|470578373|FG002|Overall Study|No longer willing to participate|1|||
130713411|NCT02072824|470578371|FG000|Overall Study|Medication error|0|||
130713412|NCT02072824|470578372|FG001|Overall Study|Medication error|1|||
130713413|NCT02072824|470578373|FG002|Overall Study|Medication error|0|||
130713414|NCT02072824|470578371|FG000|Overall Study|Adverse Event|0|||
130713415|NCT02072824|470578372|FG001|Overall Study|Adverse Event|0|||
130713416|NCT02072824|470578373|FG002|Overall Study|Adverse Event|1|||
130713417|NCT03084367|470578374|FG000|Overall Study|Lost to Follow-up|32|||
130713418|NCT03084367|470578374|FG000|Overall Study|Withdrawal by Subject|4|||
130713419|NCT03084367|470578374|FG000|Overall Study|Other|1|||
130713420|NCT00841906|470578375|FG000|Overall Study|Withdrawal by Subject|2|||
130713421|NCT00841906|470578376|FG001|Overall Study|Withdrawal by Subject|0|||
130713422|NCT02667288|470578379|FG000|Overall Study|Protocol Violation|5|||
130713423|NCT02667288|470578379|FG000|Overall Study|Lost to Follow-up|3|||
130713424|NCT02667288|470578379|FG000|Overall Study|Withdrawal by Subject|5|||
130713425|NCT01196078|470578380|FG000|Overall Study|Withdrawal by Subject|3|||
130713426|NCT01196078|470578381|FG001|Overall Study|Withdrawal by Subject|5|||
130713427|NCT01196078|470578380|FG000|Overall Study|Adverse Event|4|||
130713428|NCT01196078|470578381|FG001|Overall Study|Adverse Event|4|||
130288261|NCT00787930|469017651|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
130288262|NCT01896271|469017652|FG000|Overall Study|Physician Decision|10|||
130288263|NCT02091284|469019800|FG000|Overall Study|Withdrawal by Subject|2|||
130288264|NCT02091284|469019801|FG001|Overall Study|Withdrawal by Subject|1|||
130288265|NCT02091284|469019800|FG000|Overall Study|unreliable data|1|||
130288266|NCT02091284|469019801|FG001|Overall Study|unreliable data|0|||
130288267|NCT03383783|469019802|FG000|Overall Study|Withdrawal by Subject|2|||
130288268|NCT01340937|469019803|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
130288269|NCT01340937|469019804|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
130288270|NCT01340937|469019805|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
130288271|NCT01340937|469019806|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
130288272|NCT01340937|469019803|FG000|Period 1: Infant Series|Adverse Event|0|||
130288273|NCT01340937|469019804|FG001|Period 1: Infant Series|Adverse Event|1|||
130288274|NCT01340937|469019805|FG002|Period 1: Infant Series|Adverse Event|4|||
130288275|NCT01340937|469019806|FG003|Period 1: Infant Series|Adverse Event|0|||
130288276|NCT01340937|469019803|FG000|Period 1: Infant Series|Death|2|||
130288277|NCT01340937|469019804|FG001|Period 1: Infant Series|Death|0|||
130288278|NCT01340937|469019805|FG002|Period 1: Infant Series|Death|2|||
130288279|NCT01340937|469019806|FG003|Period 1: Infant Series|Death|0|||
130288280|NCT01340937|469019803|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
130288281|NCT01340937|469019804|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
130288282|NCT01340937|469019805|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
130288283|NCT01340937|469019806|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
130288284|NCT01340937|469019803|FG000|Period 1: Infant Series|Physician Decision|2|||
130288285|NCT01340937|469019804|FG001|Period 1: Infant Series|Physician Decision|3|||
130288286|NCT01340937|469019805|FG002|Period 1: Infant Series|Physician Decision|1|||
130288287|NCT01340937|469019806|FG003|Period 1: Infant Series|Physician Decision|0|||
130288288|NCT01340937|469019803|FG000|Period 1: Infant Series|Protocol Violation|1|||
130288289|NCT01340937|469019804|FG001|Period 1: Infant Series|Protocol Violation|4|||
130288290|NCT01340937|469019805|FG002|Period 1: Infant Series|Protocol Violation|4|||
130713429|NCT01196078|470578380|FG000|Overall Study|Protocol Violation|2|||
130713430|NCT01196078|470578381|FG001|Overall Study|Protocol Violation|1|||
130713431|NCT01196078|470578380|FG000|Overall Study|Lack of Efficacy|17|||
130288291|NCT01340937|469019806|FG003|Period 1: Infant Series|Protocol Violation|3|||
130288292|NCT01340937|469019803|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
130713432|NCT01196078|470578381|FG001|Overall Study|Lack of Efficacy|23|||
130713433|NCT01196078|470578380|FG000|Overall Study|Lost to Follow-up|1|||
130288293|NCT01340937|469019804|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
130288294|NCT01340937|469019805|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
130288295|NCT01340937|469019806|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
130288296|NCT01340937|469019803|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
130288297|NCT01340937|469019804|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
130459553|NCT00530842|469647547|FG000|Overall Study|Protocol Violation|3|||
130713434|NCT01196078|470578381|FG001|Overall Study|Lost to Follow-up|0|||
130713435|NCT01196078|470578380|FG000|Overall Study|Death|6|||
130713436|NCT01196078|470578381|FG001|Overall Study|Death|4|||
130288298|NCT01340937|469019805|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
130288299|NCT01340937|469019806|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
130713437|NCT00127036|470578382|FG000|Overall Study|Insufficient Data for Analysis|6|||
130713438|NCT00127036|470578383|FG001|Overall Study|Insufficient Data for Analysis|11|||
130288300|NCT01340937|469019803|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
130288301|NCT01340937|469019804|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
130288302|NCT01340937|469019805|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
130288303|NCT01340937|469019806|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
130288304|NCT01340937|469019803|FG000|Period 2: Interim Period|Adverse Event|1|||
130288305|NCT01340937|469019804|FG001|Period 2: Interim Period|Adverse Event|0|||
130288306|NCT01340937|469019805|FG002|Period 2: Interim Period|Adverse Event|1|||
130288307|NCT01340937|469019806|FG003|Period 2: Interim Period|Adverse Event|0|||
130288308|NCT01340937|469019803|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
130288309|NCT01340937|469019804|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
130288310|NCT01340937|469019805|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
130288311|NCT01340937|469019806|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
130288312|NCT01340937|469019803|FG000|Period 2: Interim Period|Physician Decision|0|||
130288313|NCT01340937|469019804|FG001|Period 2: Interim Period|Physician Decision|1|||
130288314|NCT01340937|469019805|FG002|Period 2: Interim Period|Physician Decision|1|||
130288315|NCT01340937|469019806|FG003|Period 2: Interim Period|Physician Decision|0|||
130288316|NCT01340937|469019803|FG000|Period 2: Interim Period|Protocol Violation|5|||
130370671|NCT00622284|469327218|FG000|Overall Study|Withdrawal by Subject|27|||
130370672|NCT00622284|469327219|FG001|Overall Study|Withdrawal by Subject|24|||
130370673|NCT00622284|469327218|FG000|Overall Study|Other reason (not specified)|33|||
130370674|NCT00622284|469327219|FG001|Overall Study|Other reason (not specified)|24|||
130288317|NCT01340937|469019804|FG001|Period 2: Interim Period|Protocol Violation|3|||
130288318|NCT01340937|469019805|FG002|Period 2: Interim Period|Protocol Violation|6|||
130288319|NCT01340937|469019806|FG003|Period 2: Interim Period|Protocol Violation|3|||
130713439|NCT00127036|470578382|FG000|Overall Study|Screen Failure|2|||
130713440|NCT00127036|470578383|FG001|Overall Study|Screen Failure|0|||
130713441|NCT00270257|470578390|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
130713442|NCT00270257|470578391|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
130713443|NCT01403064|470578392|FG000|Overall Study|Death|0|||
130713444|NCT01403064|470578393|FG001|Overall Study|Death|0|||
130713445|NCT01403064|470578394|FG002|Overall Study|Death|1|||
130713446|NCT01403064|470578395|FG003|Overall Study|Death|1|||
130713447|NCT01403064|470578392|FG000|Overall Study|Withdrawal by Subject|0|||
130713448|NCT01403064|470578393|FG001|Overall Study|Withdrawal by Subject|0|||
130713449|NCT01403064|470578394|FG002|Overall Study|Withdrawal by Subject|1|||
130713450|NCT01403064|470578395|FG003|Overall Study|Withdrawal by Subject|1|||
130713451|NCT01403064|470578392|FG000|Overall Study|Other|1|||
130713452|NCT01403064|470578393|FG001|Overall Study|Other|0|||
130370675|NCT00880009|469327220|FG000|Overall Study|Study terminated by sponsor|14|||
130370676|NCT00880009|469327220|FG000|Overall Study|Withdrawal by Subject|1|||
130713453|NCT01403064|470578394|FG002|Overall Study|Other|2|||
130713454|NCT01403064|470578395|FG003|Overall Study|Other|1|||
130713455|NCT02621034|470578396|FG000|Overall Study|Lost to Follow-up|3|||
130713456|NCT02621034|470578397|FG001|Overall Study|Lost to Follow-up|2|||
130713457|NCT02621034|470578398|FG002|Overall Study|Lost to Follow-up|5|||
130713458|NCT04688931|470578404|FG000|Overall Study|Adverse Event|4|||
130713459|NCT04688931|470578405|FG001|Overall Study|Adverse Event|1|||
130713460|NCT04688931|470578404|FG000|Overall Study|Withdrawal by Subject|5|||
130713461|NCT04688931|470578405|FG001|Overall Study|Withdrawal by Subject|16|||
130713462|NCT04688931|470578404|FG000|Overall Study|Physician Decision|3|||
130288320|NCT01340937|469019803|FG000|Period 2: Interim Period|Technical problems|4|||
130370677|NCT00880009|469327220|FG000|Overall Study|Protocol Violation|1|||
130370678|NCT02412618|469327224|FG000|Overall Study|Withdrawal by Subject|1|||
130370679|NCT02412618|469327225|FG001|Overall Study|Withdrawal by Subject|1|||
130370680|NCT02412618|469327224|FG000|Overall Study|Expulsion|1|||
130370681|NCT02412618|469327225|FG001|Overall Study|Expulsion|1|||
130370682|NCT01253408|469327226|FG000|Overall Study|Adverse Event|0|||
130370683|NCT01253408|469327227|FG001|Overall Study|Adverse Event|1|||
130370684|NCT01253408|469327228|FG002|Overall Study|Adverse Event|0|||
130370685|NCT00629707|469327232|FG000|Overall Study|Withdrawal by Subject|0|||
130370686|NCT00629707|469327233|FG001|Overall Study|Withdrawal by Subject|1|||
130370687|NCT00629707|469327232|FG000|Overall Study|Physician Decision|0|||
130370688|NCT00629707|469327233|FG001|Overall Study|Physician Decision|1|||
130370689|NCT03736447|469327234|FG000|Overall Study|Adverse Event|5|||
130370690|NCT03736447|469327235|FG001|Overall Study|Adverse Event|1|||
130459554|NCT00530842|469647548|FG001|Overall Study|Protocol Violation|2|||
130713463|NCT04688931|470578405|FG001|Overall Study|Physician Decision|5|||
130713464|NCT04688931|470578404|FG000|Overall Study|Noncompliance|0|||
130370691|NCT03736447|469327234|FG000|Overall Study|Withdrawal by Subject|5|||
130370692|NCT03736447|469327235|FG001|Overall Study|Withdrawal by Subject|1|||
130713465|NCT04688931|470578405|FG001|Overall Study|Noncompliance|1|||
130713466|NCT04688931|470578404|FG000|Overall Study|Lost to Follow-up|1|||
130713467|NCT04688931|470578405|FG001|Overall Study|Lost to Follow-up|3|||
130713468|NCT04688931|470578404|FG000|Overall Study|Randomization Error|3|||
130713469|NCT04688931|470578405|FG001|Overall Study|Randomization Error|0|||
130713470|NCT04688931|470578404|FG000|Overall Study|Not Eligible|1|||
130713471|NCT04688931|470578405|FG001|Overall Study|Not Eligible|3|||
130288321|NCT01340937|469019804|FG001|Period 2: Interim Period|Technical problems|4|||
130288322|NCT01340937|469019805|FG002|Period 2: Interim Period|Technical problems|6|||
130288323|NCT01340937|469019806|FG003|Period 2: Interim Period|Technical problems|3|||
130713472|NCT04688931|470578404|FG000|Overall Study|Disease Progression|0|||
130713473|NCT04688931|470578405|FG001|Overall Study|Disease Progression|2|||
130713474|NCT04688931|470578404|FG000|Overall Study|Sponsor Requirement|1|||
130288324|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130288325|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130288326|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130288327|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130288328|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
130288329|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
130288330|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
130288331|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
130288332|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130288333|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130459555|NCT00530842|469647547|FG000|Overall Study|Withdrawal by Subject|4|||
130459556|NCT00530842|469647548|FG001|Overall Study|Withdrawal by Subject|5|||
130459557|NCT00530842|469647547|FG000|Overall Study|Individual different reasons|4|||
130459558|NCT00530842|469647548|FG001|Overall Study|Individual different reasons|3|||
130459559|NCT00530842|469647547|FG000|Period 1|Adverse Event|7|||
130459560|NCT00530842|469647548|FG001|Period 1|Adverse Event|3|||
130459561|NCT00530842|469647547|FG000|Period 1|Lack of Efficacy|1|||
130459562|NCT00530842|469647548|FG001|Period 1|Lack of Efficacy|1|||
130459563|NCT00530842|469647547|FG000|Period 1|Protocol Violation|2|||
130459564|NCT00530842|469647548|FG001|Period 1|Protocol Violation|1|||
130459565|NCT00530842|469647547|FG000|Period 1|Withdrawal by Subject|2|||
130459566|NCT00530842|469647548|FG001|Period 1|Withdrawal by Subject|3|||
130459567|NCT00530842|469647547|FG000|Period 1|Individual different reasons|2|||
130459568|NCT00530842|469647548|FG001|Period 1|Individual different reasons|3|||
130459569|NCT00530842|469647547|FG000|Period 2|Adverse Event|3|||
130459570|NCT00530842|469647548|FG001|Period 2|Adverse Event|3|||
130459571|NCT00530842|469647547|FG000|Period 2|Lack of Efficacy|1|||
130459572|NCT00530842|469647548|FG001|Period 2|Lack of Efficacy|0|||
130459573|NCT00530842|469647547|FG000|Period 2|Lost to Follow-up|0|||
130459574|NCT00530842|469647548|FG001|Period 2|Lost to Follow-up|4|||
130459575|NCT00530842|469647547|FG000|Period 2|Protocol Violation|1|||
130459576|NCT00530842|469647548|FG001|Period 2|Protocol Violation|0|||
130459577|NCT00530842|469647547|FG000|Period 2|Withdrawal by Subject|1|||
130459578|NCT00530842|469647548|FG001|Period 2|Withdrawal by Subject|2|||
130459579|NCT00530842|469647547|FG000|Period 2|Individual different reasons|2|||
130459580|NCT00530842|469647548|FG001|Period 2|Individual different reasons|0|||
130459581|NCT00949975|469647549|FG000|Overall Study|Voluntary discontinuation|6|||
130459582|NCT00949975|469647550|FG001|Overall Study|Voluntary discontinuation|5|||
130459583|NCT00949975|469647551|FG002|Overall Study|Voluntary discontinuation|3|||
130459584|NCT00949975|469647552|FG003|Overall Study|Voluntary discontinuation|6|||
130459585|NCT00949975|469647549|FG000|Overall Study|Adverse Event|11|||
130459586|NCT00949975|469647550|FG001|Overall Study|Adverse Event|11|||
130459587|NCT00949975|469647551|FG002|Overall Study|Adverse Event|10|||
130459588|NCT00949975|469647552|FG003|Overall Study|Adverse Event|10|||
130459589|NCT00949975|469647549|FG000|Overall Study|Safety reason|0|||
130459590|NCT00949975|469647550|FG001|Overall Study|Safety reason|1|||
130459591|NCT00949975|469647551|FG002|Overall Study|Safety reason|0|||
130459592|NCT00949975|469647552|FG003|Overall Study|Safety reason|0|||
130459593|NCT00949975|469647549|FG000|Overall Study|Study-specific criteria|0|||
130459594|NCT00949975|469647550|FG001|Overall Study|Study-specific criteria|1|||
130459595|NCT00949975|469647551|FG002|Overall Study|Study-specific criteria|1|||
130459596|NCT00949975|469647552|FG003|Overall Study|Study-specific criteria|0|||
130459597|NCT00949975|469647549|FG000|Overall Study|Incorrect enrolment|5|||
130459598|NCT00949975|469647550|FG001|Overall Study|Incorrect enrolment|10|||
130713475|NCT04688931|470578405|FG001|Overall Study|Sponsor Requirement|1|||
130713476|NCT04688931|470578404|FG000|Overall Study|Other Reason|1|||
130288334|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130459599|NCT00949975|469647551|FG002|Overall Study|Incorrect enrolment|4|||
130459600|NCT00949975|469647552|FG003|Overall Study|Incorrect enrolment|7|||
130459601|NCT00949975|469647549|FG000|Overall Study|Severe non-compliance|3|||
130459602|NCT00949975|469647550|FG001|Overall Study|Severe non-compliance|1|||
130459603|NCT00949975|469647551|FG002|Overall Study|Severe non-compliance|0|||
130459604|NCT00949975|469647552|FG003|Overall Study|Severe non-compliance|2|||
130459605|NCT00949975|469647549|FG000|Overall Study|Lost to Follow-up|1|||
130459606|NCT00949975|469647550|FG001|Overall Study|Lost to Follow-up|0|||
130459607|NCT00949975|469647551|FG002|Overall Study|Lost to Follow-up|1|||
130459608|NCT00949975|469647552|FG003|Overall Study|Lost to Follow-up|3|||
130459609|NCT00949975|469647549|FG000|Overall Study|Other|1|||
130459610|NCT00949975|469647550|FG001|Overall Study|Other|0|||
130459611|NCT00949975|469647551|FG002|Overall Study|Other|0|||
130459612|NCT00949975|469647552|FG003|Overall Study|Other|0|||
130713477|NCT04688931|470578405|FG001|Overall Study|Other Reason|2|||
130713478|NCT00450619|470578406|FG000|Overall Study|refused treatment after randomization|2|||
130288335|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
130288336|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
130288337|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
130288338|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
130288339|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
130288340|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130288341|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130288342|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
130288343|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
130288344|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130288345|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130288346|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
130288347|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
130288348|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
130288349|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
130288350|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130288351|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130288352|NCT02119156|469019807|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
130288353|NCT02119156|469019808|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
130288354|NCT02119156|469019809|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
130288355|NCT02469415|469019810|FG000|Overall Study|Withdrawal by Subject|1|||
130288356|NCT02469415|469019810|FG000|Overall Study|Investigational agent placed on hold|2|||
130288357|NCT00350623|469019813|FG000|Overall Study|Lost to Follow-up|8|||
130288358|NCT00350623|469019814|FG001|Overall Study|Lost to Follow-up|3|||
130288359|NCT00350623|469019815|FG002|Overall Study|Lost to Follow-up|4|||
130288360|NCT00350623|469019813|FG000|Overall Study|Withdrawal by Subject|0|||
130288361|NCT00350623|469019814|FG001|Overall Study|Withdrawal by Subject|1|||
130288362|NCT00350623|469019815|FG002|Overall Study|Withdrawal by Subject|1|||
130288363|NCT00350623|469019813|FG000|Overall Study|patient traveling outside the country|0|||
130288364|NCT00350623|469019814|FG001|Overall Study|patient traveling outside the country|0|||
130288365|NCT00350623|469019815|FG002|Overall Study|patient traveling outside the country|1|||
130288366|NCT02685748|469019816|FG000|Overall Study|Withdrawal by Subject|3|||
130288367|NCT02685748|469019817|FG001|Overall Study|Withdrawal by Subject|2|||
130288368|NCT04126564|469019818|FG000|Overall Study|Withdrawal by Subject|0|||
130288369|NCT04126564|469019819|FG001|Overall Study|Withdrawal by Subject|2|||
130288370|NCT04126564|469019818|FG000|Overall Study|Lost to Follow-up|0|||
130288371|NCT04126564|469019819|FG001|Overall Study|Lost to Follow-up|1|||
130288372|NCT03500172|469019820|FG000|Period 1: Baseline Randomization|Death|0|||
130288373|NCT03500172|469019821|FG001|Period 1: Baseline Randomization|Death|0|||
130288374|NCT03500172|469019822|FG002|Period 1: Baseline Randomization|Death|0|||
130288375|NCT03500172|469019823|FG003|Period 1: Baseline Randomization|Death|0|||
130288376|NCT03500172|469019824|FG004|Period 1: Baseline Randomization|Death|0|||
130288377|NCT03500172|469019825|FG005|Period 1: Baseline Randomization|Death|0|||
130288378|NCT03500172|469019826|FG006|Period 1: Baseline Randomization|Death|0|||
130288379|NCT03500172|469019827|FG007|Period 1: Baseline Randomization|Death|0|||
130288380|NCT03500172|469019828|FG008|Period 1: Baseline Randomization|Death|0|||
130288381|NCT03500172|469019829|FG009|Period 1: Baseline Randomization|Death|2|||
130288382|NCT03500172|469019830|FG010|Period 1: Baseline Randomization|Death|0|||
130288383|NCT03500172|469019820|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
130288384|NCT03500172|469019821|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
130288385|NCT03500172|469019822|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
130288386|NCT03500172|469019823|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
130288387|NCT03500172|469019824|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
130288388|NCT03500172|469019825|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
130288389|NCT03500172|469019826|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
130288390|NCT03500172|469019827|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
130288391|NCT03500172|469019828|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
130288392|NCT03500172|469019829|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
130288393|NCT03500172|469019830|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
130288394|NCT03500172|469019820|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
130288395|NCT03500172|469019821|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
130288396|NCT03500172|469019822|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
130288397|NCT03500172|469019823|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
130288398|NCT03500172|469019824|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
130288399|NCT03500172|469019825|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
130288400|NCT03500172|469019826|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
130288401|NCT03500172|469019827|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
130288402|NCT03500172|469019828|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
130713479|NCT00450619|470578407|FG001|Overall Study|refused treatment after randomization|0|||
130713480|NCT00450619|470578406|FG000|Overall Study|did not progress; refused further trmt|1|||
130713481|NCT00450619|470578407|FG001|Overall Study|did not progress; refused further trmt|1|||
130713482|NCT00450619|470578406|FG000|Overall Study|Adverse Event|1|||
130713483|NCT00450619|470578407|FG001|Overall Study|Adverse Event|0|||
130713484|NCT00714493|470578419|FG000|Overall Study|Adverse Event|11|||
130713485|NCT00714493|470578419|FG000|Overall Study|Death|3|||
130713486|NCT00714493|470578419|FG000|Overall Study|Lack of Efficacy|10|||
130713487|NCT00714493|470578419|FG000|Overall Study|Lost to Follow-up|3|||
130713488|NCT00714493|470578419|FG000|Overall Study|Protocol Violation|12|||
130713489|NCT00714493|470578419|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
130713490|NCT00714493|470578419|FG000|Overall Study|OTHER|2|||
130713491|NCT02372071|470578420|FG000|Overall Study|Protocol Violation|18|||
130713492|NCT00506129|470578421|FG000|Overall Study|Disease Progression/Relapse|15|||
130713493|NCT00506129|470578421|FG000|Overall Study|Death|7|||
130713494|NCT01968694|470578422|FG000|Washout (1 Month)|Lost to Follow-up|0|||
130713495|NCT01968694|470578423|FG001|Washout (1 Month)|Lost to Follow-up|1|||
130713496|NCT00251719|470578424|FG000|Overall Study|Adverse Event|14|||
130713497|NCT00251719|470578425|FG001|Overall Study|Adverse Event|8|||
130713498|NCT00251719|470578426|FG002|Overall Study|Adverse Event|7|||
130713499|NCT00251719|470578424|FG000|Overall Study|Protocol Violation|1|||
130713500|NCT00251719|470578425|FG001|Overall Study|Protocol Violation|1|||
130713501|NCT00251719|470578426|FG002|Overall Study|Protocol Violation|1|||
130713502|NCT00251719|470578424|FG000|Overall Study|Lost to Follow-up|5|||
130713503|NCT00251719|470578425|FG001|Overall Study|Lost to Follow-up|11|||
130713504|NCT00251719|470578426|FG002|Overall Study|Lost to Follow-up|8|||
130713505|NCT00251719|470578424|FG000|Overall Study|Withdrawal by Subject|14|||
130713506|NCT00251719|470578425|FG001|Overall Study|Withdrawal by Subject|12|||
130713507|NCT00251719|470578426|FG002|Overall Study|Withdrawal by Subject|11|||
130713508|NCT00251719|470578424|FG000|Overall Study|Lack of Efficacy|2|||
130713509|NCT00251719|470578425|FG001|Overall Study|Lack of Efficacy|1|||
130713510|NCT00251719|470578426|FG002|Overall Study|Lack of Efficacy|0|||
130713511|NCT00251719|470578424|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
130713512|NCT00251719|470578425|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
130713513|NCT00251719|470578426|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
130713514|NCT00251719|470578424|FG000|Overall Study|Investigator decision|1|||
130713515|NCT00251719|470578425|FG001|Overall Study|Investigator decision|1|||
130713516|NCT00251719|470578426|FG002|Overall Study|Investigator decision|0|||
130713517|NCT00251719|470578424|FG000|Overall Study|Noncompliance|2|||
130713518|NCT00251719|470578425|FG001|Overall Study|Noncompliance|3|||
130713519|NCT00251719|470578426|FG002|Overall Study|Noncompliance|1|||
130713520|NCT00251719|470578424|FG000|Overall Study|Barrett's esophagus|2|||
130713521|NCT00251719|470578425|FG001|Overall Study|Barrett's esophagus|2|||
130713522|NCT00251719|470578426|FG002|Overall Study|Barrett's esophagus|0|||
130713523|NCT00688376|470578431|FG000|Double-Blind Phase|Adverse Event|4|||
130713524|NCT00688376|470578432|FG001|Double-Blind Phase|Adverse Event|4|||
130713525|NCT00688376|470578431|FG000|Double-Blind Phase|Protocol Violation|1|||
130713526|NCT00688376|470578432|FG001|Double-Blind Phase|Protocol Violation|2|||
130713527|NCT00688376|470578431|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130713528|NCT00688376|470578432|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130713529|NCT00688376|470578431|FG000|Double-Blind Phase|Not treated|0|||
130713530|NCT00688376|470578432|FG001|Double-Blind Phase|Not treated|1|||
130713531|NCT00688376|470578431|FG000|Blinded Extension Phase|Adverse Event|3|||
130713532|NCT00688376|470578432|FG001|Blinded Extension Phase|Adverse Event|4|||
130713533|NCT00688376|470578431|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
130713534|NCT00688376|470578432|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
130713535|NCT00688376|470578431|FG000|Blinded Extension Phase|Physician Decision|1|||
130713536|NCT00688376|470578432|FG001|Blinded Extension Phase|Physician Decision|0|||
130713537|NCT00688376|470578431|FG000|Blinded Extension Phase|Other|1|||
130713538|NCT00688376|470578432|FG001|Blinded Extension Phase|Other|0|||
130713539|NCT04392583|470578433|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
130713540|NCT01070771|470578437|FG000|Overall Study|Adverse Event|2|||
130713541|NCT01070771|470578437|FG000|Overall Study|Protocol Violation|1|||
130713542|NCT00857259|470578440|FG000|Overall Study|Protocol Violation|1|||
130713543|NCT00857259|470578441|FG001|Overall Study|Protocol Violation|0|||
130713544|NCT00857259|470578442|FG002|Overall Study|Protocol Violation|1|||
130713545|NCT02701413|470578443|FG000|Overall Study|Withdrawal by Subject|7|||
130713546|NCT02701413|470578444|FG001|Overall Study|Withdrawal by Subject|11|||
130713547|NCT01621191|470578447|FG000|Overall Study|Adverse Event|9|||
130713548|NCT01621191|470578447|FG000|Overall Study|Withdrawal by Subject|8|||
130713549|NCT01621191|470578447|FG000|Overall Study|Lack of Efficacy|6|||
130713550|NCT01621191|470578447|FG000|Overall Study|Lost to Follow-up|1|||
130713551|NCT01621191|470578447|FG000|Overall Study|Site Removed From Study|1|||
130713552|NCT00706381|470578448|FG000|Overall Study|Lost to Follow-up|0|||
130713553|NCT00706381|470578449|FG001|Overall Study|Lost to Follow-up|1|||
130713554|NCT00706381|470578450|FG002|Overall Study|Lost to Follow-up|1|||
130713555|NCT00706381|470578451|FG003|Overall Study|Lost to Follow-up|0|||
130288403|NCT03500172|469019829|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
130288404|NCT03500172|469019830|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
130288405|NCT03500172|469019820|FG000|Period 2: Re-Randomization|Death|0|||
130288406|NCT03500172|469019821|FG001|Period 2: Re-Randomization|Death|0|||
130288407|NCT03500172|469019822|FG002|Period 2: Re-Randomization|Death|0|||
130288408|NCT03500172|469019823|FG003|Period 2: Re-Randomization|Death|4|||
130288409|NCT03500172|469019824|FG004|Period 2: Re-Randomization|Death|2|||
130288410|NCT03500172|469019825|FG005|Period 2: Re-Randomization|Death|0|||
130288411|NCT03500172|469019826|FG006|Period 2: Re-Randomization|Death|5|||
130288412|NCT03500172|469019827|FG007|Period 2: Re-Randomization|Death|2|||
130288413|NCT03500172|469019828|FG008|Period 2: Re-Randomization|Death|0|||
130288414|NCT03500172|469019829|FG009|Period 2: Re-Randomization|Death|0|||
130288415|NCT03500172|469019830|FG010|Period 2: Re-Randomization|Death|0|||
130288416|NCT01974752|469019833|FG000|Overall Study|Death|33|||
130288417|NCT01974752|469019834|FG001|Overall Study|Death|11|||
130288418|NCT01974752|469019833|FG000|Overall Study|Lost to Follow-up|2|||
130288419|NCT01974752|469019834|FG001|Overall Study|Lost to Follow-up|0|||
130288420|NCT01974752|469019833|FG000|Overall Study|Withdrawal by Subject|2|||
130288421|NCT01974752|469019834|FG001|Overall Study|Withdrawal by Subject|3|||
130288422|NCT01974752|469019833|FG000|Overall Study|Other Eligibility Criteria|0|||
130288423|NCT01974752|469019834|FG001|Overall Study|Other Eligibility Criteria|1|||
130288424|NCT02435680|469019836|FG000|Overall Study|Physician Decision|3|||
130288425|NCT02435680|469019837|FG001|Overall Study|Physician Decision|0|||
130288426|NCT02435680|469019838|FG002|Overall Study|Physician Decision|0|||
130288427|NCT02435680|469019836|FG000|Overall Study|subject / guardian decision|0|||
130288428|NCT02435680|469019837|FG001|Overall Study|subject / guardian decision|3|||
130288429|NCT02435680|469019838|FG002|Overall Study|subject / guardian decision|2|||
130288430|NCT02435680|469019836|FG000|Overall Study|Adverse Event|8|||
130288431|NCT02435680|469019837|FG001|Overall Study|Adverse Event|3|||
130288432|NCT02435680|469019838|FG002|Overall Study|Adverse Event|2|||
130288433|NCT02435680|469019836|FG000|Overall Study|progressive disease|10|||
130288434|NCT02435680|469019837|FG001|Overall Study|progressive disease|7|||
130288435|NCT02435680|469019838|FG002|Overall Study|progressive disease|11|||
130288436|NCT02435680|469019836|FG000|Overall Study|not treated|0|||
130288437|NCT02435680|469019837|FG001|Overall Study|not treated|0|||
130288438|NCT02435680|469019838|FG002|Overall Study|not treated|1|||
130288439|NCT00330928|469019839|FG000|Overall Study|Lost to Follow-up|6|||
130459613|NCT04347954|469647553|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
130459614|NCT04347954|469647554|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
130459615|NCT04347954|469647555|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
130459616|NCT04347954|469647553|FG000|Overall Study|Lost to Follow-up|0|||
130459617|NCT04347954|469647554|FG001|Overall Study|Lost to Follow-up|1|||
130459618|NCT04347954|469647555|FG002|Overall Study|Lost to Follow-up|0|||
130459619|NCT02534350|469647556|FG000|Overall Study|Randomized But Not Treated|1|||
130459620|NCT02534350|469647557|FG001|Overall Study|Randomized But Not Treated|0|||
130459621|NCT02534350|469647556|FG000|Overall Study|Protocol Violation|1|||
130459622|NCT02534350|469647557|FG001|Overall Study|Protocol Violation|0|||
130459623|NCT02534350|469647556|FG000|Overall Study|Withdrew Consent|2|||
130459624|NCT02534350|469647557|FG001|Overall Study|Withdrew Consent|0|||
130459625|NCT03257813|469647573|FG000|Overall Study|Protocol Violation|6|||
130459626|NCT03257813|469647574|FG001|Overall Study|Protocol Violation|3|||
130459627|NCT02878330|469647575|FG000|Overall Study|Death|3|||
130459628|NCT02878330|469647576|FG001|Overall Study|Death|2|||
130459629|NCT02878330|469647575|FG000|Overall Study|Lost to Follow-up|11|||
130459630|NCT02878330|469647576|FG001|Overall Study|Lost to Follow-up|26|||
130459631|NCT02878330|469647575|FG000|Overall Study|Withdrawal by Subject|11|||
130459632|NCT02878330|469647576|FG001|Overall Study|Withdrawal by Subject|21|||
130459633|NCT02878330|469647575|FG000|Overall Study|Other|4|||
130459634|NCT02878330|469647576|FG001|Overall Study|Other|7|||
130459635|NCT05641311|469647581|FG000|Dosing Period 1|Adverse Event|1|||
130459636|NCT05641311|469647582|FG001|Dosing Period 1|Adverse Event|0|||
130459637|NCT00909363|469647583|FG000|Overall Study|Withdrawal by Subject|1|||
130459638|NCT00909363|469647584|FG001|Overall Study|Withdrawal by Subject|0|||
130459639|NCT00909363|469647585|FG002|Overall Study|Withdrawal by Subject|0|||
130459640|NCT00909363|469647583|FG000|Overall Study|Lack of Efficacy|1|||
130459641|NCT00909363|469647584|FG001|Overall Study|Lack of Efficacy|0|||
130288440|NCT00330928|469019839|FG000|Overall Study|Physician Decision|9|||
130288441|NCT00330928|469019839|FG000|Overall Study|Death|1|||
130288442|NCT00330928|469019839|FG000|Overall Study|IVUS could not be performed.|1|||
130288443|NCT03028480|469019842|FG000|Overall Study|No revisit after the first prescription date|2|||
130459642|NCT00909363|469647585|FG002|Overall Study|Lack of Efficacy|0|||
130459643|NCT00922207|469647588|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
130459644|NCT00922207|469647589|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
130459645|NCT00922207|469647590|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
130459646|NCT00922207|469647588|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130459647|NCT00922207|469647589|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130459648|NCT00922207|469647590|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130459649|NCT00922207|469647588|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130459650|NCT00922207|469647589|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130459651|NCT00922207|469647590|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
130459652|NCT00922207|469647588|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
130459653|NCT00922207|469647589|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130459654|NCT00922207|469647590|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130288444|NCT03028480|469019842|FG000|Overall Study|Did not use the drug|1|||
130288445|NCT03028480|469019842|FG000|Overall Study|Violation of the enrollment deadline|10|||
130288446|NCT03028480|469019842|FG000|Overall Study|Case report forms were not collected|21|||
130288447|NCT02279719|469019845|FG000|Overall Study|Patients randomized but never treated|0|||
130288448|NCT02279719|469019846|FG001|Overall Study|Patients randomized but never treated|0|||
130288449|NCT02279719|469019847|FG002|Overall Study|Patients randomized but never treated|0|||
130288450|NCT02279719|469019848|FG003|Overall Study|Patients randomized but never treated|0|||
130288451|NCT02279719|469019849|FG004|Overall Study|Patients randomized but never treated|3|||
130288452|NCT02279719|469019850|FG005|Overall Study|Patients randomized but never treated|0|||
130288453|NCT02279719|469019851|FG006|Overall Study|Patients randomized but never treated|3|||
130288454|NCT03541187|469019852|FG000|Overall Study|Lost to Follow-up|2|||
130288455|NCT03541187|469019853|FG001|Overall Study|Lost to Follow-up|6|||
130288456|NCT03541187|469019852|FG000|Overall Study|Pregnancy|0|||
130288457|NCT03541187|469019853|FG001|Overall Study|Pregnancy|1|||
130288458|NCT03541187|469019852|FG000|Overall Study|Withdrawal by Subject|6|||
130288459|NCT03541187|469019853|FG001|Overall Study|Withdrawal by Subject|2|||
130288460|NCT03541187|469019852|FG000|Overall Study|Moved out of town|1|||
130288461|NCT03541187|469019853|FG001|Overall Study|Moved out of town|0|||
130288462|NCT03541187|469019852|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
130288463|NCT03541187|469019853|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
130288464|NCT03541187|469019852|FG000|Overall Study|Did not meet randomization criteria|1|||
130288465|NCT03541187|469019853|FG001|Overall Study|Did not meet randomization criteria|1|||
130288466|NCT03541187|469019852|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
130288467|NCT03541187|469019853|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
130288468|NCT03541187|469019852|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
130288469|NCT03541187|469019853|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
130288470|NCT01369680|469019854|FG000|Overall Study|Lost to Follow-up|0|||
130288471|NCT01369680|469019855|FG001|Overall Study|Lost to Follow-up|0|||
130288472|NCT01369680|469019856|FG002|Overall Study|Lost to Follow-up|1|||
130288473|NCT01369680|469019857|FG003|Overall Study|Lost to Follow-up|2|||
130288474|NCT00585221|469019860|FG000|Overall Study|Protocol Violation|8|||
130288475|NCT01118520|469019865|FG000|Overall Study|AAA repair|9|||
130288476|NCT01118520|469019866|FG001|Overall Study|AAA repair|7|||
130288477|NCT01118520|469019867|FG002|Overall Study|AAA repair|9|||
130288478|NCT01118520|469019865|FG000|Overall Study|Adverse Event|3|||
130288479|NCT01118520|469019866|FG001|Overall Study|Adverse Event|3|||
130288480|NCT01118520|469019867|FG002|Overall Study|Adverse Event|3|||
130288481|NCT01118520|469019865|FG000|Overall Study|Withdrawal by Subject|8|||
130288482|NCT01118520|469019866|FG001|Overall Study|Withdrawal by Subject|13|||
130288483|NCT01118520|469019867|FG002|Overall Study|Withdrawal by Subject|8|||
130288484|NCT01089023|469019870|FG000|Overall Study|Lost to Follow-up|3|||
130288485|NCT01089023|469019870|FG000|Overall Study|Adverse Event|1|||
130288486|NCT01089023|469019870|FG000|Overall Study|Withdrawal by Subject|1|||
130288487|NCT01089023|469019870|FG000|Overall Study|Protocol Violation|1|||
130288488|NCT01089023|469019870|FG000|Overall Study|Lack of Efficacy|1|||
130288489|NCT03421743|469019871|FG000|Overall Study|Lack of Efficacy|1|||
130288490|NCT03421743|469019872|FG001|Overall Study|Lack of Efficacy|0|||
130288491|NCT03421743|469019871|FG000|Overall Study|Adverse Event|2|||
130288492|NCT03421743|469019872|FG001|Overall Study|Adverse Event|1|||
130288493|NCT03421743|469019871|FG000|Overall Study|Withdrawal by Subject|0|||
130288494|NCT03421743|469019872|FG001|Overall Study|Withdrawal by Subject|1|||
130288495|NCT01166373|469019873|FG000|Overall Study|Lost to Follow-up|3|||
130288496|NCT01166373|469019874|FG001|Overall Study|Lost to Follow-up|2|||
130288497|NCT01166373|469019875|FG002|Overall Study|Lost to Follow-up|2|||
130288498|NCT01166373|469019876|FG003|Overall Study|Lost to Follow-up|2|||
130288499|NCT01166373|469019873|FG000|Overall Study|Withdrawal by Subject|1|||
130288500|NCT01166373|469019874|FG001|Overall Study|Withdrawal by Subject|2|||
130288501|NCT01166373|469019875|FG002|Overall Study|Withdrawal by Subject|2|||
130288502|NCT01166373|469019876|FG003|Overall Study|Withdrawal by Subject|3|||
130288503|NCT01166373|469019873|FG000|Overall Study|Physician Decision|1|||
130288504|NCT01166373|469019874|FG001|Overall Study|Physician Decision|0|||
130288505|NCT01166373|469019875|FG002|Overall Study|Physician Decision|0|||
130288506|NCT01166373|469019876|FG003|Overall Study|Physician Decision|0|||
130288507|NCT01819129|469019877|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
130288508|NCT01819129|469019878|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
130288509|NCT01819129|469019877|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
130288510|NCT01819129|469019878|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
130288511|NCT01819129|469019877|FG000|Overall Study|Other, Subject moved out of the country|0|||
130713556|NCT00160641|470578455|FG000|Overall Study|Adverse Event|102|||
130713557|NCT00160641|470578455|FG000|Overall Study|Withdrawal by Subject|87|||
130713558|NCT00160641|470578455|FG000|Overall Study|Lost to Follow-up|8|||
130713559|NCT00160641|470578455|FG000|Overall Study|Lack of Efficacy|12|||
130713560|NCT00160641|470578455|FG000|Overall Study|Protocol Violation|3|||
130713561|NCT00160641|470578455|FG000|Overall Study|Other|9|||
130713562|NCT01782482|470578460|FG000|Overall Study|Adverse Event|2|||
130713563|NCT01782482|470578461|FG001|Overall Study|Adverse Event|1|||
130713564|NCT01782482|470578460|FG000|Overall Study|Lost to Follow-up|2|||
130713565|NCT01782482|470578461|FG001|Overall Study|Lost to Follow-up|3|||
130713566|NCT01782482|470578460|FG000|Overall Study|Physician Decision|1|||
130713567|NCT01782482|470578461|FG001|Overall Study|Physician Decision|0|||
130713568|NCT01782482|470578460|FG000|Overall Study|Protocol Violation|1|||
130713569|NCT01782482|470578461|FG001|Overall Study|Protocol Violation|0|||
130713570|NCT01782482|470578460|FG000|Overall Study|Withdrawal by Subject|2|||
130713571|NCT01782482|470578461|FG001|Overall Study|Withdrawal by Subject|3|||
130713572|NCT01782482|470578460|FG000|Overall Study|Randomized in Error|2|||
130713573|NCT01782482|470578461|FG001|Overall Study|Randomized in Error|2|||
130713574|NCT01782482|470578460|FG000|Overall Study|Habitually wearing toric lens OS|0|||
130713575|NCT01782482|470578461|FG001|Overall Study|Habitually wearing toric lens OS|1|||
130713576|NCT00038649|470578463|FG000|Overall Study|Adverse Event|9|||
130713577|NCT00995085|470578464|FG000|Overall Study|Withdrawal by Subject|5|||
130713578|NCT01640873|470578470|FG000|Overall Study|Protocol Violation|2|||
130713579|NCT01640873|470578471|FG001|Overall Study|Protocol Violation|1|||
130713580|NCT01321008|470578472|FG000|Overall Study|Early Study Termination|1|||
130713581|NCT02749292|470578473|FG000|Overall Study|Physician Decision|1|||
130713582|NCT02749292|470578474|FG001|Overall Study|Physician Decision|0|||
130713583|NCT02749292|470578473|FG000|Overall Study|Withdrawal by Subject|5|||
130713584|NCT02749292|470578474|FG001|Overall Study|Withdrawal by Subject|7|||
130713585|NCT02749292|470578473|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
130713586|NCT02749292|470578474|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
130713587|NCT02749292|470578473|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
130713588|NCT02749292|470578474|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
130713589|NCT02749292|470578473|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
130713590|NCT02749292|470578474|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
130713591|NCT02749292|470578473|FG000|Overall Study|Adverse Event|4|||
130713592|NCT02749292|470578474|FG001|Overall Study|Adverse Event|1|||
130288512|NCT01819129|469019878|FG001|Overall Study|Other, Subject moved out of the country|1|||
130288513|NCT01819129|469019877|FG000|Overall Study|Withdrawal by Subject|15|||
130288514|NCT01819129|469019878|FG001|Overall Study|Withdrawal by Subject|15|||
130288515|NCT01819129|469019877|FG000|Overall Study|Lost to Follow-up|5|||
130288516|NCT01819129|469019878|FG001|Overall Study|Lost to Follow-up|2|||
130288517|NCT01819129|469019877|FG000|Overall Study|Lack of Efficacy|0|||
130288518|NCT01819129|469019878|FG001|Overall Study|Lack of Efficacy|1|||
130288519|NCT01819129|469019877|FG000|Overall Study|Adverse Event|1|||
130288520|NCT01819129|469019878|FG001|Overall Study|Adverse Event|4|||
130288521|NCT01819129|469019877|FG000|Overall Study|Death|1|||
130288522|NCT01819129|469019878|FG001|Overall Study|Death|1|||
130288523|NCT01819129|469019877|FG000|Overall Study|Withdrawal Criteria|20|||
130288524|NCT01819129|469019878|FG001|Overall Study|Withdrawal Criteria|15|||
130288525|NCT02836873|469019888|FG000|Overall Study|Protocol Violation|0|||
130288526|NCT02836873|469019889|FG001|Overall Study|Protocol Violation|1|||
130288527|NCT02836873|469019888|FG000|Overall Study|Adverse Event|1|||
130288528|NCT02836873|469019889|FG001|Overall Study|Adverse Event|4|||
130288529|NCT02836873|469019888|FG000|Overall Study|Withdrawal by Subject|2|||
130288530|NCT02836873|469019889|FG001|Overall Study|Withdrawal by Subject|2|||
130288531|NCT02836873|469019888|FG000|Overall Study|Lost to Follow-up|1|||
130713593|NCT02749292|470578473|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
130713594|NCT02749292|470578474|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
130288532|NCT02836873|469019889|FG001|Overall Study|Lost to Follow-up|3|||
130370693|NCT03736447|469327234|FG000|Overall Study|Lost to Follow-up|1|||
130713595|NCT02749292|470578473|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
130713596|NCT02749292|470578474|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
130713597|NCT02749292|470578473|FG000|Overall Study|Requiring glucocorticoids|0|||
130713598|NCT02749292|470578474|FG001|Overall Study|Requiring glucocorticoids|3|||
130713599|NCT02749292|470578473|FG000|Overall Study|Cancer|1|||
130713600|NCT02749292|470578474|FG001|Overall Study|Cancer|0|||
130713601|NCT00251641|470578475|FG000|Overall Study|Adverse Event|80|||
130288533|NCT02836873|469019888|FG000|Overall Study|Physician Decision|0|||
130288534|NCT02836873|469019889|FG001|Overall Study|Physician Decision|1|||
130288535|NCT02836873|469019888|FG000|Overall Study|Other|1|||
130288536|NCT02836873|469019889|FG001|Overall Study|Other|0|||
130288537|NCT00694096|469019890|FG000|Overall Study|Withdrawal by Subject|5|||
130370694|NCT03736447|469327235|FG001|Overall Study|Lost to Follow-up|0|||
130713602|NCT00251641|470578476|FG001|Overall Study|Adverse Event|8|||
130713603|NCT00251641|470578475|FG000|Overall Study|Lack of Efficacy|2|||
130288538|NCT02914548|469019893|FG000|Overall Study|Adverse Event|15|||
130459655|NCT00922207|469647588|FG000|Overall Study|Withdrew Consent|2|||
130459656|NCT00922207|469647589|FG001|Overall Study|Withdrew Consent|5|||
130459657|NCT00922207|469647590|FG002|Overall Study|Withdrew Consent|2|||
130459658|NCT00922207|469647588|FG000|Overall Study|Abnormality of Laboratory Test|0|||
130288539|NCT02914548|469019894|FG001|Overall Study|Adverse Event|7|||
130459659|NCT00922207|469647589|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130288540|NCT02914548|469019895|FG002|Overall Study|Adverse Event|15|||
130288541|NCT02914548|469019893|FG000|Overall Study|Physician Decision|2|||
130288542|NCT02914548|469019894|FG001|Overall Study|Physician Decision|2|||
130288543|NCT02914548|469019895|FG002|Overall Study|Physician Decision|0|||
130288544|NCT02914548|469019893|FG000|Overall Study|Protocol Violation|1|||
130288545|NCT02914548|469019894|FG001|Overall Study|Protocol Violation|0|||
130288546|NCT02914548|469019895|FG002|Overall Study|Protocol Violation|0|||
130288547|NCT02914548|469019893|FG000|Overall Study|Withdrawal by Subject|3|||
130288548|NCT02914548|469019894|FG001|Overall Study|Withdrawal by Subject|4|||
130288549|NCT02914548|469019895|FG002|Overall Study|Withdrawal by Subject|4|||
130288550|NCT02914548|469019893|FG000|Overall Study|>40% of body surface area|0|||
130288551|NCT02914548|469019894|FG001|Overall Study|>40% of body surface area|1|||
130288552|NCT02914548|469019895|FG002|Overall Study|>40% of body surface area|1|||
130288553|NCT02214225|469019896|FG000|Overall Study|Lost to Follow-up|46|||
130288554|NCT02214225|469019897|FG001|Overall Study|Lost to Follow-up|18|||
130288555|NCT02214225|469019898|FG002|Overall Study|Lost to Follow-up|18|||
130288556|NCT02214225|469019896|FG000|Overall Study|Withdrawal by Subject|2|||
130288557|NCT02214225|469019897|FG001|Overall Study|Withdrawal by Subject|0|||
130288558|NCT02214225|469019898|FG002|Overall Study|Withdrawal by Subject|2|||
130288559|NCT02214225|469019896|FG000|Overall Study|Death|5|||
130288560|NCT02214225|469019897|FG001|Overall Study|Death|0|||
130288561|NCT02214225|469019898|FG002|Overall Study|Death|1|||
130288562|NCT02214225|469019896|FG000|Overall Study|randomized in error, not vaccinated|2|||
130288563|NCT02214225|469019897|FG001|Overall Study|randomized in error, not vaccinated|1|||
130288564|NCT02214225|469019898|FG002|Overall Study|randomized in error, not vaccinated|1|||
130288565|NCT03754582|469019899|FG000|Treatment Phase|Adverse Event|0|||
130288566|NCT03754582|469019900|FG001|Treatment Phase|Adverse Event|1|||
130288567|NCT03754582|469019901|FG002|Treatment Phase|Adverse Event|0|||
130288568|NCT03754582|469019899|FG000|Follow-up Phase|Other|0|||
130288569|NCT03754582|469019900|FG001|Follow-up Phase|Other|0|||
130288570|NCT03754582|469019901|FG002|Follow-up Phase|Other|1|||
130288571|NCT02680574|469019902|FG000|Overall Study|Death|137|||
130459660|NCT00922207|469647590|FG002|Overall Study|Abnormality of Laboratory Test|1|||
130459661|NCT00319436|469647594|FG000|Overall Study|Withdrawal by Subject|6|||
130459662|NCT00319436|469647595|FG001|Overall Study|Withdrawal by Subject|7|||
130459663|NCT02194933|469647606|FG000|Overall Study|Lost to Follow-up|1|||
130459664|NCT02194933|469647607|FG001|Overall Study|Lost to Follow-up|2|||
130459665|NCT02194933|469647606|FG000|Overall Study|Participant met withdrawal criteria|1|||
130459666|NCT02194933|469647607|FG001|Overall Study|Participant met withdrawal criteria|3|||
130459667|NCT02194933|469647606|FG000|Overall Study|Withdrawal by Subject|0|||
130459668|NCT02194933|469647607|FG001|Overall Study|Withdrawal by Subject|2|||
130459669|NCT02194933|469647606|FG000|Overall Study|Lack of Efficacy|1|||
130459670|NCT02194933|469647607|FG001|Overall Study|Lack of Efficacy|2|||
130459671|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
130459672|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
130459673|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
130459674|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
130459675|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
130459676|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
130459677|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
130459678|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
130459679|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
130459680|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
130459681|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
130713604|NCT00251641|470578476|FG001|Overall Study|Lack of Efficacy|1|||
130713605|NCT00251641|470578475|FG000|Overall Study|Progression of Disease|0|||
130288572|NCT02680574|469019903|FG001|Overall Study|Death|137|||
130288573|NCT02680574|469019902|FG000|Overall Study|Withdrawal by Subject|17|||
130288574|NCT02680574|469019903|FG001|Overall Study|Withdrawal by Subject|9|||
130288575|NCT02680574|469019902|FG000|Overall Study|Lost to Follow-up|4|||
130288576|NCT02680574|469019903|FG001|Overall Study|Lost to Follow-up|6|||
130288577|NCT02847858|469019904|FG000|Overall Study|Lost to Follow-up|401|||
130459682|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
130459683|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
130459684|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
130459685|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
130459686|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
130459687|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
130288578|NCT02847858|469019905|FG001|Overall Study|Lost to Follow-up|269|||
130288579|NCT00681564|469019906|FG000|Overall Study|Lost to Follow-up|6|||
130370695|NCT03736447|469327234|FG000|Overall Study|Physician Decision|1|||
130370696|NCT03736447|469327235|FG001|Overall Study|Physician Decision|0|||
130370697|NCT03736447|469327234|FG000|Overall Study|Continued commitment to study treatment|3|||
130370698|NCT03736447|469327235|FG001|Overall Study|Continued commitment to study treatment|0|||
130370699|NCT03736447|469327234|FG000|Overall Study|Taste aversion to study product|0|||
130370700|NCT03736447|469327235|FG001|Overall Study|Taste aversion to study product|1|||
130370701|NCT02619175|469327236|FG000|Overall Study|Withdrawal by Subject|1|||
130370702|NCT02619175|469327237|FG001|Overall Study|Withdrawal by Subject|0|||
130370703|NCT02619175|469327236|FG000|Overall Study|foot pain|1|||
130370704|NCT02619175|469327237|FG001|Overall Study|foot pain|0|||
130370705|NCT02657369|469327238|FG000|Overall Study|Death|27|||
130370706|NCT02657369|469327238|FG000|Overall Study|Study terminated by sponsor|7|||
130370707|NCT01594762|469327239|FG000|Overall Study|Withdrawal by Subject|1|||
130370708|NCT01594762|469327240|FG001|Overall Study|Withdrawal by Subject|0|||
130370709|NCT01594762|469327239|FG000|Overall Study|Lost to Follow-up|10|||
130370710|NCT01594762|469327240|FG001|Overall Study|Lost to Follow-up|10|||
130370711|NCT03547583|469327241|FG000|Overall Study|Adverse Event|16|||
130370712|NCT03547583|469327242|FG001|Overall Study|Adverse Event|11|||
130370713|NCT03547583|469327243|FG002|Overall Study|Adverse Event|10|||
130370714|NCT03547583|469327241|FG000|Overall Study|Death|11|||
130370715|NCT03547583|469327242|FG001|Overall Study|Death|7|||
130370716|NCT03547583|469327243|FG002|Overall Study|Death|4|||
130370717|NCT03547583|469327241|FG000|Overall Study|Lost to Follow-up|1|||
130370718|NCT03547583|469327242|FG001|Overall Study|Lost to Follow-up|0|||
130370719|NCT03547583|469327243|FG002|Overall Study|Lost to Follow-up|0|||
130370720|NCT03547583|469327241|FG000|Overall Study|Non-compliance with study drug|0|||
130370721|NCT03547583|469327242|FG001|Overall Study|Non-compliance with study drug|0|||
130370722|NCT03547583|469327243|FG002|Overall Study|Non-compliance with study drug|1|||
130370723|NCT03547583|469327241|FG000|Overall Study|Physician Decision|1|||
130370724|NCT03547583|469327242|FG001|Overall Study|Physician Decision|0|||
130288580|NCT00681564|469019907|FG001|Overall Study|Lost to Follow-up|6|||
130288581|NCT00681564|469019906|FG000|Overall Study|Withdrawal by Subject|0|||
130288582|NCT00681564|469019907|FG001|Overall Study|Withdrawal by Subject|1|||
130288583|NCT00681564|469019906|FG000|Overall Study|Death|0|||
130288584|NCT00681564|469019907|FG001|Overall Study|Death|1|||
130288585|NCT01009346|469019912|FG000|Overall Study|Adverse Event|4|||
130288586|NCT01253265|469019914|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
130288587|NCT01253265|469019915|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288588|NCT01253265|469019916|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288589|NCT01253265|469019917|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288590|NCT01253265|469019918|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288591|NCT01253265|469019914|FG000|Overall Study|Withdrawal by Subject|0|||
130288592|NCT01253265|469019915|FG001|Overall Study|Withdrawal by Subject|0|||
130288593|NCT01253265|469019916|FG002|Overall Study|Withdrawal by Subject|0|||
130288594|NCT01253265|469019917|FG003|Overall Study|Withdrawal by Subject|0|||
130288595|NCT01253265|469019918|FG004|Overall Study|Withdrawal by Subject|1|||
130288596|NCT00541099|469019919|FG000|Overall Study|Ineligible|3|||
130288597|NCT00066469|469019921|FG000|Overall Study|Death|3|||
130288598|NCT00066469|469019921|FG000|Overall Study|Lack of Efficacy|9|||
130288599|NCT00066469|469019921|FG000|Overall Study|Lost to Follow-up|1|||
130288600|NCT00066469|469019921|FG000|Overall Study|Physician Decision|1|||
130288601|NCT00066469|469019921|FG000|Overall Study|Withdrawal by Subject|1|||
130288602|NCT00066469|469019921|FG000|Overall Study|ineligible|1|||
130288603|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Death|8|||
130288604|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Death|8|||
130288605|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Death|0|||
130288606|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Death|0|||
130288607|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
130288608|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288609|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288610|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288611|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288612|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
130288613|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288614|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288615|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130288616|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130288617|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130370725|NCT03547583|469327243|FG002|Overall Study|Physician Decision|3|||
130370726|NCT03547583|469327241|FG000|Overall Study|Protocol Violation|2|||
130370727|NCT03547583|469327242|FG001|Overall Study|Protocol Violation|1|||
130370728|NCT03547583|469327243|FG002|Overall Study|Protocol Violation|1|||
130370729|NCT03547583|469327241|FG000|Overall Study|Withdrawal by Subject|12|||
130370730|NCT03547583|469327242|FG001|Overall Study|Withdrawal by Subject|19|||
130370731|NCT03547583|469327243|FG002|Overall Study|Withdrawal by Subject|10|||
130370732|NCT03547583|469327241|FG000|Overall Study|Other|2|||
130370733|NCT03547583|469327242|FG001|Overall Study|Other|2|||
130370734|NCT03547583|469327243|FG002|Overall Study|Other|3|||
130370735|NCT00382252|469327244|FG000|Overall Study|Death|4|||
130370736|NCT00382252|469327244|FG000|Overall Study|Protocol Violation|8|||
130370737|NCT00382252|469327244|FG000|Overall Study|Not treated by RFA|1|||
130370738|NCT05570500|469327250|FG000|Overall Study|Lost to Follow-up|7|||
130370739|NCT05570500|469327251|FG001|Overall Study|Lost to Follow-up|5|||
130370740|NCT04706091|469327252|FG000|Treatment 2|Withdrawal by Subject|1|||
130370741|NCT04706091|469327253|FG001|Treatment 2|Withdrawal by Subject|0|||
130370742|NCT02612727|469327254|FG000|Overall Study|Parent request|4|||
130370743|NCT02612727|469327255|FG001|Overall Study|Parent request|1|||
130370744|NCT02612727|469327254|FG000|Overall Study|Needed treatment incompatible with PT|1|||
130370745|NCT02612727|469327255|FG001|Overall Study|Needed treatment incompatible with PT|1|||
130370746|NCT02612727|469327254|FG000|Overall Study|Direct hyperbilirubinemia|0|||
130370747|NCT02612727|469327255|FG001|Overall Study|Direct hyperbilirubinemia|2|||
130370748|NCT01446289|469327256|FG000|Overall Study|Withdrawal by Subject|1|||
130370749|NCT01446289|469327257|FG001|Overall Study|Withdrawal by Subject|0|||
130713606|NCT00251641|470578476|FG001|Overall Study|Progression of Disease|2|||
130713607|NCT00251641|470578475|FG000|Overall Study|Lost to Follow-up|3|||
130713608|NCT00251641|470578476|FG001|Overall Study|Lost to Follow-up|3|||
130713609|NCT00251641|470578475|FG000|Overall Study|Withdrawal by Subject|6|||
130370750|NCT01446289|469327258|FG002|Overall Study|Withdrawal by Subject|1|||
130370751|NCT01446289|469327259|FG003|Overall Study|Withdrawal by Subject|0|||
130370752|NCT02302807|469327260|FG000|Overall Study|Withdrawal by Subject|28|||
130713610|NCT00251641|470578476|FG001|Overall Study|Withdrawal by Subject|8|||
130288618|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130288619|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Other|0|||
130288620|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Other|0|||
130288621|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Other|0|||
130288622|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Other|1|||
130288623|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Death|0|||
130288624|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Death|0|||
130288625|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Death|20|||
130288626|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Death|21|||
130288627|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
130288628|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
130288629|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
130288630|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
130288631|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130288632|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130370753|NCT02302807|469327261|FG001|Overall Study|Withdrawal by Subject|11|||
130370754|NCT02302807|469327260|FG000|Overall Study|Lost to Follow-up|4|||
130370755|NCT02302807|469327261|FG001|Overall Study|Lost to Follow-up|6|||
130370756|NCT02302807|469327260|FG000|Overall Study|Death|397|||
130370757|NCT02302807|469327261|FG001|Overall Study|Death|385|||
130370758|NCT02302807|469327260|FG000|Overall Study|Study Terminated By Sponsor|35|||
130370759|NCT02302807|469327261|FG001|Overall Study|Study Terminated By Sponsor|64|||
130370760|NCT02302807|469327260|FG000|Overall Study|Physician Decision|0|||
130370761|NCT02302807|469327261|FG001|Overall Study|Physician Decision|1|||
130370762|NCT03278873|469327262|FG000|Overall Study|Withdrawal by Subject|0|||
130370763|NCT03278873|469327263|FG001|Overall Study|Withdrawal by Subject|1|||
130370764|NCT03278873|469327264|FG002|Overall Study|Withdrawal by Subject|0|||
130370765|NCT03278873|469327265|FG003|Overall Study|Withdrawal by Subject|0|||
130370766|NCT03278873|469327262|FG000|Overall Study|Sponsor's decision|0|||
130370767|NCT03278873|469327263|FG001|Overall Study|Sponsor's decision|1|||
130370768|NCT03278873|469327264|FG002|Overall Study|Sponsor's decision|0|||
130370769|NCT03278873|469327265|FG003|Overall Study|Sponsor's decision|0|||
130370770|NCT03278873|469327262|FG000|Overall Study|Early Termination|2|||
130370771|NCT03278873|469327263|FG001|Overall Study|Early Termination|6|||
130370772|NCT03278873|469327264|FG002|Overall Study|Early Termination|0|||
130370773|NCT03278873|469327265|FG003|Overall Study|Early Termination|4|||
130370774|NCT03278873|469327262|FG000|Overall Study|Lost to Follow-up|0|||
130370775|NCT03278873|469327263|FG001|Overall Study|Lost to Follow-up|0|||
130370776|NCT03278873|469327264|FG002|Overall Study|Lost to Follow-up|2|||
130370777|NCT03278873|469327265|FG003|Overall Study|Lost to Follow-up|0|||
130370778|NCT03278873|469327262|FG000|Overall Study|The patient decided to withdraw via email|1|||
130370779|NCT03278873|469327263|FG001|Overall Study|The patient decided to withdraw via email|0|||
130370780|NCT03278873|469327264|FG002|Overall Study|The patient decided to withdraw via email|0|||
130370781|NCT03278873|469327265|FG003|Overall Study|The patient decided to withdraw via email|0|||
130370782|NCT03278873|469327262|FG000|Overall Study|The patient was unresponsive to contact|0|||
130370783|NCT03278873|469327263|FG001|Overall Study|The patient was unresponsive to contact|0|||
130370784|NCT03278873|469327264|FG002|Overall Study|The patient was unresponsive to contact|0|||
130713611|NCT00251641|470578475|FG000|Overall Study|Protocol Violation|10|||
130370785|NCT03278873|469327265|FG003|Overall Study|The patient was unresponsive to contact|4|||
130370786|NCT03278873|469327262|FG000|Overall Study|The patient wished to participate no longer|0|||
130370787|NCT03278873|469327263|FG001|Overall Study|The patient wished to participate no longer|1|||
130713612|NCT00251641|470578476|FG001|Overall Study|Protocol Violation|2|||
130713613|NCT00251641|470578475|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
130713614|NCT00251641|470578476|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
130288633|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
130288634|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130288635|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288636|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288637|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288638|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
130713615|NCT00251641|470578475|FG000|Overall Study|Switched Treatment|9|||
130713616|NCT00251641|470578476|FG001|Overall Study|Switched Treatment|63|||
130713617|NCT02093221|470578477|FG000|Overall Study|Adverse Event|1|||
130713618|NCT02093221|470578478|FG001|Overall Study|Adverse Event|0|||
130713619|NCT02093221|470578479|FG002|Overall Study|Adverse Event|0|||
130713620|NCT02093221|470578480|FG003|Overall Study|Adverse Event|0|||
130713621|NCT02093221|470578481|FG004|Overall Study|Adverse Event|0|||
130713622|NCT02093221|470578477|FG000|Overall Study|Withdrawal by Subject|1|||
130713623|NCT02093221|470578478|FG001|Overall Study|Withdrawal by Subject|1|||
130713624|NCT02093221|470578479|FG002|Overall Study|Withdrawal by Subject|4|||
130713625|NCT02093221|470578480|FG003|Overall Study|Withdrawal by Subject|1|||
130713626|NCT02093221|470578481|FG004|Overall Study|Withdrawal by Subject|1|||
130713627|NCT02093221|470578477|FG000|Overall Study|Lost to Follow-up|2|||
130713628|NCT02093221|470578478|FG001|Overall Study|Lost to Follow-up|0|||
130713629|NCT02093221|470578479|FG002|Overall Study|Lost to Follow-up|1|||
130713630|NCT02093221|470578480|FG003|Overall Study|Lost to Follow-up|1|||
130713631|NCT02093221|470578481|FG004|Overall Study|Lost to Follow-up|0|||
130713632|NCT02093221|470578477|FG000|Overall Study|Death|0|||
130713633|NCT02093221|470578478|FG001|Overall Study|Death|1|||
130713634|NCT02093221|470578479|FG002|Overall Study|Death|0|||
130713635|NCT02093221|470578480|FG003|Overall Study|Death|0|||
130713636|NCT02093221|470578481|FG004|Overall Study|Death|0|||
130713637|NCT02093221|470578477|FG000|Overall Study|Protocol Violation|0|||
130713638|NCT02093221|470578478|FG001|Overall Study|Protocol Violation|1|||
130713639|NCT02093221|470578479|FG002|Overall Study|Protocol Violation|0|||
130713640|NCT02093221|470578480|FG003|Overall Study|Protocol Violation|0|||
130713641|NCT02093221|470578481|FG004|Overall Study|Protocol Violation|0|||
130713642|NCT02093221|470578477|FG000|Overall Study|Study termination|6|||
130713643|NCT02093221|470578478|FG001|Overall Study|Study termination|5|||
130713644|NCT02093221|470578479|FG002|Overall Study|Study termination|4|||
130713645|NCT02093221|470578480|FG003|Overall Study|Study termination|6|||
130713646|NCT02093221|470578481|FG004|Overall Study|Study termination|7|||
130713647|NCT00062751|470578482|FG000|Overall Study|Disease progression|24|||
130713648|NCT00062751|470578483|FG001|Overall Study|Disease progression|17|||
130713649|NCT00062751|470578484|FG002|Overall Study|Disease progression|24|||
130713650|NCT00062751|470578485|FG003|Overall Study|Disease progression|2|||
130713651|NCT00062751|470578486|FG004|Overall Study|Disease progression|2|||
130713652|NCT00062751|470578482|FG000|Overall Study|Adverse Event|4|||
130713653|NCT00062751|470578483|FG001|Overall Study|Adverse Event|7|||
130713654|NCT00062751|470578484|FG002|Overall Study|Adverse Event|2|||
130713655|NCT00062751|470578485|FG003|Overall Study|Adverse Event|2|||
130713656|NCT00062751|470578486|FG004|Overall Study|Adverse Event|2|||
130713657|NCT00062751|470578482|FG000|Overall Study|Other|2|||
130713658|NCT00062751|470578483|FG001|Overall Study|Other|3|||
130713659|NCT00062751|470578484|FG002|Overall Study|Other|1|||
130713660|NCT00062751|470578485|FG003|Overall Study|Other|0|||
130713661|NCT00062751|470578486|FG004|Overall Study|Other|1|||
130713662|NCT00062751|470578482|FG000|Overall Study|Withdrawal by Subject|1|||
130713663|NCT00062751|470578483|FG001|Overall Study|Withdrawal by Subject|2|||
130713664|NCT00062751|470578484|FG002|Overall Study|Withdrawal by Subject|2|||
130713665|NCT00062751|470578485|FG003|Overall Study|Withdrawal by Subject|1|||
130288639|NCT00711802|469019926|FG000|Overall Study|Not treated (no further detail)|2|||
130288640|NCT00711802|469019927|FG001|Overall Study|Not treated (no further detail)|1|||
130288641|NCT00711802|469019928|FG002|Overall Study|Not treated (no further detail)|2|||
130713666|NCT00062751|470578486|FG004|Overall Study|Withdrawal by Subject|0|||
130713667|NCT00062751|470578482|FG000|Overall Study|Symptomatic deterioration|1|||
130713668|NCT00062751|470578483|FG001|Overall Study|Symptomatic deterioration|1|||
130713669|NCT00062751|470578484|FG002|Overall Study|Symptomatic deterioration|0|||
130713670|NCT00062751|470578485|FG003|Overall Study|Symptomatic deterioration|0|||
130713671|NCT00062751|470578486|FG004|Overall Study|Symptomatic deterioration|1|||
130713672|NCT00062751|470578482|FG000|Overall Study|Death|1|||
130713673|NCT00062751|470578483|FG001|Overall Study|Death|0|||
130713674|NCT00062751|470578484|FG002|Overall Study|Death|1|||
130713675|NCT00062751|470578485|FG003|Overall Study|Death|0|||
130713676|NCT00062751|470578486|FG004|Overall Study|Death|0|||
130288642|NCT00711802|469019929|FG003|Overall Study|Not treated (no further detail)|0|||
130713677|NCT00851643|470578487|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
130713678|NCT00851643|470578488|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713679|NCT00851643|470578489|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130288643|NCT00711802|469019930|FG004|Overall Study|Not treated (no further detail)|2|||
130288644|NCT00711802|469019931|FG005|Overall Study|Not treated (no further detail)|0|||
130288645|NCT00711802|469019932|FG006|Overall Study|Not treated (no further detail)|0|||
130288646|NCT00711802|469019933|FG007|Overall Study|Not treated (no further detail)|0|||
130713680|NCT00851643|470578490|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713681|NCT00851643|470578491|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713682|NCT00851643|470578492|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713683|NCT00851643|470578487|FG000|Base Study (Up to 12 Months)|Other|0|||
130713684|NCT00851643|470578488|FG001|Base Study (Up to 12 Months)|Other|0|||
130713685|NCT00851643|470578489|FG002|Base Study (Up to 12 Months)|Other|0|||
130713686|NCT00851643|470578490|FG003|Base Study (Up to 12 Months)|Other|0|||
130713687|NCT00851643|470578491|FG004|Base Study (Up to 12 Months)|Other|0|||
130713688|NCT00851643|470578492|FG005|Base Study (Up to 12 Months)|Other|1|||
130713689|NCT00851643|470578487|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130713690|NCT00851643|470578488|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130713691|NCT00851643|470578489|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130713692|NCT00851643|470578490|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
130713693|NCT00851643|470578491|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130713694|NCT00851643|470578492|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
130713695|NCT00851643|470578487|FG000|Extension Study (Up to 36 Months)|Moved|0|||
130713696|NCT00851643|470578488|FG001|Extension Study (Up to 36 Months)|Moved|2|||
130713697|NCT00851643|470578489|FG002|Extension Study (Up to 36 Months)|Moved|1|||
130713698|NCT00851643|470578490|FG003|Extension Study (Up to 36 Months)|Moved|1|||
130713699|NCT00851643|470578491|FG004|Extension Study (Up to 36 Months)|Moved|0|||
130713700|NCT00851643|470578492|FG005|Extension Study (Up to 36 Months)|Moved|1|||
130713701|NCT02143583|470578495|FG000|Overall Study|Withdrawal by Subject|1|||
130713702|NCT02143583|470578496|FG001|Overall Study|Withdrawal by Subject|0|||
130713703|NCT02143583|470578497|FG002|Overall Study|Withdrawal by Subject|1|||
130713704|NCT02143583|470578495|FG000|Overall Study|husband illness|0|||
130713705|NCT02143583|470578496|FG001|Overall Study|husband illness|0|||
130713706|NCT02143583|470578497|FG002|Overall Study|husband illness|1|||
130713707|NCT01244061|470578498|FG000|Overall Study|Death|1|||
130713708|NCT01244061|470578499|FG001|Overall Study|Death|0|||
130713709|NCT01244061|470578498|FG000|Overall Study|Did not meet entrance criteria|1|||
130713710|NCT01244061|470578499|FG001|Overall Study|Did not meet entrance criteria|0|||
130713711|NCT01244061|470578498|FG000|Overall Study|Lack of Efficacy|1|||
130713712|NCT01244061|470578499|FG001|Overall Study|Lack of Efficacy|3|||
130713713|NCT01244061|470578498|FG000|Overall Study|Lost to Follow-up|34|||
130713714|NCT01244061|470578499|FG001|Overall Study|Lost to Follow-up|30|||
130713715|NCT01244061|470578498|FG000|Overall Study|Withdrawal by Subject|29|||
130713716|NCT01244061|470578499|FG001|Overall Study|Withdrawal by Subject|46|||
130713717|NCT01244061|470578498|FG000|Overall Study|Other|8|||
130713718|NCT01244061|470578499|FG001|Overall Study|Other|19|||
130713719|NCT01244061|470578498|FG000|Overall Study|Protocol Violation|1|||
130713720|NCT01244061|470578499|FG001|Overall Study|Protocol Violation|1|||
130713721|NCT01244061|470578498|FG000|Overall Study|Adverse Event|5|||
130713722|NCT01244061|470578499|FG001|Overall Study|Adverse Event|2|||
130713723|NCT01244061|470578498|FG000|Overall Study|Randomized but not treated|2|||
130713724|NCT01244061|470578499|FG001|Overall Study|Randomized but not treated|2|||
130713725|NCT01641133|470578500|FG000|Overall Study|Protocol Violation|0|||
130713726|NCT01641133|470578501|FG001|Overall Study|Protocol Violation|1|||
130713727|NCT01641133|470578502|FG002|Overall Study|Protocol Violation|1|||
130713728|NCT01641133|470578500|FG000|Overall Study|Migrated/moved from study area|5|||
130713729|NCT01641133|470578501|FG001|Overall Study|Migrated/moved from study area|3|||
130713730|NCT01641133|470578502|FG002|Overall Study|Migrated/moved from study area|1|||
130713731|NCT01641133|470578500|FG000|Overall Study|Adverse Event|0|||
130713732|NCT01641133|470578501|FG001|Overall Study|Adverse Event|0|||
130713733|NCT01641133|470578502|FG002|Overall Study|Adverse Event|1|||
130713734|NCT01641133|470578500|FG000|Overall Study|Withdrawal by Subject|5|||
130713735|NCT01641133|470578501|FG001|Overall Study|Withdrawal by Subject|3|||
130713736|NCT01641133|470578502|FG002|Overall Study|Withdrawal by Subject|3|||
130288647|NCT00711802|469019926|FG000|Overall Study|Adverse Event|0|||
130713737|NCT01641133|470578500|FG000|Overall Study|Lost to Follow-up|0|||
130713738|NCT01641133|470578501|FG001|Overall Study|Lost to Follow-up|2|||
130713739|NCT01641133|470578502|FG002|Overall Study|Lost to Follow-up|2|||
130713740|NCT01929031|470578503|FG000|Overall Study|Adverse Event|3|||
130713741|NCT01929031|470578504|FG001|Overall Study|Adverse Event|1|||
130713742|NCT01929031|470578505|FG002|Overall Study|Adverse Event|1|||
130713743|NCT01929031|470578506|FG003|Overall Study|Adverse Event|0|||
130713744|NCT01929031|470578507|FG004|Overall Study|Adverse Event|0|||
130713745|NCT01929031|470578508|FG005|Overall Study|Adverse Event|0|||
130713746|NCT01929031|470578503|FG000|Overall Study|Protocol Violation|1|||
130713747|NCT01929031|470578504|FG001|Overall Study|Protocol Violation|0|||
130713748|NCT01929031|470578505|FG002|Overall Study|Protocol Violation|0|||
130713749|NCT01929031|470578506|FG003|Overall Study|Protocol Violation|0|||
130713750|NCT01929031|470578507|FG004|Overall Study|Protocol Violation|0|||
130288648|NCT00711802|469019927|FG001|Overall Study|Adverse Event|0|||
130288649|NCT00711802|469019928|FG002|Overall Study|Adverse Event|0|||
130288650|NCT00711802|469019929|FG003|Overall Study|Adverse Event|0|||
130288651|NCT00711802|469019930|FG004|Overall Study|Adverse Event|1|||
130288652|NCT00711802|469019931|FG005|Overall Study|Adverse Event|1|||
130288653|NCT00711802|469019932|FG006|Overall Study|Adverse Event|0|||
130288654|NCT00711802|469019933|FG007|Overall Study|Adverse Event|0|||
130288655|NCT00711802|469019926|FG000|Overall Study|Microbiological failure|0|||
130288656|NCT00711802|469019927|FG001|Overall Study|Microbiological failure|1|||
130288657|NCT00711802|469019928|FG002|Overall Study|Microbiological failure|0|||
130288658|NCT00711802|469019929|FG003|Overall Study|Microbiological failure|0|||
130288659|NCT00711802|469019930|FG004|Overall Study|Microbiological failure|0|||
130288660|NCT00711802|469019931|FG005|Overall Study|Microbiological failure|1|||
130288661|NCT00711802|469019932|FG006|Overall Study|Microbiological failure|0|||
130288662|NCT00711802|469019933|FG007|Overall Study|Microbiological failure|0|||
130288663|NCT00711802|469019926|FG000|Overall Study|Protocol Violation|0|||
130288664|NCT00711802|469019927|FG001|Overall Study|Protocol Violation|0|||
130288665|NCT00711802|469019928|FG002|Overall Study|Protocol Violation|0|||
130288666|NCT00711802|469019929|FG003|Overall Study|Protocol Violation|1|||
130288667|NCT00711802|469019930|FG004|Overall Study|Protocol Violation|0|||
130288668|NCT00711802|469019931|FG005|Overall Study|Protocol Violation|0|||
130713751|NCT01929031|470578508|FG005|Overall Study|Protocol Violation|1|||
130713752|NCT01929031|470578503|FG000|Overall Study|Reason other than specified above|0|||
130713753|NCT01929031|470578504|FG001|Overall Study|Reason other than specified above|1|||
130713754|NCT01929031|470578505|FG002|Overall Study|Reason other than specified above|0|||
130713755|NCT01929031|470578506|FG003|Overall Study|Reason other than specified above|0|||
130713756|NCT01929031|470578507|FG004|Overall Study|Reason other than specified above|1|||
130713757|NCT01929031|470578508|FG005|Overall Study|Reason other than specified above|0|||
130713758|NCT05816200|470578511|FG000|Overall Study|Lost to Follow-up|2|||
130713759|NCT05816200|470578512|FG001|Overall Study|Lost to Follow-up|1|||
130713760|NCT00369382|470578513|FG000|Overall Study|Death|0|||
130713761|NCT00369382|470578514|FG001|Overall Study|Death|2|||
130713762|NCT00369382|470578513|FG000|Overall Study|Physician Decision|2|||
130713763|NCT00369382|470578514|FG001|Overall Study|Physician Decision|1|||
130713764|NCT00369382|470578513|FG000|Overall Study|Withdrawal by Subject|5|||
130713765|NCT00369382|470578514|FG001|Overall Study|Withdrawal by Subject|0|||
130713766|NCT00369382|470578513|FG000|Overall Study|Randomized, not treated|2|||
130713767|NCT00369382|470578514|FG001|Overall Study|Randomized, not treated|0|||
130713768|NCT00369382|470578513|FG000|Overall Study|Other|1|||
130713769|NCT00369382|470578514|FG001|Overall Study|Other|0|||
130713770|NCT00609466|470578518|FG000|Overall Study|Withdrawal by Subject|0|||
130713771|NCT00609466|470578519|FG001|Overall Study|Withdrawal by Subject|1|||
130713772|NCT00609466|470578520|FG002|Overall Study|Withdrawal by Subject|1|||
130713773|NCT00609466|470578518|FG000|Overall Study|Adverse Event|2|||
130713774|NCT00609466|470578519|FG001|Overall Study|Adverse Event|3|||
130713775|NCT00609466|470578520|FG002|Overall Study|Adverse Event|1|||
130713776|NCT00609466|470578518|FG000|Overall Study|Lack of Efficacy|0|||
130713777|NCT00609466|470578519|FG001|Overall Study|Lack of Efficacy|2|||
130713778|NCT00609466|470578520|FG002|Overall Study|Lack of Efficacy|2|||
130713779|NCT03512262|470578521|FG000|Overall Study|Adverse Event|8|||
130713780|NCT03512262|470578522|FG001|Overall Study|Adverse Event|3|||
130713781|NCT03512262|470578521|FG000|Overall Study|Death (non-treatment emergent)|1|||
130713782|NCT03512262|470578522|FG001|Overall Study|Death (non-treatment emergent)|0|||
130713783|NCT03512262|470578521|FG000|Overall Study|Withdrawal by Subject|17|||
130713784|NCT03512262|470578522|FG001|Overall Study|Withdrawal by Subject|9|||
130288669|NCT00711802|469019932|FG006|Overall Study|Protocol Violation|0|||
130288670|NCT00711802|469019933|FG007|Overall Study|Protocol Violation|0|||
130288671|NCT00711802|469019926|FG000|Overall Study|Physician Decision|0|||
130288672|NCT00711802|469019927|FG001|Overall Study|Physician Decision|2|||
130288673|NCT00711802|469019928|FG002|Overall Study|Physician Decision|0|||
130288674|NCT00711802|469019929|FG003|Overall Study|Physician Decision|0|||
130288675|NCT00711802|469019930|FG004|Overall Study|Physician Decision|0|||
130288676|NCT00711802|469019931|FG005|Overall Study|Physician Decision|0|||
130713785|NCT03512262|470578521|FG000|Overall Study|Lost to Follow-up|7|||
130713786|NCT03512262|470578522|FG001|Overall Study|Lost to Follow-up|1|||
130713787|NCT03512262|470578521|FG000|Overall Study|Other than Specified|2|||
130713788|NCT03512262|470578522|FG001|Overall Study|Other than Specified|2|||
130288677|NCT00711802|469019932|FG006|Overall Study|Physician Decision|0|||
130288678|NCT00711802|469019933|FG007|Overall Study|Physician Decision|0|||
130288679|NCT00711802|469019926|FG000|Overall Study|Withdrawal by Subject|0|||
130288680|NCT00711802|469019927|FG001|Overall Study|Withdrawal by Subject|1|||
130288681|NCT00711802|469019928|FG002|Overall Study|Withdrawal by Subject|0|||
130713789|NCT03407430|470578523|FG000|Washout|Protocol Violation|1|||
130713790|NCT03407430|470578524|FG001|Washout|Protocol Violation|0|||
130288682|NCT00711802|469019929|FG003|Overall Study|Withdrawal by Subject|1|||
130288683|NCT00711802|469019930|FG004|Overall Study|Withdrawal by Subject|0|||
130370788|NCT03278873|469327264|FG002|Overall Study|The patient wished to participate no longer|0|||
130370789|NCT03278873|469327265|FG003|Overall Study|The patient wished to participate no longer|0|||
130288684|NCT00711802|469019931|FG005|Overall Study|Withdrawal by Subject|0|||
130288685|NCT00711802|469019932|FG006|Overall Study|Withdrawal by Subject|0|||
130288686|NCT00711802|469019933|FG007|Overall Study|Withdrawal by Subject|0|||
130288687|NCT00711802|469019926|FG000|Overall Study|Lost to Follow-up|0|||
130713791|NCT01195272|470578525|FG000|Overall Study|Adverse Event|1|||
130713792|NCT01195272|470578525|FG000|Overall Study|Lack of Efficacy|3|||
130713793|NCT03295318|470580000|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
130713794|NCT03295318|470580001|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130713795|NCT03295318|470580002|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130713796|NCT03295318|470580000|FG000|Overall Study|Death|1|||
130713797|NCT03295318|470580001|FG001|Overall Study|Death|1|||
130713798|NCT03295318|470580002|FG002|Overall Study|Death|1|||
130713799|NCT03295318|470580000|FG000|Overall Study|Protocol Violation|4|||
130713800|NCT03295318|470580001|FG001|Overall Study|Protocol Violation|3|||
130713801|NCT03295318|470580002|FG002|Overall Study|Protocol Violation|3|||
130713802|NCT03295318|470580000|FG000|Overall Study|Withdrawal by Subject|0|||
130713803|NCT03295318|470580001|FG001|Overall Study|Withdrawal by Subject|0|||
130713804|NCT03295318|470580002|FG002|Overall Study|Withdrawal by Subject|1|||
130713805|NCT03295318|470580000|FG000|Overall Study|Subject discontinued due to travel|0|||
130713806|NCT03295318|470580001|FG001|Overall Study|Subject discontinued due to travel|1|||
130713807|NCT03295318|470580002|FG002|Overall Study|Subject discontinued due to travel|0|||
130713808|NCT04319718|470580003|FG000|Overall Study|Adverse Event|0|||
130713809|NCT04319718|470580004|FG001|Overall Study|Adverse Event|2|||
130713810|NCT04319718|470580003|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
130713811|NCT04319718|470580004|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
130713812|NCT01288053|470580005|FG000|Overall Study|Death|1|||
130713813|NCT00144781|470580006|FG000|Overall Study|Adverse Event|0|||
130713814|NCT00144781|470580007|FG001|Overall Study|Adverse Event|1|||
130713815|NCT00144781|470580008|FG002|Overall Study|Adverse Event|0|||
130713816|NCT00144781|470580009|FG003|Overall Study|Adverse Event|0|||
130713817|NCT00144781|470580006|FG000|Overall Study|Non-compliant|0|||
130713818|NCT00144781|470580007|FG001|Overall Study|Non-compliant|1|||
130713819|NCT00144781|470580008|FG002|Overall Study|Non-compliant|0|||
130713820|NCT00144781|470580009|FG003|Overall Study|Non-compliant|0|||
130713821|NCT02068092|470580010|FG000|Overall Study|Physician Decision|2|||
130713822|NCT02068092|470580010|FG000|Overall Study|Adverse Event|2|||
130713823|NCT02068092|470580010|FG000|Overall Study|Lost to Follow-up|4|||
130713824|NCT02068092|470580010|FG000|Overall Study|Withdrawal by Subject|2|||
130713825|NCT01045421|470580011|FG000|Phase 1|Progressive Disease|0|||
130713826|NCT01045421|470580012|FG001|Phase 1|Progressive Disease|0|||
130713827|NCT01045421|470580013|FG002|Phase 1|Progressive Disease|0|||
130713828|NCT01045421|470580014|FG003|Phase 1|Progressive Disease|0|||
130713829|NCT01045421|470580015|FG004|Phase 1|Progressive Disease|1|||
130713830|NCT01045421|470580016|FG005|Phase 1|Progressive Disease|0|||
130713831|NCT01045421|470580017|FG006|Phase 1|Progressive Disease|0|||
130713832|NCT01045421|470580018|FG007|Phase 1|Progressive Disease|0|||
130713833|NCT01045421|470580019|FG008|Phase 1|Progressive Disease|0|||
130713834|NCT01045421|470580020|FG009|Phase 1|Progressive Disease|0|||
130713835|NCT01045421|470580021|FG010|Phase 1|Progressive Disease|0|||
130713836|NCT01045421|470580011|FG000|Phase 1|Withdrawal by Subject|0|||
130713837|NCT01045421|470580012|FG001|Phase 1|Withdrawal by Subject|0|||
130713838|NCT01045421|470580013|FG002|Phase 1|Withdrawal by Subject|0|||
130713839|NCT01045421|470580014|FG003|Phase 1|Withdrawal by Subject|1|||
130713840|NCT01045421|470580015|FG004|Phase 1|Withdrawal by Subject|0|||
130713841|NCT01045421|470580016|FG005|Phase 1|Withdrawal by Subject|0|||
130713842|NCT01045421|470580017|FG006|Phase 1|Withdrawal by Subject|0|||
130713843|NCT01045421|470580018|FG007|Phase 1|Withdrawal by Subject|0|||
130713844|NCT01045421|470580019|FG008|Phase 1|Withdrawal by Subject|0|||
130713845|NCT01045421|470580020|FG009|Phase 1|Withdrawal by Subject|0|||
130713846|NCT01045421|470580021|FG010|Phase 1|Withdrawal by Subject|0|||
130713847|NCT01045421|470580011|FG000|Phase 2|Progressive Disease|0|||
130288688|NCT00711802|469019927|FG001|Overall Study|Lost to Follow-up|0|||
130713848|NCT01045421|470580012|FG001|Phase 2|Progressive Disease|0|||
130713849|NCT01045421|470580013|FG002|Phase 2|Progressive Disease|0|||
130713850|NCT01045421|470580014|FG003|Phase 2|Progressive Disease|0|||
130713851|NCT01045421|470580015|FG004|Phase 2|Progressive Disease|0|||
130713852|NCT01045421|470580016|FG005|Phase 2|Progressive Disease|0|||
130713853|NCT01045421|470580017|FG006|Phase 2|Progressive Disease|0|||
130713854|NCT01045421|470580018|FG007|Phase 2|Progressive Disease|1|||
130713855|NCT01045421|470580019|FG008|Phase 2|Progressive Disease|1|||
130713856|NCT01045421|470580020|FG009|Phase 2|Progressive Disease|1|||
130713857|NCT01045421|470580021|FG010|Phase 2|Progressive Disease|1|||
130288689|NCT00711802|469019928|FG002|Overall Study|Lost to Follow-up|3|||
130288690|NCT00711802|469019929|FG003|Overall Study|Lost to Follow-up|1|||
130713858|NCT01045421|470580011|FG000|Phase 2|Death|0|||
130288691|NCT00711802|469019930|FG004|Overall Study|Lost to Follow-up|10|||
130713859|NCT01045421|470580012|FG001|Phase 2|Death|0|||
130713860|NCT01045421|470580013|FG002|Phase 2|Death|0|||
130713861|NCT01045421|470580014|FG003|Phase 2|Death|0|||
130713862|NCT01045421|470580015|FG004|Phase 2|Death|0|||
130713863|NCT01045421|470580016|FG005|Phase 2|Death|0|||
130713864|NCT01045421|470580017|FG006|Phase 2|Death|0|||
130713865|NCT01045421|470580018|FG007|Phase 2|Death|1|||
130713866|NCT01045421|470580019|FG008|Phase 2|Death|1|||
130713867|NCT01045421|470580020|FG009|Phase 2|Death|2|||
130713868|NCT01045421|470580021|FG010|Phase 2|Death|0|||
130713869|NCT01045421|470580011|FG000|Phase 2|Other|0|||
130713870|NCT01045421|470580012|FG001|Phase 2|Other|0|||
130713871|NCT01045421|470580013|FG002|Phase 2|Other|0|||
130713872|NCT01045421|470580014|FG003|Phase 2|Other|0|||
130713873|NCT01045421|470580015|FG004|Phase 2|Other|0|||
130713874|NCT01045421|470580016|FG005|Phase 2|Other|0|||
130713875|NCT01045421|470580017|FG006|Phase 2|Other|0|||
130713876|NCT01045421|470580018|FG007|Phase 2|Other|3|||
130713877|NCT01045421|470580019|FG008|Phase 2|Other|0|||
130713878|NCT01045421|470580020|FG009|Phase 2|Other|0|||
130713879|NCT01045421|470580021|FG010|Phase 2|Other|1|||
130713880|NCT04551911|470580022|FG000|Overall Study|Lost to Follow-up|2|||
130713881|NCT04551911|470580023|FG001|Overall Study|Lost to Follow-up|1|||
130713882|NCT04551911|470580022|FG000|Overall Study|Withdrawal by Subject|10|||
130713883|NCT04551911|470580023|FG001|Overall Study|Withdrawal by Subject|10|||
130713884|NCT04551911|470580022|FG000|Overall Study|Did not receive the study drug|3|||
130713885|NCT04551911|470580023|FG001|Overall Study|Did not receive the study drug|4|||
130713886|NCT01030341|470580024|FG000|Overall Study|Withdrawal by Subject|1|||
130713887|NCT01030341|470580024|FG000|Overall Study|Lost to Follow-up|2|||
130713888|NCT03596151|470580026|FG000|Overall Study|Withdrawal by Subject|1|||
130713889|NCT04280705|470580029|FG000|Overall Study|Enrolled but not treated|4|||
130288692|NCT00711802|469019931|FG005|Overall Study|Lost to Follow-up|6|||
130288693|NCT00711802|469019932|FG006|Overall Study|Lost to Follow-up|4|||
130288694|NCT00711802|469019933|FG007|Overall Study|Lost to Follow-up|2|||
130288695|NCT00711802|469019926|FG000|Overall Study|Reason not reported|0|||
130288696|NCT00711802|469019927|FG001|Overall Study|Reason not reported|1|||
130288697|NCT00711802|469019928|FG002|Overall Study|Reason not reported|1|||
130288698|NCT00711802|469019929|FG003|Overall Study|Reason not reported|0|||
130288699|NCT00711802|469019930|FG004|Overall Study|Reason not reported|1|||
130288700|NCT00711802|469019931|FG005|Overall Study|Reason not reported|0|||
130288701|NCT00711802|469019932|FG006|Overall Study|Reason not reported|1|||
130288702|NCT00711802|469019933|FG007|Overall Study|Reason not reported|0|||
130288703|NCT02410824|469019934|FG000|First Intervention (One Week)|Headache|0|||
130288704|NCT02410824|469019935|FG001|First Intervention (One Week)|Headache|1|||
130288705|NCT02436408|469019936|FG000|Overall Study|Death|1|||
130288706|NCT00392808|469019937|FG000|Overall Study|Lost to Follow-up|3|||
130288707|NCT00392808|469019938|FG001|Overall Study|Lost to Follow-up|2|||
130288708|NCT00392808|469019939|FG002|Overall Study|Lost to Follow-up|1|||
130288709|NCT00392808|469019940|FG003|Overall Study|Lost to Follow-up|2|||
130288710|NCT00392808|469019937|FG000|Overall Study|Unable to withdraw blood|3|||
130288711|NCT00392808|469019938|FG001|Overall Study|Unable to withdraw blood|1|||
130288712|NCT00392808|469019939|FG002|Overall Study|Unable to withdraw blood|1|||
130288713|NCT00392808|469019940|FG003|Overall Study|Unable to withdraw blood|2|||
130288714|NCT02649855|469019941|FG000|Overall Study|Refused further treatment|2|||
130288715|NCT02649855|469019942|FG001|Overall Study|Refused further treatment|1|||
130288716|NCT02649855|469019943|FG002|Overall Study|Refused further treatment|1|||
130288717|NCT02649855|469019941|FG000|Overall Study|Withdrew consent|0|||
130288718|NCT02649855|469019942|FG001|Overall Study|Withdrew consent|1|||
130288719|NCT02649855|469019943|FG002|Overall Study|Withdrew consent|0|||
130288720|NCT02649855|469019941|FG000|Overall Study|Switched to alternative treatment|0|||
130288721|NCT02649855|469019942|FG001|Overall Study|Switched to alternative treatment|1|||
130288722|NCT02649855|469019943|FG002|Overall Study|Switched to alternative treatment|1|||
130288723|NCT02649855|469019941|FG000|Overall Study|Principal investigator discretion|0|||
130288724|NCT02649855|469019942|FG001|Overall Study|Principal investigator discretion|1|||
130713890|NCT04280705|470580030|FG001|Overall Study|Enrolled but not treated|10|||
130288725|NCT02649855|469019943|FG002|Overall Study|Principal investigator discretion|1|||
130288726|NCT02649855|469019941|FG000|Overall Study|No treatment, per protocol|1|||
130288727|NCT02649855|469019942|FG001|Overall Study|No treatment, per protocol|0|||
130288728|NCT02649855|469019943|FG002|Overall Study|No treatment, per protocol|0|||
130288729|NCT02649855|469019941|FG000|Overall Study|Initiate new treatment|1|||
130288730|NCT02649855|469019942|FG001|Overall Study|Initiate new treatment|0|||
130288731|NCT02649855|469019943|FG002|Overall Study|Initiate new treatment|0|||
130288732|NCT02782325|469019944|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
130288733|NCT02782325|469019945|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
130288734|NCT02782325|469019946|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
130288735|NCT02782325|469019944|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130288736|NCT02782325|469019945|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130713891|NCT04280705|470580029|FG000|Overall Study|Physician Decision|1|||
130713892|NCT04280705|470580030|FG001|Overall Study|Physician Decision|0|||
130713893|NCT04280705|470580029|FG000|Overall Study|Withdrawal by Subject|7|||
130713894|NCT04280705|470580030|FG001|Overall Study|Withdrawal by Subject|9|||
130713895|NCT04280705|470580029|FG000|Overall Study|Adverse Event|0|||
130713896|NCT04280705|470580030|FG001|Overall Study|Adverse Event|4|||
130288737|NCT02782325|469019946|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
130288738|NCT02818036|469019950|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
130288739|NCT02818036|469019951|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
130288740|NCT02818036|469019950|FG000|Overall Study|Withdrawal by Subject|1|||
130288741|NCT02818036|469019951|FG001|Overall Study|Withdrawal by Subject|0|||
130288742|NCT01038713|469019952|FG000|Overall Study|Patient to hospice|1|||
130288743|NCT01038713|469019953|FG001|Overall Study|Patient to hospice|1|||
130288744|NCT01038713|469019954|FG002|Overall Study|Patient to hospice|1|||
130288745|NCT01038713|469019952|FG000|Overall Study|Lost to Follow-up|3|||
130288746|NCT01038713|469019953|FG001|Overall Study|Lost to Follow-up|0|||
130288747|NCT01038713|469019954|FG002|Overall Study|Lost to Follow-up|0|||
130288748|NCT01038713|469019952|FG000|Overall Study|Neuroendocrine Tumor|0|||
130288749|NCT01038713|469019953|FG001|Overall Study|Neuroendocrine Tumor|1|||
130288750|NCT01038713|469019954|FG002|Overall Study|Neuroendocrine Tumor|0|||
130288751|NCT01038713|469019952|FG000|Overall Study|died from PEP|0|||
130459688|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
130459689|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
130459690|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
130459691|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
130459692|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
130459693|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
130459694|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
130459695|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
130459696|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
130288752|NCT01038713|469019953|FG001|Overall Study|died from PEP|1|||
130288753|NCT01038713|469019954|FG002|Overall Study|died from PEP|0|||
130288754|NCT01038713|469019952|FG000|Overall Study|Autoimmune Pancreatitis|1|||
130288755|NCT01038713|469019953|FG001|Overall Study|Autoimmune Pancreatitis|0|||
130288756|NCT01038713|469019954|FG002|Overall Study|Autoimmune Pancreatitis|0|||
130288757|NCT03777917|469019957|FG000|Overall Study|Withdrawal by Subject|1|||
130288758|NCT03777917|469019958|FG001|Overall Study|Withdrawal by Subject|0|||
130288759|NCT03777917|469019957|FG000|Overall Study|Physician Decision|1|||
130288760|NCT03777917|469019958|FG001|Overall Study|Physician Decision|0|||
130288761|NCT03777917|469019957|FG000|Overall Study|Lost to Follow-up|6|||
130288762|NCT03777917|469019958|FG001|Overall Study|Lost to Follow-up|2|||
130288763|NCT03777917|469019957|FG000|Overall Study|Other|1|||
130288764|NCT03777917|469019958|FG001|Overall Study|Other|0|||
130288765|NCT01154283|469019959|FG000|0-6 Weeks|Withdrawal by Subject|7|||
130288766|NCT01154283|469019960|FG001|0-6 Weeks|Withdrawal by Subject|2|||
130288767|NCT01154283|469019959|FG000|0-6 Weeks|Death|0|||
130288768|NCT01154283|469019960|FG001|0-6 Weeks|Death|1|||
130288769|NCT01154283|469019959|FG000|7-12 Weeks|Death|1|||
130288770|NCT01154283|469019960|FG001|7-12 Weeks|Death|0|||
130288771|NCT01154283|469019959|FG000|7-12 Weeks|Withdrawal by Subject|0|||
130288772|NCT01154283|469019960|FG001|7-12 Weeks|Withdrawal by Subject|1|||
130288773|NCT00042432|469019961|FG000|Overall Study|Adverse Event|4|||
130288774|NCT00042432|469019962|FG001|Overall Study|Adverse Event|1|||
130288775|NCT00042432|469019961|FG000|Overall Study|Withdrawal by Subject|1|||
130288776|NCT00042432|469019962|FG001|Overall Study|Withdrawal by Subject|3|||
130288777|NCT00042432|469019961|FG000|Overall Study|Death|0|||
130288778|NCT00042432|469019962|FG001|Overall Study|Death|2|||
130288779|NCT00042432|469019961|FG000|Overall Study|Ineligibility determined|1|||
130288780|NCT00042432|469019962|FG001|Overall Study|Ineligibility determined|0|||
130288781|NCT00042432|469019961|FG000|Overall Study|Initiation of maintenance dialysis|1|||
130288782|NCT00042432|469019962|FG001|Overall Study|Initiation of maintenance dialysis|1|||
130288783|NCT00042432|469019961|FG000|Overall Study|Other|2|||
130288784|NCT00042432|469019962|FG001|Overall Study|Other|0|||
130288785|NCT00657150|469019963|FG000|Overall Study|Adverse Event|19|||
130288786|NCT00657150|469019964|FG001|Overall Study|Adverse Event|10|||
130288787|NCT00657150|469019963|FG000|Overall Study|Non-compliant with protocol|5|||
130288788|NCT00657150|469019964|FG001|Overall Study|Non-compliant with protocol|9|||
130288789|NCT00657150|469019963|FG000|Overall Study|Lost to Follow-up|2|||
130288790|NCT00657150|469019964|FG001|Overall Study|Lost to Follow-up|0|||
130288791|NCT00657150|469019963|FG000|Overall Study|Withdrawal by Subject|51|||
130288792|NCT00657150|469019964|FG001|Overall Study|Withdrawal by Subject|36|||
130288793|NCT00657150|469019963|FG000|Overall Study|Other|38|||
130288794|NCT00657150|469019964|FG001|Overall Study|Other|38|||
130288795|NCT00657150|469019963|FG000|Treatment|Adverse Event|60|||
130288796|NCT00657150|469019964|FG001|Treatment|Adverse Event|53|||
130459697|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
130288797|NCT00657150|469019963|FG000|Treatment|Non-compliant with protocol|10|||
130288798|NCT00657150|469019964|FG001|Treatment|Non-compliant with protocol|9|||
130288799|NCT00657150|469019963|FG000|Treatment|Lost to Follow-up|1|||
130288800|NCT00657150|469019964|FG001|Treatment|Lost to Follow-up|0|||
130288801|NCT00657150|469019963|FG000|Treatment|Withdrawal by Subject|23|||
130459698|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
130459699|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
130288802|NCT00657150|469019964|FG001|Treatment|Withdrawal by Subject|20|||
130713897|NCT04280705|470580029|FG000|Overall Study|Transferred to another hospital|1|||
130713898|NCT04280705|470580030|FG001|Overall Study|Transferred to another hospital|1|||
130288803|NCT00657150|469019963|FG000|Treatment|Other|13|||
130288804|NCT00657150|469019964|FG001|Treatment|Other|15|||
130288805|NCT02966795|469019965|FG000|Overall Study|Patient Left the Country|0|||
130288806|NCT02966795|469019966|FG001|Overall Study|Patient Left the Country|1|||
130288807|NCT00468845|469019978|FG000|Overall Study|Adverse Event|9|||
130288808|NCT00468845|469019979|FG001|Overall Study|Adverse Event|14|||
130288809|NCT00468845|469019980|FG002|Overall Study|Adverse Event|11|||
130288810|NCT00468845|469019978|FG000|Overall Study|Lost to Follow-up|2|||
130288811|NCT00468845|469019979|FG001|Overall Study|Lost to Follow-up|1|||
130288812|NCT00468845|469019980|FG002|Overall Study|Lost to Follow-up|2|||
130288813|NCT00468845|469019978|FG000|Overall Study|Other|4|||
130288814|NCT00468845|469019979|FG001|Overall Study|Other|9|||
130288815|NCT00468845|469019980|FG002|Overall Study|Other|5|||
130288816|NCT00468845|469019978|FG000|Overall Study|No longer willing to participate|5|||
130288817|NCT00468845|469019979|FG001|Overall Study|No longer willing to participate|6|||
130288818|NCT00468845|469019980|FG002|Overall Study|No longer willing to participate|10|||
130288819|NCT00468845|469019978|FG000|Overall Study|Randomized, not treated|1|||
130288820|NCT00468845|469019979|FG001|Overall Study|Randomized, not treated|4|||
130288821|NCT00468845|469019980|FG002|Overall Study|Randomized, not treated|2|||
130288822|NCT02761694|469019985|FG000|Overall Study|Lack of Efficacy|0|||
130288823|NCT02761694|469019986|FG001|Overall Study|Lack of Efficacy|0|||
130288824|NCT02761694|469019987|FG002|Overall Study|Lack of Efficacy|0|||
130459700|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
130459701|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
130459702|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
130459703|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
130459704|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459705|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
130459706|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
130459707|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
130459708|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459709|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459710|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459711|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459712|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459713|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459714|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130459715|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459716|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459717|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459718|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459719|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
130459720|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130713899|NCT03222583|470580031|FG000|Overall Study|Withdrawal by Subject|3|||
130713900|NCT03222583|470580032|FG001|Overall Study|Withdrawal by Subject|3|||
130288825|NCT02761694|469019988|FG003|Overall Study|Lack of Efficacy|0|||
130288826|NCT02761694|469019989|FG004|Overall Study|Lack of Efficacy|0|||
130288827|NCT02761694|469019990|FG005|Overall Study|Lack of Efficacy|0|||
130288828|NCT02761694|469019991|FG006|Overall Study|Lack of Efficacy|6|||
130288829|NCT02761694|469019992|FG007|Overall Study|Lack of Efficacy|0|||
130288830|NCT02761694|469019993|FG008|Overall Study|Lack of Efficacy|0|||
130288831|NCT02761694|469019994|FG009|Overall Study|Lack of Efficacy|1|||
130288832|NCT02761694|469019995|FG010|Overall Study|Lack of Efficacy|1|||
130288833|NCT02761694|469019996|FG011|Overall Study|Lack of Efficacy|4|||
130288834|NCT02761694|469019985|FG000|Overall Study|Death|0|||
130288835|NCT02761694|469019986|FG001|Overall Study|Death|0|||
130288836|NCT02761694|469019987|FG002|Overall Study|Death|0|||
130288837|NCT02761694|469019988|FG003|Overall Study|Death|0|||
130288838|NCT02761694|469019989|FG004|Overall Study|Death|0|||
130288839|NCT02761694|469019990|FG005|Overall Study|Death|0|||
130288840|NCT02761694|469019991|FG006|Overall Study|Death|2|||
130288841|NCT02761694|469019992|FG007|Overall Study|Death|0|||
130288842|NCT02761694|469019993|FG008|Overall Study|Death|2|||
130713901|NCT03222583|470580031|FG000|Overall Study|Lost to Follow-up|1|||
130288843|NCT02761694|469019994|FG009|Overall Study|Death|2|||
130288844|NCT02761694|469019995|FG010|Overall Study|Death|1|||
130288845|NCT02761694|469019996|FG011|Overall Study|Death|0|||
130288846|NCT02761694|469019985|FG000|Overall Study|Physician Decision|0|||
130288847|NCT02761694|469019986|FG001|Overall Study|Physician Decision|0|||
130459721|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130288848|NCT02761694|469019987|FG002|Overall Study|Physician Decision|0|||
130288849|NCT02761694|469019988|FG003|Overall Study|Physician Decision|0|||
130288850|NCT02761694|469019989|FG004|Overall Study|Physician Decision|0|||
130288851|NCT02761694|469019990|FG005|Overall Study|Physician Decision|0|||
130288852|NCT02761694|469019991|FG006|Overall Study|Physician Decision|1|||
130459722|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459723|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459724|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459725|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130459726|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
130459727|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459728|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459729|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459730|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459731|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459732|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459733|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459734|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459735|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459736|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
130459737|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
130459738|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
130459739|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
130459740|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
130459741|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
130459742|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
130459743|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
130459744|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
130459745|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
130459746|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
130459747|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
130459748|NCT02914522|469647608|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459749|NCT02914522|469647609|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
130459750|NCT02914522|469647610|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459751|NCT02914522|469647611|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459752|NCT02914522|469647612|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
130459753|NCT02914522|469647613|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
130459754|NCT02914522|469647614|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459755|NCT02914522|469647615|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459756|NCT02914522|469647616|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459757|NCT02914522|469647617|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459758|NCT02914522|469647618|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
130459759|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459760|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459761|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459762|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459763|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459764|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
130459765|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
130459766|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
130459767|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
130459768|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
130459769|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
130459770|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459771|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459772|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459773|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459774|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459775|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
130459776|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
130459777|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
130459778|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
130459779|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
130459780|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
130459781|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459782|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459783|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459784|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130713902|NCT03222583|470580032|FG001|Overall Study|Lost to Follow-up|0|||
130288853|NCT02761694|469019992|FG007|Overall Study|Physician Decision|0|||
130556436|NCT01233869|470006140|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
130556437|NCT01233869|470006141|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
130556438|NCT01233869|470006142|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
130556439|NCT01233869|470006143|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
130288854|NCT02761694|469019993|FG008|Overall Study|Physician Decision|0|||
130288855|NCT02761694|469019994|FG009|Overall Study|Physician Decision|0|||
130288856|NCT02761694|469019995|FG010|Overall Study|Physician Decision|0|||
130288857|NCT02761694|469019996|FG011|Overall Study|Physician Decision|0|||
130556440|NCT05696236|470006153|FG000|Overall Study|Lost to Follow-up|1|||
130556441|NCT05696236|470006154|FG001|Overall Study|Lost to Follow-up|0|||
130556442|NCT05696236|470006153|FG000|Overall Study|Later determined to not be eligible for participation|0|||
130556443|NCT05696236|470006154|FG001|Overall Study|Later determined to not be eligible for participation|1|||
130556444|NCT05696236|470006153|FG000|Overall Study|Withdrawal by Subject|2|||
130556445|NCT05696236|470006154|FG001|Overall Study|Withdrawal by Subject|2|||
130556446|NCT01145495|470006155|FG000|Overall Study|Adverse Event|6|||
130556447|NCT01145495|470006155|FG000|Overall Study|Withdrawal by Subject|6|||
130556448|NCT01145495|470006155|FG000|Overall Study|Disease progression after respone|2|||
130556449|NCT02060721|470006156|FG000|Overall Study|Lost to Follow-up|1|||
130713903|NCT03222583|470580031|FG000|Overall Study|Other|1|||
130713904|NCT03222583|470580032|FG001|Overall Study|Other|3|||
130713905|NCT03573505|470580033|FG000|Overall Study|Adverse Event|1|||
130713906|NCT03573505|470580034|FG001|Overall Study|Adverse Event|1|||
130713907|NCT03573505|470580033|FG000|Overall Study|Consent withdrawn|0|||
130713908|NCT03573505|470580034|FG001|Overall Study|Consent withdrawn|1|||
130713909|NCT03573505|470580033|FG000|Overall Study|Disease progression|0|||
130713910|NCT03573505|470580034|FG001|Overall Study|Disease progression|1|||
130713911|NCT03573505|470580033|FG000|Overall Study|Site Terminated by Sponsor|1|||
130713912|NCT03573505|470580034|FG001|Overall Study|Site Terminated by Sponsor|1|||
130713913|NCT03573505|470580033|FG000|Overall Study|Study terminated by sponsor|50|||
130713914|NCT03573505|470580034|FG001|Overall Study|Study terminated by sponsor|45|||
130713915|NCT03573505|470580033|FG000|Overall Study|Reason not specified|0|||
130713916|NCT03573505|470580034|FG001|Overall Study|Reason not specified|1|||
130713917|NCT03573505|470580033|FG000|Overall Study|Death|0|||
130713918|NCT03573505|470580034|FG001|Overall Study|Death|4|||
130713919|NCT04268316|470580035|FG000|Overall Study|Withdrawal by Subject|2|||
130713920|NCT04268316|470580036|FG001|Overall Study|Withdrawal by Subject|1|||
130713921|NCT04268316|470580037|FG002|Overall Study|Withdrawal by Subject|0|||
130713922|NCT03188718|470580038|FG000|Overall Study|Participant noncompliance|4|||
130713923|NCT03188718|470580038|FG000|Overall Study|Withdrawal by Subject|1|||
130713924|NCT03188718|470580038|FG000|Overall Study|Device failure|3|||
130713925|NCT01400919|470580040|FG000|Overall Study|Withdrawal by Subject|4|||
130713926|NCT01400919|470580040|FG000|Overall Study|Lost to Follow-up|2|||
130713927|NCT01400919|470580040|FG000|Overall Study|Missed visit|2|||
130713928|NCT02923674|470580041|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
130713929|NCT02923674|470580042|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
130713930|NCT02923674|470580043|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
130713931|NCT02923674|470580041|FG000|Overall Study|Lost to Follow-up|7|||
130713932|NCT02923674|470580042|FG001|Overall Study|Lost to Follow-up|12|||
130713933|NCT02923674|470580043|FG002|Overall Study|Lost to Follow-up|7|||
130713934|NCT02923674|470580041|FG000|Overall Study|Problem with intervention|2|||
130713935|NCT02923674|470580042|FG001|Overall Study|Problem with intervention|2|||
130713936|NCT02923674|470580043|FG002|Overall Study|Problem with intervention|1|||
130713937|NCT02923674|470580041|FG000|Overall Study|Adverse Event|3|||
130713938|NCT02923674|470580042|FG001|Overall Study|Adverse Event|1|||
130713939|NCT02923674|470580043|FG002|Overall Study|Adverse Event|1|||
130713940|NCT02923674|470580041|FG000|Overall Study|Withdrawal by Subject|2|||
130713941|NCT02923674|470580042|FG001|Overall Study|Withdrawal by Subject|2|||
130713942|NCT02923674|470580043|FG002|Overall Study|Withdrawal by Subject|2|||
130713943|NCT00158600|470580046|FG000|Overall Study|unable to commit time to study|0|||
130713944|NCT00158600|470580047|FG001|Overall Study|unable to commit time to study|1|||
130713945|NCT00158600|470580046|FG000|Overall Study|Adverse Event|2|||
130713946|NCT00158600|470580047|FG001|Overall Study|Adverse Event|1|||
130713947|NCT00158600|470580046|FG000|Overall Study|Death|1|||
130713948|NCT00158600|470580047|FG001|Overall Study|Death|0|||
130713949|NCT00158600|470580046|FG000|Overall Study|Withdrawal by Subject|2|||
130713950|NCT00158600|470580047|FG001|Overall Study|Withdrawal by Subject|2|||
130713951|NCT00846521|470580056|FG000|Overall Study|Withdrawal by Subject|5|||
130713952|NCT00846521|470580056|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
130288858|NCT02761694|469019985|FG000|Overall Study|Withdrawal by Subject|0|||
130713953|NCT00846521|470580056|FG000|Overall Study|Protocol Violation|1|||
130713954|NCT02618408|470580057|FG000|Overall Study|Withdrawal by Subject|1|||
130713955|NCT02618408|470580058|FG001|Overall Study|Withdrawal by Subject|0|||
130288859|NCT02761694|469019986|FG001|Overall Study|Withdrawal by Subject|0|||
130556450|NCT02060721|470006156|FG000|Overall Study|Physician Decision|2|||
130713956|NCT02618408|470580059|FG002|Overall Study|Withdrawal by Subject|4|||
130713957|NCT02618408|470580057|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
130713958|NCT02618408|470580058|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
130713959|NCT02618408|470580059|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
130713960|NCT02618408|470580057|FG000|Overall Study|Lost to Follow-up|4|||
130713961|NCT02618408|470580058|FG001|Overall Study|Lost to Follow-up|2|||
130713962|NCT02618408|470580059|FG002|Overall Study|Lost to Follow-up|6|||
130713963|NCT02618408|470580057|FG000|Overall Study|Adverse Event|4|||
130713964|NCT02618408|470580058|FG001|Overall Study|Adverse Event|0|||
130713965|NCT02618408|470580059|FG002|Overall Study|Adverse Event|10|||
130713966|NCT02618408|470580057|FG000|Overall Study|Physician Decision|1|||
130713967|NCT02618408|470580058|FG001|Overall Study|Physician Decision|1|||
130713968|NCT02618408|470580059|FG002|Overall Study|Physician Decision|2|||
130713969|NCT02618408|470580057|FG000|Overall Study|Protocol Violation|1|||
130713970|NCT02618408|470580058|FG001|Overall Study|Protocol Violation|1|||
130713971|NCT02618408|470580059|FG002|Overall Study|Protocol Violation|2|||
130713972|NCT02618408|470580057|FG000|Overall Study|Other, Multiple Categories|0|||
130713973|NCT02618408|470580058|FG001|Overall Study|Other, Multiple Categories|0|||
130713974|NCT02618408|470580059|FG002|Overall Study|Other, Multiple Categories|4|||
130713975|NCT00003875|470580069|FG000|Overall Study|Screen Failed|1|||
130713976|NCT01780987|470580070|FG000|Overall Study|Adverse Event|0|||
130713977|NCT01780987|470580071|FG001|Overall Study|Adverse Event|4|||
130713978|NCT01780987|470580070|FG000|Overall Study|Withdrawal by Subject|2|||
130713979|NCT01780987|470580071|FG001|Overall Study|Withdrawal by Subject|0|||
130713980|NCT01780987|470580070|FG000|Overall Study|Request of Changing Hospital|0|||
130713981|NCT01780987|470580071|FG001|Overall Study|Request of Changing Hospital|1|||
130713982|NCT01780987|470580070|FG000|Overall Study|Changing Residence|1|||
130713983|NCT01780987|470580071|FG001|Overall Study|Changing Residence|0|||
130713984|NCT01780987|470580070|FG000|Overall Study|Not Receiving any Study Medication|0|||
130713985|NCT01780987|470580071|FG001|Overall Study|Not Receiving any Study Medication|1|||
130713986|NCT04168190|470580072|FG000|Overall Study|Lost to Follow-up|0|||
130713987|NCT04168190|470580073|FG001|Overall Study|Lost to Follow-up|1|||
130713988|NCT04168190|470580074|FG002|Overall Study|Lost to Follow-up|0|||
130713989|NCT04168190|470580075|FG003|Overall Study|Lost to Follow-up|7|||
130713990|NCT04168190|470580076|FG004|Overall Study|Lost to Follow-up|5|||
130713991|NCT04168190|470580072|FG000|Overall Study|Withdrawal by Subject|1|||
130713992|NCT04168190|470580073|FG001|Overall Study|Withdrawal by Subject|0|||
130713993|NCT04168190|470580074|FG002|Overall Study|Withdrawal by Subject|0|||
130713994|NCT04168190|470580075|FG003|Overall Study|Withdrawal by Subject|2|||
130713995|NCT04168190|470580076|FG004|Overall Study|Withdrawal by Subject|4|||
130713996|NCT04168190|470580072|FG000|Overall Study|Death|0|||
130713997|NCT04168190|470580073|FG001|Overall Study|Death|0|||
130713998|NCT04168190|470580074|FG002|Overall Study|Death|0|||
130713999|NCT04168190|470580075|FG003|Overall Study|Death|1|||
130714000|NCT04168190|470580076|FG004|Overall Study|Death|0|||
130714001|NCT00629265|470580077|FG000|Overall Study|Lost to Follow-up|4|||
130714002|NCT00629265|470580078|FG001|Overall Study|Lost to Follow-up|5|||
130714003|NCT00629265|470580077|FG000|Overall Study|Withdrawal by Subject|11|||
130714004|NCT00629265|470580078|FG001|Overall Study|Withdrawal by Subject|8|||
130714005|NCT00629265|470580077|FG000|Overall Study|Death|1|||
130288860|NCT02761694|469019987|FG002|Overall Study|Withdrawal by Subject|0|||
130288861|NCT02761694|469019988|FG003|Overall Study|Withdrawal by Subject|1|||
130288862|NCT02761694|469019989|FG004|Overall Study|Withdrawal by Subject|0|||
130288863|NCT02761694|469019990|FG005|Overall Study|Withdrawal by Subject|0|||
130288864|NCT02761694|469019991|FG006|Overall Study|Withdrawal by Subject|4|||
130288865|NCT02761694|469019992|FG007|Overall Study|Withdrawal by Subject|0|||
130288866|NCT02761694|469019993|FG008|Overall Study|Withdrawal by Subject|2|||
130714006|NCT00629265|470580078|FG001|Overall Study|Death|0|||
130714007|NCT00629265|470580077|FG000|Overall Study|Adverse Event|2|||
130714008|NCT00629265|470580078|FG001|Overall Study|Adverse Event|0|||
130288867|NCT02761694|469019994|FG009|Overall Study|Withdrawal by Subject|1|||
130288868|NCT02761694|469019995|FG010|Overall Study|Withdrawal by Subject|0|||
130288869|NCT02761694|469019996|FG011|Overall Study|Withdrawal by Subject|0|||
130288870|NCT02761694|469019985|FG000|Overall Study|Lost to Follow-up|0|||
130288871|NCT02761694|469019986|FG001|Overall Study|Lost to Follow-up|0|||
130288872|NCT02761694|469019987|FG002|Overall Study|Lost to Follow-up|0|||
130288873|NCT02761694|469019988|FG003|Overall Study|Lost to Follow-up|0|||
130288874|NCT02761694|469019989|FG004|Overall Study|Lost to Follow-up|0|||
130288875|NCT02761694|469019990|FG005|Overall Study|Lost to Follow-up|0|||
130714009|NCT00629265|470580077|FG000|Overall Study|HNC Recurrence|4|||
130714010|NCT00629265|470580078|FG001|Overall Study|HNC Recurrence|0|||
130714011|NCT00629265|470580077|FG000|Overall Study|Other CA Requiring Treatment|1|||
130714012|NCT00629265|470580078|FG001|Overall Study|Other CA Requiring Treatment|3|||
130714013|NCT00629265|470580077|FG000|Overall Study|Needed Esophageal Dilation|4|||
130714014|NCT00629265|470580078|FG001|Overall Study|Needed Esophageal Dilation|1|||
130288876|NCT02761694|469019991|FG006|Overall Study|Lost to Follow-up|1|||
130288877|NCT02761694|469019992|FG007|Overall Study|Lost to Follow-up|0|||
130714015|NCT00629265|470580077|FG000|Overall Study|Unrelated Medical Complications|3|||
130714016|NCT00629265|470580078|FG001|Overall Study|Unrelated Medical Complications|1|||
130288878|NCT02761694|469019993|FG008|Overall Study|Lost to Follow-up|0|||
130288879|NCT02761694|469019994|FG009|Overall Study|Lost to Follow-up|0|||
130288880|NCT02761694|469019995|FG010|Overall Study|Lost to Follow-up|0|||
130288881|NCT02761694|469019996|FG011|Overall Study|Lost to Follow-up|1|||
130288882|NCT02761694|469019985|FG000|Overall Study|Adverse Event|0|||
130288883|NCT02761694|469019986|FG001|Overall Study|Adverse Event|0|||
130288884|NCT02761694|469019987|FG002|Overall Study|Adverse Event|0|||
130288885|NCT02761694|469019988|FG003|Overall Study|Adverse Event|0|||
130288886|NCT02761694|469019989|FG004|Overall Study|Adverse Event|0|||
130288887|NCT02761694|469019990|FG005|Overall Study|Adverse Event|0|||
130288888|NCT02761694|469019991|FG006|Overall Study|Adverse Event|1|||
130288889|NCT02761694|469019992|FG007|Overall Study|Adverse Event|0|||
130288890|NCT02761694|469019993|FG008|Overall Study|Adverse Event|1|||
130288891|NCT02761694|469019994|FG009|Overall Study|Adverse Event|0|||
130288892|NCT02761694|469019995|FG010|Overall Study|Adverse Event|0|||
130288893|NCT02761694|469019996|FG011|Overall Study|Adverse Event|1|||
130288894|NCT02761694|469019985|FG000|Overall Study|Other|4|||
130288895|NCT02761694|469019986|FG001|Overall Study|Other|4|||
130288896|NCT02761694|469019987|FG002|Overall Study|Other|1|||
130288897|NCT02761694|469019988|FG003|Overall Study|Other|2|||
130288898|NCT02761694|469019989|FG004|Overall Study|Other|3|||
130288899|NCT02761694|469019990|FG005|Overall Study|Other|3|||
130288900|NCT02761694|469019991|FG006|Overall Study|Other|18|||
130288901|NCT02761694|469019992|FG007|Overall Study|Other|8|||
130288902|NCT02761694|469019993|FG008|Overall Study|Other|0|||
130288903|NCT02761694|469019994|FG009|Overall Study|Other|1|||
130288904|NCT02761694|469019995|FG010|Overall Study|Other|1|||
130288905|NCT02761694|469019996|FG011|Overall Study|Other|0|||
130288906|NCT02395055|469019997|FG000|Overall Study|Withdrawal by Subject|7|||
130288907|NCT02395055|469019998|FG001|Overall Study|Withdrawal by Subject|3|||
130288908|NCT04070326|469020002|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
130288909|NCT04070326|469020003|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
130288910|NCT00526110|469020007|FG000|Overall Study|Adverse Event|2|||
130288911|NCT00526110|469020008|FG001|Overall Study|Adverse Event|9|||
130288912|NCT00526110|469020007|FG000|Overall Study|Disease Progression|0|||
130288913|NCT00526110|469020008|FG001|Overall Study|Disease Progression|19|||
130288914|NCT00526110|469020007|FG000|Overall Study|Maximal Response|0|||
130288915|NCT00526110|469020008|FG001|Overall Study|Maximal Response|6|||
130288916|NCT00526110|469020007|FG000|Overall Study|Withdrawal by Subject|0|||
130288917|NCT00526110|469020008|FG001|Overall Study|Withdrawal by Subject|2|||
130288918|NCT00526110|469020007|FG000|Overall Study|Poor Tolerance|0|||
130288919|NCT00526110|469020008|FG001|Overall Study|Poor Tolerance|5|||
130288920|NCT03959982|469022008|FG000|Overall Study|Withdrawal by Subject|1|||
130288921|NCT03959982|469022009|FG001|Overall Study|Withdrawal by Subject|0|||
130288922|NCT03959982|469022008|FG000|Overall Study|Physician Decision|2|||
130288923|NCT03959982|469022009|FG001|Overall Study|Physician Decision|0|||
130288924|NCT03959982|469022008|FG000|Overall Study|Lost to Follow-up|1|||
130288925|NCT03959982|469022009|FG001|Overall Study|Lost to Follow-up|0|||
130288926|NCT00758589|469022010|FG000|Overall Study|Adverse Event|3|||
130288927|NCT00758589|469022011|FG001|Overall Study|Adverse Event|2|||
130288928|NCT00758589|469022012|FG002|Overall Study|Adverse Event|5|||
130288929|NCT00758589|469022013|FG003|Overall Study|Adverse Event|4|||
130288930|NCT00758589|469022010|FG000|Overall Study|Withdrawal by Subject|0|||
130288931|NCT00758589|469022011|FG001|Overall Study|Withdrawal by Subject|1|||
130288932|NCT00758589|469022012|FG002|Overall Study|Withdrawal by Subject|1|||
130288933|NCT00758589|469022013|FG003|Overall Study|Withdrawal by Subject|1|||
130288934|NCT00758589|469022010|FG000|Overall Study|Palm stopped to work|0|||
130288935|NCT00758589|469022011|FG001|Overall Study|Palm stopped to work|0|||
130288936|NCT00758589|469022012|FG002|Overall Study|Palm stopped to work|0|||
130288937|NCT00758589|469022013|FG003|Overall Study|Palm stopped to work|1|||
130288938|NCT05320393|469022014|FG000|Overall Study|Withdrawal by Subject|1|||
130288939|NCT05320393|469022015|FG001|Overall Study|Withdrawal by Subject|0|||
130288940|NCT05320393|469022016|FG002|Overall Study|Withdrawal by Subject|2|||
130288941|NCT05320393|469022014|FG000|Overall Study|Lost to Follow-up|1|||
130288942|NCT05320393|469022015|FG001|Overall Study|Lost to Follow-up|2|||
130288943|NCT05320393|469022016|FG002|Overall Study|Lost to Follow-up|1|||
130714017|NCT00629265|470580077|FG000|Overall Study|Unknown Reason|2|||
130714018|NCT00629265|470580078|FG001|Overall Study|Unknown Reason|2|||
130288944|NCT05320393|469022014|FG000|Overall Study|Moved; too much driving|0|||
130288945|NCT05320393|469022015|FG001|Overall Study|Moved; too much driving|0|||
130714019|NCT04465630|470580079|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
130288946|NCT05320393|469022016|FG002|Overall Study|Moved; too much driving|2|||
130288947|NCT05320393|469022014|FG000|Overall Study|Did not receive treatment|0|||
130288948|NCT05320393|469022015|FG001|Overall Study|Did not receive treatment|0|||
130288949|NCT05320393|469022016|FG002|Overall Study|Did not receive treatment|1|||
130556451|NCT02060721|470006156|FG000|Overall Study|Death|14|||
130288950|NCT03559699|469022020|FG000|Overall Study|Withdrawal by Subject|6|||
130288951|NCT03559699|469022020|FG000|Overall Study|Lost to Follow-up|1|||
130288952|NCT05438602|469022025|FG000|Treatment (15 Days)|Adverse Event|2|||
130288953|NCT05438602|469022026|FG001|Treatment (15 Days)|Adverse Event|1|||
130288954|NCT05438602|469022027|FG002|Treatment (15 Days)|Adverse Event|3|||
130288955|NCT05438602|469022025|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
130288956|NCT05438602|469022026|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
130288957|NCT05438602|469022027|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
130288958|NCT05438602|469022025|FG000|Treatment (15 Days)|Other|0|||
130288959|NCT05438602|469022026|FG001|Treatment (15 Days)|Other|0|||
130288960|NCT05438602|469022027|FG002|Treatment (15 Days)|Other|1|||
130288961|NCT05438602|469022025|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
130288962|NCT05438602|469022026|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
130288963|NCT05438602|469022027|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
130288964|NCT05438602|469022025|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
130288965|NCT05438602|469022026|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
130288966|NCT05438602|469022027|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
130288967|NCT05438602|469022025|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
130288968|NCT05438602|469022026|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
130288969|NCT05438602|469022027|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
130288970|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
130288971|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
130288972|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
130288973|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
130288974|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130288975|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130288976|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
130288977|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
130288978|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
130288979|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
130288980|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
130288981|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
130288982|NCT01930890|469022028|FG000|Overall Study|Study Termination|14|||
130288983|NCT01930890|469022029|FG001|Overall Study|Study Termination|28|||
130288984|NCT01930890|469022030|FG002|Overall Study|Study Termination|13|||
130288985|NCT01930890|469022031|FG003|Overall Study|Study Termination|25|||
130288986|NCT01930890|469022028|FG000|Overall Study|Death|0|||
130288987|NCT01930890|469022029|FG001|Overall Study|Death|0|||
130288988|NCT01930890|469022030|FG002|Overall Study|Death|0|||
130288989|NCT01930890|469022031|FG003|Overall Study|Death|1|||
130288990|NCT01930890|469022028|FG000|Overall Study|Investigator Decision|0|||
130288991|NCT01930890|469022029|FG001|Overall Study|Investigator Decision|1|||
130288992|NCT01930890|469022030|FG002|Overall Study|Investigator Decision|0|||
130459785|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459786|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459787|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
130459788|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
130459789|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
130459790|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
130459791|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
130288993|NCT01930890|469022031|FG003|Overall Study|Investigator Decision|0|||
130288994|NCT01930890|469022028|FG000|Overall Study|Consent Withdrawn|0|||
130288995|NCT01930890|469022029|FG001|Overall Study|Consent Withdrawn|3|||
130288996|NCT01930890|469022030|FG002|Overall Study|Consent Withdrawn|0|||
130288997|NCT01930890|469022031|FG003|Overall Study|Consent Withdrawn|1|||
130288998|NCT01930890|469022028|FG000|Overall Study|Adverse Event|0|||
130288999|NCT01930890|469022029|FG001|Overall Study|Adverse Event|1|||
130459792|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130459793|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130459794|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130459795|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130289000|NCT01930890|469022030|FG002|Overall Study|Adverse Event|0|||
130459796|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130289001|NCT01930890|469022031|FG003|Overall Study|Adverse Event|0|||
130289002|NCT01278407|469022032|FG000|Confirmatory Phase|Adverse Event|5|||
130714020|NCT04465630|470580079|FG000|Overall Study|Screen failure|8|||
130714021|NCT04465630|470580079|FG000|Overall Study|Baseline failure|16|||
130714022|NCT02032706|470580082|FG000|Overall Study|Did not qualify|5|||
130714023|NCT02032706|470580082|FG000|Overall Study|Protocol Violation|1|||
130714024|NCT00895947|470580083|FG000|Overall Study|Adverse Event|3|||
130714025|NCT00895947|470580084|FG001|Overall Study|Adverse Event|4|||
130714026|NCT00895947|470580083|FG000|Overall Study|Lost to Follow-up|3|||
130714027|NCT00895947|470580084|FG001|Overall Study|Lost to Follow-up|4|||
130714028|NCT00895947|470580083|FG000|Overall Study|Protocol Violation|4|||
130714029|NCT00895947|470580084|FG001|Overall Study|Protocol Violation|2|||
130714030|NCT00895947|470580083|FG000|Overall Study|Withdrawal by Subject|2|||
130714031|NCT00895947|470580084|FG001|Overall Study|Withdrawal by Subject|0|||
130714032|NCT04620135|470580087|FG000|Study Completion|Adverse Event|2|||
130289003|NCT01278407|469022033|FG001|Confirmatory Phase|Adverse Event|10|||
130289004|NCT01278407|469022034|FG002|Confirmatory Phase|Adverse Event|1|||
130714033|NCT04620135|470580088|FG001|Study Completion|Adverse Event|3|||
130714034|NCT04620135|470580087|FG000|Study Completion|Withdrawal by Subject|2|||
130714035|NCT04620135|470580088|FG001|Study Completion|Withdrawal by Subject|0|||
130714036|NCT02005887|470580092|FG000|Overall Study|Protocol Violation|0|||
130714037|NCT02005887|470580093|FG001|Overall Study|Protocol Violation|2|||
130714038|NCT01615263|470580094|FG000|Overall Study|Post-randomization exclusion|0|||
130714039|NCT01615263|470580095|FG001|Overall Study|Post-randomization exclusion|2|||
130714040|NCT02138136|470580096|FG000|Overall Study|Protocol Violation|4|||
130714041|NCT02138136|470580096|FG000|Overall Study|Physician Decision|7|||
130714042|NCT02138136|470580096|FG000|Overall Study|Lack of Efficacy|35|||
130714043|NCT02138136|470580096|FG000|Overall Study|Pregnancy|2|||
130714044|NCT02138136|470580096|FG000|Overall Study|Adverse Event|18|||
130714045|NCT02138136|470580096|FG000|Overall Study|Withdrawal by Subject|36|||
130714046|NCT02138136|470580096|FG000|Overall Study|Lost to Follow-up|32|||
130714047|NCT02138136|470580096|FG000|Overall Study|Withdrawn by Sponsor|5|||
130714048|NCT01660334|470580099|FG000|Overall Study|Lost to Follow-up|1|||
130714049|NCT04355663|470580100|FG000|Overall Study|Physician Decision|2|||
130714050|NCT04355663|470580101|FG001|Overall Study|Physician Decision|7|||
130714051|NCT04355663|470580102|FG002|Overall Study|Physician Decision|0|||
130289005|NCT01278407|469022035|FG003|Confirmatory Phase|Adverse Event|0|||
130289006|NCT01278407|469022036|FG004|Confirmatory Phase|Adverse Event|0|||
130289007|NCT01278407|469022032|FG000|Confirmatory Phase|Participant's Choice|3|||
130289008|NCT01278407|469022033|FG001|Confirmatory Phase|Participant's Choice|5|||
130289009|NCT01278407|469022034|FG002|Confirmatory Phase|Participant's Choice|3|||
130289010|NCT01278407|469022035|FG003|Confirmatory Phase|Participant's Choice|0|||
130289011|NCT01278407|469022036|FG004|Confirmatory Phase|Participant's Choice|0|||
130459797|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
130459798|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
130459799|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
130459800|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
130459801|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
130459802|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
130459803|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
130289012|NCT01278407|469022032|FG000|Confirmatory Phase|Other|1|||
130289013|NCT01278407|469022033|FG001|Confirmatory Phase|Other|1|||
130289014|NCT01278407|469022034|FG002|Confirmatory Phase|Other|2|||
130289015|NCT01278407|469022035|FG003|Confirmatory Phase|Other|0|||
130289016|NCT01278407|469022036|FG004|Confirmatory Phase|Other|0|||
130289017|NCT01278407|469022032|FG000|Extension Phase|Adverse Event|0|||
130289018|NCT01278407|469022033|FG001|Extension Phase|Adverse Event|0|||
130289019|NCT01278407|469022034|FG002|Extension Phase|Adverse Event|0|||
130289020|NCT01278407|469022035|FG003|Extension Phase|Adverse Event|7|||
130289021|NCT01278407|469022036|FG004|Extension Phase|Adverse Event|16|||
130289022|NCT01278407|469022032|FG000|Extension Phase|Participant's Choice|0|||
130289023|NCT01278407|469022033|FG001|Extension Phase|Participant's Choice|0|||
130289024|NCT01278407|469022034|FG002|Extension Phase|Participant's Choice|0|||
130289025|NCT01278407|469022035|FG003|Extension Phase|Participant's Choice|4|||
130289026|NCT01278407|469022036|FG004|Extension Phase|Participant's Choice|11|||
130714052|NCT04355663|470580100|FG000|Overall Study|Adverse Event|0|||
130714053|NCT04355663|470580101|FG001|Overall Study|Adverse Event|0|||
130714054|NCT04355663|470580102|FG002|Overall Study|Adverse Event|1|||
130289027|NCT01278407|469022032|FG000|Extension Phase|Other|0|||
130289028|NCT01278407|469022033|FG001|Extension Phase|Other|0|||
130289029|NCT01278407|469022034|FG002|Extension Phase|Other|0|||
130289030|NCT01278407|469022035|FG003|Extension Phase|Other|1|||
130289031|NCT01278407|469022036|FG004|Extension Phase|Other|3|||
130714055|NCT04355663|470580100|FG000|Overall Study|Withdrawal by Subject|0|||
130714056|NCT04355663|470580101|FG001|Overall Study|Withdrawal by Subject|8|||
130714057|NCT04355663|470580102|FG002|Overall Study|Withdrawal by Subject|3|||
130714058|NCT03096847|470580103|FG000|Overall Study|Other|2|||
130714059|NCT03096847|470580104|FG001|Overall Study|Other|1|||
130714060|NCT03096847|470580105|FG002|Overall Study|Other|2|||
130289032|NCT02534935|469022037|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
130289033|NCT02534935|469022038|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
130289034|NCT02534935|469022039|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
130289035|NCT02534935|469022037|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
130289036|NCT02534935|469022038|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
130289037|NCT02534935|469022039|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
130289038|NCT02534935|469022037|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130289039|NCT02534935|469022038|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
130289040|NCT02534935|469022039|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130289041|NCT02534935|469022037|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
130289042|NCT02534935|469022038|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
130289043|NCT02534935|469022039|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
130289044|NCT02534935|469022037|FG000|Stage 1: 24 Months|Adverse Event|0|||
130289045|NCT02534935|469022038|FG001|Stage 1: 24 Months|Adverse Event|2|||
130289046|NCT02534935|469022039|FG002|Stage 1: 24 Months|Adverse Event|0|||
130289047|NCT02534935|469022037|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130289048|NCT02534935|469022038|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
130289049|NCT02534935|469022039|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130289050|NCT02534935|469022037|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130289051|NCT02534935|469022038|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
130289052|NCT02534935|469022039|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130289053|NCT01460719|469022040|FG000|Overall Study|Adverse Event|1|||
130289054|NCT01460719|469022040|FG000|Overall Study|Withdrawal by Subject|1|||
130289055|NCT00076336|469022044|FG000|Overall Study|Death|13|||
130289056|NCT00076336|469022045|FG001|Overall Study|Death|17|||
130289057|NCT00076336|469022044|FG000|Overall Study|Adverse Event|4|||
130289058|NCT00076336|469022045|FG001|Overall Study|Adverse Event|4|||
130289059|NCT00076336|469022044|FG000|Overall Study|Lost to Follow-up|4|||
130289060|NCT00076336|469022045|FG001|Overall Study|Lost to Follow-up|4|||
130289061|NCT00076336|469022044|FG000|Overall Study|Non-Compliance|2|||
130289062|NCT00076336|469022045|FG001|Overall Study|Non-Compliance|0|||
130289063|NCT00076336|469022044|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
130289064|NCT00076336|469022045|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
130289065|NCT00076336|469022044|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
130289066|NCT00076336|469022045|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
130289067|NCT00076336|469022044|FG000|Overall Study|Liver Transplantation|3|||
130289068|NCT00076336|469022045|FG001|Overall Study|Liver Transplantation|3|||
130289069|NCT00076336|469022044|FG000|Overall Study|Virologic Breakthrough|14|||
130289070|NCT00076336|469022045|FG001|Overall Study|Virologic Breakthrough|16|||
130289071|NCT00076336|469022044|FG000|Overall Study|Treatment failure|4|||
130289072|NCT00076336|469022045|FG001|Overall Study|Treatment failure|5|||
130289073|NCT02838901|469022046|FG000|Overall Study|Withdrawal by Subject|1|||
130289074|NCT02838901|469022047|FG001|Overall Study|Withdrawal by Subject|1|||
130289075|NCT02838901|469022046|FG000|Overall Study|Lost to Follow-up|1|||
130289076|NCT02838901|469022047|FG001|Overall Study|Lost to Follow-up|1|||
130289077|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130289078|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
130289079|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
130289080|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130289081|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
130289082|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
130289083|NCT01224821|469022052|FG000|Long-Term Follow-Up|Death|2|||
130459804|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
130459805|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
130459806|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
130459807|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
130459808|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
130459809|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
130459810|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
130459811|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
130459812|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
130289084|NCT01224821|469022052|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
130289085|NCT00623545|469022053|FG000|Overall Study|Adverse Event|6|||
130289086|NCT00623545|469022053|FG000|Overall Study|Withdrawal by Subject|4|||
130289087|NCT02585830|469022060|FG000|Overall Study|Withdrawal by Subject|3|||
130289088|NCT03276052|469022064|FG000|Overall Study|Withdrawal by Subject|5|||
130289089|NCT03276052|469022064|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
130289090|NCT03220581|469022066|FG000|Overall Study|Withdrawal by Subject|0|||
130289091|NCT03220581|469022067|FG001|Overall Study|Withdrawal by Subject|1|||
130289092|NCT03220581|469022066|FG000|Overall Study|Lost to Follow-up|3|||
130289093|NCT03220581|469022067|FG001|Overall Study|Lost to Follow-up|6|||
130289094|NCT00919867|469022068|FG000|First Intervention|Withdrawal by Subject|0|||
130289095|NCT00919867|469022069|FG001|First Intervention|Withdrawal by Subject|0|||
130289096|NCT00919867|469022070|FG002|First Intervention|Withdrawal by Subject|1|||
130289097|NCT00919867|469022071|FG003|First Intervention|Withdrawal by Subject|0|||
130289098|NCT00919867|469022072|FG004|First Intervention|Withdrawal by Subject|0|||
130289099|NCT00919867|469022073|FG005|First Intervention|Withdrawal by Subject|0|||
130289100|NCT00919867|469022068|FG000|First Intervention|Physician Decision|0|||
130289101|NCT00919867|469022069|FG001|First Intervention|Physician Decision|0|||
130289102|NCT00919867|469022070|FG002|First Intervention|Physician Decision|0|||
130289103|NCT00919867|469022071|FG003|First Intervention|Physician Decision|0|||
130459813|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
130289104|NCT00919867|469022072|FG004|First Intervention|Physician Decision|0|||
130289105|NCT00919867|469022073|FG005|First Intervention|Physician Decision|1|||
130289106|NCT00435162|469022074|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
130289107|NCT00435162|469022075|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
130289108|NCT00435162|469022076|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
130289109|NCT00435162|469022077|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
130289110|NCT00435162|469022078|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
130289111|NCT00435162|469022079|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
130289112|NCT01765426|469022082|FG000|Overall Study|Lost to Follow-up|0|||
130289113|NCT01765426|469022083|FG001|Overall Study|Lost to Follow-up|1|||
130289114|NCT01765426|469022084|FG002|Overall Study|Lost to Follow-up|0|||
130289115|NCT01765426|469022085|FG003|Overall Study|Lost to Follow-up|0|||
130289116|NCT01510184|469022086|FG000|Overall Study|Sponsor discretion|28|||
130289117|NCT01510184|469022087|FG001|Overall Study|Sponsor discretion|28|||
130289118|NCT01510184|469022086|FG000|Overall Study|Death|1|||
130289119|NCT01510184|469022087|FG001|Overall Study|Death|2|||
130289120|NCT01510184|469022086|FG000|Overall Study|Withdrawal by Subject|1|||
130289121|NCT01510184|469022087|FG001|Overall Study|Withdrawal by Subject|4|||
130289122|NCT01510184|469022086|FG000|Overall Study|Other|0|||
130289123|NCT01510184|469022087|FG001|Overall Study|Other|1|||
130289124|NCT01484834|469022098|FG000|Overall Study|Lost to Follow-up|5|||
130289125|NCT01484834|469022099|FG001|Overall Study|Lost to Follow-up|8|||
130289126|NCT01484834|469022100|FG002|Overall Study|Lost to Follow-up|1|||
130289127|NCT01484834|469022101|FG003|Overall Study|Lost to Follow-up|4|||
130289128|NCT00747344|469022102|FG000|Controlled Period|Adverse Event|3|||
130289129|NCT00747344|469022103|FG001|Controlled Period|Adverse Event|0|||
130289130|NCT00747344|469022104|FG002|Controlled Period|Adverse Event|0|||
130289131|NCT00747344|469022105|FG003|Controlled Period|Adverse Event|0|||
130289132|NCT00747344|469022102|FG000|Controlled Period|Lack of Efficacy|2|||
130289133|NCT00747344|469022103|FG001|Controlled Period|Lack of Efficacy|1|||
130289134|NCT00747344|469022104|FG002|Controlled Period|Lack of Efficacy|0|||
130289135|NCT00747344|469022105|FG003|Controlled Period|Lack of Efficacy|0|||
130289136|NCT00747344|469022102|FG000|Controlled Period|Other|0|||
130289137|NCT00747344|469022103|FG001|Controlled Period|Other|3|||
130289138|NCT00747344|469022104|FG002|Controlled Period|Other|0|||
130289139|NCT00747344|469022105|FG003|Controlled Period|Other|0|||
130289140|NCT00747344|469022102|FG000|After Controlled Period|Adverse Event|0|||
130289141|NCT00747344|469022103|FG001|After Controlled Period|Adverse Event|0|||
130289142|NCT00747344|469022104|FG002|After Controlled Period|Adverse Event|0|||
130289143|NCT00747344|469022105|FG003|After Controlled Period|Adverse Event|1|||
130289144|NCT00765882|469022106|FG000|Overall Study|Adverse Event|10|||
130289145|NCT00765882|469022107|FG001|Overall Study|Adverse Event|21|||
130289146|NCT00765882|469022108|FG002|Overall Study|Adverse Event|20|||
130289147|NCT00765882|469022106|FG000|Overall Study|Lack of Efficacy|4|||
130289148|NCT00765882|469022107|FG001|Overall Study|Lack of Efficacy|0|||
130289149|NCT00765882|469022108|FG002|Overall Study|Lack of Efficacy|1|||
130289150|NCT00765882|469022106|FG000|Overall Study|Protocol Violation|4|||
130459814|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459815|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130714061|NCT03096847|470580103|FG000|Overall Study|Lost to Follow-up|1|||
130289151|NCT00765882|469022107|FG001|Overall Study|Protocol Violation|3|||
130289152|NCT00765882|469022108|FG002|Overall Study|Protocol Violation|1|||
130289153|NCT00765882|469022106|FG000|Overall Study|Withdrawal by Subject|2|||
130289154|NCT00765882|469022107|FG001|Overall Study|Withdrawal by Subject|6|||
130289155|NCT00765882|469022108|FG002|Overall Study|Withdrawal by Subject|6|||
130289156|NCT00765882|469022106|FG000|Overall Study|Lost to Follow-up|1|||
130289157|NCT00765882|469022107|FG001|Overall Study|Lost to Follow-up|9|||
130289158|NCT00765882|469022108|FG002|Overall Study|Lost to Follow-up|6|||
130289159|NCT00765882|469022106|FG000|Overall Study|Other Reason|3|||
130289160|NCT00765882|469022107|FG001|Overall Study|Other Reason|1|||
130289161|NCT00765882|469022108|FG002|Overall Study|Other Reason|2|||
130289162|NCT02231762|469022109|FG000|Combination Phase|Adverse Event|10|||
130289163|NCT02231762|469022110|FG001|Combination Phase|Adverse Event|0|||
130289164|NCT02231762|469022111|FG002|Combination Phase|Adverse Event|0|||
130289165|NCT02231762|469022112|FG003|Combination Phase|Adverse Event|0|||
130289166|NCT02231762|469022109|FG000|Combination Phase|Withdrawal by Subject|2|||
130289167|NCT02231762|469022110|FG001|Combination Phase|Withdrawal by Subject|0|||
130289168|NCT02231762|469022111|FG002|Combination Phase|Withdrawal by Subject|0|||
130289169|NCT02231762|469022112|FG003|Combination Phase|Withdrawal by Subject|0|||
130289170|NCT02231762|469022109|FG000|Combination Phase|Disease Progression|6|||
130289171|NCT02231762|469022110|FG001|Combination Phase|Disease Progression|0|||
130289172|NCT02231762|469022111|FG002|Combination Phase|Disease Progression|0|||
130289173|NCT02231762|469022112|FG003|Combination Phase|Disease Progression|0|||
130289174|NCT02231762|469022109|FG000|Combination Phase|Did not meet inclusion criteria|1|||
130289175|NCT02231762|469022110|FG001|Combination Phase|Did not meet inclusion criteria|0|||
130289176|NCT02231762|469022111|FG002|Combination Phase|Did not meet inclusion criteria|0|||
130289177|NCT02231762|469022112|FG003|Combination Phase|Did not meet inclusion criteria|0|||
130289178|NCT02231762|469022109|FG000|Combination Phase|Protocol Violation|1|||
130289179|NCT02231762|469022110|FG001|Combination Phase|Protocol Violation|0|||
130289180|NCT02231762|469022111|FG002|Combination Phase|Protocol Violation|0|||
130289181|NCT02231762|469022112|FG003|Combination Phase|Protocol Violation|0|||
130289182|NCT02231762|469022109|FG000|Maintenance Phase|Disease progression|0|||
130289183|NCT02231762|469022110|FG001|Maintenance Phase|Disease progression|3|||
130289184|NCT02231762|469022111|FG002|Maintenance Phase|Disease progression|4|||
130289185|NCT02231762|469022112|FG003|Maintenance Phase|Disease progression|3|||
130289186|NCT02231762|469022109|FG000|Maintenance Phase|Adverse Event|0|||
130289187|NCT02231762|469022110|FG001|Maintenance Phase|Adverse Event|0|||
130289188|NCT02231762|469022111|FG002|Maintenance Phase|Adverse Event|1|||
130289189|NCT02231762|469022112|FG003|Maintenance Phase|Adverse Event|2|||
130289190|NCT01799239|469022113|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
130289191|NCT01799239|469022114|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
130289192|NCT01799239|469022113|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
130289193|NCT01799239|469022114|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
130289194|NCT01799239|469022113|FG000|Period 1 (7 Days)|Protocol Violation|0|||
130289195|NCT01799239|469022114|FG001|Period 1 (7 Days)|Protocol Violation|1|||
130370790|NCT03278873|469327262|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130556452|NCT02060721|470006156|FG000|Overall Study|Withdrawal by Subject|2|||
130556453|NCT02060721|470006156|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
130556454|NCT00117507|470006157|FG000|Overall Study|Adverse Event|4|||
130556455|NCT00117507|470006157|FG000|Overall Study|Abnormal laboratory values|3|||
130556456|NCT00117507|470006157|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130556457|NCT00117507|470006157|FG000|Overall Study|Patient withdrew consent|4|||
130556458|NCT00117507|470006157|FG000|Overall Study|Death|3|||
130556459|NCT05105789|470006158|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
130556460|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
130556461|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
130556462|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Death|0|||
130556463|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Death|1|||
130556464|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
130556465|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
130556466|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
130556467|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
130556468|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
130556469|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
130556470|NCT00323297|470006161|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
130556471|NCT00323297|470006162|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
130556472|NCT00323297|470006161|FG000|Part B (Open-label)|Death|0|||
130556473|NCT00323297|470006162|FG001|Part B (Open-label)|Death|1|||
130556474|NCT00323297|470006161|FG000|Part B (Open-label)|Reason unspecified|0|||
130556475|NCT00323297|470006162|FG001|Part B (Open-label)|Reason unspecified|1|||
130556476|NCT00323297|470006161|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
130556477|NCT00323297|470006162|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
130556478|NCT00323297|470006161|FG000|Part B (Open-label)|Lack of Efficacy|3|||
130714062|NCT03096847|470580104|FG001|Overall Study|Lost to Follow-up|0|||
130714063|NCT03096847|470580105|FG002|Overall Study|Lost to Follow-up|1|||
130714064|NCT03096847|470580103|FG000|Overall Study|Death|6|||
130289196|NCT01799239|469022113|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
130289197|NCT01799239|469022114|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130289198|NCT01799239|469022113|FG000|Period 2 (7 Days)|Protocol Violation|1|||
130289199|NCT01799239|469022114|FG001|Period 2 (7 Days)|Protocol Violation|0|||
130289200|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
130289201|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
130289202|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
130289203|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
130289204|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
130556479|NCT00323297|470006162|FG001|Part B (Open-label)|Lack of Efficacy|1|||
130556480|NCT00323297|470006161|FG000|Part B (Open-label)|Adverse Event|5|||
130556481|NCT00323297|470006162|FG001|Part B (Open-label)|Adverse Event|5|||
130556482|NCT00323297|470006161|FG000|Part B (Open-label)|Protocol Violation|0|||
130714065|NCT03096847|470580104|FG001|Overall Study|Death|0|||
130714066|NCT03096847|470580105|FG002|Overall Study|Death|2|||
130714067|NCT03096847|470580103|FG000|Overall Study|Protocol Violation|3|||
130714068|NCT03096847|470580104|FG001|Overall Study|Protocol Violation|0|||
130714069|NCT03096847|470580105|FG002|Overall Study|Protocol Violation|6|||
130714070|NCT03096847|470580103|FG000|Overall Study|Physician Decision|12|||
130459816|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459817|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459818|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459819|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459820|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459821|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
130459822|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
130459823|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459824|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
130459825|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459826|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459827|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459828|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459829|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459830|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459831|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459832|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459833|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
130459834|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
130459835|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
130459836|NCT02914522|469647608|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459837|NCT02914522|469647609|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459838|NCT02914522|469647610|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459839|NCT02914522|469647611|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459840|NCT02914522|469647612|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459841|NCT02914522|469647613|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459842|NCT02914522|469647614|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459843|NCT02914522|469647615|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130466751|NCT04139668|469676383|FG000|Overall Study|Withdrawal by Subject|1|||
130466752|NCT02581215|469676388|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
130466753|NCT02581215|469676389|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
130466754|NCT02581215|469676388|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130466755|NCT02581215|469676389|FG001|Overall Study|Eligibility Criteria Not Met|1|||
130466756|NCT04279574|469676392|FG000|Overall Study|Death|1|||
130466757|NCT04279574|469676393|FG001|Overall Study|Death|0|||
130466758|NCT04279574|469676392|FG000|Overall Study|lost restoration, tooth fracture|1|||
130466759|NCT04279574|469676393|FG001|Overall Study|lost restoration, tooth fracture|0|||
130466760|NCT04279574|469676392|FG000|Overall Study|Lost to Follow-up|0|||
130466761|NCT04279574|469676393|FG001|Overall Study|Lost to Follow-up|1|||
130466762|NCT04188379|469676394|FG000|Overall Study|Withdrawal by Subject|10|||
130466763|NCT04188379|469676395|FG001|Overall Study|Withdrawal by Subject|3|||
130466764|NCT04188379|469676394|FG000|Overall Study|Physician Decision|0|||
130466765|NCT04188379|469676395|FG001|Overall Study|Physician Decision|1|||
130466766|NCT04188379|469676394|FG000|Overall Study|Adverse Event|3|||
130466767|NCT04188379|469676395|FG001|Overall Study|Adverse Event|1|||
130466768|NCT04188379|469676394|FG000|Overall Study|Pregnancy|1|||
130466769|NCT04188379|469676395|FG001|Overall Study|Pregnancy|0|||
130466770|NCT04188379|469676394|FG000|Overall Study|Lack of Efficacy|8|||
130466771|NCT04188379|469676395|FG001|Overall Study|Lack of Efficacy|5|||
130466772|NCT04188379|469676394|FG000|Overall Study|Other|0|||
130466773|NCT04188379|469676395|FG001|Overall Study|Other|3|||
130466774|NCT02566902|469676401|FG000|Overall Study|Protocol Violation|2|||
130466775|NCT02566902|469676402|FG001|Overall Study|Protocol Violation|1|||
130466776|NCT02411084|469676403|FG000|Overall Study|Lack of Efficacy|6|||
130466777|NCT02411084|469676404|FG001|Overall Study|Lack of Efficacy|3|||
130466778|NCT02411084|469676403|FG000|Overall Study|Death|5|||
130466779|NCT02411084|469676404|FG001|Overall Study|Death|4|||
130466780|NCT02411084|469676403|FG000|Overall Study|Adverse Event|2|||
130466781|NCT02411084|469676404|FG001|Overall Study|Adverse Event|1|||
130466782|NCT02411084|469676403|FG000|Overall Study|Other reasons|0|||
130466783|NCT02411084|469676404|FG001|Overall Study|Other reasons|5|||
130466784|NCT05773313|469676409|FG000|Overall Study|Lost to Follow-up|3|||
130466785|NCT02748317|469676410|FG000|Overall Study|Withdrawal by Subject|14|||
130466786|NCT02748317|469676410|FG000|Overall Study|Lost to Follow-up|8|||
130466787|NCT02748317|469676410|FG000|Overall Study|Death|1|||
130466788|NCT00332241|469676412|FG000|Overall Study|Lack of Efficacy|6|||
130466789|NCT00332241|469676413|FG001|Overall Study|Lack of Efficacy|1|||
130466790|NCT00332241|469676412|FG000|Overall Study|Adverse Event|3|||
130289205|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
130289206|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
130289207|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
130289208|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
130289209|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
130289210|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
130289211|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
130289212|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
130289213|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
130289214|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
130289215|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
130289216|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
130289217|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
130289218|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
130289219|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
130289220|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
130289221|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
130289222|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
130289223|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
130289224|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
130289225|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
130289226|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
130289227|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
130289228|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
130289229|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
130289230|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Physician Decision|0|||
130289231|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Physician Decision|0|||
130289232|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Physician Decision|0|||
130289233|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Physician Decision|0|||
130289234|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Physician Decision|1|||
130289235|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Physician Decision|0|||
130459844|NCT02914522|469647616|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459845|NCT02914522|469647617|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
130289236|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Physician Decision|0|||
130289237|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Physician Decision|0|||
130289238|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Physician Decision|0|||
130289239|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Physician Decision|0|||
130289240|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Physician Decision|0|||
130289241|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Physician Decision|0|||
130289242|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Physician Decision|0|||
130289243|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Physician Decision|0|||
130289244|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Physician Decision|0|||
130289245|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Death|0|||
130289246|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Death|0|||
130289247|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Death|0|||
130289248|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Death|0|||
130289249|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Death|0|||
130289250|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Death|0|||
130289251|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Death|0|||
130289252|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Death|0|||
130289253|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Death|0|||
130289254|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Death|0|||
130289255|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Death|0|||
130289256|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Death|0|||
130289257|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Death|1|||
130289258|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Death|1|||
130289259|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Death|0|||
130289260|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Physician Decision|0|||
130289261|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Physician Decision|0|||
130289262|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Physician Decision|0|||
130459846|NCT02914522|469647618|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
130459847|NCT03383146|469647619|FG000|Overall Study|Screen Failure|1|||
130459848|NCT03383146|469647620|FG001|Overall Study|Screen Failure|0|||
130459849|NCT03383146|469647619|FG000|Overall Study|Adverse Event|6|||
130714071|NCT03096847|470580104|FG001|Overall Study|Physician Decision|2|||
130714072|NCT03096847|470580105|FG002|Overall Study|Physician Decision|8|||
130289263|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Physician Decision|0|||
130289264|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Physician Decision|0|||
130289265|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Physician Decision|0|||
130289266|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Physician Decision|0|||
130289267|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Physician Decision|0|||
130289268|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Physician Decision|0|||
130289269|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Physician Decision|0|||
130714073|NCT03096847|470580103|FG000|Overall Study|Withdrawal by Subject|24|||
130714074|NCT03096847|470580104|FG001|Overall Study|Withdrawal by Subject|1|||
130714075|NCT03096847|470580105|FG002|Overall Study|Withdrawal by Subject|12|||
130714076|NCT03096847|470580103|FG000|Overall Study|Adverse Event|72|||
130714077|NCT03096847|470580104|FG001|Overall Study|Adverse Event|6|||
130714078|NCT03096847|470580105|FG002|Overall Study|Adverse Event|28|||
130714079|NCT03096847|470580103|FG000|Overall Study|Progressive disease|97|||
130714080|NCT03096847|470580104|FG001|Overall Study|Progressive disease|10|||
130714081|NCT03096847|470580105|FG002|Overall Study|Progressive disease|78|||
130289270|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Physician Decision|1|||
130289271|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Physician Decision|1|||
130289272|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Physician Decision|0|||
130289273|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Physician Decision|1|||
130714082|NCT03096847|470580103|FG000|Overall Study|Non-compliance with study medication|1|||
130714083|NCT03096847|470580104|FG001|Overall Study|Non-compliance with study medication|0|||
130714084|NCT03096847|470580105|FG002|Overall Study|Non-compliance with study medication|0|||
130714085|NCT03096847|470580103|FG000|Overall Study|New therapy for study indication|1|||
130714086|NCT03096847|470580104|FG001|Overall Study|New therapy for study indication|0|||
130714087|NCT03096847|470580105|FG002|Overall Study|New therapy for study indication|1|||
130714088|NCT00876018|470580108|FG000|Overall Study|Lost to Follow-up|0|||
130714089|NCT00876018|470580109|FG001|Overall Study|Lost to Follow-up|1|||
130714090|NCT00876018|470580110|FG002|Overall Study|Lost to Follow-up|1|||
130714091|NCT00876018|470580108|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
130714092|NCT00876018|470580109|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
130714093|NCT00876018|470580110|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
130714094|NCT01230892|470580111|FG000|Overall Study|Withdrawal by Subject|1|||
130714095|NCT01230892|470580112|FG001|Overall Study|Withdrawal by Subject|1|||
130714096|NCT01230892|470580111|FG000|Overall Study|Lost to Follow-up|2|||
130714097|NCT01230892|470580112|FG001|Overall Study|Lost to Follow-up|0|||
130714098|NCT00679913|470580113|FG000|Overall Study|Protocol Violation|18|||
130714099|NCT00679913|470580114|FG001|Overall Study|Protocol Violation|13|||
130714100|NCT00725621|470580115|FG000|Overall Study|Adverse Event|25|||
130714101|NCT00725621|470580115|FG000|Overall Study|Lack of Efficacy|46|||
130714102|NCT00725621|470580115|FG000|Overall Study|Withdrawal by Subject|57|||
130714103|NCT00725621|470580115|FG000|Overall Study|Physician Decision|19|||
130289274|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Physician Decision|0|||
130289275|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Other|0|||
130289276|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Other|0|||
130289277|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Other|0|||
130289278|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Other|0|||
130289279|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Other|0|||
130289280|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Other|0|||
130289281|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Other|0|||
130289282|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Other|0|||
130289283|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Other|0|||
130289284|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Other|0|||
130289285|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Other|0|||
130289286|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Other|0|||
130289287|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Other|0|||
130289288|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Other|1|||
130370791|NCT03278873|469327263|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130370792|NCT03278873|469327264|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
130370793|NCT03278873|469327265|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130370794|NCT05243641|469327266|FG000|Overall Study|Adverse Event|3|||
130370795|NCT05243641|469327267|FG001|Overall Study|Adverse Event|0|||
130370796|NCT05243641|469327268|FG002|Overall Study|Adverse Event|0|||
130370797|NCT05243641|469327269|FG003|Overall Study|Adverse Event|1|||
130370798|NCT05243641|469327270|FG004|Overall Study|Adverse Event|0|||
130370799|NCT05243641|469327271|FG005|Overall Study|Adverse Event|0|||
130370800|NCT05243641|469327266|FG000|Overall Study|Disease progression|4|||
130370801|NCT05243641|469327267|FG001|Overall Study|Disease progression|0|||
130370802|NCT05243641|469327268|FG002|Overall Study|Disease progression|0|||
130370803|NCT05243641|469327269|FG003|Overall Study|Disease progression|2|||
130370804|NCT05243641|469327270|FG004|Overall Study|Disease progression|0|||
130370805|NCT05243641|469327271|FG005|Overall Study|Disease progression|0|||
130370806|NCT04518306|469327272|FG000|Double-Blind Period|Run in failure|0|||
130370807|NCT04518306|469327273|FG001|Double-Blind Period|Run in failure|0|||
130370808|NCT04518306|469327274|FG002|Double-Blind Period|Run in failure|1|||
130714104|NCT00725621|470580115|FG000|Overall Study|Lost to Follow-up|52|||
130714105|NCT00725621|470580115|FG000|Overall Study|Non-compliance|8|||
130714106|NCT00725621|470580115|FG000|Overall Study|Continued treatment by other physician|6|||
130714107|NCT00725621|470580115|FG000|Overall Study|Switched to other study|1|||
130714108|NCT00725621|470580115|FG000|Overall Study|Switched to other drug|1|||
130714109|NCT00725621|470580115|FG000|Overall Study|Prepared for elective surgery|1|||
130289289|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Other|0|||
130289290|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
130289291|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
130289292|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
130289293|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
130289294|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
130289295|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
130289296|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
130289297|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
130289298|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
130289299|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
130289300|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
130289301|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
130289302|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
130289303|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
130289304|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
130289305|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
130289306|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
130289307|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
130459850|NCT03383146|469647620|FG001|Overall Study|Adverse Event|18|||
130459851|NCT03383146|469647619|FG000|Overall Study|Lack of Efficacy|0|||
130459852|NCT03383146|469647620|FG001|Overall Study|Lack of Efficacy|3|||
130459853|NCT03383146|469647619|FG000|Overall Study|Withdrawal by Subject|20|||
130459854|NCT03383146|469647620|FG001|Overall Study|Withdrawal by Subject|36|||
130459855|NCT03383146|469647619|FG000|Overall Study|Lost to Follow-up|5|||
130459856|NCT03383146|469647620|FG001|Overall Study|Lost to Follow-up|15|||
130459857|NCT03383146|469647619|FG000|Overall Study|Death|0|||
130459858|NCT03383146|469647620|FG001|Overall Study|Death|2|||
130459859|NCT03383146|469647619|FG000|Overall Study|Physician Decision|0|||
130459860|NCT03383146|469647620|FG001|Overall Study|Physician Decision|1|||
130459861|NCT03383146|469647619|FG000|Overall Study|Protocol Deviation|1|||
130459862|NCT03383146|469647620|FG001|Overall Study|Protocol Deviation|8|||
130289308|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
130289309|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
130289310|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
130370809|NCT04518306|469327272|FG000|Double-Blind Period|Adverse Event|0|||
130370810|NCT04518306|469327273|FG001|Double-Blind Period|Adverse Event|2|||
130370811|NCT04518306|469327274|FG002|Double-Blind Period|Adverse Event|2|||
130370812|NCT04518306|469327272|FG000|Double-Blind Period|Lost to Follow-up|1|||
130370813|NCT04518306|469327273|FG001|Double-Blind Period|Lost to Follow-up|2|||
130370814|NCT04518306|469327274|FG002|Double-Blind Period|Lost to Follow-up|2|||
130370815|NCT04518306|469327272|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
130370816|NCT04518306|469327273|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
130370817|NCT04518306|469327274|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
130370818|NCT04518306|469327272|FG000|Double-Blind Period|Other|0|||
130370819|NCT04518306|469327273|FG001|Double-Blind Period|Other|2|||
130370820|NCT04518306|469327274|FG002|Double-Blind Period|Other|0|||
130370821|NCT04518306|469327272|FG000|Double-Blind Period|Missing|0|||
130370822|NCT04518306|469327273|FG001|Double-Blind Period|Missing|1|||
130370823|NCT04518306|469327274|FG002|Double-Blind Period|Missing|0|||
130370824|NCT03904043|469327276|FG000|Overall Study|Adverse Event|1|||
130370825|NCT03904043|469327277|FG001|Overall Study|Adverse Event|1|||
130370826|NCT03904043|469327276|FG000|Overall Study|Withdrawal by Subject|1|||
130370827|NCT03904043|469327277|FG001|Overall Study|Withdrawal by Subject|0|||
130370828|NCT03904043|469327276|FG000|Overall Study|Non-compliance|1|||
130370829|NCT03904043|469327277|FG001|Overall Study|Non-compliance|0|||
130370830|NCT03904043|469327276|FG000|Overall Study|Did not start treatment|1|||
130370831|NCT03904043|469327277|FG001|Overall Study|Did not start treatment|0|||
130370832|NCT00540514|469329209|FG000|Overall Study|Still on treatment|3|||
130370833|NCT00540514|469329210|FG001|Overall Study|Still on treatment|0|||
130370834|NCT00540514|469329209|FG000|Overall Study|Unacceptable Toxicity|61|||
130370835|NCT00540514|469329210|FG001|Overall Study|Unacceptable Toxicity|62|||
130370836|NCT00540514|469329209|FG000|Overall Study|Adverse Event|20|||
130370837|NCT00540514|469329210|FG001|Overall Study|Adverse Event|24|||
130370838|NCT00540514|469329209|FG000|Overall Study|Physician Decision|86|||
130370839|NCT00540514|469329210|FG001|Overall Study|Physician Decision|99|||
130370840|NCT00540514|469329209|FG000|Overall Study|Protocol Deviation|3|||
130370841|NCT00540514|469329210|FG001|Overall Study|Protocol Deviation|4|||
130370842|NCT00540514|469329209|FG000|Overall Study|Lost to Follow-up|1|||
130370843|NCT00540514|469329210|FG001|Overall Study|Lost to Follow-up|1|||
130370844|NCT00540514|469329209|FG000|Overall Study|Withdrawal by Subject|65|||
130370845|NCT00540514|469329210|FG001|Overall Study|Withdrawal by Subject|67|||
130370846|NCT00540514|469329209|FG000|Overall Study|Excluded prior to treatment|7|||
130370847|NCT00540514|469329210|FG001|Overall Study|Excluded prior to treatment|7|||
130714110|NCT00725621|470580115|FG000|Overall Study|Reason not specified|55|||
130714111|NCT01189500|470580116|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
130714112|NCT01189500|470580116|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
130714113|NCT01144364|470580126|FG000|Induction Phase|Disease progression|14|||
130714114|NCT01144364|470580127|FG001|Induction Phase|Disease progression|0|||
130714115|NCT01144364|470580128|FG002|Induction Phase|Disease progression|0|||
130714116|NCT01144364|470580126|FG000|Induction Phase|Adverse Event|9|||
130714117|NCT01144364|470580127|FG001|Induction Phase|Adverse Event|0|||
130714118|NCT01144364|470580128|FG002|Induction Phase|Adverse Event|0|||
130714119|NCT01144364|470580126|FG000|Induction Phase|Death|1|||
130714120|NCT01144364|470580127|FG001|Induction Phase|Death|0|||
130714121|NCT01144364|470580128|FG002|Induction Phase|Death|0|||
130714122|NCT01144364|470580126|FG000|Induction Phase|Withdrawal by Subject|1|||
130714123|NCT01144364|470580127|FG001|Induction Phase|Withdrawal by Subject|0|||
130714124|NCT01144364|470580128|FG002|Induction Phase|Withdrawal by Subject|0|||
130714125|NCT01144364|470580126|FG000|Induction Phase|Lost to Follow-up|2|||
130714126|NCT01144364|470580127|FG001|Induction Phase|Lost to Follow-up|0|||
130714127|NCT01144364|470580128|FG002|Induction Phase|Lost to Follow-up|0|||
130714128|NCT01144364|470580126|FG000|Induction Phase|Physician Decision|1|||
130714129|NCT01144364|470580127|FG001|Induction Phase|Physician Decision|0|||
130714130|NCT01144364|470580128|FG002|Induction Phase|Physician Decision|0|||
130714131|NCT01144364|470580126|FG000|Induction Phase|Stable disease|2|||
130714132|NCT01144364|470580127|FG001|Induction Phase|Stable disease|0|||
130714133|NCT01144364|470580128|FG002|Induction Phase|Stable disease|0|||
130714134|NCT01144364|470580126|FG000|Induction Phase|Secondary neoplasia|1|||
130714135|NCT01144364|470580127|FG001|Induction Phase|Secondary neoplasia|0|||
130714136|NCT01144364|470580128|FG002|Induction Phase|Secondary neoplasia|0|||
130714137|NCT01144364|470580126|FG000|Induction Phase|Protocol Violation|1|||
130714138|NCT01144364|470580127|FG001|Induction Phase|Protocol Violation|0|||
130714139|NCT01144364|470580128|FG002|Induction Phase|Protocol Violation|0|||
130714140|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
130714141|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
130714142|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
130714143|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
130714144|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
130714145|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
130714146|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Death|0|||
130714147|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Death|2|||
130714148|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Death|0|||
130714149|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
130714150|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130714151|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130714152|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
130714153|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
130714154|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
130714155|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
130714156|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
130289311|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
130289312|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
130289313|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
130289314|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
130289315|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
130289316|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
130289317|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
130289318|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
130289319|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
130289320|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289321|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289322|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289323|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289324|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130370848|NCT00540514|469329209|FG000|Overall Study|Paclitaxel not available|0|||
130714157|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
130714158|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
130370849|NCT00540514|469329210|FG001|Overall Study|Paclitaxel not available|2|||
130714159|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
130289325|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289326|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130370850|NCT02501473|469329211|FG000|Overall Study|Study Terminated|2|||
130714160|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
130714161|NCT01301508|470580131|FG000|Overall Study|Withdrawal by Subject|1|||
130714162|NCT01301508|470580132|FG001|Overall Study|Withdrawal by Subject|2|||
130714163|NCT01301508|470580131|FG000|Overall Study|Lost to Follow-up|0|||
130556483|NCT00323297|470006162|FG001|Part B (Open-label)|Protocol Violation|1|||
130556484|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130556485|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130556486|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
130556487|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130556488|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
130556489|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
130556490|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
130556491|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
130556492|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
130556493|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
130556494|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
130556495|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
130556496|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
130556497|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
130556498|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
130556499|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
130556500|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
130556501|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
130556502|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
130556503|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
130556504|NCT01641809|470006165|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
130556505|NCT01641809|470006166|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
130556506|NCT01641809|470006167|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
130556507|NCT01641809|470006168|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
130556508|NCT01641809|470006165|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
130556509|NCT01641809|470006166|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
130556510|NCT01641809|470006167|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
130556511|NCT01641809|470006168|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
130556512|NCT01641809|470006165|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130556513|NCT01641809|470006166|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
130556514|NCT01641809|470006167|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130556515|NCT01641809|470006168|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130556516|NCT01641809|470006165|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
130556517|NCT01641809|470006166|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
130556518|NCT01641809|470006167|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
130556519|NCT01641809|470006168|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
130556520|NCT01641809|470006165|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
130714164|NCT01301508|470580132|FG001|Overall Study|Lost to Follow-up|1|||
130714165|NCT01940497|470580133|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
130714166|NCT01940497|470580134|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
130714167|NCT01940497|470580133|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
130714168|NCT01940497|470580134|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
130714169|NCT01940497|470580133|FG000|Overall Study|Violation of Entry Criteria|1|||
130289327|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289328|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289329|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289330|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
130289331|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289332|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289333|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289334|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289335|NCT02594098|469022133|FG000|Overall Study|Lack of Efficacy|17|||
130289336|NCT02594098|469022134|FG001|Overall Study|Lack of Efficacy|6|||
130289337|NCT02594098|469022133|FG000|Overall Study|Withdrawal by Subject|1|||
130289338|NCT02594098|469022134|FG001|Overall Study|Withdrawal by Subject|3|||
130289339|NCT02594098|469022133|FG000|Overall Study|Terminated participation|6|||
130289340|NCT02594098|469022134|FG001|Overall Study|Terminated participation|2|||
130289341|NCT02594098|469022133|FG000|Overall Study|Seek alternative treatment|2|||
130289342|NCT02594098|469022134|FG001|Overall Study|Seek alternative treatment|1|||
130289343|NCT02594098|469022133|FG000|Overall Study|Other|0|||
130289344|NCT02594098|469022134|FG001|Overall Study|Other|1|||
130289345|NCT00033540|469022135|FG000|Overall Study|Adverse Event|14|||
130289346|NCT00033540|469022135|FG000|Overall Study|Death|1|||
130289347|NCT00033540|469022135|FG000|Overall Study|Progression|26|||
130289348|NCT00033540|469022135|FG000|Overall Study|Withdrawal by Subject|6|||
130289349|NCT00033540|469022135|FG000|Overall Study|Other|5|||
130289350|NCT00033540|469022135|FG000|Overall Study|Ineligible|3|||
130289351|NCT00033540|469022135|FG000|Overall Study|Never received treatment|2|||
130289352|NCT03366103|469022136|FG000|Overall Study|Disease Progression|3|||
130289353|NCT03366103|469022137|FG001|Overall Study|Disease Progression|1|||
130289354|NCT03366103|469022138|FG002|Overall Study|Disease Progression|0|||
130289355|NCT03366103|469022136|FG000|Overall Study|Adverse Event|0|||
130289356|NCT03366103|469022137|FG001|Overall Study|Adverse Event|1|||
130289357|NCT03366103|469022138|FG002|Overall Study|Adverse Event|0|||
130289358|NCT01036529|469022139|FG000|Overall Study|Adverse Event|0|||
130289359|NCT01036529|469022140|FG001|Overall Study|Adverse Event|1|||
130289360|NCT01036529|469022139|FG000|Overall Study|Lost to Follow-up|0|||
130289361|NCT01036529|469022140|FG001|Overall Study|Lost to Follow-up|1|||
130289362|NCT01036529|469022139|FG000|Overall Study|Physician Decision|1|||
130370851|NCT02501473|469329212|FG001|Overall Study|Study Terminated|3|||
130370852|NCT02501473|469329213|FG002|Overall Study|Study Terminated|7|||
130370853|NCT02501473|469329214|FG003|Overall Study|Study Terminated|9|||
130370854|NCT02501473|469329215|FG004|Overall Study|Study Terminated|2|||
130370855|NCT02501473|469329216|FG005|Overall Study|Study Terminated|10|||
130370856|NCT02501473|469329217|FG006|Overall Study|Study Terminated|1|||
130370857|NCT02501473|469329218|FG007|Overall Study|Study Terminated|0|||
130370858|NCT02501473|469329211|FG000|Overall Study|Withdrawal by Subject|0|||
130370859|NCT02501473|469329212|FG001|Overall Study|Withdrawal by Subject|0|||
130370860|NCT02501473|469329213|FG002|Overall Study|Withdrawal by Subject|3|||
130370861|NCT02501473|469329214|FG003|Overall Study|Withdrawal by Subject|3|||
130370862|NCT02501473|469329215|FG004|Overall Study|Withdrawal by Subject|2|||
130370863|NCT02501473|469329216|FG005|Overall Study|Withdrawal by Subject|2|||
130370864|NCT02501473|469329217|FG006|Overall Study|Withdrawal by Subject|0|||
130370865|NCT02501473|469329218|FG007|Overall Study|Withdrawal by Subject|0|||
130370866|NCT02501473|469329211|FG000|Overall Study|Death|0|||
130370867|NCT02501473|469329212|FG001|Overall Study|Death|0|||
130370868|NCT02501473|469329213|FG002|Overall Study|Death|1|||
130370869|NCT02501473|469329214|FG003|Overall Study|Death|1|||
130370870|NCT02501473|469329215|FG004|Overall Study|Death|0|||
130370871|NCT02501473|469329216|FG005|Overall Study|Death|1|||
130370872|NCT02501473|469329217|FG006|Overall Study|Death|0|||
130370873|NCT02501473|469329218|FG007|Overall Study|Death|0|||
130370874|NCT02501473|469329211|FG000|Overall Study|Lost to Follow-up|1|||
130370875|NCT02501473|469329212|FG001|Overall Study|Lost to Follow-up|0|||
130370876|NCT02501473|469329213|FG002|Overall Study|Lost to Follow-up|1|||
130370877|NCT02501473|469329214|FG003|Overall Study|Lost to Follow-up|0|||
130370878|NCT02501473|469329215|FG004|Overall Study|Lost to Follow-up|0|||
130370879|NCT02501473|469329216|FG005|Overall Study|Lost to Follow-up|1|||
130370880|NCT02501473|469329217|FG006|Overall Study|Lost to Follow-up|0|||
130370881|NCT02501473|469329218|FG007|Overall Study|Lost to Follow-up|0|||
130370882|NCT02501473|469329211|FG000|Overall Study|Reason not specified|0|||
130370883|NCT02501473|469329212|FG001|Overall Study|Reason not specified|0|||
130370884|NCT02501473|469329213|FG002|Overall Study|Reason not specified|1|||
130370885|NCT02501473|469329214|FG003|Overall Study|Reason not specified|1|||
130370886|NCT02501473|469329215|FG004|Overall Study|Reason not specified|0|||
130370887|NCT02501473|469329216|FG005|Overall Study|Reason not specified|0|||
130370888|NCT02501473|469329217|FG006|Overall Study|Reason not specified|0|||
130370889|NCT02501473|469329218|FG007|Overall Study|Reason not specified|0|||
130370890|NCT04487730|469329219|FG000|Overall Study|Withdrawal by Subject|3|||
130370891|NCT04487730|469329220|FG001|Overall Study|Withdrawal by Subject|1|||
130370892|NCT04487730|469329219|FG000|Overall Study|Lost to Follow-up|0|||
130370893|NCT04487730|469329220|FG001|Overall Study|Lost to Follow-up|1|||
130370894|NCT04487730|469329219|FG000|Overall Study|Physician Decision|0|||
130370895|NCT04487730|469329220|FG001|Overall Study|Physician Decision|1|||
130370896|NCT00907777|469329221|FG000|Overall Study|Withdrawal by Subject|0|||
130370897|NCT00907777|469329222|FG001|Overall Study|Withdrawal by Subject|1|||
130370898|NCT01473836|469329223|FG000|Overall Study|Adverse Event|4|||
130370899|NCT01473836|469329223|FG000|Overall Study|Lack of Efficacy|1|||
130370900|NCT01473836|469329223|FG000|Overall Study|Does not meet entrance criteria|1|||
130370901|NCT03291808|469329224|FG000|Overall Study|Lost to Follow-up|6|||
130370902|NCT03291808|469329224|FG000|Overall Study|Research burden|4|||
130370903|NCT03364023|469329225|FG000|Overall Study|Lost to Follow-up|3|||
130370904|NCT03364023|469329225|FG000|Overall Study|Death|14|||
130370905|NCT01892293|469329226|FG000|Overall Study|Apheresed but not treated|4|||
130370906|NCT03602482|469329227|FG000|Overall Study|Withdrawal by Subject|6|||
130370907|NCT03602482|469329228|FG001|Overall Study|Withdrawal by Subject|7|||
130289363|NCT01036529|469022140|FG001|Overall Study|Physician Decision|0|||
130370908|NCT03602482|469329229|FG002|Overall Study|Withdrawal by Subject|0|||
130370909|NCT03602482|469329230|FG003|Overall Study|Withdrawal by Subject|0|||
130289364|NCT01036529|469022139|FG000|Overall Study|Withdrawal by Subject|1|||
130289365|NCT01036529|469022140|FG001|Overall Study|Withdrawal by Subject|1|||
130370910|NCT02601469|469329231|FG000|Overall Study|Enrolled in Error|1|||
130370911|NCT02601469|469329232|FG001|Overall Study|Enrolled in Error|0|||
130370912|NCT04980040|469329233|FG000|Overall Study|Violated the Inclusion Criteria|260|||
130370913|NCT04980040|469329233|FG000|Overall Study|Violated the Administration & Dosage|225|||
130370914|NCT04980040|469329233|FG000|Overall Study|Lost to Safety-Follow-up|4|||
130370915|NCT04980040|469329233|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
130370916|NCT00618072|469329239|FG000|Overall Study|Lost to Follow-up|2|||
130714170|NCT01940497|470580134|FG001|Overall Study|Violation of Entry Criteria|1|||
130714171|NCT01940497|470580133|FG000|Overall Study|Refused Treatment|1|||
130714172|NCT01940497|470580134|FG001|Overall Study|Refused Treatment|3|||
130714173|NCT01940497|470580133|FG000|Overall Study|Withdrew Consent|6|||
130714174|NCT01940497|470580134|FG001|Overall Study|Withdrew Consent|2|||
130714175|NCT01940497|470580133|FG000|Overall Study|Administrative/Other|1|||
130714176|NCT01940497|470580134|FG001|Overall Study|Administrative/Other|1|||
130714177|NCT02707861|470580135|FG000|Overall Study|Went onto commercial drug|30|||
130714178|NCT02707861|470580136|FG001|Overall Study|Went onto commercial drug|23|||
130714179|NCT02707861|470580135|FG000|Overall Study|Adverse Event|2|||
130714180|NCT02707861|470580136|FG001|Overall Study|Adverse Event|3|||
130714181|NCT02707861|470580135|FG000|Overall Study|Death|5|||
130714182|NCT02707861|470580136|FG001|Overall Study|Death|2|||
130714183|NCT02707861|470580135|FG000|Overall Study|Lack of Efficacy|0|||
130714184|NCT02707861|470580136|FG001|Overall Study|Lack of Efficacy|2|||
130714185|NCT02707861|470580135|FG000|Overall Study|Physician Decision|1|||
130714186|NCT02707861|470580136|FG001|Overall Study|Physician Decision|4|||
130714187|NCT02707861|470580135|FG000|Overall Study|Withdrawal by Subject|2|||
130714188|NCT02707861|470580136|FG001|Overall Study|Withdrawal by Subject|1|||
130714189|NCT02707861|470580135|FG000|Overall Study|Lost to Follow-up|1|||
130714190|NCT02707861|470580136|FG001|Overall Study|Lost to Follow-up|3|||
130714191|NCT03123861|470580137|FG000|Overall Study|Protocol Violation|1|||
130714192|NCT03123861|470580138|FG001|Overall Study|Protocol Violation|1|||
130714193|NCT03123861|470580137|FG000|Overall Study|Withdrawal by Subject|2|||
130714194|NCT03123861|470580138|FG001|Overall Study|Withdrawal by Subject|2|||
130714195|NCT02206620|470580139|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130714196|NCT02206620|470580140|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130714197|NCT02206620|470580139|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130714198|NCT02206620|470580140|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
130714199|NCT03188666|470581644|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714200|NCT03188666|470581645|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
130714201|NCT03188666|470581646|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714202|NCT03188666|470581647|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714203|NCT03188666|470581644|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
130714204|NCT03188666|470581645|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
130714205|NCT03188666|470581646|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
130714206|NCT03188666|470581647|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
130714207|NCT03188666|470581644|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714208|NCT03188666|470581645|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714209|NCT03188666|470581646|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
130714210|NCT03188666|470581647|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714211|NCT03188666|470581644|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
130714212|NCT03188666|470581645|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
130714213|NCT03188666|470581646|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
130714214|NCT03188666|470581647|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
130714215|NCT03696953|470581648|FG000|Overall Study|Withdrawal by Subject|6|||
130714216|NCT03696953|470581649|FG001|Overall Study|Withdrawal by Subject|1|||
130714217|NCT03696953|470581648|FG000|Overall Study|missed GBS swabs|2|||
130714218|NCT03696953|470581649|FG001|Overall Study|missed GBS swabs|2|||
130714219|NCT03696953|470581648|FG000|Overall Study|lost study bottle containing capsules|2|||
130714220|NCT03696953|470581649|FG001|Overall Study|lost study bottle containing capsules|0|||
130714221|NCT03696953|470581648|FG000|Overall Study|Premature birth|1|||
130714222|NCT03696953|470581649|FG001|Overall Study|Premature birth|4|||
130714223|NCT03696953|470581648|FG000|Overall Study|Gestational hypertension|1|||
130289366|NCT01036529|469022139|FG000|Overall Study|Sponsor study termination|11|||
130289367|NCT01036529|469022140|FG001|Overall Study|Sponsor study termination|12|||
130289368|NCT01853072|469022141|FG000|Overall Study|Adverse event prior to treatment|0|||
130714224|NCT03696953|470581649|FG001|Overall Study|Gestational hypertension|1|||
130714225|NCT03696953|470581648|FG000|Overall Study|Gestational diabetes|2|||
130714226|NCT03696953|470581649|FG001|Overall Study|Gestational diabetes|1|||
130289369|NCT01853072|469022142|FG001|Overall Study|Adverse event prior to treatment|1|||
130289370|NCT01853072|469022141|FG000|Overall Study|Adverse Event|0|||
130459863|NCT03383146|469647619|FG000|Overall Study|Study Terminated by the Sponsor|48|||
130459864|NCT03383146|469647620|FG001|Overall Study|Study Terminated by the Sponsor|95|||
130459865|NCT03383146|469647619|FG000|Overall Study|Reason not Specified|4|||
130459866|NCT03383146|469647620|FG001|Overall Study|Reason not Specified|6|||
130459867|NCT05382104|469647623|FG000|Period 2 (2 Days)|Adverse Event|0|||
130459868|NCT05382104|469647624|FG001|Period 2 (2 Days)|Adverse Event|1|||
130459869|NCT05382104|469647625|FG002|Period 2 (2 Days)|Adverse Event|0|||
130459870|NCT05382104|469647626|FG003|Period 2 (2 Days)|Adverse Event|0|||
130459871|NCT05382104|469647627|FG004|Period 2 (2 Days)|Adverse Event|0|||
130459872|NCT05382104|469647628|FG005|Period 2 (2 Days)|Adverse Event|0|||
130459873|NCT00639002|469647629|FG000|Overall Study|Death|1|||
130459874|NCT00639002|469647629|FG000|Overall Study|Adverse Event|1|||
130459875|NCT00639002|469647629|FG000|Overall Study|Protocol Violation|1|||
130459876|NCT00639002|469647629|FG000|Overall Study|Disease progression|3|||
130714227|NCT03696953|470581648|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
130714228|NCT03696953|470581649|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
130714229|NCT03696953|470581648|FG000|Overall Study|Changed prenatal provider|1|||
130714230|NCT03696953|470581649|FG001|Overall Study|Changed prenatal provider|1|||
130714231|NCT03502707|470581650|FG000|Overall Study|Adverse Event|0|||
130714232|NCT03502707|470581651|FG001|Overall Study|Adverse Event|0|||
130714233|NCT03502707|470581652|FG002|Overall Study|Adverse Event|0|||
130714234|NCT03502707|470581653|FG003|Overall Study|Adverse Event|0|||
130714235|NCT03502707|470581654|FG004|Overall Study|Adverse Event|0|||
130714236|NCT03502707|470581655|FG005|Overall Study|Adverse Event|0|||
130714237|NCT03502707|470581656|FG006|Overall Study|Adverse Event|0|||
130714238|NCT03502707|470581657|FG007|Overall Study|Adverse Event|0|||
130714239|NCT03502707|470581658|FG008|Overall Study|Adverse Event|0|||
130714240|NCT03502707|470581659|FG009|Overall Study|Adverse Event|0|||
130714241|NCT03502707|470581660|FG010|Overall Study|Adverse Event|0|||
130714242|NCT03502707|470581661|FG011|Overall Study|Adverse Event|0|||
130714243|NCT03502707|470581662|FG012|Overall Study|Adverse Event|0|||
130714244|NCT03502707|470581663|FG013|Overall Study|Adverse Event|0|||
130714245|NCT03502707|470581664|FG014|Overall Study|Adverse Event|0|||
130714246|NCT03502707|470581665|FG015|Overall Study|Adverse Event|1|||
130714247|NCT03502707|470581666|FG016|Overall Study|Adverse Event|5|||
130714248|NCT03502707|470581667|FG017|Overall Study|Adverse Event|0|||
130289371|NCT01853072|469022142|FG001|Overall Study|Adverse Event|3|||
130289372|NCT01853072|469022141|FG000|Overall Study|Death|1|||
130289373|NCT01853072|469022142|FG001|Overall Study|Death|4|||
130289374|NCT01853072|469022141|FG000|Overall Study|Lost to Follow-up|0|||
130289375|NCT01853072|469022142|FG001|Overall Study|Lost to Follow-up|3|||
130289376|NCT01853072|469022141|FG000|Overall Study|Non-compliance with study drug|0|||
130289377|NCT01853072|469022142|FG001|Overall Study|Non-compliance with study drug|1|||
130289378|NCT01853072|469022141|FG000|Overall Study|Physician Decision|1|||
130289379|NCT01853072|469022142|FG001|Overall Study|Physician Decision|1|||
130289380|NCT01853072|469022141|FG000|Overall Study|Withdrawal by Subject|1|||
130289381|NCT01853072|469022142|FG001|Overall Study|Withdrawal by Subject|2|||
130289382|NCT01853072|469022141|FG000|Overall Study|Reason not specified|9|||
130289383|NCT01853072|469022142|FG001|Overall Study|Reason not specified|6|||
130289384|NCT01816906|469022143|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
130289385|NCT01816906|469022144|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
130289386|NCT01816906|469022143|FG000|Six Months|Lost to Follow-up|14|||
130289387|NCT01816906|469022144|FG001|Six Months|Lost to Follow-up|16|||
130289388|NCT01816906|469022143|FG000|12 Months|Adverse Event|2|||
130289389|NCT01816906|469022144|FG001|12 Months|Adverse Event|2|||
130289390|NCT01816906|469022143|FG000|12 Months|Death|0|||
130289391|NCT01816906|469022144|FG001|12 Months|Death|2|||
130289392|NCT01816906|469022143|FG000|12 Months|Lost to Follow-up|2|||
130289393|NCT01816906|469022144|FG001|12 Months|Lost to Follow-up|1|||
130289394|NCT00746733|469022145|FG000|Second Intervention|Adverse Event|1|||
130289395|NCT00746733|469022146|FG001|Second Intervention|Adverse Event|0|||
130289396|NCT00746733|469022145|FG000|Third Intervention|Withdrawal by Subject|1|||
130289397|NCT00746733|469022146|FG001|Third Intervention|Withdrawal by Subject|1|||
130289398|NCT01527383|469022147|FG000|Overall Study|Adverse Event|5|||
130289399|NCT01527383|469022148|FG001|Overall Study|Adverse Event|0|||
130289400|NCT01527383|469022147|FG000|Overall Study|Lost to Follow-up|3|||
130289401|NCT01527383|469022148|FG001|Overall Study|Lost to Follow-up|0|||
130289402|NCT01527383|469022147|FG000|Overall Study|Physician Decision|2|||
130289403|NCT01527383|469022148|FG001|Overall Study|Physician Decision|0|||
130289404|NCT01527383|469022147|FG000|Overall Study|Pregnancy|1|||
130289405|NCT01527383|469022148|FG001|Overall Study|Pregnancy|0|||
130289406|NCT01527383|469022147|FG000|Overall Study|Protocol Violation|1|||
130289407|NCT01527383|469022148|FG001|Overall Study|Protocol Violation|0|||
130289408|NCT01527383|469022147|FG000|Overall Study|Screen failure|1|||
130289409|NCT01527383|469022148|FG001|Overall Study|Screen failure|0|||
130289410|NCT01527383|469022147|FG000|Overall Study|Participant moved|0|||
130289411|NCT01527383|469022148|FG001|Overall Study|Participant moved|1|||
130289412|NCT01527383|469022147|FG000|Overall Study|Withdrawal by Subject|2|||
130289413|NCT01527383|469022148|FG001|Overall Study|Withdrawal by Subject|3|||
130289414|NCT03412604|469022149|FG000|Overall Study|Withdrawal by Subject|1|||
130289415|NCT00930969|469022151|FG000|Overall Study|Death|5|||
130289416|NCT00930969|469022151|FG000|Overall Study|Lost to Follow-up|1|||
130289417|NCT00930969|469022151|FG000|Overall Study|Physician Decision|13|||
130289418|NCT00930969|469022151|FG000|Overall Study|Withdrawal by Subject|19|||
130289419|NCT01287221|469022152|FG000|Overall Study|Lack of Perceived Benefit|1|||
130289420|NCT01287221|469022153|FG001|Overall Study|Lack of Perceived Benefit|1|||
130289421|NCT01287221|469022152|FG000|Overall Study|Adverse Event|3|||
130289422|NCT01287221|469022153|FG001|Overall Study|Adverse Event|3|||
130714249|NCT03502707|470581650|FG000|Overall Study|Death|0|||
130714250|NCT03502707|470581651|FG001|Overall Study|Death|0|||
130289423|NCT01287221|469022152|FG000|Overall Study|Withdrawal by Subject|0|||
130289424|NCT01287221|469022153|FG001|Overall Study|Withdrawal by Subject|1|||
130289425|NCT00787137|469022155|FG000|Overall Study|Study Termination|0|||
130289426|NCT00787137|469022156|FG001|Overall Study|Study Termination|0|||
130289427|NCT00787137|469022157|FG002|Overall Study|Study Termination|1|||
130289428|NCT02513823|469022159|FG000|Overall Study|Lost to Follow-up|4|||
130289429|NCT02513823|469022159|FG000|Overall Study|Physician Decision|1|||
130289430|NCT02743780|469022164|FG000|Part 3 (7 Days)|Adverse Event|0|||
130289431|NCT02743780|469022165|FG001|Part 3 (7 Days)|Adverse Event|0|||
130289432|NCT02743780|469022166|FG002|Part 3 (7 Days)|Adverse Event|1|||
130289433|NCT02743780|469022167|FG003|Part 3 (7 Days)|Adverse Event|0|||
130289434|NCT02743780|469022168|FG004|Part 3 (7 Days)|Adverse Event|0|||
130289435|NCT01294462|469022169|FG000|Overall Study|Lost to Follow-up|1|||
130289436|NCT01294462|469022170|FG001|Overall Study|Lost to Follow-up|0|||
130289437|NCT01294462|469022169|FG000|Overall Study|Withdrawal by Subject|65|||
130289438|NCT01294462|469022170|FG001|Overall Study|Withdrawal by Subject|63|||
130289439|NCT04342689|469022178|FG000|Overall Study|Withdrawal by Subject|32|||
130289440|NCT04342689|469022179|FG001|Overall Study|Withdrawal by Subject|33|||
130289441|NCT04342689|469022178|FG000|Overall Study|Lost to Follow-up|10|||
130289442|NCT04342689|469022179|FG001|Overall Study|Lost to Follow-up|12|||
130289443|NCT01460407|469022182|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
130289444|NCT01460407|469022183|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
130289445|NCT01367704|469022184|FG000|Overall Study|Lost to Follow-up|47|||
130289446|NCT01367704|469022185|FG001|Overall Study|Lost to Follow-up|161|||
130289447|NCT01400243|469022187|FG000|Overall Study|Protocol Violation|8|||
130289448|NCT01400243|469022188|FG001|Overall Study|Protocol Violation|11|||
130289449|NCT02193087|469022189|FG000|Overall Study|Adverse Event|2|||
130289450|NCT02193087|469022190|FG001|Overall Study|Adverse Event|0|||
130289451|NCT02193087|469022191|FG002|Overall Study|Adverse Event|0|||
130289452|NCT02193087|469022192|FG003|Overall Study|Adverse Event|11|||
130289453|NCT02193087|469022189|FG000|Overall Study|Lost to Follow-up|14|||
130289454|NCT02193087|469022190|FG001|Overall Study|Lost to Follow-up|6|||
130289455|NCT02193087|469022191|FG002|Overall Study|Lost to Follow-up|4|||
130289456|NCT02193087|469022192|FG003|Overall Study|Lost to Follow-up|37|||
130289457|NCT02193087|469022189|FG000|Overall Study|Protocol Violation|2|||
130370917|NCT00618072|469329240|FG001|Overall Study|Lost to Follow-up|0|||
130370918|NCT00618072|469329241|FG002|Overall Study|Lost to Follow-up|3|||
130370919|NCT00618072|469329239|FG000|Overall Study|Physician Decision|0|||
130370920|NCT00618072|469329240|FG001|Overall Study|Physician Decision|1|||
130370921|NCT00618072|469329241|FG002|Overall Study|Physician Decision|1|||
130370922|NCT03292588|469329242|FG000|Overall Study|Death|1|||
130370923|NCT03292588|469329243|FG001|Overall Study|Death|0|||
130370924|NCT03292588|469329242|FG000|Overall Study|Lost to Follow-up|12|||
130370925|NCT03292588|469329243|FG001|Overall Study|Lost to Follow-up|16|||
130370926|NCT03292588|469329242|FG000|Overall Study|Physician Decision|0|||
130370927|NCT03292588|469329243|FG001|Overall Study|Physician Decision|1|||
130370928|NCT03292588|469329242|FG000|Overall Study|Withdrawal by Subject|4|||
130370929|NCT03292588|469329243|FG001|Overall Study|Withdrawal by Subject|4|||
130370930|NCT03292588|469329242|FG000|Overall Study|Move out of town|1|||
130370931|NCT03292588|469329243|FG001|Overall Study|Move out of town|0|||
130370932|NCT03292588|469329242|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
130370933|NCT03292588|469329243|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
130370934|NCT00062374|469329244|FG000|Overall Study|Not treated|12|||
130370935|NCT03633695|469329247|FG000|Overall Study|Lost to Follow-up|4|||
130370936|NCT03633695|469329248|FG001|Overall Study|Lost to Follow-up|5|||
130370937|NCT03633695|469329247|FG000|Overall Study|Discontinued|8|||
130370938|NCT03633695|469329248|FG001|Overall Study|Discontinued|4|||
130289458|NCT02193087|469022190|FG001|Overall Study|Protocol Violation|0|||
130289459|NCT02193087|469022191|FG002|Overall Study|Protocol Violation|1|||
130289460|NCT02193087|469022192|FG003|Overall Study|Protocol Violation|2|||
130289461|NCT02193087|469022189|FG000|Overall Study|Withdrawal by Subject|10|||
130289462|NCT02193087|469022190|FG001|Overall Study|Withdrawal by Subject|3|||
130289463|NCT02193087|469022191|FG002|Overall Study|Withdrawal by Subject|1|||
130370939|NCT00617773|469329256|FG000|Overall Study|Physician Decision|1|||
130370940|NCT00617773|469329256|FG000|Overall Study|Lack of compliance with the protocol|1|||
130370941|NCT00617773|469329256|FG000|Overall Study|Withdrawal by Subject|1|||
130289464|NCT02193087|469022192|FG003|Overall Study|Withdrawal by Subject|19|||
130289465|NCT02193087|469022189|FG000|Overall Study|Other Reason Not Specified|7|||
130289466|NCT02193087|469022190|FG001|Overall Study|Other Reason Not Specified|2|||
130289467|NCT02193087|469022191|FG002|Overall Study|Other Reason Not Specified|1|||
130289468|NCT02193087|469022192|FG003|Overall Study|Other Reason Not Specified|9|||
130289469|NCT02193087|469022189|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
130289470|NCT02193087|469022190|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
130289471|NCT02193087|469022191|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
130289472|NCT02193087|469022192|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
130289473|NCT04096820|469022193|FG000|Overall Study|Did not return for intervention|2|||
130289474|NCT04096820|469022193|FG000|Overall Study|Death|1|||
130289475|NCT00475865|469022194|FG000|Overall Study|Adverse Event|0|||
130289476|NCT00475865|469022195|FG001|Overall Study|Adverse Event|3|||
130289477|NCT00475865|469022196|FG002|Overall Study|Adverse Event|4|||
130289478|NCT00475865|469022194|FG000|Overall Study|Lack of Efficacy|1|||
130289479|NCT00475865|469022195|FG001|Overall Study|Lack of Efficacy|0|||
130289480|NCT00475865|469022196|FG002|Overall Study|Lack of Efficacy|0|||
130289481|NCT00475865|469022194|FG000|Overall Study|Progressive disease|0|||
130289482|NCT00475865|469022195|FG001|Overall Study|Progressive disease|1|||
130289483|NCT00475865|469022196|FG002|Overall Study|Progressive disease|2|||
130289484|NCT00475865|469022194|FG000|Overall Study|Participant did not wish to continue|1|||
130289485|NCT00475865|469022195|FG001|Overall Study|Participant did not wish to continue|0|||
130289486|NCT00475865|469022196|FG002|Overall Study|Participant did not wish to continue|0|||
130289487|NCT00475865|469022194|FG000|Overall Study|Other than above|0|||
130289488|NCT00475865|469022195|FG001|Overall Study|Other than above|1|||
130289489|NCT00475865|469022196|FG002|Overall Study|Other than above|0|||
130289490|NCT00946322|469022198|FG000|Pre-treatment|participant failure to follow up|1|||
130289491|NCT00946322|469022198|FG000|Post-treatment|participant failure to follow up|2|||
130289492|NCT01453946|469022200|FG000|Overall Study|Did not receive drug for the taper phase|1|||
130714251|NCT03502707|470581652|FG002|Overall Study|Death|0|||
130714252|NCT03502707|470581653|FG003|Overall Study|Death|1|||
130714253|NCT03502707|470581654|FG004|Overall Study|Death|0|||
130714254|NCT03502707|470581655|FG005|Overall Study|Death|0|||
130714255|NCT03502707|470581656|FG006|Overall Study|Death|0|||
130714256|NCT03502707|470581657|FG007|Overall Study|Death|0|||
130714257|NCT03502707|470581658|FG008|Overall Study|Death|1|||
130714258|NCT03502707|470581659|FG009|Overall Study|Death|1|||
130714259|NCT03502707|470581660|FG010|Overall Study|Death|0|||
130289493|NCT01453946|469022200|FG000|Overall Study|Protocol Violation|2|||
130289494|NCT01453946|469022200|FG000|Overall Study|Lack of Efficacy|3|||
130289495|NCT01453946|469022200|FG000|Overall Study|Adverse Event|3|||
130289496|NCT00846040|469022201|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
130289497|NCT00846040|469022202|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
130289498|NCT00846040|469022203|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
130289499|NCT00846040|469022201|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130289500|NCT00846040|469022202|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
130289501|NCT00846040|469022203|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130289502|NCT01822535|469022206|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
130289503|NCT01822535|469022207|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
130289504|NCT01822535|469022206|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
130289505|NCT01822535|469022207|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
130289506|NCT01822535|469022206|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
130289507|NCT01822535|469022207|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
130289508|NCT02278614|469022208|FG000|Overall Study|Withdrawal by Subject|3|||
130289509|NCT02278614|469022209|FG001|Overall Study|Withdrawal by Subject|5|||
130289510|NCT02278614|469022208|FG000|Overall Study|Adverse Event|1|||
130289511|NCT02278614|469022209|FG001|Overall Study|Adverse Event|0|||
130289512|NCT02278614|469022208|FG000|Overall Study|left eye was not eligible|1|||
130289513|NCT02278614|469022209|FG001|Overall Study|left eye was not eligible|0|||
130289514|NCT02279498|469022212|FG000|Overall Study|Adverse Event|3|||
130289515|NCT02279498|469022213|FG001|Overall Study|Adverse Event|0|||
130289516|NCT02279498|469022212|FG000|Overall Study|Lack of Efficacy|4|||
130289517|NCT02279498|469022213|FG001|Overall Study|Lack of Efficacy|0|||
130289518|NCT02279498|469022212|FG000|Overall Study|Lost to Follow-up|0|||
130289519|NCT02279498|469022213|FG001|Overall Study|Lost to Follow-up|1|||
130289520|NCT02279498|469022212|FG000|Overall Study|Withdrawal by Subject|9|||
130289521|NCT02279498|469022213|FG001|Overall Study|Withdrawal by Subject|2|||
130289522|NCT02279498|469022212|FG000|Overall Study|Undefined|2|||
130556521|NCT01641809|470006166|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
130289523|NCT02279498|469022213|FG001|Overall Study|Undefined|1|||
130714260|NCT03502707|470581661|FG011|Overall Study|Death|0|||
130714261|NCT03502707|470581662|FG012|Overall Study|Death|1|||
130714262|NCT03502707|470581663|FG013|Overall Study|Death|0|||
130289524|NCT01048866|469022214|FG000|Overall Study|Adverse Event|1|||
130714263|NCT03502707|470581664|FG014|Overall Study|Death|0|||
130714264|NCT03502707|470581665|FG015|Overall Study|Death|1|||
130714265|NCT03502707|470581666|FG016|Overall Study|Death|0|||
130289525|NCT01048866|469022215|FG001|Overall Study|Adverse Event|0|||
130289526|NCT01048866|469022214|FG000|Overall Study|Protocol Violation|1|||
130289527|NCT01048866|469022215|FG001|Overall Study|Protocol Violation|0|||
130289528|NCT01048866|469022214|FG000|Overall Study|Physician Decision|1|||
130289529|NCT01048866|469022215|FG001|Overall Study|Physician Decision|0|||
130289530|NCT01048866|469022214|FG000|Overall Study|Withdrawal by Subject|0|||
130289531|NCT01048866|469022215|FG001|Overall Study|Withdrawal by Subject|2|||
130289532|NCT01048866|469022214|FG000|Overall Study|Lost to Follow-up|0|||
130289533|NCT01048866|469022215|FG001|Overall Study|Lost to Follow-up|2|||
130289534|NCT01048866|469022214|FG000|Overall Study|Other|1|||
130289535|NCT01048866|469022215|FG001|Overall Study|Other|1|||
130289536|NCT03582813|469022216|FG000|Overall Study|Lost to Follow-up|18|||
130289537|NCT03582813|469022217|FG001|Overall Study|Lost to Follow-up|21|||
130289538|NCT03582813|469022216|FG000|Overall Study|Withdrawal by Subject|1|||
130289539|NCT03582813|469022217|FG001|Overall Study|Withdrawal by Subject|0|||
130289540|NCT02230683|469022220|FG000|Overall Study|Adverse Event|1|||
130289541|NCT00260065|469022221|FG000|Overall Study|Progressive Disease|22|||
130289542|NCT00260065|469022221|FG000|Overall Study|Adverse Event|17|||
130289543|NCT00260065|469022221|FG000|Overall Study|Death|13|||
130289544|NCT00260065|469022221|FG000|Overall Study|Withdrawal by Subject|13|||
130289545|NCT00260065|469022221|FG000|Overall Study|Physician Decision|19|||
130289546|NCT00260065|469022221|FG000|Overall Study|Not otherwise specified|8|||
130289547|NCT00260065|469022221|FG000|Overall Study|Medication Noncompliance|1|||
130289548|NCT04068519|469022222|FG000|Dose Verification|Death|15|||
130289549|NCT04068519|469022222|FG000|Dose Verification|Withdrawal by Subject|1|||
130289550|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Death|35|||
130289551|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
130289552|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
130289553|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
130289554|NCT04068519|469022222|FG000|Indication Expansion|Death|152|||
130289555|NCT04068519|469022222|FG000|Indication Expansion|Withdrawal by Subject|10|||
130289556|NCT04068519|469022222|FG000|Indication Expansion|Lost to Follow-up|7|||
130289557|NCT04431713|469023659|FG000|Overall Study|Withdrawal by Subject|2|||
130289558|NCT04431713|469023660|FG001|Overall Study|Withdrawal by Subject|0|||
130289559|NCT04431713|469023659|FG000|Overall Study|Death|2|||
130289560|NCT04431713|469023660|FG001|Overall Study|Death|2|||
130289561|NCT02285114|469023662|FG000|Main Phase|Investigator's Discretion|0|||
130289562|NCT02285114|469023663|FG001|Main Phase|Investigator's Discretion|2|||
130289563|NCT02285114|469023664|FG002|Main Phase|Investigator's Discretion|0|||
130289564|NCT02285114|469023665|FG003|Main Phase|Investigator's Discretion|0|||
130289565|NCT02285114|469023666|FG004|Main Phase|Investigator's Discretion|0|||
130289566|NCT02285114|469023667|FG005|Main Phase|Investigator's Discretion|0|||
130289567|NCT02285114|469023662|FG000|Main Phase|Enrolled but Never Treated|1|||
130289568|NCT02285114|469023663|FG001|Main Phase|Enrolled but Never Treated|0|||
130289569|NCT02285114|469023664|FG002|Main Phase|Enrolled but Never Treated|0|||
130289570|NCT02285114|469023665|FG003|Main Phase|Enrolled but Never Treated|0|||
130289571|NCT02285114|469023666|FG004|Main Phase|Enrolled but Never Treated|0|||
130289572|NCT02285114|469023667|FG005|Main Phase|Enrolled but Never Treated|0|||
130289573|NCT02285114|469023662|FG000|Main Phase|Withdrew Consent|0|||
130289574|NCT02285114|469023663|FG001|Main Phase|Withdrew Consent|0|||
130289575|NCT02285114|469023664|FG002|Main Phase|Withdrew Consent|1|||
130289576|NCT02285114|469023665|FG003|Main Phase|Withdrew Consent|0|||
130289577|NCT02285114|469023666|FG004|Main Phase|Withdrew Consent|0|||
130289578|NCT02285114|469023667|FG005|Main Phase|Withdrew Consent|0|||
130289579|NCT02285114|469023662|FG000|Extension Phase|Investigator's Discretion|0|||
130289580|NCT02285114|469023663|FG001|Extension Phase|Investigator's Discretion|0|||
130289581|NCT02285114|469023664|FG002|Extension Phase|Investigator's Discretion|0|||
130289582|NCT02285114|469023665|FG003|Extension Phase|Investigator's Discretion|14|||
130289583|NCT02285114|469023666|FG004|Extension Phase|Investigator's Discretion|1|||
130289584|NCT02285114|469023667|FG005|Extension Phase|Investigator's Discretion|0|||
130289585|NCT02285114|469023662|FG000|Extension Phase|Lost to Follow-up|0|||
130459877|NCT00639002|469647629|FG000|Overall Study|Physician Decision|6|||
130459878|NCT00639002|469647629|FG000|Overall Study|Lack of Efficacy|1|||
130459879|NCT00940992|469647637|FG000|Overall Study|Adverse Event|2|||
130459880|NCT00940992|469647638|FG001|Overall Study|Adverse Event|0|||
130459881|NCT00940992|469647639|FG002|Overall Study|Adverse Event|1|||
130459882|NCT00940992|469647637|FG000|Overall Study|subject request|2|||
130459883|NCT00940992|469647638|FG001|Overall Study|subject request|1|||
130459884|NCT00940992|469647639|FG002|Overall Study|subject request|0|||
130289586|NCT02285114|469023663|FG001|Extension Phase|Lost to Follow-up|0|||
130289587|NCT02285114|469023664|FG002|Extension Phase|Lost to Follow-up|0|||
130289588|NCT02285114|469023665|FG003|Extension Phase|Lost to Follow-up|1|||
130289589|NCT02285114|469023666|FG004|Extension Phase|Lost to Follow-up|1|||
130289590|NCT02285114|469023667|FG005|Extension Phase|Lost to Follow-up|0|||
130289591|NCT02285114|469023662|FG000|Extension Phase|Non-compliance with Study Drug|0|||
130289592|NCT02285114|469023663|FG001|Extension Phase|Non-compliance with Study Drug|0|||
130289593|NCT02285114|469023664|FG002|Extension Phase|Non-compliance with Study Drug|0|||
130289594|NCT02285114|469023665|FG003|Extension Phase|Non-compliance with Study Drug|2|||
130289595|NCT02285114|469023666|FG004|Extension Phase|Non-compliance with Study Drug|0|||
130289596|NCT02285114|469023667|FG005|Extension Phase|Non-compliance with Study Drug|0|||
130289597|NCT02285114|469023662|FG000|Extension Phase|Pregnancy|0|||
130289598|NCT02285114|469023663|FG001|Extension Phase|Pregnancy|0|||
130289599|NCT02285114|469023664|FG002|Extension Phase|Pregnancy|0|||
130289600|NCT02285114|469023665|FG003|Extension Phase|Pregnancy|1|||
130556522|NCT01641809|470006167|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
130556523|NCT01641809|470006168|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
130556524|NCT01641809|470006165|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
130556525|NCT01641809|470006166|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
130556526|NCT01641809|470006167|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
130556527|NCT01641809|470006168|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
130289601|NCT02285114|469023666|FG004|Extension Phase|Pregnancy|0|||
130289602|NCT02285114|469023667|FG005|Extension Phase|Pregnancy|0|||
130289603|NCT01156389|469023673|FG000|Overall Study|Elevated liver enzymes|4|||
130289604|NCT01156389|469023674|FG001|Overall Study|Elevated liver enzymes|0|||
130289605|NCT01156389|469023673|FG000|Overall Study|Vomiting|0|||
130556528|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
130556529|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
130556530|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
130556531|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
130289606|NCT01156389|469023674|FG001|Overall Study|Vomiting|1|||
130289607|NCT04599166|469023682|FG000|Overall Study|Technological failure connecting to study app|80|||
130289608|NCT01777542|469023683|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
130289609|NCT01777542|469023684|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
130556532|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
130289610|NCT00953524|469023686|FG000|Overall Study|Adverse Event|2|||
130289611|NCT00953524|469023687|FG001|Overall Study|Adverse Event|0|||
130289612|NCT00953524|469023688|FG002|Overall Study|Adverse Event|1|||
130289613|NCT00953524|469023689|FG003|Overall Study|Adverse Event|2|||
130289614|NCT00953524|469023686|FG000|Overall Study|Protocol Violation|18|||
130289615|NCT00953524|469023687|FG001|Overall Study|Protocol Violation|10|||
130289616|NCT00953524|469023688|FG002|Overall Study|Protocol Violation|11|||
130289617|NCT00953524|469023689|FG003|Overall Study|Protocol Violation|6|||
130289618|NCT00953524|469023686|FG000|Overall Study|Lost to Follow-up|0|||
130289619|NCT00953524|469023687|FG001|Overall Study|Lost to Follow-up|1|||
130289620|NCT00953524|469023688|FG002|Overall Study|Lost to Follow-up|1|||
130289621|NCT00953524|469023689|FG003|Overall Study|Lost to Follow-up|0|||
130289622|NCT00953524|469023686|FG000|Overall Study|Withdrawal by Subject|2|||
130289623|NCT00953524|469023687|FG001|Overall Study|Withdrawal by Subject|4|||
130289624|NCT00953524|469023688|FG002|Overall Study|Withdrawal by Subject|1|||
130370942|NCT00617773|469329256|FG000|Overall Study|Death|1|||
130370943|NCT00617773|469329256|FG000|Overall Study|Progressive disease|19|||
130370944|NCT00617773|469329256|FG000|Overall Study|Protocol Violation|1|||
130370945|NCT01751867|469329257|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
130370946|NCT01751867|469329258|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
130370947|NCT01751867|469329257|FG000|Overall Study|Diease Progression|4|||
130370948|NCT01751867|469329258|FG001|Overall Study|Diease Progression|18|||
130370949|NCT01751867|469329257|FG000|Overall Study|Adverse Event|8|||
130370950|NCT01751867|469329258|FG001|Overall Study|Adverse Event|15|||
130370951|NCT01751867|469329257|FG000|Overall Study|Poor Compliance|0|||
130370952|NCT01751867|469329258|FG001|Overall Study|Poor Compliance|5|||
130370953|NCT01751867|469329257|FG000|Overall Study|Withdrawal by Subject|3|||
130370954|NCT01751867|469329258|FG001|Overall Study|Withdrawal by Subject|1|||
130370955|NCT01751867|469329257|FG000|Overall Study|Physician Decision|4|||
130370956|NCT01751867|469329258|FG001|Overall Study|Physician Decision|7|||
130370957|NCT01751867|469329257|FG000|Overall Study|Protocol Violation|0|||
130370958|NCT01751867|469329258|FG001|Overall Study|Protocol Violation|2|||
130370959|NCT01751867|469329257|FG000|Overall Study|Death|0|||
130370960|NCT01751867|469329258|FG001|Overall Study|Death|5|||
130370961|NCT01751867|469329257|FG000|Overall Study|Other|11|||
130370962|NCT01751867|469329258|FG001|Overall Study|Other|37|||
130370963|NCT01751867|469329257|FG000|Overall Study|Randomized but not treated.|2|||
130370964|NCT01751867|469329258|FG001|Overall Study|Randomized but not treated.|1|||
130370965|NCT04932096|469329259|FG000|Overall Study|Withdrawal by Subject|1|||
130289625|NCT00953524|469023689|FG003|Overall Study|Withdrawal by Subject|0|||
130289626|NCT00869050|469023697|FG000|Overall Study|Screen Failure|3|||
130289627|NCT03554772|469023701|FG000|Overall Study|Lost to Follow-up|0|||
130289628|NCT03554772|469023702|FG001|Overall Study|Lost to Follow-up|0|||
130289629|NCT03554772|469023703|FG002|Overall Study|Lost to Follow-up|0|||
130289630|NCT03554772|469023704|FG003|Overall Study|Lost to Follow-up|2|||
130370966|NCT04932096|469329260|FG001|Overall Study|Withdrawal by Subject|1|||
130370967|NCT04932096|469329259|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
130370968|NCT04932096|469329260|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
130289631|NCT01994863|469023706|FG000|Period 1|Adverse Event|4|||
130289632|NCT01994863|469023707|FG001|Period 1|Adverse Event|0|||
130289633|NCT01994863|469023706|FG000|Period 1|Withdrawal by Subject|1|||
130289634|NCT01994863|469023707|FG001|Period 1|Withdrawal by Subject|0|||
130289635|NCT01994863|469023706|FG000|Period 1|Trial stopped by sponsor|1|||
130289636|NCT01994863|469023707|FG001|Period 1|Trial stopped by sponsor|3|||
130289637|NCT01994863|469023706|FG000|Period 1|Lack of Efficacy|1|||
130289638|NCT01994863|469023707|FG001|Period 1|Lack of Efficacy|0|||
130289639|NCT01994863|469023706|FG000|Period 2|Adverse Event|0|||
130289640|NCT01994863|469023707|FG001|Period 2|Adverse Event|1|||
130289641|NCT01994863|469023706|FG000|Period 2|Lack of Efficacy|0|||
130289642|NCT01994863|469023707|FG001|Period 2|Lack of Efficacy|2|||
130289643|NCT01994863|469023706|FG000|Period 2|Withdrawal by Subject|1|||
130289644|NCT01994863|469023707|FG001|Period 2|Withdrawal by Subject|1|||
130289645|NCT01145053|469023708|FG000|Overall Study|Adverse Event|22|||
130289646|NCT01145053|469023708|FG000|Overall Study|Lost to Follow-up|28|||
130289647|NCT01145053|469023708|FG000|Overall Study|Withdrawal by Subject|25|||
130289648|NCT01145053|469023708|FG000|Overall Study|Other|18|||
130289649|NCT05136898|469023709|FG000|Overall Study|Adverse Event|2|||
130289650|NCT03060512|469023710|FG000|Overall Study|Adverse Event|4|||
130289651|NCT03060512|469023711|FG001|Overall Study|Adverse Event|6|||
130289652|NCT03060512|469023710|FG000|Overall Study|Lost to Follow-up|1|||
130289653|NCT03060512|469023711|FG001|Overall Study|Lost to Follow-up|1|||
130289654|NCT03060512|469023710|FG000|Overall Study|Withdrawal by Subject|1|||
130289655|NCT03060512|469023711|FG001|Overall Study|Withdrawal by Subject|0|||
130289656|NCT03060512|469023710|FG000|Overall Study|Non-compliance with study medication|1|||
130289657|NCT03060512|469023711|FG001|Overall Study|Non-compliance with study medication|2|||
130289658|NCT03946124|469023712|FG000|Overall Study|Withdrawal by Subject|19|||
130289659|NCT00241631|469023714|FG000|Run in (2 Weeks)|Physician Decision|3|||
130289660|NCT00241631|469023715|FG001|Run in (2 Weeks)|Physician Decision|3|||
130289661|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|sore throat|1|||
130289662|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|sore throat|0|||
130289663|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130289664|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130289665|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
130289666|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
130289667|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
130289668|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
130289669|NCT01561755|469023722|FG000|Overall Study|Lost to Follow-up|0|||
130289670|NCT01561755|469023723|FG001|Overall Study|Lost to Follow-up|1|||
130289671|NCT02813668|469023725|FG000|Overall Study|Death|4|||
130289672|NCT02813668|469023725|FG000|Overall Study|Lost to Follow-up|509|||
130289673|NCT02813668|469023725|FG000|Overall Study|Withdrawal by Subject|148|||
130289674|NCT02813668|469023725|FG000|Overall Study|No longer at worksite|85|||
130289675|NCT02813668|469023725|FG000|Overall Study|Medical reasons not related to the study|4|||
130289676|NCT04662073|469023726|FG000|Overall Study|Withdrawal by Subject|1|||
130289677|NCT04662073|469023727|FG001|Overall Study|Withdrawal by Subject|0|||
130289678|NCT02185014|469023728|FG000|Overall Study|Adverse Event|18|||
130289679|NCT02185014|469023728|FG000|Overall Study|Withdrew Consent|8|||
130289680|NCT02185014|469023728|FG000|Overall Study|Lost to Follow-up|4|||
130289681|NCT02185014|469023728|FG000|Overall Study|Lack of Efficacy|14|||
130289682|NCT02185014|469023728|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
130289683|NCT02185014|469023728|FG000|Overall Study|Subject Noncompliance|1|||
130289684|NCT02185014|469023728|FG000|Overall Study|Other|4|||
130289685|NCT02370641|469023733|FG000|Overall Study|dropped study|4|||
130289686|NCT02370641|469023734|FG001|Overall Study|dropped study|2|||
130289687|NCT02133664|469023738|FG000|Overall Study|Lost to Follow-up|2|||
130289688|NCT02133664|469023739|FG001|Overall Study|Lost to Follow-up|1|||
130289689|NCT02133664|469023738|FG000|Overall Study|Adverse Event|3|||
130289690|NCT02133664|469023739|FG001|Overall Study|Adverse Event|6|||
130289691|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
130289692|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
130289693|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
130289694|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
130289695|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
130289696|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
130289697|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
130289698|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
130289699|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
130289700|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
130289701|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
130289702|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
130289703|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
130289704|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
130289705|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
130289706|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
130289707|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
130714266|NCT03502707|470581667|FG017|Overall Study|Death|0|||
130714267|NCT03502707|470581650|FG000|Overall Study|Lost to Follow-up|0|||
130714268|NCT03502707|470581651|FG001|Overall Study|Lost to Follow-up|0|||
130714269|NCT03502707|470581652|FG002|Overall Study|Lost to Follow-up|0|||
130289708|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
130289709|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
130289710|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
130289711|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
130289712|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
130289713|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
130289714|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
130289715|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
130289716|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
130289717|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
130289718|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
130714270|NCT03502707|470581653|FG003|Overall Study|Lost to Follow-up|0|||
130714271|NCT03502707|470581654|FG004|Overall Study|Lost to Follow-up|0|||
130714272|NCT03502707|470581655|FG005|Overall Study|Lost to Follow-up|0|||
130714273|NCT03502707|470581656|FG006|Overall Study|Lost to Follow-up|0|||
130714274|NCT03502707|470581657|FG007|Overall Study|Lost to Follow-up|5|||
130714275|NCT03502707|470581658|FG008|Overall Study|Lost to Follow-up|0|||
130714276|NCT03502707|470581659|FG009|Overall Study|Lost to Follow-up|2|||
130714277|NCT03502707|470581660|FG010|Overall Study|Lost to Follow-up|1|||
130714278|NCT03502707|470581661|FG011|Overall Study|Lost to Follow-up|2|||
130714279|NCT03502707|470581662|FG012|Overall Study|Lost to Follow-up|1|||
130714280|NCT03502707|470581663|FG013|Overall Study|Lost to Follow-up|1|||
130714281|NCT03502707|470581664|FG014|Overall Study|Lost to Follow-up|0|||
130714282|NCT03502707|470581665|FG015|Overall Study|Lost to Follow-up|4|||
130714283|NCT03502707|470581666|FG016|Overall Study|Lost to Follow-up|9|||
130714284|NCT03502707|470581667|FG017|Overall Study|Lost to Follow-up|2|||
130714285|NCT03502707|470581650|FG000|Overall Study|Physician Decision|0|||
130714286|NCT03502707|470581651|FG001|Overall Study|Physician Decision|0|||
130714287|NCT03502707|470581652|FG002|Overall Study|Physician Decision|0|||
130714288|NCT03502707|470581653|FG003|Overall Study|Physician Decision|0|||
130714289|NCT03502707|470581654|FG004|Overall Study|Physician Decision|0|||
130714290|NCT03502707|470581655|FG005|Overall Study|Physician Decision|0|||
130714291|NCT03502707|470581656|FG006|Overall Study|Physician Decision|0|||
130714292|NCT03502707|470581657|FG007|Overall Study|Physician Decision|0|||
130714293|NCT03502707|470581658|FG008|Overall Study|Physician Decision|2|||
130714294|NCT03502707|470581659|FG009|Overall Study|Physician Decision|1|||
130714295|NCT03502707|470581660|FG010|Overall Study|Physician Decision|0|||
130714296|NCT03502707|470581661|FG011|Overall Study|Physician Decision|0|||
130714297|NCT03502707|470581662|FG012|Overall Study|Physician Decision|0|||
130714298|NCT03502707|470581663|FG013|Overall Study|Physician Decision|0|||
130714299|NCT03502707|470581664|FG014|Overall Study|Physician Decision|1|||
130714300|NCT03502707|470581665|FG015|Overall Study|Physician Decision|3|||
130714301|NCT03502707|470581666|FG016|Overall Study|Physician Decision|0|||
130714302|NCT03502707|470581667|FG017|Overall Study|Physician Decision|0|||
130714303|NCT03502707|470581650|FG000|Overall Study|Protocol Violation|0|||
130714304|NCT03502707|470581651|FG001|Overall Study|Protocol Violation|0|||
130714305|NCT03502707|470581652|FG002|Overall Study|Protocol Violation|0|||
130714306|NCT03502707|470581653|FG003|Overall Study|Protocol Violation|0|||
130714307|NCT03502707|470581654|FG004|Overall Study|Protocol Violation|0|||
130714308|NCT03502707|470581655|FG005|Overall Study|Protocol Violation|0|||
130714309|NCT03502707|470581656|FG006|Overall Study|Protocol Violation|0|||
130714310|NCT03502707|470581657|FG007|Overall Study|Protocol Violation|0|||
130714311|NCT03502707|470581658|FG008|Overall Study|Protocol Violation|0|||
130714312|NCT03502707|470581659|FG009|Overall Study|Protocol Violation|0|||
130714313|NCT03502707|470581660|FG010|Overall Study|Protocol Violation|0|||
130714314|NCT03502707|470581661|FG011|Overall Study|Protocol Violation|0|||
130714315|NCT03502707|470581662|FG012|Overall Study|Protocol Violation|0|||
130714316|NCT03502707|470581663|FG013|Overall Study|Protocol Violation|0|||
130714317|NCT03502707|470581664|FG014|Overall Study|Protocol Violation|0|||
130714318|NCT03502707|470581665|FG015|Overall Study|Protocol Violation|1|||
130714319|NCT03502707|470581666|FG016|Overall Study|Protocol Violation|0|||
130714320|NCT03502707|470581667|FG017|Overall Study|Protocol Violation|0|||
130714321|NCT03502707|470581650|FG000|Overall Study|Withdrawal by Subject|1|||
130714322|NCT03502707|470581651|FG001|Overall Study|Withdrawal by Subject|1|||
130714323|NCT03502707|470581652|FG002|Overall Study|Withdrawal by Subject|0|||
130714324|NCT03502707|470581653|FG003|Overall Study|Withdrawal by Subject|0|||
130714325|NCT03502707|470581654|FG004|Overall Study|Withdrawal by Subject|0|||
130714326|NCT03502707|470581655|FG005|Overall Study|Withdrawal by Subject|2|||
130714327|NCT03502707|470581656|FG006|Overall Study|Withdrawal by Subject|0|||
130714328|NCT03502707|470581657|FG007|Overall Study|Withdrawal by Subject|3|||
130714329|NCT03502707|470581658|FG008|Overall Study|Withdrawal by Subject|1|||
130714330|NCT03502707|470581659|FG009|Overall Study|Withdrawal by Subject|2|||
130714331|NCT03502707|470581660|FG010|Overall Study|Withdrawal by Subject|12|||
130714332|NCT03502707|470581661|FG011|Overall Study|Withdrawal by Subject|23|||
130714333|NCT03502707|470581662|FG012|Overall Study|Withdrawal by Subject|5|||
130714334|NCT03502707|470581663|FG013|Overall Study|Withdrawal by Subject|3|||
130714335|NCT03502707|470581664|FG014|Overall Study|Withdrawal by Subject|3|||
130289719|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
130289720|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
130289721|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
130289722|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
130289723|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
130289724|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
130289725|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Death|2|||
130289726|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Death|0|||
130289727|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
130289728|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
130289729|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
130289730|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
130289731|NCT01945775|469023744|FG000|Overall Study|Death|214|||
130289732|NCT01945775|469023745|FG001|Overall Study|Death|98|||
130289733|NCT01945775|469023744|FG000|Overall Study|Lost to Follow-up|12|||
130289734|NCT01945775|469023745|FG001|Overall Study|Lost to Follow-up|7|||
130289735|NCT01945775|469023744|FG000|Overall Study|Withdrawal by Subject|11|||
130289736|NCT01945775|469023745|FG001|Overall Study|Withdrawal by Subject|21|||
130289737|NCT01945775|469023744|FG000|Overall Study|Other|50|||
130289738|NCT01945775|469023745|FG001|Overall Study|Other|18|||
130289739|NCT02876328|469023746|FG000|Overall Study|Death|2|||
130289740|NCT02876328|469023747|FG001|Overall Study|Death|1|||
130289741|NCT02876328|469023748|FG002|Overall Study|Death|3|||
130289742|NCT02876328|469023749|FG003|Overall Study|Death|0|||
130289743|NCT02876328|469023750|FG004|Overall Study|Death|0|||
130289744|NCT02876328|469023751|FG005|Overall Study|Death|0|||
130289745|NCT02876328|469023752|FG006|Overall Study|Death|1|||
130289746|NCT02876328|469023753|FG007|Overall Study|Death|3|||
130289747|NCT02876328|469023754|FG008|Overall Study|Death|0|||
130289748|NCT02876328|469023755|FG009|Overall Study|Death|1|||
130289749|NCT02876328|469023756|FG010|Overall Study|Death|1|||
130289750|NCT02876328|469023757|FG011|Overall Study|Death|0|||
130289751|NCT02876328|469023758|FG012|Overall Study|Death|0|||
130289752|NCT02876328|469023759|FG013|Overall Study|Death|0|||
130289753|NCT02876328|469023760|FG014|Overall Study|Death|0|||
130370969|NCT02170298|469329261|FG000|Overall Study|Withdrawal by Subject|0|||
130370970|NCT02170298|469329262|FG001|Overall Study|Withdrawal by Subject|1|||
130370971|NCT02170298|469329261|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
130370972|NCT02170298|469329262|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
130370973|NCT01976338|469329263|FG000|Overall Study|Physician Decision|0|||
130370974|NCT01976338|469329264|FG001|Overall Study|Physician Decision|1|||
130370975|NCT01976338|469329263|FG000|Overall Study|Lost to Follow-up|3|||
130370976|NCT01976338|469329264|FG001|Overall Study|Lost to Follow-up|0|||
130370977|NCT01976338|469329263|FG000|Overall Study|Withdrawal by Subject|5|||
130370978|NCT01976338|469329264|FG001|Overall Study|Withdrawal by Subject|2|||
130370979|NCT01976338|469329263|FG000|Overall Study|Adverse Event|5|||
130370980|NCT01976338|469329264|FG001|Overall Study|Adverse Event|1|||
130370981|NCT00777608|469329265|FG000|Overall Study|Lost to Follow-up|1|||
130370982|NCT00777608|469329266|FG001|Overall Study|Lost to Follow-up|1|||
130370983|NCT00777608|469329265|FG000|Overall Study|Withdrawal by Subject|1|||
130370984|NCT00777608|469329266|FG001|Overall Study|Withdrawal by Subject|3|||
130370985|NCT00777608|469329265|FG000|Overall Study|Protocol Violation|1|||
130370986|NCT00777608|469329266|FG001|Overall Study|Protocol Violation|0|||
130370987|NCT00777608|469329265|FG000|Overall Study|Investigator Decision|1|||
130370988|NCT00777608|469329266|FG001|Overall Study|Investigator Decision|2|||
130370989|NCT03766581|469329267|FG000|Randomization|Other reasons|2|||
130370990|NCT03766581|469329268|FG001|Randomization|Other reasons|1|||
130370991|NCT03766581|469329269|FG002|Randomization|Other reasons|0|||
130370992|NCT03766581|469329270|FG003|Randomization|Other reasons|1|||
130370993|NCT03766581|469329271|FG004|Randomization|Other reasons|0|||
130289754|NCT02876328|469023761|FG015|Overall Study|Death|0|||
130289755|NCT02876328|469023762|FG016|Overall Study|Death|1|||
130289756|NCT02876328|469023763|FG017|Overall Study|Death|1|||
130370994|NCT03766581|469329272|FG005|Randomization|Other reasons|0|||
130370995|NCT03766581|469329273|FG006|Randomization|Other reasons|0|||
130370996|NCT03766581|469329274|FG007|Randomization|Other reasons|0|||
130370997|NCT03766581|469329267|FG000|Randomization|Participant no longer meets study criteria|5|||
130370998|NCT03766581|469329268|FG001|Randomization|Participant no longer meets study criteria|3|||
130370999|NCT03766581|469329269|FG002|Randomization|Participant no longer meets study criteria|4|||
130459885|NCT00940992|469647637|FG000|Overall Study|Lost to Follow-up|0|||
130289757|NCT02876328|469023764|FG018|Overall Study|Death|0|||
130289758|NCT02876328|469023765|FG019|Overall Study|Death|0|||
130289759|NCT02876328|469023766|FG020|Overall Study|Death|0|||
130289760|NCT02876328|469023767|FG021|Overall Study|Death|1|||
130289761|NCT02876328|469023768|FG022|Overall Study|Death|0|||
130714336|NCT03502707|470581665|FG015|Overall Study|Withdrawal by Subject|43|||
130714337|NCT03502707|470581666|FG016|Overall Study|Withdrawal by Subject|44|||
130714338|NCT03502707|470581667|FG017|Overall Study|Withdrawal by Subject|18|||
130714339|NCT03502707|470581650|FG000|Overall Study|Sponsor's Decision|1|||
130714340|NCT03502707|470581651|FG001|Overall Study|Sponsor's Decision|0|||
130714341|NCT03502707|470581652|FG002|Overall Study|Sponsor's Decision|0|||
130714342|NCT03502707|470581653|FG003|Overall Study|Sponsor's Decision|0|||
130714343|NCT03502707|470581654|FG004|Overall Study|Sponsor's Decision|0|||
130714344|NCT03502707|470581655|FG005|Overall Study|Sponsor's Decision|0|||
130714345|NCT03502707|470581656|FG006|Overall Study|Sponsor's Decision|0|||
130714346|NCT03502707|470581657|FG007|Overall Study|Sponsor's Decision|0|||
130714347|NCT03502707|470581658|FG008|Overall Study|Sponsor's Decision|0|||
130714348|NCT03502707|470581659|FG009|Overall Study|Sponsor's Decision|1|||
130714349|NCT03502707|470581660|FG010|Overall Study|Sponsor's Decision|0|||
130714350|NCT03502707|470581661|FG011|Overall Study|Sponsor's Decision|0|||
130714351|NCT03502707|470581662|FG012|Overall Study|Sponsor's Decision|0|||
130714352|NCT03502707|470581663|FG013|Overall Study|Sponsor's Decision|0|||
130289762|NCT02876328|469023769|FG023|Overall Study|Death|0|||
130289763|NCT02876328|469023746|FG000|Overall Study|Withdrawal by Subject|0|||
130289764|NCT02876328|469023747|FG001|Overall Study|Withdrawal by Subject|2|||
130289765|NCT02876328|469023748|FG002|Overall Study|Withdrawal by Subject|3|||
130289766|NCT02876328|469023749|FG003|Overall Study|Withdrawal by Subject|3|||
130289767|NCT02876328|469023750|FG004|Overall Study|Withdrawal by Subject|0|||
130289768|NCT02876328|469023751|FG005|Overall Study|Withdrawal by Subject|1|||
130289769|NCT02876328|469023752|FG006|Overall Study|Withdrawal by Subject|0|||
130289770|NCT02876328|469023753|FG007|Overall Study|Withdrawal by Subject|1|||
130289771|NCT02876328|469023754|FG008|Overall Study|Withdrawal by Subject|1|||
130289772|NCT02876328|469023755|FG009|Overall Study|Withdrawal by Subject|2|||
130289773|NCT02876328|469023756|FG010|Overall Study|Withdrawal by Subject|0|||
130289774|NCT02876328|469023757|FG011|Overall Study|Withdrawal by Subject|0|||
130289775|NCT02876328|469023758|FG012|Overall Study|Withdrawal by Subject|0|||
130289776|NCT02876328|469023759|FG013|Overall Study|Withdrawal by Subject|0|||
130289777|NCT02876328|469023760|FG014|Overall Study|Withdrawal by Subject|0|||
130289778|NCT02876328|469023761|FG015|Overall Study|Withdrawal by Subject|0|||
130289779|NCT02876328|469023762|FG016|Overall Study|Withdrawal by Subject|1|||
130289780|NCT02876328|469023763|FG017|Overall Study|Withdrawal by Subject|3|||
130289781|NCT02876328|469023764|FG018|Overall Study|Withdrawal by Subject|0|||
130289782|NCT02876328|469023765|FG019|Overall Study|Withdrawal by Subject|0|||
130289783|NCT02876328|469023766|FG020|Overall Study|Withdrawal by Subject|1|||
130289784|NCT02876328|469023767|FG021|Overall Study|Withdrawal by Subject|0|||
130289785|NCT02876328|469023768|FG022|Overall Study|Withdrawal by Subject|0|||
130289786|NCT02876328|469023769|FG023|Overall Study|Withdrawal by Subject|0|||
130289787|NCT02876328|469023746|FG000|Overall Study|Missed 12 Month Visit|15|||
130289788|NCT02876328|469023747|FG001|Overall Study|Missed 12 Month Visit|10|||
130289789|NCT02876328|469023748|FG002|Overall Study|Missed 12 Month Visit|11|||
130289790|NCT02876328|469023749|FG003|Overall Study|Missed 12 Month Visit|6|||
130289791|NCT02876328|469023750|FG004|Overall Study|Missed 12 Month Visit|10|||
130289792|NCT02876328|469023751|FG005|Overall Study|Missed 12 Month Visit|14|||
130371000|NCT03766581|469329270|FG003|Randomization|Participant no longer meets study criteria|0|||
130371001|NCT03766581|469329271|FG004|Randomization|Participant no longer meets study criteria|2|||
130371002|NCT03766581|469329272|FG005|Randomization|Participant no longer meets study criteria|3|||
130371003|NCT03766581|469329273|FG006|Randomization|Participant no longer meets study criteria|0|||
130371004|NCT03766581|469329274|FG007|Randomization|Participant no longer meets study criteria|1|||
130371005|NCT03766581|469329267|FG000|Randomization|Participant request to discontinue study treatment|1|||
130371006|NCT03766581|469329268|FG001|Randomization|Participant request to discontinue study treatment|0|||
130371007|NCT03766581|469329269|FG002|Randomization|Participant request to discontinue study treatment|0|||
130371008|NCT03766581|469329270|FG003|Randomization|Participant request to discontinue study treatment|0|||
130371009|NCT03766581|469329271|FG004|Randomization|Participant request to discontinue study treatment|1|||
130714353|NCT03502707|470581664|FG014|Overall Study|Sponsor's Decision|0|||
130714354|NCT03502707|470581665|FG015|Overall Study|Sponsor's Decision|2|||
130714355|NCT03502707|470581666|FG016|Overall Study|Sponsor's Decision|1|||
130289793|NCT02876328|469023752|FG006|Overall Study|Missed 12 Month Visit|3|||
130289794|NCT02876328|469023753|FG007|Overall Study|Missed 12 Month Visit|8|||
130289795|NCT02876328|469023754|FG008|Overall Study|Missed 12 Month Visit|9|||
130714356|NCT03502707|470581667|FG017|Overall Study|Sponsor's Decision|0|||
130714357|NCT03502707|470581650|FG000|Overall Study|Initiated Prohibited Medication|0|||
130289796|NCT02876328|469023755|FG009|Overall Study|Missed 12 Month Visit|5|||
130289797|NCT02876328|469023756|FG010|Overall Study|Missed 12 Month Visit|4|||
130289798|NCT02876328|469023757|FG011|Overall Study|Missed 12 Month Visit|1|||
130289799|NCT02876328|469023758|FG012|Overall Study|Missed 12 Month Visit|5|||
130289800|NCT02876328|469023759|FG013|Overall Study|Missed 12 Month Visit|4|||
130289801|NCT02876328|469023760|FG014|Overall Study|Missed 12 Month Visit|4|||
130289802|NCT02876328|469023761|FG015|Overall Study|Missed 12 Month Visit|4|||
130289803|NCT02876328|469023762|FG016|Overall Study|Missed 12 Month Visit|3|||
130289804|NCT02876328|469023763|FG017|Overall Study|Missed 12 Month Visit|6|||
130289805|NCT02876328|469023764|FG018|Overall Study|Missed 12 Month Visit|2|||
130289806|NCT02876328|469023765|FG019|Overall Study|Missed 12 Month Visit|2|||
130289807|NCT02876328|469023766|FG020|Overall Study|Missed 12 Month Visit|11|||
130289808|NCT02876328|469023767|FG021|Overall Study|Missed 12 Month Visit|7|||
130289809|NCT02876328|469023768|FG022|Overall Study|Missed 12 Month Visit|1|||
130289810|NCT02876328|469023769|FG023|Overall Study|Missed 12 Month Visit|0|||
130289811|NCT03515941|469023774|FG000|Overall Study|Adverse Event|1|||
130289812|NCT03515941|469023775|FG001|Overall Study|Adverse Event|0|||
130289813|NCT00334282|469023776|FG000|Overall Study|Lost to Follow-up|11|||
130289814|NCT00334282|469023777|FG001|Overall Study|Lost to Follow-up|5|||
130289815|NCT00334282|469023776|FG000|Overall Study|Withdrawal by Subject|17|||
130289816|NCT00334282|469023777|FG001|Overall Study|Withdrawal by Subject|3|||
130556533|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
130556534|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
130556535|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
130556536|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
130556537|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
130556538|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
130556539|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
130556540|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
130556541|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
130556542|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
130556543|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
130556544|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
130289817|NCT00334282|469023776|FG000|Overall Study|Death|194|||
130289818|NCT00334282|469023777|FG001|Overall Study|Death|100|||
130289819|NCT02759315|469023778|FG000|Overall Study|Adverse Event|0|||
130289820|NCT02759315|469023779|FG001|Overall Study|Adverse Event|0|||
130289821|NCT02759315|469023780|FG002|Overall Study|Adverse Event|0|||
130289822|NCT02759315|469023781|FG003|Overall Study|Adverse Event|1|||
130289823|NCT02759315|469023782|FG004|Overall Study|Adverse Event|0|||
130289824|NCT02759315|469023778|FG000|Overall Study|Death|0|||
130289825|NCT02759315|469023779|FG001|Overall Study|Death|0|||
130289826|NCT02759315|469023780|FG002|Overall Study|Death|1|||
130289827|NCT02759315|469023781|FG003|Overall Study|Death|0|||
130289828|NCT02759315|469023782|FG004|Overall Study|Death|0|||
130289829|NCT02759315|469023778|FG000|Overall Study|Lost to Follow-up|2|||
130289830|NCT02759315|469023779|FG001|Overall Study|Lost to Follow-up|0|||
130289831|NCT02759315|469023780|FG002|Overall Study|Lost to Follow-up|4|||
130289832|NCT02759315|469023781|FG003|Overall Study|Lost to Follow-up|0|||
130289833|NCT02759315|469023782|FG004|Overall Study|Lost to Follow-up|0|||
130289834|NCT02759315|469023778|FG000|Overall Study|Protocol Violation|0|||
130289835|NCT02759315|469023779|FG001|Overall Study|Protocol Violation|1|||
130289836|NCT02759315|469023780|FG002|Overall Study|Protocol Violation|0|||
130289837|NCT02759315|469023781|FG003|Overall Study|Protocol Violation|0|||
130289838|NCT02759315|469023782|FG004|Overall Study|Protocol Violation|0|||
130289839|NCT02759315|469023778|FG000|Overall Study|Study terminated prior to completion|2|||
130289840|NCT02759315|469023779|FG001|Overall Study|Study terminated prior to completion|0|||
130289841|NCT02759315|469023780|FG002|Overall Study|Study terminated prior to completion|5|||
130289842|NCT02759315|469023781|FG003|Overall Study|Study terminated prior to completion|0|||
130289843|NCT02759315|469023782|FG004|Overall Study|Study terminated prior to completion|1|||
130289844|NCT03464422|469023789|FG000|Overall Study|Lost to Follow-up|2|||
130289845|NCT03464422|469023789|FG000|Overall Study|Withdrawal by Subject|2|||
130289846|NCT01628367|469023795|FG000|Overall Study|Adverse Event|1|||
130289847|NCT01628367|469023796|FG001|Overall Study|Adverse Event|0|||
130289848|NCT03353922|469023799|FG000|Overall Study|Withdrawal by Subject|1|||
130289849|NCT03353922|469023800|FG001|Overall Study|Withdrawal by Subject|0|||
130289850|NCT03353922|469023801|FG002|Overall Study|Withdrawal by Subject|1|||
130289851|NCT03353922|469023802|FG003|Overall Study|Withdrawal by Subject|1|||
130289852|NCT03353922|469023803|FG004|Overall Study|Withdrawal by Subject|0|||
130289853|NCT03353922|469023804|FG005|Overall Study|Withdrawal by Subject|0|||
130289854|NCT03353922|469023799|FG000|Overall Study|Adverse Event|0|||
130289855|NCT03353922|469023800|FG001|Overall Study|Adverse Event|1|||
130289856|NCT03353922|469023801|FG002|Overall Study|Adverse Event|0|||
130289857|NCT03353922|469023802|FG003|Overall Study|Adverse Event|0|||
130289858|NCT03353922|469023803|FG004|Overall Study|Adverse Event|0|||
130289859|NCT03353922|469023804|FG005|Overall Study|Adverse Event|0|||
130289860|NCT00740714|469023805|FG000|Overall Study|Withdrawal by Subject|17|||
130289861|NCT00740714|469023806|FG001|Overall Study|Withdrawal by Subject|19|||
130289862|NCT00740714|469023807|FG002|Overall Study|Withdrawal by Subject|29|||
130556545|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
130289863|NCT03688555|469023808|FG000|Treatment Period|Adverse Event|0|||
130556546|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
130289864|NCT03688555|469023809|FG001|Treatment Period|Adverse Event|0|||
130459886|NCT00940992|469647638|FG001|Overall Study|Lost to Follow-up|1|||
130459887|NCT00940992|469647639|FG002|Overall Study|Lost to Follow-up|1|||
130289865|NCT03688555|469023810|FG002|Treatment Period|Adverse Event|1|||
130289866|NCT00886119|469023811|FG000|Period 1|Did not meet inclusion criteria|1|||
130289867|NCT00886119|469023812|FG001|Period 1|Did not meet inclusion criteria|0|||
130289868|NCT00259298|469023817|FG000|Overall Study|Withdrawal by Subject|1|||
130289869|NCT00259298|469023817|FG000|Overall Study|Physician Decision|2|||
130289870|NCT00645528|469023818|FG000|Overall Study|Did not show up for Visit 2|7|||
130289871|NCT01140568|469023819|FG000|Overall Study|disease progression|31|||
130289872|NCT01140568|469023819|FG000|Overall Study|Withdrawal by Subject|1|||
130289873|NCT01140568|469023819|FG000|Overall Study|Screen Fail|4|||
130289874|NCT03618628|469023820|FG000|Overall Study|Death|1|||
130289875|NCT03618628|469023820|FG000|Overall Study|Lost to Follow-up|1|||
130289876|NCT01741532|469023822|FG000|Overall Study|Adverse Event|4|||
130289877|NCT01741532|469023823|FG001|Overall Study|Adverse Event|0|||
130289878|NCT01741532|469023822|FG000|Overall Study|Withdrawal by Subject|1|||
130289879|NCT01741532|469023823|FG001|Overall Study|Withdrawal by Subject|1|||
130289880|NCT01741532|469023822|FG000|Overall Study|Protocol Violation|0|||
130289881|NCT01741532|469023823|FG001|Overall Study|Protocol Violation|1|||
130289882|NCT01741532|469023822|FG000|Overall Study|Worsening of the disease|3|||
130289883|NCT01741532|469023823|FG001|Overall Study|Worsening of the disease|1|||
130289884|NCT01741532|469023822|FG000|Overall Study|Sponsor decision|1|||
130289885|NCT01741532|469023823|FG001|Overall Study|Sponsor decision|0|||
130289886|NCT01741532|469023822|FG000|Overall Study|Medical event|1|||
130289887|NCT01741532|469023823|FG001|Overall Study|Medical event|0|||
130289888|NCT02153346|469023826|FG000|Overall Study|Lost to Follow-up|11|||
130289889|NCT03158272|469023828|FG000|Overall Study|Disease progression|3|||
130459888|NCT03210402|469647640|FG000|Overall Study|Withdrawal by Subject|0|||
130459889|NCT03210402|469647641|FG001|Overall Study|Withdrawal by Subject|1|||
130459890|NCT03586544|469647644|FG000|First Intervention|Adverse Event|0|||
130459891|NCT03586544|469647645|FG001|First Intervention|Adverse Event|1|||
130459892|NCT03586544|469647644|FG000|Second Intervention|Withdrawal by Subject|0|||
130459893|NCT03586544|469647645|FG001|Second Intervention|Withdrawal by Subject|1|||
130459894|NCT03523091|469647646|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
130459895|NCT03523091|469647647|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
130459896|NCT03523091|469647646|FG000|Overall Study|Withdrawal by Subject|0|||
130459897|NCT03523091|469647647|FG001|Overall Study|Withdrawal by Subject|3|||
130459898|NCT03523091|469647646|FG000|Overall Study|Increase Botox dose|0|||
130459899|NCT03523091|469647647|FG001|Overall Study|Increase Botox dose|1|||
130459900|NCT03863834|469647653|FG000|Overall Study|Lost to Follow-up|3|||
130459901|NCT02685488|469647654|FG000|Overall Study|Withdrawal by Subject|0|||
130459902|NCT02685488|469647655|FG001|Overall Study|Withdrawal by Subject|1|||
130459903|NCT03768206|469647656|FG000|Overall Study|Lost to Follow-up|2|||
130459904|NCT03768206|469647657|FG001|Overall Study|Lost to Follow-up|1|||
130459905|NCT03768206|469647656|FG000|Overall Study|Withdrawal by Subject|0|||
130459906|NCT03768206|469647657|FG001|Overall Study|Withdrawal by Subject|1|||
130459907|NCT02551055|469647660|FG000|Overall Study|Death|2|||
130459908|NCT02551055|469647661|FG001|Overall Study|Death|4|||
130459909|NCT02551055|469647662|FG002|Overall Study|Death|2|||
130459910|NCT02551055|469647663|FG003|Overall Study|Death|2|||
130459911|NCT02551055|469647664|FG004|Overall Study|Death|2|||
130459912|NCT02551055|469647665|FG005|Overall Study|Death|1|||
130459913|NCT02551055|469647666|FG006|Overall Study|Death|2|||
130459914|NCT02551055|469647667|FG007|Overall Study|Death|0|||
130459915|NCT02551055|469647660|FG000|Overall Study|Study Terminated by Sponsor|1|||
130459916|NCT02551055|469647661|FG001|Overall Study|Study Terminated by Sponsor|1|||
130459917|NCT02551055|469647662|FG002|Overall Study|Study Terminated by Sponsor|0|||
130459918|NCT02551055|469647663|FG003|Overall Study|Study Terminated by Sponsor|2|||
130459919|NCT02551055|469647664|FG004|Overall Study|Study Terminated by Sponsor|2|||
130714358|NCT03502707|470581651|FG001|Overall Study|Initiated Prohibited Medication|0|||
130714359|NCT03502707|470581652|FG002|Overall Study|Initiated Prohibited Medication|0|||
130289890|NCT03158272|469023829|FG001|Overall Study|Disease progression|3|||
130289891|NCT03158272|469023830|FG002|Overall Study|Disease progression|4|||
130289892|NCT03158272|469023831|FG003|Overall Study|Disease progression|6|||
130289893|NCT03158272|469023828|FG000|Overall Study|Death|0|||
130289894|NCT03158272|469023829|FG001|Overall Study|Death|0|||
130289895|NCT03158272|469023830|FG002|Overall Study|Death|1|||
130289896|NCT03158272|469023831|FG003|Overall Study|Death|0|||
130289897|NCT03158272|469023828|FG000|Overall Study|Other reasons|0|||
130289898|NCT03158272|469023829|FG001|Overall Study|Other reasons|0|||
130289899|NCT03158272|469023830|FG002|Overall Study|Other reasons|1|||
130289900|NCT03158272|469023831|FG003|Overall Study|Other reasons|0|||
130289901|NCT03158272|469023828|FG000|Overall Study|Adverse event unrelated to the drug|0|||
130289902|NCT03158272|469023829|FG001|Overall Study|Adverse event unrelated to the drug|1|||
130289903|NCT03158272|469023830|FG002|Overall Study|Adverse event unrelated to the drug|0|||
130289904|NCT03158272|469023831|FG003|Overall Study|Adverse event unrelated to the drug|0|||
130289905|NCT02366767|469023834|FG000|Overall Study|left for home after 1 day at camp|1|||
130459920|NCT02551055|469647665|FG005|Overall Study|Study Terminated by Sponsor|0|||
130371010|NCT03766581|469329272|FG005|Randomization|Participant request to discontinue study treatment|2|||
130371011|NCT03766581|469329273|FG006|Randomization|Participant request to discontinue study treatment|0|||
130371012|NCT03766581|469329274|FG007|Randomization|Participant request to discontinue study treatment|0|||
130371013|NCT03766581|469329267|FG000|Randomization|Participant withdrew consent|1|||
130371014|NCT03766581|469329268|FG001|Randomization|Participant withdrew consent|0|||
130371015|NCT03766581|469329269|FG002|Randomization|Participant withdrew consent|1|||
130371016|NCT03766581|469329270|FG003|Randomization|Participant withdrew consent|2|||
130371017|NCT03766581|469329271|FG004|Randomization|Participant withdrew consent|1|||
130371018|NCT03766581|469329272|FG005|Randomization|Participant withdrew consent|1|||
130371019|NCT03766581|469329273|FG006|Randomization|Participant withdrew consent|0|||
130371020|NCT03766581|469329274|FG007|Randomization|Participant withdrew consent|0|||
130371021|NCT03766581|469329267|FG000|Treatment|Adverse Event|82|||
130371022|NCT03766581|469329268|FG001|Treatment|Adverse Event|44|||
130371023|NCT03766581|469329269|FG002|Treatment|Adverse Event|47|||
130371024|NCT03766581|469329270|FG003|Treatment|Adverse Event|46|||
130371025|NCT03766581|469329271|FG004|Treatment|Adverse Event|50|||
130371026|NCT03766581|469329272|FG005|Treatment|Adverse Event|77|||
130371027|NCT03766581|469329273|FG006|Treatment|Adverse Event|5|||
130371028|NCT03766581|469329274|FG007|Treatment|Adverse Event|2|||
130371029|NCT03766581|469329267|FG000|Treatment|Participant request to discontinue treatment|34|||
130371030|NCT03766581|469329268|FG001|Treatment|Participant request to discontinue treatment|6|||
130371031|NCT03766581|469329269|FG002|Treatment|Participant request to discontinue treatment|10|||
130371032|NCT03766581|469329270|FG003|Treatment|Participant request to discontinue treatment|10|||
130371033|NCT03766581|469329271|FG004|Treatment|Participant request to discontinue treatment|14|||
130371034|NCT03766581|469329272|FG005|Treatment|Participant request to discontinue treatment|15|||
130371035|NCT03766581|469329273|FG006|Treatment|Participant request to discontinue treatment|0|||
130371036|NCT03766581|469329274|FG007|Treatment|Participant request to discontinue treatment|1|||
130371037|NCT03766581|469329267|FG000|Treatment|Participant withdrew consent|11|||
130371038|NCT03766581|469329268|FG001|Treatment|Participant withdrew consent|4|||
130371039|NCT03766581|469329269|FG002|Treatment|Participant withdrew consent|5|||
130371040|NCT03766581|469329270|FG003|Treatment|Participant withdrew consent|5|||
130371041|NCT03766581|469329271|FG004|Treatment|Participant withdrew consent|4|||
130714360|NCT03502707|470581653|FG003|Overall Study|Initiated Prohibited Medication|0|||
130714361|NCT03502707|470581654|FG004|Overall Study|Initiated Prohibited Medication|0|||
130714362|NCT03502707|470581655|FG005|Overall Study|Initiated Prohibited Medication|0|||
130371042|NCT03766581|469329272|FG005|Treatment|Participant withdrew consent|4|||
130371043|NCT03766581|469329273|FG006|Treatment|Participant withdrew consent|0|||
130371044|NCT03766581|469329274|FG007|Treatment|Participant withdrew consent|0|||
130371045|NCT03766581|469329267|FG000|Treatment|Death|1|||
130371046|NCT03766581|469329268|FG001|Treatment|Death|0|||
130371047|NCT03766581|469329269|FG002|Treatment|Death|0|||
130371048|NCT03766581|469329270|FG003|Treatment|Death|0|||
130371049|NCT03766581|469329271|FG004|Treatment|Death|0|||
130371050|NCT03766581|469329272|FG005|Treatment|Death|0|||
130371051|NCT03766581|469329273|FG006|Treatment|Death|0|||
130371052|NCT03766581|469329274|FG007|Treatment|Death|0|||
130371053|NCT03766581|469329267|FG000|Treatment|Lost to Follow-up|1|||
130371054|NCT03766581|469329268|FG001|Treatment|Lost to Follow-up|0|||
130371055|NCT03766581|469329269|FG002|Treatment|Lost to Follow-up|0|||
130371056|NCT03766581|469329270|FG003|Treatment|Lost to Follow-up|1|||
130371057|NCT03766581|469329271|FG004|Treatment|Lost to Follow-up|0|||
130371058|NCT03766581|469329272|FG005|Treatment|Lost to Follow-up|0|||
130371059|NCT03766581|469329273|FG006|Treatment|Lost to Follow-up|0|||
130371060|NCT03766581|469329274|FG007|Treatment|Lost to Follow-up|0|||
130371061|NCT03766581|469329267|FG000|Treatment|Poor/Non compliance|2|||
130371062|NCT03766581|469329268|FG001|Treatment|Poor/Non compliance|2|||
130371063|NCT03766581|469329269|FG002|Treatment|Poor/Non compliance|1|||
130371064|NCT03766581|469329270|FG003|Treatment|Poor/Non compliance|1|||
130371065|NCT03766581|469329271|FG004|Treatment|Poor/Non compliance|1|||
130371066|NCT03766581|469329272|FG005|Treatment|Poor/Non compliance|1|||
130371067|NCT03766581|469329273|FG006|Treatment|Poor/Non compliance|0|||
130371068|NCT03766581|469329274|FG007|Treatment|Poor/Non compliance|0|||
130371069|NCT03766581|469329267|FG000|Treatment|Participant no longer meets study criteria|9|||
130371070|NCT03766581|469329268|FG001|Treatment|Participant no longer meets study criteria|1|||
130371071|NCT03766581|469329269|FG002|Treatment|Participant no longer meets study criteria|5|||
130371072|NCT03766581|469329270|FG003|Treatment|Participant no longer meets study criteria|4|||
130371073|NCT03766581|469329271|FG004|Treatment|Participant no longer meets study criteria|4|||
130371074|NCT03766581|469329272|FG005|Treatment|Participant no longer meets study criteria|4|||
130371075|NCT03766581|469329273|FG006|Treatment|Participant no longer meets study criteria|2|||
130371076|NCT03766581|469329274|FG007|Treatment|Participant no longer meets study criteria|0|||
130371077|NCT03766581|469329267|FG000|Treatment|Other reasons|13|||
130371078|NCT03766581|469329268|FG001|Treatment|Other reasons|8|||
130371079|NCT03766581|469329269|FG002|Treatment|Other reasons|3|||
130371080|NCT03766581|469329270|FG003|Treatment|Other reasons|7|||
130371081|NCT03766581|469329271|FG004|Treatment|Other reasons|3|||
130371082|NCT03766581|469329272|FG005|Treatment|Other reasons|3|||
130289906|NCT02366767|469023835|FG001|Overall Study|left for home after 1 day at camp|0|||
130289907|NCT02558400|469023838|FG000|Overall Study|Adverse Event|47|||
130289908|NCT02558400|469023839|FG001|Overall Study|Adverse Event|53|||
130289909|NCT02558400|469023840|FG002|Overall Study|Adverse Event|4|||
130289910|NCT02558400|469023838|FG000|Overall Study|Withdrawal by Subject|13|||
130289911|NCT02558400|469023839|FG001|Overall Study|Withdrawal by Subject|9|||
130289912|NCT02558400|469023840|FG002|Overall Study|Withdrawal by Subject|8|||
130289913|NCT02558400|469023838|FG000|Overall Study|Non-Compliant|0|||
130289914|NCT02558400|469023839|FG001|Overall Study|Non-Compliant|1|||
130289915|NCT02558400|469023840|FG002|Overall Study|Non-Compliant|3|||
130289916|NCT02558400|469023838|FG000|Overall Study|Lost to Follow-up|5|||
130289917|NCT02558400|469023839|FG001|Overall Study|Lost to Follow-up|5|||
130289918|NCT02558400|469023840|FG002|Overall Study|Lost to Follow-up|4|||
130289919|NCT02558400|469023838|FG000|Overall Study|Lack of Efficacy|0|||
130289920|NCT02558400|469023839|FG001|Overall Study|Lack of Efficacy|13|||
130289921|NCT02558400|469023840|FG002|Overall Study|Lack of Efficacy|1|||
130289922|NCT02558400|469023838|FG000|Overall Study|Disallowed Concurrent Medication|6|||
130289923|NCT02558400|469023839|FG001|Overall Study|Disallowed Concurrent Medication|7|||
130289924|NCT02558400|469023840|FG002|Overall Study|Disallowed Concurrent Medication|5|||
130289925|NCT02558400|469023838|FG000|Overall Study|Physician Decision|2|||
130289926|NCT02558400|469023839|FG001|Overall Study|Physician Decision|2|||
130289927|NCT02558400|469023840|FG002|Overall Study|Physician Decision|0|||
130289928|NCT02558400|469023838|FG000|Overall Study|Protocol Violation|6|||
130289929|NCT02558400|469023839|FG001|Overall Study|Protocol Violation|3|||
130289930|NCT02558400|469023840|FG002|Overall Study|Protocol Violation|8|||
130289931|NCT02558400|469023838|FG000|Overall Study|Death|0|||
130289932|NCT02558400|469023839|FG001|Overall Study|Death|1|||
130289933|NCT02558400|469023840|FG002|Overall Study|Death|0|||
130289934|NCT02558400|469023838|FG000|Overall Study|Ineligible for the study|0|||
130289935|NCT02558400|469023839|FG001|Overall Study|Ineligible for the study|2|||
130289936|NCT02558400|469023840|FG002|Overall Study|Ineligible for the study|0|||
130289937|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
130289938|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
130289939|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
130289940|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
130289941|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
130289942|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
130289943|NCT03654885|469025314|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
130289944|NCT03654885|469025315|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
130289945|NCT03654885|469025314|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
130289946|NCT03654885|469025315|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
130289947|NCT03654885|469025314|FG000|Overall Study|Adverse Event in Study Eye|3|||
130289948|NCT03654885|469025315|FG001|Overall Study|Adverse Event in Study Eye|0|||
130289949|NCT03654885|469025314|FG000|Overall Study|Consent Withdrawn|1|||
130459921|NCT02551055|469647666|FG006|Overall Study|Study Terminated by Sponsor|0|||
130459922|NCT02551055|469647667|FG007|Overall Study|Study Terminated by Sponsor|0|||
130459923|NCT02551055|469647660|FG000|Overall Study|Withdrawal by Subject|1|||
130459924|NCT02551055|469647661|FG001|Overall Study|Withdrawal by Subject|1|||
130459925|NCT02551055|469647662|FG002|Overall Study|Withdrawal by Subject|0|||
130459926|NCT02551055|469647663|FG003|Overall Study|Withdrawal by Subject|1|||
130459927|NCT02551055|469647664|FG004|Overall Study|Withdrawal by Subject|2|||
130459928|NCT02551055|469647665|FG005|Overall Study|Withdrawal by Subject|0|||
130459929|NCT02551055|469647666|FG006|Overall Study|Withdrawal by Subject|0|||
130459930|NCT02551055|469647667|FG007|Overall Study|Withdrawal by Subject|0|||
130459931|NCT02551055|469647660|FG000|Overall Study|Reason not specified|0|||
130459932|NCT02551055|469647661|FG001|Overall Study|Reason not specified|0|||
130459933|NCT02551055|469647662|FG002|Overall Study|Reason not specified|0|||
130459934|NCT02551055|469647663|FG003|Overall Study|Reason not specified|0|||
130459935|NCT02551055|469647664|FG004|Overall Study|Reason not specified|1|||
130459936|NCT02551055|469647665|FG005|Overall Study|Reason not specified|0|||
130459937|NCT02551055|469647666|FG006|Overall Study|Reason not specified|1|||
130459938|NCT02551055|469647667|FG007|Overall Study|Reason not specified|0|||
130289950|NCT03654885|469025315|FG001|Overall Study|Consent Withdrawn|0|||
130289951|NCT03654885|469025314|FG000|Overall Study|Death|3|||
130459939|NCT00430300|469647668|FG000|Overall Study|Adverse Event|0|||
130459940|NCT00430300|469647669|FG001|Overall Study|Adverse Event|2|||
130459941|NCT00430300|469647670|FG002|Overall Study|Adverse Event|1|||
130459942|NCT00430300|469647671|FG003|Overall Study|Adverse Event|1|||
130289952|NCT03654885|469025315|FG001|Overall Study|Death|1|||
130289953|NCT03654885|469025314|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
130289954|NCT03654885|469025315|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
130289955|NCT03654885|469025314|FG000|Overall Study|Lost to Follow-up|3|||
130289956|NCT03654885|469025315|FG001|Overall Study|Lost to Follow-up|3|||
130371083|NCT03766581|469329273|FG006|Treatment|Other reasons|0|||
130371084|NCT03766581|469329274|FG007|Treatment|Other reasons|0|||
130289957|NCT05275582|469025316|FG000|Overall Study|Lost to Follow-up|1|||
130289958|NCT05275582|469025317|FG001|Overall Study|Lost to Follow-up|0|||
130289959|NCT05275582|469025316|FG000|Overall Study|Withdrawal by Subject|0|||
130289960|NCT05275582|469025317|FG001|Overall Study|Withdrawal by Subject|2|||
130371085|NCT00520936|469329275|FG000|Overall Study|Physician Decision|0|||
130371086|NCT00520936|469329276|FG001|Overall Study|Physician Decision|2|||
130371087|NCT00520936|469329277|FG002|Overall Study|Physician Decision|1|||
130371088|NCT00520936|469329278|FG003|Overall Study|Physician Decision|0|||
130371089|NCT00520936|469329279|FG004|Overall Study|Physician Decision|0|||
130371090|NCT00520936|469329280|FG005|Overall Study|Physician Decision|0|||
130371091|NCT00520936|469329281|FG006|Overall Study|Physician Decision|0|||
130371092|NCT00520936|469329282|FG007|Overall Study|Physician Decision|0|||
130289961|NCT05275582|469025316|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
130289962|NCT05275582|469025317|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
130289963|NCT05275582|469025316|FG000|Overall Study|Death|1|||
130289964|NCT05275582|469025317|FG001|Overall Study|Death|0|||
130371093|NCT00520936|469329275|FG000|Overall Study|Withdrawal by Subject|0|||
130371094|NCT00520936|469329276|FG001|Overall Study|Withdrawal by Subject|0|||
130371095|NCT00520936|469329277|FG002|Overall Study|Withdrawal by Subject|0|||
130371096|NCT00520936|469329278|FG003|Overall Study|Withdrawal by Subject|0|||
130371097|NCT00520936|469329279|FG004|Overall Study|Withdrawal by Subject|0|||
130371098|NCT00520936|469329280|FG005|Overall Study|Withdrawal by Subject|0|||
130371099|NCT00520936|469329281|FG006|Overall Study|Withdrawal by Subject|0|||
130371100|NCT00520936|469329282|FG007|Overall Study|Withdrawal by Subject|1|||
130371101|NCT00520936|469329275|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
130371102|NCT00520936|469329276|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
130371103|NCT00520936|469329277|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
130371104|NCT00520936|469329278|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
130371105|NCT00520936|469329279|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
130371106|NCT00520936|469329280|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
130371107|NCT00520936|469329281|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
130371108|NCT00520936|469329282|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
130371109|NCT00520936|469329275|FG000|Overall Study|Death|0|||
130371110|NCT00520936|469329276|FG001|Overall Study|Death|0|||
130371111|NCT00520936|469329277|FG002|Overall Study|Death|0|||
130371112|NCT00520936|469329278|FG003|Overall Study|Death|0|||
130371113|NCT00520936|469329279|FG004|Overall Study|Death|0|||
130371114|NCT00520936|469329280|FG005|Overall Study|Death|0|||
130371115|NCT00520936|469329281|FG006|Overall Study|Death|1|||
130371116|NCT00520936|469329282|FG007|Overall Study|Death|0|||
130371117|NCT00520936|469329275|FG000|Overall Study|Protocol Violation|0|||
130371118|NCT00520936|469329276|FG001|Overall Study|Protocol Violation|1|||
130371119|NCT00520936|469329277|FG002|Overall Study|Protocol Violation|1|||
130371120|NCT00520936|469329278|FG003|Overall Study|Protocol Violation|0|||
130371121|NCT00520936|469329279|FG004|Overall Study|Protocol Violation|1|||
130371122|NCT00520936|469329280|FG005|Overall Study|Protocol Violation|0|||
130371123|NCT00520936|469329281|FG006|Overall Study|Protocol Violation|1|||
130371124|NCT00520936|469329282|FG007|Overall Study|Protocol Violation|0|||
130371125|NCT00587054|469329283|FG000|Overall Study|Patient not treated|9|||
130371126|NCT02099708|469329291|FG000|Overall Study|Data Not Available|30|||
130371127|NCT02099708|469329291|FG000|Overall Study|Lost to Follow-up|141|||
130289965|NCT05275582|469025316|FG000|Overall Study|Protocol Violation|1|||
130289966|NCT05275582|469025317|FG001|Overall Study|Protocol Violation|0|||
130289967|NCT00031460|469025320|FG000|Overall Study|Lost to Follow-up|0|||
130289968|NCT00031460|469025321|FG001|Overall Study|Lost to Follow-up|1|||
130289969|NCT00031460|469025320|FG000|Overall Study|Withdrawal by Subject|1|||
130289970|NCT00031460|469025321|FG001|Overall Study|Withdrawal by Subject|1|||
130289971|NCT00031460|469025320|FG000|Overall Study|Non-Compliant|1|||
130371128|NCT02099708|469329291|FG000|Overall Study|Other|29|||
130371129|NCT05466682|469329295|FG000|Overall Study|Withdrawal by Subject|0|||
130371130|NCT05466682|469329296|FG001|Overall Study|Withdrawal by Subject|2|||
130371131|NCT05466682|469329295|FG000|Overall Study|Lost to Follow-up|2|||
130459943|NCT00430300|469647668|FG000|Overall Study|Withdrawal by Subject|1|||
130459944|NCT00430300|469647669|FG001|Overall Study|Withdrawal by Subject|0|||
130459945|NCT00430300|469647670|FG002|Overall Study|Withdrawal by Subject|5|||
130459946|NCT00430300|469647671|FG003|Overall Study|Withdrawal by Subject|0|||
130459947|NCT00430300|469647668|FG000|Overall Study|Laboratory abnormality|1|||
130371132|NCT05466682|469329296|FG001|Overall Study|Lost to Follow-up|1|||
130371133|NCT01697566|469329297|FG000|Overall Study|Withdrawal by Subject|0|||
130371134|NCT01697566|469329298|FG001|Overall Study|Withdrawal by Subject|0|||
130371135|NCT01697566|469329299|FG002|Overall Study|Withdrawal by Subject|1|||
130371136|NCT01697566|469329300|FG003|Overall Study|Withdrawal by Subject|1|||
130371137|NCT01697566|469329297|FG000|Overall Study|Final biopsy not obtained|0|||
130371138|NCT01697566|469329298|FG001|Overall Study|Final biopsy not obtained|0|||
130371139|NCT01697566|469329299|FG002|Overall Study|Final biopsy not obtained|1|||
130289972|NCT00031460|469025321|FG001|Overall Study|Non-Compliant|1|||
130289973|NCT00031460|469025320|FG000|Overall Study|Death|0|||
130289974|NCT00031460|469025321|FG001|Overall Study|Death|1|||
130289975|NCT00031460|469025320|FG000|Overall Study|Reactivation of Disease|5|||
130289976|NCT00031460|469025321|FG001|Overall Study|Reactivation of Disease|9|||
130289977|NCT00031460|469025320|FG000|Overall Study|Disruption of blinded drug supply|2|||
130289978|NCT00031460|469025321|FG001|Overall Study|Disruption of blinded drug supply|0|||
130289979|NCT00031460|469025320|FG000|Overall Study|Confirmed unevaluable|0|||
130289980|NCT00031460|469025321|FG001|Overall Study|Confirmed unevaluable|1|||
130289981|NCT02210832|469025322|FG000|Overall Study|Pregnancy termination .|3|||
130289982|NCT02210832|469025323|FG001|Overall Study|Pregnancy termination .|4|||
130289983|NCT02210832|469025324|FG002|Overall Study|Pregnancy termination .|1|||
130289984|NCT02210832|469025322|FG000|Overall Study|Lost to Follow-up|26|||
130289985|NCT02210832|469025323|FG001|Overall Study|Lost to Follow-up|32|||
130289986|NCT02210832|469025324|FG002|Overall Study|Lost to Follow-up|17|||
130289987|NCT02080260|469025329|FG000|Overall Study|Death|18|||
130289988|NCT02080260|469025329|FG000|Overall Study|Withdrawal by Subject|1|||
130289989|NCT00471887|469025332|FG000|Overall Study|Adverse Event|9|||
130289990|NCT01030874|469025336|FG000|Overall Study|Withdrawal by Subject|1|||
130289991|NCT01030874|469025337|FG001|Overall Study|Withdrawal by Subject|0|||
130289992|NCT01030874|469025336|FG000|Overall Study|Discharged in first 2 weeks|17|||
130289993|NCT01030874|469025337|FG001|Overall Study|Discharged in first 2 weeks|16|||
130289994|NCT04639219|469025338|FG000|Overall Study|Withdrawal by Subject|8|||
130289995|NCT04639219|469025338|FG000|Overall Study|Lost to Follow-up|6|||
130289996|NCT04639219|469025338|FG000|Overall Study|Death|55|||
130289997|NCT01998893|469025339|FG000|Overall Study|Adverse Event|2|||
130289998|NCT01998893|469025339|FG000|Overall Study|Death|1|||
130289999|NCT01998893|469025339|FG000|Overall Study|Lost to Follow-up|8|||
130290000|NCT01998893|469025339|FG000|Overall Study|Physician Decision|2|||
130290001|NCT01998893|469025339|FG000|Overall Study|Protocol Violation|2|||
130290002|NCT01998893|469025339|FG000|Overall Study|Withdrawal by Subject|1|||
130290003|NCT01998893|469025339|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
130290004|NCT03784846|469025340|FG000|Pre-COVID Study|Lost to Follow-up|3|||
130290005|NCT03784846|469025341|FG001|Pre-COVID Study|Lost to Follow-up|3|||
130290006|NCT03784846|469025342|FG002|Pre-COVID Study|Lost to Follow-up|2|||
130290007|NCT03784846|469025340|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
130290008|NCT03784846|469025341|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
130290009|NCT03784846|469025342|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
130290010|NCT03784846|469025340|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
130290011|NCT03784846|469025341|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
130290012|NCT03784846|469025342|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
130290013|NCT03784846|469025340|FG000|Post-COVID Study|Lost to Follow-up|3|||
130290014|NCT03784846|469025341|FG001|Post-COVID Study|Lost to Follow-up|5|||
130290015|NCT03784846|469025342|FG002|Post-COVID Study|Lost to Follow-up|1|||
130290016|NCT03784846|469025340|FG000|Post-COVID Study|Withdrawal by Subject|1|||
130290017|NCT03784846|469025341|FG001|Post-COVID Study|Withdrawal by Subject|2|||
130290018|NCT03784846|469025342|FG002|Post-COVID Study|Withdrawal by Subject|0|||
130290019|NCT00867087|469025343|FG000|Overall Study|Other|1|||
130290020|NCT00867087|469025343|FG000|Overall Study|Withdrawal by Subject|4|||
130290021|NCT00867087|469025343|FG000|Overall Study|Death|37|||
130290022|NCT03883113|469025345|FG000|Overall Study|Physician Decision|4|||
130290023|NCT03883113|469025346|FG001|Overall Study|Physician Decision|2|||
130290024|NCT03883113|469025345|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
130290025|NCT03883113|469025346|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
130290026|NCT03883113|469025345|FG000|Overall Study|Pregnancy|1|||
130290027|NCT03883113|469025346|FG001|Overall Study|Pregnancy|0|||
130290028|NCT03883113|469025345|FG000|Overall Study|Adverse Event|0|||
130290029|NCT03883113|469025346|FG001|Overall Study|Adverse Event|1|||
130290030|NCT03883113|469025345|FG000|Overall Study|Withdrawal by Subject|1|||
130290031|NCT03883113|469025346|FG001|Overall Study|Withdrawal by Subject|2|||
130290032|NCT03883113|469025345|FG000|Overall Study|Lost to Follow-up|1|||
130290033|NCT03883113|469025346|FG001|Overall Study|Lost to Follow-up|0|||
130290034|NCT01457950|469025347|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
130290035|NCT01457950|469025348|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290036|NCT01457950|469025349|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290037|NCT01457950|469025350|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290038|NCT01457950|469025347|FG000|Double-Blind Phase|Protocol Violation|2|||
130290039|NCT01457950|469025348|FG001|Double-Blind Phase|Protocol Violation|1|||
130290040|NCT01457950|469025349|FG002|Double-Blind Phase|Protocol Violation|0|||
130290041|NCT01457950|469025350|FG003|Double-Blind Phase|Protocol Violation|0|||
130290042|NCT01457950|469025347|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
130290043|NCT01457950|469025348|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130290044|NCT01457950|469025349|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130290045|NCT01457950|469025350|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130290046|NCT01457950|469025347|FG000|Open-Label Phase|Adverse Event|0|||
130290047|NCT01457950|469025348|FG001|Open-Label Phase|Adverse Event|0|||
130290048|NCT01457950|469025349|FG002|Open-Label Phase|Adverse Event|0|||
130714363|NCT03502707|470581656|FG006|Overall Study|Initiated Prohibited Medication|0|||
130714364|NCT03502707|470581657|FG007|Overall Study|Initiated Prohibited Medication|0|||
130714365|NCT03502707|470581658|FG008|Overall Study|Initiated Prohibited Medication|0|||
130714366|NCT03502707|470581659|FG009|Overall Study|Initiated Prohibited Medication|0|||
130714367|NCT03502707|470581660|FG010|Overall Study|Initiated Prohibited Medication|0|||
130290049|NCT01457950|469025350|FG003|Open-Label Phase|Adverse Event|1|||
130290050|NCT01457950|469025347|FG000|Open-Label Phase|Protocol Violation|0|||
130290051|NCT01457950|469025348|FG001|Open-Label Phase|Protocol Violation|0|||
130290052|NCT01457950|469025349|FG002|Open-Label Phase|Protocol Violation|0|||
130290053|NCT01457950|469025350|FG003|Open-Label Phase|Protocol Violation|1|||
130290054|NCT01457950|469025347|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130290055|NCT01457950|469025348|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130290056|NCT01457950|469025349|FG002|Open-Label Phase|Withdrawal by Subject|2|||
130290057|NCT01457950|469025350|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130290058|NCT00054691|469025351|FG000|Overall Study|Unmeasurable Disease|2|||
130290059|NCT00054691|469025351|FG000|Overall Study|Noncompliant|1|||
130290060|NCT02498067|469025352|FG000|Overall Study|Lost to Follow-up|22|||
130290061|NCT02498067|469025352|FG000|Overall Study|Did not meet inclusion criteria|11|||
130290062|NCT03351114|469025356|FG000|Overall Study|Withdrawal by Subject|1|||
130290063|NCT01371643|469025361|FG000|Overall Study|Withdrawal by Subject|3|||
130290064|NCT01371643|469025362|FG001|Overall Study|Withdrawal by Subject|0|||
130290065|NCT03249935|469025363|FG000|Overall Study|Discharged from facility early|36|||
130290066|NCT03249935|469025363|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
130290067|NCT03249935|469025363|FG000|Overall Study|Protocol Violation|5|||
130290068|NCT03593681|469025364|FG000|Overall Study|Inadequate sample collected|12|||
130290069|NCT03593681|469025364|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
130290070|NCT03593681|469025364|FG000|Overall Study|Protocol Violation|3|||
130290071|NCT03593681|469025364|FG000|Overall Study|Withdrawal by Subject|3|||
130290072|NCT03593681|469025364|FG000|Overall Study|Procedure not attempted|3|||
130290073|NCT03593681|469025364|FG000|Overall Study|Adverse Event|2|||
130290074|NCT03593681|469025364|FG000|Overall Study|Physician Decision|1|||
130290075|NCT03987932|469025371|FG000|Overall Study|Lost to Follow-up|2|||
130290076|NCT03987932|469025372|FG001|Overall Study|Lost to Follow-up|1|||
130290077|NCT03987932|469025373|FG002|Overall Study|Lost to Follow-up|1|||
130290078|NCT03987932|469025371|FG000|Overall Study|Non-study related elective surgery|0|||
130290079|NCT03987932|469025372|FG001|Overall Study|Non-study related elective surgery|0|||
130290080|NCT03987932|469025373|FG002|Overall Study|Non-study related elective surgery|1|||
130290081|NCT01669421|469025374|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
130290082|NCT01669421|469025374|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
130290083|NCT00810901|469025378|FG000|Overall Study|Lost to Follow-up|88|||
130290084|NCT00810901|469025379|FG001|Overall Study|Lost to Follow-up|58|||
130290085|NCT00343915|469025386|FG000|Primary Study|Withdrawal by Subject|1|||
130290086|NCT00343915|469025387|FG001|Primary Study|Withdrawal by Subject|0|||
130290087|NCT00343915|469025386|FG000|Primary Study|Lost to Follow-up|2|||
130290088|NCT00343915|469025387|FG001|Primary Study|Lost to Follow-up|3|||
130290089|NCT00343915|469025386|FG000|Primary Study|Other|1|||
130290090|NCT00343915|469025387|FG001|Primary Study|Other|0|||
130290091|NCT00882908|469025388|FG000|Overall Study|Adverse Event|0|||
130290092|NCT00882908|469025389|FG001|Overall Study|Adverse Event|0|||
130290093|NCT00882908|469025390|FG002|Overall Study|Adverse Event|1|||
130290094|NCT00882908|469025391|FG003|Overall Study|Adverse Event|0|||
130290095|NCT00882908|469025392|FG004|Overall Study|Adverse Event|1|||
130290096|NCT00882908|469025388|FG000|Overall Study|Lost to Follow-up|3|||
130290097|NCT00882908|469025389|FG001|Overall Study|Lost to Follow-up|5|||
130290098|NCT00882908|469025390|FG002|Overall Study|Lost to Follow-up|3|||
130290099|NCT00882908|469025391|FG003|Overall Study|Lost to Follow-up|1|||
130290100|NCT00882908|469025392|FG004|Overall Study|Lost to Follow-up|2|||
130290101|NCT00882908|469025388|FG000|Overall Study|Protocol Violation|0|||
130290102|NCT00882908|469025389|FG001|Overall Study|Protocol Violation|1|||
130290103|NCT00882908|469025390|FG002|Overall Study|Protocol Violation|0|||
130290104|NCT00882908|469025391|FG003|Overall Study|Protocol Violation|0|||
130290105|NCT00882908|469025392|FG004|Overall Study|Protocol Violation|0|||
130290106|NCT00882908|469025388|FG000|Overall Study|Withdrawal by Subject|0|||
130290107|NCT00882908|469025389|FG001|Overall Study|Withdrawal by Subject|0|||
130371140|NCT01697566|469329300|FG003|Overall Study|Final biopsy not obtained|0|||
130290108|NCT00882908|469025390|FG002|Overall Study|Withdrawal by Subject|3|||
130290109|NCT00882908|469025391|FG003|Overall Study|Withdrawal by Subject|5|||
130290110|NCT00882908|469025392|FG004|Overall Study|Withdrawal by Subject|2|||
130290111|NCT00882908|469025388|FG000|Overall Study|Subject reached a virologic endpoint|0|||
130290112|NCT00882908|469025389|FG001|Overall Study|Subject reached a virologic endpoint|0|||
130290113|NCT00882908|469025390|FG002|Overall Study|Subject reached a virologic endpoint|0|||
130290114|NCT00882908|469025391|FG003|Overall Study|Subject reached a virologic endpoint|0|||
130290115|NCT00882908|469025392|FG004|Overall Study|Subject reached a virologic endpoint|1|||
130290116|NCT00882908|469025388|FG000|Overall Study|Study terminated in error|0|||
130290117|NCT00882908|469025389|FG001|Overall Study|Study terminated in error|0|||
130290118|NCT00882908|469025390|FG002|Overall Study|Study terminated in error|0|||
130290119|NCT00882908|469025391|FG003|Overall Study|Study terminated in error|1|||
130290120|NCT00882908|469025392|FG004|Overall Study|Study terminated in error|0|||
130290121|NCT05291936|469025393|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130290122|NCT05291936|469025394|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130290123|NCT05291936|469025393|FG000|Period 1|Withdrew Consent during study|1|||
130290124|NCT05291936|469025394|FG001|Period 1|Withdrew Consent during study|0|||
130290125|NCT05291936|469025393|FG000|Period 2|Adverse Event|0|||
130290126|NCT05291936|469025394|FG001|Period 2|Adverse Event|1|||
130290127|NCT05291936|469025393|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130290128|NCT05291936|469025394|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130290129|NCT00581828|469025395|FG000|Overall Study|Protocol Violation|1|||
130290130|NCT02370095|469025396|FG000|Overall Study|Withdrawal by Subject|0|||
130290131|NCT02370095|469025397|FG001|Overall Study|Withdrawal by Subject|1|||
130290132|NCT01667562|469025398|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
130290133|NCT01667562|469025399|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
130290134|NCT01667562|469025398|FG000|Erlotinib Phase|Lost to Follow-up|0|||
130290135|NCT01667562|469025399|FG001|Erlotinib Phase|Lost to Follow-up|1|||
130290136|NCT01667562|469025398|FG000|Erlotinib Phase|Adverse Event|0|||
130290137|NCT01667562|469025399|FG001|Erlotinib Phase|Adverse Event|1|||
130290138|NCT01667562|469025398|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
130290139|NCT01667562|469025399|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
130290140|NCT02130986|469025403|FG000|Overall Study|Withdrawal by Subject|4|||
130290141|NCT02130986|469025404|FG001|Overall Study|Withdrawal by Subject|4|||
130290142|NCT02130986|469025403|FG000|Overall Study|Lost to Follow-up|151|||
130290143|NCT02130986|469025404|FG001|Overall Study|Lost to Follow-up|160|||
130290144|NCT01129882|469025405|FG000|Overall Study|Adverse Event|39|||
130290145|NCT01129882|469025405|FG000|Overall Study|Death|6|||
130290146|NCT01129882|469025405|FG000|Overall Study|Lack of Efficacy|5|||
130290147|NCT01129882|469025405|FG000|Overall Study|Lost to Follow-up|13|||
130290148|NCT01129882|469025405|FG000|Overall Study|Physician Decision|27|||
130290149|NCT01129882|469025405|FG000|Overall Study|Protocol Deviation|3|||
130290150|NCT01129882|469025405|FG000|Overall Study|Withdrawal Criteria Met|19|||
130290151|NCT01129882|469025405|FG000|Overall Study|Trial Termination by Sponsor|6|||
130290152|NCT01129882|469025405|FG000|Overall Study|Withdrawal by Subject|160|||
130290153|NCT05590000|469025406|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
130290154|NCT00536874|469025407|FG000|Overall Study|Adverse Event|1|||
130290155|NCT00536874|469025407|FG000|Overall Study|Death|2|||
130290156|NCT00536874|469025407|FG000|Overall Study|Withdrawal by Subject|1|||
130290157|NCT00762996|469025408|FG000|Period One|Protocol Violation|0|||
130290158|NCT00762996|469025409|FG001|Period One|Protocol Violation|0|||
130290159|NCT00762996|469025410|FG002|Period One|Protocol Violation|1|||
130290160|NCT00762996|469025411|FG003|Period One|Protocol Violation|0|||
130290161|NCT00762996|469025408|FG000|Period One|ineligible|0|||
130290162|NCT00762996|469025409|FG001|Period One|ineligible|0|||
130290163|NCT00762996|469025410|FG002|Period One|ineligible|1|||
130290164|NCT00762996|469025411|FG003|Period One|ineligible|1|||
130290165|NCT00762996|469025408|FG000|Period One|Adverse Event|0|||
130290166|NCT00762996|469025409|FG001|Period One|Adverse Event|0|||
130290167|NCT00762996|469025410|FG002|Period One|Adverse Event|1|||
130290168|NCT00762996|469025411|FG003|Period One|Adverse Event|0|||
130290169|NCT00762996|469025408|FG000|Period One|Withdrawal by Subject|0|||
130290170|NCT00762996|469025409|FG001|Period One|Withdrawal by Subject|0|||
130290171|NCT00762996|469025410|FG002|Period One|Withdrawal by Subject|1|||
130290172|NCT00762996|469025411|FG003|Period One|Withdrawal by Subject|0|||
130290173|NCT02689076|469025413|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
130290174|NCT02689076|469025414|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
130290175|NCT02689076|469025415|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
130290176|NCT02689076|469025413|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
130290177|NCT02689076|469025414|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
130290178|NCT02689076|469025415|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
130371141|NCT03953820|469329302|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
130290179|NCT02689076|469025413|FG000|Overall Study|Did not have an HIE match|2|||
130290180|NCT02689076|469025414|FG001|Overall Study|Did not have an HIE match|0|||
130290181|NCT02689076|469025415|FG002|Overall Study|Did not have an HIE match|0|||
130290182|NCT02689076|469025413|FG000|Overall Study|Death during non-VA encounter|2|||
130290183|NCT02689076|469025414|FG001|Overall Study|Death during non-VA encounter|5|||
130290184|NCT02689076|469025415|FG002|Overall Study|Death during non-VA encounter|0|||
130290185|NCT02689076|469025413|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
130290186|NCT02689076|469025414|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
130290187|NCT02689076|469025415|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
130290188|NCT02689076|469025413|FG000|Overall Study|Participant no longer active in VA system|1|||
130290189|NCT02689076|469025414|FG001|Overall Study|Participant no longer active in VA system|0|||
130290190|NCT02689076|469025415|FG002|Overall Study|Participant no longer active in VA system|0|||
130290191|NCT02689076|469025413|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130290192|NCT02689076|469025414|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
130290193|NCT02689076|469025415|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130290194|NCT02084238|469025416|FG000|Overall Study|Lost to Follow-up|2|||
130290195|NCT01304329|469025417|FG000|Third Intervention (3 Days)|Adverse Event|0|||
130290196|NCT01304329|469025418|FG001|Third Intervention (3 Days)|Adverse Event|1|||
130290197|NCT01304329|469025419|FG002|Third Intervention (3 Days)|Adverse Event|0|||
130290198|NCT01304329|469025420|FG003|Third Intervention (3 Days)|Adverse Event|0|||
130290199|NCT01304329|469025421|FG004|Third Intervention (3 Days)|Adverse Event|0|||
130290200|NCT01304329|469025422|FG005|Third Intervention (3 Days)|Adverse Event|0|||
130290201|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Adverse Event|0|||
130290202|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Adverse Event|1|||
130290203|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Adverse Event|0|||
130290204|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Adverse Event|0|||
130290205|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Adverse Event|0|||
130290206|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Adverse Event|0|||
130290207|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
130290208|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290209|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290210|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290211|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290212|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290213|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
130290214|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
130290215|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
130290216|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
130290217|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
130290218|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
130290219|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Progressive disease|0|||
130290220|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Progressive disease|1|||
130290221|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Progressive disease|1|||
130290222|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Progressive disease|0|||
130290223|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Progressive disease|0|||
130290224|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Progressive disease|0|||
130290225|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
130290226|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
130290227|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290228|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290229|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290230|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290231|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130290232|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130371142|NCT03953820|469329303|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
130290233|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290234|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290235|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290236|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290237|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290238|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290239|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130290240|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130290241|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290242|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290243|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290244|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290245|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
130290246|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290247|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290248|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290249|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290250|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
130290251|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130371143|NCT03953820|469329304|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
130371144|NCT03953820|469329302|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
130371145|NCT03953820|469329303|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
130371146|NCT03953820|469329304|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
130371147|NCT03322631|469329310|FG000|Overall Study|Withdrawal by Subject|0|||
130371148|NCT03322631|469329311|FG001|Overall Study|Withdrawal by Subject|1|||
130371149|NCT03322631|469329312|FG002|Overall Study|Withdrawal by Subject|0|||
130371150|NCT03322631|469329313|FG003|Overall Study|Withdrawal by Subject|0|||
130371151|NCT03322631|469329310|FG000|Overall Study|Adverse Event|0|||
130371152|NCT03322631|469329311|FG001|Overall Study|Adverse Event|0|||
130556547|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
130556548|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
130556549|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
130556550|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
130556551|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
130556552|NCT01641809|470006165|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
130714368|NCT03502707|470581661|FG011|Overall Study|Initiated Prohibited Medication|0|||
130714369|NCT03502707|470581662|FG012|Overall Study|Initiated Prohibited Medication|0|||
130714370|NCT03502707|470581663|FG013|Overall Study|Initiated Prohibited Medication|0|||
130714371|NCT03502707|470581664|FG014|Overall Study|Initiated Prohibited Medication|0|||
130714372|NCT03502707|470581665|FG015|Overall Study|Initiated Prohibited Medication|0|||
130714373|NCT03502707|470581666|FG016|Overall Study|Initiated Prohibited Medication|1|||
130714374|NCT03502707|470581667|FG017|Overall Study|Initiated Prohibited Medication|0|||
130714375|NCT03502707|470581650|FG000|Overall Study|Other|0|||
130714376|NCT03502707|470581651|FG001|Overall Study|Other|0|||
130714377|NCT03502707|470581652|FG002|Overall Study|Other|0|||
130714378|NCT03502707|470581653|FG003|Overall Study|Other|0|||
130714379|NCT03502707|470581654|FG004|Overall Study|Other|0|||
130714380|NCT03502707|470581655|FG005|Overall Study|Other|0|||
130714381|NCT03502707|470581656|FG006|Overall Study|Other|0|||
130290252|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290253|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290254|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290255|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
130290256|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
130290257|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
130290258|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
130290259|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
130290260|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
130290261|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|DLT|1|||
130290262|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|DLT|0|||
130290263|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|DLT|2|||
130290264|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|DLT|1|||
130290265|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|DLT|0|||
130290266|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|DLT|0|||
130290267|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
130290268|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
130290269|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
130290270|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
130290271|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
130290272|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
130290273|NCT01406015|469025443|FG000|Overall Study|Withdrawal by Subject|3|||
130290274|NCT01406015|469025444|FG001|Overall Study|Withdrawal by Subject|3|||
130290275|NCT00844805|469025445|FG000|Treatment Phase|Adverse Event|5|||
130290276|NCT00844805|469025446|FG001|Treatment Phase|Adverse Event|1|||
130290277|NCT00844805|469025447|FG002|Treatment Phase|Adverse Event|0|||
130290278|NCT00844805|469025448|FG003|Treatment Phase|Adverse Event|0|||
130290279|NCT00844805|469025445|FG000|Treatment Phase|Withdrawal by Subject|3|||
130290280|NCT00844805|469025446|FG001|Treatment Phase|Withdrawal by Subject|4|||
130290281|NCT00844805|469025447|FG002|Treatment Phase|Withdrawal by Subject|0|||
130290282|NCT00844805|469025448|FG003|Treatment Phase|Withdrawal by Subject|0|||
130290283|NCT00844805|469025445|FG000|Treatment Phase|Noncompliance With Protocol|1|||
130290284|NCT00844805|469025446|FG001|Treatment Phase|Noncompliance With Protocol|0|||
130290285|NCT00844805|469025447|FG002|Treatment Phase|Noncompliance With Protocol|0|||
130290286|NCT00844805|469025448|FG003|Treatment Phase|Noncompliance With Protocol|0|||
130290287|NCT00844805|469025445|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
130371153|NCT03322631|469329312|FG002|Overall Study|Adverse Event|1|||
130371154|NCT03322631|469329313|FG003|Overall Study|Adverse Event|0|||
130556553|NCT01641809|470006166|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
130714382|NCT03502707|470581657|FG007|Overall Study|Other|0|||
130714383|NCT03502707|470581658|FG008|Overall Study|Other|1|||
130714384|NCT03502707|470581659|FG009|Overall Study|Other|1|||
130714385|NCT03502707|470581660|FG010|Overall Study|Other|2|||
130714386|NCT03502707|470581661|FG011|Overall Study|Other|0|||
130290288|NCT00844805|469025446|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
130290289|NCT00844805|469025447|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130290290|NCT00844805|469025448|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130290291|NCT00844805|469025445|FG000|Follow-Up Phase|Adverse Event|0|||
130290292|NCT00844805|469025446|FG001|Follow-Up Phase|Adverse Event|0|||
130290293|NCT00844805|469025447|FG002|Follow-Up Phase|Adverse Event|1|||
130290294|NCT00844805|469025448|FG003|Follow-Up Phase|Adverse Event|0|||
130290295|NCT00844805|469025445|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130371155|NCT02378961|469329314|FG000|Overall Study|Lack of Efficacy|4|||
130371156|NCT02378961|469329315|FG001|Overall Study|Lack of Efficacy|2|||
130371157|NCT02378961|469329316|FG002|Overall Study|Lack of Efficacy|0|||
130371158|NCT02378961|469329317|FG003|Overall Study|Lack of Efficacy|1|||
130371159|NCT02378961|469329314|FG000|Overall Study|Death|0|||
130371160|NCT02378961|469329315|FG001|Overall Study|Death|0|||
130290296|NCT00844805|469025446|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130290297|NCT00844805|469025447|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
130290298|NCT00844805|469025448|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
130290299|NCT00844805|469025445|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
130290300|NCT00844805|469025446|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
130290301|NCT00844805|469025447|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
130290302|NCT00844805|469025448|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
130290303|NCT00844805|469025445|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
130371161|NCT02378961|469329316|FG002|Overall Study|Death|1|||
130371162|NCT02378961|469329317|FG003|Overall Study|Death|0|||
130371163|NCT01217801|469329318|FG000|Period 1|Protocol Violation|1|||
130371164|NCT01217801|469329319|FG001|Period 1|Protocol Violation|1|||
130371165|NCT01217801|469329318|FG000|Period 1|Withdrawal by Subject|0|||
130459948|NCT00430300|469647669|FG001|Overall Study|Laboratory abnormality|0|||
130459949|NCT00430300|469647670|FG002|Overall Study|Laboratory abnormality|0|||
130459950|NCT00430300|469647671|FG003|Overall Study|Laboratory abnormality|0|||
130459951|NCT00430300|469647668|FG000|Overall Study|Other|0|||
130459952|NCT00430300|469647669|FG001|Overall Study|Other|0|||
130459953|NCT00430300|469647670|FG002|Overall Study|Other|0|||
130459954|NCT00430300|469647671|FG003|Overall Study|Other|1|||
130459955|NCT02754479|469647675|FG000|Overall Study|Lost to Follow-up|1|||
130459956|NCT01049503|469649662|FG000|Overall Study|Lost to Follow-up|11|||
130459957|NCT01049503|469649663|FG001|Overall Study|Lost to Follow-up|12|||
130459958|NCT01049503|469649664|FG002|Overall Study|Lost to Follow-up|24|||
130459959|NCT01049503|469649665|FG003|Overall Study|Lost to Follow-up|26|||
130459960|NCT01049503|469649666|FG004|Overall Study|Lost to Follow-up|27|||
130459961|NCT01049503|469649667|FG005|Overall Study|Lost to Follow-up|8|||
130459962|NCT00726596|469649668|FG000|Overall Study|Adverse Event|2|||
130459963|NCT00726596|469649669|FG001|Overall Study|Adverse Event|1|||
130459964|NCT00726596|469649668|FG000|Overall Study|Withdrawal by Subject|3|||
130459965|NCT00726596|469649669|FG001|Overall Study|Withdrawal by Subject|3|||
130459966|NCT02974634|469649670|FG000|Overall Study|Advanced disease|12|||
130459967|NCT02974634|469649671|FG001|Overall Study|Advanced disease|3|||
130459968|NCT02974634|469649670|FG000|Overall Study|Noncompliance|3|||
130459969|NCT02974634|469649671|FG001|Overall Study|Noncompliance|7|||
130459970|NCT02974634|469649670|FG000|Overall Study|intervention technology related issues|5|||
130459971|NCT02974634|469649671|FG001|Overall Study|intervention technology related issues|0|||
130459972|NCT02974634|469649670|FG000|Overall Study|Death|8|||
130459973|NCT02974634|469649671|FG001|Overall Study|Death|11|||
130459974|NCT02962674|469649680|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
130459975|NCT00364286|469649681|FG000|Overall Study|Withdrawal by Subject|1|||
130459976|NCT00364286|469649681|FG000|Overall Study|Adverse Event|2|||
130459977|NCT01134562|469649684|FG000|Overall Study|Adverse Event|0|||
130459978|NCT01134562|469649685|FG001|Overall Study|Adverse Event|1|||
130459979|NCT01134562|469649686|FG002|Overall Study|Adverse Event|0|||
130459980|NCT01134562|469649687|FG003|Overall Study|Adverse Event|0|||
130459981|NCT01134562|469649688|FG004|Overall Study|Adverse Event|0|||
130459982|NCT05174013|469649697|FG000|Overall Study|Lost to Follow-up|0|||
130459983|NCT05174013|469649698|FG001|Overall Study|Lost to Follow-up|0|||
130459984|NCT05174013|469649699|FG002|Overall Study|Lost to Follow-up|0|||
130459985|NCT05174013|469649700|FG003|Overall Study|Lost to Follow-up|1|||
130459986|NCT05174013|469649701|FG004|Overall Study|Lost to Follow-up|0|||
130459987|NCT05174013|469649702|FG005|Overall Study|Lost to Follow-up|0|||
130459988|NCT05174013|469649697|FG000|Overall Study|Withdrawal by Subject|0|||
130459989|NCT05174013|469649698|FG001|Overall Study|Withdrawal by Subject|0|||
130459990|NCT05174013|469649699|FG002|Overall Study|Withdrawal by Subject|1|||
130459991|NCT05174013|469649700|FG003|Overall Study|Withdrawal by Subject|0|||
130459992|NCT05174013|469649701|FG004|Overall Study|Withdrawal by Subject|0|||
130459993|NCT05174013|469649702|FG005|Overall Study|Withdrawal by Subject|0|||
130459994|NCT03287622|469649703|FG000|Overall Study|Withdrawal by Subject|1|||
130290304|NCT00844805|469025446|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
130290305|NCT00844805|469025447|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
130371166|NCT01217801|469329319|FG001|Period 1|Withdrawal by Subject|1|||
130714387|NCT03502707|470581662|FG012|Overall Study|Other|0|||
130714388|NCT03502707|470581663|FG013|Overall Study|Other|0|||
130714389|NCT03502707|470581664|FG014|Overall Study|Other|0|||
130714390|NCT03502707|470581665|FG015|Overall Study|Other|4|||
130714391|NCT03502707|470581666|FG016|Overall Study|Other|1|||
130290306|NCT00844805|469025448|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
130290307|NCT00844805|469025445|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290308|NCT00844805|469025446|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290309|NCT00844805|469025447|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290310|NCT00844805|469025448|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
130290311|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
130290312|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
130290313|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
130290314|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
130290315|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
130290316|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
130290317|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
130290318|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
130290319|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
130290320|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
130290321|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Other|4|||
130290322|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Other|0|||
130290323|NCT01352741|469025449|FG000|Double-blind Comparative Period|Protocol Violation|2|||
130290324|NCT01352741|469025450|FG001|Double-blind Comparative Period|Protocol Violation|0|||
130290325|NCT01352741|469025449|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
130290326|NCT01352741|469025450|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
130290327|NCT01352741|469025449|FG000|Double-blind Comparative Period|Adverse Event|16|||
130290328|NCT01352741|469025450|FG001|Double-blind Comparative Period|Adverse Event|17|||
130290329|NCT01352741|469025449|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
130290330|NCT01352741|469025450|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
130290331|NCT01352741|469025449|FG000|Double-blind Comparative Period|Death|0|||
130290332|NCT01352741|469025450|FG001|Double-blind Comparative Period|Death|1|||
130290333|NCT01352741|469025449|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
130290334|NCT01352741|469025450|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
130290335|NCT01352741|469025449|FG000|Double-blind Comparative Period|Other|1|||
130290336|NCT01352741|469025450|FG001|Double-blind Comparative Period|Other|2|||
130290337|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
130290338|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
130290339|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
130290340|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
130290341|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
130290342|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
130290343|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
130290344|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
130290345|NCT01886690|469025452|FG000|Overall Study|Protocol Violation|0|||
130290346|NCT01886690|469025453|FG001|Overall Study|Protocol Violation|1|||
130290347|NCT01886690|469025452|FG000|Overall Study|Personal Reasons|0|||
130290348|NCT01886690|469025453|FG001|Overall Study|Personal Reasons|1|||
130290349|NCT01510145|469025454|FG000|Overall Study|Adverse Event|6|||
130290350|NCT01510145|469025454|FG000|Overall Study|Lost to Follow-up|5|||
130290351|NCT01510145|469025454|FG000|Overall Study|Withdrawal by Subject|6|||
130290352|NCT01510145|469025454|FG000|Overall Study|Relative reported subject withdrew|1|||
130290353|NCT03081858|469027325|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
130290354|NCT03081858|469027326|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290355|NCT03081858|469027327|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290356|NCT03081858|469027328|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290357|NCT00262847|469027331|FG000|Overall Study|Disease Progression|309|||
130290358|NCT00262847|469027332|FG001|Overall Study|Disease Progression|274|||
130290359|NCT00262847|469027333|FG002|Overall Study|Disease Progression|195|||
130290360|NCT00262847|469027331|FG000|Overall Study|Patient Refusal|41|||
130290361|NCT00262847|469027332|FG001|Overall Study|Patient Refusal|52|||
130290362|NCT00262847|469027333|FG002|Overall Study|Patient Refusal|47|||
130290363|NCT00262847|469027331|FG000|Overall Study|Adverse Event|74|||
130290364|NCT00262847|469027332|FG001|Overall Study|Adverse Event|88|||
130290365|NCT00262847|469027333|FG002|Overall Study|Adverse Event|108|||
130556554|NCT01641809|470006167|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
130714392|NCT03502707|470581667|FG017|Overall Study|Other|0|||
130290366|NCT00262847|469027331|FG000|Overall Study|Death|8|||
130371167|NCT04967443|469329322|FG000|Open Label Treatment|Death|1|||
130714393|NCT03502707|470581650|FG000|Overall Study|Randomized but not vaccinated|0|||
130371168|NCT04967443|469329323|FG001|Open Label Treatment|Death|0|||
130371169|NCT04967443|469329324|FG002|Open Label Treatment|Death|0|||
130371170|NCT04967443|469329325|FG003|Open Label Treatment|Death|0|||
130290367|NCT00262847|469027332|FG001|Overall Study|Death|8|||
130290368|NCT00262847|469027333|FG002|Overall Study|Death|11|||
130290369|NCT00262847|469027331|FG000|Overall Study|Concomitant disease|3|||
130290370|NCT00262847|469027332|FG001|Overall Study|Concomitant disease|2|||
130290371|NCT00262847|469027333|FG002|Overall Study|Concomitant disease|4|||
130290372|NCT00262847|469027331|FG000|Overall Study|Other Reasons|79|||
130290373|NCT00262847|469027332|FG001|Overall Study|Other Reasons|88|||
130290374|NCT00262847|469027333|FG002|Overall Study|Other Reasons|27|||
130290375|NCT00262847|469027331|FG000|Overall Study|Did not receive study treatment|4|||
130290376|NCT00262847|469027332|FG001|Overall Study|Did not receive study treatment|1|||
130290377|NCT00262847|469027333|FG002|Overall Study|Did not receive study treatment|4|||
130371171|NCT04967443|469329326|FG004|Open Label Treatment|Death|0|||
130371172|NCT04967443|469329327|FG005|Open Label Treatment|Death|0|||
130556555|NCT01641809|470006168|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
130556556|NCT03672461|470006171|FG000|Overall Study|COVID Related|4|||
130371173|NCT04967443|469329328|FG006|Open Label Treatment|Death|0|||
130371174|NCT04967443|469329329|FG007|Open Label Treatment|Death|0|||
130371175|NCT04967443|469329322|FG000|Open Label Treatment|Lost to Follow-up|0|||
130371176|NCT04967443|469329323|FG001|Open Label Treatment|Lost to Follow-up|0|||
130371177|NCT04967443|469329324|FG002|Open Label Treatment|Lost to Follow-up|1|||
130371178|NCT04967443|469329325|FG003|Open Label Treatment|Lost to Follow-up|0|||
130371179|NCT04967443|469329326|FG004|Open Label Treatment|Lost to Follow-up|0|||
130371180|NCT04967443|469329327|FG005|Open Label Treatment|Lost to Follow-up|0|||
130371181|NCT04967443|469329328|FG006|Open Label Treatment|Lost to Follow-up|0|||
130371182|NCT04967443|469329329|FG007|Open Label Treatment|Lost to Follow-up|0|||
130371183|NCT04967443|469329322|FG000|Open Label Treatment|Withdrawal by Subject|0|||
130371184|NCT04967443|469329323|FG001|Open Label Treatment|Withdrawal by Subject|1|||
130371185|NCT04967443|469329324|FG002|Open Label Treatment|Withdrawal by Subject|0|||
130371186|NCT04967443|469329325|FG003|Open Label Treatment|Withdrawal by Subject|1|||
130371187|NCT04967443|469329326|FG004|Open Label Treatment|Withdrawal by Subject|0|||
130371188|NCT04967443|469329327|FG005|Open Label Treatment|Withdrawal by Subject|1|||
130371189|NCT04967443|469329328|FG006|Open Label Treatment|Withdrawal by Subject|2|||
130371190|NCT04967443|469329329|FG007|Open Label Treatment|Withdrawal by Subject|3|||
130371191|NCT04967443|469329322|FG000|Follow-Up|Death|1|||
130371192|NCT04967443|469329323|FG001|Follow-Up|Death|0|||
130371193|NCT04967443|469329324|FG002|Follow-Up|Death|0|||
130556557|NCT03672461|470006172|FG001|Overall Study|COVID Related|2|||
130556558|NCT03672461|470006171|FG000|Overall Study|Adverse Event|2|||
130290378|NCT03966885|469027334|FG000|Overall Study|Death|1|||
130371194|NCT04967443|469329325|FG003|Follow-Up|Death|0|||
130290379|NCT03966885|469027335|FG001|Overall Study|Death|0|||
130290380|NCT03966885|469027334|FG000|Overall Study|Lost to Follow-up|1|||
130290381|NCT03966885|469027335|FG001|Overall Study|Lost to Follow-up|2|||
130290382|NCT03966885|469027334|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
130290383|NCT03966885|469027335|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
130290384|NCT03966885|469027334|FG000|Overall Study|Moved from study area.|0|||
130290385|NCT03966885|469027335|FG001|Overall Study|Moved from study area.|2|||
130290386|NCT05013424|469027352|FG000|Overall Study|Lost to Follow-up|1|||
130290387|NCT05013424|469027353|FG001|Overall Study|Lost to Follow-up|1|||
130290388|NCT05013424|469027354|FG002|Overall Study|Lost to Follow-up|1|||
130290389|NCT05013424|469027352|FG000|Overall Study|Withdrawal by Subject|0|||
130290390|NCT05013424|469027353|FG001|Overall Study|Withdrawal by Subject|1|||
130290391|NCT05013424|469027354|FG002|Overall Study|Withdrawal by Subject|0|||
130290392|NCT03899064|469027355|FG000|Overall Study|Lost to Follow-up|1|||
130290393|NCT03899064|469027355|FG000|Overall Study|Protocol Violation|2|||
130290394|NCT03899064|469027355|FG000|Overall Study|Withdrawal by Subject|2|||
130290395|NCT03899064|469027355|FG000|Overall Study|Other|2|||
130290396|NCT03710876|469027356|FG000|Overall Study|Death|0|||
130290397|NCT03710876|469027357|FG001|Overall Study|Death|2|||
130290398|NCT03710876|469027356|FG000|Overall Study|Withdrawal by Subject|0|||
130290399|NCT03710876|469027357|FG001|Overall Study|Withdrawal by Subject|2|||
130290400|NCT00289198|469027366|FG000|Overall Study|Adverse Event|0|||
130371195|NCT04967443|469329326|FG004|Follow-Up|Death|0|||
130371196|NCT04967443|469329327|FG005|Follow-Up|Death|0|||
130290401|NCT00289198|469027367|FG001|Overall Study|Adverse Event|2|||
130371197|NCT04967443|469329328|FG006|Follow-Up|Death|0|||
130371198|NCT04967443|469329329|FG007|Follow-Up|Death|0|||
130290402|NCT00289198|469027366|FG000|Overall Study|Protocol Violation|2|||
130290403|NCT00289198|469027367|FG001|Overall Study|Protocol Violation|1|||
130290404|NCT00289198|469027366|FG000|Overall Study|Withdrawal by Subject|4|||
130290405|NCT00289198|469027367|FG001|Overall Study|Withdrawal by Subject|1|||
130290406|NCT00289198|469027366|FG000|Overall Study|Lack of Efficacy|2|||
130290407|NCT00289198|469027367|FG001|Overall Study|Lack of Efficacy|0|||
130371199|NCT04967443|469329322|FG000|Follow-Up|Lost to Follow-up|0|||
130371200|NCT04967443|469329323|FG001|Follow-Up|Lost to Follow-up|0|||
130371201|NCT04967443|469329324|FG002|Follow-Up|Lost to Follow-up|1|||
130290408|NCT00289198|469027366|FG000|Overall Study|Other: Low compliance|0|||
130714394|NCT03502707|470581651|FG001|Overall Study|Randomized but not vaccinated|0|||
130714395|NCT03502707|470581652|FG002|Overall Study|Randomized but not vaccinated|0|||
130714396|NCT03502707|470581653|FG003|Overall Study|Randomized but not vaccinated|0|||
130714397|NCT03502707|470581654|FG004|Overall Study|Randomized but not vaccinated|0|||
130714398|NCT03502707|470581655|FG005|Overall Study|Randomized but not vaccinated|0|||
130714399|NCT03502707|470581656|FG006|Overall Study|Randomized but not vaccinated|0|||
130714400|NCT03502707|470581657|FG007|Overall Study|Randomized but not vaccinated|0|||
130714401|NCT03502707|470581658|FG008|Overall Study|Randomized but not vaccinated|0|||
130714402|NCT03502707|470581659|FG009|Overall Study|Randomized but not vaccinated|0|||
130714403|NCT03502707|470581660|FG010|Overall Study|Randomized but not vaccinated|0|||
130714404|NCT03502707|470581661|FG011|Overall Study|Randomized but not vaccinated|1|||
130714405|NCT03502707|470581662|FG012|Overall Study|Randomized but not vaccinated|0|||
130714406|NCT03502707|470581663|FG013|Overall Study|Randomized but not vaccinated|0|||
130714407|NCT03502707|470581664|FG014|Overall Study|Randomized but not vaccinated|0|||
130714408|NCT03502707|470581665|FG015|Overall Study|Randomized but not vaccinated|0|||
130714409|NCT03502707|470581666|FG016|Overall Study|Randomized but not vaccinated|0|||
130714410|NCT03502707|470581667|FG017|Overall Study|Randomized but not vaccinated|1|||
130714411|NCT04908683|470581668|FG000|Overall Study|Failure to meet continuation criteria|34|||
130714412|NCT04908683|470581669|FG001|Overall Study|Failure to meet continuation criteria|22|||
130714413|NCT04908683|470581668|FG000|Overall Study|Initiated prohibited medication|3|||
130714414|NCT04908683|470581669|FG001|Overall Study|Initiated prohibited medication|0|||
130714415|NCT04908683|470581668|FG000|Overall Study|Randomized by mistake|1|||
130714416|NCT04908683|470581669|FG001|Overall Study|Randomized by mistake|0|||
130714417|NCT04908683|470581668|FG000|Overall Study|Lost to Follow-up|679|||
130714418|NCT04908683|470581669|FG001|Overall Study|Lost to Follow-up|341|||
130714419|NCT04908683|470581668|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
130714420|NCT04908683|470581669|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
130714421|NCT04908683|470581668|FG000|Overall Study|Physician Decision|44|||
130714422|NCT04908683|470581669|FG001|Overall Study|Physician Decision|35|||
130714423|NCT04908683|470581668|FG000|Overall Study|Technical problems|12|||
130714424|NCT04908683|470581669|FG001|Overall Study|Technical problems|9|||
130714425|NCT04908683|470581668|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
130290409|NCT00289198|469027367|FG001|Overall Study|Other: Low compliance|1|||
130290410|NCT00289198|469027366|FG000|Overall Study|Other: Physician's decision|0|||
130290411|NCT00289198|469027367|FG001|Overall Study|Other: Physician's decision|1|||
130290412|NCT00289198|469027366|FG000|Overall Study|Other: Unable to attend on schedule|2|||
130290413|NCT00289198|469027367|FG001|Overall Study|Other: Unable to attend on schedule|1|||
130290414|NCT00289198|469027366|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
130290415|NCT00289198|469027367|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
130290416|NCT00289198|469027366|FG000|Overall Study|Other: Impossible to come on visit|0|||
130290417|NCT00289198|469027367|FG001|Overall Study|Other: Impossible to come on visit|1|||
130290418|NCT01176565|469027368|FG000|Overall Study|Lost to Follow-up|12|||
130290419|NCT01176565|469027369|FG001|Overall Study|Lost to Follow-up|16|||
130290420|NCT01176565|469027368|FG000|Overall Study|Withdrawal by Subject|7|||
130290421|NCT01176565|469027369|FG001|Overall Study|Withdrawal by Subject|1|||
130290422|NCT01176565|469027368|FG000|Overall Study|Not Analyzed (any other reason)|1|||
130290423|NCT01176565|469027369|FG001|Overall Study|Not Analyzed (any other reason)|2|||
130290424|NCT03602885|469027370|FG000|Overall Study|Lost to Follow-up|3|||
130290425|NCT03602885|469027371|FG001|Overall Study|Lost to Follow-up|0|||
130290426|NCT03106415|469027377|FG000|Phase 1|Withdrawal by Subject|1|||
130290427|NCT03106415|469027378|FG001|Phase 1|Withdrawal by Subject|0|||
130290428|NCT03106415|469027379|FG002|Phase 1|Withdrawal by Subject|0|||
130290429|NCT03106415|469027377|FG000|Phase 1|Adverse Event|1|||
130290430|NCT03106415|469027378|FG001|Phase 1|Adverse Event|1|||
130290431|NCT03106415|469027379|FG002|Phase 1|Adverse Event|0|||
130290432|NCT03106415|469027377|FG000|Phase 1|Protocol Violation|0|||
130290433|NCT03106415|469027378|FG001|Phase 1|Protocol Violation|1|||
130714426|NCT04908683|470581669|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
130290434|NCT03106415|469027379|FG002|Phase 1|Protocol Violation|0|||
130290435|NCT00293709|469027380|FG000|Overall Study|Other|47|||
130290436|NCT02088073|469027381|FG000|Acute Phase|Withdrawal by Subject|5|||
130714427|NCT04908683|470581668|FG000|Overall Study|Protocol Violation|2|||
130714428|NCT04908683|470581669|FG001|Overall Study|Protocol Violation|0|||
130290437|NCT02088073|469027382|FG001|Acute Phase|Withdrawal by Subject|0|||
130290438|NCT02088073|469027383|FG002|Acute Phase|Withdrawal by Subject|0|||
130290439|NCT02088073|469027384|FG003|Acute Phase|Withdrawal by Subject|0|||
130290440|NCT02088073|469027385|FG004|Acute Phase|Withdrawal by Subject|0|||
130290441|NCT02088073|469027381|FG000|Acute Phase|Hyperkalemia|2|||
130290442|NCT02088073|469027382|FG001|Acute Phase|Hyperkalemia|0|||
130290443|NCT02088073|469027383|FG002|Acute Phase|Hyperkalemia|0|||
130714429|NCT04908683|470581668|FG000|Overall Study|Withdrawal by Subject|1188|||
130714430|NCT04908683|470581669|FG001|Overall Study|Withdrawal by Subject|570|||
130714431|NCT04908683|470581668|FG000|Overall Study|Site Closure by Sponsor|6|||
130290444|NCT02088073|469027384|FG003|Acute Phase|Hyperkalemia|0|||
130290445|NCT02088073|469027385|FG004|Acute Phase|Hyperkalemia|0|||
130290446|NCT02088073|469027381|FG000|Maintanance Phase|Withdrawal by Subject|0|||
130290447|NCT02088073|469027382|FG001|Maintanance Phase|Withdrawal by Subject|2|||
130290448|NCT02088073|469027383|FG002|Maintanance Phase|Withdrawal by Subject|0|||
130290449|NCT02088073|469027384|FG003|Maintanance Phase|Withdrawal by Subject|0|||
130290450|NCT02088073|469027385|FG004|Maintanance Phase|Withdrawal by Subject|0|||
130290451|NCT02088073|469027381|FG000|Maintanance Phase|Adverse Event|0|||
130290452|NCT02088073|469027382|FG001|Maintanance Phase|Adverse Event|0|||
130290453|NCT02088073|469027383|FG002|Maintanance Phase|Adverse Event|3|||
130290454|NCT02088073|469027384|FG003|Maintanance Phase|Adverse Event|0|||
130290455|NCT02088073|469027385|FG004|Maintanance Phase|Adverse Event|1|||
130290456|NCT02088073|469027381|FG000|Maintanance Phase|Physician Decision|0|||
130290457|NCT02088073|469027382|FG001|Maintanance Phase|Physician Decision|0|||
130290458|NCT02088073|469027383|FG002|Maintanance Phase|Physician Decision|0|||
130290459|NCT02088073|469027384|FG003|Maintanance Phase|Physician Decision|0|||
130290460|NCT02088073|469027385|FG004|Maintanance Phase|Physician Decision|1|||
130290461|NCT02088073|469027381|FG000|Maintanance Phase|Sponsor's decision|0|||
130290462|NCT02088073|469027382|FG001|Maintanance Phase|Sponsor's decision|2|||
130290463|NCT02088073|469027383|FG002|Maintanance Phase|Sponsor's decision|0|||
130290464|NCT02088073|469027384|FG003|Maintanance Phase|Sponsor's decision|2|||
130290465|NCT02088073|469027385|FG004|Maintanance Phase|Sponsor's decision|1|||
130290466|NCT02088073|469027381|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
130290467|NCT02088073|469027382|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
130290468|NCT02088073|469027383|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
130290469|NCT02088073|469027384|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
130290470|NCT02088073|469027385|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
130290471|NCT02088073|469027381|FG000|Maintanance Phase|Miscellaneous|0|||
130290472|NCT02088073|469027382|FG001|Maintanance Phase|Miscellaneous|2|||
130290473|NCT02088073|469027383|FG002|Maintanance Phase|Miscellaneous|1|||
130290474|NCT02088073|469027384|FG003|Maintanance Phase|Miscellaneous|2|||
130290475|NCT02088073|469027385|FG004|Maintanance Phase|Miscellaneous|1|||
130290476|NCT02088073|469027381|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290477|NCT02088073|469027382|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290478|NCT02088073|469027383|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
130290479|NCT02088073|469027384|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290480|NCT02088073|469027385|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
130290481|NCT02088073|469027381|FG000|Maintanance Phase|Subject compliance|0|||
130290482|NCT02088073|469027382|FG001|Maintanance Phase|Subject compliance|1|||
130290483|NCT02088073|469027383|FG002|Maintanance Phase|Subject compliance|0|||
130290484|NCT02088073|469027384|FG003|Maintanance Phase|Subject compliance|0|||
130290485|NCT02088073|469027385|FG004|Maintanance Phase|Subject compliance|0|||
130290486|NCT01804582|469027386|FG000|Overall Study|Lost to Follow-up|47|||
130290487|NCT01804582|469027387|FG001|Overall Study|Lost to Follow-up|56|||
130290488|NCT01804582|469027386|FG000|Overall Study|Physician Decision|2|||
130290489|NCT01804582|469027387|FG001|Overall Study|Physician Decision|0|||
130290490|NCT02046174|469027388|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
130290491|NCT02046174|469027389|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
130290492|NCT02118597|469027390|FG000|Overall Study|Sponsor terminated the study|14|||
130290493|NCT02118597|469027390|FG000|Overall Study|Serious Adverse Event|1|||
130290494|NCT02118597|469027390|FG000|Overall Study|Investigator's decision|1|||
130290495|NCT01891344|469027391|FG000|Overall Study|Ongoing|6|||
130290496|NCT01891344|469027392|FG001|Overall Study|Ongoing|2|||
130290497|NCT01891344|469027393|FG002|Overall Study|Ongoing|0|||
130290498|NCT01891344|469027394|FG003|Overall Study|Ongoing|1|||
130290499|NCT01891344|469027395|FG004|Overall Study|Ongoing|4|||
130290500|NCT01891344|469027396|FG005|Overall Study|Ongoing|1|||
130290501|NCT01891344|469027397|FG006|Overall Study|Ongoing|0|||
130290502|NCT01891344|469027398|FG007|Overall Study|Ongoing|0|||
130290503|NCT00186537|469027402|FG000|Overall Study|Withdrawal by Subject|4|||
130290504|NCT00186537|469027403|FG001|Overall Study|Withdrawal by Subject|0|||
130290505|NCT00186537|469027404|FG002|Overall Study|Withdrawal by Subject|3|||
130290506|NCT00186537|469027402|FG000|Overall Study|ALT > 1.5 x ULN|3|||
130290507|NCT00186537|469027403|FG001|Overall Study|ALT > 1.5 x ULN|0|||
130290508|NCT00186537|469027404|FG002|Overall Study|ALT > 1.5 x ULN|0|||
130459995|NCT03287622|469649704|FG001|Overall Study|Withdrawal by Subject|0|||
130290509|NCT03294135|469027405|FG000|Overall Study|Serious Adverse Event|1|||
130290510|NCT03294135|469027406|FG001|Overall Study|Serious Adverse Event|0|||
130290511|NCT03294135|469027407|FG002|Overall Study|Serious Adverse Event|0|||
130290512|NCT03294135|469027405|FG000|Overall Study|Lost to Follow-up|1|||
130459996|NCT03287622|469649703|FG000|Overall Study|Lost to Follow-up|27|||
130290513|NCT03294135|469027406|FG001|Overall Study|Lost to Follow-up|0|||
130290514|NCT03294135|469027407|FG002|Overall Study|Lost to Follow-up|1|||
130290515|NCT03294135|469027405|FG000|Overall Study|Withdrawal by Subject|0|||
130290516|NCT03294135|469027406|FG001|Overall Study|Withdrawal by Subject|0|||
130459997|NCT03287622|469649704|FG001|Overall Study|Lost to Follow-up|15|||
130290517|NCT03294135|469027407|FG002|Overall Study|Withdrawal by Subject|1|||
130290518|NCT03294135|469027405|FG000|Overall Study|Other|2|||
130290519|NCT03294135|469027406|FG001|Overall Study|Other|0|||
130290520|NCT03294135|469027407|FG002|Overall Study|Other|0|||
130290521|NCT02763254|469027408|FG000|Overall Study|Adverse Event|1|||
130290522|NCT03684304|469027409|FG000|Overall Study|Lost to Follow-up|19|||
130290523|NCT03684304|469027410|FG001|Overall Study|Lost to Follow-up|17|||
130290524|NCT01143051|469027411|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130290525|NCT01143051|469027412|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130290526|NCT01143051|469027413|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
130290527|NCT01143051|469027414|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130290528|NCT01143051|469027415|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130290529|NCT01143051|469027416|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
130290530|NCT01143051|469027411|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130290531|NCT01143051|469027412|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130290532|NCT01143051|469027413|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
130290533|NCT01143051|469027414|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130290534|NCT01143051|469027415|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130290535|NCT01143051|469027416|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
130290536|NCT01665430|469027417|FG000|Overall Study|Adverse Event|1|||
130290537|NCT01665430|469027417|FG000|Overall Study|Withdrawal by Subject|6|||
130290538|NCT01665430|469027417|FG000|Overall Study|Other Unspecified|2|||
130290539|NCT02310230|469027418|FG000|Overall Study|Physician Decision|1|||
130290540|NCT02310230|469027419|FG001|Overall Study|Physician Decision|3|||
130290541|NCT02310230|469027418|FG000|Overall Study|monitor baseline taken after induction|2|||
130290542|NCT02310230|469027419|FG001|Overall Study|monitor baseline taken after induction|7|||
130290543|NCT02310230|469027418|FG000|Overall Study|Poor signal quality|5|||
130290544|NCT02310230|469027419|FG001|Overall Study|Poor signal quality|8|||
130290545|NCT02310230|469027418|FG000|Overall Study|Case cancelled|1|||
130290546|NCT02310230|469027419|FG001|Overall Study|Case cancelled|0|||
130290547|NCT01605227|469027420|FG000|Overall Study|Did not receive study treatment|2|||
130290548|NCT01605227|469027421|FG001|Overall Study|Did not receive study treatment|3|||
130290549|NCT01605227|469027420|FG000|Overall Study|Adverse Event|228|||
130290550|NCT01605227|469027421|FG001|Overall Study|Adverse Event|42|||
130290551|NCT01605227|469027420|FG000|Overall Study|Progressive Disease|132|||
130290552|NCT01605227|469027421|FG001|Overall Study|Progressive Disease|128|||
130290553|NCT01605227|469027420|FG000|Overall Study|Clinical Deterioration|227|||
130290554|NCT01605227|469027421|FG001|Overall Study|Clinical Deterioration|133|||
130290555|NCT01605227|469027420|FG000|Overall Study|Lost to Follow-up|1|||
130290556|NCT01605227|469027421|FG001|Overall Study|Lost to Follow-up|0|||
130290557|NCT01605227|469027420|FG000|Overall Study|Protocol Violation|1|||
130290558|NCT01605227|469027421|FG001|Overall Study|Protocol Violation|0|||
130290559|NCT01605227|469027420|FG000|Overall Study|Physician Decision|9|||
130290560|NCT01605227|469027421|FG001|Overall Study|Physician Decision|7|||
130290561|NCT01605227|469027420|FG000|Overall Study|Withdrawal by Subject|18|||
130290562|NCT01605227|469027421|FG001|Overall Study|Withdrawal by Subject|14|||
130290563|NCT01605227|469027420|FG000|Overall Study|Sponsor Decision|2|||
130290564|NCT01605227|469027421|FG001|Overall Study|Sponsor Decision|0|||
130290565|NCT01605227|469027420|FG000|Overall Study|Started New Therapy|1|||
130290566|NCT01605227|469027421|FG001|Overall Study|Started New Therapy|0|||
130290567|NCT01605227|469027420|FG000|Overall Study|Subject Decision|0|||
130290568|NCT01605227|469027421|FG001|Overall Study|Subject Decision|1|||
130290569|NCT01605227|469027420|FG000|Overall Study|Dose Held >6 weeks|0|||
130290570|NCT01605227|469027421|FG001|Overall Study|Dose Held >6 weeks|1|||
130290571|NCT02961790|469027422|FG000|Overall Study|Canceled|4|||
130290572|NCT02961790|469027423|FG001|Overall Study|Canceled|5|||
130290573|NCT02961790|469027424|FG002|Overall Study|Canceled|1|||
130371202|NCT04967443|469329325|FG003|Follow-Up|Lost to Follow-up|1|||
130371203|NCT04967443|469329326|FG004|Follow-Up|Lost to Follow-up|0|||
130371204|NCT04967443|469329327|FG005|Follow-Up|Lost to Follow-up|0|||
130371205|NCT04967443|469329328|FG006|Follow-Up|Lost to Follow-up|0|||
130371206|NCT04967443|469329329|FG007|Follow-Up|Lost to Follow-up|0|||
130371207|NCT04967443|469329322|FG000|Follow-Up|Withdrawal by Subject|0|||
130371208|NCT04967443|469329323|FG001|Follow-Up|Withdrawal by Subject|1|||
130371209|NCT04967443|469329324|FG002|Follow-Up|Withdrawal by Subject|0|||
130371210|NCT04967443|469329325|FG003|Follow-Up|Withdrawal by Subject|1|||
130371211|NCT04967443|469329326|FG004|Follow-Up|Withdrawal by Subject|0|||
130714432|NCT04908683|470581669|FG001|Overall Study|Site Closure by Sponsor|3|||
130371212|NCT04967443|469329327|FG005|Follow-Up|Withdrawal by Subject|1|||
130714433|NCT04908683|470581668|FG000|Overall Study|Adverse Event|21|||
130290574|NCT02961790|469027425|FG003|Overall Study|Canceled|4|||
130290575|NCT02961790|469027422|FG000|Overall Study|without baseline data|4|||
130290576|NCT02961790|469027423|FG001|Overall Study|without baseline data|0|||
130290577|NCT02961790|469027424|FG002|Overall Study|without baseline data|1|||
130290578|NCT02961790|469027425|FG003|Overall Study|without baseline data|0|||
130290579|NCT02961790|469027422|FG000|Overall Study|without post baseline data|7|||
130290580|NCT02961790|469027423|FG001|Overall Study|without post baseline data|6|||
130371213|NCT04967443|469329328|FG006|Follow-Up|Withdrawal by Subject|2|||
130371214|NCT04967443|469329329|FG007|Follow-Up|Withdrawal by Subject|3|||
130371215|NCT02405780|469329331|FG000|Period I|Adverse Event|8|||
130371216|NCT02405780|469329332|FG001|Period I|Adverse Event|0|||
130371217|NCT02405780|469329333|FG002|Period I|Adverse Event|3|||
130371218|NCT02405780|469329334|FG003|Period I|Adverse Event|7|||
130371219|NCT02405780|469329331|FG000|Period I|Medical reasons|1|||
130371220|NCT02405780|469329332|FG001|Period I|Medical reasons|1|||
130371221|NCT02405780|469329333|FG002|Period I|Medical reasons|0|||
130371222|NCT02405780|469329334|FG003|Period I|Medical reasons|1|||
130371223|NCT02405780|469329331|FG000|Period I|Screening Failure|1|||
130371224|NCT02405780|469329332|FG001|Period I|Screening Failure|0|||
130371225|NCT02405780|469329333|FG002|Period I|Screening Failure|1|||
130371226|NCT02405780|469329334|FG003|Period I|Screening Failure|0|||
130371227|NCT02405780|469329331|FG000|Period I|Withdrawal by Subject|9|||
130371228|NCT02405780|469329332|FG001|Period I|Withdrawal by Subject|1|||
130371229|NCT02405780|469329333|FG002|Period I|Withdrawal by Subject|3|||
130371230|NCT02405780|469329334|FG003|Period I|Withdrawal by Subject|4|||
130371231|NCT02405780|469329331|FG000|Period I|Non-compliance with study procedures|8|||
130371232|NCT02405780|469329332|FG001|Period I|Non-compliance with study procedures|6|||
130371233|NCT02405780|469329333|FG002|Period I|Non-compliance with study procedures|8|||
130371234|NCT02405780|469329334|FG003|Period I|Non-compliance with study procedures|11|||
130371235|NCT02405780|469329331|FG000|Period II|Adverse Event|3|||
130371236|NCT02405780|469329332|FG001|Period II|Adverse Event|5|||
130371237|NCT02405780|469329333|FG002|Period II|Adverse Event|4|||
130371238|NCT02405780|469329334|FG003|Period II|Adverse Event|11|||
130371239|NCT02405780|469329331|FG000|Period II|Medical reason|0|||
130371240|NCT02405780|469329332|FG001|Period II|Medical reason|1|||
130371241|NCT02405780|469329333|FG002|Period II|Medical reason|0|||
130290581|NCT02961790|469027424|FG002|Overall Study|without post baseline data|4|||
130290582|NCT02961790|469027425|FG003|Overall Study|without post baseline data|1|||
130290583|NCT02078102|469027426|FG000|Overall Study|Adverse Event|1|||
130290584|NCT02078102|469027427|FG001|Overall Study|Adverse Event|0|||
130290585|NCT02078102|469027426|FG000|Overall Study|Withdrawal by Subject|1|||
130290586|NCT02078102|469027427|FG001|Overall Study|Withdrawal by Subject|0|||
130290587|NCT02078102|469027426|FG000|Overall Study|Physician Decision|0|||
130290588|NCT02078102|469027427|FG001|Overall Study|Physician Decision|1|||
130290589|NCT03093974|469027430|FG000|Overall Study|Withdrawal by Subject|32|||
130290590|NCT03093974|469027431|FG001|Overall Study|Withdrawal by Subject|27|||
130290591|NCT03093974|469027430|FG000|Overall Study|Adverse Event|17|||
130290592|NCT03093974|469027431|FG001|Overall Study|Adverse Event|24|||
130290593|NCT03093974|469027430|FG000|Overall Study|Death|0|||
130290594|NCT03093974|469027431|FG001|Overall Study|Death|1|||
130290595|NCT03093974|469027430|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130290596|NCT03093974|469027431|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130290597|NCT03093974|469027430|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
130290598|NCT03093974|469027431|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
130290599|NCT03093974|469027430|FG000|Overall Study|Lost to Follow-up|0|||
130290600|NCT03093974|469027431|FG001|Overall Study|Lost to Follow-up|1|||
130290601|NCT03093974|469027430|FG000|Overall Study|Other|1|||
130290602|NCT03093974|469027431|FG001|Overall Study|Other|2|||
130290603|NCT01866423|469027434|FG000|Overall Study|Lack of Efficacy|3|||
130290604|NCT01866423|469027434|FG000|Overall Study|Sponsor Decision|1|||
130371242|NCT02405780|469329334|FG003|Period II|Medical reason|0|||
130371243|NCT02405780|469329331|FG000|Period II|Pregnancy|0|||
130371244|NCT02405780|469329332|FG001|Period II|Pregnancy|0|||
130290605|NCT01813721|469027435|FG000|Overall Study|Ineligibility determined|63|||
130290606|NCT01813721|469027435|FG000|Overall Study|Withdrawal by Subject|1|||
130290607|NCT02387164|469027436|FG000|Overall Study|Lost to Follow-up|2|||
130290608|NCT02387164|469027437|FG001|Overall Study|Lost to Follow-up|0|||
130290609|NCT02387164|469027436|FG000|Overall Study|Diagnosed|1|||
130290610|NCT02387164|469027437|FG001|Overall Study|Diagnosed|2|||
130371245|NCT02405780|469329333|FG002|Period II|Pregnancy|1|||
130371246|NCT02405780|469329334|FG003|Period II|Pregnancy|0|||
130371247|NCT02405780|469329331|FG000|Period II|Withdrawal by Subject|7|||
130371248|NCT02405780|469329332|FG001|Period II|Withdrawal by Subject|4|||
130371249|NCT02405780|469329333|FG002|Period II|Withdrawal by Subject|0|||
130290611|NCT01479595|469027440|FG000|Overall Study|Protocol deviation|0|||
130371250|NCT02405780|469329334|FG003|Period II|Withdrawal by Subject|3|||
130371251|NCT02405780|469329331|FG000|Period II|Non-compliance with study procedures|5|||
130371252|NCT02405780|469329332|FG001|Period II|Non-compliance with study procedures|2|||
130371253|NCT02405780|469329333|FG002|Period II|Non-compliance with study procedures|7|||
130371254|NCT02405780|469329334|FG003|Period II|Non-compliance with study procedures|4|||
130371255|NCT01654536|469329335|FG000|Overall Study|Lost to Follow-up|5|||
130371256|NCT01654536|469329336|FG001|Overall Study|Lost to Follow-up|5|||
130371257|NCT01654536|469329335|FG000|Overall Study|Physician Decision|12|||
130290612|NCT01479595|469027441|FG001|Overall Study|Protocol deviation|1|||
130290613|NCT01479595|469027440|FG000|Overall Study|Adverse Event|2|||
130290614|NCT01479595|469027441|FG001|Overall Study|Adverse Event|1|||
130290615|NCT02255565|469027443|FG000|Overall Study|Withdrawal by Subject|0|||
130371258|NCT01654536|469329336|FG001|Overall Study|Physician Decision|8|||
130371259|NCT01654536|469329335|FG000|Overall Study|Withdrawal by Subject|27|||
130371260|NCT01654536|469329336|FG001|Overall Study|Withdrawal by Subject|25|||
130714434|NCT04908683|470581669|FG001|Overall Study|Adverse Event|11|||
130290616|NCT02255565|469027444|FG001|Overall Study|Withdrawal by Subject|1|||
130290617|NCT02255565|469027445|FG002|Overall Study|Withdrawal by Subject|0|||
130290618|NCT02120365|469027446|FG000|Overall Study|Withdrawal by Subject|0|||
130290619|NCT02120365|469027447|FG001|Overall Study|Withdrawal by Subject|0|||
130290620|NCT02120365|469027448|FG002|Overall Study|Withdrawal by Subject|2|||
130290621|NCT02120365|469027449|FG003|Overall Study|Withdrawal by Subject|4|||
130290622|NCT02120365|469027450|FG004|Overall Study|Withdrawal by Subject|0|||
130290623|NCT02120365|469027451|FG005|Overall Study|Withdrawal by Subject|2|||
130290624|NCT01719003|469027454|FG000|Overall Study|Non compliant with protocol|1|||
130290625|NCT01719003|469027455|FG001|Overall Study|Non compliant with protocol|1|||
130290626|NCT01719003|469027456|FG002|Overall Study|Non compliant with protocol|0|||
130290627|NCT01719003|469027457|FG003|Overall Study|Non compliant with protocol|1|||
130290628|NCT01719003|469027458|FG004|Overall Study|Non compliant with protocol|2|||
130290629|NCT01719003|469027459|FG005|Overall Study|Non compliant with protocol|1|||
130290630|NCT01719003|469027460|FG006|Overall Study|Non compliant with protocol|2|||
130290631|NCT01719003|469027461|FG007|Overall Study|Non compliant with protocol|3|||
130290632|NCT01719003|469027462|FG008|Overall Study|Non compliant with protocol|0|||
130290633|NCT01719003|469027454|FG000|Overall Study|Adverse Event|6|||
130290634|NCT01719003|469027455|FG001|Overall Study|Adverse Event|5|||
130290635|NCT01719003|469027456|FG002|Overall Study|Adverse Event|4|||
130290636|NCT01719003|469027457|FG003|Overall Study|Adverse Event|3|||
130290637|NCT01719003|469027458|FG004|Overall Study|Adverse Event|4|||
130290638|NCT01719003|469027459|FG005|Overall Study|Adverse Event|3|||
130290639|NCT01719003|469027460|FG006|Overall Study|Adverse Event|6|||
130290640|NCT01719003|469027461|FG007|Overall Study|Adverse Event|5|||
130290641|NCT01719003|469027462|FG008|Overall Study|Adverse Event|0|||
130290642|NCT01719003|469027454|FG000|Overall Study|Lost to Follow-up|0|||
130290643|NCT01719003|469027455|FG001|Overall Study|Lost to Follow-up|6|||
130290644|NCT01719003|469027456|FG002|Overall Study|Lost to Follow-up|7|||
130290645|NCT01719003|469027457|FG003|Overall Study|Lost to Follow-up|2|||
130290646|NCT01719003|469027458|FG004|Overall Study|Lost to Follow-up|3|||
130290647|NCT01719003|469027459|FG005|Overall Study|Lost to Follow-up|4|||
130290648|NCT01719003|469027460|FG006|Overall Study|Lost to Follow-up|3|||
130290649|NCT01719003|469027461|FG007|Overall Study|Lost to Follow-up|2|||
130290650|NCT01719003|469027462|FG008|Overall Study|Lost to Follow-up|2|||
130290651|NCT01719003|469027454|FG000|Overall Study|Refusal to continue, not due to AE|2|||
130290652|NCT01719003|469027455|FG001|Overall Study|Refusal to continue, not due to AE|5|||
130290653|NCT01719003|469027456|FG002|Overall Study|Refusal to continue, not due to AE|4|||
130290654|NCT01719003|469027457|FG003|Overall Study|Refusal to continue, not due to AE|4|||
130290655|NCT01719003|469027458|FG004|Overall Study|Refusal to continue, not due to AE|4|||
130290656|NCT01719003|469027459|FG005|Overall Study|Refusal to continue, not due to AE|3|||
130290657|NCT01719003|469027460|FG006|Overall Study|Refusal to continue, not due to AE|8|||
130290658|NCT01719003|469027461|FG007|Overall Study|Refusal to continue, not due to AE|7|||
130290659|NCT01719003|469027462|FG008|Overall Study|Refusal to continue, not due to AE|1|||
130290660|NCT01719003|469027454|FG000|Overall Study|Reason other than those specified|0|||
130290661|NCT01719003|469027455|FG001|Overall Study|Reason other than those specified|0|||
130290662|NCT01719003|469027456|FG002|Overall Study|Reason other than those specified|2|||
130290663|NCT01719003|469027457|FG003|Overall Study|Reason other than those specified|3|||
130290664|NCT01719003|469027458|FG004|Overall Study|Reason other than those specified|4|||
130290665|NCT01719003|469027459|FG005|Overall Study|Reason other than those specified|1|||
130290666|NCT01719003|469027460|FG006|Overall Study|Reason other than those specified|0|||
130290667|NCT01719003|469027461|FG007|Overall Study|Reason other than those specified|3|||
130290668|NCT01719003|469027462|FG008|Overall Study|Reason other than those specified|1|||
130290669|NCT01719003|469027454|FG000|Overall Study|Lack of Efficacy|0|||
130290670|NCT01719003|469027455|FG001|Overall Study|Lack of Efficacy|0|||
130290671|NCT01719003|469027456|FG002|Overall Study|Lack of Efficacy|0|||
130290672|NCT01719003|469027457|FG003|Overall Study|Lack of Efficacy|0|||
130290673|NCT01719003|469027458|FG004|Overall Study|Lack of Efficacy|0|||
130290674|NCT01719003|469027459|FG005|Overall Study|Lack of Efficacy|0|||
130290675|NCT01719003|469027460|FG006|Overall Study|Lack of Efficacy|1|||
130290676|NCT01719003|469027461|FG007|Overall Study|Lack of Efficacy|0|||
130290677|NCT01719003|469027462|FG008|Overall Study|Lack of Efficacy|0|||
130290678|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130290679|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130290680|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
130290681|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
130290682|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
130290683|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
130290684|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130290685|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130290686|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
130371261|NCT00602797|469329337|FG000|Overall Study|Adverse Event|1|||
130371262|NCT04502693|469329341|FG000|Overall Study|Adverse Event|7|||
130371263|NCT04502693|469329342|FG001|Overall Study|Adverse Event|6|||
130290687|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
130290688|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
130290689|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290690|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290691|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290692|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290693|NCT00900146|469027463|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
130290694|NCT00900146|469027464|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
130290695|NCT00900146|469027465|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
130290696|NCT00900146|469027466|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
130290697|NCT00900146|469027467|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
130290698|NCT00900146|469027463|FG000|Intermediate: Period III|Lost to Follow-up|2|||
130290699|NCT00900146|469027464|FG001|Intermediate: Period III|Lost to Follow-up|0|||
130290700|NCT00900146|469027465|FG002|Intermediate: Period III|Lost to Follow-up|0|||
130290701|NCT00900146|469027466|FG003|Intermediate: Period III|Lost to Follow-up|0|||
130290702|NCT00900146|469027467|FG004|Intermediate: Period III|Lost to Follow-up|1|||
130290703|NCT00900146|469027463|FG000|Intermediate: Period III|Administrative problems|85|||
130290704|NCT00900146|469027464|FG001|Intermediate: Period III|Administrative problems|92|||
130290705|NCT00900146|469027465|FG002|Intermediate: Period III|Administrative problems|84|||
130290706|NCT00900146|469027466|FG003|Intermediate: Period III|Administrative problems|90|||
130290707|NCT00900146|469027467|FG004|Intermediate: Period III|Administrative problems|163|||
130290708|NCT01028716|469027472|FG000|Overall Study|Physician Decision|1|||
130290709|NCT01143896|469027477|FG000|Overall Study|Did not complete Baseline Interview|5|||
130290710|NCT01143896|469027478|FG001|Overall Study|Did not complete Baseline Interview|4|||
130290711|NCT01143896|469027477|FG000|Overall Study|Lost to Follow-up|18|||
130290712|NCT01143896|469027478|FG001|Overall Study|Lost to Follow-up|13|||
130290713|NCT01143896|469027477|FG000|Overall Study|Withdrawal by Subject|13|||
130290714|NCT01143896|469027478|FG001|Overall Study|Withdrawal by Subject|5|||
130290715|NCT01143896|469027477|FG000|Overall Study|Death|6|||
130290716|NCT01143896|469027478|FG001|Overall Study|Death|3|||
130290717|NCT00320372|469027479|FG000|Overall Study|Physician Decision|4|||
130290718|NCT00320372|469027480|FG001|Overall Study|Physician Decision|7|||
130290719|NCT00320372|469027479|FG000|Overall Study|Death|7|||
130290720|NCT00320372|469027480|FG001|Overall Study|Death|8|||
130290721|NCT00320372|469027479|FG000|Overall Study|Withdrawal by Subject|55|||
130290722|NCT00320372|469027480|FG001|Overall Study|Withdrawal by Subject|37|||
130290723|NCT00320372|469027479|FG000|Overall Study|Non-Compliance|40|||
130290724|NCT00320372|469027480|FG001|Overall Study|Non-Compliance|39|||
130290725|NCT00320372|469027479|FG000|Overall Study|Did not Meet (I/E)|3|||
130290726|NCT00320372|469027480|FG001|Overall Study|Did not Meet (I/E)|1|||
130290727|NCT00320372|469027479|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
130290728|NCT00320372|469027480|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
130290729|NCT02068118|469027482|FG000|18-month Comparative Study Period|Death|90|||
130290730|NCT02068118|469027483|FG001|18-month Comparative Study Period|Death|97|||
130290731|NCT02068118|469027482|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
130290732|NCT02068118|469027483|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
130290733|NCT02068118|469027482|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
130290734|NCT02068118|469027483|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
130290735|NCT02068118|469027482|FG000|18-month Comparative Study Period|Heart transplant|9|||
130290736|NCT02068118|469027483|FG001|18-month Comparative Study Period|Heart transplant|15|||
130290737|NCT02068118|469027482|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
130290738|NCT02068118|469027483|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
130290739|NCT02068118|469027482|FG000|18-month Comparative Study Period|Hemiplegia|0|||
130290740|NCT02068118|469027483|FG001|18-month Comparative Study Period|Hemiplegia|1|||
130290741|NCT02068118|469027482|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
130290742|NCT02068118|469027483|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
130290743|NCT02068118|469027482|FG000|18-month Comparative Study Period|Move|0|||
130290744|NCT02068118|469027483|FG001|18-month Comparative Study Period|Move|1|||
130290745|NCT02068118|469027482|FG000|18-month Comparative Study Period|Hearing loss|0|||
130290746|NCT02068118|469027483|FG001|18-month Comparative Study Period|Hearing loss|1|||
130290747|NCT02068118|469027482|FG000|Extension Period|Death|0|||
130290748|NCT02068118|469027483|FG001|Extension Period|Death|2|||
130290749|NCT02068118|469027482|FG000|Extension Period|Withdrawal by Subject|1|||
130290750|NCT02068118|469027483|FG001|Extension Period|Withdrawal by Subject|0|||
130290751|NCT02068118|469027482|FG000|Extension Period|Heart transplant|1|||
130290752|NCT02068118|469027483|FG001|Extension Period|Heart transplant|0|||
130290753|NCT02068118|469027482|FG000|Extension Period|Wrong device use|0|||
130290754|NCT02068118|469027483|FG001|Extension Period|Wrong device use|1|||
130290755|NCT00283868|469027484|FG000|Overall Study|Lost to Follow-up|7|||
130290756|NCT00283868|469027485|FG001|Overall Study|Lost to Follow-up|8|||
130714435|NCT04908683|470581668|FG000|Overall Study|Death|101|||
130371264|NCT04502693|469329343|FG002|Overall Study|Adverse Event|11|||
130371265|NCT04502693|469329344|FG003|Overall Study|Adverse Event|1|||
130714436|NCT04908683|470581669|FG001|Overall Study|Death|61|||
130714437|NCT04908683|470581668|FG000|Overall Study|Sponsor's decision|14398|||
130714438|NCT04908683|470581669|FG001|Overall Study|Sponsor's decision|7205|||
130714439|NCT04908683|470581668|FG000|Overall Study|Other|92|||
130714440|NCT04908683|470581669|FG001|Overall Study|Other|50|||
130714441|NCT04908683|470581668|FG000|Overall Study|Randomized not vaccinated|108|||
130290757|NCT01996592|469027487|FG000|Overall Study|no response to text/no diary entry|32|||
130290758|NCT01996592|469027487|FG000|Overall Study|change in surgical date|4|||
130290759|NCT01996592|469027487|FG000|Overall Study|Withdrawal by Subject|5|||
130290760|NCT01996592|469027487|FG000|Overall Study|change in mode of delivery|4|||
130290761|NCT00394901|469027488|FG000|Baseline Phase|Protocol Violation|0|||
130459998|NCT03287622|469649703|FG000|Overall Study|No prescripion after surgery|28|||
130459999|NCT03287622|469649704|FG001|Overall Study|No prescripion after surgery|31|||
130460000|NCT03287622|469649703|FG000|Overall Study|prolonged Length of stay|2|||
130460001|NCT03287622|469649704|FG001|Overall Study|prolonged Length of stay|0|||
130460002|NCT03287622|469649703|FG000|Overall Study|surgery related|0|||
130460003|NCT03287622|469649704|FG001|Overall Study|surgery related|2|||
130460004|NCT01930045|469649707|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
130460005|NCT01930045|469649708|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
130460006|NCT01930045|469649709|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
130460007|NCT01930045|469649710|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
130460008|NCT01930045|469649711|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
130460009|NCT01930045|469649712|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
130460010|NCT01930045|469649707|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
130460011|NCT01930045|469649708|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
130460012|NCT01930045|469649709|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
130460013|NCT01930045|469649710|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
130460014|NCT01930045|469649711|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
130460015|NCT01930045|469649712|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
130460016|NCT01786564|469649713|FG000|Overall Study|Lost to Follow-up|47|||
130460017|NCT01786564|469649713|FG000|Overall Study|Ineligible|17|||
130460018|NCT02506257|469649714|FG000|Overall Study|Adverse Event|0|||
130460019|NCT02506257|469649715|FG001|Overall Study|Adverse Event|2|||
130460020|NCT02506257|469649716|FG002|Overall Study|Adverse Event|3|||
130460021|NCT02506257|469649717|FG003|Overall Study|Adverse Event|0|||
130460022|NCT02506257|469649714|FG000|Overall Study|Protocol Violation|0|||
130460023|NCT02506257|469649715|FG001|Overall Study|Protocol Violation|0|||
130460024|NCT02506257|469649716|FG002|Overall Study|Protocol Violation|1|||
130460025|NCT02506257|469649717|FG003|Overall Study|Protocol Violation|0|||
130460026|NCT01924767|469649718|FG000|Overall Study|Adverse Event|1|||
130460027|NCT01924767|469649719|FG001|Overall Study|Adverse Event|0|||
130460028|NCT01924767|469649720|FG002|Overall Study|Adverse Event|1|||
130460029|NCT01924767|469649721|FG003|Overall Study|Adverse Event|0|||
130460030|NCT01924767|469649722|FG004|Overall Study|Adverse Event|0|||
130460031|NCT00139737|469649730|FG000|Overall Study|Withdrawal by Subject|190|||
130460032|NCT00139737|469649730|FG000|Overall Study|Adverse Event|58|||
130460033|NCT00139737|469649730|FG000|Overall Study|Lack of Efficacy|40|||
130460034|NCT00139737|469649730|FG000|Overall Study|Lost to Follow-up|8|||
130460035|NCT00139737|469649730|FG000|Overall Study|Death|3|||
130460036|NCT00139737|469649730|FG000|Overall Study|Laboratory Abnormality|2|||
130460037|NCT00139737|469649730|FG000|Overall Study|Protocol Violation|18|||
130460038|NCT00139737|469649730|FG000|Overall Study|Withdrew During Screening Phase|8|||
130460039|NCT00139737|469649730|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130460040|NCT00139737|469649730|FG000|Overall Study|Screened, Not Treated|13|||
130460041|NCT03781336|469649731|FG000|Overall Study|Withdrawal by Subject|2|||
130460042|NCT03781336|469649732|FG001|Overall Study|Withdrawal by Subject|2|||
130460043|NCT03460756|469649733|FG000|Overall Study|Adverse Event|0|||
130460044|NCT03460756|469649734|FG001|Overall Study|Adverse Event|0|||
130460045|NCT03460756|469649735|FG002|Overall Study|Adverse Event|0|||
130460046|NCT03460756|469649736|FG003|Overall Study|Adverse Event|1|||
130460047|NCT03460756|469649733|FG000|Overall Study|Lack of Efficacy|0|||
130460048|NCT03460756|469649734|FG001|Overall Study|Lack of Efficacy|0|||
130460049|NCT03460756|469649735|FG002|Overall Study|Lack of Efficacy|0|||
130460050|NCT03460756|469649736|FG003|Overall Study|Lack of Efficacy|2|||
130460051|NCT03460756|469649733|FG000|Overall Study|Lost to Follow-up|0|||
130460052|NCT03460756|469649734|FG001|Overall Study|Lost to Follow-up|1|||
130460053|NCT03460756|469649735|FG002|Overall Study|Lost to Follow-up|2|||
130460054|NCT03460756|469649736|FG003|Overall Study|Lost to Follow-up|1|||
130460055|NCT03460756|469649733|FG000|Overall Study|Pregnancy|0|||
130460056|NCT03460756|469649734|FG001|Overall Study|Pregnancy|0|||
130460057|NCT03460756|469649735|FG002|Overall Study|Pregnancy|0|||
130290762|NCT00394901|469027489|FG001|Baseline Phase|Protocol Violation|0|||
130460058|NCT03460756|469649736|FG003|Overall Study|Pregnancy|1|||
130460059|NCT03460756|469649733|FG000|Overall Study|Protocol Violation|0|||
130460060|NCT03460756|469649734|FG001|Overall Study|Protocol Violation|0|||
130714442|NCT04908683|470581669|FG001|Overall Study|Randomized not vaccinated|52|||
130714443|NCT02221037|470581671|FG000|Overall Study|Physician Decision|0|||
130290763|NCT00394901|469027490|FG002|Baseline Phase|Protocol Violation|1|||
130290764|NCT00394901|469027491|FG003|Baseline Phase|Protocol Violation|0|||
130290765|NCT00394901|469027488|FG000|Double-blind Phase|Adverse Event|5|||
130290766|NCT00394901|469027489|FG001|Double-blind Phase|Adverse Event|7|||
130290767|NCT00394901|469027490|FG002|Double-blind Phase|Adverse Event|16|||
130290768|NCT00394901|469027491|FG003|Double-blind Phase|Adverse Event|20|||
130290769|NCT00394901|469027488|FG000|Double-blind Phase|Lack of Efficacy|6|||
130290770|NCT00394901|469027489|FG001|Double-blind Phase|Lack of Efficacy|4|||
130290771|NCT00394901|469027490|FG002|Double-blind Phase|Lack of Efficacy|1|||
130290772|NCT00394901|469027491|FG003|Double-blind Phase|Lack of Efficacy|3|||
130290773|NCT00394901|469027488|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130290774|NCT00394901|469027489|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130290775|NCT00394901|469027490|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130290776|NCT00394901|469027491|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130290777|NCT00394901|469027488|FG000|Double-blind Phase|Lost to Follow-up|0|||
130290778|NCT00394901|469027489|FG001|Double-blind Phase|Lost to Follow-up|0|||
130290779|NCT00394901|469027490|FG002|Double-blind Phase|Lost to Follow-up|0|||
130290780|NCT00394901|469027491|FG003|Double-blind Phase|Lost to Follow-up|1|||
130290781|NCT00394901|469027488|FG000|Double-blind Phase|Protocol Violation|0|||
130290782|NCT00394901|469027489|FG001|Double-blind Phase|Protocol Violation|0|||
130290783|NCT00394901|469027490|FG002|Double-blind Phase|Protocol Violation|0|||
130290784|NCT00394901|469027491|FG003|Double-blind Phase|Protocol Violation|1|||
130460061|NCT03460756|469649735|FG002|Overall Study|Protocol Violation|0|||
130460062|NCT03460756|469649736|FG003|Overall Study|Protocol Violation|1|||
130460063|NCT03460756|469649733|FG000|Overall Study|Withdrawal by Subject|0|||
130460064|NCT03460756|469649734|FG001|Overall Study|Withdrawal by Subject|4|||
130460065|NCT03460756|469649735|FG002|Overall Study|Withdrawal by Subject|7|||
130460066|NCT03460756|469649736|FG003|Overall Study|Withdrawal by Subject|3|||
130460067|NCT03987451|469649737|FG000|Overall Study|Lost to Follow-up|1|||
130460068|NCT03987451|469649738|FG001|Overall Study|Lost to Follow-up|0|||
130460069|NCT03987451|469649737|FG000|Overall Study|Withdrawal by Subject|1|||
130460070|NCT03987451|469649738|FG001|Overall Study|Withdrawal by Subject|1|||
130460071|NCT02441036|469649739|FG000|Overall Study|No tissue resected|0|||
130460072|NCT02441036|469649740|FG001|Overall Study|No tissue resected|1|||
130460073|NCT02441036|469649741|FG002|Overall Study|No tissue resected|0|||
130460074|NCT02441036|469649742|FG003|Overall Study|No tissue resected|1|||
130460075|NCT02441036|469649743|FG004|Overall Study|No tissue resected|0|||
130460076|NCT00612586|469649747|FG000|Overall Study|Adverse Event|6|||
130290785|NCT00394901|469027488|FG000|Double-blind Phase|Death|1|||
130290786|NCT00394901|469027489|FG001|Double-blind Phase|Death|0|||
130290787|NCT00394901|469027490|FG002|Double-blind Phase|Death|0|||
130290788|NCT00394901|469027491|FG003|Double-blind Phase|Death|0|||
130290789|NCT00394901|469027488|FG000|Double-blind Phase|Subject's Personal Reason|1|||
130290790|NCT00394901|469027489|FG001|Double-blind Phase|Subject's Personal Reason|0|||
130290791|NCT00394901|469027490|FG002|Double-blind Phase|Subject's Personal Reason|0|||
130290792|NCT00394901|469027491|FG003|Double-blind Phase|Subject's Personal Reason|1|||
130290793|NCT00394901|469027488|FG000|Double-blind Phase|Lack of Compliance|0|||
130290794|NCT00394901|469027489|FG001|Double-blind Phase|Lack of Compliance|3|||
130290795|NCT00394901|469027490|FG002|Double-blind Phase|Lack of Compliance|0|||
130290796|NCT00394901|469027491|FG003|Double-blind Phase|Lack of Compliance|0|||
130290797|NCT00394901|469027488|FG000|Double-blind Phase|Entry into another study was found|0|||
130290798|NCT00394901|469027489|FG001|Double-blind Phase|Entry into another study was found|0|||
130290799|NCT00394901|469027490|FG002|Double-blind Phase|Entry into another study was found|1|||
130290800|NCT00394901|469027491|FG003|Double-blind Phase|Entry into another study was found|0|||
130290801|NCT00394901|469027488|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
130290802|NCT00394901|469027489|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
130290803|NCT00394901|469027490|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
130290804|NCT00394901|469027491|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
130290805|NCT05028517|469027492|FG000|Overall Study|Lost to Follow-up|13|||
130290806|NCT05028517|469027493|FG001|Overall Study|Lost to Follow-up|20|||
130290807|NCT05028517|469027494|FG002|Overall Study|Lost to Follow-up|12|||
130290808|NCT05028517|469027492|FG000|Overall Study|Withdrawal by Subject|0|||
130290809|NCT05028517|469027493|FG001|Overall Study|Withdrawal by Subject|0|||
130290810|NCT05028517|469027494|FG002|Overall Study|Withdrawal by Subject|1|||
130460077|NCT00612586|469649748|FG001|Overall Study|Adverse Event|2|||
130460078|NCT00612586|469649747|FG000|Overall Study|Death|1|||
130460079|NCT00612586|469649748|FG001|Overall Study|Death|0|||
130460080|NCT00612586|469649747|FG000|Overall Study|Entry Criteria Not Met|0|||
130460081|NCT00612586|469649748|FG001|Overall Study|Entry Criteria Not Met|2|||
130290811|NCT02256267|469027495|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
130290812|NCT02256267|469027495|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
130290813|NCT01066780|469027499|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130290814|NCT01066780|469027500|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130290815|NCT02360293|469027501|FG000|Overall Study|Lost to Follow-up|73|||
130290816|NCT02360293|469027502|FG001|Overall Study|Lost to Follow-up|95|||
130460082|NCT00612586|469649747|FG000|Overall Study|Withdrawal by Subject|7|||
130714444|NCT02221037|470581672|FG001|Overall Study|Physician Decision|0|||
130714445|NCT02221037|470581673|FG002|Overall Study|Physician Decision|1|||
130714446|NCT02221037|470581674|FG003|Overall Study|Physician Decision|0|||
130714447|NCT01293539|470581680|FG000|Overall Study|Physician Decision|1|||
130714448|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Death|89|||
130714449|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Death|193|||
130714450|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Death|198|||
130290817|NCT02360293|469027501|FG000|Overall Study|Withdrawal by Subject|2|||
130714451|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
130714452|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
130714453|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
130290818|NCT02360293|469027502|FG001|Overall Study|Withdrawal by Subject|1|||
130290819|NCT02360293|469027501|FG000|Overall Study|Excluded|1|||
130290820|NCT02360293|469027502|FG001|Overall Study|Excluded|0|||
130290821|NCT04316741|469027503|FG000|Baseline Enrollment|Lost to Follow-up|1|||
130290822|NCT04316741|469027504|FG001|Baseline Enrollment|Lost to Follow-up|1|||
130290823|NCT04316741|469027503|FG000|Immediate Post-Test|Lost to Follow-up|5|||
130290824|NCT04316741|469027504|FG001|Immediate Post-Test|Lost to Follow-up|1|||
130290825|NCT04316741|469027503|FG000|1-month Post-test|Lost to Follow-up|7|||
130290826|NCT04316741|469027504|FG001|1-month Post-test|Lost to Follow-up|2|||
130290827|NCT04316741|469027503|FG000|3-month Follow-up|Lost to Follow-up|10|||
130290828|NCT04316741|469027504|FG001|3-month Follow-up|Lost to Follow-up|2|||
130290829|NCT01498185|469027506|FG000|Overall Study|Adverse Event|0|||
130290830|NCT01498185|469027507|FG001|Overall Study|Adverse Event|0|||
130290831|NCT01498185|469027508|FG002|Overall Study|Adverse Event|0|||
130290832|NCT01498185|469027509|FG003|Overall Study|Adverse Event|1|||
130290833|NCT01498185|469027510|FG004|Overall Study|Adverse Event|0|||
130290834|NCT01498185|469027506|FG000|Overall Study|Withdrawal by Subject|1|||
130290835|NCT01498185|469027507|FG001|Overall Study|Withdrawal by Subject|1|||
130290836|NCT01498185|469027508|FG002|Overall Study|Withdrawal by Subject|0|||
130290837|NCT01498185|469027509|FG003|Overall Study|Withdrawal by Subject|2|||
130290838|NCT01498185|469027510|FG004|Overall Study|Withdrawal by Subject|1|||
130290839|NCT01498185|469027506|FG000|Overall Study|No longer met criteria, etc|0|||
130290840|NCT01498185|469027507|FG001|Overall Study|No longer met criteria, etc|0|||
130290841|NCT01498185|469027508|FG002|Overall Study|No longer met criteria, etc|0|||
130290842|NCT01498185|469027509|FG003|Overall Study|No longer met criteria, etc|0|||
130290843|NCT01498185|469027510|FG004|Overall Study|No longer met criteria, etc|2|||
130371266|NCT04502693|469329341|FG000|Overall Study|Lost to Follow-up|32|||
130371267|NCT04502693|469329342|FG001|Overall Study|Lost to Follow-up|36|||
130371268|NCT04502693|469329343|FG002|Overall Study|Lost to Follow-up|69|||
130371269|NCT04502693|469329344|FG003|Overall Study|Lost to Follow-up|4|||
130371270|NCT04502693|469329341|FG000|Overall Study|Protocol Violation|8|||
130371271|NCT04502693|469329342|FG001|Overall Study|Protocol Violation|8|||
130371272|NCT04502693|469329343|FG002|Overall Study|Protocol Violation|16|||
130371273|NCT04502693|469329344|FG003|Overall Study|Protocol Violation|1|||
130371274|NCT04502693|469329341|FG000|Overall Study|Withdrawal by Subject|46|||
130371275|NCT04502693|469329342|FG001|Overall Study|Withdrawal by Subject|38|||
130371276|NCT04502693|469329343|FG002|Overall Study|Withdrawal by Subject|54|||
130371277|NCT04502693|469329344|FG003|Overall Study|Withdrawal by Subject|7|||
130371278|NCT04502693|469329341|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
130371279|NCT04502693|469329342|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
130371280|NCT04502693|469329343|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
130371281|NCT04502693|469329344|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130371282|NCT04502693|469329341|FG000|Overall Study|Other|1|||
130371283|NCT04502693|469329342|FG001|Overall Study|Other|0|||
130371284|NCT04502693|469329343|FG002|Overall Study|Other|1|||
130371285|NCT04502693|469329344|FG003|Overall Study|Other|1|||
130371286|NCT03943147|469329347|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
130371287|NCT03943147|469329348|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
130371288|NCT03943147|469329347|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
130371289|NCT03943147|469329348|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
130371290|NCT03943147|469329347|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
130371291|NCT03943147|469329348|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
130371292|NCT03943147|469329347|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
130371293|NCT03943147|469329348|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
130371294|NCT03943147|469329347|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
130371295|NCT03943147|469329348|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
130371296|NCT03943147|469329347|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
130371297|NCT03943147|469329348|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
130371298|NCT01318993|469329349|FG000|Overall Study|Adverse Event|53|||
130371299|NCT01318993|469329349|FG000|Overall Study|Lack of Efficacy|121|||
130371300|NCT01318993|469329349|FG000|Overall Study|Protocol Violation|3|||
130371301|NCT01318993|469329349|FG000|Overall Study|Protocol based stopping criteria|6|||
130714454|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
130290844|NCT01827332|469027511|FG000|Overall Study|Lost to Follow-up|2|||
130290845|NCT01827332|469027512|FG001|Overall Study|Lost to Follow-up|1|||
130290846|NCT02725593|469027513|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
130290847|NCT02725593|469027514|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
130290848|NCT02725593|469027513|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
130290849|NCT02725593|469027514|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
130290850|NCT02725593|469027513|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130290851|NCT02725593|469027514|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
130290852|NCT02725593|469027513|FG000|Long Term Extension|Withdrawal by Subject|1|||
130371302|NCT01318993|469329349|FG000|Overall Study|Study closed or terminated|174|||
130556559|NCT03672461|470006172|FG001|Overall Study|Adverse Event|0|||
130556560|NCT03672461|470006171|FG000|Overall Study|Serious Adverse Event|0|||
130556561|NCT03672461|470006172|FG001|Overall Study|Serious Adverse Event|1|||
130556562|NCT03672461|470006171|FG000|Overall Study|Too Busy|3|||
130556563|NCT03672461|470006172|FG001|Overall Study|Too Busy|1|||
130556564|NCT03672461|470006171|FG000|Overall Study|Lost to Follow-up|1|||
130556565|NCT03672461|470006172|FG001|Overall Study|Lost to Follow-up|2|||
130556566|NCT03672461|470006171|FG000|Overall Study|Family|2|||
130556567|NCT03672461|470006172|FG001|Overall Study|Family|2|||
130556568|NCT03672461|470006171|FG000|Overall Study|No remote technology access|0|||
130556569|NCT03672461|470006172|FG001|Overall Study|No remote technology access|1|||
130556570|NCT03672461|470006171|FG000|Overall Study|Withdrawal by Subject|1|||
130556571|NCT03672461|470006172|FG001|Overall Study|Withdrawal by Subject|0|||
130556572|NCT03672461|470006171|FG000|Overall Study|Cannot tolerate intervention|1|||
130556573|NCT03672461|470006172|FG001|Overall Study|Cannot tolerate intervention|0|||
130556574|NCT03672461|470006171|FG000|Overall Study|Incomplete outcome data|6|||
130556575|NCT03672461|470006172|FG001|Overall Study|Incomplete outcome data|1|||
130556576|NCT07052682|470006173|FG000|Overall Study|Withdrawal by Subject|4|||
130556577|NCT04667247|470006174|FG000|Overall Study|Withdrawal by Subject|0|||
130556578|NCT04667247|470006175|FG001|Overall Study|Withdrawal by Subject|1|||
130556579|NCT01444651|470007961|FG000|Overall Study|Adverse Event|3|||
130556580|NCT01444651|470007962|FG001|Overall Study|Adverse Event|2|||
130556581|NCT01444651|470007961|FG000|Overall Study|Lost to Follow-up|5|||
130556582|NCT01444651|470007962|FG001|Overall Study|Lost to Follow-up|5|||
130556583|NCT01444651|470007961|FG000|Overall Study|Non-fasting|2|||
130556584|NCT01444651|470007962|FG001|Overall Study|Non-fasting|1|||
130556585|NCT01444651|470007961|FG000|Overall Study|Missing data|1|||
130556586|NCT01444651|470007962|FG001|Overall Study|Missing data|1|||
130556587|NCT01436071|470007963|FG000|Overall Study|Adverse Event|1|||
130556588|NCT01436071|470007964|FG001|Overall Study|Adverse Event|0|||
130371303|NCT01318993|469329349|FG000|Overall Study|Lost to Follow-up|4|||
130371304|NCT01318993|469329349|FG000|Overall Study|Physician Decision|13|||
130371305|NCT01318993|469329349|FG000|Overall Study|Withdrawal by Subject|24|||
130371306|NCT03334539|469329350|FG000|Overall Study|Adverse Event|3|||
130371307|NCT03334539|469329351|FG001|Overall Study|Adverse Event|5|||
130371308|NCT03334539|469329352|FG002|Overall Study|Adverse Event|0|||
130371309|NCT03334539|469329350|FG000|Overall Study|Withdrawal by Subject|0|||
130371310|NCT03334539|469329351|FG001|Overall Study|Withdrawal by Subject|1|||
130371311|NCT03334539|469329352|FG002|Overall Study|Withdrawal by Subject|1|||
130371312|NCT03334539|469329350|FG000|Overall Study|Administrative Reasons|1|||
130371313|NCT03334539|469329351|FG001|Overall Study|Administrative Reasons|0|||
130556589|NCT01436071|470007963|FG000|Overall Study|Lack of Efficacy|16|||
130556590|NCT01436071|470007964|FG001|Overall Study|Lack of Efficacy|7|||
130714455|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130714456|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130714457|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
130714458|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130714459|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130714460|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
130714461|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
130714462|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
130714463|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
130714464|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
130714465|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
130371314|NCT03334539|469329352|FG002|Overall Study|Administrative Reasons|0|||
130371315|NCT03334539|469329350|FG000|Overall Study|Hypertension Not Controlled|0|||
130371316|NCT03334539|469329351|FG001|Overall Study|Hypertension Not Controlled|1|||
130556591|NCT01436071|470007963|FG000|Overall Study|Protocol Violation|0|||
130371317|NCT03334539|469329352|FG002|Overall Study|Hypertension Not Controlled|0|||
130371318|NCT00968201|469329353|FG000|Base Study - (Period II)|Adverse Event|8|||
130556592|NCT01436071|470007964|FG001|Overall Study|Protocol Violation|1|||
130556593|NCT01436071|470007963|FG000|Overall Study|Lost to Follow-up|3|||
130556594|NCT01436071|470007964|FG001|Overall Study|Lost to Follow-up|1|||
130556595|NCT01436071|470007963|FG000|Overall Study|Physician Decision|1|||
130556596|NCT01436071|470007964|FG001|Overall Study|Physician Decision|0|||
130290853|NCT02725593|469027514|FG001|Long Term Extension|Withdrawal by Subject|3|||
130290854|NCT00387647|469029121|FG000|Overall Study|Death|18|||
130290855|NCT01309269|469029124|FG000|Overall Study|Adverse Event|56|||
130290856|NCT01309269|469029124|FG000|Overall Study|Withdrawal by Subject|25|||
130290857|NCT01309269|469029124|FG000|Overall Study|Lack of Acceptance|15|||
130290858|NCT01309269|469029124|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
130290859|NCT01309269|469029124|FG000|Overall Study|Kidney Transplant|25|||
130290860|NCT01309269|469029124|FG000|Overall Study|Administrative Problems|141|||
130290861|NCT01309269|469029124|FG000|Overall Study|Other|256|||
130290862|NCT01309269|469029124|FG000|Overall Study|Other|1|||
130290863|NCT01309269|469029124|FG000|Overall Study|Study Completion Data Not Recorded|95|||
130290864|NCT01309269|469029124|FG000|Overall Study|Enrolled but not Treated|107|||
130290865|NCT03131596|469029127|FG000|Overall Study|Protocol Violation|3|||
130290866|NCT03131596|469029128|FG001|Overall Study|Protocol Violation|3|||
130290867|NCT03131596|469029127|FG000|Overall Study|Lost to Follow-up|3|||
130290868|NCT03131596|469029128|FG001|Overall Study|Lost to Follow-up|0|||
130290869|NCT04411420|469029129|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
130290870|NCT04411420|469029130|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
130290871|NCT04411420|469029129|FG000|Survey Subset|Lost to Follow-up|134|||
130290872|NCT04411420|469029130|FG001|Survey Subset|Lost to Follow-up|120|||
130290873|NCT03769311|469029133|FG000|Overall Study|Withdrawal by Subject|1|||
130290874|NCT01596335|469029134|FG000|Overall Study|exacerbation of primary disease|5|||
130290875|NCT01596335|469029135|FG001|Overall Study|exacerbation of primary disease|9|||
130290876|NCT03627065|469029136|FG000|Overall Study|Study Terminated by sponsor|1|||
130290877|NCT03627065|469029136|FG000|Overall Study|Withdrawal by Subject|2|||
130290878|NCT04524455|469029137|FG000|Overall Study|Death|3|||
130290879|NCT04524455|469029138|FG001|Overall Study|Death|3|||
130290880|NCT04524455|469029137|FG000|Overall Study|Decision by Sponsor|0|||
130290881|NCT04524455|469029138|FG001|Overall Study|Decision by Sponsor|2|||
130290882|NCT04524455|469029137|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130290883|NCT04524455|469029138|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130290884|NCT04524455|469029137|FG000|Overall Study|Lost to Follow-up|0|||
130290885|NCT04524455|469029138|FG001|Overall Study|Lost to Follow-up|1|||
130290886|NCT01062061|469029143|FG000|Overall Study|Enrolled more than once|2|||
130290887|NCT01062061|469029143|FG000|Overall Study|Investigated before study start|13|||
130290888|NCT01062061|469029143|FG000|Overall Study|Outside chief indications|10|||
130290889|NCT01062061|469029143|FG000|Overall Study|Failed to meet inclusion criteria|2|||
130714466|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
130714467|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
130714468|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
130290890|NCT00524589|469029144|FG000|Overall Study|Withdrawal by Subject|2|||
130290891|NCT00524589|469029144|FG000|Overall Study|Disease Progression|16|||
130290892|NCT00098722|469029145|FG000|Double Blind Phase|Adverse Event|7|||
130290893|NCT00098722|469029146|FG001|Double Blind Phase|Adverse Event|7|||
130290894|NCT00098722|469029147|FG002|Double Blind Phase|Adverse Event|3|||
130290895|NCT00098722|469029148|FG003|Double Blind Phase|Adverse Event|0|||
130371319|NCT00968201|469329354|FG001|Base Study - (Period II)|Adverse Event|0|||
130371320|NCT00968201|469329355|FG002|Base Study - (Period II)|Adverse Event|16|||
130371321|NCT00968201|469329353|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
130371322|NCT00968201|469329354|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
130371323|NCT00968201|469329355|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
130371324|NCT00968201|469329353|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
130371325|NCT00968201|469329354|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
130371326|NCT00968201|469329355|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
130371327|NCT00968201|469329353|FG000|Base Study - (Period II)|Protocol Violation|12|||
130371328|NCT00968201|469329354|FG001|Base Study - (Period II)|Protocol Violation|0|||
130371329|NCT00968201|469329355|FG002|Base Study - (Period II)|Protocol Violation|12|||
130371330|NCT00968201|469329353|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
130371331|NCT00968201|469329354|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
130371332|NCT00968201|469329355|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
130371333|NCT00968201|469329353|FG000|Base Study - (Period II)|Site Error|0|||
130371334|NCT00968201|469329354|FG001|Base Study - (Period II)|Site Error|0|||
130371335|NCT00968201|469329355|FG002|Base Study - (Period II)|Site Error|1|||
130371336|NCT00968201|469329353|FG000|Extension Study - (Period III)|Adverse Event|0|||
130371337|NCT00968201|469329354|FG001|Extension Study - (Period III)|Adverse Event|5|||
130371338|NCT00968201|469329355|FG002|Extension Study - (Period III)|Adverse Event|22|||
130371339|NCT00968201|469329353|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
130371340|NCT00968201|469329354|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
130371341|NCT00968201|469329355|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
130460083|NCT00612586|469649748|FG001|Overall Study|Withdrawal by Subject|9|||
130460084|NCT00612586|469649747|FG000|Overall Study|Physician Decision|1|||
130290896|NCT00098722|469029149|FG004|Double Blind Phase|Adverse Event|0|||
130290897|NCT00098722|469029150|FG005|Double Blind Phase|Adverse Event|0|||
130290898|NCT00098722|469029151|FG006|Double Blind Phase|Adverse Event|0|||
130371342|NCT00968201|469329353|FG000|Extension Study - (Period III)|Protocol Violation|0|||
130290899|NCT00098722|469029145|FG000|Double Blind Phase|Death|2|||
130290900|NCT00098722|469029146|FG001|Double Blind Phase|Death|5|||
130290901|NCT00098722|469029147|FG002|Double Blind Phase|Death|0|||
130290902|NCT00098722|469029148|FG003|Double Blind Phase|Death|0|||
130290903|NCT00098722|469029149|FG004|Double Blind Phase|Death|0|||
130290904|NCT00098722|469029150|FG005|Double Blind Phase|Death|0|||
130290905|NCT00098722|469029151|FG006|Double Blind Phase|Death|0|||
130290906|NCT00098722|469029145|FG000|Double Blind Phase|Lack of Efficacy|21|||
130290907|NCT00098722|469029146|FG001|Double Blind Phase|Lack of Efficacy|23|||
130290908|NCT00098722|469029147|FG002|Double Blind Phase|Lack of Efficacy|15|||
130290909|NCT00098722|469029148|FG003|Double Blind Phase|Lack of Efficacy|0|||
130290910|NCT00098722|469029149|FG004|Double Blind Phase|Lack of Efficacy|0|||
130290911|NCT00098722|469029150|FG005|Double Blind Phase|Lack of Efficacy|0|||
130290912|NCT00098722|469029151|FG006|Double Blind Phase|Lack of Efficacy|0|||
130290913|NCT00098722|469029145|FG000|Double Blind Phase|Participant defaulted|16|||
130290914|NCT00098722|469029146|FG001|Double Blind Phase|Participant defaulted|11|||
130290915|NCT00098722|469029147|FG002|Double Blind Phase|Participant defaulted|9|||
130290916|NCT00098722|469029148|FG003|Double Blind Phase|Participant defaulted|0|||
130290917|NCT00098722|469029149|FG004|Double Blind Phase|Participant defaulted|0|||
130290918|NCT00098722|469029150|FG005|Double Blind Phase|Participant defaulted|0|||
130290919|NCT00098722|469029151|FG006|Double Blind Phase|Participant defaulted|0|||
130290920|NCT00098722|469029145|FG000|Double Blind Phase|Pregnancy|1|||
130290921|NCT00098722|469029146|FG001|Double Blind Phase|Pregnancy|0|||
130290922|NCT00098722|469029147|FG002|Double Blind Phase|Pregnancy|0|||
130290923|NCT00098722|469029148|FG003|Double Blind Phase|Pregnancy|0|||
130290924|NCT00098722|469029149|FG004|Double Blind Phase|Pregnancy|0|||
130290925|NCT00098722|469029150|FG005|Double Blind Phase|Pregnancy|0|||
130290926|NCT00098722|469029151|FG006|Double Blind Phase|Pregnancy|0|||
130290927|NCT00098722|469029145|FG000|Double Blind Phase|Randomized, not treated|4|||
130290928|NCT00098722|469029146|FG001|Double Blind Phase|Randomized, not treated|3|||
130290929|NCT00098722|469029147|FG002|Double Blind Phase|Randomized, not treated|3|||
130290930|NCT00098722|469029148|FG003|Double Blind Phase|Randomized, not treated|0|||
130290931|NCT00098722|469029149|FG004|Double Blind Phase|Randomized, not treated|0|||
130290932|NCT00098722|469029150|FG005|Double Blind Phase|Randomized, not treated|0|||
130290933|NCT00098722|469029151|FG006|Double Blind Phase|Randomized, not treated|0|||
130290934|NCT00098722|469029145|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
130290935|NCT00098722|469029146|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
130290936|NCT00098722|469029147|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
130290937|NCT00098722|469029148|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
130290938|NCT00098722|469029149|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
130290939|NCT00098722|469029150|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
130371343|NCT00968201|469329354|FG001|Extension Study - (Period III)|Protocol Violation|17|||
130371344|NCT00968201|469329355|FG002|Extension Study - (Period III)|Protocol Violation|14|||
130371345|NCT00968201|469329353|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
130371346|NCT00968201|469329354|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
130371347|NCT00968201|469329355|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
130371348|NCT00968201|469329353|FG000|Extension Study - (Period III)|Patient Relocated|0|||
130371349|NCT00968201|469329354|FG001|Extension Study - (Period III)|Patient Relocated|1|||
130371350|NCT00968201|469329355|FG002|Extension Study - (Period III)|Patient Relocated|1|||
130371351|NCT00968201|469329353|FG000|Extension Study - (Period III)|Noncompliance|0|||
130371352|NCT00968201|469329354|FG001|Extension Study - (Period III)|Noncompliance|0|||
130371353|NCT00968201|469329355|FG002|Extension Study - (Period III)|Noncompliance|3|||
130371354|NCT00968201|469329353|FG000|Extension Study - (Period III)|Other|0|||
130371355|NCT00968201|469329354|FG001|Extension Study - (Period III)|Other|0|||
130371356|NCT00968201|469329355|FG002|Extension Study - (Period III)|Other|2|||
130371357|NCT00968201|469329353|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
130371358|NCT00968201|469329354|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
130371359|NCT00968201|469329355|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
130371360|NCT04974697|469329357|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
130371361|NCT04974697|469329357|FG000|Overall Study|Lens discomfort|1|||
130371362|NCT02010775|469329358|FG000|Overall Study|Adverse Event|0|||
130371363|NCT02010775|469329359|FG001|Overall Study|Adverse Event|0|||
130371364|NCT02010775|469329360|FG002|Overall Study|Adverse Event|0|||
130371365|NCT02010775|469329361|FG003|Overall Study|Adverse Event|0|||
130714469|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Death|36|||
130290940|NCT00098722|469029151|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
130290941|NCT00098722|469029145|FG000|Double Blind Phase|Other|7|||
130290942|NCT00098722|469029146|FG001|Double Blind Phase|Other|8|||
130290943|NCT00098722|469029147|FG002|Double Blind Phase|Other|7|||
130290944|NCT00098722|469029148|FG003|Double Blind Phase|Other|0|||
130290945|NCT00098722|469029149|FG004|Double Blind Phase|Other|0|||
130290946|NCT00098722|469029150|FG005|Double Blind Phase|Other|0|||
130290947|NCT00098722|469029151|FG006|Double Blind Phase|Other|0|||
130371366|NCT02010775|469329362|FG004|Overall Study|Adverse Event|1|||
130371367|NCT02010775|469329358|FG000|Overall Study|Pregnancy|0|||
130290948|NCT00098722|469029145|FG000|Open Label Phase|Adverse Event|0|||
130290949|NCT00098722|469029146|FG001|Open Label Phase|Adverse Event|0|||
130290950|NCT00098722|469029147|FG002|Open Label Phase|Adverse Event|0|||
130290951|NCT00098722|469029148|FG003|Open Label Phase|Adverse Event|5|||
130290952|NCT00098722|469029149|FG004|Open Label Phase|Adverse Event|0|||
130290953|NCT00098722|469029150|FG005|Open Label Phase|Adverse Event|0|||
130290954|NCT00098722|469029151|FG006|Open Label Phase|Adverse Event|0|||
130290955|NCT00098722|469029145|FG000|Open Label Phase|Death|0|||
130290956|NCT00098722|469029146|FG001|Open Label Phase|Death|0|||
130290957|NCT00098722|469029147|FG002|Open Label Phase|Death|0|||
130290958|NCT00098722|469029148|FG003|Open Label Phase|Death|2|||
130290959|NCT00098722|469029149|FG004|Open Label Phase|Death|0|||
130290960|NCT00098722|469029150|FG005|Open Label Phase|Death|0|||
130290961|NCT00098722|469029151|FG006|Open Label Phase|Death|0|||
130290962|NCT00098722|469029145|FG000|Open Label Phase|Lack of Efficacy|0|||
130290963|NCT00098722|469029146|FG001|Open Label Phase|Lack of Efficacy|0|||
130290964|NCT00098722|469029147|FG002|Open Label Phase|Lack of Efficacy|0|||
130290965|NCT00098722|469029148|FG003|Open Label Phase|Lack of Efficacy|8|||
130290966|NCT00098722|469029149|FG004|Open Label Phase|Lack of Efficacy|0|||
130290967|NCT00098722|469029150|FG005|Open Label Phase|Lack of Efficacy|0|||
130290968|NCT00098722|469029151|FG006|Open Label Phase|Lack of Efficacy|0|||
130290969|NCT00098722|469029145|FG000|Open Label Phase|Pregnancy|0|||
130290970|NCT00098722|469029146|FG001|Open Label Phase|Pregnancy|0|||
130290971|NCT00098722|469029147|FG002|Open Label Phase|Pregnancy|0|||
130290972|NCT00098722|469029148|FG003|Open Label Phase|Pregnancy|1|||
130290973|NCT00098722|469029149|FG004|Open Label Phase|Pregnancy|0|||
130460085|NCT00612586|469649748|FG001|Overall Study|Physician Decision|2|||
130460086|NCT00612586|469649747|FG000|Overall Study|Sponsor Decision|1|||
130460087|NCT00612586|469649748|FG001|Overall Study|Sponsor Decision|1|||
130460088|NCT00612586|469649747|FG000|Overall Study|Progressive Disease|26|||
130460089|NCT00612586|469649748|FG001|Overall Study|Progressive Disease|24|||
130460090|NCT00612586|469649747|FG000|Overall Study|Randomized and Not Treated|1|||
130460091|NCT00612586|469649748|FG001|Overall Study|Randomized and Not Treated|1|||
130460092|NCT01194154|469649749|FG000|Overall Study|Adverse Event|12|||
130460093|NCT01194154|469649750|FG001|Overall Study|Adverse Event|7|||
130460094|NCT01194154|469649749|FG000|Overall Study|Lost to Follow-up|2|||
130460095|NCT01194154|469649750|FG001|Overall Study|Lost to Follow-up|3|||
130460096|NCT01194154|469649749|FG000|Overall Study|Protocol Violation|0|||
130460097|NCT01194154|469649750|FG001|Overall Study|Protocol Violation|1|||
130460098|NCT01194154|469649749|FG000|Overall Study|Withdrawal by Subject|5|||
130460099|NCT01194154|469649750|FG001|Overall Study|Withdrawal by Subject|6|||
130290974|NCT00098722|469029150|FG005|Open Label Phase|Pregnancy|0|||
130290975|NCT00098722|469029151|FG006|Open Label Phase|Pregnancy|0|||
130290976|NCT00098722|469029145|FG000|Open Label Phase|Participant defaulted|0|||
130290977|NCT00098722|469029146|FG001|Open Label Phase|Participant defaulted|0|||
130290978|NCT00098722|469029147|FG002|Open Label Phase|Participant defaulted|0|||
130290979|NCT00098722|469029148|FG003|Open Label Phase|Participant defaulted|18|||
130460100|NCT01194154|469649749|FG000|Overall Study|Blood pressure increase|5|||
130460101|NCT01194154|469649750|FG001|Overall Study|Blood pressure increase|3|||
130460102|NCT01194154|469649749|FG000|Overall Study|Hemoglobin decrease|0|||
130460103|NCT01194154|469649750|FG001|Overall Study|Hemoglobin decrease|1|||
130460104|NCT01194154|469649749|FG000|Overall Study|Hemoglobin increase|12|||
130460105|NCT01194154|469649750|FG001|Overall Study|Hemoglobin increase|3|||
130290980|NCT00098722|469029149|FG004|Open Label Phase|Participant defaulted|0|||
130290981|NCT00098722|469029150|FG005|Open Label Phase|Participant defaulted|0|||
130290982|NCT00098722|469029151|FG006|Open Label Phase|Participant defaulted|0|||
130290983|NCT00098722|469029145|FG000|Open Label Phase|Ongoing at cut-off date|0|||
130290984|NCT00098722|469029146|FG001|Open Label Phase|Ongoing at cut-off date|0|||
130290985|NCT00098722|469029147|FG002|Open Label Phase|Ongoing at cut-off date|0|||
130290986|NCT00098722|469029148|FG003|Open Label Phase|Ongoing at cut-off date|220|||
130290987|NCT00098722|469029149|FG004|Open Label Phase|Ongoing at cut-off date|50|||
130290988|NCT00098722|469029150|FG005|Open Label Phase|Ongoing at cut-off date|0|||
130290989|NCT00098722|469029151|FG006|Open Label Phase|Ongoing at cut-off date|0|||
130290990|NCT00098722|469029145|FG000|Open Label Phase|Other|0|||
130290991|NCT00098722|469029146|FG001|Open Label Phase|Other|0|||
130290992|NCT00098722|469029147|FG002|Open Label Phase|Other|0|||
130290993|NCT00098722|469029148|FG003|Open Label Phase|Other|18|||
130290994|NCT00098722|469029149|FG004|Open Label Phase|Other|0|||
130460106|NCT01194154|469649749|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
130460107|NCT01194154|469649750|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
130460108|NCT01194154|469649749|FG000|Overall Study|Treatment with prohibited medication|4|||
130290995|NCT00098722|469029150|FG005|Open Label Phase|Other|0|||
130290996|NCT00098722|469029151|FG006|Open Label Phase|Other|0|||
130290997|NCT00098722|469029145|FG000|Observation Phase|Death|0|||
130290998|NCT00098722|469029146|FG001|Observation Phase|Death|0|||
130290999|NCT00098722|469029147|FG002|Observation Phase|Death|0|||
130291000|NCT00098722|469029148|FG003|Observation Phase|Death|0|||
130291001|NCT00098722|469029149|FG004|Observation Phase|Death|0|||
130291002|NCT00098722|469029150|FG005|Observation Phase|Death|5|||
130291003|NCT00098722|469029151|FG006|Observation Phase|Death|3|||
130371368|NCT02010775|469329359|FG001|Overall Study|Pregnancy|0|||
130371369|NCT02010775|469329360|FG002|Overall Study|Pregnancy|2|||
130371370|NCT02010775|469329361|FG003|Overall Study|Pregnancy|0|||
130371371|NCT02010775|469329362|FG004|Overall Study|Pregnancy|0|||
130371372|NCT02010775|469329358|FG000|Overall Study|Lost to Follow-up|2|||
130371373|NCT02010775|469329359|FG001|Overall Study|Lost to Follow-up|0|||
130371374|NCT02010775|469329360|FG002|Overall Study|Lost to Follow-up|0|||
130371375|NCT02010775|469329361|FG003|Overall Study|Lost to Follow-up|1|||
130371376|NCT02010775|469329362|FG004|Overall Study|Lost to Follow-up|1|||
130371377|NCT02010775|469329358|FG000|Overall Study|Personal Reasons|3|||
130291004|NCT00098722|469029145|FG000|Observation Phase|Lack of Efficacy|0|||
130371378|NCT02010775|469329359|FG001|Overall Study|Personal Reasons|3|||
130371379|NCT02010775|469329360|FG002|Overall Study|Personal Reasons|1|||
130371380|NCT02010775|469329361|FG003|Overall Study|Personal Reasons|2|||
130371381|NCT02010775|469329362|FG004|Overall Study|Personal Reasons|4|||
130371382|NCT02030041|469329365|FG000|Overall Study|Withdrawal by Subject|2|||
130371383|NCT02030041|469329366|FG001|Overall Study|Withdrawal by Subject|2|||
130371384|NCT02030041|469329367|FG002|Overall Study|Withdrawal by Subject|1|||
130371385|NCT01197560|469329368|FG000|Overall Study|Adverse Event|6|||
130371386|NCT01197560|469329369|FG001|Overall Study|Adverse Event|8|||
130371387|NCT01197560|469329368|FG000|Overall Study|Death|3|||
130371388|NCT01197560|469329369|FG001|Overall Study|Death|5|||
130371389|NCT01197560|469329368|FG000|Overall Study|Withdrawal by Subject|1|||
130371390|NCT01197560|469329369|FG001|Overall Study|Withdrawal by Subject|1|||
130371391|NCT01197560|469329368|FG000|Overall Study|Disease progression|40|||
130371392|NCT01197560|469329369|FG001|Overall Study|Disease progression|35|||
130291005|NCT00098722|469029146|FG001|Observation Phase|Lack of Efficacy|0|||
130291006|NCT00098722|469029147|FG002|Observation Phase|Lack of Efficacy|0|||
130291007|NCT00098722|469029148|FG003|Observation Phase|Lack of Efficacy|0|||
130291008|NCT00098722|469029149|FG004|Observation Phase|Lack of Efficacy|0|||
130291009|NCT00098722|469029150|FG005|Observation Phase|Lack of Efficacy|2|||
130291010|NCT00098722|469029151|FG006|Observation Phase|Lack of Efficacy|0|||
130291011|NCT00098722|469029145|FG000|Observation Phase|Participant defaulted|0|||
130291012|NCT00098722|469029146|FG001|Observation Phase|Participant defaulted|0|||
130291013|NCT00098722|469029147|FG002|Observation Phase|Participant defaulted|0|||
130291014|NCT00098722|469029148|FG003|Observation Phase|Participant defaulted|0|||
130291015|NCT00098722|469029149|FG004|Observation Phase|Participant defaulted|0|||
130371393|NCT01197560|469329368|FG000|Overall Study|Miscellaneous|4|||
130371394|NCT01197560|469329369|FG001|Overall Study|Miscellaneous|3|||
130371395|NCT01197560|469329368|FG000|Overall Study|Missing|0|||
130371396|NCT01197560|469329369|FG001|Overall Study|Missing|1|||
130371397|NCT05201703|469329370|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
130371398|NCT05201703|469329371|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
130371399|NCT05201703|469329370|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
130371400|NCT05201703|469329371|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
130371401|NCT02006719|469329372|FG000|Overall Study|Withdrawal by Subject|10|||
130371402|NCT02006719|469329373|FG001|Overall Study|Withdrawal by Subject|2|||
130371403|NCT02006719|469329372|FG000|Overall Study|Lost to Follow-up|5|||
130371404|NCT02006719|469329373|FG001|Overall Study|Lost to Follow-up|1|||
130371405|NCT02006719|469329372|FG000|Overall Study|Protocol Violation|2|||
130371406|NCT02006719|469329373|FG001|Overall Study|Protocol Violation|0|||
130371407|NCT02006719|469329372|FG000|Overall Study|Adverse Event|1|||
130371408|NCT02006719|469329373|FG001|Overall Study|Adverse Event|1|||
130371409|NCT02006719|469329372|FG000|Overall Study|Other/Unknown|0|||
130371410|NCT02006719|469329373|FG001|Overall Study|Other/Unknown|1|||
130371411|NCT02166905|469329377|FG000|Overall Study|Withdrawal by Subject|1|||
130371412|NCT02166905|469329378|FG001|Overall Study|Withdrawal by Subject|0|||
130371413|NCT02166905|469329379|FG002|Overall Study|Withdrawal by Subject|0|||
130371414|NCT02166905|469329380|FG003|Overall Study|Withdrawal by Subject|0|||
130371415|NCT02617628|469329381|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
130371416|NCT02617628|469329382|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
130371417|NCT02801331|469329386|FG000|Overall Study|Transferred to another hospital|8|||
130371418|NCT02801331|469329387|FG001|Overall Study|Transferred to another hospital|7|||
130371419|NCT02801331|469329386|FG000|Overall Study|Withdrawal by Subject|0|||
130291016|NCT00098722|469029150|FG005|Observation Phase|Participant defaulted|17|||
130291017|NCT00098722|469029151|FG006|Observation Phase|Participant defaulted|4|||
130291018|NCT00098722|469029145|FG000|Observation Phase|Other|0|||
130291019|NCT00098722|469029146|FG001|Observation Phase|Other|0|||
130371420|NCT02801331|469329387|FG001|Overall Study|Withdrawal by Subject|4|||
130371421|NCT02801331|469329386|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
130371422|NCT02801331|469329387|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
130371423|NCT04698187|469329393|FG000|Overall Study|Withdrawal by Subject|7|||
130371424|NCT04698187|469329393|FG000|Overall Study|Death|21|||
130371425|NCT04698187|469329393|FG000|Overall Study|Sponsor Decision|15|||
130371426|NCT04698187|469329393|FG000|Overall Study|In-transit Disease|1|||
130371427|NCT00105469|469330883|FG000|Overall Study|Adverse Event|9|||
130291020|NCT00098722|469029147|FG002|Observation Phase|Other|0|||
130291021|NCT00098722|469029148|FG003|Observation Phase|Other|0|||
130291022|NCT00098722|469029149|FG004|Observation Phase|Other|0|||
130291023|NCT00098722|469029150|FG005|Observation Phase|Other|21|||
130291024|NCT00098722|469029151|FG006|Observation Phase|Other|10|||
130291025|NCT02351349|469029152|FG000|Overall Study|Withdrawal by Subject|2|||
130291026|NCT02351349|469029153|FG001|Overall Study|Withdrawal by Subject|3|||
130291027|NCT00440310|469029154|FG000|Overall Study|Lost to Follow-up|4|||
130291028|NCT00440310|469029155|FG001|Overall Study|Lost to Follow-up|5|||
130291029|NCT00440310|469029154|FG000|Overall Study|Protocol Violation|0|||
130291030|NCT00440310|469029155|FG001|Overall Study|Protocol Violation|1|||
130291031|NCT00440310|469029154|FG000|Overall Study|Withdrawal by Subject|15|||
130291032|NCT00440310|469029155|FG001|Overall Study|Withdrawal by Subject|14|||
130291033|NCT00440310|469029154|FG000|Overall Study|No Reply at EOS|7|||
130291034|NCT00440310|469029155|FG001|Overall Study|No Reply at EOS|7|||
130291035|NCT00440310|469029154|FG000|Overall Study|Other|1|||
130291036|NCT00440310|469029155|FG001|Overall Study|Other|0|||
130291037|NCT00440310|469029154|FG000|Overall Study|Status Unknown|1|||
130291038|NCT00440310|469029155|FG001|Overall Study|Status Unknown|3|||
130291039|NCT01610596|469029162|FG000|Overall Study|Lost to Follow-up|0|||
130291040|NCT01610596|469029163|FG001|Overall Study|Lost to Follow-up|1|||
130291041|NCT01519674|469029164|FG000|Overall Study|Adverse Event|3|||
130291042|NCT01519674|469029165|FG001|Overall Study|Adverse Event|3|||
130291043|NCT01519674|469029166|FG002|Overall Study|Adverse Event|0|||
130291044|NCT01519674|469029164|FG000|Overall Study|Lack of Efficacy|1|||
130291045|NCT01519674|469029165|FG001|Overall Study|Lack of Efficacy|1|||
130291046|NCT01519674|469029166|FG002|Overall Study|Lack of Efficacy|1|||
130291047|NCT01519674|469029164|FG000|Overall Study|Protocol Violation|0|||
130291048|NCT01519674|469029165|FG001|Overall Study|Protocol Violation|3|||
130291049|NCT01519674|469029166|FG002|Overall Study|Protocol Violation|1|||
130291050|NCT01519674|469029164|FG000|Overall Study|Withdrawal Criteria|7|||
130291051|NCT01519674|469029165|FG001|Overall Study|Withdrawal Criteria|2|||
130291052|NCT01519674|469029166|FG002|Overall Study|Withdrawal Criteria|7|||
130291053|NCT01519674|469029164|FG000|Overall Study|Unsclassified|10|||
130291054|NCT01519674|469029165|FG001|Overall Study|Unsclassified|4|||
130291055|NCT01519674|469029166|FG002|Overall Study|Unsclassified|3|||
130291056|NCT00799591|469029167|FG000|Overall Study|De-escalation of doses|20|||
130291057|NCT00799591|469029167|FG000|Overall Study|Death|14|||
130291058|NCT00799591|469029167|FG000|Overall Study|Technical failure|12|||
130291059|NCT00799591|469029167|FG000|Overall Study|Resistant germ|11|||
130291060|NCT00799591|469029167|FG000|Overall Study|New infection|4|||
130291061|NCT00799591|469029167|FG000|Overall Study|Resistance germ and technical failure|2|||
130291062|NCT00799591|469029167|FG000|Overall Study|Persistance of fever undetermined origin|1|||
130291063|NCT00799591|469029167|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
130291064|NCT00799591|469029167|FG000|Overall Study|Infectious origin not probable|1|||
130291065|NCT02317809|469029168|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
130291066|NCT02317809|469029169|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
130291067|NCT02317809|469029168|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
130291068|NCT02317809|469029169|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
130291069|NCT02969590|469029172|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
130291070|NCT02969590|469029173|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
130291071|NCT02969590|469029174|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
130291072|NCT02590562|469029179|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
130291073|NCT00598078|469029185|FG000|Period 2 (Day 2)|Adverse Event|1|||
130291074|NCT00598078|469029186|FG001|Period 2 (Day 2)|Adverse Event|0|||
130291075|NCT02699450|469029191|FG000|Overall Study|Death|2|||
130291076|NCT02699450|469029192|FG001|Overall Study|Death|1|||
130291077|NCT02699450|469029193|FG002|Overall Study|Death|2|||
130291078|NCT02699450|469029191|FG000|Overall Study|Met Criteria for Study Exit|0|||
130291079|NCT02699450|469029192|FG001|Overall Study|Met Criteria for Study Exit|0|||
130291080|NCT02699450|469029193|FG002|Overall Study|Met Criteria for Study Exit|1|||
130291081|NCT02699450|469029191|FG000|Overall Study|Protocol Violation|4|||
130291082|NCT02699450|469029192|FG001|Overall Study|Protocol Violation|3|||
130291083|NCT02699450|469029193|FG002|Overall Study|Protocol Violation|5|||
130291084|NCT02699450|469029191|FG000|Overall Study|Lost to Follow-up|3|||
130291085|NCT02699450|469029192|FG001|Overall Study|Lost to Follow-up|0|||
130291086|NCT02699450|469029193|FG002|Overall Study|Lost to Follow-up|5|||
130291087|NCT02699450|469029191|FG000|Overall Study|Physician Decision|2|||
130291088|NCT02699450|469029192|FG001|Overall Study|Physician Decision|0|||
130460109|NCT01194154|469649750|FG001|Overall Study|Treatment with prohibited medication|5|||
130291089|NCT02699450|469029193|FG002|Overall Study|Physician Decision|0|||
130291090|NCT02699450|469029191|FG000|Overall Study|Withdrawal by Subject|3|||
130291091|NCT02699450|469029192|FG001|Overall Study|Withdrawal by Subject|1|||
130291092|NCT02699450|469029193|FG002|Overall Study|Withdrawal by Subject|2|||
130291093|NCT02699450|469029191|FG000|Overall Study|Adverse Event|1|||
130291094|NCT02699450|469029192|FG001|Overall Study|Adverse Event|0|||
130291095|NCT02699450|469029193|FG002|Overall Study|Adverse Event|0|||
130291096|NCT01133275|469029196|FG000|Overall Study|Withdrawal by Subject|1|||
130291097|NCT01133275|469029196|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
130291098|NCT00700102|469029197|FG000|Overall Study|Died|394|||
130291099|NCT00700102|469029198|FG001|Overall Study|Died|385|||
130291100|NCT00700102|469029197|FG000|Overall Study|Lost to Follow-up|8|||
130291101|NCT00700102|469029198|FG001|Overall Study|Lost to Follow-up|10|||
130291102|NCT02525939|469029199|FG000|Overall Study|Lost to Follow-up|27|||
130291103|NCT02525939|469029200|FG001|Overall Study|Lost to Follow-up|24|||
130291104|NCT02525939|469029199|FG000|Overall Study|Physician Decision|0|||
130291105|NCT02525939|469029200|FG001|Overall Study|Physician Decision|1|||
130291106|NCT02525939|469029199|FG000|Overall Study|Withdrawal by Subject|24|||
130291107|NCT02525939|469029200|FG001|Overall Study|Withdrawal by Subject|39|||
130291108|NCT02525939|469029199|FG000|Overall Study|Death|180|||
130291109|NCT02525939|469029200|FG001|Overall Study|Death|179|||
130291110|NCT01635764|469029201|FG000|Overall Study|Adverse Event|46|||
130291111|NCT01635764|469029201|FG000|Overall Study|Lack of Efficacy|76|||
130291112|NCT01635764|469029201|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
130291113|NCT01635764|469029201|FG000|Overall Study|Protocol Deviation|1|||
130291114|NCT01635764|469029201|FG000|Overall Study|Withdrew Consent|67|||
130291115|NCT01635764|469029201|FG000|Overall Study|Lost to Follow-up|53|||
130291116|NCT01635764|469029201|FG000|Overall Study|Other|28|||
130291117|NCT01174004|469029202|FG000|Overall Study|Adverse Event|2|||
130291118|NCT01174004|469029203|FG001|Overall Study|Adverse Event|10|||
130291119|NCT01174004|469029202|FG000|Overall Study|Withdrawal by Subject|2|||
130291120|NCT01174004|469029203|FG001|Overall Study|Withdrawal by Subject|3|||
130291121|NCT01174004|469029202|FG000|Overall Study|At Discretion of Sponsor|2|||
130291122|NCT01174004|469029203|FG001|Overall Study|At Discretion of Sponsor|2|||
130291123|NCT01174004|469029202|FG000|Overall Study|Protocol Violation|0|||
130291124|NCT01174004|469029203|FG001|Overall Study|Protocol Violation|1|||
130291125|NCT01174004|469029202|FG000|Overall Study|Physician Decision|1|||
130291126|NCT01174004|469029203|FG001|Overall Study|Physician Decision|0|||
130291127|NCT00693472|469029204|FG000|Part 1|Adverse Event|1|||
130291128|NCT00693472|469029205|FG001|Part 1|Adverse Event|1|||
130291129|NCT00693472|469029206|FG002|Part 1|Adverse Event|0|||
130291130|NCT00693472|469029207|FG003|Part 1|Adverse Event|0|||
130291131|NCT00693472|469029204|FG000|Part 1|Lost to Follow-up|0|||
130291132|NCT00693472|469029205|FG001|Part 1|Lost to Follow-up|1|||
130291133|NCT00693472|469029206|FG002|Part 1|Lost to Follow-up|0|||
130291134|NCT00693472|469029207|FG003|Part 1|Lost to Follow-up|0|||
130291135|NCT00693472|469029204|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
130291136|NCT00693472|469029205|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
130291137|NCT00693472|469029206|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
130291138|NCT00693472|469029207|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
130291139|NCT00693472|469029204|FG000|Part 2|Adverse Event|0|||
130291140|NCT00693472|469029205|FG001|Part 2|Adverse Event|0|||
130291141|NCT00693472|469029206|FG002|Part 2|Adverse Event|1|||
130291142|NCT00693472|469029207|FG003|Part 2|Adverse Event|0|||
130291143|NCT00693472|469029204|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
130291144|NCT00693472|469029205|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
130291145|NCT00693472|469029206|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
130291146|NCT00693472|469029207|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
130291147|NCT00849875|469029210|FG000|Overall Study|Death|28|||
130291148|NCT00849875|469029210|FG000|Overall Study|Ongoing (unknown completion status)|11|||
130291149|NCT00849875|469029210|FG000|Overall Study|Others|6|||
130291150|NCT00849875|469029210|FG000|Overall Study|Lost to Follow-up|2|||
130291151|NCT00086502|469029211|FG000|Overall Study|Adverse Event|11|||
130291152|NCT00086502|469029212|FG001|Overall Study|Adverse Event|2|||
130291153|NCT00086502|469029211|FG000|Overall Study|Lack of Efficacy|0|||
130291154|NCT00086502|469029212|FG001|Overall Study|Lack of Efficacy|2|||
130291155|NCT00086502|469029211|FG000|Overall Study|Lost to Follow-up|3|||
130291156|NCT00086502|469029212|FG001|Overall Study|Lost to Follow-up|1|||
130291157|NCT00086502|469029211|FG000|Overall Study|Physician Decision|1|||
130291158|NCT00086502|469029212|FG001|Overall Study|Physician Decision|1|||
130291159|NCT00086502|469029211|FG000|Overall Study|Pregnancy|0|||
130291160|NCT00086502|469029212|FG001|Overall Study|Pregnancy|1|||
130291161|NCT00086502|469029211|FG000|Overall Study|Protocol Violation|3|||
130291162|NCT00086502|469029212|FG001|Overall Study|Protocol Violation|3|||
130291163|NCT00086502|469029211|FG000|Overall Study|Withdrawal by Subject|5|||
130291164|NCT00086502|469029212|FG001|Overall Study|Withdrawal by Subject|6|||
130371428|NCT00105469|469330884|FG001|Overall Study|Adverse Event|8|||
130371429|NCT00105469|469330883|FG000|Overall Study|Protocol Violation|4|||
130291165|NCT00086502|469029211|FG000|Overall Study|Patient Moved|1|||
130291166|NCT00086502|469029212|FG001|Overall Study|Patient Moved|1|||
130291167|NCT00086502|469029211|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
130291168|NCT00086502|469029212|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
130291169|NCT00086502|469029211|FG000|Overall Study|Patient Accidentally Unblinded|1|||
130291170|NCT00086502|469029212|FG001|Overall Study|Patient Accidentally Unblinded|0|||
130291171|NCT01515475|469029218|FG000|Overall Study|Lost to Follow-up|20|||
130291172|NCT01515475|469029219|FG001|Overall Study|Lost to Follow-up|15|||
130291173|NCT01515475|469029220|FG002|Overall Study|Lost to Follow-up|12|||
130371430|NCT00105469|469330884|FG001|Overall Study|Protocol Violation|0|||
130556597|NCT01436071|470007963|FG000|Overall Study|Withdrawal by Subject|2|||
130556598|NCT01436071|470007964|FG001|Overall Study|Withdrawal by Subject|2|||
130556599|NCT01436071|470007963|FG000|Overall Study|Did Not Receive Trial Medication|3|||
130556600|NCT01436071|470007964|FG001|Overall Study|Did Not Receive Trial Medication|3|||
130556601|NCT01215175|470007967|FG000|Overall Study|Lost to Follow-up|0|||
130291174|NCT01515475|469029221|FG003|Overall Study|Lost to Follow-up|12|||
130291175|NCT01420627|469029222|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
130291176|NCT00837876|469029223|FG000|Overall Study|Death|2|||
130291177|NCT00837876|469029223|FG000|Overall Study|Adverse Event|7|||
130291178|NCT00837876|469029223|FG000|Overall Study|Physician Decision|1|||
130291179|NCT00837876|469029223|FG000|Overall Study|Withdrawal by Subject|3|||
130291180|NCT00837876|469029223|FG000|Overall Study|disease progression|24|||
130291181|NCT00453973|469029224|FG000|Overall Study|Adverse Event|4|||
130291182|NCT00453973|469029225|FG001|Overall Study|Adverse Event|9|||
130291183|NCT00453973|469029224|FG000|Overall Study|Withdrawal by Subject|7|||
130291184|NCT00453973|469029225|FG001|Overall Study|Withdrawal by Subject|6|||
130291185|NCT00453973|469029224|FG000|Overall Study|PI Decision|0|||
130291186|NCT00453973|469029225|FG001|Overall Study|PI Decision|2|||
130291187|NCT00453973|469029224|FG000|Overall Study|Relocation|1|||
130291188|NCT00453973|469029225|FG001|Overall Study|Relocation|0|||
130291189|NCT00453973|469029224|FG000|Overall Study|Renal transplant|1|||
130291190|NCT00453973|469029225|FG001|Overall Study|Renal transplant|1|||
130291191|NCT00453973|469029224|FG000|Overall Study|Site closed by sponsor|3|||
130291192|NCT00453973|469029225|FG001|Overall Study|Site closed by sponsor|0|||
130291193|NCT00453973|469029224|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
130291194|NCT00453973|469029225|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
130291195|NCT00276094|469029226|FG000|Overall Study|Adverse Event|15|||
130291196|NCT00276094|469029227|FG001|Overall Study|Adverse Event|13|||
130291197|NCT00276094|469029228|FG002|Overall Study|Adverse Event|11|||
130291198|NCT00276094|469029226|FG000|Overall Study|Withdrawal by Subject|14|||
130291199|NCT00276094|469029227|FG001|Overall Study|Withdrawal by Subject|14|||
130291200|NCT00276094|469029228|FG002|Overall Study|Withdrawal by Subject|12|||
130291201|NCT00276094|469029226|FG000|Overall Study|Protocol Violation|16|||
130291202|NCT00276094|469029227|FG001|Overall Study|Protocol Violation|7|||
130291203|NCT00276094|469029228|FG002|Overall Study|Protocol Violation|10|||
130291204|NCT00276094|469029226|FG000|Overall Study|Lost to Follow-up|8|||
130291205|NCT00276094|469029227|FG001|Overall Study|Lost to Follow-up|6|||
130291206|NCT00276094|469029228|FG002|Overall Study|Lost to Follow-up|4|||
130291207|NCT00276094|469029226|FG000|Overall Study|Other-Subject moved out of country|1|||
130291208|NCT00276094|469029227|FG001|Overall Study|Other-Subject moved out of country|0|||
130291209|NCT00276094|469029228|FG002|Overall Study|Other-Subject moved out of country|0|||
130291210|NCT00276094|469029226|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
130291211|NCT00276094|469029227|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
130291212|NCT00276094|469029228|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
130291213|NCT00276094|469029226|FG000|Overall Study|Other-Lack of efficacy|1|||
130291214|NCT00276094|469029227|FG001|Overall Study|Other-Lack of efficacy|0|||
130291215|NCT00276094|469029228|FG002|Overall Study|Other-Lack of efficacy|0|||
130291216|NCT00276094|469029226|FG000|Overall Study|Other-Refused follow-up visit|1|||
130291217|NCT00276094|469029227|FG001|Overall Study|Other-Refused follow-up visit|0|||
130291218|NCT00276094|469029228|FG002|Overall Study|Other-Refused follow-up visit|0|||
130291219|NCT00276094|469029226|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130291220|NCT00276094|469029227|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
130291221|NCT00276094|469029228|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130291222|NCT00276094|469029226|FG000|Overall Study|Other-Relocation|0|||
130291223|NCT00276094|469029227|FG001|Overall Study|Other-Relocation|1|||
130291224|NCT00276094|469029228|FG002|Overall Study|Other-Relocation|0|||
130291225|NCT00276094|469029226|FG000|Overall Study|Other-Study medication lost|0|||
130291226|NCT00276094|469029227|FG001|Overall Study|Other-Study medication lost|0|||
130291227|NCT00276094|469029228|FG002|Overall Study|Other-Study medication lost|1|||
130291228|NCT02075632|469029233|FG000|Overall Study|Adverse Event|1|||
130291229|NCT02075632|469029234|FG001|Overall Study|Adverse Event|1|||
130291230|NCT02075632|469029233|FG000|Overall Study|Lost to Follow-up|0|||
130291231|NCT02075632|469029234|FG001|Overall Study|Lost to Follow-up|3|||
130291232|NCT02075632|469029233|FG000|Overall Study|Withdrawal by Subject|0|||
130291233|NCT02075632|469029234|FG001|Overall Study|Withdrawal by Subject|1|||
130291234|NCT01969500|469029243|FG000|Overall Study|Death|0|||
130291235|NCT01969500|469029244|FG001|Overall Study|Death|1|||
130291236|NCT01969500|469029243|FG000|Overall Study|extended hospitalization|1|||
130291237|NCT01969500|469029244|FG001|Overall Study|extended hospitalization|1|||
130291238|NCT01873729|469029245|FG000|Overall Study|Withdrawal by Subject|1|||
130291239|NCT02463032|469029246|FG000|Overall Study|Lack of Efficacy|61|||
130291240|NCT02463032|469029247|FG001|Overall Study|Lack of Efficacy|50|||
130291241|NCT02463032|469029246|FG000|Overall Study|Death|8|||
130291242|NCT02463032|469029247|FG001|Overall Study|Death|8|||
130291243|NCT02463032|469029246|FG000|Overall Study|Adverse Event|2|||
130291244|NCT02463032|469029247|FG001|Overall Study|Adverse Event|6|||
130291245|NCT00613080|469029248|FG000|Overall Study|Ineligible / no protocol treatment|11|||
130556602|NCT01215175|470007968|FG001|Overall Study|Lost to Follow-up|1|||
130291246|NCT03757130|469029249|FG000|Overall Study|Lost to Follow-up|0|||
130291247|NCT03757130|469029250|FG001|Overall Study|Lost to Follow-up|0|||
130291248|NCT03757130|469029251|FG002|Overall Study|Lost to Follow-up|0|||
130291249|NCT03757130|469029252|FG003|Overall Study|Lost to Follow-up|1|||
130291250|NCT03757130|469029253|FG004|Overall Study|Lost to Follow-up|0|||
130291251|NCT03757130|469029254|FG005|Overall Study|Lost to Follow-up|0|||
130291252|NCT03757130|469029255|FG006|Overall Study|Lost to Follow-up|0|||
130291253|NCT03757130|469029256|FG007|Overall Study|Lost to Follow-up|1|||
130291254|NCT03757130|469029249|FG000|Overall Study|Withdrawal by Subject|0|||
130291255|NCT03757130|469029250|FG001|Overall Study|Withdrawal by Subject|0|||
130291256|NCT03757130|469029251|FG002|Overall Study|Withdrawal by Subject|0|||
130291257|NCT03757130|469029252|FG003|Overall Study|Withdrawal by Subject|0|||
130291258|NCT03757130|469029253|FG004|Overall Study|Withdrawal by Subject|0|||
130291259|NCT03757130|469029254|FG005|Overall Study|Withdrawal by Subject|0|||
130291260|NCT03757130|469029255|FG006|Overall Study|Withdrawal by Subject|1|||
130291261|NCT03757130|469029256|FG007|Overall Study|Withdrawal by Subject|0|||
130291262|NCT02226549|469029257|FG000|Overall Study|Randomized but Never Treated|1|||
130291263|NCT02226549|469029258|FG001|Overall Study|Randomized but Never Treated|0|||
130291264|NCT02226549|469029257|FG000|Overall Study|Lost to Follow-up|0|||
130291265|NCT02226549|469029258|FG001|Overall Study|Lost to Follow-up|1|||
130291266|NCT02726880|469029260|FG000|Overall Study|Withdrawal by Subject|2|||
130291267|NCT02726880|469029261|FG001|Overall Study|Withdrawal by Subject|0|||
130291268|NCT02726880|469029260|FG000|Overall Study|Lost to Follow-up|1|||
130291269|NCT02726880|469029261|FG001|Overall Study|Lost to Follow-up|3|||
130291270|NCT02312219|469029262|FG000|Overall Study|Withdrawal by Subject|1|||
130291271|NCT02312219|469029263|FG001|Overall Study|Withdrawal by Subject|2|||
130291272|NCT02312219|469029262|FG000|Overall Study|could not schedule imaging in time|0|||
130291273|NCT02312219|469029263|FG001|Overall Study|could not schedule imaging in time|2|||
130291274|NCT02312219|469029262|FG000|Overall Study|Other|0|||
130291275|NCT02312219|469029263|FG001|Overall Study|Other|1|||
130291276|NCT02312219|469029262|FG000|Overall Study|Not randomized. Ineligible|0|||
130556603|NCT01215175|470007969|FG002|Overall Study|Lost to Follow-up|0|||
130556604|NCT01215175|470007970|FG003|Overall Study|Lost to Follow-up|1|||
130556605|NCT01215175|470007971|FG004|Overall Study|Lost to Follow-up|0|||
130556606|NCT01296035|470007977|FG000|Overall Study|Withdrawal by Subject|1|||
130556607|NCT04464265|470007978|FG000|Overall Study|Physician Decision|2|||
130556608|NCT00974090|470007983|FG000|Period 1: Double Blind Period|Adverse Event|2|||
130556609|NCT00974090|470007984|FG001|Period 1: Double Blind Period|Adverse Event|1|||
130556610|NCT00974090|470007983|FG000|Period 1: Double Blind Period|Physician Decision|1|||
130556611|NCT00974090|470007984|FG001|Period 1: Double Blind Period|Physician Decision|0|||
130556612|NCT00974090|470007983|FG000|Period 2: Open-label Period|Adverse Event|4|||
130556613|NCT00974090|470007984|FG001|Period 2: Open-label Period|Adverse Event|6|||
130556614|NCT00974090|470007983|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
130556615|NCT00974090|470007984|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
130556616|NCT00974090|470007983|FG000|Period 2: Open-label Period|Physician Decision|0|||
130556617|NCT00974090|470007984|FG001|Period 2: Open-label Period|Physician Decision|3|||
130291277|NCT02312219|469029263|FG001|Overall Study|Not randomized. Ineligible|1|||
130291278|NCT01269385|469029264|FG000|Overall Study|Adverse Event|1|||
130291279|NCT01269385|469029265|FG001|Overall Study|Adverse Event|1|||
130291280|NCT01269385|469029266|FG002|Overall Study|Adverse Event|0|||
130291281|NCT01269385|469029267|FG003|Overall Study|Adverse Event|0|||
130291282|NCT00546260|469029268|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
130291283|NCT00546260|469029269|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
130291284|NCT03759041|469029270|FG000|Overall Study|Withdrawal by Subject|4|||
130291285|NCT03759041|469029271|FG001|Overall Study|Withdrawal by Subject|10|||
130291286|NCT03759041|469029272|FG002|Overall Study|Withdrawal by Subject|10|||
130291287|NCT03759041|469029270|FG000|Overall Study|Adverse Event|1|||
130291288|NCT03759041|469029271|FG001|Overall Study|Adverse Event|3|||
130291289|NCT03759041|469029272|FG002|Overall Study|Adverse Event|4|||
130291290|NCT03759041|469029270|FG000|Overall Study|Lack of Efficacy|0|||
130291291|NCT03759041|469029271|FG001|Overall Study|Lack of Efficacy|0|||
130291292|NCT03759041|469029272|FG002|Overall Study|Lack of Efficacy|1|||
130291293|NCT03759041|469029270|FG000|Overall Study|Study Terminated by Sponsor|15|||
130291294|NCT03759041|469029271|FG001|Overall Study|Study Terminated by Sponsor|16|||
130291295|NCT03759041|469029272|FG002|Overall Study|Study Terminated by Sponsor|10|||
130291296|NCT03759041|469029270|FG000|Overall Study|Other reason for discontinuation|0|||
130291297|NCT03759041|469029271|FG001|Overall Study|Other reason for discontinuation|2|||
130291298|NCT03759041|469029272|FG002|Overall Study|Other reason for discontinuation|1|||
130291299|NCT03759041|469029270|FG000|Overall Study|Lost to Follow-up|7|||
130291300|NCT03759041|469029271|FG001|Overall Study|Lost to Follow-up|2|||
130291301|NCT03759041|469029272|FG002|Overall Study|Lost to Follow-up|2|||
130291302|NCT03759041|469029270|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
130291303|NCT03759041|469029271|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
130291304|NCT03759041|469029272|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
130291305|NCT04384107|469029273|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
130291306|NCT04384107|469029274|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130291307|NCT04384107|469029273|FG000|Overall Study|Lost to Follow-up|1|||
130291308|NCT04384107|469029274|FG001|Overall Study|Lost to Follow-up|0|||
130291309|NCT00276614|469029275|FG000|Overall Study|Progression of disease under study|3|||
130291310|NCT01522404|469029278|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
130291311|NCT01522404|469029279|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
130291312|NCT01522404|469029278|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
130291313|NCT01522404|469029279|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
130291314|NCT01522404|469029278|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
130291315|NCT01522404|469029279|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
130291316|NCT01591863|469029284|FG000|Overall Study|Adverse Event|3|||
130291317|NCT01591863|469029284|FG000|Overall Study|Withdrawal by Subject|1|||
130291318|NCT01591863|469029284|FG000|Overall Study|recurrence|9|||
130291319|NCT01591863|469029284|FG000|Overall Study|Lack of Efficacy|1|||
130291320|NCT00664326|469030648|FG000|Overall Study|Adverse Event|14|||
130291321|NCT00664326|469030648|FG000|Overall Study|Noncompliance with study medication|3|||
130291322|NCT00664326|469030648|FG000|Overall Study|Withdrawal by Subject|1|||
130291323|NCT00664326|469030648|FG000|Overall Study|Physician Decision|1|||
130291324|NCT00664326|469030648|FG000|Overall Study|Other Reasons|3|||
130291325|NCT00664326|469030648|FG000|Overall Study|Death|2|||
130291326|NCT00664326|469030648|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
130291327|NCT01266317|469030649|FG000|Overall Study|Withdrawal by Subject|2|||
130291328|NCT00490776|469030650|FG000|Overall Study|Withdrawal by Subject|1|||
130291329|NCT00490776|469030650|FG000|Overall Study|Administrative Problems|1|||
130291330|NCT00490776|469030650|FG000|Overall Study|Death|1|||
130291331|NCT00490776|469030650|FG000|Overall Study|New Cancer Therapy|1|||
130291332|NCT00490776|469030650|FG000|Overall Study|Disease Progression|5|||
130291333|NCT00046930|469030658|FG000|Overall Study|Ineligible|12|||
130291334|NCT00046930|469030659|FG001|Overall Study|Ineligible|4|||
130291335|NCT04912895|469030660|FG000|Overall Study|Unable to provide specimen|2|||
130291336|NCT04912895|469030661|FG001|Overall Study|Unable to provide specimen|0|||
130291337|NCT04912895|469030662|FG002|Overall Study|Unable to provide specimen|0|||
130291338|NCT00520013|469030663|FG000|Overall Study|Withdrawal by Subject|0|||
130291339|NCT00520013|469030664|FG001|Overall Study|Withdrawal by Subject|0|||
130291340|NCT00520013|469030665|FG002|Overall Study|Withdrawal by Subject|1|||
130291341|NCT00520013|469030663|FG000|Overall Study|Adverse Event|2|||
130291342|NCT00520013|469030664|FG001|Overall Study|Adverse Event|10|||
130291343|NCT00520013|469030665|FG002|Overall Study|Adverse Event|7|||
130291344|NCT00520013|469030663|FG000|Overall Study|Progressive Disease|7|||
130291345|NCT00520013|469030664|FG001|Overall Study|Progressive Disease|3|||
130291346|NCT00520013|469030665|FG002|Overall Study|Progressive Disease|0|||
130291347|NCT00520013|469030663|FG000|Overall Study|Clinical Progression|3|||
130291348|NCT00520013|469030664|FG001|Overall Study|Clinical Progression|1|||
130291349|NCT00520013|469030665|FG002|Overall Study|Clinical Progression|0|||
130291350|NCT00520013|469030663|FG000|Overall Study|Death|0|||
130291351|NCT00520013|469030664|FG001|Overall Study|Death|1|||
130291352|NCT00520013|469030665|FG002|Overall Study|Death|0|||
130291353|NCT00520013|469030663|FG000|Overall Study|Physician Decision|0|||
130291354|NCT00520013|469030664|FG001|Overall Study|Physician Decision|0|||
130291355|NCT00520013|469030665|FG002|Overall Study|Physician Decision|3|||
130291356|NCT02677844|469030666|FG000|Period 3|Withdrawal by Subject|0|||
130291357|NCT02677844|469030667|FG001|Period 3|Withdrawal by Subject|0|||
130291358|NCT02677844|469030668|FG002|Period 3|Withdrawal by Subject|0|||
130291359|NCT02677844|469030669|FG003|Period 3|Withdrawal by Subject|1|||
130291360|NCT02677844|469030670|FG004|Period 3|Withdrawal by Subject|0|||
130291361|NCT02677844|469030671|FG005|Period 3|Withdrawal by Subject|0|||
130291362|NCT02677844|469030672|FG006|Period 3|Withdrawal by Subject|0|||
130291363|NCT01149486|469030673|FG000|First Intervention|Adverse Event|0|||
130291364|NCT01149486|469030674|FG001|First Intervention|Adverse Event|1|||
130291365|NCT01135914|469030677|FG000|Overall Study|Withdrawal by Subject|1|||
130291366|NCT01135914|469030678|FG001|Overall Study|Withdrawal by Subject|3|||
130291367|NCT01135914|469030679|FG002|Overall Study|Withdrawal by Subject|6|||
130291368|NCT01135914|469030677|FG000|Overall Study|Lost to Follow-up|1|||
130291369|NCT01135914|469030678|FG001|Overall Study|Lost to Follow-up|0|||
130714470|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Death|87|||
130291370|NCT01135914|469030679|FG002|Overall Study|Lost to Follow-up|1|||
130291371|NCT01135914|469030677|FG000|Overall Study|Protocol Violation|0|||
130291372|NCT01135914|469030678|FG001|Overall Study|Protocol Violation|0|||
130291373|NCT01135914|469030679|FG002|Overall Study|Protocol Violation|3|||
130291374|NCT01135914|469030677|FG000|Overall Study|Lack of Efficacy|2|||
130291375|NCT01135914|469030678|FG001|Overall Study|Lack of Efficacy|1|||
130291376|NCT01135914|469030679|FG002|Overall Study|Lack of Efficacy|10|||
130291377|NCT01135914|469030677|FG000|Overall Study|Adverse Event|0|||
130291378|NCT01135914|469030678|FG001|Overall Study|Adverse Event|1|||
130291379|NCT01135914|469030679|FG002|Overall Study|Adverse Event|2|||
130291380|NCT03532932|469030680|FG000|Overall Study|Protocol Deviation|33|||
130291381|NCT03532932|469030681|FG001|Overall Study|Protocol Deviation|31|||
130291382|NCT03532932|469030680|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
130291383|NCT03532932|469030681|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
130291384|NCT03532932|469030680|FG000|Overall Study|Withdrawal by Subject|2|||
130291385|NCT03532932|469030681|FG001|Overall Study|Withdrawal by Subject|0|||
130291386|NCT03532932|469030680|FG000|Overall Study|Lost to Follow-up|15|||
130291387|NCT03532932|469030681|FG001|Overall Study|Lost to Follow-up|9|||
130291388|NCT03532932|469030680|FG000|Overall Study|Adverse Event|4|||
130291389|NCT03532932|469030681|FG001|Overall Study|Adverse Event|3|||
130291390|NCT03532932|469030680|FG000|Overall Study|Death|0|||
130291391|NCT03532932|469030681|FG001|Overall Study|Death|2|||
130291392|NCT03532932|469030680|FG000|Overall Study|Other|11|||
130291393|NCT03532932|469030681|FG001|Overall Study|Other|16|||
130291394|NCT01344629|469030686|FG000|Crossover Period 2|Withdrawal by Subject|0|||
130291395|NCT01344629|469030687|FG001|Crossover Period 2|Withdrawal by Subject|1|||
130460110|NCT01194154|469649749|FG000|Overall Study|Other|4|||
130291396|NCT00391391|469030689|FG000|Overall Study|Adverse Event|0|||
130291397|NCT00391391|469030690|FG001|Overall Study|Adverse Event|0|||
130291398|NCT00391391|469030691|FG002|Overall Study|Adverse Event|0|||
130291399|NCT00391391|469030692|FG003|Overall Study|Adverse Event|1|||
130291400|NCT00391391|469030689|FG000|Overall Study|Lost to Follow-up|1|||
130291401|NCT00391391|469030690|FG001|Overall Study|Lost to Follow-up|3|||
130291402|NCT00391391|469030691|FG002|Overall Study|Lost to Follow-up|7|||
130291403|NCT00391391|469030692|FG003|Overall Study|Lost to Follow-up|4|||
130291404|NCT00391391|469030689|FG000|Overall Study|Protocol Violation|2|||
130291405|NCT00391391|469030690|FG001|Overall Study|Protocol Violation|3|||
130291406|NCT00391391|469030691|FG002|Overall Study|Protocol Violation|6|||
130291407|NCT00391391|469030692|FG003|Overall Study|Protocol Violation|7|||
130291408|NCT00391391|469030689|FG000|Overall Study|Withdrawal by Subject|6|||
130291409|NCT00391391|469030690|FG001|Overall Study|Withdrawal by Subject|4|||
130291410|NCT00391391|469030691|FG002|Overall Study|Withdrawal by Subject|10|||
130291411|NCT00391391|469030692|FG003|Overall Study|Withdrawal by Subject|7|||
130291412|NCT04063787|469030693|FG000|Overall Study|Inadequate Doppler data|4|||
130291413|NCT04063787|469030693|FG000|Overall Study|Lost to Follow-up|2|||
130291414|NCT04063787|469030693|FG000|Overall Study|Death|3|||
130291415|NCT05545644|469030694|FG000|Overall Study|Lost to Follow-up|4|||
130291416|NCT05545644|469030695|FG001|Overall Study|Lost to Follow-up|3|||
130291417|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
130291418|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
130291419|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
130291420|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
130291421|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
130291422|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
130460111|NCT01194154|469649750|FG001|Overall Study|Other|0|||
130460112|NCT01194154|469649749|FG000|Overall Study|Did not receive study medication|2|||
130460113|NCT01194154|469649750|FG001|Overall Study|Did not receive study medication|4|||
130460114|NCT02314117|469649751|FG000|Overall Study|Lost to Follow-up|9|||
130460115|NCT02314117|469649752|FG001|Overall Study|Lost to Follow-up|14|||
130460116|NCT02314117|469649751|FG000|Overall Study|Withdrawal by Subject|3|||
130460117|NCT02314117|469649752|FG001|Overall Study|Withdrawal by Subject|2|||
130460118|NCT01069341|469649753|FG000|Overall Study|Lost to Follow-up|1|||
130460119|NCT01802632|469649754|FG000|Overall Study|Death|28|||
130460120|NCT01802632|469649755|FG001|Overall Study|Death|1|||
130460121|NCT01802632|469649756|FG002|Overall Study|Death|38|||
130460122|NCT01802632|469649757|FG003|Overall Study|Death|0|||
130460123|NCT01802632|469649758|FG004|Overall Study|Death|2|||
130460124|NCT01802632|469649759|FG005|Overall Study|Death|0|||
130460125|NCT01802632|469649754|FG000|Overall Study|Withdrawal by Subject|4|||
130460126|NCT01802632|469649755|FG001|Overall Study|Withdrawal by Subject|2|||
130291423|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130291424|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130291425|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
130291426|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
130291427|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
130291428|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
130291429|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
130291430|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
130291431|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
130460127|NCT01802632|469649756|FG002|Overall Study|Withdrawal by Subject|7|||
130460128|NCT01802632|469649757|FG003|Overall Study|Withdrawal by Subject|3|||
130460129|NCT01802632|469649758|FG004|Overall Study|Withdrawal by Subject|0|||
130460130|NCT01802632|469649759|FG005|Overall Study|Withdrawal by Subject|1|||
130291432|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130291433|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130291434|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130291435|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
130460131|NCT01802632|469649754|FG000|Overall Study|Objective Disease Progression|1|||
130466791|NCT00332241|469676413|FG001|Overall Study|Adverse Event|5|||
130714471|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Death|100|||
130714472|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
130714473|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
130714474|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
130291436|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
130291437|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
130291438|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
130291439|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
130291440|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
130291441|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
130291442|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130291443|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130291444|NCT03002623|469030701|FG000|Overall Study|Lost to Follow-up|1|||
130291445|NCT03002623|469030702|FG001|Overall Study|Lost to Follow-up|0|||
130291446|NCT03002623|469030701|FG000|Overall Study|Physician Decision|1|||
130291447|NCT03002623|469030702|FG001|Overall Study|Physician Decision|1|||
130291448|NCT00493636|469030704|FG000|Overall Study|Withdrawal by Subject|1|||
130291449|NCT00493636|469030705|FG001|Overall Study|Withdrawal by Subject|0|||
130291450|NCT00493636|469030704|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
130291451|NCT00493636|469030705|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130291452|NCT00493636|469030704|FG000|Overall Study|Mis-randomization|1|||
130291453|NCT00493636|469030705|FG001|Overall Study|Mis-randomization|1|||
130291454|NCT02012686|469030712|FG000|Overall Study|muscle contraction|0|||
130291455|NCT02012686|469030713|FG001|Overall Study|muscle contraction|1|||
130291456|NCT02012686|469030712|FG000|Overall Study|electrocardiography monitoring noise|0|||
130291457|NCT02012686|469030713|FG001|Overall Study|electrocardiography monitoring noise|1|||
130291458|NCT00612508|469030714|FG000|Overall Study|Withdrawal by Subject|3|||
130291459|NCT00612508|469030715|FG001|Overall Study|Withdrawal by Subject|4|||
130291460|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
130291461|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
130291462|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
130291463|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
130291464|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
130291465|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
130714475|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Physician Decision|0|||
130291466|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
130291467|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
130291468|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
130291469|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
130291470|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
130291471|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
130291472|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
130291473|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
130291474|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130291475|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130291476|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130291477|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130291478|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
130291479|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
130291480|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
130291481|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
130291482|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
130291483|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
130291484|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130291485|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130291486|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
130291487|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
130291488|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
130291489|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
130291490|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130291491|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130291492|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
130291493|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
130291494|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
130291495|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
130714476|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Physician Decision|1|||
130714477|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Physician Decision|0|||
130714478|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
130714479|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
130714480|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
130714481|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
130714482|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
130714483|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
130714484|NCT02031458|470581681|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
130714485|NCT02031458|470581682|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
130714486|NCT02031458|470581683|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
130714487|NCT02031458|470581681|FG000|Baseline to May 8, 2015|On Treatment|43|||
130714488|NCT02031458|470581682|FG001|Baseline to May 8, 2015|On Treatment|81|||
130714489|NCT02031458|470581683|FG002|Baseline to May 8, 2015|On Treatment|73|||
130714490|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
130714491|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
130714492|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
130714493|NCT00059787|470581684|FG000|Overall Study|Adverse Event|13|||
130714494|NCT00059787|470581684|FG000|Overall Study|disease progression|2|||
130714495|NCT00059787|470581684|FG000|Overall Study|ineligible|1|||
130714496|NCT00059787|470581684|FG000|Overall Study|Other|4|||
130714497|NCT00292188|470581685|FG000|Single-Blind|Adverse Event|14|||
130714498|NCT00292188|470581686|FG001|Single-Blind|Adverse Event|0|||
130714499|NCT00292188|470581687|FG002|Single-Blind|Adverse Event|0|||
130714500|NCT00292188|470581685|FG000|Single-Blind|Lack of Efficacy|2|||
130714501|NCT00292188|470581686|FG001|Single-Blind|Lack of Efficacy|0|||
130714502|NCT00292188|470581687|FG002|Single-Blind|Lack of Efficacy|0|||
130714503|NCT00292188|470581685|FG000|Single-Blind|Laboratory Abnormality|5|||
130714504|NCT00292188|470581686|FG001|Single-Blind|Laboratory Abnormality|0|||
130714505|NCT00292188|470581687|FG002|Single-Blind|Laboratory Abnormality|0|||
130714506|NCT00292188|470581685|FG000|Single-Blind|Lost to Follow-up|3|||
130714507|NCT00292188|470581686|FG001|Single-Blind|Lost to Follow-up|0|||
130714508|NCT00292188|470581687|FG002|Single-Blind|Lost to Follow-up|0|||
130714509|NCT00292188|470581685|FG000|Single-Blind|Other|77|||
130714510|NCT00292188|470581686|FG001|Single-Blind|Other|0|||
130714511|NCT00292188|470581687|FG002|Single-Blind|Other|0|||
130714512|NCT00292188|470581685|FG000|Single-Blind|Withdrawal by Subject|12|||
130714513|NCT00292188|470581686|FG001|Single-Blind|Withdrawal by Subject|0|||
130714514|NCT00292188|470581687|FG002|Single-Blind|Withdrawal by Subject|0|||
130714515|NCT00292188|470581685|FG000|Single-Blind|Did not receive treatment|1|||
130714516|NCT00292188|470581686|FG001|Single-Blind|Did not receive treatment|0|||
130714517|NCT00292188|470581687|FG002|Single-Blind|Did not receive treatment|0|||
130714518|NCT00292188|470581685|FG000|Double-Blind|Adverse Event|0|||
130714519|NCT00292188|470581686|FG001|Double-Blind|Adverse Event|25|||
130714520|NCT00292188|470581687|FG002|Double-Blind|Adverse Event|9|||
130714521|NCT00292188|470581685|FG000|Double-Blind|Lack of Efficacy|0|||
130714522|NCT00292188|470581686|FG001|Double-Blind|Lack of Efficacy|2|||
130714523|NCT00292188|470581687|FG002|Double-Blind|Lack of Efficacy|12|||
130714524|NCT00292188|470581685|FG000|Double-Blind|Lost to Follow-up|0|||
130714525|NCT00292188|470581686|FG001|Double-Blind|Lost to Follow-up|1|||
130714526|NCT00292188|470581687|FG002|Double-Blind|Lost to Follow-up|0|||
130714527|NCT00292188|470581685|FG000|Double-Blind|Other|0|||
130714528|NCT00292188|470581686|FG001|Double-Blind|Other|3|||
130291496|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
130291497|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
130291498|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
130291499|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
130291500|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
130291501|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
130291502|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
130714529|NCT00292188|470581687|FG002|Double-Blind|Other|4|||
130291503|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
130714530|NCT00292188|470581685|FG000|Double-Blind|Withdrawal by Subject|0|||
130714531|NCT00292188|470581686|FG001|Double-Blind|Withdrawal by Subject|0|||
130714532|NCT00292188|470581687|FG002|Double-Blind|Withdrawal by Subject|3|||
130714533|NCT00292188|470581685|FG000|Double-Blind|Laboratory Abnormality|0|||
130714534|NCT00292188|470581686|FG001|Double-Blind|Laboratory Abnormality|0|||
130714535|NCT00292188|470581687|FG002|Double-Blind|Laboratory Abnormality|1|||
130714536|NCT00824616|470581688|FG000|Overall Study|Adverse Event|2|||
130714537|NCT00824616|470581689|FG001|Overall Study|Adverse Event|1|||
130714538|NCT00824616|470581688|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
130714539|NCT00824616|470581689|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
130714540|NCT00824616|470581688|FG000|Overall Study|Hyperglycemia|1|||
130714541|NCT00824616|470581689|FG001|Overall Study|Hyperglycemia|1|||
130714542|NCT00824616|470581688|FG000|Overall Study|Lack of Efficacy|2|||
130714543|NCT00824616|470581689|FG001|Overall Study|Lack of Efficacy|1|||
130714544|NCT00824616|470581688|FG000|Overall Study|Lost to Follow-up|0|||
130714545|NCT00824616|470581689|FG001|Overall Study|Lost to Follow-up|1|||
130714546|NCT00824616|470581688|FG000|Overall Study|Withdrawal by Subject|1|||
130714547|NCT00824616|470581689|FG001|Overall Study|Withdrawal by Subject|1|||
130714548|NCT04322149|470581690|FG000|Overall Study|Adverse Event|1|||
130714549|NCT04322149|470581691|FG001|Overall Study|Adverse Event|1|||
130714550|NCT04322149|470581692|FG002|Overall Study|Adverse Event|0|||
130714551|NCT04322149|470581693|FG003|Overall Study|Adverse Event|0|||
130714552|NCT04322149|470581690|FG000|Overall Study|Withdrawal by Subject|0|||
130714553|NCT04322149|470581691|FG001|Overall Study|Withdrawal by Subject|0|||
130714554|NCT04322149|470581692|FG002|Overall Study|Withdrawal by Subject|0|||
130714555|NCT04322149|470581693|FG003|Overall Study|Withdrawal by Subject|2|||
130714556|NCT04322149|470581690|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714557|NCT04322149|470581691|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
130714558|NCT04322149|470581692|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714559|NCT04322149|470581693|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714560|NCT00103311|470581702|FG000|Overall Study|Lost to Follow-up|1|||
130291504|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
130291505|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
130291506|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
130291507|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
130291508|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
130291509|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
130291510|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
130291511|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
130291512|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
130291513|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
130291514|NCT02008357|469030716|FG000|Open-label Extension Period|Adverse Event|8|||
130291515|NCT02008357|469030717|FG001|Open-label Extension Period|Adverse Event|7|||
130291516|NCT02008357|469030716|FG000|Open-label Extension Period|Death|7|||
130291517|NCT02008357|469030717|FG001|Open-label Extension Period|Death|4|||
130291518|NCT02008357|469030716|FG000|Open-label Extension Period|Lack of Efficacy|9|||
130291519|NCT02008357|469030717|FG001|Open-label Extension Period|Lack of Efficacy|5|||
130291520|NCT02008357|469030716|FG000|Open-label Extension Period|Lost to Follow-up|2|||
130291521|NCT02008357|469030717|FG001|Open-label Extension Period|Lost to Follow-up|2|||
130291522|NCT02008357|469030716|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
130291523|NCT02008357|469030717|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
130291524|NCT02008357|469030716|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
130291525|NCT02008357|469030717|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
130291526|NCT02008357|469030716|FG000|Open-label Extension Period|Safety Risk|2|||
130291527|NCT02008357|469030717|FG001|Open-label Extension Period|Safety Risk|1|||
130291528|NCT02008357|469030716|FG000|Open-label Extension Period|Non-Compliance|0|||
130291529|NCT02008357|469030717|FG001|Open-label Extension Period|Non-Compliance|1|||
130291530|NCT02008357|469030716|FG000|Open-label Extension Period|Investigator Recommendation|0|||
130291531|NCT02008357|469030717|FG001|Open-label Extension Period|Investigator Recommendation|1|||
130291532|NCT02008357|469030716|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
130291533|NCT02008357|469030717|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
130291534|NCT02008357|469030716|FG000|Open-label Extension Period|Coordinating Center Request|2|||
130291535|NCT02008357|469030717|FG001|Open-label Extension Period|Coordinating Center Request|4|||
130291536|NCT02008357|469030716|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
130291537|NCT02008357|469030717|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
130291538|NCT02008357|469030716|FG000|Open-label Extension Period|Study Ended|20|||
130291539|NCT02008357|469030717|FG001|Open-label Extension Period|Study Ended|25|||
130291540|NCT02008357|469030716|FG000|Open-label Extension Period|Personal Reasons|0|||
130291541|NCT02008357|469030717|FG001|Open-label Extension Period|Personal Reasons|1|||
130291542|NCT02008357|469030716|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
130714561|NCT00103311|470581703|FG001|Overall Study|Lost to Follow-up|0|||
130714562|NCT00103311|470581702|FG000|Overall Study|Withdrawal by Subject|2|||
130291543|NCT02008357|469030717|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
130371431|NCT00105469|469330883|FG000|Overall Study|Withdrawal by Subject|2|||
130371432|NCT00105469|469330884|FG001|Overall Study|Withdrawal by Subject|3|||
130371433|NCT00105469|469330883|FG000|Overall Study|Lost to Follow-up|1|||
130371434|NCT00105469|469330884|FG001|Overall Study|Lost to Follow-up|0|||
130714563|NCT00103311|470581703|FG001|Overall Study|Withdrawal by Subject|1|||
130291544|NCT02008357|469030716|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
130291545|NCT02008357|469030717|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
130291546|NCT02008357|469030716|FG000|Open-label Extension Period|Other|2|||
130291547|NCT02008357|469030717|FG001|Open-label Extension Period|Other|0|||
130291548|NCT01442064|469030718|FG000|Overall Study|Adverse Event|2|||
130291549|NCT01442064|469030719|FG001|Overall Study|Adverse Event|2|||
130291550|NCT01442064|469030720|FG002|Overall Study|Adverse Event|2|||
130291551|NCT01442064|469030721|FG003|Overall Study|Adverse Event|1|||
130291552|NCT01442064|469030722|FG004|Overall Study|Adverse Event|2|||
130291553|NCT01442064|469030723|FG005|Overall Study|Adverse Event|0|||
130291554|NCT01442064|469030718|FG000|Overall Study|Death|0|||
130291555|NCT01442064|469030719|FG001|Overall Study|Death|1|||
130291556|NCT01442064|469030720|FG002|Overall Study|Death|3|||
130291557|NCT01442064|469030721|FG003|Overall Study|Death|3|||
130291558|NCT01442064|469030722|FG004|Overall Study|Death|1|||
130291559|NCT01442064|469030723|FG005|Overall Study|Death|3|||
130291560|NCT01442064|469030718|FG000|Overall Study|Lost to Follow-up|5|||
130291561|NCT01442064|469030719|FG001|Overall Study|Lost to Follow-up|5|||
130291562|NCT01442064|469030720|FG002|Overall Study|Lost to Follow-up|1|||
130291563|NCT01442064|469030721|FG003|Overall Study|Lost to Follow-up|1|||
130291564|NCT01442064|469030722|FG004|Overall Study|Lost to Follow-up|3|||
130291565|NCT01442064|469030723|FG005|Overall Study|Lost to Follow-up|3|||
130291566|NCT01442064|469030718|FG000|Overall Study|Physician Decision|1|||
130291567|NCT01442064|469030719|FG001|Overall Study|Physician Decision|1|||
130291568|NCT01442064|469030720|FG002|Overall Study|Physician Decision|2|||
130291569|NCT01442064|469030721|FG003|Overall Study|Physician Decision|3|||
130291570|NCT01442064|469030722|FG004|Overall Study|Physician Decision|3|||
130291571|NCT01442064|469030723|FG005|Overall Study|Physician Decision|1|||
130291572|NCT01442064|469030718|FG000|Overall Study|Withdrawal by Subject|6|||
130291573|NCT01442064|469030719|FG001|Overall Study|Withdrawal by Subject|3|||
130291574|NCT01442064|469030720|FG002|Overall Study|Withdrawal by Subject|2|||
130291575|NCT01442064|469030721|FG003|Overall Study|Withdrawal by Subject|2|||
130291576|NCT01442064|469030722|FG004|Overall Study|Withdrawal by Subject|2|||
130291577|NCT01442064|469030723|FG005|Overall Study|Withdrawal by Subject|1|||
130291578|NCT01442064|469030718|FG000|Overall Study|Sponsor decision|82|||
130291579|NCT01442064|469030719|FG001|Overall Study|Sponsor decision|88|||
130291580|NCT01442064|469030720|FG002|Overall Study|Sponsor decision|92|||
130291581|NCT01442064|469030721|FG003|Overall Study|Sponsor decision|88|||
130291582|NCT01442064|469030722|FG004|Overall Study|Sponsor decision|95|||
130291583|NCT01442064|469030723|FG005|Overall Study|Sponsor decision|87|||
130291584|NCT01442064|469030718|FG000|Overall Study|Subject non-compliance|0|||
130291585|NCT01442064|469030719|FG001|Overall Study|Subject non-compliance|0|||
130291586|NCT01442064|469030720|FG002|Overall Study|Subject non-compliance|0|||
130556618|NCT00974090|470007983|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
130291587|NCT01442064|469030721|FG003|Overall Study|Subject non-compliance|0|||
130291588|NCT01442064|469030722|FG004|Overall Study|Subject non-compliance|0|||
130291589|NCT01442064|469030723|FG005|Overall Study|Subject non-compliance|2|||
130291590|NCT01442064|469030718|FG000|Overall Study|Condition mandated other intervention|1|||
130291591|NCT01442064|469030719|FG001|Overall Study|Condition mandated other intervention|1|||
130291592|NCT01442064|469030720|FG002|Overall Study|Condition mandated other intervention|2|||
130291593|NCT01442064|469030721|FG003|Overall Study|Condition mandated other intervention|0|||
130291594|NCT01442064|469030722|FG004|Overall Study|Condition mandated other intervention|0|||
130291595|NCT01442064|469030723|FG005|Overall Study|Condition mandated other intervention|2|||
130291596|NCT03553498|469030726|FG000|Overall Study|Missing primary outcome|1|||
130291597|NCT03553498|469030727|FG001|Overall Study|Missing primary outcome|2|||
130291598|NCT04941807|469030728|FG000|Overall Study|Lost to Follow-up|1|||
130291599|NCT04941807|469030729|FG001|Overall Study|Lost to Follow-up|1|||
130291600|NCT02741570|469030730|FG000|Pre-Treatment Period|Other reasons|0|||
130291601|NCT02741570|469030731|FG001|Pre-Treatment Period|Other reasons|3|||
130291602|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
130291603|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
130291604|NCT02741570|469030730|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130291605|NCT02741570|469030731|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
130291606|NCT02741570|469030730|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
130291607|NCT02741570|469030731|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
130291608|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130291609|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
130291610|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130291611|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
130291612|NCT02741570|469030730|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130291613|NCT02741570|469030731|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130291614|NCT02741570|469030730|FG000|Pre-Treatment Period|Death|0|||
130556619|NCT00974090|470007984|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
130291615|NCT02741570|469030731|FG001|Pre-Treatment Period|Death|1|||
130371435|NCT00105469|469330883|FG000|Overall Study|Lack of Efficacy|2|||
130371436|NCT00105469|469330884|FG001|Overall Study|Lack of Efficacy|0|||
130371437|NCT00105469|469330883|FG000|Overall Study|Other Reason|4|||
130371438|NCT00105469|469330884|FG001|Overall Study|Other Reason|0|||
130371439|NCT00599924|469330886|FG000|Overall Study|Lack of Efficacy|3|||
130371440|NCT00599924|469330887|FG001|Overall Study|Lack of Efficacy|5|||
130371441|NCT00599924|469330888|FG002|Overall Study|Lack of Efficacy|1|||
130371442|NCT00599924|469330889|FG003|Overall Study|Lack of Efficacy|2|||
130371443|NCT00599924|469330890|FG004|Overall Study|Lack of Efficacy|3|||
130371444|NCT00599924|469330891|FG005|Overall Study|Lack of Efficacy|2|||
130371445|NCT00599924|469330892|FG006|Overall Study|Lack of Efficacy|0|||
130371446|NCT00599924|469330886|FG000|Overall Study|Adverse Event|0|||
130371447|NCT00599924|469330887|FG001|Overall Study|Adverse Event|0|||
130371448|NCT00599924|469330888|FG002|Overall Study|Adverse Event|0|||
130371449|NCT00599924|469330889|FG003|Overall Study|Adverse Event|2|||
130371450|NCT00599924|469330890|FG004|Overall Study|Adverse Event|0|||
130371451|NCT00599924|469330891|FG005|Overall Study|Adverse Event|0|||
130371452|NCT00599924|469330892|FG006|Overall Study|Adverse Event|2|||
130371453|NCT00599924|469330886|FG000|Overall Study|Death|0|||
130371454|NCT00599924|469330887|FG001|Overall Study|Death|0|||
130371455|NCT00599924|469330888|FG002|Overall Study|Death|0|||
130371456|NCT00599924|469330889|FG003|Overall Study|Death|2|||
130371457|NCT00599924|469330890|FG004|Overall Study|Death|0|||
130371458|NCT00599924|469330891|FG005|Overall Study|Death|2|||
130371459|NCT00599924|469330892|FG006|Overall Study|Death|1|||
130371460|NCT00599924|469330886|FG000|Overall Study|Protocol Violation|0|||
130371461|NCT00599924|469330887|FG001|Overall Study|Protocol Violation|0|||
130371462|NCT00599924|469330888|FG002|Overall Study|Protocol Violation|0|||
130371463|NCT00599924|469330889|FG003|Overall Study|Protocol Violation|1|||
130371464|NCT00599924|469330890|FG004|Overall Study|Protocol Violation|0|||
130371465|NCT00599924|469330891|FG005|Overall Study|Protocol Violation|0|||
130371466|NCT00599924|469330892|FG006|Overall Study|Protocol Violation|0|||
130371467|NCT00599924|469330886|FG000|Overall Study|Withdrawal by Subject|0|||
130371468|NCT00599924|469330887|FG001|Overall Study|Withdrawal by Subject|0|||
130371469|NCT00599924|469330888|FG002|Overall Study|Withdrawal by Subject|1|||
130371470|NCT00599924|469330889|FG003|Overall Study|Withdrawal by Subject|0|||
130371471|NCT00599924|469330890|FG004|Overall Study|Withdrawal by Subject|1|||
130371472|NCT00599924|469330891|FG005|Overall Study|Withdrawal by Subject|0|||
130371473|NCT00599924|469330892|FG006|Overall Study|Withdrawal by Subject|0|||
130371474|NCT00599924|469330886|FG000|Overall Study|Other|0|||
130371475|NCT00599924|469330887|FG001|Overall Study|Other|0|||
130371476|NCT00599924|469330888|FG002|Overall Study|Other|0|||
130371477|NCT00599924|469330889|FG003|Overall Study|Other|1|||
130371478|NCT00599924|469330890|FG004|Overall Study|Other|2|||
130371479|NCT00599924|469330891|FG005|Overall Study|Other|0|||
130371480|NCT00599924|469330892|FG006|Overall Study|Other|2|||
130371481|NCT01806298|469330893|FG000|Overall Study|Adverse Event|3|||
130371482|NCT01806298|469330893|FG000|Overall Study|Protocol Non-compliance|1|||
130371483|NCT01806298|469330893|FG000|Overall Study|Withdrawal by Subject|1|||
130371484|NCT01806298|469330893|FG000|Overall Study|Other|5|||
130371485|NCT03808545|469330894|FG000|Overall Study|Withdrawal by Subject|1|||
130371486|NCT03808545|469330895|FG001|Overall Study|Withdrawal by Subject|1|||
130371487|NCT05035550|469330906|FG000|Overall Study|Withdrawal by Subject|3|||
130371488|NCT05035550|469330907|FG001|Overall Study|Withdrawal by Subject|0|||
130371489|NCT01396148|469330908|FG000|Overall Study|Patient Decision|1|||
130371490|NCT02732119|469330911|FG000|Phase I|Adverse Event|1|||
130371491|NCT02732119|469330912|FG001|Phase I|Adverse Event|3|||
130371492|NCT02732119|469330913|FG002|Phase I|Adverse Event|1|||
130371493|NCT02732119|469330914|FG003|Phase I|Adverse Event|0|||
130371494|NCT02732119|469330915|FG004|Phase I|Adverse Event|0|||
130371495|NCT02732119|469330911|FG000|Phase I|Progressive disease|7|||
130371496|NCT02732119|469330912|FG001|Phase I|Progressive disease|3|||
130371497|NCT02732119|469330913|FG002|Phase I|Progressive disease|2|||
130371498|NCT02732119|469330914|FG003|Phase I|Progressive disease|0|||
130371499|NCT02732119|469330915|FG004|Phase I|Progressive disease|0|||
130371500|NCT02732119|469330911|FG000|Phase I|Protocol deviation|0|||
130371501|NCT02732119|469330912|FG001|Phase I|Protocol deviation|1|||
130371502|NCT02732119|469330913|FG002|Phase I|Protocol deviation|0|||
130371503|NCT02732119|469330914|FG003|Phase I|Protocol deviation|0|||
130556620|NCT03189862|470007985|FG000|Overall Study|Withdrawal by Subject|1|||
130371504|NCT02732119|469330915|FG004|Phase I|Protocol deviation|0|||
130371505|NCT02732119|469330911|FG000|Phase I|Physician Decision|0|||
130371506|NCT02732119|469330912|FG001|Phase I|Physician Decision|3|||
130371507|NCT02732119|469330913|FG002|Phase I|Physician Decision|4|||
130371508|NCT02732119|469330914|FG003|Phase I|Physician Decision|0|||
130371509|NCT02732119|469330915|FG004|Phase I|Physician Decision|0|||
130371510|NCT02732119|469330911|FG000|Phase II|Adverse Event|0|||
130371511|NCT02732119|469330912|FG001|Phase II|Adverse Event|0|||
130371512|NCT02732119|469330913|FG002|Phase II|Adverse Event|0|||
130371513|NCT02732119|469330914|FG003|Phase II|Adverse Event|3|||
130371514|NCT02732119|469330915|FG004|Phase II|Adverse Event|3|||
130371515|NCT02732119|469330911|FG000|Phase II|Death|0|||
130291616|NCT02741570|469030730|FG000|Pre-Treatment Period|Disease progression|0|||
130291617|NCT02741570|469030731|FG001|Pre-Treatment Period|Disease progression|1|||
130291618|NCT02741570|469030730|FG000|Treatment Period|Other reasons|47|||
130460132|NCT01802632|469649755|FG001|Overall Study|Objective Disease Progression|12|||
130460133|NCT01802632|469649756|FG002|Overall Study|Objective Disease Progression|104|||
130460134|NCT01802632|469649757|FG003|Overall Study|Objective Disease Progression|6|||
130714564|NCT00103311|470581702|FG000|Overall Study|Adverse Event|1|||
130714565|NCT00103311|470581703|FG001|Overall Study|Adverse Event|0|||
130714566|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
130714567|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
130714568|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
130714569|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
130291619|NCT02741570|469030731|FG001|Treatment Period|Other reasons|12|||
130291620|NCT02741570|469030730|FG000|Treatment Period|Poor/non-compliance|0|||
130291621|NCT02741570|469030731|FG001|Treatment Period|Poor/non-compliance|2|||
130291622|NCT02741570|469030730|FG000|Treatment Period|Maximum clinical benefit|4|||
130291623|NCT02741570|469030731|FG001|Treatment Period|Maximum clinical benefit|6|||
130291624|NCT02741570|469030730|FG000|Treatment Period|Lost to Follow-up|1|||
130291625|NCT02741570|469030731|FG001|Treatment Period|Lost to Follow-up|3|||
130291626|NCT02741570|469030730|FG000|Treatment Period|Participant withdrew consent|9|||
130291627|NCT02741570|469030731|FG001|Treatment Period|Participant withdrew consent|13|||
130291628|NCT02741570|469030730|FG000|Treatment Period|Participant request to discontinue treatment|8|||
130291629|NCT02741570|469030731|FG001|Treatment Period|Participant request to discontinue treatment|23|||
130291630|NCT02741570|469030730|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
130291631|NCT02741570|469030731|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
130291632|NCT02741570|469030730|FG000|Treatment Period|Death|9|||
130291633|NCT02741570|469030731|FG001|Treatment Period|Death|7|||
130291634|NCT02741570|469030730|FG000|Treatment Period|Study drug toxicity|55|||
130291635|NCT02741570|469030731|FG001|Treatment Period|Study drug toxicity|47|||
130291636|NCT02741570|469030730|FG000|Treatment Period|Disease progression|294|||
130291637|NCT02741570|469030731|FG001|Treatment Period|Disease progression|301|||
130291638|NCT02741570|469030730|FG000|Treatment Period|Administrative reason by sponsor|0|||
130291639|NCT02741570|469030731|FG001|Treatment Period|Administrative reason by sponsor|1|||
130291640|NCT01100567|469030732|FG000|Overall Study|Withdrawal by Subject|5|||
130291641|NCT01100567|469030733|FG001|Overall Study|Withdrawal by Subject|8|||
130291642|NCT01100567|469030732|FG000|Overall Study|Early Hospital Discharge|6|||
130291643|NCT01100567|469030733|FG001|Overall Study|Early Hospital Discharge|4|||
130291644|NCT01100567|469030732|FG000|Overall Study|Lost to Follow-up|1|||
130291645|NCT01100567|469030733|FG001|Overall Study|Lost to Follow-up|2|||
130291646|NCT01100567|469030732|FG000|Overall Study|Physician Decision|0|||
130291647|NCT01100567|469030733|FG001|Overall Study|Physician Decision|1|||
130291648|NCT01100567|469030732|FG000|Overall Study|Deemed ineligible after consent|0|||
130291649|NCT01100567|469030733|FG001|Overall Study|Deemed ineligible after consent|1|||
130291650|NCT00160199|469030736|FG000|Overall Study|Adverse Event|5|||
130291651|NCT00160199|469030737|FG001|Overall Study|Adverse Event|14|||
130291652|NCT00160199|469030736|FG000|Overall Study|Lack of Efficacy|0|||
130291653|NCT00160199|469030737|FG001|Overall Study|Lack of Efficacy|1|||
130291654|NCT00160199|469030736|FG000|Overall Study|Lost to Follow-up|7|||
130291655|NCT00160199|469030737|FG001|Overall Study|Lost to Follow-up|7|||
130291656|NCT00160199|469030736|FG000|Overall Study|Withdrawal by Subject|4|||
130291657|NCT00160199|469030737|FG001|Overall Study|Withdrawal by Subject|6|||
130291658|NCT00160199|469030736|FG000|Overall Study|Administrative|0|||
130291659|NCT00160199|469030737|FG001|Overall Study|Administrative|1|||
130291660|NCT00160199|469030736|FG000|Overall Study|Protocol Violation|8|||
130291661|NCT00160199|469030737|FG001|Overall Study|Protocol Violation|8|||
130291662|NCT03352453|469030738|FG000|Overall Study|Miscellaneous Reasons|1|||
130291663|NCT03352453|469030739|FG001|Overall Study|Miscellaneous Reasons|2|||
130291664|NCT03352453|469030738|FG000|Overall Study|Lack of Efficacy|1|||
130291665|NCT03352453|469030739|FG001|Overall Study|Lack of Efficacy|0|||
130291666|NCT03352453|469030738|FG000|Overall Study|Withdrawal by Subject|8|||
130291667|NCT03352453|469030739|FG001|Overall Study|Withdrawal by Subject|14|||
130460135|NCT01802632|469649758|FG004|Overall Study|Objective Disease Progression|4|||
130460136|NCT01802632|469649759|FG005|Overall Study|Objective Disease Progression|4|||
130460137|NCT01802632|469649754|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
130460138|NCT01802632|469649755|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
130460139|NCT01802632|469649756|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
130460140|NCT01802632|469649757|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
130714570|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
130291668|NCT03352453|469030738|FG000|Overall Study|Study Terminated by Sponsor|2|||
130291669|NCT03352453|469030739|FG001|Overall Study|Study Terminated by Sponsor|1|||
130291670|NCT03352453|469030738|FG000|Overall Study|Protocol Deviation|1|||
130291671|NCT03352453|469030739|FG001|Overall Study|Protocol Deviation|0|||
130291672|NCT03352453|469030738|FG000|Overall Study|Lost to Follow-up|7|||
130291673|NCT03352453|469030739|FG001|Overall Study|Lost to Follow-up|6|||
130291674|NCT03352453|469030738|FG000|Overall Study|Adverse Event|2|||
130291675|NCT03352453|469030739|FG001|Overall Study|Adverse Event|9|||
130291676|NCT01241760|469030744|FG000|Overall Study|Adverse Event|1|||
130291677|NCT01241760|469030745|FG001|Overall Study|Adverse Event|0|||
130291678|NCT01241760|469030744|FG000|Overall Study|Lost to Follow-up|18|||
130291679|NCT01241760|469030745|FG001|Overall Study|Lost to Follow-up|22|||
130291680|NCT01241760|469030744|FG000|Overall Study|Withdrawal by Subject|13|||
130291681|NCT01241760|469030745|FG001|Overall Study|Withdrawal by Subject|13|||
130291682|NCT01241760|469030744|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
130291683|NCT01241760|469030745|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
130291684|NCT01241760|469030744|FG000|Overall Study|Other|1|||
130291685|NCT01241760|469030745|FG001|Overall Study|Other|1|||
130291686|NCT00514020|469030746|FG000|Overall Study|Adverse Event|6|||
130291687|NCT00514020|469030746|FG000|Overall Study|Withdrawal by Subject|3|||
130291688|NCT00514020|469030746|FG000|Overall Study|Physician Decision|1|||
130291689|NCT00514020|469030746|FG000|Overall Study|disease progression|9|||
130291690|NCT00514020|469030746|FG000|Overall Study|other complicating disease|2|||
130291691|NCT00514020|469030746|FG000|Overall Study|patient went to radiation treatment|1|||
130291692|NCT00514020|469030746|FG000|Overall Study|"patients moved to the no tx group"|6|||
130291693|NCT03089944|469030747|FG000|Overall Study|Lost to Follow-up|8|||
130291694|NCT03089944|469030747|FG000|Overall Study|Withdrew Consent|2|||
130291695|NCT03089944|469030747|FG000|Overall Study|Adverse Event|1|||
130291696|NCT03089944|469030747|FG000|Overall Study|Other|1|||
130291697|NCT01636713|469030748|FG000|Overall Study|Adverse Event|16|||
130291698|NCT01636713|469030749|FG001|Overall Study|Adverse Event|16|||
130291699|NCT01636713|469030750|FG002|Overall Study|Adverse Event|7|||
130291700|NCT01636713|469030748|FG000|Overall Study|Lack of Efficacy|6|||
130291701|NCT01636713|469030749|FG001|Overall Study|Lack of Efficacy|6|||
130291702|NCT01636713|469030750|FG002|Overall Study|Lack of Efficacy|2|||
130291703|NCT01636713|469030748|FG000|Overall Study|Protocol Violation|3|||
130291704|NCT01636713|469030749|FG001|Overall Study|Protocol Violation|0|||
130291705|NCT01636713|469030750|FG002|Overall Study|Protocol Violation|1|||
130291706|NCT01636713|469030748|FG000|Overall Study|Lost to Follow-up|0|||
130291707|NCT01636713|469030749|FG001|Overall Study|Lost to Follow-up|0|||
130291708|NCT01636713|469030750|FG002|Overall Study|Lost to Follow-up|1|||
130291709|NCT01636713|469030748|FG000|Overall Study|Withdrawal by Subject|5|||
130291710|NCT01636713|469030749|FG001|Overall Study|Withdrawal by Subject|4|||
130291711|NCT01636713|469030750|FG002|Overall Study|Withdrawal by Subject|8|||
130291712|NCT01636713|469030748|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130291713|NCT01636713|469030749|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130291714|NCT01636713|469030750|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130291715|NCT03780959|469030751|FG000|Part 1|Adverse Event|1|||
130291716|NCT03780959|469030752|FG001|Part 1|Adverse Event|0|||
130291717|NCT03780959|469030753|FG002|Part 1|Adverse Event|0|||
130291718|NCT03780959|469030751|FG000|Part 1|Withdrawal by Subject|1|||
130291719|NCT03780959|469030752|FG001|Part 1|Withdrawal by Subject|0|||
130291720|NCT03780959|469030753|FG002|Part 1|Withdrawal by Subject|0|||
130291721|NCT03780959|469030751|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
130291722|NCT03780959|469030752|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
130291723|NCT03780959|469030753|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
130291724|NCT03780959|469030751|FG000|Part 1|Response Status|2|||
130291725|NCT03780959|469030752|FG001|Part 1|Response Status|0|||
130291726|NCT03780959|469030753|FG002|Part 1|Response Status|0|||
130291727|NCT03780959|469030751|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
130291728|NCT03780959|469030752|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
130291729|NCT03780959|469030753|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
130291730|NCT03780959|469030751|FG000|Part 2|Response Status|0|||
130291731|NCT03780959|469030752|FG001|Part 2|Response Status|18|||
130291732|NCT03780959|469030753|FG002|Part 2|Response Status|6|||
130460141|NCT01802632|469649758|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
130460142|NCT01802632|469649759|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
130460143|NCT01802632|469649754|FG000|Overall Study|Other (not specified)|0|||
130460144|NCT01802632|469649755|FG001|Overall Study|Other (not specified)|0|||
130460145|NCT01802632|469649756|FG002|Overall Study|Other (not specified)|7|||
130460146|NCT01802632|469649757|FG003|Overall Study|Other (not specified)|1|||
130460147|NCT01802632|469649758|FG004|Overall Study|Other (not specified)|0|||
130291733|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
130291734|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
130291735|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130291736|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130291737|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
130291738|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
130291739|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
130460148|NCT01802632|469649759|FG005|Overall Study|Other (not specified)|1|||
130460149|NCT02880241|469649760|FG000|Overall Study|Lack of Efficacy|1|||
130291740|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
130291741|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
130460150|NCT02880241|469649761|FG001|Overall Study|Lack of Efficacy|0|||
130291742|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
130291743|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130291744|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130291745|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
130291746|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291747|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291748|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291749|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130291750|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130291751|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130291752|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130291753|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291754|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291755|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
130291756|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291757|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291758|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291759|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
130291760|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291761|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130291762|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130291763|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
130291764|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
130291765|NCT03697993|469030772|FG000|Overall Study|Became Ineligible after Enrollment|1|||
130291766|NCT03697993|469030773|FG001|Overall Study|Became Ineligible after Enrollment|3|||
130291767|NCT03697993|469030772|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130291768|NCT03697993|469030773|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
130291769|NCT03697993|469030772|FG000|Overall Study|Lost to Follow-up|3|||
130291770|NCT03697993|469030773|FG001|Overall Study|Lost to Follow-up|0|||
130291771|NCT03697993|469030772|FG000|Overall Study|Physician Decision|4|||
130291772|NCT03697993|469030773|FG001|Overall Study|Physician Decision|0|||
130291773|NCT03697993|469030772|FG000|Overall Study|Initial Urine Culture Negative|0|||
130291774|NCT03697993|469030773|FG001|Overall Study|Initial Urine Culture Negative|1|||
130291775|NCT01565564|469030774|FG000|Overall Study|Lost to Follow-up|5|||
130291776|NCT01565564|469030775|FG001|Overall Study|Lost to Follow-up|1|||
130291777|NCT02698371|469030776|FG000|All Participants Flow|Lost to Follow-up|3|||
130291778|NCT02698371|469030776|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
130291779|NCT02698371|469030776|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
130291780|NCT02698371|469030776|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
130291781|NCT02698371|469030776|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
130291782|NCT02698371|469030776|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
130291783|NCT02698371|469030776|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
130291784|NCT00459537|469030781|FG000|Overall Study|Adverse Event|1|||
130291785|NCT00459537|469030782|FG001|Overall Study|Adverse Event|6|||
130291786|NCT00459537|469030781|FG000|Overall Study|Lack of Efficacy|10|||
130291787|NCT00459537|469030782|FG001|Overall Study|Lack of Efficacy|11|||
130291788|NCT00459537|469030781|FG000|Overall Study|Withdrawal by Subject|20|||
130291789|NCT00459537|469030782|FG001|Overall Study|Withdrawal by Subject|26|||
130291790|NCT00459537|469030781|FG000|Overall Study|Lost to Follow-up|27|||
130291791|NCT00459537|469030782|FG001|Overall Study|Lost to Follow-up|30|||
130291792|NCT00459537|469030781|FG000|Overall Study|Administrative problems|3|||
130291793|NCT00459537|469030782|FG001|Overall Study|Administrative problems|0|||
130291794|NCT00459537|469030781|FG000|Overall Study|Protocol Violation|4|||
130291795|NCT00459537|469030782|FG001|Overall Study|Protocol Violation|3|||
130291796|NCT00459537|469030781|FG000|Overall Study|Missing|1|||
130291797|NCT00459537|469030782|FG001|Overall Study|Missing|0|||
130291798|NCT01999218|469030783|FG000|Overall Study|Hyperglycemia|18|||
130291799|NCT01999218|469030784|FG001|Overall Study|Hyperglycemia|17|||
130291800|NCT01999218|469030785|FG002|Overall Study|Hyperglycemia|17|||
130291801|NCT01999218|469030783|FG000|Overall Study|Lack of Efficacy|1|||
130291802|NCT01999218|469030784|FG001|Overall Study|Lack of Efficacy|0|||
130291803|NCT01999218|469030785|FG002|Overall Study|Lack of Efficacy|1|||
130291804|NCT01999218|469030783|FG000|Overall Study|Lost to Follow-up|22|||
130371516|NCT02732119|469330912|FG001|Phase II|Death|0|||
130291805|NCT01999218|469030784|FG001|Overall Study|Lost to Follow-up|17|||
130291806|NCT01999218|469030785|FG002|Overall Study|Lost to Follow-up|18|||
130371517|NCT02732119|469330913|FG002|Phase II|Death|0|||
130291807|NCT01999218|469030783|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130291808|NCT01999218|469030784|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130291809|NCT01999218|469030785|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130291810|NCT01999218|469030783|FG000|Overall Study|Physician Decision|1|||
130291811|NCT01999218|469030784|FG001|Overall Study|Physician Decision|4|||
130291812|NCT01999218|469030785|FG002|Overall Study|Physician Decision|6|||
130291813|NCT01999218|469030783|FG000|Overall Study|Protocol Violation|4|||
130291814|NCT01999218|469030784|FG001|Overall Study|Protocol Violation|5|||
130291815|NCT01999218|469030785|FG002|Overall Study|Protocol Violation|4|||
130291816|NCT01999218|469030783|FG000|Overall Study|Screen failure|0|||
130291817|NCT01999218|469030784|FG001|Overall Study|Screen failure|1|||
130291818|NCT01999218|469030785|FG002|Overall Study|Screen failure|0|||
130291819|NCT01999218|469030783|FG000|Overall Study|Study Terminated By Sponsor|7|||
130291820|NCT01999218|469030784|FG001|Overall Study|Study Terminated By Sponsor|5|||
130291821|NCT01999218|469030785|FG002|Overall Study|Study Terminated By Sponsor|12|||
130291822|NCT01999218|469030783|FG000|Overall Study|Participant moves|2|||
130291823|NCT01999218|469030784|FG001|Overall Study|Participant moves|5|||
130291824|NCT01999218|469030785|FG002|Overall Study|Participant moves|3|||
130291825|NCT01999218|469030783|FG000|Overall Study|Withdrawal by Subject|28|||
130291826|NCT01999218|469030784|FG001|Overall Study|Withdrawal by Subject|29|||
130291827|NCT01999218|469030785|FG002|Overall Study|Withdrawal by Subject|34|||
130291828|NCT01999218|469030783|FG000|Overall Study|Creatinine/eGFR|0|||
130291829|NCT01999218|469030784|FG001|Overall Study|Creatinine/eGFR|0|||
130291830|NCT01999218|469030785|FG002|Overall Study|Creatinine/eGFR|1|||
130291831|NCT01999218|469030783|FG000|Overall Study|Death|7|||
130291832|NCT01999218|469030784|FG001|Overall Study|Death|1|||
130291833|NCT01999218|469030785|FG002|Overall Study|Death|2|||
130291834|NCT01999218|469030783|FG000|Overall Study|Excluded Medication|1|||
130291835|NCT01999218|469030784|FG001|Overall Study|Excluded Medication|1|||
130291836|NCT01999218|469030785|FG002|Overall Study|Excluded Medication|2|||
130291837|NCT01999218|469030783|FG000|Overall Study|Adverse Event|9|||
130291838|NCT01999218|469030784|FG001|Overall Study|Adverse Event|7|||
130291839|NCT01999218|469030785|FG002|Overall Study|Adverse Event|7|||
130291840|NCT01999218|469030783|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
130291841|NCT01999218|469030784|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
130291842|NCT01999218|469030785|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
130316230|NCT04319198|469124332|FG000|Overall Study|Reason Not Specified|0|||
130316231|NCT04319198|469124333|FG001|Overall Study|Reason Not Specified|2|||
130316232|NCT04319198|469124334|FG002|Overall Study|Reason Not Specified|4|||
130316233|NCT04319198|469124332|FG000|Overall Study|Withdrawal of Consent|0|||
130316234|NCT04319198|469124333|FG001|Overall Study|Withdrawal of Consent|0|||
130316235|NCT04319198|469124334|FG002|Overall Study|Withdrawal of Consent|5|||
130316236|NCT04319198|469124332|FG000|Overall Study|Site Terminated by Sponsor|0|||
130316237|NCT04319198|469124333|FG001|Overall Study|Site Terminated by Sponsor|1|||
130316238|NCT04319198|469124334|FG002|Overall Study|Site Terminated by Sponsor|0|||
130316239|NCT04073186|469124340|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
130316240|NCT04073186|469124340|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
130316241|NCT04073186|469124340|FG000|First Wearing Cycle|Protocol Violation|1|||
130316242|NCT04073186|469124340|FG000|First Wearing Cycle|Lens Discomfort|2|||
130316243|NCT04073186|469124340|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
130316244|NCT04073186|469124340|FG000|Second Wearing Cycle|Adverse Event|1|||
130316245|NCT00473434|469124341|FG000|Overall Study|Physician Decision|3|||
130316246|NCT00473434|469124341|FG000|Overall Study|Withdrawal by Subject|9|||
130316247|NCT00473434|469124341|FG000|Overall Study|Compliance|3|||
130316248|NCT00473434|469124341|FG000|Overall Study|Lack of Efficacy|3|||
130316249|NCT00473434|469124341|FG000|Overall Study|Adverse Event|3|||
130316250|NCT00473434|469124341|FG000|Overall Study|Patient was selling medication to others|1|||
130316251|NCT00473434|469124341|FG000|Overall Study|Safety evaluation|1|||
130316252|NCT00473434|469124341|FG000|Overall Study|Reason not specified|6|||
130316253|NCT00473434|469124341|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
130316254|NCT00473434|469124341|FG000|Overall Study|Switching to trial medication|1|||
130316255|NCT00473434|469124341|FG000|Overall Study|No longer required|1|||
130316256|NCT01453140|469124344|FG000|Overall Study|Adverse Event|3|||
130316257|NCT00743249|469124345|FG000|Overall Study|Adverse Event|0|||
130316258|NCT00743249|469124346|FG001|Overall Study|Adverse Event|4|||
130316259|NCT00743249|469124345|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
130316260|NCT00743249|469124346|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
130316261|NCT00743249|469124345|FG000|Overall Study|Unsuccessful insertion of stent|2|||
130316262|NCT00743249|469124346|FG001|Overall Study|Unsuccessful insertion of stent|1|||
130316263|NCT02653326|469124347|FG000|Overall Study|Lost to Follow-up|10|||
130316264|NCT02653326|469124348|FG001|Overall Study|Lost to Follow-up|7|||
130316265|NCT05767021|469124351|FG000|Overall Study|Adverse Event|2|||
130316266|NCT05767021|469124351|FG000|Overall Study|Protocol Deviation|1|||
130371518|NCT02732119|469330914|FG003|Phase II|Death|1|||
130316267|NCT05767021|469124351|FG000|Overall Study|Withdrawal by Subject|1|||
130316268|NCT05767021|469124351|FG000|Overall Study|Physician Decision|1|||
130291843|NCT02032407|469032314|FG000|Overall Study|Lost to Follow-up|2|||
130291844|NCT02032407|469032314|FG000|Overall Study|Pregnancy|1|||
130291845|NCT02032407|469032314|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130291846|NCT02191605|469032315|FG000|Overall Study|Lost to Follow-up|9|||
130291847|NCT02191605|469032316|FG001|Overall Study|Lost to Follow-up|4|||
130291848|NCT02191605|469032317|FG002|Overall Study|Lost to Follow-up|7|||
130291849|NCT02191605|469032318|FG003|Overall Study|Lost to Follow-up|3|||
130291850|NCT02191605|469032319|FG004|Overall Study|Lost to Follow-up|4|||
130291851|NCT03647267|469032323|FG000|Overall Study|Lost to Follow-up|1|||
130291852|NCT03647267|469032324|FG001|Overall Study|Lost to Follow-up|0|||
130291853|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
130291854|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
130291855|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
130291856|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
130291857|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
130291858|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
130291859|NCT05079477|469032327|FG000|Overall Study|Lost to Follow-up|2|||
130291860|NCT05079477|469032328|FG001|Overall Study|Lost to Follow-up|0|||
130291861|NCT05079477|469032327|FG000|Overall Study|Withdrawal by Subject|1|||
130291862|NCT05079477|469032328|FG001|Overall Study|Withdrawal by Subject|0|||
130291863|NCT05079477|469032327|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130291864|NCT05079477|469032328|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130291865|NCT05079477|469032327|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
130291866|NCT05079477|469032328|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
130291867|NCT00734071|469032329|FG000|Overall Study|Adverse Event|4|||
130291868|NCT00734071|469032330|FG001|Overall Study|Adverse Event|3|||
130291869|NCT00734071|469032329|FG000|Overall Study|Lack of Efficacy|3|||
130291870|NCT00734071|469032330|FG001|Overall Study|Lack of Efficacy|1|||
130291871|NCT00734071|469032329|FG000|Overall Study|Noncompliance|2|||
130291872|NCT00734071|469032330|FG001|Overall Study|Noncompliance|2|||
130291873|NCT00734071|469032329|FG000|Overall Study|Protocol Deviations|3|||
130291874|NCT00734071|469032330|FG001|Overall Study|Protocol Deviations|4|||
130291875|NCT00734071|469032329|FG000|Overall Study|Voluntary Withdrawal|9|||
130291876|NCT00734071|469032330|FG001|Overall Study|Voluntary Withdrawal|7|||
130291877|NCT00734071|469032329|FG000|Overall Study|Lost to Follow-up|16|||
130291878|NCT00734071|469032330|FG001|Overall Study|Lost to Follow-up|8|||
130291879|NCT00734071|469032329|FG000|Overall Study|Other|1|||
130291880|NCT00734071|469032330|FG001|Overall Study|Other|2|||
130291881|NCT00240110|469032334|FG000|Overall Study|Lost to Follow-up|6|||
130291882|NCT00240110|469032335|FG001|Overall Study|Lost to Follow-up|7|||
130291883|NCT00583791|469032336|FG000|Overall Study|Other|67|||
130291884|NCT00583791|469032336|FG000|Overall Study|Death|6|||
130291885|NCT03323736|469032337|FG000|Overall Study|Screen Failure|14|||
130291886|NCT03323736|469032338|FG001|Overall Study|Screen Failure|9|||
130291887|NCT03323736|469032339|FG002|Overall Study|Screen Failure|1|||
130291888|NCT03323736|469032337|FG000|Overall Study|Withdrawal Before Treatment|3|||
130291889|NCT03323736|469032338|FG001|Overall Study|Withdrawal Before Treatment|1|||
130291890|NCT03323736|469032339|FG002|Overall Study|Withdrawal Before Treatment|1|||
130291891|NCT03323736|469032337|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130291892|NCT03323736|469032338|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130291893|NCT03323736|469032339|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
130291894|NCT02654236|469032343|FG000|Overall Study|Withdrawal by Subject|0|||
130291895|NCT02654236|469032344|FG001|Overall Study|Withdrawal by Subject|0|||
130291896|NCT02654236|469032345|FG002|Overall Study|Withdrawal by Subject|2|||
130291897|NCT03204890|469032346|FG000|Overall Study|Withdrawal by Subject|1|||
130291898|NCT01549873|469032347|FG000|Overall Study|Physician Decision|0|||
130291899|NCT01549873|469032348|FG001|Overall Study|Physician Decision|1|||
130291900|NCT01688739|469032352|FG000|Overall Study|Administrative Decision|1|||
130291901|NCT01688739|469032353|FG001|Overall Study|Administrative Decision|0|||
130291902|NCT01688739|469032354|FG002|Overall Study|Administrative Decision|0|||
130291903|NCT01688739|469032355|FG003|Overall Study|Administrative Decision|0|||
130291904|NCT01688739|469032356|FG004|Overall Study|Administrative Decision|0|||
130460151|NCT02880241|469649762|FG002|Overall Study|Lack of Efficacy|0|||
130291905|NCT01688739|469032357|FG005|Overall Study|Administrative Decision|0|||
130291906|NCT01688739|469032358|FG006|Overall Study|Administrative Decision|0|||
130291907|NCT01688739|469032359|FG007|Overall Study|Administrative Decision|0|||
130291908|NCT01688739|469032360|FG008|Overall Study|Administrative Decision|0|||
130291909|NCT01688739|469032361|FG009|Overall Study|Administrative Decision|0|||
130291910|NCT02559414|469032363|FG000|Overall Study|Lost to Follow-up|0|||
130291911|NCT02559414|469032364|FG001|Overall Study|Lost to Follow-up|1|||
130291912|NCT02559414|469032365|FG002|Overall Study|Lost to Follow-up|0|||
130291913|NCT02559414|469032363|FG000|Overall Study|Withdrawal by Subject|1|||
130291914|NCT02559414|469032364|FG001|Overall Study|Withdrawal by Subject|0|||
130291915|NCT02559414|469032365|FG002|Overall Study|Withdrawal by Subject|1|||
130460152|NCT02880241|469649763|FG003|Overall Study|Lack of Efficacy|0|||
130291916|NCT02559414|469032363|FG000|Overall Study|Other|0|||
130291917|NCT02559414|469032364|FG001|Overall Study|Other|1|||
130291918|NCT02559414|469032365|FG002|Overall Study|Other|1|||
130291919|NCT03369431|469032366|FG000|Overall Study|Lost to Follow-up|1|||
130291920|NCT03369431|469032367|FG001|Overall Study|Lost to Follow-up|3|||
130291921|NCT03369431|469032366|FG000|Overall Study|Withdrawal by Subject|2|||
130291922|NCT03369431|469032367|FG001|Overall Study|Withdrawal by Subject|3|||
130291923|NCT03369431|469032366|FG000|Overall Study|Protocol Violation|1|||
130291924|NCT03369431|469032367|FG001|Overall Study|Protocol Violation|1|||
130291925|NCT01113580|469032372|FG000|Overall Study|Protocol Violation|1|||
130291926|NCT01113580|469032373|FG001|Overall Study|Protocol Violation|0|||
130291927|NCT02785458|469032381|FG000|1 Month|Withdrawal by Subject|2|||
130291928|NCT02785458|469032382|FG001|1 Month|Withdrawal by Subject|1|||
130291929|NCT02785458|469032381|FG000|1 Month|Lost to Follow-up|38|||
130291930|NCT02785458|469032382|FG001|1 Month|Lost to Follow-up|31|||
130291931|NCT02785458|469032381|FG000|1 Month|Deemed Ineligible|1|||
130291932|NCT02785458|469032382|FG001|1 Month|Deemed Ineligible|0|||
130291933|NCT02785458|469032381|FG000|1 Month|Completed Evaluation by Baseline|42|||
130291934|NCT02785458|469032382|FG001|1 Month|Completed Evaluation by Baseline|39|||
130291935|NCT02785458|469032381|FG000|1 Month|Partial Interview|0|||
130291936|NCT02785458|469032382|FG001|1 Month|Partial Interview|4|||
130291937|NCT02785458|469032381|FG000|3 Months|Withdrawal by Subject|3|||
130291938|NCT02785458|469032382|FG001|3 Months|Withdrawal by Subject|1|||
130291939|NCT02785458|469032381|FG000|3 Months|Lost to Follow-up|25|||
130291940|NCT02785458|469032382|FG001|3 Months|Lost to Follow-up|21|||
130291941|NCT02785458|469032381|FG000|3 Months|Completed Evaluation at 1 Month|100|||
130291942|NCT02785458|469032382|FG001|3 Months|Completed Evaluation at 1 Month|89|||
130291943|NCT00824005|469032384|FG000|Overall Study|Death|0|||
130291944|NCT00824005|469032385|FG001|Overall Study|Death|1|||
130291945|NCT00824005|469032384|FG000|Overall Study|Lost to Follow-up|0|||
130291946|NCT00824005|469032385|FG001|Overall Study|Lost to Follow-up|1|||
130291947|NCT03458702|469032386|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
130291948|NCT03458702|469032387|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
130291949|NCT03458702|469032386|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
130291950|NCT03458702|469032387|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
130291951|NCT01390779|469032388|FG000|Overall Study|Physician Decision|1|||
130291952|NCT01874275|469032389|FG000|Overall Study|Lost to Follow-up|1|||
130291953|NCT01874275|469032390|FG001|Overall Study|Lost to Follow-up|0|||
130291954|NCT01697462|469032391|FG000|Overall Study|Disease Progression|1|||
130291955|NCT01697462|469032391|FG000|Overall Study|Adverse Event|6|||
130291956|NCT01697462|469032391|FG000|Overall Study|Lost to Follow-up|21|||
130291957|NCT01697462|469032391|FG000|Overall Study|Withdrawal by Subject|12|||
130291958|NCT01697462|469032391|FG000|Overall Study|Investigator Decision|21|||
130291959|NCT01697462|469032391|FG000|Overall Study|Death|1|||
130291960|NCT01697462|469032391|FG000|Overall Study|Other|10|||
130291961|NCT01697462|469032391|FG000|Overall Study|Missing|5|||
130291962|NCT00168103|469032392|FG000|Overall Study|Withdrawal by Subject|1|||
130291963|NCT00168103|469032393|FG001|Overall Study|Withdrawal by Subject|2|||
130291964|NCT00168103|469032394|FG002|Overall Study|Withdrawal by Subject|1|||
130291965|NCT00168103|469032395|FG003|Overall Study|Withdrawal by Subject|0|||
130291966|NCT00168103|469032392|FG000|Overall Study|Lost to Follow-up|1|||
130291967|NCT00168103|469032393|FG001|Overall Study|Lost to Follow-up|3|||
130291968|NCT00168103|469032394|FG002|Overall Study|Lost to Follow-up|0|||
130291969|NCT00168103|469032395|FG003|Overall Study|Lost to Follow-up|0|||
130291970|NCT00989235|469032396|FG000|Overall Study|Death|0|||
130291971|NCT00989235|469032397|FG001|Overall Study|Death|1|||
130291972|NCT00989235|469032396|FG000|Overall Study|Adverse Event|0|||
130291973|NCT00989235|469032397|FG001|Overall Study|Adverse Event|1|||
130291974|NCT00989235|469032396|FG000|Overall Study|Lack of Efficacy|1|||
130291975|NCT00989235|469032397|FG001|Overall Study|Lack of Efficacy|0|||
130291976|NCT00989235|469032396|FG000|Overall Study|Withdrawal of Consent|1|||
130291977|NCT00989235|469032397|FG001|Overall Study|Withdrawal of Consent|1|||
130291978|NCT00989235|469032396|FG000|Overall Study|Desire to Become Pregnant|1|||
130291979|NCT00989235|469032397|FG001|Overall Study|Desire to Become Pregnant|0|||
130291980|NCT00989235|469032396|FG000|Overall Study|Randomized by Mistake|0|||
130291981|NCT00989235|469032397|FG001|Overall Study|Randomized by Mistake|2|||
130291982|NCT00989235|469032396|FG000|Overall Study|Lost to Follow-up|0|||
130291983|NCT00989235|469032397|FG001|Overall Study|Lost to Follow-up|1|||
130291984|NCT00545532|469032398|FG000|Overall Study|Withdrawal by Subject|1|||
130291985|NCT00545532|469032399|FG001|Overall Study|Withdrawal by Subject|3|||
130460153|NCT02880241|469649764|FG004|Overall Study|Lack of Efficacy|0|||
130291986|NCT00545532|469032398|FG000|Overall Study|Lost to Follow-up|5|||
130291987|NCT00545532|469032399|FG001|Overall Study|Lost to Follow-up|6|||
130460154|NCT02880241|469649765|FG005|Overall Study|Lack of Efficacy|0|||
130291988|NCT00545532|469032398|FG000|Overall Study|Death|0|||
130291989|NCT00545532|469032399|FG001|Overall Study|Death|1|||
130291990|NCT03630302|469032400|FG000|Surgery|hardware issue prevented LFP recordings|1|||
130291991|NCT03630302|469032400|FG000|3 Month Visit|Adverse Event|2|||
130291992|NCT03630302|469032400|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
130371519|NCT02732119|469330915|FG004|Phase II|Death|0|||
130371520|NCT02732119|469330911|FG000|Phase II|Progressive dissease|0|||
130371521|NCT02732119|469330912|FG001|Phase II|Progressive dissease|0|||
130371522|NCT02732119|469330913|FG002|Phase II|Progressive dissease|0|||
130371523|NCT02732119|469330914|FG003|Phase II|Progressive dissease|30|||
130371524|NCT02732119|469330915|FG004|Phase II|Progressive dissease|23|||
130371525|NCT02732119|469330911|FG000|Phase II|Study terminated by sponsor|0|||
130371526|NCT02732119|469330912|FG001|Phase II|Study terminated by sponsor|0|||
130371527|NCT02732119|469330913|FG002|Phase II|Study terminated by sponsor|0|||
130371528|NCT02732119|469330914|FG003|Phase II|Study terminated by sponsor|2|||
130371529|NCT02732119|469330915|FG004|Phase II|Study terminated by sponsor|2|||
130371530|NCT02732119|469330911|FG000|Phase II|Other|0|||
130371531|NCT02732119|469330912|FG001|Phase II|Other|0|||
130371532|NCT02732119|469330913|FG002|Phase II|Other|0|||
130371533|NCT02732119|469330914|FG003|Phase II|Other|2|||
130371534|NCT02732119|469330915|FG004|Phase II|Other|0|||
130371535|NCT02732119|469330911|FG000|Phase II|Physician Decision|0|||
130371536|NCT02732119|469330912|FG001|Phase II|Physician Decision|0|||
130371537|NCT02732119|469330913|FG002|Phase II|Physician Decision|0|||
130371538|NCT02732119|469330914|FG003|Phase II|Physician Decision|8|||
130371539|NCT02732119|469330915|FG004|Phase II|Physician Decision|5|||
130371540|NCT00003479|469330916|FG000|Overall Study|Not evaluable|3|||
130371541|NCT02128113|469330919|FG000|Overall Study|Withdrawal by Subject|3|||
130371542|NCT02128113|469330920|FG001|Overall Study|Withdrawal by Subject|1|||
130371543|NCT02128113|469330921|FG002|Overall Study|Withdrawal by Subject|0|||
130371544|NCT02128113|469330919|FG000|Overall Study|Protocol Violation|0|||
130371545|NCT02128113|469330920|FG001|Overall Study|Protocol Violation|1|||
130371546|NCT02128113|469330921|FG002|Overall Study|Protocol Violation|0|||
130371547|NCT02128113|469330919|FG000|Overall Study|Surgery cancelled|0|||
130371548|NCT02128113|469330920|FG001|Overall Study|Surgery cancelled|1|||
130371549|NCT02128113|469330921|FG002|Overall Study|Surgery cancelled|0|||
130371550|NCT02128113|469330919|FG000|Overall Study|Adverse Event|0|||
130371551|NCT02128113|469330920|FG001|Overall Study|Adverse Event|0|||
130371552|NCT02128113|469330921|FG002|Overall Study|Adverse Event|1|||
130371553|NCT01061177|469330922|FG000|Overall Study|Adverse Event|117|||
130371554|NCT01061177|469330922|FG000|Overall Study|Withdrawal by Subject|27|||
130371555|NCT01061177|469330922|FG000|Overall Study|Disease progression|17|||
130371556|NCT01061177|469330922|FG000|Overall Study|Protocol Violation|11|||
130371557|NCT01061177|469330922|FG000|Overall Study|Lost to Follow-up|9|||
130371558|NCT01061177|469330922|FG000|Overall Study|New cancer therapy|9|||
130371559|NCT01061177|469330922|FG000|Overall Study|Abnormal laboratory values|6|||
130371560|NCT01061177|469330922|FG000|Overall Study|Abnormal test procedure results|4|||
130371561|NCT01061177|469330922|FG000|Overall Study|Administratie problems|4|||
130371562|NCT01061177|469330922|FG000|Overall Study|Death|4|||
130371563|NCT02244606|469330935|FG000|Overall Study|Adverse Event|0|||
130371564|NCT02244606|469330936|FG001|Overall Study|Adverse Event|1|||
130371565|NCT02244606|469330937|FG002|Overall Study|Adverse Event|1|||
130371566|NCT02244606|469330938|FG003|Overall Study|Adverse Event|0|||
130371567|NCT02244606|469330935|FG000|Overall Study|Lost to Follow-up|2|||
130371568|NCT02244606|469330936|FG001|Overall Study|Lost to Follow-up|2|||
130371569|NCT02244606|469330937|FG002|Overall Study|Lost to Follow-up|1|||
130371570|NCT02244606|469330938|FG003|Overall Study|Lost to Follow-up|0|||
130371571|NCT02244606|469330935|FG000|Overall Study|Protocol Violation|0|||
130371572|NCT02244606|469330936|FG001|Overall Study|Protocol Violation|0|||
130371573|NCT02244606|469330937|FG002|Overall Study|Protocol Violation|0|||
130371574|NCT02244606|469330938|FG003|Overall Study|Protocol Violation|1|||
130371575|NCT02244606|469330935|FG000|Overall Study|Withdrawal by Subject|1|||
130371576|NCT02244606|469330936|FG001|Overall Study|Withdrawal by Subject|1|||
130371577|NCT02244606|469330937|FG002|Overall Study|Withdrawal by Subject|0|||
130371578|NCT02244606|469330938|FG003|Overall Study|Withdrawal by Subject|0|||
130371579|NCT02244606|469330935|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
130371580|NCT02244606|469330936|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
130371581|NCT02244606|469330937|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
130371582|NCT02244606|469330938|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
130371583|NCT00553644|469330939|FG000|Overall Study|Adverse Event|17|||
130371584|NCT00553644|469330939|FG000|Overall Study|Withdrawal by Subject|4|||
130371585|NCT00553644|469330939|FG000|Overall Study|Physician Decision|1|||
130371586|NCT00553644|469330939|FG000|Overall Study|Alternative therapy|6|||
130371587|NCT02197247|469330940|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
130371588|NCT02197247|469330940|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
130371589|NCT02197247|469330940|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
130371590|NCT02197247|469330940|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
130371591|NCT02197247|469330940|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
130371592|NCT02197247|469330940|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
130371593|NCT02197247|469330940|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
130371594|NCT02197247|469330940|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
130371595|NCT00851747|469330948|FG000|Overall Study|Physician Decision|6|||
130556621|NCT03189862|470007986|FG001|Overall Study|Withdrawal by Subject|0|||
130556622|NCT03189862|470007985|FG000|Overall Study|Lost to Follow-up|54|||
130556623|NCT03189862|470007986|FG001|Overall Study|Lost to Follow-up|62|||
130556624|NCT00056862|470007987|FG000|Overall Study|Protocol Violation|1|||
130556625|NCT00056862|470007988|FG001|Overall Study|Protocol Violation|0|||
130556626|NCT01829360|470007989|FG000|Overall Study|Protocol Violation|0|||
130556627|NCT01829360|470007990|FG001|Overall Study|Protocol Violation|0|||
130556628|NCT01829360|470007991|FG002|Overall Study|Protocol Violation|1|||
130556629|NCT01829360|470007992|FG003|Overall Study|Protocol Violation|0|||
130556630|NCT03838198|470007997|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130556631|NCT03838198|470007998|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130556632|NCT03838198|470007999|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
130556633|NCT03838198|470008000|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130556634|NCT03838198|470007997|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
130556635|NCT03838198|470007998|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
130556636|NCT03838198|470007999|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
130556637|NCT03838198|470008000|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
130556638|NCT02378220|470008001|FG000|Overall Study|Death|6|||
130556639|NCT02378220|470008002|FG001|Overall Study|Death|1|||
130556640|NCT00578786|470008003|FG000|Overall Study|Adverse Event|27|||
130556641|NCT00578786|470008004|FG001|Overall Study|Adverse Event|37|||
130556642|NCT00578786|470008005|FG002|Overall Study|Adverse Event|17|||
130556643|NCT00578786|470008003|FG000|Overall Study|Lack of Efficacy|2|||
130556644|NCT00578786|470008004|FG001|Overall Study|Lack of Efficacy|5|||
130556645|NCT00578786|470008005|FG002|Overall Study|Lack of Efficacy|2|||
130556646|NCT00578786|470008003|FG000|Overall Study|Early Escape from Prior Study|2|||
130714571|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
130714572|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
130714573|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
130291993|NCT00931801|469032403|FG000|Overall Study|Adverse Event|0|||
130291994|NCT00931801|469032404|FG001|Overall Study|Adverse Event|0|||
130291995|NCT00931801|469032405|FG002|Overall Study|Adverse Event|1|||
130291996|NCT00931801|469032403|FG000|Overall Study|Lost to Follow-up|0|||
130291997|NCT00931801|469032404|FG001|Overall Study|Lost to Follow-up|1|||
130291998|NCT00931801|469032405|FG002|Overall Study|Lost to Follow-up|0|||
130291999|NCT00931801|469032403|FG000|Overall Study|Withdrawal by Subject|1|||
130292000|NCT00931801|469032404|FG001|Overall Study|Withdrawal by Subject|0|||
130292001|NCT00931801|469032405|FG002|Overall Study|Withdrawal by Subject|0|||
130292002|NCT00931801|469032403|FG000|Overall Study|Confirmed Virologic Failure|0|||
130292003|NCT00931801|469032404|FG001|Overall Study|Confirmed Virologic Failure|0|||
130292004|NCT00931801|469032405|FG002|Overall Study|Confirmed Virologic Failure|3|||
130292005|NCT00933244|469032406|FG000|Overall Study|Withdrawal by Subject|5|||
130292006|NCT00933244|469032407|FG001|Overall Study|Withdrawal by Subject|1|||
130292007|NCT00933244|469032408|FG002|Overall Study|Withdrawal by Subject|3|||
130292008|NCT02266875|469032409|FG000|Overall Study|Withdrawal by Subject|9|||
130292009|NCT02266875|469032410|FG001|Overall Study|Withdrawal by Subject|0|||
130292010|NCT02266875|469032409|FG000|Overall Study|Lost to Follow-up|2|||
130292011|NCT02266875|469032410|FG001|Overall Study|Lost to Follow-up|0|||
130292012|NCT00875056|469032412|FG000|Overall Study|Adverse Event|6|||
130292013|NCT00875056|469032413|FG001|Overall Study|Adverse Event|1|||
130292014|NCT00875056|469032414|FG002|Overall Study|Adverse Event|2|||
130292015|NCT00875056|469032412|FG000|Overall Study|Progressive Disease|14|||
130292016|NCT00875056|469032413|FG001|Overall Study|Progressive Disease|8|||
130292017|NCT00875056|469032414|FG002|Overall Study|Progressive Disease|3|||
130292018|NCT00875056|469032412|FG000|Overall Study|Withdrawal by Subject|3|||
130292019|NCT00875056|469032413|FG001|Overall Study|Withdrawal by Subject|0|||
130292020|NCT00875056|469032414|FG002|Overall Study|Withdrawal by Subject|1|||
130292021|NCT01920152|469032421|FG000|Overall Study|Withdrawal by Subject|1|||
130292022|NCT01920152|469032422|FG001|Overall Study|Withdrawal by Subject|2|||
130292023|NCT04375397|469032423|FG000|Overall Study|Death|1|||
130292024|NCT04375397|469032424|FG001|Overall Study|Death|1|||
130292025|NCT04375397|469032423|FG000|Overall Study|Withdrew consent|2|||
130292026|NCT04375397|469032424|FG001|Overall Study|Withdrew consent|0|||
130292027|NCT04375397|469032423|FG000|Overall Study|Lost to Follow-up|6|||
130292028|NCT04375397|469032424|FG001|Overall Study|Lost to Follow-up|4|||
130292029|NCT04375397|469032423|FG000|Overall Study|Other, not specified|0|||
130292030|NCT04375397|469032424|FG001|Overall Study|Other, not specified|1|||
130292031|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292032|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292033|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
130292034|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292035|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130292036|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130292037|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
130714574|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Various|0|||
130714575|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Various|9|||
130714576|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Adverse Event|23|||
130714577|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Adverse Event|0|||
130714578|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Death|2|||
130714579|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Death|0|||
130714580|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
130714581|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
130714582|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
130714583|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
130714584|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Various|3|||
130714585|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Various|0|||
130714586|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
130714587|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
130714588|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
130714589|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
130714590|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130714591|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130714592|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
130714593|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
130714594|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130714595|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130714596|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
130714597|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
130714598|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
130714599|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
130714600|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Various|4|||
130714601|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Various|0|||
130714602|NCT01959035|470581713|FG000|Overall Study|Adverse Event|5|||
130714603|NCT01959035|470581713|FG000|Overall Study|Withdrawal by Subject|4|||
130714604|NCT01959035|470581713|FG000|Overall Study|Lost to Follow-up|1|||
130714605|NCT01959035|470581713|FG000|Overall Study|Other (no primary reason given)|1|||
130714606|NCT02034058|470581714|FG000|Overall Study|Death|3|||
130714607|NCT03254602|470581715|FG000|Overall Study|Lost to Follow-up|4|||
130714608|NCT02963311|470581720|FG000|Overall Study|Withdrawal by Subject|1|||
130714609|NCT02963311|470581720|FG000|Overall Study|Screen Failure|4|||
130714610|NCT02836496|470581723|FG000|Overall Study|Adverse Event|2|||
130714611|NCT02836496|470581724|FG001|Overall Study|Adverse Event|1|||
130714612|NCT02836496|470581723|FG000|Overall Study|Withdrawal by Subject|0|||
130714613|NCT02836496|470581724|FG001|Overall Study|Withdrawal by Subject|1|||
130714614|NCT03822832|470581725|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
130714615|NCT03822832|470581726|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
130714616|NCT03822832|470581725|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
130714617|NCT03822832|470581726|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
130714618|NCT03822832|470581725|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
130714619|NCT03822832|470581726|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
130292038|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130292039|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292040|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292041|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292042|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
130292043|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292044|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
130292045|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292046|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292047|NCT00610441|469032428|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292048|NCT00610441|469032429|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292049|NCT00610441|469032430|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
130292050|NCT00610441|469032431|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292051|NCT00610441|469032428|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292052|NCT00610441|469032429|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
130292053|NCT00610441|469032430|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292054|NCT00610441|469032431|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292055|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
130556647|NCT00578786|470008004|FG001|Overall Study|Early Escape from Prior Study|1|||
130714620|NCT03822832|470581725|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
130714621|NCT03822832|470581726|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
130714622|NCT03822832|470581725|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
130714623|NCT03822832|470581726|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
130714624|NCT03822832|470581725|FG000|Re-allocation|Not re-allocated to open label period|2|||
130292056|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
130292057|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
130292058|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
130292059|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292060|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292061|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292062|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
130292063|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
130292064|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292065|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292066|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292067|NCT01995552|469032432|FG000|Overall Study|Protocol Violation|1|||
130292068|NCT01995552|469032432|FG000|Overall Study|Lack of Efficacy|15|||
130292069|NCT01995552|469032432|FG000|Overall Study|Death|1|||
130460155|NCT02705586|469649766|FG000|Overall Study|Health Issues|2|||
130460156|NCT02705586|469649766|FG000|Overall Study|Transportation Difficulties|5|||
130460157|NCT02705586|469649766|FG000|Overall Study|Vacation/Planned Absence|1|||
130460158|NCT02045836|469649770|FG000|Overall Study|Adverse Event|4|||
130460159|NCT02045836|469649771|FG001|Overall Study|Adverse Event|4|||
130460160|NCT02045836|469649770|FG000|Overall Study|Withdrawal by Subject|1|||
130460161|NCT02045836|469649771|FG001|Overall Study|Withdrawal by Subject|1|||
130460162|NCT02045836|469649770|FG000|Overall Study|Lost to Follow-up|4|||
130460163|NCT02045836|469649771|FG001|Overall Study|Lost to Follow-up|7|||
130460164|NCT02045836|469649770|FG000|Overall Study|Migrated from study area|0|||
130460165|NCT02045836|469649771|FG001|Overall Study|Migrated from study area|2|||
130460166|NCT03920215|469649774|FG000|Overall Study|Lost to Follow-up|1|||
130460167|NCT03920215|469649775|FG001|Overall Study|Lost to Follow-up|2|||
130460168|NCT03920215|469649776|FG002|Overall Study|Lost to Follow-up|0|||
130460169|NCT03920215|469649777|FG003|Overall Study|Lost to Follow-up|0|||
130292070|NCT01011933|469032434|FG000|Overall Study|Wrong cell type|1|||
130292071|NCT01011933|469032434|FG000|Overall Study|Improper pre-protocol Rx|1|||
130292072|NCT01011933|469032434|FG000|Overall Study|Inadequate pathology|1|||
130292073|NCT01011933|469032434|FG000|Overall Study|Never treated|1|||
130292074|NCT01439074|469032435|FG000|Overall Study|Lost to Follow-up|3|||
130292075|NCT01439074|469032436|FG001|Overall Study|Lost to Follow-up|4|||
130292076|NCT01439074|469032435|FG000|Overall Study|Subject shedding|1|||
130292077|NCT01439074|469032436|FG001|Overall Study|Subject shedding|0|||
130292078|NCT01439074|469032435|FG000|Overall Study|Withdrawal by Subject|1|||
130292079|NCT01439074|469032436|FG001|Overall Study|Withdrawal by Subject|5|||
130292080|NCT01439074|469032435|FG000|Overall Study|Other|4|||
130292081|NCT01439074|469032436|FG001|Overall Study|Other|4|||
130292082|NCT02639338|469032437|FG000|Overall Study|Lost to Follow-up|2|||
130292083|NCT02639338|469032438|FG001|Overall Study|Lost to Follow-up|2|||
130292084|NCT02639338|469032437|FG000|Overall Study|Withdrew Consent|1|||
130292085|NCT02639338|469032438|FG001|Overall Study|Withdrew Consent|2|||
130292086|NCT02639338|469032437|FG000|Overall Study|Death|1|||
130292087|NCT02639338|469032438|FG001|Overall Study|Death|0|||
130292088|NCT02639338|469032437|FG000|Overall Study|Randomized but Not Treated|0|||
130292089|NCT02639338|469032438|FG001|Overall Study|Randomized but Not Treated|1|||
130292090|NCT00787202|469032439|FG000|Overall Study|Adverse Event|3|||
130292091|NCT00787202|469032440|FG001|Overall Study|Adverse Event|2|||
130292092|NCT00787202|469032441|FG002|Overall Study|Adverse Event|0|||
130292093|NCT00787202|469032442|FG003|Overall Study|Adverse Event|0|||
130292094|NCT00787202|469032443|FG004|Overall Study|Adverse Event|2|||
130292095|NCT00787202|469032439|FG000|Overall Study|Lack of Efficacy|5|||
130292096|NCT00787202|469032440|FG001|Overall Study|Lack of Efficacy|6|||
130292097|NCT00787202|469032441|FG002|Overall Study|Lack of Efficacy|5|||
130292098|NCT00787202|469032442|FG003|Overall Study|Lack of Efficacy|2|||
130292099|NCT00787202|469032443|FG004|Overall Study|Lack of Efficacy|1|||
130292100|NCT00787202|469032439|FG000|Overall Study|Lost to Follow-up|1|||
130292101|NCT00787202|469032440|FG001|Overall Study|Lost to Follow-up|0|||
130292102|NCT00787202|469032441|FG002|Overall Study|Lost to Follow-up|0|||
130460170|NCT03920215|469649774|FG000|Overall Study|Death|0|||
130460171|NCT03920215|469649775|FG001|Overall Study|Death|0|||
130460172|NCT03920215|469649776|FG002|Overall Study|Death|0|||
130460173|NCT03920215|469649777|FG003|Overall Study|Death|1|||
130292103|NCT00787202|469032442|FG003|Overall Study|Lost to Follow-up|0|||
130292104|NCT00787202|469032443|FG004|Overall Study|Lost to Follow-up|0|||
130292105|NCT00787202|469032439|FG000|Overall Study|Withdrawal by Subject|2|||
130292106|NCT00787202|469032440|FG001|Overall Study|Withdrawal by Subject|2|||
130292107|NCT00787202|469032441|FG002|Overall Study|Withdrawal by Subject|2|||
130292108|NCT00787202|469032442|FG003|Overall Study|Withdrawal by Subject|0|||
130292109|NCT00787202|469032443|FG004|Overall Study|Withdrawal by Subject|0|||
130460174|NCT02000817|469649778|FG000|Overall Study|Withdrawal by Subject|2|||
130460175|NCT02000817|469649779|FG001|Overall Study|Withdrawal by Subject|0|||
130460176|NCT02000817|469649780|FG002|Overall Study|Withdrawal by Subject|0|||
130460177|NCT02000817|469649781|FG003|Overall Study|Withdrawal by Subject|0|||
130460178|NCT02000817|469649778|FG000|Overall Study|Adverse Event|0|||
130292110|NCT00787202|469032439|FG000|Overall Study|Protocol Violation|2|||
130292111|NCT00787202|469032440|FG001|Overall Study|Protocol Violation|1|||
130292112|NCT00787202|469032441|FG002|Overall Study|Protocol Violation|0|||
130292113|NCT00787202|469032442|FG003|Overall Study|Protocol Violation|0|||
130292114|NCT00787202|469032443|FG004|Overall Study|Protocol Violation|1|||
130292115|NCT00787202|469032439|FG000|Overall Study|Randomized, not treated|1|||
130292116|NCT00787202|469032440|FG001|Overall Study|Randomized, not treated|0|||
130292117|NCT00787202|469032441|FG002|Overall Study|Randomized, not treated|0|||
130292118|NCT00787202|469032442|FG003|Overall Study|Randomized, not treated|0|||
130292119|NCT00787202|469032443|FG004|Overall Study|Randomized, not treated|0|||
130292120|NCT02525094|469032450|FG000|Overall Study|Lost to Follow-up|2|||
130292121|NCT02525094|469032451|FG001|Overall Study|Lost to Follow-up|1|||
130292122|NCT02525094|469032450|FG000|Overall Study|Withdrawal by Subject|5|||
130292123|NCT02525094|469032451|FG001|Overall Study|Withdrawal by Subject|6|||
130292124|NCT02525094|469032450|FG000|Overall Study|Not Treated|1|||
130292125|NCT02525094|469032451|FG001|Overall Study|Not Treated|1|||
130292126|NCT01751776|469032456|FG000|Overall Study|Adverse Event|0|||
130292127|NCT01751776|469032457|FG001|Overall Study|Adverse Event|0|||
130292128|NCT01751776|469032458|FG002|Overall Study|Adverse Event|0|||
130292129|NCT01751776|469032459|FG003|Overall Study|Adverse Event|0|||
130292130|NCT01751776|469032460|FG004|Overall Study|Adverse Event|0|||
130292131|NCT01751776|469032461|FG005|Overall Study|Adverse Event|0|||
130292132|NCT01751776|469032462|FG006|Overall Study|Adverse Event|4|||
130292133|NCT01751776|469032463|FG007|Overall Study|Adverse Event|2|||
130292134|NCT01751776|469032456|FG000|Overall Study|Consent withdrawn|0|||
130292135|NCT01751776|469032457|FG001|Overall Study|Consent withdrawn|0|||
130460179|NCT02000817|469649779|FG001|Overall Study|Adverse Event|1|||
130460180|NCT02000817|469649780|FG002|Overall Study|Adverse Event|0|||
130460181|NCT02000817|469649781|FG003|Overall Study|Adverse Event|0|||
130460182|NCT02000817|469649778|FG000|Overall Study|Lost to Follow-up|0|||
130460183|NCT02000817|469649779|FG001|Overall Study|Lost to Follow-up|0|||
130460184|NCT02000817|469649780|FG002|Overall Study|Lost to Follow-up|1|||
130460185|NCT02000817|469649781|FG003|Overall Study|Lost to Follow-up|0|||
130460186|NCT02798835|469649784|FG000|Overall Study|Protocol Violation|0|||
130460187|NCT02798835|469649785|FG001|Overall Study|Protocol Violation|0|||
130460188|NCT02798835|469649786|FG002|Overall Study|Protocol Violation|3|||
130460189|NCT00177216|469649787|FG000|Overall Study|Withdrawal by Subject|6|||
130460190|NCT00177216|469649788|FG001|Overall Study|Withdrawal by Subject|3|||
130460191|NCT00177216|469649789|FG002|Overall Study|Withdrawal by Subject|1|||
130460192|NCT02459899|469649794|FG000|Overall Study|Adverse Event|1|||
130460193|NCT02459899|469649795|FG001|Overall Study|Adverse Event|1|||
130460194|NCT02459899|469649796|FG002|Overall Study|Adverse Event|0|||
130556648|NCT00578786|470008005|FG002|Overall Study|Early Escape from Prior Study|2|||
130292136|NCT01751776|469032458|FG002|Overall Study|Consent withdrawn|0|||
130292137|NCT01751776|469032459|FG003|Overall Study|Consent withdrawn|0|||
130371596|NCT00851747|469330949|FG001|Overall Study|Physician Decision|6|||
130292138|NCT01751776|469032460|FG004|Overall Study|Consent withdrawn|0|||
130292139|NCT01751776|469032461|FG005|Overall Study|Consent withdrawn|0|||
130292140|NCT01751776|469032462|FG006|Overall Study|Consent withdrawn|0|||
130371597|NCT00851747|469330950|FG002|Overall Study|Physician Decision|6|||
130371598|NCT01930123|469330952|FG000|Overall Study|Adverse Event|1|||
130371599|NCT01930123|469330953|FG001|Overall Study|Adverse Event|0|||
130371600|NCT01930123|469330952|FG000|Overall Study|Physician Decision|21|||
130371601|NCT01930123|469330953|FG001|Overall Study|Physician Decision|8|||
130371602|NCT01930123|469330952|FG000|Overall Study|Withdrawal by Subject|1|||
130371603|NCT01930123|469330953|FG001|Overall Study|Withdrawal by Subject|0|||
130371604|NCT01447433|469330956|FG000|Overall Study|Lost to Follow-up|0|||
130371605|NCT01447433|469330957|FG001|Overall Study|Lost to Follow-up|2|||
130371606|NCT01447433|469330956|FG000|Overall Study|Withdrawal by Subject|3|||
130371607|NCT01447433|469330957|FG001|Overall Study|Withdrawal by Subject|3|||
130371608|NCT01447433|469330956|FG000|Overall Study|Protocol Violation|1|||
130371609|NCT01447433|469330957|FG001|Overall Study|Protocol Violation|1|||
130460195|NCT02459899|469649797|FG003|Overall Study|Adverse Event|0|||
130460196|NCT02459899|469649794|FG000|Overall Study|Lost to Follow-up|1|||
130460197|NCT02459899|469649795|FG001|Overall Study|Lost to Follow-up|2|||
130460198|NCT02459899|469649796|FG002|Overall Study|Lost to Follow-up|0|||
130460199|NCT02459899|469649797|FG003|Overall Study|Lost to Follow-up|1|||
130460200|NCT02459899|469649794|FG000|Overall Study|Non-compliance with the treatment|0|||
130460201|NCT02459899|469649795|FG001|Overall Study|Non-compliance with the treatment|0|||
130460202|NCT02459899|469649796|FG002|Overall Study|Non-compliance with the treatment|0|||
130460203|NCT02459899|469649797|FG003|Overall Study|Non-compliance with the treatment|1|||
130292141|NCT01751776|469032463|FG007|Overall Study|Consent withdrawn|1|||
130292142|NCT01751776|469032456|FG000|Overall Study|Other reason not specified above|0|||
130292143|NCT01751776|469032457|FG001|Overall Study|Other reason not specified above|0|||
130292144|NCT01751776|469032458|FG002|Overall Study|Other reason not specified above|0|||
130292145|NCT01751776|469032459|FG003|Overall Study|Other reason not specified above|0|||
130292146|NCT01751776|469032460|FG004|Overall Study|Other reason not specified above|0|||
130460204|NCT02459899|469649794|FG000|Overall Study|Withdrawal by Subject|1|||
130371610|NCT00036270|469330958|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
130371611|NCT00036270|469330959|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
130371612|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
130292147|NCT01751776|469032461|FG005|Overall Study|Other reason not specified above|0|||
130292148|NCT01751776|469032462|FG006|Overall Study|Other reason not specified above|0|||
130292149|NCT01751776|469032463|FG007|Overall Study|Other reason not specified above|1|||
130292150|NCT00831701|469032468|FG000|Overall Study|Withdrawal by Subject|2|||
130292151|NCT00831701|469032469|FG001|Overall Study|Withdrawal by Subject|0|||
130292152|NCT00831701|469032468|FG000|Overall Study|Stone expulsion before first medication|2|||
130371613|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
130371614|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
130371615|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
130371616|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
130371617|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
130371618|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Other|277|||
130371619|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Other|288|||
130371620|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
130371621|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
130371622|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
130371623|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
130371624|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
130371625|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
130371626|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
130371627|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
130371628|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
130371629|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
130371630|NCT00036270|469330958|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
130371631|NCT00036270|469330959|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
130371632|NCT01964430|469330960|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
130371633|NCT01964430|469330961|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
130371634|NCT01964430|469330960|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
130371635|NCT01964430|469330961|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
130371636|NCT01964430|469330960|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
130371637|NCT01964430|469330961|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
130371638|NCT01964430|469330960|FG000|Treatment Period|Adverse Event|71|||
130292153|NCT00831701|469032469|FG001|Overall Study|Stone expulsion before first medication|2|||
130460205|NCT02459899|469649795|FG001|Overall Study|Withdrawal by Subject|3|||
130460206|NCT02459899|469649796|FG002|Overall Study|Withdrawal by Subject|0|||
130460207|NCT02459899|469649797|FG003|Overall Study|Withdrawal by Subject|0|||
130460208|NCT02739035|469649800|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
130460209|NCT02739035|469649801|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
130556649|NCT00578786|470008003|FG000|Overall Study|Withdrawal by Subject|7|||
130292154|NCT00831701|469032468|FG000|Overall Study|Lost to Follow-up|1|||
130292155|NCT00831701|469032469|FG001|Overall Study|Lost to Follow-up|3|||
130292156|NCT02210091|469032470|FG000|Overall Study|Physician Decision|0|||
130292157|NCT02210091|469032471|FG001|Overall Study|Physician Decision|1|||
130292158|NCT02210091|469032470|FG000|Overall Study|Withdrawal by Sponsor|0|||
130292159|NCT02210091|469032471|FG001|Overall Study|Withdrawal by Sponsor|1|||
130292160|NCT02290938|469032472|FG000|Overall Study|Lost to Follow-up|14|||
130292161|NCT02290938|469032473|FG001|Overall Study|Lost to Follow-up|43|||
130292162|NCT03159104|469032474|FG000|Overall Study|Violation of inclusion criteria|1|||
130292163|NCT03159104|469032475|FG001|Overall Study|Violation of inclusion criteria|2|||
130292164|NCT00456599|469032476|FG000|Overall Study|Non-compliance|1|||
130292165|NCT00456599|469032476|FG000|Overall Study|Withdrawal by Subject|2|||
130292166|NCT00151372|469033947|FG000|Overall Study|Death|12|||
130292167|NCT00151372|469033948|FG001|Overall Study|Death|11|||
130292168|NCT00151372|469033947|FG000|Overall Study|Lost to Follow-up|5|||
130292169|NCT00151372|469033948|FG001|Overall Study|Lost to Follow-up|5|||
130292170|NCT00151372|469033947|FG000|Overall Study|Too sick medically to continue|5|||
130292171|NCT00151372|469033948|FG001|Overall Study|Too sick medically to continue|6|||
130292172|NCT00151372|469033947|FG000|Overall Study|Withdrawal by Subject|7|||
130292173|NCT00151372|469033948|FG001|Overall Study|Withdrawal by Subject|7|||
130371639|NCT01964430|469330961|FG001|Treatment Period|Adverse Event|37|||
130371640|NCT01964430|469330960|FG000|Treatment Period|Withdrawal by Subject|36|||
130460210|NCT02739035|469649800|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
130460211|NCT02739035|469649801|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
130460212|NCT02739035|469649800|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
130292174|NCT04732949|469033949|FG000|Overall Study|Withdrawal by Subject|23|||
130292175|NCT04732949|469033950|FG001|Overall Study|Withdrawal by Subject|27|||
130292176|NCT04732949|469033949|FG000|Overall Study|Protocol Violation|0|||
130292177|NCT04732949|469033950|FG001|Overall Study|Protocol Violation|1|||
130292178|NCT04732949|469033949|FG000|Overall Study|Non-compliance|0|||
130292179|NCT04732949|469033950|FG001|Overall Study|Non-compliance|2|||
130292180|NCT04732949|469033949|FG000|Overall Study|Physician Decision|2|||
130292181|NCT04732949|469033950|FG001|Overall Study|Physician Decision|1|||
130292182|NCT04732949|469033949|FG000|Overall Study|Serious adverse event (Fatal)|16|||
130292183|NCT04732949|469033950|FG001|Overall Study|Serious adverse event (Fatal)|18|||
130292184|NCT04732949|469033949|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
130292185|NCT04732949|469033950|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
130292186|NCT04732949|469033949|FG000|Overall Study|Non-serious adverse event|1|||
130292187|NCT04732949|469033950|FG001|Overall Study|Non-serious adverse event|3|||
130292188|NCT04732949|469033949|FG000|Overall Study|Lost to Follow-up|26|||
130292189|NCT04732949|469033950|FG001|Overall Study|Lost to Follow-up|27|||
130371641|NCT01964430|469330961|FG001|Treatment Period|Withdrawal by Subject|27|||
130371642|NCT01964430|469330960|FG000|Treatment Period|Death|1|||
130371643|NCT01964430|469330961|FG001|Treatment Period|Death|3|||
130371644|NCT01964430|469330960|FG000|Treatment Period|Protocol Deviation|0|||
130371645|NCT01964430|469330961|FG001|Treatment Period|Protocol Deviation|1|||
130371646|NCT01964430|469330960|FG000|Treatment Period|Physician Decision|5|||
130371647|NCT01964430|469330961|FG001|Treatment Period|Physician Decision|4|||
130371648|NCT01964430|469330960|FG000|Treatment Period|Disease Relapse|28|||
130371649|NCT01964430|469330961|FG001|Treatment Period|Disease Relapse|38|||
130371650|NCT01964430|469330960|FG000|Treatment Period|Other reasons|1|||
130371651|NCT01964430|469330961|FG001|Treatment Period|Other reasons|3|||
130371652|NCT02516163|469330962|FG000|Overall Study|Withdrawal by Subject|1|||
130371653|NCT02516163|469330962|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
130371654|NCT02516163|469330962|FG000|Overall Study|Unfit/delay in surgery|3|||
130371655|NCT02516163|469330962|FG000|Overall Study|Use of incorrect measurement technique|5|||
130371656|NCT02516163|469330962|FG000|Overall Study|Data not recorded|2|||
130371657|NCT02516163|469330962|FG000|Overall Study|MRI contraindication exclusion|6|||
130371658|NCT02801396|469330963|FG000|Period 1|Withdrawal by Subject|0|||
130371659|NCT02801396|469330964|FG001|Period 1|Withdrawal by Subject|0|||
130371660|NCT02801396|469330965|FG002|Period 1|Withdrawal by Subject|0|||
130371661|NCT02801396|469330966|FG003|Period 1|Withdrawal by Subject|0|||
130371662|NCT02801396|469330967|FG004|Period 1|Withdrawal by Subject|1|||
130371663|NCT02801396|469330968|FG005|Period 1|Withdrawal by Subject|0|||
130371664|NCT01658072|469330971|FG000|Overall Study|Protocol Violation|4|||
130371665|NCT01658072|469330972|FG001|Overall Study|Protocol Violation|2|||
130371666|NCT01874054|469330974|FG000|Overall Study|Withdrawal by Subject|3|||
130371667|NCT01874054|469330974|FG000|Overall Study|Study Termination by Sponsor|42|||
130371668|NCT01874054|469330974|FG000|Overall Study|Lost to Follow-up|5|||
130371669|NCT01874054|469330974|FG000|Overall Study|Death|5|||
130371670|NCT00702923|469330975|FG000|Overall Study|Adverse Event|1|||
130371671|NCT01844518|469330977|FG000|Overall Study|Adverse Event|7|||
130371672|NCT01844518|469330978|FG001|Overall Study|Adverse Event|1|||
130371673|NCT01844518|469330977|FG000|Overall Study|Lack of Efficacy|17|||
130371674|NCT01844518|469330978|FG001|Overall Study|Lack of Efficacy|5|||
130371675|NCT01844518|469330977|FG000|Overall Study|Participant's request to discontinue|4|||
130371676|NCT01844518|469330978|FG001|Overall Study|Participant's request to discontinue|1|||
130371677|NCT01844518|469330977|FG000|Overall Study|Poor/Non-compliance|1|||
130371678|NCT01844518|469330978|FG001|Overall Study|Poor/Non-compliance|0|||
130371679|NCT01844518|469330977|FG000|Overall Study|No Longer Met Study Criteria|2|||
130371680|NCT01844518|469330978|FG001|Overall Study|No Longer Met Study Criteria|0|||
130371681|NCT01844518|469330977|FG000|Overall Study|Withdrawal by Subject|9|||
130371682|NCT01844518|469330978|FG001|Overall Study|Withdrawal by Subject|0|||
130371683|NCT01844518|469330977|FG000|Overall Study|Pregnancy|1|||
130371684|NCT01844518|469330978|FG001|Overall Study|Pregnancy|0|||
130371685|NCT00291577|469330980|FG000|Overall Study|Adverse Event|1|||
130371686|NCT00291577|469330980|FG000|Overall Study|Other|4|||
130371687|NCT00291577|469330980|FG000|Overall Study|Withdrawal by Subject|2|||
130371688|NCT00291577|469330980|FG000|Overall Study|Lack of Efficacy|14|||
130371689|NCT04584645|469330981|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
130371690|NCT04584645|469330982|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
130371691|NCT00390468|469330983|FG000|Overall Study|Protocol Violation|2|||
130371692|NCT00390468|469330983|FG000|Overall Study|Lack of Efficacy|1|||
130371693|NCT01587001|469330989|FG000|Overall Study|Lost to Follow-up|2|||
130371694|NCT01587001|469330990|FG001|Overall Study|Lost to Follow-up|0|||
130371695|NCT01587001|469330989|FG000|Overall Study|Insufficient samples to complete testing|4|||
130371696|NCT01587001|469330990|FG001|Overall Study|Insufficient samples to complete testing|1|||
130371697|NCT02756013|469330993|FG000|Overall Study|Adverse Event|1|||
130371698|NCT02756013|469330993|FG000|Overall Study|Hypersensitivity|1|||
130371699|NCT03706456|469330994|FG000|Overall Study|Adverse Event|1|||
130371700|NCT03706456|469330994|FG000|Overall Study|Lack of Efficacy|2|||
130371701|NCT02784431|469330995|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
130371702|NCT02784431|469330995|FG000|Overall Study|Early Study Termination|19|||
130292190|NCT04732949|469033949|FG000|Overall Study|Other|6|||
130292191|NCT04732949|469033950|FG001|Overall Study|Other|3|||
130292192|NCT03747120|469033951|FG000|Overall Study|treatment related toxicity|3|||
130292193|NCT03747120|469033952|FG001|Overall Study|treatment related toxicity|0|||
130292194|NCT03747120|469033953|FG002|Overall Study|treatment related toxicity|0|||
130292195|NCT03747120|469033951|FG000|Overall Study|Withdrawal by Subject|0|||
130292196|NCT03747120|469033952|FG001|Overall Study|Withdrawal by Subject|1|||
130292197|NCT03747120|469033953|FG002|Overall Study|Withdrawal by Subject|2|||
130292198|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Death|1|||
130292199|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Death|0|||
130292200|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Death|0|||
130292201|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Death|0|||
130292202|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
130292203|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
130292204|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130292205|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130292206|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
130292207|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
130292208|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130292209|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130292210|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
130292211|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
130292212|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130292213|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130292214|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Other|8|||
130292215|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Other|5|||
130292216|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Other|0|||
130292217|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Other|0|||
130292218|NCT04271475|469033959|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130292219|NCT04271475|469033960|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130292220|NCT04271475|469033961|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
130292221|NCT04271475|469033962|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
130292222|NCT04271475|469033959|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292223|NCT04271475|469033960|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292224|NCT04271475|469033961|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292225|NCT04271475|469033962|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
130292226|NCT00159913|469033964|FG000|Overall Study|Adverse Event|1|||
130292227|NCT00159913|469033965|FG001|Overall Study|Adverse Event|0|||
130292228|NCT00159913|469033966|FG002|Overall Study|Adverse Event|1|||
130292229|NCT00159913|469033967|FG003|Overall Study|Adverse Event|0|||
130292230|NCT00159913|469033964|FG000|Overall Study|Withdrawal by Subject|0|||
130292231|NCT00159913|469033965|FG001|Overall Study|Withdrawal by Subject|0|||
130292232|NCT00159913|469033966|FG002|Overall Study|Withdrawal by Subject|0|||
130292233|NCT00159913|469033967|FG003|Overall Study|Withdrawal by Subject|1|||
130292234|NCT00159913|469033964|FG000|Overall Study|Lost to Follow-up|0|||
130292235|NCT00159913|469033965|FG001|Overall Study|Lost to Follow-up|0|||
130292236|NCT00159913|469033966|FG002|Overall Study|Lost to Follow-up|0|||
130292237|NCT00159913|469033967|FG003|Overall Study|Lost to Follow-up|1|||
130292238|NCT00159913|469033964|FG000|Overall Study|Protocol Violation|1|||
130292239|NCT00159913|469033965|FG001|Overall Study|Protocol Violation|0|||
130292240|NCT00159913|469033966|FG002|Overall Study|Protocol Violation|1|||
130292241|NCT00159913|469033967|FG003|Overall Study|Protocol Violation|0|||
130292242|NCT01318070|469033972|FG000|Overall Study|Adverse Event|1|||
130292243|NCT01318070|469033973|FG001|Overall Study|Adverse Event|1|||
130292244|NCT01318070|469033974|FG002|Overall Study|Adverse Event|5|||
130292245|NCT01318070|469033972|FG000|Overall Study|Withdrawal by Subject|0|||
130292246|NCT01318070|469033973|FG001|Overall Study|Withdrawal by Subject|1|||
130292247|NCT01318070|469033974|FG002|Overall Study|Withdrawal by Subject|1|||
130292248|NCT01318070|469033972|FG000|Overall Study|Lack of Efficacy|0|||
130292249|NCT01318070|469033973|FG001|Overall Study|Lack of Efficacy|0|||
130292250|NCT01318070|469033974|FG002|Overall Study|Lack of Efficacy|1|||
130292251|NCT01318070|469033972|FG000|Overall Study|Principal Investigator Discretion|1|||
130292252|NCT01318070|469033973|FG001|Overall Study|Principal Investigator Discretion|0|||
130292253|NCT01318070|469033974|FG002|Overall Study|Principal Investigator Discretion|0|||
130292254|NCT02956850|469033975|FG000|Overall Study|Withdrawal by Subject|0|||
130292255|NCT02956850|469033976|FG001|Overall Study|Withdrawal by Subject|0|||
130292256|NCT02956850|469033977|FG002|Overall Study|Withdrawal by Subject|0|||
130292257|NCT02956850|469033978|FG003|Overall Study|Withdrawal by Subject|0|||
130292258|NCT02956850|469033979|FG004|Overall Study|Withdrawal by Subject|0|||
130292259|NCT02956850|469033980|FG005|Overall Study|Withdrawal by Subject|0|||
130292260|NCT02956850|469033981|FG006|Overall Study|Withdrawal by Subject|0|||
130292261|NCT02956850|469033982|FG007|Overall Study|Withdrawal by Subject|0|||
130292262|NCT02956850|469033983|FG008|Overall Study|Withdrawal by Subject|0|||
130292263|NCT02956850|469033984|FG009|Overall Study|Withdrawal by Subject|0|||
130292264|NCT02956850|469033985|FG010|Overall Study|Withdrawal by Subject|0|||
130714625|NCT03822832|470581726|FG001|Re-allocation|Not re-allocated to open label period|6|||
130714626|NCT03822832|470581725|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
130714627|NCT03822832|470581726|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
130714628|NCT03822832|470581725|FG000|Period 2 - Open Label Period|Adverse Event|0|||
130714629|NCT03822832|470581726|FG001|Period 2 - Open Label Period|Adverse Event|3|||
130714630|NCT01246011|470581728|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
130714631|NCT01246011|470581729|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
130714632|NCT01246011|470581730|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
130714633|NCT01246011|470581728|FG000|Overall Study|Withdrawal by Subject|0|||
130714634|NCT01246011|470581729|FG001|Overall Study|Withdrawal by Subject|0|||
130714635|NCT01246011|470581730|FG002|Overall Study|Withdrawal by Subject|1|||
130714636|NCT04492020|470581731|FG000|Overall Study|Adverse Event|1|||
130714637|NCT04492020|470581732|FG001|Overall Study|Adverse Event|3|||
130714638|NCT04492020|470581731|FG000|Overall Study|Withdrawal by Subject|4|||
130714639|NCT04492020|470581732|FG001|Overall Study|Withdrawal by Subject|3|||
130714640|NCT04492020|470581731|FG000|Overall Study|Lost to Follow-up|4|||
130714641|NCT04492020|470581732|FG001|Overall Study|Lost to Follow-up|3|||
130714642|NCT04492020|470581731|FG000|Overall Study|Protocol Violation|5|||
130714643|NCT04492020|470581732|FG001|Overall Study|Protocol Violation|2|||
130714644|NCT04492020|470581731|FG000|Overall Study|Lack of Qualifying Event|25|||
130714645|NCT04492020|470581732|FG001|Overall Study|Lack of Qualifying Event|27|||
130714646|NCT04492020|470581731|FG000|Overall Study|Non-compliance with Study Drug|2|||
130714647|NCT04492020|470581732|FG001|Overall Study|Non-compliance with Study Drug|1|||
130714648|NCT02792959|470581737|FG000|Overall Study|Protocol Violation|1|||
130714649|NCT03914950|470581741|FG000|Overall Study|Physician Decision|54|||
130714650|NCT02575911|470581742|FG000|Overall Study|Lost to Follow-up|1|||
130714651|NCT01249365|470581743|FG000|Overall Study|Lost to Follow-up|1|||
130714652|NCT01460901|470581744|FG000|Overall Study|Withdrawal by Subject|2|||
130714653|NCT02566993|470581745|FG000|Overall Study|Randomized but not treated|5|||
130714654|NCT02566993|470581746|FG001|Overall Study|Randomized but not treated|16|||
130714655|NCT02566993|470581745|FG000|Overall Study|Progressive disease|213|||
130714656|NCT02566993|470581746|FG001|Overall Study|Progressive disease|152|||
130714657|NCT02566993|470581745|FG000|Overall Study|Withdrawal by Subject|12|||
130714658|NCT02566993|470581746|FG001|Overall Study|Withdrawal by Subject|28|||
130714659|NCT02566993|470581745|FG000|Overall Study|Death|17|||
130714660|NCT02566993|470581746|FG001|Overall Study|Death|23|||
130714661|NCT02566993|470581745|FG000|Overall Study|Physician Decision|10|||
130714662|NCT02566993|470581746|FG001|Overall Study|Physician Decision|17|||
130714663|NCT02566993|470581745|FG000|Overall Study|Study drug-related adverse event|20|||
130714664|NCT02566993|470581746|FG001|Overall Study|Study drug-related adverse event|41|||
130714665|NCT02566993|470581745|FG000|Overall Study|Non study drug-related adverse event|9|||
130292265|NCT02956850|469033986|FG011|Overall Study|Withdrawal by Subject|0|||
130292266|NCT02956850|469033987|FG012|Overall Study|Withdrawal by Subject|0|||
130292267|NCT02956850|469033988|FG013|Overall Study|Withdrawal by Subject|0|||
130292268|NCT02956850|469033989|FG014|Overall Study|Withdrawal by Subject|0|||
130292269|NCT02956850|469033990|FG015|Overall Study|Withdrawal by Subject|0|||
130292270|NCT02956850|469033991|FG016|Overall Study|Withdrawal by Subject|0|||
130292271|NCT02956850|469033992|FG017|Overall Study|Withdrawal by Subject|1|||
130292272|NCT01287195|469033997|FG000|Overall Study|Withdrawal by Subject|2|||
130292273|NCT00870194|469034001|FG000|Overall Study|Adverse Event|10|||
130292274|NCT00870194|469034002|FG001|Overall Study|Adverse Event|5|||
130292275|NCT00870194|469034001|FG000|Overall Study|Lack of Efficacy|0|||
130292276|NCT00870194|469034002|FG001|Overall Study|Lack of Efficacy|1|||
130292277|NCT00870194|469034001|FG000|Overall Study|Lost to Follow-up|2|||
130460213|NCT02739035|469649801|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
130460214|NCT02739035|469649800|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
130460215|NCT02739035|469649801|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
130460216|NCT02770248|469649804|FG000|Overall Study|Adverse Event|0|||
130460217|NCT02770248|469649805|FG001|Overall Study|Adverse Event|1|||
130460218|NCT02770248|469649804|FG000|Overall Study|Randomized in error, prior to treatment|0|||
130714666|NCT02566993|470581746|FG001|Overall Study|Non study drug-related adverse event|9|||
130292278|NCT00870194|469034002|FG001|Overall Study|Lost to Follow-up|0|||
130292279|NCT00870194|469034001|FG000|Overall Study|Physician Decision|3|||
130292280|NCT00870194|469034002|FG001|Overall Study|Physician Decision|1|||
130292281|NCT00870194|469034001|FG000|Overall Study|Protocol Violation|3|||
130292282|NCT00870194|469034002|FG001|Overall Study|Protocol Violation|3|||
130714667|NCT02566993|470581745|FG000|Overall Study|Symptomatic deterioration|9|||
130714668|NCT02566993|470581746|FG001|Overall Study|Symptomatic deterioration|16|||
130714669|NCT02566993|470581745|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
130720902|NCT01341782|470601557|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
130292283|NCT00870194|469034001|FG000|Overall Study|Entry Criteria Not Met|1|||
130460219|NCT02770248|469649805|FG001|Overall Study|Randomized in error, prior to treatment|1|||
130460220|NCT01063517|469649816|FG000|Overall Study|Consent withdrawal|1|||
130460221|NCT01063517|469649817|FG001|Overall Study|Consent withdrawal|0|||
130292284|NCT00870194|469034002|FG001|Overall Study|Entry Criteria Not Met|2|||
130371703|NCT02605824|469330996|FG000|Overall Study|Physician Decision|1|||
130371704|NCT02605824|469330997|FG001|Overall Study|Physician Decision|0|||
130371705|NCT00393029|469330998|FG000|Overall Study|Not treated|0|||
130371706|NCT00393029|469330999|FG001|Overall Study|Not treated|1|||
130371707|NCT04659161|469331000|FG000|Overall Study|Adverse Event|10|||
130371708|NCT04659161|469331001|FG001|Overall Study|Adverse Event|6|||
130371709|NCT04659161|469331000|FG000|Overall Study|Withdrawal by Subject|13|||
130371710|NCT04659161|469331001|FG001|Overall Study|Withdrawal by Subject|12|||
130371711|NCT04659161|469331000|FG000|Overall Study|Other|9|||
130371712|NCT04659161|469331001|FG001|Overall Study|Other|8|||
130371713|NCT03715530|469331002|FG000|Overall Study|Lost to Follow-up|3|||
130371714|NCT03715530|469331003|FG001|Overall Study|Lost to Follow-up|1|||
130371715|NCT03715530|469331004|FG002|Overall Study|Lost to Follow-up|2|||
130371716|NCT01929343|469331005|FG000|Overall Study|Physician Decision|0|||
130371717|NCT01929343|469331006|FG001|Overall Study|Physician Decision|2|||
130371718|NCT01929343|469331007|FG002|Overall Study|Physician Decision|0|||
130371719|NCT01929343|469331005|FG000|Overall Study|Withdrawal by Subject|1|||
130371720|NCT01929343|469331006|FG001|Overall Study|Withdrawal by Subject|0|||
130371721|NCT01929343|469331007|FG002|Overall Study|Withdrawal by Subject|0|||
130371722|NCT02197130|469331010|FG000|Overall Study|Adverse Event|13|||
130371723|NCT02197130|469331011|FG001|Overall Study|Adverse Event|4|||
130371724|NCT02197130|469331012|FG002|Overall Study|Adverse Event|23|||
130371725|NCT02197130|469331010|FG000|Overall Study|Death|0|||
130371726|NCT02197130|469331011|FG001|Overall Study|Death|1|||
130371727|NCT02197130|469331012|FG002|Overall Study|Death|0|||
130371728|NCT02197130|469331010|FG000|Overall Study|Lost to Follow-up|2|||
130371729|NCT02197130|469331011|FG001|Overall Study|Lost to Follow-up|0|||
130371730|NCT02197130|469331012|FG002|Overall Study|Lost to Follow-up|1|||
130371731|NCT02197130|469331010|FG000|Overall Study|Does not meet entrance criteria|0|||
130371732|NCT02197130|469331011|FG001|Overall Study|Does not meet entrance criteria|0|||
130371733|NCT02197130|469331012|FG002|Overall Study|Does not meet entrance criteria|1|||
130371734|NCT02197130|469331010|FG000|Overall Study|Withdrawal by Subject|0|||
130371735|NCT02197130|469331011|FG001|Overall Study|Withdrawal by Subject|3|||
130371736|NCT02197130|469331012|FG002|Overall Study|Withdrawal by Subject|4|||
130371737|NCT02197130|469331010|FG000|Overall Study|Other|1|||
130371738|NCT02197130|469331011|FG001|Overall Study|Other|0|||
130371739|NCT02197130|469331012|FG002|Overall Study|Other|3|||
130371740|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371741|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130371742|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371743|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130371744|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130460222|NCT01063517|469649816|FG000|Overall Study|Study reached data cut-off|19|||
130460223|NCT01063517|469649817|FG001|Overall Study|Study reached data cut-off|7|||
130460224|NCT01063517|469649816|FG000|Overall Study|Lost to Follow-up|4|||
130460225|NCT01063517|469649817|FG001|Overall Study|Lost to Follow-up|3|||
130460226|NCT01063517|469649816|FG000|Overall Study|Withdrawal by Subject|1|||
130460227|NCT01063517|469649817|FG001|Overall Study|Withdrawal by Subject|2|||
130460228|NCT01063517|469649816|FG000|Overall Study|Death|33|||
130460229|NCT01063517|469649817|FG001|Overall Study|Death|48|||
130460230|NCT02041104|469649818|FG000|Overall Study|Lost to Follow-up|1|||
130460231|NCT02041104|469649819|FG001|Overall Study|Lost to Follow-up|4|||
130460232|NCT02041104|469649818|FG000|Overall Study|discomfort during OGTT|0|||
130460233|NCT02041104|469649819|FG001|Overall Study|discomfort during OGTT|3|||
130460234|NCT00617201|469649822|FG000|Overall Study|Lost to Follow-up|9|||
130460235|NCT00617201|469649823|FG001|Overall Study|Lost to Follow-up|13|||
130460236|NCT00546871|469649824|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
130460237|NCT00546871|469649825|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
130460238|NCT00546871|469649824|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
130460239|NCT00546871|469649825|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
130460240|NCT00546871|469649824|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
130460241|NCT00546871|469649825|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
130371745|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371746|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371747|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371748|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371749|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371750|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371751|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371752|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371753|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130371754|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130460242|NCT00546871|469649824|FG000|Study Extension Period|Protocol Violation|1|||
130460243|NCT00546871|469649825|FG001|Study Extension Period|Protocol Violation|0|||
130460244|NCT00546871|469649824|FG000|Study Extension Period|Withdrawal by Subject|0|||
130371755|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
130292285|NCT00870194|469034001|FG000|Overall Study|Subject Decision|7|||
130292286|NCT00870194|469034002|FG001|Overall Study|Subject Decision|2|||
130292287|NCT02322190|469034003|FG000|Overall Study|Death on study|1|||
130292288|NCT02322190|469034004|FG001|Overall Study|Death on study|0|||
130714670|NCT02566993|470581746|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
130292289|NCT01685983|469034008|FG000|Overall Study|Adverse Event|7|||
130292290|NCT01685983|469034008|FG000|Overall Study|Death|1|||
130292291|NCT01685983|469034008|FG000|Overall Study|Withdrawal by Subject|19|||
130292292|NCT01685983|469034008|FG000|Overall Study|Protocol Violation|2|||
130292293|NCT01685983|469034008|FG000|Overall Study|Physician Decision|13|||
130371756|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
130371757|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
130371758|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371759|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371760|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371761|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371762|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371763|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371764|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371765|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371766|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371767|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371768|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371769|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130371770|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371771|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371772|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371773|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
130371774|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371775|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371776|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371777|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371778|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371779|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371780|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371781|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371782|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371783|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371784|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
130371785|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371786|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
130371787|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371788|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371789|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371790|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371791|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371792|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371793|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371794|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371795|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371796|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371797|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371798|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371799|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130371800|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371801|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371802|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371803|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371804|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
130371805|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371806|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371807|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371808|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371809|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130556650|NCT00578786|470008004|FG001|Overall Study|Withdrawal by Subject|8|||
130371810|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371811|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371812|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371813|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130371814|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130720903|NCT01341782|470601558|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
130292294|NCT01685983|469034008|FG000|Overall Study|Other|7|||
130292295|NCT01685983|469034008|FG000|Overall Study|Progressive Disease|32|||
130292296|NCT01685983|469034008|FG000|Overall Study|Noncompliance with Study Drug|1|||
130292297|NCT01443130|469034010|FG000|Overall Study|Lost to Follow-up|44|||
130292298|NCT01443130|469034011|FG001|Overall Study|Lost to Follow-up|42|||
130292299|NCT01443130|469034012|FG002|Overall Study|Lost to Follow-up|50|||
130292300|NCT01443130|469034013|FG003|Overall Study|Lost to Follow-up|23|||
130292301|NCT01443130|469034014|FG004|Overall Study|Lost to Follow-up|25|||
130292302|NCT01443130|469034015|FG005|Overall Study|Lost to Follow-up|21|||
130292303|NCT01443130|469034010|FG000|Overall Study|Death|0|||
130292304|NCT01443130|469034011|FG001|Overall Study|Death|1|||
130292305|NCT01443130|469034012|FG002|Overall Study|Death|0|||
130292306|NCT01443130|469034013|FG003|Overall Study|Death|7|||
130292307|NCT01443130|469034014|FG004|Overall Study|Death|10|||
130292308|NCT01443130|469034015|FG005|Overall Study|Death|8|||
130292309|NCT01443130|469034010|FG000|Overall Study|Adverse Event|2|||
130292310|NCT01443130|469034011|FG001|Overall Study|Adverse Event|1|||
130292311|NCT01443130|469034012|FG002|Overall Study|Adverse Event|1|||
130460245|NCT00546871|469649825|FG001|Study Extension Period|Withdrawal by Subject|1|||
130292312|NCT01443130|469034013|FG003|Overall Study|Adverse Event|0|||
130460246|NCT01713946|469649826|FG000|Overall Study|Death|0|||
130460247|NCT01713946|469649827|FG001|Overall Study|Death|2|||
130460248|NCT01713946|469649828|FG002|Overall Study|Death|2|||
130460249|NCT01713946|469649826|FG000|Overall Study|Adverse Event|19|||
130460250|NCT01713946|469649827|FG001|Overall Study|Adverse Event|14|||
130460251|NCT01713946|469649828|FG002|Overall Study|Adverse Event|13|||
130292313|NCT01443130|469034014|FG004|Overall Study|Adverse Event|0|||
130292314|NCT01443130|469034015|FG005|Overall Study|Adverse Event|0|||
130292315|NCT01443130|469034010|FG000|Overall Study|Protocol Violation|2|||
130292316|NCT01443130|469034011|FG001|Overall Study|Protocol Violation|1|||
130292317|NCT01443130|469034012|FG002|Overall Study|Protocol Violation|3|||
130292318|NCT01443130|469034013|FG003|Overall Study|Protocol Violation|2|||
130292319|NCT01443130|469034014|FG004|Overall Study|Protocol Violation|2|||
130292320|NCT01443130|469034015|FG005|Overall Study|Protocol Violation|3|||
130292321|NCT01443130|469034010|FG000|Overall Study|Withdrawal by Subject|15|||
130292322|NCT01443130|469034011|FG001|Overall Study|Withdrawal by Subject|14|||
130292323|NCT01443130|469034012|FG002|Overall Study|Withdrawal by Subject|12|||
130292324|NCT01443130|469034013|FG003|Overall Study|Withdrawal by Subject|7|||
130292325|NCT01443130|469034014|FG004|Overall Study|Withdrawal by Subject|7|||
130292326|NCT01443130|469034015|FG005|Overall Study|Withdrawal by Subject|2|||
130292327|NCT01443130|469034010|FG000|Overall Study|Death of Subject's Infant|5|||
130292328|NCT01443130|469034011|FG001|Overall Study|Death of Subject's Infant|10|||
130292329|NCT01443130|469034012|FG002|Overall Study|Death of Subject's Infant|11|||
130292330|NCT01443130|469034013|FG003|Overall Study|Death of Subject's Infant|0|||
130292331|NCT01443130|469034014|FG004|Overall Study|Death of Subject's Infant|0|||
130292332|NCT01443130|469034015|FG005|Overall Study|Death of Subject's Infant|0|||
130292333|NCT01167907|469034017|FG000|Overall Study|Protocol Violation|1|||
130292334|NCT01167907|469034018|FG001|Overall Study|Protocol Violation|0|||
130292335|NCT01167907|469034017|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
130292336|NCT01167907|469034018|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
130292337|NCT03077698|469034021|FG000|Progestin Monotherapy|Stable Disease|8|||
130292338|NCT03077698|469034022|FG001|Progestin Monotherapy|Stable Disease|0|||
130292339|NCT03077698|469034021|FG000|Progestin Monotherapy|Adverse Event|1|||
130292340|NCT03077698|469034022|FG001|Progestin Monotherapy|Adverse Event|0|||
130292341|NCT03077698|469034021|FG000|Progestin Monotherapy|Death|1|||
130292342|NCT03077698|469034022|FG001|Progestin Monotherapy|Death|0|||
130292343|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
130292344|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
130292345|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
130292346|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
130292347|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
130292348|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
130460252|NCT01713946|469649826|FG000|Overall Study|Withdrawal by Subject|12|||
130292349|NCT03077698|469034021|FG000|Safety Follow Up|Withdrawal by Subject|2|||
130292350|NCT03077698|469034022|FG001|Safety Follow Up|Withdrawal by Subject|1|||
130460253|NCT01713946|469649827|FG001|Overall Study|Withdrawal by Subject|12|||
130460254|NCT01713946|469649828|FG002|Overall Study|Withdrawal by Subject|8|||
130292351|NCT03077698|469034021|FG000|Safety Follow Up|Transfer of care to hospice|1|||
130292352|NCT03077698|469034022|FG001|Safety Follow Up|Transfer of care to hospice|0|||
130292353|NCT03461406|469034023|FG000|Overall Study|Death|1|||
130292354|NCT03461406|469034024|FG001|Overall Study|Death|2|||
130292355|NCT03461406|469034023|FG000|Overall Study|Consent Withdrawn by Participant|0|||
130292356|NCT03461406|469034024|FG001|Overall Study|Consent Withdrawn by Participant|1|||
130292357|NCT03461406|469034023|FG000|Overall Study|Screen Failure|3|||
130292358|NCT03461406|469034024|FG001|Overall Study|Screen Failure|1|||
130292359|NCT03461406|469034023|FG000|Overall Study|Reason not Specified|1|||
130460255|NCT01713946|469649826|FG000|Overall Study|Lack of Efficacy|8|||
130714671|NCT02566993|470581745|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130714672|NCT02566993|470581746|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130714673|NCT02566993|470581745|FG000|Overall Study|Screening failure|2|||
130714674|NCT02566993|470581746|FG001|Overall Study|Screening failure|0|||
130714675|NCT02566993|470581745|FG000|Overall Study|Lost to Follow-up|0|||
130714676|NCT02566993|470581746|FG001|Overall Study|Lost to Follow-up|1|||
130714677|NCT02566993|470581745|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
130714678|NCT02566993|470581746|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
130714679|NCT01169532|470581748|FG000|Overall Study|Withdrawal by Subject|1|||
130714680|NCT03127644|470581759|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130714681|NCT03127644|470581760|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130714682|NCT03127644|470581761|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130714683|NCT01550744|470581762|FG000|Open-Label|Lost to Follow-up|7|||
130714684|NCT01550744|470581763|FG001|Open-Label|Lost to Follow-up|0|||
130292360|NCT03461406|469034024|FG001|Overall Study|Reason not Specified|3|||
130714685|NCT01550744|470581764|FG002|Open-Label|Lost to Follow-up|0|||
130714686|NCT01550744|470581762|FG000|Open-Label|Withdrawal by Subject|13|||
130714687|NCT01550744|470581763|FG001|Open-Label|Withdrawal by Subject|0|||
130714688|NCT01550744|470581764|FG002|Open-Label|Withdrawal by Subject|0|||
130714689|NCT01550744|470581762|FG000|Open-Label|Adverse Event|11|||
130714690|NCT01550744|470581763|FG001|Open-Label|Adverse Event|0|||
130714691|NCT01550744|470581764|FG002|Open-Label|Adverse Event|0|||
130714692|NCT01550744|470581762|FG000|Open-Label|Lack of Efficacy|4|||
130714693|NCT01550744|470581763|FG001|Open-Label|Lack of Efficacy|0|||
130714694|NCT01550744|470581764|FG002|Open-Label|Lack of Efficacy|0|||
130714695|NCT01550744|470581762|FG000|Open-Label|Protocol Violation|4|||
130714696|NCT01550744|470581763|FG001|Open-Label|Protocol Violation|0|||
130714697|NCT01550744|470581764|FG002|Open-Label|Protocol Violation|0|||
130714698|NCT01550744|470581762|FG000|Open-Label|Not all 3 study drug injections received|2|||
130714699|NCT01550744|470581763|FG001|Open-Label|Not all 3 study drug injections received|0|||
130292361|NCT03461406|469034023|FG000|Overall Study|Lost to Follow-up|3|||
130292362|NCT03461406|469034024|FG001|Overall Study|Lost to Follow-up|0|||
130292363|NCT00973102|469034027|FG000|Overall Study|Protocol Violation|1|||
130292364|NCT00973102|469034028|FG001|Overall Study|Protocol Violation|0|||
130556651|NCT00578786|470008005|FG002|Overall Study|Withdrawal by Subject|5|||
130556652|NCT00578786|470008003|FG000|Overall Study|Protocol Violation|0|||
130556653|NCT00578786|470008004|FG001|Overall Study|Protocol Violation|3|||
130556654|NCT00578786|470008005|FG002|Overall Study|Protocol Violation|1|||
130556655|NCT00578786|470008003|FG000|Overall Study|Physician Decision|1|||
130556656|NCT00578786|470008004|FG001|Overall Study|Physician Decision|0|||
130556657|NCT00578786|470008005|FG002|Overall Study|Physician Decision|1|||
130556658|NCT00578786|470008003|FG000|Overall Study|Sponsor Decision|0|||
130556659|NCT00578786|470008004|FG001|Overall Study|Sponsor Decision|0|||
130556660|NCT00578786|470008005|FG002|Overall Study|Sponsor Decision|1|||
130556661|NCT00578786|470008003|FG000|Overall Study|Lost to Follow-up|0|||
130556662|NCT00578786|470008004|FG001|Overall Study|Lost to Follow-up|4|||
130556663|NCT00578786|470008005|FG002|Overall Study|Lost to Follow-up|0|||
130556664|NCT00578786|470008003|FG000|Overall Study|Pregnancy|0|||
130556665|NCT00578786|470008004|FG001|Overall Study|Pregnancy|1|||
130556666|NCT00578786|470008005|FG002|Overall Study|Pregnancy|0|||
130556667|NCT00578786|470008003|FG000|Overall Study|Not Otherwise Specified|0|||
130714700|NCT01550744|470581764|FG002|Open-Label|Not all 3 study drug injections received|0|||
130714701|NCT01550744|470581762|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
130714702|NCT01550744|470581763|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130714703|NCT01550744|470581764|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130714704|NCT01550744|470581762|FG000|Open-Label|Other|1|||
130714705|NCT01550744|470581763|FG001|Open-Label|Other|0|||
130714706|NCT01550744|470581764|FG002|Open-Label|Other|0|||
130714707|NCT01550744|470581762|FG000|Double-Blind|Lost to Follow-up|0|||
130714708|NCT01550744|470581763|FG001|Double-Blind|Lost to Follow-up|6|||
130714709|NCT01550744|470581764|FG002|Double-Blind|Lost to Follow-up|12|||
130714710|NCT01550744|470581762|FG000|Double-Blind|Withdrawal by Subject|0|||
130714711|NCT01550744|470581763|FG001|Double-Blind|Withdrawal by Subject|2|||
130292365|NCT00973102|469034027|FG000|Overall Study|Prisoner|0|||
130556668|NCT00578786|470008004|FG001|Overall Study|Not Otherwise Specified|4|||
130556669|NCT00578786|470008005|FG002|Overall Study|Not Otherwise Specified|1|||
130556670|NCT00578786|470008003|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
130556671|NCT00578786|470008004|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
130556672|NCT00578786|470008005|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
130292366|NCT00973102|469034028|FG001|Overall Study|Prisoner|1|||
130714712|NCT01550744|470581764|FG002|Double-Blind|Withdrawal by Subject|15|||
130714713|NCT01550744|470581762|FG000|Double-Blind|Adverse Event|0|||
130714714|NCT01550744|470581763|FG001|Double-Blind|Adverse Event|4|||
130714715|NCT01550744|470581764|FG002|Double-Blind|Adverse Event|15|||
130292367|NCT00966719|469034031|FG000|Overall Study|Lost to Follow-up|6|||
130292368|NCT00966719|469034032|FG001|Overall Study|Lost to Follow-up|11|||
130316269|NCT05767021|469124351|FG000|Overall Study|Lack of Efficacy|11|||
130292369|NCT01710527|469034033|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
130292370|NCT01710527|469034034|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
130292371|NCT02635347|469034037|FG000|Overall Study|Failed screening|20|||
130292372|NCT02635347|469034038|FG001|Overall Study|Failed screening|7|||
130292373|NCT02124772|469034040|FG000|Overall Study|Lack of Efficacy|2|||
130292374|NCT02124772|469034041|FG001|Overall Study|Lack of Efficacy|0|||
130292375|NCT02124772|469034042|FG002|Overall Study|Lack of Efficacy|0|||
130292376|NCT02124772|469034043|FG003|Overall Study|Lack of Efficacy|1|||
130292377|NCT02124772|469034044|FG004|Overall Study|Lack of Efficacy|2|||
130292378|NCT02124772|469034045|FG005|Overall Study|Lack of Efficacy|3|||
130292379|NCT02124772|469034046|FG006|Overall Study|Lack of Efficacy|0|||
130292380|NCT02124772|469034047|FG007|Overall Study|Lack of Efficacy|2|||
130292381|NCT02124772|469034048|FG008|Overall Study|Lack of Efficacy|0|||
130292382|NCT02124772|469034049|FG009|Overall Study|Lack of Efficacy|1|||
130292383|NCT02124772|469034050|FG010|Overall Study|Lack of Efficacy|0|||
130292384|NCT02124772|469034051|FG011|Overall Study|Lack of Efficacy|0|||
130292385|NCT02124772|469034052|FG012|Overall Study|Lack of Efficacy|1|||
130292386|NCT02124772|469034040|FG000|Overall Study|Adverse Event|1|||
130292387|NCT02124772|469034041|FG001|Overall Study|Adverse Event|4|||
130292388|NCT02124772|469034042|FG002|Overall Study|Adverse Event|1|||
130292389|NCT02124772|469034043|FG003|Overall Study|Adverse Event|5|||
130292390|NCT02124772|469034044|FG004|Overall Study|Adverse Event|2|||
130292391|NCT02124772|469034045|FG005|Overall Study|Adverse Event|1|||
130292392|NCT02124772|469034046|FG006|Overall Study|Adverse Event|1|||
130292393|NCT02124772|469034047|FG007|Overall Study|Adverse Event|5|||
130292394|NCT02124772|469034048|FG008|Overall Study|Adverse Event|0|||
130292395|NCT02124772|469034049|FG009|Overall Study|Adverse Event|3|||
130292396|NCT02124772|469034050|FG010|Overall Study|Adverse Event|1|||
130292397|NCT02124772|469034051|FG011|Overall Study|Adverse Event|3|||
130292398|NCT02124772|469034052|FG012|Overall Study|Adverse Event|1|||
130292399|NCT02124772|469034040|FG000|Overall Study|Withdrawal consent|0|||
130292400|NCT02124772|469034041|FG001|Overall Study|Withdrawal consent|1|||
130292401|NCT02124772|469034042|FG002|Overall Study|Withdrawal consent|1|||
130292402|NCT02124772|469034043|FG003|Overall Study|Withdrawal consent|1|||
130292403|NCT02124772|469034044|FG004|Overall Study|Withdrawal consent|0|||
130292404|NCT02124772|469034045|FG005|Overall Study|Withdrawal consent|1|||
130292405|NCT02124772|469034046|FG006|Overall Study|Withdrawal consent|1|||
130292406|NCT02124772|469034047|FG007|Overall Study|Withdrawal consent|0|||
130292407|NCT02124772|469034048|FG008|Overall Study|Withdrawal consent|0|||
130292408|NCT02124772|469034049|FG009|Overall Study|Withdrawal consent|1|||
130292409|NCT02124772|469034050|FG010|Overall Study|Withdrawal consent|0|||
130292410|NCT02124772|469034051|FG011|Overall Study|Withdrawal consent|1|||
130292411|NCT02124772|469034052|FG012|Overall Study|Withdrawal consent|0|||
130292412|NCT02124772|469034040|FG000|Overall Study|Investigator discretion|0|||
130292413|NCT02124772|469034041|FG001|Overall Study|Investigator discretion|2|||
130292414|NCT02124772|469034042|FG002|Overall Study|Investigator discretion|2|||
130292415|NCT02124772|469034043|FG003|Overall Study|Investigator discretion|1|||
130292416|NCT02124772|469034044|FG004|Overall Study|Investigator discretion|1|||
130292417|NCT02124772|469034045|FG005|Overall Study|Investigator discretion|0|||
130292418|NCT02124772|469034046|FG006|Overall Study|Investigator discretion|1|||
130292419|NCT02124772|469034047|FG007|Overall Study|Investigator discretion|0|||
130292420|NCT02124772|469034048|FG008|Overall Study|Investigator discretion|0|||
130292421|NCT02124772|469034049|FG009|Overall Study|Investigator discretion|1|||
130292422|NCT02124772|469034050|FG010|Overall Study|Investigator discretion|0|||
130292423|NCT02124772|469034051|FG011|Overall Study|Investigator discretion|1|||
130292424|NCT02124772|469034052|FG012|Overall Study|Investigator discretion|0|||
130292425|NCT02124772|469034040|FG000|Overall Study|Progressive disease|0|||
130292426|NCT02124772|469034041|FG001|Overall Study|Progressive disease|0|||
130292427|NCT02124772|469034042|FG002|Overall Study|Progressive disease|0|||
130292428|NCT02124772|469034043|FG003|Overall Study|Progressive disease|0|||
130292429|NCT02124772|469034044|FG004|Overall Study|Progressive disease|0|||
130292430|NCT02124772|469034045|FG005|Overall Study|Progressive disease|0|||
130292431|NCT02124772|469034046|FG006|Overall Study|Progressive disease|1|||
130292432|NCT02124772|469034047|FG007|Overall Study|Progressive disease|1|||
130292433|NCT02124772|469034048|FG008|Overall Study|Progressive disease|0|||
130292434|NCT02124772|469034049|FG009|Overall Study|Progressive disease|0|||
130371815|NCT01737697|469331018|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130292435|NCT02124772|469034050|FG010|Overall Study|Progressive disease|0|||
130292436|NCT02124772|469034051|FG011|Overall Study|Progressive disease|0|||
130292437|NCT02124772|469034052|FG012|Overall Study|Progressive disease|0|||
130292438|NCT02124772|469034040|FG000|Overall Study|Other|0|||
130292439|NCT02124772|469034041|FG001|Overall Study|Other|7|||
130292440|NCT02124772|469034042|FG002|Overall Study|Other|2|||
130371816|NCT01737697|469331019|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130292441|NCT02124772|469034043|FG003|Overall Study|Other|5|||
130292442|NCT02124772|469034044|FG004|Overall Study|Other|4|||
130292443|NCT02124772|469034045|FG005|Overall Study|Other|3|||
130292444|NCT02124772|469034046|FG006|Overall Study|Other|4|||
130292445|NCT02124772|469034047|FG007|Overall Study|Other|1|||
130292446|NCT02124772|469034048|FG008|Overall Study|Other|1|||
130714716|NCT01550744|470581762|FG000|Double-Blind|Death|0|||
130714717|NCT01550744|470581763|FG001|Double-Blind|Death|1|||
130714718|NCT01550744|470581764|FG002|Double-Blind|Death|0|||
130292447|NCT02124772|469034049|FG009|Overall Study|Other|1|||
130292448|NCT02124772|469034050|FG010|Overall Study|Other|1|||
130292449|NCT02124772|469034051|FG011|Overall Study|Other|1|||
130292450|NCT02124772|469034052|FG012|Overall Study|Other|0|||
130292451|NCT00780273|469034053|FG000|Overall Study|Death|1|||
130292452|NCT00780273|469034053|FG000|Overall Study|Lost to Follow-up|1|||
130292453|NCT01688921|469034054|FG000|Overall Study|Lost to Follow-up|7|||
130292454|NCT01688921|469034055|FG001|Overall Study|Lost to Follow-up|13|||
130292455|NCT01688921|469034054|FG000|Overall Study|Physician Decision|6|||
130292456|NCT01688921|469034055|FG001|Overall Study|Physician Decision|1|||
130292457|NCT01688921|469034054|FG000|Overall Study|Protocol Violation|0|||
130292458|NCT01688921|469034055|FG001|Overall Study|Protocol Violation|1|||
130292459|NCT01688921|469034054|FG000|Overall Study|informed consent|3|||
130292460|NCT01688921|469034055|FG001|Overall Study|informed consent|0|||
130292461|NCT02358044|469034056|FG000|Overall Study|Adverse Event|0|||
130292462|NCT02358044|469034057|FG001|Overall Study|Adverse Event|1|||
130292463|NCT02358044|469034056|FG000|Overall Study|Lost to Follow-up|2|||
130292464|NCT02358044|469034057|FG001|Overall Study|Lost to Follow-up|1|||
130292465|NCT02358044|469034056|FG000|Overall Study|Physician Decision|0|||
130292466|NCT02358044|469034057|FG001|Overall Study|Physician Decision|1|||
130292467|NCT02358044|469034056|FG000|Overall Study|Withdrawal by Subject|0|||
130292468|NCT02358044|469034057|FG001|Overall Study|Withdrawal by Subject|4|||
130292469|NCT01739803|469034060|FG000|Overall Study|Lost to Follow-up|9|||
130292470|NCT01739803|469034061|FG001|Overall Study|Lost to Follow-up|6|||
130292471|NCT00969436|469034063|FG000|Overall Study|Protocol Violation|1|||
130292472|NCT00969436|469034064|FG001|Overall Study|Protocol Violation|3|||
130292473|NCT00969436|469034065|FG002|Overall Study|Protocol Violation|0|||
130292474|NCT00969436|469034063|FG000|Overall Study|Migrated/moved from study area|12|||
130292475|NCT00969436|469034064|FG001|Overall Study|Migrated/moved from study area|10|||
130292476|NCT00969436|469034065|FG002|Overall Study|Migrated/moved from study area|2|||
130292477|NCT00969436|469034063|FG000|Overall Study|Father - serious health problem|0|||
130292478|NCT00969436|469034064|FG001|Overall Study|Father - serious health problem|0|||
130292479|NCT00969436|469034065|FG002|Overall Study|Father - serious health problem|1|||
130292480|NCT00969436|469034063|FG000|Overall Study|Parents personal problem|0|||
130292481|NCT00969436|469034064|FG001|Overall Study|Parents personal problem|0|||
130292482|NCT00969436|469034065|FG002|Overall Study|Parents personal problem|1|||
130292483|NCT00969436|469034063|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
130292484|NCT00969436|469034064|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
130292485|NCT00969436|469034065|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
130292486|NCT00969436|469034063|FG000|Overall Study|Withdrawal by Subject|3|||
130292487|NCT00969436|469034064|FG001|Overall Study|Withdrawal by Subject|0|||
130292488|NCT00969436|469034065|FG002|Overall Study|Withdrawal by Subject|2|||
130292489|NCT00969436|469034063|FG000|Overall Study|Lost to Follow-up|8|||
130292490|NCT00969436|469034064|FG001|Overall Study|Lost to Follow-up|8|||
130292491|NCT00969436|469034065|FG002|Overall Study|Lost to Follow-up|5|||
130292492|NCT03474081|469034070|FG000|Overall Study|Adverse Event|6|||
130292493|NCT03474081|469034071|FG001|Overall Study|Adverse Event|3|||
130292494|NCT03474081|469034070|FG000|Overall Study|Lost to Follow-up|2|||
130292495|NCT03474081|469034071|FG001|Overall Study|Lost to Follow-up|1|||
130292496|NCT03474081|469034070|FG000|Overall Study|Physician Decision|3|||
130292497|NCT03474081|469034071|FG001|Overall Study|Physician Decision|2|||
130292498|NCT03474081|469034070|FG000|Overall Study|Withdrawal by Subject|5|||
130292499|NCT03474081|469034071|FG001|Overall Study|Withdrawal by Subject|7|||
130292500|NCT03474081|469034070|FG000|Overall Study|Investigator site closed|1|||
130292501|NCT03474081|469034071|FG001|Overall Study|Investigator site closed|0|||
130292502|NCT01831817|469034072|FG000|Overall Study|Lost to Follow-up|1|||
130292503|NCT01831817|469034073|FG001|Overall Study|Lost to Follow-up|0|||
130292504|NCT01831817|469034074|FG002|Overall Study|Lost to Follow-up|0|||
130292505|NCT01831817|469034075|FG003|Overall Study|Lost to Follow-up|0|||
130292506|NCT01831817|469034072|FG000|Overall Study|Withdrawl of Consent|3|||
130292507|NCT01831817|469034073|FG001|Overall Study|Withdrawl of Consent|0|||
130292508|NCT01831817|469034074|FG002|Overall Study|Withdrawl of Consent|0|||
130292509|NCT01831817|469034075|FG003|Overall Study|Withdrawl of Consent|0|||
130292510|NCT02198235|469034077|FG000|Overall Study|Lost to Follow-up|3|||
130460256|NCT01713946|469649827|FG001|Overall Study|Lack of Efficacy|8|||
130460257|NCT01713946|469649828|FG002|Overall Study|Lack of Efficacy|14|||
130460258|NCT01713946|469649826|FG000|Overall Study|Protocol Violation|2|||
130460259|NCT01713946|469649827|FG001|Overall Study|Protocol Violation|4|||
130460260|NCT01713946|469649828|FG002|Overall Study|Protocol Violation|1|||
130460261|NCT01713946|469649826|FG000|Overall Study|Lost to Follow-up|0|||
130460262|NCT01713946|469649827|FG001|Overall Study|Lost to Follow-up|0|||
130460263|NCT01713946|469649828|FG002|Overall Study|Lost to Follow-up|1|||
130460264|NCT01713946|469649826|FG000|Overall Study|Administrative problems|1|||
130292511|NCT02198235|469034078|FG001|Overall Study|Lost to Follow-up|2|||
130292512|NCT02198235|469034079|FG002|Overall Study|Lost to Follow-up|2|||
130714719|NCT01550744|470581762|FG000|Double-Blind|Lack of Efficacy|0|||
130292513|NCT04573881|469034082|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
130292514|NCT00541346|469035749|FG000|Follow-up|Adverse Event|1|||
130292515|NCT05160766|469035752|FG000|Overall Study|Adverse Event|0|||
130292516|NCT05160766|469035753|FG001|Overall Study|Adverse Event|1|||
130292517|NCT05160766|469035754|FG002|Overall Study|Adverse Event|0|||
130292518|NCT05160766|469035755|FG003|Overall Study|Adverse Event|0|||
130292519|NCT05160766|469035752|FG000|Overall Study|COVID-19 infection|0|||
130292520|NCT05160766|469035753|FG001|Overall Study|COVID-19 infection|1|||
130292521|NCT05160766|469035754|FG002|Overall Study|COVID-19 infection|0|||
130292522|NCT05160766|469035755|FG003|Overall Study|COVID-19 infection|0|||
130292523|NCT05160766|469035752|FG000|Overall Study|travel time|1|||
130292524|NCT05160766|469035753|FG001|Overall Study|travel time|0|||
130292525|NCT05160766|469035754|FG002|Overall Study|travel time|0|||
130292526|NCT05160766|469035755|FG003|Overall Study|travel time|1|||
130292527|NCT05160766|469035752|FG000|Overall Study|Withdrawal by Subject|3|||
130292528|NCT05160766|469035753|FG001|Overall Study|Withdrawal by Subject|5|||
130292529|NCT05160766|469035754|FG002|Overall Study|Withdrawal by Subject|4|||
130292530|NCT05160766|469035755|FG003|Overall Study|Withdrawal by Subject|2|||
130292531|NCT05160766|469035752|FG000|Overall Study|Death|0|||
130292532|NCT05160766|469035753|FG001|Overall Study|Death|0|||
130292533|NCT05160766|469035754|FG002|Overall Study|Death|2|||
130292534|NCT05160766|469035755|FG003|Overall Study|Death|5|||
130292535|NCT05160766|469035752|FG000|Overall Study|Lost to Follow-up|0|||
130292536|NCT05160766|469035753|FG001|Overall Study|Lost to Follow-up|0|||
130292537|NCT05160766|469035754|FG002|Overall Study|Lost to Follow-up|1|||
130292538|NCT05160766|469035755|FG003|Overall Study|Lost to Follow-up|2|||
130292539|NCT05160766|469035752|FG000|Overall Study|No show|0|||
130292540|NCT05160766|469035753|FG001|Overall Study|No show|0|||
130292541|NCT05160766|469035754|FG002|Overall Study|No show|1|||
130292542|NCT05160766|469035755|FG003|Overall Study|No show|1|||
130292543|NCT05160766|469035752|FG000|Overall Study|Physician Decision|0|||
130292544|NCT05160766|469035753|FG001|Overall Study|Physician Decision|0|||
130292545|NCT05160766|469035754|FG002|Overall Study|Physician Decision|0|||
130292546|NCT05160766|469035755|FG003|Overall Study|Physician Decision|1|||
130556673|NCT00866723|470008006|FG000|Overall Study|Withdrawal by Subject|1|||
130292547|NCT05160766|469035752|FG000|Overall Study|Protocol Violation|0|||
130292548|NCT05160766|469035753|FG001|Overall Study|Protocol Violation|0|||
130292549|NCT05160766|469035754|FG002|Overall Study|Protocol Violation|1|||
130292550|NCT05160766|469035755|FG003|Overall Study|Protocol Violation|0|||
130292551|NCT02853435|469035756|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292552|NCT02853435|469035757|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292553|NCT02853435|469035758|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292554|NCT02853435|469035759|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292555|NCT02853435|469035760|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
130292556|NCT02853435|469035761|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292557|NCT00996801|469035762|FG000|Overall Study|Adverse Event|6|||
130292558|NCT00996801|469035763|FG001|Overall Study|Adverse Event|4|||
130292559|NCT00996801|469035764|FG002|Overall Study|Adverse Event|12|||
130292560|NCT00996801|469035765|FG003|Overall Study|Adverse Event|17|||
130292561|NCT00996801|469035766|FG004|Overall Study|Adverse Event|31|||
130292562|NCT00996801|469035767|FG005|Overall Study|Adverse Event|3|||
130292563|NCT00996801|469035762|FG000|Overall Study|Lack of Efficacy|3|||
130292564|NCT00996801|469035763|FG001|Overall Study|Lack of Efficacy|0|||
130292565|NCT00996801|469035764|FG002|Overall Study|Lack of Efficacy|1|||
130292566|NCT00996801|469035765|FG003|Overall Study|Lack of Efficacy|3|||
130292567|NCT00996801|469035766|FG004|Overall Study|Lack of Efficacy|0|||
130292568|NCT00996801|469035767|FG005|Overall Study|Lack of Efficacy|1|||
130292569|NCT00996801|469035762|FG000|Overall Study|Lost to Follow-up|0|||
130292570|NCT00996801|469035763|FG001|Overall Study|Lost to Follow-up|0|||
130292571|NCT00996801|469035764|FG002|Overall Study|Lost to Follow-up|0|||
130292572|NCT00996801|469035765|FG003|Overall Study|Lost to Follow-up|3|||
130292573|NCT00996801|469035766|FG004|Overall Study|Lost to Follow-up|3|||
130292574|NCT00996801|469035767|FG005|Overall Study|Lost to Follow-up|2|||
130292575|NCT00996801|469035762|FG000|Overall Study|Physician Decision|0|||
130371817|NCT01737697|469331020|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130371818|NCT01737697|469331021|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
130371819|NCT01737697|469331022|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130371820|NCT01737697|469331023|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371821|NCT01737697|469331024|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371822|NCT01737697|469331025|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371823|NCT01737697|469331026|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130556674|NCT00866723|470008006|FG000|Overall Study|Disease Progression|4|||
130292576|NCT00996801|469035763|FG001|Overall Study|Physician Decision|0|||
130292577|NCT00996801|469035764|FG002|Overall Study|Physician Decision|0|||
130292578|NCT00996801|469035765|FG003|Overall Study|Physician Decision|1|||
130292579|NCT00996801|469035766|FG004|Overall Study|Physician Decision|0|||
130292580|NCT00996801|469035767|FG005|Overall Study|Physician Decision|0|||
130292581|NCT00996801|469035762|FG000|Overall Study|Progressive Disease|0|||
130371824|NCT01737697|469331027|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371825|NCT01737697|469331028|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371826|NCT01737697|469331029|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371827|NCT01737697|469331030|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371828|NCT01737697|469331031|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371829|NCT01737697|469331032|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130371830|NCT01737697|469331018|FG000|Subacute Phase|Adverse Event|0|||
130371831|NCT01737697|469331019|FG001|Subacute Phase|Adverse Event|0|||
130371832|NCT01737697|469331020|FG002|Subacute Phase|Adverse Event|0|||
130371833|NCT01737697|469331021|FG003|Subacute Phase|Adverse Event|0|||
130371834|NCT01737697|469331022|FG004|Subacute Phase|Adverse Event|0|||
130371835|NCT01737697|469331023|FG005|Subacute Phase|Adverse Event|1|||
130371836|NCT01737697|469331024|FG006|Subacute Phase|Adverse Event|1|||
130371837|NCT01737697|469331025|FG007|Subacute Phase|Adverse Event|1|||
130371838|NCT01737697|469331026|FG008|Subacute Phase|Adverse Event|1|||
130371839|NCT01737697|469331027|FG009|Subacute Phase|Adverse Event|1|||
130371840|NCT01737697|469331028|FG010|Subacute Phase|Adverse Event|4|||
130371841|NCT01737697|469331029|FG011|Subacute Phase|Adverse Event|1|||
130371842|NCT01737697|469331030|FG012|Subacute Phase|Adverse Event|1|||
130371843|NCT01737697|469331031|FG013|Subacute Phase|Adverse Event|0|||
130371844|NCT01737697|469331032|FG014|Subacute Phase|Adverse Event|0|||
130371845|NCT01737697|469331018|FG000|Subacute Phase|Withdrawal by Subject|0|||
130371846|NCT01737697|469331019|FG001|Subacute Phase|Withdrawal by Subject|0|||
130371847|NCT01737697|469331020|FG002|Subacute Phase|Withdrawal by Subject|0|||
130371848|NCT01737697|469331021|FG003|Subacute Phase|Withdrawal by Subject|0|||
130371849|NCT01737697|469331022|FG004|Subacute Phase|Withdrawal by Subject|0|||
130371850|NCT01737697|469331023|FG005|Subacute Phase|Withdrawal by Subject|1|||
130371851|NCT01737697|469331024|FG006|Subacute Phase|Withdrawal by Subject|0|||
130371852|NCT01737697|469331025|FG007|Subacute Phase|Withdrawal by Subject|2|||
130371853|NCT01737697|469331026|FG008|Subacute Phase|Withdrawal by Subject|0|||
130460265|NCT01713946|469649827|FG001|Overall Study|Administrative problems|0|||
130460266|NCT01713946|469649828|FG002|Overall Study|Administrative problems|0|||
130460267|NCT01713946|469649826|FG000|Overall Study|Did not continue in Ext|0|||
130460268|NCT01713946|469649827|FG001|Overall Study|Did not continue in Ext|3|||
130460269|NCT01713946|469649828|FG002|Overall Study|Did not continue in Ext|0|||
130460270|NCT01713946|469649826|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
130460271|NCT01713946|469649827|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
130714720|NCT01550744|470581763|FG001|Double-Blind|Lack of Efficacy|2|||
130714721|NCT01550744|470581764|FG002|Double-Blind|Lack of Efficacy|8|||
130714722|NCT01550744|470581762|FG000|Double-Blind|Protocol Violation|0|||
130714723|NCT01550744|470581763|FG001|Double-Blind|Protocol Violation|0|||
130714724|NCT01550744|470581764|FG002|Double-Blind|Protocol Violation|4|||
130714725|NCT01550744|470581762|FG000|Double-Blind|Pregnancy|0|||
130460272|NCT01713946|469649828|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
130460273|NCT01713946|469649826|FG000|Overall Study|Patients never switched to everolimus|0|||
130460274|NCT01713946|469649827|FG001|Overall Study|Patients never switched to everolimus|0|||
130460275|NCT01713946|469649828|FG002|Overall Study|Patients never switched to everolimus|5|||
130460276|NCT03183518|469649829|FG000|Overall Study|Other (Not specified)|2|||
130460277|NCT03183518|469649829|FG000|Overall Study|Other (Withdrawal of consent)|1|||
130460278|NCT04493242|469649832|FG000|Overall Study|Death|10|||
130460279|NCT04493242|469649833|FG001|Overall Study|Death|14|||
130460280|NCT04493242|469649834|FG002|Overall Study|Death|16|||
130460281|NCT04493242|469649832|FG000|Overall Study|Lost to Follow-up|1|||
130460282|NCT04493242|469649833|FG001|Overall Study|Lost to Follow-up|1|||
130460283|NCT04493242|469649834|FG002|Overall Study|Lost to Follow-up|0|||
130460284|NCT04493242|469649832|FG000|Overall Study|Withdrawal by Subject|1|||
130460285|NCT04493242|469649833|FG001|Overall Study|Withdrawal by Subject|0|||
130460286|NCT04493242|469649834|FG002|Overall Study|Withdrawal by Subject|0|||
130460287|NCT04493242|469649832|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
130460288|NCT04493242|469649833|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
130460289|NCT04493242|469649834|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
130460290|NCT04493242|469649832|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
130460291|NCT04493242|469649833|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
130460292|NCT04493242|469649834|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
130460293|NCT04513522|469652048|FG000|Overall Study|Other reasons|1|||
130460294|NCT04513522|469652048|FG000|Overall Study|Adverse event unrelated to study drug|9|||
130371854|NCT01737697|469331027|FG009|Subacute Phase|Withdrawal by Subject|1|||
130371855|NCT01737697|469331028|FG010|Subacute Phase|Withdrawal by Subject|0|||
130371856|NCT01737697|469331029|FG011|Subacute Phase|Withdrawal by Subject|1|||
130460295|NCT04513522|469652048|FG000|Overall Study|Study drug toxicity|14|||
130460296|NCT04513522|469652048|FG000|Overall Study|Disease progression|39|||
130714726|NCT01550744|470581763|FG001|Double-Blind|Pregnancy|0|||
130714727|NCT01550744|470581764|FG002|Double-Blind|Pregnancy|3|||
130371857|NCT01737697|469331030|FG012|Subacute Phase|Withdrawal by Subject|1|||
130292582|NCT00996801|469035763|FG001|Overall Study|Progressive Disease|1|||
130292583|NCT00996801|469035764|FG002|Overall Study|Progressive Disease|0|||
130292584|NCT00996801|469035765|FG003|Overall Study|Progressive Disease|0|||
130292585|NCT00996801|469035766|FG004|Overall Study|Progressive Disease|0|||
130292586|NCT00996801|469035767|FG005|Overall Study|Progressive Disease|0|||
130292587|NCT00996801|469035762|FG000|Overall Study|Protocol Violation|3|||
130292588|NCT00996801|469035763|FG001|Overall Study|Protocol Violation|4|||
130292589|NCT00996801|469035764|FG002|Overall Study|Protocol Violation|1|||
130292590|NCT00996801|469035765|FG003|Overall Study|Protocol Violation|2|||
130292591|NCT00996801|469035766|FG004|Overall Study|Protocol Violation|3|||
130292592|NCT00996801|469035767|FG005|Overall Study|Protocol Violation|4|||
130292593|NCT00996801|469035762|FG000|Overall Study|Study Terminated by Sponsor|0|||
130292594|NCT00996801|469035763|FG001|Overall Study|Study Terminated by Sponsor|1|||
130292595|NCT00996801|469035764|FG002|Overall Study|Study Terminated by Sponsor|0|||
130292596|NCT00996801|469035765|FG003|Overall Study|Study Terminated by Sponsor|0|||
130292597|NCT00996801|469035766|FG004|Overall Study|Study Terminated by Sponsor|46|||
130292598|NCT00996801|469035767|FG005|Overall Study|Study Terminated by Sponsor|0|||
130292599|NCT00996801|469035762|FG000|Overall Study|Withdrawal by Subject|8|||
130292600|NCT00996801|469035763|FG001|Overall Study|Withdrawal by Subject|6|||
130292601|NCT00996801|469035764|FG002|Overall Study|Withdrawal by Subject|9|||
130292602|NCT00996801|469035765|FG003|Overall Study|Withdrawal by Subject|5|||
130292603|NCT00996801|469035766|FG004|Overall Study|Withdrawal by Subject|5|||
130292604|NCT00996801|469035767|FG005|Overall Study|Withdrawal by Subject|9|||
130292605|NCT02804750|469035768|FG000|Period 1|Adverse Event|0|||
130292606|NCT02804750|469035769|FG001|Period 1|Adverse Event|2|||
130292607|NCT02804750|469035768|FG000|Period 1|Withdrawal by Subject|0|||
130292608|NCT02804750|469035769|FG001|Period 1|Withdrawal by Subject|1|||
130292609|NCT02804750|469035768|FG000|Period 2|Adverse Event|1|||
130292610|NCT02804750|469035769|FG001|Period 2|Adverse Event|0|||
130292611|NCT02804750|469035768|FG000|Period 3|Adverse Event|0|||
130292612|NCT02804750|469035769|FG001|Period 3|Adverse Event|2|||
130292613|NCT02804750|469035768|FG000|Period 4|Adverse Event|0|||
130292614|NCT02804750|469035769|FG001|Period 4|Adverse Event|5|||
130292615|NCT01657760|469035773|FG000|Overall Study|Withdrawal by Subject|0|||
130292616|NCT01657760|469035774|FG001|Overall Study|Withdrawal by Subject|0|||
130292617|NCT01657760|469035775|FG002|Overall Study|Withdrawal by Subject|0|||
130292618|NCT01657760|469035776|FG003|Overall Study|Withdrawal by Subject|1|||
130292619|NCT01657760|469035773|FG000|Overall Study|Physician Decision|1|||
130292620|NCT01657760|469035774|FG001|Overall Study|Physician Decision|1|||
130292621|NCT01657760|469035775|FG002|Overall Study|Physician Decision|1|||
130292622|NCT01657760|469035776|FG003|Overall Study|Physician Decision|2|||
130292623|NCT00940485|469035781|FG000|Overall Study|HBeAb positive at Baseline|3|||
130292624|NCT00940485|469035782|FG001|Overall Study|HBeAb positive at Baseline|2|||
130292625|NCT00940485|469035781|FG000|Overall Study|Lost to Follow-up|2|||
130371858|NCT01737697|469331031|FG013|Subacute Phase|Withdrawal by Subject|1|||
130292626|NCT00940485|469035782|FG001|Overall Study|Lost to Follow-up|3|||
130292627|NCT00940485|469035781|FG000|Overall Study|Adverse Event|8|||
130292628|NCT00940485|469035782|FG001|Overall Study|Adverse Event|0|||
130292629|NCT00940485|469035781|FG000|Overall Study|Withdrawal by Subject|1|||
130292630|NCT00940485|469035782|FG001|Overall Study|Withdrawal by Subject|1|||
130292631|NCT00940485|469035781|FG000|Overall Study|Others|1|||
130292632|NCT00940485|469035782|FG001|Overall Study|Others|1|||
130292633|NCT06250738|469035788|FG000|Overall Study|Lost to Follow-up|1|||
130292634|NCT02936284|469035790|FG000|Overall Study|Withdrawal by Subject|3|||
130292635|NCT02936284|469035791|FG001|Overall Study|Withdrawal by Subject|1|||
130292636|NCT02936284|469035790|FG000|Overall Study|Lost to Follow-up|7|||
130292637|NCT02936284|469035791|FG001|Overall Study|Lost to Follow-up|8|||
130292638|NCT01068249|469035794|FG000|Overall Study|Death|1|||
130292639|NCT01068249|469035794|FG000|Overall Study|Withdrawal by Subject|3|||
130292640|NCT03921554|469035797|FG000|Overall Study|Adverse Event|2|||
130292641|NCT03921554|469035797|FG000|Overall Study|Withdrawal by Subject|1|||
130292642|NCT03921554|469035797|FG000|Overall Study|Death|3|||
130292643|NCT01146652|469035802|FG000|Overall Study|Adverse Event|506|||
130292644|NCT01146652|469035803|FG001|Overall Study|Adverse Event|15|||
130292645|NCT01146652|469035802|FG000|Overall Study|Lack of Efficacy|91|||
130292646|NCT01146652|469035803|FG001|Overall Study|Lack of Efficacy|7|||
130292647|NCT01146652|469035802|FG000|Overall Study|Poor compliance to protocol|38|||
130292648|NCT01146652|469035803|FG001|Overall Study|Poor compliance to protocol|1|||
130292649|NCT01146652|469035802|FG000|Overall Study|Other unspecified reasons|314|||
130292650|NCT01146652|469035803|FG001|Overall Study|Other unspecified reasons|22|||
130292651|NCT01146652|469035802|FG000|Overall Study|Enrolled but not treated|2|||
130292652|NCT01146652|469035803|FG001|Overall Study|Enrolled but not treated|0|||
130292653|NCT03455829|469035807|FG000|Overall Study|Death|2|||
130292654|NCT03455829|469035808|FG001|Overall Study|Death|3|||
130292655|NCT03455829|469035809|FG002|Overall Study|Death|2|||
130292656|NCT03455829|469035810|FG003|Overall Study|Death|4|||
130292657|NCT03455829|469035811|FG004|Overall Study|Death|2|||
130292658|NCT03455829|469035807|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
130292659|NCT03455829|469035808|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130292660|NCT03455829|469035809|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130292661|NCT03455829|469035810|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130292662|NCT03455829|469035811|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130292663|NCT03455829|469035807|FG000|Overall Study|Disease progression|0|||
130292664|NCT03455829|469035808|FG001|Overall Study|Disease progression|0|||
130292665|NCT03455829|469035809|FG002|Overall Study|Disease progression|0|||
130292666|NCT03455829|469035810|FG003|Overall Study|Disease progression|1|||
130292667|NCT03455829|469035811|FG004|Overall Study|Disease progression|1|||
130292668|NCT00096018|469035819|FG000|Overall Study|Became Ineligible (not treated)|0|||
130292669|NCT00096018|469035820|FG001|Overall Study|Became Ineligible (not treated)|3|||
130292670|NCT00096018|469035819|FG000|Overall Study|Miscellaneous (not treated)|0|||
130292671|NCT00096018|469035820|FG001|Overall Study|Miscellaneous (not treated)|2|||
130556675|NCT01271803|470008007|FG000|Overall Study|Progressive disease|0|||
130556676|NCT01271803|470008008|FG001|Overall Study|Progressive disease|0|||
130556677|NCT01271803|470008009|FG002|Overall Study|Progressive disease|2|||
130556678|NCT01271803|470008007|FG000|Overall Study|Death|53|||
130556679|NCT01271803|470008008|FG001|Overall Study|Death|34|||
130556680|NCT01271803|470008009|FG002|Overall Study|Death|0|||
130556681|NCT01271803|470008007|FG000|Overall Study|Withdrawal by Subject|1|||
130556682|NCT01271803|470008008|FG001|Overall Study|Withdrawal by Subject|5|||
130556683|NCT01271803|470008009|FG002|Overall Study|Withdrawal by Subject|0|||
130556684|NCT01271803|470008007|FG000|Overall Study|Lost to Follow-up|1|||
130556685|NCT01271803|470008008|FG001|Overall Study|Lost to Follow-up|0|||
130556686|NCT01271803|470008009|FG002|Overall Study|Lost to Follow-up|0|||
130556687|NCT02178553|470008015|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
130556688|NCT02178553|470008016|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
130556689|NCT02178553|470008015|FG000|Overall Study|Physician Decision|0|||
130556690|NCT02178553|470008016|FG001|Overall Study|Physician Decision|4|||
130556691|NCT02178553|470008015|FG000|Overall Study|Technical problem with injection|1|||
130556692|NCT02178553|470008016|FG001|Overall Study|Technical problem with injection|3|||
130556693|NCT02187809|470008017|FG000|Overall Study|The study was terminated|3|||
130556694|NCT05085665|470008018|FG000|Overall Study|Physician Decision|2|||
130556695|NCT00778622|470008019|FG000|Overall Study|Adverse Event|5|||
130556696|NCT00778622|470008020|FG001|Overall Study|Adverse Event|4|||
130556697|NCT00778622|470008021|FG002|Overall Study|Adverse Event|7|||
130556698|NCT00778622|470008019|FG000|Overall Study|Withdrawal by Subject|4|||
130556699|NCT00778622|470008020|FG001|Overall Study|Withdrawal by Subject|5|||
130556700|NCT00778622|470008021|FG002|Overall Study|Withdrawal by Subject|5|||
130556701|NCT00778622|470008019|FG000|Overall Study|Lost to Follow-up|3|||
130556702|NCT00778622|470008020|FG001|Overall Study|Lost to Follow-up|3|||
130556703|NCT00778622|470008021|FG002|Overall Study|Lost to Follow-up|2|||
130556704|NCT00778622|470008019|FG000|Overall Study|Protocol Violation|0|||
130556705|NCT00778622|470008020|FG001|Overall Study|Protocol Violation|3|||
130556706|NCT00778622|470008021|FG002|Overall Study|Protocol Violation|0|||
130556707|NCT00778622|470008019|FG000|Overall Study|Lack of Efficacy|2|||
130556708|NCT00778622|470008020|FG001|Overall Study|Lack of Efficacy|0|||
130556709|NCT00778622|470008021|FG002|Overall Study|Lack of Efficacy|0|||
130556710|NCT00778622|470008019|FG000|Overall Study|immigration|1|||
130556711|NCT00778622|470008020|FG001|Overall Study|immigration|0|||
130556712|NCT00778622|470008021|FG002|Overall Study|immigration|0|||
130556713|NCT00778622|470008019|FG000|Overall Study|Other|1|||
130556714|NCT00778622|470008020|FG001|Overall Study|Other|0|||
130556715|NCT00778622|470008021|FG002|Overall Study|Other|1|||
130556716|NCT01251120|470008023|FG000|Overall Study|Lack of Efficacy|0|||
130556717|NCT01251120|470008024|FG001|Overall Study|Lack of Efficacy|1|||
130714728|NCT01550744|470581762|FG000|Double-Blind|Other|0|||
130292672|NCT00096018|469035819|FG000|Overall Study|Adverse Event|0|||
130292673|NCT00096018|469035820|FG001|Overall Study|Adverse Event|5|||
130292674|NCT00096018|469035819|FG000|Overall Study|Death|0|||
130292675|NCT00096018|469035820|FG001|Overall Study|Death|1|||
130292676|NCT00096018|469035819|FG000|Overall Study|Withdrawal by Subject|0|||
130292677|NCT00096018|469035820|FG001|Overall Study|Withdrawal by Subject|2|||
130292678|NCT00096018|469035819|FG000|Overall Study|Miscellaneous|2|||
130292679|NCT00096018|469035820|FG001|Overall Study|Miscellaneous|1|||
130292680|NCT03689712|469035821|FG000|Overall Study|Adverse Event|1|||
130292681|NCT03689712|469035822|FG001|Overall Study|Adverse Event|0|||
130292682|NCT03689712|469035821|FG000|Overall Study|Death|20|||
130292683|NCT03689712|469035822|FG001|Overall Study|Death|10|||
130556718|NCT01822522|470008025|FG000|Overall Study|Adverse Event|1|||
130556719|NCT01822522|470008026|FG001|Overall Study|Adverse Event|1|||
130556720|NCT01822522|470008027|FG002|Overall Study|Adverse Event|1|||
130292684|NCT03689712|469035821|FG000|Overall Study|Lost to Follow-up|6|||
130292685|NCT03689712|469035822|FG001|Overall Study|Lost to Follow-up|6|||
130556721|NCT01822522|470008028|FG003|Overall Study|Adverse Event|0|||
130556722|NCT01822522|470008029|FG004|Overall Study|Adverse Event|0|||
130714729|NCT01550744|470581763|FG001|Double-Blind|Other|2|||
130556723|NCT01822522|470008030|FG005|Overall Study|Adverse Event|1|||
130556724|NCT01822522|470008025|FG000|Overall Study|Death|3|||
130714730|NCT01550744|470581764|FG002|Double-Blind|Other|10|||
130292686|NCT03689712|469035821|FG000|Overall Study|Other|1|||
130292687|NCT03689712|469035822|FG001|Overall Study|Other|0|||
130292688|NCT03689712|469035821|FG000|Overall Study|Patient Non-Compliance|0|||
130292689|NCT03689712|469035822|FG001|Overall Study|Patient Non-Compliance|1|||
130292690|NCT03689712|469035821|FG000|Overall Study|Withdrawal by Subject|20|||
130292691|NCT03689712|469035822|FG001|Overall Study|Withdrawal by Subject|4|||
130292692|NCT03689712|469035821|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
130292693|NCT03689712|469035822|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
130292694|NCT03689712|469035821|FG000|Overall Study|Randomized but not Treated|13|||
130292695|NCT03689712|469035822|FG001|Overall Study|Randomized but not Treated|7|||
130292696|NCT03689712|469035821|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
130292697|NCT03689712|469035822|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
130292698|NCT00689793|469035823|FG000|Overall Study|Lost to Follow-up|4|||
130292699|NCT00689793|469035824|FG001|Overall Study|Lost to Follow-up|5|||
130292700|NCT03968159|469035825|FG000|Overall Study|Adverse Event|4|||
130292701|NCT03968159|469035826|FG001|Overall Study|Adverse Event|4|||
130292702|NCT03968159|469035825|FG000|Overall Study|Lost to Follow-up|1|||
130292703|NCT03968159|469035826|FG001|Overall Study|Lost to Follow-up|1|||
130292704|NCT03968159|469035825|FG000|Overall Study|Use of prohibited medication|0|||
130292705|NCT03968159|469035826|FG001|Overall Study|Use of prohibited medication|1|||
130292706|NCT03968159|469035825|FG000|Overall Study|Protocol Violation|2|||
130292707|NCT03968159|469035826|FG001|Overall Study|Protocol Violation|2|||
130292708|NCT03968159|469035825|FG000|Overall Study|Withdrawal by Subject|4|||
130292709|NCT03968159|469035826|FG001|Overall Study|Withdrawal by Subject|6|||
130292710|NCT03968159|469035825|FG000|Overall Study|Lack of Efficacy|0|||
130292711|NCT03968159|469035826|FG001|Overall Study|Lack of Efficacy|1|||
130292712|NCT03968159|469035825|FG000|Overall Study|Not further specified|2|||
130292713|NCT03968159|469035826|FG001|Overall Study|Not further specified|0|||
130292714|NCT03283150|469035827|FG000|Overall Study|Withdrawal by Subject|6|||
130292715|NCT03283150|469035828|FG001|Overall Study|Withdrawal by Subject|0|||
130292716|NCT03283150|469035829|FG002|Overall Study|Withdrawal by Subject|0|||
130292717|NCT00864851|469035830|FG000|Overall Study|Withdrawal by Subject|0|||
130292718|NCT00864851|469035831|FG001|Overall Study|Withdrawal by Subject|1|||
130292719|NCT00864851|469035832|FG002|Overall Study|Withdrawal by Subject|0|||
130292720|NCT00864851|469035830|FG000|Overall Study|Physician Decision|1|||
130292721|NCT00864851|469035831|FG001|Overall Study|Physician Decision|0|||
130292722|NCT00864851|469035832|FG002|Overall Study|Physician Decision|0|||
130292723|NCT00864851|469035830|FG000|Overall Study|Death|1|||
130292724|NCT00864851|469035831|FG001|Overall Study|Death|0|||
130292725|NCT00864851|469035832|FG002|Overall Study|Death|0|||
130292726|NCT00864851|469035830|FG000|Overall Study|Patient uncooperative|1|||
130292727|NCT00864851|469035831|FG001|Overall Study|Patient uncooperative|0|||
130292728|NCT00864851|469035832|FG002|Overall Study|Patient uncooperative|0|||
130292729|NCT01842581|469035836|FG000|Overall Study|Adverse Event|6|||
130292730|NCT01842581|469035837|FG001|Overall Study|Adverse Event|4|||
130292731|NCT01842581|469035836|FG000|Overall Study|HE breakthrough|26|||
130292732|NCT01842581|469035837|FG001|Overall Study|HE breakthrough|13|||
130714731|NCT00311311|470581765|FG000|Overall Study|Adverse Event|3|||
130292733|NCT01842581|469035836|FG000|Overall Study|Liver transplant|2|||
130292734|NCT01842581|469035837|FG001|Overall Study|Liver transplant|0|||
130292735|NCT01842581|469035836|FG000|Overall Study|Lost to Follow-up|2|||
130292736|NCT01842581|469035837|FG001|Overall Study|Lost to Follow-up|5|||
130292737|NCT01842581|469035836|FG000|Overall Study|Withdrawal by Subject|5|||
130292738|NCT01842581|469035837|FG001|Overall Study|Withdrawal by Subject|7|||
130292739|NCT01842581|469035836|FG000|Overall Study|Other than specified|3|||
130292740|NCT01842581|469035837|FG001|Overall Study|Other than specified|1|||
130292741|NCT00353873|469035838|FG000|Overall Study|Protocol Violation|1|||
130292742|NCT00353873|469035839|FG001|Overall Study|Protocol Violation|2|||
130292743|NCT00353873|469035838|FG000|Overall Study|Exacerbation|1|||
130292744|NCT00353873|469035839|FG001|Overall Study|Exacerbation|0|||
130292745|NCT00353873|469035838|FG000|Overall Study|Adverse Event|1|||
130292746|NCT00353873|469035839|FG001|Overall Study|Adverse Event|0|||
130292747|NCT00353873|469035838|FG000|Overall Study|Physician Decision|2|||
130292748|NCT00353873|469035839|FG001|Overall Study|Physician Decision|0|||
130292749|NCT00353873|469035838|FG000|Overall Study|Withdrawal by Subject|1|||
130292750|NCT00353873|469035839|FG001|Overall Study|Withdrawal by Subject|1|||
130292751|NCT02717130|469035840|FG000|Overall Study|Withdrawal by Subject|1|||
130292752|NCT02717130|469035840|FG000|Overall Study|Adverse Event|1|||
130292753|NCT02717130|469035840|FG000|Overall Study|Physician Decision|1|||
130292754|NCT02717130|469035840|FG000|Overall Study|Study Closure|4|||
130292755|NCT00106691|469035841|FG000|Overall Study|Adverse Event|60|||
130292756|NCT00106691|469035842|FG001|Overall Study|Adverse Event|64|||
130292757|NCT00106691|469035841|FG000|Overall Study|Lost to Follow-up|23|||
130292758|NCT00106691|469035842|FG001|Overall Study|Lost to Follow-up|18|||
130292759|NCT00106691|469035841|FG000|Overall Study|Physician Decision|18|||
130371859|NCT01737697|469331032|FG014|Subacute Phase|Withdrawal by Subject|0|||
130292760|NCT00106691|469035842|FG001|Overall Study|Physician Decision|21|||
130292761|NCT00106691|469035841|FG000|Overall Study|Protocol Violation|13|||
130292762|NCT00106691|469035842|FG001|Overall Study|Protocol Violation|18|||
130292763|NCT00106691|469035841|FG000|Overall Study|Withdrawal by Subject|75|||
130292764|NCT00106691|469035842|FG001|Overall Study|Withdrawal by Subject|70|||
130292765|NCT00106691|469035841|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
130292766|NCT00106691|469035842|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
130292767|NCT00106691|469035841|FG000|Overall Study|QTc>480|3|||
130292768|NCT00106691|469035842|FG001|Overall Study|QTc>480|1|||
130292769|NCT00106691|469035841|FG000|Overall Study|mililtary deployment|2|||
130292770|NCT00106691|469035842|FG001|Overall Study|mililtary deployment|0|||
130460297|NCT04513522|469652048|FG000|Overall Study|Participants withdrew consent|2|||
130460298|NCT00589667|469652049|FG000|Overall Study|Adverse Event|2|||
130460299|NCT00589667|469652049|FG000|Overall Study|Withdrawal by Subject|1|||
130460300|NCT03538041|469652052|FG000|12-Week Treatment Period|Adverse Event|1|||
130460301|NCT03538041|469652053|FG001|12-Week Treatment Period|Adverse Event|1|||
130460302|NCT03538041|469652052|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
130460303|NCT03538041|469652053|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
130460304|NCT03538041|469652052|FG000|Treatment Extension Period|Adverse Event|4|||
130460305|NCT03538041|469652053|FG001|Treatment Extension Period|Adverse Event|1|||
130460306|NCT03538041|469652052|FG000|Treatment Extension Period|Physician Decision|1|||
130460307|NCT03538041|469652053|FG001|Treatment Extension Period|Physician Decision|1|||
130460308|NCT03538041|469652052|FG000|Treatment Extension Period|Lack of Efficacy|1|||
130460309|NCT03538041|469652053|FG001|Treatment Extension Period|Lack of Efficacy|4|||
130460310|NCT03538041|469652052|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
130460311|NCT03538041|469652053|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
130460312|NCT03538041|469652052|FG000|Treatment Extension Period|Death|0|||
130460313|NCT03538041|469652053|FG001|Treatment Extension Period|Death|1|||
130460314|NCT01266265|469652054|FG000|Overall Study|Death|95|||
130460315|NCT01266265|469652055|FG001|Overall Study|Death|73|||
130460316|NCT01266265|469652054|FG000|Overall Study|Lost to Follow-up|23|||
130460317|NCT01266265|469652055|FG001|Overall Study|Lost to Follow-up|28|||
130460318|NCT01266265|469652054|FG000|Overall Study|Withdrawal by Subject|13|||
130292771|NCT00106691|469035841|FG000|Overall Study|Study Site Closing/PI Moved|1|||
130292772|NCT00106691|469035842|FG001|Overall Study|Study Site Closing/PI Moved|2|||
130292773|NCT00106691|469035841|FG000|Overall Study|Cardiologist recommendation|1|||
130292774|NCT00106691|469035842|FG001|Overall Study|Cardiologist recommendation|0|||
130292775|NCT00106691|469035841|FG000|Overall Study|Pt. moved to another state|1|||
130292776|NCT00106691|469035842|FG001|Overall Study|Pt. moved to another state|0|||
130292777|NCT00106691|469035841|FG000|Overall Study|Taking exclusionary avodart|1|||
130292778|NCT00106691|469035842|FG001|Overall Study|Taking exclusionary avodart|0|||
130292779|NCT00106691|469035841|FG000|Overall Study|Not able to discontinue plavix|0|||
130292780|NCT00106691|469035842|FG001|Overall Study|Not able to discontinue plavix|1|||
130292781|NCT00530920|469035843|FG000|Overall Study|Randomized but not treated|0|||
130292782|NCT00530920|469035844|FG001|Overall Study|Randomized but not treated|2|||
130292783|NCT00530920|469035845|FG002|Overall Study|Randomized but not treated|0|||
130292784|NCT00530920|469035843|FG000|Overall Study|Adverse Event|0|||
130292785|NCT00530920|469035844|FG001|Overall Study|Adverse Event|0|||
130292786|NCT00530920|469035845|FG002|Overall Study|Adverse Event|3|||
130292787|NCT00530920|469035843|FG000|Overall Study|Withdrawal by Subject|0|||
130292788|NCT00530920|469035844|FG001|Overall Study|Withdrawal by Subject|0|||
130292789|NCT00530920|469035845|FG002|Overall Study|Withdrawal by Subject|1|||
130292790|NCT04957758|469035847|FG000|Overall Study|Adverse Event|1|||
130292791|NCT04957758|469035848|FG001|Overall Study|Adverse Event|0|||
130292792|NCT04957758|469035847|FG000|Overall Study|Lost to Follow-up|0|||
130292793|NCT04957758|469035848|FG001|Overall Study|Lost to Follow-up|2|||
130292794|NCT04957758|469035847|FG000|Overall Study|Withdrawal by Subject|4|||
130292795|NCT04957758|469035848|FG001|Overall Study|Withdrawal by Subject|2|||
130292796|NCT04957758|469035847|FG000|Overall Study|Protocol Violation|0|||
130292797|NCT04957758|469035848|FG001|Overall Study|Protocol Violation|1|||
130292798|NCT00707746|469035849|FG000|Treatment Period|Adverse Event|2|||
130292799|NCT00707746|469035850|FG001|Treatment Period|Adverse Event|4|||
130292800|NCT00707746|469035849|FG000|Treatment Period|Ineligibility|0|||
130292801|NCT00707746|469035850|FG001|Treatment Period|Ineligibility|1|||
130292802|NCT00685373|469035853|FG000|Overall Study|Adverse Event|3|||
130292803|NCT00685373|469035853|FG000|Overall Study|Withdrawal by Subject|5|||
130292804|NCT00685373|469035853|FG000|Overall Study|Lack of Efficacy|3|||
130460319|NCT01266265|469652055|FG001|Overall Study|Withdrawal by Subject|11|||
130460320|NCT01266265|469652054|FG000|Overall Study|Respiratory-related adverse event|2|||
130460321|NCT01266265|469652055|FG001|Overall Study|Respiratory-related adverse event|1|||
130292805|NCT00685373|469035853|FG000|Overall Study|Condition no longer requires study drug|1|||
130292806|NCT00685373|469035853|FG000|Overall Study|Lost to Follow-up|2|||
130460322|NCT01266265|469652054|FG000|Overall Study|Transferred care to another provider|22|||
130460323|NCT01266265|469652055|FG001|Overall Study|Transferred care to another provider|28|||
130460324|NCT01266265|469652054|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
130292807|NCT00685373|469035853|FG000|Overall Study|Protocol Violation|1|||
130292808|NCT02642965|469035855|FG000|Overall Study|Lack of Efficacy|4|||
130292809|NCT02642965|469035855|FG000|Overall Study|Physician Decision|9|||
130292810|NCT03099148|469035858|FG000|Wash-out|scheduling conflict|0|||
130292811|NCT03099148|469035859|FG001|Wash-out|scheduling conflict|1|||
130292812|NCT03099148|469035860|FG002|Wash-out|scheduling conflict|0|||
130292813|NCT03099148|469035861|FG003|Wash-out|scheduling conflict|0|||
130292814|NCT03099148|469035858|FG000|Wash-out|Adverse Event|0|||
130556725|NCT01822522|470008026|FG001|Overall Study|Death|0|||
130556726|NCT01822522|470008027|FG002|Overall Study|Death|2|||
130556727|NCT01822522|470008028|FG003|Overall Study|Death|0|||
130556728|NCT01822522|470008029|FG004|Overall Study|Death|0|||
130556729|NCT01822522|470008030|FG005|Overall Study|Death|0|||
130556730|NCT01822522|470008025|FG000|Overall Study|Lost to Follow-up|0|||
130556731|NCT01822522|470008026|FG001|Overall Study|Lost to Follow-up|0|||
130556732|NCT01822522|470008027|FG002|Overall Study|Lost to Follow-up|1|||
130556733|NCT01822522|470008028|FG003|Overall Study|Lost to Follow-up|1|||
130556734|NCT01822522|470008029|FG004|Overall Study|Lost to Follow-up|0|||
130556735|NCT01822522|470008030|FG005|Overall Study|Lost to Follow-up|1|||
130556736|NCT01822522|470008025|FG000|Overall Study|Withdrawal by Subject|0|||
130556737|NCT01822522|470008026|FG001|Overall Study|Withdrawal by Subject|0|||
130556738|NCT01822522|470008027|FG002|Overall Study|Withdrawal by Subject|0|||
130556739|NCT01822522|470008028|FG003|Overall Study|Withdrawal by Subject|1|||
130556740|NCT01822522|470008029|FG004|Overall Study|Withdrawal by Subject|0|||
130556741|NCT01822522|470008030|FG005|Overall Study|Withdrawal by Subject|0|||
130556742|NCT01822522|470008025|FG000|Overall Study|Lack of Efficacy|0|||
130556743|NCT01822522|470008026|FG001|Overall Study|Lack of Efficacy|0|||
130292815|NCT03099148|469035859|FG001|Wash-out|Adverse Event|1|||
130292816|NCT03099148|469035860|FG002|Wash-out|Adverse Event|0|||
130556744|NCT01822522|470008027|FG002|Overall Study|Lack of Efficacy|0|||
130556745|NCT01822522|470008028|FG003|Overall Study|Lack of Efficacy|0|||
130556746|NCT01822522|470008029|FG004|Overall Study|Lack of Efficacy|0|||
130556747|NCT01822522|470008030|FG005|Overall Study|Lack of Efficacy|2|||
130556748|NCT00890929|470008031|FG000|Overall Study|Death before treatment|2|||
130556749|NCT00890929|470008031|FG000|Overall Study|Withdrawal by Subject|3|||
130556750|NCT00890929|470008031|FG000|Overall Study|Physician Decision|1|||
130556751|NCT02558231|470008032|FG000|Overall Study|Death|4|||
130556752|NCT02558231|470008033|FG001|Overall Study|Death|12|||
130556753|NCT02558231|470008032|FG000|Overall Study|Lost to Follow-up|7|||
130556754|NCT02558231|470008033|FG001|Overall Study|Lost to Follow-up|4|||
130556755|NCT02558231|470008032|FG000|Overall Study|Withdrawal by Subject|7|||
130556756|NCT02558231|470008033|FG001|Overall Study|Withdrawal by Subject|4|||
130556757|NCT02558231|470008032|FG000|Overall Study|Physician Decision|7|||
130556758|NCT02558231|470008033|FG001|Overall Study|Physician Decision|5|||
130556759|NCT02558231|470008032|FG000|Overall Study|Sponsor Decision|0|||
130556760|NCT02558231|470008033|FG001|Overall Study|Sponsor Decision|1|||
130556761|NCT01006265|470008034|FG000|Overall Study|Lost to Follow-up|1|||
130556762|NCT01006265|470008035|FG001|Overall Study|Lost to Follow-up|0|||
130556763|NCT01006265|470008036|FG002|Overall Study|Lost to Follow-up|1|||
130556764|NCT01006265|470008037|FG003|Overall Study|Lost to Follow-up|0|||
130556765|NCT01006265|470008034|FG000|Overall Study|Withdrawal by Subject|4|||
130556766|NCT01006265|470008035|FG001|Overall Study|Withdrawal by Subject|7|||
130556767|NCT01006265|470008036|FG002|Overall Study|Withdrawal by Subject|5|||
130556768|NCT01006265|470008037|FG003|Overall Study|Withdrawal by Subject|5|||
130556769|NCT01006265|470008034|FG000|Overall Study|Administrative reason|1|||
130556770|NCT01006265|470008035|FG001|Overall Study|Administrative reason|2|||
130556771|NCT01006265|470008036|FG002|Overall Study|Administrative reason|3|||
130556772|NCT01006265|470008037|FG003|Overall Study|Administrative reason|0|||
130556773|NCT04233164|470008040|FG000|Overall Study|Unable to obtain specimen|0|||
130556774|NCT04233164|470008041|FG001|Overall Study|Unable to obtain specimen|1|||
130556775|NCT01840605|470008042|FG000|Overall Study|Adverse Event|0|||
130556776|NCT01840605|470008043|FG001|Overall Study|Adverse Event|1|||
130556777|NCT01840605|470008042|FG000|Overall Study|Physician Decision|2|||
130556778|NCT01840605|470008043|FG001|Overall Study|Physician Decision|1|||
130292817|NCT03099148|469035861|FG003|Wash-out|Adverse Event|0|||
130292818|NCT01703065|469035862|FG000|Overall Study|Lack of Efficacy|1|||
130556779|NCT03065023|470008044|FG000|Overall Study|Progressive Disease|0|||
130556780|NCT03065023|470008045|FG001|Overall Study|Progressive Disease|1|||
130556781|NCT03065023|470008046|FG002|Overall Study|Progressive Disease|0|||
130556782|NCT03065023|470008047|FG003|Overall Study|Progressive Disease|0|||
130556783|NCT03065023|470008048|FG004|Overall Study|Progressive Disease|0|||
130556784|NCT03065023|470008044|FG000|Overall Study|Death|2|||
130556785|NCT03065023|470008045|FG001|Overall Study|Death|0|||
130556786|NCT03065023|470008046|FG002|Overall Study|Death|1|||
130556787|NCT03065023|470008047|FG003|Overall Study|Death|1|||
130556788|NCT03065023|470008048|FG004|Overall Study|Death|0|||
130556789|NCT03065023|470008044|FG000|Overall Study|Lost to Follow-up|0|||
130556790|NCT03065023|470008045|FG001|Overall Study|Lost to Follow-up|1|||
130556791|NCT03065023|470008046|FG002|Overall Study|Lost to Follow-up|0|||
130292819|NCT01703065|469035863|FG001|Overall Study|Lack of Efficacy|0|||
130292820|NCT01439126|469035864|FG000|Overall Study|Adverse Event|2|||
130292821|NCT01439126|469035865|FG001|Overall Study|Adverse Event|0|||
130292822|NCT01439126|469035864|FG000|Overall Study|Withdrawal by Subject|5|||
130556792|NCT03065023|470008047|FG003|Overall Study|Lost to Follow-up|0|||
130292823|NCT01439126|469035865|FG001|Overall Study|Withdrawal by Subject|21|||
130292824|NCT01439126|469035864|FG000|Overall Study|Protocol Violation|6|||
130292825|NCT01439126|469035865|FG001|Overall Study|Protocol Violation|4|||
130292826|NCT01439126|469035864|FG000|Overall Study|Lost to Follow-up|6|||
130292827|NCT01439126|469035865|FG001|Overall Study|Lost to Follow-up|3|||
130292828|NCT01439126|469035864|FG000|Overall Study|Other-Use of prohibited treatment|0|||
130292829|NCT01439126|469035865|FG001|Overall Study|Other-Use of prohibited treatment|2|||
130292830|NCT01439126|469035864|FG000|Overall Study|Other-Miscellaneous|12|||
130292831|NCT01439126|469035865|FG001|Overall Study|Other-Miscellaneous|12|||
130292832|NCT01617447|469035866|FG000|Overall Study|Adverse Event|0|||
130292833|NCT01617447|469035867|FG001|Overall Study|Adverse Event|1|||
130292834|NCT01617447|469035866|FG000|Overall Study|Physician Decision|0|||
130292835|NCT01617447|469035867|FG001|Overall Study|Physician Decision|2|||
130292836|NCT02713529|469035869|FG000|Overall Study|Withdrawal by Subject|3|||
130292837|NCT02713529|469035870|FG001|Overall Study|Withdrawal by Subject|1|||
130292838|NCT02713529|469035871|FG002|Overall Study|Withdrawal by Subject|4|||
130292839|NCT02713529|469035872|FG003|Overall Study|Withdrawal by Subject|2|||
130292840|NCT02713529|469035873|FG004|Overall Study|Withdrawal by Subject|0|||
130292841|NCT02713529|469035874|FG005|Overall Study|Withdrawal by Subject|1|||
130292842|NCT02713529|469035875|FG006|Overall Study|Withdrawal by Subject|1|||
130292843|NCT02713529|469035869|FG000|Overall Study|Lost to Follow-up|1|||
130292844|NCT02713529|469035870|FG001|Overall Study|Lost to Follow-up|0|||
130292845|NCT02713529|469035871|FG002|Overall Study|Lost to Follow-up|1|||
130292846|NCT02713529|469035872|FG003|Overall Study|Lost to Follow-up|0|||
130292847|NCT02713529|469035873|FG004|Overall Study|Lost to Follow-up|0|||
130292848|NCT02713529|469035874|FG005|Overall Study|Lost to Follow-up|0|||
130292849|NCT02713529|469035875|FG006|Overall Study|Lost to Follow-up|0|||
130292850|NCT02713529|469035869|FG000|Overall Study|Death|3|||
130292851|NCT02713529|469035870|FG001|Overall Study|Death|3|||
130292852|NCT02713529|469035871|FG002|Overall Study|Death|26|||
130292853|NCT02713529|469035872|FG003|Overall Study|Death|27|||
130292854|NCT02713529|469035873|FG004|Overall Study|Death|3|||
130292855|NCT02713529|469035874|FG005|Overall Study|Death|13|||
130292856|NCT02713529|469035875|FG006|Overall Study|Death|3|||
130292857|NCT02827500|469035876|FG000|Overall Study|Death|7|||
130292858|NCT02827500|469035877|FG001|Overall Study|Death|3|||
130292859|NCT02827500|469035876|FG000|Overall Study|Lost to Follow-up|1|||
130292860|NCT02827500|469035877|FG001|Overall Study|Lost to Follow-up|1|||
130292861|NCT02827500|469035876|FG000|Overall Study|Withdrawal by Subject|3|||
130292862|NCT02827500|469035877|FG001|Overall Study|Withdrawal by Subject|1|||
130292863|NCT02827500|469035876|FG000|Overall Study|Missing primary endpoint data|3|||
130292864|NCT02827500|469035877|FG001|Overall Study|Missing primary endpoint data|1|||
130460325|NCT01266265|469652055|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
130460326|NCT01266265|469652054|FG000|Overall Study|Enrolled in another clinical study|15|||
130460327|NCT01266265|469652055|FG001|Overall Study|Enrolled in another clinical study|26|||
130460328|NCT01266265|469652054|FG000|Overall Study|Non-compliance|8|||
130460329|NCT01266265|469652055|FG001|Overall Study|Non-compliance|5|||
130460330|NCT01266265|469652054|FG000|Overall Study|Lung transplant|6|||
130460331|NCT01266265|469652055|FG001|Overall Study|Lung transplant|5|||
130460332|NCT01266265|469652054|FG000|Overall Study|Site closed early|4|||
130460333|NCT01266265|469652055|FG001|Overall Study|Site closed early|3|||
130460334|NCT01266265|469652054|FG000|Overall Study|Clinical worsening|1|||
130460335|NCT01266265|469652055|FG001|Overall Study|Clinical worsening|1|||
130460336|NCT01580293|469652056|FG000|Part A_Main Trial|Adverse Event|0|||
130460337|NCT01580293|469652057|FG001|Part A_Main Trial|Adverse Event|2|||
130460338|NCT01580293|469652058|FG002|Part A_Main Trial|Adverse Event|0|||
130460339|NCT01580293|469652056|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
130460340|NCT01580293|469652057|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
130460341|NCT01580293|469652058|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
130460342|NCT01580293|469652056|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
130292865|NCT02827500|469035876|FG000|Overall Study|Other|5|||
130292866|NCT02827500|469035877|FG001|Overall Study|Other|1|||
130292867|NCT02308488|469035878|FG000|Overall Study|Withdrawal by Subject|2|||
130292868|NCT02242981|469035879|FG000|Overall Study|Withdrawal by Subject|1|||
130292869|NCT02644356|469035885|FG000|Overall Study|Withdrawal by Subject|2|||
130292870|NCT00897390|469035887|FG000|Overall Study|Adverse Event|2|||
130292871|NCT00897390|469035887|FG000|Overall Study|No Longer Met Study Criteria|1|||
130292872|NCT00897390|469035887|FG000|Overall Study|Personal Reasons|1|||
130460343|NCT01580293|469652057|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
130460344|NCT01580293|469652058|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
130460345|NCT01580293|469652056|FG000|Part A_Extension|Adverse Event|0|||
130460346|NCT01580293|469652057|FG001|Part A_Extension|Adverse Event|2|||
130460347|NCT01580293|469652058|FG002|Part A_Extension|Adverse Event|0|||
130460348|NCT01580293|469652056|FG000|Part A_Extension|Withdrawal by Subject|0|||
130292873|NCT00897390|469035887|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
130292874|NCT02564978|469035889|FG000|Overall Study|Adverse Event|8|||
130292875|NCT02564978|469035889|FG000|Overall Study|Death|1|||
130292876|NCT02564978|469035889|FG000|Overall Study|Lost to Follow-up|1|||
130292877|NCT02564978|469035889|FG000|Overall Study|Withdrawal by Subject|15|||
130714732|NCT00311311|470581766|FG001|Overall Study|Adverse Event|2|||
130714733|NCT00311311|470581765|FG000|Overall Study|Withdrawal by Subject|1|||
130714734|NCT00311311|470581766|FG001|Overall Study|Withdrawal by Subject|1|||
130714735|NCT00311311|470581765|FG000|Overall Study|Noncompliance|0|||
130714736|NCT00311311|470581766|FG001|Overall Study|Noncompliance|1|||
130714737|NCT00311311|470581765|FG000|Overall Study|Study Termination by Sponsor|3|||
130714738|NCT00311311|470581766|FG001|Overall Study|Study Termination by Sponsor|4|||
130714739|NCT00311311|470581765|FG000|Overall Study|Death|1|||
130714740|NCT00311311|470581766|FG001|Overall Study|Death|0|||
130714741|NCT00311311|470581765|FG000|Overall Study|Lack of ancillary assistance|0|||
130714742|NCT00311311|470581766|FG001|Overall Study|Lack of ancillary assistance|1|||
130714743|NCT03979820|470581769|FG000|Overall Study|Protocol Violation|1|||
130714744|NCT03979820|470581770|FG001|Overall Study|Protocol Violation|0|||
130714745|NCT03979820|470581771|FG002|Overall Study|Protocol Violation|0|||
130714746|NCT03979820|470581772|FG003|Overall Study|Protocol Violation|0|||
130714747|NCT03979820|470581769|FG000|Overall Study|Withdrawal by Subject|0|||
130714748|NCT03979820|470581770|FG001|Overall Study|Withdrawal by Subject|0|||
130714749|NCT03979820|470581771|FG002|Overall Study|Withdrawal by Subject|1|||
130556793|NCT03065023|470008048|FG004|Overall Study|Lost to Follow-up|0|||
130556794|NCT03065023|470008044|FG000|Overall Study|Participant Decision|0|||
130556795|NCT03065023|470008045|FG001|Overall Study|Participant Decision|0|||
130556796|NCT03065023|470008046|FG002|Overall Study|Participant Decision|0|||
130556797|NCT03065023|470008047|FG003|Overall Study|Participant Decision|1|||
130556798|NCT03065023|470008048|FG004|Overall Study|Participant Decision|0|||
130556799|NCT03065023|470008044|FG000|Overall Study|Withdrawal by Subject|0|||
130556800|NCT03065023|470008045|FG001|Overall Study|Withdrawal by Subject|0|||
130556801|NCT03065023|470008046|FG002|Overall Study|Withdrawal by Subject|0|||
130556802|NCT03065023|470008047|FG003|Overall Study|Withdrawal by Subject|1|||
130556803|NCT03065023|470008048|FG004|Overall Study|Withdrawal by Subject|0|||
130556804|NCT04029961|470008049|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
130556805|NCT04029961|470008050|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
130556806|NCT04029961|470008049|FG000|Overall Study|Change in Treatment Course|0|||
130556807|NCT04029961|470008050|FG001|Overall Study|Change in Treatment Course|1|||
130556808|NCT03427125|470008051|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
130556809|NCT03427125|470008052|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
130556810|NCT03427125|470008053|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
130714750|NCT03979820|470581772|FG003|Overall Study|Withdrawal by Subject|0|||
130714751|NCT03979820|470581769|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
130292878|NCT02564978|469035889|FG000|Overall Study|Early Study Closure|2|||
130460349|NCT01580293|469652057|FG001|Part A_Extension|Withdrawal by Subject|3|||
130460350|NCT01580293|469652058|FG002|Part A_Extension|Withdrawal by Subject|0|||
130460351|NCT01580293|469652056|FG000|Part A_Extension|Lost to Follow-up|0|||
130460352|NCT01580293|469652057|FG001|Part A_Extension|Lost to Follow-up|1|||
130460353|NCT01580293|469652058|FG002|Part A_Extension|Lost to Follow-up|0|||
130460354|NCT01580293|469652056|FG000|Part A_Extension|Other Reason|0|||
130460355|NCT01580293|469652057|FG001|Part A_Extension|Other Reason|1|||
130460356|NCT01580293|469652058|FG002|Part A_Extension|Other Reason|0|||
130460357|NCT01580293|469652056|FG000|Part A_Extension|Completed Japan only|0|||
130460358|NCT01580293|469652057|FG001|Part A_Extension|Completed Japan only|5|||
130460359|NCT01580293|469652058|FG002|Part A_Extension|Completed Japan only|0|||
130460360|NCT01580293|469652056|FG000|Part B|Withdrawal by Subject|0|||
130460361|NCT01580293|469652057|FG001|Part B|Withdrawal by Subject|0|||
130460362|NCT01580293|469652058|FG002|Part B|Withdrawal by Subject|1|||
130460363|NCT01580293|469652056|FG000|Part B|Other reason|0|||
130460364|NCT01580293|469652057|FG001|Part B|Other reason|0|||
130460365|NCT01580293|469652058|FG002|Part B|Other reason|1|||
130460366|NCT00028769|469652059|FG000|Overall Study|Adverse Event|2|||
130460367|NCT00028769|469652059|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
130460368|NCT00028769|469652059|FG000|Overall Study|Progression or Death|31|||
130460369|NCT00028769|469652059|FG000|Overall Study|Other - Not Protocol Specified|1|||
130460370|NCT00028769|469652059|FG000|Overall Study|Ineligible|5|||
130460371|NCT00028769|469652059|FG000|Overall Study|Not Analyzable|1|||
130460372|NCT00768664|469652062|FG000|Overall Study|Death|57|||
130460373|NCT00768664|469652062|FG000|Overall Study|Lost to Follow-up|2|||
130460374|NCT00768664|469652062|FG000|Overall Study|Other|9|||
130460375|NCT00768664|469652062|FG000|Overall Study|Participant refused|1|||
130460376|NCT00708032|469652063|FG000|Overall Study|Adverse Event|0|||
130460377|NCT00708032|469652064|FG001|Overall Study|Adverse Event|2|||
130460378|NCT00708032|469652063|FG000|Overall Study|Lost to Follow-up|1|||
130460379|NCT00708032|469652064|FG001|Overall Study|Lost to Follow-up|2|||
130714752|NCT03979820|470581770|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130714753|NCT03979820|470581771|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130292879|NCT02564978|469035889|FG000|Overall Study|Other Reason|5|||
130460380|NCT00708032|469652063|FG000|Overall Study|Pregnancy|0|||
130292880|NCT01825941|469037451|FG000|Overall Study|Lost to Follow-up|4|||
130292881|NCT01825941|469037452|FG001|Overall Study|Lost to Follow-up|1|||
130292882|NCT00203021|469037453|FG000|Overall Study|Death|4|||
130292883|NCT00203021|469037454|FG001|Overall Study|Death|1|||
130292884|NCT00203021|469037453|FG000|Overall Study|Adverse Event|10|||
130292885|NCT00203021|469037454|FG001|Overall Study|Adverse Event|5|||
130292886|NCT00203021|469037453|FG000|Overall Study|Withdrawal by Subject|45|||
130292887|NCT00203021|469037454|FG001|Overall Study|Withdrawal by Subject|48|||
130292888|NCT00203021|469037453|FG000|Overall Study|Lost to Follow-up|9|||
130460381|NCT00708032|469652064|FG001|Overall Study|Pregnancy|1|||
130460382|NCT00708032|469652063|FG000|Overall Study|Poor vision|0|||
130460383|NCT00708032|469652064|FG001|Overall Study|Poor vision|6|||
130460384|NCT00708032|469652063|FG000|Overall Study|Visit out of range at month 12|4|||
130460385|NCT00708032|469652064|FG001|Overall Study|Visit out of range at month 12|1|||
130460386|NCT00708032|469652063|FG000|Overall Study|Did not meet protocol criteria|1|||
130460387|NCT00708032|469652064|FG001|Overall Study|Did not meet protocol criteria|2|||
130460388|NCT00708032|469652063|FG000|Overall Study|Protocol Violation|4|||
130460389|NCT00708032|469652064|FG001|Overall Study|Protocol Violation|1|||
130460390|NCT00708032|469652063|FG000|Overall Study|Withdrawal by Subject|0|||
130460391|NCT00708032|469652064|FG001|Overall Study|Withdrawal by Subject|1|||
130460392|NCT01400776|469652065|FG000|Overall Study|Adverse Event|7|||
130460393|NCT01400776|469652066|FG001|Overall Study|Adverse Event|2|||
130460394|NCT01400776|469652067|FG002|Overall Study|Adverse Event|9|||
130460395|NCT01400776|469652068|FG003|Overall Study|Adverse Event|2|||
130460396|NCT01400776|469652065|FG000|Overall Study|Lost to Follow-up|1|||
130292889|NCT00203021|469037454|FG001|Overall Study|Lost to Follow-up|7|||
130292890|NCT00203021|469037453|FG000|Overall Study|Other than specified|11|||
130292891|NCT00203021|469037454|FG001|Overall Study|Other than specified|16|||
130292892|NCT04284813|469037464|FG000|Overall Study|Withdrawal by Subject|1|||
130292893|NCT00431951|469037465|FG000|Overall Study|Inability to follow study procedures|1|||
130292894|NCT00431951|469037466|FG001|Overall Study|Inability to follow study procedures|0|||
130292895|NCT00431951|469037467|FG002|Overall Study|Inability to follow study procedures|1|||
130292896|NCT00431951|469037468|FG003|Overall Study|Inability to follow study procedures|2|||
130292897|NCT00431951|469037465|FG000|Overall Study|Lost to Follow-up|0|||
130292898|NCT00431951|469037466|FG001|Overall Study|Lost to Follow-up|1|||
130292899|NCT00431951|469037467|FG002|Overall Study|Lost to Follow-up|0|||
130292900|NCT00431951|469037468|FG003|Overall Study|Lost to Follow-up|0|||
130292901|NCT00431951|469037465|FG000|Overall Study|Withdrawal by Subject|0|||
130292902|NCT00431951|469037466|FG001|Overall Study|Withdrawal by Subject|1|||
130292903|NCT00431951|469037467|FG002|Overall Study|Withdrawal by Subject|0|||
130371860|NCT01737697|469331018|FG000|Subacute Phase|Lost to Follow-up|0|||
130371861|NCT01737697|469331019|FG001|Subacute Phase|Lost to Follow-up|0|||
130371862|NCT01737697|469331020|FG002|Subacute Phase|Lost to Follow-up|0|||
130460397|NCT01400776|469652066|FG001|Overall Study|Lost to Follow-up|0|||
130460398|NCT01400776|469652067|FG002|Overall Study|Lost to Follow-up|4|||
130460399|NCT01400776|469652068|FG003|Overall Study|Lost to Follow-up|1|||
130460400|NCT01400776|469652065|FG000|Overall Study|Withdrew Consent|4|||
130460401|NCT01400776|469652066|FG001|Overall Study|Withdrew Consent|2|||
130460402|NCT01400776|469652067|FG002|Overall Study|Withdrew Consent|6|||
130460403|NCT01400776|469652068|FG003|Overall Study|Withdrew Consent|1|||
130460404|NCT01400776|469652065|FG000|Overall Study|Protocol Deviation|6|||
130460405|NCT01400776|469652066|FG001|Overall Study|Protocol Deviation|1|||
130556811|NCT05975840|470008054|FG000|Overall Study|Other|1|||
130556812|NCT05975840|470008055|FG001|Overall Study|Other|0|||
130292904|NCT00431951|469037468|FG003|Overall Study|Withdrawal by Subject|0|||
130292905|NCT00431951|469037465|FG000|Overall Study|Adverse Event|0|||
130292906|NCT00431951|469037466|FG001|Overall Study|Adverse Event|0|||
130292907|NCT00431951|469037467|FG002|Overall Study|Adverse Event|1|||
130292908|NCT00431951|469037468|FG003|Overall Study|Adverse Event|0|||
130371863|NCT01737697|469331021|FG003|Subacute Phase|Lost to Follow-up|0|||
130371864|NCT01737697|469331022|FG004|Subacute Phase|Lost to Follow-up|0|||
130371865|NCT01737697|469331023|FG005|Subacute Phase|Lost to Follow-up|0|||
130371866|NCT01737697|469331024|FG006|Subacute Phase|Lost to Follow-up|0|||
130371867|NCT01737697|469331025|FG007|Subacute Phase|Lost to Follow-up|0|||
130371868|NCT01737697|469331026|FG008|Subacute Phase|Lost to Follow-up|0|||
130460406|NCT01400776|469652067|FG002|Overall Study|Protocol Deviation|5|||
130460407|NCT01400776|469652068|FG003|Overall Study|Protocol Deviation|2|||
130460408|NCT01400776|469652065|FG000|Overall Study|Reason not Specified|3|||
130460409|NCT01400776|469652066|FG001|Overall Study|Reason not Specified|0|||
130460410|NCT01400776|469652067|FG002|Overall Study|Reason not Specified|4|||
130460411|NCT01400776|469652068|FG003|Overall Study|Reason not Specified|3|||
130460412|NCT00423098|469652069|FG000|Overall Study|Adverse Event|1|||
130292909|NCT01146288|469037469|FG000|First Intervention(1 Day)|Adverse Event|0|||
130371869|NCT01737697|469331027|FG009|Subacute Phase|Lost to Follow-up|0|||
130556813|NCT05975840|470008056|FG002|Overall Study|Other|0|||
130714754|NCT03979820|470581772|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
130714755|NCT00988065|470581773|FG000|Overall Study|Adverse Event|4|||
130714756|NCT00988065|470581774|FG001|Overall Study|Adverse Event|10|||
130714757|NCT00988065|470581775|FG002|Overall Study|Adverse Event|2|||
130714758|NCT00988065|470581773|FG000|Overall Study|Lost to Follow-up|1|||
130714759|NCT00988065|470581774|FG001|Overall Study|Lost to Follow-up|2|||
130714760|NCT00988065|470581775|FG002|Overall Study|Lost to Follow-up|2|||
130292910|NCT01146288|469037470|FG001|First Intervention(1 Day)|Adverse Event|1|||
130292911|NCT00385723|469037471|FG000|Overall Study|Lost to Follow-up|1|||
130292912|NCT00385723|469037472|FG001|Overall Study|Lost to Follow-up|1|||
130292913|NCT00385723|469037473|FG002|Overall Study|Lost to Follow-up|0|||
130292914|NCT00385723|469037471|FG000|Overall Study|Withdrawal by Subject|1|||
130292915|NCT00385723|469037472|FG001|Overall Study|Withdrawal by Subject|0|||
130714761|NCT00988065|470581773|FG000|Overall Study|Subject withdrew consent|3|||
130714762|NCT00988065|470581774|FG001|Overall Study|Subject withdrew consent|5|||
130714763|NCT00988065|470581775|FG002|Overall Study|Subject withdrew consent|2|||
130714764|NCT00988065|470581773|FG000|Overall Study|Noncompliance with protocol|5|||
130714765|NCT00988065|470581774|FG001|Overall Study|Noncompliance with protocol|6|||
130714766|NCT00988065|470581775|FG002|Overall Study|Noncompliance with protocol|9|||
130714767|NCT02685202|470581776|FG000|Overall Study|Lost to Follow-up|9|||
130714768|NCT01229735|470581777|FG000|Overall Study|Lack of Efficacy|8|||
130714769|NCT01229735|470581778|FG001|Overall Study|Lack of Efficacy|8|||
130714770|NCT01229735|470581777|FG000|Overall Study|Protocol Violation|13|||
130714771|NCT01229735|470581778|FG001|Overall Study|Protocol Violation|8|||
130714772|NCT01229735|470581777|FG000|Overall Study|Lost to Follow-up|0|||
130292916|NCT00385723|469037473|FG002|Overall Study|Withdrawal by Subject|2|||
130292917|NCT01100528|469037476|FG000|Overall Study|Death|1|||
130292918|NCT01100528|469037476|FG000|Overall Study|Withdrawal by Subject|2|||
130292919|NCT01299571|469037481|FG000|Overall Study|Protocol Violation|107|||
130292920|NCT00708734|469037484|FG000|Overall Study|scheduling conflict|2|||
130292921|NCT00708734|469037484|FG000|Overall Study|moved|1|||
130292922|NCT00708734|469037484|FG000|Overall Study|leg injury|1|||
130292923|NCT00708734|469037484|FG000|Overall Study|knee replacement|1|||
130292924|NCT00708734|469037484|FG000|Overall Study|vertigo|1|||
130460413|NCT00423098|469652070|FG001|Overall Study|Adverse Event|2|||
130460414|NCT00423098|469652069|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130460415|NCT00423098|469652070|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130460416|NCT00423098|469652069|FG000|Overall Study|Administrative problems|0|||
130460417|NCT00423098|469652070|FG001|Overall Study|Administrative problems|1|||
130460418|NCT00423098|469652069|FG000|Overall Study|Death|2|||
130460419|NCT00423098|469652070|FG001|Overall Study|Death|0|||
130460420|NCT04480827|469652072|FG000|Overall Study|Adverse Event|0|||
130460421|NCT04480827|469652073|FG001|Overall Study|Adverse Event|0|||
130460422|NCT04480827|469652074|FG002|Overall Study|Adverse Event|0|||
130460423|NCT04480827|469652075|FG003|Overall Study|Adverse Event|0|||
130556814|NCT05975840|470008057|FG003|Overall Study|Other|0|||
130714773|NCT01229735|470581778|FG001|Overall Study|Lost to Follow-up|2|||
130714774|NCT01229735|470581777|FG000|Overall Study|Withdrawal by Subject|18|||
130714775|NCT01229735|470581778|FG001|Overall Study|Withdrawal by Subject|17|||
130292925|NCT00708734|469037484|FG000|Overall Study|leg fracture|1|||
130292926|NCT02006069|469037486|FG000|Overall Study|MPP other programming|239|||
130292927|NCT02006069|469037487|FG001|Overall Study|MPP other programming|0|||
130292928|NCT02006069|469037486|FG000|Overall Study|RV only pacing|0|||
130292929|NCT02006069|469037487|FG001|Overall Study|RV only pacing|3|||
130292930|NCT02066129|469037488|FG000|Overall Study|Lost to Follow-up|13|||
130292931|NCT02066129|469037489|FG001|Overall Study|Lost to Follow-up|12|||
130292932|NCT02066129|469037488|FG000|Overall Study|Withdrawal by Subject|7|||
130714776|NCT01229735|470581777|FG000|Overall Study|Other Reason|13|||
130714777|NCT01229735|470581778|FG001|Overall Study|Other Reason|10|||
130714778|NCT01229735|470581777|FG000|Overall Study|SAE, non-fatal|0|||
130292933|NCT02066129|469037489|FG001|Overall Study|Withdrawal by Subject|10|||
130292934|NCT02066129|469037488|FG000|Overall Study|Lack of Efficacy|8|||
130292935|NCT02066129|469037489|FG001|Overall Study|Lack of Efficacy|10|||
130292936|NCT02066129|469037488|FG000|Overall Study|Physician Decision|1|||
130292937|NCT02066129|469037489|FG001|Overall Study|Physician Decision|1|||
130292938|NCT00316888|469037493|FG000|Overall Study|Adverse Event|4|||
130292939|NCT00316888|469037494|FG001|Overall Study|Adverse Event|5|||
130292940|NCT00316888|469037493|FG000|Overall Study|Withdrawal by Subject|2|||
130292941|NCT00316888|469037494|FG001|Overall Study|Withdrawal by Subject|2|||
130292942|NCT00316888|469037493|FG000|Overall Study|Not start protocol therapy|0|||
130460424|NCT04480827|469652076|FG004|Overall Study|Adverse Event|0|||
130460425|NCT04480827|469652077|FG005|Overall Study|Adverse Event|1|||
130556815|NCT05975840|470008058|FG004|Overall Study|Other|1|||
130292943|NCT00316888|469037494|FG001|Overall Study|Not start protocol therapy|1|||
130292944|NCT00857948|469037495|FG000|Overall Study|Withdrawal by Subject|2|||
130460426|NCT04480827|469652078|FG006|Overall Study|Adverse Event|0|||
130714779|NCT01229735|470581778|FG001|Overall Study|SAE, non-fatal|4|||
130714780|NCT01229735|470581777|FG000|Overall Study|AE, non-serious non-fatal|13|||
130714781|NCT01229735|470581778|FG001|Overall Study|AE, non-serious non-fatal|17|||
130292945|NCT00857948|469037496|FG001|Overall Study|Withdrawal by Subject|0|||
130292946|NCT00857948|469037497|FG002|Overall Study|Withdrawal by Subject|0|||
130292947|NCT00857948|469037498|FG003|Overall Study|Withdrawal by Subject|0|||
130292948|NCT00857948|469037495|FG000|Overall Study|Protocol Violation|1|||
130292949|NCT00857948|469037496|FG001|Overall Study|Protocol Violation|0|||
130292950|NCT00857948|469037497|FG002|Overall Study|Protocol Violation|1|||
130292951|NCT00857948|469037498|FG003|Overall Study|Protocol Violation|0|||
130292952|NCT00815191|469037499|FG000|Overall Study|Protocol Violation|1|||
130292953|NCT00815191|469037500|FG001|Overall Study|Protocol Violation|1|||
130292954|NCT01814670|469037503|FG000|Overall Study|Protocol Violation|12|||
130292955|NCT03443427|469037504|FG000|Overall Study|Adverse Event|2|||
130292956|NCT03443427|469037505|FG001|Overall Study|Adverse Event|3|||
130292957|NCT03443427|469037504|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
130292958|NCT03443427|469037505|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130292959|NCT03443427|469037504|FG000|Overall Study|Other|4|||
130292960|NCT03443427|469037505|FG001|Overall Study|Other|6|||
130292961|NCT02576860|469037506|FG000|Overall Study|Adverse Event|6|||
130292962|NCT02576860|469037507|FG001|Overall Study|Adverse Event|6|||
130292963|NCT02576860|469037506|FG000|Overall Study|Lost to Follow-up|5|||
130292964|NCT02576860|469037507|FG001|Overall Study|Lost to Follow-up|7|||
130292965|NCT02576860|469037506|FG000|Overall Study|Physician Decision|0|||
130292966|NCT02576860|469037507|FG001|Overall Study|Physician Decision|1|||
130292967|NCT02576860|469037506|FG000|Overall Study|Protocol Violation|0|||
130292968|NCT02576860|469037507|FG001|Overall Study|Protocol Violation|2|||
130292969|NCT02576860|469037506|FG000|Overall Study|Withdrawal by Subject|13|||
130292970|NCT02576860|469037507|FG001|Overall Study|Withdrawal by Subject|8|||
130292971|NCT02576860|469037506|FG000|Overall Study|Disallowed medication|1|||
130292972|NCT02576860|469037507|FG001|Overall Study|Disallowed medication|0|||
130292973|NCT01541917|469037508|FG000|Overall Study|Lost to Follow-up|2|||
130292974|NCT01541917|469037509|FG001|Overall Study|Lost to Follow-up|2|||
130292975|NCT01541917|469037508|FG000|Overall Study|Withdrawal by Subject|13|||
130292976|NCT01541917|469037509|FG001|Overall Study|Withdrawal by Subject|7|||
130292977|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
130292978|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
130292979|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
130292980|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
130292981|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
130292982|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
130292983|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
130292984|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
130292985|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
130371870|NCT01737697|469331028|FG010|Subacute Phase|Lost to Follow-up|0|||
130371871|NCT01737697|469331029|FG011|Subacute Phase|Lost to Follow-up|0|||
130371872|NCT01737697|469331030|FG012|Subacute Phase|Lost to Follow-up|0|||
130371873|NCT01737697|469331031|FG013|Subacute Phase|Lost to Follow-up|0|||
130371874|NCT01737697|469331032|FG014|Subacute Phase|Lost to Follow-up|1|||
130371875|NCT01737697|469331018|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
130371876|NCT01737697|469331019|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
130371877|NCT01737697|469331020|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
130371878|NCT01737697|469331021|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
130371879|NCT01737697|469331022|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
130371880|NCT01737697|469331023|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
130371881|NCT01737697|469331024|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
130371882|NCT01737697|469331025|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
130371883|NCT01737697|469331026|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
130371884|NCT01737697|469331027|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
130371885|NCT01737697|469331028|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
130371886|NCT01737697|469331029|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
130371887|NCT01737697|469331030|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
130371888|NCT01737697|469331031|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
130371889|NCT01737697|469331032|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
130371890|NCT01737697|469331018|FG000|Subacute Phase|Protocol Violation|0|||
130292986|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
130292987|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
130292988|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
130292989|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
130292990|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
130292991|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
130292992|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
130371891|NCT01737697|469331019|FG001|Subacute Phase|Protocol Violation|0|||
130371892|NCT01737697|469331020|FG002|Subacute Phase|Protocol Violation|0|||
130371893|NCT01737697|469331021|FG003|Subacute Phase|Protocol Violation|0|||
130371894|NCT01737697|469331022|FG004|Subacute Phase|Protocol Violation|0|||
130371895|NCT01737697|469331023|FG005|Subacute Phase|Protocol Violation|1|||
130292993|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
130292994|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
130292995|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130292996|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130292997|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130292998|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130292999|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
130293000|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130293001|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130293002|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293003|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293004|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130293005|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130293006|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293007|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Other Reason|1|||
130293008|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Other Reason|0|||
130293009|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Other Reason|0|||
130293010|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Other Reason|0|||
130293011|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Other Reason|0|||
130293012|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130293013|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
130293014|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
130293015|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130293016|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
130293017|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
130293018|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
130293019|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
130293020|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
130293021|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
130293022|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
130293023|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
130293024|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
130293025|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
130293026|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
130293027|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
130293028|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
130293029|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130293030|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
130293031|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130293032|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130293033|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
130293034|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130293035|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
130293036|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
130371896|NCT01737697|469331024|FG006|Subacute Phase|Protocol Violation|0|||
130371897|NCT01737697|469331025|FG007|Subacute Phase|Protocol Violation|0|||
130371898|NCT01737697|469331026|FG008|Subacute Phase|Protocol Violation|0|||
130371899|NCT01737697|469331027|FG009|Subacute Phase|Protocol Violation|0|||
130371900|NCT01737697|469331028|FG010|Subacute Phase|Protocol Violation|1|||
130371901|NCT01737697|469331029|FG011|Subacute Phase|Protocol Violation|0|||
130371902|NCT01737697|469331030|FG012|Subacute Phase|Protocol Violation|0|||
130371903|NCT01737697|469331031|FG013|Subacute Phase|Protocol Violation|0|||
130371904|NCT01737697|469331032|FG014|Subacute Phase|Protocol Violation|0|||
130371905|NCT01737697|469331018|FG000|Subacute Phase|Physician Decision|0|||
130371906|NCT01737697|469331019|FG001|Subacute Phase|Physician Decision|0|||
130371907|NCT01737697|469331020|FG002|Subacute Phase|Physician Decision|0|||
130371908|NCT01737697|469331021|FG003|Subacute Phase|Physician Decision|0|||
130371909|NCT01737697|469331022|FG004|Subacute Phase|Physician Decision|0|||
130371910|NCT01737697|469331023|FG005|Subacute Phase|Physician Decision|0|||
130371911|NCT01737697|469331024|FG006|Subacute Phase|Physician Decision|0|||
130371912|NCT01737697|469331025|FG007|Subacute Phase|Physician Decision|0|||
130371913|NCT01737697|469331026|FG008|Subacute Phase|Physician Decision|1|||
130371914|NCT01737697|469331027|FG009|Subacute Phase|Physician Decision|0|||
130371915|NCT01737697|469331028|FG010|Subacute Phase|Physician Decision|0|||
130371916|NCT01737697|469331029|FG011|Subacute Phase|Physician Decision|0|||
130371917|NCT01737697|469331030|FG012|Subacute Phase|Physician Decision|0|||
130371918|NCT01737697|469331031|FG013|Subacute Phase|Physician Decision|0|||
130371919|NCT01737697|469331032|FG014|Subacute Phase|Physician Decision|0|||
130714782|NCT01229735|470581777|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130293037|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130293038|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
130293039|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130293040|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130293041|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130293042|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
130293043|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
130293044|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
130293045|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
130293046|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
130293047|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130293048|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
130293049|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130293050|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130293051|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130293052|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Death|0|||
130293053|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Death|0|||
130293054|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Death|0|||
130293055|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Death|1|||
130293056|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Death|0|||
130293057|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Missing|0|||
130293058|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Missing|0|||
130293059|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Missing|1|||
130293060|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Missing|0|||
130293061|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Missing|0|||
130293062|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
130293063|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
130293064|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
130293065|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
130293066|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
130293067|NCT00094107|469037525|FG000|Overall Study|Lack of Efficacy|23|||
130293068|NCT00094107|469037525|FG000|Overall Study|Death|5|||
130293069|NCT00094107|469037525|FG000|Overall Study|Adverse Event|3|||
130293070|NCT00094107|469037525|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
130293071|NCT00525824|469037528|FG000|Overall Study|Adverse Event|7|||
130293072|NCT00525824|469037529|FG001|Overall Study|Adverse Event|11|||
130293073|NCT00525824|469037530|FG002|Overall Study|Adverse Event|6|||
130293074|NCT00525824|469037531|FG003|Overall Study|Adverse Event|7|||
130293075|NCT00525824|469037528|FG000|Overall Study|Withdrawal by Subject|5|||
130293076|NCT00525824|469037529|FG001|Overall Study|Withdrawal by Subject|9|||
130293077|NCT00525824|469037530|FG002|Overall Study|Withdrawal by Subject|3|||
130293078|NCT00525824|469037531|FG003|Overall Study|Withdrawal by Subject|4|||
130293079|NCT00525824|469037528|FG000|Overall Study|Lost to Follow-up|4|||
130293080|NCT00525824|469037529|FG001|Overall Study|Lost to Follow-up|2|||
130293081|NCT00525824|469037530|FG002|Overall Study|Lost to Follow-up|4|||
130293082|NCT00525824|469037531|FG003|Overall Study|Lost to Follow-up|0|||
130293083|NCT00525824|469037528|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130293084|NCT00525824|469037529|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130293085|NCT00525824|469037530|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130293086|NCT00525824|469037531|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130293087|NCT00525824|469037528|FG000|Overall Study|Severe non-compliance|0|||
130293088|NCT00525824|469037529|FG001|Overall Study|Severe non-compliance|1|||
130293089|NCT00525824|469037530|FG002|Overall Study|Severe non-compliance|1|||
130293090|NCT00525824|469037531|FG003|Overall Study|Severe non-compliance|1|||
130293091|NCT00525824|469037528|FG000|Overall Study|Safety reasons|1|||
130293092|NCT00525824|469037529|FG001|Overall Study|Safety reasons|0|||
130293093|NCT00525824|469037530|FG002|Overall Study|Safety reasons|1|||
130293094|NCT00525824|469037531|FG003|Overall Study|Safety reasons|0|||
130293095|NCT00525824|469037528|FG000|Overall Study|Other|1|||
130293096|NCT00525824|469037529|FG001|Overall Study|Other|3|||
130714783|NCT01229735|470581778|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130293097|NCT00525824|469037530|FG002|Overall Study|Other|3|||
130293098|NCT00525824|469037531|FG003|Overall Study|Other|1|||
130293099|NCT00806442|469037535|FG000|Overall Study|Lost to Follow-up|3|||
130293100|NCT00806442|469037536|FG001|Overall Study|Lost to Follow-up|2|||
130293101|NCT00806442|469037535|FG000|Overall Study|Withdrawal by Subject|1|||
130293102|NCT00806442|469037536|FG001|Overall Study|Withdrawal by Subject|5|||
130293103|NCT01264770|469037552|FG000|Overall Study|Not reported|0|||
130293104|NCT01264770|469037553|FG001|Overall Study|Not reported|0|||
130293105|NCT01264770|469037554|FG002|Overall Study|Not reported|1|||
130556816|NCT05975840|470008059|FG005|Overall Study|Other|0|||
130556817|NCT05975840|470008060|FG006|Overall Study|Other|0|||
130556818|NCT05975840|470008061|FG007|Overall Study|Other|0|||
130556819|NCT05975840|470008054|FG000|Overall Study|Lost to Follow-up|3|||
130556820|NCT05975840|470008055|FG001|Overall Study|Lost to Follow-up|6|||
130556821|NCT05975840|470008056|FG002|Overall Study|Lost to Follow-up|3|||
130556822|NCT05975840|470008057|FG003|Overall Study|Lost to Follow-up|1|||
130556823|NCT05975840|470008058|FG004|Overall Study|Lost to Follow-up|4|||
130714784|NCT02787408|470581779|FG000|Overall Study|Death|16|||
130714785|NCT02787408|470581779|FG000|Overall Study|Withdrawal by Subject|1|||
130556824|NCT05975840|470008059|FG005|Overall Study|Lost to Follow-up|1|||
130556825|NCT05975840|470008060|FG006|Overall Study|Lost to Follow-up|2|||
130714786|NCT02787408|470581779|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
130714787|NCT00985712|470581780|FG000|Overall Study|Adverse Event|0|||
130714788|NCT00985712|470581781|FG001|Overall Study|Adverse Event|1|||
130714789|NCT00985712|470581780|FG000|Overall Study|Lost to Follow-up|2|||
130714790|NCT00985712|470581781|FG001|Overall Study|Lost to Follow-up|2|||
130714791|NCT00985712|470581780|FG000|Overall Study|Protocol Violation|0|||
130714792|NCT00985712|470581781|FG001|Overall Study|Protocol Violation|1|||
130714793|NCT00985712|470581780|FG000|Overall Study|Withdrawal by Subject|4|||
130714794|NCT00985712|470581781|FG001|Overall Study|Withdrawal by Subject|1|||
130714795|NCT00985712|470581780|FG000|Overall Study|Sponsor decision|0|||
130714796|NCT00985712|470581781|FG001|Overall Study|Sponsor decision|2|||
130714797|NCT01000493|470581782|FG000|Overall Study|Adverse Event|3|||
130714798|NCT01000493|470581783|FG001|Overall Study|Adverse Event|6|||
130714799|NCT01000493|470581782|FG000|Overall Study|Lack of Efficacy|1|||
130714800|NCT01000493|470581783|FG001|Overall Study|Lack of Efficacy|1|||
130293106|NCT01264770|469037555|FG003|Overall Study|Not reported|0|||
130293107|NCT01264770|469037556|FG004|Overall Study|Not reported|0|||
130293108|NCT01264770|469037557|FG005|Overall Study|Not reported|0|||
130293109|NCT01264770|469037552|FG000|Overall Study|e.g., change in circumstances|8|||
130293110|NCT01264770|469037553|FG001|Overall Study|e.g., change in circumstances|3|||
130293111|NCT01264770|469037554|FG002|Overall Study|e.g., change in circumstances|3|||
130293112|NCT01264770|469037555|FG003|Overall Study|e.g., change in circumstances|3|||
130293113|NCT01264770|469037556|FG004|Overall Study|e.g., change in circumstances|4|||
130293114|NCT01264770|469037557|FG005|Overall Study|e.g., change in circumstances|4|||
130293115|NCT01264770|469037552|FG000|Overall Study|Severe non-compliance to protocol|0|||
130293116|NCT01264770|469037553|FG001|Overall Study|Severe non-compliance to protocol|0|||
130293117|NCT01264770|469037554|FG002|Overall Study|Severe non-compliance to protocol|1|||
130293118|NCT01264770|469037555|FG003|Overall Study|Severe non-compliance to protocol|1|||
130293119|NCT01264770|469037556|FG004|Overall Study|Severe non-compliance to protocol|0|||
130293120|NCT01264770|469037557|FG005|Overall Study|Severe non-compliance to protocol|0|||
130293121|NCT01264770|469037552|FG000|Overall Study|Lack of therapeutic response|1|||
130293122|NCT01264770|469037553|FG001|Overall Study|Lack of therapeutic response|0|||
130293123|NCT01264770|469037554|FG002|Overall Study|Lack of therapeutic response|2|||
130293124|NCT01264770|469037555|FG003|Overall Study|Lack of therapeutic response|1|||
130293125|NCT01264770|469037556|FG004|Overall Study|Lack of therapeutic response|1|||
130293126|NCT01264770|469037557|FG005|Overall Study|Lack of therapeutic response|0|||
130293127|NCT01264770|469037552|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
130293128|NCT01264770|469037553|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130293129|NCT01264770|469037554|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
130293130|NCT01264770|469037555|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
130293131|NCT01264770|469037556|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
130293132|NCT01264770|469037557|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
130293133|NCT01264770|469037552|FG000|Overall Study|Lost to Follow-up|0|||
130293134|NCT01264770|469037553|FG001|Overall Study|Lost to Follow-up|0|||
130293135|NCT01264770|469037554|FG002|Overall Study|Lost to Follow-up|1|||
130293136|NCT01264770|469037555|FG003|Overall Study|Lost to Follow-up|1|||
130293137|NCT01264770|469037556|FG004|Overall Study|Lost to Follow-up|0|||
130714801|NCT01000493|470581782|FG000|Overall Study|Protocol Violation|1|||
130714802|NCT01000493|470581783|FG001|Overall Study|Protocol Violation|8|||
130714803|NCT01000493|470581782|FG000|Overall Study|Study closed/terminated|25|||
130714804|NCT01000493|470581783|FG001|Overall Study|Study closed/terminated|23|||
130293138|NCT01264770|469037557|FG005|Overall Study|Lost to Follow-up|0|||
130293139|NCT01264770|469037552|FG000|Overall Study|Adverse Event|7|||
130293140|NCT01264770|469037553|FG001|Overall Study|Adverse Event|7|||
130556826|NCT05975840|470008061|FG007|Overall Study|Lost to Follow-up|4|||
130556827|NCT05975840|470008054|FG000|Overall Study|Migrated/moved from the study area|1|||
130714805|NCT01000493|470581782|FG000|Overall Study|Lost to Follow-up|5|||
130714806|NCT01000493|470581783|FG001|Overall Study|Lost to Follow-up|9|||
130714807|NCT01000493|470581782|FG000|Overall Study|Physician Decision|1|||
130714808|NCT01000493|470581783|FG001|Overall Study|Physician Decision|1|||
130556828|NCT05975840|470008055|FG001|Overall Study|Migrated/moved from the study area|0|||
130714809|NCT01000493|470581782|FG000|Overall Study|Withdrawal by Subject|3|||
130714810|NCT01000493|470581783|FG001|Overall Study|Withdrawal by Subject|7|||
130714811|NCT01346774|470581784|FG000|Overall Study|Did not take a single dose|6|||
130714812|NCT01346774|470581785|FG001|Overall Study|Did not take a single dose|4|||
130714813|NCT01346774|470581784|FG000|Overall Study|Lost to Follow-up|3|||
130714814|NCT01346774|470581785|FG001|Overall Study|Lost to Follow-up|4|||
130714815|NCT01346774|470581784|FG000|Overall Study|Withdrawal by Subject|1|||
130714816|NCT01346774|470581785|FG001|Overall Study|Withdrawal by Subject|4|||
130293141|NCT01264770|469037554|FG002|Overall Study|Adverse Event|8|||
130293142|NCT01264770|469037555|FG003|Overall Study|Adverse Event|0|||
130293143|NCT01264770|469037556|FG004|Overall Study|Adverse Event|2|||
130293144|NCT01264770|469037557|FG005|Overall Study|Adverse Event|1|||
130293145|NCT02356887|469037561|FG000|Overall Study|poor compliance|2|||
130293146|NCT01490294|469037562|FG000|Overall Study|Prematurely discontinuation|4|||
130293147|NCT01490294|469037563|FG001|Overall Study|Prematurely discontinuation|0|||
130293148|NCT01490294|469037564|FG002|Overall Study|Prematurely discontinuation|1|||
130293149|NCT01490294|469037565|FG003|Overall Study|Prematurely discontinuation|1|||
130293150|NCT01490294|469037562|FG000|Overall Study|Adverse Event|1|||
130293151|NCT01490294|469037563|FG001|Overall Study|Adverse Event|0|||
130293152|NCT01490294|469037564|FG002|Overall Study|Adverse Event|0|||
130293153|NCT01490294|469037565|FG003|Overall Study|Adverse Event|0|||
130293154|NCT00160654|469037572|FG000|Overall Study|Adverse Event|14|||
130293155|NCT00160654|469037572|FG000|Overall Study|Lack of Efficacy|4|||
130293156|NCT00160654|469037572|FG000|Overall Study|Lost to Follow-up|2|||
130293157|NCT00160654|469037572|FG000|Overall Study|Intake of expired drug|7|||
130293158|NCT00160654|469037572|FG000|Overall Study|Psychological trauma|1|||
130293159|NCT00160654|469037572|FG000|Overall Study|Sponsor decision|1|||
130293160|NCT00160654|469037572|FG000|Overall Study|Patient met exclusion criteria|1|||
130293161|NCT00160654|469037572|FG000|Overall Study|Patient decision|1|||
130293162|NCT00160654|469037572|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
130293163|NCT00160654|469037572|FG000|Overall Study|Met exclusion criteria|1|||
130293164|NCT02404649|469037573|FG000|Overall Study|Adverse Event|1|||
130293165|NCT02404649|469037574|FG001|Overall Study|Adverse Event|2|||
130293166|NCT00330668|469037578|FG000|BID Dosing Period|Adverse Event|1|||
130293167|NCT00330668|469037578|FG000|BID Dosing Period|Lost to Follow-up|7|||
130293168|NCT00330668|469037578|FG000|BID Dosing Period|Non-Compliance|5|||
130293169|NCT00330668|469037578|FG000|BID Dosing Period|Withdrawal by Subject|19|||
130293170|NCT00330668|469037578|FG000|BID Dosing Period|Sponsor's decision|1|||
130293171|NCT00330668|469037578|FG000|BID Dosing Period|Other|3|||
130293172|NCT00330668|469037578|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
130293173|NCT00330668|469037578|FG000|QD Dosing Period|Other|1|||
130293174|NCT00330668|469037578|FG000|QD Dosing Period|Withdrawal by Subject|1|||
130293175|NCT00330668|469037578|FG000|QD Dosing Period|Lost to Follow-up|2|||
130293176|NCT01839656|469037579|FG000|Overall Study|Withdrawal by Subject|1|||
130293177|NCT01839656|469037580|FG001|Overall Study|Withdrawal by Subject|1|||
130293178|NCT01839656|469037579|FG000|Overall Study|Adverse event, serious fatal|1|||
130293179|NCT01839656|469037580|FG001|Overall Study|Adverse event, serious fatal|4|||
130293180|NCT01839656|469037579|FG000|Overall Study|Early study closure|0|||
130293181|NCT01839656|469037580|FG001|Overall Study|Early study closure|11|||
130293182|NCT01839656|469037579|FG000|Overall Study|Adverse Event|1|||
130293183|NCT01839656|469037580|FG001|Overall Study|Adverse Event|0|||
130293184|NCT01595581|469037581|FG000|Overall Study|Withdrawal by Subject|1|||
130293185|NCT01595581|469037582|FG001|Overall Study|Withdrawal by Subject|0|||
130293186|NCT02535416|469037592|FG000|Overall Study|Family bereavement overseas|1|||
130293187|NCT02535416|469037593|FG001|Overall Study|Family bereavement overseas|0|||
130293188|NCT02535416|469037594|FG002|Overall Study|Family bereavement overseas|0|||
130293189|NCT02535416|469037595|FG003|Overall Study|Family bereavement overseas|0|||
130293190|NCT02535416|469037596|FG004|Overall Study|Family bereavement overseas|0|||
130293191|NCT02535416|469037597|FG005|Overall Study|Family bereavement overseas|0|||
130293192|NCT02535416|469037598|FG006|Overall Study|Family bereavement overseas|0|||
130293193|NCT02535416|469037599|FG007|Overall Study|Family bereavement overseas|0|||
130293194|NCT02535416|469037600|FG008|Overall Study|Family bereavement overseas|0|||
130293195|NCT02739321|469037603|FG000|Overall Study|Lack of Efficacy|1|||
130293196|NCT02739321|469037604|FG001|Overall Study|Lack of Efficacy|1|||
130714817|NCT01346774|470581784|FG000|Overall Study|Protocol Violation|2|||
130293197|NCT02739321|469037603|FG000|Overall Study|Lost to Follow-up|1|||
130293198|NCT02739321|469037604|FG001|Overall Study|Lost to Follow-up|1|||
130293199|NCT02739321|469037603|FG000|Overall Study|Withdrawal by Subject|1|||
130714818|NCT01346774|470581785|FG001|Overall Study|Protocol Violation|3|||
130714819|NCT01346774|470581784|FG000|Overall Study|Adverse Event|1|||
130714820|NCT01346774|470581785|FG001|Overall Study|Adverse Event|2|||
130293200|NCT02739321|469037604|FG001|Overall Study|Withdrawal by Subject|2|||
130293201|NCT01711866|469037605|FG000|Overall Study|Noncompliant|3|||
130293202|NCT01711866|469037605|FG000|Overall Study|Withdrawal by Subject|3|||
130293203|NCT01711866|469037605|FG000|Overall Study|Adverse Event|2|||
130293204|NCT00958217|469037609|FG000|Overall Study|Death|2|||
130293205|NCT00958217|469037610|FG001|Overall Study|Death|1|||
130293206|NCT00958217|469037609|FG000|Overall Study|Withdrawal by Subject|4|||
130293207|NCT00958217|469037610|FG001|Overall Study|Withdrawal by Subject|3|||
130293208|NCT00958217|469037609|FG000|Overall Study|Lost to Follow-up|17|||
130293209|NCT00958217|469037610|FG001|Overall Study|Lost to Follow-up|19|||
130293210|NCT00958217|469037609|FG000|Overall Study|Moved out of area|1|||
130293211|NCT00958217|469037610|FG001|Overall Study|Moved out of area|1|||
130293212|NCT00958217|469037609|FG000|Overall Study|Inpatient hospitalization|0|||
130293213|NCT00958217|469037610|FG001|Overall Study|Inpatient hospitalization|1|||
130293214|NCT00528996|469039257|FG000|Overall Study|Other reasons than listing|6|||
130556829|NCT05975840|470008056|FG002|Overall Study|Migrated/moved from the study area|0|||
130556830|NCT05975840|470008057|FG003|Overall Study|Migrated/moved from the study area|0|||
130556831|NCT05975840|470008058|FG004|Overall Study|Migrated/moved from the study area|0|||
130556832|NCT05975840|470008059|FG005|Overall Study|Migrated/moved from the study area|0|||
130556833|NCT05975840|470008060|FG006|Overall Study|Migrated/moved from the study area|0|||
130556834|NCT05975840|470008061|FG007|Overall Study|Migrated/moved from the study area|0|||
130556835|NCT05975840|470008054|FG000|Overall Study|Withdrawal by Subject|0|||
130556836|NCT05975840|470008055|FG001|Overall Study|Withdrawal by Subject|5|||
130556837|NCT05975840|470008056|FG002|Overall Study|Withdrawal by Subject|2|||
130556838|NCT05975840|470008057|FG003|Overall Study|Withdrawal by Subject|2|||
130293215|NCT00528996|469039258|FG001|Overall Study|Other reasons than listing|7|||
130293216|NCT00528996|469039259|FG002|Overall Study|Other reasons than listing|14|||
130556839|NCT05975840|470008058|FG004|Overall Study|Withdrawal by Subject|0|||
130293217|NCT00528996|469039260|FG003|Overall Study|Other reasons than listing|11|||
130293218|NCT00528996|469039261|FG004|Overall Study|Other reasons than listing|5|||
130293219|NCT00528996|469039257|FG000|Overall Study|Refused continue medication|16|||
130293220|NCT00528996|469039258|FG001|Overall Study|Refused continue medication|0|||
130293221|NCT00528996|469039259|FG002|Overall Study|Refused continue medication|3|||
130293222|NCT00528996|469039260|FG003|Overall Study|Refused continue medication|3|||
130293223|NCT00528996|469039261|FG004|Overall Study|Refused continue medication|6|||
130293224|NCT00528996|469039257|FG000|Overall Study|Lost to Follow-up|2|||
130293225|NCT00528996|469039258|FG001|Overall Study|Lost to Follow-up|0|||
130293226|NCT00528996|469039259|FG002|Overall Study|Lost to Follow-up|4|||
130293227|NCT00528996|469039260|FG003|Overall Study|Lost to Follow-up|1|||
130293228|NCT00528996|469039261|FG004|Overall Study|Lost to Follow-up|3|||
130293229|NCT00528996|469039257|FG000|Overall Study|Protocol Violation|1|||
130293230|NCT00528996|469039258|FG001|Overall Study|Protocol Violation|2|||
130293231|NCT00528996|469039259|FG002|Overall Study|Protocol Violation|3|||
130293232|NCT00528996|469039260|FG003|Overall Study|Protocol Violation|3|||
130293233|NCT00528996|469039261|FG004|Overall Study|Protocol Violation|2|||
130293234|NCT00528996|469039257|FG000|Overall Study|Lack of Efficacy|7|||
130293235|NCT00528996|469039258|FG001|Overall Study|Lack of Efficacy|2|||
130293236|NCT00528996|469039259|FG002|Overall Study|Lack of Efficacy|1|||
130556840|NCT05975840|470008059|FG005|Overall Study|Withdrawal by Subject|2|||
130556841|NCT05975840|470008060|FG006|Overall Study|Withdrawal by Subject|2|||
130556842|NCT05975840|470008061|FG007|Overall Study|Withdrawal by Subject|1|||
130556843|NCT05975840|470008054|FG000|Overall Study|Protocol Violation|0|||
130714821|NCT00321737|470581788|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
130714822|NCT00321737|470581789|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
130714823|NCT00321737|470581790|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
130293237|NCT00528996|469039260|FG003|Overall Study|Lack of Efficacy|3|||
130293238|NCT00528996|469039261|FG004|Overall Study|Lack of Efficacy|3|||
130293239|NCT00528996|469039257|FG000|Overall Study|Adverse Event|32|||
130293240|NCT00528996|469039258|FG001|Overall Study|Adverse Event|13|||
130293241|NCT00528996|469039259|FG002|Overall Study|Adverse Event|18|||
130293242|NCT00528996|469039260|FG003|Overall Study|Adverse Event|29|||
130293243|NCT00528996|469039261|FG004|Overall Study|Adverse Event|18|||
130293244|NCT05565937|469039263|FG000|Overall Study|Adverse Event|0|||
130293245|NCT05565937|469039264|FG001|Overall Study|Adverse Event|1|||
130293246|NCT05565937|469039263|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
130293247|NCT05565937|469039264|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
130293248|NCT05565937|469039263|FG000|Overall Study|Lost to Follow-up|2|||
130293249|NCT05565937|469039264|FG001|Overall Study|Lost to Follow-up|0|||
130556844|NCT05975840|470008055|FG001|Overall Study|Protocol Violation|1|||
130556845|NCT05975840|470008056|FG002|Overall Study|Protocol Violation|0|||
130293250|NCT05565937|469039263|FG000|Overall Study|Pregnancy|0|||
130556846|NCT05975840|470008057|FG003|Overall Study|Protocol Violation|0|||
130556847|NCT05975840|470008058|FG004|Overall Study|Protocol Violation|0|||
130556848|NCT05975840|470008059|FG005|Overall Study|Protocol Violation|0|||
130293251|NCT05565937|469039264|FG001|Overall Study|Pregnancy|2|||
130293252|NCT05565937|469039263|FG000|Overall Study|Anisometropia|0|||
130293253|NCT05565937|469039264|FG001|Overall Study|Anisometropia|1|||
130293254|NCT04544683|469039265|FG000|Overall Study|Lost to Follow-up|2|||
130371920|NCT01737697|469331018|FG000|Subacute Phase|Death|0|||
130556849|NCT05975840|470008060|FG006|Overall Study|Protocol Violation|0|||
130556850|NCT05975840|470008061|FG007|Overall Study|Protocol Violation|0|||
130714824|NCT00321737|470581788|FG000|Overall Study|Adverse Event|11|||
130293255|NCT04544683|469039265|FG000|Overall Study|Underwent cervical spine surgery|6|||
130293256|NCT04938037|469039268|FG000|Overall Study|Lost to Follow-up|4|||
130293257|NCT04938037|469039269|FG001|Overall Study|Lost to Follow-up|3|||
130293258|NCT01806064|469039270|FG000|Overall Study|Randomized Not Enrolled|0|||
130293259|NCT01806064|469039271|FG001|Overall Study|Randomized Not Enrolled|0|||
130293260|NCT01806064|469039272|FG002|Overall Study|Randomized Not Enrolled|0|||
130293261|NCT01806064|469039273|FG003|Overall Study|Randomized Not Enrolled|1|||
130293262|NCT01806064|469039274|FG004|Overall Study|Randomized Not Enrolled|2|||
130293263|NCT01282294|469039278|FG000|Overall Study|Lost to Follow-up|14|||
130293264|NCT01282294|469039278|FG000|Overall Study|Screening failure|1|||
130293265|NCT01282294|469039278|FG000|Overall Study|Adverse Event|1|||
130293266|NCT01282294|469039278|FG000|Overall Study|Patient non-compliance|2|||
130293267|NCT01282294|469039278|FG000|Overall Study|Physician Decision|1|||
130293268|NCT02943915|469039279|FG000|Overall Study|Withdrawal by Subject|2|||
130293269|NCT02943915|469039280|FG001|Overall Study|Withdrawal by Subject|1|||
130293270|NCT02943915|469039281|FG002|Overall Study|Withdrawal by Subject|0|||
130293271|NCT02943915|469039282|FG003|Overall Study|Withdrawal by Subject|0|||
130293272|NCT02943915|469039279|FG000|Overall Study|Lost to Follow-up|3|||
130293273|NCT02943915|469039280|FG001|Overall Study|Lost to Follow-up|1|||
130293274|NCT02943915|469039281|FG002|Overall Study|Lost to Follow-up|0|||
130293275|NCT02943915|469039282|FG003|Overall Study|Lost to Follow-up|0|||
130293276|NCT02943915|469039279|FG000|Overall Study|excluded|0|||
130293277|NCT02943915|469039280|FG001|Overall Study|excluded|1|||
130293278|NCT02943915|469039281|FG002|Overall Study|excluded|0|||
130293279|NCT02943915|469039282|FG003|Overall Study|excluded|0|||
130293280|NCT00004445|469039285|FG000|Overall Study|Physician Decision|2|||
130293281|NCT00004445|469039285|FG000|Overall Study|Withdrawal by Subject|1|||
130293282|NCT02753127|469039295|FG000|Overall Study|Lost to Follow-up|13|||
130293283|NCT02753127|469039296|FG001|Overall Study|Lost to Follow-up|11|||
130293284|NCT02753127|469039295|FG000|Overall Study|Withdrawal by Subject|37|||
130293285|NCT02753127|469039296|FG001|Overall Study|Withdrawal by Subject|47|||
130293286|NCT02753127|469039295|FG000|Overall Study|Other|3|||
130293287|NCT02753127|469039296|FG001|Overall Study|Other|8|||
130293288|NCT02753127|469039295|FG000|Overall Study|Hospice|0|||
130293289|NCT02753127|469039296|FG001|Overall Study|Hospice|2|||
130293290|NCT01818284|469039300|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
130293291|NCT01818284|469039301|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
130293292|NCT01818284|469039300|FG000|Overall Study|Death|0|||
130293293|NCT01818284|469039301|FG001|Overall Study|Death|2|||
130293294|NCT03681678|469039302|FG000|Overall Study|Lost to Follow-up|20|||
130293295|NCT04619004|469039303|FG000|Overall Study|Death|114|||
130293296|NCT04619004|469039304|FG001|Overall Study|Death|28|||
130293297|NCT04619004|469039303|FG000|Overall Study|Lost to Follow-up|1|||
130293298|NCT04619004|469039304|FG001|Overall Study|Lost to Follow-up|1|||
130293299|NCT04619004|469039303|FG000|Overall Study|Withdrawal by Subject|24|||
130293300|NCT04619004|469039304|FG001|Overall Study|Withdrawal by Subject|7|||
130293301|NCT04619004|469039303|FG000|Overall Study|Other - Not specified|0|||
130293302|NCT04619004|469039304|FG001|Overall Study|Other - Not specified|1|||
130293303|NCT01114360|469039306|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
130293304|NCT01114360|469039307|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
130293305|NCT03007745|469039308|FG000|Overall Study|Sleep test negative for OSA|53|||
130293306|NCT03007745|469039309|FG001|Overall Study|Sleep test negative for OSA|49|||
130293307|NCT03007745|469039308|FG000|Overall Study|Physician Decision|6|||
130293308|NCT03007745|469039309|FG001|Overall Study|Physician Decision|9|||
130293309|NCT03007745|469039308|FG000|Overall Study|Withdrawal by Subject|38|||
130293310|NCT03007745|469039309|FG001|Overall Study|Withdrawal by Subject|16|||
130293311|NCT03007745|469039308|FG000|Overall Study|Lost to Follow-up|19|||
130293312|NCT03007745|469039309|FG001|Overall Study|Lost to Follow-up|25|||
130293313|NCT03007745|469039308|FG000|Overall Study|Unable to login to website|17|||
130293314|NCT03007745|469039309|FG001|Overall Study|Unable to login to website|4|||
130293315|NCT01300351|469039310|FG000|Overall Study|Did not receive treatment|2|||
130293316|NCT01300351|469039311|FG001|Overall Study|Did not receive treatment|0|||
130293317|NCT01300351|469039310|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
130293318|NCT01300351|469039311|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
130293319|NCT01300351|469039310|FG000|Overall Study|Lost to Follow-up|0|||
130293320|NCT01300351|469039311|FG001|Overall Study|Lost to Follow-up|1|||
130293321|NCT01300351|469039310|FG000|Overall Study|Adverse Event|0|||
130371921|NCT01737697|469331019|FG001|Subacute Phase|Death|0|||
130293322|NCT01300351|469039311|FG001|Overall Study|Adverse Event|4|||
130293323|NCT01300351|469039310|FG000|Overall Study|Withdrawal by Subject|7|||
130293324|NCT01300351|469039311|FG001|Overall Study|Withdrawal by Subject|10|||
130293325|NCT05824936|469039315|FG000|Overall Study|Lost to Follow-up|1|||
130293326|NCT00673881|469039316|FG000|Overall Study|Withdrawal by Subject|1|||
130293327|NCT00413010|469039317|FG000|Overall Study|Adverse Event|8|||
130293328|NCT00413010|469039318|FG001|Overall Study|Adverse Event|4|||
130293329|NCT00413010|469039317|FG000|Overall Study|Laboratory abnormality|0|||
130293330|NCT00413010|469039318|FG001|Overall Study|Laboratory abnormality|2|||
130293331|NCT00413010|469039317|FG000|Overall Study|Lack of Efficacy|0|||
130293332|NCT00413010|469039318|FG001|Overall Study|Lack of Efficacy|3|||
130293333|NCT00413010|469039317|FG000|Overall Study|Lost to Follow-up|3|||
130293334|NCT00413010|469039318|FG001|Overall Study|Lost to Follow-up|0|||
130371922|NCT01737697|469331020|FG002|Subacute Phase|Death|0|||
130371923|NCT01737697|469331021|FG003|Subacute Phase|Death|0|||
130371924|NCT01737697|469331022|FG004|Subacute Phase|Death|0|||
130293335|NCT00413010|469039317|FG000|Overall Study|Withdrawal by Subject|7|||
130293336|NCT00413010|469039318|FG001|Overall Study|Withdrawal by Subject|2|||
130293337|NCT00413010|469039317|FG000|Overall Study|Due to termination of the study|54|||
130293338|NCT00413010|469039318|FG001|Overall Study|Due to termination of the study|52|||
130293339|NCT01533922|469039319|FG000|Overall Study|Adverse Event|5|||
130293340|NCT01533922|469039320|FG001|Overall Study|Adverse Event|8|||
130293341|NCT01533922|469039321|FG002|Overall Study|Adverse Event|6|||
130293342|NCT01533922|469039322|FG003|Overall Study|Adverse Event|3|||
130293343|NCT01533922|469039323|FG004|Overall Study|Adverse Event|4|||
130293344|NCT01533922|469039319|FG000|Overall Study|Lack of Efficacy|0|||
130293345|NCT01533922|469039320|FG001|Overall Study|Lack of Efficacy|0|||
130293346|NCT01533922|469039321|FG002|Overall Study|Lack of Efficacy|1|||
130293347|NCT01533922|469039322|FG003|Overall Study|Lack of Efficacy|0|||
130293348|NCT01533922|469039323|FG004|Overall Study|Lack of Efficacy|0|||
130293349|NCT01533922|469039319|FG000|Overall Study|Protocol Violation|0|||
130293350|NCT01533922|469039320|FG001|Overall Study|Protocol Violation|3|||
130293351|NCT01533922|469039321|FG002|Overall Study|Protocol Violation|0|||
130293352|NCT01533922|469039322|FG003|Overall Study|Protocol Violation|0|||
130293353|NCT01533922|469039323|FG004|Overall Study|Protocol Violation|1|||
130293354|NCT01533922|469039319|FG000|Overall Study|Withdrawal by Subject|3|||
130293355|NCT01533922|469039320|FG001|Overall Study|Withdrawal by Subject|1|||
130293356|NCT01533922|469039321|FG002|Overall Study|Withdrawal by Subject|2|||
130293357|NCT01533922|469039322|FG003|Overall Study|Withdrawal by Subject|2|||
130293358|NCT01533922|469039323|FG004|Overall Study|Withdrawal by Subject|1|||
130293359|NCT01533922|469039319|FG000|Overall Study|Other reason not defined above|2|||
130293360|NCT01533922|469039320|FG001|Overall Study|Other reason not defined above|0|||
130293361|NCT01533922|469039321|FG002|Overall Study|Other reason not defined above|1|||
130293362|NCT01533922|469039322|FG003|Overall Study|Other reason not defined above|0|||
130293363|NCT01533922|469039323|FG004|Overall Study|Other reason not defined above|0|||
130293364|NCT02634606|469039326|FG000|Overall Study|unable to obtain the drug at start|13|||
130293365|NCT01267175|469039327|FG000|Overall Study|Withdrawal by Subject|1|||
130293366|NCT01267175|469039327|FG000|Overall Study|Lost to Follow-up|1|||
130293367|NCT00286221|469039330|FG000|Overall Study|Protocol Violation|2|||
130293368|NCT00286221|469039331|FG001|Overall Study|Protocol Violation|1|||
130293369|NCT00286221|469039332|FG002|Overall Study|Protocol Violation|6|||
130293370|NCT00286221|469039333|FG003|Overall Study|Protocol Violation|4|||
130293371|NCT00286221|469039330|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
130293372|NCT00286221|469039331|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
130293373|NCT00286221|469039332|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
130293374|NCT00286221|469039333|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
130293375|NCT00286221|469039330|FG000|Overall Study|Inability to trigger PCA|2|||
130293376|NCT00286221|469039331|FG001|Overall Study|Inability to trigger PCA|0|||
130293377|NCT00286221|469039332|FG002|Overall Study|Inability to trigger PCA|0|||
130293378|NCT00286221|469039333|FG003|Overall Study|Inability to trigger PCA|0|||
130293379|NCT00286221|469039330|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
130293380|NCT00286221|469039331|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
130293381|NCT00286221|469039332|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
130293382|NCT00286221|469039333|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
130293383|NCT02553538|469039335|FG000|Overall Study|Could Not Reach by Telephone|133|||
130293384|NCT02553538|469039336|FG001|Overall Study|Could Not Reach by Telephone|0|||
130293385|NCT02553538|469039335|FG000|Overall Study|Died or Left Network|54|||
130293386|NCT02553538|469039336|FG001|Overall Study|Died or Left Network|56|||
130293387|NCT02690649|469039337|FG000|Overall Study|Withdrawal by Subject|1|||
130293388|NCT02690649|469039338|FG001|Overall Study|Withdrawal by Subject|1|||
130293389|NCT02690649|469039337|FG000|Overall Study|Protocol Violation|0|||
130293390|NCT02690649|469039338|FG001|Overall Study|Protocol Violation|3|||
130293391|NCT02276547|469039339|FG000|Overall Study|Death|2|||
130293392|NCT02276547|469039339|FG000|Overall Study|Explant|2|||
130293393|NCT01754194|469039340|FG000|Overall Study|Lost to Follow-up|39|||
130293394|NCT01754194|469039341|FG001|Overall Study|Lost to Follow-up|14|||
130293395|NCT01754194|469039340|FG000|Overall Study|Withdrawal by Subject|4|||
130293396|NCT01754194|469039341|FG001|Overall Study|Withdrawal by Subject|5|||
130293397|NCT01754194|469039340|FG000|Overall Study|Other|9|||
130293398|NCT01754194|469039341|FG001|Overall Study|Other|8|||
130293399|NCT00907296|469039342|FG000|Overall Study|Ineligibility Determined|1|||
130293400|NCT00907296|469039343|FG001|Overall Study|Ineligibility Determined|0|||
130293401|NCT00907296|469039344|FG002|Overall Study|Ineligibility Determined|0|||
130293402|NCT00907296|469039345|FG003|Overall Study|Ineligibility Determined|1|||
130293403|NCT00907296|469039346|FG004|Overall Study|Ineligibility Determined|0|||
130293404|NCT00907296|469039347|FG005|Overall Study|Ineligibility Determined|0|||
130293405|NCT00907296|469039348|FG006|Overall Study|Ineligibility Determined|0|||
130293406|NCT00907296|469039349|FG007|Overall Study|Ineligibility Determined|1|||
130293407|NCT00907296|469039350|FG008|Overall Study|Ineligibility Determined|0|||
130293408|NCT00907296|469039351|FG009|Overall Study|Ineligibility Determined|0|||
130293409|NCT00907296|469039342|FG000|Overall Study|Protocol Deviation|0|||
130293410|NCT00907296|469039343|FG001|Overall Study|Protocol Deviation|1|||
130714825|NCT00321737|470581789|FG001|Overall Study|Adverse Event|3|||
130293411|NCT00907296|469039344|FG002|Overall Study|Protocol Deviation|0|||
130293412|NCT00907296|469039345|FG003|Overall Study|Protocol Deviation|0|||
130293413|NCT00907296|469039346|FG004|Overall Study|Protocol Deviation|0|||
130293414|NCT00907296|469039347|FG005|Overall Study|Protocol Deviation|0|||
130293415|NCT00907296|469039348|FG006|Overall Study|Protocol Deviation|0|||
130293416|NCT00907296|469039349|FG007|Overall Study|Protocol Deviation|0|||
130293417|NCT00907296|469039350|FG008|Overall Study|Protocol Deviation|0|||
130293418|NCT00907296|469039351|FG009|Overall Study|Protocol Deviation|0|||
130293419|NCT00907296|469039342|FG000|Overall Study|Noncompliance|1|||
130293420|NCT00907296|469039343|FG001|Overall Study|Noncompliance|1|||
130293421|NCT00907296|469039344|FG002|Overall Study|Noncompliance|1|||
130293422|NCT00907296|469039345|FG003|Overall Study|Noncompliance|0|||
130293423|NCT00907296|469039346|FG004|Overall Study|Noncompliance|0|||
130293424|NCT00907296|469039347|FG005|Overall Study|Noncompliance|1|||
130293425|NCT00907296|469039348|FG006|Overall Study|Noncompliance|0|||
130293426|NCT00907296|469039349|FG007|Overall Study|Noncompliance|2|||
130293427|NCT00907296|469039350|FG008|Overall Study|Noncompliance|0|||
130293428|NCT00907296|469039351|FG009|Overall Study|Noncompliance|0|||
130293429|NCT00907296|469039342|FG000|Overall Study|Adverse Event|2|||
130293430|NCT00907296|469039343|FG001|Overall Study|Adverse Event|0|||
130293431|NCT00907296|469039344|FG002|Overall Study|Adverse Event|0|||
130293432|NCT00907296|469039345|FG003|Overall Study|Adverse Event|0|||
130293433|NCT00907296|469039346|FG004|Overall Study|Adverse Event|0|||
130293434|NCT00907296|469039347|FG005|Overall Study|Adverse Event|0|||
130293435|NCT00907296|469039348|FG006|Overall Study|Adverse Event|1|||
130293436|NCT00907296|469039349|FG007|Overall Study|Adverse Event|0|||
130293437|NCT00907296|469039350|FG008|Overall Study|Adverse Event|0|||
130293438|NCT00907296|469039351|FG009|Overall Study|Adverse Event|1|||
130293439|NCT00907296|469039342|FG000|Overall Study|Withdrawal by Subject|7|||
130293440|NCT00907296|469039343|FG001|Overall Study|Withdrawal by Subject|2|||
130293441|NCT00907296|469039344|FG002|Overall Study|Withdrawal by Subject|1|||
130293442|NCT00907296|469039345|FG003|Overall Study|Withdrawal by Subject|1|||
130293443|NCT00907296|469039346|FG004|Overall Study|Withdrawal by Subject|1|||
130293444|NCT00907296|469039347|FG005|Overall Study|Withdrawal by Subject|5|||
130293445|NCT00907296|469039348|FG006|Overall Study|Withdrawal by Subject|3|||
130293446|NCT00907296|469039349|FG007|Overall Study|Withdrawal by Subject|2|||
130293447|NCT00907296|469039350|FG008|Overall Study|Withdrawal by Subject|4|||
130293448|NCT00907296|469039351|FG009|Overall Study|Withdrawal by Subject|2|||
130293449|NCT00907296|469039342|FG000|Overall Study|Lost to Follow-up|9|||
130293450|NCT00907296|469039343|FG001|Overall Study|Lost to Follow-up|1|||
130293451|NCT00907296|469039344|FG002|Overall Study|Lost to Follow-up|0|||
130293452|NCT00907296|469039345|FG003|Overall Study|Lost to Follow-up|2|||
130293453|NCT00907296|469039346|FG004|Overall Study|Lost to Follow-up|0|||
130293454|NCT00907296|469039347|FG005|Overall Study|Lost to Follow-up|3|||
130293455|NCT00907296|469039348|FG006|Overall Study|Lost to Follow-up|2|||
130293456|NCT00907296|469039349|FG007|Overall Study|Lost to Follow-up|2|||
130293457|NCT00907296|469039350|FG008|Overall Study|Lost to Follow-up|0|||
130460427|NCT00941655|469652081|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
130460428|NCT00941655|469652082|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
130460429|NCT00941655|469652081|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
130460430|NCT00941655|469652082|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
130460431|NCT00941655|469652081|FG000|Overall Study|progressed while on chemo|0|||
130460432|NCT00941655|469652082|FG001|Overall Study|progressed while on chemo|2|||
130460433|NCT00941655|469652081|FG000|Overall Study|refused further treatment|0|||
130460434|NCT00941655|469652082|FG001|Overall Study|refused further treatment|1|||
130460435|NCT00941655|469652081|FG000|Overall Study|withdrew consent|0|||
130460436|NCT00941655|469652082|FG001|Overall Study|withdrew consent|1|||
130460437|NCT00941655|469652081|FG000|Overall Study|non-compliant|0|||
130460438|NCT00941655|469652082|FG001|Overall Study|non-compliant|1|||
130460439|NCT02477670|469652086|FG000|Stage 1|Adverse Event|2|||
130460440|NCT02477670|469652087|FG001|Stage 1|Adverse Event|7|||
130460441|NCT02477670|469652088|FG002|Stage 1|Adverse Event|0|||
130460442|NCT02477670|469652089|FG003|Stage 1|Adverse Event|0|||
130293458|NCT00907296|469039351|FG009|Overall Study|Lost to Follow-up|4|||
130293459|NCT00357656|469039355|FG000|Overall Study|Other, No surgery performed|0|||
130293460|NCT00357656|469039356|FG001|Overall Study|Other, No surgery performed|3|||
130460443|NCT02477670|469652090|FG004|Stage 1|Adverse Event|0|||
130293461|NCT02573246|469039357|FG000|Overall Study|Lost to Follow-up|2|||
130293462|NCT02573246|469039358|FG001|Overall Study|Lost to Follow-up|0|||
130293463|NCT02573246|469039359|FG002|Overall Study|Lost to Follow-up|0|||
130293464|NCT02573246|469039360|FG003|Overall Study|Lost to Follow-up|0|||
130460444|NCT02477670|469652091|FG005|Stage 1|Adverse Event|0|||
130293465|NCT02573246|469039361|FG004|Overall Study|Lost to Follow-up|1|||
130293466|NCT02573246|469039357|FG000|Overall Study|Withdrawal by Subject|0|||
130293467|NCT02573246|469039358|FG001|Overall Study|Withdrawal by Subject|0|||
130293468|NCT02573246|469039359|FG002|Overall Study|Withdrawal by Subject|0|||
130460445|NCT02477670|469652092|FG006|Stage 1|Adverse Event|0|||
130460446|NCT02477670|469652086|FG000|Stage 1|Lost to Follow-up|0|||
130460447|NCT02477670|469652087|FG001|Stage 1|Lost to Follow-up|2|||
130293469|NCT02573246|469039360|FG003|Overall Study|Withdrawal by Subject|0|||
130293470|NCT02573246|469039361|FG004|Overall Study|Withdrawal by Subject|1|||
130293471|NCT02573246|469039357|FG000|Overall Study|Physician Decision|1|||
130293472|NCT02573246|469039358|FG001|Overall Study|Physician Decision|1|||
130293473|NCT02573246|469039359|FG002|Overall Study|Physician Decision|3|||
130293474|NCT02573246|469039360|FG003|Overall Study|Physician Decision|2|||
130293475|NCT02573246|469039361|FG004|Overall Study|Physician Decision|2|||
130293476|NCT01219933|469039362|FG000|Overall Study|Adverse Event|8|||
130293477|NCT01219933|469039362|FG000|Overall Study|No LDA reached|5|||
130293478|NCT01219933|469039362|FG000|Overall Study|No LDA maintained|7|||
130293479|NCT01219933|469039362|FG000|Overall Study|Lost to Follow-up|3|||
130293480|NCT01219933|469039362|FG000|Overall Study|GC free|1|||
130293481|NCT01219933|469039362|FG000|Overall Study|Withdrawal by Subject|5|||
130293482|NCT01219933|469039362|FG000|Overall Study|Protocol Violation|8|||
130293483|NCT01219933|469039362|FG000|Overall Study|Lack of Efficacy|1|||
130293484|NCT03149003|469039363|FG000|Overall Study|Randomized but not treated|0|||
130293485|NCT03149003|469039364|FG001|Overall Study|Randomized but not treated|1|||
130293486|NCT03149003|469039365|FG002|Overall Study|Randomized but not treated|18|||
130293487|NCT02900170|469039367|FG000|Overall Study|Lost to Follow-up|8|||
130293488|NCT01565941|469039368|FG000|Overall Study|Withdrawn by parent/guardian|3|||
130293489|NCT01565941|469039369|FG001|Overall Study|Withdrawn by parent/guardian|2|||
130293490|NCT01565941|469039368|FG000|Overall Study|Randomized; did not receive intevention|8|||
130293491|NCT01565941|469039369|FG001|Overall Study|Randomized; did not receive intevention|2|||
130293492|NCT03262116|469039370|FG000|Overall Study|Physician Decision|0|||
130293493|NCT03262116|469039371|FG001|Overall Study|Physician Decision|2|||
130293494|NCT03262116|469039372|FG002|Overall Study|Physician Decision|1|||
130293495|NCT03262116|469039373|FG003|Overall Study|Physician Decision|1|||
130293496|NCT03262116|469039374|FG004|Overall Study|Physician Decision|1|||
130293497|NCT03262116|469039375|FG005|Overall Study|Physician Decision|2|||
130293498|NCT02365285|469039376|FG000|Overall Study|Physician Decision|0|||
130293499|NCT02365285|469039377|FG001|Overall Study|Physician Decision|1|||
130293500|NCT02365285|469039378|FG002|Overall Study|Physician Decision|1|||
130293501|NCT02365285|469039379|FG003|Overall Study|Physician Decision|0|||
130293502|NCT02365285|469039376|FG000|Overall Study|Adverse Event|0|||
130293503|NCT02365285|469039377|FG001|Overall Study|Adverse Event|0|||
130293504|NCT02365285|469039378|FG002|Overall Study|Adverse Event|0|||
130293505|NCT02365285|469039379|FG003|Overall Study|Adverse Event|2|||
130293506|NCT02608450|469039382|FG000|Overall Study|Lost to Follow-up|39|||
130293507|NCT02608450|469039383|FG001|Overall Study|Lost to Follow-up|32|||
130293508|NCT02608450|469039382|FG000|Overall Study|Withdrawal by Subject|21|||
130293509|NCT02608450|469039383|FG001|Overall Study|Withdrawal by Subject|15|||
130293510|NCT02608450|469039382|FG000|Overall Study|Adverse Event|3|||
130293511|NCT02608450|469039383|FG001|Overall Study|Adverse Event|6|||
130293512|NCT02608450|469039382|FG000|Overall Study|Withdrawal by parent|2|||
130293513|NCT02608450|469039383|FG001|Overall Study|Withdrawal by parent|3|||
130293514|NCT02608450|469039382|FG000|Overall Study|Lack of Efficacy|0|||
130293515|NCT02608450|469039383|FG001|Overall Study|Lack of Efficacy|3|||
130293516|NCT02608450|469039382|FG000|Overall Study|Noncompliance with study drug|0|||
130293517|NCT02608450|469039383|FG001|Overall Study|Noncompliance with study drug|2|||
130293518|NCT02608450|469039382|FG000|Overall Study|Physician Decision|0|||
130293519|NCT02608450|469039383|FG001|Overall Study|Physician Decision|1|||
130293520|NCT02608450|469039382|FG000|Overall Study|Pregnancy|0|||
130293521|NCT02608450|469039383|FG001|Overall Study|Pregnancy|1|||
130293522|NCT02608450|469039382|FG000|Overall Study|Progressive disease|1|||
130293523|NCT02608450|469039383|FG001|Overall Study|Progressive disease|0|||
130293524|NCT02608450|469039382|FG000|Overall Study|Multiple reasons|0|||
130293525|NCT02608450|469039383|FG001|Overall Study|Multiple reasons|2|||
130293526|NCT00249613|469039386|FG000|12 Month Follow-up|Death|1|||
130293527|NCT00249613|469039387|FG001|12 Month Follow-up|Death|1|||
130293528|NCT00249613|469039386|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
130293529|NCT00249613|469039387|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
130293530|NCT00249613|469039386|FG000|12 Month Follow-up|Lost to Follow-up|10|||
130293531|NCT00249613|469039387|FG001|12 Month Follow-up|Lost to Follow-up|8|||
130293532|NCT00424190|469039388|FG000|Overall Study|Withdrew consent|3|||
130293533|NCT00424190|469039389|FG001|Overall Study|Withdrew consent|4|||
130293534|NCT00424190|469039388|FG000|Overall Study|Death|3|||
130293535|NCT00424190|469039389|FG001|Overall Study|Death|0|||
130293536|NCT00424190|469039388|FG000|Overall Study|Noncompliance|1|||
130293537|NCT00424190|469039389|FG001|Overall Study|Noncompliance|2|||
130293538|NCT00424190|469039388|FG000|Overall Study|Request of sponsor or investigator|0|||
130293539|NCT00424190|469039389|FG001|Overall Study|Request of sponsor or investigator|2|||
130460448|NCT02477670|469652088|FG002|Stage 1|Lost to Follow-up|0|||
130460449|NCT02477670|469652089|FG003|Stage 1|Lost to Follow-up|0|||
130293540|NCT00424190|469039388|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
130293541|NCT00424190|469039389|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
130293542|NCT00424190|469039388|FG000|Overall Study|Other|15|||
130293543|NCT00424190|469039389|FG001|Overall Study|Other|21|||
130293544|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
130293545|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
130293546|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
130293547|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
130293548|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
130293549|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
130293550|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130293551|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130293552|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
130293553|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293554|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293555|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293556|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130293557|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130293558|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
130293559|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
130293560|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130293561|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130293562|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
130293563|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
130293564|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
130293565|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
130293566|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130293567|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130293568|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
130293569|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
130293570|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
130293571|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
130293572|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130293573|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130293574|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130293575|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
130293576|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130293577|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
130293578|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
130293579|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
130293580|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
130293581|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130293582|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130293583|NCT01378429|469039395|FG000|Overall Study|Noncompliance with study drug|1|||
130293584|NCT01378429|469039396|FG001|Overall Study|Noncompliance with study drug|0|||
130293585|NCT02241187|469039397|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
130293586|NCT00199888|469039398|FG000|Overall Study|Lost to Follow-up|1|||
130293587|NCT05219669|469039399|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293588|NCT05219669|469039400|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293589|NCT05219669|469039401|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
130293590|NCT05219669|469039402|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293591|NCT05219669|469039403|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293592|NCT05219669|469039404|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293593|NCT02544373|469039406|FG000|Overall Study|Lost to Follow-up|5|||
130293594|NCT02544373|469039407|FG001|Overall Study|Lost to Follow-up|3|||
130293595|NCT02544373|469039406|FG000|Overall Study|Withdrawal by Subject|8|||
130293596|NCT02544373|469039407|FG001|Overall Study|Withdrawal by Subject|2|||
130293597|NCT02621073|469039408|FG000|Overall Study|Lost to Follow-up|0|||
130293598|NCT02621073|469039409|FG001|Overall Study|Lost to Follow-up|1|||
130293599|NCT02621073|469039408|FG000|Overall Study|Physician Decision|3|||
130293600|NCT02621073|469039409|FG001|Overall Study|Physician Decision|2|||
130293601|NCT01440881|469039410|FG000|Overall Study|Death|0|||
130293602|NCT01440881|469039411|FG001|Overall Study|Death|1|||
130371925|NCT01737697|469331023|FG005|Subacute Phase|Death|0|||
130371926|NCT01737697|469331024|FG006|Subacute Phase|Death|0|||
130371927|NCT01737697|469331025|FG007|Subacute Phase|Death|0|||
130371928|NCT01737697|469331026|FG008|Subacute Phase|Death|0|||
130371929|NCT01737697|469331027|FG009|Subacute Phase|Death|0|||
130371930|NCT01737697|469331028|FG010|Subacute Phase|Death|1|||
130371931|NCT01737697|469331029|FG011|Subacute Phase|Death|0|||
130556851|NCT05975840|470008054|FG000|Overall Study|Adverse Event|0|||
130556852|NCT05975840|470008055|FG001|Overall Study|Adverse Event|0|||
130293603|NCT02383433|469039414|FG000|Overall Study|Disease progression|2|||
130371932|NCT01737697|469331030|FG012|Subacute Phase|Death|0|||
130293604|NCT02920957|469039415|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
130293605|NCT02920957|469039416|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
130371933|NCT01737697|469331031|FG013|Subacute Phase|Death|0|||
130371934|NCT01737697|469331032|FG014|Subacute Phase|Death|0|||
130293606|NCT02920957|469039415|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
130293607|NCT02920957|469039416|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
130293608|NCT02920957|469039415|FG000|First Intervention : 1 Month|Adverse Event|1|||
130293609|NCT02920957|469039416|FG001|First Intervention : 1 Month|Adverse Event|0|||
130293610|NCT02920957|469039415|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
130293611|NCT02920957|469039416|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
130293612|NCT01345682|469039422|FG000|Overall Study|Progressive disease per RECIST|226|||
130293613|NCT01345682|469039423|FG001|Overall Study|Progressive disease per RECIST|93|||
130293614|NCT01345682|469039422|FG000|Overall Study|Worsening of underlying cancer disease|23|||
130293615|NCT01345682|469039423|FG001|Overall Study|Worsening of underlying cancer disease|12|||
130293616|NCT01345682|469039422|FG000|Overall Study|Adverse Event|51|||
130293617|NCT01345682|469039423|FG001|Overall Study|Adverse Event|41|||
130293618|NCT01345682|469039422|FG000|Overall Study|Non-compliance with protocol|0|||
130293619|NCT01345682|469039423|FG001|Overall Study|Non-compliance with protocol|1|||
130293620|NCT01345682|469039422|FG000|Overall Study|Lost to Follow-up|0|||
130293621|NCT01345682|469039423|FG001|Overall Study|Lost to Follow-up|1|||
130293622|NCT01345682|469039422|FG000|Overall Study|Refused to continue trial medication|16|||
130293623|NCT01345682|469039423|FG001|Overall Study|Refused to continue trial medication|9|||
130293624|NCT01345682|469039422|FG000|Overall Study|Not treated|2|||
130293625|NCT01345682|469039423|FG001|Overall Study|Not treated|1|||
130293626|NCT01345682|469039422|FG000|Overall Study|Reason other than those specified above|4|||
130293627|NCT01345682|469039423|FG001|Overall Study|Reason other than those specified above|3|||
130293628|NCT01075984|469039428|FG000|Treatment Phase|Adverse Event|0|||
130293629|NCT01075984|469039429|FG001|Treatment Phase|Adverse Event|1|||
130293630|NCT01075984|469039430|FG002|Treatment Phase|Adverse Event|3|||
130293631|NCT01075984|469039431|FG003|Treatment Phase|Adverse Event|7|||
130293632|NCT01075984|469039432|FG004|Treatment Phase|Adverse Event|35|||
130293633|NCT01075984|469039428|FG000|Treatment Phase|Protocol Violation|0|||
130293634|NCT01075984|469039429|FG001|Treatment Phase|Protocol Violation|0|||
130293635|NCT01075984|469039430|FG002|Treatment Phase|Protocol Violation|1|||
130293636|NCT01075984|469039431|FG003|Treatment Phase|Protocol Violation|0|||
130293637|NCT01075984|469039432|FG004|Treatment Phase|Protocol Violation|3|||
130293638|NCT01075984|469039428|FG000|Treatment Phase|Withdrawal by Subject|0|||
130293639|NCT01075984|469039429|FG001|Treatment Phase|Withdrawal by Subject|0|||
130293640|NCT01075984|469039430|FG002|Treatment Phase|Withdrawal by Subject|2|||
130293641|NCT01075984|469039431|FG003|Treatment Phase|Withdrawal by Subject|0|||
130293642|NCT01075984|469039432|FG004|Treatment Phase|Withdrawal by Subject|15|||
130293643|NCT01075984|469039428|FG000|Treatment Phase|Treatment Failure|0|||
130293644|NCT01075984|469039429|FG001|Treatment Phase|Treatment Failure|0|||
130293645|NCT01075984|469039430|FG002|Treatment Phase|Treatment Failure|1|||
130293646|NCT01075984|469039431|FG003|Treatment Phase|Treatment Failure|0|||
130293647|NCT01075984|469039432|FG004|Treatment Phase|Treatment Failure|5|||
130293648|NCT01075984|469039428|FG000|Treatment Phase|Progression of disease|0|||
130293649|NCT01075984|469039429|FG001|Treatment Phase|Progression of disease|0|||
130293650|NCT01075984|469039430|FG002|Treatment Phase|Progression of disease|0|||
130293651|NCT01075984|469039431|FG003|Treatment Phase|Progression of disease|0|||
130293652|NCT01075984|469039432|FG004|Treatment Phase|Progression of disease|2|||
130293653|NCT01075984|469039428|FG000|Follow-up Phase|Protocol Violation|0|||
130293654|NCT01075984|469039429|FG001|Follow-up Phase|Protocol Violation|0|||
130293655|NCT01075984|469039430|FG002|Follow-up Phase|Protocol Violation|1|||
130460450|NCT02477670|469652090|FG004|Stage 1|Lost to Follow-up|0|||
130293656|NCT01075984|469039431|FG003|Follow-up Phase|Protocol Violation|0|||
130293657|NCT01075984|469039432|FG004|Follow-up Phase|Protocol Violation|3|||
130293658|NCT01075984|469039428|FG000|Follow-up Phase|Adverse Event|0|||
130293659|NCT01075984|469039429|FG001|Follow-up Phase|Adverse Event|0|||
130293660|NCT01075984|469039430|FG002|Follow-up Phase|Adverse Event|0|||
130293661|NCT01075984|469039431|FG003|Follow-up Phase|Adverse Event|2|||
130293662|NCT01075984|469039432|FG004|Follow-up Phase|Adverse Event|27|||
130293663|NCT01075984|469039428|FG000|Follow-up Phase|Administrative|0|||
130460451|NCT02477670|469652091|FG005|Stage 1|Lost to Follow-up|0|||
130293664|NCT01075984|469039429|FG001|Follow-up Phase|Administrative|0|||
130460452|NCT02477670|469652092|FG006|Stage 1|Lost to Follow-up|0|||
130460453|NCT02477670|469652086|FG000|Stage 1|Withdrawal by Subject|1|||
130293665|NCT01075984|469039430|FG002|Follow-up Phase|Administrative|0|||
130293666|NCT01075984|469039431|FG003|Follow-up Phase|Administrative|0|||
130293667|NCT01075984|469039432|FG004|Follow-up Phase|Administrative|1|||
130293668|NCT01075984|469039428|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130293669|NCT01075984|469039429|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130293670|NCT01075984|469039430|FG002|Follow-up Phase|Withdrawal by Subject|0|||
130293671|NCT01075984|469039431|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130293672|NCT01075984|469039432|FG004|Follow-up Phase|Withdrawal by Subject|10|||
130293673|NCT01075984|469039428|FG000|Follow-up Phase|Progression of disease|0|||
130293674|NCT01075984|469039429|FG001|Follow-up Phase|Progression of disease|0|||
130293675|NCT01075984|469039430|FG002|Follow-up Phase|Progression of disease|0|||
130293676|NCT01075984|469039431|FG003|Follow-up Phase|Progression of disease|0|||
130293677|NCT01075984|469039432|FG004|Follow-up Phase|Progression of disease|2|||
130714826|NCT00321737|470581790|FG002|Overall Study|Adverse Event|6|||
130714827|NCT00321737|470581788|FG000|Overall Study|Lost to Follow-up|5|||
130293678|NCT01075984|469039428|FG000|Follow-up Phase|Treatment failure|0|||
130293679|NCT01075984|469039429|FG001|Follow-up Phase|Treatment failure|0|||
130293680|NCT01075984|469039430|FG002|Follow-up Phase|Treatment failure|0|||
130293681|NCT01075984|469039431|FG003|Follow-up Phase|Treatment failure|0|||
130293682|NCT01075984|469039432|FG004|Follow-up Phase|Treatment failure|4|||
130293683|NCT02440789|469039433|FG000|Overall Study|Withdrawal by Subject|3|||
130293684|NCT02440789|469039433|FG000|Overall Study|Not willing to adhere to reqs|1|||
130293685|NCT03684694|469039436|FG000|Phase 1|Withdrawal by Subject|1|||
130293686|NCT03684694|469039437|FG001|Phase 1|Withdrawal by Subject|0|||
130293687|NCT03684694|469039438|FG002|Phase 1|Withdrawal by Subject|0|||
130293688|NCT03684694|469039439|FG003|Phase 1|Withdrawal by Subject|0|||
130293689|NCT03684694|469039440|FG004|Phase 1|Withdrawal by Subject|0|||
130293690|NCT03684694|469039441|FG005|Phase 1|Withdrawal by Subject|0|||
130293691|NCT03684694|469039436|FG000|Phase 1|Investigator/Sponsor Decision|12|||
130293692|NCT03684694|469039437|FG001|Phase 1|Investigator/Sponsor Decision|2|||
130293693|NCT03684694|469039438|FG002|Phase 1|Investigator/Sponsor Decision|1|||
130293694|NCT03684694|469039439|FG003|Phase 1|Investigator/Sponsor Decision|0|||
130293695|NCT03684694|469039440|FG004|Phase 1|Investigator/Sponsor Decision|0|||
130293696|NCT03684694|469039441|FG005|Phase 1|Investigator/Sponsor Decision|0|||
130293697|NCT03684694|469039436|FG000|Phase 1|Death|24|||
130293698|NCT03684694|469039437|FG001|Phase 1|Death|0|||
130293699|NCT03684694|469039438|FG002|Phase 1|Death|3|||
130293700|NCT03684694|469039439|FG003|Phase 1|Death|0|||
130293701|NCT03684694|469039440|FG004|Phase 1|Death|0|||
130293702|NCT03684694|469039441|FG005|Phase 1|Death|0|||
130293703|NCT03684694|469039436|FG000|Phase 1|Lost to Follow-up|0|||
130293704|NCT03684694|469039437|FG001|Phase 1|Lost to Follow-up|0|||
130293705|NCT03684694|469039438|FG002|Phase 1|Lost to Follow-up|1|||
130293706|NCT03684694|469039439|FG003|Phase 1|Lost to Follow-up|0|||
130293707|NCT03684694|469039440|FG004|Phase 1|Lost to Follow-up|0|||
130293708|NCT03684694|469039441|FG005|Phase 1|Lost to Follow-up|0|||
130293709|NCT03684694|469039436|FG000|Phase 1|Miscellaneous|0|||
130293710|NCT03684694|469039437|FG001|Phase 1|Miscellaneous|1|||
130293711|NCT03684694|469039438|FG002|Phase 1|Miscellaneous|0|||
130293712|NCT03684694|469039439|FG003|Phase 1|Miscellaneous|0|||
130293713|NCT03684694|469039440|FG004|Phase 1|Miscellaneous|0|||
130293714|NCT03684694|469039441|FG005|Phase 1|Miscellaneous|0|||
130293715|NCT03684694|469039436|FG000|Phase 2|Withdrawal by Subject|0|||
130293716|NCT03684694|469039437|FG001|Phase 2|Withdrawal by Subject|0|||
130293717|NCT03684694|469039438|FG002|Phase 2|Withdrawal by Subject|0|||
130293718|NCT03684694|469039439|FG003|Phase 2|Withdrawal by Subject|0|||
130293719|NCT03684694|469039440|FG004|Phase 2|Withdrawal by Subject|0|||
130293720|NCT03684694|469039441|FG005|Phase 2|Withdrawal by Subject|1|||
130293721|NCT03684694|469039436|FG000|Phase 2|Investigator/Sponsor Decision|0|||
130293722|NCT03684694|469039437|FG001|Phase 2|Investigator/Sponsor Decision|0|||
130293723|NCT03684694|469039438|FG002|Phase 2|Investigator/Sponsor Decision|0|||
130293724|NCT03684694|469039439|FG003|Phase 2|Investigator/Sponsor Decision|17|||
130293725|NCT03684694|469039440|FG004|Phase 2|Investigator/Sponsor Decision|16|||
130293726|NCT03684694|469039441|FG005|Phase 2|Investigator/Sponsor Decision|6|||
130293727|NCT03684694|469039436|FG000|Phase 2|Death|0|||
130293728|NCT03684694|469039437|FG001|Phase 2|Death|0|||
130293729|NCT03684694|469039438|FG002|Phase 2|Death|0|||
130293730|NCT03684694|469039439|FG003|Phase 2|Death|28|||
130293731|NCT03684694|469039440|FG004|Phase 2|Death|14|||
130293732|NCT03684694|469039441|FG005|Phase 2|Death|3|||
130293733|NCT03684694|469039436|FG000|Phase 2|Lost to Follow-up|0|||
130293734|NCT03684694|469039437|FG001|Phase 2|Lost to Follow-up|0|||
130293735|NCT03684694|469039438|FG002|Phase 2|Lost to Follow-up|0|||
130293736|NCT03684694|469039439|FG003|Phase 2|Lost to Follow-up|1|||
130293737|NCT03684694|469039440|FG004|Phase 2|Lost to Follow-up|0|||
130556853|NCT05975840|470008056|FG002|Overall Study|Adverse Event|0|||
130714828|NCT00321737|470581789|FG001|Overall Study|Lost to Follow-up|5|||
130293738|NCT03684694|469039441|FG005|Phase 2|Lost to Follow-up|0|||
130293739|NCT03684694|469039436|FG000|Phase 2|Miscellaneous|0|||
130293740|NCT03684694|469039437|FG001|Phase 2|Miscellaneous|0|||
130293741|NCT03684694|469039438|FG002|Phase 2|Miscellaneous|0|||
130714829|NCT00321737|470581790|FG002|Overall Study|Lost to Follow-up|6|||
130293742|NCT03684694|469039439|FG003|Phase 2|Miscellaneous|3|||
130293743|NCT03684694|469039440|FG004|Phase 2|Miscellaneous|0|||
130293744|NCT03684694|469039441|FG005|Phase 2|Miscellaneous|0|||
130293745|NCT03172130|469040854|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
130293746|NCT03172130|469040855|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
130293747|NCT02831933|469040859|FG000|Overall Study|Physician Decision|11|||
130293748|NCT05065190|469040865|FG000|Overall Study|Other than listed|2|||
130293749|NCT05065190|469040866|FG001|Overall Study|Other than listed|12|||
130293750|NCT05065190|469040865|FG000|Overall Study|Lack of Efficacy|4|||
130293751|NCT05065190|469040866|FG001|Overall Study|Lack of Efficacy|0|||
130293752|NCT05065190|469040865|FG000|Overall Study|Adverse Event|1|||
130293753|NCT05065190|469040866|FG001|Overall Study|Adverse Event|10|||
130293754|NCT02769962|469040873|FG000|Overall Study|Physician Decision|0|||
130293755|NCT02769962|469040874|FG001|Overall Study|Physician Decision|0|||
130293756|NCT02769962|469040875|FG002|Overall Study|Physician Decision|0|||
130293757|NCT02769962|469040876|FG003|Overall Study|Physician Decision|0|||
130293758|NCT02769962|469040877|FG004|Overall Study|Physician Decision|0|||
130293759|NCT02769962|469040878|FG005|Overall Study|Physician Decision|1|||
130293760|NCT02769962|469040879|FG006|Overall Study|Physician Decision|0|||
130293761|NCT02769962|469040880|FG007|Overall Study|Physician Decision|1|||
130293762|NCT02769962|469040873|FG000|Overall Study|Refused further treatment|0|||
130293763|NCT02769962|469040874|FG001|Overall Study|Refused further treatment|0|||
130293764|NCT02769962|469040875|FG002|Overall Study|Refused further treatment|0|||
130293765|NCT02769962|469040876|FG003|Overall Study|Refused further treatment|0|||
130293766|NCT02769962|469040877|FG004|Overall Study|Refused further treatment|0|||
130293767|NCT02769962|469040878|FG005|Overall Study|Refused further treatment|1|||
130293768|NCT02769962|469040879|FG006|Overall Study|Refused further treatment|1|||
130293769|NCT02769962|469040880|FG007|Overall Study|Refused further treatment|0|||
130293770|NCT01073930|469040882|FG000|Overall Study|Withdrawal by Subject|3|||
130293771|NCT01073930|469040883|FG001|Overall Study|Withdrawal by Subject|2|||
130293772|NCT01073930|469040882|FG000|Overall Study|Lost to Follow-up|0|||
130293773|NCT01073930|469040883|FG001|Overall Study|Lost to Follow-up|1|||
130293774|NCT01073930|469040882|FG000|Overall Study|Adverse Event|0|||
130293775|NCT01073930|469040883|FG001|Overall Study|Adverse Event|1|||
130293776|NCT01073930|469040882|FG000|Overall Study|Noncompliance with study drug|0|||
130293777|NCT01073930|469040883|FG001|Overall Study|Noncompliance with study drug|1|||
130293778|NCT01073930|469040882|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
130293779|NCT01073930|469040883|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
130293780|NCT01022424|469040884|FG000|Overall Study|Adverse Event|1|||
130293781|NCT01022424|469040884|FG000|Overall Study|Physician Decision|1|||
130293782|NCT01022424|469040884|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
130293783|NCT01266590|469040885|FG000|Overall Study|Adverse Event|3|||
130293784|NCT01266590|469040885|FG000|Overall Study|Lost to Follow-up|1|||
130293785|NCT01266590|469040885|FG000|Overall Study|Withdrawal by Subject|1|||
130293786|NCT01266590|469040885|FG000|Overall Study|Physician Decision|1|||
130293787|NCT02783170|469040888|FG000|Overall Study|Randomized but not Vaccinated|1|||
130293788|NCT02783170|469040889|FG001|Overall Study|Randomized but not Vaccinated|0|||
130293789|NCT03320330|469040890|FG000|Overall Study|Lack of Efficacy|5|||
130293790|NCT03320330|469040891|FG001|Overall Study|Lack of Efficacy|5|||
130293791|NCT03320330|469040892|FG002|Overall Study|Lack of Efficacy|14|||
130293792|NCT03320330|469040890|FG000|Overall Study|Physician Decision|1|||
130293793|NCT03320330|469040891|FG001|Overall Study|Physician Decision|0|||
130293794|NCT03320330|469040892|FG002|Overall Study|Physician Decision|0|||
130293795|NCT04692077|469040894|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
130293796|NCT03826342|469040895|FG000|Overall Study|Withdrawal by Subject|8|||
130293797|NCT03826342|469040896|FG001|Overall Study|Withdrawal by Subject|1|||
130293798|NCT03826342|469040895|FG000|Overall Study|Lost to Follow-up|7|||
130293799|NCT03826342|469040896|FG001|Overall Study|Lost to Follow-up|7|||
130293800|NCT03826342|469040895|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
130293801|NCT03826342|469040896|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
130293802|NCT02046070|469040900|FG000|Overall Study|Progressive Disease|18|||
130293803|NCT02046070|469040901|FG001|Overall Study|Progressive Disease|11|||
130293804|NCT02046070|469040902|FG002|Overall Study|Progressive Disease|40|||
130293805|NCT02046070|469040900|FG000|Overall Study|Adverse Event|8|||
130293806|NCT02046070|469040901|FG001|Overall Study|Adverse Event|10|||
130293807|NCT02046070|469040902|FG002|Overall Study|Adverse Event|17|||
130293808|NCT02046070|469040900|FG000|Overall Study|Withdrawal by Subject|1|||
130293809|NCT02046070|469040901|FG001|Overall Study|Withdrawal by Subject|2|||
130293810|NCT02046070|469040902|FG002|Overall Study|Withdrawal by Subject|6|||
130293811|NCT02046070|469040900|FG000|Overall Study|Study Terminated by Sponsor|1|||
130293812|NCT02046070|469040901|FG001|Overall Study|Study Terminated by Sponsor|1|||
130293813|NCT02046070|469040902|FG002|Overall Study|Study Terminated by Sponsor|1|||
130460454|NCT02477670|469652087|FG001|Stage 1|Withdrawal by Subject|2|||
130460455|NCT02477670|469652088|FG002|Stage 1|Withdrawal by Subject|0|||
130460456|NCT02477670|469652089|FG003|Stage 1|Withdrawal by Subject|0|||
130460457|NCT02477670|469652090|FG004|Stage 1|Withdrawal by Subject|0|||
130460458|NCT02477670|469652091|FG005|Stage 1|Withdrawal by Subject|0|||
130460459|NCT02477670|469652092|FG006|Stage 1|Withdrawal by Subject|0|||
130293814|NCT02046070|469040900|FG000|Overall Study|Reason not Specified|4|||
130293815|NCT02046070|469040901|FG001|Overall Study|Reason not Specified|4|||
130293816|NCT02046070|469040902|FG002|Overall Study|Reason not Specified|6|||
130293817|NCT04030962|469040903|FG000|Stage 2|Adverse Event|0|||
130293818|NCT04030962|469040904|FG001|Stage 2|Adverse Event|0|||
130293819|NCT04030962|469040905|FG002|Stage 2|Adverse Event|0|||
130293820|NCT04030962|469040906|FG003|Stage 2|Adverse Event|0|||
130293821|NCT04030962|469040907|FG004|Stage 2|Adverse Event|0|||
130293822|NCT04030962|469040908|FG005|Stage 2|Adverse Event|0|||
130293823|NCT04030962|469040909|FG006|Stage 2|Adverse Event|0|||
130293824|NCT04030962|469040910|FG007|Stage 2|Adverse Event|0|||
130460460|NCT02477670|469652086|FG000|Stage 1|Non-compliance with Study Drug|1|||
130460461|NCT02477670|469652087|FG001|Stage 1|Non-compliance with Study Drug|2|||
130460462|NCT02477670|469652088|FG002|Stage 1|Non-compliance with Study Drug|0|||
130293825|NCT04030962|469040911|FG008|Stage 2|Adverse Event|1|||
130293826|NCT04030962|469040912|FG009|Stage 2|Adverse Event|0|||
130293827|NCT04030962|469040913|FG010|Stage 2|Adverse Event|1|||
130293828|NCT04030962|469040914|FG011|Stage 2|Adverse Event|1|||
130293829|NCT04030962|469040915|FG012|Stage 2|Adverse Event|1|||
130293830|NCT04030962|469040903|FG000|Stage 2|Withdrawal by Subject|0|||
130293831|NCT04030962|469040904|FG001|Stage 2|Withdrawal by Subject|0|||
130293832|NCT04030962|469040905|FG002|Stage 2|Withdrawal by Subject|0|||
130293833|NCT04030962|469040906|FG003|Stage 2|Withdrawal by Subject|0|||
130293834|NCT04030962|469040907|FG004|Stage 2|Withdrawal by Subject|0|||
130293835|NCT04030962|469040908|FG005|Stage 2|Withdrawal by Subject|0|||
130293836|NCT04030962|469040909|FG006|Stage 2|Withdrawal by Subject|0|||
130293837|NCT04030962|469040910|FG007|Stage 2|Withdrawal by Subject|0|||
130293838|NCT04030962|469040911|FG008|Stage 2|Withdrawal by Subject|1|||
130293839|NCT04030962|469040912|FG009|Stage 2|Withdrawal by Subject|0|||
130293840|NCT04030962|469040913|FG010|Stage 2|Withdrawal by Subject|0|||
130293841|NCT04030962|469040914|FG011|Stage 2|Withdrawal by Subject|2|||
130293842|NCT04030962|469040915|FG012|Stage 2|Withdrawal by Subject|1|||
130293843|NCT04030962|469040903|FG000|Stage 2|Lost to Follow-up|0|||
130293844|NCT04030962|469040904|FG001|Stage 2|Lost to Follow-up|0|||
130293845|NCT04030962|469040905|FG002|Stage 2|Lost to Follow-up|0|||
130293846|NCT04030962|469040906|FG003|Stage 2|Lost to Follow-up|0|||
130293847|NCT04030962|469040907|FG004|Stage 2|Lost to Follow-up|0|||
130293848|NCT04030962|469040908|FG005|Stage 2|Lost to Follow-up|0|||
130293849|NCT04030962|469040909|FG006|Stage 2|Lost to Follow-up|0|||
130293850|NCT04030962|469040910|FG007|Stage 2|Lost to Follow-up|0|||
130293851|NCT04030962|469040911|FG008|Stage 2|Lost to Follow-up|1|||
130293852|NCT04030962|469040912|FG009|Stage 2|Lost to Follow-up|0|||
130293853|NCT04030962|469040913|FG010|Stage 2|Lost to Follow-up|0|||
130293854|NCT04030962|469040914|FG011|Stage 2|Lost to Follow-up|0|||
130293855|NCT04030962|469040915|FG012|Stage 2|Lost to Follow-up|0|||
130293856|NCT04030962|469040903|FG000|Stage 2|Technical Problems|0|||
130293857|NCT04030962|469040904|FG001|Stage 2|Technical Problems|0|||
130293858|NCT04030962|469040905|FG002|Stage 2|Technical Problems|0|||
130293859|NCT04030962|469040906|FG003|Stage 2|Technical Problems|0|||
130293860|NCT04030962|469040907|FG004|Stage 2|Technical Problems|0|||
130293861|NCT04030962|469040908|FG005|Stage 2|Technical Problems|0|||
130293862|NCT04030962|469040909|FG006|Stage 2|Technical Problems|0|||
130293863|NCT04030962|469040910|FG007|Stage 2|Technical Problems|0|||
130293864|NCT04030962|469040911|FG008|Stage 2|Technical Problems|0|||
130293865|NCT04030962|469040912|FG009|Stage 2|Technical Problems|0|||
130293866|NCT04030962|469040913|FG010|Stage 2|Technical Problems|0|||
130293867|NCT04030962|469040914|FG011|Stage 2|Technical Problems|1|||
130293868|NCT04030962|469040915|FG012|Stage 2|Technical Problems|0|||
130293869|NCT05601102|469040918|FG000|Overall Study|Death|1|||
130293870|NCT05601102|469040919|FG001|Overall Study|Death|2|||
130293871|NCT05601102|469040918|FG000|Overall Study|Withdrawal by Subject|1|||
130293872|NCT05601102|469040919|FG001|Overall Study|Withdrawal by Subject|1|||
130293873|NCT05601102|469040918|FG000|Overall Study|Lost to Follow-up|0|||
130293874|NCT05601102|469040919|FG001|Overall Study|Lost to Follow-up|2|||
130293875|NCT05288166|469040920|FG000|Overall Study|Adverse Event|1|||
130293876|NCT05288166|469040921|FG001|Overall Study|Adverse Event|0|||
130293877|NCT05288166|469040920|FG000|Overall Study|Lost to Follow-up|2|||
130293878|NCT05288166|469040921|FG001|Overall Study|Lost to Follow-up|0|||
130293879|NCT05288166|469040920|FG000|Overall Study|Physician Decision|0|||
130293880|NCT05288166|469040921|FG001|Overall Study|Physician Decision|2|||
130293881|NCT05288166|469040920|FG000|Overall Study|Screen Failure|1|||
130293882|NCT05288166|469040921|FG001|Overall Study|Screen Failure|1|||
130293883|NCT05288166|469040920|FG000|Overall Study|Withdrawal by Subject|4|||
130293884|NCT05288166|469040921|FG001|Overall Study|Withdrawal by Subject|2|||
130293885|NCT05288166|469040920|FG000|Overall Study|On Study Treatment|408|||
130293886|NCT05288166|469040921|FG001|Overall Study|On Study Treatment|418|||
130293887|NCT02981524|469040923|FG000|Overall Study|Progressive Disease|14|||
130293888|NCT02981524|469040923|FG000|Overall Study|Death (unrelated)|1|||
130293889|NCT02981524|469040923|FG000|Overall Study|Treatment Related Toxicity|1|||
130293890|NCT02981524|469040923|FG000|Overall Study|Withdrawal by Subject|1|||
130293891|NCT00895661|469040927|FG000|Overall Study|Death|1|||
130293892|NCT00895661|469040927|FG000|Overall Study|reason unknown|2|||
130293893|NCT04094584|469040928|FG000|Overall Study|No interest in study|88|||
130293894|NCT04094584|469040928|FG000|Overall Study|Unwilling to undergo screening tests|36|||
130293895|NCT04094584|469040928|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
130293896|NCT04094584|469040928|FG000|Overall Study|Opioid use|7|||
130293897|NCT04094584|469040928|FG000|Overall Study|Need for major surgery in study period|4|||
130293898|NCT04094584|469040928|FG000|Overall Study|eligible but declined enrollment|4|||
130293899|NCT04094584|469040928|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
130293900|NCT04094584|469040928|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
130293901|NCT04094584|469040928|FG000|Overall Study|Lost to Follow-up|3|||
130293902|NCT04094584|469040928|FG000|Overall Study|Withdrawal by Subject|2|||
130293903|NCT00791557|469040929|FG000|Overall Study|Adverse Event|1|||
130293904|NCT03344640|469040930|FG000|Overall Study|Adverse Event|1|||
130293905|NCT03344640|469040931|FG001|Overall Study|Adverse Event|0|||
130293906|NCT03344640|469040930|FG000|Overall Study|Physician Decision|1|||
130293907|NCT03344640|469040931|FG001|Overall Study|Physician Decision|1|||
130293908|NCT03344640|469040930|FG000|Overall Study|Withdrawal by Subject|1|||
130293909|NCT03344640|469040931|FG001|Overall Study|Withdrawal by Subject|2|||
130293910|NCT03344640|469040930|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
130293911|NCT03344640|469040931|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
130293912|NCT01902888|469040932|FG000|Overall Study|Study Terminated|3|||
130293913|NCT00582738|469040933|FG000|Overall Study|Administrative Problems|7|||
130293914|NCT00582738|469040934|FG001|Overall Study|Administrative Problems|8|||
130293915|NCT00582738|469040933|FG000|Overall Study|Adverse Event|0|||
130293916|NCT00582738|469040934|FG001|Overall Study|Adverse Event|5|||
130293917|NCT00582738|469040933|FG000|Overall Study|Graft Lost|0|||
130293918|NCT00582738|469040934|FG001|Overall Study|Graft Lost|1|||
130293919|NCT00582738|469040933|FG000|Overall Study|Other|1|||
130293920|NCT00582738|469040934|FG001|Overall Study|Other|0|||
130293921|NCT00582738|469040933|FG000|Overall Study|Protocol Violation|1|||
130293922|NCT00582738|469040934|FG001|Overall Study|Protocol Violation|1|||
130293923|NCT00582738|469040933|FG000|Overall Study|Withdrawal by Subject|0|||
130293924|NCT00582738|469040934|FG001|Overall Study|Withdrawal by Subject|3|||
130293925|NCT00652899|469040935|FG000|Overall Study|Death|1|||
130293926|NCT00652899|469040935|FG000|Overall Study|Treating physician decision|1|||
130293927|NCT04135859|469040937|FG000|Overall Study|Withdrawal by Subject|1|||
130293928|NCT04135859|469040938|FG001|Overall Study|Withdrawal by Subject|0|||
130293929|NCT04135859|469040937|FG000|Overall Study|Withdrawal due to screening failure|1|||
130293930|NCT04135859|469040938|FG001|Overall Study|Withdrawal due to screening failure|2|||
130293931|NCT04135859|469040937|FG000|Overall Study|Did not complete stress test|3|||
130293932|NCT04135859|469040938|FG001|Overall Study|Did not complete stress test|3|||
130293933|NCT04135859|469040937|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
130293934|NCT04135859|469040938|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
130293935|NCT00551291|469040939|FG000|Overall Study|Physician Decision|1|||
130293936|NCT01943552|469040940|FG000|Overall Study|Adverse Event|3|||
130293937|NCT01943552|469040941|FG001|Overall Study|Adverse Event|2|||
130293938|NCT01943552|469040940|FG000|Overall Study|Withdrawal by Subject|6|||
130293939|NCT01943552|469040941|FG001|Overall Study|Withdrawal by Subject|6|||
130293940|NCT01943552|469040940|FG000|Overall Study|Other Reasons|16|||
130293941|NCT01943552|469040941|FG001|Overall Study|Other Reasons|17|||
130293942|NCT01600053|469040942|FG000|Overall Study|Adverse Event|2|||
130293943|NCT01600053|469040942|FG000|Overall Study|trial will not meet the interim endpoint|9|||
130293944|NCT04047420|469040943|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
130293945|NCT04047420|469040943|FG000|Washout Period|Refused Participation|2|||
130293946|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
130293947|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
130293948|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130293949|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130293950|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
130293951|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
130293952|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
130293953|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
130293954|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130293955|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
130293956|NCT02636946|469040945|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
130293957|NCT02636946|469040946|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
130293958|NCT00477269|469040947|FG000|Core Study|Adverse Event|6|||
130293959|NCT00477269|469040948|FG001|Core Study|Adverse Event|4|||
130556854|NCT05975840|470008057|FG003|Overall Study|Adverse Event|1|||
130556855|NCT05975840|470008058|FG004|Overall Study|Adverse Event|0|||
130293960|NCT00477269|469040949|FG002|Core Study|Adverse Event|0|||
130293961|NCT00477269|469040947|FG000|Core Study|Death|3|||
130293962|NCT00477269|469040948|FG001|Core Study|Death|3|||
130293963|NCT00477269|469040949|FG002|Core Study|Death|0|||
130293964|NCT00477269|469040947|FG000|Core Study|Withdrawn Consent|0|||
130293965|NCT00477269|469040948|FG001|Core Study|Withdrawn Consent|1|||
130293966|NCT00477269|469040949|FG002|Core Study|Withdrawn Consent|0|||
130371935|NCT03338998|469331033|FG000|Treatment Period|Withdrawal by Subject|1|||
130371936|NCT03338998|469331034|FG001|Treatment Period|Withdrawal by Subject|1|||
130371937|NCT03338998|469331033|FG000|Treatment Period|Adverse Event|0|||
130371938|NCT03338998|469331034|FG001|Treatment Period|Adverse Event|2|||
130371939|NCT03338998|469331033|FG000|Treatment Period|Protocol deviation|1|||
130371940|NCT03338998|469331034|FG001|Treatment Period|Protocol deviation|0|||
130371941|NCT03338998|469331033|FG000|Treatment Period|Physician Decision|2|||
130293967|NCT00477269|469040947|FG000|Open Label Extension|Adverse Event|0|||
130371942|NCT03338998|469331034|FG001|Treatment Period|Physician Decision|0|||
130371943|NCT03338998|469331033|FG000|Treatment Period|Subject failed swallow test|4|||
130293968|NCT00477269|469040948|FG001|Open Label Extension|Adverse Event|0|||
130293969|NCT00477269|469040949|FG002|Open Label Extension|Adverse Event|4|||
130556856|NCT05975840|470008059|FG005|Overall Study|Adverse Event|0|||
130556857|NCT05975840|470008060|FG006|Overall Study|Adverse Event|0|||
130556858|NCT05975840|470008061|FG007|Overall Study|Adverse Event|0|||
130556859|NCT05975840|470008054|FG000|Overall Study|Death|0|||
130556860|NCT05975840|470008055|FG001|Overall Study|Death|1|||
130556861|NCT05975840|470008056|FG002|Overall Study|Death|0|||
130293970|NCT00477269|469040947|FG000|Open Label Extension|Abnormal laboratory values|0|||
130293971|NCT00477269|469040948|FG001|Open Label Extension|Abnormal laboratory values|0|||
130293972|NCT00477269|469040949|FG002|Open Label Extension|Abnormal laboratory values|1|||
130293973|NCT00477269|469040947|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
130293974|NCT00477269|469040948|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
130293975|NCT00477269|469040949|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
130293976|NCT00477269|469040947|FG000|Open Label Extension|Adminiatrative problems|0|||
130293977|NCT00477269|469040948|FG001|Open Label Extension|Adminiatrative problems|0|||
130293978|NCT00477269|469040949|FG002|Open Label Extension|Adminiatrative problems|2|||
130293979|NCT00477269|469040947|FG000|Open Label Extension|Death|0|||
130293980|NCT00477269|469040948|FG001|Open Label Extension|Death|0|||
130293981|NCT00477269|469040949|FG002|Open Label Extension|Death|4|||
130293982|NCT01792518|469040952|FG000|Overall Study|Adverse Event|3|||
130293983|NCT01792518|469040953|FG001|Overall Study|Adverse Event|4|||
130293984|NCT01792518|469040952|FG000|Overall Study|Protocol Violation|0|||
130293985|NCT01792518|469040953|FG001|Overall Study|Protocol Violation|1|||
130293986|NCT01792518|469040952|FG000|Overall Study|Lost to Follow-up|3|||
130293987|NCT01792518|469040953|FG001|Overall Study|Lost to Follow-up|1|||
130371944|NCT03338998|469331034|FG001|Treatment Period|Subject failed swallow test|0|||
130371945|NCT03338998|469331033|FG000|Safety Follow-Up Period|Adverse Event|0|||
130371946|NCT03338998|469331034|FG001|Safety Follow-Up Period|Adverse Event|1|||
130371947|NCT03338998|469331033|FG000|Safety Follow-Up Period|Protocol deviation|1|||
130371948|NCT03338998|469331034|FG001|Safety Follow-Up Period|Protocol deviation|0|||
130371949|NCT03338998|469331033|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
130371950|NCT03338998|469331034|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
130371951|NCT03288129|469331036|FG000|Overall Study|Adverse Event|10|||
130371952|NCT03288129|469331036|FG000|Overall Study|Lost to Follow-up|3|||
130371953|NCT03288129|469331036|FG000|Overall Study|Withdrawal by Subject|3|||
130371954|NCT03288129|469331036|FG000|Overall Study|Withdrawal of consent/assent|1|||
130371955|NCT03288129|469331036|FG000|Overall Study|Other|5|||
130371956|NCT00558558|469331041|FG000|Overall Study|Unable to swallow|1|||
130371957|NCT00558558|469331041|FG000|Overall Study|Withdrawal by Subject|1|||
130293988|NCT01792518|469040952|FG000|Overall Study|Withdrawal by Subject|2|||
130293989|NCT01792518|469040953|FG001|Overall Study|Withdrawal by Subject|0|||
130371958|NCT00558558|469331041|FG000|Overall Study|Lack of Efficacy|4|||
130371959|NCT05255068|469333204|FG000|Overall Study|Lost to Follow-up|0|||
130293990|NCT01792518|469040952|FG000|Overall Study|Other Reason|0|||
130293991|NCT01792518|469040953|FG001|Overall Study|Other Reason|1|||
130371960|NCT05255068|469333205|FG001|Overall Study|Lost to Follow-up|1|||
130371961|NCT00980057|469333210|FG000|Overall Study|Death|13|||
130293992|NCT00351273|469040987|FG000|Overall Study|Lost to Follow-up|1|||
130371962|NCT00980057|469333211|FG001|Overall Study|Death|3|||
130371963|NCT00980057|469333210|FG000|Overall Study|Adverse Event|0|||
130371964|NCT00980057|469333211|FG001|Overall Study|Adverse Event|1|||
130293993|NCT00351273|469040988|FG001|Overall Study|Lost to Follow-up|2|||
130293994|NCT00351273|469040989|FG002|Overall Study|Lost to Follow-up|5|||
130371965|NCT00980057|469333210|FG000|Overall Study|Physician Decision|4|||
130371966|NCT00980057|469333211|FG001|Overall Study|Physician Decision|0|||
130371967|NCT00980057|469333210|FG000|Overall Study|Lost to Follow-up|1|||
130371968|NCT00980057|469333211|FG001|Overall Study|Lost to Follow-up|0|||
130371969|NCT00980057|469333210|FG000|Overall Study|Withdrawal by Subject|1|||
130371970|NCT00980057|469333211|FG001|Overall Study|Withdrawal by Subject|1|||
130371971|NCT01408485|469333215|FG000|Overall Study|Withdrawal by Subject|21|||
130371972|NCT01315678|469333216|FG000|Overall Study|Withdrawal by Subject|7|||
130371973|NCT01315678|469333217|FG001|Overall Study|Withdrawal by Subject|3|||
130371974|NCT01315678|469333216|FG000|Overall Study|Adverse Event|3|||
130371975|NCT01315678|469333217|FG001|Overall Study|Adverse Event|1|||
130371976|NCT01315678|469333216|FG000|Overall Study|Lost to Follow-up|1|||
130371977|NCT01315678|469333217|FG001|Overall Study|Lost to Follow-up|0|||
130371978|NCT01315678|469333216|FG000|Overall Study|similar reason to those listed above|3|||
130371979|NCT01315678|469333217|FG001|Overall Study|similar reason to those listed above|2|||
130371980|NCT00331682|469333218|FG000|Overall Study|Adverse Event|1|||
130371981|NCT00790023|469333219|FG000|Overall Study|Adverse Event|2|||
130371982|NCT00790023|469333220|FG001|Overall Study|Adverse Event|1|||
130371983|NCT00790023|469333221|FG002|Overall Study|Adverse Event|4|||
130371984|NCT00790023|469333219|FG000|Overall Study|Protocol Violation|2|||
130371985|NCT00790023|469333220|FG001|Overall Study|Protocol Violation|4|||
130371986|NCT00790023|469333221|FG002|Overall Study|Protocol Violation|2|||
130371987|NCT00790023|469333219|FG000|Overall Study|Withdrawal by Subject|2|||
130371988|NCT00790023|469333220|FG001|Overall Study|Withdrawal by Subject|0|||
130714830|NCT00321737|470581788|FG000|Overall Study|Withdrawal by Subject|19|||
130714831|NCT00321737|470581789|FG001|Overall Study|Withdrawal by Subject|12|||
130714832|NCT00321737|470581790|FG002|Overall Study|Withdrawal by Subject|17|||
130714833|NCT00321737|470581788|FG000|Overall Study|Protocol Violation|0|||
130714834|NCT00321737|470581789|FG001|Overall Study|Protocol Violation|0|||
130714835|NCT00321737|470581790|FG002|Overall Study|Protocol Violation|1|||
130714836|NCT00321737|470581788|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
130714837|NCT00321737|470581789|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130714838|NCT00321737|470581790|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130714839|NCT00321737|470581788|FG000|Overall Study|Possible Barrett's Esophagus|2|||
130714840|NCT00321737|470581789|FG001|Overall Study|Possible Barrett's Esophagus|1|||
130714841|NCT00321737|470581790|FG002|Overall Study|Possible Barrett's Esophagus|1|||
130714842|NCT00321737|470581788|FG000|Overall Study|Therapeutic Failure|6|||
130714843|NCT00321737|470581789|FG001|Overall Study|Therapeutic Failure|0|||
130714844|NCT00321737|470581790|FG002|Overall Study|Therapeutic Failure|2|||
130714845|NCT00321737|470581788|FG000|Overall Study|Pregnancy|0|||
130714846|NCT00321737|470581789|FG001|Overall Study|Pregnancy|2|||
130714847|NCT00321737|470581790|FG002|Overall Study|Pregnancy|0|||
130714848|NCT00321737|470581788|FG000|Overall Study|Noncompliance|2|||
130714849|NCT00321737|470581789|FG001|Overall Study|Noncompliance|0|||
130293995|NCT01977690|469040990|FG000|Overall Study|Withdrawal by Subject|0|||
130293996|NCT01977690|469040991|FG001|Overall Study|Withdrawal by Subject|4|||
130714850|NCT00321737|470581790|FG002|Overall Study|Noncompliance|0|||
130293997|NCT03442296|469040997|FG000|3 Month Follow-up|Death|3|||
130293998|NCT03442296|469040998|FG001|3 Month Follow-up|Death|1|||
130293999|NCT03442296|469040997|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130294000|NCT03442296|469040998|FG001|3 Month Follow-up|Lost to Follow-up|1|||
130294001|NCT03442296|469040997|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
130294002|NCT03442296|469040998|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
130294003|NCT03442296|469040997|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
130294004|NCT03442296|469040998|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
130294005|NCT03442296|469040997|FG000|12 Month Follow-up|Incomplete measurement|1|||
130294006|NCT03442296|469040998|FG001|12 Month Follow-up|Incomplete measurement|1|||
130294007|NCT00447122|469041000|FG000|Overall Study|worsening medical condition -came off|0|||
130294008|NCT00447122|469041001|FG001|Overall Study|worsening medical condition -came off|1|||
130714851|NCT00321737|470581788|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
130294009|NCT00447122|469041002|FG002|Overall Study|worsening medical condition -came off|0|||
130294010|NCT00447122|469041003|FG003|Overall Study|worsening medical condition -came off|0|||
130294011|NCT01174173|469041006|FG000|Overall Study|drug-drug interaction|1|||
130294012|NCT00720343|469042157|FG000|Overall Study|Lost to Follow-up|1|||
130294013|NCT00720343|469042158|FG001|Overall Study|Lost to Follow-up|0|||
130294014|NCT00720343|469042157|FG000|Overall Study|Protocol Violation|0|||
130294015|NCT00720343|469042158|FG001|Overall Study|Protocol Violation|2|||
130294016|NCT02008773|469042159|FG000|Overall Study|Adverse Event|3|||
130294017|NCT02008773|469042160|FG001|Overall Study|Adverse Event|3|||
130714852|NCT00321737|470581789|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
130714853|NCT00321737|470581790|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
130714854|NCT01769339|470581791|FG000|Overall Study|Lost to Follow-up|42|||
130714855|NCT01769339|470581791|FG000|Overall Study|Adverse Event|1|||
130714856|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714857|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714858|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714859|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714860|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714861|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
130714862|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|headache|0|||
130714863|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|headache|0|||
130714864|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|headache|0|||
130714865|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|headache|0|||
130714866|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|headache|1|||
130714867|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|headache|0|||
130714868|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714869|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714870|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714871|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
130714872|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714873|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714874|NCT04062448|470583898|FG000|Overall Study|Lost to Follow-up|1|||
130714875|NCT04062448|470583898|FG000|Overall Study|Withdrawal by Subject|2|||
130714876|NCT05101486|470583899|FG000|Overall Study|Death|1|||
130714877|NCT05101486|470583900|FG001|Overall Study|Death|0|||
130714878|NCT05101486|470583901|FG002|Overall Study|Death|1|||
130294018|NCT02008773|469042161|FG002|Overall Study|Adverse Event|1|||
130294019|NCT02008773|469042162|FG003|Overall Study|Adverse Event|2|||
130294020|NCT02008773|469042159|FG000|Overall Study|Medication Non-compliance|2|||
130294021|NCT02008773|469042160|FG001|Overall Study|Medication Non-compliance|1|||
130556862|NCT05975840|470008057|FG003|Overall Study|Death|0|||
130556863|NCT05975840|470008058|FG004|Overall Study|Death|0|||
130294022|NCT02008773|469042161|FG002|Overall Study|Medication Non-compliance|3|||
130294023|NCT02008773|469042162|FG003|Overall Study|Medication Non-compliance|2|||
130294024|NCT02008773|469042159|FG000|Overall Study|Withdrawal by Subject|8|||
130294025|NCT02008773|469042160|FG001|Overall Study|Withdrawal by Subject|4|||
130294026|NCT02008773|469042161|FG002|Overall Study|Withdrawal by Subject|7|||
130294027|NCT02008773|469042162|FG003|Overall Study|Withdrawal by Subject|6|||
130294028|NCT02008773|469042159|FG000|Overall Study|Lost to Follow-up|0|||
130294029|NCT02008773|469042160|FG001|Overall Study|Lost to Follow-up|1|||
130294030|NCT02008773|469042161|FG002|Overall Study|Lost to Follow-up|3|||
130294031|NCT02008773|469042162|FG003|Overall Study|Lost to Follow-up|2|||
130294032|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
130294033|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294034|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294035|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294036|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
130294037|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294038|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294039|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294040|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
130294041|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294042|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294043|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294044|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
130294045|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294046|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294047|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294048|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
130294049|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
130294050|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
130294051|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
130294052|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
130294053|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294054|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294055|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294056|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
130294057|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294058|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294059|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294060|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
130294061|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130294062|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130294063|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130556864|NCT05975840|470008059|FG005|Overall Study|Death|0|||
130556865|NCT05975840|470008060|FG006|Overall Study|Death|0|||
130556866|NCT05975840|470008061|FG007|Overall Study|Death|1|||
130294064|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
130294065|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294066|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294067|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294068|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
130294069|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294070|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294071|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294072|NCT02198794|469042163|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
130294073|NCT02198794|469042164|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
130294074|NCT02198794|469042165|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
130294075|NCT02198794|469042166|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
130371989|NCT00790023|469333221|FG002|Overall Study|Withdrawal by Subject|6|||
130371990|NCT00790023|469333219|FG000|Overall Study|Lost to Follow-up|0|||
130371991|NCT00790023|469333220|FG001|Overall Study|Lost to Follow-up|0|||
130371992|NCT00790023|469333221|FG002|Overall Study|Lost to Follow-up|1|||
130371993|NCT00790023|469333219|FG000|Overall Study|Other|5|||
130371994|NCT00790023|469333220|FG001|Overall Study|Other|5|||
130556867|NCT04014361|470008064|FG000|Period 2|Physician Decision|0|||
130294076|NCT02198794|469042163|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130294077|NCT02198794|469042164|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
130371995|NCT00790023|469333221|FG002|Overall Study|Other|8|||
130371996|NCT02468414|469333222|FG000|Overall Study|Early Study Termination by Sponsor|1|||
130556868|NCT04014361|470008065|FG001|Period 2|Physician Decision|0|||
130556869|NCT04014361|470008066|FG002|Period 2|Physician Decision|0|||
130556870|NCT04014361|470008067|FG003|Period 2|Physician Decision|1|||
130556871|NCT04014361|470008068|FG004|Period 2|Physician Decision|0|||
130556872|NCT04014361|470008069|FG005|Period 2|Physician Decision|0|||
130556873|NCT04014361|470008070|FG006|Period 2|Physician Decision|0|||
130556874|NCT04014361|470008071|FG007|Period 2|Physician Decision|0|||
130556875|NCT02593786|470008073|FG000|Overall Study|Disease progression|12|||
130556876|NCT02593786|470008074|FG001|Overall Study|Disease progression|16|||
130556877|NCT02593786|470008075|FG002|Overall Study|Disease progression|10|||
130556878|NCT02593786|470008076|FG003|Overall Study|Disease progression|7|||
130556879|NCT02593786|470008073|FG000|Overall Study|Study drug toxicity|1|||
130556880|NCT02593786|470008074|FG001|Overall Study|Study drug toxicity|0|||
130556881|NCT02593786|470008075|FG002|Overall Study|Study drug toxicity|0|||
130556882|NCT02593786|470008076|FG003|Overall Study|Study drug toxicity|0|||
130556883|NCT02593786|470008073|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130556884|NCT02593786|470008074|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130556885|NCT02593786|470008075|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130556886|NCT02593786|470008076|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130556887|NCT02593786|470008073|FG000|Overall Study|Participant request to discontinue study therapy|0|||
130556888|NCT02593786|470008074|FG001|Overall Study|Participant request to discontinue study therapy|2|||
130556889|NCT02593786|470008075|FG002|Overall Study|Participant request to discontinue study therapy|0|||
130556890|NCT02593786|470008076|FG003|Overall Study|Participant request to discontinue study therapy|0|||
130556891|NCT02593786|470008073|FG000|Overall Study|Other reasons|1|||
130556892|NCT02593786|470008074|FG001|Overall Study|Other reasons|1|||
130556893|NCT02593786|470008075|FG002|Overall Study|Other reasons|0|||
130294078|NCT02198794|469042165|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
130294079|NCT02198794|469042166|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130294080|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130556894|NCT02593786|470008076|FG003|Overall Study|Other reasons|5|||
130556895|NCT01130051|470008077|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
130556896|NCT01130051|470008078|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
130556897|NCT01130051|470008077|FG000|Washout Period of 14 Days|Protocol Violation|1|||
130294081|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130294082|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130294083|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
130294084|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294085|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294086|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294087|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
130294088|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294089|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294090|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294091|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
130294092|NCT01918332|469042167|FG000|Overall Study|Adverse Event|0|||
130294093|NCT01918332|469042168|FG001|Overall Study|Adverse Event|0|||
130294094|NCT01918332|469042169|FG002|Overall Study|Adverse Event|0|||
130294095|NCT01918332|469042170|FG003|Overall Study|Adverse Event|1|||
130294096|NCT01918332|469042167|FG000|Overall Study|Withdrawal by Subject|2|||
130294097|NCT01918332|469042168|FG001|Overall Study|Withdrawal by Subject|3|||
130294098|NCT01918332|469042169|FG002|Overall Study|Withdrawal by Subject|2|||
130294099|NCT01918332|469042170|FG003|Overall Study|Withdrawal by Subject|3|||
130294100|NCT01918332|469042167|FG000|Overall Study|Protocol Violation|6|||
130294101|NCT01918332|469042168|FG001|Overall Study|Protocol Violation|2|||
130294102|NCT01918332|469042169|FG002|Overall Study|Protocol Violation|6|||
130294103|NCT01918332|469042170|FG003|Overall Study|Protocol Violation|3|||
130294104|NCT01918332|469042167|FG000|Overall Study|lipid result by central lab did not meet|0|||
130294105|NCT01918332|469042168|FG001|Overall Study|lipid result by central lab did not meet|0|||
130294106|NCT01918332|469042169|FG002|Overall Study|lipid result by central lab did not meet|1|||
130294107|NCT01918332|469042170|FG003|Overall Study|lipid result by central lab did not meet|0|||
130294108|NCT02408523|469042171|FG000|Overall Study|Adverse Event|4|||
130294109|NCT02408523|469042172|FG001|Overall Study|Adverse Event|10|||
130556898|NCT01130051|470008078|FG001|Washout Period of 14 Days|Protocol Violation|1|||
130556899|NCT04252287|470008082|FG000|Overall Study|Death|5|||
130556900|NCT04252287|470008083|FG001|Overall Study|Death|3|||
130556901|NCT04252287|470008082|FG000|Overall Study|Lost to Follow-up|4|||
130556902|NCT04252287|470008083|FG001|Overall Study|Lost to Follow-up|6|||
130294110|NCT02408523|469042171|FG000|Overall Study|Lack of Efficacy|0|||
130294111|NCT02408523|469042172|FG001|Overall Study|Lack of Efficacy|1|||
130556903|NCT04252287|470008082|FG000|Overall Study|Withdrawal by Subject|19|||
130294112|NCT02408523|469042171|FG000|Overall Study|Protocol Violation|1|||
130294113|NCT02408523|469042172|FG001|Overall Study|Protocol Violation|2|||
130556904|NCT04252287|470008083|FG001|Overall Study|Withdrawal by Subject|16|||
130556905|NCT04252287|470008082|FG000|Overall Study|Protocol Violation|3|||
130556906|NCT04252287|470008083|FG001|Overall Study|Protocol Violation|4|||
130556907|NCT00835120|470008089|FG000|Overall Study|Lack of Efficacy|1|||
130556908|NCT00835120|470008089|FG000|Overall Study|Lost to Follow-up|3|||
130556909|NCT00835120|470008089|FG000|Overall Study|Adverse Event|2|||
130556910|NCT00835120|470008089|FG000|Overall Study|Withdrawal by Subject|2|||
130556911|NCT01298518|470008091|FG000|Overall Study|Withdrawal by Subject|0|||
130556912|NCT01298518|470008092|FG001|Overall Study|Withdrawal by Subject|0|||
130556913|NCT01298518|470008093|FG002|Overall Study|Withdrawal by Subject|1|||
130556914|NCT02273726|470008094|FG000|Overall Study|Death|70|||
130556915|NCT02273726|470008095|FG001|Overall Study|Death|62|||
130714879|NCT05101486|470583899|FG000|Overall Study|Lost to Follow-up|12|||
130714880|NCT05101486|470583900|FG001|Overall Study|Lost to Follow-up|8|||
130714881|NCT05101486|470583901|FG002|Overall Study|Lost to Follow-up|17|||
130714882|NCT05101486|470583899|FG000|Overall Study|Physician Decision|1|||
130714883|NCT05101486|470583900|FG001|Overall Study|Physician Decision|0|||
130714884|NCT05101486|470583901|FG002|Overall Study|Physician Decision|0|||
130714885|NCT05101486|470583899|FG000|Overall Study|Protocol Violation|0|||
130294114|NCT02408523|469042171|FG000|Overall Study|Lost to Follow-up|2|||
130294115|NCT02408523|469042172|FG001|Overall Study|Lost to Follow-up|3|||
130294116|NCT02408523|469042171|FG000|Overall Study|Withdrawal by Subject|3|||
130294117|NCT02408523|469042172|FG001|Overall Study|Withdrawal by Subject|1|||
130294118|NCT02408523|469042171|FG000|Overall Study|Sponsor request|1|||
130294119|NCT02408523|469042172|FG001|Overall Study|Sponsor request|0|||
130294120|NCT02408523|469042171|FG000|Overall Study|Did not satisfy extension conditions|0|||
130294121|NCT02408523|469042172|FG001|Overall Study|Did not satisfy extension conditions|1|||
130294122|NCT00701805|469042173|FG000|Overall Study|Withdrawal by Subject|3|||
130294123|NCT00701805|469042174|FG001|Overall Study|Withdrawal by Subject|1|||
130294124|NCT00701805|469042175|FG002|Overall Study|Withdrawal by Subject|4|||
130294125|NCT00701805|469042176|FG003|Overall Study|Withdrawal by Subject|3|||
130294126|NCT00701805|469042173|FG000|Overall Study|Adverse Event|0|||
130294127|NCT00701805|469042174|FG001|Overall Study|Adverse Event|1|||
130294128|NCT00701805|469042175|FG002|Overall Study|Adverse Event|1|||
130294129|NCT00701805|469042176|FG003|Overall Study|Adverse Event|0|||
130294130|NCT00701805|469042173|FG000|Overall Study|Missed 7 consecutive doses|0|||
130294131|NCT00701805|469042174|FG001|Overall Study|Missed 7 consecutive doses|1|||
130294132|NCT00701805|469042175|FG002|Overall Study|Missed 7 consecutive doses|0|||
130294133|NCT00701805|469042176|FG003|Overall Study|Missed 7 consecutive doses|0|||
130294134|NCT00701805|469042173|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
130294135|NCT00701805|469042174|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
130294136|NCT00701805|469042175|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
130294137|NCT00701805|469042176|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
130294138|NCT00701805|469042173|FG000|Overall Study|Physician decision, change of therapy|0|||
130294139|NCT00701805|469042174|FG001|Overall Study|Physician decision, change of therapy|0|||
130294140|NCT00701805|469042175|FG002|Overall Study|Physician decision, change of therapy|0|||
130294141|NCT00701805|469042176|FG003|Overall Study|Physician decision, change of therapy|1|||
130294142|NCT00701805|469042173|FG000|Overall Study|Difficult to travel to dialysis site|0|||
130294143|NCT00701805|469042174|FG001|Overall Study|Difficult to travel to dialysis site|0|||
130294144|NCT00701805|469042175|FG002|Overall Study|Difficult to travel to dialysis site|1|||
130294145|NCT00701805|469042176|FG003|Overall Study|Difficult to travel to dialysis site|0|||
130294146|NCT00701805|469042173|FG000|Overall Study|Resumption criteria were not met|0|||
130294147|NCT00701805|469042174|FG001|Overall Study|Resumption criteria were not met|1|||
130294148|NCT00701805|469042175|FG002|Overall Study|Resumption criteria were not met|0|||
130294149|NCT00701805|469042176|FG003|Overall Study|Resumption criteria were not met|0|||
130294150|NCT02252965|469042180|FG000|Overall Study|Adverse Event|9|||
130294151|NCT02252965|469042181|FG001|Overall Study|Adverse Event|14|||
130294152|NCT02252965|469042180|FG000|Overall Study|Lost to Follow-up|16|||
130294153|NCT02252965|469042181|FG001|Overall Study|Lost to Follow-up|8|||
130294154|NCT02252965|469042180|FG000|Overall Study|Protocol Violation|4|||
130294155|NCT02252965|469042181|FG001|Overall Study|Protocol Violation|5|||
130294156|NCT02252965|469042180|FG000|Overall Study|Lack of Efficacy|0|||
130294157|NCT02252965|469042181|FG001|Overall Study|Lack of Efficacy|2|||
130294158|NCT02252965|469042180|FG000|Overall Study|Withdrawal by Subject|7|||
130294159|NCT02252965|469042181|FG001|Overall Study|Withdrawal by Subject|9|||
130294160|NCT02252965|469042180|FG000|Overall Study|Other|4|||
130294161|NCT02252965|469042181|FG001|Overall Study|Other|5|||
130294162|NCT04256512|469042182|FG000|Overall Study|Withdrawal by Subject|1|||
130294163|NCT04435600|469042190|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294164|NCT04435600|469042191|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294165|NCT04435600|469042192|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
130294166|NCT04435600|469042193|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294167|NCT04435600|469042194|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294168|NCT04435600|469042195|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294169|NCT04435600|469042196|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294170|NCT04435600|469042197|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294171|NCT04435600|469042198|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294172|NCT04435600|469042199|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294173|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294174|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294175|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294176|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294177|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294178|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294179|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294180|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294181|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294182|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
130294183|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294184|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294185|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294186|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294187|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294188|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294189|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294190|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294191|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294192|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
130294193|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294194|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294195|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294196|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294197|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294198|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294199|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294200|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294201|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294202|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
130294203|NCT02797184|469042201|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130294204|NCT02797184|469042202|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130294205|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130294206|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130294207|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130294208|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130294209|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
130294210|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
130294211|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130294212|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130294213|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
130294214|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294215|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294216|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294217|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
130294218|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
130294219|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130294220|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130294221|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
130294222|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294223|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294224|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294225|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
130294226|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
130294227|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
130294228|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
130294229|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130294230|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130294231|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
130294232|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
130294233|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130294234|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130294235|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
130294236|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
130294237|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130294238|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130294239|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
130294240|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
130294241|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294242|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294243|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
130294244|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294245|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294246|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294247|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
130294248|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294249|NCT03199391|469042211|FG000|Overall Study|Death|1|||
130294250|NCT03199391|469042211|FG000|Overall Study|Lost to Follow-up|3|||
130294251|NCT03199391|469042211|FG000|Overall Study|Adverse Event|2|||
130294252|NCT03199391|469042211|FG000|Overall Study|Withdrawal by Subject|10|||
130294253|NCT01867086|469042212|FG000|Overall Study|Disease Progression|1|||
130294254|NCT00483041|469042214|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
130294255|NCT00483041|469042215|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
130294256|NCT02258529|469042217|FG000|Overall Study|Study Terminated by Sponsor|9|||
130294257|NCT02258529|469042217|FG000|Overall Study|Adverse Event|1|||
130294258|NCT00443781|469042218|FG000|Overall Study|Lost to Follow-up|10|||
130294259|NCT00443781|469042218|FG000|Overall Study|Physician Decision|2|||
130294260|NCT00443781|469042218|FG000|Overall Study|Protocol Violation|1|||
130294261|NCT00443781|469042218|FG000|Overall Study|Withdrawal by Subject|6|||
130294262|NCT00443781|469042218|FG000|Overall Study|Unable to comply with study follow up|2|||
130294263|NCT00443781|469042218|FG000|Overall Study|Investigator terminated participation|1|||
130294264|NCT00443781|469042218|FG000|Overall Study|Insurance not covered|2|||
130294265|NCT00443781|469042218|FG000|Overall Study|PD/FAD not done|1|||
130294266|NCT02066415|469042219|FG000|Overall Study|Decision by Sponsor|5|||
130294267|NCT02066415|469042220|FG001|Overall Study|Decision by Sponsor|4|||
130294268|NCT02066415|469042221|FG002|Overall Study|Decision by Sponsor|2|||
130294269|NCT02066415|469042219|FG000|Overall Study|Withdrawal by Subject|9|||
130294270|NCT02066415|469042220|FG001|Overall Study|Withdrawal by Subject|1|||
130294271|NCT02066415|469042221|FG002|Overall Study|Withdrawal by Subject|4|||
130294272|NCT02066415|469042219|FG000|Overall Study|Lost to Follow-up|7|||
130294273|NCT02066415|469042220|FG001|Overall Study|Lost to Follow-up|2|||
130294274|NCT02066415|469042221|FG002|Overall Study|Lost to Follow-up|2|||
130294275|NCT05432167|469042225|FG000|Overall Study|Adverse Event|0|||
130294276|NCT05432167|469042226|FG001|Overall Study|Adverse Event|2|||
130294277|NCT05432167|469042227|FG002|Overall Study|Adverse Event|1|||
130294278|NCT05432167|469042225|FG000|Overall Study|Lost to Follow-up|3|||
130294279|NCT05432167|469042226|FG001|Overall Study|Lost to Follow-up|3|||
130294280|NCT05432167|469042227|FG002|Overall Study|Lost to Follow-up|2|||
130294281|NCT05432167|469042225|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130294282|NCT05432167|469042226|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130294283|NCT05432167|469042227|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130294284|NCT05432167|469042225|FG000|Overall Study|Physician Decision|1|||
130294285|NCT05432167|469042226|FG001|Overall Study|Physician Decision|0|||
130294286|NCT05432167|469042227|FG002|Overall Study|Physician Decision|0|||
130294287|NCT05432167|469042225|FG000|Overall Study|Withdrawal by Subject|7|||
130294288|NCT05432167|469042226|FG001|Overall Study|Withdrawal by Subject|4|||
130294289|NCT05432167|469042227|FG002|Overall Study|Withdrawal by Subject|11|||
130294290|NCT05432167|469042225|FG000|Overall Study|Other|0|||
130294291|NCT05432167|469042226|FG001|Overall Study|Other|0|||
130294292|NCT05432167|469042227|FG002|Overall Study|Other|1|||
130294293|NCT02616393|469042235|FG000|Overall Study|Death|5|||
130294294|NCT02616393|469042236|FG001|Overall Study|Death|12|||
130294295|NCT02616393|469042237|FG002|Overall Study|Death|1|||
130294296|NCT02616393|469042235|FG000|Overall Study|Termination by Sponsor|4|||
130294297|NCT02616393|469042236|FG001|Overall Study|Termination by Sponsor|5|||
130294298|NCT02616393|469042237|FG002|Overall Study|Termination by Sponsor|2|||
130294299|NCT02616393|469042235|FG000|Overall Study|Other|3|||
130294300|NCT02616393|469042236|FG001|Overall Study|Other|0|||
130294301|NCT02616393|469042237|FG002|Overall Study|Other|0|||
130294302|NCT02616393|469042235|FG000|Overall Study|Withdrawal by Subject|1|||
130294303|NCT02616393|469042236|FG001|Overall Study|Withdrawal by Subject|1|||
130294304|NCT02616393|469042237|FG002|Overall Study|Withdrawal by Subject|0|||
130294305|NCT02616393|469042235|FG000|Overall Study|Lost to Follow-up|0|||
130294306|NCT02616393|469042236|FG001|Overall Study|Lost to Follow-up|2|||
130294307|NCT02616393|469042237|FG002|Overall Study|Lost to Follow-up|0|||
130294308|NCT00364533|469042239|FG000|Overall Study|Adverse Event|8|||
130294309|NCT00364533|469042240|FG001|Overall Study|Adverse Event|7|||
130294310|NCT00364533|469042241|FG002|Overall Study|Adverse Event|15|||
130294311|NCT00364533|469042242|FG003|Overall Study|Adverse Event|5|||
130294312|NCT00364533|469042243|FG004|Overall Study|Adverse Event|2|||
130371997|NCT02468414|469333223|FG001|Overall Study|Early Study Termination by Sponsor|0|||
130556916|NCT02273726|470008094|FG000|Overall Study|Withdrawal by Subject|41|||
130556917|NCT02273726|470008095|FG001|Overall Study|Withdrawal by Subject|29|||
130556918|NCT02273726|470008094|FG000|Overall Study|Kidney transplant|31|||
130556919|NCT02273726|470008095|FG001|Overall Study|Kidney transplant|39|||
130556920|NCT02273726|470008094|FG000|Overall Study|Physician Decision|30|||
130556921|NCT02273726|470008095|FG001|Overall Study|Physician Decision|15|||
130556922|NCT02273726|470008094|FG000|Overall Study|Adverse Event|27|||
130556923|NCT02273726|470008095|FG001|Overall Study|Adverse Event|9|||
130556924|NCT02273726|470008094|FG000|Overall Study|Lost to Follow-up|6|||
130556925|NCT02273726|470008095|FG001|Overall Study|Lost to Follow-up|3|||
130556926|NCT02273726|470008094|FG000|Overall Study|Lack of Efficacy|6|||
130556927|NCT02273726|470008095|FG001|Overall Study|Lack of Efficacy|1|||
130556928|NCT02273726|470008094|FG000|Overall Study|Protocol Violation|4|||
130556929|NCT02273726|470008095|FG001|Overall Study|Protocol Violation|0|||
130556930|NCT02273726|470008094|FG000|Overall Study|Other than specified|28|||
130556931|NCT02273726|470008095|FG001|Overall Study|Other than specified|30|||
130294313|NCT00364533|469042239|FG000|Overall Study|Withdrawal by Subject|4|||
130294314|NCT00364533|469042240|FG001|Overall Study|Withdrawal by Subject|8|||
130294315|NCT00364533|469042241|FG002|Overall Study|Withdrawal by Subject|6|||
130294316|NCT00364533|469042242|FG003|Overall Study|Withdrawal by Subject|6|||
130294317|NCT00364533|469042243|FG004|Overall Study|Withdrawal by Subject|6|||
130294318|NCT00364533|469042239|FG000|Overall Study|Lack of Efficacy|22|||
130294319|NCT00364533|469042240|FG001|Overall Study|Lack of Efficacy|22|||
130294320|NCT00364533|469042241|FG002|Overall Study|Lack of Efficacy|21|||
130294321|NCT00364533|469042242|FG003|Overall Study|Lack of Efficacy|17|||
130294322|NCT00364533|469042243|FG004|Overall Study|Lack of Efficacy|42|||
130294323|NCT00364533|469042239|FG000|Overall Study|Subject discharged from hospital|4|||
130294324|NCT00364533|469042240|FG001|Overall Study|Subject discharged from hospital|1|||
130294325|NCT00364533|469042241|FG002|Overall Study|Subject discharged from hospital|2|||
130294326|NCT00364533|469042242|FG003|Overall Study|Subject discharged from hospital|3|||
130294327|NCT00364533|469042243|FG004|Overall Study|Subject discharged from hospital|1|||
130294328|NCT00364533|469042239|FG000|Overall Study|Variations in drug compliance|2|||
130294329|NCT00364533|469042240|FG001|Overall Study|Variations in drug compliance|1|||
130294330|NCT00364533|469042241|FG002|Overall Study|Variations in drug compliance|1|||
130294331|NCT00364533|469042242|FG003|Overall Study|Variations in drug compliance|0|||
130294332|NCT00364533|469042243|FG004|Overall Study|Variations in drug compliance|0|||
130294333|NCT00364533|469042239|FG000|Overall Study|Non-compliance|1|||
130294334|NCT00364533|469042240|FG001|Overall Study|Non-compliance|0|||
130294335|NCT00364533|469042241|FG002|Overall Study|Non-compliance|0|||
130294336|NCT00364533|469042242|FG003|Overall Study|Non-compliance|0|||
130294337|NCT00364533|469042243|FG004|Overall Study|Non-compliance|0|||
130294338|NCT00364533|469042239|FG000|Overall Study|Protocol Violation|1|||
130294339|NCT00364533|469042240|FG001|Overall Study|Protocol Violation|1|||
130294340|NCT00364533|469042241|FG002|Overall Study|Protocol Violation|0|||
130294341|NCT00364533|469042242|FG003|Overall Study|Protocol Violation|0|||
130294342|NCT00364533|469042243|FG004|Overall Study|Protocol Violation|0|||
130294343|NCT02758301|469042244|FG000|Overall Study|Death|12|||
130294344|NCT02758301|469042245|FG001|Overall Study|Death|0|||
130294345|NCT02758301|469042244|FG000|Overall Study|Physician Decision|10|||
130294346|NCT02758301|469042245|FG001|Overall Study|Physician Decision|1|||
130294347|NCT02758301|469042244|FG000|Overall Study|Withdrawal by Subject|5|||
130294348|NCT02758301|469042245|FG001|Overall Study|Withdrawal by Subject|6|||
130294349|NCT02758301|469042244|FG000|Overall Study|Lost to Follow-up|7|||
130294350|NCT02758301|469042245|FG001|Overall Study|Lost to Follow-up|0|||
130294351|NCT02758301|469042244|FG000|Overall Study|Protocol Violation|0|||
130294352|NCT02758301|469042245|FG001|Overall Study|Protocol Violation|1|||
130294353|NCT02445573|469042246|FG000|Overall Study|Withdrawal by Subject|1|||
130294354|NCT02445573|469042247|FG001|Overall Study|Withdrawal by Subject|1|||
130294355|NCT02445573|469042246|FG000|Overall Study|Lost to Follow-up|0|||
130294356|NCT02445573|469042247|FG001|Overall Study|Lost to Follow-up|1|||
130294357|NCT02855944|469042248|FG000|Period 1: Treatment|Ongoing|14|||
130294358|NCT02855944|469042249|FG001|Period 1: Treatment|Ongoing|0|||
130294359|NCT02855944|469042248|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
130294360|NCT02855944|469042249|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
130294361|NCT02855944|469042248|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
130714886|NCT05101486|470583900|FG001|Overall Study|Protocol Violation|0|||
130294362|NCT02855944|469042249|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
130294363|NCT03242018|469042258|FG000|Overall Study|Adverse Event|7|||
130714887|NCT05101486|470583901|FG002|Overall Study|Protocol Violation|1|||
130556932|NCT03610165|470008096|FG000|Overall Study|Device didn't work|0|||
130556933|NCT03610165|470008097|FG001|Overall Study|Device didn't work|1|||
130556934|NCT02129205|470008098|FG000|Overall Study|Withdrawal by Subject|0|||
130714888|NCT05101486|470583899|FG000|Overall Study|Withdrawal by Subject|5|||
130294364|NCT03242018|469042259|FG001|Overall Study|Adverse Event|7|||
130294365|NCT03242018|469042260|FG002|Overall Study|Adverse Event|6|||
130294366|NCT03242018|469042258|FG000|Overall Study|Lost to Follow-up|2|||
130556935|NCT02129205|470008099|FG001|Overall Study|Withdrawal by Subject|0|||
130714889|NCT05101486|470583900|FG001|Overall Study|Withdrawal by Subject|2|||
130294367|NCT03242018|469042259|FG001|Overall Study|Lost to Follow-up|2|||
130294368|NCT03242018|469042260|FG002|Overall Study|Lost to Follow-up|2|||
130294369|NCT03242018|469042258|FG000|Overall Study|At the Participant's Own Request|5|||
130294370|NCT03242018|469042259|FG001|Overall Study|At the Participant's Own Request|1|||
130294371|NCT03242018|469042260|FG002|Overall Study|At the Participant's Own Request|4|||
130294372|NCT03242018|469042258|FG000|Overall Study|Reason Not Specified|3|||
130294373|NCT03242018|469042259|FG001|Overall Study|Reason Not Specified|4|||
130294374|NCT03242018|469042260|FG002|Overall Study|Reason Not Specified|1|||
130294375|NCT03242018|469042258|FG000|Overall Study|Study Terminated by Sponsor|1|||
130294376|NCT03242018|469042259|FG001|Overall Study|Study Terminated by Sponsor|0|||
130294377|NCT03242018|469042260|FG002|Overall Study|Study Terminated by Sponsor|1|||
130294378|NCT01283542|469042262|FG000|Main Phase|Acute or progressive vision loss|1|||
130294379|NCT01283542|469042262|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
130294380|NCT01283542|469042262|FG000|Main Phase|abnormal laboratory values|5|||
130294381|NCT01283542|469042262|FG000|Extension Phase|Physician Decision|1|||
130294382|NCT01283542|469042262|FG000|Extension Phase|Adverse Event|1|||
130294383|NCT01283542|469042262|FG000|Extension Phase|Administrative problems|1|||
130294384|NCT00903331|469042263|FG000|Overall Study|Death|4|||
130294385|NCT00903331|469042264|FG001|Overall Study|Death|8|||
130294386|NCT00903331|469042263|FG000|Overall Study|Withdrawal of consent|1|||
130294387|NCT00903331|469042264|FG001|Overall Study|Withdrawal of consent|8|||
130294388|NCT00903331|469042263|FG000|Overall Study|Lung transplant|0|||
130294389|NCT00903331|469042264|FG001|Overall Study|Lung transplant|2|||
130294390|NCT00257660|469042265|FG000|Overall Study|Lack of Efficacy|5|||
130294391|NCT00257660|469042266|FG001|Overall Study|Lack of Efficacy|23|||
130294392|NCT00257660|469042265|FG000|Overall Study|Withdrawal by Subject|2|||
130294393|NCT00257660|469042266|FG001|Overall Study|Withdrawal by Subject|0|||
130294394|NCT00257660|469042265|FG000|Overall Study|Lost to Follow-up|1|||
130294395|NCT00257660|469042266|FG001|Overall Study|Lost to Follow-up|0|||
130294396|NCT00257660|469042265|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
130294397|NCT00257660|469042266|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
130294398|NCT00257660|469042265|FG000|Overall Study|No longer wanted to do blood draws|1|||
130294399|NCT00257660|469042266|FG001|Overall Study|No longer wanted to do blood draws|0|||
130294400|NCT02449018|469042271|FG000|Overall Study|Abnormal laboratory value|0|||
130294401|NCT02449018|469042272|FG001|Overall Study|Abnormal laboratory value|1|||
130294402|NCT02449018|469042271|FG000|Overall Study|Administrative problems|1|||
130294403|NCT02449018|469042272|FG001|Overall Study|Administrative problems|0|||
130294404|NCT02449018|469042271|FG000|Overall Study|Adverse Event|5|||
130294405|NCT02449018|469042272|FG001|Overall Study|Adverse Event|1|||
130294406|NCT02449018|469042271|FG000|Overall Study|Protocol deviation|4|||
130294407|NCT02449018|469042272|FG001|Overall Study|Protocol deviation|0|||
130294408|NCT02449018|469042271|FG000|Overall Study|Patient decision|2|||
130294409|NCT02449018|469042272|FG001|Overall Study|Patient decision|0|||
130294410|NCT03995355|469042273|FG000|Overall Study|Adverse Event|1|||
130294411|NCT03995355|469042274|FG001|Overall Study|Adverse Event|0|||
130460463|NCT02477670|469652089|FG003|Stage 1|Non-compliance with Study Drug|0|||
130460464|NCT02477670|469652090|FG004|Stage 1|Non-compliance with Study Drug|0|||
130460465|NCT02477670|469652091|FG005|Stage 1|Non-compliance with Study Drug|0|||
130460466|NCT02477670|469652092|FG006|Stage 1|Non-compliance with Study Drug|0|||
130460467|NCT02477670|469652086|FG000|Stage 2|Adverse Event|0|||
130460468|NCT02477670|469652087|FG001|Stage 2|Adverse Event|0|||
130460469|NCT02477670|469652088|FG002|Stage 2|Adverse Event|1|||
130460470|NCT02477670|469652089|FG003|Stage 2|Adverse Event|0|||
130460471|NCT02477670|469652090|FG004|Stage 2|Adverse Event|0|||
130460472|NCT02477670|469652091|FG005|Stage 2|Adverse Event|0|||
130460473|NCT02477670|469652092|FG006|Stage 2|Adverse Event|0|||
130460474|NCT02477670|469652086|FG000|Stage 2|Antipsychotic Medication Changed|0|||
130460475|NCT02477670|469652087|FG001|Stage 2|Antipsychotic Medication Changed|0|||
130460476|NCT02477670|469652088|FG002|Stage 2|Antipsychotic Medication Changed|1|||
130460477|NCT02477670|469652089|FG003|Stage 2|Antipsychotic Medication Changed|0|||
130460478|NCT02477670|469652090|FG004|Stage 2|Antipsychotic Medication Changed|0|||
130460479|NCT02477670|469652091|FG005|Stage 2|Antipsychotic Medication Changed|0|||
130460480|NCT02477670|469652092|FG006|Stage 2|Antipsychotic Medication Changed|0|||
130460481|NCT02477670|469652086|FG000|Stage 2|Withdrawal by Subject|0|||
130460482|NCT02477670|469652087|FG001|Stage 2|Withdrawal by Subject|0|||
130460483|NCT02477670|469652088|FG002|Stage 2|Withdrawal by Subject|0|||
130460484|NCT02477670|469652089|FG003|Stage 2|Withdrawal by Subject|1|||
130460485|NCT02477670|469652090|FG004|Stage 2|Withdrawal by Subject|0|||
130294412|NCT03995355|469042273|FG000|Overall Study|Withdrawal by Subject|1|||
130294413|NCT03995355|469042274|FG001|Overall Study|Withdrawal by Subject|0|||
130294414|NCT03995355|469042273|FG000|Overall Study|Scheduling Issues|0|||
130294415|NCT03995355|469042274|FG001|Overall Study|Scheduling Issues|1|||
130294416|NCT03426631|469042275|FG000|Overall Study|Lost to Follow-up|0|||
130294417|NCT03426631|469042276|FG001|Overall Study|Lost to Follow-up|1|||
130294418|NCT00654004|469042277|FG000|Overall Study|Lost to Follow-up|1|||
130294419|NCT00654004|469042278|FG001|Overall Study|Lost to Follow-up|0|||
130460486|NCT02477670|469652091|FG005|Stage 2|Withdrawal by Subject|0|||
130460487|NCT02477670|469652092|FG006|Stage 2|Withdrawal by Subject|0|||
130714890|NCT05101486|470583901|FG002|Overall Study|Withdrawal by Subject|4|||
130714891|NCT05101486|470583899|FG000|Overall Study|Randomized but not vaccinated|1|||
130714892|NCT05101486|470583900|FG001|Overall Study|Randomized but not vaccinated|1|||
130714893|NCT05101486|470583901|FG002|Overall Study|Randomized but not vaccinated|1|||
130714894|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
130714895|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
130714896|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
130714897|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
130714898|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
130714899|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
130714900|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
130714901|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
130714902|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
130714903|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
130714904|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
130714905|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
130714906|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
130714907|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
130714908|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
130714909|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Other|3|||
130714910|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Other|0|||
130714911|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Other|0|||
130714912|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
130714913|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
130714914|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
130714915|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
130714916|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130714917|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130714918|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
130714919|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
130714920|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
130714921|NCT01884311|470583905|FG000|Overall Study|Withdrawal by Subject|3|||
130714922|NCT01884311|470583905|FG000|Overall Study|withdrew consent due to AEs|1|||
130714923|NCT01884311|470583905|FG000|Overall Study|Precautionary measure|1|||
130714924|NCT02307266|470583906|FG000|Overall Study|Adverse Event|3|||
130714925|NCT02307266|470583907|FG001|Overall Study|Adverse Event|1|||
130714926|NCT02307266|470583908|FG002|Overall Study|Adverse Event|5|||
130714927|NCT02307266|470583906|FG000|Overall Study|Withdrawal by Subject|2|||
130714928|NCT02307266|470583907|FG001|Overall Study|Withdrawal by Subject|0|||
130294420|NCT00267150|469042285|FG000|Overall Study|Adverse Event|1|||
130294421|NCT03134183|469042286|FG000|Overall Study|Withdrawal by Subject|1|||
130294422|NCT03134183|469042287|FG001|Overall Study|Withdrawal by Subject|1|||
130294423|NCT01969721|469042288|FG000|Overall Study|Adverse Event|3|||
130294424|NCT01969721|469042289|FG001|Overall Study|Adverse Event|8|||
130294425|NCT01969721|469042290|FG002|Overall Study|Adverse Event|3|||
130294426|NCT01969721|469042291|FG003|Overall Study|Adverse Event|2|||
130294427|NCT01969721|469042288|FG000|Overall Study|Lack of Efficacy|0|||
130294428|NCT01969721|469042289|FG001|Overall Study|Lack of Efficacy|0|||
130294429|NCT01969721|469042290|FG002|Overall Study|Lack of Efficacy|1|||
130294430|NCT01969721|469042291|FG003|Overall Study|Lack of Efficacy|0|||
130294431|NCT01969721|469042288|FG000|Overall Study|Non compliant with protocol|1|||
130294432|NCT01969721|469042289|FG001|Overall Study|Non compliant with protocol|1|||
130294433|NCT01969721|469042290|FG002|Overall Study|Non compliant with protocol|0|||
130294434|NCT01969721|469042291|FG003|Overall Study|Non compliant with protocol|2|||
130294435|NCT01969721|469042288|FG000|Overall Study|Other not defined above|0|||
130294436|NCT01969721|469042289|FG001|Overall Study|Other not defined above|2|||
130294437|NCT01969721|469042290|FG002|Overall Study|Other not defined above|0|||
130294438|NCT01969721|469042291|FG003|Overall Study|Other not defined above|0|||
130294439|NCT01969721|469042288|FG000|Overall Study|Discontinued during washout periods.|0|||
130294440|NCT01969721|469042289|FG001|Overall Study|Discontinued during washout periods.|1|||
130294441|NCT01969721|469042290|FG002|Overall Study|Discontinued during washout periods.|1|||
130294442|NCT01969721|469042291|FG003|Overall Study|Discontinued during washout periods.|2|||
130294443|NCT01012323|469042292|FG000|Overall Study|Investigator Judgment|1|||
130294444|NCT02117349|469042293|FG000|Overall Study|Withdrawal by Subject|1|||
130714929|NCT02307266|470583908|FG002|Overall Study|Withdrawal by Subject|1|||
130714930|NCT02307266|470583906|FG000|Overall Study|Lost to Follow-up|3|||
130714931|NCT02307266|470583907|FG001|Overall Study|Lost to Follow-up|0|||
130714932|NCT02307266|470583908|FG002|Overall Study|Lost to Follow-up|0|||
130714933|NCT01183221|470583913|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
130714934|NCT01183221|470583914|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
130294445|NCT02117349|469042294|FG001|Overall Study|Withdrawal by Subject|0|||
130294446|NCT02117349|469042293|FG000|Overall Study|Lost to Follow-up|1|||
130294447|NCT02117349|469042294|FG001|Overall Study|Lost to Follow-up|1|||
130294448|NCT02117349|469042293|FG000|Overall Study|Death|1|||
130294449|NCT02117349|469042294|FG001|Overall Study|Death|0|||
130294450|NCT00495755|469042295|FG000|Overall Study|Adverse Event|3|||
130294451|NCT02265796|469042296|FG000|Overall Study|Death|1|||
130294452|NCT02265796|469042297|FG001|Overall Study|Death|0|||
130294453|NCT02265796|469042296|FG000|Overall Study|started on excluded medication|1|||
130294454|NCT02265796|469042297|FG001|Overall Study|started on excluded medication|0|||
130294455|NCT02265796|469042296|FG000|Overall Study|Withdrawal by Subject|1|||
130294456|NCT02265796|469042297|FG001|Overall Study|Withdrawal by Subject|1|||
130294457|NCT03938324|469043706|FG000|Overall Study|Lost to Follow-up|42|||
130294458|NCT03938324|469043707|FG001|Overall Study|Lost to Follow-up|21|||
130294459|NCT03938324|469043706|FG000|Overall Study|Withdrawal by Subject|6|||
130294460|NCT03938324|469043707|FG001|Overall Study|Withdrawal by Subject|1|||
130294461|NCT00837759|469043708|FG000|Overall Study|Protocol Violation|3|||
130294462|NCT00837759|469043708|FG000|Overall Study|Lost to Follow-up|1|||
130294463|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Adverse Event|3|||
130294464|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Adverse Event|0|||
130294465|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
130294466|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
130294467|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Physician Decision|1|||
130294468|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Physician Decision|0|||
130294469|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
130294470|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
130294471|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
130294472|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
130294473|NCT02081599|469043709|FG000|Period 1：Double-blind Period|stopping criteria|1|||
130294474|NCT02081599|469043710|FG001|Period 1：Double-blind Period|stopping criteria|0|||
130294475|NCT02081599|469043709|FG000|Period 2：Open-label Period|Adverse Event|1|||
130294476|NCT02081599|469043710|FG001|Period 2：Open-label Period|Adverse Event|0|||
130294477|NCT02081599|469043709|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
130294478|NCT02081599|469043710|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
130294479|NCT02081599|469043709|FG000|Period 2：Open-label Period|Physician Decision|1|||
130294480|NCT02081599|469043710|FG001|Period 2：Open-label Period|Physician Decision|0|||
130294481|NCT02081599|469043709|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
130294482|NCT02081599|469043710|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
130294483|NCT01286077|469043711|FG000|Overall Study|Adverse Event|2|||
130294484|NCT01286077|469043712|FG001|Overall Study|Adverse Event|0|||
130294485|NCT01286077|469043711|FG000|Overall Study|Death|1|||
130294486|NCT01286077|469043712|FG001|Overall Study|Death|0|||
130294487|NCT01286077|469043711|FG000|Overall Study|Protocol Violation|1|||
130294488|NCT01286077|469043712|FG001|Overall Study|Protocol Violation|1|||
130294489|NCT01286077|469043711|FG000|Overall Study|Withdrawal by Subject|0|||
130294490|NCT01286077|469043712|FG001|Overall Study|Withdrawal by Subject|2|||
130294491|NCT01286077|469043711|FG000|Overall Study|Intercurrent illness|1|||
130294492|NCT01286077|469043712|FG001|Overall Study|Intercurrent illness|0|||
130294493|NCT01286077|469043711|FG000|Overall Study|Non-compliance|1|||
130294494|NCT01286077|469043712|FG001|Overall Study|Non-compliance|0|||
130294495|NCT01286077|469043711|FG000|Overall Study|The subject starts with alternative MMY|0|||
130294496|NCT01286077|469043712|FG001|Overall Study|The subject starts with alternative MMY|3|||
130294497|NCT01286077|469043711|FG000|Overall Study|Patient's decision to stop treatment|3|||
130294498|NCT01286077|469043712|FG001|Overall Study|Patient's decision to stop treatment|0|||
130294499|NCT01286077|469043711|FG000|Overall Study|Progression of disease|0|||
130294500|NCT01286077|469043712|FG001|Overall Study|Progression of disease|1|||
130294501|NCT01286077|469043711|FG000|Overall Study|refill medication not received in time|1|||
130294502|NCT01286077|469043712|FG001|Overall Study|refill medication not received in time|0|||
130294503|NCT05063539|469043713|FG000|Overall Study|Adverse Event|1|||
130294504|NCT05063539|469043714|FG001|Overall Study|Adverse Event|2|||
130294505|NCT05063539|469043715|FG002|Overall Study|Adverse Event|1|||
130714935|NCT02504671|470583922|FG000|Overall Study|Withdrawal by Subject|1|||
130294506|NCT05063539|469043713|FG000|Overall Study|Death|0|||
130294507|NCT05063539|469043714|FG001|Overall Study|Death|1|||
130294508|NCT05063539|469043715|FG002|Overall Study|Death|1|||
130294509|NCT05063539|469043713|FG000|Overall Study|Lost to Follow-up|0|||
130294510|NCT05063539|469043714|FG001|Overall Study|Lost to Follow-up|1|||
130714936|NCT02504671|470583923|FG001|Overall Study|Withdrawal by Subject|5|||
130294511|NCT05063539|469043715|FG002|Overall Study|Lost to Follow-up|0|||
130294512|NCT05063539|469043713|FG000|Overall Study|Physician Decision|4|||
130294513|NCT05063539|469043714|FG001|Overall Study|Physician Decision|3|||
130294514|NCT05063539|469043715|FG002|Overall Study|Physician Decision|1|||
130294515|NCT05063539|469043713|FG000|Overall Study|Progressive Disease|0|||
130294516|NCT05063539|469043714|FG001|Overall Study|Progressive Disease|2|||
130294517|NCT05063539|469043715|FG002|Overall Study|Progressive Disease|0|||
130294518|NCT05063539|469043713|FG000|Overall Study|Withdrawal by Subject|17|||
130294519|NCT05063539|469043714|FG001|Overall Study|Withdrawal by Subject|26|||
130294520|NCT05063539|469043715|FG002|Overall Study|Withdrawal by Subject|14|||
130294521|NCT05063539|469043713|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130294522|NCT05063539|469043714|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130294523|NCT05063539|469043715|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
130294524|NCT05063539|469043713|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
130294525|NCT05063539|469043714|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130294526|NCT05063539|469043715|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130294527|NCT05063539|469043713|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130294528|NCT05063539|469043714|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130294529|NCT05063539|469043715|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
130294530|NCT05063539|469043713|FG000|Overall Study|Discontinued due to Common Close Design|0|||
130294531|NCT05063539|469043714|FG001|Overall Study|Discontinued due to Common Close Design|1|||
130294532|NCT05063539|469043715|FG002|Overall Study|Discontinued due to Common Close Design|0|||
130294533|NCT05063539|469043713|FG000|Overall Study|Participant not co-operative|0|||
130294534|NCT05063539|469043714|FG001|Overall Study|Participant not co-operative|1|||
130294535|NCT05063539|469043715|FG002|Overall Study|Participant not co-operative|0|||
130294536|NCT05063539|469043713|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130294537|NCT05063539|469043714|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130294538|NCT05063539|469043715|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
130294539|NCT05063539|469043713|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130294540|NCT05063539|469043714|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
130294541|NCT05063539|469043715|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130294542|NCT01751139|469043716|FG000|Overall Study|Other|135|||
130294543|NCT01751139|469043716|FG000|Overall Study|Sponsor study termination|1609|||
130294544|NCT01751139|469043716|FG000|Overall Study|Lost to Follow-up|240|||
130294545|NCT01751139|469043716|FG000|Overall Study|Withdrawal by Subject|251|||
130294546|NCT01751139|469043716|FG000|Overall Study|Adverse Event|1|||
130294547|NCT01751139|469043716|FG000|Overall Study|Death|31|||
130294548|NCT04736628|469043717|FG000|Overall Study|Not treated|0|||
130294549|NCT04736628|469043718|FG001|Overall Study|Not treated|0|||
130294550|NCT04736628|469043719|FG002|Overall Study|Not treated|0|||
130294551|NCT04736628|469043720|FG003|Overall Study|Not treated|2|||
130294552|NCT04736628|469043717|FG000|Overall Study|Other reason than listed|1|||
130294553|NCT04736628|469043718|FG001|Overall Study|Other reason than listed|2|||
130294554|NCT04736628|469043719|FG002|Overall Study|Other reason than listed|2|||
130294555|NCT04736628|469043720|FG003|Overall Study|Other reason than listed|3|||
130294556|NCT04736628|469043717|FG000|Overall Study|Protocol deviation|0|||
130294557|NCT04736628|469043718|FG001|Overall Study|Protocol deviation|0|||
130294558|NCT04736628|469043719|FG002|Overall Study|Protocol deviation|0|||
130294559|NCT04736628|469043720|FG003|Overall Study|Protocol deviation|1|||
130294560|NCT04736628|469043717|FG000|Overall Study|Burden of study procedures|1|||
130294561|NCT04736628|469043718|FG001|Overall Study|Burden of study procedures|0|||
130294562|NCT04736628|469043719|FG002|Overall Study|Burden of study procedures|0|||
130294563|NCT04736628|469043720|FG003|Overall Study|Burden of study procedures|1|||
130294564|NCT04736628|469043717|FG000|Overall Study|Change of residence|0|||
130294565|NCT04736628|469043718|FG001|Overall Study|Change of residence|1|||
130294566|NCT04736628|469043719|FG002|Overall Study|Change of residence|0|||
130294567|NCT04736628|469043720|FG003|Overall Study|Change of residence|0|||
130294568|NCT04736628|469043717|FG000|Overall Study|Perceived lack of efficacy|1|||
130294569|NCT04736628|469043718|FG001|Overall Study|Perceived lack of efficacy|0|||
130294570|NCT04736628|469043719|FG002|Overall Study|Perceived lack of efficacy|0|||
130294571|NCT04736628|469043720|FG003|Overall Study|Perceived lack of efficacy|1|||
130294572|NCT04736628|469043717|FG000|Overall Study|Adverse Event|3|||
130294573|NCT04736628|469043718|FG001|Overall Study|Adverse Event|2|||
130294574|NCT04736628|469043719|FG002|Overall Study|Adverse Event|4|||
130294575|NCT04736628|469043720|FG003|Overall Study|Adverse Event|3|||
130294576|NCT04279613|469043721|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294577|NCT04279613|469043722|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294578|NCT04279613|469043723|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294579|NCT04279613|469043724|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294580|NCT04279613|469043725|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
130294581|NCT04279613|469043721|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294582|NCT04279613|469043722|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
130294583|NCT04279613|469043723|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294584|NCT04279613|469043724|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294585|NCT04279613|469043725|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294586|NCT04279613|469043721|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294587|NCT04279613|469043722|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294588|NCT04279613|469043723|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
130294589|NCT04279613|469043724|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294590|NCT04279613|469043725|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294591|NCT04279613|469043721|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294592|NCT04279613|469043722|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294593|NCT04279613|469043723|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294594|NCT04279613|469043724|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294595|NCT04279613|469043725|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
130294596|NCT04279613|469043721|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294597|NCT04279613|469043722|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294598|NCT04279613|469043723|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294599|NCT04279613|469043724|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
130294600|NCT04279613|469043725|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130460488|NCT00446550|469652094|FG000|Overall Study|Adverse Event|1|||
130460489|NCT00446550|469652095|FG001|Overall Study|Adverse Event|0|||
130460490|NCT02937831|469652096|FG000|Overall Study|Protocol Violation|4|||
130460491|NCT02983617|469652099|FG000|Overall Study|Adverse Event|0|||
130460492|NCT02983617|469652100|FG001|Overall Study|Adverse Event|7|||
130460493|NCT02983617|469652099|FG000|Overall Study|Death|0|||
130460494|NCT02983617|469652100|FG001|Overall Study|Death|1|||
130460495|NCT02983617|469652099|FG000|Overall Study|Investigator's Discretion|0|||
130460496|NCT02983617|469652100|FG001|Overall Study|Investigator's Discretion|1|||
130460497|NCT02027558|469652101|FG000|Overall Study|Death|0|||
130460498|NCT02027558|469652102|FG001|Overall Study|Death|1|||
130460499|NCT02027558|469652101|FG000|Overall Study|Withdrawal by Subject|2|||
130294613|NCT02704689|469043729|FG000|Overall Study|Physician Decision|1|||
130294614|NCT02704689|469043729|FG000|Overall Study|Study device not implanted|2|||
130294615|NCT02212678|469043732|FG000|Overall Study|Adverse Event|1|||
130294616|NCT02337634|469043733|FG000|Overall Study|Protocol Violation|3|||
130294617|NCT02337634|469043734|FG001|Overall Study|Protocol Violation|1|||
130294618|NCT02337634|469043733|FG000|Overall Study|Lost to Follow-up|1|||
130294619|NCT02337634|469043734|FG001|Overall Study|Lost to Follow-up|0|||
130294620|NCT04068610|469043735|FG000|Overall Study|Death|4|||
130294621|NCT04068610|469043736|FG001|Overall Study|Death|8|||
130294622|NCT04068610|469043737|FG002|Overall Study|Death|13|||
130294623|NCT04068610|469043735|FG000|Overall Study|Lost to Follow-up|0|||
130294624|NCT04068610|469043736|FG001|Overall Study|Lost to Follow-up|2|||
130294625|NCT04068610|469043737|FG002|Overall Study|Lost to Follow-up|0|||
130294626|NCT04068610|469043735|FG000|Overall Study|Withdrawal by Subject|0|||
130294627|NCT04068610|469043736|FG001|Overall Study|Withdrawal by Subject|4|||
130294628|NCT04068610|469043737|FG002|Overall Study|Withdrawal by Subject|2|||
130294629|NCT04068610|469043735|FG000|Overall Study|Other|3|||
130294630|NCT04068610|469043736|FG001|Overall Study|Other|12|||
130294631|NCT04068610|469043737|FG002|Overall Study|Other|11|||
130294632|NCT02428205|469043738|FG000|Overall Study|Lack of Efficacy|1|||
130294633|NCT02428205|469043739|FG001|Overall Study|Lack of Efficacy|0|||
130294634|NCT02428205|469043738|FG000|Overall Study|Lost to Follow-up|1|||
130294635|NCT02428205|469043739|FG001|Overall Study|Lost to Follow-up|1|||
130294636|NCT02428205|469043738|FG000|Overall Study|Worse behavior|0|||
130294637|NCT02428205|469043739|FG001|Overall Study|Worse behavior|1|||
130294638|NCT00527319|469043740|FG000|Overall Study|Withdrawal by Subject|5|||
130294639|NCT00527319|469043741|FG001|Overall Study|Withdrawal by Subject|0|||
130294640|NCT00527319|469043742|FG002|Overall Study|Withdrawal by Subject|1|||
130294641|NCT00527319|469043740|FG000|Overall Study|Lost to Follow-up|1|||
130294642|NCT00527319|469043741|FG001|Overall Study|Lost to Follow-up|0|||
130294643|NCT00527319|469043742|FG002|Overall Study|Lost to Follow-up|0|||
130371998|NCT02468414|469333222|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
130371999|NCT02468414|469333223|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
130372000|NCT02468414|469333222|FG000|Overall Study|Screen Failure|1|||
130372001|NCT02468414|469333223|FG001|Overall Study|Screen Failure|0|||
130372002|NCT01338792|469333224|FG000|Overall Study|Adverse Event|2|||
130372003|NCT01338792|469333224|FG000|Overall Study|Death|1|||
130372004|NCT01338792|469333224|FG000|Overall Study|Withdrawal by Subject|1|||
130372005|NCT00573469|469333225|FG000|Overall Study|Adverse Event|1|||
130372006|NCT00573469|469333226|FG001|Overall Study|Adverse Event|1|||
130372007|NCT00573469|469333227|FG002|Overall Study|Adverse Event|1|||
130372008|NCT00573469|469333225|FG000|Overall Study|Withdrawal by Subject|0|||
130294644|NCT00527319|469043740|FG000|Overall Study|Death|0|||
130294645|NCT00527319|469043741|FG001|Overall Study|Death|3|||
130294646|NCT00527319|469043742|FG002|Overall Study|Death|1|||
130294647|NCT00527319|469043740|FG000|Overall Study|Intercurrent Medical Illness|0|||
130294648|NCT00527319|469043741|FG001|Overall Study|Intercurrent Medical Illness|1|||
130372009|NCT00573469|469333226|FG001|Overall Study|Withdrawal by Subject|2|||
130294649|NCT00527319|469043742|FG002|Overall Study|Intercurrent Medical Illness|3|||
130294650|NCT00527319|469043740|FG000|Overall Study|Adverse Event|0|||
130294651|NCT00527319|469043741|FG001|Overall Study|Adverse Event|0|||
130294652|NCT00527319|469043742|FG002|Overall Study|Adverse Event|1|||
130294653|NCT03344172|469043745|FG000|Overall Study|Received <1 dose of treatment|1|||
130294654|NCT03344172|469043746|FG001|Overall Study|Received <1 dose of treatment|0|||
130294655|NCT00680368|469043749|FG000|Overall Study|not supervised, not eligible|15|||
130372010|NCT00573469|469333227|FG002|Overall Study|Withdrawal by Subject|0|||
130460500|NCT02027558|469652102|FG001|Overall Study|Withdrawal by Subject|0|||
130294656|NCT00430937|469043753|FG000|Overall Study|Adverse Event|3|||
130294657|NCT00430937|469043754|FG001|Overall Study|Adverse Event|8|||
130294658|NCT00430937|469043753|FG000|Overall Study|Death|0|||
130294659|NCT00430937|469043754|FG001|Overall Study|Death|1|||
130294660|NCT00430937|469043753|FG000|Overall Study|Lost to Follow-up|6|||
130294661|NCT00430937|469043754|FG001|Overall Study|Lost to Follow-up|6|||
130294662|NCT00430937|469043753|FG000|Overall Study|Withdrawal by Subject|5|||
130294663|NCT00430937|469043754|FG001|Overall Study|Withdrawal by Subject|2|||
130294664|NCT00430937|469043753|FG000|Overall Study|Protocol Violation|3|||
130294665|NCT00430937|469043754|FG001|Overall Study|Protocol Violation|2|||
130294666|NCT00430937|469043753|FG000|Overall Study|Lack of Efficacy|6|||
130294667|NCT00430937|469043754|FG001|Overall Study|Lack of Efficacy|5|||
130294668|NCT00430937|469043753|FG000|Overall Study|Inappropriate enrollment|2|||
130294669|NCT00430937|469043754|FG001|Overall Study|Inappropriate enrollment|1|||
130294670|NCT00430937|469043753|FG000|Overall Study|Administrative reasons|1|||
130294671|NCT00430937|469043754|FG001|Overall Study|Administrative reasons|0|||
130294672|NCT00430937|469043753|FG000|Overall Study|Protocol discontinuation criteria met|1|||
130294673|NCT00430937|469043754|FG001|Overall Study|Protocol discontinuation criteria met|2|||
130294674|NCT00430937|469043753|FG000|Overall Study|Unable to classify|0|||
130294675|NCT00430937|469043754|FG001|Overall Study|Unable to classify|1|||
130294676|NCT02392403|469043757|FG000|Overall Study|Adverse Event|1|||
130294677|NCT02392403|469043757|FG000|Overall Study|Death|1|||
130294678|NCT02392403|469043757|FG000|Overall Study|Withdrawal by Subject|1|||
130294679|NCT00657371|469043761|FG000|Overall Study|Poor bowel preparation|15|||
130294680|NCT00657371|469043761|FG000|Overall Study|Unable to intubate the cecum|5|||
130294681|NCT00657371|469043761|FG000|Overall Study|Protocol Violation|2|||
130294682|NCT00657371|469043761|FG000|Overall Study|Device- related reasons|13|||
130294683|NCT00657371|469043761|FG000|Overall Study|Pre-existing medical condition|4|||
130294684|NCT01639755|469043762|FG000|Overall Study|Study Ongoing|15|||
130294685|NCT01639755|469043762|FG000|Overall Study|Patient had device explantation|4|||
130294686|NCT03629912|469043763|FG000|Overall Study|Lost to Follow-up|19|||
130294687|NCT03629912|469043764|FG001|Overall Study|Lost to Follow-up|7|||
130294688|NCT03629912|469043765|FG002|Overall Study|Lost to Follow-up|5|||
130294689|NCT03629912|469043766|FG003|Overall Study|Lost to Follow-up|1|||
130294690|NCT03629912|469043763|FG000|Overall Study|Withdrawal by Subject|6|||
130294691|NCT03629912|469043764|FG001|Overall Study|Withdrawal by Subject|0|||
130294692|NCT03629912|469043765|FG002|Overall Study|Withdrawal by Subject|1|||
130294693|NCT03629912|469043766|FG003|Overall Study|Withdrawal by Subject|2|||
130294694|NCT03629912|469043763|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130294695|NCT03629912|469043764|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
130294696|NCT03629912|469043765|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130294697|NCT03629912|469043766|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
130294698|NCT03629912|469043763|FG000|Overall Study|Death|1|||
130294699|NCT03629912|469043764|FG001|Overall Study|Death|0|||
130294700|NCT03629912|469043765|FG002|Overall Study|Death|0|||
130294701|NCT03629912|469043766|FG003|Overall Study|Death|0|||
130294702|NCT01475162|469043767|FG000|Overall Study|Physician Decision|1|||
130294703|NCT01475162|469043767|FG000|Overall Study|Death|10|||
130294704|NCT01475162|469043767|FG000|Overall Study|Study closed for safety|3|||
130460501|NCT02027558|469652101|FG000|Overall Study|Lost to Follow-up|4|||
130460502|NCT02027558|469652102|FG001|Overall Study|Lost to Follow-up|1|||
130460503|NCT02027558|469652101|FG000|Overall Study|Refused assessment|3|||
130460504|NCT02027558|469652102|FG001|Overall Study|Refused assessment|0|||
130460505|NCT03720210|469652103|FG000|Overall Study|Lost to Follow-up|1|||
130460506|NCT02698891|469652104|FG000|Overall Study|Withdrawal by Subject|2|||
130460507|NCT02698891|469652104|FG000|Overall Study|deemed ineligible|1|||
130460508|NCT02698891|469652104|FG000|Overall Study|Adverse Event|9|||
130460509|NCT00114244|469652105|FG000|Overall Study|Adverse Event|2|||
130460510|NCT00114244|469652106|FG001|Overall Study|Adverse Event|5|||
130460511|NCT00114244|469652105|FG000|Overall Study|Withdrawal by Subject|0|||
130460512|NCT00114244|469652106|FG001|Overall Study|Withdrawal by Subject|2|||
130460513|NCT00711958|469652107|FG000|Overall Study|Withdrawal by Subject|6|||
130460514|NCT00711958|469652108|FG001|Overall Study|Withdrawal by Subject|8|||
130294705|NCT00490022|469043768|FG000|Overall Study|Adverse Event|0|||
130294706|NCT00490022|469043769|FG001|Overall Study|Adverse Event|2|||
130460515|NCT00711958|469652107|FG000|Overall Study|Lack of Efficacy|3|||
130294707|NCT00490022|469043768|FG000|Overall Study|Withdrawal by Subject|1|||
130294708|NCT00490022|469043769|FG001|Overall Study|Withdrawal by Subject|0|||
130294709|NCT00490022|469043768|FG000|Overall Study|Subject failed to disclose concommitant|0|||
130294710|NCT00490022|469043769|FG001|Overall Study|Subject failed to disclose concommitant|1|||
130294711|NCT05059977|469043771|FG000|Overall Study|Withdrawal by Subject|0|||
130294712|NCT05059977|469043772|FG001|Overall Study|Withdrawal by Subject|0|||
130294713|NCT05059977|469043773|FG002|Overall Study|Withdrawal by Subject|1|||
130294714|NCT00576472|469043776|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294715|NCT00576472|469043777|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
130460516|NCT00711958|469652108|FG001|Overall Study|Lack of Efficacy|1|||
130556936|NCT02129205|470008100|FG002|Overall Study|Withdrawal by Subject|0|||
130556937|NCT02129205|470008101|FG003|Overall Study|Withdrawal by Subject|0|||
130556938|NCT02129205|470008102|FG004|Overall Study|Withdrawal by Subject|1|||
130556939|NCT02129205|470008103|FG005|Overall Study|Withdrawal by Subject|1|||
130556940|NCT02129205|470008104|FG006|Overall Study|Withdrawal by Subject|1|||
130556941|NCT02129205|470008105|FG007|Overall Study|Withdrawal by Subject|0|||
130556942|NCT02129205|470008106|FG008|Overall Study|Withdrawal by Subject|1|||
130556943|NCT02129205|470008107|FG009|Overall Study|Withdrawal by Subject|0|||
130556944|NCT02129205|470008098|FG000|Overall Study|Other|1|||
130556945|NCT02129205|470008099|FG001|Overall Study|Other|0|||
130556946|NCT02129205|470008100|FG002|Overall Study|Other|0|||
130556947|NCT02129205|470008101|FG003|Overall Study|Other|0|||
130556948|NCT02129205|470008102|FG004|Overall Study|Other|2|||
130556949|NCT02129205|470008103|FG005|Overall Study|Other|3|||
130556950|NCT02129205|470008104|FG006|Overall Study|Other|3|||
130556951|NCT02129205|470008105|FG007|Overall Study|Other|2|||
130556952|NCT02129205|470008106|FG008|Overall Study|Other|1|||
130556953|NCT02129205|470008107|FG009|Overall Study|Other|0|||
130556954|NCT00671554|470008108|FG000|Overall Study|Disease progression|3|||
130556955|NCT02877927|470008109|FG000|Overall Study|Adverse Event|1|||
130556956|NCT02877927|470008110|FG001|Overall Study|Adverse Event|0|||
130556957|NCT02877927|470008109|FG000|Overall Study|Lost to Follow-up|37|||
130556958|NCT02877927|470008110|FG001|Overall Study|Lost to Follow-up|38|||
130556959|NCT02877927|470008109|FG000|Overall Study|Withdrawal by Subject|11|||
130556960|NCT02877927|470008110|FG001|Overall Study|Withdrawal by Subject|12|||
130556961|NCT02877927|470008109|FG000|Overall Study|Physician Decision|0|||
130556962|NCT02877927|470008110|FG001|Overall Study|Physician Decision|1|||
130556963|NCT02877927|470008109|FG000|Overall Study|Missed EOT/PTE Visit|5|||
130556964|NCT02877927|470008110|FG001|Overall Study|Missed EOT/PTE Visit|6|||
130556965|NCT01810016|470008111|FG000|Overall Study|Progressive disease|1|||
130556966|NCT01810016|470008112|FG001|Overall Study|Progressive disease|1|||
130556967|NCT01810016|470008113|FG002|Overall Study|Progressive disease|0|||
130556968|NCT01810016|470008111|FG000|Overall Study|Death|0|||
130556969|NCT01810016|470008112|FG001|Overall Study|Death|0|||
130556970|NCT01810016|470008113|FG002|Overall Study|Death|1|||
130556971|NCT00708175|470008114|FG000|Overall Study|Adverse Event|4|||
130556972|NCT00708175|470008115|FG001|Overall Study|Adverse Event|5|||
130556973|NCT00708175|470008114|FG000|Overall Study|Protocol Violation|2|||
130556974|NCT00708175|470008115|FG001|Overall Study|Protocol Violation|3|||
130556975|NCT00708175|470008114|FG000|Overall Study|Lost to Follow-up|5|||
130556976|NCT00708175|470008115|FG001|Overall Study|Lost to Follow-up|3|||
130556977|NCT00708175|470008114|FG000|Overall Study|Withdrawal by Subject|5|||
130556978|NCT00708175|470008115|FG001|Overall Study|Withdrawal by Subject|7|||
130294716|NCT00576472|469043778|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294717|NCT00576472|469043779|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
130294718|NCT00576472|469043780|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294719|NCT00576472|469043781|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294720|NCT00576472|469043782|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294721|NCT00576472|469043783|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294722|NCT00576472|469043784|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294723|NCT00576472|469043785|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294724|NCT00576472|469043786|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294725|NCT00576472|469043787|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294726|NCT00576472|469043788|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294727|NCT00576472|469043789|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294728|NCT00576472|469043790|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294729|NCT00576472|469043776|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
130294730|NCT00576472|469043777|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
130294731|NCT00576472|469043778|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
130294732|NCT00576472|469043779|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
130294733|NCT00576472|469043780|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
130294734|NCT00576472|469043781|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
130556979|NCT00708175|470008114|FG000|Overall Study|BMD loss >7%|2|||
130556980|NCT00708175|470008115|FG001|Overall Study|BMD loss >7%|3|||
130556981|NCT04435782|470008123|FG000|Overall Study|Study terminated by sponsor|4|||
130556982|NCT00594516|470009846|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
130294735|NCT00576472|469043782|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
130294736|NCT00576472|469043783|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
130294737|NCT00576472|469043784|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
130294738|NCT00576472|469043785|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
130556983|NCT00594516|470009847|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
130556984|NCT00594516|470009848|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
130556985|NCT00594516|470009846|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
130556986|NCT00594516|470009847|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
130556987|NCT00594516|470009848|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
130714937|NCT02504671|470583924|FG002|Overall Study|Withdrawal by Subject|4|||
130294739|NCT00576472|469043786|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
130294740|NCT00576472|469043787|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
130294741|NCT00576472|469043788|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
130294742|NCT00576472|469043789|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
130294743|NCT00576472|469043790|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
130294744|NCT00576472|469043776|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294745|NCT00576472|469043777|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294746|NCT00576472|469043778|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294747|NCT00576472|469043779|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
130294748|NCT00576472|469043780|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294749|NCT00576472|469043781|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294750|NCT00576472|469043782|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294751|NCT00576472|469043783|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294752|NCT00576472|469043784|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294753|NCT00576472|469043785|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294754|NCT00576472|469043786|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294755|NCT00576472|469043787|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294756|NCT00576472|469043788|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294757|NCT00576472|469043789|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294758|NCT00576472|469043790|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294759|NCT00576472|469043776|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
130294760|NCT00576472|469043777|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
130294761|NCT00576472|469043778|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
130294762|NCT00576472|469043779|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
130294763|NCT00576472|469043780|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
130294764|NCT00576472|469043781|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
130294765|NCT00576472|469043782|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
130294766|NCT00576472|469043783|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
130294767|NCT00576472|469043784|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
130294768|NCT00576472|469043785|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
130294769|NCT00576472|469043786|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
130294770|NCT00576472|469043787|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
130294771|NCT00576472|469043788|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
130294772|NCT00576472|469043789|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
130294773|NCT00576472|469043790|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
130294774|NCT00576472|469043776|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294775|NCT00576472|469043777|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294776|NCT00576472|469043778|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294777|NCT00576472|469043779|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
130294778|NCT00576472|469043780|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294779|NCT00576472|469043781|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294780|NCT00576472|469043782|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294781|NCT00576472|469043783|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294782|NCT00576472|469043784|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294783|NCT00576472|469043785|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294784|NCT00576472|469043786|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294785|NCT00576472|469043787|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294786|NCT00576472|469043788|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294787|NCT00576472|469043789|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294788|NCT00576472|469043790|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294789|NCT00576472|469043776|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294790|NCT00576472|469043777|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294791|NCT00576472|469043778|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294792|NCT00576472|469043779|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294793|NCT00576472|469043780|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294794|NCT00576472|469043781|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294795|NCT00576472|469043782|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
130294796|NCT00576472|469043783|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294797|NCT00576472|469043784|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294798|NCT00576472|469043785|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294799|NCT00576472|469043786|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294800|NCT00576472|469043787|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294801|NCT00576472|469043788|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294802|NCT00576472|469043789|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294803|NCT00576472|469043790|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294804|NCT00576472|469043776|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
130294805|NCT00576472|469043777|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
130294806|NCT00576472|469043778|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
130294807|NCT00576472|469043779|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
130294808|NCT00576472|469043780|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
130556988|NCT00594516|470009846|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
130556989|NCT00594516|470009847|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
130556990|NCT00594516|470009848|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
130556991|NCT00594516|470009846|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
130556992|NCT00594516|470009847|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
130556993|NCT00594516|470009848|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
130556994|NCT00594516|470009846|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
130556995|NCT00594516|470009847|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
130556996|NCT00594516|470009848|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
130556997|NCT00594516|470009846|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
130556998|NCT00594516|470009847|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
130556999|NCT00594516|470009848|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
130557000|NCT00594516|470009846|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
130557001|NCT00594516|470009847|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
130294809|NCT00576472|469043781|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
130294810|NCT00576472|469043782|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
130294811|NCT00576472|469043783|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
130294812|NCT00576472|469043784|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
130294813|NCT00576472|469043785|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
130294814|NCT00576472|469043786|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
130294815|NCT00576472|469043787|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
130294816|NCT00576472|469043788|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
130294817|NCT00576472|469043789|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
130294818|NCT00576472|469043790|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
130294819|NCT00576472|469043776|FG000|MPH Cross Over Phase|Physician Decision|0|||
130294820|NCT00576472|469043777|FG001|MPH Cross Over Phase|Physician Decision|0|||
130294821|NCT00576472|469043778|FG002|MPH Cross Over Phase|Physician Decision|0|||
130294822|NCT00576472|469043779|FG003|MPH Cross Over Phase|Physician Decision|0|||
130557002|NCT00594516|470009848|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
130557003|NCT00594516|470009846|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
130557004|NCT00594516|470009847|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
130557005|NCT00594516|470009848|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
130714938|NCT02504671|470583925|FG003|Overall Study|Withdrawal by Subject|4|||
130714939|NCT02504671|470583926|FG004|Overall Study|Withdrawal by Subject|5|||
130714940|NCT02504671|470583927|FG005|Overall Study|Withdrawal by Subject|3|||
130714941|NCT02504671|470583922|FG000|Overall Study|Lack of Efficacy|1|||
130714942|NCT02504671|470583923|FG001|Overall Study|Lack of Efficacy|3|||
130714943|NCT02504671|470583924|FG002|Overall Study|Lack of Efficacy|1|||
130714944|NCT02504671|470583925|FG003|Overall Study|Lack of Efficacy|0|||
130714945|NCT02504671|470583926|FG004|Overall Study|Lack of Efficacy|4|||
130714946|NCT02504671|470583927|FG005|Overall Study|Lack of Efficacy|4|||
130714947|NCT02504671|470583922|FG000|Overall Study|Adverse Event|1|||
130714948|NCT02504671|470583923|FG001|Overall Study|Adverse Event|1|||
130714949|NCT02504671|470583924|FG002|Overall Study|Adverse Event|0|||
130714950|NCT02504671|470583925|FG003|Overall Study|Adverse Event|1|||
130714951|NCT02504671|470583926|FG004|Overall Study|Adverse Event|0|||
130714952|NCT02504671|470583927|FG005|Overall Study|Adverse Event|2|||
130714953|NCT02504671|470583922|FG000|Overall Study|Protocol Violation|2|||
130714954|NCT02504671|470583923|FG001|Overall Study|Protocol Violation|1|||
130714955|NCT02504671|470583924|FG002|Overall Study|Protocol Violation|0|||
130714956|NCT02504671|470583925|FG003|Overall Study|Protocol Violation|0|||
130714957|NCT02504671|470583926|FG004|Overall Study|Protocol Violation|0|||
130714958|NCT02504671|470583927|FG005|Overall Study|Protocol Violation|1|||
130714959|NCT02504671|470583922|FG000|Overall Study|Lost to Follow-up|0|||
130714960|NCT02504671|470583923|FG001|Overall Study|Lost to Follow-up|0|||
130714961|NCT02504671|470583924|FG002|Overall Study|Lost to Follow-up|2|||
130714962|NCT02504671|470583925|FG003|Overall Study|Lost to Follow-up|0|||
130714963|NCT02504671|470583926|FG004|Overall Study|Lost to Follow-up|0|||
130714964|NCT02504671|470583927|FG005|Overall Study|Lost to Follow-up|1|||
130714965|NCT02504671|470583922|FG000|Overall Study|Protocol defined stopping criteria|7|||
130714966|NCT02504671|470583923|FG001|Overall Study|Protocol defined stopping criteria|4|||
130714967|NCT02504671|470583924|FG002|Overall Study|Protocol defined stopping criteria|3|||
130714968|NCT02504671|470583925|FG003|Overall Study|Protocol defined stopping criteria|5|||
130714969|NCT02504671|470583926|FG004|Overall Study|Protocol defined stopping criteria|3|||
130714970|NCT02504671|470583927|FG005|Overall Study|Protocol defined stopping criteria|3|||
130714971|NCT02518919|470583928|FG000|Overall Study|Protocol Violation|1|||
130714972|NCT02518919|470583929|FG001|Overall Study|Protocol Violation|1|||
130294823|NCT00576472|469043780|FG004|MPH Cross Over Phase|Physician Decision|0|||
130294824|NCT00576472|469043781|FG005|MPH Cross Over Phase|Physician Decision|0|||
130294825|NCT00576472|469043782|FG006|MPH Cross Over Phase|Physician Decision|4|||
130714973|NCT02518919|470583930|FG002|Overall Study|Protocol Violation|2|||
130714974|NCT00866658|470583931|FG000|Overall Study|Adverse Event|5|||
130557006|NCT00594516|470009846|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
130557007|NCT00594516|470009847|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
130557008|NCT00594516|470009848|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
130557009|NCT02462928|470009849|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130557010|NCT02462928|470009850|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130557011|NCT02462928|470009851|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
130714975|NCT00866658|470583932|FG001|Overall Study|Adverse Event|14|||
130714976|NCT00866658|470583931|FG000|Overall Study|Lack of Efficacy|2|||
130294826|NCT00576472|469043783|FG007|MPH Cross Over Phase|Physician Decision|0|||
130294827|NCT00576472|469043784|FG008|MPH Cross Over Phase|Physician Decision|0|||
130294828|NCT00576472|469043785|FG009|MPH Cross Over Phase|Physician Decision|0|||
130294829|NCT00576472|469043786|FG010|MPH Cross Over Phase|Physician Decision|0|||
130294830|NCT00576472|469043787|FG011|MPH Cross Over Phase|Physician Decision|0|||
130294831|NCT00576472|469043788|FG012|MPH Cross Over Phase|Physician Decision|0|||
130294832|NCT00576472|469043789|FG013|MPH Cross Over Phase|Physician Decision|0|||
130294833|NCT00576472|469043790|FG014|MPH Cross Over Phase|Physician Decision|0|||
130294834|NCT00576472|469043776|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294835|NCT00576472|469043777|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294836|NCT00576472|469043778|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294837|NCT00576472|469043779|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294838|NCT00576472|469043780|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294839|NCT00576472|469043781|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294840|NCT00576472|469043782|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294841|NCT00576472|469043783|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294842|NCT00576472|469043784|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
130294843|NCT00576472|469043785|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294844|NCT00576472|469043786|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
130294845|NCT00576472|469043787|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
130294846|NCT00576472|469043788|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294847|NCT00576472|469043789|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294848|NCT00576472|469043790|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294849|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294850|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294851|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294852|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294853|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294854|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294855|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294856|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130460517|NCT00711958|469652107|FG000|Overall Study|Clinical deterioration|1|||
130460518|NCT00711958|469652108|FG001|Overall Study|Clinical deterioration|0|||
130460519|NCT00711958|469652107|FG000|Overall Study|Adverse Event|9|||
130460520|NCT00711958|469652108|FG001|Overall Study|Adverse Event|7|||
130460521|NCT00711958|469652107|FG000|Overall Study|Protocol Violation|1|||
130460522|NCT00711958|469652108|FG001|Overall Study|Protocol Violation|0|||
130460523|NCT00711958|469652107|FG000|Overall Study|Lost to Follow-up|2|||
130460524|NCT00711958|469652108|FG001|Overall Study|Lost to Follow-up|2|||
130460525|NCT00711958|469652107|FG000|Overall Study|Death|10|||
130460526|NCT00711958|469652108|FG001|Overall Study|Death|5|||
130557012|NCT02462928|470009849|FG000|Overall Study|Adverse Event|47|||
130714977|NCT00866658|470583932|FG001|Overall Study|Lack of Efficacy|1|||
130714978|NCT00866658|470583931|FG000|Overall Study|Withdrawal by Subject|1|||
130714979|NCT00866658|470583932|FG001|Overall Study|Withdrawal by Subject|0|||
130714980|NCT00866658|470583931|FG000|Overall Study|Protocol Violation|1|||
130714981|NCT00866658|470583932|FG001|Overall Study|Protocol Violation|1|||
130714982|NCT00866658|470583931|FG000|Overall Study|Familial and Personal Reasons|4|||
130714983|NCT00866658|470583932|FG001|Overall Study|Familial and Personal Reasons|5|||
130714984|NCT00609518|470583934|FG000|Overall Study|Death from Study Disease|32|||
130714985|NCT00609518|470583935|FG001|Overall Study|Death from Study Disease|32|||
130714986|NCT00609518|470583934|FG000|Overall Study|Withdrawal by Subject|5|||
130714987|NCT00609518|470583935|FG001|Overall Study|Withdrawal by Subject|3|||
130714988|NCT00609518|470583934|FG000|Overall Study|Lost to Follow-up|3|||
130714989|NCT00609518|470583935|FG001|Overall Study|Lost to Follow-up|0|||
130294857|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294858|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294859|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294860|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294861|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130460527|NCT00711958|469652107|FG000|Overall Study|Progression of disease|1|||
130557013|NCT02462928|470009850|FG001|Overall Study|Adverse Event|51|||
130714990|NCT00609518|470583934|FG000|Overall Study|Physician Decision|1|||
130714991|NCT00609518|470583935|FG001|Overall Study|Physician Decision|3|||
130714992|NCT00609518|470583934|FG000|Overall Study|Death from Adverse Event|2|||
130294862|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
130294863|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294864|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
130294865|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
130294866|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
130294867|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
130294868|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
130714993|NCT00609518|470583935|FG001|Overall Study|Death from Adverse Event|2|||
130714994|NCT01687478|470583936|FG000|Overall Study|Adverse Event|3|||
130714995|NCT01687478|470583937|FG001|Overall Study|Adverse Event|10|||
130714996|NCT01687478|470583936|FG000|Overall Study|Lost to Follow-up|1|||
130714997|NCT01687478|470583937|FG001|Overall Study|Lost to Follow-up|3|||
130714998|NCT01687478|470583936|FG000|Overall Study|Protocol Violation|0|||
130460528|NCT00711958|469652108|FG001|Overall Study|Progression of disease|0|||
130460529|NCT01111526|469652109|FG000|Overall Study|GVHD Disease Progression|0|||
130460530|NCT01111526|469652110|FG001|Overall Study|GVHD Disease Progression|1|||
130460531|NCT01111526|469652111|FG002|Overall Study|GVHD Disease Progression|2|||
130460532|NCT04424641|469652114|FG000|Overall Study|Death|1|||
130460533|NCT04424641|469652115|FG001|Overall Study|Death|2|||
130714999|NCT01687478|470583937|FG001|Overall Study|Protocol Violation|2|||
130715000|NCT01687478|470583936|FG000|Overall Study|Withdrawal by Subject|21|||
130294869|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
130294870|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
130294871|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
130294872|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
130294873|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
130294874|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
130294875|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
130294876|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
130294877|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
130557014|NCT02462928|470009851|FG002|Overall Study|Adverse Event|25|||
130557015|NCT02462928|470009849|FG000|Overall Study|Lack of Efficacy|3|||
130557016|NCT02462928|470009850|FG001|Overall Study|Lack of Efficacy|8|||
130557017|NCT02462928|470009851|FG002|Overall Study|Lack of Efficacy|3|||
130557018|NCT02462928|470009849|FG000|Overall Study|Lost to Follow-up|4|||
130557019|NCT02462928|470009850|FG001|Overall Study|Lost to Follow-up|4|||
130557020|NCT02462928|470009851|FG002|Overall Study|Lost to Follow-up|1|||
130557021|NCT02462928|470009849|FG000|Overall Study|Withdrawal by Patient|31|||
130557022|NCT02462928|470009850|FG001|Overall Study|Withdrawal by Patient|21|||
130557023|NCT02462928|470009851|FG002|Overall Study|Withdrawal by Patient|21|||
130557024|NCT02462928|470009849|FG000|Overall Study|Protocol Violation|0|||
130557025|NCT02462928|470009850|FG001|Overall Study|Protocol Violation|1|||
130557026|NCT02462928|470009851|FG002|Overall Study|Protocol Violation|0|||
130557027|NCT02462928|470009849|FG000|Overall Study|Reason not Specified|4|||
130557028|NCT02462928|470009850|FG001|Overall Study|Reason not Specified|6|||
130557029|NCT02462928|470009851|FG002|Overall Study|Reason not Specified|5|||
130557030|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
130557031|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
130557032|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
130557033|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
130557034|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
130557035|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
130557036|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
130557037|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
130557038|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
130557039|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
130557040|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
130557041|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
130557042|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
130557043|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
130557044|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
130557045|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
130557046|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
130715001|NCT01687478|470583937|FG001|Overall Study|Withdrawal by Subject|19|||
130715002|NCT01687478|470583936|FG000|Overall Study|Physician Decision|1|||
130715003|NCT01687478|470583937|FG001|Overall Study|Physician Decision|3|||
130715004|NCT01687478|470583936|FG000|Overall Study|Entry Criteria Not Met|6|||
130715005|NCT01687478|470583937|FG001|Overall Study|Entry Criteria Not Met|2|||
130715006|NCT05855616|470583941|FG000|Overall Study|Lost to Follow-up|1|||
130715007|NCT05855616|470583942|FG001|Overall Study|Lost to Follow-up|2|||
130715008|NCT01859130|470583945|FG000|Overall Study|Death|4|||
130715009|NCT01859130|470583945|FG000|Overall Study|Lost to Follow-up|16|||
130715010|NCT01859130|470583945|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
130715011|NCT01859130|470583945|FG000|Overall Study|Physician Decision|6|||
130715012|NCT01859130|470583945|FG000|Overall Study|Withdrawal by Subject|17|||
130715013|NCT01859130|470583945|FG000|Overall Study|Adverse Event|11|||
130715014|NCT04442490|470583950|FG000|Overall Study|Withdrawal by Subject|18|||
130715015|NCT04442490|470583951|FG001|Overall Study|Withdrawal by Subject|10|||
130715016|NCT04442490|470583950|FG000|Overall Study|Lost to Follow-up|7|||
130715017|NCT04442490|470583951|FG001|Overall Study|Lost to Follow-up|7|||
130715018|NCT04442490|470583950|FG000|Overall Study|Adverse Event|2|||
130715019|NCT04442490|470583951|FG001|Overall Study|Adverse Event|6|||
130715020|NCT04442490|470583950|FG000|Overall Study|Noncompliance|3|||
130715021|NCT04442490|470583951|FG001|Overall Study|Noncompliance|1|||
130715022|NCT04442490|470583950|FG000|Overall Study|Physician Decision|2|||
130715023|NCT04442490|470583951|FG001|Overall Study|Physician Decision|1|||
130715024|NCT04442490|470583950|FG000|Overall Study|Reason not Specified|2|||
130715025|NCT04442490|470583951|FG001|Overall Study|Reason not Specified|1|||
130715026|NCT04442490|470583950|FG000|Overall Study|Randomized but not Treated|3|||
130294878|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
130372011|NCT00573469|469333225|FG000|Overall Study|Other|5|||
130294879|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
130294880|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
130294881|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
130294882|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
130294883|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
130294884|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
130294885|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
130294886|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
130294887|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
130294888|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
130294889|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
130294890|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
130294891|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
130294892|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
130294893|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
130294894|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Side effects|0|||
130294895|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Side effects|0|||
130294896|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Side effects|0|||
130294897|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Side effects|0|||
130294898|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Side effects|0|||
130294899|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Side effects|0|||
130294900|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Side effects|0|||
130294901|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Side effects|0|||
130294902|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Side effects|0|||
130294903|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Side effects|0|||
130294904|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Side effects|0|||
130294905|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Side effects|0|||
130294906|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Side effects|0|||
130294907|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Side effects|0|||
130294908|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Side effects|8|||
130294909|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294910|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294911|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294912|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294913|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294914|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294915|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294916|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294917|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294918|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294919|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294920|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294921|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294922|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294923|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
130294924|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
130294925|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
130294926|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
130294927|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
130294928|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
130294929|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
130294930|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
130460534|NCT04424641|469652116|FG002|Overall Study|Death|3|||
130460535|NCT04424641|469652117|FG003|Overall Study|Death|0|||
130460536|NCT04424641|469652118|FG004|Overall Study|Death|3|||
130460537|NCT04424641|469652119|FG005|Overall Study|Death|0|||
130460538|NCT04424641|469652120|FG006|Overall Study|Death|1|||
130460539|NCT04424641|469652121|FG007|Overall Study|Death|2|||
130460540|NCT04424641|469652114|FG000|Overall Study|Sponsor decision|0|||
130460541|NCT04424641|469652115|FG001|Overall Study|Sponsor decision|2|||
130460542|NCT04424641|469652116|FG002|Overall Study|Sponsor decision|3|||
130460543|NCT04424641|469652117|FG003|Overall Study|Sponsor decision|7|||
130294931|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
130294932|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
130294933|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
130294934|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
130294935|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
130294936|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
130294937|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
130294938|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
130294939|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130460544|NCT04424641|469652118|FG004|Overall Study|Sponsor decision|2|||
130460545|NCT04424641|469652119|FG005|Overall Study|Sponsor decision|2|||
130294940|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294941|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294942|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294943|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294944|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294945|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294946|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294947|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294948|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294949|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294950|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294951|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294952|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294953|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
130294954|NCT04405245|469043792|FG000|Overall Study|Adverse Event|0|||
130294955|NCT04405245|469043793|FG001|Overall Study|Adverse Event|1|||
130294956|NCT04405245|469043794|FG002|Overall Study|Adverse Event|0|||
130294957|NCT02391961|469043797|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
130294958|NCT02391961|469043798|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
130294959|NCT02391961|469043797|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130294960|NCT02391961|469043798|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
130294961|NCT02391961|469043797|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130294962|NCT02391961|469043798|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130294963|NCT03263780|469043801|FG000|Overall Study|Withdrawal by Subject|3|||
130294964|NCT03263780|469043801|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
130294965|NCT01504204|469043802|FG000|Overall Study|Lost to Follow-up|1|||
130294966|NCT01504204|469043803|FG001|Overall Study|Lost to Follow-up|1|||
130460546|NCT04424641|469652120|FG006|Overall Study|Sponsor decision|3|||
130460547|NCT04424641|469652121|FG007|Overall Study|Sponsor decision|4|||
130460548|NCT04424641|469652114|FG000|Overall Study|Withdrawal by Subject|0|||
130715027|NCT04442490|470583951|FG001|Overall Study|Randomized but not Treated|3|||
130294967|NCT02723175|469043804|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
130294968|NCT02723175|469043805|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
130294969|NCT02723175|469043804|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
130294970|NCT02723175|469043805|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
130294971|NCT03691779|469043809|FG000|Part B (24 Weeks)|Adverse Event|0|||
130294972|NCT03691779|469043810|FG001|Part B (24 Weeks)|Adverse Event|1|||
130294973|NCT03691779|469043809|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
130294974|NCT03691779|469043810|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
130294975|NCT01561963|469043811|FG000|Overall Study|Adverse Event|1|||
130294976|NCT00162266|469043814|FG000|Double-Blind Period|Adverse Event|5|||
130294977|NCT00162266|469043815|FG001|Double-Blind Period|Adverse Event|9|||
130294978|NCT00162266|469043816|FG002|Double-Blind Period|Adverse Event|11|||
130294979|NCT00162266|469043817|FG003|Double-Blind Period|Adverse Event|0|||
130294980|NCT00162266|469043814|FG000|Double-Blind Period|Death|0|||
130294981|NCT00162266|469043815|FG001|Double-Blind Period|Death|1|||
130294982|NCT00162266|469043816|FG002|Double-Blind Period|Death|0|||
130294983|NCT00162266|469043817|FG003|Double-Blind Period|Death|0|||
130294984|NCT00162266|469043814|FG000|Double-Blind Period|Lost to Follow-up|1|||
130294985|NCT00162266|469043815|FG001|Double-Blind Period|Lost to Follow-up|2|||
130294986|NCT00162266|469043816|FG002|Double-Blind Period|Lost to Follow-up|0|||
130294987|NCT00162266|469043817|FG003|Double-Blind Period|Lost to Follow-up|0|||
130294988|NCT00162266|469043814|FG000|Double-Blind Period|Other Reason|1|||
130294989|NCT00162266|469043815|FG001|Double-Blind Period|Other Reason|0|||
130294990|NCT00162266|469043816|FG002|Double-Blind Period|Other Reason|1|||
130294991|NCT00162266|469043817|FG003|Double-Blind Period|Other Reason|0|||
130294992|NCT00162266|469043814|FG000|Double-Blind Period|Lack of Efficacy|13|||
130294993|NCT00162266|469043815|FG001|Double-Blind Period|Lack of Efficacy|17|||
130294994|NCT00162266|469043816|FG002|Double-Blind Period|Lack of Efficacy|30|||
130294995|NCT00162266|469043817|FG003|Double-Blind Period|Lack of Efficacy|0|||
130294996|NCT00162266|469043814|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130294997|NCT00162266|469043815|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130460549|NCT04424641|469652115|FG001|Overall Study|Withdrawal by Subject|0|||
130294998|NCT00162266|469043816|FG002|Double-Blind Period|Withdrawal by Subject|6|||
130294999|NCT00162266|469043817|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130460550|NCT04424641|469652116|FG002|Overall Study|Withdrawal by Subject|0|||
130460551|NCT04424641|469652117|FG003|Overall Study|Withdrawal by Subject|0|||
130460552|NCT04424641|469652118|FG004|Overall Study|Withdrawal by Subject|1|||
130295000|NCT00162266|469043814|FG000|Open-Label Period|Death|0|||
130295001|NCT00162266|469043815|FG001|Open-Label Period|Death|0|||
130295002|NCT00162266|469043816|FG002|Open-Label Period|Death|0|||
130295003|NCT00162266|469043817|FG003|Open-Label Period|Death|7|||
130295004|NCT00162266|469043814|FG000|Open-Label Period|Adverse Event|0|||
130295005|NCT00162266|469043815|FG001|Open-Label Period|Adverse Event|0|||
130295006|NCT00162266|469043816|FG002|Open-Label Period|Adverse Event|0|||
130295007|NCT00162266|469043817|FG003|Open-Label Period|Adverse Event|46|||
130295008|NCT00162266|469043814|FG000|Open-Label Period|Lack of Efficacy|0|||
130295009|NCT00162266|469043815|FG001|Open-Label Period|Lack of Efficacy|0|||
130295010|NCT00162266|469043816|FG002|Open-Label Period|Lack of Efficacy|0|||
130295011|NCT00162266|469043817|FG003|Open-Label Period|Lack of Efficacy|26|||
130295012|NCT00162266|469043814|FG000|Open-Label Period|Lost to Follow-up|0|||
130295013|NCT00162266|469043815|FG001|Open-Label Period|Lost to Follow-up|0|||
130715028|NCT02227147|470583952|FG000|Controlled Treatment Period|Adverse Event|4|||
130715029|NCT02227147|470583953|FG001|Controlled Treatment Period|Adverse Event|3|||
130715030|NCT02227147|470583952|FG000|Controlled Treatment Period|Other|2|||
130715031|NCT02227147|470583953|FG001|Controlled Treatment Period|Other|0|||
130715032|NCT02227147|470583952|FG000|Follow-up Period|Other|3|||
130295014|NCT00162266|469043816|FG002|Open-Label Period|Lost to Follow-up|0|||
130295015|NCT00162266|469043817|FG003|Open-Label Period|Lost to Follow-up|3|||
130295016|NCT00162266|469043814|FG000|Open-Label Period|Withdrawal by Subject|0|||
130295017|NCT00162266|469043815|FG001|Open-Label Period|Withdrawal by Subject|0|||
130295018|NCT00162266|469043816|FG002|Open-Label Period|Withdrawal by Subject|0|||
130295019|NCT00162266|469043817|FG003|Open-Label Period|Withdrawal by Subject|31|||
130295020|NCT00162266|469043814|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
130295021|NCT00162266|469043815|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
130295022|NCT00162266|469043816|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
130295023|NCT00162266|469043817|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
130295024|NCT00162266|469043814|FG000|Open-Label Period|Other Reasons|0|||
130295025|NCT00162266|469043815|FG001|Open-Label Period|Other Reasons|0|||
130295026|NCT00162266|469043816|FG002|Open-Label Period|Other Reasons|0|||
130295027|NCT00162266|469043817|FG003|Open-Label Period|Other Reasons|15|||
130295028|NCT02299076|469043818|FG000|Overall Study|Fraudulent Entries|20|||
130295029|NCT02299076|469043819|FG001|Overall Study|Fraudulent Entries|14|||
130295030|NCT04208087|469043820|FG000|Overall Study|Adverse Event|1|||
130295031|NCT04208087|469043821|FG001|Overall Study|Adverse Event|0|||
130295032|NCT04208087|469043822|FG002|Overall Study|Adverse Event|0|||
130295033|NCT04208087|469043823|FG003|Overall Study|Adverse Event|0|||
130295034|NCT04208087|469043824|FG004|Overall Study|Adverse Event|0|||
130295035|NCT04208087|469043820|FG000|Overall Study|Withdrawal by Subject|0|||
130295036|NCT04208087|469043821|FG001|Overall Study|Withdrawal by Subject|0|||
130295037|NCT04208087|469043822|FG002|Overall Study|Withdrawal by Subject|1|||
130295038|NCT04208087|469043823|FG003|Overall Study|Withdrawal by Subject|0|||
130295039|NCT04208087|469043824|FG004|Overall Study|Withdrawal by Subject|0|||
130295040|NCT04208087|469043820|FG000|Overall Study|Other|0|||
130295041|NCT04208087|469043821|FG001|Overall Study|Other|0|||
130295042|NCT04208087|469043822|FG002|Overall Study|Other|0|||
130295043|NCT04208087|469043823|FG003|Overall Study|Other|0|||
130295044|NCT04208087|469043824|FG004|Overall Study|Other|1|||
130295045|NCT02477553|469043826|FG000|Overall Study|Screening up-to-date|12|||
130295046|NCT02477553|469043827|FG001|Overall Study|Screening up-to-date|13|||
130295047|NCT02477553|469043826|FG000|Overall Study|No MD visit|1|||
130295048|NCT02477553|469043827|FG001|Overall Study|No MD visit|1|||
130295049|NCT02477553|469043826|FG000|Overall Study|Workup consistent w/CRC|1|||
130295050|NCT02477553|469043827|FG001|Overall Study|Workup consistent w/CRC|1|||
130295051|NCT02477553|469043826|FG000|Overall Study|Technical issues with intervention|2|||
130295052|NCT02477553|469043827|FG001|Overall Study|Technical issues with intervention|0|||
130295053|NCT02477553|469043826|FG000|Overall Study|Elevated risk for CRC|2|||
130295054|NCT02477553|469043827|FG001|Overall Study|Elevated risk for CRC|2|||
130295055|NCT02477553|469043826|FG000|Overall Study|MD advised against screening|1|||
130295056|NCT02477553|469043827|FG001|Overall Study|MD advised against screening|3|||
130295057|NCT02477553|469043826|FG000|Overall Study|patient deceased|1|||
130295058|NCT02477553|469043827|FG001|Overall Study|patient deceased|0|||
130295059|NCT00637572|469043829|FG000|Overall Study|Adverse Event|1|||
130295060|NCT00637572|469043830|FG001|Overall Study|Adverse Event|2|||
130295061|NCT00637572|469043829|FG000|Overall Study|Death|0|||
130295062|NCT00637572|469043830|FG001|Overall Study|Death|1|||
130295063|NCT00637572|469043829|FG000|Overall Study|Lost to Follow-up|0|||
130295064|NCT00637572|469043830|FG001|Overall Study|Lost to Follow-up|1|||
130295065|NCT00637572|469043829|FG000|Overall Study|Physician Decision|1|||
130295066|NCT00637572|469043830|FG001|Overall Study|Physician Decision|1|||
130295067|NCT00637572|469043829|FG000|Overall Study|Withdrawal by Subject|0|||
130295068|NCT00637572|469043830|FG001|Overall Study|Withdrawal by Subject|2|||
130295069|NCT00637572|469043829|FG000|Overall Study|Illicit Drug Use|1|||
130295070|NCT00637572|469043830|FG001|Overall Study|Illicit Drug Use|0|||
130295071|NCT00896649|469043831|FG000|Overall Study|Physician Decision|1|||
130715033|NCT02227147|470583953|FG001|Follow-up Period|Other|5|||
130715034|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
130715035|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
130295072|NCT00896649|469043831|FG000|Overall Study|Pregnancy|1|||
130295073|NCT00896649|469043831|FG000|Overall Study|missing documentation|1|||
130295074|NCT00896649|469043831|FG000|Overall Study|technical difficulties|2|||
130295075|NCT03652675|469043834|FG000|Overall Study|Lost to Follow-up|4|||
130295076|NCT03652675|469043835|FG001|Overall Study|Lost to Follow-up|4|||
130295077|NCT01638559|469043836|FG000|Overall Study|Lost to Follow-up|1|||
130372012|NCT00573469|469333226|FG001|Overall Study|Other|1|||
130372013|NCT00573469|469333227|FG002|Overall Study|Other|3|||
130372014|NCT00004978|469333228|FG000|Overall Study|Death|107|||
130372015|NCT00004978|469333229|FG001|Overall Study|Death|116|||
130372016|NCT00004978|469333228|FG000|Overall Study|Lost to Follow-up|101|||
130372017|NCT00004978|469333229|FG001|Overall Study|Lost to Follow-up|108|||
130372018|NCT00004978|469333228|FG000|Overall Study|Withdrawal by Subject|17|||
130372019|NCT00004978|469333229|FG001|Overall Study|Withdrawal by Subject|26|||
130372020|NCT00004978|469333228|FG000|Overall Study|site closure - not in analysis cohort|19|||
130372021|NCT00004978|469333229|FG001|Overall Study|site closure - not in analysis cohort|20|||
130372022|NCT01652703|469333233|FG000|Overall Study|Withdrawal by Subject|0|||
130372023|NCT01652703|469333234|FG001|Overall Study|Withdrawal by Subject|1|||
130372024|NCT01652703|469333235|FG002|Overall Study|Withdrawal by Subject|3|||
130460553|NCT04424641|469652119|FG005|Overall Study|Withdrawal by Subject|0|||
130460554|NCT04424641|469652120|FG006|Overall Study|Withdrawal by Subject|0|||
130460555|NCT04424641|469652121|FG007|Overall Study|Withdrawal by Subject|0|||
130460556|NCT04424641|469652114|FG000|Overall Study|Other|0|||
130460557|NCT04424641|469652115|FG001|Overall Study|Other|0|||
130460558|NCT04424641|469652116|FG002|Overall Study|Other|1|||
130460559|NCT04424641|469652117|FG003|Overall Study|Other|0|||
130460560|NCT04424641|469652118|FG004|Overall Study|Other|0|||
130460561|NCT04424641|469652119|FG005|Overall Study|Other|0|||
130460562|NCT04424641|469652120|FG006|Overall Study|Other|0|||
130460563|NCT04424641|469652121|FG007|Overall Study|Other|0|||
130460564|NCT02694978|469652124|FG000|Overall Study|Adverse Event|10|||
130460565|NCT02694978|469652125|FG001|Overall Study|Adverse Event|9|||
130460566|NCT02694978|469652124|FG000|Overall Study|Withdrawal by Subject|22|||
130460567|NCT02694978|469652125|FG001|Overall Study|Withdrawal by Subject|19|||
130460568|NCT02694978|469652124|FG000|Overall Study|Lost to Follow-up|14|||
130460569|NCT02694978|469652125|FG001|Overall Study|Lost to Follow-up|17|||
130460570|NCT02694978|469652124|FG000|Overall Study|Death|4|||
130460571|NCT02694978|469652125|FG001|Overall Study|Death|1|||
130460572|NCT02694978|469652124|FG000|Overall Study|Other-Decision of Participant|6|||
130460573|NCT02694978|469652125|FG001|Overall Study|Other-Decision of Participant|1|||
130460574|NCT02694978|469652124|FG000|Overall Study|Other-Investigator's decision|1|||
130460575|NCT02694978|469652125|FG001|Overall Study|Other-Investigator's decision|0|||
130460576|NCT02694978|469652124|FG000|Overall Study|Other-Unable to be reached|0|||
130460577|NCT02694978|469652125|FG001|Overall Study|Other-Unable to be reached|1|||
130460578|NCT02694978|469652124|FG000|Overall Study|Other-Protocol noncompliant|2|||
130460579|NCT02694978|469652125|FG001|Overall Study|Other-Protocol noncompliant|1|||
130460580|NCT02694978|469652124|FG000|Overall Study|Other-Personal reasons|3|||
130460581|NCT02694978|469652125|FG001|Overall Study|Other-Personal reasons|3|||
130460582|NCT02694978|469652124|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
130460583|NCT02694978|469652125|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
130460584|NCT01613716|469652126|FG000|Overall Study|screen failures|3|||
130460585|NCT01613716|469652126|FG000|Overall Study|Lost to Follow-up|4|||
130460586|NCT01171625|469652127|FG000|Overall Study|On-Protocol|67|||
130460587|NCT01171625|469652127|FG000|Overall Study|Death|38|||
130460588|NCT01171625|469652127|FG000|Overall Study|Withdrawal by Subject|31|||
130460589|NCT01171625|469652127|FG000|Overall Study|Explanted|10|||
130460590|NCT01171625|469652127|FG000|Overall Study|Lost to Follow-up|5|||
130460591|NCT01171625|469652127|FG000|Overall Study|Patient received valve-in-valve|3|||
130460592|NCT01171625|469652127|FG000|Overall Study|Other|1|||
130460593|NCT01171625|469652127|FG000|Overall Study|Consented but did not receive device|25|||
130460594|NCT00743444|469652128|FG000|First Intervention|Catheter placement problems|0|||
130460595|NCT00743444|469652129|FG001|First Intervention|Catheter placement problems|1|||
130460596|NCT00743444|469652128|FG000|Washout Period|Adverse Event|0|||
130460597|NCT00743444|469652129|FG001|Washout Period|Adverse Event|1|||
130460598|NCT00486330|469652134|FG000|Overall Study|Adverse Event|2|||
130460599|NCT01087762|469652139|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
130460600|NCT01087762|469652140|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
130460601|NCT01087762|469652141|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
130460602|NCT01087762|469652142|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
130460603|NCT01087762|469652143|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
130460604|NCT01087762|469652139|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
130372025|NCT01652703|469333236|FG003|Overall Study|Withdrawal by Subject|1|||
130372026|NCT01652703|469333237|FG004|Overall Study|Withdrawal by Subject|0|||
130372027|NCT01652703|469333238|FG005|Overall Study|Withdrawal by Subject|1|||
130460605|NCT01087762|469652140|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
130460606|NCT01087762|469652141|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
130460607|NCT01087762|469652142|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
130460608|NCT01087762|469652143|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
130460609|NCT01087762|469652139|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
130460610|NCT01087762|469652140|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
130460611|NCT01087762|469652141|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
130715036|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
130715037|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
130715038|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
130715039|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
130715040|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
130715041|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
130715042|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
130715043|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
130295078|NCT01638559|469043836|FG000|Overall Study|Withdrawal by Subject|1|||
130295079|NCT01638559|469043836|FG000|Overall Study|Subject declined to travel for biopsy|1|||
130295080|NCT00483002|469043839|FG000|Overall Study|Adverse Event|68|||
130295081|NCT00483002|469043839|FG000|Overall Study|Lack of Efficacy|555|||
130295082|NCT00483002|469043839|FG000|Overall Study|Lost to Follow-up|962|||
130295083|NCT00483002|469043839|FG000|Overall Study|Other|2|||
130295084|NCT00483002|469043839|FG000|Overall Study|Other|967|||
130295085|NCT01403116|469043840|FG000|Overall Study|Adverse Event|7|||
130295086|NCT01403116|469043841|FG001|Overall Study|Adverse Event|4|||
130295087|NCT01403116|469043840|FG000|Overall Study|Lost to Follow-up|7|||
130295088|NCT01403116|469043841|FG001|Overall Study|Lost to Follow-up|5|||
130295089|NCT01403116|469043840|FG000|Overall Study|Withdrawal by Subject|12|||
130295090|NCT01403116|469043841|FG001|Overall Study|Withdrawal by Subject|15|||
130295091|NCT01403116|469043840|FG000|Overall Study|Non-compliance of study drug|3|||
130295092|NCT01403116|469043841|FG001|Overall Study|Non-compliance of study drug|0|||
130295093|NCT01403116|469043840|FG000|Overall Study|Protocol Violation|0|||
130295094|NCT01403116|469043841|FG001|Overall Study|Protocol Violation|1|||
130295095|NCT01403116|469043840|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
130295096|NCT01403116|469043841|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
130295097|NCT01403116|469043840|FG000|Overall Study|Hct >54%|2|||
130295098|NCT01403116|469043841|FG001|Overall Study|Hct >54%|0|||
130295099|NCT01403116|469043840|FG000|Overall Study|unable to keep appointments|0|||
130295100|NCT01403116|469043841|FG001|Overall Study|unable to keep appointments|2|||
130715044|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130715045|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130715046|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
130715047|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
130715048|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130715049|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130715050|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
130715051|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
130715052|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
130715053|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
130715054|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
130715055|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715056|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715057|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715058|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715059|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
130715060|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715061|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715062|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715063|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715064|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715065|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
130715066|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
130715067|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
130715068|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
130715069|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
130715070|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130715071|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130295101|NCT01895309|469043842|FG000|Overall Study|Adverse Event|13|||
130295102|NCT01895309|469043843|FG001|Overall Study|Adverse Event|17|||
130295103|NCT01895309|469043842|FG000|Overall Study|Protocol Violation|1|||
130295104|NCT01895309|469043843|FG001|Overall Study|Protocol Violation|0|||
130295105|NCT01895309|469043842|FG000|Overall Study|Lack of Efficacy|1|||
130295106|NCT01895309|469043843|FG001|Overall Study|Lack of Efficacy|3|||
130295107|NCT01895309|469043842|FG000|Overall Study|Lost to Follow-up|1|||
130295108|NCT01895309|469043843|FG001|Overall Study|Lost to Follow-up|3|||
130295109|NCT01895309|469043842|FG000|Overall Study|Physician Decision|15|||
130295110|NCT01895309|469043843|FG001|Overall Study|Physician Decision|10|||
130295111|NCT01895309|469043842|FG000|Overall Study|Withdrawal by Subject|9|||
130295112|NCT01895309|469043843|FG001|Overall Study|Withdrawal by Subject|18|||
130295113|NCT04268745|469043844|FG000|Overall Study|Lost to Follow-up|2|||
130295114|NCT04268745|469043845|FG001|Overall Study|Lost to Follow-up|3|||
130295115|NCT04268745|469043844|FG000|Overall Study|Withdrawal by Subject|4|||
130460612|NCT01087762|469652142|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
130460613|NCT01087762|469652143|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
130460614|NCT01087762|469652139|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
130460615|NCT01087762|469652140|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
130460616|NCT01087762|469652141|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
130295116|NCT04268745|469043845|FG001|Overall Study|Withdrawal by Subject|2|||
130295117|NCT04268745|469043844|FG000|Overall Study|Death in the family|1|||
130295118|NCT04268745|469043845|FG001|Overall Study|Death in the family|0|||
130295119|NCT04046250|469043848|FG000|Overall Study|Death|0|||
130460617|NCT01087762|469652142|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
130715072|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
130295120|NCT04046250|469043849|FG001|Overall Study|Death|1|||
130295121|NCT04046250|469043848|FG000|Overall Study|Withdrawal by Subject|3|||
130295122|NCT04046250|469043849|FG001|Overall Study|Withdrawal by Subject|3|||
130295123|NCT04576897|469043850|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
130295124|NCT00527332|469043853|FG000|Overall Study|Protocol Violation|4|||
130295125|NCT00527332|469043854|FG001|Overall Study|Protocol Violation|8|||
130295126|NCT00527332|469043853|FG000|Overall Study|Withdrew consent|5|||
130715073|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
130715074|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130715075|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130715076|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130715077|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130715078|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
130715079|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
130715080|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130715081|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130715082|NCT01449279|470583958|FG000|Overall Study|Lack of Efficacy|5|||
130715083|NCT01449279|470583958|FG000|Overall Study|Toxicity|2|||
130715084|NCT04234984|470583959|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
130715085|NCT04234984|470583959|FG000|Follow-up at the Second Time Point|Death|1|||
130715086|NCT04234984|470583959|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
130715087|NCT01055132|470583960|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
130715088|NCT01055132|470583961|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
130715089|NCT01055132|470583960|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
130715090|NCT01055132|470583961|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
130715091|NCT02038907|470583962|FG000|Overall Study|Protocol Violation|0|||
130715092|NCT02038907|470583963|FG001|Overall Study|Protocol Violation|0|||
130715093|NCT02038907|470583964|FG002|Overall Study|Protocol Violation|0|||
130715094|NCT02038907|470583965|FG003|Overall Study|Protocol Violation|0|||
130715095|NCT02038907|470583966|FG004|Overall Study|Protocol Violation|0|||
130715096|NCT02038907|470583967|FG005|Overall Study|Protocol Violation|0|||
130715097|NCT02038907|470583968|FG006|Overall Study|Protocol Violation|0|||
130715098|NCT02038907|470583969|FG007|Overall Study|Protocol Violation|0|||
130715099|NCT02038907|470583970|FG008|Overall Study|Protocol Violation|0|||
130715100|NCT02038907|470583971|FG009|Overall Study|Protocol Violation|0|||
130715101|NCT02038907|470583972|FG010|Overall Study|Protocol Violation|1|||
130715102|NCT02038907|470583973|FG011|Overall Study|Protocol Violation|0|||
130715103|NCT02038907|470583974|FG012|Overall Study|Protocol Violation|0|||
130715104|NCT02038907|470583975|FG013|Overall Study|Protocol Violation|0|||
130715105|NCT02038907|470583962|FG000|Overall Study|Withdrawal by Subject|0|||
130715106|NCT02038907|470583963|FG001|Overall Study|Withdrawal by Subject|0|||
130715107|NCT02038907|470583964|FG002|Overall Study|Withdrawal by Subject|0|||
130715108|NCT02038907|470583965|FG003|Overall Study|Withdrawal by Subject|0|||
130715109|NCT02038907|470583966|FG004|Overall Study|Withdrawal by Subject|0|||
130715110|NCT02038907|470583967|FG005|Overall Study|Withdrawal by Subject|0|||
130715111|NCT02038907|470583968|FG006|Overall Study|Withdrawal by Subject|0|||
130715112|NCT02038907|470583969|FG007|Overall Study|Withdrawal by Subject|0|||
130715113|NCT02038907|470583970|FG008|Overall Study|Withdrawal by Subject|0|||
130715114|NCT02038907|470583971|FG009|Overall Study|Withdrawal by Subject|0|||
130715115|NCT02038907|470583972|FG010|Overall Study|Withdrawal by Subject|1|||
130715116|NCT02038907|470583973|FG011|Overall Study|Withdrawal by Subject|0|||
130715117|NCT02038907|470583974|FG012|Overall Study|Withdrawal by Subject|0|||
130715118|NCT02038907|470583975|FG013|Overall Study|Withdrawal by Subject|0|||
130715119|NCT01156142|470583979|FG000|Overall Study|Withdrawal by Subject|8|||
130715120|NCT01156142|470583980|FG001|Overall Study|Withdrawal by Subject|6|||
130715121|NCT01156142|470583979|FG000|Overall Study|Ineligible|0|||
130715122|NCT01156142|470583980|FG001|Overall Study|Ineligible|1|||
130715123|NCT00893737|470583981|FG000|Overall Study|Adverse Event|4|||
130715124|NCT00893737|470583981|FG000|Overall Study|Withdrawal by Subject|2|||
130715125|NCT00893737|470583981|FG000|Overall Study|Lost to Follow-up|6|||
130295127|NCT00527332|469043854|FG001|Overall Study|Withdrew consent|1|||
130295128|NCT02666105|469043855|FG000|Overall Study|Death|1|||
130295129|NCT02100969|469045251|FG000|Overall Study|Did not pass screening phase|1|||
130295130|NCT01629953|469045252|FG000|Overall Study|Death|3|||
130295131|NCT01629953|469045253|FG001|Overall Study|Death|1|||
130295132|NCT01629953|469045252|FG000|Overall Study|Lost to Follow-up|10|||
130295133|NCT01629953|469045253|FG001|Overall Study|Lost to Follow-up|14|||
130295134|NCT01646203|469045254|FG000|Overall Study|Adverse Event|2|||
130295135|NCT01646203|469045255|FG001|Overall Study|Adverse Event|0|||
130295136|NCT01646203|469045256|FG002|Overall Study|Adverse Event|1|||
130295137|NCT01646203|469045254|FG000|Overall Study|Withdrawal by Subject|0|||
130295138|NCT01646203|469045255|FG001|Overall Study|Withdrawal by Subject|1|||
130295139|NCT01646203|469045256|FG002|Overall Study|Withdrawal by Subject|0|||
130295140|NCT01646203|469045254|FG000|Overall Study|Physician's Decision|0|||
130557047|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
130557048|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Early termination|0|||
130372028|NCT01652703|469333233|FG000|Overall Study|Other|0|||
130372029|NCT01652703|469333234|FG001|Overall Study|Other|0|||
130372030|NCT01652703|469333235|FG002|Overall Study|Other|0|||
130372031|NCT01652703|469333236|FG003|Overall Study|Other|1|||
130372032|NCT01652703|469333237|FG004|Overall Study|Other|1|||
130372033|NCT01652703|469333238|FG005|Overall Study|Other|1|||
130372034|NCT02155608|469333239|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
130372035|NCT02155608|469333240|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
130372036|NCT02155608|469333239|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
130372037|NCT02155608|469333240|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
130372038|NCT03555591|469333241|FG000|Overall Study|Protocol Violation|77|||
130372039|NCT01532414|469333242|FG000|Overall Study|Lost to Follow-up|3|||
130372040|NCT01532414|469333243|FG001|Overall Study|Lost to Follow-up|0|||
130372041|NCT01532414|469333244|FG002|Overall Study|Lost to Follow-up|1|||
130372042|NCT01532414|469333242|FG000|Overall Study|Withdrawal by Subject|3|||
130372043|NCT01532414|469333243|FG001|Overall Study|Withdrawal by Subject|0|||
130372044|NCT01532414|469333244|FG002|Overall Study|Withdrawal by Subject|0|||
130372045|NCT01532414|469333242|FG000|Overall Study|No V6 semen sample|0|||
130557049|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Early termination|0|||
130372046|NCT01532414|469333243|FG001|Overall Study|No V6 semen sample|1|||
130372047|NCT01532414|469333244|FG002|Overall Study|No V6 semen sample|0|||
130372048|NCT01532414|469333242|FG000|Overall Study|Adverse Event|0|||
130372049|NCT01532414|469333243|FG001|Overall Study|Adverse Event|1|||
130372050|NCT01532414|469333244|FG002|Overall Study|Adverse Event|1|||
130372051|NCT01532414|469333242|FG000|Overall Study|Unable to complete 24 hour PK|0|||
130372052|NCT01532414|469333243|FG001|Overall Study|Unable to complete 24 hour PK|0|||
130372053|NCT01532414|469333244|FG002|Overall Study|Unable to complete 24 hour PK|1|||
130372054|NCT01532414|469333242|FG000|Overall Study|Withdrawn by sponsor|1|||
130372055|NCT01532414|469333243|FG001|Overall Study|Withdrawn by sponsor|0|||
130372056|NCT01532414|469333244|FG002|Overall Study|Withdrawn by sponsor|0|||
130372057|NCT00187486|469333245|FG000|Overall Study|Protocol Violation|1|||
130372058|NCT02380677|469333246|FG000|Overall Study|Adverse Event|0|||
130372059|NCT02380677|469333247|FG001|Overall Study|Adverse Event|0|||
130372060|NCT02380677|469333248|FG002|Overall Study|Adverse Event|0|||
130372061|NCT02380677|469333249|FG003|Overall Study|Adverse Event|1|||
130372062|NCT02380677|469333250|FG004|Overall Study|Adverse Event|1|||
130715126|NCT02140411|470583982|FG000|Overall Study|Adverse Event|1|||
130715127|NCT03981419|470583985|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
130715128|NCT03981419|470583986|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
130715129|NCT01330459|470583990|FG000|Overall Study|Physician Decision|0|||
130715130|NCT01330459|470583991|FG001|Overall Study|Physician Decision|2|||
130715131|NCT01359644|470584006|FG000|Treatment Period|Lack of Efficacy|0|||
130715132|NCT01359644|470584007|FG001|Treatment Period|Lack of Efficacy|1|||
130715133|NCT01359644|470584008|FG002|Treatment Period|Lack of Efficacy|0|||
130715134|NCT01359644|470584009|FG003|Treatment Period|Lack of Efficacy|0|||
130715135|NCT01359644|470584010|FG004|Treatment Period|Lack of Efficacy|0|||
130715136|NCT01359644|470584011|FG005|Treatment Period|Lack of Efficacy|0|||
130715137|NCT01359644|470584012|FG006|Treatment Period|Lack of Efficacy|0|||
130372063|NCT02380677|469333251|FG005|Overall Study|Adverse Event|4|||
130715138|NCT01359644|470584013|FG007|Treatment Period|Lack of Efficacy|0|||
130372064|NCT02380677|469333252|FG006|Overall Study|Adverse Event|2|||
130715139|NCT01359644|470584014|FG008|Treatment Period|Lack of Efficacy|0|||
130715140|NCT01359644|470584015|FG009|Treatment Period|Lack of Efficacy|0|||
130295141|NCT01646203|469045255|FG001|Overall Study|Physician's Decision|1|||
130295142|NCT01646203|469045256|FG002|Overall Study|Physician's Decision|0|||
130295143|NCT03242252|469045258|FG000|Overall Study|At the Participant's own Request|18|||
130295144|NCT03242252|469045259|FG001|Overall Study|At the Participant's own Request|10|||
130295145|NCT03242252|469045260|FG002|Overall Study|At the Participant's own Request|15|||
130295146|NCT03242252|469045258|FG000|Overall Study|Adverse Event|8|||
130295147|NCT03242252|469045259|FG001|Overall Study|Adverse Event|6|||
130295148|NCT03242252|469045260|FG002|Overall Study|Adverse Event|9|||
130295149|NCT03242252|469045258|FG000|Overall Study|Poor Compliance to Protocol|0|||
130295150|NCT03242252|469045259|FG001|Overall Study|Poor Compliance to Protocol|2|||
130295151|NCT03242252|469045260|FG002|Overall Study|Poor Compliance to Protocol|3|||
130295152|NCT03242252|469045258|FG000|Overall Study|Study Terminated by Sponsor|1|||
130295153|NCT03242252|469045259|FG001|Overall Study|Study Terminated by Sponsor|0|||
130295154|NCT03242252|469045260|FG002|Overall Study|Study Terminated by Sponsor|0|||
130295155|NCT03242252|469045258|FG000|Overall Study|Reason not Specified|4|||
130557050|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Early termination|34|||
130295156|NCT03242252|469045259|FG001|Overall Study|Reason not Specified|4|||
130372065|NCT02380677|469333253|FG007|Overall Study|Adverse Event|2|||
130372066|NCT02380677|469333254|FG008|Overall Study|Adverse Event|2|||
130372067|NCT02380677|469333255|FG009|Overall Study|Adverse Event|1|||
130372068|NCT02380677|469333256|FG010|Overall Study|Adverse Event|2|||
130372069|NCT02380677|469333257|FG011|Overall Study|Adverse Event|1|||
130372070|NCT02380677|469333246|FG000|Overall Study|Physician Decision|1|||
130372071|NCT02380677|469333247|FG001|Overall Study|Physician Decision|0|||
130372072|NCT02380677|469333248|FG002|Overall Study|Physician Decision|1|||
130372073|NCT02380677|469333249|FG003|Overall Study|Physician Decision|1|||
130372074|NCT02380677|469333250|FG004|Overall Study|Physician Decision|0|||
130372075|NCT02380677|469333251|FG005|Overall Study|Physician Decision|0|||
130372076|NCT02380677|469333252|FG006|Overall Study|Physician Decision|0|||
130372077|NCT02380677|469333253|FG007|Overall Study|Physician Decision|0|||
130372078|NCT02380677|469333254|FG008|Overall Study|Physician Decision|0|||
130372079|NCT02380677|469333255|FG009|Overall Study|Physician Decision|0|||
130372080|NCT02380677|469333256|FG010|Overall Study|Physician Decision|0|||
130372081|NCT02380677|469333257|FG011|Overall Study|Physician Decision|0|||
130372082|NCT02380677|469333246|FG000|Overall Study|Lack of Efficacy|0|||
130372083|NCT02380677|469333247|FG001|Overall Study|Lack of Efficacy|1|||
130372084|NCT02380677|469333248|FG002|Overall Study|Lack of Efficacy|2|||
130372085|NCT02380677|469333249|FG003|Overall Study|Lack of Efficacy|0|||
130372086|NCT02380677|469333250|FG004|Overall Study|Lack of Efficacy|4|||
130372087|NCT02380677|469333251|FG005|Overall Study|Lack of Efficacy|1|||
130372088|NCT02380677|469333252|FG006|Overall Study|Lack of Efficacy|1|||
130372089|NCT02380677|469333253|FG007|Overall Study|Lack of Efficacy|2|||
130372090|NCT02380677|469333254|FG008|Overall Study|Lack of Efficacy|2|||
130372091|NCT02380677|469333255|FG009|Overall Study|Lack of Efficacy|0|||
130372092|NCT02380677|469333256|FG010|Overall Study|Lack of Efficacy|2|||
130372093|NCT02380677|469333257|FG011|Overall Study|Lack of Efficacy|1|||
130372094|NCT02380677|469333246|FG000|Overall Study|Withdrawal by Subject|0|||
130372095|NCT02380677|469333247|FG001|Overall Study|Withdrawal by Subject|0|||
130372096|NCT02380677|469333248|FG002|Overall Study|Withdrawal by Subject|0|||
130372097|NCT02380677|469333249|FG003|Overall Study|Withdrawal by Subject|0|||
130372098|NCT02380677|469333250|FG004|Overall Study|Withdrawal by Subject|0|||
130372099|NCT02380677|469333251|FG005|Overall Study|Withdrawal by Subject|0|||
130372100|NCT02380677|469333252|FG006|Overall Study|Withdrawal by Subject|0|||
130372101|NCT02380677|469333253|FG007|Overall Study|Withdrawal by Subject|0|||
130372102|NCT02380677|469333254|FG008|Overall Study|Withdrawal by Subject|0|||
130372103|NCT02380677|469333255|FG009|Overall Study|Withdrawal by Subject|1|||
130372104|NCT02380677|469333256|FG010|Overall Study|Withdrawal by Subject|0|||
130372105|NCT02380677|469333257|FG011|Overall Study|Withdrawal by Subject|3|||
130372106|NCT02380677|469333246|FG000|Overall Study|Other|0|||
130372107|NCT02380677|469333247|FG001|Overall Study|Other|0|||
130372108|NCT02380677|469333248|FG002|Overall Study|Other|0|||
130372109|NCT02380677|469333249|FG003|Overall Study|Other|1|||
130372110|NCT02380677|469333250|FG004|Overall Study|Other|1|||
130372111|NCT02380677|469333251|FG005|Overall Study|Other|1|||
130372112|NCT02380677|469333252|FG006|Overall Study|Other|0|||
130372113|NCT02380677|469333253|FG007|Overall Study|Other|0|||
130372114|NCT02380677|469333254|FG008|Overall Study|Other|0|||
130372115|NCT02380677|469333255|FG009|Overall Study|Other|0|||
130372116|NCT02380677|469333256|FG010|Overall Study|Other|0|||
130372117|NCT02380677|469333257|FG011|Overall Study|Other|0|||
130372118|NCT01029795|469333262|FG000|Overall Study|Entry Criteria Not Met|2|||
130372119|NCT01029795|469333263|FG001|Overall Study|Entry Criteria Not Met|1|||
130372120|NCT01029795|469333262|FG000|Overall Study|Physician Decision|2|||
130372121|NCT01029795|469333263|FG001|Overall Study|Physician Decision|1|||
130372122|NCT01029795|469333262|FG000|Overall Study|Sponsor Decision|11|||
130372123|NCT01029795|469333263|FG001|Overall Study|Sponsor Decision|17|||
130372124|NCT01029795|469333262|FG000|Overall Study|Withdrawal by Subject|1|||
130372125|NCT01029795|469333263|FG001|Overall Study|Withdrawal by Subject|3|||
130715141|NCT01359644|470584006|FG000|Treatment Period|Adverse Event|0|||
130715142|NCT01359644|470584007|FG001|Treatment Period|Adverse Event|0|||
130715143|NCT01359644|470584008|FG002|Treatment Period|Adverse Event|1|||
130715144|NCT01359644|470584009|FG003|Treatment Period|Adverse Event|0|||
130715145|NCT01359644|470584010|FG004|Treatment Period|Adverse Event|0|||
130715146|NCT01359644|470584011|FG005|Treatment Period|Adverse Event|1|||
130715147|NCT01359644|470584012|FG006|Treatment Period|Adverse Event|0|||
130715148|NCT01359644|470584013|FG007|Treatment Period|Adverse Event|0|||
130715149|NCT01359644|470584014|FG008|Treatment Period|Adverse Event|0|||
130715150|NCT01359644|470584015|FG009|Treatment Period|Adverse Event|0|||
130715151|NCT01359644|470584006|FG000|Treatment Period|Lost to Follow-up|0|||
130715152|NCT01359644|470584007|FG001|Treatment Period|Lost to Follow-up|0|||
130715153|NCT01359644|470584008|FG002|Treatment Period|Lost to Follow-up|0|||
130715154|NCT01359644|470584009|FG003|Treatment Period|Lost to Follow-up|0|||
130715155|NCT01359644|470584010|FG004|Treatment Period|Lost to Follow-up|0|||
130715156|NCT01359644|470584011|FG005|Treatment Period|Lost to Follow-up|1|||
130715157|NCT01359644|470584012|FG006|Treatment Period|Lost to Follow-up|0|||
130715158|NCT01359644|470584013|FG007|Treatment Period|Lost to Follow-up|0|||
130715159|NCT01359644|470584014|FG008|Treatment Period|Lost to Follow-up|0|||
130715160|NCT01359644|470584015|FG009|Treatment Period|Lost to Follow-up|0|||
130715161|NCT01359644|470584006|FG000|Follow-up Period|Withdrawal by Subject|0|||
130715162|NCT01359644|470584007|FG001|Follow-up Period|Withdrawal by Subject|0|||
130715163|NCT01359644|470584008|FG002|Follow-up Period|Withdrawal by Subject|0|||
130715164|NCT01359644|470584009|FG003|Follow-up Period|Withdrawal by Subject|0|||
130715165|NCT01359644|470584010|FG004|Follow-up Period|Withdrawal by Subject|0|||
130715166|NCT01359644|470584011|FG005|Follow-up Period|Withdrawal by Subject|1|||
130715167|NCT01359644|470584012|FG006|Follow-up Period|Withdrawal by Subject|0|||
130715168|NCT01359644|470584013|FG007|Follow-up Period|Withdrawal by Subject|0|||
130715169|NCT01359644|470584014|FG008|Follow-up Period|Withdrawal by Subject|0|||
130715170|NCT01359644|470584015|FG009|Follow-up Period|Withdrawal by Subject|0|||
130715171|NCT01359644|470584006|FG000|Follow-up Period|Lost to Follow-up|0|||
130715172|NCT01359644|470584007|FG001|Follow-up Period|Lost to Follow-up|0|||
130715173|NCT01359644|470584008|FG002|Follow-up Period|Lost to Follow-up|0|||
130715174|NCT01359644|470584009|FG003|Follow-up Period|Lost to Follow-up|0|||
130715175|NCT01359644|470584010|FG004|Follow-up Period|Lost to Follow-up|0|||
130715176|NCT01359644|470584011|FG005|Follow-up Period|Lost to Follow-up|0|||
130715177|NCT01359644|470584012|FG006|Follow-up Period|Lost to Follow-up|1|||
130715178|NCT01359644|470584013|FG007|Follow-up Period|Lost to Follow-up|2|||
130715179|NCT01359644|470584014|FG008|Follow-up Period|Lost to Follow-up|0|||
130715180|NCT01359644|470584015|FG009|Follow-up Period|Lost to Follow-up|0|||
130715181|NCT02130882|470584017|FG000|Overall Study|Withdrawal by Subject|0|||
130715182|NCT02130882|470584018|FG001|Overall Study|Withdrawal by Subject|1|||
130715183|NCT01355159|470584029|FG000|Overall Study|Withdrew consent|39|||
130715184|NCT01355159|470584030|FG001|Overall Study|Withdrew consent|47|||
130715185|NCT01355159|470584029|FG000|Overall Study|No primary outcome data|17|||
130372126|NCT03217175|469333264|FG000|Overall Study|Physician Decision|4|||
130372127|NCT03217175|469333265|FG001|Overall Study|Physician Decision|1|||
130372128|NCT01806545|469333271|FG000|Overall Study|Adverse Event|2|||
130372129|NCT01806545|469333272|FG001|Overall Study|Adverse Event|3|||
130372130|NCT01806545|469333271|FG000|Overall Study|Lost to Follow-up|1|||
130372131|NCT01806545|469333272|FG001|Overall Study|Lost to Follow-up|0|||
130372132|NCT01806545|469333271|FG000|Overall Study|Withdrawal by Subject|3|||
130372133|NCT01806545|469333272|FG001|Overall Study|Withdrawal by Subject|2|||
130372134|NCT01508650|469333273|FG000|Overall Study|Lost to Follow-up|0|||
130372135|NCT01508650|469333274|FG001|Overall Study|Lost to Follow-up|3|||
130372136|NCT02064894|469333275|FG000|Overall Study|Withdrawal by Subject|43|||
130372137|NCT02064894|469333276|FG001|Overall Study|Withdrawal by Subject|102|||
130372138|NCT02064894|469333277|FG002|Overall Study|Withdrawal by Subject|115|||
130372139|NCT00884312|469333286|FG000|Overall Study|Non-fatal Progressive Disease|0|||
130372140|NCT00884312|469333287|FG001|Overall Study|Non-fatal Progressive Disease|8|||
130372141|NCT00884312|469333286|FG000|Overall Study|Fatal Progressive Disease|0|||
130372142|NCT00884312|469333287|FG001|Overall Study|Fatal Progressive Disease|1|||
130372143|NCT00884312|469333286|FG000|Overall Study|Non-fatal Adverse Event|1|||
130372144|NCT00884312|469333287|FG001|Overall Study|Non-fatal Adverse Event|0|||
130372145|NCT00884312|469333286|FG000|Overall Study|Fatal Adverse Event|1|||
130372146|NCT00884312|469333287|FG001|Overall Study|Fatal Adverse Event|4|||
130372147|NCT00884312|469333286|FG000|Overall Study|Withdrawal by Subject|0|||
130372148|NCT00884312|469333287|FG001|Overall Study|Withdrawal by Subject|6|||
130372149|NCT00884312|469333286|FG000|Overall Study|Physician Decision|0|||
130372150|NCT00884312|469333287|FG001|Overall Study|Physician Decision|1|||
130372151|NCT00884312|469333286|FG000|Overall Study|Other|0|||
130372152|NCT00884312|469333287|FG001|Overall Study|Other|4|||
130372153|NCT00884312|469333286|FG000|Overall Study|Did Not Receive Study Drug|0|||
130372154|NCT00884312|469333287|FG001|Overall Study|Did Not Receive Study Drug|1|||
130460618|NCT01087762|469652143|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
130460619|NCT01087762|469652139|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
130460620|NCT01087762|469652140|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
130460621|NCT01087762|469652141|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
130460622|NCT01087762|469652142|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
130460623|NCT01087762|469652143|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
130460624|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
130460625|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
130460626|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
130460627|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
130460628|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
130460629|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
130460630|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
130460631|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
130460632|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
130460633|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
130460634|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
130460635|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
130460636|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
130460637|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
130460638|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
130460639|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
130460640|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
130460641|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
130715186|NCT01355159|470584030|FG001|Overall Study|No primary outcome data|11|||
130715187|NCT01355159|470584029|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
130715188|NCT01355159|470584030|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
130715189|NCT01355159|470584029|FG000|Overall Study|Early intrauterine fetal death|6|||
130715190|NCT01355159|470584030|FG001|Overall Study|Early intrauterine fetal death|6|||
130715191|NCT01194973|470584031|FG000|Screening Period|Screen Failure|3|||
130715192|NCT01194973|470584031|FG000|26 Week Treatment Period|Adverse Event|1|||
130715193|NCT01194973|470584031|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
130715194|NCT01194973|470584031|FG000|26 Week Treatment Period|Pregnancy|1|||
130715195|NCT00359632|470584034|FG000|Overall Study|Death|2|||
130715196|NCT00359632|470584035|FG001|Overall Study|Death|0|||
130715197|NCT00359632|470584034|FG000|Overall Study|Adverse Event|1|||
130715198|NCT00359632|470584035|FG001|Overall Study|Adverse Event|0|||
130715199|NCT00359632|470584034|FG000|Overall Study|Non-compliance with visit schedule|1|||
130715200|NCT00359632|470584035|FG001|Overall Study|Non-compliance with visit schedule|0|||
130715201|NCT04700280|470584036|FG000|Overall Study|Adverse Event|4|||
130715202|NCT04700280|470584037|FG001|Overall Study|Adverse Event|0|||
130715203|NCT04700280|470584036|FG000|Overall Study|Lack of Efficacy|1|||
130715204|NCT04700280|470584037|FG001|Overall Study|Lack of Efficacy|0|||
130715205|NCT04700280|470584036|FG000|Overall Study|Study terminated by sponsor|5|||
130715206|NCT04700280|470584037|FG001|Overall Study|Study terminated by sponsor|3|||
130715207|NCT04700280|470584036|FG000|Overall Study|Other than specified|1|||
130715208|NCT04700280|470584037|FG001|Overall Study|Other than specified|0|||
130715209|NCT02615171|470584038|FG000|Overall Study|Lost to Follow-up|2|||
130715210|NCT02615171|470584039|FG001|Overall Study|Lost to Follow-up|1|||
130715211|NCT00444457|470584049|FG000|Infant Series|Other|0|||
130715212|NCT00444457|470584050|FG001|Infant Series|Other|1|||
130715213|NCT00444457|470584051|FG002|Infant Series|Other|0|||
130715214|NCT00444457|470584052|FG003|Infant Series|Other|0|||
130715215|NCT00444457|470584049|FG000|Infant Series|Parent or legal guardian request|18|||
130715216|NCT00444457|470584050|FG001|Infant Series|Parent or legal guardian request|29|||
130715217|NCT00444457|470584051|FG002|Infant Series|Parent or legal guardian request|34|||
130715218|NCT00444457|470584052|FG003|Infant Series|Parent or legal guardian request|14|||
130715219|NCT00444457|470584049|FG000|Infant Series|Lost to Follow-up|10|||
130715220|NCT00444457|470584050|FG001|Infant Series|Lost to Follow-up|11|||
130715221|NCT00444457|470584051|FG002|Infant Series|Lost to Follow-up|7|||
130295157|NCT03242252|469045260|FG002|Overall Study|Reason not Specified|1|||
130295158|NCT03242252|469045258|FG000|Overall Study|Lost to Follow-up|5|||
130295159|NCT03242252|469045259|FG001|Overall Study|Lost to Follow-up|1|||
130460642|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
130460643|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
130715222|NCT00444457|470584052|FG003|Infant Series|Lost to Follow-up|6|||
130715223|NCT00444457|470584049|FG000|Infant Series|Protocol Violation|16|||
130715224|NCT00444457|470584050|FG001|Infant Series|Protocol Violation|8|||
130715225|NCT00444457|470584051|FG002|Infant Series|Protocol Violation|6|||
130715226|NCT00444457|470584052|FG003|Infant Series|Protocol Violation|3|||
130715227|NCT00444457|470584049|FG000|Infant Series|Failed to return|5|||
130715228|NCT00444457|470584050|FG001|Infant Series|Failed to return|4|||
130715229|NCT00444457|470584051|FG002|Infant Series|Failed to return|4|||
130715230|NCT00444457|470584052|FG003|Infant Series|Failed to return|2|||
130295160|NCT03242252|469045260|FG002|Overall Study|Lost to Follow-up|4|||
130295161|NCT01659255|469045261|FG000|Overall Study|Adverse Event|0|||
130295162|NCT01659255|469045262|FG001|Overall Study|Adverse Event|0|||
130295163|NCT01659255|469045263|FG002|Overall Study|Adverse Event|0|||
130295164|NCT01659255|469045264|FG003|Overall Study|Adverse Event|0|||
130295165|NCT01659255|469045265|FG004|Overall Study|Adverse Event|0|||
130295166|NCT01659255|469045266|FG005|Overall Study|Adverse Event|1|||
130295167|NCT01659255|469045267|FG006|Overall Study|Adverse Event|1|||
130295168|NCT01659255|469045268|FG007|Overall Study|Adverse Event|0|||
130295169|NCT01659255|469045269|FG008|Overall Study|Adverse Event|0|||
130295170|NCT01659255|469045270|FG009|Overall Study|Adverse Event|1|||
130295171|NCT01659255|469045271|FG010|Overall Study|Adverse Event|0|||
130295172|NCT01659255|469045272|FG011|Overall Study|Adverse Event|1|||
130295173|NCT01659255|469045273|FG012|Overall Study|Adverse Event|0|||
130295174|NCT01659255|469045274|FG013|Overall Study|Adverse Event|2|||
130295175|NCT01659255|469045275|FG014|Overall Study|Adverse Event|0|||
130295176|NCT01659255|469045276|FG015|Overall Study|Adverse Event|1|||
130295177|NCT01659255|469045277|FG016|Overall Study|Adverse Event|0|||
130295178|NCT01659255|469045261|FG000|Overall Study|Death|0|||
130295179|NCT01659255|469045262|FG001|Overall Study|Death|1|||
130295180|NCT01659255|469045263|FG002|Overall Study|Death|0|||
130295181|NCT01659255|469045264|FG003|Overall Study|Death|0|||
130295182|NCT01659255|469045265|FG004|Overall Study|Death|0|||
130295183|NCT01659255|469045266|FG005|Overall Study|Death|0|||
130295184|NCT01659255|469045267|FG006|Overall Study|Death|0|||
130295185|NCT01659255|469045268|FG007|Overall Study|Death|1|||
130295186|NCT01659255|469045269|FG008|Overall Study|Death|1|||
130295187|NCT01659255|469045270|FG009|Overall Study|Death|0|||
130295188|NCT01659255|469045271|FG010|Overall Study|Death|0|||
130295189|NCT01659255|469045272|FG011|Overall Study|Death|0|||
130295190|NCT01659255|469045273|FG012|Overall Study|Death|1|||
130295191|NCT01659255|469045274|FG013|Overall Study|Death|1|||
130295192|NCT01659255|469045275|FG014|Overall Study|Death|2|||
130295193|NCT01659255|469045276|FG015|Overall Study|Death|1|||
130295194|NCT01659255|469045277|FG016|Overall Study|Death|0|||
130295195|NCT01659255|469045261|FG000|Overall Study|Progressive Disease|2|||
130295196|NCT01659255|469045262|FG001|Overall Study|Progressive Disease|0|||
130295197|NCT01659255|469045263|FG002|Overall Study|Progressive Disease|0|||
130295198|NCT01659255|469045264|FG003|Overall Study|Progressive Disease|0|||
130295199|NCT01659255|469045265|FG004|Overall Study|Progressive Disease|0|||
130295200|NCT01659255|469045266|FG005|Overall Study|Progressive Disease|0|||
130295201|NCT01659255|469045267|FG006|Overall Study|Progressive Disease|0|||
130295202|NCT01659255|469045268|FG007|Overall Study|Progressive Disease|1|||
130295203|NCT01659255|469045269|FG008|Overall Study|Progressive Disease|0|||
130295204|NCT01659255|469045270|FG009|Overall Study|Progressive Disease|2|||
130295205|NCT01659255|469045271|FG010|Overall Study|Progressive Disease|2|||
130295206|NCT01659255|469045272|FG011|Overall Study|Progressive Disease|3|||
130372155|NCT00224042|469333288|FG000|Overall Study|Adverse Event|2|||
130295207|NCT01659255|469045273|FG012|Overall Study|Progressive Disease|5|||
130295208|NCT01659255|469045274|FG013|Overall Study|Progressive Disease|13|||
130372156|NCT00224042|469333289|FG001|Overall Study|Adverse Event|1|||
130295209|NCT01659255|469045275|FG014|Overall Study|Progressive Disease|6|||
130295210|NCT01659255|469045276|FG015|Overall Study|Progressive Disease|2|||
130295211|NCT01659255|469045277|FG016|Overall Study|Progressive Disease|3|||
130295212|NCT01659255|469045261|FG000|Overall Study|Withdrew Consent|0|||
130295213|NCT01659255|469045262|FG001|Overall Study|Withdrew Consent|0|||
130295214|NCT01659255|469045263|FG002|Overall Study|Withdrew Consent|0|||
130295215|NCT01659255|469045264|FG003|Overall Study|Withdrew Consent|0|||
130295216|NCT01659255|469045265|FG004|Overall Study|Withdrew Consent|0|||
130295217|NCT01659255|469045266|FG005|Overall Study|Withdrew Consent|0|||
130295218|NCT01659255|469045267|FG006|Overall Study|Withdrew Consent|0|||
130295219|NCT01659255|469045268|FG007|Overall Study|Withdrew Consent|0|||
130372157|NCT00224042|469333288|FG000|Overall Study|Protocol Violation|0|||
130295220|NCT01659255|469045269|FG008|Overall Study|Withdrew Consent|0|||
130295221|NCT01659255|469045270|FG009|Overall Study|Withdrew Consent|0|||
130295222|NCT01659255|469045271|FG010|Overall Study|Withdrew Consent|1|||
130295223|NCT01659255|469045272|FG011|Overall Study|Withdrew Consent|0|||
130715231|NCT00444457|470584049|FG000|Infant Series|Investigator request|4|||
130715232|NCT00444457|470584050|FG001|Infant Series|Investigator request|3|||
130715233|NCT00444457|470584051|FG002|Infant Series|Investigator request|3|||
130715234|NCT00444457|470584052|FG003|Infant Series|Investigator request|2|||
130715235|NCT00444457|470584049|FG000|Infant Series|Other|0|||
130715236|NCT00444457|470584050|FG001|Infant Series|Other|2|||
130715237|NCT00444457|470584051|FG002|Infant Series|Other|4|||
130715238|NCT00444457|470584052|FG003|Infant Series|Other|0|||
130715239|NCT00444457|470584049|FG000|Infant Series|Adverse Event|1|||
130715240|NCT00444457|470584050|FG001|Infant Series|Adverse Event|2|||
130715241|NCT00444457|470584051|FG002|Infant Series|Adverse Event|2|||
130715242|NCT00444457|470584052|FG003|Infant Series|Adverse Event|0|||
130715243|NCT00444457|470584049|FG000|Infant Series|Death|0|||
130715244|NCT00444457|470584050|FG001|Infant Series|Death|1|||
130715245|NCT00444457|470584051|FG002|Infant Series|Death|1|||
130715246|NCT00444457|470584052|FG003|Infant Series|Death|1|||
130715247|NCT00444457|470584049|FG000|After Infant Series|Other|0|||
130715248|NCT00444457|470584050|FG001|After Infant Series|Other|1|||
130715249|NCT00444457|470584051|FG002|After Infant Series|Other|1|||
130715250|NCT00444457|470584052|FG003|After Infant Series|Other|1|||
130715251|NCT00444457|470584049|FG000|After Infant Series|Parent or legal guardian request|4|||
130715252|NCT00444457|470584050|FG001|After Infant Series|Parent or legal guardian request|11|||
130715253|NCT00444457|470584051|FG002|After Infant Series|Parent or legal guardian request|6|||
130715254|NCT00444457|470584052|FG003|After Infant Series|Parent or legal guardian request|3|||
130715255|NCT00444457|470584049|FG000|After Infant Series|Failed to return|7|||
130715256|NCT00444457|470584050|FG001|After Infant Series|Failed to return|6|||
130715257|NCT00444457|470584051|FG002|After Infant Series|Failed to return|5|||
130715258|NCT00444457|470584052|FG003|After Infant Series|Failed to return|1|||
130715259|NCT00444457|470584049|FG000|After Infant Series|Lost to Follow-up|5|||
130715260|NCT00444457|470584050|FG001|After Infant Series|Lost to Follow-up|5|||
130715261|NCT00444457|470584051|FG002|After Infant Series|Lost to Follow-up|5|||
130715262|NCT00444457|470584052|FG003|After Infant Series|Lost to Follow-up|2|||
130715263|NCT00444457|470584049|FG000|After Infant Series|Protocol Violation|2|||
130715264|NCT00444457|470584050|FG001|After Infant Series|Protocol Violation|4|||
130715265|NCT00444457|470584051|FG002|After Infant Series|Protocol Violation|2|||
130715266|NCT00444457|470584052|FG003|After Infant Series|Protocol Violation|2|||
130715267|NCT00444457|470584049|FG000|After Infant Series|Adverse Event|2|||
130715268|NCT00444457|470584050|FG001|After Infant Series|Adverse Event|2|||
130715269|NCT00444457|470584051|FG002|After Infant Series|Adverse Event|0|||
130715270|NCT00444457|470584052|FG003|After Infant Series|Adverse Event|0|||
130715271|NCT00444457|470584049|FG000|After Infant Series|Investigator request|0|||
130715272|NCT00444457|470584050|FG001|After Infant Series|Investigator request|0|||
130715273|NCT00444457|470584051|FG002|After Infant Series|Investigator request|0|||
130715274|NCT00444457|470584052|FG003|After Infant Series|Investigator request|1|||
130715275|NCT00444457|470584049|FG000|After Infant Series|Other|0|||
130715276|NCT00444457|470584050|FG001|After Infant Series|Other|1|||
130715277|NCT00444457|470584051|FG002|After Infant Series|Other|0|||
130715278|NCT00444457|470584052|FG003|After Infant Series|Other|0|||
130715279|NCT00444457|470584049|FG000|Toddler Dose|Lost to Follow-up|4|||
130715280|NCT00444457|470584050|FG001|Toddler Dose|Lost to Follow-up|1|||
130715281|NCT00444457|470584051|FG002|Toddler Dose|Lost to Follow-up|1|||
130715282|NCT00444457|470584052|FG003|Toddler Dose|Lost to Follow-up|3|||
130715283|NCT00444457|470584049|FG000|Toddler Dose|Failed to return|2|||
130372158|NCT00224042|469333289|FG001|Overall Study|Protocol Violation|1|||
130372159|NCT00224042|469333288|FG000|Overall Study|Physician Decision|0|||
130372160|NCT00224042|469333289|FG001|Overall Study|Physician Decision|1|||
130372161|NCT00224042|469333288|FG000|Overall Study|Did not meet lab incusion criteria|2|||
130372162|NCT00224042|469333289|FG001|Overall Study|Did not meet lab incusion criteria|3|||
130372163|NCT00224042|469333288|FG000|Overall Study|Other|2|||
130372164|NCT00224042|469333289|FG001|Overall Study|Other|0|||
130372165|NCT00840450|469333290|FG000|Overall Study|Adverse Event|1|||
130372166|NCT00840450|469333290|FG000|Overall Study|Lack of Efficacy|2|||
130372167|NCT00617123|469333291|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
130372168|NCT00617123|469333292|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
130372169|NCT00617123|469333291|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
130372170|NCT00617123|469333292|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
130372171|NCT00617123|469333291|FG000|Referral Screening Period|Adverse Event|0|||
130372172|NCT00617123|469333292|FG001|Referral Screening Period|Adverse Event|1|||
130372173|NCT00617123|469333291|FG000|Study Treatment Period|Withdrawal by Subject|8|||
130372174|NCT00617123|469333292|FG001|Study Treatment Period|Withdrawal by Subject|12|||
130372175|NCT00617123|469333291|FG000|Study Treatment Period|Adverse Event|7|||
130372176|NCT00617123|469333292|FG001|Study Treatment Period|Adverse Event|3|||
130372177|NCT00617123|469333291|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
130372178|NCT00617123|469333292|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
130372179|NCT00617123|469333291|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
130372180|NCT00617123|469333292|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
130372181|NCT00133952|469333294|FG000|Overall Study|Adverse Event|1|||
130715284|NCT00444457|470584050|FG001|Toddler Dose|Failed to return|2|||
130715285|NCT00444457|470584051|FG002|Toddler Dose|Failed to return|1|||
130715286|NCT00444457|470584052|FG003|Toddler Dose|Failed to return|3|||
130715287|NCT00444457|470584049|FG000|Toddler Dose|Parent or legal guardian request|0|||
130715288|NCT00444457|470584050|FG001|Toddler Dose|Parent or legal guardian request|3|||
130715289|NCT00444457|470584051|FG002|Toddler Dose|Parent or legal guardian request|2|||
130715290|NCT00444457|470584052|FG003|Toddler Dose|Parent or legal guardian request|1|||
130715291|NCT00444457|470584049|FG000|Toddler Dose|Protocol Violation|1|||
130715292|NCT00444457|470584050|FG001|Toddler Dose|Protocol Violation|0|||
130715293|NCT00444457|470584051|FG002|Toddler Dose|Protocol Violation|0|||
130715294|NCT00444457|470584052|FG003|Toddler Dose|Protocol Violation|1|||
130715295|NCT01121666|470584055|FG000|Overall Study|Protocol Violation|29|||
130715296|NCT01121666|470584056|FG001|Overall Study|Protocol Violation|10|||
130715297|NCT03176459|470584059|FG000|Overall Study|Lost to Follow-up|5|||
130715298|NCT03176459|470584060|FG001|Overall Study|Lost to Follow-up|7|||
130715299|NCT01602965|470584061|FG000|Overall Study|Lost to Follow-up|4|||
130715300|NCT01602965|470584062|FG001|Overall Study|Lost to Follow-up|2|||
130715301|NCT02283294|470584063|FG000|Overall Study|Lost to Follow-up|1|||
130715302|NCT02283294|470584064|FG001|Overall Study|Lost to Follow-up|1|||
130715303|NCT02283294|470584063|FG000|Overall Study|Withdrawal by Subject|1|||
130715304|NCT02283294|470584064|FG001|Overall Study|Withdrawal by Subject|6|||
130715305|NCT02283294|470584063|FG000|Overall Study|Protocol Violation|1|||
130715306|NCT02283294|470584064|FG001|Overall Study|Protocol Violation|0|||
130715307|NCT02283294|470584063|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
130715308|NCT02283294|470584064|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
130715309|NCT03047473|470586885|FG000|Overall Study|Lost to Follow-up|2|||
130715310|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
130715311|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715312|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715313|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715314|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715315|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
130715316|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
130715317|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
130715318|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130715319|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130715320|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715321|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
130715322|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715323|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715324|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715325|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
130715326|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
130715327|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715328|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715329|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715330|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
130715331|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
130715332|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
130372182|NCT00133952|469333295|FG001|Overall Study|Adverse Event|2|||
130715333|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
130715334|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
130715335|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715336|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
130715337|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715338|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715339|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715340|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
130715341|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
130715342|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715343|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715344|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715345|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715346|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
130715347|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715348|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715349|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715350|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715351|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
130715352|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715353|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715354|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715355|NCT02935686|470586886|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715356|NCT02935686|470586887|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715357|NCT02935686|470586888|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715358|NCT02935686|470586889|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715359|NCT02935686|470586890|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
130715360|NCT02935686|470586886|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715361|NCT02935686|470586887|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715362|NCT02935686|470586888|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715363|NCT02935686|470586889|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
130715364|NCT02935686|470586890|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
130715365|NCT00541970|470586896|FG000|Month 7|Protocol Violation|9|||
130715366|NCT00541970|470586897|FG001|Month 7|Protocol Violation|13|||
130715367|NCT00541970|470586898|FG002|Month 7|Protocol Violation|11|||
130715368|NCT00541970|470586899|FG003|Month 7|Protocol Violation|5|||
130715369|NCT00541970|470586896|FG000|Month 12|Adverse Event|0|||
130715370|NCT00541970|470586897|FG001|Month 12|Adverse Event|1|||
130715371|NCT00541970|470586898|FG002|Month 12|Adverse Event|1|||
130715372|NCT00541970|470586899|FG003|Month 12|Adverse Event|1|||
130715373|NCT00541970|470586896|FG000|Month 12|Protocol Violation|12|||
130715374|NCT00541970|470586897|FG001|Month 12|Protocol Violation|21|||
130715375|NCT00541970|470586898|FG002|Month 12|Protocol Violation|20|||
130715376|NCT00541970|470586899|FG003|Month 12|Protocol Violation|15|||
130715377|NCT00541970|470586896|FG000|Month 18|Adverse Event|0|||
130715378|NCT00541970|470586897|FG001|Month 18|Adverse Event|1|||
130715379|NCT00541970|470586898|FG002|Month 18|Adverse Event|1|||
130715380|NCT00541970|470586899|FG003|Month 18|Adverse Event|1|||
130715381|NCT00541970|470586896|FG000|Month 18|Protocol Violation|14|||
130715382|NCT00541970|470586897|FG001|Month 18|Protocol Violation|23|||
130715383|NCT00541970|470586898|FG002|Month 18|Protocol Violation|24|||
130715384|NCT00541970|470586899|FG003|Month 18|Protocol Violation|16|||
130372183|NCT00133952|469333294|FG000|Overall Study|Death|3|||
130372184|NCT00133952|469333295|FG001|Overall Study|Death|2|||
130372185|NCT00133952|469333294|FG000|Overall Study|Lost to Follow-up|9|||
130372186|NCT00133952|469333295|FG001|Overall Study|Lost to Follow-up|14|||
130372187|NCT00133952|469333294|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
130372188|NCT00133952|469333295|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
130372189|NCT00133952|469333294|FG000|Overall Study|Protocol Violation|1|||
130372190|NCT00133952|469333295|FG001|Overall Study|Protocol Violation|1|||
130372191|NCT00133952|469333294|FG000|Overall Study|Withdrawal by Subject|20|||
130372192|NCT00133952|469333295|FG001|Overall Study|Withdrawal by Subject|4|||
130372193|NCT00133952|469333294|FG000|Overall Study|Physician Decision|4|||
130372194|NCT00133952|469333295|FG001|Overall Study|Physician Decision|3|||
130372195|NCT00133952|469333294|FG000|Overall Study|Sponsor Decision|0|||
130372196|NCT00133952|469333295|FG001|Overall Study|Sponsor Decision|1|||
130715385|NCT00541970|470586896|FG000|Month 24|Adverse Event|0|||
130372197|NCT00299104|469333296|FG000|Treatment Period|Adverse Event|14|||
130372198|NCT00299104|469333297|FG001|Treatment Period|Adverse Event|9|||
130372199|NCT00299104|469333298|FG002|Treatment Period|Adverse Event|7|||
130372200|NCT00299104|469333296|FG000|Treatment Period|Death|1|||
130460644|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
130372201|NCT00299104|469333297|FG001|Treatment Period|Death|1|||
130715386|NCT00541970|470586897|FG001|Month 24|Adverse Event|1|||
130715387|NCT00541970|470586898|FG002|Month 24|Adverse Event|1|||
130715388|NCT00541970|470586899|FG003|Month 24|Adverse Event|1|||
130715389|NCT00541970|470586896|FG000|Month 24|Protocol Violation|29|||
130715390|NCT00541970|470586897|FG001|Month 24|Protocol Violation|31|||
130715391|NCT00541970|470586898|FG002|Month 24|Protocol Violation|31|||
130715392|NCT00541970|470586899|FG003|Month 24|Protocol Violation|21|||
130715393|NCT00541970|470586896|FG000|Month 36|Protocol Violation|61|||
130715394|NCT00541970|470586897|FG001|Month 36|Protocol Violation|66|||
130715395|NCT00541970|470586898|FG002|Month 36|Protocol Violation|66|||
130715396|NCT00541970|470586899|FG003|Month 36|Protocol Violation|60|||
130715397|NCT00541970|470586896|FG000|Month 48|Withdrawal by Subject|2|||
130715398|NCT00541970|470586897|FG001|Month 48|Withdrawal by Subject|4|||
130715399|NCT00541970|470586898|FG002|Month 48|Withdrawal by Subject|4|||
130715400|NCT00541970|470586899|FG003|Month 48|Withdrawal by Subject|2|||
130715401|NCT00541970|470586896|FG000|Month 48|Other|3|||
130715402|NCT00541970|470586897|FG001|Month 48|Other|1|||
130715403|NCT00541970|470586898|FG002|Month 48|Other|1|||
130715404|NCT00541970|470586899|FG003|Month 48|Other|0|||
130715405|NCT00541970|470586896|FG000|Month 48|Lost to Follow-up|66|||
130715406|NCT00541970|470586897|FG001|Month 48|Lost to Follow-up|68|||
130715407|NCT00541970|470586898|FG002|Month 48|Lost to Follow-up|68|||
130715408|NCT00541970|470586899|FG003|Month 48|Lost to Follow-up|73|||
130715409|NCT00541970|470586896|FG000|Month 60|Protocol Violation|78|||
130715410|NCT00541970|470586897|FG001|Month 60|Protocol Violation|77|||
130715411|NCT00541970|470586898|FG002|Month 60|Protocol Violation|82|||
130715412|NCT00541970|470586899|FG003|Month 60|Protocol Violation|72|||
130715413|NCT00321828|470586900|FG000|Overall Study|Ineligible|3|||
130715414|NCT00321828|470586900|FG000|Overall Study|No follow up data|1|||
130715415|NCT00062010|470586903|FG000|Overall Study|Ineligible|3|||
130715416|NCT02856880|470586904|FG000|Overall Study|Withdrawal of consent|1|||
130715417|NCT00573157|470586905|FG000|Overall Study|Adverse Event|3|||
130715418|NCT00573157|470586906|FG001|Overall Study|Adverse Event|1|||
130715419|NCT00573157|470586905|FG000|Overall Study|Other|1|||
130715420|NCT00573157|470586906|FG001|Overall Study|Other|1|||
130715421|NCT02944383|470586907|FG000|Overall Study|Lost to Follow-up|0|||
130715422|NCT02944383|470586908|FG001|Overall Study|Lost to Follow-up|0|||
130715423|NCT02944383|470586909|FG002|Overall Study|Lost to Follow-up|1|||
130715424|NCT02944383|470586907|FG000|Overall Study|Withdrawal by Subject|1|||
130715425|NCT02944383|470586908|FG001|Overall Study|Withdrawal by Subject|0|||
130715426|NCT02944383|470586909|FG002|Overall Study|Withdrawal by Subject|0|||
130715427|NCT00858143|470586914|FG000|Overall Study|Adverse Event|16|||
130715428|NCT00858143|470586914|FG000|Overall Study|Lack of Efficacy|4|||
130715429|NCT00858143|470586914|FG000|Overall Study|Death|7|||
130715430|NCT00858143|470586914|FG000|Overall Study|Other|23|||
130715431|NCT00852969|470586915|FG000|Overall Study|Adverse Event|0|||
130715432|NCT00852969|470586916|FG001|Overall Study|Adverse Event|1|||
130715433|NCT00852969|470586915|FG000|Overall Study|Lost to Follow-up|0|||
130715434|NCT00852969|470586916|FG001|Overall Study|Lost to Follow-up|1|||
130715435|NCT03853148|470586917|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130715436|NCT03853148|470586918|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130715437|NCT03853148|470586919|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130715438|NCT03853148|470586920|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130715439|NCT00658658|470586921|FG000|Overall Study|Withdrawal by Subject|0|||
130715440|NCT00658658|470586922|FG001|Overall Study|Withdrawal by Subject|1|||
130715441|NCT00658658|470586923|FG002|Overall Study|Withdrawal by Subject|0|||
130715442|NCT00658658|470586924|FG003|Overall Study|Withdrawal by Subject|0|||
130715443|NCT00658658|470586925|FG004|Overall Study|Withdrawal by Subject|0|||
130715444|NCT00658658|470586921|FG000|Overall Study|Death|4|||
130715445|NCT00658658|470586922|FG001|Overall Study|Death|0|||
130715446|NCT00658658|470586923|FG002|Overall Study|Death|0|||
130295224|NCT01659255|469045273|FG012|Overall Study|Withdrew Consent|0|||
130295225|NCT01659255|469045274|FG013|Overall Study|Withdrew Consent|1|||
130715447|NCT00658658|470586924|FG003|Overall Study|Death|1|||
130715448|NCT00658658|470586925|FG004|Overall Study|Death|1|||
130715449|NCT00658658|470586921|FG000|Overall Study|Disease Progression|0|||
130715450|NCT00658658|470586922|FG001|Overall Study|Disease Progression|1|||
130715451|NCT00658658|470586923|FG002|Overall Study|Disease Progression|0|||
130715452|NCT00658658|470586924|FG003|Overall Study|Disease Progression|1|||
130715453|NCT00658658|470586925|FG004|Overall Study|Disease Progression|3|||
130715454|NCT00658658|470586921|FG000|Overall Study|Protocol-specified Criteria|1|||
130715455|NCT00658658|470586922|FG001|Overall Study|Protocol-specified Criteria|0|||
130715456|NCT00658658|470586923|FG002|Overall Study|Protocol-specified Criteria|0|||
130715457|NCT00658658|470586924|FG003|Overall Study|Protocol-specified Criteria|0|||
130715458|NCT00658658|470586925|FG004|Overall Study|Protocol-specified Criteria|0|||
130715459|NCT00658658|470586921|FG000|Overall Study|Other|0|||
130715460|NCT00658658|470586922|FG001|Overall Study|Other|0|||
130715461|NCT00658658|470586923|FG002|Overall Study|Other|0|||
130715462|NCT00658658|470586924|FG003|Overall Study|Other|0|||
130715463|NCT00658658|470586925|FG004|Overall Study|Other|1|||
130715464|NCT00678041|470586926|FG000|Overall Study|Physician Decision|5|||
130715465|NCT00678041|470586927|FG001|Overall Study|Physician Decision|5|||
130715466|NCT02358343|470586928|FG000|Screening Intervention|Death|0|||
130460645|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
130460646|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
130460647|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
130460648|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
130460649|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
130460650|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
130460651|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
130460652|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
130460653|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
130460654|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
130460655|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
130460656|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
130460657|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
130460658|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
130460659|NCT01087762|469652139|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
130460660|NCT01087762|469652140|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
130460661|NCT01087762|469652141|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
130460662|NCT01087762|469652142|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
130460663|NCT01087762|469652143|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
130460664|NCT01405924|469652146|FG000|Overall Study|Protocol Violation|8|||
130460665|NCT01405924|469652146|FG000|Overall Study|Missing/Incomplete Data|2|||
130460666|NCT03184558|469652147|FG000|Overall Study|Withdrawal by Subject|2|||
130460667|NCT03184558|469652147|FG000|Overall Study|Death|16|||
130460668|NCT03184558|469652147|FG000|Overall Study|Lost to Follow-up|2|||
130460669|NCT03184558|469652147|FG000|Overall Study|Other|9|||
130460670|NCT00395018|469652148|FG000|On-Treatment|Death|4|||
130460671|NCT00395018|469652148|FG000|On-Treatment|Other Reason|2|||
130460672|NCT00395018|469652148|FG000|On-Treatment|Poor/non-compliance|2|||
130460673|NCT00395018|469652148|FG000|On-Treatment|Subject no longer meets study criteria|2|||
130460674|NCT00395018|469652148|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
130460675|NCT00395018|469652148|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
130460676|NCT00395018|469652148|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
130460677|NCT01391130|469652150|FG000|Overall Study|Withdrawal by Subject|3|||
130460678|NCT01391130|469652151|FG001|Overall Study|Withdrawal by Subject|2|||
130460679|NCT01391130|469652150|FG000|Overall Study|Physician Decision|2|||
130460680|NCT01391130|469652151|FG001|Overall Study|Physician Decision|3|||
130460681|NCT01391130|469652150|FG000|Overall Study|Did not Receive Drug|1|||
130460682|NCT01391130|469652151|FG001|Overall Study|Did not Receive Drug|1|||
130460683|NCT03478696|469652152|FG000|Overall Study|Adverse Event|1|||
130460684|NCT03478696|469652153|FG001|Overall Study|Adverse Event|5|||
130460685|NCT03478696|469652152|FG000|Overall Study|Lost to Follow-up|1|||
130460686|NCT03478696|469652153|FG001|Overall Study|Lost to Follow-up|0|||
130460687|NCT03478696|469652152|FG000|Overall Study|Physician Decision|6|||
130460688|NCT03478696|469652153|FG001|Overall Study|Physician Decision|3|||
130460689|NCT03478696|469652152|FG000|Overall Study|Withdrawal by Subject|9|||
130715467|NCT02358343|470586929|FG001|Screening Intervention|Death|2|||
130715468|NCT02358343|470586930|FG002|Screening Intervention|Death|0|||
130715469|NCT02358343|470586931|FG003|Screening Intervention|Death|0|||
130715470|NCT02358343|470586932|FG004|Screening Intervention|Death|0|||
130715471|NCT02358343|470586928|FG000|Screening Intervention|Withdrawal by Subject|1|||
130715472|NCT02358343|470586929|FG001|Screening Intervention|Withdrawal by Subject|0|||
130715473|NCT02358343|470586930|FG002|Screening Intervention|Withdrawal by Subject|0|||
130715474|NCT02358343|470586931|FG003|Screening Intervention|Withdrawal by Subject|0|||
130715475|NCT02358343|470586932|FG004|Screening Intervention|Withdrawal by Subject|0|||
130715476|NCT02358343|470586928|FG000|Screening Intervention|Determined Ineligible|5|||
130715477|NCT02358343|470586929|FG001|Screening Intervention|Determined Ineligible|6|||
130715478|NCT02358343|470586930|FG002|Screening Intervention|Determined Ineligible|0|||
130715479|NCT02358343|470586931|FG003|Screening Intervention|Determined Ineligible|0|||
130715480|NCT02358343|470586932|FG004|Screening Intervention|Determined Ineligible|0|||
130715481|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Death|0|||
130715482|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Death|0|||
130460690|NCT03478696|469652153|FG001|Overall Study|Withdrawal by Subject|4|||
130460691|NCT03615924|469652154|FG000|Overall Study|Withdrawal by Subject|2|||
130460692|NCT03615924|469652155|FG001|Overall Study|Withdrawal by Subject|5|||
130715483|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Death|2|||
130715484|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Death|0|||
130715485|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Death|0|||
130715486|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
130460693|NCT03615924|469652154|FG000|Overall Study|Death|3|||
130460694|NCT03615924|469652155|FG001|Overall Study|Death|1|||
130295226|NCT01659255|469045275|FG014|Overall Study|Withdrew Consent|0|||
130295227|NCT01659255|469045276|FG015|Overall Study|Withdrew Consent|0|||
130295228|NCT01659255|469045277|FG016|Overall Study|Withdrew Consent|0|||
130295229|NCT01659255|469045261|FG000|Overall Study|Investigator Decision|0|||
130295230|NCT01659255|469045262|FG001|Overall Study|Investigator Decision|0|||
130295231|NCT01659255|469045263|FG002|Overall Study|Investigator Decision|0|||
130295232|NCT01659255|469045264|FG003|Overall Study|Investigator Decision|0|||
130295233|NCT01659255|469045265|FG004|Overall Study|Investigator Decision|0|||
130295234|NCT01659255|469045266|FG005|Overall Study|Investigator Decision|0|||
130295235|NCT01659255|469045267|FG006|Overall Study|Investigator Decision|0|||
130295236|NCT01659255|469045268|FG007|Overall Study|Investigator Decision|0|||
130295237|NCT01659255|469045269|FG008|Overall Study|Investigator Decision|0|||
130295238|NCT01659255|469045270|FG009|Overall Study|Investigator Decision|0|||
130295239|NCT01659255|469045271|FG010|Overall Study|Investigator Decision|0|||
130295240|NCT01659255|469045272|FG011|Overall Study|Investigator Decision|0|||
130295241|NCT01659255|469045273|FG012|Overall Study|Investigator Decision|1|||
130295242|NCT01659255|469045274|FG013|Overall Study|Investigator Decision|1|||
130295243|NCT01659255|469045275|FG014|Overall Study|Investigator Decision|0|||
130295244|NCT01659255|469045276|FG015|Overall Study|Investigator Decision|0|||
130295245|NCT01659255|469045277|FG016|Overall Study|Investigator Decision|0|||
130295246|NCT01659255|469045261|FG000|Overall Study|Sponsor's Decision|0|||
130295247|NCT01659255|469045262|FG001|Overall Study|Sponsor's Decision|0|||
130295248|NCT01659255|469045263|FG002|Overall Study|Sponsor's Decision|0|||
130295249|NCT01659255|469045264|FG003|Overall Study|Sponsor's Decision|0|||
130295250|NCT01659255|469045265|FG004|Overall Study|Sponsor's Decision|0|||
130295251|NCT01659255|469045266|FG005|Overall Study|Sponsor's Decision|0|||
130295252|NCT01659255|469045267|FG006|Overall Study|Sponsor's Decision|1|||
130460695|NCT03615924|469652154|FG000|Overall Study|Lost to Follow-up|1|||
130295253|NCT01659255|469045268|FG007|Overall Study|Sponsor's Decision|0|||
130295254|NCT01659255|469045269|FG008|Overall Study|Sponsor's Decision|0|||
130295255|NCT01659255|469045270|FG009|Overall Study|Sponsor's Decision|0|||
130295256|NCT01659255|469045271|FG010|Overall Study|Sponsor's Decision|0|||
130295257|NCT01659255|469045272|FG011|Overall Study|Sponsor's Decision|0|||
130295258|NCT01659255|469045273|FG012|Overall Study|Sponsor's Decision|0|||
130295259|NCT01659255|469045274|FG013|Overall Study|Sponsor's Decision|0|||
130295260|NCT01659255|469045275|FG014|Overall Study|Sponsor's Decision|0|||
130295261|NCT01659255|469045276|FG015|Overall Study|Sponsor's Decision|0|||
130295262|NCT01659255|469045277|FG016|Overall Study|Sponsor's Decision|0|||
130295263|NCT01659255|469045261|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295264|NCT01659255|469045262|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295265|NCT01659255|469045263|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295266|NCT01659255|469045264|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295267|NCT01659255|469045265|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295268|NCT01659255|469045266|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295269|NCT01659255|469045267|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295270|NCT01659255|469045268|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295271|NCT01659255|469045269|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295272|NCT01659255|469045270|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295273|NCT01659255|469045271|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295274|NCT01659255|469045272|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295275|NCT01659255|469045273|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295276|NCT01659255|469045274|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295277|NCT01659255|469045275|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295278|NCT01659255|469045276|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
130295279|NCT01659255|469045277|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295280|NCT01659255|469045261|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
130295281|NCT01659255|469045262|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
130295282|NCT01659255|469045263|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
130295283|NCT01659255|469045264|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
130295284|NCT01659255|469045265|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
130295285|NCT01659255|469045266|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
130295286|NCT01659255|469045267|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
130295287|NCT01659255|469045268|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
130295288|NCT01659255|469045269|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
130295289|NCT01659255|469045270|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
130295290|NCT01659255|469045271|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
130295291|NCT01659255|469045272|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
130295292|NCT01659255|469045273|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
130295293|NCT01659255|469045274|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
130295294|NCT01659255|469045275|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
130295295|NCT01659255|469045276|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
130295296|NCT01659255|469045277|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
130295297|NCT01116427|469045278|FG000|Core Phase|Adverse Event|0|||
130295298|NCT01116427|469045279|FG001|Core Phase|Adverse Event|1|||
130295299|NCT01116427|469045278|FG000|Core Phase|Lost to Follow-up|1|||
130460696|NCT03615924|469652155|FG001|Overall Study|Lost to Follow-up|0|||
130460697|NCT03615924|469652154|FG000|Overall Study|Randomized in error|1|||
130460698|NCT03615924|469652155|FG001|Overall Study|Randomized in error|0|||
130460699|NCT03615924|469652154|FG000|Overall Study|Study termination by Sponsor|94|||
130460700|NCT03615924|469652155|FG001|Overall Study|Study termination by Sponsor|86|||
130460701|NCT00880048|469652163|FG000|Overall Study|Adverse Event|2|||
130460702|NCT00880048|469652164|FG001|Overall Study|Adverse Event|3|||
130460703|NCT00880048|469652165|FG002|Overall Study|Adverse Event|5|||
130460704|NCT00880048|469652163|FG000|Overall Study|Lack of Efficacy|1|||
130460705|NCT00880048|469652164|FG001|Overall Study|Lack of Efficacy|2|||
130460706|NCT00880048|469652165|FG002|Overall Study|Lack of Efficacy|2|||
130460707|NCT00880048|469652163|FG000|Overall Study|Protocol Violation|4|||
130460708|NCT00880048|469652164|FG001|Overall Study|Protocol Violation|6|||
130460709|NCT00880048|469652165|FG002|Overall Study|Protocol Violation|5|||
130715487|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
130715488|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715489|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715490|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715491|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715492|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715493|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
130715494|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715495|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715496|NCT00090610|470586935|FG000|Overall Study|Withdrawal by Subject|1|||
130715497|NCT00090610|470586936|FG001|Overall Study|Withdrawal by Subject|1|||
130715498|NCT00807248|470586937|FG000|Overall Study|Adverse Event|1|||
130715499|NCT00807248|470586938|FG001|Overall Study|Adverse Event|2|||
130715500|NCT00807248|470586939|FG002|Overall Study|Adverse Event|2|||
130715501|NCT00807248|470586940|FG003|Overall Study|Adverse Event|6|||
130715502|NCT00807248|470586937|FG000|Overall Study|Lack of Efficacy|14|||
130715503|NCT00807248|470586938|FG001|Overall Study|Lack of Efficacy|4|||
130715504|NCT00807248|470586939|FG002|Overall Study|Lack of Efficacy|8|||
130715505|NCT00807248|470586940|FG003|Overall Study|Lack of Efficacy|3|||
130715506|NCT00807248|470586937|FG000|Overall Study|Protocol Violation|0|||
130715507|NCT00807248|470586938|FG001|Overall Study|Protocol Violation|1|||
130715508|NCT00807248|470586939|FG002|Overall Study|Protocol Violation|1|||
130715509|NCT00807248|470586940|FG003|Overall Study|Protocol Violation|0|||
130715510|NCT00807248|470586937|FG000|Overall Study|Withdrawal of Consent|5|||
130715511|NCT00807248|470586938|FG001|Overall Study|Withdrawal of Consent|5|||
130715512|NCT00807248|470586939|FG002|Overall Study|Withdrawal of Consent|5|||
130715513|NCT00807248|470586940|FG003|Overall Study|Withdrawal of Consent|5|||
130715514|NCT00807248|470586937|FG000|Overall Study|Lost to Follow-up|1|||
130715515|NCT00807248|470586938|FG001|Overall Study|Lost to Follow-up|0|||
130715516|NCT00807248|470586939|FG002|Overall Study|Lost to Follow-up|0|||
130715517|NCT00807248|470586940|FG003|Overall Study|Lost to Follow-up|0|||
130715518|NCT00807248|470586937|FG000|Overall Study|Other Reason|0|||
130715519|NCT00807248|470586938|FG001|Overall Study|Other Reason|0|||
130715520|NCT00807248|470586939|FG002|Overall Study|Other Reason|2|||
130715521|NCT00807248|470586940|FG003|Overall Study|Other Reason|0|||
130715522|NCT02444793|470586941|FG000|Overall Study|Lost to Follow-up|2|||
130715523|NCT02444793|470586942|FG001|Overall Study|Lost to Follow-up|2|||
130715524|NCT02444793|470586943|FG002|Overall Study|Lost to Follow-up|0|||
130715525|NCT02444793|470586944|FG003|Overall Study|Lost to Follow-up|0|||
130715526|NCT02444793|470586941|FG000|Overall Study|Death|0|||
130715527|NCT02444793|470586942|FG001|Overall Study|Death|3|||
130295300|NCT01116427|469045279|FG001|Core Phase|Lost to Follow-up|0|||
130715528|NCT02444793|470586943|FG002|Overall Study|Death|0|||
130715529|NCT02444793|470586944|FG003|Overall Study|Death|0|||
130715530|NCT02444793|470586941|FG000|Overall Study|Other|0|||
130715531|NCT02444793|470586942|FG001|Overall Study|Other|0|||
130715532|NCT02444793|470586943|FG002|Overall Study|Other|2|||
130715533|NCT02444793|470586944|FG003|Overall Study|Other|0|||
130715534|NCT02444793|470586941|FG000|Overall Study|Objective progression or relapse|9|||
130715535|NCT02444793|470586942|FG001|Overall Study|Objective progression or relapse|1|||
130715536|NCT02444793|470586943|FG002|Overall Study|Objective progression or relapse|2|||
130715537|NCT02444793|470586944|FG003|Overall Study|Objective progression or relapse|3|||
130295301|NCT01116427|469045278|FG000|Core Phase|Withdrawal by Subject|3|||
130295302|NCT01116427|469045279|FG001|Core Phase|Withdrawal by Subject|0|||
130460710|NCT00880048|469652163|FG000|Overall Study|Lost to Follow-up|6|||
130460711|NCT00880048|469652164|FG001|Overall Study|Lost to Follow-up|6|||
130715538|NCT00210249|470586946|FG000|Overall Study|Lost to Follow-up|5|||
130715539|NCT00210249|470586946|FG000|Overall Study|Protocol Violation|11|||
130295303|NCT01116427|469045278|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
130295304|NCT01116427|469045279|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
130295305|NCT01116427|469045278|FG000|Extension Phase|Adverse Event|1|||
130295306|NCT01116427|469045279|FG001|Extension Phase|Adverse Event|1|||
130295307|NCT01116427|469045278|FG000|Extension Phase|Lost to Follow-up|2|||
130295308|NCT01116427|469045279|FG001|Extension Phase|Lost to Follow-up|0|||
130295309|NCT01116427|469045278|FG000|Extension Phase|Withdrawal by Subject|5|||
130295310|NCT01116427|469045279|FG001|Extension Phase|Withdrawal by Subject|1|||
130295311|NCT01116427|469045278|FG000|Extension Phase|Not using appropriate birth control|1|||
130295312|NCT01116427|469045279|FG001|Extension Phase|Not using appropriate birth control|0|||
130295313|NCT02989805|469045282|FG000|Overall Study|invalid consent|6|||
130372202|NCT00299104|469333298|FG002|Treatment Period|Death|1|||
130372203|NCT00299104|469333296|FG000|Treatment Period|Insufficient therapeutic response|34|||
130295314|NCT02989805|469045283|FG001|Overall Study|invalid consent|4|||
130372204|NCT00299104|469333297|FG001|Treatment Period|Insufficient therapeutic response|13|||
130372205|NCT00299104|469333298|FG002|Treatment Period|Insufficient therapeutic response|8|||
130372206|NCT00299104|469333296|FG000|Treatment Period|Failure to return|9|||
130372207|NCT00299104|469333297|FG001|Treatment Period|Failure to return|8|||
130372208|NCT00299104|469333298|FG002|Treatment Period|Failure to return|8|||
130372209|NCT00299104|469333296|FG000|Treatment Period|Violation of selection criteria|1|||
130372210|NCT00299104|469333297|FG001|Treatment Period|Violation of selection criteria|2|||
130372211|NCT00299104|469333298|FG002|Treatment Period|Violation of selection criteria|0|||
130372212|NCT00299104|469333296|FG000|Treatment Period|Protocol Violation|1|||
130372213|NCT00299104|469333297|FG001|Treatment Period|Protocol Violation|1|||
130372214|NCT00299104|469333298|FG002|Treatment Period|Protocol Violation|0|||
130372215|NCT00299104|469333296|FG000|Treatment Period|Refused treatment|9|||
130372216|NCT00299104|469333297|FG001|Treatment Period|Refused treatment|2|||
130372217|NCT00299104|469333298|FG002|Treatment Period|Refused treatment|2|||
130372218|NCT00299104|469333296|FG000|Treatment Period|Withdrew consent|14|||
130372219|NCT00299104|469333297|FG001|Treatment Period|Withdrew consent|19|||
130715540|NCT04498403|470586947|FG000|Overall Study|Adverse Event|1|||
130715541|NCT04498403|470586948|FG001|Overall Study|Adverse Event|0|||
130715542|NCT04498403|470586947|FG000|Overall Study|Study Terminated By Sponsor|29|||
130715543|NCT04498403|470586948|FG001|Overall Study|Study Terminated By Sponsor|10|||
130715544|NCT00599521|470586949|FG000|Overall Study|Lack of Efficacy|4|||
130715545|NCT00599521|470586950|FG001|Overall Study|Lack of Efficacy|8|||
130372220|NCT00299104|469333298|FG002|Treatment Period|Withdrew consent|9|||
130372221|NCT00299104|469333296|FG000|Treatment Period|Administrative reasons|106|||
130372222|NCT00299104|469333297|FG001|Treatment Period|Administrative reasons|120|||
130372223|NCT00299104|469333298|FG002|Treatment Period|Administrative reasons|137|||
130372224|NCT00299104|469333296|FG000|Safety Follow-Up (SFU) Period|Death|3|||
130372225|NCT00299104|469333297|FG001|Safety Follow-Up (SFU) Period|Death|2|||
130372226|NCT00299104|469333298|FG002|Safety Follow-Up (SFU) Period|Death|1|||
130372227|NCT00299104|469333296|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
130372228|NCT00299104|469333297|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
130372229|NCT00299104|469333298|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
130715546|NCT00599521|470586949|FG000|Overall Study|Adverse Event|4|||
130715547|NCT00599521|470586950|FG001|Overall Study|Adverse Event|1|||
130715548|NCT00599521|470586949|FG000|Overall Study|Withdrawal by Subject|28|||
130715549|NCT00599521|470586950|FG001|Overall Study|Withdrawal by Subject|34|||
130715550|NCT00599521|470586949|FG000|Overall Study|Protocol Violation|1|||
130715551|NCT00599521|470586950|FG001|Overall Study|Protocol Violation|1|||
130715552|NCT00599521|470586949|FG000|Overall Study|Lost to Follow-up|23|||
130715553|NCT00599521|470586950|FG001|Overall Study|Lost to Follow-up|23|||
130715554|NCT00599521|470586949|FG000|Overall Study|Pregnancy|0|||
130715555|NCT00599521|470586950|FG001|Overall Study|Pregnancy|2|||
130715556|NCT01700049|470586952|FG000|Overall Study|Withdrawal by Subject|1|||
130715557|NCT01248013|470586953|FG000|Overall Study|Withdrawal by Subject|14|||
130715558|NCT00307034|470586954|FG000|Overall Study|Adverse Event|1|||
130715559|NCT00307034|470586955|FG001|Overall Study|Adverse Event|2|||
130715560|NCT00307034|470586954|FG000|Overall Study|Withdrawal by Subject|1|||
130715561|NCT00307034|470586955|FG001|Overall Study|Withdrawal by Subject|2|||
130715562|NCT00307034|470586954|FG000|Overall Study|Lost to Follow-up|0|||
130715563|NCT00307034|470586955|FG001|Overall Study|Lost to Follow-up|3|||
130715564|NCT04594707|470586956|FG000|Overall Study|Adverse Event|0|||
130372230|NCT00299104|469333296|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
130715565|NCT04594707|470586957|FG001|Overall Study|Adverse Event|0|||
130295315|NCT02211313|469045284|FG000|Overall Study|Treatment Failure|5|||
130715566|NCT04594707|470586958|FG002|Overall Study|Adverse Event|1|||
130715567|NCT04594707|470586956|FG000|Overall Study|Death|0|||
130715568|NCT04594707|470586957|FG001|Overall Study|Death|2|||
130715569|NCT04594707|470586958|FG002|Overall Study|Death|2|||
130715570|NCT04594707|470586956|FG000|Overall Study|Lung Transplant|0|||
130715571|NCT04594707|470586957|FG001|Overall Study|Lung Transplant|0|||
130295316|NCT02211313|469045285|FG001|Overall Study|Treatment Failure|2|||
130295317|NCT02211313|469045284|FG000|Overall Study|No Follow up Questionnaires|1|||
130295318|NCT02211313|469045285|FG001|Overall Study|No Follow up Questionnaires|1|||
130295319|NCT03743064|469045286|FG000|Overall Study|Adverse Event|7|||
130295320|NCT03743064|469045287|FG001|Overall Study|Adverse Event|9|||
130295321|NCT03743064|469045286|FG000|Overall Study|Death|25|||
130295322|NCT03743064|469045287|FG001|Overall Study|Death|28|||
130295323|NCT03743064|469045286|FG000|Overall Study|Lost to Follow-up|3|||
130295324|NCT03743064|469045287|FG001|Overall Study|Lost to Follow-up|6|||
130295325|NCT03743064|469045286|FG000|Overall Study|Withdrawal by Subject|28|||
130295326|NCT03743064|469045287|FG001|Overall Study|Withdrawal by Subject|25|||
130295327|NCT03743064|469045286|FG000|Overall Study|Physician Decision|2|||
130295328|NCT03743064|469045287|FG001|Overall Study|Physician Decision|4|||
130295329|NCT03743064|469045286|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130715572|NCT04594707|470586958|FG002|Overall Study|Lung Transplant|1|||
130715573|NCT04594707|470586956|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
130715574|NCT04594707|470586957|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130715575|NCT04594707|470586958|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130715576|NCT04594707|470586956|FG000|Overall Study|Study Terminated By Sponsor|19|||
130715577|NCT04594707|470586957|FG001|Overall Study|Study Terminated By Sponsor|47|||
130715578|NCT04594707|470586958|FG002|Overall Study|Study Terminated By Sponsor|41|||
130715579|NCT04594707|470586956|FG000|Overall Study|Withdrawal by Subject|1|||
130295330|NCT03743064|469045287|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
130295331|NCT02771626|469045288|FG000|Overall Study|Adverse Event|1|||
130295332|NCT02771626|469045289|FG001|Overall Study|Adverse Event|5|||
130295333|NCT02771626|469045290|FG002|Overall Study|Adverse Event|3|||
130295334|NCT02771626|469045291|FG003|Overall Study|Adverse Event|0|||
130295335|NCT02771626|469045292|FG004|Overall Study|Adverse Event|1|||
130715580|NCT04594707|470586957|FG001|Overall Study|Withdrawal by Subject|0|||
130295336|NCT02771626|469045293|FG005|Overall Study|Adverse Event|1|||
130295337|NCT02771626|469045288|FG000|Overall Study|Radiologic Disease Progression|6|||
130295338|NCT02771626|469045289|FG001|Overall Study|Radiologic Disease Progression|13|||
130295339|NCT02771626|469045290|FG002|Overall Study|Radiologic Disease Progression|10|||
130295340|NCT02771626|469045291|FG003|Overall Study|Radiologic Disease Progression|7|||
130295341|NCT02771626|469045292|FG004|Overall Study|Radiologic Disease Progression|28|||
130295342|NCT02771626|469045293|FG005|Overall Study|Radiologic Disease Progression|15|||
130295343|NCT02771626|469045288|FG000|Overall Study|Symptomatic Deterioration|0|||
130295344|NCT02771626|469045289|FG001|Overall Study|Symptomatic Deterioration|4|||
130295345|NCT02771626|469045290|FG002|Overall Study|Symptomatic Deterioration|2|||
130295346|NCT02771626|469045291|FG003|Overall Study|Symptomatic Deterioration|0|||
130295347|NCT02771626|469045292|FG004|Overall Study|Symptomatic Deterioration|5|||
130295348|NCT02771626|469045293|FG005|Overall Study|Symptomatic Deterioration|2|||
130295349|NCT02771626|469045288|FG000|Overall Study|Participant Request|0|||
130295350|NCT02771626|469045289|FG001|Overall Study|Participant Request|1|||
130295351|NCT02771626|469045290|FG002|Overall Study|Participant Request|0|||
130295352|NCT02771626|469045291|FG003|Overall Study|Participant Request|2|||
130295353|NCT02771626|469045292|FG004|Overall Study|Participant Request|0|||
130295354|NCT02771626|469045293|FG005|Overall Study|Participant Request|1|||
130295355|NCT02771626|469045288|FG000|Overall Study|Investigator Decision|0|||
130295356|NCT02771626|469045289|FG001|Overall Study|Investigator Decision|1|||
130295357|NCT02771626|469045290|FG002|Overall Study|Investigator Decision|0|||
130295358|NCT02771626|469045291|FG003|Overall Study|Investigator Decision|0|||
130295359|NCT02771626|469045292|FG004|Overall Study|Investigator Decision|1|||
130295360|NCT02771626|469045293|FG005|Overall Study|Investigator Decision|0|||
130295361|NCT02771626|469045288|FG000|Overall Study|Study Termination by Sponsor|0|||
130295362|NCT02771626|469045289|FG001|Overall Study|Study Termination by Sponsor|2|||
130295363|NCT02771626|469045290|FG002|Overall Study|Study Termination by Sponsor|1|||
130295364|NCT02771626|469045291|FG003|Overall Study|Study Termination by Sponsor|0|||
130295365|NCT02771626|469045292|FG004|Overall Study|Study Termination by Sponsor|1|||
130295366|NCT02771626|469045293|FG005|Overall Study|Study Termination by Sponsor|0|||
130295367|NCT02771626|469045288|FG000|Overall Study|Informed Consent Withdrawn|0|||
130295368|NCT02771626|469045289|FG001|Overall Study|Informed Consent Withdrawn|0|||
130295369|NCT02771626|469045290|FG002|Overall Study|Informed Consent Withdrawn|1|||
130295370|NCT02771626|469045291|FG003|Overall Study|Informed Consent Withdrawn|0|||
130295371|NCT02771626|469045292|FG004|Overall Study|Informed Consent Withdrawn|1|||
130295372|NCT02771626|469045293|FG005|Overall Study|Informed Consent Withdrawn|1|||
130295373|NCT02771626|469045288|FG000|Overall Study|Other, Not Specified|1|||
130295374|NCT02771626|469045289|FG001|Overall Study|Other, Not Specified|0|||
130295375|NCT02771626|469045290|FG002|Overall Study|Other, Not Specified|0|||
130295376|NCT02771626|469045291|FG003|Overall Study|Other, Not Specified|0|||
130295377|NCT02771626|469045292|FG004|Overall Study|Other, Not Specified|0|||
130295378|NCT02771626|469045293|FG005|Overall Study|Other, Not Specified|1|||
130295379|NCT02648217|469045294|FG000|Overall Study|Adverse Event|0|||
130295380|NCT02648217|469045295|FG001|Overall Study|Adverse Event|1|||
130295381|NCT02648217|469045294|FG000|Overall Study|Lost to Follow-up|1|||
130295382|NCT02648217|469045295|FG001|Overall Study|Lost to Follow-up|1|||
130295383|NCT02648217|469045294|FG000|Overall Study|Withdrawal by Subject|4|||
130295384|NCT02648217|469045295|FG001|Overall Study|Withdrawal by Subject|3|||
130295385|NCT02648217|469045294|FG000|Overall Study|Unclassified|5|||
130295386|NCT02648217|469045295|FG001|Overall Study|Unclassified|0|||
130295387|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
130295388|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
130295389|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
130295390|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
130295391|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
130295392|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130295393|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
130295394|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130295395|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130295396|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
130372231|NCT00299104|469333297|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
130557051|NCT01493557|470009852|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
130557052|NCT01493557|470009853|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
130557053|NCT01493557|470009854|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
130295397|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
130372232|NCT00299104|469333298|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
130295398|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130295399|NCT02335424|469045300|FG000|Overall Study|Withdrawal by Subject|19|||
130372233|NCT00299104|469333296|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
130557054|NCT01493557|470009852|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
130557055|NCT01493557|470009853|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
130557056|NCT01493557|470009854|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
130557057|NCT01493557|470009852|FG000|Randomized to Management Strategies|Other adverse event|8|||
130557058|NCT01493557|470009853|FG001|Randomized to Management Strategies|Other adverse event|5|||
130557059|NCT01493557|470009854|FG002|Randomized to Management Strategies|Other adverse event|0|||
130557060|NCT01493557|470009852|FG000|Randomized to Management Strategies|Protocol Violation|3|||
130557061|NCT01493557|470009853|FG001|Randomized to Management Strategies|Protocol Violation|0|||
130557062|NCT01493557|470009854|FG002|Randomized to Management Strategies|Protocol Violation|0|||
130557063|NCT01493557|470009852|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
130557064|NCT01493557|470009853|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
130557065|NCT01493557|470009854|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
130557066|NCT01493557|470009852|FG000|Randomized to Management Strategies|Other than stated above|1|||
130557067|NCT01493557|470009853|FG001|Randomized to Management Strategies|Other than stated above|3|||
130557068|NCT01493557|470009854|FG002|Randomized to Management Strategies|Other than stated above|0|||
130557069|NCT01493557|470009852|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
130557070|NCT01493557|470009853|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
130557071|NCT01493557|470009854|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
130557072|NCT01493557|470009852|FG000|Adding the Second Strategy|Other adverse event|1|||
130557073|NCT01493557|470009853|FG001|Adding the Second Strategy|Other adverse event|2|||
130557074|NCT01493557|470009854|FG002|Adding the Second Strategy|Other adverse event|0|||
130557075|NCT01493557|470009852|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
130557076|NCT01493557|470009853|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
130557077|NCT01493557|470009854|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
130557078|NCT01890148|470009867|FG000|Overall Study|Adverse Event|1|||
130557079|NCT01678209|470009868|FG000|Overall Study|could not scan twice|1|||
130557080|NCT01678209|470009869|FG001|Overall Study|could not scan twice|1|||
130557081|NCT01678209|470009870|FG002|Overall Study|could not scan twice|1|||
130557082|NCT01678209|470009868|FG000|Overall Study|scheduling conflicts|0|||
130557083|NCT01678209|470009869|FG001|Overall Study|scheduling conflicts|0|||
130557084|NCT01678209|470009870|FG002|Overall Study|scheduling conflicts|1|||
130557085|NCT01678209|470009868|FG000|Overall Study|screen fail|16|||
130557086|NCT01678209|470009869|FG001|Overall Study|screen fail|17|||
130557087|NCT01678209|470009870|FG002|Overall Study|screen fail|16|||
130557088|NCT00702845|470009871|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
130557089|NCT00702845|470009872|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
130557090|NCT00702845|470009871|FG000|Overall Study|Too high ovarian response|5|||
130557091|NCT00702845|470009872|FG001|Overall Study|Too high ovarian response|1|||
130557092|NCT00702845|470009871|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
130557093|NCT00702845|470009872|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
130715581|NCT04594707|470586958|FG002|Overall Study|Withdrawal by Subject|2|||
130715582|NCT01593696|470586959|FG000|Dose Escalation|Progressive Disease|2|||
130715583|NCT01593696|470586960|FG001|Dose Escalation|Progressive Disease|0|||
130715584|NCT01593696|470586961|FG002|Dose Escalation|Progressive Disease|0|||
130715585|NCT01593696|470586962|FG003|Dose Escalation|Progressive Disease|0|||
130715586|NCT01593696|470586959|FG000|Dose Expansion|Fungal infection|0|||
130715587|NCT01593696|470586960|FG001|Dose Expansion|Fungal infection|0|||
130715588|NCT01593696|470586961|FG002|Dose Expansion|Fungal infection|1|||
130715589|NCT01593696|470586962|FG003|Dose Expansion|Fungal infection|0|||
130715590|NCT01936623|470586963|FG000|Overall Study|Lost to Follow-up|0|||
130715591|NCT01936623|470586964|FG001|Overall Study|Lost to Follow-up|5|||
130715592|NCT01340768|470586965|FG000|Overall Study|Lost to Follow-up|10|||
130715593|NCT01340768|470586966|FG001|Overall Study|Lost to Follow-up|4|||
130715594|NCT01340768|470586965|FG000|Overall Study|Withdrawal by Subject|5|||
130715595|NCT01340768|470586966|FG001|Overall Study|Withdrawal by Subject|1|||
130715596|NCT01340768|470586965|FG000|Overall Study|Other|2|||
130715597|NCT01340768|470586966|FG001|Overall Study|Other|0|||
130715598|NCT03052959|470586971|FG000|Overall Study|Lost to Follow-up|4|||
130715599|NCT03052959|470586972|FG001|Overall Study|Lost to Follow-up|5|||
130715600|NCT00950963|470586973|FG000|Overall Study|Lost to Follow-up|29|||
130715601|NCT00950963|470586974|FG001|Overall Study|Lost to Follow-up|24|||
130715602|NCT00655876|470586975|FG000|Overall Study|Protocol Violation|9|||
130715603|NCT00655876|470586976|FG001|Overall Study|Protocol Violation|7|||
130715604|NCT01831765|470586977|FG000|Overall Study|Lack of Efficacy|1|||
130715605|NCT01831765|470586978|FG001|Overall Study|Lack of Efficacy|0|||
130715606|NCT01831765|470586979|FG002|Overall Study|Lack of Efficacy|0|||
130715607|NCT01831765|470586977|FG000|Overall Study|Other, sponsor withdrew subject|0|||
130715608|NCT01831765|470586978|FG001|Overall Study|Other, sponsor withdrew subject|1|||
130557094|NCT00702845|470009871|FG000|Overall Study|Insufficient ovarian response|1|||
130557095|NCT00702845|470009872|FG001|Overall Study|Insufficient ovarian response|0|||
130715609|NCT01831765|470586979|FG002|Overall Study|Other, sponsor withdrew subject|0|||
130715610|NCT01831765|470586977|FG000|Overall Study|Pregnancy|1|||
130715611|NCT01831765|470586978|FG001|Overall Study|Pregnancy|1|||
130295400|NCT02335424|469045300|FG000|Overall Study|Adverse Event|25|||
130295401|NCT02335424|469045300|FG000|Overall Study|Death|273|||
130295402|NCT02335424|469045300|FG000|Overall Study|Lost to Follow-up|3|||
130295403|NCT02335424|469045300|FG000|Overall Study|Physician Decision|13|||
130295404|NCT02335424|469045300|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
130295405|NCT02335424|469045300|FG000|Overall Study|Protocol Violation|1|||
130557096|NCT00702845|470009871|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
130715612|NCT01831765|470586979|FG002|Overall Study|Pregnancy|2|||
130715613|NCT01831765|470586977|FG000|Overall Study|Death|0|||
130715614|NCT01831765|470586978|FG001|Overall Study|Death|1|||
130715615|NCT01831765|470586979|FG002|Overall Study|Death|1|||
130715616|NCT01831765|470586977|FG000|Overall Study|Other, site closed|1|||
130715617|NCT01831765|470586978|FG001|Overall Study|Other, site closed|1|||
130715618|NCT01831765|470586979|FG002|Overall Study|Other, site closed|0|||
130715619|NCT01831765|470586977|FG000|Overall Study|Adverse Event|5|||
130715620|NCT01831765|470586978|FG001|Overall Study|Adverse Event|3|||
130715621|NCT01831765|470586979|FG002|Overall Study|Adverse Event|3|||
130715622|NCT01831765|470586977|FG000|Overall Study|Withdrawal by Subject|22|||
130715623|NCT01831765|470586978|FG001|Overall Study|Withdrawal by Subject|7|||
130715624|NCT01831765|470586979|FG002|Overall Study|Withdrawal by Subject|17|||
130715625|NCT01831765|470586977|FG000|Overall Study|Withdrawal criteria|12|||
130715626|NCT01831765|470586978|FG001|Overall Study|Withdrawal criteria|10|||
130715627|NCT01831765|470586979|FG002|Overall Study|Withdrawal criteria|16|||
130715628|NCT01831765|470586977|FG000|Overall Study|Lost to Follow-up|2|||
130715629|NCT01831765|470586978|FG001|Overall Study|Lost to Follow-up|3|||
130715630|NCT01831765|470586979|FG002|Overall Study|Lost to Follow-up|3|||
130715631|NCT00859586|470586980|FG000|Overall Study|Donors|4|||
130715632|NCT00706511|470586981|FG000|Overall Study|Withdrawal by Subject|1|||
130715633|NCT00706511|470586982|FG001|Overall Study|Withdrawal by Subject|0|||
130715634|NCT00706511|470586983|FG002|Overall Study|Withdrawal by Subject|0|||
130715635|NCT00706511|470586984|FG003|Overall Study|Withdrawal by Subject|0|||
130715636|NCT01732484|470586987|FG000|Overall Study|Death|7|||
130715637|NCT01732484|470586987|FG000|Overall Study|Lost to Follow-up|14|||
130715638|NCT01732484|470586987|FG000|Overall Study|chronical illness|5|||
130715639|NCT01087489|470586988|FG000|Overall Study|enrolled in another VA study|0|||
130715640|NCT01087489|470586989|FG001|Overall Study|enrolled in another VA study|1|||
130715641|NCT01087489|470586988|FG000|Overall Study|Death|0|||
130715642|NCT01087489|470586989|FG001|Overall Study|Death|1|||
130715643|NCT01087489|470586988|FG000|Overall Study|unable to survey by telephone|0|||
130715644|NCT01087489|470586989|FG001|Overall Study|unable to survey by telephone|1|||
130715645|NCT00928707|470586990|FG000|Overall Study|Protocol Violation|1|||
130715646|NCT00928707|470586991|FG001|Overall Study|Protocol Violation|0|||
130715647|NCT00132028|470586992|FG000|Overall Study|Adverse Event|7|||
130715648|NCT00132028|470586992|FG000|Overall Study|Death|2|||
130715649|NCT00132028|470586992|FG000|Overall Study|Lack of Efficacy|11|||
130715650|NCT00132028|470586992|FG000|Overall Study|Withdrawal by Subject|2|||
130715651|NCT00132028|470586992|FG000|Overall Study|not eligible|2|||
130715652|NCT00132028|470586992|FG000|Overall Study|Physician Decision|3|||
130715653|NCT02731326|470586993|FG000|Overall Study|Withdrawal by Subject|4|||
130715654|NCT02731326|470586994|FG001|Overall Study|Withdrawal by Subject|1|||
130715655|NCT02731326|470586993|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
130715656|NCT02731326|470586994|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
130715657|NCT02731326|470586993|FG000|Overall Study|Discharged without AliveCor|10|||
130715658|NCT02731326|470586994|FG001|Overall Study|Discharged without AliveCor|0|||
130715659|NCT02731326|470586993|FG000|Overall Study|Duplicate Participant|1|||
130715660|NCT02731326|470586994|FG001|Overall Study|Duplicate Participant|1|||
130715661|NCT02272634|470586996|FG000|Overall Study|Adverse Event|1|||
130715662|NCT02272634|470586997|FG001|Overall Study|Adverse Event|0|||
130715663|NCT02272634|470586998|FG002|Overall Study|Adverse Event|0|||
130295406|NCT02335424|469045300|FG000|Overall Study|Screen failure|1|||
130295407|NCT02776033|469045303|FG000|Overall Study|Withdrawal by Subject|0|||
130715664|NCT02272634|470586996|FG000|Overall Study|Protocol Violation|0|||
130295408|NCT02776033|469045304|FG001|Overall Study|Withdrawal by Subject|0|||
130295409|NCT02776033|469045305|FG002|Overall Study|Withdrawal by Subject|2|||
130295410|NCT02776033|469045303|FG000|Overall Study|Physician Decision|2|||
130295411|NCT02776033|469045304|FG001|Overall Study|Physician Decision|0|||
130295412|NCT02776033|469045305|FG002|Overall Study|Physician Decision|0|||
130295413|NCT02776033|469045303|FG000|Overall Study|Lost to Follow-up|1|||
130295414|NCT02776033|469045304|FG001|Overall Study|Lost to Follow-up|0|||
130295415|NCT02776033|469045305|FG002|Overall Study|Lost to Follow-up|0|||
130295416|NCT02776033|469045303|FG000|Overall Study|Adverse Event|1|||
130295417|NCT02776033|469045304|FG001|Overall Study|Adverse Event|2|||
130295418|NCT02776033|469045305|FG002|Overall Study|Adverse Event|0|||
130295419|NCT02712424|469045306|FG000|Overall Study|Lost to Follow-up|34|||
130295420|NCT02712424|469045307|FG001|Overall Study|Lost to Follow-up|32|||
130295421|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
130295422|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130295423|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130295424|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
130295425|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130295426|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130295427|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
130295428|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130295429|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130295430|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
130295431|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130295432|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130295433|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
130295434|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130295435|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130295436|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
130295437|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130295438|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130295439|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
130295440|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
130295441|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
130295442|NCT01302054|469045313|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
130295443|NCT01302054|469045314|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130295444|NCT01302054|469045315|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130295445|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130295446|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
130460712|NCT00880048|469652165|FG002|Overall Study|Lost to Follow-up|5|||
130460713|NCT00880048|469652163|FG000|Overall Study|Physician Decision|1|||
130715665|NCT02272634|470586997|FG001|Overall Study|Protocol Violation|0|||
130715666|NCT02272634|470586998|FG002|Overall Study|Protocol Violation|1|||
130715667|NCT02272634|470586996|FG000|Overall Study|Withdrawal by Subject|0|||
130295447|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
130295448|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130295449|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130295450|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130295451|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130295452|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
130295453|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
130295454|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130295455|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
130295456|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
130295457|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130295458|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
130295459|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
130295460|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130295461|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130295462|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
130295463|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Other|0|||
130295464|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Other|4|||
130295465|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Other|9|||
130295466|NCT02713867|469045316|FG000|Randomization|Other Reason|2|||
130295467|NCT02713867|469045317|FG001|Randomization|Other Reason|1|||
130295468|NCT02713867|469045316|FG000|Randomization|Participant Withdrew consent|0|||
130295469|NCT02713867|469045317|FG001|Randomization|Participant Withdrew consent|2|||
130295470|NCT02713867|469045316|FG000|Treatment Period|Other Reasons|22|||
130295471|NCT02713867|469045317|FG001|Treatment Period|Other Reasons|28|||
130295472|NCT02713867|469045316|FG000|Treatment Period|Administrative reason by sponsor|21|||
130295473|NCT02713867|469045317|FG001|Treatment Period|Administrative reason by sponsor|16|||
130295474|NCT02713867|469045316|FG000|Treatment Period|No longer meets study criteria|2|||
130295475|NCT02713867|469045317|FG001|Treatment Period|No longer meets study criteria|1|||
130295476|NCT02713867|469045316|FG000|Treatment Period|Poor/Non Compliance|1|||
130295477|NCT02713867|469045317|FG001|Treatment Period|Poor/Non Compliance|0|||
130295478|NCT02713867|469045316|FG000|Treatment Period|Maximum Clinical Benefit|5|||
130295479|NCT02713867|469045317|FG001|Treatment Period|Maximum Clinical Benefit|6|||
130295480|NCT02713867|469045316|FG000|Treatment Period|Withdrew consent|3|||
130460714|NCT00880048|469652164|FG001|Overall Study|Physician Decision|1|||
130460715|NCT00880048|469652165|FG002|Overall Study|Physician Decision|7|||
130460716|NCT00880048|469652163|FG000|Overall Study|Withdrawal by Subject|5|||
130460717|NCT00880048|469652164|FG001|Overall Study|Withdrawal by Subject|8|||
130460718|NCT00880048|469652165|FG002|Overall Study|Withdrawal by Subject|5|||
130460719|NCT00880048|469652163|FG000|Overall Study|Study closed/terminated|9|||
130460720|NCT00880048|469652164|FG001|Overall Study|Study closed/terminated|7|||
130460721|NCT00880048|469652165|FG002|Overall Study|Study closed/terminated|6|||
130460722|NCT02954848|469652170|FG000|Overall Study|Randomized but Not Treated|0|||
130460723|NCT02954848|469652171|FG001|Overall Study|Randomized but Not Treated|1|||
130460724|NCT02954848|469652170|FG000|Overall Study|Adverse Event|2|||
130460725|NCT02954848|469652171|FG001|Overall Study|Adverse Event|3|||
130460726|NCT02954848|469652170|FG000|Overall Study|Withdrawal by Participant|0|||
130460727|NCT02954848|469652171|FG001|Overall Study|Withdrawal by Participant|1|||
130460728|NCT01184508|469652173|FG000|Overall Study|Adverse Event|4|||
130460729|NCT01184508|469652174|FG001|Overall Study|Adverse Event|6|||
130460730|NCT01184508|469652173|FG000|Overall Study|Lack of Efficacy|1|||
130460731|NCT01184508|469652174|FG001|Overall Study|Lack of Efficacy|1|||
130460732|NCT01184508|469652173|FG000|Overall Study|Lost to Follow-up|1|||
130460733|NCT01184508|469652174|FG001|Overall Study|Lost to Follow-up|1|||
130460734|NCT01184508|469652173|FG000|Overall Study|Physician Decision|1|||
130715668|NCT02272634|470586997|FG001|Overall Study|Withdrawal by Subject|1|||
130715669|NCT02272634|470586998|FG002|Overall Study|Withdrawal by Subject|0|||
130715670|NCT04647721|470586999|FG000|Overall Study|Withdrawal by Subject|0|||
130715671|NCT04647721|470587000|FG001|Overall Study|Withdrawal by Subject|2|||
130295481|NCT02713867|469045317|FG001|Treatment Period|Withdrew consent|6|||
130295482|NCT02713867|469045316|FG000|Treatment Period|Requested to Discontinue|8|||
130295483|NCT02713867|469045317|FG001|Treatment Period|Requested to Discontinue|8|||
130295484|NCT02713867|469045316|FG000|Treatment Period|AE unrelated to Study Drug|11|||
130295485|NCT02713867|469045317|FG001|Treatment Period|AE unrelated to Study Drug|10|||
130295486|NCT02713867|469045316|FG000|Treatment Period|Death|7|||
130295487|NCT02713867|469045317|FG001|Treatment Period|Death|3|||
130295488|NCT02713867|469045316|FG000|Treatment Period|Study Drug Toxicity|16|||
130295489|NCT02713867|469045317|FG001|Treatment Period|Study Drug Toxicity|19|||
130295490|NCT02713867|469045316|FG000|Treatment Period|Disease Progression|82|||
130295491|NCT02713867|469045317|FG001|Treatment Period|Disease Progression|83|||
130460735|NCT01184508|469652174|FG001|Overall Study|Physician Decision|0|||
130460736|NCT01184508|469652173|FG000|Overall Study|Protocol Violation|3|||
130295492|NCT02715726|469045321|FG000|Overall Study|Adverse Event|2|||
130295493|NCT02715726|469045322|FG001|Overall Study|Adverse Event|6|||
130295494|NCT02715726|469045321|FG000|Overall Study|Protocol Violation|1|||
130295495|NCT02715726|469045322|FG001|Overall Study|Protocol Violation|0|||
130295496|NCT02715726|469045321|FG000|Overall Study|Death|2|||
130295497|NCT02715726|469045322|FG001|Overall Study|Death|1|||
130295498|NCT02715726|469045321|FG000|Overall Study|Participant moved|1|||
130295499|NCT02715726|469045322|FG001|Overall Study|Participant moved|3|||
130295500|NCT02715726|469045321|FG000|Overall Study|Other than specified above|11|||
130295501|NCT02715726|469045322|FG001|Overall Study|Other than specified above|15|||
130295502|NCT02715726|469045321|FG000|Overall Study|Randomized but not treated|1|||
130295503|NCT02715726|469045322|FG001|Overall Study|Randomized but not treated|2|||
130295504|NCT01177969|469045323|FG000|Overall Study|Protocol Violation|2|||
130295505|NCT01177969|469045324|FG001|Overall Study|Protocol Violation|1|||
130295506|NCT01177969|469045323|FG000|Overall Study|Withdrawal by Subject|1|||
130295507|NCT01177969|469045324|FG001|Overall Study|Withdrawal by Subject|2|||
130295508|NCT03230292|469045325|FG000|Overall Study|Adverse Event|1|||
130295509|NCT03230292|469045325|FG000|Overall Study|Protocol Violation|1|||
130295510|NCT03230292|469045325|FG000|Overall Study|Lost to Follow-up|1|||
130295511|NCT03230292|469045325|FG000|Overall Study|Withdrawal by Subject|3|||
130295512|NCT00635089|469045327|FG000|Overall Study|Adverse Event|7|||
130295513|NCT00635089|469045327|FG000|Overall Study|Lack of Efficacy|28|||
130295514|NCT00635089|469045327|FG000|Overall Study|Protocol Deviation|4|||
130295515|NCT00635089|469045327|FG000|Overall Study|Lost to Follow-up|8|||
130295516|NCT00635089|469045327|FG000|Overall Study|Other|31|||
130295517|NCT02565810|469045328|FG000|Overall Study|Withdrawal by Subject|1|||
130295518|NCT00491608|469045331|FG000|Overall Study|Death|2|||
130295519|NCT00491608|469045331|FG000|Overall Study|Withdrawal by Subject|1|||
130295520|NCT04109976|469045332|FG000|Overall Study|Withdrawal by Subject|1|||
130295521|NCT04109976|469045333|FG001|Overall Study|Withdrawal by Subject|0|||
130295522|NCT00413374|469045334|FG000|Overall Study|Ineligible due to screening criteria.|3|||
130295523|NCT00413374|469045335|FG001|Overall Study|Ineligible due to screening criteria.|0|||
130295524|NCT00413374|469045334|FG000|Overall Study|Adverse Event|1|||
130295525|NCT00413374|469045335|FG001|Overall Study|Adverse Event|0|||
130295526|NCT00413374|469045334|FG000|Overall Study|Lost to Follow-up|1|||
130295527|NCT00413374|469045335|FG001|Overall Study|Lost to Follow-up|0|||
130295528|NCT00413374|469045334|FG000|Overall Study|Surgery|1|||
130295529|NCT00413374|469045335|FG001|Overall Study|Surgery|0|||
130295530|NCT02613169|469045337|FG000|Overall Study|Withdrawal by Subject|4|||
130295531|NCT02613169|469045338|FG001|Overall Study|Withdrawal by Subject|1|||
130295532|NCT02613169|469045337|FG000|Overall Study|Lost to Follow-up|0|||
130295533|NCT02613169|469045338|FG001|Overall Study|Lost to Follow-up|5|||
130295534|NCT02613169|469045337|FG000|Overall Study|HIV|0|||
130295535|NCT02613169|469045338|FG001|Overall Study|HIV|2|||
130295536|NCT02613169|469045337|FG000|Overall Study|No TB infection endpoint|14|||
130295537|NCT02613169|469045338|FG001|Overall Study|No TB infection endpoint|9|||
130295538|NCT00343382|469045339|FG000|Overall Study|Adverse Event|2|||
130295539|NCT00343382|469045340|FG001|Overall Study|Adverse Event|10|||
130295540|NCT00343382|469045341|FG002|Overall Study|Adverse Event|7|||
130295541|NCT00343382|469045339|FG000|Overall Study|Withdrawal by Subject|1|||
130295542|NCT00343382|469045340|FG001|Overall Study|Withdrawal by Subject|2|||
130295543|NCT00343382|469045341|FG002|Overall Study|Withdrawal by Subject|6|||
130295544|NCT00343382|469045339|FG000|Overall Study|Other Reason Not Specified|1|||
130295545|NCT00343382|469045340|FG001|Overall Study|Other Reason Not Specified|2|||
130295546|NCT00343382|469045341|FG002|Overall Study|Other Reason Not Specified|4|||
130295547|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
130295548|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130295549|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130295550|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
130295551|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
130295552|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
130295553|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295554|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295555|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130372234|NCT00299104|469333297|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
130372235|NCT00299104|469333298|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
130372236|NCT00299104|469333296|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
130372237|NCT00299104|469333297|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
130372238|NCT00299104|469333298|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
130372239|NCT00299104|469333296|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130372240|NCT00299104|469333297|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130372241|NCT00299104|469333298|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130372242|NCT00299104|469333296|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
130372243|NCT00299104|469333297|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
130372244|NCT00299104|469333298|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
130295556|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295557|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295558|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
130295559|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
130295560|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
130557097|NCT00702845|470009872|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
130295561|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295562|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
130295563|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
130295564|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295565|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295566|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295567|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295568|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295569|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295570|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
130295571|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295572|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295573|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
130295574|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295575|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130460737|NCT01184508|469652174|FG001|Overall Study|Protocol Violation|1|||
130460738|NCT01184508|469652173|FG000|Overall Study|Sponsor Decision|5|||
130460739|NCT01184508|469652174|FG001|Overall Study|Sponsor Decision|2|||
130460740|NCT01184508|469652173|FG000|Overall Study|Withdrawal by Subject|1|||
130460741|NCT01184508|469652174|FG001|Overall Study|Withdrawal by Subject|3|||
130460742|NCT01184508|469652173|FG000|Overall Study|Randomized, Not Treated|0|||
130460743|NCT01184508|469652174|FG001|Overall Study|Randomized, Not Treated|1|||
130460744|NCT01317420|469652192|FG000|Overall Study|Progressive disease according to RECIST|2|||
130460745|NCT01317420|469652193|FG001|Overall Study|Progressive disease according to RECIST|3|||
130460746|NCT01317420|469652194|FG002|Overall Study|Progressive disease according to RECIST|3|||
130460747|NCT01317420|469652195|FG003|Overall Study|Progressive disease according to RECIST|3|||
130460748|NCT01317420|469652196|FG004|Overall Study|Progressive disease according to RECIST|3|||
130460749|NCT01317420|469652197|FG005|Overall Study|Progressive disease according to RECIST|3|||
130460750|NCT01317420|469652198|FG006|Overall Study|Progressive disease according to RECIST|3|||
130460751|NCT01317420|469652199|FG007|Overall Study|Progressive disease according to RECIST|3|||
130460752|NCT01317420|469652200|FG008|Overall Study|Progressive disease according to RECIST|3|||
130460753|NCT01317420|469652201|FG009|Overall Study|Progressive disease according to RECIST|2|||
130460754|NCT01317420|469652202|FG010|Overall Study|Progressive disease according to RECIST|3|||
130460755|NCT01317420|469652203|FG011|Overall Study|Progressive disease according to RECIST|11|||
130460756|NCT01317420|469652204|FG012|Overall Study|Progressive disease according to RECIST|16|||
130460757|NCT01317420|469652192|FG000|Overall Study|Other adverse event|1|||
130460758|NCT01317420|469652193|FG001|Overall Study|Other adverse event|0|||
130460759|NCT01317420|469652194|FG002|Overall Study|Other adverse event|0|||
130460760|NCT01317420|469652195|FG003|Overall Study|Other adverse event|0|||
130460761|NCT01317420|469652196|FG004|Overall Study|Other adverse event|0|||
130460762|NCT01317420|469652197|FG005|Overall Study|Other adverse event|0|||
130460763|NCT01317420|469652198|FG006|Overall Study|Other adverse event|0|||
130460764|NCT01317420|469652199|FG007|Overall Study|Other adverse event|0|||
130715672|NCT04647721|470586999|FG000|Overall Study|Lost to Follow-up|2|||
130715673|NCT04647721|470587000|FG001|Overall Study|Lost to Follow-up|0|||
130715674|NCT05070546|470587001|FG000|Overall Study|Death|0|||
130715675|NCT05070546|470587002|FG001|Overall Study|Death|0|||
130715676|NCT05070546|470587003|FG002|Overall Study|Death|0|||
130715677|NCT05070546|470587004|FG003|Overall Study|Death|0|||
130715678|NCT05070546|470587005|FG004|Overall Study|Death|0|||
130715679|NCT05070546|470587006|FG005|Overall Study|Death|1|||
130295576|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295577|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295578|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295579|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295580|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
130295581|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
130295582|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
130295583|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295584|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130715680|NCT05070546|470587001|FG000|Overall Study|Lost to Follow-up|8|||
130715681|NCT05070546|470587002|FG001|Overall Study|Lost to Follow-up|2|||
130715682|NCT05070546|470587003|FG002|Overall Study|Lost to Follow-up|7|||
130715683|NCT05070546|470587004|FG003|Overall Study|Lost to Follow-up|1|||
130295585|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130295586|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295587|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295588|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295589|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295590|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295591|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295592|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295593|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130295594|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295595|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295596|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130295597|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295598|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295599|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295600|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295601|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295602|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
130295603|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295604|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295605|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295606|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295607|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295608|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295609|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295610|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295611|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295612|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295613|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295614|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295615|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
130295616|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130715684|NCT05070546|470587005|FG004|Overall Study|Lost to Follow-up|2|||
130715685|NCT05070546|470587006|FG005|Overall Study|Lost to Follow-up|0|||
130715686|NCT05070546|470587001|FG000|Overall Study|Withdrawal by Subject|1|||
130715687|NCT05070546|470587002|FG001|Overall Study|Withdrawal by Subject|1|||
130715688|NCT05070546|470587003|FG002|Overall Study|Withdrawal by Subject|3|||
130715689|NCT05070546|470587004|FG003|Overall Study|Withdrawal by Subject|0|||
130715690|NCT05070546|470587005|FG004|Overall Study|Withdrawal by Subject|0|||
130715691|NCT05070546|470587006|FG005|Overall Study|Withdrawal by Subject|0|||
130715692|NCT05070546|470587001|FG000|Overall Study|Other|0|||
130715693|NCT05070546|470587002|FG001|Overall Study|Other|0|||
130715694|NCT05070546|470587003|FG002|Overall Study|Other|0|||
130715695|NCT05070546|470587004|FG003|Overall Study|Other|0|||
130715696|NCT05070546|470587005|FG004|Overall Study|Other|3|||
130715697|NCT05070546|470587006|FG005|Overall Study|Other|0|||
130715698|NCT05070546|470587001|FG000|Overall Study|Randomized but not vaccinated|1|||
130715699|NCT05070546|470587002|FG001|Overall Study|Randomized but not vaccinated|0|||
130715700|NCT05070546|470587003|FG002|Overall Study|Randomized but not vaccinated|1|||
130715701|NCT05070546|470587004|FG003|Overall Study|Randomized but not vaccinated|1|||
130715702|NCT05070546|470587005|FG004|Overall Study|Randomized but not vaccinated|3|||
130715703|NCT05070546|470587006|FG005|Overall Study|Randomized but not vaccinated|0|||
130715704|NCT00302081|470587007|FG000|Overall Study|Adverse Event|6|||
130715705|NCT00302081|470587008|FG001|Overall Study|Adverse Event|5|||
130715706|NCT00302081|470587009|FG002|Overall Study|Adverse Event|4|||
130715707|NCT00302081|470587007|FG000|Overall Study|Lost to Follow-up|21|||
130715708|NCT00302081|470587008|FG001|Overall Study|Lost to Follow-up|18|||
130715709|NCT00302081|470587009|FG002|Overall Study|Lost to Follow-up|28|||
130715710|NCT00302081|470587007|FG000|Overall Study|Withdrawal by Subject|8|||
130715711|NCT00302081|470587008|FG001|Overall Study|Withdrawal by Subject|12|||
130295617|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295618|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295619|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295620|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295621|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295622|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130715712|NCT00302081|470587009|FG002|Overall Study|Withdrawal by Subject|8|||
130715713|NCT00302081|470587007|FG000|Overall Study|Protocol Violation|5|||
130295623|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295624|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
130295625|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295626|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295627|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295628|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295629|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295630|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295631|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295632|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295633|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295634|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295635|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295636|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295637|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295638|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295639|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295640|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295641|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
130460765|NCT01317420|469652200|FG008|Overall Study|Other adverse event|0|||
130460766|NCT01317420|469652201|FG009|Overall Study|Other adverse event|0|||
130460767|NCT01317420|469652202|FG010|Overall Study|Other adverse event|0|||
130460768|NCT01317420|469652203|FG011|Overall Study|Other adverse event|0|||
130460769|NCT01317420|469652204|FG012|Overall Study|Other adverse event|2|||
130460770|NCT01317420|469652192|FG000|Overall Study|Non-compliant with protocol|0|||
130460771|NCT01317420|469652193|FG001|Overall Study|Non-compliant with protocol|0|||
130460772|NCT01317420|469652194|FG002|Overall Study|Non-compliant with protocol|0|||
130460773|NCT01317420|469652195|FG003|Overall Study|Non-compliant with protocol|0|||
130460774|NCT01317420|469652196|FG004|Overall Study|Non-compliant with protocol|0|||
130460775|NCT01317420|469652197|FG005|Overall Study|Non-compliant with protocol|0|||
130460776|NCT01317420|469652198|FG006|Overall Study|Non-compliant with protocol|0|||
130460777|NCT01317420|469652199|FG007|Overall Study|Non-compliant with protocol|0|||
130715714|NCT00302081|470587008|FG001|Overall Study|Protocol Violation|1|||
130715715|NCT00302081|470587009|FG002|Overall Study|Protocol Violation|2|||
130715716|NCT00302081|470587007|FG000|Overall Study|Lack of Efficacy|1|||
130715717|NCT00302081|470587008|FG001|Overall Study|Lack of Efficacy|0|||
130715718|NCT00302081|470587009|FG002|Overall Study|Lack of Efficacy|5|||
130715719|NCT00302081|470587007|FG000|Overall Study|Death|2|||
130715720|NCT00302081|470587008|FG001|Overall Study|Death|1|||
130715721|NCT00302081|470587009|FG002|Overall Study|Death|0|||
130715722|NCT00302081|470587007|FG000|Overall Study|Other|13|||
130715723|NCT00302081|470587008|FG001|Overall Study|Other|6|||
130295642|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
130295643|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
130295644|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
130295645|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
130295646|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295647|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295648|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295649|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295650|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295651|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295652|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
130295653|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130295654|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
130295655|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130295656|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
130372245|NCT00299104|469333296|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
130372246|NCT00299104|469333297|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
130372247|NCT00299104|469333298|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
130372248|NCT00847379|469333299|FG000|Overall Study|Study terminated by Sponsor|59|||
130372249|NCT00847379|469333300|FG001|Overall Study|Study terminated by Sponsor|57|||
130372250|NCT00847379|469333301|FG002|Overall Study|Study terminated by Sponsor|57|||
130372251|NCT00003499|469333302|FG000|Overall Study|Not evaluable|8|||
130372252|NCT02042183|469333303|FG000|Overall Study|Physician Decision|7|||
130372253|NCT02042183|469333304|FG001|Overall Study|Physician Decision|2|||
130460778|NCT01317420|469652200|FG008|Overall Study|Non-compliant with protocol|0|||
130460779|NCT01317420|469652201|FG009|Overall Study|Non-compliant with protocol|0|||
130715724|NCT00302081|470587009|FG002|Overall Study|Other|5|||
130460780|NCT01317420|469652202|FG010|Overall Study|Non-compliant with protocol|0|||
130460781|NCT01317420|469652203|FG011|Overall Study|Non-compliant with protocol|0|||
130460782|NCT01317420|469652204|FG012|Overall Study|Non-compliant with protocol|1|||
130460783|NCT01317420|469652192|FG000|Overall Study|Refused to cont. taking trial medication|0|||
130460784|NCT01317420|469652193|FG001|Overall Study|Refused to cont. taking trial medication|0|||
130460785|NCT01317420|469652194|FG002|Overall Study|Refused to cont. taking trial medication|0|||
130460786|NCT01317420|469652195|FG003|Overall Study|Refused to cont. taking trial medication|0|||
130460787|NCT01317420|469652196|FG004|Overall Study|Refused to cont. taking trial medication|0|||
130460788|NCT01317420|469652197|FG005|Overall Study|Refused to cont. taking trial medication|0|||
130460789|NCT01317420|469652198|FG006|Overall Study|Refused to cont. taking trial medication|0|||
130460790|NCT01317420|469652199|FG007|Overall Study|Refused to cont. taking trial medication|0|||
130460791|NCT01317420|469652200|FG008|Overall Study|Refused to cont. taking trial medication|0|||
130295657|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295658|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295659|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295660|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295661|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295662|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295663|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
130295664|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
130460792|NCT01317420|469652201|FG009|Overall Study|Refused to cont. taking trial medication|0|||
130460793|NCT01317420|469652202|FG010|Overall Study|Refused to cont. taking trial medication|0|||
130460794|NCT01317420|469652203|FG011|Overall Study|Refused to cont. taking trial medication|0|||
130460795|NCT01317420|469652204|FG012|Overall Study|Refused to cont. taking trial medication|1|||
130460796|NCT01317420|469652192|FG000|Overall Study|Reason other than those specified|0|||
130460797|NCT01317420|469652193|FG001|Overall Study|Reason other than those specified|0|||
130295665|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
130295666|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
130295667|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
130295668|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295669|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130460798|NCT01317420|469652194|FG002|Overall Study|Reason other than those specified|0|||
130460799|NCT01317420|469652195|FG003|Overall Study|Reason other than those specified|0|||
130460800|NCT01317420|469652196|FG004|Overall Study|Reason other than those specified|0|||
130557098|NCT00702845|470009871|FG000|Overall Study|No or abnormal fertilization|4|||
130557099|NCT00702845|470009872|FG001|Overall Study|No or abnormal fertilization|2|||
130295670|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295671|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295672|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295673|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295674|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130295675|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295676|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
130295677|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295678|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130295679|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295680|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295681|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295682|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295683|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130557100|NCT00702845|470009871|FG000|Overall Study|Patient's decision|2|||
130557101|NCT00702845|470009872|FG001|Overall Study|Patient's decision|1|||
130715725|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
130715726|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
130715727|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
130715728|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
130715729|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
130715730|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
130715731|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
130715732|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
130715733|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
130715734|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
130715735|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
130715736|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
130715737|NCT04771403|470587010|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
130295684|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295685|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130295686|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295687|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
130295688|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130295689|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
130460801|NCT01317420|469652197|FG005|Overall Study|Reason other than those specified|0|||
130460802|NCT01317420|469652198|FG006|Overall Study|Reason other than those specified|0|||
130460803|NCT01317420|469652199|FG007|Overall Study|Reason other than those specified|0|||
130460804|NCT01317420|469652200|FG008|Overall Study|Reason other than those specified|0|||
130460805|NCT01317420|469652201|FG009|Overall Study|Reason other than those specified|1|||
130460806|NCT01317420|469652202|FG010|Overall Study|Reason other than those specified|0|||
130460807|NCT01317420|469652203|FG011|Overall Study|Reason other than those specified|0|||
130460808|NCT01317420|469652204|FG012|Overall Study|Reason other than those specified|0|||
130460809|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
130460810|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
130460811|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
130460812|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
130460813|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
130460814|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
130460815|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
130460816|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
130460817|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
130460818|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
130460819|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
130460820|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
130460821|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
130460822|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
130460823|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
130460824|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460825|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460826|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
130295690|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295691|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295692|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295693|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295694|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295695|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295696|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
130295697|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295698|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
130295699|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130460827|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130372254|NCT02042183|469333303|FG000|Overall Study|Lack of Efficacy|4|||
130372255|NCT02042183|469333304|FG001|Overall Study|Lack of Efficacy|3|||
130372256|NCT02042183|469333303|FG000|Overall Study|Non-compliance with Study Drug|2|||
130372257|NCT02042183|469333304|FG001|Overall Study|Non-compliance with Study Drug|3|||
130372258|NCT02042183|469333303|FG000|Overall Study|Adverse Event|17|||
130372259|NCT02042183|469333304|FG001|Overall Study|Adverse Event|6|||
130372260|NCT02042183|469333303|FG000|Overall Study|Other|3|||
130372261|NCT02042183|469333304|FG001|Overall Study|Other|3|||
130372262|NCT02042183|469333303|FG000|Overall Study|Withdrawal by Subject|21|||
130372263|NCT02042183|469333304|FG001|Overall Study|Withdrawal by Subject|16|||
130372264|NCT02042183|469333303|FG000|Overall Study|Site Terminated by Sponsor|2|||
130372265|NCT02042183|469333304|FG001|Overall Study|Site Terminated by Sponsor|1|||
130372266|NCT02042183|469333303|FG000|Overall Study|Lost to Follow-up|9|||
130372267|NCT02042183|469333304|FG001|Overall Study|Lost to Follow-up|2|||
130372268|NCT01727297|469333305|FG000|Overall Study|Death|13|||
130372269|NCT01727297|469333306|FG001|Overall Study|Death|0|||
130372270|NCT01727297|469333305|FG000|Overall Study|Protocol Violation|1|||
130372271|NCT01727297|469333306|FG001|Overall Study|Protocol Violation|10|||
130372272|NCT01727297|469333305|FG000|Overall Study|Adverse Event|3|||
130372273|NCT01727297|469333306|FG001|Overall Study|Adverse Event|1|||
130372274|NCT01727297|469333305|FG000|Overall Study|Lost to Follow-up|11|||
130372275|NCT01727297|469333306|FG001|Overall Study|Lost to Follow-up|0|||
130372276|NCT01727297|469333305|FG000|Overall Study|Withdrawal by Subject|26|||
130372277|NCT01727297|469333306|FG001|Overall Study|Withdrawal by Subject|27|||
130372278|NCT01727297|469333305|FG000|Overall Study|Physician Decision|19|||
130372279|NCT01727297|469333306|FG001|Overall Study|Physician Decision|5|||
130372280|NCT01727297|469333305|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
130372281|NCT01727297|469333306|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
130372282|NCT02864498|469333307|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
130372283|NCT02864498|469333308|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
130372284|NCT02864498|469333309|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
130372285|NCT02864498|469333307|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
130372286|NCT02864498|469333308|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
130372287|NCT02864498|469333309|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
130372288|NCT02864498|469333307|FG000|Overall Study|Investigator Discretion|0|||
130372289|NCT02864498|469333308|FG001|Overall Study|Investigator Discretion|2|||
130372290|NCT02864498|469333309|FG002|Overall Study|Investigator Discretion|1|||
130372291|NCT02864498|469333307|FG000|Overall Study|Lost to Follow-up|8|||
130372292|NCT02864498|469333308|FG001|Overall Study|Lost to Follow-up|6|||
130372293|NCT02864498|469333309|FG002|Overall Study|Lost to Follow-up|3|||
130372294|NCT02864498|469333307|FG000|Overall Study|Lack of Efficacy|5|||
130372295|NCT02864498|469333308|FG001|Overall Study|Lack of Efficacy|3|||
130372296|NCT02864498|469333309|FG002|Overall Study|Lack of Efficacy|3|||
130372297|NCT02864498|469333307|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
130372298|NCT02864498|469333308|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
130372299|NCT02864498|469333309|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
130372300|NCT02864498|469333307|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
130372301|NCT02864498|469333308|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
130460828|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460829|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460830|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460831|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460832|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460833|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460834|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
130460835|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
130460836|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
130460837|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
130460838|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
130460839|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
130460840|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
130715738|NCT04771403|470587011|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
130372302|NCT02864498|469333309|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
130372303|NCT02864498|469333307|FG000|Overall Study|Subject moved out of the country.|0|||
130372304|NCT02864498|469333308|FG001|Overall Study|Subject moved out of the country.|0|||
130372305|NCT02864498|469333309|FG002|Overall Study|Subject moved out of the country.|1|||
130372306|NCT00378378|469333310|FG000|Overall Study|Withdrawal by Subject|0|||
130372307|NCT00378378|469333311|FG001|Overall Study|Withdrawal by Subject|1|||
130372308|NCT00378378|469333312|FG002|Overall Study|Withdrawal by Subject|0|||
130460841|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
130715739|NCT04771403|470587010|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
130715740|NCT04771403|470587011|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
130715741|NCT00816361|470587012|FG000|Overall Study|Withdrawal by Subject|0|||
130715742|NCT00816361|470587013|FG001|Overall Study|Withdrawal by Subject|0|||
130715743|NCT00816361|470587014|FG002|Overall Study|Withdrawal by Subject|0|||
130715744|NCT00816361|470587015|FG003|Overall Study|Withdrawal by Subject|0|||
130715745|NCT00816361|470587016|FG004|Overall Study|Withdrawal by Subject|1|||
130715746|NCT00816361|470587017|FG005|Overall Study|Withdrawal by Subject|2|||
130715747|NCT00816361|470587018|FG006|Overall Study|Withdrawal by Subject|0|||
130715748|NCT00816361|470587019|FG007|Overall Study|Withdrawal by Subject|2|||
130715749|NCT00816361|470587020|FG008|Overall Study|Withdrawal by Subject|1|||
130715750|NCT00816361|470587012|FG000|Overall Study|Death|4|||
130715751|NCT00816361|470587013|FG001|Overall Study|Death|3|||
130715752|NCT00816361|470587014|FG002|Overall Study|Death|3|||
130715753|NCT00816361|470587015|FG003|Overall Study|Death|3|||
130460842|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
130460843|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
130460844|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
130460845|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
130460846|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
130460847|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
130460848|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460849|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
130460850|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
130460851|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460852|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
130460853|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460854|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460855|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460856|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460857|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460858|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460859|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460860|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
130460861|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
130460862|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
130715754|NCT00816361|470587016|FG004|Overall Study|Death|1|||
130715755|NCT00816361|470587017|FG005|Overall Study|Death|1|||
130715756|NCT00816361|470587018|FG006|Overall Study|Death|3|||
130460863|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
130715757|NCT00816361|470587019|FG007|Overall Study|Death|7|||
130715758|NCT00816361|470587020|FG008|Overall Study|Death|8|||
130715759|NCT00816361|470587012|FG000|Overall Study|Other|0|||
130715760|NCT00816361|470587013|FG001|Overall Study|Other|0|||
130715761|NCT00816361|470587014|FG002|Overall Study|Other|0|||
130715762|NCT00816361|470587015|FG003|Overall Study|Other|0|||
130715763|NCT00816361|470587016|FG004|Overall Study|Other|0|||
130715764|NCT00816361|470587017|FG005|Overall Study|Other|0|||
130715765|NCT00816361|470587018|FG006|Overall Study|Other|0|||
130715766|NCT00816361|470587019|FG007|Overall Study|Other|0|||
130715767|NCT00816361|470587020|FG008|Overall Study|Other|1|||
130715768|NCT00546572|470587021|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
130715769|NCT00546572|470587022|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
130715770|NCT00546572|470587021|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
130715771|NCT00546572|470587022|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
130715772|NCT00546572|470587021|FG000|Vax 1 / Year 0|Protocol Violation|3|||
130715773|NCT00546572|470587022|FG001|Vax 1 / Year 0|Protocol Violation|4|||
130715774|NCT00546572|470587021|FG000|Vax 1 / Year 0|Death|2|||
130715775|NCT00546572|470587022|FG001|Vax 1 / Year 0|Death|2|||
130715776|NCT00546572|470587021|FG000|Vax 1 / Year 0|Adverse Event|0|||
130715777|NCT00546572|470587022|FG001|Vax 1 / Year 0|Adverse Event|1|||
130715778|NCT00546572|470587021|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
130715779|NCT00546572|470587022|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
130715780|NCT00546572|470587021|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
130715781|NCT00546572|470587022|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
130715782|NCT00546572|470587021|FG000|Vax 2 / Year 1|Other|1|||
130715783|NCT00546572|470587022|FG001|Vax 2 / Year 1|Other|1|||
130715784|NCT00546572|470587021|FG000|Vax 2 / Year 1|Adverse Event|1|||
130715785|NCT00546572|470587022|FG001|Vax 2 / Year 1|Adverse Event|0|||
130715786|NCT00546572|470587021|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
130295700|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130460864|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
130557102|NCT00702845|470009871|FG000|Overall Study|Not randomized|0|||
130715787|NCT00546572|470587022|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
130715788|NCT00741936|470587027|FG000|Overall Study|Lost to Follow-up|1|||
130715789|NCT00741936|470587028|FG001|Overall Study|Lost to Follow-up|1|||
130715790|NCT00741936|470587027|FG000|Overall Study|Adverse Event|3|||
130715791|NCT00741936|470587028|FG001|Overall Study|Adverse Event|4|||
130715792|NCT00741936|470587027|FG000|Overall Study|Pregnancy|0|||
130715793|NCT00741936|470587028|FG001|Overall Study|Pregnancy|1|||
130715794|NCT00741936|470587027|FG000|Overall Study|Protocol Violation|2|||
130715795|NCT00741936|470587028|FG001|Overall Study|Protocol Violation|0|||
130715796|NCT00741936|470587027|FG000|Overall Study|Lack of Efficacy|0|||
130715797|NCT00741936|470587028|FG001|Overall Study|Lack of Efficacy|2|||
130715798|NCT00741936|470587027|FG000|Overall Study|Low compliance|3|||
130715799|NCT00741936|470587028|FG001|Overall Study|Low compliance|0|||
130715800|NCT01408628|470587029|FG000|Consented|Withdrawal by Subject|12|||
130295701|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295702|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295703|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295704|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295705|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295706|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295707|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295708|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295709|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
130295710|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295711|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295712|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295713|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295714|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295715|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295716|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130715801|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
130715802|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
130715803|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
130715804|NCT01941940|470587030|FG000|Overall Study|Adverse Event|11|||
130715805|NCT01941940|470587030|FG000|Overall Study|Lost to Follow-up|2|||
130715806|NCT01941940|470587030|FG000|Overall Study|Physician Decision|2|||
130460865|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
130460866|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460867|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460868|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460869|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
130460870|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460871|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460872|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460873|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
130460874|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
130460875|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460876|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130295717|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130460877|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460878|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460879|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
130460880|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
130460881|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
130460882|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460883|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460884|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460885|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460886|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
130460887|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
130460888|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
130460889|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
130460890|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
130460891|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
130557103|NCT00702845|470009872|FG001|Overall Study|Not randomized|1|||
130295718|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
130295719|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130460892|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
130460893|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
130372309|NCT00378378|469333310|FG000|Overall Study|Treatment Failure|0|||
130715807|NCT01941940|470587030|FG000|Overall Study|Withdrawal by Subject|15|||
130715808|NCT01941940|470587030|FG000|Overall Study|Death|1|||
130715809|NCT01941940|470587030|FG000|Overall Study|Other|1|||
130715810|NCT01941940|470587030|FG000|Overall Study|Other|1|||
130715811|NCT00750308|470587031|FG000|First Treatment|Adverse Event|0|||
130715812|NCT00750308|470587032|FG001|First Treatment|Adverse Event|1|||
130715813|NCT00750308|470587033|FG002|First Treatment|Adverse Event|0|||
130715814|NCT00750308|470587034|FG003|First Treatment|Adverse Event|0|||
130715815|NCT00750308|470587035|FG004|First Treatment|Adverse Event|0|||
130715816|NCT00750308|470587036|FG005|First Treatment|Adverse Event|0|||
130715817|NCT00750308|470587037|FG006|First Treatment|Adverse Event|0|||
130715818|NCT00750308|470587038|FG007|First Treatment|Adverse Event|0|||
130715819|NCT00750308|470587039|FG008|First Treatment|Adverse Event|0|||
130715820|NCT00750308|470587040|FG009|First Treatment|Adverse Event|0|||
130715821|NCT00750308|470587041|FG010|First Treatment|Adverse Event|1|||
130715822|NCT00750308|470587042|FG011|First Treatment|Adverse Event|1|||
130715823|NCT00750308|470587031|FG000|First Treatment|Withdrawal by Subject|0|||
130715824|NCT00750308|470587032|FG001|First Treatment|Withdrawal by Subject|0|||
130715825|NCT00750308|470587033|FG002|First Treatment|Withdrawal by Subject|0|||
130715826|NCT00750308|470587034|FG003|First Treatment|Withdrawal by Subject|1|||
130715827|NCT00750308|470587035|FG004|First Treatment|Withdrawal by Subject|0|||
130715828|NCT00750308|470587036|FG005|First Treatment|Withdrawal by Subject|0|||
130715829|NCT00750308|470587037|FG006|First Treatment|Withdrawal by Subject|0|||
130715830|NCT00750308|470587038|FG007|First Treatment|Withdrawal by Subject|1|||
130715831|NCT00750308|470587039|FG008|First Treatment|Withdrawal by Subject|0|||
130715832|NCT00750308|470587040|FG009|First Treatment|Withdrawal by Subject|0|||
130715833|NCT00750308|470587041|FG010|First Treatment|Withdrawal by Subject|0|||
130715834|NCT00750308|470587042|FG011|First Treatment|Withdrawal by Subject|0|||
130715835|NCT00750308|470587031|FG000|Second Treatment|Adverse Event|0|||
130715836|NCT00750308|470587032|FG001|Second Treatment|Adverse Event|0|||
130715837|NCT00750308|470587033|FG002|Second Treatment|Adverse Event|0|||
130715838|NCT00750308|470587034|FG003|Second Treatment|Adverse Event|0|||
130715839|NCT00750308|470587035|FG004|Second Treatment|Adverse Event|0|||
130715840|NCT00750308|470587036|FG005|Second Treatment|Adverse Event|1|||
130715841|NCT00750308|470587037|FG006|Second Treatment|Adverse Event|0|||
130715842|NCT00750308|470587038|FG007|Second Treatment|Adverse Event|0|||
130715843|NCT00750308|470587039|FG008|Second Treatment|Adverse Event|1|||
130715844|NCT00750308|470587040|FG009|Second Treatment|Adverse Event|0|||
130715845|NCT00750308|470587041|FG010|Second Treatment|Adverse Event|0|||
130715846|NCT00750308|470587042|FG011|Second Treatment|Adverse Event|0|||
130715847|NCT00750308|470587031|FG000|Second Treatment|Withdrawal by Subject|0|||
130715848|NCT00750308|470587032|FG001|Second Treatment|Withdrawal by Subject|0|||
130715849|NCT00750308|470587033|FG002|Second Treatment|Withdrawal by Subject|0|||
130715850|NCT00750308|470587034|FG003|Second Treatment|Withdrawal by Subject|0|||
130715851|NCT00750308|470587035|FG004|Second Treatment|Withdrawal by Subject|1|||
130715852|NCT00750308|470587036|FG005|Second Treatment|Withdrawal by Subject|0|||
130715853|NCT00750308|470587037|FG006|Second Treatment|Withdrawal by Subject|0|||
130715854|NCT00750308|470587038|FG007|Second Treatment|Withdrawal by Subject|0|||
130715855|NCT00750308|470587039|FG008|Second Treatment|Withdrawal by Subject|0|||
130715856|NCT00750308|470587040|FG009|Second Treatment|Withdrawal by Subject|0|||
130715857|NCT00750308|470587041|FG010|Second Treatment|Withdrawal by Subject|0|||
130715858|NCT00750308|470587042|FG011|Second Treatment|Withdrawal by Subject|0|||
130715859|NCT00750308|470587031|FG000|Third Treatment|Withdrawal by Subject|0|||
130715860|NCT00750308|470587032|FG001|Third Treatment|Withdrawal by Subject|1|||
130715861|NCT00750308|470587033|FG002|Third Treatment|Withdrawal by Subject|0|||
130715862|NCT00750308|470587034|FG003|Third Treatment|Withdrawal by Subject|0|||
130715863|NCT00750308|470587035|FG004|Third Treatment|Withdrawal by Subject|0|||
130715864|NCT00750308|470587036|FG005|Third Treatment|Withdrawal by Subject|0|||
130372310|NCT00378378|469333311|FG001|Overall Study|Treatment Failure|0|||
130372311|NCT00378378|469333312|FG002|Overall Study|Treatment Failure|1|||
130372312|NCT00378378|469333310|FG000|Overall Study|Non-compliance with protocol|0|||
130715865|NCT00750308|470587037|FG006|Third Treatment|Withdrawal by Subject|0|||
130715866|NCT00750308|470587038|FG007|Third Treatment|Withdrawal by Subject|0|||
130715867|NCT00750308|470587039|FG008|Third Treatment|Withdrawal by Subject|0|||
130715868|NCT00750308|470587040|FG009|Third Treatment|Withdrawal by Subject|0|||
130715869|NCT00750308|470587041|FG010|Third Treatment|Withdrawal by Subject|0|||
130715870|NCT00750308|470587042|FG011|Third Treatment|Withdrawal by Subject|0|||
130715871|NCT00513682|470587043|FG000|Washout Phase|Adverse Event|2|||
130715872|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Adverse Event|0|||
130715873|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Adverse Event|0|||
130715874|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Adverse Event|2|||
130715875|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Adverse Event|0|||
130372313|NCT00378378|469333311|FG001|Overall Study|Non-compliance with protocol|0|||
130715876|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Adverse Event|0|||
130715877|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
130715878|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
130715879|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
130295720|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295721|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295722|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295723|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295724|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295725|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295726|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295727|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295728|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295729|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295730|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295731|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295732|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295733|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295734|NCT01455220|469045359|FG000|Overall Study|screen fail|30|||
130295735|NCT00521222|469045361|FG000|Overall Study|Lost to Follow-up|0|||
130295736|NCT00521222|469045362|FG001|Overall Study|Lost to Follow-up|0|||
130295737|NCT00521222|469045363|FG002|Overall Study|Lost to Follow-up|1|||
130295738|NCT00521222|469045364|FG003|Overall Study|Lost to Follow-up|1|||
130295739|NCT00521222|469045361|FG000|Overall Study|Withdrawal by Subject|0|||
130295740|NCT00521222|469045362|FG001|Overall Study|Withdrawal by Subject|0|||
130295741|NCT00521222|469045363|FG002|Overall Study|Withdrawal by Subject|2|||
130295742|NCT00521222|469045364|FG003|Overall Study|Withdrawal by Subject|0|||
130295743|NCT00521222|469045361|FG000|Overall Study|Physician Decision|0|||
130295744|NCT00521222|469045362|FG001|Overall Study|Physician Decision|1|||
130295745|NCT00521222|469045363|FG002|Overall Study|Physician Decision|0|||
130372314|NCT00378378|469333312|FG002|Overall Study|Non-compliance with protocol|1|||
130372315|NCT03782792|469333315|FG000|Overall Study|Patient left the country|0|||
130372316|NCT03782792|469333316|FG001|Overall Study|Patient left the country|1|||
130372317|NCT03782792|469333315|FG000|Overall Study|Withdrawal by Subject|1|||
130372318|NCT03782792|469333316|FG001|Overall Study|Withdrawal by Subject|2|||
130372319|NCT01854710|469333317|FG000|Overall Study|Withdrawal by Subject|2|||
130372320|NCT01854710|469333318|FG001|Overall Study|Withdrawal by Subject|1|||
130372321|NCT01854710|469333319|FG002|Overall Study|Withdrawal by Subject|0|||
130372322|NCT01854710|469333320|FG003|Overall Study|Withdrawal by Subject|0|||
130372323|NCT01854710|469333321|FG004|Overall Study|Withdrawal by Subject|0|||
130372324|NCT01854710|469333322|FG005|Overall Study|Withdrawal by Subject|0|||
130372325|NCT01854710|469333317|FG000|Overall Study|CRI procedural error|2|||
130372326|NCT01854710|469333318|FG001|Overall Study|CRI procedural error|2|||
130372327|NCT01854710|469333319|FG002|Overall Study|CRI procedural error|2|||
130372328|NCT01854710|469333320|FG003|Overall Study|CRI procedural error|2|||
130372329|NCT01854710|469333321|FG004|Overall Study|CRI procedural error|2|||
130372330|NCT01854710|469333322|FG005|Overall Study|CRI procedural error|2|||
130372331|NCT00370032|469333323|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
130372332|NCT00370032|469333324|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
130372333|NCT00370032|469333323|FG000|Washout Period|Withdrawal by Subject|0|||
130372334|NCT00370032|469333324|FG001|Washout Period|Withdrawal by Subject|1|||
130557104|NCT02973425|470009876|FG000|Overall Study|Lost to Follow-up|49|||
130295746|NCT00521222|469045364|FG003|Overall Study|Physician Decision|1|||
130295747|NCT03332160|469045365|FG000|Overall Study|Withdrawal by Subject|1|||
130295748|NCT03332160|469045366|FG001|Overall Study|Withdrawal by Subject|1|||
130295749|NCT03332160|469045365|FG000|Overall Study|Adverse Event|0|||
130295750|NCT03332160|469045366|FG001|Overall Study|Adverse Event|1|||
130295751|NCT03332160|469045365|FG000|Overall Study|Developed Exclusion Criteria|0|||
130295752|NCT03332160|469045366|FG001|Overall Study|Developed Exclusion Criteria|1|||
130295753|NCT03332160|469045365|FG000|Overall Study|Non-adherence to treatment|0|||
130295754|NCT03332160|469045366|FG001|Overall Study|Non-adherence to treatment|2|||
130295755|NCT03869333|469045367|FG000|Overall Study|Lost to Follow-up|1|||
130295756|NCT03869333|469045368|FG001|Overall Study|Lost to Follow-up|0|||
130295757|NCT03869333|469045369|FG002|Overall Study|Lost to Follow-up|0|||
130295758|NCT03869333|469045370|FG003|Overall Study|Lost to Follow-up|0|||
130295759|NCT03869333|469045367|FG000|Overall Study|Pregnancy|1|||
130295760|NCT03869333|469045368|FG001|Overall Study|Pregnancy|0|||
130295761|NCT03869333|469045369|FG002|Overall Study|Pregnancy|0|||
130295762|NCT03869333|469045370|FG003|Overall Study|Pregnancy|0|||
130295763|NCT03869333|469045367|FG000|Overall Study|Physician Decision|0|||
130295764|NCT03869333|469045368|FG001|Overall Study|Physician Decision|1|||
130295765|NCT03869333|469045369|FG002|Overall Study|Physician Decision|0|||
130295766|NCT03869333|469045370|FG003|Overall Study|Physician Decision|0|||
130295767|NCT01927055|469045371|FG000|Open-label|Adverse Event|6|||
130295768|NCT01927055|469045372|FG001|Open-label|Adverse Event|0|||
130295769|NCT01927055|469045373|FG002|Open-label|Adverse Event|0|||
130295770|NCT01927055|469045371|FG000|Open-label|Withdrawal by Subject|1|||
130295771|NCT01927055|469045372|FG001|Open-label|Withdrawal by Subject|0|||
130295772|NCT01927055|469045373|FG002|Open-label|Withdrawal by Subject|0|||
130295773|NCT01927055|469045371|FG000|Open-label|Study Stopped|4|||
130295774|NCT01927055|469045372|FG001|Open-label|Study Stopped|0|||
130295775|NCT01927055|469045373|FG002|Open-label|Study Stopped|0|||
130295776|NCT01927055|469045371|FG000|Open-label|Supine Hypertension|4|||
130295777|NCT01927055|469045372|FG001|Open-label|Supine Hypertension|0|||
130295778|NCT01927055|469045373|FG002|Open-label|Supine Hypertension|0|||
130295779|NCT01927055|469045371|FG000|Open-label|Difficulty attending study visits|1|||
130295780|NCT01927055|469045372|FG001|Open-label|Difficulty attending study visits|0|||
130295781|NCT01927055|469045373|FG002|Open-label|Difficulty attending study visits|0|||
130372335|NCT00370032|469333323|FG000|Washout Period|Lost to Follow-up|0|||
130372336|NCT00370032|469333324|FG001|Washout Period|Lost to Follow-up|1|||
130372337|NCT00370032|469333323|FG000|Washout Period|Adverse Event|1|||
130372338|NCT00370032|469333324|FG001|Washout Period|Adverse Event|0|||
130715880|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
130715881|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
130715882|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
130715883|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715884|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715885|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715886|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715887|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
130715888|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
130715889|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
130715890|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
130715891|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
130715892|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
130715893|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
130715894|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
130715895|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
130715896|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
130715897|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715898|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715899|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715900|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715901|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
130715902|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715903|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715904|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715905|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715906|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
130715907|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715908|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715909|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
130295782|NCT01927055|469045371|FG000|Double-Blind|Adverse Event|0|||
130295783|NCT01927055|469045372|FG001|Double-Blind|Adverse Event|1|||
130295784|NCT01927055|469045373|FG002|Double-Blind|Adverse Event|1|||
130295785|NCT01927055|469045371|FG000|Double-Blind|Protocol Violation|0|||
130295786|NCT01927055|469045372|FG001|Double-Blind|Protocol Violation|0|||
130295787|NCT01927055|469045373|FG002|Double-Blind|Protocol Violation|1|||
130295788|NCT01927055|469045371|FG000|Double-Blind|Withdrawal by Subject|0|||
130295789|NCT01927055|469045372|FG001|Double-Blind|Withdrawal by Subject|2|||
130295790|NCT01927055|469045373|FG002|Double-Blind|Withdrawal by Subject|3|||
130295791|NCT01927055|469045371|FG000|Double-Blind|Study Stopped|0|||
130295792|NCT01927055|469045372|FG001|Double-Blind|Study Stopped|7|||
130295793|NCT01927055|469045373|FG002|Double-Blind|Study Stopped|7|||
130295794|NCT01927055|469045371|FG000|Double-Blind|Supine Hypertension|0|||
130295795|NCT01927055|469045372|FG001|Double-Blind|Supine Hypertension|0|||
130295796|NCT01927055|469045373|FG002|Double-Blind|Supine Hypertension|1|||
130295797|NCT01927055|469045371|FG000|Double-Blind|Extended Vacation|0|||
130295798|NCT01927055|469045372|FG001|Double-Blind|Extended Vacation|1|||
130295799|NCT01927055|469045373|FG002|Double-Blind|Extended Vacation|0|||
130295800|NCT00952614|469045379|FG000|Overall Study|Death|3|||
130295801|NCT00952614|469045379|FG000|Overall Study|Lost to Follow-up|3|||
130295802|NCT00952614|469045379|FG000|Overall Study|other reason|1|||
130295803|NCT04023682|469045380|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
130295804|NCT01291277|469045381|FG000|Overall Study|Death|2|||
130295805|NCT01291277|469045382|FG001|Overall Study|Death|2|||
130295806|NCT01291277|469045381|FG000|Overall Study|Lost to Follow-up|3|||
130295807|NCT01291277|469045382|FG001|Overall Study|Lost to Follow-up|1|||
130295808|NCT02963701|469045383|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
130295809|NCT02963701|469045384|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
130295810|NCT03480009|469045387|FG000|Overall Study|Lost to Follow-up|4|||
130295811|NCT03480009|469045388|FG001|Overall Study|Lost to Follow-up|5|||
130557105|NCT02973425|470009877|FG001|Overall Study|Lost to Follow-up|53|||
130557106|NCT03876171|470009878|FG000|Overall Study|Withdrawal by Subject|3|||
130557107|NCT03876171|470009879|FG001|Overall Study|Withdrawal by Subject|3|||
130557108|NCT03876171|470009878|FG000|Overall Study|Re-arrest|0|||
130557109|NCT03876171|470009879|FG001|Overall Study|Re-arrest|4|||
130557110|NCT03503513|470009884|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
130557111|NCT03503513|470009884|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
130557112|NCT03503513|470009884|FG000|Overall Study|Physician Decision|3|||
130557113|NCT03503513|470009884|FG000|Overall Study|Withdrawal by Subject|2|||
130295812|NCT03480009|469045389|FG002|Overall Study|Lost to Follow-up|4|||
130295813|NCT03480009|469045390|FG003|Overall Study|Lost to Follow-up|0|||
130557114|NCT03503513|470009884|FG000|Overall Study|Lost to Follow-up|1|||
130715910|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715911|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
130715912|NCT00502801|470587049|FG000|Treatment Period|Withdrawal by Subject|3|||
130715913|NCT00502801|470587049|FG000|Treatment Period|Adverse Event|7|||
130715914|NCT00502801|470587049|FG000|Treatment Period|Death|14|||
130715915|NCT00502801|470587049|FG000|Treatment Period|OTHER|30|||
130715916|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
130715917|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
130715918|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Death|3|||
130715919|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|OTHER|2|||
130715920|NCT03212521|470587053|FG000|Overall Study|Adverse Event|1|||
130715921|NCT03212521|470587053|FG000|Overall Study|Lost to Follow-up|4|||
130715922|NCT03212521|470587053|FG000|Overall Study|Withdrawal by Subject|1|||
130715923|NCT03212521|470587053|FG000|Overall Study|Other|1|||
130715924|NCT02435836|470587054|FG000|Overall Study|Lost to Follow-up|21|||
130715925|NCT02435836|470587054|FG000|Overall Study|Lack of Efficacy|1|||
130715926|NCT02435836|470587054|FG000|Overall Study|Withdrawal by Subject|236|||
130715927|NCT02435836|470587054|FG000|Overall Study|Insufficient Clinical Response|26|||
130715928|NCT02435836|470587054|FG000|Overall Study|Adverse Event|44|||
130715929|NCT02435836|470587054|FG000|Overall Study|Sponsor discontinued trial|167|||
130715930|NCT02435836|470587054|FG000|Overall Study|Noncompliance|27|||
130715931|NCT02435836|470587054|FG000|Overall Study|Protocol Violation|6|||
130715932|NCT02435836|470587054|FG000|Overall Study|Met Withdrawal Criteria|7|||
130715933|NCT02435836|470587054|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
130715934|NCT01970865|470587055|FG000|Overall Study|Death|3|||
130715935|NCT01970865|470587056|FG001|Overall Study|Death|2|||
130715936|NCT01970865|470587057|FG002|Overall Study|Death|3|||
130715937|NCT01970865|470587058|FG003|Overall Study|Death|6|||
130715938|NCT01970865|470587059|FG004|Overall Study|Death|9|||
130715939|NCT01970865|470587060|FG005|Overall Study|Death|3|||
130715940|NCT01970865|470587061|FG006|Overall Study|Death|2|||
130715941|NCT01970865|470587062|FG007|Overall Study|Death|3|||
130715942|NCT01970865|470587063|FG008|Overall Study|Death|2|||
130295814|NCT01105377|469045391|FG000|Overall Study|Withdrawal by Subject|0|||
130715943|NCT01970865|470587064|FG009|Overall Study|Death|2|||
130715944|NCT01970865|470587065|FG010|Overall Study|Death|8|||
130715945|NCT01970865|470587066|FG011|Overall Study|Death|13|||
130715946|NCT01970865|470587067|FG012|Overall Study|Death|25|||
130295815|NCT01105377|469045392|FG001|Overall Study|Withdrawal by Subject|1|||
130715947|NCT01970865|470587068|FG013|Overall Study|Death|46|||
130715948|NCT01970865|470587069|FG014|Overall Study|Death|37|||
130715949|NCT01970865|470587070|FG015|Overall Study|Death|22|||
130295816|NCT02540291|469045398|FG000|Overall Study|Death|7|||
130295817|NCT02540291|469045399|FG001|Overall Study|Death|7|||
130295818|NCT02540291|469045400|FG002|Overall Study|Death|5|||
130295819|NCT02540291|469045401|FG003|Overall Study|Death|7|||
130715950|NCT01970865|470587071|FG016|Overall Study|Death|1|||
130715951|NCT01970865|470587072|FG017|Overall Study|Death|17|||
130715952|NCT01970865|470587055|FG000|Overall Study|Lost to Follow-up|0|||
130295820|NCT02540291|469045398|FG000|Overall Study|Lost to Follow-up|0|||
130295821|NCT02540291|469045399|FG001|Overall Study|Lost to Follow-up|0|||
130295822|NCT02540291|469045400|FG002|Overall Study|Lost to Follow-up|1|||
130295823|NCT02540291|469045401|FG003|Overall Study|Lost to Follow-up|0|||
130295824|NCT02540291|469045398|FG000|Overall Study|Withdrawal Of Consent|0|||
130295825|NCT02540291|469045399|FG001|Overall Study|Withdrawal Of Consent|1|||
130295826|NCT02540291|469045400|FG002|Overall Study|Withdrawal Of Consent|0|||
130295827|NCT02540291|469045401|FG003|Overall Study|Withdrawal Of Consent|0|||
130460894|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
130460895|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
130460896|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
130460897|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
130460898|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
130460899|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
130460900|NCT04707313|469652205|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460901|NCT04707313|469652206|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460902|NCT04707313|469652207|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
130460903|NCT04707313|469652208|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460904|NCT04707313|469652209|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460905|NCT04707313|469652210|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460906|NCT04707313|469652211|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460907|NCT04707313|469652212|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
130460908|NCT04707313|469652213|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130557115|NCT00929656|470009885|FG000|Overall Study|Lost to Follow-up|0|||
130715953|NCT01970865|470587056|FG001|Overall Study|Lost to Follow-up|0|||
130715954|NCT01970865|470587057|FG002|Overall Study|Lost to Follow-up|0|||
130715955|NCT01970865|470587058|FG003|Overall Study|Lost to Follow-up|1|||
130715956|NCT01970865|470587059|FG004|Overall Study|Lost to Follow-up|1|||
130715957|NCT01970865|470587060|FG005|Overall Study|Lost to Follow-up|0|||
130715958|NCT01970865|470587061|FG006|Overall Study|Lost to Follow-up|0|||
130715959|NCT01970865|470587062|FG007|Overall Study|Lost to Follow-up|0|||
130715960|NCT01970865|470587063|FG008|Overall Study|Lost to Follow-up|0|||
130715961|NCT01970865|470587064|FG009|Overall Study|Lost to Follow-up|0|||
130715962|NCT01970865|470587065|FG010|Overall Study|Lost to Follow-up|1|||
130715963|NCT01970865|470587066|FG011|Overall Study|Lost to Follow-up|0|||
130715964|NCT01970865|470587067|FG012|Overall Study|Lost to Follow-up|2|||
130715965|NCT01970865|470587068|FG013|Overall Study|Lost to Follow-up|0|||
130715966|NCT01970865|470587069|FG014|Overall Study|Lost to Follow-up|1|||
130715967|NCT01970865|470587070|FG015|Overall Study|Lost to Follow-up|4|||
130715968|NCT01970865|470587071|FG016|Overall Study|Lost to Follow-up|0|||
130715969|NCT01970865|470587072|FG017|Overall Study|Lost to Follow-up|1|||
130715970|NCT01970865|470587055|FG000|Overall Study|Other|0|||
130715971|NCT01970865|470587056|FG001|Overall Study|Other|1|||
130715972|NCT01970865|470587057|FG002|Overall Study|Other|0|||
130715973|NCT01970865|470587058|FG003|Overall Study|Other|1|||
130715974|NCT01970865|470587059|FG004|Overall Study|Other|1|||
130715975|NCT01970865|470587060|FG005|Overall Study|Other|0|||
130715976|NCT01970865|470587061|FG006|Overall Study|Other|1|||
130715977|NCT01970865|470587062|FG007|Overall Study|Other|0|||
130715978|NCT01970865|470587063|FG008|Overall Study|Other|0|||
130715979|NCT01970865|470587064|FG009|Overall Study|Other|0|||
130715980|NCT01970865|470587065|FG010|Overall Study|Other|2|||
130715981|NCT01970865|470587066|FG011|Overall Study|Other|3|||
130715982|NCT01970865|470587067|FG012|Overall Study|Other|8|||
130715983|NCT01970865|470587068|FG013|Overall Study|Other|3|||
130715984|NCT01970865|470587069|FG014|Overall Study|Other|2|||
130715985|NCT01970865|470587070|FG015|Overall Study|Other|3|||
130715986|NCT01970865|470587071|FG016|Overall Study|Other|0|||
130715987|NCT01970865|470587072|FG017|Overall Study|Other|2|||
130715988|NCT01970865|470587055|FG000|Overall Study|Participant refused further follow-up|0|||
130715989|NCT01970865|470587056|FG001|Overall Study|Participant refused further follow-up|0|||
130715990|NCT01970865|470587057|FG002|Overall Study|Participant refused further follow-up|0|||
130715991|NCT01970865|470587058|FG003|Overall Study|Participant refused further follow-up|2|||
130715992|NCT01970865|470587059|FG004|Overall Study|Participant refused further follow-up|3|||
130715993|NCT01970865|470587060|FG005|Overall Study|Participant refused further follow-up|0|||
130715994|NCT01970865|470587061|FG006|Overall Study|Participant refused further follow-up|0|||
130295828|NCT02540291|469045398|FG000|Overall Study|Study Terminated By Sponsor|1|||
130715995|NCT01970865|470587062|FG007|Overall Study|Participant refused further follow-up|0|||
130715996|NCT01970865|470587063|FG008|Overall Study|Participant refused further follow-up|0|||
130715997|NCT01970865|470587064|FG009|Overall Study|Participant refused further follow-up|0|||
130715998|NCT01970865|470587065|FG010|Overall Study|Participant refused further follow-up|1|||
130715999|NCT01970865|470587066|FG011|Overall Study|Participant refused further follow-up|4|||
130295829|NCT02540291|469045399|FG001|Overall Study|Study Terminated By Sponsor|0|||
130295830|NCT02540291|469045400|FG002|Overall Study|Study Terminated By Sponsor|0|||
130295831|NCT02540291|469045401|FG003|Overall Study|Study Terminated By Sponsor|0|||
130295832|NCT02540291|469045398|FG000|Overall Study|Other|0|||
130295833|NCT02540291|469045399|FG001|Overall Study|Other|0|||
130295834|NCT02540291|469045400|FG002|Overall Study|Other|1|||
130295835|NCT02540291|469045401|FG003|Overall Study|Other|0|||
130295836|NCT00707954|469047197|FG000|Overall Study|Physician Decision|0|||
130295837|NCT00707954|469047198|FG001|Overall Study|Physician Decision|0|||
130295838|NCT00707954|469047199|FG002|Overall Study|Physician Decision|0|||
130716000|NCT01970865|470587067|FG012|Overall Study|Participant refused further follow-up|7|||
130716001|NCT01970865|470587068|FG013|Overall Study|Participant refused further follow-up|8|||
130716002|NCT01970865|470587069|FG014|Overall Study|Participant refused further follow-up|3|||
130716003|NCT01970865|470587070|FG015|Overall Study|Participant refused further follow-up|11|||
130716004|NCT01970865|470587071|FG016|Overall Study|Participant refused further follow-up|0|||
130716005|NCT01970865|470587072|FG017|Overall Study|Participant refused further follow-up|6|||
130716006|NCT02041091|470587075|FG000|Treatment|Adverse Event|3|||
130716007|NCT02041091|470587076|FG001|Treatment|Adverse Event|3|||
130716008|NCT02041091|470587075|FG000|Treatment|Withdrawal by Subject|2|||
130716009|NCT02041091|470587076|FG001|Treatment|Withdrawal by Subject|4|||
130716010|NCT02041091|470587075|FG000|Treatment|Physician Decision|1|||
130716011|NCT02041091|470587076|FG001|Treatment|Physician Decision|0|||
130716012|NCT02041091|470587075|FG000|Treatment|Sponsor Decision|15|||
130716013|NCT02041091|470587076|FG001|Treatment|Sponsor Decision|16|||
130716014|NCT02041091|470587075|FG000|Treatment|Lost to Follow-up|1|||
130716015|NCT02041091|470587076|FG001|Treatment|Lost to Follow-up|0|||
130716016|NCT02041091|470587075|FG000|Optional Safety Extension Period|Adverse Event|4|||
130716017|NCT02041091|470587076|FG001|Optional Safety Extension Period|Adverse Event|2|||
130716018|NCT02041091|470587075|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
130716019|NCT02041091|470587076|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
130716020|NCT02041091|470587075|FG000|Optional Safety Extension Period|Protocol Violation|2|||
130716021|NCT02041091|470587076|FG001|Optional Safety Extension Period|Protocol Violation|0|||
130716022|NCT02041091|470587075|FG000|Optional Safety Extension Period|Physician Decision|2|||
130716023|NCT02041091|470587076|FG001|Optional Safety Extension Period|Physician Decision|1|||
130716024|NCT02041091|470587075|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
130716025|NCT02041091|470587076|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
130716026|NCT02041091|470587075|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
130716027|NCT02041091|470587076|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
130716028|NCT01855074|470587077|FG000|Overall Study|Adverse Event|1|||
130716029|NCT01855074|470587077|FG000|Overall Study|Lost to Follow-up|4|||
130716030|NCT01855074|470587077|FG000|Overall Study|Withdrawal by Subject|8|||
130716031|NCT01855074|470587077|FG000|Overall Study|Started but not treated|1|||
130716032|NCT01150890|470587078|FG000|Overall Study|Other|0|||
130716033|NCT01150890|470587079|FG001|Overall Study|Other|1|||
130716034|NCT01150890|470587080|FG002|Overall Study|Other|0|||
130716035|NCT01150890|470587081|FG003|Overall Study|Other|2|||
130716036|NCT01150890|470587078|FG000|Overall Study|Pregnancy|0|||
130716037|NCT01150890|470587079|FG001|Overall Study|Pregnancy|0|||
130716038|NCT01150890|470587080|FG002|Overall Study|Pregnancy|0|||
130716039|NCT01150890|470587081|FG003|Overall Study|Pregnancy|1|||
130716040|NCT01150890|470587078|FG000|Overall Study|Administrative Decision|4|||
130716041|NCT01150890|470587079|FG001|Overall Study|Administrative Decision|4|||
130716042|NCT01150890|470587080|FG002|Overall Study|Administrative Decision|5|||
130716043|NCT01150890|470587081|FG003|Overall Study|Administrative Decision|6|||
130716044|NCT01150890|470587078|FG000|Overall Study|Ineligibility determined|0|||
130716045|NCT01150890|470587079|FG001|Overall Study|Ineligibility determined|1|||
130716046|NCT01150890|470587080|FG002|Overall Study|Ineligibility determined|0|||
130295839|NCT00707954|469047200|FG003|Overall Study|Physician Decision|0|||
130295840|NCT00707954|469047201|FG004|Overall Study|Physician Decision|1|||
130295841|NCT04037254|469047202|FG000|Overall Study|Protocol Violation|1|||
130295842|NCT04037254|469047203|FG001|Overall Study|Protocol Violation|0|||
130295843|NCT04037254|469047204|FG002|Overall Study|Protocol Violation|0|||
130295844|NCT04037254|469047205|FG003|Overall Study|Protocol Violation|0|||
130295845|NCT04037254|469047206|FG004|Overall Study|Protocol Violation|0|||
130295846|NCT04037254|469047202|FG000|Overall Study|Withdrawal by Subject|0|||
130295847|NCT04037254|469047203|FG001|Overall Study|Withdrawal by Subject|0|||
130295848|NCT04037254|469047204|FG002|Overall Study|Withdrawal by Subject|1|||
130295849|NCT04037254|469047205|FG003|Overall Study|Withdrawal by Subject|0|||
130295850|NCT04037254|469047206|FG004|Overall Study|Withdrawal by Subject|0|||
130295851|NCT04037254|469047202|FG000|Overall Study|Delayed or incomplete treatment|0|||
130295852|NCT04037254|469047203|FG001|Overall Study|Delayed or incomplete treatment|2|||
130295853|NCT04037254|469047204|FG002|Overall Study|Delayed or incomplete treatment|1|||
130295854|NCT04037254|469047205|FG003|Overall Study|Delayed or incomplete treatment|0|||
130295855|NCT04037254|469047206|FG004|Overall Study|Delayed or incomplete treatment|0|||
130372339|NCT00370032|469333323|FG000|Follow-up Period|Withdrawal by Subject|1|||
130295856|NCT01306656|469047207|FG000|Overall Study|Lost to Follow-up|1|||
130295857|NCT01306656|469047208|FG001|Overall Study|Lost to Follow-up|0|||
130295858|NCT02504580|469047209|FG000|Overall Study|Other|1|||
130295859|NCT02504580|469047210|FG001|Overall Study|Other|0|||
130295860|NCT02504580|469047211|FG002|Overall Study|Other|0|||
130295861|NCT02504580|469047212|FG003|Overall Study|Other|2|||
130295862|NCT02504580|469047213|FG004|Overall Study|Other|1|||
130295863|NCT02504580|469047214|FG005|Overall Study|Other|1|||
130295864|NCT02504580|469047215|FG006|Overall Study|Other|1|||
130295865|NCT02504580|469047216|FG007|Overall Study|Other|2|||
130295866|NCT02504580|469047217|FG008|Overall Study|Other|0|||
130295867|NCT02504580|469047218|FG009|Overall Study|Other|0|||
130295868|NCT02504580|469047219|FG010|Overall Study|Other|0|||
130295869|NCT02504580|469047220|FG011|Overall Study|Other|2|||
130295870|NCT02504580|469047209|FG000|Overall Study|Subject refusal to continue|0|||
130295871|NCT02504580|469047210|FG001|Overall Study|Subject refusal to continue|1|||
130295872|NCT02504580|469047211|FG002|Overall Study|Subject refusal to continue|0|||
130295873|NCT02504580|469047212|FG003|Overall Study|Subject refusal to continue|0|||
130295874|NCT02504580|469047213|FG004|Overall Study|Subject refusal to continue|0|||
130295875|NCT02504580|469047214|FG005|Overall Study|Subject refusal to continue|0|||
130295876|NCT02504580|469047215|FG006|Overall Study|Subject refusal to continue|0|||
130295877|NCT02504580|469047216|FG007|Overall Study|Subject refusal to continue|0|||
130295878|NCT02504580|469047217|FG008|Overall Study|Subject refusal to continue|0|||
130295879|NCT02504580|469047218|FG009|Overall Study|Subject refusal to continue|0|||
130295880|NCT02504580|469047219|FG010|Overall Study|Subject refusal to continue|0|||
130295881|NCT02504580|469047220|FG011|Overall Study|Subject refusal to continue|0|||
130295882|NCT00448747|469047222|FG000|Overall Study|collapsed veins|1|||
130295883|NCT00448747|469047223|FG001|Overall Study|collapsed veins|0|||
130295884|NCT04051827|469047229|FG000|Overall Study|Death|1|||
130295885|NCT04051827|469047229|FG000|Overall Study|Withdrawal by Subject|4|||
130295886|NCT04051827|469047229|FG000|Overall Study|Progressive disease|16|||
130295887|NCT04051827|469047229|FG000|Overall Study|Physician Decision|1|||
130295888|NCT04051827|469047229|FG000|Overall Study|Other|4|||
130295889|NCT01424566|469047230|FG000|Single-blind Treatment|Adverse Event|71|||
130295890|NCT01424566|469047231|FG001|Single-blind Treatment|Adverse Event|0|||
130295891|NCT01424566|469047232|FG002|Single-blind Treatment|Adverse Event|0|||
130295892|NCT01424566|469047230|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
130295893|NCT01424566|469047231|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
130295894|NCT01424566|469047232|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
130295895|NCT01424566|469047230|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
130295896|NCT01424566|469047231|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
130295897|NCT01424566|469047232|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
130295898|NCT01424566|469047230|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
130295899|NCT01424566|469047231|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130295900|NCT01424566|469047232|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130295901|NCT01424566|469047230|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
130295902|NCT01424566|469047231|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
130295903|NCT01424566|469047232|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
130295904|NCT01424566|469047230|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
130295905|NCT01424566|469047231|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130295906|NCT01424566|469047232|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130295907|NCT01424566|469047230|FG000|Double-blind Treatment|Adverse Event|0|||
130295908|NCT01424566|469047231|FG001|Double-blind Treatment|Adverse Event|21|||
130372340|NCT00370032|469333324|FG001|Follow-up Period|Withdrawal by Subject|0|||
130372341|NCT05229406|469333325|FG000|Overall Study|Withdrawal by Subject|1|||
130372342|NCT05229406|469333326|FG001|Overall Study|Withdrawal by Subject|2|||
130372343|NCT01537393|469333327|FG000|Overall Study|Exclude prior to study|32|||
130372344|NCT01537393|469333328|FG001|Overall Study|Exclude prior to study|44|||
130372345|NCT01537393|469333327|FG000|Overall Study|Death|20|||
130460909|NCT04707313|469652214|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460910|NCT04707313|469652215|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460911|NCT04707313|469652216|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130295909|NCT01424566|469047232|FG002|Double-blind Treatment|Adverse Event|13|||
130372346|NCT01537393|469333328|FG001|Overall Study|Death|32|||
130372347|NCT01537393|469333327|FG000|Overall Study|Withdrawal by Subject|18|||
130372348|NCT01537393|469333328|FG001|Overall Study|Withdrawal by Subject|17|||
130372349|NCT01537393|469333327|FG000|Overall Study|Lost to Follow-up|53|||
130372350|NCT01537393|469333328|FG001|Overall Study|Lost to Follow-up|48|||
130372351|NCT01537393|469333327|FG000|Overall Study|Failure - Regrafted|28|||
130295910|NCT01424566|469047230|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130295911|NCT01424566|469047231|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
130295912|NCT01424566|469047232|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
130295913|NCT01424566|469047230|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
130295914|NCT01424566|469047231|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
130295915|NCT01424566|469047232|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
130372352|NCT01537393|469333328|FG001|Overall Study|Failure - Regrafted|43|||
130372353|NCT01537393|469333327|FG000|Overall Study|Failure - Not regrafted|2|||
130372354|NCT01537393|469333328|FG001|Overall Study|Failure - Not regrafted|6|||
130557116|NCT00929656|470009886|FG001|Overall Study|Lost to Follow-up|1|||
130295916|NCT01424566|469047230|FG000|Double-blind Treatment|Lack of Efficacy|0|||
130295917|NCT01424566|469047231|FG001|Double-blind Treatment|Lack of Efficacy|1|||
130295918|NCT01424566|469047232|FG002|Double-blind Treatment|Lack of Efficacy|1|||
130295919|NCT03779503|469047237|FG000|First Intervention|Adverse Event|0|||
130295920|NCT03779503|469047238|FG001|First Intervention|Adverse Event|1|||
130295921|NCT03779503|469047237|FG000|First Intervention|Withdrawal by Subject|1|||
130295922|NCT03779503|469047238|FG001|First Intervention|Withdrawal by Subject|0|||
130295923|NCT00687609|469047239|FG000|Overall Study|Physician Decision|1|||
130295924|NCT00687609|469047239|FG000|Overall Study|Withdrawal by Subject|2|||
130295925|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295926|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295927|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295928|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295929|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130295930|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295931|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
130295932|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295933|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130295934|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295935|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295936|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295937|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295938|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295939|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295940|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295941|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
130295942|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295943|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295944|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295945|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
130295946|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295947|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295948|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295949|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295950|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295951|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295952|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130295953|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295954|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295955|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130295956|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295957|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295958|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295959|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295960|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295961|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295962|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295963|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295964|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295965|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295966|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295967|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295968|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295969|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295970|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295971|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295972|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
130460912|NCT04707313|469652217|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130460913|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460914|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460915|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460916|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130295973|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295974|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295975|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130460917|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130295976|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295977|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295978|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295979|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295980|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295981|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295982|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
130295983|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295984|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
130295985|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295986|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295987|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295988|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295989|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295990|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295991|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295992|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295993|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295994|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
130295995|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295996|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295997|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130295998|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130295999|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296000|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296001|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296002|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296003|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296004|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296005|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296006|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296007|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
130296008|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296009|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296010|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296011|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296012|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296013|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296014|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296015|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296016|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296017|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296018|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
130296019|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296020|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296021|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296022|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296023|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296024|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296025|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296026|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130372355|NCT01537393|469333327|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
130372356|NCT01537393|469333328|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
130372357|NCT01578187|469333329|FG000|Usability Phase|Withdrawal by Subject|1|||
130372358|NCT03208244|469333335|FG000|Overall Study|Death|1|||
130372359|NCT01709162|469333336|FG000|Overall Study|Disease progression|3|||
130372360|NCT01709162|469333337|FG001|Overall Study|Disease progression|3|||
130372361|NCT01709162|469333336|FG000|Overall Study|Study drug toxicity|2|||
130372362|NCT01709162|469333337|FG001|Overall Study|Study drug toxicity|0|||
130372363|NCT01709162|469333336|FG000|Overall Study|Administrative reason by sponsor|0|||
130372364|NCT01709162|469333337|FG001|Overall Study|Administrative reason by sponsor|1|||
130372365|NCT01709162|469333336|FG000|Overall Study|Other|1|||
130372366|NCT01709162|469333337|FG001|Overall Study|Other|0|||
130372367|NCT01709162|469333336|FG000|Overall Study|Withdrawal by Subject|0|||
130296027|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296028|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296029|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296030|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130557117|NCT00607880|470009887|FG000|Overall Study|Unable to place port due to occlusion|1|||
130557118|NCT00607880|470009888|FG001|Overall Study|Unable to place port due to occlusion|0|||
130557119|NCT01170039|470009889|FG000|Overall Study|Withdrawal by Subject|5|||
130296031|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
130296032|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296033|NCT00581360|469047257|FG000|Overall Study|Withdrawal by Subject|1|||
130296034|NCT00552760|469047258|FG000|Overall Study|Adverse Event|3|||
130296035|NCT00552760|469047259|FG001|Overall Study|Adverse Event|5|||
130296036|NCT00552760|469047258|FG000|Overall Study|Relapsed- Depressed Event|10|||
130296037|NCT00552760|469047259|FG001|Overall Study|Relapsed- Depressed Event|16|||
130296038|NCT00552760|469047258|FG000|Overall Study|Relapse- Manic Event|3|||
130296039|NCT00552760|469047259|FG001|Overall Study|Relapse- Manic Event|3|||
130296040|NCT00552760|469047258|FG000|Overall Study|Relapsed- Mixed Event|3|||
130296041|NCT00552760|469047259|FG001|Overall Study|Relapsed- Mixed Event|5|||
130296042|NCT00552760|469047258|FG000|Overall Study|Protocol Violation|0|||
130296043|NCT00552760|469047259|FG001|Overall Study|Protocol Violation|1|||
130296044|NCT00552760|469047258|FG000|Overall Study|Lost to Follow-up|1|||
130296045|NCT00552760|469047259|FG001|Overall Study|Lost to Follow-up|1|||
130296046|NCT00552760|469047258|FG000|Overall Study|Non-compliance|1|||
130296047|NCT00552760|469047259|FG001|Overall Study|Non-compliance|1|||
130296048|NCT00552760|469047258|FG000|Overall Study|Medical Condition|1|||
130296049|NCT00552760|469047259|FG001|Overall Study|Medical Condition|1|||
130296050|NCT00552760|469047258|FG000|Overall Study|Withdrawal by Subject|3|||
130296051|NCT00552760|469047259|FG001|Overall Study|Withdrawal by Subject|0|||
130296052|NCT00552760|469047258|FG000|Overall Study|Medication Change|1|||
130296053|NCT00552760|469047259|FG001|Overall Study|Medication Change|0|||
130296054|NCT00924404|469047262|FG000|Overall Study|Lost to Follow-up|6|||
130296055|NCT00924404|469047263|FG001|Overall Study|Lost to Follow-up|4|||
130296056|NCT03831945|469047264|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130296057|NCT03831945|469047265|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130296058|NCT03831945|469047264|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130296059|NCT03831945|469047265|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130296060|NCT03831945|469047264|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
130296061|NCT03831945|469047265|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
130296062|NCT00710385|469047267|FG000|Overall Study|Did not qualify|1|||
130296063|NCT00710385|469047267|FG000|Overall Study|Withdrawal by Subject|1|||
130296064|NCT00710385|469047267|FG000|Overall Study|Undisclosed back pain|1|||
130296065|NCT00710385|469047267|FG000|Overall Study|Physician Decision|1|||
130296066|NCT00710385|469047267|FG000|Overall Study|Undisclosed excessive methadone use|1|||
130296067|NCT02976103|469047268|FG000|Overall Study|Withdrawal by Subject|1|||
130296068|NCT02976103|469047269|FG001|Overall Study|Withdrawal by Subject|0|||
130296069|NCT02976103|469047268|FG000|Overall Study|Lost to Follow-up|12|||
130296070|NCT02976103|469047269|FG001|Overall Study|Lost to Follow-up|8|||
130296071|NCT01985360|469047270|FG000|Overall Study|Withdrawal by Subject|4|||
130296072|NCT01985360|469047271|FG001|Overall Study|Withdrawal by Subject|0|||
130557120|NCT01170039|470009890|FG001|Overall Study|Withdrawal by Subject|3|||
130557121|NCT01170039|470009889|FG000|Overall Study|Lack of funding, drug not available|3|||
130557122|NCT01170039|470009890|FG001|Overall Study|Lack of funding, drug not available|3|||
130557123|NCT00908583|470009891|FG000|Phase 1|Withdrawal by Subject|1|||
130557124|NCT00908583|470009891|FG000|Phase 1|Adverse Event|4|||
130557125|NCT00908583|470009891|FG000|Phase 2|Physician Decision|1|||
130557126|NCT00908583|470009891|FG000|Phase 2|Adverse Event|1|||
130557127|NCT00908583|470009891|FG000|Phase 3|Adverse Event|2|||
130557128|NCT00908583|470009891|FG000|Phase 4|Adverse Event|1|||
130557129|NCT00908583|470009891|FG000|Phase 4|Physician Decision|1|||
130296073|NCT01985360|469047270|FG000|Overall Study|Lost to Follow-up|5|||
130296074|NCT01985360|469047271|FG001|Overall Study|Lost to Follow-up|3|||
130372368|NCT01709162|469333337|FG001|Overall Study|Withdrawal by Subject|1|||
130372369|NCT03129100|469333339|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
130296075|NCT04881747|469047274|FG000|Period 2 Washout|Adverse Event|1|||
130296076|NCT04881747|469047275|FG001|Period 2 Washout|Adverse Event|0|||
130296077|NCT04881747|469047276|FG002|Period 2 Washout|Adverse Event|0|||
130296078|NCT04881747|469047277|FG003|Period 2 Washout|Adverse Event|0|||
130557130|NCT00908583|470009891|FG000|Phase 5|Adverse Event|3|||
130557131|NCT00993954|470009892|FG000|Overall Study|Protocol Violation|21|||
130557132|NCT00993954|470009893|FG001|Overall Study|Protocol Violation|2|||
130557133|NCT00860951|470009894|FG000|Overall Study|Withdrawal by Subject|2|||
130372370|NCT03129100|469333340|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
130372371|NCT03129100|469333341|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
130372372|NCT03129100|469333342|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
130372373|NCT03129100|469333343|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
130372374|NCT03129100|469333344|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
130372375|NCT03129100|469333345|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
130372376|NCT03129100|469333346|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
130372377|NCT03129100|469333347|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
130372378|NCT03129100|469333348|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
130372379|NCT03129100|469333349|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
130372380|NCT03129100|469333350|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
130372381|NCT03129100|469333351|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
130372382|NCT03129100|469333352|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
130372383|NCT03129100|469333353|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
130372384|NCT03129100|469333354|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
130372385|NCT03129100|469333355|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
130372386|NCT03129100|469333356|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
130372387|NCT03129100|469333357|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
130372388|NCT03129100|469333358|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
130372389|NCT03129100|469333359|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
130372390|NCT03129100|469333360|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
130372391|NCT03129100|469333361|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
130372392|NCT03129100|469333362|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
130372393|NCT03129100|469333363|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
130372394|NCT03129100|469333364|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
130372395|NCT03129100|469333339|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
130372396|NCT03129100|469333340|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372397|NCT03129100|469333341|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372398|NCT03129100|469333342|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372399|NCT03129100|469333343|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372400|NCT03129100|469333344|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130716047|NCT01150890|470587081|FG003|Overall Study|Ineligibility determined|0|||
130372401|NCT03129100|469333345|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372402|NCT03129100|469333346|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372403|NCT03129100|469333347|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372404|NCT03129100|469333348|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130716048|NCT01150890|470587078|FG000|Overall Study|Adverse Event|0|||
130372405|NCT03129100|469333349|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372406|NCT03129100|469333350|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372407|NCT03129100|469333351|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372408|NCT03129100|469333352|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372409|NCT03129100|469333353|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372410|NCT03129100|469333354|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372411|NCT03129100|469333355|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372412|NCT03129100|469333356|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372413|NCT03129100|469333357|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372414|NCT03129100|469333358|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372415|NCT03129100|469333359|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372416|NCT03129100|469333360|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372417|NCT03129100|469333361|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372418|NCT03129100|469333362|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372419|NCT03129100|469333363|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372420|NCT03129100|469333364|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130372421|NCT03129100|469333339|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
130372422|NCT03129100|469333340|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
130372423|NCT03129100|469333341|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372424|NCT03129100|469333342|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372425|NCT03129100|469333343|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372426|NCT03129100|469333344|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372427|NCT03129100|469333345|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372428|NCT03129100|469333346|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372429|NCT03129100|469333347|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372430|NCT03129100|469333348|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372431|NCT03129100|469333349|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372432|NCT03129100|469333350|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372433|NCT03129100|469333351|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372434|NCT03129100|469333352|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372435|NCT03129100|469333353|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372436|NCT03129100|469333354|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372437|NCT03129100|469333355|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372438|NCT03129100|469333356|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372439|NCT03129100|469333357|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130296079|NCT04881747|469047278|FG004|Period 2 Washout|Adverse Event|1|||
130296080|NCT04881747|469047279|FG005|Period 2 Washout|Adverse Event|0|||
130296081|NCT04881747|469047274|FG000|Period 2 Washout|Withdrawal by Subject|1|||
130296082|NCT04881747|469047275|FG001|Period 2 Washout|Withdrawal by Subject|0|||
130296083|NCT04881747|469047276|FG002|Period 2 Washout|Withdrawal by Subject|0|||
130296084|NCT04881747|469047277|FG003|Period 2 Washout|Withdrawal by Subject|1|||
130296085|NCT04881747|469047278|FG004|Period 2 Washout|Withdrawal by Subject|0|||
130296086|NCT04881747|469047279|FG005|Period 2 Washout|Withdrawal by Subject|0|||
130296087|NCT04598269|469047282|FG000|Overall Study|Adverse Event|0|||
130296088|NCT04598269|469047283|FG001|Overall Study|Adverse Event|3|||
130296089|NCT04598269|469047282|FG000|Overall Study|Withdrawal by Subject|1|||
130296090|NCT04598269|469047283|FG001|Overall Study|Withdrawal by Subject|4|||
130296091|NCT04598269|469047282|FG000|Overall Study|Lost to Follow-up|1|||
130296092|NCT04598269|469047283|FG001|Overall Study|Lost to Follow-up|0|||
130296093|NCT04598269|469047282|FG000|Overall Study|Not Treated|2|||
130296094|NCT04598269|469047283|FG001|Overall Study|Not Treated|0|||
130296095|NCT02598128|469047288|FG000|Period A: Days -7 to -1|Adverse Event|1|||
130296096|NCT02598128|469047289|FG001|Period A: Days -7 to -1|Adverse Event|0|||
130296097|NCT02598128|469047290|FG002|Period A: Days -7 to -1|Adverse Event|0|||
130296098|NCT02598128|469047291|FG003|Period A: Days -7 to -1|Adverse Event|0|||
130296099|NCT01459913|469047292|FG000|Overall Study|Adverse Event|0|||
130296100|NCT01459913|469047293|FG001|Overall Study|Adverse Event|0|||
130296101|NCT01459913|469047294|FG002|Overall Study|Adverse Event|0|||
130296102|NCT01459913|469047295|FG003|Overall Study|Adverse Event|3|||
130296103|NCT01459913|469047292|FG000|Overall Study|Withdrawal by Subject|4|||
130296104|NCT01459913|469047293|FG001|Overall Study|Withdrawal by Subject|0|||
130296105|NCT01459913|469047294|FG002|Overall Study|Withdrawal by Subject|0|||
130296106|NCT01459913|469047295|FG003|Overall Study|Withdrawal by Subject|5|||
130296107|NCT01459913|469047292|FG000|Overall Study|Lost to Follow-up|7|||
130296108|NCT01459913|469047293|FG001|Overall Study|Lost to Follow-up|4|||
130296109|NCT01459913|469047294|FG002|Overall Study|Lost to Follow-up|1|||
130296110|NCT01459913|469047295|FG003|Overall Study|Lost to Follow-up|8|||
130296111|NCT01459913|469047292|FG000|Overall Study|Death|0|||
130296112|NCT01459913|469047293|FG001|Overall Study|Death|0|||
130296113|NCT01459913|469047294|FG002|Overall Study|Death|0|||
130296114|NCT01459913|469047295|FG003|Overall Study|Death|1|||
130296115|NCT01459913|469047292|FG000|Overall Study|Non- Compliance|0|||
130296116|NCT01459913|469047293|FG001|Overall Study|Non- Compliance|0|||
130296117|NCT01459913|469047294|FG002|Overall Study|Non- Compliance|0|||
130296118|NCT01459913|469047295|FG003|Overall Study|Non- Compliance|3|||
130296119|NCT01459913|469047292|FG000|Overall Study|Physician Decision|0|||
130296120|NCT01459913|469047293|FG001|Overall Study|Physician Decision|1|||
130296121|NCT01459913|469047294|FG002|Overall Study|Physician Decision|0|||
130296122|NCT01459913|469047295|FG003|Overall Study|Physician Decision|0|||
130296123|NCT01459913|469047292|FG000|Overall Study|Study Terminated by Sponsor|30|||
130296124|NCT01459913|469047293|FG001|Overall Study|Study Terminated by Sponsor|15|||
130296125|NCT01459913|469047294|FG002|Overall Study|Study Terminated by Sponsor|9|||
130296126|NCT01459913|469047295|FG003|Overall Study|Study Terminated by Sponsor|11|||
130296127|NCT01459913|469047292|FG000|Overall Study|Other|0|||
130296128|NCT01459913|469047293|FG001|Overall Study|Other|0|||
130296129|NCT01459913|469047294|FG002|Overall Study|Other|3|||
130296130|NCT01459913|469047295|FG003|Overall Study|Other|1|||
130296131|NCT01459913|469047292|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296132|NCT01459913|469047293|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296133|NCT01459913|469047294|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296134|NCT01459913|469047295|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
130296135|NCT01064687|469047297|FG000|Overall Study|Adverse Event|9|||
130296136|NCT01064687|469047298|FG001|Overall Study|Adverse Event|4|||
130296137|NCT01064687|469047299|FG002|Overall Study|Adverse Event|10|||
130296138|NCT01064687|469047300|FG003|Overall Study|Adverse Event|3|||
130296139|NCT01064687|469047297|FG000|Overall Study|Death|1|||
130296140|NCT01064687|469047298|FG001|Overall Study|Death|1|||
130296141|NCT01064687|469047299|FG002|Overall Study|Death|0|||
130296142|NCT01064687|469047300|FG003|Overall Study|Death|0|||
130557134|NCT00860951|470009894|FG000|Overall Study|Lost to Follow-up|5|||
130296143|NCT01064687|469047297|FG000|Overall Study|Entry Criteria Not Met|3|||
130296144|NCT01064687|469047298|FG001|Overall Study|Entry Criteria Not Met|0|||
130296145|NCT01064687|469047299|FG002|Overall Study|Entry Criteria Not Met|0|||
130296146|NCT01064687|469047300|FG003|Overall Study|Entry Criteria Not Met|0|||
130296147|NCT01064687|469047297|FG000|Overall Study|Lack of Efficacy|1|||
130296148|NCT01064687|469047298|FG001|Overall Study|Lack of Efficacy|0|||
130296149|NCT01064687|469047299|FG002|Overall Study|Lack of Efficacy|2|||
130296150|NCT01064687|469047300|FG003|Overall Study|Lack of Efficacy|3|||
130296151|NCT01064687|469047297|FG000|Overall Study|Lost to Follow-up|7|||
130296152|NCT01064687|469047298|FG001|Overall Study|Lost to Follow-up|10|||
130296153|NCT01064687|469047299|FG002|Overall Study|Lost to Follow-up|13|||
130296154|NCT01064687|469047300|FG003|Overall Study|Lost to Follow-up|5|||
130296155|NCT01064687|469047297|FG000|Overall Study|Physician Decision|2|||
130296156|NCT01064687|469047298|FG001|Overall Study|Physician Decision|2|||
130296157|NCT01064687|469047299|FG002|Overall Study|Physician Decision|0|||
130296158|NCT01064687|469047300|FG003|Overall Study|Physician Decision|0|||
130296159|NCT01064687|469047297|FG000|Overall Study|Protocol Violation|1|||
130296160|NCT01064687|469047298|FG001|Overall Study|Protocol Violation|1|||
130296161|NCT01064687|469047299|FG002|Overall Study|Protocol Violation|0|||
130296162|NCT01064687|469047300|FG003|Overall Study|Protocol Violation|1|||
130296163|NCT01064687|469047297|FG000|Overall Study|Sponsor Decision|0|||
130296164|NCT01064687|469047298|FG001|Overall Study|Sponsor Decision|0|||
130296165|NCT01064687|469047299|FG002|Overall Study|Sponsor Decision|3|||
130296166|NCT01064687|469047300|FG003|Overall Study|Sponsor Decision|0|||
130296167|NCT01064687|469047297|FG000|Overall Study|Withdrawal by Subject|9|||
130296168|NCT01064687|469047298|FG001|Overall Study|Withdrawal by Subject|7|||
130296169|NCT01064687|469047299|FG002|Overall Study|Withdrawal by Subject|12|||
130296170|NCT01064687|469047300|FG003|Overall Study|Withdrawal by Subject|5|||
130296171|NCT01064687|469047297|FG000|Overall Study|Treatment Noncompliance|1|||
130296172|NCT01064687|469047298|FG001|Overall Study|Treatment Noncompliance|1|||
130296173|NCT01064687|469047299|FG002|Overall Study|Treatment Noncompliance|1|||
130296174|NCT01064687|469047300|FG003|Overall Study|Treatment Noncompliance|0|||
130296175|NCT00619489|469047301|FG000|Overall Study|Adverse Event|0|||
130296176|NCT00619489|469047302|FG001|Overall Study|Adverse Event|7|||
130296177|NCT00619489|469047301|FG000|Overall Study|Withdrawal by Subject|1|||
130296178|NCT00619489|469047302|FG001|Overall Study|Withdrawal by Subject|1|||
130296179|NCT00619489|469047301|FG000|Overall Study|Lack of Efficacy|0|||
130296180|NCT00619489|469047302|FG001|Overall Study|Lack of Efficacy|11|||
130296181|NCT00619489|469047301|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
130296182|NCT00619489|469047302|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
130296183|NCT02966015|469047303|FG000|Inclusion Visit|did not answer questionnaire|8|||
130296184|NCT02966015|469047304|FG001|Inclusion Visit|did not answer questionnaire|3|||
130296185|NCT03040986|469047309|FG000|Overall Study|Hospice|1|||
130296186|NCT03040986|469047310|FG001|Overall Study|Hospice|0|||
130296187|NCT03040986|469047309|FG000|Overall Study|Adverse Event|2|||
130296188|NCT03040986|469047310|FG001|Overall Study|Adverse Event|1|||
130296189|NCT03040986|469047309|FG000|Overall Study|Disease progression on study|3|||
130296190|NCT03040986|469047310|FG001|Overall Study|Disease progression on study|1|||
130296191|NCT01183468|469047315|FG000|Overall Study|Lost to Follow-up|2|||
130296192|NCT01183468|469047316|FG001|Overall Study|Lost to Follow-up|1|||
130296193|NCT01183468|469047317|FG002|Overall Study|Lost to Follow-up|0|||
130296194|NCT01183468|469047318|FG003|Overall Study|Lost to Follow-up|0|||
130296195|NCT01183468|469047315|FG000|Overall Study|Physician Decision|1|||
130296196|NCT01183468|469047316|FG001|Overall Study|Physician Decision|0|||
130296197|NCT01183468|469047317|FG002|Overall Study|Physician Decision|0|||
130296198|NCT01183468|469047318|FG003|Overall Study|Physician Decision|0|||
130296199|NCT01183468|469047315|FG000|Overall Study|Withdrawal by Subject|0|||
130296200|NCT01183468|469047316|FG001|Overall Study|Withdrawal by Subject|1|||
130296201|NCT01183468|469047317|FG002|Overall Study|Withdrawal by Subject|0|||
130296202|NCT01183468|469047318|FG003|Overall Study|Withdrawal by Subject|0|||
130296203|NCT00845065|469047319|FG000|Overall Study|Adverse Event|3|||
130296204|NCT00845065|469047320|FG001|Overall Study|Adverse Event|23|||
130296205|NCT00845065|469047319|FG000|Overall Study|Lack of Efficacy|43|||
130296206|NCT00845065|469047320|FG001|Overall Study|Lack of Efficacy|21|||
130296207|NCT00845065|469047319|FG000|Overall Study|Non-Medical Reasons|1|||
130296208|NCT00845065|469047320|FG001|Overall Study|Non-Medical Reasons|11|||
130296209|NCT01198509|469047321|FG000|Overall Study|Withdrawal by Subject|1|||
130296210|NCT01198509|469047322|FG001|Overall Study|Withdrawal by Subject|0|||
130296211|NCT01198509|469047323|FG002|Overall Study|Withdrawal by Subject|0|||
130296212|NCT01198509|469047324|FG003|Overall Study|Withdrawal by Subject|0|||
130296213|NCT01198509|469047325|FG004|Overall Study|Withdrawal by Subject|0|||
130296214|NCT01198509|469047326|FG005|Overall Study|Withdrawal by Subject|0|||
130296215|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
130296216|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
130296217|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
130296218|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
130296219|NCT02273960|469047328|FG000|Short Term Period|Lost to Follow-up|1|||
130296220|NCT02273960|469047329|FG001|Short Term Period|Lost to Follow-up|0|||
130296221|NCT02273960|469047330|FG002|Short Term Period|Lost to Follow-up|0|||
130296222|NCT02273960|469047331|FG003|Short Term Period|Lost to Follow-up|0|||
130296223|NCT02273960|469047328|FG000|Short Term Period|Lack of Efficacy|0|||
130296224|NCT02273960|469047329|FG001|Short Term Period|Lack of Efficacy|0|||
130296225|NCT02273960|469047330|FG002|Short Term Period|Lack of Efficacy|0|||
130296226|NCT02273960|469047331|FG003|Short Term Period|Lack of Efficacy|1|||
130296227|NCT02273960|469047328|FG000|Short Term Period|ST complete, not entering LTE|4|||
130296228|NCT02273960|469047329|FG001|Short Term Period|ST complete, not entering LTE|6|||
130296229|NCT02273960|469047330|FG002|Short Term Period|ST complete, not entering LTE|4|||
130296230|NCT02273960|469047331|FG003|Short Term Period|ST complete, not entering LTE|5|||
130296231|NCT02273960|469047328|FG000|Long Term Extension|Death|0|||
130296232|NCT02273960|469047329|FG001|Long Term Extension|Death|0|||
130296233|NCT02273960|469047330|FG002|Long Term Extension|Death|0|||
130296234|NCT02273960|469047331|FG003|Long Term Extension|Death|1|||
130296235|NCT00558272|469047332|FG000|Overall Study|Adverse Event|10|||
130296236|NCT00558272|469047333|FG001|Overall Study|Adverse Event|0|||
130296237|NCT00558272|469047332|FG000|Overall Study|Death|1|||
130296238|NCT00558272|469047333|FG001|Overall Study|Death|0|||
130296239|NCT00558272|469047332|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
130296240|NCT00558272|469047333|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
130296241|NCT00558272|469047332|FG000|Overall Study|AZ study team decision|0|||
130296242|NCT00558272|469047333|FG001|Overall Study|AZ study team decision|1|||
130296243|NCT00558272|469047332|FG000|Overall Study|Incorrectly enrolled|1|||
130296244|NCT00558272|469047333|FG001|Overall Study|Incorrectly enrolled|0|||
130296245|NCT00558272|469047332|FG000|Overall Study|Withdrawal by Subject|0|||
130296246|NCT00558272|469047333|FG001|Overall Study|Withdrawal by Subject|1|||
130296247|NCT02745535|469047335|FG000|Overall Study|Death|1|||
130296248|NCT02745535|469047335|FG000|Overall Study|Adverse Event|3|||
130296249|NCT02745535|469047335|FG000|Overall Study|Lost to Follow-up|2|||
130296250|NCT00849108|469047336|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
130296251|NCT00849108|469047337|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
130296252|NCT00849108|469047336|FG000|Cohort 2 Efficacy|Adverse Event|0|||
130296253|NCT00849108|469047337|FG001|Cohort 2 Efficacy|Adverse Event|1|||
130296254|NCT00849108|469047336|FG000|Cohort 2 Efficacy|Other|0|||
130296255|NCT00849108|469047337|FG001|Cohort 2 Efficacy|Other|9|||
130296256|NCT01563172|469047338|FG000|Overall Study|Adverse Event|5|||
130296257|NCT01563172|469047338|FG000|Overall Study|Lost to Follow-up|2|||
130296258|NCT01563172|469047338|FG000|Overall Study|Other (Protocol deviation)|5|||
130296259|NCT01563172|469047338|FG000|Overall Study|Other (Not specified)|1|||
130296260|NCT02014584|469047341|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296261|NCT02014584|469047342|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
130296262|NCT02014584|469047343|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296263|NCT02014584|469047344|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296264|NCT02014584|469047345|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296265|NCT02014584|469047346|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296266|NCT02014584|469047341|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
130296267|NCT02014584|469047342|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
130296268|NCT02014584|469047343|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296269|NCT02014584|469047344|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296270|NCT02014584|469047345|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296271|NCT02014584|469047346|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296272|NCT02014584|469047341|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296273|NCT02014584|469047342|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296274|NCT02014584|469047343|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
130296275|NCT02014584|469047344|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296276|NCT02014584|469047345|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296277|NCT02014584|469047346|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296278|NCT02014584|469047341|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296279|NCT02014584|469047342|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296280|NCT02014584|469047343|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
130296281|NCT02014584|469047344|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
130296282|NCT02014584|469047345|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296283|NCT02014584|469047346|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296284|NCT02014584|469047341|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296285|NCT02014584|469047342|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296286|NCT02014584|469047343|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296287|NCT02014584|469047344|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296288|NCT02014584|469047345|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
130296289|NCT02014584|469047346|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130372440|NCT03129100|469333358|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372441|NCT03129100|469333359|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372442|NCT03129100|469333360|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372443|NCT03129100|469333361|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372444|NCT03129100|469333362|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372445|NCT03129100|469333363|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372446|NCT03129100|469333364|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130372447|NCT03129100|469333339|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
130372448|NCT03129100|469333340|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
130372449|NCT03129100|469333341|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372450|NCT03129100|469333342|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372451|NCT03129100|469333343|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372452|NCT03129100|469333344|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372453|NCT03129100|469333345|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372454|NCT03129100|469333346|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372455|NCT03129100|469333347|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130296290|NCT00772109|469047347|FG000|Overall Study|Serious adverse event|1|||
130296291|NCT00772109|469047348|FG001|Overall Study|Serious adverse event|0|||
130296292|NCT00772109|469047349|FG002|Overall Study|Serious adverse event|1|||
130296293|NCT00772109|469047350|FG003|Overall Study|Serious adverse event|0|||
130296294|NCT00772109|469047347|FG000|Overall Study|Protocol Violation|5|||
130296295|NCT00772109|469047348|FG001|Overall Study|Protocol Violation|8|||
130296296|NCT00772109|469047349|FG002|Overall Study|Protocol Violation|7|||
130296297|NCT00772109|469047350|FG003|Overall Study|Protocol Violation|6|||
130296298|NCT00772109|469047347|FG000|Overall Study|Lost to Follow-up|7|||
130296299|NCT00772109|469047348|FG001|Overall Study|Lost to Follow-up|3|||
130296300|NCT00772109|469047349|FG002|Overall Study|Lost to Follow-up|5|||
130296301|NCT00772109|469047350|FG003|Overall Study|Lost to Follow-up|9|||
130296302|NCT00772109|469047347|FG000|Overall Study|Withdrawal by Subject|8|||
130296303|NCT00772109|469047348|FG001|Overall Study|Withdrawal by Subject|8|||
130296304|NCT00772109|469047349|FG002|Overall Study|Withdrawal by Subject|6|||
130296305|NCT00772109|469047350|FG003|Overall Study|Withdrawal by Subject|16|||
130296306|NCT01624090|469047351|FG000|Overall Study|DLT, taken off therapy|0|||
130296307|NCT01624090|469047352|FG001|Overall Study|DLT, taken off therapy|1|||
130296308|NCT01624090|469047353|FG002|Overall Study|DLT, taken off therapy|0|||
130296309|NCT01624090|469047354|FG003|Overall Study|DLT, taken off therapy|0|||
130296310|NCT01624090|469047351|FG000|Overall Study|Withdrew prior to treatment|0|||
130296311|NCT01624090|469047352|FG001|Overall Study|Withdrew prior to treatment|1|||
130296312|NCT01624090|469047353|FG002|Overall Study|Withdrew prior to treatment|0|||
130296313|NCT01624090|469047354|FG003|Overall Study|Withdrew prior to treatment|0|||
130296314|NCT01624090|469047351|FG000|Overall Study|Died on study|0|||
130296315|NCT01624090|469047352|FG001|Overall Study|Died on study|0|||
130296316|NCT01624090|469047353|FG002|Overall Study|Died on study|2|||
130296317|NCT01624090|469047354|FG003|Overall Study|Died on study|0|||
130296318|NCT01624090|469047351|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
130296319|NCT01624090|469047352|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
130296320|NCT01624090|469047353|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
130296321|NCT01624090|469047354|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
130296322|NCT01624090|469047351|FG000|Overall Study|Dose escalated|0|||
130296323|NCT01624090|469047352|FG001|Overall Study|Dose escalated|0|||
130296324|NCT01624090|469047353|FG002|Overall Study|Dose escalated|3|||
130296325|NCT01624090|469047354|FG003|Overall Study|Dose escalated|0|||
130296326|NCT00752726|469047355|FG000|Overall Study|Lost to Follow-up|2|||
130296327|NCT00752726|469047356|FG001|Overall Study|Lost to Follow-up|1|||
130296328|NCT00752726|469047355|FG000|Overall Study|Adverse Event|3|||
130296329|NCT00752726|469047356|FG001|Overall Study|Adverse Event|0|||
130296330|NCT00752726|469047355|FG000|Overall Study|Withdrawal by Subject|5|||
130296331|NCT00752726|469047356|FG001|Overall Study|Withdrawal by Subject|10|||
130460918|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460919|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460920|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460921|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460922|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
130460923|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
130460924|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
130460925|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
130460926|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460927|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460928|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460929|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460930|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460931|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460932|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460933|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460934|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130460935|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
130460936|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
130460937|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
130296332|NCT00752726|469047355|FG000|Overall Study|Other Reason|1|||
130460938|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
130296333|NCT00752726|469047356|FG001|Overall Study|Other Reason|2|||
130296334|NCT00042666|469047357|FG000|Overall Study|Adverse Event|2|||
130296335|NCT00042666|469047357|FG000|Overall Study|Death|4|||
130296336|NCT00042666|469047357|FG000|Overall Study|Protocol Violation|1|||
130296337|NCT00042666|469047357|FG000|Overall Study|Participant/Physician Perception|1|||
130460939|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460940|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460941|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130296338|NCT00042666|469047357|FG000|Overall Study|Progressive Disease|41|||
130296339|NCT00042666|469047357|FG000|Overall Study|Other|1|||
130296340|NCT00042666|469047357|FG000|Overall Study|Other|4|||
130296341|NCT04232215|469047358|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130296342|NCT04232215|469047359|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130296343|NCT01555125|469047362|FG000|Induction Period|Lost to Follow-up|0|||
130296344|NCT01555125|469047363|FG001|Induction Period|Lost to Follow-up|2|||
130296345|NCT01555125|469047364|FG002|Induction Period|Lost to Follow-up|0|||
130296346|NCT01555125|469047365|FG003|Induction Period|Lost to Follow-up|0|||
130296347|NCT01555125|469047366|FG004|Induction Period|Lost to Follow-up|0|||
130296348|NCT01555125|469047362|FG000|Induction Period|Adverse Event|0|||
130296349|NCT01555125|469047363|FG001|Induction Period|Adverse Event|1|||
130296350|NCT01555125|469047364|FG002|Induction Period|Adverse Event|0|||
130296351|NCT01555125|469047365|FG003|Induction Period|Adverse Event|0|||
130296352|NCT01555125|469047366|FG004|Induction Period|Adverse Event|1|||
130296353|NCT01555125|469047362|FG000|Induction Period|Subject / guardian decision|0|||
130296354|NCT01555125|469047363|FG001|Induction Period|Subject / guardian decision|0|||
130296355|NCT01555125|469047364|FG002|Induction Period|Subject / guardian decision|0|||
130296356|NCT01555125|469047365|FG003|Induction Period|Subject / guardian decision|0|||
130296357|NCT01555125|469047366|FG004|Induction Period|Subject / guardian decision|2|||
130296358|NCT01555125|469047362|FG000|Induction Period|Death|1|||
130296359|NCT01555125|469047363|FG001|Induction Period|Death|0|||
130296360|NCT01555125|469047364|FG002|Induction Period|Death|0|||
130296361|NCT01555125|469047365|FG003|Induction Period|Death|0|||
130296362|NCT01555125|469047366|FG004|Induction Period|Death|0|||
130296363|NCT01555125|469047362|FG000|Maintenance Period|Adverse Event|1|||
130296364|NCT01555125|469047363|FG001|Maintenance Period|Adverse Event|1|||
130296365|NCT01555125|469047364|FG002|Maintenance Period|Adverse Event|0|||
130296366|NCT01555125|469047365|FG003|Maintenance Period|Adverse Event|0|||
130296367|NCT01555125|469047366|FG004|Maintenance Period|Adverse Event|0|||
130296368|NCT01555125|469047362|FG000|Maintenance Period|Subject / guardian decision|1|||
130296369|NCT01555125|469047363|FG001|Maintenance Period|Subject / guardian decision|2|||
130296370|NCT01555125|469047364|FG002|Maintenance Period|Subject / guardian decision|0|||
130296371|NCT01555125|469047365|FG003|Maintenance Period|Subject / guardian decision|0|||
130296372|NCT01555125|469047366|FG004|Maintenance Period|Subject / guardian decision|0|||
130296373|NCT01555125|469047362|FG000|Maintenance Period|Lost to Follow-up|2|||
130296374|NCT01555125|469047363|FG001|Maintenance Period|Lost to Follow-up|0|||
130296375|NCT01555125|469047364|FG002|Maintenance Period|Lost to Follow-up|0|||
130296376|NCT01555125|469047365|FG003|Maintenance Period|Lost to Follow-up|1|||
130296377|NCT01555125|469047366|FG004|Maintenance Period|Lost to Follow-up|0|||
130296378|NCT01555125|469047362|FG000|Maintenance Period|Lack of Efficacy|6|||
130296379|NCT01555125|469047363|FG001|Maintenance Period|Lack of Efficacy|1|||
130296380|NCT01555125|469047364|FG002|Maintenance Period|Lack of Efficacy|3|||
130296381|NCT01555125|469047365|FG003|Maintenance Period|Lack of Efficacy|0|||
130296382|NCT01555125|469047366|FG004|Maintenance Period|Lack of Efficacy|0|||
130296383|NCT01555125|469047362|FG000|Maintenance Period|Physician Decision|0|||
130296384|NCT01555125|469047363|FG001|Maintenance Period|Physician Decision|0|||
130296385|NCT01555125|469047364|FG002|Maintenance Period|Physician Decision|1|||
130296386|NCT01555125|469047365|FG003|Maintenance Period|Physician Decision|0|||
130296387|NCT01555125|469047366|FG004|Maintenance Period|Physician Decision|0|||
130296388|NCT01555125|469047362|FG000|Maintenance Period|Death|0|||
130296389|NCT01555125|469047363|FG001|Maintenance Period|Death|0|||
130296390|NCT01555125|469047364|FG002|Maintenance Period|Death|0|||
130296391|NCT01555125|469047365|FG003|Maintenance Period|Death|1|||
130296392|NCT01555125|469047366|FG004|Maintenance Period|Death|0|||
130296393|NCT01555125|469047362|FG000|Extension|Adverse Event|1|||
130296394|NCT01555125|469047363|FG001|Extension|Adverse Event|2|||
130296395|NCT01555125|469047364|FG002|Extension|Adverse Event|1|||
130296396|NCT01555125|469047365|FG003|Extension|Adverse Event|1|||
130296397|NCT01555125|469047366|FG004|Extension|Adverse Event|0|||
130296398|NCT01555125|469047362|FG000|Extension|Protocol deviation|1|||
130296399|NCT01555125|469047363|FG001|Extension|Protocol deviation|0|||
130296400|NCT01555125|469047364|FG002|Extension|Protocol deviation|0|||
130296401|NCT01555125|469047365|FG003|Extension|Protocol deviation|0|||
130296402|NCT01555125|469047366|FG004|Extension|Protocol deviation|0|||
130296403|NCT01555125|469047362|FG000|Extension|Lack of Efficacy|7|||
130296404|NCT01555125|469047363|FG001|Extension|Lack of Efficacy|6|||
130296405|NCT01555125|469047364|FG002|Extension|Lack of Efficacy|3|||
130296406|NCT01555125|469047365|FG003|Extension|Lack of Efficacy|0|||
130296407|NCT01555125|469047366|FG004|Extension|Lack of Efficacy|0|||
130296408|NCT01555125|469047362|FG000|Extension|Lost to Follow-up|2|||
130296409|NCT01555125|469047363|FG001|Extension|Lost to Follow-up|1|||
130296410|NCT01555125|469047364|FG002|Extension|Lost to Follow-up|2|||
130296411|NCT01555125|469047365|FG003|Extension|Lost to Follow-up|0|||
130296412|NCT01555125|469047366|FG004|Extension|Lost to Follow-up|0|||
130296413|NCT01555125|469047362|FG000|Extension|Study terminated by sponsor|32|||
130296414|NCT01555125|469047363|FG001|Extension|Study terminated by sponsor|33|||
130296415|NCT01555125|469047364|FG002|Extension|Study terminated by sponsor|16|||
130296416|NCT01555125|469047365|FG003|Extension|Study terminated by sponsor|20|||
130296417|NCT01555125|469047366|FG004|Extension|Study terminated by sponsor|0|||
130296418|NCT01555125|469047362|FG000|Extension|Subject/guardian decision|1|||
130557135|NCT00727649|470009895|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
130716049|NCT01150890|470587079|FG001|Overall Study|Adverse Event|0|||
130716050|NCT01150890|470587080|FG002|Overall Study|Adverse Event|2|||
130716051|NCT01150890|470587081|FG003|Overall Study|Adverse Event|0|||
130716052|NCT01150890|470587078|FG000|Overall Study|Withdrawal by Subject|0|||
130296419|NCT01555125|469047363|FG001|Extension|Subject/guardian decision|9|||
130296420|NCT01555125|469047364|FG002|Extension|Subject/guardian decision|1|||
130296421|NCT01555125|469047365|FG003|Extension|Subject/guardian decision|0|||
130296422|NCT01555125|469047366|FG004|Extension|Subject/guardian decision|0|||
130296423|NCT01555125|469047362|FG000|Extension|Technical Problems|1|||
130296424|NCT01555125|469047363|FG001|Extension|Technical Problems|0|||
130296425|NCT01555125|469047364|FG002|Extension|Technical Problems|0|||
130296426|NCT01555125|469047365|FG003|Extension|Technical Problems|1|||
130296427|NCT01555125|469047366|FG004|Extension|Technical Problems|0|||
130296428|NCT01555125|469047362|FG000|Follow-Up Period|Lost to Follow-up|1|||
130296429|NCT01555125|469047363|FG001|Follow-Up Period|Lost to Follow-up|0|||
130296430|NCT01555125|469047364|FG002|Follow-Up Period|Lost to Follow-up|0|||
130296431|NCT01555125|469047365|FG003|Follow-Up Period|Lost to Follow-up|0|||
130296432|NCT01555125|469047366|FG004|Follow-Up Period|Lost to Follow-up|0|||
130296433|NCT01555125|469047362|FG000|Follow-Up Period|Subject / guardian decision|3|||
130296434|NCT01555125|469047363|FG001|Follow-Up Period|Subject / guardian decision|1|||
130296435|NCT01555125|469047364|FG002|Follow-Up Period|Subject / guardian decision|1|||
130296436|NCT01555125|469047365|FG003|Follow-Up Period|Subject / guardian decision|1|||
130296437|NCT01555125|469047366|FG004|Follow-Up Period|Subject / guardian decision|0|||
130296438|NCT02651220|469047367|FG000|Overall Study|Adverse Event|1|||
130296439|NCT02651220|469047368|FG001|Overall Study|Adverse Event|5|||
130296440|NCT02651220|469047369|FG002|Overall Study|Adverse Event|1|||
130296441|NCT02651220|469047367|FG000|Overall Study|Lost to Follow-up|8|||
130296442|NCT02651220|469047368|FG001|Overall Study|Lost to Follow-up|14|||
130460942|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460943|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460944|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460945|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460946|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460947|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
130460948|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
130460949|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
130460950|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
130460951|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
130460952|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460953|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460954|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460955|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460956|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460957|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460958|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460959|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460960|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460961|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460962|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
130460963|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
130460964|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
130460965|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460966|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460967|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460968|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460969|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460970|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460971|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460972|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460973|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460974|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
130460975|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
130460976|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460977|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
130460978|NCT04707313|469652205|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130557136|NCT00727649|470009896|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
130296443|NCT02651220|469047369|FG002|Overall Study|Lost to Follow-up|14|||
130296444|NCT02651220|469047367|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130296445|NCT02651220|469047368|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130296446|NCT02651220|469047369|FG002|Overall Study|Non-Compliance with Study Drug|1|||
130460979|NCT04707313|469652206|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130296447|NCT02651220|469047367|FG000|Overall Study|Pregnancy|1|||
130296448|NCT02651220|469047368|FG001|Overall Study|Pregnancy|0|||
130296449|NCT02651220|469047369|FG002|Overall Study|Pregnancy|1|||
130296450|NCT02651220|469047367|FG000|Overall Study|Protocol Violation|0|||
130296451|NCT02651220|469047368|FG001|Overall Study|Protocol Violation|0|||
130296452|NCT02651220|469047369|FG002|Overall Study|Protocol Violation|1|||
130296453|NCT02651220|469047367|FG000|Overall Study|Withdrawal by Subject|5|||
130296454|NCT02651220|469047368|FG001|Overall Study|Withdrawal by Subject|6|||
130296455|NCT02651220|469047369|FG002|Overall Study|Withdrawal by Subject|8|||
130296456|NCT02651220|469047367|FG000|Overall Study|Miscellaneous|4|||
130296457|NCT02651220|469047368|FG001|Overall Study|Miscellaneous|1|||
130296458|NCT02651220|469047369|FG002|Overall Study|Miscellaneous|2|||
130296459|NCT02651220|469047367|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130296460|NCT02651220|469047368|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130296461|NCT02651220|469047369|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130296462|NCT05327361|469047377|FG000|Overall Study|Lost to Follow-up|4|||
130296463|NCT01439373|469047378|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
130296464|NCT01439373|469047379|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
130296465|NCT01439373|469047378|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
130296466|NCT01439373|469047379|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
130296467|NCT01078168|469047384|FG000|Overall Study|Physician Decision|0|||
130296468|NCT01078168|469047385|FG001|Overall Study|Physician Decision|1|||
130296469|NCT01264419|469047387|FG000|Overall Study|Lost to Follow-up|3|||
130296470|NCT00477152|469049878|FG000|Overall Study|Parent withdrew consent|2|||
130296471|NCT00477152|469049878|FG000|Overall Study|Adverse Event|1|||
130296472|NCT02905006|469049879|FG000|Overall Study|Adverse Event|1|||
130296473|NCT02905006|469049880|FG001|Overall Study|Adverse Event|1|||
130296474|NCT02905006|469049881|FG002|Overall Study|Adverse Event|1|||
130296475|NCT02905006|469049882|FG003|Overall Study|Adverse Event|1|||
130296476|NCT02905006|469049883|FG004|Overall Study|Adverse Event|0|||
130296477|NCT02905006|469049884|FG005|Overall Study|Adverse Event|1|||
130296478|NCT02905006|469049879|FG000|Overall Study|Lack of Efficacy|1|||
130296479|NCT02905006|469049880|FG001|Overall Study|Lack of Efficacy|0|||
130296480|NCT02905006|469049881|FG002|Overall Study|Lack of Efficacy|0|||
130296481|NCT02905006|469049882|FG003|Overall Study|Lack of Efficacy|0|||
130296482|NCT02905006|469049883|FG004|Overall Study|Lack of Efficacy|0|||
130296483|NCT02905006|469049884|FG005|Overall Study|Lack of Efficacy|0|||
130296484|NCT02905006|469049879|FG000|Overall Study|Protocol Violation|2|||
130296485|NCT02905006|469049880|FG001|Overall Study|Protocol Violation|0|||
130296486|NCT02905006|469049881|FG002|Overall Study|Protocol Violation|0|||
130296487|NCT02905006|469049882|FG003|Overall Study|Protocol Violation|0|||
130296488|NCT02905006|469049883|FG004|Overall Study|Protocol Violation|0|||
130296489|NCT02905006|469049884|FG005|Overall Study|Protocol Violation|0|||
130296490|NCT02905006|469049879|FG000|Overall Study|Lost to Follow-up|0|||
130296491|NCT02905006|469049880|FG001|Overall Study|Lost to Follow-up|0|||
130296492|NCT02905006|469049881|FG002|Overall Study|Lost to Follow-up|0|||
130296493|NCT02905006|469049882|FG003|Overall Study|Lost to Follow-up|1|||
130296494|NCT02905006|469049883|FG004|Overall Study|Lost to Follow-up|1|||
130296495|NCT02905006|469049884|FG005|Overall Study|Lost to Follow-up|0|||
130296496|NCT02905006|469049879|FG000|Overall Study|Withdrawal by Subject|0|||
130296497|NCT02905006|469049880|FG001|Overall Study|Withdrawal by Subject|0|||
130296498|NCT02905006|469049881|FG002|Overall Study|Withdrawal by Subject|1|||
130296499|NCT02905006|469049882|FG003|Overall Study|Withdrawal by Subject|1|||
130296500|NCT02905006|469049883|FG004|Overall Study|Withdrawal by Subject|0|||
130296501|NCT02905006|469049884|FG005|Overall Study|Withdrawal by Subject|1|||
130296502|NCT02905006|469049879|FG000|Overall Study|Screening exclusion criteria met|1|||
130296503|NCT02905006|469049880|FG001|Overall Study|Screening exclusion criteria met|0|||
130296504|NCT02905006|469049881|FG002|Overall Study|Screening exclusion criteria met|0|||
130296505|NCT02905006|469049882|FG003|Overall Study|Screening exclusion criteria met|0|||
130296506|NCT02905006|469049883|FG004|Overall Study|Screening exclusion criteria met|0|||
130296507|NCT02905006|469049884|FG005|Overall Study|Screening exclusion criteria met|0|||
130296508|NCT02905006|469049879|FG000|Overall Study|Lab withdrawal criterion met|0|||
130296509|NCT02905006|469049880|FG001|Overall Study|Lab withdrawal criterion met|1|||
130296510|NCT02905006|469049881|FG002|Overall Study|Lab withdrawal criterion met|2|||
130296511|NCT02905006|469049882|FG003|Overall Study|Lab withdrawal criterion met|2|||
130296512|NCT02905006|469049883|FG004|Overall Study|Lab withdrawal criterion met|2|||
130296513|NCT02905006|469049884|FG005|Overall Study|Lab withdrawal criterion met|1|||
130296514|NCT02905006|469049879|FG000|Overall Study|Positive for Tuberculosis|0|||
130296515|NCT02905006|469049880|FG001|Overall Study|Positive for Tuberculosis|1|||
130296516|NCT02905006|469049881|FG002|Overall Study|Positive for Tuberculosis|0|||
130296517|NCT02905006|469049882|FG003|Overall Study|Positive for Tuberculosis|0|||
130296518|NCT02905006|469049883|FG004|Overall Study|Positive for Tuberculosis|0|||
130296519|NCT02905006|469049884|FG005|Overall Study|Positive for Tuberculosis|0|||
130296520|NCT02905006|469049879|FG000|Overall Study|Subject positive for Hep B|0|||
130296521|NCT02905006|469049880|FG001|Overall Study|Subject positive for Hep B|0|||
130296522|NCT02905006|469049881|FG002|Overall Study|Subject positive for Hep B|1|||
130296523|NCT02905006|469049882|FG003|Overall Study|Subject positive for Hep B|0|||
130372456|NCT03129100|469333348|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372457|NCT03129100|469333349|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372458|NCT03129100|469333350|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372459|NCT03129100|469333351|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372460|NCT03129100|469333352|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130296524|NCT02905006|469049883|FG004|Overall Study|Subject positive for Hep B|0|||
130372461|NCT03129100|469333353|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372462|NCT03129100|469333354|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372463|NCT03129100|469333355|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372464|NCT03129100|469333356|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372465|NCT03129100|469333357|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372466|NCT03129100|469333358|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372467|NCT03129100|469333359|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372468|NCT03129100|469333360|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372469|NCT03129100|469333361|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372470|NCT03129100|469333362|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372471|NCT03129100|469333363|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372472|NCT03129100|469333364|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130372473|NCT03129100|469333339|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372474|NCT03129100|469333340|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
130372475|NCT03129100|469333341|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372476|NCT03129100|469333342|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372477|NCT03129100|469333343|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372478|NCT03129100|469333344|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372479|NCT03129100|469333345|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372480|NCT03129100|469333346|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372481|NCT03129100|469333347|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372482|NCT03129100|469333348|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372483|NCT03129100|469333349|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372484|NCT03129100|469333350|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372485|NCT03129100|469333351|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372486|NCT03129100|469333352|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372487|NCT03129100|469333353|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372488|NCT03129100|469333354|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372489|NCT03129100|469333355|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372490|NCT03129100|469333356|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372491|NCT03129100|469333357|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372492|NCT03129100|469333358|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372493|NCT03129100|469333359|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372494|NCT03129100|469333360|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372495|NCT03129100|469333361|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372496|NCT03129100|469333362|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372497|NCT03129100|469333363|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372498|NCT03129100|469333364|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
130372499|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130296525|NCT02905006|469049884|FG005|Overall Study|Subject positive for Hep B|0|||
130296526|NCT02905006|469049879|FG000|Overall Study|Patient moved abroad|0|||
130372500|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372501|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
130372502|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
130372503|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130296527|NCT02905006|469049880|FG001|Overall Study|Patient moved abroad|0|||
130296528|NCT02905006|469049881|FG002|Overall Study|Patient moved abroad|0|||
130296529|NCT02905006|469049882|FG003|Overall Study|Patient moved abroad|1|||
130296530|NCT02905006|469049883|FG004|Overall Study|Patient moved abroad|0|||
130296531|NCT02905006|469049884|FG005|Overall Study|Patient moved abroad|0|||
130296532|NCT02905006|469049879|FG000|Overall Study|Patient randomized by mistake|0|||
130296533|NCT02905006|469049880|FG001|Overall Study|Patient randomized by mistake|0|||
130296534|NCT02905006|469049881|FG002|Overall Study|Patient randomized by mistake|0|||
130296535|NCT02905006|469049882|FG003|Overall Study|Patient randomized by mistake|0|||
130296536|NCT02905006|469049883|FG004|Overall Study|Patient randomized by mistake|0|||
130296537|NCT02905006|469049884|FG005|Overall Study|Patient randomized by mistake|1|||
130296538|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
130296539|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
130372504|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
130372505|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372506|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130460980|NCT04707313|469652207|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460981|NCT04707313|469652208|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460982|NCT04707313|469652209|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130557137|NCT00727649|470009895|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
130557138|NCT00727649|470009896|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
130557139|NCT00727649|470009895|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
130557140|NCT00727649|470009896|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
130557141|NCT00727649|470009895|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
130557142|NCT00727649|470009896|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
130557143|NCT00727649|470009895|FG000|Second Intervention (4-weeks)|Death|1|||
130557144|NCT00727649|470009896|FG001|Second Intervention (4-weeks)|Death|0|||
130557145|NCT00727649|470009895|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
130557146|NCT00727649|470009896|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
130557147|NCT00727649|470009895|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
130557148|NCT00727649|470009896|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
130557149|NCT03823404|470009898|FG000|Overall Study|Lost to Follow-up|1|||
130557150|NCT03823404|470009899|FG001|Overall Study|Lost to Follow-up|2|||
130557151|NCT03823404|470009900|FG002|Overall Study|Lost to Follow-up|3|||
130557152|NCT03823404|470009898|FG000|Overall Study|Protocol Violation|2|||
130557153|NCT03823404|470009899|FG001|Overall Study|Protocol Violation|0|||
130557154|NCT03823404|470009900|FG002|Overall Study|Protocol Violation|2|||
130557155|NCT03823404|470009898|FG000|Overall Study|Adverse Event|35|||
130557156|NCT03823404|470009899|FG001|Overall Study|Adverse Event|38|||
130557157|NCT03823404|470009900|FG002|Overall Study|Adverse Event|8|||
130557158|NCT03823404|470009898|FG000|Overall Study|Withdrawal by Subject|38|||
130557159|NCT03823404|470009899|FG001|Overall Study|Withdrawal by Subject|40|||
130557160|NCT03823404|470009900|FG002|Overall Study|Withdrawal by Subject|35|||
130557161|NCT03823404|470009898|FG000|Overall Study|Death|4|||
130557162|NCT03823404|470009899|FG001|Overall Study|Death|0|||
130557163|NCT03823404|470009900|FG002|Overall Study|Death|0|||
130557164|NCT03823404|470009898|FG000|Overall Study|Other: Various reasons provided|5|||
130557165|NCT03823404|470009899|FG001|Overall Study|Other: Various reasons provided|5|||
130296540|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130296541|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
130296542|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130296543|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130296544|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130296545|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
130296546|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
130296547|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
130296548|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
130296549|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130296550|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
130296551|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
130296552|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130296553|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
130296554|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
130296555|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130296556|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
130296557|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
130296558|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130296559|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130296560|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
130296561|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
130296562|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
130296563|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
130296564|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
130296565|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
130296566|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
130296567|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
130296568|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130296569|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130296570|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
130557166|NCT03823404|470009900|FG002|Overall Study|Other: Various reasons provided|6|||
130557167|NCT03383289|470009903|FG000|Overall Study|Death|83|||
130716053|NCT01150890|470587079|FG001|Overall Study|Withdrawal by Subject|0|||
130716054|NCT01150890|470587080|FG002|Overall Study|Withdrawal by Subject|2|||
130557168|NCT03383289|470009904|FG001|Overall Study|Death|78|||
130557169|NCT03383289|470009903|FG000|Overall Study|discharge from facility|84|||
130716055|NCT01150890|470587081|FG003|Overall Study|Withdrawal by Subject|1|||
130557170|NCT03383289|470009904|FG001|Overall Study|discharge from facility|84|||
130557171|NCT03383289|470009903|FG000|Overall Study|Withdrawal by Subject|4|||
130557172|NCT03383289|470009904|FG001|Overall Study|Withdrawal by Subject|1|||
130716056|NCT01150890|470587078|FG000|Overall Study|Disease progression|0|||
130716057|NCT01150890|470587079|FG001|Overall Study|Disease progression|7|||
130716058|NCT01150890|470587080|FG002|Overall Study|Disease progression|3|||
130716059|NCT01150890|470587081|FG003|Overall Study|Disease progression|7|||
130716060|NCT00922987|470587082|FG000|Overall Study|Insufficient clinical response|1|||
130716061|NCT00922987|470587082|FG000|Overall Study|Protocol Violation|2|||
130716062|NCT00922987|470587082|FG000|Overall Study|Adverse Event|1|||
130716063|NCT00446199|470587083|FG000|Overall Study|Adverse Event|7|||
130296571|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
130296572|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
130296573|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
130296574|NCT04201093|469049887|FG000|Overall Study|Adverse Event|6|||
130296575|NCT04201093|469049888|FG001|Overall Study|Adverse Event|29|||
130296576|NCT04201093|469049889|FG002|Overall Study|Adverse Event|35|||
130296577|NCT04201093|469049887|FG000|Overall Study|Death|2|||
130296578|NCT04201093|469049888|FG001|Overall Study|Death|1|||
130296579|NCT04201093|469049889|FG002|Overall Study|Death|0|||
130296580|NCT04201093|469049887|FG000|Overall Study|Lack of Efficacy|5|||
130296581|NCT04201093|469049888|FG001|Overall Study|Lack of Efficacy|1|||
130296582|NCT04201093|469049889|FG002|Overall Study|Lack of Efficacy|2|||
130296583|NCT04201093|469049887|FG000|Overall Study|Lost to Follow-up|0|||
130296584|NCT04201093|469049888|FG001|Overall Study|Lost to Follow-up|0|||
130296585|NCT04201093|469049889|FG002|Overall Study|Lost to Follow-up|1|||
130296586|NCT04201093|469049887|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130296587|NCT04201093|469049888|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130296588|NCT04201093|469049889|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
130296589|NCT04201093|469049887|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130296590|NCT04201093|469049888|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130296591|NCT04201093|469049889|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130296592|NCT04201093|469049887|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
130296593|NCT04201093|469049888|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
130296594|NCT04201093|469049889|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
130296595|NCT04201093|469049887|FG000|Overall Study|Physician Decision|1|||
130296596|NCT04201093|469049888|FG001|Overall Study|Physician Decision|0|||
130296597|NCT04201093|469049889|FG002|Overall Study|Physician Decision|0|||
130296598|NCT04201093|469049887|FG000|Overall Study|Protocol Deviation|1|||
130296599|NCT04201093|469049888|FG001|Overall Study|Protocol Deviation|0|||
130296600|NCT04201093|469049889|FG002|Overall Study|Protocol Deviation|0|||
130296601|NCT04201093|469049887|FG000|Overall Study|Site Terminated by Sponsor|5|||
130716064|NCT00446199|470587084|FG001|Overall Study|Adverse Event|4|||
130716065|NCT00446199|470587085|FG002|Overall Study|Adverse Event|6|||
130716066|NCT00446199|470587086|FG003|Overall Study|Adverse Event|4|||
130716067|NCT00446199|470587083|FG000|Overall Study|Lost to Follow-up|4|||
130716068|NCT00446199|470587084|FG001|Overall Study|Lost to Follow-up|5|||
130716069|NCT00446199|470587085|FG002|Overall Study|Lost to Follow-up|2|||
130716070|NCT00446199|470587086|FG003|Overall Study|Lost to Follow-up|6|||
130716071|NCT00446199|470587083|FG000|Overall Study|Protocol Violation|1|||
130296602|NCT04201093|469049888|FG001|Overall Study|Site Terminated by Sponsor|3|||
130296603|NCT04201093|469049889|FG002|Overall Study|Site Terminated by Sponsor|1|||
130296604|NCT04201093|469049887|FG000|Overall Study|Withdrawal by Subject|7|||
130296605|NCT04201093|469049888|FG001|Overall Study|Withdrawal by Subject|8|||
130296606|NCT04201093|469049889|FG002|Overall Study|Withdrawal by Subject|15|||
130296607|NCT04201093|469049887|FG000|Overall Study|Other|0|||
130296608|NCT04201093|469049888|FG001|Overall Study|Other|1|||
130296609|NCT04201093|469049889|FG002|Overall Study|Other|2|||
130296610|NCT00007020|469049890|FG000|Overall Study|Death|16|||
130296611|NCT00007020|469049890|FG000|Overall Study|Lost to Follow-up|13|||
130296612|NCT00007020|469049890|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
130296613|NCT00007020|469049890|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
130296614|NCT00007020|469049890|FG000|Overall Study|Pt cared for by outside physician|4|||
130296615|NCT00007020|469049890|FG000|Overall Study|No evidence of treatment|6|||
130296616|NCT00881504|469049891|FG000|Overall Study|Withdrawal by Subject|1|||
130460983|NCT04707313|469652210|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460984|NCT04707313|469652211|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460985|NCT04707313|469652212|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460986|NCT04707313|469652213|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
130460987|NCT04707313|469652214|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
130460988|NCT04707313|469652215|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
130460989|NCT04707313|469652216|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
130460990|NCT04707313|469652217|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
130460991|NCT00324038|469652221|FG000|Overall Study|Adverse Event|38|||
130460992|NCT00324038|469652222|FG001|Overall Study|Adverse Event|23|||
130460993|NCT00324038|469652221|FG000|Overall Study|Lack of Efficacy|5|||
130716072|NCT00446199|470587084|FG001|Overall Study|Protocol Violation|2|||
130716073|NCT00446199|470587085|FG002|Overall Study|Protocol Violation|1|||
130296617|NCT01276223|469049892|FG000|Overall Study|Adverse Event|7|||
130296618|NCT01276223|469049893|FG001|Overall Study|Adverse Event|4|||
130296619|NCT01276223|469049894|FG002|Overall Study|Adverse Event|1|||
130296620|NCT01276223|469049892|FG000|Overall Study|Lost to Follow-up|0|||
130296621|NCT01276223|469049893|FG001|Overall Study|Lost to Follow-up|0|||
130296622|NCT01276223|469049894|FG002|Overall Study|Lost to Follow-up|1|||
130296623|NCT01276223|469049892|FG000|Overall Study|Other|0|||
130296624|NCT01276223|469049893|FG001|Overall Study|Other|0|||
130296625|NCT01276223|469049894|FG002|Overall Study|Other|1|||
130296626|NCT01276223|469049892|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
130296627|NCT01276223|469049893|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130296628|NCT01276223|469049894|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130296629|NCT01276223|469049892|FG000|Overall Study|Protocol Violation|1|||
130296630|NCT01276223|469049893|FG001|Overall Study|Protocol Violation|0|||
130296631|NCT01276223|469049894|FG002|Overall Study|Protocol Violation|0|||
130296632|NCT05856227|469049895|FG000|Overall Study|Adverse Event|0|||
130296633|NCT05856227|469049896|FG001|Overall Study|Adverse Event|1|||
130296634|NCT05856227|469049895|FG000|Overall Study|Due to Investigator absence|1|||
130296635|NCT05856227|469049896|FG001|Overall Study|Due to Investigator absence|0|||
130296636|NCT05856227|469049895|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
130296637|NCT05856227|469049896|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
130296638|NCT01571232|469049898|FG000|Overall Study|Lost to Follow-up|0|||
130296639|NCT01571232|469049899|FG001|Overall Study|Lost to Follow-up|1|||
130296640|NCT01571232|469049898|FG000|Overall Study|Withdrawal by Subject|1|||
130296641|NCT01571232|469049899|FG001|Overall Study|Withdrawal by Subject|0|||
130296642|NCT00771615|469049900|FG000|Overall Study|Withdrawal by Subject|0|||
130296643|NCT00771615|469049901|FG001|Overall Study|Withdrawal by Subject|1|||
130296644|NCT00771615|469049902|FG002|Overall Study|Withdrawal by Subject|0|||
130296645|NCT00771615|469049903|FG003|Overall Study|Withdrawal by Subject|0|||
130296646|NCT00771615|469049904|FG004|Overall Study|Withdrawal by Subject|0|||
130296647|NCT00771615|469049905|FG005|Overall Study|Withdrawal by Subject|0|||
130296648|NCT00771615|469049906|FG006|Overall Study|Withdrawal by Subject|0|||
130372507|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372508|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372509|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372510|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372511|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372512|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372513|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372514|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372515|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372516|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372517|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372518|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372519|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372520|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372521|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372522|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372523|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372524|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130372525|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Death|0|||
130372526|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Death|0|||
130372527|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Death|1|||
130372528|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Death|0|||
130372529|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Death|0|||
130372530|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Death|0|||
130372531|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Death|0|||
130372532|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Death|0|||
130372533|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Death|0|||
130372534|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Death|0|||
130372535|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Death|0|||
130372536|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Death|0|||
130372537|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Death|0|||
130372538|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Death|0|||
130296649|NCT00771615|469049907|FG007|Overall Study|Withdrawal by Subject|1|||
130296650|NCT00771615|469049908|FG008|Overall Study|Withdrawal by Subject|0|||
130296651|NCT00771615|469049900|FG000|Overall Study|Lost to Follow-up|1|||
130296652|NCT00771615|469049901|FG001|Overall Study|Lost to Follow-up|1|||
130296653|NCT00771615|469049902|FG002|Overall Study|Lost to Follow-up|1|||
130296654|NCT00771615|469049903|FG003|Overall Study|Lost to Follow-up|1|||
130296655|NCT00771615|469049904|FG004|Overall Study|Lost to Follow-up|0|||
130296656|NCT00771615|469049905|FG005|Overall Study|Lost to Follow-up|1|||
130296657|NCT00771615|469049906|FG006|Overall Study|Lost to Follow-up|1|||
130296658|NCT00771615|469049907|FG007|Overall Study|Lost to Follow-up|0|||
130296659|NCT00771615|469049908|FG008|Overall Study|Lost to Follow-up|0|||
130296660|NCT02455076|469049909|FG000|Inpatient|Withdrawal by Subject|1|||
130296661|NCT02455076|469049910|FG001|Inpatient|Withdrawal by Subject|0|||
130296662|NCT02455076|469049911|FG002|Inpatient|Withdrawal by Subject|0|||
130296663|NCT02455076|469049912|FG003|Inpatient|Withdrawal by Subject|0|||
130296664|NCT02455076|469049913|FG004|Inpatient|Withdrawal by Subject|0|||
130296665|NCT02455076|469049909|FG000|Inpatient|Discharged <24 h after admission|0|||
130296666|NCT02455076|469049910|FG001|Inpatient|Discharged <24 h after admission|1|||
130296667|NCT02455076|469049911|FG002|Inpatient|Discharged <24 h after admission|0|||
130296668|NCT02455076|469049912|FG003|Inpatient|Discharged <24 h after admission|0|||
130296669|NCT02455076|469049913|FG004|Inpatient|Discharged <24 h after admission|0|||
130296670|NCT02455076|469049909|FG000|Inpatient|Adverse Event|3|||
130296671|NCT02455076|469049910|FG001|Inpatient|Adverse Event|0|||
130296672|NCT02455076|469049911|FG002|Inpatient|Adverse Event|0|||
130296673|NCT02455076|469049912|FG003|Inpatient|Adverse Event|0|||
130296674|NCT02455076|469049913|FG004|Inpatient|Adverse Event|0|||
130296675|NCT02455076|469049909|FG000|Outpatient|Adverse Event|0|||
130296676|NCT02455076|469049910|FG001|Outpatient|Adverse Event|0|||
130296677|NCT02455076|469049911|FG002|Outpatient|Adverse Event|0|||
130296678|NCT02455076|469049912|FG003|Outpatient|Adverse Event|5|||
130296679|NCT02455076|469049913|FG004|Outpatient|Adverse Event|0|||
130296680|NCT02455076|469049909|FG000|Outpatient|Lost to Follow-up|0|||
130296681|NCT02455076|469049910|FG001|Outpatient|Lost to Follow-up|0|||
130296682|NCT02455076|469049911|FG002|Outpatient|Lost to Follow-up|0|||
130296683|NCT02455076|469049912|FG003|Outpatient|Lost to Follow-up|1|||
130296684|NCT02455076|469049913|FG004|Outpatient|Lost to Follow-up|12|||
130296685|NCT03517969|469049914|FG000|Overall Study|Never started protocol treatment|3|||
130296686|NCT03517969|469049915|FG001|Overall Study|Never started protocol treatment|5|||
130296687|NCT03517969|469049914|FG000|Overall Study|Disease progression|11|||
130296688|NCT03517969|469049915|FG001|Overall Study|Disease progression|16|||
130296689|NCT03517969|469049914|FG000|Overall Study|PSA progression|8|||
130296690|NCT03517969|469049915|FG001|Overall Study|PSA progression|1|||
130296691|NCT03517969|469049914|FG000|Overall Study|Clinical progression|4|||
130296692|NCT03517969|469049915|FG001|Overall Study|Clinical progression|2|||
130296693|NCT03517969|469049914|FG000|Overall Study|Adverse Event|5|||
130296694|NCT03517969|469049915|FG001|Overall Study|Adverse Event|4|||
130296695|NCT03517969|469049914|FG000|Overall Study|Intercurrent illness|1|||
130296696|NCT03517969|469049915|FG001|Overall Study|Intercurrent illness|2|||
130296697|NCT03517969|469049914|FG000|Overall Study|Death|1|||
130296698|NCT03517969|469049915|FG001|Overall Study|Death|1|||
130296699|NCT03517969|469049914|FG000|Overall Study|Withdrawal by Subject|1|||
130296700|NCT03517969|469049915|FG001|Overall Study|Withdrawal by Subject|2|||
130296701|NCT03517969|469049914|FG000|Overall Study|Physician Decision|1|||
130296702|NCT03517969|469049915|FG001|Overall Study|Physician Decision|1|||
130296703|NCT03517969|469049914|FG000|Overall Study|No clinical benefit|1|||
130296704|NCT03517969|469049915|FG001|Overall Study|No clinical benefit|0|||
130296705|NCT03517969|469049914|FG000|Overall Study|Delayed treatment for dental treatment|1|||
130296706|NCT03517969|469049915|FG001|Overall Study|Delayed treatment for dental treatment|0|||
130460994|NCT00324038|469652222|FG001|Overall Study|Lack of Efficacy|13|||
130460995|NCT00324038|469652221|FG000|Overall Study|Lost to Follow-up|0|||
130460996|NCT00324038|469652222|FG001|Overall Study|Lost to Follow-up|2|||
130460997|NCT00324038|469652221|FG000|Overall Study|Other|6|||
130460998|NCT00324038|469652222|FG001|Overall Study|Other|13|||
130460999|NCT03070483|469652223|FG000|Overall Study|Lost to Follow-up|2|||
130296707|NCT03517969|469049914|FG000|Overall Study|Difficult to maintain appointment|0|||
130296708|NCT03517969|469049915|FG001|Overall Study|Difficult to maintain appointment|1|||
130296709|NCT03517969|469049914|FG000|Overall Study|Protocol Violation|0|||
130296710|NCT03517969|469049915|FG001|Overall Study|Protocol Violation|1|||
130296711|NCT05779007|469049920|FG000|Overall Study|not meeting eligibility criteria|3517|||
130296712|NCT05779007|469049921|FG001|Overall Study|not meeting eligibility criteria|2009|||
130296715|NCT05147662|469049936|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130296716|NCT05147662|469049936|FG000|Overall Study|Assigned to treatment but never treated|1|||
130296717|NCT04676867|469049937|FG000|Overall Study|Screen failure|0|||
130461000|NCT01585558|469652224|FG000|Overall Study|Withdrawal by Subject|4|||
130461001|NCT01585558|469652225|FG001|Overall Study|Withdrawal by Subject|5|||
130461002|NCT01585558|469652226|FG002|Overall Study|Withdrawal by Subject|8|||
130296718|NCT04676867|469049938|FG001|Overall Study|Screen failure|0|||
130296719|NCT04676867|469049939|FG002|Overall Study|Screen failure|6|||
130296720|NCT04676867|469049940|FG003|Overall Study|Screen failure|2|||
130296721|NCT04676867|469049937|FG000|Overall Study|Death|0|||
130296722|NCT04676867|469049938|FG001|Overall Study|Death|0|||
130296723|NCT04676867|469049939|FG002|Overall Study|Death|1|||
130296724|NCT04676867|469049940|FG003|Overall Study|Death|0|||
130296725|NCT04676867|469049937|FG000|Overall Study|Withdrawal by Subject|2|||
130296726|NCT04676867|469049938|FG001|Overall Study|Withdrawal by Subject|2|||
130296727|NCT04676867|469049939|FG002|Overall Study|Withdrawal by Subject|4|||
130296728|NCT04676867|469049940|FG003|Overall Study|Withdrawal by Subject|4|||
130296729|NCT04676867|469049937|FG000|Overall Study|Lost to Follow-up|1|||
130296730|NCT04676867|469049938|FG001|Overall Study|Lost to Follow-up|0|||
130296731|NCT04676867|469049939|FG002|Overall Study|Lost to Follow-up|0|||
130296732|NCT04676867|469049940|FG003|Overall Study|Lost to Follow-up|0|||
130296733|NCT00549770|469049945|FG000|Overall Study|Protocol deviation|1|||
130296734|NCT00549770|469049946|FG001|Overall Study|Protocol deviation|1|||
130716074|NCT00446199|470587086|FG003|Overall Study|Protocol Violation|3|||
130716075|NCT00446199|470587083|FG000|Overall Study|Withdrawal by Subject|2|||
130296735|NCT00549770|469049947|FG002|Overall Study|Protocol deviation|1|||
130296736|NCT00549770|469049948|FG003|Overall Study|Protocol deviation|2|||
130296737|NCT00549770|469049949|FG004|Overall Study|Protocol deviation|2|||
130296738|NCT00549770|469049950|FG005|Overall Study|Protocol deviation|2|||
130296739|NCT00549770|469049951|FG006|Overall Study|Protocol deviation|1|||
130296740|NCT00549770|469049952|FG007|Overall Study|Protocol deviation|2|||
130296741|NCT00549770|469049945|FG000|Overall Study|Administrative problems|0|||
130296742|NCT00549770|469049946|FG001|Overall Study|Administrative problems|1|||
130296743|NCT00549770|469049947|FG002|Overall Study|Administrative problems|0|||
130296744|NCT00549770|469049948|FG003|Overall Study|Administrative problems|0|||
130296745|NCT00549770|469049949|FG004|Overall Study|Administrative problems|0|||
130296746|NCT00549770|469049950|FG005|Overall Study|Administrative problems|0|||
130296747|NCT00549770|469049951|FG006|Overall Study|Administrative problems|0|||
130296748|NCT00549770|469049952|FG007|Overall Study|Administrative problems|1|||
130296749|NCT00549770|469049945|FG000|Overall Study|Lost to Follow-up|0|||
130296750|NCT00549770|469049946|FG001|Overall Study|Lost to Follow-up|0|||
130296751|NCT00549770|469049947|FG002|Overall Study|Lost to Follow-up|2|||
130296752|NCT00549770|469049948|FG003|Overall Study|Lost to Follow-up|2|||
130296753|NCT00549770|469049949|FG004|Overall Study|Lost to Follow-up|3|||
130296754|NCT00549770|469049950|FG005|Overall Study|Lost to Follow-up|2|||
130296755|NCT00549770|469049951|FG006|Overall Study|Lost to Follow-up|0|||
130296756|NCT00549770|469049952|FG007|Overall Study|Lost to Follow-up|0|||
130296757|NCT00549770|469049945|FG000|Overall Study|Withdrawal by Subject|4|||
130296758|NCT00549770|469049946|FG001|Overall Study|Withdrawal by Subject|6|||
130296759|NCT00549770|469049947|FG002|Overall Study|Withdrawal by Subject|4|||
130296760|NCT00549770|469049948|FG003|Overall Study|Withdrawal by Subject|5|||
130296761|NCT00549770|469049949|FG004|Overall Study|Withdrawal by Subject|6|||
130296762|NCT00549770|469049950|FG005|Overall Study|Withdrawal by Subject|6|||
130296763|NCT00549770|469049951|FG006|Overall Study|Withdrawal by Subject|4|||
130296764|NCT00549770|469049952|FG007|Overall Study|Withdrawal by Subject|9|||
130296765|NCT00549770|469049945|FG000|Overall Study|Lack of Efficacy|1|||
130296766|NCT00549770|469049946|FG001|Overall Study|Lack of Efficacy|0|||
130296767|NCT00549770|469049947|FG002|Overall Study|Lack of Efficacy|2|||
130296768|NCT00549770|469049948|FG003|Overall Study|Lack of Efficacy|3|||
130296769|NCT00549770|469049949|FG004|Overall Study|Lack of Efficacy|5|||
130296770|NCT00549770|469049950|FG005|Overall Study|Lack of Efficacy|1|||
130461003|NCT01585558|469652224|FG000|Overall Study|Lost to Follow-up|2|||
130461004|NCT01585558|469652225|FG001|Overall Study|Lost to Follow-up|0|||
130461005|NCT01585558|469652226|FG002|Overall Study|Lost to Follow-up|3|||
130461006|NCT01585558|469652224|FG000|Overall Study|Adverse Event|3|||
130461007|NCT01585558|469652225|FG001|Overall Study|Adverse Event|4|||
130461008|NCT01585558|469652226|FG002|Overall Study|Adverse Event|1|||
130461009|NCT01585558|469652224|FG000|Overall Study|Protocol Violation|4|||
130461010|NCT01585558|469652225|FG001|Overall Study|Protocol Violation|3|||
130461011|NCT01585558|469652226|FG002|Overall Study|Protocol Violation|2|||
130461012|NCT01585558|469652224|FG000|Overall Study|Lack of Efficacy|0|||
130461013|NCT01585558|469652225|FG001|Overall Study|Lack of Efficacy|0|||
130461014|NCT01585558|469652226|FG002|Overall Study|Lack of Efficacy|1|||
130557173|NCT00832117|470009905|FG000|Overall Study|Death|1|||
130557174|NCT00832117|470009905|FG000|Overall Study|Disease Progression|11|||
130296771|NCT00549770|469049951|FG006|Overall Study|Lack of Efficacy|3|||
130296772|NCT00549770|469049952|FG007|Overall Study|Lack of Efficacy|8|||
130296773|NCT00549770|469049945|FG000|Overall Study|Abnormal test procedure results|0|||
130296774|NCT00549770|469049946|FG001|Overall Study|Abnormal test procedure results|0|||
130296775|NCT00549770|469049947|FG002|Overall Study|Abnormal test procedure results|0|||
130296776|NCT00549770|469049948|FG003|Overall Study|Abnormal test procedure results|2|||
130557175|NCT04439071|470009906|FG000|Overall Study|Lost to Follow-up|0|||
130461015|NCT00841035|469652228|FG000|Phase 1 Overall Study|Physician Decision|13|||
130461016|NCT01390402|469652233|FG000|Overall Study|Death|1|||
130557176|NCT04439071|470009907|FG001|Overall Study|Lost to Follow-up|3|||
130296777|NCT00549770|469049949|FG004|Overall Study|Abnormal test procedure results|0|||
130296778|NCT00549770|469049950|FG005|Overall Study|Abnormal test procedure results|1|||
130296779|NCT00549770|469049951|FG006|Overall Study|Abnormal test procedure results|1|||
130296780|NCT00549770|469049952|FG007|Overall Study|Abnormal test procedure results|1|||
130716076|NCT00446199|470587084|FG001|Overall Study|Withdrawal by Subject|5|||
130557177|NCT04439071|470009906|FG000|Overall Study|Withdrawal by Subject|3|||
130557178|NCT04439071|470009907|FG001|Overall Study|Withdrawal by Subject|8|||
130557179|NCT04439071|470009906|FG000|Overall Study|Death|6|||
130557180|NCT04439071|470009907|FG001|Overall Study|Death|4|||
130557181|NCT04439071|470009906|FG000|Overall Study|Other than specified|3|||
130557182|NCT04439071|470009907|FG001|Overall Study|Other than specified|3|||
130557183|NCT04439071|470009906|FG000|Overall Study|Randomized but not treated|2|||
130557184|NCT04439071|470009907|FG001|Overall Study|Randomized but not treated|0|||
130557185|NCT01524133|470009910|FG000|Treatment Phase|Withdrawal by Subject|13|||
130296781|NCT00549770|469049945|FG000|Overall Study|Abnormal laboratory values|0|||
130296782|NCT00549770|469049946|FG001|Overall Study|Abnormal laboratory values|0|||
130296783|NCT00549770|469049947|FG002|Overall Study|Abnormal laboratory values|0|||
130296784|NCT00549770|469049948|FG003|Overall Study|Abnormal laboratory values|0|||
130296785|NCT00549770|469049949|FG004|Overall Study|Abnormal laboratory values|0|||
130296786|NCT00549770|469049950|FG005|Overall Study|Abnormal laboratory values|1|||
130296787|NCT00549770|469049951|FG006|Overall Study|Abnormal laboratory values|0|||
130296788|NCT00549770|469049952|FG007|Overall Study|Abnormal laboratory values|0|||
130296789|NCT00549770|469049945|FG000|Overall Study|Adverse Event|1|||
130296790|NCT00549770|469049946|FG001|Overall Study|Adverse Event|3|||
130296791|NCT00549770|469049947|FG002|Overall Study|Adverse Event|1|||
130296792|NCT00549770|469049948|FG003|Overall Study|Adverse Event|2|||
130296793|NCT00549770|469049949|FG004|Overall Study|Adverse Event|1|||
130296794|NCT00549770|469049950|FG005|Overall Study|Adverse Event|0|||
130296795|NCT00549770|469049951|FG006|Overall Study|Adverse Event|5|||
130296796|NCT00549770|469049952|FG007|Overall Study|Adverse Event|4|||
130296797|NCT01079936|469049953|FG000|Phase I: MTD|First Remission Status|2|||
130296798|NCT01079936|469049954|FG001|Phase I: MTD|First Remission Status|0|||
130296799|NCT01079936|469049955|FG002|Phase I: MTD|First Remission Status|0|||
130296800|NCT01079936|469049956|FG003|Phase I: MTD|First Remission Status|0|||
130296801|NCT01079936|469049957|FG004|Phase I: MTD|First Remission Status|0|||
130296802|NCT01079936|469049953|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
130296803|NCT01079936|469049954|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
130296804|NCT01079936|469049955|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
130296805|NCT01079936|469049956|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
130296806|NCT01079936|469049957|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
130296807|NCT01079936|469049953|FG000|Phase II|Adverse Event|0|||
130296808|NCT01079936|469049954|FG001|Phase II|Adverse Event|0|||
130296809|NCT01079936|469049955|FG002|Phase II|Adverse Event|1|||
130296810|NCT01079936|469049956|FG003|Phase II|Adverse Event|0|||
130296811|NCT01079936|469049957|FG004|Phase II|Adverse Event|0|||
130296812|NCT01079936|469049953|FG000|Phase II|Insurance Issue|0|||
130296813|NCT01079936|469049954|FG001|Phase II|Insurance Issue|0|||
130296814|NCT01079936|469049955|FG002|Phase II|Insurance Issue|0|||
130296815|NCT01079936|469049956|FG003|Phase II|Insurance Issue|0|||
130296816|NCT01079936|469049957|FG004|Phase II|Insurance Issue|1|||
130296817|NCT00548717|469049958|FG000|Overall Study|Death|5|||
130296818|NCT00548717|469049959|FG001|Overall Study|Death|2|||
130296819|NCT00548717|469049958|FG000|Overall Study|Relapse|3|||
130296820|NCT00548717|469049959|FG001|Overall Study|Relapse|0|||
130296821|NCT00548717|469049958|FG000|Overall Study|Alternative treatment for GVHD|1|||
130296822|NCT00548717|469049959|FG001|Overall Study|Alternative treatment for GVHD|0|||
130296823|NCT02809053|469049961|FG000|Overall Study|Death|0|||
130557186|NCT01524133|470009911|FG001|Treatment Phase|Withdrawal by Subject|28|||
130716077|NCT00446199|470587085|FG002|Overall Study|Withdrawal by Subject|9|||
130296824|NCT02809053|469049962|FG001|Overall Study|Death|1|||
130296825|NCT02809053|469049961|FG000|Overall Study|Lost to Follow-up|3|||
130296826|NCT02809053|469049962|FG001|Overall Study|Lost to Follow-up|1|||
130296827|NCT02809053|469049961|FG000|Overall Study|Withdrawal by Subject|2|||
130296828|NCT02809053|469049962|FG001|Overall Study|Withdrawal by Subject|3|||
130296829|NCT02809053|469049961|FG000|Overall Study|Disease Progression|2|||
130296830|NCT02809053|469049962|FG001|Overall Study|Disease Progression|1|||
130296831|NCT00869401|469049965|FG000|Overall Study|Withdrawal by Subject|0|||
130296832|NCT00869401|469049966|FG001|Overall Study|Withdrawal by Subject|0|||
130296833|NCT00869401|469049967|FG002|Overall Study|Withdrawal by Subject|0|||
130296834|NCT00869401|469049968|FG003|Overall Study|Withdrawal by Subject|5|||
130296835|NCT00869401|469049969|FG004|Overall Study|Withdrawal by Subject|3|||
130296836|NCT01147900|469049970|FG000|At Year 10|Lost to Follow-up|0|||
130296837|NCT01147900|469049971|FG001|At Year 10|Lost to Follow-up|1|||
130296838|NCT01147900|469049972|FG002|At Year 10|Lost to Follow-up|0|||
130296839|NCT01953913|469049973|FG000|Overall Study|Disease Progression|349|||
130372539|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Death|0|||
130296840|NCT01953913|469049973|FG000|Overall Study|Worsening of underlying cancer|22|||
130296841|NCT01953913|469049973|FG000|Overall Study|Adverse Event|20|||
130296842|NCT01953913|469049973|FG000|Overall Study|Protocol Violation|6|||
130296843|NCT01953913|469049973|FG000|Overall Study|Lost to Follow-up|4|||
130296844|NCT01953913|469049973|FG000|Overall Study|Withdrawal by Subject|32|||
130296845|NCT01953913|469049973|FG000|Overall Study|Other than listed|108|||
130557187|NCT01524133|470009912|FG002|Treatment Phase|Withdrawal by Subject|31|||
130557188|NCT01524133|470009910|FG000|Treatment Phase|Physician Decision|6|||
130716078|NCT00446199|470587086|FG003|Overall Study|Withdrawal by Subject|10|||
130716079|NCT00446199|470587083|FG000|Overall Study|Site termination|2|||
130716080|NCT00446199|470587084|FG001|Overall Study|Site termination|0|||
130716081|NCT00446199|470587085|FG002|Overall Study|Site termination|0|||
130296846|NCT01953913|469049973|FG000|Overall Study|Not Treated|1|||
130296847|NCT01732913|469049974|FG000|Overall Study|Study Terminated by Sponsor|105|||
130296848|NCT01732913|469049975|FG001|Overall Study|Study Terminated by Sponsor|55|||
130296849|NCT01732913|469049974|FG000|Overall Study|Withdrawal by Subject|27|||
130296850|NCT01732913|469049975|FG001|Overall Study|Withdrawal by Subject|4|||
130296851|NCT01732913|469049974|FG000|Overall Study|Physician Decision|14|||
130296852|NCT01732913|469049975|FG001|Overall Study|Physician Decision|7|||
130296853|NCT01732913|469049974|FG000|Overall Study|Other|7|||
130296854|NCT01732913|469049975|FG001|Overall Study|Other|1|||
130296855|NCT01732913|469049974|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
130296856|NCT01732913|469049975|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
130296857|NCT00082381|469049976|FG000|Overall Study|Adverse Event|27|||
130461017|NCT01390402|469652233|FG000|Overall Study|Disease Progression|4|||
130461018|NCT02383472|469653839|FG000|Overall Study|Withdrawal by Subject|1|||
130461019|NCT02383472|469653840|FG001|Overall Study|Withdrawal by Subject|1|||
130461020|NCT00818454|469653843|FG000|Treatment Period 1|Adverse Event|0|||
130461021|NCT00818454|469653844|FG001|Treatment Period 1|Adverse Event|1|||
130461022|NCT00818454|469653845|FG002|Treatment Period 1|Adverse Event|0|||
130461023|NCT00818454|469653846|FG003|Treatment Period 1|Adverse Event|0|||
130461024|NCT00818454|469653843|FG000|Treatment Period 1|Other|3|||
130461025|NCT00818454|469653844|FG001|Treatment Period 1|Other|0|||
130461026|NCT00818454|469653845|FG002|Treatment Period 1|Other|0|||
130461027|NCT00818454|469653846|FG003|Treatment Period 1|Other|0|||
130461028|NCT00818454|469653843|FG000|Washout Period of 1 Week|Adverse Event|1|||
130461029|NCT00818454|469653844|FG001|Washout Period of 1 Week|Adverse Event|1|||
130461030|NCT00818454|469653845|FG002|Washout Period of 1 Week|Adverse Event|0|||
130461031|NCT00818454|469653846|FG003|Washout Period of 1 Week|Adverse Event|0|||
130461032|NCT00818454|469653843|FG000|Washout Period of 1 Week|Protocol Violation|2|||
130461033|NCT00818454|469653844|FG001|Washout Period of 1 Week|Protocol Violation|0|||
130461034|NCT00818454|469653845|FG002|Washout Period of 1 Week|Protocol Violation|0|||
130461035|NCT00818454|469653846|FG003|Washout Period of 1 Week|Protocol Violation|0|||
130461036|NCT00818454|469653843|FG000|Washout Period of 1 Week|Other|1|||
130461037|NCT00818454|469653844|FG001|Washout Period of 1 Week|Other|2|||
130461038|NCT00818454|469653845|FG002|Washout Period of 1 Week|Other|0|||
130461039|NCT00818454|469653846|FG003|Washout Period of 1 Week|Other|0|||
130461040|NCT00818454|469653843|FG000|Treatment Period 2|Other|2|||
130461041|NCT00818454|469653844|FG001|Treatment Period 2|Other|1|||
130461042|NCT00818454|469653845|FG002|Treatment Period 2|Other|0|||
130461043|NCT00818454|469653846|FG003|Treatment Period 2|Other|0|||
130461044|NCT00818454|469653843|FG000|Treatment Period 3|Adverse Event|0|||
130461045|NCT00818454|469653844|FG001|Treatment Period 3|Adverse Event|0|||
130461046|NCT00818454|469653845|FG002|Treatment Period 3|Adverse Event|0|||
130461047|NCT00818454|469653846|FG003|Treatment Period 3|Adverse Event|1|||
130461048|NCT02296424|469653848|FG000|Part 1|New therapy for study indication|0|||
130461049|NCT02296424|469653849|FG001|Part 1|New therapy for study indication|1|||
130461050|NCT02296424|469653850|FG002|Part 1|New therapy for study indication|0|||
130461051|NCT02296424|469653851|FG003|Part 1|New therapy for study indication|0|||
130461052|NCT02296424|469653848|FG000|Part 1|Protocol Violation|0|||
130461053|NCT02296424|469653849|FG001|Part 1|Protocol Violation|1|||
130461054|NCT02296424|469653850|FG002|Part 1|Protocol Violation|0|||
130461055|NCT02296424|469653851|FG003|Part 1|Protocol Violation|0|||
130461056|NCT02296424|469653848|FG000|Part 1|Withdrawal by Subject|0|||
130461057|NCT02296424|469653849|FG001|Part 1|Withdrawal by Subject|2|||
130461058|NCT02296424|469653850|FG002|Part 1|Withdrawal by Subject|0|||
130461059|NCT02296424|469653851|FG003|Part 1|Withdrawal by Subject|0|||
130461060|NCT02296424|469653848|FG000|Part 1|Study terminated by sponsor|0|||
130716082|NCT00446199|470587086|FG003|Overall Study|Site termination|1|||
130716083|NCT00446199|470587083|FG000|Overall Study|Randomization in Error|2|||
130716084|NCT00446199|470587084|FG001|Overall Study|Randomization in Error|0|||
130716085|NCT00446199|470587085|FG002|Overall Study|Randomization in Error|1|||
130716086|NCT00446199|470587086|FG003|Overall Study|Randomization in Error|1|||
130296858|NCT00082381|469049977|FG001|Overall Study|Adverse Event|2|||
130296859|NCT00082381|469049976|FG000|Overall Study|Lost to Follow-up|5|||
130461061|NCT02296424|469653849|FG001|Part 1|Study terminated by sponsor|1|||
130461062|NCT02296424|469653850|FG002|Part 1|Study terminated by sponsor|0|||
130461063|NCT02296424|469653851|FG003|Part 1|Study terminated by sponsor|0|||
130461064|NCT02296424|469653848|FG000|Part 1|Adverse Event|2|||
130461065|NCT02296424|469653849|FG001|Part 1|Adverse Event|11|||
130461066|NCT02296424|469653850|FG002|Part 1|Adverse Event|0|||
130461067|NCT02296424|469653851|FG003|Part 1|Adverse Event|0|||
130461068|NCT02296424|469653848|FG000|Part 1|Lack of Efficacy|5|||
130461069|NCT02296424|469653849|FG001|Part 1|Lack of Efficacy|17|||
130461070|NCT02296424|469653850|FG002|Part 1|Lack of Efficacy|0|||
130461071|NCT02296424|469653851|FG003|Part 1|Lack of Efficacy|0|||
130716087|NCT00446199|470587083|FG000|Overall Study|Lack of Efficacy|1|||
130716088|NCT00446199|470587084|FG001|Overall Study|Lack of Efficacy|0|||
130296860|NCT00082381|469049977|FG001|Overall Study|Lost to Follow-up|7|||
130296861|NCT00082381|469049976|FG000|Overall Study|Patient Decision|8|||
130296862|NCT00082381|469049977|FG001|Overall Study|Patient Decision|4|||
130296863|NCT00082381|469049976|FG000|Overall Study|Physician Decision|1|||
130296864|NCT00082381|469049977|FG001|Overall Study|Physician Decision|2|||
130296865|NCT00082381|469049976|FG000|Overall Study|Protocol Violation|10|||
130296866|NCT00082381|469049977|FG001|Overall Study|Protocol Violation|11|||
130296867|NCT00082381|469049976|FG000|Overall Study|Loss of Glucose Control|4|||
130296868|NCT00082381|469049977|FG001|Overall Study|Loss of Glucose Control|0|||
130296869|NCT00025155|469049978|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
130296870|NCT00025155|469049978|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
130296871|NCT03022981|469049979|FG000|Overall Study|Adverse Event|0|||
130296872|NCT03022981|469049980|FG001|Overall Study|Adverse Event|1|||
130296873|NCT03022981|469049981|FG002|Overall Study|Adverse Event|0|||
130296874|NCT03022981|469049979|FG000|Overall Study|Investigator's Discretion|0|||
130296875|NCT03022981|469049980|FG001|Overall Study|Investigator's Discretion|1|||
130296876|NCT03022981|469049981|FG002|Overall Study|Investigator's Discretion|2|||
130296877|NCT03022981|469049979|FG000|Overall Study|Lost to Follow-up|6|||
130296878|NCT03022981|469049980|FG001|Overall Study|Lost to Follow-up|2|||
130296879|NCT03022981|469049981|FG002|Overall Study|Lost to Follow-up|1|||
130296880|NCT03022981|469049979|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130296881|NCT03022981|469049980|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130296882|NCT03022981|469049981|FG002|Overall Study|Non-Compliance With Study Drug|2|||
130296883|NCT03022981|469049979|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130296884|NCT03022981|469049980|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130296885|NCT03022981|469049981|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
130461072|NCT02296424|469653848|FG000|Part 1|16 directly started part II|16|||
130461073|NCT02296424|469653849|FG001|Part 1|16 directly started part II|0|||
130461074|NCT02296424|469653850|FG002|Part 1|16 directly started part II|0|||
130461075|NCT02296424|469653851|FG003|Part 1|16 directly started part II|0|||
130461076|NCT02296424|469653848|FG000|Part 2|Lack of Efficacy|0|||
130461077|NCT02296424|469653849|FG001|Part 2|Lack of Efficacy|0|||
130461078|NCT02296424|469653850|FG002|Part 2|Lack of Efficacy|1|||
130461079|NCT02296424|469653851|FG003|Part 2|Lack of Efficacy|0|||
130461080|NCT02296424|469653848|FG000|Part 2|Adverse Event|0|||
130461081|NCT02296424|469653849|FG001|Part 2|Adverse Event|0|||
130461082|NCT02296424|469653850|FG002|Part 2|Adverse Event|1|||
130461083|NCT02296424|469653851|FG003|Part 2|Adverse Event|0|||
130461084|NCT02296424|469653848|FG000|Part 2|Lost to Follow-up|0|||
130461085|NCT02296424|469653849|FG001|Part 2|Lost to Follow-up|0|||
130461086|NCT02296424|469653850|FG002|Part 2|Lost to Follow-up|1|||
130461087|NCT02296424|469653851|FG003|Part 2|Lost to Follow-up|0|||
130461088|NCT00807144|469653852|FG000|Overall Study|Lost to Follow-up|0|||
130461089|NCT00807144|469653853|FG001|Overall Study|Lost to Follow-up|1|||
130557189|NCT01524133|470009911|FG001|Treatment Phase|Physician Decision|3|||
130557190|NCT01524133|470009912|FG002|Treatment Phase|Physician Decision|3|||
130296886|NCT00444067|469049982|FG000|Overall Study|Lost to Follow-up|0|||
130296887|NCT00444067|469049983|FG001|Overall Study|Lost to Follow-up|1|||
130296888|NCT03178669|469049984|FG000|Overall Study|Adverse Event|4|||
130296889|NCT03178669|469049985|FG001|Overall Study|Adverse Event|1|||
130296890|NCT03178669|469049986|FG002|Overall Study|Adverse Event|4|||
130296891|NCT03178669|469049987|FG003|Overall Study|Adverse Event|2|||
130296892|NCT03178669|469049988|FG004|Overall Study|Adverse Event|2|||
130296893|NCT03178669|469049984|FG000|Overall Study|Lack of Efficacy|0|||
130372540|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Death|0|||
130372541|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Death|0|||
130372542|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Death|0|||
130372543|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Death|0|||
130372544|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Death|0|||
130372545|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Death|0|||
130372546|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Death|0|||
130372547|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Death|0|||
130372548|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Death|0|||
130372549|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Death|0|||
130372550|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Death|0|||
130372551|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372552|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372553|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
130372554|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
130461090|NCT00854906|469653854|FG000|Overall Study|One person had no ocular history|1|||
130461091|NCT00814346|469653855|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
130461092|NCT00814346|469653856|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
130461093|NCT00814346|469653855|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
130461094|NCT00814346|469653856|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
130296894|NCT03178669|469049985|FG001|Overall Study|Lack of Efficacy|0|||
130557191|NCT01524133|470009910|FG000|Treatment Phase|Lost to Follow-up|0|||
130296895|NCT03178669|469049986|FG002|Overall Study|Lack of Efficacy|2|||
130296896|NCT03178669|469049987|FG003|Overall Study|Lack of Efficacy|0|||
130296897|NCT03178669|469049988|FG004|Overall Study|Lack of Efficacy|1|||
130296898|NCT03178669|469049984|FG000|Overall Study|Physician Decision|0|||
130296899|NCT03178669|469049985|FG001|Overall Study|Physician Decision|0|||
130296900|NCT03178669|469049986|FG002|Overall Study|Physician Decision|0|||
130296901|NCT03178669|469049987|FG003|Overall Study|Physician Decision|0|||
130296902|NCT03178669|469049988|FG004|Overall Study|Physician Decision|1|||
130296903|NCT03178669|469049984|FG000|Overall Study|Withdrawal by Subject|1|||
130296904|NCT03178669|469049985|FG001|Overall Study|Withdrawal by Subject|0|||
130296905|NCT03178669|469049986|FG002|Overall Study|Withdrawal by Subject|1|||
130296906|NCT03178669|469049987|FG003|Overall Study|Withdrawal by Subject|1|||
130296907|NCT03178669|469049988|FG004|Overall Study|Withdrawal by Subject|0|||
130296908|NCT03178669|469049984|FG000|Overall Study|Lost to Follow-up|0|||
130296909|NCT03178669|469049985|FG001|Overall Study|Lost to Follow-up|0|||
130296910|NCT03178669|469049986|FG002|Overall Study|Lost to Follow-up|0|||
130296911|NCT03178669|469049987|FG003|Overall Study|Lost to Follow-up|1|||
130296912|NCT03178669|469049988|FG004|Overall Study|Lost to Follow-up|0|||
130296913|NCT01600092|469049989|FG000|Overall Study|Adverse Event|2|||
130296914|NCT01600092|469049990|FG001|Overall Study|Adverse Event|0|||
130296915|NCT01600092|469049989|FG000|Overall Study|Lost to Follow-up|4|||
130296916|NCT01600092|469049990|FG001|Overall Study|Lost to Follow-up|6|||
130296917|NCT01600092|469049989|FG000|Overall Study|Withdrawal by parent/guardian|8|||
130296918|NCT01600092|469049990|FG001|Overall Study|Withdrawal by parent/guardian|6|||
130296919|NCT01600092|469049989|FG000|Overall Study|Physician Decision|1|||
130296920|NCT01600092|469049990|FG001|Overall Study|Physician Decision|1|||
130296921|NCT01600092|469049989|FG000|Overall Study|Randomized but not vaccinated|3|||
130296922|NCT01600092|469049990|FG001|Overall Study|Randomized but not vaccinated|3|||
130296923|NCT00079677|469049991|FG000|Overall Study|Adverse Event|5|||
130296924|NCT00079677|469049992|FG001|Overall Study|Adverse Event|6|||
130296925|NCT00079677|469049991|FG000|Overall Study|Lack of Efficacy|1|||
130296926|NCT00079677|469049992|FG001|Overall Study|Lack of Efficacy|0|||
130296927|NCT00079677|469049991|FG000|Overall Study|Lost to Follow-up|2|||
130296928|NCT00079677|469049992|FG001|Overall Study|Lost to Follow-up|2|||
130296929|NCT00079677|469049991|FG000|Overall Study|Physician Decision|3|||
130296930|NCT00079677|469049992|FG001|Overall Study|Physician Decision|0|||
130296931|NCT00079677|469049991|FG000|Overall Study|Protocol Violation|2|||
130296932|NCT00079677|469049992|FG001|Overall Study|Protocol Violation|3|||
130296933|NCT00079677|469049991|FG000|Overall Study|Withdrawal by Subject|5|||
130296934|NCT00079677|469049992|FG001|Overall Study|Withdrawal by Subject|3|||
130296935|NCT00079677|469049991|FG000|Overall Study|Miscellaneous|2|||
130296936|NCT00079677|469049992|FG001|Overall Study|Miscellaneous|0|||
130296937|NCT01300455|469049993|FG000|Washout|Withdrawal by Subject|1|||
130296938|NCT01300455|469049994|FG001|Washout|Withdrawal by Subject|0|||
130296939|NCT00084487|469049995|FG000|Overall Study|Death|1|||
130296940|NCT00565136|469049996|FG000|Overall Study|Lost to Follow-up|1|||
130296941|NCT00565136|469049996|FG000|Overall Study|Withdrawal by Subject|1|||
130296942|NCT00565136|469049996|FG000|Overall Study|Protocol Violation|1|||
130296943|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296944|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
130296945|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296946|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296947|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296948|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296949|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296950|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296951|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296952|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296953|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296954|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296955|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296956|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296957|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296958|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296959|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296960|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296961|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296962|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296963|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296964|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296965|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130296966|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296967|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
130296968|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296969|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130296970|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296971|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296972|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296973|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296974|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296975|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296976|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296977|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296978|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296979|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296980|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296981|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296982|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296983|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130296984|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296985|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
130296986|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296987|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130296988|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
130296989|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296990|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296991|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296992|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296993|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296994|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296995|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296996|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296997|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130461095|NCT00814346|469653855|FG000|Open Phase (17 Months)|Adverse Event|5|||
130461096|NCT00814346|469653856|FG001|Open Phase (17 Months)|Adverse Event|0|||
130716089|NCT00446199|470587085|FG002|Overall Study|Lack of Efficacy|0|||
130716090|NCT00446199|470587086|FG003|Overall Study|Lack of Efficacy|1|||
130716091|NCT00446199|470587083|FG000|Overall Study|Non-compliant with study drug|1|||
130716092|NCT00446199|470587084|FG001|Overall Study|Non-compliant with study drug|0|||
130716093|NCT00446199|470587085|FG002|Overall Study|Non-compliant with study drug|5|||
130716094|NCT00446199|470587086|FG003|Overall Study|Non-compliant with study drug|0|||
130716095|NCT00446199|470587083|FG000|Overall Study|Non-compliant with visit schedule|1|||
130716096|NCT00446199|470587084|FG001|Overall Study|Non-compliant with visit schedule|1|||
130716097|NCT00446199|470587085|FG002|Overall Study|Non-compliant with visit schedule|1|||
130716098|NCT00446199|470587086|FG003|Overall Study|Non-compliant with visit schedule|2|||
130716099|NCT00446199|470587083|FG000|Overall Study|Hormone fear|0|||
130716100|NCT00446199|470587084|FG001|Overall Study|Hormone fear|0|||
130716101|NCT00446199|470587085|FG002|Overall Study|Hormone fear|0|||
130716102|NCT00446199|470587086|FG003|Overall Study|Hormone fear|1|||
130716103|NCT00446199|470587083|FG000|Overall Study|Lost interest in study participation|0|||
130716104|NCT00446199|470587084|FG001|Overall Study|Lost interest in study participation|1|||
130716105|NCT00446199|470587085|FG002|Overall Study|Lost interest in study participation|0|||
130716106|NCT00446199|470587086|FG003|Overall Study|Lost interest in study participation|0|||
130716107|NCT00446199|470587083|FG000|Overall Study|In-/Exclusion criterion violated|2|||
130716108|NCT00446199|470587084|FG001|Overall Study|In-/Exclusion criterion violated|1|||
130716109|NCT00446199|470587085|FG002|Overall Study|In-/Exclusion criterion violated|2|||
130716110|NCT00446199|470587086|FG003|Overall Study|In-/Exclusion criterion violated|1|||
130716111|NCT00446199|470587083|FG000|Overall Study|Move|0|||
130461097|NCT00814346|469653855|FG000|Open Phase (17 Months)|Consent|2|||
130461098|NCT00814346|469653856|FG001|Open Phase (17 Months)|Consent|0|||
130461099|NCT00814346|469653855|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
130461100|NCT00814346|469653856|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
130461101|NCT00814346|469653855|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
130461102|NCT00814346|469653856|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
130461103|NCT03622580|469653857|FG000|Overall Study|Death|16|||
130461104|NCT03622580|469653858|FG001|Overall Study|Death|21|||
130716112|NCT00446199|470587084|FG001|Overall Study|Move|1|||
130716113|NCT00446199|470587085|FG002|Overall Study|Move|0|||
130716114|NCT00446199|470587086|FG003|Overall Study|Move|0|||
130716115|NCT03071094|470587090|FG000|Overall Study|Death|1|||
130296998|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296999|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130297000|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297001|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297002|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297003|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297004|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297005|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297006|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297007|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297008|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297009|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297010|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297011|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297012|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297013|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297014|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297015|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297016|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297017|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297018|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297019|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297020|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297021|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297022|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297023|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297024|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297025|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297026|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297027|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297028|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297029|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297030|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297031|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297032|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
130297033|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
130297034|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297035|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297036|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297037|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297038|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297039|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297040|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297041|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297042|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297043|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297044|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297045|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297046|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297047|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297048|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297049|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297050|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297051|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
130297052|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297053|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297054|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297055|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297056|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297057|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297058|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297059|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297060|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297061|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297062|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297063|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297064|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297065|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297066|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297067|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130297068|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297069|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130297070|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130297071|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130297072|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297073|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297074|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297075|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297076|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297077|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297078|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297079|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297080|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297081|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297082|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297083|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297084|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297085|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297086|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297087|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130297088|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130297089|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297090|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297091|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297092|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297093|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297094|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297095|NCT02528357|469049997|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297096|NCT02528357|469049998|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297097|NCT02528357|469049999|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297098|NCT02528357|469050000|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130372555|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
130372556|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
130372557|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
130557192|NCT01524133|470009911|FG001|Treatment Phase|Lost to Follow-up|1|||
130557193|NCT01524133|470009912|FG002|Treatment Phase|Lost to Follow-up|2|||
130557194|NCT01524133|470009910|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
130557195|NCT01524133|470009911|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
130557196|NCT01524133|470009912|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
130557197|NCT01524133|470009910|FG000|Overall Study 52 Weeks|Physician Decision|1|||
130557198|NCT01524133|470009911|FG001|Overall Study 52 Weeks|Physician Decision|0|||
130716116|NCT03071094|470587091|FG001|Overall Study|Death|1|||
130716117|NCT03071094|470587090|FG000|Overall Study|Adverse Event|1|||
130297099|NCT02528357|469050001|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297100|NCT02528357|469050002|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297101|NCT02528357|469050003|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297102|NCT02528357|469050004|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297103|NCT02528357|469050005|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297104|NCT02528357|469050006|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297105|NCT02528357|469050007|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297106|NCT02528357|469050008|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130716118|NCT03071094|470587091|FG001|Overall Study|Adverse Event|0|||
130716119|NCT02312063|470587092|FG000|Overall Study|Withdrawal by Subject|0|||
130716120|NCT02312063|470587093|FG001|Overall Study|Withdrawal by Subject|1|||
130716121|NCT01079832|470587094|FG000|Overall Study|Withdrawal by Subject|1|||
130716122|NCT01951885|470588760|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
130716123|NCT01951885|470588761|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
130716124|NCT01951885|470588760|FG000|Overall Study|Adverse Event|1|||
130716125|NCT01951885|470588761|FG001|Overall Study|Adverse Event|0|||
130716126|NCT01951885|470588760|FG000|Overall Study|Withdrawal by Subject|0|||
130716127|NCT01951885|470588761|FG001|Overall Study|Withdrawal by Subject|1|||
130716128|NCT01951885|470588760|FG000|Overall Study|ineligible due to a change in donor|0|||
130716129|NCT01951885|470588761|FG001|Overall Study|ineligible due to a change in donor|1|||
130716130|NCT01951885|470588760|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
130716131|NCT01951885|470588761|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
130716132|NCT00577395|470588764|FG000|Overall Study|Study was terminated early by Sponsor|7|||
130716133|NCT00577395|470588765|FG001|Overall Study|Study was terminated early by Sponsor|6|||
130716134|NCT01206101|470588768|FG000|Overall Study|Adverse Event|1|||
130716135|NCT01206101|470588769|FG001|Overall Study|Adverse Event|0|||
130716136|NCT01206101|470588768|FG000|Overall Study|Physician Decision|0|||
130716137|NCT01206101|470588769|FG001|Overall Study|Physician Decision|1|||
130461105|NCT03622580|469653859|FG002|Overall Study|Death|13|||
130461106|NCT03622580|469653857|FG000|Overall Study|Adverse Event|6|||
130461107|NCT03622580|469653858|FG001|Overall Study|Adverse Event|6|||
130461108|NCT03622580|469653859|FG002|Overall Study|Adverse Event|5|||
130461109|NCT03622580|469653857|FG000|Overall Study|Withdrawal by Subject|12|||
130461110|NCT03622580|469653858|FG001|Overall Study|Withdrawal by Subject|7|||
130461111|NCT03622580|469653859|FG002|Overall Study|Withdrawal by Subject|19|||
130461112|NCT03622580|469653857|FG000|Overall Study|Lost to Follow-up|12|||
130461113|NCT03622580|469653858|FG001|Overall Study|Lost to Follow-up|9|||
130461114|NCT03622580|469653859|FG002|Overall Study|Lost to Follow-up|9|||
130461115|NCT03622580|469653857|FG000|Overall Study|Protocol Violation|1|||
130461116|NCT03622580|469653858|FG001|Overall Study|Protocol Violation|0|||
130461117|NCT03622580|469653859|FG002|Overall Study|Protocol Violation|1|||
130461118|NCT03622580|469653857|FG000|Overall Study|Physician Decision|3|||
130461119|NCT03622580|469653858|FG001|Overall Study|Physician Decision|0|||
130716138|NCT01206101|470588768|FG000|Overall Study|Unclassified|1|||
130716139|NCT01206101|470588769|FG001|Overall Study|Unclassified|0|||
130716140|NCT04709835|470588772|FG000|Overall Study|Withdrawal by Subject|0|||
130716141|NCT04709835|470588773|FG001|Overall Study|Withdrawal by Subject|1|||
130297107|NCT02528357|469050009|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297108|NCT02528357|469050010|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297109|NCT02528357|469050011|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297110|NCT02528357|469050012|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130461120|NCT03622580|469653859|FG002|Overall Study|Physician Decision|1|||
130461121|NCT03622580|469653857|FG000|Overall Study|Pregnancy|0|||
130461122|NCT03622580|469653858|FG001|Overall Study|Pregnancy|1|||
130461123|NCT03622580|469653859|FG002|Overall Study|Pregnancy|0|||
130461124|NCT03622580|469653857|FG000|Overall Study|Lack of Efficacy|0|||
130461125|NCT03622580|469653858|FG001|Overall Study|Lack of Efficacy|0|||
130461126|NCT03622580|469653859|FG002|Overall Study|Lack of Efficacy|1|||
130461127|NCT03622580|469653857|FG000|Overall Study|Other|2|||
130461128|NCT03622580|469653858|FG001|Overall Study|Other|0|||
130461129|NCT03622580|469653859|FG002|Overall Study|Other|3|||
130461130|NCT02613871|469653862|FG000|Overall Study|Death|2|||
130461131|NCT02613871|469653862|FG000|Overall Study|Withdrew Consent|1|||
130716142|NCT04709835|470588774|FG002|Overall Study|Withdrawal by Subject|0|||
130716143|NCT04325204|470588775|FG000|Overall Study|Death|0|||
130716144|NCT04325204|470588776|FG001|Overall Study|Death|1|||
130461132|NCT00507689|469653863|FG000|Pre-Randomization Period|Adverse Event|1|||
130461133|NCT00507689|469653864|FG001|Pre-Randomization Period|Adverse Event|0|||
130716145|NCT04325204|470588775|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
130716146|NCT04325204|470588776|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
130716147|NCT04325204|470588775|FG000|Overall Study|Lost to Follow-up|8|||
130716148|NCT04325204|470588776|FG001|Overall Study|Lost to Follow-up|8|||
130461134|NCT00507689|469653863|FG000|Pre-Randomization Period|Physician Decision|1|||
130297111|NCT02528357|469050013|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
130297112|NCT02528357|469050014|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297113|NCT02528357|469050015|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297114|NCT02528357|469049997|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297115|NCT02528357|469049998|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297116|NCT02528357|469049999|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297117|NCT02528357|469050000|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297118|NCT02528357|469050001|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297119|NCT02528357|469050002|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297120|NCT02528357|469050003|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297121|NCT02528357|469050004|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297122|NCT02528357|469050005|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297123|NCT02528357|469050006|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297124|NCT02528357|469050007|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297125|NCT02528357|469050008|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297126|NCT02528357|469050009|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297127|NCT02528357|469050010|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297128|NCT02528357|469050011|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297129|NCT02528357|469050012|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297130|NCT02528357|469050013|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297131|NCT02528357|469050014|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130297132|NCT02528357|469050015|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130297133|NCT02438813|469050021|FG000|Overall Study|Patient Decision|59|||
130297134|NCT02438813|469050021|FG000|Overall Study|Patient Lost to Follow-Up|137|||
130297135|NCT02438813|469050021|FG000|Overall Study|Study Ended by Sponsor|80|||
130297136|NCT02438813|469050021|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
130297137|NCT02228096|469050032|FG000|Overall Study|Study terminated by Sponsor|24|||
130297138|NCT02228096|469050032|FG000|Overall Study|Lack of Efficacy|18|||
130297139|NCT02228096|469050032|FG000|Overall Study|Death|12|||
130297140|NCT02228096|469050032|FG000|Overall Study|Physician Decision|3|||
130297141|NCT02228096|469050032|FG000|Overall Study|Subject/guardian decision|2|||
130297142|NCT02228096|469050032|FG000|Overall Study|New therapy for study indication|1|||
130297143|NCT02228096|469050032|FG000|Overall Study|Enrolled, not infused|11|||
130297144|NCT00454649|469050033|FG000|Overall Study|Lack of Efficacy|2|||
130297145|NCT00454649|469050034|FG001|Overall Study|Lack of Efficacy|2|||
130297146|NCT00454649|469050035|FG002|Overall Study|Lack of Efficacy|10|||
130297147|NCT00454649|469050036|FG003|Overall Study|Lack of Efficacy|3|||
130297148|NCT00454649|469050037|FG004|Overall Study|Lack of Efficacy|0|||
130297149|NCT00454649|469050038|FG005|Overall Study|Lack of Efficacy|4|||
130297150|NCT00454649|469050039|FG006|Overall Study|Lack of Efficacy|5|||
130297151|NCT00454649|469050040|FG007|Overall Study|Lack of Efficacy|13|||
130297152|NCT00454649|469050041|FG008|Overall Study|Lack of Efficacy|10|||
130297153|NCT00454649|469050042|FG009|Overall Study|Lack of Efficacy|2|||
130297154|NCT00454649|469050033|FG000|Overall Study|Adverse Event|0|||
130297155|NCT00454649|469050034|FG001|Overall Study|Adverse Event|1|||
130297156|NCT00454649|469050035|FG002|Overall Study|Adverse Event|3|||
130297157|NCT00454649|469050036|FG003|Overall Study|Adverse Event|0|||
130297158|NCT00454649|469050037|FG004|Overall Study|Adverse Event|1|||
130297159|NCT00454649|469050038|FG005|Overall Study|Adverse Event|2|||
130297160|NCT00454649|469050039|FG006|Overall Study|Adverse Event|3|||
130297161|NCT00454649|469050040|FG007|Overall Study|Adverse Event|4|||
130297162|NCT00454649|469050041|FG008|Overall Study|Adverse Event|6|||
130297163|NCT00454649|469050042|FG009|Overall Study|Adverse Event|2|||
130297164|NCT00454649|469050033|FG000|Overall Study|Lost to Follow-up|0|||
130297165|NCT00454649|469050034|FG001|Overall Study|Lost to Follow-up|0|||
130297166|NCT00454649|469050035|FG002|Overall Study|Lost to Follow-up|1|||
130297167|NCT00454649|469050036|FG003|Overall Study|Lost to Follow-up|0|||
130297168|NCT00454649|469050037|FG004|Overall Study|Lost to Follow-up|0|||
130297169|NCT00454649|469050038|FG005|Overall Study|Lost to Follow-up|0|||
130297170|NCT00454649|469050039|FG006|Overall Study|Lost to Follow-up|1|||
130716149|NCT04325204|470588775|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130297171|NCT00454649|469050040|FG007|Overall Study|Lost to Follow-up|0|||
130297172|NCT00454649|469050041|FG008|Overall Study|Lost to Follow-up|0|||
130297173|NCT00454649|469050042|FG009|Overall Study|Lost to Follow-up|0|||
130297174|NCT00454649|469050033|FG000|Overall Study|Other|1|||
130297175|NCT00454649|469050034|FG001|Overall Study|Other|1|||
130297176|NCT00454649|469050035|FG002|Overall Study|Other|5|||
130297177|NCT00454649|469050036|FG003|Overall Study|Other|3|||
130297178|NCT00454649|469050037|FG004|Overall Study|Other|0|||
130297179|NCT00454649|469050038|FG005|Overall Study|Other|0|||
130297180|NCT00454649|469050039|FG006|Overall Study|Other|0|||
130297181|NCT00454649|469050040|FG007|Overall Study|Other|0|||
130297182|NCT00454649|469050041|FG008|Overall Study|Other|3|||
130297183|NCT00454649|469050042|FG009|Overall Study|Other|1|||
130297184|NCT00454649|469050033|FG000|Overall Study|Withdrawal by Subject|0|||
130297185|NCT00454649|469050034|FG001|Overall Study|Withdrawal by Subject|0|||
130297186|NCT00454649|469050035|FG002|Overall Study|Withdrawal by Subject|0|||
130297187|NCT00454649|469050036|FG003|Overall Study|Withdrawal by Subject|0|||
130297188|NCT00454649|469050037|FG004|Overall Study|Withdrawal by Subject|0|||
130297189|NCT00454649|469050038|FG005|Overall Study|Withdrawal by Subject|1|||
130297190|NCT00454649|469050039|FG006|Overall Study|Withdrawal by Subject|0|||
130297191|NCT00454649|469050040|FG007|Overall Study|Withdrawal by Subject|2|||
130297192|NCT00454649|469050041|FG008|Overall Study|Withdrawal by Subject|1|||
130297193|NCT00454649|469050042|FG009|Overall Study|Withdrawal by Subject|0|||
130297194|NCT01789606|469050043|FG000|Overall Study|Participant not Purchased the Product|0|||
130297195|NCT01789606|469050044|FG001|Overall Study|Participant not Purchased the Product|20|||
130297196|NCT01789606|469050043|FG000|Overall Study|Withdrawal by Subject|0|||
130297197|NCT01789606|469050044|FG001|Overall Study|Withdrawal by Subject|1|||
130297198|NCT01789606|469050043|FG000|Overall Study|Ineligible|6|||
130297199|NCT01789606|469050044|FG001|Overall Study|Ineligible|2|||
130297200|NCT01789606|469050043|FG000|Overall Study|Administrative Reasons|17|||
130297201|NCT01789606|469050044|FG001|Overall Study|Administrative Reasons|6|||
130297202|NCT01789606|469050043|FG000|Overall Study|No Study Medication Taken|0|||
130297203|NCT01789606|469050044|FG001|Overall Study|No Study Medication Taken|1|||
130297204|NCT01789606|469050043|FG000|Overall Study|Protocol Violation|0|||
130297205|NCT01789606|469050044|FG001|Overall Study|Protocol Violation|55|||
130297206|NCT01789606|469050043|FG000|Overall Study|Adverse Event|0|||
130297207|NCT01789606|469050044|FG001|Overall Study|Adverse Event|3|||
130297208|NCT01789606|469050043|FG000|Overall Study|Lost to Follow-up|0|||
130297209|NCT01789606|469050044|FG001|Overall Study|Lost to Follow-up|14|||
130297210|NCT01789606|469050043|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
130297211|NCT01789606|469050044|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
130297212|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130297213|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130297214|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
130297215|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
130297216|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
130297217|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
130297218|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
130297219|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
130297220|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Death|0|||
130297221|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Death|1|||
130297222|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
130297223|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
130297224|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Other|0|||
130297225|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Other|2|||
130297226|NCT03281304|469050060|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
130297227|NCT03281304|469050061|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
130297228|NCT00626405|469050062|FG000|Overall Study|Deemed Ineligible|1|||
130297229|NCT00626405|469050063|FG001|Overall Study|Deemed Ineligible|0|||
130297230|NCT00626405|469050062|FG000|Overall Study|Withdrawal by Subject|0|||
130297231|NCT00626405|469050063|FG001|Overall Study|Withdrawal by Subject|1|||
130297232|NCT03834220|469050064|FG000|Overall Study|Adverse Event|1|||
130297233|NCT03834220|469050065|FG001|Overall Study|Adverse Event|0|||
130297234|NCT03834220|469050066|FG002|Overall Study|Adverse Event|0|||
130297235|NCT03834220|469050064|FG000|Overall Study|Death|8|||
130297236|NCT03834220|469050065|FG001|Overall Study|Death|1|||
130297237|NCT03834220|469050066|FG002|Overall Study|Death|17|||
130297238|NCT03834220|469050064|FG000|Overall Study|Reason not Specified|9|||
130297239|NCT03834220|469050065|FG001|Overall Study|Reason not Specified|0|||
130297240|NCT03834220|469050066|FG002|Overall Study|Reason not Specified|6|||
130297241|NCT03834220|469050064|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
130297242|NCT03834220|469050065|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
130297243|NCT03834220|469050066|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
130297244|NCT03834220|469050064|FG000|Overall Study|Withdrawal of Consent|2|||
130297245|NCT03834220|469050065|FG001|Overall Study|Withdrawal of Consent|2|||
130297246|NCT03834220|469050066|FG002|Overall Study|Withdrawal of Consent|2|||
130297247|NCT02593318|469050067|FG000|Overall Study|Withdrawal by Subject|1|||
130297248|NCT02593318|469050068|FG001|Overall Study|Withdrawal by Subject|1|||
130297249|NCT02720692|469052143|FG000|Overall Study|Withdrawal by Subject|3|||
130297250|NCT02720692|469052144|FG001|Overall Study|Withdrawal by Subject|0|||
130297251|NCT02720692|469052143|FG000|Overall Study|Physician Decision|1|||
130297252|NCT02720692|469052144|FG001|Overall Study|Physician Decision|0|||
130297253|NCT02720692|469052143|FG000|Overall Study|Lost to Follow-up|8|||
130297254|NCT02720692|469052144|FG001|Overall Study|Lost to Follow-up|3|||
130297255|NCT02720692|469052143|FG000|Overall Study|Subject unable to return for visit|1|||
130297256|NCT02720692|469052144|FG001|Overall Study|Subject unable to return for visit|0|||
130297257|NCT05011513|469052145|FG000|Overall Study|Death|0|||
130297258|NCT05011513|469052146|FG001|Overall Study|Death|1|||
130297259|NCT05011513|469052145|FG000|Overall Study|Lost to Follow-up|4|||
130297260|NCT05011513|469052146|FG001|Overall Study|Lost to Follow-up|0|||
130297261|NCT05011513|469052145|FG000|Overall Study|Withdrawal by Subject|18|||
130297262|NCT05011513|469052146|FG001|Overall Study|Withdrawal by Subject|17|||
130297263|NCT05011513|469052145|FG000|Overall Study|Other|4|||
130297264|NCT05011513|469052146|FG001|Overall Study|Other|2|||
130297265|NCT03878758|469052147|FG000|Overall Study|Withdrawal by Subject|1|||
130297266|NCT03878758|469052147|FG000|Overall Study|Protocol defined|2|||
130297267|NCT03878758|469052147|FG000|Overall Study|Improper consent documentation|1|||
130297268|NCT02315560|469052148|FG000|Overall Study|noncompliance by subjects|3|||
130297269|NCT00358436|469052150|FG000|Overall Study|Adverse Event|29|||
130297270|NCT00358436|469052151|FG001|Overall Study|Adverse Event|13|||
130297271|NCT00358436|469052150|FG000|Overall Study|Lack of Efficacy|34|||
130297272|NCT00358436|469052151|FG001|Overall Study|Lack of Efficacy|36|||
130297273|NCT00358436|469052150|FG000|Overall Study|Lost to Follow-up|11|||
130297274|NCT00358436|469052151|FG001|Overall Study|Lost to Follow-up|6|||
130297275|NCT00358436|469052150|FG000|Overall Study|Protocol Violation|8|||
130297276|NCT00358436|469052151|FG001|Overall Study|Protocol Violation|3|||
130297277|NCT00358436|469052150|FG000|Overall Study|Withdrawal by Subject|40|||
130297278|NCT00358436|469052151|FG001|Overall Study|Withdrawal by Subject|17|||
130297279|NCT00358436|469052150|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
130297280|NCT00358436|469052151|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
130297281|NCT00358436|469052150|FG000|Overall Study|COPD exacerbation|22|||
130297282|NCT00358436|469052151|FG001|Overall Study|COPD exacerbation|10|||
130297283|NCT00358436|469052150|FG000|Overall Study|Other|6|||
130297284|NCT00358436|469052151|FG001|Overall Study|Other|1|||
130297285|NCT00321464|469052152|FG000|Overall Study|Death|169|||
130297286|NCT00321464|469052153|FG001|Overall Study|Death|174|||
130297287|NCT00321464|469052152|FG000|Overall Study|Disease progression|124|||
130297288|NCT00321464|469052153|FG001|Overall Study|Disease progression|124|||
130297289|NCT00321464|469052152|FG000|Overall Study|Withdrawal by Subject|117|||
130297290|NCT00321464|469052153|FG001|Overall Study|Withdrawal by Subject|118|||
130297291|NCT00321464|469052152|FG000|Overall Study|Participant request|57|||
130297292|NCT00321464|469052153|FG001|Overall Study|Participant request|61|||
130297293|NCT00321464|469052152|FG000|Overall Study|Adverse Event|43|||
130297294|NCT00321464|469052153|FG001|Overall Study|Adverse Event|28|||
130297295|NCT00321464|469052152|FG000|Overall Study|Physician Decision|15|||
130297296|NCT00321464|469052153|FG001|Overall Study|Physician Decision|14|||
130297297|NCT00321464|469052152|FG000|Overall Study|Noncompliance|4|||
130297298|NCT00321464|469052153|FG001|Overall Study|Noncompliance|10|||
130297299|NCT00321464|469052152|FG000|Overall Study|Lost to Follow-up|7|||
130297300|NCT00321464|469052153|FG001|Overall Study|Lost to Follow-up|8|||
130297301|NCT00321464|469052152|FG000|Overall Study|Protocol deviation|0|||
130297302|NCT00321464|469052153|FG001|Overall Study|Protocol deviation|2|||
130297303|NCT00321464|469052152|FG000|Overall Study|Ineligibility determined|2|||
130297304|NCT00321464|469052153|FG001|Overall Study|Ineligibility determined|1|||
130297305|NCT00321464|469052152|FG000|Overall Study|Other|21|||
130297306|NCT00321464|469052153|FG001|Overall Study|Other|18|||
130297307|NCT00652951|469052156|FG000|Booster Phase|Adverse event, non-fatal|0|||
130297308|NCT00652951|469052157|FG001|Booster Phase|Adverse event, non-fatal|1|||
130297309|NCT00652951|469052158|FG002|Booster Phase|Adverse event, non-fatal|0|||
130297310|NCT00652951|469052156|FG000|Booster Phase|Other|1|||
130297311|NCT00652951|469052157|FG001|Booster Phase|Other|0|||
130297312|NCT00652951|469052158|FG002|Booster Phase|Other|0|||
130297313|NCT01206582|469052159|FG000|Overall Study|Withdrew prior to study|1|||
130297314|NCT01206582|469052160|FG001|Overall Study|Withdrew prior to study|0|||
130297315|NCT01206582|469052159|FG000|Overall Study|Discontinued intervention before week 8|1|||
130297316|NCT01206582|469052160|FG001|Overall Study|Discontinued intervention before week 8|2|||
130297317|NCT06359080|469052163|FG000|Overall Study|Withdrawal by Subject|3|||
130297318|NCT00306527|469052166|FG000|Overall Study|Lost to Follow-up|3|||
130297319|NCT00306527|469052167|FG001|Overall Study|Lost to Follow-up|4|||
130297320|NCT00306527|469052168|FG002|Overall Study|Lost to Follow-up|3|||
130297321|NCT00306527|469052169|FG003|Overall Study|Lost to Follow-up|0|||
130297322|NCT00306527|469052166|FG000|Overall Study|Withdrawal by Subject|2|||
130297323|NCT00306527|469052167|FG001|Overall Study|Withdrawal by Subject|3|||
130461135|NCT00507689|469653864|FG001|Pre-Randomization Period|Physician Decision|0|||
130297324|NCT00306527|469052168|FG002|Overall Study|Withdrawal by Subject|0|||
130297325|NCT00306527|469052169|FG003|Overall Study|Withdrawal by Subject|3|||
130297326|NCT00306527|469052166|FG000|Overall Study|Adverse Event|0|||
130297327|NCT00306527|469052167|FG001|Overall Study|Adverse Event|0|||
130297328|NCT00306527|469052168|FG002|Overall Study|Adverse Event|1|||
130297329|NCT00306527|469052169|FG003|Overall Study|Adverse Event|1|||
130297330|NCT00306527|469052166|FG000|Overall Study|Death|1|||
130297331|NCT00306527|469052167|FG001|Overall Study|Death|0|||
130297332|NCT00306527|469052168|FG002|Overall Study|Death|1|||
130297333|NCT00306527|469052169|FG003|Overall Study|Death|2|||
130297334|NCT00417963|469052185|FG000|Overall Study|Lost to Follow-up|3|||
130297335|NCT00417963|469052185|FG000|Overall Study|Withdrawal by Subject|18|||
130297336|NCT00417963|469052185|FG000|Overall Study|Death|17|||
130297337|NCT00417963|469052185|FG000|Overall Study|Study device could not be deployed|3|||
130297338|NCT01023672|469052186|FG000|Overall Study|Worsening disease|2|||
130297339|NCT01023672|469052186|FG000|Overall Study|Death|1|||
130297340|NCT00387725|469052187|FG000|Overall Study|Adverse Event|0|||
130297341|NCT00387725|469052188|FG001|Overall Study|Adverse Event|0|||
130297342|NCT00387725|469052189|FG002|Overall Study|Adverse Event|0|||
130297343|NCT00387725|469052190|FG003|Overall Study|Adverse Event|1|||
130297344|NCT00387725|469052187|FG000|Overall Study|Protocol Violation|0|||
130297345|NCT00387725|469052188|FG001|Overall Study|Protocol Violation|1|||
130297346|NCT00387725|469052189|FG002|Overall Study|Protocol Violation|0|||
130297347|NCT00387725|469052190|FG003|Overall Study|Protocol Violation|0|||
130297348|NCT00387725|469052187|FG000|Overall Study|Withdrawal by Subject|1|||
130297349|NCT00387725|469052188|FG001|Overall Study|Withdrawal by Subject|0|||
130297350|NCT00387725|469052189|FG002|Overall Study|Withdrawal by Subject|1|||
130297351|NCT00387725|469052190|FG003|Overall Study|Withdrawal by Subject|0|||
130297352|NCT00387725|469052187|FG000|Overall Study|Parent/legal guardian request|0|||
130297353|NCT00387725|469052188|FG001|Overall Study|Parent/legal guardian request|0|||
130297354|NCT00387725|469052189|FG002|Overall Study|Parent/legal guardian request|1|||
130297355|NCT00387725|469052190|FG003|Overall Study|Parent/legal guardian request|1|||
130297356|NCT02017522|469052193|FG000|Overall Study|Withdrawal by Subject|1|||
130297357|NCT02166463|469052194|FG000|Overall Study|Lost to Follow-up|0|||
130297358|NCT02166463|469052195|FG001|Overall Study|Lost to Follow-up|1|||
130297359|NCT02166463|469052194|FG000|Overall Study|Physician Decision|10|||
130297360|NCT02166463|469052195|FG001|Overall Study|Physician Decision|10|||
130297361|NCT02166463|469052194|FG000|Overall Study|Ineligible|11|||
130297362|NCT02166463|469052195|FG001|Overall Study|Ineligible|2|||
130297363|NCT02166463|469052194|FG000|Overall Study|Progressive Disease|9|||
130297364|NCT02166463|469052195|FG001|Overall Study|Progressive Disease|6|||
130297365|NCT02166463|469052194|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
130461136|NCT00507689|469653863|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
130461137|NCT00507689|469653864|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
130461138|NCT00507689|469653863|FG000|Randomized Period|Adverse Event|1|||
130461139|NCT00507689|469653864|FG001|Randomized Period|Adverse Event|1|||
130297366|NCT02166463|469052195|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
130297367|NCT02166463|469052194|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
130297368|NCT02166463|469052195|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
130297369|NCT02166463|469052194|FG000|Overall Study|Refusal of further protocol therapy|5|||
130297370|NCT02166463|469052195|FG001|Overall Study|Refusal of further protocol therapy|6|||
130297371|NCT00859937|469052196|FG000|Overall Study|Protocol Violation|1|||
130297372|NCT00859937|469052197|FG001|Overall Study|Protocol Violation|0|||
130297373|NCT02478164|469052198|FG000|Overall Study|Lack of Efficacy|13|||
130297374|NCT02478164|469052198|FG000|Overall Study|Adverse Event|1|||
130297375|NCT02478164|469052198|FG000|Overall Study|Withdrawal by Subject|1|||
130297376|NCT05194267|469052199|FG000|Overall Study|Withdrawal by Subject|2|||
130297377|NCT00802893|469052200|FG000|Overall Study|study terminated|3|||
130297378|NCT06151288|469052201|FG000|Overall Study|Lost to Follow-up|4|||
130297379|NCT06151288|469052202|FG001|Overall Study|Lost to Follow-up|2|||
130297380|NCT06151288|469052203|FG002|Overall Study|Lost to Follow-up|4|||
130297381|NCT06151288|469052204|FG003|Overall Study|Lost to Follow-up|3|||
130297382|NCT06151288|469052201|FG000|Overall Study|Withdrawal by Subject|4|||
130297383|NCT06151288|469052202|FG001|Overall Study|Withdrawal by Subject|5|||
130297384|NCT06151288|469052203|FG002|Overall Study|Withdrawal by Subject|1|||
130297385|NCT06151288|469052204|FG003|Overall Study|Withdrawal by Subject|1|||
130297386|NCT04588389|469052205|FG000|Overall Study|Issues with anesthesia during surgery|2|||
130297387|NCT04588389|469052206|FG001|Overall Study|Issues with anesthesia during surgery|0|||
130297388|NCT04588389|469052207|FG002|Overall Study|Issues with anesthesia during surgery|0|||
130297389|NCT02911142|469052208|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
130297390|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
130297391|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
130297392|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
130297393|NCT00026312|469052209|FG000|Overall Study|Adverse Event|0|||
130297394|NCT00026312|469052210|FG001|Overall Study|Adverse Event|32|||
130297395|NCT00026312|469052209|FG000|Overall Study|Death|1|||
130297396|NCT00026312|469052210|FG001|Overall Study|Death|7|||
130297397|NCT00026312|469052209|FG000|Overall Study|Lack of Efficacy|19|||
130297398|NCT00026312|469052210|FG001|Overall Study|Lack of Efficacy|114|||
130297399|NCT00026312|469052209|FG000|Overall Study|Lost to Follow-up|0|||
130297400|NCT00026312|469052210|FG001|Overall Study|Lost to Follow-up|5|||
130297401|NCT00026312|469052209|FG000|Overall Study|Physician Decision|1|||
130297402|NCT00026312|469052210|FG001|Overall Study|Physician Decision|37|||
130297403|NCT00026312|469052209|FG000|Overall Study|Protocol Violation|0|||
130297404|NCT00026312|469052210|FG001|Overall Study|Protocol Violation|3|||
130297405|NCT00026312|469052209|FG000|Overall Study|Withdrawal by Subject|1|||
130297406|NCT00026312|469052210|FG001|Overall Study|Withdrawal by Subject|6|||
130297407|NCT00026312|469052209|FG000|Overall Study|Ineligible|4|||
130297408|NCT00026312|469052210|FG001|Overall Study|Ineligible|5|||
130297409|NCT00026312|469052209|FG000|Overall Study|Entry onto another COG study|0|||
130297410|NCT00026312|469052210|FG001|Overall Study|Entry onto another COG study|1|||
130297411|NCT00026312|469052209|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
130297412|NCT00026312|469052210|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
130297413|NCT00231413|469052213|FG000|Overall Study|Non-serious AE|0|||
130297414|NCT00231413|469052214|FG001|Overall Study|Non-serious AE|0|||
130297415|NCT00231413|469052215|FG002|Overall Study|Non-serious AE|1|||
130297416|NCT00231413|469052216|FG003|Overall Study|Non-serious AE|0|||
130297417|NCT00231413|469052217|FG004|Overall Study|Non-serious AE|0|||
130297418|NCT00231413|469052218|FG005|Overall Study|Non-serious AE|0|||
130297419|NCT00231413|469052219|FG006|Overall Study|Non-serious AE|1|||
130297420|NCT00231413|469052213|FG000|Overall Study|Withdrawal by Subject|3|||
130297421|NCT00231413|469052214|FG001|Overall Study|Withdrawal by Subject|1|||
130297422|NCT00231413|469052215|FG002|Overall Study|Withdrawal by Subject|4|||
130297423|NCT00231413|469052216|FG003|Overall Study|Withdrawal by Subject|2|||
130297424|NCT00231413|469052217|FG004|Overall Study|Withdrawal by Subject|2|||
130297425|NCT00231413|469052218|FG005|Overall Study|Withdrawal by Subject|0|||
130297426|NCT00231413|469052219|FG006|Overall Study|Withdrawal by Subject|3|||
130372558|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372559|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372560|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372561|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372562|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372563|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372564|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372565|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372566|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372567|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372568|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372569|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372570|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130297427|NCT00231413|469052213|FG000|Overall Study|Migrated/moved from study area|0|||
130297428|NCT00231413|469052214|FG001|Overall Study|Migrated/moved from study area|0|||
130297429|NCT00231413|469052215|FG002|Overall Study|Migrated/moved from study area|1|||
130297430|NCT00231413|469052216|FG003|Overall Study|Migrated/moved from study area|0|||
130297431|NCT00231413|469052217|FG004|Overall Study|Migrated/moved from study area|0|||
130297432|NCT00231413|469052218|FG005|Overall Study|Migrated/moved from study area|1|||
130297433|NCT00231413|469052219|FG006|Overall Study|Migrated/moved from study area|0|||
130297434|NCT00231413|469052213|FG000|Overall Study|Lost to Follow-up|4|||
130297435|NCT00231413|469052214|FG001|Overall Study|Lost to Follow-up|4|||
130297436|NCT00231413|469052215|FG002|Overall Study|Lost to Follow-up|1|||
130557199|NCT01524133|470009912|FG002|Overall Study 52 Weeks|Physician Decision|2|||
130557200|NCT01524133|470009910|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
130557201|NCT01524133|470009911|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
130557202|NCT01524133|470009912|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
130557203|NCT00059839|470009919|FG000|Overall Study|Death|1|||
130557204|NCT00059839|470009920|FG001|Overall Study|Death|1|||
130557205|NCT00059839|470009919|FG000|Overall Study|Lack of Efficacy|6|||
130716150|NCT04325204|470588776|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130716151|NCT04710979|470588778|FG000|Overall Study|Lost to Follow-up|2|||
130716152|NCT04710979|470588779|FG001|Overall Study|Lost to Follow-up|4|||
130716153|NCT04710979|470588778|FG000|Overall Study|Withdrawal by Subject|1|||
130297437|NCT00231413|469052216|FG003|Overall Study|Lost to Follow-up|1|||
130297438|NCT00231413|469052217|FG004|Overall Study|Lost to Follow-up|1|||
130297439|NCT00231413|469052218|FG005|Overall Study|Lost to Follow-up|4|||
130297440|NCT00231413|469052219|FG006|Overall Study|Lost to Follow-up|0|||
130297441|NCT00231413|469052213|FG000|Overall Study|Pregnancy|1|||
130297442|NCT00231413|469052214|FG001|Overall Study|Pregnancy|0|||
130297443|NCT00231413|469052215|FG002|Overall Study|Pregnancy|0|||
130297444|NCT00231413|469052216|FG003|Overall Study|Pregnancy|0|||
130297445|NCT00231413|469052217|FG004|Overall Study|Pregnancy|0|||
130297446|NCT00231413|469052218|FG005|Overall Study|Pregnancy|0|||
130297447|NCT00231413|469052219|FG006|Overall Study|Pregnancy|0|||
130297448|NCT02294734|469052220|FG000|Overall Study|Adverse Event|5|||
130297449|NCT02294734|469052221|FG001|Overall Study|Adverse Event|5|||
130297450|NCT02294734|469052220|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
130297451|NCT02294734|469052221|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
130297452|NCT02294734|469052220|FG000|Overall Study|Lost to Follow-up|2|||
130297453|NCT02294734|469052221|FG001|Overall Study|Lost to Follow-up|0|||
130297454|NCT02294734|469052220|FG000|Overall Study|Physician Decision|2|||
130297455|NCT02294734|469052221|FG001|Overall Study|Physician Decision|1|||
130297456|NCT02294734|469052220|FG000|Overall Study|Withdrawal by Subject|4|||
130297457|NCT02294734|469052221|FG001|Overall Study|Withdrawal by Subject|2|||
130297458|NCT03157583|469052222|FG000|Overall Study|Other (did not meet study criteria)|1|||
130297459|NCT00847015|469052225|FG000|Overall Study|Withdrawal by Subject|1|||
130297460|NCT00847015|469052225|FG000|Overall Study|declined any surgery|1|||
130297461|NCT00847015|469052225|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
130297462|NCT01141478|469052226|FG000|Overall Study|Withdrawal by Subject|1|||
130461140|NCT00507689|469653863|FG000|Randomized Period|Withdrawal by Subject|0|||
130716154|NCT04710979|470588779|FG001|Overall Study|Withdrawal by Subject|0|||
130716155|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Other|2|||
130716156|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Other|0|||
130716157|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Other|0|||
130716158|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
130297463|NCT01141478|469052227|FG001|Overall Study|Withdrawal by Subject|1|||
130297464|NCT03847909|469052237|FG000|Overall Study|Withdrawal by Subject|1|||
130461141|NCT00507689|469653864|FG001|Randomized Period|Withdrawal by Subject|1|||
130461142|NCT00494442|469653865|FG000|Overall Study|Death|1|||
130461143|NCT00494442|469653866|FG001|Overall Study|Death|1|||
130461144|NCT00494442|469653865|FG000|Overall Study|Lack of Efficacy|16|||
130461145|NCT00494442|469653866|FG001|Overall Study|Lack of Efficacy|10|||
130461146|NCT00494442|469653865|FG000|Overall Study|Adverse Event|0|||
130461147|NCT00494442|469653866|FG001|Overall Study|Adverse Event|2|||
130461148|NCT00494442|469653865|FG000|Overall Study|Physician Decision|0|||
130461149|NCT00494442|469653866|FG001|Overall Study|Physician Decision|1|||
130461150|NCT00494442|469653865|FG000|Overall Study|Non-compliance|0|||
130461151|NCT00494442|469653866|FG001|Overall Study|Non-compliance|1|||
130461152|NCT00494442|469653865|FG000|Overall Study|Intercurrent illness|0|||
130716159|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130297465|NCT03847909|469052238|FG001|Overall Study|Withdrawal by Subject|1|||
130297466|NCT00975143|469052239|FG000|Overall Study|Adverse Event|19|||
130297467|NCT00975143|469052240|FG001|Overall Study|Adverse Event|15|||
130297468|NCT00975143|469052239|FG000|Overall Study|Withdrawal by Subject|15|||
130297469|NCT00975143|469052240|FG001|Overall Study|Withdrawal by Subject|15|||
130557206|NCT00059839|470009920|FG001|Overall Study|Lack of Efficacy|5|||
130557207|NCT00059839|470009919|FG000|Overall Study|Lost to Follow-up|2|||
130297470|NCT00975143|469052239|FG000|Overall Study|Lost to Follow-up|20|||
130297471|NCT00975143|469052240|FG001|Overall Study|Lost to Follow-up|16|||
130297472|NCT00975143|469052239|FG000|Overall Study|Non-compliance|5|||
130461153|NCT00494442|469653866|FG001|Overall Study|Intercurrent illness|1|||
130297473|NCT00975143|469052240|FG001|Overall Study|Non-compliance|8|||
130297474|NCT00975143|469052239|FG000|Overall Study|Physician Decision|1|||
130297475|NCT00975143|469052240|FG001|Overall Study|Physician Decision|2|||
130297476|NCT00975143|469052239|FG000|Overall Study|Details not available|10|||
130297477|NCT00975143|469052240|FG001|Overall Study|Details not available|4|||
130297478|NCT01375608|469052241|FG000|Overall Study|Withdrawal by Subject|2|||
130297479|NCT02049138|469052244|FG000|Overall Study|Adverse Event|46|||
130297480|NCT02049138|469052245|FG001|Overall Study|Adverse Event|25|||
130297481|NCT02049138|469052246|FG002|Overall Study|Adverse Event|1|||
130297482|NCT02049138|469052244|FG000|Overall Study|Withdrawal by Subject|57|||
130297483|NCT02049138|469052245|FG001|Overall Study|Withdrawal by Subject|21|||
130297484|NCT02049138|469052246|FG002|Overall Study|Withdrawal by Subject|5|||
130297485|NCT02049138|469052244|FG000|Overall Study|Lost to Follow-up|18|||
130297486|NCT02049138|469052245|FG001|Overall Study|Lost to Follow-up|5|||
130297487|NCT02049138|469052246|FG002|Overall Study|Lost to Follow-up|1|||
130297488|NCT02049138|469052244|FG000|Overall Study|Lack of Efficacy|10|||
130297489|NCT02049138|469052245|FG001|Overall Study|Lack of Efficacy|26|||
130297490|NCT02049138|469052246|FG002|Overall Study|Lack of Efficacy|1|||
130297491|NCT02049138|469052244|FG000|Overall Study|Non-Compliance|15|||
130297492|NCT02049138|469052245|FG001|Overall Study|Non-Compliance|6|||
130461154|NCT00831415|469653867|FG000|Overall Study|Adverse Event|14|||
130297493|NCT02049138|469052246|FG002|Overall Study|Non-Compliance|0|||
130297494|NCT02049138|469052244|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
130461155|NCT00831415|469653867|FG000|Overall Study|Failed to return|3|||
130461156|NCT00831415|469653867|FG000|Overall Study|Physician Decision|6|||
130461157|NCT00831415|469653867|FG000|Overall Study|Lost to Follow-up|9|||
130461158|NCT00831415|469653867|FG000|Overall Study|Protocol Violation|3|||
130461159|NCT00831415|469653867|FG000|Overall Study|Withdrawal by Subject|35|||
130461160|NCT00831415|469653867|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
130461161|NCT00831415|469653867|FG000|Overall Study|Death|1|||
130461162|NCT01290224|469653868|FG000|Overall Study|Adverse Event|1|||
130461163|NCT01290224|469653868|FG000|Overall Study|Refused Further Treatment|4|||
130461164|NCT01241292|469653869|FG000|Overall Study|Administrative Reason by Sponsor|1|||
130461165|NCT01241292|469653870|FG001|Overall Study|Administrative Reason by Sponsor|0|||
130461166|NCT01241292|469653869|FG000|Overall Study|Disease Progression|2|||
130461167|NCT01241292|469653870|FG001|Overall Study|Disease Progression|0|||
130461168|NCT01241292|469653869|FG000|Overall Study|Study Drug Toxicity|0|||
130461169|NCT01241292|469653870|FG001|Overall Study|Study Drug Toxicity|1|||
130461170|NCT01241292|469653869|FG000|Overall Study|Participant Discontinued Treatment|0|||
130461171|NCT01241292|469653870|FG001|Overall Study|Participant Discontinued Treatment|2|||
130461172|NCT03861767|469653871|FG000|Overall Study|Withdrawal by Subject|2|||
130461173|NCT03861767|469653872|FG001|Overall Study|Withdrawal by Subject|1|||
130461174|NCT03861767|469653873|FG002|Overall Study|Withdrawal by Subject|0|||
130461175|NCT03861767|469653874|FG003|Overall Study|Withdrawal by Subject|5|||
130461176|NCT03861767|469653875|FG004|Overall Study|Withdrawal by Subject|2|||
130461177|NCT03861767|469653876|FG005|Overall Study|Withdrawal by Subject|1|||
130461178|NCT03861767|469653877|FG006|Overall Study|Withdrawal by Subject|3|||
130461179|NCT03861767|469653878|FG007|Overall Study|Withdrawal by Subject|1|||
130461180|NCT03861767|469653879|FG008|Overall Study|Withdrawal by Subject|0|||
130461181|NCT03861767|469653880|FG009|Overall Study|Withdrawal by Subject|5|||
130461182|NCT00813904|469653881|FG000|Overall Study|Death|1|||
130461183|NCT00346333|469653882|FG000|Overall Study|Death|1|||
130461184|NCT00346333|469653883|FG001|Overall Study|Death|0|||
130461185|NCT00346333|469653882|FG000|Overall Study|unwilling or unable to continue|4|||
130461186|NCT00346333|469653883|FG001|Overall Study|unwilling or unable to continue|8|||
130461187|NCT00723450|469653891|FG000|Open-Label Phase|Adverse Event|26|||
130297495|NCT02049138|469052245|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
130297496|NCT02049138|469052246|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
130297497|NCT02049138|469052244|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
130297498|NCT02049138|469052245|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130297499|NCT02049138|469052246|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130297500|NCT02049138|469052244|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130461188|NCT00723450|469653892|FG001|Open-Label Phase|Adverse Event|0|||
130461189|NCT00723450|469653893|FG002|Open-Label Phase|Adverse Event|0|||
130461190|NCT00723450|469653891|FG000|Open-Label Phase|Lack of Efficacy|18|||
130461191|NCT00723450|469653892|FG001|Open-Label Phase|Lack of Efficacy|0|||
130461192|NCT00723450|469653893|FG002|Open-Label Phase|Lack of Efficacy|0|||
130461193|NCT00723450|469653891|FG000|Open-Label Phase|Protocol Violation|35|||
130297501|NCT02049138|469052245|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
130297502|NCT02049138|469052246|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130461194|NCT00723450|469653892|FG001|Open-Label Phase|Protocol Violation|0|||
130461195|NCT00723450|469653893|FG002|Open-Label Phase|Protocol Violation|0|||
130461196|NCT00723450|469653891|FG000|Open-Label Phase|Lost to Follow-up|7|||
130461197|NCT00723450|469653892|FG001|Open-Label Phase|Lost to Follow-up|0|||
130461198|NCT00723450|469653893|FG002|Open-Label Phase|Lost to Follow-up|0|||
130557208|NCT00059839|470009920|FG001|Overall Study|Lost to Follow-up|0|||
130557209|NCT00059839|470009919|FG000|Overall Study|Physician Decision|1|||
130557210|NCT00059839|470009920|FG001|Overall Study|Physician Decision|2|||
130557211|NCT00059839|470009919|FG000|Overall Study|Withdrawal by Subject|1|||
130557212|NCT00059839|470009920|FG001|Overall Study|Withdrawal by Subject|6|||
130557213|NCT00059839|470009919|FG000|Overall Study|Ineligible|1|||
130557214|NCT00059839|470009920|FG001|Overall Study|Ineligible|3|||
130557215|NCT03842163|470009921|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
130557216|NCT03842163|470009921|FG000|Overall Study|Scintigraphy was not performed|44|||
130557217|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
130557218|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
130557219|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
130461199|NCT00723450|469653891|FG000|Open-Label Phase|Physician Decision|2|||
130461200|NCT00723450|469653892|FG001|Open-Label Phase|Physician Decision|0|||
130461201|NCT00723450|469653893|FG002|Open-Label Phase|Physician Decision|0|||
130461202|NCT00723450|469653891|FG000|Open-Label Phase|Withdrawal by Subject|37|||
130461203|NCT00723450|469653892|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130461204|NCT00723450|469653893|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130461205|NCT00723450|469653891|FG000|Randomized Phase|Adverse Event|0|||
130461206|NCT00723450|469653892|FG001|Randomized Phase|Adverse Event|26|||
130461207|NCT00723450|469653893|FG002|Randomized Phase|Adverse Event|17|||
130557220|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
130716160|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130297503|NCT02049138|469052244|FG000|Overall Study|Other|15|||
130297504|NCT02049138|469052245|FG001|Overall Study|Other|13|||
130297505|NCT02049138|469052246|FG002|Overall Study|Other|0|||
130297506|NCT02049138|469052244|FG000|Overall Study|Missing|0|||
130297507|NCT02049138|469052245|FG001|Overall Study|Missing|1|||
130297508|NCT02049138|469052246|FG002|Overall Study|Missing|0|||
130297509|NCT02925741|469052247|FG000|Overall Study|Withdrawal by Subject|11|||
130297510|NCT02925741|469052248|FG001|Overall Study|Withdrawal by Subject|0|||
130297511|NCT05086510|469052249|FG000|Overall Study|Lost to Follow-up|0|||
130297512|NCT05086510|469052250|FG001|Overall Study|Lost to Follow-up|2|||
130297513|NCT05086510|469052249|FG000|Overall Study|Death|0|||
130297514|NCT05086510|469052250|FG001|Overall Study|Death|2|||
130297515|NCT00295932|469052251|FG000|Overall Study|Not Treated|0|||
130297516|NCT00295932|469052252|FG001|Overall Study|Not Treated|0|||
130297517|NCT00295932|469052253|FG002|Overall Study|Not Treated|0|||
130297518|NCT00295932|469052254|FG003|Overall Study|Not Treated|0|||
130297519|NCT00295932|469052255|FG004|Overall Study|Not Treated|0|||
130297520|NCT00295932|469052256|FG005|Overall Study|Not Treated|0|||
130297521|NCT00295932|469052257|FG006|Overall Study|Not Treated|0|||
130297522|NCT00295932|469052258|FG007|Overall Study|Not Treated|0|||
130297523|NCT00295932|469052259|FG008|Overall Study|Not Treated|0|||
130297524|NCT00295932|469052260|FG009|Overall Study|Not Treated|0|||
130297525|NCT00295932|469052261|FG010|Overall Study|Not Treated|1|||
130297526|NCT00109577|469052262|FG000|Overall Study|Withdrawal by Subject|3|||
130297527|NCT00109577|469052263|FG001|Overall Study|Withdrawal by Subject|3|||
130297528|NCT00884832|469052264|FG000|Overall Study|Withdrawal by Subject|0|||
130297529|NCT00884832|469052265|FG001|Overall Study|Withdrawal by Subject|1|||
130297530|NCT02337725|469052266|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
130297531|NCT02337725|469052267|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
130297532|NCT02337725|469052266|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
130297533|NCT02337725|469052267|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
130297534|NCT02337725|469052266|FG000|Overall Study|Major Protocol Deviation|0|||
130297535|NCT02337725|469052267|FG001|Overall Study|Major Protocol Deviation|1|||
130297536|NCT02337725|469052266|FG000|Overall Study|Voluntary Withdrawal|14|||
130297537|NCT02337725|469052267|FG001|Overall Study|Voluntary Withdrawal|3|||
130297538|NCT02337725|469052266|FG000|Overall Study|Lack of Efficacy|4|||
130297539|NCT02337725|469052267|FG001|Overall Study|Lack of Efficacy|0|||
130297540|NCT02096263|469052268|FG000|Overall Study|Adverse Event|1|||
130297541|NCT02096263|469052269|FG001|Overall Study|Adverse Event|0|||
130297542|NCT02096263|469052270|FG002|Overall Study|Adverse Event|1|||
130297543|NCT02096263|469052268|FG000|Overall Study|Lost to Follow-up|14|||
130297544|NCT02096263|469052269|FG001|Overall Study|Lost to Follow-up|18|||
130297545|NCT02096263|469052270|FG002|Overall Study|Lost to Follow-up|15|||
130461208|NCT00723450|469653891|FG000|Randomized Phase|Lack of Efficacy|0|||
130461209|NCT00723450|469653892|FG001|Randomized Phase|Lack of Efficacy|11|||
130461210|NCT00723450|469653893|FG002|Randomized Phase|Lack of Efficacy|11|||
130557221|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
130716161|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Adverse Event|4|||
130297546|NCT02096263|469052268|FG000|Overall Study|Other|7|||
130297547|NCT02096263|469052269|FG001|Overall Study|Other|9|||
130297548|NCT02096263|469052270|FG002|Overall Study|Other|6|||
130297549|NCT02096263|469052268|FG000|Overall Study|Sponsor study termination|0|||
130297550|NCT02096263|469052269|FG001|Overall Study|Sponsor study termination|0|||
130297551|NCT02096263|469052270|FG002|Overall Study|Sponsor study termination|1|||
130297552|NCT02096263|469052268|FG000|Overall Study|Protocol Violation|7|||
130557222|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
130557223|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
130557224|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
130557225|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
130557226|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
130557227|NCT03829241|470009922|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
130557228|NCT03829241|470009923|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
130557229|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
130557230|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
130557231|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
130557232|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
130557233|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
130557234|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
130557235|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
130557236|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
130557237|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
130557238|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
130557239|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
130557240|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
130557241|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
130557242|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
130557243|NCT03829241|470009922|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
130557244|NCT03829241|470009923|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
130557245|NCT00698451|470009924|FG000|Overall Study|Adverse Event|22|||
130557246|NCT00698451|470009924|FG000|Overall Study|Physician Decision|2|||
130557247|NCT00698451|470009924|FG000|Overall Study|Protocol Violation|6|||
130557248|NCT00698451|470009924|FG000|Overall Study|Withdrawal by Subject|6|||
130557249|NCT00698451|470009924|FG000|Overall Study|Disease progression|3|||
130557250|NCT02224599|470009925|FG000|Overall Study|Physician Decision|1|||
130297553|NCT02096263|469052269|FG001|Overall Study|Protocol Violation|2|||
130297554|NCT02096263|469052270|FG002|Overall Study|Protocol Violation|8|||
130297555|NCT02096263|469052268|FG000|Overall Study|Withdrawal by Subject|5|||
130297556|NCT02096263|469052269|FG001|Overall Study|Withdrawal by Subject|7|||
130297557|NCT02096263|469052270|FG002|Overall Study|Withdrawal by Subject|8|||
130297558|NCT03322423|469052271|FG000|Period 1|Subject no longer eligible|0|||
130297559|NCT03322423|469052272|FG001|Period 1|Subject no longer eligible|1|||
130297560|NCT03322423|469052271|FG000|Period 1|Withdrawal by Subject|0|||
130297561|NCT03322423|469052272|FG001|Period 1|Withdrawal by Subject|1|||
130297562|NCT03322423|469052271|FG000|Period 1|Incorrect Lens Dispensed|1|||
130297563|NCT03322423|469052272|FG001|Period 1|Incorrect Lens Dispensed|0|||
130297564|NCT03322423|469052271|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
130297565|NCT03322423|469052272|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
130297566|NCT03322423|469052271|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
130297567|NCT03322423|469052272|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
130297568|NCT03322423|469052271|FG000|Period 2|Protocol Violation|1|||
130297569|NCT03322423|469052272|FG001|Period 2|Protocol Violation|0|||
130297570|NCT03322423|469052271|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
130297571|NCT03322423|469052272|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
130297572|NCT00500760|469052279|FG000|Overall Study|Death|32|||
130297573|NCT00500760|469052280|FG001|Overall Study|Death|15|||
130297574|NCT00500760|469052279|FG000|Overall Study|Withdrawal by Subject|5|||
130297575|NCT00500760|469052280|FG001|Overall Study|Withdrawal by Subject|7|||
130297576|NCT00500760|469052279|FG000|Overall Study|Administrative decision|2|||
130297577|NCT00500760|469052280|FG001|Overall Study|Administrative decision|0|||
130297578|NCT00500760|469052279|FG000|Overall Study|Lost to Follow-up|3|||
130297579|NCT00500760|469052280|FG001|Overall Study|Lost to Follow-up|0|||
130297580|NCT00500760|469052279|FG000|Overall Study|Other|1|||
130297581|NCT00500760|469052280|FG001|Overall Study|Other|2|||
130297582|NCT02925728|469052286|FG000|Overall Study|Death|3|||
130297583|NCT02925728|469052287|FG001|Overall Study|Death|5|||
130297584|NCT02925728|469052286|FG000|Overall Study|Physician Decision|1|||
130297585|NCT02925728|469052287|FG001|Overall Study|Physician Decision|0|||
130297586|NCT02925728|469052286|FG000|Overall Study|Withdrawal by Subject|1|||
130557251|NCT02224599|470009925|FG000|Overall Study|Progression of Disease|1|||
130557252|NCT00733304|470009926|FG000|Overall Study|Adverse Event|3|||
130557253|NCT00733304|470009927|FG001|Overall Study|Adverse Event|0|||
130557254|NCT00733304|470009928|FG002|Overall Study|Adverse Event|0|||
130557255|NCT00733304|470009926|FG000|Overall Study|Lack of Efficacy|0|||
130297587|NCT02925728|469052287|FG001|Overall Study|Withdrawal by Subject|0|||
130297588|NCT05098509|469052288|FG000|Overall Study|Withdrawal by Subject|0|||
130297589|NCT05098509|469052289|FG001|Overall Study|Withdrawal by Subject|0|||
130297590|NCT05098509|469052290|FG002|Overall Study|Withdrawal by Subject|1|||
130297591|NCT05098509|469052291|FG003|Overall Study|Withdrawal by Subject|0|||
130297592|NCT05098509|469052288|FG000|Overall Study|Early study termination|1|||
130297593|NCT05098509|469052289|FG001|Overall Study|Early study termination|1|||
130297594|NCT05098509|469052290|FG002|Overall Study|Early study termination|1|||
130297595|NCT05098509|469052291|FG003|Overall Study|Early study termination|0|||
130297596|NCT04033068|469052292|FG000|Overall Study|Withdrawal by Subject|0|||
130297597|NCT04033068|469052293|FG001|Overall Study|Withdrawal by Subject|0|||
130297598|NCT04033068|469052294|FG002|Overall Study|Withdrawal by Subject|1|||
130297599|NCT04033068|469052295|FG003|Overall Study|Withdrawal by Subject|0|||
130297600|NCT04033068|469052292|FG000|Overall Study|Lost to Follow-up|0|||
130297601|NCT04033068|469052293|FG001|Overall Study|Lost to Follow-up|1|||
130297602|NCT04033068|469052294|FG002|Overall Study|Lost to Follow-up|0|||
130297603|NCT04033068|469052295|FG003|Overall Study|Lost to Follow-up|0|||
130297604|NCT04033068|469052292|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297605|NCT04033068|469052293|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297606|NCT04033068|469052294|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297607|NCT04033068|469052295|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
130297608|NCT02986854|469052297|FG000|Overall Study|Withdrawal by Subject|0|||
130297609|NCT02986854|469052298|FG001|Overall Study|Withdrawal by Subject|1|||
130297610|NCT02986854|469052299|FG002|Overall Study|Withdrawal by Subject|1|||
130297611|NCT02986854|469052297|FG000|Overall Study|Lost to Follow-up|3|||
130297612|NCT02986854|469052298|FG001|Overall Study|Lost to Follow-up|11|||
130297613|NCT02986854|469052299|FG002|Overall Study|Lost to Follow-up|2|||
130297614|NCT00324233|469052300|FG000|First Period|unable to insert catheter|1|||
130297615|NCT00324233|469052301|FG001|First Period|unable to insert catheter|0|||
130297616|NCT00324233|469052300|FG000|Second Period|unable to insert catheter|1|||
130297617|NCT00324233|469052301|FG001|Second Period|unable to insert catheter|1|||
130297618|NCT00324233|469052300|FG000|Second Period|Protocol Violation|4|||
130297619|NCT00324233|469052301|FG001|Second Period|Protocol Violation|6|||
130297620|NCT01972789|469052306|FG000|Overall Study|Adverse Event|11|||
130297621|NCT01972789|469052307|FG001|Overall Study|Adverse Event|4|||
130297622|NCT01972789|469052306|FG000|Overall Study|Subject withdrew consent|14|||
130297623|NCT01972789|469052307|FG001|Overall Study|Subject withdrew consent|12|||
130297624|NCT01972789|469052306|FG000|Overall Study|Lost to Follow-up|4|||
130297625|NCT01972789|469052307|FG001|Overall Study|Lost to Follow-up|7|||
130297626|NCT01972789|469052306|FG000|Overall Study|Death|7|||
130557256|NCT00733304|470009927|FG001|Overall Study|Lack of Efficacy|0|||
130297627|NCT01972789|469052307|FG001|Overall Study|Death|5|||
130297628|NCT01972789|469052306|FG000|Overall Study|Protocol deviation|1|||
130297629|NCT01972789|469052307|FG001|Overall Study|Protocol deviation|0|||
130297630|NCT01972789|469052306|FG000|Overall Study|Physician Decision|3|||
130297631|NCT01972789|469052307|FG001|Overall Study|Physician Decision|2|||
130297632|NCT00086411|469052315|FG000|Overall Study|Lost to Follow-up|11|||
130297633|NCT00086411|469052316|FG001|Overall Study|Lost to Follow-up|11|||
130297634|NCT00086411|469052317|FG002|Overall Study|Lost to Follow-up|13|||
130297635|NCT00086411|469052318|FG003|Overall Study|Lost to Follow-up|12|||
130297636|NCT00279812|469052319|FG000|Overall Study|Protocol Violation|1|||
130297637|NCT00279812|469052320|FG001|Overall Study|Protocol Violation|1|||
130297638|NCT00279812|469052321|FG002|Overall Study|Protocol Violation|0|||
130297639|NCT00279812|469052322|FG003|Overall Study|Protocol Violation|0|||
130297640|NCT00279812|469052323|FG004|Overall Study|Protocol Violation|1|||
130297641|NCT00279812|469052324|FG005|Overall Study|Protocol Violation|0|||
130297642|NCT00279812|469052319|FG000|Overall Study|Withdrawal by Subject|0|||
130297643|NCT00279812|469052320|FG001|Overall Study|Withdrawal by Subject|4|||
130297644|NCT00279812|469052321|FG002|Overall Study|Withdrawal by Subject|2|||
130297645|NCT00279812|469052322|FG003|Overall Study|Withdrawal by Subject|0|||
130297646|NCT00279812|469052323|FG004|Overall Study|Withdrawal by Subject|0|||
130297647|NCT00279812|469052324|FG005|Overall Study|Withdrawal by Subject|0|||
130297648|NCT00279812|469052319|FG000|Overall Study|Adverse Event|0|||
130297649|NCT00279812|469052320|FG001|Overall Study|Adverse Event|1|||
130297650|NCT00279812|469052321|FG002|Overall Study|Adverse Event|1|||
130297651|NCT00279812|469052322|FG003|Overall Study|Adverse Event|0|||
130297652|NCT00279812|469052323|FG004|Overall Study|Adverse Event|2|||
130297653|NCT00279812|469052324|FG005|Overall Study|Adverse Event|1|||
130297654|NCT01879072|469052325|FG000|Overall Study|Withdrawal by Subject|121|||
130297655|NCT01879072|469052325|FG000|Overall Study|Not Transplanted|30|||
130297656|NCT02503501|469054097|FG000|Overall Study|Physician Decision|1|||
130297657|NCT02503501|469054098|FG001|Overall Study|Physician Decision|0|||
130297658|NCT02503501|469054097|FG000|Overall Study|Protocol Violation|0|||
130297659|NCT02503501|469054098|FG001|Overall Study|Protocol Violation|1|||
130297660|NCT02503501|469054097|FG000|Overall Study|Withdrawal by Subject|0|||
130297661|NCT02503501|469054098|FG001|Overall Study|Withdrawal by Subject|2|||
130297662|NCT01740401|469054099|FG000|Overall Study|Progression of disease|6|||
130297663|NCT01740401|469054099|FG000|Overall Study|Adverse Event|2|||
130297664|NCT01740401|469054099|FG000|Overall Study|Did not reach primary endpoint|2|||
130297665|NCT02806960|469054100|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297666|NCT02806960|469054101|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297667|NCT02806960|469054102|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297668|NCT02806960|469054103|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297669|NCT03667690|469054104|FG000|Overall Study|Adverse Event|0|||
130297670|NCT03667690|469054105|FG001|Overall Study|Adverse Event|3|||
130297671|NCT03667690|469054104|FG000|Overall Study|Death|22|||
130297672|NCT03667690|469054105|FG001|Overall Study|Death|21|||
130297673|NCT03667690|469054104|FG000|Overall Study|Lost to Follow-up|4|||
130297674|NCT03667690|469054105|FG001|Overall Study|Lost to Follow-up|5|||
130297675|NCT03667690|469054104|FG000|Overall Study|Withdrawal by Subject|7|||
130297676|NCT03667690|469054105|FG001|Overall Study|Withdrawal by Subject|8|||
130297677|NCT03667690|469054104|FG000|Overall Study|Subject could not return for additional investigational product|1|||
130297678|NCT03667690|469054105|FG001|Overall Study|Subject could not return for additional investigational product|0|||
130297679|NCT03667690|469054104|FG000|Overall Study|Subject discharged to hospice care|2|||
130297680|NCT03667690|469054105|FG001|Overall Study|Subject discharged to hospice care|0|||
130297681|NCT03667690|469054104|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
130297682|NCT03667690|469054105|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
130297683|NCT03667690|469054104|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
130297684|NCT03667690|469054105|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
130297685|NCT03667690|469054104|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130297686|NCT03667690|469054105|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130297687|NCT03667690|469054104|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
130297688|NCT03667690|469054105|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
130297689|NCT03667690|469054104|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
130297690|NCT03667690|469054105|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
130297691|NCT03495102|469054106|FG000|Overall Study|Adverse Event|5|||
130297692|NCT03495102|469054107|FG001|Overall Study|Adverse Event|7|||
130297693|NCT03495102|469054108|FG002|Overall Study|Adverse Event|10|||
130297694|NCT03495102|469054106|FG000|Overall Study|Death|3|||
130297695|NCT03495102|469054107|FG001|Overall Study|Death|4|||
130297696|NCT03495102|469054108|FG002|Overall Study|Death|4|||
130297697|NCT03495102|469054106|FG000|Overall Study|Lost to Follow-up|15|||
130297698|NCT03495102|469054107|FG001|Overall Study|Lost to Follow-up|16|||
130297699|NCT03495102|469054108|FG002|Overall Study|Lost to Follow-up|17|||
130297700|NCT03495102|469054106|FG000|Overall Study|Physician Decision|2|||
130297701|NCT03495102|469054107|FG001|Overall Study|Physician Decision|0|||
130461211|NCT00723450|469653891|FG000|Randomized Phase|Protocol Violation|0|||
130461212|NCT00723450|469653892|FG001|Randomized Phase|Protocol Violation|9|||
130461213|NCT00723450|469653893|FG002|Randomized Phase|Protocol Violation|13|||
130461214|NCT00723450|469653891|FG000|Randomized Phase|Lost to Follow-up|0|||
130461215|NCT00723450|469653892|FG001|Randomized Phase|Lost to Follow-up|2|||
130461216|NCT00723450|469653893|FG002|Randomized Phase|Lost to Follow-up|3|||
130461217|NCT00723450|469653891|FG000|Randomized Phase|Physician Decision|0|||
130461218|NCT00723450|469653892|FG001|Randomized Phase|Physician Decision|3|||
130461219|NCT00723450|469653893|FG002|Randomized Phase|Physician Decision|1|||
130461220|NCT00723450|469653891|FG000|Randomized Phase|Withdrawal by Subject|0|||
130461221|NCT00723450|469653892|FG001|Randomized Phase|Withdrawal by Subject|14|||
130461222|NCT00723450|469653893|FG002|Randomized Phase|Withdrawal by Subject|22|||
130461223|NCT00770965|469653894|FG000|Safety Set|Withdrawal by Subject|0|||
130461224|NCT00770965|469653895|FG001|Safety Set|Withdrawal by Subject|0|||
130461225|NCT00770965|469653896|FG002|Safety Set|Withdrawal by Subject|0|||
130461226|NCT00770965|469653897|FG003|Safety Set|Withdrawal by Subject|1|||
130461227|NCT00770965|469653894|FG000|Safety Set|Protocol deviation|0|||
130461228|NCT00770965|469653895|FG001|Safety Set|Protocol deviation|0|||
130461229|NCT00770965|469653896|FG002|Safety Set|Protocol deviation|1|||
130461230|NCT00770965|469653897|FG003|Safety Set|Protocol deviation|0|||
130461231|NCT00770965|469653894|FG000|Excluded Set|Administrative problems|14|||
130461232|NCT00770965|469653895|FG001|Excluded Set|Administrative problems|12|||
130461233|NCT00770965|469653896|FG002|Excluded Set|Administrative problems|12|||
130461234|NCT00770965|469653897|FG003|Excluded Set|Administrative problems|10|||
130461235|NCT00770965|469653894|FG000|Excluded Set|Withdrawal by Subject|1|||
130461236|NCT00770965|469653895|FG001|Excluded Set|Withdrawal by Subject|1|||
130297702|NCT03495102|469054108|FG002|Overall Study|Physician Decision|2|||
130461237|NCT00770965|469653896|FG002|Excluded Set|Withdrawal by Subject|2|||
130461238|NCT00770965|469653897|FG003|Excluded Set|Withdrawal by Subject|3|||
130461239|NCT03192046|469653899|FG000|Overall Study|Withdrawal by Subject|1|||
130461240|NCT03192046|469653900|FG001|Overall Study|Withdrawal by Subject|1|||
130461241|NCT00762606|469653901|FG000|Overall Study|Lost to Follow-up|18|||
130297703|NCT03495102|469054106|FG000|Overall Study|Withdrawal by Subject|25|||
130461242|NCT00762606|469653902|FG001|Overall Study|Lost to Follow-up|13|||
130461243|NCT01505881|469653903|FG000|Overall Study|Adverse Event|0|||
130461244|NCT01505881|469653904|FG001|Overall Study|Adverse Event|1|||
130716162|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Adverse Event|0|||
130716163|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Adverse Event|0|||
130716164|NCT01462318|470588785|FG000|Extension Phase|Lost to Follow-up|0|||
130716165|NCT01462318|470588786|FG001|Extension Phase|Lost to Follow-up|0|||
130297704|NCT03495102|469054107|FG001|Overall Study|Withdrawal by Subject|36|||
130297705|NCT03495102|469054108|FG002|Overall Study|Withdrawal by Subject|18|||
130297706|NCT03495102|469054106|FG000|Overall Study|Protocol Violation|1|||
130297707|NCT03495102|469054107|FG001|Overall Study|Protocol Violation|1|||
130297708|NCT03495102|469054108|FG002|Overall Study|Protocol Violation|0|||
130297709|NCT03495102|469054106|FG000|Overall Study|Site Closure|3|||
130297710|NCT03495102|469054107|FG001|Overall Study|Site Closure|1|||
130297711|NCT03495102|469054108|FG002|Overall Study|Site Closure|2|||
130297712|NCT03495102|469054106|FG000|Overall Study|Non-compliance|1|||
130297713|NCT03495102|469054107|FG001|Overall Study|Non-compliance|0|||
130297714|NCT03495102|469054108|FG002|Overall Study|Non-compliance|0|||
130297715|NCT03495102|469054106|FG000|Overall Study|Participant Duplicated at Another Site|0|||
130297716|NCT03495102|469054107|FG001|Overall Study|Participant Duplicated at Another Site|0|||
130297717|NCT03495102|469054108|FG002|Overall Study|Participant Duplicated at Another Site|1|||
130297718|NCT03495102|469054106|FG000|Overall Study|Primary Care Physician Recommendation|0|||
130297719|NCT03495102|469054107|FG001|Overall Study|Primary Care Physician Recommendation|1|||
130297720|NCT03495102|469054108|FG002|Overall Study|Primary Care Physician Recommendation|0|||
130297721|NCT03495102|469054106|FG000|Overall Study|Relocated to Another Country|0|||
130297722|NCT03495102|469054107|FG001|Overall Study|Relocated to Another Country|1|||
130297723|NCT03495102|469054108|FG002|Overall Study|Relocated to Another Country|0|||
130297724|NCT03495102|469054106|FG000|Overall Study|Participant was in Rehabilitation|1|||
130297725|NCT03495102|469054107|FG001|Overall Study|Participant was in Rehabilitation|0|||
130297726|NCT03495102|469054108|FG002|Overall Study|Participant was in Rehabilitation|0|||
130297727|NCT01161537|469054110|FG000|Part B|Withdrawal by Subject|2|||
130297728|NCT04327024|469054113|FG000|Overall Study|Death|1|||
130297729|NCT04327024|469054114|FG001|Overall Study|Death|2|||
130297730|NCT04327024|469054115|FG002|Overall Study|Death|1|||
130297731|NCT04327024|469054113|FG000|Overall Study|Non-compliance with study drug|0|||
130372571|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372572|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130716166|NCT01462318|470588787|FG002|Extension Phase|Lost to Follow-up|1|||
130716167|NCT01462318|470588785|FG000|Extension Phase|Other|0|||
130297732|NCT04327024|469054114|FG001|Overall Study|Non-compliance with study drug|1|||
130372573|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372574|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372575|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372576|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130372577|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372578|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372579|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
130372580|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372581|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372582|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372583|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372584|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372585|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372586|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372587|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372588|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372589|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372590|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372591|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372592|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372593|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372594|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372595|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130716168|NCT01462318|470588786|FG001|Extension Phase|Other|0|||
130372596|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372597|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372598|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130716169|NCT01462318|470588787|FG002|Extension Phase|Other|1|||
130297733|NCT04327024|469054115|FG002|Overall Study|Non-compliance with study drug|0|||
130297734|NCT04327024|469054113|FG000|Overall Study|Withdrawal by Subject|1|||
130461245|NCT01505881|469653903|FG000|Overall Study|Lost to Follow-up|2|||
130461246|NCT01505881|469653904|FG001|Overall Study|Lost to Follow-up|0|||
130461247|NCT01505881|469653903|FG000|Overall Study|Withdrawal by Subject|2|||
130461248|NCT01505881|469653904|FG001|Overall Study|Withdrawal by Subject|0|||
130461249|NCT00842257|469653905|FG000|Overall Study|Adverse Event|1|||
130461250|NCT04439799|469653906|FG000|Overall Study|Lost to Follow-up|6|||
130461251|NCT04439799|469653907|FG001|Overall Study|Lost to Follow-up|6|||
130461252|NCT04439799|469653906|FG000|Overall Study|Withdrawal by Subject|2|||
130461253|NCT04439799|469653907|FG001|Overall Study|Withdrawal by Subject|6|||
130716170|NCT01462318|470588785|FG000|Extension Phase|Disease Progression|0|||
130716171|NCT01462318|470588786|FG001|Extension Phase|Disease Progression|0|||
130297735|NCT04327024|469054114|FG001|Overall Study|Withdrawal by Subject|1|||
130297736|NCT04327024|469054115|FG002|Overall Study|Withdrawal by Subject|2|||
130297737|NCT01192568|469054117|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
130297738|NCT01192568|469054118|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
130297739|NCT01192568|469054119|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
130297740|NCT01192568|469054120|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
130297741|NCT01192568|469054117|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
130297742|NCT01192568|469054118|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
130297743|NCT01192568|469054119|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
130297744|NCT01192568|469054120|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
130297745|NCT02593825|469054121|FG000|Intervention|Lost to Follow-up|10|||
130297746|NCT02593825|469054122|FG001|Intervention|Lost to Follow-up|12|||
130297747|NCT02522325|469054123|FG000|Overall Study|Adverse Event|0|||
130297748|NCT02522325|469054124|FG001|Overall Study|Adverse Event|1|||
130297749|NCT01209078|469054125|FG000|Overall Study|Adverse Event|5|||
130297750|NCT01209078|469054126|FG001|Overall Study|Adverse Event|0|||
130297751|NCT01209078|469054125|FG000|Overall Study|Lost to Follow-up|4|||
130297752|NCT01209078|469054126|FG001|Overall Study|Lost to Follow-up|0|||
130297753|NCT01209078|469054125|FG000|Overall Study|Physician Decision|5|||
130297754|NCT01209078|469054126|FG001|Overall Study|Physician Decision|2|||
130297755|NCT01209078|469054125|FG000|Overall Study|Withdrawal by Subject|2|||
130297756|NCT01209078|469054126|FG001|Overall Study|Withdrawal by Subject|1|||
130297757|NCT00924508|469054127|FG000|Overall Study|Withdrawal by Subject|3|||
130297758|NCT00511134|469054129|FG000|Overall Study|Withdrawal by Subject|0|||
130297759|NCT00511134|469054130|FG001|Overall Study|Withdrawal by Subject|2|||
130297760|NCT01949090|469054131|FG000|Overall Study|Serious Adverse Event|0|||
130297761|NCT01949090|469054132|FG001|Overall Study|Serious Adverse Event|1|||
130297762|NCT01949090|469054133|FG002|Overall Study|Serious Adverse Event|2|||
130297763|NCT01949090|469054134|FG003|Overall Study|Serious Adverse Event|0|||
130297764|NCT01949090|469054135|FG004|Overall Study|Serious Adverse Event|1|||
130297765|NCT01949090|469054131|FG000|Overall Study|Withdrawal by Subject|2|||
130297766|NCT01949090|469054132|FG001|Overall Study|Withdrawal by Subject|0|||
130297767|NCT01949090|469054133|FG002|Overall Study|Withdrawal by Subject|0|||
130297768|NCT01949090|469054134|FG003|Overall Study|Withdrawal by Subject|0|||
130297769|NCT01949090|469054135|FG004|Overall Study|Withdrawal by Subject|1|||
130297770|NCT01949090|469054131|FG000|Overall Study|Protocol non-compliance|0|||
130297771|NCT01949090|469054132|FG001|Overall Study|Protocol non-compliance|0|||
130297772|NCT01949090|469054133|FG002|Overall Study|Protocol non-compliance|0|||
130297773|NCT01949090|469054134|FG003|Overall Study|Protocol non-compliance|0|||
130297774|NCT01949090|469054135|FG004|Overall Study|Protocol non-compliance|1|||
130297775|NCT01949090|469054131|FG000|Overall Study|Lost to Follow-up|2|||
130297776|NCT01949090|469054132|FG001|Overall Study|Lost to Follow-up|1|||
130297777|NCT01949090|469054133|FG002|Overall Study|Lost to Follow-up|0|||
130297778|NCT01949090|469054134|FG003|Overall Study|Lost to Follow-up|1|||
130297779|NCT01949090|469054135|FG004|Overall Study|Lost to Follow-up|1|||
130297780|NCT03459365|469054136|FG000|Overall Study|Withdrawal by Subject|6|||
130297781|NCT03459365|469054136|FG000|Overall Study|Protocol Violation|8|||
130297782|NCT00785980|469054140|FG000|7 Day Washout Period|Protocol Violation|3|||
130297783|NCT03055013|469054141|FG000|Overall Study|Adverse Event|78|||
130297784|NCT03055013|469054142|FG001|Overall Study|Adverse Event|0|||
130297785|NCT03055013|469054141|FG000|Overall Study|Death|6|||
130297786|NCT03055013|469054142|FG001|Overall Study|Death|0|||
130297787|NCT03055013|469054141|FG000|Overall Study|Disease relapse|33|||
130557257|NCT00733304|470009928|FG002|Overall Study|Lack of Efficacy|2|||
130297788|NCT03055013|469054142|FG001|Overall Study|Disease relapse|0|||
130297789|NCT03055013|469054141|FG000|Overall Study|Withdrawal by Subject|28|||
130297790|NCT03055013|469054142|FG001|Overall Study|Withdrawal by Subject|0|||
130297791|NCT03055013|469054141|FG000|Overall Study|Other complicating disease|5|||
130461254|NCT04439799|469653906|FG000|Overall Study|Adverse Event|2|||
130557258|NCT00733304|470009926|FG000|Overall Study|Lost to Follow-up|0|||
130297792|NCT03055013|469054142|FG001|Overall Study|Other complicating disease|0|||
130297793|NCT03055013|469054141|FG000|Overall Study|Physician Decision|1|||
130461255|NCT04439799|469653907|FG001|Overall Study|Adverse Event|5|||
130461256|NCT00790790|469653914|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
130297794|NCT03055013|469054142|FG001|Overall Study|Physician Decision|0|||
130297795|NCT03055013|469054141|FG000|Overall Study|Benign mass/non-RCC|4|||
130297796|NCT03055013|469054142|FG001|Overall Study|Benign mass/non-RCC|0|||
130461257|NCT00790790|469653915|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
130461258|NCT00790790|469653916|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
130461259|NCT00790790|469653914|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
130297797|NCT03055013|469054141|FG000|Overall Study|Enrolled in another trial|1|||
130297798|NCT03055013|469054142|FG001|Overall Study|Enrolled in another trial|0|||
130297799|NCT03055013|469054141|FG000|Overall Study|Non-protocol therapy|1|||
130297800|NCT03055013|469054142|FG001|Overall Study|Non-protocol therapy|0|||
130297801|NCT03055013|469054141|FG000|Overall Study|Incompliance|1|||
130297802|NCT03055013|469054142|FG001|Overall Study|Incompliance|0|||
130297803|NCT03055013|469054141|FG000|Overall Study|Insurance issues|1|||
130297804|NCT03055013|469054142|FG001|Overall Study|Insurance issues|0|||
130297805|NCT03055013|469054141|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
130297806|NCT03055013|469054142|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
130297807|NCT03055013|469054141|FG000|Overall Study|Did not receive nivolumab|10|||
130297808|NCT03055013|469054142|FG001|Overall Study|Did not receive nivolumab|0|||
130297809|NCT03055013|469054141|FG000|Overall Study|Did not receive surgery|0|||
130297810|NCT03055013|469054142|FG001|Overall Study|Did not receive surgery|28|||
130297811|NCT00528801|469054143|FG000|Overall Study|Withdrawal by Subject|1|||
130297812|NCT00528801|469054144|FG001|Overall Study|Withdrawal by Subject|1|||
130297813|NCT00528801|469054143|FG000|Overall Study|Protocol Violation|11|||
130297814|NCT00528801|469054144|FG001|Overall Study|Protocol Violation|5|||
130297815|NCT00528801|469054143|FG000|Overall Study|Lost to Follow-up|15|||
130297816|NCT00528801|469054144|FG001|Overall Study|Lost to Follow-up|4|||
130297817|NCT00528801|469054143|FG000|Overall Study|Administrative Reasons|0|||
130297818|NCT00528801|469054144|FG001|Overall Study|Administrative Reasons|1|||
130297819|NCT00344500|469054145|FG000|Overall Study|Adverse Event|6|||
130297820|NCT00344500|469054146|FG001|Overall Study|Adverse Event|2|||
130297821|NCT00344500|469054147|FG002|Overall Study|Adverse Event|0|||
130297822|NCT00344500|469054145|FG000|Overall Study|Lost to Follow-up|5|||
130297823|NCT00344500|469054146|FG001|Overall Study|Lost to Follow-up|13|||
130297824|NCT00344500|469054147|FG002|Overall Study|Lost to Follow-up|1|||
130297825|NCT00344500|469054145|FG000|Overall Study|Withdrawal by Subject|7|||
130297826|NCT00344500|469054146|FG001|Overall Study|Withdrawal by Subject|10|||
130297827|NCT00344500|469054147|FG002|Overall Study|Withdrawal by Subject|0|||
130297828|NCT00344500|469054145|FG000|Overall Study|Protocol Violation|4|||
130297829|NCT00344500|469054146|FG001|Overall Study|Protocol Violation|7|||
130297830|NCT00344500|469054147|FG002|Overall Study|Protocol Violation|1|||
130297831|NCT00344500|469054145|FG000|Overall Study|Not Noted|1|||
130297832|NCT00344500|469054146|FG001|Overall Study|Not Noted|3|||
130297833|NCT00344500|469054147|FG002|Overall Study|Not Noted|0|||
130297834|NCT02207491|469054148|FG000|Overall Study|Adverse Event|20|||
130297835|NCT02207491|469054149|FG001|Overall Study|Adverse Event|4|||
130297836|NCT02207491|469054148|FG000|Overall Study|Withdrawal by Subject|3|||
130461260|NCT00790790|469653915|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
130461261|NCT00790790|469653916|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
130461262|NCT00790790|469653914|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
130461263|NCT00790790|469653915|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
130461264|NCT00790790|469653916|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
130461265|NCT00790790|469653914|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
130461266|NCT00790790|469653915|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130461267|NCT00790790|469653916|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
130461268|NCT00790790|469653914|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
130461269|NCT00790790|469653915|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
130461270|NCT00790790|469653916|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
130461271|NCT02808338|469653919|FG000|Screening|Screen Failure|10|||
130461272|NCT02808338|469653919|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
130461273|NCT02808338|469653919|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
130461274|NCT00057837|469653920|FG000|Overall Study|Progression/relapse|12|||
130297837|NCT02207491|469054149|FG001|Overall Study|Withdrawal by Subject|2|||
130297838|NCT02207491|469054148|FG000|Overall Study|Non-compliant|0|||
130461275|NCT00057837|469653921|FG001|Overall Study|Progression/relapse|14|||
130461276|NCT00057837|469653920|FG000|Overall Study|Adverse Event|2|||
130461277|NCT00057837|469653921|FG001|Overall Study|Adverse Event|12|||
130297839|NCT02207491|469054149|FG001|Overall Study|Non-compliant|1|||
130297840|NCT02207491|469054148|FG000|Overall Study|Lost to Follow-up|0|||
130297841|NCT02207491|469054149|FG001|Overall Study|Lost to Follow-up|1|||
130297842|NCT02207491|469054148|FG000|Overall Study|Lack of Efficacy|3|||
130297843|NCT02207491|469054149|FG001|Overall Study|Lack of Efficacy|0|||
130297844|NCT02207491|469054148|FG000|Overall Study|Physician Decision|2|||
130461278|NCT00057837|469653920|FG000|Overall Study|Death|5|||
130297845|NCT02207491|469054149|FG001|Overall Study|Physician Decision|0|||
130297846|NCT02207491|469054148|FG000|Overall Study|Protocol Violation|3|||
130297847|NCT02207491|469054149|FG001|Overall Study|Protocol Violation|5|||
130461279|NCT00057837|469653921|FG001|Overall Study|Death|4|||
130461280|NCT00057837|469653920|FG000|Overall Study|Withdrawal by Subject|5|||
130461281|NCT00057837|469653921|FG001|Overall Study|Withdrawal by Subject|3|||
130297848|NCT00599755|469054150|FG000|Overall Study|Adverse Event|11|||
130297849|NCT00599755|469054150|FG000|Overall Study|Withdrawal by Subject|2|||
130297850|NCT00599755|469054150|FG000|Overall Study|Progression of Disease|3|||
130297851|NCT00599755|469054150|FG000|Overall Study|Other Reason|2|||
130297852|NCT00599755|469054150|FG000|Overall Study|No data available|1|||
130297853|NCT04680975|469054152|FG000|Overall Study|Adverse Event|3|||
130297854|NCT04680975|469054152|FG000|Overall Study|Death|1|||
130297855|NCT04680975|469054152|FG000|Overall Study|Progressive Disease|1|||
130297856|NCT04680975|469054152|FG000|Overall Study|Withdrawal by Subject|1|||
130297857|NCT03909152|469054153|FG000|Overall Study|Adverse Event|14|||
130297858|NCT03909152|469054154|FG001|Overall Study|Adverse Event|5|||
130297859|NCT03909152|469054155|FG002|Overall Study|Adverse Event|1|||
130297860|NCT03909152|469054156|FG003|Overall Study|Adverse Event|14|||
130557259|NCT00733304|470009927|FG001|Overall Study|Lost to Follow-up|1|||
130557260|NCT00733304|470009928|FG002|Overall Study|Lost to Follow-up|0|||
130557261|NCT00733304|470009926|FG000|Overall Study|Physician Decision|3|||
130557262|NCT00733304|470009927|FG001|Overall Study|Physician Decision|1|||
130557263|NCT00733304|470009928|FG002|Overall Study|Physician Decision|3|||
130557264|NCT00733304|470009926|FG000|Overall Study|Withdrawal by Subject|1|||
130557265|NCT00733304|470009927|FG001|Overall Study|Withdrawal by Subject|1|||
130557266|NCT00733304|470009928|FG002|Overall Study|Withdrawal by Subject|0|||
130557267|NCT03155373|470009938|FG000|Overall Study|No longer required surgery|1|||
130557268|NCT03155373|470009938|FG000|Overall Study|Protocol Violation|1|||
130557269|NCT03155373|470009938|FG000|Overall Study|Death|2|||
130297861|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
130297862|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
130297863|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
130297864|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
130297865|NCT02702414|469054158|FG000|Overall Study|Death|96|||
130297866|NCT02702414|469054159|FG001|Overall Study|Death|42|||
130297867|NCT02702414|469054158|FG000|Overall Study|Lost to Follow-up|0|||
130297868|NCT02702414|469054159|FG001|Overall Study|Lost to Follow-up|1|||
130297869|NCT02702414|469054158|FG000|Overall Study|Withdrawal by Subject|0|||
130297870|NCT02702414|469054159|FG001|Overall Study|Withdrawal by Subject|1|||
130297871|NCT02702414|469054158|FG000|Overall Study|Protocol Violation|1|||
130297872|NCT02702414|469054159|FG001|Overall Study|Protocol Violation|0|||
130297873|NCT02702414|469054158|FG000|Overall Study|Sponsor Decision|8|||
130297874|NCT02702414|469054159|FG001|Overall Study|Sponsor Decision|7|||
130297875|NCT02596230|469054160|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
130297876|NCT02596230|469054161|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
130557270|NCT03155373|470009938|FG000|Overall Study|Withdrawal by Subject|3|||
130557271|NCT00596934|470009941|FG000|Overall Study|Protocol Violation|1|||
130557272|NCT00596934|470009941|FG000|Overall Study|Withdrawal by Subject|1|||
130557273|NCT01214187|470009944|FG000|Overall Study|Adverse Event|6|||
130557274|NCT01214187|470009945|FG001|Overall Study|Adverse Event|2|||
130557275|NCT01214187|470009944|FG000|Overall Study|Death|1|||
130557276|NCT01214187|470009945|FG001|Overall Study|Death|1|||
130557277|NCT01214187|470009944|FG000|Overall Study|Withdrawal by Subject|0|||
130557278|NCT01214187|470009945|FG001|Overall Study|Withdrawal by Subject|3|||
130557279|NCT02308007|470009949|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
130557280|NCT02308007|470009950|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
130557281|NCT02308007|470009951|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
130716172|NCT01462318|470588787|FG002|Extension Phase|Disease Progression|1|||
130716173|NCT01462318|470588785|FG000|Extension Phase|Withdrawal by Subject|0|||
130716174|NCT01462318|470588786|FG001|Extension Phase|Withdrawal by Subject|0|||
130716175|NCT01462318|470588787|FG002|Extension Phase|Withdrawal by Subject|15|||
130716176|NCT01462318|470588785|FG000|Extension Phase|Investigator Decision|0|||
130716177|NCT01462318|470588786|FG001|Extension Phase|Investigator Decision|0|||
130716178|NCT01462318|470588787|FG002|Extension Phase|Investigator Decision|5|||
130716179|NCT01462318|470588785|FG000|Extension Phase|Adverse Event|0|||
130716180|NCT01462318|470588786|FG001|Extension Phase|Adverse Event|0|||
130716181|NCT01462318|470588787|FG002|Extension Phase|Adverse Event|22|||
130716182|NCT03827564|470588788|FG000|Overall Study|Discontinued due to Study Termination|1|||
130716183|NCT03827564|470588789|FG001|Overall Study|Discontinued due to Study Termination|0|||
130297877|NCT02596230|469054162|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130297878|NCT02596230|469054163|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
130297879|NCT02596230|469054164|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130297880|NCT02596230|469054160|FG000|Objective 2, One Year|Lost to Follow-up|0|||
130297881|NCT02596230|469054161|FG001|Objective 2, One Year|Lost to Follow-up|41|||
130297882|NCT02596230|469054162|FG002|Objective 2, One Year|Lost to Follow-up|41|||
130557282|NCT02308007|470009949|FG000|Overall Study|Positive for STD at Baseline|7|||
130557283|NCT02308007|470009950|FG001|Overall Study|Positive for STD at Baseline|11|||
130557284|NCT02308007|470009951|FG002|Overall Study|Positive for STD at Baseline|7|||
130557285|NCT02308007|470009949|FG000|Overall Study|Lost to Follow-up|3|||
130557286|NCT02308007|470009950|FG001|Overall Study|Lost to Follow-up|0|||
130557287|NCT02308007|470009951|FG002|Overall Study|Lost to Follow-up|1|||
130716184|NCT00891371|470588790|FG000|Pre-assignment|Inclusion/exclusion|5|||
130716185|NCT00891371|470588790|FG000|Pre-assignment|Consent withdrawal|1|||
130716186|NCT00891371|470588790|FG000|Treatment|Lack of Efficacy|5|||
130297883|NCT02596230|469054163|FG003|Objective 2, One Year|Lost to Follow-up|32|||
130297884|NCT02596230|469054164|FG004|Objective 2, One Year|Lost to Follow-up|46|||
130297885|NCT02596230|469054160|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
130297886|NCT02596230|469054161|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
130297887|NCT02596230|469054162|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
130297888|NCT02596230|469054163|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
130297889|NCT02596230|469054164|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
130297890|NCT02596230|469054160|FG000|Objective 2, One Year|Adverse drug reaction|0|||
130297891|NCT02596230|469054161|FG001|Objective 2, One Year|Adverse drug reaction|1|||
130297892|NCT02596230|469054162|FG002|Objective 2, One Year|Adverse drug reaction|0|||
130297893|NCT02596230|469054163|FG003|Objective 2, One Year|Adverse drug reaction|0|||
130297894|NCT02596230|469054164|FG004|Objective 2, One Year|Adverse drug reaction|0|||
130297895|NCT02596230|469054160|FG000|Objective 2, One Year|Death|0|||
130297896|NCT02596230|469054161|FG001|Objective 2, One Year|Death|12|||
130297897|NCT02596230|469054162|FG002|Objective 2, One Year|Death|41|||
130297898|NCT02596230|469054163|FG003|Objective 2, One Year|Death|21|||
130297899|NCT02596230|469054164|FG004|Objective 2, One Year|Death|30|||
130297900|NCT02596230|469054160|FG000|Objective 2, One Year|Other|0|||
130297901|NCT02596230|469054161|FG001|Objective 2, One Year|Other|3|||
130297902|NCT02596230|469054162|FG002|Objective 2, One Year|Other|2|||
130297903|NCT02596230|469054163|FG003|Objective 2, One Year|Other|0|||
130297904|NCT02596230|469054164|FG004|Objective 2, One Year|Other|0|||
130297905|NCT01272869|469054165|FG000|Period 2 (14 Days)|Adverse Event|1|||
130297906|NCT01272869|469054166|FG001|Period 2 (14 Days)|Adverse Event|0|||
130297907|NCT03908476|469054168|FG000|Overall Study|Death|3|||
130297908|NCT03908476|469054169|FG001|Overall Study|Death|0|||
130297909|NCT03908476|469054168|FG000|Overall Study|Lost to Follow-up|3|||
130297910|NCT03908476|469054169|FG001|Overall Study|Lost to Follow-up|1|||
130297911|NCT03908476|469054168|FG000|Overall Study|Withdrawal by Subject|7|||
130297912|NCT03908476|469054169|FG001|Overall Study|Withdrawal by Subject|1|||
130297913|NCT03908476|469054168|FG000|Overall Study|Physician Decision|2|||
130297914|NCT03908476|469054169|FG001|Overall Study|Physician Decision|0|||
130297915|NCT03908476|469054168|FG000|Overall Study|System Explanted and not Replaced|4|||
130297916|NCT03908476|469054169|FG001|Overall Study|System Explanted and not Replaced|0|||
130297917|NCT03908476|469054168|FG000|Overall Study|Intrathecal Pump|1|||
130297918|NCT03908476|469054169|FG001|Overall Study|Intrathecal Pump|0|||
130297919|NCT03908476|469054168|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
130297920|NCT03908476|469054169|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
130297921|NCT02868229|469054170|FG000|Overall Study|Adverse Event|1|||
130297922|NCT02868229|469054171|FG001|Overall Study|Adverse Event|0|||
130297923|NCT02868229|469054172|FG002|Overall Study|Adverse Event|0|||
130297924|NCT02868229|469054173|FG003|Overall Study|Adverse Event|1|||
130297925|NCT02868229|469054170|FG000|Overall Study|Death|0|||
130461282|NCT00057837|469653920|FG000|Overall Study|Alternative therapy|0|||
130461283|NCT00057837|469653921|FG001|Overall Study|Alternative therapy|1|||
130461284|NCT00057837|469653920|FG000|Overall Study|Other complicating disease|2|||
130461285|NCT00057837|469653921|FG001|Overall Study|Other complicating disease|1|||
130461286|NCT00057837|469653920|FG000|Overall Study|Physician Decision|1|||
130461287|NCT00057837|469653921|FG001|Overall Study|Physician Decision|0|||
130461288|NCT00057837|469653920|FG000|Overall Study|Ineligible|3|||
130461289|NCT00057837|469653921|FG001|Overall Study|Ineligible|3|||
130461290|NCT00057837|469653920|FG000|Overall Study|Never started treatment|1|||
130461291|NCT00057837|469653921|FG001|Overall Study|Never started treatment|1|||
130461292|NCT02537522|469653922|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
130461293|NCT02537522|469653923|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
130461294|NCT02537522|469653924|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
130461295|NCT02537522|469653925|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
130461296|NCT02537522|469653922|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
130297926|NCT02868229|469054171|FG001|Overall Study|Death|0|||
130297927|NCT02868229|469054172|FG002|Overall Study|Death|1|||
130297928|NCT02868229|469054173|FG003|Overall Study|Death|1|||
130297929|NCT02868229|469054170|FG000|Overall Study|Missed dose|0|||
130461297|NCT02537522|469653923|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
130297930|NCT02868229|469054171|FG001|Overall Study|Missed dose|0|||
130297931|NCT02868229|469054172|FG002|Overall Study|Missed dose|0|||
130461298|NCT02537522|469653924|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
130557288|NCT03678103|470009952|FG000|Overall Study|Withdrawn prior to completion|4|||
130297932|NCT02868229|469054173|FG003|Overall Study|Missed dose|3|||
130297933|NCT03194438|469054174|FG000|Overall Study|Withdrawal by Subject|2|||
130461299|NCT02537522|469653925|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
130461300|NCT02537522|469653922|FG000|Phase I - Contralateral|incorrect randomization|0|||
130297934|NCT02250664|469054175|FG000|Overall Study|Lost to Follow-up|18|||
130297935|NCT02250664|469054176|FG001|Overall Study|Lost to Follow-up|28|||
130297936|NCT02250664|469054177|FG002|Overall Study|Lost to Follow-up|33|||
130372599|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372600|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372601|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372602|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130372603|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372604|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372605|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
130372606|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372607|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372608|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372609|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372610|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372611|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372612|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372613|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372614|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372615|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372616|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372617|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372618|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372619|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372620|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372621|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372622|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372623|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372624|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372625|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372626|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372627|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372628|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130372629|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372630|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372631|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
130372632|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372633|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372634|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372635|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372636|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372637|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372638|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372639|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372640|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372641|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372642|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372643|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372644|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372645|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372646|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372647|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372648|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372649|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372650|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372651|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372652|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130557289|NCT01241552|470009957|FG000|Overall Study|Lack of Efficacy|1|||
130557290|NCT01241552|470009958|FG001|Overall Study|Lack of Efficacy|0|||
130557291|NCT01241552|470009959|FG002|Overall Study|Lack of Efficacy|0|||
130557292|NCT01241552|470009960|FG003|Overall Study|Lack of Efficacy|0|||
130557293|NCT01241552|470009957|FG000|Overall Study|Death|26|||
130557294|NCT01241552|470009958|FG001|Overall Study|Death|30|||
130716187|NCT00891371|470588790|FG000|Treatment|Adverse Event|2|||
130716188|NCT00891371|470588790|FG000|Treatment|Death|1|||
130557295|NCT01241552|470009959|FG002|Overall Study|Death|20|||
130557296|NCT01241552|470009960|FG003|Overall Study|Death|25|||
130557297|NCT01241552|470009957|FG000|Overall Study|Adverse Event|1|||
130716189|NCT00891371|470588790|FG000|Treatment|Lost to Follow-up|1|||
130716190|NCT02622113|470588791|FG000|Overall Study|Adverse Event|4|||
130461301|NCT02537522|469653923|FG001|Phase I - Contralateral|incorrect randomization|1|||
130461302|NCT02537522|469653924|FG002|Phase I - Contralateral|incorrect randomization|0|||
130461303|NCT02537522|469653925|FG003|Phase I - Contralateral|incorrect randomization|0|||
130461304|NCT02537522|469653922|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
130461305|NCT02537522|469653923|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
130461306|NCT02537522|469653924|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
130461307|NCT02537522|469653925|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
130461308|NCT02537522|469653922|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
130297937|NCT02250664|469054175|FG000|Overall Study|Personal Reasons|7|||
130297938|NCT02250664|469054176|FG001|Overall Study|Personal Reasons|8|||
130297939|NCT02250664|469054177|FG002|Overall Study|Personal Reasons|14|||
130297940|NCT02250664|469054175|FG000|Overall Study|Adverse Event|6|||
130297941|NCT02250664|469054176|FG001|Overall Study|Adverse Event|3|||
130297942|NCT02250664|469054177|FG002|Overall Study|Adverse Event|8|||
130297943|NCT02250664|469054175|FG000|Overall Study|Incarcerated|2|||
130297944|NCT02250664|469054176|FG001|Overall Study|Incarcerated|1|||
130297945|NCT02250664|469054177|FG002|Overall Study|Incarcerated|2|||
130297946|NCT02250664|469054175|FG000|Overall Study|Withdrawal by Subject|0|||
130297947|NCT02250664|469054176|FG001|Overall Study|Withdrawal by Subject|1|||
130297948|NCT02250664|469054177|FG002|Overall Study|Withdrawal by Subject|2|||
130297949|NCT02250664|469054175|FG000|Overall Study|Death|0|||
130297950|NCT02250664|469054176|FG001|Overall Study|Death|1|||
130297951|NCT02250664|469054177|FG002|Overall Study|Death|1|||
130297952|NCT02250664|469054175|FG000|Overall Study|Physician Decision|1|||
130297953|NCT02250664|469054176|FG001|Overall Study|Physician Decision|3|||
130297954|NCT02250664|469054177|FG002|Overall Study|Physician Decision|1|||
130297955|NCT02250664|469054175|FG000|Overall Study|Protocol Violation|1|||
130297956|NCT02250664|469054176|FG001|Overall Study|Protocol Violation|0|||
130297957|NCT02250664|469054177|FG002|Overall Study|Protocol Violation|1|||
130297958|NCT02250664|469054175|FG000|Overall Study|Reason unknown|1|||
130297959|NCT02250664|469054176|FG001|Overall Study|Reason unknown|0|||
130297960|NCT02250664|469054177|FG002|Overall Study|Reason unknown|0|||
130461309|NCT02537522|469653923|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
130461310|NCT02537522|469653924|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
130461311|NCT02537522|469653925|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
130461312|NCT02570711|469653927|FG000|Overall Study|Death|1|||
130461313|NCT02570711|469653928|FG001|Overall Study|Death|0|||
130461314|NCT02570711|469653927|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
130461315|NCT02570711|469653928|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
130461316|NCT02547922|469653929|FG000|Overall Study|Withdrawal by Subject|9|||
130461317|NCT02547922|469653930|FG001|Overall Study|Withdrawal by Subject|6|||
130461318|NCT02547922|469653931|FG002|Overall Study|Withdrawal by Subject|10|||
130461319|NCT02547922|469653929|FG000|Overall Study|Adverse Event|3|||
130461320|NCT02547922|469653930|FG001|Overall Study|Adverse Event|1|||
130461321|NCT02547922|469653931|FG002|Overall Study|Adverse Event|2|||
130461322|NCT02547922|469653929|FG000|Overall Study|Lost to Follow-up|1|||
130461323|NCT02547922|469653930|FG001|Overall Study|Lost to Follow-up|0|||
130461324|NCT02547922|469653931|FG002|Overall Study|Lost to Follow-up|0|||
130461325|NCT02547922|469653929|FG000|Overall Study|Lack of Efficacy|5|||
130461326|NCT02547922|469653930|FG001|Overall Study|Lack of Efficacy|7|||
130461327|NCT02547922|469653931|FG002|Overall Study|Lack of Efficacy|4|||
130461328|NCT02547922|469653929|FG000|Overall Study|Death|1|||
130461329|NCT02547922|469653930|FG001|Overall Study|Death|0|||
130461330|NCT02547922|469653931|FG002|Overall Study|Death|0|||
130297961|NCT00117793|469054178|FG000|Overall Study|Withdrawal by Subject|12|||
130297962|NCT04268173|469054179|FG000|Overall Study|Lost to Follow-up|75|||
130297963|NCT04268173|469054180|FG001|Overall Study|Lost to Follow-up|108|||
130297964|NCT00545103|469054181|FG000|Overall Study|Lack of Efficacy|48|||
130297965|NCT00545103|469054182|FG001|Overall Study|Lack of Efficacy|45|||
130297966|NCT00545103|469054183|FG002|Overall Study|Lack of Efficacy|31|||
130297967|NCT00545103|469054184|FG003|Overall Study|Lack of Efficacy|27|||
130297968|NCT00545103|469054181|FG000|Overall Study|Withdrawal by Subject|6|||
130297969|NCT00545103|469054182|FG001|Overall Study|Withdrawal by Subject|10|||
130297970|NCT00545103|469054183|FG002|Overall Study|Withdrawal by Subject|18|||
130297971|NCT00545103|469054184|FG003|Overall Study|Withdrawal by Subject|22|||
130297972|NCT00545103|469054181|FG000|Overall Study|Adverse Event|11|||
130297973|NCT00545103|469054182|FG001|Overall Study|Adverse Event|12|||
130461331|NCT02547922|469653929|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
130461332|NCT02547922|469653930|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
130557298|NCT01241552|470009958|FG001|Overall Study|Adverse Event|1|||
130297974|NCT00545103|469054183|FG002|Overall Study|Adverse Event|17|||
130297975|NCT00545103|469054184|FG003|Overall Study|Adverse Event|10|||
130297976|NCT00545103|469054181|FG000|Overall Study|Lost to Follow-up|4|||
130297977|NCT00545103|469054182|FG001|Overall Study|Lost to Follow-up|6|||
130297978|NCT00545103|469054183|FG002|Overall Study|Lost to Follow-up|3|||
130297979|NCT00545103|469054184|FG003|Overall Study|Lost to Follow-up|4|||
130461333|NCT02547922|469653931|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
130461334|NCT02547922|469653929|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
130461335|NCT02547922|469653930|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
130461336|NCT02547922|469653931|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
130461337|NCT02547922|469653929|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
130716191|NCT02622113|470588792|FG001|Overall Study|Adverse Event|4|||
130297980|NCT00545103|469054181|FG000|Overall Study|Protocol Violation|1|||
130297981|NCT00545103|469054182|FG001|Overall Study|Protocol Violation|2|||
130297982|NCT00545103|469054183|FG002|Overall Study|Protocol Violation|3|||
130297983|NCT00545103|469054184|FG003|Overall Study|Protocol Violation|0|||
130297984|NCT00545103|469054181|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
130297985|NCT00545103|469054182|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
130297986|NCT00545103|469054183|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
130297987|NCT00545103|469054184|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
130297988|NCT00545103|469054181|FG000|Overall Study|Difficult to open package|0|||
130297989|NCT00545103|469054182|FG001|Overall Study|Difficult to open package|0|||
130297990|NCT00545103|469054183|FG002|Overall Study|Difficult to open package|0|||
130297991|NCT00545103|469054184|FG003|Overall Study|Difficult to open package|1|||
130297992|NCT00545103|469054181|FG000|Overall Study|Investigational product not taken|1|||
130297993|NCT00545103|469054182|FG001|Overall Study|Investigational product not taken|0|||
130297994|NCT00545103|469054183|FG002|Overall Study|Investigational product not taken|0|||
130297995|NCT00545103|469054184|FG003|Overall Study|Investigational product not taken|1|||
130297996|NCT00545103|469054181|FG000|Overall Study|Wish to start a family|0|||
130297997|NCT00545103|469054182|FG001|Overall Study|Wish to start a family|0|||
130297998|NCT00545103|469054183|FG002|Overall Study|Wish to start a family|0|||
130297999|NCT00545103|469054184|FG003|Overall Study|Wish to start a family|1|||
130298000|NCT00545103|469054181|FG000|Overall Study|Diverticulitis crisis|0|||
130298001|NCT00545103|469054182|FG001|Overall Study|Diverticulitis crisis|0|||
130298002|NCT00545103|469054183|FG002|Overall Study|Diverticulitis crisis|0|||
130298003|NCT00545103|469054184|FG003|Overall Study|Diverticulitis crisis|1|||
130298004|NCT00545103|469054181|FG000|Overall Study|Personal reasons|1|||
130298005|NCT00545103|469054182|FG001|Overall Study|Personal reasons|0|||
130298006|NCT00545103|469054183|FG002|Overall Study|Personal reasons|0|||
130298007|NCT00545103|469054184|FG003|Overall Study|Personal reasons|0|||
130298008|NCT00545103|469054181|FG000|Overall Study|Subject's decision|1|||
130298009|NCT00545103|469054182|FG001|Overall Study|Subject's decision|0|||
130298010|NCT00545103|469054183|FG002|Overall Study|Subject's decision|0|||
130298011|NCT00545103|469054184|FG003|Overall Study|Subject's decision|0|||
130298012|NCT00545103|469054181|FG000|Overall Study|Noncompliance|0|||
130298013|NCT00545103|469054182|FG001|Overall Study|Noncompliance|1|||
130298014|NCT00545103|469054183|FG002|Overall Study|Noncompliance|0|||
130298015|NCT00545103|469054184|FG003|Overall Study|Noncompliance|0|||
130298016|NCT00545103|469054181|FG000|Overall Study|Investigator decision|0|||
130298017|NCT00545103|469054182|FG001|Overall Study|Investigator decision|0|||
130298018|NCT00545103|469054183|FG002|Overall Study|Investigator decision|1|||
130298019|NCT00545103|469054184|FG003|Overall Study|Investigator decision|0|||
130298020|NCT00545103|469054181|FG000|Overall Study|Subject moved|0|||
130298021|NCT00545103|469054182|FG001|Overall Study|Subject moved|1|||
130298022|NCT00545103|469054183|FG002|Overall Study|Subject moved|0|||
130298023|NCT00545103|469054184|FG003|Overall Study|Subject moved|0|||
130298024|NCT00545103|469054181|FG000|Overall Study|Use of prohibited medication|0|||
130298025|NCT00545103|469054182|FG001|Overall Study|Use of prohibited medication|0|||
130298026|NCT00545103|469054183|FG002|Overall Study|Use of prohibited medication|1|||
130298027|NCT00545103|469054184|FG003|Overall Study|Use of prohibited medication|0|||
130298028|NCT00545103|469054181|FG000|Overall Study|Does not want to take study drug anymore|1|||
130298029|NCT00545103|469054182|FG001|Overall Study|Does not want to take study drug anymore|0|||
130298030|NCT00545103|469054183|FG002|Overall Study|Does not want to take study drug anymore|1|||
130298031|NCT00545103|469054184|FG003|Overall Study|Does not want to take study drug anymore|0|||
130298032|NCT00545103|469054181|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298033|NCT00545103|469054182|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298034|NCT00545103|469054183|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
130298035|NCT00545103|469054184|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298036|NCT00545103|469054181|FG000|Overall Study|Death|0|||
130298037|NCT00545103|469054182|FG001|Overall Study|Death|1|||
130298038|NCT00545103|469054183|FG002|Overall Study|Death|0|||
130298039|NCT00545103|469054184|FG003|Overall Study|Death|0|||
130298040|NCT04891107|469054185|FG000|Overall Study|Physician Decision|1|||
130461338|NCT02547922|469653930|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
130298041|NCT04891107|469054185|FG000|Overall Study|Withdrawal by Subject|1|||
130298042|NCT04891107|469054185|FG000|Overall Study|Screen failure after consent|1|||
130298043|NCT01571453|469054186|FG000|Overall Study|Adverse Event|14|||
130298044|NCT01571453|469054187|FG001|Overall Study|Adverse Event|32|||
130298045|NCT01571453|469054186|FG000|Overall Study|Lack of Efficacy|8|||
130298046|NCT01571453|469054187|FG001|Overall Study|Lack of Efficacy|3|||
130298047|NCT01571453|469054186|FG000|Overall Study|Non-compliance|2|||
130298048|NCT01571453|469054187|FG001|Overall Study|Non-compliance|4|||
130298049|NCT01571453|469054186|FG000|Overall Study|Protocol Violation|1|||
130298050|NCT01571453|469054187|FG001|Overall Study|Protocol Violation|5|||
130298051|NCT01571453|469054186|FG000|Overall Study|Withdrawal of consent|5|||
130298052|NCT01571453|469054187|FG001|Overall Study|Withdrawal of consent|13|||
130298053|NCT01571453|469054186|FG000|Overall Study|Lost to Follow-up|4|||
130298054|NCT01571453|469054187|FG001|Overall Study|Lost to Follow-up|2|||
130298055|NCT01571453|469054186|FG000|Overall Study|Administrative or other reason(s)|4|||
130298056|NCT01571453|469054187|FG001|Overall Study|Administrative or other reason(s)|3|||
130298057|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
130298058|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
130298059|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
130298060|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
130298061|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
130298062|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
130298063|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
130298064|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298065|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298066|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298067|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298068|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298069|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
130298070|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
130298071|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298072|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298073|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298074|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298075|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
130298076|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
130298077|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
130298078|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
130298079|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
130298080|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
130298081|NCT02453555|469054188|FG000|Extension Period|Adverse Event|0|||
130298082|NCT02453555|469054189|FG001|Extension Period|Adverse Event|0|||
130298083|NCT02453555|469054190|FG002|Extension Period|Adverse Event|1|||
130298084|NCT02453555|469054191|FG003|Extension Period|Adverse Event|2|||
130298085|NCT02453555|469054192|FG004|Extension Period|Adverse Event|1|||
130298086|NCT02453555|469054193|FG005|Extension Period|Adverse Event|1|||
130298087|NCT02453555|469054188|FG000|Extension Period|Protocol Violation|0|||
130461339|NCT02547922|469653931|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
130461340|NCT02547922|469653929|FG000|Overall Study|Physician Decision|2|||
130461341|NCT02547922|469653930|FG001|Overall Study|Physician Decision|1|||
130461342|NCT02547922|469653931|FG002|Overall Study|Physician Decision|2|||
130461343|NCT02547922|469653929|FG000|Overall Study|Patients did not receive IP|1|||
130461344|NCT02547922|469653930|FG001|Overall Study|Patients did not receive IP|1|||
130461345|NCT02547922|469653931|FG002|Overall Study|Patients did not receive IP|0|||
130461346|NCT00102063|469653934|FG000|Overall Study|Lack of Efficacy|5|||
130461347|NCT00102063|469653935|FG001|Overall Study|Lack of Efficacy|1|||
130461348|NCT00102063|469653936|FG002|Overall Study|Lack of Efficacy|1|||
130461349|NCT00102063|469653934|FG000|Overall Study|Adverse Event|7|||
130461350|NCT00102063|469653935|FG001|Overall Study|Adverse Event|4|||
130461351|NCT00102063|469653936|FG002|Overall Study|Adverse Event|2|||
130461352|NCT00102063|469653934|FG000|Overall Study|Withdrawal by Subject|4|||
130461353|NCT00102063|469653935|FG001|Overall Study|Withdrawal by Subject|12|||
130461354|NCT00102063|469653936|FG002|Overall Study|Withdrawal by Subject|5|||
130461355|NCT00102063|469653934|FG000|Overall Study|Lost to Follow-up|0|||
130461356|NCT00102063|469653935|FG001|Overall Study|Lost to Follow-up|0|||
130461357|NCT00102063|469653936|FG002|Overall Study|Lost to Follow-up|1|||
130461358|NCT00102063|469653934|FG000|Overall Study|Protocol Violation|0|||
130461359|NCT00102063|469653935|FG001|Overall Study|Protocol Violation|1|||
130461360|NCT00102063|469653936|FG002|Overall Study|Protocol Violation|1|||
130461361|NCT01493778|469653937|FG000|Overall Study|Withdrawal by Subject|8|||
130461362|NCT05082025|469653938|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
130461363|NCT04210180|469653939|FG000|Overall Study|Withdrawal by Subject|2|||
130461364|NCT00857649|469653940|FG000|Overall Study|Adverse Event|15|||
130461365|NCT00857649|469653941|FG001|Overall Study|Adverse Event|10|||
130461366|NCT00857649|469653940|FG000|Overall Study|Non-compliance|1|||
130461367|NCT00857649|469653941|FG001|Overall Study|Non-compliance|1|||
130461368|NCT00857649|469653940|FG000|Overall Study|Protocol Violation|2|||
130461369|NCT00857649|469653941|FG001|Overall Study|Protocol Violation|2|||
130461370|NCT00857649|469653940|FG000|Overall Study|Withdrawal of Consent|10|||
130557299|NCT01241552|470009959|FG002|Overall Study|Adverse Event|0|||
130716192|NCT02622113|470588791|FG000|Overall Study|Physician Decision|0|||
130298088|NCT02453555|469054189|FG001|Extension Period|Protocol Violation|0|||
130298089|NCT02453555|469054190|FG002|Extension Period|Protocol Violation|1|||
130298090|NCT02453555|469054191|FG003|Extension Period|Protocol Violation|0|||
130298091|NCT02453555|469054192|FG004|Extension Period|Protocol Violation|0|||
130298092|NCT02453555|469054193|FG005|Extension Period|Protocol Violation|0|||
130298093|NCT02453555|469054188|FG000|Extension Period|Withdrawal by Subject|0|||
130298094|NCT02453555|469054189|FG001|Extension Period|Withdrawal by Subject|0|||
130298095|NCT02453555|469054190|FG002|Extension Period|Withdrawal by Subject|1|||
130298096|NCT02453555|469054191|FG003|Extension Period|Withdrawal by Subject|0|||
130298097|NCT02453555|469054192|FG004|Extension Period|Withdrawal by Subject|0|||
130298098|NCT02453555|469054193|FG005|Extension Period|Withdrawal by Subject|0|||
130298099|NCT04284774|469054194|FG000|Overall Study|Progressive disease|5|||
130298100|NCT02879578|469054195|FG000|Overall Study|Adverse Event|1|||
130298101|NCT02879578|469054196|FG001|Overall Study|Adverse Event|2|||
130298102|NCT02879578|469054197|FG002|Overall Study|Adverse Event|14|||
130298103|NCT02879578|469054195|FG000|Overall Study|Protocol Violation|0|||
130298104|NCT02879578|469054196|FG001|Overall Study|Protocol Violation|1|||
130298105|NCT02879578|469054197|FG002|Overall Study|Protocol Violation|1|||
130298106|NCT02879578|469054195|FG000|Overall Study|Withdrawal by Subject|8|||
130298107|NCT02879578|469054196|FG001|Overall Study|Withdrawal by Subject|6|||
130298108|NCT02879578|469054197|FG002|Overall Study|Withdrawal by Subject|9|||
130298109|NCT02879578|469054195|FG000|Overall Study|Lost to Follow-up|1|||
130298110|NCT02879578|469054196|FG001|Overall Study|Lost to Follow-up|0|||
130298111|NCT02879578|469054197|FG002|Overall Study|Lost to Follow-up|4|||
130298112|NCT02879578|469054195|FG000|Overall Study|Physician Decision|0|||
130298113|NCT02879578|469054196|FG001|Overall Study|Physician Decision|0|||
130298114|NCT02879578|469054197|FG002|Overall Study|Physician Decision|4|||
130298115|NCT03203291|469054203|FG000|Overall Study|Withdrawal by Subject|1|||
130298116|NCT02039856|469054204|FG000|Overall Study|Death|5|||
130298117|NCT02039856|469054205|FG001|Overall Study|Death|3|||
130298118|NCT02039856|469054204|FG000|Overall Study|Partial survey completion|61|||
130298119|NCT02039856|469054205|FG001|Overall Study|Partial survey completion|26|||
130298120|NCT02039856|469054204|FG000|Overall Study|Lost to Follow-up|388|||
130298121|NCT02039856|469054205|FG001|Overall Study|Lost to Follow-up|206|||
130298122|NCT02039856|469054204|FG000|Overall Study|Withdrawal by Subject|1573|||
130298123|NCT02039856|469054205|FG001|Overall Study|Withdrawal by Subject|618|||
130298124|NCT02409342|469054206|FG000|Overall Study|Death|211|||
130298125|NCT02409342|469054207|FG001|Overall Study|Death|201|||
130298126|NCT02409342|469054206|FG000|Overall Study|Withdrawal by Subject|24|||
130298127|NCT02409342|469054207|FG001|Overall Study|Withdrawal by Subject|17|||
130298128|NCT02409342|469054206|FG000|Overall Study|Study Terminated By Sponsor|48|||
130298129|NCT02409342|469054207|FG001|Overall Study|Study Terminated By Sponsor|59|||
130298130|NCT02409342|469054206|FG000|Overall Study|Lost to Follow-up|3|||
130298131|NCT02409342|469054207|FG001|Overall Study|Lost to Follow-up|5|||
130298132|NCT02409342|469054206|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
130298133|NCT02409342|469054207|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
130298134|NCT02409342|469054206|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
130298135|NCT02409342|469054207|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
130298136|NCT02409342|469054206|FG000|Overall Study|Sponsor Decision|1|||
130298137|NCT02409342|469054207|FG001|Overall Study|Sponsor Decision|0|||
130298138|NCT03908970|469054208|FG000|Overall Study|Adverse Event|7|||
130298139|NCT03908970|469054209|FG001|Overall Study|Adverse Event|21|||
130298140|NCT03908970|469054208|FG000|Overall Study|Physician Decision|1|||
130298141|NCT03908970|469054209|FG001|Overall Study|Physician Decision|4|||
130298142|NCT03908970|469054208|FG000|Overall Study|Withdrawal by Subject|9|||
130298143|NCT03908970|469054209|FG001|Overall Study|Withdrawal by Subject|22|||
130298144|NCT01274429|469054215|FG000|Overall Study|Study closed do to lack of funding|5|||
130298145|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298146|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298147|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298148|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
130298149|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298150|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298151|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298152|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298153|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298154|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298155|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
130298156|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298157|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298158|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298159|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
130298160|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298161|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298162|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130716193|NCT02622113|470588792|FG001|Overall Study|Physician Decision|1|||
130716194|NCT02622113|470588791|FG000|Overall Study|Withdrawal by Subject|0|||
130716195|NCT02622113|470588792|FG001|Overall Study|Withdrawal by Subject|2|||
130298163|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298164|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298165|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298166|NCT03268941|469055991|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
130298167|NCT03268941|469055992|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
130298168|NCT03268941|469055993|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
130298169|NCT03268941|469055994|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
130298170|NCT03268941|469055995|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
130298171|NCT03268941|469055996|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
130298172|NCT03268941|469055997|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
130298173|NCT03268941|469055991|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298174|NCT03268941|469055992|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298175|NCT03268941|469055993|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298176|NCT03268941|469055994|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298177|NCT03268941|469055995|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298178|NCT03268941|469055996|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298179|NCT03268941|469055997|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
130298180|NCT01216683|469055998|FG000|Induction|Never started treatment|0|||
130298181|NCT01216683|469055999|FG001|Induction|Never started treatment|6|||
130298182|NCT01216683|469056000|FG002|Induction|Never started treatment|3|||
130298183|NCT01216683|469055998|FG000|Induction|Lack of Efficacy|4|||
130461371|NCT00857649|469653941|FG001|Overall Study|Withdrawal of Consent|7|||
130298184|NCT01216683|469055999|FG001|Induction|Lack of Efficacy|3|||
130298185|NCT01216683|469056000|FG002|Induction|Lack of Efficacy|7|||
130298186|NCT01216683|469055998|FG000|Induction|Adverse Event|0|||
130298187|NCT01216683|469055999|FG001|Induction|Adverse Event|5|||
130461372|NCT00857649|469653940|FG000|Overall Study|Nursing Home Placement|2|||
130298188|NCT01216683|469056000|FG002|Induction|Adverse Event|5|||
130298189|NCT01216683|469055998|FG000|Induction|Death|0|||
130298190|NCT01216683|469055999|FG001|Induction|Death|0|||
130298191|NCT01216683|469056000|FG002|Induction|Death|2|||
130298192|NCT01216683|469055998|FG000|Induction|Withdrawal by Subject|0|||
130298193|NCT01216683|469055999|FG001|Induction|Withdrawal by Subject|4|||
130298194|NCT01216683|469056000|FG002|Induction|Withdrawal by Subject|2|||
130298195|NCT01216683|469055998|FG000|Induction|Other disease|0|||
130298196|NCT01216683|469055999|FG001|Induction|Other disease|1|||
130298197|NCT01216683|469056000|FG002|Induction|Other disease|2|||
130298198|NCT01216683|469055998|FG000|Continuation|Lack of Efficacy|3|||
130461373|NCT00857649|469653941|FG001|Overall Study|Nursing Home Placement|9|||
130461374|NCT00857649|469653940|FG000|Overall Study|Other Reasons|1|||
130461375|NCT00857649|469653941|FG001|Overall Study|Other Reasons|3|||
130461376|NCT05190419|469653942|FG000|Overall Study|Lack of Efficacy|8|||
130461377|NCT05190419|469653943|FG001|Overall Study|Lack of Efficacy|0|||
130461378|NCT05190419|469653944|FG002|Overall Study|Lack of Efficacy|1|||
130461379|NCT05190419|469653945|FG003|Overall Study|Lack of Efficacy|0|||
130461380|NCT05190419|469653942|FG000|Overall Study|Withdrawal by Subject|7|||
130461381|NCT05190419|469653943|FG001|Overall Study|Withdrawal by Subject|1|||
130461382|NCT05190419|469653944|FG002|Overall Study|Withdrawal by Subject|2|||
130461383|NCT05190419|469653945|FG003|Overall Study|Withdrawal by Subject|2|||
130461384|NCT05190419|469653942|FG000|Overall Study|Adverse Event|2|||
130461385|NCT05190419|469653943|FG001|Overall Study|Adverse Event|10|||
130461386|NCT05190419|469653944|FG002|Overall Study|Adverse Event|11|||
130461387|NCT05190419|469653945|FG003|Overall Study|Adverse Event|21|||
130461388|NCT05190419|469653942|FG000|Overall Study|Lost to Follow-up|1|||
130716196|NCT02622113|470588791|FG000|Overall Study|Stopping Criteria|1|||
130298199|NCT01216683|469055999|FG001|Continuation|Lack of Efficacy|2|||
130298200|NCT01216683|469056000|FG002|Continuation|Lack of Efficacy|7|||
130461389|NCT05190419|469653943|FG001|Overall Study|Lost to Follow-up|2|||
130461390|NCT05190419|469653944|FG002|Overall Study|Lost to Follow-up|3|||
130461391|NCT05190419|469653945|FG003|Overall Study|Lost to Follow-up|1|||
130716197|NCT02622113|470588792|FG001|Overall Study|Stopping Criteria|3|||
130461392|NCT05190419|469653942|FG000|Overall Study|Other|1|||
130461393|NCT05190419|469653943|FG001|Overall Study|Other|1|||
130298201|NCT01216683|469055998|FG000|Continuation|Adverse Event|5|||
130298202|NCT01216683|469055999|FG001|Continuation|Adverse Event|3|||
130298203|NCT01216683|469056000|FG002|Continuation|Adverse Event|16|||
130298204|NCT01216683|469055998|FG000|Continuation|Death|1|||
130298205|NCT01216683|469055999|FG001|Continuation|Death|0|||
130298206|NCT01216683|469056000|FG002|Continuation|Death|2|||
130461394|NCT05190419|469653944|FG002|Overall Study|Other|0|||
130298207|NCT01216683|469055998|FG000|Continuation|Withdrawal by Subject|4|||
130298208|NCT01216683|469055999|FG001|Continuation|Withdrawal by Subject|5|||
130461395|NCT05190419|469653945|FG003|Overall Study|Other|3|||
130461396|NCT05323734|469653951|FG000|Overall Study|Adverse Event|5|||
130461397|NCT05323734|469653952|FG001|Overall Study|Adverse Event|2|||
130461398|NCT05323734|469653951|FG000|Overall Study|Physician Decision|1|||
130298209|NCT01216683|469056000|FG002|Continuation|Withdrawal by Subject|9|||
130298210|NCT01216683|469055998|FG000|Continuation|Other diseases|0|||
130298211|NCT01216683|469055999|FG001|Continuation|Other diseases|2|||
130298212|NCT01216683|469056000|FG002|Continuation|Other diseases|1|||
130298213|NCT01216683|469055998|FG000|Continuation|Physician Decision|1|||
130298214|NCT01216683|469055999|FG001|Continuation|Physician Decision|0|||
130298215|NCT01216683|469056000|FG002|Continuation|Physician Decision|1|||
130298216|NCT01216683|469055998|FG000|Continuation|Non-compliance|1|||
130298217|NCT01216683|469055999|FG001|Continuation|Non-compliance|0|||
130298218|NCT01216683|469056000|FG002|Continuation|Non-compliance|1|||
130298219|NCT01216683|469055998|FG000|Continuation|Insurance change|0|||
130298220|NCT01216683|469055999|FG001|Continuation|Insurance change|1|||
130298221|NCT01216683|469056000|FG002|Continuation|Insurance change|0|||
130298222|NCT01216683|469055998|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130298223|NCT01216683|469055999|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
130298224|NCT01216683|469056000|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130298225|NCT01216683|469055998|FG000|Continuation|Not reported|0|||
130298226|NCT01216683|469055999|FG001|Continuation|Not reported|0|||
130298227|NCT01216683|469056000|FG002|Continuation|Not reported|1|||
130298228|NCT01216683|469055998|FG000|Continuation|Never started treatment|0|||
130298229|NCT01216683|469055999|FG001|Continuation|Never started treatment|1|||
130298230|NCT01216683|469056000|FG002|Continuation|Never started treatment|5|||
130298231|NCT00765063|469056006|FG000|Overall Study|Lack of Efficacy|5|||
130298232|NCT00765063|469056006|FG000|Overall Study|Withdrawal by Subject|1|||
130298233|NCT00765063|469056006|FG000|Overall Study|Other|16|||
130298234|NCT00765063|469056006|FG000|Overall Study|Protocol Violation|6|||
130298235|NCT00765063|469056006|FG000|Overall Study|Adverse Event|4|||
130298236|NCT03614325|469056009|FG000|Overall Study|Withdrawal by Subject|0|||
130298237|NCT03614325|469056010|FG001|Overall Study|Withdrawal by Subject|2|||
130298238|NCT03614325|469056009|FG000|Overall Study|Surgery Cancelled|2|||
130298239|NCT03614325|469056010|FG001|Overall Study|Surgery Cancelled|1|||
130298240|NCT03614325|469056009|FG000|Overall Study|Lost to Follow-up|2|||
130298241|NCT03614325|469056010|FG001|Overall Study|Lost to Follow-up|1|||
130298242|NCT03614325|469056009|FG000|Overall Study|Surgery never scheduled|1|||
130298243|NCT03614325|469056010|FG001|Overall Study|Surgery never scheduled|0|||
130298244|NCT01041287|469056011|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130298245|NCT01041287|469056012|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130298246|NCT01041287|469056011|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
130298247|NCT01041287|469056012|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
130298248|NCT02814175|469056013|FG000|Part 1|Adverse Event|2|||
130298249|NCT02814175|469056014|FG001|Part 1|Adverse Event|3|||
130298250|NCT02814175|469056015|FG002|Part 1|Adverse Event|0|||
130298251|NCT02814175|469056016|FG003|Part 1|Adverse Event|0|||
130298252|NCT02814175|469056017|FG004|Part 1|Adverse Event|0|||
130298253|NCT02814175|469056018|FG005|Part 1|Adverse Event|0|||
130298254|NCT02814175|469056013|FG000|Part 1|Withdrawal Consent|8|||
130298255|NCT02814175|469056014|FG001|Part 1|Withdrawal Consent|1|||
130298256|NCT02814175|469056015|FG002|Part 1|Withdrawal Consent|0|||
130298257|NCT02814175|469056016|FG003|Part 1|Withdrawal Consent|0|||
130298258|NCT02814175|469056017|FG004|Part 1|Withdrawal Consent|0|||
130298259|NCT02814175|469056018|FG005|Part 1|Withdrawal Consent|0|||
130298260|NCT02814175|469056013|FG000|Part 1|Lost to Follow-up|1|||
130298261|NCT02814175|469056014|FG001|Part 1|Lost to Follow-up|0|||
130372653|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130298262|NCT02814175|469056015|FG002|Part 1|Lost to Follow-up|0|||
130298263|NCT02814175|469056016|FG003|Part 1|Lost to Follow-up|0|||
130298264|NCT02814175|469056017|FG004|Part 1|Lost to Follow-up|0|||
130298265|NCT02814175|469056018|FG005|Part 1|Lost to Follow-up|0|||
130372654|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130372655|NCT03129100|469333339|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372656|NCT03129100|469333340|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372657|NCT03129100|469333341|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372658|NCT03129100|469333342|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372659|NCT03129100|469333343|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
130298266|NCT02814175|469056013|FG000|Part 1|Lack of Efficacy|1|||
130298267|NCT02814175|469056014|FG001|Part 1|Lack of Efficacy|2|||
130298268|NCT02814175|469056015|FG002|Part 1|Lack of Efficacy|0|||
130298269|NCT02814175|469056016|FG003|Part 1|Lack of Efficacy|0|||
130298270|NCT02814175|469056017|FG004|Part 1|Lack of Efficacy|0|||
130298271|NCT02814175|469056018|FG005|Part 1|Lack of Efficacy|0|||
130298272|NCT02814175|469056013|FG000|Part 2|Adverse Event|0|||
130298273|NCT02814175|469056014|FG001|Part 2|Adverse Event|0|||
130298274|NCT02814175|469056015|FG002|Part 2|Adverse Event|0|||
130298275|NCT02814175|469056016|FG003|Part 2|Adverse Event|1|||
130298276|NCT02814175|469056017|FG004|Part 2|Adverse Event|1|||
130298277|NCT02814175|469056018|FG005|Part 2|Adverse Event|2|||
130298278|NCT02814175|469056013|FG000|Part 2|Withdrawal Consent|0|||
130298279|NCT02814175|469056014|FG001|Part 2|Withdrawal Consent|0|||
130298280|NCT02814175|469056015|FG002|Part 2|Withdrawal Consent|0|||
130298281|NCT02814175|469056016|FG003|Part 2|Withdrawal Consent|2|||
130298282|NCT02814175|469056017|FG004|Part 2|Withdrawal Consent|1|||
130298283|NCT02814175|469056018|FG005|Part 2|Withdrawal Consent|1|||
130298284|NCT02814175|469056013|FG000|Part 2|Lost to Follow-up|0|||
130298285|NCT02814175|469056014|FG001|Part 2|Lost to Follow-up|0|||
130298286|NCT02814175|469056015|FG002|Part 2|Lost to Follow-up|0|||
130298287|NCT02814175|469056016|FG003|Part 2|Lost to Follow-up|1|||
130298288|NCT02814175|469056017|FG004|Part 2|Lost to Follow-up|0|||
130298289|NCT02814175|469056018|FG005|Part 2|Lost to Follow-up|0|||
130298290|NCT02814175|469056013|FG000|Part 2|Lack of Efficacy|0|||
130298291|NCT02814175|469056014|FG001|Part 2|Lack of Efficacy|0|||
130298292|NCT02814175|469056015|FG002|Part 2|Lack of Efficacy|0|||
130298293|NCT02814175|469056016|FG003|Part 2|Lack of Efficacy|0|||
130298294|NCT02814175|469056017|FG004|Part 2|Lack of Efficacy|0|||
130298295|NCT02814175|469056018|FG005|Part 2|Lack of Efficacy|3|||
130298296|NCT01673620|469056024|FG000|Overall Study|Adverse Event|1|||
130298297|NCT01673620|469056025|FG001|Overall Study|Adverse Event|0|||
130298298|NCT01597635|469056026|FG000|Part A|Adverse Event|3|||
130298299|NCT01597635|469056027|FG001|Part A|Adverse Event|0|||
130298300|NCT01597635|469056028|FG002|Part A|Adverse Event|0|||
130298301|NCT01597635|469056026|FG000|Part B|Adverse Event|0|||
130298302|NCT01597635|469056027|FG001|Part B|Adverse Event|0|||
130298303|NCT01597635|469056028|FG002|Part B|Adverse Event|1|||
130298304|NCT01597635|469056026|FG000|Part B|Protocol Violation|0|||
130298305|NCT01597635|469056027|FG001|Part B|Protocol Violation|1|||
130298306|NCT01597635|469056028|FG002|Part B|Protocol Violation|0|||
130298307|NCT01597635|469056026|FG000|Part B|Protocol-defined stopping criteria|0|||
130298308|NCT01597635|469056027|FG001|Part B|Protocol-defined stopping criteria|4|||
130298309|NCT01597635|469056028|FG002|Part B|Protocol-defined stopping criteria|3|||
130298310|NCT01597635|469056026|FG000|Part B|Withdrawal by Subject|0|||
130298311|NCT01597635|469056027|FG001|Part B|Withdrawal by Subject|1|||
130298312|NCT01597635|469056028|FG002|Part B|Withdrawal by Subject|0|||
130298313|NCT00495625|469056029|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
130298314|NCT01912339|469056030|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
130298315|NCT01912339|469056031|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
130298316|NCT01912339|469056032|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
130298317|NCT01912339|469056030|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
130298318|NCT01912339|469056031|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130298319|NCT01912339|469056032|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130298320|NCT01912339|469056030|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
130298321|NCT01912339|469056031|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130298322|NCT01912339|469056032|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130298323|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
130298324|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130298325|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130298326|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
130298327|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130298328|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130298329|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
130298330|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
130716198|NCT00667810|470588793|FG000|Overall Study|Adverse Event|13|||
130716199|NCT00667810|470588794|FG001|Overall Study|Adverse Event|14|||
130716200|NCT00667810|470588795|FG002|Overall Study|Adverse Event|19|||
130298331|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
130298332|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
130298333|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130298334|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130298335|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
130298336|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130298337|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130298338|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130298339|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130298340|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
130298341|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130298342|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130298343|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
130298344|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130298345|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130298346|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
130298347|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130298348|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130298349|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
130461399|NCT05323734|469653952|FG001|Overall Study|Physician Decision|0|||
130298350|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
130298351|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
130298352|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
130298353|NCT03464019|469056033|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
130298354|NCT03464019|469056034|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
130298355|NCT03464019|469056035|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
130298356|NCT03464019|469056033|FG000|NODE-301 Part 1|Ablation|0|||
130298357|NCT03464019|469056034|FG001|NODE-301 Part 1|Ablation|0|||
130298358|NCT03464019|469056035|FG002|NODE-301 Part 1|Ablation|16|||
130298359|NCT03464019|469056033|FG000|NODE-301 Part 1|Test Dose Failure|0|||
130298360|NCT03464019|469056034|FG001|NODE-301 Part 1|Test Dose Failure|0|||
130298361|NCT03464019|469056035|FG002|NODE-301 Part 1|Test Dose Failure|8|||
130298362|NCT03464019|469056033|FG000|NODE-301 Part 1|Adverse Event|0|||
130298363|NCT03464019|469056034|FG001|NODE-301 Part 1|Adverse Event|0|||
130298364|NCT03464019|469056035|FG002|NODE-301 Part 1|Adverse Event|5|||
130298365|NCT03464019|469056033|FG000|NODE-301 Part 1|Physician Decision|0|||
130298366|NCT03464019|469056034|FG001|NODE-301 Part 1|Physician Decision|0|||
130298367|NCT03464019|469056035|FG002|NODE-301 Part 1|Physician Decision|4|||
130298368|NCT03464019|469056033|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
130298369|NCT03464019|469056034|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
130298370|NCT03464019|469056035|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
130298371|NCT03464019|469056033|FG000|NODE-301 Part 1|Protocol Violation|0|||
130298372|NCT03464019|469056034|FG001|NODE-301 Part 1|Protocol Violation|0|||
130298373|NCT03464019|469056035|FG002|NODE-301 Part 1|Protocol Violation|2|||
130298374|NCT03464019|469056033|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
130298375|NCT03464019|469056034|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
130298376|NCT03464019|469056035|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
130298377|NCT03464019|469056033|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130298378|NCT03464019|469056034|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130298379|NCT03464019|469056035|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
130298380|NCT03464019|469056033|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130298381|NCT03464019|469056034|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130298382|NCT03464019|469056035|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
130298383|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
130298384|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
130298385|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
130298386|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
130298387|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
130298388|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
130298389|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130298390|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130298391|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
130298392|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
130298393|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
130298394|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
130298395|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130298396|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130298397|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
130298398|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
130298399|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
130298400|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
130298401|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
130298402|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
130298403|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
130298404|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130298405|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130298406|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
130298407|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130298408|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130298409|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
130298410|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
130298411|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
130298412|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
130298413|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
130298414|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
130298415|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
130298416|NCT00126776|469056036|FG000|Overall Study|follow up complete on all patients|0|||
130298417|NCT00126776|469056037|FG001|Overall Study|follow up complete on all patients|0|||
130298418|NCT03626545|469056041|FG000|Overall Study|Progressive disease|3|||
130298419|NCT03626545|469056042|FG001|Overall Study|Progressive disease|82|||
130298420|NCT03626545|469056043|FG002|Overall Study|Progressive disease|85|||
130557300|NCT01241552|470009960|FG003|Overall Study|Adverse Event|0|||
130557301|NCT01241552|470009957|FG000|Overall Study|Technical Problems|2|||
130557302|NCT01241552|470009958|FG001|Overall Study|Technical Problems|0|||
130557303|NCT01241552|470009959|FG002|Overall Study|Technical Problems|2|||
130557304|NCT01241552|470009960|FG003|Overall Study|Technical Problems|2|||
130557305|NCT01241552|470009957|FG000|Overall Study|Progressive Disease|0|||
130557306|NCT01241552|470009958|FG001|Overall Study|Progressive Disease|0|||
130557307|NCT01241552|470009959|FG002|Overall Study|Progressive Disease|1|||
130557308|NCT01241552|470009960|FG003|Overall Study|Progressive Disease|2|||
130557309|NCT01241552|470009957|FG000|Overall Study|Protocol Violation|0|||
130557310|NCT01241552|470009958|FG001|Overall Study|Protocol Violation|2|||
130716201|NCT00667810|470588796|FG003|Overall Study|Adverse Event|1|||
130716202|NCT00667810|470588793|FG000|Overall Study|Death|1|||
130716203|NCT00667810|470588794|FG001|Overall Study|Death|1|||
130716204|NCT00667810|470588795|FG002|Overall Study|Death|3|||
130716205|NCT00667810|470588796|FG003|Overall Study|Death|0|||
130716206|NCT00667810|470588793|FG000|Overall Study|Lack of Efficacy|1|||
130716207|NCT00667810|470588794|FG001|Overall Study|Lack of Efficacy|0|||
130716208|NCT00667810|470588795|FG002|Overall Study|Lack of Efficacy|2|||
130716209|NCT00667810|470588796|FG003|Overall Study|Lack of Efficacy|0|||
130716210|NCT00667810|470588793|FG000|Overall Study|Lost to Follow-up|1|||
130716211|NCT00667810|470588794|FG001|Overall Study|Lost to Follow-up|4|||
130716212|NCT00667810|470588795|FG002|Overall Study|Lost to Follow-up|2|||
130716213|NCT00667810|470588796|FG003|Overall Study|Lost to Follow-up|0|||
130716214|NCT00667810|470588793|FG000|Overall Study|Physician Decision|1|||
130716215|NCT00667810|470588794|FG001|Overall Study|Physician Decision|1|||
130716216|NCT00667810|470588795|FG002|Overall Study|Physician Decision|2|||
130716217|NCT00667810|470588796|FG003|Overall Study|Physician Decision|0|||
130716218|NCT00667810|470588793|FG000|Overall Study|Protocol Violation|0|||
130716219|NCT00667810|470588794|FG001|Overall Study|Protocol Violation|2|||
130716220|NCT00667810|470588795|FG002|Overall Study|Protocol Violation|0|||
130716221|NCT00667810|470588796|FG003|Overall Study|Protocol Violation|0|||
130716222|NCT00667810|470588793|FG000|Overall Study|Withdrawal by Subject|14|||
130716223|NCT00667810|470588794|FG001|Overall Study|Withdrawal by Subject|20|||
130716224|NCT00667810|470588795|FG002|Overall Study|Withdrawal by Subject|29|||
130716225|NCT00667810|470588796|FG003|Overall Study|Withdrawal by Subject|1|||
130716226|NCT00667810|470588793|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
130298421|NCT03626545|469056041|FG000|Overall Study|Adverse Event|3|||
130298422|NCT03626545|469056042|FG001|Overall Study|Adverse Event|13|||
130298423|NCT03626545|469056043|FG002|Overall Study|Adverse Event|10|||
130298424|NCT03626545|469056041|FG000|Overall Study|Physician Decision|1|||
130298425|NCT03626545|469056042|FG001|Overall Study|Physician Decision|18|||
130298426|NCT03626545|469056043|FG002|Overall Study|Physician Decision|14|||
130298427|NCT03626545|469056041|FG000|Overall Study|Subject Decision|0|||
130298428|NCT03626545|469056042|FG001|Overall Study|Subject Decision|5|||
130298429|NCT03626545|469056043|FG002|Overall Study|Subject Decision|5|||
130298430|NCT03626545|469056041|FG000|Overall Study|Death|1|||
130298431|NCT03626545|469056042|FG001|Overall Study|Death|1|||
130298432|NCT03626545|469056043|FG002|Overall Study|Death|1|||
130298433|NCT03626545|469056041|FG000|Overall Study|Protocol Deviation|0|||
130298434|NCT03626545|469056042|FG001|Overall Study|Protocol Deviation|1|||
130298435|NCT03626545|469056043|FG002|Overall Study|Protocol Deviation|1|||
130298436|NCT03626545|469056041|FG000|Overall Study|Guardian Decision|0|||
130298437|NCT03626545|469056042|FG001|Overall Study|Guardian Decision|0|||
130298438|NCT03626545|469056043|FG002|Overall Study|Guardian Decision|1|||
130298439|NCT01939366|469056046|FG000|Overall Study|Adverse Event|8|||
130716227|NCT00667810|470588794|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
130716228|NCT00667810|470588795|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
130298440|NCT01939366|469056047|FG001|Overall Study|Adverse Event|17|||
130298441|NCT01939366|469056048|FG002|Overall Study|Adverse Event|30|||
130298442|NCT01939366|469056049|FG003|Overall Study|Adverse Event|8|||
130298443|NCT01939366|469056050|FG004|Overall Study|Adverse Event|5|||
130557311|NCT01241552|470009959|FG002|Overall Study|Protocol Violation|6|||
130557312|NCT01241552|470009960|FG003|Overall Study|Protocol Violation|1|||
130557313|NCT01241552|470009957|FG000|Overall Study|Withdrawal by Subject|7|||
130557314|NCT01241552|470009958|FG001|Overall Study|Withdrawal by Subject|15|||
130557315|NCT01241552|470009959|FG002|Overall Study|Withdrawal by Subject|14|||
130716229|NCT00667810|470588796|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130716230|NCT00667810|470588793|FG000|Overall Study|Failed to Return|0|||
130298444|NCT01939366|469056046|FG000|Overall Study|Lack of Efficacy|2|||
130298445|NCT01939366|469056047|FG001|Overall Study|Lack of Efficacy|1|||
130298446|NCT01939366|469056048|FG002|Overall Study|Lack of Efficacy|1|||
130298447|NCT01939366|469056049|FG003|Overall Study|Lack of Efficacy|1|||
130298448|NCT01939366|469056050|FG004|Overall Study|Lack of Efficacy|3|||
130298449|NCT01939366|469056046|FG000|Overall Study|Lost to Follow-up|1|||
130298450|NCT01939366|469056047|FG001|Overall Study|Lost to Follow-up|1|||
130557316|NCT01241552|470009960|FG003|Overall Study|Withdrawal by Subject|15|||
130557317|NCT01241552|470009957|FG000|Overall Study|Physician Decision|2|||
130716231|NCT00667810|470588794|FG001|Overall Study|Failed to Return|0|||
130716232|NCT00667810|470588795|FG002|Overall Study|Failed to Return|2|||
130716233|NCT00667810|470588796|FG003|Overall Study|Failed to Return|0|||
130298451|NCT01939366|469056048|FG002|Overall Study|Lost to Follow-up|0|||
130298452|NCT01939366|469056049|FG003|Overall Study|Lost to Follow-up|0|||
130298453|NCT01939366|469056050|FG004|Overall Study|Lost to Follow-up|0|||
130298454|NCT01939366|469056046|FG000|Overall Study|Withdrawal by Subject|1|||
130298455|NCT01939366|469056047|FG001|Overall Study|Withdrawal by Subject|0|||
130298456|NCT01939366|469056048|FG002|Overall Study|Withdrawal by Subject|2|||
130298457|NCT01939366|469056049|FG003|Overall Study|Withdrawal by Subject|2|||
130298458|NCT01939366|469056050|FG004|Overall Study|Withdrawal by Subject|3|||
130298459|NCT01939366|469056046|FG000|Overall Study|Inclusion criteria not met|0|||
130298460|NCT01939366|469056047|FG001|Overall Study|Inclusion criteria not met|1|||
130298461|NCT01939366|469056048|FG002|Overall Study|Inclusion criteria not met|1|||
130298462|NCT01939366|469056049|FG003|Overall Study|Inclusion criteria not met|0|||
130298463|NCT01939366|469056050|FG004|Overall Study|Inclusion criteria not met|1|||
130298464|NCT01939366|469056046|FG000|Overall Study|Other|0|||
130298465|NCT01939366|469056047|FG001|Overall Study|Other|0|||
130298466|NCT01939366|469056048|FG002|Overall Study|Other|2|||
130298467|NCT01939366|469056049|FG003|Overall Study|Other|2|||
130298468|NCT01939366|469056050|FG004|Overall Study|Other|1|||
130298469|NCT01939366|469056046|FG000|Overall Study|Protocol Violation|0|||
130298470|NCT01939366|469056047|FG001|Overall Study|Protocol Violation|0|||
130298471|NCT01939366|469056048|FG002|Overall Study|Protocol Violation|0|||
130298472|NCT01939366|469056049|FG003|Overall Study|Protocol Violation|1|||
130298473|NCT01939366|469056050|FG004|Overall Study|Protocol Violation|0|||
130298474|NCT01939366|469056046|FG000|Overall Study|Sponsor decision|0|||
130298475|NCT01939366|469056047|FG001|Overall Study|Sponsor decision|0|||
130298476|NCT01939366|469056048|FG002|Overall Study|Sponsor decision|0|||
130298477|NCT01939366|469056049|FG003|Overall Study|Sponsor decision|0|||
130298478|NCT01939366|469056050|FG004|Overall Study|Sponsor decision|2|||
130298479|NCT01939366|469056046|FG000|Overall Study|GCP non-compliance at site|2|||
130298480|NCT01939366|469056047|FG001|Overall Study|GCP non-compliance at site|3|||
130298481|NCT01939366|469056048|FG002|Overall Study|GCP non-compliance at site|2|||
130298482|NCT01939366|469056049|FG003|Overall Study|GCP non-compliance at site|3|||
130298483|NCT01939366|469056050|FG004|Overall Study|GCP non-compliance at site|3|||
130298484|NCT02271945|469056055|FG000|Overall Study|Death|3|||
130298485|NCT02271945|469056056|FG001|Overall Study|Death|3|||
130298486|NCT02271945|469056055|FG000|Overall Study|Withdrawal by Subject|1|||
130298487|NCT02271945|469056056|FG001|Overall Study|Withdrawal by Subject|1|||
130298488|NCT02271945|469056055|FG000|Overall Study|Other|1|||
130298489|NCT02271945|469056056|FG001|Overall Study|Other|1|||
130298490|NCT00615030|469056057|FG000|Period I|Administrative problem|0|||
130298491|NCT00615030|469056058|FG001|Period I|Administrative problem|0|||
130298492|NCT00615030|469056059|FG002|Period I|Administrative problem|0|||
130298493|NCT00615030|469056060|FG003|Period I|Administrative problem|0|||
130298494|NCT00615030|469056061|FG004|Period I|Administrative problem|1|||
130298495|NCT00615030|469056062|FG005|Period I|Administrative problem|0|||
130298496|NCT00615030|469056063|FG006|Period I|Administrative problem|0|||
130298497|NCT00615030|469056064|FG007|Period I|Administrative problem|0|||
130298498|NCT00615030|469056065|FG008|Period I|Administrative problem|0|||
130298499|NCT00615030|469056066|FG009|Period I|Administrative problem|0|||
130298500|NCT00615030|469056067|FG010|Period I|Administrative problem|0|||
130298501|NCT00615030|469056068|FG011|Period I|Administrative problem|0|||
130298502|NCT00615030|469056057|FG000|Period I|Protocol deviation|1|||
130298503|NCT00615030|469056058|FG001|Period I|Protocol deviation|0|||
130298504|NCT00615030|469056059|FG002|Period I|Protocol deviation|0|||
130298505|NCT00615030|469056060|FG003|Period I|Protocol deviation|0|||
130298506|NCT00615030|469056061|FG004|Period I|Protocol deviation|0|||
130298507|NCT00615030|469056062|FG005|Period I|Protocol deviation|0|||
130298508|NCT00615030|469056063|FG006|Period I|Protocol deviation|0|||
130298509|NCT00615030|469056064|FG007|Period I|Protocol deviation|0|||
130298510|NCT00615030|469056065|FG008|Period I|Protocol deviation|0|||
130716234|NCT00667810|470588793|FG000|Overall Study|Loss of Caregiver|0|||
130716235|NCT00667810|470588794|FG001|Overall Study|Loss of Caregiver|1|||
130716236|NCT00667810|470588795|FG002|Overall Study|Loss of Caregiver|3|||
130716237|NCT00667810|470588796|FG003|Overall Study|Loss of Caregiver|0|||
130298511|NCT00615030|469056066|FG009|Period I|Protocol deviation|0|||
130716238|NCT00667810|470588793|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
130716239|NCT00667810|470588794|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
130298512|NCT00615030|469056067|FG010|Period I|Protocol deviation|0|||
130298513|NCT00615030|469056068|FG011|Period I|Protocol deviation|0|||
130716240|NCT00667810|470588795|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
130298514|NCT00615030|469056057|FG000|Period I|Subject withdrew consent|0|||
130298515|NCT00615030|469056058|FG001|Period I|Subject withdrew consent|0|||
130298516|NCT00615030|469056059|FG002|Period I|Subject withdrew consent|0|||
130298517|NCT00615030|469056060|FG003|Period I|Subject withdrew consent|0|||
130298518|NCT00615030|469056061|FG004|Period I|Subject withdrew consent|0|||
130716241|NCT00667810|470588796|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
130298519|NCT00615030|469056062|FG005|Period I|Subject withdrew consent|0|||
130298520|NCT00615030|469056063|FG006|Period I|Subject withdrew consent|0|||
130298521|NCT00615030|469056064|FG007|Period I|Subject withdrew consent|0|||
130298522|NCT00615030|469056065|FG008|Period I|Subject withdrew consent|1|||
130298523|NCT00615030|469056066|FG009|Period I|Subject withdrew consent|0|||
130298524|NCT00615030|469056067|FG010|Period I|Subject withdrew consent|1|||
130298525|NCT00615030|469056068|FG011|Period I|Subject withdrew consent|1|||
130298526|NCT00615030|469056057|FG000|Period I|Abnormal laboratory value(s)|0|||
130298527|NCT00615030|469056058|FG001|Period I|Abnormal laboratory value(s)|0|||
130298528|NCT00615030|469056059|FG002|Period I|Abnormal laboratory value(s)|0|||
130298529|NCT00615030|469056060|FG003|Period I|Abnormal laboratory value(s)|0|||
130298530|NCT00615030|469056061|FG004|Period I|Abnormal laboratory value(s)|0|||
130298531|NCT00615030|469056062|FG005|Period I|Abnormal laboratory value(s)|1|||
130298532|NCT00615030|469056063|FG006|Period I|Abnormal laboratory value(s)|0|||
130298533|NCT00615030|469056064|FG007|Period I|Abnormal laboratory value(s)|0|||
130298534|NCT00615030|469056065|FG008|Period I|Abnormal laboratory value(s)|0|||
130298535|NCT00615030|469056066|FG009|Period I|Abnormal laboratory value(s)|0|||
130298536|NCT00615030|469056067|FG010|Period I|Abnormal laboratory value(s)|0|||
130298537|NCT00615030|469056068|FG011|Period I|Abnormal laboratory value(s)|0|||
130298538|NCT00615030|469056057|FG000|Period II|Adverse Event|0|||
130298539|NCT00615030|469056058|FG001|Period II|Adverse Event|0|||
130298540|NCT00615030|469056059|FG002|Period II|Adverse Event|1|||
130298541|NCT00615030|469056060|FG003|Period II|Adverse Event|0|||
130298542|NCT00615030|469056061|FG004|Period II|Adverse Event|0|||
130298543|NCT00615030|469056062|FG005|Period II|Adverse Event|0|||
130298544|NCT00615030|469056063|FG006|Period II|Adverse Event|0|||
130298545|NCT00615030|469056064|FG007|Period II|Adverse Event|0|||
130298546|NCT00615030|469056065|FG008|Period II|Adverse Event|1|||
130298547|NCT00615030|469056066|FG009|Period II|Adverse Event|0|||
130298548|NCT00615030|469056067|FG010|Period II|Adverse Event|0|||
130298549|NCT00615030|469056068|FG011|Period II|Adverse Event|0|||
130298550|NCT00615030|469056057|FG000|Period II|Subject withdrew consent|0|||
130298551|NCT00615030|469056058|FG001|Period II|Subject withdrew consent|0|||
130298552|NCT00615030|469056059|FG002|Period II|Subject withdrew consent|0|||
130298553|NCT00615030|469056060|FG003|Period II|Subject withdrew consent|1|||
130298554|NCT00615030|469056061|FG004|Period II|Subject withdrew consent|0|||
130298555|NCT00615030|469056062|FG005|Period II|Subject withdrew consent|0|||
130461400|NCT05323734|469653951|FG000|Overall Study|Lack of Efficacy|1|||
130461401|NCT05323734|469653952|FG001|Overall Study|Lack of Efficacy|2|||
130461402|NCT05323734|469653951|FG000|Overall Study|Withdrawal by Subject|2|||
130461403|NCT05323734|469653952|FG001|Overall Study|Withdrawal by Subject|0|||
130461404|NCT05323734|469653951|FG000|Overall Study|Participant Withdrawn Due|0|||
130461405|NCT05323734|469653952|FG001|Overall Study|Participant Withdrawn Due|1|||
130461406|NCT00094575|469653953|FG000|Overall Study|Death|146|||
130461407|NCT00094575|469653954|FG001|Overall Study|Death|146|||
130461408|NCT00961636|469653958|FG000|Overall Study|Adverse Event|35|||
130461409|NCT00961636|469653959|FG001|Overall Study|Adverse Event|54|||
130461410|NCT00961636|469653960|FG002|Overall Study|Adverse Event|13|||
130461411|NCT00961636|469653958|FG000|Overall Study|Flushing Symptoms|29|||
130461412|NCT00961636|469653959|FG001|Overall Study|Flushing Symptoms|46|||
130461413|NCT00961636|469653960|FG002|Overall Study|Flushing Symptoms|3|||
130461414|NCT00961636|469653958|FG000|Overall Study|Lost to Follow-up|2|||
130461415|NCT00961636|469653959|FG001|Overall Study|Lost to Follow-up|3|||
130461416|NCT00961636|469653960|FG002|Overall Study|Lost to Follow-up|1|||
130461417|NCT00961636|469653958|FG000|Overall Study|Physician Decision|3|||
130461418|NCT00961636|469653959|FG001|Overall Study|Physician Decision|1|||
130461419|NCT00961636|469653960|FG002|Overall Study|Physician Decision|1|||
130461420|NCT00961636|469653958|FG000|Overall Study|Protocol Violation|9|||
130461421|NCT00961636|469653959|FG001|Overall Study|Protocol Violation|5|||
130461422|NCT00961636|469653960|FG002|Overall Study|Protocol Violation|1|||
130461423|NCT00961636|469653958|FG000|Overall Study|Withdrawal by Subject|29|||
130461424|NCT00961636|469653959|FG001|Overall Study|Withdrawal by Subject|22|||
130461425|NCT00961636|469653960|FG002|Overall Study|Withdrawal by Subject|13|||
130461426|NCT03603717|469653961|FG000|Overall Study|Lost to Follow-up|20|||
130298556|NCT00615030|469056063|FG006|Period II|Subject withdrew consent|1|||
130298557|NCT00615030|469056064|FG007|Period II|Subject withdrew consent|0|||
130298558|NCT00615030|469056065|FG008|Period II|Subject withdrew consent|0|||
130298559|NCT00615030|469056066|FG009|Period II|Subject withdrew consent|0|||
130298560|NCT00615030|469056067|FG010|Period II|Subject withdrew consent|0|||
130298561|NCT00615030|469056068|FG011|Period II|Subject withdrew consent|0|||
130298562|NCT00615030|469056057|FG000|Period III|Administrative problems|1|||
130298563|NCT00615030|469056058|FG001|Period III|Administrative problems|0|||
130298564|NCT00615030|469056059|FG002|Period III|Administrative problems|0|||
130298565|NCT00615030|469056060|FG003|Period III|Administrative problems|1|||
130298566|NCT00615030|469056061|FG004|Period III|Administrative problems|0|||
130298567|NCT00615030|469056062|FG005|Period III|Administrative problems|0|||
130298568|NCT00615030|469056063|FG006|Period III|Administrative problems|0|||
130298569|NCT00615030|469056064|FG007|Period III|Administrative problems|0|||
130298570|NCT00615030|469056065|FG008|Period III|Administrative problems|0|||
130298571|NCT00615030|469056066|FG009|Period III|Administrative problems|0|||
130461427|NCT03603717|469653962|FG001|Overall Study|Lost to Follow-up|20|||
130461428|NCT03603717|469653961|FG000|Overall Study|Withdrawal by Subject|16|||
130461429|NCT03603717|469653962|FG001|Overall Study|Withdrawal by Subject|10|||
130461430|NCT00732381|469653963|FG000|Overall Study|Adverse Event|1|||
130461431|NCT00732381|469653964|FG001|Overall Study|Adverse Event|0|||
130461432|NCT00732381|469653963|FG000|Overall Study|Treatment Failure|1|||
130461433|NCT00732381|469653964|FG001|Overall Study|Treatment Failure|1|||
130461434|NCT01350804|469653967|FG000|Core Study|Withdrawal by Subject|11|||
130461435|NCT01350804|469653968|FG001|Core Study|Withdrawal by Subject|17|||
130461436|NCT01350804|469653969|FG002|Core Study|Withdrawal by Subject|16|||
130461437|NCT01350804|469653970|FG003|Core Study|Withdrawal by Subject|7|||
130461438|NCT01350804|469653967|FG000|Core Study|Study terminated by Sponsor|0|||
130461439|NCT01350804|469653968|FG001|Core Study|Study terminated by Sponsor|0|||
130461440|NCT01350804|469653969|FG002|Core Study|Study terminated by Sponsor|0|||
130461441|NCT01350804|469653970|FG003|Core Study|Study terminated by Sponsor|2|||
130461442|NCT01350804|469653967|FG000|Core Study|Protocol deviation|1|||
130461443|NCT01350804|469653968|FG001|Core Study|Protocol deviation|0|||
130461444|NCT01350804|469653969|FG002|Core Study|Protocol deviation|1|||
130461445|NCT01350804|469653970|FG003|Core Study|Protocol deviation|0|||
130461446|NCT01350804|469653967|FG000|Core Study|Physician Decision|1|||
130461447|NCT01350804|469653968|FG001|Core Study|Physician Decision|0|||
130461448|NCT01350804|469653969|FG002|Core Study|Physician Decision|1|||
130461449|NCT01350804|469653970|FG003|Core Study|Physician Decision|3|||
130461450|NCT01350804|469653967|FG000|Core Study|Lost to Follow-up|3|||
130461451|NCT01350804|469653968|FG001|Core Study|Lost to Follow-up|0|||
130461452|NCT01350804|469653969|FG002|Core Study|Lost to Follow-up|2|||
130461453|NCT01350804|469653970|FG003|Core Study|Lost to Follow-up|1|||
130461454|NCT01350804|469653967|FG000|Core Study|Lack of Efficacy|16|||
130461455|NCT01350804|469653968|FG001|Core Study|Lack of Efficacy|19|||
130461456|NCT01350804|469653969|FG002|Core Study|Lack of Efficacy|18|||
130461457|NCT01350804|469653970|FG003|Core Study|Lack of Efficacy|5|||
130461458|NCT01350804|469653967|FG000|Core Study|Death|1|||
130461459|NCT01350804|469653968|FG001|Core Study|Death|1|||
130461460|NCT01350804|469653969|FG002|Core Study|Death|1|||
130461461|NCT01350804|469653970|FG003|Core Study|Death|0|||
130461462|NCT01350804|469653967|FG000|Core Study|Adverse Event|8|||
130461463|NCT01350804|469653968|FG001|Core Study|Adverse Event|10|||
130298572|NCT00615030|469056067|FG010|Period III|Administrative problems|0|||
130298573|NCT00615030|469056068|FG011|Period III|Administrative problems|0|||
130298574|NCT00151476|469056069|FG000|FAP Identified Subjects|Protocol Violation|0|||
130298575|NCT00151476|469056070|FG001|FAP Identified Subjects|Protocol Violation|1|||
130298576|NCT00151476|469056069|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
130298577|NCT00151476|469056070|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
130298578|NCT00151476|469056069|FG000|FAP Analyzed Subjects|Other study participation|0|||
130298579|NCT00151476|469056070|FG001|FAP Analyzed Subjects|Other study participation|1|||
130298580|NCT03446456|469056071|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130298581|NCT03446456|469056072|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130298582|NCT03446456|469056071|FG000|Overall Study|Lost to Follow-up|1|||
130298583|NCT03446456|469056072|FG001|Overall Study|Lost to Follow-up|3|||
130298584|NCT03446456|469056071|FG000|Overall Study|Participant failed the toxicology test|1|||
130298585|NCT03446456|469056072|FG001|Overall Study|Participant failed the toxicology test|0|||
130298586|NCT03446456|469056071|FG000|Overall Study|Break down of the experimental equipment|1|||
130298587|NCT03446456|469056072|FG001|Overall Study|Break down of the experimental equipment|0|||
130298588|NCT04099511|469056079|FG000|Overall Study|Lost to Follow-up|2|||
130298589|NCT04099511|469056080|FG001|Overall Study|Lost to Follow-up|2|||
130298590|NCT04099511|469056079|FG000|Overall Study|Withdrawal by Subject|8|||
130298591|NCT04099511|469056080|FG001|Overall Study|Withdrawal by Subject|4|||
130298592|NCT03002311|469056085|FG000|Overall Study|Lost to Follow-up|13|||
130298593|NCT03002311|469056086|FG001|Overall Study|Lost to Follow-up|26|||
130298594|NCT03002311|469056085|FG000|Overall Study|Referral provider called to schedule app|3|||
130298595|NCT03002311|469056086|FG001|Overall Study|Referral provider called to schedule app|3|||
130298596|NCT03002311|469056085|FG000|Overall Study|Physician Decision|3|||
130298597|NCT03002311|469056086|FG001|Overall Study|Physician Decision|1|||
130461464|NCT01350804|469653969|FG002|Core Study|Adverse Event|8|||
130461465|NCT01350804|469653970|FG003|Core Study|Adverse Event|8|||
130461466|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
130461467|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
130461468|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
130461469|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
130461470|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
130461471|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
130461472|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
130461473|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
130298598|NCT00320424|469056087|FG000|Overall Study|Adverse Event|3|||
130298599|NCT00320424|469056087|FG000|Overall Study|Other|3|||
130461474|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
130461475|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
130298600|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
130298601|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
130298602|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
130298603|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
130298604|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
130298605|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
130298606|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Death|1|||
130298607|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Death|4|||
130298608|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
130298609|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
130298610|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Not eligible|1|||
130298611|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Not eligible|2|||
130298612|NCT00658814|469056088|FG000|Consolidation Therapy|Not protocol specified|0|||
130298613|NCT00658814|469056089|FG001|Consolidation Therapy|Not protocol specified|1|||
130298614|NCT00658814|469056088|FG000|Consolidation Therapy|Not eligible|2|||
130298615|NCT00658814|469056089|FG001|Consolidation Therapy|Not eligible|2|||
130298616|NCT00658814|469056088|FG000|Maintenance Therapy|Adverse Event|1|||
130298617|NCT00658814|469056089|FG001|Maintenance Therapy|Adverse Event|1|||
130298618|NCT00658814|469056088|FG000|Maintenance Therapy|Not protocol specified|1|||
130298619|NCT00658814|469056089|FG001|Maintenance Therapy|Not protocol specified|0|||
130298620|NCT00658814|469056088|FG000|Maintenance Therapy|Not eligible|1|||
130298621|NCT00658814|469056089|FG001|Maintenance Therapy|Not eligible|0|||
130298622|NCT03270891|469056090|FG000|Overall Study|Lost to Follow-up|3|||
130298623|NCT03270891|469056091|FG001|Overall Study|Lost to Follow-up|6|||
130298624|NCT03270891|469056092|FG002|Overall Study|Lost to Follow-up|0|||
130298625|NCT03270891|469056090|FG000|Overall Study|Withdrawal by Subject|1|||
130298626|NCT03270891|469056091|FG001|Overall Study|Withdrawal by Subject|0|||
130298627|NCT03270891|469056092|FG002|Overall Study|Withdrawal by Subject|0|||
130298628|NCT03270891|469056090|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130298629|NCT03270891|469056091|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130298630|NCT03270891|469056092|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
130298631|NCT02540668|469056093|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
130298632|NCT02540668|469056094|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
130298633|NCT02883062|469056096|FG000|Overall Study|Withdrawal by Subject|6|||
130298634|NCT02883062|469056097|FG001|Overall Study|Withdrawal by Subject|0|||
130298635|NCT02888743|469056098|FG000|Overall Study|Withdrawal by Subject|1|||
130298636|NCT02888743|469056099|FG001|Overall Study|Withdrawal by Subject|2|||
130298637|NCT02888743|469056100|FG002|Overall Study|Withdrawal by Subject|2|||
130298638|NCT02888743|469056101|FG003|Overall Study|Withdrawal by Subject|0|||
130298639|NCT02888743|469056102|FG004|Overall Study|Withdrawal by Subject|1|||
130298640|NCT02888743|469056098|FG000|Overall Study|Disease progression before treatment|2|||
130298641|NCT02888743|469056099|FG001|Overall Study|Disease progression before treatment|0|||
130461476|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
130461477|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
130461478|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
130461479|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
130461480|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
130461481|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
130461482|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
130461483|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
130461484|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
130461485|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
130461486|NCT01350804|469653967|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
130461487|NCT01350804|469653968|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
130461488|NCT01350804|469653969|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
130461489|NCT01350804|469653970|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
130461490|NCT03175172|469656137|FG000|Overall Study|Death|3|||
130461491|NCT03175172|469656137|FG000|Overall Study|Withdrawal by Subject|3|||
130716242|NCT00667810|470588793|FG000|Overall Study|Other|6|||
130716243|NCT00667810|470588794|FG001|Overall Study|Other|6|||
130298642|NCT02888743|469056100|FG002|Overall Study|Disease progression before treatment|2|||
130716244|NCT00667810|470588795|FG002|Overall Study|Other|5|||
130298643|NCT02888743|469056101|FG003|Overall Study|Disease progression before treatment|0|||
130298644|NCT02888743|469056102|FG004|Overall Study|Disease progression before treatment|0|||
130716245|NCT00667810|470588796|FG003|Overall Study|Other|0|||
130298645|NCT02888743|469056098|FG000|Overall Study|Patient ineligible|1|||
130298646|NCT02888743|469056099|FG001|Overall Study|Patient ineligible|2|||
130716246|NCT00505375|470588799|FG000|Overall Study|Death|1|||
130298647|NCT02888743|469056100|FG002|Overall Study|Patient ineligible|0|||
130298648|NCT02888743|469056101|FG003|Overall Study|Patient ineligible|0|||
130298649|NCT02888743|469056102|FG004|Overall Study|Patient ineligible|0|||
130298650|NCT04816721|469056107|FG000|Overall Study|Withdrawal by Subject|0|||
130298651|NCT04816721|469056108|FG001|Overall Study|Withdrawal by Subject|2|||
130298652|NCT04816721|469056109|FG002|Overall Study|Withdrawal by Subject|0|||
130298653|NCT04816721|469056110|FG003|Overall Study|Withdrawal by Subject|1|||
130298654|NCT04816721|469056111|FG004|Overall Study|Withdrawal by Subject|1|||
130298655|NCT04816721|469056112|FG005|Overall Study|Withdrawal by Subject|0|||
130298656|NCT04816721|469056113|FG006|Overall Study|Withdrawal by Subject|0|||
130298657|NCT04816721|469056114|FG007|Overall Study|Withdrawal by Subject|0|||
130298658|NCT04816721|469056107|FG000|Overall Study|Miscellaneous|0|||
130298659|NCT04816721|469056108|FG001|Overall Study|Miscellaneous|0|||
130298660|NCT04816721|469056109|FG002|Overall Study|Miscellaneous|0|||
130298661|NCT04816721|469056110|FG003|Overall Study|Miscellaneous|0|||
130298662|NCT04816721|469056111|FG004|Overall Study|Miscellaneous|0|||
130298663|NCT04816721|469056112|FG005|Overall Study|Miscellaneous|1|||
130298664|NCT04816721|469056113|FG006|Overall Study|Miscellaneous|0|||
130298665|NCT04816721|469056114|FG007|Overall Study|Miscellaneous|0|||
130298666|NCT04816721|469056107|FG000|Overall Study|Lost to Follow-up|0|||
130298667|NCT04816721|469056108|FG001|Overall Study|Lost to Follow-up|0|||
130298668|NCT04816721|469056109|FG002|Overall Study|Lost to Follow-up|0|||
130298669|NCT04816721|469056110|FG003|Overall Study|Lost to Follow-up|1|||
130298670|NCT04816721|469056111|FG004|Overall Study|Lost to Follow-up|0|||
130298671|NCT04816721|469056112|FG005|Overall Study|Lost to Follow-up|0|||
130298672|NCT04816721|469056113|FG006|Overall Study|Lost to Follow-up|0|||
130298673|NCT04816721|469056114|FG007|Overall Study|Lost to Follow-up|0|||
130298674|NCT02708485|469056115|FG000|Overall Study|Withdrawal by Subject|3|||
130298675|NCT02708485|469056116|FG001|Overall Study|Withdrawal by Subject|2|||
130298676|NCT03266172|469056117|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
130298677|NCT03266172|469056118|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130298678|NCT03266172|469056119|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130298679|NCT03266172|469056117|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
130298680|NCT03266172|469056118|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
130298681|NCT03266172|469056119|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
130298682|NCT03266172|469056117|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
130298683|NCT03266172|469056118|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130298684|NCT03266172|469056119|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130298685|NCT03266172|469056117|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
130298686|NCT03266172|469056118|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
130298687|NCT03266172|469056119|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
130461492|NCT03175172|469656137|FG000|Overall Study|Lost to Follow-up|1|||
130461493|NCT03175172|469656137|FG000|Overall Study|Study Terminated by Sponsor|3|||
130461494|NCT01662336|469656138|FG000|Overall Study|Adverse Event|1|||
130461495|NCT01662336|469656138|FG000|Overall Study|No longer on LPV/r|30|||
130461496|NCT01662336|469656138|FG000|Overall Study|Other|29|||
130461497|NCT01662336|469656138|FG000|Overall Study|Withdrawal by Subject|6|||
130461498|NCT04668339|469656139|FG000|Overall Study|Physician Decision|1|||
130461499|NCT04668339|469656140|FG001|Overall Study|Physician Decision|0|||
130461500|NCT04668339|469656141|FG002|Overall Study|Physician Decision|1|||
130461501|NCT04668339|469656142|FG003|Overall Study|Physician Decision|1|||
130461502|NCT04668339|469656139|FG000|Overall Study|Lost to Follow-up|14|||
130461503|NCT04668339|469656140|FG001|Overall Study|Lost to Follow-up|12|||
130461504|NCT04668339|469656141|FG002|Overall Study|Lost to Follow-up|8|||
130461505|NCT04668339|469656142|FG003|Overall Study|Lost to Follow-up|5|||
130461506|NCT04668339|469656139|FG000|Overall Study|Adverse Event|0|||
130461507|NCT04668339|469656140|FG001|Overall Study|Adverse Event|0|||
130461508|NCT04668339|469656141|FG002|Overall Study|Adverse Event|1|||
130461509|NCT04668339|469656142|FG003|Overall Study|Adverse Event|0|||
130461510|NCT04668339|469656139|FG000|Overall Study|Other than specified|3|||
130461511|NCT04668339|469656140|FG001|Overall Study|Other than specified|0|||
130461512|NCT04668339|469656141|FG002|Overall Study|Other than specified|1|||
130461513|NCT04668339|469656142|FG003|Overall Study|Other than specified|0|||
130461514|NCT04668339|469656139|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
130461515|NCT04668339|469656140|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
130461516|NCT04668339|469656141|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
130461517|NCT04668339|469656142|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
130461518|NCT04668339|469656139|FG000|Overall Study|Vaccine not Administered|0|||
130461519|NCT04668339|469656140|FG001|Overall Study|Vaccine not Administered|0|||
130461520|NCT04668339|469656141|FG002|Overall Study|Vaccine not Administered|1|||
130461521|NCT04668339|469656142|FG003|Overall Study|Vaccine not Administered|0|||
130461522|NCT04668339|469656139|FG000|Overall Study|Protocol Violation|18|||
130461523|NCT04668339|469656140|FG001|Overall Study|Protocol Violation|23|||
130557318|NCT01241552|470009958|FG001|Overall Study|Physician Decision|4|||
130298688|NCT03266172|469056117|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298689|NCT03266172|469056118|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298690|NCT03266172|469056119|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130298691|NCT03266172|469056117|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298692|NCT03266172|469056118|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130557319|NCT01241552|470009959|FG002|Overall Study|Physician Decision|2|||
130557320|NCT01241552|470009960|FG003|Overall Study|Physician Decision|3|||
130557321|NCT01241552|470009957|FG000|Overall Study|Lost to Follow-up|2|||
130557322|NCT01241552|470009958|FG001|Overall Study|Lost to Follow-up|11|||
130557323|NCT01241552|470009959|FG002|Overall Study|Lost to Follow-up|15|||
130557324|NCT01241552|470009960|FG003|Overall Study|Lost to Follow-up|16|||
130557325|NCT00528567|470009961|FG000|Overall Study|Death|4|||
130557326|NCT00528567|470009962|FG001|Overall Study|Death|5|||
130557327|NCT00528567|470009961|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
130557328|NCT00528567|470009962|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
130557329|NCT00528567|470009961|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
130557330|NCT00528567|470009962|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
130557331|NCT00528567|470009961|FG000|Overall Study|Violation Criteria at Entry|3|||
130716247|NCT00505375|470588800|FG001|Overall Study|Death|0|||
130716248|NCT00505375|470588799|FG000|Overall Study|Withdrawal by Subject|2|||
130716249|NCT00505375|470588800|FG001|Overall Study|Withdrawal by Subject|2|||
130716250|NCT00505375|470588799|FG000|Overall Study|Lost to Follow-up|0|||
130716251|NCT00505375|470588800|FG001|Overall Study|Lost to Follow-up|2|||
130716252|NCT00505375|470588799|FG000|Overall Study|Pregnancy|1|||
130716253|NCT00505375|470588800|FG001|Overall Study|Pregnancy|0|||
130716254|NCT00505375|470588799|FG000|Overall Study|Travel issues|0|||
130716255|NCT00505375|470588800|FG001|Overall Study|Travel issues|1|||
130716256|NCT01561430|470588803|FG000|Overall Study|Adverse Event|0|||
130716257|NCT01561430|470588804|FG001|Overall Study|Adverse Event|0|||
130716258|NCT01561430|470588805|FG002|Overall Study|Adverse Event|3|||
130716259|NCT01561430|470588806|FG003|Overall Study|Adverse Event|1|||
130716260|NCT01561430|470588803|FG000|Overall Study|Withdrawal by Subject|0|||
130716261|NCT01561430|470588804|FG001|Overall Study|Withdrawal by Subject|0|||
130716262|NCT01561430|470588805|FG002|Overall Study|Withdrawal by Subject|1|||
130716263|NCT01561430|470588806|FG003|Overall Study|Withdrawal by Subject|0|||
130716264|NCT01561430|470588803|FG000|Overall Study|Physician Decision|0|||
130716265|NCT01561430|470588804|FG001|Overall Study|Physician Decision|1|||
130716266|NCT01561430|470588805|FG002|Overall Study|Physician Decision|0|||
130716267|NCT01561430|470588806|FG003|Overall Study|Physician Decision|0|||
130716268|NCT01561430|470588803|FG000|Overall Study|Sponsor Decision|1|||
130716269|NCT01561430|470588804|FG001|Overall Study|Sponsor Decision|14|||
130716270|NCT01561430|470588805|FG002|Overall Study|Sponsor Decision|13|||
130298693|NCT03266172|469056119|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130298694|NCT01554514|469056122|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
130298695|NCT01554514|469056122|FG000|Overall Study|Physician Decision|1|||
130298696|NCT00300365|469056123|FG000|Overall Study|Lost to Follow-up|1|||
130298697|NCT00300365|469056124|FG001|Overall Study|Lost to Follow-up|0|||
130298698|NCT00300365|469056123|FG000|Overall Study|Physician Decision|2|||
130298699|NCT00300365|469056124|FG001|Overall Study|Physician Decision|0|||
130298700|NCT00300365|469056123|FG000|Overall Study|Withdrawal by Subject|1|||
130298701|NCT00300365|469056124|FG001|Overall Study|Withdrawal by Subject|0|||
130298702|NCT00300365|469056123|FG000|Overall Study|Adverse Event|0|||
130298703|NCT00300365|469056124|FG001|Overall Study|Adverse Event|2|||
130298704|NCT00290498|469056125|FG000|Overall Study|Death|2|||
130298705|NCT00290498|469056126|FG001|Overall Study|Death|0|||
130298706|NCT00290498|469056125|FG000|Overall Study|Physician Decision|1|||
130298707|NCT00290498|469056126|FG001|Overall Study|Physician Decision|0|||
130298708|NCT00290498|469056125|FG000|Overall Study|Withdrawal by Subject|1|||
130298709|NCT00290498|469056126|FG001|Overall Study|Withdrawal by Subject|0|||
130298710|NCT00290498|469056125|FG000|Overall Study|Ineligible|3|||
130298711|NCT00290498|469056126|FG001|Overall Study|Ineligible|0|||
130298712|NCT00290498|469056125|FG000|Overall Study|Non-Compliance|1|||
130298713|NCT00290498|469056126|FG001|Overall Study|Non-Compliance|0|||
130298714|NCT01716104|469056128|FG000|Overall Study|Do not meet inclusion criteria|6|||
130298715|NCT01716104|469056129|FG001|Overall Study|Do not meet inclusion criteria|7|||
130298716|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298717|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130298718|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298719|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298720|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
130557332|NCT00528567|470009962|FG001|Overall Study|Violation Criteria at Entry|17|||
130557333|NCT00528567|470009961|FG000|Overall Study|Withdrew Consent|59|||
130557334|NCT00528567|470009962|FG001|Overall Study|Withdrew Consent|55|||
130716271|NCT01561430|470588806|FG003|Overall Study|Sponsor Decision|12|||
130716272|NCT03709823|470588807|FG000|Overall Study|Adverse Event|0|||
130716273|NCT03709823|470588808|FG001|Overall Study|Adverse Event|0|||
130298721|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
130298722|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130298723|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130298724|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298725|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
130298726|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298727|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298728|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
130298729|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
130298730|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
130298731|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
130298732|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298733|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298734|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298735|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
130298736|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130298737|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130298738|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130298739|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130298740|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
130298741|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
130298742|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
130298743|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
130298744|NCT05026853|469056134|FG000|Overall Study|Cancelled appointment|1|||
130298745|NCT05026853|469056135|FG001|Overall Study|Cancelled appointment|0|||
130298746|NCT05026853|469056134|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
130298747|NCT05026853|469056135|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
130298748|NCT05026853|469056134|FG000|Overall Study|Did not complete 12-week survey|16|||
130298749|NCT05026853|469056135|FG001|Overall Study|Did not complete 12-week survey|16|||
130298750|NCT03615066|469056136|FG000|Main Study|Withdrew Consent|0|||
130298751|NCT03615066|469056137|FG001|Main Study|Withdrew Consent|1|||
130298752|NCT03615066|469056138|FG002|Main Study|Withdrew Consent|1|||
130298753|NCT03615066|469056136|FG000|Main Study|Lost to Follow-up|0|||
130298754|NCT03615066|469056137|FG001|Main Study|Lost to Follow-up|0|||
130298755|NCT03615066|469056138|FG002|Main Study|Lost to Follow-up|1|||
130298756|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
130298757|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130298758|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130298759|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
130298760|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130298761|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130298762|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130298763|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
130298764|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130298765|NCT00129961|469056139|FG000|Overall Study|Adverse Event|1|||
130298766|NCT00129961|469056140|FG001|Overall Study|Adverse Event|0|||
130298767|NCT00129961|469056139|FG000|Overall Study|Death|1|||
130298768|NCT00129961|469056140|FG001|Overall Study|Death|1|||
130298769|NCT00129961|469056139|FG000|Overall Study|Withdrawal by Sponsor|14|||
130298770|NCT00129961|469056140|FG001|Overall Study|Withdrawal by Sponsor|20|||
130298771|NCT00129961|469056139|FG000|Overall Study|Physician Decision|1|||
130298772|NCT00129961|469056140|FG001|Overall Study|Physician Decision|0|||
130298773|NCT00129961|469056139|FG000|Overall Study|Withdrawal by Subject|2|||
130298774|NCT00129961|469056140|FG001|Overall Study|Withdrawal by Subject|1|||
130298775|NCT00129961|469056139|FG000|Overall Study|Missing Record|0|||
130298776|NCT00129961|469056140|FG001|Overall Study|Missing Record|1|||
130461524|NCT04668339|469656141|FG002|Overall Study|Protocol Violation|12|||
130461525|NCT04668339|469656142|FG003|Overall Study|Protocol Violation|20|||
130461526|NCT04668339|469656139|FG000|Overall Study|Withdrawal by Subject|45|||
130461527|NCT04668339|469656140|FG001|Overall Study|Withdrawal by Subject|46|||
130461528|NCT04668339|469656141|FG002|Overall Study|Withdrawal by Subject|46|||
130461529|NCT04668339|469656142|FG003|Overall Study|Withdrawal by Subject|27|||
130461530|NCT04668339|469656139|FG000|Overall Study|Study Terminated by Sponsor|59|||
130461531|NCT04668339|469656140|FG001|Overall Study|Study Terminated by Sponsor|59|||
130461532|NCT04668339|469656141|FG002|Overall Study|Study Terminated by Sponsor|71|||
130461533|NCT04668339|469656142|FG003|Overall Study|Study Terminated by Sponsor|1|||
130461534|NCT03622593|469656143|FG000|Overall Study|Withdrawal by Subject|11|||
130461535|NCT03622593|469656144|FG001|Overall Study|Withdrawal by Subject|9|||
130461536|NCT03622593|469656145|FG002|Overall Study|Withdrawal by Subject|13|||
130557335|NCT00528567|470009961|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
130557336|NCT00528567|470009962|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
130298777|NCT00694304|469056144|FG000|Overall Study|Adverse Event|42|||
130298778|NCT00694304|469056144|FG000|Overall Study|Lack of Efficacy|35|||
130298779|NCT00694304|469056144|FG000|Overall Study|Non-compliance With Study Product|16|||
130298780|NCT00694304|469056144|FG000|Overall Study|Protocol Violation|6|||
130298781|NCT00694304|469056144|FG000|Overall Study|Withdrawal of Consent|61|||
130298782|NCT00694304|469056144|FG000|Overall Study|Lost to Follow-up|15|||
130298783|NCT00694304|469056144|FG000|Overall Study|Administrative or Other Reasons|32|||
130298784|NCT01270256|469056145|FG000|Overall Study|Withdrawal by Subject|1|||
130298785|NCT01270256|469056146|FG001|Overall Study|Withdrawal by Subject|0|||
130298786|NCT04407234|469056155|FG000|Overall Study|Adverse Event|3|||
130298787|NCT04407234|469056156|FG001|Overall Study|Adverse Event|3|||
130298788|NCT00727558|469056157|FG000|Overall Study|Lens issue|0|||
130298789|NCT00727558|469056158|FG001|Overall Study|Lens issue|1|||
130298790|NCT00727558|469056157|FG000|Overall Study|Adverse Event|0|||
130298791|NCT00727558|469056158|FG001|Overall Study|Adverse Event|1|||
130298792|NCT00727558|469056157|FG000|Overall Study|Subject unable to return for follow-up|1|||
130298793|NCT00727558|469056158|FG001|Overall Study|Subject unable to return for follow-up|1|||
130298794|NCT00727558|469056157|FG000|Overall Study|Lost to Follow-up|1|||
130298795|NCT00727558|469056158|FG001|Overall Study|Lost to Follow-up|0|||
130298796|NCT01754493|469057806|FG000|Overall Study|Adverse Event|1|||
130298797|NCT01754493|469057806|FG000|Overall Study|Lost to Follow-up|3|||
130298798|NCT01754493|469057806|FG000|Overall Study|Withdrawal by Subject|1|||
130298799|NCT01754493|469057806|FG000|Overall Study|Moved out of town|1|||
130298800|NCT01754493|469057806|FG000|Overall Study|Scheduling conflict|1|||
130298801|NCT01543776|469057807|FG000|Overall Study|Withdrawal by Subject|2|||
130298802|NCT01543776|469057808|FG001|Overall Study|Withdrawal by Subject|2|||
130298803|NCT00568126|469057809|FG000|Overall Study|Adverse Event|3|||
130298804|NCT00568126|469057810|FG001|Overall Study|Adverse Event|0|||
130298805|NCT00568126|469057809|FG000|Overall Study|Withdrawal by Subject|2|||
130298806|NCT00568126|469057810|FG001|Overall Study|Withdrawal by Subject|3|||
130298807|NCT00568126|469057809|FG000|Overall Study|Lost to Follow-up|4|||
130298808|NCT00568126|469057810|FG001|Overall Study|Lost to Follow-up|3|||
130298809|NCT00568126|469057809|FG000|Overall Study|Lack of Efficacy|0|||
130298810|NCT00568126|469057810|FG001|Overall Study|Lack of Efficacy|1|||
130298811|NCT00568126|469057809|FG000|Overall Study|Physician Decision|2|||
130298812|NCT00568126|469057810|FG001|Overall Study|Physician Decision|2|||
130298813|NCT04395690|469057811|FG000|Overall Study|Lost to Follow-up|1|||
130298814|NCT04395690|469057812|FG001|Overall Study|Lost to Follow-up|1|||
130298815|NCT02421588|469057813|FG000|Overall Study|Non-treatment-related AE|8|||
130298816|NCT02421588|469057814|FG001|Overall Study|Non-treatment-related AE|8|||
130298817|NCT02421588|469057813|FG000|Overall Study|Progressive disease|152|||
130298818|NCT02421588|469057814|FG001|Overall Study|Progressive disease|135|||
130298819|NCT02421588|469057813|FG000|Overall Study|Death|11|||
130298820|NCT02421588|469057814|FG001|Overall Study|Death|3|||
130298821|NCT02421588|469057813|FG000|Overall Study|Physician Decision|8|||
130298822|NCT02421588|469057814|FG001|Overall Study|Physician Decision|17|||
130298823|NCT02421588|469057813|FG000|Overall Study|Other reason not specified|3|||
130298824|NCT02421588|469057814|FG001|Overall Study|Other reason not specified|1|||
130298825|NCT02421588|469057813|FG000|Overall Study|Symptomatic deterioration|13|||
130298826|NCT02421588|469057814|FG001|Overall Study|Symptomatic deterioration|19|||
130298827|NCT02421588|469057813|FG000|Overall Study|Treatment-related AE|10|||
130298828|NCT02421588|469057814|FG001|Overall Study|Treatment-related AE|14|||
130298829|NCT02421588|469057813|FG000|Overall Study|Withdrawal by Subject|14|||
130298830|NCT02421588|469057814|FG001|Overall Study|Withdrawal by Subject|16|||
130298831|NCT02421588|469057813|FG000|Overall Study|Not treated|2|||
130298832|NCT02421588|469057814|FG001|Overall Study|Not treated|8|||
130298833|NCT02649894|469057820|FG000|Overall Study|Adverse Event|1|||
130298834|NCT02649894|469057821|FG001|Overall Study|Adverse Event|0|||
130372660|NCT03129100|469333344|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
130298835|NCT02649894|469057820|FG000|Overall Study|Physician Decision|0|||
130298836|NCT02649894|469057821|FG001|Overall Study|Physician Decision|1|||
130298837|NCT02649894|469057820|FG000|Overall Study|Withdrawal by Subject|5|||
130298838|NCT02649894|469057821|FG001|Overall Study|Withdrawal by Subject|2|||
130298839|NCT02649894|469057820|FG000|Overall Study|Lost to Follow-up|2|||
130298840|NCT02649894|469057821|FG001|Overall Study|Lost to Follow-up|1|||
130298841|NCT02649894|469057820|FG000|Overall Study|Death|30|||
130298842|NCT02649894|469057821|FG001|Overall Study|Death|7|||
130298843|NCT02649894|469057820|FG000|Overall Study|Other, not specified|6|||
130298844|NCT02649894|469057821|FG001|Overall Study|Other, not specified|0|||
130461537|NCT03622593|469656143|FG000|Overall Study|Death|12|||
130298845|NCT00719680|469057822|FG000|Overall Study|Adverse Event|1|||
130298846|NCT00719680|469057822|FG000|Overall Study|Lost to Follow-up|1|||
130298847|NCT00719680|469057822|FG000|Overall Study|Withdrawal by Subject|3|||
130298848|NCT04071158|469057823|FG000|Overall Study|Lost to Follow-up|1|||
130298849|NCT04071158|469057824|FG001|Overall Study|Lost to Follow-up|2|||
130298850|NCT04071158|469057825|FG002|Overall Study|Lost to Follow-up|3|||
130298851|NCT04071158|469057826|FG003|Overall Study|Lost to Follow-up|3|||
130298852|NCT04071158|469057827|FG004|Overall Study|Lost to Follow-up|5|||
130298853|NCT04071158|469057823|FG000|Overall Study|Randomized but not treated|2|||
130298854|NCT04071158|469057824|FG001|Overall Study|Randomized but not treated|2|||
130298855|NCT04071158|469057825|FG002|Overall Study|Randomized but not treated|0|||
130298856|NCT04071158|469057826|FG003|Overall Study|Randomized but not treated|0|||
130298857|NCT04071158|469057827|FG004|Overall Study|Randomized but not treated|0|||
130298858|NCT01286740|469057828|FG000|Overall Study|Enrolled but not treated|1|||
130298859|NCT01286740|469057828|FG000|Overall Study|Protocol Violation|1|||
130298860|NCT01110382|469057830|FG000|Overall Study|Withdrawal by Subject|0|||
130298861|NCT01110382|469057831|FG001|Overall Study|Withdrawal by Subject|1|||
130298862|NCT01110382|469057830|FG000|Overall Study|Protocol Violation|0|||
130298863|NCT01110382|469057831|FG001|Overall Study|Protocol Violation|1|||
130298864|NCT05222555|469057832|FG000|Overall Study|Ongoing|2|||
130298865|NCT05222555|469057833|FG001|Overall Study|Ongoing|18|||
130298866|NCT05222555|469057832|FG000|Overall Study|Adverse Event|1|||
130298867|NCT05222555|469057833|FG001|Overall Study|Adverse Event|1|||
130298868|NCT05222555|469057832|FG000|Overall Study|Death|0|||
130298869|NCT05222555|469057833|FG001|Overall Study|Death|6|||
130298870|NCT05222555|469057832|FG000|Overall Study|Withdrawal by Subject|0|||
130298871|NCT05222555|469057833|FG001|Overall Study|Withdrawal by Subject|11|||
130298872|NCT01422824|469057834|FG000|Overall Study|Case record form not evaluated|1|||
130298873|NCT01422824|469057834|FG000|Overall Study|Lost to Follow-up|37|||
130298874|NCT00902174|469057835|FG000|Overall Study|Adverse Event|27|||
130298875|NCT00902174|469057836|FG001|Overall Study|Adverse Event|7|||
130298876|NCT00902174|469057835|FG000|Overall Study|Lack of Efficacy|1|||
130298877|NCT00902174|469057836|FG001|Overall Study|Lack of Efficacy|5|||
130298878|NCT00902174|469057835|FG000|Overall Study|Death|2|||
130298879|NCT00902174|469057836|FG001|Overall Study|Death|2|||
130298880|NCT00902174|469057835|FG000|Overall Study|Withdrawal by Subject|2|||
130298881|NCT00902174|469057836|FG001|Overall Study|Withdrawal by Subject|1|||
130298882|NCT00902174|469057835|FG000|Overall Study|Abnormal labs|1|||
130298883|NCT00902174|469057836|FG001|Overall Study|Abnormal labs|1|||
130298884|NCT00902174|469057835|FG000|Overall Study|Protocol Violation|1|||
130298885|NCT00902174|469057836|FG001|Overall Study|Protocol Violation|1|||
130298886|NCT00902174|469057835|FG000|Overall Study|Administration problem|0|||
130298887|NCT00902174|469057836|FG001|Overall Study|Administration problem|1|||
130298888|NCT01581619|469057837|FG000|Overall Study|Withdrawal by Subject|1|||
130298889|NCT01581619|469057837|FG000|Overall Study|Lost to Follow-up|1|||
130298890|NCT03129360|469057840|FG000|Overall Study|Did not meet entry criteria|0|||
130298891|NCT03129360|469057841|FG001|Overall Study|Did not meet entry criteria|2|||
130298892|NCT03129360|469057842|FG002|Overall Study|Did not meet entry criteria|1|||
130298893|NCT03129360|469057840|FG000|Overall Study|Excluded due to motion in scanner|1|||
130298894|NCT03129360|469057841|FG001|Overall Study|Excluded due to motion in scanner|0|||
130298895|NCT03129360|469057842|FG002|Overall Study|Excluded due to motion in scanner|0|||
130298896|NCT03006887|469057843|FG000|Overall Study|Adverse Event|1|||
130298897|NCT03836677|469057844|FG000|Period 1|Adverse Event|0|||
130298898|NCT03836677|469057845|FG001|Period 1|Adverse Event|1|||
130298899|NCT03836677|469057844|FG000|Period 2|Severe non-compliance to protocol|1|||
130298900|NCT03836677|469057845|FG001|Period 2|Severe non-compliance to protocol|0|||
130298901|NCT01353911|469057846|FG000|Overall Study|Lost to Follow-up|2|||
130298902|NCT01353911|469057847|FG001|Overall Study|Lost to Follow-up|6|||
130298903|NCT01353911|469057848|FG002|Overall Study|Lost to Follow-up|4|||
130298904|NCT01353911|469057849|FG003|Overall Study|Lost to Follow-up|0|||
130298905|NCT01353911|469057850|FG004|Overall Study|Lost to Follow-up|4|||
130298906|NCT01353911|469057851|FG005|Overall Study|Lost to Follow-up|4|||
130298907|NCT01353911|469057852|FG006|Overall Study|Lost to Follow-up|3|||
130298908|NCT01353911|469057853|FG007|Overall Study|Lost to Follow-up|6|||
130298909|NCT01353911|469057846|FG000|Overall Study|Withdrawal by Subject|2|||
130298910|NCT01353911|469057847|FG001|Overall Study|Withdrawal by Subject|3|||
130298911|NCT01353911|469057848|FG002|Overall Study|Withdrawal by Subject|4|||
130298912|NCT01353911|469057849|FG003|Overall Study|Withdrawal by Subject|2|||
130298913|NCT01353911|469057850|FG004|Overall Study|Withdrawal by Subject|2|||
130298914|NCT01353911|469057851|FG005|Overall Study|Withdrawal by Subject|3|||
130298915|NCT01353911|469057852|FG006|Overall Study|Withdrawal by Subject|3|||
130372661|NCT03129100|469333345|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
130372662|NCT03129100|469333346|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372663|NCT03129100|469333347|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372664|NCT03129100|469333348|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372665|NCT03129100|469333349|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372666|NCT03129100|469333350|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372667|NCT03129100|469333351|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372668|NCT03129100|469333352|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372669|NCT03129100|469333353|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372670|NCT03129100|469333354|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372671|NCT03129100|469333355|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372672|NCT03129100|469333356|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130298916|NCT01353911|469057853|FG007|Overall Study|Withdrawal by Subject|9|||
130298917|NCT01353911|469057846|FG000|Overall Study|Status Not Recorded|4|||
130298918|NCT01353911|469057847|FG001|Overall Study|Status Not Recorded|0|||
130298919|NCT01353911|469057848|FG002|Overall Study|Status Not Recorded|1|||
130298920|NCT01353911|469057849|FG003|Overall Study|Status Not Recorded|0|||
130298921|NCT01353911|469057850|FG004|Overall Study|Status Not Recorded|0|||
130298922|NCT01353911|469057851|FG005|Overall Study|Status Not Recorded|0|||
130298923|NCT01353911|469057852|FG006|Overall Study|Status Not Recorded|0|||
130461538|NCT03622593|469656144|FG001|Overall Study|Death|9|||
130461539|NCT03622593|469656145|FG002|Overall Study|Death|10|||
130298924|NCT01353911|469057853|FG007|Overall Study|Status Not Recorded|0|||
130298925|NCT00462748|469057858|FG000|Overall Study|Adverse Event|7|||
130298926|NCT00462748|469057859|FG001|Overall Study|Adverse Event|5|||
130298927|NCT00462748|469057860|FG002|Overall Study|Adverse Event|9|||
130298928|NCT00462748|469057858|FG000|Overall Study|Protocol Violation|0|||
130298929|NCT00462748|469057859|FG001|Overall Study|Protocol Violation|2|||
130298930|NCT00462748|469057860|FG002|Overall Study|Protocol Violation|1|||
130298931|NCT00462748|469057858|FG000|Overall Study|Withdrew consent|3|||
130298932|NCT00462748|469057859|FG001|Overall Study|Withdrew consent|3|||
130298933|NCT00462748|469057860|FG002|Overall Study|Withdrew consent|0|||
130298934|NCT00462748|469057858|FG000|Overall Study|Lost to Follow-up|1|||
130298935|NCT00462748|469057859|FG001|Overall Study|Lost to Follow-up|1|||
130298936|NCT00462748|469057860|FG002|Overall Study|Lost to Follow-up|1|||
130298937|NCT00462748|469057858|FG000|Overall Study|Discontinued after 41 days Rx|1|||
130298938|NCT00462748|469057859|FG001|Overall Study|Discontinued after 41 days Rx|0|||
130298939|NCT00462748|469057860|FG002|Overall Study|Discontinued after 41 days Rx|0|||
130298940|NCT03233438|469057861|FG000|Overall Study|Lost to Follow-up|4|||
130298941|NCT03233438|469057862|FG001|Overall Study|Lost to Follow-up|9|||
130298942|NCT03233438|469057861|FG000|Overall Study|Withdrawal by Subject|2|||
130298943|NCT03233438|469057862|FG001|Overall Study|Withdrawal by Subject|1|||
130298944|NCT03233438|469057861|FG000|Overall Study|No recording of dalbavancin|0|||
130298945|NCT03233438|469057862|FG001|Overall Study|No recording of dalbavancin|1|||
130298946|NCT03429543|469057863|FG000|Overall Study|Adverse Event|1|||
130298947|NCT03429543|469057864|FG001|Overall Study|Adverse Event|1|||
130298948|NCT03429543|469057865|FG002|Overall Study|Adverse Event|0|||
130298949|NCT03429543|469057866|FG003|Overall Study|Adverse Event|0|||
130298950|NCT03429543|469057867|FG004|Overall Study|Adverse Event|0|||
130298951|NCT03429543|469057868|FG005|Overall Study|Adverse Event|2|||
130298952|NCT03429543|469057869|FG006|Overall Study|Adverse Event|0|||
130298953|NCT03429543|469057863|FG000|Overall Study|Lost to Follow-up|1|||
130298954|NCT03429543|469057864|FG001|Overall Study|Lost to Follow-up|0|||
130298955|NCT03429543|469057865|FG002|Overall Study|Lost to Follow-up|0|||
130298956|NCT03429543|469057866|FG003|Overall Study|Lost to Follow-up|0|||
130298957|NCT03429543|469057867|FG004|Overall Study|Lost to Follow-up|1|||
130298958|NCT03429543|469057868|FG005|Overall Study|Lost to Follow-up|0|||
130298959|NCT03429543|469057869|FG006|Overall Study|Lost to Follow-up|0|||
130298960|NCT03429543|469057863|FG000|Overall Study|Withdrawal by Subject|5|||
130298961|NCT03429543|469057864|FG001|Overall Study|Withdrawal by Subject|0|||
130298962|NCT03429543|469057865|FG002|Overall Study|Withdrawal by Subject|1|||
130298963|NCT03429543|469057866|FG003|Overall Study|Withdrawal by Subject|2|||
130298964|NCT03429543|469057867|FG004|Overall Study|Withdrawal by Subject|6|||
130298965|NCT03429543|469057868|FG005|Overall Study|Withdrawal by Subject|3|||
130298966|NCT03429543|469057869|FG006|Overall Study|Withdrawal by Subject|1|||
130298967|NCT03429543|469057863|FG000|Overall Study|Other reason than listed|0|||
130298968|NCT03429543|469057864|FG001|Overall Study|Other reason than listed|1|||
130298969|NCT03429543|469057865|FG002|Overall Study|Other reason than listed|0|||
130298970|NCT03429543|469057866|FG003|Overall Study|Other reason than listed|0|||
130372673|NCT03129100|469333357|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372674|NCT03129100|469333358|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372675|NCT03129100|469333359|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372676|NCT03129100|469333360|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372677|NCT03129100|469333361|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372678|NCT03129100|469333362|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372679|NCT03129100|469333363|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130372680|NCT03129100|469333364|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130461540|NCT03622593|469656143|FG000|Overall Study|Lost to Follow-up|11|||
130461541|NCT03622593|469656144|FG001|Overall Study|Lost to Follow-up|5|||
130461542|NCT03622593|469656145|FG002|Overall Study|Lost to Follow-up|8|||
130461543|NCT03622593|469656143|FG000|Overall Study|Adverse Event|4|||
130461544|NCT03622593|469656144|FG001|Overall Study|Adverse Event|5|||
130461545|NCT03622593|469656145|FG002|Overall Study|Adverse Event|6|||
130461546|NCT03622593|469656143|FG000|Overall Study|Physician Decision|2|||
130461547|NCT03622593|469656144|FG001|Overall Study|Physician Decision|1|||
130461548|NCT03622593|469656145|FG002|Overall Study|Physician Decision|6|||
130461549|NCT03622593|469656143|FG000|Overall Study|Other|2|||
130461550|NCT03622593|469656144|FG001|Overall Study|Other|2|||
130461551|NCT03622593|469656145|FG002|Overall Study|Other|3|||
130461552|NCT03622593|469656143|FG000|Overall Study|Protocol Violation|0|||
130461553|NCT03622593|469656144|FG001|Overall Study|Protocol Violation|0|||
130461554|NCT03622593|469656145|FG002|Overall Study|Protocol Violation|1|||
130461555|NCT03622593|469656143|FG000|Overall Study|Pregnancy|0|||
130461556|NCT03622593|469656144|FG001|Overall Study|Pregnancy|0|||
130298971|NCT03429543|469057867|FG004|Overall Study|Other reason than listed|4|||
130298972|NCT03429543|469057868|FG005|Overall Study|Other reason than listed|4|||
130461557|NCT03622593|469656145|FG002|Overall Study|Pregnancy|1|||
130461558|NCT03762668|469656146|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
130461559|NCT03762668|469656147|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
130461560|NCT01393119|469656148|FG000|Overall Study|Adverse Event|1|||
130716274|NCT03709823|470588809|FG002|Overall Study|Adverse Event|1|||
130298973|NCT03429543|469057869|FG006|Overall Study|Other reason than listed|0|||
130298974|NCT03429543|469057863|FG000|Overall Study|Not treated|0|||
130298975|NCT03429543|469057864|FG001|Overall Study|Not treated|0|||
130298976|NCT03429543|469057865|FG002|Overall Study|Not treated|0|||
130298977|NCT03429543|469057866|FG003|Overall Study|Not treated|0|||
130298978|NCT03429543|469057867|FG004|Overall Study|Not treated|1|||
130298979|NCT03429543|469057868|FG005|Overall Study|Not treated|0|||
130298980|NCT03429543|469057869|FG006|Overall Study|Not treated|0|||
130298981|NCT01818492|469057870|FG000|Overall Study|Adverse Event|2|||
130298982|NCT01818492|469057870|FG000|Overall Study|Death|3|||
130298983|NCT01818492|469057870|FG000|Overall Study|Withdrawal by Subject|1|||
130298984|NCT01818492|469057870|FG000|Overall Study|Additional therapy when not allowed PP|4|||
130298985|NCT01729208|469057871|FG000|Baseline|Physician Decision|5|||
130298986|NCT01729208|469057872|FG001|Baseline|Physician Decision|4|||
130298987|NCT01729208|469057871|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
130298988|NCT01729208|469057872|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
130298989|NCT01729208|469057871|FG000|12 Months Follow-up|Lost to Follow-up|3|||
130298990|NCT01729208|469057872|FG001|12 Months Follow-up|Lost to Follow-up|3|||
130298991|NCT01729208|469057871|FG000|24 Months Follow-up|Lost to Follow-up|3|||
130298992|NCT01729208|469057872|FG001|24 Months Follow-up|Lost to Follow-up|0|||
130298993|NCT01729208|469057871|FG000|36 Months Follow-up|Physician Decision|1|||
130298994|NCT01729208|469057872|FG001|36 Months Follow-up|Physician Decision|0|||
130298995|NCT01729208|469057871|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
130298996|NCT01729208|469057872|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
130298997|NCT02428413|469057874|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
130298998|NCT02428413|469057875|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
130298999|NCT02428413|469057874|FG000|Overall Study|Protocol Violation|1|||
130299000|NCT02428413|469057875|FG001|Overall Study|Protocol Violation|2|||
130299001|NCT02428413|469057874|FG000|Overall Study|Case Cancelled|2|||
130299002|NCT02428413|469057875|FG001|Overall Study|Case Cancelled|0|||
130299003|NCT02428413|469057874|FG000|Overall Study|Missed Cases|1|||
130299004|NCT02428413|469057875|FG001|Overall Study|Missed Cases|2|||
130299005|NCT02428413|469057874|FG000|Overall Study|Nurse Refusal|1|||
130299006|NCT02428413|469057875|FG001|Overall Study|Nurse Refusal|0|||
130299007|NCT03688100|469057878|FG000|Overall Study|Lost to Follow-up|21|||
130299008|NCT03688100|469057879|FG001|Overall Study|Lost to Follow-up|15|||
130299009|NCT03688100|469057880|FG002|Overall Study|Lost to Follow-up|15|||
130299010|NCT03688100|469057881|FG003|Overall Study|Lost to Follow-up|18|||
130299011|NCT03688100|469057878|FG000|Overall Study|Withdrawal by Subject|19|||
130299012|NCT03688100|469057879|FG001|Overall Study|Withdrawal by Subject|16|||
130299013|NCT03688100|469057880|FG002|Overall Study|Withdrawal by Subject|0|||
130299014|NCT03688100|469057881|FG003|Overall Study|Withdrawal by Subject|0|||
130299015|NCT03688100|469057878|FG000|Overall Study|Death|36|||
130299016|NCT03688100|469057879|FG001|Overall Study|Death|27|||
130299017|NCT03688100|469057880|FG002|Overall Study|Death|0|||
130299018|NCT03688100|469057881|FG003|Overall Study|Death|0|||
130299019|NCT02345330|469057884|FG000|Overall Study|Death|1|||
130299020|NCT02345330|469057884|FG000|Overall Study|Progressive Disease|2|||
130299021|NCT00494507|469057885|FG000|Double-Blind Phase|Adverse Event|2|||
130299022|NCT00494507|469057886|FG001|Double-Blind Phase|Adverse Event|0|||
130299023|NCT00494507|469057887|FG002|Double-Blind Phase|Adverse Event|1|||
130299024|NCT00494507|469057888|FG003|Double-Blind Phase|Adverse Event|0|||
130299025|NCT00494507|469057885|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130299026|NCT00494507|469057886|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130299027|NCT00494507|469057887|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130299028|NCT00494507|469057888|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130299029|NCT00494507|469057885|FG000|Double-Blind Phase|Subject Non-compliance|0|||
130299030|NCT00494507|469057886|FG001|Double-Blind Phase|Subject Non-compliance|0|||
130716275|NCT03709823|470588810|FG003|Overall Study|Adverse Event|0|||
130299031|NCT00494507|469057887|FG002|Double-Blind Phase|Subject Non-compliance|1|||
130299032|NCT00494507|469057888|FG003|Double-Blind Phase|Subject Non-compliance|0|||
130299033|NCT00494507|469057885|FG000|Double-Blind Phase|Negative DNA test|0|||
130299034|NCT00494507|469057886|FG001|Double-Blind Phase|Negative DNA test|0|||
130461561|NCT01393119|469656149|FG001|Overall Study|Adverse Event|1|||
130299035|NCT00494507|469057887|FG002|Double-Blind Phase|Negative DNA test|0|||
130461562|NCT01393119|469656150|FG002|Overall Study|Adverse Event|0|||
130299036|NCT00494507|469057888|FG003|Double-Blind Phase|Negative DNA test|1|||
130299037|NCT00494507|469057885|FG000|Open-Label Phase|Adverse Event|0|||
130299038|NCT00494507|469057886|FG001|Open-Label Phase|Adverse Event|1|||
130299039|NCT00494507|469057887|FG002|Open-Label Phase|Adverse Event|5|||
130299040|NCT00494507|469057888|FG003|Open-Label Phase|Adverse Event|3|||
130299041|NCT00494507|469057885|FG000|Open-Label Phase|Worsening Disease|0|||
130299042|NCT00494507|469057886|FG001|Open-Label Phase|Worsening Disease|0|||
130299043|NCT00494507|469057887|FG002|Open-Label Phase|Worsening Disease|0|||
130716276|NCT03709823|470588811|FG004|Overall Study|Adverse Event|0|||
130716277|NCT03709823|470588812|FG005|Overall Study|Adverse Event|0|||
130716278|NCT03709823|470588807|FG000|Overall Study|Lost to Follow-up|2|||
130372681|NCT03129100|469333339|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372682|NCT03129100|469333340|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372683|NCT03129100|469333341|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372684|NCT03129100|469333342|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372685|NCT03129100|469333343|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372686|NCT03129100|469333344|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372687|NCT03129100|469333345|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372688|NCT03129100|469333346|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372689|NCT03129100|469333347|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372690|NCT03129100|469333348|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
130372691|NCT03129100|469333349|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372692|NCT03129100|469333350|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372693|NCT03129100|469333351|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372694|NCT03129100|469333352|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372695|NCT03129100|469333353|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372696|NCT03129100|469333354|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372697|NCT03129100|469333355|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372698|NCT03129100|469333356|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372699|NCT03129100|469333357|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372700|NCT03129100|469333358|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372701|NCT03129100|469333359|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372702|NCT03129100|469333360|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372703|NCT03129100|469333361|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372704|NCT03129100|469333362|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372705|NCT03129100|469333363|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130716279|NCT03709823|470588808|FG001|Overall Study|Lost to Follow-up|2|||
130716280|NCT03709823|470588809|FG002|Overall Study|Lost to Follow-up|2|||
130372706|NCT03129100|469333364|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130372707|NCT03129100|469333339|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372708|NCT03129100|469333340|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372709|NCT03129100|469333341|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372710|NCT03129100|469333342|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372711|NCT03129100|469333343|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372712|NCT03129100|469333344|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372713|NCT03129100|469333345|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372714|NCT03129100|469333346|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372715|NCT03129100|469333347|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372716|NCT03129100|469333348|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372717|NCT03129100|469333349|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372718|NCT03129100|469333350|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
130372719|NCT03129100|469333351|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372720|NCT03129100|469333352|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372721|NCT03129100|469333353|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372722|NCT03129100|469333354|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372723|NCT03129100|469333355|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372724|NCT03129100|469333356|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372725|NCT03129100|469333357|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372726|NCT03129100|469333358|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372727|NCT03129100|469333359|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372728|NCT03129100|469333360|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372729|NCT03129100|469333361|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372730|NCT03129100|469333362|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372731|NCT03129100|469333363|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372732|NCT03129100|469333364|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130372733|NCT03129100|469333339|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372734|NCT03129100|469333340|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372735|NCT03129100|469333341|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372736|NCT03129100|469333342|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372737|NCT03129100|469333343|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372738|NCT03129100|469333344|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372739|NCT03129100|469333345|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372740|NCT03129100|469333346|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130299044|NCT00494507|469057888|FG003|Open-Label Phase|Worsening Disease|2|||
130299045|NCT02437084|469057890|FG000|Overall Study|Withdrawal by Subject|2|||
130299046|NCT02437084|469057890|FG000|Overall Study|Physician Decision|1|||
130299047|NCT00587847|469057891|FG000|Overall Study|Lack of Efficacy|5|||
130299048|NCT00587847|469057891|FG000|Overall Study|Adverse Event|2|||
130299049|NCT03729245|469057892|FG000|Overall Study|Lost to Follow-up|5|||
130299050|NCT03729245|469057893|FG001|Overall Study|Lost to Follow-up|6|||
130299051|NCT03729245|469057892|FG000|Overall Study|Withdrawal by Subject|16|||
130716281|NCT03709823|470588810|FG003|Overall Study|Lost to Follow-up|1|||
130716282|NCT03709823|470588811|FG004|Overall Study|Lost to Follow-up|1|||
130716283|NCT03709823|470588812|FG005|Overall Study|Lost to Follow-up|0|||
130716284|NCT03709823|470588807|FG000|Overall Study|Withdrawal by Subject|1|||
130299052|NCT03729245|469057893|FG001|Overall Study|Withdrawal by Subject|19|||
130299053|NCT03729245|469057892|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
130299054|NCT03729245|469057893|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
130299055|NCT04032080|469057894|FG000|Overall Study|Death|6|||
130299056|NCT00989781|469057901|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
130299057|NCT00989781|469057902|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
130299058|NCT00576576|469057905|FG000|Overall Study|Lost to Follow-up|6|||
130299059|NCT00576576|469057905|FG000|Overall Study|Protocol Violation|1|||
130299060|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
130716285|NCT03709823|470588808|FG001|Overall Study|Withdrawal by Subject|3|||
130716286|NCT03709823|470588809|FG002|Overall Study|Withdrawal by Subject|0|||
130716287|NCT03709823|470588810|FG003|Overall Study|Withdrawal by Subject|0|||
130716288|NCT03709823|470588811|FG004|Overall Study|Withdrawal by Subject|0|||
130299061|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
130299062|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
130299063|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
130299064|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
130299065|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
130299066|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
130299067|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
130299068|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
130299069|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
130299070|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
130299071|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
130299072|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
130299073|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
130299074|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Death|0|||
130299075|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Death|2|||
130299076|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
130299077|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
130299078|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
130299079|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
130299080|NCT02177838|469057915|FG000|Overall Study|Withdrawal by Subject|1|||
130299081|NCT02177838|469057915|FG000|Overall Study|Physician Decision|1|||
130299082|NCT02177838|469057915|FG000|Overall Study|Death|1|||
130299083|NCT03517566|469057917|FG000|Overall Study|Adverse Event|5|||
130299084|NCT03517566|469057918|FG001|Overall Study|Adverse Event|2|||
130299085|NCT03517566|469057919|FG002|Overall Study|Adverse Event|2|||
130299086|NCT03517566|469057920|FG003|Overall Study|Adverse Event|8|||
130299087|NCT03517566|469057921|FG004|Overall Study|Adverse Event|7|||
130299088|NCT03517566|469057917|FG000|Overall Study|Lack of Efficacy|3|||
130299089|NCT03517566|469057918|FG001|Overall Study|Lack of Efficacy|2|||
130299090|NCT03517566|469057919|FG002|Overall Study|Lack of Efficacy|1|||
130299091|NCT03517566|469057920|FG003|Overall Study|Lack of Efficacy|1|||
130299092|NCT03517566|469057921|FG004|Overall Study|Lack of Efficacy|4|||
130299093|NCT03517566|469057917|FG000|Overall Study|Lost to Follow-up|3|||
130299094|NCT03517566|469057918|FG001|Overall Study|Lost to Follow-up|1|||
130299095|NCT03517566|469057919|FG002|Overall Study|Lost to Follow-up|1|||
130299096|NCT03517566|469057920|FG003|Overall Study|Lost to Follow-up|1|||
130299097|NCT03517566|469057921|FG004|Overall Study|Lost to Follow-up|0|||
130299098|NCT03517566|469057917|FG000|Overall Study|Physician Decision|1|||
130299099|NCT03517566|469057918|FG001|Overall Study|Physician Decision|1|||
130299100|NCT03517566|469057919|FG002|Overall Study|Physician Decision|0|||
130299101|NCT03517566|469057920|FG003|Overall Study|Physician Decision|1|||
130299102|NCT03517566|469057921|FG004|Overall Study|Physician Decision|0|||
130299103|NCT03517566|469057917|FG000|Overall Study|Pregnancy|0|||
130299104|NCT03517566|469057918|FG001|Overall Study|Pregnancy|1|||
130299105|NCT03517566|469057919|FG002|Overall Study|Pregnancy|0|||
130299106|NCT03517566|469057920|FG003|Overall Study|Pregnancy|0|||
130299107|NCT03517566|469057921|FG004|Overall Study|Pregnancy|0|||
130299108|NCT03517566|469057917|FG000|Overall Study|Protocol Deviation|0|||
130299109|NCT03517566|469057918|FG001|Overall Study|Protocol Deviation|1|||
130299110|NCT03517566|469057919|FG002|Overall Study|Protocol Deviation|0|||
130716289|NCT03709823|470588812|FG005|Overall Study|Withdrawal by Subject|0|||
130716290|NCT03709823|470588807|FG000|Overall Study|Other, Not Specified|0|||
130716291|NCT03709823|470588808|FG001|Overall Study|Other, Not Specified|0|||
130716292|NCT03709823|470588809|FG002|Overall Study|Other, Not Specified|0|||
130716293|NCT03709823|470588810|FG003|Overall Study|Other, Not Specified|1|||
130716294|NCT03709823|470588811|FG004|Overall Study|Other, Not Specified|0|||
130716295|NCT03709823|470588812|FG005|Overall Study|Other, Not Specified|0|||
130716296|NCT02746471|470588813|FG000|Overall Study|Death|43|||
130716297|NCT02746471|470588813|FG000|Overall Study|Exited before 36 months|1119|||
130716298|NCT03201250|470588819|FG000|Overall Study|screen failures|3|||
130716299|NCT03201250|470588820|FG001|Overall Study|screen failures|0|||
130716300|NCT03201250|470588821|FG002|Overall Study|screen failures|0|||
130716301|NCT03167723|470588822|FG000|Overall Study|Protocol Violation|4|||
130716302|NCT03167723|470588823|FG001|Overall Study|Protocol Violation|6|||
130716303|NCT01175811|470588824|FG000|Overall Study|Adverse Event|1|||
130716304|NCT01175811|470588825|FG001|Overall Study|Adverse Event|1|||
130716305|NCT01175811|470588824|FG000|Overall Study|Entry criteria not met|3|||
130299111|NCT03517566|469057920|FG003|Overall Study|Protocol Deviation|1|||
130299112|NCT03517566|469057921|FG004|Overall Study|Protocol Deviation|1|||
130299113|NCT03517566|469057917|FG000|Overall Study|Study terminated by Sponsor|11|||
130299114|NCT03517566|469057918|FG001|Overall Study|Study terminated by Sponsor|5|||
130299115|NCT03517566|469057919|FG002|Overall Study|Study terminated by Sponsor|6|||
130299116|NCT03517566|469057920|FG003|Overall Study|Study terminated by Sponsor|14|||
130299117|NCT03517566|469057921|FG004|Overall Study|Study terminated by Sponsor|12|||
130299118|NCT03517566|469057917|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
130299119|NCT03517566|469057918|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
130299120|NCT03517566|469057919|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
130299121|NCT03517566|469057920|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
130299122|NCT03517566|469057921|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
130299123|NCT04566692|469057923|FG000|Overall Study|Adverse Event|2|||
130299124|NCT04566692|469057924|FG001|Overall Study|Adverse Event|0|||
130299125|NCT04566692|469057923|FG000|Overall Study|Withdrawal by Subject|1|||
130299126|NCT04566692|469057924|FG001|Overall Study|Withdrawal by Subject|1|||
130299127|NCT04311463|469057927|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130299128|NCT04311463|469057928|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
130299129|NCT04311463|469057927|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130299130|NCT04311463|469057928|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130299131|NCT04311463|469057927|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
130299132|NCT04311463|469057928|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130299133|NCT00737633|469057930|FG000|Overall Study|Study terminated by sponsor|44|||
130299134|NCT00737633|469057931|FG001|Overall Study|Study terminated by sponsor|55|||
130299135|NCT00737633|469057930|FG000|Overall Study|Lost to Follow-up|0|||
130299136|NCT00737633|469057931|FG001|Overall Study|Lost to Follow-up|1|||
130299137|NCT00737633|469057930|FG000|Overall Study|protocol non-compliance|0|||
130299138|NCT00737633|469057931|FG001|Overall Study|protocol non-compliance|1|||
130299139|NCT01300260|469057936|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
130299140|NCT01300260|469057937|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
130299141|NCT01300260|469057936|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
130299142|NCT01300260|469057937|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
130299143|NCT01300260|469057936|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
130299144|NCT01300260|469057937|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
130299145|NCT00293020|469057943|FG000|Overall Study|Withdrawal by Subject|34|||
130299146|NCT00293020|469057943|FG000|Overall Study|Adverse Event|30|||
130299147|NCT00293020|469057943|FG000|Overall Study|Death|32|||
130299148|NCT00293020|469057943|FG000|Overall Study|Lack of Efficacy|12|||
130299149|NCT00293020|469057943|FG000|Overall Study|Lost to Follow-up|4|||
130299150|NCT00293020|469057943|FG000|Overall Study|Protocol Violation|6|||
130299151|NCT00293020|469057943|FG000|Overall Study|Physician Decision|21|||
130299152|NCT00293020|469057943|FG000|Overall Study|Other Reason|22|||
130299153|NCT00293020|469057943|FG000|Overall Study|No dose taken|1|||
130299154|NCT01147848|469057944|FG000|Run-in Period|Screen Failure|623|||
130299155|NCT01147848|469057945|FG001|Run-in Period|Screen Failure|0|||
130299156|NCT01147848|469057946|FG002|Run-in Period|Screen Failure|0|||
130299157|NCT01147848|469057944|FG000|Run-in Period|Run-in Failure|135|||
130299158|NCT01147848|469057945|FG001|Run-in Period|Run-in Failure|0|||
130299159|NCT01147848|469057946|FG002|Run-in Period|Run-in Failure|0|||
130299160|NCT01147848|469057944|FG000|Randomized Phase|Adverse Event|0|||
130299161|NCT01147848|469057945|FG001|Randomized Phase|Adverse Event|6|||
130299162|NCT01147848|469057946|FG002|Randomized Phase|Adverse Event|8|||
130372741|NCT03129100|469333347|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372742|NCT03129100|469333348|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130716306|NCT01175811|470588825|FG001|Overall Study|Entry criteria not met|1|||
130716307|NCT01175811|470588824|FG000|Overall Study|Lack of Efficacy|1|||
130716308|NCT01175811|470588825|FG001|Overall Study|Lack of Efficacy|0|||
130716309|NCT01175811|470588824|FG000|Overall Study|Lost to Follow-up|3|||
130299163|NCT01147848|469057944|FG000|Randomized Phase|Lack of Efficacy|0|||
130299164|NCT01147848|469057945|FG001|Randomized Phase|Lack of Efficacy|20|||
130299165|NCT01147848|469057946|FG002|Randomized Phase|Lack of Efficacy|11|||
130299166|NCT01147848|469057944|FG000|Randomized Phase|Protocol Violation|0|||
130299167|NCT01147848|469057945|FG001|Randomized Phase|Protocol Violation|7|||
130299168|NCT01147848|469057946|FG002|Randomized Phase|Protocol Violation|10|||
130299169|NCT01147848|469057944|FG000|Randomized Phase|Lost to Follow-up|0|||
130299170|NCT01147848|469057945|FG001|Randomized Phase|Lost to Follow-up|5|||
130299171|NCT01147848|469057946|FG002|Randomized Phase|Lost to Follow-up|7|||
130299172|NCT01147848|469057944|FG000|Randomized Phase|Physician Decision|0|||
130299173|NCT01147848|469057945|FG001|Randomized Phase|Physician Decision|0|||
130299174|NCT01147848|469057946|FG002|Randomized Phase|Physician Decision|1|||
130299175|NCT01147848|469057944|FG000|Randomized Phase|Withdrawal by Subject|0|||
130299176|NCT01147848|469057945|FG001|Randomized Phase|Withdrawal by Subject|7|||
130716310|NCT01175811|470588825|FG001|Overall Study|Lost to Follow-up|2|||
130716311|NCT01175811|470588824|FG000|Overall Study|Physician Decision|1|||
130299177|NCT01147848|469057946|FG002|Randomized Phase|Withdrawal by Subject|9|||
130299178|NCT02540265|469057948|FG000|Overall Study|Lost to Follow-up|0|||
130299179|NCT02540265|469057949|FG001|Overall Study|Lost to Follow-up|0|||
130299180|NCT02540265|469057950|FG002|Overall Study|Lost to Follow-up|1|||
130299181|NCT03157037|469057953|FG000|Overall Study|Death|1|||
130299182|NCT02102399|469057957|FG000|Overall Study|Withdrawal by Subject|6|||
130299183|NCT02102399|469057958|FG001|Overall Study|Withdrawal by Subject|4|||
130299184|NCT03101085|469057959|FG000|Overall Study|Lost to Follow-up|0|||
130299185|NCT03101085|469057960|FG001|Overall Study|Lost to Follow-up|1|||
130299186|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299187|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299188|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299189|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299190|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299191|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299192|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299193|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299194|NCT00695864|469057962|FG000|Placebo|Withdrawal by Subject|1|||
130299195|NCT00695864|469057962|FG000|Placebo|Physician Decision|4|||
130299196|NCT01704456|469057963|FG000|Overall Study|Lost to Follow-up|8|||
130299197|NCT01704456|469057964|FG001|Overall Study|Lost to Follow-up|14|||
130299198|NCT00498355|469057965|FG000|Overall Study|Lost to Follow-up|1|||
130299199|NCT04583956|469057966|FG000|Overall Study|Death|9|||
130299200|NCT04583956|469057967|FG001|Overall Study|Death|11|||
130299201|NCT04583956|469057966|FG000|Overall Study|Lost to Follow-up|7|||
130299202|NCT04583956|469057967|FG001|Overall Study|Lost to Follow-up|9|||
130716312|NCT01175811|470588825|FG001|Overall Study|Physician Decision|1|||
130716313|NCT01175811|470588824|FG000|Overall Study|Protocol Violation|1|||
130716314|NCT01175811|470588825|FG001|Overall Study|Protocol Violation|2|||
130716315|NCT01175811|470588824|FG000|Overall Study|Withdrawal by Subject|6|||
130716316|NCT01175811|470588825|FG001|Overall Study|Withdrawal by Subject|7|||
130716317|NCT03579966|470588826|FG000|Overall Study|Adverse Event|6|||
130716318|NCT03579966|470588826|FG000|Overall Study|Lost to Follow-up|4|||
130716319|NCT03579966|470588826|FG000|Overall Study|Physician Decision|10|||
130716320|NCT03579966|470588826|FG000|Overall Study|Pregnancy|1|||
130716321|NCT03579966|470588826|FG000|Overall Study|Withdrawal by Subject|16|||
130716322|NCT03579966|470588826|FG000|Overall Study|Study terminated by Sponsor|22|||
130716323|NCT03579966|470588826|FG000|Overall Study|Protocol Violation|1|||
130716324|NCT00415194|470588827|FG000|Overall Study|Adverse Event|37|||
130716325|NCT00415194|470588828|FG001|Overall Study|Adverse Event|32|||
130299203|NCT04583956|469057966|FG000|Overall Study|Protocol Violation|2|||
130299204|NCT04583956|469057967|FG001|Overall Study|Protocol Violation|0|||
130372743|NCT03129100|469333349|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130716326|NCT00415194|470588827|FG000|Overall Study|Entry Criteria Not Met|4|||
130299205|NCT04583956|469057966|FG000|Overall Study|Withdrawal by Subject|0|||
130299206|NCT04583956|469057967|FG001|Overall Study|Withdrawal by Subject|2|||
130299207|NCT04583956|469057966|FG000|Overall Study|Randomized but not dosed|2|||
130299208|NCT04583956|469057967|FG001|Overall Study|Randomized but not dosed|3|||
130299209|NCT04583956|469057966|FG000|Overall Study|Withdrawal of consent before product administration|1|||
130299210|NCT04583956|469057967|FG001|Overall Study|Withdrawal of consent before product administration|0|||
130299211|NCT04599465|469059704|FG000|Overall Study|Physician Decision|1|||
130299212|NCT04599465|469059704|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
130299213|NCT03416127|469059705|FG000|Overall Study|Withdrawal by Subject|0|||
130299214|NCT03416127|469059706|FG001|Overall Study|Withdrawal by Subject|1|||
130299215|NCT03416127|469059707|FG002|Overall Study|Withdrawal by Subject|1|||
130299216|NCT01971008|469059708|FG000|Overall Study|Protocol Violation|2|||
130299217|NCT01971008|469059709|FG001|Overall Study|Protocol Violation|1|||
130299218|NCT02489942|469059712|FG000|Overall Study|Request by patient|602|||
130716327|NCT00415194|470588828|FG001|Overall Study|Entry Criteria Not Met|8|||
130299219|NCT02489942|469059712|FG000|Overall Study|Improvement/remission|157|||
130299220|NCT02489942|469059712|FG000|Overall Study|No change/Progressive disease|263|||
130299221|NCT02489942|469059712|FG000|Overall Study|Adverse Event|522|||
130299222|NCT02489942|469059712|FG000|Overall Study|Other personal reasons|1218|||
130299223|NCT02489942|469059712|FG000|Overall Study|Lost to Follow-up|456|||
130299224|NCT02489942|469059712|FG000|Overall Study|Not continuously investigated|7|||
130299225|NCT02489942|469059712|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
130299226|NCT02489942|469059712|FG000|Overall Study|Multiple registration|1|||
130299227|NCT02489942|469059712|FG000|Overall Study|No patient visit after entry|100|||
130299228|NCT02489942|469059712|FG000|Overall Study|No treatment with Jardiance|2|||
130299229|NCT02489942|469059712|FG000|Overall Study|Patient received Jardiance before registration|1|||
130299230|NCT02489942|469059712|FG000|Overall Study|No CRF collected|86|||
130299231|NCT00858208|469059713|FG000|Overall Study|Adverse Event|3|||
130299232|NCT00858208|469059713|FG000|Overall Study|Lost to Follow-up|26|||
130299233|NCT00858208|469059713|FG000|Overall Study|Participant refused|40|||
130299234|NCT00858208|469059713|FG000|Overall Study|Other|10|||
130299235|NCT02702180|469059714|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130299236|NCT02702180|469059715|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130299237|NCT02702180|469059716|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130299238|NCT02702180|469059714|FG000|Double-blind Treatment Period|Adverse Event|0|||
130299239|NCT02702180|469059715|FG001|Double-blind Treatment Period|Adverse Event|0|||
130299240|NCT02702180|469059716|FG002|Double-blind Treatment Period|Adverse Event|1|||
130299241|NCT02702180|469059714|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130299242|NCT02702180|469059715|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130372744|NCT03129100|469333350|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
130372745|NCT03129100|469333351|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
130372746|NCT03129100|469333352|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
130372747|NCT03129100|469333353|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
130372748|NCT03129100|469333354|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372749|NCT03129100|469333355|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372750|NCT03129100|469333356|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372751|NCT03129100|469333357|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372752|NCT03129100|469333358|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372753|NCT03129100|469333359|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372754|NCT03129100|469333360|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372755|NCT03129100|469333361|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372756|NCT03129100|469333362|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372757|NCT03129100|469333363|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372758|NCT03129100|469333364|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130372759|NCT03129100|469333339|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372760|NCT03129100|469333340|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372761|NCT03129100|469333341|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372762|NCT03129100|469333342|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372763|NCT03129100|469333343|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372764|NCT03129100|469333344|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372765|NCT03129100|469333345|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372766|NCT03129100|469333346|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372767|NCT03129100|469333347|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372768|NCT03129100|469333348|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372769|NCT03129100|469333349|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372770|NCT03129100|469333350|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130372771|NCT03129100|469333351|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130461563|NCT01393119|469656151|FG003|Overall Study|Adverse Event|1|||
130461564|NCT01393119|469656148|FG000|Overall Study|Withdrawal by Subject|0|||
130461565|NCT01393119|469656149|FG001|Overall Study|Withdrawal by Subject|1|||
130461566|NCT01393119|469656150|FG002|Overall Study|Withdrawal by Subject|1|||
130461567|NCT01393119|469656151|FG003|Overall Study|Withdrawal by Subject|0|||
130461568|NCT01393119|469656148|FG000|Overall Study|Lack of Efficacy|1|||
130461569|NCT01393119|469656149|FG001|Overall Study|Lack of Efficacy|0|||
130461570|NCT01393119|469656150|FG002|Overall Study|Lack of Efficacy|2|||
130461571|NCT01393119|469656151|FG003|Overall Study|Lack of Efficacy|1|||
130461572|NCT01393119|469656148|FG000|Overall Study|Protocol Violation|0|||
130461573|NCT01393119|469656149|FG001|Overall Study|Protocol Violation|0|||
130299243|NCT02702180|469059716|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130299244|NCT02702180|469059714|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130299245|NCT02702180|469059715|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130299246|NCT02702180|469059716|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130299247|NCT02702180|469059714|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130461574|NCT01393119|469656150|FG002|Overall Study|Protocol Violation|1|||
130461575|NCT01393119|469656151|FG003|Overall Study|Protocol Violation|0|||
130461576|NCT01393119|469656148|FG000|Overall Study|Death|0|||
130461577|NCT01393119|469656149|FG001|Overall Study|Death|0|||
130716328|NCT00415194|470588827|FG000|Overall Study|Lost to Follow-up|1|||
130716329|NCT00415194|470588828|FG001|Overall Study|Lost to Follow-up|0|||
130299248|NCT02702180|469059715|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
130299249|NCT02702180|469059716|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
130299250|NCT02702180|469059714|FG000|Open-label Treatment Period|Withdrawn in error|0|||
130299251|NCT02702180|469059715|FG001|Open-label Treatment Period|Withdrawn in error|0|||
130299252|NCT02702180|469059716|FG002|Open-label Treatment Period|Withdrawn in error|1|||
130299253|NCT00567359|469059717|FG000|Overall Study|Withdrawal by Subject|1|||
130299254|NCT00679172|469059718|FG000|Overall Study|Non-compliance|1|||
130299255|NCT00679172|469059719|FG001|Overall Study|Non-compliance|1|||
130299256|NCT00679172|469059720|FG002|Overall Study|Non-compliance|0|||
130299257|NCT00679172|469059721|FG003|Overall Study|Non-compliance|1|||
130299258|NCT00679172|469059722|FG004|Overall Study|Non-compliance|0|||
130299259|NCT00679172|469059718|FG000|Overall Study|Other not specified|0|||
130299260|NCT00679172|469059719|FG001|Overall Study|Other not specified|0|||
130299261|NCT00679172|469059720|FG002|Overall Study|Other not specified|1|||
130299262|NCT00679172|469059721|FG003|Overall Study|Other not specified|0|||
130299263|NCT00679172|469059722|FG004|Overall Study|Other not specified|0|||
130299264|NCT00793325|469059723|FG000|Overall Study|Protocol Violation|18|||
130299265|NCT00793325|469059723|FG000|Overall Study|Lost to Follow-up|1|||
130299266|NCT00372697|469059724|FG000|Overall Study|Protocol Violation|1|||
130299267|NCT00372697|469059725|FG001|Overall Study|Protocol Violation|1|||
130299268|NCT01815840|469059726|FG000|Overall Study|Missing|1|||
130299269|NCT01815840|469059727|FG001|Overall Study|Missing|0|||
130299270|NCT01815840|469059726|FG000|Overall Study|Withdrew Consent|31|||
130299271|NCT01815840|469059727|FG001|Overall Study|Withdrew Consent|30|||
130299272|NCT01815840|469059726|FG000|Overall Study|Administrative/Other|1|||
130299273|NCT01815840|469059727|FG001|Overall Study|Administrative/Other|3|||
130299274|NCT01815840|469059726|FG000|Overall Study|Adverse Event|10|||
130299275|NCT01815840|469059727|FG001|Overall Study|Adverse Event|16|||
130299276|NCT01815840|469059726|FG000|Overall Study|Death|2|||
130299277|NCT01815840|469059727|FG001|Overall Study|Death|2|||
130299278|NCT01815840|469059726|FG000|Overall Study|Disease progression|3|||
130299279|NCT01815840|469059727|FG001|Overall Study|Disease progression|2|||
130299280|NCT01815840|469059726|FG000|Overall Study|Investigators Decision|2|||
130299281|NCT01815840|469059727|FG001|Overall Study|Investigators Decision|3|||
130299282|NCT01815840|469059726|FG000|Overall Study|Lost to Follow-up|3|||
130299283|NCT01815840|469059727|FG001|Overall Study|Lost to Follow-up|6|||
130299284|NCT01815840|469059726|FG000|Overall Study|Refused Treatment|5|||
130299285|NCT01815840|469059727|FG001|Overall Study|Refused Treatment|1|||
130372772|NCT03129100|469333352|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130372773|NCT03129100|469333353|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130372774|NCT03129100|469333354|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372775|NCT03129100|469333355|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372776|NCT03129100|469333356|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372777|NCT03129100|469333357|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372778|NCT03129100|469333358|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372779|NCT03129100|469333359|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372780|NCT03129100|469333360|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372781|NCT03129100|469333361|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372782|NCT03129100|469333362|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372783|NCT03129100|469333363|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372784|NCT03129100|469333364|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130372785|NCT03129100|469333339|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372786|NCT03129100|469333340|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372787|NCT03129100|469333341|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130716330|NCT00415194|470588827|FG000|Overall Study|Physician Decision|10|||
130716331|NCT00415194|470588828|FG001|Overall Study|Physician Decision|16|||
130299286|NCT01815840|469059726|FG000|Overall Study|Sponsor Termination Treatment|1|||
130299287|NCT01815840|469059727|FG001|Overall Study|Sponsor Termination Treatment|0|||
130299288|NCT03221842|469059728|FG000|Period 1 (Open-label)|Adverse Event|4|||
130299289|NCT03221842|469059729|FG001|Period 1 (Open-label)|Adverse Event|0|||
130299290|NCT03221842|469059728|FG000|Period 1 (Open-label)|Physician Decision|2|||
130299291|NCT03221842|469059729|FG001|Period 1 (Open-label)|Physician Decision|0|||
130299292|NCT03221842|469059728|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
130299293|NCT03221842|469059729|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
130299294|NCT03221842|469059728|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
130299295|NCT03221842|469059729|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
130372788|NCT03129100|469333342|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130461578|NCT01393119|469656150|FG002|Overall Study|Death|0|||
130372789|NCT03129100|469333343|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372790|NCT03129100|469333344|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372791|NCT03129100|469333345|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372792|NCT03129100|469333346|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372793|NCT03129100|469333347|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372794|NCT03129100|469333348|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372795|NCT03129100|469333349|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372796|NCT03129100|469333350|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372797|NCT03129100|469333351|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372798|NCT03129100|469333352|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372799|NCT03129100|469333353|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372800|NCT03129100|469333354|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
130372801|NCT03129100|469333355|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372802|NCT03129100|469333356|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372803|NCT03129100|469333357|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372804|NCT03129100|469333358|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372805|NCT03129100|469333359|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372806|NCT03129100|469333360|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372807|NCT03129100|469333361|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372808|NCT03129100|469333362|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372809|NCT03129100|469333363|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372810|NCT03129100|469333364|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130372811|NCT03129100|469333339|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372812|NCT03129100|469333340|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372813|NCT03129100|469333341|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372814|NCT03129100|469333342|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372815|NCT03129100|469333343|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372816|NCT03129100|469333344|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372817|NCT03129100|469333345|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372818|NCT03129100|469333346|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372819|NCT03129100|469333347|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372820|NCT03129100|469333348|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372821|NCT03129100|469333349|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372822|NCT03129100|469333350|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372823|NCT03129100|469333351|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
130372824|NCT03129100|469333352|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372825|NCT03129100|469333353|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
130372826|NCT03129100|469333354|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
130372827|NCT03129100|469333355|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372828|NCT03129100|469333356|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372829|NCT03129100|469333357|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372830|NCT03129100|469333358|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372831|NCT03129100|469333359|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372832|NCT03129100|469333360|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372833|NCT03129100|469333361|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372834|NCT03129100|469333362|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372835|NCT03129100|469333363|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130372836|NCT03129100|469333364|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130299296|NCT03221842|469059728|FG000|Period 1 (Open-label)|Other|2|||
130299297|NCT03221842|469059729|FG001|Period 1 (Open-label)|Other|0|||
130299298|NCT03221842|469059728|FG000|Period 2 (Randomized, Blinded)|Death|0|||
130299299|NCT03221842|469059729|FG001|Period 2 (Randomized, Blinded)|Death|1|||
130299300|NCT03221842|469059728|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
130299301|NCT03221842|469059729|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
130299302|NCT00704288|469059731|FG000|Overall Treatment Period|Adverse Event|11|||
130299303|NCT00704288|469059732|FG001|Overall Treatment Period|Adverse Event|8|||
130372837|NCT03129100|469333339|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372838|NCT03129100|469333340|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372839|NCT03129100|469333341|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372840|NCT03129100|469333342|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372841|NCT03129100|469333343|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372842|NCT03129100|469333344|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130299304|NCT00704288|469059733|FG002|Overall Treatment Period|Adverse Event|22|||
130299305|NCT00704288|469059731|FG000|Overall Treatment Period|Death|0|||
130299306|NCT00704288|469059732|FG001|Overall Treatment Period|Death|0|||
130372843|NCT03129100|469333345|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130299307|NCT00704288|469059733|FG002|Overall Treatment Period|Death|1|||
130299308|NCT00704288|469059731|FG000|Overall Treatment Period|Physician Decision|0|||
130299309|NCT00704288|469059732|FG001|Overall Treatment Period|Physician Decision|2|||
130299310|NCT00704288|469059733|FG002|Overall Treatment Period|Physician Decision|0|||
130299311|NCT00704288|469059731|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
130299312|NCT00704288|469059732|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
130299313|NCT00704288|469059733|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
130299314|NCT00704288|469059731|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
130299315|NCT00704288|469059732|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130299316|NCT00704288|469059733|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130299317|NCT00704288|469059731|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
130299318|NCT00704288|469059732|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
130299319|NCT00704288|469059733|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
130299320|NCT00704288|469059731|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
130299321|NCT00704288|469059732|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
130299322|NCT00704288|469059733|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
130299323|NCT00704288|469059731|FG000|Overall Treatment Period|Roll-over to another study|1|||
130299324|NCT00704288|469059732|FG001|Overall Treatment Period|Roll-over to another study|0|||
130299325|NCT00704288|469059733|FG002|Overall Treatment Period|Roll-over to another study|4|||
130299326|NCT00704288|469059731|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
130299327|NCT00704288|469059732|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130299328|NCT00704288|469059733|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130299329|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Death|41|||
130299330|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Death|50|||
130299331|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Death|93|||
130299332|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
130299333|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
130299334|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
130299335|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
130299336|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130299337|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130299338|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
130299339|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
130299340|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
130299341|NCT03387020|469059735|FG000|Overall Study|Adverse Event|0|||
130299342|NCT03387020|469059736|FG001|Overall Study|Adverse Event|2|||
130299343|NCT03387020|469059737|FG002|Overall Study|Adverse Event|0|||
130299344|NCT03387020|469059735|FG000|Overall Study|Withdrawal by Subject|2|||
130299345|NCT03387020|469059736|FG001|Overall Study|Withdrawal by Subject|0|||
130299346|NCT03387020|469059737|FG002|Overall Study|Withdrawal by Subject|0|||
130299347|NCT00434642|469059738|FG000|Blinded Treatment Phase|Adverse Event|12|||
130299348|NCT00434642|469059739|FG001|Blinded Treatment Phase|Adverse Event|58|||
130299349|NCT00434642|469059738|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
130299350|NCT00434642|469059739|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
130299351|NCT00434642|469059738|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
130299352|NCT00434642|469059739|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
130299353|NCT00434642|469059738|FG000|Blinded Treatment Phase|Physician Decision|19|||
130299354|NCT00434642|469059739|FG001|Blinded Treatment Phase|Physician Decision|27|||
130299355|NCT00434642|469059738|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
130299356|NCT00434642|469059739|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
130299357|NCT00434642|469059738|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
130299358|NCT00434642|469059739|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
130299359|NCT00434642|469059738|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
130299360|NCT00434642|469059739|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
130299361|NCT00434642|469059738|FG000|Open-label Treatment Phase|Adverse Event|0|||
130299362|NCT00434642|469059739|FG001|Open-label Treatment Phase|Adverse Event|5|||
130299363|NCT00434642|469059738|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
130299364|NCT00434642|469059739|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
130299365|NCT04512976|469059744|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299366|NCT04512976|469059745|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299367|NCT04512976|469059746|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299368|NCT04512976|469059747|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299369|NCT04512976|469059748|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299370|NCT04512976|469059749|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
130299371|NCT00527982|469059750|FG000|Overall Study|Physician Decision|1|||
130299372|NCT00527982|469059751|FG001|Overall Study|Physician Decision|0|||
130299373|NCT00753454|469059758|FG000|Overall Study|Adverse Event|4|||
130299374|NCT00753454|469059758|FG000|Overall Study|Lack of Efficacy|1|||
130299375|NCT00753454|469059758|FG000|Overall Study|Lost to Follow-up|3|||
130299376|NCT00753454|469059758|FG000|Overall Study|Withdrawal by Subject|5|||
130299377|NCT00753454|469059758|FG000|Overall Study|Investigator Decision|1|||
130299378|NCT03927144|469059759|FG000|Core Phase|Adverse Event|9|||
130299379|NCT03927144|469059760|FG001|Core Phase|Adverse Event|5|||
130299380|NCT03927144|469059759|FG000|Core Phase|Lost to Follow-up|3|||
130299381|NCT03927144|469059760|FG001|Core Phase|Lost to Follow-up|2|||
130299382|NCT03927144|469059759|FG000|Core Phase|New Therapy for Study Indication|0|||
130299383|NCT03927144|469059760|FG001|Core Phase|New Therapy for Study Indication|1|||
130299384|NCT03927144|469059759|FG000|Core Phase|No Longer Clinically Benefiting|4|||
130299385|NCT03927144|469059760|FG001|Core Phase|No Longer Clinically Benefiting|4|||
130299386|NCT03927144|469059759|FG000|Core Phase|Physician Decision|2|||
130299387|NCT03927144|469059760|FG001|Core Phase|Physician Decision|8|||
130299388|NCT03927144|469059759|FG000|Core Phase|Protocol Violation|2|||
130299389|NCT03927144|469059760|FG001|Core Phase|Protocol Violation|2|||
130299390|NCT03927144|469059759|FG000|Core Phase|Withdrawal by Subject|16|||
130299391|NCT03927144|469059760|FG001|Core Phase|Withdrawal by Subject|40|||
130299392|NCT03927144|469059759|FG000|Extension Phase|Adverse Event|2|||
130299393|NCT03927144|469059760|FG001|Extension Phase|Adverse Event|1|||
130299394|NCT03927144|469059759|FG000|Extension Phase|No longer clinically benefiting|4|||
130299395|NCT03927144|469059760|FG001|Extension Phase|No longer clinically benefiting|5|||
130299396|NCT03927144|469059759|FG000|Extension Phase|Pregnancy|1|||
130299397|NCT03927144|469059760|FG001|Extension Phase|Pregnancy|0|||
130299398|NCT03927144|469059759|FG000|Extension Phase|Protocol Violation|0|||
130299399|NCT03927144|469059760|FG001|Extension Phase|Protocol Violation|1|||
130299400|NCT03927144|469059759|FG000|Extension Phase|Withdrawal by Subject|8|||
130299401|NCT03927144|469059760|FG001|Extension Phase|Withdrawal by Subject|3|||
130299402|NCT04541628|469059763|FG000|Overall Study|Study Terminated|1|||
130299403|NCT04541628|469059764|FG001|Overall Study|Study Terminated|1|||
130299404|NCT04541628|469059765|FG002|Overall Study|Study Terminated|1|||
130299405|NCT05011058|469059769|FG000|Overall Study|Sponsor Decision|2|||
130299406|NCT05011058|469059770|FG001|Overall Study|Sponsor Decision|0|||
130299407|NCT05011058|469059771|FG002|Overall Study|Sponsor Decision|14|||
130299408|NCT05011058|469059772|FG003|Overall Study|Sponsor Decision|0|||
130299409|NCT05011058|469059773|FG004|Overall Study|Sponsor Decision|0|||
130299410|NCT05011058|469059774|FG005|Overall Study|Sponsor Decision|1|||
130299411|NCT05011058|469059775|FG006|Overall Study|Sponsor Decision|0|||
130299412|NCT05011058|469059776|FG007|Overall Study|Sponsor Decision|5|||
130299413|NCT01452919|469059777|FG000|Open-Label Treatment|Adverse Event|5|||
130299414|NCT01452919|469059778|FG001|Open-Label Treatment|Adverse Event|0|||
130299415|NCT01452919|469059779|FG002|Open-Label Treatment|Adverse Event|0|||
130299416|NCT01452919|469059777|FG000|Open-Label Treatment|Lost to Follow-up|4|||
130299417|NCT01452919|469059778|FG001|Open-Label Treatment|Lost to Follow-up|0|||
130299418|NCT01452919|469059779|FG002|Open-Label Treatment|Lost to Follow-up|0|||
130299419|NCT01452919|469059777|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
130299420|NCT01452919|469059778|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
130299421|NCT01452919|469059779|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
130299422|NCT01452919|469059777|FG000|Open-Label Treatment|Protocol Violation|4|||
130299423|NCT01452919|469059778|FG001|Open-Label Treatment|Protocol Violation|0|||
130299424|NCT01452919|469059779|FG002|Open-Label Treatment|Protocol Violation|0|||
130299425|NCT01452919|469059777|FG000|Open-Label Treatment|Sponsor Decision|1|||
130299426|NCT01452919|469059778|FG001|Open-Label Treatment|Sponsor Decision|0|||
130299427|NCT01452919|469059779|FG002|Open-Label Treatment|Sponsor Decision|0|||
130299428|NCT01452919|469059777|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
130299429|NCT01452919|469059778|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130299430|NCT01452919|469059779|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
130299431|NCT01452919|469059777|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
130299432|NCT01452919|469059778|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
130299433|NCT01452919|469059779|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
130299434|NCT01452919|469059777|FG000|Randomization Treatment|Adverse Event|0|||
130299435|NCT01452919|469059778|FG001|Randomization Treatment|Adverse Event|0|||
130299436|NCT01452919|469059779|FG002|Randomization Treatment|Adverse Event|2|||
130299437|NCT01452919|469059777|FG000|Randomization Treatment|Sponsor Decision|0|||
130299438|NCT01452919|469059778|FG001|Randomization Treatment|Sponsor Decision|1|||
130299439|NCT01452919|469059779|FG002|Randomization Treatment|Sponsor Decision|0|||
130557337|NCT00528567|470009961|FG000|Overall Study|Failure to Return|1|||
130299440|NCT01452919|469059777|FG000|Randomization Treatment|Withdrawal by Subject|0|||
130299441|NCT01452919|469059778|FG001|Randomization Treatment|Withdrawal by Subject|1|||
130299442|NCT01452919|469059779|FG002|Randomization Treatment|Withdrawal by Subject|0|||
130299443|NCT01452919|469059777|FG000|Randomization Treatment|Subject is moving or has moved|0|||
130299444|NCT01452919|469059778|FG001|Randomization Treatment|Subject is moving or has moved|1|||
130299445|NCT01452919|469059779|FG002|Randomization Treatment|Subject is moving or has moved|0|||
130461579|NCT01393119|469656151|FG003|Overall Study|Death|1|||
130461580|NCT01393119|469656148|FG000|Overall Study|Randomized but Not treated|1|||
130461581|NCT01393119|469656149|FG001|Overall Study|Randomized but Not treated|0|||
130461582|NCT01393119|469656150|FG002|Overall Study|Randomized but Not treated|1|||
130461583|NCT01393119|469656151|FG003|Overall Study|Randomized but Not treated|1|||
130461584|NCT01393119|469656148|FG000|Overall Study|Sponsor Termination of Study|11|||
130461585|NCT01393119|469656149|FG001|Overall Study|Sponsor Termination of Study|12|||
130461586|NCT01393119|469656150|FG002|Overall Study|Sponsor Termination of Study|9|||
130461587|NCT01393119|469656151|FG003|Overall Study|Sponsor Termination of Study|12|||
130461588|NCT00465816|469656153|FG000|Overall Study|Lost to Follow-up|0|||
130461589|NCT00465816|469656154|FG001|Overall Study|Lost to Follow-up|0|||
130461590|NCT00465816|469656155|FG002|Overall Study|Lost to Follow-up|2|||
130461591|NCT00004124|469656156|FG000|Overall Study|Received no protocol therapy|12|||
130461592|NCT00004124|469656157|FG001|Overall Study|Received no protocol therapy|20|||
130557338|NCT00528567|470009962|FG001|Overall Study|Failure to Return|4|||
130557339|NCT00528567|470009961|FG000|Overall Study|Other Protocol Violation|5|||
130716332|NCT00415194|470588827|FG000|Overall Study|Progressive Disease|180|||
130299446|NCT01192412|469059780|FG000|Overall Study|Lost to Follow-up|2|||
130299447|NCT01192412|469059781|FG001|Overall Study|Lost to Follow-up|1|||
130299448|NCT01192412|469059780|FG000|Overall Study|Withdrawal by Subject|2|||
130299449|NCT01192412|469059781|FG001|Overall Study|Withdrawal by Subject|1|||
130299450|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
130299451|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130299452|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130299453|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
130299454|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
130299455|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
130299456|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130299457|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
130299458|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130299459|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
130299460|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130299461|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130299462|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
130299463|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
130299464|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
130299465|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130299466|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
130299467|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130299468|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299469|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299470|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299471|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130299472|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
130299473|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130299474|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
130299475|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
130299476|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
130299477|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
130299478|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
130299479|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
130299480|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
130299481|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130299482|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130299483|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130299484|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
130299485|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130299486|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299487|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299488|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299489|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130299490|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
130299491|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130299492|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
130299493|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
130299494|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
130299495|NCT00308074|469059790|FG000|Overall Study|Withdrawal by Subject|1|||
130299496|NCT01529034|469059797|FG000|Overall Study|Discontinued prior to study treatment|14|||
130461593|NCT01759264|469656158|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
130461594|NCT01759264|469656158|FG000|Overall Study|Adverse Event|1|||
130299497|NCT01529034|469059797|FG000|Overall Study|Site closure|62|||
130299498|NCT01529034|469059797|FG000|Overall Study|Study termination|29|||
130299499|NCT01529034|469059797|FG000|Overall Study|Withdrawal by Subject|25|||
130299500|NCT01529034|469059797|FG000|Overall Study|No treated SCs within protocol window|13|||
130299501|NCT01529034|469059797|FG000|Overall Study|Noncompliance|8|||
130299502|NCT01529034|469059797|FG000|Overall Study|Caregiver no longer available|7|||
130299503|NCT01529034|469059797|FG000|Overall Study|Adverse Event|4|||
130299504|NCT01529034|469059797|FG000|Overall Study|Protocol Violation|4|||
130299505|NCT01529034|469059797|FG000|Overall Study|Lack of Efficacy|4|||
130299506|NCT01529034|469059797|FG000|Overall Study|Investigator no longer available|2|||
130299507|NCT01529034|469059797|FG000|Overall Study|Study drug not available|2|||
130299508|NCT03194646|469059800|FG000|Overall Study|Adverse Event|24|||
130299509|NCT03194646|469059801|FG001|Overall Study|Adverse Event|25|||
130299510|NCT03194646|469059802|FG002|Overall Study|Adverse Event|14|||
130299511|NCT03194646|469059803|FG003|Overall Study|Adverse Event|17|||
130299512|NCT03194646|469059800|FG000|Overall Study|Lack of Efficacy|4|||
130299513|NCT03194646|469059801|FG001|Overall Study|Lack of Efficacy|2|||
130299514|NCT03194646|469059802|FG002|Overall Study|Lack of Efficacy|2|||
130299515|NCT03194646|469059803|FG003|Overall Study|Lack of Efficacy|12|||
130299516|NCT03194646|469059800|FG000|Overall Study|Lost to Follow-up|30|||
130299517|NCT03194646|469059801|FG001|Overall Study|Lost to Follow-up|22|||
130299518|NCT03194646|469059802|FG002|Overall Study|Lost to Follow-up|12|||
130299519|NCT03194646|469059803|FG003|Overall Study|Lost to Follow-up|35|||
130299520|NCT03194646|469059800|FG000|Overall Study|Non-compliance with study drug|4|||
130299521|NCT03194646|469059801|FG001|Overall Study|Non-compliance with study drug|0|||
130299522|NCT03194646|469059802|FG002|Overall Study|Non-compliance with study drug|1|||
130299523|NCT03194646|469059803|FG003|Overall Study|Non-compliance with study drug|1|||
130299524|NCT03194646|469059800|FG000|Overall Study|Other|89|||
130299525|NCT03194646|469059801|FG001|Overall Study|Other|68|||
130299526|NCT03194646|469059802|FG002|Overall Study|Other|34|||
130299527|NCT03194646|469059803|FG003|Overall Study|Other|31|||
130299528|NCT03194646|469059800|FG000|Overall Study|Physician Decision|7|||
130299529|NCT03194646|469059801|FG001|Overall Study|Physician Decision|9|||
130299530|NCT03194646|469059802|FG002|Overall Study|Physician Decision|5|||
130299531|NCT03194646|469059803|FG003|Overall Study|Physician Decision|4|||
130299532|NCT03194646|469059800|FG000|Overall Study|Pregnancy|4|||
130299533|NCT03194646|469059801|FG001|Overall Study|Pregnancy|5|||
130299534|NCT03194646|469059802|FG002|Overall Study|Pregnancy|1|||
130299535|NCT03194646|469059803|FG003|Overall Study|Pregnancy|2|||
130299536|NCT03194646|469059800|FG000|Overall Study|Protocol Violation|4|||
130299537|NCT03194646|469059801|FG001|Overall Study|Protocol Violation|2|||
130299538|NCT03194646|469059802|FG002|Overall Study|Protocol Violation|1|||
130299539|NCT03194646|469059803|FG003|Overall Study|Protocol Violation|1|||
130299540|NCT03194646|469059800|FG000|Overall Study|Site terminated by sponsor|0|||
130299541|NCT03194646|469059801|FG001|Overall Study|Site terminated by sponsor|0|||
130299542|NCT03194646|469059802|FG002|Overall Study|Site terminated by sponsor|2|||
130299543|NCT03194646|469059803|FG003|Overall Study|Site terminated by sponsor|0|||
130299544|NCT03194646|469059800|FG000|Overall Study|Study terminated by sponsor|62|||
130299545|NCT03194646|469059801|FG001|Overall Study|Study terminated by sponsor|61|||
130299546|NCT03194646|469059802|FG002|Overall Study|Study terminated by sponsor|30|||
130299547|NCT03194646|469059803|FG003|Overall Study|Study terminated by sponsor|34|||
130299548|NCT03194646|469059800|FG000|Overall Study|Withdrawal by Subject|75|||
130299549|NCT03194646|469059801|FG001|Overall Study|Withdrawal by Subject|74|||
130299550|NCT03194646|469059802|FG002|Overall Study|Withdrawal by Subject|36|||
130299551|NCT03194646|469059803|FG003|Overall Study|Withdrawal by Subject|131|||
130299552|NCT03194646|469059800|FG000|Overall Study|Missing|1|||
130299553|NCT03194646|469059801|FG001|Overall Study|Missing|0|||
130299554|NCT03194646|469059802|FG002|Overall Study|Missing|1|||
130299555|NCT03194646|469059803|FG003|Overall Study|Missing|12|||
130299556|NCT02141360|469059805|FG000|Overall Study|Withdrawal by Subject|6|||
130299557|NCT02141360|469059806|FG001|Overall Study|Withdrawal by Subject|0|||
130299558|NCT02141360|469059807|FG002|Overall Study|Withdrawal by Subject|0|||
130299559|NCT02141360|469059805|FG000|Overall Study|Study Terminated before Visit|1|||
130299560|NCT02141360|469059806|FG001|Overall Study|Study Terminated before Visit|0|||
130299561|NCT02141360|469059807|FG002|Overall Study|Study Terminated before Visit|0|||
130299562|NCT01178099|469059808|FG000|Overall Study|Physician Decision|0|||
130299563|NCT01178099|469059809|FG001|Overall Study|Physician Decision|1|||
130299564|NCT02516592|469059812|FG000|Overall Study|Patient withdrew consent|5|||
130716333|NCT00415194|470588828|FG001|Overall Study|Progressive Disease|217|||
130299565|NCT02516592|469059813|FG001|Overall Study|Patient withdrew consent|2|||
130299566|NCT02516592|469059812|FG000|Overall Study|Protocol deviation|4|||
130299567|NCT02516592|469059813|FG001|Overall Study|Protocol deviation|4|||
130299568|NCT02516592|469059812|FG000|Overall Study|Lost to Follow-up|2|||
130299569|NCT02516592|469059813|FG001|Overall Study|Lost to Follow-up|3|||
130299570|NCT02516592|469059812|FG000|Overall Study|Patient/guardian decision|2|||
130299571|NCT02516592|469059813|FG001|Overall Study|Patient/guardian decision|1|||
130299572|NCT02516592|469059812|FG000|Overall Study|Adverse Event|1|||
130299573|NCT02516592|469059813|FG001|Overall Study|Adverse Event|2|||
130299574|NCT02516592|469059812|FG000|Overall Study|Abnormal test procedure result|1|||
130299575|NCT02516592|469059813|FG001|Overall Study|Abnormal test procedure result|0|||
130299576|NCT02516592|469059812|FG000|Overall Study|Death|1|||
130299577|NCT02516592|469059813|FG001|Overall Study|Death|1|||
130299578|NCT02473367|469059814|FG000|Wait 1|Withdrawal by Subject|1|||
130299579|NCT02473367|469059814|FG000|Period 4|Lost to Follow-up|1|||
130299580|NCT00454584|469059816|FG000|Controlled Period|Adverse Event|5|||
130299581|NCT00454584|469059817|FG001|Controlled Period|Adverse Event|2|||
130299582|NCT00454584|469059818|FG002|Controlled Period|Adverse Event|1|||
130299583|NCT00454584|469059819|FG003|Controlled Period|Adverse Event|0|||
130299584|NCT00454584|469059820|FG004|Controlled Period|Adverse Event|0|||
130299585|NCT00454584|469059821|FG005|Controlled Period|Adverse Event|0|||
130299586|NCT00454584|469059816|FG000|Controlled Period|Lost to Follow-up|1|||
130299587|NCT00454584|469059817|FG001|Controlled Period|Lost to Follow-up|2|||
130299588|NCT00454584|469059818|FG002|Controlled Period|Lost to Follow-up|2|||
130299589|NCT00454584|469059819|FG003|Controlled Period|Lost to Follow-up|0|||
130299590|NCT00454584|469059820|FG004|Controlled Period|Lost to Follow-up|0|||
130299591|NCT00454584|469059821|FG005|Controlled Period|Lost to Follow-up|0|||
130299592|NCT00454584|469059816|FG000|Controlled Period|Other|5|||
130299593|NCT00454584|469059817|FG001|Controlled Period|Other|4|||
130299594|NCT00454584|469059818|FG002|Controlled Period|Other|2|||
130299595|NCT00454584|469059819|FG003|Controlled Period|Other|0|||
130299596|NCT00454584|469059820|FG004|Controlled Period|Other|0|||
130299597|NCT00454584|469059821|FG005|Controlled Period|Other|0|||
130299598|NCT00454584|469059816|FG000|After Controlled Period|Adverse Event|0|||
130299599|NCT00454584|469059817|FG001|After Controlled Period|Adverse Event|0|||
130372844|NCT03129100|469333346|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372845|NCT03129100|469333347|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372846|NCT03129100|469333348|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372847|NCT03129100|469333349|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372848|NCT03129100|469333350|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372849|NCT03129100|469333351|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372850|NCT03129100|469333352|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372851|NCT03129100|469333353|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372852|NCT03129100|469333354|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372853|NCT03129100|469333355|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372854|NCT03129100|469333356|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
130372855|NCT03129100|469333357|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372856|NCT03129100|469333358|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
130372857|NCT03129100|469333359|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372858|NCT03129100|469333360|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372859|NCT03129100|469333361|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372860|NCT03129100|469333362|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372861|NCT03129100|469333363|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372862|NCT03129100|469333364|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130372863|NCT03129100|469333339|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372864|NCT03129100|469333340|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372865|NCT03129100|469333341|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372866|NCT03129100|469333342|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372867|NCT03129100|469333343|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372868|NCT03129100|469333344|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372869|NCT03129100|469333345|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372870|NCT03129100|469333346|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372871|NCT03129100|469333347|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372872|NCT03129100|469333348|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372873|NCT03129100|469333349|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372874|NCT03129100|469333350|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372875|NCT03129100|469333351|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372876|NCT03129100|469333352|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372877|NCT03129100|469333353|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372878|NCT03129100|469333354|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372879|NCT03129100|469333355|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372880|NCT03129100|469333356|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372881|NCT03129100|469333357|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372882|NCT03129100|469333358|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372883|NCT03129100|469333359|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
130461595|NCT01759264|469656158|FG000|Overall Study|Other|2|||
130461596|NCT01759264|469656158|FG000|Overall Study|Lost to Follow-up|2|||
130372884|NCT03129100|469333360|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130299600|NCT00454584|469059818|FG002|After Controlled Period|Adverse Event|0|||
130299601|NCT00454584|469059819|FG003|After Controlled Period|Adverse Event|9|||
130299602|NCT00454584|469059820|FG004|After Controlled Period|Adverse Event|3|||
130299603|NCT00454584|469059821|FG005|After Controlled Period|Adverse Event|9|||
130299604|NCT00454584|469059816|FG000|After Controlled Period|Lack of Efficacy|0|||
130372885|NCT03129100|469333361|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372886|NCT03129100|469333362|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130299605|NCT00454584|469059817|FG001|After Controlled Period|Lack of Efficacy|0|||
130299606|NCT00454584|469059818|FG002|After Controlled Period|Lack of Efficacy|0|||
130299607|NCT00454584|469059819|FG003|After Controlled Period|Lack of Efficacy|1|||
130299608|NCT00454584|469059820|FG004|After Controlled Period|Lack of Efficacy|0|||
130299609|NCT00454584|469059821|FG005|After Controlled Period|Lack of Efficacy|0|||
130299610|NCT00454584|469059816|FG000|After Controlled Period|Lost to Follow-up|0|||
130299611|NCT00454584|469059817|FG001|After Controlled Period|Lost to Follow-up|0|||
130299612|NCT00454584|469059818|FG002|After Controlled Period|Lost to Follow-up|0|||
130299613|NCT00454584|469059819|FG003|After Controlled Period|Lost to Follow-up|2|||
130299614|NCT00454584|469059820|FG004|After Controlled Period|Lost to Follow-up|4|||
130299615|NCT00454584|469059821|FG005|After Controlled Period|Lost to Follow-up|6|||
130299616|NCT00454584|469059816|FG000|After Controlled Period|Other|0|||
130299617|NCT00454584|469059817|FG001|After Controlled Period|Other|0|||
130299618|NCT00454584|469059818|FG002|After Controlled Period|Other|0|||
130299619|NCT00454584|469059819|FG003|After Controlled Period|Other|1|||
130299620|NCT00454584|469059820|FG004|After Controlled Period|Other|0|||
130299621|NCT00454584|469059821|FG005|After Controlled Period|Other|0|||
130299622|NCT00454584|469059816|FG000|After Controlled Period|Other|0|||
130299623|NCT00454584|469059817|FG001|After Controlled Period|Other|0|||
130299624|NCT00454584|469059818|FG002|After Controlled Period|Other|0|||
130299625|NCT00454584|469059819|FG003|After Controlled Period|Other|13|||
130299626|NCT00454584|469059820|FG004|After Controlled Period|Other|5|||
130299627|NCT00454584|469059821|FG005|After Controlled Period|Other|17|||
130299628|NCT00454181|469059823|FG000|Overall Study|Adverse Event|1|||
130299629|NCT00454181|469059824|FG001|Overall Study|Adverse Event|1|||
130299630|NCT00454181|469059823|FG000|Overall Study|Lost to Follow-up|11|||
130299631|NCT00454181|469059824|FG001|Overall Study|Lost to Follow-up|1|||
130299632|NCT00454181|469059823|FG000|Overall Study|Protocol Violation|1|||
130299633|NCT00454181|469059824|FG001|Overall Study|Protocol Violation|1|||
130299634|NCT00454181|469059823|FG000|Overall Study|Withdrawal by Subject|2|||
130299635|NCT00454181|469059824|FG001|Overall Study|Withdrawal by Subject|0|||
130299636|NCT03689855|469059836|FG000|Overall Study|Adverse Event|3|||
130299637|NCT03689855|469059836|FG000|Overall Study|Withdrawal by Subject|1|||
130299638|NCT02409719|469059837|FG000|Overall Study|Lost to Follow-up|3|||
130299639|NCT02409719|469059838|FG001|Overall Study|Lost to Follow-up|3|||
130299640|NCT00764673|469059839|FG000|Overall Study|Death|1|||
130299641|NCT00764673|469059839|FG000|Overall Study|Lost to Follow-up|3|||
130299642|NCT00764673|469059839|FG000|Overall Study|Withdrawal by Subject|6|||
130372887|NCT03129100|469333363|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372888|NCT03129100|469333364|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130372889|NCT03129100|469333339|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
130372890|NCT03129100|469333340|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
130372891|NCT03129100|469333341|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
130372892|NCT03129100|469333342|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
130372893|NCT03129100|469333343|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
130372894|NCT03129100|469333344|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
130372895|NCT03129100|469333345|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
130372896|NCT03129100|469333346|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
130372897|NCT03129100|469333347|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
130372898|NCT03129100|469333348|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
130372899|NCT03129100|469333349|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
130372900|NCT03129100|469333350|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
130372901|NCT03129100|469333351|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
130372902|NCT03129100|469333352|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
130372903|NCT03129100|469333353|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
130372904|NCT03129100|469333354|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
130372905|NCT03129100|469333355|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
130372906|NCT03129100|469333356|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
130372907|NCT03129100|469333357|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
130372908|NCT03129100|469333358|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
130372909|NCT03129100|469333359|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
130372910|NCT03129100|469333360|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
130372911|NCT03129100|469333361|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
130372912|NCT03129100|469333362|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
130372913|NCT03129100|469333363|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
130372914|NCT03129100|469333364|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
130372915|NCT03129100|469333339|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130716334|NCT00415194|470588827|FG000|Overall Study|Protocol Violation|4|||
130716335|NCT00415194|470588828|FG001|Overall Study|Protocol Violation|2|||
130299643|NCT00764673|469059839|FG000|Overall Study|Revision of Device|2|||
130299644|NCT01438177|469059840|FG000|Overall Study|Withdrawal by Subject|1|||
130299645|NCT01438177|469059840|FG000|Overall Study|Initiation of new therapy|1|||
130299646|NCT01727336|469059843|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299647|NCT01727336|469059844|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
130299648|NCT01727336|469059845|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
130461597|NCT01759264|469656158|FG000|Overall Study|Withdrawal by Subject|3|||
130461598|NCT01759264|469656158|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
130461599|NCT02013830|469656159|FG000|Overall Study|Adverse Event|3|||
130461600|NCT02013830|469656159|FG000|Overall Study|Death|1|||
130461601|NCT02013830|469656159|FG000|Overall Study|Insufficient therapeutic response|25|||
130461602|NCT02013830|469656159|FG000|Overall Study|Refused treatment|1|||
130461603|NCT00186186|469656163|FG000|Overall Study|Lack of Efficacy|3|||
130461604|NCT00186186|469656163|FG000|Overall Study|Withdrawal by Subject|3|||
130461605|NCT00186186|469656163|FG000|Overall Study|Not reported as to reason|2|||
130461606|NCT01337635|469656164|FG000|Overall Study|Lost to Follow-up|0|||
130461607|NCT01337635|469656165|FG001|Overall Study|Lost to Follow-up|1|||
130461608|NCT02567656|469656168|FG000|Overall Study|Premature discontinuation due to PD|1|||
130461609|NCT02567656|469656169|FG001|Overall Study|Premature discontinuation due to PD|1|||
130461610|NCT02567656|469656170|FG002|Overall Study|Premature discontinuation due to PD|2|||
130461611|NCT02567656|469656171|FG003|Overall Study|Premature discontinuation due to PD|0|||
130461612|NCT02567656|469656172|FG004|Overall Study|Premature discontinuation due to PD|0|||
130461613|NCT02567656|469656173|FG005|Overall Study|Premature discontinuation due to PD|0|||
130461614|NCT01307267|469656174|FG000|Overall Study|Death|4|||
130461615|NCT01307267|469656175|FG001|Overall Study|Death|3|||
130461616|NCT01307267|469656176|FG002|Overall Study|Death|5|||
130461617|NCT01307267|469656177|FG003|Overall Study|Death|3|||
130461618|NCT01307267|469656178|FG004|Overall Study|Death|1|||
130461619|NCT01307267|469656179|FG005|Overall Study|Death|26|||
130461620|NCT01307267|469656180|FG006|Overall Study|Death|2|||
130461621|NCT01307267|469656181|FG007|Overall Study|Death|2|||
130461622|NCT01307267|469656182|FG008|Overall Study|Death|21|||
130461623|NCT01307267|469656183|FG009|Overall Study|Death|2|||
130461624|NCT01307267|469656184|FG010|Overall Study|Death|3|||
130461625|NCT01307267|469656185|FG011|Overall Study|Death|9|||
130461626|NCT01307267|469656186|FG012|Overall Study|Death|0|||
130461627|NCT01307267|469656187|FG013|Overall Study|Death|0|||
130461628|NCT01307267|469656188|FG014|Overall Study|Death|0|||
130461629|NCT01307267|469656189|FG015|Overall Study|Death|0|||
130461630|NCT01307267|469656190|FG016|Overall Study|Death|1|||
130461631|NCT01307267|469656191|FG017|Overall Study|Death|1|||
130461632|NCT01307267|469656192|FG018|Overall Study|Death|2|||
130461633|NCT01307267|469656193|FG019|Overall Study|Death|8|||
130461634|NCT01307267|469656194|FG020|Overall Study|Death|1|||
130461635|NCT01307267|469656195|FG021|Overall Study|Death|2|||
130461636|NCT01307267|469656196|FG022|Overall Study|Death|2|||
130461637|NCT01307267|469656174|FG000|Overall Study|Lost to Follow-up|0|||
130461638|NCT01307267|469656175|FG001|Overall Study|Lost to Follow-up|0|||
130461639|NCT01307267|469656176|FG002|Overall Study|Lost to Follow-up|0|||
130461640|NCT01307267|469656177|FG003|Overall Study|Lost to Follow-up|0|||
130461641|NCT01307267|469656178|FG004|Overall Study|Lost to Follow-up|0|||
130461642|NCT01307267|469656179|FG005|Overall Study|Lost to Follow-up|7|||
130461643|NCT01307267|469656180|FG006|Overall Study|Lost to Follow-up|0|||
130461644|NCT01307267|469656181|FG007|Overall Study|Lost to Follow-up|0|||
130461645|NCT01307267|469656182|FG008|Overall Study|Lost to Follow-up|1|||
130461646|NCT01307267|469656183|FG009|Overall Study|Lost to Follow-up|2|||
130461647|NCT01307267|469656184|FG010|Overall Study|Lost to Follow-up|1|||
130461648|NCT01307267|469656185|FG011|Overall Study|Lost to Follow-up|0|||
130461649|NCT01307267|469656186|FG012|Overall Study|Lost to Follow-up|0|||
130461650|NCT01307267|469656187|FG013|Overall Study|Lost to Follow-up|0|||
130461651|NCT01307267|469656188|FG014|Overall Study|Lost to Follow-up|0|||
130461652|NCT01307267|469656189|FG015|Overall Study|Lost to Follow-up|0|||
130461653|NCT01307267|469656190|FG016|Overall Study|Lost to Follow-up|0|||
130461654|NCT01307267|469656191|FG017|Overall Study|Lost to Follow-up|0|||
130461655|NCT01307267|469656192|FG018|Overall Study|Lost to Follow-up|0|||
130461656|NCT01307267|469656193|FG019|Overall Study|Lost to Follow-up|2|||
130299649|NCT01727336|469059846|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299650|NCT01727336|469059847|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130461657|NCT01307267|469656194|FG020|Overall Study|Lost to Follow-up|0|||
130461658|NCT01307267|469656195|FG021|Overall Study|Lost to Follow-up|0|||
130461659|NCT01307267|469656196|FG022|Overall Study|Lost to Follow-up|0|||
130461660|NCT01307267|469656174|FG000|Overall Study|Withdrawal by Subject|0|||
130461661|NCT01307267|469656175|FG001|Overall Study|Withdrawal by Subject|0|||
130461662|NCT01307267|469656176|FG002|Overall Study|Withdrawal by Subject|0|||
130461663|NCT01307267|469656177|FG003|Overall Study|Withdrawal by Subject|0|||
130461664|NCT01307267|469656178|FG004|Overall Study|Withdrawal by Subject|0|||
130716336|NCT00415194|470588827|FG000|Overall Study|Withdrawal by Subject|28|||
130461665|NCT01307267|469656179|FG005|Overall Study|Withdrawal by Subject|1|||
130461666|NCT01307267|469656180|FG006|Overall Study|Withdrawal by Subject|0|||
130461667|NCT01307267|469656181|FG007|Overall Study|Withdrawal by Subject|1|||
130461668|NCT01307267|469656182|FG008|Overall Study|Withdrawal by Subject|5|||
130716337|NCT00415194|470588828|FG001|Overall Study|Withdrawal by Subject|21|||
130716338|NCT00415194|470588827|FG000|Overall Study|Death Due to Study Disease|26|||
130461669|NCT01307267|469656183|FG009|Overall Study|Withdrawal by Subject|1|||
130461670|NCT01307267|469656184|FG010|Overall Study|Withdrawal by Subject|1|||
130461671|NCT01307267|469656185|FG011|Overall Study|Withdrawal by Subject|1|||
130461672|NCT01307267|469656186|FG012|Overall Study|Withdrawal by Subject|0|||
130461673|NCT01307267|469656187|FG013|Overall Study|Withdrawal by Subject|0|||
130461674|NCT01307267|469656188|FG014|Overall Study|Withdrawal by Subject|0|||
130461675|NCT01307267|469656189|FG015|Overall Study|Withdrawal by Subject|0|||
130461676|NCT01307267|469656190|FG016|Overall Study|Withdrawal by Subject|0|||
130461677|NCT01307267|469656191|FG017|Overall Study|Withdrawal by Subject|0|||
130461678|NCT01307267|469656192|FG018|Overall Study|Withdrawal by Subject|0|||
130461679|NCT01307267|469656193|FG019|Overall Study|Withdrawal by Subject|3|||
130461680|NCT01307267|469656194|FG020|Overall Study|Withdrawal by Subject|0|||
130461681|NCT01307267|469656195|FG021|Overall Study|Withdrawal by Subject|0|||
130461682|NCT01307267|469656196|FG022|Overall Study|Withdrawal by Subject|0|||
130461683|NCT01307267|469656174|FG000|Overall Study|Other|0|||
130461684|NCT01307267|469656175|FG001|Overall Study|Other|0|||
130461685|NCT01307267|469656176|FG002|Overall Study|Other|0|||
130461686|NCT01307267|469656177|FG003|Overall Study|Other|0|||
130461687|NCT01307267|469656178|FG004|Overall Study|Other|0|||
130461688|NCT01307267|469656179|FG005|Overall Study|Other|7|||
130461689|NCT01307267|469656180|FG006|Overall Study|Other|0|||
130461690|NCT01307267|469656181|FG007|Overall Study|Other|1|||
130461691|NCT01307267|469656182|FG008|Overall Study|Other|3|||
130461692|NCT01307267|469656183|FG009|Overall Study|Other|0|||
130461693|NCT01307267|469656184|FG010|Overall Study|Other|1|||
130461694|NCT01307267|469656185|FG011|Overall Study|Other|1|||
130461695|NCT01307267|469656186|FG012|Overall Study|Other|1|||
130461696|NCT01307267|469656187|FG013|Overall Study|Other|0|||
130461697|NCT01307267|469656188|FG014|Overall Study|Other|2|||
130461698|NCT01307267|469656189|FG015|Overall Study|Other|1|||
130461699|NCT01307267|469656190|FG016|Overall Study|Other|0|||
130461700|NCT01307267|469656191|FG017|Overall Study|Other|0|||
130461701|NCT01307267|469656192|FG018|Overall Study|Other|0|||
130461702|NCT01307267|469656193|FG019|Overall Study|Other|19|||
130461703|NCT01307267|469656194|FG020|Overall Study|Other|2|||
130461704|NCT01307267|469656195|FG021|Overall Study|Other|3|||
130461705|NCT01307267|469656196|FG022|Overall Study|Other|2|||
130461706|NCT04956575|469656197|FG000|Overall Study|Death|1|||
130461707|NCT04956575|469656198|FG001|Overall Study|Death|0|||
130461708|NCT04956575|469656199|FG002|Overall Study|Death|0|||
130461709|NCT04956575|469656200|FG003|Overall Study|Death|0|||
130461710|NCT04956575|469656201|FG004|Overall Study|Death|0|||
130461711|NCT04956575|469656202|FG005|Overall Study|Death|0|||
130461712|NCT04956575|469656203|FG006|Overall Study|Death|0|||
130461713|NCT04956575|469656204|FG007|Overall Study|Death|1|||
130461714|NCT04956575|469656205|FG008|Overall Study|Death|0|||
130461715|NCT04956575|469656206|FG009|Overall Study|Death|1|||
130461716|NCT04956575|469656207|FG010|Overall Study|Death|0|||
130461717|NCT04956575|469656208|FG011|Overall Study|Death|0|||
130461718|NCT04956575|469656197|FG000|Overall Study|Lost to Follow-up|3|||
130461719|NCT04956575|469656198|FG001|Overall Study|Lost to Follow-up|4|||
130461720|NCT04956575|469656199|FG002|Overall Study|Lost to Follow-up|2|||
130461721|NCT04956575|469656200|FG003|Overall Study|Lost to Follow-up|3|||
130461722|NCT04956575|469656201|FG004|Overall Study|Lost to Follow-up|1|||
130461723|NCT04956575|469656202|FG005|Overall Study|Lost to Follow-up|10|||
130461724|NCT04956575|469656203|FG006|Overall Study|Lost to Follow-up|11|||
130461725|NCT04956575|469656204|FG007|Overall Study|Lost to Follow-up|7|||
130461726|NCT04956575|469656205|FG008|Overall Study|Lost to Follow-up|4|||
130461727|NCT04956575|469656206|FG009|Overall Study|Lost to Follow-up|2|||
130461728|NCT04956575|469656207|FG010|Overall Study|Lost to Follow-up|3|||
130716339|NCT00415194|470588828|FG001|Overall Study|Death Due to Study Disease|29|||
130716340|NCT00415194|470588827|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
130716341|NCT00415194|470588828|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
130716342|NCT00415194|470588827|FG000|Overall Study|Death Due to Procedural Related AE|0|||
130461729|NCT04956575|469656208|FG011|Overall Study|Lost to Follow-up|8|||
130461730|NCT04956575|469656197|FG000|Overall Study|Withdrawal by Subject|1|||
130461731|NCT04956575|469656198|FG001|Overall Study|Withdrawal by Subject|2|||
130461732|NCT04956575|469656199|FG002|Overall Study|Withdrawal by Subject|1|||
130461733|NCT04956575|469656200|FG003|Overall Study|Withdrawal by Subject|4|||
130461734|NCT04956575|469656201|FG004|Overall Study|Withdrawal by Subject|2|||
130461735|NCT04956575|469656202|FG005|Overall Study|Withdrawal by Subject|8|||
130461736|NCT04956575|469656203|FG006|Overall Study|Withdrawal by Subject|5|||
130461737|NCT04956575|469656204|FG007|Overall Study|Withdrawal by Subject|1|||
130461738|NCT04956575|469656205|FG008|Overall Study|Withdrawal by Subject|1|||
130461739|NCT04956575|469656206|FG009|Overall Study|Withdrawal by Subject|0|||
130461740|NCT04956575|469656207|FG010|Overall Study|Withdrawal by Subject|3|||
130461741|NCT04956575|469656208|FG011|Overall Study|Withdrawal by Subject|1|||
130461742|NCT03593876|469656209|FG000|Overall Study|Withdrawal by Subject|1|||
130461743|NCT03593876|469656209|FG000|Overall Study|Discharged home before intervention completion|2|||
130461744|NCT05136443|469656220|FG000|Overall Study|Lost to Follow-up|2|||
130461745|NCT05136443|469656220|FG000|Overall Study|Adverse Event|2|||
130461746|NCT03034915|469656231|FG000|Overall Study|Adverse Event|29|||
130461747|NCT03034915|469656232|FG001|Overall Study|Adverse Event|32|||
130461748|NCT03034915|469656233|FG002|Overall Study|Adverse Event|22|||
130716343|NCT00415194|470588828|FG001|Overall Study|Death Due to Procedural Related AE|1|||
130716344|NCT00415194|470588827|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
130716345|NCT00415194|470588828|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
130716346|NCT01297465|470588829|FG000|Overall Study|Lack of Ovarian Response|1|||
130716347|NCT01297465|470588830|FG001|Overall Study|Lack of Ovarian Response|1|||
130716348|NCT01297465|470588829|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130716349|NCT01297465|470588830|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130716350|NCT01297465|470588829|FG000|Overall Study|No Oocytes Retrieved|1|||
130716351|NCT01297465|470588830|FG001|Overall Study|No Oocytes Retrieved|1|||
130716352|NCT01297465|470588829|FG000|Overall Study|Poor oocyte quality|0|||
130299651|NCT01727336|469059848|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299652|NCT01727336|469059843|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130299653|NCT01727336|469059844|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
130299654|NCT01727336|469059845|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130299655|NCT01727336|469059846|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299656|NCT01727336|469059847|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299657|NCT01727336|469059848|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299658|NCT01727336|469059843|FG000|Part 2 Blinded|Death|0|||
130299659|NCT01727336|469059844|FG001|Part 2 Blinded|Death|0|||
130299660|NCT01727336|469059845|FG002|Part 2 Blinded|Death|0|||
130299661|NCT01727336|469059846|FG003|Part 2 Blinded|Death|0|||
130299662|NCT01727336|469059847|FG004|Part 2 Blinded|Death|20|||
130299663|NCT01727336|469059848|FG005|Part 2 Blinded|Death|16|||
130299664|NCT01727336|469059843|FG000|Part 2 Blinded|Lack of Efficacy|0|||
130299665|NCT01727336|469059844|FG001|Part 2 Blinded|Lack of Efficacy|0|||
130299666|NCT01727336|469059845|FG002|Part 2 Blinded|Lack of Efficacy|0|||
130299667|NCT01727336|469059846|FG003|Part 2 Blinded|Lack of Efficacy|0|||
130299668|NCT01727336|469059847|FG004|Part 2 Blinded|Lack of Efficacy|42|||
130299669|NCT01727336|469059848|FG005|Part 2 Blinded|Lack of Efficacy|44|||
130299670|NCT01727336|469059843|FG000|Part 2 Blinded|Lost to Follow-up|0|||
130299671|NCT01727336|469059844|FG001|Part 2 Blinded|Lost to Follow-up|0|||
130299672|NCT01727336|469059845|FG002|Part 2 Blinded|Lost to Follow-up|0|||
130299673|NCT01727336|469059846|FG003|Part 2 Blinded|Lost to Follow-up|0|||
130299674|NCT01727336|469059847|FG004|Part 2 Blinded|Lost to Follow-up|0|||
130299675|NCT01727336|469059848|FG005|Part 2 Blinded|Lost to Follow-up|1|||
130299676|NCT01727336|469059843|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
130299677|NCT01727336|469059844|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
130299678|NCT01727336|469059845|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
130299679|NCT01727336|469059846|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
130299680|NCT01727336|469059847|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
130299681|NCT01727336|469059848|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
130299682|NCT01727336|469059843|FG000|Part 2 Blinded|use of prohibited medications|0|||
130299683|NCT01727336|469059844|FG001|Part 2 Blinded|use of prohibited medications|0|||
130299684|NCT01727336|469059845|FG002|Part 2 Blinded|use of prohibited medications|0|||
130299685|NCT01727336|469059846|FG003|Part 2 Blinded|use of prohibited medications|0|||
130299686|NCT01727336|469059847|FG004|Part 2 Blinded|use of prohibited medications|1|||
130299687|NCT01727336|469059848|FG005|Part 2 Blinded|use of prohibited medications|3|||
130299688|NCT00619099|469059849|FG000|Overall Study|Progressive Disease|7|||
130299689|NCT00619099|469059850|FG001|Overall Study|Progressive Disease|5|||
130299690|NCT00619099|469059849|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
130299691|NCT00619099|469059850|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
130299692|NCT00619099|469059849|FG000|Overall Study|Adverse Event|4|||
130299693|NCT00619099|469059850|FG001|Overall Study|Adverse Event|3|||
130299694|NCT00619099|469059849|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
130299695|NCT00619099|469059850|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
130299696|NCT00619099|469059849|FG000|Overall Study|Withdrawal by Subject|10|||
130299697|NCT00619099|469059850|FG001|Overall Study|Withdrawal by Subject|2|||
130299698|NCT00619099|469059849|FG000|Overall Study|Physician Decision|9|||
130299699|NCT00619099|469059850|FG001|Overall Study|Physician Decision|6|||
130299700|NCT00129467|469059851|FG000|Received Intervention|Death|1|||
130299701|NCT00129467|469059852|FG001|Received Intervention|Death|1|||
130299702|NCT00129467|469059851|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
130461749|NCT03034915|469656231|FG000|Overall Study|Lost to Follow-up|5|||
130716353|NCT01297465|470588830|FG001|Overall Study|Poor oocyte quality|1|||
130716354|NCT01297465|470588829|FG000|Overall Study|No Fertilization|6|||
130716355|NCT01297465|470588830|FG001|Overall Study|No Fertilization|4|||
130461750|NCT03034915|469656232|FG001|Overall Study|Lost to Follow-up|13|||
130461751|NCT03034915|469656233|FG002|Overall Study|Lost to Follow-up|3|||
130716356|NCT01297465|470588829|FG000|Overall Study|All Embryos Discarded|0|||
130716357|NCT01297465|470588830|FG001|Overall Study|All Embryos Discarded|1|||
130716358|NCT01297465|470588829|FG000|Overall Study|Intention to Freeze all Embryos|0|||
130299703|NCT00129467|469059852|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
130299704|NCT00129467|469059851|FG000|Received Intervention|Delirium|2|||
130299705|NCT00129467|469059852|FG001|Received Intervention|Delirium|0|||
130461752|NCT03034915|469656231|FG000|Overall Study|Withdrawal by Subject|29|||
130299706|NCT00129467|469059851|FG000|Received Intervention|Withdrawal by Subject|1|||
130299707|NCT00129467|469059852|FG001|Received Intervention|Withdrawal by Subject|0|||
130299708|NCT00129467|469059851|FG000|Received Intervention|Nausea|1|||
130299709|NCT00129467|469059852|FG001|Received Intervention|Nausea|0|||
130299710|NCT00129467|469059851|FG000|Received Intervention|Intolerance to citalopram|0|||
130299711|NCT00129467|469059852|FG001|Received Intervention|Intolerance to citalopram|1|||
130299712|NCT00129467|469059851|FG000|Received Intervention|Dizzyness, fatigue|0|||
130299713|NCT00129467|469059852|FG001|Received Intervention|Dizzyness, fatigue|1|||
130299714|NCT00129467|469059851|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
130299715|NCT00129467|469059852|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
130299716|NCT00129467|469059851|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
130299717|NCT00129467|469059852|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
130299718|NCT01424228|469059858|FG000|Overall Study|Withdrawal by Subject|27|||
130299719|NCT01424228|469059859|FG001|Overall Study|Withdrawal by Subject|11|||
130299720|NCT01424228|469059858|FG000|Overall Study|Adverse Event|10|||
130299721|NCT01424228|469059859|FG001|Overall Study|Adverse Event|14|||
130299722|NCT01424228|469059858|FG000|Overall Study|Sponsor's decision|9|||
130299723|NCT01424228|469059859|FG001|Overall Study|Sponsor's decision|12|||
130299724|NCT01424228|469059858|FG000|Overall Study|Lack of Efficacy|5|||
130299725|NCT01424228|469059859|FG001|Overall Study|Lack of Efficacy|7|||
130299726|NCT01424228|469059858|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
130299727|NCT01424228|469059859|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
130299728|NCT01424228|469059858|FG000|Overall Study|Non-compliance|2|||
130299729|NCT01424228|469059859|FG001|Overall Study|Non-compliance|0|||
130299730|NCT01424228|469059858|FG000|Overall Study|Worsening of symptoms|1|||
130299731|NCT01424228|469059859|FG001|Overall Study|Worsening of symptoms|0|||
130299732|NCT01424228|469059858|FG000|Overall Study|Unplanned journey|0|||
130299733|NCT01424228|469059859|FG001|Overall Study|Unplanned journey|1|||
130299734|NCT00671437|469059862|FG000|Overall Study|Progressive disease before C1 week 8|8|||
130299735|NCT00671437|469059862|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
130461753|NCT03034915|469656232|FG001|Overall Study|Withdrawal by Subject|46|||
130461754|NCT03034915|469656233|FG002|Overall Study|Withdrawal by Subject|41|||
130299736|NCT00671437|469059862|FG000|Overall Study|Adverse Event|3|||
130299737|NCT00671437|469059862|FG000|Overall Study|Ineligible post-hoc|1|||
130299738|NCT03927404|469059864|FG000|Overall Study|Withdrawal by Subject|1|||
130299739|NCT01229449|469059865|FG000|Overall Study|Withdrawal by Subject|0|||
130299740|NCT01229449|469059866|FG001|Overall Study|Withdrawal by Subject|3|||
130299741|NCT01229449|469059867|FG002|Overall Study|Withdrawal by Subject|0|||
130299742|NCT01229449|469059868|FG003|Overall Study|Withdrawal by Subject|1|||
130299743|NCT01229449|469059869|FG004|Overall Study|Withdrawal by Subject|1|||
130299744|NCT01229449|469059865|FG000|Overall Study|Lost to Follow-up|1|||
130299745|NCT01229449|469059866|FG001|Overall Study|Lost to Follow-up|1|||
130299746|NCT01229449|469059867|FG002|Overall Study|Lost to Follow-up|1|||
130299747|NCT01229449|469059868|FG003|Overall Study|Lost to Follow-up|0|||
130299748|NCT01229449|469059869|FG004|Overall Study|Lost to Follow-up|0|||
130299749|NCT01229449|469059865|FG000|Overall Study|Physician Decision|0|||
130299750|NCT01229449|469059866|FG001|Overall Study|Physician Decision|0|||
130461755|NCT03034915|469656231|FG000|Overall Study|Protocol Deviation|2|||
130461756|NCT03034915|469656232|FG001|Overall Study|Protocol Deviation|14|||
130461757|NCT03034915|469656233|FG002|Overall Study|Protocol Deviation|7|||
130461758|NCT03034915|469656231|FG000|Overall Study|Lack of Efficacy|8|||
130461759|NCT03034915|469656232|FG001|Overall Study|Lack of Efficacy|16|||
130461760|NCT03034915|469656233|FG002|Overall Study|Lack of Efficacy|18|||
130461761|NCT03034915|469656231|FG000|Overall Study|Site closed|2|||
130461762|NCT03034915|469656232|FG001|Overall Study|Site closed|2|||
130461763|NCT03034915|469656233|FG002|Overall Study|Site closed|4|||
130461764|NCT03034915|469656231|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
130461765|NCT03034915|469656232|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
130461766|NCT03034915|469656233|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
130557340|NCT00528567|470009962|FG001|Overall Study|Other Protocol Violation|21|||
130557341|NCT00528567|470009961|FG000|Overall Study|Administrative/Other|22|||
130299751|NCT01229449|469059867|FG002|Overall Study|Physician Decision|1|||
130299752|NCT01229449|469059868|FG003|Overall Study|Physician Decision|0|||
130299753|NCT01229449|469059869|FG004|Overall Study|Physician Decision|0|||
130299754|NCT00377364|469059870|FG000|Overall Study|Lost to Follow-up|1|||
130299755|NCT00377364|469059871|FG001|Overall Study|Lost to Follow-up|0|||
130299756|NCT00377364|469059870|FG000|Overall Study|Withdrawal by Subject|1|||
130299757|NCT00377364|469059871|FG001|Overall Study|Withdrawal by Subject|0|||
130299758|NCT03180307|469059875|FG000|Overall Study|Lost to Follow-up|2|||
130299759|NCT03180307|469059876|FG001|Overall Study|Lost to Follow-up|0|||
130299760|NCT03180307|469059875|FG000|Overall Study|Death|1|||
130299761|NCT03180307|469059876|FG001|Overall Study|Death|0|||
130461767|NCT03034915|469656231|FG000|Overall Study|Physician Decision|1|||
130461768|NCT03034915|469656232|FG001|Overall Study|Physician Decision|5|||
130461769|NCT03034915|469656233|FG002|Overall Study|Physician Decision|2|||
130461770|NCT00424762|469656239|FG000|Overall Study|Withdrawal by Subject|18|||
130461771|NCT00424762|469656240|FG001|Overall Study|Withdrawal by Subject|19|||
130299762|NCT03180307|469059875|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
130299763|NCT03180307|469059876|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
130299764|NCT03596450|469059877|FG000|Overall Study|Death|9|||
130299765|NCT03596450|469059878|FG001|Overall Study|Death|9|||
130299766|NCT03596450|469059877|FG000|Overall Study|Protocol Violation|18|||
130299767|NCT03596450|469059878|FG001|Overall Study|Protocol Violation|26|||
130299768|NCT03596450|469059877|FG000|Overall Study|Lost to Follow-up|50|||
130299769|NCT03596450|469059878|FG001|Overall Study|Lost to Follow-up|56|||
130299770|NCT03596450|469059877|FG000|Overall Study|Adverse Event|14|||
130299771|NCT03596450|469059878|FG001|Overall Study|Adverse Event|7|||
130299772|NCT03596450|469059877|FG000|Overall Study|Withdrawal by Subject|38|||
130299773|NCT03596450|469059878|FG001|Overall Study|Withdrawal by Subject|36|||
130299774|NCT03596450|469059877|FG000|Overall Study|Accidentally Randomized|2|||
130299775|NCT03596450|469059878|FG001|Overall Study|Accidentally Randomized|0|||
130299776|NCT03596450|469059877|FG000|Overall Study|Other reasons|48|||
130299777|NCT03596450|469059878|FG001|Overall Study|Other reasons|53|||
130299778|NCT03596450|469059877|FG000|Overall Study|Pregnancy|2|||
130299779|NCT03596450|469059878|FG001|Overall Study|Pregnancy|0|||
130299780|NCT00410605|469059882|FG000|Overall Study|Adverse Event|12|||
130299781|NCT00410605|469059882|FG000|Overall Study|Physician Decision|3|||
130299782|NCT00410605|469059882|FG000|Overall Study|Withdrawal by Subject|5|||
130299783|NCT00410605|469059882|FG000|Overall Study|Started Non-Protocol Therapy|3|||
130299784|NCT00410605|469059882|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
130299785|NCT00410605|469059882|FG000|Overall Study|Transferred to another Institution|1|||
130299786|NCT02100475|469062233|FG000|Overall Study|Unclassified|1|||
130299787|NCT02100475|469062234|FG001|Overall Study|Unclassified|2|||
130299788|NCT02100475|469062233|FG000|Overall Study|Withdrawal criteria|1|||
130299789|NCT02100475|469062234|FG001|Overall Study|Withdrawal criteria|0|||
130299790|NCT00649428|469062235|FG000|Overall Study|Adverse Event|2|||
130299791|NCT00649428|469062236|FG001|Overall Study|Adverse Event|2|||
130299792|NCT00649428|469062235|FG000|Overall Study|Withdrawal by Subject|6|||
130299793|NCT00649428|469062236|FG001|Overall Study|Withdrawal by Subject|6|||
130299794|NCT00649428|469062235|FG000|Overall Study|Lost to Follow-up|1|||
130299795|NCT00649428|469062236|FG001|Overall Study|Lost to Follow-up|3|||
130299796|NCT00649428|469062235|FG000|Overall Study|Insufficient manufacturing yield|5|||
130299797|NCT00649428|469062236|FG001|Overall Study|Insufficient manufacturing yield|1|||
130299798|NCT00649428|469062235|FG000|Overall Study|Protocol Violation|6|||
130299799|NCT00649428|469062236|FG001|Overall Study|Protocol Violation|2|||
130299800|NCT00649428|469062235|FG000|Overall Study|Physician Decision|0|||
130299801|NCT00649428|469062236|FG001|Overall Study|Physician Decision|1|||
130299802|NCT00742417|469062237|FG000|Randomized|Withdrawal by legal representative|0|||
130299803|NCT00742417|469062238|FG001|Randomized|Withdrawal by legal representative|1|||
130299804|NCT00742417|469062237|FG000|Randomized|Withdrawal by Subject|1|||
130299805|NCT00742417|469062238|FG001|Randomized|Withdrawal by Subject|0|||
130299806|NCT00742417|469062237|FG000|Randomized|Physician Decision|1|||
130299807|NCT00742417|469062238|FG001|Randomized|Physician Decision|0|||
130299808|NCT00742417|469062237|FG000|Intensive Period|Withdrawal by Subject|1|||
130299809|NCT00742417|469062238|FG001|Intensive Period|Withdrawal by Subject|1|||
130299810|NCT00742417|469062237|FG000|Intensive Period|Adverse Event|2|||
130299811|NCT00742417|469062238|FG001|Intensive Period|Adverse Event|0|||
130299812|NCT04566601|469062239|FG000|Overall Study|Other than listed|13|||
130299813|NCT04566601|469062240|FG001|Overall Study|Other than listed|4|||
130299814|NCT04566601|469062241|FG002|Overall Study|Other than listed|2|||
130299815|NCT04566601|469062242|FG003|Overall Study|Other than listed|1|||
130299816|NCT04566601|469062243|FG004|Overall Study|Other than listed|4|||
130299817|NCT04566601|469062239|FG000|Overall Study|Protocol deviation|3|||
130299818|NCT04566601|469062240|FG001|Overall Study|Protocol deviation|0|||
130299819|NCT04566601|469062241|FG002|Overall Study|Protocol deviation|1|||
130299820|NCT04566601|469062242|FG003|Overall Study|Protocol deviation|1|||
130299821|NCT04566601|469062243|FG004|Overall Study|Protocol deviation|1|||
130299822|NCT04566601|469062239|FG000|Overall Study|Technical problems|0|||
130299823|NCT04566601|469062240|FG001|Overall Study|Technical problems|0|||
130299824|NCT04566601|469062241|FG002|Overall Study|Technical problems|1|||
130299825|NCT04566601|469062242|FG003|Overall Study|Technical problems|0|||
130299826|NCT04566601|469062243|FG004|Overall Study|Technical problems|0|||
130299827|NCT04566601|469062239|FG000|Overall Study|No reason available|3|||
130299828|NCT04566601|469062240|FG001|Overall Study|No reason available|2|||
130299829|NCT04566601|469062241|FG002|Overall Study|No reason available|7|||
130299830|NCT04566601|469062242|FG003|Overall Study|No reason available|1|||
130299831|NCT04566601|469062243|FG004|Overall Study|No reason available|5|||
130299832|NCT04566601|469062239|FG000|Overall Study|Burden of study procedures|3|||
130299833|NCT04566601|469062240|FG001|Overall Study|Burden of study procedures|0|||
130372916|NCT03129100|469333340|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372917|NCT03129100|469333341|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130299834|NCT04566601|469062241|FG002|Overall Study|Burden of study procedures|0|||
130299835|NCT04566601|469062242|FG003|Overall Study|Burden of study procedures|3|||
130299836|NCT04566601|469062243|FG004|Overall Study|Burden of study procedures|1|||
130299837|NCT04566601|469062239|FG000|Overall Study|Change of residence|2|||
130716359|NCT01297465|470588830|FG001|Overall Study|Intention to Freeze all Embryos|1|||
130716360|NCT00369655|470588831|FG000|Overall Study|Refusal of further treatment|2|||
130716361|NCT04049617|470588832|FG000|Overall Study|Adverse Event|0|||
130716362|NCT04049617|470588833|FG001|Overall Study|Adverse Event|0|||
130716363|NCT04049617|470588834|FG002|Overall Study|Adverse Event|0|||
130716364|NCT04049617|470588835|FG003|Overall Study|Adverse Event|1|||
130716365|NCT04049617|470588836|FG004|Overall Study|Adverse Event|0|||
130716366|NCT04049617|470588837|FG005|Overall Study|Adverse Event|0|||
130716367|NCT04049617|470588832|FG000|Overall Study|Death|0|||
130716368|NCT04049617|470588833|FG001|Overall Study|Death|0|||
130716369|NCT04049617|470588834|FG002|Overall Study|Death|0|||
130716370|NCT04049617|470588835|FG003|Overall Study|Death|0|||
130716371|NCT04049617|470588836|FG004|Overall Study|Death|0|||
130716372|NCT04049617|470588837|FG005|Overall Study|Death|1|||
130716373|NCT04049617|470588832|FG000|Overall Study|Lost to Follow-up|0|||
130299838|NCT04566601|469062240|FG001|Overall Study|Change of residence|2|||
130299839|NCT04566601|469062241|FG002|Overall Study|Change of residence|0|||
130299840|NCT04566601|469062242|FG003|Overall Study|Change of residence|1|||
130299841|NCT04566601|469062243|FG004|Overall Study|Change of residence|2|||
130299842|NCT04566601|469062239|FG000|Overall Study|Perceived lack of efficacy|2|||
130299843|NCT04566601|469062240|FG001|Overall Study|Perceived lack of efficacy|0|||
130299844|NCT04566601|469062241|FG002|Overall Study|Perceived lack of efficacy|1|||
130299845|NCT04566601|469062242|FG003|Overall Study|Perceived lack of efficacy|1|||
130299846|NCT04566601|469062243|FG004|Overall Study|Perceived lack of efficacy|2|||
130299847|NCT04566601|469062239|FG000|Overall Study|Adverse Event|7|||
130299848|NCT04566601|469062240|FG001|Overall Study|Adverse Event|4|||
130299849|NCT04566601|469062241|FG002|Overall Study|Adverse Event|6|||
130299850|NCT04566601|469062242|FG003|Overall Study|Adverse Event|5|||
130299851|NCT04566601|469062243|FG004|Overall Study|Adverse Event|12|||
130299852|NCT01363661|469062245|FG000|Overall Study|Adverse Event|9|||
130299853|NCT01363661|469062246|FG001|Overall Study|Adverse Event|2|||
130299854|NCT01363661|469062245|FG000|Overall Study|Withdrawal by Subject|1|||
130299855|NCT01363661|469062246|FG001|Overall Study|Withdrawal by Subject|1|||
130299856|NCT01363661|469062245|FG000|Overall Study|Protocol Violation|1|||
130299857|NCT01363661|469062246|FG001|Overall Study|Protocol Violation|0|||
130299858|NCT01363661|469062245|FG000|Overall Study|Lost to Follow-up|3|||
130299859|NCT01363661|469062246|FG001|Overall Study|Lost to Follow-up|1|||
130299860|NCT03775512|469062247|FG000|Overall Study|Death|1|||
130299861|NCT03775512|469062248|FG001|Overall Study|Death|1|||
130299862|NCT03775512|469062247|FG000|Overall Study|Withdrawal by Subject|7|||
130299863|NCT03775512|469062248|FG001|Overall Study|Withdrawal by Subject|4|||
130299864|NCT03775512|469062247|FG000|Overall Study|Lost to Follow-up|5|||
130299865|NCT03775512|469062248|FG001|Overall Study|Lost to Follow-up|5|||
130299866|NCT03775512|469062247|FG000|Overall Study|Excluded before Catheter insertion|14|||
130299867|NCT03775512|469062248|FG001|Overall Study|Excluded before Catheter insertion|5|||
130299868|NCT03775512|469062247|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
130299869|NCT03775512|469062248|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
130299870|NCT03775512|469062247|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
130299871|NCT03775512|469062248|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
130299872|NCT01378325|469062251|FG000|Overall Study|Protocol Violation|0|||
130299873|NCT01378325|469062252|FG001|Overall Study|Protocol Violation|1|||
130299874|NCT00767806|469062253|FG000|Overall Study|Adverse Event|30|||
130299875|NCT00767806|469062254|FG001|Overall Study|Adverse Event|11|||
130299876|NCT00767806|469062253|FG000|Overall Study|Withdrawal by Subject|8|||
130299877|NCT00767806|469062254|FG001|Overall Study|Withdrawal by Subject|13|||
130557342|NCT00528567|470009962|FG001|Overall Study|Administrative/Other|75|||
130557343|NCT00631189|470009965|FG000|Initial Phase|Protocol Violation|347|||
130716374|NCT04049617|470588833|FG001|Overall Study|Lost to Follow-up|0|||
130716375|NCT04049617|470588834|FG002|Overall Study|Lost to Follow-up|0|||
130716376|NCT04049617|470588835|FG003|Overall Study|Lost to Follow-up|1|||
130716377|NCT04049617|470588836|FG004|Overall Study|Lost to Follow-up|0|||
130716378|NCT04049617|470588837|FG005|Overall Study|Lost to Follow-up|0|||
130716379|NCT04049617|470588832|FG000|Overall Study|Withdrew consent|0|||
130716380|NCT04049617|470588833|FG001|Overall Study|Withdrew consent|0|||
130299878|NCT00767806|469062253|FG000|Overall Study|Protocol Violation|6|||
130299879|NCT00767806|469062254|FG001|Overall Study|Protocol Violation|5|||
130299880|NCT00767806|469062253|FG000|Overall Study|Lack of Efficacy|1|||
130299881|NCT00767806|469062254|FG001|Overall Study|Lack of Efficacy|9|||
130299882|NCT00767806|469062253|FG000|Overall Study|Physician Decision|4|||
130299883|NCT00767806|469062254|FG001|Overall Study|Physician Decision|3|||
130299884|NCT00767806|469062253|FG000|Overall Study|Lost to Follow-up|1|||
130299885|NCT00767806|469062254|FG001|Overall Study|Lost to Follow-up|4|||
130299886|NCT00767806|469062253|FG000|Overall Study|Entry Criteria Not Met|1|||
130299887|NCT00767806|469062254|FG001|Overall Study|Entry Criteria Not Met|1|||
130299888|NCT00767806|469062253|FG000|Overall Study|Sponsor Decision|0|||
130299889|NCT00767806|469062254|FG001|Overall Study|Sponsor Decision|1|||
130299890|NCT01272635|469062255|FG000|Overall Study|Lost to Follow-up|31|||
130716381|NCT04049617|470588834|FG002|Overall Study|Withdrew consent|1|||
130716382|NCT04049617|470588835|FG003|Overall Study|Withdrew consent|0|||
130716383|NCT04049617|470588836|FG004|Overall Study|Withdrew consent|0|||
130716384|NCT04049617|470588837|FG005|Overall Study|Withdrew consent|0|||
130716385|NCT03551496|470588838|FG000|Overall Study|Death|11|||
130299891|NCT01272635|469062256|FG001|Overall Study|Lost to Follow-up|20|||
130299892|NCT01272635|469062257|FG002|Overall Study|Lost to Follow-up|31|||
130299893|NCT01272635|469062258|FG003|Overall Study|Lost to Follow-up|23|||
130299894|NCT02397057|469062261|FG000|Overall Study|Withdrawal by Subject|6|||
130299895|NCT02397057|469062262|FG001|Overall Study|Withdrawal by Subject|7|||
130299896|NCT02397057|469062261|FG000|Overall Study|Lost to Follow-up|4|||
130299897|NCT02397057|469062262|FG001|Overall Study|Lost to Follow-up|3|||
130299898|NCT02397057|469062261|FG000|Overall Study|Death|1|||
130299899|NCT02397057|469062262|FG001|Overall Study|Death|0|||
130299900|NCT02397057|469062261|FG000|Overall Study|Adverse Event|0|||
130299901|NCT02397057|469062262|FG001|Overall Study|Adverse Event|1|||
130299902|NCT02397057|469062261|FG000|Overall Study|Physician Decision|0|||
130299903|NCT02397057|469062262|FG001|Overall Study|Physician Decision|1|||
130299904|NCT02397057|469062261|FG000|Overall Study|Subject did not receive study drug|0|||
130299905|NCT02397057|469062262|FG001|Overall Study|Subject did not receive study drug|1|||
130299906|NCT01393639|469062263|FG000|Overall Study|Protocol Violation|0|||
130299907|NCT01393639|469062264|FG001|Overall Study|Protocol Violation|0|||
130299908|NCT01393639|469062265|FG002|Overall Study|Protocol Violation|0|||
130299909|NCT01393639|469062266|FG003|Overall Study|Protocol Violation|1|||
130299910|NCT01393639|469062267|FG004|Overall Study|Protocol Violation|0|||
130299911|NCT01393639|469062268|FG005|Overall Study|Protocol Violation|0|||
130299912|NCT01393639|469062269|FG006|Overall Study|Protocol Violation|0|||
130299913|NCT01393639|469062263|FG000|Overall Study|Other|0|||
130299914|NCT01393639|469062264|FG001|Overall Study|Other|2|||
130299915|NCT01393639|469062265|FG002|Overall Study|Other|0|||
130299916|NCT01393639|469062266|FG003|Overall Study|Other|2|||
130299917|NCT01393639|469062267|FG004|Overall Study|Other|1|||
130299918|NCT01393639|469062268|FG005|Overall Study|Other|0|||
130299919|NCT01393639|469062269|FG006|Overall Study|Other|1|||
130299920|NCT01393639|469062263|FG000|Overall Study|Withdrawal by Subject|1|||
130299921|NCT01393639|469062264|FG001|Overall Study|Withdrawal by Subject|1|||
130299922|NCT01393639|469062265|FG002|Overall Study|Withdrawal by Subject|0|||
130299923|NCT01393639|469062266|FG003|Overall Study|Withdrawal by Subject|0|||
130299924|NCT01393639|469062267|FG004|Overall Study|Withdrawal by Subject|0|||
130299925|NCT01393639|469062268|FG005|Overall Study|Withdrawal by Subject|0|||
130299926|NCT01393639|469062269|FG006|Overall Study|Withdrawal by Subject|1|||
130299927|NCT01393639|469062263|FG000|Overall Study|Medication error without associated AE|0|||
130299928|NCT01393639|469062264|FG001|Overall Study|Medication error without associated AE|0|||
130299929|NCT01393639|469062265|FG002|Overall Study|Medication error without associated AE|0|||
130299930|NCT01393639|469062266|FG003|Overall Study|Medication error without associated AE|0|||
130299931|NCT01393639|469062267|FG004|Overall Study|Medication error without associated AE|0|||
130299932|NCT01393639|469062268|FG005|Overall Study|Medication error without associated AE|0|||
130299933|NCT01393639|469062269|FG006|Overall Study|Medication error without associated AE|1|||
130299934|NCT01393639|469062263|FG000|Overall Study|Lost to Follow-up|0|||
130299935|NCT01393639|469062264|FG001|Overall Study|Lost to Follow-up|1|||
130299936|NCT01393639|469062265|FG002|Overall Study|Lost to Follow-up|0|||
130299937|NCT01393639|469062266|FG003|Overall Study|Lost to Follow-up|0|||
130299938|NCT01393639|469062267|FG004|Overall Study|Lost to Follow-up|0|||
130716386|NCT03551496|470588839|FG001|Overall Study|Death|7|||
130716387|NCT03551496|470588838|FG000|Overall Study|Withdrawal by Subject|4|||
130716388|NCT03551496|470588839|FG001|Overall Study|Withdrawal by Subject|3|||
130716389|NCT03551496|470588838|FG000|Overall Study|Other Reasons|1|||
130716390|NCT03551496|470588839|FG001|Overall Study|Other Reasons|0|||
130299939|NCT01393639|469062268|FG005|Overall Study|Lost to Follow-up|0|||
130299940|NCT01393639|469062269|FG006|Overall Study|Lost to Follow-up|1|||
130299941|NCT01393639|469062263|FG000|Overall Study|Lack of Efficacy|0|||
130299942|NCT01393639|469062264|FG001|Overall Study|Lack of Efficacy|0|||
130299943|NCT01393639|469062265|FG002|Overall Study|Lack of Efficacy|0|||
130299944|NCT01393639|469062266|FG003|Overall Study|Lack of Efficacy|0|||
130299945|NCT01393639|469062267|FG004|Overall Study|Lack of Efficacy|0|||
130299946|NCT01393639|469062268|FG005|Overall Study|Lack of Efficacy|0|||
130299947|NCT01393639|469062269|FG006|Overall Study|Lack of Efficacy|1|||
130299948|NCT01393639|469062263|FG000|Overall Study|Adverse Event|2|||
130299949|NCT01393639|469062264|FG001|Overall Study|Adverse Event|3|||
130299950|NCT01393639|469062265|FG002|Overall Study|Adverse Event|1|||
130299951|NCT01393639|469062266|FG003|Overall Study|Adverse Event|2|||
130299952|NCT01393639|469062267|FG004|Overall Study|Adverse Event|0|||
130299953|NCT01393639|469062268|FG005|Overall Study|Adverse Event|2|||
130299954|NCT01393639|469062269|FG006|Overall Study|Adverse Event|3|||
130299955|NCT02241343|469062272|FG000|Overall Study|Adverse Event|1|||
130299956|NCT01329939|469062275|FG000|Overall Study|Lost to Follow-up|3|||
130299957|NCT01329939|469062276|FG001|Overall Study|Lost to Follow-up|0|||
130716391|NCT00140426|470588840|FG000|Overall Study|Withdrawal by Subject|0|||
130299958|NCT01329939|469062277|FG002|Overall Study|Lost to Follow-up|1|||
130299959|NCT01329939|469062278|FG003|Overall Study|Lost to Follow-up|2|||
130299960|NCT01329939|469062275|FG000|Overall Study|Withdrawal by Subject|0|||
130299961|NCT01329939|469062276|FG001|Overall Study|Withdrawal by Subject|1|||
130299962|NCT01329939|469062277|FG002|Overall Study|Withdrawal by Subject|0|||
130299963|NCT01329939|469062278|FG003|Overall Study|Withdrawal by Subject|0|||
130299964|NCT01329939|469062275|FG000|Overall Study|Adverse Event|0|||
130299965|NCT01329939|469062276|FG001|Overall Study|Adverse Event|0|||
130299966|NCT01329939|469062277|FG002|Overall Study|Adverse Event|0|||
130299967|NCT01329939|469062278|FG003|Overall Study|Adverse Event|3|||
130299968|NCT03722524|469062279|FG000|Overall Study|Protocol Violation|86|||
130299969|NCT03722524|469062279|FG000|Overall Study|Adverse Event|7|||
130299970|NCT03722524|469062279|FG000|Overall Study|Lost to Follow-up|1|||
130299971|NCT03722524|469062279|FG000|Overall Study|Reason is not stated|1|||
130299972|NCT03722524|469062279|FG000|Overall Study|Physician Decision|1|||
130299973|NCT03722524|469062279|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
130299974|NCT02942485|469062280|FG000|Overall Study|Lost to Follow-up|1|||
130299975|NCT02942485|469062281|FG001|Overall Study|Lost to Follow-up|0|||
130299976|NCT04369950|469062283|FG000|Overall Study|Protocol Violation|2|||
130299977|NCT04369950|469062284|FG001|Overall Study|Protocol Violation|2|||
130299978|NCT00989963|469062285|FG000|Overall Study|Adverse Event|1|||
130299979|NCT00989963|469062286|FG001|Overall Study|Adverse Event|1|||
130299980|NCT00989963|469062287|FG002|Overall Study|Adverse Event|1|||
130299981|NCT01240200|469062288|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
130299982|NCT01240200|469062289|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
130299983|NCT00646399|469062292|FG000|Overall Study|Death|63|||
130299984|NCT00646399|469062293|FG001|Overall Study|Death|53|||
130299985|NCT00646399|469062292|FG000|Overall Study|Withdrawal by Subject|9|||
130299986|NCT00646399|469062293|FG001|Overall Study|Withdrawal by Subject|10|||
130299987|NCT00646399|469062292|FG000|Overall Study|Other Reason|11|||
130299988|NCT00646399|469062293|FG001|Overall Study|Other Reason|11|||
130299989|NCT00455143|469062297|FG000|Overall Study|Physician Decision|1|||
130299990|NCT00455143|469062297|FG000|Overall Study|Withdrawal by Subject|1|||
130299991|NCT00455143|469062297|FG000|Overall Study|Staff was not avail to follow patient|2|||
130299992|NCT00455143|469062297|FG000|Overall Study|No longer met Inclusion Criteria|1|||
130299993|NCT00455143|469062297|FG000|Overall Study|Surgical time, staff not available|1|||
130299994|NCT00470418|469062298|FG000|Overall Study|Withdrawal by Subject|1|||
130299995|NCT00470418|469062299|FG001|Overall Study|Withdrawal by Subject|0|||
130299996|NCT02479139|469062300|FG000|Overall Study|Lost to Follow-up|2|||
130299997|NCT02479139|469062301|FG001|Overall Study|Lost to Follow-up|4|||
130299998|NCT02479139|469062302|FG002|Overall Study|Lost to Follow-up|4|||
130716392|NCT00140426|470588841|FG001|Overall Study|Withdrawal by Subject|3|||
130716393|NCT02149108|470588842|FG000|Overall Study|Not treated|1|||
130716394|NCT02149108|470588843|FG001|Overall Study|Not treated|2|||
130299999|NCT02479139|469062303|FG003|Overall Study|Lost to Follow-up|2|||
130300000|NCT02479139|469062304|FG004|Overall Study|Lost to Follow-up|3|||
130300001|NCT02479139|469062305|FG005|Overall Study|Lost to Follow-up|5|||
130300002|NCT02479139|469062300|FG000|Overall Study|Withdrew Consent|5|||
130461772|NCT00424762|469656239|FG000|Overall Study|Lost to Follow-up|2|||
130461773|NCT00424762|469656240|FG001|Overall Study|Lost to Follow-up|3|||
130461774|NCT01147341|469656243|FG000|Double Blind Period|Lack of Efficacy|1|||
130461775|NCT01147341|469656244|FG001|Double Blind Period|Lack of Efficacy|1|||
130461776|NCT01147341|469656243|FG000|Double Blind Period|Withdrawal by Subject|0|||
130461777|NCT01147341|469656244|FG001|Double Blind Period|Withdrawal by Subject|1|||
130716395|NCT02149108|470588842|FG000|Overall Study|Progressive Disease (PD)|324|||
130716396|NCT02149108|470588843|FG001|Overall Study|Progressive Disease (PD)|318|||
130716397|NCT02149108|470588842|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
130716398|NCT02149108|470588843|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
130300003|NCT02479139|469062301|FG001|Overall Study|Withdrew Consent|6|||
130300004|NCT02479139|469062302|FG002|Overall Study|Withdrew Consent|1|||
130300005|NCT02479139|469062303|FG003|Overall Study|Withdrew Consent|4|||
130300006|NCT02479139|469062304|FG004|Overall Study|Withdrew Consent|1|||
130300007|NCT02479139|469062305|FG005|Overall Study|Withdrew Consent|1|||
130300008|NCT02479139|469062300|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300009|NCT02479139|469062301|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300010|NCT02479139|469062302|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
130300011|NCT02479139|469062303|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300012|NCT02479139|469062304|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300013|NCT02479139|469062305|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300014|NCT02479139|469062300|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130300015|NCT02479139|469062301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130300016|NCT02479139|469062302|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130300017|NCT02479139|469062303|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130300018|NCT02479139|469062304|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130300019|NCT02479139|469062305|FG005|Overall Study|Other Miscellaneous Reasons|0|||
130461778|NCT01147341|469656243|FG000|Open Label Period|Lack of Efficacy|3|||
130461779|NCT01147341|469656244|FG001|Open Label Period|Lack of Efficacy|0|||
130716399|NCT02149108|470588842|FG000|Overall Study|Other Adverse Event (AE)|8|||
130716400|NCT02149108|470588843|FG001|Overall Study|Other Adverse Event (AE)|18|||
130716401|NCT02149108|470588842|FG000|Overall Study|Other not defined above|0|||
130300020|NCT00885482|469062306|FG000|Overall Study|Pregnancy|1|||
130300021|NCT00885482|469062306|FG000|Overall Study|Lack of Efficacy|1|||
130300022|NCT00885482|469062306|FG000|Overall Study|Death|1|||
130300023|NCT00885482|469062306|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
130300024|NCT00084656|469062307|FG000|Overall Study|Other reasons|0|||
130300025|NCT00084656|469062308|FG001|Overall Study|Other reasons|12|||
130300026|NCT00084656|469062309|FG002|Overall Study|Other reasons|11|||
130300027|NCT00084656|469062307|FG000|Overall Study|Withdrawal by Subject|15|||
130300028|NCT00084656|469062308|FG001|Overall Study|Withdrawal by Subject|4|||
130300029|NCT00084656|469062309|FG002|Overall Study|Withdrawal by Subject|4|||
130300030|NCT00084656|469062307|FG000|Overall Study|Disease relapse|0|||
130300031|NCT00084656|469062308|FG001|Overall Study|Disease relapse|9|||
130300032|NCT00084656|469062309|FG002|Overall Study|Disease relapse|10|||
130300033|NCT00084656|469062307|FG000|Overall Study|Disease progression|9|||
130300034|NCT00084656|469062308|FG001|Overall Study|Disease progression|0|||
130300035|NCT00084656|469062309|FG002|Overall Study|Disease progression|0|||
130300036|NCT00084656|469062307|FG000|Overall Study|Lost to Follow-up|1|||
130300037|NCT00084656|469062308|FG001|Overall Study|Lost to Follow-up|0|||
130300038|NCT00084656|469062309|FG002|Overall Study|Lost to Follow-up|1|||
130300039|NCT02772978|469062310|FG000|Overall Study|Withdrawal by Subject|1|||
130300040|NCT02772978|469062311|FG001|Overall Study|Withdrawal by Subject|1|||
130300041|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
130300042|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
130300043|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
130300044|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
130300045|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
130300046|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
130300047|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
130300048|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
130300049|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130300050|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130300051|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
130300052|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
130300053|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
130300054|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
130300055|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
130300056|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
130300057|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
130300058|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
130300059|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
130300060|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
130300061|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
130300062|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
130300063|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
130300064|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
130300065|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
130300066|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
130300067|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
130300068|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
130300069|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
130300070|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
130300071|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130300072|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130300073|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130300074|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130372918|NCT03129100|469333342|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372919|NCT03129100|469333343|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372920|NCT03129100|469333344|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372921|NCT03129100|469333345|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372922|NCT03129100|469333346|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372923|NCT03129100|469333347|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372924|NCT03129100|469333348|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372925|NCT03129100|469333349|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372926|NCT03129100|469333350|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372927|NCT03129100|469333351|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130716402|NCT02149108|470588843|FG001|Overall Study|Other not defined above|2|||
130716403|NCT02149108|470588842|FG000|Overall Study|Refusal to continue trial medication|15|||
130461780|NCT01147341|469656243|FG000|Open Label Period|Subject moved|1|||
130461781|NCT01147341|469656244|FG001|Open Label Period|Subject moved|0|||
130461782|NCT00367991|469656245|FG000|Overall Study|Withdrawal by Subject|1|||
130372928|NCT03129100|469333352|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372929|NCT03129100|469333353|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372930|NCT03129100|469333354|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372931|NCT03129100|469333355|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372932|NCT03129100|469333356|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372933|NCT03129100|469333357|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372934|NCT03129100|469333358|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372935|NCT03129100|469333359|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
130372936|NCT03129100|469333360|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372937|NCT03129100|469333361|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372938|NCT03129100|469333362|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372939|NCT03129100|469333363|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372940|NCT03129100|469333364|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130372941|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
130372942|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
130372943|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
130372944|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
130372945|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
130372946|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
130372947|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
130372948|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
130372949|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
130372950|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
130461783|NCT00367991|469656246|FG001|Overall Study|Withdrawal by Subject|1|||
130461784|NCT00367991|469656245|FG000|Overall Study|Adverse Event|1|||
130461785|NCT00367991|469656246|FG001|Overall Study|Adverse Event|1|||
130461786|NCT03024606|469656251|FG000|Overall Study|Withdrawal by Subject|9|||
130461787|NCT03024606|469656252|FG001|Overall Study|Withdrawal by Subject|10|||
130461788|NCT03401112|469656253|FG000|Overall Study|Adverse Event|1|||
130300075|NCT01331291|469062314|FG000|Overall Study|Lack of Efficacy|2|||
130300076|NCT01331291|469062315|FG001|Overall Study|Lack of Efficacy|8|||
130300077|NCT01331291|469062314|FG000|Overall Study|Death|0|||
130300078|NCT01331291|469062315|FG001|Overall Study|Death|1|||
130300079|NCT00778895|469062316|FG000|Active Phase|Adverse Event|3|||
130300080|NCT00778895|469062317|FG001|Active Phase|Adverse Event|1|||
130300081|NCT00778895|469062318|FG002|Active Phase|Adverse Event|0|||
130300082|NCT00778895|469062316|FG000|Active Phase|Withdrawal by Subject|1|||
130300083|NCT00778895|469062317|FG001|Active Phase|Withdrawal by Subject|4|||
130300084|NCT00778895|469062318|FG002|Active Phase|Withdrawal by Subject|0|||
130300085|NCT00778895|469062316|FG000|Active Phase|Lost to Follow-up|1|||
130300086|NCT00778895|469062317|FG001|Active Phase|Lost to Follow-up|1|||
130300087|NCT00778895|469062318|FG002|Active Phase|Lost to Follow-up|0|||
130300088|NCT00778895|469062316|FG000|Active Phase|Other|2|||
130300089|NCT00778895|469062317|FG001|Active Phase|Other|0|||
130300090|NCT00778895|469062318|FG002|Active Phase|Other|0|||
130300091|NCT00778895|469062316|FG000|ESFU Phase|Adverse Event|2|||
130300092|NCT00778895|469062317|FG001|ESFU Phase|Adverse Event|1|||
130300093|NCT00778895|469062318|FG002|ESFU Phase|Adverse Event|0|||
130300094|NCT00778895|469062316|FG000|ESFU Phase|Withdrawal by Subject|1|||
130300095|NCT00778895|469062317|FG001|ESFU Phase|Withdrawal by Subject|4|||
130300096|NCT00778895|469062318|FG002|ESFU Phase|Withdrawal by Subject|0|||
130300097|NCT00778895|469062316|FG000|ESFU Phase|Lost to Follow-up|6|||
130300098|NCT00778895|469062317|FG001|ESFU Phase|Lost to Follow-up|7|||
130300099|NCT00778895|469062318|FG002|ESFU Phase|Lost to Follow-up|2|||
130300100|NCT00778895|469062316|FG000|ESFU Phase|Other|2|||
130300101|NCT00778895|469062317|FG001|ESFU Phase|Other|0|||
130300102|NCT00778895|469062318|FG002|ESFU Phase|Other|0|||
130300103|NCT02540993|469062320|FG000|Overall Study|Lost to Follow-up|5|||
130372951|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
130372952|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
130372953|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
130372954|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
130461789|NCT03401112|469656254|FG001|Overall Study|Adverse Event|2|||
130461790|NCT03401112|469656255|FG002|Overall Study|Adverse Event|3|||
130300104|NCT02540993|469062321|FG001|Overall Study|Lost to Follow-up|3|||
130300105|NCT02540993|469062320|FG000|Overall Study|Withdrawal by Subject|4|||
130300106|NCT02540993|469062321|FG001|Overall Study|Withdrawal by Subject|6|||
130300107|NCT02540993|469062320|FG000|Overall Study|GCP violations|33|||
130300108|NCT02540993|469062321|FG001|Overall Study|GCP violations|27|||
130300109|NCT00409344|469062322|FG000|Overall Study|no enrollment|0|||
130300110|NCT00409344|469062323|FG001|Overall Study|no enrollment|0|||
130300111|NCT01009086|469062324|FG000|Overall Study|Lack of Efficacy|16|||
130300112|NCT01009086|469062325|FG001|Overall Study|Lack of Efficacy|15|||
130300113|NCT01009086|469062326|FG002|Overall Study|Lack of Efficacy|9|||
130300114|NCT01009086|469062324|FG000|Overall Study|Lost to Follow-up|4|||
130716404|NCT02149108|470588843|FG001|Overall Study|Refusal to continue trial medication|11|||
130716405|NCT02149108|470588842|FG000|Overall Study|Lost to Follow-up|1|||
130716406|NCT02149108|470588843|FG001|Overall Study|Lost to Follow-up|0|||
130300115|NCT01009086|469062325|FG001|Overall Study|Lost to Follow-up|5|||
130300116|NCT01009086|469062326|FG002|Overall Study|Lost to Follow-up|3|||
130300117|NCT01009086|469062324|FG000|Overall Study|Adverse Event|12|||
130300118|NCT01009086|469062325|FG001|Overall Study|Adverse Event|11|||
130300119|NCT01009086|469062326|FG002|Overall Study|Adverse Event|8|||
130300120|NCT01009086|469062324|FG000|Overall Study|Withdrawal by Subject|9|||
130300121|NCT01009086|469062325|FG001|Overall Study|Withdrawal by Subject|11|||
130300122|NCT01009086|469062326|FG002|Overall Study|Withdrawal by Subject|13|||
130300123|NCT01009086|469062324|FG000|Overall Study|Other|3|||
130300124|NCT01009086|469062325|FG001|Overall Study|Other|5|||
130300125|NCT01009086|469062326|FG002|Overall Study|Other|1|||
130300126|NCT03135210|469062327|FG000|Overall Study|Death|0|||
130300127|NCT03135210|469062328|FG001|Overall Study|Death|1|||
130300128|NCT00590577|469062330|FG000|Overall Study|Lack of Efficacy|31|||
130300129|NCT00590577|469062331|FG001|Overall Study|Lack of Efficacy|28|||
130300130|NCT00590577|469062332|FG002|Overall Study|Lack of Efficacy|23|||
130300131|NCT00590577|469062333|FG003|Overall Study|Lack of Efficacy|45|||
130300132|NCT00590577|469062330|FG000|Overall Study|Withdrawal by Subject|23|||
130300133|NCT00590577|469062331|FG001|Overall Study|Withdrawal by Subject|28|||
130300134|NCT00590577|469062332|FG002|Overall Study|Withdrawal by Subject|30|||
130300135|NCT00590577|469062333|FG003|Overall Study|Withdrawal by Subject|26|||
130300136|NCT00590577|469062330|FG000|Overall Study|Adverse Event|10|||
130300137|NCT00590577|469062331|FG001|Overall Study|Adverse Event|10|||
130300138|NCT00590577|469062332|FG002|Overall Study|Adverse Event|13|||
130300139|NCT00590577|469062333|FG003|Overall Study|Adverse Event|11|||
130300140|NCT00590577|469062330|FG000|Overall Study|Lost to Follow-up|12|||
130300141|NCT00590577|469062331|FG001|Overall Study|Lost to Follow-up|6|||
130300142|NCT00590577|469062332|FG002|Overall Study|Lost to Follow-up|6|||
130300143|NCT00590577|469062333|FG003|Overall Study|Lost to Follow-up|9|||
130300144|NCT00590577|469062330|FG000|Overall Study|Pregnancy|0|||
130300145|NCT00590577|469062331|FG001|Overall Study|Pregnancy|1|||
130300146|NCT00590577|469062332|FG002|Overall Study|Pregnancy|0|||
130300147|NCT00590577|469062333|FG003|Overall Study|Pregnancy|0|||
130300148|NCT00590577|469062330|FG000|Overall Study|Various reasons|1|||
130300149|NCT00590577|469062331|FG001|Overall Study|Various reasons|3|||
130300150|NCT00590577|469062332|FG002|Overall Study|Various reasons|1|||
130300151|NCT00590577|469062333|FG003|Overall Study|Various reasons|2|||
130300152|NCT04349033|469062334|FG000|Overall Study|Lost to Follow-up|3|||
130300153|NCT04349033|469062335|FG001|Overall Study|Lost to Follow-up|1|||
130300154|NCT04349033|469062336|FG002|Overall Study|Lost to Follow-up|1|||
130300155|NCT04058886|469062340|FG000|Overall Study|Withdrawal by Subject|4|||
130300156|NCT04058886|469062340|FG000|Overall Study|Inadequate deafness interpreter service|1|||
130300157|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
130300158|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
130300159|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
130300160|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
130300161|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
130300162|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
130300163|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
130300164|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
130300165|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
130300166|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
130300167|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
130300168|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
130300169|NCT02220712|469062346|FG000|Overall Study|Adverse Event|1|||
130300170|NCT02220712|469062346|FG000|Overall Study|Withdrawal by Subject|2|||
130300171|NCT02220712|469062346|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
130716407|NCT04765384|470588844|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
130716408|NCT04765384|470588845|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
130716409|NCT04765384|470588846|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
130716410|NCT04765384|470588847|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
130300172|NCT00760838|469062347|FG000|Overall Study|Adverse Event|1|||
130300173|NCT00760838|469062348|FG001|Overall Study|Adverse Event|1|||
130300174|NCT00760838|469062347|FG000|Overall Study|Lack of Efficacy|1|||
130300175|NCT00760838|469062348|FG001|Overall Study|Lack of Efficacy|0|||
130300176|NCT00760838|469062347|FG000|Overall Study|Lost to Follow-up|2|||
130300177|NCT00760838|469062348|FG001|Overall Study|Lost to Follow-up|0|||
130300178|NCT00760838|469062347|FG000|Overall Study|Withdrawal by Subject|1|||
130716411|NCT04765384|470588848|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
130300179|NCT00760838|469062348|FG001|Overall Study|Withdrawal by Subject|1|||
130300180|NCT03624127|469062349|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130300181|NCT03624127|469062350|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
130461791|NCT03401112|469656256|FG003|Overall Study|Adverse Event|2|||
130300182|NCT03624127|469062351|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130300183|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
130300184|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
130300185|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
130300186|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Death|0|||
130300187|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Death|1|||
130300188|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Death|0|||
130300189|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
130300190|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130300191|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130300192|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
130300193|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
130300194|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
130300195|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
130300196|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
130300197|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
130300198|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
130300199|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130300200|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130300201|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
130300202|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
130300203|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
130300204|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
130300205|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
130300206|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
130300207|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
130300208|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130300209|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130300210|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130300211|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130300212|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
130300213|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
130300214|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
130300215|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
130300216|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
130300217|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
130300218|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
130300219|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
130300220|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
130300221|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
130300222|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
130300223|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
130300224|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
130300225|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
130300226|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130300227|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130300228|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
130300229|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
130300230|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
130300231|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
130300232|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
130300233|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
130300234|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
130300235|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130300236|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130300237|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
130300238|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130300239|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130300240|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
130300241|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
130300242|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
130300243|NCT02607228|469062352|FG000|Overall Study|Progressive Disease|4|||
130461792|NCT03401112|469656257|FG004|Overall Study|Adverse Event|0|||
130300244|NCT02607228|469062353|FG001|Overall Study|Progressive Disease|3|||
130300245|NCT02607228|469062354|FG002|Overall Study|Progressive Disease|1|||
130300246|NCT02607228|469062355|FG003|Overall Study|Progressive Disease|5|||
130300247|NCT02607228|469062356|FG004|Overall Study|Progressive Disease|4|||
130300248|NCT02607228|469062357|FG005|Overall Study|Progressive Disease|3|||
130300249|NCT02607228|469062358|FG006|Overall Study|Progressive Disease|1|||
130300250|NCT02607228|469062352|FG000|Overall Study|Adverse Event|1|||
130300251|NCT02607228|469062353|FG001|Overall Study|Adverse Event|0|||
130461793|NCT03401112|469656253|FG000|Overall Study|Lost to Follow-up|1|||
130372955|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
130372956|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
130372957|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
130372958|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
130372959|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
130372960|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
130372961|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
130372962|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
130372963|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
130372964|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
130372965|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
130372966|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
130372967|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372968|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372969|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372970|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372971|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372972|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372973|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372974|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372975|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372976|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372977|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372978|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372979|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372980|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372981|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372982|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372983|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372984|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372985|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372986|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372987|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372988|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372989|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372990|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130372991|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
130372992|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
130372993|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372994|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372995|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372996|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372997|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372998|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130372999|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373000|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373001|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373002|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373003|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373004|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373005|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373006|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373007|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373008|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373009|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373010|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373011|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373012|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373013|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373014|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373015|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130373016|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
130373017|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
130373018|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
130373019|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373020|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130300252|NCT02607228|469062354|FG002|Overall Study|Adverse Event|1|||
130300253|NCT02607228|469062355|FG003|Overall Study|Adverse Event|0|||
130300254|NCT02607228|469062356|FG004|Overall Study|Adverse Event|1|||
130300255|NCT02607228|469062357|FG005|Overall Study|Adverse Event|1|||
130300256|NCT02607228|469062358|FG006|Overall Study|Adverse Event|1|||
130300257|NCT02607228|469062352|FG000|Overall Study|Investigator's Discretion|0|||
130300258|NCT02607228|469062353|FG001|Overall Study|Investigator's Discretion|0|||
130300259|NCT02607228|469062354|FG002|Overall Study|Investigator's Discretion|1|||
130300260|NCT02607228|469062355|FG003|Overall Study|Investigator's Discretion|0|||
130300261|NCT02607228|469062356|FG004|Overall Study|Investigator's Discretion|0|||
130300262|NCT02607228|469062357|FG005|Overall Study|Investigator's Discretion|1|||
130300263|NCT02607228|469062358|FG006|Overall Study|Investigator's Discretion|0|||
130300264|NCT02607228|469062352|FG000|Overall Study|Withdrew Consent|0|||
130300265|NCT02607228|469062353|FG001|Overall Study|Withdrew Consent|1|||
130300266|NCT02607228|469062354|FG002|Overall Study|Withdrew Consent|0|||
130300267|NCT02607228|469062355|FG003|Overall Study|Withdrew Consent|0|||
130300268|NCT02607228|469062356|FG004|Overall Study|Withdrew Consent|0|||
130300269|NCT02607228|469062357|FG005|Overall Study|Withdrew Consent|1|||
130300270|NCT02607228|469062358|FG006|Overall Study|Withdrew Consent|0|||
130300271|NCT02607228|469062352|FG000|Overall Study|Study Terminated by Sponsor|0|||
130300272|NCT02607228|469062353|FG001|Overall Study|Study Terminated by Sponsor|0|||
130300273|NCT02607228|469062354|FG002|Overall Study|Study Terminated by Sponsor|0|||
130300274|NCT02607228|469062355|FG003|Overall Study|Study Terminated by Sponsor|1|||
130300275|NCT02607228|469062356|FG004|Overall Study|Study Terminated by Sponsor|0|||
130300276|NCT02607228|469062357|FG005|Overall Study|Study Terminated by Sponsor|0|||
130300277|NCT02607228|469062358|FG006|Overall Study|Study Terminated by Sponsor|0|||
130300278|NCT03576716|469062361|FG000|Overall Study|Withdrawal by Subject|0|||
130300279|NCT03576716|469062362|FG001|Overall Study|Withdrawal by Subject|1|||
130300280|NCT00559988|469062363|FG000|Overall Study|Death|147|||
130300281|NCT00559988|469062364|FG001|Overall Study|Death|140|||
130300282|NCT00559988|469062363|FG000|Overall Study|Withdrawal by Subject|152|||
130300283|NCT00559988|469062364|FG001|Overall Study|Withdrawal by Subject|139|||
130300284|NCT00559988|469062363|FG000|Overall Study|Lost to Follow-up|42|||
130300285|NCT00559988|469062364|FG001|Overall Study|Lost to Follow-up|56|||
130300286|NCT00559988|469062363|FG000|Overall Study|ICD device explanted|10|||
130300287|NCT00559988|469062364|FG001|Overall Study|ICD device explanted|17|||
130300288|NCT01455194|469062365|FG000|Overall Study|Screen Failure|20|||
130300289|NCT01455194|469062366|FG001|Overall Study|Screen Failure|0|||
130300290|NCT01455194|469062367|FG002|Overall Study|Screen Failure|0|||
130300291|NCT01455194|469062368|FG003|Overall Study|Screen Failure|0|||
130300292|NCT01455194|469062365|FG000|Overall Study|Randomisation Failure|90|||
130300293|NCT01455194|469062366|FG001|Overall Study|Randomisation Failure|0|||
130300294|NCT01455194|469062367|FG002|Overall Study|Randomisation Failure|0|||
130300295|NCT01455194|469062368|FG003|Overall Study|Randomisation Failure|0|||
130300296|NCT01455194|469062365|FG000|Overall Study|Deterioration in asthma|12|||
130300297|NCT01455194|469062366|FG001|Overall Study|Deterioration in asthma|6|||
130300298|NCT01455194|469062367|FG002|Overall Study|Deterioration in asthma|14|||
130300299|NCT01455194|469062368|FG003|Overall Study|Deterioration in asthma|9|||
130300300|NCT01455194|469062365|FG000|Overall Study|Adverse Event|1|||
130300301|NCT01455194|469062366|FG001|Overall Study|Adverse Event|1|||
130300302|NCT01455194|469062367|FG002|Overall Study|Adverse Event|1|||
130300303|NCT01455194|469062368|FG003|Overall Study|Adverse Event|3|||
130300304|NCT01455194|469062365|FG000|Overall Study|Withdrawal by Subject|21|||
130300305|NCT01455194|469062366|FG001|Overall Study|Withdrawal by Subject|16|||
130300306|NCT01455194|469062367|FG002|Overall Study|Withdrawal by Subject|12|||
130300307|NCT01455194|469062368|FG003|Overall Study|Withdrawal by Subject|9|||
130300308|NCT01455194|469062365|FG000|Overall Study|Lost to Follow-up|2|||
130300309|NCT01455194|469062366|FG001|Overall Study|Lost to Follow-up|0|||
130300310|NCT01455194|469062367|FG002|Overall Study|Lost to Follow-up|1|||
130300311|NCT01455194|469062368|FG003|Overall Study|Lost to Follow-up|1|||
130300312|NCT01455194|469062365|FG000|Overall Study|Pregnancy|0|||
130300313|NCT01455194|469062366|FG001|Overall Study|Pregnancy|1|||
130300314|NCT01455194|469062367|FG002|Overall Study|Pregnancy|1|||
130300315|NCT01455194|469062368|FG003|Overall Study|Pregnancy|0|||
130300316|NCT01455194|469062365|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
130300317|NCT01455194|469062366|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
130300318|NCT01455194|469062367|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
130300319|NCT01455194|469062368|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
130300320|NCT01455194|469062365|FG000|Overall Study|Miscellaneous|4|||
130300321|NCT01455194|469062366|FG001|Overall Study|Miscellaneous|5|||
130300322|NCT01455194|469062367|FG002|Overall Study|Miscellaneous|1|||
130300323|NCT01455194|469062368|FG003|Overall Study|Miscellaneous|4|||
130300324|NCT02249182|469062369|FG000|Treatment Phase|Lost to Follow-up|4|||
130300325|NCT02249182|469062370|FG001|Treatment Phase|Lost to Follow-up|0|||
130300326|NCT02249182|469062371|FG002|Treatment Phase|Lost to Follow-up|0|||
130300327|NCT02249182|469062372|FG003|Treatment Phase|Lost to Follow-up|0|||
130300328|NCT02249182|469062373|FG004|Treatment Phase|Lost to Follow-up|0|||
130300329|NCT04356040|469062376|FG000|Overall Study|Death|2|||
130300330|NCT04356040|469062377|FG001|Overall Study|Death|0|||
130461794|NCT03401112|469656254|FG001|Overall Study|Lost to Follow-up|0|||
130461795|NCT03401112|469656255|FG002|Overall Study|Lost to Follow-up|0|||
130461796|NCT03401112|469656256|FG003|Overall Study|Lost to Follow-up|0|||
130461797|NCT03401112|469656257|FG004|Overall Study|Lost to Follow-up|0|||
130461798|NCT03401112|469656253|FG000|Overall Study|Noncompliance|1|||
130461799|NCT03401112|469656254|FG001|Overall Study|Noncompliance|2|||
130300331|NCT04356040|469062376|FG000|Overall Study|Lost to Follow-up|1|||
130300332|NCT04356040|469062377|FG001|Overall Study|Lost to Follow-up|0|||
130300333|NCT04356040|469062376|FG000|Overall Study|Physician Decision|0|||
130300334|NCT04356040|469062377|FG001|Overall Study|Physician Decision|1|||
130300335|NCT04356040|469062376|FG000|Overall Study|Withdrawal by Subject|13|||
130300336|NCT04356040|469062377|FG001|Overall Study|Withdrawal by Subject|1|||
130300337|NCT04356040|469062376|FG000|Overall Study|Enrollment Pause|10|||
130300338|NCT04356040|469062377|FG001|Overall Study|Enrollment Pause|0|||
130300339|NCT04356040|469062376|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
130300340|NCT04356040|469062377|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
130300341|NCT04356040|469062376|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
130300342|NCT04356040|469062377|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
130300343|NCT04356040|469062376|FG000|Overall Study|PI left institution|3|||
130300344|NCT04356040|469062377|FG001|Overall Study|PI left institution|0|||
130300345|NCT00788710|469062378|FG000|Overall Study|Adverse Event|1|||
130300346|NCT00788710|469062379|FG001|Overall Study|Adverse Event|3|||
130300347|NCT00788710|469062380|FG002|Overall Study|Adverse Event|4|||
130300348|NCT00788710|469062378|FG000|Overall Study|Lack of Efficacy|0|||
130300349|NCT00788710|469062379|FG001|Overall Study|Lack of Efficacy|0|||
130300350|NCT00788710|469062380|FG002|Overall Study|Lack of Efficacy|1|||
130300351|NCT00788710|469062378|FG000|Overall Study|Lost to Follow-up|0|||
130300352|NCT00788710|469062379|FG001|Overall Study|Lost to Follow-up|1|||
130300353|NCT00788710|469062380|FG002|Overall Study|Lost to Follow-up|0|||
130300354|NCT00788710|469062378|FG000|Overall Study|Physician Decision|2|||
130300355|NCT00788710|469062379|FG001|Overall Study|Physician Decision|1|||
130300356|NCT00788710|469062380|FG002|Overall Study|Physician Decision|0|||
130300357|NCT00788710|469062378|FG000|Overall Study|Protocol Violation|0|||
130300358|NCT00788710|469062379|FG001|Overall Study|Protocol Violation|1|||
130300359|NCT00788710|469062380|FG002|Overall Study|Protocol Violation|1|||
130300360|NCT00788710|469062378|FG000|Overall Study|Withdrawal by Subject|2|||
130300361|NCT00788710|469062379|FG001|Overall Study|Withdrawal by Subject|2|||
130300362|NCT00788710|469062380|FG002|Overall Study|Withdrawal by Subject|0|||
130300363|NCT01990859|469062381|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
130300364|NCT01990859|469062381|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
130300365|NCT01717326|469062382|FG000|Overall Study|Death|0|||
130300366|NCT01717326|469062383|FG001|Overall Study|Death|0|||
130300367|NCT01717326|469062384|FG002|Overall Study|Death|0|||
130300368|NCT01717326|469062385|FG003|Overall Study|Death|0|||
130300369|NCT01717326|469062386|FG004|Overall Study|Death|0|||
130300370|NCT01717326|469062387|FG005|Overall Study|Death|0|||
130300371|NCT01717326|469062388|FG006|Overall Study|Death|0|||
130300372|NCT01717326|469062389|FG007|Overall Study|Death|0|||
130300373|NCT01717326|469062390|FG008|Overall Study|Death|0|||
130300374|NCT01717326|469062391|FG009|Overall Study|Death|0|||
130300375|NCT01717326|469062392|FG010|Overall Study|Death|1|||
130300376|NCT01717326|469062393|FG011|Overall Study|Death|0|||
130300377|NCT01717326|469062394|FG012|Overall Study|Death|0|||
130300378|NCT01717326|469062395|FG013|Overall Study|Death|0|||
130300379|NCT01717326|469062396|FG014|Overall Study|Death|0|||
130300380|NCT01717326|469062397|FG015|Overall Study|Death|0|||
130300381|NCT01717326|469062398|FG016|Overall Study|Death|0|||
130300382|NCT01717326|469062399|FG017|Overall Study|Death|0|||
130300383|NCT01717326|469062400|FG018|Overall Study|Death|0|||
130461800|NCT03401112|469656255|FG002|Overall Study|Noncompliance|3|||
130461801|NCT03401112|469656256|FG003|Overall Study|Noncompliance|0|||
130461802|NCT03401112|469656257|FG004|Overall Study|Noncompliance|0|||
130461803|NCT03401112|469656253|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
130461804|NCT03401112|469656254|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
130300384|NCT01717326|469062401|FG019|Overall Study|Death|0|||
130300385|NCT01717326|469062382|FG000|Overall Study|Lost to Follow-up|3|||
130300386|NCT01717326|469062383|FG001|Overall Study|Lost to Follow-up|0|||
130300387|NCT01717326|469062384|FG002|Overall Study|Lost to Follow-up|0|||
130300388|NCT01717326|469062385|FG003|Overall Study|Lost to Follow-up|2|||
130300389|NCT01717326|469062386|FG004|Overall Study|Lost to Follow-up|1|||
130461805|NCT03401112|469656255|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
130461806|NCT03401112|469656256|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
130461807|NCT03401112|469656257|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
130461808|NCT03401112|469656253|FG000|Overall Study|Withdrawal by Subject|0|||
130300390|NCT01717326|469062387|FG005|Overall Study|Lost to Follow-up|0|||
130300391|NCT01717326|469062388|FG006|Overall Study|Lost to Follow-up|1|||
130300392|NCT01717326|469062389|FG007|Overall Study|Lost to Follow-up|0|||
130300393|NCT01717326|469062390|FG008|Overall Study|Lost to Follow-up|0|||
130300394|NCT01717326|469062391|FG009|Overall Study|Lost to Follow-up|0|||
130300395|NCT01717326|469062392|FG010|Overall Study|Lost to Follow-up|1|||
130300396|NCT01717326|469062393|FG011|Overall Study|Lost to Follow-up|0|||
130300397|NCT01717326|469062394|FG012|Overall Study|Lost to Follow-up|0|||
130300398|NCT01717326|469062395|FG013|Overall Study|Lost to Follow-up|0|||
130300399|NCT01717326|469062396|FG014|Overall Study|Lost to Follow-up|0|||
130300400|NCT01717326|469062397|FG015|Overall Study|Lost to Follow-up|2|||
130300401|NCT01717326|469062398|FG016|Overall Study|Lost to Follow-up|1|||
130300402|NCT01717326|469062399|FG017|Overall Study|Lost to Follow-up|0|||
130300403|NCT01717326|469062400|FG018|Overall Study|Lost to Follow-up|2|||
130300404|NCT01717326|469062401|FG019|Overall Study|Lost to Follow-up|3|||
130300405|NCT01717326|469062382|FG000|Overall Study|Physician Decision|0|||
130300406|NCT01717326|469062383|FG001|Overall Study|Physician Decision|0|||
130300407|NCT01717326|469062384|FG002|Overall Study|Physician Decision|0|||
130300408|NCT01717326|469062385|FG003|Overall Study|Physician Decision|0|||
130300409|NCT01717326|469062386|FG004|Overall Study|Physician Decision|0|||
130300410|NCT01717326|469062387|FG005|Overall Study|Physician Decision|0|||
130300411|NCT01717326|469062388|FG006|Overall Study|Physician Decision|0|||
130300412|NCT01717326|469062389|FG007|Overall Study|Physician Decision|0|||
130300413|NCT01717326|469062390|FG008|Overall Study|Physician Decision|0|||
130300414|NCT01717326|469062391|FG009|Overall Study|Physician Decision|1|||
130300415|NCT01717326|469062392|FG010|Overall Study|Physician Decision|0|||
130300416|NCT01717326|469062393|FG011|Overall Study|Physician Decision|0|||
130300417|NCT01717326|469062394|FG012|Overall Study|Physician Decision|0|||
130300418|NCT01717326|469062395|FG013|Overall Study|Physician Decision|0|||
130300419|NCT01717326|469062396|FG014|Overall Study|Physician Decision|0|||
130300420|NCT01717326|469062397|FG015|Overall Study|Physician Decision|0|||
130300421|NCT01717326|469062398|FG016|Overall Study|Physician Decision|0|||
130300422|NCT01717326|469062399|FG017|Overall Study|Physician Decision|0|||
130300423|NCT01717326|469062400|FG018|Overall Study|Physician Decision|0|||
130300424|NCT01717326|469062401|FG019|Overall Study|Physician Decision|0|||
130300425|NCT01717326|469062382|FG000|Overall Study|Protocol Violation|0|||
130300426|NCT01717326|469062383|FG001|Overall Study|Protocol Violation|0|||
130300427|NCT01717326|469062384|FG002|Overall Study|Protocol Violation|0|||
130300428|NCT01717326|469062385|FG003|Overall Study|Protocol Violation|0|||
130300429|NCT01717326|469062386|FG004|Overall Study|Protocol Violation|1|||
130300430|NCT01717326|469062387|FG005|Overall Study|Protocol Violation|0|||
130300431|NCT01717326|469062388|FG006|Overall Study|Protocol Violation|0|||
130300432|NCT01717326|469062389|FG007|Overall Study|Protocol Violation|0|||
130300433|NCT01717326|469062390|FG008|Overall Study|Protocol Violation|0|||
130300434|NCT01717326|469062391|FG009|Overall Study|Protocol Violation|0|||
130300435|NCT01717326|469062392|FG010|Overall Study|Protocol Violation|0|||
130300436|NCT01717326|469062393|FG011|Overall Study|Protocol Violation|0|||
130300437|NCT01717326|469062394|FG012|Overall Study|Protocol Violation|0|||
130300438|NCT01717326|469062395|FG013|Overall Study|Protocol Violation|0|||
130300439|NCT01717326|469062396|FG014|Overall Study|Protocol Violation|0|||
130300440|NCT01717326|469062397|FG015|Overall Study|Protocol Violation|0|||
130300441|NCT01717326|469062398|FG016|Overall Study|Protocol Violation|0|||
130300442|NCT01717326|469062399|FG017|Overall Study|Protocol Violation|0|||
130300443|NCT01717326|469062400|FG018|Overall Study|Protocol Violation|0|||
130300444|NCT01717326|469062401|FG019|Overall Study|Protocol Violation|0|||
130300445|NCT01717326|469062382|FG000|Overall Study|Withdrawal by Subject|0|||
130373021|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373022|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373023|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373024|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373025|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373026|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373027|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373028|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130716412|NCT04765384|470588849|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
130716413|NCT04765384|470588844|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
130716414|NCT04765384|470588845|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
130716415|NCT04765384|470588846|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
130300446|NCT01717326|469062383|FG001|Overall Study|Withdrawal by Subject|1|||
130300447|NCT01717326|469062384|FG002|Overall Study|Withdrawal by Subject|0|||
130300448|NCT01717326|469062385|FG003|Overall Study|Withdrawal by Subject|0|||
130300449|NCT01717326|469062386|FG004|Overall Study|Withdrawal by Subject|0|||
130300450|NCT01717326|469062387|FG005|Overall Study|Withdrawal by Subject|0|||
130300451|NCT01717326|469062388|FG006|Overall Study|Withdrawal by Subject|0|||
130716416|NCT04765384|470588847|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
130716417|NCT04765384|470588848|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
130300452|NCT01717326|469062389|FG007|Overall Study|Withdrawal by Subject|0|||
130300453|NCT01717326|469062390|FG008|Overall Study|Withdrawal by Subject|0|||
130300454|NCT01717326|469062391|FG009|Overall Study|Withdrawal by Subject|1|||
130300455|NCT01717326|469062392|FG010|Overall Study|Withdrawal by Subject|0|||
130300456|NCT01717326|469062393|FG011|Overall Study|Withdrawal by Subject|0|||
130300457|NCT01717326|469062394|FG012|Overall Study|Withdrawal by Subject|1|||
130300458|NCT01717326|469062395|FG013|Overall Study|Withdrawal by Subject|0|||
130300459|NCT01717326|469062396|FG014|Overall Study|Withdrawal by Subject|0|||
130300460|NCT01717326|469062397|FG015|Overall Study|Withdrawal by Subject|1|||
130300461|NCT01717326|469062398|FG016|Overall Study|Withdrawal by Subject|0|||
130300462|NCT01717326|469062399|FG017|Overall Study|Withdrawal by Subject|0|||
130300463|NCT01717326|469062400|FG018|Overall Study|Withdrawal by Subject|2|||
130300464|NCT01717326|469062401|FG019|Overall Study|Withdrawal by Subject|3|||
130300465|NCT02262754|469062403|FG000|Overall Study|Adverse Event|3|||
130300466|NCT02262754|469062404|FG001|Overall Study|Adverse Event|4|||
130300467|NCT02262754|469062405|FG002|Overall Study|Adverse Event|0|||
130300468|NCT02262754|469062403|FG000|Overall Study|Lack of Efficacy|2|||
130300469|NCT02262754|469062404|FG001|Overall Study|Lack of Efficacy|0|||
130300470|NCT02262754|469062405|FG002|Overall Study|Lack of Efficacy|1|||
130300471|NCT02262754|469062403|FG000|Overall Study|Lost to Follow-up|0|||
130300472|NCT02262754|469062404|FG001|Overall Study|Lost to Follow-up|0|||
130300473|NCT02262754|469062405|FG002|Overall Study|Lost to Follow-up|1|||
130300474|NCT02262754|469062403|FG000|Overall Study|No longer meets eligibility criteria|0|||
130300475|NCT02262754|469062404|FG001|Overall Study|No longer meets eligibility criteria|1|||
130300476|NCT02262754|469062405|FG002|Overall Study|No longer meets eligibility criteria|0|||
130300477|NCT02262754|469062403|FG000|Overall Study|Study terminated by sponsor|5|||
130300478|NCT02262754|469062404|FG001|Overall Study|Study terminated by sponsor|4|||
130300479|NCT02262754|469062405|FG002|Overall Study|Study terminated by sponsor|4|||
130300480|NCT02262754|469062403|FG000|Overall Study|Protocol Violation|1|||
130300481|NCT02262754|469062404|FG001|Overall Study|Protocol Violation|0|||
130300482|NCT02262754|469062405|FG002|Overall Study|Protocol Violation|0|||
130300483|NCT02262754|469062403|FG000|Overall Study|Withdrawal by Subject|1|||
130300484|NCT02262754|469062404|FG001|Overall Study|Withdrawal by Subject|0|||
130300485|NCT02262754|469062405|FG002|Overall Study|Withdrawal by Subject|1|||
130300486|NCT02262754|469062403|FG000|Overall Study|Other|4|||
130300487|NCT02262754|469062404|FG001|Overall Study|Other|0|||
130300488|NCT02262754|469062405|FG002|Overall Study|Other|2|||
130300489|NCT03208088|469062410|FG000|Period 2|Withdrawal by Subject|0|||
130300490|NCT03208088|469062411|FG001|Period 2|Withdrawal by Subject|0|||
130300491|NCT03208088|469062412|FG002|Period 2|Withdrawal by Subject|0|||
130300492|NCT03208088|469062413|FG003|Period 2|Withdrawal by Subject|0|||
130300493|NCT03208088|469062414|FG004|Period 2|Withdrawal by Subject|0|||
130300494|NCT03208088|469062415|FG005|Period 2|Withdrawal by Subject|0|||
130300495|NCT03208088|469062416|FG006|Period 2|Withdrawal by Subject|0|||
130300496|NCT03208088|469062417|FG007|Period 2|Withdrawal by Subject|0|||
130300497|NCT03208088|469062418|FG008|Period 2|Withdrawal by Subject|1|||
130300498|NCT03208088|469062419|FG009|Period 2|Withdrawal by Subject|0|||
130300499|NCT03208088|469062410|FG000|Period 3|Unsatisfactory Test Article|0|||
130300500|NCT03208088|469062411|FG001|Period 3|Unsatisfactory Test Article|0|||
130300501|NCT03208088|469062412|FG002|Period 3|Unsatisfactory Test Article|0|||
130300502|NCT03208088|469062413|FG003|Period 3|Unsatisfactory Test Article|1|||
130300503|NCT03208088|469062414|FG004|Period 3|Unsatisfactory Test Article|0|||
130300504|NCT03208088|469062415|FG005|Period 3|Unsatisfactory Test Article|0|||
130300505|NCT03208088|469062416|FG006|Period 3|Unsatisfactory Test Article|0|||
130300506|NCT03208088|469062417|FG007|Period 3|Unsatisfactory Test Article|0|||
130300507|NCT03208088|469062418|FG008|Period 3|Unsatisfactory Test Article|0|||
130300508|NCT03208088|469062419|FG009|Period 3|Unsatisfactory Test Article|0|||
130300509|NCT03208088|469062410|FG000|Period 4|Unsatisfactory Test Article|0|||
130300510|NCT03208088|469062411|FG001|Period 4|Unsatisfactory Test Article|0|||
130300511|NCT03208088|469062412|FG002|Period 4|Unsatisfactory Test Article|0|||
130300512|NCT03208088|469062413|FG003|Period 4|Unsatisfactory Test Article|1|||
130300513|NCT03208088|469062414|FG004|Period 4|Unsatisfactory Test Article|0|||
130300514|NCT03208088|469062415|FG005|Period 4|Unsatisfactory Test Article|0|||
130373029|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130300515|NCT03208088|469062416|FG006|Period 4|Unsatisfactory Test Article|0|||
130300516|NCT03208088|469062417|FG007|Period 4|Unsatisfactory Test Article|0|||
130300517|NCT03208088|469062418|FG008|Period 4|Unsatisfactory Test Article|0|||
130300518|NCT03208088|469062419|FG009|Period 4|Unsatisfactory Test Article|0|||
130300519|NCT02577016|469062420|FG000|Overall Study|Adverse Event|2|||
130300520|NCT02577016|469062421|FG001|Overall Study|Adverse Event|1|||
130373030|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373031|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130300521|NCT02577016|469062420|FG000|Overall Study|Physician Decision|0|||
130300522|NCT02577016|469062421|FG001|Overall Study|Physician Decision|1|||
130300523|NCT02126839|469062422|FG000|Overall Study|Adverse Event|0|||
130300524|NCT02126839|469062423|FG001|Overall Study|Adverse Event|1|||
130300525|NCT02126839|469062422|FG000|Overall Study|Withdrawal by Subject|1|||
130300526|NCT02126839|469062423|FG001|Overall Study|Withdrawal by Subject|0|||
130300527|NCT02126839|469062422|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130300528|NCT02126839|469062423|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130300529|NCT02126839|469062422|FG000|Overall Study|Protocol Violation|2|||
130373032|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130557344|NCT00631189|470009966|FG001|Initial Phase|Protocol Violation|0|||
130300530|NCT02126839|469062423|FG001|Overall Study|Protocol Violation|3|||
130300531|NCT02126839|469062422|FG000|Overall Study|Sponsor request|0|||
130300532|NCT02126839|469062423|FG001|Overall Study|Sponsor request|1|||
130300533|NCT02126839|469062422|FG000|Overall Study|Lost to Follow-up|1|||
130300534|NCT02126839|469062423|FG001|Overall Study|Lost to Follow-up|4|||
130300535|NCT02126839|469062422|FG000|Overall Study|Other|5|||
130300536|NCT02126839|469062423|FG001|Overall Study|Other|5|||
130300537|NCT00812565|469062424|FG000|Overall Study|Did Not Receive Study Medication|1|||
130300538|NCT00812565|469062425|FG001|Overall Study|Did Not Receive Study Medication|1|||
130300539|NCT00812565|469062426|FG002|Overall Study|Did Not Receive Study Medication|0|||
130300540|NCT00812565|469062427|FG003|Overall Study|Did Not Receive Study Medication|0|||
130300541|NCT00812565|469062428|FG004|Overall Study|Did Not Receive Study Medication|0|||
130300542|NCT00812565|469062429|FG005|Overall Study|Did Not Receive Study Medication|0|||
130300543|NCT00812565|469062430|FG006|Overall Study|Did Not Receive Study Medication|0|||
130300544|NCT00812565|469062431|FG007|Overall Study|Did Not Receive Study Medication|0|||
130300545|NCT00812565|469062424|FG000|Overall Study|Adverse Event|0|||
130300546|NCT00812565|469062425|FG001|Overall Study|Adverse Event|0|||
130300547|NCT00812565|469062426|FG002|Overall Study|Adverse Event|0|||
130300548|NCT00812565|469062427|FG003|Overall Study|Adverse Event|2|||
130300549|NCT00812565|469062428|FG004|Overall Study|Adverse Event|0|||
130300550|NCT00812565|469062429|FG005|Overall Study|Adverse Event|0|||
130300551|NCT00812565|469062430|FG006|Overall Study|Adverse Event|0|||
130300552|NCT00812565|469062431|FG007|Overall Study|Adverse Event|1|||
130300553|NCT00812565|469062424|FG000|Overall Study|Did Not Come to Study Visit|1|||
130300554|NCT00812565|469062425|FG001|Overall Study|Did Not Come to Study Visit|0|||
130300555|NCT00812565|469062426|FG002|Overall Study|Did Not Come to Study Visit|0|||
130300556|NCT00812565|469062427|FG003|Overall Study|Did Not Come to Study Visit|0|||
130300557|NCT00812565|469062428|FG004|Overall Study|Did Not Come to Study Visit|0|||
130300558|NCT00812565|469062429|FG005|Overall Study|Did Not Come to Study Visit|0|||
130300559|NCT00812565|469062430|FG006|Overall Study|Did Not Come to Study Visit|0|||
130300560|NCT00812565|469062431|FG007|Overall Study|Did Not Come to Study Visit|0|||
130300561|NCT00812565|469062424|FG000|Overall Study|Withdrawal of Consent|1|||
130300562|NCT00812565|469062425|FG001|Overall Study|Withdrawal of Consent|0|||
130300563|NCT00812565|469062426|FG002|Overall Study|Withdrawal of Consent|0|||
130300564|NCT00812565|469062427|FG003|Overall Study|Withdrawal of Consent|0|||
130300565|NCT00812565|469062428|FG004|Overall Study|Withdrawal of Consent|1|||
130300566|NCT00812565|469062429|FG005|Overall Study|Withdrawal of Consent|0|||
130300567|NCT00812565|469062430|FG006|Overall Study|Withdrawal of Consent|0|||
130300568|NCT00812565|469062431|FG007|Overall Study|Withdrawal of Consent|0|||
130300569|NCT00812565|469062424|FG000|Overall Study|Reason Not Specified|0|||
130300570|NCT00812565|469062425|FG001|Overall Study|Reason Not Specified|0|||
130300571|NCT00812565|469062426|FG002|Overall Study|Reason Not Specified|0|||
130300572|NCT00812565|469062427|FG003|Overall Study|Reason Not Specified|0|||
130300573|NCT00812565|469062428|FG004|Overall Study|Reason Not Specified|0|||
130300574|NCT00812565|469062429|FG005|Overall Study|Reason Not Specified|1|||
130300575|NCT00812565|469062430|FG006|Overall Study|Reason Not Specified|0|||
130300576|NCT00812565|469062431|FG007|Overall Study|Reason Not Specified|0|||
130300577|NCT02596945|469062434|FG000|Overall Study|No documentation of study drug dosing|3|||
130300578|NCT02596945|469062434|FG000|Overall Study|Other|32|||
130557345|NCT00631189|470009967|FG002|Initial Phase|Protocol Violation|0|||
130300579|NCT02596945|469062434|FG000|Overall Study|Change to hemodialysis|15|||
130300580|NCT02596945|469062434|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
130300581|NCT02596945|469062434|FG000|Overall Study|Withdrawal by Subject|1|||
130300582|NCT02596945|469062434|FG000|Overall Study|Missing|1|||
130300583|NCT00422383|469062435|FG000|Overall Study|Adverse Event|5|||
130300584|NCT00422383|469062436|FG001|Overall Study|Adverse Event|3|||
130300585|NCT00422383|469062437|FG002|Overall Study|Adverse Event|1|||
130300586|NCT00422383|469062438|FG003|Overall Study|Adverse Event|1|||
130300587|NCT00422383|469062439|FG004|Overall Study|Adverse Event|0|||
130300588|NCT00422383|469062435|FG000|Overall Study|Lack of Efficacy|4|||
130300589|NCT00422383|469062436|FG001|Overall Study|Lack of Efficacy|4|||
130300590|NCT00422383|469062437|FG002|Overall Study|Lack of Efficacy|2|||
130300591|NCT00422383|469062438|FG003|Overall Study|Lack of Efficacy|1|||
130300592|NCT00422383|469062439|FG004|Overall Study|Lack of Efficacy|1|||
130300593|NCT00422383|469062435|FG000|Overall Study|Lost to Follow-up|0|||
130300594|NCT00422383|469062436|FG001|Overall Study|Lost to Follow-up|1|||
130300595|NCT00422383|469062437|FG002|Overall Study|Lost to Follow-up|0|||
130300596|NCT00422383|469062438|FG003|Overall Study|Lost to Follow-up|0|||
130300597|NCT00422383|469062439|FG004|Overall Study|Lost to Follow-up|1|||
130300598|NCT00422383|469062435|FG000|Overall Study|Protocol Violation|1|||
130300599|NCT00422383|469062436|FG001|Overall Study|Protocol Violation|1|||
130300600|NCT00422383|469062437|FG002|Overall Study|Protocol Violation|1|||
130300601|NCT00422383|469062438|FG003|Overall Study|Protocol Violation|0|||
130300602|NCT00422383|469062439|FG004|Overall Study|Protocol Violation|0|||
130300603|NCT00422383|469062435|FG000|Overall Study|Withdrawal by Subject|5|||
130300604|NCT00422383|469062436|FG001|Overall Study|Withdrawal by Subject|5|||
130300605|NCT00422383|469062437|FG002|Overall Study|Withdrawal by Subject|0|||
130300606|NCT00422383|469062438|FG003|Overall Study|Withdrawal by Subject|0|||
130300607|NCT00422383|469062439|FG004|Overall Study|Withdrawal by Subject|1|||
130300608|NCT05066165|469064081|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
130300609|NCT05066165|469064082|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
130300610|NCT05066165|469064081|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130300611|NCT05066165|469064082|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130300612|NCT03738618|469064083|FG000|Overall Study|Protocol deviation|23|||
130300613|NCT03738618|469064084|FG001|Overall Study|Protocol deviation|0|||
130300614|NCT03738618|469064083|FG000|Overall Study|Adverse Event|4|||
130300615|NCT03738618|469064084|FG001|Overall Study|Adverse Event|0|||
130300616|NCT03738618|469064083|FG000|Overall Study|Lost to Follow-up|2|||
130300617|NCT03738618|469064084|FG001|Overall Study|Lost to Follow-up|0|||
130300618|NCT03738618|469064083|FG000|Overall Study|Randomization failure|1|||
130300619|NCT03738618|469064084|FG001|Overall Study|Randomization failure|0|||
130300620|NCT03738618|469064083|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
130300621|NCT03738618|469064084|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
130300622|NCT03738618|469064083|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
130300623|NCT03738618|469064084|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
130300624|NCT01769196|469064085|FG000|Overall Study|Adverse Event|24|||
130300625|NCT01769196|469064086|FG001|Overall Study|Adverse Event|20|||
130300626|NCT01769196|469064085|FG000|Overall Study|Death|21|||
130300627|NCT01769196|469064086|FG001|Overall Study|Death|26|||
130300628|NCT01769196|469064085|FG000|Overall Study|Investigator Discretion|7|||
130300629|NCT01769196|469064086|FG001|Overall Study|Investigator Discretion|3|||
130300630|NCT01769196|469064085|FG000|Overall Study|Lack of Efficacy|3|||
130300631|NCT01769196|469064086|FG001|Overall Study|Lack of Efficacy|2|||
130300632|NCT01769196|469064085|FG000|Overall Study|Progressive disease|11|||
130300633|NCT01769196|469064086|FG001|Overall Study|Progressive disease|6|||
130300634|NCT01769196|469064085|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
130300635|NCT01769196|469064086|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
130300636|NCT01769196|469064085|FG000|Overall Study|Protocol Violation|0|||
130300637|NCT01769196|469064086|FG001|Overall Study|Protocol Violation|3|||
130300638|NCT01769196|469064085|FG000|Overall Study|Study terminated by sponsor|160|||
130373033|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373034|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130300639|NCT01769196|469064086|FG001|Overall Study|Study terminated by sponsor|161|||
130300640|NCT01769196|469064085|FG000|Overall Study|Participant never dosed with study drug|1|||
130300641|NCT01769196|469064086|FG001|Overall Study|Participant never dosed with study drug|0|||
130300642|NCT01769196|469064085|FG000|Overall Study|Withdrew consent|36|||
130300643|NCT01769196|469064086|FG001|Overall Study|Withdrew consent|40|||
130300644|NCT01450098|469064093|FG000|Period 3|Protocol Violation|0|||
130300645|NCT01450098|469064094|FG001|Period 3|Protocol Violation|1|||
130300646|NCT01450098|469064093|FG000|Period 3|Withdrawal by Subject|0|||
130300647|NCT01450098|469064094|FG001|Period 3|Withdrawal by Subject|2|||
130373035|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130300648|NCT00655629|469064095|FG000|Overall Study|Adverse Event|4|||
130300649|NCT00655629|469064096|FG001|Overall Study|Adverse Event|1|||
130300650|NCT00655629|469064095|FG000|Overall Study|Lack of Efficacy|2|||
130300651|NCT00655629|469064096|FG001|Overall Study|Lack of Efficacy|12|||
130300652|NCT00655629|469064095|FG000|Overall Study|Lost to Follow-up|4|||
130300653|NCT00655629|469064096|FG001|Overall Study|Lost to Follow-up|3|||
130300654|NCT00655629|469064095|FG000|Overall Study|Protocol Violation|5|||
130300655|NCT00655629|469064096|FG001|Overall Study|Protocol Violation|3|||
130300656|NCT00655629|469064095|FG000|Overall Study|consent withdrawn|6|||
130300657|NCT00655629|469064096|FG001|Overall Study|consent withdrawn|4|||
130300658|NCT00705367|469064097|FG000|Long-term Extension Period|Adverse Event|2|||
130300659|NCT00705367|469064098|FG001|Long-term Extension Period|Adverse Event|0|||
130300660|NCT00705367|469064097|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
130300661|NCT00705367|469064098|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
130300662|NCT00705367|469064097|FG000|Long-term Extension Period|Lack of Efficacy|1|||
130300663|NCT00705367|469064098|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130300664|NCT00705367|469064097|FG000|Long-term Extension Period|No longer met study criteria|1|||
130300665|NCT00705367|469064098|FG001|Long-term Extension Period|No longer met study criteria|0|||
130300666|NCT00705367|469064097|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
130300667|NCT00705367|469064098|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
130300668|NCT01832155|469064099|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
130300669|NCT01832155|469064100|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
130300670|NCT01832155|469064099|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
130300671|NCT01832155|469064100|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
130300672|NCT01055314|469064101|FG000|Overall Study|Adverse Event|7|||
130300673|NCT01055314|469064102|FG001|Overall Study|Adverse Event|4|||
130300674|NCT01055314|469064101|FG000|Overall Study|Death|2|||
130300675|NCT01055314|469064102|FG001|Overall Study|Death|1|||
130300676|NCT01055314|469064101|FG000|Overall Study|Lack of Efficacy|11|||
130300677|NCT01055314|469064102|FG001|Overall Study|Lack of Efficacy|19|||
130300678|NCT01055314|469064101|FG000|Overall Study|Physician Decision|10|||
130300679|NCT01055314|469064102|FG001|Overall Study|Physician Decision|5|||
130300680|NCT01055314|469064101|FG000|Overall Study|Withdrawal by Subject|1|||
130300681|NCT01055314|469064102|FG001|Overall Study|Withdrawal by Subject|0|||
130300682|NCT01055314|469064101|FG000|Overall Study|Ineligible|3|||
130300683|NCT01055314|469064102|FG001|Overall Study|Ineligible|5|||
130300684|NCT01055314|469064101|FG000|Overall Study|Refusal of further protocol therapy|10|||
130300685|NCT01055314|469064102|FG001|Overall Study|Refusal of further protocol therapy|4|||
130300686|NCT01055314|469064101|FG000|Overall Study|No treatment|1|||
130300687|NCT01055314|469064102|FG001|Overall Study|No treatment|0|||
130300688|NCT01279616|469064103|FG000|Overall Study|donor could not be located|5|||
130300689|NCT01279616|469064103|FG000|Overall Study|no signs of sickle cell disease|2|||
130300690|NCT02462720|469064104|FG000|Part 2|Withdrawal by Subject|1|||
130300691|NCT02462720|469064105|FG001|Part 2|Withdrawal by Subject|0|||
130300692|NCT02462720|469064104|FG000|Part 2|Protocol Violation|0|||
130300693|NCT02462720|469064105|FG001|Part 2|Protocol Violation|1|||
130300694|NCT00183625|469064108|FG000|Overall Study|Withdrawal by Subject|18|||
130300695|NCT00183625|469064109|FG001|Overall Study|Withdrawal by Subject|18|||
130300696|NCT00183625|469064110|FG002|Overall Study|Withdrawal by Subject|19|||
130300697|NCT00183625|469064111|FG003|Overall Study|Withdrawal by Subject|14|||
130373036|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373037|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373038|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373039|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373040|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373041|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373042|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373043|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
130373044|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130373045|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373046|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373047|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373048|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373049|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373050|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373051|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373052|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373053|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373054|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373055|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373056|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373057|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373058|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130557346|NCT00631189|470009968|FG003|Initial Phase|Protocol Violation|0|||
130300698|NCT05249569|469064114|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
130300699|NCT02678923|469064115|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
130300700|NCT02678923|469064116|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
130300701|NCT02678923|469064115|FG000|Overall Study|Withdrawal by Subject|3|||
130300702|NCT02678923|469064116|FG001|Overall Study|Withdrawal by Subject|2|||
130300703|NCT02678923|469064115|FG000|Overall Study|Lost to Follow-up|1|||
130300704|NCT02678923|469064116|FG001|Overall Study|Lost to Follow-up|0|||
130300705|NCT02678923|469064115|FG000|Overall Study|Did Not Return for Study Visits|1|||
130300706|NCT02678923|469064116|FG001|Overall Study|Did Not Return for Study Visits|0|||
130300707|NCT00098306|469064119|FG000|Double Blind|Randomized, not treated|9|||
130300708|NCT00098306|469064120|FG001|Double Blind|Randomized, not treated|5|||
130300709|NCT00098306|469064121|FG002|Double Blind|Randomized, not treated|2|||
130300710|NCT00098306|469064122|FG003|Double Blind|Randomized, not treated|0|||
130300711|NCT00098306|469064123|FG004|Double Blind|Randomized, not treated|0|||
130300712|NCT00098306|469064124|FG005|Double Blind|Randomized, not treated|0|||
130300713|NCT00098306|469064125|FG006|Double Blind|Randomized, not treated|0|||
130300714|NCT00098306|469064119|FG000|Double Blind|Ongoing at cut-off date|151|||
130300715|NCT00098306|469064120|FG001|Double Blind|Ongoing at cut-off date|166|||
130300716|NCT00098306|469064121|FG002|Double Blind|Ongoing at cut-off date|72|||
130300717|NCT00098306|469064122|FG003|Double Blind|Ongoing at cut-off date|0|||
130300718|NCT00098306|469064123|FG004|Double Blind|Ongoing at cut-off date|0|||
130300719|NCT00098306|469064124|FG005|Double Blind|Ongoing at cut-off date|0|||
130300720|NCT00098306|469064125|FG006|Double Blind|Ongoing at cut-off date|0|||
130300721|NCT00098306|469064119|FG000|Double Blind|Adverse Event|11|||
130300722|NCT00098306|469064120|FG001|Double Blind|Adverse Event|10|||
130300723|NCT00098306|469064121|FG002|Double Blind|Adverse Event|6|||
130300724|NCT00098306|469064122|FG003|Double Blind|Adverse Event|0|||
130300725|NCT00098306|469064123|FG004|Double Blind|Adverse Event|0|||
130300726|NCT00098306|469064124|FG005|Double Blind|Adverse Event|0|||
130300727|NCT00098306|469064125|FG006|Double Blind|Adverse Event|0|||
130300728|NCT00098306|469064119|FG000|Double Blind|Lack of Efficacy|43|||
130300729|NCT00098306|469064120|FG001|Double Blind|Lack of Efficacy|34|||
130300730|NCT00098306|469064121|FG002|Double Blind|Lack of Efficacy|17|||
130300731|NCT00098306|469064122|FG003|Double Blind|Lack of Efficacy|0|||
130300732|NCT00098306|469064123|FG004|Double Blind|Lack of Efficacy|0|||
130300733|NCT00098306|469064124|FG005|Double Blind|Lack of Efficacy|0|||
130300734|NCT00098306|469064125|FG006|Double Blind|Lack of Efficacy|0|||
130300735|NCT00098306|469064119|FG000|Double Blind|Death|1|||
130300736|NCT00098306|469064120|FG001|Double Blind|Death|4|||
130300737|NCT00098306|469064121|FG002|Double Blind|Death|1|||
130300738|NCT00098306|469064122|FG003|Double Blind|Death|0|||
130300739|NCT00098306|469064123|FG004|Double Blind|Death|0|||
130300740|NCT00098306|469064124|FG005|Double Blind|Death|0|||
130300741|NCT00098306|469064125|FG006|Double Blind|Death|0|||
130300742|NCT00098306|469064119|FG000|Double Blind|Participant defaulted|19|||
130300743|NCT00098306|469064120|FG001|Double Blind|Participant defaulted|18|||
130300744|NCT00098306|469064121|FG002|Double Blind|Participant defaulted|11|||
130300745|NCT00098306|469064122|FG003|Double Blind|Participant defaulted|0|||
130300746|NCT00098306|469064123|FG004|Double Blind|Participant defaulted|0|||
130300747|NCT00098306|469064124|FG005|Double Blind|Participant defaulted|0|||
130300748|NCT00098306|469064125|FG006|Double Blind|Participant defaulted|0|||
130300749|NCT00098306|469064119|FG000|Double Blind|Un-specified|7|||
130300750|NCT00098306|469064120|FG001|Double Blind|Un-specified|3|||
130300751|NCT00098306|469064121|FG002|Double Blind|Un-specified|11|||
130300752|NCT00098306|469064122|FG003|Double Blind|Un-specified|0|||
130300753|NCT00098306|469064123|FG004|Double Blind|Un-specified|0|||
130300754|NCT00098306|469064124|FG005|Double Blind|Un-specified|0|||
130300755|NCT00098306|469064125|FG006|Double Blind|Un-specified|0|||
130300756|NCT00098306|469064119|FG000|Open Label|Lack of Efficacy|0|||
130300757|NCT00098306|469064120|FG001|Open Label|Lack of Efficacy|0|||
130300758|NCT00098306|469064121|FG002|Open Label|Lack of Efficacy|0|||
130300759|NCT00098306|469064122|FG003|Open Label|Lack of Efficacy|13|||
130300760|NCT00098306|469064123|FG004|Open Label|Lack of Efficacy|0|||
130300761|NCT00098306|469064124|FG005|Open Label|Lack of Efficacy|0|||
130300762|NCT00098306|469064125|FG006|Open Label|Lack of Efficacy|0|||
130300763|NCT00098306|469064119|FG000|Open Label|Adverse Event|0|||
130300764|NCT00098306|469064120|FG001|Open Label|Adverse Event|0|||
130300765|NCT00098306|469064121|FG002|Open Label|Adverse Event|0|||
130300766|NCT00098306|469064122|FG003|Open Label|Adverse Event|2|||
130300767|NCT00098306|469064123|FG004|Open Label|Adverse Event|0|||
130300768|NCT00098306|469064124|FG005|Open Label|Adverse Event|0|||
130300769|NCT00098306|469064125|FG006|Open Label|Adverse Event|0|||
130300770|NCT00098306|469064119|FG000|Open Label|Death|0|||
130300771|NCT00098306|469064120|FG001|Open Label|Death|0|||
130300772|NCT00098306|469064121|FG002|Open Label|Death|0|||
130300773|NCT00098306|469064122|FG003|Open Label|Death|4|||
130300774|NCT00098306|469064123|FG004|Open Label|Death|0|||
130300775|NCT00098306|469064124|FG005|Open Label|Death|0|||
130300776|NCT00098306|469064125|FG006|Open Label|Death|0|||
130300777|NCT00098306|469064119|FG000|Open Label|Participant defaulted|0|||
130300778|NCT00098306|469064120|FG001|Open Label|Participant defaulted|0|||
130300779|NCT00098306|469064121|FG002|Open Label|Participant defaulted|0|||
130300780|NCT00098306|469064122|FG003|Open Label|Participant defaulted|24|||
130300781|NCT00098306|469064123|FG004|Open Label|Participant defaulted|0|||
130300782|NCT00098306|469064124|FG005|Open Label|Participant defaulted|0|||
130300783|NCT00098306|469064125|FG006|Open Label|Participant defaulted|0|||
130300784|NCT00098306|469064119|FG000|Open Label|Un-specified|0|||
130300785|NCT00098306|469064120|FG001|Open Label|Un-specified|0|||
130300786|NCT00098306|469064121|FG002|Open Label|Un-specified|0|||
130300787|NCT00098306|469064122|FG003|Open Label|Un-specified|15|||
130300788|NCT00098306|469064123|FG004|Open Label|Un-specified|0|||
130300789|NCT00098306|469064124|FG005|Open Label|Un-specified|0|||
130300790|NCT00098306|469064125|FG006|Open Label|Un-specified|0|||
130300791|NCT00098306|469064119|FG000|Open Label|Ongoing at cut-off date|0|||
130300792|NCT00098306|469064120|FG001|Open Label|Ongoing at cut-off date|0|||
130300793|NCT00098306|469064121|FG002|Open Label|Ongoing at cut-off date|0|||
130300794|NCT00098306|469064122|FG003|Open Label|Ongoing at cut-off date|269|||
130300795|NCT00098306|469064123|FG004|Open Label|Ongoing at cut-off date|62|||
130300796|NCT00098306|469064124|FG005|Open Label|Ongoing at cut-off date|0|||
130300797|NCT00098306|469064125|FG006|Open Label|Ongoing at cut-off date|0|||
130300798|NCT00098306|469064119|FG000|Observational Phase|Death|0|||
130300799|NCT00098306|469064120|FG001|Observational Phase|Death|0|||
130300800|NCT00098306|469064121|FG002|Observational Phase|Death|0|||
130300801|NCT00098306|469064122|FG003|Observational Phase|Death|0|||
130300802|NCT00098306|469064123|FG004|Observational Phase|Death|0|||
130300803|NCT00098306|469064124|FG005|Observational Phase|Death|5|||
130300804|NCT00098306|469064125|FG006|Observational Phase|Death|4|||
130300805|NCT00098306|469064119|FG000|Observational Phase|Participant defaulted|0|||
130300806|NCT00098306|469064120|FG001|Observational Phase|Participant defaulted|0|||
130300807|NCT00098306|469064121|FG002|Observational Phase|Participant defaulted|0|||
130300808|NCT00098306|469064122|FG003|Observational Phase|Participant defaulted|0|||
130300809|NCT00098306|469064123|FG004|Observational Phase|Participant defaulted|0|||
130300810|NCT00098306|469064124|FG005|Observational Phase|Participant defaulted|34|||
130300811|NCT00098306|469064125|FG006|Observational Phase|Participant defaulted|18|||
130300812|NCT00098306|469064119|FG000|Observational Phase|Un-specified|0|||
130300813|NCT00098306|469064120|FG001|Observational Phase|Un-specified|0|||
130300814|NCT00098306|469064121|FG002|Observational Phase|Un-specified|0|||
130300815|NCT00098306|469064122|FG003|Observational Phase|Un-specified|0|||
130300816|NCT00098306|469064123|FG004|Observational Phase|Un-specified|0|||
130300817|NCT00098306|469064124|FG005|Observational Phase|Un-specified|7|||
130300818|NCT00098306|469064125|FG006|Observational Phase|Un-specified|4|||
130300819|NCT01423916|469064126|FG000|Overall Study|Adverse Event|5|||
130300820|NCT01423916|469064127|FG001|Overall Study|Adverse Event|9|||
130300821|NCT01423916|469064128|FG002|Overall Study|Adverse Event|2|||
130300822|NCT01423916|469064126|FG000|Overall Study|Met Withdrawal Criteria|1|||
130300823|NCT01423916|469064127|FG001|Overall Study|Met Withdrawal Criteria|1|||
130300824|NCT01423916|469064128|FG002|Overall Study|Met Withdrawal Criteria|1|||
130300825|NCT01423916|469064126|FG000|Overall Study|Physician Decision|1|||
130300826|NCT01423916|469064127|FG001|Overall Study|Physician Decision|0|||
130300827|NCT01423916|469064128|FG002|Overall Study|Physician Decision|1|||
130300828|NCT01423916|469064126|FG000|Overall Study|Withdrawal by Subject|3|||
130300829|NCT01423916|469064127|FG001|Overall Study|Withdrawal by Subject|10|||
130300830|NCT01423916|469064128|FG002|Overall Study|Withdrawal by Subject|3|||
130300831|NCT01423916|469064126|FG000|Overall Study|Protocol Deviation|1|||
130300832|NCT01423916|469064127|FG001|Overall Study|Protocol Deviation|0|||
130300833|NCT01423916|469064128|FG002|Overall Study|Protocol Deviation|0|||
130300834|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300835|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300836|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300837|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
130300838|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300839|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
130300840|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130373059|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130557347|NCT00631189|470009965|FG000|Initial Phase|Withdrawal by Subject|4|||
130557348|NCT00631189|470009966|FG001|Initial Phase|Withdrawal by Subject|0|||
130300841|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300842|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300843|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300844|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300845|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300846|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300847|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300848|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300849|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130300850|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130300851|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300852|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
130300853|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300854|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300855|NCT01966445|469064131|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300856|NCT01966445|469064132|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300857|NCT01966445|469064133|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300858|NCT01966445|469064134|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300859|NCT01966445|469064135|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300860|NCT01966445|469064136|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300861|NCT01966445|469064137|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
130300862|NCT01966445|469064131|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300863|NCT01966445|469064132|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300864|NCT01966445|469064133|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300865|NCT01966445|469064134|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300866|NCT01966445|469064135|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300867|NCT01966445|469064136|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300868|NCT01966445|469064137|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
130300869|NCT01374178|469064140|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
130300870|NCT01374178|469064141|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
130300871|NCT01374178|469064140|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
130300872|NCT01374178|469064141|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
130300873|NCT04856904|469064144|FG000|Overall Study|Physician Decision|1|||
130300874|NCT04856904|469064145|FG001|Overall Study|Physician Decision|1|||
130300875|NCT04856904|469064144|FG000|Overall Study|Withdrawal by Subject|13|||
130300876|NCT04856904|469064145|FG001|Overall Study|Withdrawal by Subject|13|||
130300877|NCT04856904|469064144|FG000|Overall Study|Adverse Event|1|||
130300878|NCT04856904|469064145|FG001|Overall Study|Adverse Event|1|||
130300879|NCT04856904|469064144|FG000|Overall Study|Non-compliance with study drug|1|||
130300880|NCT04856904|469064145|FG001|Overall Study|Non-compliance with study drug|1|||
130300881|NCT04856904|469064144|FG000|Overall Study|Lost to Follow-up|4|||
130300882|NCT04856904|469064145|FG001|Overall Study|Lost to Follow-up|4|||
130300883|NCT04856904|469064144|FG000|Overall Study|Withdrawal by Subject|1|||
130300884|NCT04856904|469064145|FG001|Overall Study|Withdrawal by Subject|1|||
130300885|NCT04856904|469064144|FG000|Overall Study|Protocol Violation|1|||
130300886|NCT04856904|469064145|FG001|Overall Study|Protocol Violation|1|||
130300887|NCT00077649|469064146|FG000|Overall Study|Adverse Event|5|||
130300888|NCT00077649|469064147|FG001|Overall Study|Adverse Event|1|||
130300889|NCT00077649|469064148|FG002|Overall Study|Adverse Event|7|||
130300890|NCT00077649|469064149|FG003|Overall Study|Adverse Event|9|||
130300891|NCT00077649|469064146|FG000|Overall Study|Lack of Efficacy|5|||
130300892|NCT00077649|469064147|FG001|Overall Study|Lack of Efficacy|3|||
130300893|NCT00077649|469064148|FG002|Overall Study|Lack of Efficacy|3|||
130300894|NCT00077649|469064149|FG003|Overall Study|Lack of Efficacy|2|||
130300895|NCT00077649|469064146|FG000|Overall Study|Withdrawal by Subject|0|||
130300896|NCT00077649|469064147|FG001|Overall Study|Withdrawal by Subject|1|||
130300897|NCT00077649|469064148|FG002|Overall Study|Withdrawal by Subject|1|||
130300898|NCT00077649|469064149|FG003|Overall Study|Withdrawal by Subject|2|||
130300899|NCT00077649|469064146|FG000|Overall Study|Lost to Follow-up|2|||
130300900|NCT00077649|469064147|FG001|Overall Study|Lost to Follow-up|2|||
130300901|NCT00077649|469064148|FG002|Overall Study|Lost to Follow-up|3|||
130300902|NCT00077649|469064149|FG003|Overall Study|Lost to Follow-up|2|||
130300903|NCT00077649|469064146|FG000|Overall Study|Abnormality of Laboratory Test|1|||
130300904|NCT00077649|469064147|FG001|Overall Study|Abnormality of Laboratory Test|2|||
130300905|NCT00077649|469064148|FG002|Overall Study|Abnormality of Laboratory Test|1|||
130300906|NCT00077649|469064149|FG003|Overall Study|Abnormality of Laboratory Test|2|||
130300907|NCT00077649|469064146|FG000|Overall Study|Randomized but never dosed|1|||
130300908|NCT00077649|469064147|FG001|Overall Study|Randomized but never dosed|0|||
130300909|NCT00077649|469064148|FG002|Overall Study|Randomized but never dosed|0|||
130300910|NCT00077649|469064149|FG003|Overall Study|Randomized but never dosed|0|||
130300911|NCT01641822|469064150|FG000|Run-in Phase|Noncompliance with study drug|1|||
130300912|NCT01641822|469064151|FG001|Run-in Phase|Noncompliance with study drug|0|||
130300913|NCT01641822|469064152|FG002|Run-in Phase|Noncompliance with study drug|0|||
130300914|NCT01641822|469064150|FG000|Run-in Phase|Adverse Event|3|||
130300915|NCT01641822|469064151|FG001|Run-in Phase|Adverse Event|0|||
130300916|NCT01641822|469064152|FG002|Run-in Phase|Adverse Event|0|||
130300917|NCT01641822|469064150|FG000|Run-in Phase|Withdrew consent|1|||
130300918|NCT01641822|469064151|FG001|Run-in Phase|Withdrew consent|0|||
130300919|NCT01641822|469064152|FG002|Run-in Phase|Withdrew consent|0|||
130300920|NCT01641822|469064150|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
130300921|NCT01641822|469064151|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
130557349|NCT00631189|470009967|FG002|Initial Phase|Withdrawal by Subject|0|||
130557350|NCT00631189|470009968|FG003|Initial Phase|Withdrawal by Subject|0|||
130557351|NCT00631189|470009965|FG000|Treatment Phase|Withdrawal by Subject|0|||
130716418|NCT04765384|470588849|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
130716419|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130300922|NCT01641822|469064152|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
130300923|NCT01641822|469064150|FG000|Comparative Phase|Noncompliance with study drug|0|||
130300924|NCT01641822|469064151|FG001|Comparative Phase|Noncompliance with study drug|1|||
130300925|NCT01641822|469064152|FG002|Comparative Phase|Noncompliance with study drug|0|||
130300926|NCT01641822|469064150|FG000|Comparative Phase|Investigator's discretion|0|||
130300927|NCT01641822|469064151|FG001|Comparative Phase|Investigator's discretion|0|||
130300928|NCT01641822|469064152|FG002|Comparative Phase|Investigator's discretion|1|||
130300929|NCT01641822|469064150|FG000|Comparative Phase|Pregnancy|0|||
130300930|NCT01641822|469064151|FG001|Comparative Phase|Pregnancy|0|||
130300931|NCT01641822|469064152|FG002|Comparative Phase|Pregnancy|1|||
130300932|NCT01641822|469064150|FG000|Comparative Phase|Adverse event, serious fatal|0|||
130300933|NCT01641822|469064151|FG001|Comparative Phase|Adverse event, serious fatal|1|||
130300934|NCT01641822|469064152|FG002|Comparative Phase|Adverse event, serious fatal|0|||
130300935|NCT01641822|469064150|FG000|Comparative Phase|Withdrew consent|0|||
130300936|NCT01641822|469064151|FG001|Comparative Phase|Withdrew consent|3|||
130300937|NCT01641822|469064152|FG002|Comparative Phase|Withdrew consent|7|||
130300938|NCT01641822|469064150|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
130300939|NCT01641822|469064151|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130300940|NCT01641822|469064152|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130300941|NCT02421601|469064153|FG000|Overall Study|Adverse Event|4|||
130300942|NCT02421601|469064153|FG000|Overall Study|Lack of Efficacy|5|||
130300943|NCT02421601|469064153|FG000|Overall Study|Physician Decision|1|||
130300944|NCT02421601|469064153|FG000|Overall Study|Withdrawal by Subject|31|||
130300945|NCT02421601|469064153|FG000|Overall Study|Others|41|||
130300946|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
130300947|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
130300948|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
130300949|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
130300950|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130300951|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130300952|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130300953|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130300954|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130300955|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130300956|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130300957|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130300958|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130300959|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130300960|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130300961|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130300962|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130300963|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130300964|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130300965|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130300966|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
130300967|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
130300968|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
130300969|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
130300970|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300971|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300972|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300973|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
130300974|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
130300975|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
130300976|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
130300977|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
130300978|NCT00599638|469064154|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
130300979|NCT00599638|469064155|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300980|NCT00599638|469064156|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300981|NCT00599638|469064157|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300982|NCT02895945|469064160|FG000|Overall Study|Physician Decision|2|||
130300983|NCT02895945|469064161|FG001|Overall Study|Physician Decision|1|||
130300984|NCT01026220|469064165|FG000|Induction|Death|1|||
130716420|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130300985|NCT01026220|469064166|FG001|Induction|Death|0|||
130300986|NCT01026220|469064167|FG002|Induction|Death|0|||
130300987|NCT01026220|469064165|FG000|Induction|Lack of Efficacy|2|||
130300988|NCT01026220|469064166|FG001|Induction|Lack of Efficacy|0|||
130373060|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130300989|NCT01026220|469064167|FG002|Induction|Lack of Efficacy|0|||
130300990|NCT01026220|469064165|FG000|Induction|Physician Decision|12|||
130300991|NCT01026220|469064166|FG001|Induction|Physician Decision|0|||
130300992|NCT01026220|469064167|FG002|Induction|Physician Decision|0|||
130300993|NCT01026220|469064165|FG000|Induction|Withdrawal by Subject|9|||
130300994|NCT01026220|469064166|FG001|Induction|Withdrawal by Subject|0|||
130300995|NCT01026220|469064167|FG002|Induction|Withdrawal by Subject|0|||
130300996|NCT01026220|469064165|FG000|Induction|Ineligible|1|||
130300997|NCT01026220|469064166|FG001|Induction|Ineligible|0|||
130300998|NCT01026220|469064167|FG002|Induction|Ineligible|0|||
130300999|NCT01026220|469064165|FG000|Consolidation Maintenance|Death|0|||
130301000|NCT01026220|469064166|FG001|Consolidation Maintenance|Death|1|||
130301001|NCT01026220|469064167|FG002|Consolidation Maintenance|Death|0|||
130301002|NCT01026220|469064165|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
130301003|NCT01026220|469064166|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
130301004|NCT01026220|469064167|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
130301005|NCT01026220|469064165|FG000|Consolidation Maintenance|Physician Decision|0|||
130301006|NCT01026220|469064166|FG001|Consolidation Maintenance|Physician Decision|2|||
130301007|NCT01026220|469064167|FG002|Consolidation Maintenance|Physician Decision|7|||
130301008|NCT01026220|469064165|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
130301009|NCT01026220|469064166|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
130301010|NCT01026220|469064167|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
130301011|NCT03550404|469064168|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
130301012|NCT03550404|469064169|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130301013|NCT03550404|469064170|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130301014|NCT03550404|469064168|FG000|Phase 2|Vacated position|1|||
130301015|NCT03550404|469064169|FG001|Phase 2|Vacated position|0|||
130301016|NCT03550404|469064170|FG002|Phase 2|Vacated position|0|||
130301017|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
130301018|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
130301019|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
130301020|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
130301021|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
130301022|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
130301023|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
130301024|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
130301025|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
130301026|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
130301027|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
130301028|NCT05096312|469064173|FG000|Overall Study|Lost to Follow-up|2|||
130301029|NCT05096312|469064174|FG001|Overall Study|Lost to Follow-up|4|||
130301030|NCT05096312|469064173|FG000|Overall Study|Adverse Event|1|||
130301031|NCT05096312|469064174|FG001|Overall Study|Adverse Event|0|||
130301032|NCT00844558|469064176|FG000|Overall Study|Withdrawal by Subject|9|||
130301033|NCT00844558|469064177|FG001|Overall Study|Withdrawal by Subject|2|||
130301034|NCT00844558|469064176|FG000|Overall Study|Death|1|||
130301035|NCT00844558|469064177|FG001|Overall Study|Death|0|||
130301036|NCT00844558|469064176|FG000|Overall Study|Protocol Violation|1|||
130301037|NCT00844558|469064177|FG001|Overall Study|Protocol Violation|1|||
130301038|NCT00844558|469064176|FG000|Overall Study|Lost to Follow-up|0|||
130301039|NCT00844558|469064177|FG001|Overall Study|Lost to Follow-up|1|||
130301040|NCT00844558|469064176|FG000|Overall Study|Physician Decision|1|||
130301041|NCT00844558|469064177|FG001|Overall Study|Physician Decision|0|||
130301042|NCT01894022|469064193|FG000|Overall Study|Death|1|||
130301043|NCT01894022|469064194|FG001|Overall Study|Death|0|||
130301044|NCT01894022|469064193|FG000|Overall Study|Adverse Event, non-fatal|1|||
130301045|NCT01894022|469064194|FG001|Overall Study|Adverse Event, non-fatal|0|||
130301046|NCT01894022|469064193|FG000|Overall Study|Study Closed/terminated|7|||
130301047|NCT01894022|469064194|FG001|Overall Study|Study Closed/terminated|10|||
130301048|NCT04294147|469064203|FG000|Overall Study|Protocol Violation|2|||
130301049|NCT04294147|469064204|FG001|Overall Study|Protocol Violation|0|||
130301050|NCT05392803|469064205|FG000|Overall Study|Lost to Follow-up|0|||
130301051|NCT05392803|469064206|FG001|Overall Study|Lost to Follow-up|2|||
130301052|NCT01887353|469064209|FG000|Overall Study|Study stopped early|4|||
130301053|NCT01887353|469064210|FG001|Overall Study|Study stopped early|3|||
130301054|NCT00699335|469064211|FG000|Overall Study|Combination of multiple reasons|176|||
130301055|NCT00699335|469064211|FG000|Overall Study|Missing data|52|||
130716421|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130301056|NCT01069705|469064212|FG000|Overall Study|Adverse Event|1|||
130301057|NCT01069705|469064212|FG000|Overall Study|Withdrawal by Subject|2|||
130301058|NCT02999633|469064213|FG000|Overall Study|Adverse Event|2|||
130716422|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130301059|NCT02999633|469064213|FG000|Overall Study|Progressive disease|12|||
130301060|NCT03262441|469064214|FG000|Overall Study|Withdrawal by Subject|1|||
130301061|NCT01545050|469064215|FG000|Overall Study|Lack of Efficacy|0|||
130301062|NCT01545050|469064216|FG001|Overall Study|Lack of Efficacy|0|||
130301063|NCT01545050|469064217|FG002|Overall Study|Lack of Efficacy|0|||
130301064|NCT01545050|469064218|FG003|Overall Study|Lack of Efficacy|3|||
130301065|NCT01545050|469064219|FG004|Overall Study|Lack of Efficacy|2|||
130301066|NCT01545050|469064215|FG000|Overall Study|Adverse Event|1|||
130301067|NCT01545050|469064216|FG001|Overall Study|Adverse Event|1|||
130301068|NCT01545050|469064217|FG002|Overall Study|Adverse Event|2|||
130301069|NCT01545050|469064218|FG003|Overall Study|Adverse Event|2|||
130301070|NCT01545050|469064219|FG004|Overall Study|Adverse Event|0|||
130301071|NCT01545050|469064215|FG000|Overall Study|Discontinued study treatment|1|||
130301072|NCT01545050|469064216|FG001|Overall Study|Discontinued study treatment|0|||
130301073|NCT01545050|469064217|FG002|Overall Study|Discontinued study treatment|0|||
130301074|NCT01545050|469064218|FG003|Overall Study|Discontinued study treatment|0|||
130301075|NCT01545050|469064219|FG004|Overall Study|Discontinued study treatment|0|||
130301076|NCT01545050|469064215|FG000|Overall Study|Withdrawal by Subject|1|||
130301077|NCT01545050|469064216|FG001|Overall Study|Withdrawal by Subject|0|||
130301078|NCT01545050|469064217|FG002|Overall Study|Withdrawal by Subject|0|||
130301079|NCT01545050|469064218|FG003|Overall Study|Withdrawal by Subject|2|||
130301080|NCT01545050|469064219|FG004|Overall Study|Withdrawal by Subject|1|||
130301081|NCT01545050|469064215|FG000|Overall Study|Participant no longer meets study criteria|0|||
130301082|NCT01545050|469064216|FG001|Overall Study|Participant no longer meets study criteria|2|||
130301083|NCT01545050|469064217|FG002|Overall Study|Participant no longer meets study criteria|0|||
130301084|NCT01545050|469064218|FG003|Overall Study|Participant no longer meets study criteria|0|||
130301085|NCT01545050|469064219|FG004|Overall Study|Participant no longer meets study criteria|1|||
130301086|NCT01545050|469064215|FG000|Overall Study|Administrative reason by sponsor|4|||
130301087|NCT01545050|469064216|FG001|Overall Study|Administrative reason by sponsor|2|||
130301088|NCT01545050|469064217|FG002|Overall Study|Administrative reason by sponsor|3|||
130301089|NCT01545050|469064218|FG003|Overall Study|Administrative reason by sponsor|5|||
130301090|NCT01545050|469064219|FG004|Overall Study|Administrative reason by sponsor|5|||
130301091|NCT03235089|469064220|FG000|Overall Study|Lost to Follow-up|1|||
130301092|NCT03235089|469064221|FG001|Overall Study|Lost to Follow-up|1|||
130301093|NCT03235089|469064220|FG000|Overall Study|Physician Decision|2|||
130301094|NCT03235089|469064221|FG001|Overall Study|Physician Decision|2|||
130301095|NCT03238924|469064222|FG000|Overall Study|Withdrawal by Subject|2|||
130301096|NCT03238924|469064223|FG001|Overall Study|Withdrawal by Subject|2|||
130301097|NCT04667104|469064226|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130301098|NCT04667104|469064227|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130301099|NCT04667104|469064228|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
130301100|NCT02188849|469064229|FG000|Overall Study|Lost to Follow-up|3|||
130301101|NCT02188849|469064230|FG001|Overall Study|Lost to Follow-up|8|||
130301102|NCT01630889|469064231|FG000|Overall Study|Death|2|||
130301103|NCT01630889|469064231|FG000|Overall Study|Withdrawal by Subject|1|||
130301104|NCT01630889|469064231|FG000|Overall Study|Other than Specified|2|||
130301105|NCT01630889|469064231|FG000|Overall Study|Lost to Follow-up|4|||
130301106|NCT01630889|469064231|FG000|Overall Study|Other|1|||
130301107|NCT00605345|469064232|FG000|Overall Study|Withdrawal by Subject|1|||
130301108|NCT00605345|469064233|FG001|Overall Study|Withdrawal by Subject|0|||
130301109|NCT00605345|469064232|FG000|Overall Study|Adverse Event|0|||
130301110|NCT00605345|469064233|FG001|Overall Study|Adverse Event|1|||
130301111|NCT00605345|469064232|FG000|Overall Study|Protocol Violation|0|||
130301112|NCT00605345|469064233|FG001|Overall Study|Protocol Violation|2|||
130301113|NCT00566254|469064234|FG000|Overall Study|Adverse Event|3|||
130301114|NCT00566254|469064235|FG001|Overall Study|Adverse Event|1|||
130301115|NCT00566254|469064234|FG000|Overall Study|Protocol Violation|1|||
130301116|NCT00566254|469064235|FG001|Overall Study|Protocol Violation|3|||
130301117|NCT00566254|469064234|FG000|Overall Study|Withdrawal by Subject|1|||
130301118|NCT00566254|469064235|FG001|Overall Study|Withdrawal by Subject|2|||
130301119|NCT00566254|469064234|FG000|Overall Study|Lack of Efficacy|5|||
130301120|NCT00566254|469064235|FG001|Overall Study|Lack of Efficacy|6|||
130301121|NCT00566254|469064234|FG000|Overall Study|Other|0|||
130301122|NCT00566254|469064235|FG001|Overall Study|Other|2|||
130301123|NCT00238238|469064236|FG000|Overall Study|Withdrawal by Subject|0|||
130301124|NCT00238238|469064237|FG001|Overall Study|Withdrawal by Subject|3|||
130373061|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373062|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373063|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373064|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130301125|NCT00238238|469064238|FG002|Overall Study|Withdrawal by Subject|0|||
130301126|NCT01345669|469064239|FG000|Overall Study|Primary tumour recurrence|53|||
130301127|NCT01345669|469064240|FG001|Overall Study|Primary tumour recurrence|32|||
130301128|NCT01345669|469064239|FG000|Overall Study|Second primary tumour|4|||
130301129|NCT01345669|469064240|FG001|Overall Study|Second primary tumour|3|||
130301130|NCT01345669|469064239|FG000|Overall Study|Adverse Event|63|||
130301131|NCT01345669|469064240|FG001|Overall Study|Adverse Event|9|||
130301132|NCT01345669|469064239|FG000|Overall Study|Protocol Violation|3|||
130301133|NCT01345669|469064240|FG001|Overall Study|Protocol Violation|1|||
130301134|NCT01345669|469064239|FG000|Overall Study|Lost to Follow-up|1|||
130301135|NCT01345669|469064240|FG001|Overall Study|Lost to Follow-up|1|||
130301136|NCT01345669|469064239|FG000|Overall Study|Withdrawal by Subject|52|||
130301137|NCT01345669|469064240|FG001|Overall Study|Withdrawal by Subject|13|||
130301138|NCT01345669|469064239|FG000|Overall Study|Other Reasons|111|||
130301139|NCT01345669|469064240|FG001|Overall Study|Other Reasons|60|||
130301140|NCT01793883|469064241|FG000|Overall Study|Withdrawal by Subject|3|||
130301141|NCT01793883|469064242|FG001|Overall Study|Withdrawal by Subject|7|||
130301142|NCT01793883|469064243|FG002|Overall Study|Withdrawal by Subject|3|||
130301143|NCT01793883|469064241|FG000|Overall Study|Subject noncompliance|0|||
130301144|NCT01793883|469064242|FG001|Overall Study|Subject noncompliance|1|||
130301145|NCT01793883|469064243|FG002|Overall Study|Subject noncompliance|1|||
130301146|NCT01793883|469064241|FG000|Overall Study|Lost to Follow-up|5|||
130301147|NCT01793883|469064242|FG001|Overall Study|Lost to Follow-up|1|||
130301148|NCT01793883|469064243|FG002|Overall Study|Lost to Follow-up|3|||
130301149|NCT01793883|469064241|FG000|Overall Study|Randomized in error|1|||
130301150|NCT01793883|469064242|FG001|Overall Study|Randomized in error|0|||
130301151|NCT01793883|469064243|FG002|Overall Study|Randomized in error|0|||
130301152|NCT01793883|469064241|FG000|Overall Study|Unable to complete spriometry|1|||
130301153|NCT01793883|469064242|FG001|Overall Study|Unable to complete spriometry|0|||
130301154|NCT01793883|469064243|FG002|Overall Study|Unable to complete spriometry|0|||
130301155|NCT01793883|469064241|FG000|Overall Study|Unable to complete measurements|1|||
130301156|NCT01793883|469064242|FG001|Overall Study|Unable to complete measurements|0|||
130301157|NCT01793883|469064243|FG002|Overall Study|Unable to complete measurements|0|||
130301158|NCT01793883|469064241|FG000|Overall Study|Met exclusion criteria|1|||
130301159|NCT01793883|469064242|FG001|Overall Study|Met exclusion criteria|0|||
130301160|NCT01793883|469064243|FG002|Overall Study|Met exclusion criteria|0|||
130301161|NCT01793883|469064241|FG000|Overall Study|Dosing error|0|||
130301162|NCT01793883|469064242|FG001|Overall Study|Dosing error|1|||
130301163|NCT01793883|469064243|FG002|Overall Study|Dosing error|0|||
130301164|NCT01793883|469064241|FG000|Overall Study|Respiratory distress during spirometry|0|||
130301165|NCT01793883|469064242|FG001|Overall Study|Respiratory distress during spirometry|0|||
130301166|NCT01793883|469064243|FG002|Overall Study|Respiratory distress during spirometry|1|||
130301167|NCT02478255|469064244|FG000|Overall Study|Physician Decision|6|||
130301168|NCT02478255|469064245|FG001|Overall Study|Physician Decision|0|||
130301169|NCT02478255|469064244|FG000|Overall Study|Withdrawal by Subject|2|||
130301170|NCT02478255|469064245|FG001|Overall Study|Withdrawal by Subject|0|||
130301171|NCT01730586|469064246|FG000|Overall Study|Progressive Disease|2|||
130301172|NCT01730586|469064246|FG000|Overall Study|Inadequate Trial|8|||
130301173|NCT01730586|469064246|FG000|Overall Study|Adverse Event|2|||
130301174|NCT01730586|469064246|FG000|Overall Study|Hospice|1|||
130301175|NCT00061633|469064247|FG000|Overall Study|Adverse Event|1|||
130301176|NCT00061633|469064248|FG001|Overall Study|Adverse Event|2|||
130301177|NCT00061633|469064247|FG000|Overall Study|Withdrawal by Subject|2|||
130301178|NCT00061633|469064248|FG001|Overall Study|Withdrawal by Subject|2|||
130301179|NCT00061633|469064247|FG000|Overall Study|Lost to Follow-up|1|||
130301180|NCT00061633|469064248|FG001|Overall Study|Lost to Follow-up|4|||
130301181|NCT00061633|469064247|FG000|Overall Study|Other|1|||
130301182|NCT00061633|469064248|FG001|Overall Study|Other|1|||
130301183|NCT00061633|469064247|FG000|Overall Study|Never received study treatment|0|||
130301184|NCT00061633|469064248|FG001|Overall Study|Never received study treatment|2|||
130301185|NCT00842543|469066562|FG000|Overall Study|Withdrawal by Subject|2|||
130301186|NCT00842543|469066563|FG001|Overall Study|Withdrawal by Subject|0|||
130301187|NCT00842543|469066564|FG002|Overall Study|Withdrawal by Subject|3|||
130301188|NCT00842543|469066565|FG003|Overall Study|Withdrawal by Subject|4|||
130301189|NCT01483183|469066570|FG000|Overall Study|Physician Decision|0|||
130301190|NCT01483183|469066571|FG001|Overall Study|Physician Decision|0|||
130301191|NCT01483183|469066572|FG002|Overall Study|Physician Decision|0|||
130301192|NCT01483183|469066573|FG003|Overall Study|Physician Decision|0|||
130301193|NCT01483183|469066574|FG004|Overall Study|Physician Decision|0|||
130301194|NCT01483183|469066575|FG005|Overall Study|Physician Decision|0|||
130301195|NCT01483183|469066576|FG006|Overall Study|Physician Decision|2|||
130301196|NCT01483183|469066577|FG007|Overall Study|Physician Decision|0|||
130301197|NCT01483183|469066578|FG008|Overall Study|Physician Decision|0|||
130301198|NCT01483183|469066579|FG009|Overall Study|Physician Decision|0|||
130301199|NCT01483183|469066570|FG000|Overall Study|Withdrawal by Subject|0|||
130301200|NCT01483183|469066571|FG001|Overall Study|Withdrawal by Subject|0|||
130301201|NCT01483183|469066572|FG002|Overall Study|Withdrawal by Subject|0|||
130301202|NCT01483183|469066573|FG003|Overall Study|Withdrawal by Subject|0|||
130301203|NCT01483183|469066574|FG004|Overall Study|Withdrawal by Subject|0|||
130301204|NCT01483183|469066575|FG005|Overall Study|Withdrawal by Subject|0|||
130301205|NCT01483183|469066576|FG006|Overall Study|Withdrawal by Subject|0|||
130301206|NCT01483183|469066577|FG007|Overall Study|Withdrawal by Subject|0|||
130301207|NCT01483183|469066578|FG008|Overall Study|Withdrawal by Subject|0|||
130301208|NCT01483183|469066579|FG009|Overall Study|Withdrawal by Subject|1|||
130301209|NCT00239928|469066580|FG000|Overall Study|Lack of Efficacy|1|||
130301210|NCT00239928|469066580|FG000|Overall Study|Adverse Event|4|||
130301211|NCT00239928|469066580|FG000|Overall Study|Not need to continue study|3|||
130301212|NCT00239928|469066580|FG000|Overall Study|Withdrawal by Subject|2|||
130301213|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301214|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301215|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
130301216|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
130301217|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
130301218|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301219|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
130301220|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
130301221|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
130301222|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301223|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301224|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301225|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301226|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130301227|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301228|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
130301229|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301230|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301231|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301232|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301233|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301234|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130301235|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301236|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301237|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301238|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301239|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301240|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301241|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301242|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301243|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301244|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301245|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301246|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301247|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301248|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301249|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301250|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301251|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301252|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301253|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301254|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301255|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301256|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301257|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301258|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301259|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301260|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301261|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301262|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301263|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301264|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301265|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301266|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301267|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301268|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130301269|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301270|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301271|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301272|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130301273|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301274|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301275|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130716423|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130301276|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301277|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301278|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301279|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301280|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301281|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130301282|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301283|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301284|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130301285|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301286|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301287|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301288|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301289|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301290|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301291|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301292|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
130716424|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
130716425|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Death|0|||
130716426|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Death|0|||
130716427|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Death|0|||
130716428|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Death|1|||
130716429|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Death|0|||
130716430|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Death|0|||
130301293|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301294|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301295|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301296|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301297|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301298|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301299|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301300|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301301|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301302|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301303|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301304|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
130301305|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301306|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301307|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301308|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301309|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301310|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301311|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301312|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301313|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301314|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301315|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301316|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301317|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301318|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301319|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301320|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301321|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301322|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301323|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
130301324|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301325|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301326|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130373065|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373066|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130716431|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130301327|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130373067|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130301328|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301329|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301330|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301331|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301332|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301333|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301334|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301335|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301336|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301337|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301338|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301339|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301340|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
130301341|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
130301342|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
130301343|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301344|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301345|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301346|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301347|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301348|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301349|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301350|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301351|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301352|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301353|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
130301354|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
130301355|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301356|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301357|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301358|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301359|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301360|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301361|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301362|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301363|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301364|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301365|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
130301366|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
130301367|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301368|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
130301369|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301370|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301371|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130373068|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373069|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130373070|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
130373071|NCT03129100|469333339|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
130373072|NCT03129100|469333340|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
130373073|NCT03129100|469333341|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
130373074|NCT03129100|469333342|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
130373075|NCT03129100|469333343|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
130373076|NCT03129100|469333344|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
130373077|NCT03129100|469333345|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
130373078|NCT03129100|469333346|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
130373079|NCT03129100|469333347|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
130373080|NCT03129100|469333348|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
130373081|NCT03129100|469333349|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
130373082|NCT03129100|469333350|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
130373083|NCT03129100|469333351|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
130373084|NCT03129100|469333352|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
130373085|NCT03129100|469333353|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
130301372|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301373|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301374|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130373086|NCT03129100|469333354|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
130373087|NCT03129100|469333355|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
130461809|NCT03401112|469656254|FG001|Overall Study|Withdrawal by Subject|3|||
130373088|NCT03129100|469333356|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
130373089|NCT03129100|469333357|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
130373090|NCT03129100|469333358|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
130373091|NCT03129100|469333359|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
130373092|NCT03129100|469333360|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
130373093|NCT03129100|469333361|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
130301375|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301376|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301377|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301378|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301379|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
130301380|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301381|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301382|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301383|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301384|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301385|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301386|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301387|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301388|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301389|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301390|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301391|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301392|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301393|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301394|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
130301395|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301396|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301397|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301398|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301399|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301400|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301401|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301402|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301403|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301404|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
130301405|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301406|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301407|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301408|NCT00774800|469066596|FG000|Intervention 4|Withdrawal by Subject|1|||
130301409|NCT01331109|469066597|FG000|Overall Study|Adverse Event|6|||
130301410|NCT01331109|469066597|FG000|Overall Study|Lack of Efficacy|2|||
130301411|NCT01331109|469066597|FG000|Overall Study|Protocol Violation|3|||
130301412|NCT01331109|469066597|FG000|Overall Study|Withdrawal by Subject|7|||
130301413|NCT01331109|469066597|FG000|Overall Study|Lost to Follow-up|1|||
130301414|NCT01331109|469066597|FG000|Overall Study|Study Terminated by Sponsor|38|||
130301415|NCT00479856|469066598|FG000|Overall Study|Adverse Event|1|||
130301416|NCT00479856|469066598|FG000|Overall Study|Withdrawal by Subject|1|||
130301417|NCT00479856|469066598|FG000|Overall Study|Physician Decision|1|||
130301418|NCT00661622|469066601|FG000|Overall Study|Protocol Violation|1|||
130301419|NCT00661622|469066602|FG001|Overall Study|Protocol Violation|0|||
130301420|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
130301421|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
130301422|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
130301423|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
130301424|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Death|2|||
130301425|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Death|2|||
130301426|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Death|0|||
130301427|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Death|0|||
130301428|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
130301429|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
130301430|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
130301431|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
130301432|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
130301433|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301434|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301435|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301436|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
130301437|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
130301438|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130301439|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130301440|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
130301441|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301442|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301443|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301444|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301445|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
130461810|NCT03401112|469656255|FG002|Overall Study|Withdrawal by Subject|2|||
130373094|NCT03129100|469333362|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
130373095|NCT03129100|469333363|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
130373096|NCT03129100|469333364|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
130373097|NCT03845985|469333365|FG000|Overall Study|Lost to Follow-up|2|||
130373098|NCT03845985|469333366|FG001|Overall Study|Lost to Follow-up|1|||
130373099|NCT03845985|469333365|FG000|Overall Study|Physician Decision|1|||
130373100|NCT03845985|469333366|FG001|Overall Study|Physician Decision|0|||
130373101|NCT03845985|469333365|FG000|Overall Study|Withdrawal by Subject|4|||
130373102|NCT03845985|469333366|FG001|Overall Study|Withdrawal by Subject|1|||
130301446|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301447|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301448|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
130301449|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
130301450|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130301451|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130301452|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
130301453|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
130301454|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
130301455|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
130301456|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Death|0|||
130373103|NCT03302234|469333373|FG000|Overall Study|Death|191|||
130373104|NCT03302234|469333374|FG001|Overall Study|Death|192|||
130373105|NCT03302234|469333373|FG000|Overall Study|Withdrawal by Subject|2|||
130373106|NCT03302234|469333374|FG001|Overall Study|Withdrawal by Subject|2|||
130373107|NCT03302234|469333373|FG000|Overall Study|Sponsor Decision|90|||
130373108|NCT03302234|469333374|FG001|Overall Study|Sponsor Decision|89|||
130373109|NCT03302234|469333373|FG000|Overall Study|Laryngeal carcinoma|0|||
130373110|NCT03302234|469333374|FG001|Overall Study|Laryngeal carcinoma|1|||
130373111|NCT03302234|469333373|FG000|Overall Study|Not Reported|1|||
130373112|NCT03302234|469333374|FG001|Overall Study|Not Reported|0|||
130373113|NCT02795832|469333375|FG000|Overall Study|Adverse Event|0|||
130373114|NCT02795832|469333376|FG001|Overall Study|Adverse Event|0|||
130373115|NCT02795832|469333377|FG002|Overall Study|Adverse Event|0|||
130373116|NCT02795832|469333378|FG003|Overall Study|Adverse Event|0|||
130373117|NCT02795832|469333379|FG004|Overall Study|Adverse Event|0|||
130373118|NCT02795832|469333380|FG005|Overall Study|Adverse Event|3|||
130373119|NCT04523220|469333381|FG000|Main Treatment Period|Physician Decision|1|||
130373120|NCT04523220|469333382|FG001|Main Treatment Period|Physician Decision|1|||
130373121|NCT04523220|469333383|FG002|Main Treatment Period|Physician Decision|0|||
130373122|NCT04523220|469333381|FG000|Main Treatment Period|Other|5|||
130373123|NCT04523220|469333382|FG001|Main Treatment Period|Other|2|||
130373124|NCT04523220|469333383|FG002|Main Treatment Period|Other|4|||
130373125|NCT04523220|469333381|FG000|Main Treatment Period|Subject Decision|5|||
130373126|NCT04523220|469333382|FG001|Main Treatment Period|Subject Decision|7|||
130373127|NCT04523220|469333383|FG002|Main Treatment Period|Subject Decision|3|||
130373128|NCT04523220|469333381|FG000|Main Treatment Period|Death|5|||
130373129|NCT04523220|469333382|FG001|Main Treatment Period|Death|11|||
130301457|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Death|0|||
130373130|NCT04523220|469333383|FG002|Main Treatment Period|Death|4|||
130373131|NCT04523220|469333381|FG000|Main Treatment Period|Adverse Event|11|||
130373132|NCT04523220|469333382|FG001|Main Treatment Period|Adverse Event|9|||
130373133|NCT04523220|469333383|FG002|Main Treatment Period|Adverse Event|9|||
130373134|NCT04523220|469333381|FG000|Main Treatment Period|Withdrawal by Subject|3|||
130373135|NCT04523220|469333382|FG001|Main Treatment Period|Withdrawal by Subject|3|||
130373136|NCT04523220|469333383|FG002|Main Treatment Period|Withdrawal by Subject|4|||
130373137|NCT04523220|469333381|FG000|Main Treatment Period|Study drug never adminstered|10|||
130373138|NCT04523220|469333382|FG001|Main Treatment Period|Study drug never adminstered|3|||
130373139|NCT04523220|469333383|FG002|Main Treatment Period|Study drug never adminstered|5|||
130461811|NCT03401112|469656256|FG003|Overall Study|Withdrawal by Subject|1|||
130461812|NCT03401112|469656257|FG004|Overall Study|Withdrawal by Subject|0|||
130461813|NCT03401112|469656253|FG000|Overall Study|Physician Decision|0|||
130373140|NCT04523220|469333381|FG000|Extension Treatment Period|Physician Decision|1|||
130373141|NCT04523220|469333382|FG001|Extension Treatment Period|Physician Decision|0|||
130373142|NCT04523220|469333383|FG002|Extension Treatment Period|Physician Decision|3|||
130373143|NCT04523220|469333381|FG000|Extension Treatment Period|Other|2|||
130373144|NCT04523220|469333382|FG001|Extension Treatment Period|Other|6|||
130373145|NCT04523220|469333383|FG002|Extension Treatment Period|Other|6|||
130373146|NCT04523220|469333381|FG000|Extension Treatment Period|Subject Decision|5|||
130301458|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Death|0|||
130301459|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Death|1|||
130301460|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
130301461|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
130301462|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
130301463|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
130301464|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301465|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301466|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
130301467|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301468|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301469|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301470|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
130301471|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301472|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130301473|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130301474|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
130301475|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
130301476|NCT04496453|469066616|FG000|Overall Study|Lost to Follow-up|6|||
130301477|NCT03997825|469066617|FG000|Overall Study|Death|3|||
130301478|NCT03997825|469066617|FG000|Overall Study|Lost to Follow-up|10|||
130301479|NCT03997825|469066617|FG000|Overall Study|Withdrawal by Subject|3|||
130301480|NCT03997825|469066617|FG000|Overall Study|Refused participation|1|||
130301481|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
130301482|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
130301483|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
130301484|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
130301485|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
130301486|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
130301487|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
130301488|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
130301489|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
130301490|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
130301491|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
130301492|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
130301493|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
130301494|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130301495|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
130301496|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
130301497|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
130301498|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
130301499|NCT00767819|469066620|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130301500|NCT00767819|469066621|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
130301501|NCT00767819|469066622|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130301502|NCT00767819|469066620|FG000|Overall Study|Withdrawal by Subject|1|||
130301503|NCT00767819|469066621|FG001|Overall Study|Withdrawal by Subject|1|||
130301504|NCT00767819|469066622|FG002|Overall Study|Withdrawal by Subject|0|||
130301505|NCT00767819|469066620|FG000|Overall Study|Administrative problems|0|||
130301506|NCT00767819|469066621|FG001|Overall Study|Administrative problems|1|||
130301507|NCT00767819|469066622|FG002|Overall Study|Administrative problems|0|||
130301508|NCT00767819|469066620|FG000|Overall Study|Death|2|||
130301509|NCT00767819|469066621|FG001|Overall Study|Death|3|||
130301510|NCT00767819|469066622|FG002|Overall Study|Death|0|||
130301511|NCT00767819|469066620|FG000|Overall Study|Adverse Event|2|||
130301512|NCT00767819|469066621|FG001|Overall Study|Adverse Event|0|||
130301513|NCT00767819|469066622|FG002|Overall Study|Adverse Event|0|||
130301514|NCT00767819|469066620|FG000|Overall Study|Abnormal lab values|1|||
130301515|NCT00767819|469066621|FG001|Overall Study|Abnormal lab values|0|||
130301516|NCT00767819|469066622|FG002|Overall Study|Abnormal lab values|0|||
130301517|NCT00767819|469066620|FG000|Overall Study|Lost to Follow-up|1|||
130301518|NCT00767819|469066621|FG001|Overall Study|Lost to Follow-up|0|||
130301519|NCT00767819|469066622|FG002|Overall Study|Lost to Follow-up|0|||
130301520|NCT02726022|469066624|FG000|Overall Study|Adverse Event|14|||
130301521|NCT02726022|469066624|FG000|Overall Study|Treatment Failure|8|||
130301522|NCT02726022|469066624|FG000|Overall Study|Poor Compliance|13|||
130301523|NCT02726022|469066624|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
130301524|NCT00915551|469066625|FG000|Overall Study|Withdrawal by Subject|0|||
130301525|NCT00915551|469066626|FG001|Overall Study|Withdrawal by Subject|1|||
130301526|NCT00235716|469066627|FG000|Overall Study|Death|26|||
130301527|NCT00235716|469066628|FG001|Overall Study|Death|39|||
130301528|NCT00235716|469066629|FG002|Overall Study|Death|32|||
130301529|NCT00235716|469066630|FG003|Overall Study|Death|31|||
130557352|NCT00631189|470009966|FG001|Treatment Phase|Withdrawal by Subject|2|||
130557353|NCT00631189|470009967|FG002|Treatment Phase|Withdrawal by Subject|1|||
130557354|NCT00631189|470009968|FG003|Treatment Phase|Withdrawal by Subject|1|||
130557355|NCT00631189|470009965|FG000|Treatment Phase|Protocol Violation|0|||
130557356|NCT00631189|470009966|FG001|Treatment Phase|Protocol Violation|1|||
130301530|NCT00235716|469066627|FG000|Overall Study|Withdrawal by Subject|23|||
130301531|NCT00235716|469066628|FG001|Overall Study|Withdrawal by Subject|19|||
130301532|NCT00235716|469066629|FG002|Overall Study|Withdrawal by Subject|17|||
130301533|NCT00235716|469066630|FG003|Overall Study|Withdrawal by Subject|18|||
130301534|NCT00235716|469066627|FG000|Overall Study|Lost to Follow-up|12|||
130301535|NCT00235716|469066628|FG001|Overall Study|Lost to Follow-up|7|||
130301536|NCT00235716|469066629|FG002|Overall Study|Lost to Follow-up|14|||
130301537|NCT00235716|469066630|FG003|Overall Study|Lost to Follow-up|10|||
130301538|NCT00235716|469066627|FG000|Overall Study|Adverse Event|1|||
130301539|NCT00235716|469066628|FG001|Overall Study|Adverse Event|1|||
130301540|NCT00235716|469066629|FG002|Overall Study|Adverse Event|1|||
130301541|NCT00235716|469066630|FG003|Overall Study|Adverse Event|0|||
130301542|NCT00235716|469066627|FG000|Overall Study|Physician Decision|0|||
130301543|NCT00235716|469066628|FG001|Overall Study|Physician Decision|1|||
130301544|NCT00235716|469066629|FG002|Overall Study|Physician Decision|1|||
130301545|NCT00235716|469066630|FG003|Overall Study|Physician Decision|3|||
130301546|NCT04390841|469066631|FG000|Overall Study|Withdrawal by Subject|2|||
130301547|NCT02891382|469066644|FG000|Overall Study|Lost to Follow-up|3|||
130301548|NCT02891382|469066645|FG001|Overall Study|Lost to Follow-up|4|||
130301549|NCT02891382|469066646|FG002|Overall Study|Lost to Follow-up|5|||
130301550|NCT02891382|469066647|FG003|Overall Study|Lost to Follow-up|3|||
130301551|NCT02891382|469066648|FG004|Overall Study|Lost to Follow-up|4|||
130301552|NCT02516228|469066651|FG000|Overall Study|Lost to Follow-up|1|||
130301553|NCT02516228|469066651|FG000|Overall Study|Withdrawal by Subject|1|||
130301554|NCT02516228|469066651|FG000|Overall Study|Physician Decision|1|||
130301555|NCT03916484|469066654|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301556|NCT03916484|469066655|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
130301557|NCT03916484|469066656|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301558|NCT03916484|469066657|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301559|NCT03916484|469066654|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130301560|NCT03916484|469066655|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
130301561|NCT03916484|469066656|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
130301562|NCT03916484|469066657|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130301563|NCT00504894|469066666|FG000|Overall Study|fMRI technical problems|1|||
130301564|NCT00504894|469066667|FG001|Overall Study|fMRI technical problems|1|||
130301565|NCT00504894|469066668|FG002|Overall Study|fMRI technical problems|0|||
130301566|NCT00504894|469066666|FG000|Overall Study|Withdrawal by Subject|0|||
130301567|NCT00504894|469066667|FG001|Overall Study|Withdrawal by Subject|1|||
130301568|NCT00504894|469066668|FG002|Overall Study|Withdrawal by Subject|0|||
130301569|NCT00504894|469066666|FG000|Overall Study|Infusion technical problems|0|||
130301570|NCT00504894|469066667|FG001|Overall Study|Infusion technical problems|1|||
130301571|NCT00504894|469066668|FG002|Overall Study|Infusion technical problems|0|||
130301572|NCT00504894|469066666|FG000|Overall Study|poor subject data|2|||
130301573|NCT00504894|469066667|FG001|Overall Study|poor subject data|0|||
130373147|NCT04523220|469333382|FG001|Extension Treatment Period|Subject Decision|2|||
130373148|NCT04523220|469333383|FG002|Extension Treatment Period|Subject Decision|4|||
130373149|NCT04523220|469333381|FG000|Extension Treatment Period|Death|6|||
130373150|NCT04523220|469333382|FG001|Extension Treatment Period|Death|4|||
130373151|NCT04523220|469333383|FG002|Extension Treatment Period|Death|7|||
130373152|NCT04523220|469333381|FG000|Extension Treatment Period|Adverse Event|6|||
130373153|NCT04523220|469333382|FG001|Extension Treatment Period|Adverse Event|7|||
130373154|NCT04523220|469333383|FG002|Extension Treatment Period|Adverse Event|9|||
130373155|NCT04523220|469333381|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
130373156|NCT04523220|469333382|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
130373157|NCT04523220|469333383|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
130373158|NCT04523220|469333381|FG000|Extension Treatment Period|Study drug never administered|0|||
130373159|NCT04523220|469333382|FG001|Extension Treatment Period|Study drug never administered|1|||
130373160|NCT04523220|469333383|FG002|Extension Treatment Period|Study drug never administered|0|||
130301574|NCT00504894|469066668|FG002|Overall Study|poor subject data|0|||
130301575|NCT05090852|469066669|FG000|Overall Study|Physician Decision|5|||
130301576|NCT01196416|469066670|FG000|Overall Study|Withdrawal by Subject|2|||
130301577|NCT00148941|469066672|FG000|Overall Study|Lost to Follow-up|17|||
130301578|NCT00148941|469066673|FG001|Overall Study|Lost to Follow-up|24|||
130301579|NCT00148941|469066674|FG002|Overall Study|Lost to Follow-up|18|||
130373161|NCT00571948|469333384|FG000|Overall Study|Lost to Follow-up|2|||
130373162|NCT00571948|469333385|FG001|Overall Study|Lost to Follow-up|0|||
130557357|NCT00631189|470009967|FG002|Treatment Phase|Protocol Violation|6|||
130301580|NCT00148941|469066675|FG003|Overall Study|Lost to Follow-up|22|||
130461814|NCT03401112|469656254|FG001|Overall Study|Physician Decision|0|||
130461815|NCT03401112|469656255|FG002|Overall Study|Physician Decision|0|||
130461816|NCT03401112|469656256|FG003|Overall Study|Physician Decision|2|||
130461817|NCT03401112|469656257|FG004|Overall Study|Physician Decision|0|||
130461818|NCT03401112|469656253|FG000|Overall Study|Study was Terminated by Sponsor|0|||
130461819|NCT03401112|469656254|FG001|Overall Study|Study was Terminated by Sponsor|0|||
130301581|NCT00148941|469066672|FG000|Overall Study|Withdrawal by Subject|1|||
130301582|NCT00148941|469066673|FG001|Overall Study|Withdrawal by Subject|0|||
130301583|NCT00148941|469066674|FG002|Overall Study|Withdrawal by Subject|1|||
130301584|NCT00148941|469066675|FG003|Overall Study|Withdrawal by Subject|0|||
130301585|NCT00148941|469066672|FG000|Overall Study|Other|0|||
130301586|NCT00148941|469066673|FG001|Overall Study|Other|0|||
130301587|NCT00148941|469066674|FG002|Overall Study|Other|1|||
130301588|NCT00148941|469066675|FG003|Overall Study|Other|2|||
130301589|NCT02673684|469066676|FG000|Overall Study|Study not completed d/t loss of funding|9|||
130301590|NCT02673684|469066677|FG001|Overall Study|Study not completed d/t loss of funding|8|||
130301591|NCT01092663|469066678|FG000|Overall Study|Withdrawal by Subject|3|||
130301592|NCT01092663|469066679|FG001|Overall Study|Withdrawal by Subject|2|||
130301593|NCT01092663|469066678|FG000|Overall Study|Glucose >300mg/dL|1|||
130301594|NCT01092663|469066679|FG001|Overall Study|Glucose >300mg/dL|0|||
130301595|NCT01092663|469066678|FG000|Overall Study|High fasting triglyceride|2|||
130301596|NCT01092663|469066679|FG001|Overall Study|High fasting triglyceride|0|||
130301597|NCT01092663|469066678|FG000|Overall Study|Adverse Event|1|||
130301598|NCT01092663|469066679|FG001|Overall Study|Adverse Event|1|||
130301599|NCT01092663|469066678|FG000|Overall Study|Protocol Violation|0|||
130301600|NCT01092663|469066679|FG001|Overall Study|Protocol Violation|1|||
130301601|NCT03688620|469066680|FG000|Overall Study|Other|0|||
130301602|NCT03688620|469066681|FG001|Overall Study|Other|0|||
130301603|NCT03688620|469066682|FG002|Overall Study|Other|1|||
130301604|NCT03688620|469066680|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
130301605|NCT03688620|469066681|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
130301606|NCT03688620|469066682|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
130301607|NCT03688620|469066680|FG000|Overall Study|Lost to Follow-up|16|||
130301608|NCT03688620|469066681|FG001|Overall Study|Lost to Follow-up|0|||
130301609|NCT03688620|469066682|FG002|Overall Study|Lost to Follow-up|1|||
130301610|NCT03688620|469066680|FG000|Overall Study|Withdrawal by Subject|0|||
130301611|NCT03688620|469066681|FG001|Overall Study|Withdrawal by Subject|0|||
130301612|NCT03688620|469066682|FG002|Overall Study|Withdrawal by Subject|6|||
130301613|NCT01008904|469066683|FG000|Overall Study|Lost to Follow-up|1|||
130301614|NCT01008904|469066683|FG000|Overall Study|Adverse Event|2|||
130301615|NCT01008904|469066683|FG000|Overall Study|unexpected unrelated surgery|1|||
130301616|NCT01183065|469066684|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
130301617|NCT02456857|469066685|FG000|Overall Study|Disease Progression|4|||
130301618|NCT00781859|469066686|FG000|Overall Study|Adverse Event|2|||
130301619|NCT00781859|469066687|FG001|Overall Study|Adverse Event|2|||
130301620|NCT00781859|469066686|FG000|Overall Study|Withdrawal by Subject|8|||
130301621|NCT00781859|469066687|FG001|Overall Study|Withdrawal by Subject|4|||
130301622|NCT00781859|469066686|FG000|Overall Study|Lost to Follow-up|6|||
130301623|NCT00781859|469066687|FG001|Overall Study|Lost to Follow-up|3|||
130301624|NCT00781859|469066686|FG000|Overall Study|Death|3|||
130301625|NCT00781859|469066687|FG001|Overall Study|Death|0|||
130301626|NCT01983774|469066691|FG000|Overall Study|Lung Transplant|0|||
130301627|NCT01983774|469066692|FG001|Overall Study|Lung Transplant|1|||
130301628|NCT01983774|469066691|FG000|Overall Study|Lost to Follow-up|1|||
130301629|NCT01983774|469066692|FG001|Overall Study|Lost to Follow-up|0|||
130301630|NCT01008449|469066693|FG000|Overall Study|Lost to Follow-up|29|||
130301631|NCT01008449|469066694|FG001|Overall Study|Lost to Follow-up|19|||
130301632|NCT01220180|469066695|FG000|Overall Study|Lost to Follow-up|76|||
130301633|NCT01220180|469066695|FG000|Overall Study|Other|72|||
130301634|NCT01220180|469066695|FG000|Overall Study|Adverse Event|35|||
130461820|NCT03401112|469656255|FG002|Overall Study|Study was Terminated by Sponsor|0|||
130461821|NCT03401112|469656256|FG003|Overall Study|Study was Terminated by Sponsor|1|||
130557358|NCT00631189|470009968|FG003|Treatment Phase|Protocol Violation|2|||
130557359|NCT00631189|470009965|FG000|Treatment Phase|Adverse Event|0|||
130557360|NCT00631189|470009966|FG001|Treatment Phase|Adverse Event|3|||
130557361|NCT00631189|470009967|FG002|Treatment Phase|Adverse Event|2|||
130557362|NCT00631189|470009968|FG003|Treatment Phase|Adverse Event|4|||
130301635|NCT01220180|469066695|FG000|Overall Study|Lack of Efficacy|22|||
130301636|NCT01220180|469066695|FG000|Overall Study|Death|1|||
130301637|NCT01220180|469066695|FG000|Overall Study|Randomized but not treated|1|||
130301638|NCT01067469|469066700|FG000|Overall Study|Withdrawal by Subject|0|||
130301639|NCT01067469|469066701|FG001|Overall Study|Withdrawal by Subject|1|||
130301640|NCT01067469|469066700|FG000|Overall Study|Disease Progression|0|||
130301641|NCT01067469|469066701|FG001|Overall Study|Disease Progression|1|||
130301642|NCT01299116|469066704|FG000|Overall Study|Lost to Follow-up|65|||
130301643|NCT01299116|469066705|FG001|Overall Study|Lost to Follow-up|9|||
130301644|NCT01299116|469066706|FG002|Overall Study|Lost to Follow-up|11|||
130301645|NCT01620944|469066707|FG000|Overall Study|Early termination of Study|2|||
130461822|NCT03401112|469656257|FG004|Overall Study|Study was Terminated by Sponsor|0|||
130461823|NCT03401112|469656253|FG000|Overall Study|Day 1 Assessment not Done|1|||
130301646|NCT01620944|469066708|FG001|Overall Study|Early termination of Study|1|||
130301647|NCT01123707|469066710|FG000|Overall Study|Lost to Follow-up|3|||
130301648|NCT01123707|469066711|FG001|Overall Study|Lost to Follow-up|1|||
130301649|NCT01123707|469066712|FG002|Overall Study|Lost to Follow-up|3|||
130301650|NCT01123707|469066713|FG003|Overall Study|Lost to Follow-up|2|||
130301651|NCT01123707|469066710|FG000|Overall Study|Adverse Event|5|||
130301652|NCT01123707|469066711|FG001|Overall Study|Adverse Event|7|||
130301653|NCT01123707|469066712|FG002|Overall Study|Adverse Event|5|||
130301654|NCT01123707|469066713|FG003|Overall Study|Adverse Event|3|||
130301655|NCT01123707|469066710|FG000|Overall Study|Sponsor Discontinued Study|30|||
130301656|NCT01123707|469066711|FG001|Overall Study|Sponsor Discontinued Study|24|||
130301657|NCT01123707|469066712|FG002|Overall Study|Sponsor Discontinued Study|25|||
130301658|NCT01123707|469066713|FG003|Overall Study|Sponsor Discontinued Study|40|||
130301659|NCT01123707|469066710|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130301660|NCT01123707|469066711|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130301661|NCT01123707|469066712|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
130301662|NCT01123707|469066713|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130301663|NCT01123707|469066710|FG000|Overall Study|Investigator Withdrew Participant|0|||
130301664|NCT01123707|469066711|FG001|Overall Study|Investigator Withdrew Participant|1|||
130301665|NCT01123707|469066712|FG002|Overall Study|Investigator Withdrew Participant|1|||
130301666|NCT01123707|469066713|FG003|Overall Study|Investigator Withdrew Participant|1|||
130301667|NCT01123707|469066710|FG000|Overall Study|Subject Withdrew Consent|4|||
130301668|NCT01123707|469066711|FG001|Overall Study|Subject Withdrew Consent|5|||
130301669|NCT01123707|469066712|FG002|Overall Study|Subject Withdrew Consent|1|||
130301670|NCT01123707|469066713|FG003|Overall Study|Subject Withdrew Consent|2|||
130301671|NCT01123707|469066710|FG000|Overall Study|Lack of Efficacy|1|||
130301672|NCT01123707|469066711|FG001|Overall Study|Lack of Efficacy|2|||
130301673|NCT01123707|469066712|FG002|Overall Study|Lack of Efficacy|1|||
130301674|NCT01123707|469066713|FG003|Overall Study|Lack of Efficacy|0|||
130301675|NCT01123707|469066710|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
130301676|NCT01123707|469066711|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
130301677|NCT01123707|469066712|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
130301678|NCT01123707|469066713|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
130301679|NCT04378114|469066714|FG000|Overall Study|Withdrawal by Subject|5|||
130301680|NCT01959243|469066717|FG000|Overall Study|Investigator Decision|3|||
130301681|NCT01959243|469066718|FG001|Overall Study|Investigator Decision|0|||
130301682|NCT01959243|469066717|FG000|Overall Study|Adverse Event|5|||
130301683|NCT01959243|469066718|FG001|Overall Study|Adverse Event|2|||
130301684|NCT01959243|469066717|FG000|Overall Study|Administrative reasons|2|||
130301685|NCT01959243|469066718|FG001|Overall Study|Administrative reasons|1|||
130301686|NCT01959243|469066717|FG000|Overall Study|Lost to Follow-up|3|||
130301687|NCT01959243|469066718|FG001|Overall Study|Lost to Follow-up|1|||
130301688|NCT00629798|469066721|FG000|Overall Study|Not Treated|4|||
130301689|NCT02554981|469066722|FG000|Overall Study|Adverse Event|1|||
130301690|NCT02554981|469066722|FG000|Overall Study|Administrative Reasons|1|||
130301691|NCT02554981|469066722|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130301692|NCT01114438|469066723|FG000|Overall Study|Adverse Event|10|||
130301693|NCT01114438|469066723|FG000|Overall Study|concomitant medication|1|||
130301694|NCT01114438|469066723|FG000|Overall Study|Physician Decision|1|||
130301695|NCT01114438|469066723|FG000|Overall Study|Withdrawal by Subject|2|||
130301696|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Adverse Event|2|||
130301697|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Adverse Event|4|||
130461824|NCT03401112|469656254|FG001|Overall Study|Day 1 Assessment not Done|0|||
130461825|NCT03401112|469656255|FG002|Overall Study|Day 1 Assessment not Done|0|||
130461826|NCT03401112|469656256|FG003|Overall Study|Day 1 Assessment not Done|0|||
130461827|NCT03401112|469656257|FG004|Overall Study|Day 1 Assessment not Done|0|||
130461828|NCT03401112|469656253|FG000|Overall Study|Not Dosed|0|||
130301698|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Adverse Event|4|||
130461829|NCT03401112|469656254|FG001|Overall Study|Not Dosed|0|||
130461830|NCT03401112|469656255|FG002|Overall Study|Not Dosed|1|||
130461831|NCT03401112|469656256|FG003|Overall Study|Not Dosed|0|||
130461832|NCT03401112|469656257|FG004|Overall Study|Not Dosed|0|||
130461833|NCT03401112|469656253|FG000|Overall Study|Missed Clinical Visit|0|||
130461834|NCT03401112|469656254|FG001|Overall Study|Missed Clinical Visit|0|||
130301699|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
130301700|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
130301701|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
130301702|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
130301703|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130301704|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130301705|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
130301706|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
130461835|NCT03401112|469656255|FG002|Overall Study|Missed Clinical Visit|1|||
130461836|NCT03401112|469656256|FG003|Overall Study|Missed Clinical Visit|0|||
130461837|NCT03401112|469656257|FG004|Overall Study|Missed Clinical Visit|0|||
130461838|NCT03401112|469656253|FG000|Overall Study|Missed Doses|0|||
130461839|NCT03401112|469656254|FG001|Overall Study|Missed Doses|0|||
130461840|NCT03401112|469656255|FG002|Overall Study|Missed Doses|1|||
130461841|NCT03401112|469656256|FG003|Overall Study|Missed Doses|0|||
130461842|NCT03401112|469656257|FG004|Overall Study|Missed Doses|0|||
130461843|NCT01968226|469656258|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
130461844|NCT04975308|469656265|FG000|Overall Study|Withdrawal by Subject|6|||
130461845|NCT04975308|469656266|FG001|Overall Study|Withdrawal by Subject|16|||
130461846|NCT04975308|469656267|FG002|Overall Study|Withdrawal by Subject|6|||
130461847|NCT04975308|469656265|FG000|Overall Study|Physician Decision|0|||
130461848|NCT04975308|469656266|FG001|Overall Study|Physician Decision|3|||
130461849|NCT04975308|469656267|FG002|Overall Study|Physician Decision|1|||
130461850|NCT04975308|469656265|FG000|Overall Study|Adverse Event|10|||
130461851|NCT04975308|469656266|FG001|Overall Study|Adverse Event|1|||
130461852|NCT04975308|469656267|FG002|Overall Study|Adverse Event|12|||
130461853|NCT04975308|469656265|FG000|Overall Study|On study treatment (Ongoing)|65|||
130461854|NCT04975308|469656266|FG001|Overall Study|On study treatment (Ongoing)|43|||
130461855|NCT04975308|469656267|FG002|Overall Study|On study treatment (Ongoing)|75|||
130301707|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
130301708|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
130301709|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130301710|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130301711|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130301712|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130301713|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
130301714|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
130301715|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130301716|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130301717|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
130301718|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130301719|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130301720|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130301721|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
130301722|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130301723|NCT00488826|469066731|FG000|Overall Study|Withdrawal by Subject|40|||
130301724|NCT00488826|469066732|FG001|Overall Study|Withdrawal by Subject|35|||
130301725|NCT00488826|469066733|FG002|Overall Study|Withdrawal by Subject|19|||
130301726|NCT00488826|469066731|FG000|Overall Study|Protocol Violation|0|||
130301727|NCT00488826|469066732|FG001|Overall Study|Protocol Violation|0|||
130301728|NCT00488826|469066733|FG002|Overall Study|Protocol Violation|2|||
130301729|NCT00488826|469066731|FG000|Overall Study|Adverse Event|9|||
130301730|NCT00488826|469066732|FG001|Overall Study|Adverse Event|15|||
130301731|NCT00488826|469066733|FG002|Overall Study|Adverse Event|4|||
130301732|NCT00488826|469066731|FG000|Overall Study|Lost to Follow-up|5|||
130301733|NCT00488826|469066732|FG001|Overall Study|Lost to Follow-up|1|||
130301734|NCT00488826|469066733|FG002|Overall Study|Lost to Follow-up|0|||
130301735|NCT00488826|469066731|FG000|Overall Study|Protocol Deviations|2|||
130301736|NCT00488826|469066732|FG001|Overall Study|Protocol Deviations|1|||
130301737|NCT00488826|469066733|FG002|Overall Study|Protocol Deviations|1|||
130301738|NCT02292706|469066734|FG000|Overall Study|Lost to Follow-up|20|||
130301739|NCT02292706|469066735|FG001|Overall Study|Lost to Follow-up|44|||
130301740|NCT02292706|469066736|FG002|Overall Study|Lost to Follow-up|24|||
130461856|NCT04975308|469656265|FG000|Overall Study|Protocol Deviation|4|||
130461857|NCT04975308|469656266|FG001|Overall Study|Protocol Deviation|3|||
130461858|NCT04975308|469656267|FG002|Overall Study|Protocol Deviation|2|||
130461859|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
130301741|NCT02292706|469066737|FG003|Overall Study|Lost to Follow-up|61|||
130301742|NCT02292706|469066738|FG004|Overall Study|Lost to Follow-up|21|||
130301743|NCT02292706|469066739|FG005|Overall Study|Lost to Follow-up|52|||
130301744|NCT02292706|469066740|FG006|Overall Study|Lost to Follow-up|25|||
130301745|NCT02292706|469066741|FG007|Overall Study|Lost to Follow-up|0|||
130301746|NCT02292706|469066734|FG000|Overall Study|Withdrew consent|15|||
130301747|NCT02292706|469066735|FG001|Overall Study|Withdrew consent|56|||
130461860|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
130301748|NCT02292706|469066736|FG002|Overall Study|Withdrew consent|43|||
130461861|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
130301749|NCT02292706|469066737|FG003|Overall Study|Withdrew consent|36|||
130461862|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
130461863|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
130461864|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
130301750|NCT02292706|469066738|FG004|Overall Study|Withdrew consent|13|||
130301751|NCT02292706|469066739|FG005|Overall Study|Withdrew consent|51|||
130301752|NCT02292706|469066740|FG006|Overall Study|Withdrew consent|20|||
130301753|NCT02292706|469066741|FG007|Overall Study|Withdrew consent|0|||
130301754|NCT02292706|469066734|FG000|Overall Study|Death|3|||
130301755|NCT02292706|469066735|FG001|Overall Study|Death|11|||
130301756|NCT02292706|469066736|FG002|Overall Study|Death|16|||
130301757|NCT02292706|469066737|FG003|Overall Study|Death|22|||
130301758|NCT02292706|469066738|FG004|Overall Study|Death|8|||
130301759|NCT02292706|469066739|FG005|Overall Study|Death|17|||
130301760|NCT02292706|469066740|FG006|Overall Study|Death|3|||
130301761|NCT02292706|469066741|FG007|Overall Study|Death|0|||
130301762|NCT02292706|469066734|FG000|Overall Study|Study terminated by sponsor|0|||
130301763|NCT02292706|469066735|FG001|Overall Study|Study terminated by sponsor|9|||
130301764|NCT02292706|469066736|FG002|Overall Study|Study terminated by sponsor|4|||
130301765|NCT02292706|469066737|FG003|Overall Study|Study terminated by sponsor|21|||
130301766|NCT02292706|469066738|FG004|Overall Study|Study terminated by sponsor|11|||
130301767|NCT02292706|469066739|FG005|Overall Study|Study terminated by sponsor|13|||
130301768|NCT02292706|469066740|FG006|Overall Study|Study terminated by sponsor|3|||
130301769|NCT02292706|469066741|FG007|Overall Study|Study terminated by sponsor|0|||
130301770|NCT02292706|469066734|FG000|Overall Study|Investigator's discretion|4|||
130301771|NCT02292706|469066735|FG001|Overall Study|Investigator's discretion|9|||
130301772|NCT02292706|469066736|FG002|Overall Study|Investigator's discretion|7|||
130301773|NCT02292706|469066737|FG003|Overall Study|Investigator's discretion|11|||
130301774|NCT02292706|469066738|FG004|Overall Study|Investigator's discretion|4|||
130301775|NCT02292706|469066739|FG005|Overall Study|Investigator's discretion|10|||
130301776|NCT02292706|469066740|FG006|Overall Study|Investigator's discretion|1|||
130301777|NCT02292706|469066741|FG007|Overall Study|Investigator's discretion|0|||
130301778|NCT02292706|469066734|FG000|Overall Study|Liver transplant|1|||
130301779|NCT02292706|469066735|FG001|Overall Study|Liver transplant|1|||
130301780|NCT02292706|469066736|FG002|Overall Study|Liver transplant|11|||
130301781|NCT02292706|469066737|FG003|Overall Study|Liver transplant|16|||
130301782|NCT02292706|469066738|FG004|Overall Study|Liver transplant|5|||
130301783|NCT02292706|469066739|FG005|Overall Study|Liver transplant|6|||
130301784|NCT02292706|469066740|FG006|Overall Study|Liver transplant|5|||
130301785|NCT02292706|469066741|FG007|Overall Study|Liver transplant|0|||
130301786|NCT02292706|469066734|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
130301787|NCT02292706|469066735|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
130301788|NCT02292706|469066736|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
130301789|NCT02292706|469066737|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
130301790|NCT02292706|469066738|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
130301791|NCT02292706|469066739|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
130301792|NCT02292706|469066740|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
130301793|NCT02292706|469066741|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
130301794|NCT02292706|469066734|FG000|Overall Study|Subject terminated by sponsor|1|||
130301795|NCT02292706|469066735|FG001|Overall Study|Subject terminated by sponsor|0|||
130301796|NCT02292706|469066736|FG002|Overall Study|Subject terminated by sponsor|0|||
130301797|NCT02292706|469066737|FG003|Overall Study|Subject terminated by sponsor|2|||
130301798|NCT02292706|469066738|FG004|Overall Study|Subject terminated by sponsor|1|||
130301799|NCT02292706|469066739|FG005|Overall Study|Subject terminated by sponsor|0|||
130301800|NCT02292706|469066740|FG006|Overall Study|Subject terminated by sponsor|0|||
130301801|NCT02292706|469066741|FG007|Overall Study|Subject terminated by sponsor|0|||
130301802|NCT02292706|469066734|FG000|Overall Study|Missing|0|||
130301803|NCT02292706|469066735|FG001|Overall Study|Missing|0|||
130301804|NCT02292706|469066736|FG002|Overall Study|Missing|1|||
130301805|NCT02292706|469066737|FG003|Overall Study|Missing|1|||
130301806|NCT02292706|469066738|FG004|Overall Study|Missing|0|||
130301807|NCT02292706|469066739|FG005|Overall Study|Missing|1|||
130301808|NCT02292706|469066740|FG006|Overall Study|Missing|0|||
130301809|NCT02292706|469066741|FG007|Overall Study|Missing|0|||
130301810|NCT02292706|469066734|FG000|Overall Study|Virologic relapse or reinfection|1|||
130301811|NCT02292706|469066735|FG001|Overall Study|Virologic relapse or reinfection|0|||
130301812|NCT02292706|469066736|FG002|Overall Study|Virologic relapse or reinfection|0|||
130301813|NCT02292706|469066737|FG003|Overall Study|Virologic relapse or reinfection|1|||
130461865|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
130301814|NCT02292706|469066738|FG004|Overall Study|Virologic relapse or reinfection|0|||
130461866|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
130461867|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
130461868|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
130301815|NCT02292706|469066739|FG005|Overall Study|Virologic relapse or reinfection|1|||
130301816|NCT02292706|469066740|FG006|Overall Study|Virologic relapse or reinfection|0|||
130301817|NCT02292706|469066741|FG007|Overall Study|Virologic relapse or reinfection|0|||
130301818|NCT02725866|469066744|FG000|Overall Study|Failure to return|6|||
130461869|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
130301819|NCT02725866|469066744|FG000|Overall Study|Withdrew consent|3|||
130301820|NCT02725866|469066744|FG000|Overall Study|Insufficient virological response|1|||
130301821|NCT02725866|469066744|FG000|Overall Study|Other, not specified|4|||
130557363|NCT00631189|470009965|FG000|Treatment Phase|Lost to Follow-up|0|||
130301822|NCT03043651|469066750|FG000|Overall Study|Death|1|||
130301823|NCT03043651|469066750|FG000|Overall Study|Progressive Disease|2|||
130301824|NCT03043651|469066750|FG000|Overall Study|Adverse Event|2|||
130301825|NCT03043651|469066750|FG000|Overall Study|Withdrawal by Subject|4|||
130301826|NCT03043651|469066750|FG000|Overall Study|Study Terminated by Sponsor|39|||
130301827|NCT03597061|469066758|FG000|Overall Study|Lost to Follow-up|1|||
130301828|NCT03597061|469066759|FG001|Overall Study|Lost to Follow-up|0|||
130301829|NCT03597061|469066758|FG000|Overall Study|Protocol Violation|0|||
130301830|NCT03597061|469066759|FG001|Overall Study|Protocol Violation|1|||
130301831|NCT00411632|469066760|FG000|Overall Study|Death|1|||
130301832|NCT00761527|469066761|FG000|Overall Study|Adverse Event|3|||
130301833|NCT00761527|469066761|FG000|Overall Study|Poor Compliance|8|||
130301834|NCT00761527|469066761|FG000|Overall Study|Lost to Follow-up|9|||
130301835|NCT00761527|469066761|FG000|Overall Study|Unknown reason|2|||
130301836|NCT01431963|469066762|FG000|Overall Study|Adverse Event|18|||
130301837|NCT01431963|469066762|FG000|Overall Study|Lack of Efficacy|7|||
130301838|NCT01431963|469066762|FG000|Overall Study|Protocol Violation|1|||
130301839|NCT01431963|469066762|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130301840|NCT01431963|469066762|FG000|Overall Study|Physician Decision|4|||
130301841|NCT01431963|469066762|FG000|Overall Study|Withdrawal by Subject|3|||
130301842|NCT02921087|469066765|FG000|Overall Study|Withdrawal by Subject|0|||
130301843|NCT02921087|469066766|FG001|Overall Study|Withdrawal by Subject|1|||
130301844|NCT00687531|469066767|FG000|Overall Study|Did not meet protocol eligibility|104|||
130301845|NCT00687531|469066767|FG000|Overall Study|Adverse Event|5|||
130301846|NCT00687531|469066767|FG000|Overall Study|Lost to Follow-up|26|||
130301847|NCT00619307|469066768|FG000|Overall Study|Adverse Event|0|||
130301848|NCT00619307|469066769|FG001|Overall Study|Adverse Event|1|||
130301849|NCT00619307|469066768|FG000|Overall Study|Lost to Follow-up|0|||
130301850|NCT00619307|469066769|FG001|Overall Study|Lost to Follow-up|1|||
130301851|NCT00619307|469066768|FG000|Overall Study|Protocol Violation|3|||
130301852|NCT00619307|469066769|FG001|Overall Study|Protocol Violation|0|||
130301853|NCT00619307|469066768|FG000|Overall Study|Withdrew consent|1|||
130301854|NCT00619307|469066769|FG001|Overall Study|Withdrew consent|0|||
130301855|NCT00619307|469066768|FG000|Overall Study|Severe migraine|0|||
130301856|NCT00619307|469066769|FG001|Overall Study|Severe migraine|1|||
130301857|NCT00619307|469066768|FG000|Overall Study|MS attack plus steroids|0|||
130301858|NCT00619307|469066769|FG001|Overall Study|MS attack plus steroids|1|||
130301859|NCT03210961|469068474|FG000|Overall Study|Adverse Event|0|||
130301860|NCT03210961|469068475|FG001|Overall Study|Adverse Event|0|||
130301861|NCT03210961|469068476|FG002|Overall Study|Adverse Event|0|||
130301862|NCT03210961|469068477|FG003|Overall Study|Adverse Event|0|||
130301863|NCT03210961|469068478|FG004|Overall Study|Adverse Event|0|||
130301864|NCT03210961|469068479|FG005|Overall Study|Adverse Event|0|||
130301865|NCT03210961|469068480|FG006|Overall Study|Adverse Event|0|||
130301866|NCT03210961|469068481|FG007|Overall Study|Adverse Event|0|||
130301867|NCT03210961|469068482|FG008|Overall Study|Adverse Event|0|||
130301868|NCT03210961|469068483|FG009|Overall Study|Adverse Event|0|||
130301869|NCT03210961|469068484|FG010|Overall Study|Adverse Event|0|||
130301870|NCT03210961|469068485|FG011|Overall Study|Adverse Event|0|||
130301871|NCT03210961|469068486|FG012|Overall Study|Adverse Event|0|||
130301872|NCT03210961|469068487|FG013|Overall Study|Adverse Event|1|||
130301873|NCT03210961|469068488|FG014|Overall Study|Adverse Event|0|||
130301874|NCT03210961|469068474|FG000|Overall Study|Lost to Follow-up|0|||
130301875|NCT03210961|469068475|FG001|Overall Study|Lost to Follow-up|0|||
130301876|NCT03210961|469068476|FG002|Overall Study|Lost to Follow-up|0|||
130301877|NCT03210961|469068477|FG003|Overall Study|Lost to Follow-up|0|||
130301878|NCT03210961|469068478|FG004|Overall Study|Lost to Follow-up|0|||
130301879|NCT03210961|469068479|FG005|Overall Study|Lost to Follow-up|0|||
130301880|NCT03210961|469068480|FG006|Overall Study|Lost to Follow-up|0|||
130301881|NCT03210961|469068481|FG007|Overall Study|Lost to Follow-up|0|||
130301882|NCT03210961|469068482|FG008|Overall Study|Lost to Follow-up|0|||
130301883|NCT03210961|469068483|FG009|Overall Study|Lost to Follow-up|0|||
130301884|NCT03210961|469068484|FG010|Overall Study|Lost to Follow-up|0|||
130301885|NCT03210961|469068485|FG011|Overall Study|Lost to Follow-up|0|||
130301886|NCT03210961|469068486|FG012|Overall Study|Lost to Follow-up|0|||
130301887|NCT03210961|469068487|FG013|Overall Study|Lost to Follow-up|0|||
130301888|NCT03210961|469068488|FG014|Overall Study|Lost to Follow-up|1|||
130301889|NCT03210961|469068474|FG000|Overall Study|Withdrawal by Subject|0|||
130301890|NCT03210961|469068475|FG001|Overall Study|Withdrawal by Subject|0|||
130301891|NCT03210961|469068476|FG002|Overall Study|Withdrawal by Subject|0|||
130301892|NCT03210961|469068477|FG003|Overall Study|Withdrawal by Subject|0|||
130301893|NCT03210961|469068478|FG004|Overall Study|Withdrawal by Subject|0|||
130373163|NCT00571948|469333384|FG000|Overall Study|Withdrawal by Subject|1|||
130373164|NCT00571948|469333385|FG001|Overall Study|Withdrawal by Subject|2|||
130301894|NCT03210961|469068479|FG005|Overall Study|Withdrawal by Subject|0|||
130301895|NCT03210961|469068480|FG006|Overall Study|Withdrawal by Subject|0|||
130301896|NCT03210961|469068481|FG007|Overall Study|Withdrawal by Subject|0|||
130301897|NCT03210961|469068482|FG008|Overall Study|Withdrawal by Subject|0|||
130301898|NCT03210961|469068483|FG009|Overall Study|Withdrawal by Subject|0|||
130301899|NCT03210961|469068484|FG010|Overall Study|Withdrawal by Subject|0|||
130301900|NCT03210961|469068485|FG011|Overall Study|Withdrawal by Subject|0|||
130301901|NCT03210961|469068486|FG012|Overall Study|Withdrawal by Subject|0|||
130301902|NCT03210961|469068487|FG013|Overall Study|Withdrawal by Subject|0|||
130301903|NCT03210961|469068488|FG014|Overall Study|Withdrawal by Subject|1|||
130301904|NCT03210961|469068474|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301905|NCT03210961|469068475|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301906|NCT03210961|469068476|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301907|NCT03210961|469068477|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301908|NCT03210961|469068478|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301909|NCT03210961|469068479|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301910|NCT03210961|469068480|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301911|NCT03210961|469068481|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301912|NCT03210961|469068482|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301913|NCT03210961|469068483|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301914|NCT03210961|469068484|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301915|NCT03210961|469068485|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301916|NCT03210961|469068486|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301917|NCT03210961|469068487|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
130301918|NCT03210961|469068488|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301919|NCT03210961|469068474|FG000|Overall Study|Other|0|||
130301920|NCT03210961|469068475|FG001|Overall Study|Other|0|||
130301921|NCT03210961|469068476|FG002|Overall Study|Other|0|||
130301922|NCT03210961|469068477|FG003|Overall Study|Other|1|||
130301923|NCT03210961|469068478|FG004|Overall Study|Other|0|||
130301924|NCT03210961|469068479|FG005|Overall Study|Other|0|||
130301925|NCT03210961|469068480|FG006|Overall Study|Other|1|||
130301926|NCT03210961|469068481|FG007|Overall Study|Other|0|||
130301927|NCT03210961|469068482|FG008|Overall Study|Other|0|||
130301928|NCT03210961|469068483|FG009|Overall Study|Other|0|||
130301929|NCT03210961|469068484|FG010|Overall Study|Other|1|||
130301930|NCT03210961|469068485|FG011|Overall Study|Other|0|||
130301931|NCT03210961|469068486|FG012|Overall Study|Other|2|||
130301932|NCT03210961|469068487|FG013|Overall Study|Other|2|||
130301933|NCT03210961|469068488|FG014|Overall Study|Other|0|||
130301934|NCT00602420|469068489|FG000|Overall Study|Death|1|||
130301935|NCT00602420|469068490|FG001|Overall Study|Death|4|||
130301936|NCT00602420|469068489|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
130301937|NCT00602420|469068490|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
130301938|NCT00602420|469068489|FG000|Overall Study|Withdrawal by Subject|18|||
130301939|NCT00602420|469068490|FG001|Overall Study|Withdrawal by Subject|17|||
130301940|NCT00602420|469068489|FG000|Overall Study|Adverse Event|1|||
130301941|NCT00602420|469068490|FG001|Overall Study|Adverse Event|0|||
130301942|NCT00703924|469068499|FG000|Overall Study|Withdrawal by Subject|1|||
130301943|NCT00703924|469068500|FG001|Overall Study|Withdrawal by Subject|1|||
130301944|NCT03077919|469068501|FG000|Overall Study|Lost to Follow-up|4|||
130301945|NCT03077919|469068502|FG001|Overall Study|Lost to Follow-up|1|||
130301946|NCT03592368|469068503|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301947|NCT03592368|469068504|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
130301948|NCT03592368|469068505|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301949|NCT03592368|469068506|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301950|NCT03592368|469068503|FG000|Overall Study|Adverse Event|0|||
130301951|NCT03592368|469068504|FG001|Overall Study|Adverse Event|0|||
130301952|NCT03592368|469068505|FG002|Overall Study|Adverse Event|0|||
130301953|NCT03592368|469068506|FG003|Overall Study|Adverse Event|1|||
130301954|NCT03592368|469068503|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130301955|NCT03592368|469068504|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130301956|NCT03592368|469068505|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130373165|NCT00571948|469333384|FG000|Overall Study|Protocol Violation|3|||
130373166|NCT00571948|469333385|FG001|Overall Study|Protocol Violation|3|||
130373167|NCT00571948|469333384|FG000|Overall Study|infant refused study meal|3|||
130373168|NCT00571948|469333385|FG001|Overall Study|infant refused study meal|4|||
130373169|NCT00571948|469333384|FG000|Overall Study|Parent were afraid of blood colection|2|||
130373170|NCT00571948|469333385|FG001|Overall Study|Parent were afraid of blood colection|5|||
130373171|NCT04112784|469333386|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
130373172|NCT04112784|469333386|FG000|Overall Study|Screen Failures|4|||
130373173|NCT00256750|469333387|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
130373174|NCT00256750|469333388|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
130373175|NCT00256750|469333389|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
130373176|NCT00256750|469333387|FG000|Transplanted Pre-Treatment|Other|2|||
130301957|NCT03592368|469068506|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130301958|NCT03499314|469068507|FG000|Overall Study|Time Commitment|1|||
130461870|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
130461871|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
130301959|NCT03499314|469068508|FG001|Overall Study|Time Commitment|2|||
130301960|NCT03499314|469068507|FG000|Overall Study|Medical issue unrelated to research study|1|||
130301961|NCT03499314|469068508|FG001|Overall Study|Medical issue unrelated to research study|1|||
130301962|NCT01618695|469068510|FG000|Core Phase|Adverse Event|4|||
130301963|NCT01618695|469068511|FG001|Core Phase|Adverse Event|5|||
130301964|NCT01618695|469068512|FG002|Core Phase|Adverse Event|15|||
130301965|NCT01618695|469068513|FG003|Core Phase|Adverse Event|20|||
130301966|NCT01618695|469068510|FG000|Core Phase|Lost to Follow-up|0|||
130301967|NCT01618695|469068511|FG001|Core Phase|Lost to Follow-up|0|||
130301968|NCT01618695|469068512|FG002|Core Phase|Lost to Follow-up|1|||
130301969|NCT01618695|469068513|FG003|Core Phase|Lost to Follow-up|0|||
130301970|NCT01618695|469068510|FG000|Core Phase|Withdrawal by Subject|16|||
130301971|NCT01618695|469068511|FG001|Core Phase|Withdrawal by Subject|11|||
130301972|NCT01618695|469068512|FG002|Core Phase|Withdrawal by Subject|9|||
130301973|NCT01618695|469068513|FG003|Core Phase|Withdrawal by Subject|13|||
130301974|NCT01618695|469068510|FG000|Core Phase|Pregnancy|2|||
130301975|NCT01618695|469068511|FG001|Core Phase|Pregnancy|0|||
130301976|NCT01618695|469068512|FG002|Core Phase|Pregnancy|0|||
130301977|NCT01618695|469068513|FG003|Core Phase|Pregnancy|0|||
130301978|NCT01618695|469068510|FG000|Core Phase|Lack of Efficacy|1|||
130301979|NCT01618695|469068511|FG001|Core Phase|Lack of Efficacy|2|||
130301980|NCT01618695|469068512|FG002|Core Phase|Lack of Efficacy|1|||
130301981|NCT01618695|469068513|FG003|Core Phase|Lack of Efficacy|1|||
130301982|NCT01618695|469068510|FG000|Core Phase|Other than specified|1|||
130301983|NCT01618695|469068511|FG001|Core Phase|Other than specified|2|||
130301984|NCT01618695|469068512|FG002|Core Phase|Other than specified|2|||
130301985|NCT01618695|469068513|FG003|Core Phase|Other than specified|2|||
130301986|NCT01618695|469068510|FG000|Core Phase|Not treated|1|||
130301987|NCT01618695|469068511|FG001|Core Phase|Not treated|0|||
130301988|NCT01618695|469068512|FG002|Core Phase|Not treated|2|||
130301989|NCT01618695|469068513|FG003|Core Phase|Not treated|0|||
130301990|NCT01618695|469068510|FG000|Extension Phase|Lack of Efficacy|17|||
130301991|NCT01618695|469068511|FG001|Extension Phase|Lack of Efficacy|33|||
130301992|NCT01618695|469068512|FG002|Extension Phase|Lack of Efficacy|26|||
130301993|NCT01618695|469068513|FG003|Extension Phase|Lack of Efficacy|24|||
130301994|NCT01618695|469068510|FG000|Extension Phase|Pregnancy|2|||
130301995|NCT01618695|469068511|FG001|Extension Phase|Pregnancy|0|||
130301996|NCT01618695|469068512|FG002|Extension Phase|Pregnancy|1|||
130301997|NCT01618695|469068513|FG003|Extension Phase|Pregnancy|1|||
130301998|NCT01618695|469068510|FG000|Extension Phase|Withdrawal by Subject|43|||
130301999|NCT01618695|469068511|FG001|Extension Phase|Withdrawal by Subject|48|||
130302000|NCT01618695|469068512|FG002|Extension Phase|Withdrawal by Subject|42|||
130302001|NCT01618695|469068513|FG003|Extension Phase|Withdrawal by Subject|33|||
130302002|NCT01618695|469068510|FG000|Extension Phase|Adverse Event|18|||
130302003|NCT01618695|469068511|FG001|Extension Phase|Adverse Event|16|||
130302004|NCT01618695|469068512|FG002|Extension Phase|Adverse Event|9|||
130302005|NCT01618695|469068513|FG003|Extension Phase|Adverse Event|20|||
130302006|NCT01618695|469068510|FG000|Extension Phase|Lost to Follow-up|2|||
130302007|NCT01618695|469068511|FG001|Extension Phase|Lost to Follow-up|1|||
130302008|NCT01618695|469068512|FG002|Extension Phase|Lost to Follow-up|1|||
130302009|NCT01618695|469068513|FG003|Extension Phase|Lost to Follow-up|1|||
130302010|NCT01618695|469068510|FG000|Extension Phase|Other than specified|13|||
130302011|NCT01618695|469068511|FG001|Extension Phase|Other than specified|18|||
130302012|NCT01618695|469068512|FG002|Extension Phase|Other than specified|13|||
130302013|NCT01618695|469068513|FG003|Extension Phase|Other than specified|18|||
130302014|NCT02454478|469068516|FG000|Overall Study|Incomplete DLT Evaluation|1|||
130302015|NCT02352753|469068520|FG000|6-Month Dosing Period|Decision by sponsor|2|||
130302016|NCT02352753|469068520|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
130302017|NCT02352753|469068520|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
130302018|NCT02352753|469068520|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
130302019|NCT02352753|469068520|FG000|3-Month Dosing Period|Decision by sponsor|14|||
130302020|NCT02352753|469068520|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
130302021|NCT00539305|469068521|FG000|Overall Study|Adverse Event|1|||
130302022|NCT00539305|469068522|FG001|Overall Study|Adverse Event|0|||
130302023|NCT00539305|469068521|FG000|Overall Study|Substance Use|0|||
130302024|NCT00539305|469068522|FG001|Overall Study|Substance Use|1|||
130302025|NCT00539305|469068521|FG000|Overall Study|Withdrawal by Subject|0|||
130302026|NCT00539305|469068522|FG001|Overall Study|Withdrawal by Subject|1|||
130302027|NCT00413036|469068528|FG000|Overall Study|Adverse Event|44|||
130302028|NCT00413036|469068528|FG000|Overall Study|Lack of Efficacy|129|||
130302029|NCT00413036|469068528|FG000|Overall Study|Withdrawal by Subject|7|||
130302030|NCT00413036|469068528|FG000|Overall Study|Death|9|||
130302031|NCT00413036|469068528|FG000|Overall Study|Other|26|||
130302032|NCT00413036|469068528|FG000|Overall Study|Missing|2|||
130302033|NCT01369641|469068529|FG000|Overall Study|Withdrawal by Subject|1|||
130302034|NCT02760810|469068537|FG000|Overall Study|Protocol Violation|1|||
130302035|NCT00820222|469068538|FG000|Overall Study|Lost to Follow-up|10|||
130302036|NCT00820222|469068539|FG001|Overall Study|Lost to Follow-up|9|||
130302037|NCT00820222|469068538|FG000|Overall Study|Withdrawal by Subject|19|||
130302038|NCT00820222|469068539|FG001|Overall Study|Withdrawal by Subject|21|||
130302039|NCT00820222|469068538|FG000|Overall Study|Physician Decision|93|||
130302040|NCT00820222|469068539|FG001|Overall Study|Physician Decision|88|||
130302041|NCT00820222|469068538|FG000|Overall Study|Sponsor Terminated Study|43|||
130302042|NCT00820222|469068539|FG001|Overall Study|Sponsor Terminated Study|65|||
130302043|NCT00820222|469068538|FG000|Overall Study|Unkown|11|||
130302044|NCT00820222|469068539|FG001|Overall Study|Unkown|7|||
130302045|NCT00932165|469068540|FG000|Overall Study|Lost to Follow-up|1|||
130302046|NCT00588094|469068541|FG000|Overall Study|Adverse Event|3|||
130302047|NCT00588094|469068541|FG000|Overall Study|Progression of Disease|2|||
130302048|NCT01336023|469068542|FG000|Week 0 to Week 26|Adverse Event|8|||
130302049|NCT01336023|469068543|FG001|Week 0 to Week 26|Adverse Event|10|||
130302050|NCT01336023|469068544|FG002|Week 0 to Week 26|Adverse Event|24|||
130302051|NCT01336023|469068542|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
130302052|NCT01336023|469068543|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
130302053|NCT01336023|469068544|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
130302054|NCT01336023|469068542|FG000|Week 0 to Week 26|Protocol Violation|1|||
130302055|NCT01336023|469068543|FG001|Week 0 to Week 26|Protocol Violation|2|||
130302056|NCT01336023|469068544|FG002|Week 0 to Week 26|Protocol Violation|0|||
130302057|NCT01336023|469068542|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
130302058|NCT01336023|469068543|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
130302059|NCT01336023|469068544|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
130302060|NCT01336023|469068542|FG000|Week 0 to Week 26|Unclassified|5|||
130302061|NCT01336023|469068543|FG001|Week 0 to Week 26|Unclassified|16|||
130302062|NCT01336023|469068544|FG002|Week 0 to Week 26|Unclassified|9|||
130302063|NCT01336023|469068542|FG000|Week 27 to 52|Adverse Event|1|||
130302064|NCT01336023|469068543|FG001|Week 27 to 52|Adverse Event|5|||
130302065|NCT01336023|469068544|FG002|Week 27 to 52|Adverse Event|2|||
130302066|NCT01336023|469068542|FG000|Week 27 to 52|Protocol Violation|0|||
130302067|NCT01336023|469068543|FG001|Week 27 to 52|Protocol Violation|2|||
130302068|NCT01336023|469068544|FG002|Week 27 to 52|Protocol Violation|1|||
130302069|NCT01336023|469068542|FG000|Week 27 to 52|Withdrawal Criteria|14|||
130302070|NCT01336023|469068543|FG001|Week 27 to 52|Withdrawal Criteria|19|||
130302071|NCT01336023|469068544|FG002|Week 27 to 52|Withdrawal Criteria|16|||
130302072|NCT01336023|469068542|FG000|Week 27 to 52|Unclassified|13|||
130302073|NCT01336023|469068543|FG001|Week 27 to 52|Unclassified|18|||
130302074|NCT01336023|469068544|FG002|Week 27 to 52|Unclassified|9|||
130302075|NCT00666965|469068547|FG000|Overall Study|Adverse Event|0|||
130302076|NCT00666965|469068548|FG001|Overall Study|Adverse Event|2|||
130302077|NCT00666965|469068549|FG002|Overall Study|Adverse Event|1|||
130302078|NCT00666965|469068550|FG003|Overall Study|Adverse Event|9|||
130302079|NCT00666965|469068547|FG000|Overall Study|Lack of Efficacy|1|||
130302080|NCT00666965|469068548|FG001|Overall Study|Lack of Efficacy|1|||
130302081|NCT00666965|469068549|FG002|Overall Study|Lack of Efficacy|0|||
130302082|NCT00666965|469068550|FG003|Overall Study|Lack of Efficacy|0|||
130302083|NCT00666965|469068547|FG000|Overall Study|Protocol Violation|0|||
130302084|NCT00666965|469068548|FG001|Overall Study|Protocol Violation|0|||
130302085|NCT00666965|469068549|FG002|Overall Study|Protocol Violation|0|||
130302086|NCT00666965|469068550|FG003|Overall Study|Protocol Violation|2|||
130302087|NCT00666965|469068547|FG000|Overall Study|Discontinuation criteria|2|||
130302088|NCT00666965|469068548|FG001|Overall Study|Discontinuation criteria|1|||
130302089|NCT00666965|469068549|FG002|Overall Study|Discontinuation criteria|1|||
130302090|NCT00666965|469068550|FG003|Overall Study|Discontinuation criteria|2|||
130302091|NCT00666965|469068547|FG000|Overall Study|Withdrawal by Subject|0|||
130302092|NCT00666965|469068548|FG001|Overall Study|Withdrawal by Subject|0|||
130302093|NCT00666965|469068549|FG002|Overall Study|Withdrawal by Subject|0|||
130302094|NCT00666965|469068550|FG003|Overall Study|Withdrawal by Subject|2|||
130302095|NCT01853878|469068554|FG000|Overall Study|Recurrence|2|||
130373177|NCT00256750|469333388|FG001|Transplanted Pre-Treatment|Other|0|||
130302096|NCT01853878|469068555|FG001|Overall Study|Recurrence|0|||
130302097|NCT01853878|469068554|FG000|Overall Study|Adverse Event|2|||
130302098|NCT01853878|469068555|FG001|Overall Study|Adverse Event|0|||
130302099|NCT01853878|469068554|FG000|Overall Study|Withdrawal by Subject|3|||
130302100|NCT01853878|469068555|FG001|Overall Study|Withdrawal by Subject|1|||
130373178|NCT00256750|469333389|FG002|Transplanted Pre-Treatment|Other|0|||
130302101|NCT01853878|469068554|FG000|Overall Study|Migrated/moved from the study area|1|||
130302102|NCT01853878|469068555|FG001|Overall Study|Migrated/moved from the study area|0|||
130302103|NCT01853878|469068554|FG000|Overall Study|Other|55|||
130302104|NCT01853878|469068555|FG001|Overall Study|Other|43|||
130302105|NCT01361178|469068556|FG000|Overall Study|Death|13|||
130302106|NCT01361178|469068557|FG001|Overall Study|Death|0|||
130302107|NCT00391625|469068558|FG000|Month 14|Withdrawal by Subject|1|||
130302108|NCT00391625|469068558|FG000|Month 50|Physician Decision|1|||
130373179|NCT00256750|469333387|FG000|Transplanted Pre-Treatment|Death|1|||
130302109|NCT03916081|469068561|FG000|Overall Study|Adverse Event|1|||
130302110|NCT03916081|469068562|FG001|Overall Study|Adverse Event|0|||
130302111|NCT03916081|469068563|FG002|Overall Study|Adverse Event|0|||
130302112|NCT03916081|469068561|FG000|Overall Study|Physician Decision|0|||
130373180|NCT00256750|469333388|FG001|Transplanted Pre-Treatment|Death|0|||
130302113|NCT03916081|469068562|FG001|Overall Study|Physician Decision|0|||
130302114|NCT03916081|469068563|FG002|Overall Study|Physician Decision|1|||
130302115|NCT03916081|469068561|FG000|Overall Study|Lost to Follow-up|0|||
130302116|NCT03916081|469068562|FG001|Overall Study|Lost to Follow-up|1|||
130302117|NCT03916081|469068563|FG002|Overall Study|Lost to Follow-up|0|||
130302118|NCT03916081|469068561|FG000|Overall Study|Withdrawal by Subject|3|||
130302119|NCT03916081|469068562|FG001|Overall Study|Withdrawal by Subject|0|||
130302120|NCT03916081|469068563|FG002|Overall Study|Withdrawal by Subject|1|||
130302121|NCT03916081|469068561|FG000|Overall Study|Worsening of AD|0|||
130302122|NCT03916081|469068562|FG001|Overall Study|Worsening of AD|0|||
130302123|NCT03916081|469068563|FG002|Overall Study|Worsening of AD|1|||
130302124|NCT03244826|469068564|FG000|Overall Study|Withdrawal by Subject|2|||
130302125|NCT03244826|469068565|FG001|Overall Study|Withdrawal by Subject|0|||
130302126|NCT03244826|469068564|FG000|Overall Study|Transplant delayed or withdrawn|12|||
130302127|NCT03244826|469068565|FG001|Overall Study|Transplant delayed or withdrawn|10|||
130302128|NCT00416455|469068569|FG000|Overall Study|PET / CT not done|3|||
130302129|NCT00416455|469068570|FG001|Overall Study|PET / CT not done|5|||
130302130|NCT00416455|469068569|FG000|Overall Study|PET / CT poor quality|2|||
130302131|NCT00416455|469068570|FG001|Overall Study|PET / CT poor quality|1|||
130302132|NCT00416455|469068569|FG000|Overall Study|Inadequate pathology|11|||
130302133|NCT00416455|469068570|FG001|Overall Study|Inadequate pathology|2|||
130302134|NCT00348309|469068572|FG000|Overall Study|Adverse Event|56|||
130302135|NCT00348309|469068573|FG001|Overall Study|Adverse Event|28|||
130302136|NCT00348309|469068574|FG002|Overall Study|Adverse Event|63|||
130302137|NCT00348309|469068572|FG000|Overall Study|Lost to Follow-up|6|||
130716432|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716433|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716434|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130302138|NCT00348309|469068573|FG001|Overall Study|Lost to Follow-up|7|||
130302139|NCT00348309|469068574|FG002|Overall Study|Lost to Follow-up|4|||
130302140|NCT00348309|469068572|FG000|Overall Study|Protocol Violation|7|||
130302141|NCT00348309|469068573|FG001|Overall Study|Protocol Violation|12|||
130302142|NCT00348309|469068574|FG002|Overall Study|Protocol Violation|7|||
130302143|NCT00348309|469068572|FG000|Overall Study|Withdrawal by Subject|33|||
130302144|NCT00348309|469068573|FG001|Overall Study|Withdrawal by Subject|37|||
130302145|NCT00348309|469068574|FG002|Overall Study|Withdrawal by Subject|40|||
130302146|NCT00348309|469068572|FG000|Overall Study|Non-compliance|8|||
130302147|NCT00348309|469068573|FG001|Overall Study|Non-compliance|6|||
130302148|NCT00348309|469068574|FG002|Overall Study|Non-compliance|8|||
130302149|NCT00348309|469068572|FG000|Overall Study|Death of caregiver|1|||
130302150|NCT00348309|469068573|FG001|Overall Study|Death of caregiver|0|||
130302151|NCT00348309|469068574|FG002|Overall Study|Death of caregiver|1|||
130302152|NCT00348309|469068572|FG000|Overall Study|Lack of insight, dementia|1|||
130302153|NCT00348309|469068573|FG001|Overall Study|Lack of insight, dementia|0|||
130302154|NCT00348309|469068574|FG002|Overall Study|Lack of insight, dementia|0|||
130302155|NCT00348309|469068572|FG000|Overall Study|Wrong bottle allocated|1|||
130302156|NCT00348309|469068573|FG001|Overall Study|Wrong bottle allocated|0|||
130302157|NCT00348309|469068574|FG002|Overall Study|Wrong bottle allocated|0|||
130302158|NCT00348309|469068572|FG000|Overall Study|Caregiver sick|1|||
130302159|NCT00348309|469068573|FG001|Overall Study|Caregiver sick|0|||
130302160|NCT00348309|469068574|FG002|Overall Study|Caregiver sick|0|||
130302161|NCT00348309|469068572|FG000|Overall Study|Use of prohibited medication|5|||
130302162|NCT00348309|469068573|FG001|Overall Study|Use of prohibited medication|2|||
130302163|NCT00348309|469068574|FG002|Overall Study|Use of prohibited medication|2|||
130302164|NCT00348309|469068572|FG000|Overall Study|Caregiver withdrawal|3|||
130302165|NCT00348309|469068573|FG001|Overall Study|Caregiver withdrawal|0|||
130302166|NCT00348309|469068574|FG002|Overall Study|Caregiver withdrawal|7|||
130302167|NCT00348309|469068572|FG000|Overall Study|Unable to complete ET visit|1|||
130302168|NCT00348309|469068573|FG001|Overall Study|Unable to complete ET visit|0|||
130302169|NCT00348309|469068574|FG002|Overall Study|Unable to complete ET visit|0|||
130302170|NCT00348309|469068572|FG000|Overall Study|PI closing medical practice|1|||
130302171|NCT00348309|469068573|FG001|Overall Study|PI closing medical practice|0|||
130302172|NCT00348309|469068574|FG002|Overall Study|PI closing medical practice|0|||
130302173|NCT00348309|469068572|FG000|Overall Study|Principal investigator's decision|1|||
130302174|NCT00348309|469068573|FG001|Overall Study|Principal investigator's decision|0|||
130302175|NCT00348309|469068574|FG002|Overall Study|Principal investigator's decision|0|||
130302176|NCT00348309|469068572|FG000|Overall Study|No disponibility of medication|1|||
130302177|NCT00348309|469068573|FG001|Overall Study|No disponibility of medication|0|||
130302178|NCT00348309|469068574|FG002|Overall Study|No disponibility of medication|0|||
130302179|NCT00348309|469068572|FG000|Overall Study|Worsened neurodegenerative disease|1|||
130302180|NCT00348309|469068573|FG001|Overall Study|Worsened neurodegenerative disease|0|||
130302181|NCT00348309|469068574|FG002|Overall Study|Worsened neurodegenerative disease|0|||
130302182|NCT00348309|469068572|FG000|Overall Study|Cognitive and behaviour worsening|2|||
130302183|NCT00348309|469068573|FG001|Overall Study|Cognitive and behaviour worsening|0|||
130302184|NCT00348309|469068574|FG002|Overall Study|Cognitive and behaviour worsening|0|||
130557364|NCT00631189|470009966|FG001|Treatment Phase|Lost to Follow-up|1|||
130557365|NCT00631189|470009967|FG002|Treatment Phase|Lost to Follow-up|0|||
130302185|NCT00348309|469068572|FG000|Overall Study|Worsening of alzheimer|1|||
130302186|NCT00348309|469068573|FG001|Overall Study|Worsening of alzheimer|0|||
130302187|NCT00348309|469068574|FG002|Overall Study|Worsening of alzheimer|1|||
130302188|NCT00348309|469068572|FG000|Overall Study|Did not appear in time for Visit 3|1|||
130302189|NCT00348309|469068573|FG001|Overall Study|Did not appear in time for Visit 3|0|||
130302190|NCT00348309|469068574|FG002|Overall Study|Did not appear in time for Visit 3|0|||
130302191|NCT00348309|469068572|FG000|Overall Study|Participant died|2|||
130302192|NCT00348309|469068573|FG001|Overall Study|Participant died|1|||
130302193|NCT00348309|469068574|FG002|Overall Study|Participant died|1|||
130302194|NCT00348309|469068572|FG000|Overall Study|Decision of sponsor|1|||
130302195|NCT00348309|469068573|FG001|Overall Study|Decision of sponsor|0|||
130302196|NCT00348309|469068574|FG002|Overall Study|Decision of sponsor|0|||
130302197|NCT00348309|469068572|FG000|Overall Study|Ineffectiveness of treatment|0|||
130302198|NCT00348309|469068573|FG001|Overall Study|Ineffectiveness of treatment|1|||
130302199|NCT00348309|469068574|FG002|Overall Study|Ineffectiveness of treatment|0|||
130302200|NCT00348309|469068572|FG000|Overall Study|A foul of exclusion criteria|0|||
130302201|NCT00348309|469068573|FG001|Overall Study|A foul of exclusion criteria|1|||
130302202|NCT00348309|469068574|FG002|Overall Study|A foul of exclusion criteria|0|||
130302203|NCT00348309|469068572|FG000|Overall Study|Participant was hospitalized|0|||
130302204|NCT00348309|469068573|FG001|Overall Study|Participant was hospitalized|1|||
130302205|NCT00348309|469068574|FG002|Overall Study|Participant was hospitalized|0|||
130302206|NCT00348309|469068572|FG000|Overall Study|Sponsor refuseal|0|||
130302207|NCT00348309|469068573|FG001|Overall Study|Sponsor refuseal|1|||
130302208|NCT00348309|469068574|FG002|Overall Study|Sponsor refuseal|1|||
130302209|NCT00348309|469068572|FG000|Overall Study|Forgot often medication|0|||
130302210|NCT00348309|469068573|FG001|Overall Study|Forgot often medication|1|||
130302211|NCT00348309|469068574|FG002|Overall Study|Forgot often medication|0|||
130302212|NCT00348309|469068572|FG000|Overall Study|Medical Monitor decision|0|||
130302213|NCT00348309|469068573|FG001|Overall Study|Medical Monitor decision|0|||
130302214|NCT00348309|469068574|FG002|Overall Study|Medical Monitor decision|1|||
130302215|NCT00348309|469068572|FG000|Overall Study|Increased dose of Aricept|0|||
130302216|NCT00348309|469068573|FG001|Overall Study|Increased dose of Aricept|0|||
130302217|NCT00348309|469068574|FG002|Overall Study|Increased dose of Aricept|1|||
130302218|NCT00348309|469068572|FG000|Overall Study|Site closure|0|||
130302219|NCT00348309|469068573|FG001|Overall Study|Site closure|0|||
130302220|NCT00348309|469068574|FG002|Overall Study|Site closure|1|||
130302221|NCT00348309|469068572|FG000|Overall Study|Adverse event not attended|0|||
130302222|NCT00348309|469068573|FG001|Overall Study|Adverse event not attended|0|||
130302223|NCT00348309|469068574|FG002|Overall Study|Adverse event not attended|1|||
130302224|NCT00348309|469068572|FG000|Overall Study|ECG abnormal|0|||
130302225|NCT00348309|469068573|FG001|Overall Study|ECG abnormal|0|||
130302226|NCT00348309|469068574|FG002|Overall Study|ECG abnormal|2|||
130302227|NCT00348309|469068572|FG000|Overall Study|Cardiologist recommendations|0|||
130302228|NCT00348309|469068573|FG001|Overall Study|Cardiologist recommendations|0|||
130302229|NCT00348309|469068574|FG002|Overall Study|Cardiologist recommendations|1|||
130302230|NCT00348309|469068572|FG000|Overall Study|HCV career|0|||
130302231|NCT00348309|469068573|FG001|Overall Study|HCV career|0|||
130302232|NCT00348309|469068574|FG002|Overall Study|HCV career|1|||
130302233|NCT00622388|469068575|FG000|Overall Study|Disease Progression|47|||
130302234|NCT00622388|469068575|FG000|Overall Study|Adverse Event|6|||
130302235|NCT00622388|469068575|FG000|Overall Study|Protocol Violation|3|||
130373181|NCT00256750|469333389|FG002|Transplanted Pre-Treatment|Death|0|||
130373182|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
130373183|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
130373184|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
130373185|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Death|3|||
130373186|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Death|2|||
130373187|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Death|4|||
130373188|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
130373189|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
130373190|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
130557366|NCT00631189|470009968|FG003|Treatment Phase|Lost to Follow-up|0|||
130302236|NCT00622388|469068575|FG000|Overall Study|Participant Refusal|1|||
130302237|NCT00622388|469068575|FG000|Overall Study|Death|3|||
130302238|NCT00622388|469068575|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
130302239|NCT00622388|469068575|FG000|Overall Study|Took Prohibited Medication|2|||
130302240|NCT00622388|469068575|FG000|Overall Study|Withdrew Consent|1|||
130302241|NCT00622388|469068575|FG000|Overall Study|Insurance Expired|1|||
130302242|NCT00828750|469068576|FG000|Overall Study|Lack of Efficacy|3|||
130302243|NCT00828750|469068576|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
130302244|NCT04079114|469068577|FG000|Overall Study|Study prematuely terminated.|166|||
130557367|NCT00631189|470009965|FG000|Treatment Phase|Pregnancy|0|||
130302245|NCT01364389|469068578|FG000|Overall Study|Withdrawal by Subject|0|||
130302246|NCT01364389|469068579|FG001|Overall Study|Withdrawal by Subject|1|||
130302247|NCT01364389|469068580|FG002|Overall Study|Withdrawal by Subject|0|||
130302248|NCT01364389|469068578|FG000|Overall Study|Protocol deviation|0|||
130302249|NCT01364389|469068579|FG001|Overall Study|Protocol deviation|0|||
130302250|NCT01364389|469068580|FG002|Overall Study|Protocol deviation|1|||
130302251|NCT01364389|469068578|FG000|Overall Study|Administrative problems|1|||
130302252|NCT01364389|469068579|FG001|Overall Study|Administrative problems|0|||
130302253|NCT01364389|469068580|FG002|Overall Study|Administrative problems|0|||
130302254|NCT01364389|469068578|FG000|Overall Study|Adverse Event|1|||
130302255|NCT01364389|469068579|FG001|Overall Study|Adverse Event|0|||
130302256|NCT01364389|469068580|FG002|Overall Study|Adverse Event|0|||
130302257|NCT01068158|469068581|FG000|Overall Study|Withdrawal by Subject|1|||
130302258|NCT01068158|469068582|FG001|Overall Study|Withdrawal by Subject|2|||
130302259|NCT01068158|469068581|FG000|Overall Study|Lost to Follow-up|7|||
130302260|NCT01068158|469068582|FG001|Overall Study|Lost to Follow-up|0|||
130302261|NCT01068158|469068581|FG000|Overall Study|Protocol Violation|0|||
130302262|NCT01068158|469068582|FG001|Overall Study|Protocol Violation|2|||
130302263|NCT00991406|469068583|FG000|Overall Study|One participant did not respond to FES.|1|||
130302264|NCT01300572|469068584|FG000|Overall Study|HAMA + post dosimetry|1|||
130302265|NCT02160145|469068586|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
130302266|NCT02160145|469068587|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130302267|NCT02160145|469068588|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130302268|NCT02160145|469068586|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
130302269|NCT02160145|469068587|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130302270|NCT02160145|469068588|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130302271|NCT02160145|469068586|FG000|Randomized Double-blind Period|Subject decision|0|||
130302272|NCT02160145|469068587|FG001|Randomized Double-blind Period|Subject decision|21|||
130302273|NCT02160145|469068588|FG002|Randomized Double-blind Period|Subject decision|20|||
130302274|NCT02160145|469068586|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
130302275|NCT02160145|469068587|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
130302276|NCT02160145|469068588|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
130302277|NCT02160145|469068586|FG000|Randomized Double-blind Period|Physician Decision|0|||
130302278|NCT02160145|469068587|FG001|Randomized Double-blind Period|Physician Decision|7|||
130302279|NCT02160145|469068588|FG002|Randomized Double-blind Period|Physician Decision|5|||
130302280|NCT00375518|469068589|FG000|Overall Study|Withdrawal by Subject|2|||
130302281|NCT00375518|469068590|FG001|Overall Study|Withdrawal by Subject|10|||
130302282|NCT00375518|469068589|FG000|Overall Study|Patient Not Treated|6|||
130302283|NCT00375518|469068590|FG001|Overall Study|Patient Not Treated|6|||
130302284|NCT00375518|469068589|FG000|Overall Study|Death|0|||
130302285|NCT00375518|469068590|FG001|Overall Study|Death|1|||
130302286|NCT01108523|469068591|FG000|Overall Study|Protocol Violation|4|||
130302287|NCT03848949|469068601|FG000|Overall Study|Lost to Follow-up|5|||
130302288|NCT03848949|469068602|FG001|Overall Study|Lost to Follow-up|7|||
130302289|NCT02353728|469068605|FG000|Overall Study|Subject non-compliance|1|||
130302290|NCT02301624|469068606|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
130373191|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
130373192|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
130373193|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
130373194|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Other|5|||
130373195|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Other|4|||
130373196|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Other|2|||
130373197|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
130373198|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
130373199|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
130373200|NCT00256750|469333387|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
130373201|NCT00256750|469333388|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
130373202|NCT00256750|469333389|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
130373203|NCT00256750|469333387|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
130373204|NCT00256750|469333388|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
130373205|NCT00256750|469333389|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
130373206|NCT00256750|469333387|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
130373207|NCT00256750|469333388|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
130373208|NCT00256750|469333389|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
130373209|NCT00256750|469333387|FG000|Post-Transplant Treated (24 Months)|Death|3|||
130373210|NCT00256750|469333388|FG001|Post-Transplant Treated (24 Months)|Death|0|||
130373211|NCT00256750|469333389|FG002|Post-Transplant Treated (24 Months)|Death|0|||
130557368|NCT00631189|470009966|FG001|Treatment Phase|Pregnancy|0|||
130302291|NCT02301624|469068607|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
130302292|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
130302293|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
130302294|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Adverse Event|2|||
130302295|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Adverse Event|5|||
130302296|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Physician Decision|3|||
130302297|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Physician Decision|3|||
130302298|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Death|2|||
130302299|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Death|1|||
130302300|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
130302301|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
130302302|NCT00895310|469068608|FG000|Overall Study|Withdrawal by Subject|1|||
130302303|NCT00659230|469068609|FG000|Overall Study|Lost to Follow-up|2|||
130302304|NCT00659230|469068610|FG001|Overall Study|Lost to Follow-up|5|||
130302305|NCT00659230|469068609|FG000|Overall Study|Lost source documentation|5|||
130302306|NCT00659230|469068610|FG001|Overall Study|Lost source documentation|4|||
130302307|NCT00659230|469068609|FG000|Overall Study|Did not return post-randomization|2|||
130302308|NCT00659230|469068610|FG001|Overall Study|Did not return post-randomization|3|||
130302309|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Adverse Event|1|||
130302310|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Adverse Event|0|||
130302311|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
130302312|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
130302313|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
130302314|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
130302315|NCT00547521|469068611|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
130302316|NCT00547521|469068612|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
130302317|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
130302318|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
130302319|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
130302320|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
130302321|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
130302322|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
130302323|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
130302324|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
130302325|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Other|0|||
130302326|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Other|2|||
130302327|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
130302328|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
130302329|NCT03109184|469071144|FG000|Overall Study|Lost to Follow-up|6|||
130302330|NCT03109184|469071145|FG001|Overall Study|Lost to Follow-up|6|||
130302331|NCT03109184|469071144|FG000|Overall Study|Withdrawal by Subject|1|||
130302332|NCT03109184|469071145|FG001|Overall Study|Withdrawal by Subject|1|||
130302333|NCT01031979|469071148|FG000|Overall Study|Lost to Follow-up|5|||
130302334|NCT01031979|469071149|FG001|Overall Study|Lost to Follow-up|4|||
130302335|NCT03831100|469071151|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
130302336|NCT03831100|469071152|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
130302337|NCT02008227|469071156|FG000|Overall Study|Lost to Follow-up|7|||
130302338|NCT02008227|469071157|FG001|Overall Study|Lost to Follow-up|9|||
130302339|NCT02008227|469071156|FG000|Overall Study|Death|494|||
130302340|NCT02008227|469071157|FG001|Overall Study|Death|485|||
130302341|NCT02008227|469071156|FG000|Overall Study|Withdrawal by Subject|67|||
130302342|NCT02008227|469071157|FG001|Overall Study|Withdrawal by Subject|36|||
130302343|NCT02008227|469071156|FG000|Overall Study|Study Terminated By Sponsor|44|||
130302344|NCT02008227|469071157|FG001|Overall Study|Study Terminated By Sponsor|83|||
130302345|NCT01487265|469071160|FG000|Overall Study|Adverse Event|8|||
130302346|NCT01487265|469071160|FG000|Overall Study|Withdrawal by Subject|5|||
130302347|NCT01487265|469071160|FG000|Overall Study|Disease Progression|21|||
130302348|NCT01487265|469071160|FG000|Overall Study|Death|2|||
130302349|NCT01487265|469071160|FG000|Overall Study|Still on Treatment|1|||
130302350|NCT00965575|469071161|FG000|Overall Study|subject unwillingness to swallow study c|1|||
130302351|NCT00965575|469071162|FG001|Overall Study|subject unwillingness to swallow study c|0|||
130302352|NCT01959841|469071163|FG000|Overall Study|Adverse Event|1|||
130302353|NCT01959841|469071164|FG001|Overall Study|Adverse Event|3|||
130302354|NCT01959841|469071165|FG002|Overall Study|Adverse Event|2|||
130302355|NCT01959841|469071163|FG000|Overall Study|Lack of Efficacy|5|||
130302356|NCT01959841|469071164|FG001|Overall Study|Lack of Efficacy|0|||
130302357|NCT01959841|469071165|FG002|Overall Study|Lack of Efficacy|0|||
130302358|NCT01959841|469071163|FG000|Overall Study|Lost to Follow-up|1|||
130302359|NCT01959841|469071164|FG001|Overall Study|Lost to Follow-up|1|||
130373212|NCT00256750|469333387|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
130302360|NCT01959841|469071165|FG002|Overall Study|Lost to Follow-up|0|||
130302361|NCT01959841|469071163|FG000|Overall Study|Physician Decision|0|||
130302362|NCT01959841|469071164|FG001|Overall Study|Physician Decision|2|||
130302363|NCT01959841|469071165|FG002|Overall Study|Physician Decision|3|||
130302364|NCT01959841|469071163|FG000|Overall Study|Protocol Violation|16|||
130302365|NCT01959841|469071164|FG001|Overall Study|Protocol Violation|23|||
130302366|NCT01959841|469071165|FG002|Overall Study|Protocol Violation|16|||
130302367|NCT01959841|469071163|FG000|Overall Study|Withdrawal by Subject|7|||
130302368|NCT01959841|469071164|FG001|Overall Study|Withdrawal by Subject|7|||
130302369|NCT01959841|469071165|FG002|Overall Study|Withdrawal by Subject|5|||
130302370|NCT01959841|469071163|FG000|Overall Study|Clinical laboratory value|2|||
130302371|NCT01959841|469071164|FG001|Overall Study|Clinical laboratory value|6|||
130302372|NCT01959841|469071165|FG002|Overall Study|Clinical laboratory value|6|||
130302373|NCT01959841|469071163|FG000|Overall Study|Platelet count below on day1 or 4|11|||
130302374|NCT01959841|469071164|FG001|Overall Study|Platelet count below on day1 or 4|15|||
130302375|NCT01959841|469071165|FG002|Overall Study|Platelet count below on day1 or 4|11|||
130302376|NCT00780416|469071166|FG000|Overall Study|Physician Decision|3|||
130302377|NCT00780416|469071167|FG001|Overall Study|Physician Decision|3|||
130302378|NCT00780416|469071166|FG000|Overall Study|Protocol Violation|1|||
130302379|NCT00780416|469071167|FG001|Overall Study|Protocol Violation|0|||
130302380|NCT00780416|469071166|FG000|Overall Study|Withdrawal by Subject|8|||
130302381|NCT00780416|469071167|FG001|Overall Study|Withdrawal by Subject|6|||
130302382|NCT00666224|469071168|FG000|Double-Blind|Adverse Event|15|||
130302383|NCT00666224|469071169|FG001|Double-Blind|Adverse Event|5|||
130302384|NCT00666224|469071168|FG000|Double-Blind|Lost to Follow-up|2|||
130302385|NCT00666224|469071169|FG001|Double-Blind|Lost to Follow-up|2|||
130302386|NCT00666224|469071168|FG000|Double-Blind|Withdrawal by Subject|18|||
130302387|NCT00666224|469071169|FG001|Double-Blind|Withdrawal by Subject|14|||
130302388|NCT00666224|469071168|FG000|Double-Blind|Physician Decision|0|||
130302389|NCT00666224|469071169|FG001|Double-Blind|Physician Decision|3|||
130302390|NCT00666224|469071168|FG000|Double-Blind|Sponsor decision|1|||
130302391|NCT00666224|469071169|FG001|Double-Blind|Sponsor decision|0|||
130302392|NCT00666224|469071168|FG000|Double-Blind|Pregnancy|3|||
130302393|NCT00666224|469071169|FG001|Double-Blind|Pregnancy|2|||
130302394|NCT00666224|469071168|FG000|Double-Blind|Noncompliance|1|||
130302395|NCT00666224|469071169|FG001|Double-Blind|Noncompliance|0|||
130302396|NCT00666224|469071168|FG000|Double-Blind|Death|1|||
130302397|NCT00666224|469071169|FG001|Double-Blind|Death|0|||
130302398|NCT00666224|469071168|FG000|Double-Blind|Undefined/Unknown|4|||
130302399|NCT00666224|469071169|FG001|Double-Blind|Undefined/Unknown|1|||
130302400|NCT00666224|469071168|FG000|Open-Label|Adverse Event|8|||
130302401|NCT00666224|469071169|FG001|Open-Label|Adverse Event|43|||
130302402|NCT00666224|469071168|FG000|Open-Label|Lost to Follow-up|4|||
130302403|NCT00666224|469071169|FG001|Open-Label|Lost to Follow-up|5|||
130302404|NCT00666224|469071168|FG000|Open-Label|Withdrawal by Subject|12|||
130302405|NCT00666224|469071169|FG001|Open-Label|Withdrawal by Subject|25|||
130302406|NCT00666224|469071168|FG000|Open-Label|Physician Decision|7|||
130302407|NCT00666224|469071169|FG001|Open-Label|Physician Decision|5|||
130302408|NCT00666224|469071168|FG000|Open-Label|Pregnancy|1|||
130302409|NCT00666224|469071169|FG001|Open-Label|Pregnancy|5|||
130302410|NCT00666224|469071168|FG000|Open-Label|Noncompliance|2|||
130302411|NCT00666224|469071169|FG001|Open-Label|Noncompliance|1|||
130302412|NCT00666224|469071168|FG000|Open-Label|Undefined/Unknown|1|||
130302413|NCT00666224|469071169|FG001|Open-Label|Undefined/Unknown|1|||
130302414|NCT03521141|469071173|FG000|Overall Study|Death|1|||
130302415|NCT03521141|469071174|FG001|Overall Study|Death|0|||
130302416|NCT03521141|469071175|FG002|Overall Study|Death|1|||
130302417|NCT01271725|469071182|FG000|Part A|Progressive disease according to RECIST|8|||
130302418|NCT01271725|469071183|FG001|Part A|Progressive disease according to RECIST|0|||
130302419|NCT01271725|469071182|FG000|Part A|Clinical signs/symptoms of progression|2|||
130302420|NCT01271725|469071183|FG001|Part A|Clinical signs/symptoms of progression|0|||
130302421|NCT01271725|469071182|FG000|Part A|Other Adverse Event|8|||
130302422|NCT01271725|469071183|FG001|Part A|Other Adverse Event|0|||
130302423|NCT01271725|469071182|FG000|Part A|Lost to Follow-up|1|||
130302424|NCT01271725|469071183|FG001|Part A|Lost to Follow-up|0|||
130302425|NCT01271725|469071182|FG000|Part A|Withdrawal by Subject|12|||
130302426|NCT01271725|469071183|FG001|Part A|Withdrawal by Subject|0|||
130302427|NCT01271725|469071182|FG000|Part A|Other than specified|3|||
130302428|NCT01271725|469071183|FG001|Part A|Other than specified|0|||
130302429|NCT01271725|469071182|FG000|Part A|Protocol Violation|1|||
130302430|NCT01271725|469071183|FG001|Part A|Protocol Violation|0|||
130302431|NCT01271725|469071182|FG000|Part B|Other than specified|0|||
130302432|NCT01271725|469071183|FG001|Part B|Other than specified|2|||
130302433|NCT01271725|469071182|FG000|Part B|Clinical signs/symptoms of progression|0|||
130302434|NCT01271725|469071183|FG001|Part B|Clinical signs/symptoms of progression|2|||
130302435|NCT01271725|469071182|FG000|Part B|Other Adverse Event|0|||
130302436|NCT01271725|469071183|FG001|Part B|Other Adverse Event|1|||
130302437|NCT01271725|469071182|FG000|Part B|Protocol Violation|0|||
130302438|NCT01271725|469071183|FG001|Part B|Protocol Violation|1|||
130302439|NCT01271725|469071182|FG000|Part B|Withdrawal by Subject|0|||
130302440|NCT01271725|469071183|FG001|Part B|Withdrawal by Subject|6|||
130302441|NCT01702025|469071184|FG000|Overall Study|Equipment failure|1|||
130302442|NCT01702025|469071185|FG001|Overall Study|Equipment failure|0|||
130302443|NCT01702025|469071186|FG002|Overall Study|Equipment failure|0|||
130302444|NCT01702025|469071187|FG003|Overall Study|Equipment failure|0|||
130302445|NCT01702025|469071184|FG000|Overall Study|Adverse Event|1|||
130302446|NCT01702025|469071185|FG001|Overall Study|Adverse Event|1|||
130302447|NCT01702025|469071186|FG002|Overall Study|Adverse Event|1|||
130302448|NCT01702025|469071187|FG003|Overall Study|Adverse Event|0|||
130302449|NCT03354273|469071188|FG000|Overall Study|Adverse Event|5|||
130302450|NCT03354273|469071188|FG000|Overall Study|Screen Failure|21|||
130302451|NCT03354273|469071188|FG000|Overall Study|Withdrawal by Subject|34|||
130302452|NCT03354273|469071188|FG000|Overall Study|Technical Problems|30|||
130302453|NCT03354273|469071188|FG000|Overall Study|Lost to Follow-up|4|||
130302454|NCT03354273|469071188|FG000|Overall Study|Investigator Decision|3|||
130302455|NCT03354273|469071188|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
130302456|NCT03354273|469071188|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
130302457|NCT03354273|469071188|FG000|Overall Study|COVID-19 Restrictions|9|||
130302458|NCT03354273|469071188|FG000|Overall Study|Other|5|||
130302459|NCT03229109|469071194|FG000|Overall Study|Withdrawal by Subject|0|||
130302460|NCT03229109|469071195|FG001|Overall Study|Withdrawal by Subject|0|||
130302461|NCT03229109|469071196|FG002|Overall Study|Withdrawal by Subject|0|||
130302462|NCT03229109|469071197|FG003|Overall Study|Withdrawal by Subject|1|||
130302463|NCT04207749|469071198|FG000|Overall Study|Lost to Follow-up|0|||
130302464|NCT04207749|469071199|FG001|Overall Study|Lost to Follow-up|2|||
130302465|NCT04207749|469071198|FG000|Overall Study|Protocol Violation|0|||
130302466|NCT04207749|469071199|FG001|Overall Study|Protocol Violation|1|||
130302467|NCT04207749|469071198|FG000|Overall Study|Withdrawal by Subject|3|||
130302468|NCT04207749|469071199|FG001|Overall Study|Withdrawal by Subject|0|||
130302469|NCT04207749|469071198|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
130302470|NCT04207749|469071199|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
130302471|NCT01835223|469071202|FG000|Overall Study|Adverse Event|1|||
130302472|NCT01835223|469071203|FG001|Overall Study|Adverse Event|0|||
130302473|NCT01835223|469071202|FG000|Overall Study|Withdrawal by Subject|2|||
130302474|NCT01835223|469071203|FG001|Overall Study|Withdrawal by Subject|0|||
130302475|NCT01835223|469071202|FG000|Overall Study|Disease progression|2|||
130302476|NCT01835223|469071203|FG001|Overall Study|Disease progression|1|||
130302477|NCT01835223|469071202|FG000|Overall Study|Became Inelligible|4|||
130302478|NCT01835223|469071203|FG001|Overall Study|Became Inelligible|0|||
130302479|NCT01504841|469071207|FG000|Overall Study|Withdrawal by Subject|1|||
130302480|NCT01504841|469071208|FG001|Overall Study|Withdrawal by Subject|1|||
130302481|NCT01504841|469071209|FG002|Overall Study|Withdrawal by Subject|0|||
130302482|NCT03149055|469071214|FG000|Overall Study|Not treated|4|||
130302483|NCT02629822|469071215|FG000|Base Study|Lost to Follow-up|2|||
130302484|NCT02629822|469071215|FG000|Base Study|Non-Compliance With Study Drug|1|||
130302485|NCT02629822|469071215|FG000|Extension Study|Adverse Event|1|||
130302486|NCT02629822|469071215|FG000|Extension Study|Lost to Follow-up|1|||
130461872|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
130461873|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
130461874|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
130461875|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
130461876|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
130461877|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
130461878|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
130461879|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
130461880|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
130461881|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
130461882|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
130461883|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
130461884|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
130557369|NCT00631189|470009967|FG002|Treatment Phase|Pregnancy|1|||
130557370|NCT00631189|470009968|FG003|Treatment Phase|Pregnancy|0|||
130557371|NCT00631189|470009965|FG000|Treatment Phase|patient did not take pravastatin|0|||
130557372|NCT00631189|470009966|FG001|Treatment Phase|patient did not take pravastatin|0|||
130557373|NCT00631189|470009967|FG002|Treatment Phase|patient did not take pravastatin|1|||
130557374|NCT00631189|470009968|FG003|Treatment Phase|patient did not take pravastatin|0|||
130557375|NCT01132612|470009969|FG000|Overall Study|Death|0|||
130557376|NCT01132612|470009970|FG001|Overall Study|Death|0|||
130557377|NCT01132612|470009971|FG002|Overall Study|Death|1|||
130557378|NCT01132612|470009969|FG000|Overall Study|Protocol deviation|0|||
130557379|NCT01132612|470009970|FG001|Overall Study|Protocol deviation|0|||
130557380|NCT01132612|470009971|FG002|Overall Study|Protocol deviation|3|||
130302487|NCT04440813|469071216|FG000|Overall Study|Lost to Follow-up|5|||
130557381|NCT01132612|470009969|FG000|Overall Study|Lost to Follow-up|2|||
130302488|NCT04440813|469071217|FG001|Overall Study|Lost to Follow-up|5|||
130302489|NCT03679624|469071218|FG000|Overall Study|Adverse Event|1|||
130557382|NCT01132612|470009970|FG001|Overall Study|Lost to Follow-up|2|||
130302490|NCT03679624|469071219|FG001|Overall Study|Adverse Event|0|||
130302491|NCT01610336|469071220|FG000|Overall Study|Progressive Disease|4|||
130302492|NCT01610336|469071221|FG001|Overall Study|Progressive Disease|6|||
130302493|NCT01610336|469071222|FG002|Overall Study|Progressive Disease|6|||
130302494|NCT01610336|469071223|FG003|Overall Study|Progressive Disease|5|||
130302495|NCT01610336|469071224|FG004|Overall Study|Progressive Disease|3|||
130557383|NCT01132612|470009971|FG002|Overall Study|Lost to Follow-up|7|||
130557384|NCT01132612|470009969|FG000|Overall Study|Adverse Event|5|||
130716435|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716436|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
130716437|NCT01971970|470588850|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
130716438|NCT01971970|470588851|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
130716439|NCT01971970|470588850|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
130716440|NCT01971970|470588851|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
130716441|NCT01971970|470588850|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
130716442|NCT01971970|470588851|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
130302496|NCT01610336|469071225|FG005|Overall Study|Progressive Disease|10|||
130302497|NCT01610336|469071226|FG006|Overall Study|Progressive Disease|1|||
130302498|NCT01610336|469071227|FG007|Overall Study|Progressive Disease|6|||
130302499|NCT01610336|469071228|FG008|Overall Study|Progressive Disease|6|||
130557385|NCT01132612|470009970|FG001|Overall Study|Adverse Event|2|||
130716443|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
130716444|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
130716445|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
130302500|NCT01610336|469071229|FG009|Overall Study|Progressive Disease|40|||
130302501|NCT01610336|469071230|FG010|Overall Study|Progressive Disease|36|||
130302502|NCT01610336|469071220|FG000|Overall Study|Adverse Event|0|||
130302503|NCT01610336|469071221|FG001|Overall Study|Adverse Event|0|||
130302504|NCT01610336|469071222|FG002|Overall Study|Adverse Event|0|||
130302505|NCT01610336|469071223|FG003|Overall Study|Adverse Event|1|||
130302506|NCT01610336|469071224|FG004|Overall Study|Adverse Event|1|||
130302507|NCT01610336|469071225|FG005|Overall Study|Adverse Event|1|||
130302508|NCT01610336|469071226|FG006|Overall Study|Adverse Event|0|||
130302509|NCT01610336|469071227|FG007|Overall Study|Adverse Event|0|||
130302510|NCT01610336|469071228|FG008|Overall Study|Adverse Event|2|||
130716446|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
130302511|NCT01610336|469071229|FG009|Overall Study|Adverse Event|8|||
130302512|NCT01610336|469071230|FG010|Overall Study|Adverse Event|6|||
130302513|NCT01610336|469071220|FG000|Overall Study|Subject/Guardian decision|1|||
130302514|NCT01610336|469071221|FG001|Overall Study|Subject/Guardian decision|1|||
130302515|NCT01610336|469071222|FG002|Overall Study|Subject/Guardian decision|0|||
130302516|NCT01610336|469071223|FG003|Overall Study|Subject/Guardian decision|1|||
130302517|NCT01610336|469071224|FG004|Overall Study|Subject/Guardian decision|0|||
130302518|NCT01610336|469071225|FG005|Overall Study|Subject/Guardian decision|0|||
130302519|NCT01610336|469071226|FG006|Overall Study|Subject/Guardian decision|0|||
130302520|NCT01610336|469071227|FG007|Overall Study|Subject/Guardian decision|1|||
130302521|NCT01610336|469071228|FG008|Overall Study|Subject/Guardian decision|0|||
130302522|NCT01610336|469071229|FG009|Overall Study|Subject/Guardian decision|2|||
130302523|NCT01610336|469071230|FG010|Overall Study|Subject/Guardian decision|2|||
130302524|NCT01610336|469071220|FG000|Overall Study|Death|0|||
130302525|NCT01610336|469071221|FG001|Overall Study|Death|0|||
130716447|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
130716448|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
130716449|NCT01971970|470588850|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
130716450|NCT01971970|470588851|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
130302526|NCT01610336|469071222|FG002|Overall Study|Death|0|||
130302527|NCT01610336|469071223|FG003|Overall Study|Death|0|||
130302528|NCT01610336|469071224|FG004|Overall Study|Death|0|||
130302529|NCT01610336|469071225|FG005|Overall Study|Death|1|||
130302530|NCT01610336|469071226|FG006|Overall Study|Death|3|||
130302531|NCT01610336|469071227|FG007|Overall Study|Death|0|||
130302532|NCT01610336|469071228|FG008|Overall Study|Death|0|||
130302533|NCT01610336|469071229|FG009|Overall Study|Death|1|||
130302534|NCT01610336|469071230|FG010|Overall Study|Death|2|||
130302535|NCT01610336|469071220|FG000|Overall Study|Non-Compliance with study treatment|0|||
130302536|NCT01610336|469071221|FG001|Overall Study|Non-Compliance with study treatment|0|||
130302537|NCT01610336|469071222|FG002|Overall Study|Non-Compliance with study treatment|0|||
130302538|NCT01610336|469071223|FG003|Overall Study|Non-Compliance with study treatment|0|||
130302539|NCT01610336|469071224|FG004|Overall Study|Non-Compliance with study treatment|0|||
130302540|NCT01610336|469071225|FG005|Overall Study|Non-Compliance with study treatment|0|||
130302541|NCT01610336|469071226|FG006|Overall Study|Non-Compliance with study treatment|0|||
130302542|NCT01610336|469071227|FG007|Overall Study|Non-Compliance with study treatment|0|||
130302543|NCT01610336|469071228|FG008|Overall Study|Non-Compliance with study treatment|0|||
130302544|NCT01610336|469071229|FG009|Overall Study|Non-Compliance with study treatment|1|||
130302545|NCT01610336|469071230|FG010|Overall Study|Non-Compliance with study treatment|0|||
130302546|NCT01610336|469071220|FG000|Overall Study|Physician Decision|0|||
130302547|NCT01610336|469071221|FG001|Overall Study|Physician Decision|0|||
130302548|NCT01610336|469071222|FG002|Overall Study|Physician Decision|0|||
130302549|NCT01610336|469071223|FG003|Overall Study|Physician Decision|0|||
130557386|NCT01132612|470009971|FG002|Overall Study|Adverse Event|15|||
130302550|NCT01610336|469071224|FG004|Overall Study|Physician Decision|0|||
130302551|NCT01610336|469071225|FG005|Overall Study|Physician Decision|0|||
130302552|NCT01610336|469071226|FG006|Overall Study|Physician Decision|1|||
130373213|NCT00256750|469333388|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
130373214|NCT00256750|469333389|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
130373215|NCT00256750|469333387|FG000|Post-Transplant Treated (24 Months)|Other|2|||
130373216|NCT00256750|469333388|FG001|Post-Transplant Treated (24 Months)|Other|0|||
130373217|NCT00256750|469333389|FG002|Post-Transplant Treated (24 Months)|Other|1|||
130373218|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
130373219|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
130557387|NCT01132612|470009969|FG000|Overall Study|Withdrawal by Subject|5|||
130557388|NCT01132612|470009970|FG001|Overall Study|Withdrawal by Subject|8|||
130557389|NCT01132612|470009971|FG002|Overall Study|Withdrawal by Subject|19|||
130557390|NCT01132612|470009969|FG000|Overall Study|Administrative problems|5|||
130557391|NCT01132612|470009970|FG001|Overall Study|Administrative problems|1|||
130557392|NCT01132612|470009971|FG002|Overall Study|Administrative problems|52|||
130557393|NCT01132612|470009969|FG000|Overall Study|Lack of Efficacy|23|||
130557394|NCT01132612|470009970|FG001|Overall Study|Lack of Efficacy|22|||
130557395|NCT01132612|470009971|FG002|Overall Study|Lack of Efficacy|73|||
130557396|NCT02252536|470009973|FG000|Overall Study|Lost to Follow-up|5|||
130557397|NCT02252536|470009974|FG001|Overall Study|Lost to Follow-up|3|||
130557398|NCT01438151|470009977|FG000|Overall Study|study terminated|8|||
130557399|NCT01026142|470009980|FG000|Overall Study|Death|136|||
130557400|NCT01026142|470009981|FG001|Overall Study|Death|134|||
130557401|NCT01026142|470009980|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
130557402|NCT01026142|470009981|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
130557403|NCT01351623|470009985|FG000|Overall Study|Protocol Violation|2|||
130557404|NCT01351623|470009985|FG000|Overall Study|Adverse Event|4|||
130557405|NCT01351623|470009985|FG000|Overall Study|Withdrawal by Subject|1|||
130557406|NCT01351623|470009985|FG000|Overall Study|Death|2|||
130557407|NCT04201821|470009986|FG000|Overall Study|Withdrawal by Subject|2|||
130557408|NCT01130974|470009987|FG000|Overall Study|Protocol Violation|10|||
130557409|NCT01130974|470009988|FG001|Overall Study|Protocol Violation|10|||
130557410|NCT01130974|470009987|FG000|Overall Study|Withdrawal by Subject|0|||
130557411|NCT01130974|470009988|FG001|Overall Study|Withdrawal by Subject|1|||
130557412|NCT01130974|470009987|FG000|Overall Study|Ineligibility criteria|5|||
130557413|NCT01130974|470009988|FG001|Overall Study|Ineligibility criteria|2|||
130557414|NCT00387764|470009989|FG000|Overall Study|Adverse Event|12|||
130557415|NCT00387764|470009989|FG000|Overall Study|Withdrawal by Subject|8|||
130557416|NCT00387764|470009989|FG000|Overall Study|Sponsor Terminated Study|1|||
130557417|NCT00387764|470009989|FG000|Overall Study|Physician Decision|1|||
130302553|NCT01610336|469071227|FG007|Overall Study|Physician Decision|0|||
130302554|NCT01610336|469071228|FG008|Overall Study|Physician Decision|0|||
130302555|NCT01610336|469071229|FG009|Overall Study|Physician Decision|0|||
130302556|NCT01610336|469071230|FG010|Overall Study|Physician Decision|0|||
130302557|NCT01610336|469071220|FG000|Overall Study|Protocol Deviation|0|||
130302558|NCT01610336|469071221|FG001|Overall Study|Protocol Deviation|0|||
130302559|NCT01610336|469071222|FG002|Overall Study|Protocol Deviation|0|||
130302560|NCT01610336|469071223|FG003|Overall Study|Protocol Deviation|0|||
130302561|NCT01610336|469071224|FG004|Overall Study|Protocol Deviation|0|||
130302562|NCT01610336|469071225|FG005|Overall Study|Protocol Deviation|0|||
130302563|NCT01610336|469071226|FG006|Overall Study|Protocol Deviation|0|||
130302564|NCT01610336|469071227|FG007|Overall Study|Protocol Deviation|0|||
130302565|NCT01610336|469071228|FG008|Overall Study|Protocol Deviation|0|||
130302566|NCT01610336|469071229|FG009|Overall Study|Protocol Deviation|1|||
130302567|NCT01610336|469071230|FG010|Overall Study|Protocol Deviation|0|||
130302568|NCT01610336|469071220|FG000|Overall Study|Transfer to another trial|0|||
130302569|NCT01610336|469071221|FG001|Overall Study|Transfer to another trial|0|||
130302570|NCT01610336|469071222|FG002|Overall Study|Transfer to another trial|0|||
130302571|NCT01610336|469071223|FG003|Overall Study|Transfer to another trial|0|||
130302572|NCT01610336|469071224|FG004|Overall Study|Transfer to another trial|0|||
130302573|NCT01610336|469071225|FG005|Overall Study|Transfer to another trial|0|||
130302574|NCT01610336|469071226|FG006|Overall Study|Transfer to another trial|0|||
130302575|NCT01610336|469071227|FG007|Overall Study|Transfer to another trial|0|||
130302576|NCT01610336|469071228|FG008|Overall Study|Transfer to another trial|0|||
130302577|NCT01610336|469071229|FG009|Overall Study|Transfer to another trial|0|||
130302578|NCT01610336|469071230|FG010|Overall Study|Transfer to another trial|1|||
130302579|NCT00741013|469071231|FG000|Overall Study|Adverse Event|1|||
130373220|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
130373221|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
130302580|NCT00741013|469071232|FG001|Overall Study|Adverse Event|0|||
130302581|NCT00741013|469071233|FG002|Overall Study|Adverse Event|0|||
130302582|NCT00741013|469071231|FG000|Overall Study|Withdrawal by Subject|0|||
130302583|NCT00741013|469071232|FG001|Overall Study|Withdrawal by Subject|0|||
130302584|NCT00741013|469071233|FG002|Overall Study|Withdrawal by Subject|1|||
130302585|NCT00741013|469071231|FG000|Overall Study|Discovered failed screen after enrolled|0|||
130302586|NCT00741013|469071232|FG001|Overall Study|Discovered failed screen after enrolled|2|||
130373222|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
130557418|NCT00387764|470009989|FG000|Overall Study|Other|2|||
130557419|NCT00387764|470009989|FG000|Overall Study|Death|7|||
130302587|NCT00741013|469071233|FG002|Overall Study|Discovered failed screen after enrolled|0|||
130302588|NCT01559675|469071237|FG000|Overall Study|Protocol Violation|1|||
130302589|NCT01559675|469071238|FG001|Overall Study|Protocol Violation|2|||
130302590|NCT01559675|469071237|FG000|Overall Study|2nd operation on same patient excluded|14|||
130302591|NCT01559675|469071238|FG001|Overall Study|2nd operation on same patient excluded|12|||
130302592|NCT00291018|469071239|FG000|Overall Study|Not Consented or Declined PAS|12|||
130302593|NCT00291018|469071240|FG001|Overall Study|Not Consented or Declined PAS|15|||
130302594|NCT00291018|469071241|FG002|Overall Study|Not Consented or Declined PAS|15|||
130302595|NCT00291018|469071239|FG000|Overall Study|Death|3|||
130302596|NCT00291018|469071240|FG001|Overall Study|Death|3|||
130302597|NCT00291018|469071241|FG002|Overall Study|Death|4|||
130302598|NCT00291018|469071239|FG000|Overall Study|Withdrawal by Subject|2|||
130302599|NCT00291018|469071240|FG001|Overall Study|Withdrawal by Subject|8|||
130302600|NCT00291018|469071241|FG002|Overall Study|Withdrawal by Subject|1|||
130302601|NCT00291018|469071239|FG000|Overall Study|Failures|5|||
130302602|NCT00291018|469071240|FG001|Overall Study|Failures|12|||
130302603|NCT00291018|469071241|FG002|Overall Study|Failures|5|||
130302604|NCT00291018|469071239|FG000|Overall Study|Lost to Follow-up|3|||
130302605|NCT00291018|469071240|FG001|Overall Study|Lost to Follow-up|4|||
130302606|NCT00291018|469071241|FG002|Overall Study|Lost to Follow-up|18|||
130302607|NCT01496469|469071242|FG000|Overall Study|Adverse Event|1|||
130302608|NCT01496469|469071243|FG001|Overall Study|Adverse Event|0|||
130302609|NCT01496469|469071242|FG000|Overall Study|Protocol Violation|2|||
130302610|NCT01496469|469071243|FG001|Overall Study|Protocol Violation|0|||
130302611|NCT01496469|469071242|FG000|Overall Study|Lost to Follow-up|1|||
130302612|NCT01496469|469071243|FG001|Overall Study|Lost to Follow-up|1|||
130302613|NCT01496469|469071242|FG000|Overall Study|Withdrawal by Subject|4|||
130302614|NCT01496469|469071243|FG001|Overall Study|Withdrawal by Subject|4|||
130302615|NCT01496469|469071242|FG000|Overall Study|BP exceeds protocol limits|1|||
130302616|NCT01496469|469071243|FG001|Overall Study|BP exceeds protocol limits|2|||
130302617|NCT01496469|469071242|FG000|Overall Study|Other|1|||
130302618|NCT01496469|469071243|FG001|Overall Study|Other|1|||
130302619|NCT00193180|469071244|FG000|Overall Study|Lack of Efficacy|1|||
130302620|NCT00193180|469071244|FG000|Overall Study|Adverse Event|8|||
130302621|NCT00193180|469071244|FG000|Overall Study|Protocol Violation|1|||
130302622|NCT01357551|469071245|FG000|Overall Study|Withdrawal by Subject|6|||
130302623|NCT01357551|469071246|FG001|Overall Study|Withdrawal by Subject|4|||
130302624|NCT01357551|469071245|FG000|Overall Study|Death|0|||
130302625|NCT01357551|469071246|FG001|Overall Study|Death|1|||
130302626|NCT01357551|469071245|FG000|Overall Study|Lost to Follow-up|16|||
130302627|NCT01357551|469071246|FG001|Overall Study|Lost to Follow-up|6|||
130302628|NCT05362058|469071247|FG000|Treatment Period|Adverse Event|3|||
130302629|NCT05362058|469071248|FG001|Treatment Period|Adverse Event|3|||
130302630|NCT05362058|469071247|FG000|Treatment Period|Assigned treatment by mistake|3|||
130302631|NCT05362058|469071248|FG001|Treatment Period|Assigned treatment by mistake|4|||
130302632|NCT05362058|469071247|FG000|Treatment Period|Death|1|||
130302633|NCT05362058|469071248|FG001|Treatment Period|Death|1|||
130302634|NCT05362058|469071247|FG000|Treatment Period|Lost to Follow-up|6|||
130302635|NCT05362058|469071248|FG001|Treatment Period|Lost to Follow-up|3|||
130302636|NCT05362058|469071247|FG000|Treatment Period|Non-compliance with study drug|0|||
130302637|NCT05362058|469071248|FG001|Treatment Period|Non-compliance with study drug|1|||
130302638|NCT05362058|469071247|FG000|Treatment Period|Physician Decision|1|||
130302639|NCT05362058|469071248|FG001|Treatment Period|Physician Decision|0|||
130302640|NCT05362058|469071247|FG000|Treatment Period|Protocol deviation|1|||
130302641|NCT05362058|469071248|FG001|Treatment Period|Protocol deviation|0|||
130302642|NCT05362058|469071247|FG000|Treatment Period|Withdrawal by Subject|10|||
130302643|NCT05362058|469071248|FG001|Treatment Period|Withdrawal by Subject|11|||
130373223|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
130557420|NCT01184053|470009990|FG000|Overall Study|progression while on treatment|3|||
130716451|NCT00848107|470588852|FG000|Overall Study|Lost to Follow-up|2|||
130716452|NCT00848107|470588852|FG000|Overall Study|Withdrawal by Subject|8|||
130716453|NCT00848107|470588852|FG000|Overall Study|Adverse Event|9|||
130716454|NCT00848107|470588852|FG000|Overall Study|Death|1|||
130716455|NCT00848107|470588852|FG000|Overall Study|Pregnancy|1|||
130716456|NCT02335983|470588853|FG000|Overall Study|Sponsor Decision|0|||
130302644|NCT05362058|469071247|FG000|Follow-Up Period|Death|1|||
130302645|NCT05362058|469071248|FG001|Follow-Up Period|Death|0|||
130302646|NCT05362058|469071247|FG000|Follow-Up Period|Lost to Follow-up|2|||
130302647|NCT05362058|469071248|FG001|Follow-Up Period|Lost to Follow-up|1|||
130716457|NCT02335983|470588854|FG001|Overall Study|Sponsor Decision|0|||
130716458|NCT02335983|470588855|FG002|Overall Study|Sponsor Decision|1|||
130302648|NCT05362058|469071247|FG000|Follow-Up Period|Protocol deviation|1|||
130302649|NCT05362058|469071248|FG001|Follow-Up Period|Protocol deviation|1|||
130302650|NCT05362058|469071247|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130302651|NCT05362058|469071248|FG001|Follow-Up Period|Withdrawal by Subject|3|||
130302652|NCT01235234|469071249|FG000|Overall Study|Adverse Event|2|||
130302653|NCT01235234|469071250|FG001|Overall Study|Adverse Event|2|||
130302654|NCT01235234|469071251|FG002|Overall Study|Adverse Event|1|||
130302655|NCT00286494|469071258|FG000|Overall Study|Hyperglycemic rescue|12|||
130302656|NCT00286494|469071259|FG001|Overall Study|Hyperglycemic rescue|19|||
130302657|NCT00286494|469071260|FG002|Overall Study|Hyperglycemic rescue|18|||
130302658|NCT00286494|469071258|FG000|Overall Study|Withdrawal by Subject|2|||
130302659|NCT00286494|469071259|FG001|Overall Study|Withdrawal by Subject|10|||
130302660|NCT00286494|469071260|FG002|Overall Study|Withdrawal by Subject|9|||
130302661|NCT00286494|469071258|FG000|Overall Study|Adverse Event|3|||
130302662|NCT00286494|469071259|FG001|Overall Study|Adverse Event|8|||
130302663|NCT00286494|469071260|FG002|Overall Study|Adverse Event|6|||
130302664|NCT00286494|469071258|FG000|Overall Study|Physician Decision|5|||
130302665|NCT00286494|469071259|FG001|Overall Study|Physician Decision|5|||
130302666|NCT00286494|469071260|FG002|Overall Study|Physician Decision|1|||
130461885|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
130461886|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
130461887|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
130302667|NCT00286494|469071258|FG000|Overall Study|Lost to Follow-up|3|||
130302668|NCT00286494|469071259|FG001|Overall Study|Lost to Follow-up|1|||
130302669|NCT00286494|469071260|FG002|Overall Study|Lost to Follow-up|3|||
130302670|NCT00286494|469071258|FG000|Overall Study|Protocol Violation|1|||
130302671|NCT00286494|469071259|FG001|Overall Study|Protocol Violation|1|||
130302672|NCT00286494|469071260|FG002|Overall Study|Protocol Violation|2|||
130302673|NCT04776317|469071261|FG000|Overall Study|Physician Decision|0|||
130302674|NCT04776317|469071262|FG001|Overall Study|Physician Decision|1|||
130302675|NCT04776317|469071263|FG002|Overall Study|Physician Decision|0|||
130302676|NCT04776317|469071264|FG003|Overall Study|Physician Decision|0|||
130302677|NCT04776317|469071265|FG004|Overall Study|Physician Decision|0|||
130302678|NCT04776317|469071266|FG005|Overall Study|Physician Decision|0|||
130302679|NCT04776317|469071267|FG006|Overall Study|Physician Decision|0|||
130302680|NCT04776317|469071268|FG007|Overall Study|Physician Decision|0|||
130302681|NCT04776317|469071269|FG008|Overall Study|Physician Decision|0|||
130302682|NCT04776317|469071270|FG009|Overall Study|Physician Decision|0|||
130302683|NCT04776317|469071271|FG010|Overall Study|Physician Decision|0|||
130302684|NCT04776317|469071272|FG011|Overall Study|Physician Decision|0|||
130302685|NCT04776317|469071273|FG012|Overall Study|Physician Decision|0|||
130302686|NCT04776317|469071274|FG013|Overall Study|Physician Decision|0|||
130302687|NCT04776317|469071275|FG014|Overall Study|Physician Decision|0|||
130302688|NCT04776317|469071261|FG000|Overall Study|Protocol Violation|0|||
130302689|NCT04776317|469071262|FG001|Overall Study|Protocol Violation|0|||
130302690|NCT04776317|469071263|FG002|Overall Study|Protocol Violation|1|||
130302691|NCT04776317|469071264|FG003|Overall Study|Protocol Violation|0|||
130302692|NCT04776317|469071265|FG004|Overall Study|Protocol Violation|0|||
130302693|NCT04776317|469071266|FG005|Overall Study|Protocol Violation|0|||
130302694|NCT04776317|469071267|FG006|Overall Study|Protocol Violation|0|||
130302695|NCT04776317|469071268|FG007|Overall Study|Protocol Violation|0|||
130302696|NCT04776317|469071269|FG008|Overall Study|Protocol Violation|0|||
130461888|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
130461889|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
130461890|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
130461891|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
130461892|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
130461893|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
130461894|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
130461895|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
130461896|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
130461897|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
130461898|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
130461899|NCT02709655|469656268|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
130461900|NCT02709655|469656269|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
130461901|NCT02709655|469656270|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
130302697|NCT04776317|469071270|FG009|Overall Study|Protocol Violation|0|||
130302698|NCT04776317|469071271|FG010|Overall Study|Protocol Violation|0|||
130302699|NCT04776317|469071272|FG011|Overall Study|Protocol Violation|0|||
130302700|NCT04776317|469071273|FG012|Overall Study|Protocol Violation|0|||
130302701|NCT04776317|469071274|FG013|Overall Study|Protocol Violation|0|||
130302702|NCT04776317|469071275|FG014|Overall Study|Protocol Violation|0|||
130302703|NCT04776317|469071261|FG000|Overall Study|Withdrawal by Subject|0|||
130302704|NCT04776317|469071262|FG001|Overall Study|Withdrawal by Subject|0|||
130302705|NCT04776317|469071263|FG002|Overall Study|Withdrawal by Subject|0|||
130302706|NCT04776317|469071264|FG003|Overall Study|Withdrawal by Subject|0|||
130302707|NCT04776317|469071265|FG004|Overall Study|Withdrawal by Subject|1|||
130302708|NCT04776317|469071266|FG005|Overall Study|Withdrawal by Subject|0|||
130461902|NCT02709655|469656271|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
130461903|NCT02709655|469656272|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
130461904|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
130461905|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
130461906|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
130461907|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
130716459|NCT02335983|470588856|FG003|Overall Study|Sponsor Decision|1|||
130716460|NCT02335983|470588857|FG004|Overall Study|Sponsor Decision|0|||
130716461|NCT02335983|470588858|FG005|Overall Study|Sponsor Decision|1|||
130716462|NCT02335983|470588853|FG000|Overall Study|Withdrawal by Subject|3|||
130302709|NCT04776317|469071267|FG006|Overall Study|Withdrawal by Subject|0|||
130302710|NCT04776317|469071268|FG007|Overall Study|Withdrawal by Subject|0|||
130302711|NCT04776317|469071269|FG008|Overall Study|Withdrawal by Subject|0|||
130302712|NCT04776317|469071270|FG009|Overall Study|Withdrawal by Subject|0|||
130302713|NCT04776317|469071271|FG010|Overall Study|Withdrawal by Subject|0|||
130302714|NCT04776317|469071272|FG011|Overall Study|Withdrawal by Subject|0|||
130302715|NCT04776317|469071273|FG012|Overall Study|Withdrawal by Subject|0|||
130302716|NCT04776317|469071274|FG013|Overall Study|Withdrawal by Subject|0|||
130302717|NCT04776317|469071275|FG014|Overall Study|Withdrawal by Subject|0|||
130302718|NCT04207060|469071276|FG000|Overall Study|Lost to Follow-up|2|||
130302719|NCT04207060|469071277|FG001|Overall Study|Lost to Follow-up|0|||
130302720|NCT02524158|469071278|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
130302721|NCT02524158|469071279|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
130302722|NCT02524158|469071278|FG000|12-weeks Assessment|Lost to Follow-up|18|||
130302723|NCT02524158|469071279|FG001|12-weeks Assessment|Lost to Follow-up|12|||
130302724|NCT02524158|469071278|FG000|6-month Assessment|Withdrawal by Subject|1|||
130302725|NCT02524158|469071279|FG001|6-month Assessment|Withdrawal by Subject|1|||
130302726|NCT02524158|469071278|FG000|6-month Assessment|Lost to Follow-up|21|||
130302727|NCT02524158|469071279|FG001|6-month Assessment|Lost to Follow-up|20|||
130302728|NCT03671304|469071280|FG000|Overall Study|study terminated|7|||
130302729|NCT02718716|469071281|FG000|Overall Study|Lack of Efficacy|1|||
130302730|NCT02718716|469071282|FG001|Overall Study|Lack of Efficacy|0|||
130302731|NCT02718716|469071283|FG002|Overall Study|Lack of Efficacy|0|||
130302732|NCT02718716|469071284|FG003|Overall Study|Lack of Efficacy|0|||
130302733|NCT02718716|469071285|FG004|Overall Study|Lack of Efficacy|0|||
130302734|NCT04869358|469071289|FG000|Overall Study|Wish to have children.|1|||
130302735|NCT04869358|469071290|FG001|Overall Study|Wish to have children.|0|||
130302736|NCT04869358|469071291|FG002|Overall Study|Wish to have children.|0|||
130302737|NCT04869358|469071292|FG003|Overall Study|Wish to have children.|0|||
130302738|NCT04164732|469071293|FG000|Treatment run-in Period|Adverse Event|4|||
130302739|NCT04164732|469071294|FG001|Treatment run-in Period|Adverse Event|0|||
130302740|NCT04164732|469071295|FG002|Treatment run-in Period|Adverse Event|0|||
130302741|NCT04164732|469071293|FG000|Treatment run-in Period|Physician Decision|1|||
130302742|NCT04164732|469071294|FG001|Treatment run-in Period|Physician Decision|0|||
130302743|NCT04164732|469071295|FG002|Treatment run-in Period|Physician Decision|0|||
130302744|NCT04164732|469071293|FG000|Treatment run-in Period|Screen Failure|1|||
130302745|NCT04164732|469071294|FG001|Treatment run-in Period|Screen Failure|0|||
130302746|NCT04164732|469071295|FG002|Treatment run-in Period|Screen Failure|0|||
130302747|NCT04164732|469071293|FG000|Randomized Treatment Period|Adverse Event|0|||
130302748|NCT04164732|469071294|FG001|Randomized Treatment Period|Adverse Event|1|||
130302749|NCT04164732|469071295|FG002|Randomized Treatment Period|Adverse Event|0|||
130302750|NCT04164732|469071293|FG000|Randomized Treatment Period|Protocol Deviation|0|||
130302751|NCT04164732|469071294|FG001|Randomized Treatment Period|Protocol Deviation|1|||
130302752|NCT04164732|469071295|FG002|Randomized Treatment Period|Protocol Deviation|1|||
130302753|NCT04164732|469071293|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
130461908|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
130716463|NCT02335983|470588854|FG001|Overall Study|Withdrawal by Subject|2|||
130716464|NCT02335983|470588855|FG002|Overall Study|Withdrawal by Subject|2|||
130716465|NCT02335983|470588856|FG003|Overall Study|Withdrawal by Subject|1|||
130302754|NCT04164732|469071294|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
130302755|NCT04164732|469071295|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
130302756|NCT04302545|469071296|FG000|Overall Study|Lost to Follow-up|3|||
130302757|NCT04302545|469071297|FG001|Overall Study|Lost to Follow-up|4|||
130302758|NCT02690714|469071301|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
130302759|NCT02690714|469071301|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
130302760|NCT02202538|469071302|FG000|Overall Study|Withdrawal by Subject|5|||
130302761|NCT02202538|469071302|FG000|Overall Study|Did not meet all inclusion criteria|2|||
130302762|NCT02202538|469071302|FG000|Overall Study|Investigator Decision|1|||
130302763|NCT01457846|469071303|FG000|Overall Study|Death before treatment|1|||
130557421|NCT04399122|470009991|FG000|Overall Study|Lost to Follow-up|2|||
130716466|NCT02335983|470588857|FG004|Overall Study|Withdrawal by Subject|3|||
130716467|NCT02335983|470588858|FG005|Overall Study|Withdrawal by Subject|9|||
130716468|NCT02335983|470588853|FG000|Overall Study|Death|0|||
130716469|NCT02335983|470588854|FG001|Overall Study|Death|0|||
130716470|NCT02335983|470588855|FG002|Overall Study|Death|2|||
130716471|NCT02335983|470588856|FG003|Overall Study|Death|0|||
130716472|NCT02335983|470588857|FG004|Overall Study|Death|0|||
130716473|NCT02335983|470588858|FG005|Overall Study|Death|0|||
130716474|NCT02335983|470588853|FG000|Overall Study|Lost to Follow-up|0|||
130716475|NCT02335983|470588854|FG001|Overall Study|Lost to Follow-up|0|||
130716476|NCT02335983|470588855|FG002|Overall Study|Lost to Follow-up|0|||
130716477|NCT02335983|470588856|FG003|Overall Study|Lost to Follow-up|0|||
130716478|NCT02335983|470588857|FG004|Overall Study|Lost to Follow-up|0|||
130716479|NCT02335983|470588858|FG005|Overall Study|Lost to Follow-up|1|||
130716480|NCT02335983|470588853|FG000|Overall Study|Protocol Specified Criteria|5|||
130716481|NCT02335983|470588854|FG001|Overall Study|Protocol Specified Criteria|7|||
130716482|NCT02335983|470588855|FG002|Overall Study|Protocol Specified Criteria|27|||
130716483|NCT02335983|470588856|FG003|Overall Study|Protocol Specified Criteria|7|||
130716484|NCT02335983|470588857|FG004|Overall Study|Protocol Specified Criteria|5|||
130716485|NCT02335983|470588858|FG005|Overall Study|Protocol Specified Criteria|21|||
130716486|NCT00987389|470588859|FG000|Overall Study|Ineligible|0|||
130716487|NCT00987389|470588860|FG001|Overall Study|Ineligible|3|||
130716488|NCT00987389|470588861|FG002|Overall Study|Ineligible|0|||
130716489|NCT00987389|470588862|FG003|Overall Study|Ineligible|0|||
130716490|NCT00987389|470588859|FG000|Overall Study|Lost to Follow-up|4|||
130716491|NCT00987389|470588860|FG001|Overall Study|Lost to Follow-up|1|||
130716492|NCT00987389|470588861|FG002|Overall Study|Lost to Follow-up|3|||
130716493|NCT00987389|470588862|FG003|Overall Study|Lost to Follow-up|1|||
130716494|NCT00987389|470588859|FG000|Overall Study|Withdrawal by Subject|4|||
130716495|NCT00987389|470588860|FG001|Overall Study|Withdrawal by Subject|3|||
130716496|NCT00987389|470588861|FG002|Overall Study|Withdrawal by Subject|2|||
130716497|NCT00987389|470588862|FG003|Overall Study|Withdrawal by Subject|1|||
130716498|NCT00987389|470588859|FG000|Overall Study|Withdrawn from Treatment|0|||
130716499|NCT00987389|470588860|FG001|Overall Study|Withdrawn from Treatment|1|||
130716500|NCT00987389|470588861|FG002|Overall Study|Withdrawn from Treatment|0|||
130716501|NCT00987389|470588862|FG003|Overall Study|Withdrawn from Treatment|0|||
130716502|NCT00987389|470588859|FG000|Overall Study|Multiple different reasons|1|||
130716503|NCT00987389|470588860|FG001|Overall Study|Multiple different reasons|0|||
130716504|NCT00987389|470588861|FG002|Overall Study|Multiple different reasons|3|||
130716505|NCT00987389|470588862|FG003|Overall Study|Multiple different reasons|1|||
130716506|NCT00326963|470588863|FG000|Overall Study|Adverse Event|2|||
130716507|NCT00326963|470588863|FG000|Overall Study|Injection site reaction|1|||
130716508|NCT00326963|470588863|FG000|Overall Study|Death|1|||
130716509|NCT00326963|470588863|FG000|Overall Study|Failure to return|10|||
130716510|NCT00326963|470588863|FG000|Overall Study|Withdrawal by Subject|10|||
130716511|NCT00326963|470588863|FG000|Overall Study|Refused treatment / did not cooperate|5|||
130716512|NCT00326963|470588863|FG000|Overall Study|Violation of selection criteria at entry|2|||
130716513|NCT00326963|470588863|FG000|Overall Study|Other protocol violation|1|||
130716514|NCT00326963|470588863|FG000|Overall Study|Administrative / other|1|||
130716515|NCT02524730|470588864|FG000|Overall Study|Lost to Follow-up|5|||
130716516|NCT02524730|470588864|FG000|Overall Study|Withdrawal by Subject|18|||
130716517|NCT02524730|470588864|FG000|Overall Study|Death|10|||
130716518|NCT02524730|470588864|FG000|Overall Study|Adverse Event|8|||
130716519|NCT02524730|470588864|FG000|Overall Study|Protocol Violation|1|||
130302764|NCT01457846|469071304|FG001|Overall Study|Death before treatment|2|||
130302765|NCT01457846|469071303|FG000|Overall Study|Did not receive treatment|0|||
130302766|NCT01457846|469071304|FG001|Overall Study|Did not receive treatment|1|||
130302767|NCT01457846|469071303|FG000|Overall Study|Death|27|||
130302768|NCT01457846|469071304|FG001|Overall Study|Death|16|||
130302769|NCT01457846|469071303|FG000|Overall Study|Unclassified reason for not completed|11|||
130302770|NCT01457846|469071304|FG001|Overall Study|Unclassified reason for not completed|10|||
130557422|NCT04399122|470009992|FG001|Overall Study|Lost to Follow-up|0|||
130716520|NCT02524730|470588864|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
130716521|NCT00507130|470588865|FG000|Overall Study|Lost to Follow-up|0|||
130716522|NCT00507130|470588866|FG001|Overall Study|Lost to Follow-up|0|||
130716523|NCT00507130|470588867|FG002|Overall Study|Lost to Follow-up|1|||
130716524|NCT00507130|470588868|FG003|Overall Study|Lost to Follow-up|1|||
130716525|NCT00507130|470588865|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
130716526|NCT00507130|470588866|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716527|NCT00507130|470588867|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716528|NCT00507130|470588868|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716529|NCT00080938|470588873|FG000|Overall Study|Adverse Event|3|||
130716530|NCT00080938|470588873|FG000|Overall Study|Withdrawal by Subject|6|||
130302771|NCT01457846|469071303|FG000|Overall Study|Withdrawal by Subject|1|||
130716531|NCT00080938|470588873|FG000|Overall Study|Death|2|||
130461909|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
130461910|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
130461911|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
130461912|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
130461913|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
130461914|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
130461915|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
130461916|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
130461917|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
130461918|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
130461919|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
130461920|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
130461921|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
130461922|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
130461923|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
130461924|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
130461925|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
130461926|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
130461927|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
130461928|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
130461929|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
130461930|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
130461931|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
130461932|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
130461933|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
130461934|NCT02709655|469656268|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
130461935|NCT02709655|469656269|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
130461936|NCT02709655|469656270|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
130461937|NCT02709655|469656271|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
130461938|NCT02709655|469656272|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
130461939|NCT01179334|469656273|FG000|Treatment Period|Adverse Event|1|||
130461940|NCT01179334|469656274|FG001|Treatment Period|Adverse Event|0|||
130461941|NCT01179334|469656273|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
130461942|NCT01179334|469656274|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
130461943|NCT01179334|469656273|FG000|Long-term Extension (LTE) Period|Death|3|||
130461944|NCT01179334|469656274|FG001|Long-term Extension (LTE) Period|Death|0|||
130461945|NCT01179334|469656273|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
130461946|NCT01179334|469656274|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
130461947|NCT00919763|469656275|FG000|Overall Study|Adverse Event|7|||
130461948|NCT00919763|469656276|FG001|Overall Study|Adverse Event|1|||
130461949|NCT00919763|469656275|FG000|Overall Study|Lost to Follow-up|1|||
130461950|NCT00919763|469656276|FG001|Overall Study|Lost to Follow-up|0|||
130461951|NCT00919763|469656275|FG000|Overall Study|Protocol Violation|1|||
130461952|NCT00919763|469656276|FG001|Overall Study|Protocol Violation|1|||
130461953|NCT00919763|469656275|FG000|Overall Study|Withdrawal by Subject|3|||
130461954|NCT00919763|469656276|FG001|Overall Study|Withdrawal by Subject|1|||
130461955|NCT00919763|469656275|FG000|Overall Study|Non-compliance|0|||
130461956|NCT00919763|469656276|FG001|Overall Study|Non-compliance|1|||
130461957|NCT00547118|469656277|FG000|Overall Study|Did not qualify prior to starting drug|1|||
130461958|NCT00547118|469656278|FG001|Overall Study|Did not qualify prior to starting drug|1|||
130461959|NCT00547118|469656277|FG000|Overall Study|Study suspended|7|||
130461960|NCT00547118|469656278|FG001|Overall Study|Study suspended|8|||
130461961|NCT02248480|469656279|FG000|Overall Study|Lack of Efficacy|4|||
130461962|NCT02248480|469656280|FG001|Overall Study|Lack of Efficacy|6|||
130461963|NCT02248480|469656279|FG000|Overall Study|Adverse Event|11|||
130461964|NCT02248480|469656280|FG001|Overall Study|Adverse Event|2|||
130461965|NCT02248480|469656279|FG000|Overall Study|Withdrawal by Subject|2|||
130461966|NCT02248480|469656280|FG001|Overall Study|Withdrawal by Subject|4|||
130461967|NCT02248480|469656279|FG000|Overall Study|Entry Criteria Not Met|0|||
130461968|NCT02248480|469656280|FG001|Overall Study|Entry Criteria Not Met|1|||
130461969|NCT02248480|469656279|FG000|Overall Study|Other:Physician Decision|0|||
130461970|NCT02248480|469656280|FG001|Overall Study|Other:Physician Decision|1|||
130461971|NCT01595321|469656281|FG000|Overall Study|Adverse Event|1|||
130461972|NCT01595321|469656282|FG001|Overall Study|Adverse Event|1|||
130461973|NCT01595321|469656283|FG002|Overall Study|Adverse Event|1|||
130461974|NCT01595321|469656281|FG000|Overall Study|Lack of Efficacy|0|||
130461975|NCT01595321|469656282|FG001|Overall Study|Lack of Efficacy|0|||
130461976|NCT01595321|469656283|FG002|Overall Study|Lack of Efficacy|4|||
130461977|NCT04504916|469656284|FG000|Overall Study|Study terminated|7|||
130461978|NCT04504916|469656285|FG001|Overall Study|Study terminated|8|||
130461979|NCT04504916|469656284|FG000|Overall Study|Death|54|||
130461980|NCT04504916|469656285|FG001|Overall Study|Death|18|||
130461981|NCT04504916|469656284|FG000|Overall Study|Lost to Follow-up|1|||
130461982|NCT04504916|469656285|FG001|Overall Study|Lost to Follow-up|1|||
130461983|NCT04504916|469656284|FG000|Overall Study|Withdrawal by Subject|8|||
130461984|NCT04504916|469656285|FG001|Overall Study|Withdrawal by Subject|4|||
130461985|NCT04504916|469656284|FG000|Overall Study|Did not agree to follow-up|0|||
130461986|NCT04504916|469656285|FG001|Overall Study|Did not agree to follow-up|1|||
130461987|NCT00834834|469656287|FG000|Overall Study|Withdrawal by Subject|4|||
130461988|NCT00834834|469656288|FG001|Overall Study|Withdrawal by Subject|3|||
130461989|NCT00539292|469656289|FG000|Overall Study|Physician Decision|1|||
130461990|NCT00539292|469656290|FG001|Overall Study|Physician Decision|0|||
130461991|NCT00997386|469656292|FG000|Overall Study|Death|7|||
130302772|NCT01457846|469071304|FG001|Overall Study|Withdrawal by Subject|1|||
130302773|NCT01457846|469071303|FG000|Overall Study|Lost to Follow-up|1|||
130302774|NCT01457846|469071304|FG001|Overall Study|Lost to Follow-up|0|||
130302775|NCT02161757|469071305|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
130302776|NCT02161757|469071306|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
130302777|NCT02161757|469071307|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
130302778|NCT02161757|469071305|FG000|Treatment Through Study Completion|Adverse Event|1|||
130302779|NCT02161757|469071306|FG001|Treatment Through Study Completion|Adverse Event|1|||
130302780|NCT02161757|469071307|FG002|Treatment Through Study Completion|Adverse Event|0|||
130302781|NCT02161757|469071305|FG000|Treatment Through Study Completion|Protocol Violation|0|||
130302782|NCT02161757|469071306|FG001|Treatment Through Study Completion|Protocol Violation|1|||
130302783|NCT02161757|469071307|FG002|Treatment Through Study Completion|Protocol Violation|2|||
130302784|NCT02161757|469071305|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
130302785|NCT02161757|469071306|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
130302786|NCT02161757|469071307|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
130302787|NCT02161757|469071305|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
130302788|NCT02161757|469071306|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
130302789|NCT02161757|469071307|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
130302790|NCT02161757|469071305|FG000|Treatment Through Study Completion|Other|20|||
130302791|NCT02161757|469071306|FG001|Treatment Through Study Completion|Other|19|||
130302792|NCT02161757|469071307|FG002|Treatment Through Study Completion|Other|12|||
130302793|NCT02161757|469071305|FG000|Treatment Through Study Completion|Death|2|||
130302794|NCT02161757|469071306|FG001|Treatment Through Study Completion|Death|1|||
130302795|NCT02161757|469071307|FG002|Treatment Through Study Completion|Death|1|||
130302796|NCT00465647|469071310|FG000|Overall Study|Administrative|2|||
130302797|NCT00465647|469071311|FG001|Overall Study|Administrative|2|||
130302798|NCT00465647|469071312|FG002|Overall Study|Administrative|3|||
130302799|NCT00465647|469071313|FG003|Overall Study|Administrative|2|||
130302800|NCT00465647|469071310|FG000|Overall Study|Adverse Event|2|||
130302801|NCT00465647|469071311|FG001|Overall Study|Adverse Event|0|||
130302802|NCT00465647|469071312|FG002|Overall Study|Adverse Event|3|||
130302803|NCT00465647|469071313|FG003|Overall Study|Adverse Event|2|||
130302804|NCT00465647|469071310|FG000|Overall Study|Withdrawal by Subject|1|||
130302805|NCT00465647|469071311|FG001|Overall Study|Withdrawal by Subject|2|||
130302806|NCT00465647|469071312|FG002|Overall Study|Withdrawal by Subject|2|||
130302807|NCT00465647|469071313|FG003|Overall Study|Withdrawal by Subject|7|||
130302808|NCT00465647|469071310|FG000|Overall Study|"The other reasons included loss of IV"|8|||
130302809|NCT00465647|469071311|FG001|Overall Study|"The other reasons included loss of IV"|4|||
130302810|NCT00465647|469071312|FG002|Overall Study|"The other reasons included loss of IV"|3|||
130302811|NCT00465647|469071313|FG003|Overall Study|"The other reasons included loss of IV"|2|||
130302812|NCT01240135|469071316|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130302813|NCT01240135|469071317|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130302814|NCT01240135|469071316|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
130302815|NCT01240135|469071317|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
130302816|NCT01371305|469071318|FG000|Overall Study|Adverse Event|0|||
130302817|NCT01371305|469071319|FG001|Overall Study|Adverse Event|0|||
130302818|NCT01371305|469071320|FG002|Overall Study|Adverse Event|0|||
130302819|NCT01371305|469071321|FG003|Overall Study|Adverse Event|2|||
130302820|NCT01371305|469071322|FG004|Overall Study|Adverse Event|1|||
130302821|NCT01371305|469071323|FG005|Overall Study|Adverse Event|0|||
130461992|NCT01579916|469656293|FG000|Overall Study|Lost to Follow-up|6|||
130557423|NCT04399122|470009991|FG000|Overall Study|Withdrawal by Subject|1|||
130557424|NCT04399122|470009992|FG001|Overall Study|Withdrawal by Subject|0|||
130557425|NCT02536755|470009995|FG000|Overall Study|Adverse Event|4|||
130302822|NCT01371305|469071318|FG000|Overall Study|Study terminated by sponsor|0|||
130302823|NCT01371305|469071319|FG001|Overall Study|Study terminated by sponsor|0|||
130302824|NCT01371305|469071320|FG002|Overall Study|Study terminated by sponsor|0|||
130302825|NCT01371305|469071321|FG003|Overall Study|Study terminated by sponsor|0|||
130302826|NCT01371305|469071322|FG004|Overall Study|Study terminated by sponsor|3|||
130461993|NCT01579916|469656294|FG001|Overall Study|Lost to Follow-up|1|||
130461994|NCT01579916|469656293|FG000|Overall Study|Withdrawal by Subject|1|||
130461995|NCT01579916|469656294|FG001|Overall Study|Withdrawal by Subject|1|||
130461996|NCT01579916|469656293|FG000|Overall Study|Death|1|||
130461997|NCT01579916|469656294|FG001|Overall Study|Death|0|||
130461998|NCT02994654|469656296|FG000|Overall Study|Lost to Follow-up|1|||
130461999|NCT02299336|469656301|FG000|Overall Study|Withdrawal by Subject|11|||
130462000|NCT02299336|469656301|FG000|Overall Study|Adverse Event|1|||
130462001|NCT02299336|469656301|FG000|Overall Study|Death|1|||
130462002|NCT02299336|469656301|FG000|Overall Study|Lost to Follow-up|1|||
130462003|NCT02106442|469656303|FG000|Overall Study|Case Report Forms Uncollected|7|||
130462004|NCT02106442|469656303|FG000|Overall Study|Protocol Deviation|30|||
130462005|NCT00573833|469656304|FG000|Overall Study|Not Treated|2|||
130462006|NCT05328297|469657426|FG000|Overall Study|Adverse Event|5|||
130462007|NCT05328297|469657427|FG001|Overall Study|Adverse Event|7|||
130462008|NCT05328297|469657426|FG000|Overall Study|Withdrawal by Subject|4|||
130462009|NCT05328297|469657427|FG001|Overall Study|Withdrawal by Subject|3|||
130462010|NCT05328297|469657426|FG000|Overall Study|Lack of Efficacy|1|||
130462011|NCT05328297|469657427|FG001|Overall Study|Lack of Efficacy|0|||
130462012|NCT05328297|469657426|FG000|Overall Study|Lost to Follow-up|1|||
130302827|NCT01371305|469071323|FG005|Overall Study|Study terminated by sponsor|1|||
130302828|NCT01371305|469071318|FG000|Overall Study|Subject request|0|||
130302829|NCT01371305|469071319|FG001|Overall Study|Subject request|0|||
130302830|NCT01371305|469071320|FG002|Overall Study|Subject request|0|||
130302831|NCT01371305|469071321|FG003|Overall Study|Subject request|0|||
130302832|NCT01371305|469071322|FG004|Overall Study|Subject request|0|||
130302833|NCT01371305|469071323|FG005|Overall Study|Subject request|1|||
130302834|NCT02828020|469071326|FG000|Treatment Period|Adverse Event|3|||
130302835|NCT02828020|469071327|FG001|Treatment Period|Adverse Event|1|||
130302836|NCT02828020|469071328|FG002|Treatment Period|Adverse Event|1|||
130302837|NCT02828020|469071326|FG000|Treatment Period|Withdrawal of Consent|10|||
130302838|NCT02828020|469071327|FG001|Treatment Period|Withdrawal of Consent|14|||
130302839|NCT02828020|469071328|FG002|Treatment Period|Withdrawal of Consent|9|||
130302840|NCT02828020|469071326|FG000|Treatment Period|Lost to Follow-up|21|||
130302841|NCT02828020|469071327|FG001|Treatment Period|Lost to Follow-up|24|||
130302842|NCT02828020|469071328|FG002|Treatment Period|Lost to Follow-up|18|||
130302843|NCT02828020|469071326|FG000|Treatment Period|Lack of Qualifying Event|44|||
130302844|NCT02828020|469071327|FG001|Treatment Period|Lack of Qualifying Event|53|||
130302845|NCT02828020|469071328|FG002|Treatment Period|Lack of Qualifying Event|43|||
130302846|NCT02828020|469071326|FG000|Treatment Period|Pregnancy|0|||
130302847|NCT02828020|469071327|FG001|Treatment Period|Pregnancy|2|||
130302848|NCT02828020|469071328|FG002|Treatment Period|Pregnancy|0|||
130302849|NCT02828020|469071326|FG000|Treatment Period|Protocol Violation|2|||
130302850|NCT02828020|469071327|FG001|Treatment Period|Protocol Violation|4|||
130302851|NCT02828020|469071328|FG002|Treatment Period|Protocol Violation|7|||
130462013|NCT05328297|469657427|FG001|Overall Study|Lost to Follow-up|0|||
130462014|NCT05328297|469657426|FG000|Overall Study|Protocol Violation|1|||
130462015|NCT05328297|469657427|FG001|Overall Study|Protocol Violation|0|||
130302852|NCT02828020|469071326|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130302853|NCT02828020|469071327|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
130462016|NCT05328297|469657426|FG000|Overall Study|Randomized but not treated|1|||
130462017|NCT05328297|469657427|FG001|Overall Study|Randomized but not treated|1|||
130462018|NCT03544515|469657437|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
130462019|NCT03544515|469657438|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
130462020|NCT03544515|469657437|FG000|Overall Study|Lost to Follow-up|2|||
130462021|NCT03544515|469657438|FG001|Overall Study|Lost to Follow-up|0|||
130462022|NCT00178399|469657442|FG000|Overall Study|Physician Decision|4|||
130462023|NCT00178399|469657442|FG000|Overall Study|Withdrawal by Subject|8|||
130462024|NCT00178399|469657442|FG000|Overall Study|Lost to Follow-up|1|||
130462025|NCT02544152|469657443|FG000|Overall Study|Adverse Event|0|||
130462026|NCT02544152|469657444|FG001|Overall Study|Adverse Event|4|||
130462027|NCT02544152|469657443|FG000|Overall Study|Withdrawal by Subject|0|||
130462028|NCT02544152|469657444|FG001|Overall Study|Withdrawal by Subject|3|||
130302854|NCT02828020|469071328|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130302855|NCT02828020|469071326|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
130462029|NCT02544152|469657443|FG000|Overall Study|Other|1|||
130462030|NCT02544152|469657444|FG001|Overall Study|Other|0|||
130462031|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
130462032|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
130462033|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
130302856|NCT02828020|469071327|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
130462034|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
130462035|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
130462036|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
130462037|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
130462038|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
130462039|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
130302857|NCT02828020|469071328|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
130302858|NCT02828020|469071326|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
130302859|NCT02828020|469071327|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
130557426|NCT01174238|470009996|FG000|Overall Study|Lost to Follow-up|2|||
130557427|NCT02301936|470009997|FG000|Overall Study|Lost to Follow-up|1|||
130716532|NCT00080938|470588873|FG000|Overall Study|Lack of Efficacy|7|||
130716533|NCT00080938|470588873|FG000|Overall Study|other disease|1|||
130716534|NCT00080938|470588873|FG000|Overall Study|Not started protocol therapy|1|||
130716535|NCT00080938|470588873|FG000|Overall Study|Ineligible|4|||
130716536|NCT00977379|470588874|FG000|Overall Study|Withdrawal by Subject|1|||
130716537|NCT00977379|470588875|FG001|Overall Study|Withdrawal by Subject|1|||
130716538|NCT00977379|470588874|FG000|Overall Study|Death|7|||
130716539|NCT00977379|470588875|FG001|Overall Study|Death|9|||
130716540|NCT00977379|470588874|FG000|Overall Study|Premature Study Termination|4|||
130716541|NCT00977379|470588875|FG001|Overall Study|Premature Study Termination|0|||
130716542|NCT00977379|470588874|FG000|Overall Study|Participant Moving House|0|||
130716543|NCT00977379|470588875|FG001|Overall Study|Participant Moving House|1|||
130716544|NCT00977379|470588874|FG000|Overall Study|Randomization Error|0|||
130716545|NCT00977379|470588875|FG001|Overall Study|Randomization Error|1|||
130716546|NCT02992418|470588883|FG000|Overall Study|Withdrawal by Subject|11|||
130716547|NCT02992418|470588884|FG001|Overall Study|Withdrawal by Subject|12|||
130716548|NCT02992418|470588883|FG000|Overall Study|Non-compliance with the protocol|308|||
130716549|NCT02992418|470588884|FG001|Overall Study|Non-compliance with the protocol|308|||
130716550|NCT02992418|470588883|FG000|Overall Study|Lost to Follow-up|27|||
130716551|NCT02992418|470588884|FG001|Overall Study|Lost to Follow-up|22|||
130302860|NCT02828020|469071328|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
130302861|NCT02828020|469071326|FG000|Safety Follow-up Period|Protocol Violation|0|||
130302862|NCT02828020|469071327|FG001|Safety Follow-up Period|Protocol Violation|2|||
130302863|NCT02828020|469071328|FG002|Safety Follow-up Period|Protocol Violation|1|||
130302864|NCT02828020|469071326|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
130302865|NCT02828020|469071327|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130302866|NCT02828020|469071328|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130302867|NCT01339897|469071329|FG000|Overall Study|Adverse Event|1|||
130302868|NCT01339897|469071330|FG001|Overall Study|Adverse Event|0|||
130302869|NCT01339897|469071331|FG002|Overall Study|Adverse Event|0|||
130302870|NCT01339897|469071332|FG003|Overall Study|Adverse Event|1|||
130302871|NCT01138501|469071333|FG000|Overall Study|Protocol Violation|2|||
130302872|NCT01138501|469071333|FG000|Overall Study|Withdrawal by Subject|3|||
130302873|NCT00847197|469071337|FG000|Overall Study|Adverse Event|21|||
130302874|NCT00847197|469071338|FG001|Overall Study|Adverse Event|3|||
130302875|NCT00847197|469071337|FG000|Overall Study|Protocol Violation|0|||
130302876|NCT00847197|469071338|FG001|Overall Study|Protocol Violation|1|||
130302877|NCT00847197|469071337|FG000|Overall Study|Withdrawal by Subject|3|||
130302878|NCT00847197|469071338|FG001|Overall Study|Withdrawal by Subject|1|||
130302879|NCT01743040|469071339|FG000|Overall Study|Death|1|||
130302880|NCT01743040|469071339|FG000|Overall Study|Lost to Follow-up|66|||
130302881|NCT01743040|469071339|FG000|Overall Study|Physician Decision|40|||
130302882|NCT01743040|469071339|FG000|Overall Study|Protocol Violation|1|||
130302883|NCT01743040|469071339|FG000|Overall Study|Withdrawal by Subject|121|||
130302884|NCT01894243|469071340|FG000|Overall Study|Adverse Event|0|||
130302885|NCT01894243|469071341|FG001|Overall Study|Adverse Event|1|||
130373224|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Death|0|||
130302886|NCT01894243|469071342|FG002|Overall Study|Adverse Event|2|||
130302887|NCT01894243|469071340|FG000|Overall Study|Death|0|||
130302888|NCT01894243|469071341|FG001|Overall Study|Death|0|||
130302889|NCT01894243|469071342|FG002|Overall Study|Death|3|||
130373225|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Death|2|||
130373226|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Death|1|||
130373227|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
130373228|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
130373229|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
130373230|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
130373231|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
130302890|NCT01894243|469071340|FG000|Overall Study|Lack of Efficacy|3|||
130302891|NCT01894243|469071341|FG001|Overall Study|Lack of Efficacy|3|||
130302892|NCT01894243|469071342|FG002|Overall Study|Lack of Efficacy|1|||
130373232|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
130373233|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
130557428|NCT02301936|470009998|FG001|Overall Study|Lost to Follow-up|0|||
130716552|NCT03246126|470588889|FG000|Overall Study|Withdrawal by Subject|0|||
130716553|NCT03246126|470588890|FG001|Overall Study|Withdrawal by Subject|1|||
130716554|NCT05297578|470588900|FG000|Overall Study|Lost to Follow-up|1|||
130716555|NCT05297578|470588901|FG001|Overall Study|Lost to Follow-up|1|||
130716556|NCT05297578|470588902|FG002|Overall Study|Lost to Follow-up|2|||
130716557|NCT05297578|470588903|FG003|Overall Study|Lost to Follow-up|1|||
130716558|NCT05297578|470588900|FG000|Overall Study|Death|0|||
130302893|NCT01894243|469071340|FG000|Overall Study|Condition under investigation worsened|8|||
130302894|NCT01894243|469071341|FG001|Overall Study|Condition under investigation worsened|6|||
130302895|NCT01894243|469071342|FG002|Overall Study|Condition under investigation worsened|2|||
130302896|NCT01894243|469071340|FG000|Overall Study|Subject decision|1|||
130302897|NCT01894243|469071341|FG001|Overall Study|Subject decision|0|||
130302898|NCT01894243|469071342|FG002|Overall Study|Subject decision|0|||
130302899|NCT01894243|469071340|FG000|Overall Study|Other|1|||
130302900|NCT01894243|469071341|FG001|Overall Study|Other|0|||
130302901|NCT01894243|469071342|FG002|Overall Study|Other|0|||
130302902|NCT00830180|469071346|FG000|Overall Study|Adverse Event|6|||
130302903|NCT00830180|469071346|FG000|Overall Study|Death|11|||
130302904|NCT00830180|469071346|FG000|Overall Study|Insufficient clinical response|1|||
130302905|NCT00830180|469071346|FG000|Overall Study|Withdrawal by Subject|5|||
130302906|NCT00830180|469071346|FG000|Overall Study|Progressive disease|2|||
130302907|NCT00830180|469071346|FG000|Overall Study|Other - Unspecified|1|||
130302908|NCT01832532|469071347|FG000|Overall Study|Withdrawal by Subject|5|||
130302909|NCT01832532|469071348|FG001|Overall Study|Withdrawal by Subject|2|||
130302910|NCT02687581|469071350|FG000|Overall Study|Withdrawal by Subject|1|||
130302911|NCT02687581|469071351|FG001|Overall Study|Withdrawal by Subject|0|||
130302912|NCT02687581|469071352|FG002|Overall Study|Withdrawal by Subject|0|||
130302913|NCT02687581|469071353|FG003|Overall Study|Withdrawal by Subject|1|||
130302914|NCT02687581|469071350|FG000|Overall Study|Lost to Follow-up|2|||
130302915|NCT02687581|469071351|FG001|Overall Study|Lost to Follow-up|2|||
130302916|NCT02687581|469071352|FG002|Overall Study|Lost to Follow-up|0|||
130302917|NCT02687581|469071353|FG003|Overall Study|Lost to Follow-up|0|||
130302918|NCT02687581|469071350|FG000|Overall Study|the device is too small for the patient.|1|||
130302919|NCT02687581|469071351|FG001|Overall Study|the device is too small for the patient.|0|||
130302920|NCT02687581|469071352|FG002|Overall Study|the device is too small for the patient.|0|||
130302921|NCT02687581|469071353|FG003|Overall Study|the device is too small for the patient.|0|||
130302922|NCT01990612|469071356|FG000|Overall Study|Lost to Follow-up|2|||
130302923|NCT01990612|469071357|FG001|Overall Study|Lost to Follow-up|1|||
130302924|NCT01990612|469071356|FG000|Overall Study|Withdrawal by Subject|5|||
130302925|NCT01990612|469071357|FG001|Overall Study|Withdrawal by Subject|2|||
130302926|NCT02974842|469071358|FG000|Overall Study|Withdrawal by Subject|4|||
130302927|NCT02974842|469071358|FG000|Overall Study|Screen failures|4|||
130302928|NCT02467582|469073357|FG000|Allocation|Withdrawal by Subject|1|||
130302929|NCT02467582|469073358|FG001|Allocation|Withdrawal by Subject|0|||
130302930|NCT02467582|469073357|FG000|Follow-up|Death|5|||
130302931|NCT02467582|469073358|FG001|Follow-up|Death|4|||
130302932|NCT02467582|469073357|FG000|Follow-up|Lost to Follow-up|6|||
130302933|NCT02467582|469073358|FG001|Follow-up|Lost to Follow-up|5|||
130302934|NCT02291419|469073359|FG000|Overall Study|Early study termination|1|||
130302935|NCT02291419|469073360|FG001|Overall Study|Early study termination|5|||
130302936|NCT03047031|469073372|FG000|Overall Study|Other than listed|1|||
130302937|NCT03047031|469073373|FG001|Overall Study|Other than listed|0|||
130462040|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
130462041|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
130462042|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
130462043|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
130462044|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
130462045|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
130462046|NCT00516321|469657447|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
130462047|NCT00516321|469657448|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
130462048|NCT00516321|469657449|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
130462049|NCT00516321|469657447|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
130462050|NCT00516321|469657448|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
130462051|NCT00516321|469657449|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
130462052|NCT00516321|469657447|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
130462053|NCT00516321|469657448|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
130462054|NCT00516321|469657449|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
130462055|NCT00516321|469657447|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
130462056|NCT00516321|469657448|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
130462057|NCT00516321|469657449|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
130462058|NCT00516321|469657447|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
130716559|NCT05297578|470588901|FG001|Overall Study|Death|1|||
130302938|NCT03047031|469073374|FG002|Overall Study|Other than listed|0|||
130302939|NCT03047031|469073372|FG000|Overall Study|Lost to Follow-up|4|||
130302940|NCT03047031|469073373|FG001|Overall Study|Lost to Follow-up|0|||
130302941|NCT03047031|469073374|FG002|Overall Study|Lost to Follow-up|0|||
130302942|NCT03047031|469073372|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
130302943|NCT03047031|469073373|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
130302944|NCT03047031|469073374|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
130302945|NCT03047031|469073372|FG000|Overall Study|Adverse Event|1|||
130302946|NCT03047031|469073373|FG001|Overall Study|Adverse Event|0|||
130302947|NCT03047031|469073374|FG002|Overall Study|Adverse Event|0|||
130462059|NCT00516321|469657448|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
130462060|NCT00516321|469657449|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
130462061|NCT00516321|469657447|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
130462062|NCT00516321|469657448|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
130462063|NCT00516321|469657449|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
130462064|NCT02015546|469657451|FG000|Overall Study|Withdrawal by Subject|1|||
130462065|NCT02015546|469657452|FG001|Overall Study|Withdrawal by Subject|1|||
130462066|NCT02015546|469657453|FG002|Overall Study|Withdrawal by Subject|1|||
130462067|NCT02015546|469657451|FG000|Overall Study|Screem Failure|2|||
130462068|NCT02015546|469657452|FG001|Overall Study|Screem Failure|1|||
130462069|NCT02015546|469657453|FG002|Overall Study|Screem Failure|3|||
130462070|NCT01426269|469657456|FG000|Period 1: 12 Weeks|Adverse Event|5|||
130462071|NCT01426269|469657457|FG001|Period 1: 12 Weeks|Adverse Event|0|||
130462072|NCT01426269|469657458|FG002|Period 1: 12 Weeks|Adverse Event|0|||
130462073|NCT01426269|469657456|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
130462074|NCT01426269|469657457|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
130462075|NCT01426269|469657458|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
130462076|NCT01426269|469657456|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
130462077|NCT01426269|469657457|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
130462078|NCT01426269|469657458|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
130462079|NCT01426269|469657456|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
130462080|NCT01426269|469657457|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
130462081|NCT01426269|469657458|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
130462082|NCT01426269|469657456|FG000|Period 1: 12 Weeks|Pregnancy|1|||
130462083|NCT01426269|469657457|FG001|Period 1: 12 Weeks|Pregnancy|0|||
130462084|NCT01426269|469657458|FG002|Period 1: 12 Weeks|Pregnancy|0|||
130462085|NCT01426269|469657456|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
130462086|NCT01426269|469657457|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
130462087|NCT01426269|469657458|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
130716560|NCT05297578|470588902|FG002|Overall Study|Death|0|||
130716561|NCT05297578|470588903|FG003|Overall Study|Death|0|||
130716562|NCT05297578|470588900|FG000|Overall Study|Withdrawal by Subject|0|||
130716563|NCT05297578|470588901|FG001|Overall Study|Withdrawal by Subject|0|||
130716564|NCT05297578|470588902|FG002|Overall Study|Withdrawal by Subject|1|||
130462088|NCT01426269|469657456|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
130716565|NCT05297578|470588903|FG003|Overall Study|Withdrawal by Subject|0|||
130716566|NCT02266134|470588904|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
130716567|NCT02266134|470588905|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
130716568|NCT02266134|470588906|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130716569|NCT02266134|470588907|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130716570|NCT02266134|470588904|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
130716571|NCT02266134|470588905|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
130716572|NCT02266134|470588906|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130716573|NCT02266134|470588907|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130716574|NCT02266134|470588904|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
130716575|NCT02266134|470588905|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
130716576|NCT02266134|470588906|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130716577|NCT02266134|470588907|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130716578|NCT02266134|470588904|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
130716579|NCT02266134|470588905|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130716580|NCT02266134|470588906|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130716581|NCT02266134|470588907|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130302948|NCT03047031|469073372|FG000|Overall Study|Withdrawal by Subject|2|||
130302949|NCT03047031|469073373|FG001|Overall Study|Withdrawal by Subject|0|||
130462089|NCT01426269|469657457|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
130462090|NCT01426269|469657458|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
130462091|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Adverse Event|0|||
130462092|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Adverse Event|1|||
130716582|NCT02266134|470588904|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
130716583|NCT02266134|470588905|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
130716584|NCT02266134|470588906|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130716585|NCT02266134|470588907|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130716586|NCT02266134|470588904|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
130302950|NCT03047031|469073374|FG002|Overall Study|Withdrawal by Subject|0|||
130462093|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Adverse Event|2|||
130462094|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
130716587|NCT02266134|470588905|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130716588|NCT02266134|470588906|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130302951|NCT03047031|469073372|FG000|Overall Study|Change to other medication|2|||
130462095|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
130462096|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
130462097|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
130462098|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
130462099|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
130462100|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
130462101|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
130462102|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
130462103|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Site closed|0|||
130462104|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Site closed|6|||
130462105|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Site closed|5|||
130557429|NCT01102803|470010000|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
130557430|NCT01102803|470010001|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
130557431|NCT01102803|470010000|FG000|Post to Follow-Up|Lost to Follow-up|1|||
130557432|NCT01102803|470010001|FG001|Post to Follow-Up|Lost to Follow-up|3|||
130557433|NCT02684279|470010002|FG000|Overall Study|Adverse Event|87|||
130557434|NCT02684279|470010002|FG000|Overall Study|Lack of Efficacy|4|||
130557435|NCT02684279|470010002|FG000|Overall Study|Lost to Follow-up|61|||
130462106|NCT01426269|469657456|FG000|Period 2: 40 Weeks|Relapsed|0|||
130462107|NCT01426269|469657457|FG001|Period 2: 40 Weeks|Relapsed|9|||
130462108|NCT01426269|469657458|FG002|Period 2: 40 Weeks|Relapsed|18|||
130462109|NCT00545077|469657462|FG000|Overall Study|Treatment not received|5|||
130462110|NCT00545077|469657463|FG001|Overall Study|Treatment not received|1|||
130462111|NCT00545077|469657462|FG000|Overall Study|Disease Progression|131|||
130462112|NCT00545077|469657463|FG001|Overall Study|Disease Progression|98|||
130462113|NCT00545077|469657462|FG000|Overall Study|Withdrawal by Subject|3|||
130462114|NCT00545077|469657463|FG001|Overall Study|Withdrawal by Subject|14|||
130462115|NCT00545077|469657462|FG000|Overall Study|Physician Decision|6|||
130462116|NCT00545077|469657463|FG001|Overall Study|Physician Decision|3|||
130462117|NCT00545077|469657462|FG000|Overall Study|Lost to Follow-up|2|||
130462118|NCT00545077|469657463|FG001|Overall Study|Lost to Follow-up|0|||
130462119|NCT00545077|469657462|FG000|Overall Study|Protocol Violation|1|||
130462120|NCT00545077|469657463|FG001|Overall Study|Protocol Violation|0|||
130462121|NCT00545077|469657462|FG000|Overall Study|Adverse Event|0|||
130462122|NCT00545077|469657463|FG001|Overall Study|Adverse Event|31|||
130462123|NCT00545077|469657462|FG000|Overall Study|Death|0|||
130462124|NCT00545077|469657463|FG001|Overall Study|Death|8|||
130462125|NCT02202499|469657464|FG000|Overall Study|Cancer diagnosis|0|||
130462126|NCT02202499|469657465|FG001|Overall Study|Cancer diagnosis|0|||
130462127|NCT02202499|469657466|FG002|Overall Study|Cancer diagnosis|1|||
130462128|NCT02202499|469657464|FG000|Overall Study|Moved from area|0|||
130462129|NCT02202499|469657465|FG001|Overall Study|Moved from area|0|||
130462130|NCT02202499|469657466|FG002|Overall Study|Moved from area|1|||
130302952|NCT03047031|469073373|FG001|Overall Study|Change to other medication|0|||
130302953|NCT03047031|469073374|FG002|Overall Study|Change to other medication|0|||
130302954|NCT03047031|469073372|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
130302955|NCT03047031|469073373|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
130302956|NCT03047031|469073374|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
130302957|NCT01959139|469073385|FG000|Phase II|Disease progression|0|||
130302958|NCT01959139|469073386|FG001|Phase II|Disease progression|0|||
130302959|NCT01959139|469073387|FG002|Phase II|Disease progression|26|||
130302960|NCT01959139|469073388|FG003|Phase II|Disease progression|34|||
130302961|NCT01959139|469073385|FG000|Phase II|Adverse Event|0|||
130302962|NCT01959139|469073386|FG001|Phase II|Adverse Event|0|||
130302963|NCT01959139|469073387|FG002|Phase II|Adverse Event|10|||
130302964|NCT01959139|469073388|FG003|Phase II|Adverse Event|11|||
130302965|NCT01959139|469073385|FG000|Phase II|Patient Refusal|0|||
130302966|NCT01959139|469073386|FG001|Phase II|Patient Refusal|0|||
130302967|NCT01959139|469073387|FG002|Phase II|Patient Refusal|5|||
130302968|NCT01959139|469073388|FG003|Phase II|Patient Refusal|4|||
130462131|NCT02202499|469657464|FG000|Overall Study|Declined before randomization|1|||
130462132|NCT02202499|469657465|FG001|Overall Study|Declined before randomization|0|||
130462133|NCT02202499|469657466|FG002|Overall Study|Declined before randomization|0|||
130462134|NCT02202499|469657464|FG000|Overall Study|Auto accident|1|||
130462135|NCT02202499|469657465|FG001|Overall Study|Auto accident|0|||
130557436|NCT02684279|470010002|FG000|Overall Study|Protocol Violation|6|||
130557437|NCT02684279|470010002|FG000|Overall Study|Pregnancy|8|||
130557438|NCT02684279|470010002|FG000|Overall Study|Withdrawal by Subject|92|||
130462136|NCT02202499|469657466|FG002|Overall Study|Auto accident|0|||
130302969|NCT01959139|469073385|FG000|Phase II|Death|0|||
130302970|NCT01959139|469073386|FG001|Phase II|Death|0|||
130302971|NCT01959139|469073387|FG002|Phase II|Death|3|||
130302972|NCT01959139|469073388|FG003|Phase II|Death|1|||
130302973|NCT01959139|469073385|FG000|Phase II|Other/Unknown|0|||
130462137|NCT00535145|469657468|FG000|Phase I|Adverse Event|3|||
130462138|NCT00535145|469657468|FG000|Phase I|Lost to Follow-up|7|||
130462139|NCT00535145|469657468|FG000|Phase I|Withdrawal by Subject|6|||
130557439|NCT02684279|470010002|FG000|Overall Study|non-compliance with study drug|9|||
130302974|NCT01959139|469073386|FG001|Phase II|Other/Unknown|0|||
130302975|NCT01959139|469073387|FG002|Phase II|Other/Unknown|8|||
130557440|NCT02684279|470010002|FG000|Overall Study|non compliance with study visits|2|||
130462140|NCT00535145|469657468|FG000|Phase I|(eligibility)|8|||
130462141|NCT00535145|469657468|FG000|Phase I|(protocol violation)|1|||
130462142|NCT00535145|469657468|FG000|Phase I|(PI decision)|1|||
130462143|NCT00535145|469657468|FG000|Phase I|(diagnosis)|3|||
130462144|NCT00535145|469657468|FG000|Phase II|Adverse Event|2|||
130462145|NCT00535145|469657468|FG000|Phase II|Lack of Efficacy|1|||
130462146|NCT00535145|469657468|FG000|Phase II|Lost to Follow-up|5|||
130462147|NCT00535145|469657468|FG000|Phase II|Withdrawal by Subject|5|||
130462148|NCT00535145|469657468|FG000|Phase II|Subject non-compliance|2|||
130462149|NCT03260140|469657469|FG000|Overall Study|Death|4|||
130462150|NCT03260140|469657470|FG001|Overall Study|Death|1|||
130462151|NCT03260140|469657469|FG000|Overall Study|Withdrawal by Subject|1|||
130462152|NCT03260140|469657470|FG001|Overall Study|Withdrawal by Subject|4|||
130462153|NCT00463788|469657471|FG000|Overall Study|Progressive Disease|86|||
130462154|NCT00463788|469657472|FG001|Overall Study|Progressive Disease|42|||
130462155|NCT00463788|469657471|FG000|Overall Study|Adverse Event|6|||
130462156|NCT00463788|469657472|FG001|Overall Study|Adverse Event|2|||
130462157|NCT00463788|469657471|FG000|Overall Study|Withdrawal by Subject|6|||
130462158|NCT00463788|469657472|FG001|Overall Study|Withdrawal by Subject|2|||
130462159|NCT00463788|469657471|FG000|Overall Study|Death|4|||
130462160|NCT00463788|469657472|FG001|Overall Study|Death|3|||
130462161|NCT00463788|469657471|FG000|Overall Study|Symptomatic Deterioration|2|||
130462162|NCT00463788|469657472|FG001|Overall Study|Symptomatic Deterioration|3|||
130462163|NCT00463788|469657471|FG000|Overall Study|Lost to Follow-up|1|||
130462164|NCT00463788|469657472|FG001|Overall Study|Lost to Follow-up|0|||
130462165|NCT00463788|469657471|FG000|Overall Study|Protocol Violation|0|||
130462166|NCT00463788|469657472|FG001|Overall Study|Protocol Violation|1|||
130462167|NCT00463788|469657471|FG000|Overall Study|Other|3|||
130462168|NCT00463788|469657472|FG001|Overall Study|Other|0|||
130462169|NCT00463788|469657471|FG000|Overall Study|Randomized but not treated|1|||
130462170|NCT00463788|469657472|FG001|Overall Study|Randomized but not treated|1|||
130462171|NCT00360698|469657473|FG000|Run-In|Physician Decision|0|||
130462172|NCT00360698|469657474|FG001|Run-In|Physician Decision|1|||
130462173|NCT00360698|469657473|FG000|Run-In|Withdrawal by Subject|0|||
130462174|NCT00360698|469657474|FG001|Run-In|Withdrawal by Subject|2|||
130462175|NCT00360698|469657473|FG000|Run-In|Non compliance with treatment procedure|0|||
130462176|NCT00360698|469657474|FG001|Run-In|Non compliance with treatment procedure|1|||
130462177|NCT00360698|469657473|FG000|Run-In|Sponsor request|0|||
130462178|NCT00360698|469657474|FG001|Run-In|Sponsor request|2|||
130462179|NCT00360698|469657473|FG000|Run-In|Patient did not meet inclusion criteria|0|||
130462180|NCT00360698|469657474|FG001|Run-In|Patient did not meet inclusion criteria|1|||
130462181|NCT00360698|469657473|FG000|Run-In|Patient personal reasons|0|||
130462182|NCT00360698|469657474|FG001|Run-In|Patient personal reasons|2|||
130462183|NCT00360698|469657473|FG000|Run-In|Need of insulin with meals|0|||
130462184|NCT00360698|469657474|FG001|Run-In|Need of insulin with meals|1|||
130462185|NCT00360698|469657473|FG000|Treatment Period|Non compliance with treatment procedure|1|||
130462186|NCT00360698|469657474|FG001|Treatment Period|Non compliance with treatment procedure|0|||
130462187|NCT00360698|469657473|FG000|Treatment Period|Early termination by error|0|||
130302976|NCT01959139|469073388|FG003|Phase II|Other/Unknown|5|||
130302977|NCT01959139|469073385|FG000|Phase II|On treatment|0|||
130302978|NCT01959139|469073386|FG001|Phase II|On treatment|0|||
130302979|NCT01959139|469073387|FG002|Phase II|On treatment|4|||
130302980|NCT01959139|469073388|FG003|Phase II|On treatment|0|||
130302981|NCT00630344|469073391|FG000|Overall Study|Adverse Event|5|||
130302982|NCT00630344|469073391|FG000|Overall Study|Progressive Disease|19|||
130302983|NCT00630344|469073391|FG000|Overall Study|Physician Decision|9|||
130302984|NCT00630344|469073391|FG000|Overall Study|Withdrawal by Subject|1|||
130302985|NCT00630344|469073391|FG000|Overall Study|Intercurrent Illness|1|||
130462188|NCT00360698|469657474|FG001|Treatment Period|Early termination by error|1|||
130462189|NCT00712335|469657479|FG000|Overall Study|Withdrawal by Subject|0|||
130462190|NCT00712335|469657480|FG001|Overall Study|Withdrawal by Subject|7|||
130462191|NCT00712335|469657481|FG002|Overall Study|Withdrawal by Subject|2|||
130462192|NCT00712335|469657482|FG003|Overall Study|Withdrawal by Subject|3|||
130462193|NCT00712335|469657483|FG004|Overall Study|Withdrawal by Subject|0|||
130302986|NCT00630344|469073391|FG000|Overall Study|Other|1|||
130462194|NCT00712335|469657479|FG000|Overall Study|Lost to Follow-up|2|||
130716589|NCT02266134|470588907|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130302987|NCT00930553|469073394|FG000|Overall Study|Adverse Event|1|||
130302988|NCT00930553|469073394|FG000|Overall Study|Lack of Efficacy|7|||
130302989|NCT00930553|469073394|FG000|Overall Study|Physician Decision|39|||
130462195|NCT00712335|469657480|FG001|Overall Study|Lost to Follow-up|5|||
130462196|NCT00712335|469657481|FG002|Overall Study|Lost to Follow-up|0|||
130462197|NCT00712335|469657482|FG003|Overall Study|Lost to Follow-up|1|||
130462198|NCT00712335|469657483|FG004|Overall Study|Lost to Follow-up|0|||
130462199|NCT00712335|469657479|FG000|Overall Study|Protocol Violation|1|||
130462200|NCT00712335|469657480|FG001|Overall Study|Protocol Violation|2|||
130462201|NCT00712335|469657481|FG002|Overall Study|Protocol Violation|1|||
130462202|NCT00712335|469657482|FG003|Overall Study|Protocol Violation|0|||
130462203|NCT00712335|469657483|FG004|Overall Study|Protocol Violation|0|||
130462204|NCT00712335|469657479|FG000|Overall Study|Lack of Efficacy|0|||
130462205|NCT00712335|469657480|FG001|Overall Study|Lack of Efficacy|0|||
130462206|NCT00712335|469657481|FG002|Overall Study|Lack of Efficacy|1|||
130462207|NCT00712335|469657482|FG003|Overall Study|Lack of Efficacy|1|||
130462208|NCT00712335|469657483|FG004|Overall Study|Lack of Efficacy|0|||
130462209|NCT00712335|469657479|FG000|Overall Study|Other Reason|0|||
130462210|NCT00712335|469657480|FG001|Overall Study|Other Reason|3|||
130462211|NCT00712335|469657481|FG002|Overall Study|Other Reason|1|||
130462212|NCT00712335|469657482|FG003|Overall Study|Other Reason|0|||
130462213|NCT00712335|469657483|FG004|Overall Study|Other Reason|0|||
130462214|NCT03194958|469657484|FG000|Overall Study|Death|0|||
130462215|NCT03194958|469657485|FG001|Overall Study|Death|1|||
130462216|NCT03194958|469657486|FG002|Overall Study|Death|1|||
130462217|NCT03194958|469657487|FG003|Overall Study|Death|1|||
130462218|NCT03194958|469657484|FG000|Overall Study|Withdrawal by Subject|24|||
130462219|NCT03194958|469657485|FG001|Overall Study|Withdrawal by Subject|27|||
130462220|NCT03194958|469657486|FG002|Overall Study|Withdrawal by Subject|7|||
130462221|NCT03194958|469657487|FG003|Overall Study|Withdrawal by Subject|22|||
130462222|NCT03194958|469657484|FG000|Overall Study|Lost to Follow-up|168|||
130462223|NCT03194958|469657485|FG001|Overall Study|Lost to Follow-up|196|||
130462224|NCT03194958|469657486|FG002|Overall Study|Lost to Follow-up|174|||
130462225|NCT03194958|469657487|FG003|Overall Study|Lost to Follow-up|186|||
130462226|NCT01202955|469657489|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
130462227|NCT01202955|469657490|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
130462228|NCT01909778|469657491|FG000|Overall Study|failed screening|1|||
130462229|NCT00256243|469657496|FG000|Overall Study|Lost to Follow-up|2|||
130462230|NCT00256243|469657496|FG000|Overall Study|Death|7|||
130462231|NCT00256243|469657496|FG000|Overall Study|Not treated|1|||
130462232|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
130462233|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
130462234|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
130462235|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462236|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462237|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462238|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462239|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462240|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462241|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462242|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462243|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
130462244|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
130462245|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
130462246|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
130462247|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
130462248|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
130462249|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
130462250|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
130462251|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
130462252|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
130462253|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
130462254|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
130462255|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
130462256|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
130462257|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462258|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462259|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130302990|NCT00930553|469073394|FG000|Overall Study|Protocol Violation|1|||
130302991|NCT00930553|469073394|FG000|Overall Study|Pregnancy|1|||
130302992|NCT00930553|469073394|FG000|Overall Study|Withdrawal by Subject|88|||
130462260|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462261|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462262|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462263|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130302993|NCT00930553|469073394|FG000|Overall Study|Lost to Follow-up|25|||
130462264|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462265|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462266|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462267|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130462268|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462269|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462270|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
130302994|NCT00930553|469073394|FG000|Overall Study|Death|9|||
130302995|NCT00930553|469073394|FG000|Overall Study|Study terminated by sponsor|24|||
130302996|NCT00930553|469073394|FG000|Overall Study|Other than specified above|28|||
130302997|NCT01964963|469073395|FG000|Overall Study|Case Report Forms Uncollected|888|||
130302998|NCT01964963|469073395|FG000|Overall Study|Protocol Deviation|50|||
130302999|NCT01964963|469073395|FG000|Overall Study|Data Reliability was not Assured|5|||
130303000|NCT00856544|469073404|FG000|Overall Study|Randomized but not treated|3|||
130303001|NCT00856544|469073405|FG001|Overall Study|Randomized but not treated|0|||
130303002|NCT00856544|469073406|FG002|Overall Study|Randomized but not treated|0|||
130303003|NCT00856544|469073407|FG003|Overall Study|Randomized but not treated|0|||
130303004|NCT00856544|469073404|FG000|Overall Study|Death|0|||
130373234|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
130373235|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
130373236|NCT00256750|469333387|FG000|Post-Transplant Treated (36 Months)|Other|0|||
130373237|NCT00256750|469333388|FG001|Post-Transplant Treated (36 Months)|Other|1|||
130373238|NCT00256750|469333389|FG002|Post-Transplant Treated (36 Months)|Other|1|||
130373239|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
130373240|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
130373241|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
130373242|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
130373243|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
130373244|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
130373245|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
130373246|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
130373247|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
130373248|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
130373249|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
130373250|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
130373251|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
130373252|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
130373253|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
130373254|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
130373255|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
130373256|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
130373257|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
130373258|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
130373259|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
130373260|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
130373261|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
130373262|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
130462271|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462272|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462273|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462274|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462275|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462276|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462277|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462278|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462279|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
130462280|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
130462281|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
130462282|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
130462283|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
130462284|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462285|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462286|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462287|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462288|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462289|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462290|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462291|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130462292|NCT05061693|469657497|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
130462293|NCT05061693|469657498|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
130462294|NCT05061693|469657499|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
130462295|NCT05061693|469657500|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
130462296|NCT05061693|469657501|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462297|NCT05061693|469657502|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462298|NCT05061693|469657503|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130303005|NCT00856544|469073405|FG001|Overall Study|Death|2|||
130303006|NCT00856544|469073406|FG002|Overall Study|Death|0|||
130462299|NCT05061693|469657504|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462300|NCT05061693|469657505|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462301|NCT05061693|469657506|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462302|NCT05061693|469657507|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462303|NCT05061693|469657508|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
130462304|NCT05061693|469657497|FG000|24-week Extension Period|Adverse Event|0|||
130462305|NCT05061693|469657498|FG001|24-week Extension Period|Adverse Event|0|||
130462306|NCT05061693|469657499|FG002|24-week Extension Period|Adverse Event|0|||
130462307|NCT05061693|469657500|FG003|24-week Extension Period|Adverse Event|0|||
130462308|NCT05061693|469657501|FG004|24-week Extension Period|Adverse Event|0|||
130303007|NCT00856544|469073407|FG003|Overall Study|Death|0|||
130303008|NCT00856544|469073404|FG000|Overall Study|Adverse Event|20|||
130303009|NCT00856544|469073405|FG001|Overall Study|Adverse Event|29|||
130303010|NCT00856544|469073406|FG002|Overall Study|Adverse Event|2|||
130303011|NCT00856544|469073407|FG003|Overall Study|Adverse Event|3|||
130303012|NCT00856544|469073404|FG000|Overall Study|Lack of Efficacy|16|||
130303013|NCT00856544|469073405|FG001|Overall Study|Lack of Efficacy|12|||
130303014|NCT00856544|469073406|FG002|Overall Study|Lack of Efficacy|3|||
130303015|NCT00856544|469073407|FG003|Overall Study|Lack of Efficacy|3|||
130303016|NCT00856544|469073404|FG000|Overall Study|Other|9|||
130303017|NCT00856544|469073405|FG001|Overall Study|Other|16|||
130303018|NCT00856544|469073406|FG002|Overall Study|Other|1|||
130303019|NCT00856544|469073407|FG003|Overall Study|Other|6|||
130303020|NCT00856544|469073404|FG000|Overall Study|Lost to Follow-up|1|||
130303021|NCT00856544|469073405|FG001|Overall Study|Lost to Follow-up|2|||
130462309|NCT05061693|469657502|FG005|24-week Extension Period|Adverse Event|0|||
130462310|NCT05061693|469657503|FG006|24-week Extension Period|Adverse Event|0|||
130462311|NCT05061693|469657504|FG007|24-week Extension Period|Adverse Event|2|||
130303022|NCT00856544|469073406|FG002|Overall Study|Lost to Follow-up|2|||
130303023|NCT00856544|469073407|FG003|Overall Study|Lost to Follow-up|0|||
130303024|NCT00856544|469073404|FG000|Overall Study|Withdrawal by Subject|8|||
130303025|NCT00856544|469073405|FG001|Overall Study|Withdrawal by Subject|5|||
130303026|NCT00856544|469073406|FG002|Overall Study|Withdrawal by Subject|0|||
130303027|NCT00856544|469073407|FG003|Overall Study|Withdrawal by Subject|1|||
130303028|NCT00787189|469073408|FG000|Overall Study|Lost to Follow-up|2|||
130303029|NCT00787189|469073409|FG001|Overall Study|Lost to Follow-up|2|||
130303030|NCT00296140|469073410|FG000|Overall Study|Lost to Follow-up|1|||
130303031|NCT00296140|469073411|FG001|Overall Study|Lost to Follow-up|0|||
130303032|NCT00296140|469073410|FG000|Overall Study|Withdrawal by Subject|1|||
130303033|NCT00296140|469073411|FG001|Overall Study|Withdrawal by Subject|0|||
130303034|NCT00296140|469073410|FG000|Overall Study|Discharge to Nursing Home|1|||
130303035|NCT00296140|469073411|FG001|Overall Study|Discharge to Nursing Home|0|||
130303036|NCT01856582|469073412|FG000|Overall Study|Died prior to Boost infusion|1|||
130303037|NCT00596830|469073413|FG000|Overall Study|Death|258|||
130303038|NCT00596830|469073414|FG001|Overall Study|Death|247|||
130303039|NCT00596830|469073413|FG000|Overall Study|Lost to Follow-up|7|||
130303040|NCT00596830|469073414|FG001|Overall Study|Lost to Follow-up|11|||
130303041|NCT00596830|469073413|FG000|Overall Study|Withdrawal by Subject|22|||
130303042|NCT00596830|469073414|FG001|Overall Study|Withdrawal by Subject|12|||
130303043|NCT00596830|469073413|FG000|Overall Study|Study terminated by sponsor|51|||
130303044|NCT00596830|469073414|FG001|Overall Study|Study terminated by sponsor|62|||
130303045|NCT00596830|469073413|FG000|Overall Study|Follow-up was discontinued|1|||
130303046|NCT00596830|469073414|FG001|Overall Study|Follow-up was discontinued|0|||
130303047|NCT00596830|469073413|FG000|Overall Study|Randomized but not treated|3|||
130303048|NCT00596830|469073414|FG001|Overall Study|Randomized but not treated|7|||
130303049|NCT00887926|469073415|FG000|Overall Study|Withdrawal by Subject|0|||
130716590|NCT01437943|470588908|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
130462312|NCT05061693|469657505|FG008|24-week Extension Period|Adverse Event|2|||
130462313|NCT05061693|469657506|FG009|24-week Extension Period|Adverse Event|0|||
130462314|NCT05061693|469657507|FG010|24-week Extension Period|Adverse Event|1|||
130462315|NCT05061693|469657508|FG011|24-week Extension Period|Adverse Event|3|||
130462316|NCT05061693|469657497|FG000|24-week Extension Period|Lack of Efficacy|0|||
130716591|NCT01437943|470588909|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
130462317|NCT05061693|469657498|FG001|24-week Extension Period|Lack of Efficacy|0|||
130462318|NCT05061693|469657499|FG002|24-week Extension Period|Lack of Efficacy|0|||
130303050|NCT00887926|469073416|FG001|Overall Study|Withdrawal by Subject|1|||
130303051|NCT00887926|469073417|FG002|Overall Study|Withdrawal by Subject|0|||
130303052|NCT00887926|469073418|FG003|Overall Study|Withdrawal by Subject|0|||
130303053|NCT00880191|469073419|FG000|Overall Study|Refused further treatment|4|||
130303054|NCT00880191|469073420|FG001|Overall Study|Refused further treatment|1|||
130303055|NCT00880191|469073419|FG000|Overall Study|Adverse Event|8|||
130303056|NCT00880191|469073420|FG001|Overall Study|Adverse Event|6|||
130303057|NCT00880191|469073419|FG000|Overall Study|Hospitalization/efficacy|1|||
130303058|NCT00880191|469073420|FG001|Overall Study|Hospitalization/efficacy|1|||
130716592|NCT01437943|470588908|FG000|Overall Study|Subject expressed pregnancy plans|1|||
130716593|NCT01437943|470588909|FG001|Overall Study|Subject expressed pregnancy plans|0|||
130716594|NCT01437943|470588908|FG000|Overall Study|Adverse Event|2|||
130716595|NCT01437943|470588909|FG001|Overall Study|Adverse Event|0|||
130716596|NCT04740814|470588910|FG000|Overall Study|Adverse Event|3|||
130716597|NCT04740814|470588910|FG000|Overall Study|Protocol Violation|2|||
130716598|NCT04740814|470588910|FG000|Overall Study|Lost to Follow-up|2|||
130716599|NCT04740814|470588910|FG000|Overall Study|Withdrawal by Subject|3|||
130716600|NCT02500641|470588913|FG000|Overall Study|Adverse Event|0|||
130716601|NCT02500641|470588914|FG001|Overall Study|Adverse Event|2|||
130716602|NCT02500641|470588913|FG000|Overall Study|Withdrawal by Subject|4|||
130716603|NCT02500641|470588914|FG001|Overall Study|Withdrawal by Subject|5|||
130716604|NCT02500641|470588913|FG000|Overall Study|Unable to follow study procedures|3|||
130716605|NCT02500641|470588914|FG001|Overall Study|Unable to follow study procedures|2|||
130716606|NCT02500641|470588913|FG000|Overall Study|Protocol Violation|1|||
130716607|NCT02500641|470588914|FG001|Overall Study|Protocol Violation|2|||
130716608|NCT02500641|470588913|FG000|Overall Study|Lost to Follow-up|1|||
130716609|NCT02500641|470588914|FG001|Overall Study|Lost to Follow-up|0|||
130716610|NCT02500641|470588913|FG000|Overall Study|Sponsor decision|1|||
130716611|NCT02500641|470588914|FG001|Overall Study|Sponsor decision|0|||
130716612|NCT02500641|470588913|FG000|Overall Study|Non compliance to study drug|0|||
130716613|NCT02500641|470588914|FG001|Overall Study|Non compliance to study drug|1|||
130716614|NCT02331368|470588919|FG000|Overall Study|Withdrawal by Subject|3|||
130716615|NCT01763684|470588924|FG000|Overall Study|Study terminated early due to low enrollment|126|||
130716616|NCT01763684|470588925|FG001|Overall Study|Study terminated early due to low enrollment|127|||
130716617|NCT01763684|470588924|FG000|Overall Study|Study surgery not performed|7|||
130716618|NCT01763684|470588925|FG001|Overall Study|Study surgery not performed|6|||
130716619|NCT00643565|470588926|FG000|Overall Study|Death|12|||
130716620|NCT00643565|470588927|FG001|Overall Study|Death|11|||
130716621|NCT00643565|470588926|FG000|Overall Study|Withdrawal by Subject|4|||
130303059|NCT02097030|469073421|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
130303060|NCT02097030|469073422|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
130303061|NCT02097030|469073421|FG000|First Intervention (3 Days)|Visual Acuity|0|||
130303062|NCT02097030|469073422|FG001|First Intervention (3 Days)|Visual Acuity|1|||
130303063|NCT01919801|469073423|FG000|Overall Study|Withdrawal by Subject|1|||
130303064|NCT01919801|469073424|FG001|Overall Study|Withdrawal by Subject|0|||
130303065|NCT01919801|469073423|FG000|Overall Study|Physician Decision|0|||
130303066|NCT01919801|469073424|FG001|Overall Study|Physician Decision|1|||
130303067|NCT01919801|469073423|FG000|Overall Study|Lost to Follow-up|0|||
130303068|NCT01919801|469073424|FG001|Overall Study|Lost to Follow-up|1|||
130303069|NCT01919801|469073423|FG000|Overall Study|Other|0|||
130303070|NCT01919801|469073424|FG001|Overall Study|Other|1|||
130303071|NCT01843062|469073425|FG000|Overall Study|Protocol Violation|1|||
130303072|NCT01843062|469073426|FG001|Overall Study|Protocol Violation|0|||
130303073|NCT01843062|469073425|FG000|Overall Study|New treatment following progression|2|||
130303074|NCT01843062|469073426|FG001|Overall Study|New treatment following progression|0|||
130303075|NCT01843062|469073425|FG000|Overall Study|Pregnancy|1|||
130303076|NCT01843062|469073426|FG001|Overall Study|Pregnancy|0|||
130557441|NCT02684279|470010002|FG000|Overall Study|subject to have surgery|1|||
130557442|NCT02684279|470010002|FG000|Overall Study|family emergency|1|||
130557443|NCT02684279|470010002|FG000|Overall Study|Site closures|7|||
130557444|NCT02684279|470010002|FG000|Overall Study|Physician Decision|1|||
130557445|NCT06950879|470010003|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
130557446|NCT04752475|470011741|FG000|Overall Study|Withdrawal by Subject|1|||
130557447|NCT04752475|470011742|FG001|Overall Study|Withdrawal by Subject|1|||
130557448|NCT02113579|470011745|FG000|Overall Study|Adverse Event|1|||
130557449|NCT02113579|470011746|FG001|Overall Study|Adverse Event|0|||
130557450|NCT02113579|470011745|FG000|Overall Study|Withdrawal by Subject|3|||
130557451|NCT02113579|470011746|FG001|Overall Study|Withdrawal by Subject|2|||
130557452|NCT02113579|470011745|FG000|Overall Study|Lost to Follow-up|6|||
130557453|NCT02113579|470011746|FG001|Overall Study|Lost to Follow-up|2|||
130557454|NCT02217436|470011747|FG000|Overall Study|Protocol Violation|1|||
130557455|NCT02217436|470011748|FG001|Overall Study|Protocol Violation|1|||
130557456|NCT02217436|470011747|FG000|Overall Study|Incomplete data|0|||
130557457|NCT02217436|470011748|FG001|Overall Study|Incomplete data|1|||
130716622|NCT00643565|470588927|FG001|Overall Study|Withdrawal by Subject|1|||
130303077|NCT01843062|469073425|FG000|Overall Study|Adverse Event|2|||
130303078|NCT01843062|469073426|FG001|Overall Study|Adverse Event|0|||
130303079|NCT01843062|469073425|FG000|Overall Study|Incorrect randomisation|1|||
130303080|NCT01843062|469073426|FG001|Overall Study|Incorrect randomisation|0|||
130557458|NCT01667081|470011751|FG000|Overall Study|Death|43|||
130557459|NCT01667081|470011752|FG001|Overall Study|Death|3|||
130557460|NCT01667081|470011751|FG000|Overall Study|Lost to Follow-up|99|||
130716623|NCT00643565|470588926|FG000|Overall Study|Lost to Follow-up|0|||
130716624|NCT00643565|470588927|FG001|Overall Study|Lost to Follow-up|6|||
130716625|NCT00643565|470588926|FG000|Overall Study|Other|7|||
130716626|NCT00643565|470588927|FG001|Overall Study|Other|8|||
130716627|NCT00643565|470588926|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
130462319|NCT05061693|469657500|FG003|24-week Extension Period|Lack of Efficacy|0|||
130462320|NCT05061693|469657501|FG004|24-week Extension Period|Lack of Efficacy|0|||
130462321|NCT05061693|469657502|FG005|24-week Extension Period|Lack of Efficacy|0|||
130462322|NCT05061693|469657503|FG006|24-week Extension Period|Lack of Efficacy|0|||
130462323|NCT05061693|469657504|FG007|24-week Extension Period|Lack of Efficacy|0|||
130462324|NCT05061693|469657505|FG008|24-week Extension Period|Lack of Efficacy|0|||
130462325|NCT05061693|469657506|FG009|24-week Extension Period|Lack of Efficacy|0|||
130462326|NCT05061693|469657507|FG010|24-week Extension Period|Lack of Efficacy|2|||
130462327|NCT05061693|469657508|FG011|24-week Extension Period|Lack of Efficacy|0|||
130462328|NCT05061693|469657497|FG000|24-week Extension Period|Lost to Follow-up|0|||
130462329|NCT05061693|469657498|FG001|24-week Extension Period|Lost to Follow-up|0|||
130462330|NCT05061693|469657499|FG002|24-week Extension Period|Lost to Follow-up|0|||
130462331|NCT05061693|469657500|FG003|24-week Extension Period|Lost to Follow-up|0|||
130462332|NCT05061693|469657501|FG004|24-week Extension Period|Lost to Follow-up|0|||
130462333|NCT05061693|469657502|FG005|24-week Extension Period|Lost to Follow-up|0|||
130462334|NCT05061693|469657503|FG006|24-week Extension Period|Lost to Follow-up|1|||
130462335|NCT05061693|469657504|FG007|24-week Extension Period|Lost to Follow-up|0|||
130462336|NCT05061693|469657505|FG008|24-week Extension Period|Lost to Follow-up|1|||
130462337|NCT05061693|469657506|FG009|24-week Extension Period|Lost to Follow-up|1|||
130462338|NCT05061693|469657507|FG010|24-week Extension Period|Lost to Follow-up|0|||
130462339|NCT05061693|469657508|FG011|24-week Extension Period|Lost to Follow-up|0|||
130462340|NCT05061693|469657497|FG000|24-week Extension Period|Withdrawal by Subject|0|||
130462341|NCT05061693|469657498|FG001|24-week Extension Period|Withdrawal by Subject|0|||
130462342|NCT05061693|469657499|FG002|24-week Extension Period|Withdrawal by Subject|0|||
130462343|NCT05061693|469657500|FG003|24-week Extension Period|Withdrawal by Subject|0|||
130462344|NCT05061693|469657501|FG004|24-week Extension Period|Withdrawal by Subject|0|||
130462345|NCT05061693|469657502|FG005|24-week Extension Period|Withdrawal by Subject|0|||
130462346|NCT05061693|469657503|FG006|24-week Extension Period|Withdrawal by Subject|0|||
130462347|NCT05061693|469657504|FG007|24-week Extension Period|Withdrawal by Subject|0|||
130462348|NCT05061693|469657505|FG008|24-week Extension Period|Withdrawal by Subject|1|||
130462349|NCT05061693|469657506|FG009|24-week Extension Period|Withdrawal by Subject|2|||
130462350|NCT05061693|469657507|FG010|24-week Extension Period|Withdrawal by Subject|2|||
130462351|NCT05061693|469657508|FG011|24-week Extension Period|Withdrawal by Subject|1|||
130462352|NCT05061693|469657497|FG000|24-week Extension Period|Sponsor Decision|0|||
130462353|NCT05061693|469657498|FG001|24-week Extension Period|Sponsor Decision|0|||
130462354|NCT05061693|469657499|FG002|24-week Extension Period|Sponsor Decision|0|||
130462355|NCT05061693|469657500|FG003|24-week Extension Period|Sponsor Decision|0|||
130462356|NCT05061693|469657501|FG004|24-week Extension Period|Sponsor Decision|0|||
130462357|NCT05061693|469657502|FG005|24-week Extension Period|Sponsor Decision|0|||
130462358|NCT05061693|469657503|FG006|24-week Extension Period|Sponsor Decision|0|||
130462359|NCT05061693|469657504|FG007|24-week Extension Period|Sponsor Decision|1|||
130462360|NCT05061693|469657505|FG008|24-week Extension Period|Sponsor Decision|0|||
130462361|NCT05061693|469657506|FG009|24-week Extension Period|Sponsor Decision|0|||
130462362|NCT05061693|469657507|FG010|24-week Extension Period|Sponsor Decision|0|||
130462363|NCT05061693|469657508|FG011|24-week Extension Period|Sponsor Decision|0|||
130462364|NCT05061693|469657497|FG000|24-week Extension Period|Site Closure|0|||
130462365|NCT05061693|469657498|FG001|24-week Extension Period|Site Closure|0|||
130462366|NCT05061693|469657499|FG002|24-week Extension Period|Site Closure|0|||
130462367|NCT05061693|469657500|FG003|24-week Extension Period|Site Closure|0|||
130462368|NCT05061693|469657501|FG004|24-week Extension Period|Site Closure|0|||
130462369|NCT05061693|469657502|FG005|24-week Extension Period|Site Closure|0|||
130462370|NCT05061693|469657503|FG006|24-week Extension Period|Site Closure|0|||
130462371|NCT05061693|469657504|FG007|24-week Extension Period|Site Closure|0|||
130462372|NCT05061693|469657505|FG008|24-week Extension Period|Site Closure|1|||
130557461|NCT01667081|470011752|FG001|Overall Study|Lost to Follow-up|48|||
130303081|NCT01843062|469073425|FG000|Overall Study|Withdrawal by Subject|12|||
130303082|NCT01843062|469073426|FG001|Overall Study|Withdrawal by Subject|3|||
130303083|NCT01843062|469073425|FG000|Overall Study|Death|1|||
130303084|NCT01843062|469073426|FG001|Overall Study|Death|2|||
130303085|NCT01843062|469073425|FG000|Overall Study|Lost to Follow-up|2|||
130303086|NCT01843062|469073426|FG001|Overall Study|Lost to Follow-up|4|||
130303087|NCT01677858|469073427|FG000|Overall Study|Adverse Event|0|||
130303088|NCT01677858|469073428|FG001|Overall Study|Adverse Event|0|||
130303089|NCT01677858|469073429|FG002|Overall Study|Adverse Event|2|||
130303090|NCT01677858|469073430|FG003|Overall Study|Adverse Event|3|||
130303091|NCT01677858|469073431|FG004|Overall Study|Adverse Event|13|||
130462373|NCT05061693|469657506|FG009|24-week Extension Period|Site Closure|0|||
130462374|NCT05061693|469657507|FG010|24-week Extension Period|Site Closure|0|||
130462375|NCT05061693|469657508|FG011|24-week Extension Period|Site Closure|1|||
130462376|NCT00258895|469657509|FG000|Overall Study|Lost to Follow-up|3|||
130462377|NCT00258895|469657510|FG001|Overall Study|Lost to Follow-up|1|||
130557462|NCT01667081|470011751|FG000|Overall Study|Physician Decision|16|||
130303092|NCT01677858|469073427|FG000|Overall Study|Death|0|||
130303093|NCT01677858|469073428|FG001|Overall Study|Death|0|||
130303094|NCT01677858|469073429|FG002|Overall Study|Death|0|||
130462378|NCT00258895|469657509|FG000|Overall Study|Protocol Violation|6|||
130462379|NCT00258895|469657510|FG001|Overall Study|Protocol Violation|2|||
130462380|NCT00258895|469657509|FG000|Overall Study|Withdrawal by Subject|1|||
130462381|NCT00258895|469657510|FG001|Overall Study|Withdrawal by Subject|0|||
130462382|NCT00373529|469657511|FG000|Overall Study|Physician Decision|19|||
130462383|NCT00373529|469657511|FG000|Overall Study|Withdrawal by Subject|7|||
130462384|NCT00373529|469657511|FG000|Overall Study|Adverse Event|7|||
130462385|NCT00373529|469657511|FG000|Overall Study|Treatment failure|36|||
130462386|NCT00373529|469657511|FG000|Overall Study|Disease recurrence|10|||
130462387|NCT00373529|469657511|FG000|Overall Study|Death|16|||
130462388|NCT00373529|469657511|FG000|Overall Study|Need for treatment prohibited by study|1|||
130462389|NCT00373529|469657511|FG000|Overall Study|Other|8|||
130462390|NCT00373529|469657511|FG000|Overall Study|Failed independent confirmation of AML|3|||
130462391|NCT00373529|469657511|FG000|Overall Study|Consent violation|1|||
130462392|NCT00442117|469657512|FG000|Overall Study|Adverse Event|3|||
130462393|NCT00442117|469657513|FG001|Overall Study|Adverse Event|2|||
130462394|NCT00442117|469657512|FG000|Overall Study|Lack of Efficacy|2|||
130462395|NCT00442117|469657513|FG001|Overall Study|Lack of Efficacy|6|||
130462396|NCT00442117|469657512|FG000|Overall Study|Lost to Follow-up|1|||
130462397|NCT00442117|469657513|FG001|Overall Study|Lost to Follow-up|2|||
130462398|NCT00442117|469657512|FG000|Overall Study|Withdrawal by Subject|2|||
130462399|NCT00442117|469657513|FG001|Overall Study|Withdrawal by Subject|2|||
130462400|NCT00442117|469657512|FG000|Overall Study|Major Deviation|25|||
130462401|NCT00442117|469657513|FG001|Overall Study|Major Deviation|20|||
130462402|NCT00442117|469657512|FG000|Overall Study|Non compliance with protocol|3|||
130462403|NCT00442117|469657513|FG001|Overall Study|Non compliance with protocol|5|||
130462404|NCT00442117|469657512|FG000|Overall Study|Met Withdrawal Criteria|2|||
130462405|NCT00442117|469657513|FG001|Overall Study|Met Withdrawal Criteria|1|||
130557463|NCT01667081|470011752|FG001|Overall Study|Physician Decision|2|||
130303095|NCT01677858|469073430|FG003|Overall Study|Death|0|||
130303096|NCT01677858|469073431|FG004|Overall Study|Death|1|||
130303097|NCT01677858|469073427|FG000|Overall Study|Physician Decision|1|||
130303098|NCT01677858|469073428|FG001|Overall Study|Physician Decision|0|||
130303099|NCT01677858|469073429|FG002|Overall Study|Physician Decision|2|||
130303100|NCT01677858|469073430|FG003|Overall Study|Physician Decision|0|||
130303101|NCT01677858|469073431|FG004|Overall Study|Physician Decision|12|||
130303102|NCT01677858|469073427|FG000|Overall Study|Progressive Disease|2|||
130303103|NCT01677858|469073428|FG001|Overall Study|Progressive Disease|1|||
130303104|NCT01677858|469073429|FG002|Overall Study|Progressive Disease|9|||
130462406|NCT00630786|469657514|FG000|Overall Study|Physician Decision|0|||
130462407|NCT00630786|469657515|FG001|Overall Study|Physician Decision|0|||
130303105|NCT01677858|469073430|FG003|Overall Study|Progressive Disease|3|||
130303106|NCT01677858|469073431|FG004|Overall Study|Progressive Disease|43|||
130462408|NCT00630786|469657516|FG002|Overall Study|Physician Decision|1|||
130462409|NCT00630786|469657514|FG000|Overall Study|Withdrawal by Subject|0|||
130462410|NCT00630786|469657515|FG001|Overall Study|Withdrawal by Subject|1|||
130303107|NCT01677858|469073427|FG000|Overall Study|Withdrawal by Subject|0|||
130303108|NCT01677858|469073428|FG001|Overall Study|Withdrawal by Subject|1|||
130462411|NCT00630786|469657516|FG002|Overall Study|Withdrawal by Subject|1|||
130462412|NCT00630786|469657514|FG000|Overall Study|Lost to Follow-up|0|||
130462413|NCT00630786|469657515|FG001|Overall Study|Lost to Follow-up|1|||
130462414|NCT00630786|469657516|FG002|Overall Study|Lost to Follow-up|0|||
130462415|NCT00630786|469657514|FG000|Overall Study|Other|1|||
130462416|NCT00630786|469657515|FG001|Overall Study|Other|0|||
130462417|NCT00630786|469657516|FG002|Overall Study|Other|0|||
130462418|NCT04009577|469657517|FG000|Core Study|Adverse Event|1|||
130462419|NCT04009577|469657518|FG001|Core Study|Adverse Event|0|||
130462420|NCT04009577|469657519|FG002|Core Study|Adverse Event|2|||
130303109|NCT01677858|469073429|FG002|Overall Study|Withdrawal by Subject|1|||
130303110|NCT01677858|469073430|FG003|Overall Study|Withdrawal by Subject|0|||
130303111|NCT01677858|469073431|FG004|Overall Study|Withdrawal by Subject|15|||
130303112|NCT01677858|469073427|FG000|Overall Study|Lost to Follow-up|0|||
130303113|NCT01677858|469073428|FG001|Overall Study|Lost to Follow-up|0|||
130303114|NCT01677858|469073429|FG002|Overall Study|Lost to Follow-up|0|||
130303115|NCT01677858|469073430|FG003|Overall Study|Lost to Follow-up|0|||
130303116|NCT01677858|469073431|FG004|Overall Study|Lost to Follow-up|1|||
130303117|NCT00773747|469073432|FG000|Overall Study|Lack of Efficacy|112|||
130303118|NCT00773747|469073433|FG001|Overall Study|Lack of Efficacy|144|||
130303119|NCT00773747|469073432|FG000|Overall Study|Physician Decision|26|||
130303120|NCT00773747|469073433|FG001|Overall Study|Physician Decision|18|||
130303121|NCT00773747|469073432|FG000|Overall Study|Lost to Follow-up|0|||
130303122|NCT00773747|469073433|FG001|Overall Study|Lost to Follow-up|1|||
130303123|NCT00773747|469073432|FG000|Overall Study|Protocol Violation|2|||
130462421|NCT04009577|469657520|FG003|Core Study|Adverse Event|4|||
130462422|NCT04009577|469657517|FG000|Core Study|Withdrawal by Subject|0|||
130462423|NCT04009577|469657518|FG001|Core Study|Withdrawal by Subject|0|||
130462424|NCT04009577|469657519|FG002|Core Study|Withdrawal by Subject|2|||
130462425|NCT04009577|469657520|FG003|Core Study|Withdrawal by Subject|0|||
130462426|NCT04009577|469657517|FG000|Core Study|Other|0|||
130462427|NCT04009577|469657518|FG001|Core Study|Other|0|||
130462428|NCT04009577|469657519|FG002|Core Study|Other|0|||
130462429|NCT04009577|469657520|FG003|Core Study|Other|1|||
130462430|NCT04009577|469657517|FG000|Extension Phase|Adverse Event|0|||
130462431|NCT04009577|469657518|FG001|Extension Phase|Adverse Event|0|||
130462432|NCT04009577|469657519|FG002|Extension Phase|Adverse Event|0|||
130462433|NCT04009577|469657520|FG003|Extension Phase|Adverse Event|1|||
130462434|NCT04009577|469657517|FG000|Extension Phase|Inadequate therapeutic effect|0|||
130462435|NCT04009577|469657518|FG001|Extension Phase|Inadequate therapeutic effect|0|||
130462436|NCT04009577|469657519|FG002|Extension Phase|Inadequate therapeutic effect|1|||
130462437|NCT04009577|469657520|FG003|Extension Phase|Inadequate therapeutic effect|0|||
130716628|NCT00643565|470588927|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
130716629|NCT00643565|470588926|FG000|Overall Study|Recurrence of Disease|2|||
130716630|NCT00643565|470588927|FG001|Overall Study|Recurrence of Disease|1|||
130716631|NCT00643565|470588926|FG000|Overall Study|Progression of Disease|18|||
130716632|NCT00643565|470588927|FG001|Overall Study|Progression of Disease|14|||
130716633|NCT00643565|470588926|FG000|Overall Study|Protocol Violation|3|||
130716634|NCT00643565|470588927|FG001|Overall Study|Protocol Violation|0|||
130716635|NCT00643565|470588926|FG000|Overall Study|Did Not Cooperate|0|||
130716636|NCT00643565|470588927|FG001|Overall Study|Did Not Cooperate|1|||
130716637|NCT00643565|470588926|FG000|Overall Study|Administrative|22|||
130716638|NCT00643565|470588927|FG001|Overall Study|Administrative|16|||
130716639|NCT00643565|470588926|FG000|Overall Study|Adverse Event|5|||
130716640|NCT00643565|470588927|FG001|Overall Study|Adverse Event|8|||
130716641|NCT02317614|470588928|FG000|Overall Study|Lost to Follow-up|1|||
130716642|NCT02317614|470588929|FG001|Overall Study|Lost to Follow-up|1|||
130716643|NCT02317614|470588928|FG000|Overall Study|Withdrawal by Subject|1|||
130716644|NCT02317614|470588929|FG001|Overall Study|Withdrawal by Subject|0|||
130716645|NCT02317614|470588928|FG000|Overall Study|Death|1|||
130716646|NCT02317614|470588929|FG001|Overall Study|Death|1|||
130716647|NCT00669071|470588934|FG000|Overall Study|Lost to Follow-up|3|||
130716648|NCT00669071|470588934|FG000|Overall Study|Final visit 40 days out of window|1|||
130716649|NCT06077487|470590886|FG000|Overall Study|Withdrawal by Subject|0|||
130716650|NCT06077487|470590887|FG001|Overall Study|Withdrawal by Subject|1|||
130716651|NCT00759902|470590889|FG000|Overall Study|Adverse Event|0|||
130716652|NCT00759902|470590890|FG001|Overall Study|Adverse Event|1|||
130462438|NCT04009577|469657517|FG000|Extension Phase|Withdrawal by Subject|0|||
130716653|NCT02128217|470590893|FG000|Overall Study|Lost to Follow-up|0|||
130716654|NCT02128217|470590894|FG001|Overall Study|Lost to Follow-up|1|||
130303124|NCT00773747|469073433|FG001|Overall Study|Protocol Violation|2|||
130303125|NCT00773747|469073432|FG000|Overall Study|Withdrawal by Subject|89|||
130303126|NCT00773747|469073433|FG001|Overall Study|Withdrawal by Subject|61|||
130462439|NCT04009577|469657518|FG001|Extension Phase|Withdrawal by Subject|0|||
130462440|NCT04009577|469657519|FG002|Extension Phase|Withdrawal by Subject|1|||
130716655|NCT05071313|470590895|FG000|Overall Study|Lost to Follow-up|17|||
130716656|NCT05071313|470590896|FG001|Overall Study|Lost to Follow-up|10|||
130303127|NCT00773747|469073432|FG000|Overall Study|Adverse Event|61|||
130462441|NCT04009577|469657520|FG003|Extension Phase|Withdrawal by Subject|0|||
130462442|NCT04009577|469657517|FG000|Extension Phase|Not Treated|0|||
130462443|NCT04009577|469657518|FG001|Extension Phase|Not Treated|0|||
130716657|NCT05071313|470590895|FG000|Overall Study|Physician Decision|1|||
130462444|NCT04009577|469657519|FG002|Extension Phase|Not Treated|2|||
130462445|NCT04009577|469657520|FG003|Extension Phase|Not Treated|0|||
130462446|NCT02020616|469657524|FG000|Overall Study|Adverse Event|0|||
130462447|NCT02020616|469657525|FG001|Overall Study|Adverse Event|0|||
130462448|NCT02020616|469657526|FG002|Overall Study|Adverse Event|0|||
130462449|NCT02020616|469657527|FG003|Overall Study|Adverse Event|0|||
130462450|NCT02020616|469657528|FG004|Overall Study|Adverse Event|0|||
130462451|NCT02020616|469657529|FG005|Overall Study|Adverse Event|1|||
130462452|NCT02020616|469657530|FG006|Overall Study|Adverse Event|1|||
130462453|NCT02020616|469657524|FG000|Overall Study|Physician Decision|0|||
130462454|NCT02020616|469657525|FG001|Overall Study|Physician Decision|0|||
130462455|NCT02020616|469657526|FG002|Overall Study|Physician Decision|0|||
130462456|NCT02020616|469657527|FG003|Overall Study|Physician Decision|0|||
130462457|NCT02020616|469657528|FG004|Overall Study|Physician Decision|0|||
130462458|NCT02020616|469657529|FG005|Overall Study|Physician Decision|1|||
130462459|NCT02020616|469657530|FG006|Overall Study|Physician Decision|2|||
130462460|NCT02020616|469657524|FG000|Overall Study|Withdrawal by Subject|0|||
130462461|NCT02020616|469657525|FG001|Overall Study|Withdrawal by Subject|0|||
130462462|NCT02020616|469657526|FG002|Overall Study|Withdrawal by Subject|1|||
130462463|NCT02020616|469657527|FG003|Overall Study|Withdrawal by Subject|0|||
130462464|NCT02020616|469657528|FG004|Overall Study|Withdrawal by Subject|0|||
130462465|NCT02020616|469657529|FG005|Overall Study|Withdrawal by Subject|1|||
130462466|NCT02020616|469657530|FG006|Overall Study|Withdrawal by Subject|1|||
130462467|NCT02020616|469657524|FG000|Overall Study|Lost to Follow-up|0|||
130462468|NCT02020616|469657525|FG001|Overall Study|Lost to Follow-up|1|||
130462469|NCT02020616|469657526|FG002|Overall Study|Lost to Follow-up|0|||
130462470|NCT02020616|469657527|FG003|Overall Study|Lost to Follow-up|1|||
130462471|NCT02020616|469657528|FG004|Overall Study|Lost to Follow-up|1|||
130462472|NCT02020616|469657529|FG005|Overall Study|Lost to Follow-up|1|||
130462473|NCT02020616|469657530|FG006|Overall Study|Lost to Follow-up|0|||
130462474|NCT02020616|469657524|FG000|Overall Study|Early Termination Criteria Met|0|||
130462475|NCT02020616|469657525|FG001|Overall Study|Early Termination Criteria Met|0|||
130462476|NCT02020616|469657526|FG002|Overall Study|Early Termination Criteria Met|1|||
130462477|NCT02020616|469657527|FG003|Overall Study|Early Termination Criteria Met|0|||
130462478|NCT02020616|469657528|FG004|Overall Study|Early Termination Criteria Met|0|||
130462479|NCT02020616|469657529|FG005|Overall Study|Early Termination Criteria Met|1|||
130462480|NCT02020616|469657530|FG006|Overall Study|Early Termination Criteria Met|0|||
130462481|NCT02020616|469657524|FG000|Overall Study|Randomized in Error|0|||
130462482|NCT02020616|469657525|FG001|Overall Study|Randomized in Error|0|||
130462483|NCT02020616|469657526|FG002|Overall Study|Randomized in Error|0|||
130462484|NCT02020616|469657527|FG003|Overall Study|Randomized in Error|1|||
130462485|NCT02020616|469657528|FG004|Overall Study|Randomized in Error|0|||
130462486|NCT02020616|469657529|FG005|Overall Study|Randomized in Error|0|||
130462487|NCT02020616|469657530|FG006|Overall Study|Randomized in Error|0|||
130462488|NCT02020616|469657524|FG000|Overall Study|Lack of Efficacy|0|||
130462489|NCT02020616|469657525|FG001|Overall Study|Lack of Efficacy|0|||
130462490|NCT02020616|469657526|FG002|Overall Study|Lack of Efficacy|0|||
130462491|NCT02020616|469657527|FG003|Overall Study|Lack of Efficacy|0|||
130462492|NCT02020616|469657528|FG004|Overall Study|Lack of Efficacy|1|||
130462493|NCT02020616|469657529|FG005|Overall Study|Lack of Efficacy|0|||
130462494|NCT02020616|469657530|FG006|Overall Study|Lack of Efficacy|0|||
130557464|NCT01667081|470011751|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
130557465|NCT01667081|470011752|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
130462495|NCT02031471|469657535|FG000|24 Week Treatment Period|Adverse Event|6|||
130462496|NCT02031471|469657535|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
130716658|NCT05071313|470590896|FG001|Overall Study|Physician Decision|6|||
130716659|NCT05071313|470590895|FG000|Overall Study|Death|1|||
130303128|NCT00773747|469073433|FG001|Overall Study|Adverse Event|62|||
130462497|NCT02031471|469657535|FG000|24 Week Treatment Period|Protocol Violation|1|||
130462498|NCT02031471|469657535|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
130462499|NCT02031471|469657535|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
130462500|NCT02031471|469657535|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
130462501|NCT02031471|469657535|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
130462502|NCT00658996|469657538|FG000|First Intervention|Positive slit lamp finding|1|||
130716660|NCT05071313|470590896|FG001|Overall Study|Death|0|||
130716661|NCT05071313|470590895|FG000|Overall Study|Withdrawal by Subject|10|||
130716662|NCT05071313|470590896|FG001|Overall Study|Withdrawal by Subject|15|||
130716663|NCT05071313|470590895|FG000|Overall Study|Other|1|||
130716664|NCT05071313|470590896|FG001|Overall Study|Other|0|||
130716665|NCT05071313|470590895|FG000|Overall Study|Randomized but not vaccinated|4|||
130716666|NCT05071313|470590896|FG001|Overall Study|Randomized but not vaccinated|2|||
130716667|NCT03107026|470590897|FG000|Overall Study|Adverse Event|2|||
130716668|NCT03107026|470590898|FG001|Overall Study|Adverse Event|14|||
130716669|NCT03107026|470590899|FG002|Overall Study|Adverse Event|23|||
130716670|NCT03107026|470590897|FG000|Overall Study|Lost to Follow-up|12|||
130716671|NCT03107026|470590898|FG001|Overall Study|Lost to Follow-up|12|||
130462503|NCT00658996|469657539|FG001|First Intervention|Positive slit lamp finding|0|||
130462504|NCT00658996|469657538|FG000|First Intervention|Lack of lenses|0|||
130462505|NCT00658996|469657539|FG001|First Intervention|Lack of lenses|1|||
130462506|NCT00658996|469657538|FG000|Crossover Period|Physician Decision|1|||
130462507|NCT00658996|469657539|FG001|Crossover Period|Physician Decision|0|||
130462508|NCT00658996|469657538|FG000|Crossover Period|Ineligible|1|||
130462509|NCT00658996|469657539|FG001|Crossover Period|Ineligible|1|||
130462510|NCT00658996|469657538|FG000|Second Intervention|Developed a stye on upper lid|1|||
130462511|NCT00658996|469657539|FG001|Second Intervention|Developed a stye on upper lid|0|||
130462512|NCT00658996|469657538|FG000|Second Intervention|Positive slit lamp finding|0|||
130462513|NCT00658996|469657539|FG001|Second Intervention|Positive slit lamp finding|1|||
130462514|NCT01810263|469657545|FG000|Overall Study|Lost to Follow-up|8|||
130462515|NCT01810263|469657546|FG001|Overall Study|Lost to Follow-up|7|||
130303129|NCT00773747|469073432|FG000|Overall Study|Death|5|||
130303130|NCT00773747|469073433|FG001|Overall Study|Death|8|||
130303131|NCT00773747|469073432|FG000|Overall Study|Not Treated|2|||
130303132|NCT00773747|469073433|FG001|Overall Study|Not Treated|0|||
130303133|NCT02669212|469073436|FG000|Overall Study|Lost to Follow-up|1|||
130303134|NCT02669212|469073437|FG001|Overall Study|Lost to Follow-up|0|||
130462516|NCT00688519|469657547|FG000|Overall Study|Adverse Event|2|||
130462517|NCT00688519|469657548|FG001|Overall Study|Adverse Event|3|||
130462518|NCT00688519|469657547|FG000|Overall Study|Lost to Follow-up|3|||
130462519|NCT00688519|469657548|FG001|Overall Study|Lost to Follow-up|3|||
130462520|NCT00688519|469657547|FG000|Overall Study|Lack of Efficacy|3|||
130462521|NCT00688519|469657548|FG001|Overall Study|Lack of Efficacy|1|||
130462522|NCT00688519|469657547|FG000|Overall Study|Withdrawal by Subject|7|||
130462523|NCT00688519|469657548|FG001|Overall Study|Withdrawal by Subject|6|||
130462524|NCT00688519|469657547|FG000|Overall Study|Prohibited medication|1|||
130462525|NCT00688519|469657548|FG001|Overall Study|Prohibited medication|0|||
130462526|NCT00688519|469657547|FG000|Overall Study|Non-compliance|0|||
130462527|NCT00688519|469657548|FG001|Overall Study|Non-compliance|1|||
130462528|NCT00688519|469657547|FG000|Overall Study|Subject moved out of state|1|||
130462529|NCT00688519|469657548|FG001|Overall Study|Subject moved out of state|0|||
130462530|NCT00688519|469657547|FG000|Overall Study|Investigator decision|1|||
130462531|NCT00688519|469657548|FG001|Overall Study|Investigator decision|0|||
130462532|NCT00688519|469657547|FG000|Overall Study|Subject moved out of area|1|||
130462533|NCT00688519|469657548|FG001|Overall Study|Subject moved out of area|0|||
130462534|NCT00688519|469657547|FG000|Overall Study|Pregnancy|0|||
130462535|NCT00688519|469657548|FG001|Overall Study|Pregnancy|1|||
130462536|NCT01353963|469657549|FG000|Overall Study|Adverse Event|2|||
130462537|NCT03351075|469658504|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
130462538|NCT03351075|469658505|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
130462539|NCT03351075|469658504|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
130462540|NCT03351075|469658505|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
130462541|NCT03351075|469658504|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
130462542|NCT03351075|469658505|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
130462543|NCT03351075|469658504|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
130462544|NCT03351075|469658505|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
130462545|NCT03169244|469658508|FG000|Overall Study|Lost to Follow-up|1|||
130462546|NCT03169244|469658509|FG001|Overall Study|Lost to Follow-up|2|||
130462547|NCT03169244|469658508|FG000|Overall Study|Adverse Event|1|||
130462548|NCT03169244|469658509|FG001|Overall Study|Adverse Event|0|||
130462549|NCT03169244|469658508|FG000|Overall Study|Withdrawal by Subject|2|||
130462550|NCT03169244|469658509|FG001|Overall Study|Withdrawal by Subject|2|||
130462551|NCT03169244|469658508|FG000|Overall Study|Physician Decision|1|||
130462552|NCT03169244|469658509|FG001|Overall Study|Physician Decision|0|||
130462553|NCT04603924|469658510|FG000|Overall Study|Not Dosed|2|||
130462554|NCT04603924|469658511|FG001|Overall Study|Not Dosed|1|||
130462555|NCT04603924|469658510|FG000|Overall Study|Withdrawal by Subject|6|||
130462556|NCT04603924|469658511|FG001|Overall Study|Withdrawal by Subject|6|||
130462557|NCT04603924|469658510|FG000|Overall Study|Adverse Event|2|||
130462558|NCT04603924|469658511|FG001|Overall Study|Adverse Event|2|||
130303135|NCT02669212|469073436|FG000|Overall Study|Medical Condition|3|||
130303136|NCT02669212|469073437|FG001|Overall Study|Medical Condition|4|||
130462559|NCT02139046|469658514|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130462560|NCT02139046|469658515|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
130462561|NCT02139046|469658516|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
130303137|NCT02669212|469073436|FG000|Overall Study|Withdrawal by Subject|0|||
130303138|NCT02669212|469073437|FG001|Overall Study|Withdrawal by Subject|2|||
130462562|NCT02139046|469658517|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
130462563|NCT02139046|469658518|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
130462564|NCT02139046|469658514|FG000|Overall Study|Major Protocol Deviation|9|||
130462565|NCT02139046|469658515|FG001|Overall Study|Major Protocol Deviation|10|||
130462566|NCT02139046|469658516|FG002|Overall Study|Major Protocol Deviation|16|||
130462567|NCT02139046|469658517|FG003|Overall Study|Major Protocol Deviation|12|||
130462568|NCT02139046|469658518|FG004|Overall Study|Major Protocol Deviation|6|||
130462569|NCT02139046|469658514|FG000|Overall Study|Lost to Follow-up|13|||
130462570|NCT02139046|469658515|FG001|Overall Study|Lost to Follow-up|16|||
130462571|NCT02139046|469658516|FG002|Overall Study|Lost to Follow-up|16|||
130462572|NCT02139046|469658517|FG003|Overall Study|Lost to Follow-up|18|||
130462573|NCT02139046|469658518|FG004|Overall Study|Lost to Follow-up|13|||
130462574|NCT02139046|469658514|FG000|Overall Study|Voluntary Withdrawal|20|||
130462575|NCT02139046|469658515|FG001|Overall Study|Voluntary Withdrawal|8|||
130462576|NCT02139046|469658516|FG002|Overall Study|Voluntary Withdrawal|10|||
130462577|NCT02139046|469658517|FG003|Overall Study|Voluntary Withdrawal|15|||
130462578|NCT02139046|469658518|FG004|Overall Study|Voluntary Withdrawal|16|||
130462579|NCT02139046|469658514|FG000|Overall Study|Lack of Efficacy|0|||
130462580|NCT02139046|469658515|FG001|Overall Study|Lack of Efficacy|1|||
130462581|NCT02139046|469658516|FG002|Overall Study|Lack of Efficacy|2|||
130462582|NCT02139046|469658517|FG003|Overall Study|Lack of Efficacy|1|||
130462583|NCT02139046|469658518|FG004|Overall Study|Lack of Efficacy|2|||
130462584|NCT02139046|469658514|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
130462585|NCT02139046|469658515|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
130462586|NCT02139046|469658516|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
130462587|NCT02139046|469658517|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
130462588|NCT02139046|469658518|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
130462589|NCT02139046|469658514|FG000|Overall Study|Other Miscellaneous Reasons|10|||
130462590|NCT02139046|469658515|FG001|Overall Study|Other Miscellaneous Reasons|9|||
130462591|NCT02139046|469658516|FG002|Overall Study|Other Miscellaneous Reasons|4|||
130462592|NCT02139046|469658517|FG003|Overall Study|Other Miscellaneous Reasons|9|||
130462593|NCT02139046|469658518|FG004|Overall Study|Other Miscellaneous Reasons|12|||
130462594|NCT03557008|469658519|FG000|Overall Study|Withdrawal by Subject|2|||
130462595|NCT03557008|469658520|FG001|Overall Study|Withdrawal by Subject|2|||
130462596|NCT03557008|469658519|FG000|Overall Study|Early termination from study|3|||
130462597|NCT03557008|469658520|FG001|Overall Study|Early termination from study|1|||
130462598|NCT01113931|469658522|FG000|Overall Study|Adverse Event|2|||
130462599|NCT01113931|469658523|FG001|Overall Study|Adverse Event|2|||
130462600|NCT01113931|469658522|FG000|Overall Study|Physician Decision|0|||
130462601|NCT01113931|469658523|FG001|Overall Study|Physician Decision|2|||
130462602|NCT01113931|469658522|FG000|Overall Study|Lost to Follow-up|12|||
130462603|NCT01113931|469658523|FG001|Overall Study|Lost to Follow-up|9|||
130462604|NCT01113931|469658522|FG000|Overall Study|Various|2|||
130462605|NCT01113931|469658523|FG001|Overall Study|Various|4|||
130462606|NCT01113931|469658522|FG000|Overall Study|Withdrawal by Subject|3|||
130462607|NCT01113931|469658523|FG001|Overall Study|Withdrawal by Subject|0|||
130462608|NCT00071799|469658525|FG000|Overall Study|Adverse Event|19|||
130462609|NCT00071799|469658526|FG001|Overall Study|Adverse Event|10|||
130462610|NCT00071799|469658525|FG000|Overall Study|Protocol Violation|1|||
130462611|NCT00071799|469658526|FG001|Overall Study|Protocol Violation|7|||
130462612|NCT00071799|469658525|FG000|Overall Study|Lost to Follow-up|1|||
130462613|NCT00071799|469658526|FG001|Overall Study|Lost to Follow-up|1|||
130462614|NCT00071799|469658525|FG000|Overall Study|Withdrawal by Subject|15|||
130462615|NCT00071799|469658526|FG001|Overall Study|Withdrawal by Subject|37|||
130462616|NCT00071799|469658525|FG000|Overall Study|Physician Decision|0|||
130462617|NCT00071799|469658526|FG001|Overall Study|Physician Decision|2|||
130462618|NCT00071799|469658525|FG000|Overall Study|Lack of Efficacy|11|||
130462619|NCT00071799|469658526|FG001|Overall Study|Lack of Efficacy|18|||
130462620|NCT00071799|469658525|FG000|Overall Study|Disease Progression|23|||
130462621|NCT00071799|469658526|FG001|Overall Study|Disease Progression|20|||
130462622|NCT00071799|469658525|FG000|Overall Study|Different Central+Local Pathology Review|0|||
130462623|NCT00071799|469658526|FG001|Overall Study|Different Central+Local Pathology Review|1|||
130462624|NCT00071799|469658525|FG000|Overall Study|Not Documented|0|||
130462625|NCT00071799|469658526|FG001|Overall Study|Not Documented|2|||
130462626|NCT03959241|469658527|FG000|Overall Study|Withdrawal by Subject|7|||
130462627|NCT03959241|469658528|FG001|Overall Study|Withdrawal by Subject|8|||
130462628|NCT03959241|469658527|FG000|Overall Study|Lost to Follow-up|1|||
130462629|NCT03959241|469658528|FG001|Overall Study|Lost to Follow-up|0|||
130462630|NCT03959241|469658527|FG000|Overall Study|Move to Hospice Care|1|||
130462631|NCT03959241|469658528|FG001|Overall Study|Move to Hospice Care|0|||
130462632|NCT03959241|469658527|FG000|Overall Study|Screen Failure|1|||
130303139|NCT02669212|469073436|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
130303140|NCT02669212|469073437|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
130303141|NCT03549104|469073438|FG000|Overall Study|Withdrawal by Subject|5|||
130462633|NCT03959241|469658528|FG001|Overall Study|Screen Failure|0|||
130462634|NCT03959241|469658527|FG000|Overall Study|Disease Relapse|0|||
130462635|NCT03959241|469658528|FG001|Overall Study|Disease Relapse|1|||
130303142|NCT03549104|469073439|FG001|Overall Study|Withdrawal by Subject|2|||
130462636|NCT03959241|469658527|FG000|Overall Study|Off Study|1|||
130462637|NCT03959241|469658528|FG001|Overall Study|Off Study|0|||
130462638|NCT01145885|469658529|FG000|Overall Study|Progressive Disease|7|||
130462639|NCT00346151|469658532|FG000|Overall Study|Withdrawal by Subject|3|||
130462640|NCT04054635|469658538|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
130462641|NCT04054635|469658539|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
130462642|NCT04054635|469658540|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
130462643|NCT04054635|469658538|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
130462644|NCT04054635|469658539|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
130462645|NCT04054635|469658540|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
130462646|NCT01692938|469658546|FG000|Overall Study|Protocol Deviation|1|||
130462647|NCT01692938|469658547|FG001|Overall Study|Protocol Deviation|1|||
130557466|NCT01667081|470011751|FG000|Overall Study|Withdrawal by Subject|90|||
130557467|NCT01667081|470011752|FG001|Overall Study|Withdrawal by Subject|35|||
130557468|NCT03034460|470011753|FG000|Overall Study|Adverse Event|0|||
130557469|NCT03034460|470011754|FG001|Overall Study|Adverse Event|1|||
130557470|NCT03034460|470011753|FG000|Overall Study|Withdrawal by Subject|2|||
130557471|NCT03034460|470011754|FG001|Overall Study|Withdrawal by Subject|2|||
130557472|NCT03034460|470011753|FG000|Overall Study|Personal Reasons|1|||
130557473|NCT03034460|470011754|FG001|Overall Study|Personal Reasons|0|||
130557474|NCT01798992|470011755|FG000|Overall Study|Administrative withdrawal|0|||
130557475|NCT01798992|470011756|FG001|Overall Study|Administrative withdrawal|1|||
130557476|NCT01798992|470011757|FG002|Overall Study|Administrative withdrawal|0|||
130557477|NCT01798992|470011758|FG003|Overall Study|Administrative withdrawal|1|||
130557478|NCT01798992|470011755|FG000|Overall Study|Lost to Follow-up|0|||
130557479|NCT01798992|470011756|FG001|Overall Study|Lost to Follow-up|1|||
130557480|NCT01798992|470011757|FG002|Overall Study|Lost to Follow-up|1|||
130557481|NCT01798992|470011758|FG003|Overall Study|Lost to Follow-up|0|||
130557482|NCT01798992|470011755|FG000|Overall Study|Insufficient biopsy tissue|0|||
130557483|NCT01798992|470011756|FG001|Overall Study|Insufficient biopsy tissue|0|||
130557484|NCT01798992|470011757|FG002|Overall Study|Insufficient biopsy tissue|1|||
130557485|NCT01798992|470011758|FG003|Overall Study|Insufficient biopsy tissue|0|||
130557486|NCT04004429|470011767|FG000|Overall Study|Protocol Violation|1|||
130557487|NCT04004429|470011768|FG001|Overall Study|Protocol Violation|0|||
130557488|NCT04004429|470011769|FG002|Overall Study|Protocol Violation|0|||
130557489|NCT04004429|470011767|FG000|Overall Study|Physician Decision|0|||
130557490|NCT04004429|470011768|FG001|Overall Study|Physician Decision|1|||
130557491|NCT04004429|470011769|FG002|Overall Study|Physician Decision|1|||
130557492|NCT04004429|470011767|FG000|Overall Study|Withdrawal by Subject|1|||
130557493|NCT04004429|470011768|FG001|Overall Study|Withdrawal by Subject|1|||
130557494|NCT04004429|470011769|FG002|Overall Study|Withdrawal by Subject|1|||
130716672|NCT03107026|470590899|FG002|Overall Study|Lost to Follow-up|13|||
130462648|NCT01692938|469658546|FG000|Overall Study|Study completed prior to site completion|3|||
130303143|NCT03549104|469073438|FG000|Overall Study|Covid shelter in place|1|||
130303144|NCT03549104|469073439|FG001|Overall Study|Covid shelter in place|2|||
130303145|NCT03078855|469073440|FG000|Overall Study|Lack of Efficacy|62|||
130303146|NCT03078855|469073441|FG001|Overall Study|Lack of Efficacy|31|||
130303147|NCT03078855|469073440|FG000|Overall Study|Death|1|||
130303148|NCT03078855|469073441|FG001|Overall Study|Death|0|||
130303149|NCT03078855|469073440|FG000|Overall Study|Withdrawal by Subject|12|||
130303150|NCT03078855|469073441|FG001|Overall Study|Withdrawal by Subject|6|||
130303151|NCT03078855|469073440|FG000|Overall Study|Physician Decision|3|||
130462649|NCT01692938|469658547|FG001|Overall Study|Study completed prior to site completion|3|||
130462650|NCT02423291|469658549|FG000|Overall Study|Lack of Efficacy|14|||
130462651|NCT02423291|469658549|FG000|Overall Study|Adverse Event|1|||
130462652|NCT05283395|469658551|FG000|Overall Study|Adverse Event|4|||
130462653|NCT05283395|469658552|FG001|Overall Study|Adverse Event|4|||
130462654|NCT05283395|469658553|FG002|Overall Study|Adverse Event|0|||
130716673|NCT03107026|470590897|FG000|Overall Study|Protocol Violation|1|||
130303152|NCT03078855|469073441|FG001|Overall Study|Physician Decision|2|||
130303153|NCT03078855|469073440|FG000|Overall Study|Second Malignancy|4|||
130303154|NCT03078855|469073441|FG001|Overall Study|Second Malignancy|0|||
130303155|NCT03078855|469073440|FG000|Overall Study|Ineligible|2|||
130303156|NCT03078855|469073441|FG001|Overall Study|Ineligible|0|||
130303157|NCT03078855|469073440|FG000|Overall Study|Withdrew before day 1 treatment|2|||
130462655|NCT05283395|469658551|FG000|Overall Study|Patient Lost to Follow-Up|0|||
130462656|NCT05283395|469658552|FG001|Overall Study|Patient Lost to Follow-Up|0|||
130462657|NCT05283395|469658553|FG002|Overall Study|Patient Lost to Follow-Up|1|||
130716674|NCT03107026|470590898|FG001|Overall Study|Protocol Violation|2|||
130462658|NCT05283395|469658551|FG000|Overall Study|Patient Withdrawal|2|||
130716675|NCT03107026|470590899|FG002|Overall Study|Protocol Violation|0|||
130716676|NCT03107026|470590897|FG000|Overall Study|Pregnancy|1|||
130716677|NCT03107026|470590898|FG001|Overall Study|Pregnancy|0|||
130303158|NCT03078855|469073441|FG001|Overall Study|Withdrew before day 1 treatment|1|||
130303159|NCT00391027|469073442|FG000|Overall Study|Adverse Event|8|||
130303160|NCT00391027|469073443|FG001|Overall Study|Adverse Event|8|||
130303161|NCT00391027|469073442|FG000|Overall Study|Lack of Efficacy|3|||
130303162|NCT00391027|469073443|FG001|Overall Study|Lack of Efficacy|0|||
130462659|NCT05283395|469658552|FG001|Overall Study|Patient Withdrawal|4|||
130557495|NCT03085758|470011770|FG000|Overall Study|Death|26|||
130716678|NCT03107026|470590899|FG002|Overall Study|Pregnancy|0|||
130462660|NCT05283395|469658553|FG002|Overall Study|Patient Withdrawal|2|||
130557496|NCT03085758|470011771|FG001|Overall Study|Death|24|||
130557497|NCT03085758|470011772|FG002|Overall Study|Death|53|||
130462661|NCT05283395|469658551|FG000|Overall Study|Investigator Decision|1|||
130462662|NCT05283395|469658552|FG001|Overall Study|Investigator Decision|0|||
130462663|NCT05283395|469658553|FG002|Overall Study|Investigator Decision|1|||
130462664|NCT05283395|469658551|FG000|Overall Study|Enrolled in error|0|||
130462665|NCT05283395|469658552|FG001|Overall Study|Enrolled in error|0|||
130462666|NCT05283395|469658553|FG002|Overall Study|Enrolled in error|1|||
130462667|NCT00424645|469658557|FG000|Overall Study|Death|1|||
130462668|NCT00424645|469658558|FG001|Overall Study|Death|0|||
130462669|NCT00959946|469658561|FG000|Overall Study|Adverse Event|0|||
130462670|NCT00959946|469658562|FG001|Overall Study|Adverse Event|0|||
130462671|NCT00959946|469658563|FG002|Overall Study|Adverse Event|2|||
130462672|NCT00959946|469658564|FG003|Overall Study|Adverse Event|1|||
130462673|NCT00959946|469658565|FG004|Overall Study|Adverse Event|0|||
130462674|NCT00959946|469658566|FG005|Overall Study|Adverse Event|1|||
130462675|NCT00959946|469658567|FG006|Overall Study|Adverse Event|0|||
130462676|NCT00959946|469658568|FG007|Overall Study|Adverse Event|0|||
130462677|NCT00959946|469658561|FG000|Overall Study|Death|0|||
130462678|NCT00959946|469658562|FG001|Overall Study|Death|0|||
130462679|NCT00959946|469658563|FG002|Overall Study|Death|0|||
130462680|NCT00959946|469658564|FG003|Overall Study|Death|0|||
130462681|NCT00959946|469658565|FG004|Overall Study|Death|0|||
130462682|NCT00959946|469658566|FG005|Overall Study|Death|1|||
130462683|NCT00959946|469658567|FG006|Overall Study|Death|0|||
130462684|NCT00959946|469658568|FG007|Overall Study|Death|0|||
130462685|NCT00959946|469658561|FG000|Overall Study|Disease Progression|2|||
130462686|NCT00959946|469658562|FG001|Overall Study|Disease Progression|4|||
130462687|NCT00959946|469658563|FG002|Overall Study|Disease Progression|2|||
130462688|NCT00959946|469658564|FG003|Overall Study|Disease Progression|4|||
130462689|NCT00959946|469658565|FG004|Overall Study|Disease Progression|4|||
130462690|NCT00959946|469658566|FG005|Overall Study|Disease Progression|6|||
130462691|NCT00959946|469658567|FG006|Overall Study|Disease Progression|2|||
130462692|NCT00959946|469658568|FG007|Overall Study|Disease Progression|2|||
130462693|NCT00959946|469658561|FG000|Overall Study|Withdrawal by Subject|0|||
130462694|NCT00959946|469658562|FG001|Overall Study|Withdrawal by Subject|0|||
130462695|NCT00959946|469658563|FG002|Overall Study|Withdrawal by Subject|0|||
130462696|NCT00959946|469658564|FG003|Overall Study|Withdrawal by Subject|0|||
130462697|NCT00959946|469658565|FG004|Overall Study|Withdrawal by Subject|0|||
130462698|NCT00959946|469658566|FG005|Overall Study|Withdrawal by Subject|1|||
130462699|NCT00959946|469658567|FG006|Overall Study|Withdrawal by Subject|0|||
130462700|NCT00959946|469658568|FG007|Overall Study|Withdrawal by Subject|0|||
130462701|NCT02115139|469658571|FG000|Overall Study|Protocol Violation|1|||
130462702|NCT02115139|469658571|FG000|Overall Study|treatment discontinuation|6|||
130462703|NCT02471755|469658572|FG000|Overall Study|Withdrawal by Subject|1|||
130462704|NCT02471755|469658573|FG001|Overall Study|Withdrawal by Subject|0|||
130462705|NCT02471755|469658572|FG000|Overall Study|Lost to Follow-up|0|||
130462706|NCT02471755|469658573|FG001|Overall Study|Lost to Follow-up|1|||
130462707|NCT04740164|469658574|FG000|Overall Study|Lack of Efficacy|4|||
130462708|NCT04740164|469658575|FG001|Overall Study|Lack of Efficacy|0|||
130462709|NCT04740164|469658574|FG000|Overall Study|Physician Decision|3|||
130462710|NCT04740164|469658575|FG001|Overall Study|Physician Decision|3|||
130462711|NCT04177394|469658576|FG000|Overall Study|Death|16|||
130462712|NCT04177394|469658576|FG000|Overall Study|Withdrawal by Subject|19|||
130462713|NCT04177394|469658576|FG000|Overall Study|Missed visits|61|||
130462714|NCT04177394|469658576|FG000|Overall Study|Expected Visits|15|||
130462715|NCT03823911|469658577|FG000|Overall Study|Lost to Follow-up|1|||
130462716|NCT03823911|469658578|FG001|Overall Study|Lost to Follow-up|5|||
130462717|NCT03823911|469658579|FG002|Overall Study|Lost to Follow-up|2|||
130462718|NCT03823911|469658577|FG000|Overall Study|Did not meet eligibility criteria|13|||
130462719|NCT03823911|469658578|FG001|Overall Study|Did not meet eligibility criteria|7|||
130462720|NCT03823911|469658579|FG002|Overall Study|Did not meet eligibility criteria|4|||
130462721|NCT03823911|469658577|FG000|Overall Study|Death|0|||
130462722|NCT03823911|469658578|FG001|Overall Study|Death|1|||
130462723|NCT03823911|469658579|FG002|Overall Study|Death|0|||
130462724|NCT01152190|469658580|FG000|Overall Study|Adverse Event|2|||
130462725|NCT01152190|469658581|FG001|Overall Study|Adverse Event|4|||
130462726|NCT01152190|469658580|FG000|Overall Study|Death|1|||
130462727|NCT01152190|469658581|FG001|Overall Study|Death|0|||
130462728|NCT01152190|469658580|FG000|Overall Study|Protocol Violation|1|||
130716679|NCT03107026|470590897|FG000|Overall Study|Withdrawal by Subject|13|||
130462729|NCT01152190|469658581|FG001|Overall Study|Protocol Violation|1|||
130462730|NCT01152190|469658580|FG000|Overall Study|Withdrawal by Subject|1|||
130462731|NCT01152190|469658581|FG001|Overall Study|Withdrawal by Subject|3|||
130462732|NCT01121549|469658596|FG000|Overall Study|Adverse Event|10|||
130462733|NCT01121549|469658596|FG000|Overall Study|Lack of Efficacy|11|||
130462734|NCT01121549|469658596|FG000|Overall Study|Lost to Follow-up|12|||
130462735|NCT01121549|469658596|FG000|Overall Study|Did not meet entrance criteria|9|||
130462736|NCT01121549|469658596|FG000|Overall Study|Study terminated by sponsor|197|||
130462737|NCT01121549|469658596|FG000|Overall Study|Pregnancy|1|||
130462738|NCT01121549|469658596|FG000|Overall Study|Protocol Violation|33|||
130462739|NCT01121549|469658596|FG000|Overall Study|Withdrawal by Subject|16|||
130373263|NCT00256750|469333387|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
130373264|NCT00256750|469333388|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
130373265|NCT00256750|469333389|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
130373266|NCT00211510|469333390|FG000|Overall Study|Physician Decision|3|||
130373267|NCT00211510|469333391|FG001|Overall Study|Physician Decision|1|||
130373268|NCT00211510|469333390|FG000|Overall Study|Withdrawal by Subject|3|||
130373269|NCT00211510|469333391|FG001|Overall Study|Withdrawal by Subject|1|||
130373270|NCT01962896|469333392|FG000|Overall Study|Lack of Efficacy|4|||
130373271|NCT01949506|469333395|FG000|Overall Study|Physician Decision|1|||
130373272|NCT02915016|469333396|FG000|Overall Study|Lost to Follow-up|4|||
130373273|NCT02915016|469333397|FG001|Overall Study|Lost to Follow-up|2|||
130373274|NCT02915016|469333398|FG002|Overall Study|Lost to Follow-up|5|||
130373275|NCT02915016|469333399|FG003|Overall Study|Lost to Follow-up|3|||
130373276|NCT02915016|469333400|FG004|Overall Study|Lost to Follow-up|5|||
130373277|NCT02915016|469333401|FG005|Overall Study|Lost to Follow-up|2|||
130373278|NCT02915016|469333402|FG006|Overall Study|Lost to Follow-up|8|||
130373279|NCT02915016|469333403|FG007|Overall Study|Lost to Follow-up|2|||
130373280|NCT02915016|469333396|FG000|Overall Study|Physician Decision|0|||
130373281|NCT02915016|469333397|FG001|Overall Study|Physician Decision|0|||
130373282|NCT02915016|469333398|FG002|Overall Study|Physician Decision|1|||
130373283|NCT02915016|469333399|FG003|Overall Study|Physician Decision|0|||
130373284|NCT02915016|469333400|FG004|Overall Study|Physician Decision|0|||
130373285|NCT02915016|469333401|FG005|Overall Study|Physician Decision|1|||
130373286|NCT02915016|469333402|FG006|Overall Study|Physician Decision|2|||
130373287|NCT02915016|469333403|FG007|Overall Study|Physician Decision|0|||
130373288|NCT02915016|469333396|FG000|Overall Study|Withdrawal by Subject|2|||
130373289|NCT02915016|469333397|FG001|Overall Study|Withdrawal by Subject|0|||
130373290|NCT02915016|469333398|FG002|Overall Study|Withdrawal by Subject|1|||
130373291|NCT02915016|469333399|FG003|Overall Study|Withdrawal by Subject|0|||
130373292|NCT02915016|469333400|FG004|Overall Study|Withdrawal by Subject|1|||
130373293|NCT02915016|469333401|FG005|Overall Study|Withdrawal by Subject|3|||
130373294|NCT02915016|469333402|FG006|Overall Study|Withdrawal by Subject|1|||
130373295|NCT02915016|469333403|FG007|Overall Study|Withdrawal by Subject|1|||
130373296|NCT02915016|469333396|FG000|Overall Study|Elected not to continue|0|||
130373297|NCT02915016|469333397|FG001|Overall Study|Elected not to continue|0|||
130373298|NCT02915016|469333398|FG002|Overall Study|Elected not to continue|0|||
130373299|NCT02915016|469333399|FG003|Overall Study|Elected not to continue|1|||
130373300|NCT02915016|469333400|FG004|Overall Study|Elected not to continue|0|||
130373301|NCT02915016|469333401|FG005|Overall Study|Elected not to continue|0|||
130373302|NCT02915016|469333402|FG006|Overall Study|Elected not to continue|1|||
130373303|NCT02915016|469333403|FG007|Overall Study|Elected not to continue|0|||
130373304|NCT02915016|469333396|FG000|Overall Study|HIV infection|1|||
130373305|NCT02915016|469333397|FG001|Overall Study|HIV infection|1|||
130373306|NCT02915016|469333398|FG002|Overall Study|HIV infection|1|||
130373307|NCT02915016|469333399|FG003|Overall Study|HIV infection|0|||
130373308|NCT02915016|469333400|FG004|Overall Study|HIV infection|1|||
130373309|NCT02915016|469333401|FG005|Overall Study|HIV infection|0|||
130373310|NCT02915016|469333402|FG006|Overall Study|HIV infection|0|||
130373311|NCT02915016|469333403|FG007|Overall Study|HIV infection|0|||
130373312|NCT02915016|469333396|FG000|Overall Study|Participant unable to adhere|0|||
130373313|NCT02915016|469333397|FG001|Overall Study|Participant unable to adhere|0|||
130373314|NCT02915016|469333398|FG002|Overall Study|Participant unable to adhere|0|||
130373315|NCT02915016|469333399|FG003|Overall Study|Participant unable to adhere|0|||
130373316|NCT02915016|469333400|FG004|Overall Study|Participant unable to adhere|0|||
130373317|NCT02915016|469333401|FG005|Overall Study|Participant unable to adhere|0|||
130373318|NCT02915016|469333402|FG006|Overall Study|Participant unable to adhere|0|||
130373319|NCT02915016|469333403|FG007|Overall Study|Participant unable to adhere|1|||
130373320|NCT05425745|469333413|FG000|Overall Study|Withdrawal of Consent|3|||
130373321|NCT05425745|469333414|FG001|Overall Study|Withdrawal of Consent|3|||
130373322|NCT05425745|469333413|FG000|Overall Study|Death|2|||
130373323|NCT05425745|469333414|FG001|Overall Study|Death|3|||
130373324|NCT05425745|469333413|FG000|Overall Study|Lost to Follow-up|1|||
130373325|NCT05425745|469333414|FG001|Overall Study|Lost to Follow-up|2|||
130373326|NCT05425745|469333413|FG000|Overall Study|Adverse Event|0|||
130373327|NCT05425745|469333414|FG001|Overall Study|Adverse Event|1|||
130373328|NCT05425745|469333413|FG000|Overall Study|Did not return for end of study visit|0|||
130373329|NCT05425745|469333414|FG001|Overall Study|Did not return for end of study visit|1|||
130373330|NCT05425745|469333413|FG000|Overall Study|End of study visit completed by phone|1|||
130373331|NCT05425745|469333414|FG001|Overall Study|End of study visit completed by phone|0|||
130373332|NCT05425745|469333413|FG000|Overall Study|Subject decision|1|||
130373333|NCT05425745|469333414|FG001|Overall Study|Subject decision|0|||
130373334|NCT02820753|469334948|FG000|2 Month|Withdrawal by Subject|3|||
130373335|NCT02820753|469334949|FG001|2 Month|Withdrawal by Subject|3|||
130373336|NCT02820753|469334948|FG000|2 Month|Lost to Follow-up|24|||
130373337|NCT02820753|469334949|FG001|2 Month|Lost to Follow-up|26|||
130373338|NCT02820753|469334948|FG000|2 Month|Stopped per NIH Hold|51|||
130462740|NCT01121549|469658596|FG000|Overall Study|Other|58|||
130462741|NCT04789408|469658597|FG000|Overall Study|Death|4|||
130462742|NCT04789408|469658598|FG001|Overall Study|Death|3|||
130462743|NCT04789408|469658599|FG002|Overall Study|Death|6|||
130462744|NCT04789408|469658597|FG000|Overall Study|Did not meet eligibility criteria|1|||
130462745|NCT04789408|469658598|FG001|Overall Study|Did not meet eligibility criteria|0|||
130462746|NCT04789408|469658599|FG002|Overall Study|Did not meet eligibility criteria|0|||
130462747|NCT04789408|469658597|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
130303163|NCT00391027|469073442|FG000|Overall Study|Withdrawal by Subject|10|||
130303164|NCT00391027|469073443|FG001|Overall Study|Withdrawal by Subject|1|||
130303165|NCT00391027|469073442|FG000|Overall Study|Other|4|||
130303166|NCT00391027|469073443|FG001|Overall Study|Other|3|||
130303167|NCT01846741|469073451|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
130303168|NCT01628965|469073452|FG000|Overall Study|Adverse Event|30|||
130303169|NCT01628965|469073452|FG000|Overall Study|Lack of Efficacy|7|||
130303170|NCT01628965|469073452|FG000|Overall Study|Withdrawal by Subject|3|||
130303171|NCT01628965|469073452|FG000|Overall Study|Lost to Follow-up|1|||
130303172|NCT01628965|469073452|FG000|Overall Study|Discontinuation criteria|8|||
130303173|NCT00360568|469073454|FG000|Overall Study|Adverse Event|1|||
130303174|NCT00360568|469073455|FG001|Overall Study|Adverse Event|2|||
130303175|NCT00360568|469073454|FG000|Overall Study|Lack of Efficacy|1|||
130303176|NCT00360568|469073455|FG001|Overall Study|Lack of Efficacy|0|||
130303177|NCT00360568|469073454|FG000|Overall Study|Withdrawal by Subject|0|||
130303178|NCT00360568|469073455|FG001|Overall Study|Withdrawal by Subject|3|||
130303179|NCT04006392|469073456|FG000|Overall Study|Lost to Follow-up|0|||
130303180|NCT04006392|469073457|FG001|Overall Study|Lost to Follow-up|1|||
130303181|NCT03824587|469073458|FG000|Run-in Period|Screen Failure|0|||
130303182|NCT03824587|469073459|FG001|Run-in Period|Screen Failure|275|||
130303183|NCT03824587|469073458|FG000|Treatment Period|Adverse Event|4|||
130303184|NCT03824587|469073459|FG001|Treatment Period|Adverse Event|1|||
130303185|NCT03824587|469073458|FG000|Treatment Period|Withdrawal by Subject|0|||
130303186|NCT03824587|469073459|FG001|Treatment Period|Withdrawal by Subject|1|||
130462748|NCT04789408|469658598|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
130462749|NCT04789408|469658599|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
130462750|NCT01420549|469658600|FG000|Overall Study|Adverse Event|1|||
130462751|NCT01420549|469658601|FG001|Overall Study|Adverse Event|1|||
130462752|NCT01420549|469658600|FG000|Overall Study|Lost to Follow-up|2|||
130462753|NCT01420549|469658601|FG001|Overall Study|Lost to Follow-up|2|||
130462754|NCT01420549|469658600|FG000|Overall Study|Protocol Violation|0|||
130462755|NCT01420549|469658601|FG001|Overall Study|Protocol Violation|1|||
130462756|NCT01420549|469658600|FG000|Overall Study|Non-adherence to medication|4|||
130462757|NCT01420549|469658601|FG001|Overall Study|Non-adherence to medication|1|||
130462758|NCT00493649|469660130|FG000|Overall Study|Adverse Event|44|||
130462759|NCT00493649|469660130|FG000|Overall Study|Patient Request|21|||
130462760|NCT00493649|469660130|FG000|Overall Study|Investigator Request|2|||
130462761|NCT00493649|469660130|FG000|Overall Study|Disease Progression|1|||
130462762|NCT00493649|469660130|FG000|Overall Study|Lost to Follow-up|1|||
130462763|NCT00493649|469660130|FG000|Overall Study|Other|13|||
130462764|NCT05219253|469660131|FG000|Overall Study|Withdrawal by Subject|1|||
130462765|NCT05219253|469660132|FG001|Overall Study|Withdrawal by Subject|2|||
130462766|NCT03086369|469660133|FG000|Overall Study|Lost to Follow-up|1|||
130462767|NCT03086369|469660134|FG001|Overall Study|Lost to Follow-up|0|||
130462768|NCT03086369|469660135|FG002|Overall Study|Lost to Follow-up|0|||
130462769|NCT03086369|469660136|FG003|Overall Study|Lost to Follow-up|2|||
130462770|NCT03086369|469660137|FG004|Overall Study|Lost to Follow-up|1|||
130462771|NCT03086369|469660133|FG000|Overall Study|Physician Decision|0|||
130462772|NCT03086369|469660134|FG001|Overall Study|Physician Decision|0|||
130303187|NCT03824587|469073458|FG000|Treatment Period|Kidney Transplant|1|||
130303188|NCT03824587|469073459|FG001|Treatment Period|Kidney Transplant|1|||
130303189|NCT00986362|469073460|FG000|Overall Study|Death|2|||
130303190|NCT00986362|469073461|FG001|Overall Study|Death|0|||
130303191|NCT00986362|469073460|FG000|Overall Study|Lost to Follow-up|0|||
130303192|NCT00986362|469073461|FG001|Overall Study|Lost to Follow-up|1|||
130303193|NCT02006979|469073462|FG000|Overall Study|Withdrawal by Subject|1|||
130303194|NCT02006979|469073463|FG001|Overall Study|Withdrawal by Subject|1|||
130462773|NCT03086369|469660135|FG002|Overall Study|Physician Decision|0|||
130462774|NCT03086369|469660136|FG003|Overall Study|Physician Decision|1|||
130462775|NCT03086369|469660137|FG004|Overall Study|Physician Decision|2|||
130462776|NCT03086369|469660133|FG000|Overall Study|Withdrawal by Subject|0|||
130462777|NCT03086369|469660134|FG001|Overall Study|Withdrawal by Subject|0|||
130716680|NCT03107026|470590898|FG001|Overall Study|Withdrawal by Subject|5|||
130716681|NCT03107026|470590899|FG002|Overall Study|Withdrawal by Subject|17|||
130303195|NCT02006979|469073462|FG000|Overall Study|Protocol Violation|0|||
130303196|NCT02006979|469073463|FG001|Overall Study|Protocol Violation|1|||
130303197|NCT03170193|469073464|FG000|Overall Study|Withdrawal by Subject|0|||
130303198|NCT03170193|469073465|FG001|Overall Study|Withdrawal by Subject|0|||
130462778|NCT03086369|469660135|FG002|Overall Study|Withdrawal by Subject|0|||
130462779|NCT03086369|469660136|FG003|Overall Study|Withdrawal by Subject|5|||
130462780|NCT03086369|469660137|FG004|Overall Study|Withdrawal by Subject|3|||
130462781|NCT03086369|469660133|FG000|Overall Study|Progressive Disease|0|||
130462782|NCT03086369|469660134|FG001|Overall Study|Progressive Disease|0|||
130462783|NCT03086369|469660135|FG002|Overall Study|Progressive Disease|0|||
130462784|NCT03086369|469660136|FG003|Overall Study|Progressive Disease|1|||
130462785|NCT03086369|469660137|FG004|Overall Study|Progressive Disease|1|||
130462786|NCT01765543|469660143|FG000|Overall Study|Death|1|||
130462787|NCT01765543|469660143|FG000|Overall Study|Withdrawal by Subject|2|||
130462788|NCT01424397|469660144|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462789|NCT01424397|469660145|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462790|NCT01424397|469660146|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
130462791|NCT01424397|469660147|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462792|NCT01424397|469660148|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462793|NCT01424397|469660149|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462794|NCT01424397|469660150|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462795|NCT01424397|469660151|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462796|NCT01424397|469660152|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462797|NCT01424397|469660153|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462798|NCT01424397|469660154|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462799|NCT01424397|469660155|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
130462800|NCT05876949|469660156|FG000|Overall Study|Withdrawal by Subject|1|||
130462801|NCT05876949|469660157|FG001|Overall Study|Withdrawal by Subject|3|||
130462802|NCT05876949|469660156|FG000|Overall Study|Physician Decision|0|||
130462803|NCT05876949|469660157|FG001|Overall Study|Physician Decision|2|||
130462804|NCT05876949|469660156|FG000|Overall Study|Death|0|||
130462805|NCT05876949|469660157|FG001|Overall Study|Death|1|||
130462806|NCT03644849|469660158|FG000|Overall Study|Lost to Follow-up|1|||
130462807|NCT03644849|469660159|FG001|Overall Study|Lost to Follow-up|3|||
130462808|NCT02755805|469660160|FG000|Overall Study|Lost to Follow-up|1|||
130462809|NCT02755805|469660161|FG001|Overall Study|Lost to Follow-up|2|||
130462810|NCT02755805|469660160|FG000|Overall Study|Refused assessments|1|||
130462811|NCT02755805|469660161|FG001|Overall Study|Refused assessments|0|||
130462812|NCT02755805|469660160|FG000|Overall Study|Withdrawal by Subject|0|||
130462813|NCT02755805|469660161|FG001|Overall Study|Withdrawal by Subject|2|||
130462814|NCT02252042|469660164|FG000|Overall Study|Adverse Event|9|||
130462815|NCT02252042|469660165|FG001|Overall Study|Adverse Event|6|||
130462816|NCT02252042|469660164|FG000|Overall Study|Death|209|||
130462817|NCT02252042|469660165|FG001|Overall Study|Death|217|||
130462818|NCT02252042|469660164|FG000|Overall Study|Physician Decision|0|||
130462819|NCT02252042|469660165|FG001|Overall Study|Physician Decision|2|||
130462820|NCT02252042|469660164|FG000|Overall Study|Transferred to Extension Study|7|||
130462821|NCT02252042|469660165|FG001|Overall Study|Transferred to Extension Study|1|||
130462822|NCT02252042|469660164|FG000|Overall Study|Did Not Continue on Extension Study|7|||
130462823|NCT02252042|469660165|FG001|Overall Study|Did Not Continue on Extension Study|2|||
130303199|NCT03170193|469073466|FG002|Overall Study|Withdrawal by Subject|0|||
130303200|NCT03170193|469073467|FG003|Overall Study|Withdrawal by Subject|1|||
130303201|NCT03170193|469073468|FG004|Overall Study|Withdrawal by Subject|0|||
130303202|NCT03170193|469073469|FG005|Overall Study|Withdrawal by Subject|0|||
130303203|NCT03170193|469073470|FG006|Overall Study|Withdrawal by Subject|0|||
130303204|NCT03170193|469073464|FG000|Overall Study|Lost to Follow-up|1|||
130303205|NCT03170193|469073465|FG001|Overall Study|Lost to Follow-up|1|||
130303206|NCT03170193|469073466|FG002|Overall Study|Lost to Follow-up|0|||
130303207|NCT03170193|469073467|FG003|Overall Study|Lost to Follow-up|0|||
130303208|NCT03170193|469073468|FG004|Overall Study|Lost to Follow-up|0|||
130303209|NCT03170193|469073469|FG005|Overall Study|Lost to Follow-up|0|||
130303210|NCT03170193|469073470|FG006|Overall Study|Lost to Follow-up|0|||
130303211|NCT01368081|469073471|FG000|Overall Study|Adverse Event|4|||
130303212|NCT01368081|469073472|FG001|Overall Study|Adverse Event|4|||
130303213|NCT01368081|469073473|FG002|Overall Study|Adverse Event|3|||
130303214|NCT01368081|469073474|FG003|Overall Study|Adverse Event|2|||
130303215|NCT01368081|469073475|FG004|Overall Study|Adverse Event|2|||
130303216|NCT01368081|469073476|FG005|Overall Study|Adverse Event|5|||
130303217|NCT01368081|469073477|FG006|Overall Study|Adverse Event|6|||
130303218|NCT01368081|469073478|FG007|Overall Study|Adverse Event|2|||
130303219|NCT01368081|469073479|FG008|Overall Study|Adverse Event|3|||
130303220|NCT01368081|469073480|FG009|Overall Study|Adverse Event|5|||
130303221|NCT01368081|469073481|FG010|Overall Study|Adverse Event|6|||
130303222|NCT01368081|469073482|FG011|Overall Study|Adverse Event|1|||
130303223|NCT01368081|469073483|FG012|Overall Study|Adverse Event|3|||
130303224|NCT01368081|469073471|FG000|Overall Study|Lack of Efficacy|0|||
130303225|NCT01368081|469073472|FG001|Overall Study|Lack of Efficacy|1|||
130303226|NCT01368081|469073473|FG002|Overall Study|Lack of Efficacy|0|||
130303227|NCT01368081|469073474|FG003|Overall Study|Lack of Efficacy|1|||
130462824|NCT02252042|469660164|FG000|Overall Study|Withdrawal by Subject|15|||
130462825|NCT02252042|469660165|FG001|Overall Study|Withdrawal by Subject|20|||
130462826|NCT02593149|469660166|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
130303228|NCT01368081|469073475|FG004|Overall Study|Lack of Efficacy|0|||
130303229|NCT01368081|469073476|FG005|Overall Study|Lack of Efficacy|0|||
130303230|NCT01368081|469073477|FG006|Overall Study|Lack of Efficacy|0|||
130462827|NCT02593149|469660167|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
130462828|NCT02593149|469660166|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
130462829|NCT02593149|469660167|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
130462830|NCT01177670|469660169|FG000|Overall Study|Study Terminated|115|||
130462831|NCT01177670|469660169|FG000|Overall Study|Physician Decision|50|||
130462832|NCT01177670|469660169|FG000|Overall Study|Withdrawal by Subject|4|||
130462833|NCT03691428|469660174|FG000|Overall Study|Withdrawal by Subject|6|||
130462834|NCT03691428|469660175|FG001|Overall Study|Withdrawal by Subject|8|||
130462835|NCT02527148|469660176|FG000|Overall Study|Did not receive study intervention|1|||
130462836|NCT02527148|469660177|FG001|Overall Study|Did not receive study intervention|0|||
130462837|NCT01140048|469660182|FG000|Overall Study|Physician Decision|1|||
130462838|NCT01140048|469660182|FG000|Overall Study|Withdrawal by Subject|13|||
130462839|NCT01140048|469660182|FG000|Overall Study|Lost to Follow-up|31|||
130462840|NCT01831791|469660183|FG000|Overall Study|Withdrawal by Subject|10|||
130462841|NCT00494780|469660184|FG000|Overall Study|Adverse Event|1|||
130462842|NCT00494780|469660185|FG001|Overall Study|Adverse Event|0|||
130462843|NCT00494780|469660184|FG000|Overall Study|Withdrew before Dosed|0|||
130462844|NCT00494780|469660185|FG001|Overall Study|Withdrew before Dosed|1|||
130462845|NCT00494780|469660184|FG000|Overall Study|Progression of Study Disease|7|||
130462846|NCT00494780|469660185|FG001|Overall Study|Progression of Study Disease|8|||
130462847|NCT00494780|469660184|FG000|Overall Study|New Treatment|2|||
130462848|NCT00494780|469660185|FG001|Overall Study|New Treatment|2|||
130462849|NCT00494780|469660184|FG000|Overall Study|Non-compliance|1|||
130462850|NCT00494780|469660185|FG001|Overall Study|Non-compliance|0|||
130462851|NCT00494780|469660184|FG000|Overall Study|Residual Tumour Mass|0|||
130462852|NCT00494780|469660185|FG001|Overall Study|Residual Tumour Mass|1|||
130462853|NCT00494780|469660184|FG000|Overall Study|Insurance Issues|0|||
130462854|NCT00494780|469660185|FG001|Overall Study|Insurance Issues|1|||
130462855|NCT01254019|469660186|FG000|Overall Study|Adverse Event|0|||
130462856|NCT01254019|469660187|FG001|Overall Study|Adverse Event|2|||
130462857|NCT01254019|469660186|FG000|Overall Study|Protocol Violation|1|||
130462858|NCT01254019|469660187|FG001|Overall Study|Protocol Violation|0|||
130462859|NCT01254019|469660186|FG000|Overall Study|Withdrawal by Subject|0|||
130462860|NCT01254019|469660187|FG001|Overall Study|Withdrawal by Subject|2|||
130462861|NCT03061474|469660188|FG000|Overall Study|Adverse Event|2|||
130462862|NCT03061474|469660189|FG001|Overall Study|Adverse Event|0|||
130462863|NCT03061474|469660188|FG000|Overall Study|Safety Risk|0|||
130462864|NCT03061474|469660189|FG001|Overall Study|Safety Risk|1|||
130462865|NCT03061474|469660188|FG000|Overall Study|Participant unwilling or unable to participate|0|||
130462866|NCT03061474|469660189|FG001|Overall Study|Participant unwilling or unable to participate|2|||
130462867|NCT03061474|469660188|FG000|Overall Study|Lost to Follow-up|0|||
130462868|NCT03061474|469660189|FG001|Overall Study|Lost to Follow-up|1|||
130462869|NCT02888080|469660190|FG000|Overall Study|Subject / Guardian decision|1|||
130462870|NCT02888080|469660191|FG001|Overall Study|Subject / Guardian decision|3|||
130462871|NCT02888080|469660190|FG000|Overall Study|New Therapy for study indication|1|||
130462872|NCT02888080|469660191|FG001|Overall Study|New Therapy for study indication|0|||
130462873|NCT02888080|469660190|FG000|Overall Study|Lack of Efficacy|0|||
130462874|NCT02888080|469660191|FG001|Overall Study|Lack of Efficacy|1|||
130462875|NCT02888080|469660190|FG000|Overall Study|Adverse Event|0|||
130462876|NCT02888080|469660191|FG001|Overall Study|Adverse Event|1|||
130462877|NCT00845832|469660192|FG000|Treatment Period|Adverse Event|0|||
130462878|NCT00845832|469660193|FG001|Treatment Period|Adverse Event|2|||
130462879|NCT00845832|469660194|FG002|Treatment Period|Adverse Event|0|||
130462880|NCT00845832|469660192|FG000|Treatment Period|Protocol Violation|1|||
130462881|NCT00845832|469660193|FG001|Treatment Period|Protocol Violation|1|||
130462882|NCT00845832|469660194|FG002|Treatment Period|Protocol Violation|0|||
130462883|NCT00845832|469660192|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
130462884|NCT00845832|469660193|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
130462885|NCT00845832|469660194|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
130462886|NCT00845832|469660192|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
130462887|NCT00845832|469660193|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
130462888|NCT00845832|469660194|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
130462889|NCT00189202|469660199|FG000|Overall Study|Physician Decision|5|||
130462890|NCT00980330|469660200|FG000|Overall Study|Adverse Event|0|||
130462891|NCT00980330|469660201|FG001|Overall Study|Adverse Event|0|||
130462892|NCT00980330|469660202|FG002|Overall Study|Adverse Event|0|||
130462893|NCT00980330|469660203|FG003|Overall Study|Adverse Event|1|||
130462894|NCT00980330|469660204|FG004|Overall Study|Adverse Event|0|||
130462895|NCT00980330|469660205|FG005|Overall Study|Adverse Event|0|||
130462896|NCT00980330|469660206|FG006|Overall Study|Adverse Event|0|||
130462897|NCT00980330|469660200|FG000|Overall Study|Lost to Follow-up|1|||
130462898|NCT00980330|469660201|FG001|Overall Study|Lost to Follow-up|1|||
130462899|NCT00980330|469660202|FG002|Overall Study|Lost to Follow-up|4|||
130462900|NCT00980330|469660203|FG003|Overall Study|Lost to Follow-up|2|||
130303231|NCT01368081|469073478|FG007|Overall Study|Lack of Efficacy|2|||
130462901|NCT00980330|469660204|FG004|Overall Study|Lost to Follow-up|1|||
130462902|NCT00980330|469660205|FG005|Overall Study|Lost to Follow-up|1|||
130462903|NCT00980330|469660206|FG006|Overall Study|Lost to Follow-up|2|||
130462904|NCT00980330|469660200|FG000|Overall Study|Withdrawal by Subject|2|||
130462905|NCT00980330|469660201|FG001|Overall Study|Withdrawal by Subject|4|||
130462906|NCT00980330|469660202|FG002|Overall Study|Withdrawal by Subject|4|||
130462907|NCT00980330|469660203|FG003|Overall Study|Withdrawal by Subject|1|||
130462908|NCT00980330|469660204|FG004|Overall Study|Withdrawal by Subject|3|||
130462909|NCT00980330|469660205|FG005|Overall Study|Withdrawal by Subject|2|||
130462910|NCT00980330|469660206|FG006|Overall Study|Withdrawal by Subject|5|||
130462911|NCT00980330|469660200|FG000|Overall Study|(not specified)|2|||
130462912|NCT00980330|469660201|FG001|Overall Study|(not specified)|0|||
130462913|NCT00980330|469660202|FG002|Overall Study|(not specified)|0|||
130462914|NCT00980330|469660203|FG003|Overall Study|(not specified)|1|||
130462915|NCT00980330|469660204|FG004|Overall Study|(not specified)|1|||
130462916|NCT00980330|469660205|FG005|Overall Study|(not specified)|1|||
130462917|NCT00980330|469660206|FG006|Overall Study|(not specified)|0|||
130462918|NCT00666276|469660209|FG000|Overall Study|Protocol Violation|34|||
130462919|NCT00665444|469660212|FG000|Overall Study|Physician Decision|1|||
130462920|NCT00665444|469660212|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
130462921|NCT03299816|469660213|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
130462922|NCT03299816|469660214|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
130462923|NCT03299816|469660213|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
130462924|NCT03299816|469660214|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
130462925|NCT03299816|469660213|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
130462926|NCT03299816|469660214|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
130462927|NCT03520413|469660215|FG000|Overall Study|Lost to Follow-up|1|||
130462928|NCT03520413|469660216|FG001|Overall Study|Lost to Follow-up|1|||
130462929|NCT03520413|469660215|FG000|Overall Study|Withdrawal by Subject|1|||
130462930|NCT03520413|469660216|FG001|Overall Study|Withdrawal by Subject|2|||
130462931|NCT03520413|469660215|FG000|Overall Study|Death|0|||
130462932|NCT03520413|469660216|FG001|Overall Study|Death|1|||
130462933|NCT03520413|469660215|FG000|Overall Study|Physician Decision|3|||
130462934|NCT03520413|469660216|FG001|Overall Study|Physician Decision|3|||
130462935|NCT03520413|469660215|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
130462936|NCT03520413|469660216|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
130462937|NCT00869323|469660219|FG000|Maintenance Therapy|concurrent illness|1|||
130462938|NCT01135511|469660220|FG000|Overall Study|Adverse Event|0|||
130462939|NCT01135511|469660221|FG001|Overall Study|Adverse Event|1|||
130462940|NCT01135511|469660222|FG002|Overall Study|Adverse Event|2|||
130462941|NCT01135511|469660223|FG003|Overall Study|Adverse Event|0|||
130462942|NCT01135511|469660224|FG004|Overall Study|Adverse Event|0|||
130462943|NCT01135511|469660225|FG005|Overall Study|Adverse Event|1|||
130462944|NCT01135511|469660226|FG006|Overall Study|Adverse Event|0|||
130462945|NCT01135511|469660227|FG007|Overall Study|Adverse Event|1|||
130462946|NCT01135511|469660228|FG008|Overall Study|Adverse Event|0|||
130462947|NCT01135511|469660220|FG000|Overall Study|Lack of Efficacy|0|||
130462948|NCT01135511|469660221|FG001|Overall Study|Lack of Efficacy|1|||
130462949|NCT01135511|469660222|FG002|Overall Study|Lack of Efficacy|1|||
130462950|NCT01135511|469660223|FG003|Overall Study|Lack of Efficacy|2|||
130462951|NCT01135511|469660224|FG004|Overall Study|Lack of Efficacy|0|||
130462952|NCT01135511|469660225|FG005|Overall Study|Lack of Efficacy|0|||
130462953|NCT01135511|469660226|FG006|Overall Study|Lack of Efficacy|0|||
130462954|NCT01135511|469660227|FG007|Overall Study|Lack of Efficacy|0|||
130462955|NCT01135511|469660228|FG008|Overall Study|Lack of Efficacy|0|||
130462956|NCT01135511|469660220|FG000|Overall Study|Protocol Violation|0|||
130462957|NCT01135511|469660221|FG001|Overall Study|Protocol Violation|0|||
130303232|NCT01368081|469073479|FG008|Overall Study|Lack of Efficacy|0|||
130462958|NCT01135511|469660222|FG002|Overall Study|Protocol Violation|3|||
130462959|NCT01135511|469660223|FG003|Overall Study|Protocol Violation|0|||
130462960|NCT01135511|469660224|FG004|Overall Study|Protocol Violation|0|||
130716682|NCT03107026|470590897|FG000|Overall Study|non compliance with study visits|1|||
130716683|NCT03107026|470590898|FG001|Overall Study|non compliance with study visits|2|||
130716684|NCT03107026|470590899|FG002|Overall Study|non compliance with study visits|0|||
130716685|NCT03107026|470590897|FG000|Overall Study|non-compliance with study drug|2|||
130716686|NCT03107026|470590898|FG001|Overall Study|non-compliance with study drug|2|||
130716687|NCT03107026|470590899|FG002|Overall Study|non-compliance with study drug|3|||
130716688|NCT03107026|470590897|FG000|Overall Study|Physician Decision|0|||
130716689|NCT03107026|470590898|FG001|Overall Study|Physician Decision|1|||
130303233|NCT01368081|469073480|FG009|Overall Study|Lack of Efficacy|0|||
130462961|NCT01135511|469660225|FG005|Overall Study|Protocol Violation|0|||
130462962|NCT01135511|469660226|FG006|Overall Study|Protocol Violation|0|||
130462963|NCT01135511|469660227|FG007|Overall Study|Protocol Violation|0|||
130462964|NCT01135511|469660228|FG008|Overall Study|Protocol Violation|0|||
130462965|NCT01135511|469660220|FG000|Overall Study|Pregnancy|0|||
130462966|NCT01135511|469660221|FG001|Overall Study|Pregnancy|0|||
130462967|NCT01135511|469660222|FG002|Overall Study|Pregnancy|0|||
130462968|NCT01135511|469660223|FG003|Overall Study|Pregnancy|1|||
130462969|NCT01135511|469660224|FG004|Overall Study|Pregnancy|0|||
130462970|NCT01135511|469660225|FG005|Overall Study|Pregnancy|0|||
130462971|NCT01135511|469660226|FG006|Overall Study|Pregnancy|0|||
130462972|NCT01135511|469660227|FG007|Overall Study|Pregnancy|0|||
130462973|NCT01135511|469660228|FG008|Overall Study|Pregnancy|0|||
130462974|NCT01135511|469660220|FG000|Overall Study|could not visit the clinic|0|||
130462975|NCT01135511|469660221|FG001|Overall Study|could not visit the clinic|1|||
130462976|NCT01135511|469660222|FG002|Overall Study|could not visit the clinic|2|||
130462977|NCT01135511|469660223|FG003|Overall Study|could not visit the clinic|0|||
130462978|NCT01135511|469660224|FG004|Overall Study|could not visit the clinic|0|||
130462979|NCT01135511|469660225|FG005|Overall Study|could not visit the clinic|0|||
130462980|NCT01135511|469660226|FG006|Overall Study|could not visit the clinic|0|||
130462981|NCT01135511|469660227|FG007|Overall Study|could not visit the clinic|0|||
130462982|NCT01135511|469660228|FG008|Overall Study|could not visit the clinic|0|||
130462983|NCT01135511|469660220|FG000|Overall Study|noncompliance with study drug taken|0|||
130462984|NCT01135511|469660221|FG001|Overall Study|noncompliance with study drug taken|0|||
130462985|NCT01135511|469660222|FG002|Overall Study|noncompliance with study drug taken|0|||
130462986|NCT01135511|469660223|FG003|Overall Study|noncompliance with study drug taken|0|||
130462987|NCT01135511|469660224|FG004|Overall Study|noncompliance with study drug taken|1|||
130462988|NCT01135511|469660225|FG005|Overall Study|noncompliance with study drug taken|0|||
130462989|NCT01135511|469660226|FG006|Overall Study|noncompliance with study drug taken|0|||
130462990|NCT01135511|469660227|FG007|Overall Study|noncompliance with study drug taken|0|||
130462991|NCT01135511|469660228|FG008|Overall Study|noncompliance with study drug taken|0|||
130462992|NCT01135511|469660220|FG000|Overall Study|Withdrawal by Subject|0|||
130462993|NCT01135511|469660221|FG001|Overall Study|Withdrawal by Subject|0|||
130462994|NCT01135511|469660222|FG002|Overall Study|Withdrawal by Subject|0|||
130462995|NCT01135511|469660223|FG003|Overall Study|Withdrawal by Subject|0|||
130462996|NCT01135511|469660224|FG004|Overall Study|Withdrawal by Subject|0|||
130462997|NCT01135511|469660225|FG005|Overall Study|Withdrawal by Subject|0|||
130462998|NCT01135511|469660226|FG006|Overall Study|Withdrawal by Subject|1|||
130462999|NCT01135511|469660227|FG007|Overall Study|Withdrawal by Subject|0|||
130463000|NCT01135511|469660228|FG008|Overall Study|Withdrawal by Subject|1|||
130463001|NCT00891930|469660231|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
130463002|NCT00891930|469660231|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
130463003|NCT00891930|469660231|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
130463004|NCT00891930|469660231|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
130463005|NCT00891930|469660231|FG000|Part 2 Panitumumab + AMG479|Death|30|||
130463006|NCT00638963|469660232|FG000|Overall Study|Withdrawal by Subject|1|||
130463007|NCT00638963|469660233|FG001|Overall Study|Withdrawal by Subject|0|||
130463008|NCT05001945|469660237|FG000|Overall Study|Adverse Event|0|||
130463009|NCT05001945|469660238|FG001|Overall Study|Adverse Event|0|||
130463010|NCT05001945|469660239|FG002|Overall Study|Adverse Event|0|||
130463011|NCT05001945|469660240|FG003|Overall Study|Adverse Event|1|||
130463012|NCT05001945|469660241|FG004|Overall Study|Adverse Event|0|||
130463013|NCT05001945|469660242|FG005|Overall Study|Adverse Event|0|||
130463014|NCT05001945|469660243|FG006|Overall Study|Adverse Event|0|||
130463015|NCT05001945|469660244|FG007|Overall Study|Adverse Event|0|||
130463016|NCT05001945|469660237|FG000|Overall Study|Lost to Follow-up|0|||
130463017|NCT05001945|469660238|FG001|Overall Study|Lost to Follow-up|1|||
130463018|NCT05001945|469660239|FG002|Overall Study|Lost to Follow-up|1|||
130463019|NCT05001945|469660240|FG003|Overall Study|Lost to Follow-up|2|||
130463020|NCT05001945|469660241|FG004|Overall Study|Lost to Follow-up|0|||
130463021|NCT05001945|469660242|FG005|Overall Study|Lost to Follow-up|1|||
130463022|NCT05001945|469660243|FG006|Overall Study|Lost to Follow-up|0|||
130463023|NCT05001945|469660244|FG007|Overall Study|Lost to Follow-up|0|||
130463024|NCT05001945|469660237|FG000|Overall Study|Protocol Violation|1|||
130463025|NCT05001945|469660238|FG001|Overall Study|Protocol Violation|0|||
130463026|NCT05001945|469660239|FG002|Overall Study|Protocol Violation|1|||
130303234|NCT01368081|469073481|FG010|Overall Study|Lack of Efficacy|0|||
130463027|NCT05001945|469660240|FG003|Overall Study|Protocol Violation|1|||
130463028|NCT05001945|469660241|FG004|Overall Study|Protocol Violation|0|||
130463029|NCT05001945|469660242|FG005|Overall Study|Protocol Violation|1|||
130463030|NCT05001945|469660243|FG006|Overall Study|Protocol Violation|0|||
130463031|NCT05001945|469660244|FG007|Overall Study|Protocol Violation|0|||
130463032|NCT05001945|469660237|FG000|Overall Study|Withdrawal by Subject|0|||
130463033|NCT05001945|469660238|FG001|Overall Study|Withdrawal by Subject|0|||
130463034|NCT05001945|469660239|FG002|Overall Study|Withdrawal by Subject|0|||
130463035|NCT05001945|469660240|FG003|Overall Study|Withdrawal by Subject|1|||
130463036|NCT05001945|469660241|FG004|Overall Study|Withdrawal by Subject|1|||
130463037|NCT05001945|469660242|FG005|Overall Study|Withdrawal by Subject|1|||
130463038|NCT05001945|469660243|FG006|Overall Study|Withdrawal by Subject|0|||
130463039|NCT05001945|469660244|FG007|Overall Study|Withdrawal by Subject|1|||
130463040|NCT05001945|469660237|FG000|Overall Study|Not specified by Investigator|0|||
130463041|NCT05001945|469660238|FG001|Overall Study|Not specified by Investigator|3|||
130463042|NCT05001945|469660239|FG002|Overall Study|Not specified by Investigator|0|||
130463043|NCT05001945|469660240|FG003|Overall Study|Not specified by Investigator|0|||
130463044|NCT05001945|469660241|FG004|Overall Study|Not specified by Investigator|1|||
130463045|NCT05001945|469660242|FG005|Overall Study|Not specified by Investigator|0|||
130463046|NCT05001945|469660243|FG006|Overall Study|Not specified by Investigator|0|||
130463047|NCT05001945|469660244|FG007|Overall Study|Not specified by Investigator|0|||
130463048|NCT02425111|469660245|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
130463049|NCT02425111|469660245|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
130463050|NCT02425111|469660245|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
130463051|NCT02425111|469660245|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
130463052|NCT02425111|469660245|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
130463053|NCT02425111|469660245|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
130463054|NCT01444417|469660248|FG000|Overall Study|Ineligibility Determined|0|||
130463055|NCT01444417|469660249|FG001|Overall Study|Ineligibility Determined|1|||
130463056|NCT01444417|469660248|FG000|Overall Study|Withdrawal by Subject|2|||
130463057|NCT01444417|469660249|FG001|Overall Study|Withdrawal by Subject|0|||
130463058|NCT02755116|469660250|FG000|Overall Study|surgery converted to open, pt admitted|3|||
130463059|NCT02755116|469660251|FG001|Overall Study|surgery converted to open, pt admitted|1|||
130463060|NCT01124734|469660252|FG000|Overall Study|Disease progression|13|||
130463061|NCT01124734|469660252|FG000|Overall Study|Adverse Event|1|||
130463062|NCT01124734|469660252|FG000|Overall Study|Withdrawal by Subject|1|||
130463063|NCT01124734|469660252|FG000|Overall Study|Elected for alternative treatment|2|||
130463064|NCT01063972|469660253|FG000|Overall Study|Death|12|||
130463065|NCT01063972|469660254|FG001|Overall Study|Death|11|||
130463066|NCT01063972|469660253|FG000|Overall Study|Incarcerated|2|||
130463067|NCT01063972|469660254|FG001|Overall Study|Incarcerated|1|||
130463068|NCT03475316|469660256|FG000|6 Month Intervention|Adverse Event|2|||
130463069|NCT03475316|469660257|FG001|6 Month Intervention|Adverse Event|1|||
130463070|NCT03475316|469660256|FG000|6 Month Intervention|Withdrawal by Subject|2|||
130463071|NCT03475316|469660257|FG001|6 Month Intervention|Withdrawal by Subject|0|||
130463072|NCT03475316|469660256|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
130463073|NCT03475316|469660257|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
130463074|NCT03475316|469660256|FG000|9 Months|Study stopped due to COVID pandemic|3|||
130463075|NCT03475316|469660257|FG001|9 Months|Study stopped due to COVID pandemic|4|||
130463076|NCT00457743|469660260|FG000|Overall Study|Adverse Event|0|||
130463077|NCT00457743|469660261|FG001|Overall Study|Adverse Event|4|||
130463078|NCT00457743|469660262|FG002|Overall Study|Adverse Event|0|||
130463079|NCT00457743|469660260|FG000|Overall Study|Lack of Efficacy|3|||
130716690|NCT03107026|470590899|FG002|Overall Study|Physician Decision|0|||
130716691|NCT02049450|470590900|FG000|Overall Study|Adverse Event|2|||
130463080|NCT00457743|469660261|FG001|Overall Study|Lack of Efficacy|23|||
130463081|NCT00457743|469660262|FG002|Overall Study|Lack of Efficacy|3|||
130463082|NCT00566527|469660263|FG000|Overall Study|Reason not provided|3|||
130463083|NCT00566527|469660264|FG001|Overall Study|Reason not provided|11|||
130463084|NCT00566527|469660265|FG002|Overall Study|Reason not provided|10|||
130463085|NCT00566527|469660263|FG000|Overall Study|Adverse Event|2|||
130463086|NCT00566527|469660264|FG001|Overall Study|Adverse Event|0|||
130463087|NCT00566527|469660265|FG002|Overall Study|Adverse Event|1|||
130463088|NCT00566527|469660263|FG000|Overall Study|Physician Decision|3|||
130463089|NCT00566527|469660264|FG001|Overall Study|Physician Decision|8|||
130463090|NCT00566527|469660265|FG002|Overall Study|Physician Decision|20|||
130463091|NCT00566527|469660263|FG000|Overall Study|Lost to Follow-up|3|||
130463092|NCT00566527|469660264|FG001|Overall Study|Lost to Follow-up|4|||
130463093|NCT00566527|469660265|FG002|Overall Study|Lost to Follow-up|4|||
130463094|NCT00566527|469660263|FG000|Overall Study|Withdrawal by Subject|6|||
130463095|NCT00566527|469660264|FG001|Overall Study|Withdrawal by Subject|43|||
130463096|NCT00566527|469660265|FG002|Overall Study|Withdrawal by Subject|43|||
130463097|NCT00305695|469660269|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
130463098|NCT00305695|469660270|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
130463099|NCT00305695|469660269|FG000|Overall Study|Did not have baseline scan|1|||
130463100|NCT00305695|469660270|FG001|Overall Study|Did not have baseline scan|1|||
130463101|NCT00206375|469660271|FG000|Overall Study|Lost to Follow-up|1|||
130463102|NCT00206375|469660272|FG001|Overall Study|Lost to Follow-up|0|||
130463103|NCT00206375|469660273|FG002|Overall Study|Lost to Follow-up|0|||
130463104|NCT00206375|469660271|FG000|Overall Study|Withdrawal by Subject|2|||
130716692|NCT02049450|470590900|FG000|Overall Study|Withdrawal by Subject|1|||
130463105|NCT00206375|469660272|FG001|Overall Study|Withdrawal by Subject|1|||
130463106|NCT00206375|469660273|FG002|Overall Study|Withdrawal by Subject|3|||
130716693|NCT02049450|470590900|FG000|Overall Study|Patients/guardian decision|1|||
130463107|NCT00206375|469660271|FG000|Overall Study|Study terminated due to lack of funds|0|||
130463108|NCT00206375|469660272|FG001|Overall Study|Study terminated due to lack of funds|1|||
130463109|NCT00206375|469660273|FG002|Overall Study|Study terminated due to lack of funds|1|||
130716694|NCT04711902|470590901|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
130463110|NCT00979992|469661661|FG000|Overall Study|Ineligible - inadequate pathology|1|||
130463111|NCT00979992|469661661|FG000|Overall Study|Ineligible - wrong cell type|2|||
130463112|NCT00979992|469661661|FG000|Overall Study|Refused - Never Treated|2|||
130463113|NCT04532528|469661665|FG000|Overall Study|Adverse Event|12|||
130463114|NCT04532528|469661666|FG001|Overall Study|Adverse Event|17|||
130463115|NCT04532528|469661665|FG000|Overall Study|Withdrawal of consent|16|||
130463116|NCT04532528|469661666|FG001|Overall Study|Withdrawal of consent|17|||
130463117|NCT04532528|469661665|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
130463118|NCT04532528|469661666|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
130463119|NCT04532528|469661665|FG000|Overall Study|Lost to Follow-up|69|||
130463120|NCT04532528|469661666|FG001|Overall Study|Lost to Follow-up|68|||
130463121|NCT04532528|469661665|FG000|Overall Study|Administrative problems|12|||
130463122|NCT04532528|469661666|FG001|Overall Study|Administrative problems|14|||
130463123|NCT04532528|469661665|FG000|Overall Study|Death|3|||
130463124|NCT04532528|469661666|FG001|Overall Study|Death|3|||
130463125|NCT04532528|469661665|FG000|Overall Study|Other|38|||
130463126|NCT04532528|469661666|FG001|Overall Study|Other|46|||
130463127|NCT01636687|469661667|FG000|Induction Period|Withdrawal by Subject|1|||
130463128|NCT01636687|469661668|FG001|Induction Period|Withdrawal by Subject|0|||
130463129|NCT01636687|469661669|FG002|Induction Period|Withdrawal by Subject|0|||
130463130|NCT01636687|469661670|FG003|Induction Period|Withdrawal by Subject|0|||
130463131|NCT01636687|469661671|FG004|Induction Period|Withdrawal by Subject|0|||
130463132|NCT01636687|469661667|FG000|Induction Period|Adverse Event|1|||
130463133|NCT01636687|469661668|FG001|Induction Period|Adverse Event|0|||
130463134|NCT01636687|469661669|FG002|Induction Period|Adverse Event|0|||
130463135|NCT01636687|469661670|FG003|Induction Period|Adverse Event|0|||
130463136|NCT01636687|469661671|FG004|Induction Period|Adverse Event|1|||
130463137|NCT01636687|469661667|FG000|Induction Period|Lack of Efficacy|0|||
130463138|NCT01636687|469661668|FG001|Induction Period|Lack of Efficacy|0|||
130463139|NCT01636687|469661669|FG002|Induction Period|Lack of Efficacy|0|||
130463140|NCT01636687|469661670|FG003|Induction Period|Lack of Efficacy|0|||
130463141|NCT01636687|469661671|FG004|Induction Period|Lack of Efficacy|1|||
130463142|NCT01636687|469661667|FG000|Induction Period|Physician Decision|1|||
130463143|NCT01636687|469661668|FG001|Induction Period|Physician Decision|0|||
130463144|NCT01636687|469661669|FG002|Induction Period|Physician Decision|0|||
130463145|NCT01636687|469661670|FG003|Induction Period|Physician Decision|0|||
130463146|NCT01636687|469661671|FG004|Induction Period|Physician Decision|0|||
130463147|NCT01636687|469661667|FG000|Maintenance Period|Withdrawal by Subject|2|||
130463148|NCT01636687|469661668|FG001|Maintenance Period|Withdrawal by Subject|0|||
130463149|NCT01636687|469661669|FG002|Maintenance Period|Withdrawal by Subject|2|||
130463150|NCT01636687|469661670|FG003|Maintenance Period|Withdrawal by Subject|0|||
130463151|NCT01636687|469661671|FG004|Maintenance Period|Withdrawal by Subject|0|||
130463152|NCT01636687|469661667|FG000|Maintenance Period|Adverse Event|1|||
130463153|NCT01636687|469661668|FG001|Maintenance Period|Adverse Event|0|||
130303235|NCT01368081|469073482|FG011|Overall Study|Lack of Efficacy|0|||
130303236|NCT01368081|469073483|FG012|Overall Study|Lack of Efficacy|0|||
130303237|NCT01368081|469073471|FG000|Overall Study|Protocol Violation|0|||
130463154|NCT01636687|469661669|FG002|Maintenance Period|Adverse Event|0|||
130463155|NCT01636687|469661670|FG003|Maintenance Period|Adverse Event|0|||
130463156|NCT01636687|469661671|FG004|Maintenance Period|Adverse Event|0|||
130463157|NCT01636687|469661667|FG000|Maintenance Period|Lack of Efficacy|4|||
130463158|NCT01636687|469661668|FG001|Maintenance Period|Lack of Efficacy|1|||
130463159|NCT01636687|469661669|FG002|Maintenance Period|Lack of Efficacy|0|||
130463160|NCT01636687|469661670|FG003|Maintenance Period|Lack of Efficacy|0|||
130463161|NCT01636687|469661671|FG004|Maintenance Period|Lack of Efficacy|0|||
130463162|NCT01636687|469661667|FG000|Maintenance Period|Lost to Follow-up|1|||
130463163|NCT01636687|469661668|FG001|Maintenance Period|Lost to Follow-up|1|||
130463164|NCT01636687|469661669|FG002|Maintenance Period|Lost to Follow-up|0|||
130463165|NCT01636687|469661670|FG003|Maintenance Period|Lost to Follow-up|0|||
130463166|NCT01636687|469661671|FG004|Maintenance Period|Lost to Follow-up|1|||
130463167|NCT01636687|469661667|FG000|Maintenance Period|Physician Decision|0|||
130463168|NCT01636687|469661668|FG001|Maintenance Period|Physician Decision|0|||
130463169|NCT01636687|469661669|FG002|Maintenance Period|Physician Decision|0|||
130463170|NCT01636687|469661670|FG003|Maintenance Period|Physician Decision|0|||
130463171|NCT01636687|469661671|FG004|Maintenance Period|Physician Decision|1|||
130463172|NCT01636687|469661667|FG000|Extension Period|technical problems|0|||
130463173|NCT01636687|469661668|FG001|Extension Period|technical problems|1|||
130463174|NCT01636687|469661669|FG002|Extension Period|technical problems|2|||
130463175|NCT01636687|469661670|FG003|Extension Period|technical problems|1|||
130463176|NCT01636687|469661671|FG004|Extension Period|technical problems|0|||
130463177|NCT01636687|469661667|FG000|Extension Period|Adverse Event|4|||
130463178|NCT01636687|469661668|FG001|Extension Period|Adverse Event|3|||
130463179|NCT01636687|469661669|FG002|Extension Period|Adverse Event|2|||
130463180|NCT01636687|469661670|FG003|Extension Period|Adverse Event|1|||
130463181|NCT01636687|469661671|FG004|Extension Period|Adverse Event|0|||
130463182|NCT01636687|469661667|FG000|Extension Period|Lack of Efficacy|7|||
130463183|NCT01636687|469661668|FG001|Extension Period|Lack of Efficacy|0|||
130463184|NCT01636687|469661669|FG002|Extension Period|Lack of Efficacy|2|||
130463185|NCT01636687|469661670|FG003|Extension Period|Lack of Efficacy|1|||
130463186|NCT01636687|469661671|FG004|Extension Period|Lack of Efficacy|0|||
130463187|NCT01636687|469661667|FG000|Extension Period|Lost to Follow-up|1|||
130303238|NCT01368081|469073472|FG001|Overall Study|Protocol Violation|0|||
130557498|NCT03085758|470011770|FG000|Overall Study|Lost to Follow-up|1|||
130557499|NCT03085758|470011771|FG001|Overall Study|Lost to Follow-up|1|||
130557500|NCT03085758|470011772|FG002|Overall Study|Lost to Follow-up|1|||
130557501|NCT03085758|470011770|FG000|Overall Study|Withdrawal by Subject|2|||
130557502|NCT03085758|470011771|FG001|Overall Study|Withdrawal by Subject|2|||
130557503|NCT03085758|470011772|FG002|Overall Study|Withdrawal by Subject|1|||
130557504|NCT03085758|470011770|FG000|Overall Study|Refusal to recall it up to day 90|0|||
130557505|NCT03085758|470011771|FG001|Overall Study|Refusal to recall it up to day 90|0|||
130557506|NCT03085758|470011772|FG002|Overall Study|Refusal to recall it up to day 90|1|||
130373339|NCT02820753|469334949|FG001|2 Month|Stopped per NIH Hold|13|||
130373340|NCT02820753|469334948|FG000|6 Month|Withdrawal by Subject|2|||
130373341|NCT02820753|469334949|FG001|6 Month|Withdrawal by Subject|2|||
130373342|NCT02820753|469334948|FG000|6 Month|Lost to Follow-up|20|||
130557507|NCT03085758|470011770|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
130557508|NCT03085758|470011771|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
130557509|NCT03085758|470011772|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
130557510|NCT01122576|470011775|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
130557511|NCT01122576|470011776|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
130557512|NCT01122576|470011777|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
130557513|NCT01122576|470011775|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
130557514|NCT01122576|470011776|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
130557515|NCT01122576|470011777|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
130557516|NCT01122576|470011775|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
130557517|NCT01122576|470011776|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
130557518|NCT01122576|470011777|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
130557519|NCT00931944|470011778|FG000|Overall Study|Adverse Event|4|||
130557520|NCT00931944|470011778|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
130557521|NCT00931944|470011778|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
130557522|NCT00931944|470011778|FG000|Overall Study|Death|28|||
130557523|NCT00931944|470011778|FG000|Overall Study|Other|2|||
130557524|NCT02459769|470011782|FG000|Overall Study|Withdrawal by Subject|7|||
130557525|NCT02459769|470011783|FG001|Overall Study|Withdrawal by Subject|4|||
130557526|NCT02459769|470011784|FG002|Overall Study|Withdrawal by Subject|8|||
130557527|NCT02459769|470011785|FG003|Overall Study|Withdrawal by Subject|5|||
130557528|NCT02459769|470011782|FG000|Overall Study|Lost to Follow-up|1|||
130557529|NCT02459769|470011783|FG001|Overall Study|Lost to Follow-up|0|||
130557530|NCT02459769|470011784|FG002|Overall Study|Lost to Follow-up|1|||
130557531|NCT02459769|470011785|FG003|Overall Study|Lost to Follow-up|0|||
130557532|NCT01287364|470011786|FG000|Overall Study|Adverse Event|0|||
130557533|NCT01287364|470011787|FG001|Overall Study|Adverse Event|3|||
130557534|NCT01287364|470011786|FG000|Overall Study|Protocol Violation|5|||
130557535|NCT01287364|470011787|FG001|Overall Study|Protocol Violation|5|||
130557536|NCT01287364|470011786|FG000|Overall Study|Other Reason|4|||
130557537|NCT01287364|470011787|FG001|Overall Study|Other Reason|2|||
130557538|NCT05372653|470011797|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
130557539|NCT05372653|470011798|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
130716695|NCT04711902|470590902|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716696|NCT04711902|470590903|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
130716697|NCT04711902|470590904|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716698|NCT04711902|470590905|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
130373343|NCT02820753|469334949|FG001|6 Month|Lost to Follow-up|27|||
130373344|NCT02820753|469334948|FG000|6 Month|Stopped per NIH Hold|81|||
130373345|NCT02820753|469334949|FG001|6 Month|Stopped per NIH Hold|81|||
130373346|NCT02820753|469334948|FG000|6 Month|Death|0|||
130373347|NCT02820753|469334949|FG001|6 Month|Death|1|||
130373348|NCT02161731|469334950|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
130373349|NCT02161731|469334951|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
130373350|NCT02161731|469334950|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
130373351|NCT02161731|469334951|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
130373352|NCT03761277|469334952|FG000|Enrollment to Implant|Screen Failure|17|||
130373353|NCT03761277|469334952|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
130373354|NCT03761277|469334952|FG000|Enrollment to Implant|Physician Decision|2|||
130373355|NCT03761277|469334952|FG000|Enrollment to Implant|Site Closure|3|||
130373356|NCT03761277|469334952|FG000|Enrollment to Implant|Sponsor Request|2|||
130373357|NCT03761277|469334952|FG000|Post-Implant to 6 Months|Adverse Event|2|||
130373358|NCT03761277|469334952|FG000|Post-Implant to 6 Months|Death|1|||
130373359|NCT03761277|469334952|FG000|Post-Implant to 6 Months|Site Closure|2|||
130373360|NCT03761277|469334952|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
130557540|NCT05372653|470011797|FG000|Overall Study|Adverse Event|0|||
130557541|NCT05372653|470011798|FG001|Overall Study|Adverse Event|1|||
130557542|NCT00711529|470011799|FG000|Overall Study|Protocol Violation|2|||
130557543|NCT00711529|470011800|FG001|Overall Study|Protocol Violation|0|||
130557544|NCT00711529|470011799|FG000|Overall Study|Withdrawal by Subject|2|||
130557545|NCT00711529|470011800|FG001|Overall Study|Withdrawal by Subject|6|||
130557546|NCT03740997|470011806|FG000|Overall Study|Withdrawal by Subject|1|||
130463188|NCT01636687|469661668|FG001|Extension Period|Lost to Follow-up|0|||
130463189|NCT01636687|469661669|FG002|Extension Period|Lost to Follow-up|1|||
130463190|NCT01636687|469661670|FG003|Extension Period|Lost to Follow-up|0|||
130463191|NCT01636687|469661671|FG004|Extension Period|Lost to Follow-up|0|||
130463192|NCT01636687|469661667|FG000|Extension Period|Physician Decision|1|||
130463193|NCT01636687|469661668|FG001|Extension Period|Physician Decision|0|||
130463194|NCT01636687|469661669|FG002|Extension Period|Physician Decision|0|||
130463195|NCT01636687|469661670|FG003|Extension Period|Physician Decision|1|||
130463196|NCT01636687|469661671|FG004|Extension Period|Physician Decision|0|||
130463197|NCT01636687|469661667|FG000|Extension Period|study terminated by sponsor|33|||
130463198|NCT01636687|469661668|FG001|Extension Period|study terminated by sponsor|50|||
130463199|NCT01636687|469661669|FG002|Extension Period|study terminated by sponsor|17|||
130463200|NCT01636687|469661670|FG003|Extension Period|study terminated by sponsor|23|||
130463201|NCT01636687|469661671|FG004|Extension Period|study terminated by sponsor|0|||
130463202|NCT01636687|469661667|FG000|Extension Period|Withdrawal by Subject|1|||
130463203|NCT01636687|469661668|FG001|Extension Period|Withdrawal by Subject|0|||
130463204|NCT01636687|469661669|FG002|Extension Period|Withdrawal by Subject|1|||
130463205|NCT01636687|469661670|FG003|Extension Period|Withdrawal by Subject|1|||
130463206|NCT01636687|469661671|FG004|Extension Period|Withdrawal by Subject|0|||
130463207|NCT01636687|469661667|FG000|Follow-up Period|Withdrawal by Subject|1|||
130463208|NCT01636687|469661668|FG001|Follow-up Period|Withdrawal by Subject|0|||
130463209|NCT01636687|469661669|FG002|Follow-up Period|Withdrawal by Subject|0|||
130463210|NCT01636687|469661670|FG003|Follow-up Period|Withdrawal by Subject|0|||
130463211|NCT01636687|469661671|FG004|Follow-up Period|Withdrawal by Subject|1|||
130463212|NCT01460290|469661677|FG000|Overall Study|Adverse Event|3|||
130463213|NCT01460290|469661677|FG000|Overall Study|Elevated liver function|1|||
130463214|NCT01039688|469661678|FG000|Overall Study|Adverse Event|38|||
130463215|NCT01039688|469661679|FG001|Overall Study|Adverse Event|39|||
130463216|NCT01039688|469661680|FG002|Overall Study|Adverse Event|24|||
130463217|NCT01039688|469661678|FG000|Overall Study|Lack of Efficacy|20|||
130463218|NCT01039688|469661679|FG001|Overall Study|Lack of Efficacy|11|||
130463219|NCT01039688|469661680|FG002|Overall Study|Lack of Efficacy|26|||
130716699|NCT04711902|470590906|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716700|NCT02238626|470590907|FG000|Overall Study|Adverse Event|3|||
130463220|NCT01039688|469661678|FG000|Overall Study|Lost to Follow-up|11|||
130463221|NCT01039688|469661679|FG001|Overall Study|Lost to Follow-up|9|||
130463222|NCT01039688|469661680|FG002|Overall Study|Lost to Follow-up|5|||
130463223|NCT01039688|469661678|FG000|Overall Study|Other|13|||
130463224|NCT01039688|469661679|FG001|Overall Study|Other|25|||
130463225|NCT01039688|469661680|FG002|Overall Study|Other|12|||
130463226|NCT01039688|469661678|FG000|Overall Study|Withdrawal by Subject|23|||
130463227|NCT01039688|469661679|FG001|Overall Study|Withdrawal by Subject|27|||
130463228|NCT01039688|469661680|FG002|Overall Study|Withdrawal by Subject|13|||
130463229|NCT01039688|469661678|FG000|Overall Study|Death|2|||
130463230|NCT01039688|469661679|FG001|Overall Study|Death|0|||
130463231|NCT01039688|469661680|FG002|Overall Study|Death|0|||
130463232|NCT00668863|469661681|FG000|Overall Study|Objective Progression or Relapse|42|||
130463233|NCT00668863|469661681|FG000|Overall Study|Adverse Event|13|||
130463234|NCT00668863|469661681|FG000|Overall Study|Study Terminated by Sponsor|8|||
130463235|NCT00668863|469661681|FG000|Overall Study|Global Deterioration of Health Status|4|||
130463236|NCT00668863|469661681|FG000|Overall Study|Withdrawal by Subject|1|||
130463237|NCT00668863|469661681|FG000|Overall Study|Surgery|1|||
130463238|NCT00668863|469661681|FG000|Overall Study|Subject's work scheduling problem|1|||
130463239|NCT00668863|469661681|FG000|Overall Study|Physician Decision|1|||
130463240|NCT02969863|469661685|FG000|Overall Study|Physician Decision|1|||
130463241|NCT02969863|469661686|FG001|Overall Study|Physician Decision|0|||
130463242|NCT02969863|469661687|FG002|Overall Study|Physician Decision|0|||
130463243|NCT02969863|469661688|FG003|Overall Study|Physician Decision|0|||
130463244|NCT02969863|469661689|FG004|Overall Study|Physician Decision|0|||
130557547|NCT03740997|470011807|FG001|Overall Study|Withdrawal by Subject|0|||
130557548|NCT03740997|470011806|FG000|Overall Study|Participant was unable to complete study procedures|1|||
130716701|NCT02238626|470590908|FG001|Overall Study|Adverse Event|5|||
130716702|NCT02238626|470590909|FG002|Overall Study|Adverse Event|0|||
130716703|NCT02238626|470590910|FG003|Overall Study|Adverse Event|3|||
130463245|NCT02969863|469661690|FG005|Overall Study|Physician Decision|0|||
130463246|NCT03737240|469661691|FG000|Overall Study|Lost to Follow-up|16|||
130463247|NCT03737240|469661692|FG001|Overall Study|Lost to Follow-up|15|||
130463248|NCT02448446|469661693|FG000|Overall Study|Withdrawal by Subject|1|||
130463249|NCT02448446|469661694|FG001|Overall Study|Withdrawal by Subject|0|||
130463250|NCT01254188|469661695|FG000|Overall Study|Disease Progression|6|||
130463251|NCT01254188|469661695|FG000|Overall Study|Protocol Violation|6|||
130716704|NCT02238626|470590907|FG000|Overall Study|Lost to Follow-up|2|||
130716705|NCT02238626|470590908|FG001|Overall Study|Lost to Follow-up|4|||
130463252|NCT01254188|469661695|FG000|Overall Study|Pregnancy|2|||
130463253|NCT01254188|469661695|FG000|Overall Study|Death|4|||
130463254|NCT01254188|469661695|FG000|Overall Study|Lost to Follow-up|5|||
130463255|NCT01254188|469661695|FG000|Overall Study|Withdrawal by Subject|7|||
130716706|NCT02238626|470590909|FG002|Overall Study|Lost to Follow-up|2|||
130463256|NCT01254188|469661695|FG000|Overall Study|Adverse Event|43|||
130463257|NCT01254188|469661695|FG000|Overall Study|per investigator discretion|20|||
130463258|NCT02957136|469661708|FG000|Overall Study|Withdrawal by Subject|2|||
130463259|NCT02957136|469661709|FG001|Overall Study|Withdrawal by Subject|1|||
130463260|NCT02200770|469661710|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
130463261|NCT02200770|469661711|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
130463262|NCT02200770|469661710|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
130463263|NCT02200770|469661711|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
130463264|NCT02200770|469661710|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
130463265|NCT02200770|469661711|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
130463266|NCT02200770|469661710|FG000|Randomized-controlled Period (RCP)|Other|1|||
130463267|NCT02200770|469661711|FG001|Randomized-controlled Period (RCP)|Other|2|||
130463268|NCT02200770|469661710|FG000|Open-label Period (OLP)|Adverse Event|1|||
130463269|NCT02200770|469661711|FG001|Open-label Period (OLP)|Adverse Event|2|||
130463270|NCT02200770|469661710|FG000|Open-label Period (OLP)|Death|1|||
130463271|NCT02200770|469661711|FG001|Open-label Period (OLP)|Death|2|||
130463272|NCT02200770|469661710|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
130463273|NCT02200770|469661711|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
130463274|NCT02200770|469661710|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
130463275|NCT02200770|469661711|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
130463276|NCT02200770|469661710|FG000|Open-label Period (OLP)|Other|6|||
130463277|NCT02200770|469661711|FG001|Open-label Period (OLP)|Other|15|||
130463278|NCT02214160|469661716|FG000|Overall Study|Withdrawal by Subject|1|||
130463279|NCT02214160|469661717|FG001|Overall Study|Withdrawal by Subject|0|||
130463280|NCT02214160|469661718|FG002|Overall Study|Withdrawal by Subject|6|||
130463281|NCT02214160|469661716|FG000|Overall Study|Death|2|||
130463282|NCT02214160|469661717|FG001|Overall Study|Death|2|||
130463283|NCT02214160|469661718|FG002|Overall Study|Death|1|||
130463284|NCT02214160|469661716|FG000|Overall Study|Subject Non-Compliance|0|||
130463285|NCT02214160|469661717|FG001|Overall Study|Subject Non-Compliance|3|||
130463286|NCT02214160|469661718|FG002|Overall Study|Subject Non-Compliance|1|||
130463287|NCT02214160|469661716|FG000|Overall Study|Adverse Event|0|||
130463288|NCT02214160|469661717|FG001|Overall Study|Adverse Event|1|||
130463289|NCT02214160|469661718|FG002|Overall Study|Adverse Event|1|||
130463290|NCT02214160|469661716|FG000|Overall Study|Sponsor Decision|0|||
130463291|NCT02214160|469661717|FG001|Overall Study|Sponsor Decision|2|||
130463292|NCT02214160|469661718|FG002|Overall Study|Sponsor Decision|0|||
130463293|NCT02214160|469661716|FG000|Overall Study|Protocol Violation|1|||
130463294|NCT02214160|469661717|FG001|Overall Study|Protocol Violation|0|||
130463295|NCT02214160|469661718|FG002|Overall Study|Protocol Violation|0|||
130463296|NCT02214160|469661716|FG000|Overall Study|Physician Decision|0|||
130463297|NCT02214160|469661717|FG001|Overall Study|Physician Decision|0|||
130463298|NCT02214160|469661718|FG002|Overall Study|Physician Decision|1|||
130463299|NCT02423798|469661719|FG000|Overall Study|Withdrawal by Subject|3|||
130463300|NCT01264679|469661720|FG000|Overall Study|Participation in Another Clinical Trial|1|||
130463301|NCT01264679|469661720|FG000|Overall Study|Physician Decision|1|||
130463302|NCT01264679|469661720|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
130463303|NCT01264679|469661720|FG000|Overall Study|Withdrawal by Subject|1|||
130463304|NCT02555215|469661723|FG000|Overall Study|Other|1|||
130463305|NCT02555215|469661723|FG000|Overall Study|Investigator Decision|2|||
130463306|NCT00468052|469661724|FG000|Overall Study|Protocol Violation|7|||
130463307|NCT00468052|469661725|FG001|Overall Study|Protocol Violation|8|||
130463308|NCT00356265|469661726|FG000|Overall Study|Withdrawal by Subject|0|||
130463309|NCT00356265|469661727|FG001|Overall Study|Withdrawal by Subject|0|||
130463310|NCT00356265|469661728|FG002|Overall Study|Withdrawal by Subject|1|||
130463311|NCT01837966|469661729|FG000|Overall Study|Withdrawal by Subject|2|||
130716707|NCT02238626|470590910|FG003|Overall Study|Lost to Follow-up|2|||
130716708|NCT02238626|470590907|FG000|Overall Study|Withdrawal by Subject|0|||
130716709|NCT02238626|470590908|FG001|Overall Study|Withdrawal by Subject|3|||
130716710|NCT02238626|470590909|FG002|Overall Study|Withdrawal by Subject|0|||
130716711|NCT02238626|470590910|FG003|Overall Study|Withdrawal by Subject|1|||
130463312|NCT01837966|469661730|FG001|Overall Study|Withdrawal by Subject|1|||
130716712|NCT02238626|470590907|FG000|Overall Study|Death|0|||
130716713|NCT02238626|470590908|FG001|Overall Study|Death|0|||
130463313|NCT00159783|469661731|FG000|Overall Study|Adverse Event|5|||
130463314|NCT00159783|469661732|FG001|Overall Study|Adverse Event|7|||
130716714|NCT02238626|470590909|FG002|Overall Study|Death|1|||
130463315|NCT00159783|469661733|FG002|Overall Study|Adverse Event|9|||
130463316|NCT00159783|469661731|FG000|Overall Study|Lack of Efficacy|1|||
130463317|NCT00159783|469661732|FG001|Overall Study|Lack of Efficacy|2|||
130463318|NCT00159783|469661733|FG002|Overall Study|Lack of Efficacy|3|||
130463319|NCT00159783|469661731|FG000|Overall Study|Withdrawal by Subject|7|||
130463320|NCT00159783|469661732|FG001|Overall Study|Withdrawal by Subject|11|||
130463321|NCT00159783|469661733|FG002|Overall Study|Withdrawal by Subject|12|||
130463322|NCT00159783|469661731|FG000|Overall Study|Lost to Follow-up|6|||
130716715|NCT02238626|470590910|FG003|Overall Study|Death|1|||
130716716|NCT02238626|470590907|FG000|Overall Study|Other|0|||
130303239|NCT01368081|469073473|FG002|Overall Study|Protocol Violation|0|||
130303240|NCT01368081|469073474|FG003|Overall Study|Protocol Violation|0|||
130303241|NCT01368081|469073475|FG004|Overall Study|Protocol Violation|0|||
130303242|NCT01368081|469073476|FG005|Overall Study|Protocol Violation|1|||
130303243|NCT01368081|469073477|FG006|Overall Study|Protocol Violation|0|||
130303244|NCT01368081|469073478|FG007|Overall Study|Protocol Violation|1|||
130303245|NCT01368081|469073479|FG008|Overall Study|Protocol Violation|0|||
130303246|NCT01368081|469073480|FG009|Overall Study|Protocol Violation|0|||
130303247|NCT01368081|469073481|FG010|Overall Study|Protocol Violation|0|||
130303248|NCT01368081|469073482|FG011|Overall Study|Protocol Violation|0|||
130303249|NCT01368081|469073483|FG012|Overall Study|Protocol Violation|0|||
130303250|NCT01368081|469073471|FG000|Overall Study|Lost to Follow-up|0|||
130303251|NCT01368081|469073472|FG001|Overall Study|Lost to Follow-up|0|||
130303252|NCT01368081|469073473|FG002|Overall Study|Lost to Follow-up|0|||
130303253|NCT01368081|469073474|FG003|Overall Study|Lost to Follow-up|0|||
130303254|NCT01368081|469073475|FG004|Overall Study|Lost to Follow-up|0|||
130303255|NCT01368081|469073476|FG005|Overall Study|Lost to Follow-up|0|||
130303256|NCT01368081|469073477|FG006|Overall Study|Lost to Follow-up|0|||
130303257|NCT01368081|469073478|FG007|Overall Study|Lost to Follow-up|0|||
130303258|NCT01368081|469073479|FG008|Overall Study|Lost to Follow-up|0|||
130303259|NCT01368081|469073480|FG009|Overall Study|Lost to Follow-up|0|||
130303260|NCT01368081|469073481|FG010|Overall Study|Lost to Follow-up|0|||
130303261|NCT01368081|469073482|FG011|Overall Study|Lost to Follow-up|0|||
130303262|NCT01368081|469073483|FG012|Overall Study|Lost to Follow-up|1|||
130303263|NCT01368081|469073471|FG000|Overall Study|Withdrawal by Subject|4|||
130303264|NCT01368081|469073472|FG001|Overall Study|Withdrawal by Subject|4|||
130303265|NCT01368081|469073473|FG002|Overall Study|Withdrawal by Subject|1|||
130373361|NCT03761277|469334952|FG000|6 Months to 12 Months|Physician Decision|2|||
130373362|NCT03761277|469334952|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
130373363|NCT00429273|469334956|FG000|Overall Study|Lost to Follow-up|1|||
130373364|NCT00429273|469334957|FG001|Overall Study|Lost to Follow-up|2|||
130373365|NCT00429273|469334958|FG002|Overall Study|Lost to Follow-up|2|||
130373366|NCT00429273|469334956|FG000|Overall Study|Physician Decision|6|||
130373367|NCT00429273|469334957|FG001|Overall Study|Physician Decision|5|||
130373368|NCT00429273|469334958|FG002|Overall Study|Physician Decision|5|||
130373369|NCT00429273|469334956|FG000|Overall Study|Adverse Event|1|||
130373370|NCT00429273|469334957|FG001|Overall Study|Adverse Event|1|||
130373371|NCT00429273|469334958|FG002|Overall Study|Adverse Event|2|||
130373372|NCT01438957|469334959|FG000|Overall Study|Physician Decision|1|||
130373373|NCT01438957|469334960|FG001|Overall Study|Physician Decision|1|||
130373374|NCT01438957|469334961|FG002|Overall Study|Physician Decision|0|||
130373375|NCT01438957|469334962|FG003|Overall Study|Physician Decision|1|||
130373376|NCT01438957|469334963|FG004|Overall Study|Physician Decision|0|||
130373377|NCT03052725|469334964|FG000|Overall Study|Adverse Event|2|||
130373378|NCT03052725|469334965|FG001|Overall Study|Adverse Event|0|||
130373379|NCT03052725|469334964|FG000|Overall Study|Withdrawal by Subject|3|||
130373380|NCT03052725|469334965|FG001|Overall Study|Withdrawal by Subject|4|||
130373381|NCT03052725|469334964|FG000|Overall Study|Pregnancy|0|||
130303266|NCT01368081|469073474|FG003|Overall Study|Withdrawal by Subject|1|||
130373382|NCT03052725|469334965|FG001|Overall Study|Pregnancy|1|||
130373383|NCT03052725|469334964|FG000|Overall Study|Site closure|0|||
130373384|NCT03052725|469334965|FG001|Overall Study|Site closure|1|||
130373385|NCT03052725|469334964|FG000|Overall Study|Study terminated by sponsor|143|||
130373386|NCT03052725|469334965|FG001|Overall Study|Study terminated by sponsor|144|||
130373387|NCT00727025|469334971|FG000|Overall Study|Physician Decision|23|||
130373388|NCT02548650|469334978|FG000|Triple Therapy|Adverse Event|1|||
130373389|NCT02548650|469334979|FG001|Triple Therapy|Adverse Event|0|||
130373390|NCT02548650|469334978|FG000|Triple Therapy|Withdrawal by Subject|0|||
130373391|NCT02548650|469334979|FG001|Triple Therapy|Withdrawal by Subject|4|||
130373392|NCT02548650|469334978|FG000|Double Therapy|Adverse Event|1|||
130373393|NCT02548650|469334979|FG001|Double Therapy|Adverse Event|1|||
130373394|NCT02548650|469334978|FG000|Double Therapy|Withdrawal by Subject|0|||
130303267|NCT01368081|469073475|FG004|Overall Study|Withdrawal by Subject|0|||
130303268|NCT01368081|469073476|FG005|Overall Study|Withdrawal by Subject|3|||
130303269|NCT01368081|469073477|FG006|Overall Study|Withdrawal by Subject|4|||
130303270|NCT01368081|469073478|FG007|Overall Study|Withdrawal by Subject|2|||
130373395|NCT02548650|469334979|FG001|Double Therapy|Withdrawal by Subject|1|||
130303271|NCT01368081|469073479|FG008|Overall Study|Withdrawal by Subject|5|||
130303272|NCT01368081|469073480|FG009|Overall Study|Withdrawal by Subject|4|||
130373396|NCT01909674|469334980|FG000|Overall Study|Withdrawal by Subject|5|||
130373397|NCT01909674|469334981|FG001|Overall Study|Withdrawal by Subject|2|||
130373398|NCT02969369|469334982|FG000|Study|Adverse Event|1|||
130463323|NCT00159783|469661732|FG001|Overall Study|Lost to Follow-up|5|||
130303273|NCT01368081|469073481|FG010|Overall Study|Withdrawal by Subject|3|||
130373399|NCT02969369|469334983|FG001|Study|Adverse Event|6|||
130303274|NCT01368081|469073482|FG011|Overall Study|Withdrawal by Subject|2|||
130373400|NCT02969369|469334982|FG000|Study|Lack of Efficacy|0|||
130373401|NCT02969369|469334983|FG001|Study|Lack of Efficacy|1|||
130373402|NCT02969369|469334982|FG000|Study|Lost to Follow-up|0|||
130373403|NCT02969369|469334983|FG001|Study|Lost to Follow-up|1|||
130463324|NCT00159783|469661733|FG002|Overall Study|Lost to Follow-up|11|||
130463325|NCT00159783|469661731|FG000|Overall Study|Other|0|||
130463326|NCT00159783|469661732|FG001|Overall Study|Other|2|||
130463327|NCT00159783|469661733|FG002|Overall Study|Other|4|||
130463328|NCT02928224|469661734|FG000|Overall Study|Lost to Follow-up|1|||
130463329|NCT02928224|469661735|FG001|Overall Study|Lost to Follow-up|1|||
130463330|NCT02928224|469661736|FG002|Overall Study|Lost to Follow-up|3|||
130463331|NCT02928224|469661737|FG003|Overall Study|Lost to Follow-up|0|||
130463332|NCT02928224|469661734|FG000|Overall Study|Death|30|||
130463333|NCT02928224|469661735|FG001|Overall Study|Death|209|||
130463334|NCT02928224|469661736|FG002|Overall Study|Death|193|||
130463335|NCT02928224|469661737|FG003|Overall Study|Death|198|||
130463336|NCT02928224|469661734|FG000|Overall Study|Withdrawal by Subject|0|||
130463337|NCT02928224|469661735|FG001|Overall Study|Withdrawal by Subject|3|||
130463338|NCT02928224|469661736|FG002|Overall Study|Withdrawal by Subject|7|||
130463339|NCT02928224|469661737|FG003|Overall Study|Withdrawal by Subject|20|||
130463340|NCT02928224|469661734|FG000|Overall Study|Study participation terminated by sponsor|3|||
130463341|NCT02928224|469661735|FG001|Overall Study|Study participation terminated by sponsor|8|||
130463342|NCT02928224|469661736|FG002|Overall Study|Study participation terminated by sponsor|12|||
130463343|NCT02928224|469661737|FG003|Overall Study|Study participation terminated by sponsor|3|||
130463344|NCT02928224|469661734|FG000|Overall Study|Other|3|||
130463345|NCT02928224|469661735|FG001|Overall Study|Other|3|||
130463346|NCT02928224|469661736|FG002|Overall Study|Other|5|||
130463347|NCT02928224|469661737|FG003|Overall Study|Other|0|||
130463348|NCT02538107|469661738|FG000|Overall Study|Did not receive any Mircera dose|11|||
130463349|NCT02538107|469661738|FG000|Overall Study|Missing|5|||
130303275|NCT01368081|469073483|FG012|Overall Study|Withdrawal by Subject|0|||
130303276|NCT01368081|469073471|FG000|Overall Study|Other reason not defined above|2|||
130303277|NCT01368081|469073472|FG001|Overall Study|Other reason not defined above|0|||
130303278|NCT01368081|469073473|FG002|Overall Study|Other reason not defined above|0|||
130303279|NCT01368081|469073474|FG003|Overall Study|Other reason not defined above|1|||
130303280|NCT01368081|469073475|FG004|Overall Study|Other reason not defined above|0|||
130303281|NCT01368081|469073476|FG005|Overall Study|Other reason not defined above|1|||
130303282|NCT01368081|469073477|FG006|Overall Study|Other reason not defined above|2|||
130303283|NCT01368081|469073478|FG007|Overall Study|Other reason not defined above|0|||
130303284|NCT01368081|469073479|FG008|Overall Study|Other reason not defined above|0|||
130303285|NCT01368081|469073480|FG009|Overall Study|Other reason not defined above|1|||
130303286|NCT01368081|469073481|FG010|Overall Study|Other reason not defined above|0|||
130303287|NCT01368081|469073482|FG011|Overall Study|Other reason not defined above|0|||
130303288|NCT01368081|469073483|FG012|Overall Study|Other reason not defined above|3|||
130303289|NCT03755661|469073486|FG000|Overall Study|Lost to Follow-up|1|||
130303290|NCT03755661|469073487|FG001|Overall Study|Lost to Follow-up|0|||
130303291|NCT02277119|469073488|FG000|Overall Study|Lack of Efficacy|1|||
130303292|NCT02277119|469073489|FG001|Overall Study|Lack of Efficacy|1|||
130303293|NCT02277119|469073490|FG002|Overall Study|Lack of Efficacy|1|||
130463350|NCT02538107|469661738|FG000|Overall Study|Necessity of dialysis|20|||
130463351|NCT02538107|469661738|FG000|Overall Study|Administration of other ESA|11|||
130463352|NCT02538107|469661738|FG000|Overall Study|No further treatment necessary|18|||
130463353|NCT02538107|469661738|FG000|Overall Study|Withdrawal by Subject|17|||
130463354|NCT02538107|469661738|FG000|Overall Study|Death|4|||
130463355|NCT02538107|469661738|FG000|Overall Study|Administrative reason|5|||
130463356|NCT02538107|469661738|FG000|Overall Study|Adverse Event|4|||
130303294|NCT02277119|469073488|FG000|Overall Study|Protocol Violation|2|||
130303295|NCT02277119|469073489|FG001|Overall Study|Protocol Violation|3|||
130303296|NCT02277119|469073490|FG002|Overall Study|Protocol Violation|7|||
130303297|NCT04699461|469073491|FG000|Overall Study|Withdrawal by Subject|1|||
130303298|NCT04699461|469073492|FG001|Overall Study|Withdrawal by Subject|0|||
130303299|NCT04699461|469073491|FG000|Overall Study|Study termination by sponsor|2|||
130463357|NCT02538107|469661738|FG000|Overall Study|Surgery|1|||
130463358|NCT02538107|469661738|FG000|Overall Study|Other|7|||
130463359|NCT02538107|469661738|FG000|Overall Study|Not recorded|7|||
130463360|NCT01278394|469661741|FG000|Overall Study|Lost to Follow-up|1|||
130463361|NCT01236560|469661742|FG000|Overall Study|Adverse Event|0|||
130463362|NCT01236560|469661743|FG001|Overall Study|Adverse Event|2|||
130463363|NCT01236560|469661744|FG002|Overall Study|Adverse Event|1|||
130463364|NCT01236560|469661745|FG003|Overall Study|Adverse Event|3|||
130463365|NCT01236560|469661746|FG004|Overall Study|Adverse Event|0|||
130463366|NCT01236560|469661747|FG005|Overall Study|Adverse Event|0|||
130463367|NCT01236560|469661742|FG000|Overall Study|Death|0|||
130463368|NCT01236560|469661743|FG001|Overall Study|Death|1|||
130463369|NCT01236560|469661744|FG002|Overall Study|Death|0|||
130463370|NCT01236560|469661745|FG003|Overall Study|Death|1|||
130463371|NCT01236560|469661746|FG004|Overall Study|Death|0|||
130463372|NCT01236560|469661747|FG005|Overall Study|Death|0|||
130463373|NCT01236560|469661742|FG000|Overall Study|Lost to Follow-up|0|||
130463374|NCT01236560|469661743|FG001|Overall Study|Lost to Follow-up|1|||
130463375|NCT01236560|469661744|FG002|Overall Study|Lost to Follow-up|1|||
130463376|NCT01236560|469661745|FG003|Overall Study|Lost to Follow-up|0|||
130303300|NCT04699461|469073492|FG001|Overall Study|Study termination by sponsor|1|||
130463377|NCT01236560|469661746|FG004|Overall Study|Lost to Follow-up|0|||
130463378|NCT01236560|469661747|FG005|Overall Study|Lost to Follow-up|0|||
130463379|NCT01236560|469661742|FG000|Overall Study|Physician Decision|0|||
130463380|NCT01236560|469661743|FG001|Overall Study|Physician Decision|1|||
130463381|NCT01236560|469661744|FG002|Overall Study|Physician Decision|8|||
130463382|NCT01236560|469661745|FG003|Overall Study|Physician Decision|0|||
130463383|NCT01236560|469661746|FG004|Overall Study|Physician Decision|0|||
130463384|NCT01236560|469661747|FG005|Overall Study|Physician Decision|0|||
130463385|NCT01236560|469661742|FG000|Overall Study|Withdrawal by Subject|0|||
130463386|NCT01236560|469661743|FG001|Overall Study|Withdrawal by Subject|0|||
130463387|NCT01236560|469661744|FG002|Overall Study|Withdrawal by Subject|1|||
130463388|NCT01236560|469661745|FG003|Overall Study|Withdrawal by Subject|2|||
130463389|NCT01236560|469661746|FG004|Overall Study|Withdrawal by Subject|0|||
130463390|NCT01236560|469661747|FG005|Overall Study|Withdrawal by Subject|0|||
130463391|NCT01236560|469661742|FG000|Overall Study|Progressive disease|5|||
130463392|NCT01236560|469661743|FG001|Overall Study|Progressive disease|19|||
130463393|NCT01236560|469661744|FG002|Overall Study|Progressive disease|9|||
130463394|NCT01236560|469661745|FG003|Overall Study|Progressive disease|16|||
130463395|NCT01236560|469661746|FG004|Overall Study|Progressive disease|0|||
130463396|NCT01236560|469661747|FG005|Overall Study|Progressive disease|0|||
130463397|NCT00468910|469661748|FG000|Overall Study|Lost to Follow-up|2|||
130463398|NCT00468910|469661749|FG001|Overall Study|Lost to Follow-up|1|||
130463399|NCT00468910|469661748|FG000|Overall Study|Withdrawal by Subject|2|||
130463400|NCT00468910|469661749|FG001|Overall Study|Withdrawal by Subject|1|||
130463401|NCT00468910|469661748|FG000|Overall Study|Medical Contraindication|0|||
130716717|NCT02238626|470590908|FG001|Overall Study|Other|2|||
130303301|NCT04699461|469073491|FG000|Overall Study|Death|1|||
130463402|NCT00468910|469661749|FG001|Overall Study|Medical Contraindication|1|||
130463403|NCT01576484|469661751|FG000|Overall Study|Adverse Event|1|||
130463404|NCT01576484|469661752|FG001|Overall Study|Adverse Event|1|||
130463405|NCT01576484|469661751|FG000|Overall Study|Protocol Violation|0|||
130463406|NCT01576484|469661752|FG001|Overall Study|Protocol Violation|2|||
130463407|NCT01576484|469661751|FG000|Overall Study|Sponsor Decision|2|||
130463408|NCT01576484|469661752|FG001|Overall Study|Sponsor Decision|8|||
130463409|NCT01576484|469661751|FG000|Overall Study|Withdrawal by Subject|0|||
130463410|NCT01576484|469661752|FG001|Overall Study|Withdrawal by Subject|3|||
130463411|NCT01576484|469661751|FG000|Overall Study|Other|2|||
130463412|NCT01576484|469661752|FG001|Overall Study|Other|5|||
130463413|NCT00457691|469661761|FG000|Overall Study|Adverse Event|4|||
130463414|NCT00457691|469661762|FG001|Overall Study|Adverse Event|1|||
130463415|NCT00457691|469661761|FG000|Overall Study|Death|163|||
130463416|NCT00457691|469661762|FG001|Overall Study|Death|148|||
130463417|NCT00457691|469661761|FG000|Overall Study|Protocol Violation|1|||
130463418|NCT00457691|469661762|FG001|Overall Study|Protocol Violation|3|||
130463419|NCT00457691|469661761|FG000|Overall Study|Lost to Follow-up|23|||
130463420|NCT00457691|469661762|FG001|Overall Study|Lost to Follow-up|14|||
130463421|NCT00457691|469661761|FG000|Overall Study|Study terminated by Sponsor|1|||
130463422|NCT00457691|469661762|FG001|Overall Study|Study terminated by Sponsor|1|||
130463423|NCT00457691|469661761|FG000|Overall Study|Subject refused (reason other than AE)|14|||
130463424|NCT00457691|469661762|FG001|Overall Study|Subject refused (reason other than AE)|19|||
130463425|NCT00457691|469661761|FG000|Overall Study|Disease progression, study terminated|180|||
130463426|NCT00457691|469661762|FG001|Overall Study|Disease progression, study terminated|196|||
130463427|NCT02079844|469661763|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
130716718|NCT02238626|470590909|FG002|Overall Study|Other|0|||
130463428|NCT02079844|469661764|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
130463429|NCT02079844|469661765|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
130463430|NCT02079844|469661763|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
130463431|NCT02079844|469661764|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
130463432|NCT02079844|469661765|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
130463433|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
130303302|NCT04699461|469073492|FG001|Overall Study|Death|0|||
130303303|NCT04699461|469073491|FG000|Overall Study|Radiographic progression|0|||
130463434|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
130463435|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
130463436|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
130463437|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
130463438|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
130463439|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
130463440|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
130463441|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
130463442|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
130716719|NCT02238626|470590910|FG003|Overall Study|Other|0|||
130303304|NCT04699461|469073492|FG001|Overall Study|Radiographic progression|1|||
130463443|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
130716720|NCT03347422|470590916|FG000|Part A (26 Weeks)|Adverse Event|3|||
130463444|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
130463445|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
130463446|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
130303305|NCT03068767|469073493|FG000|Overall Study|Lost to Follow-up|7|||
130303306|NCT03068767|469073494|FG001|Overall Study|Lost to Follow-up|3|||
130303307|NCT03068767|469073493|FG000|Overall Study|Protocol Violation|3|||
130303308|NCT03068767|469073494|FG001|Overall Study|Protocol Violation|0|||
130303309|NCT04167137|469073497|FG000|Overall Study|Disease progression|1|||
130303310|NCT04167137|469073498|FG001|Overall Study|Disease progression|1|||
130303311|NCT04167137|469073499|FG002|Overall Study|Disease progression|3|||
130303312|NCT04167137|469073500|FG003|Overall Study|Disease progression|3|||
130303313|NCT04167137|469073501|FG004|Overall Study|Disease progression|2|||
130303314|NCT04167137|469073502|FG005|Overall Study|Disease progression|3|||
130303315|NCT04167137|469073503|FG006|Overall Study|Disease progression|2|||
130303316|NCT04167137|469073504|FG007|Overall Study|Disease progression|2|||
130303317|NCT04167137|469073497|FG000|Overall Study|Withdrawal by Subject|1|||
130303318|NCT04167137|469073498|FG001|Overall Study|Withdrawal by Subject|0|||
130303319|NCT04167137|469073499|FG002|Overall Study|Withdrawal by Subject|0|||
130303320|NCT04167137|469073500|FG003|Overall Study|Withdrawal by Subject|1|||
130303321|NCT04167137|469073501|FG004|Overall Study|Withdrawal by Subject|0|||
130303322|NCT04167137|469073502|FG005|Overall Study|Withdrawal by Subject|2|||
130303323|NCT04167137|469073503|FG006|Overall Study|Withdrawal by Subject|1|||
130303324|NCT04167137|469073504|FG007|Overall Study|Withdrawal by Subject|0|||
130303325|NCT04167137|469073497|FG000|Overall Study|Adverse Event|0|||
130303326|NCT04167137|469073498|FG001|Overall Study|Adverse Event|0|||
130303327|NCT04167137|469073499|FG002|Overall Study|Adverse Event|0|||
130303328|NCT04167137|469073500|FG003|Overall Study|Adverse Event|0|||
130303329|NCT04167137|469073501|FG004|Overall Study|Adverse Event|0|||
130303330|NCT04167137|469073502|FG005|Overall Study|Adverse Event|1|||
130303331|NCT04167137|469073503|FG006|Overall Study|Adverse Event|0|||
130303332|NCT04167137|469073504|FG007|Overall Study|Adverse Event|1|||
130303333|NCT04167137|469073497|FG000|Overall Study|Physician Decision|0|||
130303334|NCT04167137|469073498|FG001|Overall Study|Physician Decision|0|||
130303335|NCT04167137|469073499|FG002|Overall Study|Physician Decision|0|||
130303336|NCT04167137|469073500|FG003|Overall Study|Physician Decision|1|||
130303337|NCT04167137|469073501|FG004|Overall Study|Physician Decision|0|||
130303338|NCT04167137|469073502|FG005|Overall Study|Physician Decision|0|||
130303339|NCT04167137|469073503|FG006|Overall Study|Physician Decision|1|||
130303340|NCT04167137|469073504|FG007|Overall Study|Physician Decision|0|||
130303341|NCT04167137|469073497|FG000|Overall Study|Death|0|||
130303342|NCT04167137|469073498|FG001|Overall Study|Death|1|||
130303343|NCT04167137|469073499|FG002|Overall Study|Death|0|||
130303344|NCT04167137|469073500|FG003|Overall Study|Death|0|||
130303345|NCT04167137|469073501|FG004|Overall Study|Death|0|||
130303346|NCT04167137|469073502|FG005|Overall Study|Death|0|||
130303347|NCT04167137|469073503|FG006|Overall Study|Death|0|||
130303348|NCT04167137|469073504|FG007|Overall Study|Death|0|||
130303349|NCT04167137|469073497|FG000|Overall Study|Study terminated by Sponsor|0|||
130303350|NCT04167137|469073498|FG001|Overall Study|Study terminated by Sponsor|0|||
130303351|NCT04167137|469073499|FG002|Overall Study|Study terminated by Sponsor|0|||
130303352|NCT04167137|469073500|FG003|Overall Study|Study terminated by Sponsor|0|||
130303353|NCT04167137|469073501|FG004|Overall Study|Study terminated by Sponsor|0|||
130303354|NCT04167137|469073502|FG005|Overall Study|Study terminated by Sponsor|0|||
130303355|NCT04167137|469073503|FG006|Overall Study|Study terminated by Sponsor|0|||
130303356|NCT04167137|469073504|FG007|Overall Study|Study terminated by Sponsor|1|||
130303357|NCT01748825|469073507|FG000|Dose Escalation|Refused further treatment|2|||
130303358|NCT01748825|469073508|FG001|Dose Escalation|Refused further treatment|2|||
130303359|NCT01748825|469073509|FG002|Dose Escalation|Refused further treatment|0|||
130303360|NCT01748825|469073510|FG003|Dose Escalation|Refused further treatment|0|||
130303361|NCT01748825|469073511|FG004|Dose Escalation|Refused further treatment|1|||
130303362|NCT01748825|469073512|FG005|Dose Escalation|Refused further treatment|2|||
130303363|NCT01748825|469073513|FG006|Dose Escalation|Refused further treatment|0|||
130303364|NCT01748825|469073514|FG007|Dose Escalation|Refused further treatment|0|||
130303365|NCT01748825|469073515|FG008|Dose Escalation|Refused further treatment|0|||
130303366|NCT01748825|469073516|FG009|Dose Escalation|Refused further treatment|0|||
130303367|NCT01748825|469073507|FG000|Dose Escalation|Switched to alternative treatment|0|||
130303368|NCT01748825|469073508|FG001|Dose Escalation|Switched to alternative treatment|0|||
130303369|NCT01748825|469073509|FG002|Dose Escalation|Switched to alternative treatment|0|||
130303370|NCT01748825|469073510|FG003|Dose Escalation|Switched to alternative treatment|1|||
130303371|NCT01748825|469073511|FG004|Dose Escalation|Switched to alternative treatment|0|||
130303372|NCT01748825|469073512|FG005|Dose Escalation|Switched to alternative treatment|0|||
130303373|NCT01748825|469073513|FG006|Dose Escalation|Switched to alternative treatment|0|||
130303374|NCT01748825|469073514|FG007|Dose Escalation|Switched to alternative treatment|0|||
130303375|NCT01748825|469073515|FG008|Dose Escalation|Switched to alternative treatment|0|||
130303376|NCT01748825|469073516|FG009|Dose Escalation|Switched to alternative treatment|0|||
130303377|NCT01748825|469073507|FG000|Dose Escalation|Adverse Event|0|||
130303378|NCT01748825|469073508|FG001|Dose Escalation|Adverse Event|0|||
130463447|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
130463448|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
130463449|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
130463450|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
130463451|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
130463452|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
130463453|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
130463454|NCT00304031|469663453|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
130463455|NCT00304031|469663454|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
130463456|NCT00304031|469663455|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
130303379|NCT01748825|469073509|FG002|Dose Escalation|Adverse Event|0|||
130303380|NCT01748825|469073510|FG003|Dose Escalation|Adverse Event|0|||
130303381|NCT01748825|469073511|FG004|Dose Escalation|Adverse Event|0|||
130303382|NCT01748825|469073512|FG005|Dose Escalation|Adverse Event|0|||
130303383|NCT01748825|469073513|FG006|Dose Escalation|Adverse Event|1|||
130463457|NCT00304031|469663453|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
130463458|NCT00304031|469663454|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
130463459|NCT00304031|469663455|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
130303384|NCT01748825|469073514|FG007|Dose Escalation|Adverse Event|0|||
130303385|NCT01748825|469073515|FG008|Dose Escalation|Adverse Event|0|||
130303386|NCT01748825|469073516|FG009|Dose Escalation|Adverse Event|0|||
130303387|NCT01748825|469073507|FG000|Dose Expansion|Refused further treatment|0|||
130303388|NCT01748825|469073508|FG001|Dose Expansion|Refused further treatment|0|||
130303389|NCT01748825|469073509|FG002|Dose Expansion|Refused further treatment|0|||
130303390|NCT01748825|469073510|FG003|Dose Expansion|Refused further treatment|0|||
130303391|NCT01748825|469073511|FG004|Dose Expansion|Refused further treatment|0|||
130303392|NCT01748825|469073512|FG005|Dose Expansion|Refused further treatment|0|||
130303393|NCT01748825|469073513|FG006|Dose Expansion|Refused further treatment|0|||
130303394|NCT01748825|469073514|FG007|Dose Expansion|Refused further treatment|0|||
130303395|NCT01748825|469073515|FG008|Dose Expansion|Refused further treatment|1|||
130303396|NCT01748825|469073516|FG009|Dose Expansion|Refused further treatment|1|||
130303397|NCT01748825|469073507|FG000|Dose Expansion|Switched to alternative treatment|0|||
130303398|NCT01748825|469073508|FG001|Dose Expansion|Switched to alternative treatment|0|||
130303399|NCT01748825|469073509|FG002|Dose Expansion|Switched to alternative treatment|0|||
130303400|NCT01748825|469073510|FG003|Dose Expansion|Switched to alternative treatment|0|||
130303401|NCT01748825|469073511|FG004|Dose Expansion|Switched to alternative treatment|0|||
130303402|NCT01748825|469073512|FG005|Dose Expansion|Switched to alternative treatment|0|||
130303403|NCT01748825|469073513|FG006|Dose Expansion|Switched to alternative treatment|0|||
130463460|NCT00683696|469663456|FG000|Overall Study|Withdrawn due to study closure|337|||
130463461|NCT00683696|469663457|FG001|Overall Study|Withdrawn due to study closure|338|||
130463462|NCT00683696|469663456|FG000|Overall Study|Withdrawn prior to study closure|13|||
130463463|NCT00683696|469663457|FG001|Overall Study|Withdrawn prior to study closure|28|||
130463464|NCT00683696|469663456|FG000|Overall Study|Lost to Follow-up|5|||
130463465|NCT00683696|469663457|FG001|Overall Study|Lost to Follow-up|6|||
130463466|NCT00683696|469663456|FG000|Overall Study|Vital status follow-up only|3|||
130463467|NCT00683696|469663457|FG001|Overall Study|Vital status follow-up only|3|||
130463468|NCT00683696|469663456|FG000|Overall Study|Death|46|||
130463469|NCT00683696|469663457|FG001|Overall Study|Death|30|||
130463470|NCT02396316|469663458|FG000|Overall Study|Physician Decision|1|||
130463471|NCT02396316|469663459|FG001|Overall Study|Physician Decision|0|||
130463472|NCT02396316|469663458|FG000|Overall Study|Progressive disease|6|||
130463473|NCT02396316|469663459|FG001|Overall Study|Progressive disease|3|||
130463474|NCT02396316|469663458|FG000|Overall Study|Protocol Violation|0|||
130463475|NCT02396316|469663459|FG001|Overall Study|Protocol Violation|1|||
130463476|NCT02396316|469663458|FG000|Overall Study|Treatment unblinded|0|||
130463477|NCT02396316|469663459|FG001|Overall Study|Treatment unblinded|1|||
130463478|NCT01823536|469663460|FG000|Overall Study|Lost to Follow-up|1|||
130463479|NCT01823536|469663461|FG001|Overall Study|Lost to Follow-up|0|||
130463480|NCT01823536|469663462|FG002|Overall Study|Lost to Follow-up|0|||
130463481|NCT01823536|469663463|FG003|Overall Study|Lost to Follow-up|1|||
130463482|NCT01823536|469663464|FG004|Overall Study|Lost to Follow-up|1|||
130463483|NCT01823536|469663465|FG005|Overall Study|Lost to Follow-up|0|||
130463484|NCT01823536|469663460|FG000|Overall Study|Protocol Violation|0|||
130463485|NCT01823536|469663461|FG001|Overall Study|Protocol Violation|1|||
130463486|NCT01823536|469663462|FG002|Overall Study|Protocol Violation|0|||
130463487|NCT01823536|469663463|FG003|Overall Study|Protocol Violation|0|||
130463488|NCT01823536|469663464|FG004|Overall Study|Protocol Violation|0|||
130716721|NCT03347422|470590917|FG001|Part A (26 Weeks)|Adverse Event|0|||
130716722|NCT03347422|470590916|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
130303404|NCT01748825|469073514|FG007|Dose Expansion|Switched to alternative treatment|0|||
130303405|NCT01748825|469073515|FG008|Dose Expansion|Switched to alternative treatment|0|||
130303406|NCT01748825|469073516|FG009|Dose Expansion|Switched to alternative treatment|1|||
130303407|NCT01748825|469073507|FG000|Dose Expansion|Adverse Event|0|||
130303408|NCT01748825|469073508|FG001|Dose Expansion|Adverse Event|0|||
130303409|NCT01748825|469073509|FG002|Dose Expansion|Adverse Event|0|||
130303410|NCT01748825|469073510|FG003|Dose Expansion|Adverse Event|0|||
130303411|NCT01748825|469073511|FG004|Dose Expansion|Adverse Event|0|||
130303412|NCT01748825|469073512|FG005|Dose Expansion|Adverse Event|0|||
130303413|NCT01748825|469073513|FG006|Dose Expansion|Adverse Event|0|||
130303414|NCT01748825|469073514|FG007|Dose Expansion|Adverse Event|0|||
130303415|NCT01748825|469073515|FG008|Dose Expansion|Adverse Event|0|||
130303416|NCT01748825|469073516|FG009|Dose Expansion|Adverse Event|3|||
130303417|NCT01748825|469073507|FG000|Dose Expansion|Physician Decision|0|||
130303418|NCT01748825|469073508|FG001|Dose Expansion|Physician Decision|0|||
130303419|NCT01748825|469073509|FG002|Dose Expansion|Physician Decision|0|||
130303420|NCT01748825|469073510|FG003|Dose Expansion|Physician Decision|0|||
130303421|NCT01748825|469073511|FG004|Dose Expansion|Physician Decision|0|||
130303422|NCT01748825|469073512|FG005|Dose Expansion|Physician Decision|0|||
130303423|NCT01748825|469073513|FG006|Dose Expansion|Physician Decision|0|||
130303424|NCT01748825|469073514|FG007|Dose Expansion|Physician Decision|0|||
130303425|NCT01748825|469073515|FG008|Dose Expansion|Physician Decision|1|||
130303426|NCT01748825|469073516|FG009|Dose Expansion|Physician Decision|0|||
130303427|NCT04412707|469073520|FG000|Cycle 1|Death|0|||
130303428|NCT04412707|469073521|FG001|Cycle 1|Death|3|||
130303429|NCT04412707|469073520|FG000|Cycle 1|Disease progression|1|||
130303430|NCT04412707|469073521|FG001|Cycle 1|Disease progression|2|||
130303431|NCT04412707|469073520|FG000|Cycle 2|Death|0|||
130303432|NCT04412707|469073521|FG001|Cycle 2|Death|1|||
130303433|NCT04412707|469073520|FG000|Cycle 2|Disease progression|3|||
130303434|NCT04412707|469073521|FG001|Cycle 2|Disease progression|0|||
130303435|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
130303436|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
130303437|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
130303438|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
130303439|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
130303440|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
130303441|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
130303442|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
130303443|NCT01370265|469074853|FG000|First Intervention|Adverse Event|1|||
130303444|NCT01370265|469074854|FG001|First Intervention|Adverse Event|1|||
130303445|NCT01732770|469074856|FG000|Overall Study|Lost to Follow-up|2|||
130303446|NCT01732770|469074857|FG001|Overall Study|Lost to Follow-up|3|||
130303447|NCT01732770|469074856|FG000|Overall Study|Withdrawal by Subject|5|||
130303448|NCT01732770|469074857|FG001|Overall Study|Withdrawal by Subject|3|||
130303449|NCT01732770|469074856|FG000|Overall Study|Decision by Sponsor|2|||
130303450|NCT01732770|469074857|FG001|Overall Study|Decision by Sponsor|2|||
130303451|NCT01732770|469074856|FG000|Overall Study|Death|1|||
130303452|NCT01732770|469074857|FG001|Overall Study|Death|0|||
130303453|NCT00871338|469074860|FG000|Prior to Booster|Withdrawal by Subject|1|||
130303454|NCT00871338|469074861|FG001|Prior to Booster|Withdrawal by Subject|3|||
130303455|NCT00871338|469074860|FG000|Prior to Booster|Lost to Follow-up|1|||
130303456|NCT00871338|469074861|FG001|Prior to Booster|Lost to Follow-up|0|||
130303457|NCT02391363|469074862|FG000|Overall Study|Lost to Follow-up|5|||
130303458|NCT02391363|469074863|FG001|Overall Study|Lost to Follow-up|5|||
130303459|NCT02391363|469074862|FG000|Overall Study|Withdrawal by Subject|6|||
130303460|NCT02391363|469074863|FG001|Overall Study|Withdrawal by Subject|3|||
130303461|NCT04794270|469074864|FG000|Period 1|Non Compliance|1|||
130303462|NCT04794270|469074865|FG001|Period 1|Non Compliance|0|||
130303463|NCT04794270|469074864|FG000|Period 1|Adverse Event|1|||
130303464|NCT04794270|469074865|FG001|Period 1|Adverse Event|0|||
130303465|NCT04794270|469074864|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
130303466|NCT04794270|469074865|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
130303467|NCT00265317|469074868|FG000|Lead-In|Objective progression or relapse|6|||
130303468|NCT00265317|469074869|FG001|Lead-In|Objective progression or relapse|11|||
130303469|NCT00265317|469074870|FG002|Lead-In|Objective progression or relapse|0|||
130303470|NCT00265317|469074871|FG003|Lead-In|Objective progression or relapse|0|||
130303471|NCT00265317|469074868|FG000|Lead-In|Adverse Event|2|||
130303472|NCT00265317|469074869|FG001|Lead-In|Adverse Event|1|||
130303473|NCT00265317|469074870|FG002|Lead-In|Adverse Event|0|||
130303474|NCT00265317|469074871|FG003|Lead-In|Adverse Event|0|||
130303475|NCT00265317|469074868|FG000|Lead-In|Death|3|||
130303476|NCT00265317|469074869|FG001|Lead-In|Death|5|||
130303477|NCT00265317|469074870|FG002|Lead-In|Death|0|||
130303478|NCT00265317|469074871|FG003|Lead-In|Death|0|||
130303479|NCT00265317|469074868|FG000|Lead-In|Withdrawal/other than adverse event|1|||
130303480|NCT00265317|469074869|FG001|Lead-In|Withdrawal/other than adverse event|0|||
130303481|NCT00265317|469074870|FG002|Lead-In|Withdrawal/other than adverse event|0|||
130303482|NCT00265317|469074871|FG003|Lead-In|Withdrawal/other than adverse event|0|||
130303483|NCT00265317|469074868|FG000|Phase 2|Objective progression or relapse|0|||
130303484|NCT00265317|469074869|FG001|Phase 2|Objective progression or relapse|0|||
130303485|NCT00265317|469074870|FG002|Phase 2|Objective progression or relapse|37|||
130303486|NCT00265317|469074871|FG003|Phase 2|Objective progression or relapse|38|||
130303487|NCT00265317|469074868|FG000|Phase 2|Global deterioration of health status|0|||
130303488|NCT00265317|469074869|FG001|Phase 2|Global deterioration of health status|0|||
130303489|NCT00265317|469074870|FG002|Phase 2|Global deterioration of health status|3|||
130303490|NCT00265317|469074871|FG003|Phase 2|Global deterioration of health status|0|||
130303491|NCT00265317|469074868|FG000|Phase 2|Adverse Event|0|||
130303492|NCT00265317|469074869|FG001|Phase 2|Adverse Event|0|||
130303493|NCT00265317|469074870|FG002|Phase 2|Adverse Event|7|||
130303494|NCT00265317|469074871|FG003|Phase 2|Adverse Event|5|||
130303495|NCT00265317|469074868|FG000|Phase 2|Death|0|||
130303496|NCT00265317|469074869|FG001|Phase 2|Death|0|||
130303497|NCT00265317|469074870|FG002|Phase 2|Death|12|||
130303498|NCT00265317|469074871|FG003|Phase 2|Death|15|||
130303499|NCT00265317|469074868|FG000|Phase 2|Protocol Violation|0|||
130303500|NCT00265317|469074869|FG001|Phase 2|Protocol Violation|0|||
130303501|NCT00265317|469074870|FG002|Phase 2|Protocol Violation|1|||
130303502|NCT00265317|469074871|FG003|Phase 2|Protocol Violation|4|||
130303503|NCT00265317|469074868|FG000|Phase 2|Lost to Follow-up|0|||
130303504|NCT00265317|469074869|FG001|Phase 2|Lost to Follow-up|0|||
130303505|NCT00265317|469074870|FG002|Phase 2|Lost to Follow-up|0|||
130373404|NCT02969369|469334982|FG000|Study|Withdrawal by Subject|3|||
130373405|NCT02969369|469334983|FG001|Study|Withdrawal by Subject|5|||
130373406|NCT02969369|469334982|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
130373407|NCT02969369|469334983|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
130373408|NCT02969369|469334982|FG000|Double-blind Period|Adverse Event|1|||
130373409|NCT02969369|469334983|FG001|Double-blind Period|Adverse Event|5|||
130373410|NCT02969369|469334982|FG000|Double-blind Period|Lost to Follow-up|0|||
130373411|NCT02969369|469334983|FG001|Double-blind Period|Lost to Follow-up|1|||
130373412|NCT02969369|469334982|FG000|Double-blind Period|Withdrawal by Subject|2|||
130373413|NCT02969369|469334983|FG001|Double-blind Period|Withdrawal by Subject|3|||
130373414|NCT02969369|469334982|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
130373415|NCT02969369|469334983|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
130373416|NCT02969369|469334982|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
130373417|NCT02969369|469334983|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
130373418|NCT02969369|469334982|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
130373419|NCT02969369|469334983|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
130373420|NCT02969369|469334982|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
130373421|NCT02969369|469334983|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
130373422|NCT00521014|469334984|FG000|Overall Study|Inevaluable, not treated|1|||
130373423|NCT04390191|469334985|FG000|Overall Study|Withdrawal by Subject|1|||
130373424|NCT04390191|469334986|FG001|Overall Study|Withdrawal by Subject|0|||
130373425|NCT02794883|469334987|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
130373426|NCT02794883|469334988|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
130373427|NCT02794883|469334989|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
130373428|NCT02794883|469334987|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
130373429|NCT02794883|469334988|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
130373430|NCT02794883|469334989|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
130373431|NCT02794883|469334987|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
130373432|NCT02794883|469334988|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
130373433|NCT02794883|469334989|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
130373434|NCT02794883|469334987|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
130373435|NCT02794883|469334988|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
130373436|NCT02794883|469334989|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
130373437|NCT02794883|469334987|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
130373438|NCT02794883|469334988|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
130373439|NCT02794883|469334989|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
130373440|NCT02794883|469334987|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
130373441|NCT02794883|469334988|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
130373442|NCT02794883|469334989|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
130373443|NCT02794883|469334987|FG000|Follow-up Period (up to 2 Years)|Death|12|||
130373444|NCT02794883|469334988|FG001|Follow-up Period (up to 2 Years)|Death|10|||
130373445|NCT02794883|469334989|FG002|Follow-up Period (up to 2 Years)|Death|10|||
130373446|NCT03978832|469334990|FG000|Overall Study|Adverse Event|1|||
130373447|NCT03978832|469334990|FG000|Overall Study|Lost to Follow-up|1|||
130373448|NCT03978832|469334990|FG000|Overall Study|Withdrawal by Subject|6|||
130373449|NCT03978832|469334990|FG000|Overall Study|Physician Decision|2|||
130373450|NCT03978832|469334990|FG000|Overall Study|did not pass screening criteria|44|||
130463489|NCT01823536|469663465|FG005|Overall Study|Protocol Violation|0|||
130303506|NCT00265317|469074871|FG003|Phase 2|Lost to Follow-up|1|||
130303507|NCT00265317|469074868|FG000|Phase 2|Withdrawal/other than adverse event|0|||
130303508|NCT00265317|469074869|FG001|Phase 2|Withdrawal/other than adverse event|0|||
130303509|NCT00265317|469074870|FG002|Phase 2|Withdrawal/other than adverse event|2|||
130373451|NCT00407797|469334997|FG000|Overall Study|Lost to Follow-up|2|||
130716723|NCT03347422|470590917|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
130303510|NCT00265317|469074871|FG003|Phase 2|Withdrawal/other than adverse event|1|||
130303511|NCT00265317|469074868|FG000|Phase 2|Study terminated by sponsor|0|||
130463490|NCT01823536|469663460|FG000|Overall Study|Withdrawal by Subject|1|||
130463491|NCT01823536|469663461|FG001|Overall Study|Withdrawal by Subject|1|||
130463492|NCT01823536|469663462|FG002|Overall Study|Withdrawal by Subject|0|||
130463493|NCT01823536|469663463|FG003|Overall Study|Withdrawal by Subject|0|||
130463494|NCT01823536|469663464|FG004|Overall Study|Withdrawal by Subject|0|||
130463495|NCT01823536|469663465|FG005|Overall Study|Withdrawal by Subject|0|||
130463496|NCT01823536|469663460|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
130463497|NCT01823536|469663461|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
130463498|NCT01823536|469663462|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
130463499|NCT01823536|469663463|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
130463500|NCT01823536|469663464|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
130463501|NCT01823536|469663465|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
130463502|NCT01823536|469663460|FG000|Overall Study|Met exclusion criterion No 6|0|||
130463503|NCT01823536|469663461|FG001|Overall Study|Met exclusion criterion No 6|0|||
130463504|NCT01823536|469663462|FG002|Overall Study|Met exclusion criterion No 6|0|||
130463505|NCT01823536|469663463|FG003|Overall Study|Met exclusion criterion No 6|1|||
130463506|NCT01823536|469663464|FG004|Overall Study|Met exclusion criterion No 6|0|||
130463507|NCT01823536|469663465|FG005|Overall Study|Met exclusion criterion No 6|0|||
130463508|NCT01823536|469663460|FG000|Overall Study|Subject moved out of the state|0|||
130463509|NCT01823536|469663461|FG001|Overall Study|Subject moved out of the state|0|||
130463510|NCT01823536|469663462|FG002|Overall Study|Subject moved out of the state|0|||
130463511|NCT01823536|469663463|FG003|Overall Study|Subject moved out of the state|0|||
130463512|NCT01823536|469663464|FG004|Overall Study|Subject moved out of the state|1|||
130463513|NCT01823536|469663465|FG005|Overall Study|Subject moved out of the state|0|||
130463514|NCT03648762|469663469|FG000|Overall Study|Lost to Follow-up|1|||
130463515|NCT03648762|469663470|FG001|Overall Study|Lost to Follow-up|2|||
130463516|NCT03648762|469663471|FG002|Overall Study|Lost to Follow-up|0|||
130463517|NCT03648762|469663469|FG000|Overall Study|Withdrawal by Subject|5|||
130463518|NCT03648762|469663470|FG001|Overall Study|Withdrawal by Subject|2|||
130463519|NCT03648762|469663471|FG002|Overall Study|Withdrawal by Subject|1|||
130463520|NCT02731755|469663481|FG000|First Intervention|Withdrawal by Subject|0|||
130463521|NCT02731755|469663482|FG001|First Intervention|Withdrawal by Subject|2|||
130463522|NCT00002842|469663483|FG000|Overall Study|ineligible for surgical resection|27|||
130463523|NCT01599104|469663484|FG000|Overall Study|Withdrawal by Subject|1|||
130463524|NCT01599104|469663485|FG001|Overall Study|Withdrawal by Subject|1|||
130463525|NCT01599104|469663486|FG002|Overall Study|Withdrawal by Subject|2|||
130303512|NCT00265317|469074869|FG001|Phase 2|Study terminated by sponsor|0|||
130303513|NCT00265317|469074870|FG002|Phase 2|Study terminated by sponsor|1|||
130303514|NCT00265317|469074871|FG003|Phase 2|Study terminated by sponsor|0|||
130303515|NCT00265317|469074868|FG000|Phase 2|Other|0|||
130303516|NCT00265317|469074869|FG001|Phase 2|Other|0|||
130303517|NCT00265317|469074870|FG002|Phase 2|Other|1|||
130303518|NCT00265317|469074871|FG003|Phase 2|Other|1|||
130303519|NCT02510001|469074872|FG000|Overall Study|Early disease progression|0|||
130463526|NCT01599104|469663484|FG000|Overall Study|Technical Problems|1|||
130463527|NCT01599104|469663485|FG001|Overall Study|Technical Problems|0|||
130463528|NCT01599104|469663486|FG002|Overall Study|Technical Problems|0|||
130303520|NCT02510001|469074873|FG001|Overall Study|Early disease progression|0|||
130303521|NCT02510001|469074874|FG002|Overall Study|Early disease progression|0|||
130303522|NCT02510001|469074875|FG003|Overall Study|Early disease progression|1|||
130303523|NCT02510001|469074876|FG004|Overall Study|Early disease progression|1|||
130303524|NCT02510001|469074877|FG005|Overall Study|Early disease progression|1|||
130303525|NCT02510001|469074878|FG006|Overall Study|Early disease progression|0|||
130303526|NCT02510001|469074879|FG007|Overall Study|Early disease progression|0|||
130303527|NCT02510001|469074872|FG000|Overall Study|Adverse Event|0|||
130463529|NCT01599104|469663484|FG000|Overall Study|Physician Decision|3|||
130463530|NCT01599104|469663485|FG001|Overall Study|Physician Decision|2|||
130303528|NCT02510001|469074873|FG001|Overall Study|Adverse Event|0|||
130463531|NCT01599104|469663486|FG002|Overall Study|Physician Decision|2|||
130463532|NCT01599104|469663484|FG000|Overall Study|Non-compliance with study treatment|0|||
130463533|NCT01599104|469663485|FG001|Overall Study|Non-compliance with study treatment|1|||
130463534|NCT01599104|469663486|FG002|Overall Study|Non-compliance with study treatment|0|||
130463535|NCT01599104|469663484|FG000|Overall Study|Lack of Efficacy|4|||
130303529|NCT02510001|469074874|FG002|Overall Study|Adverse Event|0|||
130463536|NCT01599104|469663485|FG001|Overall Study|Lack of Efficacy|4|||
130463537|NCT01599104|469663486|FG002|Overall Study|Lack of Efficacy|10|||
130463538|NCT01599104|469663484|FG000|Overall Study|Adverse Event|7|||
130463539|NCT01599104|469663485|FG001|Overall Study|Adverse Event|6|||
130463540|NCT01599104|469663486|FG002|Overall Study|Adverse Event|12|||
130463541|NCT02271854|469663489|FG000|Overall Study|Withdrawal by Subject|2|||
130716724|NCT03347422|470590916|FG000|Part B (149 Weeks)|Adverse Event|0|||
130303530|NCT02510001|469074875|FG003|Overall Study|Adverse Event|1|||
130303531|NCT02510001|469074876|FG004|Overall Study|Adverse Event|2|||
130303532|NCT02510001|469074877|FG005|Overall Study|Adverse Event|1|||
130303533|NCT02510001|469074878|FG006|Overall Study|Adverse Event|2|||
130303534|NCT02510001|469074879|FG007|Overall Study|Adverse Event|5|||
130463542|NCT02271854|469663489|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
130463543|NCT02271854|469663489|FG000|Overall Study|Lost to Follow-up|1|||
130463544|NCT03454529|469663498|FG000|Overall Study|Did not receive treatment|6|||
130463545|NCT03454529|469663498|FG000|Overall Study|Received < 80% doses|1|||
130463546|NCT01582100|469663502|FG000|Overall Study|Adverse Event|1|||
130463547|NCT01582100|469663502|FG000|Overall Study|Withdrawal by Subject|1|||
130463548|NCT02564744|469663503|FG000|Overall Study|Investigator decision|0|||
130463549|NCT02564744|469663504|FG001|Overall Study|Investigator decision|0|||
130463550|NCT02564744|469663505|FG002|Overall Study|Investigator decision|0|||
130463551|NCT02564744|469663506|FG003|Overall Study|Investigator decision|0|||
130463552|NCT02564744|469663507|FG004|Overall Study|Investigator decision|1|||
130463553|NCT02564744|469663503|FG000|Overall Study|Death|10|||
130463554|NCT02564744|469663504|FG001|Overall Study|Death|5|||
130463555|NCT02564744|469663505|FG002|Overall Study|Death|4|||
130463556|NCT02564744|469663506|FG003|Overall Study|Death|16|||
130463557|NCT02564744|469663507|FG004|Overall Study|Death|16|||
130463558|NCT02564744|469663503|FG000|Overall Study|End of study Page Missing|0|||
130463559|NCT02564744|469663504|FG001|Overall Study|End of study Page Missing|0|||
130463560|NCT02564744|469663505|FG002|Overall Study|End of study Page Missing|3|||
130463561|NCT02564744|469663506|FG003|Overall Study|End of study Page Missing|3|||
130303535|NCT02510001|469074872|FG000|Overall Study|Physician Decision|0|||
130303536|NCT02510001|469074873|FG001|Overall Study|Physician Decision|0|||
130303537|NCT02510001|469074874|FG002|Overall Study|Physician Decision|0|||
130303538|NCT02510001|469074875|FG003|Overall Study|Physician Decision|0|||
130303539|NCT02510001|469074876|FG004|Overall Study|Physician Decision|1|||
130303540|NCT02510001|469074877|FG005|Overall Study|Physician Decision|0|||
130303541|NCT02510001|469074878|FG006|Overall Study|Physician Decision|0|||
130303542|NCT02510001|469074879|FG007|Overall Study|Physician Decision|0|||
130303543|NCT02510001|469074872|FG000|Overall Study|Withdrawal by Subject|0|||
130303544|NCT02510001|469074873|FG001|Overall Study|Withdrawal by Subject|0|||
130303545|NCT02510001|469074874|FG002|Overall Study|Withdrawal by Subject|0|||
130303546|NCT02510001|469074875|FG003|Overall Study|Withdrawal by Subject|0|||
130303547|NCT02510001|469074876|FG004|Overall Study|Withdrawal by Subject|0|||
130303548|NCT02510001|469074877|FG005|Overall Study|Withdrawal by Subject|0|||
130303549|NCT02510001|469074878|FG006|Overall Study|Withdrawal by Subject|0|||
130303550|NCT02510001|469074879|FG007|Overall Study|Withdrawal by Subject|2|||
130303551|NCT02950480|469074884|FG000|Overall Study|Withdrawal by Subject|1|||
130303552|NCT02950480|469074885|FG001|Overall Study|Withdrawal by Subject|0|||
130303553|NCT00711971|469074888|FG000|Overall Study|Lost to Follow-up|3|||
130303554|NCT00711971|469074889|FG001|Overall Study|Lost to Follow-up|4|||
130303555|NCT00711971|469074890|FG002|Overall Study|Lost to Follow-up|1|||
130303556|NCT02644343|469074891|FG000|Overall Study|Withdrawal by Subject|1|||
130303557|NCT03704688|469074894|FG000|Overall Study|Adverse Event|0|||
130303558|NCT03704688|469074895|FG001|Overall Study|Adverse Event|0|||
130303559|NCT03704688|469074896|FG002|Overall Study|Adverse Event|0|||
130303560|NCT03704688|469074897|FG003|Overall Study|Adverse Event|4|||
130303561|NCT03704688|469074898|FG004|Overall Study|Adverse Event|1|||
130303562|NCT03704688|469074899|FG005|Overall Study|Adverse Event|0|||
130303563|NCT03704688|469074894|FG000|Overall Study|Disease Progression|0|||
130303564|NCT03704688|469074895|FG001|Overall Study|Disease Progression|0|||
130303565|NCT03704688|469074896|FG002|Overall Study|Disease Progression|0|||
130303566|NCT03704688|469074897|FG003|Overall Study|Disease Progression|3|||
130303567|NCT03704688|469074898|FG004|Overall Study|Disease Progression|1|||
130303568|NCT03704688|469074899|FG005|Overall Study|Disease Progression|0|||
130303569|NCT03704688|469074894|FG000|Overall Study|Death|0|||
130303570|NCT03704688|469074895|FG001|Overall Study|Death|0|||
130303571|NCT03704688|469074896|FG002|Overall Study|Death|0|||
130303572|NCT03704688|469074897|FG003|Overall Study|Death|0|||
130303573|NCT03704688|469074898|FG004|Overall Study|Death|3|||
130303574|NCT03704688|469074899|FG005|Overall Study|Death|0|||
130463562|NCT02564744|469663507|FG004|Overall Study|End of study Page Missing|0|||
130303575|NCT01440816|469074903|FG000|Overall Study|Disease Progression|0|||
130303576|NCT01440816|469074904|FG001|Overall Study|Disease Progression|9|||
130303577|NCT01440816|469074903|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
130463563|NCT02564744|469663503|FG000|Overall Study|Subject Withdrew Consent|1|||
130463564|NCT02564744|469663504|FG001|Overall Study|Subject Withdrew Consent|1|||
130463565|NCT02564744|469663505|FG002|Overall Study|Subject Withdrew Consent|1|||
130303578|NCT01440816|469074904|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
130303579|NCT00847886|469074905|FG000|Overall Study|Adverse Event|0|||
130303580|NCT00847886|469074906|FG001|Overall Study|Adverse Event|1|||
130303581|NCT01687101|469074907|FG000|Overall Study|Lost to Follow-up|7|||
130303582|NCT03920254|469074909|FG000|Overall Study|Adverse Event|1|||
130303583|NCT03920254|469074910|FG001|Overall Study|Adverse Event|0|||
130303584|NCT03920254|469074911|FG002|Overall Study|Adverse Event|0|||
130303585|NCT03920254|469074909|FG000|Overall Study|Physician Decision|0|||
130463566|NCT02564744|469663506|FG003|Overall Study|Subject Withdrew Consent|0|||
130463567|NCT02564744|469663507|FG004|Overall Study|Subject Withdrew Consent|2|||
130303586|NCT03920254|469074910|FG001|Overall Study|Physician Decision|1|||
130303587|NCT03920254|469074911|FG002|Overall Study|Physician Decision|2|||
130303588|NCT03920254|469074909|FG000|Overall Study|Study Terminated By Sponsor|12|||
130303589|NCT03920254|469074910|FG001|Overall Study|Study Terminated By Sponsor|17|||
130303590|NCT03920254|469074911|FG002|Overall Study|Study Terminated By Sponsor|12|||
130303591|NCT03920254|469074909|FG000|Overall Study|Withdrawal by Subject|0|||
130557549|NCT03740997|470011807|FG001|Overall Study|Participant was unable to complete study procedures|0|||
130557550|NCT01829425|470011808|FG000|Overall Study|Withdrawal by Subject|4|||
130557551|NCT01829425|470011809|FG001|Overall Study|Withdrawal by Subject|3|||
130557552|NCT01829425|470011808|FG000|Overall Study|Lost to Follow-up|2|||
130557553|NCT01829425|470011809|FG001|Overall Study|Lost to Follow-up|1|||
130557554|NCT05211739|470011810|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
130557555|NCT05211739|470011811|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
130716725|NCT03347422|470590917|FG001|Part B (149 Weeks)|Adverse Event|1|||
130303592|NCT03920254|469074910|FG001|Overall Study|Withdrawal by Subject|0|||
130303593|NCT03920254|469074911|FG002|Overall Study|Withdrawal by Subject|1|||
130303594|NCT03250182|469074912|FG000|Overall Study|Withdrawal by Subject|1|||
130303595|NCT05274269|469074913|FG000|Overall Study|Adverse Event|0|||
130303596|NCT05274269|469074914|FG001|Overall Study|Adverse Event|3|||
130303597|NCT05274269|469074913|FG000|Overall Study|Death|0|||
130303598|NCT05274269|469074914|FG001|Overall Study|Death|1|||
130303599|NCT05274269|469074913|FG000|Overall Study|Other|0|||
130303600|NCT05274269|469074914|FG001|Overall Study|Other|2|||
130373452|NCT00407797|469334997|FG000|Overall Study|Adverse Event|6|||
130373453|NCT00407797|469334997|FG000|Overall Study|Other|7|||
130373454|NCT00407797|469334997|FG000|Overall Study|Withdrawal by Subject|3|||
130373455|NCT01812174|469334998|FG000|Overall Study|Death|1|||
130373456|NCT01812174|469334999|FG001|Overall Study|Death|0|||
130373457|NCT01812174|469334998|FG000|Overall Study|Protocol Violation|2|||
130373458|NCT01812174|469334999|FG001|Overall Study|Protocol Violation|0|||
130373459|NCT03132220|469335001|FG000|Overall Study|Lost to Follow-up|17|||
130373460|NCT03132220|469335002|FG001|Overall Study|Lost to Follow-up|8|||
130373461|NCT03132220|469335001|FG000|Overall Study|Withdrawal by Subject|1|||
130373462|NCT03132220|469335002|FG001|Overall Study|Withdrawal by Subject|4|||
130373463|NCT01051323|469335005|FG000|Overall Study|Discontinuation of treatment|103|||
130373464|NCT01051323|469335005|FG000|Overall Study|Transplantation|28|||
130373465|NCT01051323|469335005|FG000|Overall Study|Dialysis dependency|22|||
130373466|NCT01051323|469335005|FG000|Overall Study|Withdrawal by Subject|13|||
130373467|NCT01051323|469335005|FG000|Overall Study|Lost to Follow-up|31|||
130373468|NCT01051323|469335005|FG000|Overall Study|Death|129|||
130373469|NCT01051323|469335005|FG000|Overall Study|Hospitalization|28|||
130373470|NCT01051323|469335005|FG000|Overall Study|Other|148|||
130373471|NCT01051323|469335005|FG000|Overall Study|Missing|37|||
130373472|NCT00601458|469335006|FG000|Overall Study|Dosing Error|1|||
130373473|NCT00601458|469335007|FG001|Overall Study|Dosing Error|0|||
130373474|NCT00601458|469335008|FG002|Overall Study|Dosing Error|0|||
130373475|NCT00601458|469335006|FG000|Overall Study|Incomplete Data|0|||
130373476|NCT00601458|469335007|FG001|Overall Study|Incomplete Data|2|||
130373477|NCT00601458|469335008|FG002|Overall Study|Incomplete Data|0|||
130373478|NCT00601458|469335006|FG000|Overall Study|Protocol Violation|3|||
130373479|NCT00601458|469335007|FG001|Overall Study|Protocol Violation|2|||
130373480|NCT00601458|469335008|FG002|Overall Study|Protocol Violation|1|||
130373481|NCT00601458|469335006|FG000|Overall Study|Early Termination|0|||
130373482|NCT00601458|469335007|FG001|Overall Study|Early Termination|1|||
130373483|NCT00601458|469335008|FG002|Overall Study|Early Termination|1|||
130373484|NCT00518986|469335009|FG000|Overall Study|Adverse Event|12|||
130373485|NCT00518986|469335010|FG001|Overall Study|Adverse Event|7|||
130373486|NCT00518986|469335009|FG000|Overall Study|Lack of Efficacy|0|||
130716726|NCT03347422|470590916|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
130716727|NCT03347422|470590917|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
130716728|NCT03347422|470590916|FG000|Part B (149 Weeks)|Other|1|||
130716729|NCT03347422|470590917|FG001|Part B (149 Weeks)|Other|0|||
130716730|NCT05183217|470590918|FG000|Overall Study|Withdrawal by Subject|1|||
130716731|NCT05183217|470590919|FG001|Overall Study|Withdrawal by Subject|1|||
130716732|NCT00969540|470590922|FG000|Overall Study|Lost to Follow-up|1|||
130303601|NCT05274269|469074913|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130303602|NCT05274269|469074914|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130373487|NCT00518986|469335010|FG001|Overall Study|Lack of Efficacy|2|||
130373488|NCT00518986|469335009|FG000|Overall Study|Lost to Follow-up|3|||
130373489|NCT00518986|469335010|FG001|Overall Study|Lost to Follow-up|2|||
130557556|NCT05211739|470011810|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
130716733|NCT00969540|470590923|FG001|Overall Study|Lost to Follow-up|1|||
130303603|NCT01858740|469074918|FG000|Overall Study|Death|4|||
130373490|NCT00518986|469335009|FG000|Overall Study|Physician Decision|0|||
130716734|NCT02397408|470590924|FG000|Overall Study|Physician Decision|4|||
130373491|NCT00518986|469335010|FG001|Overall Study|Physician Decision|3|||
130373492|NCT00518986|469335009|FG000|Overall Study|Protocol Violation|5|||
130373493|NCT00518986|469335010|FG001|Overall Study|Protocol Violation|7|||
130373494|NCT00518986|469335009|FG000|Overall Study|Withdrawal by Subject|4|||
130373495|NCT00518986|469335010|FG001|Overall Study|Withdrawal by Subject|4|||
130463568|NCT02564744|469663503|FG000|Overall Study|Lost to Follow-up|0|||
130463569|NCT02564744|469663504|FG001|Overall Study|Lost to Follow-up|1|||
130463570|NCT02564744|469663505|FG002|Overall Study|Lost to Follow-up|0|||
130463571|NCT02564744|469663506|FG003|Overall Study|Lost to Follow-up|0|||
130463572|NCT02564744|469663507|FG004|Overall Study|Lost to Follow-up|1|||
130463573|NCT02564744|469663503|FG000|Overall Study|Reason not specified|1|||
130463574|NCT02564744|469663504|FG001|Overall Study|Reason not specified|0|||
130463575|NCT02564744|469663505|FG002|Overall Study|Reason not specified|0|||
130463576|NCT02564744|469663506|FG003|Overall Study|Reason not specified|0|||
130463577|NCT02564744|469663507|FG004|Overall Study|Reason not specified|0|||
130463578|NCT00508924|469663508|FG000|Overall Study|Protocol Violation|0|||
130463579|NCT00508924|469663509|FG001|Overall Study|Protocol Violation|0|||
130463580|NCT00508924|469663510|FG002|Overall Study|Protocol Violation|1|||
130463581|NCT00508924|469663511|FG003|Overall Study|Protocol Violation|1|||
130463582|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
130463583|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
130463584|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
130463585|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
130463586|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
130463587|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
130463588|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
130463589|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
130463590|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
130463591|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
130463592|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
130463593|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
130463594|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
130463595|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
130463596|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
130463597|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
130463598|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
130463599|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
130463600|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
130463601|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
130463602|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
130463603|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
130463604|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
130463605|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
130463606|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
130463607|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
130463608|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
130463609|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
130463610|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
130463611|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
130463612|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
130463613|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
130463614|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
130463615|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
130463616|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
130463617|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
130463618|NCT03593213|469663513|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
130463619|NCT03593213|469663514|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
130463620|NCT03593213|469663515|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
130463621|NCT03593213|469663516|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
130463622|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
130463623|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
130463624|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
130463625|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
130463626|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
130557557|NCT05211739|470011811|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
130557558|NCT05211739|470011810|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
130557559|NCT05211739|470011811|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
130463627|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
130557560|NCT05211739|470011810|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
130303604|NCT01068769|469074919|FG000|Overall Study|Ineligible|1|||
130303605|NCT00709618|469074920|FG000|Overall Study|Withdrawal by Subject|4|||
130303606|NCT00709618|469074920|FG000|Overall Study|Lost to Follow-up|1|||
130303607|NCT00709618|469074920|FG000|Overall Study|Study Closed/Terminated|25|||
130303608|NCT04042909|469074921|FG000|Overall Study|Withdrawal by Subject|1|||
130303609|NCT04042909|469074922|FG001|Overall Study|Withdrawal by Subject|0|||
130303610|NCT04042909|469074923|FG002|Overall Study|Withdrawal by Subject|0|||
130303611|NCT04042909|469074921|FG000|Overall Study|duplicate cases|2|||
130303612|NCT04042909|469074922|FG001|Overall Study|duplicate cases|0|||
130303613|NCT04042909|469074923|FG002|Overall Study|duplicate cases|0|||
130303614|NCT04042909|469074921|FG000|Overall Study|technical problem|0|||
130303615|NCT04042909|469074922|FG001|Overall Study|technical problem|1|||
130303616|NCT04042909|469074923|FG002|Overall Study|technical problem|0|||
130303617|NCT00894361|469074926|FG000|Overall Study|deaths and less than 2 years followup|24|||
130303618|NCT00894361|469074927|FG001|Overall Study|deaths and less than 2 years followup|64|||
130373496|NCT00518986|469335009|FG000|Overall Study|Non-Specific|2|||
130373497|NCT00518986|469335010|FG001|Overall Study|Non-Specific|1|||
130373498|NCT05683249|469335011|FG000|Overall Study|Adverse Event|3|||
130373499|NCT05683249|469335012|FG001|Overall Study|Adverse Event|1|||
130373500|NCT05683249|469335011|FG000|Overall Study|Lack of Efficacy|0|||
130373501|NCT05683249|469335012|FG001|Overall Study|Lack of Efficacy|2|||
130373502|NCT05683249|469335011|FG000|Overall Study|Lost to Follow-up|6|||
130373503|NCT05683249|469335012|FG001|Overall Study|Lost to Follow-up|5|||
130373504|NCT05683249|469335011|FG000|Overall Study|Non-compliance with Study Drug|2|||
130373505|NCT05683249|469335012|FG001|Overall Study|Non-compliance with Study Drug|0|||
130373506|NCT05683249|469335011|FG000|Overall Study|Protocol Violation|6|||
130373507|NCT05683249|469335012|FG001|Overall Study|Protocol Violation|3|||
130373508|NCT05683249|469335011|FG000|Overall Study|Withdrawal by Subject|9|||
130373509|NCT05683249|469335012|FG001|Overall Study|Withdrawal by Subject|8|||
130373510|NCT05683249|469335011|FG000|Overall Study|Other|0|||
130373511|NCT05683249|469335012|FG001|Overall Study|Other|2|||
130373512|NCT01637272|469335014|FG000|Overall Study|Adverse Event|6|||
130373513|NCT01637272|469335014|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130373514|NCT01637272|469335014|FG000|Overall Study|Withdrawal by Subject|3|||
130373515|NCT01637272|469335014|FG000|Overall Study|Lost to Follow-up|2|||
130373516|NCT01637272|469335014|FG000|Overall Study|completed core, did not enter ext. phase|4|||
130373517|NCT01637272|469335014|FG000|Overall Study|Administrative problems|1|||
130373518|NCT01637272|469335014|FG000|Overall Study|Protocol Violation|2|||
130373519|NCT01496612|469335015|FG000|1st Intervention|Adverse Event|1|||
130373520|NCT01496612|469335016|FG001|1st Intervention|Adverse Event|0|||
130373521|NCT01496612|469335015|FG000|1st Intervention|Withdrawal by Subject|1|||
130373522|NCT01496612|469335016|FG001|1st Intervention|Withdrawal by Subject|0|||
130373523|NCT03708328|469335024|FG000|Overall Study|Death|3|||
130373524|NCT03708328|469335025|FG001|Overall Study|Death|3|||
130373525|NCT03708328|469335026|FG002|Overall Study|Death|4|||
130373526|NCT03708328|469335027|FG003|Overall Study|Death|2|||
130373527|NCT03708328|469335028|FG004|Overall Study|Death|2|||
130373528|NCT03708328|469335029|FG005|Overall Study|Death|13|||
130373529|NCT03708328|469335030|FG006|Overall Study|Death|26|||
130373530|NCT03708328|469335031|FG007|Overall Study|Death|18|||
130373531|NCT03708328|469335032|FG008|Overall Study|Death|13|||
130373532|NCT03708328|469335033|FG009|Overall Study|Death|8|||
130373533|NCT03708328|469335024|FG000|Overall Study|Lost to Follow-up|0|||
130373534|NCT03708328|469335025|FG001|Overall Study|Lost to Follow-up|1|||
130373535|NCT03708328|469335026|FG002|Overall Study|Lost to Follow-up|0|||
130373536|NCT03708328|469335027|FG003|Overall Study|Lost to Follow-up|1|||
130373537|NCT03708328|469335028|FG004|Overall Study|Lost to Follow-up|0|||
130373538|NCT03708328|469335029|FG005|Overall Study|Lost to Follow-up|3|||
130373539|NCT03708328|469335030|FG006|Overall Study|Lost to Follow-up|3|||
130373540|NCT03708328|469335031|FG007|Overall Study|Lost to Follow-up|0|||
130373541|NCT03708328|469335032|FG008|Overall Study|Lost to Follow-up|0|||
130373542|NCT03708328|469335033|FG009|Overall Study|Lost to Follow-up|1|||
130373543|NCT03708328|469335024|FG000|Overall Study|Physician Decision|0|||
130373544|NCT03708328|469335025|FG001|Overall Study|Physician Decision|0|||
130373545|NCT03708328|469335026|FG002|Overall Study|Physician Decision|0|||
130373546|NCT03708328|469335027|FG003|Overall Study|Physician Decision|0|||
130373547|NCT03708328|469335028|FG004|Overall Study|Physician Decision|0|||
130373548|NCT03708328|469335029|FG005|Overall Study|Physician Decision|1|||
130373549|NCT03708328|469335030|FG006|Overall Study|Physician Decision|0|||
130303619|NCT04124705|469074936|FG000|Titration Period|Adverse Event|9|||
130373550|NCT03708328|469335031|FG007|Overall Study|Physician Decision|0|||
130373551|NCT03708328|469335032|FG008|Overall Study|Physician Decision|0|||
130373552|NCT03708328|469335033|FG009|Overall Study|Physician Decision|0|||
130373553|NCT03708328|469335024|FG000|Overall Study|Withdrawal by Subject|0|||
130373554|NCT03708328|469335025|FG001|Overall Study|Withdrawal by Subject|0|||
130373555|NCT03708328|469335026|FG002|Overall Study|Withdrawal by Subject|0|||
130303620|NCT04124705|469074937|FG001|Titration Period|Adverse Event|5|||
130303621|NCT04124705|469074936|FG000|Titration Period|Withdrawal by Subject|6|||
130373556|NCT03708328|469335027|FG003|Overall Study|Withdrawal by Subject|0|||
130373557|NCT03708328|469335028|FG004|Overall Study|Withdrawal by Subject|1|||
130463628|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
130463629|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
130463630|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
130463631|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
130463632|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
130463633|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
130463634|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
130463635|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
130463636|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
130463637|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
130463638|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
130463639|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
130463640|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
130463641|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
130463642|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
130463643|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
130463644|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
130463645|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
130463646|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
130463647|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
130463648|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
130463649|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
130463650|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
130463651|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
130463652|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
130557561|NCT05211739|470011811|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
130557562|NCT01862640|470011812|FG000|Overall Study|Adverse Event|4|||
130557563|NCT01862640|470011813|FG001|Overall Study|Adverse Event|10|||
130557564|NCT01862640|470011814|FG002|Overall Study|Adverse Event|6|||
130557565|NCT01862640|470011815|FG003|Overall Study|Adverse Event|8|||
130557566|NCT01862640|470011812|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130557567|NCT01862640|470011813|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130557568|NCT01862640|470011814|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
130557569|NCT01862640|470011815|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130557570|NCT01862640|470011812|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
130557571|NCT01862640|470011813|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
130557572|NCT01862640|470011814|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
130557573|NCT01862640|470011815|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
130557574|NCT01862640|470011812|FG000|Overall Study|Withdrawal by Subject|2|||
130557575|NCT01862640|470011813|FG001|Overall Study|Withdrawal by Subject|4|||
130557576|NCT01862640|470011814|FG002|Overall Study|Withdrawal by Subject|8|||
130557577|NCT01862640|470011815|FG003|Overall Study|Withdrawal by Subject|5|||
130557578|NCT01862640|470011812|FG000|Overall Study|Protocol Deviation|0|||
130557579|NCT01862640|470011813|FG001|Overall Study|Protocol Deviation|0|||
130557580|NCT01862640|470011814|FG002|Overall Study|Protocol Deviation|1|||
130557581|NCT01862640|470011815|FG003|Overall Study|Protocol Deviation|0|||
130557582|NCT04178967|470011816|FG000|Induction Period|Adverse Event|4|||
130557583|NCT04178967|470011817|FG001|Induction Period|Adverse Event|6|||
130557584|NCT04178967|470011818|FG002|Induction Period|Adverse Event|0|||
130557585|NCT04178967|470011819|FG003|Induction Period|Adverse Event|0|||
130557586|NCT04178967|470011820|FG004|Induction Period|Adverse Event|0|||
130557587|NCT04178967|470011821|FG005|Induction Period|Adverse Event|0|||
130557588|NCT04178967|470011822|FG006|Induction Period|Adverse Event|0|||
130557589|NCT04178967|470011823|FG007|Induction Period|Adverse Event|0|||
130557590|NCT04178967|470011824|FG008|Induction Period|Adverse Event|0|||
130557591|NCT04178967|470011825|FG009|Induction Period|Adverse Event|0|||
130557592|NCT04178967|470011826|FG010|Induction Period|Adverse Event|0|||
130557593|NCT04178967|470011816|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
130557594|NCT04178967|470011817|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
130557595|NCT04178967|470011818|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
130463653|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
130463654|NCT03593213|469663513|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
130463655|NCT03593213|469663514|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
130463656|NCT03593213|469663515|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
130557596|NCT04178967|470011819|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
130557597|NCT04178967|470011820|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
130557598|NCT04178967|470011821|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
130557599|NCT04178967|470011822|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130557600|NCT04178967|470011823|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
130463657|NCT03593213|469663516|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
130463658|NCT02594735|469663523|FG000|Overall Study|Adverse Event|1|||
130463659|NCT03844269|469663527|FG000|Overall Study|Withdrawal pre-intervention|1|||
130463660|NCT03844269|469663527|FG000|Overall Study|Did not complete the intervention|2|||
130463661|NCT00101010|469663531|FG000|Overall Study|Physician Decision|1|||
130463662|NCT00585533|469663532|FG000|Overall Study|objective or symptomatic progression|9|||
130463663|NCT01369498|469663533|FG000|Overall Study|Lack of Efficacy|9|||
130463664|NCT01369498|469663534|FG001|Overall Study|Lack of Efficacy|9|||
130463665|NCT01369498|469663535|FG002|Overall Study|Lack of Efficacy|1|||
130463666|NCT01369498|469663536|FG003|Overall Study|Lack of Efficacy|3|||
130463667|NCT01369498|469663533|FG000|Overall Study|Adverse Event|1|||
130463668|NCT01369498|469663534|FG001|Overall Study|Adverse Event|2|||
130463669|NCT01369498|469663535|FG002|Overall Study|Adverse Event|0|||
130463670|NCT01369498|469663536|FG003|Overall Study|Adverse Event|1|||
130463671|NCT01369498|469663533|FG000|Overall Study|Withdrawal of Consent|0|||
130463672|NCT01369498|469663534|FG001|Overall Study|Withdrawal of Consent|1|||
130463673|NCT01369498|469663535|FG002|Overall Study|Withdrawal of Consent|1|||
130463674|NCT01369498|469663536|FG003|Overall Study|Withdrawal of Consent|1|||
130463675|NCT01369498|469663533|FG000|Overall Study|Death|0|||
130463676|NCT01369498|469663534|FG001|Overall Study|Death|0|||
130463677|NCT01369498|469663535|FG002|Overall Study|Death|1|||
130463678|NCT01369498|469663536|FG003|Overall Study|Death|0|||
130463679|NCT01369498|469663533|FG000|Overall Study|Investigator's Discretion|1|||
130463680|NCT01369498|469663534|FG001|Overall Study|Investigator's Discretion|0|||
130463681|NCT01369498|469663535|FG002|Overall Study|Investigator's Discretion|1|||
130463682|NCT01369498|469663536|FG003|Overall Study|Investigator's Discretion|3|||
130463683|NCT01369498|469663533|FG000|Overall Study|Unknown Reason|1|||
130463684|NCT01369498|469663534|FG001|Overall Study|Unknown Reason|0|||
130463685|NCT01369498|469663535|FG002|Overall Study|Unknown Reason|11|||
130463686|NCT01369498|469663536|FG003|Overall Study|Unknown Reason|6|||
130463687|NCT01369498|469663533|FG000|Overall Study|Disease Progression|0|||
130463688|NCT01369498|469663534|FG001|Overall Study|Disease Progression|0|||
130463689|NCT01369498|469663535|FG002|Overall Study|Disease Progression|0|||
130463690|NCT01369498|469663536|FG003|Overall Study|Disease Progression|1|||
130463691|NCT05082935|469663540|FG000|Overall Study|Lost to Follow-up|549|||
130463692|NCT05082935|469663541|FG001|Overall Study|Lost to Follow-up|631|||
130463693|NCT05082935|469663540|FG000|Overall Study|Withdrawal by Subject|27|||
130463694|NCT05082935|469663541|FG001|Overall Study|Withdrawal by Subject|58|||
130463695|NCT00439569|469663542|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
130463696|NCT00439569|469663542|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
130463697|NCT00439569|469663542|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
130463698|NCT03482011|469663543|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
130463699|NCT03482011|469663544|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
130463700|NCT03482011|469663545|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
130463701|NCT03482011|469663546|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
130463702|NCT03482011|469663547|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130463703|NCT03482011|469663548|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130463704|NCT03482011|469663549|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130463705|NCT03482011|469663550|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
130463706|NCT03482011|469663543|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
130463707|NCT03482011|469663544|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
130463708|NCT03482011|469663545|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130463709|NCT03482011|469663546|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130463710|NCT03482011|469663547|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130463711|NCT03482011|469663548|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130716735|NCT02397408|470590924|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
130716736|NCT01646138|470590925|FG000|Overall Study|Lost to Follow-up|0|||
130716737|NCT01646138|470590926|FG001|Overall Study|Lost to Follow-up|0|||
130716738|NCT01646138|470590927|FG002|Overall Study|Lost to Follow-up|0|||
130716739|NCT01646138|470590928|FG003|Overall Study|Lost to Follow-up|0|||
130463712|NCT03482011|469663549|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130463713|NCT03482011|469663550|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130463714|NCT03482011|469663543|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463715|NCT03482011|469663544|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
130463716|NCT03482011|469663545|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463717|NCT03482011|469663546|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463718|NCT03482011|469663547|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463719|NCT03482011|469663548|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463720|NCT03482011|469663549|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130463721|NCT03482011|469663550|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
130716740|NCT01646138|470590929|FG004|Overall Study|Lost to Follow-up|2|||
130463722|NCT03482011|469663543|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
130463723|NCT03482011|469663544|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
130463724|NCT03482011|469663545|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
130463725|NCT03482011|469663546|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
130463726|NCT03482011|469663547|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
130463727|NCT03482011|469663548|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
130463728|NCT03482011|469663549|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
130463729|NCT03482011|469663550|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
130463730|NCT03482011|469663543|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130463731|NCT03482011|469663544|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
130463732|NCT03482011|469663545|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463733|NCT03482011|469663546|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463734|NCT03482011|469663547|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463735|NCT03482011|469663548|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463736|NCT03482011|469663549|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463737|NCT03482011|469663550|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130463738|NCT03482011|469663543|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
130463739|NCT03482011|469663544|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
130463740|NCT03482011|469663545|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
130463741|NCT03482011|469663546|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
130463742|NCT03482011|469663547|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
130463743|NCT03482011|469663548|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
130463744|NCT03482011|469663549|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
130463745|NCT03482011|469663550|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
130463746|NCT03482011|469663543|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130463747|NCT03482011|469663544|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130463748|NCT03482011|469663545|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
130463749|NCT03482011|469663546|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
130463750|NCT03482011|469663547|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
130463751|NCT03482011|469663548|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
130463752|NCT03482011|469663549|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130463753|NCT03482011|469663550|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
130463754|NCT03482011|469663543|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463755|NCT03482011|469663544|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463756|NCT03482011|469663545|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463757|NCT03482011|469663546|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463758|NCT03482011|469663547|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
130463759|NCT03482011|469663548|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463760|NCT03482011|469663549|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130463761|NCT03482011|469663550|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
130463762|NCT03482011|469663543|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
130463763|NCT03482011|469663544|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
130463764|NCT03482011|469663545|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
130463765|NCT03482011|469663546|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
130463766|NCT03482011|469663547|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
130463767|NCT03482011|469663548|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
130463768|NCT03482011|469663549|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
130463769|NCT03482011|469663550|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
130463770|NCT03482011|469663543|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130463771|NCT03482011|469663544|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130463772|NCT03482011|469663545|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130463773|NCT03482011|469663546|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
130463774|NCT03482011|469663547|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130463775|NCT03482011|469663548|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
130463776|NCT03482011|469663549|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130463777|NCT03482011|469663550|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130463778|NCT03482011|469663543|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130463779|NCT03482011|469663544|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130463780|NCT03482011|469663545|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130463781|NCT03482011|469663546|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
130463782|NCT03482011|469663547|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130463783|NCT03482011|469663548|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
130463784|NCT03482011|469663549|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
130463785|NCT03482011|469663550|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
130463786|NCT03482011|469663543|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
130303622|NCT04124705|469074937|FG001|Titration Period|Withdrawal by Subject|3|||
130303623|NCT04124705|469074936|FG000|Titration Period|Lost to Follow-up|0|||
130303624|NCT04124705|469074937|FG001|Titration Period|Lost to Follow-up|1|||
130463787|NCT03482011|469663544|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
130463788|NCT03482011|469663545|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
130463789|NCT03482011|469663546|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
130463790|NCT03482011|469663547|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
130463791|NCT03482011|469663548|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
130303625|NCT04124705|469074936|FG000|Titration Period|Death|1|||
130303626|NCT04124705|469074937|FG001|Titration Period|Death|1|||
130303627|NCT04124705|469074936|FG000|Titration Period|Lack of Efficacy|2|||
130303628|NCT04124705|469074937|FG001|Titration Period|Lack of Efficacy|0|||
130463792|NCT03482011|469663549|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
130303629|NCT04124705|469074936|FG000|Titration Period|Physician Decision|2|||
130303630|NCT04124705|469074937|FG001|Titration Period|Physician Decision|0|||
130303631|NCT04124705|469074936|FG000|Titration Period|Non-compliance with Study Drug|2|||
130303632|NCT04124705|469074937|FG001|Titration Period|Non-compliance with Study Drug|0|||
130303633|NCT04124705|469074936|FG000|Titration Period|Other|4|||
130303634|NCT04124705|469074937|FG001|Titration Period|Other|9|||
130303635|NCT04124705|469074936|FG000|Stabilization Period|Adverse Event|4|||
130303636|NCT04124705|469074937|FG001|Stabilization Period|Adverse Event|2|||
130303637|NCT04124705|469074936|FG000|Stabilization Period|Withdrawal by Subject|1|||
130303638|NCT04124705|469074937|FG001|Stabilization Period|Withdrawal by Subject|1|||
130303639|NCT04124705|469074936|FG000|Stabilization Period|Lost to Follow-up|0|||
130303640|NCT04124705|469074937|FG001|Stabilization Period|Lost to Follow-up|1|||
130303641|NCT04124705|469074936|FG000|Stabilization Period|Lack of Efficacy|4|||
130463793|NCT03482011|469663550|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
130463794|NCT03482011|469663543|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
130463795|NCT03482011|469663544|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
130463796|NCT03482011|469663545|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
130463797|NCT03482011|469663546|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
130463798|NCT03482011|469663547|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
130463799|NCT03482011|469663548|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
130463800|NCT03482011|469663549|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
130463801|NCT03482011|469663550|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
130463802|NCT03482011|469663543|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463803|NCT03482011|469663544|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463804|NCT03482011|469663545|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463805|NCT03482011|469663546|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463806|NCT03482011|469663547|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463807|NCT03482011|469663548|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463808|NCT03482011|469663549|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
130463809|NCT03482011|469663550|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
130463810|NCT03482011|469663543|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463811|NCT03482011|469663544|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463812|NCT03482011|469663545|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463813|NCT03482011|469663546|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463814|NCT03482011|469663547|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463815|NCT03482011|469663548|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463816|NCT03482011|469663549|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130463817|NCT03482011|469663550|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
130463818|NCT01595061|469663554|FG000|Overall Study|Never Treated|3|||
130463819|NCT01595061|469663554|FG000|Overall Study|Inadequate Pathology|1|||
130463820|NCT00529789|469663555|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
130463821|NCT00529789|469663555|FG000|Study Period II/III|Adverse Event|3|||
130463822|NCT00529789|469663555|FG000|Study Period II/III|Lack of Efficacy|2|||
130463823|NCT00529789|469663555|FG000|Study Period II/III|Withdrawal by Subject|1|||
130463824|NCT00529789|469663555|FG000|Study Period II/III|Protocol Violation|3|||
130463825|NCT00529789|469663555|FG000|Study Period II/III|Physician Decision|3|||
130463826|NCT00529789|469663555|FG000|Study Period II/III|Lost to Follow-up|3|||
130463827|NCT00529789|469663555|FG000|Study Period IV|Parent/Caregiver Decision|1|||
130463828|NCT00529789|469663555|FG000|Study Period IV|Adverse Event|1|||
130463829|NCT00529789|469663555|FG000|Study Period IV|Lack of Efficacy|1|||
130463830|NCT00529789|469663555|FG000|Study Period IV|Lost to Follow-up|3|||
130463831|NCT01430611|469663556|FG000|Overall Study|Adverse Event|0|||
130463832|NCT01430611|469663557|FG001|Overall Study|Adverse Event|1|||
130463833|NCT01430611|469663556|FG000|Overall Study|Protocol Violation|1|||
130303642|NCT04124705|469074937|FG001|Stabilization Period|Lack of Efficacy|2|||
130303643|NCT04124705|469074936|FG000|Stabilization Period|Protocol Deviation|0|||
130463834|NCT01430611|469663557|FG001|Overall Study|Protocol Violation|0|||
130463835|NCT01430611|469663556|FG000|Overall Study|Lost to Follow-up|1|||
130463836|NCT01430611|469663557|FG001|Overall Study|Lost to Follow-up|0|||
130463837|NCT01430611|469663556|FG000|Overall Study|Withdrawal by Subject|15|||
130463838|NCT01430611|469663557|FG001|Overall Study|Withdrawal by Subject|14|||
130303644|NCT04124705|469074937|FG001|Stabilization Period|Protocol Deviation|2|||
130303645|NCT04124705|469074936|FG000|Stabilization Period|Other|2|||
130303646|NCT04124705|469074937|FG001|Stabilization Period|Other|2|||
130463839|NCT00960141|469663558|FG000|Overall Study|Adverse Event|4|||
130463840|NCT00960141|469663559|FG001|Overall Study|Adverse Event|8|||
130463841|NCT00960141|469663560|FG002|Overall Study|Adverse Event|2|||
130463842|NCT00960141|469663558|FG000|Overall Study|Lack of Efficacy|3|||
130463843|NCT00960141|469663559|FG001|Overall Study|Lack of Efficacy|4|||
130303647|NCT01636986|469074938|FG000|Overall Study|Withdrawal by Subject|0|||
130303648|NCT01636986|469074939|FG001|Overall Study|Withdrawal by Subject|1|||
130303649|NCT01636986|469074938|FG000|Overall Study|Corneal Staining|0|||
130303650|NCT01636986|469074939|FG001|Overall Study|Corneal Staining|1|||
130716741|NCT01683838|470590930|FG000|Overall Study|Adverse Event|12|||
130716742|NCT01683838|470590931|FG001|Overall Study|Adverse Event|2|||
130716743|NCT01683838|470590930|FG000|Overall Study|Protocol Violation|3|||
130716744|NCT01683838|470590931|FG001|Overall Study|Protocol Violation|1|||
130716745|NCT01683838|470590930|FG000|Overall Study|Withdrawal by Subject|6|||
130716746|NCT01683838|470590931|FG001|Overall Study|Withdrawal by Subject|5|||
130716747|NCT01683838|470590930|FG000|Overall Study|Lost to Follow-up|1|||
130716748|NCT01683838|470590931|FG001|Overall Study|Lost to Follow-up|1|||
130716749|NCT01683838|470590930|FG000|Overall Study|Other|4|||
130716750|NCT01683838|470590931|FG001|Overall Study|Other|3|||
130716751|NCT01524679|470590932|FG000|Overall Study|Lost to Follow-up|1|||
130716752|NCT01524679|470590933|FG001|Overall Study|Lost to Follow-up|4|||
130716753|NCT01524679|470590932|FG000|Overall Study|Withdrawal by Subject|4|||
130716754|NCT01524679|470590933|FG001|Overall Study|Withdrawal by Subject|4|||
130716755|NCT01524679|470590932|FG000|Overall Study|Adverse Event|9|||
130716756|NCT01524679|470590933|FG001|Overall Study|Adverse Event|0|||
130716757|NCT01524679|470590932|FG000|Overall Study|Protocol Violation|1|||
130716758|NCT01524679|470590933|FG001|Overall Study|Protocol Violation|0|||
130716759|NCT01524679|470590932|FG000|Overall Study|Lack of Efficacy|2|||
130716760|NCT01524679|470590933|FG001|Overall Study|Lack of Efficacy|0|||
130716761|NCT01524679|470590932|FG000|Overall Study|e.g.wish for children, relocation|6|||
130716762|NCT01524679|470590933|FG001|Overall Study|e.g.wish for children, relocation|1|||
130716763|NCT00801099|470590934|FG000|Overall Study|Lost to Follow-up|101|||
130303651|NCT01844778|469074946|FG000|Overall Study|Protocol deviation|0|||
130303652|NCT01844778|469074947|FG001|Overall Study|Protocol deviation|1|||
130303653|NCT01844778|469074948|FG002|Overall Study|Protocol deviation|2|||
130303654|NCT01844778|469074946|FG000|Overall Study|Withdrawal by Subject|2|||
130303655|NCT01844778|469074947|FG001|Overall Study|Withdrawal by Subject|0|||
130303656|NCT01844778|469074948|FG002|Overall Study|Withdrawal by Subject|0|||
130303657|NCT01844778|469074946|FG000|Overall Study|Adverse Event|0|||
130303658|NCT01844778|469074947|FG001|Overall Study|Adverse Event|2|||
130303659|NCT01844778|469074948|FG002|Overall Study|Adverse Event|2|||
130303660|NCT01153698|469074950|FG000|Overall Study|Adverse Event|12|||
130303661|NCT01153698|469074950|FG000|Overall Study|Lost to Follow-up|4|||
130303662|NCT01153698|469074950|FG000|Overall Study|Withdrawal by Subject|2|||
130303663|NCT01153698|469074950|FG000|Overall Study|Switch to other anticoagulants|4|||
130303664|NCT01153698|469074950|FG000|Overall Study|Other|2|||
130303665|NCT01153698|469074950|FG000|Overall Study|Not treated with Pradaxa|5|||
130303666|NCT02106403|469074952|FG000|Follow-Up Visit 3|Other Reason|0|||
130303667|NCT02106403|469074953|FG001|Follow-Up Visit 3|Other Reason|0|||
130303668|NCT02106403|469074954|FG002|Follow-Up Visit 3|Other Reason|0|||
130303669|NCT02106403|469074955|FG003|Follow-Up Visit 3|Other Reason|0|||
130303670|NCT02106403|469074956|FG004|Follow-Up Visit 3|Other Reason|0|||
130303671|NCT02106403|469074957|FG005|Follow-Up Visit 3|Other Reason|1|||
130303672|NCT01496846|469074961|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130303673|NCT01496846|469074962|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130303674|NCT01496846|469074963|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303675|NCT01496846|469074964|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303676|NCT01496846|469074965|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303677|NCT01496846|469074966|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303678|NCT01772576|469074969|FG000|Overall Study|Death|15|||
130303679|NCT01772576|469074969|FG000|Overall Study|Protocol Violation|1|||
130303680|NCT01772576|469074969|FG000|Overall Study|Lost to Follow-up|3|||
130303681|NCT01772576|469074969|FG000|Overall Study|Study device not used|3|||
130303682|NCT01772576|469074969|FG000|Overall Study|Adverse Event|6|||
130303683|NCT01772576|469074969|FG000|Overall Study|Withdrawal by Subject|6|||
130303684|NCT04356352|469074976|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
130303685|NCT04356352|469074977|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
130303686|NCT04356352|469074978|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
130463844|NCT00960141|469663560|FG002|Overall Study|Lack of Efficacy|2|||
130463845|NCT00960141|469663558|FG000|Overall Study|Lost to Follow-up|1|||
130463846|NCT00960141|469663559|FG001|Overall Study|Lost to Follow-up|0|||
130716764|NCT03321630|470590942|FG000|Overall Study|Adverse Event|1|||
130716765|NCT03321630|470590942|FG000|Overall Study|Investigator Discretion|2|||
130716766|NCT03321630|470590942|FG000|Overall Study|Withdrawal by Subject|1|||
130716767|NCT02455050|470590943|FG000|Treatment Period 1|Lost to Follow-up|1|||
130716768|NCT02455050|470590944|FG001|Treatment Period 1|Lost to Follow-up|1|||
130716769|NCT02455050|470590945|FG002|Treatment Period 1|Lost to Follow-up|1|||
130716770|NCT02455050|470590946|FG003|Treatment Period 1|Lost to Follow-up|2|||
130303687|NCT04356352|469074976|FG000|Overall Study|Protocol Violation|0|||
130303688|NCT04356352|469074977|FG001|Overall Study|Protocol Violation|3|||
130303689|NCT04356352|469074978|FG002|Overall Study|Protocol Violation|1|||
130303690|NCT00379912|469074983|FG000|Overall Study|Lack of Efficacy|1|||
130303691|NCT00379912|469074984|FG001|Overall Study|Lack of Efficacy|0|||
130463847|NCT00960141|469663560|FG002|Overall Study|Lost to Follow-up|0|||
130463848|NCT00960141|469663558|FG000|Overall Study|Protocol Violation|1|||
130463849|NCT00960141|469663559|FG001|Overall Study|Protocol Violation|3|||
130463850|NCT00960141|469663560|FG002|Overall Study|Protocol Violation|2|||
130463851|NCT00960141|469663558|FG000|Overall Study|Withdrawal by Subject|1|||
130463852|NCT00960141|469663559|FG001|Overall Study|Withdrawal by Subject|2|||
130463853|NCT00960141|469663560|FG002|Overall Study|Withdrawal by Subject|1|||
130463854|NCT01792830|469663563|FG000|Overall Study|Withdrawal by Subject|22|||
130463855|NCT01792830|469663564|FG001|Overall Study|Withdrawal by Subject|0|||
130463856|NCT01792830|469663565|FG002|Overall Study|Withdrawal by Subject|0|||
130463857|NCT01792830|469663566|FG003|Overall Study|Withdrawal by Subject|2|||
130463858|NCT01792830|469663567|FG004|Overall Study|Withdrawal by Subject|1|||
130463859|NCT01792830|469663568|FG005|Overall Study|Withdrawal by Subject|1|||
130463860|NCT01792830|469663569|FG006|Overall Study|Withdrawal by Subject|1|||
130463861|NCT01792830|469663570|FG007|Overall Study|Withdrawal by Subject|1|||
130463862|NCT01792830|469663571|FG008|Overall Study|Withdrawal by Subject|7|||
130463863|NCT01792830|469663572|FG009|Overall Study|Withdrawal by Subject|0|||
130463864|NCT01792830|469663573|FG010|Overall Study|Withdrawal by Subject|2|||
130463865|NCT01792830|469663563|FG000|Overall Study|Death|3|||
130463866|NCT01792830|469663564|FG001|Overall Study|Death|0|||
130463867|NCT01792830|469663565|FG002|Overall Study|Death|0|||
130463868|NCT01792830|469663566|FG003|Overall Study|Death|1|||
130463869|NCT01792830|469663567|FG004|Overall Study|Death|0|||
130463870|NCT01792830|469663568|FG005|Overall Study|Death|0|||
130463871|NCT01792830|469663569|FG006|Overall Study|Death|1|||
130463872|NCT01792830|469663570|FG007|Overall Study|Death|0|||
130463873|NCT01792830|469663571|FG008|Overall Study|Death|1|||
130463874|NCT01792830|469663572|FG009|Overall Study|Death|0|||
130463875|NCT01792830|469663573|FG010|Overall Study|Death|1|||
130463876|NCT01792830|469663563|FG000|Overall Study|Adverse Event|0|||
130463877|NCT01792830|469663564|FG001|Overall Study|Adverse Event|0|||
130463878|NCT01792830|469663565|FG002|Overall Study|Adverse Event|0|||
130463879|NCT01792830|469663566|FG003|Overall Study|Adverse Event|0|||
130463880|NCT01792830|469663567|FG004|Overall Study|Adverse Event|0|||
130463881|NCT01792830|469663568|FG005|Overall Study|Adverse Event|0|||
130463882|NCT01792830|469663569|FG006|Overall Study|Adverse Event|0|||
130463883|NCT01792830|469663570|FG007|Overall Study|Adverse Event|0|||
130463884|NCT01792830|469663571|FG008|Overall Study|Adverse Event|1|||
130463885|NCT01792830|469663572|FG009|Overall Study|Adverse Event|0|||
130463886|NCT01792830|469663573|FG010|Overall Study|Adverse Event|0|||
130463887|NCT01943799|469663589|FG000|Overall Study|Lost to Follow-up|0|||
130463888|NCT01943799|469663590|FG001|Overall Study|Lost to Follow-up|1|||
130463889|NCT01943799|469663591|FG002|Overall Study|Lost to Follow-up|1|||
130463890|NCT01943799|469663592|FG003|Overall Study|Lost to Follow-up|0|||
130463891|NCT01943799|469663589|FG000|Overall Study|Protocol Violation|1|||
130463892|NCT01943799|469663590|FG001|Overall Study|Protocol Violation|0|||
130463893|NCT01943799|469663591|FG002|Overall Study|Protocol Violation|0|||
130463894|NCT01943799|469663592|FG003|Overall Study|Protocol Violation|0|||
130463895|NCT01943799|469663589|FG000|Overall Study|Withdrawal by Subject|4|||
130463896|NCT01943799|469663590|FG001|Overall Study|Withdrawal by Subject|2|||
130463897|NCT01943799|469663591|FG002|Overall Study|Withdrawal by Subject|1|||
130463898|NCT01943799|469663592|FG003|Overall Study|Withdrawal by Subject|0|||
130463899|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
130463900|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
130463901|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
130463902|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
130303692|NCT00621140|469074985|FG000|Overall Study|Adverse Event|4|||
130303693|NCT00621140|469074986|FG001|Overall Study|Adverse Event|5|||
130303694|NCT00621140|469074985|FG000|Overall Study|Lost to Follow-up|1|||
130463903|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
130463904|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
130303695|NCT00621140|469074986|FG001|Overall Study|Lost to Follow-up|2|||
130303696|NCT00621140|469074985|FG000|Overall Study|Withdrawal by Subject|4|||
130303697|NCT00621140|469074986|FG001|Overall Study|Withdrawal by Subject|6|||
130463905|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
130463906|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
130463907|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
130303698|NCT00621140|469074985|FG000|Overall Study|Other incl. lack of efficacy|6|||
130303699|NCT00621140|469074986|FG001|Overall Study|Other incl. lack of efficacy|5|||
130463908|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
130463909|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
130463910|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
130463911|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
130463912|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
130463913|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
130303700|NCT02873338|469074987|FG000|Overall Study|Adverse Event|0|||
130463914|NCT00958633|469663595|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
130463915|NCT00958633|469663596|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
130463916|NCT00958633|469663597|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
130463917|NCT00958633|469663595|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
130463918|NCT00958633|469663596|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
130463919|NCT00958633|469663597|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
130463920|NCT03144674|469663606|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
130463921|NCT03144674|469663607|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
130463922|NCT03144674|469663608|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
130463923|NCT03144674|469663609|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
130463924|NCT03144674|469663606|FG000|Overall Study|Death|3|||
130463925|NCT03144674|469663607|FG001|Overall Study|Death|2|||
130463926|NCT03144674|469663608|FG002|Overall Study|Death|6|||
130463927|NCT03144674|469663609|FG003|Overall Study|Death|24|||
130463928|NCT03144674|469663606|FG000|Overall Study|Lost to Follow-up|0|||
130463929|NCT03144674|469663607|FG001|Overall Study|Lost to Follow-up|1|||
130463930|NCT03144674|469663608|FG002|Overall Study|Lost to Follow-up|0|||
130463931|NCT03144674|469663609|FG003|Overall Study|Lost to Follow-up|4|||
130463932|NCT03144674|469663606|FG000|Overall Study|Withdrawal by Participant|0|||
130303701|NCT02873338|469074988|FG001|Overall Study|Adverse Event|2|||
130303702|NCT02873338|469074989|FG002|Overall Study|Adverse Event|1|||
130303703|NCT02873338|469074987|FG000|Overall Study|Death|2|||
130463933|NCT03144674|469663607|FG001|Overall Study|Withdrawal by Participant|0|||
130463934|NCT03144674|469663608|FG002|Overall Study|Withdrawal by Participant|2|||
130463935|NCT03144674|469663609|FG003|Overall Study|Withdrawal by Participant|6|||
130463936|NCT03144674|469663606|FG000|Overall Study|Discharged from the Trust|0|||
130463937|NCT03144674|469663607|FG001|Overall Study|Discharged from the Trust|0|||
130463938|NCT03144674|469663608|FG002|Overall Study|Discharged from the Trust|1|||
130463939|NCT03144674|469663609|FG003|Overall Study|Discharged from the Trust|0|||
130463940|NCT03144674|469663606|FG000|Overall Study|Exclusion Criteria Met|0|||
130557601|NCT04178967|470011824|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130557602|NCT04178967|470011825|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
130303704|NCT02873338|469074988|FG001|Overall Study|Death|1|||
130303705|NCT02873338|469074989|FG002|Overall Study|Death|1|||
130303706|NCT02873338|469074987|FG000|Overall Study|Withdrawal by Subject|2|||
130463941|NCT03144674|469663607|FG001|Overall Study|Exclusion Criteria Met|0|||
130463942|NCT03144674|469663608|FG002|Overall Study|Exclusion Criteria Met|1|||
130716771|NCT02455050|470590943|FG000|Treatment Period 2|Lost to Follow-up|1|||
130716772|NCT02455050|470590944|FG001|Treatment Period 2|Lost to Follow-up|0|||
130716773|NCT02455050|470590945|FG002|Treatment Period 2|Lost to Follow-up|2|||
130716774|NCT02455050|470590946|FG003|Treatment Period 2|Lost to Follow-up|1|||
130303707|NCT02873338|469074988|FG001|Overall Study|Withdrawal by Subject|1|||
130303708|NCT02873338|469074989|FG002|Overall Study|Withdrawal by Subject|3|||
130303709|NCT02873338|469074987|FG000|Overall Study|Lack of Efficacy|0|||
130303710|NCT02873338|469074988|FG001|Overall Study|Lack of Efficacy|2|||
130303711|NCT02873338|469074989|FG002|Overall Study|Lack of Efficacy|0|||
130303712|NCT02873338|469074987|FG000|Overall Study|Other or Missing|14|||
130303713|NCT02873338|469074988|FG001|Overall Study|Other or Missing|15|||
130303714|NCT02873338|469074989|FG002|Overall Study|Other or Missing|13|||
130303715|NCT03657095|469074990|FG000|Overall Study|Withdrawal by Subject|1|||
130373558|NCT03708328|469335029|FG005|Overall Study|Withdrawal by Subject|0|||
130373559|NCT03708328|469335030|FG006|Overall Study|Withdrawal by Subject|2|||
130373560|NCT03708328|469335031|FG007|Overall Study|Withdrawal by Subject|4|||
130373561|NCT03708328|469335032|FG008|Overall Study|Withdrawal by Subject|1|||
130373562|NCT03708328|469335033|FG009|Overall Study|Withdrawal by Subject|5|||
130373563|NCT03708328|469335024|FG000|Overall Study|Study Closed Locally|0|||
130373564|NCT03708328|469335025|FG001|Overall Study|Study Closed Locally|0|||
130373565|NCT03708328|469335026|FG002|Overall Study|Study Closed Locally|0|||
130373566|NCT03708328|469335027|FG003|Overall Study|Study Closed Locally|0|||
130373567|NCT03708328|469335028|FG004|Overall Study|Study Closed Locally|0|||
130373568|NCT03708328|469335029|FG005|Overall Study|Study Closed Locally|0|||
130373569|NCT03708328|469335030|FG006|Overall Study|Study Closed Locally|0|||
130373570|NCT03708328|469335031|FG007|Overall Study|Study Closed Locally|1|||
130373571|NCT03708328|469335032|FG008|Overall Study|Study Closed Locally|0|||
130373572|NCT03708328|469335033|FG009|Overall Study|Study Closed Locally|0|||
130373573|NCT03708328|469335024|FG000|Overall Study|Study Ended By Sponsor|0|||
130373574|NCT03708328|469335025|FG001|Overall Study|Study Ended By Sponsor|0|||
130373575|NCT03708328|469335026|FG002|Overall Study|Study Ended By Sponsor|0|||
130373576|NCT03708328|469335027|FG003|Overall Study|Study Ended By Sponsor|0|||
130373577|NCT03708328|469335028|FG004|Overall Study|Study Ended By Sponsor|0|||
130373578|NCT03708328|469335029|FG005|Overall Study|Study Ended By Sponsor|1|||
130373579|NCT03708328|469335030|FG006|Overall Study|Study Ended By Sponsor|0|||
130373580|NCT03708328|469335031|FG007|Overall Study|Study Ended By Sponsor|1|||
130373581|NCT03708328|469335032|FG008|Overall Study|Study Ended By Sponsor|0|||
130373582|NCT03708328|469335033|FG009|Overall Study|Study Ended By Sponsor|0|||
130373583|NCT03708328|469335024|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373584|NCT03708328|469335025|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373585|NCT03708328|469335026|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373586|NCT03708328|469335027|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373587|NCT03708328|469335028|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373588|NCT03708328|469335029|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373589|NCT03708328|469335030|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373590|NCT03708328|469335031|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373591|NCT03708328|469335032|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
130373592|NCT03708328|469335033|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130373593|NCT02695329|469335036|FG000|Overall Study|Adverse Event|1|||
130373594|NCT02695329|469335037|FG001|Overall Study|Adverse Event|0|||
130373595|NCT02695329|469335036|FG000|Overall Study|Poor X-ray quality for measurement|4|||
130373596|NCT02695329|469335037|FG001|Overall Study|Poor X-ray quality for measurement|5|||
130373597|NCT03648983|469335039|FG000|Overall Study|Study was terminated due to PI departure|95|||
130373598|NCT01269463|469335040|FG000|First Intervention|Withdrawal by Subject|1|||
130373599|NCT01269463|469335041|FG001|First Intervention|Withdrawal by Subject|0|||
130373600|NCT01269463|469335040|FG000|First Intervention|Adverse Event|1|||
130373601|NCT01269463|469335041|FG001|First Intervention|Adverse Event|0|||
130373602|NCT01269463|469335040|FG000|First Intervention|Lack of Efficacy|0|||
130373603|NCT01269463|469335041|FG001|First Intervention|Lack of Efficacy|1|||
130373604|NCT01269463|469335040|FG000|First Intervention|Physician Decision|0|||
130373605|NCT01269463|469335041|FG001|First Intervention|Physician Decision|1|||
130373606|NCT04404361|469335045|FG000|Overall Study|Death|12|||
130373607|NCT04404361|469335046|FG001|Overall Study|Death|12|||
130373608|NCT04404361|469335045|FG000|Overall Study|Withdrawal by Subject|13|||
130373609|NCT04404361|469335046|FG001|Overall Study|Withdrawal by Subject|5|||
130373610|NCT04404361|469335045|FG000|Overall Study|Lost to Follow-up|6|||
130373611|NCT04404361|469335046|FG001|Overall Study|Lost to Follow-up|3|||
130373612|NCT04404361|469335045|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
130376675|NCT01327885|469345895|FG000|Overall Study|Administrative decision|0|||
130716775|NCT02981303|470590947|FG000|Overall Study|Progressive Disease|17|||
130716776|NCT02981303|470590948|FG001|Overall Study|Progressive Disease|37|||
130716777|NCT02981303|470590947|FG000|Overall Study|Adverse Event|1|||
130716778|NCT02981303|470590948|FG001|Overall Study|Adverse Event|4|||
130303716|NCT03657095|469074991|FG001|Overall Study|Withdrawal by Subject|1|||
130303717|NCT03657095|469074990|FG000|Overall Study|Adverse Event|0|||
130716779|NCT02981303|470590947|FG000|Overall Study|Withdrawal by Subject|0|||
130716780|NCT02981303|470590948|FG001|Overall Study|Withdrawal by Subject|1|||
130716781|NCT02325518|470590949|FG000|Overall Study|Adverse Event|4|||
130716782|NCT02325518|470590950|FG001|Overall Study|Adverse Event|1|||
130716783|NCT02325518|470590949|FG000|Overall Study|Physician Decision|0|||
130716784|NCT02325518|470590950|FG001|Overall Study|Physician Decision|1|||
130716785|NCT02325518|470590949|FG000|Overall Study|Withdrawal by Subject|0|||
130716786|NCT02325518|470590950|FG001|Overall Study|Withdrawal by Subject|1|||
130716787|NCT03393806|470590953|FG000|Overall Study|Physician Decision|1|||
130716788|NCT03393806|470590954|FG001|Overall Study|Physician Decision|0|||
130303718|NCT03657095|469074991|FG001|Overall Study|Adverse Event|3|||
130303719|NCT03657095|469074990|FG000|Overall Study|Study Terminated by Sponsor|58|||
130303720|NCT03657095|469074991|FG001|Overall Study|Study Terminated by Sponsor|49|||
130303721|NCT02980133|469074992|FG000|Overall Study|Other than specified|1|||
130303722|NCT02980133|469074993|FG001|Overall Study|Other than specified|1|||
130303723|NCT02980133|469074994|FG002|Overall Study|Other than specified|2|||
130303724|NCT02980133|469074995|FG003|Overall Study|Other than specified|2|||
130303725|NCT02980133|469074992|FG000|Overall Study|Lost to Follow-up|0|||
130303726|NCT02980133|469074993|FG001|Overall Study|Lost to Follow-up|0|||
130303727|NCT02980133|469074994|FG002|Overall Study|Lost to Follow-up|1|||
130303728|NCT02980133|469074995|FG003|Overall Study|Lost to Follow-up|3|||
130303729|NCT02980133|469074992|FG000|Overall Study|Protocol Violation|0|||
130303730|NCT02980133|469074993|FG001|Overall Study|Protocol Violation|1|||
130303731|NCT02980133|469074994|FG002|Overall Study|Protocol Violation|0|||
130303732|NCT02980133|469074995|FG003|Overall Study|Protocol Violation|0|||
130373613|NCT04404361|469335046|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
130373614|NCT02862171|469335047|FG000|Overall Study|Death|1|||
130373615|NCT02862171|469335047|FG000|Overall Study|Lost to Follow-up|13|||
130373616|NCT02862171|469335047|FG000|Overall Study|Withdrawal by Subject|57|||
130373617|NCT02862171|469335047|FG000|Overall Study|Non-compliance|4|||
130373618|NCT02862171|469335047|FG000|Overall Study|HIV-1 seroconversion|18|||
130373619|NCT02549937|469335049|FG000|Overall Study|Death|0|||
130373620|NCT02549937|469335050|FG001|Overall Study|Death|1|||
130373621|NCT02549937|469335051|FG002|Overall Study|Death|0|||
130373622|NCT02549937|469335052|FG003|Overall Study|Death|1|||
130373623|NCT02549937|469335053|FG004|Overall Study|Death|0|||
130373624|NCT02549937|469335054|FG005|Overall Study|Death|8|||
130373625|NCT02549937|469335055|FG006|Overall Study|Death|0|||
130373626|NCT02549937|469335056|FG007|Overall Study|Death|0|||
130373627|NCT02549937|469335057|FG008|Overall Study|Death|19|||
130373628|NCT02549937|469335049|FG000|Overall Study|No follow up required|3|||
130373629|NCT02549937|469335050|FG001|Overall Study|No follow up required|6|||
130373630|NCT02549937|469335051|FG002|Overall Study|No follow up required|3|||
130373631|NCT02549937|469335052|FG003|Overall Study|No follow up required|8|||
130373632|NCT02549937|469335053|FG004|Overall Study|No follow up required|12|||
130373633|NCT02549937|469335054|FG005|Overall Study|No follow up required|21|||
130373634|NCT02549937|469335055|FG006|Overall Study|No follow up required|9|||
130373635|NCT02549937|469335056|FG007|Overall Study|No follow up required|11|||
130373636|NCT02549937|469335057|FG008|Overall Study|No follow up required|0|||
130373637|NCT02549937|469335049|FG000|Overall Study|Other|0|||
130373638|NCT02549937|469335050|FG001|Overall Study|Other|0|||
130373639|NCT02549937|469335051|FG002|Overall Study|Other|0|||
130373640|NCT02549937|469335052|FG003|Overall Study|Other|0|||
130373641|NCT02549937|469335053|FG004|Overall Study|Other|1|||
130373642|NCT02549937|469335054|FG005|Overall Study|Other|0|||
130373643|NCT02549937|469335055|FG006|Overall Study|Other|3|||
130373644|NCT02549937|469335056|FG007|Overall Study|Other|2|||
130373645|NCT02549937|469335057|FG008|Overall Study|Other|3|||
130373646|NCT02549937|469335049|FG000|Overall Study|Lost to Follow-up|0|||
130373647|NCT02549937|469335050|FG001|Overall Study|Lost to Follow-up|0|||
130373648|NCT02549937|469335051|FG002|Overall Study|Lost to Follow-up|0|||
130373649|NCT02549937|469335052|FG003|Overall Study|Lost to Follow-up|0|||
130373650|NCT02549937|469335053|FG004|Overall Study|Lost to Follow-up|0|||
130373651|NCT02549937|469335054|FG005|Overall Study|Lost to Follow-up|0|||
130373652|NCT02549937|469335055|FG006|Overall Study|Lost to Follow-up|0|||
130373653|NCT02549937|469335056|FG007|Overall Study|Lost to Follow-up|0|||
130716789|NCT00886288|470590955|FG000|Overall Study|no respect of the 12 weeks period|657|||
130303733|NCT02980133|469074992|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130303734|NCT02980133|469074993|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130303735|NCT02980133|469074994|FG002|Overall Study|Withdrawal by parent/guardian|3|||
130373654|NCT02549937|469335057|FG008|Overall Study|Lost to Follow-up|3|||
130373655|NCT02549937|469335049|FG000|Overall Study|Withdrawal by Subject|0|||
130373656|NCT02549937|469335050|FG001|Overall Study|Withdrawal by Subject|0|||
130373657|NCT02549937|469335051|FG002|Overall Study|Withdrawal by Subject|0|||
130373658|NCT02549937|469335052|FG003|Overall Study|Withdrawal by Subject|0|||
130373659|NCT02549937|469335053|FG004|Overall Study|Withdrawal by Subject|0|||
130373660|NCT02549937|469335054|FG005|Overall Study|Withdrawal by Subject|1|||
130716790|NCT00886288|470590956|FG001|Overall Study|no respect of the 12 weeks period|227|||
130557603|NCT04178967|470011826|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
130557604|NCT04178967|470011816|FG000|Induction Period|Lack of Efficacy|4|||
130557605|NCT04178967|470011817|FG001|Induction Period|Lack of Efficacy|1|||
130557606|NCT04178967|470011818|FG002|Induction Period|Lack of Efficacy|0|||
130557607|NCT04178967|470011819|FG003|Induction Period|Lack of Efficacy|0|||
130557608|NCT04178967|470011820|FG004|Induction Period|Lack of Efficacy|0|||
130716791|NCT00886288|470590955|FG000|Overall Study|Lost to Follow-up|86|||
130716792|NCT00886288|470590956|FG001|Overall Study|Lost to Follow-up|0|||
130716793|NCT01259115|470590957|FG000|Period 1|Adverse Event|1|||
130716794|NCT01259115|470590958|FG001|Period 1|Adverse Event|0|||
130716795|NCT01259115|470590957|FG000|Period 1|Protocol Violation|2|||
130716796|NCT01259115|470590958|FG001|Period 1|Protocol Violation|0|||
130716797|NCT01259115|470590957|FG000|Period 1|Lost to Follow-up|0|||
130716798|NCT01259115|470590958|FG001|Period 1|Lost to Follow-up|1|||
130716799|NCT01259115|470590957|FG000|Period 2|Adverse Event|1|||
130716800|NCT01259115|470590958|FG001|Period 2|Adverse Event|0|||
130716801|NCT01675661|470590959|FG000|Overall Study|Lost to Follow-up|22|||
130716802|NCT01675661|470590960|FG001|Overall Study|Lost to Follow-up|23|||
130716803|NCT01675661|470590959|FG000|Overall Study|Practical problems|9|||
130303736|NCT02980133|469074995|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130303737|NCT02980133|469074992|FG000|Overall Study|Withdrawal by Subject|0|||
130303738|NCT02980133|469074993|FG001|Overall Study|Withdrawal by Subject|0|||
130303739|NCT02980133|469074994|FG002|Overall Study|Withdrawal by Subject|1|||
130303740|NCT02980133|469074995|FG003|Overall Study|Withdrawal by Subject|0|||
130303741|NCT00384332|469074996|FG000|Overall Study|Lost to Follow-up|4|||
130303742|NCT00384332|469074997|FG001|Overall Study|Lost to Follow-up|0|||
130303743|NCT02560012|469074998|FG000|Overall Study|Study Terminated|2|||
130303744|NCT01007838|469074999|FG000|Overall Study|Withdrawal by Subject|1|||
130303745|NCT01007838|469075000|FG001|Overall Study|Withdrawal by Subject|0|||
130373661|NCT02549937|469335055|FG006|Overall Study|Withdrawal by Subject|4|||
130303746|NCT01007838|469075001|FG002|Overall Study|Withdrawal by Subject|0|||
130303747|NCT01007838|469075002|FG003|Overall Study|Withdrawal by Subject|0|||
130303748|NCT01007838|469074999|FG000|Overall Study|Physician Decision|1|||
130303749|NCT01007838|469075000|FG001|Overall Study|Physician Decision|0|||
130303750|NCT01007838|469075001|FG002|Overall Study|Physician Decision|0|||
130303751|NCT01007838|469075002|FG003|Overall Study|Physician Decision|0|||
130303752|NCT01007838|469074999|FG000|Overall Study|Started home haemodialysis|1|||
130303753|NCT01007838|469075000|FG001|Overall Study|Started home haemodialysis|0|||
130303754|NCT01007838|469075001|FG002|Overall Study|Started home haemodialysis|0|||
130303755|NCT01007838|469075002|FG003|Overall Study|Started home haemodialysis|0|||
130303756|NCT00852241|469075003|FG000|Overall Study|Physician Decision|18|||
130303757|NCT00118430|469075005|FG000|Overall Study|Withdrawal by Subject|6|||
130303758|NCT00118430|469075006|FG001|Overall Study|Withdrawal by Subject|2|||
130303759|NCT00118430|469075007|FG002|Overall Study|Withdrawal by Subject|0|||
130303760|NCT00118430|469075005|FG000|Overall Study|Lost to Follow-up|15|||
130303761|NCT00118430|469075006|FG001|Overall Study|Lost to Follow-up|22|||
130303762|NCT00118430|469075007|FG002|Overall Study|Lost to Follow-up|28|||
130303763|NCT02147288|469075008|FG000|Overall Study|post-operative hematoma|1|||
130303764|NCT02147288|469075009|FG001|Overall Study|post-operative hematoma|1|||
130303765|NCT02147288|469075010|FG002|Overall Study|post-operative hematoma|0|||
130303766|NCT02147288|469075011|FG003|Overall Study|post-operative hematoma|0|||
130303767|NCT02147288|469075012|FG004|Overall Study|post-operative hematoma|0|||
130303768|NCT02147288|469075013|FG005|Overall Study|post-operative hematoma|0|||
130303769|NCT02147288|469075014|FG006|Overall Study|post-operative hematoma|0|||
130303770|NCT02147288|469075015|FG007|Overall Study|post-operative hematoma|0|||
130303771|NCT02147288|469075016|FG008|Overall Study|post-operative hematoma|0|||
130303772|NCT02147288|469075017|FG009|Overall Study|post-operative hematoma|0|||
130303773|NCT02147288|469075008|FG000|Overall Study|complications from concurrent hernia rep|0|||
130303774|NCT02147288|469075009|FG001|Overall Study|complications from concurrent hernia rep|1|||
130303775|NCT02147288|469075010|FG002|Overall Study|complications from concurrent hernia rep|0|||
130303776|NCT02147288|469075011|FG003|Overall Study|complications from concurrent hernia rep|0|||
130303777|NCT02147288|469075012|FG004|Overall Study|complications from concurrent hernia rep|0|||
130303778|NCT02147288|469075013|FG005|Overall Study|complications from concurrent hernia rep|0|||
130303779|NCT02147288|469075014|FG006|Overall Study|complications from concurrent hernia rep|0|||
130303780|NCT02147288|469075015|FG007|Overall Study|complications from concurrent hernia rep|0|||
130303781|NCT02147288|469075016|FG008|Overall Study|complications from concurrent hernia rep|0|||
130303782|NCT02147288|469075017|FG009|Overall Study|complications from concurrent hernia rep|0|||
130303783|NCT02069392|469075020|FG000|Overall Study|Withdrawal by Subject|4|||
130303784|NCT02069392|469075021|FG001|Overall Study|Withdrawal by Subject|2|||
130303785|NCT00269633|469075022|FG000|Overall Study|Withdrawal by Subject|1|||
130303786|NCT00269633|469075023|FG001|Overall Study|Withdrawal by Subject|0|||
130303787|NCT02927938|469075024|FG000|Overall Study|Death|0|||
130303788|NCT02927938|469075025|FG001|Overall Study|Death|1|||
130373662|NCT02549937|469335056|FG007|Overall Study|Withdrawal by Subject|3|||
130716804|NCT01675661|470590960|FG001|Overall Study|Practical problems|5|||
130716805|NCT01675661|470590959|FG000|Overall Study|Moved away|5|||
130716806|NCT01675661|470590960|FG001|Overall Study|Moved away|6|||
130303789|NCT02927938|469075026|FG002|Overall Study|Death|0|||
130303790|NCT02927938|469075027|FG003|Overall Study|Death|4|||
130303791|NCT02927938|469075024|FG000|Overall Study|Early Study Termination|1|||
130303792|NCT02927938|469075025|FG001|Overall Study|Early Study Termination|5|||
130303793|NCT02927938|469075026|FG002|Overall Study|Early Study Termination|4|||
130303794|NCT02927938|469075027|FG003|Overall Study|Early Study Termination|3|||
130303795|NCT02476006|469075028|FG000|Overall Study|Death|4|||
130303796|NCT02476006|469075028|FG000|Overall Study|Lack of treatment efficacy|2|||
130303797|NCT02476006|469075028|FG000|Overall Study|Pregnancy|1|||
130303798|NCT02476006|469075028|FG000|Overall Study|Participant did not wish to continue|39|||
130303799|NCT02476006|469075028|FG000|Overall Study|Adverse Event|41|||
130303800|NCT02476006|469075028|FG000|Overall Study|Poor compliance to study protocol|3|||
130303801|NCT02476006|469075028|FG000|Overall Study|Sponsor decision|6|||
130303802|NCT02476006|469075028|FG000|Overall Study|Lost to Follow-up|5|||
130303803|NCT02476006|469075028|FG000|Overall Study|Physician Decision|5|||
130303804|NCT02476006|469075028|FG000|Overall Study|Study ended treatment not available|4|||
130303805|NCT02476006|469075028|FG000|Overall Study|Switched to commercial drug|4|||
130303806|NCT02476006|469075028|FG000|Overall Study|Excluded from study|1|||
130303807|NCT02476006|469075028|FG000|Overall Study|Protocol Violation|1|||
130303808|NCT02476006|469075028|FG000|Overall Study|Enrolled but not treated|4|||
130303809|NCT02611817|469077312|FG000|Open-label Induction Phase|Reason not Specified|9|||
130303810|NCT02611817|469077313|FG001|Open-label Induction Phase|Reason not Specified|0|||
130303811|NCT02611817|469077314|FG002|Open-label Induction Phase|Reason not Specified|0|||
130303812|NCT02611817|469077312|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
130303813|NCT02611817|469077313|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
130303814|NCT02611817|469077314|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
130303815|NCT02611817|469077312|FG000|Open-label Induction Phase|Pregnancy|1|||
130303816|NCT02611817|469077313|FG001|Open-label Induction Phase|Pregnancy|0|||
130303817|NCT02611817|469077314|FG002|Open-label Induction Phase|Pregnancy|0|||
130303818|NCT02611817|469077312|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
130303819|NCT02611817|469077313|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
130303820|NCT02611817|469077314|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
130303821|NCT02611817|469077312|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
130303822|NCT02611817|469077313|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
130303823|NCT02611817|469077314|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
130303824|NCT02611817|469077312|FG000|Open-label Induction Phase|Protocol Violation|5|||
130716807|NCT01675661|470590959|FG000|Overall Study|Withdrawal by Subject|3|||
130716808|NCT01675661|470590960|FG001|Overall Study|Withdrawal by Subject|7|||
130716809|NCT01675661|470590959|FG000|Overall Study|Physician Decision|0|||
130716810|NCT01675661|470590960|FG001|Overall Study|Physician Decision|2|||
130716811|NCT01675661|470590959|FG000|Overall Study|Death|0|||
130303825|NCT02611817|469077313|FG001|Open-label Induction Phase|Protocol Violation|0|||
130303826|NCT02611817|469077314|FG002|Open-label Induction Phase|Protocol Violation|0|||
130303827|NCT02611817|469077312|FG000|Open-label Induction Phase|Adverse Event|16|||
130303828|NCT02611817|469077313|FG001|Open-label Induction Phase|Adverse Event|0|||
130303829|NCT02611817|469077314|FG002|Open-label Induction Phase|Adverse Event|0|||
130303830|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
130303831|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
130373663|NCT02549937|469335057|FG008|Overall Study|Withdrawal by Subject|2|||
130373664|NCT02549937|469335049|FG000|Overall Study|Sponsor Decision|0|||
130373665|NCT02549937|469335050|FG001|Overall Study|Sponsor Decision|0|||
130373666|NCT02549937|469335051|FG002|Overall Study|Sponsor Decision|0|||
130373667|NCT02549937|469335052|FG003|Overall Study|Sponsor Decision|0|||
130373668|NCT02549937|469335053|FG004|Overall Study|Sponsor Decision|0|||
130373669|NCT02549937|469335054|FG005|Overall Study|Sponsor Decision|0|||
130373670|NCT02549937|469335055|FG006|Overall Study|Sponsor Decision|0|||
130373671|NCT02549937|469335056|FG007|Overall Study|Sponsor Decision|0|||
130373672|NCT02549937|469335057|FG008|Overall Study|Sponsor Decision|6|||
130373673|NCT03930797|469335058|FG000|Overall Study|Lost to Follow-up|3|||
130373674|NCT03930797|469335059|FG001|Overall Study|Lost to Follow-up|10|||
130373675|NCT00662012|469335060|FG000|Overall Study|Lost to Follow-up|85|||
130373676|NCT00662012|469335060|FG000|Overall Study|Death|1|||
130373677|NCT00662012|469335060|FG000|Overall Study|Withdrawal by Subject|1|||
130373678|NCT01744197|469335064|FG000|Overall Study|Received 1 patch|2|||
130373679|NCT01744197|469335065|FG001|Overall Study|Received 1 patch|1|||
130373680|NCT01744197|469335064|FG000|Overall Study|No patch received|2|||
130373681|NCT01744197|469335065|FG001|Overall Study|No patch received|2|||
130373682|NCT02144012|469335068|FG000|Overall Study|Adverse Event|1|||
130373683|NCT02144012|469335069|FG001|Overall Study|Adverse Event|0|||
130373684|NCT02144012|469335068|FG000|Overall Study|Death|1|||
130373685|NCT02144012|469335069|FG001|Overall Study|Death|0|||
130373686|NCT02144012|469335068|FG000|Overall Study|Withdrawal by Subject|11|||
130373687|NCT02144012|469335069|FG001|Overall Study|Withdrawal by Subject|3|||
130373688|NCT02144012|469335068|FG000|Overall Study|Study Terminated by Sponsor|18|||
130373689|NCT02144012|469335069|FG001|Overall Study|Study Terminated by Sponsor|12|||
130373690|NCT02144012|469335068|FG000|Overall Study|Other|3|||
130716812|NCT01675661|470590960|FG001|Overall Study|Death|1|||
130303832|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
130303833|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130303834|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
130303835|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130303836|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
130303837|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
130303838|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
130303839|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
130303840|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
130303841|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
130303842|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
130303843|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
130303844|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
130303845|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
130303846|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
130303847|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
130303848|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130303849|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130303850|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
130303851|NCT00931606|469077315|FG000|Overall Study|Death|1|||
130303852|NCT00931606|469077316|FG001|Overall Study|Death|3|||
130303853|NCT00931606|469077317|FG002|Overall Study|Death|2|||
130303854|NCT00931606|469077318|FG003|Overall Study|Death|0|||
130303855|NCT00931606|469077315|FG000|Overall Study|Lost to Follow-up|0|||
130303856|NCT00931606|469077316|FG001|Overall Study|Lost to Follow-up|1|||
130303857|NCT00931606|469077317|FG002|Overall Study|Lost to Follow-up|0|||
130303858|NCT00931606|469077318|FG003|Overall Study|Lost to Follow-up|0|||
130303859|NCT00931606|469077315|FG000|Overall Study|Physician Decision|0|||
130303860|NCT00931606|469077316|FG001|Overall Study|Physician Decision|0|||
130303861|NCT00931606|469077317|FG002|Overall Study|Physician Decision|3|||
130303862|NCT00931606|469077318|FG003|Overall Study|Physician Decision|0|||
130303863|NCT00931606|469077315|FG000|Overall Study|Sponsor Decision|1|||
130303864|NCT00931606|469077316|FG001|Overall Study|Sponsor Decision|4|||
130303865|NCT00931606|469077317|FG002|Overall Study|Sponsor Decision|0|||
130303866|NCT00931606|469077318|FG003|Overall Study|Sponsor Decision|2|||
130303867|NCT00931606|469077315|FG000|Overall Study|Withdrawal by Subject|3|||
130303868|NCT00931606|469077316|FG001|Overall Study|Withdrawal by Subject|1|||
130303869|NCT00931606|469077317|FG002|Overall Study|Withdrawal by Subject|1|||
130303870|NCT00931606|469077318|FG003|Overall Study|Withdrawal by Subject|1|||
130303871|NCT03412812|469077326|FG000|Level 1|Death|3|||
130303872|NCT03412812|469077327|FG001|Level 1|Death|0|||
130303873|NCT03412812|469077326|FG000|Level 1|Adverse Event|0|||
130303874|NCT03412812|469077327|FG001|Level 1|Adverse Event|1|||
130303875|NCT03828617|469077331|FG000|Overall Study|Lost to Follow-up|22|||
130303876|NCT03828617|469077332|FG001|Overall Study|Lost to Follow-up|12|||
130303877|NCT03828617|469077333|FG002|Overall Study|Lost to Follow-up|23|||
130303878|NCT03828617|469077334|FG003|Overall Study|Lost to Follow-up|7|||
130303879|NCT03828617|469077331|FG000|Overall Study|No longer met eligibility criteria|0|||
130303880|NCT03828617|469077332|FG001|Overall Study|No longer met eligibility criteria|1|||
130303881|NCT03828617|469077333|FG002|Overall Study|No longer met eligibility criteria|1|||
130303882|NCT03828617|469077334|FG003|Overall Study|No longer met eligibility criteria|3|||
130303883|NCT03828617|469077331|FG000|Overall Study|Protocol Violation|0|||
130303884|NCT03828617|469077332|FG001|Overall Study|Protocol Violation|2|||
130303885|NCT03828617|469077333|FG002|Overall Study|Protocol Violation|0|||
130303886|NCT03828617|469077334|FG003|Overall Study|Protocol Violation|0|||
130303887|NCT03828617|469077331|FG000|Overall Study|Withdrawal by Subject|2|||
130303888|NCT03828617|469077332|FG001|Overall Study|Withdrawal by Subject|0|||
130303889|NCT03828617|469077333|FG002|Overall Study|Withdrawal by Subject|2|||
130303890|NCT03828617|469077334|FG003|Overall Study|Withdrawal by Subject|0|||
130303891|NCT03826186|469077335|FG000|Overall Study|Protocol Violation|2|||
130303892|NCT03826186|469077336|FG001|Overall Study|Protocol Violation|0|||
130303893|NCT03826186|469077335|FG000|Overall Study|Withdrawal by Subject|1|||
130303894|NCT03826186|469077336|FG001|Overall Study|Withdrawal by Subject|0|||
130463943|NCT03144674|469663609|FG003|Overall Study|Exclusion Criteria Met|0|||
130303895|NCT00082407|469077339|FG000|Overall Study|Adverse Event|20|||
130303896|NCT00082407|469077340|FG001|Overall Study|Adverse Event|0|||
130303897|NCT00082407|469077339|FG000|Overall Study|Protocol Violation|14|||
130303898|NCT00082407|469077340|FG001|Overall Study|Protocol Violation|12|||
130303899|NCT00082407|469077339|FG000|Overall Study|Patient Decision|13|||
130303900|NCT00082407|469077340|FG001|Overall Study|Patient Decision|6|||
130303901|NCT00082407|469077339|FG000|Overall Study|Physician Decision|5|||
130303902|NCT00082407|469077340|FG001|Overall Study|Physician Decision|3|||
130303903|NCT00082407|469077339|FG000|Overall Study|Loss of Glucose Control|2|||
130463944|NCT03144674|469663606|FG000|Overall Study|Changed Physicians|0|||
130303904|NCT00082407|469077340|FG001|Overall Study|Loss of Glucose Control|2|||
130303905|NCT00082407|469077339|FG000|Overall Study|Death|2|||
130303906|NCT00082407|469077340|FG001|Overall Study|Death|1|||
130463945|NCT03144674|469663607|FG001|Overall Study|Changed Physicians|0|||
130463946|NCT03144674|469663608|FG002|Overall Study|Changed Physicians|0|||
130463947|NCT03144674|469663609|FG003|Overall Study|Changed Physicians|1|||
130463948|NCT03144674|469663606|FG000|Overall Study|Removed for Safety|0|||
130463949|NCT03144674|469663607|FG001|Overall Study|Removed for Safety|0|||
130303907|NCT00082407|469077339|FG000|Overall Study|Lost to Follow-up|0|||
130303908|NCT00082407|469077340|FG001|Overall Study|Lost to Follow-up|3|||
130303909|NCT00891228|469077342|FG000|Overall Study|Adverse Event|0|||
130303910|NCT00891228|469077343|FG001|Overall Study|Adverse Event|2|||
130303911|NCT00891228|469077344|FG002|Overall Study|Adverse Event|3|||
130303912|NCT00891228|469077342|FG000|Overall Study|Withdrawal by Subject|2|||
130303913|NCT00891228|469077343|FG001|Overall Study|Withdrawal by Subject|4|||
130303914|NCT00891228|469077344|FG002|Overall Study|Withdrawal by Subject|5|||
130303915|NCT00891228|469077342|FG000|Overall Study|Protocol Violation|3|||
130303916|NCT00891228|469077343|FG001|Overall Study|Protocol Violation|1|||
130303917|NCT00891228|469077344|FG002|Overall Study|Protocol Violation|2|||
130303918|NCT00891228|469077342|FG000|Overall Study|Physician Decision|2|||
130303919|NCT00891228|469077343|FG001|Overall Study|Physician Decision|1|||
130303920|NCT00891228|469077344|FG002|Overall Study|Physician Decision|0|||
130303921|NCT00891228|469077342|FG000|Overall Study|Lost to Follow-up|4|||
130303922|NCT00891228|469077343|FG001|Overall Study|Lost to Follow-up|4|||
130303923|NCT00891228|469077344|FG002|Overall Study|Lost to Follow-up|5|||
130303924|NCT00891228|469077342|FG000|Overall Study|Pregnancy|0|||
130303925|NCT00891228|469077343|FG001|Overall Study|Pregnancy|1|||
130303926|NCT00891228|469077344|FG002|Overall Study|Pregnancy|0|||
130303927|NCT02688985|469077347|FG000|Overall Study|Adverse Event|1|||
130303928|NCT02688985|469077348|FG001|Overall Study|Adverse Event|2|||
130303929|NCT02688985|469077349|FG002|Overall Study|Adverse Event|2|||
130303930|NCT02688985|469077350|FG003|Overall Study|Adverse Event|0|||
130303931|NCT02688985|469077351|FG004|Overall Study|Adverse Event|0|||
130303932|NCT02688985|469077347|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130303933|NCT02688985|469077348|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130303934|NCT02688985|469077349|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
130303935|NCT02688985|469077350|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
130373691|NCT02144012|469335069|FG001|Overall Study|Other|0|||
130373692|NCT02674529|469336758|FG000|Overall Study|Lost to Follow-up|1|||
130373693|NCT02674529|469336759|FG001|Overall Study|Lost to Follow-up|2|||
130373694|NCT02674529|469336758|FG000|Overall Study|Withdrawal by Subject|2|||
130373695|NCT02674529|469336759|FG001|Overall Study|Withdrawal by Subject|1|||
130373696|NCT02674529|469336758|FG000|Overall Study|Physician Decision|0|||
130373697|NCT02674529|469336759|FG001|Overall Study|Physician Decision|1|||
130373698|NCT02674529|469336758|FG000|Overall Study|Protocol Violation|0|||
130373699|NCT02674529|469336759|FG001|Overall Study|Protocol Violation|1|||
130373700|NCT02891850|469336760|FG000|Overall Study|Adverse Event|3|||
130373701|NCT02891850|469336761|FG001|Overall Study|Adverse Event|0|||
130373702|NCT02891850|469336760|FG000|Overall Study|Death|0|||
130373703|NCT02891850|469336761|FG001|Overall Study|Death|4|||
130373704|NCT02891850|469336760|FG000|Overall Study|Physician Decision|1|||
130373705|NCT02891850|469336761|FG001|Overall Study|Physician Decision|0|||
130373706|NCT02891850|469336760|FG000|Overall Study|Pregnancy|1|||
130373707|NCT02891850|469336761|FG001|Overall Study|Pregnancy|0|||
130373708|NCT02891850|469336760|FG000|Overall Study|Withdrawal by Subject|2|||
130373709|NCT02891850|469336761|FG001|Overall Study|Withdrawal by Subject|3|||
130373710|NCT00630396|469336762|FG000|Overall Study|Death|4|||
130373711|NCT00630396|469336762|FG000|Overall Study|Lost to Follow-up|3|||
130373712|NCT00903695|469336766|FG000|Overall Study|medical exclusion after 1st testing|1|||
130373713|NCT00903695|469336767|FG001|Overall Study|medical exclusion after 1st testing|0|||
130373714|NCT00903695|469336766|FG000|Overall Study|lung cancer|1|||
130373715|NCT00903695|469336767|FG001|Overall Study|lung cancer|0|||
130373716|NCT00543140|469336768|FG000|Overall Study|Lost to Follow-up|33|||
130373717|NCT00543140|469336768|FG000|Overall Study|Withdrawal by Subject|13|||
130373718|NCT00543140|469336768|FG000|Overall Study|Protocol Violation|10|||
130373719|NCT00543140|469336768|FG000|Overall Study|Insufficient weight loss|10|||
130373720|NCT00543140|469336768|FG000|Overall Study|SAE leading to explant of SAGB|3|||
130373721|NCT00543140|469336768|FG000|Overall Study|Death|1|||
130373722|NCT00543140|469336768|FG000|Overall Study|Subject moved|1|||
130373723|NCT00543140|469336768|FG000|Overall Study|Conversion to different procedure|1|||
130373724|NCT00578812|469336769|FG000|Overall Study|Not treated|6|||
130373725|NCT00578812|469336770|FG001|Overall Study|Not treated|7|||
130373726|NCT04532164|469336773|FG000|Overall Study|Adverse Event|1|||
130373727|NCT04532164|469336773|FG000|Overall Study|Protocol Violation|5|||
130373728|NCT04532164|469336773|FG000|Overall Study|Lost to Follow-up|1|||
130373729|NCT04532164|469336773|FG000|Overall Study|Found to be Ineligible|3|||
130373730|NCT04532164|469336773|FG000|Overall Study|Withdrawal by Subject|14|||
130373731|NCT02269241|469336780|FG000|Overall Study|Lost to Follow-up|269|||
130373732|NCT02269241|469336780|FG000|Overall Study|Withdrawal by Subject|155|||
130373733|NCT02269241|469336780|FG000|Overall Study|Protocol Violation|1|||
130373734|NCT02269241|469336780|FG000|Overall Study|Physician Decision|7|||
130463950|NCT03144674|469663608|FG002|Overall Study|Removed for Safety|0|||
130463951|NCT03144674|469663609|FG003|Overall Study|Removed for Safety|1|||
130463952|NCT03144674|469663606|FG000|Overall Study|Site Closed|0|||
130463953|NCT03144674|469663607|FG001|Overall Study|Site Closed|0|||
130463954|NCT03144674|469663608|FG002|Overall Study|Site Closed|0|||
130463955|NCT03144674|469663609|FG003|Overall Study|Site Closed|1|||
130463956|NCT03144674|469663606|FG000|Overall Study|Histological Criteria Not Met|0|||
130463957|NCT03144674|469663607|FG001|Overall Study|Histological Criteria Not Met|0|||
130463958|NCT03144674|469663608|FG002|Overall Study|Histological Criteria Not Met|0|||
130463959|NCT03144674|469663609|FG003|Overall Study|Histological Criteria Not Met|1|||
130463960|NCT03144674|469663606|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
130463961|NCT03144674|469663607|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
130463962|NCT03144674|469663608|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
130463963|NCT03144674|469663609|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
130463964|NCT03144674|469663606|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
130463965|NCT03144674|469663607|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
130463966|NCT03144674|469663608|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
130463967|NCT03144674|469663609|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
130463968|NCT01373346|469663613|FG000|Overall Study|Death|1|||
130463969|NCT01198028|469663614|FG000|Overall Study|Adverse Event|5|||
130463970|NCT01198028|469663614|FG000|Overall Study|Death|3|||
130463971|NCT01198028|469663614|FG000|Overall Study|Physician Decision|2|||
130463972|NCT01395758|469663615|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
130463973|NCT01395758|469663616|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130463974|NCT01395758|469663617|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130463975|NCT00433199|469663618|FG000|Double-Blind Period|Adverse Event|0|||
130463976|NCT00433199|469663619|FG001|Double-Blind Period|Adverse Event|25|||
130463977|NCT00433199|469663618|FG000|Double-Blind Period|Lack of Efficacy|0|||
130463978|NCT00433199|469663619|FG001|Double-Blind Period|Lack of Efficacy|2|||
130463979|NCT00433199|469663618|FG000|Double-Blind Period|Lost to Follow-up|2|||
130463980|NCT00433199|469663619|FG001|Double-Blind Period|Lost to Follow-up|5|||
130463981|NCT00433199|469663618|FG000|Double-Blind Period|Withdrawal by Subject|8|||
130463982|NCT00433199|469663619|FG001|Double-Blind Period|Withdrawal by Subject|19|||
130463983|NCT00433199|469663618|FG000|Double-Blind Period|Protocol Violation|1|||
130463984|NCT00433199|469663619|FG001|Double-Blind Period|Protocol Violation|10|||
130463985|NCT00433199|469663618|FG000|Double-Blind Period|Administrative|1|||
130463986|NCT00433199|469663619|FG001|Double-Blind Period|Administrative|5|||
130463987|NCT00433199|469663618|FG000|Open-Label Period|Adverse Event|0|||
130463988|NCT00433199|469663619|FG001|Open-Label Period|Adverse Event|19|||
130463989|NCT00433199|469663618|FG000|Open-Label Period|Lack of Efficacy|0|||
130463990|NCT00433199|469663619|FG001|Open-Label Period|Lack of Efficacy|2|||
130463991|NCT00433199|469663618|FG000|Open-Label Period|Lost to Follow-up|0|||
130303936|NCT02688985|469077351|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
130463992|NCT00433199|469663619|FG001|Open-Label Period|Lost to Follow-up|3|||
130463993|NCT00433199|469663618|FG000|Open-Label Period|Withdrawal by Subject|0|||
130463994|NCT00433199|469663619|FG001|Open-Label Period|Withdrawal by Subject|7|||
130463995|NCT00433199|469663618|FG000|Open-Label Period|Protocol Violation|0|||
130463996|NCT00433199|469663619|FG001|Open-Label Period|Protocol Violation|2|||
130463997|NCT00433199|469663618|FG000|Open-Label Period|Administrative|0|||
130463998|NCT00433199|469663619|FG001|Open-Label Period|Administrative|1|||
130463999|NCT00357097|469663622|FG000|Overall Study|Did not meet inclusion criteria|5|||
130464000|NCT00357097|469663623|FG001|Overall Study|Did not meet inclusion criteria|3|||
130303937|NCT02688985|469077347|FG000|Overall Study|Death|0|||
130303938|NCT02688985|469077348|FG001|Overall Study|Death|0|||
130303939|NCT02688985|469077349|FG002|Overall Study|Death|0|||
130303940|NCT02688985|469077350|FG003|Overall Study|Death|0|||
130303941|NCT02688985|469077351|FG004|Overall Study|Death|1|||
130303942|NCT02688985|469077347|FG000|Overall Study|Lack of Efficacy|0|||
130303943|NCT02688985|469077348|FG001|Overall Study|Lack of Efficacy|0|||
130303944|NCT02688985|469077349|FG002|Overall Study|Lack of Efficacy|0|||
130303945|NCT02688985|469077350|FG003|Overall Study|Lack of Efficacy|0|||
130464001|NCT00357097|469663622|FG000|Overall Study|Adverse Event|34|||
130303946|NCT02688985|469077351|FG004|Overall Study|Lack of Efficacy|1|||
130303947|NCT02688985|469077347|FG000|Overall Study|Lost to Follow-up|2|||
130303948|NCT02688985|469077348|FG001|Overall Study|Lost to Follow-up|0|||
130557609|NCT04178967|470011821|FG005|Induction Period|Lack of Efficacy|0|||
130303949|NCT02688985|469077349|FG002|Overall Study|Lost to Follow-up|1|||
130303950|NCT02688985|469077350|FG003|Overall Study|Lost to Follow-up|1|||
130464002|NCT00357097|469663623|FG001|Overall Study|Adverse Event|6|||
130303951|NCT02688985|469077351|FG004|Overall Study|Lost to Follow-up|1|||
130303952|NCT02688985|469077347|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130303953|NCT02688985|469077348|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130464003|NCT00357097|469663622|FG000|Overall Study|Withdrawal by Subject|8|||
130464004|NCT00357097|469663623|FG001|Overall Study|Withdrawal by Subject|7|||
130303954|NCT02688985|469077349|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130464005|NCT00357097|469663622|FG000|Overall Study|Non-compliance|1|||
130464006|NCT00357097|469663623|FG001|Overall Study|Non-compliance|2|||
130464007|NCT00357097|469663622|FG000|Overall Study|Lack of Efficacy|2|||
130464008|NCT00357097|469663623|FG001|Overall Study|Lack of Efficacy|8|||
130464009|NCT00357097|469663622|FG000|Overall Study|Met Exclusion Criteria|3|||
130464010|NCT00357097|469663623|FG001|Overall Study|Met Exclusion Criteria|1|||
130464011|NCT00357097|469663622|FG000|Overall Study|Other|1|||
130464012|NCT00357097|469663623|FG001|Overall Study|Other|1|||
130464013|NCT00357097|469663622|FG000|Overall Study|Increase of RLS Symptoms|0|||
130464014|NCT00357097|469663623|FG001|Overall Study|Increase of RLS Symptoms|1|||
130464015|NCT00794118|469663624|FG000|Overall Study|Lost to Follow-up|16|||
130464016|NCT00794118|469663624|FG000|Overall Study|Withdrawal by Subject|9|||
130464017|NCT00794118|469663624|FG000|Overall Study|Changed hospital center|2|||
130464018|NCT04305405|469663625|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130464019|NCT04305405|469663626|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130464020|NCT01170962|469663628|FG000|Treatment Period|Lack of Efficacy|96|||
130464021|NCT01170962|469663629|FG001|Treatment Period|Lack of Efficacy|91|||
130464022|NCT01170962|469663630|FG002|Treatment Period|Lack of Efficacy|7|||
130464023|NCT01170962|469663628|FG000|Treatment Period|Adverse Event|11|||
130464024|NCT01170962|469663629|FG001|Treatment Period|Adverse Event|12|||
130464025|NCT01170962|469663630|FG002|Treatment Period|Adverse Event|3|||
130464026|NCT01170962|469663628|FG000|Treatment Period|Withdrawal by Subject|2|||
130464027|NCT01170962|469663629|FG001|Treatment Period|Withdrawal by Subject|1|||
130464028|NCT01170962|469663630|FG002|Treatment Period|Withdrawal by Subject|0|||
130464029|NCT01170962|469663628|FG000|Treatment Period|Lost to Follow-up|1|||
130464030|NCT01170962|469663629|FG001|Treatment Period|Lost to Follow-up|1|||
130464031|NCT01170962|469663630|FG002|Treatment Period|Lost to Follow-up|1|||
130464032|NCT01170962|469663628|FG000|Treatment Period|Participant no longer meets criteria|0|||
130464033|NCT01170962|469663629|FG001|Treatment Period|Participant no longer meets criteria|1|||
130464034|NCT01170962|469663630|FG002|Treatment Period|Participant no longer meets criteria|0|||
130464035|NCT01170962|469663628|FG000|Treatment Period|Request to discontinue treatment|7|||
130464036|NCT01170962|469663629|FG001|Treatment Period|Request to discontinue treatment|3|||
130464037|NCT01170962|469663630|FG002|Treatment Period|Request to discontinue treatment|1|||
130464038|NCT01170962|469663628|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
130464039|NCT01170962|469663629|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
130464040|NCT01170962|469663630|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
130464041|NCT01170962|469663628|FG000|Follow up Period|Withdrawal by Subject|14|||
130464042|NCT01170962|469663629|FG001|Follow up Period|Withdrawal by Subject|10|||
130464043|NCT01170962|469663630|FG002|Follow up Period|Withdrawal by Subject|2|||
130464044|NCT01170962|469663628|FG000|Follow up Period|Lost to Follow-up|13|||
130464045|NCT01170962|469663629|FG001|Follow up Period|Lost to Follow-up|8|||
130464046|NCT01170962|469663630|FG002|Follow up Period|Lost to Follow-up|1|||
130464047|NCT01170962|469663628|FG000|Follow up Period|Death|2|||
130464048|NCT01170962|469663629|FG001|Follow up Period|Death|2|||
130464049|NCT01170962|469663630|FG002|Follow up Period|Death|0|||
130464050|NCT01170962|469663628|FG000|Follow up Period|Others|10|||
130464051|NCT01170962|469663629|FG001|Follow up Period|Others|7|||
130464052|NCT01170962|469663630|FG002|Follow up Period|Others|3|||
130464053|NCT03887650|469663631|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
130464054|NCT03887650|469663632|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
130464055|NCT03887650|469663631|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
130464056|NCT03887650|469663632|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
130464057|NCT03887650|469663631|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
130464058|NCT03887650|469663632|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
130464059|NCT03368664|469663635|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
130464060|NCT03368664|469663635|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
130464061|NCT03368664|469663635|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
130464062|NCT03368664|469663635|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
130464063|NCT00837616|469663636|FG000|Overall Study|Withdrawal by Subject|0|||
130464064|NCT00837616|469663637|FG001|Overall Study|Withdrawal by Subject|1|||
130464065|NCT01597258|469663642|FG000|Overall Study|No Drug Administration|1|||
130303955|NCT02688985|469077350|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130464066|NCT00925899|469665142|FG000|Part 1|Death|1|||
130303956|NCT02688985|469077351|FG004|Overall Study|Non-Compliance With Study Drug|1|||
130303957|NCT02688985|469077347|FG000|Overall Study|Other|3|||
130464067|NCT00925899|469665143|FG001|Part 1|Death|2|||
130464068|NCT00925899|469665142|FG000|Part 1|Withdrawal by Subject|10|||
130464069|NCT00925899|469665143|FG001|Part 1|Withdrawal by Subject|9|||
130464070|NCT01875848|469665144|FG000|Overall Study|Withdrawal by Subject|2|||
130464071|NCT01875848|469665145|FG001|Overall Study|Withdrawal by Subject|0|||
130464072|NCT02189252|469665146|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
130464073|NCT02189252|469665147|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
130464074|NCT02189252|469665148|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
130303958|NCT02688985|469077348|FG001|Overall Study|Other|4|||
130303959|NCT02688985|469077349|FG002|Overall Study|Other|1|||
130303960|NCT02688985|469077350|FG003|Overall Study|Other|0|||
130303961|NCT02688985|469077351|FG004|Overall Study|Other|0|||
130303962|NCT02688985|469077347|FG000|Overall Study|Physician Decision|2|||
130464075|NCT02189252|469665149|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
130464076|NCT02189252|469665146|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
130464077|NCT02189252|469665147|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
130464078|NCT02189252|469665148|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
130303963|NCT02688985|469077348|FG001|Overall Study|Physician Decision|2|||
130303964|NCT02688985|469077349|FG002|Overall Study|Physician Decision|0|||
130303965|NCT02688985|469077350|FG003|Overall Study|Physician Decision|0|||
130303966|NCT02688985|469077351|FG004|Overall Study|Physician Decision|1|||
130303967|NCT02688985|469077347|FG000|Overall Study|Pregnancy|0|||
130303968|NCT02688985|469077348|FG001|Overall Study|Pregnancy|0|||
130303969|NCT02688985|469077349|FG002|Overall Study|Pregnancy|2|||
130303970|NCT02688985|469077350|FG003|Overall Study|Pregnancy|1|||
130464079|NCT02189252|469665149|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
130464080|NCT00840177|469665150|FG000|Overall Study|Adverse Event|5|||
130464081|NCT00840177|469665151|FG001|Overall Study|Adverse Event|1|||
130464082|NCT00840177|469665152|FG002|Overall Study|Adverse Event|1|||
130303971|NCT02688985|469077351|FG004|Overall Study|Pregnancy|0|||
130303972|NCT02688985|469077347|FG000|Overall Study|Study Terminated By Sponsor|0|||
130303973|NCT02688985|469077348|FG001|Overall Study|Study Terminated By Sponsor|0|||
130303974|NCT02688985|469077349|FG002|Overall Study|Study Terminated By Sponsor|0|||
130303975|NCT02688985|469077350|FG003|Overall Study|Study Terminated By Sponsor|1|||
130303976|NCT02688985|469077351|FG004|Overall Study|Study Terminated By Sponsor|0|||
130303977|NCT02688985|469077347|FG000|Overall Study|Withdrawal by Subject|2|||
130303978|NCT02688985|469077348|FG001|Overall Study|Withdrawal by Subject|8|||
130303979|NCT02688985|469077349|FG002|Overall Study|Withdrawal by Subject|7|||
130303980|NCT02688985|469077350|FG003|Overall Study|Withdrawal by Subject|1|||
130303981|NCT02688985|469077351|FG004|Overall Study|Withdrawal by Subject|4|||
130303982|NCT01726582|469077354|FG000|Overall Study|Physician Decision|99|||
130464083|NCT00840177|469665150|FG000|Overall Study|Refusal unrelated to adverse events|1|||
130464084|NCT00840177|469665151|FG001|Overall Study|Refusal unrelated to adverse events|0|||
130464085|NCT00840177|469665152|FG002|Overall Study|Refusal unrelated to adverse events|1|||
130464086|NCT00840177|469665150|FG000|Overall Study|Progression/relapse|2|||
130464087|NCT00840177|469665151|FG001|Overall Study|Progression/relapse|0|||
130303983|NCT01726582|469077354|FG000|Overall Study|Death|85|||
130303984|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
130303985|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
130303986|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
130303987|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
130464088|NCT00840177|469665152|FG002|Overall Study|Progression/relapse|0|||
130464089|NCT00840177|469665150|FG000|Overall Study|Death|4|||
130464090|NCT00840177|469665151|FG001|Overall Study|Death|5|||
130464091|NCT00840177|469665152|FG002|Overall Study|Death|5|||
130464092|NCT00840177|469665150|FG000|Overall Study|not protocol specified|6|||
130464093|NCT00840177|469665151|FG001|Overall Study|not protocol specified|3|||
130464094|NCT00840177|469665152|FG002|Overall Study|not protocol specified|0|||
130464095|NCT00840177|469665150|FG000|Overall Study|Ineligible|0|||
130464096|NCT00840177|469665151|FG001|Overall Study|Ineligible|0|||
130464097|NCT00840177|469665152|FG002|Overall Study|Ineligible|3|||
130464098|NCT00840177|469665150|FG000|Overall Study|Did not start treatment|0|||
130464099|NCT00840177|469665151|FG001|Overall Study|Did not start treatment|0|||
130464100|NCT00840177|469665152|FG002|Overall Study|Did not start treatment|1|||
130464101|NCT01391832|469665153|FG000|Overall Study|Withdrawal by Subject|21|||
130303988|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
130464102|NCT01391832|469665154|FG001|Overall Study|Withdrawal by Subject|22|||
130464103|NCT01391832|469665153|FG000|Overall Study|Lost to Follow-up|0|||
130464104|NCT01391832|469665154|FG001|Overall Study|Lost to Follow-up|1|||
130464105|NCT03345901|469665160|FG000|Overall Study|The study was terminated|18|||
130464106|NCT00566735|469665161|FG000|Overall Study|Withdrawal by Subject|0|||
130464107|NCT00566735|469665162|FG001|Overall Study|Withdrawal by Subject|1|||
130464108|NCT00566735|469665161|FG000|Overall Study|Refused neuropsychological testing|2|||
130464109|NCT00566735|469665162|FG001|Overall Study|Refused neuropsychological testing|5|||
130464110|NCT00566735|469665161|FG000|Overall Study|Switched into a manic episode|0|||
130464111|NCT00566735|469665162|FG001|Overall Study|Switched into a manic episode|1|||
130464112|NCT00722046|469665163|FG000|Overall Study|Adverse Event|0|||
130303989|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
130303990|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
130303991|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
130303992|NCT03437577|469077357|FG000|Pre-Randomization|Withdrawal by Subject|0|||
130303993|NCT03437577|469077358|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130303994|NCT03437577|469077359|FG002|Pre-Randomization|Withdrawal by Subject|10|||
130303995|NCT03437577|469077357|FG000|Post-Randomization|Physician Decision|0|||
130464113|NCT00722046|469665164|FG001|Overall Study|Adverse Event|1|||
130464114|NCT00722046|469665165|FG002|Overall Study|Adverse Event|2|||
130464115|NCT00722046|469665166|FG003|Overall Study|Adverse Event|1|||
130464116|NCT00722046|469665167|FG004|Overall Study|Adverse Event|2|||
130464117|NCT00722046|469665168|FG005|Overall Study|Adverse Event|1|||
130464118|NCT00722046|469665169|FG006|Overall Study|Adverse Event|0|||
130464119|NCT00722046|469665163|FG000|Overall Study|Death|0|||
130464120|NCT00722046|469665164|FG001|Overall Study|Death|1|||
130464121|NCT00722046|469665165|FG002|Overall Study|Death|0|||
130464122|NCT00722046|469665166|FG003|Overall Study|Death|0|||
130464123|NCT00722046|469665167|FG004|Overall Study|Death|0|||
130464124|NCT00722046|469665168|FG005|Overall Study|Death|0|||
130464125|NCT00722046|469665169|FG006|Overall Study|Death|2|||
130464126|NCT00722046|469665163|FG000|Overall Study|Protocol Violation|1|||
130464127|NCT00722046|469665164|FG001|Overall Study|Protocol Violation|0|||
130464128|NCT00722046|469665165|FG002|Overall Study|Protocol Violation|0|||
130464129|NCT00722046|469665166|FG003|Overall Study|Protocol Violation|0|||
130464130|NCT00722046|469665167|FG004|Overall Study|Protocol Violation|0|||
130464131|NCT00722046|469665168|FG005|Overall Study|Protocol Violation|1|||
130464132|NCT00722046|469665169|FG006|Overall Study|Protocol Violation|0|||
130464133|NCT00722046|469665163|FG000|Overall Study|Withdrawal by Subject|3|||
130464134|NCT00722046|469665164|FG001|Overall Study|Withdrawal by Subject|3|||
130464135|NCT00722046|469665165|FG002|Overall Study|Withdrawal by Subject|4|||
130464136|NCT00722046|469665166|FG003|Overall Study|Withdrawal by Subject|4|||
130464137|NCT00722046|469665167|FG004|Overall Study|Withdrawal by Subject|4|||
130464138|NCT00722046|469665168|FG005|Overall Study|Withdrawal by Subject|7|||
130464139|NCT00722046|469665169|FG006|Overall Study|Withdrawal by Subject|3|||
130464140|NCT00722046|469665163|FG000|Overall Study|Randomized, but not treated|1|||
130464141|NCT00722046|469665164|FG001|Overall Study|Randomized, but not treated|1|||
130464142|NCT00722046|469665165|FG002|Overall Study|Randomized, but not treated|0|||
130464143|NCT00722046|469665166|FG003|Overall Study|Randomized, but not treated|2|||
130464144|NCT00722046|469665167|FG004|Overall Study|Randomized, but not treated|0|||
130464145|NCT00722046|469665168|FG005|Overall Study|Randomized, but not treated|0|||
130464146|NCT00722046|469665169|FG006|Overall Study|Randomized, but not treated|0|||
130464147|NCT00722046|469665163|FG000|Overall Study|Other|0|||
130464148|NCT00722046|469665164|FG001|Overall Study|Other|0|||
130464149|NCT00722046|469665165|FG002|Overall Study|Other|1|||
130464150|NCT00722046|469665166|FG003|Overall Study|Other|1|||
130464151|NCT00722046|469665167|FG004|Overall Study|Other|3|||
130464152|NCT00722046|469665168|FG005|Overall Study|Other|2|||
130464153|NCT00722046|469665169|FG006|Overall Study|Other|1|||
130464154|NCT00925587|469665171|FG000|Overall Study|Protocol Specified Criteria|6|||
130464155|NCT00925587|469665172|FG001|Overall Study|Protocol Specified Criteria|6|||
130464156|NCT00925587|469665171|FG000|Overall Study|Physician Decision|4|||
130716813|NCT01675661|470590959|FG000|Overall Study|Other reason|1|||
130716814|NCT01675661|470590960|FG001|Overall Study|Other reason|2|||
130716815|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716816|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130303996|NCT03437577|469077358|FG001|Post-Randomization|Physician Decision|2|||
130303997|NCT03437577|469077359|FG002|Post-Randomization|Physician Decision|0|||
130464157|NCT00925587|469665172|FG001|Overall Study|Physician Decision|1|||
130464158|NCT00925587|469665171|FG000|Overall Study|Protocol Violation|6|||
130464159|NCT00925587|469665172|FG001|Overall Study|Protocol Violation|4|||
130464160|NCT00925587|469665171|FG000|Overall Study|Withdrawal by Subject|9|||
130464161|NCT00925587|469665172|FG001|Overall Study|Withdrawal by Subject|6|||
130464162|NCT00925587|469665171|FG000|Overall Study|Death|5|||
130464163|NCT00925587|469665172|FG001|Overall Study|Death|5|||
130464164|NCT00925587|469665171|FG000|Overall Study|Adverse Event|6|||
130464165|NCT00925587|469665172|FG001|Overall Study|Adverse Event|2|||
130464166|NCT00925587|469665171|FG000|Overall Study|Lost to Follow-up|0|||
130464167|NCT00925587|469665172|FG001|Overall Study|Lost to Follow-up|1|||
130464168|NCT00686855|469665180|FG000|Overall Study|Lost to Follow-up|1|||
130464169|NCT00686855|469665181|FG001|Overall Study|Lost to Follow-up|0|||
130464170|NCT00686855|469665180|FG000|Overall Study|Progressive GVHD|0|||
130464171|NCT00686855|469665181|FG001|Overall Study|Progressive GVHD|1|||
130464172|NCT01460446|469665187|FG000|Overall Study|Non-compliance|2|||
130464173|NCT01460446|469665188|FG001|Overall Study|Non-compliance|9|||
130464174|NCT01460446|469665187|FG000|Overall Study|Consent Withdrawn|0|||
130464175|NCT01460446|469665188|FG001|Overall Study|Consent Withdrawn|4|||
130464176|NCT01460446|469665187|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
130716817|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130464177|NCT01460446|469665188|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
130464178|NCT01460446|469665187|FG000|Overall Study|Surgery/Illness|1|||
130464179|NCT01460446|469665188|FG001|Overall Study|Surgery/Illness|1|||
130464180|NCT01460446|469665187|FG000|Overall Study|Pregnancy|1|||
130464181|NCT01460446|469665188|FG001|Overall Study|Pregnancy|0|||
130303998|NCT00536471|469077360|FG000|Overall Study|Lost to Follow-up|48|||
130464182|NCT01460446|469665187|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
130464183|NCT01460446|469665188|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
130464184|NCT04218110|469665189|FG000|Overall Study|Withdrawal by Subject|0|||
130464185|NCT04218110|469665190|FG001|Overall Study|Withdrawal by Subject|0|||
130464186|NCT04218110|469665191|FG002|Overall Study|Withdrawal by Subject|0|||
130464187|NCT04218110|469665192|FG003|Overall Study|Withdrawal by Subject|1|||
130464188|NCT00799396|469665194|FG000|Clopidogrel Treatment|Adverse Event|6|||
130464189|NCT00799396|469665194|FG000|Clopidogrel Treatment|Physician Decision|5|||
130464190|NCT00799396|469665194|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
130464191|NCT00799396|469665194|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
130464192|NCT00799396|469665194|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
130464193|NCT01867216|469665195|FG000|Overall Study|Withdrawal by Subject|2|||
130464194|NCT01867216|469665196|FG001|Overall Study|Withdrawal by Subject|0|||
130464195|NCT01867216|469665197|FG002|Overall Study|Withdrawal by Subject|0|||
130464196|NCT01867216|469665198|FG003|Overall Study|Withdrawal by Subject|0|||
130464197|NCT01867216|469665199|FG004|Overall Study|Withdrawal by Subject|1|||
130464198|NCT01867216|469665200|FG005|Overall Study|Withdrawal by Subject|0|||
130464199|NCT01867216|469665201|FG006|Overall Study|Withdrawal by Subject|1|||
130464200|NCT01867216|469665195|FG000|Overall Study|Physician Decision|1|||
130464201|NCT01867216|469665196|FG001|Overall Study|Physician Decision|0|||
130464202|NCT01867216|469665197|FG002|Overall Study|Physician Decision|0|||
130464203|NCT01867216|469665198|FG003|Overall Study|Physician Decision|0|||
130464204|NCT01867216|469665199|FG004|Overall Study|Physician Decision|0|||
130464205|NCT01867216|469665200|FG005|Overall Study|Physician Decision|0|||
130464206|NCT01867216|469665201|FG006|Overall Study|Physician Decision|0|||
130464207|NCT01867216|469665195|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
130464208|NCT01867216|469665196|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130464209|NCT01867216|469665197|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130464210|NCT01867216|469665198|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130464211|NCT01867216|469665199|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130464212|NCT01867216|469665200|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130464213|NCT01867216|469665201|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
130557610|NCT04178967|470011822|FG006|Induction Period|Lack of Efficacy|0|||
130557611|NCT04178967|470011823|FG007|Induction Period|Lack of Efficacy|0|||
130557612|NCT04178967|470011824|FG008|Induction Period|Lack of Efficacy|0|||
130557613|NCT04178967|470011825|FG009|Induction Period|Lack of Efficacy|0|||
130557614|NCT04178967|470011826|FG010|Induction Period|Lack of Efficacy|0|||
130557615|NCT04178967|470011816|FG000|Induction Period|Protocol Violation|0|||
130557616|NCT04178967|470011817|FG001|Induction Period|Protocol Violation|6|||
130464214|NCT01318382|469665204|FG000|Overall Study|Physician Decision|2|||
130464215|NCT01318382|469665204|FG000|Overall Study|Device Malfunction|10|||
130464216|NCT01318382|469665204|FG000|Overall Study|Protocol Violation|1|||
130557617|NCT04178967|470011818|FG002|Induction Period|Protocol Violation|0|||
130557618|NCT04178967|470011819|FG003|Induction Period|Protocol Violation|0|||
130464217|NCT00714714|469665205|FG000|Overall Study|Adverse Event|1|||
130464218|NCT01308567|469665214|FG000|Overall Study|Lost to Follow-up|2|||
130464219|NCT01308567|469665215|FG001|Overall Study|Lost to Follow-up|4|||
130464220|NCT01308567|469665216|FG002|Overall Study|Lost to Follow-up|4|||
130464221|NCT00542789|469665217|FG000|Overall Study|Adverse Event|18|||
130464222|NCT00542789|469665218|FG001|Overall Study|Adverse Event|17|||
130464223|NCT00542789|469665217|FG000|Overall Study|Withdrawal by Subject|7|||
130464224|NCT00542789|469665218|FG001|Overall Study|Withdrawal by Subject|3|||
130464225|NCT00542789|469665217|FG000|Overall Study|Protocol Violation|8|||
130464226|NCT00542789|469665218|FG001|Overall Study|Protocol Violation|1|||
130464227|NCT00542789|469665217|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
130464228|NCT00542789|469665218|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
130464229|NCT01040689|469665222|FG000|Overall Study|Adverse Event|0|||
130464230|NCT01040689|469665223|FG001|Overall Study|Adverse Event|0|||
130464231|NCT01040689|469665224|FG002|Overall Study|Adverse Event|2|||
130464232|NCT01040689|469665225|FG003|Overall Study|Adverse Event|4|||
130464233|NCT01040689|469665222|FG000|Overall Study|Lack of Efficacy|0|||
130464234|NCT01040689|469665223|FG001|Overall Study|Lack of Efficacy|0|||
130464235|NCT01040689|469665224|FG002|Overall Study|Lack of Efficacy|1|||
130464236|NCT01040689|469665225|FG003|Overall Study|Lack of Efficacy|0|||
130464237|NCT01040689|469665222|FG000|Overall Study|Lost to Follow-up|1|||
130464238|NCT01040689|469665223|FG001|Overall Study|Lost to Follow-up|0|||
130464239|NCT01040689|469665224|FG002|Overall Study|Lost to Follow-up|0|||
130464240|NCT01040689|469665225|FG003|Overall Study|Lost to Follow-up|0|||
130464241|NCT01040689|469665222|FG000|Overall Study|Withdrawal by Subject|2|||
130464242|NCT01040689|469665223|FG001|Overall Study|Withdrawal by Subject|1|||
130464243|NCT01040689|469665224|FG002|Overall Study|Withdrawal by Subject|1|||
130464244|NCT01040689|469665225|FG003|Overall Study|Withdrawal by Subject|0|||
130464245|NCT01040689|469665222|FG000|Overall Study|Other reasons not listed above|0|||
130464246|NCT01040689|469665223|FG001|Overall Study|Other reasons not listed above|1|||
130464247|NCT01040689|469665224|FG002|Overall Study|Other reasons not listed above|0|||
130464248|NCT01040689|469665225|FG003|Overall Study|Other reasons not listed above|0|||
130464249|NCT01185561|469665226|FG000|Overall Study|Lost to Follow-up|0|||
130464250|NCT01185561|469665227|FG001|Overall Study|Lost to Follow-up|4|||
130464251|NCT01185561|469665226|FG000|Overall Study|Withdrawal by Subject|2|||
130464252|NCT01185561|469665227|FG001|Overall Study|Withdrawal by Subject|8|||
130464253|NCT02616900|469665228|FG000|Overall Study|Lack of Efficacy|7|||
130464254|NCT02616900|469665228|FG000|Overall Study|Lost to Follow-up|2|||
130464255|NCT02616900|469665228|FG000|Overall Study|Protocol Violation|5|||
130464256|NCT02616900|469665228|FG000|Overall Study|Withdrawal by Subject|3|||
130464257|NCT02616900|469665228|FG000|Overall Study|Incomplete data|6|||
130464258|NCT02499159|469665229|FG000|Randomization|Protocol Violation|1|||
130464259|NCT02499159|469665230|FG001|Randomization|Protocol Violation|1|||
130464260|NCT02499159|469665229|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
130464261|NCT02499159|469665230|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
130464262|NCT02499159|469665229|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
130464263|NCT02499159|469665230|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
130464264|NCT02499159|469665229|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
130464265|NCT02499159|469665230|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
130464266|NCT02499159|469665229|FG000|30-Day Follow-Up Phone Call|Other|1|||
130464267|NCT02499159|469665230|FG001|30-Day Follow-Up Phone Call|Other|0|||
130716818|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130303999|NCT00536471|469077361|FG001|Overall Study|Lost to Follow-up|23|||
130304000|NCT00536471|469077362|FG002|Overall Study|Lost to Follow-up|48|||
130304001|NCT00536471|469077363|FG003|Overall Study|Lost to Follow-up|22|||
130464268|NCT01190007|469665231|FG000|Overall Study|Withdrawal by Subject|4|||
130464269|NCT01190007|469665231|FG000|Overall Study|Adverse Event|8|||
130464270|NCT01190007|469665231|FG000|Overall Study|Difficulty of visit for complications|1|||
130464271|NCT01190007|469665231|FG000|Overall Study|Participant was arrested|1|||
130464272|NCT00364013|469665232|FG000|Overall Study|Ineligibility determined|4|||
130464273|NCT00364013|469665233|FG001|Overall Study|Ineligibility determined|2|||
130464274|NCT00364013|469665232|FG000|Overall Study|Adverse Event|4|||
130464275|NCT00364013|469665233|FG001|Overall Study|Adverse Event|3|||
130464276|NCT00364013|469665232|FG000|Overall Study|Withdrawal by Subject|13|||
130464277|NCT00364013|469665233|FG001|Overall Study|Withdrawal by Subject|18|||
130464278|NCT00364013|469665232|FG000|Overall Study|Physician Decision|3|||
130464279|NCT00364013|469665233|FG001|Overall Study|Physician Decision|3|||
130464280|NCT00364013|469665232|FG000|Overall Study|Lost to Follow-up|10|||
130464281|NCT00364013|469665233|FG001|Overall Study|Lost to Follow-up|3|||
130464282|NCT00364013|469665232|FG000|Overall Study|Protocol-specified criteria|6|||
130464283|NCT00364013|469665233|FG001|Overall Study|Protocol-specified criteria|6|||
130464284|NCT00364013|469665232|FG000|Overall Study|Other|41|||
130464285|NCT00364013|469665233|FG001|Overall Study|Other|47|||
130464286|NCT00364013|469665232|FG000|Overall Study|Ongoing|20|||
130464287|NCT00364013|469665233|FG001|Overall Study|Ongoing|13|||
130464288|NCT01510717|469665234|FG000|Overall Study|Adverse Event|1|||
130464289|NCT01510717|469665235|FG001|Overall Study|Adverse Event|2|||
130304002|NCT00536471|469077360|FG000|Overall Study|Adverse Event|32|||
130304003|NCT00536471|469077361|FG001|Overall Study|Adverse Event|16|||
130304004|NCT00536471|469077362|FG002|Overall Study|Adverse Event|28|||
130304005|NCT00536471|469077363|FG003|Overall Study|Adverse Event|13|||
130304006|NCT00536471|469077360|FG000|Overall Study|Withdrawal by Subject|40|||
130304007|NCT00536471|469077361|FG001|Overall Study|Withdrawal by Subject|24|||
130464290|NCT01510717|469665234|FG000|Overall Study|Death|1|||
130464291|NCT01510717|469665235|FG001|Overall Study|Death|0|||
130464292|NCT01510717|469665234|FG000|Overall Study|Lost to Follow-up|0|||
130464293|NCT01510717|469665235|FG001|Overall Study|Lost to Follow-up|1|||
130464294|NCT01510717|469665234|FG000|Overall Study|Withdrawal by Subject|0|||
130464295|NCT01510717|469665235|FG001|Overall Study|Withdrawal by Subject|2|||
130464296|NCT02204982|469665236|FG000|Overall Study|Patient ineligible-medical monitor|1|||
130464297|NCT02204982|469665237|FG001|Overall Study|Patient ineligible-medical monitor|0|||
130464298|NCT02204982|469665236|FG000|Overall Study|Withdrawal by Subject|1|||
130464299|NCT02204982|469665237|FG001|Overall Study|Withdrawal by Subject|0|||
130464300|NCT02204982|469665236|FG000|Overall Study|Adverse Event|1|||
130464301|NCT02204982|469665237|FG001|Overall Study|Adverse Event|0|||
130464302|NCT02204982|469665236|FG000|Overall Study|Adverse Event and Investigator decision|1|||
130464303|NCT02204982|469665237|FG001|Overall Study|Adverse Event and Investigator decision|0|||
130464304|NCT02204982|469665236|FG000|Overall Study|Physician Decision|0|||
130464305|NCT02204982|469665237|FG001|Overall Study|Physician Decision|2|||
130464306|NCT02204982|469665236|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
130464307|NCT02204982|469665237|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
130464308|NCT02204982|469665236|FG000|Overall Study|Termination of Study bySponsor|0|||
130464309|NCT02204982|469665237|FG001|Overall Study|Termination of Study bySponsor|1|||
130464310|NCT05274217|469665238|FG000|Overall Study|Study terminated.|11|||
130464311|NCT05274217|469665239|FG001|Overall Study|Study terminated.|0|||
130464312|NCT04594759|469665240|FG000|Overall Study|Lost to Follow-up|3|||
130464313|NCT02261467|469665243|FG000|Overall Study|Enrolled in Error|1|||
130464314|NCT02261467|469665244|FG001|Overall Study|Enrolled in Error|0|||
130464315|NCT02261467|469665243|FG000|Overall Study|Protocol Violation|0|||
130464316|NCT02261467|469665244|FG001|Overall Study|Protocol Violation|1|||
130464317|NCT02261467|469665243|FG000|Overall Study|Personal Reasons|17|||
130464318|NCT02261467|469665244|FG001|Overall Study|Personal Reasons|22|||
130464319|NCT02261467|469665243|FG000|Overall Study|Lost to Follow-up|2|||
130464320|NCT02261467|469665244|FG001|Overall Study|Lost to Follow-up|13|||
130464321|NCT02261467|469665243|FG000|Overall Study|Adverse Event|1|||
130464322|NCT02261467|469665244|FG001|Overall Study|Adverse Event|1|||
130464323|NCT00529659|469665245|FG000|Overall Study|Adverse Event|8|||
130464324|NCT00529659|469665246|FG001|Overall Study|Adverse Event|7|||
130464325|NCT00529659|469665245|FG000|Overall Study|Lost to Follow-up|0|||
130464326|NCT00529659|469665246|FG001|Overall Study|Lost to Follow-up|2|||
130464327|NCT00529659|469665245|FG000|Overall Study|Physician Decision|0|||
130464328|NCT00529659|469665246|FG001|Overall Study|Physician Decision|2|||
130304008|NCT00536471|469077362|FG002|Overall Study|Withdrawal by Subject|43|||
130304009|NCT00536471|469077363|FG003|Overall Study|Withdrawal by Subject|21|||
130304010|NCT00536471|469077360|FG000|Overall Study|Lack of Efficacy|17|||
130304011|NCT00536471|469077361|FG001|Overall Study|Lack of Efficacy|18|||
130304012|NCT00536471|469077362|FG002|Overall Study|Lack of Efficacy|11|||
130304013|NCT00536471|469077363|FG003|Overall Study|Lack of Efficacy|9|||
130304014|NCT00536471|469077360|FG000|Overall Study|Protocol Violation|8|||
130304015|NCT00536471|469077361|FG001|Overall Study|Protocol Violation|1|||
130304016|NCT00536471|469077362|FG002|Overall Study|Protocol Violation|2|||
130304017|NCT00536471|469077363|FG003|Overall Study|Protocol Violation|3|||
130304018|NCT00536471|469077360|FG000|Overall Study|Physician Decision|11|||
130304019|NCT00536471|469077361|FG001|Overall Study|Physician Decision|1|||
130304020|NCT00536471|469077362|FG002|Overall Study|Physician Decision|3|||
130304021|NCT00536471|469077363|FG003|Overall Study|Physician Decision|2|||
130304022|NCT00536471|469077360|FG000|Overall Study|Death|0|||
130304023|NCT00536471|469077361|FG001|Overall Study|Death|0|||
130304024|NCT00536471|469077362|FG002|Overall Study|Death|1|||
130304025|NCT00536471|469077363|FG003|Overall Study|Death|2|||
130464329|NCT00529659|469665245|FG000|Overall Study|Protocol Violation|2|||
130304026|NCT00536471|469077360|FG000|Overall Study|Sponsor Decision|0|||
130464330|NCT00529659|469665246|FG001|Overall Study|Protocol Violation|6|||
130464331|NCT00529659|469665245|FG000|Overall Study|Withdrawal by Subject|1|||
130464332|NCT00529659|469665246|FG001|Overall Study|Withdrawal by Subject|6|||
130464333|NCT02674750|469665253|FG000|Overall Study|Death|4|||
130464334|NCT02674750|469665254|FG001|Overall Study|Death|5|||
130464335|NCT02674750|469665255|FG002|Overall Study|Death|8|||
130304027|NCT00536471|469077361|FG001|Overall Study|Sponsor Decision|1|||
130304028|NCT00536471|469077362|FG002|Overall Study|Sponsor Decision|3|||
130304029|NCT00536471|469077363|FG003|Overall Study|Sponsor Decision|2|||
130304030|NCT00988091|469077373|FG000|Double-blind Period|Withdrawal by Subject|15|||
130304031|NCT00988091|469077374|FG001|Double-blind Period|Withdrawal by Subject|13|||
130464336|NCT02674750|469665253|FG000|Overall Study|Lost to Follow-up|0|||
130304032|NCT00988091|469077373|FG000|Double-blind Period|Lost to Follow-up|12|||
130304033|NCT00988091|469077374|FG001|Double-blind Period|Lost to Follow-up|14|||
130304034|NCT00988091|469077373|FG000|Double-blind Period|Other|8|||
130304035|NCT00988091|469077374|FG001|Double-blind Period|Other|8|||
130304036|NCT00988091|469077373|FG000|Double-blind Period|Adverse Event|6|||
130304037|NCT00988091|469077374|FG001|Double-blind Period|Adverse Event|9|||
130304038|NCT00988091|469077373|FG000|Double-blind Period|Use of exclusionary medication|2|||
130304039|NCT00988091|469077374|FG001|Double-blind Period|Use of exclusionary medication|3|||
130304040|NCT00988091|469077373|FG000|Open-label Period|Adverse Event|4|||
130304041|NCT00988091|469077374|FG001|Open-label Period|Adverse Event|7|||
130304042|NCT00988091|469077373|FG000|Open-label Period|Use of exclusionary medication|1|||
130304043|NCT00988091|469077374|FG001|Open-label Period|Use of exclusionary medication|1|||
130304044|NCT00988091|469077373|FG000|Open-label Period|Protocol Violation|1|||
130304045|NCT00988091|469077374|FG001|Open-label Period|Protocol Violation|1|||
130304046|NCT00988091|469077373|FG000|Open-label Period|Withdrawal by Subject|10|||
130304047|NCT00988091|469077374|FG001|Open-label Period|Withdrawal by Subject|16|||
130304048|NCT00988091|469077373|FG000|Open-label Period|Lost to Follow-up|3|||
130304049|NCT00988091|469077374|FG001|Open-label Period|Lost to Follow-up|5|||
130304050|NCT00988091|469077373|FG000|Open-label Period|Other|2|||
130304051|NCT00988091|469077374|FG001|Open-label Period|Other|3|||
130304052|NCT00994422|469077375|FG000|Overall Study|Lost to Follow-up|7|||
130304053|NCT00994422|469077376|FG001|Overall Study|Lost to Follow-up|1|||
130304054|NCT00836186|469077381|FG000|Overall Study|Blood could not be drawn|1|||
130304055|NCT00532298|469077382|FG000|Overall Study|Adverse Event|1|||
130304056|NCT00532298|469077383|FG001|Overall Study|Adverse Event|0|||
130304057|NCT00532298|469077384|FG002|Overall Study|Adverse Event|0|||
130304058|NCT00532298|469077385|FG003|Overall Study|Adverse Event|0|||
130304059|NCT00532298|469077386|FG004|Overall Study|Adverse Event|1|||
130304060|NCT00532298|469077387|FG005|Overall Study|Adverse Event|1|||
130304061|NCT00532298|469077382|FG000|Overall Study|Lost to Follow-up|1|||
130304062|NCT00532298|469077383|FG001|Overall Study|Lost to Follow-up|1|||
130304063|NCT00532298|469077384|FG002|Overall Study|Lost to Follow-up|1|||
130304064|NCT00532298|469077385|FG003|Overall Study|Lost to Follow-up|0|||
130304065|NCT00532298|469077386|FG004|Overall Study|Lost to Follow-up|0|||
130304066|NCT00532298|469077387|FG005|Overall Study|Lost to Follow-up|1|||
130304067|NCT01973998|469077388|FG000|Overall Study|Death|2|||
130304068|NCT01973998|469077389|FG001|Overall Study|Death|2|||
130304069|NCT02951429|469077396|FG000|Overall Study|Adverse Event|3|||
130304070|NCT02951429|469077397|FG001|Overall Study|Adverse Event|7|||
130304071|NCT02951429|469077396|FG000|Overall Study|Death|28|||
130304072|NCT02951429|469077397|FG001|Overall Study|Death|36|||
130304073|NCT02951429|469077396|FG000|Overall Study|Lack of Efficacy|0|||
130304074|NCT02951429|469077397|FG001|Overall Study|Lack of Efficacy|1|||
130304075|NCT02951429|469077396|FG000|Overall Study|Lost to Follow-up|0|||
130304076|NCT02951429|469077397|FG001|Overall Study|Lost to Follow-up|1|||
130304077|NCT02951429|469077396|FG000|Overall Study|Lung Transplantation|9|||
130304078|NCT02951429|469077397|FG001|Overall Study|Lung Transplantation|6|||
130304079|NCT02951429|469077396|FG000|Overall Study|Other|1|||
130304080|NCT02951429|469077397|FG001|Overall Study|Other|3|||
130304081|NCT02951429|469077396|FG000|Overall Study|Progressive Disease|1|||
130304082|NCT02951429|469077397|FG001|Overall Study|Progressive Disease|1|||
130304083|NCT02951429|469077396|FG000|Overall Study|Withdrawal by Subject|7|||
130304084|NCT02951429|469077397|FG001|Overall Study|Withdrawal by Subject|11|||
130304085|NCT02951429|469077396|FG000|Overall Study|Participant ongoing in the study|23|||
130304086|NCT02951429|469077397|FG001|Overall Study|Participant ongoing in the study|17|||
130304087|NCT01620528|469077398|FG000|Treatment Period|Did Not Receive Study Drug|0|||
130304088|NCT01620528|469077399|FG001|Treatment Period|Did Not Receive Study Drug|0|||
130304089|NCT01620528|469077400|FG002|Treatment Period|Did Not Receive Study Drug|1|||
130304090|NCT01620528|469077398|FG000|Treatment Period|Withdrawal by Subject|35|||
130304091|NCT01620528|469077399|FG001|Treatment Period|Withdrawal by Subject|21|||
130304092|NCT01620528|469077400|FG002|Treatment Period|Withdrawal by Subject|16|||
130304093|NCT01620528|469077398|FG000|Treatment Period|Adverse Event|17|||
130304094|NCT01620528|469077399|FG001|Treatment Period|Adverse Event|13|||
130304095|NCT01620528|469077400|FG002|Treatment Period|Adverse Event|21|||
130304096|NCT01620528|469077398|FG000|Treatment Period|Lost to Follow-up|16|||
130304097|NCT01620528|469077399|FG001|Treatment Period|Lost to Follow-up|8|||
130304098|NCT01620528|469077400|FG002|Treatment Period|Lost to Follow-up|14|||
130304099|NCT01620528|469077398|FG000|Treatment Period|Other|9|||
130304100|NCT01620528|469077399|FG001|Treatment Period|Other|5|||
130304101|NCT01620528|469077400|FG002|Treatment Period|Other|7|||
130304102|NCT01620528|469077398|FG000|Treatment Period|Subject Noncompliant|11|||
130304103|NCT01620528|469077399|FG001|Treatment Period|Subject Noncompliant|2|||
130304104|NCT01620528|469077400|FG002|Treatment Period|Subject Noncompliant|2|||
130304105|NCT01620528|469077398|FG000|Treatment Period|Pregnancy|7|||
130304106|NCT01620528|469077399|FG001|Treatment Period|Pregnancy|2|||
130304107|NCT01620528|469077400|FG002|Treatment Period|Pregnancy|2|||
130304108|NCT01620528|469077398|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
130304109|NCT01620528|469077399|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
130373735|NCT02269241|469336780|FG000|Overall Study|Pregnancy|15|||
130304110|NCT01620528|469077400|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
130304111|NCT01620528|469077398|FG000|Treatment Period|Exclusionary Medication Received|0|||
130304112|NCT01620528|469077399|FG001|Treatment Period|Exclusionary Medication Received|1|||
130304113|NCT01620528|469077400|FG002|Treatment Period|Exclusionary Medication Received|0|||
130304114|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130304115|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130304116|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130304117|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130304118|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130304119|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130304120|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
130304121|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130304122|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130304123|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
130304124|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
130304125|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
130304126|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Other|6|||
130304127|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Other|4|||
130304128|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Other|2|||
130304129|NCT03664765|469077401|FG000|Overall Study|Withdrawal by Subject|4|||
130304130|NCT03664765|469077402|FG001|Overall Study|Withdrawal by Subject|1|||
130304131|NCT03664765|469077401|FG000|Overall Study|Lost to Follow-up|0|||
130304132|NCT03664765|469077402|FG001|Overall Study|Lost to Follow-up|1|||
130304133|NCT01090063|469077403|FG000|Screen|Screen Failed|4|||
130304134|NCT01090063|469077403|FG000|Treatment|Withdrawal by Subject|4|||
130304135|NCT04038567|469077407|FG000|Overall Study|Lost to Follow-up|6|||
130304136|NCT04038567|469077408|FG001|Overall Study|Lost to Follow-up|4|||
130304137|NCT04038567|469077409|FG002|Overall Study|Lost to Follow-up|5|||
130304138|NCT04038567|469077410|FG003|Overall Study|Lost to Follow-up|4|||
130304139|NCT04038567|469077411|FG004|Overall Study|Lost to Follow-up|6|||
130304140|NCT04038567|469077412|FG005|Overall Study|Lost to Follow-up|4|||
130304141|NCT04038567|469077413|FG006|Overall Study|Lost to Follow-up|4|||
130304142|NCT04038567|469077414|FG007|Overall Study|Lost to Follow-up|1|||
130304143|NCT04038567|469077407|FG000|Overall Study|Withdrawal by Subject|2|||
130304144|NCT04038567|469077408|FG001|Overall Study|Withdrawal by Subject|1|||
130304145|NCT04038567|469077409|FG002|Overall Study|Withdrawal by Subject|1|||
130304146|NCT04038567|469077410|FG003|Overall Study|Withdrawal by Subject|1|||
130304147|NCT04038567|469077411|FG004|Overall Study|Withdrawal by Subject|4|||
130304148|NCT04038567|469077412|FG005|Overall Study|Withdrawal by Subject|1|||
130304149|NCT04038567|469077413|FG006|Overall Study|Withdrawal by Subject|1|||
130304150|NCT04038567|469077414|FG007|Overall Study|Withdrawal by Subject|1|||
130304151|NCT04038567|469077407|FG000|Overall Study|missed survey window|1|||
130304152|NCT04038567|469077408|FG001|Overall Study|missed survey window|2|||
130304153|NCT04038567|469077409|FG002|Overall Study|missed survey window|0|||
130304154|NCT04038567|469077410|FG003|Overall Study|missed survey window|0|||
130304155|NCT04038567|469077411|FG004|Overall Study|missed survey window|1|||
130304156|NCT04038567|469077412|FG005|Overall Study|missed survey window|1|||
130304157|NCT04038567|469077413|FG006|Overall Study|missed survey window|2|||
130304158|NCT04038567|469077414|FG007|Overall Study|missed survey window|2|||
130304159|NCT04038567|469077407|FG000|Overall Study|technical issues|0|||
130304160|NCT04038567|469077408|FG001|Overall Study|technical issues|0|||
130304161|NCT04038567|469077409|FG002|Overall Study|technical issues|0|||
130304162|NCT04038567|469077410|FG003|Overall Study|technical issues|0|||
130304163|NCT04038567|469077411|FG004|Overall Study|technical issues|0|||
130304164|NCT04038567|469077412|FG005|Overall Study|technical issues|0|||
130304165|NCT04038567|469077413|FG006|Overall Study|technical issues|1|||
130304166|NCT04038567|469077414|FG007|Overall Study|technical issues|0|||
130304167|NCT04038567|469077407|FG000|Overall Study|Medical issues (i.e., illness)|0|||
130304168|NCT04038567|469077408|FG001|Overall Study|Medical issues (i.e., illness)|1|||
130304169|NCT04038567|469077409|FG002|Overall Study|Medical issues (i.e., illness)|2|||
130304170|NCT04038567|469077410|FG003|Overall Study|Medical issues (i.e., illness)|1|||
130304171|NCT04038567|469077411|FG004|Overall Study|Medical issues (i.e., illness)|1|||
130304172|NCT04038567|469077412|FG005|Overall Study|Medical issues (i.e., illness)|1|||
130304173|NCT04038567|469077413|FG006|Overall Study|Medical issues (i.e., illness)|0|||
130304174|NCT04038567|469077414|FG007|Overall Study|Medical issues (i.e., illness)|0|||
130304175|NCT04038567|469077407|FG000|Overall Study|Death|0|||
130304176|NCT04038567|469077408|FG001|Overall Study|Death|0|||
130304177|NCT04038567|469077409|FG002|Overall Study|Death|0|||
130304178|NCT04038567|469077410|FG003|Overall Study|Death|1|||
130304179|NCT04038567|469077411|FG004|Overall Study|Death|1|||
130557619|NCT04178967|470011820|FG004|Induction Period|Protocol Violation|0|||
130557620|NCT04178967|470011821|FG005|Induction Period|Protocol Violation|0|||
130304180|NCT04038567|469077412|FG005|Overall Study|Death|0|||
130304181|NCT04038567|469077413|FG006|Overall Study|Death|0|||
130557621|NCT04178967|470011822|FG006|Induction Period|Protocol Violation|0|||
130304182|NCT04038567|469077414|FG007|Overall Study|Death|1|||
130304183|NCT01817959|469077415|FG000|Overall Study|Graft loss|1|||
130304184|NCT01817959|469077416|FG001|Overall Study|Graft loss|1|||
130304185|NCT01817959|469077415|FG000|Overall Study|forbidden medication|1|||
130304186|NCT01817959|469077416|FG001|Overall Study|forbidden medication|1|||
130304187|NCT01817959|469077415|FG000|Overall Study|Adverse Event|1|||
130304188|NCT01817959|469077416|FG001|Overall Study|Adverse Event|0|||
130304189|NCT01817959|469077415|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130304190|NCT01817959|469077416|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130304191|NCT00923845|469077419|FG000|Induction Therapy|Poor performance status|0|||
130304192|NCT00923845|469077420|FG001|Induction Therapy|Poor performance status|2|||
130304193|NCT01128946|469077424|FG000|Period I|Protocol Violation|0|||
130304194|NCT01128946|469077425|FG001|Period I|Protocol Violation|1|||
130304195|NCT01128946|469077426|FG002|Period I|Protocol Violation|0|||
130304196|NCT01128946|469077427|FG003|Period I|Protocol Violation|0|||
130304197|NCT01128946|469077424|FG000|Period I|Withdrawal by Subject|0|||
130304198|NCT01128946|469077425|FG001|Period I|Withdrawal by Subject|0|||
130304199|NCT01128946|469077426|FG002|Period I|Withdrawal by Subject|1|||
130304200|NCT01128946|469077427|FG003|Period I|Withdrawal by Subject|1|||
130304201|NCT01128946|469077424|FG000|Period II|Protocol Violation|0|||
130304202|NCT01128946|469077425|FG001|Period II|Protocol Violation|1|||
130304203|NCT01128946|469077426|FG002|Period II|Protocol Violation|0|||
130304204|NCT01128946|469077427|FG003|Period II|Protocol Violation|0|||
130304205|NCT01128946|469077424|FG000|Period II|Withdrawal by Subject|0|||
130304206|NCT01128946|469077425|FG001|Period II|Withdrawal by Subject|0|||
130304207|NCT01128946|469077426|FG002|Period II|Withdrawal by Subject|0|||
130304208|NCT01128946|469077427|FG003|Period II|Withdrawal by Subject|1|||
130304209|NCT01128946|469077424|FG000|Period III|Protocol Violation|1|||
130304210|NCT01128946|469077425|FG001|Period III|Protocol Violation|0|||
130304211|NCT01128946|469077426|FG002|Period III|Protocol Violation|0|||
130304212|NCT01128946|469077427|FG003|Period III|Protocol Violation|0|||
130304213|NCT01371734|469077428|FG000|Overall Study|Other|2|||
130304214|NCT01371734|469077429|FG001|Overall Study|Other|1|||
130304215|NCT01371734|469077430|FG002|Overall Study|Other|2|||
130304216|NCT01371734|469077428|FG000|Overall Study|Withdrawal by Subject|3|||
130304217|NCT01371734|469077429|FG001|Overall Study|Withdrawal by Subject|4|||
130304218|NCT01371734|469077430|FG002|Overall Study|Withdrawal by Subject|9|||
130304219|NCT01371734|469077428|FG000|Overall Study|Lost to Follow-up|5|||
130304220|NCT01371734|469077429|FG001|Overall Study|Lost to Follow-up|3|||
130304221|NCT01371734|469077430|FG002|Overall Study|Lost to Follow-up|1|||
130304222|NCT01371734|469077428|FG000|Overall Study|Protocol Violation|3|||
130304223|NCT01371734|469077429|FG001|Overall Study|Protocol Violation|1|||
130304224|NCT01371734|469077430|FG002|Overall Study|Protocol Violation|2|||
130304225|NCT01371734|469077428|FG000|Overall Study|Adverse Event|8|||
130304226|NCT01371734|469077429|FG001|Overall Study|Adverse Event|8|||
130304227|NCT01371734|469077430|FG002|Overall Study|Adverse Event|3|||
130304228|NCT01371734|469077428|FG000|Overall Study|Lack of Efficacy|2|||
130304229|NCT01371734|469077429|FG001|Overall Study|Lack of Efficacy|2|||
130304230|NCT01371734|469077430|FG002|Overall Study|Lack of Efficacy|0|||
130304231|NCT03565237|469077431|FG000|Overall Study|Non-compliance of Investigational Product|1|||
130304232|NCT03565237|469077431|FG000|Overall Study|Physician Decision|1|||
130304233|NCT01140061|469077435|FG000|Part I|Adverse Event|1|||
130304234|NCT01140061|469077436|FG001|Part I|Adverse Event|0|||
130304235|NCT01140061|469077437|FG002|Part I|Adverse Event|0|||
130304236|NCT01140061|469077438|FG003|Part I|Adverse Event|0|||
130304237|NCT01140061|469077439|FG004|Part I|Adverse Event|0|||
130304238|NCT01140061|469077440|FG005|Part I|Adverse Event|0|||
130304239|NCT01140061|469077441|FG006|Part I|Adverse Event|0|||
130304240|NCT01140061|469077442|FG007|Part I|Adverse Event|0|||
130304241|NCT01140061|469077443|FG008|Part I|Adverse Event|0|||
130304242|NCT01140061|469077444|FG009|Part I|Adverse Event|0|||
130304243|NCT01140061|469077435|FG000|Extension|Laboratory Adverse Event|0|||
130304244|NCT01140061|469077436|FG001|Extension|Laboratory Adverse Event|0|||
130304245|NCT01140061|469077437|FG002|Extension|Laboratory Adverse Event|0|||
130304246|NCT01140061|469077438|FG003|Extension|Laboratory Adverse Event|0|||
130304247|NCT01140061|469077439|FG004|Extension|Laboratory Adverse Event|0|||
130304248|NCT01140061|469077440|FG005|Extension|Laboratory Adverse Event|0|||
130304249|NCT01140061|469077441|FG006|Extension|Laboratory Adverse Event|0|||
130304250|NCT01140061|469077442|FG007|Extension|Laboratory Adverse Event|0|||
130304251|NCT01140061|469077443|FG008|Extension|Laboratory Adverse Event|0|||
130304252|NCT01140061|469077444|FG009|Extension|Laboratory Adverse Event|1|||
130304253|NCT02708355|469077445|FG000|Overall Study|Adverse Event|1|||
130304254|NCT02708355|469077446|FG001|Overall Study|Adverse Event|0|||
130464337|NCT02674750|469665254|FG001|Overall Study|Lost to Follow-up|8|||
130304255|NCT02708355|469077447|FG002|Overall Study|Adverse Event|0|||
130304256|NCT02669121|469077448|FG000|Overall Study|Adverse Event|4|||
130304257|NCT02669121|469077449|FG001|Overall Study|Adverse Event|5|||
130304258|NCT02669121|469077448|FG000|Overall Study|Lost to Follow-up|15|||
130304259|NCT02669121|469077449|FG001|Overall Study|Lost to Follow-up|27|||
130304260|NCT02669121|469077448|FG000|Overall Study|Withdrawal by Subject|132|||
130304261|NCT02669121|469077449|FG001|Overall Study|Withdrawal by Subject|140|||
130304262|NCT02669121|469077448|FG000|Overall Study|Pregnancy|0|||
130304263|NCT02669121|469077449|FG001|Overall Study|Pregnancy|1|||
130304264|NCT02669121|469077448|FG000|Overall Study|Discharged from US Military Active Service|117|||
130304265|NCT02669121|469077449|FG001|Overall Study|Discharged from US Military Active Service|91|||
130304266|NCT02669121|469077448|FG000|Overall Study|Reason not Specified|22|||
130304267|NCT02669121|469077449|FG001|Overall Study|Reason not Specified|18|||
130304268|NCT03216746|469077450|FG000|Overall Study|Lost to Follow-up|6|||
130304269|NCT03216746|469077451|FG001|Overall Study|Lost to Follow-up|8|||
130304270|NCT03216746|469077452|FG002|Overall Study|Lost to Follow-up|5|||
130304271|NCT03216746|469077453|FG003|Overall Study|Lost to Follow-up|6|||
130304272|NCT04384523|469077454|FG000|Overall Study|Lost to Follow-up|0|||
130304273|NCT04384523|469077455|FG001|Overall Study|Lost to Follow-up|0|||
130304274|NCT04384523|469077456|FG002|Overall Study|Lost to Follow-up|0|||
130304275|NCT04384523|469077457|FG003|Overall Study|Lost to Follow-up|0|||
130304276|NCT04384523|469077458|FG004|Overall Study|Lost to Follow-up|0|||
130304277|NCT04384523|469077459|FG005|Overall Study|Lost to Follow-up|1|||
130304278|NCT04384523|469077454|FG000|Overall Study|Protocol Violation|0|||
130304279|NCT04384523|469077455|FG001|Overall Study|Protocol Violation|1|||
130304280|NCT04384523|469077456|FG002|Overall Study|Protocol Violation|0|||
130304281|NCT04384523|469077457|FG003|Overall Study|Protocol Violation|0|||
130304282|NCT04384523|469077458|FG004|Overall Study|Protocol Violation|0|||
130304283|NCT04384523|469077459|FG005|Overall Study|Protocol Violation|0|||
130304284|NCT04384523|469077454|FG000|Overall Study|Withdrawal by Subject|1|||
130304285|NCT04384523|469077455|FG001|Overall Study|Withdrawal by Subject|0|||
130304286|NCT04384523|469077456|FG002|Overall Study|Withdrawal by Subject|0|||
130304287|NCT04384523|469077457|FG003|Overall Study|Withdrawal by Subject|0|||
130304288|NCT04384523|469077458|FG004|Overall Study|Withdrawal by Subject|0|||
130304289|NCT04384523|469077459|FG005|Overall Study|Withdrawal by Subject|0|||
130304290|NCT00835341|469077460|FG000|Overall Study|Lost to Follow-up|3|||
130304291|NCT00835341|469077461|FG001|Overall Study|Lost to Follow-up|12|||
130304292|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
130304293|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
130304294|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
130304295|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304296|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304297|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304298|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304299|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304300|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304301|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Physician Decision|1|||
130304302|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Physician Decision|2|||
130304303|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Physician Decision|0|||
130304304|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Physician Decision|0|||
130304305|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Physician Decision|0|||
130304306|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Physician Decision|0|||
130304307|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Physician Decision|0|||
130304308|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Physician Decision|0|||
130304309|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Physician Decision|0|||
130304310|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
130304311|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
130304312|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
130304313|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
130304314|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
130304315|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
130304316|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
130304317|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
130304318|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
130304319|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
130304320|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304321|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304322|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304323|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304324|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304325|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304326|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304327|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304328|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
130304329|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
130304330|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304331|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304332|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304333|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304334|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304335|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304336|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304337|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Other than Specified|0|||
130304338|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Other than Specified|0|||
130304339|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Other than Specified|3|||
130304340|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Other than Specified|0|||
130304341|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Other than Specified|0|||
130304342|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Other than Specified|0|||
130304343|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Other than Specified|0|||
130304344|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Other than Specified|0|||
130304345|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Other than Specified|0|||
130304346|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304347|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304348|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304349|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
130304350|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
130304351|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
130304352|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304353|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304354|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304355|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304356|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304357|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304358|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304359|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
130304360|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304361|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304362|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304363|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304364|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304365|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304366|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304367|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
130304368|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
130304369|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
130304370|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304371|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304372|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304373|NCT04405076|469077463|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304374|NCT04405076|469077464|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304375|NCT04405076|469077465|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304376|NCT04405076|469077466|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304377|NCT04405076|469077467|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304378|NCT04405076|469077468|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304379|NCT04405076|469077469|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304380|NCT04405076|469077470|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
130304381|NCT04405076|469077471|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
130304382|NCT04405076|469077463|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304383|NCT04405076|469077464|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304384|NCT04405076|469077465|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304385|NCT04405076|469077466|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304386|NCT04405076|469077467|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304387|NCT04405076|469077468|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304388|NCT04405076|469077469|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
130304389|NCT04405076|469077470|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304390|NCT04405076|469077471|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304391|NCT00392990|469077474|FG000|Treatment on Study|Adverse Event|3|||
130304392|NCT00392990|469077475|FG001|Treatment on Study|Adverse Event|1|||
130304393|NCT00392990|469077474|FG000|Follow up for 2 Years|Death|4|||
130304394|NCT00392990|469077475|FG001|Follow up for 2 Years|Death|0|||
130304395|NCT03052816|469077478|FG000|Overall Study|Withdrawal by Subject|1|||
130304396|NCT03052816|469077479|FG001|Overall Study|Withdrawal by Subject|0|||
130304397|NCT03052816|469077478|FG000|Overall Study|Desired opioids|2|||
130304398|NCT03052816|469077479|FG001|Overall Study|Desired opioids|0|||
130304399|NCT00408434|469077480|FG000|Overall Study|Adverse Event|0|||
130304400|NCT00408434|469077481|FG001|Overall Study|Adverse Event|0|||
130304401|NCT00408434|469077482|FG002|Overall Study|Adverse Event|1|||
130304402|NCT00408434|469077483|FG003|Overall Study|Adverse Event|0|||
130304403|NCT00408434|469077484|FG004|Overall Study|Adverse Event|0|||
130304404|NCT00408434|469077485|FG005|Overall Study|Adverse Event|0|||
130304405|NCT00408434|469077486|FG006|Overall Study|Adverse Event|0|||
130304406|NCT00408434|469077480|FG000|Overall Study|Progressive disease|6|||
130304407|NCT00408434|469077481|FG001|Overall Study|Progressive disease|3|||
130304408|NCT00408434|469077482|FG002|Overall Study|Progressive disease|4|||
130304409|NCT00408434|469077483|FG003|Overall Study|Progressive disease|3|||
130304410|NCT00408434|469077484|FG004|Overall Study|Progressive disease|3|||
130304411|NCT00408434|469077485|FG005|Overall Study|Progressive disease|1|||
130304412|NCT00408434|469077486|FG006|Overall Study|Progressive disease|4|||
130304413|NCT00408434|469077480|FG000|Overall Study|Other|0|||
130304414|NCT00408434|469077481|FG001|Overall Study|Other|0|||
130304415|NCT00408434|469077482|FG002|Overall Study|Other|1|||
130304416|NCT00408434|469077483|FG003|Overall Study|Other|0|||
130304417|NCT00408434|469077484|FG004|Overall Study|Other|2|||
130304418|NCT00408434|469077485|FG005|Overall Study|Other|1|||
130304419|NCT00408434|469077486|FG006|Overall Study|Other|0|||
130304420|NCT00408434|469077480|FG000|Overall Study|Terminated by Investigator|0|||
130304421|NCT00408434|469077481|FG001|Overall Study|Terminated by Investigator|0|||
130304422|NCT00408434|469077482|FG002|Overall Study|Terminated by Investigator|0|||
130304423|NCT00408434|469077483|FG003|Overall Study|Terminated by Investigator|0|||
130304424|NCT00408434|469077484|FG004|Overall Study|Terminated by Investigator|1|||
130304425|NCT00408434|469077485|FG005|Overall Study|Terminated by Investigator|1|||
130304426|NCT00408434|469077486|FG006|Overall Study|Terminated by Investigator|0|||
130304427|NCT04000581|469077487|FG000|Overall Study|Withdrawal by Subject|0|||
130304428|NCT04000581|469077488|FG001|Overall Study|Withdrawal by Subject|1|||
130304429|NCT00588354|469077489|FG000|Baseline to 2 Weeks|Adverse Event|1|||
130304430|NCT00588354|469077490|FG001|Baseline to 2 Weeks|Adverse Event|0|||
130304431|NCT00588354|469077489|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
130304432|NCT00588354|469077490|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
130304433|NCT00588354|469077489|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
130304434|NCT00588354|469077490|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
130716819|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130304435|NCT00895453|469077491|FG000|Overall Study|Lost to Follow-up|25|||
130304436|NCT00895453|469077492|FG001|Overall Study|Lost to Follow-up|25|||
130304437|NCT00895453|469077493|FG002|Overall Study|Lost to Follow-up|23|||
130304438|NCT01736618|469077500|FG000|Overall Study|Death|294|||
130304439|NCT01736618|469077500|FG000|Overall Study|Lost to Follow-up|193|||
130304440|NCT01736618|469077500|FG000|Overall Study|Withdrawal by Subject|54|||
130304441|NCT01736618|469077500|FG000|Overall Study|Subject unable to be followed at study location|223|||
130304442|NCT01736618|469077500|FG000|Overall Study|Physician Decision|33|||
130304443|NCT01736618|469077500|FG000|Overall Study|Transplant or removal of target organ|19|||
130716820|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130304444|NCT01736618|469077500|FG000|Overall Study|Change in indication or condition|78|||
130304445|NCT01736618|469077500|FG000|Overall Study|Study device explant|103|||
130716821|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130304446|NCT01736618|469077500|FG000|Overall Study|Unable to complete implant|2|||
130304447|NCT00400569|469077505|FG000|Overall Study|Death|1|||
130304448|NCT00620113|469077508|FG000|Overall Study|Adverse Event|3|||
130304449|NCT00620113|469077509|FG001|Overall Study|Adverse Event|2|||
130304450|NCT00620113|469077510|FG002|Overall Study|Adverse Event|2|||
130304451|NCT00620113|469077511|FG003|Overall Study|Adverse Event|1|||
130304452|NCT00620113|469077508|FG000|Overall Study|Lack of Efficacy|2|||
130304453|NCT00620113|469077509|FG001|Overall Study|Lack of Efficacy|3|||
130373736|NCT02269241|469336780|FG000|Overall Study|Wish for pregnancy|5|||
130373737|NCT02269241|469336780|FG000|Overall Study|Development of an exclusion criteria|16|||
130373738|NCT02269241|469336780|FG000|Overall Study|Adverse Event|113|||
130373739|NCT02269241|469336780|FG000|Overall Study|At the specific request of the sponsor|20|||
130373740|NCT02269241|469336780|FG000|Overall Study|Several reasons not classified|53|||
130373741|NCT02269241|469336780|FG000|Overall Study|Screening failures|546|||
130373742|NCT02270957|469336781|FG000|Overall Study|Lack of Efficacy|2|||
130373743|NCT02270957|469336782|FG001|Overall Study|Lack of Efficacy|4|||
130373744|NCT02270957|469336781|FG000|Overall Study|Adverse Event|2|||
130373745|NCT02270957|469336782|FG001|Overall Study|Adverse Event|0|||
130373746|NCT01218204|469336791|FG000|Part B Washout|Adverse Event|0|||
130373747|NCT01218204|469336792|FG001|Part B Washout|Adverse Event|1|||
130373748|NCT01218204|469336793|FG002|Part B Washout|Adverse Event|0|||
130373749|NCT01218204|469336794|FG003|Part B Washout|Adverse Event|0|||
130373750|NCT01218204|469336791|FG000|Part B Washout|Lost to Follow-up|0|||
130373751|NCT01218204|469336792|FG001|Part B Washout|Lost to Follow-up|2|||
130373752|NCT01218204|469336793|FG002|Part B Washout|Lost to Follow-up|0|||
130373753|NCT01218204|469336794|FG003|Part B Washout|Lost to Follow-up|0|||
130373754|NCT01218204|469336791|FG000|Part B Washout|Physician Decision|0|||
130373755|NCT01218204|469336792|FG001|Part B Washout|Physician Decision|14|||
130373756|NCT01218204|469336793|FG002|Part B Washout|Physician Decision|0|||
130373757|NCT01218204|469336794|FG003|Part B Washout|Physician Decision|0|||
130373758|NCT01218204|469336791|FG000|Part B Washout|Withdrawal by Subject|0|||
130373759|NCT01218204|469336792|FG001|Part B Washout|Withdrawal by Subject|14|||
130716822|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716823|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716824|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130304454|NCT00620113|469077510|FG002|Overall Study|Lack of Efficacy|0|||
130304455|NCT00620113|469077511|FG003|Overall Study|Lack of Efficacy|2|||
130304456|NCT00620113|469077508|FG000|Overall Study|Physician Decision|1|||
130304457|NCT00620113|469077509|FG001|Overall Study|Physician Decision|0|||
130304458|NCT00620113|469077510|FG002|Overall Study|Physician Decision|0|||
130304459|NCT00620113|469077511|FG003|Overall Study|Physician Decision|2|||
130304460|NCT00620113|469077508|FG000|Overall Study|Protocol Violation|2|||
130304461|NCT00620113|469077509|FG001|Overall Study|Protocol Violation|1|||
130304462|NCT00620113|469077510|FG002|Overall Study|Protocol Violation|0|||
130304463|NCT00620113|469077511|FG003|Overall Study|Protocol Violation|0|||
130304464|NCT00620113|469077508|FG000|Overall Study|Withdrawal by Subject|5|||
130304465|NCT00620113|469077509|FG001|Overall Study|Withdrawal by Subject|1|||
130304466|NCT00620113|469077510|FG002|Overall Study|Withdrawal by Subject|3|||
130304467|NCT00620113|469077511|FG003|Overall Study|Withdrawal by Subject|5|||
130716825|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716826|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716827|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716828|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716829|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716830|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716831|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716832|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716833|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716834|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716835|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716836|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716837|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716838|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716839|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716840|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716841|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
130373760|NCT01218204|469336793|FG002|Part B Washout|Withdrawal by Subject|0|||
130373761|NCT01218204|469336794|FG003|Part B Washout|Withdrawal by Subject|0|||
130373762|NCT01218204|469336791|FG000|Part B Washout|Reached defined stopping criteria|0|||
130304468|NCT02461745|469077514|FG000|Overall Study|Lack of Efficacy|9|||
130304469|NCT02461745|469077515|FG001|Overall Study|Lack of Efficacy|1|||
130373763|NCT01218204|469336792|FG001|Part B Washout|Reached defined stopping criteria|2|||
130373764|NCT01218204|469336793|FG002|Part B Washout|Reached defined stopping criteria|0|||
130373765|NCT01218204|469336794|FG003|Part B Washout|Reached defined stopping criteria|0|||
130373766|NCT01218204|469336791|FG000|Part B Washout|Did not meet continuation criteria|0|||
130373767|NCT01218204|469336792|FG001|Part B Washout|Did not meet continuation criteria|112|||
130373768|NCT01218204|469336793|FG002|Part B Washout|Did not meet continuation criteria|0|||
130373769|NCT01218204|469336794|FG003|Part B Washout|Did not meet continuation criteria|0|||
130373770|NCT01218204|469336791|FG000|Part B Run-in|Adverse Event|0|||
130373771|NCT01218204|469336792|FG001|Part B Run-in|Adverse Event|0|||
130373772|NCT01218204|469336793|FG002|Part B Run-in|Adverse Event|1|||
130373773|NCT01218204|469336794|FG003|Part B Run-in|Adverse Event|0|||
130373774|NCT01218204|469336791|FG000|Part B Run-in|Protocol Violation|0|||
130373775|NCT01218204|469336792|FG001|Part B Run-in|Protocol Violation|0|||
130373776|NCT01218204|469336793|FG002|Part B Run-in|Protocol Violation|2|||
130373777|NCT01218204|469336794|FG003|Part B Run-in|Protocol Violation|0|||
130373778|NCT01218204|469336791|FG000|Part B Run-in|Withdrawal by Subject|0|||
130373779|NCT01218204|469336792|FG001|Part B Run-in|Withdrawal by Subject|0|||
130373780|NCT01218204|469336793|FG002|Part B Run-in|Withdrawal by Subject|3|||
130373781|NCT01218204|469336794|FG003|Part B Run-in|Withdrawal by Subject|0|||
130373782|NCT01218204|469336791|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
130373783|NCT01218204|469336792|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
130373784|NCT01218204|469336793|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
130373785|NCT01218204|469336794|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
130373786|NCT01218204|469336791|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
130373787|NCT01218204|469336792|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
130373788|NCT01218204|469336793|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
130373789|NCT01218204|469336794|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
130373790|NCT00545168|469336795|FG000|Overall Study|Lost to Follow-up|5|||
130373791|NCT00545168|469336796|FG001|Overall Study|Lost to Follow-up|5|||
130373792|NCT00545168|469336797|FG002|Overall Study|Lost to Follow-up|5|||
130373793|NCT00545168|469336795|FG000|Overall Study|Withdrawal by Subject|9|||
130373794|NCT00545168|469336796|FG001|Overall Study|Withdrawal by Subject|0|||
130373795|NCT00545168|469336797|FG002|Overall Study|Withdrawal by Subject|13|||
130373796|NCT00545168|469336795|FG000|Overall Study|Protocol Violation|1|||
130373797|NCT00545168|469336796|FG001|Overall Study|Protocol Violation|0|||
130373798|NCT00545168|469336797|FG002|Overall Study|Protocol Violation|1|||
130373799|NCT00545168|469336795|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
130373800|NCT00545168|469336796|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
130373801|NCT00545168|469336797|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
130373802|NCT01987505|469336798|FG000|Overall Study|Other|9|||
130373803|NCT01987505|469336798|FG000|Overall Study|Withdrawal by Subject|2|||
130373804|NCT01987505|469336798|FG000|Overall Study|Other Reason|2|||
130373805|NCT01987505|469336798|FG000|Overall Study|Lost to Follow-up|15|||
130373806|NCT01987505|469336798|FG000|Overall Study|Investigator Decision|2|||
130373807|NCT01987505|469336798|FG000|Overall Study|Death|4|||
130373808|NCT00489541|469336799|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
130373809|NCT00489541|469336800|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
130464338|NCT02674750|469665255|FG002|Overall Study|Lost to Follow-up|0|||
130464339|NCT02674750|469665253|FG000|Overall Study|Lack of Efficacy|1|||
130304470|NCT02461745|469077514|FG000|Overall Study|Lost to Follow-up|2|||
130304471|NCT02461745|469077515|FG001|Overall Study|Lost to Follow-up|2|||
130304472|NCT02461745|469077514|FG000|Overall Study|Withdrawal by Subject|3|||
130304473|NCT02461745|469077515|FG001|Overall Study|Withdrawal by Subject|1|||
130304474|NCT00211887|469077518|FG000|Overall Study|Adverse Event|8|||
130304475|NCT00211887|469077519|FG001|Overall Study|Adverse Event|4|||
130304476|NCT00211887|469077520|FG002|Overall Study|Adverse Event|6|||
130304477|NCT00211887|469077518|FG000|Overall Study|Death|1|||
130304478|NCT00211887|469077519|FG001|Overall Study|Death|1|||
130304479|NCT00211887|469077520|FG002|Overall Study|Death|1|||
130304480|NCT00211887|469077518|FG000|Overall Study|Lost to Follow-up|28|||
130304481|NCT00211887|469077519|FG001|Overall Study|Lost to Follow-up|13|||
130304482|NCT00211887|469077520|FG002|Overall Study|Lost to Follow-up|9|||
130304483|NCT00211887|469077518|FG000|Overall Study|Non-medical reason|31|||
130304484|NCT00211887|469077519|FG001|Overall Study|Non-medical reason|14|||
130304485|NCT00211887|469077520|FG002|Overall Study|Non-medical reason|8|||
130304486|NCT00211887|469077518|FG000|Overall Study|Other medical reason|15|||
130464340|NCT02674750|469665254|FG001|Overall Study|Lack of Efficacy|17|||
130373810|NCT00489541|469336799|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
130373811|NCT00489541|469336800|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
130373812|NCT00489541|469336799|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
130373813|NCT00489541|469336800|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
130373814|NCT00489541|469336799|FG000|12-Month Clinical Follow-up|Death|3|||
130373815|NCT00489541|469336800|FG001|12-Month Clinical Follow-up|Death|2|||
130304487|NCT00211887|469077519|FG001|Overall Study|Other medical reason|11|||
130304488|NCT00211887|469077520|FG002|Overall Study|Other medical reason|7|||
130304489|NCT00211887|469077518|FG000|Overall Study|Side effects|19|||
130304490|NCT00211887|469077519|FG001|Overall Study|Side effects|13|||
130304491|NCT00211887|469077520|FG002|Overall Study|Side effects|5|||
130373816|NCT00489541|469336799|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
130373817|NCT00489541|469336800|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
130464341|NCT02674750|469665255|FG002|Overall Study|Lack of Efficacy|3|||
130304492|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Adverse Event|33|||
130304493|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
130304494|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
130304495|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
130304496|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Physician Decision|6|||
130304497|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
130304498|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
130304499|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
130304500|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
130304501|NCT00965419|469077524|FG000|Follow-up Phase|Adverse Event|9|||
130304502|NCT00965419|469077524|FG000|Follow-up Phase|Protocol Violation|4|||
130304503|NCT00965419|469077524|FG000|Follow-up Phase|Withdrawal by Subject|8|||
130304504|NCT00965419|469077524|FG000|Follow-up Phase|Physician Decision|4|||
130304505|NCT00965419|469077524|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
130304506|NCT00965419|469077524|FG000|Follow-up Phase|Lack of Efficacy|28|||
130304507|NCT00826618|469079025|FG000|Overall Study|Withdrawal by Subject|1|||
130304508|NCT03712787|469079026|FG000|Overall Study|Adverse Event|2|||
130716842|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716843|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130304509|NCT03712787|469079027|FG001|Overall Study|Adverse Event|3|||
130304510|NCT03712787|469079028|FG002|Overall Study|Adverse Event|0|||
130304511|NCT03712787|469079029|FG003|Overall Study|Adverse Event|4|||
130304512|NCT03712787|469079026|FG000|Overall Study|Withdrawal by Subject|4|||
130304513|NCT03712787|469079027|FG001|Overall Study|Withdrawal by Subject|14|||
130304514|NCT03712787|469079028|FG002|Overall Study|Withdrawal by Subject|12|||
130304515|NCT03712787|469079029|FG003|Overall Study|Withdrawal by Subject|8|||
130304516|NCT03712787|469079026|FG000|Overall Study|Lost to Follow-up|1|||
130304517|NCT03712787|469079027|FG001|Overall Study|Lost to Follow-up|1|||
130304518|NCT03712787|469079028|FG002|Overall Study|Lost to Follow-up|2|||
130304519|NCT03712787|469079029|FG003|Overall Study|Lost to Follow-up|1|||
130304520|NCT03712787|469079026|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130304521|NCT03712787|469079027|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130304522|NCT03712787|469079028|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130304523|NCT03712787|469079029|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130304524|NCT03712787|469079026|FG000|Overall Study|COVID-19 Infection|0|||
130304525|NCT03712787|469079027|FG001|Overall Study|COVID-19 Infection|1|||
130304526|NCT03712787|469079028|FG002|Overall Study|COVID-19 Infection|0|||
130304527|NCT03712787|469079029|FG003|Overall Study|COVID-19 Infection|0|||
130304528|NCT03712787|469079026|FG000|Overall Study|Other, Not Specified|79|||
130304529|NCT03712787|469079027|FG001|Overall Study|Other, Not Specified|77|||
130304530|NCT03712787|469079028|FG002|Overall Study|Other, Not Specified|74|||
130304531|NCT03712787|469079029|FG003|Overall Study|Other, Not Specified|78|||
130304532|NCT00732875|469079030|FG000|Overall Study|Adverse Event|16|||
130304533|NCT00732875|469079030|FG000|Overall Study|Withdrawal by Subject|6|||
130304534|NCT00732875|469079030|FG000|Overall Study|Lack of Efficacy|13|||
130304535|NCT00303485|469079040|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
130304536|NCT00303485|469079041|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
130304537|NCT00303485|469079040|FG000|Overall Study|Failure to return|0|||
130304538|NCT00303485|469079041|FG001|Overall Study|Failure to return|1|||
130304539|NCT00303485|469079040|FG000|Overall Study|Withdrawal by Subject|1|||
130304540|NCT00303485|469079041|FG001|Overall Study|Withdrawal by Subject|0|||
130304541|NCT02219334|469079047|FG000|Overall Study|Withdrawal by Subject|1|||
130304542|NCT02219334|469079048|FG001|Overall Study|Withdrawal by Subject|0|||
130304543|NCT02219334|469079047|FG000|Overall Study|Protocol Violation|7|||
130304544|NCT02219334|469079048|FG001|Overall Study|Protocol Violation|3|||
130304545|NCT02630472|469079051|FG000|Overall Study|Physician Decision|10|||
130304546|NCT02630472|469079052|FG001|Overall Study|Physician Decision|0|||
130304547|NCT04878211|469079053|FG000|Overall Study|Lost to Follow-up|0|||
130304548|NCT04878211|469079054|FG001|Overall Study|Lost to Follow-up|0|||
130304549|NCT04878211|469079055|FG002|Overall Study|Lost to Follow-up|0|||
130304550|NCT04878211|469079056|FG003|Overall Study|Lost to Follow-up|1|||
130304551|NCT04878211|469079057|FG004|Overall Study|Lost to Follow-up|0|||
130304552|NCT04878211|469079058|FG005|Overall Study|Lost to Follow-up|1|||
130716844|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716845|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130304553|NCT04878211|469079053|FG000|Overall Study|Protocol deviation|1|||
130304554|NCT04878211|469079054|FG001|Overall Study|Protocol deviation|0|||
130304555|NCT04878211|469079055|FG002|Overall Study|Protocol deviation|0|||
130304556|NCT04878211|469079056|FG003|Overall Study|Protocol deviation|0|||
130304557|NCT04878211|469079057|FG004|Overall Study|Protocol deviation|0|||
130304558|NCT04878211|469079058|FG005|Overall Study|Protocol deviation|0|||
130304559|NCT04878211|469079053|FG000|Overall Study|Study terminated by sponsor|0|||
130716846|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130304560|NCT04878211|469079054|FG001|Overall Study|Study terminated by sponsor|0|||
130304561|NCT04878211|469079055|FG002|Overall Study|Study terminated by sponsor|0|||
130304562|NCT04878211|469079056|FG003|Overall Study|Study terminated by sponsor|0|||
130304563|NCT04878211|469079057|FG004|Overall Study|Study terminated by sponsor|9|||
130304564|NCT04878211|469079058|FG005|Overall Study|Study terminated by sponsor|4|||
130304565|NCT04878211|469079053|FG000|Overall Study|Subject decision|0|||
130304566|NCT04878211|469079054|FG001|Overall Study|Subject decision|0|||
130304567|NCT04878211|469079055|FG002|Overall Study|Subject decision|0|||
130304568|NCT04878211|469079056|FG003|Overall Study|Subject decision|0|||
130304569|NCT04878211|469079057|FG004|Overall Study|Subject decision|1|||
130304570|NCT04878211|469079058|FG005|Overall Study|Subject decision|0|||
130304571|NCT04774926|469079059|FG000|Overall Study|Adverse Event|15|||
130304572|NCT04774926|469079059|FG000|Overall Study|Lost to Follow-up|3|||
130304573|NCT04774926|469079059|FG000|Overall Study|Physician Decision|6|||
130304574|NCT04774926|469079059|FG000|Overall Study|Withdrawal by Subject|3|||
130304575|NCT04774926|469079059|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
130304576|NCT02783599|469079060|FG000|Overall Study|Progressive disease|23|||
130304577|NCT02783599|469079060|FG000|Overall Study|Surgical Resection|10|||
130304578|NCT02783599|469079060|FG000|Overall Study|Adverse Event|4|||
130304579|NCT02783599|469079060|FG000|Overall Study|Physician Decision|2|||
130304580|NCT02783599|469079060|FG000|Overall Study|Death|1|||
130304581|NCT05173012|469079064|FG000|Overall Study|Adverse Event|2|||
130304582|NCT05173012|469079065|FG001|Overall Study|Adverse Event|3|||
130304583|NCT05173012|469079066|FG002|Overall Study|Adverse Event|4|||
130304584|NCT05173012|469079067|FG003|Overall Study|Adverse Event|13|||
130304585|NCT05173012|469079068|FG004|Overall Study|Adverse Event|0|||
130304586|NCT05173012|469079069|FG005|Overall Study|Adverse Event|0|||
130304587|NCT05173012|469079070|FG006|Overall Study|Adverse Event|2|||
130304588|NCT05173012|469079071|FG007|Overall Study|Adverse Event|4|||
130304589|NCT05173012|469079064|FG000|Overall Study|Lost to Follow-up|0|||
130304590|NCT05173012|469079065|FG001|Overall Study|Lost to Follow-up|0|||
130304591|NCT05173012|469079066|FG002|Overall Study|Lost to Follow-up|0|||
130304592|NCT05173012|469079067|FG003|Overall Study|Lost to Follow-up|1|||
130304593|NCT05173012|469079068|FG004|Overall Study|Lost to Follow-up|0|||
130304594|NCT05173012|469079069|FG005|Overall Study|Lost to Follow-up|0|||
130304595|NCT05173012|469079070|FG006|Overall Study|Lost to Follow-up|0|||
130304596|NCT05173012|469079071|FG007|Overall Study|Lost to Follow-up|0|||
130304597|NCT05173012|469079064|FG000|Overall Study|Withdrawal by Subject|1|||
130304598|NCT05173012|469079065|FG001|Overall Study|Withdrawal by Subject|0|||
130304599|NCT05173012|469079066|FG002|Overall Study|Withdrawal by Subject|1|||
130304600|NCT05173012|469079067|FG003|Overall Study|Withdrawal by Subject|3|||
130304601|NCT05173012|469079068|FG004|Overall Study|Withdrawal by Subject|1|||
130304602|NCT05173012|469079069|FG005|Overall Study|Withdrawal by Subject|0|||
130304603|NCT05173012|469079070|FG006|Overall Study|Withdrawal by Subject|1|||
130304604|NCT05173012|469079071|FG007|Overall Study|Withdrawal by Subject|0|||
130304605|NCT05173012|469079064|FG000|Overall Study|Protocol Deviation|0|||
130304606|NCT05173012|469079065|FG001|Overall Study|Protocol Deviation|0|||
130304607|NCT05173012|469079066|FG002|Overall Study|Protocol Deviation|0|||
130304608|NCT05173012|469079067|FG003|Overall Study|Protocol Deviation|1|||
130304609|NCT05173012|469079068|FG004|Overall Study|Protocol Deviation|0|||
130304610|NCT05173012|469079069|FG005|Overall Study|Protocol Deviation|0|||
130304611|NCT05173012|469079070|FG006|Overall Study|Protocol Deviation|0|||
130716847|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716848|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716849|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716850|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716851|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716852|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130304612|NCT05173012|469079071|FG007|Overall Study|Protocol Deviation|0|||
130304613|NCT05173012|469079064|FG000|Overall Study|Other|0|||
130304614|NCT05173012|469079065|FG001|Overall Study|Other|0|||
130304615|NCT05173012|469079066|FG002|Overall Study|Other|0|||
130304616|NCT05173012|469079067|FG003|Overall Study|Other|2|||
130304617|NCT05173012|469079068|FG004|Overall Study|Other|0|||
130304618|NCT05173012|469079069|FG005|Overall Study|Other|0|||
130304619|NCT05173012|469079070|FG006|Overall Study|Other|0|||
130304620|NCT05173012|469079071|FG007|Overall Study|Other|0|||
130304621|NCT02936843|469079072|FG000|Overall Study|Lost to Follow-up|3|||
130304622|NCT02936843|469079073|FG001|Overall Study|Lost to Follow-up|1|||
130304623|NCT02936843|469079072|FG000|Overall Study|Withdrawal by Subject|1|||
130304624|NCT02936843|469079073|FG001|Overall Study|Withdrawal by Subject|1|||
130304625|NCT03668613|469079074|FG000|Overall Study|Adverse Event|1|||
130373818|NCT00489541|469336799|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
130304626|NCT03668613|469079075|FG001|Overall Study|Adverse Event|2|||
130304627|NCT03668613|469079074|FG000|Overall Study|Lack of Efficacy|5|||
130304628|NCT03668613|469079075|FG001|Overall Study|Lack of Efficacy|1|||
130304629|NCT03668613|469079074|FG000|Overall Study|Pregnancy|0|||
130304630|NCT03668613|469079075|FG001|Overall Study|Pregnancy|2|||
130304631|NCT03668613|469079074|FG000|Overall Study|Protocol Violation|1|||
130304632|NCT03668613|469079075|FG001|Overall Study|Protocol Violation|0|||
130304633|NCT03668613|469079074|FG000|Overall Study|Physician Decision|1|||
130304634|NCT03668613|469079075|FG001|Overall Study|Physician Decision|0|||
130304635|NCT03668613|469079074|FG000|Overall Study|Withdrawal by Subject|2|||
130304636|NCT03668613|469079075|FG001|Overall Study|Withdrawal by Subject|1|||
130304637|NCT03668613|469079074|FG000|Overall Study|Guardian decision|1|||
130304638|NCT03668613|469079075|FG001|Overall Study|Guardian decision|0|||
130304639|NCT01393821|469079076|FG000|Overall Study|Cancel|1|||
130304640|NCT01393821|469079077|FG001|Overall Study|Cancel|1|||
130304641|NCT01393821|469079076|FG000|Overall Study|not evaluable for primary endpoint|4|||
130304642|NCT01393821|469079077|FG001|Overall Study|not evaluable for primary endpoint|2|||
130304643|NCT03386487|469079078|FG000|Overall Study|Lost to Follow-up|5|||
130304644|NCT03386487|469079079|FG001|Overall Study|Lost to Follow-up|6|||
130304645|NCT03386487|469079078|FG000|Overall Study|Withdrawal by Subject|11|||
130304646|NCT03386487|469079079|FG001|Overall Study|Withdrawal by Subject|7|||
130304647|NCT03386487|469079078|FG000|Overall Study|Physician Decision|11|||
130304648|NCT03386487|469079079|FG001|Overall Study|Physician Decision|8|||
130304649|NCT02703324|469079080|FG000|Period Two|Withdrawal by Subject|0|||
130304650|NCT02703324|469079081|FG001|Period Two|Withdrawal by Subject|0|||
130304651|NCT02703324|469079082|FG002|Period Two|Withdrawal by Subject|1|||
130304652|NCT02703324|469079083|FG003|Period Two|Withdrawal by Subject|0|||
130304653|NCT02703324|469079084|FG004|Period Two|Withdrawal by Subject|0|||
130304654|NCT02703324|469079085|FG005|Period Two|Withdrawal by Subject|0|||
130304655|NCT06312592|469079086|FG000|Overall Study|Lost to Follow-up|29|||
130304656|NCT06312592|469079087|FG001|Overall Study|Lost to Follow-up|13|||
130304657|NCT01948063|469079090|FG000|Overall Study|Boston MCI halted research protocol|0|||
130304658|NCT01948063|469079091|FG001|Overall Study|Boston MCI halted research protocol|1|||
130304659|NCT01948063|469079090|FG000|Overall Study|Discovered an enrollment in other study|0|||
130304660|NCT01948063|469079091|FG001|Overall Study|Discovered an enrollment in other study|1|||
130304661|NCT01948063|469079090|FG000|Overall Study|Blood samples were accidentally thawed|1|||
130304662|NCT01948063|469079091|FG001|Overall Study|Blood samples were accidentally thawed|0|||
130304663|NCT01858766|469079092|FG000|Overall Study|Randomized but Never Treated|0|||
130304664|NCT01858766|469079093|FG001|Overall Study|Randomized but Never Treated|0|||
130304665|NCT01858766|469079094|FG002|Overall Study|Randomized but Never Treated|0|||
130304666|NCT01858766|469079095|FG003|Overall Study|Randomized but Never Treated|0|||
130304667|NCT01858766|469079096|FG004|Overall Study|Randomized but Never Treated|0|||
130304668|NCT01858766|469079097|FG005|Overall Study|Randomized but Never Treated|1|||
130304669|NCT01858766|469079098|FG006|Overall Study|Randomized but Never Treated|0|||
130304670|NCT01858766|469079099|FG007|Overall Study|Randomized but Never Treated|0|||
130304671|NCT01858766|469079100|FG008|Overall Study|Randomized but Never Treated|0|||
130304672|NCT01858766|469079101|FG009|Overall Study|Randomized but Never Treated|0|||
130304673|NCT01858766|469079102|FG010|Overall Study|Randomized but Never Treated|0|||
130304674|NCT01858766|469079103|FG011|Overall Study|Randomized but Never Treated|0|||
130304675|NCT01858766|469079104|FG012|Overall Study|Randomized but Never Treated|0|||
130304676|NCT01858766|469079105|FG013|Overall Study|Randomized but Never Treated|0|||
130304677|NCT01858766|469079106|FG014|Overall Study|Randomized but Never Treated|0|||
130304678|NCT01858766|469079107|FG015|Overall Study|Randomized but Never Treated|0|||
130304679|NCT01858766|469079108|FG016|Overall Study|Randomized but Never Treated|0|||
130304680|NCT01858766|469079109|FG017|Overall Study|Randomized but Never Treated|1|||
130304681|NCT01858766|469079110|FG018|Overall Study|Randomized but Never Treated|0|||
130304682|NCT01858766|469079092|FG000|Overall Study|Death|0|||
130304683|NCT01858766|469079093|FG001|Overall Study|Death|0|||
130304684|NCT01858766|469079094|FG002|Overall Study|Death|1|||
130304685|NCT01858766|469079095|FG003|Overall Study|Death|0|||
130304686|NCT01858766|469079096|FG004|Overall Study|Death|0|||
130304687|NCT01858766|469079097|FG005|Overall Study|Death|0|||
130304688|NCT01858766|469079098|FG006|Overall Study|Death|0|||
130304689|NCT01858766|469079099|FG007|Overall Study|Death|0|||
130304690|NCT01858766|469079100|FG008|Overall Study|Death|0|||
130304691|NCT01858766|469079101|FG009|Overall Study|Death|0|||
130304692|NCT01858766|469079102|FG010|Overall Study|Death|0|||
130304693|NCT01858766|469079103|FG011|Overall Study|Death|0|||
130304694|NCT01858766|469079104|FG012|Overall Study|Death|0|||
130304695|NCT01858766|469079105|FG013|Overall Study|Death|0|||
130304696|NCT01858766|469079106|FG014|Overall Study|Death|0|||
130304697|NCT01858766|469079107|FG015|Overall Study|Death|0|||
130304698|NCT01858766|469079108|FG016|Overall Study|Death|0|||
130304699|NCT01858766|469079109|FG017|Overall Study|Death|0|||
130304700|NCT01858766|469079110|FG018|Overall Study|Death|0|||
130304701|NCT01858766|469079092|FG000|Overall Study|Lack of Efficacy|1|||
130376676|NCT01327885|469345896|FG001|Overall Study|Administrative decision|1|||
130304702|NCT01858766|469079093|FG001|Overall Study|Lack of Efficacy|0|||
130304703|NCT01858766|469079094|FG002|Overall Study|Lack of Efficacy|0|||
130304704|NCT01858766|469079095|FG003|Overall Study|Lack of Efficacy|0|||
130304705|NCT01858766|469079096|FG004|Overall Study|Lack of Efficacy|1|||
130304706|NCT01858766|469079097|FG005|Overall Study|Lack of Efficacy|2|||
130304707|NCT01858766|469079098|FG006|Overall Study|Lack of Efficacy|0|||
130304708|NCT01858766|469079099|FG007|Overall Study|Lack of Efficacy|0|||
130304709|NCT01858766|469079100|FG008|Overall Study|Lack of Efficacy|0|||
130304710|NCT01858766|469079101|FG009|Overall Study|Lack of Efficacy|0|||
130304711|NCT01858766|469079102|FG010|Overall Study|Lack of Efficacy|0|||
130304712|NCT01858766|469079103|FG011|Overall Study|Lack of Efficacy|3|||
130304713|NCT01858766|469079104|FG012|Overall Study|Lack of Efficacy|5|||
130304714|NCT01858766|469079105|FG013|Overall Study|Lack of Efficacy|3|||
130304715|NCT01858766|469079106|FG014|Overall Study|Lack of Efficacy|5|||
130304716|NCT01858766|469079107|FG015|Overall Study|Lack of Efficacy|5|||
130304717|NCT01858766|469079108|FG016|Overall Study|Lack of Efficacy|2|||
130304718|NCT01858766|469079109|FG017|Overall Study|Lack of Efficacy|3|||
130304719|NCT01858766|469079110|FG018|Overall Study|Lack of Efficacy|3|||
130304720|NCT01858766|469079092|FG000|Overall Study|Lost to Follow-up|0|||
130304721|NCT01858766|469079093|FG001|Overall Study|Lost to Follow-up|0|||
130304722|NCT01858766|469079094|FG002|Overall Study|Lost to Follow-up|0|||
130304723|NCT01858766|469079095|FG003|Overall Study|Lost to Follow-up|0|||
130304724|NCT01858766|469079096|FG004|Overall Study|Lost to Follow-up|0|||
130304725|NCT01858766|469079097|FG005|Overall Study|Lost to Follow-up|1|||
130304726|NCT01858766|469079098|FG006|Overall Study|Lost to Follow-up|0|||
130304727|NCT01858766|469079099|FG007|Overall Study|Lost to Follow-up|2|||
130304728|NCT01858766|469079100|FG008|Overall Study|Lost to Follow-up|0|||
130304729|NCT01858766|469079101|FG009|Overall Study|Lost to Follow-up|0|||
130304730|NCT01858766|469079102|FG010|Overall Study|Lost to Follow-up|0|||
130304731|NCT01858766|469079103|FG011|Overall Study|Lost to Follow-up|1|||
130304732|NCT01858766|469079104|FG012|Overall Study|Lost to Follow-up|0|||
130304733|NCT01858766|469079105|FG013|Overall Study|Lost to Follow-up|0|||
130304734|NCT01858766|469079106|FG014|Overall Study|Lost to Follow-up|3|||
130304735|NCT01858766|469079107|FG015|Overall Study|Lost to Follow-up|1|||
130304736|NCT01858766|469079108|FG016|Overall Study|Lost to Follow-up|1|||
130304737|NCT01858766|469079109|FG017|Overall Study|Lost to Follow-up|0|||
130304738|NCT01858766|469079110|FG018|Overall Study|Lost to Follow-up|1|||
130304739|NCT01858766|469079092|FG000|Overall Study|Withdrew Consent|0|||
130304740|NCT01858766|469079093|FG001|Overall Study|Withdrew Consent|0|||
130304741|NCT01858766|469079094|FG002|Overall Study|Withdrew Consent|0|||
130304742|NCT01858766|469079095|FG003|Overall Study|Withdrew Consent|0|||
130304743|NCT01858766|469079096|FG004|Overall Study|Withdrew Consent|0|||
130304744|NCT01858766|469079097|FG005|Overall Study|Withdrew Consent|0|||
130304745|NCT01858766|469079098|FG006|Overall Study|Withdrew Consent|0|||
130304746|NCT01858766|469079099|FG007|Overall Study|Withdrew Consent|0|||
130304747|NCT01858766|469079100|FG008|Overall Study|Withdrew Consent|0|||
130304748|NCT01858766|469079101|FG009|Overall Study|Withdrew Consent|0|||
130304749|NCT01858766|469079102|FG010|Overall Study|Withdrew Consent|0|||
130304750|NCT01858766|469079103|FG011|Overall Study|Withdrew Consent|1|||
130304751|NCT01858766|469079104|FG012|Overall Study|Withdrew Consent|0|||
130304752|NCT01858766|469079105|FG013|Overall Study|Withdrew Consent|0|||
130304753|NCT01858766|469079106|FG014|Overall Study|Withdrew Consent|0|||
130304754|NCT01858766|469079107|FG015|Overall Study|Withdrew Consent|0|||
130304755|NCT01858766|469079108|FG016|Overall Study|Withdrew Consent|0|||
130304756|NCT01858766|469079109|FG017|Overall Study|Withdrew Consent|0|||
130304757|NCT01858766|469079110|FG018|Overall Study|Withdrew Consent|0|||
130304758|NCT03517228|469079113|FG000|Overall Study|Withdrawal by Subject|2|||
130304759|NCT03517228|469079113|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
130304760|NCT03517228|469079113|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
130304761|NCT03517228|469079113|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
130304762|NCT03517228|469079113|FG000|Overall Study|Canceled due to device being updated|1|||
130304763|NCT03517228|469079113|FG000|Overall Study|No V Cares in stock|1|||
130304764|NCT03517228|469079113|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
130304765|NCT03781414|469079124|FG000|Overall Study|Study terminated by sponsor|39|||
130304766|NCT03781414|469079125|FG001|Overall Study|Study terminated by sponsor|34|||
130304767|NCT03781414|469079126|FG002|Overall Study|Study terminated by sponsor|25|||
130304768|NCT03781414|469079124|FG000|Overall Study|Adverse Event|3|||
130304769|NCT03781414|469079125|FG001|Overall Study|Adverse Event|6|||
130304770|NCT03781414|469079126|FG002|Overall Study|Adverse Event|3|||
130304771|NCT03781414|469079124|FG000|Overall Study|Physician Decision|2|||
130304772|NCT03781414|469079125|FG001|Overall Study|Physician Decision|0|||
130304773|NCT03781414|469079126|FG002|Overall Study|Physician Decision|1|||
130304774|NCT03781414|469079124|FG000|Overall Study|Withdrawal by Subject|2|||
130304775|NCT03781414|469079125|FG001|Overall Study|Withdrawal by Subject|3|||
130304776|NCT03781414|469079126|FG002|Overall Study|Withdrawal by Subject|3|||
130304777|NCT03781414|469079124|FG000|Overall Study|Death|1|||
130304778|NCT03781414|469079125|FG001|Overall Study|Death|4|||
130304779|NCT03781414|469079126|FG002|Overall Study|Death|0|||
130304780|NCT03781414|469079124|FG000|Overall Study|Lost to Follow-up|1|||
130304781|NCT03781414|469079125|FG001|Overall Study|Lost to Follow-up|1|||
130304782|NCT03781414|469079126|FG002|Overall Study|Lost to Follow-up|0|||
130304783|NCT04752358|469079130|FG000|Overall Study|Death|2|||
130304784|NCT04752358|469079131|FG001|Overall Study|Death|1|||
130304785|NCT00719355|469079134|FG000|Overall Study|Death|0|||
130304786|NCT00719355|469079135|FG001|Overall Study|Death|1|||
130304787|NCT00719355|469079134|FG000|Overall Study|Medical|14|||
130304788|NCT00719355|469079135|FG001|Overall Study|Medical|5|||
130304789|NCT00719355|469079134|FG000|Overall Study|Compliance|4|||
130304790|NCT00719355|469079135|FG001|Overall Study|Compliance|6|||
130304791|NCT00719355|469079134|FG000|Overall Study|Moved|0|||
130304792|NCT00719355|469079135|FG001|Overall Study|Moved|1|||
130304793|NCT01835158|469079136|FG000|Overall Study|Withdrawal by Subject|1|||
130304794|NCT01835158|469079137|FG001|Overall Study|Withdrawal by Subject|6|||
130304795|NCT03364738|469079139|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
130304796|NCT03364738|469079139|FG000|Overall Study|Withdrawal by Subject|1|||
130304797|NCT03364738|469079139|FG000|Overall Study|Adverse Event|1|||
130304798|NCT03245398|469079143|FG000|Overall Study|Travelled to another island|1|||
130304799|NCT03245398|469079144|FG001|Overall Study|Travelled to another island|0|||
130304800|NCT03422536|469079151|FG000|Randomized|Physician Decision|1|||
130304801|NCT03422536|469079152|FG001|Randomized|Physician Decision|1|||
130304802|NCT03422536|469079151|FG000|Allocation - Received Intervention|Disease progression|19|||
130304803|NCT03422536|469079152|FG001|Allocation - Received Intervention|Disease progression|25|||
130304804|NCT03422536|469079151|FG000|Allocation - Received Intervention|Death|1|||
130304805|NCT03422536|469079152|FG001|Allocation - Received Intervention|Death|3|||
130304806|NCT03422536|469079151|FG000|Allocation - Received Intervention|Adverse Event|1|||
130304807|NCT03422536|469079152|FG001|Allocation - Received Intervention|Adverse Event|0|||
130304808|NCT03422536|469079151|FG000|Allocation - Received Intervention|Physician Decision|1|||
130304809|NCT03422536|469079152|FG001|Allocation - Received Intervention|Physician Decision|1|||
130304810|NCT03422536|469079151|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
130304811|NCT03422536|469079152|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
130304812|NCT03422536|469079151|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
130304813|NCT03422536|469079152|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
130304814|NCT04531241|469079153|FG000|Period 1|Withdrawal by Subject|2|||
130304815|NCT04531241|469079154|FG001|Period 1|Withdrawal by Subject|0|||
130304816|NCT04531241|469079153|FG000|Period 1|Dispesed incorrect lens power|1|||
130304817|NCT04531241|469079154|FG001|Period 1|Dispesed incorrect lens power|0|||
130304818|NCT04531241|469079153|FG000|Period 1|Protocol Violation|1|||
130304819|NCT04531241|469079154|FG001|Period 1|Protocol Violation|0|||
130304820|NCT04531241|469079153|FG000|Period 1|No longer eligible|0|||
130304821|NCT04531241|469079154|FG001|Period 1|No longer eligible|1|||
130304822|NCT04531241|469079153|FG000|Period 1|Lens Discomfort|0|||
130304823|NCT04531241|469079154|FG001|Period 1|Lens Discomfort|1|||
130304824|NCT04531241|469079153|FG000|Period 2|Covid-19 Related|1|||
130304825|NCT04531241|469079154|FG001|Period 2|Covid-19 Related|1|||
130304826|NCT02023996|469079155|FG000|Overall Study|Protocol Violation|6|||
130304827|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
130304828|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304829|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304830|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304831|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
130304832|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304833|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304834|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304835|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
130304836|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304837|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304838|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304839|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130304840|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130304841|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
130373819|NCT00489541|469336800|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
130373820|NCT05131646|469336801|FG000|Overall Study|Withdrawal by Subject|1|||
130373821|NCT05131646|469336802|FG001|Overall Study|Withdrawal by Subject|0|||
130373822|NCT05131646|469336803|FG002|Overall Study|Withdrawal by Subject|0|||
130304842|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
130304843|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
130304844|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304845|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304846|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304847|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
130373823|NCT03266107|469336804|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
130373824|NCT03266107|469336804|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
130373825|NCT03266107|469336804|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
130373826|NCT03266107|469336804|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
130373827|NCT01191801|469336809|FG000|Overall Study|Death|36|||
130304848|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130373828|NCT01191801|469336810|FG001|Overall Study|Death|12|||
130304849|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130304850|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130304851|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
130304852|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304853|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304854|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304855|NCT01620762|469079168|FG000|Overall Study|Protocol Violation|1|||
130304856|NCT01620762|469079169|FG001|Overall Study|Protocol Violation|1|||
130304857|NCT01620762|469079170|FG002|Overall Study|Protocol Violation|1|||
130304858|NCT01620762|469079168|FG000|Overall Study|Adverse Event|9|||
130304859|NCT01620762|469079169|FG001|Overall Study|Adverse Event|5|||
130304860|NCT01620762|469079170|FG002|Overall Study|Adverse Event|2|||
130304861|NCT01620762|469079168|FG000|Overall Study|Withdrawal by Subject|23|||
130304862|NCT01620762|469079169|FG001|Overall Study|Withdrawal by Subject|26|||
130304863|NCT01620762|469079170|FG002|Overall Study|Withdrawal by Subject|27|||
130304864|NCT01620762|469079168|FG000|Overall Study|Lost to Follow-up|11|||
130304865|NCT01620762|469079169|FG001|Overall Study|Lost to Follow-up|17|||
130304866|NCT01620762|469079170|FG002|Overall Study|Lost to Follow-up|10|||
130304867|NCT01620762|469079168|FG000|Overall Study|Protocol deviation|1|||
130304868|NCT01620762|469079169|FG001|Overall Study|Protocol deviation|1|||
130304869|NCT01620762|469079170|FG002|Overall Study|Protocol deviation|6|||
130304870|NCT01620762|469079168|FG000|Overall Study|Subject deterioration|0|||
130304871|NCT01620762|469079169|FG001|Overall Study|Subject deterioration|1|||
130304872|NCT01620762|469079170|FG002|Overall Study|Subject deterioration|1|||
130304873|NCT01620762|469079168|FG000|Overall Study|Non-specified|3|||
130304874|NCT01620762|469079169|FG001|Overall Study|Non-specified|6|||
130304875|NCT01620762|469079170|FG002|Overall Study|Non-specified|5|||
130304876|NCT01620762|469079168|FG000|Overall Study|Use of prohibted therapies|0|||
130304877|NCT01620762|469079169|FG001|Overall Study|Use of prohibted therapies|1|||
130304878|NCT01620762|469079170|FG002|Overall Study|Use of prohibted therapies|1|||
130304879|NCT00705146|469079175|FG000|Overall Study|Lost to Follow-up|1|||
130304880|NCT00705146|469079176|FG001|Overall Study|Lost to Follow-up|1|||
130304881|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
130304882|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304883|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304884|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304885|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304886|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304887|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
130304888|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304889|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304890|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304891|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304892|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304893|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
130304894|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304895|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304896|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304897|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304898|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304899|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
130304900|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
130304901|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
130304902|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
130304903|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
130304904|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
130304905|NCT00095173|469079179|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304906|NCT00095173|469079180|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
130304907|NCT00095173|469079181|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
130304908|NCT00095173|469079182|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304909|NCT00095173|469079183|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304910|NCT00095173|469079184|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304911|NCT00095173|469079179|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304912|NCT00095173|469079180|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
130304913|NCT00095173|469079181|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304914|NCT00095173|469079182|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304915|NCT00095173|469079183|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304916|NCT00095173|469079184|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304917|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Death|0|||
130304918|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Death|0|||
130304919|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Death|0|||
130373829|NCT01191801|469336809|FG000|Overall Study|Lack of Efficacy|176|||
130373830|NCT01191801|469336810|FG001|Overall Study|Lack of Efficacy|258|||
130373831|NCT01191801|469336809|FG000|Overall Study|Adverse Event|9|||
130373832|NCT01191801|469336810|FG001|Overall Study|Adverse Event|8|||
130373833|NCT01191801|469336809|FG000|Overall Study|Protocol Violation|2|||
130373834|NCT01191801|469336810|FG001|Overall Study|Protocol Violation|4|||
130373835|NCT01191801|469336809|FG000|Overall Study|Physician Decision|47|||
130373836|NCT01191801|469336810|FG001|Overall Study|Physician Decision|24|||
130373837|NCT01191801|469336809|FG000|Overall Study|Withdrawal by Subject|1|||
130304920|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Death|0|||
130304921|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Death|0|||
130304922|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Death|1|||
130304923|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304924|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304925|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304926|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
130304927|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
130304928|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
130304929|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130304930|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130373838|NCT01191801|469336810|FG001|Overall Study|Withdrawal by Subject|4|||
130304931|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130304932|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
130304933|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
130304934|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
130304935|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304936|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304937|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304938|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
130304939|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
130304940|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
130304941|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304942|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304943|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130373839|NCT01191801|469336809|FG000|Overall Study|Not Provided|45|||
130373840|NCT01191801|469336810|FG001|Overall Study|Not Provided|27|||
130373841|NCT05147350|469336818|FG000|Overall Study|Death|2|||
130373842|NCT05147350|469336819|FG001|Overall Study|Death|3|||
130373843|NCT05147350|469336820|FG002|Overall Study|Death|3|||
130373844|NCT05147350|469336821|FG003|Overall Study|Death|2|||
130373845|NCT05147350|469336822|FG004|Overall Study|Death|2|||
130373846|NCT05147350|469336823|FG005|Overall Study|Death|1|||
130373847|NCT05147350|469336824|FG006|Overall Study|Death|1|||
130373848|NCT05147350|469336825|FG007|Overall Study|Death|3|||
130373849|NCT05147350|469336818|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
130557622|NCT04178967|470011823|FG007|Induction Period|Protocol Violation|0|||
130557623|NCT04178967|470011824|FG008|Induction Period|Protocol Violation|0|||
130716853|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130304944|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
130304945|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
130304946|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304947|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304948|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304949|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304950|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304951|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130304952|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130304953|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304954|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304955|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130373850|NCT05147350|469336819|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
130373851|NCT05147350|469336820|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
130716854|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716855|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130373852|NCT05147350|469336821|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
130373853|NCT05147350|469336822|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
130557624|NCT04178967|470011825|FG009|Induction Period|Protocol Violation|0|||
130373854|NCT05147350|469336823|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
130557625|NCT04178967|470011826|FG010|Induction Period|Protocol Violation|0|||
130557626|NCT04178967|470011816|FG000|Induction Period|Withdrawal by Subject|6|||
130304956|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304957|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130304958|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130304959|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304960|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304961|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304962|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
130304963|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
130304964|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
130304965|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Other|0|||
130304966|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Other|0|||
130304967|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Other|0|||
130304968|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Other|4|||
130304969|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Other|6|||
130304970|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Other|8|||
130304971|NCT00330681|469079188|FG000|Overall Study|Adverse Event|3|||
130304972|NCT00330681|469079189|FG001|Overall Study|Adverse Event|6|||
130304973|NCT00330681|469079188|FG000|Overall Study|Protocol Violation|0|||
130304974|NCT00330681|469079189|FG001|Overall Study|Protocol Violation|1|||
130304975|NCT00330681|469079188|FG000|Overall Study|Withdrawal by Subject|5|||
130304976|NCT00330681|469079189|FG001|Overall Study|Withdrawal by Subject|5|||
130304977|NCT00330681|469079188|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
130304978|NCT00330681|469079189|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
130304979|NCT04698993|469079190|FG000|Overall Study|PCR results not accessible|2|||
130304980|NCT04698993|469079191|FG001|Overall Study|PCR results not accessible|7|||
130304981|NCT04698993|469079190|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
130304982|NCT04698993|469079191|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
130304983|NCT02578186|469079192|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130304984|NCT02578186|469079193|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130304985|NCT02578186|469079192|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130304986|NCT02578186|469079193|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130304987|NCT00527904|469079194|FG000|Overall Study|Adverse Event|45|||
130304988|NCT00527904|469079194|FG000|Overall Study|Withdrawal by Subject|21|||
130304989|NCT00527904|469079194|FG000|Overall Study|Lost to Follow-up|8|||
130304990|NCT00527904|469079194|FG000|Overall Study|misc|22|||
130304991|NCT00428389|469079195|FG000|Core Phase|Adverse Event|6|||
130304992|NCT00428389|469079196|FG001|Core Phase|Adverse Event|4|||
130304993|NCT00428389|469079195|FG000|Core Phase|Lack of Efficacy|2|||
130304994|NCT00428389|469079196|FG001|Core Phase|Lack of Efficacy|0|||
130304995|NCT00428389|469079195|FG000|Core Phase|Abnormal test procedure result(s)|0|||
130304996|NCT00428389|469079196|FG001|Core Phase|Abnormal test procedure result(s)|1|||
130304997|NCT00428389|469079195|FG000|Core Phase|Withdrawal by Subject|3|||
130304998|NCT00428389|469079196|FG001|Core Phase|Withdrawal by Subject|4|||
130304999|NCT00428389|469079195|FG000|Core Phase|Protocol deviation|0|||
130305000|NCT00428389|469079196|FG001|Core Phase|Protocol deviation|2|||
130305001|NCT00428389|469079195|FG000|Extension Phase|Adverse Event|17|||
130305002|NCT00428389|469079196|FG001|Extension Phase|Adverse Event|11|||
130305003|NCT00428389|469079195|FG000|Extension Phase|Lack of Efficacy|4|||
130305004|NCT00428389|469079196|FG001|Extension Phase|Lack of Efficacy|3|||
130305005|NCT00428389|469079195|FG000|Extension Phase|Withdrawal by Subject|6|||
130305006|NCT00428389|469079196|FG001|Extension Phase|Withdrawal by Subject|6|||
130305007|NCT00428389|469079195|FG000|Extension Phase|Lost to Follow-up|0|||
130305008|NCT00428389|469079196|FG001|Extension Phase|Lost to Follow-up|3|||
130305009|NCT00428389|469079195|FG000|Extension Phase|Death|1|||
130305010|NCT00428389|469079196|FG001|Extension Phase|Death|0|||
130305011|NCT00428389|469079195|FG000|Extension Phase|Protocol Violation|3|||
130305012|NCT00428389|469079196|FG001|Extension Phase|Protocol Violation|2|||
130305013|NCT00428389|469079195|FG000|Extension Phase|Administrative problems|1|||
130305014|NCT00428389|469079196|FG001|Extension Phase|Administrative problems|1|||
130305015|NCT01534195|469079197|FG000|Overall Study|Withdrawal by Subject|1|||
130305016|NCT01534195|469079198|FG001|Overall Study|Withdrawal by Subject|1|||
130305017|NCT01320202|469079199|FG000|Overall Study|Adverse Event|5|||
130305018|NCT01320202|469079200|FG001|Overall Study|Adverse Event|5|||
130305019|NCT01320202|469079199|FG000|Overall Study|Death|5|||
130305020|NCT01320202|469079200|FG001|Overall Study|Death|3|||
130373855|NCT05147350|469336824|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
130373856|NCT05147350|469336825|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
130373857|NCT05147350|469336818|FG000|Overall Study|Withdrawal by Subject|0|||
130305021|NCT01320202|469079199|FG000|Overall Study|Lost to Follow-up|1|||
130305022|NCT01320202|469079200|FG001|Overall Study|Lost to Follow-up|0|||
130305023|NCT01320202|469079199|FG000|Overall Study|Physician Decision|3|||
130305024|NCT01320202|469079200|FG001|Overall Study|Physician Decision|1|||
130305025|NCT01320202|469079199|FG000|Overall Study|Protocol Violation|2|||
130305026|NCT01320202|469079200|FG001|Overall Study|Protocol Violation|1|||
130305027|NCT01320202|469079199|FG000|Overall Study|Withdrawal by Subject|10|||
130305028|NCT01320202|469079200|FG001|Overall Study|Withdrawal by Subject|3|||
130305029|NCT01320202|469079199|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
130305030|NCT01320202|469079200|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
130305031|NCT01320202|469079199|FG000|Overall Study|kidney transplant|1|||
130305032|NCT01320202|469079200|FG001|Overall Study|kidney transplant|2|||
130305033|NCT01320202|469079199|FG000|Overall Study|blood transfusion|1|||
130305034|NCT01320202|469079200|FG001|Overall Study|blood transfusion|7|||
130305035|NCT01320202|469079199|FG000|Overall Study|moved/changed dialysis|5|||
130305036|NCT01320202|469079200|FG001|Overall Study|moved/changed dialysis|2|||
130305037|NCT01320202|469079199|FG000|Overall Study|sponsor request|2|||
130305038|NCT01320202|469079200|FG001|Overall Study|sponsor request|0|||
130305039|NCT01320202|469079199|FG000|Overall Study|ineligible|3|||
130305040|NCT01320202|469079200|FG001|Overall Study|ineligible|0|||
130305041|NCT01320202|469079199|FG000|Overall Study|regained renal function|1|||
130305042|NCT01320202|469079200|FG001|Overall Study|regained renal function|0|||
130305043|NCT00635882|469079201|FG000|Overall Study|Protocol Violation|1|||
130305044|NCT00635882|469079202|FG001|Overall Study|Protocol Violation|0|||
130305045|NCT00635882|469079203|FG002|Overall Study|Protocol Violation|0|||
130305046|NCT00635882|469079204|FG003|Overall Study|Protocol Violation|0|||
130305047|NCT00635882|469079205|FG004|Overall Study|Protocol Violation|0|||
130305048|NCT00635882|469079206|FG005|Overall Study|Protocol Violation|0|||
130305049|NCT00825812|469079207|FG000|Overall Study|Never entered follow up|0|||
130305050|NCT00825812|469079208|FG001|Overall Study|Never entered follow up|0|||
130305051|NCT00825812|469079209|FG002|Overall Study|Never entered follow up|0|||
130305052|NCT00825812|469079210|FG003|Overall Study|Never entered follow up|1|||
130305053|NCT00825812|469079207|FG000|Overall Study|Adverse Event|0|||
130305054|NCT00825812|469079208|FG001|Overall Study|Adverse Event|0|||
130305055|NCT00825812|469079209|FG002|Overall Study|Adverse Event|0|||
130305056|NCT00825812|469079210|FG003|Overall Study|Adverse Event|1|||
130305057|NCT00825812|469079207|FG000|Overall Study|Subject withdrew consent|0|||
130305058|NCT00825812|469079208|FG001|Overall Study|Subject withdrew consent|0|||
130305059|NCT00825812|469079209|FG002|Overall Study|Subject withdrew consent|3|||
130305060|NCT00825812|469079210|FG003|Overall Study|Subject withdrew consent|2|||
130305061|NCT00825812|469079207|FG000|Overall Study|Non-compliance with protocol|0|||
130305062|NCT00825812|469079208|FG001|Overall Study|Non-compliance with protocol|0|||
130305063|NCT00825812|469079209|FG002|Overall Study|Non-compliance with protocol|0|||
130305064|NCT00825812|469079210|FG003|Overall Study|Non-compliance with protocol|1|||
130305065|NCT00825812|469079207|FG000|Overall Study|Administrative|0|||
130305066|NCT00825812|469079208|FG001|Overall Study|Administrative|1|||
130305067|NCT00825812|469079209|FG002|Overall Study|Administrative|3|||
130305068|NCT00825812|469079210|FG003|Overall Study|Administrative|5|||
130305069|NCT01278797|469079213|FG000|Period 1|Adverse Event|0|||
130305070|NCT01278797|469079214|FG001|Period 1|Adverse Event|1|||
130305071|NCT01278797|469079213|FG000|Period 1|Protocol Violation|1|||
130305072|NCT01278797|469079214|FG001|Period 1|Protocol Violation|0|||
130305073|NCT03343626|469081599|FG000|Overall Study|Lost to Follow-up|4|||
130305074|NCT03343626|469081600|FG001|Overall Study|Lost to Follow-up|3|||
130305075|NCT03343626|469081601|FG002|Overall Study|Lost to Follow-up|2|||
130305076|NCT03343626|469081602|FG003|Overall Study|Lost to Follow-up|5|||
130305077|NCT03343626|469081603|FG004|Overall Study|Lost to Follow-up|4|||
130305078|NCT03343626|469081604|FG005|Overall Study|Lost to Follow-up|4|||
130305079|NCT03343626|469081605|FG006|Overall Study|Lost to Follow-up|4|||
130305080|NCT03343626|469081606|FG007|Overall Study|Lost to Follow-up|7|||
130305081|NCT03343626|469081599|FG000|Overall Study|Withdrawal of Consent|2|||
130305082|NCT03343626|469081600|FG001|Overall Study|Withdrawal of Consent|1|||
130305083|NCT03343626|469081601|FG002|Overall Study|Withdrawal of Consent|0|||
130305084|NCT03343626|469081602|FG003|Overall Study|Withdrawal of Consent|3|||
130305085|NCT03343626|469081603|FG004|Overall Study|Withdrawal of Consent|3|||
130305086|NCT03343626|469081604|FG005|Overall Study|Withdrawal of Consent|1|||
130305087|NCT03343626|469081605|FG006|Overall Study|Withdrawal of Consent|1|||
130305088|NCT03343626|469081606|FG007|Overall Study|Withdrawal of Consent|2|||
130305089|NCT03343626|469081599|FG000|Overall Study|Reason not Specified|0|||
130305090|NCT03343626|469081600|FG001|Overall Study|Reason not Specified|1|||
130305091|NCT03343626|469081601|FG002|Overall Study|Reason not Specified|0|||
130305092|NCT03343626|469081602|FG003|Overall Study|Reason not Specified|0|||
130305093|NCT03343626|469081603|FG004|Overall Study|Reason not Specified|0|||
130305094|NCT03343626|469081604|FG005|Overall Study|Reason not Specified|0|||
130305095|NCT03343626|469081605|FG006|Overall Study|Reason not Specified|0|||
130305096|NCT03343626|469081606|FG007|Overall Study|Reason not Specified|1|||
130305097|NCT03343626|469081599|FG000|Overall Study|Data Entry Error|0|||
130305098|NCT03343626|469081600|FG001|Overall Study|Data Entry Error|0|||
130305099|NCT03343626|469081601|FG002|Overall Study|Data Entry Error|0|||
130305100|NCT03343626|469081602|FG003|Overall Study|Data Entry Error|0|||
130305101|NCT03343626|469081603|FG004|Overall Study|Data Entry Error|0|||
130305102|NCT03343626|469081604|FG005|Overall Study|Data Entry Error|0|||
130305103|NCT03343626|469081605|FG006|Overall Study|Data Entry Error|0|||
130305104|NCT03343626|469081606|FG007|Overall Study|Data Entry Error|1|||
130305105|NCT02475278|469081609|FG000|Overall Study|Lost to Follow-up|1|||
130305106|NCT02475278|469081609|FG000|Overall Study|Reason Not Specified|1|||
130305107|NCT01865448|469081610|FG000|Overall Study|Adverse Event|1|||
130305108|NCT01865448|469081611|FG001|Overall Study|Adverse Event|1|||
130305109|NCT01865448|469081610|FG000|Overall Study|Pregnancy|0|||
130305110|NCT01865448|469081611|FG001|Overall Study|Pregnancy|1|||
130305111|NCT01865448|469081610|FG000|Overall Study|dropout unrelated to study|1|||
130305112|NCT01865448|469081611|FG001|Overall Study|dropout unrelated to study|1|||
130305113|NCT05111249|469081615|FG000|Overall Study|Lost to Follow-up|0|||
130305114|NCT05111249|469081616|FG001|Overall Study|Lost to Follow-up|2|||
130305115|NCT05111249|469081615|FG000|Overall Study|Physician Decision|0|||
130305116|NCT05111249|469081616|FG001|Overall Study|Physician Decision|1|||
130305117|NCT05111249|469081615|FG000|Overall Study|Participant decision|1|||
130305118|NCT05111249|469081616|FG001|Overall Study|Participant decision|5|||
130305119|NCT05128578|469081617|FG000|Overall Study|Withdrawal by Subject|9|||
130305120|NCT05128578|469081617|FG000|Overall Study|Lost to Follow-up|5|||
130305121|NCT00872599|469081620|FG000|Second Washout Period|Adverse Event|1|||
130305122|NCT00872599|469081621|FG001|Second Washout Period|Adverse Event|1|||
130305123|NCT00801229|469081624|FG000|Signed Consent|Withdrawal by Subject|2|||
130305124|NCT00801229|469081625|FG001|Signed Consent|Withdrawal by Subject|2|||
130305125|NCT00801229|469081624|FG000|Signed Consent|Found Ineligible|1|||
130305126|NCT00801229|469081625|FG001|Signed Consent|Found Ineligible|1|||
130305127|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
130305128|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
130305129|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
130305130|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
130305131|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
130305132|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
130305133|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
130305134|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
130305135|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
130305136|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
130305137|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Adverse Event|1|||
130305138|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Adverse Event|1|||
130305139|NCT02610777|469081626|FG000|Overall Study|Lost to Follow-up|1|||
130305140|NCT02610777|469081627|FG001|Overall Study|Lost to Follow-up|0|||
130305141|NCT02610777|469081626|FG000|Overall Study|Site Terminated by Sponsor|9|||
130305142|NCT02610777|469081627|FG001|Overall Study|Site Terminated by Sponsor|8|||
130305143|NCT02610777|469081626|FG000|Overall Study|Withdrawal by Subject|2|||
130305144|NCT02610777|469081627|FG001|Overall Study|Withdrawal by Subject|2|||
130305145|NCT02610777|469081626|FG000|Overall Study|Reason not Specified|0|||
130305146|NCT02610777|469081627|FG001|Overall Study|Reason not Specified|1|||
130305147|NCT02610777|469081626|FG000|Overall Study|Death|50|||
130305148|NCT02610777|469081627|FG001|Overall Study|Death|47|||
130305149|NCT02300259|469081630|FG000|Period 1|Adverse Event|0|||
130305150|NCT02300259|469081631|FG001|Period 1|Adverse Event|0|||
130305151|NCT02300259|469081632|FG002|Period 1|Adverse Event|1|||
130305152|NCT02300259|469081630|FG000|Period 1|Withdrawal by Subject|0|||
130305153|NCT02300259|469081631|FG001|Period 1|Withdrawal by Subject|0|||
130305154|NCT02300259|469081632|FG002|Period 1|Withdrawal by Subject|1|||
130305155|NCT02300259|469081630|FG000|Period 2|Adverse Event|1|||
130305156|NCT02300259|469081631|FG001|Period 2|Adverse Event|0|||
130305157|NCT02300259|469081632|FG002|Period 2|Adverse Event|0|||
130305158|NCT02300259|469081630|FG000|Period 2|Withdrawal by Subject|0|||
130305159|NCT02300259|469081631|FG001|Period 2|Withdrawal by Subject|0|||
130305160|NCT02300259|469081632|FG002|Period 2|Withdrawal by Subject|1|||
130305161|NCT02737475|469081633|FG000|Overall Study|Other reasons|0|||
130305162|NCT02737475|469081634|FG001|Overall Study|Other reasons|0|||
130305163|NCT02737475|469081635|FG002|Overall Study|Other reasons|0|||
130305164|NCT02737475|469081636|FG003|Overall Study|Other reasons|0|||
130305165|NCT02737475|469081637|FG004|Overall Study|Other reasons|1|||
130305166|NCT02737475|469081638|FG005|Overall Study|Other reasons|1|||
130305167|NCT02737475|469081639|FG006|Overall Study|Other reasons|0|||
130305168|NCT02737475|469081640|FG007|Overall Study|Other reasons|0|||
130305169|NCT02737475|469081641|FG008|Overall Study|Other reasons|1|||
130305170|NCT02737475|469081642|FG009|Overall Study|Other reasons|0|||
130305171|NCT02737475|469081643|FG010|Overall Study|Other reasons|1|||
130305172|NCT02737475|469081644|FG011|Overall Study|Other reasons|0|||
130305173|NCT02737475|469081645|FG012|Overall Study|Other reasons|0|||
130305174|NCT02737475|469081646|FG013|Overall Study|Other reasons|0|||
130305175|NCT02737475|469081647|FG014|Overall Study|Other reasons|0|||
130305176|NCT02737475|469081648|FG015|Overall Study|Other reasons|0|||
130305177|NCT02737475|469081649|FG016|Overall Study|Other reasons|0|||
130373858|NCT05147350|469336819|FG001|Overall Study|Withdrawal by Subject|0|||
130305178|NCT02737475|469081650|FG017|Overall Study|Other reasons|0|||
130305179|NCT02737475|469081651|FG018|Overall Study|Other reasons|0|||
130305180|NCT02737475|469081652|FG019|Overall Study|Other reasons|0|||
130305181|NCT02737475|469081653|FG020|Overall Study|Other reasons|0|||
130305182|NCT02737475|469081654|FG021|Overall Study|Other reasons|1|||
130305183|NCT02737475|469081655|FG022|Overall Study|Other reasons|0|||
130305184|NCT02737475|469081656|FG023|Overall Study|Other reasons|1|||
130305185|NCT02737475|469081657|FG024|Overall Study|Other reasons|1|||
130305186|NCT02737475|469081658|FG025|Overall Study|Other reasons|1|||
130305187|NCT02737475|469081659|FG026|Overall Study|Other reasons|0|||
130305188|NCT02737475|469081633|FG000|Overall Study|Death|1|||
130305189|NCT02737475|469081634|FG001|Overall Study|Death|0|||
130305190|NCT02737475|469081635|FG002|Overall Study|Death|0|||
130305191|NCT02737475|469081636|FG003|Overall Study|Death|1|||
130305192|NCT02737475|469081637|FG004|Overall Study|Death|0|||
130305193|NCT02737475|469081638|FG005|Overall Study|Death|0|||
130305194|NCT02737475|469081639|FG006|Overall Study|Death|0|||
130305195|NCT02737475|469081640|FG007|Overall Study|Death|2|||
130305196|NCT02737475|469081641|FG008|Overall Study|Death|0|||
130305197|NCT02737475|469081642|FG009|Overall Study|Death|0|||
130305198|NCT02737475|469081643|FG010|Overall Study|Death|0|||
130305199|NCT02737475|469081644|FG011|Overall Study|Death|4|||
130305200|NCT02737475|469081645|FG012|Overall Study|Death|2|||
130305201|NCT02737475|469081646|FG013|Overall Study|Death|2|||
130305202|NCT02737475|469081647|FG014|Overall Study|Death|0|||
130305203|NCT02737475|469081648|FG015|Overall Study|Death|2|||
130305204|NCT02737475|469081649|FG016|Overall Study|Death|2|||
130305205|NCT02737475|469081650|FG017|Overall Study|Death|2|||
130305206|NCT02737475|469081651|FG018|Overall Study|Death|1|||
130305207|NCT02737475|469081652|FG019|Overall Study|Death|0|||
130305208|NCT02737475|469081653|FG020|Overall Study|Death|0|||
130305209|NCT02737475|469081654|FG021|Overall Study|Death|0|||
130305210|NCT02737475|469081655|FG022|Overall Study|Death|0|||
130305211|NCT02737475|469081656|FG023|Overall Study|Death|0|||
130305212|NCT02737475|469081657|FG024|Overall Study|Death|0|||
130305213|NCT02737475|469081658|FG025|Overall Study|Death|0|||
130305214|NCT02737475|469081659|FG026|Overall Study|Death|0|||
130305215|NCT02737475|469081633|FG000|Overall Study|Participant withdrew consent|0|||
130305216|NCT02737475|469081634|FG001|Overall Study|Participant withdrew consent|0|||
130305217|NCT02737475|469081635|FG002|Overall Study|Participant withdrew consent|0|||
130305218|NCT02737475|469081636|FG003|Overall Study|Participant withdrew consent|0|||
130305219|NCT02737475|469081637|FG004|Overall Study|Participant withdrew consent|0|||
130305220|NCT02737475|469081638|FG005|Overall Study|Participant withdrew consent|2|||
130305221|NCT02737475|469081639|FG006|Overall Study|Participant withdrew consent|0|||
130305222|NCT02737475|469081640|FG007|Overall Study|Participant withdrew consent|0|||
130305223|NCT02737475|469081641|FG008|Overall Study|Participant withdrew consent|0|||
130305224|NCT02737475|469081642|FG009|Overall Study|Participant withdrew consent|0|||
130305225|NCT02737475|469081643|FG010|Overall Study|Participant withdrew consent|0|||
130305226|NCT02737475|469081644|FG011|Overall Study|Participant withdrew consent|0|||
130305227|NCT02737475|469081645|FG012|Overall Study|Participant withdrew consent|0|||
130305228|NCT02737475|469081646|FG013|Overall Study|Participant withdrew consent|0|||
130305229|NCT02737475|469081647|FG014|Overall Study|Participant withdrew consent|1|||
130305230|NCT02737475|469081648|FG015|Overall Study|Participant withdrew consent|0|||
130305231|NCT02737475|469081649|FG016|Overall Study|Participant withdrew consent|0|||
130305232|NCT02737475|469081650|FG017|Overall Study|Participant withdrew consent|2|||
130305233|NCT02737475|469081651|FG018|Overall Study|Participant withdrew consent|1|||
130305234|NCT02737475|469081652|FG019|Overall Study|Participant withdrew consent|0|||
130305235|NCT02737475|469081653|FG020|Overall Study|Participant withdrew consent|2|||
130305236|NCT02737475|469081654|FG021|Overall Study|Participant withdrew consent|0|||
130305237|NCT02737475|469081655|FG022|Overall Study|Participant withdrew consent|0|||
130305238|NCT02737475|469081656|FG023|Overall Study|Participant withdrew consent|0|||
130305239|NCT02737475|469081657|FG024|Overall Study|Participant withdrew consent|0|||
130716856|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716857|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305240|NCT02737475|469081658|FG025|Overall Study|Participant withdrew consent|0|||
130305241|NCT02737475|469081659|FG026|Overall Study|Participant withdrew consent|0|||
130305242|NCT02737475|469081633|FG000|Overall Study|Lost to Follow-up|0|||
130305243|NCT02737475|469081634|FG001|Overall Study|Lost to Follow-up|0|||
130716858|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716859|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305244|NCT02737475|469081635|FG002|Overall Study|Lost to Follow-up|0|||
130305245|NCT02737475|469081636|FG003|Overall Study|Lost to Follow-up|0|||
130305246|NCT02737475|469081637|FG004|Overall Study|Lost to Follow-up|0|||
130305247|NCT02737475|469081638|FG005|Overall Study|Lost to Follow-up|0|||
130305248|NCT02737475|469081639|FG006|Overall Study|Lost to Follow-up|0|||
130305249|NCT02737475|469081640|FG007|Overall Study|Lost to Follow-up|0|||
130305250|NCT02737475|469081641|FG008|Overall Study|Lost to Follow-up|0|||
130305251|NCT02737475|469081642|FG009|Overall Study|Lost to Follow-up|0|||
130305252|NCT02737475|469081643|FG010|Overall Study|Lost to Follow-up|0|||
130305253|NCT02737475|469081644|FG011|Overall Study|Lost to Follow-up|0|||
130305254|NCT02737475|469081645|FG012|Overall Study|Lost to Follow-up|0|||
130305255|NCT02737475|469081646|FG013|Overall Study|Lost to Follow-up|0|||
130305256|NCT02737475|469081647|FG014|Overall Study|Lost to Follow-up|0|||
130305257|NCT02737475|469081648|FG015|Overall Study|Lost to Follow-up|1|||
130305258|NCT02737475|469081649|FG016|Overall Study|Lost to Follow-up|0|||
130305259|NCT02737475|469081650|FG017|Overall Study|Lost to Follow-up|0|||
130305260|NCT02737475|469081651|FG018|Overall Study|Lost to Follow-up|0|||
130305261|NCT02737475|469081652|FG019|Overall Study|Lost to Follow-up|0|||
130305262|NCT02737475|469081653|FG020|Overall Study|Lost to Follow-up|0|||
130305263|NCT02737475|469081654|FG021|Overall Study|Lost to Follow-up|0|||
130557627|NCT04178967|470011817|FG001|Induction Period|Withdrawal by Subject|4|||
130305264|NCT02737475|469081655|FG022|Overall Study|Lost to Follow-up|0|||
130305265|NCT02737475|469081656|FG023|Overall Study|Lost to Follow-up|0|||
130305266|NCT02737475|469081657|FG024|Overall Study|Lost to Follow-up|0|||
130305267|NCT02737475|469081658|FG025|Overall Study|Lost to Follow-up|0|||
130305268|NCT02737475|469081659|FG026|Overall Study|Lost to Follow-up|0|||
130305269|NCT02737475|469081633|FG000|Overall Study|Disease Progression|0|||
130305270|NCT02737475|469081634|FG001|Overall Study|Disease Progression|0|||
130305271|NCT02737475|469081635|FG002|Overall Study|Disease Progression|0|||
130305272|NCT02737475|469081636|FG003|Overall Study|Disease Progression|0|||
130305273|NCT02737475|469081637|FG004|Overall Study|Disease Progression|0|||
130305274|NCT02737475|469081638|FG005|Overall Study|Disease Progression|0|||
130305275|NCT02737475|469081639|FG006|Overall Study|Disease Progression|0|||
130305276|NCT02737475|469081640|FG007|Overall Study|Disease Progression|0|||
130305277|NCT02737475|469081641|FG008|Overall Study|Disease Progression|0|||
130305278|NCT02737475|469081642|FG009|Overall Study|Disease Progression|0|||
130305279|NCT02737475|469081643|FG010|Overall Study|Disease Progression|0|||
130305280|NCT02737475|469081644|FG011|Overall Study|Disease Progression|0|||
130305281|NCT02737475|469081645|FG012|Overall Study|Disease Progression|0|||
130305282|NCT02737475|469081646|FG013|Overall Study|Disease Progression|0|||
130305283|NCT02737475|469081647|FG014|Overall Study|Disease Progression|0|||
130305284|NCT02737475|469081648|FG015|Overall Study|Disease Progression|0|||
130305285|NCT02737475|469081649|FG016|Overall Study|Disease Progression|0|||
130305286|NCT02737475|469081650|FG017|Overall Study|Disease Progression|0|||
130305287|NCT02737475|469081651|FG018|Overall Study|Disease Progression|0|||
130305288|NCT02737475|469081652|FG019|Overall Study|Disease Progression|0|||
130305289|NCT02737475|469081653|FG020|Overall Study|Disease Progression|0|||
130305290|NCT02737475|469081654|FG021|Overall Study|Disease Progression|0|||
130305291|NCT02737475|469081655|FG022|Overall Study|Disease Progression|0|||
130305292|NCT02737475|469081656|FG023|Overall Study|Disease Progression|0|||
130305293|NCT02737475|469081657|FG024|Overall Study|Disease Progression|0|||
130305294|NCT02737475|469081658|FG025|Overall Study|Disease Progression|0|||
130305295|NCT02737475|469081659|FG026|Overall Study|Disease Progression|1|||
130305296|NCT03688074|469081660|FG000|Overall Study|Adverse Event|0|||
130305297|NCT03688074|469081661|FG001|Overall Study|Adverse Event|1|||
130305298|NCT03688074|469081660|FG000|Overall Study|Other|1|||
130305299|NCT03688074|469081661|FG001|Overall Study|Other|0|||
130305300|NCT00660179|469081662|FG000|Overall Study|Death|44|||
130305301|NCT00660179|469081663|FG001|Overall Study|Death|47|||
130305302|NCT00660179|469081664|FG002|Overall Study|Death|34|||
130305303|NCT00660179|469081662|FG000|Overall Study|Withdrawal of consent|4|||
130305304|NCT00660179|469081663|FG001|Overall Study|Withdrawal of consent|6|||
130305305|NCT00660179|469081664|FG002|Overall Study|Withdrawal of consent|4|||
130716860|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716861|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305306|NCT00660179|469081662|FG000|Overall Study|Lost to Follow-up|7|||
130305307|NCT00660179|469081663|FG001|Overall Study|Lost to Follow-up|5|||
130305308|NCT00660179|469081664|FG002|Overall Study|Lost to Follow-up|2|||
130305309|NCT00660179|469081662|FG000|Overall Study|Administrative reason|0|||
130305310|NCT00660179|469081663|FG001|Overall Study|Administrative reason|0|||
130305311|NCT00660179|469081664|FG002|Overall Study|Administrative reason|1|||
130305312|NCT00660179|469081662|FG000|Overall Study|Incorrect randomization|1|||
130305313|NCT00660179|469081663|FG001|Overall Study|Incorrect randomization|0|||
130305314|NCT00660179|469081664|FG002|Overall Study|Incorrect randomization|0|||
130305315|NCT02255461|469081665|FG000|Overall Study|Adverse Event|0|||
130557628|NCT04178967|470011818|FG002|Induction Period|Withdrawal by Subject|0|||
130716862|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305316|NCT02255461|469081666|FG001|Overall Study|Adverse Event|1|||
130305317|NCT02255461|469081667|FG002|Overall Study|Adverse Event|0|||
130305318|NCT02255461|469081668|FG003|Overall Study|Adverse Event|0|||
130305319|NCT02255461|469081669|FG004|Overall Study|Adverse Event|1|||
130305320|NCT02255461|469081665|FG000|Overall Study|Withdrawal by Subject|0|||
130305321|NCT02255461|469081666|FG001|Overall Study|Withdrawal by Subject|0|||
130305322|NCT02255461|469081667|FG002|Overall Study|Withdrawal by Subject|1|||
130305323|NCT02255461|469081668|FG003|Overall Study|Withdrawal by Subject|0|||
130305324|NCT02255461|469081669|FG004|Overall Study|Withdrawal by Subject|1|||
130376677|NCT03824912|469345899|FG000|Overall Study|Lost to Follow-up|18|||
130557629|NCT04178967|470011819|FG003|Induction Period|Withdrawal by Subject|0|||
130305325|NCT02255461|469081665|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
130305326|NCT02255461|469081666|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
130305327|NCT02255461|469081667|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
130305328|NCT02255461|469081668|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
130305329|NCT02255461|469081669|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
130305330|NCT03056339|469081674|FG000|Overall Study|Failed Requirements|0|||
130305331|NCT03056339|469081675|FG001|Overall Study|Failed Requirements|2|||
130305332|NCT03056339|469081676|FG002|Overall Study|Failed Requirements|7|||
130305333|NCT03056339|469081677|FG003|Overall Study|Failed Requirements|1|||
130305334|NCT01128244|469081682|FG000|Overall Study|Adverse Event|1|||
130305335|NCT01128244|469081682|FG000|Overall Study|Scheduling conflict|2|||
130305336|NCT04171219|469081685|FG000|Overall Study|Adverse Event|1|||
130305337|NCT04171219|469081686|FG001|Overall Study|Adverse Event|0|||
130305338|NCT04171219|469081685|FG000|Overall Study|Death|0|||
130305339|NCT04171219|469081686|FG001|Overall Study|Death|1|||
130305340|NCT04171219|469081685|FG000|Overall Study|Lack of Efficacy|9|||
130305341|NCT04171219|469081686|FG001|Overall Study|Lack of Efficacy|13|||
130305342|NCT04171219|469081685|FG000|Overall Study|Withdrawal by Subject|1|||
130305343|NCT04171219|469081686|FG001|Overall Study|Withdrawal by Subject|2|||
130305344|NCT04171219|469081685|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130305345|NCT04171219|469081686|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130305346|NCT04171219|469081685|FG000|Overall Study|Clinical PD/Patient choice|1|||
130305347|NCT04171219|469081686|FG001|Overall Study|Clinical PD/Patient choice|0|||
130305348|NCT04171219|469081685|FG000|Overall Study|Toxicity/ Patient choice|1|||
130305349|NCT04171219|469081686|FG001|Overall Study|Toxicity/ Patient choice|0|||
130305350|NCT04809285|469081687|FG000|Phase 1|Lost to Follow-up|6|||
130305351|NCT04809285|469081687|FG000|Phase 1|Protocol Violation|2|||
130305352|NCT04809285|469081687|FG000|Phase 1|Physician Decision|3|||
130305353|NCT04809285|469081687|FG000|Phase 1|Withdrawal by Subject|29|||
130305354|NCT04809285|469081687|FG000|Phase 2|Protocol Violation|3|||
130305355|NCT04809285|469081687|FG000|Phase 2|Withdrawal by Subject|4|||
130305356|NCT03040674|469081691|FG000|Overall Study|Lost to Follow-up|225|||
130305357|NCT03040674|469081691|FG000|Overall Study|Death|23|||
130305358|NCT02206035|469081692|FG000|Overall Study|Physician Decision|10|||
130305359|NCT02206035|469081693|FG001|Overall Study|Physician Decision|0|||
130305360|NCT02206035|469081694|FG002|Overall Study|Physician Decision|175|||
130305361|NCT01934010|469081695|FG000|Overall Study|Adverse Event|1|||
130305362|NCT01934010|469081696|FG001|Overall Study|Adverse Event|1|||
130305363|NCT01934010|469081697|FG002|Overall Study|Adverse Event|0|||
130305364|NCT01934010|469081695|FG000|Overall Study|Withdrawal by Subject|15|||
130305365|NCT01934010|469081696|FG001|Overall Study|Withdrawal by Subject|6|||
130305366|NCT01934010|469081697|FG002|Overall Study|Withdrawal by Subject|2|||
130305367|NCT01934010|469081695|FG000|Overall Study|Lost to Follow-up|7|||
130305368|NCT01934010|469081696|FG001|Overall Study|Lost to Follow-up|4|||
130305369|NCT01934010|469081697|FG002|Overall Study|Lost to Follow-up|0|||
130305370|NCT04303572|469081698|FG000|Overall Study|Study closed due to poor enrollment|1|||
130305371|NCT04929249|469081699|FG000|Overall Study|Adverse Event|2|||
130305372|NCT04929249|469081700|FG001|Overall Study|Adverse Event|1|||
130305373|NCT04929249|469081699|FG000|Overall Study|Death|2|||
130305374|NCT04929249|469081700|FG001|Overall Study|Death|1|||
130305375|NCT04929249|469081699|FG000|Overall Study|Lost to Follow-up|3|||
130305376|NCT04929249|469081700|FG001|Overall Study|Lost to Follow-up|11|||
130305377|NCT04929249|469081699|FG000|Overall Study|Technical problems|0|||
130305378|NCT04929249|469081700|FG001|Overall Study|Technical problems|1|||
130305379|NCT04929249|469081699|FG000|Overall Study|Subject decision|6|||
130305380|NCT04929249|469081700|FG001|Overall Study|Subject decision|8|||
130305381|NCT04929249|469081699|FG000|Overall Study|Withdrew consent|0|||
130305382|NCT04929249|469081700|FG001|Overall Study|Withdrew consent|8|||
130305383|NCT00172042|469081712|FG000|Overall Study|Adverse Event|27|||
130305384|NCT00172042|469081713|FG001|Overall Study|Adverse Event|13|||
130305385|NCT00172042|469081712|FG000|Overall Study|Abnormal laboratory value(s)|5|||
130305386|NCT00172042|469081713|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130373859|NCT05147350|469336820|FG002|Overall Study|Withdrawal by Subject|3|||
130373860|NCT05147350|469336821|FG003|Overall Study|Withdrawal by Subject|1|||
130305387|NCT00172042|469081712|FG000|Overall Study|Abnormal test procedure(s)|0|||
130305388|NCT00172042|469081713|FG001|Overall Study|Abnormal test procedure(s)|3|||
130305389|NCT00172042|469081712|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130305390|NCT00172042|469081713|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130305391|NCT00172042|469081712|FG000|Overall Study|Patient no longer requires study drug|10|||
130305392|NCT00172042|469081713|FG001|Overall Study|Patient no longer requires study drug|8|||
130305393|NCT00172042|469081712|FG000|Overall Study|Protocol Violation|8|||
130373861|NCT05147350|469336822|FG004|Overall Study|Withdrawal by Subject|1|||
130305394|NCT00172042|469081713|FG001|Overall Study|Protocol Violation|7|||
130305395|NCT00172042|469081712|FG000|Overall Study|Withdrawal by Subject|37|||
130305396|NCT00172042|469081713|FG001|Overall Study|Withdrawal by Subject|25|||
130305397|NCT00172042|469081712|FG000|Overall Study|Lost to Follow-up|3|||
130305398|NCT00172042|469081713|FG001|Overall Study|Lost to Follow-up|5|||
130305399|NCT00172042|469081712|FG000|Overall Study|Administrative problems|13|||
130305400|NCT00172042|469081713|FG001|Overall Study|Administrative problems|10|||
130305401|NCT00172042|469081712|FG000|Overall Study|Death|42|||
130305402|NCT00172042|469081713|FG001|Overall Study|Death|42|||
130305403|NCT01771250|469081714|FG000|Period 1|Met exclusion criteria|1|||
130305404|NCT01771250|469081715|FG001|Period 1|Met exclusion criteria|0|||
130305405|NCT00483938|469081716|FG000|Overall Study|Protocol Violation|0|||
130305406|NCT00483938|469081717|FG001|Overall Study|Protocol Violation|0|||
130305407|NCT00483938|469081718|FG002|Overall Study|Protocol Violation|0|||
130305408|NCT00483938|469081719|FG003|Overall Study|Protocol Violation|0|||
130305409|NCT00483938|469081720|FG004|Overall Study|Protocol Violation|0|||
130305410|NCT00483938|469081721|FG005|Overall Study|Protocol Violation|0|||
130305411|NCT00483938|469081722|FG006|Overall Study|Protocol Violation|3|||
130305412|NCT00483938|469081716|FG000|Overall Study|Withdrawal by Subject|1|||
130305413|NCT00483938|469081717|FG001|Overall Study|Withdrawal by Subject|6|||
130305414|NCT00483938|469081718|FG002|Overall Study|Withdrawal by Subject|0|||
130305415|NCT00483938|469081719|FG003|Overall Study|Withdrawal by Subject|0|||
130305416|NCT00483938|469081720|FG004|Overall Study|Withdrawal by Subject|1|||
130305417|NCT00483938|469081721|FG005|Overall Study|Withdrawal by Subject|3|||
130305418|NCT00483938|469081722|FG006|Overall Study|Withdrawal by Subject|2|||
130305419|NCT00483938|469081716|FG000|Overall Study|Lost to Follow-up|1|||
130305420|NCT00483938|469081717|FG001|Overall Study|Lost to Follow-up|2|||
130305421|NCT00483938|469081718|FG002|Overall Study|Lost to Follow-up|0|||
130305422|NCT00483938|469081719|FG003|Overall Study|Lost to Follow-up|2|||
130305423|NCT00483938|469081720|FG004|Overall Study|Lost to Follow-up|1|||
130305424|NCT00483938|469081721|FG005|Overall Study|Lost to Follow-up|1|||
130305425|NCT00483938|469081722|FG006|Overall Study|Lost to Follow-up|3|||
130305426|NCT00483938|469081716|FG000|Overall Study|Death|0|||
130305427|NCT00483938|469081717|FG001|Overall Study|Death|2|||
130305428|NCT00483938|469081718|FG002|Overall Study|Death|0|||
130305429|NCT00483938|469081719|FG003|Overall Study|Death|0|||
130305430|NCT00483938|469081720|FG004|Overall Study|Death|0|||
130305431|NCT00483938|469081721|FG005|Overall Study|Death|0|||
130305432|NCT00483938|469081722|FG006|Overall Study|Death|0|||
130305433|NCT00483938|469081716|FG000|Overall Study|Other|3|||
130305434|NCT00483938|469081717|FG001|Overall Study|Other|9|||
130305435|NCT00483938|469081718|FG002|Overall Study|Other|0|||
130305436|NCT00483938|469081719|FG003|Overall Study|Other|4|||
130305437|NCT00483938|469081720|FG004|Overall Study|Other|0|||
130305438|NCT00483938|469081721|FG005|Overall Study|Other|4|||
130305439|NCT00483938|469081722|FG006|Overall Study|Other|32|||
130305440|NCT02218008|469081723|FG000|Stage 1 (S1)|Adverse Event|6|||
130305441|NCT02218008|469081724|FG001|Stage 1 (S1)|Adverse Event|5|||
130305442|NCT02218008|469081725|FG002|Stage 1 (S1)|Adverse Event|11|||
130305443|NCT02218008|469081726|FG003|Stage 1 (S1)|Adverse Event|0|||
130373862|NCT05147350|469336823|FG005|Overall Study|Withdrawal by Subject|0|||
130373863|NCT05147350|469336824|FG006|Overall Study|Withdrawal by Subject|1|||
130373864|NCT05147350|469336825|FG007|Overall Study|Withdrawal by Subject|0|||
130373865|NCT05147350|469336818|FG000|Overall Study|Other Reasons|0|||
130305444|NCT02218008|469081727|FG004|Stage 1 (S1)|Adverse Event|0|||
130305445|NCT02218008|469081728|FG005|Stage 1 (S1)|Adverse Event|0|||
130305446|NCT02218008|469081723|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
130305447|NCT02218008|469081724|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
130373866|NCT05147350|469336819|FG001|Overall Study|Other Reasons|0|||
130373867|NCT05147350|469336820|FG002|Overall Study|Other Reasons|2|||
130373868|NCT05147350|469336821|FG003|Overall Study|Other Reasons|0|||
130373869|NCT05147350|469336822|FG004|Overall Study|Other Reasons|0|||
130373870|NCT05147350|469336823|FG005|Overall Study|Other Reasons|2|||
130557630|NCT04178967|470011820|FG004|Induction Period|Withdrawal by Subject|0|||
130716863|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305448|NCT02218008|469081725|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
130373871|NCT05147350|469336824|FG006|Overall Study|Other Reasons|1|||
130373872|NCT05147350|469336825|FG007|Overall Study|Other Reasons|1|||
130305449|NCT02218008|469081726|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
130373873|NCT01539538|469336826|FG000|Overall Study|Adverse Event|13|||
130716864|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130305450|NCT02218008|469081727|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
130305451|NCT02218008|469081728|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
130373874|NCT01539538|469336827|FG001|Overall Study|Adverse Event|18|||
130373875|NCT01539538|469336826|FG000|Overall Study|Lack of Efficacy|13|||
130373876|NCT01539538|469336827|FG001|Overall Study|Lack of Efficacy|16|||
130305452|NCT02218008|469081723|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
130305453|NCT02218008|469081724|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
130305454|NCT02218008|469081725|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
130305455|NCT02218008|469081726|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
130305456|NCT02218008|469081727|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
130305457|NCT02218008|469081728|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
130305458|NCT02218008|469081723|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
130305459|NCT02218008|469081724|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
130305460|NCT02218008|469081725|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
130305461|NCT02218008|469081726|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
130305462|NCT02218008|469081727|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
130305463|NCT02218008|469081728|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
130305464|NCT02218008|469081723|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
130305465|NCT02218008|469081724|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
130305466|NCT02218008|469081725|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305467|NCT02218008|469081726|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305468|NCT02218008|469081727|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305469|NCT02218008|469081728|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305470|NCT02218008|469081723|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
130305471|NCT02218008|469081724|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
130305472|NCT02218008|469081725|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
130305473|NCT02218008|469081726|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
130305474|NCT02218008|469081727|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
130305475|NCT02218008|469081728|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
130305476|NCT02218008|469081723|FG000|Stage 1 (S1)|Pregnancy|0|||
130305477|NCT02218008|469081724|FG001|Stage 1 (S1)|Pregnancy|0|||
130305478|NCT02218008|469081725|FG002|Stage 1 (S1)|Pregnancy|1|||
130305479|NCT02218008|469081726|FG003|Stage 1 (S1)|Pregnancy|0|||
130305480|NCT02218008|469081727|FG004|Stage 1 (S1)|Pregnancy|0|||
130305481|NCT02218008|469081728|FG005|Stage 1 (S1)|Pregnancy|0|||
130373877|NCT01539538|469336826|FG000|Overall Study|Withdrawal by Subject|2|||
130305482|NCT02218008|469081723|FG000|Stage 1 (S1)|Protocol Violation|0|||
130305483|NCT02218008|469081724|FG001|Stage 1 (S1)|Protocol Violation|0|||
130305484|NCT02218008|469081725|FG002|Stage 1 (S1)|Protocol Violation|1|||
130373878|NCT01539538|469336827|FG001|Overall Study|Withdrawal by Subject|3|||
130373879|NCT01539538|469336826|FG000|Overall Study|PCA no longer required or PCA problem|3|||
130305485|NCT02218008|469081726|FG003|Stage 1 (S1)|Protocol Violation|0|||
130305486|NCT02218008|469081727|FG004|Stage 1 (S1)|Protocol Violation|0|||
130305487|NCT02218008|469081728|FG005|Stage 1 (S1)|Protocol Violation|0|||
130305488|NCT02218008|469081723|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
130305489|NCT02218008|469081724|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305490|NCT02218008|469081725|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305491|NCT02218008|469081726|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305492|NCT02218008|469081727|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305493|NCT02218008|469081728|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305494|NCT02218008|469081723|FG000|Stage 2 (S2)|Adverse Event|0|||
130305495|NCT02218008|469081724|FG001|Stage 2 (S2)|Adverse Event|0|||
130305496|NCT02218008|469081725|FG002|Stage 2 (S2)|Adverse Event|0|||
130305497|NCT02218008|469081726|FG003|Stage 2 (S2)|Adverse Event|2|||
130305498|NCT02218008|469081727|FG004|Stage 2 (S2)|Adverse Event|3|||
130305499|NCT02218008|469081728|FG005|Stage 2 (S2)|Adverse Event|3|||
130305500|NCT02218008|469081723|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
130305501|NCT02218008|469081724|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
130305502|NCT02218008|469081725|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
130305503|NCT02218008|469081726|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
130305504|NCT02218008|469081727|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
130305505|NCT02218008|469081728|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
130305506|NCT02218008|469081723|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
130305507|NCT02218008|469081724|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
130305508|NCT02218008|469081725|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
130305509|NCT02218008|469081726|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
130305510|NCT02218008|469081727|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
130305511|NCT02218008|469081728|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
130305512|NCT02218008|469081723|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305513|NCT02218008|469081724|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305514|NCT02218008|469081725|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305515|NCT02218008|469081726|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
130305516|NCT02218008|469081727|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305517|NCT02218008|469081728|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305518|NCT02218008|469081723|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
130305519|NCT02218008|469081724|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
130305520|NCT02218008|469081725|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
130305521|NCT02218008|469081726|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
130305522|NCT02218008|469081727|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
130305523|NCT02218008|469081728|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
130305524|NCT02038075|469081729|FG000|Overall Study|Withdrawal by Subject|3|||
130305525|NCT02038075|469081730|FG001|Overall Study|Withdrawal by Subject|0|||
130305526|NCT00106353|469081731|FG000|Part 1|Disease progression|3|||
130305527|NCT00106353|469081732|FG001|Part 1|Disease progression|4|||
130305528|NCT00106353|469081733|FG002|Part 1|Disease progression|1|||
130305529|NCT00106353|469081734|FG003|Part 1|Disease progression|3|||
130305530|NCT00106353|469081735|FG004|Part 1|Disease progression|0|||
130305531|NCT00106353|469081736|FG005|Part 1|Disease progression|0|||
130305532|NCT00106353|469081737|FG006|Part 1|Disease progression|0|||
130305533|NCT00106353|469081731|FG000|Part 1|Withdrawal by Subject|0|||
130373880|NCT01539538|469336827|FG001|Overall Study|PCA no longer required or PCA problem|7|||
130373881|NCT01192516|469336832|FG000|Overall Study|Lost to Follow-up|7|||
130373882|NCT01192516|469336833|FG001|Overall Study|Lost to Follow-up|10|||
130373883|NCT01192516|469336834|FG002|Overall Study|Lost to Follow-up|7|||
130716865|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
130716866|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
130716867|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
130373884|NCT01192516|469336832|FG000|Overall Study|Withdrawal by Subject|4|||
130716868|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
130305534|NCT00106353|469081732|FG001|Part 1|Withdrawal by Subject|0|||
130305535|NCT00106353|469081733|FG002|Part 1|Withdrawal by Subject|1|||
130305536|NCT00106353|469081734|FG003|Part 1|Withdrawal by Subject|2|||
130305537|NCT00106353|469081735|FG004|Part 1|Withdrawal by Subject|0|||
130305538|NCT00106353|469081736|FG005|Part 1|Withdrawal by Subject|0|||
130305539|NCT00106353|469081737|FG006|Part 1|Withdrawal by Subject|0|||
130305540|NCT00106353|469081731|FG000|Part 1|Symptomatic deterioration|0|||
130305541|NCT00106353|469081732|FG001|Part 1|Symptomatic deterioration|0|||
130305542|NCT00106353|469081733|FG002|Part 1|Symptomatic deterioration|1|||
130305543|NCT00106353|469081734|FG003|Part 1|Symptomatic deterioration|0|||
130305544|NCT00106353|469081735|FG004|Part 1|Symptomatic deterioration|0|||
130305545|NCT00106353|469081736|FG005|Part 1|Symptomatic deterioration|0|||
130305546|NCT00106353|469081737|FG006|Part 1|Symptomatic deterioration|0|||
130305547|NCT00106353|469081731|FG000|Part 1|Entered follow-up phase|1|||
130305548|NCT00106353|469081732|FG001|Part 1|Entered follow-up phase|1|||
130305549|NCT00106353|469081733|FG002|Part 1|Entered follow-up phase|0|||
130305550|NCT00106353|469081734|FG003|Part 1|Entered follow-up phase|1|||
130373885|NCT01192516|469336833|FG001|Overall Study|Withdrawal by Subject|4|||
130716869|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
130716870|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
130305551|NCT00106353|469081735|FG004|Part 1|Entered follow-up phase|0|||
130305552|NCT00106353|469081736|FG005|Part 1|Entered follow-up phase|0|||
130305553|NCT00106353|469081737|FG006|Part 1|Entered follow-up phase|0|||
130305554|NCT00106353|469081731|FG000|Part 1|Adverse Event|0|||
130305555|NCT00106353|469081732|FG001|Part 1|Adverse Event|0|||
130305556|NCT00106353|469081733|FG002|Part 1|Adverse Event|0|||
130305557|NCT00106353|469081734|FG003|Part 1|Adverse Event|1|||
130305558|NCT00106353|469081735|FG004|Part 1|Adverse Event|0|||
130305559|NCT00106353|469081736|FG005|Part 1|Adverse Event|0|||
130305560|NCT00106353|469081737|FG006|Part 1|Adverse Event|0|||
130305561|NCT00106353|469081731|FG000|Part 2|Disease progression|0|||
130305562|NCT00106353|469081732|FG001|Part 2|Disease progression|0|||
130305563|NCT00106353|469081733|FG002|Part 2|Disease progression|0|||
130305564|NCT00106353|469081734|FG003|Part 2|Disease progression|0|||
130305565|NCT00106353|469081735|FG004|Part 2|Disease progression|8|||
130305566|NCT00106353|469081736|FG005|Part 2|Disease progression|14|||
130305567|NCT00106353|469081737|FG006|Part 2|Disease progression|13|||
130305568|NCT00106353|469081731|FG000|Part 2|Death|0|||
130305569|NCT00106353|469081732|FG001|Part 2|Death|0|||
130305570|NCT00106353|469081733|FG002|Part 2|Death|0|||
130305571|NCT00106353|469081734|FG003|Part 2|Death|0|||
130305572|NCT00106353|469081735|FG004|Part 2|Death|3|||
130305573|NCT00106353|469081736|FG005|Part 2|Death|0|||
130305574|NCT00106353|469081737|FG006|Part 2|Death|1|||
130305575|NCT00106353|469081731|FG000|Part 2|Symptomatic deterioration|0|||
130305576|NCT00106353|469081732|FG001|Part 2|Symptomatic deterioration|0|||
130305577|NCT00106353|469081733|FG002|Part 2|Symptomatic deterioration|0|||
130305578|NCT00106353|469081734|FG003|Part 2|Symptomatic deterioration|0|||
130305579|NCT00106353|469081735|FG004|Part 2|Symptomatic deterioration|3|||
130305580|NCT00106353|469081736|FG005|Part 2|Symptomatic deterioration|0|||
130305581|NCT00106353|469081737|FG006|Part 2|Symptomatic deterioration|0|||
130305582|NCT00106353|469081731|FG000|Part 2|Adverse Event|0|||
130305583|NCT00106353|469081732|FG001|Part 2|Adverse Event|0|||
130305584|NCT00106353|469081733|FG002|Part 2|Adverse Event|0|||
130305585|NCT00106353|469081734|FG003|Part 2|Adverse Event|0|||
130305586|NCT00106353|469081735|FG004|Part 2|Adverse Event|0|||
130305587|NCT00106353|469081736|FG005|Part 2|Adverse Event|2|||
130305588|NCT00106353|469081737|FG006|Part 2|Adverse Event|1|||
130305589|NCT00106353|469081731|FG000|Part 2|Other|0|||
130305590|NCT00106353|469081732|FG001|Part 2|Other|0|||
130305591|NCT00106353|469081733|FG002|Part 2|Other|0|||
130305592|NCT00106353|469081734|FG003|Part 2|Other|0|||
130305593|NCT00106353|469081735|FG004|Part 2|Other|1|||
130305594|NCT00106353|469081736|FG005|Part 2|Other|1|||
130305595|NCT00106353|469081737|FG006|Part 2|Other|1|||
130305596|NCT00106353|469081731|FG000|Part 2|Withdrawal by Subject|0|||
130305597|NCT00106353|469081732|FG001|Part 2|Withdrawal by Subject|0|||
130305598|NCT00106353|469081733|FG002|Part 2|Withdrawal by Subject|0|||
130305599|NCT00106353|469081734|FG003|Part 2|Withdrawal by Subject|0|||
130305600|NCT00106353|469081735|FG004|Part 2|Withdrawal by Subject|1|||
130305601|NCT00106353|469081736|FG005|Part 2|Withdrawal by Subject|0|||
130305602|NCT00106353|469081737|FG006|Part 2|Withdrawal by Subject|0|||
130305603|NCT00106353|469081731|FG000|Part 2|Physician Decision|0|||
130305604|NCT00106353|469081732|FG001|Part 2|Physician Decision|0|||
130305605|NCT00106353|469081733|FG002|Part 2|Physician Decision|0|||
130305606|NCT00106353|469081734|FG003|Part 2|Physician Decision|0|||
130305607|NCT00106353|469081735|FG004|Part 2|Physician Decision|0|||
130305608|NCT00106353|469081736|FG005|Part 2|Physician Decision|1|||
130305609|NCT00106353|469081737|FG006|Part 2|Physician Decision|0|||
130305610|NCT03477838|469081741|FG000|Overall Study|Lost to Follow-up|14|||
130373886|NCT01192516|469336834|FG002|Overall Study|Withdrawal by Subject|1|||
130373887|NCT01192516|469336832|FG000|Overall Study|started new treatment|5|||
130373888|NCT01192516|469336833|FG001|Overall Study|started new treatment|1|||
130557631|NCT04178967|470011821|FG005|Induction Period|Withdrawal by Subject|0|||
130716871|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
130305611|NCT02519595|469081742|FG000|Overall Study|Protocol Violation|8|||
130305612|NCT02519595|469081743|FG001|Overall Study|Protocol Violation|22|||
130305613|NCT02519595|469081744|FG002|Overall Study|Protocol Violation|16|||
130305614|NCT00850538|469081747|FG000|Overall Study|unable/unwilling to complete MRI|13|||
130305615|NCT00850538|469081747|FG000|Overall Study|specimen missed due to scheduling error|14|||
130305616|NCT00850538|469081747|FG000|Overall Study|specimen unusable|7|||
130305617|NCT00850538|469081747|FG000|Overall Study|Withdrawal by Subject|3|||
130305618|NCT00850538|469081747|FG000|Overall Study|radiology error|2|||
130305619|NCT00850538|469081747|FG000|Overall Study|Protocol Violation|2|||
130305620|NCT03188510|469081748|FG000|Overall Study|Inappropriate behavior with site staff|0|||
130305621|NCT03188510|469081749|FG001|Overall Study|Inappropriate behavior with site staff|1|||
130305622|NCT03188510|469081750|FG002|Overall Study|Inappropriate behavior with site staff|0|||
130305623|NCT03052049|469081757|FG000|Overall Study|Withdrawal by Subject|2|||
130305624|NCT00999518|469081761|FG000|Overall Study|Adverse Event|1|||
130305625|NCT00999518|469081762|FG001|Overall Study|Adverse Event|6|||
130305626|NCT00999518|469081763|FG002|Overall Study|Adverse Event|3|||
130305627|NCT00999518|469081764|FG003|Overall Study|Adverse Event|1|||
130373889|NCT01192516|469336834|FG002|Overall Study|started new treatment|0|||
130305628|NCT00999518|469081765|FG004|Overall Study|Adverse Event|2|||
130305629|NCT00999518|469081761|FG000|Overall Study|Lack of Efficacy|2|||
130305630|NCT00999518|469081762|FG001|Overall Study|Lack of Efficacy|0|||
130305631|NCT00999518|469081763|FG002|Overall Study|Lack of Efficacy|0|||
130305632|NCT00999518|469081764|FG003|Overall Study|Lack of Efficacy|2|||
130305633|NCT00999518|469081765|FG004|Overall Study|Lack of Efficacy|2|||
130305634|NCT00999518|469081761|FG000|Overall Study|Lost to Follow-up|0|||
130305635|NCT00999518|469081762|FG001|Overall Study|Lost to Follow-up|0|||
130305636|NCT00999518|469081763|FG002|Overall Study|Lost to Follow-up|0|||
130305637|NCT00999518|469081764|FG003|Overall Study|Lost to Follow-up|4|||
130305638|NCT00999518|469081765|FG004|Overall Study|Lost to Follow-up|1|||
130305639|NCT00999518|469081761|FG000|Overall Study|Did not meet entrance criteria|0|||
130305640|NCT00999518|469081762|FG001|Overall Study|Did not meet entrance criteria|0|||
130305641|NCT00999518|469081763|FG002|Overall Study|Did not meet entrance criteria|0|||
130305642|NCT00999518|469081764|FG003|Overall Study|Did not meet entrance criteria|0|||
130305643|NCT00999518|469081765|FG004|Overall Study|Did not meet entrance criteria|1|||
130305644|NCT00999518|469081761|FG000|Overall Study|Study terminated by sponsor|10|||
130305645|NCT00999518|469081762|FG001|Overall Study|Study terminated by sponsor|6|||
130305646|NCT00999518|469081763|FG002|Overall Study|Study terminated by sponsor|5|||
130305647|NCT00999518|469081764|FG003|Overall Study|Study terminated by sponsor|5|||
130305648|NCT00999518|469081765|FG004|Overall Study|Study terminated by sponsor|9|||
130305649|NCT00999518|469081761|FG000|Overall Study|Pregnancy|0|||
130305650|NCT00999518|469081762|FG001|Overall Study|Pregnancy|0|||
130305651|NCT00999518|469081763|FG002|Overall Study|Pregnancy|1|||
130305652|NCT00999518|469081764|FG003|Overall Study|Pregnancy|0|||
130305653|NCT00999518|469081765|FG004|Overall Study|Pregnancy|0|||
130305654|NCT00999518|469081761|FG000|Overall Study|Protocol Violation|0|||
130305655|NCT00999518|469081762|FG001|Overall Study|Protocol Violation|1|||
130305656|NCT00999518|469081763|FG002|Overall Study|Protocol Violation|0|||
130305657|NCT00999518|469081764|FG003|Overall Study|Protocol Violation|0|||
130305658|NCT00999518|469081765|FG004|Overall Study|Protocol Violation|2|||
130305659|NCT00999518|469081761|FG000|Overall Study|Withdrawal by Subject|5|||
130305660|NCT00999518|469081762|FG001|Overall Study|Withdrawal by Subject|4|||
130305661|NCT00999518|469081763|FG002|Overall Study|Withdrawal by Subject|10|||
130305662|NCT00999518|469081764|FG003|Overall Study|Withdrawal by Subject|6|||
130305663|NCT00999518|469081765|FG004|Overall Study|Withdrawal by Subject|1|||
130305664|NCT00999518|469081761|FG000|Overall Study|Other|5|||
130305665|NCT00999518|469081762|FG001|Overall Study|Other|7|||
130305666|NCT00999518|469081763|FG002|Overall Study|Other|1|||
130305667|NCT00999518|469081764|FG003|Overall Study|Other|4|||
130305668|NCT00999518|469081765|FG004|Overall Study|Other|5|||
130305669|NCT00999518|469081761|FG000|Overall Study|Randomized but not Treated|1|||
130305670|NCT00999518|469081762|FG001|Overall Study|Randomized but not Treated|1|||
130305671|NCT00999518|469081763|FG002|Overall Study|Randomized but not Treated|2|||
130305672|NCT00999518|469081764|FG003|Overall Study|Randomized but not Treated|0|||
130305673|NCT00999518|469081765|FG004|Overall Study|Randomized but not Treated|1|||
130305674|NCT01088399|469081766|FG000|Overall Study|Adverse Event|211|||
130305675|NCT01088399|469081767|FG001|Overall Study|Adverse Event|16|||
130305676|NCT01088399|469081768|FG002|Overall Study|Adverse Event|0|||
130305677|NCT01088399|469081766|FG000|Overall Study|Death|204|||
130305678|NCT01088399|469081767|FG001|Overall Study|Death|45|||
130305679|NCT01088399|469081768|FG002|Overall Study|Death|0|||
130305680|NCT01088399|469081766|FG000|Overall Study|Lack of Efficacy|298|||
130305681|NCT01088399|469081767|FG001|Overall Study|Lack of Efficacy|7|||
130305682|NCT01088399|469081768|FG002|Overall Study|Lack of Efficacy|5|||
130305683|NCT01088399|469081766|FG000|Overall Study|Lost to Follow-up|1070|||
130305684|NCT01088399|469081767|FG001|Overall Study|Lost to Follow-up|278|||
130305685|NCT01088399|469081768|FG002|Overall Study|Lost to Follow-up|58|||
130716872|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
130716873|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
130716874|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
130716875|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
130716876|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
130716877|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
130305686|NCT01088399|469081766|FG000|Overall Study|Physician Decision|531|||
130305687|NCT01088399|469081767|FG001|Overall Study|Physician Decision|88|||
130305688|NCT01088399|469081768|FG002|Overall Study|Physician Decision|16|||
130305689|NCT01088399|469081766|FG000|Overall Study|Withdrawal by Subject|544|||
130305690|NCT01088399|469081767|FG001|Overall Study|Withdrawal by Subject|195|||
130305691|NCT01088399|469081768|FG002|Overall Study|Withdrawal by Subject|33|||
130305692|NCT01088399|469081766|FG000|Overall Study|Change to or start of somatropin therapy|234|||
130305693|NCT01088399|469081767|FG001|Overall Study|Change to or start of somatropin therapy|17|||
130305694|NCT01088399|469081768|FG002|Overall Study|Change to or start of somatropin therapy|12|||
130305695|NCT01088399|469081766|FG000|Overall Study|Sponsor decision|1573|||
130305696|NCT01088399|469081767|FG001|Overall Study|Sponsor decision|298|||
130305697|NCT01088399|469081768|FG002|Overall Study|Sponsor decision|7|||
130305698|NCT01088399|469081766|FG000|Overall Study|Protocol Violation|10|||
130305699|NCT01088399|469081767|FG001|Overall Study|Protocol Violation|1|||
130716878|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
130305700|NCT01088399|469081768|FG002|Overall Study|Protocol Violation|0|||
130305701|NCT01088399|469081766|FG000|Overall Study|Enrollment criteria not met|48|||
130305702|NCT01088399|469081767|FG001|Overall Study|Enrollment criteria not met|119|||
130305703|NCT01088399|469081768|FG002|Overall Study|Enrollment criteria not met|70|||
130305704|NCT01088399|469081766|FG000|Overall Study|Study summary visit not completed|2398|||
130305705|NCT01088399|469081767|FG001|Overall Study|Study summary visit not completed|283|||
130305706|NCT01088399|469081768|FG002|Overall Study|Study summary visit not completed|80|||
130305707|NCT00782483|469081769|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
130305708|NCT01946152|469083410|FG000|Overall Study|Adverse Event|1|||
130305709|NCT01946152|469083411|FG001|Overall Study|Adverse Event|0|||
130305710|NCT01946152|469083412|FG002|Overall Study|Adverse Event|0|||
130305711|NCT01946152|469083413|FG003|Overall Study|Adverse Event|0|||
130305712|NCT01946152|469083410|FG000|Overall Study|Withdrawal by Subject|0|||
130305713|NCT01946152|469083411|FG001|Overall Study|Withdrawal by Subject|2|||
130305714|NCT01946152|469083412|FG002|Overall Study|Withdrawal by Subject|0|||
130305715|NCT01946152|469083413|FG003|Overall Study|Withdrawal by Subject|0|||
130305716|NCT01946152|469083410|FG000|Overall Study|Progression|0|||
130305717|NCT01946152|469083411|FG001|Overall Study|Progression|1|||
130305718|NCT01946152|469083412|FG002|Overall Study|Progression|4|||
130305719|NCT01946152|469083413|FG003|Overall Study|Progression|7|||
130305720|NCT01946152|469083410|FG000|Overall Study|Physician Decision|0|||
130305721|NCT01946152|469083411|FG001|Overall Study|Physician Decision|0|||
130305722|NCT01946152|469083412|FG002|Overall Study|Physician Decision|1|||
130305723|NCT01946152|469083413|FG003|Overall Study|Physician Decision|0|||
130305724|NCT01946152|469083410|FG000|Overall Study|Second malignancy|0|||
130305725|NCT01946152|469083411|FG001|Overall Study|Second malignancy|0|||
130305726|NCT01946152|469083412|FG002|Overall Study|Second malignancy|1|||
130305727|NCT01946152|469083413|FG003|Overall Study|Second malignancy|0|||
130305728|NCT01946152|469083410|FG000|Overall Study|Adverse Event|0|||
130305729|NCT01946152|469083411|FG001|Overall Study|Adverse Event|0|||
130305730|NCT01946152|469083412|FG002|Overall Study|Adverse Event|0|||
130305731|NCT01946152|469083413|FG003|Overall Study|Adverse Event|1|||
130305732|NCT01016600|469083419|FG000|Overall Study|Did not start treatment|1|||
130305733|NCT01016600|469083420|FG001|Overall Study|Did not start treatment|0|||
130305734|NCT01016600|469083421|FG002|Overall Study|Did not start treatment|0|||
130305735|NCT01016600|469083422|FG003|Overall Study|Did not start treatment|0|||
130305736|NCT02679755|469083423|FG000|Overall Study|Death|0|||
130305737|NCT02679755|469083424|FG001|Overall Study|Death|3|||
130305738|NCT02679755|469083423|FG000|Overall Study|Global deterioration of health status|1|||
130305739|NCT02679755|469083424|FG001|Overall Study|Global deterioration of health status|8|||
130305740|NCT02679755|469083423|FG000|Overall Study|Lost to Follow-up|1|||
130305741|NCT02679755|469083424|FG001|Overall Study|Lost to Follow-up|0|||
130305742|NCT02679755|469083423|FG000|Overall Study|Objective progression or relapse|24|||
130305743|NCT02679755|469083424|FG001|Overall Study|Objective progression or relapse|83|||
130305744|NCT02679755|469083423|FG000|Overall Study|Not defined|0|||
130305745|NCT02679755|469083424|FG001|Overall Study|Not defined|2|||
130305746|NCT02679755|469083423|FG000|Overall Study|Withdrawal by participant|6|||
130305747|NCT02679755|469083424|FG001|Overall Study|Withdrawal by participant|3|||
130305748|NCT02679755|469083423|FG000|Overall Study|Adverse Event|1|||
130305749|NCT02679755|469083424|FG001|Overall Study|Adverse Event|4|||
130305750|NCT02679755|469083423|FG000|Overall Study|Adverse events not related to study drug|1|||
130305751|NCT02679755|469083424|FG001|Overall Study|Adverse events not related to study drug|2|||
130305752|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
130305753|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
130305754|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Death|0|||
130305755|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Death|1|||
130305756|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
130716879|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
130716880|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
130716881|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
130716882|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
130716883|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
130716884|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
130716885|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
130716886|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
130716887|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
130716888|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
130716889|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
130716890|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
130716891|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716892|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716893|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716894|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716895|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716896|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716897|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716898|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716899|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716900|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716901|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716902|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716903|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716904|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716905|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716906|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716907|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716908|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716909|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716910|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716911|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130305757|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
130305758|NCT04737278|469083431|FG000|Overall Study|Lost to Follow-up|1|||
130305759|NCT04737278|469083432|FG001|Overall Study|Lost to Follow-up|1|||
130305760|NCT04737278|469083431|FG000|Overall Study|Withdrawal by Subject|1|||
130305761|NCT04737278|469083432|FG001|Overall Study|Withdrawal by Subject|0|||
130305762|NCT04737278|469083431|FG000|Overall Study|Protocol Violation|1|||
130305763|NCT04737278|469083432|FG001|Overall Study|Protocol Violation|1|||
130305764|NCT04737278|469083431|FG000|Overall Study|failure to complete questionnaire|1|||
130305765|NCT04737278|469083432|FG001|Overall Study|failure to complete questionnaire|1|||
130305766|NCT00546000|469083433|FG000|Overall Study|Adverse Event|1|||
130305767|NCT00546000|469083433|FG000|Overall Study|Lost to Follow-up|1|||
130305768|NCT00546000|469083433|FG000|Overall Study|Baseline HPA Axis Supression|2|||
130305769|NCT01504412|469083435|FG000|Overall Study|Adverse Event|1|||
130305770|NCT01504412|469083436|FG001|Overall Study|Adverse Event|8|||
130305771|NCT01504412|469083437|FG002|Overall Study|Adverse Event|1|||
130305772|NCT01504412|469083438|FG003|Overall Study|Adverse Event|7|||
130305773|NCT01504412|469083439|FG004|Overall Study|Adverse Event|10|||
130305774|NCT01504412|469083435|FG000|Overall Study|Withdrawal by Subject|2|||
130305775|NCT01504412|469083436|FG001|Overall Study|Withdrawal by Subject|1|||
130305776|NCT01504412|469083437|FG002|Overall Study|Withdrawal by Subject|1|||
130716912|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716913|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716914|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716915|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716916|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716917|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716918|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716919|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716920|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130716921|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130716922|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716923|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716924|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
130716925|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716926|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716927|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716928|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716929|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716930|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716931|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716932|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716933|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716934|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716935|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716936|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716937|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716938|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716939|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716940|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716941|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716942|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716943|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716944|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716945|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716946|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
130716947|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716948|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716949|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716950|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716951|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716952|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716953|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716954|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716955|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716956|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716957|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130305777|NCT01504412|469083438|FG003|Overall Study|Withdrawal by Subject|5|||
130305778|NCT01504412|469083439|FG004|Overall Study|Withdrawal by Subject|1|||
130305779|NCT01504412|469083435|FG000|Overall Study|Other|2|||
130305780|NCT01504412|469083436|FG001|Overall Study|Other|1|||
130305781|NCT01504412|469083437|FG002|Overall Study|Other|1|||
130305782|NCT01504412|469083438|FG003|Overall Study|Other|6|||
130305783|NCT01504412|469083439|FG004|Overall Study|Other|1|||
130305784|NCT01504412|469083435|FG000|Overall Study|Lost to Follow-up|0|||
130305785|NCT01504412|469083436|FG001|Overall Study|Lost to Follow-up|2|||
130305786|NCT01504412|469083437|FG002|Overall Study|Lost to Follow-up|0|||
130305787|NCT01504412|469083438|FG003|Overall Study|Lost to Follow-up|0|||
130305788|NCT01504412|469083439|FG004|Overall Study|Lost to Follow-up|0|||
130305789|NCT01504412|469083435|FG000|Overall Study|Lack of Efficacy|0|||
130305790|NCT01504412|469083436|FG001|Overall Study|Lack of Efficacy|0|||
130305791|NCT01504412|469083437|FG002|Overall Study|Lack of Efficacy|1|||
130305792|NCT01504412|469083438|FG003|Overall Study|Lack of Efficacy|0|||
130305793|NCT01504412|469083439|FG004|Overall Study|Lack of Efficacy|1|||
130305794|NCT01504412|469083435|FG000|Overall Study|Death|0|||
130305795|NCT01504412|469083436|FG001|Overall Study|Death|0|||
130305796|NCT01504412|469083437|FG002|Overall Study|Death|0|||
130305797|NCT01504412|469083438|FG003|Overall Study|Death|1|||
130373890|NCT01192516|469336832|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
130373891|NCT01192516|469336833|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
130373892|NCT01192516|469336834|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
130373893|NCT01256008|469336835|FG000|Overall Study|Lost to Follow-up|6|||
130716958|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716959|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716960|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716961|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716962|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716963|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716964|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716965|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716966|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716967|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716968|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716969|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716970|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716971|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716972|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716973|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716974|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716975|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716976|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
130716977|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
130716978|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
130716979|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
130716980|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716981|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716982|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716983|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716984|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716985|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716986|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716987|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716988|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716989|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716990|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716991|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716992|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716993|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716994|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716995|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716996|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716997|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716998|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716999|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717000|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130717001|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130717002|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130305798|NCT01504412|469083439|FG004|Overall Study|Death|0|||
130305799|NCT02974257|469083440|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
130373894|NCT01256008|469336836|FG001|Overall Study|Lost to Follow-up|4|||
130305800|NCT02974257|469083441|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
130305801|NCT02974257|469083440|FG000|Overall Study|Clinical indication for thiamine|1|||
130305802|NCT02974257|469083441|FG001|Overall Study|Clinical indication for thiamine|0|||
130305803|NCT02974257|469083440|FG000|Overall Study|Already on thiamine|1|||
130305804|NCT02974257|469083441|FG001|Overall Study|Already on thiamine|0|||
130305805|NCT02974257|469083440|FG000|Overall Study|Extubated prior to study drug|0|||
130305806|NCT02974257|469083441|FG001|Overall Study|Extubated prior to study drug|1|||
130305807|NCT02974257|469083440|FG000|Overall Study|Death|0|||
130305808|NCT02974257|469083441|FG001|Overall Study|Death|1|||
130305809|NCT01449006|469083446|FG000|Overall Study|Lost to Follow-up|1|||
130305810|NCT01449006|469083447|FG001|Overall Study|Lost to Follow-up|0|||
130305811|NCT01449006|469083446|FG000|Overall Study|Withdrawal by Subject|1|||
130305812|NCT01449006|469083447|FG001|Overall Study|Withdrawal by Subject|0|||
130305813|NCT01449006|469083446|FG000|Overall Study|Protocol Violation|1|||
130305814|NCT01449006|469083447|FG001|Overall Study|Protocol Violation|0|||
130305815|NCT03350815|469083448|FG000|Period 1|Adverse Event|10|||
130305816|NCT03350815|469083449|FG001|Period 1|Adverse Event|0|||
130305817|NCT03350815|469083450|FG002|Period 1|Adverse Event|0|||
130305818|NCT03350815|469083451|FG003|Period 1|Adverse Event|0|||
130305819|NCT03350815|469083448|FG000|Period 1|Technical problems|1|||
130305820|NCT03350815|469083449|FG001|Period 1|Technical problems|0|||
130305821|NCT03350815|469083450|FG002|Period 1|Technical problems|0|||
130305822|NCT03350815|469083451|FG003|Period 1|Technical problems|0|||
130305823|NCT03350815|469083448|FG000|Period 1|Lost to Follow-up|3|||
130305824|NCT03350815|469083449|FG001|Period 1|Lost to Follow-up|0|||
130305825|NCT03350815|469083450|FG002|Period 1|Lost to Follow-up|0|||
130305826|NCT03350815|469083451|FG003|Period 1|Lost to Follow-up|0|||
130305827|NCT03350815|469083448|FG000|Period 1|Physician Decision|1|||
130305828|NCT03350815|469083449|FG001|Period 1|Physician Decision|0|||
130305829|NCT03350815|469083450|FG002|Period 1|Physician Decision|0|||
130305830|NCT03350815|469083451|FG003|Period 1|Physician Decision|0|||
130305831|NCT03350815|469083448|FG000|Period 1|Withdrawal by Subject|8|||
130305832|NCT03350815|469083449|FG001|Period 1|Withdrawal by Subject|0|||
130305833|NCT03350815|469083450|FG002|Period 1|Withdrawal by Subject|0|||
130305834|NCT03350815|469083451|FG003|Period 1|Withdrawal by Subject|0|||
130305835|NCT03350815|469083448|FG000|Period 1|Lack of Efficacy|15|||
130305836|NCT03350815|469083449|FG001|Period 1|Lack of Efficacy|0|||
130305837|NCT03350815|469083450|FG002|Period 1|Lack of Efficacy|0|||
130305838|NCT03350815|469083451|FG003|Period 1|Lack of Efficacy|0|||
130305839|NCT03350815|469083448|FG000|Period 1|Non-compliance with study treatment|2|||
130305840|NCT03350815|469083449|FG001|Period 1|Non-compliance with study treatment|0|||
130305841|NCT03350815|469083450|FG002|Period 1|Non-compliance with study treatment|0|||
130305842|NCT03350815|469083451|FG003|Period 1|Non-compliance with study treatment|0|||
130305843|NCT03350815|469083448|FG000|Period 1|Protocol Violation|3|||
130305844|NCT03350815|469083449|FG001|Period 1|Protocol Violation|0|||
130373895|NCT01256008|469336837|FG002|Overall Study|Lost to Follow-up|11|||
130373896|NCT01256008|469336835|FG000|Overall Study|Withdrawal by Subject|2|||
130717003|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717004|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717005|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717006|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717007|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717008|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717009|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717010|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717011|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717012|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717013|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717014|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130305845|NCT03350815|469083450|FG002|Period 1|Protocol Violation|0|||
130305846|NCT03350815|469083451|FG003|Period 1|Protocol Violation|0|||
130305847|NCT03350815|469083448|FG000|Period 2|Adverse Event|0|||
130305848|NCT03350815|469083449|FG001|Period 2|Adverse Event|3|||
130305849|NCT03350815|469083450|FG002|Period 2|Adverse Event|5|||
130373897|NCT01256008|469336836|FG001|Overall Study|Withdrawal by Subject|3|||
130305850|NCT03350815|469083451|FG003|Period 2|Adverse Event|0|||
130305851|NCT03350815|469083448|FG000|Period 2|Technical problem|0|||
130305852|NCT03350815|469083449|FG001|Period 2|Technical problem|1|||
130305853|NCT03350815|469083450|FG002|Period 2|Technical problem|0|||
130305854|NCT03350815|469083451|FG003|Period 2|Technical problem|0|||
130305855|NCT03350815|469083448|FG000|Period 2|Lost to Follow-up|0|||
130305856|NCT03350815|469083449|FG001|Period 2|Lost to Follow-up|3|||
130373898|NCT01256008|469336837|FG002|Overall Study|Withdrawal by Subject|10|||
130305857|NCT03350815|469083450|FG002|Period 2|Lost to Follow-up|3|||
130305858|NCT03350815|469083451|FG003|Period 2|Lost to Follow-up|0|||
130305859|NCT03350815|469083448|FG000|Period 2|Physician Decision|0|||
130305860|NCT03350815|469083449|FG001|Period 2|Physician Decision|0|||
130305861|NCT03350815|469083450|FG002|Period 2|Physician Decision|1|||
130305862|NCT03350815|469083451|FG003|Period 2|Physician Decision|0|||
130305863|NCT03350815|469083448|FG000|Period 2|Withdrawal by Subject|0|||
130305864|NCT03350815|469083449|FG001|Period 2|Withdrawal by Subject|3|||
130305865|NCT03350815|469083450|FG002|Period 2|Withdrawal by Subject|4|||
130305866|NCT03350815|469083451|FG003|Period 2|Withdrawal by Subject|0|||
130305867|NCT03350815|469083448|FG000|Period 2|Lack of Efficacy|0|||
130305868|NCT03350815|469083449|FG001|Period 2|Lack of Efficacy|6|||
130305869|NCT03350815|469083450|FG002|Period 2|Lack of Efficacy|2|||
130305870|NCT03350815|469083451|FG003|Period 2|Lack of Efficacy|0|||
130305871|NCT03350815|469083448|FG000|Period 2|Protocol Violation|0|||
130373899|NCT02321800|469336840|FG000|Overall Study|Withdrawal by Subject|3|||
130373900|NCT02321800|469336841|FG001|Overall Study|Withdrawal by Subject|3|||
130373901|NCT02321800|469336840|FG000|Overall Study|Death|1|||
130717015|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
130717016|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
130717017|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
130717018|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
130717019|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
130717020|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
130717021|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
130717022|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
130717023|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
130717024|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
130717025|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
130717026|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
130717027|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
130717028|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
130717029|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
130717030|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
130717031|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
130717032|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
130717033|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
130717034|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
130717035|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
130717036|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
130717037|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
130717038|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
130717039|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
130717040|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717041|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717042|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717043|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717044|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717045|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717046|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717047|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717048|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717049|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717050|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717051|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
130717052|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717053|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
130717054|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717055|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717056|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717057|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717058|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717059|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717060|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717061|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717062|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717063|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717064|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717065|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717066|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717067|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717068|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717069|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717070|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717071|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717072|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717073|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717074|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717075|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717076|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717077|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717078|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130305872|NCT03350815|469083449|FG001|Period 2|Protocol Violation|0|||
130305873|NCT03350815|469083450|FG002|Period 2|Protocol Violation|1|||
130305874|NCT03350815|469083451|FG003|Period 2|Protocol Violation|0|||
130305875|NCT03350815|469083448|FG000|Period 2|New therapy for study indication|0|||
130305876|NCT03350815|469083449|FG001|Period 2|New therapy for study indication|0|||
130305877|NCT03350815|469083450|FG002|Period 2|New therapy for study indication|1|||
130305878|NCT03350815|469083451|FG003|Period 2|New therapy for study indication|0|||
130305879|NCT02837029|469083454|FG000|Screening|Failed to meet screening requirements.|7|||
130305880|NCT02837029|469083455|FG001|Screening|Failed to meet screening requirements.|3|||
130305881|NCT02837029|469083456|FG002|Screening|Failed to meet screening requirements.|0|||
130305882|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
130305883|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130305884|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130305885|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130305886|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
130305887|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130373902|NCT02321800|469336841|FG001|Overall Study|Death|0|||
130305888|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130305889|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
130305890|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130305891|NCT02837029|469083454|FG000|Cycle 2 and Beyond|Adverse Event|1|||
130305892|NCT02837029|469083455|FG001|Cycle 2 and Beyond|Adverse Event|0|||
130305893|NCT02837029|469083456|FG002|Cycle 2 and Beyond|Adverse Event|0|||
130305894|NCT02837029|469083454|FG000|2 Year Follow-up|Death|6|||
130717079|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717080|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717081|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717082|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717083|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717084|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717085|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
130717086|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717087|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717088|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717089|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717090|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Death|0|||
130717091|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Death|0|||
130717092|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Death|0|||
130717093|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Death|0|||
130717094|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Death|0|||
130717095|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Death|0|||
130717096|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Death|0|||
130717097|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Death|0|||
130717098|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Death|0|||
130717099|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Death|0|||
130717100|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Death|0|||
130717101|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Death|0|||
130717102|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Death|0|||
130717103|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Death|0|||
130717104|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Death|0|||
130717105|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Death|1|||
130717106|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Death|7|||
130717107|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Death|5|||
130717108|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Death|5|||
130717109|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Death|3|||
130717110|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Death|7|||
130717111|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Death|5|||
130717112|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Death|6|||
130717113|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Death|3|||
130717114|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Death|0|||
130717115|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717116|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717117|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717118|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717119|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717120|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717121|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717122|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717123|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717124|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717125|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717126|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717127|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717128|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717129|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717130|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717131|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717132|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717133|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717134|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717135|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717136|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717137|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717138|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
130717139|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717140|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Disease Progression|0|||
130717141|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Disease Progression|0|||
130717142|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Disease Progression|0|||
130717143|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Disease Progression|0|||
130717144|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Disease Progression|0|||
130717145|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Disease Progression|0|||
130717146|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Disease Progression|0|||
130717147|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Disease Progression|0|||
130717148|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Disease Progression|0|||
130717149|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Disease Progression|0|||
130717150|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Disease Progression|0|||
130464342|NCT02674750|469665253|FG000|Overall Study|Withdrawal by Subject|0|||
130464343|NCT02674750|469665254|FG001|Overall Study|Withdrawal by Subject|7|||
130464344|NCT02674750|469665255|FG002|Overall Study|Withdrawal by Subject|1|||
130464345|NCT02674750|469665253|FG000|Overall Study|Other|0|||
130464346|NCT02674750|469665254|FG001|Overall Study|Other|8|||
130464347|NCT02674750|469665255|FG002|Overall Study|Other|0|||
130464348|NCT01199705|469665256|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
130464349|NCT01415349|469665257|FG000|Treatment Period 1|Adverse Event|0|||
130464350|NCT01415349|469665258|FG001|Treatment Period 1|Adverse Event|1|||
130464351|NCT01415349|469665257|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130464352|NCT01415349|469665258|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130464353|NCT03473340|469665259|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
130464354|NCT03473340|469665260|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
130464355|NCT03473340|469665259|FG000|Overall Study|Withdrawal by Subject|1|||
130464356|NCT03473340|469665260|FG001|Overall Study|Withdrawal by Subject|0|||
130464357|NCT03473340|469665259|FG000|Overall Study|Lost to Follow-up|1|||
130464358|NCT03473340|469665260|FG001|Overall Study|Lost to Follow-up|2|||
130464359|NCT01616459|469665261|FG000|Overall Study|Adverse Event|1|||
130464360|NCT01616459|469665262|FG001|Overall Study|Adverse Event|1|||
130464361|NCT01616459|469665263|FG002|Overall Study|Adverse Event|2|||
130464362|NCT01616459|469665264|FG003|Overall Study|Adverse Event|0|||
130464363|NCT01616459|469665261|FG000|Overall Study|Lost to Follow-up|1|||
130464364|NCT01616459|469665262|FG001|Overall Study|Lost to Follow-up|11|||
130464365|NCT01616459|469665263|FG002|Overall Study|Lost to Follow-up|3|||
130464366|NCT01616459|469665264|FG003|Overall Study|Lost to Follow-up|2|||
130464367|NCT01616459|469665261|FG000|Overall Study|Protocol Violation|0|||
130464368|NCT01616459|469665262|FG001|Overall Study|Protocol Violation|0|||
130464369|NCT01616459|469665263|FG002|Overall Study|Protocol Violation|0|||
130464370|NCT01616459|469665264|FG003|Overall Study|Protocol Violation|2|||
130464371|NCT01616459|469665261|FG000|Overall Study|Withdrawal by Subject|2|||
130464372|NCT01616459|469665262|FG001|Overall Study|Withdrawal by Subject|4|||
130464373|NCT01616459|469665263|FG002|Overall Study|Withdrawal by Subject|4|||
130305895|NCT02837029|469083455|FG001|2 Year Follow-up|Death|7|||
130464374|NCT01616459|469665264|FG003|Overall Study|Withdrawal by Subject|4|||
130464375|NCT01616459|469665261|FG000|Overall Study|Other reason|0|||
130464376|NCT01616459|469665262|FG001|Overall Study|Other reason|1|||
130464377|NCT01616459|469665263|FG002|Overall Study|Other reason|1|||
130464378|NCT01616459|469665264|FG003|Overall Study|Other reason|0|||
130464379|NCT03394885|469665266|FG000|Overall Study|Adverse Event|4|||
130305896|NCT02837029|469083456|FG002|2 Year Follow-up|Death|0|||
130305897|NCT00398567|469083457|FG000|Overall Study|Disease Progression|3|||
130305898|NCT00398567|469083458|FG001|Overall Study|Disease Progression|4|||
130305899|NCT00398567|469083459|FG002|Overall Study|Disease Progression|27|||
130305900|NCT00398567|469083457|FG000|Overall Study|Withdrawal by Subject|1|||
130305901|NCT00398567|469083458|FG001|Overall Study|Withdrawal by Subject|0|||
130305902|NCT00398567|469083459|FG002|Overall Study|Withdrawal by Subject|4|||
130305903|NCT00398567|469083457|FG000|Overall Study|Adverse Event|0|||
130305904|NCT00398567|469083458|FG001|Overall Study|Adverse Event|0|||
130305905|NCT00398567|469083459|FG002|Overall Study|Adverse Event|2|||
130305906|NCT00398567|469083457|FG000|Overall Study|Protocol Violation|0|||
130305907|NCT00398567|469083458|FG001|Overall Study|Protocol Violation|0|||
130305908|NCT00398567|469083459|FG002|Overall Study|Protocol Violation|1|||
130305909|NCT02034877|469083460|FG000|Overall Study|Lost to Follow-up|0|||
130305910|NCT02034877|469083461|FG001|Overall Study|Lost to Follow-up|3|||
130305911|NCT02034877|469083460|FG000|Overall Study|No Longer Willing to Participate|0|||
130305912|NCT02034877|469083461|FG001|Overall Study|No Longer Willing to Participate|3|||
130305913|NCT03906071|469083464|FG000|Overall Study|Death|180|||
130305914|NCT03906071|469083465|FG001|Overall Study|Death|185|||
130305915|NCT03906071|469083464|FG000|Overall Study|Lost to Follow-up|3|||
130305916|NCT03906071|469083465|FG001|Overall Study|Lost to Follow-up|3|||
130305917|NCT03906071|469083464|FG000|Overall Study|Withdrawal by Subject|15|||
130305918|NCT03906071|469083465|FG001|Overall Study|Withdrawal by Subject|27|||
130305919|NCT03906071|469083464|FG000|Overall Study|Other|2|||
130305920|NCT03906071|469083465|FG001|Overall Study|Other|1|||
130305921|NCT01564732|469083477|FG000|Overall Study|Early termination by the study sponsor|6|||
130305922|NCT01564732|469083478|FG001|Overall Study|Early termination by the study sponsor|5|||
130305923|NCT01979952|469083481|FG000|Overall Study|Adverse Event|4|||
130305924|NCT01979952|469083482|FG001|Overall Study|Adverse Event|5|||
130305925|NCT01979952|469083481|FG000|Overall Study|Protocol Violation|1|||
130305926|NCT01979952|469083482|FG001|Overall Study|Protocol Violation|0|||
130305927|NCT01979952|469083481|FG000|Overall Study|Withdrawal by Subject|2|||
130305928|NCT01979952|469083482|FG001|Overall Study|Withdrawal by Subject|1|||
130305929|NCT01979952|469083481|FG000|Overall Study|Other than specified above|1|||
130305930|NCT01979952|469083482|FG001|Overall Study|Other than specified above|0|||
130305931|NCT05438576|469083483|FG000|Overall Study|Death|1|||
130305932|NCT05438576|469083484|FG001|Overall Study|Death|1|||
130305933|NCT05438576|469083483|FG000|Overall Study|Withdrawal by Subject|4|||
130305934|NCT05438576|469083484|FG001|Overall Study|Withdrawal by Subject|2|||
130305935|NCT05438576|469083483|FG000|Overall Study|Not Eligible|2|||
130305936|NCT05438576|469083484|FG001|Overall Study|Not Eligible|1|||
130305937|NCT05438576|469083483|FG000|Overall Study|Did not complete baseline testing|22|||
130305938|NCT05438576|469083484|FG001|Overall Study|Did not complete baseline testing|4|||
130305939|NCT01067144|469083490|FG000|Treatment|Did not receive allocated intervention|4|||
130305940|NCT01067144|469083491|FG001|Treatment|Did not receive allocated intervention|7|||
130305941|NCT01067144|469083490|FG000|Follow-up|Lost to Follow-up|22|||
130305942|NCT01067144|469083491|FG001|Follow-up|Lost to Follow-up|12|||
130305943|NCT01067144|469083490|FG000|Follow-up|Censored owing to second surgery|19|||
130305944|NCT01067144|469083491|FG001|Follow-up|Censored owing to second surgery|28|||
130305945|NCT01067144|469083490|FG000|Follow-up|Withdrawal by Subject|18|||
130305946|NCT01067144|469083491|FG001|Follow-up|Withdrawal by Subject|14|||
130305947|NCT01067144|469083490|FG000|Follow-up|Surgery cancelled|0|||
130305948|NCT01067144|469083491|FG001|Follow-up|Surgery cancelled|1|||
130305949|NCT01067144|469083490|FG000|Follow-up|Death|0|||
130305950|NCT01067144|469083491|FG001|Follow-up|Death|1|||
130305951|NCT00475709|469083492|FG000|Overall Study|Did not meet eligibility criteria|8|||
130305952|NCT00475709|469083492|FG000|Overall Study|Death|41|||
130305953|NCT00475709|469083492|FG000|Overall Study|Device Explant|6|||
130305954|NCT00475709|469083492|FG000|Overall Study|Lost to Follow-up|21|||
130305955|NCT00555672|469083493|FG000|Overall Study|Death|0|||
130305956|NCT00555672|469083494|FG001|Overall Study|Death|2|||
130305957|NCT00555672|469083493|FG000|Overall Study|Adverse Event|8|||
130305958|NCT00555672|469083494|FG001|Overall Study|Adverse Event|2|||
130305959|NCT00555672|469083493|FG000|Overall Study|Objective progression or relapse|11|||
130305960|NCT00555672|469083494|FG001|Overall Study|Objective progression or relapse|5|||
130305961|NCT00555672|469083493|FG000|Overall Study|Other|3|||
130305962|NCT00555672|469083494|FG001|Overall Study|Other|1|||
130305963|NCT00555672|469083493|FG000|Overall Study|Participant refused|2|||
130305964|NCT00555672|469083494|FG001|Overall Study|Participant refused|0|||
130305965|NCT01415401|469083499|FG000|Overall Study|Adverse Event|5|||
130305966|NCT01415401|469083499|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
130305967|NCT01415401|469083499|FG000|Overall Study|Terminated by Sponsor|1|||
130305968|NCT04765202|469083513|FG000|Overall Study|Lost to Follow-up|1|||
130305969|NCT04765202|469083514|FG001|Overall Study|Lost to Follow-up|1|||
130305970|NCT04765202|469083515|FG002|Overall Study|Lost to Follow-up|2|||
130305971|NCT04765202|469083516|FG003|Overall Study|Lost to Follow-up|2|||
130305972|NCT04765202|469083513|FG000|Overall Study|Physician Decision|0|||
130305973|NCT04765202|469083514|FG001|Overall Study|Physician Decision|0|||
130305974|NCT04765202|469083515|FG002|Overall Study|Physician Decision|1|||
130305975|NCT04765202|469083516|FG003|Overall Study|Physician Decision|1|||
130305976|NCT02305238|469083518|FG000|Overall Study|Death|2|||
130305977|NCT02305238|469083519|FG001|Overall Study|Death|1|||
130557632|NCT04178967|470011822|FG006|Induction Period|Withdrawal by Subject|0|||
130305978|NCT02305238|469083520|FG002|Overall Study|Death|0|||
130305979|NCT02305238|469083518|FG000|Overall Study|Progressive disease|4|||
130305980|NCT02305238|469083519|FG001|Overall Study|Progressive disease|4|||
130305981|NCT02305238|469083520|FG002|Overall Study|Progressive disease|0|||
130305982|NCT02305238|469083518|FG000|Overall Study|Logistical difficulties|1|||
130305983|NCT02305238|469083519|FG001|Overall Study|Logistical difficulties|3|||
130305984|NCT02305238|469083520|FG002|Overall Study|Logistical difficulties|0|||
130305985|NCT02305238|469083518|FG000|Overall Study|Protocol Violation|0|||
130305986|NCT02305238|469083519|FG001|Overall Study|Protocol Violation|3|||
130305987|NCT02305238|469083520|FG002|Overall Study|Protocol Violation|0|||
130305988|NCT02305238|469083518|FG000|Overall Study|Physician Decision|2|||
130305989|NCT02305238|469083519|FG001|Overall Study|Physician Decision|1|||
130305990|NCT02305238|469083520|FG002|Overall Study|Physician Decision|0|||
130305991|NCT02305238|469083518|FG000|Overall Study|Adverse Event|4|||
130305992|NCT02305238|469083519|FG001|Overall Study|Adverse Event|2|||
130305993|NCT02305238|469083520|FG002|Overall Study|Adverse Event|0|||
130305994|NCT02305238|469083518|FG000|Overall Study|Withdrawal by Subject|3|||
130305995|NCT02305238|469083519|FG001|Overall Study|Withdrawal by Subject|4|||
130305996|NCT02305238|469083520|FG002|Overall Study|Withdrawal by Subject|0|||
130305997|NCT02305238|469083518|FG000|Overall Study|Randomized failure|0|||
130305998|NCT02305238|469083519|FG001|Overall Study|Randomized failure|0|||
130305999|NCT02305238|469083520|FG002|Overall Study|Randomized failure|8|||
130306000|NCT02305238|469083518|FG000|Overall Study|Required procedure failed|0|||
130306001|NCT02305238|469083519|FG001|Overall Study|Required procedure failed|1|||
130306002|NCT02305238|469083520|FG002|Overall Study|Required procedure failed|0|||
130306003|NCT01019369|469083521|FG000|Overall Study|Lost to Follow-up|10|||
130306004|NCT01019369|469083522|FG001|Overall Study|Lost to Follow-up|6|||
130306005|NCT01019369|469083521|FG000|Overall Study|Withdrawal by Subject|0|||
130306006|NCT01019369|469083522|FG001|Overall Study|Withdrawal by Subject|1|||
130306007|NCT02513472|469083523|FG000|Overall Study|Radiological Disease Progression|45|||
130306008|NCT02513472|469083524|FG001|Overall Study|Radiological Disease Progression|57|||
130306009|NCT02513472|469083523|FG000|Overall Study|Clinical Disease Progression|5|||
130306010|NCT02513472|469083524|FG001|Overall Study|Clinical Disease Progression|13|||
130306011|NCT02513472|469083523|FG000|Overall Study|Adverse Event|8|||
130306012|NCT02513472|469083524|FG001|Overall Study|Adverse Event|11|||
130306013|NCT02513472|469083523|FG000|Overall Study|Withdrawal by Subject|0|||
130306014|NCT02513472|469083524|FG001|Overall Study|Withdrawal by Subject|4|||
130306015|NCT02513472|469083523|FG000|Overall Study|Subject Choice|2|||
130306016|NCT02513472|469083524|FG001|Overall Study|Subject Choice|7|||
130306017|NCT02513472|469083523|FG000|Overall Study|Treatment Completed as per Protocol|3|||
130306018|NCT02513472|469083524|FG001|Overall Study|Treatment Completed as per Protocol|3|||
130306019|NCT02513472|469083523|FG000|Overall Study|Other|3|||
130306020|NCT02513472|469083524|FG001|Overall Study|Other|6|||
130464380|NCT03394885|469665266|FG000|Overall Study|Lack of Efficacy|1|||
130464381|NCT03394885|469665266|FG000|Overall Study|Physician Decision|1|||
130464382|NCT03394885|469665266|FG000|Overall Study|Withdrawal by Subject|8|||
130464383|NCT03394885|469665266|FG000|Overall Study|Alternative Therapy|1|||
130464384|NCT04980755|469665270|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
130464385|NCT04980755|469665270|FG000|Body Reprogramming Courses|Work commitment|2|||
130464386|NCT04980755|469665270|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
130464387|NCT04980755|469665270|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
130464388|NCT00801983|469665275|FG000|Period 1|Lost to Follow-up|2|||
130464389|NCT00801983|469665276|FG001|Period 1|Lost to Follow-up|0|||
130464390|NCT00801983|469665275|FG000|Period 1|Withdrawal by Subject|2|||
130464391|NCT00801983|469665276|FG001|Period 1|Withdrawal by Subject|8|||
130464392|NCT00801983|469665275|FG000|Period 2|Withdrawal by Subject|2|||
130464393|NCT00801983|469665276|FG001|Period 2|Withdrawal by Subject|1|||
130464394|NCT05135000|469665281|FG000|Overall Study|Adverse Event|2|||
130464395|NCT05135000|469665282|FG001|Overall Study|Adverse Event|0|||
130464396|NCT05135000|469665281|FG000|Overall Study|Lost to Follow-up|1|||
130464397|NCT05135000|469665282|FG001|Overall Study|Lost to Follow-up|0|||
130464398|NCT05135000|469665281|FG000|Overall Study|Study Terminated by Sponsor|6|||
130464399|NCT05135000|469665282|FG001|Overall Study|Study Terminated by Sponsor|3|||
130464400|NCT03215927|469667124|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
130464401|NCT03215927|469667125|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
130464402|NCT03215927|469667124|FG000|Open Label Extension|Adverse Event|1|||
130464403|NCT03215927|469667125|FG001|Open Label Extension|Adverse Event|0|||
130464404|NCT03215927|469667124|FG000|Open Label Extension|Lack of Efficacy|1|||
130464405|NCT03215927|469667125|FG001|Open Label Extension|Lack of Efficacy|0|||
130464406|NCT03215927|469667124|FG000|Open Label Extension|Death|0|||
130464407|NCT03215927|469667125|FG001|Open Label Extension|Death|1|||
130306021|NCT01380834|469083525|FG000|Overall Study|Physician Decision|1|||
130306022|NCT01380834|469083526|FG001|Overall Study|Physician Decision|0|||
130306023|NCT04310566|469083527|FG000|Period 1|Study Termination due to COVID-19|15|||
130464408|NCT03073941|469667126|FG000|Overall Study|Received non-study device intraoperatively|0|||
130464409|NCT03073941|469667127|FG001|Overall Study|Received non-study device intraoperatively|2|||
130464410|NCT03073941|469667126|FG000|Overall Study|Death|1|||
130464411|NCT03073941|469667127|FG001|Overall Study|Death|0|||
130464412|NCT03073941|469667126|FG000|Overall Study|Withdrawal by Subject|1|||
130464413|NCT03073941|469667127|FG001|Overall Study|Withdrawal by Subject|3|||
130464414|NCT03073941|469667126|FG000|Overall Study|Lost to Follow-up|5|||
130306024|NCT04310566|469083528|FG001|Period 1|Study Termination due to COVID-19|17|||
130306025|NCT04310566|469083527|FG000|Period 1|Protocol Violation|0|||
130306026|NCT04310566|469083528|FG001|Period 1|Protocol Violation|1|||
130306027|NCT04310566|469083527|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
130306028|NCT04310566|469083528|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
130306029|NCT04310566|469083527|FG000|Period 1|Lost to Follow-up|1|||
130306030|NCT04310566|469083528|FG001|Period 1|Lost to Follow-up|0|||
130306031|NCT04310566|469083527|FG000|Period 1|Withdrawal by Subject|0|||
130306032|NCT04310566|469083528|FG001|Period 1|Withdrawal by Subject|1|||
130306033|NCT04310566|469083527|FG000|Period 2|Study Termination|7|||
130306034|NCT04310566|469083528|FG001|Period 2|Study Termination|5|||
130306035|NCT04565951|469083529|FG000|Overall Study|Lost to Follow-up|66|||
130306036|NCT04565951|469083530|FG001|Overall Study|Lost to Follow-up|38|||
130306037|NCT04565951|469083529|FG000|Overall Study|Withdrawal by Subject|14|||
130306038|NCT04565951|469083530|FG001|Overall Study|Withdrawal by Subject|7|||
130306039|NCT04565951|469083529|FG000|Overall Study|Death|0|||
130306040|NCT04565951|469083530|FG001|Overall Study|Death|1|||
130306041|NCT00429169|469083539|FG000|Overall Study|Lost to Follow-up|0|||
130306042|NCT00429169|469083540|FG001|Overall Study|Lost to Follow-up|1|||
130306043|NCT00429169|469083539|FG000|Overall Study|Ineligibility discovered after entry|2|||
130306044|NCT00429169|469083540|FG001|Overall Study|Ineligibility discovered after entry|1|||
130306045|NCT01711645|469083541|FG000|Overall Study|Withdrawal by Subject|8|||
130306046|NCT01711645|469083541|FG000|Overall Study|Lost to Follow-up|6|||
130306047|NCT01711645|469083541|FG000|Overall Study|Physician Decision|5|||
130306048|NCT01746173|469083547|FG000|Overall Study|Disease Progression|2|||
130306049|NCT01371552|469083551|FG000|Part 1, First 3 Days|Inconvenience|0|||
130464415|NCT03073941|469667127|FG001|Overall Study|Lost to Follow-up|4|||
130306050|NCT01371552|469083552|FG001|Part 1, First 3 Days|Inconvenience|0|||
130306051|NCT01371552|469083553|FG002|Part 1, First 3 Days|Inconvenience|1|||
130306052|NCT01371552|469083554|FG003|Part 1, First 3 Days|Inconvenience|0|||
130306053|NCT01371552|469083555|FG004|Part 1, First 3 Days|Inconvenience|0|||
130306054|NCT01371552|469083556|FG005|Part 1, First 3 Days|Inconvenience|0|||
130306055|NCT02328027|469083557|FG000|Overall Study|Withdrawal by Subject|0|||
130306056|NCT02328027|469083558|FG001|Overall Study|Withdrawal by Subject|1|||
130306057|NCT03304873|469083559|FG000|Overall Study|Lost to Follow-up|1|||
130306058|NCT03304873|469083560|FG001|Overall Study|Lost to Follow-up|8|||
130306059|NCT03319212|469083561|FG000|Overall Study|Discontinued as moving out of local area|0|||
130306060|NCT03319212|469083562|FG001|Overall Study|Discontinued as moving out of local area|1|||
130306061|NCT03319212|469083561|FG000|Overall Study|Adverse Event|2|||
130306062|NCT03319212|469083562|FG001|Overall Study|Adverse Event|2|||
130306063|NCT03319212|469083561|FG000|Overall Study|Withdrawal by Subject|0|||
130557633|NCT04178967|470011823|FG007|Induction Period|Withdrawal by Subject|0|||
130557634|NCT04178967|470011824|FG008|Induction Period|Withdrawal by Subject|0|||
130717151|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Disease Progression|0|||
130717152|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Disease Progression|0|||
130717153|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Disease Progression|0|||
130717154|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Disease Progression|0|||
130717155|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Disease Progression|0|||
130717156|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Disease Progression|0|||
130717157|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Disease Progression|0|||
130717158|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Disease Progression|0|||
130717159|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Disease Progression|0|||
130717160|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Disease Progression|2|||
130717161|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Disease Progression|1|||
130717162|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Disease Progression|0|||
130717163|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Disease Progression|0|||
130717164|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Disease Progression|0|||
130717165|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717166|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717167|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717168|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717169|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717170|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717171|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717172|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717173|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717174|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717175|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717176|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717177|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717178|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717179|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717180|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717181|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717182|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717183|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717184|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717185|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
130717186|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
130717187|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717188|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717189|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717190|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717191|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717192|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717193|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717194|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717195|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717196|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717197|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717198|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717199|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717200|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717201|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130720904|NCT01341782|470601557|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130306064|NCT03319212|469083562|FG001|Overall Study|Withdrawal by Subject|1|||
130306065|NCT03319212|469083561|FG000|Overall Study|Lost to Follow-up|0|||
130557635|NCT04178967|470011825|FG009|Induction Period|Withdrawal by Subject|0|||
130306066|NCT03319212|469083562|FG001|Overall Study|Lost to Follow-up|1|||
130306067|NCT03319212|469083561|FG000|Overall Study|Physician Decision|1|||
130306068|NCT03319212|469083562|FG001|Overall Study|Physician Decision|0|||
130306069|NCT00250276|469083563|FG000|Overall Study|Serious Adverse Event|0|||
130306070|NCT00250276|469083564|FG001|Overall Study|Serious Adverse Event|0|||
130306071|NCT00250276|469083565|FG002|Overall Study|Serious Adverse Event|1|||
130306072|NCT00250276|469083566|FG003|Overall Study|Serious Adverse Event|0|||
130306073|NCT00250276|469083563|FG000|Overall Study|Non-serious Adverse Event|2|||
130306074|NCT00250276|469083564|FG001|Overall Study|Non-serious Adverse Event|0|||
130306075|NCT00250276|469083565|FG002|Overall Study|Non-serious Adverse Event|0|||
130306076|NCT00250276|469083566|FG003|Overall Study|Non-serious Adverse Event|2|||
130306077|NCT00250276|469083563|FG000|Overall Study|Protocol Violation|0|||
130306078|NCT00250276|469083564|FG001|Overall Study|Protocol Violation|1|||
130306079|NCT00250276|469083565|FG002|Overall Study|Protocol Violation|0|||
130306080|NCT00250276|469083566|FG003|Overall Study|Protocol Violation|0|||
130306081|NCT00250276|469083563|FG000|Overall Study|Withdrawal by Subject|1|||
130306082|NCT00250276|469083564|FG001|Overall Study|Withdrawal by Subject|2|||
130306083|NCT00250276|469083565|FG002|Overall Study|Withdrawal by Subject|3|||
130306084|NCT00250276|469083566|FG003|Overall Study|Withdrawal by Subject|2|||
130306085|NCT00250276|469083563|FG000|Overall Study|Migrated/moved from study area|3|||
130306086|NCT00250276|469083564|FG001|Overall Study|Migrated/moved from study area|0|||
130373903|NCT02321800|469336840|FG000|Overall Study|Protocol Violation|1|||
130373904|NCT02321800|469336841|FG001|Overall Study|Protocol Violation|0|||
130306087|NCT00250276|469083565|FG002|Overall Study|Migrated/moved from study area|2|||
130306088|NCT00250276|469083566|FG003|Overall Study|Migrated/moved from study area|7|||
130306089|NCT00250276|469083563|FG000|Overall Study|Lost to Follow-up|11|||
130306090|NCT00250276|469083564|FG001|Overall Study|Lost to Follow-up|18|||
130306091|NCT00250276|469083565|FG002|Overall Study|Lost to Follow-up|13|||
130306092|NCT00250276|469083566|FG003|Overall Study|Lost to Follow-up|8|||
130306093|NCT01546688|469083567|FG000|Overall Study|Adverse Event|0|||
130306094|NCT01546688|469083568|FG001|Overall Study|Adverse Event|4|||
130306095|NCT01546688|469083567|FG000|Overall Study|Withdrawal by Subject|2|||
130306096|NCT01546688|469083568|FG001|Overall Study|Withdrawal by Subject|1|||
130306097|NCT01546688|469083567|FG000|Overall Study|Lack of Efficacy|1|||
130306098|NCT01546688|469083568|FG001|Overall Study|Lack of Efficacy|0|||
130306099|NCT01811186|469083569|FG000|Overall Study|Adverse Event|54|||
130306100|NCT01811186|469083570|FG001|Overall Study|Adverse Event|38|||
130306101|NCT01811186|469083569|FG000|Overall Study|Protocol Violation|5|||
130306102|NCT01811186|469083570|FG001|Overall Study|Protocol Violation|6|||
130306103|NCT01811186|469083569|FG000|Overall Study|Withdrawal by Subject|5|||
130306104|NCT01811186|469083570|FG001|Overall Study|Withdrawal by Subject|10|||
130306105|NCT01811186|469083569|FG000|Overall Study|Lack of Efficacy|3|||
130306106|NCT01811186|469083570|FG001|Overall Study|Lack of Efficacy|6|||
130306107|NCT01811186|469083569|FG000|Overall Study|Lost to Follow-up|4|||
130306108|NCT01811186|469083570|FG001|Overall Study|Lost to Follow-up|2|||
130306109|NCT03369236|469083571|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
130306110|NCT03369236|469083572|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
130306111|NCT03369236|469083571|FG000|Open-label Extension Period|Lack of Efficacy|2|||
130306112|NCT03369236|469083572|FG001|Open-label Extension Period|Lack of Efficacy|1|||
130306113|NCT03369236|469083571|FG000|Open-label Extension Period|Adverse Event|0|||
130306114|NCT03369236|469083572|FG001|Open-label Extension Period|Adverse Event|1|||
130306115|NCT03369236|469083571|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
130306116|NCT03369236|469083572|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
130306117|NCT01153724|469083575|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130306118|NCT01153724|469083575|FG000|Treatment Period 2|Adverse Event|1|||
130306119|NCT01153724|469083575|FG000|Treatment Period 2|Other reason not defined above|1|||
130306120|NCT02508428|469083586|FG000|Overall Study|Death|32|||
130306121|NCT02508428|469083587|FG001|Overall Study|Death|33|||
130306122|NCT02508428|469083586|FG000|Overall Study|Liner revised|3|||
130306123|NCT02508428|469083587|FG001|Overall Study|Liner revised|19|||
130306124|NCT02508428|469083586|FG000|Overall Study|Incomplete follow-up|17|||
130306125|NCT02508428|469083587|FG001|Overall Study|Incomplete follow-up|15|||
130306126|NCT00534976|469083592|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
130306127|NCT00534976|469083593|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
130306128|NCT00534976|469083592|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
130306129|NCT00534976|469083593|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
130306130|NCT00534976|469083592|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
130306131|NCT00534976|469083593|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
130306132|NCT02123576|469083594|FG000|Overall Study|Adverse Event|1|||
130306133|NCT02123576|469083595|FG001|Overall Study|Adverse Event|0|||
130306134|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
130306135|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
130306136|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Adverse Event|4|||
130306137|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Adverse Event|1|||
130306138|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
130306139|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
130306140|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Patient preference|1|||
130306141|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Patient preference|3|||
130306142|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Pain|1|||
130306143|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Pain|0|||
130306144|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Too tired|1|||
130306145|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Too tired|0|||
130306146|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
130306147|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
130306148|NCT00934128|469083596|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
130306149|NCT00934128|469083597|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
130306150|NCT02834247|469083598|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
130306151|NCT02834247|469083599|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
130306152|NCT02834247|469083600|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130306153|NCT02834247|469083601|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130306154|NCT02834247|469083598|FG000|Dose Escalation Phase|Death|5|||
130306155|NCT02834247|469083599|FG001|Dose Escalation Phase|Death|6|||
130306156|NCT02834247|469083600|FG002|Dose Escalation Phase|Death|5|||
130306157|NCT02834247|469083601|FG003|Dose Escalation Phase|Death|0|||
130306158|NCT02834247|469083598|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
130306159|NCT02834247|469083599|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
130306160|NCT02834247|469083600|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
130306161|NCT02834247|469083601|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
130306162|NCT02834247|469083598|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
130306163|NCT02834247|469083599|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
130306164|NCT02834247|469083600|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130306165|NCT02834247|469083601|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130306166|NCT02834247|469083598|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306167|NCT02834247|469083599|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306168|NCT02834247|469083600|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306169|NCT02834247|469083601|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
130306170|NCT02834247|469083598|FG000|Dose Expansion Phase|Death|0|||
130306171|NCT02834247|469083599|FG001|Dose Expansion Phase|Death|0|||
130306172|NCT02834247|469083600|FG002|Dose Expansion Phase|Death|0|||
130306173|NCT02834247|469083601|FG003|Dose Expansion Phase|Death|8|||
130306174|NCT02834247|469083598|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
130306175|NCT02834247|469083599|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130306176|NCT02834247|469083600|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
130306177|NCT02834247|469083601|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
130306178|NCT02834247|469083598|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
130373905|NCT02321800|469336840|FG000|Overall Study|Lost to Follow-up|10|||
130306179|NCT02834247|469083599|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
130306180|NCT02834247|469083600|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
130306181|NCT02834247|469083601|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
130306182|NCT00799266|469085140|FG000|Overall Study|Adverse Event|0|||
130306183|NCT00799266|469085141|FG001|Overall Study|Adverse Event|1|||
130306184|NCT00799266|469085140|FG000|Overall Study|Subject withdrew consent|3|||
130306185|NCT00799266|469085141|FG001|Overall Study|Subject withdrew consent|0|||
130306186|NCT01061359|469085143|FG000|Overall Study|Death|32|||
130306187|NCT01061359|469085143|FG000|Overall Study|Lost to Follow-up|1072|||
130306188|NCT01061359|469085143|FG000|Overall Study|Relapse|187|||
130306189|NCT01061359|469085143|FG000|Overall Study|Secondary neoplasm|11|||
130306190|NCT04273893|469085150|FG000|Overall Study|Withdrawal by Subject|0|||
130306191|NCT04273893|469085151|FG001|Overall Study|Withdrawal by Subject|2|||
130306192|NCT04273893|469085150|FG000|Overall Study|Treatment of Disease Progression|0|||
130306193|NCT04273893|469085151|FG001|Overall Study|Treatment of Disease Progression|2|||
130306194|NCT04273893|469085150|FG000|Overall Study|Death|1|||
130306195|NCT04273893|469085151|FG001|Overall Study|Death|2|||
130306196|NCT04273893|469085150|FG000|Overall Study|Lost to Follow-up|0|||
130306197|NCT04273893|469085151|FG001|Overall Study|Lost to Follow-up|2|||
130306198|NCT04273893|469085150|FG000|Overall Study|Physician Decision|1|||
130306199|NCT04273893|469085151|FG001|Overall Study|Physician Decision|0|||
130306200|NCT01036321|469085153|FG000|Overall Study|Ineligible after randomization|0|||
130306201|NCT01036321|469085154|FG001|Overall Study|Ineligible after randomization|1|||
130306202|NCT01036321|469085153|FG000|Overall Study|Withdrawal by Subject|3|||
130306203|NCT01036321|469085154|FG001|Overall Study|Withdrawal by Subject|2|||
130306204|NCT01036321|469085153|FG000|Overall Study|Adverse Event|2|||
130306205|NCT01036321|469085154|FG001|Overall Study|Adverse Event|1|||
130306206|NCT00381693|469085157|FG000|Overall Study|Death|1|||
130306207|NCT00381693|469085157|FG000|Overall Study|Adverse Event|4|||
130306208|NCT00381693|469085157|FG000|Overall Study|Patient Choice|1|||
130306209|NCT00381693|469085157|FG000|Overall Study|Progression|2|||
130306210|NCT02598297|469085158|FG000|Overall Study|Study terminated by Sponsor|21|||
130306211|NCT02598297|469085159|FG001|Overall Study|Study terminated by Sponsor|23|||
130306212|NCT02598297|469085158|FG000|Overall Study|Adverse Event|1|||
130306213|NCT02598297|469085159|FG001|Overall Study|Adverse Event|1|||
130306214|NCT02598297|469085158|FG000|Overall Study|Physician Decision|1|||
130306215|NCT02598297|469085159|FG001|Overall Study|Physician Decision|0|||
130306216|NCT02598297|469085158|FG000|Overall Study|Subject/guardian decision|1|||
130306217|NCT02598297|469085159|FG001|Overall Study|Subject/guardian decision|0|||
130306218|NCT02598297|469085158|FG000|Overall Study|Followed for survival|1|||
130306219|NCT02598297|469085159|FG001|Overall Study|Followed for survival|0|||
130306220|NCT00394706|469085170|FG000|Overall Study|Withdrawal by Subject|2|||
130306221|NCT00394706|469085171|FG001|Overall Study|Withdrawal by Subject|0|||
130306222|NCT00394706|469085172|FG002|Overall Study|Withdrawal by Subject|1|||
130306223|NCT00394706|469085173|FG003|Overall Study|Withdrawal by Subject|0|||
130306224|NCT00394706|469085174|FG004|Overall Study|Withdrawal by Subject|0|||
130306225|NCT00394706|469085175|FG005|Overall Study|Withdrawal by Subject|2|||
130306226|NCT00394706|469085176|FG006|Overall Study|Withdrawal by Subject|1|||
130464416|NCT03073941|469667126|FG000|Overall Study|Adverse Event|4|||
130306227|NCT00394706|469085177|FG007|Overall Study|Withdrawal by Subject|0|||
130306228|NCT00394706|469085170|FG000|Overall Study|Lost to Follow-up|2|||
130306229|NCT00394706|469085171|FG001|Overall Study|Lost to Follow-up|2|||
130306230|NCT00394706|469085172|FG002|Overall Study|Lost to Follow-up|8|||
130306231|NCT00394706|469085173|FG003|Overall Study|Lost to Follow-up|1|||
130306232|NCT00394706|469085174|FG004|Overall Study|Lost to Follow-up|2|||
130306233|NCT00394706|469085175|FG005|Overall Study|Lost to Follow-up|5|||
130306234|NCT00394706|469085176|FG006|Overall Study|Lost to Follow-up|2|||
130306235|NCT00394706|469085177|FG007|Overall Study|Lost to Follow-up|0|||
130306236|NCT02003534|469085181|FG000|Overall Study|Lost to Follow-up|47|||
130306237|NCT02506192|469085184|FG000|Overall Study|Withdrawal by Subject|1|||
130306238|NCT02506192|469085185|FG001|Overall Study|Withdrawal by Subject|1|||
130306239|NCT05292131|469085188|FG000|Overall Study|Lost to Follow-up|1|||
130306240|NCT05292131|469085189|FG001|Overall Study|Lost to Follow-up|1|||
130306241|NCT05292131|469085188|FG000|Overall Study|Withdrawal by Subject|0|||
130306242|NCT05292131|469085189|FG001|Overall Study|Withdrawal by Subject|1|||
130306243|NCT06136897|469085190|FG000|Overall Study|Ineligible|3|||
130717202|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717203|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717204|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717205|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717206|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717207|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717208|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717209|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717210|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
130717211|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717212|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717213|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717214|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717215|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Adverse Event|0|||
130717216|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Adverse Event|0|||
130717217|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Adverse Event|0|||
130717218|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Adverse Event|0|||
130717219|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Adverse Event|0|||
130717220|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Adverse Event|0|||
130717221|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Adverse Event|0|||
130717222|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Adverse Event|0|||
130717223|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Adverse Event|0|||
130717224|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Adverse Event|0|||
130717225|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Adverse Event|0|||
130717226|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Adverse Event|0|||
130717227|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Adverse Event|0|||
130717228|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Adverse Event|0|||
130717229|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Adverse Event|0|||
130717230|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Adverse Event|0|||
130717231|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Adverse Event|0|||
130306244|NCT06136897|469085190|FG000|Overall Study|Mutation status not confirmed|7|||
130306245|NCT06136897|469085190|FG000|Overall Study|Adverse Event|2|||
130306246|NCT06136897|469085190|FG000|Overall Study|Death|1|||
130306247|NCT06136897|469085190|FG000|Overall Study|Disease progression|18|||
130557636|NCT04178967|470011826|FG010|Induction Period|Withdrawal by Subject|0|||
130557637|NCT04178967|470011816|FG000|Induction Period|Lost to Follow-up|2|||
130557638|NCT04178967|470011817|FG001|Induction Period|Lost to Follow-up|0|||
130557639|NCT04178967|470011818|FG002|Induction Period|Lost to Follow-up|0|||
130717232|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Adverse Event|0|||
130717233|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Adverse Event|0|||
130717234|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Adverse Event|0|||
130717235|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Adverse Event|0|||
130717236|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Adverse Event|0|||
130717237|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Adverse Event|0|||
130717238|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Adverse Event|1|||
130717239|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Adverse Event|0|||
130717240|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717241|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717242|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717243|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717244|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717245|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717246|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717247|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717248|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717249|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717250|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717251|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717252|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717253|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717254|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717255|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717256|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717257|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717258|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717259|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717260|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717261|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717262|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717263|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
130717264|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717265|NCT01006135|470590986|FG000|Overall Study|Adverse Event|22|||
130717266|NCT01006135|470590986|FG000|Overall Study|Protocol Violation|14|||
130717267|NCT01006135|470590986|FG000|Overall Study|Lost to Follow-up|32|||
130717268|NCT01006135|470590986|FG000|Overall Study|Other|72|||
130717269|NCT00117325|470590987|FG000|Overall Study|Adverse Event|3|||
130717270|NCT00117325|470590988|FG001|Overall Study|Adverse Event|3|||
130717271|NCT00117325|470590987|FG000|Overall Study|Lost to Follow-up|1|||
130717272|NCT00117325|470590988|FG001|Overall Study|Lost to Follow-up|1|||
130717273|NCT00117325|470590987|FG000|Overall Study|Protocol Violation|2|||
130717274|NCT00117325|470590988|FG001|Overall Study|Protocol Violation|3|||
130306248|NCT06136897|469085190|FG000|Overall Study|Other complicating disease|1|||
130306249|NCT06136897|469085190|FG000|Overall Study|Withdrawal by Subject|1|||
130717275|NCT00117325|470590987|FG000|Overall Study|Withdrawal by Subject|3|||
130717276|NCT00117325|470590988|FG001|Overall Study|Withdrawal by Subject|2|||
130717277|NCT00117325|470590987|FG000|Overall Study|Lack of Efficacy|1|||
130306250|NCT06136897|469085190|FG000|Overall Study|Still on treatment|1|||
130557640|NCT04178967|470011819|FG003|Induction Period|Lost to Follow-up|0|||
130557641|NCT04178967|470011820|FG004|Induction Period|Lost to Follow-up|0|||
130557642|NCT04178967|470011821|FG005|Induction Period|Lost to Follow-up|0|||
130557643|NCT04178967|470011822|FG006|Induction Period|Lost to Follow-up|0|||
130557644|NCT04178967|470011823|FG007|Induction Period|Lost to Follow-up|0|||
130557645|NCT04178967|470011824|FG008|Induction Period|Lost to Follow-up|0|||
130557646|NCT04178967|470011825|FG009|Induction Period|Lost to Follow-up|0|||
130557647|NCT04178967|470011826|FG010|Induction Period|Lost to Follow-up|0|||
130557648|NCT04178967|470011816|FG000|Induction Period|Participant Missed Study Visits|0|||
130557649|NCT04178967|470011817|FG001|Induction Period|Participant Missed Study Visits|1|||
130557650|NCT04178967|470011818|FG002|Induction Period|Participant Missed Study Visits|0|||
130557651|NCT04178967|470011819|FG003|Induction Period|Participant Missed Study Visits|0|||
130557652|NCT04178967|470011820|FG004|Induction Period|Participant Missed Study Visits|0|||
130557653|NCT04178967|470011821|FG005|Induction Period|Participant Missed Study Visits|0|||
130557654|NCT04178967|470011822|FG006|Induction Period|Participant Missed Study Visits|0|||
130557655|NCT04178967|470011823|FG007|Induction Period|Participant Missed Study Visits|0|||
130557656|NCT04178967|470011824|FG008|Induction Period|Participant Missed Study Visits|0|||
130557657|NCT04178967|470011825|FG009|Induction Period|Participant Missed Study Visits|0|||
130557658|NCT04178967|470011826|FG010|Induction Period|Participant Missed Study Visits|0|||
130557659|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557660|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557661|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557662|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557663|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557664|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
130557665|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
130557666|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
130557667|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557668|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557669|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
130557670|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557671|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557672|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557673|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557674|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557675|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
130557676|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557677|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557678|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557679|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557680|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130557681|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130717278|NCT00117325|470590988|FG001|Overall Study|Lack of Efficacy|0|||
130717279|NCT00117325|470590987|FG000|Overall Study|Use of prohibited medicine|1|||
130717280|NCT00117325|470590988|FG001|Overall Study|Use of prohibited medicine|2|||
130717281|NCT00117325|470590987|FG000|Overall Study|Early termination|1|||
130717282|NCT00117325|470590988|FG001|Overall Study|Early termination|1|||
130717283|NCT00117325|470590987|FG000|Overall Study|Admisnitrative|1|||
130717284|NCT00117325|470590988|FG001|Overall Study|Admisnitrative|0|||
130717285|NCT00338455|470590996|FG000|Overall Study|Death|2|||
130717286|NCT00338455|470590997|FG001|Overall Study|Death|1|||
130717287|NCT00338455|470590996|FG000|Overall Study|Physician Decision|1|||
130717288|NCT00338455|470590997|FG001|Overall Study|Physician Decision|0|||
130717289|NCT05084963|470591002|FG000|Overall Study|Withdrawal by Subject|0|||
130717290|NCT05084963|470591003|FG001|Overall Study|Withdrawal by Subject|0|||
130717291|NCT05084963|470591004|FG002|Overall Study|Withdrawal by Subject|1|||
130717292|NCT05442866|470591005|FG000|Overall Study|Death|1|||
130717293|NCT05442866|470591005|FG000|Overall Study|Lost to Follow-up|9|||
130717294|NCT05442866|470591005|FG000|Overall Study|Protocol Violation|1|||
130717295|NCT03819049|470591006|FG000|Overall Study|Lost to Follow-up|1|||
130717296|NCT03819049|470591007|FG001|Overall Study|Lost to Follow-up|2|||
130717297|NCT03819049|470591008|FG002|Overall Study|Lost to Follow-up|9|||
130717298|NCT03819049|470591009|FG003|Overall Study|Lost to Follow-up|0|||
130717299|NCT03819049|470591010|FG004|Overall Study|Lost to Follow-up|3|||
130717300|NCT03819049|470591011|FG005|Overall Study|Lost to Follow-up|1|||
130717301|NCT03819049|470591012|FG006|Overall Study|Lost to Follow-up|0|||
130717302|NCT03819049|470591006|FG000|Overall Study|Withdrawal by Subject|0|||
130557682|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130717303|NCT03819049|470591007|FG001|Overall Study|Withdrawal by Subject|0|||
130717304|NCT03819049|470591008|FG002|Overall Study|Withdrawal by Subject|18|||
130717305|NCT03819049|470591009|FG003|Overall Study|Withdrawal by Subject|0|||
130717306|NCT03819049|470591010|FG004|Overall Study|Withdrawal by Subject|10|||
130306251|NCT06136897|469085190|FG000|Overall Study|Lost to Follow-up|1|||
130306252|NCT03785405|469085191|FG000|Overall Study|Adverse Event|16|||
130306253|NCT03785405|469085192|FG001|Overall Study|Adverse Event|1|||
130306254|NCT03785405|469085191|FG000|Overall Study|Death|6|||
130306255|NCT03785405|469085192|FG001|Overall Study|Death|4|||
130306256|NCT03785405|469085191|FG000|Overall Study|Guardian decision|4|||
130306257|NCT03785405|469085192|FG001|Overall Study|Guardian decision|1|||
130306258|NCT03785405|469085191|FG000|Overall Study|Lost to Follow-up|1|||
130306259|NCT03785405|469085192|FG001|Overall Study|Lost to Follow-up|0|||
130306260|NCT03785405|469085191|FG000|Overall Study|Physician Decision|8|||
130306261|NCT03785405|469085192|FG001|Overall Study|Physician Decision|5|||
130306262|NCT03785405|469085191|FG000|Overall Study|Participant decision|2|||
130306263|NCT03785405|469085192|FG001|Overall Study|Participant decision|0|||
130306264|NCT03785405|469085191|FG000|Overall Study|Other|1|||
130306265|NCT03785405|469085192|FG001|Overall Study|Other|0|||
130306266|NCT03785405|469085191|FG000|Overall Study|No treatment was received|0|||
130306267|NCT03785405|469085192|FG001|Overall Study|No treatment was received|1|||
130306268|NCT03705559|469085193|FG000|Overall Study|COVID Shut down|1|||
130306269|NCT02881762|469085196|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130306270|NCT02881762|469085197|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130306271|NCT00203424|469085201|FG000|Treatment Period|Withdrawal by Subject|4|||
130306272|NCT00203424|469085201|FG000|Treatment Period|Adverse Event|5|||
130306273|NCT00203424|469085201|FG000|Treatment Period|progressive disease|2|||
130306274|NCT00203424|469085201|FG000|Follow-up Period|Withdrawal by Subject|1|||
130306275|NCT00203424|469085201|FG000|Follow-up Period|progressive disease|4|||
130306276|NCT00203424|469085201|FG000|Follow-up Period|Lost to Follow-up|1|||
130306277|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
130306278|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306279|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306280|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306281|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306282|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306283|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
130306284|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306285|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306286|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306287|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306288|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306289|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
130306290|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306291|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306292|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306293|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306294|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306295|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
130306296|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306297|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306298|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306299|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306300|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306301|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
130557683|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130557684|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130557685|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130306302|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306303|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306304|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130557686|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130717307|NCT03819049|470591011|FG005|Overall Study|Withdrawal by Subject|9|||
130717308|NCT03819049|470591012|FG006|Overall Study|Withdrawal by Subject|1|||
130717309|NCT03819049|470591006|FG000|Overall Study|Ongoing|0|||
130717310|NCT03819049|470591007|FG001|Overall Study|Ongoing|0|||
130717311|NCT03819049|470591008|FG002|Overall Study|Ongoing|75|||
130717312|NCT03819049|470591009|FG003|Overall Study|Ongoing|0|||
130717313|NCT03819049|470591010|FG004|Overall Study|Ongoing|41|||
130717314|NCT03819049|470591011|FG005|Overall Study|Ongoing|0|||
130717315|NCT03819049|470591012|FG006|Overall Study|Ongoing|0|||
130717316|NCT03819049|470591006|FG000|Overall Study|Other|0|||
130717317|NCT03819049|470591007|FG001|Overall Study|Other|0|||
130717318|NCT03819049|470591008|FG002|Overall Study|Other|2|||
130717319|NCT03819049|470591009|FG003|Overall Study|Other|0|||
130717320|NCT03819049|470591010|FG004|Overall Study|Other|0|||
130717321|NCT03819049|470591011|FG005|Overall Study|Other|0|||
130557687|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130557688|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130557689|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130557690|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130557691|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130306305|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306306|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306307|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130306308|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306309|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306310|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306311|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306312|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306313|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130306314|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
130306315|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
130306316|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
130306317|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
130306318|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
130306319|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130557692|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557693|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557694|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557695|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557696|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557697|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557698|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
130557699|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557700|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557701|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557702|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
130557703|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557704|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557705|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557706|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557707|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130557708|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
130557709|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557710|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
130557711|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557712|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557713|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130557714|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130557715|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130557716|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130557717|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130557718|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130557719|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130557720|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
130557721|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
130557722|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130717322|NCT03819049|470591012|FG006|Overall Study|Other|0|||
130717323|NCT03819049|470591006|FG000|Overall Study|Randomized but not vaccinated|0|||
130717324|NCT03819049|470591007|FG001|Overall Study|Randomized but not vaccinated|0|||
130717325|NCT03819049|470591008|FG002|Overall Study|Randomized but not vaccinated|0|||
130717326|NCT03819049|470591009|FG003|Overall Study|Randomized but not vaccinated|1|||
130717327|NCT03819049|470591010|FG004|Overall Study|Randomized but not vaccinated|0|||
130717328|NCT03819049|470591011|FG005|Overall Study|Randomized but not vaccinated|2|||
130717329|NCT03819049|470591012|FG006|Overall Study|Randomized but not vaccinated|1|||
130717330|NCT03819049|470591006|FG000|Overall Study|Physician Decision|0|||
130717331|NCT03819049|470591007|FG001|Overall Study|Physician Decision|0|||
130717332|NCT03819049|470591008|FG002|Overall Study|Physician Decision|0|||
130717333|NCT03819049|470591009|FG003|Overall Study|Physician Decision|0|||
130717334|NCT03819049|470591010|FG004|Overall Study|Physician Decision|0|||
130717335|NCT03819049|470591011|FG005|Overall Study|Physician Decision|0|||
130717336|NCT03819049|470591012|FG006|Overall Study|Physician Decision|1|||
130717337|NCT01568320|470591013|FG000|Overall Study|Death|20|||
130306320|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130306321|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130306322|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130306323|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130306324|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130306325|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130306326|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
130306327|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
130306328|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130306329|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
130306330|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130306331|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130306332|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130306333|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130306334|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130306335|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
130306336|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130306337|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130306338|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
130306339|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
130306340|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
130306341|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130306342|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
130306343|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130306344|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
130306345|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130306346|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130306347|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130306348|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130306349|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130306350|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306351|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
130306352|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306353|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306354|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
130306355|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130306356|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
130306357|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130306358|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130306359|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
130306360|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130306361|NCT01922271|469085208|FG000|WASHOUT Period|Withdrawal by Subject|1|||
130306362|NCT01922271|469085209|FG001|WASHOUT Period|Withdrawal by Subject|0|||
130306363|NCT01824355|469085210|FG000|Overall Study|Adverse Event|2|||
130306364|NCT01824355|469085210|FG000|Overall Study|unevaluable reference method results per|1|||
130306365|NCT02576795|469085212|FG000|Overall Study|Lost to Follow-up|0|||
130306366|NCT02576795|469085213|FG001|Overall Study|Lost to Follow-up|0|||
130306367|NCT02576795|469085214|FG002|Overall Study|Lost to Follow-up|1|||
130306368|NCT02576795|469085215|FG003|Overall Study|Lost to Follow-up|0|||
130306369|NCT04427072|469085217|FG000|Randomized Treatment Phase|Progressive disease|9|||
130306370|NCT04427072|469085218|FG001|Randomized Treatment Phase|Progressive disease|4|||
130306371|NCT04427072|469085217|FG000|Randomized Treatment Phase|Adverse Event|3|||
130306372|NCT04427072|469085218|FG001|Randomized Treatment Phase|Adverse Event|1|||
130306373|NCT04427072|469085217|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
130306374|NCT04427072|469085218|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
130306375|NCT04427072|469085217|FG000|Randomized Treatment Phase|Death|0|||
130306376|NCT04427072|469085218|FG001|Randomized Treatment Phase|Death|1|||
130306377|NCT04427072|469085217|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
130306378|NCT04427072|469085218|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
130306379|NCT04427072|469085217|FG000|Extension Treatment Phase|Progressive disease|0|||
130306380|NCT04427072|469085218|FG001|Extension Treatment Phase|Progressive disease|5|||
130306381|NCT05232864|469085219|FG000|Overall Study|Adverse Event|0|||
130306382|NCT05232864|469085220|FG001|Overall Study|Adverse Event|1|||
130306383|NCT05232864|469085219|FG000|Overall Study|Study terminated by sponsor|16|||
130306384|NCT05232864|469085220|FG001|Overall Study|Study terminated by sponsor|14|||
130306385|NCT00465452|469085227|FG000|Overall Study|Adverse Event|1|||
130306386|NCT02104947|469085233|FG000|Overall Study|Withdrawal by Subject|10|||
130306387|NCT02104947|469085234|FG001|Overall Study|Withdrawal by Subject|3|||
130306388|NCT02104947|469085233|FG000|Overall Study|Lost to Follow-up|4|||
130306389|NCT02104947|469085234|FG001|Overall Study|Lost to Follow-up|4|||
130306390|NCT02104947|469085233|FG000|Overall Study|Protocol Violation|6|||
130306391|NCT02104947|469085234|FG001|Overall Study|Protocol Violation|8|||
130306392|NCT02104947|469085233|FG000|Overall Study|Adverse Event|57|||
130306393|NCT02104947|469085234|FG001|Overall Study|Adverse Event|38|||
130306394|NCT02104947|469085233|FG000|Overall Study|Other than stated above|2|||
130306395|NCT02104947|469085234|FG001|Overall Study|Other than stated above|3|||
130306396|NCT00145574|469085235|FG000|Double Blind|Adverse Event|0|||
130306397|NCT00145574|469085236|FG001|Double Blind|Adverse Event|3|||
130306398|NCT00145574|469085237|FG002|Double Blind|Adverse Event|1|||
130306399|NCT00145574|469085235|FG000|Double Blind|Withdrawal by Subject|1|||
130306400|NCT00145574|469085236|FG001|Double Blind|Withdrawal by Subject|1|||
130306401|NCT00145574|469085237|FG002|Double Blind|Withdrawal by Subject|1|||
130306402|NCT00145574|469085235|FG000|Double Blind|required restricted medicine|0|||
130306403|NCT00145574|469085236|FG001|Double Blind|required restricted medicine|1|||
130306404|NCT00145574|469085237|FG002|Double Blind|required restricted medicine|0|||
130306405|NCT00145574|469085235|FG000|Open Label Long-term Extension|Adverse Event|0|||
130306406|NCT00145574|469085236|FG001|Open Label Long-term Extension|Adverse Event|0|||
130306407|NCT00145574|469085237|FG002|Open Label Long-term Extension|Adverse Event|5|||
130306408|NCT00145574|469085235|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
130306409|NCT00145574|469085236|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
130306410|NCT00145574|469085237|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
130306411|NCT00145574|469085235|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
130306412|NCT00145574|469085236|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
130306413|NCT00145574|469085237|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
130306414|NCT00145574|469085235|FG000|Open Label Long-term Extension|required restricted medicine|0|||
130306415|NCT00145574|469085236|FG001|Open Label Long-term Extension|required restricted medicine|0|||
130306416|NCT00145574|469085237|FG002|Open Label Long-term Extension|required restricted medicine|1|||
130306417|NCT00858637|469085241|FG000|Active Comparison Phase|Adverse Event|14|||
130306418|NCT00858637|469085242|FG001|Active Comparison Phase|Adverse Event|0|||
130306419|NCT00858637|469085243|FG002|Active Comparison Phase|Adverse Event|0|||
130306420|NCT00858637|469085244|FG003|Active Comparison Phase|Adverse Event|9|||
130306421|NCT00858637|469085245|FG004|Active Comparison Phase|Adverse Event|0|||
130306422|NCT00858637|469085246|FG005|Active Comparison Phase|Adverse Event|0|||
130717338|NCT01568320|470591013|FG000|Overall Study|Lost to Follow-up|9|||
130717339|NCT01568320|470591013|FG000|Overall Study|Withdrawal by Subject|10|||
130717340|NCT01568320|470591013|FG000|Overall Study|Conversion to open repair|1|||
130717341|NCT01568320|470591013|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
130717342|NCT01616953|470591014|FG000|Overall Study|Lost to Follow-up|1|||
130717343|NCT01616953|470591015|FG001|Overall Study|Lost to Follow-up|0|||
130717344|NCT01616953|470591014|FG000|Overall Study|lack of bone and soft tissue|1|||
130717345|NCT01616953|470591015|FG001|Overall Study|lack of bone and soft tissue|0|||
130717346|NCT01394952|470591016|FG000|Overall Study|Lost to Follow-up|0|||
130717347|NCT01394952|470591017|FG001|Overall Study|Lost to Follow-up|5|||
130717348|NCT01394952|470591016|FG000|Overall Study|Withdrawal by Subject|10|||
130717349|NCT01394952|470591017|FG001|Overall Study|Withdrawal by Subject|5|||
130717350|NCT01394952|470591016|FG000|Overall Study|Physician Decision|2|||
130717351|NCT01394952|470591017|FG001|Overall Study|Physician Decision|0|||
130717352|NCT01394952|470591016|FG000|Overall Study|Sponsor Decision|5|||
130717353|NCT01394952|470591017|FG001|Overall Study|Sponsor Decision|7|||
130717354|NCT01986010|470591018|FG000|Overall Study|Adverse Event|0|||
130306423|NCT00858637|469085241|FG000|Active Comparison Phase|Death|1|||
130306424|NCT00858637|469085242|FG001|Active Comparison Phase|Death|0|||
130306425|NCT00858637|469085243|FG002|Active Comparison Phase|Death|0|||
130306426|NCT00858637|469085244|FG003|Active Comparison Phase|Death|1|||
130306427|NCT00858637|469085245|FG004|Active Comparison Phase|Death|0|||
130306428|NCT00858637|469085246|FG005|Active Comparison Phase|Death|0|||
130306429|NCT00858637|469085241|FG000|Active Comparison Phase|Physician Decision|1|||
130306430|NCT00858637|469085242|FG001|Active Comparison Phase|Physician Decision|0|||
130306431|NCT00858637|469085243|FG002|Active Comparison Phase|Physician Decision|0|||
130306432|NCT00858637|469085244|FG003|Active Comparison Phase|Physician Decision|1|||
130717355|NCT01986010|470591019|FG001|Overall Study|Adverse Event|1|||
130717356|NCT01986010|470591020|FG002|Overall Study|Adverse Event|0|||
130306433|NCT00858637|469085245|FG004|Active Comparison Phase|Physician Decision|0|||
130306434|NCT00858637|469085246|FG005|Active Comparison Phase|Physician Decision|0|||
130306435|NCT00858637|469085241|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
130306436|NCT00858637|469085242|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
130306437|NCT00858637|469085243|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
130717357|NCT01986010|470591021|FG003|Overall Study|Adverse Event|0|||
130717358|NCT01986010|470591022|FG004|Overall Study|Adverse Event|0|||
130306438|NCT00858637|469085244|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
130306439|NCT00858637|469085245|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
130306440|NCT00858637|469085246|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
130306441|NCT00858637|469085241|FG000|Active Comparison Phase|Other Reasons|1|||
130306442|NCT00858637|469085242|FG001|Active Comparison Phase|Other Reasons|0|||
130306443|NCT00858637|469085243|FG002|Active Comparison Phase|Other Reasons|0|||
130306444|NCT00858637|469085244|FG003|Active Comparison Phase|Other Reasons|1|||
130306445|NCT00858637|469085245|FG004|Active Comparison Phase|Other Reasons|0|||
130306446|NCT00858637|469085246|FG005|Active Comparison Phase|Other Reasons|0|||
130306447|NCT00858637|469085241|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
130306448|NCT00858637|469085242|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
130306449|NCT00858637|469085243|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
130306450|NCT00858637|469085244|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
130306451|NCT00858637|469085245|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
130306452|NCT00858637|469085246|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
130306453|NCT00858637|469085241|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306454|NCT00858637|469085242|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306455|NCT00858637|469085243|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306456|NCT00858637|469085244|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306457|NCT00858637|469085245|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306458|NCT00858637|469085246|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
130306459|NCT04677504|469085250|FG000|Overall Study|Death|51|||
130557723|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130557724|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130306460|NCT04677504|469085251|FG001|Overall Study|Death|49|||
130306461|NCT04677504|469085250|FG000|Overall Study|Progressive Disease|1|||
130306462|NCT04677504|469085251|FG001|Overall Study|Progressive Disease|0|||
130306463|NCT04677504|469085250|FG000|Overall Study|Symptomatic Deterioration|1|||
130306464|NCT04677504|469085251|FG001|Overall Study|Symptomatic Deterioration|0|||
130306465|NCT04677504|469085250|FG000|Overall Study|Withdrawal by Subject|2|||
130306466|NCT04677504|469085251|FG001|Overall Study|Withdrawal by Subject|5|||
130306467|NCT04677504|469085250|FG000|Overall Study|Study Terminated By Sponsor|28|||
130306468|NCT04677504|469085251|FG001|Overall Study|Study Terminated By Sponsor|24|||
130306469|NCT04677504|469085250|FG000|Overall Study|Adverse Event|0|||
130306470|NCT04677504|469085251|FG001|Overall Study|Adverse Event|1|||
130306471|NCT03182907|469085252|FG000|Overall Study|Death|3|||
130557725|NCT04178967|470011816|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130306472|NCT03182907|469085253|FG001|Overall Study|Death|0|||
130306473|NCT03182907|469085252|FG000|Overall Study|Protocol Violation|4|||
130373906|NCT02321800|469336841|FG001|Overall Study|Lost to Follow-up|4|||
130306474|NCT03182907|469085253|FG001|Overall Study|Protocol Violation|0|||
130306475|NCT03182907|469085252|FG000|Overall Study|Lost to Follow-up|1|||
130306476|NCT03182907|469085253|FG001|Overall Study|Lost to Follow-up|0|||
130306477|NCT03182907|469085252|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130306478|NCT03182907|469085253|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130306479|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
130306480|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130306481|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130306482|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
130306483|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130306484|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130306485|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
130306486|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130306487|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130306488|NCT04230213|469085263|FG000|TP2: Week 10 to Week 16|Other|0|||
130306489|NCT04230213|469085264|FG001|TP2: Week 10 to Week 16|Other|2|||
130306490|NCT04230213|469085265|FG002|TP2: Week 10 to Week 16|Other|1|||
130306491|NCT04230213|469085263|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130306492|NCT04230213|469085264|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130306493|NCT04230213|469085265|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
130306494|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130306495|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130306496|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
130306497|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130306498|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130306499|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
130306500|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
130306501|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
130306502|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
130306503|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Other|0|||
130306504|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Other|1|||
130306505|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Other|3|||
130306506|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Other|0|||
130306507|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Other|5|||
130306508|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Other|5|||
130306509|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
130464417|NCT03073941|469667127|FG001|Overall Study|Adverse Event|2|||
130464418|NCT03073941|469667126|FG000|Overall Study|Met an exclusion criterion|0|||
130464419|NCT03073941|469667127|FG001|Overall Study|Met an exclusion criterion|1|||
130464420|NCT04250883|469667128|FG000|Overall Study|Lost to Follow-up|1|||
130464421|NCT04250883|469667129|FG001|Overall Study|Lost to Follow-up|0|||
130464422|NCT01188655|469667131|FG000|Overall Study|Lack of Efficacy|1|||
130464423|NCT01188655|469667131|FG000|Overall Study|Lost to Follow-up|1|||
130464424|NCT01188655|469667131|FG000|Overall Study|Other|11|||
130464425|NCT00089544|469667132|FG000|Overall Study|Ineligible|1|||
130464426|NCT00089544|469667133|FG001|Overall Study|Ineligible|0|||
130464427|NCT02407249|469667138|FG000|Overall Study|Did not complete 12-month follow-up|13|||
130464428|NCT02407249|469667138|FG000|Overall Study|Not treated|13|||
130464429|NCT04425629|469667139|FG000|Overall Study|Adverse Event|0|||
130306510|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
130306511|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
130306512|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
130306513|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
130557726|NCT04178967|470011817|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130306514|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
130306515|NCT04230213|469085263|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130306516|NCT04230213|469085264|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130306517|NCT04230213|469085265|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
130306518|NCT04230213|469085263|FG000|Follow up: Week 32 to Week 36|Other|0|||
130306519|NCT04230213|469085264|FG001|Follow up: Week 32 to Week 36|Other|1|||
130306520|NCT04230213|469085265|FG002|Follow up: Week 32 to Week 36|Other|1|||
130306521|NCT01957202|469087097|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306522|NCT01957202|469087098|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130306523|NCT01957202|469087099|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306524|NCT01957202|469087100|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306525|NCT01957202|469087101|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306526|NCT01957202|469087102|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306527|NCT01957202|469087103|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306528|NCT01957202|469087104|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306529|NCT01957202|469087105|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130373907|NCT02321800|469336840|FG000|Overall Study|Adverse Event|2|||
130557727|NCT04178967|470011818|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130717359|NCT01986010|470591023|FG005|Overall Study|Adverse Event|0|||
130717360|NCT01986010|470591024|FG006|Overall Study|Adverse Event|0|||
130717361|NCT01986010|470591025|FG007|Overall Study|Adverse Event|0|||
130717362|NCT01986010|470591026|FG008|Overall Study|Adverse Event|0|||
130717363|NCT01986010|470591027|FG009|Overall Study|Adverse Event|0|||
130717364|NCT01986010|470591028|FG010|Overall Study|Adverse Event|0|||
130717365|NCT01986010|470591029|FG011|Overall Study|Adverse Event|0|||
130717366|NCT01986010|470591030|FG012|Overall Study|Adverse Event|0|||
130717367|NCT01986010|470591031|FG013|Overall Study|Adverse Event|0|||
130717368|NCT01986010|470591032|FG014|Overall Study|Adverse Event|0|||
130717369|NCT01986010|470591033|FG015|Overall Study|Adverse Event|1|||
130717370|NCT01986010|470591034|FG016|Overall Study|Adverse Event|0|||
130717371|NCT01986010|470591018|FG000|Overall Study|Lost to Follow-up|2|||
130717372|NCT01986010|470591019|FG001|Overall Study|Lost to Follow-up|1|||
130717373|NCT01986010|470591020|FG002|Overall Study|Lost to Follow-up|2|||
130717374|NCT01986010|470591021|FG003|Overall Study|Lost to Follow-up|2|||
130717375|NCT01986010|470591022|FG004|Overall Study|Lost to Follow-up|2|||
130717376|NCT01986010|470591023|FG005|Overall Study|Lost to Follow-up|2|||
130717377|NCT01986010|470591024|FG006|Overall Study|Lost to Follow-up|0|||
130717378|NCT01986010|470591025|FG007|Overall Study|Lost to Follow-up|0|||
130717379|NCT01986010|470591026|FG008|Overall Study|Lost to Follow-up|4|||
130717380|NCT01986010|470591027|FG009|Overall Study|Lost to Follow-up|2|||
130717381|NCT01986010|470591028|FG010|Overall Study|Lost to Follow-up|0|||
130717382|NCT01986010|470591029|FG011|Overall Study|Lost to Follow-up|1|||
130717383|NCT01986010|470591030|FG012|Overall Study|Lost to Follow-up|1|||
130717384|NCT01986010|470591031|FG013|Overall Study|Lost to Follow-up|1|||
130717385|NCT01986010|470591032|FG014|Overall Study|Lost to Follow-up|2|||
130717386|NCT01986010|470591033|FG015|Overall Study|Lost to Follow-up|0|||
130717387|NCT01986010|470591034|FG016|Overall Study|Lost to Follow-up|0|||
130717388|NCT01986010|470591018|FG000|Overall Study|Physician Decision|0|||
130717389|NCT01986010|470591019|FG001|Overall Study|Physician Decision|0|||
130717390|NCT01986010|470591020|FG002|Overall Study|Physician Decision|0|||
130717391|NCT01986010|470591021|FG003|Overall Study|Physician Decision|0|||
130717392|NCT01986010|470591022|FG004|Overall Study|Physician Decision|0|||
130717393|NCT01986010|470591023|FG005|Overall Study|Physician Decision|0|||
130717394|NCT01986010|470591024|FG006|Overall Study|Physician Decision|0|||
130717395|NCT01986010|470591025|FG007|Overall Study|Physician Decision|0|||
130717396|NCT01986010|470591026|FG008|Overall Study|Physician Decision|0|||
130717397|NCT01986010|470591027|FG009|Overall Study|Physician Decision|0|||
130717398|NCT01986010|470591028|FG010|Overall Study|Physician Decision|0|||
130717399|NCT01986010|470591029|FG011|Overall Study|Physician Decision|0|||
130717400|NCT01986010|470591030|FG012|Overall Study|Physician Decision|0|||
130717401|NCT01986010|470591031|FG013|Overall Study|Physician Decision|0|||
130717402|NCT01986010|470591032|FG014|Overall Study|Physician Decision|1|||
130717403|NCT01986010|470591033|FG015|Overall Study|Physician Decision|0|||
130717404|NCT01986010|470591034|FG016|Overall Study|Physician Decision|0|||
130717405|NCT01986010|470591018|FG000|Overall Study|Withdrawal by Subject|2|||
130717406|NCT01986010|470591019|FG001|Overall Study|Withdrawal by Subject|2|||
130717407|NCT01986010|470591020|FG002|Overall Study|Withdrawal by Subject|3|||
130717408|NCT01986010|470591021|FG003|Overall Study|Withdrawal by Subject|0|||
130717409|NCT01986010|470591022|FG004|Overall Study|Withdrawal by Subject|2|||
130717410|NCT01986010|470591023|FG005|Overall Study|Withdrawal by Subject|4|||
130717411|NCT01986010|470591024|FG006|Overall Study|Withdrawal by Subject|0|||
130717412|NCT01986010|470591025|FG007|Overall Study|Withdrawal by Subject|0|||
130717413|NCT01986010|470591026|FG008|Overall Study|Withdrawal by Subject|0|||
130717414|NCT01986010|470591027|FG009|Overall Study|Withdrawal by Subject|0|||
130717415|NCT01986010|470591028|FG010|Overall Study|Withdrawal by Subject|0|||
130717416|NCT01986010|470591029|FG011|Overall Study|Withdrawal by Subject|2|||
130717417|NCT01986010|470591030|FG012|Overall Study|Withdrawal by Subject|0|||
130717418|NCT01986010|470591031|FG013|Overall Study|Withdrawal by Subject|1|||
130717419|NCT01986010|470591032|FG014|Overall Study|Withdrawal by Subject|2|||
130717420|NCT01986010|470591033|FG015|Overall Study|Withdrawal by Subject|0|||
130557728|NCT04178967|470011819|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130557729|NCT04178967|470011820|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130557730|NCT04178967|470011821|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
130557731|NCT04178967|470011822|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130557732|NCT04178967|470011823|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
130557733|NCT04178967|470011824|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130717421|NCT01986010|470591034|FG016|Overall Study|Withdrawal by Subject|0|||
130717422|NCT01986010|470591018|FG000|Overall Study|Status Not Recorded|2|||
130717423|NCT01986010|470591019|FG001|Overall Study|Status Not Recorded|4|||
130717424|NCT01986010|470591020|FG002|Overall Study|Status Not Recorded|2|||
130717425|NCT01986010|470591021|FG003|Overall Study|Status Not Recorded|0|||
130717426|NCT01986010|470591022|FG004|Overall Study|Status Not Recorded|1|||
130717427|NCT01986010|470591023|FG005|Overall Study|Status Not Recorded|2|||
130717428|NCT01986010|470591024|FG006|Overall Study|Status Not Recorded|0|||
130717429|NCT01986010|470591025|FG007|Overall Study|Status Not Recorded|0|||
130717430|NCT01986010|470591026|FG008|Overall Study|Status Not Recorded|2|||
130717431|NCT01986010|470591027|FG009|Overall Study|Status Not Recorded|1|||
130717432|NCT01986010|470591028|FG010|Overall Study|Status Not Recorded|7|||
130717433|NCT01986010|470591029|FG011|Overall Study|Status Not Recorded|7|||
130717434|NCT01986010|470591030|FG012|Overall Study|Status Not Recorded|9|||
130717435|NCT01986010|470591031|FG013|Overall Study|Status Not Recorded|9|||
130717436|NCT01986010|470591032|FG014|Overall Study|Status Not Recorded|5|||
130717437|NCT01986010|470591033|FG015|Overall Study|Status Not Recorded|10|||
130717438|NCT01986010|470591034|FG016|Overall Study|Status Not Recorded|4|||
130717439|NCT01335997|470591035|FG000|Period I and II|Adverse Event|63|||
130717440|NCT01335997|470591036|FG001|Period I and II|Adverse Event|43|||
130717441|NCT01335997|470591035|FG000|Period I and II|Noncompliance with Study Drug|1|||
130717442|NCT01335997|470591036|FG001|Period I and II|Noncompliance with Study Drug|1|||
130717443|NCT01335997|470591035|FG000|Period I and II|Lost to Follow-up|3|||
130717444|NCT01335997|470591036|FG001|Period I and II|Lost to Follow-up|5|||
130717445|NCT01335997|470591035|FG000|Period I and II|Withdrawal by Subject|9|||
130717446|NCT01335997|470591036|FG001|Period I and II|Withdrawal by Subject|4|||
130717447|NCT01335997|470591035|FG000|Period I and II|Study Terminated by Sponsor|406|||
130717448|NCT01335997|470591036|FG001|Period I and II|Study Terminated by Sponsor|415|||
130717449|NCT01335997|470591035|FG000|Period I and II|Protocol Violation|9|||
130717450|NCT01335997|470591036|FG001|Period I and II|Protocol Violation|10|||
130717451|NCT01335997|470591035|FG000|Period I and II|Physician Decision|2|||
130717452|NCT01335997|470591036|FG001|Period I and II|Physician Decision|1|||
130717453|NCT01335997|470591035|FG000|Period III|Adverse Event|0|||
130717454|NCT01335997|470591036|FG001|Period III|Adverse Event|2|||
130717455|NCT01335997|470591035|FG000|Period III|Study Terminated by Sponsor|77|||
130717456|NCT01335997|470591036|FG001|Period III|Study Terminated by Sponsor|76|||
130717457|NCT01335997|470591035|FG000|Period III|Protocol Violation|0|||
130717458|NCT01335997|470591036|FG001|Period III|Protocol Violation|1|||
130717459|NCT01335997|470591035|FG000|Period III|Lost to Follow-up|1|||
130717460|NCT01335997|470591036|FG001|Period III|Lost to Follow-up|0|||
130717461|NCT01103466|470591039|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
130717462|NCT01103466|470591040|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130717463|NCT01103466|470591041|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130717464|NCT01103466|470591039|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
130717465|NCT01103466|470591040|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
130717466|NCT01103466|470591041|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
130306530|NCT01957202|469087106|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306531|NCT01957202|469087107|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306532|NCT01957202|469087108|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306533|NCT01957202|469087109|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306534|NCT01957202|469087110|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306535|NCT01957202|469087111|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306536|NCT01957202|469087112|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306537|NCT01957202|469087113|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130306538|NCT01957202|469087114|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306539|NCT01957202|469087097|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306540|NCT01957202|469087098|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306541|NCT01957202|469087099|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306542|NCT01957202|469087100|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306543|NCT01957202|469087101|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306544|NCT01957202|469087102|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306545|NCT01957202|469087103|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306546|NCT01957202|469087104|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306547|NCT01957202|469087105|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306548|NCT01957202|469087106|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306549|NCT01957202|469087107|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306550|NCT01957202|469087108|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306551|NCT01957202|469087109|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306552|NCT01957202|469087110|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306553|NCT01957202|469087111|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306554|NCT01957202|469087112|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306555|NCT01957202|469087113|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
130306556|NCT01957202|469087114|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306557|NCT01456169|469087115|FG000|Overall Study|Adverse Event|1|||
130306558|NCT01456169|469087116|FG001|Overall Study|Adverse Event|2|||
130306559|NCT01456169|469087117|FG002|Overall Study|Adverse Event|7|||
130306560|NCT01456169|469087115|FG000|Overall Study|Major Protocol Deviation|3|||
130306561|NCT01456169|469087116|FG001|Overall Study|Major Protocol Deviation|2|||
130306562|NCT01456169|469087117|FG002|Overall Study|Major Protocol Deviation|3|||
130306563|NCT01456169|469087115|FG000|Overall Study|Voluntary Withdrawal|3|||
130306564|NCT01456169|469087116|FG001|Overall Study|Voluntary Withdrawal|0|||
130306565|NCT01456169|469087117|FG002|Overall Study|Voluntary Withdrawal|2|||
130306566|NCT01456169|469087115|FG000|Overall Study|Lack of Efficacy|2|||
130306567|NCT01456169|469087116|FG001|Overall Study|Lack of Efficacy|0|||
130306568|NCT01456169|469087117|FG002|Overall Study|Lack of Efficacy|0|||
130306569|NCT01456169|469087115|FG000|Overall Study|Other|1|||
130306570|NCT01456169|469087116|FG001|Overall Study|Other|1|||
130306571|NCT01456169|469087117|FG002|Overall Study|Other|0|||
130306572|NCT02342223|469087122|FG000|Overall Study|Lost to Follow-up|1|||
130464430|NCT04425629|469667140|FG001|Overall Study|Adverse Event|0|||
130464431|NCT04425629|469667141|FG002|Overall Study|Adverse Event|0|||
130306573|NCT01200368|469087127|FG000|Infant Series|Adverse Event|2|||
130306574|NCT01200368|469087128|FG001|Infant Series|Adverse Event|2|||
130306575|NCT01200368|469087129|FG002|Infant Series|Adverse Event|3|||
130306576|NCT01200368|469087127|FG000|Infant Series|Withdrawal by Subject|0|||
130306577|NCT01200368|469087128|FG001|Infant Series|Withdrawal by Subject|2|||
130306578|NCT01200368|469087129|FG002|Infant Series|Withdrawal by Subject|2|||
130306579|NCT01200368|469087127|FG000|Infant Series|Did not meet entrance criteria|0|||
130306580|NCT01200368|469087128|FG001|Infant Series|Did not meet entrance criteria|1|||
130306581|NCT01200368|469087129|FG002|Infant Series|Did not meet entrance criteria|0|||
130306582|NCT01200368|469087127|FG000|Infant Series|Randomized, not vaccinated|0|||
130306583|NCT01200368|469087128|FG001|Infant Series|Randomized, not vaccinated|1|||
130306584|NCT01200368|469087129|FG002|Infant Series|Randomized, not vaccinated|1|||
130306585|NCT01200368|469087127|FG000|Infant Series|Other|1|||
130306586|NCT01200368|469087128|FG001|Infant Series|Other|0|||
130306587|NCT01200368|469087129|FG002|Infant Series|Other|0|||
130306588|NCT01200368|469087127|FG000|After Infant Series|Adverse Event|6|||
130306589|NCT01200368|469087128|FG001|After Infant Series|Adverse Event|6|||
130306590|NCT01200368|469087129|FG002|After Infant Series|Adverse Event|3|||
130306591|NCT01200368|469087127|FG000|After Infant Series|Withdrawal by Subject|10|||
130306592|NCT01200368|469087128|FG001|After Infant Series|Withdrawal by Subject|8|||
130306593|NCT01200368|469087129|FG002|After Infant Series|Withdrawal by Subject|4|||
130306594|NCT01200368|469087127|FG000|After Infant Series|Lost to Follow-up|1|||
130306595|NCT01200368|469087128|FG001|After Infant Series|Lost to Follow-up|0|||
130306596|NCT01200368|469087129|FG002|After Infant Series|Lost to Follow-up|0|||
130717467|NCT01103466|470591039|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717468|NCT01103466|470591040|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717469|NCT01103466|470591041|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717470|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
130717471|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130717472|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130717473|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717474|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717475|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717476|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
130717477|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
130717478|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
130717479|NCT02283983|470591050|FG000|Overall Study|Inclusion criteria not met|0|||
130717480|NCT02283983|470591051|FG001|Overall Study|Inclusion criteria not met|1|||
130717481|NCT02283983|470591050|FG000|Overall Study|Withdrawal by Subject|4|||
130717482|NCT02283983|470591051|FG001|Overall Study|Withdrawal by Subject|2|||
130717483|NCT02283983|470591050|FG000|Overall Study|Protocol Violation|0|||
130717484|NCT02283983|470591051|FG001|Overall Study|Protocol Violation|4|||
130717485|NCT02283983|470591050|FG000|Overall Study|Physician Decision|2|||
130717486|NCT02283983|470591051|FG001|Overall Study|Physician Decision|4|||
130717487|NCT02283983|470591050|FG000|Overall Study|Death|1|||
130717488|NCT02283983|470591051|FG001|Overall Study|Death|0|||
130717489|NCT02283983|470591050|FG000|Overall Study|Adverse Event|1|||
130717490|NCT02283983|470591051|FG001|Overall Study|Adverse Event|0|||
130717491|NCT02283983|470591050|FG000|Overall Study|Lost to Follow-up|9|||
130717492|NCT02283983|470591051|FG001|Overall Study|Lost to Follow-up|8|||
130717493|NCT02283983|470591050|FG000|Overall Study|Relapse|1|||
130717494|NCT02283983|470591051|FG001|Overall Study|Relapse|0|||
130717495|NCT04453202|470591053|FG000|Overall Study|Adverse Event|0|||
130464432|NCT04425629|469667142|FG003|Overall Study|Adverse Event|0|||
130717496|NCT04453202|470591054|FG001|Overall Study|Adverse Event|0|||
130717497|NCT04453202|470591055|FG002|Overall Study|Adverse Event|0|||
130717498|NCT04453202|470591056|FG003|Overall Study|Adverse Event|0|||
130717499|NCT04453202|470591057|FG004|Overall Study|Adverse Event|0|||
130306597|NCT01200368|469087127|FG000|After Infant Series|Other|1|||
130717500|NCT04453202|470591058|FG005|Overall Study|Adverse Event|0|||
130306598|NCT01200368|469087128|FG001|After Infant Series|Other|2|||
130717501|NCT04453202|470591059|FG006|Overall Study|Adverse Event|1|||
130306599|NCT01200368|469087129|FG002|After Infant Series|Other|2|||
130306600|NCT01200368|469087127|FG000|Toddler Dose|Adverse Event|0|||
130306601|NCT01200368|469087128|FG001|Toddler Dose|Adverse Event|3|||
130306602|NCT01200368|469087129|FG002|Toddler Dose|Adverse Event|1|||
130306603|NCT02221674|469087132|FG000|Overall Study|Lost to Follow-up|1|||
130306604|NCT02221674|469087133|FG001|Overall Study|Lost to Follow-up|0|||
130306605|NCT02221674|469087134|FG002|Overall Study|Lost to Follow-up|0|||
130306606|NCT02557542|469087136|FG000|Overall Study|Poor recruitment|3|||
130464433|NCT04425629|469667143|FG004|Overall Study|Adverse Event|1|||
130717502|NCT04453202|470591060|FG007|Overall Study|Adverse Event|0|||
130717503|NCT04453202|470591061|FG008|Overall Study|Adverse Event|0|||
130717504|NCT04453202|470591062|FG009|Overall Study|Adverse Event|0|||
130717505|NCT04453202|470591063|FG010|Overall Study|Adverse Event|0|||
130717506|NCT04453202|470591053|FG000|Overall Study|Death|0|||
130717507|NCT04453202|470591054|FG001|Overall Study|Death|0|||
130717508|NCT04453202|470591055|FG002|Overall Study|Death|0|||
130717509|NCT04453202|470591056|FG003|Overall Study|Death|0|||
130717510|NCT04453202|470591057|FG004|Overall Study|Death|0|||
130717511|NCT04453202|470591058|FG005|Overall Study|Death|0|||
130717512|NCT04453202|470591059|FG006|Overall Study|Death|0|||
130717513|NCT04453202|470591060|FG007|Overall Study|Death|0|||
130717514|NCT04453202|470591061|FG008|Overall Study|Death|0|||
130717515|NCT04453202|470591062|FG009|Overall Study|Death|1|||
130717516|NCT04453202|470591063|FG010|Overall Study|Death|0|||
130717517|NCT04453202|470591053|FG000|Overall Study|Lost to Follow-up|0|||
130717518|NCT04453202|470591054|FG001|Overall Study|Lost to Follow-up|1|||
130717519|NCT04453202|470591055|FG002|Overall Study|Lost to Follow-up|0|||
130717520|NCT04453202|470591056|FG003|Overall Study|Lost to Follow-up|1|||
130717521|NCT04453202|470591057|FG004|Overall Study|Lost to Follow-up|0|||
130717522|NCT04453202|470591058|FG005|Overall Study|Lost to Follow-up|0|||
130717523|NCT04453202|470591059|FG006|Overall Study|Lost to Follow-up|0|||
130717524|NCT04453202|470591060|FG007|Overall Study|Lost to Follow-up|0|||
130717525|NCT04453202|470591061|FG008|Overall Study|Lost to Follow-up|0|||
130717526|NCT04453202|470591062|FG009|Overall Study|Lost to Follow-up|1|||
130717527|NCT04453202|470591063|FG010|Overall Study|Lost to Follow-up|1|||
130717528|NCT04453202|470591053|FG000|Overall Study|Withdrawal by Subject|1|||
130717529|NCT04453202|470591054|FG001|Overall Study|Withdrawal by Subject|2|||
130717530|NCT04453202|470591055|FG002|Overall Study|Withdrawal by Subject|1|||
130717531|NCT04453202|470591056|FG003|Overall Study|Withdrawal by Subject|2|||
130717532|NCT04453202|470591057|FG004|Overall Study|Withdrawal by Subject|1|||
130717533|NCT04453202|470591058|FG005|Overall Study|Withdrawal by Subject|1|||
130464434|NCT04425629|469667144|FG005|Overall Study|Adverse Event|0|||
130717534|NCT04453202|470591059|FG006|Overall Study|Withdrawal by Subject|0|||
130306607|NCT02557542|469087137|FG001|Overall Study|Poor recruitment|0|||
130306608|NCT04390880|469087138|FG000|Overall Study|Withdrawal by Subject|1|||
130717535|NCT04453202|470591060|FG007|Overall Study|Withdrawal by Subject|0|||
130717536|NCT04453202|470591061|FG008|Overall Study|Withdrawal by Subject|0|||
130717537|NCT04453202|470591062|FG009|Overall Study|Withdrawal by Subject|1|||
130717538|NCT04453202|470591063|FG010|Overall Study|Withdrawal by Subject|0|||
130717539|NCT04453202|470591053|FG000|Overall Study|Adverse Event|0|||
130717540|NCT04453202|470591054|FG001|Overall Study|Adverse Event|0|||
130717541|NCT04453202|470591055|FG002|Overall Study|Adverse Event|0|||
130717542|NCT04453202|470591056|FG003|Overall Study|Adverse Event|0|||
130717543|NCT04453202|470591057|FG004|Overall Study|Adverse Event|0|||
130717544|NCT04453202|470591058|FG005|Overall Study|Adverse Event|1|||
130306609|NCT00245037|469087139|FG000|Overall Study|Death|17|||
130306610|NCT03724890|469087143|FG000|Overall Study|Death|2|||
130306611|NCT03724890|469087144|FG001|Overall Study|Death|6|||
130306612|NCT03724890|469087145|FG002|Overall Study|Death|3|||
130306613|NCT03724890|469087146|FG003|Overall Study|Death|5|||
130306614|NCT03724890|469087147|FG004|Overall Study|Death|2|||
130306615|NCT03724890|469087148|FG005|Overall Study|Death|0|||
130306616|NCT03724890|469087149|FG006|Overall Study|Death|2|||
130306617|NCT03724890|469087150|FG007|Overall Study|Death|3|||
130306618|NCT03724890|469087151|FG008|Overall Study|Death|4|||
130306619|NCT03724890|469087152|FG009|Overall Study|Death|2|||
130306620|NCT03724890|469087153|FG010|Overall Study|Death|2|||
130306621|NCT03724890|469087143|FG000|Overall Study|Lost to Follow-up|0|||
130306622|NCT03724890|469087144|FG001|Overall Study|Lost to Follow-up|3|||
130306623|NCT03724890|469087145|FG002|Overall Study|Lost to Follow-up|0|||
130306624|NCT03724890|469087146|FG003|Overall Study|Lost to Follow-up|1|||
130306625|NCT03724890|469087147|FG004|Overall Study|Lost to Follow-up|2|||
130306626|NCT03724890|469087148|FG005|Overall Study|Lost to Follow-up|2|||
130306627|NCT03724890|469087149|FG006|Overall Study|Lost to Follow-up|1|||
130306628|NCT03724890|469087150|FG007|Overall Study|Lost to Follow-up|0|||
130306629|NCT03724890|469087151|FG008|Overall Study|Lost to Follow-up|2|||
130306630|NCT03724890|469087152|FG009|Overall Study|Lost to Follow-up|0|||
130306631|NCT03724890|469087153|FG010|Overall Study|Lost to Follow-up|0|||
130306632|NCT03724890|469087143|FG000|Overall Study|Withdrawal by Subject|1|||
130306633|NCT03724890|469087144|FG001|Overall Study|Withdrawal by Subject|2|||
130306634|NCT03724890|469087145|FG002|Overall Study|Withdrawal by Subject|1|||
130306635|NCT03724890|469087146|FG003|Overall Study|Withdrawal by Subject|0|||
130306636|NCT03724890|469087147|FG004|Overall Study|Withdrawal by Subject|0|||
130306637|NCT03724890|469087148|FG005|Overall Study|Withdrawal by Subject|1|||
130306638|NCT03724890|469087149|FG006|Overall Study|Withdrawal by Subject|0|||
130306639|NCT03724890|469087150|FG007|Overall Study|Withdrawal by Subject|0|||
130306640|NCT03724890|469087151|FG008|Overall Study|Withdrawal by Subject|2|||
130306641|NCT03724890|469087152|FG009|Overall Study|Withdrawal by Subject|2|||
130306642|NCT03724890|469087153|FG010|Overall Study|Withdrawal by Subject|1|||
130306643|NCT03724890|469087143|FG000|Overall Study|Other|1|||
130306644|NCT03724890|469087144|FG001|Overall Study|Other|0|||
130306645|NCT03724890|469087145|FG002|Overall Study|Other|0|||
130306646|NCT03724890|469087146|FG003|Overall Study|Other|0|||
130306647|NCT03724890|469087147|FG004|Overall Study|Other|0|||
130306648|NCT03724890|469087148|FG005|Overall Study|Other|0|||
130306649|NCT03724890|469087149|FG006|Overall Study|Other|0|||
130464435|NCT04425629|469667145|FG006|Overall Study|Adverse Event|0|||
130306650|NCT03724890|469087150|FG007|Overall Study|Other|1|||
130306651|NCT03724890|469087151|FG008|Overall Study|Other|1|||
130306652|NCT03724890|469087152|FG009|Overall Study|Other|0|||
130306653|NCT03724890|469087153|FG010|Overall Study|Other|2|||
130306654|NCT02123823|469087156|FG000|Overall Study|Lack of Efficacy|0|||
130306655|NCT02123823|469087157|FG001|Overall Study|Lack of Efficacy|2|||
130306656|NCT02123823|469087158|FG002|Overall Study|Lack of Efficacy|8|||
130306657|NCT02123823|469087159|FG003|Overall Study|Lack of Efficacy|10|||
130306658|NCT02123823|469087156|FG000|Overall Study|Progressive disease|3|||
130306659|NCT02123823|469087157|FG001|Overall Study|Progressive disease|19|||
130306660|NCT02123823|469087158|FG002|Overall Study|Progressive disease|52|||
130306661|NCT02123823|469087159|FG003|Overall Study|Progressive disease|53|||
130306662|NCT02123823|469087156|FG000|Overall Study|Withdrawal by Subject|0|||
130306663|NCT02123823|469087157|FG001|Overall Study|Withdrawal by Subject|0|||
130306664|NCT02123823|469087158|FG002|Overall Study|Withdrawal by Subject|7|||
130306665|NCT02123823|469087159|FG003|Overall Study|Withdrawal by Subject|2|||
130306666|NCT02123823|469087156|FG000|Overall Study|Adverse Event|0|||
130306667|NCT02123823|469087157|FG001|Overall Study|Adverse Event|0|||
130306668|NCT02123823|469087158|FG002|Overall Study|Adverse Event|3|||
130306669|NCT02123823|469087159|FG003|Overall Study|Adverse Event|5|||
130306670|NCT01635855|469087161|FG000|Overall Study|Withdrawal by Subject|4|||
130306671|NCT05870865|469087164|FG000|Randomized|Did not receive study treatment|2|||
130306672|NCT05870865|469087165|FG001|Randomized|Did not receive study treatment|4|||
130306673|NCT05870865|469087166|FG002|Randomized|Did not receive study treatment|4|||
130306674|NCT05870865|469087167|FG003|Randomized|Did not receive study treatment|3|||
130306675|NCT05870865|469087164|FG000|Treatment Period|Adverse Event|1|||
130306676|NCT05870865|469087165|FG001|Treatment Period|Adverse Event|1|||
130306677|NCT05870865|469087166|FG002|Treatment Period|Adverse Event|1|||
130306678|NCT05870865|469087167|FG003|Treatment Period|Adverse Event|1|||
130306679|NCT05870865|469087164|FG000|Treatment Period|Lost to Follow-up|0|||
130306680|NCT05870865|469087165|FG001|Treatment Period|Lost to Follow-up|1|||
130306681|NCT05870865|469087166|FG002|Treatment Period|Lost to Follow-up|2|||
130306682|NCT05870865|469087167|FG003|Treatment Period|Lost to Follow-up|0|||
130306683|NCT05870865|469087164|FG000|Treatment Period|Protocol Violation|0|||
130306684|NCT05870865|469087165|FG001|Treatment Period|Protocol Violation|0|||
130306685|NCT05870865|469087166|FG002|Treatment Period|Protocol Violation|0|||
130306686|NCT05870865|469087167|FG003|Treatment Period|Protocol Violation|1|||
130306687|NCT05870865|469087164|FG000|Treatment Period|Withdrawal by Subject|0|||
130306688|NCT05870865|469087165|FG001|Treatment Period|Withdrawal by Subject|1|||
130306689|NCT05870865|469087166|FG002|Treatment Period|Withdrawal by Subject|1|||
130306690|NCT05870865|469087167|FG003|Treatment Period|Withdrawal by Subject|1|||
130306691|NCT03828019|469087171|FG000|Overall Study|Withdrawal by Subject|3|||
130306692|NCT03828019|469087172|FG001|Overall Study|Withdrawal by Subject|8|||
130306693|NCT03828019|469087171|FG000|Overall Study|Lost to Follow-up|1|||
130306694|NCT03828019|469087172|FG001|Overall Study|Lost to Follow-up|6|||
130464436|NCT04425629|469667146|FG007|Overall Study|Adverse Event|0|||
130717545|NCT04453202|470591059|FG006|Overall Study|Adverse Event|0|||
130717546|NCT04453202|470591060|FG007|Overall Study|Adverse Event|0|||
130717547|NCT04453202|470591061|FG008|Overall Study|Adverse Event|0|||
130717548|NCT04453202|470591062|FG009|Overall Study|Adverse Event|0|||
130717549|NCT04453202|470591063|FG010|Overall Study|Adverse Event|0|||
130717550|NCT02912650|470591064|FG000|Overall Study|Withdrawal by Subject|1|||
130717551|NCT02912650|470591065|FG001|Overall Study|Withdrawal by Subject|0|||
130717552|NCT02912650|470591066|FG002|Overall Study|Withdrawal by Subject|1|||
130717553|NCT02912650|470591067|FG003|Overall Study|Withdrawal by Subject|5|||
130717554|NCT02912650|470591064|FG000|Overall Study|Adverse Event|0|||
130717555|NCT02912650|470591065|FG001|Overall Study|Adverse Event|0|||
130717556|NCT02912650|470591066|FG002|Overall Study|Adverse Event|1|||
130717557|NCT02912650|470591067|FG003|Overall Study|Adverse Event|0|||
130717558|NCT02562482|470591069|FG000|Overall Study|Enrolled, but did not receive product|4|||
130717559|NCT02562482|470591070|FG001|Overall Study|Enrolled, but did not receive product|0|||
130717560|NCT02562482|470591069|FG000|Overall Study|Lost to Follow-up|9|||
130306695|NCT03828019|469087171|FG000|Overall Study|Incarcerated|1|||
130306696|NCT03828019|469087172|FG001|Overall Study|Incarcerated|0|||
130306697|NCT03828019|469087171|FG000|Overall Study|Adverse Event|0|||
130306698|NCT03828019|469087172|FG001|Overall Study|Adverse Event|1|||
130306699|NCT03400176|469087173|FG000|Dose Escalation|Progressive disease|1|||
130306700|NCT03400176|469087174|FG001|Dose Escalation|Progressive disease|1|||
130306701|NCT03400176|469087175|FG002|Dose Escalation|Progressive disease|0|||
130306702|NCT03400176|469087176|FG003|Dose Escalation|Progressive disease|0|||
130717561|NCT02562482|470591070|FG001|Overall Study|Lost to Follow-up|6|||
130306703|NCT03400176|469087177|FG004|Dose Escalation|Progressive disease|1|||
130464437|NCT04425629|469667147|FG008|Overall Study|Adverse Event|0|||
130717562|NCT02562482|470591069|FG000|Overall Study|Moved from area|2|||
130306704|NCT03400176|469087173|FG000|Dose Escalation|Patient decision|0|||
130306705|NCT03400176|469087174|FG001|Dose Escalation|Patient decision|0|||
130717563|NCT02562482|470591070|FG001|Overall Study|Moved from area|3|||
130717564|NCT02562482|470591069|FG000|Overall Study|Withdrawal by Subject|5|||
130717565|NCT02562482|470591070|FG001|Overall Study|Withdrawal by Subject|3|||
130306706|NCT03400176|469087175|FG002|Dose Escalation|Patient decision|0|||
130306707|NCT03400176|469087176|FG003|Dose Escalation|Patient decision|0|||
130306708|NCT03400176|469087177|FG004|Dose Escalation|Patient decision|1|||
130306709|NCT03400176|469087173|FG000|Dose Expansion|Patient decision|0|||
130306710|NCT03400176|469087174|FG001|Dose Expansion|Patient decision|0|||
130306711|NCT03400176|469087175|FG002|Dose Expansion|Patient decision|0|||
130306712|NCT03400176|469087176|FG003|Dose Expansion|Patient decision|1|||
130306713|NCT03400176|469087177|FG004|Dose Expansion|Patient decision|0|||
130306714|NCT03400176|469087173|FG000|Dose Expansion|Adverse Event|0|||
130306715|NCT03400176|469087174|FG001|Dose Expansion|Adverse Event|0|||
130306716|NCT03400176|469087175|FG002|Dose Expansion|Adverse Event|0|||
130306717|NCT03400176|469087176|FG003|Dose Expansion|Adverse Event|1|||
130306718|NCT03400176|469087177|FG004|Dose Expansion|Adverse Event|0|||
130306719|NCT03400176|469087173|FG000|Dose Expansion|Physician Decision|0|||
130306720|NCT03400176|469087174|FG001|Dose Expansion|Physician Decision|0|||
130306721|NCT03400176|469087175|FG002|Dose Expansion|Physician Decision|0|||
130306722|NCT03400176|469087176|FG003|Dose Expansion|Physician Decision|1|||
130306723|NCT03400176|469087177|FG004|Dose Expansion|Physician Decision|0|||
130306724|NCT03400176|469087173|FG000|Dose Expansion|Progressive disease|0|||
130306725|NCT03400176|469087174|FG001|Dose Expansion|Progressive disease|0|||
130306726|NCT03400176|469087175|FG002|Dose Expansion|Progressive disease|1|||
130306727|NCT03400176|469087176|FG003|Dose Expansion|Progressive disease|1|||
130306728|NCT03400176|469087177|FG004|Dose Expansion|Progressive disease|0|||
130306729|NCT00206440|469087178|FG000|Overall Study|Protocol Violation|1|||
130306730|NCT00206440|469087179|FG001|Overall Study|Protocol Violation|2|||
130306731|NCT00206440|469087178|FG000|Overall Study|Adverse Event|4|||
130306732|NCT00206440|469087179|FG001|Overall Study|Adverse Event|2|||
130306733|NCT01298765|469087180|FG000|Titration Period|Adverse Event|26|||
130306734|NCT01298765|469087180|FG000|Titration Period|Death|1|||
130306735|NCT01298765|469087180|FG000|Titration Period|Lack of Efficacy|21|||
130306736|NCT01298765|469087180|FG000|Titration Period|Lost to Follow-up|9|||
130306737|NCT01298765|469087180|FG000|Titration Period|Physician Decision|1|||
130306738|NCT01298765|469087180|FG000|Titration Period|Withdrawal by Subject|10|||
130306739|NCT01298765|469087180|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
130306740|NCT01298765|469087180|FG000|Long-Term Treatment Period|Adverse Event|19|||
130306741|NCT01298765|469087180|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
130306742|NCT01298765|469087180|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
130306743|NCT01298765|469087180|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
130306744|NCT01298765|469087180|FG000|Long-Term Treatment Period|Physician Decision|1|||
130306745|NCT01298765|469087180|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
130306746|NCT00766051|469087182|FG000|Overall Study|Withdrawal by Subject|2|||
130306747|NCT00766051|469087183|FG001|Overall Study|Withdrawal by Subject|0|||
130717566|NCT02562482|470591069|FG000|Overall Study|Physician Decision|1|||
130717567|NCT02562482|470591070|FG001|Overall Study|Physician Decision|3|||
130717568|NCT02562482|470591069|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130717569|NCT02562482|470591070|FG001|Overall Study|Illness/Injury unrelated to product|1|||
130717570|NCT01674647|470591071|FG000|Treatment Period|Death|4|||
130717571|NCT01674647|470591072|FG001|Treatment Period|Death|1|||
130717572|NCT01674647|470591071|FG000|Treatment Period|Efficacy outcome reached|0|||
130717573|NCT01674647|470591072|FG001|Treatment Period|Efficacy outcome reached|1|||
130717574|NCT01674647|470591071|FG000|Treatment Period|Physician Decision|3|||
130717575|NCT01674647|470591072|FG001|Treatment Period|Physician Decision|1|||
130717576|NCT01674647|470591071|FG000|Treatment Period|Adverse Event|60|||
130717577|NCT01674647|470591072|FG001|Treatment Period|Adverse Event|22|||
130717578|NCT01674647|470591071|FG000|Treatment Period|Non-compliance with study drug|3|||
130717579|NCT01674647|470591072|FG001|Treatment Period|Non-compliance with study drug|0|||
130717580|NCT01674647|470591071|FG000|Treatment Period|Lost to Follow-up|1|||
130717581|NCT01674647|470591072|FG001|Treatment Period|Lost to Follow-up|1|||
130717582|NCT01674647|470591071|FG000|Treatment Period|Withdrawal by Subject|19|||
130717583|NCT01674647|470591072|FG001|Treatment Period|Withdrawal by Subject|16|||
130717584|NCT01674647|470591071|FG000|Treatment Period|Switching to other therapy|5|||
130717585|NCT01674647|470591072|FG001|Treatment Period|Switching to other therapy|2|||
130717586|NCT01674647|470591071|FG000|Treatment Period|Logistical difficulties|5|||
130717587|NCT01674647|470591072|FG001|Treatment Period|Logistical difficulties|8|||
130717588|NCT01674647|470591071|FG000|Treatment Period|Treatment failure|0|||
130717589|NCT01674647|470591072|FG001|Treatment Period|Treatment failure|14|||
130717590|NCT01674647|470591071|FG000|Treatment Period|Protocol Violation|56|||
130717591|NCT01674647|470591072|FG001|Treatment Period|Protocol Violation|36|||
130717592|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Death|3|||
130717593|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Death|2|||
130717594|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
130717595|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
130717596|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
130717597|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
130717598|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
130717599|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
130717600|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
130717601|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
130717602|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
130717603|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
130717604|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
130717605|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
130717606|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
130717607|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
130717608|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
130306748|NCT03302247|469087186|FG000|Overall Study|the study has closed prematurely|2|||
130306749|NCT03302247|469087186|FG000|Overall Study|Death|1|||
130373908|NCT02321800|469336841|FG001|Overall Study|Adverse Event|3|||
130306750|NCT04090242|469087187|FG000|Overall Study|Withdrawal by Subject|1|||
130306751|NCT04090242|469087188|FG001|Overall Study|Withdrawal by Subject|0|||
130306752|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
130717609|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
130717610|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
130717611|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
130717612|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
130717613|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
130717614|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
130717615|NCT02980874|470591074|FG000|Overall Study|Adverse Event|2|||
130717616|NCT02980874|470591075|FG001|Overall Study|Adverse Event|7|||
130717617|NCT02980874|470591074|FG000|Overall Study|Withdrawal by Subject|7|||
130717618|NCT02980874|470591075|FG001|Overall Study|Withdrawal by Subject|2|||
130717619|NCT02980874|470591074|FG000|Overall Study|Lost to Follow-up|5|||
130717620|NCT02980874|470591075|FG001|Overall Study|Lost to Follow-up|5|||
130717621|NCT02980874|470591074|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
130717622|NCT02980874|470591075|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
130717623|NCT02980874|470591074|FG000|Overall Study|Unknown study completion status|1|||
130717624|NCT02980874|470591075|FG001|Overall Study|Unknown study completion status|0|||
130717625|NCT00914459|470591076|FG000|Overall Study|Protocol Violation|0|||
130717626|NCT00914459|470591077|FG001|Overall Study|Protocol Violation|1|||
130717627|NCT00914459|470591076|FG000|Overall Study|Parent/Legal guardian request|1|||
130717628|NCT00914459|470591077|FG001|Overall Study|Parent/Legal guardian request|0|||
130717629|NCT01661179|470591078|FG000|Overall Study|Death|1|||
130717630|NCT01661179|470591078|FG000|Overall Study|Withdrawal by Subject|1|||
130717631|NCT01661179|470591078|FG000|Overall Study|Other Eligibility criteria|4|||
130717632|NCT04188301|470591079|FG000|Month 3|Lost to Follow-up|0|||
130717633|NCT04188301|470591080|FG001|Month 3|Lost to Follow-up|0|||
130717634|NCT04188301|470591081|FG002|Month 3|Lost to Follow-up|1|||
130717635|NCT04188301|470591079|FG000|Month 12|Lost to Follow-up|0|||
130717636|NCT04188301|470591080|FG001|Month 12|Lost to Follow-up|0|||
130717637|NCT04188301|470591081|FG002|Month 12|Lost to Follow-up|2|||
130717638|NCT04188301|470591079|FG000|Month 12|Death|1|||
130717639|NCT04188301|470591080|FG001|Month 12|Death|1|||
130717640|NCT04188301|470591081|FG002|Month 12|Death|0|||
130717641|NCT04188301|470591079|FG000|Month 18|Lost to Follow-up|6|||
130717642|NCT04188301|470591080|FG001|Month 18|Lost to Follow-up|0|||
130717643|NCT04188301|470591081|FG002|Month 18|Lost to Follow-up|0|||
130717644|NCT04221789|470593108|FG000|Overall Study|deviation from protoco|22|||
130717645|NCT04221789|470593109|FG001|Overall Study|deviation from protoco|8|||
130717646|NCT03747601|470593110|FG000|Overall Study|COVID halt to visits|4|||
130717647|NCT03303625|470593111|FG000|Overall Study|Withdrawal by Subject|2|||
130717648|NCT03303625|470593112|FG001|Overall Study|Withdrawal by Subject|0|||
130717649|NCT03303625|470593113|FG002|Overall Study|Withdrawal by Subject|0|||
130717650|NCT03303625|470593114|FG003|Overall Study|Withdrawal by Subject|0|||
130717651|NCT01367665|470593115|FG000|Overall Study|Death|102|||
130717652|NCT01367665|470593116|FG001|Overall Study|Death|19|||
130717653|NCT01367665|470593115|FG000|Overall Study|Lost to Follow-up|222|||
130717654|NCT01367665|470593116|FG001|Overall Study|Lost to Follow-up|22|||
130717655|NCT01367665|470593115|FG000|Overall Study|Not Done|118|||
130717656|NCT01367665|470593116|FG001|Overall Study|Not Done|14|||
130717657|NCT02906930|470593117|FG000|Overall Study|Withdrawal by Subject|0|||
130717658|NCT02906930|470593118|FG001|Overall Study|Withdrawal by Subject|5|||
130717659|NCT02906930|470593119|FG002|Overall Study|Withdrawal by Subject|5|||
130717660|NCT02906930|470593120|FG003|Overall Study|Withdrawal by Subject|4|||
130717661|NCT02906930|470593117|FG000|Overall Study|Lost to Follow-up|5|||
130717662|NCT02906930|470593118|FG001|Overall Study|Lost to Follow-up|7|||
130717663|NCT02906930|470593119|FG002|Overall Study|Lost to Follow-up|5|||
130717664|NCT02906930|470593120|FG003|Overall Study|Lost to Follow-up|2|||
130717665|NCT02906930|470593117|FG000|Overall Study|Death|0|||
130717666|NCT02906930|470593118|FG001|Overall Study|Death|0|||
130717667|NCT02906930|470593119|FG002|Overall Study|Death|1|||
130717668|NCT02906930|470593120|FG003|Overall Study|Death|0|||
130717669|NCT02906930|470593117|FG000|Overall Study|Other|1|||
130717670|NCT02906930|470593118|FG001|Overall Study|Other|2|||
130717671|NCT02906930|470593119|FG002|Overall Study|Other|1|||
130717672|NCT02906930|470593120|FG003|Overall Study|Other|2|||
130717673|NCT02564211|470593121|FG000|Overall Study|Adverse Event|4|||
130306753|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
130717674|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
130717675|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
130376678|NCT03824912|469345900|FG001|Overall Study|Lost to Follow-up|15|||
130717676|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
130717677|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
130717678|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
130717679|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
130306754|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
130306755|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Death|0|||
130306756|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Death|2|||
130306757|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Death|0|||
130306758|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130306759|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130306760|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
130306761|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
130306762|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
130306763|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
130306764|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
130306765|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
130306766|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
130306767|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
130306768|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
130306769|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
130306770|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130306771|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
130306772|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130306773|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Recovery|1|||
130306774|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Recovery|0|||
130306775|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Recovery|1|||
130306776|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
130306777|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
130306778|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
130306779|NCT00195663|469087189|FG000|Open-Label Extension Period|Adverse Event|21|||
130306780|NCT00195663|469087190|FG001|Open-Label Extension Period|Adverse Event|32|||
130306781|NCT00195663|469087191|FG002|Open-Label Extension Period|Adverse Event|36|||
130306782|NCT00195663|469087189|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
130306783|NCT00195663|469087190|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
130306784|NCT00195663|469087191|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
130306785|NCT00195663|469087189|FG000|Open-Label Extension Period|Recovery|0|||
130306786|NCT00195663|469087190|FG001|Open-Label Extension Period|Recovery|2|||
130306787|NCT00195663|469087191|FG002|Open-Label Extension Period|Recovery|2|||
130306788|NCT00195663|469087189|FG000|Open-Label Extension Period|Protocol Violation|3|||
130306789|NCT00195663|469087190|FG001|Open-Label Extension Period|Protocol Violation|4|||
130306790|NCT00195663|469087191|FG002|Open-Label Extension Period|Protocol Violation|4|||
130306791|NCT00195663|469087189|FG000|Open-Label Extension Period|Death|2|||
130306792|NCT00195663|469087190|FG001|Open-Label Extension Period|Death|2|||
130306793|NCT00195663|469087191|FG002|Open-Label Extension Period|Death|2|||
130306794|NCT00195663|469087189|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
130306795|NCT00195663|469087190|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
130306796|NCT00195663|469087191|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
130306797|NCT00195663|469087189|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
130306798|NCT00195663|469087190|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
130306799|NCT00195663|469087191|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
130717680|NCT04585789|470593124|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
130717681|NCT04585789|470593125|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130717682|NCT04585789|470593126|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130717683|NCT04585789|470593124|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
130717684|NCT04585789|470593125|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130717685|NCT04585789|470593126|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130717686|NCT01383135|470593133|FG000|Overall Study|Not Scanned / Imaged|1|||
130717687|NCT01383135|470593134|FG001|Overall Study|Not Scanned / Imaged|0|||
130717688|NCT01383135|470593135|FG002|Overall Study|Not Scanned / Imaged|1|||
130717689|NCT01383135|470593136|FG003|Overall Study|Not Scanned / Imaged|0|||
130717690|NCT01154816|470593138|FG000|Overall Study|Withdrawal by Subject|1|||
130717691|NCT01154816|470593139|FG001|Overall Study|Withdrawal by Subject|0|||
130717692|NCT01154816|470593140|FG002|Overall Study|Withdrawal by Subject|0|||
130717693|NCT01154816|470593141|FG003|Overall Study|Withdrawal by Subject|1|||
130717694|NCT01154816|470593142|FG004|Overall Study|Withdrawal by Subject|0|||
130717695|NCT01154816|470593143|FG005|Overall Study|Withdrawal by Subject|0|||
130717696|NCT01154816|470593144|FG006|Overall Study|Withdrawal by Subject|0|||
130717697|NCT01154816|470593145|FG007|Overall Study|Withdrawal by Subject|0|||
130717698|NCT01154816|470593146|FG008|Overall Study|Withdrawal by Subject|1|||
130717699|NCT01154816|470593147|FG009|Overall Study|Withdrawal by Subject|3|||
130717700|NCT01154816|470593148|FG010|Overall Study|Withdrawal by Subject|0|||
130717701|NCT01154816|470593149|FG011|Overall Study|Withdrawal by Subject|0|||
130717702|NCT01154816|470593138|FG000|Overall Study|Progressive Disease|13|||
130717703|NCT01154816|470593139|FG001|Overall Study|Progressive Disease|8|||
130717704|NCT01154816|470593140|FG002|Overall Study|Progressive Disease|9|||
130717705|NCT01154816|470593141|FG003|Overall Study|Progressive Disease|9|||
130717706|NCT01154816|470593142|FG004|Overall Study|Progressive Disease|8|||
130717707|NCT01154816|470593143|FG005|Overall Study|Progressive Disease|8|||
130717708|NCT01154816|470593144|FG006|Overall Study|Progressive Disease|5|||
130717709|NCT01154816|470593145|FG007|Overall Study|Progressive Disease|6|||
130717710|NCT01154816|470593146|FG008|Overall Study|Progressive Disease|8|||
130717711|NCT01154816|470593147|FG009|Overall Study|Progressive Disease|6|||
130717712|NCT01154816|470593148|FG010|Overall Study|Progressive Disease|10|||
130717713|NCT01154816|470593149|FG011|Overall Study|Progressive Disease|3|||
130717714|NCT01154816|470593138|FG000|Overall Study|Physician Decision|1|||
130717715|NCT01154816|470593139|FG001|Overall Study|Physician Decision|0|||
130717716|NCT01154816|470593140|FG002|Overall Study|Physician Decision|1|||
130717717|NCT01154816|470593141|FG003|Overall Study|Physician Decision|0|||
130717718|NCT01154816|470593142|FG004|Overall Study|Physician Decision|2|||
130717719|NCT01154816|470593143|FG005|Overall Study|Physician Decision|0|||
130717720|NCT01154816|470593144|FG006|Overall Study|Physician Decision|0|||
130717721|NCT01154816|470593145|FG007|Overall Study|Physician Decision|0|||
130717722|NCT01154816|470593146|FG008|Overall Study|Physician Decision|0|||
130717723|NCT01154816|470593147|FG009|Overall Study|Physician Decision|1|||
130717724|NCT01154816|470593148|FG010|Overall Study|Physician Decision|1|||
130717725|NCT01154816|470593149|FG011|Overall Study|Physician Decision|1|||
130717726|NCT01154816|470593138|FG000|Overall Study|Adverse Event|5|||
130717727|NCT01154816|470593139|FG001|Overall Study|Adverse Event|2|||
130717728|NCT01154816|470593140|FG002|Overall Study|Adverse Event|0|||
130717729|NCT01154816|470593141|FG003|Overall Study|Adverse Event|0|||
130717730|NCT01154816|470593142|FG004|Overall Study|Adverse Event|0|||
130717731|NCT01154816|470593143|FG005|Overall Study|Adverse Event|0|||
130717732|NCT01154816|470593144|FG006|Overall Study|Adverse Event|1|||
130717733|NCT01154816|470593145|FG007|Overall Study|Adverse Event|1|||
130717734|NCT01154816|470593146|FG008|Overall Study|Adverse Event|0|||
130717735|NCT01154816|470593147|FG009|Overall Study|Adverse Event|0|||
130717736|NCT01154816|470593148|FG010|Overall Study|Adverse Event|0|||
130717737|NCT01154816|470593149|FG011|Overall Study|Adverse Event|0|||
130717738|NCT03397771|470593150|FG000|Overall Study|2 erroneously randomized, never treated|3|||
130717739|NCT03397771|470593151|FG001|Overall Study|2 erroneously randomized, never treated|1|||
130717740|NCT03397771|470593150|FG000|Overall Study|Withdrawal by Subject|1|||
130717741|NCT03397771|470593151|FG001|Overall Study|Withdrawal by Subject|3|||
130717742|NCT03397771|470593150|FG000|Overall Study|Protocol Violation|2|||
130717743|NCT03397771|470593151|FG001|Overall Study|Protocol Violation|2|||
130306800|NCT00195663|469087189|FG000|Open-Label Extension Period|Administrative reasons|11|||
130717744|NCT03397771|470593150|FG000|Overall Study|Adverse Event|2|||
130717745|NCT03397771|470593151|FG001|Overall Study|Adverse Event|1|||
130717746|NCT04078126|470593152|FG000|Washout|Study put on hold due to COVID-19|0|||
130717747|NCT04078126|470593153|FG001|Washout|Study put on hold due to COVID-19|2|||
130717748|NCT04078126|470593152|FG000|Period 2|Study put on hold due to COVID-19|1|||
130306801|NCT00195663|469087190|FG001|Open-Label Extension Period|Administrative reasons|11|||
130306802|NCT00195663|469087191|FG002|Open-Label Extension Period|Administrative reasons|13|||
130306803|NCT03214406|469087192|FG000|Overall Study|did not meet enrollment criteria|9|||
130306804|NCT03214406|469087193|FG001|Overall Study|did not meet enrollment criteria|13|||
130306805|NCT03214406|469087192|FG000|Overall Study|Withdrawal by Subject|1|||
130306806|NCT03214406|469087193|FG001|Overall Study|Withdrawal by Subject|0|||
130306807|NCT03214406|469087192|FG000|Overall Study|Lost to Follow-up|0|||
130306808|NCT03214406|469087193|FG001|Overall Study|Lost to Follow-up|2|||
130306809|NCT00604695|469087194|FG000|Overall Study|Did not receive first bolus.|0|||
130306810|NCT00604695|469087195|FG001|Overall Study|Did not receive first bolus.|4|||
130306811|NCT01098305|469087196|FG000|Overall Study|Lost to Follow-up|31|||
130306812|NCT01098305|469087197|FG001|Overall Study|Lost to Follow-up|33|||
130306813|NCT01180296|469087204|FG000|Overall Study|Protocol Violation|1|||
130306814|NCT01180296|469087205|FG001|Overall Study|Protocol Violation|2|||
130306815|NCT03364309|469087208|FG000|Induction Period|Adverse Event|4|||
130306816|NCT03364309|469087209|FG001|Induction Period|Adverse Event|0|||
130306817|NCT03364309|469087210|FG002|Induction Period|Adverse Event|1|||
130306818|NCT03364309|469087211|FG003|Induction Period|Adverse Event|0|||
130306819|NCT03364309|469087212|FG004|Induction Period|Adverse Event|0|||
130306820|NCT03364309|469087213|FG005|Induction Period|Adverse Event|0|||
130306821|NCT03364309|469087214|FG006|Induction Period|Adverse Event|0|||
130306822|NCT03364309|469087215|FG007|Induction Period|Adverse Event|0|||
130306823|NCT03364309|469087216|FG008|Induction Period|Adverse Event|0|||
130306824|NCT03364309|469087217|FG009|Induction Period|Adverse Event|0|||
130306825|NCT03364309|469087218|FG010|Induction Period|Adverse Event|0|||
130306826|NCT03364309|469087219|FG011|Induction Period|Adverse Event|0|||
130306827|NCT03364309|469087220|FG012|Induction Period|Adverse Event|0|||
130306828|NCT03364309|469087221|FG013|Induction Period|Adverse Event|0|||
130306829|NCT03364309|469087222|FG014|Induction Period|Adverse Event|0|||
130306830|NCT03364309|469087223|FG015|Induction Period|Adverse Event|0|||
130306831|NCT03364309|469087224|FG016|Induction Period|Adverse Event|0|||
130306832|NCT03364309|469087225|FG017|Induction Period|Adverse Event|0|||
130306833|NCT03364309|469087226|FG018|Induction Period|Adverse Event|0|||
130306834|NCT03364309|469087208|FG000|Induction Period|Withdrawal by Subject|1|||
130306835|NCT03364309|469087209|FG001|Induction Period|Withdrawal by Subject|3|||
130306836|NCT03364309|469087210|FG002|Induction Period|Withdrawal by Subject|0|||
130306837|NCT03364309|469087211|FG003|Induction Period|Withdrawal by Subject|0|||
130306838|NCT03364309|469087212|FG004|Induction Period|Withdrawal by Subject|0|||
130306839|NCT03364309|469087213|FG005|Induction Period|Withdrawal by Subject|0|||
130306840|NCT03364309|469087214|FG006|Induction Period|Withdrawal by Subject|0|||
130306841|NCT03364309|469087215|FG007|Induction Period|Withdrawal by Subject|0|||
130306842|NCT03364309|469087216|FG008|Induction Period|Withdrawal by Subject|0|||
130306843|NCT03364309|469087217|FG009|Induction Period|Withdrawal by Subject|0|||
130306844|NCT03364309|469087218|FG010|Induction Period|Withdrawal by Subject|0|||
130306845|NCT03364309|469087219|FG011|Induction Period|Withdrawal by Subject|0|||
130306846|NCT03364309|469087220|FG012|Induction Period|Withdrawal by Subject|0|||
130306847|NCT03364309|469087221|FG013|Induction Period|Withdrawal by Subject|0|||
130306848|NCT03364309|469087222|FG014|Induction Period|Withdrawal by Subject|0|||
130306849|NCT03364309|469087223|FG015|Induction Period|Withdrawal by Subject|0|||
130306850|NCT03364309|469087224|FG016|Induction Period|Withdrawal by Subject|0|||
130306851|NCT03364309|469087225|FG017|Induction Period|Withdrawal by Subject|0|||
130306852|NCT03364309|469087226|FG018|Induction Period|Withdrawal by Subject|0|||
130306853|NCT03364309|469087208|FG000|Induction Period|Lost to Follow-up|1|||
130306854|NCT03364309|469087209|FG001|Induction Period|Lost to Follow-up|0|||
130306855|NCT03364309|469087210|FG002|Induction Period|Lost to Follow-up|0|||
130306856|NCT03364309|469087211|FG003|Induction Period|Lost to Follow-up|0|||
130306857|NCT03364309|469087212|FG004|Induction Period|Lost to Follow-up|0|||
130306858|NCT03364309|469087213|FG005|Induction Period|Lost to Follow-up|0|||
130306859|NCT03364309|469087214|FG006|Induction Period|Lost to Follow-up|0|||
130306860|NCT03364309|469087215|FG007|Induction Period|Lost to Follow-up|0|||
130306861|NCT03364309|469087216|FG008|Induction Period|Lost to Follow-up|0|||
130306862|NCT03364309|469087217|FG009|Induction Period|Lost to Follow-up|0|||
130306863|NCT03364309|469087218|FG010|Induction Period|Lost to Follow-up|0|||
130306864|NCT03364309|469087219|FG011|Induction Period|Lost to Follow-up|0|||
130306865|NCT03364309|469087220|FG012|Induction Period|Lost to Follow-up|0|||
130306866|NCT03364309|469087221|FG013|Induction Period|Lost to Follow-up|0|||
130306867|NCT03364309|469087222|FG014|Induction Period|Lost to Follow-up|0|||
130306868|NCT03364309|469087223|FG015|Induction Period|Lost to Follow-up|0|||
130306869|NCT03364309|469087224|FG016|Induction Period|Lost to Follow-up|0|||
130306870|NCT03364309|469087225|FG017|Induction Period|Lost to Follow-up|0|||
130306871|NCT03364309|469087226|FG018|Induction Period|Lost to Follow-up|0|||
130306872|NCT03364309|469087208|FG000|Induction Period|Physician Decision|0|||
130306873|NCT03364309|469087209|FG001|Induction Period|Physician Decision|1|||
130306874|NCT03364309|469087210|FG002|Induction Period|Physician Decision|0|||
130306875|NCT03364309|469087211|FG003|Induction Period|Physician Decision|0|||
130306876|NCT03364309|469087212|FG004|Induction Period|Physician Decision|0|||
130306877|NCT03364309|469087213|FG005|Induction Period|Physician Decision|0|||
130306878|NCT03364309|469087214|FG006|Induction Period|Physician Decision|0|||
130306879|NCT03364309|469087215|FG007|Induction Period|Physician Decision|0|||
130306880|NCT03364309|469087216|FG008|Induction Period|Physician Decision|0|||
130306881|NCT03364309|469087217|FG009|Induction Period|Physician Decision|0|||
130306882|NCT03364309|469087218|FG010|Induction Period|Physician Decision|0|||
130306883|NCT03364309|469087219|FG011|Induction Period|Physician Decision|0|||
130306884|NCT03364309|469087220|FG012|Induction Period|Physician Decision|0|||
130306885|NCT03364309|469087221|FG013|Induction Period|Physician Decision|0|||
130306886|NCT03364309|469087222|FG014|Induction Period|Physician Decision|0|||
130306887|NCT03364309|469087223|FG015|Induction Period|Physician Decision|0|||
130306888|NCT03364309|469087224|FG016|Induction Period|Physician Decision|0|||
130306889|NCT03364309|469087225|FG017|Induction Period|Physician Decision|0|||
130306890|NCT03364309|469087226|FG018|Induction Period|Physician Decision|0|||
130306891|NCT03364309|469087208|FG000|Maintenance Period|Withdrawal by Subject|0|||
130306892|NCT03364309|469087209|FG001|Maintenance Period|Withdrawal by Subject|0|||
130306893|NCT03364309|469087210|FG002|Maintenance Period|Withdrawal by Subject|0|||
130306894|NCT03364309|469087211|FG003|Maintenance Period|Withdrawal by Subject|1|||
130306895|NCT03364309|469087212|FG004|Maintenance Period|Withdrawal by Subject|3|||
130306896|NCT03364309|469087213|FG005|Maintenance Period|Withdrawal by Subject|1|||
130306897|NCT03364309|469087214|FG006|Maintenance Period|Withdrawal by Subject|3|||
130306898|NCT03364309|469087215|FG007|Maintenance Period|Withdrawal by Subject|0|||
130306899|NCT03364309|469087216|FG008|Maintenance Period|Withdrawal by Subject|1|||
130306900|NCT03364309|469087217|FG009|Maintenance Period|Withdrawal by Subject|1|||
130306901|NCT03364309|469087218|FG010|Maintenance Period|Withdrawal by Subject|2|||
130306902|NCT03364309|469087219|FG011|Maintenance Period|Withdrawal by Subject|0|||
130306903|NCT03364309|469087220|FG012|Maintenance Period|Withdrawal by Subject|0|||
130306904|NCT03364309|469087221|FG013|Maintenance Period|Withdrawal by Subject|0|||
130306905|NCT03364309|469087222|FG014|Maintenance Period|Withdrawal by Subject|0|||
130306906|NCT03364309|469087223|FG015|Maintenance Period|Withdrawal by Subject|0|||
130306907|NCT03364309|469087224|FG016|Maintenance Period|Withdrawal by Subject|0|||
130306908|NCT03364309|469087225|FG017|Maintenance Period|Withdrawal by Subject|0|||
130306909|NCT03364309|469087226|FG018|Maintenance Period|Withdrawal by Subject|0|||
130306910|NCT03364309|469087208|FG000|Maintenance Period|Adverse Event|0|||
130306911|NCT03364309|469087209|FG001|Maintenance Period|Adverse Event|0|||
130306912|NCT03364309|469087210|FG002|Maintenance Period|Adverse Event|0|||
130306913|NCT03364309|469087211|FG003|Maintenance Period|Adverse Event|0|||
130306914|NCT03364309|469087212|FG004|Maintenance Period|Adverse Event|2|||
130306915|NCT03364309|469087213|FG005|Maintenance Period|Adverse Event|0|||
130306916|NCT03364309|469087214|FG006|Maintenance Period|Adverse Event|3|||
130306917|NCT03364309|469087215|FG007|Maintenance Period|Adverse Event|0|||
130306918|NCT03364309|469087216|FG008|Maintenance Period|Adverse Event|1|||
130306919|NCT03364309|469087217|FG009|Maintenance Period|Adverse Event|0|||
130306920|NCT03364309|469087218|FG010|Maintenance Period|Adverse Event|2|||
130306921|NCT03364309|469087219|FG011|Maintenance Period|Adverse Event|0|||
130306922|NCT03364309|469087220|FG012|Maintenance Period|Adverse Event|0|||
130306923|NCT03364309|469087221|FG013|Maintenance Period|Adverse Event|0|||
130306924|NCT03364309|469087222|FG014|Maintenance Period|Adverse Event|0|||
130306925|NCT03364309|469087223|FG015|Maintenance Period|Adverse Event|0|||
130306926|NCT03364309|469087224|FG016|Maintenance Period|Adverse Event|0|||
130306927|NCT03364309|469087225|FG017|Maintenance Period|Adverse Event|0|||
130306928|NCT03364309|469087226|FG018|Maintenance Period|Adverse Event|0|||
130306929|NCT03364309|469087208|FG000|Maintenance Period|Relapsed|0|||
130306930|NCT03364309|469087209|FG001|Maintenance Period|Relapsed|0|||
130306931|NCT03364309|469087210|FG002|Maintenance Period|Relapsed|0|||
130306932|NCT03364309|469087211|FG003|Maintenance Period|Relapsed|43|||
130306933|NCT03364309|469087212|FG004|Maintenance Period|Relapsed|7|||
130306934|NCT03364309|469087213|FG005|Maintenance Period|Relapsed|45|||
130306935|NCT03364309|469087214|FG006|Maintenance Period|Relapsed|10|||
130306936|NCT03364309|469087215|FG007|Maintenance Period|Relapsed|2|||
130306937|NCT03364309|469087216|FG008|Maintenance Period|Relapsed|0|||
130557734|NCT04178967|470011825|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130557735|NCT04178967|470011826|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130306938|NCT03364309|469087217|FG009|Maintenance Period|Relapsed|0|||
130306939|NCT03364309|469087218|FG010|Maintenance Period|Relapsed|0|||
130306940|NCT03364309|469087219|FG011|Maintenance Period|Relapsed|0|||
130306941|NCT03364309|469087220|FG012|Maintenance Period|Relapsed|0|||
130306942|NCT03364309|469087221|FG013|Maintenance Period|Relapsed|0|||
130306943|NCT03364309|469087222|FG014|Maintenance Period|Relapsed|0|||
130306944|NCT03364309|469087223|FG015|Maintenance Period|Relapsed|0|||
130306945|NCT03364309|469087224|FG016|Maintenance Period|Relapsed|0|||
130306946|NCT03364309|469087225|FG017|Maintenance Period|Relapsed|0|||
130306947|NCT03364309|469087226|FG018|Maintenance Period|Relapsed|0|||
130306948|NCT03364309|469087208|FG000|Maintenance Period|Lack of Efficacy|0|||
130306949|NCT03364309|469087209|FG001|Maintenance Period|Lack of Efficacy|0|||
130306950|NCT03364309|469087210|FG002|Maintenance Period|Lack of Efficacy|0|||
130306951|NCT03364309|469087211|FG003|Maintenance Period|Lack of Efficacy|0|||
130306952|NCT03364309|469087212|FG004|Maintenance Period|Lack of Efficacy|0|||
130306953|NCT03364309|469087213|FG005|Maintenance Period|Lack of Efficacy|0|||
130306954|NCT03364309|469087214|FG006|Maintenance Period|Lack of Efficacy|0|||
130306955|NCT03364309|469087215|FG007|Maintenance Period|Lack of Efficacy|0|||
130306956|NCT03364309|469087216|FG008|Maintenance Period|Lack of Efficacy|1|||
130306957|NCT03364309|469087217|FG009|Maintenance Period|Lack of Efficacy|3|||
130306958|NCT03364309|469087218|FG010|Maintenance Period|Lack of Efficacy|2|||
130306959|NCT03364309|469087219|FG011|Maintenance Period|Lack of Efficacy|0|||
130306960|NCT03364309|469087220|FG012|Maintenance Period|Lack of Efficacy|0|||
130306961|NCT03364309|469087221|FG013|Maintenance Period|Lack of Efficacy|0|||
130306962|NCT03364309|469087222|FG014|Maintenance Period|Lack of Efficacy|0|||
130306963|NCT03364309|469087223|FG015|Maintenance Period|Lack of Efficacy|0|||
130306964|NCT03364309|469087224|FG016|Maintenance Period|Lack of Efficacy|0|||
130306965|NCT03364309|469087225|FG017|Maintenance Period|Lack of Efficacy|0|||
130306966|NCT03364309|469087226|FG018|Maintenance Period|Lack of Efficacy|0|||
130306967|NCT03364309|469087208|FG000|Maintenance Period|Death|0|||
130306968|NCT03364309|469087209|FG001|Maintenance Period|Death|0|||
130306969|NCT03364309|469087210|FG002|Maintenance Period|Death|0|||
130306970|NCT03364309|469087211|FG003|Maintenance Period|Death|0|||
130306971|NCT03364309|469087212|FG004|Maintenance Period|Death|0|||
130306972|NCT03364309|469087213|FG005|Maintenance Period|Death|0|||
130306973|NCT03364309|469087214|FG006|Maintenance Period|Death|0|||
130306974|NCT03364309|469087215|FG007|Maintenance Period|Death|0|||
130306975|NCT03364309|469087216|FG008|Maintenance Period|Death|1|||
130306976|NCT03364309|469087217|FG009|Maintenance Period|Death|0|||
130306977|NCT03364309|469087218|FG010|Maintenance Period|Death|0|||
130306978|NCT03364309|469087219|FG011|Maintenance Period|Death|0|||
130306979|NCT03364309|469087220|FG012|Maintenance Period|Death|0|||
130306980|NCT03364309|469087221|FG013|Maintenance Period|Death|0|||
130306981|NCT03364309|469087222|FG014|Maintenance Period|Death|0|||
130306982|NCT03364309|469087223|FG015|Maintenance Period|Death|0|||
130306983|NCT03364309|469087224|FG016|Maintenance Period|Death|0|||
130306984|NCT03364309|469087225|FG017|Maintenance Period|Death|0|||
130306985|NCT03364309|469087226|FG018|Maintenance Period|Death|0|||
130306986|NCT03364309|469087208|FG000|Maintenance Period|Lost to Follow-up|0|||
130306987|NCT03364309|469087209|FG001|Maintenance Period|Lost to Follow-up|0|||
130306988|NCT03364309|469087210|FG002|Maintenance Period|Lost to Follow-up|0|||
130306989|NCT03364309|469087211|FG003|Maintenance Period|Lost to Follow-up|0|||
130306990|NCT03364309|469087212|FG004|Maintenance Period|Lost to Follow-up|0|||
130306991|NCT03364309|469087213|FG005|Maintenance Period|Lost to Follow-up|0|||
130306992|NCT03364309|469087214|FG006|Maintenance Period|Lost to Follow-up|0|||
130306993|NCT03364309|469087215|FG007|Maintenance Period|Lost to Follow-up|0|||
130306994|NCT03364309|469087216|FG008|Maintenance Period|Lost to Follow-up|1|||
130306995|NCT03364309|469087217|FG009|Maintenance Period|Lost to Follow-up|0|||
130306996|NCT03364309|469087218|FG010|Maintenance Period|Lost to Follow-up|0|||
130306997|NCT03364309|469087219|FG011|Maintenance Period|Lost to Follow-up|0|||
130306998|NCT03364309|469087220|FG012|Maintenance Period|Lost to Follow-up|0|||
130306999|NCT03364309|469087221|FG013|Maintenance Period|Lost to Follow-up|0|||
130307000|NCT03364309|469087222|FG014|Maintenance Period|Lost to Follow-up|0|||
130307001|NCT03364309|469087223|FG015|Maintenance Period|Lost to Follow-up|0|||
130307002|NCT03364309|469087224|FG016|Maintenance Period|Lost to Follow-up|0|||
130307003|NCT03364309|469087225|FG017|Maintenance Period|Lost to Follow-up|0|||
130307004|NCT03364309|469087226|FG018|Maintenance Period|Lost to Follow-up|0|||
130307005|NCT03364309|469087208|FG000|Maintenance Period|Miscellaneous|0|||
130307006|NCT03364309|469087209|FG001|Maintenance Period|Miscellaneous|0|||
130307007|NCT03364309|469087210|FG002|Maintenance Period|Miscellaneous|0|||
130307008|NCT03364309|469087211|FG003|Maintenance Period|Miscellaneous|0|||
130307009|NCT03364309|469087212|FG004|Maintenance Period|Miscellaneous|0|||
130307010|NCT03364309|469087213|FG005|Maintenance Period|Miscellaneous|0|||
130307011|NCT03364309|469087214|FG006|Maintenance Period|Miscellaneous|0|||
130307012|NCT03364309|469087215|FG007|Maintenance Period|Miscellaneous|0|||
130307013|NCT03364309|469087216|FG008|Maintenance Period|Miscellaneous|1|||
130307014|NCT03364309|469087217|FG009|Maintenance Period|Miscellaneous|0|||
130307015|NCT03364309|469087218|FG010|Maintenance Period|Miscellaneous|0|||
130307016|NCT03364309|469087219|FG011|Maintenance Period|Miscellaneous|0|||
130307017|NCT03364309|469087220|FG012|Maintenance Period|Miscellaneous|0|||
130307018|NCT03364309|469087221|FG013|Maintenance Period|Miscellaneous|0|||
130307019|NCT03364309|469087222|FG014|Maintenance Period|Miscellaneous|0|||
130307020|NCT03364309|469087223|FG015|Maintenance Period|Miscellaneous|0|||
130307021|NCT03364309|469087224|FG016|Maintenance Period|Miscellaneous|0|||
130307022|NCT03364309|469087225|FG017|Maintenance Period|Miscellaneous|0|||
130307023|NCT03364309|469087226|FG018|Maintenance Period|Miscellaneous|0|||
130307024|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307025|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307026|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307027|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307028|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307029|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307030|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307031|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307032|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307033|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307034|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307035|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307036|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307037|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307038|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307039|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307040|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307041|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307042|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307043|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307044|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307045|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307046|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307047|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307048|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307049|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307050|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307051|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307052|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307053|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307054|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307055|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307056|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307057|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
130307058|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307059|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307060|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307061|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307062|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
130307063|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
130307064|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
130307065|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
130307066|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
130307067|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
130307068|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
130307069|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
130307070|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
130307071|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
130307072|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
130307073|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
130307074|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
130307075|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
130307076|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
130307077|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
130307078|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
130307079|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
130307080|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
130307081|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307082|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307083|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307084|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307085|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307086|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307087|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307088|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307089|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307090|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130373909|NCT02321800|469336840|FG000|Overall Study|Other, Miscellaneous|3|||
130373910|NCT02321800|469336841|FG001|Overall Study|Other, Miscellaneous|1|||
130307091|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307092|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307093|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307094|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307095|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307096|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307097|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130307098|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
130307099|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
130307100|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Adverse Event|0|||
130307101|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Adverse Event|0|||
130307102|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Adverse Event|0|||
130307103|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Adverse Event|0|||
130307104|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130307105|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Adverse Event|0|||
130307106|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Adverse Event|0|||
130307107|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Adverse Event|0|||
130307108|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Adverse Event|0|||
130307109|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Adverse Event|0|||
130307110|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Adverse Event|0|||
130307111|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Adverse Event|0|||
130307112|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Adverse Event|0|||
130307113|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Adverse Event|0|||
130307114|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Adverse Event|0|||
130307115|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Adverse Event|0|||
130307116|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Adverse Event|2|||
130307117|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Adverse Event|6|||
130307118|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Adverse Event|1|||
130307119|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307120|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307121|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307122|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307123|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307124|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307125|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307126|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307127|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307128|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307129|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307130|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307131|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307132|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307133|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307134|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307135|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307136|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
130307137|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307138|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
130307139|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
130307140|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
130307141|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
130307142|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
130307143|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
130307144|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
130307145|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
130307146|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
130307147|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
130307148|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
130307149|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
130307150|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
130307151|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
130307152|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
130307153|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
130307154|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
130307155|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
130307156|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
130307157|NCT00167310|469087227|FG000|Overall Study|Protocol Violation|5|||
130307158|NCT00167310|469087228|FG001|Overall Study|Protocol Violation|3|||
130307159|NCT00167310|469087227|FG000|Overall Study|Withdrawal by Subject|3|||
130307160|NCT00167310|469087228|FG001|Overall Study|Withdrawal by Subject|7|||
130307161|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
130307162|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
130307163|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
130307164|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
130307165|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
130307166|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
130307167|NCT01052077|469087234|FG000|Phase A|Lost to Follow-up|22|||
130307168|NCT01052077|469087235|FG001|Phase A|Lost to Follow-up|0|||
130307169|NCT01052077|469087236|FG002|Phase A|Lost to Follow-up|0|||
130307170|NCT01052077|469087237|FG003|Phase A|Lost to Follow-up|0|||
130307171|NCT01052077|469087234|FG000|Phase A|Adverse Event|32|||
130307172|NCT01052077|469087235|FG001|Phase A|Adverse Event|0|||
130307173|NCT01052077|469087236|FG002|Phase A|Adverse Event|0|||
130307174|NCT01052077|469087237|FG003|Phase A|Adverse Event|0|||
130307175|NCT01052077|469087234|FG000|Phase A|Met Withdrawal Criteria|26|||
130307176|NCT01052077|469087235|FG001|Phase A|Met Withdrawal Criteria|0|||
130307177|NCT01052077|469087236|FG002|Phase A|Met Withdrawal Criteria|0|||
130307178|NCT01052077|469087237|FG003|Phase A|Met Withdrawal Criteria|0|||
130307179|NCT01052077|469087234|FG000|Phase A|Physician Decision|10|||
130307180|NCT01052077|469087235|FG001|Phase A|Physician Decision|0|||
130307181|NCT01052077|469087236|FG002|Phase A|Physician Decision|0|||
130307182|NCT01052077|469087237|FG003|Phase A|Physician Decision|0|||
130307183|NCT01052077|469087234|FG000|Phase A|Withdrawal by Subject|29|||
130307184|NCT01052077|469087235|FG001|Phase A|Withdrawal by Subject|0|||
130307185|NCT01052077|469087236|FG002|Phase A|Withdrawal by Subject|0|||
130307186|NCT01052077|469087237|FG003|Phase A|Withdrawal by Subject|0|||
130307187|NCT01052077|469087234|FG000|Phase A|Protocol Deviation|27|||
130307188|NCT01052077|469087235|FG001|Phase A|Protocol Deviation|0|||
130307189|NCT01052077|469087236|FG002|Phase A|Protocol Deviation|0|||
130307190|NCT01052077|469087237|FG003|Phase A|Protocol Deviation|0|||
130307191|NCT01052077|469087234|FG000|Phase B|Lost to Follow-up|0|||
130307192|NCT01052077|469087235|FG001|Phase B|Lost to Follow-up|2|||
130307193|NCT01052077|469087236|FG002|Phase B|Lost to Follow-up|3|||
130307194|NCT01052077|469087237|FG003|Phase B|Lost to Follow-up|0|||
130307195|NCT01052077|469087234|FG000|Phase B|Adverse Event|0|||
130307196|NCT01052077|469087235|FG001|Phase B|Adverse Event|9|||
130307197|NCT01052077|469087236|FG002|Phase B|Adverse Event|2|||
130307198|NCT01052077|469087237|FG003|Phase B|Adverse Event|0|||
130307199|NCT01052077|469087234|FG000|Phase B|Met Withdrawal Criteria|0|||
130307200|NCT01052077|469087235|FG001|Phase B|Met Withdrawal Criteria|2|||
130307201|NCT01052077|469087236|FG002|Phase B|Met Withdrawal Criteria|1|||
130307202|NCT01052077|469087237|FG003|Phase B|Met Withdrawal Criteria|0|||
130307203|NCT01052077|469087234|FG000|Phase B|Physician Decision|0|||
130307204|NCT01052077|469087235|FG001|Phase B|Physician Decision|1|||
130307205|NCT01052077|469087236|FG002|Phase B|Physician Decision|1|||
130307206|NCT01052077|469087237|FG003|Phase B|Physician Decision|0|||
130307207|NCT01052077|469087234|FG000|Phase B|Withdrawal by Subject|0|||
130307208|NCT01052077|469087235|FG001|Phase B|Withdrawal by Subject|0|||
130307209|NCT01052077|469087236|FG002|Phase B|Withdrawal by Subject|5|||
130307210|NCT01052077|469087237|FG003|Phase B|Withdrawal by Subject|0|||
130307211|NCT01052077|469087234|FG000|Phase B|Protocol Deviation|0|||
130307212|NCT01052077|469087235|FG001|Phase B|Protocol Deviation|3|||
130307213|NCT01052077|469087236|FG002|Phase B|Protocol Deviation|4|||
130307214|NCT01052077|469087237|FG003|Phase B|Protocol Deviation|0|||
130307215|NCT01052077|469087234|FG000|Phase B|Lack of Efficacy|0|||
130307216|NCT01052077|469087235|FG001|Phase B|Lack of Efficacy|1|||
130307217|NCT01052077|469087236|FG002|Phase B|Lack of Efficacy|0|||
130307218|NCT01052077|469087237|FG003|Phase B|Lack of Efficacy|0|||
130307219|NCT01052077|469087234|FG000|Phase A+|Lost to Follow-up|0|||
130307220|NCT01052077|469087235|FG001|Phase A+|Lost to Follow-up|0|||
130307221|NCT01052077|469087236|FG002|Phase A+|Lost to Follow-up|0|||
130307222|NCT01052077|469087237|FG003|Phase A+|Lost to Follow-up|8|||
130307223|NCT01052077|469087234|FG000|Phase A+|Adverse Event|0|||
130307224|NCT01052077|469087235|FG001|Phase A+|Adverse Event|0|||
130307225|NCT01052077|469087236|FG002|Phase A+|Adverse Event|0|||
130307226|NCT01052077|469087237|FG003|Phase A+|Adverse Event|4|||
130307227|NCT01052077|469087234|FG000|Phase A+|Met Withdrawal Criteria|0|||
130307228|NCT01052077|469087235|FG001|Phase A+|Met Withdrawal Criteria|0|||
130307229|NCT01052077|469087236|FG002|Phase A+|Met Withdrawal Criteria|0|||
130307230|NCT01052077|469087237|FG003|Phase A+|Met Withdrawal Criteria|2|||
130307231|NCT01052077|469087234|FG000|Phase A+|Withdrawal by Subject|0|||
130307232|NCT01052077|469087235|FG001|Phase A+|Withdrawal by Subject|0|||
130307233|NCT01052077|469087236|FG002|Phase A+|Withdrawal by Subject|0|||
130307234|NCT01052077|469087237|FG003|Phase A+|Withdrawal by Subject|7|||
130307235|NCT02465203|469087238|FG000|Overall Study|Protocol Violation|1|||
130307236|NCT02465203|469087239|FG001|Overall Study|Protocol Violation|1|||
130307237|NCT02465203|469087240|FG002|Overall Study|Protocol Violation|1|||
130307238|NCT02465203|469087238|FG000|Overall Study|Study terminated by sponsor|50|||
130307239|NCT02465203|469087239|FG001|Overall Study|Study terminated by sponsor|34|||
130307240|NCT02465203|469087240|FG002|Overall Study|Study terminated by sponsor|11|||
130307241|NCT02465203|469087238|FG000|Overall Study|New therapy for study indication|4|||
130307242|NCT02465203|469087239|FG001|Overall Study|New therapy for study indication|0|||
130307243|NCT02465203|469087240|FG002|Overall Study|New therapy for study indication|0|||
130307244|NCT02465203|469087238|FG000|Overall Study|Patient/guardian decision|1|||
130307245|NCT02465203|469087239|FG001|Overall Study|Patient/guardian decision|1|||
130307246|NCT02465203|469087240|FG002|Overall Study|Patient/guardian decision|1|||
130307247|NCT00042991|469087245|FG000|Overall Study|Adverse Event|1|||
130307248|NCT00042991|469087246|FG001|Overall Study|Adverse Event|4|||
130307249|NCT00042991|469087247|FG002|Overall Study|Adverse Event|2|||
130307250|NCT00042991|469087248|FG003|Overall Study|Adverse Event|0|||
130307251|NCT00042991|469087249|FG004|Overall Study|Adverse Event|0|||
130307252|NCT00042991|469087250|FG005|Overall Study|Adverse Event|1|||
130307253|NCT00042991|469087251|FG006|Overall Study|Adverse Event|0|||
130307254|NCT00042991|469087245|FG000|Overall Study|Withdrawal by Subject|0|||
130307255|NCT00042991|469087246|FG001|Overall Study|Withdrawal by Subject|7|||
130307256|NCT00042991|469087247|FG002|Overall Study|Withdrawal by Subject|2|||
130307257|NCT00042991|469087248|FG003|Overall Study|Withdrawal by Subject|0|||
130307258|NCT00042991|469087249|FG004|Overall Study|Withdrawal by Subject|1|||
130307259|NCT00042991|469087250|FG005|Overall Study|Withdrawal by Subject|0|||
130307260|NCT00042991|469087251|FG006|Overall Study|Withdrawal by Subject|0|||
130557736|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130307261|NCT00042991|469087245|FG000|Overall Study|Disease Progression|5|||
130307262|NCT00042991|469087246|FG001|Overall Study|Disease Progression|29|||
130307263|NCT00042991|469087247|FG002|Overall Study|Disease Progression|2|||
130307264|NCT00042991|469087248|FG003|Overall Study|Disease Progression|2|||
130307265|NCT00042991|469087249|FG004|Overall Study|Disease Progression|1|||
130307266|NCT00042991|469087250|FG005|Overall Study|Disease Progression|4|||
130557737|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130307267|NCT00042991|469087251|FG006|Overall Study|Disease Progression|2|||
130717749|NCT04078126|470593153|FG001|Period 2|Study put on hold due to COVID-19|1|||
130717750|NCT02669758|470593156|FG000|Overall Study|Withdrawal by Subject|43|||
130717751|NCT02669758|470593156|FG000|Overall Study|Lost to Follow-up|19|||
130717752|NCT02669758|470593156|FG000|Overall Study|Adverse Event|16|||
130717753|NCT02669758|470593156|FG000|Overall Study|Non-Compliance with Study Drug|8|||
130717754|NCT02669758|470593156|FG000|Overall Study|Lack of Efficacy|5|||
130717755|NCT02669758|470593156|FG000|Overall Study|Pregnancy|1|||
130717756|NCT02669758|470593156|FG000|Overall Study|Study noncompliance|1|||
130717757|NCT02669758|470593156|FG000|Overall Study|Protocol Violation|1|||
130717758|NCT02605993|470593159|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717759|NCT02605993|470593160|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717760|NCT02605993|470593161|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
130717761|NCT02605993|470593162|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717762|NCT02603393|470593163|FG000|Overall Study|Patient/guardian decision|32|||
130717763|NCT02603393|470593164|FG001|Overall Study|Patient/guardian decision|18|||
130717764|NCT02603393|470593163|FG000|Overall Study|Adverse Event|17|||
130717765|NCT02603393|470593164|FG001|Overall Study|Adverse Event|15|||
130717766|NCT02603393|470593163|FG000|Overall Study|Technical problems|4|||
130717767|NCT02603393|470593164|FG001|Overall Study|Technical problems|7|||
130717768|NCT02603393|470593163|FG000|Overall Study|Lack of Efficacy|7|||
130717769|NCT02603393|470593164|FG001|Overall Study|Lack of Efficacy|2|||
130717770|NCT02603393|470593163|FG000|Overall Study|Death|3|||
130717771|NCT02603393|470593164|FG001|Overall Study|Death|4|||
130717772|NCT02603393|470593163|FG000|Overall Study|Physician Decision|3|||
130717773|NCT02603393|470593164|FG001|Overall Study|Physician Decision|3|||
130717774|NCT02603393|470593163|FG000|Overall Study|Protocol deviation|2|||
130717775|NCT02603393|470593164|FG001|Overall Study|Protocol deviation|3|||
130717776|NCT02603393|470593163|FG000|Overall Study|Lost to Follow-up|1|||
130717777|NCT02603393|470593164|FG001|Overall Study|Lost to Follow-up|2|||
130717778|NCT02603393|470593163|FG000|Overall Study|Non-compliance with study treatment|1|||
130307268|NCT00042991|469087245|FG000|Overall Study|Alternative Therapy|0|||
130307269|NCT00042991|469087246|FG001|Overall Study|Alternative Therapy|0|||
130307270|NCT00042991|469087247|FG002|Overall Study|Alternative Therapy|0|||
130717779|NCT02603393|470593164|FG001|Overall Study|Non-compliance with study treatment|0|||
130307271|NCT00042991|469087248|FG003|Overall Study|Alternative Therapy|0|||
130307272|NCT00042991|469087249|FG004|Overall Study|Alternative Therapy|1|||
130717780|NCT02603393|470593163|FG000|Overall Study|Sponsor decision|1|||
130717781|NCT02603393|470593164|FG001|Overall Study|Sponsor decision|0|||
130307273|NCT00042991|469087250|FG005|Overall Study|Alternative Therapy|0|||
130307274|NCT00042991|469087251|FG006|Overall Study|Alternative Therapy|0|||
130307275|NCT04072887|469087252|FG000|Overall Study|Withdrawal by Subject|3|||
130307276|NCT04072887|469087253|FG001|Overall Study|Withdrawal by Subject|8|||
130307277|NCT04072887|469087254|FG002|Overall Study|Withdrawal by Subject|1|||
130307278|NCT04072887|469087255|FG003|Overall Study|Withdrawal by Subject|3|||
130307279|NCT04072887|469087256|FG004|Overall Study|Withdrawal by Subject|3|||
130307280|NCT04072887|469087257|FG005|Overall Study|Withdrawal by Subject|13|||
130307281|NCT04072887|469087252|FG000|Overall Study|Adverse Event|2|||
130307282|NCT04072887|469087253|FG001|Overall Study|Adverse Event|4|||
130307283|NCT04072887|469087254|FG002|Overall Study|Adverse Event|1|||
130307284|NCT04072887|469087255|FG003|Overall Study|Adverse Event|4|||
130307285|NCT04072887|469087256|FG004|Overall Study|Adverse Event|0|||
130307286|NCT04072887|469087257|FG005|Overall Study|Adverse Event|1|||
130307287|NCT04072887|469087252|FG000|Overall Study|Physician Decision|2|||
130307288|NCT04072887|469087253|FG001|Overall Study|Physician Decision|0|||
130307289|NCT04072887|469087254|FG002|Overall Study|Physician Decision|0|||
130307290|NCT04072887|469087255|FG003|Overall Study|Physician Decision|0|||
130717782|NCT01868893|470593167|FG000|Overall Study|Adverse Event|2|||
130717783|NCT01868893|470593167|FG000|Overall Study|Commercial availability of study drug|17|||
130717784|NCT01868893|470593167|FG000|Overall Study|Neutropenia|1|||
130717785|NCT01783548|470593168|FG000|Overall Study|Adverse Event|8|||
130717786|NCT01783548|470593169|FG001|Overall Study|Adverse Event|4|||
130717787|NCT01783548|470593168|FG000|Overall Study|Withdrawal by Subject|11|||
130717788|NCT01783548|470593169|FG001|Overall Study|Withdrawal by Subject|8|||
130717789|NCT01783548|470593168|FG000|Overall Study|Non-compliance|4|||
130717790|NCT01783548|470593169|FG001|Overall Study|Non-compliance|0|||
130717791|NCT01783548|470593168|FG000|Overall Study|Protocol Violation|2|||
130717792|NCT01783548|470593169|FG001|Overall Study|Protocol Violation|2|||
130717793|NCT01783548|470593168|FG000|Overall Study|Lost to Follow-up|8|||
130717794|NCT01783548|470593169|FG001|Overall Study|Lost to Follow-up|3|||
130717795|NCT01783548|470593168|FG000|Overall Study|Lack of Efficacy|1|||
130717796|NCT01783548|470593169|FG001|Overall Study|Lack of Efficacy|1|||
130717797|NCT00988442|470593170|FG000|Overall Study|Death|1|||
130717798|NCT00988442|470593171|FG001|Overall Study|Death|2|||
130717799|NCT00988442|470593170|FG000|Overall Study|Lost to Follow-up|0|||
130717800|NCT00988442|470593171|FG001|Overall Study|Lost to Follow-up|1|||
130717801|NCT00988442|470593170|FG000|Overall Study|Early Study Closure|29|||
130717802|NCT00988442|470593171|FG001|Overall Study|Early Study Closure|25|||
130717803|NCT01735955|470593175|FG000|Overall Study|Administrative problems|1|||
130717804|NCT01735955|470593175|FG000|Overall Study|Patient/guardian decision|1|||
130717805|NCT01735955|470593175|FG000|Overall Study|Patient withdrew consent|2|||
130717806|NCT01735955|470593175|FG000|Overall Study|Physician Decision|4|||
130717807|NCT01735955|470593175|FG000|Overall Study|Disease progression|24|||
130717808|NCT01735955|470593175|FG000|Overall Study|Adverse Event|5|||
130717809|NCT03317834|470593178|FG000|Overall Study|Death|2|||
130717810|NCT03317834|470593178|FG000|Overall Study|Device Revision|5|||
130717811|NCT03317834|470593178|FG000|Overall Study|Withdrawal by Subject|13|||
130717812|NCT03317834|470593178|FG000|Overall Study|Lost to Follow-up|13|||
130717813|NCT00123474|470593184|FG000|Randomized to Treatment|Randomized, never treated|1|||
130717814|NCT00123474|470593185|FG001|Randomized to Treatment|Randomized, never treated|4|||
130717815|NCT00123474|470593186|FG002|Randomized to Treatment|Randomized, never treated|2|||
130717816|NCT00123474|470593187|FG003|Randomized to Treatment|Randomized, never treated|1|||
130717817|NCT00123474|470593184|FG000|As Treated at Study Closure|not reported when site closed|1|||
130717818|NCT00123474|470593185|FG001|As Treated at Study Closure|not reported when site closed|0|||
130717819|NCT00123474|470593186|FG002|As Treated at Study Closure|not reported when site closed|1|||
130717820|NCT00123474|470593187|FG003|As Treated at Study Closure|not reported when site closed|0|||
130717821|NCT00123474|470593184|FG000|As Treated at Study Closure|Adverse Event|10|||
130717822|NCT00123474|470593185|FG001|As Treated at Study Closure|Adverse Event|4|||
130717823|NCT00123474|470593186|FG002|As Treated at Study Closure|Adverse Event|10|||
130717824|NCT00123474|470593187|FG003|As Treated at Study Closure|Adverse Event|8|||
130717825|NCT00123474|470593184|FG000|As Treated at Study Closure|Disease Progression|35|||
130717826|NCT00123474|470593185|FG001|As Treated at Study Closure|Disease Progression|42|||
130717827|NCT00123474|470593186|FG002|As Treated at Study Closure|Disease Progression|29|||
130717828|NCT00123474|470593187|FG003|As Treated at Study Closure|Disease Progression|27|||
130717829|NCT00123474|470593184|FG000|As Treated at Study Closure|Investigator Request|12|||
130307291|NCT04072887|469087256|FG004|Overall Study|Physician Decision|0|||
130307292|NCT04072887|469087257|FG005|Overall Study|Physician Decision|1|||
130307293|NCT04072887|469087252|FG000|Overall Study|Lost to Follow-up|1|||
130307294|NCT04072887|469087253|FG001|Overall Study|Lost to Follow-up|3|||
130717830|NCT00123474|470593185|FG001|As Treated at Study Closure|Investigator Request|6|||
130717831|NCT00123474|470593186|FG002|As Treated at Study Closure|Investigator Request|7|||
130717832|NCT00123474|470593187|FG003|As Treated at Study Closure|Investigator Request|5|||
130717833|NCT00123474|470593184|FG000|As Treated at Study Closure|non-specified|54|||
130717834|NCT00123474|470593185|FG001|As Treated at Study Closure|non-specified|47|||
130717835|NCT00123474|470593186|FG002|As Treated at Study Closure|non-specified|57|||
130717836|NCT00123474|470593187|FG003|As Treated at Study Closure|non-specified|60|||
130307295|NCT04072887|469087254|FG002|Overall Study|Lost to Follow-up|0|||
130307296|NCT04072887|469087255|FG003|Overall Study|Lost to Follow-up|0|||
130307297|NCT04072887|469087256|FG004|Overall Study|Lost to Follow-up|0|||
130307298|NCT04072887|469087257|FG005|Overall Study|Lost to Follow-up|0|||
130307299|NCT04072887|469087252|FG000|Overall Study|Death|0|||
130307300|NCT04072887|469087253|FG001|Overall Study|Death|2|||
130307301|NCT04072887|469087254|FG002|Overall Study|Death|0|||
130307302|NCT04072887|469087255|FG003|Overall Study|Death|2|||
130307303|NCT04072887|469087256|FG004|Overall Study|Death|3|||
130307304|NCT04072887|469087257|FG005|Overall Study|Death|0|||
130307305|NCT03193736|469087258|FG000|Overall Study|Death|2|||
130307306|NCT03193736|469087258|FG000|Overall Study|Withdrawal by Subject|1|||
130307307|NCT03193736|469087258|FG000|Overall Study|Lost to Follow-up|1|||
130307308|NCT03193736|469087258|FG000|Overall Study|implant not received|1|||
130307309|NCT00423449|469087259|FG000|Overall Study|Clinical Adverse Event|1|||
130307310|NCT00423449|469087260|FG001|Overall Study|Clinical Adverse Event|0|||
130307311|NCT00423449|469087261|FG002|Overall Study|Clinical Adverse Event|1|||
130307312|NCT00423449|469087262|FG003|Overall Study|Clinical Adverse Event|8|||
130307313|NCT00423449|469087263|FG004|Overall Study|Clinical Adverse Event|2|||
130307314|NCT00423449|469087259|FG000|Overall Study|Death|1|||
130307315|NCT00423449|469087260|FG001|Overall Study|Death|0|||
130307316|NCT00423449|469087261|FG002|Overall Study|Death|2|||
130307317|NCT00423449|469087262|FG003|Overall Study|Death|1|||
130307318|NCT00423449|469087263|FG004|Overall Study|Death|1|||
130307319|NCT00423449|469087259|FG000|Overall Study|Progressive Disease|1|||
130307320|NCT00423449|469087260|FG001|Overall Study|Progressive Disease|3|||
130307321|NCT00423449|469087261|FG002|Overall Study|Progressive Disease|8|||
130307322|NCT00423449|469087262|FG003|Overall Study|Progressive Disease|11|||
130307323|NCT00423449|469087263|FG004|Overall Study|Progressive Disease|4|||
130307324|NCT00423449|469087259|FG000|Overall Study|Laboratory Adverse Event|0|||
130307325|NCT00423449|469087260|FG001|Overall Study|Laboratory Adverse Event|1|||
130307326|NCT00423449|469087261|FG002|Overall Study|Laboratory Adverse Event|2|||
130307327|NCT00423449|469087262|FG003|Overall Study|Laboratory Adverse Event|0|||
130307328|NCT00423449|469087263|FG004|Overall Study|Laboratory Adverse Event|0|||
130307329|NCT00423449|469087259|FG000|Overall Study|Other|0|||
130307330|NCT00423449|469087260|FG001|Overall Study|Other|0|||
130307331|NCT00423449|469087261|FG002|Overall Study|Other|0|||
130307332|NCT00423449|469087262|FG003|Overall Study|Other|1|||
130307333|NCT00423449|469087263|FG004|Overall Study|Other|0|||
130307334|NCT00423449|469087259|FG000|Overall Study|Protocol Violation|0|||
130307335|NCT00423449|469087260|FG001|Overall Study|Protocol Violation|0|||
130307336|NCT00423449|469087261|FG002|Overall Study|Protocol Violation|2|||
130307337|NCT00423449|469087262|FG003|Overall Study|Protocol Violation|1|||
130307338|NCT00423449|469087263|FG004|Overall Study|Protocol Violation|0|||
130307339|NCT02697435|469087264|FG000|Overall Study|Withdrawal by Subject|1|||
130307340|NCT02697435|469087265|FG001|Overall Study|Withdrawal by Subject|0|||
130307341|NCT02697435|469087264|FG000|Overall Study|Physician Decision|0|||
130307342|NCT02697435|469087265|FG001|Overall Study|Physician Decision|4|||
130307343|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
130307344|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
130307345|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
130307346|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
130307347|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
130307348|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
130307349|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130307350|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130307351|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
130307352|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
130307353|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
130307354|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
130307355|NCT00861471|469087282|FG000|Overall Study|Withdrawal by Subject|1|||
130307356|NCT00861471|469087282|FG000|Overall Study|Adverse Event|2|||
130307357|NCT00861471|469087282|FG000|Overall Study|Lack of Efficacy|3|||
130464438|NCT04425629|469667148|FG009|Overall Study|Adverse Event|3|||
130464439|NCT04425629|469667149|FG010|Overall Study|Adverse Event|2|||
130464440|NCT04425629|469667150|FG011|Overall Study|Adverse Event|1|||
130307358|NCT00861471|469087282|FG000|Overall Study|treatment for lumbar laminectomy|1|||
130307359|NCT00861471|469087282|FG000|Overall Study|Physician Decision|2|||
130307360|NCT01445080|469087283|FG000|Overall Study|Adverse Event|5|||
130307361|NCT01445080|469087284|FG001|Overall Study|Adverse Event|3|||
130307362|NCT01445080|469087285|FG002|Overall Study|Adverse Event|11|||
130307363|NCT01445080|469087286|FG003|Overall Study|Adverse Event|6|||
130307364|NCT01445080|469087287|FG004|Overall Study|Adverse Event|2|||
130307365|NCT01445080|469087288|FG005|Overall Study|Adverse Event|3|||
130307366|NCT01445080|469087289|FG006|Overall Study|Adverse Event|0|||
130307367|NCT01445080|469087290|FG007|Overall Study|Adverse Event|3|||
130307368|NCT01445080|469087291|FG008|Overall Study|Adverse Event|10|||
130307369|NCT01445080|469087283|FG000|Overall Study|Physician Decision|0|||
130307370|NCT01445080|469087284|FG001|Overall Study|Physician Decision|0|||
130307371|NCT01445080|469087285|FG002|Overall Study|Physician Decision|1|||
130307372|NCT01445080|469087286|FG003|Overall Study|Physician Decision|0|||
130307373|NCT01445080|469087287|FG004|Overall Study|Physician Decision|0|||
130307374|NCT01445080|469087288|FG005|Overall Study|Physician Decision|3|||
130307375|NCT01445080|469087289|FG006|Overall Study|Physician Decision|2|||
130307376|NCT01445080|469087290|FG007|Overall Study|Physician Decision|2|||
130307377|NCT01445080|469087291|FG008|Overall Study|Physician Decision|0|||
130307378|NCT01445080|469087283|FG000|Overall Study|Withdrawal by Subject|1|||
130307379|NCT01445080|469087284|FG001|Overall Study|Withdrawal by Subject|0|||
130307380|NCT01445080|469087285|FG002|Overall Study|Withdrawal by Subject|0|||
130307381|NCT01445080|469087286|FG003|Overall Study|Withdrawal by Subject|1|||
130307382|NCT01445080|469087287|FG004|Overall Study|Withdrawal by Subject|0|||
130307383|NCT01445080|469087288|FG005|Overall Study|Withdrawal by Subject|0|||
130307384|NCT01445080|469087289|FG006|Overall Study|Withdrawal by Subject|0|||
130307385|NCT01445080|469087290|FG007|Overall Study|Withdrawal by Subject|0|||
130307386|NCT01445080|469087291|FG008|Overall Study|Withdrawal by Subject|2|||
130307387|NCT01445080|469087283|FG000|Overall Study|Ineligible/Inevaluable|1|||
130307388|NCT01445080|469087284|FG001|Overall Study|Ineligible/Inevaluable|2|||
130307389|NCT01445080|469087285|FG002|Overall Study|Ineligible/Inevaluable|0|||
130307390|NCT01445080|469087286|FG003|Overall Study|Ineligible/Inevaluable|1|||
130307391|NCT01445080|469087287|FG004|Overall Study|Ineligible/Inevaluable|2|||
130307392|NCT01445080|469087288|FG005|Overall Study|Ineligible/Inevaluable|3|||
130307393|NCT01445080|469087289|FG006|Overall Study|Ineligible/Inevaluable|0|||
130307394|NCT01445080|469087290|FG007|Overall Study|Ineligible/Inevaluable|0|||
130307395|NCT01445080|469087291|FG008|Overall Study|Ineligible/Inevaluable|6|||
130307396|NCT00445770|469087292|FG000|Overall Study|Adverse Event|9|||
130307397|NCT00445770|469087293|FG001|Overall Study|Adverse Event|15|||
130307398|NCT00445770|469087294|FG002|Overall Study|Adverse Event|19|||
130307399|NCT00445770|469087292|FG000|Overall Study|Lack of Efficacy|38|||
130307400|NCT00445770|469087293|FG001|Overall Study|Lack of Efficacy|13|||
130307401|NCT00445770|469087294|FG002|Overall Study|Lack of Efficacy|6|||
130307402|NCT00445770|469087292|FG000|Overall Study|Lost to Follow-up|0|||
130307403|NCT00445770|469087293|FG001|Overall Study|Lost to Follow-up|2|||
130307404|NCT00445770|469087294|FG002|Overall Study|Lost to Follow-up|0|||
130307405|NCT00445770|469087292|FG000|Overall Study|Other|6|||
130307406|NCT00445770|469087293|FG001|Overall Study|Other|5|||
130307407|NCT00445770|469087294|FG002|Overall Study|Other|6|||
130307408|NCT03857542|469087295|FG000|Overall Study|Adverse Event|1|||
130307409|NCT03857542|469087296|FG001|Overall Study|Adverse Event|3|||
130307410|NCT03857542|469087295|FG000|Overall Study|Withdrawal by Subject|2|||
130307411|NCT03857542|469087296|FG001|Overall Study|Withdrawal by Subject|1|||
130307412|NCT03857542|469087295|FG000|Overall Study|Lost to Follow-up|2|||
130307413|NCT03857542|469087296|FG001|Overall Study|Lost to Follow-up|1|||
130307414|NCT03857542|469087295|FG000|Overall Study|Reason not Specified|1|||
130307415|NCT03857542|469087296|FG001|Overall Study|Reason not Specified|0|||
130307416|NCT03058692|469089155|FG000|Overall Study|Lost to Follow-up|2|||
130307417|NCT03058692|469089156|FG001|Overall Study|Lost to Follow-up|1|||
130307418|NCT03058692|469089155|FG000|Overall Study|Withdrawal by Subject|1|||
130307419|NCT03058692|469089156|FG001|Overall Study|Withdrawal by Subject|1|||
130307420|NCT01698814|469089159|FG000|Overall Study|Adverse Event|0|||
130307421|NCT01698814|469089160|FG001|Overall Study|Adverse Event|2|||
130307422|NCT01698814|469089159|FG000|Overall Study|Lost to Follow-up|0|||
130307423|NCT01698814|469089160|FG001|Overall Study|Lost to Follow-up|1|||
130307424|NCT01698814|469089159|FG000|Overall Study|Pregnancy|1|||
130307425|NCT01698814|469089160|FG001|Overall Study|Pregnancy|0|||
130307426|NCT01698814|469089159|FG000|Overall Study|Randomized in error|1|||
130307427|NCT01698814|469089160|FG001|Overall Study|Randomized in error|0|||
130307428|NCT04014062|469089161|FG000|Period I: Dosing|Medical Grounds|4|||
130307429|NCT04014062|469089162|FG001|Period I: Dosing|Medical Grounds|5|||
130307430|NCT04014062|469089161|FG000|Period I: Dosing|Withdrawal by Subject|3|||
130307431|NCT04014062|469089162|FG001|Period I: Dosing|Withdrawal by Subject|1|||
130307432|NCT03038126|469089164|FG000|Overall Study|Death|1|||
130307433|NCT03038126|469089165|FG001|Overall Study|Death|1|||
130307434|NCT03038126|469089164|FG000|Overall Study|Withdrawal by Subject|5|||
130307435|NCT03038126|469089165|FG001|Overall Study|Withdrawal by Subject|0|||
130464441|NCT04425629|469667151|FG012|Overall Study|Adverse Event|1|||
130307436|NCT03038126|469089164|FG000|Overall Study|Lost to Follow-up|0|||
130307437|NCT03038126|469089165|FG001|Overall Study|Lost to Follow-up|1|||
130307438|NCT03038126|469089164|FG000|Overall Study|Long Term Hospitalization|2|||
130307439|NCT03038126|469089165|FG001|Overall Study|Long Term Hospitalization|0|||
130307440|NCT03038126|469089164|FG000|Overall Study|Too Ill to Participate|1|||
130307441|NCT03038126|469089165|FG001|Overall Study|Too Ill to Participate|2|||
130307442|NCT01724866|469089166|FG000|Overall Study|Adverse Event|0|||
130307443|NCT01724866|469089167|FG001|Overall Study|Adverse Event|0|||
130307444|NCT01724866|469089168|FG002|Overall Study|Adverse Event|1|||
130307445|NCT01724866|469089169|FG003|Overall Study|Adverse Event|1|||
130307446|NCT01724866|469089166|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307447|NCT01724866|469089167|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
130307448|NCT01724866|469089168|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307449|NCT01724866|469089169|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307450|NCT01724866|469089166|FG000|Overall Study|Investigator's Discretion|0|||
130307451|NCT01724866|469089167|FG001|Overall Study|Investigator's Discretion|1|||
130307452|NCT01724866|469089168|FG002|Overall Study|Investigator's Discretion|1|||
130307453|NCT01724866|469089169|FG003|Overall Study|Investigator's Discretion|0|||
130307454|NCT01724866|469089166|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
130307455|NCT01724866|469089167|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307456|NCT01724866|469089168|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307457|NCT01724866|469089169|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307458|NCT01724866|469089166|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130307459|NCT01724866|469089167|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
130307460|NCT01724866|469089168|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
130307461|NCT01724866|469089169|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130307462|NCT01424501|469089170|FG000|Overall Study|Withdrawal by Subject|1|||
130307463|NCT01424501|469089171|FG001|Overall Study|Withdrawal by Subject|0|||
130307464|NCT01424501|469089172|FG002|Overall Study|Withdrawal by Subject|1|||
130307465|NCT01424501|469089173|FG003|Overall Study|Withdrawal by Subject|0|||
130307466|NCT01424501|469089174|FG004|Overall Study|Withdrawal by Subject|0|||
130307467|NCT01424501|469089175|FG005|Overall Study|Withdrawal by Subject|0|||
130307468|NCT01424501|469089170|FG000|Overall Study|Lost to Follow-up|0|||
130307469|NCT01424501|469089171|FG001|Overall Study|Lost to Follow-up|1|||
130307470|NCT01424501|469089172|FG002|Overall Study|Lost to Follow-up|1|||
130307471|NCT01424501|469089173|FG003|Overall Study|Lost to Follow-up|0|||
130307472|NCT01424501|469089174|FG004|Overall Study|Lost to Follow-up|0|||
130307473|NCT01424501|469089175|FG005|Overall Study|Lost to Follow-up|0|||
130307474|NCT01980095|469089176|FG000|Overall Study|Lost to Follow-up|6|||
130307475|NCT01980095|469089177|FG001|Overall Study|Lost to Follow-up|7|||
130307476|NCT01980095|469089176|FG000|Overall Study|Withdrawal by Subject|2|||
130307477|NCT01980095|469089177|FG001|Overall Study|Withdrawal by Subject|3|||
130307478|NCT01980095|469089176|FG000|Overall Study|Poor compliance|5|||
130307479|NCT01980095|469089177|FG001|Overall Study|Poor compliance|0|||
130307480|NCT01980095|469089176|FG000|Overall Study|Safety issue|0|||
130307481|NCT01980095|469089177|FG001|Overall Study|Safety issue|1|||
130307482|NCT01980095|469089176|FG000|Overall Study|Study drug discontinued|1|||
130307483|NCT01980095|469089177|FG001|Overall Study|Study drug discontinued|0|||
130307484|NCT01980095|469089176|FG000|Overall Study|Randomized by mistake|1|||
130307485|NCT01980095|469089177|FG001|Overall Study|Randomized by mistake|0|||
130307486|NCT01362608|469089182|FG000|Overall Study|Protocol Violation|0|||
130307487|NCT01362608|469089183|FG001|Overall Study|Protocol Violation|1|||
130464442|NCT04425629|469667152|FG013|Overall Study|Adverse Event|0|||
130464443|NCT04425629|469667153|FG014|Overall Study|Adverse Event|0|||
130307488|NCT01362608|469089182|FG000|Overall Study|Lost to Follow-up|3|||
130307489|NCT01362608|469089183|FG001|Overall Study|Lost to Follow-up|1|||
130307490|NCT01362608|469089182|FG000|Overall Study|Withdrawal by Subject|1|||
130307491|NCT01362608|469089183|FG001|Overall Study|Withdrawal by Subject|2|||
130464444|NCT04425629|469667154|FG015|Overall Study|Adverse Event|0|||
130307492|NCT01362608|469089182|FG000|Overall Study|Lack of Efficacy|0|||
130307493|NCT01362608|469089183|FG001|Overall Study|Lack of Efficacy|2|||
130307494|NCT01362608|469089182|FG000|Overall Study|Adverse Event|0|||
130307495|NCT01362608|469089183|FG001|Overall Study|Adverse Event|2|||
130307496|NCT04506502|469089191|FG000|Overall Study|Withdrawal by Subject|1|||
130307497|NCT04506502|469089191|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
130464445|NCT04425629|469667155|FG016|Overall Study|Adverse Event|0|||
130464446|NCT04425629|469667156|FG017|Overall Study|Adverse Event|0|||
130464447|NCT04425629|469667157|FG018|Overall Study|Adverse Event|0|||
130464448|NCT04425629|469667139|FG000|Overall Study|Lost to Follow-up|1|||
130464449|NCT04425629|469667140|FG001|Overall Study|Lost to Follow-up|3|||
130464450|NCT04425629|469667141|FG002|Overall Study|Lost to Follow-up|1|||
130464451|NCT04425629|469667142|FG003|Overall Study|Lost to Follow-up|7|||
130464452|NCT04425629|469667143|FG004|Overall Study|Lost to Follow-up|1|||
130464453|NCT04425629|469667144|FG005|Overall Study|Lost to Follow-up|2|||
130464454|NCT04425629|469667145|FG006|Overall Study|Lost to Follow-up|1|||
130464455|NCT04425629|469667146|FG007|Overall Study|Lost to Follow-up|0|||
130464456|NCT04425629|469667147|FG008|Overall Study|Lost to Follow-up|1|||
130464457|NCT04425629|469667148|FG009|Overall Study|Lost to Follow-up|64|||
130307498|NCT03526146|469089193|FG000|Overall Study|Lost to Follow-up|5|||
130307499|NCT03526146|469089193|FG000|Overall Study|Withdrawal by Subject|6|||
130307500|NCT03526146|469089193|FG000|Overall Study|class canceled due to COVID-19|4|||
130307501|NCT01136408|469089196|FG000|Overall Study|Adverse Event|4|||
130307502|NCT01136408|469089197|FG001|Overall Study|Adverse Event|8|||
130307503|NCT01136408|469089198|FG002|Overall Study|Adverse Event|4|||
130307504|NCT01136408|469089196|FG000|Overall Study|Protocol Violation|1|||
130307505|NCT01136408|469089197|FG001|Overall Study|Protocol Violation|1|||
130307506|NCT01136408|469089198|FG002|Overall Study|Protocol Violation|1|||
130307507|NCT02828436|469089199|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
130307508|NCT02828436|469089200|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
130307509|NCT02828436|469089199|FG000|Period 1|Lost to Follow-up|0|||
130307510|NCT02828436|469089200|FG001|Period 1|Lost to Follow-up|1|||
130307511|NCT02828436|469089199|FG000|Period 2|Withdrawal by Subject|4|||
130307512|NCT02828436|469089200|FG001|Period 2|Withdrawal by Subject|0|||
130307513|NCT02828436|469089199|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
130307514|NCT02828436|469089200|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
130307515|NCT02828436|469089199|FG000|Period 2|Lost to Follow-up|1|||
130307516|NCT02828436|469089200|FG001|Period 2|Lost to Follow-up|0|||
130307517|NCT04421482|469089203|FG000|Overall Study|Physician Decision|1|||
130307518|NCT03010319|469089206|FG000|Overall Study|Adverse Event|15|||
130307519|NCT03010319|469089207|FG001|Overall Study|Adverse Event|9|||
130307520|NCT03010319|469089206|FG000|Overall Study|Withdrawal by Subject|1|||
130307521|NCT03010319|469089207|FG001|Overall Study|Withdrawal by Subject|6|||
130307522|NCT03010319|469089206|FG000|Overall Study|Physician Decision|2|||
130307523|NCT03010319|469089207|FG001|Overall Study|Physician Decision|4|||
130307524|NCT03010319|469089206|FG000|Overall Study|Sponsor requested withdrawal|2|||
130307525|NCT03010319|469089207|FG001|Overall Study|Sponsor requested withdrawal|2|||
130307526|NCT03010319|469089206|FG000|Overall Study|Death|1|||
130307527|NCT03010319|469089207|FG001|Overall Study|Death|0|||
130307528|NCT03010319|469089206|FG000|Overall Study|Lost to Follow-up|0|||
130307529|NCT03010319|469089207|FG001|Overall Study|Lost to Follow-up|1|||
130307530|NCT03010319|469089206|FG000|Overall Study|Other Reason|5|||
130307531|NCT03010319|469089207|FG001|Overall Study|Other Reason|7|||
130307532|NCT02128724|469089208|FG000|Overall Study|Death|1|||
130307533|NCT02128724|469089209|FG001|Overall Study|Death|0|||
130307534|NCT02128724|469089210|FG002|Overall Study|Death|0|||
130307535|NCT02128724|469089211|FG003|Overall Study|Death|0|||
130307536|NCT02128724|469089208|FG000|Overall Study|Adverse Event|0|||
130464458|NCT04425629|469667149|FG010|Overall Study|Lost to Follow-up|70|||
130464459|NCT04425629|469667150|FG011|Overall Study|Lost to Follow-up|98|||
130307537|NCT02128724|469089209|FG001|Overall Study|Adverse Event|1|||
130307538|NCT02128724|469089210|FG002|Overall Study|Adverse Event|0|||
130307539|NCT02128724|469089211|FG003|Overall Study|Adverse Event|0|||
130464460|NCT04425629|469667151|FG012|Overall Study|Lost to Follow-up|30|||
130717837|NCT00123474|470593184|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
130307540|NCT02128724|469089208|FG000|Overall Study|Physician Decision|0|||
130307541|NCT02128724|469089209|FG001|Overall Study|Physician Decision|0|||
130307542|NCT02128724|469089210|FG002|Overall Study|Physician Decision|0|||
130307543|NCT02128724|469089211|FG003|Overall Study|Physician Decision|2|||
130307544|NCT02128724|469089208|FG000|Overall Study|Withdrawal by Subject|0|||
130307545|NCT02128724|469089209|FG001|Overall Study|Withdrawal by Subject|0|||
130307546|NCT02128724|469089210|FG002|Overall Study|Withdrawal by Subject|0|||
130307547|NCT02128724|469089211|FG003|Overall Study|Withdrawal by Subject|1|||
130307548|NCT03329092|469089212|FG000|Overall Study|Other|2|||
130307549|NCT03329092|469089213|FG001|Overall Study|Other|2|||
130464461|NCT04425629|469667152|FG013|Overall Study|Lost to Follow-up|0|||
130464462|NCT04425629|469667153|FG014|Overall Study|Lost to Follow-up|5|||
130464463|NCT04425629|469667154|FG015|Overall Study|Lost to Follow-up|4|||
130464464|NCT04425629|469667155|FG016|Overall Study|Lost to Follow-up|0|||
130307550|NCT03329092|469089212|FG000|Overall Study|Withdrawal by Subject|16|||
130307551|NCT03329092|469089213|FG001|Overall Study|Withdrawal by Subject|3|||
130307552|NCT03329092|469089212|FG000|Overall Study|Physician Decision|1|||
130307553|NCT03329092|469089213|FG001|Overall Study|Physician Decision|0|||
130307554|NCT03329092|469089212|FG000|Overall Study|Death|17|||
130307555|NCT03329092|469089213|FG001|Overall Study|Death|11|||
130307556|NCT03329092|469089212|FG000|Overall Study|Adverse Event|3|||
130307557|NCT03329092|469089213|FG001|Overall Study|Adverse Event|1|||
130307558|NCT03329092|469089212|FG000|Overall Study|Lost to Follow-up|1|||
130307559|NCT03329092|469089213|FG001|Overall Study|Lost to Follow-up|1|||
130376679|NCT03824912|469345901|FG002|Overall Study|Lost to Follow-up|8|||
130376680|NCT03824912|469345899|FG000|Overall Study|Negative Baseline Culture Result|118|||
130376681|NCT03824912|469345900|FG001|Overall Study|Negative Baseline Culture Result|112|||
130376682|NCT03824912|469345901|FG002|Overall Study|Negative Baseline Culture Result|57|||
130376683|NCT03824912|469345899|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130376684|NCT03824912|469345900|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130376685|NCT03824912|469345901|FG002|Overall Study|Non-Compliance with Study Drug|1|||
130376686|NCT03824912|469345899|FG000|Overall Study|Protocol Violation|1|||
130376687|NCT03824912|469345900|FG001|Overall Study|Protocol Violation|4|||
130376688|NCT03824912|469345901|FG002|Overall Study|Protocol Violation|1|||
130376689|NCT03824912|469345899|FG000|Overall Study|Withdrawal by Subject|3|||
130376690|NCT03824912|469345900|FG001|Overall Study|Withdrawal by Subject|2|||
130464465|NCT04425629|469667156|FG017|Overall Study|Lost to Follow-up|3|||
130464466|NCT04425629|469667157|FG018|Overall Study|Lost to Follow-up|1|||
130307560|NCT05786508|469089214|FG000|Overall Study|Withdrawal by Subject|2|||
130307561|NCT05786508|469089215|FG001|Overall Study|Withdrawal by Subject|0|||
130307562|NCT04426318|469089216|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
130307563|NCT04426318|469089217|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
130307564|NCT03574779|469089218|FG000|Overall Study|Screening failure|13|||
130307565|NCT03574779|469089219|FG001|Overall Study|Screening failure|83|||
130307566|NCT02588261|469089220|FG000|Overall Study|Study Terminated by Sponsor|157|||
130307567|NCT02588261|469089221|FG001|Overall Study|Study Terminated by Sponsor|142|||
130307568|NCT02588261|469089220|FG000|Overall Study|Protocol Deviation|1|||
130307569|NCT02588261|469089221|FG001|Overall Study|Protocol Deviation|0|||
130307570|NCT02588261|469089220|FG000|Overall Study|Death|1|||
130307571|NCT02588261|469089221|FG001|Overall Study|Death|2|||
130307572|NCT02588261|469089220|FG000|Overall Study|Withdrawal by Subject|12|||
130307573|NCT02588261|469089221|FG001|Overall Study|Withdrawal by Subject|8|||
130307574|NCT02588261|469089220|FG000|Overall Study|Noncompliance with Study Drug|0|||
130307575|NCT02588261|469089221|FG001|Overall Study|Noncompliance with Study Drug|1|||
130307576|NCT02588261|469089220|FG000|Overall Study|Miscellaneous|5|||
130307577|NCT02588261|469089221|FG001|Overall Study|Miscellaneous|4|||
130307578|NCT02588261|469089220|FG000|Overall Study|Progressive Disease|61|||
130307579|NCT02588261|469089221|FG001|Overall Study|Progressive Disease|82|||
130307580|NCT02588261|469089220|FG000|Overall Study|Adverse Event|29|||
130307581|NCT02588261|469089221|FG001|Overall Study|Adverse Event|24|||
130307582|NCT02588261|469089220|FG000|Overall Study|Lost to Follow-up|1|||
130307583|NCT02588261|469089221|FG001|Overall Study|Lost to Follow-up|0|||
130307584|NCT03781778|469089223|FG000|Overall Study|Withdrawal by Subject|2|||
130307585|NCT03781778|469089224|FG001|Overall Study|Withdrawal by Subject|2|||
130307586|NCT02287467|469089225|FG000|Overall Study|Protocol Violation|12|||
130307587|NCT02287467|469089226|FG001|Overall Study|Protocol Violation|9|||
130307588|NCT02652156|469089227|FG000|Overall Study|Physician Decision|1|||
130307589|NCT02652156|469089228|FG001|Overall Study|Physician Decision|0|||
130307590|NCT02652156|469089229|FG002|Overall Study|Physician Decision|0|||
130307591|NCT00108862|469089230|FG000|Overall Study|Death|31|||
130307592|NCT00108862|469089231|FG001|Overall Study|Death|37|||
130307593|NCT00108862|469089230|FG000|Overall Study|Withdrawal by Subject|10|||
130307594|NCT00108862|469089231|FG001|Overall Study|Withdrawal by Subject|6|||
130307595|NCT00108862|469089230|FG000|Overall Study|Lost to Follow-up|27|||
130307596|NCT00108862|469089231|FG001|Overall Study|Lost to Follow-up|19|||
130307597|NCT03534141|469089232|FG000|Overall Study|Enrolled in other clinical trial|1|||
130307598|NCT03534141|469089233|FG001|Overall Study|Enrolled in other clinical trial|0|||
130307599|NCT03534141|469089232|FG000|Overall Study|Liver transplant aborted after randomization|0|||
130307600|NCT03534141|469089233|FG001|Overall Study|Liver transplant aborted after randomization|2|||
130307601|NCT03534141|469089232|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
130307602|NCT03534141|469089233|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
130307603|NCT00517361|469089234|FG000|Overall Study|Death|6|||
130307604|NCT00517361|469089234|FG000|Overall Study|The study was terminated|5|||
130307605|NCT01685697|469089235|FG000|Overall Study|Protocol Violation|3|||
130307606|NCT01685697|469089236|FG001|Overall Study|Protocol Violation|3|||
130307607|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Death|0|||
130307608|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Death|0|||
130464467|NCT04425629|469667139|FG000|Overall Study|Subject Decision|0|||
130307609|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Death|0|||
130307610|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Death|0|||
130307611|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Death|1|||
130307612|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Death|0|||
130307613|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Death|0|||
130307614|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Death|0|||
130307615|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
130307616|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
130307617|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
130307618|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
130307619|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
130307620|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
130307621|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
130307622|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
130307623|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130307624|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307625|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307626|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
130307627|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307628|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130307629|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130464468|NCT04425629|469667140|FG001|Overall Study|Subject Decision|2|||
130464469|NCT04425629|469667141|FG002|Overall Study|Subject Decision|1|||
130464470|NCT04425629|469667142|FG003|Overall Study|Subject Decision|3|||
130464471|NCT04425629|469667143|FG004|Overall Study|Subject Decision|6|||
130464472|NCT04425629|469667144|FG005|Overall Study|Subject Decision|6|||
130464473|NCT04425629|469667145|FG006|Overall Study|Subject Decision|3|||
130464474|NCT04425629|469667146|FG007|Overall Study|Subject Decision|3|||
130464475|NCT04425629|469667147|FG008|Overall Study|Subject Decision|1|||
130464476|NCT04425629|469667148|FG009|Overall Study|Subject Decision|70|||
130464477|NCT04425629|469667149|FG010|Overall Study|Subject Decision|95|||
130464478|NCT04425629|469667150|FG011|Overall Study|Subject Decision|124|||
130464479|NCT04425629|469667151|FG012|Overall Study|Subject Decision|25|||
130464480|NCT04425629|469667152|FG013|Overall Study|Subject Decision|0|||
130464481|NCT04425629|469667153|FG014|Overall Study|Subject Decision|1|||
130464482|NCT04425629|469667154|FG015|Overall Study|Subject Decision|4|||
130464483|NCT04425629|469667155|FG016|Overall Study|Subject Decision|1|||
130464484|NCT04425629|469667156|FG017|Overall Study|Subject Decision|0|||
130464485|NCT04425629|469667157|FG018|Overall Study|Subject Decision|2|||
130464486|NCT04425629|469667139|FG000|Overall Study|Death|0|||
130464487|NCT04425629|469667140|FG001|Overall Study|Death|0|||
130464488|NCT04425629|469667141|FG002|Overall Study|Death|0|||
130464489|NCT04425629|469667142|FG003|Overall Study|Death|0|||
130464490|NCT04425629|469667143|FG004|Overall Study|Death|0|||
130464491|NCT04425629|469667144|FG005|Overall Study|Death|0|||
130464492|NCT04425629|469667145|FG006|Overall Study|Death|0|||
130464493|NCT04425629|469667146|FG007|Overall Study|Death|0|||
130464494|NCT04425629|469667147|FG008|Overall Study|Death|0|||
130464495|NCT04425629|469667148|FG009|Overall Study|Death|11|||
130464496|NCT04425629|469667149|FG010|Overall Study|Death|2|||
130464497|NCT04425629|469667150|FG011|Overall Study|Death|4|||
130464498|NCT04425629|469667151|FG012|Overall Study|Death|0|||
130464499|NCT04425629|469667152|FG013|Overall Study|Death|0|||
130464500|NCT04425629|469667153|FG014|Overall Study|Death|0|||
130464501|NCT04425629|469667154|FG015|Overall Study|Death|0|||
130464502|NCT04425629|469667155|FG016|Overall Study|Death|0|||
130464503|NCT04425629|469667156|FG017|Overall Study|Death|0|||
130464504|NCT04425629|469667157|FG018|Overall Study|Death|0|||
130464505|NCT04425629|469667139|FG000|Overall Study|Sponsor Request|0|||
130464506|NCT04425629|469667140|FG001|Overall Study|Sponsor Request|0|||
130464507|NCT04425629|469667141|FG002|Overall Study|Sponsor Request|0|||
130307630|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307631|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
130307632|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
130307633|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
130307634|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
130307635|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
130307636|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
130307637|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
130307638|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
130307639|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130307640|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307641|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307642|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130307643|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
130307644|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307645|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130307646|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130307647|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
130464508|NCT04425629|469667142|FG003|Overall Study|Sponsor Request|2|||
130557738|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130557739|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130307648|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130464509|NCT04425629|469667143|FG004|Overall Study|Sponsor Request|2|||
130464510|NCT04425629|469667144|FG005|Overall Study|Sponsor Request|2|||
130557740|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130464511|NCT04425629|469667145|FG006|Overall Study|Sponsor Request|1|||
130464512|NCT04425629|469667146|FG007|Overall Study|Sponsor Request|0|||
130464513|NCT04425629|469667147|FG008|Overall Study|Sponsor Request|0|||
130464514|NCT04425629|469667148|FG009|Overall Study|Sponsor Request|9|||
130464515|NCT04425629|469667149|FG010|Overall Study|Sponsor Request|9|||
130464516|NCT04425629|469667150|FG011|Overall Study|Sponsor Request|10|||
130464517|NCT04425629|469667151|FG012|Overall Study|Sponsor Request|8|||
130464518|NCT04425629|469667152|FG013|Overall Study|Sponsor Request|0|||
130464519|NCT04425629|469667153|FG014|Overall Study|Sponsor Request|0|||
130464520|NCT04425629|469667154|FG015|Overall Study|Sponsor Request|1|||
130464521|NCT04425629|469667155|FG016|Overall Study|Sponsor Request|0|||
130307649|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307650|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
130307651|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
130307652|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
130307653|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307654|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307655|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
130307656|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307657|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307658|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307659|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307660|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307661|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307662|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307663|NCT00726232|469089237|FG000|Expansion Phase|Death|0|||
130307664|NCT00726232|469089238|FG001|Expansion Phase|Death|0|||
130307665|NCT00726232|469089239|FG002|Expansion Phase|Death|0|||
130307666|NCT00726232|469089240|FG003|Expansion Phase|Death|0|||
130307667|NCT00726232|469089241|FG004|Expansion Phase|Death|0|||
130307668|NCT00726232|469089242|FG005|Expansion Phase|Death|0|||
130307669|NCT00726232|469089243|FG006|Expansion Phase|Death|0|||
130307670|NCT00726232|469089244|FG007|Expansion Phase|Death|1|||
130307671|NCT00726232|469089237|FG000|Expansion Phase|Adverse Event|0|||
130307672|NCT00726232|469089238|FG001|Expansion Phase|Adverse Event|0|||
130307673|NCT00726232|469089239|FG002|Expansion Phase|Adverse Event|0|||
130307674|NCT00726232|469089240|FG003|Expansion Phase|Adverse Event|0|||
130307675|NCT00726232|469089241|FG004|Expansion Phase|Adverse Event|0|||
130307676|NCT00726232|469089242|FG005|Expansion Phase|Adverse Event|0|||
130307677|NCT00726232|469089243|FG006|Expansion Phase|Adverse Event|6|||
130307678|NCT00726232|469089244|FG007|Expansion Phase|Adverse Event|11|||
130307679|NCT00726232|469089237|FG000|Expansion Phase|Withdrawal by Subject|0|||
130307680|NCT00726232|469089238|FG001|Expansion Phase|Withdrawal by Subject|0|||
130307681|NCT00726232|469089239|FG002|Expansion Phase|Withdrawal by Subject|0|||
130307682|NCT00726232|469089240|FG003|Expansion Phase|Withdrawal by Subject|0|||
130307683|NCT00726232|469089241|FG004|Expansion Phase|Withdrawal by Subject|0|||
130307684|NCT00726232|469089242|FG005|Expansion Phase|Withdrawal by Subject|0|||
130307685|NCT00726232|469089243|FG006|Expansion Phase|Withdrawal by Subject|2|||
130307686|NCT00726232|469089244|FG007|Expansion Phase|Withdrawal by Subject|3|||
130307687|NCT00726232|469089237|FG000|Expansion Phase|Disease progression|0|||
130307688|NCT00726232|469089238|FG001|Expansion Phase|Disease progression|0|||
130307689|NCT00726232|469089239|FG002|Expansion Phase|Disease progression|0|||
130307690|NCT00726232|469089240|FG003|Expansion Phase|Disease progression|0|||
130307691|NCT00726232|469089241|FG004|Expansion Phase|Disease progression|0|||
130307692|NCT00726232|469089242|FG005|Expansion Phase|Disease progression|0|||
130307693|NCT00726232|469089243|FG006|Expansion Phase|Disease progression|4|||
130307694|NCT00726232|469089244|FG007|Expansion Phase|Disease progression|0|||
130307695|NCT00726232|469089237|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
130307696|NCT00726232|469089238|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
130307697|NCT00726232|469089239|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
130307698|NCT00726232|469089240|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
130307699|NCT00726232|469089241|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
130307700|NCT00726232|469089242|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
130307701|NCT00726232|469089243|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
130307702|NCT00726232|469089244|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
130307703|NCT00726232|469089237|FG000|Expansion Phase|Per Investigator: lack of response|0|||
130307704|NCT00726232|469089238|FG001|Expansion Phase|Per Investigator: lack of response|0|||
130307705|NCT00726232|469089239|FG002|Expansion Phase|Per Investigator: lack of response|0|||
130464522|NCT04425629|469667156|FG017|Overall Study|Sponsor Request|0|||
130464523|NCT04425629|469667157|FG018|Overall Study|Sponsor Request|0|||
130464524|NCT04425629|469667139|FG000|Overall Study|Physician Decision|0|||
130307706|NCT00726232|469089240|FG003|Expansion Phase|Per Investigator: lack of response|0|||
130307707|NCT00726232|469089241|FG004|Expansion Phase|Per Investigator: lack of response|0|||
130307708|NCT00726232|469089242|FG005|Expansion Phase|Per Investigator: lack of response|0|||
130307709|NCT00726232|469089243|FG006|Expansion Phase|Per Investigator: lack of response|1|||
130307710|NCT00726232|469089244|FG007|Expansion Phase|Per Investigator: lack of response|7|||
130307711|NCT00726232|469089237|FG000|Expansion Phase|Unspecified reason|0|||
130307712|NCT00726232|469089238|FG001|Expansion Phase|Unspecified reason|0|||
130307713|NCT00726232|469089239|FG002|Expansion Phase|Unspecified reason|0|||
130307714|NCT00726232|469089240|FG003|Expansion Phase|Unspecified reason|0|||
130307715|NCT00726232|469089241|FG004|Expansion Phase|Unspecified reason|0|||
130307716|NCT00726232|469089242|FG005|Expansion Phase|Unspecified reason|0|||
130464525|NCT04425629|469667140|FG001|Overall Study|Physician Decision|0|||
130464526|NCT04425629|469667141|FG002|Overall Study|Physician Decision|0|||
130464527|NCT04425629|469667142|FG003|Overall Study|Physician Decision|0|||
130464528|NCT04425629|469667143|FG004|Overall Study|Physician Decision|0|||
130464529|NCT04425629|469667144|FG005|Overall Study|Physician Decision|0|||
130464530|NCT04425629|469667145|FG006|Overall Study|Physician Decision|0|||
130464531|NCT04425629|469667146|FG007|Overall Study|Physician Decision|0|||
130464532|NCT04425629|469667147|FG008|Overall Study|Physician Decision|0|||
130464533|NCT04425629|469667148|FG009|Overall Study|Physician Decision|4|||
130464534|NCT04425629|469667149|FG010|Overall Study|Physician Decision|3|||
130464535|NCT04425629|469667150|FG011|Overall Study|Physician Decision|5|||
130464536|NCT04425629|469667151|FG012|Overall Study|Physician Decision|1|||
130464537|NCT04425629|469667152|FG013|Overall Study|Physician Decision|0|||
130464538|NCT04425629|469667153|FG014|Overall Study|Physician Decision|0|||
130464539|NCT04425629|469667154|FG015|Overall Study|Physician Decision|1|||
130464540|NCT04425629|469667155|FG016|Overall Study|Physician Decision|0|||
130464541|NCT04425629|469667156|FG017|Overall Study|Physician Decision|0|||
130464542|NCT04425629|469667157|FG018|Overall Study|Physician Decision|0|||
130464543|NCT04425629|469667139|FG000|Overall Study|Lack of Efficacy|0|||
130464544|NCT04425629|469667140|FG001|Overall Study|Lack of Efficacy|0|||
130464545|NCT04425629|469667141|FG002|Overall Study|Lack of Efficacy|0|||
130464546|NCT04425629|469667142|FG003|Overall Study|Lack of Efficacy|0|||
130464547|NCT04425629|469667143|FG004|Overall Study|Lack of Efficacy|0|||
130464548|NCT04425629|469667144|FG005|Overall Study|Lack of Efficacy|0|||
130464549|NCT04425629|469667145|FG006|Overall Study|Lack of Efficacy|0|||
130464550|NCT04425629|469667146|FG007|Overall Study|Lack of Efficacy|0|||
130464551|NCT04425629|469667147|FG008|Overall Study|Lack of Efficacy|0|||
130464552|NCT04425629|469667148|FG009|Overall Study|Lack of Efficacy|0|||
130464553|NCT04425629|469667149|FG010|Overall Study|Lack of Efficacy|1|||
130464554|NCT04425629|469667150|FG011|Overall Study|Lack of Efficacy|0|||
130464555|NCT04425629|469667151|FG012|Overall Study|Lack of Efficacy|0|||
130464556|NCT04425629|469667152|FG013|Overall Study|Lack of Efficacy|0|||
130464557|NCT04425629|469667153|FG014|Overall Study|Lack of Efficacy|0|||
130557741|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130557742|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130717838|NCT00123474|470593185|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
130307717|NCT00726232|469089243|FG006|Expansion Phase|Unspecified reason|1|||
130307718|NCT00726232|469089244|FG007|Expansion Phase|Unspecified reason|0|||
130307719|NCT00195091|469089245|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
130307720|NCT04526145|469089248|FG000|Overall Study|Withdrawal by Subject|5|||
130307721|NCT00566852|469089251|FG000|Overall Study|Protocol Violation|22|||
130307722|NCT00566852|469089252|FG001|Overall Study|Protocol Violation|24|||
130307723|NCT00566852|469089251|FG000|Overall Study|Death|95|||
130307724|NCT00566852|469089252|FG001|Overall Study|Death|78|||
130307725|NCT00566852|469089251|FG000|Overall Study|Withdrawal by Subject|30|||
130307726|NCT00566852|469089252|FG001|Overall Study|Withdrawal by Subject|25|||
130307727|NCT00566852|469089251|FG000|Overall Study|Patient refusal|37|||
130307728|NCT00566852|469089252|FG001|Overall Study|Patient refusal|37|||
130307729|NCT00566852|469089251|FG000|Overall Study|Not tested due to disability|6|||
130307730|NCT00566852|469089252|FG001|Overall Study|Not tested due to disability|12|||
130307731|NCT00566852|469089251|FG000|Overall Study|Missing reason not specified|1|||
130307732|NCT00566852|469089252|FG001|Overall Study|Missing reason not specified|2|||
130307733|NCT00566852|469089251|FG000|Overall Study|Missing reason not reported|16|||
130307734|NCT00566852|469089252|FG001|Overall Study|Missing reason not reported|20|||
130307735|NCT04079816|469089253|FG000|Overall Study|Request of Subject|2|||
130307736|NCT04079816|469089253|FG000|Overall Study|Unable to draw samples|1|||
130307737|NCT04137731|469089254|FG000|Overall Study|Surgery Cancellation|1|||
130307738|NCT04137731|469089255|FG001|Overall Study|Surgery Cancellation|2|||
130307739|NCT04137731|469089254|FG000|Overall Study|Withdrawal by Subject|2|||
130307740|NCT04137731|469089255|FG001|Overall Study|Withdrawal by Subject|0|||
130307741|NCT04137731|469089254|FG000|Overall Study|Protocol Violation|0|||
130307742|NCT04137731|469089255|FG001|Overall Study|Protocol Violation|1|||
130307743|NCT00310817|469089256|FG000|Overall Study|AE or Death|3|||
130307744|NCT00310817|469089257|FG001|Overall Study|AE or Death|1|||
130307745|NCT00310817|469089258|FG002|Overall Study|AE or Death|0|||
130307746|NCT00310817|469089259|FG003|Overall Study|AE or Death|0|||
130307747|NCT00310817|469089256|FG000|Overall Study|Withdrawal by Subject|1|||
130307748|NCT00310817|469089257|FG001|Overall Study|Withdrawal by Subject|4|||
130307749|NCT00310817|469089258|FG002|Overall Study|Withdrawal by Subject|6|||
130307750|NCT00310817|469089259|FG003|Overall Study|Withdrawal by Subject|7|||
130557743|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130464558|NCT04425629|469667154|FG015|Overall Study|Lack of Efficacy|0|||
130464559|NCT04425629|469667155|FG016|Overall Study|Lack of Efficacy|0|||
130464560|NCT04425629|469667156|FG017|Overall Study|Lack of Efficacy|0|||
130464561|NCT04425629|469667157|FG018|Overall Study|Lack of Efficacy|0|||
130464562|NCT00610649|469667159|FG000|Overall Study|Adverse Event|1|||
130464563|NCT00610649|469667160|FG001|Overall Study|Adverse Event|0|||
130464564|NCT00610649|469667161|FG002|Overall Study|Adverse Event|0|||
130464565|NCT00610649|469667162|FG003|Overall Study|Adverse Event|0|||
130464566|NCT00610649|469667163|FG004|Overall Study|Adverse Event|0|||
130464567|NCT00610649|469667164|FG005|Overall Study|Adverse Event|0|||
130464568|NCT00610649|469667165|FG006|Overall Study|Adverse Event|0|||
130464569|NCT00610649|469667166|FG007|Overall Study|Adverse Event|0|||
130464570|NCT00610649|469667167|FG008|Overall Study|Adverse Event|0|||
130464571|NCT00610649|469667168|FG009|Overall Study|Adverse Event|0|||
130464572|NCT00610649|469667169|FG010|Overall Study|Adverse Event|1|||
130464573|NCT00610649|469667159|FG000|Overall Study|Family Emergency|0|||
130307751|NCT00310817|469089256|FG000|Overall Study|Lost to Follow-up|2|||
130307752|NCT00310817|469089257|FG001|Overall Study|Lost to Follow-up|1|||
130307753|NCT00310817|469089258|FG002|Overall Study|Lost to Follow-up|0|||
130307754|NCT00310817|469089259|FG003|Overall Study|Lost to Follow-up|0|||
130307755|NCT00310817|469089256|FG000|Overall Study|Inappropriate Enrollment|1|||
130307756|NCT00310817|469089257|FG001|Overall Study|Inappropriate Enrollment|0|||
130307757|NCT00310817|469089258|FG002|Overall Study|Inappropriate Enrollment|1|||
130307758|NCT00310817|469089259|FG003|Overall Study|Inappropriate Enrollment|0|||
130307759|NCT00310817|469089256|FG000|Overall Study|Protocol Violation|1|||
130307760|NCT00310817|469089257|FG001|Overall Study|Protocol Violation|1|||
130307761|NCT00310817|469089258|FG002|Overall Study|Protocol Violation|1|||
130307762|NCT00310817|469089259|FG003|Overall Study|Protocol Violation|1|||
130307763|NCT00310817|469089256|FG000|Overall Study|Unable to classify|3|||
130307764|NCT00310817|469089257|FG001|Overall Study|Unable to classify|1|||
130307765|NCT00310817|469089258|FG002|Overall Study|Unable to classify|0|||
130307766|NCT00310817|469089259|FG003|Overall Study|Unable to classify|0|||
130307767|NCT01702246|469089260|FG000|Overall Study|Lost to Follow-up|2|||
130307768|NCT01702246|469089260|FG000|Overall Study|Withdrawal by Subject|2|||
130307769|NCT01702246|469089260|FG000|Overall Study|Physician Decision|1|||
130307770|NCT01587040|469089261|FG000|Overall Study|Protocol Violation|0|||
130307771|NCT01587040|469089262|FG001|Overall Study|Protocol Violation|0|||
130307772|NCT01587040|469089263|FG002|Overall Study|Protocol Violation|1|||
130307773|NCT01587040|469089264|FG003|Overall Study|Protocol Violation|0|||
130307774|NCT01587040|469089261|FG000|Overall Study|Adverse Event|0|||
130307775|NCT01587040|469089262|FG001|Overall Study|Adverse Event|1|||
130307776|NCT01587040|469089263|FG002|Overall Study|Adverse Event|10|||
130307777|NCT01587040|469089264|FG003|Overall Study|Adverse Event|0|||
130307778|NCT01587040|469089261|FG000|Overall Study|Disease progression|12|||
130307779|NCT01587040|469089262|FG001|Overall Study|Disease progression|1|||
130307780|NCT01587040|469089263|FG002|Overall Study|Disease progression|15|||
130307781|NCT01587040|469089264|FG003|Overall Study|Disease progression|3|||
130307782|NCT01587040|469089261|FG000|Overall Study|Other than specified|5|||
130307783|NCT01587040|469089262|FG001|Overall Study|Other than specified|1|||
130307784|NCT01587040|469089263|FG002|Overall Study|Other than specified|11|||
130307785|NCT01587040|469089264|FG003|Overall Study|Other than specified|1|||
130307786|NCT04607837|469089267|FG000|Overall Study|Adverse Event|8|||
130307787|NCT04607837|469089268|FG001|Overall Study|Adverse Event|2|||
130307788|NCT04607837|469089267|FG000|Overall Study|Withdrawal by Subject|8|||
130307789|NCT04607837|469089268|FG001|Overall Study|Withdrawal by Subject|7|||
130307790|NCT04607837|469089267|FG000|Overall Study|Physician Decision|2|||
130307791|NCT04607837|469089268|FG001|Overall Study|Physician Decision|0|||
130307792|NCT04607837|469089267|FG000|Overall Study|Lack of Efficacy|2|||
130307793|NCT04607837|469089268|FG001|Overall Study|Lack of Efficacy|0|||
130307794|NCT04607837|469089267|FG000|Overall Study|Participant terminated by sponsor|1|||
130307795|NCT04607837|469089268|FG001|Overall Study|Participant terminated by sponsor|0|||
130307796|NCT04607837|469089267|FG000|Overall Study|Disease worsening|36|||
130307797|NCT04607837|469089268|FG001|Overall Study|Disease worsening|36|||
130307798|NCT04607837|469089267|FG000|Overall Study|Other|1|||
130307799|NCT04607837|469089268|FG001|Overall Study|Other|0|||
130307800|NCT04346654|469089269|FG000|Overall Study|Adverse Event|2|||
130307801|NCT04346654|469089270|FG001|Overall Study|Adverse Event|0|||
130307802|NCT04346654|469089269|FG000|Overall Study|Non-response|1|||
130307803|NCT04346654|469089270|FG001|Overall Study|Non-response|1|||
130307804|NCT04346654|469089269|FG000|Overall Study|Withdrawal by Subject|2|||
130307805|NCT04346654|469089270|FG001|Overall Study|Withdrawal by Subject|0|||
130307806|NCT04346654|469089269|FG000|Overall Study|Lost to Follow-up|0|||
130307807|NCT04346654|469089270|FG001|Overall Study|Lost to Follow-up|1|||
130307808|NCT04346654|469089269|FG000|Overall Study|Pregnancy|0|||
130307809|NCT04346654|469089270|FG001|Overall Study|Pregnancy|1|||
130307810|NCT05715242|469089271|FG000|Overall Study|Lost to Follow-up|0|||
130307811|NCT05715242|469089272|FG001|Overall Study|Lost to Follow-up|0|||
130464574|NCT00610649|469667160|FG001|Overall Study|Family Emergency|1|||
130464575|NCT00610649|469667161|FG002|Overall Study|Family Emergency|0|||
130307812|NCT05715242|469089273|FG002|Overall Study|Lost to Follow-up|1|||
130307813|NCT05715242|469089274|FG003|Overall Study|Lost to Follow-up|0|||
130307814|NCT05715242|469089275|FG004|Overall Study|Lost to Follow-up|0|||
130307815|NCT05715242|469089276|FG005|Overall Study|Lost to Follow-up|1|||
130307816|NCT05715242|469089277|FG006|Overall Study|Lost to Follow-up|0|||
130464576|NCT00610649|469667162|FG003|Overall Study|Family Emergency|0|||
130464577|NCT00610649|469667163|FG004|Overall Study|Family Emergency|0|||
130307817|NCT05715242|469089278|FG007|Overall Study|Lost to Follow-up|0|||
130307818|NCT05715242|469089279|FG008|Overall Study|Lost to Follow-up|0|||
130307819|NCT05715242|469089280|FG009|Overall Study|Lost to Follow-up|0|||
130307820|NCT05715242|469089281|FG010|Overall Study|Lost to Follow-up|0|||
130464578|NCT00610649|469667164|FG005|Overall Study|Family Emergency|0|||
130464579|NCT00610649|469667165|FG006|Overall Study|Family Emergency|0|||
130464580|NCT00610649|469667166|FG007|Overall Study|Family Emergency|0|||
130464581|NCT00610649|469667167|FG008|Overall Study|Family Emergency|0|||
130464582|NCT00610649|469667168|FG009|Overall Study|Family Emergency|0|||
130464583|NCT00610649|469667169|FG010|Overall Study|Family Emergency|0|||
130464584|NCT00610649|469667159|FG000|Overall Study|Withdrawal by Subject|0|||
130464585|NCT00610649|469667160|FG001|Overall Study|Withdrawal by Subject|0|||
130464586|NCT00610649|469667161|FG002|Overall Study|Withdrawal by Subject|0|||
130464587|NCT00610649|469667162|FG003|Overall Study|Withdrawal by Subject|0|||
130464588|NCT00610649|469667163|FG004|Overall Study|Withdrawal by Subject|0|||
130464589|NCT00610649|469667164|FG005|Overall Study|Withdrawal by Subject|0|||
130464590|NCT00610649|469667165|FG006|Overall Study|Withdrawal by Subject|0|||
130464591|NCT00610649|469667166|FG007|Overall Study|Withdrawal by Subject|0|||
130464592|NCT00610649|469667167|FG008|Overall Study|Withdrawal by Subject|0|||
130464593|NCT00610649|469667168|FG009|Overall Study|Withdrawal by Subject|1|||
130464594|NCT00610649|469667169|FG010|Overall Study|Withdrawal by Subject|0|||
130464595|NCT04252586|469667172|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130464596|NCT04252586|469667172|FG000|Overall Study|Adverse Event|1|||
130464597|NCT04252586|469667172|FG000|Overall Study|Death|2|||
130464598|NCT04252586|469667172|FG000|Overall Study|Study terminated by sponsor|4|||
130464599|NCT04252586|469667172|FG000|Overall Study|Sponsor request|10|||
130464600|NCT04252586|469667172|FG000|Overall Study|Did not complete treatment period|1|||
130464601|NCT00414544|469667173|FG000|Overall Study|Lost to Follow-up|14|||
130464602|NCT03452189|469667174|FG000|First Intervention (3 Months)|Adverse Event|1|||
130464603|NCT03452189|469667175|FG001|First Intervention (3 Months)|Adverse Event|0|||
130464604|NCT03452189|469667174|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
130464605|NCT03452189|469667175|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
130464606|NCT01149369|469667176|FG000|Overall Study|Adverse Event|6|||
130464607|NCT01149369|469667177|FG001|Overall Study|Adverse Event|3|||
130464608|NCT01078116|469667182|FG000|Overall Study|Lost to Follow-up|17|||
130464609|NCT01078116|469667182|FG000|Overall Study|Adverse Event|5|||
130464610|NCT01078116|469667182|FG000|Overall Study|Withdrawal by Subject|8|||
130464611|NCT01078116|469667182|FG000|Overall Study|Lack of effectiveness|15|||
130464612|NCT01078116|469667182|FG000|Overall Study|Case report form not completed|3|||
130464613|NCT02601820|469667183|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
130464614|NCT02601820|469667183|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
130464615|NCT02601820|469667183|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
130464616|NCT02601820|469667183|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
130464617|NCT02242487|469667184|FG000|Overall Study|Adverse Event|13|||
130464618|NCT02242487|469667185|FG001|Overall Study|Adverse Event|15|||
130464619|NCT02242487|469667184|FG000|Overall Study|Lack of Efficacy|4|||
130464620|NCT02242487|469667185|FG001|Overall Study|Lack of Efficacy|6|||
130464621|NCT02242487|469667184|FG000|Overall Study|Protocol Violation|2|||
130464622|NCT02242487|469667185|FG001|Overall Study|Protocol Violation|0|||
130464623|NCT02242487|469667184|FG000|Overall Study|Lost to Follow-up|2|||
130464624|NCT02242487|469667185|FG001|Overall Study|Lost to Follow-up|1|||
130464625|NCT02242487|469667184|FG000|Overall Study|Other - Miscellaneous|4|||
130464626|NCT02242487|469667185|FG001|Overall Study|Other - Miscellaneous|6|||
130464627|NCT02242487|469667184|FG000|Overall Study|Withdrawal by Subject|37|||
130464628|NCT02242487|469667185|FG001|Overall Study|Withdrawal by Subject|19|||
130464629|NCT01599793|469667186|FG000|Overall Study|Adverse Event|2|||
130464630|NCT00391898|469667200|FG000|Overall Study|Adverse Event|3|||
130464631|NCT00391898|469667201|FG001|Overall Study|Adverse Event|0|||
130464632|NCT00391898|469667200|FG000|Overall Study|Other|8|||
130464633|NCT00391898|469667201|FG001|Overall Study|Other|10|||
130464634|NCT02918279|469667204|FG000|Overall Study|Lost to Follow-up|3|||
130464635|NCT02918279|469667205|FG001|Overall Study|Lost to Follow-up|6|||
130464636|NCT02918279|469667204|FG000|Overall Study|Withdrawal by Subject|5|||
130464637|NCT02918279|469667205|FG001|Overall Study|Withdrawal by Subject|15|||
130464638|NCT02918279|469667204|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130464639|NCT02918279|469667205|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130464640|NCT02918279|469667204|FG000|Overall Study|Other|3|||
130464641|NCT02918279|469667205|FG001|Overall Study|Other|1|||
130464642|NCT00309907|469667206|FG000|Overall Study|Death|4|||
130464643|NCT00309907|469667206|FG000|Overall Study|Physician Decision|1|||
130464644|NCT00309907|469667206|FG000|Overall Study|Ineligible|11|||
130464645|NCT00309907|469667206|FG000|Overall Study|Major infectious event|4|||
130464646|NCT00869258|469667207|FG000|Overall Study|Physician Decision|1|||
130464647|NCT00636207|469667208|FG000|Overall Study|Adverse Event|1|||
130464648|NCT00636207|469667209|FG001|Overall Study|Adverse Event|0|||
130464649|NCT00636207|469667210|FG002|Overall Study|Adverse Event|0|||
130464650|NCT00636207|469667211|FG003|Overall Study|Adverse Event|0|||
130464651|NCT00636207|469667212|FG004|Overall Study|Adverse Event|0|||
130464652|NCT00636207|469667213|FG005|Overall Study|Adverse Event|0|||
130464653|NCT00636207|469667214|FG006|Overall Study|Adverse Event|0|||
130464654|NCT00636207|469667208|FG000|Overall Study|Withdrawal by Subject|0|||
130464655|NCT00636207|469667209|FG001|Overall Study|Withdrawal by Subject|1|||
130464656|NCT00636207|469667210|FG002|Overall Study|Withdrawal by Subject|0|||
130464657|NCT00636207|469667211|FG003|Overall Study|Withdrawal by Subject|0|||
130464658|NCT00636207|469667212|FG004|Overall Study|Withdrawal by Subject|1|||
130464659|NCT00636207|469667213|FG005|Overall Study|Withdrawal by Subject|0|||
130464660|NCT00636207|469667214|FG006|Overall Study|Withdrawal by Subject|0|||
130464661|NCT01641198|469667215|FG000|After 12 Months of Function|Lost to Follow-up|3|||
130464662|NCT01641198|469667216|FG001|After 12 Months of Function|Lost to Follow-up|2|||
130464663|NCT01641198|469667217|FG002|After 12 Months of Function|Lost to Follow-up|2|||
130464664|NCT01641198|469667215|FG000|After 12 Months of Function|Protocol Violation|1|||
130307821|NCT05715242|469089282|FG011|Overall Study|Lost to Follow-up|0|||
130307822|NCT05715242|469089283|FG012|Overall Study|Lost to Follow-up|0|||
130307823|NCT05715242|469089284|FG013|Overall Study|Lost to Follow-up|0|||
130307824|NCT05715242|469089285|FG014|Overall Study|Lost to Follow-up|0|||
130307825|NCT05715242|469089286|FG015|Overall Study|Lost to Follow-up|0|||
130307826|NCT02915978|469089287|FG000|Overall Study|Adverse Event|2|||
130307827|NCT02915978|469089288|FG001|Overall Study|Adverse Event|1|||
130307828|NCT02915978|469089289|FG002|Overall Study|Adverse Event|0|||
130307829|NCT02343406|469089295|FG000|Overall Study|Progressive disease|72|||
130307830|NCT02343406|469089296|FG001|Overall Study|Progressive disease|70|||
130307831|NCT02343406|469089297|FG002|Overall Study|Progressive disease|43|||
130307832|NCT02343406|469089298|FG003|Overall Study|Progressive disease|15|||
130464665|NCT01641198|469667216|FG001|After 12 Months of Function|Protocol Violation|0|||
130464666|NCT01641198|469667217|FG002|After 12 Months of Function|Protocol Violation|0|||
130464667|NCT01641198|469667215|FG000|After 12 Months of Function|Adverse Event|0|||
130464668|NCT01641198|469667216|FG001|After 12 Months of Function|Adverse Event|1|||
130464669|NCT01641198|469667217|FG002|After 12 Months of Function|Adverse Event|0|||
130464670|NCT01641198|469667215|FG000|After 24 Months of Function|Lost to Follow-up|4|||
130464671|NCT01641198|469667216|FG001|After 24 Months of Function|Lost to Follow-up|9|||
130464672|NCT01641198|469667217|FG002|After 24 Months of Function|Lost to Follow-up|6|||
130464673|NCT01641198|469667215|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
130464674|NCT01641198|469667216|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
130307833|NCT02343406|469089299|FG004|Overall Study|Progressive disease|5|||
130307834|NCT02343406|469089295|FG000|Overall Study|Adverse Event|6|||
130307835|NCT02343406|469089296|FG001|Overall Study|Adverse Event|8|||
130464675|NCT01641198|469667217|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
130464676|NCT01641198|469667215|FG000|At 15-20 Years of Function|Death|1|||
130464677|NCT01641198|469667216|FG001|At 15-20 Years of Function|Death|0|||
130464678|NCT01641198|469667217|FG002|At 15-20 Years of Function|Death|1|||
130464679|NCT02529995|469667219|FG000|Part A|Ongoing Study at Data Cut-off|14|||
130464680|NCT02529995|469667220|FG001|Part A|Ongoing Study at Data Cut-off|16|||
130464681|NCT02529995|469667219|FG000|Part A|Discontinued Study|1|||
130464682|NCT02529995|469667220|FG001|Part A|Discontinued Study|0|||
130464683|NCT02529995|469667219|FG000|Part B|Ongoing Study at Data Cut-off|0|||
130464684|NCT02529995|469667220|FG001|Part B|Ongoing Study at Data Cut-off|7|||
130464685|NCT02529995|469667219|FG000|Part B|Discontinued Study|6|||
130464686|NCT02529995|469667220|FG001|Part B|Discontinued Study|5|||
130464687|NCT01075217|469667223|FG000|Overall Study|Adverse Event|1|||
130464688|NCT01075217|469667224|FG001|Overall Study|Adverse Event|1|||
130464689|NCT01075217|469667223|FG000|Overall Study|Physician Decision|1|||
130464690|NCT01075217|469667224|FG001|Overall Study|Physician Decision|0|||
130464691|NCT01068743|469667225|FG000|Period 3|Adverse Event|0|||
130464692|NCT01068743|469667226|FG001|Period 3|Adverse Event|1|||
130464693|NCT01068743|469667227|FG002|Period 3|Adverse Event|0|||
130464694|NCT01068743|469667228|FG003|Period 3|Adverse Event|0|||
130464695|NCT02507752|469667229|FG000|Overall Study|Adverse Event|1|||
130464696|NCT02507752|469667229|FG000|Overall Study|Protocol Violation|6|||
130464697|NCT02507752|469667229|FG000|Overall Study|Lost to Follow-up|7|||
130464698|NCT02507752|469667229|FG000|Overall Study|Infusion reaction at first infusion|1|||
130464699|NCT02507752|469667229|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
130464700|NCT02507752|469667229|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
130464701|NCT01943916|469667231|FG000|Overall Study|Technically invalid images|10|||
130464702|NCT01943916|469667231|FG000|Overall Study|Enrollment Failure|23|||
130464703|NCT01943916|469667231|FG000|Overall Study|Pilot Phase exclusion|100|||
130464704|NCT01943916|469667231|FG000|Overall Study|Quality Assurance Reader Fail|130|||
130464705|NCT01943916|469667231|FG000|Overall Study|Technical Failure|39|||
130464706|NCT01943916|469667231|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
130464707|NCT01943916|469667231|FG000|Overall Study|No Truth Panel Review|38|||
130464708|NCT01943916|469667231|FG000|Overall Study|Protocol Deviation|1|||
130464709|NCT03811574|469667232|FG000|Overall Study|Withdrawal by Subject|2|||
130464710|NCT03811574|469667233|FG001|Overall Study|Withdrawal by Subject|4|||
130464711|NCT03811574|469667234|FG002|Overall Study|Withdrawal by Subject|0|||
130557744|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
130557745|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
130717839|NCT00123474|470593186|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
130717840|NCT00123474|470593187|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
130717841|NCT00123474|470593184|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
130717842|NCT00123474|470593185|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
130717843|NCT00123474|470593186|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
130717844|NCT00123474|470593187|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
130717845|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
130717846|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
130717847|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717848|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717849|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
130717850|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717851|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717852|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717853|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717854|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717855|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
130717856|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717857|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717858|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130557746|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130717859|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717860|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717861|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130307836|NCT02343406|469089297|FG002|Overall Study|Adverse Event|6|||
130464712|NCT01832480|469667235|FG000|Overall Study|Lost to Follow-up|33|||
130464713|NCT01832480|469667236|FG001|Overall Study|Lost to Follow-up|30|||
130464714|NCT01832480|469667235|FG000|Overall Study|Withdrawal by Subject|0|||
130464715|NCT01832480|469667236|FG001|Overall Study|Withdrawal by Subject|2|||
130464716|NCT01832480|469667235|FG000|Overall Study|post randomization ineligible|8|||
130464717|NCT01832480|469667236|FG001|Overall Study|post randomization ineligible|10|||
130464718|NCT05609032|469667237|FG000|Overall Study|Lost to Follow-up|3|||
130373911|NCT05228132|469336845|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
130373912|NCT05228132|469336845|FG000|Overall Study|Adverse Event|3|||
130373913|NCT05228132|469336845|FG000|Overall Study|Lost to Follow-up|1|||
130373914|NCT05228132|469336845|FG000|Overall Study|Arteriovenous-fistula mature|1|||
130373915|NCT01336764|469336846|FG000|Overall Study|Withdrawal by Subject|5|||
130373916|NCT01336764|469336847|FG001|Overall Study|Withdrawal by Subject|5|||
130373917|NCT00730132|469336848|FG000|Overall Study|Protocol Violation|154|||
130373918|NCT00730132|469336848|FG000|Overall Study|Death|1|||
130373919|NCT01626391|469336849|FG000|Overall Study|Physician Decision|1|||
130373920|NCT01626391|469336850|FG001|Overall Study|Physician Decision|0|||
130373921|NCT01626391|469336849|FG000|Overall Study|Withdrawal by Subject|1|||
130373922|NCT01626391|469336850|FG001|Overall Study|Withdrawal by Subject|0|||
130373923|NCT00420927|469336851|FG000|Period 1|Adverse Event|19|||
130373924|NCT00420927|469336852|FG001|Period 1|Adverse Event|15|||
130373925|NCT00420927|469336853|FG002|Period 1|Adverse Event|0|||
130557747|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130717862|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717863|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717864|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
130717865|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717866|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
130717867|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717868|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717869|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717870|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717871|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717872|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717873|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
130717874|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717875|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
130717876|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717877|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717878|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717879|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717880|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717881|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130717882|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130717883|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
130717884|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717885|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
130717886|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717887|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717888|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717889|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717890|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717891|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
130717892|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717893|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717894|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717895|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130373926|NCT00420927|469336854|FG003|Period 1|Adverse Event|0|||
130373927|NCT00420927|469336855|FG004|Period 1|Adverse Event|0|||
130373928|NCT00420927|469336856|FG005|Period 1|Adverse Event|0|||
130373929|NCT00420927|469336857|FG006|Period 1|Adverse Event|0|||
130373930|NCT00420927|469336851|FG000|Period 1|Withdrawal by Subject|7|||
130373931|NCT00420927|469336852|FG001|Period 1|Withdrawal by Subject|12|||
130373932|NCT00420927|469336853|FG002|Period 1|Withdrawal by Subject|0|||
130373933|NCT00420927|469336854|FG003|Period 1|Withdrawal by Subject|0|||
130373934|NCT00420927|469336855|FG004|Period 1|Withdrawal by Subject|0|||
130373935|NCT00420927|469336856|FG005|Period 1|Withdrawal by Subject|0|||
130373936|NCT00420927|469336857|FG006|Period 1|Withdrawal by Subject|0|||
130373937|NCT00420927|469336851|FG000|Period 1|Lost to Follow-up|8|||
130373938|NCT00420927|469336852|FG001|Period 1|Lost to Follow-up|6|||
130373939|NCT00420927|469336853|FG002|Period 1|Lost to Follow-up|0|||
130373940|NCT00420927|469336854|FG003|Period 1|Lost to Follow-up|0|||
130717896|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717897|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717898|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717899|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717900|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717901|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130373941|NCT00420927|469336855|FG004|Period 1|Lost to Follow-up|0|||
130717902|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
130717903|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717904|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717905|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717906|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717907|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717908|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717909|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
130717910|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130717911|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130717912|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717913|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717914|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717915|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717916|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717917|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
130717918|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
130717919|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
130717920|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
130717921|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
130373942|NCT00420927|469336856|FG005|Period 1|Lost to Follow-up|0|||
130373943|NCT00420927|469336857|FG006|Period 1|Lost to Follow-up|0|||
130373944|NCT00420927|469336851|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
130373945|NCT00420927|469336852|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
130373946|NCT00420927|469336853|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
130373947|NCT00420927|469336854|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
130373948|NCT00420927|469336855|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
130373949|NCT00420927|469336856|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
130373950|NCT00420927|469336857|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
130373951|NCT00420927|469336851|FG000|Period 1|Death|2|||
130373952|NCT00420927|469336852|FG001|Period 1|Death|0|||
130373953|NCT00420927|469336853|FG002|Period 1|Death|0|||
130373954|NCT00420927|469336854|FG003|Period 1|Death|0|||
130373955|NCT00420927|469336855|FG004|Period 1|Death|0|||
130373956|NCT00420927|469336856|FG005|Period 1|Death|0|||
130373957|NCT00420927|469336857|FG006|Period 1|Death|0|||
130373958|NCT00420927|469336851|FG000|Period 1|Subject moved/relocated|0|||
130373959|NCT00420927|469336852|FG001|Period 1|Subject moved/relocated|2|||
130373960|NCT00420927|469336853|FG002|Period 1|Subject moved/relocated|0|||
130373961|NCT00420927|469336854|FG003|Period 1|Subject moved/relocated|0|||
130373962|NCT00420927|469336855|FG004|Period 1|Subject moved/relocated|0|||
130373963|NCT00420927|469336856|FG005|Period 1|Subject moved/relocated|0|||
130373964|NCT00420927|469336857|FG006|Period 1|Subject moved/relocated|0|||
130373965|NCT00420927|469336851|FG000|Period 1|Noncompliant with study drug|1|||
130373966|NCT00420927|469336852|FG001|Period 1|Noncompliant with study drug|1|||
130373967|NCT00420927|469336853|FG002|Period 1|Noncompliant with study drug|0|||
130373968|NCT00420927|469336854|FG003|Period 1|Noncompliant with study drug|0|||
130373969|NCT00420927|469336855|FG004|Period 1|Noncompliant with study drug|0|||
130373970|NCT00420927|469336856|FG005|Period 1|Noncompliant with study drug|0|||
130373971|NCT00420927|469336857|FG006|Period 1|Noncompliant with study drug|0|||
130373972|NCT00420927|469336851|FG000|Period 1|Randomization error|1|||
130373973|NCT00420927|469336852|FG001|Period 1|Randomization error|0|||
130373974|NCT00420927|469336853|FG002|Period 1|Randomization error|0|||
130373975|NCT00420927|469336854|FG003|Period 1|Randomization error|0|||
130373976|NCT00420927|469336855|FG004|Period 1|Randomization error|0|||
130373977|NCT00420927|469336856|FG005|Period 1|Randomization error|0|||
130373978|NCT00420927|469336857|FG006|Period 1|Randomization error|0|||
130373979|NCT00420927|469336851|FG000|Period 1|Suspected tuberculosis/positive test|1|||
130373980|NCT00420927|469336852|FG001|Period 1|Suspected tuberculosis/positive test|1|||
130373981|NCT00420927|469336853|FG002|Period 1|Suspected tuberculosis/positive test|0|||
130373982|NCT00420927|469336854|FG003|Period 1|Suspected tuberculosis/positive test|0|||
130373983|NCT00420927|469336855|FG004|Period 1|Suspected tuberculosis/positive test|0|||
130373984|NCT00420927|469336856|FG005|Period 1|Suspected tuberculosis/positive test|0|||
130373985|NCT00420927|469336857|FG006|Period 1|Suspected tuberculosis/positive test|0|||
130373986|NCT00420927|469336851|FG000|Period 1|Study site closure|0|||
130373987|NCT00420927|469336852|FG001|Period 1|Study site closure|1|||
130464719|NCT05609032|469667238|FG001|Overall Study|Lost to Follow-up|1|||
130464720|NCT05609032|469667237|FG000|Overall Study|Withdrawal by Subject|1|||
130464721|NCT05609032|469667238|FG001|Overall Study|Withdrawal by Subject|0|||
130464722|NCT01685606|469667240|FG000|Overall Study|Withdrawal by Subject|1|||
130464723|NCT01787760|469667243|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
130464724|NCT01787760|469667244|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
130464725|NCT01787760|469667245|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
130464726|NCT01787760|469667243|FG000|Overall Study|Decompensated on left exotropia|0|||
130464727|NCT01787760|469667244|FG001|Overall Study|Decompensated on left exotropia|0|||
130464728|NCT01787760|469667245|FG002|Overall Study|Decompensated on left exotropia|1|||
130464729|NCT01787760|469667243|FG000|Overall Study|Dryness|0|||
130464730|NCT01787760|469667244|FG001|Overall Study|Dryness|1|||
130464731|NCT01787760|469667245|FG002|Overall Study|Dryness|0|||
130464732|NCT01787760|469667243|FG000|Overall Study|Relocation|1|||
130464733|NCT01787760|469667244|FG001|Overall Study|Relocation|1|||
130307837|NCT02343406|469089298|FG003|Overall Study|Adverse Event|3|||
130464734|NCT01787760|469667245|FG002|Overall Study|Relocation|0|||
130464735|NCT01787760|469667243|FG000|Overall Study|Lens discomfort|3|||
130464736|NCT01787760|469667244|FG001|Overall Study|Lens discomfort|0|||
130464737|NCT01787760|469667245|FG002|Overall Study|Lens discomfort|0|||
130464738|NCT01787760|469667243|FG000|Overall Study|Lens handling difficulty|1|||
130464739|NCT01787760|469667244|FG001|Overall Study|Lens handling difficulty|2|||
130464740|NCT01787760|469667245|FG002|Overall Study|Lens handling difficulty|0|||
130464741|NCT01787760|469667243|FG000|Overall Study|Protocol Violation|6|||
130464742|NCT01787760|469667244|FG001|Overall Study|Protocol Violation|0|||
130464743|NCT01787760|469667245|FG002|Overall Study|Protocol Violation|1|||
130464744|NCT01787760|469667243|FG000|Overall Study|Withdrawal by Subject|5|||
130464745|NCT01787760|469667244|FG001|Overall Study|Withdrawal by Subject|1|||
130464746|NCT01787760|469667245|FG002|Overall Study|Withdrawal by Subject|2|||
130464747|NCT01787760|469667243|FG000|Overall Study|Lost to Follow-up|1|||
130464748|NCT01787760|469667244|FG001|Overall Study|Lost to Follow-up|0|||
130464749|NCT01787760|469667245|FG002|Overall Study|Lost to Follow-up|1|||
130464750|NCT01787760|469667243|FG000|Overall Study|Stroke|1|||
130464751|NCT01787760|469667244|FG001|Overall Study|Stroke|0|||
130557748|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130557749|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130307838|NCT02343406|469089299|FG004|Overall Study|Adverse Event|0|||
130307839|NCT02343406|469089295|FG000|Overall Study|Withdrawal by Subject|6|||
130307840|NCT02343406|469089296|FG001|Overall Study|Withdrawal by Subject|4|||
130307841|NCT02343406|469089297|FG002|Overall Study|Withdrawal by Subject|8|||
130307842|NCT02343406|469089298|FG003|Overall Study|Withdrawal by Subject|3|||
130307843|NCT02343406|469089299|FG004|Overall Study|Withdrawal by Subject|0|||
130307844|NCT02343406|469089295|FG000|Overall Study|Death|2|||
130307845|NCT02343406|469089296|FG001|Overall Study|Death|1|||
130307846|NCT02343406|469089297|FG002|Overall Study|Death|0|||
130307847|NCT02343406|469089298|FG003|Overall Study|Death|0|||
130307848|NCT02343406|469089299|FG004|Overall Study|Death|0|||
130307849|NCT02343406|469089295|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
130307850|NCT02343406|469089296|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
130307851|NCT02343406|469089297|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
130307852|NCT02343406|469089298|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
130307853|NCT02343406|469089299|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
130307854|NCT02343406|469089295|FG000|Overall Study|Other primary malignancy|0|||
130307855|NCT02343406|469089296|FG001|Overall Study|Other primary malignancy|1|||
130307856|NCT02343406|469089297|FG002|Overall Study|Other primary malignancy|0|||
130307857|NCT02343406|469089298|FG003|Overall Study|Other primary malignancy|0|||
130307858|NCT02343406|469089299|FG004|Overall Study|Other primary malignancy|0|||
130464752|NCT01787760|469667245|FG002|Overall Study|Stroke|0|||
130464753|NCT01787760|469667243|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
130557750|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130464754|NCT01787760|469667244|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
130464755|NCT01787760|469667245|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
130464756|NCT01787760|469667243|FG000|Overall Study|Unsatisfactory physiological response|2|||
130464757|NCT01787760|469667244|FG001|Overall Study|Unsatisfactory physiological response|4|||
130464758|NCT01787760|469667245|FG002|Overall Study|Unsatisfactory physiological response|0|||
130307859|NCT02343406|469089295|FG000|Overall Study|Other, not specified|2|||
130307860|NCT02343406|469089296|FG001|Overall Study|Other, not specified|1|||
130464759|NCT01787760|469667243|FG000|Overall Study|Unsatisfactory visual response|1|||
130464760|NCT01787760|469667244|FG001|Overall Study|Unsatisfactory visual response|1|||
130464761|NCT01787760|469667245|FG002|Overall Study|Unsatisfactory visual response|0|||
130464762|NCT01787760|469667243|FG000|Overall Study|Near vision blur|1|||
130464763|NCT01787760|469667244|FG001|Overall Study|Near vision blur|0|||
130464764|NCT01787760|469667245|FG002|Overall Study|Near vision blur|0|||
130464765|NCT03512756|469667246|FG000|Part 1|Death|23|||
130464766|NCT03512756|469667247|FG001|Part 1|Death|18|||
130464767|NCT03512756|469667248|FG002|Part 1|Death|0|||
130464768|NCT03512756|469667249|FG003|Part 1|Death|0|||
130464769|NCT03512756|469667246|FG000|Part 1|Lost to Follow-up|0|||
130464770|NCT03512756|469667247|FG001|Part 1|Lost to Follow-up|3|||
130464771|NCT03512756|469667248|FG002|Part 1|Lost to Follow-up|0|||
130464772|NCT03512756|469667249|FG003|Part 1|Lost to Follow-up|0|||
130464773|NCT03512756|469667246|FG000|Part 1|Physician Decision|0|||
130464774|NCT03512756|469667247|FG001|Part 1|Physician Decision|1|||
130464775|NCT03512756|469667248|FG002|Part 1|Physician Decision|0|||
130464776|NCT03512756|469667249|FG003|Part 1|Physician Decision|0|||
130464777|NCT03512756|469667246|FG000|Part 1|Withdrawal by Subject|2|||
130717922|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
130717923|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
130717924|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
130717925|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
130717926|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717927|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717928|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717929|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717930|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717931|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717932|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
130717933|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717934|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130307861|NCT02343406|469089297|FG002|Overall Study|Other, not specified|1|||
130307862|NCT02343406|469089298|FG003|Overall Study|Other, not specified|4|||
130307863|NCT02343406|469089299|FG004|Overall Study|Other, not specified|0|||
130307864|NCT02451124|469089300|FG000|Overall Study|Withdrawal by Subject|1|||
130307865|NCT00958165|469089301|FG000|Overall Study|Lost to Follow-up|5|||
130307866|NCT00958165|469089301|FG000|Overall Study|Not eligible|9|||
130307867|NCT00166439|469089305|FG000|Overall Study|Ineligible|5|||
130307868|NCT00615992|469089306|FG000|Overall Study|Protocol Violation|67|||
130307869|NCT00856297|469089307|FG000|Overall Study|Unable to classify|2|||
130307870|NCT00856297|469089308|FG001|Overall Study|Unable to classify|0|||
130307871|NCT00856297|469089309|FG002|Overall Study|Unable to classify|0|||
130307872|NCT00856297|469089310|FG003|Overall Study|Unable to classify|0|||
130307873|NCT00856297|469089311|FG004|Overall Study|Unable to classify|0|||
130307874|NCT01392547|469091041|FG000|Overall Study|Adverse Event|2|||
130307875|NCT01392547|469091041|FG000|Overall Study|Non-compliance|2|||
130307876|NCT01392547|469091041|FG000|Overall Study|Withdrawal criteria|3|||
130307877|NCT01392547|469091041|FG000|Overall Study|Unclassified|1|||
130307878|NCT00615017|469091042|FG000|Overall Study|Adverse Event|0|||
130307879|NCT00615017|469091043|FG001|Overall Study|Adverse Event|1|||
130307880|NCT00615017|469091044|FG002|Overall Study|Adverse Event|2|||
130307881|NCT00615017|469091045|FG003|Overall Study|Adverse Event|0|||
130307882|NCT00615017|469091046|FG004|Overall Study|Adverse Event|0|||
130307883|NCT00615017|469091047|FG005|Overall Study|Adverse Event|1|||
130307884|NCT00615017|469091042|FG000|Overall Study|Death|0|||
130307885|NCT00615017|469091043|FG001|Overall Study|Death|0|||
130307886|NCT00615017|469091044|FG002|Overall Study|Death|2|||
130307887|NCT00615017|469091045|FG003|Overall Study|Death|0|||
130307888|NCT00615017|469091046|FG004|Overall Study|Death|1|||
130307889|NCT00615017|469091047|FG005|Overall Study|Death|1|||
130307890|NCT00615017|469091042|FG000|Overall Study|Sepsis resolved|0|||
130307891|NCT00615017|469091043|FG001|Overall Study|Sepsis resolved|0|||
130307892|NCT00615017|469091044|FG002|Overall Study|Sepsis resolved|1|||
130464778|NCT03512756|469667247|FG001|Part 1|Withdrawal by Subject|2|||
130464779|NCT03512756|469667248|FG002|Part 1|Withdrawal by Subject|0|||
130464780|NCT03512756|469667249|FG003|Part 1|Withdrawal by Subject|0|||
130464781|NCT03512756|469667246|FG000|Part 2|Death|0|||
130557751|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130307893|NCT00615017|469091045|FG003|Overall Study|Sepsis resolved|0|||
130307894|NCT00615017|469091046|FG004|Overall Study|Sepsis resolved|0|||
130307895|NCT00615017|469091047|FG005|Overall Study|Sepsis resolved|0|||
130307896|NCT00615017|469091042|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
130307897|NCT00615017|469091043|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
130307898|NCT00615017|469091044|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
130464782|NCT03512756|469667247|FG001|Part 2|Death|0|||
130464783|NCT03512756|469667248|FG002|Part 2|Death|32|||
130464784|NCT03512756|469667249|FG003|Part 2|Death|21|||
130720905|NCT01341782|470601558|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130307899|NCT00615017|469091045|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
130307900|NCT00615017|469091046|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
130307901|NCT00615017|469091047|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
130307902|NCT00615017|469091042|FG000|Overall Study|Physician discontinued drug|0|||
130307903|NCT00615017|469091043|FG001|Overall Study|Physician discontinued drug|0|||
130307904|NCT00615017|469091044|FG002|Overall Study|Physician discontinued drug|0|||
130307905|NCT00615017|469091045|FG003|Overall Study|Physician discontinued drug|0|||
130307906|NCT00615017|469091046|FG004|Overall Study|Physician discontinued drug|0|||
130307907|NCT00615017|469091047|FG005|Overall Study|Physician discontinued drug|1|||
130307908|NCT00806988|469091048|FG000|Overall Study|Death|15|||
130307909|NCT00806988|469091049|FG001|Overall Study|Death|16|||
130307910|NCT00806988|469091048|FG000|Overall Study|Withdrawal by Subject|8|||
130307911|NCT00806988|469091049|FG001|Overall Study|Withdrawal by Subject|8|||
130307912|NCT00806988|469091048|FG000|Overall Study|Lost to Follow-up|4|||
130307913|NCT00806988|469091049|FG001|Overall Study|Lost to Follow-up|19|||
130307914|NCT04775953|469091050|FG000|Overall Study|Lost to Follow-up|6|||
130307915|NCT04775953|469091051|FG001|Overall Study|Lost to Follow-up|11|||
130307916|NCT04775953|469091050|FG000|Overall Study|Death|5|||
130307917|NCT04775953|469091051|FG001|Overall Study|Death|4|||
130307918|NCT04775953|469091050|FG000|Overall Study|Withdrawal by Subject|3|||
130307919|NCT04775953|469091051|FG001|Overall Study|Withdrawal by Subject|3|||
130307920|NCT04775953|469091050|FG000|Overall Study|Protocol Violation|2|||
130307921|NCT04775953|469091051|FG001|Overall Study|Protocol Violation|0|||
130307922|NCT04775953|469091050|FG000|Overall Study|Participant non-compliance|0|||
130307923|NCT04775953|469091051|FG001|Overall Study|Participant non-compliance|1|||
130307924|NCT00855959|469091052|FG000|Overall Study|Adverse Event|2|||
130307925|NCT00855959|469091052|FG000|Overall Study|Lost to Follow-up|2|||
130307926|NCT00855959|469091052|FG000|Overall Study|Withdrawal by Subject|3|||
130307927|NCT00855959|469091052|FG000|Overall Study|Pregnancy|1|||
130307928|NCT00855959|469091052|FG000|Overall Study|Incorrect enrolment|1|||
130307929|NCT02813889|469091053|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
130307930|NCT02813889|469091054|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
130307931|NCT00368641|469091055|FG000|Overall Study|Adverse Event|2|||
130307932|NCT00368641|469091056|FG001|Overall Study|Adverse Event|1|||
130307933|NCT00368641|469091055|FG000|Overall Study|Death|1|||
130307934|NCT00368641|469091056|FG001|Overall Study|Death|0|||
130307935|NCT00368641|469091055|FG000|Overall Study|Withdrawal by Subject|1|||
130307936|NCT00368641|469091056|FG001|Overall Study|Withdrawal by Subject|0|||
130307937|NCT00368641|469091055|FG000|Overall Study|Sponsor decision to terminate study|2|||
130307938|NCT00368641|469091056|FG001|Overall Study|Sponsor decision to terminate study|5|||
130307939|NCT02517541|469091063|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
130307940|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
130307941|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
130307942|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
130307943|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
130307944|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
130307945|NCT00699608|469091064|FG000|First Intervention|Withdrawal by Subject|0|||
130307946|NCT00699608|469091065|FG001|First Intervention|Withdrawal by Subject|0|||
130307947|NCT00699608|469091066|FG002|First Intervention|Withdrawal by Subject|1|||
130307948|NCT00699608|469091067|FG003|First Intervention|Withdrawal by Subject|0|||
130307949|NCT00699608|469091068|FG004|First Intervention|Withdrawal by Subject|0|||
130307950|NCT00699608|469091069|FG005|First Intervention|Withdrawal by Subject|0|||
130307951|NCT00699608|469091064|FG000|First Intervention|Protocol Violation|0|||
130307952|NCT00699608|469091065|FG001|First Intervention|Protocol Violation|0|||
130307953|NCT00699608|469091066|FG002|First Intervention|Protocol Violation|0|||
130307954|NCT00699608|469091067|FG003|First Intervention|Protocol Violation|0|||
130307955|NCT00699608|469091068|FG004|First Intervention|Protocol Violation|1|||
130307956|NCT00699608|469091069|FG005|First Intervention|Protocol Violation|0|||
130307957|NCT00699608|469091064|FG000|Second Intervention|Adverse Event|0|||
130307958|NCT00699608|469091065|FG001|Second Intervention|Adverse Event|0|||
130307959|NCT00699608|469091066|FG002|Second Intervention|Adverse Event|1|||
130307960|NCT00699608|469091067|FG003|Second Intervention|Adverse Event|0|||
130464785|NCT03512756|469667246|FG000|Part 2|Lost to Follow-up|0|||
130464786|NCT03512756|469667247|FG001|Part 2|Lost to Follow-up|0|||
130307961|NCT00699608|469091068|FG004|Second Intervention|Adverse Event|0|||
130307962|NCT00699608|469091069|FG005|Second Intervention|Adverse Event|0|||
130307963|NCT00699608|469091064|FG000|Second Intervention|Withdrawal by Subject|0|||
130307964|NCT00699608|469091065|FG001|Second Intervention|Withdrawal by Subject|0|||
130307965|NCT00699608|469091066|FG002|Second Intervention|Withdrawal by Subject|0|||
130307966|NCT00699608|469091067|FG003|Second Intervention|Withdrawal by Subject|1|||
130307967|NCT00699608|469091068|FG004|Second Intervention|Withdrawal by Subject|0|||
130307968|NCT00699608|469091069|FG005|Second Intervention|Withdrawal by Subject|0|||
130307969|NCT03078556|469091072|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
130464787|NCT03512756|469667248|FG002|Part 2|Lost to Follow-up|1|||
130717935|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717936|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130307970|NCT03078556|469091073|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
130307971|NCT03078556|469091074|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
130307972|NCT03078556|469091075|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
130307973|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
130307974|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130307975|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
130307976|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130307977|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130307978|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
130307979|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130307980|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130307981|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
130307982|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
130307983|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
130307984|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
130307985|NCT04306510|469091076|FG000|Overall Study|Voluntarily withdrawal|1|||
130307986|NCT04306510|469091076|FG000|Overall Study|Enrolled but Not Treated|1|||
130307987|NCT04720417|469091077|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
130307988|NCT00496080|469091083|FG000|Overall Study|Lost to Follow-up|9|||
130307989|NCT00496080|469091083|FG000|Overall Study|Surgical re-intervention|7|||
130307990|NCT00496080|469091083|FG000|Overall Study|Withdrawal by Subject|5|||
130307991|NCT00496080|469091083|FG000|Overall Study|Physician Decision|6|||
130307992|NCT00570310|469091084|FG000|Overall Study|Adverse Event|1|||
130307993|NCT00570310|469091085|FG001|Overall Study|Adverse Event|2|||
130307994|NCT00570310|469091084|FG000|Overall Study|Lack of Efficacy|1|||
130307995|NCT00570310|469091085|FG001|Overall Study|Lack of Efficacy|4|||
130307996|NCT00887549|469091086|FG000|Induction Therapy|Adverse Event|8|||
130307997|NCT00887549|469091086|FG000|Induction Therapy|Physician Decision|1|||
130307998|NCT00887549|469091086|FG000|Induction Therapy|Progressive Disease|13|||
130307999|NCT00887549|469091086|FG000|Induction Therapy|Death due to Study Disease|4|||
130308000|NCT00887549|469091086|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
130308001|NCT00887549|469091086|FG000|Maintenance Therapy|Adverse Event|16|||
130308002|NCT00887549|469091086|FG000|Maintenance Therapy|Physician Decision|1|||
130308003|NCT00887549|469091086|FG000|Maintenance Therapy|Progressive Disease|25|||
130373988|NCT00420927|469336853|FG002|Period 1|Study site closure|0|||
130373989|NCT00420927|469336854|FG003|Period 1|Study site closure|0|||
130373990|NCT00420927|469336855|FG004|Period 1|Study site closure|0|||
130373991|NCT00420927|469336856|FG005|Period 1|Study site closure|0|||
130373992|NCT00420927|469336857|FG006|Period 1|Study site closure|0|||
130373993|NCT00420927|469336851|FG000|Period 1|Subject received new diagnosis|0|||
130373994|NCT00420927|469336852|FG001|Period 1|Subject received new diagnosis|2|||
130373995|NCT00420927|469336853|FG002|Period 1|Subject received new diagnosis|0|||
130373996|NCT00420927|469336854|FG003|Period 1|Subject received new diagnosis|0|||
130373997|NCT00420927|469336855|FG004|Period 1|Subject received new diagnosis|0|||
130373998|NCT00420927|469336856|FG005|Period 1|Subject received new diagnosis|0|||
130373999|NCT00420927|469336857|FG006|Period 1|Subject received new diagnosis|0|||
130374000|NCT00420927|469336851|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
130374001|NCT00420927|469336852|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
130374002|NCT00420927|469336853|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
130374003|NCT00420927|469336854|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
130374004|NCT00420927|469336855|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
130374005|NCT00420927|469336856|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
130374006|NCT00420927|469336857|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
130374007|NCT00420927|469336851|FG000|Period 1|Failed to meet entry criteria|8|||
130374008|NCT00420927|469336852|FG001|Period 1|Failed to meet entry criteria|7|||
130374009|NCT00420927|469336853|FG002|Period 1|Failed to meet entry criteria|0|||
130374010|NCT00420927|469336854|FG003|Period 1|Failed to meet entry criteria|0|||
130374011|NCT00420927|469336855|FG004|Period 1|Failed to meet entry criteria|0|||
130374012|NCT00420927|469336856|FG005|Period 1|Failed to meet entry criteria|0|||
130374013|NCT00420927|469336857|FG006|Period 1|Failed to meet entry criteria|0|||
130374014|NCT00420927|469336851|FG000|Period 1|Took prohibited medication|1|||
130374015|NCT00420927|469336852|FG001|Period 1|Took prohibited medication|3|||
130374016|NCT00420927|469336853|FG002|Period 1|Took prohibited medication|0|||
130374017|NCT00420927|469336854|FG003|Period 1|Took prohibited medication|0|||
130374018|NCT00420927|469336855|FG004|Period 1|Took prohibited medication|0|||
130308004|NCT00887549|469091086|FG000|Maintenance Therapy|Death due to adverse event|1|||
130308005|NCT03472950|469091090|FG000|Overall Study|Lost to Follow-up|0|||
130374019|NCT00420927|469336856|FG005|Period 1|Took prohibited medication|0|||
130374020|NCT00420927|469336857|FG006|Period 1|Took prohibited medication|0|||
130374021|NCT00420927|469336851|FG000|Period 2|Adverse Event|0|||
130374022|NCT00420927|469336852|FG001|Period 2|Adverse Event|0|||
130374023|NCT00420927|469336853|FG002|Period 2|Adverse Event|7|||
130557752|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130720906|NCT01341782|470601557|FG000|Overall Study|Other|5|||
130308006|NCT03472950|469091091|FG001|Overall Study|Lost to Follow-up|1|||
130308007|NCT03472950|469091090|FG000|Overall Study|Adverse Event|0|||
130308008|NCT03472950|469091091|FG001|Overall Study|Adverse Event|3|||
130308009|NCT00377858|469091097|FG000|Overall Study|Withdrawal by Subject|12|||
130308010|NCT00377858|469091098|FG001|Overall Study|Withdrawal by Subject|11|||
130308011|NCT00377858|469091097|FG000|Overall Study|Lost to Follow-up|6|||
130308012|NCT00377858|469091098|FG001|Overall Study|Lost to Follow-up|1|||
130308013|NCT00377858|469091097|FG000|Overall Study|Physician Decision|5|||
130308014|NCT00377858|469091098|FG001|Overall Study|Physician Decision|5|||
130308015|NCT00377858|469091097|FG000|Overall Study|Protocol Violation|3|||
130308016|NCT00377858|469091098|FG001|Overall Study|Protocol Violation|4|||
130308017|NCT00377858|469091097|FG000|Overall Study|Adverse Event|2|||
130308018|NCT00377858|469091098|FG001|Overall Study|Adverse Event|1|||
130308019|NCT00377858|469091097|FG000|Overall Study|Entry Criteria Not Met|2|||
130308020|NCT00377858|469091098|FG001|Overall Study|Entry Criteria Not Met|0|||
130308021|NCT00377858|469091097|FG000|Overall Study|Sponsor Decision|1|||
130308022|NCT00377858|469091098|FG001|Overall Study|Sponsor Decision|2|||
130308023|NCT00377858|469091097|FG000|Overall Study|Death|0|||
130308024|NCT00377858|469091098|FG001|Overall Study|Death|3|||
130308025|NCT04034004|469091103|FG000|Overall Study|Withdrawal by Subject|1|||
130308026|NCT04034004|469091104|FG001|Overall Study|Withdrawal by Subject|2|||
130308027|NCT04034004|469091105|FG002|Overall Study|Withdrawal by Subject|2|||
130308028|NCT04034004|469091106|FG003|Overall Study|Withdrawal by Subject|3|||
130308029|NCT04034004|469091103|FG000|Overall Study|could not find vein to administer IV|2|||
130308030|NCT04034004|469091104|FG001|Overall Study|could not find vein to administer IV|1|||
130308031|NCT04034004|469091105|FG002|Overall Study|could not find vein to administer IV|0|||
130308032|NCT04034004|469091106|FG003|Overall Study|could not find vein to administer IV|0|||
130308033|NCT04034004|469091103|FG000|Overall Study|nurse accidentally unblinded subject|0|||
130308034|NCT04034004|469091104|FG001|Overall Study|nurse accidentally unblinded subject|0|||
130308035|NCT04034004|469091105|FG002|Overall Study|nurse accidentally unblinded subject|0|||
130308036|NCT04034004|469091106|FG003|Overall Study|nurse accidentally unblinded subject|1|||
130308037|NCT01502228|469091114|FG000|Overall Study|Death|1|||
130308038|NCT06964165|469091119|FG000|Overall Study|Withdrawal by Subject|0|||
130308039|NCT06964165|469091120|FG001|Overall Study|Withdrawal by Subject|1|||
130308040|NCT06964165|469091119|FG000|Overall Study|Ongoing at the time of analysis|15|||
130308041|NCT06964165|469091120|FG001|Overall Study|Ongoing at the time of analysis|14|||
130308042|NCT06964165|469091119|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
130308043|NCT06964165|469091120|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
130308044|NCT06964165|469091119|FG000|Overall Study|Participant removed due to non-compliance|0|||
130308045|NCT06964165|469091120|FG001|Overall Study|Participant removed due to non-compliance|1|||
130308046|NCT01514201|469091135|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
130308047|NCT01514201|469091136|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308048|NCT01514201|469091137|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308049|NCT01514201|469091138|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308050|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308051|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130308052|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130308053|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308054|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130308055|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130308056|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
130308057|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308058|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130308059|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130308060|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130374024|NCT00420927|469336854|FG003|Period 2|Adverse Event|3|||
130374025|NCT00420927|469336855|FG004|Period 2|Adverse Event|17|||
130374026|NCT00420927|469336856|FG005|Period 2|Adverse Event|6|||
130374027|NCT00420927|469336857|FG006|Period 2|Adverse Event|20|||
130374028|NCT00420927|469336851|FG000|Period 2|Withdrawal by Subject|0|||
130374029|NCT00420927|469336852|FG001|Period 2|Withdrawal by Subject|0|||
130374030|NCT00420927|469336853|FG002|Period 2|Withdrawal by Subject|1|||
130374031|NCT00420927|469336854|FG003|Period 2|Withdrawal by Subject|3|||
130374032|NCT00420927|469336855|FG004|Period 2|Withdrawal by Subject|11|||
130374033|NCT00420927|469336856|FG005|Period 2|Withdrawal by Subject|2|||
130374034|NCT00420927|469336857|FG006|Period 2|Withdrawal by Subject|12|||
130374035|NCT00420927|469336851|FG000|Period 2|Lost to Follow-up|0|||
130374036|NCT00420927|469336852|FG001|Period 2|Lost to Follow-up|0|||
130374037|NCT00420927|469336853|FG002|Period 2|Lost to Follow-up|2|||
130374038|NCT00420927|469336854|FG003|Period 2|Lost to Follow-up|2|||
130374039|NCT00420927|469336855|FG004|Period 2|Lost to Follow-up|6|||
130308061|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308062|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308063|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308064|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308065|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
130308066|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308067|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308068|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308069|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
130308070|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308071|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308072|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308073|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
130308074|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308075|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308076|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308077|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
130308078|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308079|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308080|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308081|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
130308082|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308083|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308084|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308085|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
130308086|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308087|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308088|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308089|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
130308090|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308091|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308092|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308093|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
130308094|NCT05888181|469091140|FG000|Overall Study|Lost to Follow-up|1|||
130308095|NCT05888181|469091141|FG001|Overall Study|Lost to Follow-up|1|||
130308096|NCT05888181|469091142|FG002|Overall Study|Lost to Follow-up|0|||
130308097|NCT02534909|469091149|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
130308098|NCT01625000|469091152|FG000|Overall Study|Physician Decision|15|||
130308099|NCT01625000|469091153|FG001|Overall Study|Physician Decision|7|||
130308100|NCT01625000|469091154|FG002|Overall Study|Physician Decision|7|||
130308101|NCT01625000|469091155|FG003|Overall Study|Physician Decision|2|||
130308102|NCT01625000|469091156|FG004|Overall Study|Physician Decision|15|||
130308103|NCT01625000|469091152|FG000|Overall Study|Protocol Violation|3|||
130308104|NCT01625000|469091153|FG001|Overall Study|Protocol Violation|10|||
130308105|NCT01625000|469091154|FG002|Overall Study|Protocol Violation|4|||
130308106|NCT01625000|469091155|FG003|Overall Study|Protocol Violation|1|||
130308107|NCT01625000|469091156|FG004|Overall Study|Protocol Violation|2|||
130308108|NCT01625000|469091152|FG000|Overall Study|Withdrawal by Subject|19|||
130308109|NCT01625000|469091153|FG001|Overall Study|Withdrawal by Subject|16|||
130308110|NCT01625000|469091154|FG002|Overall Study|Withdrawal by Subject|11|||
130308111|NCT01625000|469091155|FG003|Overall Study|Withdrawal by Subject|9|||
130308112|NCT01625000|469091156|FG004|Overall Study|Withdrawal by Subject|17|||
130308113|NCT01625000|469091152|FG000|Overall Study|Adverse Event (including Death)|15|||
130308114|NCT01625000|469091153|FG001|Overall Study|Adverse Event (including Death)|19|||
130308115|NCT01625000|469091154|FG002|Overall Study|Adverse Event (including Death)|11|||
130308116|NCT01625000|469091155|FG003|Overall Study|Adverse Event (including Death)|7|||
130308117|NCT01625000|469091156|FG004|Overall Study|Adverse Event (including Death)|21|||
130308118|NCT00577824|469091159|FG000|Overall Study|Adverse Event|6|||
130308119|NCT00577824|469091160|FG001|Overall Study|Adverse Event|18|||
130308120|NCT00577824|469091161|FG002|Overall Study|Adverse Event|1|||
130308121|NCT00577824|469091159|FG000|Overall Study|Patient decision|0|||
130308122|NCT00577824|469091160|FG001|Overall Study|Patient decision|1|||
130308123|NCT00577824|469091161|FG002|Overall Study|Patient decision|1|||
130308124|NCT00577824|469091159|FG000|Overall Study|Protocol Violation|1|||
130308125|NCT00577824|469091160|FG001|Overall Study|Protocol Violation|1|||
130308126|NCT00577824|469091161|FG002|Overall Study|Protocol Violation|0|||
130308127|NCT00362648|469091162|FG000|Overall Study|Adverse Event|12|||
130464788|NCT03512756|469667249|FG003|Part 2|Lost to Follow-up|0|||
130308128|NCT00362648|469091163|FG001|Overall Study|Adverse Event|21|||
130308129|NCT00362648|469091164|FG002|Overall Study|Adverse Event|1|||
130308130|NCT00362648|469091165|FG003|Overall Study|Adverse Event|0|||
130464789|NCT03512756|469667246|FG000|Part 2|Physician Decision|0|||
130464790|NCT03512756|469667247|FG001|Part 2|Physician Decision|0|||
130464791|NCT03512756|469667248|FG002|Part 2|Physician Decision|2|||
130464792|NCT03512756|469667249|FG003|Part 2|Physician Decision|4|||
130464793|NCT03512756|469667246|FG000|Part 2|Study Terminated by Sponsor|0|||
130464794|NCT03512756|469667247|FG001|Part 2|Study Terminated by Sponsor|0|||
130464795|NCT03512756|469667248|FG002|Part 2|Study Terminated by Sponsor|2|||
130464796|NCT03512756|469667249|FG003|Part 2|Study Terminated by Sponsor|6|||
130464797|NCT03512756|469667246|FG000|Part 2|Protocol Violation|0|||
130464798|NCT03512756|469667247|FG001|Part 2|Protocol Violation|0|||
130308131|NCT00362648|469091162|FG000|Overall Study|Lost to Follow-up|62|||
130308132|NCT00362648|469091163|FG001|Overall Study|Lost to Follow-up|69|||
130308133|NCT00362648|469091164|FG002|Overall Study|Lost to Follow-up|4|||
130308134|NCT00362648|469091165|FG003|Overall Study|Lost to Follow-up|3|||
130308135|NCT00362648|469091162|FG000|Overall Study|Protocol Violation|4|||
130308136|NCT00362648|469091163|FG001|Overall Study|Protocol Violation|2|||
130308137|NCT00362648|469091164|FG002|Overall Study|Protocol Violation|2|||
130308138|NCT00362648|469091165|FG003|Overall Study|Protocol Violation|2|||
130308139|NCT00362648|469091162|FG000|Overall Study|Withdrawal by Subject|48|||
130308140|NCT00362648|469091163|FG001|Overall Study|Withdrawal by Subject|42|||
130308141|NCT00362648|469091164|FG002|Overall Study|Withdrawal by Subject|2|||
130308142|NCT00362648|469091165|FG003|Overall Study|Withdrawal by Subject|6|||
130308143|NCT03983304|469091166|FG000|Overall Study|Withdrawal by Subject|5|||
130308144|NCT03983304|469091166|FG000|Overall Study|Lost to Follow-up|2|||
130308145|NCT01518374|469091169|FG000|Overall Study|Withdrawal by Subject|2|||
130308146|NCT01518374|469091169|FG000|Overall Study|Protocol Violation|3|||
130308147|NCT01518374|469091169|FG000|Overall Study|Lost to Follow-up|2|||
130308148|NCT04300309|469091170|FG000|Overall Study|Lost to Follow-up|1|||
130308149|NCT04300309|469091171|FG001|Overall Study|Lost to Follow-up|0|||
130308150|NCT02362464|469091174|FG000|Overall Study|Switched to alternative therapy|1|||
130308151|NCT02362464|469091174|FG000|Overall Study|Refused further treatment|1|||
130308152|NCT02362464|469091174|FG000|Overall Study|Physician Decision|4|||
130308153|NCT04752332|469091175|FG000|Overall Study|Adverse Event|3|||
130308154|NCT04752332|469091176|FG001|Overall Study|Adverse Event|1|||
130308155|NCT04752332|469091175|FG000|Overall Study|Disease Relapse|1|||
130308156|NCT04752332|469091176|FG001|Overall Study|Disease Relapse|0|||
130308157|NCT04752332|469091175|FG000|Overall Study|Non-compliance With Study Drug|2|||
130308158|NCT04752332|469091176|FG001|Overall Study|Non-compliance With Study Drug|0|||
130308159|NCT04752332|469091175|FG000|Overall Study|Physician Decision|2|||
130308160|NCT04752332|469091176|FG001|Overall Study|Physician Decision|1|||
130308161|NCT04752332|469091175|FG000|Overall Study|Protocol Violation|1|||
130308162|NCT04752332|469091176|FG001|Overall Study|Protocol Violation|1|||
130308163|NCT04752332|469091175|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
130308164|NCT04752332|469091176|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
130308165|NCT04752332|469091175|FG000|Overall Study|Study Terminated by Sponsor|10|||
130308166|NCT04752332|469091176|FG001|Overall Study|Study Terminated by Sponsor|48|||
130308167|NCT04752332|469091175|FG000|Overall Study|Withdrawal by Subject|11|||
130308168|NCT04752332|469091176|FG001|Overall Study|Withdrawal by Subject|3|||
130308169|NCT00048347|469091177|FG000|Overall Study|Screen failure|2|||
130308170|NCT02058563|469091178|FG000|Overall Study|Lost to Follow-up|26|||
130308171|NCT02058563|469091179|FG001|Overall Study|Lost to Follow-up|22|||
130308172|NCT02058563|469091178|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
130308173|NCT02058563|469091179|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
130308174|NCT02058563|469091178|FG000|Overall Study|Consent Withdrawal|1|||
130308175|NCT02058563|469091179|FG001|Overall Study|Consent Withdrawal|1|||
130308176|NCT02058563|469091178|FG000|Overall Study|Other (patient incarcerated)|0|||
130308177|NCT02058563|469091179|FG001|Overall Study|Other (patient incarcerated)|1|||
130308178|NCT04039217|469091180|FG000|Overall Study|Lost to Follow-up|1|||
130308179|NCT04522141|469091181|FG000|Overall Study|Withdrawal by Subject|1|||
130308180|NCT04522141|469091182|FG001|Overall Study|Withdrawal by Subject|0|||
130464799|NCT03512756|469667248|FG002|Part 2|Protocol Violation|1|||
130720907|NCT01341782|470601558|FG001|Overall Study|Other|0|||
130308181|NCT03508609|469091183|FG000|Overall Study|Withdrawal by Subject|1|||
130308182|NCT00555217|469091184|FG000|Overall Study|Withdrawal by Subject|35|||
130308183|NCT00555217|469091185|FG001|Overall Study|Withdrawal by Subject|31|||
130308184|NCT00555217|469091184|FG000|Overall Study|Lost to Follow-up|19|||
130308185|NCT00555217|469091185|FG001|Overall Study|Lost to Follow-up|20|||
130308186|NCT00555217|469091184|FG000|Overall Study|close out sites|21|||
130308187|NCT00555217|469091185|FG001|Overall Study|close out sites|17|||
130308188|NCT01868477|469091186|FG000|Overall Study|Adverse Event|2|||
130308189|NCT01868477|469091187|FG001|Overall Study|Adverse Event|4|||
130308190|NCT01868477|469091186|FG000|Overall Study|Disease progression|1|||
130308191|NCT01868477|469091187|FG001|Overall Study|Disease progression|1|||
130308192|NCT01868477|469091186|FG000|Overall Study|Withdrawal by Subject|1|||
130308193|NCT01868477|469091187|FG001|Overall Study|Withdrawal by Subject|0|||
130308194|NCT00367835|469091190|FG000|Overall Study|Adverse Event|14|||
130308195|NCT00367835|469091191|FG001|Overall Study|Adverse Event|1|||
130464800|NCT03512756|469667249|FG003|Part 2|Protocol Violation|0|||
130464801|NCT03512756|469667246|FG000|Part 2|Withdrawal by Subject|0|||
130464802|NCT03512756|469667247|FG001|Part 2|Withdrawal by Subject|0|||
130717937|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130308196|NCT00367835|469091190|FG000|Overall Study|Protocol Violation|1|||
130308197|NCT00367835|469091191|FG001|Overall Study|Protocol Violation|7|||
130308198|NCT00367835|469091190|FG000|Overall Study|Withdrawal by Subject|7|||
130308199|NCT00367835|469091191|FG001|Overall Study|Withdrawal by Subject|6|||
130308200|NCT00367835|469091190|FG000|Overall Study|Lost to Follow-up|1|||
130308201|NCT00367835|469091191|FG001|Overall Study|Lost to Follow-up|4|||
130308202|NCT00367835|469091190|FG000|Overall Study|Lack of Efficacy|3|||
130308203|NCT00367835|469091191|FG001|Overall Study|Lack of Efficacy|12|||
130308204|NCT00367835|469091190|FG000|Overall Study|Subject in juvenile detention center|1|||
130308205|NCT00367835|469091191|FG001|Overall Study|Subject in juvenile detention center|0|||
130308206|NCT00367835|469091190|FG000|Overall Study|refused blood collection|1|||
130308207|NCT00367835|469091191|FG001|Overall Study|refused blood collection|0|||
130308208|NCT00367835|469091190|FG000|Overall Study|Did not respond to calls|1|||
130308209|NCT00367835|469091191|FG001|Overall Study|Did not respond to calls|0|||
130308210|NCT00367835|469091190|FG000|Overall Study|History of lead poisoning|0|||
130308211|NCT00367835|469091191|FG001|Overall Study|History of lead poisoning|1|||
130308212|NCT03761810|469091193|FG000|Overall Study|Adverse Event|12|||
130308213|NCT03761810|469091194|FG001|Overall Study|Adverse Event|0|||
130308214|NCT03761810|469091193|FG000|Overall Study|Lost to Follow-up|15|||
130308215|NCT03761810|469091194|FG001|Overall Study|Lost to Follow-up|7|||
130308216|NCT03761810|469091193|FG000|Overall Study|Pregnancy|1|||
130308217|NCT03761810|469091194|FG001|Overall Study|Pregnancy|0|||
130308218|NCT03761810|469091193|FG000|Overall Study|Withdrawal by Subject|14|||
130308219|NCT03761810|469091194|FG001|Overall Study|Withdrawal by Subject|5|||
130308220|NCT03761810|469091193|FG000|Overall Study|Physician Decision|1|||
130308221|NCT03761810|469091194|FG001|Overall Study|Physician Decision|0|||
130308222|NCT03761810|469091193|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
130308223|NCT03761810|469091194|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130308224|NCT03761810|469091193|FG000|Overall Study|Other Than Specified|1|||
130308225|NCT03761810|469091194|FG001|Overall Study|Other Than Specified|0|||
130308226|NCT01574651|469091195|FG000|Overall Study|Lost to Follow-up|2|||
130308227|NCT01574651|469091196|FG001|Overall Study|Lost to Follow-up|4|||
130308228|NCT01574651|469091195|FG000|Overall Study|Administrative problems|0|||
130308229|NCT01574651|469091196|FG001|Overall Study|Administrative problems|1|||
130308230|NCT01574651|469091195|FG000|Overall Study|Death|3|||
130308231|NCT01574651|469091196|FG001|Overall Study|Death|3|||
130308232|NCT01574651|469091195|FG000|Overall Study|Patient's inability to use the device|0|||
130308233|NCT01574651|469091196|FG001|Overall Study|Patient's inability to use the device|1|||
130308234|NCT01574651|469091195|FG000|Overall Study|Adverse Event|36|||
130308235|NCT01574651|469091196|FG001|Overall Study|Adverse Event|27|||
130308236|NCT01574651|469091195|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130308237|NCT01574651|469091196|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130308238|NCT01574651|469091195|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130308239|NCT01574651|469091196|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130308240|NCT01574651|469091195|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130308241|NCT01574651|469091196|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130308242|NCT01574651|469091195|FG000|Overall Study|Protocol Violation|3|||
130374040|NCT00420927|469336856|FG005|Period 2|Lost to Follow-up|3|||
130374041|NCT00420927|469336857|FG006|Period 2|Lost to Follow-up|9|||
130374042|NCT00420927|469336851|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
130374043|NCT00420927|469336852|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
130374044|NCT00420927|469336853|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
130374045|NCT00420927|469336854|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
130374046|NCT00420927|469336855|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
130374047|NCT00420927|469336856|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
130374048|NCT00420927|469336857|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
130374049|NCT00420927|469336851|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
130374050|NCT00420927|469336852|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
130374051|NCT00420927|469336853|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
130374052|NCT00420927|469336854|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
130374053|NCT00420927|469336855|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
130374054|NCT00420927|469336856|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
130374055|NCT00420927|469336857|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
130308243|NCT01574651|469091196|FG001|Overall Study|Protocol Violation|5|||
130374056|NCT00420927|469336851|FG000|Period 2|Subject unable to find transportation|0|||
130374057|NCT00420927|469336852|FG001|Period 2|Subject unable to find transportation|0|||
130308244|NCT01574651|469091195|FG000|Overall Study|Withdrawal by Subject|9|||
130308245|NCT01574651|469091196|FG001|Overall Study|Withdrawal by Subject|10|||
130308246|NCT03887221|469091197|FG000|Overall Study|Protocol Violation|1|||
130308247|NCT03887221|469091198|FG001|Overall Study|Protocol Violation|0|||
130308248|NCT02092025|469091199|FG000|Overall Study|Case Report Forms Uncollected|44|||
130308249|NCT02092025|469091199|FG000|Overall Study|Protocol Deviation|24|||
130308250|NCT03228212|469091201|FG000|Period 1|Adverse Event|1|||
130308251|NCT03228212|469091202|FG001|Period 1|Adverse Event|0|||
130308252|NCT03228212|469091201|FG000|Period 1|no longer meets eligibility criteria|0|||
130308253|NCT03228212|469091202|FG001|Period 1|no longer meets eligibility criteria|1|||
130308254|NCT03228212|469091201|FG000|Period 2|Lost to Follow-up|1|||
130308255|NCT03228212|469091202|FG001|Period 2|Lost to Follow-up|0|||
130308256|NCT01807299|469091203|FG000|Overall Study|Protocol Violation|3|||
130308257|NCT01807299|469091204|FG001|Overall Study|Protocol Violation|1|||
130308258|NCT01807299|469091205|FG002|Overall Study|Protocol Violation|0|||
130308259|NCT01807299|469091206|FG003|Overall Study|Protocol Violation|2|||
130308260|NCT00811174|469091207|FG000|Overall Study|Protocol Violation|2|||
130308261|NCT00811174|469091207|FG000|Overall Study|Sponsors Decision|1|||
130308262|NCT02451943|469092278|FG000|Overall Study|Withdrawal by Subject|13|||
130308263|NCT02451943|469092279|FG001|Overall Study|Withdrawal by Subject|16|||
130308264|NCT02451943|469092278|FG000|Overall Study|Lost to Follow-up|3|||
130308265|NCT02451943|469092279|FG001|Overall Study|Lost to Follow-up|4|||
130308266|NCT02451943|469092278|FG000|Overall Study|Sponsor Decision|0|||
130308267|NCT02451943|469092279|FG001|Overall Study|Sponsor Decision|4|||
130308268|NCT01101035|469092281|FG000|Overall Study|Adverse Event|191|||
130308269|NCT01101035|469092282|FG001|Overall Study|Adverse Event|172|||
130308270|NCT01101035|469092281|FG000|Overall Study|Major Protocol Deviation|52|||
130308271|NCT01101035|469092282|FG001|Overall Study|Major Protocol Deviation|46|||
130308272|NCT01101035|469092281|FG000|Overall Study|Lost to Follow-up|226|||
130308273|NCT01101035|469092282|FG001|Overall Study|Lost to Follow-up|223|||
130308274|NCT01101035|469092281|FG000|Overall Study|Voluntary Withdrawal|595|||
130308275|NCT01101035|469092282|FG001|Overall Study|Voluntary Withdrawal|587|||
130308276|NCT01101035|469092281|FG000|Overall Study|Reason not Specified|333|||
130308277|NCT01101035|469092282|FG001|Overall Study|Reason not Specified|363|||
130308278|NCT00681629|469092283|FG000|Overall Study|Study termination|4|||
130308279|NCT00681629|469092284|FG001|Overall Study|Study termination|2|||
130308280|NCT00681629|469092283|FG000|Overall Study|Adverse Event|1|||
130308281|NCT00681629|469092284|FG001|Overall Study|Adverse Event|0|||
130308282|NCT01510158|469092292|FG000|Overall Study|Adverse Event|7|||
130308283|NCT01510158|469092293|FG001|Overall Study|Adverse Event|8|||
130308284|NCT01510158|469092294|FG002|Overall Study|Adverse Event|5|||
130308285|NCT01510158|469092292|FG000|Overall Study|Gout flare|1|||
130308286|NCT01510158|469092293|FG001|Overall Study|Gout flare|0|||
130308287|NCT01510158|469092294|FG002|Overall Study|Gout flare|0|||
130308288|NCT01510158|469092292|FG000|Overall Study|Protocol Violation|17|||
130308289|NCT01510158|469092293|FG001|Overall Study|Protocol Violation|16|||
130308290|NCT01510158|469092294|FG002|Overall Study|Protocol Violation|24|||
130308291|NCT01510158|469092292|FG000|Overall Study|Sponsor terminated study.|2|||
130308292|NCT01510158|469092293|FG001|Overall Study|Sponsor terminated study.|0|||
130308293|NCT01510158|469092294|FG002|Overall Study|Sponsor terminated study.|2|||
130308294|NCT01510158|469092292|FG000|Overall Study|Lost to Follow-up|13|||
130308295|NCT01510158|469092293|FG001|Overall Study|Lost to Follow-up|16|||
130308296|NCT01510158|469092294|FG002|Overall Study|Lost to Follow-up|9|||
130308297|NCT01510158|469092292|FG000|Overall Study|Withdrawal by Subject|10|||
130308298|NCT01510158|469092293|FG001|Overall Study|Withdrawal by Subject|13|||
130308299|NCT01510158|469092294|FG002|Overall Study|Withdrawal by Subject|10|||
130308300|NCT01510158|469092292|FG000|Overall Study|Death|1|||
130308301|NCT01510158|469092293|FG001|Overall Study|Death|0|||
130308302|NCT01510158|469092294|FG002|Overall Study|Death|0|||
130308303|NCT01442714|469092296|FG000|Overall Study|Death|11|||
130308304|NCT01442714|469092296|FG000|Overall Study|Withdrawal by Subject|1|||
130308305|NCT03314987|469092297|FG000|Overall Study|Lost to Follow-up|13|||
130308306|NCT03314987|469092298|FG001|Overall Study|Lost to Follow-up|13|||
130308307|NCT02751580|469092299|FG000|Overall Study|Lost to Follow-up|4|||
130308308|NCT02751580|469092299|FG000|Overall Study|Death|2|||
130308309|NCT04829916|469092303|FG000|Overall Study|Withdrawal by Subject|1|||
130717938|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717939|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717940|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130308310|NCT04829916|469092304|FG001|Overall Study|Withdrawal by Subject|0|||
130308311|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Technical problems|0|||
130308312|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Technical problems|0|||
130308313|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Technical problems|0|||
130308314|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Technical problems|1|||
130308315|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308316|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
130308317|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308318|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308319|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
130308320|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
130308321|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
130308322|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
130308323|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
130308324|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
130308325|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
130464803|NCT03512756|469667248|FG002|Part 2|Withdrawal by Subject|3|||
130464804|NCT03512756|469667249|FG003|Part 2|Withdrawal by Subject|9|||
130464805|NCT00736853|469667250|FG000|Open-Label Period|Physician Decision|2|||
130308326|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
130308327|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Death|0|||
130308328|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Death|3|||
130308329|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Death|1|||
130308330|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Death|0|||
130308331|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130308332|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130308333|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130308334|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130308335|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130308336|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
130308337|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
130308338|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130308339|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
130308340|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
130308341|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130308342|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130308343|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
130308344|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308345|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308346|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308347|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130308348|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130308349|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130308350|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130308351|NCT04343755|469092315|FG000|Overall Study|Death|11|||
130308352|NCT04343755|469092315|FG000|Overall Study|Screen Failure|1|||
130308353|NCT03755882|469092316|FG000|Period 1|Protocol Violation|1|||
130308354|NCT03755882|469092317|FG001|Period 1|Protocol Violation|0|||
130308355|NCT03755882|469092316|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
130308356|NCT03755882|469092317|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
130308357|NCT02292446|469092318|FG000|Overall Study|Adverse Event|12|||
130308358|NCT02292446|469092318|FG000|Overall Study|Death|1|||
130308359|NCT02292446|469092318|FG000|Overall Study|Disease progression|2|||
130308360|NCT02292446|469092318|FG000|Overall Study|Subject/guardian decision|2|||
130308361|NCT02292446|469092318|FG000|Overall Study|Withdrawal by Subject|3|||
130308362|NCT01290757|469092321|FG000|Overall Study|Adverse Event|1|||
130308363|NCT01290757|469092322|FG001|Overall Study|Adverse Event|0|||
130308364|NCT01290757|469092321|FG000|Overall Study|Protocol Violation|1|||
130308365|NCT01290757|469092322|FG001|Overall Study|Protocol Violation|1|||
130308366|NCT01290757|469092321|FG000|Overall Study|Other|0|||
130308367|NCT01290757|469092322|FG001|Overall Study|Other|1|||
130308368|NCT03329846|469092324|FG000|Overall Study|Disease progression|4|||
130308369|NCT03329846|469092325|FG001|Overall Study|Disease progression|6|||
130308370|NCT03329846|469092324|FG000|Overall Study|Study drug toxicity|1|||
130308371|NCT03329846|469092325|FG001|Overall Study|Study drug toxicity|0|||
130308372|NCT03329846|469092324|FG000|Overall Study|Participant request to discontinue treatment|0|||
130308373|NCT03329846|469092325|FG001|Overall Study|Participant request to discontinue treatment|1|||
130308374|NCT03329846|469092324|FG000|Overall Study|Participant withdrew consent|1|||
130308375|NCT03329846|469092325|FG001|Overall Study|Participant withdrew consent|0|||
130308376|NCT03329846|469092324|FG000|Overall Study|Other reasons|2|||
130308377|NCT03329846|469092325|FG001|Overall Study|Other reasons|2|||
130308378|NCT00479336|469092326|FG000|Overall Study|Adverse Event|1|||
130308379|NCT00479336|469092327|FG001|Overall Study|Adverse Event|1|||
130308380|NCT00479336|469092328|FG002|Overall Study|Adverse Event|1|||
130308381|NCT00479336|469092329|FG003|Overall Study|Adverse Event|3|||
130308382|NCT00479336|469092326|FG000|Overall Study|Lack of Efficacy|1|||
130308383|NCT00479336|469092327|FG001|Overall Study|Lack of Efficacy|0|||
130308384|NCT00479336|469092328|FG002|Overall Study|Lack of Efficacy|0|||
130308385|NCT00479336|469092329|FG003|Overall Study|Lack of Efficacy|0|||
130308386|NCT00479336|469092326|FG000|Overall Study|Protocol Violation|0|||
130308387|NCT00479336|469092327|FG001|Overall Study|Protocol Violation|1|||
130308388|NCT00479336|469092328|FG002|Overall Study|Protocol Violation|0|||
130308389|NCT00479336|469092329|FG003|Overall Study|Protocol Violation|0|||
130308390|NCT00479336|469092326|FG000|Overall Study|Withdrawal by Subject|1|||
130308391|NCT00479336|469092327|FG001|Overall Study|Withdrawal by Subject|2|||
130464806|NCT00736853|469667251|FG001|Open-Label Period|Physician Decision|0|||
130464807|NCT00736853|469667252|FG002|Open-Label Period|Physician Decision|0|||
130308392|NCT00479336|469092328|FG002|Overall Study|Withdrawal by Subject|0|||
130308393|NCT00479336|469092329|FG003|Overall Study|Withdrawal by Subject|0|||
130308394|NCT00479336|469092326|FG000|Overall Study|Physician Decision|0|||
130308395|NCT00479336|469092327|FG001|Overall Study|Physician Decision|1|||
130308396|NCT00479336|469092328|FG002|Overall Study|Physician Decision|0|||
130308397|NCT00479336|469092329|FG003|Overall Study|Physician Decision|2|||
130308398|NCT00479336|469092326|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
130308399|NCT00479336|469092327|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
130308400|NCT00479336|469092328|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
130308401|NCT00479336|469092329|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
130308402|NCT03066193|469092330|FG000|Overall Study|Withdrawal by Subject|1|||
130308403|NCT02021643|469092331|FG000|Overall Study|Enrolled but Never Treated|1|||
130308404|NCT02021643|469092332|FG001|Overall Study|Enrolled but Never Treated|0|||
130308405|NCT02021643|469092333|FG002|Overall Study|Enrolled but Never Treated|0|||
130308406|NCT02021643|469092334|FG003|Overall Study|Enrolled but Never Treated|0|||
130308407|NCT02021643|469092331|FG000|Overall Study|Adverse Event|0|||
130308408|NCT02021643|469092332|FG001|Overall Study|Adverse Event|1|||
130308409|NCT02021643|469092333|FG002|Overall Study|Adverse Event|0|||
130308410|NCT02021643|469092334|FG003|Overall Study|Adverse Event|0|||
130308411|NCT02021643|469092331|FG000|Overall Study|Death|0|||
130308412|NCT02021643|469092332|FG001|Overall Study|Death|1|||
130308413|NCT02021643|469092333|FG002|Overall Study|Death|0|||
130308414|NCT02021643|469092334|FG003|Overall Study|Death|0|||
130308415|NCT02021643|469092331|FG000|Overall Study|Investigator's Discretion|1|||
130308416|NCT02021643|469092332|FG001|Overall Study|Investigator's Discretion|0|||
130308417|NCT02021643|469092333|FG002|Overall Study|Investigator's Discretion|0|||
130308418|NCT02021643|469092334|FG003|Overall Study|Investigator's Discretion|0|||
130308419|NCT02021643|469092331|FG000|Overall Study|Lack of Efficacy|7|||
130308420|NCT02021643|469092332|FG001|Overall Study|Lack of Efficacy|6|||
130308421|NCT02021643|469092333|FG002|Overall Study|Lack of Efficacy|0|||
130308422|NCT02021643|469092334|FG003|Overall Study|Lack of Efficacy|12|||
130308423|NCT02021643|469092331|FG000|Overall Study|Lost to Follow-up|0|||
130308424|NCT02021643|469092332|FG001|Overall Study|Lost to Follow-up|1|||
130308425|NCT02021643|469092333|FG002|Overall Study|Lost to Follow-up|0|||
130308426|NCT02021643|469092334|FG003|Overall Study|Lost to Follow-up|0|||
130308427|NCT02021643|469092331|FG000|Overall Study|Withdrew Consent|0|||
130308428|NCT02021643|469092332|FG001|Overall Study|Withdrew Consent|1|||
130308429|NCT02021643|469092333|FG002|Overall Study|Withdrew Consent|0|||
130308430|NCT02021643|469092334|FG003|Overall Study|Withdrew Consent|0|||
130308431|NCT04854551|469092335|FG000|Overall Study|Withdrawal by Subject|1|||
130308432|NCT04854551|469092336|FG001|Overall Study|Withdrawal by Subject|1|||
130308433|NCT02631551|469092337|FG000|Overall Study|Adverse Event|1|||
130308434|NCT02631551|469092338|FG001|Overall Study|Adverse Event|2|||
130308435|NCT02631551|469092339|FG002|Overall Study|Adverse Event|4|||
130308436|NCT02631551|469092340|FG003|Overall Study|Adverse Event|0|||
130308437|NCT02631551|469092337|FG000|Overall Study|Lack of Efficacy|0|||
130308438|NCT02631551|469092338|FG001|Overall Study|Lack of Efficacy|0|||
130308439|NCT02631551|469092339|FG002|Overall Study|Lack of Efficacy|1|||
130308440|NCT02631551|469092340|FG003|Overall Study|Lack of Efficacy|0|||
130308441|NCT02631551|469092337|FG000|Overall Study|Lost to Follow-up|1|||
130308442|NCT02631551|469092338|FG001|Overall Study|Lost to Follow-up|2|||
130308443|NCT02631551|469092339|FG002|Overall Study|Lost to Follow-up|0|||
130308444|NCT02631551|469092340|FG003|Overall Study|Lost to Follow-up|3|||
130308445|NCT02631551|469092337|FG000|Overall Study|Withdrawal by Subject|2|||
130308446|NCT02631551|469092338|FG001|Overall Study|Withdrawal by Subject|2|||
130308447|NCT02631551|469092339|FG002|Overall Study|Withdrawal by Subject|0|||
130308448|NCT02631551|469092340|FG003|Overall Study|Withdrawal by Subject|5|||
130308449|NCT02631551|469092337|FG000|Overall Study|Protocol deviation|3|||
130308450|NCT02631551|469092338|FG001|Overall Study|Protocol deviation|6|||
130308451|NCT02631551|469092339|FG002|Overall Study|Protocol deviation|3|||
130308452|NCT02631551|469092340|FG003|Overall Study|Protocol deviation|0|||
130308453|NCT02631551|469092337|FG000|Overall Study|Non-compliance with study procedures|0|||
130464808|NCT00736853|469667250|FG000|Open-Label Period|Adverse Event|31|||
130464809|NCT00736853|469667251|FG001|Open-Label Period|Adverse Event|0|||
130464810|NCT00736853|469667252|FG002|Open-Label Period|Adverse Event|0|||
130464811|NCT00736853|469667250|FG000|Open-Label Period|Withdrawal by Subject|16|||
130464812|NCT00736853|469667251|FG001|Open-Label Period|Withdrawal by Subject|0|||
130464813|NCT00736853|469667252|FG002|Open-Label Period|Withdrawal by Subject|0|||
130308454|NCT02631551|469092338|FG001|Overall Study|Non-compliance with study procedures|0|||
130308455|NCT02631551|469092339|FG002|Overall Study|Non-compliance with study procedures|1|||
130464814|NCT00736853|469667250|FG000|Open-Label Period|Started but not treated|42|||
130720908|NCT00620555|470601559|FG000|Overall Study|Adverse Event|4|||
130308456|NCT02631551|469092340|FG003|Overall Study|Non-compliance with study procedures|1|||
130308457|NCT02631551|469092337|FG000|Overall Study|Non-compliance with study drug|1|||
130308458|NCT02631551|469092338|FG001|Overall Study|Non-compliance with study drug|0|||
130308459|NCT02631551|469092339|FG002|Overall Study|Non-compliance with study drug|0|||
130308460|NCT02631551|469092340|FG003|Overall Study|Non-compliance with study drug|0|||
130308461|NCT02631551|469092337|FG000|Overall Study|Other, specific reasons not collected|5|||
130308462|NCT02631551|469092338|FG001|Overall Study|Other, specific reasons not collected|7|||
130308463|NCT02631551|469092339|FG002|Overall Study|Other, specific reasons not collected|2|||
130464815|NCT00736853|469667251|FG001|Open-Label Period|Started but not treated|0|||
130464816|NCT00736853|469667252|FG002|Open-Label Period|Started but not treated|0|||
130717941|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130717942|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130308464|NCT02631551|469092340|FG003|Overall Study|Other, specific reasons not collected|2|||
130308465|NCT04112303|469092341|FG000|Overall Study|Death|1|||
130308466|NCT05636852|469092349|FG000|Overall Study|Withdrawal by Subject|1|||
130308467|NCT05636852|469092349|FG000|Overall Study|Other than specified|1|||
130308468|NCT01076036|469092350|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
130308469|NCT03088917|469092351|FG000|Overall Study|In care/cured elsewhere|15|||
130308470|NCT03088917|469092351|FG000|Overall Study|Refuse re-evaluation|13|||
130308471|NCT03088917|469092351|FG000|Overall Study|Contact not established|13|||
130308472|NCT03088917|469092351|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
130308473|NCT03088917|469092351|FG000|Overall Study|Moved outside study region|50|||
130308474|NCT01221350|469092352|FG000|Overall Study|Discontinued intervention (GERD)|1|||
130308475|NCT01221350|469092353|FG001|Overall Study|Discontinued intervention (GERD)|0|||
130308476|NCT01221350|469092352|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
130308477|NCT01221350|469092353|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
130308478|NCT01221350|469092352|FG000|Overall Study|Withdrawal by Subject|4|||
130308479|NCT01221350|469092353|FG001|Overall Study|Withdrawal by Subject|2|||
130308480|NCT02735343|469092357|FG000|Overall Study|screen fail|0|||
130308481|NCT02735343|469092358|FG001|Overall Study|screen fail|2|||
130308482|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
130308483|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
130308484|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
130308485|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
130308486|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
130308487|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
130308488|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
130308489|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
130308490|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130308491|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130308492|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
130308493|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
130308494|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
130308495|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
130308496|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
130308497|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308498|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308499|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
130308500|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308501|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308502|NCT04209205|469092370|FG000|Overall Study|Adverse Event|2|||
130308503|NCT04209205|469092371|FG001|Overall Study|Adverse Event|3|||
130308504|NCT04209205|469092370|FG000|Overall Study|Lost to Follow-up|3|||
130308505|NCT04209205|469092371|FG001|Overall Study|Lost to Follow-up|1|||
130308506|NCT04209205|469092370|FG000|Overall Study|Physician Decision|1|||
130308507|NCT04209205|469092371|FG001|Overall Study|Physician Decision|1|||
130308508|NCT04209205|469092370|FG000|Overall Study|Subject decision|10|||
130308509|NCT04209205|469092371|FG001|Overall Study|Subject decision|10|||
130308510|NCT04209205|469092370|FG000|Overall Study|Progressive disease|1|||
130308511|NCT04209205|469092371|FG001|Overall Study|Progressive disease|0|||
130308512|NCT04209205|469092370|FG000|Overall Study|Protocol deviation|0|||
130308513|NCT04209205|469092371|FG001|Overall Study|Protocol deviation|1|||
130308514|NCT04209205|469092370|FG000|Overall Study|New therapy for study indication|1|||
130308515|NCT04209205|469092371|FG001|Overall Study|New therapy for study indication|0|||
130308516|NCT04209205|469092370|FG000|Overall Study|Adverse event - placebo not switched|0|||
130308517|NCT04209205|469092371|FG001|Overall Study|Adverse event - placebo not switched|1|||
130308518|NCT04209205|469092370|FG000|Overall Study|Subject decision - placebo not switched|0|||
130717943|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130308519|NCT04209205|469092371|FG001|Overall Study|Subject decision - placebo not switched|5|||
130308520|NCT04209205|469092370|FG000|Overall Study|Death - placebo not switched|0|||
130308521|NCT04209205|469092371|FG001|Overall Study|Death - placebo not switched|1|||
130308522|NCT03197376|469092372|FG000|Primary and Booster Phase|Adverse Event|0|||
130308523|NCT03197376|469092373|FG001|Primary and Booster Phase|Adverse Event|0|||
130717944|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
130308524|NCT03197376|469092374|FG002|Primary and Booster Phase|Adverse Event|0|||
130308525|NCT03197376|469092375|FG003|Primary and Booster Phase|Adverse Event|1|||
130308526|NCT03197376|469092372|FG000|Primary and Booster Phase|Death|1|||
130308527|NCT03197376|469092373|FG001|Primary and Booster Phase|Death|0|||
130374058|NCT00420927|469336853|FG002|Period 2|Subject unable to find transportation|0|||
130374059|NCT00420927|469336854|FG003|Period 2|Subject unable to find transportation|0|||
130374060|NCT00420927|469336855|FG004|Period 2|Subject unable to find transportation|0|||
130374061|NCT00420927|469336856|FG005|Period 2|Subject unable to find transportation|0|||
130374062|NCT00420927|469336857|FG006|Period 2|Subject unable to find transportation|1|||
130374063|NCT00420927|469336851|FG000|Period 2|Physician Decision|0|||
130374064|NCT00420927|469336852|FG001|Period 2|Physician Decision|0|||
130374065|NCT00420927|469336853|FG002|Period 2|Physician Decision|0|||
130374066|NCT00420927|469336854|FG003|Period 2|Physician Decision|0|||
130374067|NCT00420927|469336855|FG004|Period 2|Physician Decision|1|||
130374068|NCT00420927|469336856|FG005|Period 2|Physician Decision|1|||
130374069|NCT00420927|469336857|FG006|Period 2|Physician Decision|0|||
130374070|NCT00420927|469336851|FG000|Period 2|Sponsor decision|0|||
130374071|NCT00420927|469336852|FG001|Period 2|Sponsor decision|0|||
130374072|NCT00420927|469336853|FG002|Period 2|Sponsor decision|1|||
130374073|NCT00420927|469336854|FG003|Period 2|Sponsor decision|0|||
130374074|NCT00420927|469336855|FG004|Period 2|Sponsor decision|0|||
130374075|NCT00420927|469336856|FG005|Period 2|Sponsor decision|0|||
130374076|NCT00420927|469336857|FG006|Period 2|Sponsor decision|1|||
130374077|NCT00420927|469336851|FG000|Period 2|Randomization error|0|||
130374078|NCT00420927|469336852|FG001|Period 2|Randomization error|0|||
130374079|NCT00420927|469336853|FG002|Period 2|Randomization error|0|||
130374080|NCT00420927|469336854|FG003|Period 2|Randomization error|0|||
130374081|NCT00420927|469336855|FG004|Period 2|Randomization error|1|||
130374082|NCT00420927|469336856|FG005|Period 2|Randomization error|1|||
130374083|NCT00420927|469336857|FG006|Period 2|Randomization error|0|||
130374084|NCT00420927|469336851|FG000|Period 2|Noncompliant with study drug|0|||
130374085|NCT00420927|469336852|FG001|Period 2|Noncompliant with study drug|0|||
130374086|NCT00420927|469336853|FG002|Period 2|Noncompliant with study drug|0|||
130374087|NCT00420927|469336854|FG003|Period 2|Noncompliant with study drug|1|||
130374088|NCT00420927|469336855|FG004|Period 2|Noncompliant with study drug|0|||
130374089|NCT00420927|469336856|FG005|Period 2|Noncompliant with study drug|0|||
130374090|NCT00420927|469336857|FG006|Period 2|Noncompliant with study drug|2|||
130374091|NCT00420927|469336851|FG000|Period 2|Methotrexate intolerance|0|||
130374092|NCT00420927|469336852|FG001|Period 2|Methotrexate intolerance|0|||
130374093|NCT00420927|469336853|FG002|Period 2|Methotrexate intolerance|0|||
130374094|NCT00420927|469336854|FG003|Period 2|Methotrexate intolerance|0|||
130374095|NCT00420927|469336855|FG004|Period 2|Methotrexate intolerance|0|||
130374096|NCT00420927|469336856|FG005|Period 2|Methotrexate intolerance|0|||
130374097|NCT00420927|469336857|FG006|Period 2|Methotrexate intolerance|1|||
130374098|NCT00420927|469336851|FG000|Period 2|Took prohibited medication|0|||
130374099|NCT00420927|469336852|FG001|Period 2|Took prohibited medication|0|||
130374100|NCT00420927|469336853|FG002|Period 2|Took prohibited medication|0|||
130374101|NCT00420927|469336854|FG003|Period 2|Took prohibited medication|0|||
130374102|NCT00420927|469336855|FG004|Period 2|Took prohibited medication|1|||
130374103|NCT00420927|469336856|FG005|Period 2|Took prohibited medication|0|||
130374104|NCT00420927|469336857|FG006|Period 2|Took prohibited medication|0|||
130374105|NCT00320411|469336858|FG000|Overall Study|No investigational product admin.|4|||
130374106|NCT02088047|469336860|FG000|Overall Study|Withdrawal by Subject|1|||
130374107|NCT02088047|469336861|FG001|Overall Study|Withdrawal by Subject|0|||
130374108|NCT01032837|469336863|FG000|Overall Study|Adverse event/internal illness|0|||
130374109|NCT01032837|469336864|FG001|Overall Study|Adverse event/internal illness|1|||
130374110|NCT01032837|469336865|FG002|Overall Study|Adverse event/internal illness|0|||
130374111|NCT01032837|469336866|FG003|Overall Study|Adverse event/internal illness|1|||
130374112|NCT01032837|469336863|FG000|Overall Study|Withdrew consent|0|||
130374113|NCT01032837|469336864|FG001|Overall Study|Withdrew consent|2|||
130374114|NCT01032837|469336865|FG002|Overall Study|Withdrew consent|0|||
130374115|NCT01032837|469336866|FG003|Overall Study|Withdrew consent|1|||
130374116|NCT01032837|469336863|FG000|Overall Study|Failed to return|0|||
130374117|NCT01032837|469336864|FG001|Overall Study|Failed to return|0|||
130374118|NCT01032837|469336865|FG002|Overall Study|Failed to return|1|||
130374119|NCT01032837|469336866|FG003|Overall Study|Failed to return|0|||
130374120|NCT01032837|469336863|FG000|Overall Study|Refused treatment|0|||
130374121|NCT01032837|469336864|FG001|Overall Study|Refused treatment|0|||
130374122|NCT01032837|469336865|FG002|Overall Study|Refused treatment|0|||
130374123|NCT01032837|469336866|FG003|Overall Study|Refused treatment|1|||
130374124|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
130374125|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
130374126|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130374127|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130374128|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130374129|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130374130|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
130374131|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
130374132|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130720909|NCT00620555|470601559|FG000|Overall Study|Protocol Violation|2|||
130464817|NCT00736853|469667250|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
130308528|NCT03197376|469092374|FG002|Primary and Booster Phase|Death|0|||
130308529|NCT03197376|469092375|FG003|Primary and Booster Phase|Death|2|||
130308530|NCT03197376|469092372|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
130308531|NCT03197376|469092373|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
130308532|NCT03197376|469092374|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
130308533|NCT03197376|469092375|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
130308534|NCT03197376|469092372|FG000|Primary and Booster Phase|Physician Decision|1|||
130308535|NCT03197376|469092373|FG001|Primary and Booster Phase|Physician Decision|0|||
130308536|NCT03197376|469092374|FG002|Primary and Booster Phase|Physician Decision|1|||
130308537|NCT03197376|469092375|FG003|Primary and Booster Phase|Physician Decision|3|||
130308538|NCT03197376|469092372|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130308539|NCT03197376|469092373|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
130308540|NCT03197376|469092374|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
130308541|NCT03197376|469092375|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130308542|NCT03197376|469092372|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
130308543|NCT03197376|469092373|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
130308544|NCT03197376|469092374|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
130308545|NCT03197376|469092375|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
130308546|NCT03197376|469092372|FG000|Primary and Booster Phase|Not vaccine related|1|||
130308547|NCT03197376|469092373|FG001|Primary and Booster Phase|Not vaccine related|2|||
130308548|NCT03197376|469092374|FG002|Primary and Booster Phase|Not vaccine related|0|||
130308549|NCT03197376|469092375|FG003|Primary and Booster Phase|Not vaccine related|6|||
130308550|NCT03197376|469092372|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
130308551|NCT03197376|469092373|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
130308552|NCT03197376|469092374|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
130308553|NCT03197376|469092375|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
130308554|NCT03197376|469092372|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130308555|NCT03197376|469092373|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130308556|NCT03197376|469092374|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
130308557|NCT03197376|469092375|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
130308558|NCT03197376|469092372|FG000|Immune Persistence Phase|Not vaccine related|1|||
130308559|NCT03197376|469092373|FG001|Immune Persistence Phase|Not vaccine related|0|||
130308560|NCT03197376|469092374|FG002|Immune Persistence Phase|Not vaccine related|1|||
130308561|NCT03197376|469092375|FG003|Immune Persistence Phase|Not vaccine related|1|||
130308562|NCT01123395|469092376|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
130308563|NCT01123395|469092377|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
130308564|NCT03691571|469092378|FG000|Overall Study|Withdrawal by Subject|9|||
130308565|NCT03691571|469092379|FG001|Overall Study|Withdrawal by Subject|2|||
130308566|NCT00186901|469092382|FG000|Overall Study|Pregnancy|6|||
130308567|NCT00186901|469092383|FG001|Overall Study|Pregnancy|3|||
130308568|NCT00186901|469092384|FG002|Overall Study|Pregnancy|0|||
130308569|NCT00186901|469092382|FG000|Overall Study|Lost to Follow-up|6|||
130308570|NCT00186901|469092383|FG001|Overall Study|Lost to Follow-up|3|||
130308571|NCT00186901|469092384|FG002|Overall Study|Lost to Follow-up|0|||
130308572|NCT00186901|469092382|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
130308573|NCT00186901|469092383|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
130308574|NCT00186901|469092384|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
130308575|NCT00186901|469092382|FG000|Overall Study|ALL relapse or second malignancy|1|||
130308576|NCT00186901|469092383|FG001|Overall Study|ALL relapse or second malignancy|2|||
130308577|NCT00186901|469092384|FG002|Overall Study|ALL relapse or second malignancy|0|||
130308578|NCT00186901|469092382|FG000|Overall Study|Withdrawal by Subject|4|||
130308579|NCT00186901|469092383|FG001|Overall Study|Withdrawal by Subject|5|||
130308580|NCT00186901|469092384|FG002|Overall Study|Withdrawal by Subject|0|||
130308581|NCT00186901|469092382|FG000|Overall Study|Open label|3|||
130308582|NCT00186901|469092383|FG001|Overall Study|Open label|2|||
130308583|NCT00186901|469092384|FG002|Overall Study|Open label|0|||
130308584|NCT00186901|469092382|FG000|Overall Study|Limited adherence to study requirements|20|||
130308585|NCT00186901|469092383|FG001|Overall Study|Limited adherence to study requirements|23|||
130308586|NCT00186901|469092384|FG002|Overall Study|Limited adherence to study requirements|0|||
130308587|NCT00186901|469092382|FG000|Overall Study|Bone Mineral Density > 0|0|||
130308588|NCT00186901|469092383|FG001|Overall Study|Bone Mineral Density > 0|0|||
130308589|NCT00186901|469092384|FG002|Overall Study|Bone Mineral Density > 0|149|||
130308590|NCT00291486|469092390|FG000|Overall Study|Adverse Event|0|||
130308591|NCT00291486|469092391|FG001|Overall Study|Adverse Event|3|||
130308592|NCT00291486|469092392|FG002|Overall Study|Adverse Event|0|||
130464818|NCT00736853|469667251|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
130720910|NCT00620555|470601559|FG000|Overall Study|Lack of Efficacy|12|||
130308593|NCT00291486|469092393|FG003|Overall Study|Adverse Event|1|||
130308594|NCT00291486|469092394|FG004|Overall Study|Adverse Event|0|||
130308595|NCT00291486|469092390|FG000|Overall Study|Withdrawal by Subject|0|||
130308596|NCT00291486|469092391|FG001|Overall Study|Withdrawal by Subject|0|||
130308597|NCT00291486|469092392|FG002|Overall Study|Withdrawal by Subject|0|||
130464819|NCT00736853|469667252|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
130464820|NCT00736853|469667250|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
130464821|NCT00736853|469667251|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
130464822|NCT00736853|469667252|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
130464823|NCT00736853|469667250|FG000|Double-Blind Period|Lack of Efficacy|0|||
130464824|NCT00736853|469667251|FG001|Double-Blind Period|Lack of Efficacy|19|||
130464825|NCT00736853|469667252|FG002|Double-Blind Period|Lack of Efficacy|42|||
130717945|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
130308598|NCT00291486|469092393|FG003|Overall Study|Withdrawal by Subject|0|||
130308599|NCT00291486|469092394|FG004|Overall Study|Withdrawal by Subject|1|||
130308600|NCT00291486|469092390|FG000|Overall Study|Disease progression|1|||
130308601|NCT00291486|469092391|FG001|Overall Study|Disease progression|0|||
130308602|NCT00291486|469092392|FG002|Overall Study|Disease progression|1|||
130308603|NCT00291486|469092393|FG003|Overall Study|Disease progression|0|||
130308604|NCT00291486|469092394|FG004|Overall Study|Disease progression|0|||
130308605|NCT01099397|469092395|FG000|Overall Study|Lost to Follow-up|4|||
130308606|NCT01099397|469092395|FG000|Overall Study|Protocol Violation|4|||
130308607|NCT01099397|469092395|FG000|Overall Study|Withdrawal by Subject|5|||
130308608|NCT02487030|469092402|FG000|Overall Study|Lack of Efficacy|2|||
130308609|NCT02487030|469092403|FG001|Overall Study|Lack of Efficacy|4|||
130308610|NCT02487030|469092404|FG002|Overall Study|Lack of Efficacy|1|||
130308611|NCT02487030|469092405|FG003|Overall Study|Lack of Efficacy|0|||
130308612|NCT02487030|469092406|FG004|Overall Study|Lack of Efficacy|1|||
130308613|NCT02487030|469092407|FG005|Overall Study|Lack of Efficacy|0|||
130308614|NCT02487030|469092408|FG006|Overall Study|Lack of Efficacy|0|||
130308615|NCT02487030|469092402|FG000|Overall Study|Lost to Follow-up|0|||
130308616|NCT02487030|469092403|FG001|Overall Study|Lost to Follow-up|0|||
130308617|NCT02487030|469092404|FG002|Overall Study|Lost to Follow-up|1|||
130308618|NCT02487030|469092405|FG003|Overall Study|Lost to Follow-up|1|||
130308619|NCT02487030|469092406|FG004|Overall Study|Lost to Follow-up|0|||
130308620|NCT02487030|469092407|FG005|Overall Study|Lost to Follow-up|1|||
130308621|NCT02487030|469092408|FG006|Overall Study|Lost to Follow-up|0|||
130308622|NCT02487030|469092402|FG000|Overall Study|Adverse Event|0|||
130308623|NCT02487030|469092403|FG001|Overall Study|Adverse Event|0|||
130308624|NCT02487030|469092404|FG002|Overall Study|Adverse Event|0|||
130308625|NCT02487030|469092405|FG003|Overall Study|Adverse Event|1|||
130308626|NCT02487030|469092406|FG004|Overall Study|Adverse Event|0|||
130308627|NCT02487030|469092407|FG005|Overall Study|Adverse Event|0|||
130308628|NCT02487030|469092408|FG006|Overall Study|Adverse Event|0|||
130308629|NCT02487030|469092402|FG000|Overall Study|Death|0|||
130308630|NCT02487030|469092403|FG001|Overall Study|Death|0|||
130308631|NCT02487030|469092404|FG002|Overall Study|Death|0|||
130308632|NCT02487030|469092405|FG003|Overall Study|Death|0|||
130308633|NCT02487030|469092406|FG004|Overall Study|Death|1|||
130308634|NCT02487030|469092407|FG005|Overall Study|Death|0|||
130308635|NCT02487030|469092408|FG006|Overall Study|Death|0|||
130308636|NCT00264537|469092409|FG000|Overall Study|Death|0|||
130308637|NCT00264537|469092410|FG001|Overall Study|Death|3|||
130308638|NCT00264537|469092411|FG002|Overall Study|Death|3|||
130308639|NCT00264537|469092412|FG003|Overall Study|Death|2|||
130308640|NCT00264537|469092409|FG000|Overall Study|Lost to Follow-up|3|||
130308641|NCT00264537|469092410|FG001|Overall Study|Lost to Follow-up|4|||
130308642|NCT00264537|469092411|FG002|Overall Study|Lost to Follow-up|7|||
130308643|NCT00264537|469092412|FG003|Overall Study|Lost to Follow-up|6|||
130308644|NCT00264537|469092409|FG000|Overall Study|Adverse Event|21|||
130308645|NCT00264537|469092410|FG001|Overall Study|Adverse Event|32|||
130464826|NCT00736853|469667250|FG000|Double-Blind Period|Adverse Event|0|||
130464827|NCT00736853|469667251|FG001|Double-Blind Period|Adverse Event|3|||
130464828|NCT00736853|469667252|FG002|Double-Blind Period|Adverse Event|2|||
130464829|NCT00736853|469667250|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130717946|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
130308646|NCT00264537|469092411|FG002|Overall Study|Adverse Event|24|||
130464830|NCT00736853|469667251|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130464831|NCT00736853|469667252|FG002|Double-Blind Period|Withdrawal by Subject|4|||
130464832|NCT00736853|469667250|FG000|Double-Blind Period|Ineligible to participate the study|0|||
130308647|NCT00264537|469092412|FG003|Overall Study|Adverse Event|34|||
130308648|NCT00264537|469092409|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130308649|NCT00264537|469092410|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130308650|NCT00264537|469092411|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130308651|NCT00264537|469092412|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
130308652|NCT00264537|469092409|FG000|Overall Study|Other|21|||
130464833|NCT00736853|469667251|FG001|Double-Blind Period|Ineligible to participate the study|1|||
130308653|NCT00264537|469092410|FG001|Overall Study|Other|11|||
130308654|NCT00264537|469092411|FG002|Overall Study|Other|10|||
130308655|NCT00264537|469092412|FG003|Overall Study|Other|11|||
130308656|NCT00264537|469092409|FG000|Overall Study|Not treated|0|||
130308657|NCT00264537|469092410|FG001|Overall Study|Not treated|2|||
130308658|NCT00264537|469092411|FG002|Overall Study|Not treated|1|||
130308659|NCT00264537|469092412|FG003|Overall Study|Not treated|0|||
130374133|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130374134|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130374135|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130374136|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
130374137|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
130374138|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130374139|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130374140|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130374141|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130374142|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
130374143|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
130374144|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130374145|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130374146|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130374147|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130374148|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
130374149|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
130374150|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130374151|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130374152|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130374153|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130374154|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130374155|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
130374156|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130374157|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130374158|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130374159|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130308660|NCT00999544|469094172|FG000|Overall Study|Withdrawal by Subject|1|||
130308661|NCT02936635|469094177|FG000|Overall Study|Adverse Event|43|||
130308662|NCT02936635|469094178|FG001|Overall Study|Adverse Event|25|||
130557753|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130557754|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130557755|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
130557756|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
130557757|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
130557758|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130717947|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
130717948|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
130717949|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
130717950|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
130308663|NCT02936635|469094177|FG000|Overall Study|Progressive Disease|10|||
130308664|NCT02936635|469094178|FG001|Overall Study|Progressive Disease|18|||
130308665|NCT02936635|469094177|FG000|Overall Study|Sponsor Discretion|10|||
130308666|NCT02936635|469094178|FG001|Overall Study|Sponsor Discretion|16|||
130308667|NCT02936635|469094177|FG000|Overall Study|Death|9|||
130308668|NCT02936635|469094178|FG001|Overall Study|Death|15|||
130308669|NCT02936635|469094177|FG000|Overall Study|Withdrawal by Subject|8|||
130308670|NCT02936635|469094178|FG001|Overall Study|Withdrawal by Subject|15|||
130308671|NCT02936635|469094177|FG000|Overall Study|Physician Decision|2|||
130308672|NCT02936635|469094178|FG001|Overall Study|Physician Decision|9|||
130308673|NCT02936635|469094177|FG000|Overall Study|Lost to Follow-up|1|||
130308674|NCT02936635|469094178|FG001|Overall Study|Lost to Follow-up|2|||
130308675|NCT02936635|469094177|FG000|Overall Study|Protocol Violation|1|||
130308676|NCT02936635|469094178|FG001|Overall Study|Protocol Violation|0|||
130308677|NCT02936635|469094177|FG000|Overall Study|Lack of effect/Entry into other study|31|||
130308678|NCT02936635|469094178|FG001|Overall Study|Lack of effect/Entry into other study|65|||
130717951|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
130717952|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
130717953|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717954|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717955|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717956|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717957|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717958|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717959|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717960|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
130717961|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717962|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717963|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717964|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717965|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717966|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717967|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717968|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717969|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
130308679|NCT02407223|469094179|FG000|Overall Study|Adverse Event|1|||
130308680|NCT02407223|469094180|FG001|Overall Study|Adverse Event|0|||
130308681|NCT02407223|469094181|FG002|Overall Study|Adverse Event|1|||
130308682|NCT02407223|469094179|FG000|Overall Study|Lack of Efficacy|6|||
130308683|NCT02407223|469094180|FG001|Overall Study|Lack of Efficacy|6|||
130374160|NCT00843024|469336867|FG000|Single-blind Placebo Run-In Phase|Other|0|||
130374161|NCT00843024|469336868|FG001|Single-blind Placebo Run-In Phase|Other|1|||
130374162|NCT00843024|469336869|FG002|Single-blind Placebo Run-In Phase|Other|0|||
130374163|NCT00843024|469336870|FG003|Single-blind Placebo Run-In Phase|Other|0|||
130374164|NCT00843024|469336871|FG004|Single-blind Placebo Run-In Phase|Other|0|||
130374165|NCT00843024|469336872|FG005|Single-blind Placebo Run-In Phase|Other|0|||
130374166|NCT00843024|469336867|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
130374167|NCT00843024|469336868|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
130374168|NCT00843024|469336869|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
130374169|NCT00843024|469336870|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
130374170|NCT00843024|469336871|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
130374171|NCT00843024|469336872|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
130374172|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130374173|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130557759|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130557760|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130464834|NCT00736853|469667252|FG002|Double-Blind Period|Ineligible to participate the study|0|||
130464835|NCT00933400|469667253|FG000|Overall Study|Withdrawal by Subject|21|||
130464836|NCT00933400|469667254|FG001|Overall Study|Withdrawal by Subject|1|||
130464837|NCT01041417|469667257|FG000|Overall Study|Adverse Event|5|||
130464838|NCT01041417|469667258|FG001|Overall Study|Adverse Event|2|||
130374174|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
130374175|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
130374176|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
130374177|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
130374178|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130374179|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130374180|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130374181|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130374182|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130374183|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
130374184|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130374185|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
130374186|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
130374187|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
130374188|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
130374189|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
130374190|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Physician Decision|0|||
130374191|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Physician Decision|0|||
130374192|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Physician Decision|0|||
130374193|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Physician Decision|3|||
130374194|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Physician Decision|1|||
130374195|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Physician Decision|1|||
130374196|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130374197|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130374198|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130374199|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Adverse Event|0|||
130374200|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Adverse Event|1|||
130374201|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Adverse Event|1|||
130374202|NCT00843024|469336867|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130374203|NCT00843024|469336868|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
130464839|NCT01041417|469667257|FG000|Overall Study|Lost to Follow-up|1|||
130374204|NCT00843024|469336869|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
130374205|NCT00843024|469336870|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
130464840|NCT01041417|469667258|FG001|Overall Study|Lost to Follow-up|1|||
130464841|NCT01041417|469667257|FG000|Overall Study|Death|1|||
130464842|NCT01041417|469667258|FG001|Overall Study|Death|0|||
130464843|NCT02299375|469667261|FG000|Overall Study|Adverse Event, serious fatal|1|||
130464844|NCT02299375|469667262|FG001|Overall Study|Adverse Event, serious fatal|3|||
130464845|NCT02299375|469667261|FG000|Overall Study|Adverse Event, non-fatal|8|||
130464846|NCT02299375|469667262|FG001|Overall Study|Adverse Event, non-fatal|9|||
130464847|NCT02299375|469667261|FG000|Overall Study|Lack of Efficacy|1|||
130464848|NCT02299375|469667262|FG001|Overall Study|Lack of Efficacy|3|||
130464849|NCT02299375|469667261|FG000|Overall Study|Protocol Violation|1|||
130464850|NCT02299375|469667262|FG001|Overall Study|Protocol Violation|3|||
130464851|NCT02299375|469667261|FG000|Overall Study|Other: Met stopping criteria|1|||
130464852|NCT02299375|469667262|FG001|Overall Study|Other: Met stopping criteria|0|||
130464853|NCT02299375|469667261|FG000|Overall Study|Other: Study closed/terminated|66|||
130464854|NCT02299375|469667262|FG001|Overall Study|Other: Study closed/terminated|55|||
130464855|NCT02299375|469667261|FG000|Overall Study|Lost to Follow-up|0|||
130464856|NCT02299375|469667262|FG001|Overall Study|Lost to Follow-up|2|||
130464857|NCT02299375|469667261|FG000|Overall Study|Physician Decision|1|||
130464858|NCT02299375|469667262|FG001|Overall Study|Physician Decision|1|||
130464859|NCT02299375|469667261|FG000|Overall Study|Withdrawal by Subject|1|||
130464860|NCT02299375|469667262|FG001|Overall Study|Withdrawal by Subject|4|||
130464861|NCT00704184|469667265|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
130464862|NCT00704184|469667266|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
130464863|NCT00704184|469667267|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
130464864|NCT00704184|469667268|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
130464865|NCT00704184|469667269|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
130464866|NCT00704184|469667265|FG000|Open-Label Treatment|Adverse Event|0|||
130464867|NCT00704184|469667266|FG001|Open-Label Treatment|Adverse Event|0|||
130464868|NCT00704184|469667267|FG002|Open-Label Treatment|Adverse Event|2|||
130464869|NCT00704184|469667268|FG003|Open-Label Treatment|Adverse Event|0|||
130464870|NCT00704184|469667269|FG004|Open-Label Treatment|Adverse Event|1|||
130464871|NCT00704184|469667265|FG000|Open-Label Treatment|Lack of Efficacy|0|||
130464872|NCT00704184|469667266|FG001|Open-Label Treatment|Lack of Efficacy|2|||
130464873|NCT00704184|469667267|FG002|Open-Label Treatment|Lack of Efficacy|2|||
130464874|NCT00704184|469667268|FG003|Open-Label Treatment|Lack of Efficacy|2|||
130464875|NCT00704184|469667269|FG004|Open-Label Treatment|Lack of Efficacy|1|||
130464876|NCT00704184|469667265|FG000|Open-Label Treatment|Physician Decision|0|||
130464877|NCT00704184|469667266|FG001|Open-Label Treatment|Physician Decision|0|||
130464878|NCT00704184|469667267|FG002|Open-Label Treatment|Physician Decision|0|||
130464879|NCT00704184|469667268|FG003|Open-Label Treatment|Physician Decision|0|||
130464880|NCT00704184|469667269|FG004|Open-Label Treatment|Physician Decision|1|||
130717970|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717971|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717972|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717973|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130308684|NCT02407223|469094181|FG002|Overall Study|Lack of Efficacy|4|||
130308685|NCT02407223|469094179|FG000|Overall Study|Lost to Follow-up|1|||
130308686|NCT02407223|469094180|FG001|Overall Study|Lost to Follow-up|0|||
130308687|NCT02407223|469094181|FG002|Overall Study|Lost to Follow-up|2|||
130308688|NCT02407223|469094179|FG000|Overall Study|Withdrawal by Subject|2|||
130308689|NCT02407223|469094180|FG001|Overall Study|Withdrawal by Subject|4|||
130308690|NCT02407223|469094181|FG002|Overall Study|Withdrawal by Subject|4|||
130308691|NCT02407223|469094179|FG000|Overall Study|Study Terminated by Sponsor|77|||
130308692|NCT02407223|469094180|FG001|Overall Study|Study Terminated by Sponsor|80|||
130308693|NCT02407223|469094181|FG002|Overall Study|Study Terminated by Sponsor|86|||
130308694|NCT02407223|469094179|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
130308695|NCT02407223|469094180|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
130308696|NCT02407223|469094181|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
130308697|NCT02407223|469094179|FG000|Overall Study|Other|29|||
130308698|NCT02407223|469094180|FG001|Overall Study|Other|27|||
130308699|NCT02407223|469094181|FG002|Overall Study|Other|25|||
130308700|NCT04864639|469094182|FG000|Overall Study|Death|1|||
130308701|NCT04864639|469094182|FG000|Overall Study|Lost to Follow-up|1|||
130308702|NCT01478971|469094191|FG000|Standard of Care Period|Adverse Event|1|||
130308703|NCT01478971|469094191|FG000|Standard of Care Period|Withdrawal by Subject|3|||
130308704|NCT01478971|469094191|FG000|Standard of Care Period|Death|8|||
130464881|NCT00704184|469667265|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
130464882|NCT00704184|469667266|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130464883|NCT00704184|469667267|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
130464884|NCT00704184|469667268|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
130464885|NCT00704184|469667269|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
130464886|NCT00716859|469667270|FG000|Overall Study|Adverse Event|4|||
130464887|NCT00716859|469667271|FG001|Overall Study|Adverse Event|1|||
130464888|NCT00716859|469667270|FG000|Overall Study|Lack of Efficacy|3|||
130464889|NCT00716859|469667271|FG001|Overall Study|Lack of Efficacy|0|||
130464890|NCT00716859|469667270|FG000|Overall Study|Withdrawal by Subject|1|||
130308705|NCT01478971|469094191|FG000|Standard of Care Period|Lost to Follow-up|9|||
130308706|NCT01478971|469094191|FG000|Standard of Care Period|Other|4|||
130308707|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Adverse Event|1|||
130308708|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
130308709|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Death|4|||
130308710|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
130308711|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Other|4|||
130308712|NCT00584012|469094192|FG000|Overall Study|Withdrawal by Subject|1|||
130308713|NCT01525615|469094193|FG000|Overall Study|Adverse Event|11|||
130308714|NCT01525615|469094194|FG001|Overall Study|Adverse Event|7|||
130308715|NCT01525615|469094195|FG002|Overall Study|Adverse Event|5|||
130308716|NCT01525615|469094193|FG000|Overall Study|Lost to Follow-up|1|||
130308717|NCT01525615|469094194|FG001|Overall Study|Lost to Follow-up|0|||
130308718|NCT01525615|469094195|FG002|Overall Study|Lost to Follow-up|0|||
130308719|NCT01525615|469094193|FG000|Overall Study|Withdrawal by Subject|1|||
130308720|NCT01525615|469094194|FG001|Overall Study|Withdrawal by Subject|0|||
130308721|NCT01525615|469094195|FG002|Overall Study|Withdrawal by Subject|0|||
130308722|NCT01525615|469094193|FG000|Overall Study|Other reason not described above|1|||
130308723|NCT01525615|469094194|FG001|Overall Study|Other reason not described above|0|||
130308724|NCT01525615|469094195|FG002|Overall Study|Other reason not described above|1|||
130308725|NCT04050618|469094196|FG000|First Intervention|Withdrawal by Subject|2|||
130308726|NCT04050618|469094197|FG001|First Intervention|Withdrawal by Subject|0|||
130308727|NCT04050618|469094196|FG000|Second Intervention|Withdrawal by Subject|1|||
130308728|NCT04050618|469094197|FG001|Second Intervention|Withdrawal by Subject|0|||
130308729|NCT04404556|469094198|FG000|Intervention|Withdrawal by Subject|15|||
130308730|NCT04404556|469094199|FG001|Intervention|Withdrawal by Subject|3|||
130308731|NCT04404556|469094198|FG000|Intervention|Did not complete all intervention sessions|2|||
130308732|NCT04404556|469094199|FG001|Intervention|Did not complete all intervention sessions|1|||
130308733|NCT04404556|469094198|FG000|Post-Intervention|Missing Data|1|||
130308734|NCT04404556|469094199|FG001|Post-Intervention|Missing Data|2|||
130308735|NCT04404556|469094198|FG000|Follow-up 1|Withdrawal by Subject|5|||
130308736|NCT04404556|469094199|FG001|Follow-up 1|Withdrawal by Subject|1|||
130308737|NCT04404556|469094198|FG000|Follow-up 1|Missing Data|4|||
130308738|NCT04404556|469094199|FG001|Follow-up 1|Missing Data|7|||
130308739|NCT04404556|469094198|FG000|Follow-up 2|Withdrawal by Subject|1|||
130308740|NCT04404556|469094199|FG001|Follow-up 2|Withdrawal by Subject|1|||
130308741|NCT04404556|469094198|FG000|Follow-up 2|Missing Data|6|||
130308742|NCT04404556|469094199|FG001|Follow-up 2|Missing Data|5|||
130308743|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130308744|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
130308745|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
130308746|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130308747|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130308748|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130308749|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130308750|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130308751|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130308752|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
130308753|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130308754|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
130308755|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130308756|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130308757|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
130374206|NCT00843024|469336871|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
130308758|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
130308759|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130308760|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
130374207|NCT00843024|469336872|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
130374208|NCT02615145|469336874|FG000|Overall Study|Did Not Start Treatment|0|||
130374209|NCT02615145|469336875|FG001|Overall Study|Did Not Start Treatment|0|||
130374210|NCT02615145|469336876|FG002|Overall Study|Did Not Start Treatment|1|||
130374211|NCT02615145|469336877|FG003|Overall Study|Did Not Start Treatment|1|||
130374212|NCT02615145|469336874|FG000|Overall Study|Failure to Return|20|||
130374213|NCT02615145|469336875|FG001|Overall Study|Failure to Return|10|||
130374214|NCT02615145|469336876|FG002|Overall Study|Failure to Return|7|||
130374215|NCT02615145|469336877|FG003|Overall Study|Failure to Return|0|||
130374216|NCT02615145|469336874|FG000|Overall Study|Death|2|||
130374217|NCT02615145|469336875|FG001|Overall Study|Death|3|||
130374218|NCT02615145|469336876|FG002|Overall Study|Death|0|||
130308761|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130374219|NCT02615145|469336877|FG003|Overall Study|Death|0|||
130374220|NCT02615145|469336874|FG000|Overall Study|Other, Not Specified|5|||
130557761|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130374221|NCT02615145|469336875|FG001|Overall Study|Other, Not Specified|2|||
130717974|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130308762|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130308763|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
130308764|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
130308765|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
130308766|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
130308767|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130308768|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
130308769|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130308770|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
130308771|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130308772|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
130308773|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
130308774|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130308775|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130308776|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
130308777|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130308778|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
130308779|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130308780|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130308781|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130308782|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130308783|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130308784|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130308785|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130308786|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130308787|NCT00763386|469094205|FG000|Overall Study|Adverse Event|43|||
130308788|NCT00763386|469094206|FG001|Overall Study|Adverse Event|33|||
130308789|NCT00763386|469094205|FG000|Overall Study|Death|1|||
130308790|NCT00763386|469094206|FG001|Overall Study|Death|2|||
130308791|NCT00763386|469094205|FG000|Overall Study|Lost to Follow-up|3|||
130308792|NCT00763386|469094206|FG001|Overall Study|Lost to Follow-up|3|||
130308793|NCT00763386|469094205|FG000|Overall Study|Withdrawal by Subject|0|||
130308794|NCT00763386|469094206|FG001|Overall Study|Withdrawal by Subject|1|||
130308795|NCT00763386|469094205|FG000|Overall Study|CRF missing|0|||
130308796|NCT00763386|469094206|FG001|Overall Study|CRF missing|1|||
130308797|NCT00763386|469094205|FG000|Overall Study|Study Prosthesis Removed|1|||
130308798|NCT00763386|469094206|FG001|Overall Study|Study Prosthesis Removed|0|||
130308799|NCT00411671|469094207|FG000|Overall Study|Adverse Event|15|||
130308800|NCT00411671|469094207|FG000|Overall Study|Death|2|||
130308801|NCT00411671|469094207|FG000|Overall Study|Lost to Follow-up|3|||
130308802|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
130308803|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308804|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308805|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308806|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308807|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
130308808|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308809|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308810|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308811|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308812|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
130308813|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308814|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308815|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308816|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308817|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
130308818|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308819|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308820|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308821|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308822|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
130308823|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308824|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308825|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308826|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130374222|NCT02615145|469336876|FG002|Overall Study|Other, Not Specified|0|||
130374223|NCT02615145|469336877|FG003|Overall Study|Other, Not Specified|0|||
130374224|NCT03727347|469336878|FG000|Overall Study|Withdrawal by Subject|2|||
130464891|NCT00716859|469667271|FG001|Overall Study|Withdrawal by Subject|3|||
130464892|NCT00716859|469667270|FG000|Overall Study|Not treated|1|||
130464893|NCT00716859|469667271|FG001|Overall Study|Not treated|1|||
130308827|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
130308828|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130464894|NCT01764464|469667272|FG000|First Intervention|Withdrawal by Subject|1|||
130464895|NCT01764464|469667273|FG001|First Intervention|Withdrawal by Subject|0|||
130308829|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308830|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308831|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308832|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
130308833|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308834|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308835|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308836|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308837|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130308838|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
130308839|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
130308840|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
130308841|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
130308842|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130308843|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
130308844|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
130308845|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
130308846|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
130308847|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130464896|NCT01764464|469667272|FG000|First Intervention|Lost to Follow-up|1|||
130464897|NCT01764464|469667273|FG001|First Intervention|Lost to Follow-up|0|||
130308848|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
130464898|NCT01764464|469667272|FG000|First Intervention|Adverse Event|0|||
130464899|NCT01764464|469667273|FG001|First Intervention|Adverse Event|2|||
130464900|NCT01764464|469667272|FG000|First Intervention|did not receive study drug|0|||
130464901|NCT01764464|469667273|FG001|First Intervention|did not receive study drug|1|||
130464902|NCT01764464|469667272|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
130464903|NCT01764464|469667273|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
130464904|NCT01170026|469668743|FG000|Overall Study|Lost to Follow-up|4|||
130308849|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130308850|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
130308851|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
130308852|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130308853|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130464905|NCT01170026|469668744|FG001|Overall Study|Lost to Follow-up|2|||
130464906|NCT04623008|469668745|FG000|Baseline to T2|Withdrawal by Subject|4|||
130464907|NCT04623008|469668746|FG001|Baseline to T2|Withdrawal by Subject|2|||
130464908|NCT04623008|469668745|FG000|Baseline to T3|Withdrawal by Subject|4|||
130464909|NCT04623008|469668746|FG001|Baseline to T3|Withdrawal by Subject|2|||
130464910|NCT03785782|469668755|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
130717975|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717976|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717977|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717978|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
130717979|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717980|NCT03893565|470593192|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717981|NCT03893565|470593193|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717982|NCT03893565|470593194|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717983|NCT03893565|470593195|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717984|NCT03893565|470593196|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717985|NCT03893565|470593197|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717986|NCT03893565|470593198|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717987|NCT03893565|470593199|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717988|NCT03893565|470593200|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
130717989|NCT02387983|470593204|FG000|Overall Study|Adverse Event|4|||
130717990|NCT02387983|470593204|FG000|Overall Study|Protocol Violation|1|||
130717991|NCT02387983|470593204|FG000|Overall Study|Withdrawal by Subject|2|||
130717992|NCT02440568|470593205|FG000|Overall Study|Death|1|||
130717993|NCT02440568|470593206|FG001|Overall Study|Death|3|||
130717994|NCT02440568|470593207|FG002|Overall Study|Death|4|||
130717995|NCT02440568|470593208|FG003|Overall Study|Death|2|||
130717996|NCT02440568|470593205|FG000|Overall Study|Lack of Efficacy|2|||
130717997|NCT02440568|470593206|FG001|Overall Study|Lack of Efficacy|0|||
130717998|NCT02440568|470593207|FG002|Overall Study|Lack of Efficacy|1|||
130717999|NCT02440568|470593208|FG003|Overall Study|Lack of Efficacy|0|||
130718000|NCT02440568|470593205|FG000|Overall Study|Lost to Follow-up|1|||
130718001|NCT02440568|470593206|FG001|Overall Study|Lost to Follow-up|0|||
130718002|NCT02440568|470593207|FG002|Overall Study|Lost to Follow-up|0|||
130718003|NCT02440568|470593208|FG003|Overall Study|Lost to Follow-up|0|||
130718004|NCT02302859|470593211|FG000|Overall Study|Lost Phone|1|||
130718005|NCT02302859|470593212|FG001|Overall Study|Lost Phone|1|||
130718006|NCT02302859|470593211|FG000|Overall Study|Withdrawal by Subject|0|||
130718007|NCT02302859|470593212|FG001|Overall Study|Withdrawal by Subject|1|||
130718008|NCT01157897|470593222|FG000|Overall Study|Lost to Follow-up|2|||
130718009|NCT01157897|470593223|FG001|Overall Study|Lost to Follow-up|0|||
130718010|NCT01157897|470593224|FG002|Overall Study|Lost to Follow-up|0|||
130718011|NCT01157897|470593225|FG003|Overall Study|Lost to Follow-up|1|||
130718012|NCT01157897|470593222|FG000|Overall Study|Relocated|0|||
130718013|NCT01157897|470593223|FG001|Overall Study|Relocated|2|||
130718014|NCT01157897|470593224|FG002|Overall Study|Relocated|0|||
130308854|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130308855|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130308856|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
130464911|NCT03785782|469668756|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
130464912|NCT03785782|469668755|FG000|Overall Study|Withdrawal by Subject|1|||
130464913|NCT03785782|469668756|FG001|Overall Study|Withdrawal by Subject|1|||
130464914|NCT03785782|469668755|FG000|Overall Study|insufficient image quality.|3|||
130718015|NCT01157897|470593225|FG003|Overall Study|Relocated|0|||
130718016|NCT03734666|470593226|FG000|Overall Study|Other|7|||
130718017|NCT03734666|470593227|FG001|Overall Study|Other|4|||
130718018|NCT03734666|470593226|FG000|Overall Study|Lost to Follow-up|12|||
130718019|NCT03734666|470593227|FG001|Overall Study|Lost to Follow-up|12|||
130718020|NCT03276221|470593228|FG000|Overall Study|Lost to Follow-up|6|||
130718021|NCT03276221|470593229|FG001|Overall Study|Lost to Follow-up|2|||
130308857|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
130308858|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
130308859|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130308860|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
130308861|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130308862|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
130308863|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130308864|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
130308865|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
130308866|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
130308867|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308868|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308869|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308870|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130308871|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
130308872|NCT03951077|469094214|FG000|Overall Study|Adverse Event|1|||
130308873|NCT03951077|469094215|FG001|Overall Study|Adverse Event|0|||
130308874|NCT03951077|469094216|FG002|Overall Study|Adverse Event|0|||
130308875|NCT03951077|469094217|FG003|Overall Study|Adverse Event|0|||
130308876|NCT03951077|469094218|FG004|Overall Study|Adverse Event|0|||
130308877|NCT03951077|469094219|FG005|Overall Study|Adverse Event|0|||
130308878|NCT03951077|469094214|FG000|Overall Study|Withdrawal by Subject|3|||
130308879|NCT03951077|469094215|FG001|Overall Study|Withdrawal by Subject|3|||
130308880|NCT03951077|469094216|FG002|Overall Study|Withdrawal by Subject|0|||
130308881|NCT03951077|469094217|FG003|Overall Study|Withdrawal by Subject|3|||
130308882|NCT03951077|469094218|FG004|Overall Study|Withdrawal by Subject|3|||
130308883|NCT03951077|469094219|FG005|Overall Study|Withdrawal by Subject|2|||
130308884|NCT03951077|469094214|FG000|Overall Study|Lost to Follow-up|1|||
130308885|NCT03951077|469094215|FG001|Overall Study|Lost to Follow-up|1|||
130308886|NCT03951077|469094216|FG002|Overall Study|Lost to Follow-up|2|||
130308887|NCT03951077|469094217|FG003|Overall Study|Lost to Follow-up|3|||
130308888|NCT03951077|469094218|FG004|Overall Study|Lost to Follow-up|2|||
130308889|NCT03951077|469094219|FG005|Overall Study|Lost to Follow-up|3|||
130308890|NCT03951077|469094214|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
130308891|NCT03951077|469094215|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
130308892|NCT03951077|469094216|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
130308893|NCT03951077|469094217|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
130308894|NCT03951077|469094218|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
130308895|NCT03951077|469094219|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
130308896|NCT03951077|469094214|FG000|Overall Study|Other, Not Specified|12|||
130308897|NCT03951077|469094215|FG001|Overall Study|Other, Not Specified|10|||
130308898|NCT03951077|469094216|FG002|Overall Study|Other, Not Specified|10|||
130308899|NCT03951077|469094217|FG003|Overall Study|Other, Not Specified|5|||
130308900|NCT03951077|469094218|FG004|Overall Study|Other, Not Specified|9|||
130308901|NCT03951077|469094219|FG005|Overall Study|Other, Not Specified|6|||
130308902|NCT03951077|469094214|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
130308903|NCT03951077|469094215|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
130308904|NCT03951077|469094216|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
130308905|NCT03951077|469094217|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
130308906|NCT03951077|469094218|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
130308907|NCT03951077|469094219|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
130308908|NCT01395901|469094222|FG000|Overall Study|Lost to Follow-up|4|||
130308909|NCT01395901|469094223|FG001|Overall Study|Lost to Follow-up|0|||
130308910|NCT01395901|469094222|FG000|Overall Study|Randomized but not received study drug|5|||
130308911|NCT01395901|469094223|FG001|Overall Study|Randomized but not received study drug|4|||
130308912|NCT01395901|469094222|FG000|Overall Study|Adverse Event|0|||
130308913|NCT01395901|469094223|FG001|Overall Study|Adverse Event|1|||
130308914|NCT01395901|469094222|FG000|Overall Study|Withdrawal of consent|1|||
130308915|NCT01395901|469094223|FG001|Overall Study|Withdrawal of consent|0|||
130308916|NCT00713544|469094229|FG000|Overall Study|Adverse Event|5|||
130308917|NCT00713544|469094230|FG001|Overall Study|Adverse Event|3|||
130308918|NCT00713544|469094231|FG002|Overall Study|Adverse Event|7|||
130308919|NCT00713544|469094232|FG003|Overall Study|Adverse Event|7|||
130464915|NCT03785782|469668756|FG001|Overall Study|insufficient image quality.|0|||
130464916|NCT03779048|469668757|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
130464917|NCT03779048|469668758|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
130308920|NCT00713544|469094233|FG004|Overall Study|Adverse Event|3|||
130308921|NCT00713544|469094234|FG005|Overall Study|Adverse Event|5|||
130308922|NCT00713544|469094229|FG000|Overall Study|Withdrawal by Subject|2|||
130464918|NCT03779048|469668759|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
130464919|NCT03779048|469668757|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
130308923|NCT00713544|469094230|FG001|Overall Study|Withdrawal by Subject|0|||
130308924|NCT00713544|469094231|FG002|Overall Study|Withdrawal by Subject|3|||
130308925|NCT00713544|469094232|FG003|Overall Study|Withdrawal by Subject|2|||
130308926|NCT00713544|469094233|FG004|Overall Study|Withdrawal by Subject|3|||
130308927|NCT00713544|469094234|FG005|Overall Study|Withdrawal by Subject|1|||
130308928|NCT00713544|469094229|FG000|Overall Study|Protocol Violation|0|||
130308929|NCT00713544|469094230|FG001|Overall Study|Protocol Violation|0|||
130308930|NCT00713544|469094231|FG002|Overall Study|Protocol Violation|0|||
130308931|NCT00713544|469094232|FG003|Overall Study|Protocol Violation|0|||
130308932|NCT00713544|469094233|FG004|Overall Study|Protocol Violation|0|||
130308933|NCT00713544|469094234|FG005|Overall Study|Protocol Violation|1|||
130308934|NCT00713544|469094229|FG000|Overall Study|Physician Decision|0|||
130308935|NCT00713544|469094230|FG001|Overall Study|Physician Decision|0|||
130308936|NCT00713544|469094231|FG002|Overall Study|Physician Decision|0|||
130308937|NCT00713544|469094232|FG003|Overall Study|Physician Decision|0|||
130308938|NCT00713544|469094233|FG004|Overall Study|Physician Decision|0|||
130308939|NCT00713544|469094234|FG005|Overall Study|Physician Decision|2|||
130308940|NCT00713544|469094229|FG000|Overall Study|Lack of Efficacy|0|||
130308941|NCT00713544|469094230|FG001|Overall Study|Lack of Efficacy|1|||
130308942|NCT00713544|469094231|FG002|Overall Study|Lack of Efficacy|0|||
130308943|NCT00713544|469094232|FG003|Overall Study|Lack of Efficacy|1|||
130308944|NCT00713544|469094233|FG004|Overall Study|Lack of Efficacy|1|||
130308945|NCT00713544|469094234|FG005|Overall Study|Lack of Efficacy|0|||
130308946|NCT00713544|469094229|FG000|Overall Study|Lost to Follow-up|0|||
130308947|NCT00713544|469094230|FG001|Overall Study|Lost to Follow-up|0|||
130308948|NCT00713544|469094231|FG002|Overall Study|Lost to Follow-up|1|||
130308949|NCT00713544|469094232|FG003|Overall Study|Lost to Follow-up|0|||
130308950|NCT00713544|469094233|FG004|Overall Study|Lost to Follow-up|0|||
130308951|NCT00713544|469094234|FG005|Overall Study|Lost to Follow-up|0|||
130308952|NCT00713544|469094229|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308953|NCT00713544|469094230|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
130308954|NCT00713544|469094231|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308955|NCT00713544|469094232|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308956|NCT00713544|469094233|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308957|NCT00713544|469094234|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308958|NCT00713544|469094229|FG000|Overall Study|Incorrect enrollment|0|||
130308959|NCT00713544|469094230|FG001|Overall Study|Incorrect enrollment|1|||
130308960|NCT00713544|469094231|FG002|Overall Study|Incorrect enrollment|0|||
130308961|NCT00713544|469094232|FG003|Overall Study|Incorrect enrollment|0|||
130308962|NCT00713544|469094233|FG004|Overall Study|Incorrect enrollment|0|||
130308963|NCT00713544|469094234|FG005|Overall Study|Incorrect enrollment|0|||
130308964|NCT00713544|469094229|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
130308965|NCT00713544|469094230|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
130308966|NCT00713544|469094231|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
130308967|NCT00713544|469094232|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
130308968|NCT00713544|469094233|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
130308969|NCT00713544|469094234|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
130308970|NCT02380287|469094235|FG000|Overall Study|Adverse Event|0|||
130308971|NCT02380287|469094236|FG001|Overall Study|Adverse Event|0|||
130308972|NCT02380287|469094237|FG002|Overall Study|Adverse Event|1|||
130308973|NCT02380287|469094238|FG003|Overall Study|Adverse Event|0|||
130308974|NCT02380287|469094239|FG004|Overall Study|Adverse Event|0|||
130308975|NCT02380287|469094240|FG005|Overall Study|Adverse Event|0|||
130308976|NCT02380287|469094241|FG006|Overall Study|Adverse Event|0|||
130308977|NCT02380287|469094242|FG007|Overall Study|Adverse Event|0|||
130308978|NCT01641601|469094243|FG000|Overall Study|Study discontinued.|3|||
130308979|NCT01641601|469094244|FG001|Overall Study|Study discontinued.|5|||
130308980|NCT00950846|469094247|FG000|Overall Study|Death|6|||
130308981|NCT00950846|469094247|FG000|Overall Study|Lost to Follow-up|3|||
130308982|NCT00950846|469094247|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
130308983|NCT01799226|469094248|FG000|Overall Study|Withdrawal by Subject|1|||
130308984|NCT01799226|469094249|FG001|Overall Study|Withdrawal by Subject|0|||
130308985|NCT01799226|469094248|FG000|Overall Study|Disqualified at Day 14|1|||
130308986|NCT01799226|469094249|FG001|Overall Study|Disqualified at Day 14|0|||
130308987|NCT02178995|469094250|FG000|Double Blind|Adverse Event|0|||
130308988|NCT02178995|469094251|FG001|Double Blind|Adverse Event|0|||
130308989|NCT02178995|469094252|FG002|Double Blind|Adverse Event|0|||
130308990|NCT02178995|469094253|FG003|Double Blind|Adverse Event|0|||
130308991|NCT02178995|469094254|FG004|Double Blind|Adverse Event|0|||
130308992|NCT02178995|469094255|FG005|Double Blind|Adverse Event|1|||
130308993|NCT02178995|469094256|FG006|Double Blind|Adverse Event|0|||
130308994|NCT02178995|469094257|FG007|Double Blind|Adverse Event|1|||
130308995|NCT02178995|469094258|FG008|Double Blind|Adverse Event|1|||
130308996|NCT02178995|469094250|FG000|Double Blind|Lost to Follow-up|0|||
130308997|NCT02178995|469094251|FG001|Double Blind|Lost to Follow-up|1|||
130308998|NCT02178995|469094252|FG002|Double Blind|Lost to Follow-up|0|||
130308999|NCT02178995|469094253|FG003|Double Blind|Lost to Follow-up|0|||
130309000|NCT02178995|469094254|FG004|Double Blind|Lost to Follow-up|0|||
130464920|NCT03779048|469668758|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
130464921|NCT03779048|469668759|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
130464922|NCT03779048|469668757|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
130309001|NCT02178995|469094255|FG005|Double Blind|Lost to Follow-up|0|||
130309002|NCT02178995|469094256|FG006|Double Blind|Lost to Follow-up|0|||
130309003|NCT02178995|469094257|FG007|Double Blind|Lost to Follow-up|1|||
130309004|NCT02178995|469094258|FG008|Double Blind|Lost to Follow-up|0|||
130309005|NCT02178995|469094250|FG000|Open Label|Adverse Event|2|||
130309006|NCT02178995|469094251|FG001|Open Label|Adverse Event|0|||
130309007|NCT02178995|469094252|FG002|Open Label|Adverse Event|0|||
130309008|NCT02178995|469094253|FG003|Open Label|Adverse Event|0|||
130309009|NCT02178995|469094254|FG004|Open Label|Adverse Event|0|||
130309010|NCT02178995|469094255|FG005|Open Label|Adverse Event|0|||
130309011|NCT02178995|469094256|FG006|Open Label|Adverse Event|0|||
130309012|NCT02178995|469094257|FG007|Open Label|Adverse Event|0|||
130309013|NCT02178995|469094258|FG008|Open Label|Adverse Event|0|||
130309014|NCT02274792|469094259|FG000|Overall Study|Withdrawal by Subject|13|||
130309015|NCT02274792|469094259|FG000|Overall Study|Lost to Follow-up|8|||
130309016|NCT02274792|469094259|FG000|Overall Study|Protocol Specified Criteria|2|||
130309017|NCT02274792|469094259|FG000|Overall Study|Sponsor Decision|2|||
130309018|NCT05258149|469094266|FG000|Period 1|Protocol Deviation|1|||
130309019|NCT05258149|469094267|FG001|Period 1|Protocol Deviation|0|||
130309020|NCT05258149|469094266|FG000|Period 1|Adverse Event|0|||
130309021|NCT05258149|469094267|FG001|Period 1|Adverse Event|1|||
130309022|NCT05258149|469094266|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130309023|NCT05258149|469094267|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130309024|NCT05258149|469094266|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130309025|NCT05258149|469094267|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130309026|NCT05258149|469094266|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
130309027|NCT05258149|469094267|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
130309028|NCT00832416|469094270|FG000|Overall Study|Lack of Efficacy|17|||
130309029|NCT00832416|469094271|FG001|Overall Study|Lack of Efficacy|15|||
130309030|NCT00832416|469094272|FG002|Overall Study|Lack of Efficacy|13|||
130309031|NCT00832416|469094273|FG003|Overall Study|Lack of Efficacy|52|||
130309032|NCT00832416|469094270|FG000|Overall Study|Withdrawal by Subject|5|||
130309033|NCT00832416|469094271|FG001|Overall Study|Withdrawal by Subject|7|||
130309034|NCT00832416|469094272|FG002|Overall Study|Withdrawal by Subject|2|||
130309035|NCT00832416|469094273|FG003|Overall Study|Withdrawal by Subject|10|||
130374225|NCT03727347|469336878|FG000|Overall Study|Lost to Follow-up|1|||
130374226|NCT02837783|469336881|FG000|Overall Study|Adverse Event|1|||
130374227|NCT02837783|469336882|FG001|Overall Study|Adverse Event|0|||
130374228|NCT02837783|469336881|FG000|Overall Study|Other, Not Specified|1|||
130374229|NCT02837783|469336882|FG001|Overall Study|Other, Not Specified|2|||
130374230|NCT01487200|469336883|FG000|Overall Study|Withdrawal by Subject|0|||
130374231|NCT01487200|469336884|FG001|Overall Study|Withdrawal by Subject|1|||
130374232|NCT01487200|469336885|FG002|Overall Study|Withdrawal by Subject|0|||
130374233|NCT01487200|469336886|FG003|Overall Study|Withdrawal by Subject|0|||
130374234|NCT02216591|469336887|FG000|Overall Study|Lost to Follow-up|0|||
130374235|NCT02216591|469336888|FG001|Overall Study|Lost to Follow-up|1|||
130374236|NCT01866930|469336889|FG000|Treatment Period|Other|1|||
130374237|NCT01866930|469336890|FG001|Treatment Period|Other|0|||
130374238|NCT01866930|469336889|FG000|Treatment Period|Death|0|||
130374239|NCT01866930|469336890|FG001|Treatment Period|Death|2|||
130374240|NCT01866930|469336889|FG000|Treatment Period|Poor/non compliance|0|||
130374241|NCT01866930|469336890|FG001|Treatment Period|Poor/non compliance|2|||
130374242|NCT01866930|469336889|FG000|Treatment Period|No longer meets study criteria|0|||
130374243|NCT01866930|469336890|FG001|Treatment Period|No longer meets study criteria|1|||
130374244|NCT01866930|469336889|FG000|Treatment Period|Withdrawal by Subject|2|||
130374245|NCT01866930|469336890|FG001|Treatment Period|Withdrawal by Subject|8|||
130374246|NCT01866930|469336889|FG000|Treatment Period|Lack of Efficacy|1|||
130374247|NCT01866930|469336890|FG001|Treatment Period|Lack of Efficacy|9|||
130374248|NCT01866930|469336889|FG000|Treatment Period|Adverse Event|4|||
130374249|NCT01866930|469336890|FG001|Treatment Period|Adverse Event|12|||
130309036|NCT00832416|469094270|FG000|Overall Study|Physician Decision|2|||
130309037|NCT00832416|469094271|FG001|Overall Study|Physician Decision|12|||
130309038|NCT00832416|469094272|FG002|Overall Study|Physician Decision|5|||
130309039|NCT00832416|469094273|FG003|Overall Study|Physician Decision|10|||
130374250|NCT01866930|469336889|FG000|Treatment Period|Lost to Follow-up|1|||
130374251|NCT01866930|469336890|FG001|Treatment Period|Lost to Follow-up|1|||
130374252|NCT01866930|469336889|FG000|Follow-up Period|Lost to Follow-up|1|||
130374253|NCT01866930|469336890|FG001|Follow-up Period|Lost to Follow-up|1|||
130374254|NCT01866930|469336889|FG000|Follow-up Period|Other|1|||
130464923|NCT03779048|469668758|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
130464924|NCT03779048|469668759|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
130309040|NCT00832416|469094270|FG000|Overall Study|Administrative|0|||
130309041|NCT00832416|469094271|FG001|Overall Study|Administrative|0|||
130309042|NCT00832416|469094272|FG002|Overall Study|Administrative|0|||
130309043|NCT00832416|469094273|FG003|Overall Study|Administrative|1|||
130309044|NCT00832416|469094270|FG000|Overall Study|Adverse Event|21|||
130309045|NCT00832416|469094271|FG001|Overall Study|Adverse Event|19|||
130309046|NCT00832416|469094272|FG002|Overall Study|Adverse Event|41|||
130309047|NCT00832416|469094273|FG003|Overall Study|Adverse Event|10|||
130309048|NCT00832416|469094270|FG000|Overall Study|Death|1|||
130309049|NCT00832416|469094271|FG001|Overall Study|Death|0|||
130309050|NCT00832416|469094272|FG002|Overall Study|Death|0|||
130309051|NCT00832416|469094273|FG003|Overall Study|Death|0|||
130309052|NCT02741596|469094280|FG000|Overall Study|Adverse Event|1|||
130309053|NCT02741596|469094281|FG001|Overall Study|Adverse Event|5|||
130309054|NCT02741596|469094280|FG000|Overall Study|Lost to Follow-up|1|||
130309055|NCT02741596|469094281|FG001|Overall Study|Lost to Follow-up|1|||
130309056|NCT02741596|469094280|FG000|Overall Study|Physician Decision|2|||
130309057|NCT02741596|469094281|FG001|Overall Study|Physician Decision|1|||
130309058|NCT02741596|469094280|FG000|Overall Study|Pregnancy|3|||
130309059|NCT02741596|469094281|FG001|Overall Study|Pregnancy|1|||
130309060|NCT02741596|469094280|FG000|Overall Study|Other (Unspecified)|0|||
130309061|NCT02741596|469094281|FG001|Overall Study|Other (Unspecified)|3|||
130309062|NCT02741596|469094280|FG000|Overall Study|Subject withdrawn-Other|17|||
130309063|NCT02741596|469094281|FG001|Overall Study|Subject withdrawn-Other|4|||
130309064|NCT02741596|469094280|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
130309065|NCT02741596|469094281|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
130309066|NCT02859246|469094284|FG000|Overall Study|Screen fails|3|||
130309067|NCT02859246|469094284|FG000|Overall Study|Adverse Event|1|||
130309068|NCT02859246|469094284|FG000|Overall Study|Withdrawal by Subject|1|||
130309069|NCT00100789|469094285|FG000|Overall Study|Adverse Event|10|||
130309070|NCT00100789|469094285|FG000|Overall Study|Withdrawal by Subject|1|||
130309071|NCT00100789|469094285|FG000|Overall Study|Progression/relapse|42|||
130309072|NCT00100789|469094285|FG000|Overall Study|Death|2|||
130309073|NCT00100789|469094285|FG000|Overall Study|Not protocol specified|5|||
130309074|NCT00100789|469094285|FG000|Overall Study|Ineligible|3|||
130309075|NCT00100789|469094285|FG000|Overall Study|Never received treatment|1|||
130309076|NCT01746368|469094286|FG000|Overall Study|Lost to Follow-up|2|||
130309077|NCT01746368|469094287|FG001|Overall Study|Lost to Follow-up|0|||
130309078|NCT01746368|469094286|FG000|Overall Study|Withdrawal by Subject|0|||
130309079|NCT01746368|469094287|FG001|Overall Study|Withdrawal by Subject|1|||
130309080|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
130309081|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
130309082|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
130309083|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309084|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309085|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309086|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309087|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
130309088|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309089|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130464925|NCT03889925|469668760|FG000|Overall Study|Lost to Follow-up|11|||
130464926|NCT03889925|469668761|FG001|Overall Study|Lost to Follow-up|10|||
130464927|NCT05777785|469668762|FG000|Overall Study|Withdrawal by Subject|5|||
130464928|NCT05777785|469668762|FG000|Overall Study|Lost to Follow-up|1|||
130464929|NCT04588259|469668764|FG000|Run-in Period|Run-in failure|0|||
130464930|NCT04588259|469668765|FG001|Run-in Period|Run-in failure|23|||
130464931|NCT04588259|469668764|FG000|Run-in Period|Withdrawn before randomisation|0|||
130464932|NCT04588259|469668765|FG001|Run-in Period|Withdrawn before randomisation|8|||
130718022|NCT03276221|470593230|FG002|Overall Study|Lost to Follow-up|0|||
130718023|NCT03276221|470593228|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
130718024|NCT03276221|470593229|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
130718025|NCT03276221|470593230|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
130718026|NCT00681590|470593231|FG000|Overall Study|Withdrawal by Subject|2|||
130718027|NCT00681590|470593232|FG001|Overall Study|Withdrawal by Subject|12|||
130464933|NCT04588259|469668764|FG000|Treatment Period|Withdrawal by Subject|6|||
130718028|NCT00424775|470593233|FG000|Overall Study|Adverse Event|2|||
130309090|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309091|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130464934|NCT04588259|469668765|FG001|Treatment Period|Withdrawal by Subject|6|||
130464935|NCT02763319|469668769|FG000|Overall Study|Adverse Event|12|||
130309092|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309093|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309094|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130374255|NCT01866930|469336890|FG001|Follow-up Period|Other|5|||
130374256|NCT01866930|469336889|FG000|Follow-up Period|No longer required per protocol|1|||
130374257|NCT01866930|469336890|FG001|Follow-up Period|No longer required per protocol|0|||
130374258|NCT01866930|469336889|FG000|Follow-up Period|Withdrawal by Subject|3|||
130374259|NCT01866930|469336890|FG001|Follow-up Period|Withdrawal by Subject|3|||
130374260|NCT00279305|469336893|FG000|Overall Study|Pregnancy|1|||
130374261|NCT00279305|469336894|FG001|Overall Study|Pregnancy|0|||
130374262|NCT00279305|469336893|FG000|Overall Study|Withdrawal by Subject|2|||
130374263|NCT00279305|469336894|FG001|Overall Study|Withdrawal by Subject|0|||
130374264|NCT00279305|469336893|FG000|Overall Study|Dificulting establishing IV|1|||
130374265|NCT00279305|469336894|FG001|Overall Study|Dificulting establishing IV|0|||
130374266|NCT00279305|469336893|FG000|Overall Study|FDA Safety Alert|4|||
130374267|NCT00279305|469336894|FG001|Overall Study|FDA Safety Alert|1|||
130374268|NCT00317356|469336898|FG000|Overall Study|Adverse Event|0|||
130374269|NCT00317356|469336899|FG001|Overall Study|Adverse Event|0|||
130374270|NCT00317356|469336900|FG002|Overall Study|Adverse Event|1|||
130374271|NCT00317356|469336901|FG003|Overall Study|Adverse Event|0|||
130374272|NCT00317356|469336898|FG000|Overall Study|Lack of Efficacy|1|||
130374273|NCT00317356|469336899|FG001|Overall Study|Lack of Efficacy|1|||
130374274|NCT00317356|469336900|FG002|Overall Study|Lack of Efficacy|0|||
130374275|NCT00317356|469336901|FG003|Overall Study|Lack of Efficacy|3|||
130374276|NCT00317356|469336898|FG000|Overall Study|Physician Decision|0|||
130374277|NCT00317356|469336899|FG001|Overall Study|Physician Decision|1|||
130374278|NCT00317356|469336900|FG002|Overall Study|Physician Decision|0|||
130374279|NCT00317356|469336901|FG003|Overall Study|Physician Decision|0|||
130374280|NCT00621153|469336908|FG000|Overall Study|Safety Reason|8|||
130374281|NCT00621153|469336909|FG001|Overall Study|Safety Reason|7|||
130374282|NCT00621153|469336908|FG000|Overall Study|Adverse Event|3|||
130374283|NCT00621153|469336909|FG001|Overall Study|Adverse Event|2|||
130374284|NCT00621153|469336908|FG000|Overall Study|Lost to Follow-up|5|||
130374285|NCT00621153|469336909|FG001|Overall Study|Lost to Follow-up|1|||
130374286|NCT00621153|469336908|FG000|Overall Study|Withdrawal by Subject|4|||
130374287|NCT00621153|469336909|FG001|Overall Study|Withdrawal by Subject|5|||
130374288|NCT00753415|469336910|FG000|Part A|Disease progression|1|||
130374289|NCT00753415|469336911|FG001|Part A|Disease progression|0|||
130374290|NCT00753415|469336912|FG002|Part A|Disease progression|1|||
130374291|NCT00753415|469336913|FG003|Part A|Disease progression|2|||
130374292|NCT00753415|469336914|FG004|Part A|Disease progression|0|||
130374293|NCT00753415|469336915|FG005|Part A|Disease progression|0|||
130374294|NCT00753415|469336916|FG006|Part A|Disease progression|0|||
130374295|NCT00753415|469336917|FG007|Part A|Disease progression|0|||
130374296|NCT00753415|469336918|FG008|Part A|Disease progression|0|||
130374297|NCT00753415|469336919|FG009|Part A|Disease progression|0|||
130374298|NCT00753415|469336910|FG000|Part A|Withdrawal by Subject|0|||
130374299|NCT00753415|469336911|FG001|Part A|Withdrawal by Subject|0|||
130374300|NCT00753415|469336912|FG002|Part A|Withdrawal by Subject|1|||
130374301|NCT00753415|469336913|FG003|Part A|Withdrawal by Subject|0|||
130374302|NCT00753415|469336914|FG004|Part A|Withdrawal by Subject|0|||
130374303|NCT00753415|469336915|FG005|Part A|Withdrawal by Subject|0|||
130374304|NCT00753415|469336916|FG006|Part A|Withdrawal by Subject|0|||
130374305|NCT00753415|469336917|FG007|Part A|Withdrawal by Subject|0|||
130374306|NCT00753415|469336918|FG008|Part A|Withdrawal by Subject|0|||
130374307|NCT00753415|469336919|FG009|Part A|Withdrawal by Subject|0|||
130374308|NCT00753415|469336910|FG000|Part B|Lost to Follow-up|0|||
130374309|NCT00753415|469336911|FG001|Part B|Lost to Follow-up|0|||
130374310|NCT00753415|469336912|FG002|Part B|Lost to Follow-up|0|||
130374311|NCT00753415|469336913|FG003|Part B|Lost to Follow-up|0|||
130374312|NCT00753415|469336914|FG004|Part B|Lost to Follow-up|0|||
130374313|NCT00753415|469336915|FG005|Part B|Lost to Follow-up|0|||
130374314|NCT00753415|469336916|FG006|Part B|Lost to Follow-up|0|||
130374315|NCT00753415|469336917|FG007|Part B|Lost to Follow-up|1|||
130374316|NCT00753415|469336918|FG008|Part B|Lost to Follow-up|1|||
130374317|NCT00753415|469336919|FG009|Part B|Lost to Follow-up|0|||
130374318|NCT00753415|469336910|FG000|Part B|Disease progression|0|||
130374319|NCT00753415|469336911|FG001|Part B|Disease progression|0|||
130374320|NCT00753415|469336912|FG002|Part B|Disease progression|0|||
130374321|NCT00753415|469336913|FG003|Part B|Disease progression|0|||
130374322|NCT00753415|469336914|FG004|Part B|Disease progression|0|||
130374323|NCT00753415|469336915|FG005|Part B|Disease progression|0|||
130374324|NCT00753415|469336916|FG006|Part B|Disease progression|0|||
130374325|NCT00753415|469336917|FG007|Part B|Disease progression|0|||
130374326|NCT00753415|469336918|FG008|Part B|Disease progression|2|||
130374327|NCT00753415|469336919|FG009|Part B|Disease progression|1|||
130374328|NCT04212650|469336920|FG000|Overall Study|Withdrawal by Subject|1|||
130374329|NCT04212650|469336921|FG001|Overall Study|Withdrawal by Subject|0|||
130374330|NCT04419714|469336922|FG000|Overall Study|Technical Fault|5|||
130374331|NCT04419714|469336922|FG000|Overall Study|Protocol Deviation|2|||
130374332|NCT04419714|469336922|FG000|Overall Study|Withdrawal by Subject|1|||
130376691|NCT03824912|469345901|FG002|Overall Study|Withdrawal by Subject|1|||
130376692|NCT03824912|469345899|FG000|Overall Study|Participation in another study|0|||
130376693|NCT03824912|469345900|FG001|Overall Study|Participation in another study|1|||
130557762|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130718029|NCT00424775|470593234|FG001|Overall Study|Adverse Event|0|||
130718030|NCT00424775|470593233|FG000|Overall Study|Lack of Efficacy|1|||
130718031|NCT00424775|470593234|FG001|Overall Study|Lack of Efficacy|0|||
130718032|NCT01791153|470593235|FG000|Part 1: Blinded Period|Adverse Event|7|||
130718033|NCT01791153|470593236|FG001|Part 1: Blinded Period|Adverse Event|3|||
130718034|NCT01791153|470593237|FG002|Part 1: Blinded Period|Adverse Event|2|||
130718035|NCT01791153|470593238|FG003|Part 1: Blinded Period|Adverse Event|0|||
130718036|NCT01791153|470593239|FG004|Part 1: Blinded Period|Adverse Event|0|||
130718037|NCT01791153|470593240|FG005|Part 1: Blinded Period|Adverse Event|0|||
130718038|NCT01791153|470593241|FG006|Part 1: Blinded Period|Adverse Event|0|||
130718039|NCT01791153|470593242|FG007|Part 1: Blinded Period|Adverse Event|0|||
130718040|NCT01791153|470593235|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
130718041|NCT01791153|470593236|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
130718042|NCT01791153|470593237|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
130718043|NCT01791153|470593238|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
130718044|NCT01791153|470593239|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
130718045|NCT01791153|470593240|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
130718046|NCT01791153|470593241|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
130718047|NCT01791153|470593242|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
130718048|NCT01791153|470593235|FG000|Part 1: Blinded Period|Non-Compliance|1|||
130718049|NCT01791153|470593236|FG001|Part 1: Blinded Period|Non-Compliance|0|||
130718050|NCT01791153|470593237|FG002|Part 1: Blinded Period|Non-Compliance|0|||
130718051|NCT01791153|470593238|FG003|Part 1: Blinded Period|Non-Compliance|0|||
130718052|NCT01791153|470593239|FG004|Part 1: Blinded Period|Non-Compliance|0|||
130718053|NCT01791153|470593240|FG005|Part 1: Blinded Period|Non-Compliance|0|||
130718054|NCT01791153|470593241|FG006|Part 1: Blinded Period|Non-Compliance|0|||
130718055|NCT01791153|470593242|FG007|Part 1: Blinded Period|Non-Compliance|0|||
130718056|NCT01791153|470593235|FG000|Part 1: Blinded Period|Physician Decision|0|||
130718057|NCT01791153|470593236|FG001|Part 1: Blinded Period|Physician Decision|0|||
130718058|NCT01791153|470593237|FG002|Part 1: Blinded Period|Physician Decision|0|||
130718059|NCT01791153|470593238|FG003|Part 1: Blinded Period|Physician Decision|1|||
130718060|NCT01791153|470593239|FG004|Part 1: Blinded Period|Physician Decision|0|||
130718061|NCT01791153|470593240|FG005|Part 1: Blinded Period|Physician Decision|0|||
130718062|NCT01791153|470593241|FG006|Part 1: Blinded Period|Physician Decision|0|||
130718063|NCT01791153|470593242|FG007|Part 1: Blinded Period|Physician Decision|0|||
130718064|NCT01791153|470593235|FG000|Part 1: Blinded Period|Protocol Violation|0|||
130718065|NCT01791153|470593236|FG001|Part 1: Blinded Period|Protocol Violation|0|||
130718066|NCT01791153|470593237|FG002|Part 1: Blinded Period|Protocol Violation|0|||
130718067|NCT01791153|470593238|FG003|Part 1: Blinded Period|Protocol Violation|1|||
130718068|NCT01791153|470593239|FG004|Part 1: Blinded Period|Protocol Violation|0|||
130718069|NCT01791153|470593240|FG005|Part 1: Blinded Period|Protocol Violation|0|||
130718070|NCT01791153|470593241|FG006|Part 1: Blinded Period|Protocol Violation|0|||
130718071|NCT01791153|470593242|FG007|Part 1: Blinded Period|Protocol Violation|0|||
130718072|NCT01791153|470593235|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
130718073|NCT01791153|470593236|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
130718074|NCT01791153|470593237|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
130718075|NCT01791153|470593238|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
130718076|NCT01791153|470593239|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718077|NCT01791153|470593240|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718078|NCT01791153|470593241|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718079|NCT01791153|470593242|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718080|NCT01791153|470593235|FG000|Part 2: Open-label Period|Adverse Event|0|||
130718081|NCT01791153|470593236|FG001|Part 2: Open-label Period|Adverse Event|0|||
130309095|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
130309096|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309097|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309098|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309099|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309100|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309101|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309102|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309103|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
130309104|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130316270|NCT05767021|469124351|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130316271|NCT04154943|469124355|FG000|Overall Study|Study Ongoing|68|||
130316272|NCT04154943|469124355|FG000|Overall Study|Lost to Follow-up|1|||
130316273|NCT04154943|469124355|FG000|Overall Study|Decision by the Investigator|1|||
130316274|NCT04154943|469124355|FG000|Overall Study|Death|5|||
130464936|NCT02763319|469668770|FG001|Overall Study|Adverse Event|3|||
130309105|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309106|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309107|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309108|NCT05280717|469094288|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309109|NCT05280717|469094289|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309110|NCT05280717|469094290|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309111|NCT05280717|469094291|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309112|NCT05280717|469094292|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309113|NCT05280717|469094293|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
130309114|NCT05280717|469094294|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309115|NCT05280717|469094288|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309116|NCT05280717|469094289|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309117|NCT05280717|469094290|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309118|NCT05280717|469094291|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309119|NCT05280717|469094292|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309120|NCT05280717|469094293|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
130309121|NCT05280717|469094294|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309122|NCT00080301|469094295|FG000|Overall Study|Randomized but Never Treated|5|||
130309123|NCT00080301|469094296|FG001|Overall Study|Randomized but Never Treated|10|||
130309124|NCT00080301|469094295|FG000|Overall Study|Still on Treatment as of CSR date|0|||
130309125|NCT00080301|469094296|FG001|Overall Study|Still on Treatment as of CSR date|1|||
130309126|NCT02518971|469094297|FG000|Overall Study|Lost to Follow-up|0|||
130309127|NCT02518971|469094298|FG001|Overall Study|Lost to Follow-up|1|||
130309128|NCT02518971|469094297|FG000|Overall Study|Physician Decision|6|||
130309129|NCT02518971|469094298|FG001|Overall Study|Physician Decision|6|||
130309130|NCT02518971|469094297|FG000|Overall Study|Protocol Violation|6|||
130309131|NCT02518971|469094298|FG001|Overall Study|Protocol Violation|4|||
130309132|NCT02518971|469094297|FG000|Overall Study|Withdrawal by Subject|4|||
130309133|NCT02518971|469094298|FG001|Overall Study|Withdrawal by Subject|5|||
130309134|NCT02518971|469094297|FG000|Overall Study|Side effects|1|||
130309135|NCT02518971|469094298|FG001|Overall Study|Side effects|0|||
130309136|NCT02518971|469094297|FG000|Overall Study|medication lost in mail|0|||
130309137|NCT02518971|469094298|FG001|Overall Study|medication lost in mail|1|||
130309138|NCT02518971|469094297|FG000|Overall Study|eligibility criteria no longer met|6|||
130309139|NCT02518971|469094298|FG001|Overall Study|eligibility criteria no longer met|3|||
130309140|NCT02336230|469094299|FG000|Overall Study|Adverse Event|1|||
130309141|NCT02336230|469094299|FG000|Overall Study|Withdrawal of consent|1|||
130309142|NCT02336230|469094299|FG000|Overall Study|Death|9|||
130309143|NCT02336230|469094299|FG000|Overall Study|Dose not received due to shipping delay|1|||
130309144|NCT02336230|469094299|FG000|Overall Study|Discontinuation of MSC infusion|1|||
130309145|NCT02524171|469094300|FG000|6-month Follow-up|Lost to Follow-up|53|||
130309146|NCT02524171|469094301|FG001|6-month Follow-up|Lost to Follow-up|45|||
130309147|NCT02524171|469094300|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
130309148|NCT02524171|469094301|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
130309149|NCT00757237|469094304|FG000|Overall Study|Lost to Follow-up|0|||
130309150|NCT00757237|469094305|FG001|Overall Study|Lost to Follow-up|1|||
130309151|NCT00757237|469094304|FG000|Overall Study|Protocol Violation|0|||
130309152|NCT00757237|469094305|FG001|Overall Study|Protocol Violation|2|||
130374333|NCT04023526|469338349|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
130374334|NCT04023526|469338350|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
130557763|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130309153|NCT00757237|469094304|FG000|Overall Study|Physician Decision|2|||
130309154|NCT00757237|469094305|FG001|Overall Study|Physician Decision|3|||
130309155|NCT00757237|469094304|FG000|Overall Study|Withdrawal by Subject|8|||
130309156|NCT00757237|469094305|FG001|Overall Study|Withdrawal by Subject|12|||
130309157|NCT00757237|469094304|FG000|Overall Study|Safety or Tolerability|3|||
130557764|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130718082|NCT01791153|470593237|FG002|Part 2: Open-label Period|Adverse Event|0|||
130718083|NCT01791153|470593238|FG003|Part 2: Open-label Period|Adverse Event|0|||
130718084|NCT01791153|470593239|FG004|Part 2: Open-label Period|Adverse Event|0|||
130718085|NCT01791153|470593240|FG005|Part 2: Open-label Period|Adverse Event|1|||
130718086|NCT01791153|470593241|FG006|Part 2: Open-label Period|Adverse Event|1|||
130718087|NCT01791153|470593242|FG007|Part 2: Open-label Period|Adverse Event|2|||
130718088|NCT01791153|470593235|FG000|Part 2: Open-label Period|Death|0|||
130718089|NCT01791153|470593236|FG001|Part 2: Open-label Period|Death|0|||
130718090|NCT01791153|470593237|FG002|Part 2: Open-label Period|Death|0|||
130718091|NCT01791153|470593238|FG003|Part 2: Open-label Period|Death|0|||
130718092|NCT01791153|470593239|FG004|Part 2: Open-label Period|Death|0|||
130718093|NCT01791153|470593240|FG005|Part 2: Open-label Period|Death|1|||
130718094|NCT01791153|470593241|FG006|Part 2: Open-label Period|Death|1|||
130718095|NCT01791153|470593242|FG007|Part 2: Open-label Period|Death|1|||
130718096|NCT01791153|470593235|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
130718097|NCT01791153|470593236|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
130718098|NCT01791153|470593237|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
130718099|NCT01791153|470593238|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
130718100|NCT01791153|470593239|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
130718101|NCT01791153|470593240|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
130718102|NCT01791153|470593241|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
130718103|NCT01791153|470593242|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
130718104|NCT01791153|470593235|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
130718105|NCT01791153|470593236|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
130718106|NCT01791153|470593237|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
130718107|NCT01791153|470593238|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
130718108|NCT01791153|470593239|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
130718109|NCT01791153|470593240|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
130718110|NCT01791153|470593241|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
130718111|NCT01791153|470593242|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
130718112|NCT01791153|470593235|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718113|NCT01791153|470593236|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718114|NCT01791153|470593237|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718115|NCT01791153|470593238|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718116|NCT01791153|470593239|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
130718117|NCT01791153|470593240|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
130718118|NCT01791153|470593241|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
130718119|NCT01791153|470593242|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
130718120|NCT01791153|470593235|FG000|Part 2: Open-label Period|Physician Decision|0|||
130718121|NCT01791153|470593236|FG001|Part 2: Open-label Period|Physician Decision|0|||
130718122|NCT01791153|470593237|FG002|Part 2: Open-label Period|Physician Decision|0|||
130718123|NCT01791153|470593238|FG003|Part 2: Open-label Period|Physician Decision|0|||
130718124|NCT01791153|470593239|FG004|Part 2: Open-label Period|Physician Decision|1|||
130718125|NCT01791153|470593240|FG005|Part 2: Open-label Period|Physician Decision|1|||
130718126|NCT01791153|470593241|FG006|Part 2: Open-label Period|Physician Decision|0|||
130718127|NCT01791153|470593242|FG007|Part 2: Open-label Period|Physician Decision|0|||
130718128|NCT00975286|470593243|FG000|Overall Study|Adverse Event|9|||
130718129|NCT00975286|470593244|FG001|Overall Study|Adverse Event|19|||
130718130|NCT00975286|470593243|FG000|Overall Study|Protocol Violation|1|||
130718131|NCT00975286|470593244|FG001|Overall Study|Protocol Violation|2|||
130718132|NCT00975286|470593243|FG000|Overall Study|Withdrawal by Subject|0|||
130718133|NCT00975286|470593244|FG001|Overall Study|Withdrawal by Subject|2|||
130718134|NCT00975286|470593243|FG000|Overall Study|Familial and Personal Reasons|2|||
130718135|NCT00975286|470593244|FG001|Overall Study|Familial and Personal Reasons|2|||
130718136|NCT00975286|470593243|FG000|Overall Study|Poor Compliance to Protocol|0|||
130718137|NCT00975286|470593244|FG001|Overall Study|Poor Compliance to Protocol|2|||
130718138|NCT00975286|470593243|FG000|Overall Study|Sponsor Decision|0|||
130718139|NCT00975286|470593244|FG001|Overall Study|Sponsor Decision|2|||
130718140|NCT02357342|470593245|FG000|First 6 Months|Death|2|||
130718141|NCT02357342|470593246|FG001|First 6 Months|Death|0|||
130718142|NCT04156620|470593248|FG000|Overall Study|Adverse event - TP 1|5|||
130718143|NCT04156620|470593249|FG001|Overall Study|Adverse event - TP 1|2|||
130718144|NCT04156620|470593248|FG000|Overall Study|Lost to follow-up TP 1|1|||
130718145|NCT04156620|470593249|FG001|Overall Study|Lost to follow-up TP 1|1|||
130718146|NCT04156620|470593248|FG000|Overall Study|Progressive disease - TP 1|0|||
130718147|NCT04156620|470593249|FG001|Overall Study|Progressive disease - TP 1|1|||
130718148|NCT04156620|470593248|FG000|Overall Study|Subject decision - TP 1|3|||
130718149|NCT04156620|470593249|FG001|Overall Study|Subject decision - TP 1|5|||
130718150|NCT04156620|470593248|FG000|Overall Study|Adverse event - TP 2|5|||
130718151|NCT04156620|470593249|FG001|Overall Study|Adverse event - TP 2|6|||
130718152|NCT04156620|470593248|FG000|Overall Study|Death - TP 2|1|||
130718153|NCT04156620|470593249|FG001|Overall Study|Death - TP 2|0|||
130718154|NCT04156620|470593248|FG000|Overall Study|Lost to follow-up - TP 2|5|||
130464937|NCT02763319|469668769|FG000|Overall Study|Death|123|||
130464938|NCT02763319|469668770|FG001|Overall Study|Death|123|||
130464939|NCT02763319|469668769|FG000|Overall Study|Lost to Follow-up|6|||
130464940|NCT02763319|469668770|FG001|Overall Study|Lost to Follow-up|7|||
130464941|NCT02763319|469668769|FG000|Overall Study|Noncompliance with Study Drug|2|||
130464942|NCT02763319|469668770|FG001|Overall Study|Noncompliance with Study Drug|0|||
130464943|NCT02763319|469668769|FG000|Overall Study|"Captured as Other in Database"|29|||
130464944|NCT02763319|469668770|FG001|Overall Study|"Captured as Other in Database"|34|||
130464945|NCT02763319|469668769|FG000|Overall Study|Physician Decision|1|||
130464946|NCT02763319|469668770|FG001|Overall Study|Physician Decision|7|||
130464947|NCT02763319|469668769|FG000|Overall Study|Progressive Disease|24|||
130464948|NCT02763319|469668770|FG001|Overall Study|Progressive Disease|27|||
130464949|NCT02763319|469668769|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
130464950|NCT02763319|469668770|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
130464951|NCT02763319|469668769|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
130464952|NCT02763319|469668770|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
130464953|NCT02763319|469668769|FG000|Overall Study|Withdrawal by Subject|26|||
130464954|NCT02763319|469668770|FG001|Overall Study|Withdrawal by Subject|25|||
130464955|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Death|186|||
130464956|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Death|222|||
130464957|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Death|0|||
130464958|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
130464959|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
130464960|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
130464961|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
130464962|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
130464963|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
130464964|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
130464965|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
130464966|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
130464967|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Adverse Event|83|||
130464968|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Adverse Event|100|||
130464969|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Adverse Event|0|||
130464970|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Other|70|||
130464971|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Other|75|||
130464972|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Other|0|||
130464973|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
130309158|NCT00757237|469094305|FG001|Overall Study|Safety or Tolerability|5|||
130464974|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
130464975|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
130464976|NCT00232180|469668774|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
130464977|NCT00232180|469668775|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
130464978|NCT00232180|469668776|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
130464979|NCT00232180|469668774|FG000|Open Label Phase|Death|0|||
130464980|NCT00232180|469668775|FG001|Open Label Phase|Death|0|||
130464981|NCT00232180|469668776|FG002|Open Label Phase|Death|48|||
130464982|NCT00232180|469668774|FG000|Open Label Phase|Lost to Follow-up|0|||
130464983|NCT00232180|469668775|FG001|Open Label Phase|Lost to Follow-up|0|||
130464984|NCT00232180|469668776|FG002|Open Label Phase|Lost to Follow-up|5|||
130309159|NCT00757237|469094304|FG000|Overall Study|Other|0|||
130309160|NCT00757237|469094305|FG001|Overall Study|Other|2|||
130309161|NCT01345188|469094306|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
130309162|NCT01345188|469094306|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
130309163|NCT05150990|469094307|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
130309164|NCT05150990|469094308|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
130309165|NCT05150990|469094307|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
130309166|NCT05150990|469094308|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
130309167|NCT05150990|469094307|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
130309168|NCT05150990|469094308|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
130464985|NCT00232180|469668774|FG000|Open Label Phase|Protocol Violation|0|||
130464986|NCT00232180|469668775|FG001|Open Label Phase|Protocol Violation|0|||
130464987|NCT00232180|469668776|FG002|Open Label Phase|Protocol Violation|3|||
130309169|NCT05150990|469094307|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
130309170|NCT05150990|469094308|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
130309171|NCT05150990|469094307|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
130309172|NCT05150990|469094308|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
130309173|NCT05150990|469094307|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
130309174|NCT05150990|469094308|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
130309175|NCT05150990|469094307|FG000|Overall Study|Death (unrelated to the intervention)|1|||
130309176|NCT05150990|469094308|FG001|Overall Study|Death (unrelated to the intervention)|2|||
130309177|NCT00466921|469094309|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
130309178|NCT00466921|469094309|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
130309179|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
130309180|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
130309181|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
130309182|NCT00466921|469094309|FG000|Follow up for a Minimum of 1 Year|Death|6|||
130309183|NCT05447663|469094311|FG000|Overall Study|Study terminated by Sponsor|5|||
130309184|NCT05447663|469094311|FG000|Overall Study|Death|2|||
130309185|NCT05447663|469094311|FG000|Overall Study|Withdrawal by Subject|1|||
130309186|NCT01397461|469094312|FG000|Overall Study|Withdrawal by Subject|2|||
130309187|NCT01397461|469094313|FG001|Overall Study|Withdrawal by Subject|1|||
130309188|NCT01397461|469094314|FG002|Overall Study|Withdrawal by Subject|0|||
130309189|NCT01397461|469094312|FG000|Overall Study|Lost to Follow-up|0|||
130309190|NCT01397461|469094313|FG001|Overall Study|Lost to Follow-up|2|||
130309191|NCT01397461|469094314|FG002|Overall Study|Lost to Follow-up|1|||
130309192|NCT01397461|469094312|FG000|Overall Study|Lack of Efficacy|0|||
130309193|NCT01397461|469094313|FG001|Overall Study|Lack of Efficacy|3|||
130309194|NCT01397461|469094314|FG002|Overall Study|Lack of Efficacy|0|||
130309195|NCT01397461|469094312|FG000|Overall Study|Not treated|0|||
130309196|NCT01397461|469094313|FG001|Overall Study|Not treated|0|||
130309197|NCT01397461|469094314|FG002|Overall Study|Not treated|1|||
130309198|NCT05729568|469094331|FG000|Overall Study|Still on Study|52|||
130309199|NCT05729568|469094332|FG001|Overall Study|Still on Study|26|||
130309200|NCT05729568|469094331|FG000|Overall Study|Randomized but Never Treated|3|||
130309201|NCT05729568|469094332|FG001|Overall Study|Randomized but Never Treated|0|||
130309202|NCT05729568|469094331|FG000|Overall Study|Adverse Event|0|||
130309203|NCT05729568|469094332|FG001|Overall Study|Adverse Event|1|||
130309204|NCT05729568|469094331|FG000|Overall Study|Investigator's Discretion|1|||
130309205|NCT05729568|469094332|FG001|Overall Study|Investigator's Discretion|0|||
130309206|NCT04181762|469094333|FG000|Overall Study|Adverse Event|1|||
130309207|NCT04181762|469094334|FG001|Overall Study|Adverse Event|3|||
130309208|NCT04181762|469094333|FG000|Overall Study|Lost to Follow-up|1|||
130309209|NCT04181762|469094334|FG001|Overall Study|Lost to Follow-up|1|||
130309210|NCT04181762|469094333|FG000|Overall Study|Physician Decision|1|||
130309211|NCT04181762|469094334|FG001|Overall Study|Physician Decision|3|||
130309212|NCT04181762|469094333|FG000|Overall Study|Pregnancy|0|||
130309213|NCT04181762|469094334|FG001|Overall Study|Pregnancy|1|||
130309214|NCT04181762|469094333|FG000|Overall Study|Lack of Efficacy|2|||
130309215|NCT04181762|469094334|FG001|Overall Study|Lack of Efficacy|2|||
130309216|NCT04181762|469094333|FG000|Overall Study|Study terminated by sponsor|95|||
130309217|NCT04181762|469094334|FG001|Overall Study|Study terminated by sponsor|97|||
130309218|NCT04181762|469094333|FG000|Overall Study|Subject decision|11|||
130309219|NCT04181762|469094334|FG001|Overall Study|Subject decision|4|||
130309220|NCT04181762|469094333|FG000|Overall Study|Death|1|||
130309221|NCT04181762|469094334|FG001|Overall Study|Death|1|||
130309222|NCT04181762|469094333|FG000|Overall Study|Protocol deviation|1|||
130309223|NCT04181762|469094334|FG001|Overall Study|Protocol deviation|0|||
130309224|NCT04181762|469094333|FG000|Overall Study|Withdrawal of informed consent|1|||
130309225|NCT04181762|469094334|FG001|Overall Study|Withdrawal of informed consent|3|||
130309226|NCT06041919|469094335|FG000|Overall Study|Lost to Follow-up|1|||
130309227|NCT06041919|469094336|FG001|Overall Study|Lost to Follow-up|0|||
130309228|NCT06041919|469094337|FG002|Overall Study|Lost to Follow-up|0|||
130309229|NCT06041919|469094338|FG003|Overall Study|Lost to Follow-up|0|||
130309230|NCT06041919|469094339|FG004|Overall Study|Lost to Follow-up|0|||
130309231|NCT06041919|469094335|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
130309232|NCT06041919|469094336|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
130309233|NCT06041919|469094337|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
130309234|NCT06041919|469094338|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
130309235|NCT06041919|469094339|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
130309236|NCT00637416|469094342|FG000|Overall Study|Lost to Follow-up|1|||
130309237|NCT00637416|469094343|FG001|Overall Study|Lost to Follow-up|1|||
130309238|NCT00637416|469094342|FG000|Overall Study|Unable to take study drug|0|||
130309239|NCT00637416|469094343|FG001|Overall Study|Unable to take study drug|1|||
130309240|NCT01147055|469094344|FG000|First Intervention Period|Lost to Follow-up|1|||
130309241|NCT01147055|469094345|FG001|First Intervention Period|Lost to Follow-up|0|||
130309242|NCT05236257|469094378|FG000|Overall Study|Ongoing with study treatment|29|||
130309243|NCT05236257|469094379|FG001|Overall Study|Ongoing with study treatment|1|||
130309244|NCT05236257|469094378|FG000|Overall Study|Discontinued study treatment|22|||
130309245|NCT05236257|469094379|FG001|Overall Study|Discontinued study treatment|41|||
130309246|NCT00874848|469094382|FG000|Overall Study|Adverse Event|13|||
130309247|NCT00874848|469094383|FG001|Overall Study|Adverse Event|2|||
130309248|NCT00874848|469094382|FG000|Overall Study|Progressive neoplastic disease|38|||
130309249|NCT00874848|469094383|FG001|Overall Study|Progressive neoplastic disease|18|||
130309250|NCT00874848|469094382|FG000|Overall Study|Withdrawal by Subject|7|||
130309251|NCT00874848|469094383|FG001|Overall Study|Withdrawal by Subject|4|||
130309252|NCT00874848|469094382|FG000|Overall Study|Noncompliance|1|||
130309253|NCT00874848|469094383|FG001|Overall Study|Noncompliance|1|||
130309254|NCT00874848|469094382|FG000|Overall Study|Failure to comply with protocol|0|||
130309255|NCT00874848|469094383|FG001|Overall Study|Failure to comply with protocol|1|||
130309256|NCT00874848|469094382|FG000|Overall Study|Physician Decision|0|||
130309257|NCT00874848|469094383|FG001|Overall Study|Physician Decision|2|||
130309258|NCT02713828|469094385|FG000|Overall Study|Death|2|||
130309259|NCT02713828|469094386|FG001|Overall Study|Death|0|||
130309260|NCT02713828|469094385|FG000|Overall Study|Withdrawal by Subject|1|||
130309261|NCT02713828|469094386|FG001|Overall Study|Withdrawal by Subject|0|||
130309262|NCT02713828|469094385|FG000|Overall Study|study terminated but patient allowed to|2|||
130309263|NCT02713828|469094386|FG001|Overall Study|study terminated but patient allowed to|0|||
130309264|NCT00003199|469094387|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
130309265|NCT00003199|469094387|FG000|Overall Study|Lack of insurance clearance|2|||
130309266|NCT00003199|469094387|FG000|Overall Study|Screen fail|15|||
130309267|NCT03553758|469095888|FG000|Overall Study|Lost to Follow-up|1|||
130309268|NCT00447226|469095889|FG000|12-Week Open-label Phase|Adverse Event|0|||
130309269|NCT00447226|469095890|FG001|12-Week Open-label Phase|Adverse Event|3|||
130309270|NCT00447226|469095889|FG000|12-Week Open-label Phase|Protocol Violation|0|||
130309271|NCT00447226|469095890|FG001|12-Week Open-label Phase|Protocol Violation|1|||
130309272|NCT00447226|469095889|FG000|12-Week Open-label Phase|Disease Progression|0|||
130309273|NCT00447226|469095890|FG001|12-Week Open-label Phase|Disease Progression|20|||
130309274|NCT00447226|469095889|FG000|12-Week Open-label Phase|Physician Decision|0|||
130309275|NCT00447226|469095890|FG001|12-Week Open-label Phase|Physician Decision|1|||
130309276|NCT00447226|469095889|FG000|Double-blind Phase|Disease Progression|4|||
130309277|NCT00447226|469095890|FG001|Double-blind Phase|Disease Progression|3|||
130309278|NCT00502671|469095894|FG000|Overall Study|Disease Progression|13|||
130309279|NCT00502671|469095894|FG000|Overall Study|Personal Reasons|22|||
130309280|NCT00502671|469095894|FG000|Overall Study|Lost to Follow-up|7|||
130309281|NCT00502671|469095894|FG000|Overall Study|Protocol Violation|16|||
130309282|NCT00502671|469095894|FG000|Overall Study|Adverse Event|19|||
130309283|NCT00412893|469095897|FG000|Overall Study|Adverse Event|31|||
130309284|NCT00412893|469095898|FG001|Overall Study|Adverse Event|53|||
130309285|NCT00412893|469095897|FG000|Overall Study|Death|17|||
130309286|NCT00412893|469095898|FG001|Overall Study|Death|21|||
130309287|NCT00412893|469095897|FG000|Overall Study|Insufficient Therapeutic Response|39|||
130309288|NCT00412893|469095898|FG001|Overall Study|Insufficient Therapeutic Response|23|||
130309289|NCT00412893|469095897|FG000|Overall Study|Lost to Follow-up|2|||
130309290|NCT00412893|469095898|FG001|Overall Study|Lost to Follow-up|1|||
130309291|NCT00412893|469095897|FG000|Overall Study|Violation of Selection at Entry|17|||
130309292|NCT00412893|469095898|FG001|Overall Study|Violation of Selection at Entry|10|||
130309293|NCT00412893|469095897|FG000|Overall Study|Other Protocol Violation|10|||
130309294|NCT00412893|469095898|FG001|Overall Study|Other Protocol Violation|6|||
130309295|NCT00412893|469095897|FG000|Overall Study|Did Not Cooperate|12|||
130309296|NCT00412893|469095898|FG001|Overall Study|Did Not Cooperate|9|||
130374335|NCT04023526|469338349|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
130374336|NCT04023526|469338350|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
130374337|NCT00056316|469338352|FG000|Overall Study|Withdrawal by Subject|2|||
130374338|NCT00056316|469338353|FG001|Overall Study|Withdrawal by Subject|2|||
130374339|NCT00056316|469338352|FG000|Overall Study|Death/NH placement of pt|1|||
130374340|NCT00056316|469338353|FG001|Overall Study|Death/NH placement of pt|1|||
130374341|NCT02599129|469338355|FG000|Overall Study|Lack of Efficacy|2|||
130374342|NCT02599129|469338356|FG001|Overall Study|Lack of Efficacy|2|||
130374343|NCT02599129|469338355|FG000|Overall Study|Lost to Follow-up|1|||
130374344|NCT02599129|469338356|FG001|Overall Study|Lost to Follow-up|0|||
130374345|NCT02599129|469338355|FG000|Overall Study|Withdrawal by Subject|2|||
130374346|NCT02599129|469338356|FG001|Overall Study|Withdrawal by Subject|1|||
130374347|NCT03489720|469338357|FG000|Overall Study|Withdrawal by Subject|2|||
130374348|NCT03489720|469338358|FG001|Overall Study|Withdrawal by Subject|0|||
130309297|NCT00412893|469095897|FG000|Overall Study|Administrative Reason|12|||
130309298|NCT00412893|469095898|FG001|Overall Study|Administrative Reason|15|||
130374349|NCT00166114|469338362|FG000|Overall Study|Protocol Violation|2|||
130309299|NCT00412893|469095897|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
130309300|NCT00412893|469095898|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
130309301|NCT04473963|469095900|FG000|Overall Study|Withdrawal by Subject|1|||
130309302|NCT04473963|469095901|FG001|Overall Study|Withdrawal by Subject|1|||
130309303|NCT04473963|469095902|FG002|Overall Study|Withdrawal by Subject|0|||
130309304|NCT04473963|469095900|FG000|Overall Study|Not inducible in AF|0|||
130309305|NCT04473963|469095901|FG001|Overall Study|Not inducible in AF|0|||
130309306|NCT04473963|469095902|FG002|Overall Study|Not inducible in AF|2|||
130309307|NCT00587158|469095906|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
130309308|NCT00587158|469095907|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
130309309|NCT00587158|469095906|FG000|Overall Study|Physician Decision|0|||
130309310|NCT00587158|469095907|FG001|Overall Study|Physician Decision|1|||
130309311|NCT00587158|469095906|FG000|Overall Study|Lost to Follow-up|1|||
130309312|NCT00587158|469095907|FG001|Overall Study|Lost to Follow-up|2|||
130309313|NCT00587158|469095906|FG000|Overall Study|Death|0|||
130309314|NCT00587158|469095907|FG001|Overall Study|Death|1|||
130309315|NCT00587158|469095906|FG000|Overall Study|Subject did not want to take study med|0|||
130309316|NCT00587158|469095907|FG001|Overall Study|Subject did not want to take study med|1|||
130309317|NCT02114606|469095908|FG000|Overall Study|Unable to swallow Cytosponge|6|||
130309318|NCT00981461|469095909|FG000|Overall Study|Lost to Follow-up|5|||
130718155|NCT04156620|470593249|FG001|Overall Study|Lost to follow-up - TP 2|2|||
130718156|NCT04156620|470593248|FG000|Overall Study|Physician decision - TP 2|4|||
130718157|NCT04156620|470593249|FG001|Overall Study|Physician decision - TP 2|2|||
130718158|NCT04156620|470593248|FG000|Overall Study|Pregnancy - TP 2|1|||
130718159|NCT04156620|470593249|FG001|Overall Study|Pregnancy - TP 2|1|||
130309319|NCT00981461|469095910|FG001|Overall Study|Lost to Follow-up|2|||
130309320|NCT03361293|469095919|FG000|Overall Study|Lost to Follow-up|0|||
130309321|NCT03361293|469095920|FG001|Overall Study|Lost to Follow-up|2|||
130309322|NCT03361293|469095919|FG000|Overall Study|Withdrawal by Subject|1|||
130309323|NCT03361293|469095920|FG001|Overall Study|Withdrawal by Subject|3|||
130309324|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
130718160|NCT04156620|470593248|FG000|Overall Study|Subject decision - TP 2|11|||
130309325|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
130718161|NCT04156620|470593249|FG001|Overall Study|Subject decision - TP 2|9|||
130718162|NCT04156620|470593248|FG000|Overall Study|New therapy for study indication - TP 2|1|||
130718163|NCT04156620|470593249|FG001|Overall Study|New therapy for study indication - TP 2|0|||
130718164|NCT02722148|470593250|FG000|Overall Study|Lost to Follow-up|2|||
130718165|NCT02722148|470593250|FG000|Overall Study|Non compliant with treatment regimen|3|||
130718166|NCT01753336|470593252|FG000|Overall Study|Patient decision|12|||
130718167|NCT01753336|470593252|FG000|Overall Study|Lost to Follow-up|3|||
130718168|NCT01753336|470593252|FG000|Overall Study|Physician Decision|2|||
130718169|NCT01753336|470593252|FG000|Overall Study|Sponsor's decision|2|||
130718170|NCT01753336|470593252|FG000|Overall Study|Withdrawal by Subject|1|||
130718171|NCT01946191|470593256|FG000|Allocation|Did not complete orientation|1|||
130718172|NCT01946191|470593257|FG001|Allocation|Did not complete orientation|1|||
130718173|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
130718174|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
130718175|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
130718176|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
130718177|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
130718178|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
130718179|NCT01629966|470593258|FG000|Overall Study|Pregnancy|0|||
130718180|NCT01629966|470593259|FG001|Overall Study|Pregnancy|1|||
130718181|NCT01629966|470593260|FG002|Overall Study|Pregnancy|0|||
130718182|NCT01629966|470593258|FG000|Overall Study|Lost to Follow-up|10|||
130718183|NCT01629966|470593259|FG001|Overall Study|Lost to Follow-up|13|||
130718184|NCT01629966|470593260|FG002|Overall Study|Lost to Follow-up|9|||
130718185|NCT01629966|470593258|FG000|Overall Study|Withdrawal by Subject|8|||
130718186|NCT01629966|470593259|FG001|Overall Study|Withdrawal by Subject|9|||
130309326|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
130309327|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
130309328|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130309329|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130309330|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
130309331|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
130374350|NCT00166114|469338363|FG001|Overall Study|Protocol Violation|1|||
130374351|NCT00166114|469338362|FG000|Overall Study|Withdrawal by Subject|10|||
130374352|NCT00166114|469338363|FG001|Overall Study|Withdrawal by Subject|4|||
130374353|NCT00166114|469338362|FG000|Overall Study|Adverse Event|2|||
130374354|NCT00166114|469338363|FG001|Overall Study|Adverse Event|1|||
130374355|NCT00127660|469338364|FG000|Overall Study|Protocol Violation|3|||
130374356|NCT00127660|469338365|FG001|Overall Study|Protocol Violation|3|||
130374357|NCT00127660|469338366|FG002|Overall Study|Protocol Violation|5|||
130374358|NCT00127660|469338367|FG003|Overall Study|Protocol Violation|0|||
130374359|NCT03018704|469338370|FG000|Overall Study|Lost to Follow-up|1|||
130557765|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130557766|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130718187|NCT01629966|470593260|FG002|Overall Study|Withdrawal by Subject|16|||
130718188|NCT01629966|470593258|FG000|Overall Study|Protocol Violation|7|||
130309332|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
130309333|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
130309334|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
130309335|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
130309336|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
130309337|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
130309338|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
130309339|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130309340|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130309341|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
130309342|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
130309343|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
130309344|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
130309345|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130309346|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130309347|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
130309348|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130309349|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130309350|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
130309351|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130309352|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130309353|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
130309354|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130309355|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130309356|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
130309357|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130309358|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130309359|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
130309360|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130374360|NCT03018704|469338371|FG001|Overall Study|Lost to Follow-up|1|||
130374361|NCT00642460|469338374|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
130374362|NCT00642460|469338375|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
130374363|NCT00642460|469338376|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
130374364|NCT00642460|469338377|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
130374365|NCT00642460|469338378|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
130374366|NCT00642460|469338379|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
130374367|NCT00642460|469338374|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
130374368|NCT00642460|469338375|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130374369|NCT00642460|469338376|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130374370|NCT00642460|469338377|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130374371|NCT00642460|469338378|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130374372|NCT00642460|469338379|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130374373|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
130374374|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
130374375|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130374376|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130374377|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130374378|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130374379|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Death|0|||
130374380|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Death|1|||
130374381|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Death|0|||
130374382|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Death|2|||
130374383|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Death|0|||
130374384|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Death|0|||
130374385|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
130374386|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
130374387|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130374388|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130374389|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130374390|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130374391|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
130374392|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
130718189|NCT01629966|470593259|FG001|Overall Study|Protocol Violation|9|||
130718190|NCT01629966|470593260|FG002|Overall Study|Protocol Violation|7|||
130718191|NCT01629966|470593258|FG000|Overall Study|Lack of Efficacy|5|||
130718192|NCT01629966|470593259|FG001|Overall Study|Lack of Efficacy|2|||
130718193|NCT01629966|470593260|FG002|Overall Study|Lack of Efficacy|4|||
130718194|NCT01629966|470593258|FG000|Overall Study|Adverse Event|11|||
130718195|NCT01629966|470593259|FG001|Overall Study|Adverse Event|18|||
130718196|NCT01629966|470593260|FG002|Overall Study|Adverse Event|30|||
130718197|NCT04568031|470593261|FG000|Overall Study|Lost to Follow-up|1|||
130718198|NCT04568031|470593262|FG001|Overall Study|Lost to Follow-up|0|||
130718199|NCT04568031|470593263|FG002|Overall Study|Lost to Follow-up|0|||
130718200|NCT04568031|470593264|FG003|Overall Study|Lost to Follow-up|0|||
130718201|NCT04568031|470593261|FG000|Overall Study|Physician Decision|1|||
130718202|NCT04568031|470593262|FG001|Overall Study|Physician Decision|0|||
130718203|NCT04568031|470593263|FG002|Overall Study|Physician Decision|1|||
130464988|NCT00232180|469668774|FG000|Open Label Phase|Study terminated by sponsor|0|||
130464989|NCT00232180|469668775|FG001|Open Label Phase|Study terminated by sponsor|0|||
130464990|NCT00232180|469668776|FG002|Open Label Phase|Study terminated by sponsor|3|||
130464991|NCT00232180|469668774|FG000|Open Label Phase|Withdrawal by Subject|0|||
130464992|NCT00232180|469668775|FG001|Open Label Phase|Withdrawal by Subject|0|||
130464993|NCT00232180|469668776|FG002|Open Label Phase|Withdrawal by Subject|37|||
130464994|NCT00232180|469668774|FG000|Open Label Phase|Other|0|||
130718204|NCT04568031|470593264|FG003|Overall Study|Physician Decision|0|||
130718205|NCT04568031|470593261|FG000|Overall Study|Withdrawal by Subject|1|||
130718206|NCT04568031|470593262|FG001|Overall Study|Withdrawal by Subject|0|||
130718207|NCT04568031|470593263|FG002|Overall Study|Withdrawal by Subject|4|||
130718208|NCT04568031|470593264|FG003|Overall Study|Withdrawal by Subject|1|||
130718209|NCT03753763|470593281|FG000|Overall Study|Adverse Event|2|||
130718210|NCT03753763|470593282|FG001|Overall Study|Adverse Event|0|||
130718211|NCT03753763|470593281|FG000|Overall Study|Withdrawal by Subject|3|||
130718212|NCT03753763|470593282|FG001|Overall Study|Withdrawal by Subject|1|||
130718213|NCT03753763|470593281|FG000|Overall Study|clinical deterioration|1|||
130718214|NCT03753763|470593282|FG001|Overall Study|clinical deterioration|0|||
130718215|NCT01104779|470593283|FG000|Overall Study|Protocol Violation|1|||
130718216|NCT01104779|470593284|FG001|Overall Study|Protocol Violation|2|||
130718217|NCT01104779|470593285|FG002|Overall Study|Protocol Violation|2|||
130718218|NCT01104779|470593283|FG000|Overall Study|Lack of Efficacy|26|||
130718219|NCT01104779|470593284|FG001|Overall Study|Lack of Efficacy|12|||
130718220|NCT01104779|470593285|FG002|Overall Study|Lack of Efficacy|13|||
130718221|NCT01104779|470593283|FG000|Overall Study|Adverse Event|13|||
130718222|NCT01104779|470593284|FG001|Overall Study|Adverse Event|14|||
130718223|NCT01104779|470593285|FG002|Overall Study|Adverse Event|13|||
130718224|NCT01104779|470593283|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130718225|NCT01104779|470593284|FG001|Overall Study|Did not meet inc/exc criteria|1|||
130718226|NCT01104779|470593285|FG002|Overall Study|Did not meet inc/exc criteria|1|||
130718227|NCT01104779|470593283|FG000|Overall Study|Other reasons|0|||
130718228|NCT01104779|470593284|FG001|Overall Study|Other reasons|1|||
130718229|NCT01104779|470593285|FG002|Overall Study|Other reasons|0|||
130718230|NCT01104779|470593283|FG000|Overall Study|Lost to Follow-up|2|||
130718231|NCT01104779|470593284|FG001|Overall Study|Lost to Follow-up|0|||
130718232|NCT01104779|470593285|FG002|Overall Study|Lost to Follow-up|1|||
130718233|NCT01104779|470593283|FG000|Overall Study|Withdrawal by Subject|16|||
130718234|NCT01104779|470593284|FG001|Overall Study|Withdrawal by Subject|25|||
130718235|NCT01104779|470593285|FG002|Overall Study|Withdrawal by Subject|32|||
130718236|NCT00389831|470593286|FG000|Overall Study|Lack of Efficacy|0|||
130718237|NCT00389831|470593287|FG001|Overall Study|Lack of Efficacy|2|||
130718238|NCT00389831|470593286|FG000|Overall Study|Did not receive treatment.|0|||
130718239|NCT00389831|470593287|FG001|Overall Study|Did not receive treatment.|2|||
130718240|NCT00389831|470593286|FG000|Overall Study|Other reasons|0|||
130718241|NCT00389831|470593287|FG001|Overall Study|Other reasons|2|||
130718242|NCT00389831|470593286|FG000|Overall Study|Lost to Follow-up|0|||
130718243|NCT00389831|470593287|FG001|Overall Study|Lost to Follow-up|1|||
130718244|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
130718245|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
130718246|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718247|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718248|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718249|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718250|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718251|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718252|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718253|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718254|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718255|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718256|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718257|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718258|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
130718259|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
130718260|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718261|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718262|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718263|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718264|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718265|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718266|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718267|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130464995|NCT00232180|469668775|FG001|Open Label Phase|Other|0|||
130464996|NCT00232180|469668776|FG002|Open Label Phase|Other|16|||
130464997|NCT00232180|469668774|FG000|Open Label Phase|Adverse Event|0|||
130464998|NCT00232180|469668775|FG001|Open Label Phase|Adverse Event|0|||
130464999|NCT00232180|469668776|FG002|Open Label Phase|Adverse Event|25|||
130465000|NCT00232180|469668774|FG000|Open Label Phase|Laboratory abnormality|0|||
130465001|NCT00232180|469668775|FG001|Open Label Phase|Laboratory abnormality|0|||
130465002|NCT00232180|469668776|FG002|Open Label Phase|Laboratory abnormality|10|||
130465003|NCT00232180|469668774|FG000|Open Label Phase|Randomized but not treated|0|||
130465004|NCT00232180|469668775|FG001|Open Label Phase|Randomized but not treated|0|||
130465005|NCT00232180|469668776|FG002|Open Label Phase|Randomized but not treated|1|||
130465006|NCT01571596|469668779|FG000|Overall Study|Adverse Event|2|||
130465007|NCT01571596|469668780|FG001|Overall Study|Adverse Event|0|||
130465008|NCT01571596|469668781|FG002|Overall Study|Adverse Event|0|||
130465009|NCT01571596|469668779|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130465010|NCT01571596|469668780|FG001|Overall Study|Study Terminated by the Sponsor|1|||
130465011|NCT01571596|469668781|FG002|Overall Study|Study Terminated by the Sponsor|1|||
130465012|NCT04512482|469668785|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
130465013|NCT04512482|469668786|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
130465014|NCT00446459|469668787|FG000|8 Months|Protocol Violation|12|||
130465015|NCT00446459|469668787|FG000|12 Months|Protocol Violation|4|||
130465016|NCT00446459|469668787|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
130465017|NCT01236001|469668795|FG000|Overall Study|Adverse Event|5|||
130465018|NCT01236001|469668796|FG001|Overall Study|Adverse Event|14|||
130465019|NCT01236001|469668795|FG000|Overall Study|Lack of Efficacy|6|||
130465020|NCT01236001|469668796|FG001|Overall Study|Lack of Efficacy|6|||
130309361|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130309362|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
130309363|NCT00483405|469095926|FG000|Overall Study|Adverse Event|8|||
130309364|NCT00483405|469095926|FG000|Overall Study|Lack of Efficacy|14|||
130309365|NCT00483405|469095926|FG000|Overall Study|Death|3|||
130309366|NCT00483405|469095926|FG000|Overall Study|Withdrawal by Subject|2|||
130309367|NCT00483405|469095926|FG000|Overall Study|Other complicating disease|1|||
130309368|NCT00571038|469095927|FG000|Overall Study|Lost to Follow-up|1|||
130309369|NCT00571038|469095928|FG001|Overall Study|Lost to Follow-up|4|||
130309370|NCT00571038|469095927|FG000|Overall Study|Death|7|||
130309371|NCT00571038|469095928|FG001|Overall Study|Death|5|||
130309372|NCT00571038|469095927|FG000|Overall Study|Withdrawal by Subject|1|||
130309373|NCT00571038|469095928|FG001|Overall Study|Withdrawal by Subject|3|||
130309374|NCT00571038|469095927|FG000|Overall Study|Moved out of state|2|||
130309375|NCT00571038|469095928|FG001|Overall Study|Moved out of state|2|||
130309376|NCT01550757|469095929|FG000|Overall Study|Lost to Follow-up|21|||
130309377|NCT01550757|469095930|FG001|Overall Study|Lost to Follow-up|14|||
130309378|NCT01550757|469095931|FG002|Overall Study|Lost to Follow-up|42|||
130309379|NCT01550757|469095932|FG003|Overall Study|Lost to Follow-up|53|||
130309380|NCT01550757|469095929|FG000|Overall Study|Withdrawal by Subject|2|||
130309381|NCT01550757|469095930|FG001|Overall Study|Withdrawal by Subject|0|||
130309382|NCT01550757|469095931|FG002|Overall Study|Withdrawal by Subject|3|||
130309383|NCT01550757|469095932|FG003|Overall Study|Withdrawal by Subject|1|||
130309384|NCT00740584|469095934|FG000|Overall Study|Withdrawal by Subject|1|||
130309385|NCT00413218|469095936|FG000|Overall Study|Randomized but didn't receive study drug|2|||
130309386|NCT00413218|469095937|FG001|Overall Study|Randomized but didn't receive study drug|8|||
130309387|NCT00413218|469095936|FG000|Overall Study|Death|57|||
130309388|NCT00413218|469095937|FG001|Overall Study|Death|56|||
130309389|NCT00413218|469095936|FG000|Overall Study|Lost to Follow-up|14|||
130309390|NCT00413218|469095937|FG001|Overall Study|Lost to Follow-up|17|||
130309391|NCT00413218|469095936|FG000|Overall Study|Admin|20|||
130309392|NCT00413218|469095937|FG001|Overall Study|Admin|14|||
130309393|NCT00413218|469095936|FG000|Overall Study|Missing|1|||
130309394|NCT00413218|469095937|FG001|Overall Study|Missing|0|||
130309395|NCT00413218|469095936|FG000|Overall Study|Withdrawal by Subject|9|||
130309396|NCT00413218|469095937|FG001|Overall Study|Withdrawal by Subject|1|||
130465021|NCT01236001|469668795|FG000|Overall Study|Lost to Follow-up|6|||
130465022|NCT01236001|469668796|FG001|Overall Study|Lost to Follow-up|1|||
130557767|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
130309397|NCT01196026|469095939|FG000|Overall Study|Withdrawal by Subject|1|||
130309398|NCT01196026|469095940|FG001|Overall Study|Withdrawal by Subject|4|||
130309399|NCT01196026|469095941|FG002|Overall Study|Withdrawal by Subject|0|||
130465023|NCT01236001|469668795|FG000|Overall Study|Incompliance|1|||
130465024|NCT01236001|469668796|FG001|Overall Study|Incompliance|0|||
130557768|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130557769|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557770|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130309400|NCT01196026|469095942|FG003|Overall Study|Withdrawal by Subject|0|||
130309401|NCT01196026|469095943|FG004|Overall Study|Withdrawal by Subject|0|||
130309402|NCT01196026|469095944|FG005|Overall Study|Withdrawal by Subject|0|||
130309403|NCT01196026|469095939|FG000|Overall Study|Lost to Follow-up|0|||
130309404|NCT01196026|469095940|FG001|Overall Study|Lost to Follow-up|3|||
130309405|NCT01196026|469095941|FG002|Overall Study|Lost to Follow-up|0|||
130465025|NCT01236001|469668795|FG000|Overall Study|Planned Visit After End of Study|0|||
130465026|NCT01236001|469668796|FG001|Overall Study|Planned Visit After End of Study|1|||
130465027|NCT01759771|469668811|FG000|Overall Study|Withdrawal by Subject|1|||
130465028|NCT01759771|469668812|FG001|Overall Study|Withdrawal by Subject|1|||
130465029|NCT02528188|469668813|FG000|Overall Study|Adverse Event|23|||
130465030|NCT02528188|469668814|FG001|Overall Study|Adverse Event|22|||
130465031|NCT02528188|469668815|FG002|Overall Study|Adverse Event|8|||
130465032|NCT02528188|469668813|FG000|Overall Study|Protocol Violation|4|||
130465033|NCT02528188|469668814|FG001|Overall Study|Protocol Violation|6|||
130465034|NCT02528188|469668815|FG002|Overall Study|Protocol Violation|4|||
130465035|NCT02528188|469668813|FG000|Overall Study|Lack of Efficacy|19|||
130465036|NCT02528188|469668814|FG001|Overall Study|Lack of Efficacy|21|||
130465037|NCT02528188|469668815|FG002|Overall Study|Lack of Efficacy|22|||
130465038|NCT02528188|469668813|FG000|Overall Study|Withdrawal by Subject|97|||
130465039|NCT02528188|469668814|FG001|Overall Study|Withdrawal by Subject|104|||
130465040|NCT02528188|469668815|FG002|Overall Study|Withdrawal by Subject|100|||
130465041|NCT02528188|469668813|FG000|Overall Study|Lost to Follow-up|25|||
130465042|NCT02528188|469668814|FG001|Overall Study|Lost to Follow-up|21|||
130465043|NCT02528188|469668815|FG002|Overall Study|Lost to Follow-up|31|||
130309406|NCT01196026|469095942|FG003|Overall Study|Lost to Follow-up|0|||
130309407|NCT01196026|469095943|FG004|Overall Study|Lost to Follow-up|1|||
130309408|NCT01196026|469095944|FG005|Overall Study|Lost to Follow-up|0|||
130309409|NCT01196026|469095939|FG000|Overall Study|Other|0|||
130309410|NCT01196026|469095940|FG001|Overall Study|Other|1|||
130309411|NCT01196026|469095941|FG002|Overall Study|Other|0|||
130309412|NCT01196026|469095942|FG003|Overall Study|Other|0|||
130309413|NCT01196026|469095943|FG004|Overall Study|Other|0|||
130309414|NCT01196026|469095944|FG005|Overall Study|Other|0|||
130309415|NCT01687296|469095945|FG000|Overall Study|Lack of Efficacy|1|||
130309416|NCT01687296|469095946|FG001|Overall Study|Lack of Efficacy|1|||
130309417|NCT01687296|469095945|FG000|Overall Study|Protocol Violation|0|||
130309418|NCT01687296|469095946|FG001|Overall Study|Protocol Violation|1|||
130309419|NCT01687296|469095945|FG000|Overall Study|Withdrawal by Subject|6|||
130309420|NCT01687296|469095946|FG001|Overall Study|Withdrawal by Subject|3|||
130309421|NCT03672292|469095950|FG000|Overall Study|Adverse Event|3|||
130309422|NCT03672292|469095951|FG001|Overall Study|Adverse Event|1|||
130309423|NCT03672292|469095950|FG000|Overall Study|Physician Decision|0|||
130309424|NCT03672292|469095951|FG001|Overall Study|Physician Decision|1|||
130309425|NCT03672292|469095950|FG000|Overall Study|Withdrawal by Subject|1|||
130309426|NCT03672292|469095951|FG001|Overall Study|Withdrawal by Subject|2|||
130309427|NCT03797586|469095952|FG000|Overall Study|Lost to Follow-up|3|||
130309428|NCT03797586|469095953|FG001|Overall Study|Lost to Follow-up|6|||
130309429|NCT03797586|469095952|FG000|Overall Study|Death|1|||
130309430|NCT03797586|469095953|FG001|Overall Study|Death|1|||
130309431|NCT03797586|469095952|FG000|Overall Study|Adverse Event|0|||
130309432|NCT03797586|469095953|FG001|Overall Study|Adverse Event|2|||
130309433|NCT02864901|469095954|FG000|Overall Study|Withdrawal by Subject|1|||
130309434|NCT02864901|469095955|FG001|Overall Study|Withdrawal by Subject|0|||
130309435|NCT05730387|469095956|FG000|Overall Study|Stillbirth|0|||
130309436|NCT05730387|469095957|FG001|Overall Study|Stillbirth|262|||
130309437|NCT05730387|469095956|FG000|Overall Study|Died during or after delivery|2|||
130309438|NCT05730387|469095957|FG001|Overall Study|Died during or after delivery|85|||
130309439|NCT05730387|469095956|FG000|Overall Study|Died after being admitted|0|||
130309440|NCT05730387|469095957|FG001|Overall Study|Died after being admitted|44|||
130309441|NCT05730387|469095956|FG000|Overall Study|Lost to Follow-up|69|||
130309442|NCT05730387|469095957|FG001|Overall Study|Lost to Follow-up|77|||
130309443|NCT01219985|469095958|FG000|Overall Study|Physician Decision|20|||
130309444|NCT04797780|469095959|FG000|Overall Study|Lost to Follow-up|1|||
130309445|NCT04797780|469095960|FG001|Overall Study|Lost to Follow-up|1|||
130309446|NCT04797780|469095959|FG000|Overall Study|Withdrawal by Subject|14|||
130309447|NCT04797780|469095960|FG001|Overall Study|Withdrawal by Subject|9|||
130309448|NCT04797780|469095959|FG000|Overall Study|Death|49|||
130309449|NCT04797780|469095960|FG001|Overall Study|Death|20|||
130309450|NCT05973006|469095961|FG000|Overall Study|Early termination|3|||
130309451|NCT05973006|469095962|FG001|Overall Study|Early termination|9|||
130309452|NCT00132808|469095970|FG000|Stratum I|Adverse Event|2|||
130309453|NCT00132808|469095971|FG001|Stratum I|Adverse Event|1|||
130309454|NCT00132808|469095972|FG002|Stratum I|Adverse Event|0|||
130465044|NCT02528188|469668813|FG000|Overall Study|Death|4|||
130309455|NCT00132808|469095970|FG000|Stratum I|Lost to Follow-up|3|||
130309456|NCT00132808|469095971|FG001|Stratum I|Lost to Follow-up|4|||
130309457|NCT00132808|469095972|FG002|Stratum I|Lost to Follow-up|1|||
130309458|NCT00132808|469095970|FG000|Stratum I|Withdrawal by Subject|4|||
130309459|NCT00132808|469095971|FG001|Stratum I|Withdrawal by Subject|7|||
130309460|NCT00132808|469095972|FG002|Stratum I|Withdrawal by Subject|3|||
130309461|NCT00132808|469095970|FG000|Stratum I|Abnormal test procedure result (s)|0|||
130309462|NCT00132808|469095971|FG001|Stratum I|Abnormal test procedure result (s)|0|||
130465045|NCT02528188|469668814|FG001|Overall Study|Death|4|||
130465046|NCT02528188|469668815|FG002|Overall Study|Death|0|||
130309463|NCT00132808|469095972|FG002|Stratum I|Abnormal test procedure result (s)|1|||
130465047|NCT02528188|469668813|FG000|Overall Study|Other|89|||
130465048|NCT02528188|469668814|FG001|Overall Study|Other|91|||
130465049|NCT02528188|469668815|FG002|Overall Study|Other|74|||
130718268|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718269|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718270|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718271|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718272|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
130718273|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
130718274|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718275|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718276|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718277|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718278|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718279|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718280|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718281|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718282|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718283|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718284|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718285|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718286|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
130718287|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
130718288|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718289|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718290|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718291|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718292|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718293|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718294|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718295|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718296|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718297|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718298|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718299|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718300|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
130718301|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
130718302|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718303|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718304|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718305|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718306|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718307|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718308|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718309|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718310|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718311|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718312|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718313|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718314|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
130718315|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
130718316|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718317|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718318|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718319|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718320|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718321|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718322|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718323|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718324|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718325|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718326|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718327|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718328|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
130718329|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
130718330|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718331|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718332|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130374393|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130374394|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130557771|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130374395|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130374396|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130374397|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
130374398|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
130374399|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
130374400|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
130374401|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
130374402|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
130374403|NCT00642460|469338374|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130374404|NCT00642460|469338375|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130309464|NCT00132808|469095970|FG000|Stratum II|Adverse Event|1|||
130309465|NCT00132808|469095971|FG001|Stratum II|Adverse Event|2|||
130309466|NCT00132808|469095972|FG002|Stratum II|Adverse Event|1|||
130309467|NCT00132808|469095970|FG000|Stratum II|Death|1|||
130309468|NCT00132808|469095971|FG001|Stratum II|Death|0|||
130309469|NCT00132808|469095972|FG002|Stratum II|Death|0|||
130309470|NCT00132808|469095970|FG000|Stratum II|Lost to Follow-up|2|||
130718333|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718334|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718335|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718336|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718337|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718338|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718339|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718340|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718341|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718342|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
130718343|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
130718344|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718345|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718346|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718347|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718348|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718349|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718350|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718351|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718352|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718353|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718354|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718355|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718356|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
130718357|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
130718358|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718359|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718360|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718361|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718362|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718363|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718364|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718365|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718366|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718367|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718368|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718369|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718370|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
130718371|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
130718372|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718373|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718374|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718375|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718376|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718377|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718378|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718379|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718380|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718381|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718382|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718383|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718384|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
130718385|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
130309471|NCT00132808|469095971|FG001|Stratum II|Lost to Follow-up|2|||
130309472|NCT00132808|469095972|FG002|Stratum II|Lost to Follow-up|1|||
130309473|NCT00132808|469095970|FG000|Stratum II|Protocol Violation|0|||
130309474|NCT00132808|469095971|FG001|Stratum II|Protocol Violation|2|||
130309475|NCT00132808|469095972|FG002|Stratum II|Protocol Violation|1|||
130718386|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718387|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130309476|NCT00132808|469095970|FG000|Stratum II|Withdrawal by Subject|4|||
130557772|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557773|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557774|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557775|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557776|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130557777|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
130309477|NCT00132808|469095971|FG001|Stratum II|Withdrawal by Subject|9|||
130309478|NCT00132808|469095972|FG002|Stratum II|Withdrawal by Subject|6|||
130309479|NCT00924443|469095981|FG000|Overall Study|Physician Decision|2|||
130309480|NCT00924443|469095981|FG000|Overall Study|Protocol Violation|1|||
130309481|NCT00595478|469095987|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
130309482|NCT00595478|469095988|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
130309483|NCT00595478|469095987|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
130309484|NCT00595478|469095988|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
130309485|NCT03405818|469095991|FG000|Overall Study|Withdrawal by Subject|4|||
130309486|NCT03405818|469095991|FG000|Overall Study|Lost to Follow-up|4|||
130309487|NCT02363959|469095994|FG000|Overall Study|Medical instability|1|||
130309488|NCT02363959|469095995|FG001|Overall Study|Medical instability|0|||
130309489|NCT00950248|469095996|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
130309490|NCT00950248|469095997|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
130309491|NCT00950248|469095998|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
130309492|NCT00950248|469095996|FG000|Year 1: Baseline|worsening of symptoms|2|||
130309493|NCT00950248|469095997|FG001|Year 1: Baseline|worsening of symptoms|0|||
130309494|NCT00950248|469095998|FG002|Year 1: Baseline|worsening of symptoms|0|||
130309495|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
130309496|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
130309497|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
130309498|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130309499|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
130309500|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130309501|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|Death|0|||
130309502|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|Death|0|||
130309503|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|Death|1|||
130309504|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130309505|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
130374405|NCT00642460|469338376|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130374406|NCT00642460|469338377|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
130374407|NCT00642460|469338378|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130374408|NCT00642460|469338379|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130374409|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130374410|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130374411|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130374412|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130374413|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
130374414|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
130374415|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130374416|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130374417|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130374418|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130374419|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
130374420|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
130374421|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130374422|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130374423|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130374424|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130374425|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
130557778|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
130557779|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130557780|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557781|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557782|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557783|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130309506|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130309507|NCT01900652|469095999|FG000|Overall Study|Progressive Disease|1|||
130309508|NCT01900652|469096000|FG001|Overall Study|Progressive Disease|0|||
130309509|NCT01900652|469095999|FG000|Overall Study|Consent withdrawn by subject|1|||
130309510|NCT01900652|469096000|FG001|Overall Study|Consent withdrawn by subject|1|||
130309511|NCT01900652|469095999|FG000|Overall Study|Death|3|||
130309512|NCT01900652|469096000|FG001|Overall Study|Death|0|||
130309513|NCT01900652|469095999|FG000|Overall Study|Adverse Event|2|||
130309514|NCT01900652|469096000|FG001|Overall Study|Adverse Event|1|||
130309515|NCT01900652|469095999|FG000|Overall Study|Physician Decision|1|||
130309516|NCT01900652|469096000|FG001|Overall Study|Physician Decision|1|||
130309517|NCT00869518|469096003|FG000|Overall Study|Lost to Follow-up|1|||
130309518|NCT00869518|469096004|FG001|Overall Study|Lost to Follow-up|1|||
130309519|NCT00947115|469096005|FG000|Overall Study|Missed reporting interval|3|||
130309520|NCT00947115|469096006|FG001|Overall Study|Missed reporting interval|4|||
130309521|NCT00947115|469096007|FG002|Overall Study|Missed reporting interval|2|||
130309522|NCT00947115|469096005|FG000|Overall Study|Physician Decision|0|||
130309523|NCT00947115|469096006|FG001|Overall Study|Physician Decision|2|||
130309524|NCT00947115|469096007|FG002|Overall Study|Physician Decision|0|||
130309525|NCT00947115|469096005|FG000|Overall Study|Death|0|||
130309526|NCT00947115|469096006|FG001|Overall Study|Death|1|||
130309527|NCT00947115|469096007|FG002|Overall Study|Death|1|||
130309528|NCT00947115|469096005|FG000|Overall Study|Migrated from study area|2|||
130309529|NCT00947115|469096006|FG001|Overall Study|Migrated from study area|0|||
130309530|NCT00947115|469096007|FG002|Overall Study|Migrated from study area|0|||
130309531|NCT00947115|469096005|FG000|Overall Study|Withdrawal by Subject|1|||
130309532|NCT00947115|469096006|FG001|Overall Study|Withdrawal by Subject|3|||
130309533|NCT00947115|469096007|FG002|Overall Study|Withdrawal by Subject|4|||
130309534|NCT00947115|469096005|FG000|Overall Study|Lost to Follow-up|11|||
130309535|NCT00947115|469096006|FG001|Overall Study|Lost to Follow-up|12|||
130309536|NCT00947115|469096007|FG002|Overall Study|Lost to Follow-up|8|||
130309537|NCT01223183|469096009|FG000|Imaging Day 1|Physician Decision|0|||
130309538|NCT01223183|469096010|FG001|Imaging Day 1|Physician Decision|1|||
130309539|NCT01223183|469096009|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
130309540|NCT01223183|469096010|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
130309541|NCT01223183|469096009|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
130309542|NCT01223183|469096010|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
130309543|NCT00900029|469096013|FG000|Overall Study|Lost to Follow-up|0|||
130309544|NCT00900029|469096014|FG001|Overall Study|Lost to Follow-up|2|||
130309545|NCT00900029|469096015|FG002|Overall Study|Lost to Follow-up|1|||
130309546|NCT00900029|469096016|FG003|Overall Study|Lost to Follow-up|4|||
130309547|NCT00900029|469096017|FG004|Overall Study|Lost to Follow-up|4|||
130309548|NCT00900029|469096013|FG000|Overall Study|Withdrawal by Subject|2|||
130309549|NCT00900029|469096014|FG001|Overall Study|Withdrawal by Subject|2|||
130309550|NCT00900029|469096015|FG002|Overall Study|Withdrawal by Subject|1|||
130309551|NCT00900029|469096016|FG003|Overall Study|Withdrawal by Subject|1|||
130309552|NCT00900029|469096017|FG004|Overall Study|Withdrawal by Subject|1|||
130309553|NCT00900029|469096013|FG000|Overall Study|Adverse Event|0|||
130309554|NCT00900029|469096014|FG001|Overall Study|Adverse Event|0|||
130309555|NCT00900029|469096015|FG002|Overall Study|Adverse Event|1|||
130309556|NCT00900029|469096016|FG003|Overall Study|Adverse Event|1|||
130309557|NCT00900029|469096017|FG004|Overall Study|Adverse Event|1|||
130309558|NCT00900029|469096013|FG000|Overall Study|Death|1|||
130309559|NCT00900029|469096014|FG001|Overall Study|Death|0|||
130309560|NCT00900029|469096015|FG002|Overall Study|Death|0|||
130309561|NCT00900029|469096016|FG003|Overall Study|Death|1|||
130309562|NCT00900029|469096017|FG004|Overall Study|Death|0|||
130309563|NCT00511238|469096020|FG000|Overall Study|Adverse Event|13|||
130309564|NCT00511238|469096021|FG001|Overall Study|Adverse Event|33|||
130309565|NCT00511238|469096020|FG000|Overall Study|Withdrawal by Subject|2|||
130309566|NCT00511238|469096021|FG001|Overall Study|Withdrawal by Subject|22|||
130309567|NCT00511238|469096020|FG000|Overall Study|Progressive Disease|23|||
130309568|NCT00511238|469096021|FG001|Overall Study|Progressive Disease|157|||
130309569|NCT00511238|469096020|FG000|Overall Study|various reasons|4|||
130309570|NCT00511238|469096021|FG001|Overall Study|various reasons|14|||
130309571|NCT03772665|469096022|FG000|Overall Study|Protocol Violation|1|||
130309572|NCT03772665|469096023|FG001|Overall Study|Protocol Violation|0|||
130309573|NCT00163020|469096024|FG000|Overall Study|Lost to Follow-up|0|||
130309574|NCT00163020|469096025|FG001|Overall Study|Lost to Follow-up|2|||
130309575|NCT00922623|469098992|FG000|Overall Study|Other|4|||
130309576|NCT00922623|469098992|FG000|Overall Study|Lost to Follow-up|1|||
130309577|NCT02871635|469098993|FG000|Overall Study|Primary lack of efficacy|4|||
130309578|NCT02871635|469098994|FG001|Overall Study|Primary lack of efficacy|4|||
130309579|NCT02871635|469098993|FG000|Overall Study|Protocol Violation|3|||
130309580|NCT02871635|469098994|FG001|Overall Study|Protocol Violation|1|||
130309581|NCT02871635|469098993|FG000|Overall Study|Lost to Follow-up|1|||
130309582|NCT02871635|469098994|FG001|Overall Study|Lost to Follow-up|2|||
130309583|NCT02871635|469098993|FG000|Overall Study|Pregnancy|0|||
130309584|NCT02871635|469098994|FG001|Overall Study|Pregnancy|2|||
130374426|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
130374427|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130374428|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130374429|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130374430|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130374431|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
130374432|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
130374433|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Other|0|||
130374434|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Other|0|||
130374435|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Other|0|||
130374436|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Other|0|||
130374437|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Other|2|||
130374438|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Other|2|||
130374439|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Death|0|||
130374440|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Death|0|||
130374441|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Death|0|||
130374442|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Death|0|||
130374443|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Death|0|||
130374444|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Death|3|||
130374445|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130374446|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130374447|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130374448|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130557784|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557785|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557786|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557787|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557788|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557789|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
130557790|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130557791|NCT04178967|470011816|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557792|NCT04178967|470011817|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557793|NCT04178967|470011818|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557794|NCT04178967|470011819|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557795|NCT04178967|470011820|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557796|NCT04178967|470011821|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557797|NCT04178967|470011822|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557798|NCT04178967|470011823|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557799|NCT04178967|470011824|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557800|NCT04178967|470011825|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
130557801|NCT04178967|470011826|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130557802|NCT03681951|470011827|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
130557803|NCT03681951|470011828|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557804|NCT03681951|470011829|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557805|NCT03681951|470011830|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557806|NCT03681951|470011831|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557807|NCT03681951|470011832|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130309585|NCT02871635|469098993|FG000|Overall Study|Physician Decision|1|||
130309586|NCT02871635|469098994|FG001|Overall Study|Physician Decision|1|||
130309587|NCT02871635|469098993|FG000|Overall Study|Withdrawal by Subject|3|||
130309588|NCT02871635|469098994|FG001|Overall Study|Withdrawal by Subject|4|||
130309589|NCT02871635|469098993|FG000|Overall Study|Adverse Event|4|||
130309590|NCT02871635|469098994|FG001|Overall Study|Adverse Event|4|||
130465050|NCT02528188|469668813|FG000|Overall Study|Randomized but not treated|6|||
130465051|NCT02528188|469668814|FG001|Overall Study|Randomized but not treated|7|||
130309591|NCT02871635|469098993|FG000|Overall Study|Secondary lack of efficacy|2|||
130309592|NCT02871635|469098994|FG001|Overall Study|Secondary lack of efficacy|1|||
130309593|NCT02420379|469098995|FG000|Overall Study|Withdrawal by Subject|0|||
130309594|NCT02420379|469098996|FG001|Overall Study|Withdrawal by Subject|3|||
130309595|NCT02420379|469098995|FG000|Overall Study|Unable to complete due to schooling|0|||
130309596|NCT02420379|469098996|FG001|Overall Study|Unable to complete due to schooling|1|||
130309597|NCT02420379|469098995|FG000|Overall Study|Transitioned to commercial drug|1|||
130309598|NCT02420379|469098996|FG001|Overall Study|Transitioned to commercial drug|0|||
130309599|NCT01402817|469098997|FG000|Overall Study|Withdrawal by Subject|3|||
130309600|NCT01402817|469098997|FG000|Overall Study|Study Suspended by FDA|8|||
130309601|NCT01473732|469098999|FG000|Overall Study|Adverse Event|1|||
130309602|NCT01473732|469099000|FG001|Overall Study|Adverse Event|0|||
130309603|NCT01473732|469098999|FG000|Overall Study|Death|1|||
130309604|NCT01473732|469099000|FG001|Overall Study|Death|0|||
130309605|NCT01217944|469099003|FG000|Overall Study|Protocol Violation|1|||
130309606|NCT01217944|469099004|FG001|Overall Study|Protocol Violation|1|||
130309607|NCT01217944|469099005|FG002|Overall Study|Protocol Violation|0|||
130309608|NCT01217944|469099003|FG000|Overall Study|Lost to Follow-up|3|||
130465052|NCT02528188|469668815|FG002|Overall Study|Randomized but not treated|12|||
130465053|NCT03942042|469668816|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
130465054|NCT03942042|469668817|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
130465055|NCT03942042|469668816|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
130465056|NCT03942042|469668817|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
130465057|NCT02918071|469668829|FG000|Overall Study|Withdrawal by Subject|2|||
130465058|NCT02918071|469668829|FG000|Overall Study|Lost to Follow-up|1|||
130465059|NCT00203411|469668831|FG000|Follow-up|Progressive Disease|4|||
130465060|NCT01212991|469668832|FG000|Double-blind|Lost to Follow-up|8|||
130465061|NCT01212991|469668833|FG001|Double-blind|Lost to Follow-up|4|||
130465062|NCT01212991|469668834|FG002|Double-blind|Lost to Follow-up|0|||
130465063|NCT01212991|469668832|FG000|Double-blind|Death|699|||
130465064|NCT01212991|469668833|FG001|Double-blind|Death|550|||
130465065|NCT01212991|469668834|FG002|Double-blind|Death|0|||
130465066|NCT01212991|469668832|FG000|Double-blind|Withdrawal by Subject|16|||
130465067|NCT01212991|469668833|FG001|Double-blind|Withdrawal by Subject|19|||
130465068|NCT01212991|469668834|FG002|Double-blind|Withdrawal by Subject|0|||
130465069|NCT01212991|469668832|FG000|Double-blind|Other|7|||
130465070|NCT01212991|469668833|FG001|Double-blind|Other|0|||
130465071|NCT01212991|469668834|FG002|Double-blind|Other|0|||
130465072|NCT01212991|469668832|FG000|Double-blind|Sponsor decision|142|||
130465073|NCT01212991|469668833|FG001|Double-blind|Sponsor decision|38|||
130309609|NCT01217944|469099004|FG001|Overall Study|Lost to Follow-up|1|||
130465074|NCT01212991|469668834|FG002|Double-blind|Sponsor decision|0|||
130465075|NCT01212991|469668832|FG000|Open-label|Death|0|||
130465076|NCT01212991|469668833|FG001|Open-label|Death|0|||
130465077|NCT01212991|469668834|FG002|Open-label|Death|166|||
130465078|NCT01212991|469668832|FG000|Open-label|Lost to Follow-up|0|||
130465079|NCT01212991|469668833|FG001|Open-label|Lost to Follow-up|0|||
130309610|NCT01217944|469099005|FG002|Overall Study|Lost to Follow-up|0|||
130309611|NCT01217944|469099003|FG000|Overall Study|Withdrawal by Subject|1|||
130465080|NCT01212991|469668834|FG002|Open-label|Lost to Follow-up|5|||
130465081|NCT01212991|469668832|FG000|Open-label|Withdrawal by Subject|0|||
130465082|NCT01212991|469668833|FG001|Open-label|Withdrawal by Subject|0|||
130465083|NCT01212991|469668834|FG002|Open-label|Withdrawal by Subject|7|||
130465084|NCT01212991|469668832|FG000|Open-label|Sponsor decision|0|||
130465085|NCT01212991|469668833|FG001|Open-label|Sponsor decision|0|||
130465086|NCT01212991|469668834|FG002|Open-label|Sponsor decision|53|||
130465087|NCT01212991|469668832|FG000|Open-label|Other|0|||
130465088|NCT01212991|469668833|FG001|Open-label|Other|0|||
130465089|NCT01212991|469668834|FG002|Open-label|Other|3|||
130465090|NCT01622868|469670226|FG000|Overall Study|Protocol Violation|7|||
130465091|NCT01622868|469670227|FG001|Overall Study|Protocol Violation|0|||
130465092|NCT02767765|469670230|FG000|Overall Study|Adverse Event|4|||
130465093|NCT02767765|469670230|FG000|Overall Study|Death|1|||
130465094|NCT02767765|469670230|FG000|Overall Study|Insufficient response|1|||
130465095|NCT02767765|469670230|FG000|Overall Study|Lost to Follow-up|2|||
130465096|NCT02767765|469670230|FG000|Overall Study|Investigator decision|1|||
130465097|NCT02767765|469670230|FG000|Overall Study|Non-Compliance|1|||
130465098|NCT02767765|469670230|FG000|Overall Study|Withdrawal by Subject|1|||
130465099|NCT01951170|469670231|FG000|Overall Study|Investigator decision|1|||
130465100|NCT00077675|469670241|FG000|Overall Study|Adverse Event|1|||
130465101|NCT00077675|469670242|FG001|Overall Study|Adverse Event|2|||
130465102|NCT00077675|469670241|FG000|Overall Study|Lost to Follow-up|6|||
130309612|NCT01217944|469099004|FG001|Overall Study|Withdrawal by Subject|2|||
130309613|NCT01217944|469099005|FG002|Overall Study|Withdrawal by Subject|0|||
130309614|NCT01217944|469099003|FG000|Overall Study|Lack of Efficacy|1|||
130309615|NCT01217944|469099004|FG001|Overall Study|Lack of Efficacy|0|||
130465103|NCT00077675|469670242|FG001|Overall Study|Lost to Follow-up|3|||
130465104|NCT00077675|469670241|FG000|Overall Study|Withdrawal by Subject|1|||
130309616|NCT01217944|469099005|FG002|Overall Study|Lack of Efficacy|0|||
130309617|NCT04098809|469099006|FG000|Overall Study|Withdrawal by Subject|1|||
130309618|NCT04098809|469099007|FG001|Overall Study|Withdrawal by Subject|3|||
130309619|NCT04098809|469099006|FG000|Overall Study|Physician Decision|2|||
130309620|NCT04098809|469099007|FG001|Overall Study|Physician Decision|1|||
130309621|NCT00193206|469099008|FG000|Preoperative Therapy|Lack of Efficacy|2|||
130309622|NCT00193206|469099008|FG000|Preoperative Therapy|Adverse Event|2|||
130309623|NCT00193206|469099008|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
130309624|NCT00193206|469099008|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
130309625|NCT00193206|469099008|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
130309626|NCT00193206|469099008|FG000|Postoperative Therapy|Physician Decision|3|||
130309627|NCT00193206|469099008|FG000|Postoperative Therapy|Intercurrent Illness|2|||
130309628|NCT00193206|469099008|FG000|Postoperative Therapy|Lack of Efficacy|1|||
130309629|NCT00193206|469099008|FG000|Postoperative Therapy|Protocol Violation|1|||
130309630|NCT01426958|469099009|FG000|Overall Study|Adverse Event|2|||
130309631|NCT00991939|469099012|FG000|Overall Study|Lost to Follow-up|0|||
130309632|NCT00991939|469099013|FG001|Overall Study|Lost to Follow-up|1|||
130309633|NCT00991939|469099012|FG000|Overall Study|Withdrawal by Subject|1|||
130309634|NCT00991939|469099013|FG001|Overall Study|Withdrawal by Subject|0|||
130309635|NCT00991939|469099012|FG000|Overall Study|Entire study terminated|4|||
130309636|NCT00991939|469099013|FG001|Overall Study|Entire study terminated|1|||
130309637|NCT02073682|469099018|FG000|Overall Study|Low Creatinine Clearance|1|||
130309638|NCT02073682|469099019|FG001|Overall Study|Low Creatinine Clearance|2|||
130309639|NCT02073682|469099018|FG000|Overall Study|Death|86|||
130309640|NCT02073682|469099019|FG001|Overall Study|Death|100|||
130309641|NCT02073682|469099018|FG000|Overall Study|Cancer Cured|10|||
130309642|NCT02073682|469099019|FG001|Overall Study|Cancer Cured|15|||
130309643|NCT02073682|469099018|FG000|Overall Study|ID: Patient Noncompliance|1|||
130309644|NCT02073682|469099019|FG001|Overall Study|ID: Patient Noncompliance|2|||
130309645|NCT02073682|469099018|FG000|Overall Study|ID: Palliative Treatment Only|10|||
130309646|NCT02073682|469099019|FG001|Overall Study|ID: Palliative Treatment Only|7|||
130309647|NCT02073682|469099018|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
130309648|NCT02073682|469099019|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
130309649|NCT02073682|469099018|FG000|Overall Study|Platelet Count <50,000/mL|1|||
130309650|NCT02073682|469099019|FG001|Overall Study|Platelet Count <50,000/mL|2|||
130309651|NCT02073682|469099018|FG000|Overall Study|Surgery/Medical Procedure|3|||
130309652|NCT02073682|469099019|FG001|Overall Study|Surgery/Medical Procedure|1|||
130309653|NCT02073682|469099018|FG000|Overall Study|Withdrawal by Subject|6|||
130309654|NCT02073682|469099019|FG001|Overall Study|Withdrawal by Subject|8|||
130309655|NCT02073682|469099018|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
130309656|NCT02073682|469099019|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
130309657|NCT02073682|469099018|FG000|Overall Study|Cancer Progression|53|||
130309658|NCT02073682|469099019|FG001|Overall Study|Cancer Progression|33|||
130309659|NCT02073682|469099018|FG000|Overall Study|Protocol Violation|1|||
130309660|NCT02073682|469099019|FG001|Overall Study|Protocol Violation|0|||
130309661|NCT02073682|469099018|FG000|Overall Study|Adverse Event|79|||
130309662|NCT02073682|469099019|FG001|Overall Study|Adverse Event|62|||
130309663|NCT02073682|469099018|FG000|Overall Study|No reason provided|11|||
130309664|NCT02073682|469099019|FG001|Overall Study|No reason provided|9|||
130309665|NCT02073682|469099018|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
130309666|NCT02073682|469099019|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
130309667|NCT02073682|469099018|FG000|Overall Study|Lost to Follow-up|1|||
130309668|NCT02073682|469099019|FG001|Overall Study|Lost to Follow-up|1|||
130309669|NCT02073682|469099018|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
130309670|NCT02073682|469099019|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
130309671|NCT00181766|469099020|FG000|Overall Study|Lost to Follow-up|6|||
130557808|NCT03681951|470011833|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557809|NCT03681951|470011834|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130557810|NCT03681951|470011827|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
130718388|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718389|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718390|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718391|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718392|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718393|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718394|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718395|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718396|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718397|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718398|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130718399|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130718400|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718401|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130309672|NCT00181766|469099020|FG000|Overall Study|Adverse Event|4|||
130309673|NCT00181766|469099020|FG000|Overall Study|non-compliance|2|||
130309674|NCT00855816|469099021|FG000|Overall Study|Withdrawal by Subject|22|||
130718402|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718403|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130309675|NCT00855816|469099022|FG001|Overall Study|Withdrawal by Subject|15|||
130309676|NCT00855816|469099021|FG000|Overall Study|Lost to Follow-up|3|||
130309677|NCT00855816|469099022|FG001|Overall Study|Lost to Follow-up|5|||
130309678|NCT00855816|469099021|FG000|Overall Study|Death|1|||
130309679|NCT00855816|469099022|FG001|Overall Study|Death|0|||
130309680|NCT00855816|469099021|FG000|Overall Study|Became ineligible|0|||
130309681|NCT00855816|469099022|FG001|Overall Study|Became ineligible|1|||
130309682|NCT01965704|469099026|FG000|Overall Study|Withdrawal by Subject|2|||
130309683|NCT01965704|469099027|FG001|Overall Study|Withdrawal by Subject|2|||
130309684|NCT01965704|469099028|FG002|Overall Study|Withdrawal by Subject|1|||
130309685|NCT01965704|469099029|FG003|Overall Study|Withdrawal by Subject|1|||
130309686|NCT01965704|469099026|FG000|Overall Study|Delivered at home|1|||
130309687|NCT01965704|469099027|FG001|Overall Study|Delivered at home|1|||
130309688|NCT01965704|469099028|FG002|Overall Study|Delivered at home|0|||
130309689|NCT01965704|469099029|FG003|Overall Study|Delivered at home|0|||
130309690|NCT01965704|469099026|FG000|Overall Study|Experienced complications|0|||
130718404|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718405|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718406|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718407|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718408|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718409|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718410|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718411|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718412|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718413|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718414|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718415|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
130718416|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718417|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718418|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718419|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718420|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718421|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718422|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718423|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718424|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718425|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718426|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718427|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718428|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
130718429|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718430|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718431|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718432|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718433|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718434|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718435|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718436|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718437|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718438|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718439|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130309691|NCT01965704|469099027|FG001|Overall Study|Experienced complications|0|||
130465105|NCT00077675|469670242|FG001|Overall Study|Withdrawal by Subject|0|||
130465106|NCT00077675|469670241|FG000|Overall Study|Other|0|||
130465107|NCT00077675|469670242|FG001|Overall Study|Other|1|||
130309692|NCT01965704|469099028|FG002|Overall Study|Experienced complications|2|||
130309693|NCT01965704|469099029|FG003|Overall Study|Experienced complications|2|||
130309694|NCT01965704|469099026|FG000|Overall Study|Adverse Event|0|||
130309695|NCT01965704|469099027|FG001|Overall Study|Adverse Event|0|||
130309696|NCT01965704|469099028|FG002|Overall Study|Adverse Event|1|||
130465108|NCT00077675|469670241|FG000|Overall Study|Never received study treatment|3|||
130465109|NCT00077675|469670242|FG001|Overall Study|Never received study treatment|3|||
130465110|NCT00244855|469670243|FG000|Overall Study|Withdrawal by Subject|0|||
130557811|NCT03681951|470011828|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557812|NCT03681951|470011829|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557813|NCT03681951|470011830|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557814|NCT03681951|470011831|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557815|NCT03681951|470011832|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557816|NCT03681951|470011833|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557817|NCT03681951|470011834|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130557818|NCT03681951|470011827|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
130557819|NCT03681951|470011828|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557820|NCT03681951|470011829|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557821|NCT03681951|470011830|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557822|NCT03681951|470011831|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557823|NCT03681951|470011832|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557824|NCT03681951|470011833|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557825|NCT03681951|470011834|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130557826|NCT01975428|470011835|FG000|Overall Study|Lost to Follow-up|17|||
130557827|NCT01975428|470011836|FG001|Overall Study|Lost to Follow-up|4|||
130557828|NCT01975428|470011835|FG000|Overall Study|Withdrawal by Subject|3|||
130557829|NCT01975428|470011836|FG001|Overall Study|Withdrawal by Subject|10|||
130557830|NCT00628251|470011837|FG000|Randomised Part|Withdrawal by Subject|0|||
130557831|NCT00628251|470011838|FG001|Randomised Part|Withdrawal by Subject|0|||
130557832|NCT00628251|470011839|FG002|Randomised Part|Withdrawal by Subject|1|||
130557833|NCT00628251|470011837|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
130557834|NCT00628251|470011838|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
130557835|NCT00628251|470011839|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
130557836|NCT00628251|470011837|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
130718440|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718441|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718442|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
130718443|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718444|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718445|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718446|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718447|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718448|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130309697|NCT01965704|469099029|FG003|Overall Study|Adverse Event|1|||
130309698|NCT01965704|469099026|FG000|Overall Study|Did not meet inclusion criteria|0|||
130557837|NCT00628251|470011838|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
130559417|NCT01621542|470016495|FG005|Overall Study|Withdrawal by Subject|3|||
130718449|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718450|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130309699|NCT01965704|469099027|FG001|Overall Study|Did not meet inclusion criteria|0|||
130309700|NCT01965704|469099028|FG002|Overall Study|Did not meet inclusion criteria|1|||
130309701|NCT01965704|469099029|FG003|Overall Study|Did not meet inclusion criteria|1|||
130309702|NCT00687804|469099037|FG000|Core Study|Adverse Event|5|||
130309703|NCT00687804|469099038|FG001|Core Study|Adverse Event|3|||
130309704|NCT00687804|469099039|FG002|Core Study|Adverse Event|3|||
130309705|NCT00687804|469099037|FG000|Core Study|Abnormal laboratory value(s)|1|||
130309706|NCT00687804|469099038|FG001|Core Study|Abnormal laboratory value(s)|0|||
130309707|NCT00687804|469099039|FG002|Core Study|Abnormal laboratory value(s)|0|||
130309708|NCT00687804|469099037|FG000|Core Study|Lack of Efficacy|1|||
130309709|NCT00687804|469099038|FG001|Core Study|Lack of Efficacy|1|||
130309710|NCT00687804|469099039|FG002|Core Study|Lack of Efficacy|1|||
130309711|NCT00687804|469099037|FG000|Core Study|Withdrawal by Subject|4|||
130309712|NCT00687804|469099038|FG001|Core Study|Withdrawal by Subject|7|||
130309713|NCT00687804|469099039|FG002|Core Study|Withdrawal by Subject|7|||
130309714|NCT00687804|469099037|FG000|Core Study|Lost to Follow-up|0|||
130309715|NCT00687804|469099038|FG001|Core Study|Lost to Follow-up|1|||
130309716|NCT00687804|469099039|FG002|Core Study|Lost to Follow-up|0|||
130309717|NCT00687804|469099037|FG000|Core Study|Death|2|||
130309718|NCT00687804|469099038|FG001|Core Study|Death|2|||
130309719|NCT00687804|469099039|FG002|Core Study|Death|2|||
130309720|NCT00687804|469099037|FG000|Core Study|Protocol Violation|1|||
130309721|NCT00687804|469099038|FG001|Core Study|Protocol Violation|1|||
130309722|NCT00687804|469099039|FG002|Core Study|Protocol Violation|0|||
130557838|NCT00628251|470011839|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
130718451|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718452|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718453|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718454|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718455|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718456|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
130718457|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
130718458|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718459|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718460|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718461|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718462|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718463|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718464|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718465|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718466|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718467|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718468|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718469|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718470|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718471|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
130718472|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718473|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718474|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718475|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718476|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718477|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718478|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718479|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718480|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718481|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718482|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718483|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718484|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
130718485|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
130718486|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718487|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130309723|NCT00687804|469099037|FG000|Open-Label Extension Study|Adverse Event|2|||
130309724|NCT00687804|469099038|FG001|Open-Label Extension Study|Adverse Event|2|||
130557839|NCT00628251|470011837|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
130309725|NCT00687804|469099039|FG002|Open-Label Extension Study|Adverse Event|2|||
130309726|NCT00687804|469099037|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
130309727|NCT00687804|469099038|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
130309728|NCT00687804|469099039|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
130309729|NCT00687804|469099037|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
130309730|NCT00687804|469099038|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
130309731|NCT00687804|469099039|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
130309732|NCT00687804|469099037|FG000|Open-Label Extension Study|Administrative problems|1|||
130309733|NCT00687804|469099038|FG001|Open-Label Extension Study|Administrative problems|1|||
130309734|NCT00687804|469099039|FG002|Open-Label Extension Study|Administrative problems|0|||
130309735|NCT00687804|469099037|FG000|Open-Label Extension Study|Death|2|||
130309736|NCT00687804|469099038|FG001|Open-Label Extension Study|Death|3|||
130309737|NCT00687804|469099039|FG002|Open-Label Extension Study|Death|3|||
130309738|NCT04390243|469099040|FG000|Overall Study|Death|1|||
130309739|NCT04390243|469099040|FG000|Overall Study|Disease Progression|4|||
130309740|NCT04390243|469099040|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
130309741|NCT00799903|469099043|FG000|Overall Study|Investigator Site Closed|25|||
130309742|NCT00799903|469099044|FG001|Overall Study|Investigator Site Closed|23|||
130309743|NCT00799903|469099043|FG000|Overall Study|Withdrawal by Subject|179|||
130309744|NCT00799903|469099044|FG001|Overall Study|Withdrawal by Subject|175|||
130309745|NCT00799903|469099043|FG000|Overall Study|Lost to Follow-up|69|||
130309746|NCT00799903|469099044|FG001|Overall Study|Lost to Follow-up|80|||
130309747|NCT00556998|469099049|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
130309748|NCT00556998|469099049|FG000|Voriconazole Intravenous (IV)|Other|4|||
130309749|NCT00556998|469099049|FG000|Voriconazole Oral|Adverse Event|1|||
130309750|NCT00556998|469099049|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
130309751|NCT00216671|469099058|FG000|Overall Study|Adverse Event|4|||
130309752|NCT00216671|469099059|FG001|Overall Study|Adverse Event|9|||
130309753|NCT00216671|469099058|FG000|Overall Study|Pregnancy|0|||
130309754|NCT00216671|469099059|FG001|Overall Study|Pregnancy|1|||
130309755|NCT00216671|469099058|FG000|Overall Study|Withdrawal by Subject|4|||
130309756|NCT00216671|469099059|FG001|Overall Study|Withdrawal by Subject|2|||
130309757|NCT00216671|469099058|FG000|Overall Study|Refused Injections|3|||
130309758|NCT00216671|469099059|FG001|Overall Study|Refused Injections|13|||
130309759|NCT00216671|469099058|FG000|Overall Study|No Need to Continue Medication|1|||
130309760|NCT00216671|469099059|FG001|Overall Study|No Need to Continue Medication|1|||
130309761|NCT00216671|469099058|FG000|Overall Study|Insufficient Response|9|||
130309762|NCT00216671|469099059|FG001|Overall Study|Insufficient Response|4|||
130309763|NCT00216671|469099058|FG000|Overall Study|Lost to Follow-up|3|||
130309764|NCT00216671|469099059|FG001|Overall Study|Lost to Follow-up|5|||
130309765|NCT00216671|469099058|FG000|Overall Study|Non compliant|2|||
130309766|NCT00216671|469099059|FG001|Overall Study|Non compliant|2|||
130309767|NCT00216671|469099058|FG000|Overall Study|Ineligible|0|||
130309768|NCT00216671|469099059|FG001|Overall Study|Ineligible|2|||
130309769|NCT00216671|469099058|FG000|Overall Study|Physician Decision|1|||
130309770|NCT00216671|469099059|FG001|Overall Study|Physician Decision|1|||
130309771|NCT00216671|469099058|FG000|Overall Study|Protocol Violation|3|||
130309772|NCT00216671|469099059|FG001|Overall Study|Protocol Violation|5|||
130309773|NCT00216671|469099058|FG000|Overall Study|Relapse|1|||
130309774|NCT00216671|469099059|FG001|Overall Study|Relapse|0|||
130309775|NCT00216671|469099058|FG000|Overall Study|Investigator Illness|0|||
130309776|NCT00216671|469099059|FG001|Overall Study|Investigator Illness|1|||
130309777|NCT00216671|469099058|FG000|Overall Study|Patient Moved|0|||
130309778|NCT00216671|469099059|FG001|Overall Study|Patient Moved|1|||
130309779|NCT00216671|469099058|FG000|Overall Study|Ineligible, no efficacy data|2|||
130309780|NCT00216671|469099059|FG001|Overall Study|Ineligible, no efficacy data|2|||
130309781|NCT00216671|469099058|FG000|Overall Study|Insufficient Response Adverse Event|2|||
130309782|NCT00216671|469099059|FG001|Overall Study|Insufficient Response Adverse Event|1|||
130309783|NCT04961541|469099060|FG000|Overall Study|Adverse Event|0|||
130309784|NCT04961541|469099061|FG001|Overall Study|Adverse Event|0|||
130309785|NCT04961541|469099062|FG002|Overall Study|Adverse Event|0|||
130309786|NCT04961541|469099063|FG003|Overall Study|Adverse Event|0|||
130309787|NCT04961541|469099064|FG004|Overall Study|Adverse Event|0|||
130309788|NCT04961541|469099065|FG005|Overall Study|Adverse Event|1|||
130309789|NCT04961541|469099066|FG006|Overall Study|Adverse Event|0|||
130309790|NCT04961541|469099067|FG007|Overall Study|Adverse Event|0|||
130309791|NCT04961541|469099068|FG008|Overall Study|Adverse Event|0|||
130309792|NCT04961541|469099069|FG009|Overall Study|Adverse Event|0|||
130309793|NCT04961541|469099070|FG010|Overall Study|Adverse Event|0|||
130309794|NCT04961541|469099071|FG011|Overall Study|Adverse Event|0|||
130557840|NCT00628251|470011838|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
130557841|NCT00628251|470011839|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
130557842|NCT00628251|470011837|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
130557843|NCT00628251|470011838|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
130557844|NCT00628251|470011839|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
130557845|NCT00628251|470011837|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
130718488|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718489|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718490|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718491|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718492|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718493|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718494|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718495|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718496|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718497|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718498|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718499|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718500|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718501|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718502|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718503|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718504|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
130718505|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718506|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718507|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718508|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718509|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718510|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718511|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718512|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718513|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718514|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718515|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718516|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718517|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718518|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
130718519|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718520|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718521|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718522|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130557846|NCT00628251|470011838|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
130718523|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718524|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718525|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718526|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718527|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718528|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718529|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718530|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718531|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718532|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
130718533|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718534|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718535|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718536|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718537|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718538|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718539|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718540|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718541|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718542|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718543|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718544|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718545|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718546|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
130718547|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718548|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718549|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718550|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718551|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718552|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718553|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718554|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130465111|NCT00244855|469670244|FG001|Overall Study|Withdrawal by Subject|1|||
130465112|NCT02706717|469670245|FG000|Overall Study|Withdrawal by Subject|1|||
130718555|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718556|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718557|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718558|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718559|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718560|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
130718561|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718562|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718563|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718564|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718565|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718566|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718567|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718568|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718569|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718570|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718571|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
130718572|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718573|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
130718574|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
130718575|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718576|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718577|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718578|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718579|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718580|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718581|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718582|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718583|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718584|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718585|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718586|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718587|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718588|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
130718589|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718590|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718591|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718592|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718593|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718594|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718595|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718596|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130465113|NCT02706717|469670246|FG001|Overall Study|Withdrawal by Subject|8|||
130465114|NCT02706717|469670245|FG000|Overall Study|Lost to Follow-up|0|||
130465115|NCT02706717|469670246|FG001|Overall Study|Lost to Follow-up|1|||
130465116|NCT02706717|469670245|FG000|Overall Study|Physician Decision|0|||
130465117|NCT02706717|469670246|FG001|Overall Study|Physician Decision|1|||
130465118|NCT02706717|469670245|FG000|Overall Study|Death|0|||
130465119|NCT02706717|469670246|FG001|Overall Study|Death|1|||
130465120|NCT00293293|469670249|FG000|Overall Study|Withdrawal by Subject|1|||
130309795|NCT04961541|469099072|FG012|Overall Study|Adverse Event|0|||
130309796|NCT04961541|469099073|FG013|Overall Study|Adverse Event|0|||
130309797|NCT04961541|469099060|FG000|Overall Study|Lost to Follow-up|0|||
130309798|NCT04961541|469099061|FG001|Overall Study|Lost to Follow-up|0|||
130309799|NCT04961541|469099062|FG002|Overall Study|Lost to Follow-up|3|||
130309800|NCT04961541|469099063|FG003|Overall Study|Lost to Follow-up|0|||
130309801|NCT04961541|469099064|FG004|Overall Study|Lost to Follow-up|0|||
130309802|NCT04961541|469099065|FG005|Overall Study|Lost to Follow-up|0|||
130309803|NCT04961541|469099066|FG006|Overall Study|Lost to Follow-up|1|||
130309804|NCT04961541|469099067|FG007|Overall Study|Lost to Follow-up|1|||
130309805|NCT04961541|469099068|FG008|Overall Study|Lost to Follow-up|0|||
130309806|NCT04961541|469099069|FG009|Overall Study|Lost to Follow-up|1|||
130309807|NCT04961541|469099070|FG010|Overall Study|Lost to Follow-up|0|||
130309808|NCT04961541|469099071|FG011|Overall Study|Lost to Follow-up|0|||
130309809|NCT04961541|469099072|FG012|Overall Study|Lost to Follow-up|1|||
130309810|NCT04961541|469099073|FG013|Overall Study|Lost to Follow-up|0|||
130309811|NCT04961541|469099060|FG000|Overall Study|Withdrawal by Subject|0|||
130309812|NCT04961541|469099061|FG001|Overall Study|Withdrawal by Subject|0|||
130309813|NCT04961541|469099062|FG002|Overall Study|Withdrawal by Subject|1|||
130309814|NCT04961541|469099063|FG003|Overall Study|Withdrawal by Subject|1|||
130309815|NCT04961541|469099064|FG004|Overall Study|Withdrawal by Subject|0|||
130309816|NCT04961541|469099065|FG005|Overall Study|Withdrawal by Subject|0|||
130309817|NCT04961541|469099066|FG006|Overall Study|Withdrawal by Subject|0|||
130309818|NCT04961541|469099067|FG007|Overall Study|Withdrawal by Subject|0|||
130309819|NCT04961541|469099068|FG008|Overall Study|Withdrawal by Subject|0|||
130309820|NCT04961541|469099069|FG009|Overall Study|Withdrawal by Subject|1|||
130309821|NCT04961541|469099070|FG010|Overall Study|Withdrawal by Subject|0|||
130309822|NCT04961541|469099071|FG011|Overall Study|Withdrawal by Subject|0|||
130309823|NCT04961541|469099072|FG012|Overall Study|Withdrawal by Subject|0|||
130309824|NCT04961541|469099073|FG013|Overall Study|Withdrawal by Subject|0|||
130309825|NCT03539601|469099075|FG000|Overall Study|Withdraw by parent/guardian|1|||
130309826|NCT03539601|469099076|FG001|Overall Study|Withdraw by parent/guardian|0|||
130309827|NCT03539601|469099077|FG002|Overall Study|Withdraw by parent/guardian|1|||
130309828|NCT03539601|469099078|FG003|Overall Study|Withdraw by parent/guardian|0|||
130309829|NCT03539601|469099075|FG000|Overall Study|Adverse Event|0|||
130309830|NCT03539601|469099076|FG001|Overall Study|Adverse Event|2|||
130309831|NCT03539601|469099077|FG002|Overall Study|Adverse Event|0|||
130309832|NCT03539601|469099078|FG003|Overall Study|Adverse Event|0|||
130309833|NCT03539601|469099075|FG000|Overall Study|Lost to Follow-up|2|||
130309834|NCT03539601|469099076|FG001|Overall Study|Lost to Follow-up|4|||
130309835|NCT03539601|469099077|FG002|Overall Study|Lost to Follow-up|5|||
130465121|NCT00293293|469670250|FG001|Overall Study|Withdrawal by Subject|1|||
130465122|NCT00293293|469670249|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
130465123|NCT00293293|469670250|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
130465124|NCT00293293|469670249|FG000|Overall Study|Patient discontinued chemotherapy|0|||
130465125|NCT00293293|469670250|FG001|Overall Study|Patient discontinued chemotherapy|1|||
130465126|NCT02512965|469670253|FG000|Overall Study|Withdrawal by Subject|0|||
130465127|NCT02512965|469670254|FG001|Overall Study|Withdrawal by Subject|4|||
130465128|NCT00835770|469670255|FG000|Overall Study|MS Relapse|17|||
130465129|NCT00835770|469670256|FG001|Overall Study|MS Relapse|23|||
130465130|NCT00835770|469670255|FG000|Overall Study|MS Progression|14|||
130465131|NCT00835770|469670256|FG001|Overall Study|MS Progression|9|||
130465132|NCT00835770|469670255|FG000|Overall Study|Adverse Event|113|||
130465133|NCT00835770|469670256|FG001|Overall Study|Adverse Event|124|||
130465134|NCT00835770|469670255|FG000|Overall Study|Lost to Follow-up|22|||
130465135|NCT00835770|469670256|FG001|Overall Study|Lost to Follow-up|19|||
130465136|NCT00835770|469670255|FG000|Overall Study|Consent Withdrawn|144|||
130465137|NCT00835770|469670256|FG001|Overall Study|Consent Withdrawn|156|||
130465138|NCT00835770|469670255|FG000|Overall Study|Investigator Decision|42|||
130465139|NCT00835770|469670256|FG001|Overall Study|Investigator Decision|42|||
130465140|NCT00835770|469670255|FG000|Overall Study|Participant Non-Compliance|11|||
130465141|NCT00835770|469670256|FG001|Overall Study|Participant Non-Compliance|9|||
130465142|NCT00835770|469670255|FG000|Overall Study|Death|4|||
130465143|NCT00835770|469670256|FG001|Overall Study|Death|6|||
130465144|NCT00835770|469670255|FG000|Overall Study|Other|115|||
130309836|NCT03539601|469099078|FG003|Overall Study|Lost to Follow-up|0|||
130309837|NCT03539601|469099075|FG000|Overall Study|Withdrawal by Subject|2|||
130309838|NCT03539601|469099076|FG001|Overall Study|Withdrawal by Subject|0|||
130465145|NCT00835770|469670256|FG001|Overall Study|Other|104|||
130309839|NCT03539601|469099077|FG002|Overall Study|Withdrawal by Subject|0|||
130309840|NCT03539601|469099078|FG003|Overall Study|Withdrawal by Subject|1|||
130309841|NCT03539601|469099075|FG000|Overall Study|Randomized but not treated|1|||
130309842|NCT03539601|469099076|FG001|Overall Study|Randomized but not treated|1|||
130309843|NCT03539601|469099077|FG002|Overall Study|Randomized but not treated|0|||
130557847|NCT00628251|470011839|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
130309844|NCT03539601|469099078|FG003|Overall Study|Randomized but not treated|0|||
130309845|NCT01970306|469099079|FG000|Overall Study|Not eligible|3|||
130309846|NCT01970306|469099079|FG000|Overall Study|Not able to be treated|9|||
130465146|NCT00835770|469670255|FG000|Overall Study|Other|2|||
130465147|NCT00835770|469670256|FG001|Overall Study|Other|1|||
130465148|NCT01185782|469670257|FG000|Overall Study|Adverse Event|0|||
130309847|NCT00226811|469099080|FG000|Overall Study|Death|8|||
130309848|NCT00226811|469099080|FG000|Overall Study|Adverse Event|11|||
130309849|NCT00226811|469099080|FG000|Overall Study|Lack of Efficacy|55|||
130309850|NCT00226811|469099080|FG000|Overall Study|Withdrawal by Subject|2|||
130309851|NCT03081884|469099081|FG000|Overall Study|deferred prostate cancer treatment|1|||
130309852|NCT03081884|469099081|FG000|Overall Study|metastasis managed with systemic therapy|3|||
130309853|NCT03948334|469099083|FG000|Overall Study|Adverse Event|1|||
130309854|NCT03948334|469099084|FG001|Overall Study|Adverse Event|4|||
130309855|NCT03948334|469099083|FG000|Overall Study|Lack of Efficacy|2|||
130309856|NCT03948334|469099084|FG001|Overall Study|Lack of Efficacy|0|||
130309857|NCT03948334|469099083|FG000|Overall Study|Lost to Follow-up|1|||
130309858|NCT03948334|469099084|FG001|Overall Study|Lost to Follow-up|0|||
130309859|NCT03948334|469099083|FG000|Overall Study|Physician Decision|1|||
130309860|NCT03948334|469099084|FG001|Overall Study|Physician Decision|0|||
130309861|NCT03948334|469099083|FG000|Overall Study|Pregnancy|0|||
130309862|NCT03948334|469099084|FG001|Overall Study|Pregnancy|1|||
130309863|NCT03948334|469099083|FG000|Overall Study|Protocol Deviation|1|||
130309864|NCT03948334|469099084|FG001|Overall Study|Protocol Deviation|0|||
130309865|NCT03948334|469099083|FG000|Overall Study|Study terminated by Sponsor|50|||
130309866|NCT03948334|469099084|FG001|Overall Study|Study terminated by Sponsor|51|||
130309867|NCT03948334|469099083|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
130309868|NCT03948334|469099084|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
130309869|NCT01100320|469099087|FG000|Period 1|Withdrawal by Subject|2|||
130309870|NCT01100320|469099088|FG001|Period 1|Withdrawal by Subject|4|||
130309871|NCT01100320|469099087|FG000|Period 1|Positive Drug Screen|1|||
130309872|NCT01100320|469099088|FG001|Period 1|Positive Drug Screen|1|||
130309873|NCT01100320|469099087|FG000|Period 1|Adverse Event|2|||
130309874|NCT01100320|469099088|FG001|Period 1|Adverse Event|2|||
130309875|NCT01100320|469099087|FG000|Period 2|Withdrawal by Subject|1|||
130309876|NCT01100320|469099088|FG001|Period 2|Withdrawal by Subject|1|||
130309877|NCT00550953|469099089|FG000|Overall Study|Adverse Event|4|||
130309878|NCT00550953|469099090|FG001|Overall Study|Adverse Event|3|||
130309879|NCT00550953|469099089|FG000|Overall Study|Not able to visit the site|2|||
130309880|NCT00550953|469099090|FG001|Overall Study|Not able to visit the site|3|||
130309881|NCT00596752|469099091|FG000|Overall Study|Other Reason|44|||
130309882|NCT00596752|469099092|FG001|Overall Study|Other Reason|49|||
130309883|NCT00596752|469099091|FG000|Overall Study|Adverse Event|34|||
130309884|NCT00596752|469099092|FG001|Overall Study|Adverse Event|34|||
130309885|NCT00596752|469099091|FG000|Overall Study|Lost to Follow-up|22|||
130309886|NCT00596752|469099092|FG001|Overall Study|Lost to Follow-up|38|||
130309887|NCT00596752|469099091|FG000|Overall Study|Withdrawal by Subject|12|||
130309888|NCT00596752|469099092|FG001|Overall Study|Withdrawal by Subject|9|||
130309889|NCT00596752|469099091|FG000|Overall Study|Unsatisfactory Compliance|9|||
130309890|NCT00596752|469099092|FG001|Overall Study|Unsatisfactory Compliance|6|||
130309891|NCT00596752|469099091|FG000|Overall Study|Lack of Efficacy|4|||
130309892|NCT00596752|469099092|FG001|Overall Study|Lack of Efficacy|7|||
130309893|NCT00596752|469099091|FG000|Overall Study|Protocol Violation|1|||
130309894|NCT00596752|469099092|FG001|Overall Study|Protocol Violation|0|||
130309895|NCT04669301|469099093|FG000|Overall Study|Lost to Follow-up|0|||
130309896|NCT04669301|469099094|FG001|Overall Study|Lost to Follow-up|1|||
130309897|NCT04669301|469099095|FG002|Overall Study|Lost to Follow-up|0|||
130309898|NCT04669301|469099093|FG000|Overall Study|Withdrawal by Subject|3|||
130309899|NCT04669301|469099094|FG001|Overall Study|Withdrawal by Subject|2|||
130309900|NCT04669301|469099095|FG002|Overall Study|Withdrawal by Subject|0|||
130309901|NCT02940496|469099096|FG000|Overall Study|Adverse Event|1|||
130309902|NCT02940496|469099097|FG001|Overall Study|Adverse Event|0|||
130309903|NCT02940496|469099096|FG000|Overall Study|Death|2|||
130465149|NCT01185782|469670258|FG001|Overall Study|Adverse Event|1|||
130309904|NCT02940496|469099097|FG001|Overall Study|Death|0|||
130309905|NCT02940496|469099096|FG000|Overall Study|Hospice Care|1|||
130309906|NCT02940496|469099097|FG001|Overall Study|Hospice Care|0|||
130309907|NCT02940496|469099096|FG000|Overall Study|No MRE Done|1|||
130309908|NCT02940496|469099097|FG001|Overall Study|No MRE Done|0|||
130309909|NCT02940496|469099096|FG000|Overall Study|MRE Failure|1|||
130309910|NCT02940496|469099097|FG001|Overall Study|MRE Failure|0|||
130465150|NCT01185782|469670257|FG000|Overall Study|Protocol Violation|1|||
130465151|NCT01185782|469670258|FG001|Overall Study|Protocol Violation|0|||
130309911|NCT00548145|469099102|FG000|Overall Study|Death|0|||
130309912|NCT00548145|469099103|FG001|Overall Study|Death|1|||
130309913|NCT00548145|469099102|FG000|Overall Study|Withdrawal by Subject|0|||
130309914|NCT00548145|469099103|FG001|Overall Study|Withdrawal by Subject|2|||
130309915|NCT00548145|469099102|FG000|Overall Study|Physician Decision|1|||
130309916|NCT00548145|469099103|FG001|Overall Study|Physician Decision|1|||
130309917|NCT02119663|469099105|FG000|Overall Study|Disease progression|26|||
130309918|NCT02119663|469099106|FG001|Overall Study|Disease progression|27|||
130309919|NCT02119663|469099105|FG000|Overall Study|Adverse Event|5|||
130309920|NCT02119663|469099106|FG001|Overall Study|Adverse Event|5|||
130309921|NCT02119663|469099105|FG000|Overall Study|Death|3|||
130309922|NCT02119663|469099106|FG001|Overall Study|Death|2|||
130309923|NCT02119663|469099105|FG000|Overall Study|Physician Decision|1|||
130309924|NCT02119663|469099106|FG001|Overall Study|Physician Decision|2|||
130309925|NCT02119663|469099105|FG000|Overall Study|Other unspecified|2|||
130309926|NCT02119663|469099106|FG001|Overall Study|Other unspecified|0|||
130309927|NCT02119663|469099105|FG000|Overall Study|Subject decision|0|||
130309928|NCT02119663|469099106|FG001|Overall Study|Subject decision|1|||
130309929|NCT02119663|469099105|FG000|Overall Study|Study Terminated by the Sponsor|3|||
130309930|NCT02119663|469099106|FG001|Overall Study|Study Terminated by the Sponsor|4|||
130309931|NCT02863328|469099107|FG000|Overall Study|Lost to Follow-up|4|||
130309932|NCT02863328|469099108|FG001|Overall Study|Lost to Follow-up|10|||
130309933|NCT02863328|469099107|FG000|Overall Study|Withdrawal by Subject|7|||
130309934|NCT02863328|469099108|FG001|Overall Study|Withdrawal by Subject|12|||
130309935|NCT02863328|469099107|FG000|Overall Study|Died|0|||
130309936|NCT02863328|469099108|FG001|Overall Study|Died|1|||
130309937|NCT00892775|469099109|FG000|Overall Study|Protocol Violation|1|||
130309938|NCT00892775|469099110|FG001|Overall Study|Protocol Violation|0|||
130309939|NCT00892775|469099109|FG000|Overall Study|Subject difficulties with blood drawing|1|||
130309940|NCT00892775|469099110|FG001|Overall Study|Subject difficulties with blood drawing|0|||
130309941|NCT00892775|469099109|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
130309942|NCT00892775|469099110|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
130309943|NCT00892775|469099109|FG000|Overall Study|Migrated/ moved from study area|1|||
130309944|NCT00892775|469099110|FG001|Overall Study|Migrated/ moved from study area|0|||
130309945|NCT00892775|469099109|FG000|Overall Study|Withdrawal by Subject|0|||
130309946|NCT00892775|469099110|FG001|Overall Study|Withdrawal by Subject|1|||
130309947|NCT00892775|469099109|FG000|Overall Study|Lost to Follow-up|1|||
130309948|NCT00892775|469099110|FG001|Overall Study|Lost to Follow-up|0|||
130309949|NCT00699660|469099111|FG000|Overall Study|Lost to Follow-up|4|||
130309950|NCT00699660|469099112|FG001|Overall Study|Lost to Follow-up|2|||
130309951|NCT00699660|469099111|FG000|Overall Study|missing reports and recording failures|10|||
130309952|NCT00699660|469099112|FG001|Overall Study|missing reports and recording failures|6|||
130309953|NCT00398320|469099113|FG000|Overall Study|Death|1|||
130309954|NCT00398320|469099113|FG000|Overall Study|Adverse Event|4|||
130309955|NCT00398320|469099113|FG000|Overall Study|Physician Decision|1|||
130309956|NCT00064792|469099114|FG000|Overall Study|Withdrawal by Subject|2|||
130309957|NCT00064792|469099115|FG001|Overall Study|Withdrawal by Subject|0|||
130309958|NCT00064792|469099114|FG000|Overall Study|Adverse Event|3|||
130309959|NCT00064792|469099115|FG001|Overall Study|Adverse Event|0|||
130309960|NCT01870726|469099116|FG000|Overall Study|Withdrawal of informed consent|0|||
130309961|NCT01870726|469099117|FG001|Overall Study|Withdrawal of informed consent|0|||
130309962|NCT01870726|469099118|FG002|Overall Study|Withdrawal of informed consent|0|||
130309963|NCT01870726|469099119|FG003|Overall Study|Withdrawal of informed consent|1|||
130309964|NCT01870726|469099120|FG004|Overall Study|Withdrawal of informed consent|0|||
130309965|NCT01870726|469099121|FG005|Overall Study|Withdrawal of informed consent|0|||
130309966|NCT01870726|469099122|FG006|Overall Study|Withdrawal of informed consent|0|||
130309967|NCT01870726|469099116|FG000|Overall Study|Withdrawal by Subject|0|||
130309968|NCT01870726|469099117|FG001|Overall Study|Withdrawal by Subject|1|||
130309969|NCT01870726|469099118|FG002|Overall Study|Withdrawal by Subject|0|||
130309970|NCT01870726|469099119|FG003|Overall Study|Withdrawal by Subject|0|||
130309971|NCT01870726|469099120|FG004|Overall Study|Withdrawal by Subject|0|||
130309972|NCT01870726|469099121|FG005|Overall Study|Withdrawal by Subject|0|||
130309973|NCT01870726|469099122|FG006|Overall Study|Withdrawal by Subject|0|||
130309974|NCT01870726|469099116|FG000|Overall Study|Adverse Event|0|||
130309975|NCT01870726|469099117|FG001|Overall Study|Adverse Event|0|||
130309976|NCT01870726|469099118|FG002|Overall Study|Adverse Event|0|||
130309977|NCT01870726|469099119|FG003|Overall Study|Adverse Event|0|||
130309978|NCT01870726|469099120|FG004|Overall Study|Adverse Event|1|||
130309979|NCT01870726|469099121|FG005|Overall Study|Adverse Event|1|||
130309980|NCT01870726|469099122|FG006|Overall Study|Adverse Event|0|||
130309981|NCT01870726|469099116|FG000|Overall Study|Progressive disease|5|||
130309982|NCT01870726|469099117|FG001|Overall Study|Progressive disease|5|||
130309983|NCT01870726|469099118|FG002|Overall Study|Progressive disease|4|||
130309984|NCT01870726|469099119|FG003|Overall Study|Progressive disease|5|||
130309985|NCT01870726|469099120|FG004|Overall Study|Progressive disease|6|||
130309986|NCT01870726|469099121|FG005|Overall Study|Progressive disease|4|||
130309987|NCT01870726|469099122|FG006|Overall Study|Progressive disease|10|||
130309988|NCT03301350|469099123|FG000|Overall Study|Withdrawal by Subject|4|||
130309989|NCT03301350|469099123|FG000|Overall Study|Adverse Event|1|||
130309990|NCT03301350|469099123|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
130309991|NCT03301350|469099123|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
130309992|NCT03301350|469099123|FG000|Overall Study|no detail provided|1|||
130309993|NCT01248949|469099126|FG000|Overall Study|Lost to Follow-up|2|||
130309994|NCT01248949|469099127|FG001|Overall Study|Lost to Follow-up|2|||
130309995|NCT01248949|469099128|FG002|Overall Study|Lost to Follow-up|2|||
130309996|NCT01248949|469099129|FG003|Overall Study|Lost to Follow-up|1|||
130309997|NCT01248949|469099130|FG004|Overall Study|Lost to Follow-up|0|||
130557848|NCT01020448|470011840|FG000|Pre-assignment|Adverse Event|6|||
130557849|NCT01020448|470011840|FG000|Pre-assignment|Withdrawal by Subject|5|||
130557850|NCT01020448|470011840|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
130557851|NCT01020448|470011840|FG000|Treatment|Adverse Event|11|||
130557852|NCT01020448|470011840|FG000|Treatment|Consent Withdrawn|3|||
130557853|NCT01020448|470011840|FG000|Treatment|Disease Progression|2|||
130557854|NCT01020448|470011840|FG000|Treatment|Lack of Efficacy|8|||
130557855|NCT01020448|470011840|FG000|Treatment|Lost to Follow-up|2|||
130557856|NCT00728481|470011841|FG000|Overall Study|Withdrawal by Subject|0|||
130557857|NCT00728481|470011842|FG001|Overall Study|Withdrawal by Subject|1|||
130557858|NCT00728481|470011841|FG000|Overall Study|Adverse Event|0|||
130557859|NCT00728481|470011842|FG001|Overall Study|Adverse Event|1|||
130557860|NCT00728481|470011841|FG000|Overall Study|Study medication non-compliance|0|||
130557861|NCT00728481|470011842|FG001|Overall Study|Study medication non-compliance|2|||
130557862|NCT00728481|470011841|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
130557863|NCT00728481|470011842|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
130557864|NCT02545322|470011843|FG000|Overall Study|Withdrawal by Subject|3|||
130557865|NCT00041067|470011844|FG000|Overall Study|Adverse Event|20|||
130557866|NCT00041067|470011844|FG000|Overall Study|Progression|19|||
130557867|NCT00041067|470011844|FG000|Overall Study|Patient refusal|12|||
130557868|NCT00041067|470011844|FG000|Overall Study|Other reasons|23|||
130557869|NCT00041067|470011844|FG000|Overall Study|Ineligible|2|||
130557870|NCT01505010|470011845|FG000|Overall Study|Protocol Violation|0|||
130557871|NCT01505010|470011846|FG001|Overall Study|Protocol Violation|1|||
130557872|NCT01505010|470011845|FG000|Overall Study|Lost to Follow-up|0|||
130557873|NCT01505010|470011846|FG001|Overall Study|Lost to Follow-up|1|||
130557874|NCT01968070|470011853|FG000|Period 1|Withdrawal by Subject|0|||
130557875|NCT01968070|470011854|FG001|Period 1|Withdrawal by Subject|1|||
130557876|NCT01968070|470011855|FG002|Period 1|Withdrawal by Subject|0|||
130557877|NCT01968070|470011856|FG003|Period 1|Withdrawal by Subject|0|||
130557878|NCT01968070|470011857|FG004|Period 1|Withdrawal by Subject|0|||
130557879|NCT01968070|470011858|FG005|Period 1|Withdrawal by Subject|0|||
130557880|NCT01968070|470011859|FG006|Period 1|Withdrawal by Subject|1|||
130557881|NCT01968070|470011860|FG007|Period 1|Withdrawal by Subject|0|||
130557882|NCT01968070|470011861|FG008|Period 1|Withdrawal by Subject|0|||
130557883|NCT01968070|470011862|FG009|Period 1|Withdrawal by Subject|0|||
130557884|NCT01968070|470011863|FG010|Period 1|Withdrawal by Subject|0|||
130557885|NCT01968070|470011864|FG011|Period 1|Withdrawal by Subject|0|||
130557886|NCT01968070|470011865|FG012|Period 1|Withdrawal by Subject|0|||
130557887|NCT01968070|470011866|FG013|Period 1|Withdrawal by Subject|0|||
130557888|NCT01968070|470011867|FG014|Period 1|Withdrawal by Subject|0|||
130557889|NCT01968070|470011868|FG015|Period 1|Withdrawal by Subject|1|||
130557890|NCT01968070|470011869|FG016|Period 1|Withdrawal by Subject|0|||
130557891|NCT01968070|470011870|FG017|Period 1|Withdrawal by Subject|0|||
130557892|NCT01968070|470011853|FG000|Period 1|Protocol Violation|0|||
130557893|NCT01968070|470011854|FG001|Period 1|Protocol Violation|0|||
130557894|NCT01968070|470011855|FG002|Period 1|Protocol Violation|0|||
130718597|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130557895|NCT01968070|470011856|FG003|Period 1|Protocol Violation|1|||
130557896|NCT01968070|470011857|FG004|Period 1|Protocol Violation|1|||
130557897|NCT01968070|470011858|FG005|Period 1|Protocol Violation|0|||
130557898|NCT01968070|470011859|FG006|Period 1|Protocol Violation|0|||
130557899|NCT01968070|470011860|FG007|Period 1|Protocol Violation|0|||
130557900|NCT01968070|470011861|FG008|Period 1|Protocol Violation|0|||
130557901|NCT01968070|470011862|FG009|Period 1|Protocol Violation|0|||
130557902|NCT01968070|470011863|FG010|Period 1|Protocol Violation|0|||
130557903|NCT01968070|470011864|FG011|Period 1|Protocol Violation|0|||
130718598|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718599|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
130718600|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718601|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
130718602|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
130718603|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718604|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718605|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718606|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130557904|NCT01968070|470011865|FG012|Period 1|Protocol Violation|0|||
130557905|NCT01968070|470011866|FG013|Period 1|Protocol Violation|0|||
130557906|NCT01968070|470011867|FG014|Period 1|Protocol Violation|0|||
130557907|NCT01968070|470011868|FG015|Period 1|Protocol Violation|0|||
130557908|NCT01968070|470011869|FG016|Period 1|Protocol Violation|0|||
130557909|NCT01968070|470011870|FG017|Period 1|Protocol Violation|0|||
130557910|NCT01968070|470011853|FG000|Period 1|Lost to Follow-up|0|||
130557911|NCT01968070|470011854|FG001|Period 1|Lost to Follow-up|0|||
130557912|NCT01968070|470011855|FG002|Period 1|Lost to Follow-up|0|||
130557913|NCT01968070|470011856|FG003|Period 1|Lost to Follow-up|1|||
130557914|NCT01968070|470011857|FG004|Period 1|Lost to Follow-up|0|||
130557915|NCT01968070|470011858|FG005|Period 1|Lost to Follow-up|0|||
130557916|NCT01968070|470011859|FG006|Period 1|Lost to Follow-up|0|||
130557917|NCT01968070|470011860|FG007|Period 1|Lost to Follow-up|0|||
130557918|NCT01968070|470011861|FG008|Period 1|Lost to Follow-up|0|||
130718607|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130557919|NCT01968070|470011862|FG009|Period 1|Lost to Follow-up|0|||
130557920|NCT01968070|470011863|FG010|Period 1|Lost to Follow-up|0|||
130557921|NCT01968070|470011864|FG011|Period 1|Lost to Follow-up|0|||
130557922|NCT01968070|470011865|FG012|Period 1|Lost to Follow-up|0|||
130557923|NCT01968070|470011866|FG013|Period 1|Lost to Follow-up|0|||
130557924|NCT01968070|470011867|FG014|Period 1|Lost to Follow-up|0|||
130557925|NCT01968070|470011868|FG015|Period 1|Lost to Follow-up|0|||
130557926|NCT01968070|470011869|FG016|Period 1|Lost to Follow-up|0|||
130557927|NCT01968070|470011870|FG017|Period 1|Lost to Follow-up|0|||
130557928|NCT01968070|470011853|FG000|Period 1|Adverse Event|0|||
130557929|NCT01968070|470011854|FG001|Period 1|Adverse Event|0|||
130557930|NCT01968070|470011855|FG002|Period 1|Adverse Event|0|||
130557931|NCT01968070|470011856|FG003|Period 1|Adverse Event|0|||
130557932|NCT01968070|470011857|FG004|Period 1|Adverse Event|0|||
130465152|NCT01185782|469670257|FG000|Overall Study|Poor Response to Treatment|3|||
130465153|NCT01185782|469670258|FG001|Overall Study|Poor Response to Treatment|1|||
130465154|NCT01185782|469670257|FG000|Overall Study|Other|2|||
130465155|NCT01185782|469670258|FG001|Overall Study|Other|5|||
130465156|NCT01185782|469670257|FG000|Overall Study|Randomized but not treated|0|||
130465157|NCT01185782|469670258|FG001|Overall Study|Randomized but not treated|4|||
130465158|NCT02988817|469670263|FG000|Overall Study|Withdrawal by Subject|1|||
130465159|NCT02988817|469670264|FG001|Overall Study|Withdrawal by Subject|0|||
130465160|NCT02988817|469670265|FG002|Overall Study|Withdrawal by Subject|0|||
130465161|NCT02988817|469670266|FG003|Overall Study|Withdrawal by Subject|1|||
130465162|NCT02988817|469670267|FG004|Overall Study|Withdrawal by Subject|3|||
130465163|NCT02988817|469670268|FG005|Overall Study|Withdrawal by Subject|1|||
130465164|NCT02988817|469670269|FG006|Overall Study|Withdrawal by Subject|2|||
130557933|NCT01968070|470011858|FG005|Period 1|Adverse Event|0|||
130557934|NCT01968070|470011859|FG006|Period 1|Adverse Event|1|||
130557935|NCT01968070|470011860|FG007|Period 1|Adverse Event|0|||
130718608|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718609|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718610|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718611|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718612|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718613|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718614|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718615|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718616|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718617|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130718618|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130718619|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
130718620|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
130718621|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
130718622|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718623|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718624|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718625|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718626|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718627|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718628|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718629|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718630|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718631|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
130718632|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130309998|NCT01248949|469099126|FG000|Overall Study|Withdrawal by Subject|5|||
130465165|NCT02988817|469670270|FG007|Overall Study|Withdrawal by Subject|1|||
130465166|NCT02988817|469670271|FG008|Overall Study|Withdrawal by Subject|1|||
130309999|NCT01248949|469099127|FG001|Overall Study|Withdrawal by Subject|3|||
130465167|NCT02988817|469670272|FG009|Overall Study|Withdrawal by Subject|1|||
130557936|NCT01968070|470011861|FG008|Period 1|Adverse Event|0|||
130557937|NCT01968070|470011862|FG009|Period 1|Adverse Event|0|||
130557938|NCT01968070|470011863|FG010|Period 1|Adverse Event|0|||
130557939|NCT01968070|470011864|FG011|Period 1|Adverse Event|0|||
130557940|NCT01968070|470011865|FG012|Period 1|Adverse Event|0|||
130557941|NCT01968070|470011866|FG013|Period 1|Adverse Event|0|||
130557942|NCT01968070|470011867|FG014|Period 1|Adverse Event|0|||
130557943|NCT01968070|470011868|FG015|Period 1|Adverse Event|0|||
130557944|NCT01968070|470011869|FG016|Period 1|Adverse Event|0|||
130557945|NCT01968070|470011870|FG017|Period 1|Adverse Event|0|||
130557946|NCT01968070|470011853|FG000|Period 1|Physician Decision|0|||
130557947|NCT01968070|470011854|FG001|Period 1|Physician Decision|0|||
130557948|NCT01968070|470011855|FG002|Period 1|Physician Decision|0|||
130557949|NCT01968070|470011856|FG003|Period 1|Physician Decision|0|||
130557950|NCT01968070|470011857|FG004|Period 1|Physician Decision|0|||
130557951|NCT01968070|470011858|FG005|Period 1|Physician Decision|0|||
130557952|NCT01968070|470011859|FG006|Period 1|Physician Decision|0|||
130557953|NCT01968070|470011860|FG007|Period 1|Physician Decision|0|||
130310000|NCT01248949|469099128|FG002|Overall Study|Withdrawal by Subject|11|||
130465168|NCT02988817|469670273|FG010|Overall Study|Withdrawal by Subject|1|||
130465169|NCT02988817|469670274|FG011|Overall Study|Withdrawal by Subject|12|||
130465170|NCT02988817|469670275|FG012|Overall Study|Withdrawal by Subject|6|||
130465171|NCT02988817|469670276|FG013|Overall Study|Withdrawal by Subject|6|||
130465172|NCT02988817|469670277|FG014|Overall Study|Withdrawal by Subject|4|||
130465173|NCT02988817|469670278|FG015|Overall Study|Withdrawal by Subject|5|||
130465174|NCT02988817|469670279|FG016|Overall Study|Withdrawal by Subject|4|||
130465175|NCT02988817|469670280|FG017|Overall Study|Withdrawal by Subject|11|||
130465176|NCT02988817|469670281|FG018|Overall Study|Withdrawal by Subject|4|||
130465177|NCT02988817|469670282|FG019|Overall Study|Withdrawal by Subject|2|||
130465178|NCT02988817|469670263|FG000|Overall Study|Death|0|||
130465179|NCT02988817|469670264|FG001|Overall Study|Death|1|||
130465180|NCT02988817|469670265|FG002|Overall Study|Death|3|||
130465181|NCT02988817|469670266|FG003|Overall Study|Death|1|||
130465182|NCT02988817|469670267|FG004|Overall Study|Death|6|||
130465183|NCT02988817|469670268|FG005|Overall Study|Death|10|||
130465184|NCT02988817|469670269|FG006|Overall Study|Death|1|||
130465185|NCT02988817|469670270|FG007|Overall Study|Death|2|||
130465186|NCT02988817|469670271|FG008|Overall Study|Death|1|||
130465187|NCT02988817|469670272|FG009|Overall Study|Death|5|||
130465188|NCT02988817|469670273|FG010|Overall Study|Death|1|||
130465189|NCT02988817|469670274|FG011|Overall Study|Death|8|||
130465190|NCT02988817|469670275|FG012|Overall Study|Death|9|||
130465191|NCT02988817|469670276|FG013|Overall Study|Death|17|||
130465192|NCT02988817|469670277|FG014|Overall Study|Death|18|||
130465193|NCT02988817|469670278|FG015|Overall Study|Death|30|||
130465194|NCT02988817|469670279|FG016|Overall Study|Death|17|||
130465195|NCT02988817|469670280|FG017|Overall Study|Death|38|||
130465196|NCT02988817|469670281|FG018|Overall Study|Death|14|||
130465197|NCT02988817|469670282|FG019|Overall Study|Death|16|||
130465198|NCT02988817|469670263|FG000|Overall Study|Other|0|||
130465199|NCT02988817|469670264|FG001|Overall Study|Other|0|||
130465200|NCT02988817|469670265|FG002|Overall Study|Other|0|||
130465201|NCT02988817|469670266|FG003|Overall Study|Other|1|||
130465202|NCT02988817|469670267|FG004|Overall Study|Other|1|||
130465203|NCT02988817|469670268|FG005|Overall Study|Other|0|||
130465204|NCT02988817|469670269|FG006|Overall Study|Other|0|||
130465205|NCT02988817|469670270|FG007|Overall Study|Other|0|||
130465206|NCT02988817|469670271|FG008|Overall Study|Other|0|||
130465207|NCT02988817|469670272|FG009|Overall Study|Other|0|||
130465208|NCT02988817|469670273|FG010|Overall Study|Other|0|||
130465209|NCT02988817|469670274|FG011|Overall Study|Other|0|||
130465210|NCT02988817|469670275|FG012|Overall Study|Other|0|||
130465211|NCT02988817|469670276|FG013|Overall Study|Other|0|||
130465212|NCT02988817|469670277|FG014|Overall Study|Other|0|||
130465213|NCT02988817|469670278|FG015|Overall Study|Other|1|||
130465214|NCT02988817|469670279|FG016|Overall Study|Other|0|||
130465215|NCT02988817|469670280|FG017|Overall Study|Other|0|||
130465216|NCT02988817|469670281|FG018|Overall Study|Other|0|||
130465217|NCT02988817|469670282|FG019|Overall Study|Other|0|||
130465218|NCT02988817|469670263|FG000|Overall Study|Lost to Follow-up|0|||
130465219|NCT02988817|469670264|FG001|Overall Study|Lost to Follow-up|0|||
130465220|NCT02988817|469670265|FG002|Overall Study|Lost to Follow-up|0|||
130465221|NCT02988817|469670266|FG003|Overall Study|Lost to Follow-up|0|||
130465222|NCT02988817|469670267|FG004|Overall Study|Lost to Follow-up|0|||
130465223|NCT02988817|469670268|FG005|Overall Study|Lost to Follow-up|0|||
130465224|NCT02988817|469670269|FG006|Overall Study|Lost to Follow-up|0|||
130465225|NCT02988817|469670270|FG007|Overall Study|Lost to Follow-up|0|||
130465226|NCT02988817|469670271|FG008|Overall Study|Lost to Follow-up|1|||
130465227|NCT02988817|469670272|FG009|Overall Study|Lost to Follow-up|0|||
130465228|NCT02988817|469670273|FG010|Overall Study|Lost to Follow-up|1|||
130465229|NCT02988817|469670274|FG011|Overall Study|Lost to Follow-up|1|||
130465230|NCT02988817|469670275|FG012|Overall Study|Lost to Follow-up|0|||
130465231|NCT02988817|469670276|FG013|Overall Study|Lost to Follow-up|0|||
130465232|NCT02988817|469670277|FG014|Overall Study|Lost to Follow-up|1|||
130465233|NCT02988817|469670278|FG015|Overall Study|Lost to Follow-up|1|||
130557954|NCT01968070|470011861|FG008|Period 1|Physician Decision|0|||
130557955|NCT01968070|470011862|FG009|Period 1|Physician Decision|0|||
130557956|NCT01968070|470011863|FG010|Period 1|Physician Decision|0|||
130557957|NCT01968070|470011864|FG011|Period 1|Physician Decision|1|||
130310001|NCT01248949|469099129|FG003|Overall Study|Withdrawal by Subject|3|||
130310002|NCT01248949|469099130|FG004|Overall Study|Withdrawal by Subject|1|||
130310003|NCT01248949|469099126|FG000|Overall Study|Death|22|||
130310004|NCT01248949|469099127|FG001|Overall Study|Death|7|||
130310005|NCT01248949|469099128|FG002|Overall Study|Death|21|||
130310006|NCT01248949|469099129|FG003|Overall Study|Death|6|||
130310007|NCT01248949|469099130|FG004|Overall Study|Death|2|||
130310008|NCT01248949|469099126|FG000|Overall Study|Alternative Therapy|1|||
130310009|NCT01248949|469099127|FG001|Overall Study|Alternative Therapy|0|||
130310010|NCT01248949|469099128|FG002|Overall Study|Alternative Therapy|0|||
130310011|NCT01248949|469099129|FG003|Overall Study|Alternative Therapy|0|||
130310012|NCT01248949|469099130|FG004|Overall Study|Alternative Therapy|0|||
130310013|NCT01248949|469099126|FG000|Overall Study|Alternative Therapy.|1|||
130310014|NCT01248949|469099127|FG001|Overall Study|Alternative Therapy.|0|||
130310015|NCT01248949|469099128|FG002|Overall Study|Alternative Therapy.|0|||
130310016|NCT01248949|469099129|FG003|Overall Study|Alternative Therapy.|0|||
130310017|NCT01248949|469099130|FG004|Overall Study|Alternative Therapy.|0|||
130310018|NCT01248949|469099126|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
130310019|NCT01248949|469099127|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310020|NCT01248949|469099128|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310021|NCT01248949|469099129|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310022|NCT01248949|469099130|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310023|NCT01248949|469099126|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310024|NCT01248949|469099127|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310025|NCT01248949|469099128|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310026|NCT01248949|469099129|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310027|NCT01248949|469099130|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
130310028|NCT01248949|469099126|FG000|Overall Study|Participant Went To Hospice|0|||
130310029|NCT01248949|469099127|FG001|Overall Study|Participant Went To Hospice|0|||
130310030|NCT01248949|469099128|FG002|Overall Study|Participant Went To Hospice|1|||
130310031|NCT01248949|469099129|FG003|Overall Study|Participant Went To Hospice|0|||
130310032|NCT01248949|469099130|FG004|Overall Study|Participant Went To Hospice|0|||
130310033|NCT01248949|469099126|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
130310034|NCT01248949|469099127|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310035|NCT01248949|469099128|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310036|NCT01248949|469099129|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310037|NCT01248949|469099130|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310038|NCT01248949|469099126|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
130310039|NCT01248949|469099127|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
130310040|NCT01248949|469099128|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
130310041|NCT01248949|469099129|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
130310042|NCT01248949|469099130|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
130310043|NCT01248949|469099126|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310044|NCT01248949|469099127|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
130310045|NCT01248949|469099128|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310046|NCT01248949|469099129|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310047|NCT01248949|469099130|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310048|NCT01248949|469099126|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310049|NCT01248949|469099127|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310050|NCT01248949|469099128|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
130310051|NCT01248949|469099129|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310052|NCT01248949|469099130|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310053|NCT00286429|469099131|FG000|Overall Study|Adverse Event|4|||
130310054|NCT00286429|469099132|FG001|Overall Study|Adverse Event|1|||
130310055|NCT00286429|469099133|FG002|Overall Study|Adverse Event|6|||
130310056|NCT00286429|469099131|FG000|Overall Study|Lack of Efficacy|52|||
130557958|NCT01968070|470011865|FG012|Period 1|Physician Decision|0|||
130557959|NCT01968070|470011866|FG013|Period 1|Physician Decision|0|||
130557960|NCT01968070|470011867|FG014|Period 1|Physician Decision|0|||
130557961|NCT01968070|470011868|FG015|Period 1|Physician Decision|0|||
130557962|NCT01968070|470011869|FG016|Period 1|Physician Decision|0|||
130310057|NCT00286429|469099132|FG001|Overall Study|Lack of Efficacy|27|||
130310058|NCT00286429|469099133|FG002|Overall Study|Lack of Efficacy|25|||
130310059|NCT00286429|469099131|FG000|Overall Study|Lost to Follow-up|2|||
130310060|NCT00286429|469099132|FG001|Overall Study|Lost to Follow-up|4|||
130310061|NCT00286429|469099133|FG002|Overall Study|Lost to Follow-up|3|||
130310062|NCT00286429|469099131|FG000|Overall Study|Physician Decision|10|||
130310063|NCT00286429|469099132|FG001|Overall Study|Physician Decision|7|||
130310064|NCT00286429|469099133|FG002|Overall Study|Physician Decision|7|||
130310065|NCT00286429|469099131|FG000|Overall Study|Protocol Violation|3|||
130310066|NCT00286429|469099132|FG001|Overall Study|Protocol Violation|5|||
130310067|NCT00286429|469099133|FG002|Overall Study|Protocol Violation|4|||
130310068|NCT00286429|469099131|FG000|Overall Study|Withdrawal by Subject|3|||
130557963|NCT01968070|470011870|FG017|Period 1|Physician Decision|0|||
130718633|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718634|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718635|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718636|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718637|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718638|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718639|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718640|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718641|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718642|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718643|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718644|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718645|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718646|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718647|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718648|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718649|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
130718650|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718651|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718652|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718653|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718654|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718655|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718656|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718657|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718658|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718659|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718660|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
130718661|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
130310069|NCT00286429|469099132|FG001|Overall Study|Withdrawal by Subject|2|||
130310070|NCT00286429|469099133|FG002|Overall Study|Withdrawal by Subject|6|||
130310071|NCT00286429|469099131|FG000|Overall Study|Administrative Error|1|||
130310072|NCT00286429|469099132|FG001|Overall Study|Administrative Error|1|||
130310073|NCT00286429|469099133|FG002|Overall Study|Administrative Error|1|||
130310074|NCT00286429|469099131|FG000|Overall Study|Administrative Decision|0|||
130310075|NCT00286429|469099132|FG001|Overall Study|Administrative Decision|1|||
130310076|NCT00286429|469099133|FG002|Overall Study|Administrative Decision|0|||
130310077|NCT01746225|469099136|FG000|Overall Study|Death|1|||
130310078|NCT01746225|469099137|FG001|Overall Study|Death|0|||
130310079|NCT01746225|469099138|FG002|Overall Study|Death|1|||
130310080|NCT01746225|469099136|FG000|Overall Study|Withdrawal by Subject|5|||
130310081|NCT01746225|469099137|FG001|Overall Study|Withdrawal by Subject|15|||
130310082|NCT01746225|469099138|FG002|Overall Study|Withdrawal by Subject|19|||
130310083|NCT01746225|469099136|FG000|Overall Study|Physician Decision|14|||
130310084|NCT01746225|469099137|FG001|Overall Study|Physician Decision|11|||
130310085|NCT01746225|469099138|FG002|Overall Study|Physician Decision|3|||
130310086|NCT01746225|469099136|FG000|Overall Study|Adverse Event|15|||
130310087|NCT01746225|469099137|FG001|Overall Study|Adverse Event|12|||
130310088|NCT01746225|469099138|FG002|Overall Study|Adverse Event|17|||
130310089|NCT01746225|469099136|FG000|Overall Study|Continuing Treatment|5|||
130310090|NCT01746225|469099137|FG001|Overall Study|Continuing Treatment|8|||
130310091|NCT01746225|469099138|FG002|Overall Study|Continuing Treatment|3|||
130310092|NCT03915470|469099139|FG000|Overall Study|Death|3|||
130310093|NCT03915470|469099140|FG001|Overall Study|Death|1|||
130310094|NCT03915470|469099139|FG000|Overall Study|Adverse Event|1|||
130310095|NCT03915470|469099140|FG001|Overall Study|Adverse Event|0|||
130310096|NCT03915470|469099139|FG000|Overall Study|Physician Decision|1|||
130310097|NCT03915470|469099140|FG001|Overall Study|Physician Decision|0|||
130310098|NCT03915470|469099139|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130310099|NCT03915470|469099140|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130310100|NCT03160898|469099141|FG000|Overall Study|Adverse Event|4|||
130310101|NCT03160898|469099142|FG001|Overall Study|Adverse Event|8|||
130310102|NCT03160898|469099143|FG002|Overall Study|Adverse Event|7|||
130310103|NCT03160898|469099144|FG003|Overall Study|Adverse Event|10|||
130718662|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
130310104|NCT03160898|469099141|FG000|Overall Study|Death|1|||
130310105|NCT03160898|469099142|FG001|Overall Study|Death|0|||
130310106|NCT03160898|469099143|FG002|Overall Study|Death|0|||
130310107|NCT03160898|469099144|FG003|Overall Study|Death|1|||
130310108|NCT03160898|469099141|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
130310109|NCT03160898|469099142|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130557964|NCT01968070|470011853|FG000|Period 2|Withdrawal by Subject|0|||
130557965|NCT01968070|470011854|FG001|Period 2|Withdrawal by Subject|0|||
130557966|NCT01968070|470011855|FG002|Period 2|Withdrawal by Subject|0|||
130557967|NCT01968070|470011856|FG003|Period 2|Withdrawal by Subject|0|||
130557968|NCT01968070|470011857|FG004|Period 2|Withdrawal by Subject|1|||
130557969|NCT01968070|470011858|FG005|Period 2|Withdrawal by Subject|0|||
130557970|NCT01968070|470011859|FG006|Period 2|Withdrawal by Subject|0|||
130557971|NCT01968070|470011860|FG007|Period 2|Withdrawal by Subject|0|||
130557972|NCT01968070|470011861|FG008|Period 2|Withdrawal by Subject|0|||
130557973|NCT01968070|470011862|FG009|Period 2|Withdrawal by Subject|0|||
130557974|NCT01968070|470011863|FG010|Period 2|Withdrawal by Subject|0|||
130557975|NCT01968070|470011864|FG011|Period 2|Withdrawal by Subject|0|||
130557976|NCT01968070|470011865|FG012|Period 2|Withdrawal by Subject|0|||
130310110|NCT03160898|469099143|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130310111|NCT03160898|469099144|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
130310112|NCT03160898|469099141|FG000|Overall Study|Lost to Follow-up|1|||
130310113|NCT03160898|469099142|FG001|Overall Study|Lost to Follow-up|1|||
130310114|NCT03160898|469099143|FG002|Overall Study|Lost to Follow-up|1|||
130310115|NCT03160898|469099144|FG003|Overall Study|Lost to Follow-up|2|||
130310116|NCT03160898|469099141|FG000|Overall Study|Physician Decision|1|||
130310117|NCT03160898|469099142|FG001|Overall Study|Physician Decision|0|||
130310118|NCT03160898|469099143|FG002|Overall Study|Physician Decision|0|||
130310119|NCT03160898|469099144|FG003|Overall Study|Physician Decision|1|||
130310120|NCT03160898|469099141|FG000|Overall Study|Progressive Disease|4|||
130310121|NCT03160898|469099142|FG001|Overall Study|Progressive Disease|1|||
130310122|NCT03160898|469099143|FG002|Overall Study|Progressive Disease|2|||
130310123|NCT03160898|469099144|FG003|Overall Study|Progressive Disease|1|||
130310124|NCT03160898|469099141|FG000|Overall Study|Protocol Violation|1|||
130310125|NCT03160898|469099142|FG001|Overall Study|Protocol Violation|0|||
130310126|NCT03160898|469099143|FG002|Overall Study|Protocol Violation|2|||
130310127|NCT03160898|469099144|FG003|Overall Study|Protocol Violation|0|||
130310128|NCT03160898|469099141|FG000|Overall Study|Sponsor Discretion|2|||
130310129|NCT03160898|469099142|FG001|Overall Study|Sponsor Discretion|0|||
130310130|NCT03160898|469099143|FG002|Overall Study|Sponsor Discretion|0|||
130310131|NCT03160898|469099144|FG003|Overall Study|Sponsor Discretion|0|||
130310132|NCT03160898|469099141|FG000|Overall Study|Withdrawal by Subject|1|||
130310133|NCT03160898|469099142|FG001|Overall Study|Withdrawal by Subject|3|||
130310134|NCT03160898|469099143|FG002|Overall Study|Withdrawal by Subject|2|||
130310135|NCT03160898|469099144|FG003|Overall Study|Withdrawal by Subject|1|||
130310136|NCT03160898|469099141|FG000|Overall Study|Other|2|||
130310137|NCT03160898|469099142|FG001|Overall Study|Other|0|||
130310138|NCT03160898|469099143|FG002|Overall Study|Other|2|||
130310139|NCT03160898|469099144|FG003|Overall Study|Other|2|||
130310140|NCT03245775|469099145|FG000|Overall Study|Lost to Follow-up|25|||
130310141|NCT03245775|469099146|FG001|Overall Study|Lost to Follow-up|26|||
130310142|NCT03245775|469099147|FG002|Overall Study|Lost to Follow-up|16|||
130310143|NCT03245775|469099148|FG003|Overall Study|Lost to Follow-up|16|||
130310144|NCT02978833|469099155|FG000|Overall Study|Study terminated|1|||
130310145|NCT02978833|469099156|FG001|Overall Study|Study terminated|1|||
130310146|NCT00103740|469099157|FG000|Period 1 - Core|Adverse Event|1|||
130310147|NCT00103740|469099158|FG001|Period 1 - Core|Adverse Event|0|||
130310148|NCT00103740|469099157|FG000|Period 1 - Core|Protocol Violation|3|||
130310149|NCT00103740|469099158|FG001|Period 1 - Core|Protocol Violation|2|||
130310150|NCT00103740|469099157|FG000|Period 1 - Core|Patient withdrew consent|3|||
130310151|NCT00103740|469099158|FG001|Period 1 - Core|Patient withdrew consent|2|||
130310152|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
130310153|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
130310154|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
130310155|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
130310156|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
130310157|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
130557977|NCT01968070|470011866|FG013|Period 2|Withdrawal by Subject|0|||
130557978|NCT01968070|470011867|FG014|Period 2|Withdrawal by Subject|0|||
130557979|NCT01968070|470011868|FG015|Period 2|Withdrawal by Subject|0|||
130310158|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Death|6|||
130557980|NCT01968070|470011869|FG016|Period 2|Withdrawal by Subject|0|||
130374449|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130310159|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Death|2|||
130310160|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
130310161|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
130310162|NCT02663622|469099165|FG000|Overall Study|Death|3|||
130310163|NCT02663622|469099166|FG001|Overall Study|Death|1|||
130557981|NCT01968070|470011870|FG017|Period 2|Withdrawal by Subject|0|||
130557982|NCT00108069|470011875|FG000|Overall Study|Never rec'd study drug|0|||
130557983|NCT00108069|470011876|FG001|Overall Study|Never rec'd study drug|1|||
130557984|NCT00108069|470011875|FG000|Overall Study|Adverse Event|1|||
130310164|NCT02663622|469099167|FG002|Overall Study|Death|1|||
130310165|NCT02663622|469099168|FG003|Overall Study|Death|8|||
130310166|NCT02663622|469099165|FG000|Overall Study|Protocol Violation|0|||
130310167|NCT02663622|469099166|FG001|Overall Study|Protocol Violation|0|||
130310168|NCT02663622|469099167|FG002|Overall Study|Protocol Violation|0|||
130310169|NCT02663622|469099168|FG003|Overall Study|Protocol Violation|1|||
130310170|NCT02587819|469099169|FG000|Overall Study|Adverse Event|1|||
130310171|NCT02587819|469099169|FG000|Overall Study|Lost to Follow-up|1|||
130310172|NCT01594931|469100610|FG000|Overall Study|Adverse Event|3|||
130310173|NCT01594931|469100611|FG001|Overall Study|Adverse Event|1|||
130310174|NCT01594931|469100612|FG002|Overall Study|Adverse Event|1|||
130310175|NCT01594931|469100610|FG000|Overall Study|Withdrawal by Subject|2|||
130310176|NCT01594931|469100611|FG001|Overall Study|Withdrawal by Subject|1|||
130310177|NCT01594931|469100612|FG002|Overall Study|Withdrawal by Subject|1|||
130310178|NCT01594931|469100610|FG000|Overall Study|Lack of Efficacy|7|||
130310179|NCT01594931|469100611|FG001|Overall Study|Lack of Efficacy|2|||
130310180|NCT01594931|469100612|FG002|Overall Study|Lack of Efficacy|2|||
130310181|NCT01594931|469100610|FG000|Overall Study|Lost to Follow-up|4|||
130310182|NCT01594931|469100611|FG001|Overall Study|Lost to Follow-up|3|||
130310183|NCT01594931|469100612|FG002|Overall Study|Lost to Follow-up|3|||
130310184|NCT01594931|469100610|FG000|Overall Study|Protocol Violation|2|||
130310185|NCT01594931|469100611|FG001|Overall Study|Protocol Violation|1|||
130310186|NCT01594931|469100612|FG002|Overall Study|Protocol Violation|0|||
130310187|NCT01594931|469100610|FG000|Overall Study|No defiined|11|||
130310188|NCT01594931|469100611|FG001|Overall Study|No defiined|4|||
130310189|NCT01594931|469100612|FG002|Overall Study|No defiined|7|||
130310190|NCT01467505|469100614|FG000|Overall Study|Adverse Event|1|||
130310191|NCT01467505|469100615|FG001|Overall Study|Adverse Event|0|||
130310192|NCT01467505|469100614|FG000|Overall Study|Withdrawal by Subject|4|||
130310193|NCT01467505|469100615|FG001|Overall Study|Withdrawal by Subject|0|||
130310194|NCT01467505|469100614|FG000|Overall Study|Study Terminated by Sponsor|28|||
130310195|NCT01467505|469100615|FG001|Overall Study|Study Terminated by Sponsor|3|||
130310196|NCT03449758|469100616|FG000|Overall Study|Major protocol deviation|1|||
130310197|NCT03449758|469100616|FG000|Overall Study|Treatment inefficacy|5|||
130310198|NCT03449758|469100616|FG000|Overall Study|Adverse Event|9|||
130310199|NCT03449758|469100616|FG000|Overall Study|Consent withdrawal|1|||
130310200|NCT03449758|469100616|FG000|Overall Study|Other unspecified reason|3|||
130310201|NCT00086047|469100629|FG000|Overall Study|Lost to Follow-up|7|||
130310202|NCT00086047|469100630|FG001|Overall Study|Lost to Follow-up|6|||
130310203|NCT00086047|469100629|FG000|Overall Study|Physician Decision|0|||
130310204|NCT00086047|469100630|FG001|Overall Study|Physician Decision|1|||
130310205|NCT03579940|469100631|FG000|Period 2|Withdrawal by Subject|0|||
130310206|NCT03579940|469100632|FG001|Period 2|Withdrawal by Subject|0|||
130310207|NCT03579940|469100633|FG002|Period 2|Withdrawal by Subject|1|||
130310208|NCT03579940|469100634|FG003|Period 2|Withdrawal by Subject|0|||
130310209|NCT03579940|469100635|FG004|Period 2|Withdrawal by Subject|0|||
130310210|NCT03579940|469100636|FG005|Period 2|Withdrawal by Subject|0|||
130310211|NCT03579940|469100637|FG006|Period 2|Withdrawal by Subject|0|||
130310212|NCT03579940|469100638|FG007|Period 2|Withdrawal by Subject|0|||
130310213|NCT03579940|469100639|FG008|Period 2|Withdrawal by Subject|0|||
130310214|NCT03579940|469100640|FG009|Period 2|Withdrawal by Subject|0|||
130310215|NCT03579940|469100641|FG010|Period 2|Withdrawal by Subject|0|||
130310216|NCT00671034|469100642|FG000|Overall Study|Adverse Event|5|||
130310217|NCT00671034|469100643|FG001|Overall Study|Adverse Event|7|||
130310218|NCT00671034|469100644|FG002|Overall Study|Adverse Event|1|||
130310219|NCT00671034|469100642|FG000|Overall Study|Death|3|||
130310220|NCT00671034|469100643|FG001|Overall Study|Death|2|||
130310221|NCT00671034|469100644|FG002|Overall Study|Death|1|||
130310222|NCT00671034|469100642|FG000|Overall Study|Physician Decision|12|||
130310223|NCT00671034|469100643|FG001|Overall Study|Physician Decision|4|||
130310224|NCT00671034|469100644|FG002|Overall Study|Physician Decision|5|||
130310225|NCT00671034|469100642|FG000|Overall Study|VHR ALL feature|8|||
130310226|NCT00671034|469100643|FG001|Overall Study|VHR ALL feature|3|||
130310227|NCT00671034|469100644|FG002|Overall Study|VHR ALL feature|5|||
130310228|NCT00671034|469100642|FG000|Overall Study|Refusal|5|||
130310229|NCT00671034|469100643|FG001|Overall Study|Refusal|3|||
130310230|NCT00671034|469100644|FG002|Overall Study|Refusal|5|||
130310231|NCT00671034|469100642|FG000|Overall Study|includes Alternative therapy, etc.|6|||
130310232|NCT00671034|469100643|FG001|Overall Study|includes Alternative therapy, etc.|1|||
130310233|NCT00671034|469100644|FG002|Overall Study|includes Alternative therapy, etc.|7|||
130310234|NCT00853151|469100645|FG000|Overall Study|Adverse Event|1|||
130310235|NCT00853151|469100646|FG001|Overall Study|Adverse Event|4|||
130310236|NCT00853151|469100647|FG002|Overall Study|Adverse Event|2|||
130310237|NCT00853151|469100648|FG003|Overall Study|Adverse Event|0|||
130310238|NCT00853151|469100645|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130310239|NCT00853151|469100646|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310240|NCT00853151|469100647|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310241|NCT00853151|469100648|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310242|NCT00853151|469100645|FG000|Overall Study|Lost to Follow-up|2|||
130310243|NCT00853151|469100646|FG001|Overall Study|Lost to Follow-up|0|||
130310244|NCT00853151|469100647|FG002|Overall Study|Lost to Follow-up|3|||
130310245|NCT00853151|469100648|FG003|Overall Study|Lost to Follow-up|0|||
130310246|NCT00853151|469100645|FG000|Overall Study|Death|1|||
130310247|NCT00853151|469100646|FG001|Overall Study|Death|0|||
130310248|NCT00853151|469100647|FG002|Overall Study|Death|0|||
130310249|NCT00853151|469100648|FG003|Overall Study|Death|1|||
130310250|NCT00853151|469100645|FG000|Overall Study|Protocol Violation|0|||
130310251|NCT00853151|469100646|FG001|Overall Study|Protocol Violation|0|||
130310252|NCT00853151|469100647|FG002|Overall Study|Protocol Violation|0|||
130310253|NCT00853151|469100648|FG003|Overall Study|Protocol Violation|1|||
130310254|NCT00853151|469100645|FG000|Overall Study|Withdrawal by Subject|5|||
130310255|NCT00853151|469100646|FG001|Overall Study|Withdrawal by Subject|4|||
130310256|NCT00853151|469100647|FG002|Overall Study|Withdrawal by Subject|2|||
130310257|NCT00853151|469100648|FG003|Overall Study|Withdrawal by Subject|1|||
130310258|NCT00853151|469100645|FG000|Overall Study|Physician Decision|0|||
130310259|NCT00853151|469100646|FG001|Overall Study|Physician Decision|2|||
130310260|NCT00853151|469100647|FG002|Overall Study|Physician Decision|1|||
130310261|NCT00853151|469100648|FG003|Overall Study|Physician Decision|0|||
130310262|NCT00853151|469100645|FG000|Overall Study|Sponsor Decision|0|||
130310263|NCT00853151|469100646|FG001|Overall Study|Sponsor Decision|3|||
130310264|NCT00853151|469100647|FG002|Overall Study|Sponsor Decision|0|||
130310265|NCT00853151|469100648|FG003|Overall Study|Sponsor Decision|0|||
130310266|NCT00269919|469100649|FG000|Overall Study|Other|26|||
130310267|NCT00269919|469100649|FG000|Overall Study|Started but not treated|1|||
130310268|NCT02471014|469100652|FG000|Overall Study|Lost to Follow-up|2|||
130310269|NCT02471014|469100653|FG001|Overall Study|Lost to Follow-up|2|||
130310270|NCT01751984|469100654|FG000|Overall Study|Adverse Event|5|||
130310271|NCT01751984|469100655|FG001|Overall Study|Adverse Event|3|||
130310272|NCT01751984|469100654|FG000|Overall Study|Withdrawal by Subject|0|||
130310273|NCT01751984|469100655|FG001|Overall Study|Withdrawal by Subject|1|||
130310274|NCT01751984|469100654|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130310275|NCT01751984|469100655|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130310276|NCT01388907|469100656|FG000|Overall Study|Adverse Event|2|||
130310277|NCT01388907|469100657|FG001|Overall Study|Adverse Event|0|||
130310278|NCT03187132|469100658|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
130310279|NCT03187132|469100659|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
130310280|NCT03187132|469100658|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
130310281|NCT03187132|469100659|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
130310282|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
130310283|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
130310284|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
130310285|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
130310286|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
130310287|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
130310288|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
130310289|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
130310290|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
130310291|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
130310292|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
130310293|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
130310294|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
130310295|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
130310296|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
130310297|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
130310298|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
130310299|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
130310300|NCT02045095|469100660|FG000|Overall Study|Other|0|||
130310301|NCT02045095|469100661|FG001|Overall Study|Other|0|||
130557985|NCT00108069|470011876|FG001|Overall Study|Adverse Event|1|||
130557986|NCT00108069|470011875|FG000|Overall Study|Withdrawal by Subject|1|||
130557987|NCT00108069|470011876|FG001|Overall Study|Withdrawal by Subject|0|||
130557988|NCT00108069|470011875|FG000|Overall Study|Death|1|||
130557989|NCT00108069|470011876|FG001|Overall Study|Death|0|||
130718663|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130557990|NCT00108069|470011875|FG000|Overall Study|Progessive disease|27|||
130310302|NCT02045095|469100662|FG002|Overall Study|Other|1|||
130310303|NCT02045095|469100663|FG003|Overall Study|Other|0|||
130310304|NCT02045095|469100664|FG004|Overall Study|Other|0|||
130310305|NCT02045095|469100665|FG005|Overall Study|Other|2|||
130310306|NCT02045095|469100666|FG006|Overall Study|Other|0|||
130310307|NCT02045095|469100660|FG000|Overall Study|Progressive Disease|3|||
130310308|NCT02045095|469100661|FG001|Overall Study|Progressive Disease|3|||
130374450|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
130310309|NCT02045095|469100662|FG002|Overall Study|Progressive Disease|2|||
130310310|NCT02045095|469100663|FG003|Overall Study|Progressive Disease|4|||
130557991|NCT00108069|470011876|FG001|Overall Study|Progessive disease|11|||
130310311|NCT02045095|469100664|FG004|Overall Study|Progressive Disease|2|||
130310312|NCT02045095|469100665|FG005|Overall Study|Progressive Disease|4|||
130310313|NCT02045095|469100666|FG006|Overall Study|Progressive Disease|1|||
130310314|NCT02045095|469100660|FG000|Overall Study|Withdrawal by Subject|0|||
130310315|NCT02045095|469100661|FG001|Overall Study|Withdrawal by Subject|0|||
130310316|NCT02045095|469100662|FG002|Overall Study|Withdrawal by Subject|0|||
130310317|NCT02045095|469100663|FG003|Overall Study|Withdrawal by Subject|0|||
130310318|NCT02045095|469100664|FG004|Overall Study|Withdrawal by Subject|3|||
130310319|NCT02045095|469100665|FG005|Overall Study|Withdrawal by Subject|0|||
130310320|NCT02045095|469100666|FG006|Overall Study|Withdrawal by Subject|0|||
130310321|NCT02045095|469100660|FG000|Overall Study|Adverse Event|0|||
130310322|NCT02045095|469100661|FG001|Overall Study|Adverse Event|1|||
130310323|NCT02045095|469100662|FG002|Overall Study|Adverse Event|1|||
130310324|NCT02045095|469100663|FG003|Overall Study|Adverse Event|0|||
130310325|NCT02045095|469100664|FG004|Overall Study|Adverse Event|0|||
130310326|NCT02045095|469100665|FG005|Overall Study|Adverse Event|2|||
130310327|NCT02045095|469100666|FG006|Overall Study|Adverse Event|0|||
130310328|NCT03594773|469100667|FG000|Overall Study|Withdrawal by Subject|3|||
130310329|NCT03594773|469100668|FG001|Overall Study|Withdrawal by Subject|2|||
130310330|NCT03594773|469100667|FG000|Overall Study|Lost to Follow-up|3|||
130310331|NCT03594773|469100668|FG001|Overall Study|Lost to Follow-up|4|||
130310332|NCT00714415|469100670|FG000|Overall Study|Lack of Efficacy|1|||
130310333|NCT00714415|469100671|FG001|Overall Study|Lack of Efficacy|0|||
130310334|NCT00714415|469100670|FG000|Overall Study|Death|1|||
130310335|NCT00714415|469100671|FG001|Overall Study|Death|0|||
130310336|NCT01461707|469100674|FG000|Overall Study|Withdrawal by Subject|1|||
130310337|NCT01461707|469100675|FG001|Overall Study|Withdrawal by Subject|0|||
130310338|NCT03461146|469100681|FG000|Overall Study|Adverse Event|2|||
130310339|NCT03461146|469100681|FG000|Overall Study|Physician Decision|1|||
130310340|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130310341|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130310342|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
130310343|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
130310344|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
130310345|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
130310346|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
130310347|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
130310348|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
130310349|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
130310350|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
130310351|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
130310352|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
130310353|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
130310354|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
130310355|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
130310356|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
130310357|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
130310358|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
130310359|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
130310360|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
130310361|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
130310362|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
130310363|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
130310364|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
130310365|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
130718664|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130310366|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
130465234|NCT02988817|469670279|FG016|Overall Study|Lost to Follow-up|2|||
130465235|NCT02988817|469670280|FG017|Overall Study|Lost to Follow-up|3|||
130465236|NCT02988817|469670281|FG018|Overall Study|Lost to Follow-up|0|||
130465237|NCT02988817|469670282|FG019|Overall Study|Lost to Follow-up|0|||
130718665|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718666|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718667|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718668|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718669|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130310367|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
130310368|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
130310369|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
130465238|NCT02988817|469670263|FG000|Overall Study|Sponsor decision|0|||
130718670|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718671|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718672|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718673|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718674|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718675|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718676|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718677|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
130310370|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
130310371|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
130310372|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
130310373|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
130310374|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
130310375|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
130310376|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
130310377|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
130310378|NCT01338818|469100691|FG000|Overall Study|Adverse Event|8|||
130310379|NCT01338818|469100691|FG000|Overall Study|Lack of Efficacy|5|||
130310380|NCT01338818|469100691|FG000|Overall Study|no longer require study drug|1|||
130465239|NCT02988817|469670264|FG001|Overall Study|Sponsor decision|0|||
130465240|NCT02988817|469670265|FG002|Overall Study|Sponsor decision|0|||
130465241|NCT02988817|469670266|FG003|Overall Study|Sponsor decision|0|||
130465242|NCT02988817|469670267|FG004|Overall Study|Sponsor decision|0|||
130465243|NCT02988817|469670268|FG005|Overall Study|Sponsor decision|0|||
130310381|NCT01338818|469100691|FG000|Overall Study|Withdrawal by Subject|11|||
130310382|NCT01338818|469100691|FG000|Overall Study|Lost to Follow-up|4|||
130310383|NCT01338818|469100691|FG000|Overall Study|Administrative problems|3|||
130310384|NCT01338818|469100691|FG000|Overall Study|Protocol Deviation|4|||
130310385|NCT02868554|469100692|FG000|Overall Study|Lost to Follow-up|3|||
130310386|NCT02868554|469100693|FG001|Overall Study|Lost to Follow-up|0|||
130310387|NCT02868554|469100694|FG002|Overall Study|Lost to Follow-up|1|||
130310388|NCT02714569|469100695|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
130310389|NCT02714569|469100696|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
130310390|NCT02714569|469100697|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
130310391|NCT02714569|469100698|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
130310392|NCT02714569|469100699|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
130310393|NCT02714569|469100700|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
130310394|NCT02714569|469100701|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
130310395|NCT02714569|469100702|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
130310396|NCT02714569|469100703|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
130310397|NCT02714569|469100704|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
130310398|NCT02714569|469100705|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
130310399|NCT02714569|469100695|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310400|NCT02714569|469100696|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310401|NCT02714569|469100697|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310402|NCT02714569|469100698|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
130310403|NCT02714569|469100699|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310404|NCT02714569|469100700|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310405|NCT02714569|469100701|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310406|NCT02714569|469100702|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130465244|NCT02988817|469670269|FG006|Overall Study|Sponsor decision|0|||
130465245|NCT02988817|469670270|FG007|Overall Study|Sponsor decision|0|||
130465246|NCT02988817|469670271|FG008|Overall Study|Sponsor decision|0|||
130465247|NCT02988817|469670272|FG009|Overall Study|Sponsor decision|0|||
130465248|NCT02988817|469670273|FG010|Overall Study|Sponsor decision|0|||
130465249|NCT02988817|469670274|FG011|Overall Study|Sponsor decision|1|||
130718678|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718679|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718680|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130310407|NCT02714569|469100703|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130465250|NCT02988817|469670275|FG012|Overall Study|Sponsor decision|1|||
130465251|NCT02988817|469670276|FG013|Overall Study|Sponsor decision|2|||
130465252|NCT02988817|469670277|FG014|Overall Study|Sponsor decision|2|||
130465253|NCT02988817|469670278|FG015|Overall Study|Sponsor decision|6|||
130465254|NCT02988817|469670279|FG016|Overall Study|Sponsor decision|2|||
130557992|NCT00995007|470011877|FG000|Overall Study|Withdrew consent|1|||
130465255|NCT02988817|469670280|FG017|Overall Study|Sponsor decision|3|||
130465256|NCT02988817|469670281|FG018|Overall Study|Sponsor decision|2|||
130465257|NCT02988817|469670282|FG019|Overall Study|Sponsor decision|7|||
130310408|NCT02714569|469100704|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310409|NCT02714569|469100705|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310410|NCT02714569|469100695|FG000|Part A Third Intervention|Adverse Event|0|||
130310411|NCT02714569|469100696|FG001|Part A Third Intervention|Adverse Event|0|||
130310412|NCT02714569|469100697|FG002|Part A Third Intervention|Adverse Event|1|||
130310413|NCT02714569|469100698|FG003|Part A Third Intervention|Adverse Event|0|||
130310414|NCT02714569|469100699|FG004|Part A Third Intervention|Adverse Event|0|||
130310415|NCT02714569|469100700|FG005|Part A Third Intervention|Adverse Event|0|||
130310416|NCT02714569|469100701|FG006|Part A Third Intervention|Adverse Event|0|||
130310417|NCT02714569|469100702|FG007|Part A Third Intervention|Adverse Event|0|||
130310418|NCT02714569|469100703|FG008|Part A Third Intervention|Adverse Event|0|||
130310419|NCT02714569|469100704|FG009|Part A Third Intervention|Adverse Event|0|||
130310420|NCT02714569|469100705|FG010|Part A Third Intervention|Adverse Event|0|||
130310421|NCT02714569|469100695|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130310422|NCT02714569|469100696|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310423|NCT02714569|469100697|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310424|NCT02714569|469100698|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310425|NCT02714569|469100699|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310426|NCT02714569|469100700|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130310427|NCT02714569|469100701|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310428|NCT02714569|469100702|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310429|NCT02714569|469100703|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310430|NCT02714569|469100704|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310431|NCT02714569|469100705|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310432|NCT02714569|469100695|FG000|Part B (Overall)|Lost to Follow-up|0|||
130310433|NCT02714569|469100696|FG001|Part B (Overall)|Lost to Follow-up|0|||
130310434|NCT02714569|469100697|FG002|Part B (Overall)|Lost to Follow-up|0|||
130310435|NCT02714569|469100698|FG003|Part B (Overall)|Lost to Follow-up|0|||
130310436|NCT02714569|469100699|FG004|Part B (Overall)|Lost to Follow-up|0|||
130310437|NCT02714569|469100700|FG005|Part B (Overall)|Lost to Follow-up|0|||
130310438|NCT02714569|469100701|FG006|Part B (Overall)|Lost to Follow-up|1|||
130310439|NCT02714569|469100702|FG007|Part B (Overall)|Lost to Follow-up|0|||
130310440|NCT02714569|469100703|FG008|Part B (Overall)|Lost to Follow-up|0|||
130310441|NCT02714569|469100704|FG009|Part B (Overall)|Lost to Follow-up|0|||
130310442|NCT02714569|469100705|FG010|Part B (Overall)|Lost to Follow-up|0|||
130310443|NCT02714569|469100695|FG000|Part B (Overall)|Withdrawal by Subject|0|||
130310444|NCT02714569|469100696|FG001|Part B (Overall)|Withdrawal by Subject|0|||
130310445|NCT02714569|469100697|FG002|Part B (Overall)|Withdrawal by Subject|0|||
130310446|NCT02714569|469100698|FG003|Part B (Overall)|Withdrawal by Subject|0|||
130310447|NCT02714569|469100699|FG004|Part B (Overall)|Withdrawal by Subject|0|||
130310448|NCT02714569|469100700|FG005|Part B (Overall)|Withdrawal by Subject|0|||
130310449|NCT02714569|469100701|FG006|Part B (Overall)|Withdrawal by Subject|0|||
130310450|NCT02714569|469100702|FG007|Part B (Overall)|Withdrawal by Subject|1|||
130310451|NCT02714569|469100703|FG008|Part B (Overall)|Withdrawal by Subject|0|||
130310452|NCT02714569|469100704|FG009|Part B (Overall)|Withdrawal by Subject|1|||
130310453|NCT02714569|469100705|FG010|Part B (Overall)|Withdrawal by Subject|0|||
130310454|NCT02714569|469100695|FG000|Part B (Overall)|Adverse Event|0|||
130310455|NCT02714569|469100696|FG001|Part B (Overall)|Adverse Event|0|||
130310456|NCT02714569|469100697|FG002|Part B (Overall)|Adverse Event|0|||
130310457|NCT02714569|469100698|FG003|Part B (Overall)|Adverse Event|0|||
130310458|NCT02714569|469100699|FG004|Part B (Overall)|Adverse Event|0|||
130310459|NCT02714569|469100700|FG005|Part B (Overall)|Adverse Event|0|||
130310460|NCT02714569|469100701|FG006|Part B (Overall)|Adverse Event|0|||
130310461|NCT02714569|469100702|FG007|Part B (Overall)|Adverse Event|0|||
130310462|NCT02714569|469100703|FG008|Part B (Overall)|Adverse Event|0|||
130310463|NCT02714569|469100704|FG009|Part B (Overall)|Adverse Event|1|||
130310464|NCT02714569|469100705|FG010|Part B (Overall)|Adverse Event|0|||
130310465|NCT00191308|469100706|FG000|Overall Study|Adverse Event|1|||
130310466|NCT01843023|469100707|FG000|Overall Study|Death|1|||
130310467|NCT01843023|469100708|FG001|Overall Study|Death|0|||
130310468|NCT01843023|469100707|FG000|Overall Study|Lost to Follow-up|24|||
130310469|NCT01843023|469100708|FG001|Overall Study|Lost to Follow-up|29|||
130310470|NCT01843023|469100707|FG000|Overall Study|Withdrawal by Subject|8|||
130310471|NCT01843023|469100708|FG001|Overall Study|Withdrawal by Subject|6|||
130310472|NCT00779025|469100709|FG000|Overall Study|Withdrawal by Subject|1|||
130310473|NCT03305770|469100710|FG000|Overall Study|Physician Decision - prior to dispense|0|||
130310474|NCT03305770|469100711|FG001|Overall Study|Physician Decision - prior to dispense|1|||
130310475|NCT03305770|469100710|FG000|Overall Study|Subject moved|1|||
130310476|NCT03305770|469100711|FG001|Overall Study|Subject moved|0|||
130465258|NCT02988817|469670263|FG000|Overall Study|Physician Decision|0|||
130465259|NCT02988817|469670264|FG001|Overall Study|Physician Decision|0|||
130465260|NCT02988817|469670265|FG002|Overall Study|Physician Decision|0|||
130465261|NCT02988817|469670266|FG003|Overall Study|Physician Decision|0|||
130465262|NCT02988817|469670267|FG004|Overall Study|Physician Decision|0|||
130310477|NCT03472326|469100714|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130310478|NCT03472326|469100715|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130310479|NCT03472326|469100716|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
130310480|NCT03472326|469100717|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
130310481|NCT03472326|469100714|FG000|Part 2: Combination Therapy|Pregnancy|0|||
130310482|NCT03472326|469100715|FG001|Part 2: Combination Therapy|Pregnancy|0|||
130310483|NCT03472326|469100716|FG002|Part 2: Combination Therapy|Pregnancy|0|||
130310484|NCT03472326|469100717|FG003|Part 2: Combination Therapy|Pregnancy|1|||
130310485|NCT00700713|469100718|FG000|Overall Study|Protocol Violation|1|||
130310486|NCT00700713|469100719|FG001|Overall Study|Protocol Violation|0|||
130310487|NCT00700713|469100720|FG002|Overall Study|Protocol Violation|1|||
130310488|NCT00700713|469100718|FG000|Overall Study|Withdrawal by Subject|0|||
130310489|NCT00700713|469100719|FG001|Overall Study|Withdrawal by Subject|0|||
130310490|NCT00700713|469100720|FG002|Overall Study|Withdrawal by Subject|1|||
130310491|NCT04980612|469100721|FG000|Overall Study|Withdrawal by Subject|7|||
130310492|NCT04980612|469100722|FG001|Overall Study|Withdrawal by Subject|5|||
130310493|NCT02446717|469100723|FG000|Overall Study|Adverse Event|0|||
130310494|NCT02446717|469100724|FG001|Overall Study|Adverse Event|0|||
130310495|NCT02446717|469100725|FG002|Overall Study|Adverse Event|1|||
130310496|NCT02446717|469100726|FG003|Overall Study|Adverse Event|0|||
130310497|NCT02446717|469100727|FG004|Overall Study|Adverse Event|0|||
130310498|NCT02446717|469100723|FG000|Overall Study|Lost to Follow-up|0|||
130310499|NCT02446717|469100724|FG001|Overall Study|Lost to Follow-up|1|||
130310500|NCT02446717|469100725|FG002|Overall Study|Lost to Follow-up|1|||
130310501|NCT02446717|469100726|FG003|Overall Study|Lost to Follow-up|0|||
130310502|NCT02446717|469100727|FG004|Overall Study|Lost to Follow-up|1|||
130310503|NCT02446717|469100723|FG000|Overall Study|Withdrew consent|0|||
130465263|NCT02988817|469670268|FG005|Overall Study|Physician Decision|0|||
130465264|NCT02988817|469670269|FG006|Overall Study|Physician Decision|0|||
130465265|NCT02988817|469670270|FG007|Overall Study|Physician Decision|0|||
130465266|NCT02988817|469670271|FG008|Overall Study|Physician Decision|0|||
130465267|NCT02988817|469670272|FG009|Overall Study|Physician Decision|0|||
130465268|NCT02988817|469670273|FG010|Overall Study|Physician Decision|0|||
130465269|NCT02988817|469670274|FG011|Overall Study|Physician Decision|0|||
130465270|NCT02988817|469670275|FG012|Overall Study|Physician Decision|0|||
130465271|NCT02988817|469670276|FG013|Overall Study|Physician Decision|0|||
130465272|NCT02988817|469670277|FG014|Overall Study|Physician Decision|0|||
130465273|NCT02988817|469670278|FG015|Overall Study|Physician Decision|1|||
130465274|NCT02988817|469670279|FG016|Overall Study|Physician Decision|0|||
130465275|NCT02988817|469670280|FG017|Overall Study|Physician Decision|0|||
130465276|NCT02988817|469670281|FG018|Overall Study|Physician Decision|1|||
130465277|NCT02988817|469670282|FG019|Overall Study|Physician Decision|1|||
130465278|NCT04530747|469670285|FG000|Overall Study|Withdrawal by Subject|1|||
130465279|NCT04530747|469670286|FG001|Overall Study|Withdrawal by Subject|0|||
130465280|NCT03292913|469670287|FG000|Overall Study|Death|9|||
130465281|NCT03292913|469670288|FG001|Overall Study|Death|3|||
130465282|NCT03292913|469670287|FG000|Overall Study|Lost to Follow-up|49|||
130465283|NCT03292913|469670288|FG001|Overall Study|Lost to Follow-up|49|||
130465284|NCT03292913|469670287|FG000|Overall Study|Withdrawal by Subject|2|||
130465285|NCT03292913|469670288|FG001|Overall Study|Withdrawal by Subject|0|||
130465286|NCT03292913|469670287|FG000|Overall Study|Clinic closed due to COVID|22|||
130465287|NCT03292913|469670288|FG001|Overall Study|Clinic closed due to COVID|36|||
130465288|NCT03950622|469670289|FG000|Overall Study|Withdrawal by Subject|1|||
130465289|NCT03950622|469670290|FG001|Overall Study|Withdrawal by Subject|0|||
130465290|NCT03950622|469670289|FG000|Overall Study|Protocol Deviation|0|||
130465291|NCT03950622|469670290|FG001|Overall Study|Protocol Deviation|1|||
130465292|NCT03950622|469670289|FG000|Overall Study|Physician Decision|1|||
130465293|NCT03950622|469670290|FG001|Overall Study|Physician Decision|0|||
130465294|NCT03950622|469670289|FG000|Overall Study|Lost to Follow-up|5|||
130465295|NCT03950622|469670290|FG001|Overall Study|Lost to Follow-up|5|||
130465296|NCT03950622|469670289|FG000|Overall Study|Death|1|||
130465297|NCT03950622|469670290|FG001|Overall Study|Death|1|||
130465298|NCT01546753|469670293|FG000|Overall Study|anxiety|1|||
130465299|NCT01546753|469670294|FG001|Overall Study|anxiety|1|||
130465300|NCT01546753|469670293|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
130465301|NCT01546753|469670294|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
130465302|NCT00939510|469670295|FG000|Overall Study|Withdrawal by Subject|1|||
130465303|NCT05782231|469670311|FG000|Overall Study|Withdrawal by Subject|1|||
130465304|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
130465305|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
130465306|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
130465307|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
130465308|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
130465309|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
130465310|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
130465311|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
130310504|NCT02446717|469100724|FG001|Overall Study|Withdrew consent|0|||
130465312|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
130465313|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
130465314|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
130465315|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
130310505|NCT02446717|469100725|FG002|Overall Study|Withdrew consent|0|||
130310506|NCT02446717|469100726|FG003|Overall Study|Withdrew consent|1|||
130310507|NCT02446717|469100727|FG004|Overall Study|Withdrew consent|0|||
130310508|NCT02680665|469100728|FG000|Overall Study|No visit after the first prescription|5|||
130310509|NCT01327599|469100729|FG000|Overall Study|Adverse Event|1|||
130310510|NCT01327599|469100729|FG000|Overall Study|Could Not Attend Visit|1|||
130310511|NCT01327599|469100729|FG000|Overall Study|Withdrawal of Consent|1|||
130310512|NCT02715609|469100731|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
130310513|NCT02715609|469100732|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
130310514|NCT02715609|469100733|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
130310515|NCT02715609|469100731|FG000|Overall Study|Withdrawal by Subject|0|||
130310516|NCT02715609|469100732|FG001|Overall Study|Withdrawal by Subject|0|||
130310517|NCT02715609|469100733|FG002|Overall Study|Withdrawal by Subject|1|||
130310518|NCT05907395|469100736|FG000|Period 1|No longer met eligibility criteria|0|||
130310519|NCT05907395|469100737|FG001|Period 1|No longer met eligibility criteria|1|||
130310520|NCT05907395|469100738|FG002|Period 1|No longer met eligibility criteria|0|||
130310521|NCT05907395|469100739|FG003|Period 1|No longer met eligibility criteria|0|||
130310522|NCT05907395|469100740|FG004|Period 1|No longer met eligibility criteria|0|||
130310523|NCT05907395|469100741|FG005|Period 1|No longer met eligibility criteria|1|||
130310524|NCT05907395|469100742|FG006|Period 1|No longer met eligibility criteria|1|||
130310525|NCT05907395|469100743|FG007|Period 1|No longer met eligibility criteria|0|||
130310526|NCT05907395|469100744|FG008|Period 1|No longer met eligibility criteria|0|||
130310527|NCT05907395|469100745|FG009|Period 1|No longer met eligibility criteria|0|||
130310528|NCT05907395|469100746|FG010|Period 1|No longer met eligibility criteria|0|||
130310529|NCT05907395|469100747|FG011|Period 1|No longer met eligibility criteria|0|||
130310530|NCT05907395|469100736|FG000|Period 2|Adverse Event|0|||
130310531|NCT05907395|469100737|FG001|Period 2|Adverse Event|0|||
130310532|NCT05907395|469100738|FG002|Period 2|Adverse Event|0|||
130310533|NCT05907395|469100739|FG003|Period 2|Adverse Event|1|||
130310534|NCT05907395|469100740|FG004|Period 2|Adverse Event|0|||
130310535|NCT05907395|469100741|FG005|Period 2|Adverse Event|0|||
130310536|NCT05907395|469100742|FG006|Period 2|Adverse Event|0|||
130310537|NCT05907395|469100743|FG007|Period 2|Adverse Event|1|||
130310538|NCT05907395|469100744|FG008|Period 2|Adverse Event|0|||
130310539|NCT05907395|469100745|FG009|Period 2|Adverse Event|0|||
130310540|NCT05907395|469100746|FG010|Period 2|Adverse Event|0|||
130310541|NCT05907395|469100747|FG011|Period 2|Adverse Event|0|||
130310542|NCT05907395|469100736|FG000|Period 2|Personal reason|0|||
130310543|NCT05907395|469100737|FG001|Period 2|Personal reason|0|||
130310544|NCT05907395|469100738|FG002|Period 2|Personal reason|0|||
130310545|NCT05907395|469100739|FG003|Period 2|Personal reason|0|||
130310546|NCT05907395|469100740|FG004|Period 2|Personal reason|0|||
130310547|NCT05907395|469100741|FG005|Period 2|Personal reason|0|||
130310548|NCT05907395|469100742|FG006|Period 2|Personal reason|0|||
130310549|NCT05907395|469100743|FG007|Period 2|Personal reason|0|||
130310550|NCT05907395|469100744|FG008|Period 2|Personal reason|0|||
130310551|NCT05907395|469100745|FG009|Period 2|Personal reason|1|||
130310552|NCT05907395|469100746|FG010|Period 2|Personal reason|0|||
130310553|NCT05907395|469100747|FG011|Period 2|Personal reason|0|||
130310554|NCT05907395|469100736|FG000|Period 3|Adverse Event|0|||
130310555|NCT05907395|469100737|FG001|Period 3|Adverse Event|0|||
130310556|NCT05907395|469100738|FG002|Period 3|Adverse Event|0|||
130310557|NCT05907395|469100739|FG003|Period 3|Adverse Event|0|||
130310558|NCT05907395|469100740|FG004|Period 3|Adverse Event|1|||
130310559|NCT05907395|469100741|FG005|Period 3|Adverse Event|0|||
130310560|NCT05907395|469100742|FG006|Period 3|Adverse Event|0|||
130310561|NCT05907395|469100743|FG007|Period 3|Adverse Event|0|||
130310562|NCT05907395|469100744|FG008|Period 3|Adverse Event|0|||
130465316|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
130465317|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
130465318|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
130310563|NCT05907395|469100745|FG009|Period 3|Adverse Event|0|||
130310564|NCT05907395|469100746|FG010|Period 3|Adverse Event|0|||
130310565|NCT05907395|469100747|FG011|Period 3|Adverse Event|0|||
130310566|NCT04544956|469100748|FG000|Overall Study|Withdrawal by Subject|1|||
130310567|NCT00434109|469100749|FG000|Overall Study|Physician Decision|9|||
130310568|NCT00434109|469100749|FG000|Overall Study|Adverse Event|5|||
130310569|NCT00434109|469100749|FG000|Overall Study|Protocol Violation|1|||
130310570|NCT00434109|469100749|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
130310571|NCT01797263|469102930|FG000|Overall Study|Withdrawal by Subject|21|||
130310572|NCT01797263|469102931|FG001|Overall Study|Withdrawal by Subject|25|||
130310573|NCT01797263|469102930|FG000|Overall Study|Death|1|||
130310574|NCT01797263|469102931|FG001|Overall Study|Death|0|||
130310575|NCT01797263|469102930|FG000|Overall Study|Lost to Follow-up|15|||
130557993|NCT00995007|470011878|FG001|Overall Study|Withdrew consent|0|||
130557994|NCT00995007|470011877|FG000|Overall Study|Refused further treatment|8|||
130557995|NCT00995007|470011878|FG001|Overall Study|Refused further treatment|2|||
130557996|NCT00995007|470011877|FG000|Overall Study|Toxicity|8|||
130557997|NCT00995007|470011878|FG001|Overall Study|Toxicity|0|||
130557998|NCT00882310|470011881|FG000|Overall Study|Screen Failure|10|||
130557999|NCT00882310|470011881|FG000|Overall Study|Never received treatment|1|||
130558000|NCT00882310|470011881|FG000|Overall Study|Death|6|||
130558001|NCT00882310|470011881|FG000|Overall Study|Progression of disease|4|||
130558002|NCT00882310|470011881|FG000|Overall Study|Adverse Event|1|||
130558003|NCT02733185|470011887|FG000|Overall Study|Withdrawal by Subject|12|||
130558004|NCT02733185|470011888|FG001|Overall Study|Withdrawal by Subject|10|||
130558005|NCT02733185|470011889|FG002|Overall Study|Withdrawal by Subject|17|||
130558006|NCT02733185|470011890|FG003|Overall Study|Withdrawal by Subject|21|||
130558007|NCT02733185|470011887|FG000|Overall Study|Death|46|||
130558008|NCT02733185|470011888|FG001|Overall Study|Death|34|||
130558009|NCT02733185|470011889|FG002|Overall Study|Death|35|||
130558010|NCT02733185|470011890|FG003|Overall Study|Death|43|||
130558011|NCT02733185|470011887|FG000|Overall Study|Lost to Follow-up|17|||
130558012|NCT02733185|470011888|FG001|Overall Study|Lost to Follow-up|18|||
130558013|NCT02733185|470011889|FG002|Overall Study|Lost to Follow-up|16|||
130558014|NCT02733185|470011890|FG003|Overall Study|Lost to Follow-up|11|||
130558015|NCT01624259|470011891|FG000|Overall Study|Adverse Event|18|||
130558016|NCT01624259|470011892|FG001|Overall Study|Adverse Event|18|||
130558017|NCT01624259|470011891|FG000|Overall Study|Protocol Violation|1|||
130558018|NCT01624259|470011892|FG001|Overall Study|Protocol Violation|2|||
130558019|NCT01624259|470011891|FG000|Overall Study|Withdrawal by Subject|5|||
130465319|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
130465320|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
130465321|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
130465322|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
130465323|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
130465324|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
130465325|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
130465326|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
130465327|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
130465328|NCT00311363|469670314|FG000|24-Week Single-Blind Treatment Period|Death|1|||
130558020|NCT01624259|470011892|FG001|Overall Study|Withdrawal by Subject|7|||
130558021|NCT01624259|470011891|FG000|Overall Study|Physician Decision|1|||
130558022|NCT01624259|470011892|FG001|Overall Study|Physician Decision|1|||
130558023|NCT01624259|470011891|FG000|Overall Study|Lost to Follow-up|2|||
130558024|NCT01624259|470011892|FG001|Overall Study|Lost to Follow-up|3|||
130558025|NCT01624259|470011891|FG000|Overall Study|Abnormal laboratory measure|3|||
130558026|NCT01624259|470011892|FG001|Overall Study|Abnormal laboratory measure|0|||
130558027|NCT03828292|470011893|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130558028|NCT03828292|470011894|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
130558029|NCT03828292|470011895|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130558030|NCT03828292|470011896|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130558031|NCT03828292|470011897|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130558032|NCT03828292|470011898|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130558033|NCT03828292|470011893|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130558034|NCT03828292|470011894|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130558035|NCT03828292|470011895|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
130558036|NCT03828292|470011896|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130310576|NCT01797263|469102931|FG001|Overall Study|Lost to Follow-up|15|||
130310577|NCT01172535|469102932|FG000|Overall Study|Death|3|||
130310578|NCT01172535|469102932|FG000|Overall Study|Withdrawal by Subject|2|||
130310579|NCT01172535|469102932|FG000|Overall Study|Lost to Follow-up|1|||
130465329|NCT00311363|469670315|FG001|24-Week Single-Blind Treatment Period|Death|0|||
130310580|NCT01172535|469102932|FG000|Overall Study|Ineligible at study entry|1|||
130310581|NCT01172535|469102932|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130310582|NCT00988598|469102933|FG000|Overall Study|Withdrawal by Subject|2|||
130310583|NCT00988598|469102934|FG001|Overall Study|Withdrawal by Subject|0|||
130310584|NCT01450761|469102939|FG000|Randomization|Subject no longer meets study criteria|1|||
130558037|NCT03828292|470011897|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130558038|NCT03828292|470011898|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130558039|NCT03828292|470011893|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130558040|NCT03828292|470011894|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130558041|NCT03828292|470011895|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130558042|NCT03828292|470011896|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
130558043|NCT03828292|470011897|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130558044|NCT03828292|470011898|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130310585|NCT01450761|469102940|FG001|Randomization|Subject no longer meets study criteria|2|||
130310586|NCT01450761|469102939|FG000|Randomization|Withdrawal by Subject|2|||
130310587|NCT01450761|469102940|FG001|Randomization|Withdrawal by Subject|0|||
130310588|NCT01450761|469102939|FG000|Randomization|Disease progression|0|||
130310589|NCT01450761|469102940|FG001|Randomization|Disease progression|2|||
130310590|NCT01450761|469102939|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130310591|NCT01450761|469102940|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130310592|NCT01450761|469102939|FG000|Randomization|Other|0|||
130310593|NCT01450761|469102940|FG001|Randomization|Other|1|||
130310594|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Disease progression|33|||
130310595|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Disease progression|32|||
130310596|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
130310597|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
130310598|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
130310599|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
130310600|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
130310601|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
130310602|NCT01450761|469102939|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
130310603|NCT01450761|469102940|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
130310604|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Death|3|||
130310605|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Death|3|||
130310606|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Other|2|||
130310607|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Other|2|||
130310608|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
130310609|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
130310610|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
130310611|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
130310612|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
130310613|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
130310614|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
130310615|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
130310616|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
130310617|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
130310618|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
130310619|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
130310620|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Death|5|||
130310621|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Death|6|||
130310622|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
130310623|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
130310624|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
130310625|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
130310626|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
130310627|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
130310628|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
130310629|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
130310630|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
130310631|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
130310632|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
130310633|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
130310634|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
130310635|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
130310636|NCT01818596|469102951|FG000|Overall Study|Enrolled but Not Treated|4|||
130310637|NCT01818596|469102952|FG001|Overall Study|Enrolled but Not Treated|0|||
130310638|NCT01818596|469102951|FG000|Overall Study|Adverse Event|7|||
130310639|NCT01818596|469102952|FG001|Overall Study|Adverse Event|0|||
130310640|NCT01818596|469102951|FG000|Overall Study|Death|3|||
130310641|NCT01818596|469102952|FG001|Overall Study|Death|0|||
130310642|NCT01818596|469102951|FG000|Overall Study|Investigator's Discretion|4|||
130310643|NCT01818596|469102952|FG001|Overall Study|Investigator's Discretion|0|||
130310644|NCT01818596|469102951|FG000|Overall Study|Protocol Violation|1|||
130310645|NCT01818596|469102952|FG001|Overall Study|Protocol Violation|0|||
130310646|NCT01818596|469102951|FG000|Overall Study|Withdrew Consent|5|||
130310647|NCT01818596|469102952|FG001|Overall Study|Withdrew Consent|0|||
130310648|NCT01818596|469102951|FG000|Overall Study|Lost to Follow-up|7|||
130310649|NCT01818596|469102952|FG001|Overall Study|Lost to Follow-up|0|||
130310650|NCT03801174|469102955|FG000|Overall Study|Withdrawal by Subject|14|||
130310651|NCT03801174|469102956|FG001|Overall Study|Withdrawal by Subject|15|||
130310652|NCT03801174|469102955|FG000|Overall Study|Death|1|||
130310653|NCT03801174|469102956|FG001|Overall Study|Death|0|||
130310654|NCT03801174|469102955|FG000|Overall Study|Pregnancy|2|||
130310655|NCT03801174|469102956|FG001|Overall Study|Pregnancy|2|||
130718681|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130310656|NCT03801174|469102955|FG000|Overall Study|Lost to Follow-up|19|||
130310657|NCT03801174|469102956|FG001|Overall Study|Lost to Follow-up|10|||
130310658|NCT03801174|469102955|FG000|Overall Study|Other|4|||
130310659|NCT03801174|469102956|FG001|Overall Study|Other|3|||
130310660|NCT03801174|469102955|FG000|Overall Study|Lack of Efficacy|4|||
130310661|NCT03801174|469102956|FG001|Overall Study|Lack of Efficacy|0|||
130310662|NCT03801174|469102955|FG000|Overall Study|Unwilling to complete activities|5|||
130310663|NCT03801174|469102956|FG001|Overall Study|Unwilling to complete activities|6|||
130310664|NCT03801174|469102955|FG000|Overall Study|Moved out of area|3|||
130310665|NCT03801174|469102956|FG001|Overall Study|Moved out of area|0|||
130310666|NCT00337207|469102959|FG000|Overall Study|Withdrawal by Subject|3|||
130310667|NCT00837213|469102969|FG000|Overall Study|Lost to Follow-up|3|||
130310668|NCT00837213|469102970|FG001|Overall Study|Lost to Follow-up|2|||
130310669|NCT00837213|469102969|FG000|Overall Study|Withdrawal by Subject|2|||
130310670|NCT00837213|469102970|FG001|Overall Study|Withdrawal by Subject|2|||
130310671|NCT00837213|469102969|FG000|Overall Study|not stated|1|||
130310672|NCT00837213|469102970|FG001|Overall Study|not stated|1|||
130310673|NCT02698826|469102972|FG000|Overall Study|Death|13|||
130310674|NCT02698826|469102972|FG000|Overall Study|Adverse Event|1|||
130310675|NCT02915263|469102973|FG000|Overall Study|Covid|3|||
130310676|NCT02915263|469102974|FG001|Overall Study|Covid|2|||
130310677|NCT01879683|469102978|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
130310678|NCT04317040|469102979|FG000|Overall Study|Lost to Follow-up|2|||
130310679|NCT04317040|469102980|FG001|Overall Study|Lost to Follow-up|0|||
130310680|NCT04317040|469102979|FG000|Overall Study|Death|16|||
130310681|NCT04317040|469102980|FG001|Overall Study|Death|18|||
130310682|NCT04317040|469102979|FG000|Overall Study|Withdrawal by Subject|0|||
130310683|NCT04317040|469102980|FG001|Overall Study|Withdrawal by Subject|1|||
130310684|NCT04317040|469102979|FG000|Overall Study|Incomplete assessments|0|||
130310685|NCT04317040|469102980|FG001|Overall Study|Incomplete assessments|1|||
130310686|NCT01177007|469102983|FG000|Overall Study|Lost to Follow-up|2|||
130310687|NCT01177007|469102983|FG000|Overall Study|Death|4|||
130310688|NCT01177007|469102983|FG000|Overall Study|Entered hospice care|5|||
130310689|NCT01177007|469102983|FG000|Overall Study|Required additional Y90 treatment|6|||
130310690|NCT01177007|469102983|FG000|Overall Study|Change in treatment modality|21|||
130310691|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Progressive disease|50|||
130310692|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Progressive disease|110|||
130310693|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Progressive disease|0|||
130310694|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Progressive disease|0|||
130310695|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130310696|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
130310697|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130310698|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130310699|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Adverse Event|7|||
130310700|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Adverse Event|7|||
130310701|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130310702|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Adverse Event|0|||
130310703|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Other|1|||
130310704|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Other|3|||
130310705|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Other|0|||
130374451|NCT00642460|469338374|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130374452|NCT00642460|469338375|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130374453|NCT00642460|469338376|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130374454|NCT00642460|469338377|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130374455|NCT00642460|469338378|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
130374456|NCT00642460|469338379|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
130374457|NCT02557646|469338382|FG000|Overall Study|Adverse Event|40|||
130374458|NCT02557646|469338382|FG000|Overall Study|Death|1|||
130374459|NCT02557646|469338382|FG000|Overall Study|Lack of Efficacy|186|||
130374460|NCT02557646|469338382|FG000|Overall Study|Withdrawal by Subject|18|||
130374461|NCT02557646|469338382|FG000|Overall Study|Lost to Follow-up|17|||
130374462|NCT02557646|469338382|FG000|Overall Study|Other|14|||
130374463|NCT04448171|469338383|FG000|Overall Study|Procedure Cancelled|1|||
130374464|NCT04448171|469338384|FG001|Overall Study|Procedure Cancelled|0|||
130374465|NCT04448171|469338383|FG000|Overall Study|Protocol Violation|1|||
130374466|NCT04448171|469338384|FG001|Overall Study|Protocol Violation|0|||
130374467|NCT04605484|469338387|FG000|Overall Study|Lost to Follow-up|0|||
130374468|NCT04605484|469338388|FG001|Overall Study|Lost to Follow-up|1|||
130374469|NCT04605484|469338389|FG002|Overall Study|Lost to Follow-up|1|||
130374470|NCT04605484|469338387|FG000|Overall Study|Other|0|||
130374471|NCT04605484|469338388|FG001|Overall Study|Other|1|||
130374472|NCT04605484|469338389|FG002|Overall Study|Other|0|||
130374473|NCT00459953|469338390|FG000|Overall Study|not analyzed-household member in study|1|||
130374474|NCT00459953|469338391|FG001|Overall Study|not analyzed-household member in study|1|||
130718682|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130558045|NCT03828292|470011893|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130558046|NCT03828292|470011894|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130558047|NCT03828292|470011895|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130558048|NCT03828292|470011896|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
130558049|NCT03828292|470011897|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130558050|NCT03828292|470011898|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130558051|NCT03828292|470011893|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130558052|NCT03828292|470011894|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130558053|NCT03828292|470011895|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
130558054|NCT03828292|470011896|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
130558055|NCT03828292|470011897|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130558056|NCT03828292|470011898|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130558057|NCT04313153|470013096|FG000|Overall Study|Adverse Event (includes Death)|14|||
130558058|NCT04313153|470013097|FG001|Overall Study|Adverse Event (includes Death)|19|||
130558059|NCT04313153|470013098|FG002|Overall Study|Adverse Event (includes Death)|10|||
130558060|NCT04313153|470013096|FG000|Overall Study|Physician Decision|4|||
130558061|NCT04313153|470013097|FG001|Overall Study|Physician Decision|2|||
130558062|NCT04313153|470013098|FG002|Overall Study|Physician Decision|1|||
130558063|NCT04313153|470013096|FG000|Overall Study|Withdrawal by Subject|7|||
130558064|NCT04313153|470013097|FG001|Overall Study|Withdrawal by Subject|6|||
130558065|NCT04313153|470013098|FG002|Overall Study|Withdrawal by Subject|2|||
130558066|NCT04313153|470013096|FG000|Overall Study|Lack of Efficacy|3|||
130558067|NCT04313153|470013097|FG001|Overall Study|Lack of Efficacy|3|||
130558068|NCT04313153|470013098|FG002|Overall Study|Lack of Efficacy|0|||
130558069|NCT04313153|470013096|FG000|Overall Study|Lost to Follow-up|1|||
130558070|NCT04313153|470013097|FG001|Overall Study|Lost to Follow-up|0|||
130558071|NCT04313153|470013098|FG002|Overall Study|Lost to Follow-up|2|||
130558072|NCT04313153|470013096|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
130558073|NCT04313153|470013097|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
130558074|NCT04313153|470013098|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
130558075|NCT04313153|470013096|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
130558076|NCT04313153|470013097|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
130558077|NCT04313153|470013098|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
130558078|NCT04313153|470013096|FG000|Overall Study|Change in Dialysis Modality|0|||
130558079|NCT04313153|470013097|FG001|Overall Study|Change in Dialysis Modality|1|||
130558080|NCT04313153|470013098|FG002|Overall Study|Change in Dialysis Modality|2|||
130558081|NCT04313153|470013096|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
130558082|NCT04313153|470013097|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
130558083|NCT04313153|470013098|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
130558084|NCT04313153|470013096|FG000|Overall Study|Other|5|||
130558085|NCT04313153|470013097|FG001|Overall Study|Other|3|||
130558086|NCT04313153|470013098|FG002|Overall Study|Other|2|||
130558087|NCT00332839|470013099|FG000|Core (Months 0 - 12)|Administrative problems|1|||
130558088|NCT00332839|470013100|FG001|Core (Months 0 - 12)|Administrative problems|1|||
130558089|NCT00332839|470013099|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
130558090|NCT00332839|470013100|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
130558091|NCT00332839|470013099|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
130558092|NCT00332839|470013100|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
130558093|NCT00332839|470013099|FG000|Core (Months 0 - 12)|Adverse Event|5|||
130558094|NCT00332839|470013100|FG001|Core (Months 0 - 12)|Adverse Event|15|||
130558095|NCT00332839|470013099|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
130558096|NCT00332839|470013100|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
130558097|NCT00332839|470013099|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
130558098|NCT00332839|470013100|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
130558099|NCT00332839|470013099|FG000|Follow-up (Months 12 - 60)|Death|1|||
130558100|NCT00332839|470013100|FG001|Follow-up (Months 12 - 60)|Death|1|||
130558101|NCT04641299|470013102|FG000|Overall Study|Adverse Event|0|||
130558102|NCT04641299|470013103|FG001|Overall Study|Adverse Event|0|||
130465330|NCT00311363|469670316|FG002|24-Week Single-Blind Treatment Period|Death|0|||
130465331|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
130465332|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
130465333|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
130465334|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
130465335|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
130465336|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130465337|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
130465338|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
130558103|NCT04641299|470013104|FG002|Overall Study|Adverse Event|2|||
130465339|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
130558104|NCT04641299|470013105|FG003|Overall Study|Adverse Event|0|||
130558105|NCT04641299|470013102|FG000|Overall Study|Lost to Follow-up|0|||
130558106|NCT04641299|470013103|FG001|Overall Study|Lost to Follow-up|1|||
130558107|NCT04641299|470013104|FG002|Overall Study|Lost to Follow-up|0|||
130558108|NCT04641299|470013105|FG003|Overall Study|Lost to Follow-up|0|||
130558109|NCT04641299|470013102|FG000|Overall Study|Withdrawal by Subject|1|||
130558110|NCT04641299|470013103|FG001|Overall Study|Withdrawal by Subject|0|||
130558111|NCT04641299|470013104|FG002|Overall Study|Withdrawal by Subject|0|||
130558112|NCT04641299|470013105|FG003|Overall Study|Withdrawal by Subject|0|||
130558113|NCT04641299|470013102|FG000|Overall Study|Reason not given|1|||
130558114|NCT04641299|470013103|FG001|Overall Study|Reason not given|0|||
130558115|NCT04641299|470013104|FG002|Overall Study|Reason not given|0|||
130558116|NCT04641299|470013105|FG003|Overall Study|Reason not given|0|||
130558117|NCT01016964|470013108|FG000|Overall Study|Lost to Follow-up|3|||
130558118|NCT01016964|470013109|FG001|Overall Study|Lost to Follow-up|3|||
130558119|NCT01920594|470013110|FG000|Overall Study|Adverse Event|4|||
130558120|NCT01920594|470013111|FG001|Overall Study|Adverse Event|2|||
130558121|NCT01920594|470013110|FG000|Overall Study|Lost to Follow-up|1|||
130558122|NCT01920594|470013111|FG001|Overall Study|Lost to Follow-up|0|||
130558123|NCT01920594|470013110|FG000|Overall Study|Recovery|2|||
130558124|NCT01920594|470013111|FG001|Overall Study|Recovery|0|||
130558125|NCT01920594|470013110|FG000|Overall Study|Investigator discretion|0|||
130558126|NCT01920594|470013111|FG001|Overall Study|Investigator discretion|1|||
130558127|NCT00928564|470013112|FG000|Overall Study|Lost to Follow-up|6|||
130558128|NCT00928564|470013113|FG001|Overall Study|Lost to Follow-up|0|||
130558129|NCT02460497|470013117|FG000|Overall Study|Participant Requested Withdrawal|4|||
130558130|NCT02460497|470013117|FG000|Overall Study|Non-Compliance|1|||
130558131|NCT02460497|470013117|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
130558132|NCT02460497|470013117|FG000|Overall Study|Lost to Follow-up|2|||
130558133|NCT02460497|470013117|FG000|Overall Study|Investigator Decision|1|||
130558134|NCT02012296|470013122|FG000|Overall Study|Lack of Efficacy|0|||
130558135|NCT02012296|470013123|FG001|Overall Study|Lack of Efficacy|0|||
130558136|NCT02012296|470013124|FG002|Overall Study|Lack of Efficacy|15|||
130558137|NCT02012296|470013122|FG000|Overall Study|Adverse Event|0|||
130558138|NCT02012296|470013123|FG001|Overall Study|Adverse Event|0|||
130558139|NCT02012296|470013124|FG002|Overall Study|Adverse Event|2|||
130558140|NCT02012296|470013122|FG000|Overall Study|Early study closure|0|||
130558141|NCT02012296|470013123|FG001|Overall Study|Early study closure|0|||
130558142|NCT02012296|470013124|FG002|Overall Study|Early study closure|5|||
130558143|NCT02012296|470013122|FG000|Overall Study|Protocol Violation|0|||
130558144|NCT02012296|470013123|FG001|Overall Study|Protocol Violation|1|||
130558145|NCT02012296|470013124|FG002|Overall Study|Protocol Violation|0|||
130558146|NCT01448213|470013125|FG000|Overall Study|Lost to Follow-up|12|||
130558147|NCT01448213|470013126|FG001|Overall Study|Lost to Follow-up|10|||
130558148|NCT01448213|470013125|FG000|Overall Study|Adverse Event|4|||
130558149|NCT01448213|470013126|FG001|Overall Study|Adverse Event|10|||
130558150|NCT01448213|470013125|FG000|Overall Study|Protocol Violation|1|||
130558151|NCT01448213|470013126|FG001|Overall Study|Protocol Violation|2|||
130558152|NCT01330914|470013127|FG000|Overall Study|Withdrawal by Subject|4|||
130558153|NCT01330914|470013127|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
130558154|NCT03631667|470013132|FG000|Overall Study|Withdrawal by Subject|3|||
130558155|NCT00884325|470013133|FG000|Overall Study|Lost to Follow-up|1|||
130718683|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130374475|NCT00040664|469338392|FG000|Overall Study|Adverse Event|12|||
130374476|NCT00040664|469338393|FG001|Overall Study|Adverse Event|3|||
130374477|NCT00040664|469338394|FG002|Overall Study|Adverse Event|2|||
130374478|NCT00040664|469338395|FG003|Overall Study|Adverse Event|7|||
130374479|NCT00040664|469338392|FG000|Overall Study|Lack of Efficacy|9|||
130374480|NCT00040664|469338393|FG001|Overall Study|Lack of Efficacy|2|||
130374481|NCT00040664|469338394|FG002|Overall Study|Lack of Efficacy|3|||
130374482|NCT00040664|469338395|FG003|Overall Study|Lack of Efficacy|4|||
130374483|NCT00040664|469338392|FG000|Overall Study|Insufficient CD4 response|1|||
130374484|NCT00040664|469338393|FG001|Overall Study|Insufficient CD4 response|0|||
130374485|NCT00040664|469338394|FG002|Overall Study|Insufficient CD4 response|1|||
130374486|NCT00040664|469338395|FG003|Overall Study|Insufficient CD4 response|0|||
130374487|NCT00040664|469338392|FG000|Overall Study|Lost to Follow-up|4|||
130374488|NCT00040664|469338393|FG001|Overall Study|Lost to Follow-up|2|||
130374489|NCT00040664|469338394|FG002|Overall Study|Lost to Follow-up|0|||
130374490|NCT00040664|469338395|FG003|Overall Study|Lost to Follow-up|2|||
130374491|NCT00040664|469338392|FG000|Overall Study|Protocol Violation|2|||
130374492|NCT00040664|469338393|FG001|Overall Study|Protocol Violation|1|||
130374493|NCT00040664|469338394|FG002|Overall Study|Protocol Violation|0|||
130374494|NCT00040664|469338395|FG003|Overall Study|Protocol Violation|1|||
130374495|NCT00040664|469338392|FG000|Overall Study|Withdrawal by Subject|7|||
130374496|NCT00040664|469338393|FG001|Overall Study|Withdrawal by Subject|0|||
130374497|NCT00040664|469338394|FG002|Overall Study|Withdrawal by Subject|3|||
130374498|NCT00040664|469338395|FG003|Overall Study|Withdrawal by Subject|4|||
130558156|NCT00884325|470013134|FG001|Overall Study|Lost to Follow-up|2|||
130558157|NCT00884325|470013133|FG000|Overall Study|Lack of Efficacy|0|||
130310706|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Other|0|||
130310707|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Physician Decision|6|||
130310708|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Physician Decision|3|||
130310709|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Physician Decision|0|||
130310710|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Physician Decision|0|||
130310711|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Death|1|||
130310712|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Death|1|||
130310713|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Death|0|||
130310714|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Death|0|||
130310715|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310716|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
130310717|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310718|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310719|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
130310720|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
130310721|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
130310722|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
130310723|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130310724|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130310725|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
130310726|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
130310727|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
130310728|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
130310729|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
130310730|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
130310731|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Other|0|||
130310732|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Other|0|||
130310733|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Other|4|||
130310734|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Other|7|||
130310735|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
130310736|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
130310737|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
130310738|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
130310739|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Death|0|||
130310740|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Death|0|||
130310741|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Death|2|||
130310742|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Death|7|||
130310743|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310744|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310745|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310746|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
130310747|NCT00684996|469102992|FG000|Overall Study|Adverse Event|1|||
130310748|NCT00684996|469102992|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130310749|NCT00684996|469102992|FG000|Overall Study|Progression/relapse|2|||
130310750|NCT00684996|469102992|FG000|Overall Study|Other reasons not protocol specified|1|||
130310751|NCT03030417|469102995|FG000|Dose Expansion|Disease progression before treatment|0|||
130310752|NCT03030417|469102996|FG001|Dose Expansion|Disease progression before treatment|0|||
130310753|NCT03030417|469102997|FG002|Dose Expansion|Disease progression before treatment|0|||
130310754|NCT03030417|469102998|FG003|Dose Expansion|Disease progression before treatment|0|||
130310755|NCT03030417|469102999|FG004|Dose Expansion|Disease progression before treatment|0|||
130310756|NCT03030417|469103000|FG005|Dose Expansion|Disease progression before treatment|0|||
130310757|NCT03030417|469103001|FG006|Dose Expansion|Disease progression before treatment|0|||
130310758|NCT03030417|469103002|FG007|Dose Expansion|Disease progression before treatment|0|||
130310759|NCT03030417|469103003|FG008|Dose Expansion|Disease progression before treatment|0|||
130310760|NCT03030417|469103004|FG009|Dose Expansion|Disease progression before treatment|0|||
130310761|NCT03030417|469103005|FG010|Dose Expansion|Disease progression before treatment|0|||
130310762|NCT03030417|469103006|FG011|Dose Expansion|Disease progression before treatment|0|||
130310763|NCT03030417|469103007|FG012|Dose Expansion|Disease progression before treatment|1|||
130310764|NCT01076959|469103008|FG000|Overall Study|Adverse Event|767|||
130310765|NCT01076959|469103008|FG000|Overall Study|Lack of Efficacy|849|||
130310766|NCT01076959|469103008|FG000|Overall Study|Non-compliance|274|||
130310767|NCT01076959|469103008|FG000|Overall Study|Lost to Follow-up|241|||
130310768|NCT01076959|469103008|FG000|Overall Study|Other|119|||
130558158|NCT00884325|470013134|FG001|Overall Study|Lack of Efficacy|1|||
130558159|NCT00884325|470013133|FG000|Overall Study|Withdrawal by Subject|1|||
130558160|NCT00884325|470013134|FG001|Overall Study|Withdrawal by Subject|1|||
130310769|NCT01078441|469103009|FG000|Overall Study|Withdrawal by Subject|1|||
130310770|NCT02175017|469103010|FG000|Overall Study|Did not receive the investigational product|1|||
130310771|NCT02175017|469103011|FG001|Overall Study|Did not receive the investigational product|2|||
130310772|NCT02175017|469103010|FG000|Overall Study|Withdrawal by Subject|6|||
130310773|NCT02175017|469103011|FG001|Overall Study|Withdrawal by Subject|3|||
130310774|NCT02175017|469103010|FG000|Overall Study|Met an exclusion criteria|0|||
130310775|NCT02175017|469103011|FG001|Overall Study|Met an exclusion criteria|1|||
130310776|NCT02175017|469103010|FG000|Overall Study|Adverse Event|3|||
130310777|NCT02175017|469103011|FG001|Overall Study|Adverse Event|10|||
130310778|NCT02175017|469103010|FG000|Overall Study|Disease progression|20|||
130310779|NCT02175017|469103011|FG001|Overall Study|Disease progression|27|||
130310780|NCT02175017|469103010|FG000|Overall Study|Other than above reasons|3|||
130310781|NCT02175017|469103011|FG001|Overall Study|Other than above reasons|0|||
130310782|NCT02491983|469103012|FG000|Overall Study|Physician Decision|1|||
130310783|NCT02491983|469103013|FG001|Overall Study|Physician Decision|0|||
130310784|NCT02491983|469103012|FG000|Overall Study|Not meet selection criteria|1|||
130310785|NCT02491983|469103013|FG001|Overall Study|Not meet selection criteria|0|||
130310786|NCT02491983|469103012|FG000|Overall Study|Withdrawal by Subject|0|||
130310787|NCT02491983|469103013|FG001|Overall Study|Withdrawal by Subject|1|||
130310788|NCT04915729|469103014|FG000|Overall Study|Lost to Follow-up|20|||
130310789|NCT04915729|469103015|FG001|Overall Study|Lost to Follow-up|10|||
130310790|NCT04915729|469103014|FG000|Overall Study|Withdrawal by Subject|12|||
130310791|NCT04915729|469103015|FG001|Overall Study|Withdrawal by Subject|5|||
130310792|NCT04915729|469103014|FG000|Overall Study|Death|34|||
130310793|NCT04915729|469103015|FG001|Overall Study|Death|44|||
130310794|NCT04915729|469103014|FG000|Overall Study|not treated|3|||
130310795|NCT04915729|469103015|FG001|Overall Study|not treated|6|||
130310796|NCT04915729|469103014|FG000|Overall Study|Investigator removed subject|1|||
130310797|NCT04915729|469103015|FG001|Overall Study|Investigator removed subject|2|||
130310798|NCT04915729|469103014|FG000|Overall Study|questionnaire result not evaluated|1|||
130310799|NCT04915729|469103015|FG001|Overall Study|questionnaire result not evaluated|0|||
130310800|NCT04915729|469103014|FG000|Overall Study|refuse of hospital visit|1|||
130310801|NCT04915729|469103015|FG001|Overall Study|refuse of hospital visit|3|||
130310802|NCT04915729|469103014|FG000|Overall Study|Subject withdrew|1|||
130310803|NCT04915729|469103015|FG001|Overall Study|Subject withdrew|0|||
130310804|NCT01684202|469103016|FG000|Dose-escalation Period|Adverse Event|0|||
130310805|NCT01684202|469103017|FG001|Dose-escalation Period|Adverse Event|1|||
130310806|NCT01684202|469103018|FG002|Dose-escalation Period|Adverse Event|0|||
130310807|NCT01684202|469103019|FG003|Dose-escalation Period|Adverse Event|0|||
130310808|NCT01684202|469103016|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
130310809|NCT01684202|469103017|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
130310810|NCT01684202|469103018|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
130310811|NCT01684202|469103019|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
130310812|NCT01684202|469103016|FG000|Maintenance Period|Adverse Event|1|||
130310813|NCT01684202|469103017|FG001|Maintenance Period|Adverse Event|1|||
130310814|NCT01684202|469103018|FG002|Maintenance Period|Adverse Event|1|||
130310815|NCT01684202|469103019|FG003|Maintenance Period|Adverse Event|1|||
130310816|NCT01684202|469103016|FG000|Maintenance Period|Physician Decision|0|||
130310817|NCT01684202|469103017|FG001|Maintenance Period|Physician Decision|1|||
130310818|NCT01684202|469103018|FG002|Maintenance Period|Physician Decision|0|||
130310819|NCT01684202|469103019|FG003|Maintenance Period|Physician Decision|0|||
130310820|NCT01684202|469103016|FG000|Maintenance Period|Withdrawal by Subject|0|||
130310821|NCT01684202|469103017|FG001|Maintenance Period|Withdrawal by Subject|1|||
130310822|NCT01684202|469103018|FG002|Maintenance Period|Withdrawal by Subject|0|||
130310823|NCT01684202|469103019|FG003|Maintenance Period|Withdrawal by Subject|0|||
130310824|NCT03710642|469103023|FG000|Overall Study|Adverse Event|5|||
130310825|NCT03710642|469103024|FG001|Overall Study|Adverse Event|1|||
130310826|NCT03710642|469103023|FG000|Overall Study|non-site physician recommendation|1|||
130310827|NCT03710642|469103024|FG001|Overall Study|non-site physician recommendation|0|||
130558161|NCT00884325|470013133|FG000|Overall Study|Not provided|1|||
130558162|NCT00884325|470013134|FG001|Overall Study|Not provided|0|||
130558163|NCT00892177|470013135|FG000|Phase II|Ineligible|0|||
130558164|NCT00892177|470013136|FG001|Phase II|Ineligible|0|||
130558165|NCT00892177|470013137|FG002|Phase II|Ineligible|0|||
130310828|NCT03710642|469103023|FG000|Overall Study|Participant unwilling or unable to participate|1|||
130310829|NCT03710642|469103024|FG001|Overall Study|Participant unwilling or unable to participate|1|||
130310830|NCT03710642|469103023|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
130310831|NCT03710642|469103024|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
130310832|NCT03710642|469103023|FG000|Overall Study|NA-no code provided|1|||
130310833|NCT03710642|469103024|FG001|Overall Study|NA-no code provided|0|||
130310834|NCT03710642|469103023|FG000|Overall Study|Withdrawal by Subject|1|||
130310835|NCT03710642|469103024|FG001|Overall Study|Withdrawal by Subject|0|||
130310836|NCT02741635|469103027|FG000|Overall Study|Withdrawal by Subject|1|||
130310837|NCT01427933|469103031|FG000|Overall Study|Withdrawal by Subject|5|||
130310838|NCT01427933|469103032|FG001|Overall Study|Withdrawal by Subject|8|||
130310839|NCT01427933|469103031|FG000|Overall Study|Lost to Follow-up|1|||
130310840|NCT01427933|469103032|FG001|Overall Study|Lost to Follow-up|5|||
130558166|NCT00892177|470013138|FG003|Phase II|Ineligible|0|||
130558167|NCT00892177|470013139|FG004|Phase II|Ineligible|1|||
130558168|NCT00892177|470013140|FG005|Phase II|Ineligible|1|||
130558169|NCT00892177|470013135|FG000|Phase II|Withdrawal by Subject|0|||
130558170|NCT00892177|470013136|FG001|Phase II|Withdrawal by Subject|0|||
130558171|NCT00892177|470013137|FG002|Phase II|Withdrawal by Subject|0|||
130558172|NCT00892177|470013138|FG003|Phase II|Withdrawal by Subject|0|||
130558173|NCT00892177|470013139|FG004|Phase II|Withdrawal by Subject|4|||
130558174|NCT00892177|470013140|FG005|Phase II|Withdrawal by Subject|1|||
130558175|NCT00381563|470013150|FG000|Overall Study|Withdrawal by Subject|5|||
130558176|NCT00381563|470013151|FG001|Overall Study|Withdrawal by Subject|5|||
130558177|NCT00381563|470013150|FG000|Overall Study|Lost to Follow-up|2|||
130558178|NCT00381563|470013151|FG001|Overall Study|Lost to Follow-up|0|||
130558179|NCT00381563|470013150|FG000|Overall Study|Protocol Violation|0|||
130310841|NCT01427933|469103031|FG000|Overall Study|Other|1|||
130310842|NCT01427933|469103032|FG001|Overall Study|Other|0|||
130310843|NCT01427933|469103031|FG000|Overall Study|Investigator's Decision|1|||
130310844|NCT01427933|469103032|FG001|Overall Study|Investigator's Decision|0|||
130310845|NCT01633541|469103033|FG000|Overall Study|Death|1|||
130310846|NCT01633541|469103034|FG001|Overall Study|Death|0|||
130310847|NCT01010971|469103035|FG000|Overall Study|Adverse Event|2|||
130310848|NCT01010971|469103036|FG001|Overall Study|Adverse Event|4|||
130310849|NCT01010971|469103037|FG002|Overall Study|Adverse Event|3|||
130310850|NCT01010971|469103035|FG000|Overall Study|Withdrawal by Subject|0|||
130310851|NCT01010971|469103036|FG001|Overall Study|Withdrawal by Subject|2|||
130310852|NCT01010971|469103037|FG002|Overall Study|Withdrawal by Subject|5|||
130310853|NCT01010971|469103035|FG000|Overall Study|Lost to Follow-up|0|||
130310854|NCT01010971|469103036|FG001|Overall Study|Lost to Follow-up|2|||
130310855|NCT01010971|469103037|FG002|Overall Study|Lost to Follow-up|3|||
130310856|NCT01010971|469103035|FG000|Overall Study|Other|1|||
130310857|NCT01010971|469103036|FG001|Overall Study|Other|0|||
130310858|NCT01010971|469103037|FG002|Overall Study|Other|2|||
130310859|NCT03386721|469103038|FG000|Overall Study|Death|12|||
130310860|NCT03386721|469103039|FG001|Overall Study|Death|21|||
130310861|NCT03386721|469103040|FG002|Overall Study|Death|2|||
130310862|NCT03386721|469103041|FG003|Overall Study|Death|5|||
130310863|NCT03386721|469103042|FG004|Overall Study|Death|1|||
130310864|NCT03386721|469103043|FG005|Overall Study|Death|12|||
130310865|NCT03386721|469103044|FG006|Overall Study|Death|1|||
130310866|NCT03386721|469103045|FG007|Overall Study|Death|1|||
130310867|NCT03386721|469103046|FG008|Overall Study|Death|12|||
130310868|NCT03386721|469103047|FG009|Overall Study|Death|20|||
130310869|NCT03386721|469103048|FG010|Overall Study|Death|21|||
130310870|NCT03386721|469103049|FG011|Overall Study|Death|21|||
130310871|NCT03386721|469103050|FG012|Overall Study|Death|14|||
130310872|NCT03386721|469103051|FG013|Overall Study|Death|2|||
130310873|NCT03386721|469103052|FG014|Overall Study|Death|1|||
130310874|NCT03386721|469103038|FG000|Overall Study|Lost to Follow-up|1|||
130310875|NCT03386721|469103039|FG001|Overall Study|Lost to Follow-up|3|||
130310876|NCT03386721|469103040|FG002|Overall Study|Lost to Follow-up|0|||
130310877|NCT03386721|469103041|FG003|Overall Study|Lost to Follow-up|0|||
130310878|NCT03386721|469103042|FG004|Overall Study|Lost to Follow-up|0|||
130310879|NCT03386721|469103043|FG005|Overall Study|Lost to Follow-up|2|||
130310880|NCT03386721|469103044|FG006|Overall Study|Lost to Follow-up|1|||
130310881|NCT03386721|469103045|FG007|Overall Study|Lost to Follow-up|0|||
130310882|NCT03386721|469103046|FG008|Overall Study|Lost to Follow-up|1|||
130310883|NCT03386721|469103047|FG009|Overall Study|Lost to Follow-up|2|||
130310884|NCT03386721|469103048|FG010|Overall Study|Lost to Follow-up|1|||
130310885|NCT03386721|469103049|FG011|Overall Study|Lost to Follow-up|0|||
130310886|NCT03386721|469103050|FG012|Overall Study|Lost to Follow-up|0|||
130310887|NCT03386721|469103051|FG013|Overall Study|Lost to Follow-up|0|||
130310888|NCT03386721|469103052|FG014|Overall Study|Lost to Follow-up|0|||
130558180|NCT00381563|470013151|FG001|Overall Study|Protocol Violation|1|||
130558181|NCT01109173|470013153|FG000|Overall Study|Adverse Event|15|||
130558182|NCT01109173|470013154|FG001|Overall Study|Adverse Event|17|||
130310889|NCT03386721|469103038|FG000|Overall Study|Reason not specified|3|||
130310890|NCT03386721|469103039|FG001|Overall Study|Reason not specified|0|||
130558183|NCT01109173|470013155|FG002|Overall Study|Adverse Event|9|||
130558184|NCT01109173|470013156|FG003|Overall Study|Adverse Event|6|||
130558185|NCT01109173|470013153|FG000|Overall Study|Lost to Follow-up|0|||
130310891|NCT03386721|469103040|FG002|Overall Study|Reason not specified|0|||
130310892|NCT03386721|469103041|FG003|Overall Study|Reason not specified|0|||
130310893|NCT03386721|469103042|FG004|Overall Study|Reason not specified|0|||
130310894|NCT03386721|469103043|FG005|Overall Study|Reason not specified|3|||
130310895|NCT03386721|469103044|FG006|Overall Study|Reason not specified|1|||
130310896|NCT03386721|469103045|FG007|Overall Study|Reason not specified|0|||
130310897|NCT03386721|469103046|FG008|Overall Study|Reason not specified|0|||
130310898|NCT03386721|469103047|FG009|Overall Study|Reason not specified|1|||
130310899|NCT03386721|469103048|FG010|Overall Study|Reason not specified|2|||
130310900|NCT03386721|469103049|FG011|Overall Study|Reason not specified|6|||
130310901|NCT03386721|469103050|FG012|Overall Study|Reason not specified|1|||
130310902|NCT03386721|469103051|FG013|Overall Study|Reason not specified|0|||
130310903|NCT03386721|469103052|FG014|Overall Study|Reason not specified|0|||
130310904|NCT03386721|469103038|FG000|Overall Study|Progressive Disease|0|||
130310905|NCT03386721|469103039|FG001|Overall Study|Progressive Disease|0|||
130310906|NCT03386721|469103040|FG002|Overall Study|Progressive Disease|1|||
130310907|NCT03386721|469103041|FG003|Overall Study|Progressive Disease|0|||
130310908|NCT03386721|469103042|FG004|Overall Study|Progressive Disease|0|||
130310909|NCT03386721|469103043|FG005|Overall Study|Progressive Disease|1|||
130310910|NCT03386721|469103044|FG006|Overall Study|Progressive Disease|0|||
130310911|NCT03386721|469103045|FG007|Overall Study|Progressive Disease|0|||
130310912|NCT03386721|469103046|FG008|Overall Study|Progressive Disease|2|||
130310913|NCT03386721|469103047|FG009|Overall Study|Progressive Disease|1|||
130310914|NCT03386721|469103048|FG010|Overall Study|Progressive Disease|1|||
130310915|NCT03386721|469103049|FG011|Overall Study|Progressive Disease|0|||
130310916|NCT03386721|469103050|FG012|Overall Study|Progressive Disease|1|||
130310917|NCT03386721|469103051|FG013|Overall Study|Progressive Disease|0|||
130310918|NCT03386721|469103052|FG014|Overall Study|Progressive Disease|0|||
130310919|NCT03386721|469103038|FG000|Overall Study|Site Terminated by Sponsor|5|||
130310920|NCT03386721|469103039|FG001|Overall Study|Site Terminated by Sponsor|5|||
130310921|NCT03386721|469103040|FG002|Overall Study|Site Terminated by Sponsor|0|||
130310922|NCT03386721|469103041|FG003|Overall Study|Site Terminated by Sponsor|0|||
130310923|NCT03386721|469103042|FG004|Overall Study|Site Terminated by Sponsor|1|||
130310924|NCT03386721|469103043|FG005|Overall Study|Site Terminated by Sponsor|3|||
130310925|NCT03386721|469103044|FG006|Overall Study|Site Terminated by Sponsor|0|||
130310926|NCT03386721|469103045|FG007|Overall Study|Site Terminated by Sponsor|1|||
130310927|NCT03386721|469103046|FG008|Overall Study|Site Terminated by Sponsor|4|||
130310928|NCT03386721|469103047|FG009|Overall Study|Site Terminated by Sponsor|5|||
130310929|NCT03386721|469103048|FG010|Overall Study|Site Terminated by Sponsor|3|||
130310930|NCT03386721|469103049|FG011|Overall Study|Site Terminated by Sponsor|11|||
130310931|NCT03386721|469103050|FG012|Overall Study|Site Terminated by Sponsor|6|||
130310932|NCT03386721|469103051|FG013|Overall Study|Site Terminated by Sponsor|0|||
130310933|NCT03386721|469103052|FG014|Overall Study|Site Terminated by Sponsor|0|||
130310934|NCT03386721|469103038|FG000|Overall Study|Symptomatic Deterioration|0|||
130310935|NCT03386721|469103039|FG001|Overall Study|Symptomatic Deterioration|0|||
130310936|NCT03386721|469103040|FG002|Overall Study|Symptomatic Deterioration|0|||
130310937|NCT03386721|469103041|FG003|Overall Study|Symptomatic Deterioration|0|||
130310938|NCT03386721|469103042|FG004|Overall Study|Symptomatic Deterioration|0|||
130310939|NCT03386721|469103043|FG005|Overall Study|Symptomatic Deterioration|0|||
130310940|NCT03386721|469103044|FG006|Overall Study|Symptomatic Deterioration|0|||
130310941|NCT03386721|469103045|FG007|Overall Study|Symptomatic Deterioration|0|||
130310942|NCT03386721|469103046|FG008|Overall Study|Symptomatic Deterioration|1|||
130310943|NCT03386721|469103047|FG009|Overall Study|Symptomatic Deterioration|0|||
130310944|NCT03386721|469103048|FG010|Overall Study|Symptomatic Deterioration|0|||
130310945|NCT03386721|469103049|FG011|Overall Study|Symptomatic Deterioration|1|||
130310946|NCT03386721|469103050|FG012|Overall Study|Symptomatic Deterioration|0|||
130310947|NCT03386721|469103051|FG013|Overall Study|Symptomatic Deterioration|0|||
130310948|NCT03386721|469103052|FG014|Overall Study|Symptomatic Deterioration|0|||
130310949|NCT03386721|469103038|FG000|Overall Study|Withdrawal by Subject|1|||
130310950|NCT03386721|469103039|FG001|Overall Study|Withdrawal by Subject|2|||
130310951|NCT03386721|469103040|FG002|Overall Study|Withdrawal by Subject|0|||
130310952|NCT03386721|469103041|FG003|Overall Study|Withdrawal by Subject|0|||
130310953|NCT03386721|469103042|FG004|Overall Study|Withdrawal by Subject|0|||
130310954|NCT03386721|469103043|FG005|Overall Study|Withdrawal by Subject|0|||
130310955|NCT03386721|469103044|FG006|Overall Study|Withdrawal by Subject|0|||
130310956|NCT03386721|469103045|FG007|Overall Study|Withdrawal by Subject|0|||
130310957|NCT03386721|469103046|FG008|Overall Study|Withdrawal by Subject|2|||
130310958|NCT03386721|469103047|FG009|Overall Study|Withdrawal by Subject|1|||
130310959|NCT03386721|469103048|FG010|Overall Study|Withdrawal by Subject|3|||
130310960|NCT03386721|469103049|FG011|Overall Study|Withdrawal by Subject|2|||
130310961|NCT03386721|469103050|FG012|Overall Study|Withdrawal by Subject|3|||
130310962|NCT03386721|469103051|FG013|Overall Study|Withdrawal by Subject|0|||
130310963|NCT03386721|469103052|FG014|Overall Study|Withdrawal by Subject|0|||
130310964|NCT05114473|469103053|FG000|Overall Study|Lost to Follow-up|2|||
130310965|NCT05114473|469103054|FG001|Overall Study|Lost to Follow-up|2|||
130310966|NCT05114473|469103055|FG002|Overall Study|Lost to Follow-up|0|||
130310967|NCT02330055|469103056|FG000|Overall Study|technical issues|2|||
130558186|NCT01109173|470013154|FG001|Overall Study|Lost to Follow-up|1|||
130558187|NCT01109173|470013155|FG002|Overall Study|Lost to Follow-up|0|||
130310968|NCT02330055|469103057|FG001|Overall Study|technical issues|0|||
130310969|NCT02330055|469103056|FG000|Overall Study|participant forgot to wear device|5|||
130310970|NCT02330055|469103057|FG001|Overall Study|participant forgot to wear device|5|||
130310971|NCT02330055|469103056|FG000|Overall Study|data for less than 60 minutes|3|||
130310972|NCT02330055|469103057|FG001|Overall Study|data for less than 60 minutes|3|||
130310973|NCT02330055|469103056|FG000|Overall Study|participant did not sleep|0|||
130310974|NCT02330055|469103057|FG001|Overall Study|participant did not sleep|1|||
130310975|NCT01369784|469103061|FG000|Overall Study|Protocol Violation|12|||
130310976|NCT00782717|469103062|FG000|Overall Study|Adverse Event|2|||
130310977|NCT00782717|469103063|FG001|Overall Study|Adverse Event|5|||
130310978|NCT00782717|469103062|FG000|Overall Study|Patient decision unrelated to AE|6|||
130310979|NCT00782717|469103063|FG001|Overall Study|Patient decision unrelated to AE|3|||
130310980|NCT00782717|469103062|FG000|Overall Study|Noncompliance|2|||
130310981|NCT00782717|469103063|FG001|Overall Study|Noncompliance|1|||
130310982|NCT00782717|469103062|FG000|Overall Study|Treatment failure|3|||
130310983|NCT00782717|469103063|FG001|Overall Study|Treatment failure|14|||
130310984|NCT00782717|469103062|FG000|Overall Study|Enrollment close prior to surgery|1|||
130310985|NCT00782717|469103063|FG001|Overall Study|Enrollment close prior to surgery|0|||
130310986|NCT00782717|469103062|FG000|Overall Study|Did not meet entrance criteria|1|||
130310987|NCT00782717|469103063|FG001|Overall Study|Did not meet entrance criteria|3|||
130310988|NCT00782717|469103062|FG000|Overall Study|Exited in error|0|||
130310989|NCT00782717|469103063|FG001|Overall Study|Exited in error|2|||
130465340|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
130465341|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
130465342|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
130465343|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
130465344|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
130465345|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
130465346|NCT00311363|469670314|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
130465347|NCT00311363|469670315|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
130465348|NCT00311363|469670316|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
130465349|NCT03830866|469670317|FG000|Overall Study|Death|90|||
130465350|NCT03830866|469670318|FG001|Overall Study|Death|111|||
130465351|NCT03830866|469670317|FG000|Overall Study|Lost to Follow-up|7|||
130465352|NCT03830866|469670318|FG001|Overall Study|Lost to Follow-up|7|||
130465353|NCT03830866|469670317|FG000|Overall Study|Withdrawal by Subject|19|||
130465354|NCT03830866|469670318|FG001|Overall Study|Withdrawal by Subject|16|||
130465355|NCT03830866|469670317|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
130465356|NCT03830866|469670318|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
130465357|NCT03830866|469670317|FG000|Overall Study|Other|1|||
130465358|NCT03830866|469670318|FG001|Overall Study|Other|1|||
130465359|NCT00510887|469670320|FG000|Overall Study|Lost to Follow-up|1|||
130465360|NCT03485950|469670325|FG000|Overall Study|Adverse Event|1|||
130465361|NCT03485950|469670326|FG001|Overall Study|Adverse Event|0|||
130465362|NCT03485950|469670325|FG000|Overall Study|Death|3|||
130558188|NCT01109173|470013156|FG003|Overall Study|Lost to Follow-up|0|||
130558189|NCT01109173|470013153|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
130718684|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718685|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718686|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718687|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718688|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718689|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718690|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
130718691|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
130310990|NCT02905266|469103064|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
130310991|NCT02905266|469103065|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
130310992|NCT02905266|469103064|FG000|Treatment Phase Part 1|Disease Progression|6|||
130558190|NCT01109173|470013154|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
130558191|NCT01109173|470013155|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
130558192|NCT01109173|470013156|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
130558193|NCT01109173|470013153|FG000|Overall Study|Noncompliance|0|||
130558194|NCT01109173|470013154|FG001|Overall Study|Noncompliance|1|||
130558195|NCT01109173|470013155|FG002|Overall Study|Noncompliance|0|||
130558196|NCT01109173|470013156|FG003|Overall Study|Noncompliance|0|||
130558197|NCT01109173|470013153|FG000|Overall Study|Treatment Failure|25|||
130558198|NCT01109173|470013154|FG001|Overall Study|Treatment Failure|32|||
130558199|NCT01109173|470013155|FG002|Overall Study|Treatment Failure|69|||
130718692|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718693|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718694|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718695|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718696|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718697|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718698|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130310993|NCT02905266|469103065|FG001|Treatment Phase Part 1|Disease Progression|7|||
130310994|NCT02905266|469103064|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
130310995|NCT02905266|469103065|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
130465363|NCT03485950|469670326|FG001|Overall Study|Death|2|||
130465364|NCT03485950|469670325|FG000|Overall Study|Withdrawal by Subject|3|||
130310996|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
130310997|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
130310998|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
130310999|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
130311000|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
130311001|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
130311002|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Death|0|||
130311003|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Death|1|||
130311004|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
130311005|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
130311006|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
130311007|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
130311008|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Disease Progression|9|||
130311009|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Disease Progression|2|||
130311010|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
130311011|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
130311012|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
130311013|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
130311014|NCT02292719|469103071|FG000|Overall Study|Withdrawal by Subject|0|||
130311015|NCT02292719|469103072|FG001|Overall Study|Withdrawal by Subject|0|||
130311016|NCT02292719|469103073|FG002|Overall Study|Withdrawal by Subject|0|||
130311017|NCT02292719|469103074|FG003|Overall Study|Withdrawal by Subject|1|||
130311018|NCT02292719|469103075|FG004|Overall Study|Withdrawal by Subject|1|||
130311019|NCT02292719|469103076|FG005|Overall Study|Withdrawal by Subject|0|||
130311020|NCT02292719|469103071|FG000|Overall Study|Subject enrolled in new study.|0|||
130311021|NCT02292719|469103072|FG001|Overall Study|Subject enrolled in new study.|0|||
130311022|NCT02292719|469103073|FG002|Overall Study|Subject enrolled in new study.|1|||
130311023|NCT02292719|469103074|FG003|Overall Study|Subject enrolled in new study.|0|||
130311024|NCT02292719|469103075|FG004|Overall Study|Subject enrolled in new study.|0|||
130311025|NCT02292719|469103076|FG005|Overall Study|Subject enrolled in new study.|0|||
130311026|NCT02586727|469103082|FG000|Overall Study|Lost to Follow-up|1|||
130311027|NCT02586727|469103083|FG001|Overall Study|Lost to Follow-up|0|||
130311028|NCT04378270|469103085|FG000|Overall Study|Lack of Efficacy|1|||
130311029|NCT04378270|469103085|FG000|Overall Study|Withdrawal by Subject|1|||
130311030|NCT04378270|469103085|FG000|Overall Study|Screen Failure|1|||
130311031|NCT04378270|469103085|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
130311032|NCT01132313|469103086|FG000|Overall Study|Lack of Efficacy|1|||
130311033|NCT01132313|469103087|FG001|Overall Study|Lack of Efficacy|0|||
130311034|NCT01132313|469103088|FG002|Overall Study|Lack of Efficacy|0|||
130311035|NCT01132313|469103089|FG003|Overall Study|Lack of Efficacy|0|||
130311036|NCT01132313|469103090|FG004|Overall Study|Lack of Efficacy|0|||
130311037|NCT01132313|469103091|FG005|Overall Study|Lack of Efficacy|0|||
130311038|NCT01132313|469103092|FG006|Overall Study|Lack of Efficacy|0|||
130311039|NCT01132313|469103093|FG007|Overall Study|Lack of Efficacy|3|||
130311040|NCT01132313|469103094|FG008|Overall Study|Lack of Efficacy|14|||
130311041|NCT01132313|469103095|FG009|Overall Study|Lack of Efficacy|16|||
130311042|NCT01132313|469103096|FG010|Overall Study|Lack of Efficacy|0|||
130311043|NCT01132313|469103097|FG011|Overall Study|Lack of Efficacy|0|||
130311044|NCT01132313|469103086|FG000|Overall Study|Not treated|2|||
130311045|NCT01132313|469103087|FG001|Overall Study|Not treated|0|||
130311046|NCT01132313|469103088|FG002|Overall Study|Not treated|0|||
130311047|NCT01132313|469103089|FG003|Overall Study|Not treated|0|||
130558200|NCT01109173|470013156|FG003|Overall Study|Treatment Failure|64|||
130558201|NCT01109173|470013153|FG000|Overall Study|Protocol Violation|4|||
130558202|NCT01109173|470013154|FG001|Overall Study|Protocol Violation|5|||
130311048|NCT01132313|469103090|FG004|Overall Study|Not treated|2|||
130311049|NCT01132313|469103091|FG005|Overall Study|Not treated|1|||
130311050|NCT01132313|469103092|FG006|Overall Study|Not treated|3|||
130311051|NCT01132313|469103093|FG007|Overall Study|Not treated|0|||
130311052|NCT01132313|469103094|FG008|Overall Study|Not treated|0|||
130311053|NCT01132313|469103095|FG009|Overall Study|Not treated|0|||
130311054|NCT01132313|469103096|FG010|Overall Study|Not treated|0|||
130311055|NCT01132313|469103097|FG011|Overall Study|Not treated|0|||
130311056|NCT01132313|469103086|FG000|Overall Study|Adverse Event|0|||
130558203|NCT01109173|470013155|FG002|Overall Study|Protocol Violation|1|||
130311057|NCT01132313|469103087|FG001|Overall Study|Adverse Event|0|||
130311058|NCT01132313|469103088|FG002|Overall Study|Adverse Event|4|||
130311059|NCT01132313|469103089|FG003|Overall Study|Adverse Event|10|||
130311060|NCT01132313|469103090|FG004|Overall Study|Adverse Event|19|||
130558204|NCT01109173|470013156|FG003|Overall Study|Protocol Violation|2|||
130311061|NCT01132313|469103091|FG005|Overall Study|Adverse Event|6|||
130311062|NCT01132313|469103092|FG006|Overall Study|Adverse Event|5|||
130311063|NCT01132313|469103093|FG007|Overall Study|Adverse Event|3|||
130311064|NCT01132313|469103094|FG008|Overall Study|Adverse Event|7|||
130311065|NCT01132313|469103095|FG009|Overall Study|Adverse Event|2|||
130311066|NCT01132313|469103096|FG010|Overall Study|Adverse Event|0|||
130311067|NCT01132313|469103097|FG011|Overall Study|Adverse Event|0|||
130311068|NCT01132313|469103086|FG000|Overall Study|Protocol Violation|0|||
130311069|NCT01132313|469103087|FG001|Overall Study|Protocol Violation|0|||
130311070|NCT01132313|469103088|FG002|Overall Study|Protocol Violation|0|||
130311071|NCT01132313|469103089|FG003|Overall Study|Protocol Violation|1|||
130311072|NCT01132313|469103090|FG004|Overall Study|Protocol Violation|0|||
130311073|NCT01132313|469103091|FG005|Overall Study|Protocol Violation|0|||
130311074|NCT01132313|469103092|FG006|Overall Study|Protocol Violation|0|||
130311075|NCT01132313|469103093|FG007|Overall Study|Protocol Violation|0|||
130311076|NCT01132313|469103094|FG008|Overall Study|Protocol Violation|0|||
130311077|NCT01132313|469103095|FG009|Overall Study|Protocol Violation|0|||
130465365|NCT03485950|469670326|FG001|Overall Study|Withdrawal by Subject|0|||
130465366|NCT00988858|469670328|FG000|Overall Study|Adverse Event|7|||
130465367|NCT00988858|469670328|FG000|Overall Study|Death|1|||
130465368|NCT00988858|469670328|FG000|Overall Study|Physician Decision|1|||
130465369|NCT00988858|469670328|FG000|Overall Study|Sponsor Decision|1|||
130465370|NCT05510245|469670335|FG000|Overall Study|Withdrawal by Subject|1|||
130465371|NCT05510245|469670336|FG001|Overall Study|Withdrawal by Subject|0|||
130465372|NCT05510245|469670337|FG002|Overall Study|Withdrawal by Subject|0|||
130465373|NCT00411216|469670341|FG000|Overall Study|Ten participants were entered into the c|0|||
130465374|NCT00411216|469670342|FG001|Overall Study|Ten participants were entered into the c|2|||
130465375|NCT01251354|469670346|FG000|Overall Study|Adverse Event|1|||
130465376|NCT01251354|469670346|FG000|Overall Study|Investigator's Decision|1|||
130465377|NCT01251354|469670346|FG000|Overall Study|Disease Progression|4|||
130465378|NCT03807778|469670347|FG000|Overall Study|Adverse Event|0|||
130465379|NCT03807778|469670348|FG001|Overall Study|Adverse Event|0|||
130465380|NCT03807778|469670349|FG002|Overall Study|Adverse Event|3|||
130465381|NCT03807778|469670350|FG003|Overall Study|Adverse Event|5|||
130465382|NCT03807778|469670347|FG000|Overall Study|Progressive Disease|4|||
130465383|NCT03807778|469670348|FG001|Overall Study|Progressive Disease|2|||
130465384|NCT03807778|469670349|FG002|Overall Study|Progressive Disease|8|||
130465385|NCT03807778|469670350|FG003|Overall Study|Progressive Disease|15|||
130465386|NCT03807778|469670347|FG000|Overall Study|Symptomatic Deterioration|0|||
130465387|NCT03807778|469670348|FG001|Overall Study|Symptomatic Deterioration|1|||
130465388|NCT03807778|469670349|FG002|Overall Study|Symptomatic Deterioration|0|||
130465389|NCT03807778|469670350|FG003|Overall Study|Symptomatic Deterioration|1|||
130465390|NCT03807778|469670347|FG000|Overall Study|Withdrawal by Subject|0|||
130465391|NCT03807778|469670348|FG001|Overall Study|Withdrawal by Subject|1|||
130465392|NCT03807778|469670349|FG002|Overall Study|Withdrawal by Subject|0|||
130465393|NCT03807778|469670350|FG003|Overall Study|Withdrawal by Subject|1|||
130465394|NCT03807778|469670347|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
130465395|NCT03807778|469670348|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
130465396|NCT03807778|469670349|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
130465397|NCT03807778|469670350|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
130465398|NCT05094141|469670353|FG000|Overall Study|Death|0|||
130465399|NCT05094141|469670354|FG001|Overall Study|Death|0|||
130465400|NCT05094141|469670355|FG002|Overall Study|Death|1|||
130465401|NCT05094141|469670353|FG000|Overall Study|Withdrawal by Subject|0|||
130465402|NCT05094141|469670354|FG001|Overall Study|Withdrawal by Subject|0|||
130465403|NCT05094141|469670355|FG002|Overall Study|Withdrawal by Subject|1|||
130465404|NCT05094141|469670353|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
130465405|NCT05094141|469670354|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
130465406|NCT05094141|469670355|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
130465407|NCT05094141|469670353|FG000|Overall Study|Did not participate in randomization|0|||
130465408|NCT05094141|469670354|FG001|Overall Study|Did not participate in randomization|0|||
130465409|NCT05094141|469670355|FG002|Overall Study|Did not participate in randomization|33|||
130465410|NCT04411056|469671896|FG000|Overall Study|surgery cancelled|1|||
130465411|NCT04411056|469671897|FG001|Overall Study|surgery cancelled|0|||
130465412|NCT04411056|469671896|FG000|Overall Study|Equipment problem during intubation|0|||
130465413|NCT04411056|469671897|FG001|Overall Study|Equipment problem during intubation|1|||
130465414|NCT03122886|469671901|FG000|Overall Study|Withdrawal by Subject|1|||
130465415|NCT03122886|469671902|FG001|Overall Study|Withdrawal by Subject|2|||
130465416|NCT03422276|469671903|FG000|Overall Study|Withdrawal by Subject|21|||
130465417|NCT03422276|469671904|FG001|Overall Study|Withdrawal by Subject|25|||
130465418|NCT03422276|469671905|FG002|Overall Study|Withdrawal by Subject|14|||
130311078|NCT01132313|469103096|FG010|Overall Study|Protocol Violation|0|||
130311079|NCT01132313|469103097|FG011|Overall Study|Protocol Violation|0|||
130311080|NCT01132313|469103086|FG000|Overall Study|Lost to Follow-up|0|||
130311081|NCT01132313|469103087|FG001|Overall Study|Lost to Follow-up|0|||
130311082|NCT01132313|469103088|FG002|Overall Study|Lost to Follow-up|1|||
130465419|NCT03422276|469671906|FG003|Overall Study|Withdrawal by Subject|16|||
130465420|NCT03422276|469671903|FG000|Overall Study|Death|14|||
130465421|NCT03422276|469671904|FG001|Overall Study|Death|21|||
130465422|NCT03422276|469671905|FG002|Overall Study|Death|3|||
130465423|NCT03422276|469671906|FG003|Overall Study|Death|1|||
130465424|NCT03422276|469671903|FG000|Overall Study|Discontinued, ineligible|4|||
130558205|NCT01109173|470013153|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
130558206|NCT01109173|470013154|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
130558207|NCT01109173|470013155|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
130558208|NCT01109173|470013156|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
130558209|NCT01109173|470013153|FG000|Overall Study|Not Specifiied|5|||
130558210|NCT01109173|470013154|FG001|Overall Study|Not Specifiied|4|||
130558211|NCT01109173|470013155|FG002|Overall Study|Not Specifiied|9|||
130558212|NCT01109173|470013156|FG003|Overall Study|Not Specifiied|14|||
130558213|NCT00006392|470013164|FG000|Overall Study|Ineligible|11|||
130558214|NCT00006392|470013165|FG001|Overall Study|Ineligible|3|||
130558215|NCT00006392|470013166|FG002|Overall Study|Ineligible|5|||
130558216|NCT00006392|470013167|FG003|Overall Study|Ineligible|5|||
130558217|NCT00006392|470013164|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
130558218|NCT00006392|470013165|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130558219|NCT00006392|470013166|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130718699|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718700|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718701|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718702|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718703|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718704|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
130718705|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718706|NCT00594646|470593302|FG000|Overall Study|Withdrawal by Subject|1|||
130718707|NCT00594646|470593302|FG000|Overall Study|Lost to Follow-up|15|||
130718708|NCT03907462|470593305|FG000|Overall Study|Physician Decision|1|||
130718709|NCT03907462|470593306|FG001|Overall Study|Physician Decision|3|||
130718710|NCT03907462|470593307|FG002|Overall Study|Physician Decision|1|||
130718711|NCT03907462|470593305|FG000|Overall Study|Withdrawal by Subject|6|||
130718712|NCT03907462|470593306|FG001|Overall Study|Withdrawal by Subject|3|||
130718713|NCT03907462|470593307|FG002|Overall Study|Withdrawal by Subject|3|||
130718714|NCT03907462|470593305|FG000|Overall Study|Pregnancy|4|||
130718715|NCT03907462|470593306|FG001|Overall Study|Pregnancy|2|||
130718716|NCT03907462|470593307|FG002|Overall Study|Pregnancy|6|||
130718717|NCT03907462|470593305|FG000|Overall Study|Lost to Follow-up|16|||
130718718|NCT03907462|470593306|FG001|Overall Study|Lost to Follow-up|18|||
130718719|NCT03907462|470593307|FG002|Overall Study|Lost to Follow-up|22|||
130718720|NCT03548064|470597202|FG000|Overall Study|Withdrawal by Subject|0|||
130718721|NCT03548064|470597203|FG001|Overall Study|Withdrawal by Subject|0|||
130718722|NCT03548064|470597204|FG002|Overall Study|Withdrawal by Subject|0|||
130718723|NCT03548064|470597205|FG003|Overall Study|Withdrawal by Subject|1|||
130718724|NCT03548064|470597206|FG004|Overall Study|Withdrawal by Subject|0|||
130718725|NCT03548064|470597207|FG005|Overall Study|Withdrawal by Subject|0|||
130718726|NCT03548064|470597208|FG006|Overall Study|Withdrawal by Subject|0|||
130718727|NCT03548064|470597209|FG007|Overall Study|Withdrawal by Subject|0|||
130718728|NCT03548064|470597202|FG000|Overall Study|Lost to Follow-up|0|||
130718729|NCT03548064|470597203|FG001|Overall Study|Lost to Follow-up|0|||
130718730|NCT03548064|470597204|FG002|Overall Study|Lost to Follow-up|0|||
130718731|NCT03548064|470597205|FG003|Overall Study|Lost to Follow-up|0|||
130718732|NCT03548064|470597206|FG004|Overall Study|Lost to Follow-up|2|||
130718733|NCT03548064|470597207|FG005|Overall Study|Lost to Follow-up|0|||
130718734|NCT03548064|470597208|FG006|Overall Study|Lost to Follow-up|0|||
130718735|NCT03548064|470597209|FG007|Overall Study|Lost to Follow-up|0|||
130718736|NCT03548064|470597202|FG000|Overall Study|Covid-19 Pandemic|0|||
130718737|NCT03548064|470597203|FG001|Overall Study|Covid-19 Pandemic|0|||
130718738|NCT03548064|470597204|FG002|Overall Study|Covid-19 Pandemic|0|||
130718739|NCT03548064|470597205|FG003|Overall Study|Covid-19 Pandemic|0|||
130718740|NCT03548064|470597206|FG004|Overall Study|Covid-19 Pandemic|10|||
130718741|NCT03548064|470597207|FG005|Overall Study|Covid-19 Pandemic|3|||
130718742|NCT03548064|470597208|FG006|Overall Study|Covid-19 Pandemic|0|||
130718743|NCT03548064|470597209|FG007|Overall Study|Covid-19 Pandemic|0|||
130718744|NCT05011123|470597210|FG000|Overall Study|Withdrawal by Subject|4|||
130718745|NCT05011123|470597211|FG001|Overall Study|Withdrawal by Subject|2|||
130374499|NCT00040664|469338392|FG000|Overall Study|Pregnancy|3|||
130374500|NCT00040664|469338393|FG001|Overall Study|Pregnancy|0|||
130374501|NCT00040664|469338394|FG002|Overall Study|Pregnancy|0|||
130718746|NCT05011123|470597210|FG000|Overall Study|Lost to Follow-up|7|||
130718747|NCT05011123|470597211|FG001|Overall Study|Lost to Follow-up|6|||
130718748|NCT05011123|470597210|FG000|Overall Study|Ongoing at the time of DBL date|36|||
130718749|NCT05011123|470597211|FG001|Overall Study|Ongoing at the time of DBL date|10|||
130718750|NCT05011123|470597210|FG000|Overall Study|Randomized but did not receive vaccination|1|||
130718751|NCT05011123|470597211|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130718752|NCT00006721|470597212|FG000|Overall Study|Adverse Event|0|||
130718753|NCT00006721|470597213|FG001|Overall Study|Adverse Event|4|||
130718754|NCT00006721|470597214|FG002|Overall Study|Adverse Event|4|||
130558220|NCT00006392|470013167|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130718755|NCT00006721|470597212|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130718756|NCT00006721|470597213|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
130374502|NCT00040664|469338395|FG003|Overall Study|Pregnancy|3|||
130374503|NCT00040664|469338392|FG000|Overall Study|Medication adherence/compliance problems|8|||
130374504|NCT00040664|469338393|FG001|Overall Study|Medication adherence/compliance problems|2|||
130374505|NCT00040664|469338394|FG002|Overall Study|Medication adherence/compliance problems|1|||
130374506|NCT00040664|469338395|FG003|Overall Study|Medication adherence/compliance problems|5|||
130374507|NCT00040664|469338392|FG000|Overall Study|Poor taste|2|||
130374508|NCT00040664|469338393|FG001|Overall Study|Poor taste|0|||
130374509|NCT00040664|469338394|FG002|Overall Study|Poor taste|2|||
130374510|NCT00040664|469338395|FG003|Overall Study|Poor taste|0|||
130374511|NCT00040664|469338392|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
130374512|NCT00040664|469338393|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
130374513|NCT00040664|469338394|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
130374514|NCT00040664|469338395|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
130374515|NCT00040664|469338392|FG000|Overall Study|Change of formulation|2|||
130374516|NCT00040664|469338393|FG001|Overall Study|Change of formulation|2|||
130374517|NCT00040664|469338394|FG002|Overall Study|Change of formulation|0|||
130374518|NCT00040664|469338395|FG003|Overall Study|Change of formulation|0|||
130465425|NCT03422276|469671904|FG001|Overall Study|Discontinued, ineligible|3|||
130465426|NCT03422276|469671905|FG002|Overall Study|Discontinued, ineligible|0|||
130465427|NCT03422276|469671906|FG003|Overall Study|Discontinued, ineligible|0|||
130465428|NCT03422276|469671903|FG000|Overall Study|Lost to Follow-up|15|||
130465429|NCT03422276|469671904|FG001|Overall Study|Lost to Follow-up|8|||
130718757|NCT00006721|470597214|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
130718758|NCT00006721|470597212|FG000|Overall Study|Progression/Relapse|0|||
130718759|NCT00006721|470597213|FG001|Overall Study|Progression/Relapse|1|||
130718760|NCT00006721|470597214|FG002|Overall Study|Progression/Relapse|2|||
130718761|NCT00006721|470597212|FG000|Overall Study|Death|0|||
130718762|NCT00006721|470597213|FG001|Overall Study|Death|1|||
130718763|NCT00006721|470597214|FG002|Overall Study|Death|2|||
130718764|NCT00006721|470597212|FG000|Overall Study|Other - Not Protocol Specified|0|||
130718765|NCT00006721|470597213|FG001|Overall Study|Other - Not Protocol Specified|7|||
130718766|NCT00006721|470597214|FG002|Overall Study|Other - Not Protocol Specified|7|||
130718767|NCT00006721|470597212|FG000|Overall Study|Ineligible|2|||
130718768|NCT00006721|470597213|FG001|Overall Study|Ineligible|12|||
130718769|NCT00006721|470597214|FG002|Overall Study|Ineligible|10|||
130718770|NCT00006721|470597212|FG000|Overall Study|Eligible but no Treatment Received|1|||
130718771|NCT00006721|470597213|FG001|Overall Study|Eligible but no Treatment Received|0|||
130718772|NCT00006721|470597214|FG002|Overall Study|Eligible but no Treatment Received|0|||
130718773|NCT04732221|470597215|FG000|Base Period|Death|2|||
130718774|NCT04732221|470597216|FG001|Base Period|Death|0|||
130718775|NCT04732221|470597217|FG002|Base Period|Death|0|||
130718776|NCT04732221|470597218|FG003|Base Period|Death|0|||
130718777|NCT04732221|470597219|FG004|Base Period|Death|0|||
130718778|NCT04732221|470597220|FG005|Base Period|Death|0|||
130718779|NCT04732221|470597221|FG006|Base Period|Death|0|||
130718780|NCT04732221|470597215|FG000|Base Period|Withdrawal by Subject|0|||
130718781|NCT04732221|470597216|FG001|Base Period|Withdrawal by Subject|1|||
130718782|NCT04732221|470597217|FG002|Base Period|Withdrawal by Subject|1|||
130718783|NCT04732221|470597218|FG003|Base Period|Withdrawal by Subject|0|||
130718784|NCT04732221|470597219|FG004|Base Period|Withdrawal by Subject|0|||
130718785|NCT04732221|470597220|FG005|Base Period|Withdrawal by Subject|0|||
130718786|NCT04732221|470597221|FG006|Base Period|Withdrawal by Subject|0|||
130718787|NCT04732221|470597215|FG000|Extension Period|Adverse Event|0|||
130718788|NCT04732221|470597216|FG001|Extension Period|Adverse Event|0|||
130718789|NCT04732221|470597217|FG002|Extension Period|Adverse Event|0|||
130718790|NCT04732221|470597218|FG003|Extension Period|Adverse Event|0|||
130718791|NCT04732221|470597219|FG004|Extension Period|Adverse Event|0|||
130718792|NCT04732221|470597220|FG005|Extension Period|Adverse Event|1|||
130718793|NCT04732221|470597221|FG006|Extension Period|Adverse Event|0|||
130718794|NCT04732221|470597215|FG000|Extension Period|Death|0|||
130718795|NCT04732221|470597216|FG001|Extension Period|Death|0|||
130718796|NCT04732221|470597217|FG002|Extension Period|Death|0|||
130718797|NCT04732221|470597218|FG003|Extension Period|Death|0|||
130718798|NCT04732221|470597219|FG004|Extension Period|Death|1|||
130718799|NCT04732221|470597220|FG005|Extension Period|Death|0|||
130718800|NCT04732221|470597221|FG006|Extension Period|Death|2|||
130718801|NCT04732221|470597215|FG000|Extension Period|Pregnancy|0|||
130718802|NCT04732221|470597216|FG001|Extension Period|Pregnancy|0|||
130718803|NCT04732221|470597217|FG002|Extension Period|Pregnancy|0|||
130718804|NCT04732221|470597218|FG003|Extension Period|Pregnancy|0|||
130718805|NCT04732221|470597219|FG004|Extension Period|Pregnancy|1|||
130374519|NCT00040664|469338392|FG000|Overall Study|Non-viability of oral suspension|1|||
130465430|NCT03422276|469671905|FG002|Overall Study|Lost to Follow-up|13|||
130718806|NCT04732221|470597220|FG005|Extension Period|Pregnancy|0|||
130718807|NCT04732221|470597221|FG006|Extension Period|Pregnancy|0|||
130718808|NCT04732221|470597215|FG000|Extension Period|Sponsors Decision|0|||
130718809|NCT04732221|470597216|FG001|Extension Period|Sponsors Decision|0|||
130718810|NCT04732221|470597217|FG002|Extension Period|Sponsors Decision|0|||
130718811|NCT04732221|470597218|FG003|Extension Period|Sponsors Decision|0|||
130718812|NCT04732221|470597219|FG004|Extension Period|Sponsors Decision|41|||
130311083|NCT01132313|469103089|FG003|Overall Study|Lost to Follow-up|0|||
130311084|NCT01132313|469103090|FG004|Overall Study|Lost to Follow-up|0|||
130311085|NCT01132313|469103091|FG005|Overall Study|Lost to Follow-up|0|||
130311086|NCT01132313|469103092|FG006|Overall Study|Lost to Follow-up|0|||
130311087|NCT01132313|469103093|FG007|Overall Study|Lost to Follow-up|1|||
130311088|NCT01132313|469103094|FG008|Overall Study|Lost to Follow-up|0|||
130311089|NCT01132313|469103095|FG009|Overall Study|Lost to Follow-up|0|||
130311090|NCT01132313|469103096|FG010|Overall Study|Lost to Follow-up|0|||
130311091|NCT01132313|469103097|FG011|Overall Study|Lost to Follow-up|0|||
130311092|NCT01132313|469103086|FG000|Overall Study|Withdrawal by Subject|0|||
130311093|NCT01132313|469103087|FG001|Overall Study|Withdrawal by Subject|0|||
130311094|NCT01132313|469103088|FG002|Overall Study|Withdrawal by Subject|3|||
130311095|NCT01132313|469103089|FG003|Overall Study|Withdrawal by Subject|3|||
130311096|NCT01132313|469103090|FG004|Overall Study|Withdrawal by Subject|6|||
130311097|NCT01132313|469103091|FG005|Overall Study|Withdrawal by Subject|0|||
130311098|NCT01132313|469103092|FG006|Overall Study|Withdrawal by Subject|1|||
130311099|NCT01132313|469103093|FG007|Overall Study|Withdrawal by Subject|0|||
130311100|NCT01132313|469103094|FG008|Overall Study|Withdrawal by Subject|0|||
130311101|NCT01132313|469103095|FG009|Overall Study|Withdrawal by Subject|2|||
130311102|NCT01132313|469103096|FG010|Overall Study|Withdrawal by Subject|0|||
130311103|NCT01132313|469103097|FG011|Overall Study|Withdrawal by Subject|0|||
130311104|NCT01132313|469103086|FG000|Overall Study|Lack of antiviral response|0|||
130311105|NCT01132313|469103087|FG001|Overall Study|Lack of antiviral response|0|||
130311106|NCT01132313|469103088|FG002|Overall Study|Lack of antiviral response|12|||
130311107|NCT01132313|469103089|FG003|Overall Study|Lack of antiviral response|18|||
130311108|NCT01132313|469103090|FG004|Overall Study|Lack of antiviral response|18|||
130311109|NCT01132313|469103091|FG005|Overall Study|Lack of antiviral response|18|||
130311110|NCT01132313|469103092|FG006|Overall Study|Lack of antiviral response|21|||
130311111|NCT01132313|469103093|FG007|Overall Study|Lack of antiviral response|0|||
130311112|NCT01132313|469103094|FG008|Overall Study|Lack of antiviral response|0|||
130311113|NCT01132313|469103095|FG009|Overall Study|Lack of antiviral response|0|||
130311114|NCT01132313|469103096|FG010|Overall Study|Lack of antiviral response|1|||
130311115|NCT01132313|469103097|FG011|Overall Study|Lack of antiviral response|0|||
130311116|NCT01132313|469103086|FG000|Overall Study|Other reason not defined above|0|||
130311117|NCT01132313|469103087|FG001|Overall Study|Other reason not defined above|0|||
130311118|NCT01132313|469103088|FG002|Overall Study|Other reason not defined above|0|||
130311119|NCT01132313|469103089|FG003|Overall Study|Other reason not defined above|0|||
130311120|NCT01132313|469103090|FG004|Overall Study|Other reason not defined above|0|||
130311121|NCT01132313|469103091|FG005|Overall Study|Other reason not defined above|0|||
130311122|NCT01132313|469103092|FG006|Overall Study|Other reason not defined above|0|||
130311123|NCT01132313|469103093|FG007|Overall Study|Other reason not defined above|1|||
130311124|NCT01132313|469103094|FG008|Overall Study|Other reason not defined above|0|||
130311125|NCT01132313|469103095|FG009|Overall Study|Other reason not defined above|0|||
130311126|NCT01132313|469103096|FG010|Overall Study|Other reason not defined above|0|||
130311127|NCT01132313|469103097|FG011|Overall Study|Other reason not defined above|0|||
130311128|NCT03201419|469103098|FG000|Overall Study|Adverse Event|3|||
130311129|NCT03201419|469103099|FG001|Overall Study|Adverse Event|1|||
130311130|NCT03201419|469103100|FG002|Overall Study|Adverse Event|0|||
130311131|NCT03201419|469103101|FG003|Overall Study|Adverse Event|0|||
130311132|NCT03201419|469103102|FG004|Overall Study|Adverse Event|1|||
130311133|NCT03201419|469103103|FG005|Overall Study|Adverse Event|1|||
130311134|NCT03201419|469103104|FG006|Overall Study|Adverse Event|5|||
130311135|NCT03201419|469103105|FG007|Overall Study|Adverse Event|0|||
130311136|NCT03201419|469103106|FG008|Overall Study|Adverse Event|0|||
130311137|NCT03201419|469103098|FG000|Overall Study|Lost to Follow-up|1|||
130311138|NCT03201419|469103099|FG001|Overall Study|Lost to Follow-up|0|||
130311139|NCT03201419|469103100|FG002|Overall Study|Lost to Follow-up|0|||
130311140|NCT03201419|469103101|FG003|Overall Study|Lost to Follow-up|0|||
130311141|NCT03201419|469103102|FG004|Overall Study|Lost to Follow-up|0|||
130311142|NCT03201419|469103103|FG005|Overall Study|Lost to Follow-up|0|||
130311143|NCT03201419|469103104|FG006|Overall Study|Lost to Follow-up|0|||
130311144|NCT03201419|469103105|FG007|Overall Study|Lost to Follow-up|0|||
130311145|NCT03201419|469103106|FG008|Overall Study|Lost to Follow-up|0|||
130311146|NCT03201419|469103098|FG000|Overall Study|Protocol Deviation|0|||
130311147|NCT03201419|469103099|FG001|Overall Study|Protocol Deviation|0|||
130311148|NCT03201419|469103100|FG002|Overall Study|Protocol Deviation|0|||
130311149|NCT03201419|469103101|FG003|Overall Study|Protocol Deviation|0|||
130311150|NCT03201419|469103102|FG004|Overall Study|Protocol Deviation|0|||
130311151|NCT03201419|469103103|FG005|Overall Study|Protocol Deviation|0|||
130311152|NCT03201419|469103104|FG006|Overall Study|Protocol Deviation|1|||
130311153|NCT03201419|469103105|FG007|Overall Study|Protocol Deviation|0|||
130311154|NCT03201419|469103106|FG008|Overall Study|Protocol Deviation|0|||
130311155|NCT03201419|469103098|FG000|Overall Study|Withdrawal by Subject|4|||
130311156|NCT03201419|469103099|FG001|Overall Study|Withdrawal by Subject|2|||
130311157|NCT03201419|469103100|FG002|Overall Study|Withdrawal by Subject|1|||
130311158|NCT03201419|469103101|FG003|Overall Study|Withdrawal by Subject|0|||
130311159|NCT03201419|469103102|FG004|Overall Study|Withdrawal by Subject|0|||
130558221|NCT01186796|470013168|FG000|Overall Study|Adverse Event|3|||
130558222|NCT01186796|470013169|FG001|Overall Study|Adverse Event|0|||
130558223|NCT01186796|470013168|FG000|Overall Study|Withdrawal by Subject|1|||
130558224|NCT01186796|470013169|FG001|Overall Study|Withdrawal by Subject|1|||
130558225|NCT01186796|470013168|FG000|Overall Study|Protocol Violation|0|||
130558226|NCT01186796|470013169|FG001|Overall Study|Protocol Violation|1|||
130558227|NCT03933397|470013173|FG000|Overall Study|No emergency department visit|65|||
130558228|NCT03933397|470013174|FG001|Overall Study|No emergency department visit|71|||
130558229|NCT03933397|470013173|FG000|Overall Study|Missed emergency department visit|25|||
130558230|NCT03933397|470013174|FG001|Overall Study|Missed emergency department visit|30|||
130558231|NCT03933397|470013173|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
130558232|NCT03933397|470013174|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
130558233|NCT03933397|470013173|FG000|Overall Study|Withdrawal by Subject|1|||
130558234|NCT03933397|470013174|FG001|Overall Study|Withdrawal by Subject|0|||
130558235|NCT03933397|470013173|FG000|Overall Study|Physician Decision|1|||
130558236|NCT03933397|470013174|FG001|Overall Study|Physician Decision|1|||
130558237|NCT03933397|470013173|FG000|Overall Study|missing pain score|1|||
130558238|NCT03933397|470013174|FG001|Overall Study|missing pain score|1|||
130558239|NCT03933397|470013173|FG000|Overall Study|Confirmed COVID-19|1|||
130558240|NCT03933397|470013174|FG001|Overall Study|Confirmed COVID-19|2|||
130558241|NCT01910116|470013175|FG000|Overall Study|Adverse Event|0|||
130558242|NCT01910116|470013176|FG001|Overall Study|Adverse Event|3|||
130558243|NCT01910116|470013175|FG000|Overall Study|Lack of Efficacy|3|||
130558244|NCT01910116|470013176|FG001|Overall Study|Lack of Efficacy|4|||
130558245|NCT01910116|470013175|FG000|Overall Study|Lost to Follow-up|1|||
130311160|NCT03201419|469103103|FG005|Overall Study|Withdrawal by Subject|0|||
130311161|NCT03201419|469103104|FG006|Overall Study|Withdrawal by Subject|0|||
130311162|NCT03201419|469103105|FG007|Overall Study|Withdrawal by Subject|1|||
130311163|NCT03201419|469103106|FG008|Overall Study|Withdrawal by Subject|2|||
130311164|NCT03201419|469103098|FG000|Overall Study|Other|0|||
130311165|NCT03201419|469103099|FG001|Overall Study|Other|0|||
130311166|NCT03201419|469103100|FG002|Overall Study|Other|1|||
130311167|NCT03201419|469103101|FG003|Overall Study|Other|0|||
130311168|NCT03201419|469103102|FG004|Overall Study|Other|0|||
130311169|NCT03201419|469103103|FG005|Overall Study|Other|0|||
130311170|NCT03201419|469103104|FG006|Overall Study|Other|0|||
130311171|NCT03201419|469103105|FG007|Overall Study|Other|0|||
130311172|NCT03201419|469103106|FG008|Overall Study|Other|0|||
130311173|NCT01657292|469103108|FG000|Overall Study|Adverse Event|6|||
130311174|NCT01657292|469103108|FG000|Overall Study|Withdrawal by Subject|2|||
130311175|NCT01657292|469103108|FG000|Overall Study|Violation of eligibility criteria|1|||
130311176|NCT01657292|469103108|FG000|Overall Study|Change of therapy|1|||
130311177|NCT00650845|469103109|FG000|Overall Study|Withdrawal by Subject|5|||
130311178|NCT00650845|469103110|FG001|Overall Study|Withdrawal by Subject|0|||
130311179|NCT00650845|469103109|FG000|Overall Study|Protocol Violation|0|||
130311180|NCT00650845|469103110|FG001|Overall Study|Protocol Violation|13|||
130311181|NCT04178720|469103111|FG000|Overall Study|Withdrawal by Subject|2|||
130311182|NCT04178720|469103112|FG001|Overall Study|Withdrawal by Subject|0|||
130311183|NCT04178720|469103111|FG000|Overall Study|Relocation|0|||
130311184|NCT04178720|469103112|FG001|Overall Study|Relocation|1|||
130311185|NCT01301833|469103113|FG000|Overall Study|Adverse Event|7|||
130311186|NCT01301833|469103114|FG001|Overall Study|Adverse Event|5|||
130311187|NCT01301833|469103115|FG002|Overall Study|Adverse Event|5|||
130311188|NCT01301833|469103116|FG003|Overall Study|Adverse Event|5|||
130311189|NCT01301833|469103113|FG000|Overall Study|Lack of Efficacy|1|||
130311190|NCT01301833|469103114|FG001|Overall Study|Lack of Efficacy|1|||
130311191|NCT01301833|469103115|FG002|Overall Study|Lack of Efficacy|0|||
130311192|NCT01301833|469103116|FG003|Overall Study|Lack of Efficacy|0|||
130311193|NCT01301833|469103113|FG000|Overall Study|Physician Decision|3|||
130311194|NCT01301833|469103114|FG001|Overall Study|Physician Decision|1|||
130311195|NCT01301833|469103115|FG002|Overall Study|Physician Decision|1|||
130311196|NCT01301833|469103116|FG003|Overall Study|Physician Decision|0|||
130558246|NCT01910116|470013176|FG001|Overall Study|Lost to Follow-up|0|||
130718813|NCT04732221|470597220|FG005|Extension Period|Sponsors Decision|40|||
130311197|NCT01301833|469103113|FG000|Overall Study|Withdrawal by Subject|3|||
130311198|NCT01301833|469103114|FG001|Overall Study|Withdrawal by Subject|1|||
130311199|NCT01301833|469103115|FG002|Overall Study|Withdrawal by Subject|1|||
130311200|NCT01301833|469103116|FG003|Overall Study|Withdrawal by Subject|2|||
130311201|NCT01301833|469103113|FG000|Overall Study|Personal matter|1|||
130311202|NCT01301833|469103114|FG001|Overall Study|Personal matter|0|||
130311203|NCT01301833|469103115|FG002|Overall Study|Personal matter|0|||
130311204|NCT01301833|469103116|FG003|Overall Study|Personal matter|0|||
130558247|NCT01910116|470013175|FG000|Overall Study|Protocol Violation|1|||
130558248|NCT01910116|470013176|FG001|Overall Study|Protocol Violation|2|||
130558249|NCT01910116|470013175|FG000|Overall Study|Withdrawal by Subject|8|||
130558250|NCT01910116|470013176|FG001|Overall Study|Withdrawal by Subject|3|||
130558251|NCT01910116|470013175|FG000|Overall Study|uncertain allocation|1|||
130558252|NCT01910116|470013176|FG001|Overall Study|uncertain allocation|3|||
130465431|NCT03422276|469671906|FG003|Overall Study|Lost to Follow-up|4|||
130465432|NCT03422276|469671903|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
130465433|NCT03422276|469671904|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
130465434|NCT03422276|469671905|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
130465435|NCT03422276|469671906|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
130465436|NCT03422276|469671903|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
130465437|NCT03422276|469671904|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
130465438|NCT03422276|469671905|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
130465439|NCT03422276|469671906|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
130465440|NCT03422276|469671903|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
130465441|NCT03422276|469671904|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
130718814|NCT04732221|470597221|FG006|Extension Period|Sponsors Decision|40|||
130311205|NCT03922620|469103117|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
130311206|NCT03922620|469103118|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
130311207|NCT04177212|469103119|FG000|Overall Study|Withdrawal by Subject|9|||
130311208|NCT04177212|469103120|FG001|Overall Study|Withdrawal by Subject|7|||
130311209|NCT04177212|469103119|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130311210|NCT04177212|469103120|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
130311211|NCT04177212|469103119|FG000|Overall Study|Physician Decision|1|||
130311212|NCT04177212|469103120|FG001|Overall Study|Physician Decision|0|||
130311213|NCT04177212|469103119|FG000|Overall Study|Lost to Follow-up|0|||
130311214|NCT04177212|469103120|FG001|Overall Study|Lost to Follow-up|3|||
130311215|NCT04177212|469103119|FG000|Overall Study|Adverse Event|0|||
130311216|NCT04177212|469103120|FG001|Overall Study|Adverse Event|1|||
130311217|NCT04177212|469103119|FG000|Overall Study|Other|1|||
130311218|NCT04177212|469103120|FG001|Overall Study|Other|2|||
130311219|NCT04725500|469103121|FG000|Screening|Screen Failure|26|||
130311220|NCT04725500|469103121|FG000|Screening|Withdrawal by Subject|1|||
130311221|NCT04725500|469103121|FG000|2 Week Take Home|Screen Fail|5|||
130311222|NCT01792115|469103122|FG000|Overall Study|Lost to Follow-up|0|||
130311223|NCT01792115|469103123|FG001|Overall Study|Lost to Follow-up|1|||
130311224|NCT01792115|469103124|FG002|Overall Study|Lost to Follow-up|0|||
130311225|NCT04618744|469103126|FG000|Overall Study|Adverse Event|0|||
130311226|NCT04618744|469103127|FG001|Overall Study|Adverse Event|1|||
130311227|NCT04618744|469103126|FG000|Overall Study|Withdrawal by Subject|0|||
130311228|NCT04618744|469103127|FG001|Overall Study|Withdrawal by Subject|1|||
130311229|NCT00930930|469103128|FG000|Overall Study|Death|1|||
130311230|NCT00930930|469103129|FG001|Overall Study|Death|0|||
130311231|NCT00930930|469103128|FG000|Overall Study|Physician Decision|1|||
130311232|NCT00930930|469103129|FG001|Overall Study|Physician Decision|0|||
130311233|NCT00930930|469103128|FG000|Overall Study|Adverse Event|13|||
130311234|NCT00930930|469103129|FG001|Overall Study|Adverse Event|3|||
130311235|NCT00930930|469103128|FG000|Overall Study|Withdrawal by Subject|3|||
130311236|NCT00930930|469103129|FG001|Overall Study|Withdrawal by Subject|1|||
130311237|NCT00930930|469103128|FG000|Overall Study|Disease progression|2|||
130311238|NCT00930930|469103129|FG001|Overall Study|Disease progression|3|||
130311239|NCT00930930|469103128|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
130311240|NCT00930930|469103129|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
130311241|NCT00930930|469103128|FG000|Overall Study|patients not compliant|1|||
130311242|NCT00930930|469103129|FG001|Overall Study|patients not compliant|1|||
130311243|NCT02709330|469103130|FG000|Overall Study|Death|5|||
130311244|NCT02709330|469103131|FG001|Overall Study|Death|0|||
130311245|NCT02709330|469103130|FG000|Overall Study|Lost to Follow-up|2|||
130311246|NCT02709330|469103131|FG001|Overall Study|Lost to Follow-up|0|||
130311247|NCT02709330|469103130|FG000|Overall Study|Physician Decision|2|||
130311248|NCT02709330|469103131|FG001|Overall Study|Physician Decision|0|||
130311249|NCT02709330|469103130|FG000|Overall Study|Withdrawal by Subject|4|||
130311250|NCT02709330|469103131|FG001|Overall Study|Withdrawal by Subject|0|||
130311251|NCT01279681|469103132|FG000|Overall Study|Disease Progression|9|||
130311252|NCT01279681|469103133|FG001|Overall Study|Disease Progression|6|||
130311253|NCT01279681|469103132|FG000|Overall Study|Withdrawal by Subject|3|||
130311254|NCT01279681|469103133|FG001|Overall Study|Withdrawal by Subject|4|||
130311255|NCT01279681|469103132|FG000|Overall Study|Adverse Event|2|||
130311256|NCT01279681|469103133|FG001|Overall Study|Adverse Event|3|||
130558253|NCT01910116|470013175|FG000|Overall Study|incomplete data|0|||
130718815|NCT04732221|470597215|FG000|Extension Period|Withdrawal by Subject|0|||
130311257|NCT01279681|469103132|FG000|Overall Study|Death|0|||
130311258|NCT01279681|469103133|FG001|Overall Study|Death|1|||
130311259|NCT01279681|469103132|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
130311260|NCT01279681|469103133|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
130311261|NCT01279681|469103132|FG000|Overall Study|Physician Decision|1|||
130311262|NCT01279681|469103133|FG001|Overall Study|Physician Decision|0|||
130311263|NCT01279681|469103132|FG000|Overall Study|Other Reason|0|||
130311264|NCT01279681|469103133|FG001|Overall Study|Other Reason|2|||
130311265|NCT01633788|469105283|FG000|Overall Study|Adverse Event|1|||
130311266|NCT01633788|469105284|FG001|Overall Study|Adverse Event|3|||
130311267|NCT01633788|469105285|FG002|Overall Study|Adverse Event|3|||
130311268|NCT01633788|469105286|FG003|Overall Study|Adverse Event|3|||
130311269|NCT01633788|469105283|FG000|Overall Study|Lost to Follow-up|2|||
130311270|NCT01633788|469105284|FG001|Overall Study|Lost to Follow-up|2|||
130311271|NCT01633788|469105285|FG002|Overall Study|Lost to Follow-up|2|||
130311272|NCT01633788|469105286|FG003|Overall Study|Lost to Follow-up|0|||
130311273|NCT01633788|469105283|FG000|Overall Study|Personal Reasons|3|||
130311274|NCT01633788|469105284|FG001|Overall Study|Personal Reasons|1|||
130311275|NCT01633788|469105285|FG002|Overall Study|Personal Reasons|1|||
130311276|NCT01633788|469105286|FG003|Overall Study|Personal Reasons|3|||
130311277|NCT01633788|469105283|FG000|Overall Study|Protocol Violation|1|||
130311278|NCT01633788|469105284|FG001|Overall Study|Protocol Violation|0|||
130311279|NCT01633788|469105285|FG002|Overall Study|Protocol Violation|1|||
130311280|NCT01633788|469105286|FG003|Overall Study|Protocol Violation|0|||
130311281|NCT01633788|469105283|FG000|Overall Study|Other Reasons|0|||
130311282|NCT01633788|469105284|FG001|Overall Study|Other Reasons|2|||
130311283|NCT01633788|469105285|FG002|Overall Study|Other Reasons|3|||
130311284|NCT01633788|469105286|FG003|Overall Study|Other Reasons|7|||
130311285|NCT01929226|469105287|FG000|Overall Study|Lost to Follow-up|4|||
130311286|NCT01929226|469105288|FG001|Overall Study|Lost to Follow-up|0|||
130311287|NCT01929226|469105287|FG000|Overall Study|Withdrawal by Subject|1|||
130311288|NCT01929226|469105288|FG001|Overall Study|Withdrawal by Subject|1|||
130311289|NCT02807623|469105291|FG000|Overall Study|Lost to Follow-up|23|||
130311290|NCT02807623|469105292|FG001|Overall Study|Lost to Follow-up|18|||
130311291|NCT02807623|469105293|FG002|Overall Study|Lost to Follow-up|22|||
130311292|NCT02807623|469105291|FG000|Overall Study|Drug intolerance|0|||
130311293|NCT02807623|469105292|FG001|Overall Study|Drug intolerance|1|||
130311294|NCT02807623|469105293|FG002|Overall Study|Drug intolerance|0|||
130311295|NCT02807623|469105291|FG000|Overall Study|incomplete blood draw|0|||
130311296|NCT02807623|469105292|FG001|Overall Study|incomplete blood draw|2|||
130311297|NCT02807623|469105293|FG002|Overall Study|incomplete blood draw|1|||
130311298|NCT00859547|469105294|FG000|Overall Study|Lost to Follow-up|1|||
130311299|NCT00859547|469105294|FG000|Overall Study|Parent withdrew consent|1|||
130311300|NCT03310723|469105295|FG000|Overall Study|Withdrawal by Subject|0|||
130311301|NCT03310723|469105296|FG001|Overall Study|Withdrawal by Subject|1|||
130311302|NCT03310723|469105295|FG000|Overall Study|Protocol Violation|0|||
130311303|NCT03310723|469105296|FG001|Overall Study|Protocol Violation|2|||
130311304|NCT02098746|469105298|FG000|Overall Study|Changes of Investigator|2|||
130311305|NCT02098746|469105298|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130311306|NCT02098746|469105298|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
130374520|NCT00040664|469338393|FG001|Overall Study|Non-viability of oral suspension|0|||
130374521|NCT00040664|469338394|FG002|Overall Study|Non-viability of oral suspension|1|||
130374522|NCT00040664|469338395|FG003|Overall Study|Non-viability of oral suspension|0|||
130374523|NCT01233258|469338397|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
130374524|NCT01233258|469338398|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
130374525|NCT01233258|469338399|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
130374526|NCT01233258|469338400|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
130374527|NCT01233258|469338401|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
130374528|NCT01233258|469338402|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
130374529|NCT01233258|469338397|FG000|First Intervention (6 Months)|Protocol Violation|0|||
130374530|NCT01233258|469338398|FG001|First Intervention (6 Months)|Protocol Violation|0|||
130374531|NCT01233258|469338399|FG002|First Intervention (6 Months)|Protocol Violation|1|||
130374532|NCT01233258|469338400|FG003|First Intervention (6 Months)|Protocol Violation|0|||
130374533|NCT01233258|469338401|FG004|First Intervention (6 Months)|Protocol Violation|0|||
130374534|NCT01233258|469338402|FG005|First Intervention (6 Months)|Protocol Violation|0|||
130374535|NCT01233258|469338397|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
130374536|NCT01233258|469338398|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
130374537|NCT01233258|469338399|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
130374538|NCT01233258|469338400|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
130374539|NCT01233258|469338401|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
130374540|NCT01233258|469338402|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
130374541|NCT01049308|469338403|FG000|Pill Counts|Withdrawal by Subject|83|||
130374542|NCT03926169|469338408|FG000|Period A|Adverse Event|2|||
130374543|NCT03926169|469338409|FG001|Period A|Adverse Event|2|||
130374544|NCT03926169|469338410|FG002|Period A|Adverse Event|1|||
130311307|NCT02098746|469105298|FG000|Overall Study|Data Not Available After Treatment|1|||
130311308|NCT01410890|469105299|FG000|Overall Study|Withdrawal by Subject|0|||
130311309|NCT01410890|469105300|FG001|Overall Study|Withdrawal by Subject|1|||
130311310|NCT00217425|469105303|FG000|Overall Study|Never started treatment|2|||
130311311|NCT00217425|469105303|FG000|Overall Study|Patient ineligible|5|||
130311312|NCT00217425|469105303|FG000|Overall Study|Lack of Efficacy|13|||
130311313|NCT00217425|469105303|FG000|Overall Study|Adverse Event|8|||
130311314|NCT00217425|469105303|FG000|Overall Study|Withdrawal by Subject|4|||
130374545|NCT03926169|469338408|FG000|Period A|Withdrawal by Subject|2|||
130374546|NCT03926169|469338409|FG001|Period A|Withdrawal by Subject|2|||
130374547|NCT03926169|469338410|FG002|Period A|Withdrawal by Subject|2|||
130374548|NCT03926169|469338408|FG000|Period A|Lost to Follow-up|3|||
130374549|NCT03926169|469338409|FG001|Period A|Lost to Follow-up|1|||
130374550|NCT03926169|469338410|FG002|Period A|Lost to Follow-up|0|||
130374551|NCT03926169|469338408|FG000|Period A|Lack of Efficacy|0|||
130374552|NCT03926169|469338409|FG001|Period A|Lack of Efficacy|2|||
130374553|NCT03926169|469338410|FG002|Period A|Lack of Efficacy|2|||
130374554|NCT03926169|469338408|FG000|Period A|COVID-19 Infection|0|||
130374555|NCT03926169|469338409|FG001|Period A|COVID-19 Infection|1|||
130374556|NCT03926169|469338410|FG002|Period A|COVID-19 Infection|0|||
130374557|NCT03926169|469338408|FG000|Period A|COVID-19 Logistical Restrictions|0|||
130374558|NCT03926169|469338409|FG001|Period A|COVID-19 Logistical Restrictions|2|||
130374559|NCT03926169|469338410|FG002|Period A|COVID-19 Logistical Restrictions|1|||
130558254|NCT01910116|470013176|FG001|Overall Study|incomplete data|1|||
130558255|NCT04029116|470013177|FG000|Overall Study|Adverse Event|0|||
130558256|NCT04029116|470013178|FG001|Overall Study|Adverse Event|2|||
130558257|NCT04029116|470013177|FG000|Overall Study|Lost to Follow-up|3|||
130558258|NCT04029116|470013178|FG001|Overall Study|Lost to Follow-up|5|||
130558259|NCT04029116|470013177|FG000|Overall Study|Physician Decision|2|||
130558260|NCT04029116|470013178|FG001|Overall Study|Physician Decision|0|||
130558261|NCT04029116|470013177|FG000|Overall Study|Pregnancy|1|||
130558262|NCT04029116|470013178|FG001|Overall Study|Pregnancy|2|||
130558263|NCT04029116|470013177|FG000|Overall Study|Withdrawal by Subject|4|||
130558264|NCT04029116|470013178|FG001|Overall Study|Withdrawal by Subject|6|||
130558265|NCT04029116|470013177|FG000|Overall Study|Other|2|||
130558266|NCT04029116|470013178|FG001|Overall Study|Other|1|||
130558267|NCT03606980|470013179|FG000|Overall Study|Lost to Follow-up|3|||
130558268|NCT03606980|470013180|FG001|Overall Study|Lost to Follow-up|2|||
130558269|NCT03606980|470013181|FG002|Overall Study|Lost to Follow-up|3|||
130558270|NCT03606980|470013179|FG000|Overall Study|Withdrawal by Subject|1|||
130558271|NCT03606980|470013180|FG001|Overall Study|Withdrawal by Subject|0|||
130558272|NCT03606980|470013181|FG002|Overall Study|Withdrawal by Subject|4|||
130558273|NCT02469896|470013184|FG000|Overall Study|Withdrawal by Subject|2|||
130374560|NCT03926169|469338408|FG000|Period A|Other, Not Specified|1|||
130374561|NCT03926169|469338409|FG001|Period A|Other, Not Specified|0|||
130374562|NCT03926169|469338410|FG002|Period A|Other, Not Specified|0|||
130374563|NCT03926169|469338408|FG000|Period B|Adverse Event|3|||
130374564|NCT03926169|469338409|FG001|Period B|Adverse Event|1|||
130374565|NCT03926169|469338410|FG002|Period B|Adverse Event|1|||
130558274|NCT02469896|470013185|FG001|Overall Study|Withdrawal by Subject|0|||
130558275|NCT01294150|470013186|FG000|Overall Study|Physician Decision|2|||
130558276|NCT01294150|470013187|FG001|Overall Study|Physician Decision|2|||
130558277|NCT03675776|470013188|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
130558278|NCT03675776|470013189|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
130558279|NCT03675776|470013190|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
130558280|NCT03675776|470013188|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130374566|NCT03926169|469338408|FG000|Period B|Withdrawal by Subject|1|||
130374567|NCT03926169|469338409|FG001|Period B|Withdrawal by Subject|3|||
130374568|NCT03926169|469338410|FG002|Period B|Withdrawal by Subject|0|||
130374569|NCT03926169|469338408|FG000|Period B|Lack of Efficacy|3|||
130374570|NCT03926169|469338409|FG001|Period B|Lack of Efficacy|1|||
130374571|NCT03926169|469338410|FG002|Period B|Lack of Efficacy|1|||
130374572|NCT03926169|469338408|FG000|Period B|Lost to Follow-up|1|||
130374573|NCT03926169|469338409|FG001|Period B|Lost to Follow-up|1|||
130374574|NCT03926169|469338410|FG002|Period B|Lost to Follow-up|4|||
130374575|NCT03926169|469338408|FG000|Period B|Other, Not Specified|62|||
130374576|NCT03926169|469338409|FG001|Period B|Other, Not Specified|57|||
130374577|NCT03926169|469338410|FG002|Period B|Other, Not Specified|65|||
130374578|NCT02439138|469338416|FG000|Overall Study|Adverse Event|1|||
130374579|NCT02439138|469338416|FG000|Overall Study|PI decision to terminate the study|2|||
130374580|NCT00006237|469338419|FG000|Overall Study|Adverse Event|39|||
130374581|NCT00006237|469338420|FG001|Overall Study|Adverse Event|29|||
130374582|NCT00006237|469338419|FG000|Overall Study|Death|1|||
130374583|NCT00006237|469338420|FG001|Overall Study|Death|0|||
130374584|NCT00006237|469338419|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
130558281|NCT03675776|470013189|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130558282|NCT03675776|470013190|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130558283|NCT02401412|470013191|FG000|Overall Study|Lost to Follow-up|1|||
130558284|NCT02401412|470013192|FG001|Overall Study|Lost to Follow-up|0|||
130374585|NCT00006237|469338420|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
130374586|NCT00006237|469338419|FG000|Overall Study|Progression/relapse|54|||
130374587|NCT00006237|469338420|FG001|Overall Study|Progression/relapse|2|||
130374588|NCT00006237|469338419|FG000|Overall Study|Not eligible|9|||
130374589|NCT00006237|469338420|FG001|Overall Study|Not eligible|20|||
130374590|NCT00006237|469338419|FG000|Overall Study|Withdrawal by Subject|0|||
130374591|NCT00006237|469338420|FG001|Overall Study|Withdrawal by Subject|1|||
130374592|NCT00006237|469338419|FG000|Overall Study|Not protocol specified|14|||
130311315|NCT00217425|469105303|FG000|Overall Study|Other complicating disease|1|||
130311316|NCT00217425|469105303|FG000|Overall Study|Other|4|||
130311317|NCT01121146|469105304|FG000|Overall Study|Death|17|||
130311318|NCT01121146|469105305|FG001|Overall Study|Death|15|||
130311319|NCT01121146|469105304|FG000|Overall Study|Adverse Event|2|||
130311320|NCT01121146|469105305|FG001|Overall Study|Adverse Event|11|||
130311321|NCT01121146|469105304|FG000|Overall Study|Lost to Follow-up|7|||
130311322|NCT01121146|469105305|FG001|Overall Study|Lost to Follow-up|16|||
130311323|NCT00997035|469105308|FG000|3-week Followup Visit|Lost to Follow-up|9|||
130311324|NCT00997035|469105309|FG001|3-week Followup Visit|Lost to Follow-up|6|||
130311325|NCT00997035|469105308|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
130311326|NCT00997035|469105309|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
130311327|NCT02544503|469105310|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
130311328|NCT02544503|469105311|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
130311329|NCT02544503|469105310|FG000|Overall Study|Lost to Follow-up|9|||
130311330|NCT02544503|469105311|FG001|Overall Study|Lost to Follow-up|0|||
130311331|NCT02544503|469105310|FG000|Overall Study|Withdrawal by Subject|1|||
130311332|NCT02544503|469105311|FG001|Overall Study|Withdrawal by Subject|0|||
130311333|NCT01080807|469105315|FG000|Overall Study|Adverse Event|9|||
130311334|NCT01080807|469105316|FG001|Overall Study|Adverse Event|1|||
130311335|NCT01080807|469105315|FG000|Overall Study|Lack of Efficacy|0|||
130311336|NCT01080807|469105316|FG001|Overall Study|Lack of Efficacy|1|||
130311337|NCT01080807|469105315|FG000|Overall Study|Withdrawal by Subject|7|||
130311338|NCT01080807|469105316|FG001|Overall Study|Withdrawal by Subject|2|||
130311339|NCT01080807|469105315|FG000|Overall Study|Protocol Violation|7|||
130311340|NCT01080807|469105316|FG001|Overall Study|Protocol Violation|6|||
130311341|NCT01080807|469105315|FG000|Overall Study|Lost to Follow-up|6|||
130311342|NCT01080807|469105316|FG001|Overall Study|Lost to Follow-up|4|||
130311343|NCT01080807|469105315|FG000|Overall Study|Noncompliance with drug administration|1|||
130311344|NCT01080807|469105316|FG001|Overall Study|Noncompliance with drug administration|1|||
130311345|NCT01080807|469105315|FG000|Overall Study|Noncompliance to study procedures|1|||
130311346|NCT01080807|469105316|FG001|Overall Study|Noncompliance to study procedures|1|||
130311347|NCT01080807|469105315|FG000|Overall Study|Began working day shift|0|||
130311348|NCT01080807|469105316|FG001|Overall Study|Began working day shift|2|||
130311349|NCT01080807|469105315|FG000|Overall Study|Laid off or terminated from job|1|||
130311350|NCT01080807|469105316|FG001|Overall Study|Laid off or terminated from job|2|||
130311351|NCT01080807|469105315|FG000|Overall Study|Stopped working consistent night shifts|0|||
130311352|NCT01080807|469105316|FG001|Overall Study|Stopped working consistent night shifts|1|||
130311353|NCT01080807|469105315|FG000|Overall Study|Work schedule changing|1|||
130311354|NCT01080807|469105316|FG001|Overall Study|Work schedule changing|1|||
130311355|NCT01080807|469105315|FG000|Overall Study|Work schedule and travel|0|||
130311356|NCT01080807|469105316|FG001|Overall Study|Work schedule and travel|1|||
130311357|NCT01080807|469105315|FG000|Overall Study|Switched to first shift|1|||
130311358|NCT01080807|469105316|FG001|Overall Study|Switched to first shift|0|||
130311359|NCT01080807|469105315|FG000|Overall Study|Moved away without notifying center|1|||
130311360|NCT01080807|469105316|FG001|Overall Study|Moved away without notifying center|0|||
130311361|NCT03922581|469105319|FG000|Overall Study|Lost to Follow-up|20|||
130311362|NCT03922581|469105320|FG001|Overall Study|Lost to Follow-up|9|||
130311363|NCT03922581|469105319|FG000|Overall Study|Physician Decision|1|||
130311364|NCT03922581|469105320|FG001|Overall Study|Physician Decision|1|||
130311365|NCT03922581|469105319|FG000|Overall Study|Withdrawal by Subject|1|||
130311366|NCT03922581|469105320|FG001|Overall Study|Withdrawal by Subject|0|||
130311367|NCT04685798|469105323|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
130311368|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130311369|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311370|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311371|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311372|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311373|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311374|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311375|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311376|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311377|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311378|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130465442|NCT03422276|469671905|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
130311379|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311380|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311381|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311382|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
130311383|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130718816|NCT04732221|470597216|FG001|Extension Period|Withdrawal by Subject|0|||
130718817|NCT04732221|470597217|FG002|Extension Period|Withdrawal by Subject|0|||
130374593|NCT00006237|469338420|FG001|Overall Study|Not protocol specified|5|||
130374594|NCT01846416|469338421|FG000|Treatment Phase|Death|2|||
130374595|NCT01846416|469338422|FG001|Treatment Phase|Death|9|||
130374596|NCT01846416|469338423|FG002|Treatment Phase|Death|1|||
130374597|NCT01846416|469338421|FG000|Treatment Phase|Withdrawal by Subject|2|||
130374598|NCT01846416|469338422|FG001|Treatment Phase|Withdrawal by Subject|4|||
130718818|NCT04732221|470597218|FG003|Extension Period|Withdrawal by Subject|0|||
130374599|NCT01846416|469338423|FG002|Treatment Phase|Withdrawal by Subject|2|||
130374600|NCT01846416|469338421|FG000|Treatment Phase|Other|1|||
130374601|NCT01846416|469338422|FG001|Treatment Phase|Other|5|||
130374602|NCT01846416|469338423|FG002|Treatment Phase|Other|1|||
130374603|NCT01846416|469338421|FG000|Treatment Phase|Physician Decision|1|||
130374604|NCT01846416|469338422|FG001|Treatment Phase|Physician Decision|2|||
130374605|NCT01846416|469338423|FG002|Treatment Phase|Physician Decision|0|||
130374606|NCT01846416|469338421|FG000|Treatment Phase|Adverse Event|3|||
130374607|NCT01846416|469338422|FG001|Treatment Phase|Adverse Event|4|||
130374608|NCT01846416|469338423|FG002|Treatment Phase|Adverse Event|0|||
130718819|NCT04732221|470597219|FG004|Extension Period|Withdrawal by Subject|1|||
130718820|NCT04732221|470597220|FG005|Extension Period|Withdrawal by Subject|5|||
130718821|NCT04732221|470597221|FG006|Extension Period|Withdrawal by Subject|2|||
130718822|NCT04347122|470597222|FG000|Overall Study|Physician Decision|0|||
130718823|NCT04347122|470597223|FG001|Overall Study|Physician Decision|3|||
130718824|NCT04347122|470597224|FG002|Overall Study|Physician Decision|3|||
130718825|NCT04347122|470597225|FG003|Overall Study|Physician Decision|6|||
130718826|NCT05327816|470597226|FG000|Overall Study|Lost to Follow-up|1|||
130718827|NCT05327816|470597227|FG001|Overall Study|Lost to Follow-up|0|||
130718828|NCT05327816|470597228|FG002|Overall Study|Lost to Follow-up|0|||
130718829|NCT05327816|470597229|FG003|Overall Study|Lost to Follow-up|0|||
130718830|NCT05327816|470597230|FG004|Overall Study|Lost to Follow-up|0|||
130718831|NCT05327816|470597231|FG005|Overall Study|Lost to Follow-up|0|||
130718832|NCT05327816|470597232|FG006|Overall Study|Lost to Follow-up|0|||
130718833|NCT05327816|470597233|FG007|Overall Study|Lost to Follow-up|0|||
130718834|NCT05327816|470597234|FG008|Overall Study|Lost to Follow-up|0|||
130718835|NCT05327816|470597235|FG009|Overall Study|Lost to Follow-up|1|||
130718836|NCT05327816|470597236|FG010|Overall Study|Lost to Follow-up|0|||
130718837|NCT05327816|470597226|FG000|Overall Study|Withdrawal by Subject|0|||
130718838|NCT05327816|470597227|FG001|Overall Study|Withdrawal by Subject|0|||
130718839|NCT05327816|470597228|FG002|Overall Study|Withdrawal by Subject|0|||
130718840|NCT05327816|470597229|FG003|Overall Study|Withdrawal by Subject|0|||
130718841|NCT05327816|470597230|FG004|Overall Study|Withdrawal by Subject|1|||
130718842|NCT05327816|470597231|FG005|Overall Study|Withdrawal by Subject|1|||
130718843|NCT05327816|470597232|FG006|Overall Study|Withdrawal by Subject|0|||
130718844|NCT05327816|470597233|FG007|Overall Study|Withdrawal by Subject|0|||
130718845|NCT05327816|470597234|FG008|Overall Study|Withdrawal by Subject|0|||
130718846|NCT05327816|470597235|FG009|Overall Study|Withdrawal by Subject|0|||
130718847|NCT05327816|470597236|FG010|Overall Study|Withdrawal by Subject|0|||
130718848|NCT05327816|470597226|FG000|Overall Study|Study Terminated by Sponsor|11|||
130718849|NCT05327816|470597227|FG001|Overall Study|Study Terminated by Sponsor|12|||
130718850|NCT05327816|470597228|FG002|Overall Study|Study Terminated by Sponsor|12|||
130718851|NCT05327816|470597229|FG003|Overall Study|Study Terminated by Sponsor|12|||
130718852|NCT05327816|470597230|FG004|Overall Study|Study Terminated by Sponsor|11|||
130718853|NCT05327816|470597231|FG005|Overall Study|Study Terminated by Sponsor|11|||
130718854|NCT05327816|470597232|FG006|Overall Study|Study Terminated by Sponsor|11|||
130718855|NCT05327816|470597233|FG007|Overall Study|Study Terminated by Sponsor|11|||
130718856|NCT05327816|470597234|FG008|Overall Study|Study Terminated by Sponsor|11|||
130718857|NCT05327816|470597235|FG009|Overall Study|Study Terminated by Sponsor|11|||
130718858|NCT05327816|470597236|FG010|Overall Study|Study Terminated by Sponsor|12|||
130718859|NCT05327816|470597226|FG000|Overall Study|Randomized but not treated|0|||
130718860|NCT05327816|470597227|FG001|Overall Study|Randomized but not treated|0|||
130718861|NCT05327816|470597228|FG002|Overall Study|Randomized but not treated|0|||
130718862|NCT05327816|470597229|FG003|Overall Study|Randomized but not treated|0|||
130718863|NCT05327816|470597230|FG004|Overall Study|Randomized but not treated|0|||
130718864|NCT05327816|470597231|FG005|Overall Study|Randomized but not treated|0|||
130718865|NCT05327816|470597232|FG006|Overall Study|Randomized but not treated|1|||
130718866|NCT05327816|470597233|FG007|Overall Study|Randomized but not treated|1|||
130718867|NCT05327816|470597234|FG008|Overall Study|Randomized but not treated|1|||
130718868|NCT05327816|470597235|FG009|Overall Study|Randomized but not treated|0|||
130718869|NCT05327816|470597236|FG010|Overall Study|Randomized but not treated|0|||
130718870|NCT01167257|470597238|FG000|Overall Study|Lost to Follow-up|2|||
130718871|NCT01167257|470597239|FG001|Overall Study|Lost to Follow-up|2|||
130718872|NCT01167257|470597238|FG000|Overall Study|Withdrew consent|1|||
130374609|NCT01846416|469338421|FG000|Treatment Phase|Non-compliance|0|||
130374610|NCT01846416|469338422|FG001|Treatment Phase|Non-compliance|2|||
130374611|NCT01846416|469338423|FG002|Treatment Phase|Non-compliance|0|||
130374612|NCT01846416|469338421|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
130374613|NCT01846416|469338422|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
130558285|NCT02401412|470013191|FG000|Overall Study|Discontinued Intervention|15|||
130558286|NCT02401412|470013192|FG001|Overall Study|Discontinued Intervention|21|||
130558287|NCT02401412|470013191|FG000|Overall Study|Withdrawal by Subject|4|||
130558288|NCT02401412|470013192|FG001|Overall Study|Withdrawal by Subject|4|||
130558289|NCT02401412|470013191|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
130558290|NCT02401412|470013192|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
130558291|NCT02401412|470013191|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
130558292|NCT02401412|470013192|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
130558293|NCT04246801|470013193|FG000|Overall Study|Adverse Event|1|||
130558294|NCT04246801|470013194|FG001|Overall Study|Adverse Event|1|||
130558295|NCT04246801|470013193|FG000|Overall Study|Protocol Violation|1|||
130558296|NCT04246801|470013194|FG001|Overall Study|Protocol Violation|1|||
130558297|NCT04246801|470013193|FG000|Overall Study|Lack of Efficacy|0|||
130558298|NCT04246801|470013194|FG001|Overall Study|Lack of Efficacy|2|||
130558299|NCT04246801|470013193|FG000|Overall Study|Lost to Follow-up|1|||
130558300|NCT04246801|470013194|FG001|Overall Study|Lost to Follow-up|1|||
130558301|NCT04246801|470013193|FG000|Overall Study|Withdrawal by Subject|2|||
130558302|NCT04246801|470013194|FG001|Overall Study|Withdrawal by Subject|1|||
130558303|NCT03684642|470013195|FG000|Overall Study|Adverse Event|6|||
130558304|NCT03684642|470013196|FG001|Overall Study|Adverse Event|15|||
130558305|NCT03684642|470013197|FG002|Overall Study|Adverse Event|11|||
130558306|NCT03684642|470013195|FG000|Overall Study|Withdrawal by Subject|35|||
130558307|NCT03684642|470013196|FG001|Overall Study|Withdrawal by Subject|53|||
130558308|NCT03684642|470013197|FG002|Overall Study|Withdrawal by Subject|23|||
130558309|NCT03684642|470013195|FG000|Overall Study|Lack of Efficacy|0|||
130558310|NCT03684642|470013196|FG001|Overall Study|Lack of Efficacy|0|||
130558311|NCT03684642|470013197|FG002|Overall Study|Lack of Efficacy|1|||
130558312|NCT03684642|470013195|FG000|Overall Study|Poor compliance to protocol|0|||
130558313|NCT03684642|470013196|FG001|Overall Study|Poor compliance to protocol|4|||
130558314|NCT03684642|470013197|FG002|Overall Study|Poor compliance to protocol|1|||
130558315|NCT03684642|470013195|FG000|Overall Study|Other than specified|62|||
130558316|NCT03684642|470013196|FG001|Overall Study|Other than specified|60|||
130558317|NCT03684642|470013197|FG002|Overall Study|Other than specified|67|||
130558318|NCT03684642|470013195|FG000|Overall Study|Randomized and not treated|0|||
130558319|NCT03684642|470013196|FG001|Overall Study|Randomized and not treated|0|||
130558320|NCT03684642|470013197|FG002|Overall Study|Randomized and not treated|1|||
130558321|NCT03684642|470013195|FG000|Overall Study|Missing completion status but alive at last contact|0|||
130465443|NCT03422276|469671906|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
130465444|NCT03422276|469671903|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
130465445|NCT03422276|469671904|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
130465446|NCT03422276|469671905|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
130465447|NCT03422276|469671906|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
130465448|NCT03422276|469671903|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
130465449|NCT03422276|469671904|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
130465450|NCT03422276|469671905|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
130465451|NCT03422276|469671906|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
130718873|NCT01167257|470597239|FG001|Overall Study|Withdrew consent|1|||
130718874|NCT04305587|470597240|FG000|Overall Study|Withdrawal by Subject|0|||
130718875|NCT04305587|470597241|FG001|Overall Study|Withdrawal by Subject|0|||
130718876|NCT04305587|470597242|FG002|Overall Study|Withdrawal by Subject|0|||
130465452|NCT05985044|469671907|FG000|Overall Study|Death|6|||
130718877|NCT04305587|470597243|FG003|Overall Study|Withdrawal by Subject|1|||
130718878|NCT04305587|470597244|FG004|Overall Study|Withdrawal by Subject|0|||
130718879|NCT04305587|470597245|FG005|Overall Study|Withdrawal by Subject|0|||
130718880|NCT04305587|470597246|FG006|Overall Study|Withdrawal by Subject|0|||
130718881|NCT04305587|470597247|FG007|Overall Study|Withdrawal by Subject|0|||
130718882|NCT04305587|470597248|FG008|Overall Study|Withdrawal by Subject|0|||
130718883|NCT02752906|470597249|FG000|Overall Study|Protocol Violation|2|||
130465453|NCT05985044|469671907|FG000|Overall Study|Lost to Follow-up|4|||
130465454|NCT05985044|469671907|FG000|Overall Study|Incapacitation|3|||
130558322|NCT03684642|470013196|FG001|Overall Study|Missing completion status but alive at last contact|1|||
130558323|NCT03684642|470013197|FG002|Overall Study|Missing completion status but alive at last contact|2|||
130558324|NCT01326728|470013205|FG000|Overall Study|Death|13|||
130465455|NCT05985044|469671907|FG000|Overall Study|Withdrawal by Subject|2|||
130558325|NCT01326728|470013206|FG001|Overall Study|Death|0|||
130558326|NCT01326728|470013205|FG000|Overall Study|Early closure of study|34|||
130558327|NCT01326728|470013206|FG001|Overall Study|Early closure of study|9|||
130558328|NCT02966223|470013207|FG000|Overall Study|Physician Decision|3|||
130558329|NCT02966223|470013207|FG000|Overall Study|Withdrawal by Subject|11|||
130558330|NCT02966223|470013207|FG000|Overall Study|Lost to Follow-up|1|||
130558331|NCT00805025|470013212|FG000|Overall Study|Screened but not enrolled/treated|42|||
130558332|NCT00805025|470013212|FG000|Overall Study|Adverse Event|4|||
130311384|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311385|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311386|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311387|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311388|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311389|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311390|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311391|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311392|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311393|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311394|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311395|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
130311396|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311397|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311398|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311399|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311400|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311401|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311402|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311403|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311404|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311405|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311406|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311407|NCT04640311|469105324|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
130311408|NCT04640311|469105325|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
130311409|NCT04640311|469105326|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
130311410|NCT04640311|469105327|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311411|NCT04640311|469105328|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311412|NCT04640311|469105329|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311413|NCT04640311|469105330|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311414|NCT04640311|469105331|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311415|NCT04640311|469105332|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311416|NCT04640311|469105333|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311417|NCT04640311|469105334|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311418|NCT04640311|469105335|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311419|NCT04640311|469105336|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311420|NCT04640311|469105324|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311421|NCT04640311|469105325|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311422|NCT04640311|469105326|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
130311423|NCT04640311|469105327|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311424|NCT04640311|469105328|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311425|NCT04640311|469105329|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311426|NCT04640311|469105330|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311427|NCT04640311|469105331|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311428|NCT04640311|469105332|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311429|NCT04640311|469105333|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311430|NCT04640311|469105334|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311431|NCT04640311|469105335|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311432|NCT04640311|469105336|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311433|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311434|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311435|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311436|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130311437|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311438|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311439|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130311440|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311441|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311442|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311443|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311444|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311445|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311446|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311447|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311448|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311449|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311450|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311451|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130311452|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311453|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311454|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
130311455|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311456|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311457|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311458|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311459|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311460|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311461|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311462|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311463|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311464|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311465|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130311466|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311467|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311468|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311469|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130311470|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311471|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311472|NCT04640311|469105324|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311473|NCT04640311|469105325|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311474|NCT04640311|469105326|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311475|NCT04640311|469105327|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311476|NCT04640311|469105328|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311477|NCT04640311|469105329|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311478|NCT04640311|469105330|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311479|NCT04640311|469105331|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311480|NCT04640311|469105332|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311481|NCT04640311|469105333|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311482|NCT04640311|469105334|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311483|NCT04640311|469105335|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
130311484|NCT04640311|469105336|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311485|NCT03956550|469105337|FG000|Overall Study|Sponsor decision|65|||
130311486|NCT03956550|469105338|FG001|Overall Study|Sponsor decision|66|||
130311487|NCT03956550|469105339|FG002|Overall Study|Sponsor decision|64|||
130311488|NCT03956550|469105337|FG000|Overall Study|Adverse Event|0|||
130311489|NCT03956550|469105338|FG001|Overall Study|Adverse Event|1|||
130311490|NCT03956550|469105339|FG002|Overall Study|Adverse Event|0|||
130311491|NCT03956550|469105337|FG000|Overall Study|Withdrawal by Subject|5|||
130311492|NCT03956550|469105338|FG001|Overall Study|Withdrawal by Subject|5|||
130311493|NCT03956550|469105339|FG002|Overall Study|Withdrawal by Subject|6|||
130374614|NCT01846416|469338423|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
130374615|NCT01846416|469338421|FG000|Treatment Phase|Progressive Disease|21|||
130374616|NCT01846416|469338422|FG001|Treatment Phase|Progressive Disease|63|||
130374617|NCT01846416|469338423|FG002|Treatment Phase|Progressive Disease|9|||
130374618|NCT01846416|469338421|FG000|Survival Follow-up|Death|21|||
130374619|NCT01846416|469338422|FG001|Survival Follow-up|Death|62|||
130374620|NCT01846416|469338423|FG002|Survival Follow-up|Death|9|||
130374621|NCT01846416|469338421|FG000|Survival Follow-up|Lost to Follow-up|0|||
130374622|NCT01846416|469338422|FG001|Survival Follow-up|Lost to Follow-up|2|||
130311494|NCT00592904|469105342|FG000|Overall Study|Adverse Event|15|||
130311495|NCT00592904|469105343|FG001|Overall Study|Adverse Event|25|||
130311496|NCT00592904|469105344|FG002|Overall Study|Adverse Event|13|||
130311497|NCT00592904|469105345|FG003|Overall Study|Adverse Event|5|||
130311498|NCT00592904|469105342|FG000|Overall Study|Protocol Violation|1|||
130311499|NCT00592904|469105343|FG001|Overall Study|Protocol Violation|1|||
130311500|NCT00592904|469105344|FG002|Overall Study|Protocol Violation|0|||
130311501|NCT00592904|469105345|FG003|Overall Study|Protocol Violation|1|||
130311502|NCT00592904|469105342|FG000|Overall Study|Withdrawal by Subject|4|||
130311503|NCT00592904|469105343|FG001|Overall Study|Withdrawal by Subject|16|||
130311504|NCT00592904|469105344|FG002|Overall Study|Withdrawal by Subject|1|||
130311505|NCT00592904|469105345|FG003|Overall Study|Withdrawal by Subject|2|||
130311506|NCT00592904|469105342|FG000|Overall Study|Lack of Efficacy|2|||
130311507|NCT00592904|469105343|FG001|Overall Study|Lack of Efficacy|7|||
130311508|NCT00592904|469105344|FG002|Overall Study|Lack of Efficacy|2|||
130311509|NCT00592904|469105345|FG003|Overall Study|Lack of Efficacy|3|||
130311510|NCT00592904|469105342|FG000|Overall Study|Physician Decision|0|||
130311511|NCT00592904|469105343|FG001|Overall Study|Physician Decision|3|||
130311512|NCT00592904|469105344|FG002|Overall Study|Physician Decision|1|||
130311513|NCT00592904|469105345|FG003|Overall Study|Physician Decision|0|||
130311514|NCT00592904|469105342|FG000|Overall Study|Other|3|||
130311515|NCT00592904|469105343|FG001|Overall Study|Other|3|||
130311516|NCT00592904|469105344|FG002|Overall Study|Other|0|||
130311517|NCT00592904|469105345|FG003|Overall Study|Other|0|||
130311518|NCT01359904|469105346|FG000|Overall Study|Withdrawal by Subject|1|||
130311519|NCT01359904|469105347|FG001|Overall Study|Withdrawal by Subject|0|||
130311520|NCT03191630|469105349|FG000|Overall Study|Lost to Follow-up|7|||
130311521|NCT03191630|469105350|FG001|Overall Study|Lost to Follow-up|7|||
130311522|NCT02640547|469105353|FG000|Overall Study|Failure to Return|1|||
130311523|NCT02640547|469105353|FG000|Overall Study|Withdrawal by Subject|1|||
130311524|NCT02640547|469105353|FG000|Overall Study|Death|6|||
130311525|NCT02640547|469105353|FG000|Overall Study|Miscellaneous|3|||
130311526|NCT02525588|469105354|FG000|Overall Study|Death|3|||
130311527|NCT02525588|469105355|FG001|Overall Study|Death|1|||
130311528|NCT02525588|469105354|FG000|Overall Study|Lost to Follow-up|2|||
130311529|NCT02525588|469105355|FG001|Overall Study|Lost to Follow-up|0|||
130311530|NCT02525588|469105354|FG000|Overall Study|Withdrawal by Subject|1|||
130311531|NCT02525588|469105355|FG001|Overall Study|Withdrawal by Subject|1|||
130311532|NCT02525588|469105354|FG000|Overall Study|Adverse Event|0|||
130311533|NCT02525588|469105355|FG001|Overall Study|Adverse Event|1|||
130311534|NCT03369418|469105358|FG000|Overall Study|Withdrawal by Subject|3|||
130311535|NCT03369418|469105359|FG001|Overall Study|Withdrawal by Subject|3|||
130311536|NCT01485094|469105360|FG000|Overall Study|Adverse Event|1|||
130311537|NCT01485094|469105361|FG001|Overall Study|Adverse Event|1|||
130311538|NCT01485094|469105362|FG002|Overall Study|Adverse Event|1|||
130311539|NCT01485094|469105360|FG000|Overall Study|Lost to Follow-up|1|||
130311540|NCT01485094|469105361|FG001|Overall Study|Lost to Follow-up|0|||
130311541|NCT01485094|469105362|FG002|Overall Study|Lost to Follow-up|0|||
130311542|NCT01485094|469105360|FG000|Overall Study|Withdrawal by Subject|1|||
130311543|NCT01485094|469105361|FG001|Overall Study|Withdrawal by Subject|1|||
130311544|NCT01485094|469105362|FG002|Overall Study|Withdrawal by Subject|0|||
130311545|NCT01367834|469105366|FG000|Overall Study|Withdrawal by Subject|2|||
130311546|NCT01367834|469105367|FG001|Overall Study|Withdrawal by Subject|2|||
130311547|NCT01367834|469105366|FG000|Overall Study|Study was ended.|0|||
130311548|NCT01367834|469105367|FG001|Overall Study|Study was ended.|1|||
130311549|NCT01618669|469105377|FG000|Overall Study|Lost to Follow-up|1|||
130311550|NCT01618669|469105378|FG001|Overall Study|Lost to Follow-up|1|||
130311551|NCT01618669|469105377|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
130311552|NCT01618669|469105378|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
130311553|NCT01618669|469105377|FG000|Overall Study|Adverse Event|16|||
130311554|NCT01618669|469105378|FG001|Overall Study|Adverse Event|7|||
130311555|NCT01618669|469105377|FG000|Overall Study|Protocol Violation|5|||
130311556|NCT01618669|469105378|FG001|Overall Study|Protocol Violation|3|||
130311557|NCT01618669|469105377|FG000|Overall Study|Withdrawal by Subject|9|||
130311558|NCT01618669|469105378|FG001|Overall Study|Withdrawal by Subject|9|||
130311559|NCT01618669|469105377|FG000|Overall Study|Miscellaneous Reason|0|||
130311560|NCT01618669|469105378|FG001|Overall Study|Miscellaneous Reason|1|||
130311561|NCT01702558|469105379|FG000|Overall Study|Withdrawal by Subject|0|||
130311562|NCT01702558|469105380|FG001|Overall Study|Withdrawal by Subject|0|||
130311563|NCT01702558|469105381|FG002|Overall Study|Withdrawal by Subject|0|||
130311564|NCT01702558|469105382|FG003|Overall Study|Withdrawal by Subject|12|||
130311565|NCT01702558|469105383|FG004|Overall Study|Withdrawal by Subject|4|||
130311566|NCT01702558|469105379|FG000|Overall Study|Lost to Follow-up|0|||
130311567|NCT01702558|469105380|FG001|Overall Study|Lost to Follow-up|0|||
130311568|NCT01702558|469105381|FG002|Overall Study|Lost to Follow-up|0|||
130311569|NCT01702558|469105382|FG003|Overall Study|Lost to Follow-up|3|||
130311570|NCT01702558|469105383|FG004|Overall Study|Lost to Follow-up|0|||
130311571|NCT01702558|469105379|FG000|Overall Study|Death|4|||
130311572|NCT01702558|469105380|FG001|Overall Study|Death|3|||
130311573|NCT01702558|469105381|FG002|Overall Study|Death|3|||
130311574|NCT01702558|469105382|FG003|Overall Study|Death|16|||
130311575|NCT01702558|469105383|FG004|Overall Study|Death|20|||
130311576|NCT01702558|469105379|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311577|NCT01702558|469105380|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311578|NCT01702558|469105381|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
130311579|NCT01702558|469105382|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311580|NCT01702558|469105383|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311581|NCT01702558|469105379|FG000|Overall Study|Study Terminated by Sponsor|0|||
130311582|NCT01702558|469105380|FG001|Overall Study|Study Terminated by Sponsor|1|||
130311583|NCT01702558|469105381|FG002|Overall Study|Study Terminated by Sponsor|0|||
130311584|NCT01702558|469105382|FG003|Overall Study|Study Terminated by Sponsor|0|||
130311585|NCT01702558|469105383|FG004|Overall Study|Study Terminated by Sponsor|1|||
130311586|NCT01702558|469105379|FG000|Overall Study|Other|0|||
130311587|NCT01702558|469105380|FG001|Overall Study|Other|0|||
130311588|NCT01702558|469105381|FG002|Overall Study|Other|0|||
130311589|NCT01702558|469105382|FG003|Overall Study|Other|16|||
130311590|NCT01702558|469105383|FG004|Overall Study|Other|17|||
130311591|NCT03259087|469105388|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311592|NCT03259087|469105389|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311593|NCT03259087|469105390|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311594|NCT03259087|469105391|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311595|NCT03259087|469105392|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
130311596|NCT03259087|469105388|FG000|Period 2 of Part 2|Adverse Event|0|||
130311597|NCT03259087|469105389|FG001|Period 2 of Part 2|Adverse Event|0|||
130311598|NCT03259087|469105390|FG002|Period 2 of Part 2|Adverse Event|0|||
130311599|NCT03259087|469105391|FG003|Period 2 of Part 2|Adverse Event|0|||
130311600|NCT03259087|469105392|FG004|Period 2 of Part 2|Adverse Event|1|||
130311601|NCT04950465|469105393|FG000|Overall Study|Lost to Follow-up|1|||
130311602|NCT04950465|469105394|FG001|Overall Study|Lost to Follow-up|0|||
130311603|NCT04950465|469105395|FG002|Overall Study|Lost to Follow-up|0|||
130311604|NCT02366195|469105396|FG000|Overall Study|Protocol-specified criteria|3|||
130311605|NCT02366195|469105396|FG000|Overall Study|Withdrawal by Subject|9|||
130311606|NCT02366195|469105396|FG000|Overall Study|Lost to Follow-up|1|||
130311607|NCT02366195|469105396|FG000|Overall Study|Death|41|||
130311608|NCT01788566|469105397|FG000|Overall Study|Death|4|||
130311609|NCT01788566|469105397|FG000|Overall Study|Adverse Event|1|||
130311610|NCT01788566|469105397|FG000|Overall Study|Clinical Progressive Disease|3|||
130311611|NCT01620086|469105400|FG000|Overall Study|Withdrawal by Subject|3|||
130311612|NCT01620086|469105401|FG001|Overall Study|Withdrawal by Subject|3|||
130311613|NCT01620086|469105402|FG002|Overall Study|Withdrawal by Subject|0|||
130311614|NCT01620086|469105400|FG000|Overall Study|failed study criteria|1|||
130311615|NCT01620086|469105401|FG001|Overall Study|failed study criteria|4|||
130311616|NCT01620086|469105402|FG002|Overall Study|failed study criteria|0|||
130311617|NCT01620086|469105400|FG000|Overall Study|Physician Decision|1|||
130311618|NCT01620086|469105401|FG001|Overall Study|Physician Decision|0|||
130311619|NCT01620086|469105402|FG002|Overall Study|Physician Decision|0|||
130311620|NCT02562716|469105403|FG000|Overall Study|Adverse Event|7|||
130311621|NCT02562716|469105404|FG001|Overall Study|Adverse Event|14|||
130311622|NCT02562716|469105403|FG000|Overall Study|Withdrawal unrelated to AE|7|||
130311623|NCT02562716|469105404|FG001|Overall Study|Withdrawal unrelated to AE|1|||
130311624|NCT02562716|469105403|FG000|Overall Study|Progression|8|||
130311625|NCT02562716|469105404|FG001|Overall Study|Progression|10|||
130311626|NCT02562716|469105403|FG000|Overall Study|Death|2|||
130311627|NCT02562716|469105404|FG001|Overall Study|Death|1|||
130311628|NCT02562716|469105403|FG000|Overall Study|Not protocol specified|4|||
130311629|NCT02562716|469105404|FG001|Overall Study|Not protocol specified|2|||
130311630|NCT01539759|469105405|FG000|Overall Study|Lost to Follow-up|6|||
130311631|NCT01539759|469105406|FG001|Overall Study|Lost to Follow-up|8|||
130311632|NCT01425801|469105407|FG000|Period 1|Withdrawal by Subject|0|||
130311633|NCT01425801|469105408|FG001|Period 1|Withdrawal by Subject|0|||
130311634|NCT01425801|469105409|FG002|Period 1|Withdrawal by Subject|0|||
130311635|NCT01425801|469105410|FG003|Period 1|Withdrawal by Subject|0|||
130311636|NCT01425801|469105411|FG004|Period 1|Withdrawal by Subject|1|||
130311637|NCT01425801|469105412|FG005|Period 1|Withdrawal by Subject|0|||
130311638|NCT01425801|469105407|FG000|Period 2|Withdrawal by Subject|0|||
130311639|NCT01425801|469105408|FG001|Period 2|Withdrawal by Subject|0|||
130311640|NCT01425801|469105409|FG002|Period 2|Withdrawal by Subject|0|||
130311641|NCT01425801|469105410|FG003|Period 2|Withdrawal by Subject|0|||
130311642|NCT01425801|469105411|FG004|Period 2|Withdrawal by Subject|1|||
130311643|NCT01425801|469105412|FG005|Period 2|Withdrawal by Subject|0|||
130311644|NCT01425801|469105407|FG000|Period 3|Stability criteria not fullfilled|0|||
130311645|NCT01425801|469105408|FG001|Period 3|Stability criteria not fullfilled|0|||
130311646|NCT01425801|469105409|FG002|Period 3|Stability criteria not fullfilled|1|||
130311647|NCT01425801|469105410|FG003|Period 3|Stability criteria not fullfilled|0|||
130311648|NCT01425801|469105411|FG004|Period 3|Stability criteria not fullfilled|0|||
130465456|NCT02279095|469671910|FG000|Overall Study|Non-Compliance|1|||
130558333|NCT00805025|470013212|FG000|Overall Study|Withdrawal by Subject|2|||
130558334|NCT00805025|470013212|FG000|Overall Study|Physician Decision|1|||
130558335|NCT00375219|470013213|FG000|Overall Study|Failure to achieve a response|16|||
130558336|NCT00375219|470013214|FG001|Overall Study|Failure to achieve a response|2|||
130558337|NCT00375219|470013215|FG002|Overall Study|Failure to achieve a response|0|||
130558338|NCT00375219|470013213|FG000|Overall Study|Adverse Event|8|||
130558339|NCT00375219|470013214|FG001|Overall Study|Adverse Event|2|||
130558340|NCT00375219|470013215|FG002|Overall Study|Adverse Event|1|||
130558341|NCT00375219|470013213|FG000|Overall Study|Protocol Violation|1|||
130558342|NCT00375219|470013214|FG001|Overall Study|Protocol Violation|0|||
130718884|NCT02752906|470597250|FG001|Overall Study|Protocol Violation|1|||
130718885|NCT02752906|470597249|FG000|Overall Study|Withdrawal by Subject|2|||
130374623|NCT01846416|469338423|FG002|Survival Follow-up|Lost to Follow-up|2|||
130374624|NCT01846416|469338421|FG000|Survival Follow-up|Withdrawal by Subject|2|||
130374625|NCT01846416|469338422|FG001|Survival Follow-up|Withdrawal by Subject|7|||
130374626|NCT01846416|469338423|FG002|Survival Follow-up|Withdrawal by Subject|0|||
130374627|NCT01846416|469338421|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
130374628|NCT01846416|469338422|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
130374629|NCT01846416|469338423|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
130718886|NCT02752906|470597250|FG001|Overall Study|Withdrawal by Subject|2|||
130718887|NCT02752906|470597249|FG000|Overall Study|Lost to Follow-up|3|||
130311649|NCT01425801|469105412|FG005|Period 3|Stability criteria not fullfilled|0|||
130311650|NCT01425801|469105407|FG000|Period 4|Not able to maintain visit schedule|0|||
130311651|NCT01425801|469105408|FG001|Period 4|Not able to maintain visit schedule|0|||
130311652|NCT01425801|469105409|FG002|Period 4|Not able to maintain visit schedule|1|||
130311653|NCT01425801|469105410|FG003|Period 4|Not able to maintain visit schedule|0|||
130311654|NCT01425801|469105411|FG004|Period 4|Not able to maintain visit schedule|0|||
130311655|NCT01425801|469105412|FG005|Period 4|Not able to maintain visit schedule|0|||
130311656|NCT02728089|469105413|FG000|Overall Study|Physician Decision|2|||
130311657|NCT02728089|469105413|FG000|Overall Study|Withdrawal by Subject|1|||
130311658|NCT00731679|469105414|FG000|Overall Study|Adverse Event|7|||
130311659|NCT00731679|469105415|FG001|Overall Study|Adverse Event|8|||
130311660|NCT00731679|469105414|FG000|Overall Study|Withdrawal by Subject|8|||
130311661|NCT00731679|469105415|FG001|Overall Study|Withdrawal by Subject|8|||
130311662|NCT00731679|469105414|FG000|Overall Study|Lost to Follow-up|7|||
130311663|NCT00731679|469105415|FG001|Overall Study|Lost to Follow-up|8|||
130311664|NCT00731679|469105414|FG000|Overall Study|Noncompliance|0|||
130311665|NCT00731679|469105415|FG001|Overall Study|Noncompliance|1|||
130311666|NCT00731679|469105414|FG000|Overall Study|Pregnancy|0|||
130311667|NCT00731679|469105415|FG001|Overall Study|Pregnancy|1|||
130311668|NCT02488005|469105418|FG000|Overall Study|Lost to Follow-up|2|||
130311669|NCT02326597|469105425|FG000|Overall Study|Lost to Follow-up|42|||
130311670|NCT02326597|469105426|FG001|Overall Study|Lost to Follow-up|32|||
130374630|NCT01846416|469338421|FG000|Survival Follow-up|Other|3|||
130374631|NCT01846416|469338422|FG001|Survival Follow-up|Other|1|||
130374632|NCT01846416|469338423|FG002|Survival Follow-up|Other|1|||
130374633|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
130718888|NCT02752906|470597250|FG001|Overall Study|Lost to Follow-up|2|||
130718889|NCT02492880|470597252|FG000|Overall Study|Lost to Follow-up|1|||
130718890|NCT02492880|470597252|FG000|Overall Study|Protocol Violation|1|||
130718891|NCT00554190|470597253|FG000|Overall Study|Termination forms not completed|10|||
130718892|NCT04241315|470597260|FG000|Overall Study|Withdrawal by Subject|0|||
130718893|NCT04241315|470597261|FG001|Overall Study|Withdrawal by Subject|1|||
130718894|NCT00699283|470597262|FG000|Overall Study|Lack of Efficacy|15|||
130718895|NCT00699283|470597263|FG001|Overall Study|Lack of Efficacy|5|||
130718896|NCT00699283|470597262|FG000|Overall Study|Lost to Follow-up|2|||
130718897|NCT00699283|470597263|FG001|Overall Study|Lost to Follow-up|0|||
130718898|NCT00699283|470597262|FG000|Overall Study|Withdrawal by Subject|1|||
130718899|NCT00699283|470597263|FG001|Overall Study|Withdrawal by Subject|0|||
130718900|NCT00699283|470597262|FG000|Overall Study|Other Reason|5|||
130718901|NCT00699283|470597263|FG001|Overall Study|Other Reason|1|||
130718902|NCT00699283|470597262|FG000|Overall Study|SAE, non-fatal|1|||
130718903|NCT00699283|470597263|FG001|Overall Study|SAE, non-fatal|1|||
130311671|NCT04089761|469105429|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
130311672|NCT04089761|469105429|FG000|"Run In Phase"|Lost to Follow-up|1|||
130374634|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
130718904|NCT00699283|470597262|FG000|Overall Study|AE, non-serious non-fatal|8|||
130718905|NCT00699283|470597263|FG001|Overall Study|AE, non-serious non-fatal|1|||
130311673|NCT04089761|469105429|FG000|"Treatment Phase"|No evaluable data|5|||
130311674|NCT04089761|469105429|FG000|"Treatment Phase"|Lost to Follow-up|1|||
130311675|NCT04739436|469105430|FG000|Overall Study|Lost to Follow-up|21|||
130718906|NCT00699283|470597262|FG000|Overall Study|AE of unknown type|1|||
130718907|NCT00699283|470597263|FG001|Overall Study|AE of unknown type|0|||
130718908|NCT00394524|470597264|FG000|Overall Study|Protocol Violation|2|||
130374635|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
130558343|NCT00375219|470013215|FG002|Overall Study|Protocol Violation|1|||
130558344|NCT00375219|470013213|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
130718909|NCT00394524|470597265|FG001|Overall Study|Protocol Violation|3|||
130718910|NCT00394524|470597264|FG000|Overall Study|Death|1|||
130718911|NCT00394524|470597265|FG001|Overall Study|Death|0|||
130465457|NCT02279095|469671910|FG000|Overall Study|Withdrawal by Subject|8|||
130465458|NCT02279095|469671910|FG000|Overall Study|Adverse Event|2|||
130465459|NCT02279095|469671910|FG000|Overall Study|Other|7|||
130465460|NCT02279095|469671910|FG000|Overall Study|Lost to Follow-up|1|||
130311676|NCT04739436|469105431|FG001|Overall Study|Lost to Follow-up|23|||
130311677|NCT04739436|469105430|FG000|Overall Study|Withdrawal by Subject|4|||
130311678|NCT04739436|469105431|FG001|Overall Study|Withdrawal by Subject|6|||
130311679|NCT04739436|469105430|FG000|Overall Study|not randomized properly|1|||
130311680|NCT04739436|469105431|FG001|Overall Study|not randomized properly|0|||
130311681|NCT04628780|469105432|FG000|Overall Study|Death|0|||
130311682|NCT04628780|469105433|FG001|Overall Study|Death|1|||
130311683|NCT04628780|469105434|FG002|Overall Study|Death|0|||
130311684|NCT04628780|469105435|FG003|Overall Study|Death|0|||
130311685|NCT04628780|469105436|FG004|Overall Study|Death|1|||
130311686|NCT04628780|469105437|FG005|Overall Study|Death|0|||
130311687|NCT04628780|469105432|FG000|Overall Study|Physician Decision|2|||
130311688|NCT04628780|469105433|FG001|Overall Study|Physician Decision|0|||
130311689|NCT04628780|469105434|FG002|Overall Study|Physician Decision|0|||
130311690|NCT04628780|469105435|FG003|Overall Study|Physician Decision|0|||
130311691|NCT04628780|469105436|FG004|Overall Study|Physician Decision|2|||
130311692|NCT04628780|469105437|FG005|Overall Study|Physician Decision|0|||
130311693|NCT04628780|469105432|FG000|Overall Study|Progressive disease|2|||
130311694|NCT04628780|469105433|FG001|Overall Study|Progressive disease|2|||
130311695|NCT04628780|469105434|FG002|Overall Study|Progressive disease|2|||
130311696|NCT04628780|469105435|FG003|Overall Study|Progressive disease|3|||
130311697|NCT04628780|469105436|FG004|Overall Study|Progressive disease|9|||
130311698|NCT04628780|469105437|FG005|Overall Study|Progressive disease|4|||
130311699|NCT04628780|469105432|FG000|Overall Study|Withdrawal by Subject|0|||
130311700|NCT04628780|469105433|FG001|Overall Study|Withdrawal by Subject|1|||
130311701|NCT04628780|469105434|FG002|Overall Study|Withdrawal by Subject|2|||
130311702|NCT04628780|469105435|FG003|Overall Study|Withdrawal by Subject|0|||
130311703|NCT04628780|469105436|FG004|Overall Study|Withdrawal by Subject|3|||
130311704|NCT04628780|469105437|FG005|Overall Study|Withdrawal by Subject|1|||
130311705|NCT04628780|469105432|FG000|Overall Study|Global deterioration of health status|0|||
130311706|NCT04628780|469105433|FG001|Overall Study|Global deterioration of health status|0|||
130311707|NCT04628780|469105434|FG002|Overall Study|Global deterioration of health status|0|||
130311708|NCT04628780|469105435|FG003|Overall Study|Global deterioration of health status|0|||
130311709|NCT04628780|469105436|FG004|Overall Study|Global deterioration of health status|1|||
130311710|NCT04628780|469105437|FG005|Overall Study|Global deterioration of health status|1|||
130311711|NCT03622814|469105439|FG000|Overall Study|Lost to Follow-up|8|||
130311712|NCT03622814|469105440|FG001|Overall Study|Lost to Follow-up|14|||
130311713|NCT01156714|469105443|FG000|Overall Study|Withdrawal by Subject|9|||
130311714|NCT01156714|469105444|FG001|Overall Study|Withdrawal by Subject|4|||
130311715|NCT01156714|469105445|FG002|Overall Study|Withdrawal by Subject|3|||
130311716|NCT04896593|469105451|FG000|Overall Study|Withdrawal by Subject|2|||
130311717|NCT04896593|469105451|FG000|Overall Study|Lost to Follow-up|1|||
130311718|NCT04896593|469105451|FG000|Overall Study|Did not complete onboarding|2|||
130311719|NCT02777827|469105452|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
130465461|NCT05938413|469671911|FG000|Overall Study|Lost to Follow-up|1|||
130465462|NCT05938413|469671912|FG001|Overall Study|Lost to Follow-up|7|||
130465463|NCT05938413|469671911|FG000|Overall Study|Withdrawal by Subject|1|||
130465464|NCT05938413|469671912|FG001|Overall Study|Withdrawal by Subject|1|||
130311720|NCT02777827|469105453|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311721|NCT02777827|469105454|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
130311722|NCT02777827|469105455|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311723|NCT02777827|469105456|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311724|NCT02777827|469105457|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311725|NCT00176462|469105458|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
130311726|NCT00176462|469105459|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
130311727|NCT00176462|469105458|FG000|Induction (4 Weeks)|Death|1|||
130311728|NCT00176462|469105459|FG001|Induction (4 Weeks)|Death|2|||
130311729|NCT00176462|469105458|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
130311730|NCT00176462|469105459|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
130311731|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
130311732|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
130311733|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
130311734|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
130311735|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
130311736|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
130465465|NCT02675244|469671929|FG000|Overall Study|Death|9|||
130465466|NCT02675244|469671930|FG001|Overall Study|Death|6|||
130465467|NCT02675244|469671929|FG000|Overall Study|Withdrawal by Subject|3|||
130718912|NCT00394524|470597264|FG000|Overall Study|Withdrawal by Subject|0|||
130718913|NCT00394524|470597265|FG001|Overall Study|Withdrawal by Subject|1|||
130311737|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Not documented|0|||
130311738|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Not documented|1|||
130311739|NCT00176462|469105458|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
130311740|NCT00176462|469105459|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
130311741|NCT00176462|469105458|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
130311742|NCT00176462|469105459|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
130311743|NCT01408459|469105460|FG000|Overall Study|Withdrawal by Subject|1|||
130311744|NCT01408459|469105461|FG001|Overall Study|Withdrawal by Subject|1|||
130311745|NCT00330759|469106834|FG000|Overall Study|Death|316|||
130311746|NCT00330759|469106835|FG001|Overall Study|Death|310|||
130311747|NCT00330759|469106834|FG000|Overall Study|Disease progression|104|||
130311748|NCT00330759|469106835|FG001|Overall Study|Disease progression|126|||
130311749|NCT00330759|469106834|FG000|Overall Study|Withdrawal by Subject|143|||
130311750|NCT00330759|469106835|FG001|Overall Study|Withdrawal by Subject|124|||
130311751|NCT00330759|469106834|FG000|Overall Study|Adverse Event|48|||
130311752|NCT00330759|469106835|FG001|Overall Study|Adverse Event|36|||
130311753|NCT00330759|469106834|FG000|Overall Study|Participant request|31|||
130311754|NCT00330759|469106835|FG001|Overall Study|Participant request|22|||
130311755|NCT00330759|469106834|FG000|Overall Study|Lost to Follow-up|16|||
130311756|NCT00330759|469106835|FG001|Overall Study|Lost to Follow-up|22|||
130311757|NCT00330759|469106834|FG000|Overall Study|Noncompliance|15|||
130311758|NCT00330759|469106835|FG001|Overall Study|Noncompliance|17|||
130311759|NCT00330759|469106834|FG000|Overall Study|Physician Decision|1|||
130311760|NCT00330759|469106835|FG001|Overall Study|Physician Decision|2|||
130311761|NCT00330759|469106834|FG000|Overall Study|Protocol deviation|0|||
130311762|NCT00330759|469106835|FG001|Overall Study|Protocol deviation|2|||
130311763|NCT00330759|469106834|FG000|Overall Study|Ineligibility determined|2|||
130311764|NCT00330759|469106835|FG001|Overall Study|Ineligibility determined|1|||
130311765|NCT00330759|469106834|FG000|Overall Study|Other|36|||
130311766|NCT00330759|469106835|FG001|Overall Study|Other|44|||
130311767|NCT01380769|469106840|FG000|Overall Study|Withdrawal by Subject|7|||
130311768|NCT01380769|469106841|FG001|Overall Study|Withdrawal by Subject|11|||
130311769|NCT01380769|469106840|FG000|Overall Study|Physician Decision|1|||
130311770|NCT01380769|469106841|FG001|Overall Study|Physician Decision|1|||
130311771|NCT01380769|469106840|FG000|Overall Study|Adverse Event|1|||
130311772|NCT01380769|469106841|FG001|Overall Study|Adverse Event|1|||
130311773|NCT01380769|469106840|FG000|Overall Study|Protocol Violation|0|||
130311774|NCT01380769|469106841|FG001|Overall Study|Protocol Violation|1|||
130311775|NCT03654690|469106842|FG000|Overall Study|Withdrawal by Subject|1|||
130311776|NCT03654690|469106843|FG001|Overall Study|Withdrawal by Subject|0|||
130311777|NCT03654690|469106844|FG002|Overall Study|Withdrawal by Subject|0|||
130311778|NCT00742183|469106847|FG000|Overall Study|Adverse Event|2|||
130311779|NCT00742183|469106848|FG001|Overall Study|Adverse Event|2|||
130311780|NCT00742183|469106847|FG000|Overall Study|Death|1|||
130311781|NCT00742183|469106848|FG001|Overall Study|Death|0|||
130311782|NCT00742183|469106847|FG000|Overall Study|Physician Decision|0|||
130311783|NCT00742183|469106848|FG001|Overall Study|Physician Decision|2|||
130311784|NCT00742183|469106847|FG000|Overall Study|Lost to Follow-up|4|||
130311785|NCT00742183|469106848|FG001|Overall Study|Lost to Follow-up|4|||
130311786|NCT00742183|469106847|FG000|Overall Study|Required skin-graft|1|||
130311787|NCT00742183|469106848|FG001|Overall Study|Required skin-graft|1|||
130311788|NCT00742183|469106847|FG000|Overall Study|Withdrawal by Subject|1|||
130311789|NCT00742183|469106848|FG001|Overall Study|Withdrawal by Subject|0|||
130311790|NCT00742183|469106847|FG000|Overall Study|Lack of Efficacy|0|||
130311791|NCT00742183|469106848|FG001|Overall Study|Lack of Efficacy|3|||
130311792|NCT00786799|469106852|FG000|Overall Study|Lost to Follow-up|1|||
130311793|NCT00786799|469106853|FG001|Overall Study|Lost to Follow-up|1|||
130311794|NCT02223715|469106857|FG000|Overall Study|Death|31|||
130311795|NCT02223715|469106857|FG000|Overall Study|Lost to Follow-up|73|||
130311796|NCT01745367|469106858|FG000|Overall Study|Death|1|||
130311797|NCT01745367|469106859|FG001|Overall Study|Death|0|||
130311798|NCT01745367|469106858|FG000|Overall Study|Withdrawal by Subject|1|||
130311799|NCT01745367|469106859|FG001|Overall Study|Withdrawal by Subject|2|||
130311800|NCT01745367|469106858|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
130465468|NCT02675244|469671930|FG001|Overall Study|Withdrawal by Subject|6|||
130465469|NCT02675244|469671929|FG000|Overall Study|Lost to Follow-up|1|||
130311801|NCT01745367|469106859|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
130311802|NCT01745367|469106858|FG000|Overall Study|Other Reasons Unspecified|0|||
130311803|NCT01745367|469106859|FG001|Overall Study|Other Reasons Unspecified|2|||
130311804|NCT03018691|469106863|FG000|Overall Study|Adverse Event|1|||
130311805|NCT03018691|469106864|FG001|Overall Study|Adverse Event|1|||
130311806|NCT03018691|469106865|FG002|Overall Study|Adverse Event|4|||
130311807|NCT03018691|469106863|FG000|Overall Study|Lack of Efficacy|0|||
130311808|NCT03018691|469106864|FG001|Overall Study|Lack of Efficacy|0|||
130311809|NCT03018691|469106865|FG002|Overall Study|Lack of Efficacy|1|||
130311810|NCT03018691|469106863|FG000|Overall Study|Withdrawal by Subject|0|||
130311811|NCT03018691|469106864|FG001|Overall Study|Withdrawal by Subject|0|||
130311812|NCT03018691|469106865|FG002|Overall Study|Withdrawal by Subject|1|||
130311813|NCT03018691|469106863|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130311814|NCT03018691|469106864|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130311815|NCT03018691|469106865|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130311816|NCT01020786|469106870|FG000|Induction Period|Entry Criteria Not Met|2|||
130311817|NCT01020786|469106870|FG000|Induction Period|Adverse Event|10|||
130311818|NCT01020786|469106870|FG000|Induction Period|Progressive Disease|31|||
130311819|NCT01020786|469106870|FG000|Induction Period|Investigator Decision|3|||
130311820|NCT01020786|469106870|FG000|Induction Period|Withdrawal by Subject|3|||
130311821|NCT01020786|469106870|FG000|Maintenance Period|Adverse Event|8|||
130311822|NCT01020786|469106870|FG000|Maintenance Period|Progressive Disease|43|||
130311823|NCT01020786|469106870|FG000|Maintenance Period|Withdrawal by Subject|8|||
130311824|NCT01020786|469106870|FG000|Maintenance Period|Sponsor Decision|1|||
130311825|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
130311826|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
130311827|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
130311828|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
130311829|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
130311830|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
130311831|NCT01521507|469106881|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
130311832|NCT01521507|469106882|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
130311833|NCT01521507|469106881|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
130311834|NCT01521507|469106882|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
130311835|NCT01521507|469106881|FG000|Stage 2: Observational Design|Physician Decision|1|||
130311836|NCT01521507|469106882|FG001|Stage 2: Observational Design|Physician Decision|0|||
130311837|NCT01358825|469106887|FG000|Overall Study|Blood sample not drawn|0|||
130311838|NCT01358825|469106888|FG001|Overall Study|Blood sample not drawn|1|||
130311839|NCT01479868|469106889|FG000|Overall Study|Adverse Event|1|||
130311840|NCT01479868|469106889|FG000|Overall Study|Lost to Follow-up|4|||
130311841|NCT01479868|469106889|FG000|Overall Study|Protocol Violation|1|||
130311842|NCT01479868|469106889|FG000|Overall Study|Withdrawal by Subject|1|||
130311843|NCT01479868|469106889|FG000|Overall Study|Sponsor's Decision|1|||
130311844|NCT01479868|469106889|FG000|Overall Study|Initiation of new HCV Therapy|1|||
130311845|NCT01508169|469106890|FG000|Overall Study|Adverse Event|1|||
130311846|NCT01508169|469106891|FG001|Overall Study|Adverse Event|0|||
130311847|NCT01508169|469106890|FG000|Overall Study|Withdrawal by Subject|1|||
130311848|NCT01508169|469106891|FG001|Overall Study|Withdrawal by Subject|0|||
130311849|NCT01508169|469106890|FG000|Overall Study|Lost to Follow-up|1|||
130311850|NCT01508169|469106891|FG001|Overall Study|Lost to Follow-up|2|||
130311851|NCT01363700|469106897|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311852|NCT01363700|469106898|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
130311853|NCT01363700|469106899|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311854|NCT01363700|469106900|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311855|NCT01363700|469106901|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311856|NCT00113841|469106906|FG000|Overall Study|Disease progression|0|||
130311857|NCT00113841|469106907|FG001|Overall Study|Disease progression|2|||
130311858|NCT00113841|469106906|FG000|Overall Study|Non-compliant|1|||
130311859|NCT00113841|469106907|FG001|Overall Study|Non-compliant|0|||
130311860|NCT00580723|469106912|FG000|Overall Study|Did not want to participate in extension|3|||
130311861|NCT00580723|469106912|FG000|Overall Study|Lost to Follow-up|5|||
130311862|NCT05202418|469106913|FG000|Overall Study|Withdrawal by Subject|2|||
130311863|NCT05202418|469106914|FG001|Overall Study|Withdrawal by Subject|1|||
130311864|NCT05202418|469106913|FG000|Overall Study|Lost to Follow-up|1|||
130311865|NCT05202418|469106914|FG001|Overall Study|Lost to Follow-up|1|||
130311866|NCT02753946|469106915|FG000|Overall Study|Adverse Event|7|||
130374636|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374637|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374638|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374639|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374640|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374641|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374642|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374643|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130374644|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
130311867|NCT02753946|469106916|FG001|Overall Study|Adverse Event|6|||
130311868|NCT02753946|469106915|FG000|Overall Study|Withdrawal by Subject|6|||
130311869|NCT02753946|469106916|FG001|Overall Study|Withdrawal by Subject|1|||
130311870|NCT02753946|469106915|FG000|Overall Study|Lack of Efficacy|1|||
130311871|NCT02753946|469106916|FG001|Overall Study|Lack of Efficacy|0|||
130311872|NCT02753946|469106915|FG000|Overall Study|Physician Decision|0|||
130311873|NCT02753946|469106916|FG001|Overall Study|Physician Decision|2|||
130465470|NCT02675244|469671930|FG001|Overall Study|Lost to Follow-up|1|||
130718914|NCT01398514|470597266|FG000|Overall Study|Adverse Event|1|||
130311874|NCT02519439|469106917|FG000|Overall Study|Study Termination|19|||
130311875|NCT02519439|469106917|FG000|Overall Study|Withdrawal by Subject|1|||
130311876|NCT02519439|469106917|FG000|Overall Study|Adverse Event|1|||
130311877|NCT03901144|469106921|FG000|Overall Study|Lost to Follow-up|1|||
130311878|NCT03901144|469106922|FG001|Overall Study|Lost to Follow-up|1|||
130311879|NCT03901144|469106923|FG002|Overall Study|Lost to Follow-up|1|||
130311880|NCT03901144|469106924|FG003|Overall Study|Lost to Follow-up|1|||
130311881|NCT02294058|469106927|FG000|Overall Study|Adverse Event|16|||
130311882|NCT02294058|469106928|FG001|Overall Study|Adverse Event|7|||
130311883|NCT02294058|469106929|FG002|Overall Study|Adverse Event|13|||
130311884|NCT02294058|469106927|FG000|Overall Study|Lack of Efficacy|3|||
130311885|NCT02294058|469106928|FG001|Overall Study|Lack of Efficacy|3|||
130311886|NCT02294058|469106929|FG002|Overall Study|Lack of Efficacy|0|||
130311887|NCT02294058|469106927|FG000|Overall Study|Lost to Follow-up|1|||
130311888|NCT02294058|469106928|FG001|Overall Study|Lost to Follow-up|0|||
130311889|NCT02294058|469106929|FG002|Overall Study|Lost to Follow-up|2|||
130311890|NCT02294058|469106927|FG000|Overall Study|Withdrawal by Subject|10|||
130311891|NCT02294058|469106928|FG001|Overall Study|Withdrawal by Subject|14|||
130311892|NCT02294058|469106929|FG002|Overall Study|Withdrawal by Subject|13|||
130311893|NCT02294058|469106927|FG000|Overall Study|Physician Decision|2|||
130311894|NCT02294058|469106928|FG001|Overall Study|Physician Decision|1|||
130311895|NCT02294058|469106929|FG002|Overall Study|Physician Decision|0|||
130311896|NCT02294058|469106927|FG000|Overall Study|Miscellaneous|4|||
130311897|NCT02294058|469106928|FG001|Overall Study|Miscellaneous|1|||
130311898|NCT02294058|469106929|FG002|Overall Study|Miscellaneous|1|||
130311899|NCT03575403|469106930|FG000|Overall Study|Adverse Event|1|||
130311900|NCT03575403|469106931|FG001|Overall Study|Adverse Event|0|||
130311901|NCT03575403|469106932|FG002|Overall Study|Adverse Event|0|||
130311902|NCT03575403|469106930|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
130311903|NCT03575403|469106931|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130311904|NCT03575403|469106932|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130311905|NCT03359174|469106935|FG000|Overall Study|Adverse Event|1|||
130311906|NCT01332994|469106939|FG000|Overall Study|Adverse Event|34|||
130311907|NCT01332994|469106939|FG000|Overall Study|Death|1|||
130311908|NCT01332994|469106939|FG000|Overall Study|Lack of Efficacy|1|||
130311909|NCT01332994|469106939|FG000|Overall Study|Lost to Follow-up|4|||
130311910|NCT01332994|469106939|FG000|Overall Study|Protocol Violation|6|||
130311911|NCT01332994|469106939|FG000|Overall Study|Withdrawal by Subject|15|||
130311912|NCT01332994|469106939|FG000|Overall Study|Administrative Problem|2|||
130311913|NCT01332994|469106939|FG000|Overall Study|Other|8|||
130311914|NCT02800863|469106940|FG000|Overall Study|Adverse Event|14|||
130311915|NCT02800863|469106940|FG000|Overall Study|Another Device Implanted|1|||
130311916|NCT02800863|469106940|FG000|Overall Study|Device Explanted|1|||
130311917|NCT02800863|469106940|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
130311918|NCT02800863|469106940|FG000|Overall Study|Health Issues|1|||
130311919|NCT02800863|469106940|FG000|Overall Study|Insurance Denial|8|||
130311920|NCT02800863|469106940|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
130311921|NCT02800863|469106940|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
130311922|NCT02800863|469106940|FG000|Overall Study|Screen Failure|1|||
130311923|NCT02800863|469106940|FG000|Overall Study|Sponsor Request|6|||
130311924|NCT02800863|469106940|FG000|Overall Study|Death|3|||
130311925|NCT02800863|469106940|FG000|Overall Study|Subject Implant at Another Facility|1|||
130311926|NCT02800863|469106940|FG000|Overall Study|Lost to Follow-up|26|||
130311927|NCT02800863|469106940|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
130311928|NCT02800863|469106940|FG000|Overall Study|Subject and/or Family Request|64|||
130311929|NCT02800863|469106940|FG000|Overall Study|Trial Failure|81|||
130311930|NCT02800863|469106940|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
130311931|NCT00279916|469106941|FG000|Overall Study|Withdrawal by Subject|4|||
130311932|NCT00279916|469106942|FG001|Overall Study|Withdrawal by Subject|3|||
130311933|NCT00279916|469106941|FG000|Overall Study|Lost to Follow-up|3|||
130311934|NCT00279916|469106942|FG001|Overall Study|Lost to Follow-up|2|||
130311935|NCT02717494|469106944|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
130311936|NCT02717494|469106945|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
130311937|NCT02717494|469106946|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
130311938|NCT02717494|469106944|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
130311939|NCT02717494|469106945|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
130311940|NCT02717494|469106946|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
130311941|NCT02717494|469106944|FG000|First Intervention (Step 1)|Death|0|||
130311942|NCT02717494|469106945|FG001|First Intervention (Step 1)|Death|0|||
130311943|NCT02717494|469106946|FG002|First Intervention (Step 1)|Death|1|||
130311944|NCT02717494|469106944|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130311945|NCT02717494|469106945|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130311946|NCT02717494|469106946|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
130311947|NCT00770601|469106947|FG000|Overall Study|Withdrawal by Subject|1|||
130311948|NCT00428948|469106950|FG000|Overall Study|Lost to Follow-up|15|||
130311949|NCT00428948|469106951|FG001|Overall Study|Lost to Follow-up|8|||
130311950|NCT00428948|469106950|FG000|Overall Study|Adverse Event|148|||
130311951|NCT00428948|469106951|FG001|Overall Study|Adverse Event|24|||
130311952|NCT00428948|469106950|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
130311953|NCT00428948|469106951|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
130311954|NCT00428948|469106950|FG000|Overall Study|Investigator Withdrew Subject|3|||
130311955|NCT00428948|469106951|FG001|Overall Study|Investigator Withdrew Subject|4|||
130311956|NCT00428948|469106950|FG000|Overall Study|Subject Withdrew Consent|50|||
130311957|NCT00428948|469106951|FG001|Overall Study|Subject Withdrew Consent|30|||
130311958|NCT00428948|469106950|FG000|Overall Study|Protocol Deviation|1|||
130311959|NCT00428948|469106951|FG001|Overall Study|Protocol Deviation|1|||
130311960|NCT04417361|469106953|FG000|Overall Study|Withdrawal by Subject|1|||
130311961|NCT04417361|469106954|FG001|Overall Study|Withdrawal by Subject|0|||
130311962|NCT04417361|469106953|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
130311963|NCT04417361|469106954|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
130311964|NCT01288989|469106955|FG000|Overall Study|Death|0|||
130311965|NCT01288989|469106956|FG001|Overall Study|Death|0|||
130311966|NCT01288989|469106957|FG002|Overall Study|Death|0|||
130311967|NCT01288989|469106958|FG003|Overall Study|Death|1|||
130311968|NCT01288989|469106959|FG004|Overall Study|Death|0|||
130311969|NCT01288989|469106955|FG000|Overall Study|Dose limiting toxicity|1|||
130311970|NCT01288989|469106956|FG001|Overall Study|Dose limiting toxicity|0|||
130311971|NCT01288989|469106957|FG002|Overall Study|Dose limiting toxicity|0|||
130311972|NCT01288989|469106958|FG003|Overall Study|Dose limiting toxicity|0|||
130311973|NCT01288989|469106959|FG004|Overall Study|Dose limiting toxicity|0|||
130311974|NCT01288989|469106955|FG000|Overall Study|Adverse Event|0|||
130311975|NCT01288989|469106956|FG001|Overall Study|Adverse Event|0|||
130311976|NCT01288989|469106957|FG002|Overall Study|Adverse Event|0|||
130311977|NCT01288989|469106958|FG003|Overall Study|Adverse Event|0|||
130311978|NCT01288989|469106959|FG004|Overall Study|Adverse Event|2|||
130311979|NCT01288989|469106955|FG000|Overall Study|Physician Decision|0|||
130311980|NCT01288989|469106956|FG001|Overall Study|Physician Decision|0|||
130311981|NCT01288989|469106957|FG002|Overall Study|Physician Decision|0|||
130311982|NCT01288989|469106958|FG003|Overall Study|Physician Decision|0|||
130311983|NCT01288989|469106959|FG004|Overall Study|Physician Decision|1|||
130311984|NCT01288989|469106955|FG000|Overall Study|Withdrawal by Subject|0|||
130311985|NCT01288989|469106956|FG001|Overall Study|Withdrawal by Subject|0|||
130311986|NCT01288989|469106957|FG002|Overall Study|Withdrawal by Subject|0|||
130311987|NCT01288989|469106958|FG003|Overall Study|Withdrawal by Subject|0|||
130311988|NCT01288989|469106959|FG004|Overall Study|Withdrawal by Subject|3|||
130311989|NCT00165672|469106961|FG000|Overall Study|Adverse Event|0|||
130311990|NCT00165672|469106962|FG001|Overall Study|Adverse Event|1|||
130311991|NCT04965688|469106968|FG000|Overall Study|Withdrawal by Subject|2|||
130311992|NCT05864586|469106969|FG000|Overall Study|Ineligible|4|||
130311993|NCT05864586|469106970|FG001|Overall Study|Ineligible|12|||
130311994|NCT05864586|469106969|FG000|Overall Study|Pregnancy|0|||
130311995|NCT05864586|469106970|FG001|Overall Study|Pregnancy|1|||
130311996|NCT05864586|469106969|FG000|Overall Study|Withdrawal by Subject|0|||
130311997|NCT05864586|469106970|FG001|Overall Study|Withdrawal by Subject|1|||
130311998|NCT00369577|469106971|FG000|Overall Study|Withdrawal by Subject|0|||
130311999|NCT00369577|469106972|FG001|Overall Study|Withdrawal by Subject|0|||
130312000|NCT00369577|469106973|FG002|Overall Study|Withdrawal by Subject|1|||
130312001|NCT01059318|469106984|FG000|Core Study (26 Week)|Adverse Event|3|||
130312002|NCT01059318|469106984|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
130312003|NCT01059318|469106984|FG000|Extension (36 Week)|Adverse Event|3|||
130312004|NCT00983385|469106985|FG000|Observation Period|Not eligible to be dosed|20|||
130312005|NCT00983385|469106985|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
130312006|NCT00824473|469108395|FG000|Overall Study|Adverse Event|4|||
130312007|NCT00824473|469108396|FG001|Overall Study|Adverse Event|5|||
130312008|NCT00824473|469108395|FG000|Overall Study|Lack of Efficacy|2|||
130374645|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374646|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
130374647|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374648|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374649|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374650|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374651|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374652|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374653|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130465471|NCT02675244|469671929|FG000|Overall Study|Ongoing at 2 Years|190|||
130312009|NCT00824473|469108396|FG001|Overall Study|Lack of Efficacy|2|||
130312010|NCT00824473|469108395|FG000|Overall Study|Protocol Violation|2|||
130312011|NCT00824473|469108396|FG001|Overall Study|Protocol Violation|0|||
130312012|NCT00824473|469108395|FG000|Overall Study|Non-Compliance|4|||
130312013|NCT00824473|469108396|FG001|Overall Study|Non-Compliance|2|||
130312014|NCT00824473|469108395|FG000|Overall Study|Withdrawal by Subject|2|||
130312015|NCT00824473|469108396|FG001|Overall Study|Withdrawal by Subject|3|||
130312016|NCT00824473|469108395|FG000|Overall Study|Other|1|||
130312017|NCT00824473|469108396|FG001|Overall Study|Other|1|||
130312018|NCT02478463|469108397|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
130312019|NCT02478463|469108397|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
130312020|NCT02478463|469108397|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
130312021|NCT01814527|469108399|FG000|Overall Study|RTP greater than 30 days|6|||
130312022|NCT01814527|469108400|FG001|Overall Study|RTP greater than 30 days|1|||
130312023|NCT04524858|469108401|FG000|Overall Study|Adverse Event|1|||
130312024|NCT00148759|469108408|FG000|Overall Study|Withdrawal by Subject|1|||
130312025|NCT00148759|469108409|FG001|Overall Study|Withdrawal by Subject|1|||
130312026|NCT00148759|469108408|FG000|Overall Study|Lost to Follow-up|1|||
130312027|NCT00148759|469108409|FG001|Overall Study|Lost to Follow-up|0|||
130312028|NCT02721875|469108411|FG000|Overall Study|Progressive disease/relapse|1|||
130312029|NCT02721875|469108412|FG001|Overall Study|Progressive disease/relapse|0|||
130312030|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
130312031|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
130312032|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
130312033|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
130312034|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130312035|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130312036|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Death|7|||
130312037|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Death|5|||
130312038|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Death|6|||
130312039|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
130312040|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
130312041|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
130312042|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130312043|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
130312044|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130312045|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Other|1|||
130312046|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Other|0|||
130312047|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Other|0|||
130312048|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
130312049|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
130312050|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
130312051|NCT00104650|469108415|FG000|Follow-up Period|Physician Decision|1|||
130312052|NCT00104650|469108416|FG001|Follow-up Period|Physician Decision|1|||
130312053|NCT00104650|469108417|FG002|Follow-up Period|Physician Decision|0|||
130312054|NCT00104650|469108415|FG000|Follow-up Period|Adverse Event|1|||
130312055|NCT00104650|469108416|FG001|Follow-up Period|Adverse Event|0|||
130312056|NCT00104650|469108417|FG002|Follow-up Period|Adverse Event|1|||
130312057|NCT00104650|469108415|FG000|Follow-up Period|Withdrawal by Subject|0|||
130312058|NCT00104650|469108416|FG001|Follow-up Period|Withdrawal by Subject|3|||
130312059|NCT00104650|469108417|FG002|Follow-up Period|Withdrawal by Subject|3|||
130312060|NCT00104650|469108415|FG000|Follow-up Period|Death|6|||
130312061|NCT00104650|469108416|FG001|Follow-up Period|Death|6|||
130312062|NCT00104650|469108417|FG002|Follow-up Period|Death|4|||
130312063|NCT00104650|469108415|FG000|Follow-up Period|Disease progression|3|||
130312064|NCT00104650|469108416|FG001|Follow-up Period|Disease progression|1|||
130312065|NCT00104650|469108417|FG002|Follow-up Period|Disease progression|0|||
130312066|NCT00104650|469108415|FG000|Follow-up Period|Lost to Follow-up|0|||
130312067|NCT00104650|469108416|FG001|Follow-up Period|Lost to Follow-up|1|||
130312068|NCT00104650|469108417|FG002|Follow-up Period|Lost to Follow-up|2|||
130312069|NCT00104650|469108415|FG000|Follow-up Period|Other|0|||
130312070|NCT00104650|469108416|FG001|Follow-up Period|Other|1|||
130312071|NCT00104650|469108417|FG002|Follow-up Period|Other|0|||
130312072|NCT00773513|469108419|FG000|Overall Study|Renal Transplant|254|||
130312073|NCT00773513|469108420|FG001|Overall Study|Renal Transplant|263|||
130374654|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130374655|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
130374656|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
130374657|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
130374658|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374659|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374660|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374661|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374662|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374663|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130312074|NCT00773513|469108419|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
130312075|NCT00773513|469108420|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
130312076|NCT00773513|469108419|FG000|Overall Study|Withdrew Consent|68|||
130718915|NCT01398514|470597267|FG001|Overall Study|Adverse Event|0|||
130312077|NCT00773513|469108420|FG001|Overall Study|Withdrew Consent|69|||
130312078|NCT00773513|469108419|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
130312079|NCT00773513|469108420|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
130312080|NCT00773513|469108419|FG000|Overall Study|Failure to Return|22|||
130312081|NCT00773513|469108420|FG001|Overall Study|Failure to Return|8|||
130312082|NCT00773513|469108419|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130312083|NCT00773513|469108420|FG001|Overall Study|Insufficient Therapeutic Response|18|||
130312084|NCT00773513|469108419|FG000|Overall Study|Reason Not Specified|159|||
130312085|NCT00773513|469108420|FG001|Overall Study|Reason Not Specified|126|||
130312086|NCT00773513|469108419|FG000|Overall Study|Death|531|||
130312087|NCT00773513|469108420|FG001|Overall Study|Death|545|||
130312088|NCT01807598|469108421|FG000|Overall Study|Withdrawal by Subject|4|||
130312089|NCT01807598|469108421|FG000|Overall Study|Adverse Event|1|||
130312090|NCT01807598|469108421|FG000|Overall Study|Other Physician Decision|1|||
130312091|NCT03384940|469108428|FG000|Overall Study|Progressive disease|36|||
130312092|NCT03384940|469108429|FG001|Overall Study|Progressive disease|11|||
130312093|NCT03384940|469108430|FG002|Overall Study|Progressive disease|13|||
130312094|NCT03384940|469108428|FG000|Overall Study|Clinical progression|4|||
130312095|NCT03384940|469108429|FG001|Overall Study|Clinical progression|0|||
130312096|NCT03384940|469108430|FG002|Overall Study|Clinical progression|3|||
130312097|NCT03384940|469108428|FG000|Overall Study|Adverse Event|7|||
130312098|NCT03384940|469108429|FG001|Overall Study|Adverse Event|1|||
130312099|NCT03384940|469108430|FG002|Overall Study|Adverse Event|1|||
130312100|NCT03384940|469108428|FG000|Overall Study|Withdrawal by Subject|3|||
130312101|NCT03384940|469108429|FG001|Overall Study|Withdrawal by Subject|1|||
130312102|NCT03384940|469108430|FG002|Overall Study|Withdrawal by Subject|0|||
130312103|NCT03384940|469108428|FG000|Overall Study|Physician Decision|1|||
130312104|NCT03384940|469108429|FG001|Overall Study|Physician Decision|1|||
130312105|NCT03384940|469108430|FG002|Overall Study|Physician Decision|0|||
130312106|NCT03384940|469108428|FG000|Overall Study|Death|2|||
130312107|NCT03384940|469108429|FG001|Overall Study|Death|1|||
130312108|NCT03384940|469108430|FG002|Overall Study|Death|0|||
130312109|NCT03384940|469108428|FG000|Overall Study|Other|0|||
130312110|NCT03384940|469108429|FG001|Overall Study|Other|0|||
130312111|NCT03384940|469108430|FG002|Overall Study|Other|1|||
130312112|NCT03089580|469108436|FG000|Overall Study|Lost to Follow-up|2|||
130312113|NCT03087513|469108437|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
130312114|NCT04170543|469108438|FG000|Overall Study|Death|1|||
130312115|NCT04170543|469108439|FG001|Overall Study|Death|1|||
130312116|NCT04170543|469108440|FG002|Overall Study|Death|1|||
130312117|NCT04170543|469108441|FG003|Overall Study|Death|1|||
130312118|NCT04170543|469108442|FG004|Overall Study|Death|1|||
130312119|NCT04170543|469108438|FG000|Overall Study|Lost to Follow-up|3|||
130312120|NCT04170543|469108439|FG001|Overall Study|Lost to Follow-up|3|||
130312121|NCT04170543|469108440|FG002|Overall Study|Lost to Follow-up|0|||
130312122|NCT04170543|469108441|FG003|Overall Study|Lost to Follow-up|3|||
130312123|NCT04170543|469108442|FG004|Overall Study|Lost to Follow-up|1|||
130312124|NCT04170543|469108438|FG000|Overall Study|Withdrawal by Subject|13|||
130312125|NCT04170543|469108439|FG001|Overall Study|Withdrawal by Subject|6|||
130312126|NCT04170543|469108440|FG002|Overall Study|Withdrawal by Subject|5|||
130312127|NCT04170543|469108441|FG003|Overall Study|Withdrawal by Subject|4|||
130312128|NCT04170543|469108442|FG004|Overall Study|Withdrawal by Subject|9|||
130312129|NCT04170543|469108438|FG000|Overall Study|Not able to transition to phase 2b|8|||
130312130|NCT04170543|469108439|FG001|Overall Study|Not able to transition to phase 2b|0|||
130312131|NCT04170543|469108440|FG002|Overall Study|Not able to transition to phase 2b|10|||
130312132|NCT04170543|469108441|FG003|Overall Study|Not able to transition to phase 2b|0|||
130312133|NCT04170543|469108442|FG004|Overall Study|Not able to transition to phase 2b|6|||
130312134|NCT04170543|469108438|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
130312135|NCT04170543|469108439|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
130718916|NCT01398514|470597266|FG000|Overall Study|Non-compliance with study procedures|2|||
130312136|NCT04170543|469108440|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
130312137|NCT04170543|469108441|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
130312138|NCT04170543|469108442|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
130312139|NCT04170543|469108438|FG000|Overall Study|Not Treated|0|||
130312140|NCT04170543|469108439|FG001|Overall Study|Not Treated|0|||
130312141|NCT04170543|469108440|FG002|Overall Study|Not Treated|0|||
130312142|NCT04170543|469108441|FG003|Overall Study|Not Treated|0|||
130312143|NCT04170543|469108442|FG004|Overall Study|Not Treated|2|||
130312144|NCT04170543|469108438|FG000|Overall Study|(CRF)|16|||
130312145|NCT04170543|469108439|FG001|Overall Study|(CRF)|15|||
130312146|NCT04170543|469108440|FG002|Overall Study|(CRF)|12|||
130312147|NCT04170543|469108441|FG003|Overall Study|(CRF)|17|||
130312148|NCT04170543|469108442|FG004|Overall Study|(CRF)|17|||
130312149|NCT04170543|469108438|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130312150|NCT04170543|469108439|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
130312151|NCT04170543|469108440|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
130312152|NCT04170543|469108441|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
130312153|NCT04170543|469108442|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
130312154|NCT00801216|469108443|FG000|Overall Study|Screening Failure|2|||
130312155|NCT05481359|469108444|FG000|Overall Study|Lost to Follow-up|3|||
130312156|NCT05481359|469108444|FG000|Overall Study|Withdrawal by Subject|1|||
130312157|NCT00452790|469108448|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
130312158|NCT00452790|469108449|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
130312159|NCT00452790|469108448|FG000|Infant Series|Parent/legal guardian request|8|||
130312160|NCT00452790|469108449|FG001|Infant Series|Parent/legal guardian request|6|||
130312161|NCT00452790|469108448|FG000|Infant Series|Failed to return|4|||
130312162|NCT00452790|469108449|FG001|Infant Series|Failed to return|1|||
130312163|NCT00452790|469108448|FG000|Infant Series|Protocol Violation|1|||
130312164|NCT00452790|469108449|FG001|Infant Series|Protocol Violation|3|||
130312165|NCT00452790|469108448|FG000|Infant Series|Lost to Follow-up|2|||
130312166|NCT00452790|469108449|FG001|Infant Series|Lost to Follow-up|2|||
130312167|NCT00452790|469108448|FG000|Infant Series|Adverse Event|1|||
130312168|NCT00452790|469108449|FG001|Infant Series|Adverse Event|2|||
130312169|NCT00452790|469108448|FG000|Infant Series|Other reasons|1|||
130312170|NCT00452790|469108449|FG001|Infant Series|Other reasons|2|||
130312171|NCT00452790|469108448|FG000|Infant Series|Investigator request|0|||
130312172|NCT00452790|469108449|FG001|Infant Series|Investigator request|1|||
130312173|NCT00452790|469108448|FG000|Infant Series|Death|0|||
130312174|NCT00452790|469108449|FG001|Infant Series|Death|1|||
130312175|NCT00452790|469108448|FG000|After Infant Series|Investigator request|10|||
130312176|NCT00452790|469108449|FG001|After Infant Series|Investigator request|10|||
130312177|NCT00452790|469108448|FG000|After Infant Series|Adverse Event|4|||
130312178|NCT00452790|469108449|FG001|After Infant Series|Adverse Event|1|||
130312179|NCT00452790|469108448|FG000|After Infant Series|Parent/legal guardian request|1|||
130312180|NCT00452790|469108449|FG001|After Infant Series|Parent/legal guardian request|3|||
130312181|NCT00452790|469108448|FG000|After Infant Series|Lost to Follow-up|4|||
130312182|NCT00452790|469108449|FG001|After Infant Series|Lost to Follow-up|0|||
130312183|NCT00452790|469108448|FG000|After Infant Series|Failed to return|1|||
130312184|NCT00452790|469108449|FG001|After Infant Series|Failed to return|0|||
130312185|NCT00452790|469108448|FG000|After Infant Series|Other reasons|1|||
130312186|NCT00452790|469108449|FG001|After Infant Series|Other reasons|0|||
130312187|NCT00452790|469108448|FG000|Toddler Dose|Failed to return|0|||
130312188|NCT00452790|469108449|FG001|Toddler Dose|Failed to return|1|||
130312189|NCT00452790|469108448|FG000|Toddler Dose|Parent/legal guardian request|0|||
130312190|NCT00452790|469108449|FG001|Toddler Dose|Parent/legal guardian request|1|||
130312191|NCT00319254|469108465|FG000|Overall Study|Withdrawal by Subject|4|||
130312192|NCT00319254|469108465|FG000|Overall Study|Death|46|||
130312193|NCT00319254|469108465|FG000|Overall Study|Lost to Follow-up|2|||
130312194|NCT00319254|469108465|FG000|Overall Study|Enrolled, Not Treated|2|||
130312195|NCT01505374|469108466|FG000|Overall Study|Lost to Follow-up|1|||
130312196|NCT01505374|469108467|FG001|Overall Study|Lost to Follow-up|0|||
130312197|NCT01712204|469108468|FG000|Overall Study|Adverse Event|3|||
130312198|NCT01712204|469108469|FG001|Overall Study|Adverse Event|1|||
130312199|NCT01712204|469108468|FG000|Overall Study|Withdrawal by Subject|3|||
130312200|NCT01712204|469108469|FG001|Overall Study|Withdrawal by Subject|3|||
130312201|NCT01712204|469108468|FG000|Overall Study|Lost to Follow-up|1|||
130312202|NCT01712204|469108469|FG001|Overall Study|Lost to Follow-up|0|||
130312203|NCT01712204|469108468|FG000|Overall Study|Protocol Violation|1|||
130312204|NCT01712204|469108469|FG001|Overall Study|Protocol Violation|1|||
130312205|NCT02360228|469108470|FG000|Overall Study|Withdrawal by Subject|1|||
130312206|NCT02360228|469108471|FG001|Overall Study|Withdrawal by Subject|0|||
130312207|NCT02360228|469108472|FG002|Overall Study|Withdrawal by Subject|0|||
130312208|NCT02360228|469108470|FG000|Overall Study|Self-discontinued medication|0|||
130312209|NCT02360228|469108471|FG001|Overall Study|Self-discontinued medication|1|||
130312210|NCT02360228|469108472|FG002|Overall Study|Self-discontinued medication|0|||
130312211|NCT02360228|469108470|FG000|Overall Study|Unstable symptoms during screening|0|||
130312212|NCT02360228|469108471|FG001|Overall Study|Unstable symptoms during screening|0|||
130312213|NCT02360228|469108472|FG002|Overall Study|Unstable symptoms during screening|1|||
130312214|NCT02452424|469108475|FG000|Overall Study|Death|2|||
130312215|NCT02452424|469108476|FG001|Overall Study|Death|2|||
130374664|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374665|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130374666|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
130374667|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
130374668|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374669|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374670|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374671|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374672|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374673|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130312216|NCT02452424|469108477|FG002|Overall Study|Death|2|||
130312217|NCT02452424|469108478|FG003|Overall Study|Death|6|||
130312218|NCT02452424|469108479|FG004|Overall Study|Death|2|||
130312219|NCT02452424|469108480|FG005|Overall Study|Death|0|||
130312220|NCT02452424|469108481|FG006|Overall Study|Death|5|||
130312221|NCT02452424|469108482|FG007|Overall Study|Death|1|||
130312222|NCT02452424|469108483|FG008|Overall Study|Death|3|||
130312223|NCT02452424|469108484|FG009|Overall Study|Death|1|||
130312224|NCT02452424|469108485|FG010|Overall Study|Death|0|||
130312225|NCT02452424|469108475|FG000|Overall Study|Lost to Follow-up|0|||
130312226|NCT02452424|469108476|FG001|Overall Study|Lost to Follow-up|1|||
130312227|NCT02452424|469108477|FG002|Overall Study|Lost to Follow-up|1|||
130312228|NCT02452424|469108478|FG003|Overall Study|Lost to Follow-up|0|||
130312229|NCT02452424|469108479|FG004|Overall Study|Lost to Follow-up|0|||
130312230|NCT02452424|469108480|FG005|Overall Study|Lost to Follow-up|0|||
130312231|NCT02452424|469108481|FG006|Overall Study|Lost to Follow-up|0|||
130312232|NCT02452424|469108482|FG007|Overall Study|Lost to Follow-up|0|||
130312233|NCT02452424|469108483|FG008|Overall Study|Lost to Follow-up|0|||
130312234|NCT02452424|469108484|FG009|Overall Study|Lost to Follow-up|0|||
130312235|NCT02452424|469108485|FG010|Overall Study|Lost to Follow-up|0|||
130312236|NCT02452424|469108475|FG000|Overall Study|Withdrawal by Subject|0|||
130312237|NCT02452424|469108476|FG001|Overall Study|Withdrawal by Subject|0|||
130312238|NCT02452424|469108477|FG002|Overall Study|Withdrawal by Subject|3|||
130312239|NCT02452424|469108478|FG003|Overall Study|Withdrawal by Subject|2|||
130312240|NCT02452424|469108479|FG004|Overall Study|Withdrawal by Subject|0|||
130312241|NCT02452424|469108480|FG005|Overall Study|Withdrawal by Subject|0|||
130312242|NCT02452424|469108481|FG006|Overall Study|Withdrawal by Subject|1|||
130312243|NCT02452424|469108482|FG007|Overall Study|Withdrawal by Subject|0|||
130312244|NCT02452424|469108483|FG008|Overall Study|Withdrawal by Subject|1|||
130312245|NCT02452424|469108484|FG009|Overall Study|Withdrawal by Subject|1|||
130312246|NCT02452424|469108485|FG010|Overall Study|Withdrawal by Subject|0|||
130312247|NCT02452424|469108475|FG000|Overall Study|Other|0|||
130312248|NCT02452424|469108476|FG001|Overall Study|Other|0|||
130312249|NCT02452424|469108477|FG002|Overall Study|Other|1|||
130312250|NCT02452424|469108478|FG003|Overall Study|Other|0|||
130312251|NCT02452424|469108479|FG004|Overall Study|Other|0|||
130312252|NCT02452424|469108480|FG005|Overall Study|Other|1|||
130312253|NCT02452424|469108481|FG006|Overall Study|Other|4|||
130312254|NCT02452424|469108482|FG007|Overall Study|Other|3|||
130312255|NCT02452424|469108483|FG008|Overall Study|Other|0|||
130312256|NCT02452424|469108484|FG009|Overall Study|Other|0|||
130312257|NCT02452424|469108485|FG010|Overall Study|Other|1|||
130312258|NCT02452424|469108475|FG000|Overall Study|Progressive disease (per RECIST)|0|||
130312259|NCT02452424|469108476|FG001|Overall Study|Progressive disease (per RECIST)|0|||
130312260|NCT02452424|469108477|FG002|Overall Study|Progressive disease (per RECIST)|0|||
130312261|NCT02452424|469108478|FG003|Overall Study|Progressive disease (per RECIST)|0|||
130312262|NCT02452424|469108479|FG004|Overall Study|Progressive disease (per RECIST)|0|||
130312263|NCT02452424|469108480|FG005|Overall Study|Progressive disease (per RECIST)|0|||
130312264|NCT02452424|469108481|FG006|Overall Study|Progressive disease (per RECIST)|0|||
130312265|NCT02452424|469108482|FG007|Overall Study|Progressive disease (per RECIST)|0|||
130312266|NCT02452424|469108483|FG008|Overall Study|Progressive disease (per RECIST)|2|||
130312267|NCT02452424|469108484|FG009|Overall Study|Progressive disease (per RECIST)|0|||
130312268|NCT02452424|469108485|FG010|Overall Study|Progressive disease (per RECIST)|0|||
130312269|NCT02452424|469108475|FG000|Overall Study|Adverse Event|0|||
130312270|NCT02452424|469108476|FG001|Overall Study|Adverse Event|0|||
130312271|NCT02452424|469108477|FG002|Overall Study|Adverse Event|0|||
130312272|NCT02452424|469108478|FG003|Overall Study|Adverse Event|0|||
130312273|NCT02452424|469108479|FG004|Overall Study|Adverse Event|0|||
130312274|NCT02452424|469108480|FG005|Overall Study|Adverse Event|0|||
130312275|NCT02452424|469108481|FG006|Overall Study|Adverse Event|0|||
130312276|NCT02452424|469108482|FG007|Overall Study|Adverse Event|0|||
130312277|NCT02452424|469108483|FG008|Overall Study|Adverse Event|0|||
130312278|NCT02452424|469108484|FG009|Overall Study|Adverse Event|0|||
130312279|NCT02452424|469108485|FG010|Overall Study|Adverse Event|1|||
130312280|NCT01463306|469108486|FG000|Overall Study|Adverse Event|6|||
130312281|NCT01463306|469108487|FG001|Overall Study|Adverse Event|9|||
130312282|NCT01463306|469108488|FG002|Overall Study|Adverse Event|3|||
130312283|NCT01463306|469108486|FG000|Overall Study|Death|3|||
130312284|NCT01463306|469108487|FG001|Overall Study|Death|3|||
130312285|NCT01463306|469108488|FG002|Overall Study|Death|0|||
130312286|NCT01463306|469108486|FG000|Overall Study|Lack of Efficacy|22|||
130312287|NCT01463306|469108487|FG001|Overall Study|Lack of Efficacy|16|||
130312288|NCT01463306|469108488|FG002|Overall Study|Lack of Efficacy|1|||
130312289|NCT01463306|469108486|FG000|Overall Study|Lost to Follow-up|5|||
130312290|NCT01463306|469108487|FG001|Overall Study|Lost to Follow-up|2|||
130312291|NCT01463306|469108488|FG002|Overall Study|Lost to Follow-up|0|||
130312292|NCT01463306|469108486|FG000|Overall Study|Protocol Violation|4|||
130312293|NCT01463306|469108487|FG001|Overall Study|Protocol Violation|0|||
130312294|NCT01463306|469108488|FG002|Overall Study|Protocol Violation|0|||
130312295|NCT01463306|469108486|FG000|Overall Study|Withdrawal by Subject|19|||
130312296|NCT01463306|469108487|FG001|Overall Study|Withdrawal by Subject|9|||
130312297|NCT01463306|469108488|FG002|Overall Study|Withdrawal by Subject|1|||
130312298|NCT01463306|469108486|FG000|Overall Study|Other|26|||
130312299|NCT01463306|469108487|FG001|Overall Study|Other|13|||
130312300|NCT01463306|469108488|FG002|Overall Study|Other|0|||
130312301|NCT01463306|469108486|FG000|Overall Study|Approval expiry at site|1|||
130312302|NCT01463306|469108487|FG001|Overall Study|Approval expiry at site|0|||
130312303|NCT01463306|469108488|FG002|Overall Study|Approval expiry at site|0|||
130312304|NCT04186871|469108491|FG000|Overall Study|Lack of Efficacy|0|||
130312305|NCT04186871|469108492|FG001|Overall Study|Lack of Efficacy|1|||
130312306|NCT04186871|469108493|FG002|Overall Study|Lack of Efficacy|0|||
130312307|NCT04186871|469108494|FG003|Overall Study|Lack of Efficacy|0|||
130312308|NCT04186871|469108495|FG004|Overall Study|Lack of Efficacy|1|||
130312309|NCT04186871|469108496|FG005|Overall Study|Lack of Efficacy|1|||
130312310|NCT04186871|469108491|FG000|Overall Study|Adverse Event|1|||
130312311|NCT04186871|469108492|FG001|Overall Study|Adverse Event|1|||
130312312|NCT04186871|469108493|FG002|Overall Study|Adverse Event|0|||
130312313|NCT04186871|469108494|FG003|Overall Study|Adverse Event|0|||
130312314|NCT04186871|469108495|FG004|Overall Study|Adverse Event|0|||
130312315|NCT04186871|469108496|FG005|Overall Study|Adverse Event|2|||
130312316|NCT04186871|469108491|FG000|Overall Study|Study terminated by sponsor|1|||
130312317|NCT04186871|469108492|FG001|Overall Study|Study terminated by sponsor|2|||
130312318|NCT04186871|469108493|FG002|Overall Study|Study terminated by sponsor|0|||
130312319|NCT04186871|469108494|FG003|Overall Study|Study terminated by sponsor|1|||
130312320|NCT04186871|469108495|FG004|Overall Study|Study terminated by sponsor|0|||
130312321|NCT04186871|469108496|FG005|Overall Study|Study terminated by sponsor|0|||
130312322|NCT04186871|469108491|FG000|Overall Study|Other reasons|0|||
130312323|NCT04186871|469108492|FG001|Overall Study|Other reasons|0|||
130312324|NCT04186871|469108493|FG002|Overall Study|Other reasons|0|||
130312325|NCT04186871|469108494|FG003|Overall Study|Other reasons|0|||
130312326|NCT04186871|469108495|FG004|Overall Study|Other reasons|0|||
130312327|NCT04186871|469108496|FG005|Overall Study|Other reasons|1|||
130312328|NCT04186871|469108491|FG000|Overall Study|Withdrawal by Subject|0|||
130312329|NCT04186871|469108492|FG001|Overall Study|Withdrawal by Subject|0|||
130312330|NCT04186871|469108493|FG002|Overall Study|Withdrawal by Subject|0|||
130312331|NCT04186871|469108494|FG003|Overall Study|Withdrawal by Subject|0|||
130312332|NCT04186871|469108495|FG004|Overall Study|Withdrawal by Subject|0|||
130312333|NCT04186871|469108496|FG005|Overall Study|Withdrawal by Subject|1|||
130312334|NCT04186871|469108491|FG000|Overall Study|Lost to Follow-up|0|||
130312335|NCT04186871|469108492|FG001|Overall Study|Lost to Follow-up|0|||
130312336|NCT04186871|469108493|FG002|Overall Study|Lost to Follow-up|0|||
130312337|NCT04186871|469108494|FG003|Overall Study|Lost to Follow-up|0|||
130312338|NCT04186871|469108495|FG004|Overall Study|Lost to Follow-up|0|||
130312339|NCT04186871|469108496|FG005|Overall Study|Lost to Follow-up|1|||
130312340|NCT03790917|469108497|FG000|Overall Study|Death|1|||
130312341|NCT02464410|469108498|FG000|Overall Study|Death|3|||
130312342|NCT02464410|469108499|FG001|Overall Study|Death|4|||
130312343|NCT02464410|469108498|FG000|Overall Study|Lost to Follow-up|7|||
130312344|NCT02464410|469108499|FG001|Overall Study|Lost to Follow-up|9|||
130312345|NCT02464410|469108498|FG000|Overall Study|Withdrawal by Subject|12|||
130312346|NCT02464410|469108499|FG001|Overall Study|Withdrawal by Subject|3|||
130312347|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
130312348|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
130312349|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
130312350|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
130312351|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
130312352|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
130312353|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
130312354|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
130374674|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374675|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374676|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130374677|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
130374678|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
130374679|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
130374680|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374681|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374682|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374683|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374684|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374685|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374686|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374687|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130374688|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374689|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
130312355|NCT02679287|469108510|FG000|Period 2|Work/Scheduling Conflict|1|||
130312356|NCT02679287|469108511|FG001|Period 2|Work/Scheduling Conflict|0|||
130312357|NCT02679287|469108510|FG000|Period 2|Disliked Mobile System|2|||
130312358|NCT02679287|469108511|FG001|Period 2|Disliked Mobile System|0|||
130312359|NCT02679287|469108510|FG000|Period 3|Work/Scheduling Conflict|0|||
130312360|NCT02679287|469108511|FG001|Period 3|Work/Scheduling Conflict|1|||
130312361|NCT01045694|469108513|FG000|Overall Study|Withdrawal by Subject|2|||
130312362|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Death|2|||
130312363|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Death|0|||
130312364|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Death|0|||
130312365|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
130312366|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130312367|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130312368|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130312369|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130312370|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
130312371|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130312372|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
130312373|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130312374|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
130312375|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
130312376|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
130312377|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
130312378|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130312379|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130312380|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Death|2|||
130312381|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Death|0|||
130312382|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Death|0|||
130312383|NCT00992459|469108524|FG000|Overall Study|Withdrawal by Subject|0|||
130312384|NCT00992459|469108525|FG001|Overall Study|Withdrawal by Subject|1|||
130312385|NCT00992459|469108524|FG000|Overall Study|Adverse Event|1|||
130312386|NCT00992459|469108525|FG001|Overall Study|Adverse Event|0|||
130312387|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Adverse Event|0|||
130312388|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Adverse Event|1|||
130312389|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Adverse Event|0|||
130312390|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Adverse Event|0|||
130312391|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Adverse Event|0|||
130312392|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Adverse Event|0|||
130312393|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Adverse Event|0|||
130312394|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Adverse Event|1|||
130312395|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Adverse Event|1|||
130312396|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Adverse Event|0|||
130312397|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Adverse Event|0|||
130312398|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Physician Decision|0|||
130312399|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Physician Decision|0|||
130312400|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Physician Decision|1|||
130312401|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Physician Decision|0|||
130312402|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Physician Decision|0|||
130312403|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Physician Decision|0|||
130312404|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Physician Decision|0|||
130312405|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Physician Decision|1|||
130312406|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Physician Decision|0|||
130312407|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Physician Decision|0|||
130312408|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Physician Decision|0|||
130312409|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312410|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130312411|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130312412|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312413|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312414|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312415|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
130312416|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130312417|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130312418|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130312419|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130312420|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312421|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130558345|NCT00375219|470013214|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
130312422|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312423|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312424|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130558346|NCT00375219|470013215|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
130312425|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312426|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
130312427|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312428|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312429|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312430|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312431|NCT00543387|469108528|FG000|Crossover Participants|Progressive Disease|0|||
130312432|NCT00543387|469108529|FG001|Crossover Participants|Progressive Disease|0|||
130312433|NCT00543387|469108530|FG002|Crossover Participants|Progressive Disease|0|||
130312434|NCT00543387|469108531|FG003|Crossover Participants|Progressive Disease|0|||
130312435|NCT00543387|469108532|FG004|Crossover Participants|Progressive Disease|0|||
130312436|NCT00543387|469108533|FG005|Crossover Participants|Progressive Disease|0|||
130312437|NCT00543387|469108534|FG006|Crossover Participants|Progressive Disease|0|||
130312438|NCT00543387|469108535|FG007|Crossover Participants|Progressive Disease|0|||
130312439|NCT00543387|469108536|FG008|Crossover Participants|Progressive Disease|0|||
130312440|NCT00543387|469108537|FG009|Crossover Participants|Progressive Disease|1|||
130312441|NCT00543387|469108538|FG010|Crossover Participants|Progressive Disease|2|||
130312442|NCT00543387|469108528|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
130312443|NCT00543387|469108529|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
130312444|NCT00543387|469108530|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
130312445|NCT00543387|469108531|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
130312446|NCT00543387|469108532|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
130312447|NCT00543387|469108533|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
130312448|NCT00543387|469108534|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
130312449|NCT00543387|469108535|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
130312450|NCT00543387|469108536|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
130312451|NCT00543387|469108537|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
130312452|NCT00543387|469108538|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
130312453|NCT01114828|469108539|FG000|Overall Study|Adverse Event|1|||
130312454|NCT01114828|469108540|FG001|Overall Study|Adverse Event|1|||
130312455|NCT01114828|469108539|FG000|Overall Study|Lack of Efficacy|0|||
130312456|NCT01114828|469108540|FG001|Overall Study|Lack of Efficacy|2|||
130312457|NCT01114828|469108539|FG000|Overall Study|Protocol Violation|2|||
130312458|NCT01114828|469108540|FG001|Overall Study|Protocol Violation|0|||
130312459|NCT01114828|469108539|FG000|Overall Study|Withdrawal by Subject|0|||
130312460|NCT01114828|469108540|FG001|Overall Study|Withdrawal by Subject|1|||
130312461|NCT00940498|469108541|FG000|Overall Study|Death|2|||
130312462|NCT00940498|469108542|FG001|Overall Study|Death|0|||
130312463|NCT00940498|469108543|FG002|Overall Study|Death|0|||
130312464|NCT00940498|469108544|FG003|Overall Study|Death|1|||
130312465|NCT00940498|469108545|FG004|Overall Study|Death|5|||
130312466|NCT00940498|469108546|FG005|Overall Study|Death|0|||
130312467|NCT00940498|469108547|FG006|Overall Study|Death|1|||
130312468|NCT00940498|469108548|FG007|Overall Study|Death|0|||
130312469|NCT00940498|469108541|FG000|Overall Study|Lost to Follow-up|1|||
130312470|NCT00940498|469108542|FG001|Overall Study|Lost to Follow-up|1|||
130312471|NCT00940498|469108543|FG002|Overall Study|Lost to Follow-up|2|||
130312472|NCT00940498|469108544|FG003|Overall Study|Lost to Follow-up|0|||
130312473|NCT00940498|469108545|FG004|Overall Study|Lost to Follow-up|1|||
130312474|NCT00940498|469108546|FG005|Overall Study|Lost to Follow-up|0|||
130312475|NCT00940498|469108547|FG006|Overall Study|Lost to Follow-up|0|||
130312476|NCT00940498|469108548|FG007|Overall Study|Lost to Follow-up|1|||
130312477|NCT00940498|469108541|FG000|Overall Study|Disease Progression|0|||
130312478|NCT00940498|469108542|FG001|Overall Study|Disease Progression|0|||
130312479|NCT00940498|469108543|FG002|Overall Study|Disease Progression|1|||
130312480|NCT00940498|469108544|FG003|Overall Study|Disease Progression|1|||
130312481|NCT00940498|469108545|FG004|Overall Study|Disease Progression|0|||
130312482|NCT00940498|469108546|FG005|Overall Study|Disease Progression|1|||
130312483|NCT00940498|469108547|FG006|Overall Study|Disease Progression|0|||
130312484|NCT00940498|469108548|FG007|Overall Study|Disease Progression|0|||
130312485|NCT00940498|469108541|FG000|Overall Study|Physician Decision|0|||
130312486|NCT00940498|469108542|FG001|Overall Study|Physician Decision|0|||
130312487|NCT00940498|469108543|FG002|Overall Study|Physician Decision|0|||
130312488|NCT00940498|469108544|FG003|Overall Study|Physician Decision|0|||
130312489|NCT00940498|469108545|FG004|Overall Study|Physician Decision|2|||
130312490|NCT00940498|469108546|FG005|Overall Study|Physician Decision|0|||
130312491|NCT00940498|469108547|FG006|Overall Study|Physician Decision|0|||
130312492|NCT00940498|469108548|FG007|Overall Study|Physician Decision|0|||
130312493|NCT00940498|469108541|FG000|Overall Study|Not treated due to disease related pain|0|||
130718917|NCT01398514|470597267|FG001|Overall Study|Non-compliance with study procedures|0|||
130718918|NCT01398514|470597266|FG000|Overall Study|Physiologic non-responsiveness|1|||
130312494|NCT00940498|469108542|FG001|Overall Study|Not treated due to disease related pain|0|||
130465472|NCT02675244|469671930|FG001|Overall Study|Ongoing at 2 Years|185|||
130465473|NCT01839331|469671931|FG000|Overall Study|Early Termination|3|||
130465474|NCT01839331|469671932|FG001|Overall Study|Early Termination|0|||
130465475|NCT01839331|469671933|FG002|Overall Study|Early Termination|1|||
130558347|NCT00375219|470013213|FG000|Overall Study|Lost to Follow-up|1|||
130558348|NCT00375219|470013214|FG001|Overall Study|Lost to Follow-up|1|||
130558349|NCT00375219|470013215|FG002|Overall Study|Lost to Follow-up|0|||
130558350|NCT00375219|470013213|FG000|Overall Study|Disease progression|18|||
130558351|NCT00375219|470013214|FG001|Overall Study|Disease progression|9|||
130558352|NCT00375219|470013215|FG002|Overall Study|Disease progression|12|||
130558353|NCT00375219|470013213|FG000|Overall Study|Death|4|||
130558354|NCT00375219|470013214|FG001|Overall Study|Death|3|||
130558355|NCT00375219|470013215|FG002|Overall Study|Death|7|||
130558356|NCT00375219|470013213|FG000|Overall Study|Hematologic resistance|1|||
130558357|NCT00375219|470013214|FG001|Overall Study|Hematologic resistance|0|||
130558358|NCT00375219|470013215|FG002|Overall Study|Hematologic resistance|0|||
130558359|NCT00375219|470013213|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
130558360|NCT00375219|470013214|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
130558361|NCT00375219|470013215|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
130558362|NCT00375219|470013213|FG000|Overall Study|Allograft|2|||
130558363|NCT00375219|470013214|FG001|Overall Study|Allograft|0|||
130558364|NCT00375219|470013215|FG002|Overall Study|Allograft|0|||
130558365|NCT00375219|470013213|FG000|Overall Study|Cord blood transplantation|1|||
130558366|NCT00375219|470013214|FG001|Overall Study|Cord blood transplantation|0|||
130558367|NCT00375219|470013215|FG002|Overall Study|Cord blood transplantation|0|||
130558368|NCT00375219|470013213|FG000|Overall Study|Withdrawal by Subject|1|||
130558369|NCT00375219|470013214|FG001|Overall Study|Withdrawal by Subject|0|||
130558370|NCT00375219|470013215|FG002|Overall Study|Withdrawal by Subject|0|||
130558371|NCT01667107|470013216|FG000|Overall Study|Adverse Event|4|||
130558372|NCT01667107|470013217|FG001|Overall Study|Adverse Event|3|||
130558373|NCT01667107|470013216|FG000|Overall Study|Tolerability issues|0|||
130558374|NCT01667107|470013217|FG001|Overall Study|Tolerability issues|2|||
130558375|NCT01667107|470013216|FG000|Overall Study|Protocol Violation|0|||
130558376|NCT01667107|470013217|FG001|Overall Study|Protocol Violation|1|||
130558377|NCT01667107|470013216|FG000|Overall Study|Lack of Efficacy|0|||
130558378|NCT01667107|470013217|FG001|Overall Study|Lack of Efficacy|1|||
130558379|NCT01162239|470013218|FG000|Treatment Phase|Withdrawal by Subject|1|||
130558380|NCT01162239|470013219|FG001|Treatment Phase|Withdrawal by Subject|3|||
130558381|NCT01162239|470013220|FG002|Treatment Phase|Withdrawal by Subject|2|||
130558382|NCT01162239|470013221|FG003|Treatment Phase|Withdrawal by Subject|3|||
130558383|NCT01162239|470013218|FG000|Treatment Phase|Death|0|||
130558384|NCT01162239|470013219|FG001|Treatment Phase|Death|0|||
130558385|NCT01162239|470013220|FG002|Treatment Phase|Death|0|||
130558386|NCT01162239|470013221|FG003|Treatment Phase|Death|1|||
130558387|NCT01162239|470013218|FG000|Treatment Phase|Lost to Follow-up|5|||
130558388|NCT01162239|470013219|FG001|Treatment Phase|Lost to Follow-up|4|||
130558389|NCT01162239|470013220|FG002|Treatment Phase|Lost to Follow-up|2|||
130558390|NCT01162239|470013221|FG003|Treatment Phase|Lost to Follow-up|1|||
130558391|NCT01162239|470013218|FG000|Extended Follow-up|Lost to Follow-up|8|||
130558392|NCT01162239|470013219|FG001|Extended Follow-up|Lost to Follow-up|13|||
130558393|NCT01162239|470013220|FG002|Extended Follow-up|Lost to Follow-up|8|||
130558394|NCT01162239|470013221|FG003|Extended Follow-up|Lost to Follow-up|6|||
130558395|NCT00228566|470013222|FG000|Overall Study|Adverse Event|31|||
130558396|NCT00228566|470013222|FG000|Overall Study|Lack of Efficacy|14|||
130558397|NCT00228566|470013222|FG000|Overall Study|Lost to Follow-up|16|||
130558398|NCT00228566|470013222|FG000|Overall Study|Physician Decision|5|||
130718919|NCT01398514|470597267|FG001|Overall Study|Physiologic non-responsiveness|3|||
130374690|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
130374691|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374692|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374693|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374694|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374695|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374696|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130558399|NCT00228566|470013222|FG000|Overall Study|Withdrawal by Subject|4|||
130718920|NCT01398514|470597266|FG000|Overall Study|Failure to show a conditioned response|4|||
130718921|NCT01398514|470597267|FG001|Overall Study|Failure to show a conditioned response|3|||
130374697|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130558400|NCT00228566|470013222|FG000|Overall Study|Miscellaneous|1|||
130558401|NCT04448756|470013223|FG000|Overall Study|Adverse Event|0|||
130558402|NCT04448756|470013224|FG001|Overall Study|Adverse Event|1|||
130558403|NCT04448756|470013225|FG002|Overall Study|Adverse Event|0|||
130558404|NCT04448756|470013223|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
130558405|NCT04448756|470013224|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
130558406|NCT04448756|470013225|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
130558407|NCT04448756|470013223|FG000|Overall Study|Withdrawal by Subject|0|||
130558408|NCT04448756|470013224|FG001|Overall Study|Withdrawal by Subject|3|||
130558409|NCT04448756|470013225|FG002|Overall Study|Withdrawal by Subject|1|||
130558410|NCT04448756|470013223|FG000|Overall Study|Death|2|||
130558411|NCT04448756|470013224|FG001|Overall Study|Death|1|||
130558412|NCT04448756|470013225|FG002|Overall Study|Death|0|||
130374698|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130374699|NCT02207244|469338426|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374700|NCT02207244|469338427|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
130558413|NCT00232141|470013226|FG000|Overall Study|Adverse Event|9|||
130558414|NCT00232141|470013227|FG001|Overall Study|Adverse Event|4|||
130558415|NCT00232141|470013226|FG000|Overall Study|Lack of Efficacy|0|||
130558416|NCT00232141|470013227|FG001|Overall Study|Lack of Efficacy|3|||
130558417|NCT00232141|470013226|FG000|Overall Study|Lost to Follow-up|9|||
130374701|NCT02207244|469338428|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374702|NCT02207244|469338429|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374703|NCT02207244|469338430|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374704|NCT02207244|469338431|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374705|NCT02207244|469338432|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374706|NCT02207244|469338433|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374707|NCT02207244|469338434|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374708|NCT02207244|469338435|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374709|NCT02207244|469338436|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
130374710|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130465476|NCT01839331|469671934|FG003|Overall Study|Early Termination|2|||
130465477|NCT01839331|469671931|FG000|Overall Study|Protocol Violation|1|||
130465478|NCT01839331|469671932|FG001|Overall Study|Protocol Violation|6|||
130465479|NCT01839331|469671933|FG002|Overall Study|Protocol Violation|4|||
130465480|NCT01839331|469671934|FG003|Overall Study|Protocol Violation|3|||
130465481|NCT03752151|469671935|FG000|Overall Study|Withdrawal by Subject|1|||
130465482|NCT03752151|469671935|FG000|Overall Study|Protocol Violation|1|||
130465483|NCT00529516|469671936|FG000|Overall Study|Adverse Event|2|||
130465484|NCT00529516|469671937|FG001|Overall Study|Adverse Event|1|||
130465485|NCT00529516|469671938|FG002|Overall Study|Adverse Event|0|||
130465486|NCT00529516|469671936|FG000|Overall Study|Withdrawal by Subject|1|||
130465487|NCT00529516|469671937|FG001|Overall Study|Withdrawal by Subject|1|||
130465488|NCT00529516|469671938|FG002|Overall Study|Withdrawal by Subject|0|||
130465489|NCT00529516|469671936|FG000|Overall Study|Lost to Follow-up|0|||
130465490|NCT00529516|469671937|FG001|Overall Study|Lost to Follow-up|0|||
130465491|NCT00529516|469671938|FG002|Overall Study|Lost to Follow-up|1|||
130465492|NCT04056624|469671939|FG000|Overall Study|Withdrawal by Subject|0|||
130465493|NCT04056624|469671940|FG001|Overall Study|Withdrawal by Subject|0|||
130465494|NCT04056624|469671941|FG002|Overall Study|Withdrawal by Subject|1|||
130465495|NCT04056624|469671939|FG000|Overall Study|Protocol Violation|1|||
130465496|NCT04056624|469671940|FG001|Overall Study|Protocol Violation|2|||
130465497|NCT04056624|469671941|FG002|Overall Study|Protocol Violation|0|||
130465498|NCT03051165|469671946|FG000|Overall Study|Withdrawal by Subject|1|||
130465499|NCT03051165|469671946|FG000|Overall Study|Early termination of study|12|||
130465500|NCT02092116|469671948|FG000|Overall Study|Withdrawal by Subject|0|||
130465501|NCT02092116|469671949|FG001|Overall Study|Withdrawal by Subject|3|||
130465502|NCT02092116|469671948|FG000|Overall Study|Adverse Event|0|||
130465503|NCT02092116|469671949|FG001|Overall Study|Adverse Event|1|||
130465504|NCT03531840|469671950|FG000|Overall Study|Death on study|3|||
130465505|NCT03531840|469671951|FG001|Overall Study|Death on study|2|||
130465506|NCT03531840|469671952|FG002|Overall Study|Death on study|1|||
130465507|NCT03531840|469671953|FG003|Overall Study|Death on study|2|||
130465508|NCT03531840|469671950|FG000|Overall Study|Death during follow up|2|||
130465509|NCT03531840|469671951|FG001|Overall Study|Death during follow up|3|||
130465510|NCT03531840|469671952|FG002|Overall Study|Death during follow up|4|||
130465511|NCT03531840|469671953|FG003|Overall Study|Death during follow up|1|||
130465512|NCT00761605|469671955|FG000|Overall Study|Adverse Event|26|||
130465513|NCT00761605|469671955|FG000|Overall Study|Death|2|||
130465514|NCT00761605|469671955|FG000|Overall Study|Lack of Efficacy|26|||
130465515|NCT00761605|469671955|FG000|Overall Study|Lost to Follow-up|29|||
130465516|NCT00761605|469671955|FG000|Overall Study|Withdrawal by Subject|37|||
130465517|NCT00761605|469671955|FG000|Overall Study|Other|21|||
130465518|NCT02267824|469671956|FG000|Overall Study|Pregnancy|1|||
130465519|NCT02267824|469671957|FG001|Overall Study|Pregnancy|1|||
130465520|NCT02267824|469671956|FG000|Overall Study|Lost to Follow-up|4|||
130465521|NCT02267824|469671957|FG001|Overall Study|Lost to Follow-up|0|||
130558418|NCT00232141|470013227|FG001|Overall Study|Lost to Follow-up|6|||
130465522|NCT02267824|469671956|FG000|Overall Study|Protocol Violation|3|||
130465523|NCT02267824|469671957|FG001|Overall Study|Protocol Violation|0|||
130465524|NCT02267824|469671956|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
130465525|NCT02267824|469671957|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
130465526|NCT03074331|469671958|FG000|Overall Study|Enrolled but Not Treated|1|||
130465527|NCT03074331|469671958|FG000|Overall Study|Lost to Follow-up|5|||
130465528|NCT03074331|469671958|FG000|Overall Study|Withdrew Consent|1|||
130465529|NCT03451721|469671960|FG000|Overall Study|Death|1|||
130465530|NCT01985334|469671962|FG000|Overall Study|Administrative problems|1|||
130465531|NCT01985334|469671963|FG001|Overall Study|Administrative problems|1|||
130558419|NCT00232141|470013226|FG000|Overall Study|Other|8|||
130374711|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374712|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130558420|NCT00232141|470013227|FG001|Overall Study|Other|10|||
130558421|NCT00232141|470013226|FG000|Overall Study|Withdrawal by Subject|5|||
130558422|NCT00232141|470013227|FG001|Overall Study|Withdrawal by Subject|3|||
130558423|NCT01479829|470013228|FG000|Overall Study|Withdrawal by Subject|8|||
130558424|NCT01479829|470013229|FG001|Overall Study|Withdrawal by Subject|10|||
130558425|NCT00601250|470013230|FG000|Overall Study|Adverse Event|3|||
130558426|NCT00601250|470013231|FG001|Overall Study|Adverse Event|9|||
130558427|NCT00601250|470013230|FG000|Overall Study|Protocol Violation|3|||
130558428|NCT00601250|470013231|FG001|Overall Study|Protocol Violation|2|||
130558429|NCT00601250|470013230|FG000|Overall Study|Lost to Follow-up|2|||
130558430|NCT00601250|470013231|FG001|Overall Study|Lost to Follow-up|6|||
130558431|NCT00601250|470013230|FG000|Overall Study|Withdrawal by Subject|4|||
130558432|NCT00601250|470013231|FG001|Overall Study|Withdrawal by Subject|13|||
130558433|NCT00601250|470013230|FG000|Overall Study|Other incl. lack of efficacy|2|||
130558434|NCT00601250|470013231|FG001|Overall Study|Other incl. lack of efficacy|9|||
130558435|NCT01791803|470013232|FG000|Overall Study|Withdrawal by Subject|0|||
130558436|NCT01791803|470013233|FG001|Overall Study|Withdrawal by Subject|0|||
130558437|NCT01791803|470013234|FG002|Overall Study|Withdrawal by Subject|0|||
130558438|NCT01791803|470013235|FG003|Overall Study|Withdrawal by Subject|2|||
130558439|NCT01791803|470013232|FG000|Overall Study|Physician Decision|0|||
130558440|NCT01791803|470013233|FG001|Overall Study|Physician Decision|2|||
130558441|NCT01791803|470013234|FG002|Overall Study|Physician Decision|0|||
130558442|NCT01791803|470013235|FG003|Overall Study|Physician Decision|1|||
130558443|NCT01791803|470013232|FG000|Overall Study|Death|0|||
130558444|NCT01791803|470013233|FG001|Overall Study|Death|0|||
130558445|NCT01791803|470013234|FG002|Overall Study|Death|2|||
130558446|NCT01791803|470013235|FG003|Overall Study|Death|2|||
130558447|NCT04572854|470013236|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
130558448|NCT04572854|470013237|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
130558449|NCT04572854|470013238|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
130558450|NCT04572854|470013239|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
130558451|NCT04572854|470013236|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130558452|NCT04572854|470013237|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130558453|NCT04572854|470013238|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
130558454|NCT04572854|470013239|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130558455|NCT01444456|470013241|FG000|Overall Study|Withdrawal by Subject|21|||
130558456|NCT01444456|470013241|FG000|Overall Study|Physician Decision|9|||
130558457|NCT01444456|470013241|FG000|Overall Study|Lost to Follow-up|37|||
130558458|NCT01444456|470013241|FG000|Overall Study|Death|73|||
130558459|NCT01444456|470013241|FG000|Overall Study|Ineligibility determined|23|||
130558460|NCT01444456|470013241|FG000|Overall Study|Other|18|||
130558461|NCT01444456|470013241|FG000|Overall Study|Not treated|104|||
130558462|NCT00523718|470014806|FG000|Overall Study|Withdrawal by Subject|1|||
130558463|NCT00523718|470014807|FG001|Overall Study|Withdrawal by Subject|0|||
130558464|NCT00523718|470014806|FG000|Overall Study|Protocol Violation|2|||
130558465|NCT00523718|470014807|FG001|Overall Study|Protocol Violation|0|||
130558466|NCT03441334|470014808|FG000|Overall Study|Withdrawal by Subject|1|||
130558467|NCT03441334|470014809|FG001|Overall Study|Withdrawal by Subject|0|||
130558468|NCT02615470|470014813|FG000|Overall Study|Lost to Follow-up|21|||
130558469|NCT02615470|470014814|FG001|Overall Study|Lost to Follow-up|32|||
130558470|NCT01650285|470014817|FG000|Overall Study|Adverse Event|1|||
130558471|NCT00659529|470014818|FG000|Overall Study|Withdrawal by Subject|4|||
130558472|NCT00659529|470014818|FG000|Overall Study|Protocol Violation|3|||
130558473|NCT00659529|470014818|FG000|Overall Study|Screen failure|9|||
130558474|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
130558475|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130558476|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130374713|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374714|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
130374715|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
130374716|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374717|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374718|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374719|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130558477|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130558478|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130558479|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
130558480|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130558481|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130558482|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130558483|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130558484|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
130312495|NCT00940498|469108543|FG002|Overall Study|Not treated due to disease related pain|0|||
130312496|NCT00940498|469108544|FG003|Overall Study|Not treated due to disease related pain|0|||
130312497|NCT00940498|469108545|FG004|Overall Study|Not treated due to disease related pain|1|||
130312498|NCT00940498|469108546|FG005|Overall Study|Not treated due to disease related pain|0|||
130312499|NCT00940498|469108547|FG006|Overall Study|Not treated due to disease related pain|0|||
130312500|NCT00940498|469108548|FG007|Overall Study|Not treated due to disease related pain|0|||
130312501|NCT00549445|469108549|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
130312502|NCT00549445|469108550|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
130312503|NCT03932760|469108551|FG000|Overall Study|Became Ineligible|2|||
130312504|NCT03932760|469108552|FG001|Overall Study|Became Ineligible|5|||
130312505|NCT03932760|469108551|FG000|Overall Study|Withdrawal by Subject|6|||
130312506|NCT03932760|469108552|FG001|Overall Study|Withdrawal by Subject|6|||
130312507|NCT03566082|469108553|FG000|Overall Study|Death|7|||
130312508|NCT03566082|469108553|FG000|Overall Study|Failures (revision required)|2|||
130312509|NCT03566082|469108553|FG000|Overall Study|Lost to Follow-up|8|||
130312510|NCT00227721|469109912|FG000|Overall Study|On study, but never treated.|1|||
130312511|NCT01389882|469109917|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
130312512|NCT01389882|469109918|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
130312513|NCT01389882|469109917|FG000|Overall Study|Withdrawal by Subject|0|||
130312514|NCT01389882|469109918|FG001|Overall Study|Withdrawal by Subject|1|||
130312515|NCT00961181|469109919|FG000|Overall Study|Death|2|||
130312516|NCT00961181|469109919|FG000|Overall Study|Withdrawal by Subject|2|||
130312517|NCT00961181|469109919|FG000|Overall Study|Lost to Follow-up|1|||
130312518|NCT00280917|469109920|FG000|Overall Study|Adverse Event|1|||
130312519|NCT00280917|469109921|FG001|Overall Study|Adverse Event|1|||
130312520|NCT00280917|469109922|FG002|Overall Study|Adverse Event|4|||
130312521|NCT00280917|469109923|FG003|Overall Study|Adverse Event|1|||
130312522|NCT00280917|469109920|FG000|Overall Study|Change Therapy|1|||
130312523|NCT00280917|469109921|FG001|Overall Study|Change Therapy|2|||
130312524|NCT00280917|469109922|FG002|Overall Study|Change Therapy|0|||
130312525|NCT00280917|469109923|FG003|Overall Study|Change Therapy|0|||
130312526|NCT00280917|469109920|FG000|Overall Study|Withdrawal by Subject|0|||
130312527|NCT00280917|469109921|FG001|Overall Study|Withdrawal by Subject|2|||
130312528|NCT00280917|469109922|FG002|Overall Study|Withdrawal by Subject|0|||
130312529|NCT00280917|469109923|FG003|Overall Study|Withdrawal by Subject|1|||
130312530|NCT00280917|469109920|FG000|Overall Study|Noncompliance|0|||
130312531|NCT00280917|469109921|FG001|Overall Study|Noncompliance|1|||
130312532|NCT00280917|469109922|FG002|Overall Study|Noncompliance|2|||
130312533|NCT00280917|469109923|FG003|Overall Study|Noncompliance|0|||
130312534|NCT01276639|469109938|FG000|Week 0 to 16|Death|1|||
130312535|NCT01276639|469109939|FG001|Week 0 to 16|Death|0|||
130312536|NCT01276639|469109940|FG002|Week 0 to 16|Death|0|||
130312537|NCT01276639|469109941|FG003|Week 0 to 16|Death|0|||
130312538|NCT01276639|469109942|FG004|Week 0 to 16|Death|0|||
130312539|NCT01276639|469109938|FG000|Week 0 to 16|Adverse Event|11|||
130312540|NCT01276639|469109939|FG001|Week 0 to 16|Adverse Event|8|||
130312541|NCT01276639|469109940|FG002|Week 0 to 16|Adverse Event|11|||
130312542|NCT01276639|469109941|FG003|Week 0 to 16|Adverse Event|0|||
130312543|NCT01276639|469109942|FG004|Week 0 to 16|Adverse Event|0|||
130312544|NCT01276639|469109938|FG000|Week 0 to 16|Lack of Efficacy|20|||
130312545|NCT01276639|469109939|FG001|Week 0 to 16|Lack of Efficacy|15|||
130312546|NCT01276639|469109940|FG002|Week 0 to 16|Lack of Efficacy|25|||
130312547|NCT01276639|469109941|FG003|Week 0 to 16|Lack of Efficacy|0|||
130312548|NCT01276639|469109942|FG004|Week 0 to 16|Lack of Efficacy|0|||
130312549|NCT01276639|469109938|FG000|Week 0 to 16|Lost to Follow-up|3|||
130312550|NCT01276639|469109939|FG001|Week 0 to 16|Lost to Follow-up|5|||
130312551|NCT01276639|469109940|FG002|Week 0 to 16|Lost to Follow-up|3|||
130312552|NCT01276639|469109941|FG003|Week 0 to 16|Lost to Follow-up|0|||
130312553|NCT01276639|469109942|FG004|Week 0 to 16|Lost to Follow-up|0|||
130312554|NCT01276639|469109938|FG000|Week 0 to 16|Withdrawal by Subject|8|||
130312555|NCT01276639|469109939|FG001|Week 0 to 16|Withdrawal by Subject|5|||
130312556|NCT01276639|469109940|FG002|Week 0 to 16|Withdrawal by Subject|4|||
130312557|NCT01276639|469109941|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130312558|NCT01276639|469109942|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130312559|NCT01276639|469109938|FG000|Week 0 to 16|Other|7|||
130312560|NCT01276639|469109939|FG001|Week 0 to 16|Other|7|||
130312561|NCT01276639|469109940|FG002|Week 0 to 16|Other|2|||
130374720|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130374721|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130312562|NCT01276639|469109941|FG003|Week 0 to 16|Other|0|||
130312563|NCT01276639|469109942|FG004|Week 0 to 16|Other|0|||
130312564|NCT01276639|469109938|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
130312565|NCT01276639|469109939|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
130312566|NCT01276639|469109940|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
130312567|NCT01276639|469109941|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
130312568|NCT01276639|469109942|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
130312569|NCT01276639|469109938|FG000|Week 16 to 52|Death|1|||
130312570|NCT01276639|469109939|FG001|Week 16 to 52|Death|0|||
130312571|NCT01276639|469109940|FG002|Week 16 to 52|Death|0|||
130312572|NCT01276639|469109941|FG003|Week 16 to 52|Death|0|||
130312573|NCT01276639|469109942|FG004|Week 16 to 52|Death|0|||
130312574|NCT01276639|469109938|FG000|Week 16 to 52|Adverse Event|10|||
130312575|NCT01276639|469109939|FG001|Week 16 to 52|Adverse Event|13|||
130312576|NCT01276639|469109940|FG002|Week 16 to 52|Adverse Event|0|||
130312577|NCT01276639|469109941|FG003|Week 16 to 52|Adverse Event|1|||
130312578|NCT01276639|469109942|FG004|Week 16 to 52|Adverse Event|3|||
130312579|NCT01276639|469109938|FG000|Week 16 to 52|Lack of Efficacy|99|||
130312580|NCT01276639|469109939|FG001|Week 16 to 52|Lack of Efficacy|71|||
130312581|NCT01276639|469109940|FG002|Week 16 to 52|Lack of Efficacy|0|||
130312582|NCT01276639|469109941|FG003|Week 16 to 52|Lack of Efficacy|14|||
130312583|NCT01276639|469109942|FG004|Week 16 to 52|Lack of Efficacy|13|||
130312584|NCT01276639|469109938|FG000|Week 16 to 52|Lost to Follow-up|3|||
130312585|NCT01276639|469109939|FG001|Week 16 to 52|Lost to Follow-up|1|||
130312586|NCT01276639|469109940|FG002|Week 16 to 52|Lost to Follow-up|0|||
130312587|NCT01276639|469109941|FG003|Week 16 to 52|Lost to Follow-up|0|||
130718922|NCT02771795|470597268|FG000|Overall Study|Withdrawal by Subject|47|||
130718923|NCT02771795|470597269|FG001|Overall Study|Withdrawal by Subject|37|||
130718924|NCT02771795|470597268|FG000|Overall Study|Termination by premature discontinuation of study|168|||
130718925|NCT02771795|470597269|FG001|Overall Study|Termination by premature discontinuation of study|185|||
130312588|NCT01276639|469109942|FG004|Week 16 to 52|Lost to Follow-up|1|||
130312589|NCT01276639|469109938|FG000|Week 16 to 52|Withdrawal by Subject|4|||
130312590|NCT01276639|469109939|FG001|Week 16 to 52|Withdrawal by Subject|4|||
130312591|NCT01276639|469109940|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130312592|NCT01276639|469109941|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130312593|NCT01276639|469109942|FG004|Week 16 to 52|Withdrawal by Subject|1|||
130312594|NCT01276639|469109938|FG000|Week 16 to 52|Other|10|||
130312595|NCT01276639|469109939|FG001|Week 16 to 52|Other|12|||
130312596|NCT01276639|469109940|FG002|Week 16 to 52|Other|0|||
130312597|NCT01276639|469109941|FG003|Week 16 to 52|Other|1|||
130312598|NCT01276639|469109942|FG004|Week 16 to 52|Other|3|||
130312599|NCT00466440|469109947|FG000|Overall Study|Adverse Event|0|||
130312600|NCT00466440|469109948|FG001|Overall Study|Adverse Event|3|||
130312601|NCT00466440|469109949|FG002|Overall Study|Adverse Event|1|||
130312602|NCT00466440|469109947|FG000|Overall Study|Death|1|||
130312603|NCT00466440|469109948|FG001|Overall Study|Death|1|||
130718926|NCT01345175|470597274|FG000|Overall Study|Physician Decision|0|||
130718927|NCT01345175|470597275|FG001|Overall Study|Physician Decision|1|||
130718928|NCT01345175|470597274|FG000|Overall Study|Withdrawal by Subject|1|||
130718929|NCT01345175|470597275|FG001|Overall Study|Withdrawal by Subject|1|||
130718930|NCT01345175|470597274|FG000|Overall Study|Failed to complete BFI|3|||
130718931|NCT01345175|470597275|FG001|Overall Study|Failed to complete BFI|2|||
130718932|NCT01345175|470597274|FG000|Overall Study|Stopped taking medication|2|||
130718933|NCT01345175|470597275|FG001|Overall Study|Stopped taking medication|2|||
130718934|NCT04112173|470597276|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
130718935|NCT02570113|470597286|FG000|Overall Study|Withdrawal by Subject|3|||
130718936|NCT00910091|470597287|FG000|Pre-assignment|Withdrawal by Subject|0|||
130718937|NCT00910091|470597288|FG001|Pre-assignment|Withdrawal by Subject|2|||
130718938|NCT00910091|470597287|FG000|Treatment and Survival|Withdrawal by Subject|3|||
130718939|NCT00910091|470597288|FG001|Treatment and Survival|Withdrawal by Subject|4|||
130718940|NCT00910091|470597287|FG000|Treatment and Survival|Adverse Event|1|||
130718941|NCT00910091|470597288|FG001|Treatment and Survival|Adverse Event|0|||
130718942|NCT00622466|470597289|FG000|Overall Study|Death|1|||
130718943|NCT00622466|470597289|FG000|Overall Study|Adverse Event|1|||
130718944|NCT00622466|470597289|FG000|Overall Study|Withdrawal by Subject|2|||
130718945|NCT01908816|470597292|FG000|Overall Study|Subject's no longer requires study drug|0|||
130718946|NCT01908816|470597293|FG001|Overall Study|Subject's no longer requires study drug|0|||
130718947|NCT01908816|470597294|FG002|Overall Study|Subject's no longer requires study drug|0|||
130718948|NCT01908816|470597295|FG003|Overall Study|Subject's no longer requires study drug|1|||
130718949|NCT01908816|470597292|FG000|Overall Study|Protocol deviation|1|||
130718950|NCT01908816|470597293|FG001|Overall Study|Protocol deviation|2|||
130718951|NCT01908816|470597294|FG002|Overall Study|Protocol deviation|1|||
130718952|NCT01908816|470597295|FG003|Overall Study|Protocol deviation|1|||
130718953|NCT01908816|470597292|FG000|Overall Study|Withdrawal by Subject|0|||
130718954|NCT01908816|470597293|FG001|Overall Study|Withdrawal by Subject|4|||
130718955|NCT01908816|470597294|FG002|Overall Study|Withdrawal by Subject|2|||
130312604|NCT00466440|469109949|FG002|Overall Study|Death|0|||
130312605|NCT00466440|469109947|FG000|Overall Study|Progressive disease|13|||
130312606|NCT00466440|469109948|FG001|Overall Study|Progressive disease|5|||
130312607|NCT00466440|469109949|FG002|Overall Study|Progressive disease|4|||
130312608|NCT00466440|469109947|FG000|Overall Study|Lost to Follow-up|0|||
130312609|NCT00466440|469109948|FG001|Overall Study|Lost to Follow-up|1|||
130312610|NCT00466440|469109949|FG002|Overall Study|Lost to Follow-up|0|||
130312611|NCT00466440|469109947|FG000|Overall Study|Physician Decision|0|||
130312612|NCT00466440|469109948|FG001|Overall Study|Physician Decision|1|||
130312613|NCT00466440|469109949|FG002|Overall Study|Physician Decision|2|||
130312614|NCT00466440|469109947|FG000|Overall Study|Protocol entry criteria not met|0|||
130312615|NCT00466440|469109948|FG001|Overall Study|Protocol entry criteria not met|0|||
130312616|NCT00466440|469109949|FG002|Overall Study|Protocol entry criteria not met|4|||
130312617|NCT00466440|469109947|FG000|Overall Study|Withdrawal by Subject|0|||
130312618|NCT00466440|469109948|FG001|Overall Study|Withdrawal by Subject|1|||
130312619|NCT00466440|469109949|FG002|Overall Study|Withdrawal by Subject|0|||
130312620|NCT00466440|469109947|FG000|Overall Study|Sponsor decision|0|||
130312621|NCT00466440|469109948|FG001|Overall Study|Sponsor decision|0|||
130312622|NCT00466440|469109949|FG002|Overall Study|Sponsor decision|1|||
130312623|NCT00965081|469109950|FG000|Overall Study|Adverse Event|14|||
130312624|NCT00965081|469109951|FG001|Overall Study|Adverse Event|9|||
130312625|NCT00965081|469109950|FG000|Overall Study|Lack of Efficacy|2|||
130312626|NCT00965081|469109951|FG001|Overall Study|Lack of Efficacy|5|||
130312627|NCT00965081|469109950|FG000|Overall Study|Lost to Follow-up|4|||
130312628|NCT00965081|469109951|FG001|Overall Study|Lost to Follow-up|5|||
130312629|NCT00965081|469109950|FG000|Overall Study|Physician Decision|2|||
130312630|NCT00965081|469109951|FG001|Overall Study|Physician Decision|0|||
130312631|NCT00965081|469109950|FG000|Overall Study|Protocol Violation|2|||
130312632|NCT00965081|469109951|FG001|Overall Study|Protocol Violation|5|||
130312633|NCT00965081|469109950|FG000|Overall Study|Sponsor Decision|1|||
130312634|NCT00965081|469109951|FG001|Overall Study|Sponsor Decision|0|||
130312635|NCT00965081|469109950|FG000|Overall Study|Withdrawal by Subject|4|||
130312636|NCT00965081|469109951|FG001|Overall Study|Withdrawal by Subject|7|||
130312637|NCT00965081|469109950|FG000|Overall Study|Switched to Rescue Arm|5|||
130312638|NCT00965081|469109951|FG001|Overall Study|Switched to Rescue Arm|12|||
130312639|NCT00796666|469109954|FG000|Overall Study|Death|2|||
130312640|NCT00796666|469109955|FG001|Overall Study|Death|4|||
130312641|NCT00796666|469109954|FG000|Overall Study|Withdrawal by Subject|2|||
130312642|NCT00796666|469109955|FG001|Overall Study|Withdrawal by Subject|0|||
130312643|NCT00796666|469109954|FG000|Overall Study|Adverse Event|7|||
130312644|NCT00796666|469109955|FG001|Overall Study|Adverse Event|5|||
130312645|NCT00796666|469109954|FG000|Overall Study|Protocol Violation|1|||
130312646|NCT00796666|469109955|FG001|Overall Study|Protocol Violation|0|||
130312647|NCT00796666|469109954|FG000|Overall Study|Other|1|||
130312648|NCT00796666|469109955|FG001|Overall Study|Other|0|||
130312649|NCT00796666|469109954|FG000|Overall Study|Terminated by sponsor|53|||
130312650|NCT00796666|469109955|FG001|Overall Study|Terminated by sponsor|55|||
130312651|NCT00796666|469109954|FG000|Overall Study|Randomized and not treated|1|||
130312652|NCT00796666|469109955|FG001|Overall Study|Randomized and not treated|0|||
130312653|NCT00256724|469109958|FG000|Overall Study|Physician Decision|2|||
130312654|NCT00256724|469109959|FG001|Overall Study|Physician Decision|5|||
130312655|NCT00256724|469109958|FG000|Overall Study|Protocol Violation|3|||
130312656|NCT00256724|469109959|FG001|Overall Study|Protocol Violation|3|||
130312657|NCT01217463|469109960|FG000|Overall Study|Adverse Event|8|||
130312658|NCT01217463|469109961|FG001|Overall Study|Adverse Event|5|||
130312659|NCT01217463|469109960|FG000|Overall Study|Physician Decision|0|||
130312660|NCT01217463|469109961|FG001|Overall Study|Physician Decision|1|||
130312661|NCT01217463|469109960|FG000|Overall Study|Withdrawal by Subject|3|||
130312662|NCT01217463|469109961|FG001|Overall Study|Withdrawal by Subject|0|||
130312663|NCT01217463|469109960|FG000|Overall Study|Surgery on the Target Limb|0|||
130312664|NCT01217463|469109961|FG001|Overall Study|Surgery on the Target Limb|1|||
130312665|NCT01217463|469109960|FG000|Overall Study|Patient Non-compliant|1|||
130312666|NCT01217463|469109961|FG001|Overall Study|Patient Non-compliant|0|||
130312667|NCT01217463|469109960|FG000|Overall Study|Other|1|||
130312668|NCT01217463|469109961|FG001|Overall Study|Other|1|||
130312669|NCT02090426|469109965|FG000|Overall Study|Lost to Follow-up|12|||
130312670|NCT02090426|469109966|FG001|Overall Study|Lost to Follow-up|6|||
130312671|NCT01141712|469109967|FG000|Overall Study|Disease progression|3|||
130312672|NCT01012258|469109973|FG000|Overall Study|Death|14|||
130312673|NCT01012258|469109973|FG000|Overall Study|Lost to Follow-up|1|||
130312674|NCT01012258|469109973|FG000|Overall Study|Adverse Event|1|||
130312675|NCT01012258|469109973|FG000|Overall Study|Progressive Disease (PD)|18|||
130312676|NCT01012258|469109973|FG000|Overall Study|Symptomatic Deterioration|1|||
130312677|NCT01012258|469109973|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
130312678|NCT01012258|469109973|FG000|Overall Study|Another Tumor Discovered|1|||
130312679|NCT01012258|469109973|FG000|Overall Study|Ongoing|29|||
130312680|NCT03600740|469109974|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
130312681|NCT03571204|469109975|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
130312682|NCT03571204|469109976|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
130312683|NCT03571204|469109977|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
130312684|NCT03571204|469109975|FG000|Overall Study|Physician Decision|0|||
130312685|NCT03571204|469109976|FG001|Overall Study|Physician Decision|1|||
130312686|NCT03571204|469109977|FG002|Overall Study|Physician Decision|0|||
130312687|NCT02396212|469109978|FG000|Overall Study|Adverse Event|1|||
130312688|NCT02396212|469109978|FG000|Overall Study|Lack of Efficacy|2|||
130312689|NCT01623115|469109979|FG000|Overall Study|Randomized but not treated|0|||
130312690|NCT01623115|469109980|FG001|Overall Study|Randomized but not treated|1|||
130558485|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130558486|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130558487|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130558488|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130558489|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
130558490|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130558491|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130558492|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130558493|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130558494|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
130558495|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130558496|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130374722|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374723|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374724|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374725|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374726|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
130374727|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374728|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374729|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374730|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374731|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130374732|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374733|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374734|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374735|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
130374736|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
130374737|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
130558497|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130558498|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130558499|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
130558500|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130558501|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130374738|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374739|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130558502|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130558503|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130558504|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
130558505|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130374740|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374741|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130374742|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130558506|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130558507|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130558508|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130558509|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
130558510|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130558511|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130558512|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130558513|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130558514|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
130558515|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130558516|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130558517|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130558518|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130558519|NCT03627767|470014825|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
130558520|NCT03627767|470014826|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130558521|NCT03627767|470014827|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130558522|NCT03627767|470014828|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130558523|NCT03627767|470014829|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130558524|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
130558525|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
130558526|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
130558527|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
130558528|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
130558529|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130558530|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130558531|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
130558532|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
130558533|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130558534|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
130558535|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
130558536|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
130558537|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
130558538|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
130558539|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130558540|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
130558541|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
130558542|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
130558543|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130558544|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130558545|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130558546|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
130558547|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130558548|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130558549|NCT03627767|470014825|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
130558550|NCT03627767|470014826|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
130558551|NCT03627767|470014827|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
130558552|NCT03627767|470014828|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
130465532|NCT01985334|469671964|FG002|Overall Study|Administrative problems|0|||
130465533|NCT01985334|469671965|FG003|Overall Study|Administrative problems|2|||
130465534|NCT01985334|469671966|FG004|Overall Study|Administrative problems|0|||
130465535|NCT01985334|469671967|FG005|Overall Study|Administrative problems|1|||
130465536|NCT01985334|469671968|FG006|Overall Study|Administrative problems|1|||
130312691|NCT01623115|469109979|FG000|Overall Study|Physician Decision|1|||
130312692|NCT01623115|469109980|FG001|Overall Study|Physician Decision|0|||
130312693|NCT01623115|469109979|FG000|Overall Study|Participants moved|1|||
130312694|NCT01623115|469109980|FG001|Overall Study|Participants moved|5|||
130312695|NCT01623115|469109979|FG000|Overall Study|Adverse Event|10|||
130465537|NCT01985334|469671969|FG007|Overall Study|Administrative problems|3|||
130465538|NCT01985334|469671962|FG000|Overall Study|Death|1|||
130465539|NCT01985334|469671963|FG001|Overall Study|Death|0|||
130465540|NCT01985334|469671964|FG002|Overall Study|Death|0|||
130465541|NCT01985334|469671965|FG003|Overall Study|Death|3|||
130465542|NCT01985334|469671966|FG004|Overall Study|Death|0|||
130465543|NCT01985334|469671967|FG005|Overall Study|Death|0|||
130465544|NCT01985334|469671968|FG006|Overall Study|Death|1|||
130465545|NCT01985334|469671969|FG007|Overall Study|Death|2|||
130465546|NCT01985334|469671962|FG000|Overall Study|Worsening of disease|0|||
130465547|NCT01985334|469671963|FG001|Overall Study|Worsening of disease|0|||
130465548|NCT01985334|469671964|FG002|Overall Study|Worsening of disease|0|||
130465549|NCT01985334|469671965|FG003|Overall Study|Worsening of disease|1|||
130465550|NCT01985334|469671966|FG004|Overall Study|Worsening of disease|0|||
130465551|NCT01985334|469671967|FG005|Overall Study|Worsening of disease|3|||
130465552|NCT01985334|469671968|FG006|Overall Study|Worsening of disease|0|||
130465553|NCT01985334|469671969|FG007|Overall Study|Worsening of disease|1|||
130465554|NCT01985334|469671962|FG000|Overall Study|Other|2|||
130465555|NCT01985334|469671963|FG001|Overall Study|Other|9|||
130465556|NCT01985334|469671964|FG002|Overall Study|Other|7|||
130465557|NCT01985334|469671965|FG003|Overall Study|Other|17|||
130465558|NCT01985334|469671966|FG004|Overall Study|Other|4|||
130465559|NCT01985334|469671967|FG005|Overall Study|Other|8|||
130465560|NCT01985334|469671968|FG006|Overall Study|Other|4|||
130465561|NCT01985334|469671969|FG007|Overall Study|Other|7|||
130465562|NCT01985334|469671962|FG000|Overall Study|Protocol deviation|6|||
130465563|NCT01985334|469671963|FG001|Overall Study|Protocol deviation|31|||
130718956|NCT01908816|470597295|FG003|Overall Study|Withdrawal by Subject|2|||
130312696|NCT01623115|469109980|FG001|Overall Study|Adverse Event|13|||
130312697|NCT01623115|469109979|FG000|Overall Study|Poor compliance to protocol|4|||
130465564|NCT01985334|469671964|FG002|Overall Study|Protocol deviation|25|||
130465565|NCT01985334|469671965|FG003|Overall Study|Protocol deviation|84|||
130465566|NCT01985334|469671966|FG004|Overall Study|Protocol deviation|17|||
130465567|NCT01985334|469671967|FG005|Overall Study|Protocol deviation|47|||
130465568|NCT01985334|469671968|FG006|Overall Study|Protocol deviation|15|||
130465569|NCT01985334|469671969|FG007|Overall Study|Protocol deviation|42|||
130558553|NCT03627767|470014829|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
130558554|NCT03627767|470014825|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130558555|NCT03627767|470014826|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130558556|NCT03627767|470014827|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130558557|NCT03627767|470014828|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130558558|NCT03627767|470014829|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
130558559|NCT03627767|470014825|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130558560|NCT03627767|470014826|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130558561|NCT03627767|470014827|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130558562|NCT03627767|470014828|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130558563|NCT03627767|470014829|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
130558564|NCT03627767|470014825|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130558565|NCT03627767|470014826|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130558566|NCT03627767|470014827|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130558567|NCT03627767|470014828|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130558568|NCT03627767|470014829|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
130558569|NCT03627767|470014825|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
130558570|NCT03627767|470014826|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
130558571|NCT03627767|470014827|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
130558572|NCT03627767|470014828|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
130558573|NCT03627767|470014829|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
130558574|NCT04163900|470014830|FG000|Overall Study|Radiological disease progression|112|||
130558575|NCT04163900|470014831|FG001|Overall Study|Radiological disease progression|127|||
130558576|NCT04163900|470014830|FG000|Overall Study|Study closure|98|||
130558577|NCT04163900|470014831|FG001|Overall Study|Study closure|133|||
130558578|NCT04163900|470014830|FG000|Overall Study|Adverse Event|78|||
130558579|NCT04163900|470014831|FG001|Overall Study|Adverse Event|32|||
130558580|NCT04163900|470014830|FG000|Overall Study|Withdrawal by Subject|37|||
130558581|NCT04163900|470014831|FG001|Overall Study|Withdrawal by Subject|34|||
130558582|NCT04163900|470014830|FG000|Overall Study|Death|29|||
130558583|NCT04163900|470014831|FG001|Overall Study|Death|16|||
130558584|NCT04163900|470014830|FG000|Overall Study|Physician Decision|17|||
130558585|NCT04163900|470014831|FG001|Overall Study|Physician Decision|25|||
130558586|NCT04163900|470014830|FG000|Overall Study|Clinical disease progression|14|||
130558587|NCT04163900|470014831|FG001|Overall Study|Clinical disease progression|13|||
130558588|NCT04163900|470014830|FG000|Overall Study|Protocol Violation|3|||
130558589|NCT04163900|470014831|FG001|Overall Study|Protocol Violation|4|||
130558590|NCT04163900|470014830|FG000|Overall Study|Lost to Follow-up|0|||
130558591|NCT04163900|470014831|FG001|Overall Study|Lost to Follow-up|1|||
130558592|NCT01873417|470014832|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
130558593|NCT01873417|470014832|FG000|Overall Study|Adverse Event|24|||
130374743|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374744|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374745|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374746|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
130374747|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
130374748|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
130374749|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374750|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374751|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374752|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130558594|NCT01873417|470014832|FG000|Overall Study|Lost to Follow-up|2|||
130558595|NCT01873417|470014832|FG000|Overall Study|Withdrawal by Subject|2|||
130558596|NCT01873417|470014832|FG000|Overall Study|Physician Decision|3|||
130558597|NCT00785044|470014833|FG000|Overall Study|Dosed at non-participating sites|152|||
130558598|NCT00785044|470014833|FG000|Overall Study|Death|77|||
130374753|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130374754|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374755|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374756|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374757|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
130374758|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374759|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
130374760|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374761|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374762|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374763|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374764|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130374765|NCT02207244|469338426|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374766|NCT02207244|469338427|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
130465570|NCT01985334|469671962|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
130465571|NCT01985334|469671963|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
130465572|NCT01985334|469671964|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
130465573|NCT01985334|469671965|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
130465574|NCT01985334|469671966|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
130465575|NCT01985334|469671967|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
130465576|NCT01985334|469671968|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
130465577|NCT01985334|469671969|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
130465578|NCT01985334|469671962|FG000|Overall Study|Subject withdrawal of consent|3|||
130465579|NCT01985334|469671963|FG001|Overall Study|Subject withdrawal of consent|6|||
130465580|NCT01985334|469671964|FG002|Overall Study|Subject withdrawal of consent|2|||
130465581|NCT01985334|469671965|FG003|Overall Study|Subject withdrawal of consent|28|||
130465582|NCT01985334|469671966|FG004|Overall Study|Subject withdrawal of consent|4|||
130718957|NCT01908816|470597292|FG000|Overall Study|Lost to Follow-up|3|||
130718958|NCT01908816|470597293|FG001|Overall Study|Lost to Follow-up|5|||
130718959|NCT01908816|470597294|FG002|Overall Study|Lost to Follow-up|4|||
130312698|NCT01623115|469109980|FG001|Overall Study|Poor compliance to protocol|10|||
130312699|NCT01623115|469109979|FG000|Overall Study|Consent withdrawn by participant|2|||
130312700|NCT01623115|469109980|FG001|Overall Study|Consent withdrawn by participant|6|||
130312701|NCT01623115|469109979|FG000|Overall Study|Related to study drug administration|0|||
130312702|NCT01623115|469109980|FG001|Overall Study|Related to study drug administration|2|||
130312703|NCT01623115|469109979|FG000|Overall Study|Last visit outside protocol visit window|14|||
130312704|NCT01623115|469109980|FG001|Overall Study|Last visit outside protocol visit window|26|||
130312705|NCT01623115|469109979|FG000|Overall Study|Site closure|1|||
130312706|NCT01623115|469109980|FG001|Overall Study|Site closure|7|||
130312707|NCT01623115|469109979|FG000|Overall Study|Death|0|||
130312708|NCT01623115|469109980|FG001|Overall Study|Death|4|||
130312709|NCT01623115|469109979|FG000|Overall Study|Other than specified above|0|||
130312710|NCT01623115|469109980|FG001|Overall Study|Other than specified above|3|||
130312711|NCT01454596|469109983|FG000|Overall Study|Death|0|||
130312712|NCT01454596|469109984|FG001|Overall Study|Death|0|||
130312713|NCT01454596|469109985|FG002|Overall Study|Death|0|||
130312714|NCT01454596|469109986|FG003|Overall Study|Death|0|||
130312715|NCT01454596|469109987|FG004|Overall Study|Death|0|||
130312716|NCT01454596|469109988|FG005|Overall Study|Death|0|||
130312717|NCT01454596|469109989|FG006|Overall Study|Death|0|||
130312718|NCT01454596|469109990|FG007|Overall Study|Death|0|||
130312719|NCT01454596|469109991|FG008|Overall Study|Death|0|||
130312720|NCT01454596|469109992|FG009|Overall Study|Death|1|||
130312721|NCT01454596|469109993|FG010|Overall Study|Death|1|||
130312722|NCT01454596|469109994|FG011|Overall Study|Death|0|||
130312723|NCT00857285|469109996|FG000|Overall Study|Adverse Event|4|||
130312724|NCT00857285|469109997|FG001|Overall Study|Adverse Event|2|||
130312725|NCT00857285|469109996|FG000|Overall Study|Lack of Efficacy|0|||
130312726|NCT00857285|469109997|FG001|Overall Study|Lack of Efficacy|2|||
130312727|NCT00857285|469109996|FG000|Overall Study|Protocol Violation|3|||
130312728|NCT00857285|469109997|FG001|Overall Study|Protocol Violation|1|||
130312729|NCT00857285|469109996|FG000|Overall Study|Withdrawal by Subject|4|||
130312730|NCT00857285|469109997|FG001|Overall Study|Withdrawal by Subject|0|||
130312731|NCT00857285|469109996|FG000|Overall Study|Randomization criteria not met|1|||
130312732|NCT00857285|469109997|FG001|Overall Study|Randomization criteria not met|1|||
130312733|NCT00430716|469109998|FG000|Double Blind Phase|Death|1|||
130465583|NCT01985334|469671967|FG005|Overall Study|Subject withdrawal of consent|19|||
130465584|NCT01985334|469671968|FG006|Overall Study|Subject withdrawal of consent|0|||
130465585|NCT01985334|469671969|FG007|Overall Study|Subject withdrawal of consent|20|||
130465586|NCT01985334|469671962|FG000|Overall Study|Adverse Event|0|||
130312734|NCT00430716|469109999|FG001|Double Blind Phase|Death|0|||
130312735|NCT00430716|469110000|FG002|Double Blind Phase|Death|0|||
130312736|NCT00430716|469109998|FG000|Double Blind Phase|No longer willing to participate|2|||
130312737|NCT00430716|469109999|FG001|Double Blind Phase|No longer willing to participate|1|||
130312738|NCT00430716|469110000|FG002|Double Blind Phase|No longer willing to participate|1|||
130312739|NCT00430716|469109998|FG000|Double Blind Phase|Other|0|||
130312740|NCT00430716|469109999|FG001|Double Blind Phase|Other|2|||
130312741|NCT00430716|469110000|FG002|Double Blind Phase|Other|0|||
130312742|NCT00430716|469109998|FG000|Double Blind Phase|Study terminated by sponsor|1|||
130312743|NCT00430716|469109999|FG001|Double Blind Phase|Study terminated by sponsor|1|||
130312744|NCT00430716|469110000|FG002|Double Blind Phase|Study terminated by sponsor|2|||
130312745|NCT00430716|469109998|FG000|Double Blind Phase|Adverse Event|1|||
130312746|NCT00430716|469109999|FG001|Double Blind Phase|Adverse Event|1|||
130465587|NCT01985334|469671963|FG001|Overall Study|Adverse Event|8|||
130312747|NCT00430716|469110000|FG002|Double Blind Phase|Adverse Event|3|||
130312748|NCT00430716|469109998|FG000|Double Blind Phase|Not treated|1|||
130312749|NCT00430716|469109999|FG001|Double Blind Phase|Not treated|0|||
130312750|NCT00430716|469110000|FG002|Double Blind Phase|Not treated|0|||
130312751|NCT00430716|469109998|FG000|Open Label Phase|Lost to Follow-up|1|||
130312752|NCT00430716|469109999|FG001|Open Label Phase|Lost to Follow-up|0|||
130718960|NCT01908816|470597295|FG003|Overall Study|Lost to Follow-up|2|||
130374767|NCT02207244|469338428|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374768|NCT02207244|469338429|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
130374769|NCT02207244|469338430|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374770|NCT02207244|469338431|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374771|NCT02207244|469338432|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374772|NCT02207244|469338433|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374773|NCT02207244|469338434|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374774|NCT02207244|469338435|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374775|NCT02207244|469338436|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
130374776|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374777|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374778|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374779|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374780|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374781|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374782|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
130374783|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
130374784|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
130374785|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
130374786|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130374787|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374788|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374789|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374790|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374791|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374792|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374793|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374794|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
130374795|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374796|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130374797|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130558599|NCT00785044|470014833|FG000|Overall Study|Lost to Follow-up|266|||
130558600|NCT00785044|470014833|FG000|Overall Study|Withdrawal by Subject|1|||
130558601|NCT01628107|470014834|FG000|Overall Study|Withdrawal by Subject|17|||
130374798|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374799|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374800|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374801|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374802|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374803|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374804|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
130374805|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
130374806|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
130374807|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
130374808|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130374809|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374810|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374811|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374812|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374813|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374814|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374815|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
130374816|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
130374817|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374818|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
130374819|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130374820|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374821|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374822|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374823|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374824|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374825|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374826|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130374827|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
130558602|NCT01628107|470014834|FG000|Overall Study|Lost to Follow-up|4|||
130558603|NCT01628107|470014834|FG000|Overall Study|Adverse Event|33|||
130312753|NCT00430716|469110000|FG002|Open Label Phase|Lost to Follow-up|1|||
130312754|NCT00430716|469109998|FG000|Open Label Phase|No longer willing to participate|0|||
130312755|NCT00430716|469109999|FG001|Open Label Phase|No longer willing to participate|1|||
130312756|NCT00430716|469110000|FG002|Open Label Phase|No longer willing to participate|1|||
130312757|NCT00430716|469109998|FG000|Open Label Phase|Other|3|||
130312758|NCT00430716|469109999|FG001|Open Label Phase|Other|1|||
130312759|NCT00430716|469110000|FG002|Open Label Phase|Other|1|||
130312760|NCT00430716|469109998|FG000|Open Label Phase|Protocol Violation|1|||
130312761|NCT00430716|469109999|FG001|Open Label Phase|Protocol Violation|0|||
130312762|NCT00430716|469110000|FG002|Open Label Phase|Protocol Violation|0|||
130312763|NCT00430716|469109998|FG000|Open Label Phase|Study terminated by sponsor|4|||
130312764|NCT00430716|469109999|FG001|Open Label Phase|Study terminated by sponsor|5|||
130312765|NCT00430716|469110000|FG002|Open Label Phase|Study terminated by sponsor|4|||
130312766|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
130312767|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
130312768|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312769|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312770|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312771|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130312772|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
130312773|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130312774|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130312775|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130312776|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130312777|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130312778|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
130312779|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130312780|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130312781|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312782|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
130312783|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312784|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130465588|NCT01985334|469671964|FG002|Overall Study|Adverse Event|2|||
130465589|NCT01985334|469671965|FG003|Overall Study|Adverse Event|26|||
130465590|NCT01985334|469671966|FG004|Overall Study|Adverse Event|3|||
130465591|NCT01985334|469671967|FG005|Overall Study|Adverse Event|18|||
130465592|NCT01985334|469671968|FG006|Overall Study|Adverse Event|3|||
130465593|NCT01985334|469671969|FG007|Overall Study|Adverse Event|15|||
130465594|NCT01985334|469671962|FG000|Overall Study|Other|4|||
130465595|NCT01985334|469671963|FG001|Overall Study|Other|2|||
130465596|NCT01985334|469671964|FG002|Overall Study|Other|3|||
130465597|NCT01985334|469671965|FG003|Overall Study|Other|10|||
130465598|NCT01985334|469671966|FG004|Overall Study|Other|1|||
130465599|NCT01985334|469671967|FG005|Overall Study|Other|6|||
130465600|NCT01985334|469671968|FG006|Overall Study|Other|2|||
130465601|NCT01985334|469671969|FG007|Overall Study|Other|2|||
130465602|NCT01985334|469671962|FG000|Overall Study|Medication non-compliance|0|||
130465603|NCT01985334|469671963|FG001|Overall Study|Medication non-compliance|4|||
130465604|NCT01985334|469671964|FG002|Overall Study|Medication non-compliance|1|||
130465605|NCT01985334|469671965|FG003|Overall Study|Medication non-compliance|6|||
130465606|NCT01985334|469671966|FG004|Overall Study|Medication non-compliance|2|||
130465607|NCT01985334|469671967|FG005|Overall Study|Medication non-compliance|3|||
130465608|NCT01985334|469671968|FG006|Overall Study|Medication non-compliance|1|||
130465609|NCT01985334|469671969|FG007|Overall Study|Medication non-compliance|3|||
130465610|NCT01985334|469671962|FG000|Overall Study|Use of prohibited treatment|1|||
130465611|NCT01985334|469671963|FG001|Overall Study|Use of prohibited treatment|4|||
130465612|NCT01985334|469671964|FG002|Overall Study|Use of prohibited treatment|1|||
130465613|NCT01985334|469671965|FG003|Overall Study|Use of prohibited treatment|2|||
130465614|NCT01985334|469671966|FG004|Overall Study|Use of prohibited treatment|1|||
130465615|NCT01985334|469671967|FG005|Overall Study|Use of prohibited treatment|6|||
130465616|NCT01985334|469671968|FG006|Overall Study|Use of prohibited treatment|2|||
130465617|NCT01985334|469671969|FG007|Overall Study|Use of prohibited treatment|0|||
130465618|NCT01985334|469671962|FG000|Overall Study|Investigator decision|0|||
130465619|NCT01985334|469671963|FG001|Overall Study|Investigator decision|3|||
130465620|NCT01985334|469671964|FG002|Overall Study|Investigator decision|0|||
130465621|NCT01985334|469671965|FG003|Overall Study|Investigator decision|7|||
130465622|NCT01985334|469671966|FG004|Overall Study|Investigator decision|1|||
130465623|NCT01985334|469671967|FG005|Overall Study|Investigator decision|1|||
130465624|NCT01985334|469671968|FG006|Overall Study|Investigator decision|0|||
130465625|NCT01985334|469671969|FG007|Overall Study|Investigator decision|4|||
130465626|NCT01985334|469671962|FG000|Overall Study|Lost to Follow-up|0|||
130558604|NCT01628107|470014834|FG000|Overall Study|Physician Decision|2|||
130465627|NCT01985334|469671963|FG001|Overall Study|Lost to Follow-up|2|||
130465628|NCT01985334|469671964|FG002|Overall Study|Lost to Follow-up|0|||
130465629|NCT01985334|469671965|FG003|Overall Study|Lost to Follow-up|3|||
130465630|NCT01985334|469671966|FG004|Overall Study|Lost to Follow-up|1|||
130312785|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312786|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312787|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
130718961|NCT01908816|470597292|FG000|Overall Study|Death|1|||
130718962|NCT01908816|470597293|FG001|Overall Study|Death|0|||
130718963|NCT01908816|470597294|FG002|Overall Study|Death|7|||
130718964|NCT01908816|470597295|FG003|Overall Study|Death|1|||
130718965|NCT01908816|470597292|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130718966|NCT01908816|470597293|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130718967|NCT01908816|470597294|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130718968|NCT01908816|470597295|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130718969|NCT01908816|470597292|FG000|Overall Study|Early termination|87|||
130718970|NCT01908816|470597293|FG001|Overall Study|Early termination|60|||
130718971|NCT01908816|470597294|FG002|Overall Study|Early termination|43|||
130718972|NCT01908816|470597295|FG003|Overall Study|Early termination|28|||
130718973|NCT02628743|470597297|FG000|Overall Study|Other|3|||
130718974|NCT02628743|470597297|FG000|Overall Study|Withdrawal by Subject|50|||
130718975|NCT02628743|470597297|FG000|Overall Study|Study Terminated by Sponsor|76|||
130718976|NCT02628743|470597297|FG000|Overall Study|Physician Decision|2|||
130718977|NCT02534844|470597298|FG000|Part B|Withdrawal by Subject|0|||
130718978|NCT02534844|470597299|FG001|Part B|Withdrawal by Subject|0|||
130718979|NCT02534844|470597300|FG002|Part B|Withdrawal by Subject|0|||
130718980|NCT02534844|470597301|FG003|Part B|Withdrawal by Subject|0|||
130718981|NCT02534844|470597302|FG004|Part B|Withdrawal by Subject|2|||
130718982|NCT02534844|470597303|FG005|Part B|Withdrawal by Subject|1|||
130718983|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
130718984|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
130718985|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130718986|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130718987|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
130312788|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312789|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312790|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312791|NCT01329978|469110004|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312792|NCT01329978|469110005|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312793|NCT01329978|469110006|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312794|NCT01329978|469110007|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
130312795|NCT01329978|469110008|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
130312796|NCT01329978|469110004|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312797|NCT01329978|469110005|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312798|NCT01329978|469110006|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312799|NCT01329978|469110007|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312800|NCT01329978|469110008|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
130312801|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130312802|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130312803|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
130312804|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
130312805|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
130312806|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
130312807|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
130312808|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
130312809|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
130312810|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
130312811|NCT01987102|469110015|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
130312812|NCT01987102|469110016|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
130312813|NCT01236521|469110017|FG000|Overall Study|Withdrawal by Subject|12|||
130312814|NCT01236521|469110018|FG001|Overall Study|Withdrawal by Subject|17|||
130312815|NCT01236521|469110017|FG000|Overall Study|Death|2|||
130312816|NCT01236521|469110018|FG001|Overall Study|Death|1|||
130312817|NCT01236521|469110017|FG000|Overall Study|Lost to Follow-up|9|||
130312818|NCT01236521|469110018|FG001|Overall Study|Lost to Follow-up|7|||
130312819|NCT03116685|469110023|FG000|Overall Study|Physician Decision|0|||
130465631|NCT01985334|469671967|FG005|Overall Study|Lost to Follow-up|4|||
130465632|NCT01985334|469671968|FG006|Overall Study|Lost to Follow-up|0|||
130465633|NCT01985334|469671969|FG007|Overall Study|Lost to Follow-up|3|||
130465634|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
130465635|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
130465636|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
130718988|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
130720911|NCT00620555|470601559|FG000|Overall Study|Withdrawal by Subject|1|||
130312820|NCT03116685|469110024|FG001|Overall Study|Physician Decision|1|||
130312821|NCT01943591|469110030|FG000|Overall Study|Lost to Follow-up|3|||
130312822|NCT01943591|469110031|FG001|Overall Study|Lost to Follow-up|4|||
130312823|NCT01943591|469110030|FG000|Overall Study|Death|2|||
130312824|NCT01943591|469110031|FG001|Overall Study|Death|7|||
130312825|NCT03790111|469111228|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
130312826|NCT02796677|469111235|FG000|Overall Study|Adverse Event|11|||
130312827|NCT02796677|469111236|FG001|Overall Study|Adverse Event|22|||
130312828|NCT02796677|469111237|FG002|Overall Study|Adverse Event|14|||
130312829|NCT02796677|469111238|FG003|Overall Study|Adverse Event|14|||
130312830|NCT02796677|469111235|FG000|Overall Study|Protocol Violation|7|||
130312831|NCT02796677|469111236|FG001|Overall Study|Protocol Violation|5|||
130312832|NCT02796677|469111237|FG002|Overall Study|Protocol Violation|4|||
130312833|NCT02796677|469111238|FG003|Overall Study|Protocol Violation|8|||
130312834|NCT02796677|469111235|FG000|Overall Study|Lost to Follow-up|1|||
130312835|NCT02796677|469111236|FG001|Overall Study|Lost to Follow-up|5|||
130312836|NCT02796677|469111237|FG002|Overall Study|Lost to Follow-up|2|||
130312837|NCT02796677|469111238|FG003|Overall Study|Lost to Follow-up|2|||
130312838|NCT02796677|469111235|FG000|Overall Study|Lack of Efficacy|7|||
130312839|NCT02796677|469111236|FG001|Overall Study|Lack of Efficacy|9|||
130312840|NCT02796677|469111237|FG002|Overall Study|Lack of Efficacy|14|||
130312841|NCT02796677|469111238|FG003|Overall Study|Lack of Efficacy|20|||
130312842|NCT02796677|469111235|FG000|Overall Study|Withdrawal by Subject|4|||
130312843|NCT02796677|469111236|FG001|Overall Study|Withdrawal by Subject|14|||
130312844|NCT02796677|469111237|FG002|Overall Study|Withdrawal by Subject|6|||
130312845|NCT02796677|469111238|FG003|Overall Study|Withdrawal by Subject|7|||
130312846|NCT02796677|469111235|FG000|Overall Study|Progressive disease|6|||
130312847|NCT02796677|469111236|FG001|Overall Study|Progressive disease|15|||
130312848|NCT02796677|469111237|FG002|Overall Study|Progressive disease|13|||
130312849|NCT02796677|469111238|FG003|Overall Study|Progressive disease|18|||
130312850|NCT02796677|469111235|FG000|Overall Study|Reason not mentioned|2|||
130312851|NCT02796677|469111236|FG001|Overall Study|Reason not mentioned|3|||
130312852|NCT02796677|469111237|FG002|Overall Study|Reason not mentioned|0|||
130312853|NCT02796677|469111238|FG003|Overall Study|Reason not mentioned|5|||
130312854|NCT03811340|469111241|FG000|Overall Study|subjects did not complete the survey.|90|||
130312855|NCT01045967|469111242|FG000|Second Intervention|Protocol Violation|0|||
130312856|NCT01045967|469111243|FG001|Second Intervention|Protocol Violation|1|||
130312857|NCT01777308|469111244|FG000|Overall Study|Withdrawal by Subject|5|||
130312858|NCT01777308|469111245|FG001|Overall Study|Withdrawal by Subject|1|||
130312859|NCT01777308|469111244|FG000|Overall Study|Migrated/moved from study area|1|||
130312860|NCT01777308|469111245|FG001|Overall Study|Migrated/moved from study area|0|||
130312861|NCT01777308|469111244|FG000|Overall Study|Lost to Follow-up|7|||
130312862|NCT01777308|469111245|FG001|Overall Study|Lost to Follow-up|2|||
130312863|NCT01777308|469111244|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
130312864|NCT01777308|469111245|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
130312865|NCT03212326|469111246|FG000|Overall Study|Physician Decision|4|||
130312866|NCT02219464|469111248|FG000|Overall Study|Withdrawal by Subject|1|||
130312867|NCT02219464|469111249|FG001|Overall Study|Withdrawal by Subject|0|||
130312868|NCT02219464|469111248|FG000|Overall Study|case cancelled|1|||
130312869|NCT02219464|469111249|FG001|Overall Study|case cancelled|0|||
130312870|NCT02219464|469111248|FG000|Overall Study|catheter malfunction|1|||
130312871|NCT02219464|469111249|FG001|Overall Study|catheter malfunction|0|||
130312872|NCT01544920|469111262|FG000|Overall Study|Adverse Event|0|||
130312873|NCT01544920|469111263|FG001|Overall Study|Adverse Event|3|||
130312874|NCT01544920|469111262|FG000|Overall Study|Death|0|||
130312875|NCT01544920|469111263|FG001|Overall Study|Death|1|||
130312876|NCT01544920|469111262|FG000|Overall Study|Lost to Follow-up|11|||
130312877|NCT01544920|469111263|FG001|Overall Study|Lost to Follow-up|12|||
130465637|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
130465638|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
130465639|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
130465640|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
130465641|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
130465642|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130465643|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130465644|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130465645|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130465646|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
130465647|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
130312878|NCT01544920|469111262|FG000|Overall Study|Protocol Violation|0|||
130312879|NCT01544920|469111263|FG001|Overall Study|Protocol Violation|2|||
130312880|NCT01544920|469111262|FG000|Overall Study|Physician Decision|4|||
130312881|NCT01544920|469111263|FG001|Overall Study|Physician Decision|1|||
130465648|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130312882|NCT01544920|469111262|FG000|Overall Study|Withdrawal by Subject|4|||
130312883|NCT01544920|469111263|FG001|Overall Study|Withdrawal by Subject|4|||
130374828|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130374829|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130374830|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130374831|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374832|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374833|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374834|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374835|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374836|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374837|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374838|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
130374839|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
130374840|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374841|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130374842|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374843|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374844|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374845|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374846|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374847|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374848|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374849|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374850|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
130374851|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130374852|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130718989|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
130718990|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
130718991|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
130312884|NCT00474955|469111266|FG000|Overall Study|Adverse Event|2|||
130312885|NCT00474955|469111266|FG000|Overall Study|Drug unavailability|1|||
130312886|NCT00474955|469111266|FG000|Overall Study|Personal reasons|5|||
130312887|NCT02576639|469111267|FG000|Overall Study|Withdrawal by Subject|1|||
130312888|NCT02576639|469111268|FG001|Overall Study|Withdrawal by Subject|2|||
130312889|NCT02576639|469111269|FG002|Overall Study|Withdrawal by Subject|1|||
130312890|NCT02576639|469111270|FG003|Overall Study|Withdrawal by Subject|0|||
130312891|NCT02576639|469111271|FG004|Overall Study|Withdrawal by Subject|1|||
130312892|NCT02576639|469111267|FG000|Overall Study|Adverse Event|1|||
130312893|NCT02576639|469111268|FG001|Overall Study|Adverse Event|0|||
130312894|NCT02576639|469111269|FG002|Overall Study|Adverse Event|1|||
130312895|NCT02576639|469111270|FG003|Overall Study|Adverse Event|1|||
130312896|NCT02576639|469111271|FG004|Overall Study|Adverse Event|2|||
130312897|NCT02576639|469111267|FG000|Overall Study|Physician Decision|0|||
130312898|NCT02576639|469111268|FG001|Overall Study|Physician Decision|0|||
130312899|NCT02576639|469111269|FG002|Overall Study|Physician Decision|0|||
130312900|NCT02576639|469111270|FG003|Overall Study|Physician Decision|0|||
130312901|NCT02576639|469111271|FG004|Overall Study|Physician Decision|1|||
130312902|NCT01135134|469111272|FG000|Overall Study|Adverse Event|1|||
130312903|NCT01135134|469111273|FG001|Overall Study|Adverse Event|1|||
130312904|NCT01135134|469111272|FG000|Overall Study|Did not meet protocol eligibility|1|||
130312905|NCT01135134|469111273|FG001|Overall Study|Did not meet protocol eligibility|0|||
130312906|NCT00255190|469111274|FG000|Overall Study|Adverse Event|17|||
130312907|NCT00255190|469111275|FG001|Overall Study|Adverse Event|36|||
130312908|NCT00255190|469111274|FG000|Overall Study|Protocol Violation|2|||
130312909|NCT00255190|469111275|FG001|Overall Study|Protocol Violation|2|||
130312910|NCT00255190|469111274|FG000|Overall Study|Lost to Follow-up|10|||
130312911|NCT00255190|469111275|FG001|Overall Study|Lost to Follow-up|27|||
130312912|NCT00255190|469111274|FG000|Overall Study|Withdrew Consent|17|||
130312913|NCT00255190|469111275|FG001|Overall Study|Withdrew Consent|48|||
130374853|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374854|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374855|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374856|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130718992|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
130718993|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
130312914|NCT00255190|469111274|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130312915|NCT00255190|469111275|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130312916|NCT00255190|469111274|FG000|Overall Study|Erosive esophagitis not healed|0|||
130312917|NCT00255190|469111275|FG001|Overall Study|Erosive esophagitis not healed|20|||
130312918|NCT00255190|469111274|FG000|Overall Study|Various|4|||
130312919|NCT00255190|469111275|FG001|Overall Study|Various|23|||
130312920|NCT01569841|469111278|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
130312921|NCT01569841|469111279|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
130312922|NCT01859923|469111280|FG000|Overall Study|Adverse Event|0|||
130312923|NCT01859923|469111281|FG001|Overall Study|Adverse Event|0|||
130312924|NCT01859923|469111282|FG002|Overall Study|Adverse Event|1|||
130312925|NCT01859923|469111283|FG003|Overall Study|Adverse Event|1|||
130312926|NCT00057863|469111286|FG000|Overall Study|Death|1|||
130312927|NCT00057863|469111286|FG000|Overall Study|Withdrawal by Subject|2|||
130312928|NCT00764361|469111287|FG000|Overall Study|Withdrawal by Subject|2|||
130312929|NCT00764361|469111288|FG001|Overall Study|Withdrawal by Subject|3|||
130312930|NCT00764361|469111287|FG000|Overall Study|Adverse Event|0|||
130312931|NCT00764361|469111288|FG001|Overall Study|Adverse Event|1|||
130312932|NCT02079038|469111292|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
130312933|NCT02079038|469111293|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
130312934|NCT02079038|469111292|FG000|Modified Intent to Treat Population|Death|1|||
130312935|NCT02079038|469111293|FG001|Modified Intent to Treat Population|Death|0|||
130312936|NCT02079038|469111292|FG000|Completed 6 Months|Lost to Follow-up|2|||
130312937|NCT02079038|469111293|FG001|Completed 6 Months|Lost to Follow-up|1|||
130312938|NCT01308736|469111294|FG000|Overall Study|Did not attend a single session|6|||
130312939|NCT01308736|469111295|FG001|Overall Study|Did not attend a single session|5|||
130312940|NCT03634085|469111296|FG000|Overall Study|Adverse Event|1|||
130312941|NCT03634085|469111297|FG001|Overall Study|Adverse Event|0|||
130312942|NCT03634085|469111296|FG000|Overall Study|Withdrawal by Subject|0|||
130312943|NCT03634085|469111297|FG001|Overall Study|Withdrawal by Subject|2|||
130312944|NCT00985465|469111300|FG000|Overall Study|Withdrawal by Subject|1|||
130312945|NCT00985465|469111301|FG001|Overall Study|Withdrawal by Subject|2|||
130312946|NCT00985465|469111300|FG000|Overall Study|Considered to be part of the other group|0|||
130312947|NCT00985465|469111301|FG001|Overall Study|Considered to be part of the other group|1|||
130312948|NCT04701333|469111302|FG000|Overall Study|Lost to Follow-up|3|||
130312949|NCT04701333|469111303|FG001|Overall Study|Lost to Follow-up|7|||
130312950|NCT04701333|469111302|FG000|Overall Study|Withdrawal by Subject|0|||
130312951|NCT04701333|469111303|FG001|Overall Study|Withdrawal by Subject|1|||
130312952|NCT01292187|469111304|FG000|Overall Study|Adverse Event|10|||
130312953|NCT01292187|469111305|FG001|Overall Study|Adverse Event|5|||
130312954|NCT01292187|469111304|FG000|Overall Study|Withdrawal by Subject|6|||
130312955|NCT01292187|469111305|FG001|Overall Study|Withdrawal by Subject|5|||
130312956|NCT01292187|469111304|FG000|Overall Study|All other reasons|1|||
130312957|NCT01292187|469111305|FG001|Overall Study|All other reasons|3|||
130312958|NCT01216202|469111309|FG000|Overall Study|Withdrawal by Subject|8|||
130312959|NCT01216202|469111310|FG001|Overall Study|Withdrawal by Subject|0|||
130312960|NCT01216202|469111309|FG000|Overall Study|Death|0|||
130312961|NCT01216202|469111310|FG001|Overall Study|Death|2|||
130312962|NCT01216202|469111309|FG000|Overall Study|Lost to Follow-up|14|||
130312963|NCT01216202|469111310|FG001|Overall Study|Lost to Follow-up|0|||
130312964|NCT02888106|469111318|FG000|Overall Study|Withdrawal by Subject|1|||
130312965|NCT02888106|469111319|FG001|Overall Study|Withdrawal by Subject|2|||
130312966|NCT02888106|469111320|FG002|Overall Study|Withdrawal by Subject|0|||
130312967|NCT02888106|469111321|FG003|Overall Study|Withdrawal by Subject|1|||
130312968|NCT02888106|469111322|FG004|Overall Study|Withdrawal by Subject|0|||
130312969|NCT02888106|469111323|FG005|Overall Study|Withdrawal by Subject|0|||
130312970|NCT02888106|469111318|FG000|Overall Study|Lost to Follow-up|1|||
130312971|NCT02888106|469111319|FG001|Overall Study|Lost to Follow-up|0|||
130312972|NCT02888106|469111320|FG002|Overall Study|Lost to Follow-up|0|||
130312973|NCT02888106|469111321|FG003|Overall Study|Lost to Follow-up|1|||
130312974|NCT02888106|469111322|FG004|Overall Study|Lost to Follow-up|0|||
130312975|NCT02888106|469111323|FG005|Overall Study|Lost to Follow-up|1|||
130312976|NCT02888106|469111318|FG000|Overall Study|Adverse Event|2|||
130312977|NCT02888106|469111319|FG001|Overall Study|Adverse Event|0|||
130374857|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374858|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374859|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374860|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
130558605|NCT01628107|470014834|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
130312978|NCT02888106|469111320|FG002|Overall Study|Adverse Event|0|||
130312979|NCT02888106|469111321|FG003|Overall Study|Adverse Event|0|||
130312980|NCT02888106|469111322|FG004|Overall Study|Adverse Event|0|||
130312981|NCT02888106|469111323|FG005|Overall Study|Adverse Event|0|||
130312982|NCT02888106|469111318|FG000|Overall Study|Withdrawal of consent|0|||
130312983|NCT02888106|469111319|FG001|Overall Study|Withdrawal of consent|0|||
130312984|NCT02888106|469111320|FG002|Overall Study|Withdrawal of consent|0|||
130312985|NCT02888106|469111321|FG003|Overall Study|Withdrawal of consent|0|||
130312986|NCT02888106|469111322|FG004|Overall Study|Withdrawal of consent|1|||
130312987|NCT02888106|469111323|FG005|Overall Study|Withdrawal of consent|0|||
130312988|NCT02888106|469111318|FG000|Overall Study|Pregnancy|1|||
130312989|NCT02888106|469111319|FG001|Overall Study|Pregnancy|0|||
130312990|NCT02888106|469111320|FG002|Overall Study|Pregnancy|0|||
130312991|NCT02888106|469111321|FG003|Overall Study|Pregnancy|0|||
130312992|NCT02888106|469111322|FG004|Overall Study|Pregnancy|0|||
130312993|NCT02888106|469111323|FG005|Overall Study|Pregnancy|0|||
130312994|NCT01188772|469111326|FG000|Overall Study|Randomized but Not Treated|0|||
130312995|NCT01188772|469111327|FG001|Overall Study|Randomized but Not Treated|1|||
130312996|NCT01188772|469111328|FG002|Overall Study|Randomized but Not Treated|0|||
130312997|NCT01188772|469111329|FG003|Overall Study|Randomized but Not Treated|0|||
130312998|NCT01188772|469111326|FG000|Overall Study|Adverse Event|0|||
130312999|NCT01188772|469111327|FG001|Overall Study|Adverse Event|1|||
130313000|NCT01188772|469111328|FG002|Overall Study|Adverse Event|2|||
130313001|NCT01188772|469111329|FG003|Overall Study|Adverse Event|0|||
130313002|NCT01188772|469111326|FG000|Overall Study|Lost to Follow-up|4|||
130313003|NCT01188772|469111327|FG001|Overall Study|Lost to Follow-up|1|||
130313004|NCT01188772|469111328|FG002|Overall Study|Lost to Follow-up|1|||
130313005|NCT01188772|469111329|FG003|Overall Study|Lost to Follow-up|1|||
130313006|NCT01188772|469111326|FG000|Overall Study|Non-responder|0|||
130313007|NCT01188772|469111327|FG001|Overall Study|Non-responder|0|||
130313008|NCT01188772|469111328|FG002|Overall Study|Non-responder|3|||
130313009|NCT01188772|469111329|FG003|Overall Study|Non-responder|0|||
130313010|NCT01188772|469111326|FG000|Overall Study|Physician Decision|0|||
130313011|NCT01188772|469111327|FG001|Overall Study|Physician Decision|0|||
130313012|NCT01188772|469111328|FG002|Overall Study|Physician Decision|1|||
130313013|NCT01188772|469111329|FG003|Overall Study|Physician Decision|0|||
130313014|NCT01188772|469111326|FG000|Overall Study|Terminated by Sponsor|0|||
130313015|NCT01188772|469111327|FG001|Overall Study|Terminated by Sponsor|0|||
130313016|NCT01188772|469111328|FG002|Overall Study|Terminated by Sponsor|1|||
130313017|NCT01188772|469111329|FG003|Overall Study|Terminated by Sponsor|0|||
130313018|NCT01188772|469111326|FG000|Overall Study|Treatment Failure|0|||
130313019|NCT01188772|469111327|FG001|Overall Study|Treatment Failure|0|||
130313020|NCT01188772|469111328|FG002|Overall Study|Treatment Failure|1|||
130313021|NCT01188772|469111329|FG003|Overall Study|Treatment Failure|0|||
130313022|NCT01188772|469111326|FG000|Overall Study|Virologic Failure|1|||
130313023|NCT01188772|469111327|FG001|Overall Study|Virologic Failure|0|||
130313024|NCT01188772|469111328|FG002|Overall Study|Virologic Failure|0|||
130313025|NCT01188772|469111329|FG003|Overall Study|Virologic Failure|0|||
130313026|NCT01188772|469111326|FG000|Overall Study|Withdrawal by Subject|0|||
130313027|NCT01188772|469111327|FG001|Overall Study|Withdrawal by Subject|0|||
130313028|NCT01188772|469111328|FG002|Overall Study|Withdrawal by Subject|2|||
130313029|NCT01188772|469111329|FG003|Overall Study|Withdrawal by Subject|0|||
130313030|NCT01433172|469111330|FG000|Overall Study|Withdrawal by Subject|0|||
130313031|NCT01433172|469111331|FG001|Overall Study|Withdrawal by Subject|1|||
130313032|NCT01433172|469111332|FG002|Overall Study|Withdrawal by Subject|0|||
130313033|NCT01433172|469111330|FG000|Overall Study|Disease Progression|0|||
130313034|NCT01433172|469111331|FG001|Overall Study|Disease Progression|0|||
130313035|NCT01433172|469111332|FG002|Overall Study|Disease Progression|1|||
130313036|NCT01433172|469111330|FG000|Overall Study|Death|0|||
130313037|NCT01433172|469111331|FG001|Overall Study|Death|2|||
130313038|NCT01433172|469111332|FG002|Overall Study|Death|0|||
130313039|NCT01894607|469111336|FG000|Overall Study|Ineligible|1|||
130313040|NCT04393493|469111337|FG000|First 4 Days of Intervention|Early improvement|5|||
130313041|NCT04393493|469111338|FG001|First 4 Days of Intervention|Early improvement|7|||
130313042|NCT04303559|469111339|FG000|Overall Study|Study closed due to poor enrollment.|1|||
130313043|NCT01572480|469111340|FG000|Participants Enrolled|Withdrawal by Subject|1|||
130313044|NCT01572480|469111340|FG000|Drug Administration|Discontinued drug/Off Study|1|||
130313045|NCT01572480|469111340|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
130313046|NCT01572480|469111340|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
130313047|NCT04037891|469111341|FG000|Open-label Period|Withdrawal by Subject|1|||
130374861|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374862|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374863|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130374864|NCT02207244|469338426|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130313048|NCT04037891|469111342|FG001|Open-label Period|Withdrawal by Subject|0|||
130313049|NCT04037891|469111343|FG002|Open-label Period|Withdrawal by Subject|0|||
130313050|NCT04037891|469111341|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130374865|NCT02207244|469338427|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130718994|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
130313051|NCT04037891|469111342|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
130313052|NCT04037891|469111343|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130313053|NCT03446313|469111344|FG000|Overall Study|Lost to Follow-up|1|||
130313054|NCT03446313|469111345|FG001|Overall Study|Lost to Follow-up|2|||
130313055|NCT03446313|469111344|FG000|Overall Study|Failed primary screening|3|||
130313056|NCT03446313|469111345|FG001|Overall Study|Failed primary screening|0|||
130313057|NCT03446313|469111344|FG000|Overall Study|Diagnosed with terminal cancer|1|||
130313058|NCT03446313|469111345|FG001|Overall Study|Diagnosed with terminal cancer|0|||
130313059|NCT03446313|469111344|FG000|Overall Study|Excluded from analysis|1|||
130313060|NCT03446313|469111345|FG001|Overall Study|Excluded from analysis|1|||
130374866|NCT02207244|469338428|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374867|NCT02207244|469338429|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374868|NCT02207244|469338430|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374869|NCT02207244|469338431|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374870|NCT02207244|469338432|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
130374871|NCT02207244|469338433|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374872|NCT02207244|469338434|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374873|NCT02207244|469338435|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374874|NCT02207244|469338436|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130374875|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374876|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374877|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374878|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374879|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374880|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374881|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374882|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374883|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
130374884|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130374885|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
130374886|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374887|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374888|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374889|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374890|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374891|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374892|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374893|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374894|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
130374895|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130374896|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
130374897|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374898|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374899|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374900|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374901|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374902|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374903|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374904|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374905|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
130374906|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130374907|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
130374908|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374909|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374910|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374911|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374912|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374913|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374914|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374915|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374916|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
130374917|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130374918|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
130374919|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
130374920|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
130374921|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
130374922|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
130374923|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
130374924|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
130374925|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
130374926|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
130374927|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
130374928|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
130374929|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
130374930|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
130313061|NCT04491136|469111346|FG000|Overall Study|Patient withdraw informed consent|9|||
130313062|NCT04491136|469111346|FG000|Overall Study|Adverse Event|2|||
130313063|NCT04491136|469111346|FG000|Overall Study|Death|3|||
130313064|NCT04491136|469111346|FG000|Overall Study|Lost to Follow-up|3|||
130313065|NCT04491136|469111346|FG000|Overall Study|Physician Decision|45|||
130313066|NCT04491136|469111346|FG000|Overall Study|sponsor terminated the study early|16|||
130313067|NCT04491136|469111346|FG000|Overall Study|Patient/guardian's decision|1|||
130313068|NCT01611194|469111347|FG000|Overall Study|Lost to Follow-up|0|||
130313069|NCT01611194|469111348|FG001|Overall Study|Lost to Follow-up|1|||
130313070|NCT01611194|469111347|FG000|Overall Study|Withdrawal by Subject|0|||
130313071|NCT01611194|469111348|FG001|Overall Study|Withdrawal by Subject|1|||
130313072|NCT01611194|469111347|FG000|Overall Study|drug use|0|||
130313073|NCT01611194|469111348|FG001|Overall Study|drug use|1|||
130313074|NCT00348673|469111349|FG000|Stage 1|Randomized but not Treated|0|||
130313075|NCT00348673|469111350|FG001|Stage 1|Randomized but not Treated|0|||
130313076|NCT00348673|469111351|FG002|Stage 1|Randomized but not Treated|1|||
130313077|NCT00348673|469111352|FG003|Stage 1|Randomized but not Treated|0|||
130313078|NCT00348673|469111353|FG004|Stage 1|Randomized but not Treated|0|||
130313079|NCT00348673|469111354|FG005|Stage 1|Randomized but not Treated|0|||
130313080|NCT00348673|469111355|FG006|Stage 1|Randomized but not Treated|0|||
130313081|NCT00348673|469111356|FG007|Stage 1|Randomized but not Treated|0|||
130313082|NCT00348673|469111357|FG008|Stage 1|Randomized but not Treated|0|||
130313083|NCT02719171|469113534|FG000|Overall Study|Adverse Event|1|||
130313084|NCT02719171|469113535|FG001|Overall Study|Adverse Event|2|||
130313085|NCT02719171|469113536|FG002|Overall Study|Adverse Event|0|||
130313086|NCT02719171|469113537|FG003|Overall Study|Adverse Event|0|||
130313087|NCT02719171|469113538|FG004|Overall Study|Adverse Event|2|||
130313088|NCT02719171|469113534|FG000|Overall Study|Lost to Follow-up|0|||
130313089|NCT02719171|469113535|FG001|Overall Study|Lost to Follow-up|0|||
130313090|NCT02719171|469113536|FG002|Overall Study|Lost to Follow-up|1|||
130313091|NCT02719171|469113537|FG003|Overall Study|Lost to Follow-up|0|||
130313092|NCT02719171|469113538|FG004|Overall Study|Lost to Follow-up|0|||
130313093|NCT02719171|469113534|FG000|Overall Study|Subject Withdrawal|0|||
130313094|NCT02719171|469113535|FG001|Overall Study|Subject Withdrawal|2|||
130313095|NCT02719171|469113536|FG002|Overall Study|Subject Withdrawal|2|||
130313096|NCT02719171|469113537|FG003|Overall Study|Subject Withdrawal|1|||
130313097|NCT02719171|469113538|FG004|Overall Study|Subject Withdrawal|0|||
130313098|NCT02719171|469113534|FG000|Overall Study|Other|0|||
130313099|NCT02719171|469113535|FG001|Overall Study|Other|0|||
130313100|NCT02719171|469113536|FG002|Overall Study|Other|0|||
130313101|NCT02719171|469113537|FG003|Overall Study|Other|1|||
130313102|NCT02719171|469113538|FG004|Overall Study|Other|0|||
130313103|NCT02614729|469113539|FG000|Overall Study|Withdrawal by Subject|1|||
130313104|NCT02614729|469113540|FG001|Overall Study|Withdrawal by Subject|0|||
130313105|NCT02539797|469113543|FG000|Overall Study|Lost to Follow-up|0|||
130313106|NCT02539797|469113544|FG001|Overall Study|Lost to Follow-up|1|||
130313107|NCT02539797|469113545|FG002|Overall Study|Lost to Follow-up|0|||
130313108|NCT03798717|469113547|FG000|Overall Study|Failed Screening|0|||
130313109|NCT03798717|469113548|FG001|Overall Study|Failed Screening|0|||
130313110|NCT03798717|469113549|FG002|Overall Study|Failed Screening|0|||
130313111|NCT03798717|469113550|FG003|Overall Study|Failed Screening|0|||
130313112|NCT03798717|469113551|FG004|Overall Study|Failed Screening|0|||
130313113|NCT03798717|469113552|FG005|Overall Study|Failed Screening|1|||
130313114|NCT03798717|469113547|FG000|Overall Study|Physician Decision|1|||
130313115|NCT03798717|469113548|FG001|Overall Study|Physician Decision|0|||
130313116|NCT03798717|469113549|FG002|Overall Study|Physician Decision|1|||
130313117|NCT03798717|469113550|FG003|Overall Study|Physician Decision|0|||
130313118|NCT03798717|469113551|FG004|Overall Study|Physician Decision|0|||
130313119|NCT03798717|469113552|FG005|Overall Study|Physician Decision|0|||
130313120|NCT03798717|469113547|FG000|Overall Study|Withdrawal by Subject|0|||
130313121|NCT03798717|469113548|FG001|Overall Study|Withdrawal by Subject|0|||
130313122|NCT03798717|469113549|FG002|Overall Study|Withdrawal by Subject|0|||
130313123|NCT03798717|469113550|FG003|Overall Study|Withdrawal by Subject|1|||
130313124|NCT03798717|469113551|FG004|Overall Study|Withdrawal by Subject|0|||
130313125|NCT03798717|469113552|FG005|Overall Study|Withdrawal by Subject|0|||
130313126|NCT03798717|469113547|FG000|Overall Study|Lost to Follow-up|1|||
130313127|NCT03798717|469113548|FG001|Overall Study|Lost to Follow-up|0|||
130313128|NCT03798717|469113549|FG002|Overall Study|Lost to Follow-up|0|||
130313129|NCT03798717|469113550|FG003|Overall Study|Lost to Follow-up|1|||
130313130|NCT03798717|469113551|FG004|Overall Study|Lost to Follow-up|0|||
130313131|NCT03798717|469113552|FG005|Overall Study|Lost to Follow-up|0|||
130313132|NCT03798717|469113547|FG000|Overall Study|Adverse Event|0|||
130313133|NCT03798717|469113548|FG001|Overall Study|Adverse Event|1|||
130313134|NCT03798717|469113549|FG002|Overall Study|Adverse Event|0|||
130313135|NCT03798717|469113550|FG003|Overall Study|Adverse Event|0|||
130313136|NCT03798717|469113551|FG004|Overall Study|Adverse Event|0|||
130313137|NCT03798717|469113552|FG005|Overall Study|Adverse Event|0|||
130313138|NCT03798717|469113547|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313139|NCT03798717|469113548|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313140|NCT03798717|469113549|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313141|NCT03798717|469113550|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313142|NCT03798717|469113551|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
130313143|NCT03798717|469113552|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313144|NCT04002960|469113554|FG000|Overall Study|Withdrawn prior to Completion|2|||
130313145|NCT00383786|469113569|FG000|Overall Study|Protocol Violation|2|||
130313146|NCT00383786|469113570|FG001|Overall Study|Protocol Violation|6|||
130313147|NCT00383786|469113569|FG000|Overall Study|Withdrawal by Subject|2|||
130313148|NCT00383786|469113570|FG001|Overall Study|Withdrawal by Subject|5|||
130313149|NCT00383786|469113569|FG000|Overall Study|Physician Decision|0|||
130313150|NCT00383786|469113570|FG001|Overall Study|Physician Decision|1|||
130313151|NCT00985673|469113571|FG000|Overall Study|Lost to Follow-up|6|||
130313152|NCT00985673|469113572|FG001|Overall Study|Lost to Follow-up|7|||
130313153|NCT00985673|469113573|FG002|Overall Study|Lost to Follow-up|6|||
130313154|NCT00985673|469113574|FG003|Overall Study|Lost to Follow-up|10|||
130313155|NCT00985673|469113575|FG004|Overall Study|Lost to Follow-up|5|||
130313156|NCT00985673|469113576|FG005|Overall Study|Lost to Follow-up|3|||
130313157|NCT00985673|469113571|FG000|Overall Study|Withdrawal by Subject|0|||
130313158|NCT00985673|469113572|FG001|Overall Study|Withdrawal by Subject|4|||
130313159|NCT00985673|469113573|FG002|Overall Study|Withdrawal by Subject|5|||
130313160|NCT00985673|469113574|FG003|Overall Study|Withdrawal by Subject|2|||
130313161|NCT00985673|469113575|FG004|Overall Study|Withdrawal by Subject|2|||
130313162|NCT00985673|469113576|FG005|Overall Study|Withdrawal by Subject|3|||
130313163|NCT00985673|469113571|FG000|Overall Study|Other|1|||
130313164|NCT00985673|469113572|FG001|Overall Study|Other|0|||
130313165|NCT00985673|469113573|FG002|Overall Study|Other|1|||
130313166|NCT00985673|469113574|FG003|Overall Study|Other|0|||
130313167|NCT00985673|469113575|FG004|Overall Study|Other|1|||
130313168|NCT00985673|469113576|FG005|Overall Study|Other|0|||
130313169|NCT02252146|469113577|FG000|Overall Study|Lack of Efficacy|4|||
130313170|NCT02252146|469113577|FG000|Overall Study|Entered hospice care|1|||
130313171|NCT02252146|469113577|FG000|Overall Study|Inability to travel to study site|1|||
130313172|NCT00531284|469113580|FG000|Overall Study|Progressive Disease|1|||
130313173|NCT00531284|469113581|FG001|Overall Study|Progressive Disease|3|||
130313174|NCT00531284|469113582|FG002|Overall Study|Progressive Disease|5|||
130313175|NCT00531284|469113583|FG003|Overall Study|Progressive Disease|42|||
130313176|NCT00531284|469113584|FG004|Overall Study|Progressive Disease|4|||
130313177|NCT00531284|469113585|FG005|Overall Study|Progressive Disease|4|||
130313178|NCT00531284|469113586|FG006|Overall Study|Progressive Disease|3|||
130313179|NCT00531284|469113587|FG007|Overall Study|Progressive Disease|8|||
130313180|NCT00531284|469113588|FG008|Overall Study|Progressive Disease|6|||
130313181|NCT00531284|469113589|FG009|Overall Study|Progressive Disease|3|||
130313182|NCT00531284|469113590|FG010|Overall Study|Progressive Disease|3|||
130313183|NCT00531284|469113591|FG011|Overall Study|Progressive Disease|14|||
130313184|NCT00531284|469113592|FG012|Overall Study|Progressive Disease|2|||
130313185|NCT00531284|469113593|FG013|Overall Study|Progressive Disease|1|||
130313186|NCT00531284|469113594|FG014|Overall Study|Progressive Disease|2|||
130313187|NCT00531284|469113595|FG015|Overall Study|Progressive Disease|11|||
130313188|NCT00531284|469113596|FG016|Overall Study|Progressive Disease|5|||
130313189|NCT00531284|469113580|FG000|Overall Study|Adverse Event|0|||
130313190|NCT00531284|469113581|FG001|Overall Study|Adverse Event|1|||
130313191|NCT00531284|469113582|FG002|Overall Study|Adverse Event|1|||
130313192|NCT00531284|469113583|FG003|Overall Study|Adverse Event|7|||
130374931|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
130374932|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
130374933|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
130374934|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
130374935|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
130374936|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
130374937|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
130374938|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
130374939|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
130465649|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
130313193|NCT00531284|469113584|FG004|Overall Study|Adverse Event|0|||
130313194|NCT00531284|469113585|FG005|Overall Study|Adverse Event|2|||
130313195|NCT00531284|469113586|FG006|Overall Study|Adverse Event|3|||
130313196|NCT00531284|469113587|FG007|Overall Study|Adverse Event|2|||
130313197|NCT00531284|469113588|FG008|Overall Study|Adverse Event|3|||
130313198|NCT00531284|469113589|FG009|Overall Study|Adverse Event|0|||
130313199|NCT00531284|469113590|FG010|Overall Study|Adverse Event|0|||
130313200|NCT00531284|469113591|FG011|Overall Study|Adverse Event|5|||
130313201|NCT00531284|469113592|FG012|Overall Study|Adverse Event|0|||
130313202|NCT00531284|469113593|FG013|Overall Study|Adverse Event|1|||
130313203|NCT00531284|469113594|FG014|Overall Study|Adverse Event|1|||
130374940|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
130374941|NCT02207244|469338426|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130313204|NCT00531284|469113595|FG015|Overall Study|Adverse Event|0|||
130313205|NCT00531284|469113596|FG016|Overall Study|Adverse Event|2|||
130313206|NCT00531284|469113580|FG000|Overall Study|Withdrawal by Subject|1|||
130313207|NCT00531284|469113581|FG001|Overall Study|Withdrawal by Subject|0|||
130313208|NCT00531284|469113582|FG002|Overall Study|Withdrawal by Subject|0|||
130313209|NCT00531284|469113583|FG003|Overall Study|Withdrawal by Subject|4|||
130313210|NCT00531284|469113584|FG004|Overall Study|Withdrawal by Subject|0|||
130313211|NCT00531284|469113585|FG005|Overall Study|Withdrawal by Subject|0|||
130313212|NCT00531284|469113586|FG006|Overall Study|Withdrawal by Subject|0|||
130313213|NCT00531284|469113587|FG007|Overall Study|Withdrawal by Subject|0|||
130313214|NCT00531284|469113588|FG008|Overall Study|Withdrawal by Subject|0|||
130313215|NCT00531284|469113589|FG009|Overall Study|Withdrawal by Subject|0|||
130313216|NCT00531284|469113590|FG010|Overall Study|Withdrawal by Subject|0|||
130313217|NCT00531284|469113591|FG011|Overall Study|Withdrawal by Subject|3|||
130313218|NCT00531284|469113592|FG012|Overall Study|Withdrawal by Subject|0|||
130313219|NCT00531284|469113593|FG013|Overall Study|Withdrawal by Subject|1|||
130313220|NCT00531284|469113594|FG014|Overall Study|Withdrawal by Subject|0|||
130313221|NCT00531284|469113595|FG015|Overall Study|Withdrawal by Subject|1|||
130313222|NCT00531284|469113596|FG016|Overall Study|Withdrawal by Subject|1|||
130313223|NCT00531284|469113580|FG000|Overall Study|Other|1|||
130313224|NCT00531284|469113581|FG001|Overall Study|Other|0|||
130313225|NCT00531284|469113582|FG002|Overall Study|Other|0|||
130313226|NCT00531284|469113583|FG003|Overall Study|Other|10|||
130313227|NCT00531284|469113584|FG004|Overall Study|Other|2|||
130313228|NCT00531284|469113585|FG005|Overall Study|Other|1|||
130313229|NCT00531284|469113586|FG006|Overall Study|Other|0|||
130313230|NCT00531284|469113587|FG007|Overall Study|Other|0|||
130313231|NCT00531284|469113588|FG008|Overall Study|Other|2|||
130313232|NCT00531284|469113589|FG009|Overall Study|Other|1|||
130313233|NCT00531284|469113590|FG010|Overall Study|Other|0|||
130313234|NCT00531284|469113591|FG011|Overall Study|Other|2|||
130313235|NCT00531284|469113592|FG012|Overall Study|Other|0|||
130313236|NCT00531284|469113593|FG013|Overall Study|Other|0|||
130313237|NCT00531284|469113594|FG014|Overall Study|Other|1|||
130313238|NCT00531284|469113595|FG015|Overall Study|Other|0|||
130313239|NCT00531284|469113596|FG016|Overall Study|Other|0|||
130313240|NCT00984256|469113597|FG000|Overall Study|Withdrawal by Subject|0|||
130313241|NCT00984256|469113598|FG001|Overall Study|Withdrawal by Subject|1|||
130313242|NCT03057496|469113599|FG000|Overall Study|Withdrawal by Subject|8|||
130313243|NCT03057496|469113599|FG000|Overall Study|Lost to Follow-up|5|||
130313244|NCT03057496|469113599|FG000|Overall Study|Did not use device during home trial|3|||
130313245|NCT03057496|469113599|FG000|Overall Study|Device failure|2|||
130313246|NCT02723773|469113607|FG000|Overall Study|Adverse Event|934|||
130313247|NCT02723773|469113608|FG001|Overall Study|Adverse Event|3|||
130313248|NCT02723773|469113609|FG002|Overall Study|Adverse Event|1|||
130313249|NCT02723773|469113610|FG003|Overall Study|Adverse Event|9|||
130313250|NCT02723773|469113607|FG000|Overall Study|Protocol Violation|1|||
130313251|NCT02723773|469113608|FG001|Overall Study|Protocol Violation|0|||
130313252|NCT02723773|469113609|FG002|Overall Study|Protocol Violation|0|||
130313253|NCT02723773|469113610|FG003|Overall Study|Protocol Violation|0|||
130313254|NCT02723773|469113607|FG000|Overall Study|Withdrawal by Subject|360|||
130313255|NCT02723773|469113608|FG001|Overall Study|Withdrawal by Subject|5|||
130313256|NCT02723773|469113609|FG002|Overall Study|Withdrawal by Subject|6|||
130313257|NCT02723773|469113610|FG003|Overall Study|Withdrawal by Subject|10|||
130374942|NCT02207244|469338427|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374943|NCT02207244|469338428|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374944|NCT02207244|469338429|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374945|NCT02207244|469338430|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374946|NCT02207244|469338431|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374947|NCT02207244|469338432|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374948|NCT02207244|469338433|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374949|NCT02207244|469338434|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374950|NCT02207244|469338435|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130374951|NCT02207244|469338436|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
130374952|NCT00039130|469338437|FG000|Overall Study|Adverse Event|11|||
130313258|NCT02723773|469113607|FG000|Overall Study|Migrated/moved from study area|37|||
130313259|NCT02723773|469113608|FG001|Overall Study|Migrated/moved from study area|0|||
130374953|NCT00039130|469338437|FG000|Overall Study|Death|9|||
130720912|NCT00620555|470601559|FG000|Overall Study|Choice of other treatment|1|||
130374954|NCT00039130|469338437|FG000|Overall Study|Withdrawal by Subject|3|||
130374955|NCT00039130|469338437|FG000|Overall Study|Progression|2|||
130374956|NCT00039130|469338437|FG000|Overall Study|Subsequent treatment|2|||
130313260|NCT02723773|469113609|FG002|Overall Study|Migrated/moved from study area|0|||
130313261|NCT02723773|469113610|FG003|Overall Study|Migrated/moved from study area|1|||
130313262|NCT02723773|469113607|FG000|Overall Study|Lost to Follow-up|198|||
130313263|NCT02723773|469113608|FG001|Overall Study|Lost to Follow-up|0|||
130313264|NCT02723773|469113609|FG002|Overall Study|Lost to Follow-up|0|||
130313265|NCT02723773|469113610|FG003|Overall Study|Lost to Follow-up|0|||
130313266|NCT02723773|469113607|FG000|Overall Study|Other|189|||
130313267|NCT02723773|469113608|FG001|Overall Study|Other|1|||
130313268|NCT02723773|469113609|FG002|Overall Study|Other|2|||
130313269|NCT02723773|469113610|FG003|Overall Study|Other|2|||
130313270|NCT03347123|469113611|FG000|Overall Study|Death|1|||
130313271|NCT03347123|469113612|FG001|Overall Study|Death|2|||
130313272|NCT03347123|469113613|FG002|Overall Study|Death|0|||
130313273|NCT03347123|469113614|FG003|Overall Study|Death|0|||
130313274|NCT03347123|469113615|FG004|Overall Study|Death|0|||
130313275|NCT03347123|469113616|FG005|Overall Study|Death|0|||
130313276|NCT03347123|469113617|FG006|Overall Study|Death|0|||
130313277|NCT03347123|469113611|FG000|Overall Study|Withdrawal by Subject|1|||
130313278|NCT03347123|469113612|FG001|Overall Study|Withdrawal by Subject|0|||
130313279|NCT03347123|469113613|FG002|Overall Study|Withdrawal by Subject|0|||
130313280|NCT03347123|469113614|FG003|Overall Study|Withdrawal by Subject|0|||
130313281|NCT03347123|469113615|FG004|Overall Study|Withdrawal by Subject|0|||
130313282|NCT03347123|469113616|FG005|Overall Study|Withdrawal by Subject|0|||
130313283|NCT03347123|469113617|FG006|Overall Study|Withdrawal by Subject|0|||
130313284|NCT03347123|469113611|FG000|Overall Study|Reason not Specified|3|||
130313285|NCT03347123|469113612|FG001|Overall Study|Reason not Specified|4|||
130313286|NCT03347123|469113613|FG002|Overall Study|Reason not Specified|0|||
130313287|NCT03347123|469113614|FG003|Overall Study|Reason not Specified|0|||
130313288|NCT03347123|469113615|FG004|Overall Study|Reason not Specified|0|||
130313289|NCT03347123|469113616|FG005|Overall Study|Reason not Specified|0|||
130313290|NCT03347123|469113617|FG006|Overall Study|Reason not Specified|0|||
130313291|NCT01132807|469113620|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
130313292|NCT01132807|469113621|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130313293|NCT01132807|469113622|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130313294|NCT01132807|469113620|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
130313295|NCT01132807|469113621|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130313296|NCT01132807|469113622|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130313297|NCT01731912|469113625|FG000|Overall Study|noncompliance|2|||
130313298|NCT02222558|469113626|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
130313299|NCT02222558|469113627|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
130313300|NCT02222558|469113628|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
130313301|NCT02222558|469113629|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
130313302|NCT02222558|469113630|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
130313303|NCT02222558|469113631|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
130313304|NCT02222558|469113626|FG000|Period 3|Withdrawal by Subject|0|||
130313305|NCT02222558|469113627|FG001|Period 3|Withdrawal by Subject|0|||
130313306|NCT02222558|469113628|FG002|Period 3|Withdrawal by Subject|0|||
130313307|NCT02222558|469113629|FG003|Period 3|Withdrawal by Subject|0|||
130313308|NCT02222558|469113630|FG004|Period 3|Withdrawal by Subject|0|||
130313309|NCT02222558|469113631|FG005|Period 3|Withdrawal by Subject|1|||
130313310|NCT01285401|469113632|FG000|Overall Study|Prematurely withdrawn from the study|17|||
130313311|NCT01285401|469113633|FG001|Overall Study|Prematurely withdrawn from the study|29|||
130313312|NCT02322281|469113634|FG000|Overall Study|Progressive Disease|42|||
130313313|NCT02322281|469113635|FG001|Overall Study|Progressive Disease|14|||
130313314|NCT02322281|469113636|FG002|Overall Study|Progressive Disease|49|||
130313315|NCT02322281|469113634|FG000|Overall Study|Adverse Event|3|||
130313316|NCT02322281|469113635|FG001|Overall Study|Adverse Event|4|||
130313317|NCT02322281|469113636|FG002|Overall Study|Adverse Event|6|||
130313318|NCT02322281|469113634|FG000|Overall Study|Death|3|||
130313319|NCT02322281|469113635|FG001|Overall Study|Death|3|||
130313320|NCT02322281|469113636|FG002|Overall Study|Death|3|||
130313321|NCT02322281|469113634|FG000|Overall Study|Withdrawal by Subject|1|||
130313322|NCT02322281|469113635|FG001|Overall Study|Withdrawal by Subject|1|||
130313323|NCT02322281|469113636|FG002|Overall Study|Withdrawal by Subject|6|||
130313324|NCT02322281|469113634|FG000|Overall Study|Physician Decision|2|||
130558606|NCT01628107|470014834|FG000|Overall Study|Non-compliant with Study Procedures|10|||
130558607|NCT01628107|470014834|FG000|Overall Study|Not Treated|8|||
130558608|NCT01628107|470014834|FG000|Overall Study|Sponsor Decision|11|||
130558609|NCT01628107|470014834|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
130558610|NCT01628107|470014834|FG000|Overall Study|Relocated|8|||
130558611|NCT01628107|470014834|FG000|Overall Study|Kidney Transplant|9|||
130718995|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130313325|NCT02322281|469113635|FG001|Overall Study|Physician Decision|0|||
130313326|NCT02322281|469113636|FG002|Overall Study|Physician Decision|5|||
130558612|NCT01628107|470014834|FG000|Overall Study|Use of Standard of Care|9|||
130313327|NCT02322281|469113634|FG000|Overall Study|Study Terminated by Sponsor|2|||
130313328|NCT02322281|469113635|FG001|Overall Study|Study Terminated by Sponsor|0|||
130313329|NCT02322281|469113636|FG002|Overall Study|Study Terminated by Sponsor|0|||
130313330|NCT02322281|469113634|FG000|Overall Study|Missing|0|||
130313331|NCT02322281|469113635|FG001|Overall Study|Missing|0|||
130313332|NCT02322281|469113636|FG002|Overall Study|Missing|1|||
130313333|NCT02322281|469113634|FG000|Overall Study|Miscellaneous|0|||
130313334|NCT02322281|469113635|FG001|Overall Study|Miscellaneous|0|||
130313335|NCT02322281|469113636|FG002|Overall Study|Miscellaneous|4|||
130313336|NCT00936702|469113637|FG000|Overall Study|Disease progression|34|||
130313337|NCT00936702|469113637|FG000|Overall Study|Adverse Event|8|||
130313338|NCT00936702|469113637|FG000|Overall Study|Withdrawal by Subject|2|||
130313339|NCT00936702|469113637|FG000|Overall Study|Alternative Treatment|1|||
130313340|NCT00936702|469113637|FG000|Overall Study|Other|1|||
130313341|NCT02532465|469113638|FG000|Overall Study|Protocol Violation|1|||
130313342|NCT02532465|469113639|FG001|Overall Study|Protocol Violation|0|||
130313343|NCT02532465|469113638|FG000|Overall Study|Lack of Efficacy|0|||
130313344|NCT02532465|469113639|FG001|Overall Study|Lack of Efficacy|1|||
130313345|NCT00354679|469113644|FG000|Overall Study|Patient Not Treated|1|||
130313346|NCT00622505|469113646|FG000|Overall Study|Adverse Event|9|||
130313347|NCT00622505|469113647|FG001|Overall Study|Adverse Event|7|||
130313348|NCT00622505|469113646|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
130313349|NCT00622505|469113647|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
130313350|NCT00622505|469113646|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130313351|NCT00622505|469113647|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130313352|NCT00622505|469113646|FG000|Overall Study|Withdrawal by Subject|12|||
130313353|NCT00622505|469113647|FG001|Overall Study|Withdrawal by Subject|5|||
130313354|NCT00622505|469113646|FG000|Overall Study|Administrative Problems|2|||
130313355|NCT00622505|469113647|FG001|Overall Study|Administrative Problems|4|||
130313356|NCT00622505|469113646|FG000|Overall Study|Death|2|||
130313357|NCT00622505|469113647|FG001|Overall Study|Death|2|||
130313358|NCT02420093|469113650|FG000|Overall Study|Withdrawal by Subject|1|||
130313359|NCT02420093|469113651|FG001|Overall Study|Withdrawal by Subject|1|||
130313360|NCT03244917|469113654|FG000|Overall Study|Lost to Follow-up|2|||
130313361|NCT03244917|469113655|FG001|Overall Study|Lost to Follow-up|2|||
130313362|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313363|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313364|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313365|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313366|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313367|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313368|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313369|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130465650|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130718996|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130718997|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
130718998|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
130718999|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
130719000|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
130719001|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719002|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719003|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719004|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
130719005|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719006|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719007|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719008|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
130719009|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
130719010|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
130719011|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
130719012|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
130719013|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719014|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719015|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719016|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
130719017|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Various|0|||
130719018|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Various|0|||
130719019|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Various|0|||
130719020|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Various|25|||
130719021|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130719022|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
130719023|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130719024|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
130719025|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
130719026|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
130313370|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313371|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130465651|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130313372|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130374957|NCT00039130|469338437|FG000|Overall Study|Physician Decision|3|||
130374958|NCT01950741|469338438|FG000|Overall Study|Lost to Follow-up|1|||
130374959|NCT01950741|469338438|FG000|Overall Study|Death|1|||
130374960|NCT01950741|469338438|FG000|Overall Study|Withdrawal by Subject|1|||
130374961|NCT02521870|469338439|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374962|NCT02521870|469338440|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
130374963|NCT02521870|469338441|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374964|NCT02521870|469338442|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130465652|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130465653|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130465654|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130465655|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130465656|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
130465657|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
130465658|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
130465659|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
130465660|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
130465661|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
130465662|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
130313373|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313374|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313375|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313376|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313377|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313378|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313379|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313380|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313381|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130313382|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313383|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130313384|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130313385|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313386|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313387|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313388|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313389|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313390|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313391|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130313392|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
130313393|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
130313394|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
130313395|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
130313396|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
130313397|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
130313398|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
130313399|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
130313400|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
130313401|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
130313402|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
130313403|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
130313404|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
130313405|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
130313406|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
130313407|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313408|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313409|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130374965|NCT02521870|469338443|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130465663|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
130465664|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
130465665|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
130313410|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313411|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313412|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313413|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313414|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313415|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313416|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130374966|NCT02521870|469338444|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374967|NCT02521870|469338445|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130465666|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
130313417|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313418|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313419|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313420|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313421|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313422|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313423|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313424|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313425|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313426|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313427|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313428|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313429|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313430|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313431|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313432|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313433|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313434|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313435|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313436|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313437|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313438|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313439|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313440|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
130313441|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313442|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313443|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313444|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313445|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313446|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313447|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
130313448|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313449|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313450|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313451|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313452|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313453|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313454|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313455|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313456|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313457|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313458|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313459|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313460|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313461|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313462|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313463|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313464|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313465|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313466|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313467|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
130313468|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
130313469|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
130313470|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
130313471|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
130313472|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
130313473|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
130313474|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
130313475|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
130313476|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
130313477|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
130313478|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
130313479|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
130374968|NCT02521870|469338446|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374969|NCT02521870|469338447|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374970|NCT02521870|469338448|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374971|NCT02521870|469338449|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374972|NCT02521870|469338450|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130374973|NCT02521870|469338439|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
130374974|NCT02521870|469338440|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
130374975|NCT02521870|469338441|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
130374976|NCT02521870|469338442|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
130374977|NCT02521870|469338443|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
130374978|NCT02521870|469338444|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
130374979|NCT02521870|469338445|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
130374980|NCT02521870|469338446|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
130374981|NCT02521870|469338447|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
130374982|NCT02521870|469338448|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
130374983|NCT02521870|469338449|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
130374984|NCT02521870|469338450|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
130374985|NCT02521870|469338439|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
130374986|NCT02521870|469338440|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
130374987|NCT02521870|469338441|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
130374988|NCT02521870|469338442|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
130374989|NCT02521870|469338443|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
130374990|NCT02521870|469338444|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
130374991|NCT02521870|469338445|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
130374992|NCT02521870|469338446|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
130374993|NCT02521870|469338447|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
130374994|NCT02521870|469338448|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
130374995|NCT02521870|469338449|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
130374996|NCT02521870|469338450|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
130374997|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130374998|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130374999|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130375000|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130375001|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
130375002|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130375003|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130375004|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130375005|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130375006|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130375007|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
130375008|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130375009|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
130375010|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
130375011|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
130375012|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
130375013|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
130375014|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
130375015|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
130375016|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
130375017|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
130375018|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
130375019|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
130375020|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
130558613|NCT02953639|470014835|FG000|Overall Study|Adverse Event|2|||
130375021|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
130375022|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
130375023|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
130375024|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
130375025|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
130375026|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
130375027|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
130375028|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
130375029|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
130375030|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
130375031|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
130375032|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
130375033|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Death|0|||
130375034|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Death|0|||
130375035|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Death|0|||
130375036|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Death|0|||
130375037|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Death|1|||
130375038|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Death|1|||
130375039|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Death|3|||
130375040|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Death|1|||
130375041|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Death|1|||
130558614|NCT02953639|470014836|FG001|Overall Study|Adverse Event|0|||
130465667|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
130465668|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
130465669|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
130465670|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
130313480|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
130313481|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
130313482|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313483|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313484|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313485|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313486|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
130313487|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313488|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313489|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313490|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313491|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313492|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313493|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313494|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313495|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313496|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313497|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313498|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313499|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313500|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
130313501|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313502|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313503|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313504|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313505|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313506|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313507|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313508|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313509|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313510|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313511|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313512|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313513|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313514|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313515|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313516|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313517|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313518|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313519|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313520|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313521|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313522|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130465671|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
130465672|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
130465673|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
130465674|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465675|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465676|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465677|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
130465678|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465679|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465680|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130465681|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130313523|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313524|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313525|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313526|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313527|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313528|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130465682|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
130558615|NCT02953639|470014837|FG002|Overall Study|Adverse Event|1|||
130313529|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313530|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
130313531|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313532|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313533|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313534|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313535|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313536|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313537|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
130313538|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313539|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313540|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313541|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313542|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313543|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313544|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313545|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313546|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313547|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313548|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313549|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313550|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313551|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313552|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313553|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313554|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
130313555|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313556|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313557|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313558|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313559|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130465683|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
130465684|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
130465685|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
130465686|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
130465687|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
130465688|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
130465689|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
130465690|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
130465691|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465692|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465693|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465694|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465695|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
130465696|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465697|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
130465698|NCT03903822|469671971|FG000|Treatment Phase (6 Weeks)|Other|2|||
130465699|NCT03903822|469671972|FG001|Treatment Phase (6 Weeks)|Other|1|||
130465700|NCT03903822|469671973|FG002|Treatment Phase (6 Weeks)|Other|0|||
130465701|NCT03903822|469671974|FG003|Treatment Phase (6 Weeks)|Other|0|||
130465702|NCT03903822|469671975|FG004|Treatment Phase (6 Weeks)|Other|1|||
130465703|NCT03903822|469671976|FG005|Treatment Phase (6 Weeks)|Other|1|||
130465704|NCT03903822|469671977|FG006|Treatment Phase (6 Weeks)|Other|0|||
130465705|NCT03903822|469671978|FG007|Treatment Phase (6 Weeks)|Other|0|||
130465706|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
130465707|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
130465708|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
130465709|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
130465710|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
130465711|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
130465712|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
130465713|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
130313560|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313561|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313562|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313563|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313564|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313565|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313566|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130375042|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Death|5|||
130375043|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Death|2|||
130375044|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Death|2|||
130375045|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Other|0|||
130375046|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Other|0|||
130375047|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Other|0|||
130375048|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Other|0|||
130375049|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Other|10|||
130375050|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Other|3|||
130375051|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Other|2|||
130375052|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Other|0|||
130375053|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Other|10|||
130375054|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Other|5|||
130375055|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Other|1|||
130375056|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Other|7|||
130375057|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375058|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375059|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375060|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375061|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
130375062|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375063|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375064|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375065|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375066|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375067|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375068|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130375069|NCT02521870|469338439|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375070|NCT02521870|469338440|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375071|NCT02521870|469338441|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375072|NCT02521870|469338442|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375073|NCT02521870|469338443|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
130375074|NCT02521870|469338444|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375075|NCT02521870|469338445|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375076|NCT02521870|469338446|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375077|NCT02521870|469338447|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375078|NCT02521870|469338448|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375079|NCT02521870|469338449|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375080|NCT02521870|469338450|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130375081|NCT00519831|469338451|FG000|Overall Study|Adverse Event|3|||
130375082|NCT02854631|469338452|FG000|Overall Study|Adverse Event|1|||
130375083|NCT02854631|469338453|FG001|Overall Study|Adverse Event|2|||
130375084|NCT02854631|469338452|FG000|Overall Study|Withdrew Consent|3|||
130375085|NCT02854631|469338453|FG001|Overall Study|Withdrew Consent|2|||
130375086|NCT02854631|469338452|FG000|Overall Study|Investigator's Discretion|2|||
130375087|NCT02854631|469338453|FG001|Overall Study|Investigator's Discretion|0|||
130375088|NCT02854631|469338452|FG000|Overall Study|Death|12|||
130375089|NCT02854631|469338453|FG001|Overall Study|Death|8|||
130375090|NCT02854631|469338452|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
130375091|NCT02854631|469338453|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
130375092|NCT02854631|469338452|FG000|Overall Study|Protocol Violation|0|||
130375093|NCT02854631|469338453|FG001|Overall Study|Protocol Violation|1|||
130375094|NCT02854631|469338452|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
130375095|NCT02854631|469338453|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
130375096|NCT02854631|469338452|FG000|Overall Study|Lost to Follow-up|4|||
130375097|NCT02854631|469338453|FG001|Overall Study|Lost to Follow-up|2|||
130375098|NCT03200860|469338454|FG000|Overall Study|Withdrawal by Subject|1|||
130375099|NCT03200860|469338455|FG001|Overall Study|Withdrawal by Subject|0|||
130375100|NCT04342897|469338456|FG000|Overall Study|Death|7|||
130375101|NCT04342897|469338457|FG001|Overall Study|Death|4|||
130375102|NCT04342897|469338456|FG000|Overall Study|Lost to Follow-up|6|||
130375103|NCT04342897|469338457|FG001|Overall Study|Lost to Follow-up|6|||
130375104|NCT04342897|469338456|FG000|Overall Study|Withdrawal by Subject|1|||
130375105|NCT04342897|469338457|FG001|Overall Study|Withdrawal by Subject|2|||
130375106|NCT02634320|469338459|FG000|Overall Study|Adverse Event|2|||
130375107|NCT02634320|469338459|FG000|Overall Study|Lost to Follow-up|3|||
130375108|NCT02634320|469338459|FG000|Overall Study|Moved out of area|2|||
130375109|NCT02634320|469338459|FG000|Overall Study|Out of window for study visits|1|||
130375110|NCT02634320|469338459|FG000|Overall Study|Protocol Violation|1|||
130375111|NCT02634320|469338459|FG000|Overall Study|Withdrawal by Subject|5|||
130375112|NCT02634320|469338459|FG000|Overall Study|Lack of Efficacy|2|||
130375113|NCT03919799|469338463|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
130375114|NCT03919799|469338464|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
130375115|NCT03919799|469338465|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
130375116|NCT03919799|469338466|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
130465714|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465715|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465716|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465717|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465718|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
130465719|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465720|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465721|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130465722|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
130465723|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
130465724|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
130465725|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
130465726|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
130465727|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
130465728|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
130465729|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
130465730|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465731|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465732|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465733|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
130465734|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
130465735|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465736|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465737|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
130465738|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
130465739|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
130465740|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
130465741|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
130465742|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
130465743|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
130465744|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
130465745|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
130465746|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465747|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465748|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465749|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465750|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465751|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
130465752|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465753|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130465754|NCT03903822|469671971|FG000|Follow up Phase (4 Weeks)|Other|1|||
130465755|NCT03903822|469671972|FG001|Follow up Phase (4 Weeks)|Other|1|||
130465756|NCT03903822|469671973|FG002|Follow up Phase (4 Weeks)|Other|0|||
130465757|NCT03903822|469671974|FG003|Follow up Phase (4 Weeks)|Other|0|||
130465758|NCT03903822|469671975|FG004|Follow up Phase (4 Weeks)|Other|0|||
130465759|NCT03903822|469671976|FG005|Follow up Phase (4 Weeks)|Other|0|||
130465760|NCT03903822|469671977|FG006|Follow up Phase (4 Weeks)|Other|0|||
130465761|NCT03903822|469671978|FG007|Follow up Phase (4 Weeks)|Other|0|||
130465762|NCT00546754|469671981|FG000|Overall Study|Serious Adverse Event|1|||
130465763|NCT00546754|469671982|FG001|Overall Study|Serious Adverse Event|1|||
130465764|NCT00546754|469671981|FG000|Overall Study|Adverse Event|11|||
130465765|NCT00546754|469671982|FG001|Overall Study|Adverse Event|16|||
130465766|NCT00546754|469671981|FG000|Overall Study|Lack of Efficacy|1|||
130465767|NCT00546754|469671982|FG001|Overall Study|Lack of Efficacy|1|||
130465768|NCT00546754|469671981|FG000|Overall Study|Lost to Follow-up|9|||
130465769|NCT00546754|469671982|FG001|Overall Study|Lost to Follow-up|15|||
130465770|NCT00546754|469671981|FG000|Overall Study|Protocol Violation|3|||
130465771|NCT00546754|469671982|FG001|Overall Study|Protocol Violation|0|||
130465772|NCT00546754|469671981|FG000|Overall Study|Withdrawal by Subject|6|||
130465773|NCT00546754|469671982|FG001|Overall Study|Withdrawal by Subject|7|||
130465774|NCT00546754|469671981|FG000|Overall Study|Dyspnea|1|||
130465775|NCT00546754|469671982|FG001|Overall Study|Dyspnea|0|||
130465776|NCT00546754|469671981|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
130465777|NCT00546754|469671982|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
130465778|NCT00546754|469671981|FG000|Overall Study|Hip Replacement|1|||
130465779|NCT00546754|469671982|FG001|Overall Study|Hip Replacement|0|||
130465780|NCT00546754|469671981|FG000|Overall Study|Suicide|1|||
130465781|NCT00546754|469671982|FG001|Overall Study|Suicide|0|||
130465782|NCT00546754|469671981|FG000|Overall Study|Missing Cooperation|1|||
130465783|NCT00546754|469671982|FG001|Overall Study|Missing Cooperation|0|||
130465784|NCT00546754|469671981|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
130465785|NCT00546754|469671982|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
130465786|NCT00546754|469671981|FG000|Overall Study|Patient's Decision|0|||
130313567|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313568|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313569|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130313570|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130719027|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130719028|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130719029|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130719030|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130719031|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
130719032|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
130719033|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Various|1|||
130719034|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Various|1|||
130719035|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Various|1|||
130719036|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Various|0|||
130719037|NCT01857271|470597321|FG000|Overall Study|Lost to Follow-up|1|||
130719038|NCT03493386|470597322|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719039|NCT03493386|470597323|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130719040|NCT03493386|470597324|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719041|NCT03493386|470597325|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719042|NCT04645966|470597326|FG000|Vaccination Phase|Adverse Event|1|||
130719043|NCT04645966|470597327|FG001|Vaccination Phase|Adverse Event|0|||
130719044|NCT04645966|470597328|FG002|Vaccination Phase|Adverse Event|0|||
130719045|NCT04645966|470597329|FG003|Vaccination Phase|Adverse Event|0|||
130719046|NCT04645966|470597330|FG004|Vaccination Phase|Adverse Event|0|||
130719047|NCT04645966|470597331|FG005|Vaccination Phase|Adverse Event|0|||
130719048|NCT04645966|470597332|FG006|Vaccination Phase|Adverse Event|1|||
130719049|NCT04645966|470597333|FG007|Vaccination Phase|Adverse Event|0|||
130719050|NCT04645966|470597334|FG008|Vaccination Phase|Adverse Event|0|||
130719051|NCT04645966|470597326|FG000|Vaccination Phase|Death|0|||
130719052|NCT04645966|470597327|FG001|Vaccination Phase|Death|0|||
130719053|NCT04645966|470597328|FG002|Vaccination Phase|Death|0|||
130719054|NCT04645966|470597329|FG003|Vaccination Phase|Death|0|||
130719055|NCT04645966|470597330|FG004|Vaccination Phase|Death|0|||
130313571|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130313572|NCT02159066|469113673|FG000|Part I|Adverse Event|7|||
130313573|NCT02159066|469113674|FG001|Part I|Adverse Event|5|||
130313574|NCT02159066|469113675|FG002|Part I|Adverse Event|0|||
130313575|NCT02159066|469113676|FG003|Part I|Adverse Event|0|||
130313576|NCT02159066|469113677|FG004|Part I|Adverse Event|0|||
130313577|NCT02159066|469113678|FG005|Part I|Adverse Event|0|||
130313578|NCT02159066|469113673|FG000|Part I|Death|11|||
130313579|NCT02159066|469113674|FG001|Part I|Death|9|||
130313580|NCT02159066|469113675|FG002|Part I|Death|0|||
130313581|NCT02159066|469113676|FG003|Part I|Death|0|||
130313582|NCT02159066|469113677|FG004|Part I|Death|0|||
130313583|NCT02159066|469113678|FG005|Part I|Death|0|||
130313584|NCT02159066|469113673|FG000|Part I|Progressive Disease|37|||
130313585|NCT02159066|469113674|FG001|Part I|Progressive Disease|46|||
130313586|NCT02159066|469113675|FG002|Part I|Progressive Disease|0|||
130313587|NCT02159066|469113676|FG003|Part I|Progressive Disease|0|||
130313588|NCT02159066|469113677|FG004|Part I|Progressive Disease|0|||
130313589|NCT02159066|469113678|FG005|Part I|Progressive Disease|0|||
130313590|NCT02159066|469113673|FG000|Part I|New Therapy for Study Indication|5|||
130313591|NCT02159066|469113674|FG001|Part I|New Therapy for Study Indication|4|||
130313592|NCT02159066|469113675|FG002|Part I|New Therapy for Study Indication|0|||
130313593|NCT02159066|469113676|FG003|Part I|New Therapy for Study Indication|0|||
130313594|NCT02159066|469113677|FG004|Part I|New Therapy for Study Indication|0|||
130313595|NCT02159066|469113678|FG005|Part I|New Therapy for Study Indication|0|||
130313596|NCT02159066|469113673|FG000|Part I|Termination of participants from the study|3|||
130313597|NCT02159066|469113674|FG001|Part I|Termination of participants from the study|3|||
130313598|NCT02159066|469113675|FG002|Part I|Termination of participants from the study|0|||
130313599|NCT02159066|469113676|FG003|Part I|Termination of participants from the study|0|||
130313600|NCT02159066|469113677|FG004|Part I|Termination of participants from the study|0|||
130313601|NCT02159066|469113678|FG005|Part I|Termination of participants from the study|0|||
130313602|NCT02159066|469113673|FG000|Part I|Physician Decision|2|||
130313603|NCT02159066|469113674|FG001|Part I|Physician Decision|9|||
130313604|NCT02159066|469113675|FG002|Part I|Physician Decision|0|||
130313605|NCT02159066|469113676|FG003|Part I|Physician Decision|0|||
130313606|NCT02159066|469113677|FG004|Part I|Physician Decision|0|||
130313607|NCT02159066|469113678|FG005|Part I|Physician Decision|0|||
130313608|NCT02159066|469113673|FG000|Part I|Participant/Guardian Decision|9|||
130313609|NCT02159066|469113674|FG001|Part I|Participant/Guardian Decision|3|||
130313610|NCT02159066|469113675|FG002|Part I|Participant/Guardian Decision|0|||
130313611|NCT02159066|469113676|FG003|Part I|Participant/Guardian Decision|0|||
130313612|NCT02159066|469113677|FG004|Part I|Participant/Guardian Decision|0|||
130465787|NCT00546754|469671982|FG001|Overall Study|Patient's Decision|1|||
130465788|NCT00546754|469671981|FG000|Overall Study|Missing|14|||
130465789|NCT00546754|469671982|FG001|Overall Study|Missing|7|||
130465790|NCT03733119|469671983|FG000|Overall Study|Physician Decision|2|||
130465791|NCT03733119|469671984|FG001|Overall Study|Physician Decision|1|||
130465792|NCT03733119|469671983|FG000|Overall Study|ineligible to treat per protocol|0|||
130465793|NCT03733119|469671984|FG001|Overall Study|ineligible to treat per protocol|1|||
130465794|NCT03764475|469671990|FG000|Overall Study|Adverse Event|11|||
130465795|NCT03764475|469671991|FG001|Overall Study|Adverse Event|2|||
130465796|NCT03764475|469671990|FG000|Overall Study|Lost to Follow-up|24|||
130465797|NCT03764475|469671991|FG001|Overall Study|Lost to Follow-up|10|||
130465798|NCT03764475|469671990|FG000|Overall Study|Withdrawal by Subject|26|||
130465799|NCT03764475|469671991|FG001|Overall Study|Withdrawal by Subject|10|||
130465800|NCT03764475|469671990|FG000|Overall Study|Lack of Efficacy|3|||
130465801|NCT03764475|469671991|FG001|Overall Study|Lack of Efficacy|0|||
130465802|NCT03764475|469671990|FG000|Overall Study|COVID-19 Disruption|2|||
130465803|NCT03764475|469671991|FG001|Overall Study|COVID-19 Disruption|0|||
130465804|NCT00390299|469671992|FG000|Overall Study|Cancellation|1|||
130465805|NCT00390299|469671993|FG001|Overall Study|Cancellation|0|||
130465806|NCT00390299|469671994|FG002|Overall Study|Cancellation|0|||
130465807|NCT00390299|469671995|FG003|Overall Study|Cancellation|0|||
130465808|NCT00390299|469671996|FG004|Overall Study|Cancellation|0|||
130465809|NCT00970359|469671997|FG000|Overall Study|Not Treated|4|||
130465810|NCT01565148|469671998|FG000|Overall Study|Withdrawal by Subject|1|||
130465811|NCT01565148|469671999|FG001|Overall Study|Withdrawal by Subject|1|||
130465812|NCT01565148|469672000|FG002|Overall Study|Withdrawal by Subject|1|||
130465813|NCT01565148|469672001|FG003|Overall Study|Withdrawal by Subject|2|||
130465814|NCT01565148|469671998|FG000|Overall Study|Lost to Follow-up|4|||
130465815|NCT01565148|469671999|FG001|Overall Study|Lost to Follow-up|4|||
130465816|NCT01565148|469672000|FG002|Overall Study|Lost to Follow-up|0|||
130465817|NCT01565148|469672001|FG003|Overall Study|Lost to Follow-up|3|||
130465818|NCT01565148|469671998|FG000|Overall Study|Rescue Therapy|8|||
130465819|NCT01565148|469671999|FG001|Overall Study|Rescue Therapy|5|||
130465820|NCT01565148|469672000|FG002|Overall Study|Rescue Therapy|5|||
130465821|NCT01565148|469672001|FG003|Overall Study|Rescue Therapy|8|||
130465822|NCT01565148|469671998|FG000|Overall Study|Death|0|||
130465823|NCT01565148|469671999|FG001|Overall Study|Death|0|||
130465824|NCT01565148|469672000|FG002|Overall Study|Death|1|||
130465825|NCT01565148|469672001|FG003|Overall Study|Death|0|||
130465826|NCT01565148|469671998|FG000|Overall Study|Physician Decision|2|||
130465827|NCT01565148|469671999|FG001|Overall Study|Physician Decision|5|||
130465828|NCT01565148|469672000|FG002|Overall Study|Physician Decision|0|||
130465829|NCT01565148|469672001|FG003|Overall Study|Physician Decision|0|||
130465830|NCT01061671|469672002|FG000|Overall Study|Withdrawal by Subject|16|||
130465831|NCT01061671|469672003|FG001|Overall Study|Withdrawal by Subject|20|||
130465832|NCT01061671|469672002|FG000|Overall Study|Lost to Follow-up|3|||
130465833|NCT01061671|469672003|FG001|Overall Study|Lost to Follow-up|5|||
130465834|NCT01061671|469672002|FG000|Overall Study|Death|28|||
130465835|NCT01061671|469672003|FG001|Overall Study|Death|30|||
130465836|NCT05368831|469672004|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
130465837|NCT01692730|469672012|FG000|Overall Study|Lost to Follow-up|225|||
130465838|NCT01692730|469672013|FG001|Overall Study|Lost to Follow-up|227|||
130465839|NCT01199575|469672014|FG000|Overall Study|Withdrawal by Subject|5|||
130465840|NCT01849055|469672015|FG000|Overall Study|Withdrawal by Subject|0|||
130465841|NCT01849055|469672016|FG001|Overall Study|Withdrawal by Subject|0|||
130465842|NCT01849055|469672017|FG002|Overall Study|Withdrawal by Subject|1|||
130465843|NCT01849055|469672018|FG003|Overall Study|Withdrawal by Subject|0|||
130465844|NCT01849055|469672019|FG004|Overall Study|Withdrawal by Subject|0|||
130465845|NCT01849055|469672020|FG005|Overall Study|Withdrawal by Subject|0|||
130313613|NCT02159066|469113678|FG005|Part I|Participant/Guardian Decision|0|||
130313614|NCT02159066|469113673|FG000|Part I|Missing Data|1|||
130313615|NCT02159066|469113674|FG001|Part I|Missing Data|0|||
130465846|NCT00223795|469672021|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
130465847|NCT00223795|469672022|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
130313616|NCT02159066|469113675|FG002|Part I|Missing Data|0|||
130313617|NCT02159066|469113676|FG003|Part I|Missing Data|0|||
130465848|NCT00223795|469672021|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
130465849|NCT00223795|469672022|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
130465850|NCT01239316|469672023|FG000|Overall Study|Progression/Relapse|11|||
130465851|NCT01239316|469672023|FG000|Overall Study|Adverse Event|1|||
130465852|NCT02139943|469672028|FG000|Overall Study|Adverse Event|0|||
130465853|NCT02139943|469672029|FG001|Overall Study|Adverse Event|1|||
130465854|NCT02139943|469672030|FG002|Overall Study|Adverse Event|2|||
130465855|NCT02139943|469672028|FG000|Overall Study|Lost to Follow-up|3|||
130465856|NCT02139943|469672029|FG001|Overall Study|Lost to Follow-up|2|||
130465857|NCT02139943|469672030|FG002|Overall Study|Lost to Follow-up|2|||
130465858|NCT02139943|469672028|FG000|Overall Study|Withdrawal by Subject|4|||
130465859|NCT02139943|469672029|FG001|Overall Study|Withdrawal by Subject|3|||
130465860|NCT02139943|469672030|FG002|Overall Study|Withdrawal by Subject|0|||
130465861|NCT02139943|469672028|FG000|Overall Study|Other|0|||
130465862|NCT02139943|469672029|FG001|Overall Study|Other|0|||
130465863|NCT02139943|469672030|FG002|Overall Study|Other|1|||
130465864|NCT02139943|469672028|FG000|Overall Study|Participant wishes to discontinue|2|||
130465865|NCT02139943|469672029|FG001|Overall Study|Participant wishes to discontinue|0|||
130465866|NCT02139943|469672030|FG002|Overall Study|Participant wishes to discontinue|0|||
130465867|NCT02139943|469672028|FG000|Overall Study|Participant in Poor Compliance|1|||
130465868|NCT02139943|469672029|FG001|Overall Study|Participant in Poor Compliance|0|||
130465869|NCT02139943|469672030|FG002|Overall Study|Participant in Poor Compliance|1|||
130465870|NCT02139943|469672028|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
130465871|NCT02139943|469672029|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
130465872|NCT02139943|469672030|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
130465873|NCT03750968|469672033|FG000|Overall Study|Adverse Event|2|||
130465874|NCT03750968|469672034|FG001|Overall Study|Adverse Event|0|||
130465875|NCT03750968|469672033|FG000|Overall Study|Lost to Follow-up|1|||
130465876|NCT03750968|469672034|FG001|Overall Study|Lost to Follow-up|3|||
130465877|NCT00088413|469672036|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
130465878|NCT00088413|469672037|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
130465879|NCT00088413|469672038|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
130465880|NCT00088413|469672039|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
130465881|NCT00088413|469672036|FG000|Overall Study|Adverse Events/Side Effects|0|||
130465882|NCT00088413|469672037|FG001|Overall Study|Adverse Events/Side Effects|1|||
130465883|NCT00088413|469672038|FG002|Overall Study|Adverse Events/Side Effects|1|||
130465884|NCT00088413|469672039|FG003|Overall Study|Adverse Events/Side Effects|0|||
130465885|NCT00088413|469672036|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
130465886|NCT00088413|469672037|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
130465887|NCT00088413|469672038|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
130465888|NCT00088413|469672039|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
130465889|NCT00088413|469672036|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
130465890|NCT00088413|469672037|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
130465891|NCT00088413|469672038|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
130465892|NCT00088413|469672039|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
130465893|NCT00088413|469672036|FG000|Overall Study|Death|0|||
130465894|NCT00088413|469672037|FG001|Overall Study|Death|1|||
130465895|NCT00088413|469672038|FG002|Overall Study|Death|0|||
130465896|NCT00088413|469672039|FG003|Overall Study|Death|0|||
130465897|NCT00088413|469672036|FG000|Overall Study|Progressive disease|9|||
130465898|NCT00088413|469672037|FG001|Overall Study|Progressive disease|11|||
130465899|NCT00088413|469672038|FG002|Overall Study|Progressive disease|8|||
130465900|NCT00088413|469672039|FG003|Overall Study|Progressive disease|14|||
130465901|NCT00088413|469672036|FG000|Overall Study|Other|0|||
130465902|NCT00088413|469672037|FG001|Overall Study|Other|1|||
130465903|NCT00088413|469672038|FG002|Overall Study|Other|0|||
130465904|NCT00088413|469672039|FG003|Overall Study|Other|0|||
130465905|NCT00088413|469672036|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
130465906|NCT00088413|469672037|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
130465907|NCT00088413|469672038|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
130465908|NCT00088413|469672039|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
130465909|NCT00632424|469672040|FG000|Overall Study|Disease Progression|17|||
130465910|NCT00632424|469672040|FG000|Overall Study|Study Drug Toxicity|1|||
130465911|NCT02531113|469672041|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
130465912|NCT02531113|469672041|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
130465913|NCT02531113|469672041|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
130465914|NCT02531113|469672041|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
130465915|NCT02531113|469672041|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
130465916|NCT02531113|469672041|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
130465917|NCT02531113|469672041|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
130465918|NCT02531113|469672041|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
130465919|NCT05644444|469673512|FG000|Tolerance Phase|Adverse Event|0|||
130465920|NCT05644444|469673513|FG001|Tolerance Phase|Adverse Event|2|||
130465921|NCT05644444|469673512|FG000|Treatment Phase|Adverse Event|0|||
130465922|NCT05644444|469673513|FG001|Treatment Phase|Adverse Event|2|||
130465923|NCT04817670|469673514|FG000|Overall Study|Withdrawal by Subject|1|||
130465924|NCT04817670|469673515|FG001|Overall Study|Withdrawal by Subject|0|||
130465925|NCT04817670|469673516|FG002|Overall Study|Withdrawal by Subject|0|||
130465926|NCT04817670|469673517|FG003|Overall Study|Withdrawal by Subject|0|||
130465927|NCT04817670|469673518|FG004|Overall Study|Withdrawal by Subject|0|||
130465928|NCT04817670|469673514|FG000|Overall Study|Lost to Follow-up|0|||
130465929|NCT04817670|469673515|FG001|Overall Study|Lost to Follow-up|0|||
130719056|NCT04645966|470597331|FG005|Vaccination Phase|Death|1|||
130465930|NCT04817670|469673516|FG002|Overall Study|Lost to Follow-up|1|||
130465931|NCT04817670|469673517|FG003|Overall Study|Lost to Follow-up|0|||
130465932|NCT04817670|469673518|FG004|Overall Study|Lost to Follow-up|0|||
130465933|NCT03312907|469673519|FG000|Overall Study|Adverse Event|1|||
130719057|NCT04645966|470597332|FG006|Vaccination Phase|Death|0|||
130465934|NCT03312907|469673520|FG001|Overall Study|Adverse Event|6|||
130465935|NCT03312907|469673521|FG002|Overall Study|Adverse Event|1|||
130465936|NCT03312907|469673519|FG000|Overall Study|Protocol Violation|2|||
130465937|NCT03312907|469673520|FG001|Overall Study|Protocol Violation|3|||
130465938|NCT03312907|469673521|FG002|Overall Study|Protocol Violation|4|||
130465939|NCT03312907|469673519|FG000|Overall Study|Lost to Follow-up|2|||
130465940|NCT03312907|469673520|FG001|Overall Study|Lost to Follow-up|3|||
130465941|NCT03312907|469673521|FG002|Overall Study|Lost to Follow-up|2|||
130465942|NCT03312907|469673519|FG000|Overall Study|Physician Decision|3|||
130465943|NCT03312907|469673520|FG001|Overall Study|Physician Decision|4|||
130465944|NCT03312907|469673521|FG002|Overall Study|Physician Decision|2|||
130465945|NCT03312907|469673519|FG000|Overall Study|Withdrawal by Subject|9|||
130465946|NCT03312907|469673520|FG001|Overall Study|Withdrawal by Subject|14|||
130465947|NCT03312907|469673521|FG002|Overall Study|Withdrawal by Subject|10|||
130465948|NCT03112174|469673525|FG000|Overall Study|Withdrawal by Subject|3|||
130465949|NCT03112174|469673526|FG001|Overall Study|Withdrawal by Subject|0|||
130465950|NCT03112174|469673527|FG002|Overall Study|Withdrawal by Subject|11|||
130465951|NCT03112174|469673528|FG003|Overall Study|Withdrawal by Subject|9|||
130465952|NCT03112174|469673529|FG004|Overall Study|Withdrawal by Subject|7|||
130465953|NCT03112174|469673525|FG000|Overall Study|Lost to Follow-up|1|||
130465954|NCT03112174|469673526|FG001|Overall Study|Lost to Follow-up|1|||
130465955|NCT03112174|469673527|FG002|Overall Study|Lost to Follow-up|2|||
130465956|NCT03112174|469673528|FG003|Overall Study|Lost to Follow-up|3|||
130465957|NCT03112174|469673529|FG004|Overall Study|Lost to Follow-up|2|||
130465958|NCT03112174|469673525|FG000|Overall Study|Death|8|||
130465959|NCT03112174|469673526|FG001|Overall Study|Death|3|||
130465960|NCT03112174|469673527|FG002|Overall Study|Death|67|||
130465961|NCT03112174|469673528|FG003|Overall Study|Death|73|||
130465962|NCT03112174|469673529|FG004|Overall Study|Death|18|||
130465963|NCT03112174|469673525|FG000|Overall Study|Other, Not Specified|1|||
130465964|NCT03112174|469673526|FG001|Overall Study|Other, Not Specified|0|||
130465965|NCT03112174|469673527|FG002|Overall Study|Other, Not Specified|1|||
130465966|NCT03112174|469673528|FG003|Overall Study|Other, Not Specified|2|||
130465967|NCT03112174|469673529|FG004|Overall Study|Other, Not Specified|0|||
130465968|NCT04259450|469673532|FG000|Overall Study|Adverse event/ Toxicity|0|||
130465969|NCT04259450|469673533|FG001|Overall Study|Adverse event/ Toxicity|3|||
130465970|NCT04259450|469673534|FG002|Overall Study|Adverse event/ Toxicity|0|||
130465971|NCT04259450|469673535|FG003|Overall Study|Adverse event/ Toxicity|1|||
130465972|NCT04259450|469673536|FG004|Overall Study|Adverse event/ Toxicity|0|||
130465973|NCT04259450|469673537|FG005|Overall Study|Adverse event/ Toxicity|0|||
130465974|NCT04259450|469673538|FG006|Overall Study|Adverse event/ Toxicity|0|||
130465975|NCT04259450|469673539|FG007|Overall Study|Adverse event/ Toxicity|1|||
130465976|NCT04259450|469673540|FG008|Overall Study|Adverse event/ Toxicity|0|||
130465977|NCT04259450|469673541|FG009|Overall Study|Adverse event/ Toxicity|3|||
130465978|NCT04259450|469673532|FG000|Overall Study|Disease progression|2|||
130465979|NCT04259450|469673533|FG001|Overall Study|Disease progression|3|||
130465980|NCT04259450|469673534|FG002|Overall Study|Disease progression|4|||
130465981|NCT04259450|469673535|FG003|Overall Study|Disease progression|4|||
130465982|NCT04259450|469673536|FG004|Overall Study|Disease progression|6|||
130465983|NCT04259450|469673537|FG005|Overall Study|Disease progression|6|||
130465984|NCT04259450|469673538|FG006|Overall Study|Disease progression|6|||
130465985|NCT04259450|469673539|FG007|Overall Study|Disease progression|15|||
130465986|NCT04259450|469673540|FG008|Overall Study|Disease progression|6|||
130465987|NCT04259450|469673541|FG009|Overall Study|Disease progression|18|||
130465988|NCT04259450|469673532|FG000|Overall Study|Death|0|||
130465989|NCT04259450|469673533|FG001|Overall Study|Death|0|||
130465990|NCT04259450|469673534|FG002|Overall Study|Death|0|||
130465991|NCT04259450|469673535|FG003|Overall Study|Death|0|||
130465992|NCT04259450|469673536|FG004|Overall Study|Death|0|||
130465993|NCT04259450|469673537|FG005|Overall Study|Death|0|||
130465994|NCT04259450|469673538|FG006|Overall Study|Death|0|||
130465995|NCT04259450|469673539|FG007|Overall Study|Death|1|||
130465996|NCT04259450|469673540|FG008|Overall Study|Death|1|||
130465997|NCT04259450|469673541|FG009|Overall Study|Death|0|||
130465998|NCT04259450|469673532|FG000|Overall Study|Withdrawal by Subject|0|||
130465999|NCT04259450|469673533|FG001|Overall Study|Withdrawal by Subject|0|||
130466000|NCT04259450|469673534|FG002|Overall Study|Withdrawal by Subject|0|||
130466001|NCT04259450|469673535|FG003|Overall Study|Withdrawal by Subject|0|||
130466002|NCT04259450|469673536|FG004|Overall Study|Withdrawal by Subject|0|||
130466003|NCT04259450|469673537|FG005|Overall Study|Withdrawal by Subject|0|||
130466004|NCT04259450|469673538|FG006|Overall Study|Withdrawal by Subject|0|||
130466005|NCT04259450|469673539|FG007|Overall Study|Withdrawal by Subject|1|||
130466006|NCT04259450|469673540|FG008|Overall Study|Withdrawal by Subject|0|||
130466007|NCT04259450|469673541|FG009|Overall Study|Withdrawal by Subject|0|||
130466008|NCT04259450|469673532|FG000|Overall Study|Other than listed|0|||
130466009|NCT04259450|469673533|FG001|Overall Study|Other than listed|0|||
130466010|NCT04259450|469673534|FG002|Overall Study|Other than listed|0|||
130466011|NCT04259450|469673535|FG003|Overall Study|Other than listed|0|||
130466012|NCT04259450|469673536|FG004|Overall Study|Other than listed|0|||
130466013|NCT04259450|469673537|FG005|Overall Study|Other than listed|0|||
130466014|NCT04259450|469673538|FG006|Overall Study|Other than listed|0|||
130466015|NCT04259450|469673539|FG007|Overall Study|Other than listed|1|||
130466016|NCT04259450|469673540|FG008|Overall Study|Other than listed|1|||
130466017|NCT04259450|469673541|FG009|Overall Study|Other than listed|2|||
130466018|NCT01534494|469673542|FG000|Overall Study|Withdrawal by Subject|1|||
130466019|NCT02724592|469673543|FG000|Overall Study|Lost to Follow-up|4|||
130466020|NCT02724592|469673544|FG001|Overall Study|Lost to Follow-up|1|||
130466021|NCT02584829|469673545|FG000|Overall Study|Physician Decision|1|||
130466022|NCT02584829|469673546|FG001|Overall Study|Physician Decision|0|||
130466023|NCT02584829|469673545|FG000|Overall Study|Withdrawal by Subject|0|||
130466024|NCT02584829|469673546|FG001|Overall Study|Withdrawal by Subject|1|||
130466025|NCT02584829|469673545|FG000|Overall Study|Progressive Disease|0|||
130466026|NCT02584829|469673546|FG001|Overall Study|Progressive Disease|3|||
130466027|NCT00434304|469673552|FG000|Overall Study|Adverse Event|14|||
130466028|NCT00434304|469673552|FG000|Overall Study|Lack of Efficacy|2|||
130466029|NCT00434304|469673552|FG000|Overall Study|Withdrawal by Subject|4|||
130466030|NCT05262738|469673553|FG000|Overall Study|Withdrawal by Subject|1|||
130466031|NCT05262738|469673554|FG001|Overall Study|Withdrawal by Subject|0|||
130466032|NCT02374463|469673555|FG000|Overall Study|Withdrawal by Subject|3|||
130466033|NCT02374463|469673556|FG001|Overall Study|Withdrawal by Subject|3|||
130466034|NCT01939899|469673563|FG000|Lead-in Dose Finding Phase|Death|0|||
130466035|NCT01939899|469673564|FG001|Lead-in Dose Finding Phase|Death|3|||
130466036|NCT01939899|469673565|FG002|Lead-in Dose Finding Phase|Death|1|||
130466037|NCT01939899|469673566|FG003|Lead-in Dose Finding Phase|Death|0|||
130466038|NCT01939899|469673567|FG004|Lead-in Dose Finding Phase|Death|0|||
130466039|NCT01939899|469673563|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
130466040|NCT01939899|469673564|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
130466041|NCT01939899|469673565|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
130466042|NCT01939899|469673566|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
130466043|NCT01939899|469673567|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
130466044|NCT01939899|469673563|FG000|Lead-in Dose Finding Phase|Other|0|||
130466045|NCT01939899|469673564|FG001|Lead-in Dose Finding Phase|Other|0|||
130466046|NCT01939899|469673565|FG002|Lead-in Dose Finding Phase|Other|1|||
130466047|NCT01939899|469673566|FG003|Lead-in Dose Finding Phase|Other|0|||
130466048|NCT01939899|469673567|FG004|Lead-in Dose Finding Phase|Other|0|||
130466049|NCT01939899|469673563|FG000|Phase 2|Withdrawal by Subject|0|||
130466050|NCT01939899|469673564|FG001|Phase 2|Withdrawal by Subject|0|||
130466051|NCT01939899|469673565|FG002|Phase 2|Withdrawal by Subject|0|||
130466052|NCT01939899|469673566|FG003|Phase 2|Withdrawal by Subject|2|||
130466053|NCT01939899|469673567|FG004|Phase 2|Withdrawal by Subject|0|||
130466054|NCT01939899|469673563|FG000|Phase 2|Disease Progression|0|||
130466055|NCT01939899|469673564|FG001|Phase 2|Disease Progression|0|||
130466056|NCT01939899|469673565|FG002|Phase 2|Disease Progression|0|||
130466057|NCT01939899|469673566|FG003|Phase 2|Disease Progression|9|||
130466058|NCT01939899|469673567|FG004|Phase 2|Disease Progression|1|||
130466059|NCT00585052|469673568|FG000|Overall Study|Withdrawal by Subject|1|||
130719058|NCT04645966|470597333|FG007|Vaccination Phase|Death|0|||
130719059|NCT04645966|470597334|FG008|Vaccination Phase|Death|0|||
130719060|NCT04645966|470597326|FG000|Vaccination Phase|Protocol Violation|0|||
130719061|NCT04645966|470597327|FG001|Vaccination Phase|Protocol Violation|0|||
130313618|NCT02159066|469113677|FG004|Part I|Missing Data|0|||
130313619|NCT02159066|469113678|FG005|Part I|Missing Data|0|||
130313620|NCT02159066|469113673|FG000|Part II|Adverse Event|0|||
130313621|NCT02159066|469113674|FG001|Part II|Adverse Event|0|||
130313622|NCT02159066|469113675|FG002|Part II|Adverse Event|1|||
130313623|NCT02159066|469113676|FG003|Part II|Adverse Event|0|||
130313624|NCT02159066|469113677|FG004|Part II|Adverse Event|1|||
130313625|NCT02159066|469113678|FG005|Part II|Adverse Event|1|||
130313626|NCT02159066|469113673|FG000|Part II|Death|0|||
130313627|NCT02159066|469113674|FG001|Part II|Death|0|||
130313628|NCT02159066|469113675|FG002|Part II|Death|1|||
130313629|NCT02159066|469113676|FG003|Part II|Death|0|||
130313630|NCT02159066|469113677|FG004|Part II|Death|2|||
130313631|NCT02159066|469113678|FG005|Part II|Death|1|||
130313632|NCT02159066|469113673|FG000|Part II|Progressive Disease|0|||
130313633|NCT02159066|469113674|FG001|Part II|Progressive Disease|0|||
130313634|NCT02159066|469113675|FG002|Part II|Progressive Disease|35|||
130313635|NCT02159066|469113676|FG003|Part II|Progressive Disease|1|||
130313636|NCT02159066|469113677|FG004|Part II|Progressive Disease|7|||
130313637|NCT02159066|469113678|FG005|Part II|Progressive Disease|4|||
130313638|NCT02159066|469113673|FG000|Part II|New Therapy for Study Indication|0|||
130313639|NCT02159066|469113674|FG001|Part II|New Therapy for Study Indication|0|||
130466060|NCT04723394|469673569|FG000|Overall Study|Adverse Event|0|||
130719062|NCT04645966|470597328|FG002|Vaccination Phase|Protocol Violation|0|||
130313640|NCT02159066|469113675|FG002|Part II|New Therapy for Study Indication|0|||
130313641|NCT02159066|469113676|FG003|Part II|New Therapy for Study Indication|0|||
130313642|NCT02159066|469113677|FG004|Part II|New Therapy for Study Indication|1|||
130313643|NCT02159066|469113678|FG005|Part II|New Therapy for Study Indication|0|||
130313644|NCT02159066|469113673|FG000|Part II|Physician Decision|0|||
130466061|NCT04723394|469673570|FG001|Overall Study|Adverse Event|3|||
130466062|NCT04723394|469673569|FG000|Overall Study|Death|8|||
130466063|NCT04723394|469673570|FG001|Overall Study|Death|8|||
130466064|NCT04723394|469673569|FG000|Overall Study|Lost to Follow-up|20|||
130466065|NCT04723394|469673570|FG001|Overall Study|Lost to Follow-up|17|||
130466066|NCT04723394|469673569|FG000|Overall Study|Physician Decision|1|||
130466067|NCT04723394|469673570|FG001|Overall Study|Physician Decision|0|||
130466068|NCT04723394|469673569|FG000|Overall Study|Withdrawal by Subject|20|||
130466069|NCT04723394|469673570|FG001|Overall Study|Withdrawal by Subject|34|||
130466070|NCT04723394|469673569|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
130466071|NCT04723394|469673570|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
130466072|NCT00774397|469673571|FG000|Overall Study|Adverse Event|1|||
130466073|NCT00774397|469673572|FG001|Overall Study|Adverse Event|3|||
130466074|NCT00774397|469673573|FG002|Overall Study|Adverse Event|16|||
130466075|NCT00774397|469673574|FG003|Overall Study|Adverse Event|8|||
130466076|NCT00774397|469673575|FG004|Overall Study|Adverse Event|8|||
130466077|NCT00774397|469673576|FG005|Overall Study|Adverse Event|3|||
130466078|NCT00774397|469673577|FG006|Overall Study|Adverse Event|16|||
130466079|NCT00774397|469673571|FG000|Overall Study|Lack of Efficacy|11|||
130466080|NCT00774397|469673572|FG001|Overall Study|Lack of Efficacy|4|||
130466081|NCT00774397|469673573|FG002|Overall Study|Lack of Efficacy|5|||
130466082|NCT00774397|469673574|FG003|Overall Study|Lack of Efficacy|3|||
130719063|NCT04645966|470597329|FG003|Vaccination Phase|Protocol Violation|0|||
130719064|NCT04645966|470597330|FG004|Vaccination Phase|Protocol Violation|1|||
130719065|NCT04645966|470597331|FG005|Vaccination Phase|Protocol Violation|0|||
130719066|NCT04645966|470597332|FG006|Vaccination Phase|Protocol Violation|0|||
130719067|NCT04645966|470597333|FG007|Vaccination Phase|Protocol Violation|0|||
130719068|NCT04645966|470597334|FG008|Vaccination Phase|Protocol Violation|0|||
130719069|NCT04645966|470597326|FG000|Vaccination Phase|Study terminated by sponsor|0|||
130719070|NCT04645966|470597327|FG001|Vaccination Phase|Study terminated by sponsor|0|||
130719071|NCT04645966|470597328|FG002|Vaccination Phase|Study terminated by sponsor|14|||
130719072|NCT04645966|470597329|FG003|Vaccination Phase|Study terminated by sponsor|15|||
130719073|NCT04645966|470597330|FG004|Vaccination Phase|Study terminated by sponsor|47|||
130719074|NCT04645966|470597331|FG005|Vaccination Phase|Study terminated by sponsor|43|||
130719075|NCT04645966|470597332|FG006|Vaccination Phase|Study terminated by sponsor|29|||
130719076|NCT04645966|470597333|FG007|Vaccination Phase|Study terminated by sponsor|29|||
130719077|NCT04645966|470597334|FG008|Vaccination Phase|Study terminated by sponsor|12|||
130719078|NCT04645966|470597326|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719079|NCT04645966|470597327|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719080|NCT04645966|470597328|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
130719081|NCT04645966|470597329|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
130719082|NCT04645966|470597330|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
130719083|NCT04645966|470597331|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
130719084|NCT04645966|470597332|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719085|NCT04645966|470597333|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
130719086|NCT04645966|470597334|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719087|NCT04645966|470597326|FG000|Vaccination Phase|Other|0|||
130719088|NCT04645966|470597327|FG001|Vaccination Phase|Other|0|||
130719089|NCT04645966|470597328|FG002|Vaccination Phase|Other|0|||
130719090|NCT04645966|470597329|FG003|Vaccination Phase|Other|0|||
130719091|NCT04645966|470597330|FG004|Vaccination Phase|Other|0|||
130719092|NCT04645966|470597331|FG005|Vaccination Phase|Other|2|||
130719093|NCT04645966|470597332|FG006|Vaccination Phase|Other|0|||
130719094|NCT04645966|470597333|FG007|Vaccination Phase|Other|0|||
130719095|NCT04645966|470597334|FG008|Vaccination Phase|Other|0|||
130719096|NCT04645966|470597326|FG000|Vaccination Phase|Lost to Follow-up|0|||
130719097|NCT04645966|470597327|FG001|Vaccination Phase|Lost to Follow-up|0|||
130719098|NCT04645966|470597328|FG002|Vaccination Phase|Lost to Follow-up|0|||
130719099|NCT04645966|470597329|FG003|Vaccination Phase|Lost to Follow-up|0|||
130719100|NCT04645966|470597330|FG004|Vaccination Phase|Lost to Follow-up|0|||
130719101|NCT04645966|470597331|FG005|Vaccination Phase|Lost to Follow-up|0|||
130719102|NCT04645966|470597332|FG006|Vaccination Phase|Lost to Follow-up|0|||
130719103|NCT04645966|470597333|FG007|Vaccination Phase|Lost to Follow-up|1|||
130719104|NCT04645966|470597334|FG008|Vaccination Phase|Lost to Follow-up|0|||
130719105|NCT04645966|470597326|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
130719106|NCT04645966|470597327|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
130719107|NCT04645966|470597328|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
130719108|NCT04645966|470597329|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
130719109|NCT04645966|470597330|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
130719110|NCT04645966|470597331|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
130466083|NCT00774397|469673575|FG004|Overall Study|Lack of Efficacy|27|||
130466084|NCT00774397|469673576|FG005|Overall Study|Lack of Efficacy|15|||
130466085|NCT00774397|469673577|FG006|Overall Study|Lack of Efficacy|9|||
130466086|NCT00774397|469673571|FG000|Overall Study|Protocol Violation|0|||
130719111|NCT04645966|470597332|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
130719112|NCT04645966|470597333|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
130466087|NCT00774397|469673572|FG001|Overall Study|Protocol Violation|1|||
130466088|NCT00774397|469673573|FG002|Overall Study|Protocol Violation|3|||
130466089|NCT00774397|469673574|FG003|Overall Study|Protocol Violation|1|||
130466090|NCT00774397|469673575|FG004|Overall Study|Protocol Violation|2|||
130466091|NCT00774397|469673576|FG005|Overall Study|Protocol Violation|1|||
130466092|NCT00774397|469673577|FG006|Overall Study|Protocol Violation|0|||
130313645|NCT02159066|469113674|FG001|Part II|Physician Decision|0|||
130313646|NCT02159066|469113675|FG002|Part II|Physician Decision|1|||
130313647|NCT02159066|469113676|FG003|Part II|Physician Decision|0|||
130313648|NCT02159066|469113677|FG004|Part II|Physician Decision|0|||
130313649|NCT02159066|469113678|FG005|Part II|Physician Decision|0|||
130313650|NCT02159066|469113673|FG000|Part II|Participant/Guardian Decision|0|||
130313651|NCT02159066|469113674|FG001|Part II|Participant/Guardian Decision|0|||
130313652|NCT02159066|469113675|FG002|Part II|Participant/Guardian Decision|0|||
130313653|NCT02159066|469113676|FG003|Part II|Participant/Guardian Decision|0|||
130313654|NCT02159066|469113677|FG004|Part II|Participant/Guardian Decision|2|||
130313655|NCT02159066|469113678|FG005|Part II|Participant/Guardian Decision|0|||
130313656|NCT00296816|469113694|FG000|Overall Study|Disease Progression|37|||
130313657|NCT00296816|469113694|FG000|Overall Study|Adverse Event|18|||
130313658|NCT00296816|469113694|FG000|Overall Study|Investigator/Participant request|5|||
130313659|NCT00296816|469113694|FG000|Overall Study|Non-compliance|1|||
130313660|NCT00296816|469113694|FG000|Overall Study|Missing for end of treatment|4|||
130313661|NCT00296816|469113694|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
130466093|NCT00774397|469673571|FG000|Overall Study|Lost to Follow-up|0|||
130466094|NCT00774397|469673572|FG001|Overall Study|Lost to Follow-up|1|||
130466095|NCT00774397|469673573|FG002|Overall Study|Lost to Follow-up|1|||
130466096|NCT00774397|469673574|FG003|Overall Study|Lost to Follow-up|1|||
130466097|NCT00774397|469673575|FG004|Overall Study|Lost to Follow-up|0|||
130466098|NCT00774397|469673576|FG005|Overall Study|Lost to Follow-up|1|||
130466099|NCT00774397|469673577|FG006|Overall Study|Lost to Follow-up|0|||
130466100|NCT00774397|469673571|FG000|Overall Study|Refused to continue trial medication|1|||
130466101|NCT00774397|469673572|FG001|Overall Study|Refused to continue trial medication|3|||
130466102|NCT00774397|469673573|FG002|Overall Study|Refused to continue trial medication|2|||
130466103|NCT00774397|469673574|FG003|Overall Study|Refused to continue trial medication|2|||
130466104|NCT00774397|469673575|FG004|Overall Study|Refused to continue trial medication|6|||
130466105|NCT00774397|469673576|FG005|Overall Study|Refused to continue trial medication|2|||
130466106|NCT00774397|469673577|FG006|Overall Study|Refused to continue trial medication|3|||
130466107|NCT00774397|469673571|FG000|Overall Study|Not treated|0|||
130466108|NCT00774397|469673572|FG001|Overall Study|Not treated|0|||
130466109|NCT00774397|469673573|FG002|Overall Study|Not treated|0|||
130466110|NCT00774397|469673574|FG003|Overall Study|Not treated|0|||
130466111|NCT00774397|469673575|FG004|Overall Study|Not treated|1|||
130466112|NCT00774397|469673576|FG005|Overall Study|Not treated|0|||
130466113|NCT00774397|469673577|FG006|Overall Study|Not treated|1|||
130466114|NCT00774397|469673571|FG000|Overall Study|Other than those stated above|1|||
130466115|NCT00774397|469673572|FG001|Overall Study|Other than those stated above|1|||
130466116|NCT00774397|469673573|FG002|Overall Study|Other than those stated above|3|||
130466117|NCT00774397|469673574|FG003|Overall Study|Other than those stated above|2|||
130466118|NCT00774397|469673575|FG004|Overall Study|Other than those stated above|2|||
130466119|NCT00774397|469673576|FG005|Overall Study|Other than those stated above|0|||
130466120|NCT00774397|469673577|FG006|Overall Study|Other than those stated above|1|||
130466121|NCT00858117|469673579|FG000|Treatment on Study|Adverse Event|2|||
130558616|NCT02953639|470014835|FG000|Overall Study|Lost to Follow-up|8|||
130558617|NCT02953639|470014836|FG001|Overall Study|Lost to Follow-up|4|||
130558618|NCT02953639|470014837|FG002|Overall Study|Lost to Follow-up|3|||
130558619|NCT02953639|470014835|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130558620|NCT02953639|470014836|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130558621|NCT02953639|470014837|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130558622|NCT02953639|470014835|FG000|Overall Study|Multiple Reasons|1|||
130558623|NCT02953639|470014836|FG001|Overall Study|Multiple Reasons|0|||
130313662|NCT00296816|469113694|FG000|Overall Study|Poor performance status|1|||
130313663|NCT00296816|469113694|FG000|Overall Study|Relocation to Florida|1|||
130313664|NCT00296816|469113694|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
130466122|NCT00858117|469673579|FG000|Follow up for 5 Years|Death|4|||
130466123|NCT00858117|469673579|FG000|Follow up for 5 Years|No further data collected for study|9|||
130466124|NCT02765100|469673582|FG000|Overall Study|subject found ineligible after baseline|1|||
130466125|NCT02765100|469673583|FG001|Overall Study|subject found ineligible after baseline|1|||
130558624|NCT02953639|470014837|FG002|Overall Study|Multiple Reasons|1|||
130558625|NCT02953639|470014835|FG000|Overall Study|Physician Decision|1|||
130558626|NCT02953639|470014836|FG001|Overall Study|Physician Decision|0|||
130313665|NCT00296816|469113694|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
130313666|NCT00296816|469113694|FG000|Overall Study|Neuropathy/patient preference|1|||
130313667|NCT00296816|469113694|FG000|Overall Study|Proteinuria|1|||
130466126|NCT02765100|469673582|FG000|Overall Study|Lost to Follow-up|0|||
130466127|NCT02765100|469673583|FG001|Overall Study|Lost to Follow-up|1|||
130466128|NCT02652442|469673584|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
130466129|NCT00106080|469673590|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
130466130|NCT00106080|469673591|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
130313668|NCT00296816|469113694|FG000|Overall Study|ineligibility due to radiation treatment|1|||
130313669|NCT01721161|469113695|FG000|Overall Study|Adverse Event|2|||
130313670|NCT01721161|469113696|FG001|Overall Study|Adverse Event|3|||
130313671|NCT01721161|469113695|FG000|Overall Study|Lost to Follow-up|1|||
130466131|NCT03740009|469673592|FG000|Overall Study|Physician Decision|9|||
130466132|NCT03740009|469673592|FG000|Overall Study|Lost to Follow-up|1|||
130466133|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
130466134|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
130466135|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
130466136|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
130466137|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
130466138|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
130466139|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
130466140|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
130466141|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
130466142|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
130466143|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
130466144|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
130466145|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
130466146|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
130466147|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
130466148|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
130466149|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
130466150|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
130466151|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
130466152|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
130466153|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
130313672|NCT01721161|469113696|FG001|Overall Study|Lost to Follow-up|2|||
130313673|NCT01721161|469113695|FG000|Overall Study|Withdrawal by Subject|1|||
130313674|NCT01721161|469113696|FG001|Overall Study|Withdrawal by Subject|1|||
130313675|NCT01721161|469113695|FG000|Overall Study|Other|0|||
130313676|NCT01721161|469113696|FG001|Overall Study|Other|1|||
130313677|NCT03259555|469113714|FG000|Overall Study|Adverse Event|6|||
130313678|NCT03259555|469113715|FG001|Overall Study|Adverse Event|4|||
130313679|NCT03259555|469113714|FG000|Overall Study|Lack of Efficacy|6|||
130313680|NCT03259555|469113715|FG001|Overall Study|Lack of Efficacy|4|||
130313681|NCT03259555|469113714|FG000|Overall Study|Lost to Follow-up|0|||
130313682|NCT03259555|469113715|FG001|Overall Study|Lost to Follow-up|2|||
130313683|NCT03259555|469113714|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130313684|NCT03259555|469113715|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130313685|NCT03259555|469113714|FG000|Overall Study|Progressive Disease|0|||
130313686|NCT03259555|469113715|FG001|Overall Study|Progressive Disease|2|||
130313687|NCT03259555|469113714|FG000|Overall Study|Withdrawal by Subject|19|||
130313688|NCT03259555|469113715|FG001|Overall Study|Withdrawal by Subject|16|||
130313689|NCT03259555|469113714|FG000|Overall Study|Physician Decision|1|||
130313690|NCT03259555|469113715|FG001|Overall Study|Physician Decision|2|||
130313691|NCT03259555|469113714|FG000|Overall Study|Other|1|||
130313692|NCT03259555|469113715|FG001|Overall Study|Other|0|||
130313693|NCT01125800|469113717|FG000|Phase I|Protocol Violation|0|||
130313694|NCT01125800|469113718|FG001|Phase I|Protocol Violation|3|||
130313695|NCT01125800|469113719|FG002|Phase I|Protocol Violation|1|||
130313696|NCT01125800|469113720|FG003|Phase I|Protocol Violation|1|||
130313697|NCT01125800|469113721|FG004|Phase I|Protocol Violation|0|||
130466154|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
130313698|NCT01125800|469113717|FG000|Phase I|Adverse Event|2|||
130313699|NCT01125800|469113718|FG001|Phase I|Adverse Event|2|||
130313700|NCT01125800|469113719|FG002|Phase I|Adverse Event|1|||
130313701|NCT01125800|469113720|FG003|Phase I|Adverse Event|7|||
130313702|NCT01125800|469113721|FG004|Phase I|Adverse Event|0|||
130313703|NCT01125800|469113717|FG000|Phase I|Administrative problems|1|||
130313704|NCT01125800|469113718|FG001|Phase I|Administrative problems|0|||
130313705|NCT01125800|469113719|FG002|Phase I|Administrative problems|0|||
130313706|NCT01125800|469113720|FG003|Phase I|Administrative problems|0|||
130313707|NCT01125800|469113721|FG004|Phase I|Administrative problems|0|||
130313708|NCT01125800|469113717|FG000|Phase I|Withdrawal by Subject|0|||
130313709|NCT01125800|469113718|FG001|Phase I|Withdrawal by Subject|0|||
130313710|NCT01125800|469113719|FG002|Phase I|Withdrawal by Subject|1|||
130313711|NCT01125800|469113720|FG003|Phase I|Withdrawal by Subject|0|||
130313712|NCT01125800|469113721|FG004|Phase I|Withdrawal by Subject|0|||
130466155|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
130466156|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
130313713|NCT01125800|469113717|FG000|Phase I|Disease progression|5|||
130313714|NCT01125800|469113718|FG001|Phase I|Disease progression|4|||
130313715|NCT01125800|469113719|FG002|Phase I|Disease progression|1|||
130313716|NCT01125800|469113720|FG003|Phase I|Disease progression|3|||
130313717|NCT01125800|469113721|FG004|Phase I|Disease progression|0|||
130313718|NCT01125800|469113717|FG000|Phase II|Protocol Violation|0|||
130313719|NCT01125800|469113718|FG001|Phase II|Protocol Violation|0|||
130313720|NCT01125800|469113719|FG002|Phase II|Protocol Violation|0|||
130313721|NCT01125800|469113720|FG003|Phase II|Protocol Violation|0|||
130313722|NCT01125800|469113721|FG004|Phase II|Protocol Violation|1|||
130313723|NCT01125800|469113717|FG000|Phase II|Adverse Event|0|||
130313724|NCT01125800|469113718|FG001|Phase II|Adverse Event|0|||
130313725|NCT01125800|469113719|FG002|Phase II|Adverse Event|0|||
130313726|NCT01125800|469113720|FG003|Phase II|Adverse Event|0|||
130313727|NCT01125800|469113721|FG004|Phase II|Adverse Event|2|||
130313728|NCT01125800|469113717|FG000|Phase II|Disease progression|0|||
130313729|NCT01125800|469113718|FG001|Phase II|Disease progression|0|||
130313730|NCT01125800|469113719|FG002|Phase II|Disease progression|0|||
130313731|NCT01125800|469113720|FG003|Phase II|Disease progression|1|||
130313732|NCT01125800|469113721|FG004|Phase II|Disease progression|8|||
130313733|NCT03370718|469113726|FG000|Overall Study|Withdrawal by Subject|1|||
130313734|NCT04970654|469113729|FG000|Overall Study|Withdrawal by parents/guardian|1|||
130313735|NCT04970654|469113730|FG001|Overall Study|Withdrawal by parents/guardian|2|||
130313736|NCT04970654|469113729|FG000|Overall Study|Unclassified|2|||
130313737|NCT04970654|469113730|FG001|Overall Study|Unclassified|1|||
130313738|NCT04970654|469113729|FG000|Overall Study|Lost to Follow-up|1|||
130313739|NCT04970654|469113730|FG001|Overall Study|Lost to Follow-up|0|||
130313740|NCT06172348|469113733|FG000|Treatment Period 2|Adverse Event|0|||
130313741|NCT06172348|469113734|FG001|Treatment Period 2|Adverse Event|0|||
130313742|NCT06172348|469113735|FG002|Treatment Period 2|Adverse Event|1|||
130313743|NCT06172348|469113736|FG003|Treatment Period 2|Adverse Event|0|||
130313744|NCT06172348|469113737|FG004|Treatment Period 2|Adverse Event|0|||
130313745|NCT06172348|469113738|FG005|Treatment Period 2|Adverse Event|0|||
130313746|NCT01232868|469115935|FG000|Overall Study|Lost to Follow-up|2|||
130313747|NCT01232868|469115936|FG001|Overall Study|Lost to Follow-up|4|||
130313748|NCT04481243|469115937|FG000|Overall Study|Withdrawal by Subject|4|||
130313749|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313750|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
130313751|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313752|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313753|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313754|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130313755|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130313756|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313757|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313758|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313759|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130313760|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130313761|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313762|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313763|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313764|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
130313765|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
130313766|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313767|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313768|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313769|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
130313770|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
130313771|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313772|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313773|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313774|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
130313775|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
130313776|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313777|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313778|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313779|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
130313780|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
130313781|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313782|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313783|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313784|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313785|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
130313786|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313787|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313788|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313789|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313790|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313791|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
130313792|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
130313793|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313794|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313795|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313796|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130313797|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313798|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313799|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313800|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313801|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130313802|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130313803|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313804|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313805|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313806|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
130313807|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313808|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313809|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313810|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313811|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
130313812|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
130313813|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313814|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313815|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313816|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
130313817|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
130375117|NCT03919799|469338467|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
130375118|NCT03919799|469338463|FG000|DB Period (28 Weeks)|Adverse Event|1|||
130375119|NCT03919799|469338464|FG001|DB Period (28 Weeks)|Adverse Event|1|||
130375120|NCT03919799|469338465|FG002|DB Period (28 Weeks)|Adverse Event|1|||
130375121|NCT03919799|469338466|FG003|DB Period (28 Weeks)|Adverse Event|0|||
130375122|NCT03919799|469338467|FG004|DB Period (28 Weeks)|Adverse Event|0|||
130375123|NCT03919799|469338463|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130375124|NCT03919799|469338464|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
130375125|NCT03919799|469338465|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130375126|NCT03919799|469338466|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130375127|NCT03919799|469338467|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130375128|NCT03919799|469338463|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130375129|NCT03919799|469338464|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
130375130|NCT03919799|469338465|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130375131|NCT03919799|469338466|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130375132|NCT03919799|469338467|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130375133|NCT03919799|469338463|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
130375134|NCT03919799|469338464|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
130375135|NCT03919799|469338465|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
130375136|NCT03919799|469338466|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
130375137|NCT03919799|469338467|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
130375138|NCT04656691|469338472|FG000|Overall Study|Adverse Event|1|||
130375139|NCT03199274|469338473|FG000|Overall Study|Withdrawal by Subject|4|||
130375140|NCT03199274|469338474|FG001|Overall Study|Withdrawal by Subject|0|||
130375141|NCT03199274|469338473|FG000|Overall Study|Lost to Follow-up|0|||
130375142|NCT03199274|469338474|FG001|Overall Study|Lost to Follow-up|1|||
130375143|NCT03199274|469338473|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
130375144|NCT03199274|469338474|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
130375145|NCT05980182|469338480|FG000|Overall Study|Lost to Follow-up|10|||
130466157|NCT01061151|469673593|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
130466158|NCT01061151|469673594|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
130466159|NCT01061151|469673595|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
130313818|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313819|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313820|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313821|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
130313822|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
130313823|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313824|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313825|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130466160|NCT01061151|469673596|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
130466161|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
130466162|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
130466163|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
130466164|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
130466165|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
130466166|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
130466167|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
130466168|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
130466169|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
130466170|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
130466171|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
130466172|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
130466173|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
130466174|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
130313826|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313827|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313828|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
130313829|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313830|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313831|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313832|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313833|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
130313834|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313835|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313836|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313837|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313838|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
130313839|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313840|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313841|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313842|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313843|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
130313844|NCT02544321|469115947|FG000|Overall Study|Withdrawal by Subject|1|||
130313845|NCT02544321|469115948|FG001|Overall Study|Withdrawal by Subject|2|||
130313846|NCT02544321|469115947|FG000|Overall Study|Adverse Event|1|||
130313847|NCT02544321|469115948|FG001|Overall Study|Adverse Event|1|||
130313848|NCT02544321|469115947|FG000|Overall Study|Protocol Violation|0|||
130313849|NCT02544321|469115948|FG001|Overall Study|Protocol Violation|1|||
130313850|NCT01517750|469115949|FG000|Overall Study|Lost to Follow-up|1|||
130558627|NCT02953639|470014837|FG002|Overall Study|Physician Decision|0|||
130558628|NCT02953639|470014835|FG000|Overall Study|Withdrawal by Subject|7|||
130558629|NCT02953639|470014836|FG001|Overall Study|Withdrawal by Subject|8|||
130558630|NCT02953639|470014837|FG002|Overall Study|Withdrawal by Subject|10|||
130558631|NCT02953639|470014835|FG000|Overall Study|Completed or Discontinued information is missing|1|||
130558632|NCT02953639|470014836|FG001|Overall Study|Completed or Discontinued information is missing|0|||
130558633|NCT02953639|470014837|FG002|Overall Study|Completed or Discontinued information is missing|0|||
130558634|NCT01830855|470014838|FG000|Overall Study|Other|7|||
130558635|NCT01830855|470014839|FG001|Overall Study|Other|1|||
130558636|NCT01830855|470014840|FG002|Overall Study|Other|4|||
130558637|NCT01830855|470014841|FG003|Overall Study|Other|4|||
130558638|NCT01830855|470014838|FG000|Overall Study|Medication error without associated AE|1|||
130558639|NCT01830855|470014839|FG001|Overall Study|Medication error without associated AE|0|||
130313851|NCT01517750|469115950|FG001|Overall Study|Lost to Follow-up|2|||
130313852|NCT01517750|469115951|FG002|Overall Study|Lost to Follow-up|4|||
130466175|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
130466176|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
130466177|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
130558640|NCT01830855|470014840|FG002|Overall Study|Medication error without associated AE|0|||
130313853|NCT01517750|469115952|FG003|Overall Study|Lost to Follow-up|1|||
130313854|NCT01584232|469115953|FG000|Overall Study|Adverse Event|3|||
130313855|NCT01584232|469115954|FG001|Overall Study|Adverse Event|1|||
130313856|NCT01584232|469115953|FG000|Overall Study|Withdrawal by Subject|2|||
130313857|NCT01584232|469115954|FG001|Overall Study|Withdrawal by Subject|1|||
130313858|NCT01584232|469115953|FG000|Overall Study|Physician Decision|2|||
130313859|NCT01584232|469115954|FG001|Overall Study|Physician Decision|1|||
130313860|NCT01584232|469115953|FG000|Overall Study|Lost to Follow-up|1|||
130313861|NCT01584232|469115954|FG001|Overall Study|Lost to Follow-up|0|||
130313862|NCT01307319|469115955|FG000|Overall Study|Adverse Event|2|||
130313863|NCT01307319|469115956|FG001|Overall Study|Adverse Event|2|||
130313864|NCT01307319|469115957|FG002|Overall Study|Adverse Event|1|||
130313865|NCT01307319|469115955|FG000|Overall Study|Lost to Follow-up|1|||
130558641|NCT01830855|470014841|FG003|Overall Study|Medication error without associated AE|1|||
130558642|NCT01830855|470014838|FG000|Overall Study|Pregnancy|3|||
130558643|NCT01830855|470014839|FG001|Overall Study|Pregnancy|1|||
130558644|NCT01830855|470014840|FG002|Overall Study|Pregnancy|2|||
130558645|NCT01830855|470014841|FG003|Overall Study|Pregnancy|1|||
130558646|NCT01830855|470014838|FG000|Overall Study|No longer meets eligibility criteria|11|||
130558647|NCT01830855|470014839|FG001|Overall Study|No longer meets eligibility criteria|2|||
130558648|NCT01830855|470014840|FG002|Overall Study|No longer meets eligibility criteria|3|||
130558649|NCT01830855|470014841|FG003|Overall Study|No longer meets eligibility criteria|5|||
130558650|NCT01830855|470014838|FG000|Overall Study|Adverse Event|11|||
130313866|NCT01307319|469115956|FG001|Overall Study|Lost to Follow-up|0|||
130313867|NCT01307319|469115957|FG002|Overall Study|Lost to Follow-up|1|||
130313868|NCT01307319|469115955|FG000|Overall Study|Protocol Violation|1|||
130313869|NCT01307319|469115956|FG001|Overall Study|Protocol Violation|1|||
130313870|NCT01307319|469115957|FG002|Overall Study|Protocol Violation|0|||
130313871|NCT01307319|469115955|FG000|Overall Study|Withdrawal by Subject|0|||
130313872|NCT01307319|469115956|FG001|Overall Study|Withdrawal by Subject|1|||
130313873|NCT01307319|469115957|FG002|Overall Study|Withdrawal by Subject|2|||
130313874|NCT01307319|469115955|FG000|Overall Study|Other|0|||
130313875|NCT01307319|469115956|FG001|Overall Study|Other|4|||
130313876|NCT01307319|469115957|FG002|Overall Study|Other|3|||
130313877|NCT03629886|469115959|FG000|Overall Study|Migrated / moved from the study area|0|||
130313878|NCT03629886|469115960|FG001|Overall Study|Migrated / moved from the study area|55|||
130313879|NCT03629886|469115959|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
130313880|NCT03629886|469115960|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
130313881|NCT03629886|469115959|FG000|Overall Study|Study vaccine not administrated|0|||
130313882|NCT03629886|469115960|FG001|Overall Study|Study vaccine not administrated|3|||
130313883|NCT03629886|469115959|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
130313884|NCT03629886|469115960|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
130313885|NCT03629886|469115959|FG000|Overall Study|Refused vaccination step of the study|0|||
130313886|NCT03629886|469115960|FG001|Overall Study|Refused vaccination step of the study|44|||
130375146|NCT05475236|469338481|FG000|Overall Study|Withdrawal by Subject|0|||
130558651|NCT01830855|470014839|FG001|Overall Study|Adverse Event|5|||
130558652|NCT01830855|470014840|FG002|Overall Study|Adverse Event|6|||
130558653|NCT01830855|470014841|FG003|Overall Study|Adverse Event|3|||
130558654|NCT01830855|470014838|FG000|Overall Study|Protocol deviation|10|||
130375147|NCT05475236|469338482|FG001|Overall Study|Withdrawal by Subject|1|||
130375148|NCT00638378|469339722|FG000|Overall Study|Death|2|||
130375149|NCT00638378|469339722|FG000|Overall Study|Adverse Event|1|||
130375150|NCT00638378|469339722|FG000|Overall Study|Disease progression|15|||
130375151|NCT00638378|469339722|FG000|Overall Study|Physician Decision|4|||
130375152|NCT01411774|469339740|FG000|Overall Study|Withdrawal by Subject|0|||
130375153|NCT01411774|469339741|FG001|Overall Study|Withdrawal by Subject|3|||
130375154|NCT02990910|469339747|FG000|Overall Study|Lack of Efficacy|6|||
130375155|NCT02990910|469339748|FG001|Overall Study|Lack of Efficacy|10|||
130375156|NCT00309387|469339753|FG000|Overall Study|Death|72|||
130375157|NCT00309387|469339754|FG001|Overall Study|Death|73|||
130375158|NCT00309387|469339753|FG000|Overall Study|Lost to Follow-up|70|||
130375159|NCT00309387|469339754|FG001|Overall Study|Lost to Follow-up|86|||
130375160|NCT02483520|469339755|FG000|Overall Study|Lost to Follow-up|3|||
130375161|NCT02483520|469339756|FG001|Overall Study|Lost to Follow-up|4|||
130375162|NCT02483520|469339755|FG000|Overall Study|Withdrawal by Subject|4|||
130375163|NCT02483520|469339756|FG001|Overall Study|Withdrawal by Subject|14|||
130375164|NCT02483520|469339755|FG000|Overall Study|Hospitalized|2|||
130375165|NCT02483520|469339756|FG001|Overall Study|Hospitalized|3|||
130558655|NCT01830855|470014839|FG001|Overall Study|Protocol deviation|5|||
130558656|NCT01830855|470014840|FG002|Overall Study|Protocol deviation|6|||
130313887|NCT02730728|469115961|FG000|Overall Study|Withdrawal by Subject|0|||
130313888|NCT02730728|469115962|FG001|Overall Study|Withdrawal by Subject|1|||
130313889|NCT02730728|469115963|FG002|Overall Study|Withdrawal by Subject|0|||
130313890|NCT02730728|469115961|FG000|Overall Study|Lack of Efficacy|0|||
130375166|NCT02483520|469339755|FG000|Overall Study|Moved to LTC|2|||
130375167|NCT02483520|469339756|FG001|Overall Study|Moved to LTC|3|||
130313891|NCT02730728|469115962|FG001|Overall Study|Lack of Efficacy|1|||
130313892|NCT02730728|469115963|FG002|Overall Study|Lack of Efficacy|1|||
130313893|NCT01855412|469115964|FG000|Overall Study|Death|77|||
130313894|NCT01855412|469115965|FG001|Overall Study|Death|123|||
130313895|NCT01855412|469115966|FG002|Overall Study|Death|30|||
130313896|NCT01855412|469115964|FG000|Overall Study|Lost to Follow-up|28|||
130313897|NCT01855412|469115965|FG001|Overall Study|Lost to Follow-up|46|||
130313898|NCT01855412|469115966|FG002|Overall Study|Lost to Follow-up|15|||
130313899|NCT01855412|469115964|FG000|Overall Study|Withdrawal by Subject|77|||
130313900|NCT01855412|469115965|FG001|Overall Study|Withdrawal by Subject|123|||
130313901|NCT01855412|469115966|FG002|Overall Study|Withdrawal by Subject|24|||
130313902|NCT01855412|469115964|FG000|Overall Study|Physician Decision|25|||
130313903|NCT01855412|469115965|FG001|Overall Study|Physician Decision|31|||
130313904|NCT01855412|469115966|FG002|Overall Study|Physician Decision|3|||
130313905|NCT01855412|469115964|FG000|Overall Study|Site Closure|4|||
130313906|NCT01855412|469115965|FG001|Overall Study|Site Closure|18|||
130313907|NCT01855412|469115966|FG002|Overall Study|Site Closure|1|||
130313908|NCT01855412|469115964|FG000|Overall Study|Reason not Specified|1|||
130313909|NCT01855412|469115965|FG001|Overall Study|Reason not Specified|2|||
130313910|NCT01855412|469115966|FG002|Overall Study|Reason not Specified|3|||
130313911|NCT01702844|469115967|FG000|Overall Study|Adverse Event|9|||
130313912|NCT01702844|469115967|FG000|Overall Study|Death|1|||
130313913|NCT01702844|469115967|FG000|Overall Study|Withdrawal by Subject|3|||
130313914|NCT01702844|469115967|FG000|Overall Study|Physician Decision|6|||
130313915|NCT03431441|469115968|FG000|Overall Study|Withdrawal by Subject|2|||
130313916|NCT03431441|469115968|FG000|Overall Study|Adverse Event|2|||
130313917|NCT03431441|469115968|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
130313918|NCT00346216|469115969|FG000|Overall Study|Other|181|||
130313919|NCT00346216|469115970|FG001|Overall Study|Other|231|||
130313920|NCT00346216|469115971|FG002|Overall Study|Other|205|||
130313921|NCT00346216|469115969|FG000|Overall Study|No longer willing to participate|600|||
130313922|NCT00346216|469115970|FG001|Overall Study|No longer willing to participate|606|||
130313923|NCT00346216|469115971|FG002|Overall Study|No longer willing to participate|585|||
130313924|NCT00346216|469115969|FG000|Overall Study|Withdrawal by Subject|661|||
130313925|NCT00346216|469115970|FG001|Overall Study|Withdrawal by Subject|692|||
130313926|NCT00346216|469115971|FG002|Overall Study|Withdrawal by Subject|651|||
130313927|NCT00346216|469115969|FG000|Overall Study|Lost to Follow-up|611|||
130313928|NCT00346216|469115970|FG001|Overall Study|Lost to Follow-up|588|||
130313929|NCT00346216|469115971|FG002|Overall Study|Lost to Follow-up|542|||
130313930|NCT00346216|469115969|FG000|Overall Study|Physician Decision|80|||
130313931|NCT00346216|469115970|FG001|Overall Study|Physician Decision|76|||
130313932|NCT00346216|469115971|FG002|Overall Study|Physician Decision|59|||
130313933|NCT00346216|469115969|FG000|Overall Study|Does not meet entrance criteria|13|||
130313934|NCT00346216|469115970|FG001|Overall Study|Does not meet entrance criteria|10|||
130313935|NCT00346216|469115971|FG002|Overall Study|Does not meet entrance criteria|8|||
130313936|NCT00346216|469115969|FG000|Overall Study|Death|189|||
130313937|NCT00346216|469115970|FG001|Overall Study|Death|192|||
130313938|NCT00346216|469115971|FG002|Overall Study|Death|228|||
130313939|NCT00346216|469115969|FG000|Overall Study|Study terminated by sponsor|11|||
130313940|NCT00346216|469115970|FG001|Overall Study|Study terminated by sponsor|4|||
130313941|NCT00346216|469115971|FG002|Overall Study|Study terminated by sponsor|8|||
130313942|NCT00346216|469115969|FG000|Overall Study|Missing Subject Summary Status|62|||
130313943|NCT00346216|469115970|FG001|Overall Study|Missing Subject Summary Status|61|||
130313944|NCT00346216|469115971|FG002|Overall Study|Missing Subject Summary Status|62|||
130313945|NCT02043938|469115977|FG000|Overall Study|Withdrawal by Subject|7|||
130313946|NCT02043938|469115977|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
130313947|NCT02043938|469115977|FG000|Overall Study|No show by subject|1|||
130313948|NCT02043938|469115977|FG000|Overall Study|Investigator decision|1|||
130313949|NCT03985761|469115984|FG000|Overall Study|Withdrawal by Subject|2|||
130313950|NCT03985761|469115985|FG001|Overall Study|Withdrawal by Subject|3|||
130313951|NCT03400852|469115986|FG000|Blinded Treatment Period|Physician Decision|0|||
130375168|NCT03902574|469339766|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
130375169|NCT03902574|469339767|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
130375170|NCT03902574|469339768|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
130375171|NCT04492618|469339770|FG000|Overall Study|Withdrawal by Subject|1|||
130375172|NCT02101060|469339775|FG000|Overall Study|Adverse Event|1|||
130375173|NCT02101060|469339776|FG001|Overall Study|Adverse Event|0|||
130375174|NCT02101060|469339775|FG000|Overall Study|Withdrawal by Subject|1|||
130375175|NCT02101060|469339776|FG001|Overall Study|Withdrawal by Subject|1|||
130375176|NCT02101060|469339775|FG000|Overall Study|Lost to Follow-up|3|||
130375177|NCT02101060|469339776|FG001|Overall Study|Lost to Follow-up|3|||
130313952|NCT03400852|469115987|FG001|Blinded Treatment Period|Physician Decision|1|||
130313953|NCT03400852|469115988|FG002|Blinded Treatment Period|Physician Decision|0|||
130313954|NCT03400852|469115986|FG000|Blinded Treatment Period|Adverse Event|1|||
130313955|NCT03400852|469115987|FG001|Blinded Treatment Period|Adverse Event|1|||
130375178|NCT00743340|469339780|FG000|Overall Study|Study medication non-compliance|1|||
130313956|NCT03400852|469115988|FG002|Blinded Treatment Period|Adverse Event|0|||
130313957|NCT03400852|469115986|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
130313958|NCT03400852|469115987|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
130313959|NCT03400852|469115988|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
130313960|NCT03400852|469115986|FG000|Open Label Period|Physician Decision|0|||
130313961|NCT03400852|469115987|FG001|Open Label Period|Physician Decision|0|||
130313962|NCT03400852|469115988|FG002|Open Label Period|Physician Decision|1|||
130313963|NCT03400852|469115986|FG000|Open Label Period|Study terminated by sponsor|0|||
130313964|NCT03400852|469115987|FG001|Open Label Period|Study terminated by sponsor|0|||
130313965|NCT03400852|469115988|FG002|Open Label Period|Study terminated by sponsor|21|||
130313966|NCT00248495|469115989|FG000|Overall Study|Withdrawal by Subject|1|||
130313967|NCT03812380|469115990|FG000|Overall Study|Protocol Violation|3|||
130313968|NCT03812380|469115991|FG001|Overall Study|Protocol Violation|3|||
130313969|NCT03812380|469115990|FG000|Overall Study|Withdrawal by Subject|5|||
130313970|NCT03812380|469115991|FG001|Overall Study|Withdrawal by Subject|4|||
130313971|NCT03812380|469115990|FG000|Overall Study|Early termination of study|14|||
130313972|NCT03812380|469115991|FG001|Overall Study|Early termination of study|14|||
130313973|NCT02648204|469115992|FG000|Overall Study|Withdrawal by Subject|12|||
130313974|NCT02648204|469115993|FG001|Overall Study|Withdrawal by Subject|8|||
130313975|NCT02648204|469115994|FG002|Overall Study|Withdrawal by Subject|2|||
130313976|NCT02648204|469115995|FG003|Overall Study|Withdrawal by Subject|6|||
130313977|NCT02648204|469115992|FG000|Overall Study|Lost to Follow-up|5|||
130313978|NCT02648204|469115993|FG001|Overall Study|Lost to Follow-up|8|||
130313979|NCT02648204|469115994|FG002|Overall Study|Lost to Follow-up|4|||
130313980|NCT02648204|469115995|FG003|Overall Study|Lost to Follow-up|6|||
130313981|NCT02648204|469115992|FG000|Overall Study|Missing follow-up information|4|||
130313982|NCT02648204|469115993|FG001|Overall Study|Missing follow-up information|4|||
130313983|NCT02648204|469115994|FG002|Overall Study|Missing follow-up information|4|||
130313984|NCT02648204|469115995|FG003|Overall Study|Missing follow-up information|2|||
130313985|NCT02648204|469115992|FG000|Overall Study|Death|1|||
130313986|NCT02648204|469115993|FG001|Overall Study|Death|1|||
130313987|NCT02648204|469115994|FG002|Overall Study|Death|2|||
130313988|NCT02648204|469115995|FG003|Overall Study|Death|2|||
130313989|NCT02648204|469115992|FG000|Overall Study|Adverse Event|0|||
130313990|NCT02648204|469115993|FG001|Overall Study|Adverse Event|0|||
130313991|NCT02648204|469115994|FG002|Overall Study|Adverse Event|1|||
130313992|NCT02648204|469115995|FG003|Overall Study|Adverse Event|0|||
130313993|NCT02366312|469116007|FG000|Overall Study|Lost to Follow-up|0|||
130313994|NCT02366312|469116008|FG001|Overall Study|Lost to Follow-up|1|||
130313995|NCT03719131|469116012|FG000|Overall Study|Death|1|||
130313996|NCT03719131|469116013|FG001|Overall Study|Death|2|||
130313997|NCT00619515|469116014|FG000|Overall Study|Study Termination by IRB|73|||
130313998|NCT03294590|469116015|FG000|Overall Study|Lost to Follow-up|105|||
130313999|NCT03294590|469116016|FG001|Overall Study|Lost to Follow-up|107|||
130314000|NCT04862065|469116019|FG000|Screening|Protocol Violation|54|||
130314001|NCT04862065|469116020|FG001|Screening|Protocol Violation|0|||
130314002|NCT04862065|469116021|FG002|Screening|Protocol Violation|0|||
130314003|NCT04862065|469116019|FG000|Screening|Insufficient Sample|1|||
130314004|NCT04862065|469116020|FG001|Screening|Insufficient Sample|0|||
130314005|NCT04862065|469116021|FG002|Screening|Insufficient Sample|0|||
130314006|NCT04862065|469116019|FG000|Follow-Up|Lost to Follow-up|3|||
130314007|NCT04862065|469116020|FG001|Follow-Up|Lost to Follow-up|0|||
130314008|NCT04862065|469116021|FG002|Follow-Up|Lost to Follow-up|0|||
130466178|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
130466179|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
130466180|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
130466181|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
130466182|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
130466183|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
130466184|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
130719113|NCT04645966|470597334|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
130719114|NCT04645966|470597326|FG000|Follow-up Phase|Lost to Follow-up|0|||
130719115|NCT04645966|470597327|FG001|Follow-up Phase|Lost to Follow-up|0|||
130314009|NCT01272232|469116025|FG000|Weeks 0-56|Adverse Event|39|||
130314010|NCT01272232|469116026|FG001|Weeks 0-56|Adverse Event|18|||
130314011|NCT01272232|469116027|FG002|Weeks 0-56|Adverse Event|7|||
130314012|NCT01272232|469116025|FG000|Weeks 0-56|Lack of Efficacy|0|||
130314013|NCT01272232|469116026|FG001|Weeks 0-56|Lack of Efficacy|0|||
130466185|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
130719116|NCT04645966|470597328|FG002|Follow-up Phase|Lost to Follow-up|0|||
130719117|NCT04645966|470597329|FG003|Follow-up Phase|Lost to Follow-up|0|||
130314014|NCT01272232|469116027|FG002|Weeks 0-56|Lack of Efficacy|3|||
130314015|NCT01272232|469116025|FG000|Weeks 0-56|Protocol Violation|12|||
130314016|NCT01272232|469116026|FG001|Weeks 0-56|Protocol Violation|8|||
130314017|NCT01272232|469116027|FG002|Weeks 0-56|Protocol Violation|13|||
130314018|NCT01272232|469116025|FG000|Weeks 0-56|Withdrawal criteria|32|||
130314019|NCT01272232|469116026|FG001|Weeks 0-56|Withdrawal criteria|14|||
130314020|NCT01272232|469116027|FG002|Weeks 0-56|Withdrawal criteria|37|||
130314021|NCT01272232|469116025|FG000|Weeks 0-56|Unclassified|16|||
130314022|NCT01272232|469116026|FG001|Weeks 0-56|Unclassified|7|||
130314023|NCT01272232|469116027|FG002|Weeks 0-56|Unclassified|12|||
130314024|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130314025|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130314026|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
130314027|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
130314028|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130314029|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130314030|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130314031|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
130314032|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130314033|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
130314034|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
130314035|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
130314036|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130314037|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130314038|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
130314039|NCT00628030|469116030|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
130314040|NCT00628030|469116031|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
130314041|NCT00628030|469116030|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
130314042|NCT00628030|469116031|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
130314043|NCT00628030|469116030|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
130314044|NCT00628030|469116031|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
130314045|NCT01156480|469116033|FG000|Overall Study|change in diagnosis|0|||
130314046|NCT01156480|469116034|FG001|Overall Study|change in diagnosis|1|||
130314047|NCT03367858|469116035|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130314048|NCT03367858|469116036|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130314049|NCT03367858|469116035|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
130314050|NCT03367858|469116036|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
130314051|NCT03367858|469116035|FG000|3 Month Follow Up|Lost to Follow-up|8|||
130314052|NCT03367858|469116036|FG001|3 Month Follow Up|Lost to Follow-up|3|||
130314053|NCT03367858|469116035|FG000|3 Month Follow Up|Moved out of study area|2|||
130314054|NCT03367858|469116036|FG001|3 Month Follow Up|Moved out of study area|6|||
130314055|NCT03367858|469116035|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
130314056|NCT03367858|469116036|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
130314057|NCT03367858|469116035|FG000|3 Month Follow Up|MRI contraindication|2|||
130314058|NCT03367858|469116036|FG001|3 Month Follow Up|MRI contraindication|1|||
130314059|NCT03367858|469116035|FG000|3 Month Follow Up|Incarcerated|0|||
130314060|NCT03367858|469116036|FG001|3 Month Follow Up|Incarcerated|1|||
130314061|NCT03367858|469116035|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
130314062|NCT03367858|469116036|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130314063|NCT03367858|469116035|FG000|6 Month Follow Up|Lost to Follow-up|5|||
130314064|NCT03367858|469116036|FG001|6 Month Follow Up|Lost to Follow-up|2|||
130314065|NCT03367858|469116035|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130314066|NCT03367858|469116036|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
130314067|NCT03367858|469116035|FG000|12 Month Follow Up|Lost to Follow-up|3|||
130314068|NCT03367858|469116036|FG001|12 Month Follow Up|Lost to Follow-up|3|||
130314069|NCT03367858|469116035|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130314070|NCT03367858|469116036|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130314071|NCT04276233|469116037|FG000|Overall Study|Adverse Event|1|||
130314072|NCT04276233|469116037|FG000|Overall Study|Lost to Follow-up|3|||
130314073|NCT04276233|469116037|FG000|Overall Study|Physician Decision|4|||
130314074|NCT04276233|469116037|FG000|Overall Study|Withdrawal by Subject|2|||
130314075|NCT01946139|469116038|FG000|Overall Study|Withdrawal by Subject|8|||
130314076|NCT01946139|469116038|FG000|Overall Study|ineligible|8|||
130314077|NCT01946139|469116038|FG000|Overall Study|Specimens not available|4|||
130314078|NCT03275740|469116045|FG000|Overall Study|Adverse Event|0|||
130314079|NCT03275740|469116046|FG001|Overall Study|Adverse Event|0|||
130314080|NCT03275740|469116047|FG002|Overall Study|Adverse Event|0|||
130314081|NCT03275740|469116048|FG003|Overall Study|Adverse Event|0|||
130314082|NCT03275740|469116049|FG004|Overall Study|Adverse Event|1|||
130314083|NCT03275740|469116050|FG005|Overall Study|Adverse Event|0|||
130314084|NCT03275740|469116051|FG006|Overall Study|Adverse Event|0|||
130314085|NCT03275740|469116052|FG007|Overall Study|Adverse Event|0|||
130314086|NCT03275740|469116053|FG008|Overall Study|Adverse Event|0|||
130314087|NCT03275740|469116054|FG009|Overall Study|Adverse Event|0|||
130314088|NCT03275740|469116055|FG010|Overall Study|Adverse Event|0|||
130314089|NCT03275740|469116056|FG011|Overall Study|Adverse Event|0|||
130314090|NCT03275740|469116045|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314091|NCT03275740|469116046|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130375179|NCT00743340|469339780|FG000|Overall Study|Lost to Follow-up|1|||
130558657|NCT01830855|470014841|FG003|Overall Study|Protocol deviation|6|||
130558658|NCT01830855|470014838|FG000|Overall Study|Withdrawal by Subject|33|||
130558659|NCT01830855|470014839|FG001|Overall Study|Withdrawal by Subject|14|||
130558660|NCT01830855|470014840|FG002|Overall Study|Withdrawal by Subject|10|||
130558661|NCT01830855|470014841|FG003|Overall Study|Withdrawal by Subject|12|||
130558662|NCT01830855|470014838|FG000|Overall Study|No longer willing to participate|32|||
130558663|NCT01830855|470014839|FG001|Overall Study|No longer willing to participate|13|||
130558664|NCT01830855|470014840|FG002|Overall Study|No longer willing to participate|12|||
130558665|NCT01830855|470014841|FG003|Overall Study|No longer willing to participate|17|||
130558666|NCT01830855|470014838|FG000|Overall Study|Lost to Follow-up|47|||
130558667|NCT01830855|470014839|FG001|Overall Study|Lost to Follow-up|20|||
130558668|NCT01830855|470014840|FG002|Overall Study|Lost to Follow-up|23|||
130558669|NCT01830855|470014841|FG003|Overall Study|Lost to Follow-up|33|||
130558670|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Adverse Event|2|||
130558671|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Adverse Event|2|||
130558672|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Adverse Event|4|||
130558673|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Adverse Event|0|||
130558674|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Adverse Event|0|||
130558675|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Progressive disease|0|||
130558676|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Progressive disease|0|||
130558677|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Progressive disease|1|||
130558678|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Progressive disease|0|||
130558679|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Progressive disease|0|||
130558680|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
130558681|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
130558682|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
130558683|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
130558684|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
130558685|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
130558686|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130558687|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130558688|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130558689|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130558690|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
130558691|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
130558692|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
130558693|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
130558694|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
130558695|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
130558696|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
130558697|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
130558698|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
130314092|NCT03275740|469116047|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314093|NCT03275740|469116048|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314094|NCT03275740|469116049|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314095|NCT03275740|469116050|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
130314096|NCT03275740|469116051|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314097|NCT03275740|469116052|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314098|NCT03275740|469116053|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314099|NCT03275740|469116054|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314100|NCT03275740|469116055|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314101|NCT03275740|469116056|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314102|NCT03275740|469116045|FG000|Overall Study|Withdrawal by Subject|0|||
130314103|NCT03275740|469116046|FG001|Overall Study|Withdrawal by Subject|0|||
130558699|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
130314104|NCT03275740|469116047|FG002|Overall Study|Withdrawal by Subject|0|||
130558700|NCT03523728|470014842|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
130558701|NCT03523728|470014843|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
130558702|NCT03523728|470014844|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
130558703|NCT03523728|470014845|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
130558704|NCT03523728|470014846|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
130558705|NCT03523728|470014842|FG000|Stage 2 (24 Months)|Adverse Event|0|||
130558706|NCT03523728|470014843|FG001|Stage 2 (24 Months)|Adverse Event|0|||
130558707|NCT03523728|470014844|FG002|Stage 2 (24 Months)|Adverse Event|0|||
130314105|NCT03275740|469116048|FG003|Overall Study|Withdrawal by Subject|0|||
130558708|NCT03523728|470014845|FG003|Stage 2 (24 Months)|Adverse Event|1|||
130558709|NCT03523728|470014846|FG004|Stage 2 (24 Months)|Adverse Event|2|||
130558710|NCT03523728|470014842|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130558711|NCT03523728|470014843|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130558712|NCT03523728|470014844|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130558713|NCT03523728|470014845|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130558714|NCT03523728|470014846|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
130558715|NCT03523728|470014842|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130314106|NCT03275740|469116049|FG004|Overall Study|Withdrawal by Subject|0|||
130314107|NCT03275740|469116050|FG005|Overall Study|Withdrawal by Subject|0|||
130314108|NCT03275740|469116051|FG006|Overall Study|Withdrawal by Subject|0|||
130314109|NCT03275740|469116052|FG007|Overall Study|Withdrawal by Subject|0|||
130314110|NCT03275740|469116053|FG008|Overall Study|Withdrawal by Subject|1|||
130314111|NCT03275740|469116054|FG009|Overall Study|Withdrawal by Subject|1|||
130314112|NCT03275740|469116055|FG010|Overall Study|Withdrawal by Subject|0|||
130314113|NCT03275740|469116056|FG011|Overall Study|Withdrawal by Subject|0|||
130314114|NCT03827655|469116058|FG000|Overall Study|Death|0|||
130314115|NCT03827655|469116059|FG001|Overall Study|Death|0|||
130314116|NCT03827655|469116060|FG002|Overall Study|Death|0|||
130314117|NCT03827655|469116061|FG003|Overall Study|Death|0|||
130314118|NCT03827655|469116062|FG004|Overall Study|Death|1|||
130314119|NCT03827655|469116058|FG000|Overall Study|Protocol Deviation|1|||
130314120|NCT03827655|469116059|FG001|Overall Study|Protocol Deviation|0|||
130314121|NCT03827655|469116060|FG002|Overall Study|Protocol Deviation|1|||
130314122|NCT03827655|469116061|FG003|Overall Study|Protocol Deviation|1|||
130375180|NCT00743340|469339780|FG000|Overall Study|Withdrawal from the Study|5|||
130375181|NCT00743340|469339780|FG000|Overall Study|Protocol Violation|1|||
130375182|NCT00743340|469339780|FG000|Overall Study|Virologic failure|8|||
130375183|NCT00743340|469339780|FG000|Overall Study|Pregnancy|1|||
130375184|NCT00743340|469339780|FG000|Overall Study|Rolled over to other Gilead Study|23|||
130719118|NCT04645966|470597330|FG004|Follow-up Phase|Lost to Follow-up|0|||
130719119|NCT04645966|470597331|FG005|Follow-up Phase|Lost to Follow-up|0|||
130719120|NCT04645966|470597332|FG006|Follow-up Phase|Lost to Follow-up|0|||
130719121|NCT04645966|470597333|FG007|Follow-up Phase|Lost to Follow-up|1|||
130719122|NCT04645966|470597334|FG008|Follow-up Phase|Lost to Follow-up|0|||
130719123|NCT02116608|470597336|FG000|Overall Study|Lost to Follow-up|0|||
130719124|NCT02116608|470597337|FG001|Overall Study|Lost to Follow-up|0|||
130719125|NCT02116608|470597338|FG002|Overall Study|Lost to Follow-up|1|||
130719126|NCT02116608|470597336|FG000|Overall Study|Physician Decision|0|||
130719127|NCT02116608|470597337|FG001|Overall Study|Physician Decision|1|||
130719128|NCT02116608|470597338|FG002|Overall Study|Physician Decision|0|||
130719129|NCT02116608|470597336|FG000|Overall Study|Death|0|||
130719130|NCT02116608|470597337|FG001|Overall Study|Death|1|||
130719131|NCT02116608|470597338|FG002|Overall Study|Death|0|||
130719132|NCT01468818|470597342|FG000|Overall Study|Death during treatment|2|||
130719133|NCT01212588|470597343|FG000|Overall Study|Physician Decision|0|||
130719134|NCT01212588|470597344|FG001|Overall Study|Physician Decision|1|||
130719135|NCT01212588|470597343|FG000|Overall Study|Protocol Violation|1|||
130719136|NCT01212588|470597344|FG001|Overall Study|Protocol Violation|1|||
130719137|NCT01059344|470597345|FG000|Overall Study|Adverse Event|12|||
130314123|NCT03827655|469116062|FG004|Overall Study|Protocol Deviation|0|||
130314124|NCT03827655|469116058|FG000|Overall Study|Withdrawal by Subject|3|||
130314125|NCT03827655|469116059|FG001|Overall Study|Withdrawal by Subject|2|||
130375185|NCT00743340|469339780|FG000|Overall Study|Participant Relocated|1|||
130375186|NCT01402492|469339785|FG000|Overall Study|Withdrawal by Subject|17|||
130375187|NCT01402492|469339786|FG001|Overall Study|Withdrawal by Subject|11|||
130375188|NCT01402492|469339787|FG002|Overall Study|Withdrawal by Subject|11|||
130375189|NCT01402492|469339785|FG000|Overall Study|Adverse Event|2|||
130375190|NCT01402492|469339786|FG001|Overall Study|Adverse Event|3|||
130375191|NCT01402492|469339787|FG002|Overall Study|Adverse Event|4|||
130375192|NCT01402492|469339785|FG000|Overall Study|Physician Decision|0|||
130375193|NCT01402492|469339786|FG001|Overall Study|Physician Decision|3|||
130375194|NCT01402492|469339787|FG002|Overall Study|Physician Decision|0|||
130375195|NCT01402492|469339785|FG000|Overall Study|Incarcerated (N=3)|2|||
130375196|NCT01402492|469339786|FG001|Overall Study|Incarcerated (N=3)|0|||
130375197|NCT01402492|469339787|FG002|Overall Study|Incarcerated (N=3)|1|||
130375198|NCT00814164|469339788|FG000|Overall Study|Progression|7|||
130375199|NCT00814164|469339788|FG000|Overall Study|not stated|7|||
130375200|NCT00814164|469339788|FG000|Overall Study|Death|5|||
130375201|NCT01169493|469339794|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
130375202|NCT01169493|469339795|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
130375203|NCT01169493|469339796|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
130375204|NCT01169493|469339797|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
130466792|NCT00332241|469676412|FG000|Overall Study|Withdrawal by Subject|2|||
130719138|NCT01059344|470597346|FG001|Overall Study|Adverse Event|30|||
130314126|NCT03827655|469116060|FG002|Overall Study|Withdrawal by Subject|2|||
130314127|NCT03827655|469116061|FG003|Overall Study|Withdrawal by Subject|0|||
130314128|NCT03827655|469116062|FG004|Overall Study|Withdrawal by Subject|1|||
130314129|NCT03827655|469116058|FG000|Overall Study|Reason not Specified|3|||
130375205|NCT01169493|469339798|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
130375206|NCT01169493|469339799|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
130375207|NCT01169493|469339794|FG000|Period 3 (6 Months)|Adverse Event|0|||
130375208|NCT01169493|469339795|FG001|Period 3 (6 Months)|Adverse Event|1|||
130375209|NCT01169493|469339796|FG002|Period 3 (6 Months)|Adverse Event|0|||
130719139|NCT01059344|470597345|FG000|Overall Study|Withdrawal by Subject|6|||
130719140|NCT01059344|470597346|FG001|Overall Study|Withdrawal by Subject|9|||
130719141|NCT01059344|470597345|FG000|Overall Study|Lost to Follow-up|1|||
130719142|NCT01059344|470597346|FG001|Overall Study|Lost to Follow-up|1|||
130314130|NCT03827655|469116059|FG001|Overall Study|Reason not Specified|1|||
130314131|NCT03827655|469116060|FG002|Overall Study|Reason not Specified|1|||
130466186|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
130466187|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
130314132|NCT03827655|469116061|FG003|Overall Study|Reason not Specified|1|||
130314133|NCT03827655|469116062|FG004|Overall Study|Reason not Specified|1|||
130314134|NCT02336607|469116063|FG000|Overall Study|Physician Decision|1|||
130314135|NCT02336607|469116064|FG001|Overall Study|Physician Decision|4|||
130314136|NCT02336607|469116065|FG002|Overall Study|Physician Decision|3|||
130314137|NCT02336607|469116066|FG003|Overall Study|Physician Decision|15|||
130314138|NCT02336607|469116063|FG000|Overall Study|Lack of Efficacy|1|||
130314139|NCT02336607|469116064|FG001|Overall Study|Lack of Efficacy|0|||
130314140|NCT02336607|469116065|FG002|Overall Study|Lack of Efficacy|0|||
130314141|NCT02336607|469116066|FG003|Overall Study|Lack of Efficacy|2|||
130314142|NCT02336607|469116063|FG000|Overall Study|Lost to Follow-up|2|||
130314143|NCT02336607|469116064|FG001|Overall Study|Lost to Follow-up|1|||
130314144|NCT02336607|469116065|FG002|Overall Study|Lost to Follow-up|0|||
130314145|NCT02336607|469116066|FG003|Overall Study|Lost to Follow-up|21|||
130314146|NCT02336607|469116063|FG000|Overall Study|Protocol Violation|0|||
130314147|NCT02336607|469116064|FG001|Overall Study|Protocol Violation|1|||
130314148|NCT02336607|469116065|FG002|Overall Study|Protocol Violation|1|||
130314149|NCT02336607|469116066|FG003|Overall Study|Protocol Violation|3|||
130314150|NCT02336607|469116063|FG000|Overall Study|Adverse Event|0|||
130314151|NCT02336607|469116064|FG001|Overall Study|Adverse Event|2|||
130466188|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
130466189|NCT01061151|469673593|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
130466190|NCT01061151|469673594|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
130466191|NCT01061151|469673595|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
130466192|NCT01061151|469673596|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
130466193|NCT01290341|469673601|FG000|Overall Study|Protocol Violation|7|||
130466194|NCT01290341|469673602|FG001|Overall Study|Protocol Violation|3|||
130719143|NCT01059344|470597345|FG000|Overall Study|Other|3|||
130719144|NCT01059344|470597346|FG001|Overall Study|Other|6|||
130719145|NCT01739348|470597347|FG000|Part I (Base Study)|Adverse Event|41|||
130314152|NCT02336607|469116065|FG002|Overall Study|Adverse Event|2|||
130314153|NCT02336607|469116066|FG003|Overall Study|Adverse Event|26|||
130314154|NCT02336607|469116063|FG000|Overall Study|Withdrawal by Subject|0|||
130314155|NCT02336607|469116064|FG001|Overall Study|Withdrawal by Subject|2|||
130314156|NCT02336607|469116065|FG002|Overall Study|Withdrawal by Subject|0|||
130314157|NCT02336607|469116066|FG003|Overall Study|Withdrawal by Subject|20|||
130314158|NCT02552966|469116067|FG000|Overall Study|Lost to Follow-up|2|||
130314159|NCT02552966|469116067|FG000|Overall Study|Withdrawal by Subject|3|||
130314160|NCT01091675|469116072|FG000|Overall Study|Adverse Event|7|||
130466195|NCT01290341|469673601|FG000|Overall Study|Adverse Event|1|||
130466196|NCT01290341|469673602|FG001|Overall Study|Adverse Event|0|||
130719146|NCT01739348|470597348|FG001|Part I (Base Study)|Adverse Event|52|||
130719147|NCT01739348|470597349|FG002|Part I (Base Study)|Adverse Event|8|||
130719148|NCT01739348|470597350|FG003|Part I (Base Study)|Adverse Event|33|||
130719149|NCT01739348|470597347|FG000|Part I (Base Study)|Death|10|||
130719150|NCT01739348|470597348|FG001|Part I (Base Study)|Death|7|||
130719151|NCT01739348|470597349|FG002|Part I (Base Study)|Death|2|||
130719152|NCT01739348|470597350|FG003|Part I (Base Study)|Death|8|||
130719153|NCT01739348|470597347|FG000|Part I (Base Study)|Lack of Efficacy|3|||
130719154|NCT01739348|470597348|FG001|Part I (Base Study)|Lack of Efficacy|8|||
130719155|NCT01739348|470597349|FG002|Part I (Base Study)|Lack of Efficacy|0|||
130719156|NCT01739348|470597350|FG003|Part I (Base Study)|Lack of Efficacy|7|||
130719157|NCT01739348|470597347|FG000|Part I (Base Study)|Lost to Follow-up|4|||
130719158|NCT01739348|470597348|FG001|Part I (Base Study)|Lost to Follow-up|2|||
130719159|NCT01739348|470597349|FG002|Part I (Base Study)|Lost to Follow-up|4|||
130719160|NCT01739348|470597350|FG003|Part I (Base Study)|Lost to Follow-up|4|||
130719161|NCT01739348|470597347|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
130719162|NCT01739348|470597348|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
130719163|NCT01739348|470597349|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130466197|NCT01290341|469673601|FG000|Overall Study|Lost to Follow-up|21|||
130466198|NCT01290341|469673602|FG001|Overall Study|Lost to Follow-up|10|||
130466199|NCT01290341|469673601|FG000|Overall Study|Withdrawal by Subject|19|||
130466200|NCT01290341|469673602|FG001|Overall Study|Withdrawal by Subject|5|||
130314161|NCT01091675|469116072|FG000|Overall Study|Lack of Efficacy|27|||
130314162|NCT00614380|469116073|FG000|Overall Study|Adverse Event|14|||
130314163|NCT00614380|469116074|FG001|Overall Study|Adverse Event|4|||
130314164|NCT00614380|469116075|FG002|Overall Study|Adverse Event|0|||
130314165|NCT00614380|469116076|FG003|Overall Study|Adverse Event|0|||
130314166|NCT00614380|469116073|FG000|Overall Study|Lost to Follow-up|6|||
130719164|NCT01739348|470597350|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130719165|NCT01739348|470597347|FG000|Part I (Base Study)|Physician Decision|10|||
130719166|NCT01739348|470597348|FG001|Part I (Base Study)|Physician Decision|7|||
130314167|NCT00614380|469116074|FG001|Overall Study|Lost to Follow-up|1|||
130558716|NCT03523728|470014843|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130558717|NCT03523728|470014844|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130558718|NCT03523728|470014845|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
130558719|NCT03523728|470014846|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
130558720|NCT03523728|470014842|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
130314168|NCT00614380|469116075|FG002|Overall Study|Lost to Follow-up|0|||
130314169|NCT00614380|469116076|FG003|Overall Study|Lost to Follow-up|0|||
130314170|NCT00614380|469116073|FG000|Overall Study|Non compliant with the protocol|12|||
130314171|NCT00614380|469116074|FG001|Overall Study|Non compliant with the protocol|2|||
130314172|NCT00614380|469116075|FG002|Overall Study|Non compliant with the protocol|1|||
130314173|NCT00614380|469116076|FG003|Overall Study|Non compliant with the protocol|2|||
130314174|NCT00614380|469116073|FG000|Overall Study|Consent withdrawn|3|||
130314175|NCT00614380|469116074|FG001|Overall Study|Consent withdrawn|1|||
130558721|NCT03523728|470014843|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
130558722|NCT03523728|470014844|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
130558723|NCT03523728|470014845|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
130558724|NCT03523728|470014846|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
130558725|NCT03523728|470014842|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
130558726|NCT03523728|470014843|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
130558727|NCT03523728|470014844|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
130558728|NCT03523728|470014845|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
130558729|NCT03523728|470014846|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
130558730|NCT00621751|470014847|FG000|Overall Study|Adverse Event|0|||
130558731|NCT00621751|470014848|FG001|Overall Study|Adverse Event|1|||
130558732|NCT00295633|470014849|FG000|Overall Study|Lack of Efficacy|19|||
130558733|NCT00295633|470014850|FG001|Overall Study|Lack of Efficacy|7|||
130558734|NCT00295633|470014851|FG002|Overall Study|Lack of Efficacy|16|||
130558735|NCT00295633|470014849|FG000|Overall Study|Withdrawal of consent by subject|16|||
130558736|NCT00295633|470014850|FG001|Overall Study|Withdrawal of consent by subject|16|||
130558737|NCT00295633|470014851|FG002|Overall Study|Withdrawal of consent by subject|26|||
130558738|NCT00295633|470014849|FG000|Overall Study|Adverse Event|9|||
130558739|NCT00295633|470014850|FG001|Overall Study|Adverse Event|17|||
130558740|NCT00295633|470014851|FG002|Overall Study|Adverse Event|9|||
130314176|NCT00614380|469116075|FG002|Overall Study|Consent withdrawn|0|||
130314177|NCT00614380|469116076|FG003|Overall Study|Consent withdrawn|0|||
130558741|NCT00295633|470014849|FG000|Overall Study|Lost to Follow-up|6|||
130558742|NCT00295633|470014850|FG001|Overall Study|Lost to Follow-up|11|||
130558743|NCT00295633|470014851|FG002|Overall Study|Lost to Follow-up|7|||
130558744|NCT00295633|470014849|FG000|Overall Study|Physician Decision|9|||
130558745|NCT00295633|470014850|FG001|Overall Study|Physician Decision|10|||
130558746|NCT00295633|470014851|FG002|Overall Study|Physician Decision|8|||
130558747|NCT00295633|470014849|FG000|Overall Study|Poor/Noncompliance|2|||
130558748|NCT00295633|470014850|FG001|Overall Study|Poor/Noncompliance|2|||
130558749|NCT00295633|470014851|FG002|Overall Study|Poor/Noncompliance|6|||
130558750|NCT00295633|470014849|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130558751|NCT00295633|470014850|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
130558752|NCT00295633|470014851|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
130558753|NCT00295633|470014849|FG000|Overall Study|Death|1|||
130558754|NCT00295633|470014850|FG001|Overall Study|Death|1|||
130558755|NCT00295633|470014851|FG002|Overall Study|Death|0|||
130558756|NCT00295633|470014849|FG000|Overall Study|Administrative reason by sponsor|0|||
130558757|NCT00295633|470014850|FG001|Overall Study|Administrative reason by sponsor|0|||
130558758|NCT00295633|470014851|FG002|Overall Study|Administrative reason by sponsor|1|||
130558759|NCT00419120|470014853|FG000|Long Term Follow up Period|study ongoing|10|||
130558760|NCT01950247|470014854|FG000|Overall Study|Withdrawal by Subject|28|||
130558761|NCT01950247|470014855|FG001|Overall Study|Withdrawal by Subject|13|||
130558762|NCT01950247|470014854|FG000|Overall Study|Lost to Follow-up|18|||
130558763|NCT01950247|470014855|FG001|Overall Study|Lost to Follow-up|16|||
130558764|NCT01950247|470014854|FG000|Overall Study|Physician Decision|3|||
130314178|NCT01670721|469116090|FG000|Overall Study|Participant's decision|15|||
130314179|NCT01670721|469116090|FG000|Overall Study|Other than specified above|38|||
130314180|NCT00191334|469116091|FG000|Overall Study|Adverse Event|4|||
130558765|NCT01950247|470014855|FG001|Overall Study|Physician Decision|4|||
130314181|NCT00191334|469116091|FG000|Overall Study|Disease Progression or Relapse|8|||
130314182|NCT00191334|469116091|FG000|Overall Study|Physician Decision|1|||
130314183|NCT00191334|469116091|FG000|Overall Study|Withdrawal by Subject|4|||
130314184|NCT05274958|469116092|FG000|Overall Study|Only completed 1 set of PROMs|22|||
130314185|NCT05274958|469116093|FG001|Overall Study|Only completed 1 set of PROMs|35|||
130314186|NCT05579977|469116101|FG000|Treatment Phase|Other|0|||
130314187|NCT05579977|469116102|FG001|Treatment Phase|Other|0|||
130314188|NCT05579977|469116103|FG002|Treatment Phase|Other|0|||
130314189|NCT05579977|469116104|FG003|Treatment Phase|Other|2|||
130314190|NCT05579977|469116105|FG004|Treatment Phase|Other|1|||
130314191|NCT05579977|469116106|FG005|Treatment Phase|Other|2|||
130558766|NCT01950247|470014854|FG000|Overall Study|Adverse Event|3|||
130558767|NCT01950247|470014855|FG001|Overall Study|Adverse Event|2|||
130558768|NCT01950247|470014854|FG000|Overall Study|Death|1|||
130558769|NCT01950247|470014855|FG001|Overall Study|Death|1|||
130558770|NCT01950247|470014854|FG000|Overall Study|Not Defined|4|||
130558771|NCT01950247|470014855|FG001|Overall Study|Not Defined|10|||
130558772|NCT00763971|470014856|FG000|Overall Study|Adverse Event|5|||
130558773|NCT00763971|470014857|FG001|Overall Study|Adverse Event|2|||
130558774|NCT00763971|470014858|FG002|Overall Study|Adverse Event|4|||
130558775|NCT00763971|470014856|FG000|Overall Study|Protocol Violation|3|||
130558776|NCT00763971|470014857|FG001|Overall Study|Protocol Violation|3|||
130558777|NCT00763971|470014858|FG002|Overall Study|Protocol Violation|2|||
130558778|NCT00763971|470014856|FG000|Overall Study|Withdrawal by Subject|4|||
130558779|NCT00763971|470014857|FG001|Overall Study|Withdrawal by Subject|5|||
130558780|NCT00763971|470014858|FG002|Overall Study|Withdrawal by Subject|5|||
130558781|NCT00763971|470014856|FG000|Overall Study|Lost to Follow-up|0|||
130558782|NCT00763971|470014857|FG001|Overall Study|Lost to Follow-up|1|||
130719167|NCT01739348|470597349|FG002|Part I (Base Study)|Physician Decision|1|||
130719168|NCT01739348|470597350|FG003|Part I (Base Study)|Physician Decision|4|||
130719169|NCT01739348|470597347|FG000|Part I (Base Study)|Protocol Violation|2|||
130719170|NCT01739348|470597348|FG001|Part I (Base Study)|Protocol Violation|0|||
130719171|NCT01739348|470597349|FG002|Part I (Base Study)|Protocol Violation|1|||
130719172|NCT01739348|470597350|FG003|Part I (Base Study)|Protocol Violation|2|||
130719173|NCT01739348|470597347|FG000|Part I (Base Study)|Screen Failure|2|||
130719174|NCT01739348|470597348|FG001|Part I (Base Study)|Screen Failure|0|||
130719175|NCT01739348|470597349|FG002|Part I (Base Study)|Screen Failure|0|||
130719176|NCT01739348|470597350|FG003|Part I (Base Study)|Screen Failure|0|||
130719177|NCT01739348|470597347|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
130719178|NCT01739348|470597348|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
130719179|NCT01739348|470597349|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
130719180|NCT01739348|470597350|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
130719181|NCT01739348|470597347|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
130719182|NCT01739348|470597348|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
130719183|NCT01739348|470597349|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
130719184|NCT01739348|470597350|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
130719185|NCT01739348|470597347|FG000|Part I (Base Study)|Participant Moved|4|||
130719186|NCT01739348|470597348|FG001|Part I (Base Study)|Participant Moved|3|||
130719187|NCT01739348|470597349|FG002|Part I (Base Study)|Participant Moved|1|||
130719188|NCT01739348|470597350|FG003|Part I (Base Study)|Participant Moved|7|||
130719189|NCT01739348|470597347|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
130719190|NCT01739348|470597348|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
130719191|NCT01739348|470597349|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
130719192|NCT01739348|470597350|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130719193|NCT01739348|470597347|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
130719194|NCT01739348|470597348|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
130719195|NCT01739348|470597349|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
130719196|NCT01739348|470597350|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
130719197|NCT01739348|470597347|FG000|Part II (Extension Study)|Adverse Event|10|||
130719198|NCT01739348|470597348|FG001|Part II (Extension Study)|Adverse Event|11|||
130719199|NCT01739348|470597349|FG002|Part II (Extension Study)|Adverse Event|7|||
130719200|NCT01739348|470597350|FG003|Part II (Extension Study)|Adverse Event|26|||
130719201|NCT01739348|470597347|FG000|Part II (Extension Study)|Death|3|||
130719202|NCT01739348|470597348|FG001|Part II (Extension Study)|Death|3|||
130719203|NCT01739348|470597349|FG002|Part II (Extension Study)|Death|2|||
130719204|NCT01739348|470597350|FG003|Part II (Extension Study)|Death|6|||
130719205|NCT01739348|470597347|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
130719206|NCT01739348|470597348|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
130719207|NCT01739348|470597349|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
130719208|NCT01739348|470597350|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
130719209|NCT01739348|470597347|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
130719210|NCT01739348|470597348|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
130719211|NCT01739348|470597349|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
130719212|NCT01739348|470597350|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
130719213|NCT01739348|470597347|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130558783|NCT00763971|470014858|FG002|Overall Study|Lost to Follow-up|0|||
130558784|NCT00763971|470014856|FG000|Overall Study|Lack of Efficacy|11|||
130558785|NCT00763971|470014857|FG001|Overall Study|Lack of Efficacy|22|||
130719214|NCT01739348|470597348|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130719215|NCT01739348|470597349|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130719216|NCT01739348|470597350|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
130719217|NCT01739348|470597347|FG000|Part II (Extension Study)|Physician Decision|7|||
130719218|NCT01739348|470597348|FG001|Part II (Extension Study)|Physician Decision|11|||
130719219|NCT01739348|470597349|FG002|Part II (Extension Study)|Physician Decision|6|||
130558786|NCT00763971|470014858|FG002|Overall Study|Lack of Efficacy|54|||
130558787|NCT00763971|470014856|FG000|Overall Study|Unable to swallow capsule|2|||
130558788|NCT00763971|470014857|FG001|Overall Study|Unable to swallow capsule|1|||
130558789|NCT00763971|470014858|FG002|Overall Study|Unable to swallow capsule|1|||
130314192|NCT05579977|469116107|FG006|Treatment Phase|Other|1|||
130314193|NCT05579977|469116108|FG007|Treatment Phase|Other|2|||
130314194|NCT05579977|469116109|FG008|Treatment Phase|Other|2|||
130314195|NCT05579977|469116110|FG009|Treatment Phase|Other|1|||
130314196|NCT05579977|469116111|FG010|Treatment Phase|Other|0|||
130314197|NCT05579977|469116112|FG011|Treatment Phase|Other|0|||
130719220|NCT01739348|470597350|FG003|Part II (Extension Study)|Physician Decision|12|||
130719221|NCT01739348|470597347|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
130719222|NCT01739348|470597348|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
130719223|NCT01739348|470597349|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
130719224|NCT01739348|470597350|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
130719225|NCT01739348|470597347|FG000|Part II (Extension Study)|Participant Moved|3|||
130719226|NCT01739348|470597348|FG001|Part II (Extension Study)|Participant Moved|3|||
130719227|NCT01739348|470597349|FG002|Part II (Extension Study)|Participant Moved|0|||
130719228|NCT01739348|470597350|FG003|Part II (Extension Study)|Participant Moved|3|||
130719229|NCT01739348|470597347|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130719230|NCT01739348|470597348|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
130719231|NCT01739348|470597349|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
130719232|NCT01739348|470597350|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
130719233|NCT01739348|470597347|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
130719234|NCT01739348|470597348|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
130719235|NCT01739348|470597349|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
130719236|NCT01739348|470597350|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
130719237|NCT01447420|470597354|FG000|Overall Study|Adverse Event|2|||
130719238|NCT01447420|470597355|FG001|Overall Study|Adverse Event|4|||
130719239|NCT01447420|470597356|FG002|Overall Study|Adverse Event|2|||
130719240|NCT01447420|470597354|FG000|Overall Study|Protocol Violation|3|||
130719241|NCT01447420|470597355|FG001|Overall Study|Protocol Violation|3|||
130719242|NCT01447420|470597356|FG002|Overall Study|Protocol Violation|0|||
130719243|NCT01447420|470597354|FG000|Overall Study|Withdrawal by Subject|4|||
130719244|NCT01447420|470597355|FG001|Overall Study|Withdrawal by Subject|1|||
130719245|NCT01447420|470597356|FG002|Overall Study|Withdrawal by Subject|0|||
130719246|NCT01447420|470597354|FG000|Overall Study|Lack of Efficacy|1|||
130719247|NCT01447420|470597355|FG001|Overall Study|Lack of Efficacy|19|||
130719248|NCT01447420|470597356|FG002|Overall Study|Lack of Efficacy|8|||
130719249|NCT05788289|470597363|FG000|Overall Study|Death|3|||
130719250|NCT01974440|470597364|FG000|Overall Study|Lost to Follow-up|7|||
130719251|NCT01974440|470597365|FG001|Overall Study|Lost to Follow-up|7|||
130719252|NCT01974440|470597364|FG000|Overall Study|Withdrawal by Subject|24|||
130719253|NCT01974440|470597365|FG001|Overall Study|Withdrawal by Subject|20|||
130719254|NCT01974440|470597364|FG000|Overall Study|Sponsor decision|109|||
130719255|NCT01974440|470597365|FG001|Overall Study|Sponsor decision|110|||
130719256|NCT00762437|470597366|FG000|Overall Study|Lost to Follow-up|7|||
130719257|NCT00762437|470597366|FG000|Overall Study|Missed final study visit|11|||
130719258|NCT00762437|470597366|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
130719259|NCT03569228|470597367|FG000|Overall Study|Withdrawal by PI|0|||
130719260|NCT03569228|470597368|FG001|Overall Study|Withdrawal by PI|0|||
130719261|NCT03569228|470597369|FG002|Overall Study|Withdrawal by PI|2|||
130719262|NCT03569228|470597370|FG003|Overall Study|Withdrawal by PI|2|||
130719263|NCT03569228|470597371|FG004|Overall Study|Withdrawal by PI|1|||
130719264|NCT03569228|470597372|FG005|Overall Study|Withdrawal by PI|0|||
130719265|NCT03569228|470597373|FG006|Overall Study|Withdrawal by PI|0|||
130719266|NCT03569228|470597374|FG007|Overall Study|Withdrawal by PI|0|||
130719267|NCT03569228|470597375|FG008|Overall Study|Withdrawal by PI|0|||
130719268|NCT03569228|470597367|FG000|Overall Study|Lost to Follow-up|0|||
130719269|NCT03569228|470597368|FG001|Overall Study|Lost to Follow-up|0|||
130719270|NCT03569228|470597369|FG002|Overall Study|Lost to Follow-up|0|||
130719271|NCT03569228|470597370|FG003|Overall Study|Lost to Follow-up|0|||
130719272|NCT03569228|470597371|FG004|Overall Study|Lost to Follow-up|0|||
130719273|NCT03569228|470597372|FG005|Overall Study|Lost to Follow-up|0|||
130719274|NCT03569228|470597373|FG006|Overall Study|Lost to Follow-up|0|||
130719275|NCT03569228|470597374|FG007|Overall Study|Lost to Follow-up|0|||
130719276|NCT03569228|470597375|FG008|Overall Study|Lost to Follow-up|1|||
130719277|NCT03569228|470597367|FG000|Overall Study|Screen Fail|2|||
130719278|NCT03569228|470597368|FG001|Overall Study|Screen Fail|2|||
130314198|NCT05579977|469116113|FG012|Treatment Phase|Other|3|||
130314199|NCT05579977|469116101|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
130719279|NCT03569228|470597369|FG002|Overall Study|Screen Fail|1|||
130719280|NCT03569228|470597370|FG003|Overall Study|Screen Fail|1|||
130719281|NCT03569228|470597371|FG004|Overall Study|Screen Fail|1|||
130719282|NCT03569228|470597372|FG005|Overall Study|Screen Fail|3|||
130719283|NCT03569228|470597373|FG006|Overall Study|Screen Fail|1|||
130719284|NCT03569228|470597374|FG007|Overall Study|Screen Fail|5|||
130719285|NCT03569228|470597375|FG008|Overall Study|Screen Fail|2|||
130719286|NCT00085423|470597380|FG000|Overall Study|Withdrawal by Subject|1|||
130314200|NCT05579977|469116102|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
130314201|NCT05579977|469116103|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
130558790|NCT00763971|470014856|FG000|Overall Study|Personal reason|3|||
130558791|NCT00763971|470014857|FG001|Overall Study|Personal reason|0|||
130558792|NCT00763971|470014858|FG002|Overall Study|Personal reason|0|||
130558793|NCT00763971|470014856|FG000|Overall Study|Exclusion criteria met|1|||
130558794|NCT00763971|470014857|FG001|Overall Study|Exclusion criteria met|0|||
130558795|NCT00763971|470014858|FG002|Overall Study|Exclusion criteria met|0|||
130558796|NCT00763971|470014856|FG000|Overall Study|Sponsor decision|1|||
130558797|NCT00763971|470014857|FG001|Overall Study|Sponsor decision|0|||
130558798|NCT00763971|470014858|FG002|Overall Study|Sponsor decision|0|||
130558799|NCT00763971|470014856|FG000|Overall Study|Due to holiday season|2|||
130558800|NCT00763971|470014857|FG001|Overall Study|Due to holiday season|0|||
130558801|NCT00763971|470014858|FG002|Overall Study|Due to holiday season|1|||
130558802|NCT00763971|470014856|FG000|Overall Study|Randomization error|0|||
130558803|NCT00763971|470014857|FG001|Overall Study|Randomization error|0|||
130314202|NCT05579977|469116104|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
130314203|NCT05579977|469116105|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
130314204|NCT05579977|469116106|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
130314205|NCT05579977|469116107|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
130558804|NCT00763971|470014858|FG002|Overall Study|Randomization error|1|||
130558805|NCT00763971|470014856|FG000|Overall Study|Medical monitor decision|0|||
130558806|NCT00763971|470014857|FG001|Overall Study|Medical monitor decision|0|||
130558807|NCT00763971|470014858|FG002|Overall Study|Medical monitor decision|1|||
130558808|NCT00763971|470014856|FG000|Overall Study|Moved to another country|0|||
130558809|NCT00763971|470014857|FG001|Overall Study|Moved to another country|1|||
130719287|NCT00085423|470597380|FG000|Overall Study|screen failure|1|||
130314206|NCT05579977|469116108|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
130314207|NCT05579977|469116109|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
130314208|NCT05579977|469116110|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
130314209|NCT05579977|469116111|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
130314210|NCT05579977|469116112|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
130375210|NCT01169493|469339797|FG003|Period 3 (6 Months)|Adverse Event|0|||
130375211|NCT01169493|469339798|FG004|Period 3 (6 Months)|Adverse Event|0|||
130375212|NCT01169493|469339799|FG005|Period 3 (6 Months)|Adverse Event|0|||
130375213|NCT01169493|469339794|FG000|Period 3 (6 Months)|Physician Decision|0|||
130375214|NCT01169493|469339795|FG001|Period 3 (6 Months)|Physician Decision|1|||
130375215|NCT01169493|469339796|FG002|Period 3 (6 Months)|Physician Decision|1|||
130375216|NCT01169493|469339797|FG003|Period 3 (6 Months)|Physician Decision|0|||
130375217|NCT01169493|469339798|FG004|Period 3 (6 Months)|Physician Decision|0|||
130375218|NCT01169493|469339799|FG005|Period 3 (6 Months)|Physician Decision|0|||
130375219|NCT01906008|469339803|FG000|Overall Study|Lost to Follow-up|2|||
130375220|NCT01906008|469339804|FG001|Overall Study|Lost to Follow-up|0|||
130375221|NCT01906008|469339803|FG000|Overall Study|Oxaliplatin toxicity|2|||
130375222|NCT01906008|469339804|FG001|Overall Study|Oxaliplatin toxicity|0|||
130375223|NCT01906008|469339803|FG000|Overall Study|Protocol Violation|0|||
130375224|NCT01906008|469339804|FG001|Overall Study|Protocol Violation|1|||
130375225|NCT01906008|469339803|FG000|Overall Study|Withdrawal by Subject|1|||
130375226|NCT01906008|469339804|FG001|Overall Study|Withdrawal by Subject|5|||
130375227|NCT01906008|469339803|FG000|Overall Study|Did not start study med|3|||
130375228|NCT01906008|469339804|FG001|Overall Study|Did not start study med|4|||
130375229|NCT01906008|469339803|FG000|Overall Study|Oxaliplatin stops|10|||
130375230|NCT01906008|469339804|FG001|Overall Study|Oxaliplatin stops|8|||
130375231|NCT01906008|469339803|FG000|Overall Study|Hospice|1|||
130375232|NCT01906008|469339804|FG001|Overall Study|Hospice|0|||
130375233|NCT01906008|469339803|FG000|Overall Study|Physician Decision|3|||
130375234|NCT01906008|469339804|FG001|Overall Study|Physician Decision|3|||
130375235|NCT01906008|469339803|FG000|Overall Study|Lack of compliance of study med|5|||
130375236|NCT01906008|469339804|FG001|Overall Study|Lack of compliance of study med|3|||
130375237|NCT01906008|469339803|FG000|Overall Study|Adverse Event|0|||
130375238|NCT01906008|469339804|FG001|Overall Study|Adverse Event|3|||
130375239|NCT02651922|469339806|FG000|Overall Study|due to exclusion criteria|2|||
130375240|NCT00171730|469339808|FG000|Overall Study|Adverse Event|3|||
130375241|NCT00171730|469339808|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130375242|NCT00171730|469339808|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
130375243|NCT00171730|469339808|FG000|Overall Study|Withdrawal by Subject|3|||
130375244|NCT02220205|469339809|FG000|Overall Study|Withdrawal by Subject|1|||
130375245|NCT02220205|469339810|FG001|Overall Study|Withdrawal by Subject|0|||
130558810|NCT00763971|470014858|FG002|Overall Study|Moved to another country|0|||
130558811|NCT00763971|470014856|FG000|Overall Study|Subject wanted dose reduction|0|||
130558812|NCT00763971|470014857|FG001|Overall Study|Subject wanted dose reduction|1|||
130558813|NCT00763971|470014858|FG002|Overall Study|Subject wanted dose reduction|0|||
130719288|NCT00536263|470597386|FG000|Overall Study|Adverse Event|5|||
130375246|NCT02266225|469339811|FG000|Overall Study|Lost to Follow-up|2|||
130375247|NCT02266225|469339811|FG000|Overall Study|Death|1|||
130375248|NCT02266225|469339811|FG000|Overall Study|Withdrawal by Subject|13|||
130375249|NCT01465997|469339812|FG000|Overall Study|Adverse Event|12|||
130375250|NCT01465997|469339813|FG001|Overall Study|Adverse Event|22|||
130375251|NCT01465997|469339812|FG000|Overall Study|Lack of Efficacy|13|||
130375252|NCT01465997|469339813|FG001|Overall Study|Lack of Efficacy|1|||
130375253|NCT01465997|469339812|FG000|Overall Study|Protocol Violation|1|||
130375254|NCT01465997|469339813|FG001|Overall Study|Protocol Violation|4|||
130375255|NCT01465997|469339812|FG000|Overall Study|Lost to Follow-up|6|||
130466201|NCT01290341|469673601|FG000|Overall Study|Negative baseline culture and others|44|||
130466202|NCT01290341|469673602|FG001|Overall Study|Negative baseline culture and others|11|||
130466203|NCT01102231|469673607|FG000|Overall Study|Protocol Violation|3|||
130466204|NCT01102231|469673607|FG000|Overall Study|Lack of Efficacy|2|||
130466205|NCT01102231|469673607|FG000|Overall Study|Death|2|||
130466206|NCT01102231|469673607|FG000|Overall Study|Adverse Event|3|||
130466207|NCT01102231|469673607|FG000|Overall Study|Withdrawal by Subject|1|||
130466208|NCT01102231|469673607|FG000|Overall Study|Did not received the treatment|4|||
130466209|NCT02568683|469673610|FG000|Overall Study|Death|0|||
130466210|NCT02568683|469673611|FG001|Overall Study|Death|2|||
130466211|NCT02568683|469673610|FG000|Overall Study|Withdrew Consent|1|||
130466212|NCT02568683|469673611|FG001|Overall Study|Withdrew Consent|0|||
130466213|NCT02568683|469673610|FG000|Overall Study|Study Terminated By Sponsor|5|||
130466214|NCT02568683|469673611|FG001|Overall Study|Study Terminated By Sponsor|2|||
130466215|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
130466216|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
130466217|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
130466218|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
130466219|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
130466220|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
130466221|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
130466222|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
130466223|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
130466224|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
130466225|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
130466226|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
130466227|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
130466228|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
130466229|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
130466230|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
130466231|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
130466232|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
130466233|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
130466234|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
130466235|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
130466236|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
130466237|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
130466238|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
130466239|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
130466240|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
130466241|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
130466242|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
130466243|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
130466244|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
130466245|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
130466246|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
130466247|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
130466248|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
130466249|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
130466250|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
130466251|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
130466252|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
130466253|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
130466254|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
130466255|NCT02409667|469673628|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
130466256|NCT02409667|469673629|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
130375256|NCT01465997|469339813|FG001|Overall Study|Lost to Follow-up|9|||
130375257|NCT01465997|469339812|FG000|Overall Study|Withdrawal by Subject|32|||
130375258|NCT01465997|469339813|FG001|Overall Study|Withdrawal by Subject|35|||
130375259|NCT01465997|469339812|FG000|Overall Study|investigator's decision|1|||
130375260|NCT01465997|469339813|FG001|Overall Study|investigator's decision|1|||
130558814|NCT00763971|470014856|FG000|Overall Study|Lack of availability|0|||
130558815|NCT00763971|470014857|FG001|Overall Study|Lack of availability|1|||
130558816|NCT00763971|470014858|FG002|Overall Study|Lack of availability|0|||
130558817|NCT00763971|470014856|FG000|Overall Study|Performed final visit on phone|0|||
130558818|NCT00763971|470014857|FG001|Overall Study|Performed final visit on phone|1|||
130558819|NCT00763971|470014858|FG002|Overall Study|Performed final visit on phone|0|||
130558820|NCT00763971|470014856|FG000|Overall Study|Participation in 489-326 required|1|||
130558821|NCT00763971|470014857|FG001|Overall Study|Participation in 489-326 required|0|||
130558822|NCT00763971|470014858|FG002|Overall Study|Participation in 489-326 required|0|||
130558823|NCT00710879|470014860|FG000|Overall Study|Lost to Follow-up|2|||
130558824|NCT00710879|470014861|FG001|Overall Study|Lost to Follow-up|1|||
130558825|NCT00710879|470014860|FG000|Overall Study|Protocol Violation|0|||
130558826|NCT00710879|470014861|FG001|Overall Study|Protocol Violation|3|||
130558827|NCT01809132|470014862|FG000|Overall Study|Withdrawal by Subject|0|||
130558828|NCT01809132|470014863|FG001|Overall Study|Withdrawal by Subject|0|||
130558829|NCT01809132|470014864|FG002|Overall Study|Withdrawal by Subject|1|||
130558830|NCT03349775|470014865|FG000|Overall Study|Side Effects|1|||
130558831|NCT03349775|470014866|FG001|Overall Study|Side Effects|2|||
130558832|NCT03349775|470014865|FG000|Overall Study|Withdrawal by Subject|1|||
130558833|NCT03349775|470014866|FG001|Overall Study|Withdrawal by Subject|1|||
130558834|NCT03349775|470014865|FG000|Overall Study|No primary outcome measurements|0|||
130558835|NCT03349775|470014866|FG001|Overall Study|No primary outcome measurements|1|||
130558836|NCT01516970|470014867|FG000|Overall Study|Lost to Follow-up|7|||
130314211|NCT05579977|469116113|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
130314212|NCT05579977|469116101|FG000|Treatment Phase|Withdrawal by Subject|2|||
130314213|NCT05579977|469116102|FG001|Treatment Phase|Withdrawal by Subject|0|||
130558837|NCT01516970|470014868|FG001|Overall Study|Lost to Follow-up|8|||
130558838|NCT01516970|470014867|FG000|Overall Study|Adverse Event|1|||
130558839|NCT01516970|470014868|FG001|Overall Study|Adverse Event|5|||
130314214|NCT05579977|469116103|FG002|Treatment Phase|Withdrawal by Subject|0|||
130314215|NCT05579977|469116104|FG003|Treatment Phase|Withdrawal by Subject|1|||
130314216|NCT05579977|469116105|FG004|Treatment Phase|Withdrawal by Subject|2|||
130314217|NCT05579977|469116106|FG005|Treatment Phase|Withdrawal by Subject|0|||
130314218|NCT05579977|469116107|FG006|Treatment Phase|Withdrawal by Subject|1|||
130314219|NCT05579977|469116108|FG007|Treatment Phase|Withdrawal by Subject|8|||
130314220|NCT05579977|469116109|FG008|Treatment Phase|Withdrawal by Subject|3|||
130314221|NCT05579977|469116110|FG009|Treatment Phase|Withdrawal by Subject|3|||
130314222|NCT05579977|469116111|FG010|Treatment Phase|Withdrawal by Subject|5|||
130314223|NCT05579977|469116112|FG011|Treatment Phase|Withdrawal by Subject|1|||
130314224|NCT05579977|469116113|FG012|Treatment Phase|Withdrawal by Subject|3|||
130314225|NCT05579977|469116101|FG000|Treatment Phase|Study terminated by sponsor|70|||
130314226|NCT05579977|469116102|FG001|Treatment Phase|Study terminated by sponsor|70|||
130314227|NCT05579977|469116103|FG002|Treatment Phase|Study terminated by sponsor|61|||
130314228|NCT05579977|469116104|FG003|Treatment Phase|Study terminated by sponsor|59|||
130314229|NCT05579977|469116105|FG004|Treatment Phase|Study terminated by sponsor|63|||
130314230|NCT05579977|469116106|FG005|Treatment Phase|Study terminated by sponsor|53|||
130314231|NCT05579977|469116107|FG006|Treatment Phase|Study terminated by sponsor|66|||
130314232|NCT05579977|469116108|FG007|Treatment Phase|Study terminated by sponsor|48|||
130314233|NCT05579977|469116109|FG008|Treatment Phase|Study terminated by sponsor|47|||
130314234|NCT05579977|469116110|FG009|Treatment Phase|Study terminated by sponsor|37|||
130314235|NCT05579977|469116111|FG010|Treatment Phase|Study terminated by sponsor|44|||
130314236|NCT05579977|469116112|FG011|Treatment Phase|Study terminated by sponsor|36|||
130314237|NCT05579977|469116113|FG012|Treatment Phase|Study terminated by sponsor|32|||
130314238|NCT05579977|469116101|FG000|Treatment Phase|Pregnancy|0|||
130314239|NCT05579977|469116102|FG001|Treatment Phase|Pregnancy|0|||
130314240|NCT05579977|469116103|FG002|Treatment Phase|Pregnancy|0|||
130314241|NCT05579977|469116104|FG003|Treatment Phase|Pregnancy|0|||
130314242|NCT05579977|469116105|FG004|Treatment Phase|Pregnancy|0|||
130314243|NCT05579977|469116106|FG005|Treatment Phase|Pregnancy|0|||
130314244|NCT05579977|469116107|FG006|Treatment Phase|Pregnancy|0|||
130314245|NCT05579977|469116108|FG007|Treatment Phase|Pregnancy|0|||
130314246|NCT05579977|469116109|FG008|Treatment Phase|Pregnancy|0|||
130314247|NCT05579977|469116110|FG009|Treatment Phase|Pregnancy|1|||
130314248|NCT05579977|469116111|FG010|Treatment Phase|Pregnancy|0|||
130314249|NCT05579977|469116112|FG011|Treatment Phase|Pregnancy|0|||
130375261|NCT01465997|469339812|FG000|Overall Study|Death|0|||
130314250|NCT05579977|469116113|FG012|Treatment Phase|Pregnancy|0|||
130314251|NCT05579977|469116101|FG000|Treatment Phase|Physician Decision|0|||
130558840|NCT01516970|470014867|FG000|Overall Study|Withdrawal by Subject|1|||
130558841|NCT01516970|470014868|FG001|Overall Study|Withdrawal by Subject|1|||
130558842|NCT01516970|470014867|FG000|Overall Study|Other|9|||
130558843|NCT01516970|470014868|FG001|Overall Study|Other|7|||
130558844|NCT00434421|470014869|FG000|Overall Study|Withdrawal by Subject|1|||
130558845|NCT00434421|470014869|FG000|Overall Study|Non-compliance with study treatment|1|||
130558846|NCT01756040|470014870|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
130558847|NCT01756040|470014870|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
130314252|NCT05579977|469116102|FG001|Treatment Phase|Physician Decision|0|||
130314253|NCT05579977|469116103|FG002|Treatment Phase|Physician Decision|0|||
130314254|NCT05579977|469116104|FG003|Treatment Phase|Physician Decision|0|||
130314255|NCT05579977|469116105|FG004|Treatment Phase|Physician Decision|0|||
130314256|NCT05579977|469116106|FG005|Treatment Phase|Physician Decision|0|||
130314257|NCT05579977|469116107|FG006|Treatment Phase|Physician Decision|0|||
130314258|NCT05579977|469116108|FG007|Treatment Phase|Physician Decision|0|||
130314259|NCT05579977|469116109|FG008|Treatment Phase|Physician Decision|0|||
130466257|NCT02409667|469673630|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
130466258|NCT02409667|469673631|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
130466259|NCT02409667|469673632|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
130466260|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
130466261|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
130466262|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
130466263|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
130466264|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
130466265|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
130466266|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
130466267|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
130466268|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
130466269|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
130466270|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
130466271|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
130466272|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
130466273|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
130466274|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
130466275|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
130466276|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
130466277|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
130466278|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
130466279|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
130466280|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
130466281|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
130466282|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
130466283|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
130466284|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
130466285|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
130466286|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
130466287|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
130466288|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
130314260|NCT05579977|469116110|FG009|Treatment Phase|Physician Decision|0|||
130466289|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
130466290|NCT02409667|469673628|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
130466291|NCT02409667|469673629|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
130466292|NCT02409667|469673630|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
130466293|NCT02409667|469673631|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
130466294|NCT02409667|469673632|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
130466295|NCT00774852|469673634|FG000|Overall Study|Adverse Event|9|||
130466296|NCT00774852|469673635|FG001|Overall Study|Adverse Event|6|||
130466297|NCT00774852|469673634|FG000|Overall Study|Death|2|||
130466298|NCT00774852|469673635|FG001|Overall Study|Death|1|||
130466299|NCT00774852|469673634|FG000|Overall Study|Lack of Efficacy|3|||
130466300|NCT00774852|469673635|FG001|Overall Study|Lack of Efficacy|7|||
130466301|NCT00774852|469673634|FG000|Overall Study|Lost to Follow-up|9|||
130466302|NCT00774852|469673635|FG001|Overall Study|Lost to Follow-up|5|||
130466303|NCT00774852|469673634|FG000|Overall Study|Physician Decision|2|||
130466304|NCT00774852|469673635|FG001|Overall Study|Physician Decision|6|||
130466305|NCT00774852|469673634|FG000|Overall Study|Pregnancy|1|||
130466306|NCT00774852|469673635|FG001|Overall Study|Pregnancy|2|||
130466307|NCT00774852|469673634|FG000|Overall Study|Withdrawal by Subject|2|||
130466308|NCT00774852|469673635|FG001|Overall Study|Withdrawal by Subject|2|||
130466309|NCT00774852|469673634|FG000|Overall Study|Non-responder|15|||
130466310|NCT00774852|469673635|FG001|Overall Study|Non-responder|11|||
130314261|NCT05579977|469116111|FG010|Treatment Phase|Physician Decision|0|||
130314262|NCT05579977|469116112|FG011|Treatment Phase|Physician Decision|1|||
130314263|NCT05579977|469116113|FG012|Treatment Phase|Physician Decision|0|||
130466311|NCT00774852|469673634|FG000|Overall Study|Subject non-compliance|0|||
130466312|NCT00774852|469673635|FG001|Overall Study|Subject non-compliance|1|||
130314264|NCT05579977|469116101|FG000|Treatment Phase|Lost to Follow-up|0|||
130314265|NCT05579977|469116102|FG001|Treatment Phase|Lost to Follow-up|0|||
130314266|NCT05579977|469116103|FG002|Treatment Phase|Lost to Follow-up|0|||
130558848|NCT01756040|470014870|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
130558849|NCT01205438|470014871|FG000|Overall Study|Adverse Event|19|||
130558850|NCT01205438|470014872|FG001|Overall Study|Adverse Event|17|||
130558851|NCT01205438|470014873|FG002|Overall Study|Adverse Event|24|||
130558852|NCT01205438|470014871|FG000|Overall Study|Death|1|||
130558853|NCT01205438|470014872|FG001|Overall Study|Death|1|||
130558854|NCT01205438|470014873|FG002|Overall Study|Death|3|||
130558855|NCT01205438|470014871|FG000|Overall Study|Entry Criteria Not Met|16|||
130558856|NCT01205438|470014872|FG001|Overall Study|Entry Criteria Not Met|15|||
130558857|NCT01205438|470014873|FG002|Overall Study|Entry Criteria Not Met|13|||
130558858|NCT01205438|470014871|FG000|Overall Study|Lack of Efficacy|14|||
130558859|NCT01205438|470014872|FG001|Overall Study|Lack of Efficacy|11|||
130558860|NCT01205438|470014873|FG002|Overall Study|Lack of Efficacy|14|||
130558861|NCT01205438|470014871|FG000|Overall Study|Lost to Follow-up|6|||
130558862|NCT01205438|470014872|FG001|Overall Study|Lost to Follow-up|7|||
130558863|NCT01205438|470014873|FG002|Overall Study|Lost to Follow-up|8|||
130558864|NCT01205438|470014871|FG000|Overall Study|Withdrawal by Subject|19|||
130558865|NCT01205438|470014872|FG001|Overall Study|Withdrawal by Subject|25|||
130558866|NCT01205438|470014873|FG002|Overall Study|Withdrawal by Subject|19|||
130558867|NCT01205438|470014871|FG000|Overall Study|Physician Decision|0|||
130558868|NCT01205438|470014872|FG001|Overall Study|Physician Decision|3|||
130558869|NCT01205438|470014873|FG002|Overall Study|Physician Decision|2|||
130558870|NCT01205438|470014871|FG000|Overall Study|Protocol Violation|2|||
130558871|NCT01205438|470014872|FG001|Overall Study|Protocol Violation|7|||
130558872|NCT01205438|470014873|FG002|Overall Study|Protocol Violation|4|||
130558873|NCT01205438|470014871|FG000|Overall Study|Sponsor Decision|0|||
130558874|NCT01205438|470014872|FG001|Overall Study|Sponsor Decision|1|||
130558875|NCT01205438|470014873|FG002|Overall Study|Sponsor Decision|1|||
130558876|NCT01446016|470014874|FG000|Overall Study|Lost to Follow-up|3|||
130558877|NCT01446016|470014874|FG000|Overall Study|Withdrawal by Subject|1|||
130558878|NCT01446016|470014874|FG000|Overall Study|Toxicity|3|||
130558879|NCT01087957|470014881|FG000|Overall Study|Death|2|||
130558880|NCT01087957|470014882|FG001|Overall Study|Death|2|||
130558881|NCT01087957|470014881|FG000|Overall Study|Lost to Follow-up|3|||
130558882|NCT01087957|470014882|FG001|Overall Study|Lost to Follow-up|4|||
130558883|NCT01087957|470014881|FG000|Overall Study|Protocol Violation|13|||
130558884|NCT01087957|470014882|FG001|Overall Study|Protocol Violation|25|||
130558885|NCT01087957|470014881|FG000|Overall Study|Withdrawal by Subject|18|||
130558886|NCT01087957|470014882|FG001|Overall Study|Withdrawal by Subject|15|||
130558887|NCT01087957|470014881|FG000|Overall Study|Physician Decision|5|||
130558888|NCT01087957|470014882|FG001|Overall Study|Physician Decision|9|||
130558889|NCT01186939|470014883|FG000|Overall Study|Death|7|||
130558890|NCT01186939|470014883|FG000|Overall Study|Withdrawal by Subject|2|||
130558891|NCT01186939|470014883|FG000|Overall Study|No longer receiving clinical benefit|17|||
130314267|NCT05579977|469116104|FG003|Treatment Phase|Lost to Follow-up|1|||
130314268|NCT05579977|469116105|FG004|Treatment Phase|Lost to Follow-up|1|||
130558892|NCT01186939|470014883|FG000|Overall Study|Program closed|5|||
130558893|NCT01186939|470014883|FG000|Overall Study|Sponsor decision|4|||
130558894|NCT01186939|470014883|FG000|Overall Study|Started additional treatment|1|||
130558895|NCT01186939|470014883|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
130558896|NCT01186939|470014883|FG000|Overall Study|Myocardial infarction|1|||
130558897|NCT01186939|470014883|FG000|Overall Study|Bone marrow transplant|1|||
130558898|NCT01186939|470014883|FG000|Overall Study|Transformation to AML|1|||
130314269|NCT05579977|469116106|FG005|Treatment Phase|Lost to Follow-up|1|||
130314270|NCT05579977|469116107|FG006|Treatment Phase|Lost to Follow-up|0|||
130314271|NCT05579977|469116108|FG007|Treatment Phase|Lost to Follow-up|1|||
130314272|NCT05579977|469116109|FG008|Treatment Phase|Lost to Follow-up|2|||
130314273|NCT05579977|469116110|FG009|Treatment Phase|Lost to Follow-up|2|||
130314274|NCT05579977|469116111|FG010|Treatment Phase|Lost to Follow-up|1|||
130314275|NCT05579977|469116112|FG011|Treatment Phase|Lost to Follow-up|4|||
130314276|NCT05579977|469116113|FG012|Treatment Phase|Lost to Follow-up|3|||
130314277|NCT05579977|469116101|FG000|Treatment Phase|Death|1|||
130314278|NCT05579977|469116102|FG001|Treatment Phase|Death|0|||
130314279|NCT05579977|469116103|FG002|Treatment Phase|Death|0|||
130314280|NCT05579977|469116104|FG003|Treatment Phase|Death|0|||
130314281|NCT05579977|469116105|FG004|Treatment Phase|Death|0|||
130314282|NCT05579977|469116106|FG005|Treatment Phase|Death|0|||
130314283|NCT05579977|469116107|FG006|Treatment Phase|Death|0|||
130314284|NCT05579977|469116108|FG007|Treatment Phase|Death|0|||
130314285|NCT05579977|469116109|FG008|Treatment Phase|Death|0|||
130558899|NCT00616434|470014888|FG000|Overall Study|Adverse Event|5|||
130314286|NCT05579977|469116110|FG009|Treatment Phase|Death|0|||
130314287|NCT05579977|469116111|FG010|Treatment Phase|Death|0|||
130314288|NCT05579977|469116112|FG011|Treatment Phase|Death|0|||
130314289|NCT05579977|469116113|FG012|Treatment Phase|Death|0|||
130314290|NCT05579977|469116101|FG000|Treatment Phase|Adverse Event|0|||
130314291|NCT05579977|469116102|FG001|Treatment Phase|Adverse Event|3|||
130314292|NCT05579977|469116103|FG002|Treatment Phase|Adverse Event|11|||
130558900|NCT00616434|470014889|FG001|Overall Study|Adverse Event|2|||
130558901|NCT00616434|470014888|FG000|Overall Study|Physician Decision|0|||
130558902|NCT00616434|470014889|FG001|Overall Study|Physician Decision|4|||
130558903|NCT00616434|470014888|FG000|Overall Study|Withdrawal by Subject|1|||
130558904|NCT00616434|470014889|FG001|Overall Study|Withdrawal by Subject|1|||
130558905|NCT00616434|470014888|FG000|Overall Study|Protocol deviation|0|||
130558906|NCT00616434|470014889|FG001|Overall Study|Protocol deviation|1|||
130558907|NCT01118325|470014892|FG000|Overall Study|Adverse Event|1|||
130558908|NCT01118325|470014893|FG001|Overall Study|Adverse Event|0|||
130558909|NCT01118325|470014894|FG002|Overall Study|Adverse Event|1|||
130558910|NCT03334409|470014895|FG000|Overall Study|Did not meet inclusion criteria|1|||
130558911|NCT03334409|470014896|FG001|Overall Study|Did not meet inclusion criteria|0|||
130558912|NCT00975715|470014897|FG000|Titration Period|Adverse Event|6|||
130558913|NCT00975715|470014898|FG001|Titration Period|Adverse Event|0|||
130558914|NCT00975715|470014897|FG000|Titration Period|Protocol Violation|1|||
130558915|NCT00975715|470014898|FG001|Titration Period|Protocol Violation|0|||
130558916|NCT00975715|470014897|FG000|Maintenance Period|Adverse Event|2|||
130558917|NCT00975715|470014898|FG001|Maintenance Period|Adverse Event|1|||
130558918|NCT01674712|470014905|FG000|Overall Study|Adverse Event|5|||
130558919|NCT01674712|470014906|FG001|Overall Study|Adverse Event|6|||
130558920|NCT01674712|470014907|FG002|Overall Study|Adverse Event|3|||
130558921|NCT01674712|470014908|FG003|Overall Study|Adverse Event|4|||
130558922|NCT01674712|470014909|FG004|Overall Study|Adverse Event|6|||
130558923|NCT01674712|470014905|FG000|Overall Study|Lost to Follow-up|1|||
130558924|NCT01674712|470014906|FG001|Overall Study|Lost to Follow-up|0|||
130558925|NCT01674712|470014907|FG002|Overall Study|Lost to Follow-up|0|||
130558926|NCT01674712|470014908|FG003|Overall Study|Lost to Follow-up|0|||
130558927|NCT01674712|470014909|FG004|Overall Study|Lost to Follow-up|0|||
130558928|NCT01674712|470014905|FG000|Overall Study|Protocol Violation|2|||
130558929|NCT01674712|470014906|FG001|Overall Study|Protocol Violation|0|||
130558930|NCT01674712|470014907|FG002|Overall Study|Protocol Violation|0|||
130558931|NCT01674712|470014908|FG003|Overall Study|Protocol Violation|0|||
130558932|NCT01674712|470014909|FG004|Overall Study|Protocol Violation|0|||
130558933|NCT01674712|470014905|FG000|Overall Study|Withdrawal by Subject|2|||
130558934|NCT01674712|470014906|FG001|Overall Study|Withdrawal by Subject|2|||
130558935|NCT01674712|470014907|FG002|Overall Study|Withdrawal by Subject|5|||
130558936|NCT01674712|470014908|FG003|Overall Study|Withdrawal by Subject|4|||
130558937|NCT01674712|470014909|FG004|Overall Study|Withdrawal by Subject|3|||
130558938|NCT01674712|470014905|FG000|Overall Study|Administrative|0|||
130558939|NCT01674712|470014906|FG001|Overall Study|Administrative|1|||
130558940|NCT01674712|470014907|FG002|Overall Study|Administrative|0|||
130558941|NCT01674712|470014908|FG003|Overall Study|Administrative|0|||
130558942|NCT01674712|470014909|FG004|Overall Study|Administrative|1|||
130558943|NCT01674712|470014905|FG000|Overall Study|Lack of Efficacy|0|||
130558944|NCT01674712|470014906|FG001|Overall Study|Lack of Efficacy|0|||
130558945|NCT01674712|470014907|FG002|Overall Study|Lack of Efficacy|1|||
130558946|NCT01674712|470014908|FG003|Overall Study|Lack of Efficacy|0|||
130558947|NCT01674712|470014909|FG004|Overall Study|Lack of Efficacy|1|||
130558948|NCT00874770|470014910|FG000|Overall Study|Lack of Efficacy|2|||
130558949|NCT00874770|470014911|FG001|Overall Study|Lack of Efficacy|0|||
130558950|NCT00874770|470014912|FG002|Overall Study|Lack of Efficacy|0|||
130558951|NCT00874770|470014913|FG003|Overall Study|Lack of Efficacy|2|||
130558952|NCT00874770|470014910|FG000|Overall Study|Adverse Event|1|||
130558953|NCT00874770|470014911|FG001|Overall Study|Adverse Event|1|||
130558954|NCT00874770|470014912|FG002|Overall Study|Adverse Event|4|||
130558955|NCT00874770|470014913|FG003|Overall Study|Adverse Event|2|||
130558956|NCT00874770|470014910|FG000|Overall Study|Lost to Follow-up|1|||
130558957|NCT00874770|470014911|FG001|Overall Study|Lost to Follow-up|0|||
130558958|NCT00874770|470014912|FG002|Overall Study|Lost to Follow-up|0|||
130558959|NCT00874770|470014913|FG003|Overall Study|Lost to Follow-up|1|||
130558960|NCT00874770|470014910|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
130558961|NCT00874770|470014911|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
130558962|NCT00874770|470014912|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
130558963|NCT00874770|470014913|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
130558964|NCT05395104|470014914|FG000|Overall Study|Met Liver Stopping Criteria|1|||
130558965|NCT05395104|470014914|FG000|Overall Study|Withdrawal by Subject|1|||
130558966|NCT03974334|470014915|FG000|Overall Study|Lost to Follow-up|1|||
130558967|NCT00024167|470014916|FG000|Overall Study|Death|53|||
130558968|NCT00024167|470014917|FG001|Overall Study|Death|47|||
130558969|NCT00770770|470014932|FG000|Overall Study|Lost to Follow-up|1|||
130558970|NCT00770770|470014933|FG001|Overall Study|Lost to Follow-up|0|||
130558971|NCT00770770|470014932|FG000|Overall Study|Withdrawal by Subject|1|||
130558972|NCT00770770|470014933|FG001|Overall Study|Withdrawal by Subject|0|||
130558973|NCT00770770|470014932|FG000|Overall Study|Death|0|||
130558974|NCT00770770|470014933|FG001|Overall Study|Death|1|||
130558975|NCT00770770|470014932|FG000|Overall Study|Study Terminated|8|||
130558976|NCT00770770|470014933|FG001|Overall Study|Study Terminated|0|||
130558977|NCT01230554|470014941|FG000|Overall Study|Lost to Follow-up|2|||
130558978|NCT01230554|470014941|FG000|Overall Study|Inability to maintain visit schedule|1|||
130466313|NCT00774852|469673634|FG000|Overall Study|Protocol Violation|1|||
130466314|NCT00774852|469673635|FG001|Overall Study|Protocol Violation|0|||
130466315|NCT00774852|469673634|FG000|Overall Study|Subject received prohibited medication|1|||
130466316|NCT00774852|469673635|FG001|Overall Study|Subject received prohibited medication|0|||
130466317|NCT03997916|469673636|FG000|Overall Study|Protocol Violation|35|||
130466318|NCT03482635|469673640|FG000|Overall Study|Lack of Efficacy|0|||
130466319|NCT03482635|469673641|FG001|Overall Study|Lack of Efficacy|0|||
130466320|NCT03482635|469673642|FG002|Overall Study|Lack of Efficacy|1|||
130466321|NCT03482635|469673643|FG003|Overall Study|Lack of Efficacy|3|||
130466322|NCT03482635|469673640|FG000|Overall Study|Adverse Event|2|||
130466323|NCT03482635|469673641|FG001|Overall Study|Adverse Event|2|||
130466324|NCT03482635|469673642|FG002|Overall Study|Adverse Event|0|||
130466325|NCT03482635|469673643|FG003|Overall Study|Adverse Event|3|||
130466326|NCT03482635|469673640|FG000|Overall Study|Withdrawal by Subject|2|||
130466327|NCT03482635|469673641|FG001|Overall Study|Withdrawal by Subject|1|||
130466328|NCT03482635|469673642|FG002|Overall Study|Withdrawal by Subject|0|||
130466329|NCT03482635|469673643|FG003|Overall Study|Withdrawal by Subject|1|||
130466330|NCT03482635|469673640|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
130466331|NCT03482635|469673641|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
130466332|NCT03482635|469673642|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
130466333|NCT03482635|469673643|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
130466334|NCT03482635|469673640|FG000|Overall Study|Not treated|0|||
130466335|NCT03482635|469673641|FG001|Overall Study|Not treated|0|||
130466336|NCT03482635|469673642|FG002|Overall Study|Not treated|0|||
130466337|NCT03482635|469673643|FG003|Overall Study|Not treated|1|||
130466338|NCT03237481|469674766|FG000|Overall Study|Lost to Follow-up|1|||
130466339|NCT03237481|469674767|FG001|Overall Study|Lost to Follow-up|0|||
130466340|NCT03237481|469674768|FG002|Overall Study|Lost to Follow-up|0|||
130466341|NCT03237481|469674766|FG000|Overall Study|Protocol Violation|1|||
130466342|NCT03237481|469674767|FG001|Overall Study|Protocol Violation|0|||
130466343|NCT03237481|469674768|FG002|Overall Study|Protocol Violation|0|||
130466344|NCT03237481|469674766|FG000|Overall Study|Withdrawal by Subject|3|||
130466345|NCT03237481|469674767|FG001|Overall Study|Withdrawal by Subject|2|||
130466346|NCT03237481|469674768|FG002|Overall Study|Withdrawal by Subject|1|||
130466347|NCT01780298|469674769|FG000|Overall Study|Physician Decision|1|||
130466348|NCT01780298|469674770|FG001|Overall Study|Physician Decision|5|||
130466349|NCT01780298|469674771|FG002|Overall Study|Physician Decision|1|||
130466350|NCT01780298|469674772|FG003|Overall Study|Physician Decision|1|||
130466351|NCT01780298|469674769|FG000|Overall Study|Subject not matched|1|||
130466352|NCT01780298|469674770|FG001|Overall Study|Subject not matched|0|||
130466353|NCT01780298|469674771|FG002|Overall Study|Subject not matched|1|||
130466354|NCT01780298|469674772|FG003|Overall Study|Subject not matched|0|||
130466355|NCT01780298|469674769|FG000|Overall Study|Adverse Event|0|||
130466356|NCT01780298|469674770|FG001|Overall Study|Adverse Event|0|||
130466357|NCT01780298|469674771|FG002|Overall Study|Adverse Event|2|||
130466358|NCT01780298|469674772|FG003|Overall Study|Adverse Event|0|||
130466359|NCT04907474|469674773|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
130466360|NCT04907474|469674774|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
130466361|NCT03873779|469674775|FG000|Overall Study|Withdrawal by Subject|1|||
130466362|NCT03936660|469674776|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
130466363|NCT03936660|469674777|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
130466364|NCT04425863|469674779|FG000|Overall Study|Death|0|||
130466365|NCT04425863|469674780|FG001|Overall Study|Death|0|||
130466366|NCT04425863|469674781|FG002|Overall Study|Death|1|||
130466367|NCT00277355|469674786|FG000|Overall Study|Withdrawal by Subject|3|||
130466368|NCT00277355|469674787|FG001|Overall Study|Withdrawal by Subject|3|||
130466369|NCT00277355|469674786|FG000|Overall Study|Lost to Follow-up|2|||
130466370|NCT00277355|469674787|FG001|Overall Study|Lost to Follow-up|2|||
130466371|NCT00277355|469674786|FG000|Overall Study|Adverse Event|5|||
130466372|NCT00277355|469674787|FG001|Overall Study|Adverse Event|0|||
130466373|NCT00277355|469674786|FG000|Overall Study|Death|3|||
130466374|NCT00277355|469674787|FG001|Overall Study|Death|0|||
130466375|NCT00277355|469674786|FG000|Overall Study|Physician Decision|1|||
130466376|NCT00277355|469674787|FG001|Overall Study|Physician Decision|0|||
130719289|NCT00536263|470597387|FG001|Overall Study|Adverse Event|5|||
130466377|NCT02597920|469674790|FG000|Overall Study|Worsening of other pre-existing disease|0|||
130466378|NCT02597920|469674791|FG001|Overall Study|Worsening of other pre-existing disease|1|||
130466379|NCT02597920|469674792|FG002|Overall Study|Worsening of other pre-existing disease|0|||
130466380|NCT02597920|469674790|FG000|Overall Study|Other adverse event|20|||
130466381|NCT02597920|469674791|FG001|Overall Study|Other adverse event|30|||
130466382|NCT02597920|469674792|FG002|Overall Study|Other adverse event|0|||
130466383|NCT02597920|469674790|FG000|Overall Study|Lost to Follow-up|7|||
130466384|NCT02597920|469674791|FG001|Overall Study|Lost to Follow-up|9|||
130466385|NCT02597920|469674792|FG002|Overall Study|Lost to Follow-up|0|||
130466386|NCT02597920|469674790|FG000|Overall Study|Refuse to continue in the study|3|||
130466387|NCT02597920|469674791|FG001|Overall Study|Refuse to continue in the study|13|||
130466388|NCT02597920|469674792|FG002|Overall Study|Refuse to continue in the study|1|||
130314293|NCT05579977|469116104|FG003|Treatment Phase|Adverse Event|10|||
130314294|NCT05579977|469116105|FG004|Treatment Phase|Adverse Event|5|||
130314295|NCT05579977|469116106|FG005|Treatment Phase|Adverse Event|17|||
130314296|NCT05579977|469116107|FG006|Treatment Phase|Adverse Event|5|||
130314297|NCT05579977|469116108|FG007|Treatment Phase|Adverse Event|5|||
130314298|NCT05579977|469116109|FG008|Treatment Phase|Adverse Event|12|||
130314299|NCT05579977|469116110|FG009|Treatment Phase|Adverse Event|20|||
130314300|NCT05579977|469116111|FG010|Treatment Phase|Adverse Event|15|||
130314301|NCT05579977|469116112|FG011|Treatment Phase|Adverse Event|24|||
130314302|NCT05579977|469116113|FG012|Treatment Phase|Adverse Event|23|||
130314303|NCT05579977|469116101|FG000|Treatment Phase|Randomized not treated|0|||
130314304|NCT05579977|469116102|FG001|Treatment Phase|Randomized not treated|0|||
130314305|NCT05579977|469116103|FG002|Treatment Phase|Randomized not treated|0|||
130314306|NCT05579977|469116104|FG003|Treatment Phase|Randomized not treated|0|||
130314307|NCT05579977|469116105|FG004|Treatment Phase|Randomized not treated|1|||
130314308|NCT05579977|469116106|FG005|Treatment Phase|Randomized not treated|0|||
130314309|NCT05579977|469116107|FG006|Treatment Phase|Randomized not treated|0|||
130314310|NCT05579977|469116108|FG007|Treatment Phase|Randomized not treated|0|||
130314311|NCT05579977|469116109|FG008|Treatment Phase|Randomized not treated|0|||
130314312|NCT05579977|469116110|FG009|Treatment Phase|Randomized not treated|0|||
130314313|NCT05579977|469116111|FG010|Treatment Phase|Randomized not treated|0|||
130314314|NCT05579977|469116112|FG011|Treatment Phase|Randomized not treated|0|||
130314315|NCT05579977|469116113|FG012|Treatment Phase|Randomized not treated|0|||
130314316|NCT05579977|469116101|FG000|Follow up|Death|1|||
130314317|NCT05579977|469116102|FG001|Follow up|Death|0|||
130314318|NCT05579977|469116103|FG002|Follow up|Death|0|||
130314319|NCT05579977|469116104|FG003|Follow up|Death|0|||
130314320|NCT05579977|469116105|FG004|Follow up|Death|0|||
130314321|NCT05579977|469116106|FG005|Follow up|Death|0|||
130314322|NCT05579977|469116107|FG006|Follow up|Death|0|||
130314323|NCT05579977|469116108|FG007|Follow up|Death|0|||
130314324|NCT05579977|469116109|FG008|Follow up|Death|0|||
130314325|NCT05579977|469116110|FG009|Follow up|Death|0|||
130314326|NCT05579977|469116111|FG010|Follow up|Death|0|||
130314327|NCT05579977|469116112|FG011|Follow up|Death|0|||
130314328|NCT05579977|469116113|FG012|Follow up|Death|0|||
130314329|NCT05579977|469116101|FG000|Follow up|Lost to Follow-up|0|||
130314330|NCT05579977|469116102|FG001|Follow up|Lost to Follow-up|0|||
130314331|NCT05579977|469116103|FG002|Follow up|Lost to Follow-up|0|||
130314332|NCT05579977|469116104|FG003|Follow up|Lost to Follow-up|1|||
130314333|NCT05579977|469116105|FG004|Follow up|Lost to Follow-up|1|||
130314334|NCT05579977|469116106|FG005|Follow up|Lost to Follow-up|2|||
130314335|NCT05579977|469116107|FG006|Follow up|Lost to Follow-up|1|||
130314336|NCT05579977|469116108|FG007|Follow up|Lost to Follow-up|1|||
130314337|NCT05579977|469116109|FG008|Follow up|Lost to Follow-up|3|||
130314338|NCT05579977|469116110|FG009|Follow up|Lost to Follow-up|2|||
130314339|NCT05579977|469116111|FG010|Follow up|Lost to Follow-up|2|||
130314340|NCT05579977|469116112|FG011|Follow up|Lost to Follow-up|4|||
130314341|NCT05579977|469116113|FG012|Follow up|Lost to Follow-up|4|||
130314342|NCT05579977|469116101|FG000|Follow up|Withdrawal by Subject|2|||
130314343|NCT05579977|469116102|FG001|Follow up|Withdrawal by Subject|0|||
130314344|NCT05579977|469116103|FG002|Follow up|Withdrawal by Subject|0|||
130314345|NCT05579977|469116104|FG003|Follow up|Withdrawal by Subject|0|||
130314346|NCT05579977|469116105|FG004|Follow up|Withdrawal by Subject|1|||
130314347|NCT05579977|469116106|FG005|Follow up|Withdrawal by Subject|0|||
130314348|NCT05579977|469116107|FG006|Follow up|Withdrawal by Subject|1|||
130314349|NCT05579977|469116108|FG007|Follow up|Withdrawal by Subject|4|||
130719290|NCT00536263|470597388|FG002|Overall Study|Adverse Event|7|||
130314350|NCT05579977|469116109|FG008|Follow up|Withdrawal by Subject|2|||
130314351|NCT05579977|469116110|FG009|Follow up|Withdrawal by Subject|3|||
130314352|NCT05579977|469116111|FG010|Follow up|Withdrawal by Subject|3|||
130314353|NCT05579977|469116112|FG011|Follow up|Withdrawal by Subject|1|||
130314354|NCT05579977|469116113|FG012|Follow up|Withdrawal by Subject|3|||
130314355|NCT00866814|469116114|FG000|Overall Study|Lost to Follow-up|12|||
130314356|NCT00866814|469116114|FG000|Overall Study|Adverse Event|2|||
130314357|NCT00866814|469116114|FG000|Overall Study|Physician Decision|1|||
130314358|NCT00866814|469116114|FG000|Overall Study|Death|1|||
130314359|NCT00866814|469116114|FG000|Overall Study|No longer wished to participate|1|||
130314360|NCT00866814|469116114|FG000|Overall Study|Unable to meet follow-up requirements|2|||
130314361|NCT00866814|469116114|FG000|Overall Study|Moved to area without study site|1|||
130314362|NCT01420926|469116117|FG000|Overall Study|Adverse Event|6|||
130314363|NCT01420926|469116118|FG001|Overall Study|Adverse Event|4|||
130314364|NCT01420926|469116117|FG000|Overall Study|Death|18|||
130314365|NCT01420926|469116118|FG001|Overall Study|Death|17|||
130314366|NCT01420926|469116117|FG000|Overall Study|Withdrawal by Subject|11|||
130314367|NCT01420926|469116118|FG001|Overall Study|Withdrawal by Subject|17|||
130314368|NCT01420926|469116117|FG000|Overall Study|Non-protocol treatment|17|||
130314369|NCT01420926|469116118|FG001|Overall Study|Non-protocol treatment|20|||
130314370|NCT01420926|469116117|FG000|Overall Study|Physician Decision|8|||
130314371|NCT01420926|469116118|FG001|Overall Study|Physician Decision|5|||
130375262|NCT01465997|469339813|FG001|Overall Study|Death|1|||
130375263|NCT01465997|469339812|FG000|Overall Study|sponsor's decision|1|||
130466389|NCT02597920|469674790|FG000|Overall Study|Other than specified|10|||
130466390|NCT02597920|469674791|FG001|Overall Study|Other than specified|31|||
130466391|NCT02597920|469674792|FG002|Overall Study|Other than specified|5|||
130466392|NCT02597920|469674790|FG000|Overall Study|Other|1|||
130719291|NCT00536263|470597386|FG000|Overall Study|Lost to Follow-up|3|||
130719292|NCT00536263|470597387|FG001|Overall Study|Lost to Follow-up|4|||
130719293|NCT00536263|470597388|FG002|Overall Study|Lost to Follow-up|4|||
130719294|NCT00536263|470597386|FG000|Overall Study|Subject withdrew - not treatment related|2|||
130719295|NCT00536263|470597387|FG001|Overall Study|Subject withdrew - not treatment related|0|||
130719296|NCT00536263|470597388|FG002|Overall Study|Subject withdrew - not treatment related|5|||
130719297|NCT00536263|470597386|FG000|Overall Study|Subject withdrew - treatment related|0|||
130719298|NCT00536263|470597387|FG001|Overall Study|Subject withdrew - treatment related|3|||
130719299|NCT00536263|470597388|FG002|Overall Study|Subject withdrew - treatment related|2|||
130719300|NCT00536263|470597386|FG000|Overall Study|Noncompliance with protocol|0|||
130719301|NCT00536263|470597387|FG001|Overall Study|Noncompliance with protocol|0|||
130719302|NCT00536263|470597388|FG002|Overall Study|Noncompliance with protocol|1|||
130719303|NCT00536263|470597386|FG000|Overall Study|Did not meet protocol eligibility|1|||
130314372|NCT04564846|469118247|FG000|Overall Study|Withdrawal by Subject|2|||
130314373|NCT04564846|469118248|FG001|Overall Study|Withdrawal by Subject|1|||
130314374|NCT04564846|469118247|FG000|Overall Study|Physician Decision|0|||
130314375|NCT04564846|469118248|FG001|Overall Study|Physician Decision|1|||
130719304|NCT00536263|470597387|FG001|Overall Study|Did not meet protocol eligibility|2|||
130719305|NCT00536263|470597388|FG002|Overall Study|Did not meet protocol eligibility|2|||
130314376|NCT04564846|469118247|FG000|Overall Study|Lost to Follow-up|0|||
130314377|NCT04564846|469118248|FG001|Overall Study|Lost to Follow-up|1|||
130314378|NCT04564846|469118247|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130314379|NCT04564846|469118248|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130314380|NCT04564846|469118247|FG000|Overall Study|Subject non-compliance|1|||
130314381|NCT04564846|469118248|FG001|Overall Study|Subject non-compliance|0|||
130314382|NCT00865345|469118249|FG000|Overall Study|Withdrawal by Subject|2|||
130314383|NCT04388111|469118252|FG000|Overall Study|Lost to Follow-up|5|||
130314384|NCT04388111|469118253|FG001|Overall Study|Lost to Follow-up|3|||
130314385|NCT04388111|469118252|FG000|Overall Study|Adverse Event|1|||
130314386|NCT04388111|469118253|FG001|Overall Study|Adverse Event|1|||
130314387|NCT04388111|469118252|FG000|Overall Study|Protocol Violation|2|||
130314388|NCT04388111|469118253|FG001|Overall Study|Protocol Violation|4|||
130314389|NCT04388111|469118252|FG000|Overall Study|Withdrawal by Subject|1|||
130314390|NCT04388111|469118253|FG001|Overall Study|Withdrawal by Subject|0|||
130314391|NCT02735239|469118254|FG000|Overall Study|Adverse Event|0|||
130466393|NCT02597920|469674791|FG001|Overall Study|Other|0|||
130466394|NCT02597920|469674792|FG002|Overall Study|Other|0|||
130466395|NCT00642850|469674796|FG000|Overall Study|Death|7|||
130466396|NCT00642850|469674796|FG000|Overall Study|Adverse Event|2|||
130466397|NCT00642850|469674796|FG000|Overall Study|Lack of Efficacy|1|||
130466398|NCT00642850|469674796|FG000|Overall Study|Protocol Violation|2|||
130466399|NCT00642850|469674796|FG000|Overall Study|Kidney transplantation|8|||
130466400|NCT00642850|469674796|FG000|Overall Study|Blood transfusion|6|||
130466401|NCT00642850|469674796|FG000|Overall Study|Other reasons|7|||
130466402|NCT05489484|469674799|FG000|Overall Study|withdrawn|1|||
130466403|NCT00444600|469674802|FG000|Overall Study|Death|7|||
130466404|NCT00444600|469674803|FG001|Overall Study|Death|5|||
130466405|NCT00444600|469674804|FG002|Overall Study|Death|3|||
130466406|NCT00444600|469674805|FG003|Overall Study|Death|2|||
130466407|NCT00444600|469674802|FG000|Overall Study|Dropped|11|||
130466408|NCT00444600|469674803|FG001|Overall Study|Dropped|11|||
130466409|NCT00444600|469674804|FG002|Overall Study|Dropped|7|||
130466410|NCT00444600|469674805|FG003|Overall Study|Dropped|7|||
130466411|NCT00444600|469674802|FG000|Overall Study|Missed visit|1|||
130466412|NCT00444600|469674803|FG001|Overall Study|Missed visit|0|||
130466413|NCT00444600|469674804|FG002|Overall Study|Missed visit|0|||
130466414|NCT00444600|469674805|FG003|Overall Study|Missed visit|1|||
130466415|NCT05132478|469674806|FG000|Overall Study|did not complete survey after consent|1|||
130466416|NCT05132478|469674807|FG001|Overall Study|did not complete survey after consent|1|||
130466417|NCT05132478|469674806|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
130466418|NCT05132478|469674807|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
130466419|NCT02549170|469674808|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
130466420|NCT02549170|469674809|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
130466421|NCT02549170|469674810|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
130719306|NCT03285308|470597391|FG000|Overall Study|Adverse Event|3|||
130466422|NCT02549170|469674811|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
130466423|NCT02549170|469674812|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
130719307|NCT03285308|470597392|FG001|Overall Study|Adverse Event|7|||
130719308|NCT03285308|470597391|FG000|Overall Study|Withdrawal by Subject|8|||
130314392|NCT02735239|469118255|FG001|Overall Study|Adverse Event|0|||
130314393|NCT02735239|469118256|FG002|Overall Study|Adverse Event|4|||
130314394|NCT02735239|469118257|FG003|Overall Study|Adverse Event|0|||
130314395|NCT02735239|469118258|FG004|Overall Study|Adverse Event|0|||
130314396|NCT02735239|469118259|FG005|Overall Study|Adverse Event|0|||
130314397|NCT02735239|469118254|FG000|Overall Study|Death|1|||
130314398|NCT02735239|469118255|FG001|Overall Study|Death|1|||
130466424|NCT02549170|469674808|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
130719309|NCT03285308|470597392|FG001|Overall Study|Withdrawal by Subject|9|||
130719310|NCT03285308|470597391|FG000|Overall Study|Lost to Follow-up|3|||
130719311|NCT03285308|470597392|FG001|Overall Study|Lost to Follow-up|1|||
130719312|NCT03285308|470597391|FG000|Overall Study|Protocol Deviation|6|||
130719313|NCT03285308|470597392|FG001|Overall Study|Protocol Deviation|5|||
130719314|NCT03285308|470597391|FG000|Overall Study|Reason not Specified|0|||
130719315|NCT03285308|470597392|FG001|Overall Study|Reason not Specified|1|||
130719316|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
130719317|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
130719318|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
130719319|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
130719320|NCT04135196|470597395|FG000|Overall Study|Lost to Follow-up|8|||
130719321|NCT04135196|470597396|FG001|Overall Study|Lost to Follow-up|7|||
130719322|NCT04135196|470597397|FG002|Overall Study|Lost to Follow-up|8|||
130719323|NCT04135196|470597398|FG003|Overall Study|Lost to Follow-up|9|||
130719324|NCT04135196|470597399|FG004|Overall Study|Lost to Follow-up|1|||
130719325|NCT04135196|470597395|FG000|Overall Study|Pregnancy|0|||
130719326|NCT04135196|470597396|FG001|Overall Study|Pregnancy|0|||
130719327|NCT04135196|470597397|FG002|Overall Study|Pregnancy|1|||
130719328|NCT04135196|470597398|FG003|Overall Study|Pregnancy|0|||
130719329|NCT04135196|470597399|FG004|Overall Study|Pregnancy|0|||
130719330|NCT04135196|470597395|FG000|Overall Study|Withdrawal by Subject|0|||
130719331|NCT04135196|470597396|FG001|Overall Study|Withdrawal by Subject|0|||
130719332|NCT04135196|470597397|FG002|Overall Study|Withdrawal by Subject|0|||
130719333|NCT04135196|470597398|FG003|Overall Study|Withdrawal by Subject|0|||
130719334|NCT04135196|470597399|FG004|Overall Study|Withdrawal by Subject|1|||
130719335|NCT00809159|470597400|FG000|Part 1|Adverse Event|1|||
130719336|NCT00809159|470597401|FG001|Part 1|Adverse Event|1|||
130719337|NCT00809159|470597402|FG002|Part 1|Adverse Event|0|||
130719338|NCT00809159|470597403|FG003|Part 1|Adverse Event|0|||
130719339|NCT00809159|470597404|FG004|Part 1|Adverse Event|0|||
130719340|NCT00809159|470597405|FG005|Part 1|Adverse Event|0|||
130719341|NCT00809159|470597400|FG000|Part 1|Lost to Follow-up|1|||
130719342|NCT00809159|470597401|FG001|Part 1|Lost to Follow-up|0|||
130719343|NCT00809159|470597402|FG002|Part 1|Lost to Follow-up|0|||
130719344|NCT00809159|470597403|FG003|Part 1|Lost to Follow-up|0|||
130719345|NCT00809159|470597404|FG004|Part 1|Lost to Follow-up|0|||
130719346|NCT00809159|470597405|FG005|Part 1|Lost to Follow-up|0|||
130719347|NCT00809159|470597400|FG000|Part 1|Withdrawal by Subject|3|||
130719348|NCT00809159|470597401|FG001|Part 1|Withdrawal by Subject|1|||
130719349|NCT00809159|470597402|FG002|Part 1|Withdrawal by Subject|0|||
130719350|NCT00809159|470597403|FG003|Part 1|Withdrawal by Subject|0|||
130719351|NCT00809159|470597404|FG004|Part 1|Withdrawal by Subject|0|||
130719352|NCT00809159|470597405|FG005|Part 1|Withdrawal by Subject|0|||
130719353|NCT00809159|470597400|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
130719354|NCT00809159|470597401|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
130719355|NCT00809159|470597402|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
130719356|NCT00809159|470597403|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
130719357|NCT00809159|470597404|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
130719358|NCT00809159|470597405|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
130719359|NCT00809159|470597400|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130719360|NCT00809159|470597401|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130314399|NCT02735239|469118256|FG002|Overall Study|Death|0|||
130314400|NCT02735239|469118257|FG003|Overall Study|Death|0|||
130719361|NCT00809159|470597402|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
130719362|NCT00809159|470597403|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
130719363|NCT00809159|470597404|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
130719364|NCT00809159|470597405|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
130719365|NCT00809159|470597400|FG000|Part 1 and 2|Administrative problems|0|||
130719366|NCT00809159|470597401|FG001|Part 1 and 2|Administrative problems|0|||
130719367|NCT00809159|470597402|FG002|Part 1 and 2|Administrative problems|0|||
130719368|NCT00809159|470597403|FG003|Part 1 and 2|Administrative problems|1|||
130314401|NCT02735239|469118258|FG004|Overall Study|Death|0|||
130719369|NCT00809159|470597404|FG004|Part 1 and 2|Administrative problems|0|||
130719370|NCT00809159|470597405|FG005|Part 1 and 2|Administrative problems|0|||
130719371|NCT00809159|470597400|FG000|Part 1 and 2|Adverse Event|0|||
130314402|NCT02735239|469118259|FG005|Overall Study|Death|0|||
130719372|NCT00809159|470597401|FG001|Part 1 and 2|Adverse Event|0|||
130719373|NCT00809159|470597402|FG002|Part 1 and 2|Adverse Event|1|||
130719374|NCT00809159|470597403|FG003|Part 1 and 2|Adverse Event|0|||
130719375|NCT00809159|470597404|FG004|Part 1 and 2|Adverse Event|1|||
130719376|NCT00809159|470597405|FG005|Part 1 and 2|Adverse Event|1|||
130719377|NCT00809159|470597400|FG000|Part 1 and 2|Lost to Follow-up|0|||
130719378|NCT00809159|470597401|FG001|Part 1 and 2|Lost to Follow-up|0|||
130719379|NCT00809159|470597402|FG002|Part 1 and 2|Lost to Follow-up|1|||
130719380|NCT00809159|470597403|FG003|Part 1 and 2|Lost to Follow-up|1|||
130719381|NCT00809159|470597404|FG004|Part 1 and 2|Lost to Follow-up|0|||
130719382|NCT00809159|470597405|FG005|Part 1 and 2|Lost to Follow-up|0|||
130719383|NCT00809159|470597400|FG000|Part 1 and 2|Withdrawal by Subject|0|||
130719384|NCT00809159|470597401|FG001|Part 1 and 2|Withdrawal by Subject|0|||
130719385|NCT00809159|470597402|FG002|Part 1 and 2|Withdrawal by Subject|4|||
130719386|NCT00809159|470597403|FG003|Part 1 and 2|Withdrawal by Subject|0|||
130719387|NCT00809159|470597404|FG004|Part 1 and 2|Withdrawal by Subject|0|||
130719388|NCT00809159|470597405|FG005|Part 1 and 2|Withdrawal by Subject|1|||
130719389|NCT03201211|470597406|FG000|Overall Study|Adverse Event|1|||
130719390|NCT03201211|470597407|FG001|Overall Study|Adverse Event|0|||
130719391|NCT03201211|470597408|FG002|Overall Study|Adverse Event|0|||
130719392|NCT03201211|470597406|FG000|Overall Study|Protocol Violation|1|||
130719393|NCT03201211|470597407|FG001|Overall Study|Protocol Violation|0|||
130719394|NCT03201211|470597408|FG002|Overall Study|Protocol Violation|0|||
130719395|NCT03201211|470597406|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130466425|NCT02549170|469674809|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
130466426|NCT02549170|469674810|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
130466427|NCT02549170|469674811|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
130466428|NCT02549170|469674812|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
130466429|NCT02549170|469674808|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
130466430|NCT02549170|469674809|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
130719396|NCT03201211|470597407|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130719397|NCT03201211|470597408|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130719398|NCT03201211|470597406|FG000|Overall Study|OTHER unknown reasons|0|||
130719399|NCT03201211|470597407|FG001|Overall Study|OTHER unknown reasons|1|||
130466431|NCT02549170|469674810|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
130466432|NCT02549170|469674811|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
130466433|NCT02549170|469674812|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
130466434|NCT01414738|469674813|FG000|Overall Study|Death|26|||
130466435|NCT01414738|469674813|FG000|Overall Study|Refused testing|5|||
130466436|NCT01414738|469674813|FG000|Overall Study|Lost to Follow-up|2|||
130466437|NCT01414738|469674813|FG000|Overall Study|Refused, disease progression|8|||
130466438|NCT01414738|469674813|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
130466439|NCT02379819|469674815|FG000|Overall Study|Withdrawal by Subject|10|||
130558979|NCT00685685|470014942|FG000|Washout Period of 7 Days|Adverse Event|2|||
130719400|NCT03201211|470597408|FG002|Overall Study|OTHER unknown reasons|0|||
130719401|NCT01083810|470597409|FG000|Overall Study|Lost to Follow-up|23|||
130558980|NCT00685685|470014943|FG001|Washout Period of 7 Days|Adverse Event|0|||
130558981|NCT00685685|470014942|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130558982|NCT00685685|470014943|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130719402|NCT01083810|470597410|FG001|Overall Study|Lost to Follow-up|11|||
130719403|NCT01083810|470597411|FG002|Overall Study|Lost to Follow-up|4|||
130719404|NCT01083810|470597409|FG000|Overall Study|Adverse Event|15|||
130719405|NCT01083810|470597410|FG001|Overall Study|Adverse Event|11|||
130719406|NCT01083810|470597411|FG002|Overall Study|Adverse Event|4|||
130719407|NCT01083810|470597409|FG000|Overall Study|Withdrawal by Subject|7|||
130719408|NCT01083810|470597410|FG001|Overall Study|Withdrawal by Subject|2|||
130719409|NCT01083810|470597411|FG002|Overall Study|Withdrawal by Subject|4|||
130719410|NCT01083810|470597409|FG000|Overall Study|Reason not reported|6|||
130719411|NCT01083810|470597410|FG001|Overall Study|Reason not reported|1|||
130719412|NCT01083810|470597411|FG002|Overall Study|Reason not reported|1|||
130719413|NCT01083810|470597409|FG000|Overall Study|Non-compliance|4|||
130719414|NCT01083810|470597410|FG001|Overall Study|Non-compliance|7|||
130719415|NCT01083810|470597411|FG002|Overall Study|Non-compliance|2|||
130719416|NCT01083810|470597409|FG000|Overall Study|Simplification|4|||
130719417|NCT01083810|470597410|FG001|Overall Study|Simplification|1|||
130719418|NCT01083810|470597411|FG002|Overall Study|Simplification|0|||
130719419|NCT01083810|470597409|FG000|Overall Study|Death|2|||
130719420|NCT01083810|470597410|FG001|Overall Study|Death|2|||
130558983|NCT04513665|470014944|FG000|Overall Study|Adverse Event|2|||
130719421|NCT01083810|470597411|FG002|Overall Study|Death|3|||
130719422|NCT01083810|470597409|FG000|Overall Study|Co-morbidities|1|||
130719423|NCT01083810|470597410|FG001|Overall Study|Co-morbidities|0|||
130719424|NCT01083810|470597411|FG002|Overall Study|Co-morbidities|0|||
130719425|NCT01083810|470597409|FG000|Overall Study|Participation in study|1|||
130719426|NCT01083810|470597410|FG001|Overall Study|Participation in study|0|||
130719427|NCT01083810|470597411|FG002|Overall Study|Participation in study|0|||
130719428|NCT01083810|470597409|FG000|Overall Study|Therapy break|1|||
130719429|NCT01083810|470597410|FG001|Overall Study|Therapy break|2|||
130719430|NCT01083810|470597411|FG002|Overall Study|Therapy break|2|||
130719431|NCT01083810|470597409|FG000|Overall Study|Virologic failure|1|||
130719432|NCT01083810|470597410|FG001|Overall Study|Virologic failure|8|||
130719433|NCT01083810|470597411|FG002|Overall Study|Virologic failure|0|||
130719434|NCT02991430|470597414|FG000|Treatment Period 1|Adverse Event|1|||
130719435|NCT02991430|470597415|FG001|Treatment Period 1|Adverse Event|0|||
130719436|NCT02991430|470597416|FG002|Treatment Period 1|Adverse Event|2|||
130719437|NCT02991430|470597414|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130719438|NCT02991430|470597415|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130719439|NCT02991430|470597416|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130719440|NCT02991430|470597414|FG000|Treatment Period 2|Study Termination|6|||
130719441|NCT02991430|470597415|FG001|Treatment Period 2|Study Termination|3|||
130719442|NCT02991430|470597416|FG002|Treatment Period 2|Study Termination|3|||
130719443|NCT02991430|470597414|FG000|Treatment Period 2|Lost to Follow-up|0|||
130719444|NCT02991430|470597415|FG001|Treatment Period 2|Lost to Follow-up|0|||
130719445|NCT02991430|470597416|FG002|Treatment Period 2|Lost to Follow-up|1|||
130719446|NCT02991430|470597414|FG000|Post-treatment Observation Period|Study Termination|3|||
130719447|NCT02991430|470597415|FG001|Post-treatment Observation Period|Study Termination|6|||
130719448|NCT02991430|470597416|FG002|Post-treatment Observation Period|Study Termination|5|||
130719449|NCT03118570|470597417|FG000|Overall Study|Adverse Event|2|||
130719450|NCT03118570|470597418|FG001|Overall Study|Adverse Event|0|||
130719451|NCT03118570|470597419|FG002|Overall Study|Adverse Event|0|||
130719452|NCT03118570|470597420|FG003|Overall Study|Adverse Event|0|||
130719453|NCT03118570|470597421|FG004|Overall Study|Adverse Event|3|||
130719454|NCT03118570|470597417|FG000|Overall Study|Withdrawal by Subject|0|||
130719455|NCT03118570|470597418|FG001|Overall Study|Withdrawal by Subject|1|||
130719456|NCT03118570|470597419|FG002|Overall Study|Withdrawal by Subject|4|||
130719457|NCT03118570|470597420|FG003|Overall Study|Withdrawal by Subject|0|||
130719458|NCT03118570|470597421|FG004|Overall Study|Withdrawal by Subject|1|||
130719459|NCT03118570|470597417|FG000|Overall Study|Lost to Follow-up|2|||
130719460|NCT03118570|470597418|FG001|Overall Study|Lost to Follow-up|3|||
130719461|NCT03118570|470597419|FG002|Overall Study|Lost to Follow-up|1|||
130314403|NCT02735239|469118254|FG000|Overall Study|Physician Decision|0|||
130314404|NCT02735239|469118255|FG001|Overall Study|Physician Decision|0|||
130314405|NCT02735239|469118256|FG002|Overall Study|Physician Decision|1|||
130314406|NCT02735239|469118257|FG003|Overall Study|Physician Decision|0|||
130314407|NCT02735239|469118258|FG004|Overall Study|Physician Decision|0|||
130314408|NCT02735239|469118259|FG005|Overall Study|Physician Decision|0|||
130719462|NCT03118570|470597420|FG003|Overall Study|Lost to Follow-up|0|||
130719463|NCT03118570|470597421|FG004|Overall Study|Lost to Follow-up|1|||
130719464|NCT03118570|470597417|FG000|Overall Study|Other, Not Specified|1|||
130719465|NCT03118570|470597418|FG001|Overall Study|Other, Not Specified|3|||
130314409|NCT02735239|469118254|FG000|Overall Study|Progressive disease|3|||
130314410|NCT02735239|469118255|FG001|Overall Study|Progressive disease|1|||
130314411|NCT02735239|469118256|FG002|Overall Study|Progressive disease|3|||
130314412|NCT02735239|469118257|FG003|Overall Study|Progressive disease|0|||
130314413|NCT02735239|469118258|FG004|Overall Study|Progressive disease|0|||
130314414|NCT02735239|469118259|FG005|Overall Study|Progressive disease|2|||
130314415|NCT02735239|469118254|FG000|Overall Study|Withdrawal by Subject|0|||
130314416|NCT02735239|469118255|FG001|Overall Study|Withdrawal by Subject|1|||
130314417|NCT02735239|469118256|FG002|Overall Study|Withdrawal by Subject|0|||
130314418|NCT02735239|469118257|FG003|Overall Study|Withdrawal by Subject|0|||
130314419|NCT02735239|469118258|FG004|Overall Study|Withdrawal by Subject|0|||
130314420|NCT02735239|469118259|FG005|Overall Study|Withdrawal by Subject|0|||
130314421|NCT00387881|469118260|FG000|Overall Study|Lost to Follow-up|23|||
130314422|NCT00387881|469118261|FG001|Overall Study|Lost to Follow-up|23|||
130314423|NCT00387881|469118260|FG000|Overall Study|Protocol Violation|2|||
130314424|NCT00387881|469118261|FG001|Overall Study|Protocol Violation|12|||
130314425|NCT00387881|469118260|FG000|Overall Study|Withdrawal by Subject|15|||
130314426|NCT00387881|469118261|FG001|Overall Study|Withdrawal by Subject|18|||
130314427|NCT00387881|469118260|FG000|Overall Study|Sponsor terminated Study|0|||
130314428|NCT00387881|469118261|FG001|Overall Study|Sponsor terminated Study|1|||
130314429|NCT00387881|469118260|FG000|Overall Study|Not eligible|6|||
130314430|NCT00387881|469118261|FG001|Overall Study|Not eligible|7|||
130314431|NCT00387881|469118260|FG000|Overall Study|No opportunity to treat headache|32|||
130314432|NCT00387881|469118261|FG001|Overall Study|No opportunity to treat headache|34|||
130314433|NCT00387881|469118260|FG000|Overall Study|Not otherwise specified|11|||
130314434|NCT00387881|469118261|FG001|Overall Study|Not otherwise specified|7|||
130314435|NCT01790594|469118263|FG000|Overall Study|Death|1|||
130314436|NCT01790594|469118264|FG001|Overall Study|Death|0|||
130314437|NCT01790594|469118265|FG002|Overall Study|Death|0|||
130314438|NCT01790594|469118263|FG000|Overall Study|Physician Decision|2|||
130314439|NCT01790594|469118264|FG001|Overall Study|Physician Decision|1|||
130314440|NCT01790594|469118265|FG002|Overall Study|Physician Decision|0|||
130719466|NCT03118570|470597419|FG002|Overall Study|Other, Not Specified|0|||
130314441|NCT01790594|469118263|FG000|Overall Study|Withdrawal by Subject|2|||
130314442|NCT01790594|469118264|FG001|Overall Study|Withdrawal by Subject|0|||
130314443|NCT01790594|469118265|FG002|Overall Study|Withdrawal by Subject|0|||
130314444|NCT01790594|469118263|FG000|Overall Study|Transplant was not done|0|||
130719467|NCT03118570|470597420|FG003|Overall Study|Other, Not Specified|0|||
130719468|NCT03118570|470597421|FG004|Overall Study|Other, Not Specified|0|||
130719469|NCT03970837|470597422|FG000|Overall Study|Adverse Event|23|||
130719470|NCT03970837|470597423|FG001|Overall Study|Adverse Event|20|||
130719471|NCT03970837|470597424|FG002|Overall Study|Adverse Event|16|||
130719472|NCT03970837|470597425|FG003|Overall Study|Adverse Event|6|||
130719473|NCT03970837|470597426|FG004|Overall Study|Adverse Event|4|||
130719474|NCT03970837|470597427|FG005|Overall Study|Adverse Event|5|||
130719475|NCT03970837|470597428|FG006|Overall Study|Adverse Event|1|||
130719476|NCT03970837|470597429|FG007|Overall Study|Adverse Event|5|||
130719477|NCT03970837|470597430|FG008|Overall Study|Adverse Event|0|||
130719478|NCT03970837|470597431|FG009|Overall Study|Adverse Event|0|||
130719479|NCT03970837|470597432|FG010|Overall Study|Adverse Event|1|||
130719480|NCT03970837|470597433|FG011|Overall Study|Adverse Event|1|||
130719481|NCT03970837|470597422|FG000|Overall Study|Lack of Efficacy|14|||
130719482|NCT03970837|470597423|FG001|Overall Study|Lack of Efficacy|12|||
130719483|NCT03970837|470597424|FG002|Overall Study|Lack of Efficacy|1|||
130719484|NCT03970837|470597425|FG003|Overall Study|Lack of Efficacy|2|||
130719485|NCT03970837|470597426|FG004|Overall Study|Lack of Efficacy|3|||
130719486|NCT03970837|470597427|FG005|Overall Study|Lack of Efficacy|4|||
130719487|NCT03970837|470597428|FG006|Overall Study|Lack of Efficacy|6|||
130314445|NCT01790594|469118264|FG001|Overall Study|Transplant was not done|0|||
130314446|NCT01790594|469118265|FG002|Overall Study|Transplant was not done|3|||
130314447|NCT01790594|469118263|FG000|Overall Study|Terminated prior to week 76|0|||
130314448|NCT01790594|469118264|FG001|Overall Study|Terminated prior to week 76|2|||
130314449|NCT01790594|469118265|FG002|Overall Study|Terminated prior to week 76|0|||
130314450|NCT03291067|469118266|FG000|Overall Study|Adverse Event|0|||
130314451|NCT03291067|469118267|FG001|Overall Study|Adverse Event|2|||
130314452|NCT03291067|469118268|FG002|Overall Study|Adverse Event|17|||
130314453|NCT03291067|469118269|FG003|Overall Study|Adverse Event|3|||
130314454|NCT03291067|469118266|FG000|Overall Study|Lost to Follow-up|2|||
130314455|NCT03291067|469118267|FG001|Overall Study|Lost to Follow-up|1|||
130314456|NCT03291067|469118268|FG002|Overall Study|Lost to Follow-up|0|||
130314457|NCT03291067|469118269|FG003|Overall Study|Lost to Follow-up|1|||
130314458|NCT03291067|469118266|FG000|Overall Study|Physician Decision|0|||
130314459|NCT03291067|469118267|FG001|Overall Study|Physician Decision|0|||
130314460|NCT03291067|469118268|FG002|Overall Study|Physician Decision|1|||
130314461|NCT03291067|469118269|FG003|Overall Study|Physician Decision|0|||
130314462|NCT03291067|469118266|FG000|Overall Study|Protocol Violation|5|||
130314463|NCT03291067|469118267|FG001|Overall Study|Protocol Violation|3|||
130314464|NCT03291067|469118268|FG002|Overall Study|Protocol Violation|4|||
130314465|NCT03291067|469118269|FG003|Overall Study|Protocol Violation|2|||
130314466|NCT03291067|469118266|FG000|Overall Study|Withdrawal by Subject|3|||
130314467|NCT03291067|469118267|FG001|Overall Study|Withdrawal by Subject|4|||
130314468|NCT03291067|469118268|FG002|Overall Study|Withdrawal by Subject|7|||
130314469|NCT03291067|469118269|FG003|Overall Study|Withdrawal by Subject|5|||
130314470|NCT03291067|469118266|FG000|Overall Study|Other|0|||
130314471|NCT03291067|469118267|FG001|Overall Study|Other|4|||
130314472|NCT03291067|469118268|FG002|Overall Study|Other|4|||
130314473|NCT03291067|469118269|FG003|Overall Study|Other|6|||
130314474|NCT02038153|469118270|FG000|Overall Study|Withdrawal by Subject|1|||
130314475|NCT01050634|469118271|FG000|Overall Study|Enrolled, but Not Treated|56|||
130314476|NCT01050634|469118271|FG000|Overall Study|Death|2|||
130314477|NCT01050634|469118271|FG000|Overall Study|Adverse Event|42|||
130314478|NCT01050634|469118271|FG000|Overall Study|Lost to Follow-up|2|||
130314479|NCT01050634|469118271|FG000|Overall Study|Other|21|||
130314480|NCT01050634|469118271|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
130314481|NCT00496015|469118272|FG000|Overall Study|Other|1|||
130314482|NCT00496015|469118273|FG001|Overall Study|Other|0|||
130314483|NCT00496015|469118274|FG002|Overall Study|Other|0|||
130314484|NCT00496015|469118275|FG003|Overall Study|Other|1|||
130314485|NCT00496015|469118276|FG004|Overall Study|Other|0|||
130314486|NCT00527735|469118277|FG000|Overall Study|Disease progression|47|||
130375264|NCT01465997|469339813|FG001|Overall Study|sponsor's decision|1|||
130375265|NCT01465997|469339812|FG000|Overall Study|subject withdrew consent|1|||
130719488|NCT03970837|470597429|FG007|Overall Study|Lack of Efficacy|1|||
130719489|NCT03970837|470597430|FG008|Overall Study|Lack of Efficacy|1|||
130719490|NCT03970837|470597431|FG009|Overall Study|Lack of Efficacy|0|||
130314487|NCT00527735|469118278|FG001|Overall Study|Disease progression|61|||
130314488|NCT00527735|469118279|FG002|Overall Study|Disease progression|53|||
130314489|NCT00527735|469118277|FG000|Overall Study|Death|23|||
130314490|NCT00527735|469118278|FG001|Overall Study|Death|13|||
130314491|NCT00527735|469118279|FG002|Overall Study|Death|15|||
130314492|NCT00527735|469118277|FG000|Overall Study|Completed treatment in treatment phase|14|||
130314493|NCT00527735|469118278|FG001|Overall Study|Completed treatment in treatment phase|13|||
130719491|NCT03970837|470597432|FG010|Overall Study|Lack of Efficacy|0|||
130719492|NCT03970837|470597433|FG011|Overall Study|Lack of Efficacy|0|||
130314494|NCT00527735|469118279|FG002|Overall Study|Completed treatment in treatment phase|18|||
130314495|NCT00527735|469118277|FG000|Overall Study|Adverse Event|10|||
130314496|NCT00527735|469118278|FG001|Overall Study|Adverse Event|6|||
130314497|NCT00527735|469118279|FG002|Overall Study|Adverse Event|7|||
130314498|NCT00527735|469118277|FG000|Overall Study|Not identified|5|||
130314499|NCT00527735|469118278|FG001|Overall Study|Not identified|5|||
130314500|NCT00527735|469118279|FG002|Overall Study|Not identified|5|||
130314501|NCT00527735|469118277|FG000|Overall Study|Withdrawal by Subject|5|||
130314502|NCT00527735|469118278|FG001|Overall Study|Withdrawal by Subject|4|||
130719493|NCT03970837|470597422|FG000|Overall Study|Lost to Follow-up|6|||
130719494|NCT03970837|470597423|FG001|Overall Study|Lost to Follow-up|5|||
130719495|NCT03970837|470597424|FG002|Overall Study|Lost to Follow-up|5|||
130719496|NCT03970837|470597425|FG003|Overall Study|Lost to Follow-up|1|||
130719497|NCT03970837|470597426|FG004|Overall Study|Lost to Follow-up|0|||
130719498|NCT03970837|470597427|FG005|Overall Study|Lost to Follow-up|2|||
130719499|NCT03970837|470597428|FG006|Overall Study|Lost to Follow-up|0|||
130719500|NCT03970837|470597429|FG007|Overall Study|Lost to Follow-up|0|||
130719501|NCT03970837|470597430|FG008|Overall Study|Lost to Follow-up|0|||
130719502|NCT03970837|470597431|FG009|Overall Study|Lost to Follow-up|0|||
130719503|NCT03970837|470597432|FG010|Overall Study|Lost to Follow-up|0|||
130719504|NCT03970837|470597433|FG011|Overall Study|Lost to Follow-up|0|||
130719505|NCT03970837|470597422|FG000|Overall Study|Protocol Violation|1|||
130719506|NCT03970837|470597423|FG001|Overall Study|Protocol Violation|0|||
130719507|NCT03970837|470597424|FG002|Overall Study|Protocol Violation|0|||
130719508|NCT03970837|470597425|FG003|Overall Study|Protocol Violation|0|||
130719509|NCT03970837|470597426|FG004|Overall Study|Protocol Violation|0|||
130719510|NCT03970837|470597427|FG005|Overall Study|Protocol Violation|0|||
130719511|NCT03970837|470597428|FG006|Overall Study|Protocol Violation|0|||
130719512|NCT03970837|470597429|FG007|Overall Study|Protocol Violation|0|||
130719513|NCT03970837|470597430|FG008|Overall Study|Protocol Violation|0|||
130719514|NCT03970837|470597431|FG009|Overall Study|Protocol Violation|0|||
130719515|NCT03970837|470597432|FG010|Overall Study|Protocol Violation|0|||
130719516|NCT03970837|470597433|FG011|Overall Study|Protocol Violation|0|||
130719517|NCT03970837|470597422|FG000|Overall Study|Physician Decision|5|||
130719518|NCT03970837|470597423|FG001|Overall Study|Physician Decision|8|||
130719519|NCT03970837|470597424|FG002|Overall Study|Physician Decision|4|||
130719520|NCT03970837|470597425|FG003|Overall Study|Physician Decision|1|||
130719521|NCT03970837|470597426|FG004|Overall Study|Physician Decision|5|||
130719522|NCT03970837|470597427|FG005|Overall Study|Physician Decision|2|||
130719523|NCT03970837|470597428|FG006|Overall Study|Physician Decision|4|||
130719524|NCT03970837|470597429|FG007|Overall Study|Physician Decision|5|||
130719525|NCT03970837|470597430|FG008|Overall Study|Physician Decision|0|||
130719526|NCT03970837|470597431|FG009|Overall Study|Physician Decision|1|||
130719527|NCT03970837|470597432|FG010|Overall Study|Physician Decision|0|||
130719528|NCT03970837|470597433|FG011|Overall Study|Physician Decision|0|||
130719529|NCT03970837|470597422|FG000|Overall Study|Withdrawal by Subject|32|||
130719530|NCT03970837|470597423|FG001|Overall Study|Withdrawal by Subject|35|||
130719531|NCT03970837|470597424|FG002|Overall Study|Withdrawal by Subject|12|||
130719532|NCT03970837|470597425|FG003|Overall Study|Withdrawal by Subject|8|||
130719533|NCT03970837|470597426|FG004|Overall Study|Withdrawal by Subject|6|||
130719534|NCT03970837|470597427|FG005|Overall Study|Withdrawal by Subject|8|||
130719535|NCT03970837|470597428|FG006|Overall Study|Withdrawal by Subject|2|||
130719536|NCT03970837|470597429|FG007|Overall Study|Withdrawal by Subject|3|||
130719537|NCT03970837|470597430|FG008|Overall Study|Withdrawal by Subject|0|||
130719538|NCT03970837|470597431|FG009|Overall Study|Withdrawal by Subject|0|||
130719539|NCT03970837|470597432|FG010|Overall Study|Withdrawal by Subject|0|||
130719540|NCT03970837|470597433|FG011|Overall Study|Withdrawal by Subject|1|||
130719541|NCT03970837|470597422|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
130719542|NCT03970837|470597423|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
130719543|NCT03970837|470597424|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130719544|NCT03970837|470597425|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719545|NCT03970837|470597426|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130719546|NCT03970837|470597427|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719547|NCT03970837|470597428|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130314503|NCT00527735|469118279|FG002|Overall Study|Withdrawal by Subject|3|||
130719548|NCT03970837|470597429|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719549|NCT03970837|470597430|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719550|NCT03970837|470597431|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719551|NCT03970837|470597432|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719552|NCT03970837|470597433|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719553|NCT03970837|470597422|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719554|NCT03970837|470597423|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130314504|NCT00527735|469118277|FG000|Overall Study|No longer met study criteria|2|||
130719555|NCT03970837|470597424|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130314505|NCT00527735|469118278|FG001|Overall Study|No longer met study criteria|2|||
130719556|NCT03970837|470597425|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130314506|NCT00527735|469118279|FG002|Overall Study|No longer met study criteria|1|||
130314507|NCT00527735|469118277|FG000|Overall Study|Lost to Follow-up|0|||
130314508|NCT00527735|469118278|FG001|Overall Study|Lost to Follow-up|0|||
130314509|NCT00527735|469118279|FG002|Overall Study|Lost to Follow-up|3|||
130314510|NCT00527735|469118277|FG000|Overall Study|Poor compliance or noncompliance|0|||
130314511|NCT00527735|469118278|FG001|Overall Study|Poor compliance or noncompliance|1|||
130314512|NCT00527735|469118279|FG002|Overall Study|Poor compliance or noncompliance|1|||
130314513|NCT00527735|469118277|FG000|Overall Study|Completed treatment during maintenance|2|||
130314514|NCT00527735|469118278|FG001|Overall Study|Completed treatment during maintenance|2|||
130314515|NCT00527735|469118279|FG002|Overall Study|Completed treatment during maintenance|1|||
130314516|NCT01535807|469118280|FG000|Overall Study|Withdrawal by Subject|1|||
130314517|NCT01535807|469118281|FG001|Overall Study|Withdrawal by Subject|1|||
130314518|NCT01535807|469118280|FG000|Overall Study|Data collection error|1|||
130314519|NCT01535807|469118281|FG001|Overall Study|Data collection error|1|||
130314520|NCT00404651|469118285|FG000|Overall Study|Serious Adverse Event|0|||
130314521|NCT00404651|469118286|FG001|Overall Study|Serious Adverse Event|0|||
130314522|NCT00404651|469118287|FG002|Overall Study|Serious Adverse Event|2|||
130314523|NCT00404651|469118288|FG003|Overall Study|Serious Adverse Event|0|||
130314524|NCT00404651|469118285|FG000|Overall Study|Protocol Violation|10|||
130314525|NCT00404651|469118286|FG001|Overall Study|Protocol Violation|5|||
130314526|NCT00404651|469118287|FG002|Overall Study|Protocol Violation|14|||
130314527|NCT00404651|469118288|FG003|Overall Study|Protocol Violation|5|||
130466440|NCT02379819|469674815|FG000|Overall Study|Death|2|||
130466441|NCT02379819|469674815|FG000|Overall Study|Lack of Efficacy|1|||
130466442|NCT02379819|469674815|FG000|Overall Study|Lost to Follow-up|1|||
130466443|NCT00703820|469674818|FG000|Overall Study|Adverse Event|12|||
130466444|NCT00703820|469674819|FG001|Overall Study|Adverse Event|17|||
130466445|NCT00703820|469674818|FG000|Overall Study|Death|5|||
130466446|NCT00703820|469674819|FG001|Overall Study|Death|0|||
130466447|NCT00703820|469674818|FG000|Overall Study|Lack of Efficacy|11|||
130719557|NCT03970837|470597426|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719558|NCT03970837|470597427|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719559|NCT03970837|470597428|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
130719560|NCT03970837|470597429|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
130719561|NCT03970837|470597430|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130719562|NCT03970837|470597431|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130719563|NCT03970837|470597432|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130314528|NCT00404651|469118285|FG000|Overall Study|Lost to Follow-up|15|||
130314529|NCT00404651|469118286|FG001|Overall Study|Lost to Follow-up|11|||
130314530|NCT00404651|469118287|FG002|Overall Study|Lost to Follow-up|13|||
130314531|NCT00404651|469118288|FG003|Overall Study|Lost to Follow-up|10|||
130314532|NCT00404651|469118285|FG000|Overall Study|Withdrawal by Subject|14|||
130314533|NCT00404651|469118286|FG001|Overall Study|Withdrawal by Subject|12|||
130314534|NCT00404651|469118287|FG002|Overall Study|Withdrawal by Subject|16|||
130314535|NCT00404651|469118288|FG003|Overall Study|Withdrawal by Subject|6|||
130314536|NCT02123134|469118303|FG000|Overall Study|Withdrawal of consent|3|||
130314537|NCT02123134|469118304|FG001|Overall Study|Withdrawal of consent|2|||
130314538|NCT02123134|469118303|FG000|Overall Study|Administrative decision|0|||
130314539|NCT02123134|469118304|FG001|Overall Study|Administrative decision|1|||
130314540|NCT03010527|469118313|FG000|Overall Study|Death|0|||
130314541|NCT03010527|469118314|FG001|Overall Study|Death|0|||
130314542|NCT03010527|469118315|FG002|Overall Study|Death|1|||
130314543|NCT03010527|469118313|FG000|Overall Study|Adverse Event|0|||
130314544|NCT03010527|469118314|FG001|Overall Study|Adverse Event|4|||
130314545|NCT03010527|469118315|FG002|Overall Study|Adverse Event|2|||
130314546|NCT03010527|469118313|FG000|Overall Study|Protocol Violation|0|||
130314547|NCT03010527|469118314|FG001|Overall Study|Protocol Violation|1|||
130314548|NCT03010527|469118315|FG002|Overall Study|Protocol Violation|0|||
130314549|NCT03010527|469118313|FG000|Overall Study|Lost to Follow-up|0|||
130314550|NCT03010527|469118314|FG001|Overall Study|Lost to Follow-up|2|||
130466448|NCT00703820|469674819|FG001|Overall Study|Lack of Efficacy|11|||
130466449|NCT00703820|469674818|FG000|Overall Study|Received non-protocol therapy|1|||
130314551|NCT03010527|469118315|FG002|Overall Study|Lost to Follow-up|1|||
130314552|NCT03010527|469118313|FG000|Overall Study|Withdrawal by Subject|0|||
130314553|NCT03010527|469118314|FG001|Overall Study|Withdrawal by Subject|3|||
130314554|NCT03010527|469118315|FG002|Overall Study|Withdrawal by Subject|4|||
130314555|NCT03010527|469118313|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
130314556|NCT03010527|469118314|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
130314557|NCT03010527|469118315|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
130314558|NCT03010527|469118313|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
130466450|NCT00703820|469674819|FG001|Overall Study|Received non-protocol therapy|0|||
130314559|NCT03010527|469118314|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
130314560|NCT03010527|469118315|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
130314561|NCT03010527|469118313|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130719564|NCT03970837|470597433|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
130314562|NCT03010527|469118314|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
130719565|NCT02132754|470597434|FG000|Overall Study|Adverse Event|0|||
130719566|NCT02132754|470597435|FG001|Overall Study|Adverse Event|0|||
130719567|NCT02132754|470597436|FG002|Overall Study|Adverse Event|0|||
130719568|NCT02132754|470597437|FG003|Overall Study|Adverse Event|0|||
130719569|NCT02132754|470597438|FG004|Overall Study|Adverse Event|0|||
130719570|NCT02132754|470597439|FG005|Overall Study|Adverse Event|0|||
130719571|NCT02132754|470597440|FG006|Overall Study|Adverse Event|0|||
130719572|NCT02132754|470597441|FG007|Overall Study|Adverse Event|0|||
130719573|NCT02132754|470597442|FG008|Overall Study|Adverse Event|0|||
130719574|NCT02132754|470597443|FG009|Overall Study|Adverse Event|0|||
130719575|NCT02132754|470597444|FG010|Overall Study|Adverse Event|0|||
130719576|NCT02132754|470597445|FG011|Overall Study|Adverse Event|0|||
130719577|NCT02132754|470597446|FG012|Overall Study|Adverse Event|0|||
130719578|NCT02132754|470597447|FG013|Overall Study|Adverse Event|0|||
130719579|NCT02132754|470597448|FG014|Overall Study|Adverse Event|0|||
130719580|NCT02132754|470597449|FG015|Overall Study|Adverse Event|0|||
130719581|NCT02132754|470597450|FG016|Overall Study|Adverse Event|0|||
130719582|NCT02132754|470597451|FG017|Overall Study|Adverse Event|1|||
130719583|NCT02132754|470597452|FG018|Overall Study|Adverse Event|0|||
130719584|NCT02132754|470597453|FG019|Overall Study|Adverse Event|0|||
130719585|NCT02132754|470597454|FG020|Overall Study|Adverse Event|0|||
130719586|NCT02132754|470597455|FG021|Overall Study|Adverse Event|0|||
130314563|NCT03010527|469118315|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130314564|NCT00764699|469118316|FG000|Overall Study|PI left and study terminated|3|||
130314565|NCT01755234|469118317|FG000|Overall Study|Lost to Follow-up|11|||
130314566|NCT01755234|469118318|FG001|Overall Study|Lost to Follow-up|6|||
130314567|NCT01755234|469118317|FG000|Overall Study|Change in surgical case|2|||
130314568|NCT01755234|469118318|FG001|Overall Study|Change in surgical case|1|||
130314569|NCT01755234|469118317|FG000|Overall Study|case cancelled|1|||
130314570|NCT01755234|469118318|FG001|Overall Study|case cancelled|0|||
130314571|NCT01755234|469118317|FG000|Overall Study|Withdrawal by Subject|0|||
130314572|NCT01755234|469118318|FG001|Overall Study|Withdrawal by Subject|1|||
130314573|NCT01755234|469118317|FG000|Overall Study|unblinded|1|||
130314574|NCT01755234|469118318|FG001|Overall Study|unblinded|0|||
130314575|NCT03001557|469118322|FG000|Core Phase|Randomized but not treated|0|||
130314576|NCT03001557|469118323|FG001|Core Phase|Randomized but not treated|0|||
130314577|NCT03001557|469118324|FG002|Core Phase|Randomized but not treated|1|||
130314578|NCT03001557|469118325|FG003|Core Phase|Randomized but not treated|0|||
130314579|NCT03001557|469118326|FG004|Core Phase|Randomized but not treated|0|||
130314580|NCT03001557|469118327|FG005|Core Phase|Randomized but not treated|0|||
130314581|NCT03001557|469118328|FG006|Core Phase|Randomized but not treated|0|||
130314582|NCT03001557|469118329|FG007|Core Phase|Randomized but not treated|0|||
130314583|NCT03001557|469118322|FG000|Extension Phase|Adverse Event|0|||
130314584|NCT03001557|469118323|FG001|Extension Phase|Adverse Event|0|||
130314585|NCT03001557|469118324|FG002|Extension Phase|Adverse Event|0|||
130314586|NCT03001557|469118325|FG003|Extension Phase|Adverse Event|0|||
130314587|NCT03001557|469118326|FG004|Extension Phase|Adverse Event|0|||
130314588|NCT03001557|469118327|FG005|Extension Phase|Adverse Event|2|||
130314589|NCT03001557|469118328|FG006|Extension Phase|Adverse Event|0|||
130314590|NCT03001557|469118329|FG007|Extension Phase|Adverse Event|0|||
130314591|NCT03001557|469118322|FG000|Extension Phase|Withdrawal by Subject|0|||
130314592|NCT03001557|469118323|FG001|Extension Phase|Withdrawal by Subject|0|||
130314593|NCT03001557|469118324|FG002|Extension Phase|Withdrawal by Subject|0|||
130375266|NCT01465997|469339813|FG001|Overall Study|subject withdrew consent|0|||
130375267|NCT01465997|469339812|FG000|Overall Study|local lab unblinded site|1|||
130375268|NCT01465997|469339813|FG001|Overall Study|local lab unblinded site|0|||
130375269|NCT01465997|469339812|FG000|Overall Study|withdrew before follow-up|0|||
130375270|NCT01465997|469339813|FG001|Overall Study|withdrew before follow-up|13|||
130375271|NCT01465997|469339812|FG000|Overall Study|decision by site staff|0|||
130375272|NCT01465997|469339813|FG001|Overall Study|decision by site staff|1|||
130375273|NCT01465997|469339812|FG000|Overall Study|subject left participation SP0993|0|||
130375274|NCT01465997|469339813|FG001|Overall Study|subject left participation SP0993|1|||
130375275|NCT02246660|469339814|FG000|Overall Study|Withdrawal by Subject|0|||
130375276|NCT02246660|469339815|FG001|Overall Study|Withdrawal by Subject|1|||
130375277|NCT02246660|469339816|FG002|Overall Study|Withdrawal by Subject|0|||
130375278|NCT02246660|469339814|FG000|Overall Study|Death|0|||
130375279|NCT02246660|469339815|FG001|Overall Study|Death|0|||
130719587|NCT02132754|470597456|FG022|Overall Study|Adverse Event|0|||
130719588|NCT02132754|470597457|FG023|Overall Study|Adverse Event|0|||
130719589|NCT02132754|470597458|FG024|Overall Study|Adverse Event|0|||
130719590|NCT02132754|470597459|FG025|Overall Study|Adverse Event|1|||
130375280|NCT02246660|469339816|FG002|Overall Study|Death|1|||
130375281|NCT00660309|469339819|FG000|Overall Study|Adverse Event|2|||
130375282|NCT00660309|469339820|FG001|Overall Study|Adverse Event|0|||
130466451|NCT00703820|469674818|FG000|Overall Study|Physician Decision|4|||
130719591|NCT02132754|470597460|FG026|Overall Study|Adverse Event|1|||
130719592|NCT02132754|470597461|FG027|Overall Study|Adverse Event|0|||
130719593|NCT02132754|470597462|FG028|Overall Study|Adverse Event|0|||
130314594|NCT03001557|469118325|FG003|Extension Phase|Withdrawal by Subject|0|||
130719594|NCT02132754|470597463|FG029|Overall Study|Adverse Event|0|||
130314595|NCT03001557|469118326|FG004|Extension Phase|Withdrawal by Subject|0|||
130314596|NCT03001557|469118327|FG005|Extension Phase|Withdrawal by Subject|1|||
130314597|NCT03001557|469118328|FG006|Extension Phase|Withdrawal by Subject|5|||
130314598|NCT03001557|469118329|FG007|Extension Phase|Withdrawal by Subject|2|||
130314599|NCT03001557|469118322|FG000|Extension Phase|Lost to Follow-up|0|||
130314600|NCT03001557|469118323|FG001|Extension Phase|Lost to Follow-up|0|||
130314601|NCT03001557|469118324|FG002|Extension Phase|Lost to Follow-up|0|||
130314602|NCT03001557|469118325|FG003|Extension Phase|Lost to Follow-up|0|||
130314603|NCT03001557|469118326|FG004|Extension Phase|Lost to Follow-up|0|||
130314604|NCT03001557|469118327|FG005|Extension Phase|Lost to Follow-up|0|||
130314605|NCT03001557|469118328|FG006|Extension Phase|Lost to Follow-up|2|||
130314606|NCT03001557|469118329|FG007|Extension Phase|Lost to Follow-up|1|||
130314607|NCT03001557|469118322|FG000|Extension Phase|Administrative Reason|0|||
130314608|NCT03001557|469118323|FG001|Extension Phase|Administrative Reason|0|||
130314609|NCT03001557|469118324|FG002|Extension Phase|Administrative Reason|0|||
130314610|NCT03001557|469118325|FG003|Extension Phase|Administrative Reason|0|||
130314611|NCT03001557|469118326|FG004|Extension Phase|Administrative Reason|0|||
130314612|NCT03001557|469118327|FG005|Extension Phase|Administrative Reason|1|||
130314613|NCT03001557|469118328|FG006|Extension Phase|Administrative Reason|3|||
130314614|NCT03001557|469118329|FG007|Extension Phase|Administrative Reason|3|||
130314615|NCT03001557|469118322|FG000|Extension Phase|Loss of caregiver|0|||
130314616|NCT03001557|469118323|FG001|Extension Phase|Loss of caregiver|0|||
130314617|NCT03001557|469118324|FG002|Extension Phase|Loss of caregiver|0|||
130314618|NCT03001557|469118325|FG003|Extension Phase|Loss of caregiver|0|||
130314619|NCT03001557|469118326|FG004|Extension Phase|Loss of caregiver|0|||
130314620|NCT03001557|469118327|FG005|Extension Phase|Loss of caregiver|0|||
130314621|NCT03001557|469118328|FG006|Extension Phase|Loss of caregiver|1|||
130314622|NCT03001557|469118329|FG007|Extension Phase|Loss of caregiver|0|||
130314623|NCT03001557|469118322|FG000|Extension Phase|Others|0|||
130314624|NCT03001557|469118323|FG001|Extension Phase|Others|0|||
130314625|NCT03001557|469118324|FG002|Extension Phase|Others|0|||
130466452|NCT00703820|469674819|FG001|Overall Study|Physician Decision|5|||
130466453|NCT00703820|469674818|FG000|Overall Study|Withdrawal by Subject|2|||
130466454|NCT00703820|469674819|FG001|Overall Study|Withdrawal by Subject|1|||
130466455|NCT00350792|469674822|FG000|Overall Study|Adverse Event|11|||
130466456|NCT00350792|469674822|FG000|Overall Study|Death from Study Disease|1|||
130466457|NCT00350792|469674822|FG000|Overall Study|Death from Study Drug Toxicity|1|||
130466458|NCT00350792|469674822|FG000|Overall Study|Death Not Study Drug Related|2|||
130466459|NCT00350792|469674822|FG000|Overall Study|Protocol Violation|1|||
130466460|NCT00350792|469674822|FG000|Overall Study|Withdrawal by Subject|4|||
130466461|NCT00350792|469674822|FG000|Overall Study|Physician Decision|2|||
130466462|NCT00350792|469674822|FG000|Overall Study|Lack of Efficacy|11|||
130466463|NCT00914589|469674823|FG000|Overall Study|Adverse Event|1|||
130466464|NCT00914589|469674824|FG001|Overall Study|Adverse Event|0|||
130466465|NCT00914589|469674825|FG002|Overall Study|Adverse Event|1|||
130466466|NCT00914589|469674823|FG000|Overall Study|Protocol Violation|8|||
130466467|NCT00914589|469674824|FG001|Overall Study|Protocol Violation|6|||
130466468|NCT00914589|469674825|FG002|Overall Study|Protocol Violation|3|||
130466469|NCT00914589|469674823|FG000|Overall Study|unclassified|16|||
130466470|NCT00914589|469674824|FG001|Overall Study|unclassified|9|||
130466471|NCT00914589|469674825|FG002|Overall Study|unclassified|7|||
130466472|NCT00914589|469674823|FG000|Overall Study|Death|0|||
130466473|NCT00914589|469674824|FG001|Overall Study|Death|1|||
130466474|NCT00914589|469674825|FG002|Overall Study|Death|1|||
130466475|NCT03988023|469674826|FG000|Overall Study|Non-compliance|3|||
130466476|NCT03988023|469674827|FG001|Overall Study|Non-compliance|0|||
130466477|NCT03988023|469674826|FG000|Overall Study|Withdrawal by Subject|39|||
130466478|NCT03988023|469674827|FG001|Overall Study|Withdrawal by Subject|37|||
130466479|NCT03988023|469674826|FG000|Overall Study|Adverse Event|0|||
130466480|NCT03988023|469674827|FG001|Overall Study|Adverse Event|2|||
130466481|NCT03988023|469674826|FG000|Overall Study|Physician Decision|0|||
130466482|NCT03988023|469674827|FG001|Overall Study|Physician Decision|1|||
130466483|NCT03988023|469674826|FG000|Overall Study|Lost to Follow-up|5|||
130466484|NCT03988023|469674827|FG001|Overall Study|Lost to Follow-up|8|||
130466485|NCT03988023|469674826|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
130466486|NCT03988023|469674827|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
130466487|NCT03988023|469674826|FG000|Overall Study|Lack of Efficacy|3|||
130466488|NCT03988023|469674827|FG001|Overall Study|Lack of Efficacy|1|||
130466489|NCT03988023|469674826|FG000|Overall Study|COVID-19 pandemic|225|||
130466490|NCT03988023|469674827|FG001|Overall Study|COVID-19 pandemic|227|||
130314626|NCT03001557|469118325|FG003|Extension Phase|Others|0|||
130314627|NCT03001557|469118326|FG004|Extension Phase|Others|0|||
130314628|NCT03001557|469118327|FG005|Extension Phase|Others|1|||
130466491|NCT03036813|469674828|FG000|Overall Study|Adverse Event|6|||
130314629|NCT03001557|469118328|FG006|Extension Phase|Others|3|||
130314630|NCT03001557|469118329|FG007|Extension Phase|Others|0|||
130314631|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
130314632|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
130314633|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Death|1|||
130466492|NCT03036813|469674829|FG001|Overall Study|Adverse Event|11|||
130719595|NCT02132754|470597464|FG030|Overall Study|Adverse Event|1|||
130719596|NCT02132754|470597465|FG031|Overall Study|Adverse Event|0|||
130719597|NCT02132754|470597466|FG032|Overall Study|Adverse Event|1|||
130719598|NCT02132754|470597467|FG033|Overall Study|Adverse Event|1|||
130719599|NCT02132754|470597434|FG000|Overall Study|Clinical Progression|0|||
130719600|NCT02132754|470597435|FG001|Overall Study|Clinical Progression|0|||
130719601|NCT02132754|470597436|FG002|Overall Study|Clinical Progression|0|||
130719602|NCT02132754|470597437|FG003|Overall Study|Clinical Progression|0|||
130719603|NCT02132754|470597438|FG004|Overall Study|Clinical Progression|0|||
130719604|NCT02132754|470597439|FG005|Overall Study|Clinical Progression|0|||
130719605|NCT02132754|470597440|FG006|Overall Study|Clinical Progression|0|||
130719606|NCT02132754|470597441|FG007|Overall Study|Clinical Progression|0|||
130719607|NCT02132754|470597442|FG008|Overall Study|Clinical Progression|0|||
130719608|NCT02132754|470597443|FG009|Overall Study|Clinical Progression|1|||
130719609|NCT02132754|470597444|FG010|Overall Study|Clinical Progression|0|||
130719610|NCT02132754|470597445|FG011|Overall Study|Clinical Progression|0|||
130719611|NCT02132754|470597446|FG012|Overall Study|Clinical Progression|0|||
130719612|NCT02132754|470597447|FG013|Overall Study|Clinical Progression|0|||
130719613|NCT02132754|470597448|FG014|Overall Study|Clinical Progression|0|||
130719614|NCT02132754|470597449|FG015|Overall Study|Clinical Progression|0|||
130314634|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Death|2|||
130314635|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
130314636|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
130314637|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
130314638|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
130314639|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
130314640|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
130314641|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
130314642|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
130314643|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
130314644|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
130314645|NCT01794000|469118330|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
130314646|NCT01794000|469118331|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130314647|NCT01176058|469118333|FG000|Overall Study|Adverse Event|1|||
130314648|NCT01176058|469118334|FG001|Overall Study|Adverse Event|0|||
130314649|NCT01176058|469118333|FG000|Overall Study|Insufficient clinical response|2|||
130314650|NCT01176058|469118334|FG001|Overall Study|Insufficient clinical response|2|||
130375283|NCT00660309|469339819|FG000|Overall Study|Withdrawal by Subject|0|||
130375284|NCT00660309|469339820|FG001|Overall Study|Withdrawal by Subject|3|||
130375285|NCT02573311|469339823|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
130375286|NCT02573311|469339824|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
130375287|NCT02573311|469339823|FG000|Disposition for Part 2|Physician Decision|25|||
130375288|NCT02573311|469339824|FG001|Disposition for Part 2|Physician Decision|7|||
130375289|NCT02573311|469339823|FG000|Disposition for Part 2|Adverse Event|36|||
130375290|NCT02573311|469339824|FG001|Disposition for Part 2|Adverse Event|5|||
130375291|NCT02573311|469339823|FG000|Disposition for Part 2|Lost to Follow-up|76|||
130375292|NCT02573311|469339824|FG001|Disposition for Part 2|Lost to Follow-up|7|||
130375293|NCT02573311|469339823|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
130375294|NCT02573311|469339824|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
130375295|NCT02573311|469339823|FG000|Disposition for Part 2|Investigator decision|0|||
130375296|NCT02573311|469339824|FG001|Disposition for Part 2|Investigator decision|1|||
130375297|NCT02573311|469339823|FG000|Disposition for Part 2|Other than specified above|13|||
130375298|NCT02573311|469339824|FG001|Disposition for Part 2|Other than specified above|3|||
130375299|NCT04171531|469339826|FG000|Overall Study|Lost to Follow-up|4|||
130375300|NCT04171531|469339827|FG001|Overall Study|Lost to Follow-up|5|||
130375301|NCT04171531|469339826|FG000|Overall Study|Consent only through 6 months|1|||
130375302|NCT04171531|469339827|FG001|Overall Study|Consent only through 6 months|1|||
130375303|NCT04171531|469339826|FG000|Overall Study|Insurance did not cover procedure|0|||
130375304|NCT04171531|469339827|FG001|Overall Study|Insurance did not cover procedure|1|||
130375305|NCT04171531|469339826|FG000|Overall Study|Physician Decision|0|||
130375306|NCT04171531|469339827|FG001|Overall Study|Physician Decision|3|||
130375307|NCT04171531|469339826|FG000|Overall Study|Withdrawal by Subject|1|||
130375308|NCT04171531|469339827|FG001|Overall Study|Withdrawal by Subject|5|||
130375309|NCT04862585|469339830|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
130375310|NCT04862585|469339831|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
130375311|NCT04862585|469339830|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
130375312|NCT04862585|469339831|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
130719615|NCT02132754|470597450|FG016|Overall Study|Clinical Progression|1|||
130719616|NCT02132754|470597451|FG017|Overall Study|Clinical Progression|1|||
130719617|NCT02132754|470597452|FG018|Overall Study|Clinical Progression|0|||
130719618|NCT02132754|470597453|FG019|Overall Study|Clinical Progression|1|||
130719619|NCT02132754|470597454|FG020|Overall Study|Clinical Progression|0|||
130314651|NCT01176058|469118333|FG000|Overall Study|Insufficient mycological response|0|||
130314652|NCT01176058|469118334|FG001|Overall Study|Insufficient mycological response|1|||
130314653|NCT01176058|469118333|FG000|Overall Study|Withdrawal by Subject|1|||
130719620|NCT02132754|470597455|FG021|Overall Study|Clinical Progression|0|||
130719621|NCT02132754|470597456|FG022|Overall Study|Clinical Progression|1|||
130719622|NCT02132754|470597457|FG023|Overall Study|Clinical Progression|0|||
130719623|NCT02132754|470597458|FG024|Overall Study|Clinical Progression|1|||
130719624|NCT02132754|470597459|FG025|Overall Study|Clinical Progression|1|||
130719625|NCT02132754|470597460|FG026|Overall Study|Clinical Progression|0|||
130719626|NCT02132754|470597461|FG027|Overall Study|Clinical Progression|1|||
130719627|NCT02132754|470597462|FG028|Overall Study|Clinical Progression|1|||
130719628|NCT02132754|470597463|FG029|Overall Study|Clinical Progression|0|||
130719629|NCT02132754|470597464|FG030|Overall Study|Clinical Progression|1|||
130719630|NCT02132754|470597465|FG031|Overall Study|Clinical Progression|0|||
130719631|NCT02132754|470597466|FG032|Overall Study|Clinical Progression|0|||
130719632|NCT02132754|470597467|FG033|Overall Study|Clinical Progression|2|||
130719633|NCT02132754|470597434|FG000|Overall Study|Death|0|||
130719634|NCT02132754|470597435|FG001|Overall Study|Death|0|||
130719635|NCT02132754|470597436|FG002|Overall Study|Death|0|||
130719636|NCT02132754|470597437|FG003|Overall Study|Death|0|||
130719637|NCT02132754|470597438|FG004|Overall Study|Death|0|||
130719638|NCT02132754|470597439|FG005|Overall Study|Death|0|||
130719639|NCT02132754|470597440|FG006|Overall Study|Death|0|||
130719640|NCT02132754|470597441|FG007|Overall Study|Death|0|||
130719641|NCT02132754|470597442|FG008|Overall Study|Death|0|||
130719642|NCT02132754|470597443|FG009|Overall Study|Death|0|||
130719643|NCT02132754|470597444|FG010|Overall Study|Death|0|||
130719644|NCT02132754|470597445|FG011|Overall Study|Death|0|||
130719645|NCT02132754|470597446|FG012|Overall Study|Death|0|||
130719646|NCT02132754|470597447|FG013|Overall Study|Death|0|||
130719647|NCT02132754|470597448|FG014|Overall Study|Death|0|||
130719648|NCT02132754|470597449|FG015|Overall Study|Death|1|||
130719649|NCT02132754|470597450|FG016|Overall Study|Death|0|||
130719650|NCT02132754|470597451|FG017|Overall Study|Death|0|||
130719651|NCT02132754|470597452|FG018|Overall Study|Death|0|||
130719652|NCT02132754|470597453|FG019|Overall Study|Death|1|||
130719653|NCT02132754|470597454|FG020|Overall Study|Death|0|||
130719654|NCT02132754|470597455|FG021|Overall Study|Death|1|||
130719655|NCT02132754|470597456|FG022|Overall Study|Death|0|||
130719656|NCT02132754|470597457|FG023|Overall Study|Death|0|||
130719657|NCT02132754|470597458|FG024|Overall Study|Death|0|||
130719658|NCT02132754|470597459|FG025|Overall Study|Death|0|||
130719659|NCT02132754|470597460|FG026|Overall Study|Death|1|||
130719660|NCT02132754|470597461|FG027|Overall Study|Death|0|||
130719661|NCT02132754|470597462|FG028|Overall Study|Death|0|||
130719662|NCT02132754|470597463|FG029|Overall Study|Death|0|||
130719663|NCT02132754|470597464|FG030|Overall Study|Death|0|||
130719664|NCT02132754|470597465|FG031|Overall Study|Death|0|||
130719665|NCT02132754|470597466|FG032|Overall Study|Death|0|||
130719666|NCT02132754|470597467|FG033|Overall Study|Death|2|||
130719667|NCT02132754|470597434|FG000|Overall Study|Excluded Medication|0|||
130719668|NCT02132754|470597435|FG001|Overall Study|Excluded Medication|0|||
130719669|NCT02132754|470597436|FG002|Overall Study|Excluded Medication|0|||
130719670|NCT02132754|470597437|FG003|Overall Study|Excluded Medication|0|||
130719671|NCT02132754|470597438|FG004|Overall Study|Excluded Medication|0|||
130719672|NCT02132754|470597439|FG005|Overall Study|Excluded Medication|0|||
130719673|NCT02132754|470597440|FG006|Overall Study|Excluded Medication|0|||
130719674|NCT02132754|470597441|FG007|Overall Study|Excluded Medication|0|||
130719675|NCT02132754|470597442|FG008|Overall Study|Excluded Medication|0|||
130719676|NCT02132754|470597443|FG009|Overall Study|Excluded Medication|0|||
130719677|NCT02132754|470597444|FG010|Overall Study|Excluded Medication|0|||
130719678|NCT02132754|470597445|FG011|Overall Study|Excluded Medication|0|||
130314654|NCT01176058|469118334|FG001|Overall Study|Withdrawal by Subject|0|||
130314655|NCT03480152|469118335|FG000|Phase I|Signed consent. Died before treatment.|1|||
130314656|NCT03480152|469118336|FG001|Phase I|Signed consent. Died before treatment.|0|||
130719679|NCT02132754|470597446|FG012|Overall Study|Excluded Medication|0|||
130719680|NCT02132754|470597447|FG013|Overall Study|Excluded Medication|0|||
130314657|NCT03480152|469118337|FG002|Phase I|Signed consent. Died before treatment.|0|||
130314658|NCT00687401|469118338|FG000|Overall Study|Protocol Violation|7|||
130466493|NCT03036813|469674830|FG002|Overall Study|Adverse Event|6|||
130719681|NCT02132754|470597448|FG014|Overall Study|Excluded Medication|0|||
130719682|NCT02132754|470597449|FG015|Overall Study|Excluded Medication|0|||
130719683|NCT02132754|470597450|FG016|Overall Study|Excluded Medication|0|||
130719684|NCT02132754|470597451|FG017|Overall Study|Excluded Medication|0|||
130719685|NCT02132754|470597452|FG018|Overall Study|Excluded Medication|0|||
130719686|NCT02132754|470597453|FG019|Overall Study|Excluded Medication|0|||
130719687|NCT02132754|470597454|FG020|Overall Study|Excluded Medication|1|||
130719688|NCT02132754|470597455|FG021|Overall Study|Excluded Medication|0|||
130558984|NCT04513665|470014945|FG001|Overall Study|Adverse Event|0|||
130558985|NCT04513665|470014944|FG000|Overall Study|Lack of Efficacy|14|||
130558986|NCT04513665|470014945|FG001|Overall Study|Lack of Efficacy|0|||
130558987|NCT02608879|470014947|FG000|Overall Study|Lost to Follow-up|1|||
130558988|NCT02608879|470014948|FG001|Overall Study|Lost to Follow-up|0|||
130558989|NCT02608879|470014949|FG002|Overall Study|Lost to Follow-up|0|||
130558990|NCT02608879|470014947|FG000|Overall Study|Did not meet continuation criteria|0|||
130558991|NCT02608879|470014948|FG001|Overall Study|Did not meet continuation criteria|0|||
130558992|NCT02608879|470014949|FG002|Overall Study|Did not meet continuation criteria|3|||
130558993|NCT03785678|470014950|FG000|Overall Study|Death|44|||
130558994|NCT03785678|470014951|FG001|Overall Study|Death|42|||
130558995|NCT03785678|470014950|FG000|Overall Study|Lost to Follow-up|4|||
130558996|NCT03785678|470014951|FG001|Overall Study|Lost to Follow-up|2|||
130558997|NCT03785678|470014950|FG000|Overall Study|Physician Decision|0|||
130558998|NCT03785678|470014951|FG001|Overall Study|Physician Decision|2|||
130558999|NCT03785678|470014950|FG000|Overall Study|Withdrawal by Subject|5|||
130559000|NCT03785678|470014951|FG001|Overall Study|Withdrawal by Subject|3|||
130559001|NCT02374021|470014953|FG000|Overall Study|Adverse Event|1|||
130559002|NCT02374021|470014954|FG001|Overall Study|Adverse Event|0|||
130559003|NCT02374021|470014953|FG000|Overall Study|Lost to Follow-up|3|||
130559004|NCT02374021|470014954|FG001|Overall Study|Lost to Follow-up|2|||
130559005|NCT02374021|470014953|FG000|Overall Study|Physician Decision|0|||
130559006|NCT02374021|470014954|FG001|Overall Study|Physician Decision|3|||
130559007|NCT02374021|470014953|FG000|Overall Study|Withdrawal by Subject|6|||
130559008|NCT02374021|470014954|FG001|Overall Study|Withdrawal by Subject|5|||
130559009|NCT02374021|470014953|FG000|Overall Study|Poor Adherence|0|||
130559010|NCT02374021|470014954|FG001|Overall Study|Poor Adherence|1|||
130559011|NCT02374021|470014953|FG000|Overall Study|Scan protocol not followed|0|||
130559012|NCT02374021|470014954|FG001|Overall Study|Scan protocol not followed|1|||
130559013|NCT02374021|470014953|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
130314659|NCT00687401|469118338|FG000|Overall Study|Adverse Event|6|||
130314660|NCT00687401|469118338|FG000|Overall Study|Lack of Efficacy|6|||
130314661|NCT00687401|469118338|FG000|Overall Study|Withdrawal by Subject|4|||
130314662|NCT00687401|469118338|FG000|Overall Study|Did not return for visit|3|||
130719689|NCT02132754|470597456|FG022|Overall Study|Excluded Medication|0|||
130719690|NCT02132754|470597457|FG023|Overall Study|Excluded Medication|0|||
130719691|NCT02132754|470597458|FG024|Overall Study|Excluded Medication|0|||
130719692|NCT02132754|470597459|FG025|Overall Study|Excluded Medication|0|||
130719693|NCT02132754|470597460|FG026|Overall Study|Excluded Medication|0|||
130719694|NCT02132754|470597461|FG027|Overall Study|Excluded Medication|0|||
130719695|NCT02132754|470597462|FG028|Overall Study|Excluded Medication|0|||
130719696|NCT02132754|470597463|FG029|Overall Study|Excluded Medication|0|||
130719697|NCT02132754|470597464|FG030|Overall Study|Excluded Medication|0|||
130719698|NCT02132754|470597465|FG031|Overall Study|Excluded Medication|0|||
130719699|NCT02132754|470597466|FG032|Overall Study|Excluded Medication|0|||
130719700|NCT02132754|470597467|FG033|Overall Study|Excluded Medication|1|||
130719701|NCT02132754|470597434|FG000|Overall Study|Physician Decision|0|||
130559014|NCT02374021|470014954|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
130559015|NCT00972777|470014966|FG000|Overall Study|Adverse Event|3|||
130719702|NCT02132754|470597435|FG001|Overall Study|Physician Decision|0|||
130719703|NCT02132754|470597436|FG002|Overall Study|Physician Decision|0|||
130719704|NCT02132754|470597437|FG003|Overall Study|Physician Decision|0|||
130559016|NCT00972777|470014967|FG001|Overall Study|Adverse Event|2|||
130559017|NCT00972777|470014966|FG000|Overall Study|Lost to Follow-up|0|||
130719705|NCT02132754|470597438|FG004|Overall Study|Physician Decision|0|||
130314663|NCT00687401|469118338|FG000|Overall Study|For reasons different from those above|4|||
130314664|NCT02920892|469118339|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
130559018|NCT00972777|470014967|FG001|Overall Study|Lost to Follow-up|4|||
130559019|NCT00972777|470014966|FG000|Overall Study|Withdrawal by Subject|4|||
130559020|NCT00972777|470014967|FG001|Overall Study|Withdrawal by Subject|5|||
130719706|NCT02132754|470597439|FG005|Overall Study|Physician Decision|0|||
130719707|NCT02132754|470597440|FG006|Overall Study|Physician Decision|0|||
130719708|NCT02132754|470597441|FG007|Overall Study|Physician Decision|0|||
130559021|NCT00972777|470014966|FG000|Overall Study|Physician Decision|4|||
130559022|NCT00972777|470014967|FG001|Overall Study|Physician Decision|0|||
130559023|NCT00972777|470014966|FG000|Overall Study|Protocol Violation|0|||
130559024|NCT00972777|470014967|FG001|Overall Study|Protocol Violation|2|||
130559025|NCT00972777|470014966|FG000|Overall Study|Screening Failure|2|||
130559026|NCT00972777|470014967|FG001|Overall Study|Screening Failure|1|||
130559027|NCT00972777|470014966|FG000|Overall Study|Missed visit|1|||
130559028|NCT00972777|470014967|FG001|Overall Study|Missed visit|0|||
130559029|NCT01093326|470014968|FG000|Overall Study|Death|0|||
130559030|NCT01093326|470014969|FG001|Overall Study|Death|1|||
130559031|NCT01093326|470014970|FG002|Overall Study|Death|0|||
130559032|NCT01093326|470014968|FG000|Overall Study|Lack of Efficacy|7|||
130559033|NCT01093326|470014969|FG001|Overall Study|Lack of Efficacy|6|||
130559034|NCT01093326|470014970|FG002|Overall Study|Lack of Efficacy|3|||
130559035|NCT01093326|470014968|FG000|Overall Study|Lost to Follow-up|2|||
130559036|NCT01093326|470014969|FG001|Overall Study|Lost to Follow-up|5|||
130559037|NCT01093326|470014970|FG002|Overall Study|Lost to Follow-up|4|||
130559038|NCT01093326|470014968|FG000|Overall Study|Physician Decision|3|||
130559039|NCT01093326|470014969|FG001|Overall Study|Physician Decision|1|||
130559040|NCT01093326|470014970|FG002|Overall Study|Physician Decision|3|||
130559041|NCT01093326|470014968|FG000|Overall Study|Withdrawal by Subject|30|||
130559042|NCT01093326|470014969|FG001|Overall Study|Withdrawal by Subject|27|||
130559043|NCT01093326|470014970|FG002|Overall Study|Withdrawal by Subject|26|||
130559044|NCT01093326|470014968|FG000|Overall Study|Adverse Event|2|||
130559045|NCT01093326|470014969|FG001|Overall Study|Adverse Event|1|||
130559046|NCT01093326|470014970|FG002|Overall Study|Adverse Event|4|||
130559047|NCT01093326|470014968|FG000|Overall Study|Other|0|||
130559048|NCT01093326|470014969|FG001|Overall Study|Other|0|||
130559049|NCT01093326|470014970|FG002|Overall Study|Other|1|||
130559050|NCT04263896|470014971|FG000|Overall Study|Withdrawal by Subject|2|||
130559051|NCT04263896|470014972|FG001|Overall Study|Withdrawal by Subject|4|||
130559052|NCT04263896|470014971|FG000|Overall Study|converted to open procedure|0|||
130559053|NCT04263896|470014972|FG001|Overall Study|converted to open procedure|1|||
130559054|NCT04263896|470014971|FG000|Overall Study|Lost to Follow-up|9|||
130559055|NCT04263896|470014972|FG001|Overall Study|Lost to Follow-up|11|||
130559056|NCT04263896|470014971|FG000|Overall Study|surveys lost in mail|5|||
130559057|NCT04263896|470014972|FG001|Overall Study|surveys lost in mail|3|||
130559058|NCT04263896|470014971|FG000|Overall Study|excluded from analysis|1|||
130559059|NCT04263896|470014972|FG001|Overall Study|excluded from analysis|0|||
130559060|NCT05586269|470016395|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
130559061|NCT05586269|470016396|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
130559062|NCT05586269|470016397|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
130559063|NCT05586269|470016398|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
130314665|NCT02920892|469118340|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
130314666|NCT02920892|469118341|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
130314667|NCT02920892|469118339|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
130559064|NCT05586269|470016395|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
130559065|NCT05586269|470016396|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
130559066|NCT05586269|470016397|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
130719709|NCT02132754|470597442|FG008|Overall Study|Physician Decision|0|||
130719710|NCT02132754|470597443|FG009|Overall Study|Physician Decision|1|||
130719711|NCT02132754|470597444|FG010|Overall Study|Physician Decision|0|||
130719712|NCT02132754|470597445|FG011|Overall Study|Physician Decision|1|||
130719713|NCT02132754|470597446|FG012|Overall Study|Physician Decision|1|||
130719714|NCT02132754|470597447|FG013|Overall Study|Physician Decision|0|||
130719715|NCT02132754|470597448|FG014|Overall Study|Physician Decision|0|||
130719716|NCT02132754|470597449|FG015|Overall Study|Physician Decision|1|||
130719717|NCT02132754|470597450|FG016|Overall Study|Physician Decision|0|||
130719718|NCT02132754|470597451|FG017|Overall Study|Physician Decision|0|||
130719719|NCT02132754|470597452|FG018|Overall Study|Physician Decision|0|||
130719720|NCT02132754|470597453|FG019|Overall Study|Physician Decision|0|||
130719721|NCT02132754|470597454|FG020|Overall Study|Physician Decision|0|||
130719722|NCT02132754|470597455|FG021|Overall Study|Physician Decision|0|||
130719723|NCT02132754|470597456|FG022|Overall Study|Physician Decision|0|||
130719724|NCT02132754|470597457|FG023|Overall Study|Physician Decision|0|||
130719725|NCT02132754|470597458|FG024|Overall Study|Physician Decision|1|||
130719726|NCT02132754|470597459|FG025|Overall Study|Physician Decision|0|||
130314668|NCT02920892|469118340|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
130314669|NCT02920892|469118341|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
130719727|NCT02132754|470597460|FG026|Overall Study|Physician Decision|0|||
130719728|NCT02132754|470597461|FG027|Overall Study|Physician Decision|0|||
130719729|NCT02132754|470597462|FG028|Overall Study|Physician Decision|0|||
130559067|NCT05586269|470016398|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
130559068|NCT00088907|470016400|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
130559069|NCT00088907|470016401|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
130559070|NCT00088907|470016400|FG000|Randomized Study (Step 1)|Adverse Event|14|||
130559071|NCT00088907|470016401|FG001|Randomized Study (Step 1)|Adverse Event|19|||
130559072|NCT00088907|470016400|FG000|Randomized Study (Step 1)|Death|11|||
130719730|NCT02132754|470597463|FG029|Overall Study|Physician Decision|0|||
130719731|NCT02132754|470597464|FG030|Overall Study|Physician Decision|0|||
130719732|NCT02132754|470597465|FG031|Overall Study|Physician Decision|1|||
130719733|NCT02132754|470597466|FG032|Overall Study|Physician Decision|0|||
130719734|NCT02132754|470597467|FG033|Overall Study|Physician Decision|3|||
130719735|NCT02132754|470597434|FG000|Overall Study|Progressive Disease|1|||
130719736|NCT02132754|470597435|FG001|Overall Study|Progressive Disease|1|||
130719737|NCT02132754|470597436|FG002|Overall Study|Progressive Disease|1|||
130719738|NCT02132754|470597437|FG003|Overall Study|Progressive Disease|1|||
130375313|NCT04862585|469339830|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
130375314|NCT04862585|469339831|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
130375315|NCT04862585|469339830|FG000|Overall Study|one withdrew without providing a reason|0|||
130375316|NCT04862585|469339831|FG001|Overall Study|one withdrew without providing a reason|1|||
130375317|NCT03366337|469339832|FG000|Overall Study|Lost to Follow-up|1|||
130375318|NCT03366337|469339833|FG001|Overall Study|Lost to Follow-up|0|||
130375319|NCT03366337|469339834|FG002|Overall Study|Lost to Follow-up|1|||
130375320|NCT03366337|469339835|FG003|Overall Study|Lost to Follow-up|0|||
130375321|NCT03366337|469339832|FG000|Overall Study|Withdrawal by Subject|2|||
130375322|NCT03366337|469339833|FG001|Overall Study|Withdrawal by Subject|0|||
130375323|NCT03366337|469339834|FG002|Overall Study|Withdrawal by Subject|1|||
130375324|NCT03366337|469339835|FG003|Overall Study|Withdrawal by Subject|1|||
130375325|NCT05288062|469339837|FG000|Overall Study|Ineligible|0|||
130375326|NCT05288062|469339838|FG001|Overall Study|Ineligible|0|||
130375327|NCT05288062|469339839|FG002|Overall Study|Ineligible|1|||
130375328|NCT05288062|469339840|FG003|Overall Study|Ineligible|0|||
130375329|NCT05288062|469339837|FG000|Overall Study|Withdrawal by Subject|0|||
130375330|NCT05288062|469339838|FG001|Overall Study|Withdrawal by Subject|0|||
130375331|NCT05288062|469339839|FG002|Overall Study|Withdrawal by Subject|1|||
130375332|NCT05288062|469339840|FG003|Overall Study|Withdrawal by Subject|0|||
130375333|NCT00211809|469339841|FG000|Overall Study|Lack of Efficacy|1|||
130375334|NCT00211809|469339841|FG000|Overall Study|Lost to Follow-up|2|||
130375335|NCT00211809|469339841|FG000|Overall Study|Pregnancy|1|||
130375336|NCT00211809|469339841|FG000|Overall Study|side effects|2|||
130375337|NCT00496470|469339842|FG000|Overall Study|Adverse Event|8|||
130375338|NCT00496470|469339843|FG001|Overall Study|Adverse Event|10|||
130375339|NCT00496470|469339842|FG000|Overall Study|Withdrawal by Subject|5|||
130375340|NCT00496470|469339843|FG001|Overall Study|Withdrawal by Subject|12|||
130375341|NCT00496470|469339842|FG000|Overall Study|Incorrectly enrolled|13|||
130375342|NCT00496470|469339843|FG001|Overall Study|Incorrectly enrolled|5|||
130375343|NCT00496470|469339842|FG000|Overall Study|Other reason|0|||
130375344|NCT00496470|469339843|FG001|Overall Study|Other reason|2|||
130375345|NCT01370356|469339844|FG000|Overall Study|Death|1|||
130375346|NCT01370356|469339845|FG001|Overall Study|Death|0|||
130375347|NCT01370356|469339844|FG000|Overall Study|Lack of Efficacy|6|||
130375348|NCT01370356|469339845|FG001|Overall Study|Lack of Efficacy|28|||
130375349|NCT01370356|469339844|FG000|Overall Study|Lost to Follow-up|76|||
130375350|NCT01370356|469339845|FG001|Overall Study|Lost to Follow-up|81|||
130375351|NCT01370356|469339844|FG000|Overall Study|Withdrawal by Subject|54|||
130375352|NCT01370356|469339845|FG001|Overall Study|Withdrawal by Subject|59|||
130375353|NCT01370356|469339844|FG000|Overall Study|Reason not specified|39|||
130375354|NCT01370356|469339845|FG001|Overall Study|Reason not specified|43|||
130375355|NCT01370356|469339844|FG000|Overall Study|Protocol Violation|3|||
130375356|NCT01370356|469339845|FG001|Overall Study|Protocol Violation|3|||
130375357|NCT01370356|469339844|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
130375358|NCT01370356|469339845|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
130375359|NCT01370356|469339844|FG000|Overall Study|AE Not Related to Study Drug|1|||
130375360|NCT01370356|469339845|FG001|Overall Study|AE Not Related to Study Drug|4|||
130375361|NCT00729651|469339846|FG000|Overall Study|Withdrawal by Subject|5|||
130375362|NCT00729651|469339847|FG001|Overall Study|Withdrawal by Subject|6|||
130375363|NCT00729651|469339846|FG000|Overall Study|Lost to Follow-up|5|||
130375364|NCT00729651|469339847|FG001|Overall Study|Lost to Follow-up|4|||
130466494|NCT03036813|469674828|FG000|Overall Study|Withdrawal by Subject|12|||
130719739|NCT02132754|470597438|FG004|Overall Study|Progressive Disease|1|||
130375365|NCT00729651|469339846|FG000|Overall Study|Protocol Violation|0|||
130375366|NCT00729651|469339847|FG001|Overall Study|Protocol Violation|1|||
130375367|NCT00729651|469339846|FG000|Overall Study|Adverse Event|7|||
130375368|NCT00729651|469339847|FG001|Overall Study|Adverse Event|3|||
130375369|NCT00729651|469339846|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
130375370|NCT00729651|469339847|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
130375371|NCT00729651|469339846|FG000|Overall Study|Subject's private reason|2|||
130466495|NCT03036813|469674829|FG001|Overall Study|Withdrawal by Subject|6|||
130719740|NCT02132754|470597439|FG005|Overall Study|Progressive Disease|1|||
130719741|NCT02132754|470597440|FG006|Overall Study|Progressive Disease|1|||
130375372|NCT00729651|469339847|FG001|Overall Study|Subject's private reason|0|||
130375373|NCT01218243|469339848|FG000|Overall Study|Lack of Efficacy|1|||
130375374|NCT01218243|469339849|FG001|Overall Study|Lack of Efficacy|1|||
130375375|NCT01218243|469339848|FG000|Overall Study|Lost to Follow-up|3|||
130375376|NCT01218243|469339849|FG001|Overall Study|Lost to Follow-up|3|||
130559073|NCT00088907|470016401|FG001|Randomized Study (Step 1)|Death|12|||
130559074|NCT00088907|470016400|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
130559075|NCT00088907|470016401|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
130559076|NCT00088907|470016400|FG000|Randomized Study (Step 1)|complicating disease|3|||
130559077|NCT00088907|470016401|FG001|Randomized Study (Step 1)|complicating disease|1|||
130559078|NCT00088907|470016400|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
130559079|NCT00088907|470016401|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
130559080|NCT00088907|470016400|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
130559081|NCT00088907|470016401|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
130559082|NCT00088907|470016400|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
130559083|NCT00088907|470016401|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
130559084|NCT00088907|470016400|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
130559085|NCT00088907|470016401|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
130559086|NCT00088907|470016400|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
130559087|NCT00088907|470016401|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
130559088|NCT00088907|470016400|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
130559089|NCT00088907|470016401|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
130559090|NCT03426787|470016406|FG000|Overall Study|Withdrawal by Subject|6|||
130559091|NCT03426787|470016406|FG000|Overall Study|Lost to Follow-up|7|||
130559092|NCT03426787|470016406|FG000|Overall Study|Unrelated to intervention death|1|||
130559093|NCT02020863|470016407|FG000|Overall Study|Discovery of Metastatic disease|4|||
130559094|NCT02020863|470016407|FG000|Overall Study|Team chose not to place an a line|1|||
130559095|NCT00907257|470016408|FG000|Overall Study|Adverse Event|0|||
130559096|NCT00907257|470016409|FG001|Overall Study|Adverse Event|4|||
130559097|NCT00907257|470016408|FG000|Overall Study|Protocol Violation|1|||
130559098|NCT00907257|470016409|FG001|Overall Study|Protocol Violation|2|||
130559099|NCT00907257|470016408|FG000|Overall Study|Lost to Follow-up|3|||
130559100|NCT00907257|470016409|FG001|Overall Study|Lost to Follow-up|3|||
130559101|NCT00907257|470016408|FG000|Overall Study|Withdrawal by Subject|1|||
130559102|NCT00907257|470016409|FG001|Overall Study|Withdrawal by Subject|2|||
130559103|NCT00907257|470016408|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
130559104|NCT00907257|470016409|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
130559105|NCT00907257|470016408|FG000|Overall Study|Moved|1|||
130559106|NCT00907257|470016409|FG001|Overall Study|Moved|0|||
130559107|NCT00907257|470016408|FG000|Overall Study|Personal Reasons|6|||
130559108|NCT00907257|470016409|FG001|Overall Study|Personal Reasons|1|||
130559109|NCT00283049|470016410|FG000|Overall Study|Adverse Event|6|||
130559110|NCT00283049|470016411|FG001|Overall Study|Adverse Event|1|||
130559111|NCT00283049|470016412|FG002|Overall Study|Adverse Event|4|||
130559112|NCT00283049|470016410|FG000|Overall Study|Protocol Violation|3|||
130559113|NCT00283049|470016411|FG001|Overall Study|Protocol Violation|0|||
130559114|NCT00283049|470016412|FG002|Overall Study|Protocol Violation|3|||
130559115|NCT00283049|470016410|FG000|Overall Study|Death|1|||
130559116|NCT00283049|470016411|FG001|Overall Study|Death|1|||
130559117|NCT00283049|470016412|FG002|Overall Study|Death|1|||
130559118|NCT00283049|470016410|FG000|Overall Study|Lack of Efficacy|0|||
130559119|NCT00283049|470016411|FG001|Overall Study|Lack of Efficacy|1|||
130559120|NCT00283049|470016412|FG002|Overall Study|Lack of Efficacy|1|||
130559121|NCT00283049|470016410|FG000|Overall Study|Lost to Follow-up|4|||
130559122|NCT00283049|470016411|FG001|Overall Study|Lost to Follow-up|2|||
130559123|NCT00283049|470016412|FG002|Overall Study|Lost to Follow-up|5|||
130719742|NCT02132754|470597441|FG007|Overall Study|Progressive Disease|1|||
130719743|NCT02132754|470597442|FG008|Overall Study|Progressive Disease|1|||
130719744|NCT02132754|470597443|FG009|Overall Study|Progressive Disease|3|||
130466496|NCT03036813|469674830|FG002|Overall Study|Withdrawal by Subject|10|||
130466497|NCT03036813|469674828|FG000|Overall Study|Lost to Follow-up|1|||
130466498|NCT03036813|469674829|FG001|Overall Study|Lost to Follow-up|1|||
130466499|NCT03036813|469674830|FG002|Overall Study|Lost to Follow-up|0|||
130466500|NCT03036813|469674828|FG000|Overall Study|Physician Decision|2|||
130466501|NCT03036813|469674829|FG001|Overall Study|Physician Decision|1|||
130466502|NCT03036813|469674830|FG002|Overall Study|Physician Decision|1|||
130719745|NCT02132754|470597444|FG010|Overall Study|Progressive Disease|3|||
130719746|NCT02132754|470597445|FG011|Overall Study|Progressive Disease|2|||
130719747|NCT02132754|470597446|FG012|Overall Study|Progressive Disease|2|||
130719748|NCT02132754|470597447|FG013|Overall Study|Progressive Disease|3|||
130719749|NCT02132754|470597448|FG014|Overall Study|Progressive Disease|2|||
130719750|NCT02132754|470597449|FG015|Overall Study|Progressive Disease|1|||
130719751|NCT02132754|470597450|FG016|Overall Study|Progressive Disease|2|||
130719752|NCT02132754|470597451|FG017|Overall Study|Progressive Disease|1|||
130559124|NCT00283049|470016410|FG000|Overall Study|Withdrawal by Subject|26|||
130719753|NCT02132754|470597452|FG018|Overall Study|Progressive Disease|3|||
130719754|NCT02132754|470597453|FG019|Overall Study|Progressive Disease|1|||
130466503|NCT03036813|469674828|FG000|Overall Study|Non-Compliance|1|||
130466504|NCT03036813|469674829|FG001|Overall Study|Non-Compliance|5|||
130559125|NCT00283049|470016411|FG001|Overall Study|Withdrawal by Subject|24|||
130559126|NCT00283049|470016412|FG002|Overall Study|Withdrawal by Subject|19|||
130559127|NCT00283049|470016410|FG000|Overall Study|Discontinuation of Study|18|||
130719755|NCT02132754|470597454|FG020|Overall Study|Progressive Disease|1|||
130719756|NCT02132754|470597455|FG021|Overall Study|Progressive Disease|3|||
130719757|NCT02132754|470597456|FG022|Overall Study|Progressive Disease|2|||
130719758|NCT02132754|470597457|FG023|Overall Study|Progressive Disease|3|||
130719759|NCT02132754|470597458|FG024|Overall Study|Progressive Disease|0|||
130719760|NCT02132754|470597459|FG025|Overall Study|Progressive Disease|1|||
130719761|NCT02132754|470597460|FG026|Overall Study|Progressive Disease|2|||
130719762|NCT02132754|470597461|FG027|Overall Study|Progressive Disease|1|||
130719763|NCT02132754|470597462|FG028|Overall Study|Progressive Disease|2|||
130719764|NCT02132754|470597463|FG029|Overall Study|Progressive Disease|3|||
130719765|NCT02132754|470597464|FG030|Overall Study|Progressive Disease|1|||
130719766|NCT02132754|470597465|FG031|Overall Study|Progressive Disease|1|||
130719767|NCT02132754|470597466|FG032|Overall Study|Progressive Disease|3|||
130719768|NCT02132754|470597467|FG033|Overall Study|Progressive Disease|6|||
130719769|NCT02132754|470597434|FG000|Overall Study|Screen Failure|0|||
130719770|NCT02132754|470597435|FG001|Overall Study|Screen Failure|0|||
130719771|NCT02132754|470597436|FG002|Overall Study|Screen Failure|0|||
130719772|NCT02132754|470597437|FG003|Overall Study|Screen Failure|0|||
130719773|NCT02132754|470597438|FG004|Overall Study|Screen Failure|0|||
130719774|NCT02132754|470597439|FG005|Overall Study|Screen Failure|0|||
130719775|NCT02132754|470597440|FG006|Overall Study|Screen Failure|0|||
130719776|NCT02132754|470597441|FG007|Overall Study|Screen Failure|0|||
130719777|NCT02132754|470597442|FG008|Overall Study|Screen Failure|0|||
130719778|NCT02132754|470597443|FG009|Overall Study|Screen Failure|0|||
130719779|NCT02132754|470597444|FG010|Overall Study|Screen Failure|0|||
130719780|NCT02132754|470597445|FG011|Overall Study|Screen Failure|0|||
130719781|NCT02132754|470597446|FG012|Overall Study|Screen Failure|0|||
130719782|NCT02132754|470597447|FG013|Overall Study|Screen Failure|0|||
130719783|NCT02132754|470597448|FG014|Overall Study|Screen Failure|0|||
130719784|NCT02132754|470597449|FG015|Overall Study|Screen Failure|0|||
130719785|NCT02132754|470597450|FG016|Overall Study|Screen Failure|0|||
130719786|NCT02132754|470597451|FG017|Overall Study|Screen Failure|0|||
130719787|NCT02132754|470597452|FG018|Overall Study|Screen Failure|0|||
130719788|NCT02132754|470597453|FG019|Overall Study|Screen Failure|1|||
130719789|NCT02132754|470597454|FG020|Overall Study|Screen Failure|0|||
130719790|NCT02132754|470597455|FG021|Overall Study|Screen Failure|1|||
130719791|NCT02132754|470597456|FG022|Overall Study|Screen Failure|0|||
130719792|NCT02132754|470597457|FG023|Overall Study|Screen Failure|0|||
130719793|NCT02132754|470597458|FG024|Overall Study|Screen Failure|0|||
130719794|NCT02132754|470597459|FG025|Overall Study|Screen Failure|0|||
130719795|NCT02132754|470597460|FG026|Overall Study|Screen Failure|0|||
130719796|NCT02132754|470597461|FG027|Overall Study|Screen Failure|0|||
130719797|NCT02132754|470597462|FG028|Overall Study|Screen Failure|0|||
130719798|NCT02132754|470597463|FG029|Overall Study|Screen Failure|0|||
130719799|NCT02132754|470597464|FG030|Overall Study|Screen Failure|0|||
130719800|NCT02132754|470597465|FG031|Overall Study|Screen Failure|0|||
130719801|NCT02132754|470597466|FG032|Overall Study|Screen Failure|0|||
130719802|NCT02132754|470597467|FG033|Overall Study|Screen Failure|0|||
130719803|NCT02132754|470597434|FG000|Overall Study|Transferred to Extension Study|0|||
130719804|NCT02132754|470597435|FG001|Overall Study|Transferred to Extension Study|0|||
130719805|NCT02132754|470597436|FG002|Overall Study|Transferred to Extension Study|0|||
130719806|NCT02132754|470597437|FG003|Overall Study|Transferred to Extension Study|0|||
130719807|NCT02132754|470597438|FG004|Overall Study|Transferred to Extension Study|0|||
130719808|NCT02132754|470597439|FG005|Overall Study|Transferred to Extension Study|0|||
130719809|NCT02132754|470597440|FG006|Overall Study|Transferred to Extension Study|0|||
130719810|NCT02132754|470597441|FG007|Overall Study|Transferred to Extension Study|0|||
130719811|NCT02132754|470597442|FG008|Overall Study|Transferred to Extension Study|0|||
130719812|NCT02132754|470597443|FG009|Overall Study|Transferred to Extension Study|0|||
130719813|NCT02132754|470597444|FG010|Overall Study|Transferred to Extension Study|0|||
130719814|NCT02132754|470597445|FG011|Overall Study|Transferred to Extension Study|0|||
130719815|NCT02132754|470597446|FG012|Overall Study|Transferred to Extension Study|0|||
130719816|NCT02132754|470597447|FG013|Overall Study|Transferred to Extension Study|0|||
130719817|NCT02132754|470597448|FG014|Overall Study|Transferred to Extension Study|0|||
130719818|NCT02132754|470597449|FG015|Overall Study|Transferred to Extension Study|0|||
130719819|NCT02132754|470597450|FG016|Overall Study|Transferred to Extension Study|0|||
130719820|NCT02132754|470597451|FG017|Overall Study|Transferred to Extension Study|0|||
130719821|NCT02132754|470597452|FG018|Overall Study|Transferred to Extension Study|0|||
130719822|NCT02132754|470597453|FG019|Overall Study|Transferred to Extension Study|0|||
130719823|NCT02132754|470597454|FG020|Overall Study|Transferred to Extension Study|0|||
130719824|NCT02132754|470597455|FG021|Overall Study|Transferred to Extension Study|0|||
130719825|NCT02132754|470597456|FG022|Overall Study|Transferred to Extension Study|0|||
130719826|NCT02132754|470597457|FG023|Overall Study|Transferred to Extension Study|0|||
130719827|NCT02132754|470597458|FG024|Overall Study|Transferred to Extension Study|0|||
130719828|NCT02132754|470597459|FG025|Overall Study|Transferred to Extension Study|0|||
130719829|NCT02132754|470597460|FG026|Overall Study|Transferred to Extension Study|0|||
130719830|NCT02132754|470597461|FG027|Overall Study|Transferred to Extension Study|0|||
130719831|NCT02132754|470597462|FG028|Overall Study|Transferred to Extension Study|0|||
130559128|NCT00283049|470016411|FG001|Overall Study|Discontinuation of Study|16|||
130559129|NCT00283049|470016412|FG002|Overall Study|Discontinuation of Study|20|||
130559130|NCT00283049|470016410|FG000|Overall Study|No longer requires study treatment|0|||
130559131|NCT00283049|470016411|FG001|Overall Study|No longer requires study treatment|0|||
130559132|NCT00283049|470016412|FG002|Overall Study|No longer requires study treatment|1|||
130559133|NCT01086410|470016413|FG000|Overall Study|Adverse Event|1|||
130559134|NCT01086410|470016414|FG001|Overall Study|Adverse Event|0|||
130559135|NCT01086410|470016415|FG002|Overall Study|Adverse Event|0|||
130559136|NCT01086410|470016416|FG003|Overall Study|Adverse Event|2|||
130314670|NCT02920892|469118339|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
130314671|NCT02920892|469118340|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
130314672|NCT02920892|469118341|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
130314673|NCT02920892|469118339|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
130314674|NCT02920892|469118340|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
130719832|NCT02132754|470597463|FG029|Overall Study|Transferred to Extension Study|0|||
130719833|NCT02132754|470597464|FG030|Overall Study|Transferred to Extension Study|0|||
130719834|NCT02132754|470597465|FG031|Overall Study|Transferred to Extension Study|0|||
130719835|NCT02132754|470597466|FG032|Overall Study|Transferred to Extension Study|0|||
130719836|NCT02132754|470597467|FG033|Overall Study|Transferred to Extension Study|6|||
130719837|NCT02132754|470597434|FG000|Overall Study|Withdrawal by Subject|0|||
130719838|NCT02132754|470597435|FG001|Overall Study|Withdrawal by Subject|0|||
130719839|NCT02132754|470597436|FG002|Overall Study|Withdrawal by Subject|0|||
130719840|NCT02132754|470597437|FG003|Overall Study|Withdrawal by Subject|0|||
130719841|NCT02132754|470597438|FG004|Overall Study|Withdrawal by Subject|0|||
130719842|NCT02132754|470597439|FG005|Overall Study|Withdrawal by Subject|0|||
130719843|NCT02132754|470597440|FG006|Overall Study|Withdrawal by Subject|0|||
130719844|NCT02132754|470597441|FG007|Overall Study|Withdrawal by Subject|0|||
130719845|NCT02132754|470597442|FG008|Overall Study|Withdrawal by Subject|0|||
130719846|NCT02132754|470597443|FG009|Overall Study|Withdrawal by Subject|1|||
130719847|NCT02132754|470597444|FG010|Overall Study|Withdrawal by Subject|0|||
130719848|NCT02132754|470597445|FG011|Overall Study|Withdrawal by Subject|0|||
130719849|NCT02132754|470597446|FG012|Overall Study|Withdrawal by Subject|1|||
130719850|NCT02132754|470597447|FG013|Overall Study|Withdrawal by Subject|0|||
130719851|NCT02132754|470597448|FG014|Overall Study|Withdrawal by Subject|1|||
130719852|NCT02132754|470597449|FG015|Overall Study|Withdrawal by Subject|2|||
130719853|NCT02132754|470597450|FG016|Overall Study|Withdrawal by Subject|1|||
130719854|NCT02132754|470597451|FG017|Overall Study|Withdrawal by Subject|0|||
130719855|NCT02132754|470597452|FG018|Overall Study|Withdrawal by Subject|0|||
130719856|NCT02132754|470597453|FG019|Overall Study|Withdrawal by Subject|0|||
130719857|NCT02132754|470597454|FG020|Overall Study|Withdrawal by Subject|1|||
130719858|NCT02132754|470597455|FG021|Overall Study|Withdrawal by Subject|0|||
130719859|NCT02132754|470597456|FG022|Overall Study|Withdrawal by Subject|0|||
130719860|NCT02132754|470597457|FG023|Overall Study|Withdrawal by Subject|0|||
130719861|NCT02132754|470597458|FG024|Overall Study|Withdrawal by Subject|1|||
130719862|NCT02132754|470597459|FG025|Overall Study|Withdrawal by Subject|0|||
130719863|NCT02132754|470597460|FG026|Overall Study|Withdrawal by Subject|0|||
130719864|NCT02132754|470597461|FG027|Overall Study|Withdrawal by Subject|1|||
130719865|NCT02132754|470597462|FG028|Overall Study|Withdrawal by Subject|0|||
130719866|NCT02132754|470597463|FG029|Overall Study|Withdrawal by Subject|0|||
130719867|NCT02132754|470597464|FG030|Overall Study|Withdrawal by Subject|0|||
130719868|NCT02132754|470597465|FG031|Overall Study|Withdrawal by Subject|1|||
130719869|NCT02132754|470597466|FG032|Overall Study|Withdrawal by Subject|0|||
130719870|NCT02132754|470597467|FG033|Overall Study|Withdrawal by Subject|2|||
130719871|NCT00477295|470597472|FG000|Overall Study|Adverse Event|31|||
130314675|NCT02920892|469118341|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
130314676|NCT02920892|469118339|FG000|Placebo-Controlled Period|Physician Decision|0|||
130375377|NCT01218243|469339848|FG000|Overall Study|Protocol Violation|5|||
130375378|NCT01218243|469339849|FG001|Overall Study|Protocol Violation|10|||
130375379|NCT00844896|469339850|FG000|Overall Study|Lost to Follow-up|12|||
130375380|NCT00844896|469339851|FG001|Overall Study|Lost to Follow-up|16|||
130375381|NCT00844896|469339850|FG000|Overall Study|Parents did not have time to complete|0|||
130375382|NCT00844896|469339851|FG001|Overall Study|Parents did not have time to complete|1|||
130375383|NCT02233647|469339852|FG000|Overall Study|Adverse Event|1|||
130375384|NCT02846779|469339856|FG000|Overall Study|Lost Enrollment|83|||
130375385|NCT02846779|469339857|FG001|Overall Study|Lost Enrollment|82|||
130375386|NCT02846779|469339858|FG002|Overall Study|Lost Enrollment|86|||
130375387|NCT02846779|469339856|FG000|Overall Study|Less than 31 days of follow-up|56|||
130375388|NCT02846779|469339857|FG001|Overall Study|Less than 31 days of follow-up|45|||
130375389|NCT02846779|469339858|FG002|Overall Study|Less than 31 days of follow-up|52|||
130375390|NCT02324569|469341877|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130375391|NCT02324569|469341878|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130375392|NCT02324569|469341877|FG000|Overall Study|Voluntary Withdrawal|3|||
130375393|NCT02324569|469341878|FG001|Overall Study|Voluntary Withdrawal|6|||
130559137|NCT01086410|470016413|FG000|Overall Study|Lack of Efficacy|1|||
130559138|NCT01086410|470016414|FG001|Overall Study|Lack of Efficacy|1|||
130559139|NCT01086410|470016415|FG002|Overall Study|Lack of Efficacy|0|||
130559140|NCT01086410|470016416|FG003|Overall Study|Lack of Efficacy|0|||
130559141|NCT01086410|470016413|FG000|Overall Study|Protocol Violation|1|||
130559142|NCT01086410|470016414|FG001|Overall Study|Protocol Violation|1|||
130559143|NCT01086410|470016415|FG002|Overall Study|Protocol Violation|0|||
130559144|NCT01086410|470016416|FG003|Overall Study|Protocol Violation|0|||
130559145|NCT01086410|470016413|FG000|Overall Study|Lost to Follow-up|0|||
130559146|NCT01086410|470016414|FG001|Overall Study|Lost to Follow-up|0|||
130559147|NCT01086410|470016415|FG002|Overall Study|Lost to Follow-up|1|||
130559148|NCT01086410|470016416|FG003|Overall Study|Lost to Follow-up|0|||
130559149|NCT04196803|470016417|FG000|Overall Study|Withdrawal by Subject|1|||
130559150|NCT04196803|470016418|FG001|Overall Study|Withdrawal by Subject|3|||
130559151|NCT04196803|470016417|FG000|Overall Study|Adverse Event|4|||
130559152|NCT04196803|470016418|FG001|Overall Study|Adverse Event|2|||
130559153|NCT04196803|470016417|FG000|Overall Study|Lost to Follow-up|0|||
130559154|NCT04196803|470016418|FG001|Overall Study|Lost to Follow-up|1|||
130559155|NCT01022996|470016419|FG000|Overall Study|Adverse Event|14|||
130559156|NCT01022996|470016419|FG000|Overall Study|Withdrawal by Subject|3|||
130559157|NCT01022996|470016419|FG000|Overall Study|Lost to Follow-up|1|||
130559158|NCT01022996|470016419|FG000|Overall Study|Administrative problems|6|||
130559159|NCT01022996|470016419|FG000|Overall Study|Disease Progression|32|||
130559160|NCT01022996|470016419|FG000|Overall Study|Protocol Violation|1|||
130559161|NCT00930722|470016420|FG000|Overall Study|Lost to Follow-up|16|||
130559162|NCT00930722|470016420|FG000|Overall Study|No longer willing to participate|9|||
130559163|NCT00930722|470016420|FG000|Overall Study|Study terminated by sponsor|2|||
130559164|NCT01069120|470016421|FG000|Overall Study|Study prematurely terminated|27|||
130559165|NCT05097716|470016422|FG000|Period 1|Adverse Event|1|||
130559166|NCT05097716|470016422|FG000|Period 1|Close contact with highly-transmissible infection|1|||
130719872|NCT00477295|470597473|FG001|Overall Study|Adverse Event|35|||
130719873|NCT00477295|470597472|FG000|Overall Study|Withdrawal by Subject|35|||
130719874|NCT00477295|470597473|FG001|Overall Study|Withdrawal by Subject|24|||
130719875|NCT00477295|470597472|FG000|Overall Study|Lack of Efficacy|23|||
130719876|NCT00477295|470597473|FG001|Overall Study|Lack of Efficacy|23|||
130719877|NCT00477295|470597472|FG000|Overall Study|Protocol Violation|3|||
130719878|NCT00477295|470597473|FG001|Overall Study|Protocol Violation|8|||
130719879|NCT00477295|470597472|FG000|Overall Study|Physician Decision|4|||
130719880|NCT00477295|470597473|FG001|Overall Study|Physician Decision|5|||
130719881|NCT00477295|470597472|FG000|Overall Study|Lost to Follow-up|21|||
130719882|NCT00477295|470597473|FG001|Overall Study|Lost to Follow-up|11|||
130719883|NCT00477295|470597472|FG000|Overall Study|Other|4|||
130719884|NCT00477295|470597473|FG001|Overall Study|Other|3|||
130719885|NCT00228423|470597476|FG000|Overall Study|Adverse Event|2|||
130719886|NCT00228423|470597477|FG001|Overall Study|Adverse Event|5|||
130719887|NCT00228423|470597476|FG000|Overall Study|Withdrawal by Subject|7|||
130719888|NCT00228423|470597477|FG001|Overall Study|Withdrawal by Subject|3|||
130719889|NCT00228423|470597476|FG000|Overall Study|Protocol Violation|1|||
130719890|NCT00228423|470597477|FG001|Overall Study|Protocol Violation|3|||
130719891|NCT00228423|470597476|FG000|Overall Study|Physician Decision|0|||
130719892|NCT00228423|470597477|FG001|Overall Study|Physician Decision|1|||
130719893|NCT01709838|470597491|FG000|Overall Study|Withdrawal by Subject|21|||
130719894|NCT01709838|470597491|FG000|Overall Study|Lost to Follow-up|16|||
130719895|NCT01709838|470597491|FG000|Overall Study|Pregnancy|10|||
130719896|NCT01709838|470597491|FG000|Overall Study|Subject/guardian decision|8|||
130719897|NCT01709838|470597491|FG000|Overall Study|Adverse Event|4|||
130719898|NCT01709838|470597491|FG000|Overall Study|Physician Decision|4|||
130719899|NCT01709838|470597491|FG000|Overall Study|Death|3|||
130719900|NCT01709838|470597491|FG000|Overall Study|Protocol Violation|1|||
130719901|NCT03190330|470599630|FG000|Overall Study|Adverse Event|2|||
130719902|NCT03190330|470599630|FG000|Overall Study|Death|10|||
130719903|NCT03190330|470599630|FG000|Overall Study|Lost to Follow-up|1|||
130719904|NCT03190330|470599630|FG000|Overall Study|Withdrawal by Subject|6|||
130719905|NCT03190330|470599630|FG000|Overall Study|Progressive Disease|1|||
130719906|NCT03845296|470599639|FG000|Overall Study|On Treatment|2|||
130719907|NCT03845296|470599640|FG001|Overall Study|On Treatment|1|||
130559167|NCT01754857|470016425|FG000|Overall Study|Adverse Event|7|||
130719908|NCT03845296|470599639|FG000|Overall Study|Adverse Event|4|||
130719909|NCT03845296|470599640|FG001|Overall Study|Adverse Event|11|||
130719910|NCT03845296|470599639|FG000|Overall Study|Refusal unrelated to adverse event|0|||
130559168|NCT01754857|470016425|FG000|Overall Study|Disease progression|3|||
130559169|NCT01754857|470016425|FG000|Overall Study|Physician Decision|2|||
130559170|NCT01754857|470016425|FG000|Overall Study|Withdrawal by Subject|3|||
130559171|NCT01754857|470016425|FG000|Overall Study|other complicating disease|1|||
130559172|NCT01754857|470016425|FG000|Overall Study|ineligible to continue onto maintenance|1|||
130559173|NCT01754857|470016425|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
130559174|NCT01754857|470016425|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
130719911|NCT03845296|470599640|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130719912|NCT03845296|470599639|FG000|Overall Study|Progression/relapse|14|||
130559175|NCT01509079|470016426|FG000|Overall Study|Lack of Efficacy|0|||
130559176|NCT01509079|470016427|FG001|Overall Study|Lack of Efficacy|2|||
130559177|NCT01509079|470016426|FG000|Overall Study|started an excluded medication|0|||
130559178|NCT01509079|470016427|FG001|Overall Study|started an excluded medication|1|||
130559179|NCT01399190|470016430|FG000|Overall Study|Not Eligible for Final Analysis|5|||
130559180|NCT01399190|470016430|FG000|Overall Study|Adverse Event|8|||
130559181|NCT01399190|470016430|FG000|Overall Study|Participant's Request|5|||
130559182|NCT01399190|470016430|FG000|Overall Study|Physician Decision|2|||
130559183|NCT00436618|470016434|FG000|Overall Study|Withdrawal by Subject|5|||
130559184|NCT00436618|470016435|FG001|Overall Study|Withdrawal by Subject|8|||
130559185|NCT00436618|470016436|FG002|Overall Study|Withdrawal by Subject|11|||
130559186|NCT00436618|470016434|FG000|Overall Study|Adverse Event|8|||
130559187|NCT00436618|470016435|FG001|Overall Study|Adverse Event|8|||
130559188|NCT00436618|470016436|FG002|Overall Study|Adverse Event|9|||
130559189|NCT00436618|470016434|FG000|Overall Study|Alternate Treatment|3|||
130559190|NCT00436618|470016435|FG001|Overall Study|Alternate Treatment|4|||
130559191|NCT00436618|470016436|FG002|Overall Study|Alternate Treatment|12|||
130559192|NCT00436618|470016434|FG000|Overall Study|Other Medical Problems|3|||
130559193|NCT00436618|470016435|FG001|Overall Study|Other Medical Problems|1|||
130559194|NCT00436618|470016436|FG002|Overall Study|Other Medical Problems|7|||
130559195|NCT00436618|470016434|FG000|Overall Study|Death|4|||
130559196|NCT00436618|470016435|FG001|Overall Study|Death|2|||
130559197|NCT00436618|470016436|FG002|Overall Study|Death|3|||
130559198|NCT00436618|470016434|FG000|Overall Study|New Primary or Other Reasons|6|||
130559199|NCT00436618|470016435|FG001|Overall Study|New Primary or Other Reasons|2|||
130559200|NCT00436618|470016436|FG002|Overall Study|New Primary or Other Reasons|12|||
130559201|NCT00436618|470016434|FG000|Overall Study|Still on treatment|1|||
130559202|NCT00436618|470016435|FG001|Overall Study|Still on treatment|2|||
130559203|NCT00436618|470016436|FG002|Overall Study|Still on treatment|7|||
130559204|NCT00698204|470016437|FG000|Overall Study|Withdrawal by Subject|1|||
130559205|NCT00698204|470016438|FG001|Overall Study|Withdrawal by Subject|0|||
130559206|NCT03083847|470016439|FG000|Main|Physician Decision|0|||
130559207|NCT03083847|470016440|FG001|Main|Physician Decision|0|||
130559208|NCT03083847|470016441|FG002|Main|Physician Decision|0|||
130559209|NCT03083847|470016442|FG003|Main|Physician Decision|0|||
130559210|NCT03083847|470016443|FG004|Main|Physician Decision|0|||
130559211|NCT03083847|470016444|FG005|Main|Physician Decision|1|||
130559212|NCT03083847|470016445|FG006|Main|Physician Decision|0|||
130559213|NCT03083847|470016446|FG007|Main|Physician Decision|0|||
130559214|NCT03083847|470016447|FG008|Main|Physician Decision|0|||
130559215|NCT03083847|470016448|FG009|Main|Physician Decision|0|||
130559216|NCT03083847|470016439|FG000|Main|Pregnancy|0|||
130559217|NCT03083847|470016440|FG001|Main|Pregnancy|0|||
130559218|NCT03083847|470016441|FG002|Main|Pregnancy|0|||
130559219|NCT03083847|470016442|FG003|Main|Pregnancy|0|||
130559220|NCT03083847|470016443|FG004|Main|Pregnancy|0|||
130559221|NCT03083847|470016444|FG005|Main|Pregnancy|0|||
130559222|NCT03083847|470016445|FG006|Main|Pregnancy|0|||
130559223|NCT03083847|470016446|FG007|Main|Pregnancy|1|||
130559224|NCT03083847|470016447|FG008|Main|Pregnancy|0|||
130559225|NCT03083847|470016448|FG009|Main|Pregnancy|0|||
130559226|NCT03083847|470016439|FG000|Main|Adverse Event|0|||
130559227|NCT03083847|470016440|FG001|Main|Adverse Event|0|||
130559228|NCT03083847|470016441|FG002|Main|Adverse Event|0|||
130559229|NCT03083847|470016442|FG003|Main|Adverse Event|0|||
130559230|NCT03083847|470016443|FG004|Main|Adverse Event|0|||
130559231|NCT03083847|470016444|FG005|Main|Adverse Event|0|||
130559232|NCT03083847|470016445|FG006|Main|Adverse Event|0|||
130559233|NCT03083847|470016446|FG007|Main|Adverse Event|2|||
130559234|NCT03083847|470016447|FG008|Main|Adverse Event|0|||
130559235|NCT03083847|470016448|FG009|Main|Adverse Event|0|||
130559236|NCT03083847|470016439|FG000|Main|Withdrawal by Subject|0|||
130314677|NCT02920892|469118340|FG001|Placebo-Controlled Period|Physician Decision|0|||
130314678|NCT02920892|469118341|FG002|Placebo-Controlled Period|Physician Decision|1|||
130559237|NCT03083847|470016440|FG001|Main|Withdrawal by Subject|0|||
130559238|NCT03083847|470016441|FG002|Main|Withdrawal by Subject|0|||
130559239|NCT03083847|470016442|FG003|Main|Withdrawal by Subject|0|||
130559240|NCT03083847|470016443|FG004|Main|Withdrawal by Subject|0|||
130559241|NCT03083847|470016444|FG005|Main|Withdrawal by Subject|0|||
130559242|NCT03083847|470016445|FG006|Main|Withdrawal by Subject|1|||
130559243|NCT03083847|470016446|FG007|Main|Withdrawal by Subject|1|||
130559244|NCT03083847|470016447|FG008|Main|Withdrawal by Subject|0|||
130314679|NCT02920892|469118339|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
130559245|NCT03083847|470016448|FG009|Main|Withdrawal by Subject|0|||
130559246|NCT01949155|470016450|FG000|Overall Study|Lost to Follow-up|1|||
130559247|NCT01949155|470016451|FG001|Overall Study|Lost to Follow-up|0|||
130559248|NCT01949155|470016450|FG000|Overall Study|Protocol Violation|1|||
130559249|NCT01949155|470016451|FG001|Overall Study|Protocol Violation|0|||
130559250|NCT00314249|470016452|FG000|Overall Study|Adverse Event|73|||
130559251|NCT00314249|470016453|FG001|Overall Study|Adverse Event|94|||
130559252|NCT00314249|470016452|FG000|Overall Study|Lack of Efficacy|33|||
130559253|NCT00314249|470016453|FG001|Overall Study|Lack of Efficacy|24|||
130719913|NCT03845296|470599640|FG001|Overall Study|Progression/relapse|18|||
130719914|NCT03845296|470599639|FG000|Overall Study|Death|4|||
130719915|NCT03845296|470599640|FG001|Overall Study|Death|0|||
130719916|NCT03845296|470599639|FG000|Overall Study|Other - not protocol specified|1|||
130719917|NCT03845296|470599640|FG001|Overall Study|Other - not protocol specified|3|||
130719918|NCT05091307|470599641|FG000|Overall Study|Death|0|||
130719919|NCT05091307|470599642|FG001|Overall Study|Death|0|||
130719920|NCT05091307|470599643|FG002|Overall Study|Death|1|||
130719921|NCT05091307|470599644|FG003|Overall Study|Death|0|||
130719922|NCT05091307|470599641|FG000|Overall Study|Lost to Follow-up|33|||
130719923|NCT05091307|470599642|FG001|Overall Study|Lost to Follow-up|33|||
130719924|NCT05091307|470599643|FG002|Overall Study|Lost to Follow-up|2|||
130719925|NCT05091307|470599644|FG003|Overall Study|Lost to Follow-up|0|||
130719926|NCT05091307|470599641|FG000|Overall Study|Physician Decision|1|||
130719927|NCT05091307|470599642|FG001|Overall Study|Physician Decision|0|||
130719928|NCT05091307|470599643|FG002|Overall Study|Physician Decision|0|||
130719929|NCT05091307|470599644|FG003|Overall Study|Physician Decision|0|||
130719930|NCT05091307|470599641|FG000|Overall Study|Protocol Violation|1|||
130719931|NCT05091307|470599642|FG001|Overall Study|Protocol Violation|0|||
130719932|NCT05091307|470599643|FG002|Overall Study|Protocol Violation|0|||
130719933|NCT05091307|470599644|FG003|Overall Study|Protocol Violation|0|||
130719934|NCT05091307|470599641|FG000|Overall Study|Withdrawal by Subject|16|||
130719935|NCT05091307|470599642|FG001|Overall Study|Withdrawal by Subject|16|||
130719936|NCT05091307|470599643|FG002|Overall Study|Withdrawal by Subject|0|||
130719937|NCT05091307|470599644|FG003|Overall Study|Withdrawal by Subject|1|||
130719938|NCT05091307|470599641|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
130719939|NCT05091307|470599642|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
130719940|NCT05091307|470599643|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
130719941|NCT05091307|470599644|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
130719942|NCT05091307|470599641|FG000|Overall Study|Initiated Prohibited Medication|1|||
130719943|NCT05091307|470599642|FG001|Overall Study|Initiated Prohibited Medication|0|||
130719944|NCT05091307|470599643|FG002|Overall Study|Initiated Prohibited Medication|0|||
130719945|NCT05091307|470599644|FG003|Overall Study|Initiated Prohibited Medication|0|||
130719946|NCT05091307|470599641|FG000|Overall Study|Other|4|||
130719947|NCT05091307|470599642|FG001|Overall Study|Other|4|||
130719948|NCT05091307|470599643|FG002|Overall Study|Other|0|||
130719949|NCT05091307|470599644|FG003|Overall Study|Other|0|||
130719950|NCT05091307|470599641|FG000|Overall Study|Randomized but not vaccinated|0|||
130719951|NCT05091307|470599642|FG001|Overall Study|Randomized but not vaccinated|2|||
130719952|NCT05091307|470599643|FG002|Overall Study|Randomized but not vaccinated|0|||
130719953|NCT05091307|470599644|FG003|Overall Study|Randomized but not vaccinated|0|||
130719954|NCT03611543|470599647|FG000|Overall Study|Withdrawal by Subject|4|||
130719955|NCT03611543|470599648|FG001|Overall Study|Withdrawal by Subject|4|||
130719956|NCT03611543|470599647|FG000|Overall Study|Physician Decision|1|||
130719957|NCT03611543|470599648|FG001|Overall Study|Physician Decision|1|||
130719958|NCT03611543|470599647|FG000|Overall Study|Protocol Violation|2|||
130719959|NCT03611543|470599648|FG001|Overall Study|Protocol Violation|2|||
130719960|NCT03611543|470599647|FG000|Overall Study|Device failure|2|||
130719961|NCT03611543|470599648|FG001|Overall Study|Device failure|2|||
130719962|NCT03611543|470599647|FG000|Overall Study|Missing information|5|||
130719963|NCT03611543|470599648|FG001|Overall Study|Missing information|5|||
130719964|NCT02081209|470599649|FG000|Overall Study|Withdrawal by Subject|1|||
130719965|NCT02799095|470599657|FG000|Part A|Adverse Event|1|||
130719966|NCT02799095|470599658|FG001|Part A|Adverse Event|0|||
130719967|NCT02799095|470599659|FG002|Part A|Adverse Event|1|||
130719968|NCT02799095|470599660|FG003|Part A|Adverse Event|4|||
130719969|NCT02799095|470599661|FG004|Part A|Adverse Event|1|||
130719970|NCT02799095|470599662|FG005|Part A|Adverse Event|0|||
130719971|NCT02799095|470599663|FG006|Part A|Adverse Event|0|||
130719972|NCT02799095|470599664|FG007|Part A|Adverse Event|0|||
130719973|NCT02799095|470599665|FG008|Part A|Adverse Event|0|||
130719974|NCT02799095|470599666|FG009|Part A|Adverse Event|0|||
130719975|NCT02799095|470599667|FG010|Part A|Adverse Event|0|||
130719976|NCT02799095|470599668|FG011|Part A|Adverse Event|0|||
130719977|NCT02799095|470599669|FG012|Part A|Adverse Event|0|||
130719978|NCT02799095|470599670|FG013|Part A|Adverse Event|0|||
130719979|NCT02799095|470599671|FG014|Part A|Adverse Event|0|||
130719980|NCT02799095|470599672|FG015|Part A|Adverse Event|0|||
130719981|NCT02799095|470599673|FG016|Part A|Adverse Event|0|||
130719982|NCT02799095|470599657|FG000|Part A|Death|0|||
130719983|NCT02799095|470599658|FG001|Part A|Death|0|||
130719984|NCT02799095|470599659|FG002|Part A|Death|0|||
130719985|NCT02799095|470599660|FG003|Part A|Death|0|||
130719986|NCT02799095|470599661|FG004|Part A|Death|0|||
130719987|NCT02799095|470599662|FG005|Part A|Death|0|||
130719988|NCT02799095|470599663|FG006|Part A|Death|3|||
130719989|NCT02799095|470599664|FG007|Part A|Death|0|||
130719990|NCT02799095|470599665|FG008|Part A|Death|0|||
130719991|NCT02799095|470599666|FG009|Part A|Death|0|||
130719992|NCT02799095|470599667|FG010|Part A|Death|0|||
130719993|NCT02799095|470599668|FG011|Part A|Death|0|||
130719994|NCT02799095|470599669|FG012|Part A|Death|0|||
130719995|NCT02799095|470599670|FG013|Part A|Death|0|||
130719996|NCT02799095|470599671|FG014|Part A|Death|0|||
130719997|NCT02799095|470599672|FG015|Part A|Death|0|||
130719998|NCT02799095|470599673|FG016|Part A|Death|0|||
130719999|NCT02799095|470599657|FG000|Part A|Lost to Follow-up|0|||
130720000|NCT02799095|470599658|FG001|Part A|Lost to Follow-up|1|||
130720001|NCT02799095|470599659|FG002|Part A|Lost to Follow-up|0|||
130720002|NCT02799095|470599660|FG003|Part A|Lost to Follow-up|0|||
130720003|NCT02799095|470599661|FG004|Part A|Lost to Follow-up|0|||
130720004|NCT02799095|470599662|FG005|Part A|Lost to Follow-up|0|||
130720005|NCT02799095|470599663|FG006|Part A|Lost to Follow-up|1|||
130720006|NCT02799095|470599664|FG007|Part A|Lost to Follow-up|0|||
130720007|NCT02799095|470599665|FG008|Part A|Lost to Follow-up|0|||
130720008|NCT02799095|470599666|FG009|Part A|Lost to Follow-up|0|||
130720009|NCT02799095|470599667|FG010|Part A|Lost to Follow-up|0|||
130720010|NCT02799095|470599668|FG011|Part A|Lost to Follow-up|0|||
130720011|NCT02799095|470599669|FG012|Part A|Lost to Follow-up|0|||
130720012|NCT02799095|470599670|FG013|Part A|Lost to Follow-up|0|||
130720013|NCT02799095|470599671|FG014|Part A|Lost to Follow-up|0|||
130720014|NCT02799095|470599672|FG015|Part A|Lost to Follow-up|0|||
130720015|NCT02799095|470599673|FG016|Part A|Lost to Follow-up|0|||
130720016|NCT02799095|470599657|FG000|Part A|Progressive Disease|3|||
130720017|NCT02799095|470599658|FG001|Part A|Progressive Disease|3|||
130720018|NCT02799095|470599659|FG002|Part A|Progressive Disease|3|||
130720019|NCT02799095|470599660|FG003|Part A|Progressive Disease|2|||
130720020|NCT02799095|470599661|FG004|Part A|Progressive Disease|2|||
130720021|NCT02799095|470599662|FG005|Part A|Progressive Disease|0|||
130720022|NCT02799095|470599663|FG006|Part A|Progressive Disease|0|||
130720023|NCT02799095|470599664|FG007|Part A|Progressive Disease|0|||
130720024|NCT02799095|470599665|FG008|Part A|Progressive Disease|0|||
130720025|NCT02799095|470599666|FG009|Part A|Progressive Disease|0|||
130720026|NCT02799095|470599667|FG010|Part A|Progressive Disease|0|||
130720027|NCT02799095|470599668|FG011|Part A|Progressive Disease|0|||
130720028|NCT02799095|470599669|FG012|Part A|Progressive Disease|0|||
130720029|NCT02799095|470599670|FG013|Part A|Progressive Disease|0|||
130720030|NCT02799095|470599671|FG014|Part A|Progressive Disease|0|||
130720031|NCT02799095|470599672|FG015|Part A|Progressive Disease|0|||
130720032|NCT02799095|470599673|FG016|Part A|Progressive Disease|0|||
130720033|NCT02799095|470599657|FG000|Part A|Clinical Progression|1|||
130720034|NCT02799095|470599658|FG001|Part A|Clinical Progression|0|||
130720035|NCT02799095|470599659|FG002|Part A|Clinical Progression|2|||
130720036|NCT02799095|470599660|FG003|Part A|Clinical Progression|1|||
130720037|NCT02799095|470599661|FG004|Part A|Clinical Progression|5|||
130720038|NCT02799095|470599662|FG005|Part A|Clinical Progression|0|||
130720039|NCT02799095|470599663|FG006|Part A|Clinical Progression|0|||
130720040|NCT02799095|470599664|FG007|Part A|Clinical Progression|0|||
130720041|NCT02799095|470599665|FG008|Part A|Clinical Progression|0|||
130720042|NCT02799095|470599666|FG009|Part A|Clinical Progression|0|||
130720043|NCT02799095|470599667|FG010|Part A|Clinical Progression|0|||
130720044|NCT02799095|470599668|FG011|Part A|Clinical Progression|0|||
130720045|NCT02799095|470599669|FG012|Part A|Clinical Progression|0|||
130720046|NCT02799095|470599670|FG013|Part A|Clinical Progression|0|||
130720047|NCT02799095|470599671|FG014|Part A|Clinical Progression|0|||
130720048|NCT02799095|470599672|FG015|Part A|Clinical Progression|0|||
130720049|NCT02799095|470599673|FG016|Part A|Clinical Progression|0|||
130720050|NCT02799095|470599657|FG000|Part A|Protocol Deviation|0|||
130720051|NCT02799095|470599658|FG001|Part A|Protocol Deviation|0|||
130720052|NCT02799095|470599659|FG002|Part A|Protocol Deviation|1|||
130720053|NCT02799095|470599660|FG003|Part A|Protocol Deviation|0|||
130720054|NCT02799095|470599661|FG004|Part A|Protocol Deviation|0|||
130720055|NCT02799095|470599662|FG005|Part A|Protocol Deviation|0|||
130720056|NCT02799095|470599663|FG006|Part A|Protocol Deviation|0|||
130466505|NCT03036813|469674830|FG002|Overall Study|Non-Compliance|3|||
130466506|NCT03036813|469674828|FG000|Overall Study|Pregnancy|0|||
130466507|NCT03036813|469674829|FG001|Overall Study|Pregnancy|0|||
130720057|NCT02799095|470599664|FG007|Part A|Protocol Deviation|0|||
130720058|NCT02799095|470599665|FG008|Part A|Protocol Deviation|0|||
130720059|NCT02799095|470599666|FG009|Part A|Protocol Deviation|0|||
130720060|NCT02799095|470599667|FG010|Part A|Protocol Deviation|0|||
130720061|NCT02799095|470599668|FG011|Part A|Protocol Deviation|0|||
130720062|NCT02799095|470599669|FG012|Part A|Protocol Deviation|0|||
130720063|NCT02799095|470599670|FG013|Part A|Protocol Deviation|0|||
130720064|NCT02799095|470599671|FG014|Part A|Protocol Deviation|0|||
130720065|NCT02799095|470599672|FG015|Part A|Protocol Deviation|0|||
130720066|NCT02799095|470599673|FG016|Part A|Protocol Deviation|0|||
130720067|NCT02799095|470599657|FG000|Part A|Withdrawal by Subject|0|||
130720068|NCT02799095|470599658|FG001|Part A|Withdrawal by Subject|0|||
130720069|NCT02799095|470599659|FG002|Part A|Withdrawal by Subject|0|||
130720070|NCT02799095|470599660|FG003|Part A|Withdrawal by Subject|1|||
130720071|NCT02799095|470599661|FG004|Part A|Withdrawal by Subject|3|||
130720072|NCT02799095|470599662|FG005|Part A|Withdrawal by Subject|1|||
130720073|NCT02799095|470599663|FG006|Part A|Withdrawal by Subject|1|||
130720074|NCT02799095|470599664|FG007|Part A|Withdrawal by Subject|0|||
130720075|NCT02799095|470599665|FG008|Part A|Withdrawal by Subject|0|||
130720076|NCT02799095|470599666|FG009|Part A|Withdrawal by Subject|0|||
130314680|NCT02920892|469118340|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
130314681|NCT02920892|469118341|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
130314682|NCT02920892|469118339|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130314683|NCT02920892|469118340|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
130314684|NCT02920892|469118341|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130720077|NCT02799095|470599667|FG010|Part A|Withdrawal by Subject|0|||
130720078|NCT02799095|470599668|FG011|Part A|Withdrawal by Subject|0|||
130720079|NCT02799095|470599669|FG012|Part A|Withdrawal by Subject|0|||
130720080|NCT02799095|470599670|FG013|Part A|Withdrawal by Subject|0|||
130720081|NCT02799095|470599671|FG014|Part A|Withdrawal by Subject|0|||
130720082|NCT02799095|470599672|FG015|Part A|Withdrawal by Subject|0|||
130720083|NCT02799095|470599673|FG016|Part A|Withdrawal by Subject|0|||
130720084|NCT02799095|470599657|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
130720085|NCT02799095|470599658|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
130720086|NCT02799095|470599659|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
130720087|NCT02799095|470599660|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
130720088|NCT02799095|470599661|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
130720089|NCT02799095|470599662|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
130720090|NCT02799095|470599663|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
130720091|NCT02799095|470599664|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
130720092|NCT02799095|470599665|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
130720093|NCT02799095|470599666|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
130720094|NCT02799095|470599667|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
130720095|NCT02799095|470599668|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
130720096|NCT02799095|470599669|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
130720097|NCT02799095|470599670|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
130720098|NCT02799095|470599671|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
130720099|NCT02799095|470599672|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
130720100|NCT02799095|470599673|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
130720101|NCT02799095|470599657|FG000|Part B|Death|0|||
130720102|NCT02799095|470599658|FG001|Part B|Death|0|||
130720103|NCT02799095|470599659|FG002|Part B|Death|0|||
130720104|NCT02799095|470599660|FG003|Part B|Death|0|||
130720105|NCT02799095|470599661|FG004|Part B|Death|0|||
130720106|NCT02799095|470599662|FG005|Part B|Death|0|||
130720107|NCT02799095|470599663|FG006|Part B|Death|0|||
130720108|NCT02799095|470599664|FG007|Part B|Death|7|||
130720109|NCT02799095|470599665|FG008|Part B|Death|7|||
130720110|NCT02799095|470599666|FG009|Part B|Death|0|||
130720111|NCT02799095|470599667|FG010|Part B|Death|0|||
130720112|NCT02799095|470599668|FG011|Part B|Death|0|||
130720113|NCT02799095|470599669|FG012|Part B|Death|0|||
130720114|NCT02799095|470599670|FG013|Part B|Death|0|||
130720115|NCT02799095|470599671|FG014|Part B|Death|0|||
130720116|NCT02799095|470599672|FG015|Part B|Death|0|||
130720117|NCT02799095|470599673|FG016|Part B|Death|0|||
130720118|NCT02799095|470599657|FG000|Part B|Progressive Disease|0|||
130720119|NCT02799095|470599658|FG001|Part B|Progressive Disease|0|||
130720120|NCT02799095|470599659|FG002|Part B|Progressive Disease|0|||
130720121|NCT02799095|470599660|FG003|Part B|Progressive Disease|0|||
130720122|NCT02799095|470599661|FG004|Part B|Progressive Disease|0|||
130720123|NCT02799095|470599662|FG005|Part B|Progressive Disease|0|||
130720124|NCT02799095|470599663|FG006|Part B|Progressive Disease|0|||
130720125|NCT02799095|470599664|FG007|Part B|Progressive Disease|1|||
130720126|NCT02799095|470599665|FG008|Part B|Progressive Disease|0|||
130720127|NCT02799095|470599666|FG009|Part B|Progressive Disease|0|||
130720128|NCT02799095|470599667|FG010|Part B|Progressive Disease|0|||
130720129|NCT02799095|470599668|FG011|Part B|Progressive Disease|0|||
130720130|NCT02799095|470599669|FG012|Part B|Progressive Disease|0|||
130720131|NCT02799095|470599670|FG013|Part B|Progressive Disease|0|||
130314685|NCT02920892|469118339|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
130314686|NCT02920892|469118340|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
130466508|NCT03036813|469674830|FG002|Overall Study|Pregnancy|1|||
130720132|NCT02799095|470599671|FG014|Part B|Progressive Disease|0|||
130720133|NCT02799095|470599672|FG015|Part B|Progressive Disease|0|||
130720134|NCT02799095|470599673|FG016|Part B|Progressive Disease|0|||
130720135|NCT02799095|470599657|FG000|Part B|Withdrawal by Subject|0|||
130720136|NCT02799095|470599658|FG001|Part B|Withdrawal by Subject|0|||
130720137|NCT02799095|470599659|FG002|Part B|Withdrawal by Subject|0|||
130720138|NCT02799095|470599660|FG003|Part B|Withdrawal by Subject|0|||
130720139|NCT02799095|470599661|FG004|Part B|Withdrawal by Subject|0|||
130466509|NCT03036813|469674828|FG000|Overall Study|Other|0|||
130720140|NCT02799095|470599662|FG005|Part B|Withdrawal by Subject|0|||
130720141|NCT02799095|470599663|FG006|Part B|Withdrawal by Subject|0|||
130720142|NCT02799095|470599664|FG007|Part B|Withdrawal by Subject|10|||
130720143|NCT02799095|470599665|FG008|Part B|Withdrawal by Subject|7|||
130720144|NCT02799095|470599666|FG009|Part B|Withdrawal by Subject|0|||
130720145|NCT02799095|470599667|FG010|Part B|Withdrawal by Subject|0|||
130720146|NCT02799095|470599668|FG011|Part B|Withdrawal by Subject|0|||
130314687|NCT02920892|469118341|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
130314688|NCT04486235|469118342|FG000|Overall Study|Pregnancy|1|||
130314689|NCT04486235|469118343|FG001|Overall Study|Pregnancy|0|||
130314690|NCT04486235|469118342|FG000|Overall Study|Lost to Follow-up|1|||
130314691|NCT04486235|469118343|FG001|Overall Study|Lost to Follow-up|0|||
130314692|NCT01092728|469118344|FG000|Overall Study|Withdrawal by Subject|2|||
130314693|NCT01092728|469118345|FG001|Overall Study|Withdrawal by Subject|0|||
130314694|NCT01092728|469118344|FG000|Overall Study|Adverse Event|0|||
130314695|NCT01092728|469118345|FG001|Overall Study|Adverse Event|1|||
130314696|NCT01092728|469118344|FG000|Overall Study|Disease Progression|1|||
130314697|NCT01092728|469118345|FG001|Overall Study|Disease Progression|13|||
130314698|NCT01092728|469118344|FG000|Overall Study|Prohibited Concomitant Medications|1|||
130314699|NCT01092728|469118345|FG001|Overall Study|Prohibited Concomitant Medications|0|||
130314700|NCT00721396|469118346|FG000|Overall Study|Adverse Event|4|||
130314701|NCT00721396|469118347|FG001|Overall Study|Adverse Event|7|||
130314702|NCT00721396|469118348|FG002|Overall Study|Adverse Event|2|||
130314703|NCT00721396|469118349|FG003|Overall Study|Adverse Event|0|||
130314704|NCT00721396|469118346|FG000|Overall Study|Withdrawal by Subject|12|||
130314705|NCT00721396|469118347|FG001|Overall Study|Withdrawal by Subject|15|||
130314706|NCT00721396|469118348|FG002|Overall Study|Withdrawal by Subject|3|||
130314707|NCT00721396|469118349|FG003|Overall Study|Withdrawal by Subject|7|||
130314708|NCT00721396|469118346|FG000|Overall Study|Lost to Follow-up|7|||
130314709|NCT00721396|469118347|FG001|Overall Study|Lost to Follow-up|9|||
130314710|NCT00721396|469118348|FG002|Overall Study|Lost to Follow-up|3|||
130314711|NCT00721396|469118349|FG003|Overall Study|Lost to Follow-up|3|||
130314712|NCT00721396|469118346|FG000|Overall Study|Protocol Violation|4|||
130375394|NCT02324569|469341877|FG000|Overall Study|Lack of Efficacy|2|||
130375395|NCT02324569|469341878|FG001|Overall Study|Lack of Efficacy|3|||
130720147|NCT02799095|470599669|FG012|Part B|Withdrawal by Subject|0|||
130720148|NCT02799095|470599670|FG013|Part B|Withdrawal by Subject|0|||
130720149|NCT02799095|470599671|FG014|Part B|Withdrawal by Subject|0|||
130720150|NCT02799095|470599672|FG015|Part B|Withdrawal by Subject|0|||
130720151|NCT02799095|470599673|FG016|Part B|Withdrawal by Subject|0|||
130720152|NCT02799095|470599657|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
130720153|NCT02799095|470599658|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
130720154|NCT02799095|470599659|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
130720155|NCT02799095|470599660|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
130720156|NCT02799095|470599661|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
130720157|NCT02799095|470599662|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
130720158|NCT02799095|470599663|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
130720159|NCT02799095|470599664|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
130720160|NCT02799095|470599665|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
130720161|NCT02799095|470599666|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
130720162|NCT02799095|470599667|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
130720163|NCT02799095|470599668|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
130720164|NCT02799095|470599669|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
130720165|NCT02799095|470599670|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
130720166|NCT02799095|470599671|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
130720167|NCT02799095|470599672|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
130720168|NCT02799095|470599673|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
130720169|NCT02799095|470599657|FG000|Part C|Adverse Event|0|||
130720170|NCT02799095|470599658|FG001|Part C|Adverse Event|0|||
130720171|NCT02799095|470599659|FG002|Part C|Adverse Event|0|||
130720172|NCT02799095|470599660|FG003|Part C|Adverse Event|0|||
130720173|NCT02799095|470599661|FG004|Part C|Adverse Event|0|||
130314713|NCT00721396|469118347|FG001|Overall Study|Protocol Violation|3|||
130375396|NCT02324569|469341877|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
130375397|NCT02324569|469341878|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
130375398|NCT02324569|469341877|FG000|Overall Study|Inconvenient Schedule|2|||
130375399|NCT02324569|469341878|FG001|Overall Study|Inconvenient Schedule|0|||
130375400|NCT01943292|469341885|FG000|Overall Study|Withdrawal by Subject|1|||
130375401|NCT01943292|469341886|FG001|Overall Study|Withdrawal by Subject|0|||
130375402|NCT01943292|469341887|FG002|Overall Study|Withdrawal by Subject|0|||
130375403|NCT00911820|469341888|FG000|Overall Study|RECIST progression|12|||
130314714|NCT00721396|469118348|FG002|Overall Study|Protocol Violation|1|||
130314715|NCT00721396|469118349|FG003|Overall Study|Protocol Violation|0|||
130314716|NCT00721396|469118346|FG000|Overall Study|Inappropriate enrollment|0|||
130314717|NCT00721396|469118347|FG001|Overall Study|Inappropriate enrollment|2|||
130314718|NCT00721396|469118348|FG002|Overall Study|Inappropriate enrollment|0|||
130314719|NCT00721396|469118349|FG003|Overall Study|Inappropriate enrollment|0|||
130375404|NCT00911820|469341889|FG001|Overall Study|RECIST progression|8|||
130720174|NCT02799095|470599662|FG005|Part C|Adverse Event|0|||
130720175|NCT02799095|470599663|FG006|Part C|Adverse Event|0|||
130720176|NCT02799095|470599664|FG007|Part C|Adverse Event|0|||
130720177|NCT02799095|470599665|FG008|Part C|Adverse Event|0|||
130720178|NCT02799095|470599666|FG009|Part C|Adverse Event|0|||
130720179|NCT02799095|470599667|FG010|Part C|Adverse Event|3|||
130720180|NCT02799095|470599668|FG011|Part C|Adverse Event|1|||
130375405|NCT00911820|469341888|FG000|Overall Study|Adverse Event|8|||
130720181|NCT02799095|470599669|FG012|Part C|Adverse Event|0|||
130720182|NCT02799095|470599670|FG013|Part C|Adverse Event|1|||
130720183|NCT02799095|470599671|FG014|Part C|Adverse Event|0|||
130720184|NCT02799095|470599672|FG015|Part C|Adverse Event|0|||
130720185|NCT02799095|470599673|FG016|Part C|Adverse Event|0|||
130720186|NCT02799095|470599657|FG000|Part C|Death|0|||
130720187|NCT02799095|470599658|FG001|Part C|Death|0|||
130720188|NCT02799095|470599659|FG002|Part C|Death|0|||
130720189|NCT02799095|470599660|FG003|Part C|Death|0|||
130720190|NCT02799095|470599661|FG004|Part C|Death|0|||
130720191|NCT02799095|470599662|FG005|Part C|Death|0|||
130720192|NCT02799095|470599663|FG006|Part C|Death|0|||
130720193|NCT02799095|470599664|FG007|Part C|Death|0|||
130720194|NCT02799095|470599665|FG008|Part C|Death|0|||
130720195|NCT02799095|470599666|FG009|Part C|Death|0|||
130720196|NCT02799095|470599667|FG010|Part C|Death|7|||
130720197|NCT02799095|470599668|FG011|Part C|Death|5|||
130720198|NCT02799095|470599669|FG012|Part C|Death|6|||
130720199|NCT02799095|470599670|FG013|Part C|Death|8|||
130720200|NCT02799095|470599671|FG014|Part C|Death|1|||
130720201|NCT02799095|470599672|FG015|Part C|Death|8|||
130720202|NCT02799095|470599673|FG016|Part C|Death|1|||
130720203|NCT02799095|470599657|FG000|Part C|Lost to Follow-up|0|||
130720204|NCT02799095|470599658|FG001|Part C|Lost to Follow-up|0|||
130720205|NCT02799095|470599659|FG002|Part C|Lost to Follow-up|0|||
130720206|NCT02799095|470599660|FG003|Part C|Lost to Follow-up|0|||
130375406|NCT00911820|469341889|FG001|Overall Study|Adverse Event|8|||
130720207|NCT02799095|470599661|FG004|Part C|Lost to Follow-up|0|||
130375407|NCT00911820|469341888|FG000|Overall Study|Clinical Progression|7|||
130375408|NCT00911820|469341889|FG001|Overall Study|Clinical Progression|5|||
130375409|NCT00911820|469341888|FG000|Overall Study|Physician Decision|5|||
130375410|NCT00911820|469341889|FG001|Overall Study|Physician Decision|9|||
130375411|NCT00911820|469341888|FG000|Overall Study|Decline in Performance Status|4|||
130375412|NCT00911820|469341889|FG001|Overall Study|Decline in Performance Status|2|||
130375413|NCT00911820|469341888|FG000|Overall Study|Withdrawal by Subject|3|||
130375414|NCT00911820|469341889|FG001|Overall Study|Withdrawal by Subject|4|||
130375415|NCT00911820|469341888|FG000|Overall Study|Death|1|||
130375416|NCT00911820|469341889|FG001|Overall Study|Death|2|||
130375417|NCT00911820|469341888|FG000|Overall Study|Pursue surgery|1|||
130375418|NCT00911820|469341889|FG001|Overall Study|Pursue surgery|1|||
130375419|NCT00911820|469341888|FG000|Overall Study|Pursue Radiation|1|||
130375420|NCT00911820|469341889|FG001|Overall Study|Pursue Radiation|0|||
130375421|NCT00911820|469341888|FG000|Overall Study|Still on Therapy|2|||
130375422|NCT00911820|469341889|FG001|Overall Study|Still on Therapy|2|||
130375423|NCT00911820|469341888|FG000|Overall Study|Pathology Not Confirmed|1|||
130375424|NCT00911820|469341889|FG001|Overall Study|Pathology Not Confirmed|0|||
130375425|NCT00911820|469341888|FG000|Overall Study|Withdraw before Receive Treatment|0|||
130375426|NCT00911820|469341889|FG001|Overall Study|Withdraw before Receive Treatment|2|||
130375427|NCT01852110|469341890|FG000|Overall Study|Adverse Event|12|||
130375428|NCT01852110|469341891|FG001|Overall Study|Adverse Event|5|||
130375429|NCT01852110|469341892|FG002|Overall Study|Adverse Event|0|||
130375430|NCT01852110|469341893|FG003|Overall Study|Adverse Event|0|||
130375431|NCT01852110|469341894|FG004|Overall Study|Adverse Event|0|||
130375432|NCT01852110|469341895|FG005|Overall Study|Adverse Event|0|||
130375433|NCT01852110|469341890|FG000|Overall Study|Lost to Follow-up|1|||
130375434|NCT01852110|469341891|FG001|Overall Study|Lost to Follow-up|3|||
130375435|NCT01852110|469341892|FG002|Overall Study|Lost to Follow-up|0|||
130375436|NCT01852110|469341893|FG003|Overall Study|Lost to Follow-up|0|||
130375437|NCT01852110|469341894|FG004|Overall Study|Lost to Follow-up|0|||
130375438|NCT01852110|469341895|FG005|Overall Study|Lost to Follow-up|0|||
130375439|NCT01852110|469341890|FG000|Overall Study|Non-compliance with Study Drug|2|||
130375440|NCT01852110|469341891|FG001|Overall Study|Non-compliance with Study Drug|1|||
130375441|NCT01852110|469341892|FG002|Overall Study|Non-compliance with Study Drug|0|||
130375442|NCT01852110|469341893|FG003|Overall Study|Non-compliance with Study Drug|0|||
130375443|NCT01852110|469341894|FG004|Overall Study|Non-compliance with Study Drug|0|||
130375444|NCT01852110|469341895|FG005|Overall Study|Non-compliance with Study Drug|0|||
130375445|NCT01852110|469341890|FG000|Overall Study|Physician Decision|1|||
130375446|NCT01852110|469341891|FG001|Overall Study|Physician Decision|0|||
130720208|NCT02799095|470599662|FG005|Part C|Lost to Follow-up|0|||
130375447|NCT01852110|469341892|FG002|Overall Study|Physician Decision|0|||
130375448|NCT01852110|469341893|FG003|Overall Study|Physician Decision|0|||
130375449|NCT01852110|469341894|FG004|Overall Study|Physician Decision|0|||
130720209|NCT02799095|470599663|FG006|Part C|Lost to Follow-up|0|||
130720210|NCT02799095|470599664|FG007|Part C|Lost to Follow-up|0|||
130720211|NCT02799095|470599665|FG008|Part C|Lost to Follow-up|0|||
130720212|NCT02799095|470599666|FG009|Part C|Lost to Follow-up|0|||
130720213|NCT02799095|470599667|FG010|Part C|Lost to Follow-up|1|||
130720214|NCT02799095|470599668|FG011|Part C|Lost to Follow-up|1|||
130720215|NCT02799095|470599669|FG012|Part C|Lost to Follow-up|1|||
130720216|NCT02799095|470599670|FG013|Part C|Lost to Follow-up|3|||
130720217|NCT02799095|470599671|FG014|Part C|Lost to Follow-up|0|||
130720218|NCT02799095|470599672|FG015|Part C|Lost to Follow-up|0|||
130720219|NCT02799095|470599673|FG016|Part C|Lost to Follow-up|0|||
130720220|NCT02799095|470599657|FG000|Part C|Progressive Disease|0|||
130720221|NCT02799095|470599658|FG001|Part C|Progressive Disease|0|||
130720222|NCT02799095|470599659|FG002|Part C|Progressive Disease|0|||
130720223|NCT02799095|470599660|FG003|Part C|Progressive Disease|0|||
130720224|NCT02799095|470599661|FG004|Part C|Progressive Disease|0|||
130720225|NCT02799095|470599662|FG005|Part C|Progressive Disease|0|||
130720226|NCT02799095|470599663|FG006|Part C|Progressive Disease|0|||
130720227|NCT02799095|470599664|FG007|Part C|Progressive Disease|0|||
130720228|NCT02799095|470599665|FG008|Part C|Progressive Disease|0|||
130720229|NCT02799095|470599666|FG009|Part C|Progressive Disease|2|||
130720230|NCT02799095|470599667|FG010|Part C|Progressive Disease|13|||
130720231|NCT02799095|470599668|FG011|Part C|Progressive Disease|2|||
130720232|NCT02799095|470599669|FG012|Part C|Progressive Disease|0|||
130720233|NCT02799095|470599670|FG013|Part C|Progressive Disease|1|||
130720234|NCT02799095|470599671|FG014|Part C|Progressive Disease|0|||
130720235|NCT02799095|470599672|FG015|Part C|Progressive Disease|0|||
130720236|NCT02799095|470599673|FG016|Part C|Progressive Disease|0|||
130720237|NCT02799095|470599657|FG000|Part C|Clinical Progression|0|||
130720238|NCT02799095|470599658|FG001|Part C|Clinical Progression|0|||
130720239|NCT02799095|470599659|FG002|Part C|Clinical Progression|0|||
130720240|NCT02799095|470599660|FG003|Part C|Clinical Progression|0|||
130720241|NCT02799095|470599661|FG004|Part C|Clinical Progression|0|||
130720242|NCT02799095|470599662|FG005|Part C|Clinical Progression|0|||
130720243|NCT02799095|470599663|FG006|Part C|Clinical Progression|0|||
130720244|NCT02799095|470599664|FG007|Part C|Clinical Progression|0|||
130720245|NCT02799095|470599665|FG008|Part C|Clinical Progression|0|||
130720246|NCT02799095|470599666|FG009|Part C|Clinical Progression|1|||
130720247|NCT02799095|470599667|FG010|Part C|Clinical Progression|3|||
130720248|NCT02799095|470599668|FG011|Part C|Clinical Progression|0|||
130720249|NCT02799095|470599669|FG012|Part C|Clinical Progression|0|||
130720250|NCT02799095|470599670|FG013|Part C|Clinical Progression|1|||
130720251|NCT02799095|470599671|FG014|Part C|Clinical Progression|0|||
130720252|NCT02799095|470599672|FG015|Part C|Clinical Progression|0|||
130720253|NCT02799095|470599673|FG016|Part C|Clinical Progression|0|||
130720254|NCT02799095|470599657|FG000|Part C|Withdrawal by Subject|0|||
130720255|NCT02799095|470599658|FG001|Part C|Withdrawal by Subject|0|||
130720256|NCT02799095|470599659|FG002|Part C|Withdrawal by Subject|0|||
130720257|NCT02799095|470599660|FG003|Part C|Withdrawal by Subject|0|||
130720258|NCT02799095|470599661|FG004|Part C|Withdrawal by Subject|0|||
130720259|NCT02799095|470599662|FG005|Part C|Withdrawal by Subject|0|||
130720260|NCT02799095|470599663|FG006|Part C|Withdrawal by Subject|0|||
130720261|NCT02799095|470599664|FG007|Part C|Withdrawal by Subject|0|||
130720262|NCT02799095|470599665|FG008|Part C|Withdrawal by Subject|0|||
130375450|NCT01852110|469341895|FG005|Overall Study|Physician Decision|0|||
130375451|NCT01852110|469341890|FG000|Overall Study|Protocol Violation|0|||
130375452|NCT01852110|469341891|FG001|Overall Study|Protocol Violation|1|||
130375453|NCT01852110|469341892|FG002|Overall Study|Protocol Violation|0|||
130375454|NCT01852110|469341893|FG003|Overall Study|Protocol Violation|0|||
130375455|NCT01852110|469341894|FG004|Overall Study|Protocol Violation|0|||
130375456|NCT01852110|469341895|FG005|Overall Study|Protocol Violation|0|||
130375457|NCT01852110|469341890|FG000|Overall Study|Study Terminated by Sponsor|30|||
130375458|NCT01852110|469341891|FG001|Overall Study|Study Terminated by Sponsor|32|||
130375459|NCT01852110|469341892|FG002|Overall Study|Study Terminated by Sponsor|0|||
130375460|NCT01852110|469341893|FG003|Overall Study|Study Terminated by Sponsor|0|||
130375461|NCT01852110|469341894|FG004|Overall Study|Study Terminated by Sponsor|0|||
130375462|NCT01852110|469341895|FG005|Overall Study|Study Terminated by Sponsor|0|||
130375463|NCT01852110|469341890|FG000|Overall Study|Withdrawal by Subject|4|||
130466510|NCT03036813|469674829|FG001|Overall Study|Other|3|||
130466511|NCT03036813|469674830|FG002|Overall Study|Other|5|||
130466512|NCT00785512|469674831|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
130466513|NCT00785512|469674832|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
130466514|NCT00785512|469674831|FG000|Overall Study|Adverse Event|0|||
130466515|NCT00785512|469674832|FG001|Overall Study|Adverse Event|0|||
130466516|NCT00785512|469674831|FG000|Overall Study|Lack of Efficacy|0|||
130466517|NCT00785512|469674832|FG001|Overall Study|Lack of Efficacy|2|||
130466518|NCT00785512|469674831|FG000|Overall Study|Withdrawal by Subject|0|||
130375464|NCT01852110|469341891|FG001|Overall Study|Withdrawal by Subject|4|||
130720263|NCT02799095|470599666|FG009|Part C|Withdrawal by Subject|0|||
130720264|NCT02799095|470599667|FG010|Part C|Withdrawal by Subject|13|||
130720265|NCT02799095|470599668|FG011|Part C|Withdrawal by Subject|15|||
130720266|NCT02799095|470599669|FG012|Part C|Withdrawal by Subject|13|||
130720267|NCT02799095|470599670|FG013|Part C|Withdrawal by Subject|21|||
130720268|NCT02799095|470599671|FG014|Part C|Withdrawal by Subject|0|||
130720269|NCT02799095|470599672|FG015|Part C|Withdrawal by Subject|12|||
130375465|NCT01852110|469341892|FG002|Overall Study|Withdrawal by Subject|0|||
130466519|NCT00785512|469674832|FG001|Overall Study|Withdrawal by Subject|1|||
130720270|NCT02799095|470599673|FG016|Part C|Withdrawal by Subject|1|||
130720271|NCT02799095|470599657|FG000|Part C|Physician Decision|0|||
130720272|NCT02799095|470599658|FG001|Part C|Physician Decision|0|||
130720273|NCT02799095|470599659|FG002|Part C|Physician Decision|0|||
130375466|NCT01852110|469341893|FG003|Overall Study|Withdrawal by Subject|0|||
130375467|NCT01852110|469341894|FG004|Overall Study|Withdrawal by Subject|0|||
130375468|NCT01852110|469341895|FG005|Overall Study|Withdrawal by Subject|0|||
130375469|NCT00410046|469341898|FG000|Overall Study|Adverse Event|3|||
130375470|NCT00410046|469341898|FG000|Overall Study|Withdrawal by Subject|1|||
130375471|NCT00410046|469341898|FG000|Overall Study|Lost to Follow-up|1|||
130375472|NCT03098550|469341899|FG000|Overall Study|Disease Progression|30|||
130375473|NCT03098550|469341900|FG001|Overall Study|Disease Progression|19|||
130375474|NCT03098550|469341901|FG002|Overall Study|Disease Progression|41|||
130375475|NCT03098550|469341899|FG000|Overall Study|Study Drug Toxicity|2|||
130375476|NCT03098550|469341900|FG001|Overall Study|Study Drug Toxicity|1|||
130559254|NCT00314249|470016452|FG000|Overall Study|Withdrawal by Subject|21|||
130559255|NCT00314249|470016453|FG001|Overall Study|Withdrawal by Subject|28|||
130559256|NCT00314249|470016452|FG000|Overall Study|Lost to Follow-up|15|||
130559257|NCT00314249|470016453|FG001|Overall Study|Lost to Follow-up|9|||
130559258|NCT00314249|470016452|FG000|Overall Study|Physician Decision|1|||
130559259|NCT00314249|470016453|FG001|Overall Study|Physician Decision|1|||
130559260|NCT00314249|470016452|FG000|Overall Study|Withdrawn for other reasons|4|||
130559261|NCT00314249|470016453|FG001|Overall Study|Withdrawn for other reasons|1|||
130559262|NCT00314249|470016452|FG000|Overall Study|Non-Compliant|5|||
130559263|NCT00314249|470016453|FG001|Overall Study|Non-Compliant|6|||
130559264|NCT00210184|470016454|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
130559265|NCT04060563|470016457|FG000|Overall Study|Lost to Follow-up|1|||
130559266|NCT04060563|470016458|FG001|Overall Study|Lost to Follow-up|1|||
130559267|NCT04060563|470016457|FG000|Overall Study|Physician Decision|0|||
130559268|NCT04060563|470016458|FG001|Overall Study|Physician Decision|1|||
130559269|NCT00851682|470016459|FG000|Overall Study|screen failure|5|||
130559270|NCT00851682|470016460|FG001|Overall Study|screen failure|0|||
130559271|NCT01379573|470016464|FG000|Overall Study|Lost to Follow-up|1|||
130559272|NCT01379573|470016464|FG000|Overall Study|Screen Failure|10|||
130559273|NCT00962390|470016465|FG000|Overall Study|Adverse Event|0|||
130375477|NCT03098550|469341901|FG002|Overall Study|Study Drug Toxicity|0|||
130375478|NCT03098550|469341899|FG000|Overall Study|Death|1|||
130375479|NCT03098550|469341900|FG001|Overall Study|Death|0|||
130375480|NCT03098550|469341901|FG002|Overall Study|Death|0|||
130375481|NCT03098550|469341899|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
130375482|NCT03098550|469341900|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
130375483|NCT03098550|469341901|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
130375484|NCT03098550|469341899|FG000|Overall Study|Administrative reason by sponsor|0|||
130466520|NCT00785512|469674831|FG000|Overall Study|Lost to Follow-up|3|||
130466521|NCT00785512|469674832|FG001|Overall Study|Lost to Follow-up|0|||
130466522|NCT00785512|469674831|FG000|Overall Study|Precedure Refused|0|||
130466523|NCT00785512|469674832|FG001|Overall Study|Precedure Refused|0|||
130466524|NCT00785512|469674831|FG000|Overall Study|IVRS Programing Error|0|||
130466525|NCT00785512|469674832|FG001|Overall Study|IVRS Programing Error|0|||
130466526|NCT00785512|469674831|FG000|Overall Study|Physician Decision|0|||
130466527|NCT00785512|469674832|FG001|Overall Study|Physician Decision|0|||
130466528|NCT00785512|469674831|FG000|Overall Study|Lack of compliance|0|||
130466529|NCT00785512|469674832|FG001|Overall Study|Lack of compliance|1|||
130466530|NCT00529100|469674836|FG000|Overall Study|Adverse Event|0|||
130466531|NCT00529100|469674837|FG001|Overall Study|Adverse Event|5|||
130466532|NCT00529100|469674836|FG000|Overall Study|Protocol Violation|0|||
130466533|NCT00529100|469674837|FG001|Overall Study|Protocol Violation|1|||
130466534|NCT00529100|469674836|FG000|Overall Study|Progressive Disease|0|||
130466535|NCT00529100|469674837|FG001|Overall Study|Progressive Disease|1|||
130466536|NCT00529100|469674836|FG000|Overall Study|Withdrawal by Subject|0|||
130466537|NCT00529100|469674837|FG001|Overall Study|Withdrawal by Subject|1|||
130466538|NCT00529100|469674836|FG000|Overall Study|Participant Ineligibility|0|||
130375485|NCT03098550|469341900|FG001|Overall Study|Administrative reason by sponsor|0|||
130375486|NCT03098550|469341901|FG002|Overall Study|Administrative reason by sponsor|1|||
130375487|NCT03098550|469341899|FG000|Overall Study|Other reasons|2|||
130375488|NCT03098550|469341900|FG001|Overall Study|Other reasons|0|||
130375489|NCT03098550|469341901|FG002|Overall Study|Other reasons|0|||
130466539|NCT00529100|469674837|FG001|Overall Study|Participant Ineligibility|1|||
130466540|NCT00807937|469674839|FG000|Overall Study|Adverse Event|12|||
130466541|NCT00807937|469674840|FG001|Overall Study|Adverse Event|12|||
130466542|NCT00807937|469674841|FG002|Overall Study|Adverse Event|5|||
130375490|NCT00684307|469341905|FG000|Overall Study|Adverse Event|11|||
130375491|NCT00684307|469341906|FG001|Overall Study|Adverse Event|6|||
130375492|NCT00684307|469341907|FG002|Overall Study|Adverse Event|15|||
130375493|NCT00684307|469341908|FG003|Overall Study|Adverse Event|16|||
130559274|NCT00962390|470016466|FG001|Overall Study|Adverse Event|0|||
130559275|NCT00962390|470016467|FG002|Overall Study|Adverse Event|3|||
130559276|NCT00962390|470016468|FG003|Overall Study|Adverse Event|1|||
130559277|NCT00962390|470016465|FG000|Overall Study|Lost to Follow-up|2|||
130559278|NCT00962390|470016466|FG001|Overall Study|Lost to Follow-up|2|||
130466543|NCT00807937|469674842|FG003|Overall Study|Adverse Event|4|||
130466544|NCT00807937|469674839|FG000|Overall Study|Protocol Violation|4|||
130314720|NCT00721396|469118346|FG000|Overall Study|Administrative reason|3|||
130375494|NCT00684307|469341909|FG004|Overall Study|Adverse Event|8|||
130375495|NCT00684307|469341905|FG000|Overall Study|Development of increasing Liver Function|0|||
130375496|NCT00684307|469341906|FG001|Overall Study|Development of increasing Liver Function|2|||
130375497|NCT00684307|469341907|FG002|Overall Study|Development of increasing Liver Function|0|||
130375498|NCT00684307|469341908|FG003|Overall Study|Development of increasing Liver Function|1|||
130375499|NCT00684307|469341909|FG004|Overall Study|Development of increasing Liver Function|0|||
130375500|NCT00684307|469341905|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
130375501|NCT00684307|469341906|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
130375502|NCT00684307|469341907|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
130375503|NCT00684307|469341908|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
130375504|NCT00684307|469341909|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
130375505|NCT00684307|469341905|FG000|Overall Study|Incorrect enrolment or randomization|4|||
130375506|NCT00684307|469341906|FG001|Overall Study|Incorrect enrolment or randomization|0|||
130375507|NCT00684307|469341907|FG002|Overall Study|Incorrect enrolment or randomization|0|||
130375508|NCT00684307|469341908|FG003|Overall Study|Incorrect enrolment or randomization|0|||
130375509|NCT00684307|469341909|FG004|Overall Study|Incorrect enrolment or randomization|0|||
130375510|NCT00684307|469341905|FG000|Overall Study|Interupted IP for more than 7 days|0|||
130375511|NCT00684307|469341906|FG001|Overall Study|Interupted IP for more than 7 days|4|||
130375512|NCT00684307|469341907|FG002|Overall Study|Interupted IP for more than 7 days|1|||
130375513|NCT00684307|469341908|FG003|Overall Study|Interupted IP for more than 7 days|3|||
130375514|NCT00684307|469341909|FG004|Overall Study|Interupted IP for more than 7 days|3|||
130375515|NCT00684307|469341905|FG000|Overall Study|Severe non compliance to protocol|1|||
130375516|NCT00684307|469341906|FG001|Overall Study|Severe non compliance to protocol|0|||
130375517|NCT00684307|469341907|FG002|Overall Study|Severe non compliance to protocol|0|||
130375518|NCT00684307|469341908|FG003|Overall Study|Severe non compliance to protocol|1|||
130375519|NCT00684307|469341909|FG004|Overall Study|Severe non compliance to protocol|2|||
130375520|NCT00684307|469341905|FG000|Overall Study|Participant not willing to continue|7|||
130375521|NCT00684307|469341906|FG001|Overall Study|Participant not willing to continue|10|||
130375522|NCT00684307|469341907|FG002|Overall Study|Participant not willing to continue|11|||
130375523|NCT00684307|469341908|FG003|Overall Study|Participant not willing to continue|5|||
130375524|NCT00684307|469341909|FG004|Overall Study|Participant not willing to continue|8|||
130375525|NCT00684307|469341905|FG000|Overall Study|Criteria from the CSR|0|||
130375526|NCT00684307|469341906|FG001|Overall Study|Criteria from the CSR|0|||
130375527|NCT00684307|469341907|FG002|Overall Study|Criteria from the CSR|1|||
130375528|NCT00684307|469341908|FG003|Overall Study|Criteria from the CSR|3|||
130375529|NCT00684307|469341909|FG004|Overall Study|Criteria from the CSR|3|||
130375530|NCT02430311|469341910|FG000|Part A|Adverse Event|0|||
130375531|NCT02430311|469341911|FG001|Part A|Adverse Event|1|||
130375532|NCT02430311|469341910|FG000|Part A|Withdrawal by Subject|1|||
130375533|NCT02430311|469341911|FG001|Part A|Withdrawal by Subject|0|||
130375534|NCT02430311|469341910|FG000|Part B|Meet study-specific withdrawal criteria|6|||
130375535|NCT02430311|469341911|FG001|Part B|Meet study-specific withdrawal criteria|6|||
130375536|NCT02430311|469341910|FG000|Part B|Withdrawal by Subject|2|||
130375537|NCT02430311|469341911|FG001|Part B|Withdrawal by Subject|2|||
130375538|NCT02430311|469341910|FG000|Part B|Adverse Event|1|||
130375539|NCT02430311|469341911|FG001|Part B|Adverse Event|0|||
130375540|NCT02430311|469341910|FG000|Part B|Death|1|||
130375541|NCT02430311|469341911|FG001|Part B|Death|0|||
130375542|NCT04160091|469341912|FG000|Overall Study|Terminated by Sponsor|7|||
130375543|NCT04160091|469341913|FG001|Overall Study|Terminated by Sponsor|3|||
130375544|NCT04160091|469341914|FG002|Overall Study|Terminated by Sponsor|5|||
130375545|NCT04160091|469341915|FG003|Overall Study|Terminated by Sponsor|2|||
130375546|NCT04160091|469341912|FG000|Overall Study|Noncompliance|0|||
130375547|NCT04160091|469341913|FG001|Overall Study|Noncompliance|0|||
130375548|NCT04160091|469341914|FG002|Overall Study|Noncompliance|0|||
130375549|NCT04160091|469341915|FG003|Overall Study|Noncompliance|1|||
130375550|NCT04160091|469341912|FG000|Overall Study|Withdrawal by Subject|0|||
130375551|NCT04160091|469341913|FG001|Overall Study|Withdrawal by Subject|0|||
130375552|NCT04160091|469341914|FG002|Overall Study|Withdrawal by Subject|0|||
130375553|NCT04160091|469341915|FG003|Overall Study|Withdrawal by Subject|1|||
130375554|NCT00381095|469341921|FG000|Overall Study|Death|3|||
130375555|NCT00381095|469341922|FG001|Overall Study|Death|4|||
130375556|NCT00381095|469341921|FG000|Overall Study|Lack of Efficacy|2|||
130375557|NCT00381095|469341922|FG001|Overall Study|Lack of Efficacy|4|||
130375558|NCT00381095|469341921|FG000|Overall Study|Other|2|||
130375559|NCT00381095|469341922|FG001|Overall Study|Other|2|||
130375560|NCT00381095|469341921|FG000|Overall Study|Protocol Violation|1|||
130375561|NCT00381095|469341922|FG001|Overall Study|Protocol Violation|1|||
130375562|NCT00381095|469341921|FG000|Overall Study|Withdrawal by Subject|3|||
130375563|NCT00381095|469341922|FG001|Overall Study|Withdrawal by Subject|3|||
130375564|NCT00381095|469341921|FG000|Overall Study|Adverse Event|2|||
130720274|NCT02799095|470599660|FG003|Part C|Physician Decision|0|||
130314721|NCT00721396|469118347|FG001|Overall Study|Administrative reason|0|||
130314722|NCT00721396|469118348|FG002|Overall Study|Administrative reason|1|||
130314723|NCT00721396|469118349|FG003|Overall Study|Administrative reason|0|||
130314724|NCT03546621|469118350|FG000|Overall Study|Withdrawal by Subject|0|||
130375565|NCT00381095|469341922|FG001|Overall Study|Adverse Event|7|||
130720275|NCT02799095|470599661|FG004|Part C|Physician Decision|0|||
130314725|NCT03546621|469118351|FG001|Overall Study|Withdrawal by Subject|1|||
130314726|NCT03546621|469118352|FG002|Overall Study|Withdrawal by Subject|2|||
130314727|NCT03546621|469118353|FG003|Overall Study|Withdrawal by Subject|1|||
130314728|NCT03546621|469118350|FG000|Overall Study|Lost to Follow-up|0|||
130314729|NCT03546621|469118351|FG001|Overall Study|Lost to Follow-up|1|||
130314730|NCT03546621|469118352|FG002|Overall Study|Lost to Follow-up|0|||
130314731|NCT03546621|469118353|FG003|Overall Study|Lost to Follow-up|0|||
130314732|NCT03546621|469118350|FG000|Overall Study|Adverse Event|0|||
130314733|NCT03546621|469118351|FG001|Overall Study|Adverse Event|1|||
130314734|NCT03546621|469118352|FG002|Overall Study|Adverse Event|0|||
130314735|NCT03546621|469118353|FG003|Overall Study|Adverse Event|1|||
130314736|NCT03546621|469118350|FG000|Overall Study|Progressive disease|0|||
130314737|NCT03546621|469118351|FG001|Overall Study|Progressive disease|0|||
130314738|NCT03546621|469118352|FG002|Overall Study|Progressive disease|0|||
130314739|NCT03546621|469118353|FG003|Overall Study|Progressive disease|1|||
130314740|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314741|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314742|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314743|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
130314744|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314745|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314746|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314747|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314748|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314749|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314750|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
130314751|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
130314752|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314753|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
130314754|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
130314755|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
130314756|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314757|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314758|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314759|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314760|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
130314761|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314762|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314763|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314764|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
130314765|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314766|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314767|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314768|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314769|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314770|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314771|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314772|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314773|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314774|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314775|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
130375566|NCT01104493|469341923|FG000|Overall Study|Lost to Follow-up|0|||
130375567|NCT01104493|469341924|FG001|Overall Study|Lost to Follow-up|2|||
130375568|NCT01342796|469341926|FG000|Overall Study|Withdrawal by Subject|2|||
130375569|NCT01342796|469341927|FG001|Overall Study|Withdrawal by Subject|0|||
130375570|NCT01342796|469341926|FG000|Overall Study|Lost to Follow-up|0|||
130375571|NCT01342796|469341927|FG001|Overall Study|Lost to Follow-up|3|||
130375572|NCT01342796|469341926|FG000|Overall Study|Inappropriate enrollment|1|||
130375573|NCT01342796|469341927|FG001|Overall Study|Inappropriate enrollment|0|||
130375574|NCT01599234|469341933|FG000|Overall Study|Adverse Event|9|||
130375575|NCT01599234|469341934|FG001|Overall Study|Adverse Event|5|||
130375576|NCT01599234|469341933|FG000|Overall Study|Withdrawal by Subject|2|||
130375577|NCT01599234|469341934|FG001|Overall Study|Withdrawal by Subject|1|||
130375578|NCT01599234|469341933|FG000|Overall Study|Lost to Follow-up|1|||
130720276|NCT02799095|470599662|FG005|Part C|Physician Decision|0|||
130720277|NCT02799095|470599663|FG006|Part C|Physician Decision|0|||
130720278|NCT02799095|470599664|FG007|Part C|Physician Decision|0|||
130720279|NCT02799095|470599665|FG008|Part C|Physician Decision|0|||
130720280|NCT02799095|470599666|FG009|Part C|Physician Decision|0|||
130720281|NCT02799095|470599667|FG010|Part C|Physician Decision|1|||
130720282|NCT02799095|470599668|FG011|Part C|Physician Decision|0|||
130720283|NCT02799095|470599669|FG012|Part C|Physician Decision|0|||
130720284|NCT02799095|470599670|FG013|Part C|Physician Decision|0|||
130720285|NCT02799095|470599671|FG014|Part C|Physician Decision|0|||
130720286|NCT02799095|470599672|FG015|Part C|Physician Decision|0|||
130720287|NCT02799095|470599673|FG016|Part C|Physician Decision|0|||
130720288|NCT02799095|470599657|FG000|Part C|Other|0|||
130720289|NCT02799095|470599658|FG001|Part C|Other|0|||
130720290|NCT02799095|470599659|FG002|Part C|Other|0|||
130314776|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
130720291|NCT02799095|470599660|FG003|Part C|Other|0|||
130720292|NCT02799095|470599661|FG004|Part C|Other|0|||
130720293|NCT02799095|470599662|FG005|Part C|Other|0|||
130720294|NCT02799095|470599663|FG006|Part C|Other|0|||
130720295|NCT02799095|470599664|FG007|Part C|Other|0|||
130720296|NCT02799095|470599665|FG008|Part C|Other|0|||
130720297|NCT02799095|470599666|FG009|Part C|Other|0|||
130720298|NCT02799095|470599667|FG010|Part C|Other|0|||
130720299|NCT02799095|470599668|FG011|Part C|Other|2|||
130720300|NCT02799095|470599669|FG012|Part C|Other|2|||
130720301|NCT02799095|470599670|FG013|Part C|Other|0|||
130720302|NCT02799095|470599671|FG014|Part C|Other|0|||
130720303|NCT02799095|470599672|FG015|Part C|Other|0|||
130720304|NCT02799095|470599673|FG016|Part C|Other|0|||
130720305|NCT03589768|470599681|FG000|Overall Study|Death|1|||
130720306|NCT03589768|470599682|FG001|Overall Study|Death|0|||
130720307|NCT03589768|470599683|FG002|Overall Study|Death|8|||
130720308|NCT03589768|470599684|FG003|Overall Study|Death|3|||
130720309|NCT03589768|470599681|FG000|Overall Study|Withdrawal by Subject|2|||
130720310|NCT03589768|470599682|FG001|Overall Study|Withdrawal by Subject|0|||
130720311|NCT03589768|470599683|FG002|Overall Study|Withdrawal by Subject|0|||
130720312|NCT03589768|470599684|FG003|Overall Study|Withdrawal by Subject|0|||
130720313|NCT03589768|470599681|FG000|Overall Study|Protocol Violation|1|||
130720314|NCT03589768|470599682|FG001|Overall Study|Protocol Violation|0|||
130720315|NCT03589768|470599683|FG002|Overall Study|Protocol Violation|0|||
130720316|NCT03589768|470599684|FG003|Overall Study|Protocol Violation|0|||
130720317|NCT00112866|470599685|FG000|Overall Study|Protocol Violation|1|||
130720318|NCT00112866|470599686|FG001|Overall Study|Protocol Violation|0|||
130720319|NCT00112866|470599685|FG000|Overall Study|did not start treatment post-op|1|||
130720320|NCT00112866|470599686|FG001|Overall Study|did not start treatment post-op|2|||
130720321|NCT02213510|470599689|FG000|Overall Study|Death|0|||
130720322|NCT02213510|470599690|FG001|Overall Study|Death|1|||
130720323|NCT02213510|470599689|FG000|Overall Study|Lost to Follow-up|1|||
130720324|NCT02213510|470599690|FG001|Overall Study|Lost to Follow-up|0|||
130720325|NCT01502410|470599693|FG000|Overall Study|Adverse Event|1|||
130720326|NCT01502410|470599694|FG001|Overall Study|Adverse Event|2|||
130720327|NCT01502410|470599695|FG002|Overall Study|Adverse Event|0|||
130720328|NCT01502410|470599696|FG003|Overall Study|Adverse Event|0|||
130720329|NCT01502410|470599693|FG000|Overall Study|Lack of Efficacy|7|||
130720330|NCT01502410|470599694|FG001|Overall Study|Lack of Efficacy|7|||
130720331|NCT01502410|470599695|FG002|Overall Study|Lack of Efficacy|0|||
130720332|NCT01502410|470599696|FG003|Overall Study|Lack of Efficacy|0|||
130720333|NCT01502410|470599693|FG000|Overall Study|Physician Decision|0|||
130720334|NCT01502410|470599694|FG001|Overall Study|Physician Decision|1|||
130720335|NCT01502410|470599695|FG002|Overall Study|Physician Decision|0|||
130720336|NCT01502410|470599696|FG003|Overall Study|Physician Decision|0|||
130720337|NCT01502410|470599693|FG000|Overall Study|Withdrawal by Subject|2|||
130720338|NCT01502410|470599694|FG001|Overall Study|Withdrawal by Subject|0|||
130720339|NCT01502410|470599695|FG002|Overall Study|Withdrawal by Subject|0|||
130720340|NCT01502410|470599696|FG003|Overall Study|Withdrawal by Subject|0|||
130720341|NCT02903030|470599697|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130314777|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314778|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314779|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314780|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130720342|NCT02903030|470599698|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130720343|NCT03786718|470599702|FG000|Overall Study|Lost to Follow-up|3|||
130720344|NCT03786718|470599702|FG000|Overall Study|Withdrawal by Subject|1|||
130720345|NCT03786718|470599702|FG000|Overall Study|Did not use the intervention|2|||
130720346|NCT03786718|470599702|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
130720347|NCT00754650|470599716|FG000|Overall Study|Disease Progression|2|||
130720348|NCT00805675|470599717|FG000|Overall Study|Adverse Event|0|||
130720349|NCT00805675|470599718|FG001|Overall Study|Adverse Event|0|||
130720350|NCT00805675|470599719|FG002|Overall Study|Adverse Event|1|||
130720351|NCT03537599|470599723|FG000|Overall Study|Disease Progression|2|||
130720352|NCT03537599|470599724|FG001|Overall Study|Disease Progression|1|||
130720353|NCT03537599|470599723|FG000|Overall Study|Death|0|||
130720354|NCT03537599|470599724|FG001|Overall Study|Death|1|||
130720355|NCT01007942|470599725|FG000|Overall Study|Adverse Event|29|||
130720356|NCT01007942|470599726|FG001|Overall Study|Adverse Event|14|||
130720357|NCT01007942|470599725|FG000|Overall Study|Abnormal test procedure|0|||
130720358|NCT01007942|470599726|FG001|Overall Study|Abnormal test procedure|1|||
130720359|NCT01007942|470599725|FG000|Overall Study|Disease progression|217|||
130720360|NCT01007942|470599726|FG001|Overall Study|Disease progression|242|||
130720361|NCT01007942|470599725|FG000|Overall Study|New cancer therapy|5|||
130720362|NCT01007942|470599726|FG001|Overall Study|New cancer therapy|1|||
130720363|NCT01007942|470599725|FG000|Overall Study|Protocol Violation|1|||
130720364|NCT01007942|470599726|FG001|Overall Study|Protocol Violation|1|||
130720365|NCT01007942|470599725|FG000|Overall Study|Withdrawal by Subject|19|||
130720366|NCT01007942|470599726|FG001|Overall Study|Withdrawal by Subject|14|||
130720367|NCT01007942|470599725|FG000|Overall Study|Lost to Follow-up|1|||
130720368|NCT01007942|470599726|FG001|Overall Study|Lost to Follow-up|0|||
130720369|NCT01007942|470599725|FG000|Overall Study|Administrative problems|2|||
130720370|NCT01007942|470599726|FG001|Overall Study|Administrative problems|0|||
130720371|NCT01007942|470599725|FG000|Overall Study|Death|3|||
130720372|NCT01007942|470599726|FG001|Overall Study|Death|2|||
130720373|NCT01007942|470599725|FG000|Overall Study|Patients untreated|4|||
130720374|NCT01007942|470599726|FG001|Overall Study|Patients untreated|3|||
130720375|NCT05083585|470599727|FG000|Overall Study|Death|1|||
130720376|NCT05083585|470599728|FG001|Overall Study|Death|1|||
130720377|NCT05083585|470599727|FG000|Overall Study|Lost to Follow-up|1|||
130720378|NCT05083585|470599728|FG001|Overall Study|Lost to Follow-up|1|||
130720379|NCT05083585|470599727|FG000|Overall Study|Withdrawal by Subject|2|||
130720380|NCT05083585|470599728|FG001|Overall Study|Withdrawal by Subject|0|||
130720381|NCT05083585|470599727|FG000|Overall Study|Randomized but not vaccinated|2|||
130720382|NCT05083585|470599728|FG001|Overall Study|Randomized but not vaccinated|0|||
130720383|NCT03929757|470599729|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
130720384|NCT03929757|470599730|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130720385|NCT03929757|470599731|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130720386|NCT03929757|470599729|FG000|Main Study: Up to Day 365|Other|1|||
130720387|NCT03929757|470599730|FG001|Main Study: Up to Day 365|Other|0|||
130720388|NCT03929757|470599731|FG002|Main Study: Up to Day 365|Other|0|||
130720389|NCT03929757|470599729|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130720390|NCT03929757|470599730|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130720391|NCT03929757|470599731|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
130720392|NCT00114166|470599732|FG000|Overall Study|Wrong primary|0|||
130720393|NCT00114166|470599733|FG001|Overall Study|Wrong primary|1|||
130720394|NCT00806286|470599734|FG000|Overall Study|Adverse Event|5|||
130720395|NCT00806286|470599735|FG001|Overall Study|Adverse Event|2|||
130314781|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314782|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
130314783|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314784|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130314785|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314786|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314787|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314788|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314789|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314790|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314791|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314792|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314793|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314794|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314795|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314796|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314797|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314798|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314799|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314800|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314801|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130720396|NCT00806286|470599736|FG002|Overall Study|Adverse Event|0|||
130720397|NCT00806286|470599734|FG000|Overall Study|Disease progression|31|||
130720398|NCT00806286|470599735|FG001|Overall Study|Disease progression|38|||
130720399|NCT00806286|470599736|FG002|Overall Study|Disease progression|1|||
130720400|NCT00806286|470599734|FG000|Overall Study|Death|1|||
130720401|NCT00806286|470599735|FG001|Overall Study|Death|6|||
130720402|NCT00806286|470599736|FG002|Overall Study|Death|0|||
130720403|NCT00806286|470599734|FG000|Overall Study|Lost to Follow-up|0|||
130720404|NCT00806286|470599735|FG001|Overall Study|Lost to Follow-up|1|||
130720405|NCT00806286|470599736|FG002|Overall Study|Lost to Follow-up|0|||
130720406|NCT00806286|470599734|FG000|Overall Study|Withdrawal by Subject|8|||
130375579|NCT01599234|469341934|FG001|Overall Study|Lost to Follow-up|2|||
130375580|NCT01599234|469341933|FG000|Overall Study|Lack of Efficacy|2|||
130375581|NCT01599234|469341934|FG001|Overall Study|Lack of Efficacy|4|||
130375582|NCT01599234|469341933|FG000|Overall Study|Unable to operate spray|1|||
130375583|NCT01599234|469341934|FG001|Overall Study|Unable to operate spray|0|||
130375584|NCT01599234|469341933|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
130375585|NCT01599234|469341934|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
130375586|NCT01599234|469341933|FG000|Overall Study|Death|1|||
130375587|NCT01599234|469341934|FG001|Overall Study|Death|0|||
130375588|NCT01599234|469341933|FG000|Overall Study|Patient would not stop driving|1|||
130375589|NCT01599234|469341934|FG001|Overall Study|Patient would not stop driving|0|||
130375590|NCT01599234|469341933|FG000|Overall Study|Contra-indication discovered|0|||
130375591|NCT01599234|469341934|FG001|Overall Study|Contra-indication discovered|1|||
130375592|NCT01599234|469341933|FG000|Overall Study|Pregnancy|0|||
130375593|NCT01599234|469341934|FG001|Overall Study|Pregnancy|1|||
130375594|NCT02485301|469341939|FG000|Overall Study|Serious Adverse Events|2|||
130375595|NCT02485301|469341940|FG001|Overall Study|Serious Adverse Events|1|||
130375596|NCT02485301|469341939|FG000|Overall Study|Protocol Violation|0|||
130375597|NCT02485301|469341940|FG001|Overall Study|Protocol Violation|1|||
130375598|NCT02485301|469341939|FG000|Overall Study|Withdrawal by Subject|6|||
130375599|NCT02485301|469341940|FG001|Overall Study|Withdrawal by Subject|7|||
130375600|NCT02485301|469341939|FG000|Overall Study|Migrated/moved from study area|10|||
130375601|NCT02485301|469341940|FG001|Overall Study|Migrated/moved from study area|19|||
130375602|NCT02485301|469341939|FG000|Overall Study|Lost to Follow-up|17|||
130375603|NCT02485301|469341940|FG001|Overall Study|Lost to Follow-up|17|||
130375604|NCT02485301|469341939|FG000|Overall Study|Other|3|||
130375605|NCT02485301|469341940|FG001|Overall Study|Other|4|||
130375606|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375607|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375608|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375609|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375610|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375611|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130375612|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
130375613|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375614|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375615|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375616|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375617|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375618|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130375619|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
130375620|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
130375621|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
130375622|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
130375623|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
130375624|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
130375625|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
130314802|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
130314803|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314804|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314805|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314806|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130466545|NCT00807937|469674840|FG001|Overall Study|Protocol Violation|5|||
130466546|NCT00807937|469674841|FG002|Overall Study|Protocol Violation|3|||
130720407|NCT00806286|470599735|FG001|Overall Study|Withdrawal by Subject|3|||
130720408|NCT00806286|470599736|FG002|Overall Study|Withdrawal by Subject|1|||
130720409|NCT00806286|470599734|FG000|Overall Study|Physician Decision|2|||
130720410|NCT00806286|470599735|FG001|Overall Study|Physician Decision|2|||
130720411|NCT00806286|470599736|FG002|Overall Study|Physician Decision|0|||
130720412|NCT00806286|470599734|FG000|Overall Study|Due to a variety of reasons|7|||
130720413|NCT00806286|470599735|FG001|Overall Study|Due to a variety of reasons|2|||
130720414|NCT00806286|470599736|FG002|Overall Study|Due to a variety of reasons|1|||
130314807|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130720415|NCT03402750|470599737|FG000|Overall Study|Lost to Follow-up|2|||
130314808|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314809|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130375626|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
130375627|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130375628|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130375629|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130720416|NCT03402750|470599738|FG001|Overall Study|Lost to Follow-up|1|||
130720417|NCT03469336|470599739|FG000|Overall Study|Adverse Event|1|||
130375630|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130375631|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130375632|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130375633|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
130375634|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
130375635|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
130375636|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
130375637|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
130375638|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
130375639|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
130375640|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
130375641|NCT01059825|469341944|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
130375642|NCT01059825|469341945|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
130375643|NCT01059825|469341946|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
130375644|NCT01059825|469341947|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
130375645|NCT01059825|469341948|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
130375646|NCT01059825|469341949|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
130375647|NCT01059825|469341950|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
130375648|NCT01059825|469341944|FG000|Treatment Period|Lost to Follow-up|2|||
130375649|NCT01059825|469341945|FG001|Treatment Period|Lost to Follow-up|1|||
130375650|NCT01059825|469341946|FG002|Treatment Period|Lost to Follow-up|0|||
130375651|NCT01059825|469341947|FG003|Treatment Period|Lost to Follow-up|1|||
130375652|NCT01059825|469341948|FG004|Treatment Period|Lost to Follow-up|2|||
130375653|NCT01059825|469341949|FG005|Treatment Period|Lost to Follow-up|0|||
130375654|NCT01059825|469341950|FG006|Treatment Period|Lost to Follow-up|0|||
130375655|NCT01059825|469341944|FG000|Treatment Period|Withdrawal by Subject|3|||
130375656|NCT01059825|469341945|FG001|Treatment Period|Withdrawal by Subject|0|||
130375657|NCT01059825|469341946|FG002|Treatment Period|Withdrawal by Subject|1|||
130375658|NCT01059825|469341947|FG003|Treatment Period|Withdrawal by Subject|5|||
130375659|NCT01059825|469341948|FG004|Treatment Period|Withdrawal by Subject|4|||
130375660|NCT01059825|469341949|FG005|Treatment Period|Withdrawal by Subject|1|||
130375661|NCT01059825|469341950|FG006|Treatment Period|Withdrawal by Subject|0|||
130375662|NCT01059825|469341944|FG000|Treatment Period|Other reason not specified|1|||
130375663|NCT01059825|469341945|FG001|Treatment Period|Other reason not specified|2|||
130375664|NCT01059825|469341946|FG002|Treatment Period|Other reason not specified|1|||
130375665|NCT01059825|469341947|FG003|Treatment Period|Other reason not specified|2|||
130375666|NCT01059825|469341948|FG004|Treatment Period|Other reason not specified|0|||
130375667|NCT01059825|469341949|FG005|Treatment Period|Other reason not specified|0|||
130375668|NCT01059825|469341950|FG006|Treatment Period|Other reason not specified|0|||
130375669|NCT01059825|469341944|FG000|Treatment Period|Protocol Violation|0|||
130375670|NCT01059825|469341945|FG001|Treatment Period|Protocol Violation|0|||
130375671|NCT01059825|469341946|FG002|Treatment Period|Protocol Violation|1|||
130375672|NCT01059825|469341947|FG003|Treatment Period|Protocol Violation|1|||
130375673|NCT01059825|469341948|FG004|Treatment Period|Protocol Violation|1|||
130375674|NCT01059825|469341949|FG005|Treatment Period|Protocol Violation|1|||
130375675|NCT01059825|469341950|FG006|Treatment Period|Protocol Violation|0|||
130375676|NCT01059825|469341944|FG000|Treatment Period|Adverse event related to study drug|1|||
130375677|NCT01059825|469341945|FG001|Treatment Period|Adverse event related to study drug|0|||
130375678|NCT01059825|469341946|FG002|Treatment Period|Adverse event related to study drug|1|||
130375679|NCT01059825|469341947|FG003|Treatment Period|Adverse event related to study drug|1|||
130375680|NCT01059825|469341948|FG004|Treatment Period|Adverse event related to study drug|0|||
130375681|NCT01059825|469341949|FG005|Treatment Period|Adverse event related to study drug|0|||
130375682|NCT01059825|469341950|FG006|Treatment Period|Adverse event related to study drug|0|||
130375683|NCT01059825|469341944|FG000|Treatment Period|Insufficient clinical response|3|||
130375684|NCT01059825|469341945|FG001|Treatment Period|Insufficient clinical response|0|||
130375685|NCT01059825|469341946|FG002|Treatment Period|Insufficient clinical response|0|||
130375686|NCT01059825|469341947|FG003|Treatment Period|Insufficient clinical response|0|||
130375687|NCT01059825|469341948|FG004|Treatment Period|Insufficient clinical response|0|||
130375688|NCT01059825|469341949|FG005|Treatment Period|Insufficient clinical response|0|||
130375689|NCT01059825|469341950|FG006|Treatment Period|Insufficient clinical response|0|||
130375690|NCT01059825|469341944|FG000|Treatment Period|Adverse event not related to study drug|0|||
130375691|NCT01059825|469341945|FG001|Treatment Period|Adverse event not related to study drug|1|||
130375692|NCT01059825|469341946|FG002|Treatment Period|Adverse event not related to study drug|2|||
130375693|NCT01059825|469341947|FG003|Treatment Period|Adverse event not related to study drug|1|||
130375694|NCT01059825|469341948|FG004|Treatment Period|Adverse event not related to study drug|1|||
130375695|NCT01059825|469341949|FG005|Treatment Period|Adverse event not related to study drug|1|||
130375696|NCT01059825|469341950|FG006|Treatment Period|Adverse event not related to study drug|0|||
130375697|NCT02495168|469341951|FG000|Overall Study|Other than Specified|18|||
130375698|NCT02495168|469341952|FG001|Overall Study|Other than Specified|22|||
130375699|NCT02495168|469341953|FG002|Overall Study|Other than Specified|5|||
130375700|NCT02495168|469341951|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
130375701|NCT02495168|469341952|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
130375702|NCT02495168|469341953|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
130375703|NCT02495168|469341951|FG000|Overall Study|Physician Decision|1|||
130375704|NCT02495168|469341952|FG001|Overall Study|Physician Decision|1|||
130375705|NCT02495168|469341953|FG002|Overall Study|Physician Decision|0|||
130375706|NCT02495168|469341951|FG000|Overall Study|Lost to Follow-up|10|||
130375707|NCT02495168|469341952|FG001|Overall Study|Lost to Follow-up|6|||
130375708|NCT02495168|469341953|FG002|Overall Study|Lost to Follow-up|1|||
130375709|NCT02495168|469341951|FG000|Overall Study|Withdrawal by Subject|1|||
130375710|NCT02495168|469341952|FG001|Overall Study|Withdrawal by Subject|4|||
130375711|NCT02495168|469341953|FG002|Overall Study|Withdrawal by Subject|2|||
130375712|NCT02495168|469341951|FG000|Overall Study|Protocol Violation|0|||
130375713|NCT02495168|469341952|FG001|Overall Study|Protocol Violation|10|||
130375714|NCT02495168|469341953|FG002|Overall Study|Protocol Violation|1|||
130375715|NCT02495168|469341951|FG000|Overall Study|Adverse Event|4|||
130375716|NCT02495168|469341952|FG001|Overall Study|Adverse Event|8|||
130375717|NCT02495168|469341953|FG002|Overall Study|Adverse Event|3|||
130720418|NCT03825341|470599740|FG000|Overall Study|Withdrawal by Subject|0|||
130720419|NCT03825341|470599741|FG001|Overall Study|Withdrawal by Subject|1|||
130720420|NCT00289536|470599743|FG000|Period 3|Lost to Follow-up|0|||
130720421|NCT00289536|470599744|FG001|Period 3|Lost to Follow-up|0|||
130720422|NCT00289536|470599745|FG002|Period 3|Lost to Follow-up|1|||
130720423|NCT04283500|470599749|FG000|Overall Study|Lost to Follow-up|8|||
130720424|NCT04283500|470599749|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
130375718|NCT02495168|469341951|FG000|Overall Study|Lack of Efficacy|0|||
130375719|NCT02495168|469341952|FG001|Overall Study|Lack of Efficacy|0|||
130375720|NCT02495168|469341953|FG002|Overall Study|Lack of Efficacy|3|||
130375721|NCT04626297|469341956|FG000|Overall Study|Adverse Event|5|||
130375722|NCT04626297|469341957|FG001|Overall Study|Adverse Event|3|||
130375723|NCT04626297|469341956|FG000|Overall Study|Lost to Follow-up|7|||
130375724|NCT04626297|469341957|FG001|Overall Study|Lost to Follow-up|3|||
130375725|NCT04626297|469341956|FG000|Overall Study|Protocol Violation|5|||
130375726|NCT04626297|469341957|FG001|Overall Study|Protocol Violation|1|||
130375727|NCT04626297|469341956|FG000|Overall Study|Withdrawal by Subject|20|||
130375728|NCT04626297|469341957|FG001|Overall Study|Withdrawal by Subject|6|||
130375729|NCT04626297|469341956|FG000|Overall Study|Sponsor decision|2|||
130375730|NCT04626297|469341957|FG001|Overall Study|Sponsor decision|1|||
130375731|NCT03521934|469341964|FG000|Overall Study|Death|65|||
130375732|NCT03521934|469341965|FG001|Overall Study|Death|73|||
130375733|NCT03521934|469341964|FG000|Overall Study|Withdrawal by Subject|18|||
130375734|NCT03521934|469341965|FG001|Overall Study|Withdrawal by Subject|23|||
130375735|NCT03521934|469341964|FG000|Overall Study|Site Terminated by Sponsor|39|||
130375736|NCT03521934|469341965|FG001|Overall Study|Site Terminated by Sponsor|35|||
130375737|NCT03521934|469341964|FG000|Overall Study|Study Terminated by Sponsor|483|||
130375738|NCT03521934|469341965|FG001|Overall Study|Study Terminated by Sponsor|477|||
130375739|NCT03521934|469341964|FG000|Overall Study|Reason not Specified|3|||
130375740|NCT03521934|469341965|FG001|Overall Study|Reason not Specified|6|||
130375741|NCT03020160|469341966|FG000|Overall Study|Withdrawal by Subject|1|||
130375742|NCT03020160|469341967|FG001|Overall Study|Withdrawal by Subject|0|||
130375743|NCT01513473|469341968|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
130375744|NCT01513473|469341969|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
130375745|NCT01513473|469341968|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
130375746|NCT01513473|469341969|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
130375747|NCT01513473|469341968|FG000|Main Trial (26 Weeks)|Unclassified|0|||
130375748|NCT01513473|469341969|FG001|Main Trial (26 Weeks)|Unclassified|2|||
130375749|NCT01513473|469341968|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
130375750|NCT01513473|469341969|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
130466547|NCT00807937|469674842|FG003|Overall Study|Protocol Violation|3|||
130466548|NCT00807937|469674839|FG000|Overall Study|Withdrawal by Subject|5|||
130466549|NCT00807937|469674840|FG001|Overall Study|Withdrawal by Subject|4|||
130466550|NCT00807937|469674841|FG002|Overall Study|Withdrawal by Subject|1|||
130466551|NCT00807937|469674842|FG003|Overall Study|Withdrawal by Subject|4|||
130466552|NCT00807937|469674839|FG000|Overall Study|Lost to Follow-up|4|||
130466553|NCT00807937|469674840|FG001|Overall Study|Lost to Follow-up|0|||
130466554|NCT00807937|469674841|FG002|Overall Study|Lost to Follow-up|2|||
130466555|NCT00807937|469674842|FG003|Overall Study|Lost to Follow-up|1|||
130466556|NCT00807937|469674839|FG000|Overall Study|Lack of Efficacy|0|||
130466557|NCT00807937|469674840|FG001|Overall Study|Lack of Efficacy|0|||
130466558|NCT00807937|469674841|FG002|Overall Study|Lack of Efficacy|1|||
130466559|NCT00807937|469674842|FG003|Overall Study|Lack of Efficacy|2|||
130466560|NCT00807937|469674839|FG000|Overall Study|Intake of prohibited medicine|0|||
130466561|NCT00807937|469674840|FG001|Overall Study|Intake of prohibited medicine|0|||
130466562|NCT00807937|469674841|FG002|Overall Study|Intake of prohibited medicine|2|||
130466563|NCT00807937|469674842|FG003|Overall Study|Intake of prohibited medicine|0|||
130466564|NCT00807937|469674839|FG000|Overall Study|All other reasons (not provided)|2|||
130375751|NCT01513473|469341968|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
130375752|NCT01513473|469341969|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
130375753|NCT03462082|469341970|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375754|NCT03462082|469341971|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375755|NCT03462082|469341972|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375756|NCT03462082|469341973|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375757|NCT03462082|469341974|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375758|NCT03462082|469341975|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130375759|NCT03462082|469341976|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
130375760|NCT03462082|469341977|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
130375761|NCT01425281|469341982|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
130375762|NCT01425281|469341983|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
130375763|NCT01425281|469341982|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
130375764|NCT01425281|469341983|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
130375765|NCT01425281|469341982|FG000|At 180-day Clinical Follow-up|Death|0|||
130375766|NCT01425281|469341983|FG001|At 180-day Clinical Follow-up|Death|1|||
130375767|NCT01425281|469341982|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
130375768|NCT01425281|469341983|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
130375769|NCT01425281|469341982|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
130375770|NCT01425281|469341983|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
130375771|NCT01425281|469341982|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
130375772|NCT01425281|469341983|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
130375773|NCT01425281|469341982|FG000|At 2-year Clinical Follow-up|Death|2|||
130375774|NCT01425281|469341983|FG001|At 2-year Clinical Follow-up|Death|0|||
130375775|NCT01425281|469341982|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
130375776|NCT01425281|469341983|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
130375777|NCT01425281|469341982|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
130375778|NCT01425281|469341983|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
130375779|NCT01425281|469341982|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
130375780|NCT01425281|469341983|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
130375781|NCT01425281|469341982|FG000|At 3-year Clinical Follow-up|Death|2|||
130375782|NCT01425281|469341983|FG001|At 3-year Clinical Follow-up|Death|3|||
130375783|NCT01425281|469341982|FG000|At 4-year Clinical Follow-up|Death|7|||
130375784|NCT01425281|469341983|FG001|At 4-year Clinical Follow-up|Death|3|||
130375785|NCT01425281|469341982|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
130375786|NCT01425281|469341983|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
130375787|NCT01425281|469341982|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
130375788|NCT01425281|469341983|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
130375789|NCT01425281|469341982|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
130375790|NCT01425281|469341983|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
130375791|NCT01425281|469341982|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
130375792|NCT01425281|469341983|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
130375793|NCT01425281|469341982|FG000|At 5-year Clinical Follow-up|Death|2|||
130375794|NCT01425281|469341983|FG001|At 5-year Clinical Follow-up|Death|0|||
130375795|NCT01425281|469341982|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
130375796|NCT01425281|469341983|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
130375797|NCT01425281|469341982|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
130375798|NCT01425281|469341983|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
130375799|NCT01425281|469341982|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
130375800|NCT01425281|469341983|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
130375801|NCT03454997|469341984|FG000|Overall Study|Staff Coach - Left Oranization|1|||
130375802|NCT03454997|469341985|FG001|Overall Study|Staff Coach - Left Oranization|1|||
130375803|NCT03454997|469341984|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
130375804|NCT03454997|469341985|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
130375805|NCT03454997|469341984|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
130375806|NCT03454997|469341985|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
130375807|NCT03454997|469341984|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
130375808|NCT03454997|469341985|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
130375809|NCT03454997|469341984|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
130375810|NCT03454997|469341985|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
130559279|NCT00962390|470016467|FG002|Overall Study|Lost to Follow-up|0|||
130375811|NCT03454997|469341984|FG000|Overall Study|Client with SMI - Left organization|0|||
130375812|NCT03454997|469341985|FG001|Overall Study|Client with SMI - Left organization|1|||
130375813|NCT03454997|469341984|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
130375814|NCT03454997|469341985|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
130559280|NCT00962390|470016468|FG003|Overall Study|Lost to Follow-up|0|||
130559281|NCT00962390|470016465|FG000|Overall Study|Protocol Violation|1|||
130559282|NCT00962390|470016466|FG001|Overall Study|Protocol Violation|0|||
130375815|NCT00299975|469341987|FG000|Overall Study|Adverse Event|1|||
130375816|NCT00299975|469341988|FG001|Overall Study|Adverse Event|0|||
130720425|NCT02006693|470599752|FG000|Overall Study|No Reason Specified|6|||
130720426|NCT02006693|470599753|FG001|Overall Study|No Reason Specified|8|||
130720427|NCT02006693|470599752|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
130720428|NCT02006693|470599753|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
130720429|NCT02006693|470599752|FG000|Overall Study|XEN Implant Explantation|0|||
130720430|NCT02006693|470599753|FG001|Overall Study|XEN Implant Explantation|1|||
130375817|NCT00299975|469341989|FG002|Overall Study|Adverse Event|2|||
130375818|NCT00299975|469341987|FG000|Overall Study|Pregnancy|0|||
130375819|NCT00299975|469341988|FG001|Overall Study|Pregnancy|0|||
130375820|NCT00299975|469341989|FG002|Overall Study|Pregnancy|1|||
130375821|NCT00299975|469341987|FG000|Overall Study|Lack of Efficacy|1|||
130375822|NCT00299975|469341988|FG001|Overall Study|Lack of Efficacy|0|||
130375823|NCT00299975|469341989|FG002|Overall Study|Lack of Efficacy|1|||
130375824|NCT00299975|469341987|FG000|Overall Study|Lost to Follow-up|1|||
130375825|NCT00299975|469341988|FG001|Overall Study|Lost to Follow-up|0|||
130375826|NCT00299975|469341989|FG002|Overall Study|Lost to Follow-up|0|||
130375827|NCT00299975|469341987|FG000|Overall Study|Withdrawal by Subject|0|||
130375828|NCT00299975|469341988|FG001|Overall Study|Withdrawal by Subject|1|||
130375829|NCT00299975|469341989|FG002|Overall Study|Withdrawal by Subject|3|||
130375830|NCT00299975|469341987|FG000|Overall Study|Physician Decision|0|||
130375831|NCT00299975|469341988|FG001|Overall Study|Physician Decision|0|||
130375832|NCT00299975|469341989|FG002|Overall Study|Physician Decision|1|||
130375833|NCT00982878|469341990|FG000|Overall Study|Physician Decision|1|||
130375834|NCT03167411|469341991|FG000|Overall Study|Adverse Event|0|||
130375835|NCT03167411|469341992|FG001|Overall Study|Adverse Event|1|||
130375836|NCT02627144|469341995|FG000|Overall Study|Serious adverse event|32|||
130375837|NCT02627144|469341995|FG000|Overall Study|Cancer progression|171|||
130375838|NCT02627144|469341995|FG000|Overall Study|Death from cancer|20|||
130375839|NCT02627144|469341995|FG000|Overall Study|Death from other cause|8|||
130375840|NCT02627144|469341995|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
130375841|NCT02627144|469341995|FG000|Overall Study|Administrative reasons|65|||
130375842|NCT02627144|469341995|FG000|Overall Study|Lost to Follow-up|8|||
130375843|NCT02627144|469341995|FG000|Overall Study|Enrolled, not treated|6|||
130375844|NCT02627144|469341995|FG000|Overall Study|Other|17|||
130375845|NCT01217814|469342000|FG000|Overall Study|Adverse Event|1|||
130375846|NCT01217814|469342001|FG001|Overall Study|Adverse Event|1|||
130375847|NCT01217814|469342002|FG002|Overall Study|Adverse Event|0|||
130466565|NCT00807937|469674840|FG001|Overall Study|All other reasons (not provided)|4|||
130466566|NCT00807937|469674841|FG002|Overall Study|All other reasons (not provided)|0|||
130466567|NCT00807937|469674842|FG003|Overall Study|All other reasons (not provided)|1|||
130466568|NCT04629950|469674843|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
130466569|NCT04629950|469674844|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
130466570|NCT04629950|469674845|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
130466571|NCT04629950|469674846|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
130466572|NCT04629950|469674843|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
130466573|NCT04629950|469674844|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
130466574|NCT04629950|469674845|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
130559283|NCT00962390|470016467|FG002|Overall Study|Protocol Violation|0|||
130559284|NCT00962390|470016468|FG003|Overall Study|Protocol Violation|0|||
130720431|NCT02006693|470599752|FG000|Overall Study|Death|2|||
130720432|NCT02006693|470599753|FG001|Overall Study|Death|2|||
130720433|NCT02006693|470599752|FG000|Overall Study|Lost to Follow-up|4|||
130375848|NCT01217814|469342000|FG000|Overall Study|Lack of Efficacy|0|||
130375849|NCT01217814|469342001|FG001|Overall Study|Lack of Efficacy|0|||
130375850|NCT01217814|469342002|FG002|Overall Study|Lack of Efficacy|1|||
130375851|NCT01756898|469342003|FG000|Overall Study|Adverse Event|7|||
130375852|NCT01756898|469342004|FG001|Overall Study|Adverse Event|1|||
130375853|NCT01756898|469342005|FG002|Overall Study|Adverse Event|0|||
130375854|NCT01756898|469342006|FG003|Overall Study|Adverse Event|0|||
130559285|NCT00962390|470016465|FG000|Overall Study|Withdrawal by Subject|1|||
130720434|NCT02006693|470599753|FG001|Overall Study|Lost to Follow-up|1|||
130720435|NCT02006693|470599752|FG000|Overall Study|Patient Decision|4|||
130375855|NCT01756898|469342003|FG000|Overall Study|Lack of Efficacy|4|||
130375856|NCT01756898|469342004|FG001|Overall Study|Lack of Efficacy|7|||
130375857|NCT01756898|469342005|FG002|Overall Study|Lack of Efficacy|6|||
130375858|NCT01756898|469342006|FG003|Overall Study|Lack of Efficacy|6|||
130375859|NCT01756898|469342003|FG000|Overall Study|Lost to Follow-up|2|||
130375860|NCT01756898|469342004|FG001|Overall Study|Lost to Follow-up|4|||
130375861|NCT01756898|469342005|FG002|Overall Study|Lost to Follow-up|2|||
130375862|NCT01756898|469342006|FG003|Overall Study|Lost to Follow-up|3|||
130375863|NCT01756898|469342003|FG000|Overall Study|Protocol Violation|1|||
130375864|NCT01756898|469342004|FG001|Overall Study|Protocol Violation|2|||
130375865|NCT01756898|469342005|FG002|Overall Study|Protocol Violation|2|||
130720436|NCT02006693|470599753|FG001|Overall Study|Patient Decision|0|||
130375866|NCT01756898|469342006|FG003|Overall Study|Protocol Violation|1|||
130375867|NCT01756898|469342003|FG000|Overall Study|Withdrew Consent|5|||
130559286|NCT00962390|470016466|FG001|Overall Study|Withdrawal by Subject|1|||
130559287|NCT00962390|470016467|FG002|Overall Study|Withdrawal by Subject|1|||
130559288|NCT00962390|470016468|FG003|Overall Study|Withdrawal by Subject|0|||
130559289|NCT02613884|470016469|FG000|Overall Study|Death|1|||
130559290|NCT02613884|470016469|FG000|Overall Study|Lost to Follow-up|1|||
130559291|NCT01514136|470016470|FG000|Test Period 1; Test A|Protocol Violation|1|||
130559292|NCT01514136|470016471|FG001|Test Period 1; Test A|Protocol Violation|0|||
130559293|NCT01514136|470016472|FG002|Test Period 1; Test A|Protocol Violation|0|||
130559294|NCT01514136|470016473|FG003|Test Period 1; Test A|Protocol Violation|0|||
130559295|NCT01514136|470016474|FG004|Test Period 1; Test A|Protocol Violation|0|||
130559296|NCT01514136|470016475|FG005|Test Period 1; Test A|Protocol Violation|0|||
130559297|NCT01514136|470016476|FG006|Test Period 1; Test A|Protocol Violation|0|||
130559298|NCT01514136|470016477|FG007|Test Period 1; Test A|Protocol Violation|0|||
130559299|NCT01514136|470016470|FG000|Test Period 1; Test A|Break from study holiday|2|||
130559300|NCT01514136|470016471|FG001|Test Period 1; Test A|Break from study holiday|0|||
130559301|NCT01514136|470016472|FG002|Test Period 1; Test A|Break from study holiday|0|||
130559302|NCT01514136|470016473|FG003|Test Period 1; Test A|Break from study holiday|0|||
130559303|NCT01514136|470016474|FG004|Test Period 1; Test A|Break from study holiday|0|||
130559304|NCT01514136|470016475|FG005|Test Period 1; Test A|Break from study holiday|0|||
130375868|NCT01756898|469342004|FG001|Overall Study|Withdrew Consent|3|||
130375869|NCT01756898|469342005|FG002|Overall Study|Withdrew Consent|5|||
130375870|NCT01756898|469342006|FG003|Overall Study|Withdrew Consent|6|||
130375871|NCT01756898|469342003|FG000|Overall Study|Other|0|||
130375872|NCT01756898|469342004|FG001|Overall Study|Other|2|||
130375873|NCT01756898|469342005|FG002|Overall Study|Other|2|||
130375874|NCT01756898|469342006|FG003|Overall Study|Other|0|||
130375875|NCT00496054|469342011|FG000|Overall Study|Adverse Event|1|||
130559305|NCT01514136|470016476|FG006|Test Period 1; Test A|Break from study holiday|0|||
130559306|NCT01514136|470016477|FG007|Test Period 1; Test A|Break from study holiday|0|||
130559307|NCT01514136|470016470|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
130559308|NCT01514136|470016471|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
130559309|NCT01514136|470016472|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
130559310|NCT01514136|470016473|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
130559311|NCT01514136|470016474|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
130559312|NCT01514136|470016475|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
130559313|NCT01514136|470016476|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
130559314|NCT01514136|470016477|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
130559315|NCT01514136|470016470|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559316|NCT01514136|470016471|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559317|NCT01514136|470016472|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559318|NCT01514136|470016473|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
130559319|NCT01514136|470016474|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559320|NCT01514136|470016475|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559321|NCT01514136|470016476|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559322|NCT01514136|470016477|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
130559323|NCT01514136|470016470|FG000|Test Period 2; Test A*|Adverse Event|0|||
130559324|NCT01514136|470016471|FG001|Test Period 2; Test A*|Adverse Event|0|||
130559325|NCT01514136|470016472|FG002|Test Period 2; Test A*|Adverse Event|0|||
130559326|NCT01514136|470016473|FG003|Test Period 2; Test A*|Adverse Event|0|||
130559327|NCT01514136|470016474|FG004|Test Period 2; Test A*|Adverse Event|1|||
130559328|NCT01514136|470016475|FG005|Test Period 2; Test A*|Adverse Event|0|||
130559329|NCT01514136|470016476|FG006|Test Period 2; Test A*|Adverse Event|0|||
130559330|NCT01514136|470016477|FG007|Test Period 2; Test A*|Adverse Event|0|||
130559331|NCT01514136|470016470|FG000|Test Period 2; Test A*|Holiday|0|||
130375876|NCT00496054|469342011|FG000|Overall Study|Lost to Follow-up|7|||
130375877|NCT00471328|469342018|FG000|Core Phase|Adverse Event|18|||
130375878|NCT00471328|469342019|FG001|Core Phase|Adverse Event|6|||
130375879|NCT00471328|469342018|FG000|Core Phase|Death|8|||
130375880|NCT00471328|469342019|FG001|Core Phase|Death|4|||
130375881|NCT00471328|469342018|FG000|Core Phase|Withdrawal by Subject|2|||
130375882|NCT00471328|469342019|FG001|Core Phase|Withdrawal by Subject|2|||
130375883|NCT00471328|469342018|FG000|Core Phase|Abnormal laboratory value|1|||
130375884|NCT00471328|469342019|FG001|Core Phase|Abnormal laboratory value|0|||
130375885|NCT00471328|469342018|FG000|Core Phase|Disease Progression|78|||
130375886|NCT00471328|469342019|FG001|Core Phase|Disease Progression|53|||
130375887|NCT00471328|469342018|FG000|Core Phase|Administrative Problem|0|||
130375888|NCT00471328|469342019|FG001|Core Phase|Administrative Problem|1|||
130375889|NCT00471328|469342018|FG000|Core Phase|Protocol Deviation|0|||
130375890|NCT00471328|469342019|FG001|Core Phase|Protocol Deviation|1|||
130375891|NCT00471328|469342018|FG000|Extension Phase|Adverse Event|3|||
130375892|NCT00471328|469342019|FG001|Extension Phase|Adverse Event|12|||
130375893|NCT00471328|469342018|FG000|Extension Phase|Withdrawal by Subject|0|||
130375894|NCT00471328|469342019|FG001|Extension Phase|Withdrawal by Subject|2|||
130375895|NCT00471328|469342018|FG000|Extension Phase|Death|1|||
130375896|NCT00471328|469342019|FG001|Extension Phase|Death|7|||
130375897|NCT00471328|469342018|FG000|Extension Phase|Protocol Deviation|3|||
130375898|NCT00471328|469342019|FG001|Extension Phase|Protocol Deviation|1|||
130375899|NCT00471328|469342018|FG000|Extension Phase|Treatment duration as per protocol|0|||
130375900|NCT00471328|469342019|FG001|Extension Phase|Treatment duration as per protocol|1|||
130375901|NCT00471328|469342018|FG000|Extension Phase|Disease Progression|32|||
130375902|NCT00471328|469342019|FG001|Extension Phase|Disease Progression|44|||
130375903|NCT00471328|469342018|FG000|Extension Phase|New cancer Therapy|1|||
130375904|NCT00471328|469342019|FG001|Extension Phase|New cancer Therapy|0|||
130375905|NCT00471328|469342018|FG000|Extension Phase|Administrative Problem|1|||
130375906|NCT00471328|469342019|FG001|Extension Phase|Administrative Problem|0|||
130375907|NCT01835587|469342020|FG000|Overall Study|Disease Recurrence or Relapse|0|||
130375908|NCT01835587|469342021|FG001|Overall Study|Disease Recurrence or Relapse|3|||
130375909|NCT01835587|469342022|FG002|Overall Study|Disease Recurrence or Relapse|0|||
130375910|NCT01835587|469342023|FG003|Overall Study|Disease Recurrence or Relapse|3|||
130375911|NCT01835587|469342020|FG000|Overall Study|Withdrawal by Subject|2|||
130375912|NCT01835587|469342021|FG001|Overall Study|Withdrawal by Subject|0|||
130375913|NCT01835587|469342022|FG002|Overall Study|Withdrawal by Subject|0|||
130375914|NCT01835587|469342023|FG003|Overall Study|Withdrawal by Subject|3|||
130375915|NCT01835587|469342020|FG000|Overall Study|Adverse Event|0|||
130375916|NCT01835587|469342021|FG001|Overall Study|Adverse Event|0|||
130375917|NCT01835587|469342022|FG002|Overall Study|Adverse Event|2|||
130375918|NCT01835587|469342023|FG003|Overall Study|Adverse Event|2|||
130375919|NCT01835587|469342020|FG000|Overall Study|Death|0|||
130375920|NCT01835587|469342021|FG001|Overall Study|Death|0|||
130375921|NCT01835587|469342022|FG002|Overall Study|Death|0|||
130375922|NCT01835587|469342023|FG003|Overall Study|Death|1|||
130375923|NCT01835587|469342020|FG000|Overall Study|Miscellaneous|0|||
130375924|NCT01835587|469342021|FG001|Overall Study|Miscellaneous|1|||
130375925|NCT01835587|469342022|FG002|Overall Study|Miscellaneous|0|||
130375926|NCT01835587|469342023|FG003|Overall Study|Miscellaneous|0|||
130375927|NCT02132130|469342024|FG000|Overall Study|Lost to Follow-up|0|||
130375928|NCT02132130|469342025|FG001|Overall Study|Lost to Follow-up|2|||
130375929|NCT02132130|469342026|FG002|Overall Study|Lost to Follow-up|0|||
130375930|NCT02132130|469342027|FG003|Overall Study|Lost to Follow-up|0|||
130375931|NCT02132130|469342024|FG000|Overall Study|Withdrawal by Subject|0|||
130375932|NCT02132130|469342025|FG001|Overall Study|Withdrawal by Subject|0|||
130375933|NCT02132130|469342026|FG002|Overall Study|Withdrawal by Subject|0|||
130375934|NCT02132130|469342027|FG003|Overall Study|Withdrawal by Subject|1|||
130375935|NCT00838578|469342028|FG000|Overall Study|Protocol Violation|2|||
130375936|NCT00357968|469342029|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
130375937|NCT00357968|469342030|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
130375938|NCT00357968|469342029|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
130375939|NCT00357968|469342030|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
130375940|NCT00439244|469342047|FG000|Overall Study|Adverse Event|5|||
130375941|NCT00439244|469342048|FG001|Overall Study|Adverse Event|2|||
130375942|NCT00439244|469342049|FG002|Overall Study|Adverse Event|3|||
130375943|NCT00439244|469342047|FG000|Overall Study|Withdrawal by Subject|3|||
130375944|NCT00439244|469342048|FG001|Overall Study|Withdrawal by Subject|1|||
130375945|NCT00439244|469342049|FG002|Overall Study|Withdrawal by Subject|2|||
130375946|NCT00439244|469342047|FG000|Overall Study|Lost to Follow-up|2|||
130375947|NCT00439244|469342048|FG001|Overall Study|Lost to Follow-up|1|||
130375948|NCT00439244|469342049|FG002|Overall Study|Lost to Follow-up|2|||
130375949|NCT00439244|469342047|FG000|Overall Study|Death|0|||
130375950|NCT00439244|469342048|FG001|Overall Study|Death|1|||
130375951|NCT00439244|469342049|FG002|Overall Study|Death|0|||
130375952|NCT00439244|469342047|FG000|Overall Study|Protocol Violation|0|||
130375953|NCT00439244|469342048|FG001|Overall Study|Protocol Violation|1|||
130375954|NCT00439244|469342049|FG002|Overall Study|Protocol Violation|0|||
130375955|NCT00439244|469342047|FG000|Overall Study|Administrative problems|1|||
130375956|NCT00439244|469342048|FG001|Overall Study|Administrative problems|0|||
130375957|NCT00439244|469342049|FG002|Overall Study|Administrative problems|0|||
130466575|NCT04629950|469674846|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
130466576|NCT04629950|469674843|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
130466577|NCT04629950|469674844|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
130466578|NCT04629950|469674845|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
130375958|NCT04102020|469342050|FG000|Overall Study|Adverse Event|1|||
130375959|NCT04102020|469342051|FG001|Overall Study|Adverse Event|0|||
130375960|NCT04102020|469342052|FG002|Overall Study|Adverse Event|0|||
130375961|NCT04102020|469342053|FG003|Overall Study|Adverse Event|1|||
130375962|NCT04102020|469342054|FG004|Overall Study|Adverse Event|0|||
130375963|NCT04102020|469342050|FG000|Overall Study|Withdrawal by Subject|0|||
130375964|NCT04102020|469342051|FG001|Overall Study|Withdrawal by Subject|1|||
130375965|NCT04102020|469342052|FG002|Overall Study|Withdrawal by Subject|1|||
130375966|NCT04102020|469342053|FG003|Overall Study|Withdrawal by Subject|1|||
130375967|NCT04102020|469342054|FG004|Overall Study|Withdrawal by Subject|1|||
130375968|NCT04102020|469342050|FG000|Overall Study|Death|1|||
130375969|NCT04102020|469342051|FG001|Overall Study|Death|4|||
130375970|NCT04102020|469342052|FG002|Overall Study|Death|1|||
130720437|NCT01119508|470599756|FG000|Overall Study|Adverse Event|56|||
130720438|NCT01119508|470599756|FG000|Overall Study|Withdrawal by Subject|2|||
130720439|NCT01119508|470599756|FG000|Overall Study|Died before tumor response evaluation|1|||
130720440|NCT00265395|470599757|FG000|Overall Study|Adverse Event|3|||
130720441|NCT00265395|470599758|FG001|Overall Study|Adverse Event|6|||
130720442|NCT00265395|470599757|FG000|Overall Study|Lost to Follow-up|2|||
130720443|NCT00265395|470599758|FG001|Overall Study|Lost to Follow-up|1|||
130720444|NCT00265395|470599757|FG000|Overall Study|Withdrawal by Subject|1|||
130720445|NCT00265395|470599758|FG001|Overall Study|Withdrawal by Subject|6|||
130720446|NCT00265395|470599757|FG000|Overall Study|Protocol Violation|2|||
130720447|NCT00265395|470599758|FG001|Overall Study|Protocol Violation|2|||
130720448|NCT00265395|470599757|FG000|Overall Study|Lack of Efficacy|0|||
130720449|NCT00265395|470599758|FG001|Overall Study|Lack of Efficacy|1|||
130720450|NCT00265395|470599757|FG000|Overall Study|Administrative|0|||
130720451|NCT00265395|470599758|FG001|Overall Study|Administrative|1|||
130720452|NCT00552578|470599764|FG000|Overall Study|Lost to Follow-up|1|||
130720453|NCT00552578|470599765|FG001|Overall Study|Lost to Follow-up|1|||
130720454|NCT04053465|470599766|FG000|Overall Study|Withdrawal by Subject|4|||
130720455|NCT04053465|470599767|FG001|Overall Study|Withdrawal by Subject|4|||
130720456|NCT02338193|470599769|FG000|Overall Study|Withdrawal by Subject|0|||
130720457|NCT02338193|470599770|FG001|Overall Study|Withdrawal by Subject|0|||
130720458|NCT02338193|470599771|FG002|Overall Study|Withdrawal by Subject|2|||
130720459|NCT02338193|470599769|FG000|Overall Study|Pregnancy|0|||
130720460|NCT02338193|470599770|FG001|Overall Study|Pregnancy|1|||
130720461|NCT02338193|470599771|FG002|Overall Study|Pregnancy|1|||
130720462|NCT02338193|470599769|FG000|Overall Study|Noncompliant with visits|2|||
130720463|NCT02338193|470599770|FG001|Overall Study|Noncompliant with visits|2|||
130720464|NCT02338193|470599771|FG002|Overall Study|Noncompliant with visits|7|||
130720465|NCT02338193|470599769|FG000|Overall Study|moved out of state|0|||
130720466|NCT02338193|470599770|FG001|Overall Study|moved out of state|1|||
130720467|NCT02338193|470599771|FG002|Overall Study|moved out of state|0|||
130720468|NCT02338193|470599769|FG000|Overall Study|intolerant of side effects|1|||
130720469|NCT02338193|470599770|FG001|Overall Study|intolerant of side effects|0|||
130720470|NCT02338193|470599771|FG002|Overall Study|intolerant of side effects|0|||
130720471|NCT00742924|470599772|FG000|Overall Study|Adverse Event|0|||
130720472|NCT00742924|470599773|FG001|Overall Study|Adverse Event|0|||
130720473|NCT00742924|470599774|FG002|Overall Study|Adverse Event|1|||
130720474|NCT00742924|470599775|FG003|Overall Study|Adverse Event|1|||
130720475|NCT00742924|470599772|FG000|Overall Study|Lack of Efficacy|5|||
130720476|NCT00742924|470599773|FG001|Overall Study|Lack of Efficacy|1|||
130720477|NCT00742924|470599774|FG002|Overall Study|Lack of Efficacy|2|||
130720478|NCT00742924|470599775|FG003|Overall Study|Lack of Efficacy|4|||
130720479|NCT00742924|470599772|FG000|Overall Study|Physician Decision|0|||
130720480|NCT00742924|470599773|FG001|Overall Study|Physician Decision|0|||
130720481|NCT00742924|470599774|FG002|Overall Study|Physician Decision|0|||
130720482|NCT00742924|470599775|FG003|Overall Study|Physician Decision|1|||
130720483|NCT00742924|470599772|FG000|Overall Study|Withdrawal by Subject|0|||
130720484|NCT00742924|470599773|FG001|Overall Study|Withdrawal by Subject|1|||
130314810|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314811|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314812|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314813|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314814|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314815|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314816|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
130375971|NCT04102020|469342053|FG003|Overall Study|Death|1|||
130720485|NCT00742924|470599774|FG002|Overall Study|Withdrawal by Subject|1|||
130720486|NCT00742924|470599775|FG003|Overall Study|Withdrawal by Subject|0|||
130720487|NCT00660400|470599776|FG000|Overall Study|Lack of insurance approval|1|||
130720488|NCT00660400|470599776|FG000|Overall Study|Suboptimal organ function|1|||
130720489|NCT00660400|470599776|FG000|Overall Study|Intracranial hemorrhage|1|||
130720490|NCT00660400|470599776|FG000|Overall Study|Withdrawal by Subject|1|||
130720491|NCT02643355|470599777|FG000|Overall Study|Withdrawal by Subject|1|||
130720492|NCT02643355|470599778|FG001|Overall Study|Withdrawal by Subject|3|||
130720493|NCT02643355|470599777|FG000|Overall Study|Protocol Violation|0|||
130720494|NCT02643355|470599778|FG001|Overall Study|Protocol Violation|2|||
130375972|NCT04102020|469342054|FG004|Overall Study|Death|0|||
130375973|NCT04102020|469342050|FG000|Overall Study|Physician Decision|1|||
130375974|NCT04102020|469342051|FG001|Overall Study|Physician Decision|2|||
130375975|NCT04102020|469342052|FG002|Overall Study|Physician Decision|2|||
130375976|NCT04102020|469342053|FG003|Overall Study|Physician Decision|0|||
130375977|NCT04102020|469342054|FG004|Overall Study|Physician Decision|1|||
130375978|NCT04102020|469342050|FG000|Overall Study|COVID-19 Infection|1|||
130375979|NCT04102020|469342051|FG001|Overall Study|COVID-19 Infection|0|||
130375980|NCT04102020|469342052|FG002|Overall Study|COVID-19 Infection|0|||
130375981|NCT04102020|469342053|FG003|Overall Study|COVID-19 Infection|0|||
130375982|NCT04102020|469342054|FG004|Overall Study|COVID-19 Infection|0|||
130375983|NCT04102020|469342050|FG000|Overall Study|Not disclosed|5|||
130375984|NCT04102020|469342051|FG001|Overall Study|Not disclosed|3|||
130720495|NCT06354998|470599779|FG000|Overall Study|Withdrawal by Subject|3|||
130314817|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314818|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314819|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314820|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314821|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314822|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314823|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314824|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314825|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314826|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
130314827|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314828|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130314829|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130314830|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314831|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314832|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314833|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314834|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314835|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314836|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
130314837|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
130314838|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
130314839|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
130314840|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314841|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314842|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314843|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314844|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314845|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314846|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130314847|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314848|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
130314849|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130314850|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314851|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314852|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314853|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314854|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314855|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314856|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130314857|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314858|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130314859|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314860|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
130314861|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130314862|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130314863|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
130720496|NCT06354998|470599780|FG001|Overall Study|Withdrawal by Subject|0|||
130314864|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130375985|NCT04102020|469342052|FG002|Overall Study|Not disclosed|8|||
130375986|NCT04102020|469342053|FG003|Overall Study|Not disclosed|0|||
130375987|NCT04102020|469342054|FG004|Overall Study|Not disclosed|1|||
130375988|NCT04102020|469342050|FG000|Overall Study|MIssing|1|||
130375989|NCT04102020|469342051|FG001|Overall Study|MIssing|0|||
130375990|NCT04102020|469342052|FG002|Overall Study|MIssing|1|||
130375991|NCT04102020|469342053|FG003|Overall Study|MIssing|1|||
130375992|NCT04102020|469342054|FG004|Overall Study|MIssing|1|||
130375993|NCT04102020|469342050|FG000|Overall Study|Continuing in ongoing study|13|||
130375994|NCT04102020|469342051|FG001|Overall Study|Continuing in ongoing study|13|||
130375995|NCT04102020|469342052|FG002|Overall Study|Continuing in ongoing study|7|||
130375996|NCT04102020|469342053|FG003|Overall Study|Continuing in ongoing study|26|||
130375997|NCT04102020|469342054|FG004|Overall Study|Continuing in ongoing study|12|||
130375998|NCT04600921|469342057|FG000|Overall Study|Withdrawal by Subject|3|||
130375999|NCT04600921|469342058|FG001|Overall Study|Withdrawal by Subject|5|||
130376000|NCT04600921|469342057|FG000|Overall Study|Death|0|||
130376001|NCT04600921|469342058|FG001|Overall Study|Death|1|||
130376002|NCT02239978|469343550|FG000|Overall Study|Withdrawal by Subject|2|||
130376003|NCT02239978|469343551|FG001|Overall Study|Withdrawal by Subject|0|||
130376004|NCT00996216|469343557|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
130376005|NCT00996216|469343557|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
130376006|NCT00996216|469343557|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
130376007|NCT00482612|469343564|FG000|In-treatment Period|No study medication administered|0|||
130376008|NCT00482612|469343565|FG001|In-treatment Period|No study medication administered|0|||
130376009|NCT00482612|469343566|FG002|In-treatment Period|No study medication administered|1|||
130376010|NCT00482612|469343567|FG003|In-treatment Period|No study medication administered|0|||
130376011|NCT00482612|469343564|FG000|Follow-up Period|Other|4|||
130376012|NCT00482612|469343565|FG001|Follow-up Period|Other|2|||
130376013|NCT00482612|469343566|FG002|Follow-up Period|Other|1|||
130376014|NCT00482612|469343567|FG003|Follow-up Period|Other|2|||
130376015|NCT00482612|469343564|FG000|Follow-up Period|Lack of compliance|0|||
130376016|NCT00482612|469343565|FG001|Follow-up Period|Lack of compliance|0|||
130376017|NCT00482612|469343566|FG002|Follow-up Period|Lack of compliance|1|||
130376018|NCT00482612|469343567|FG003|Follow-up Period|Lack of compliance|0|||
130376019|NCT00482612|469343564|FG000|Follow-up Period|Lost to Follow-up|0|||
130376020|NCT00482612|469343565|FG001|Follow-up Period|Lost to Follow-up|4|||
130376021|NCT00482612|469343566|FG002|Follow-up Period|Lost to Follow-up|2|||
130376022|NCT00482612|469343567|FG003|Follow-up Period|Lost to Follow-up|1|||
130376023|NCT00482612|469343564|FG000|Follow-up Period|Adverse Event|4|||
130376024|NCT00482612|469343565|FG001|Follow-up Period|Adverse Event|7|||
130376025|NCT00482612|469343566|FG002|Follow-up Period|Adverse Event|9|||
130376026|NCT00482612|469343567|FG003|Follow-up Period|Adverse Event|0|||
130376027|NCT00482612|469343564|FG000|Follow-up Period|Lack of Efficacy|2|||
130376028|NCT00482612|469343565|FG001|Follow-up Period|Lack of Efficacy|0|||
130376029|NCT00482612|469343566|FG002|Follow-up Period|Lack of Efficacy|1|||
130376030|NCT00482612|469343567|FG003|Follow-up Period|Lack of Efficacy|0|||
130376031|NCT00482612|469343564|FG000|Follow-up Period|Withdrawal by Subject|3|||
130376032|NCT00482612|469343565|FG001|Follow-up Period|Withdrawal by Subject|5|||
130376033|NCT00482612|469343566|FG002|Follow-up Period|Withdrawal by Subject|7|||
130376034|NCT00482612|469343567|FG003|Follow-up Period|Withdrawal by Subject|2|||
130376035|NCT00482612|469343564|FG000|Follow-up Period|Reasons not related to trial|1|||
130376036|NCT00482612|469343565|FG001|Follow-up Period|Reasons not related to trial|0|||
130376037|NCT00482612|469343566|FG002|Follow-up Period|Reasons not related to trial|1|||
130376038|NCT00482612|469343567|FG003|Follow-up Period|Reasons not related to trial|3|||
130376039|NCT01366521|469343568|FG000|Overall Study|Adverse Event|1|||
130376040|NCT01366521|469343569|FG001|Overall Study|Adverse Event|0|||
130376041|NCT01366521|469343570|FG002|Overall Study|Adverse Event|0|||
130376042|NCT01366521|469343571|FG003|Overall Study|Adverse Event|0|||
130376043|NCT01366521|469343568|FG000|Overall Study|Protocol Violation|0|||
130376044|NCT01366521|469343569|FG001|Overall Study|Protocol Violation|0|||
130376045|NCT01366521|469343570|FG002|Overall Study|Protocol Violation|1|||
130376046|NCT01366521|469343571|FG003|Overall Study|Protocol Violation|0|||
130376047|NCT01366521|469343568|FG000|Overall Study|Physician Decision|0|||
130376048|NCT01366521|469343569|FG001|Overall Study|Physician Decision|0|||
130376049|NCT01366521|469343570|FG002|Overall Study|Physician Decision|1|||
130376050|NCT01366521|469343571|FG003|Overall Study|Physician Decision|0|||
130376051|NCT01366521|469343568|FG000|Overall Study|Withdrawal by Subject|0|||
130376052|NCT01366521|469343569|FG001|Overall Study|Withdrawal by Subject|1|||
130376053|NCT01366521|469343570|FG002|Overall Study|Withdrawal by Subject|0|||
130376054|NCT01366521|469343571|FG003|Overall Study|Withdrawal by Subject|0|||
130376055|NCT00759031|469343572|FG000|First Intervention (1 Day)|Physician Decision|1|||
130376056|NCT00759031|469343573|FG001|First Intervention (1 Day)|Physician Decision|0|||
130376057|NCT00759031|469343572|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130376058|NCT00759031|469343573|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130376059|NCT00759031|469343572|FG000|First Intervention (1 Day)|Screening failure|1|||
130376060|NCT00759031|469343573|FG001|First Intervention (1 Day)|Screening failure|0|||
130376061|NCT03506815|469343574|FG000|Overall Study|Adverse Event|8|||
130376062|NCT03506815|469343575|FG001|Overall Study|Adverse Event|0|||
130376063|NCT03506815|469343574|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
130376064|NCT03506815|469343575|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
130376065|NCT03506815|469343574|FG000|Overall Study|Protocol Violation|1|||
130376066|NCT03506815|469343575|FG001|Overall Study|Protocol Violation|0|||
130376067|NCT03506815|469343574|FG000|Overall Study|Elective Surgery|1|||
130376068|NCT03506815|469343575|FG001|Overall Study|Elective Surgery|0|||
130376069|NCT02899988|469343579|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130376070|NCT02899988|469343580|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
130376071|NCT02899988|469343581|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376072|NCT02899988|469343582|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376073|NCT02899988|469343583|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376074|NCT02899988|469343584|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130559332|NCT01514136|470016471|FG001|Test Period 2; Test A*|Holiday|0|||
130720497|NCT00826449|470599783|FG000|Overall Study|Disease Progression|4|||
130720498|NCT00826449|470599783|FG000|Overall Study|Withdrawal by Subject|1|||
130720499|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
130720500|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
130720501|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
130720502|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
130720503|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
130720504|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
130720505|NCT03233230|470599786|FG000|Overall Study|Adverse Event|6|||
130720506|NCT03233230|470599787|FG001|Overall Study|Adverse Event|3|||
130720507|NCT03233230|470599788|FG002|Overall Study|Adverse Event|6|||
130720508|NCT03233230|470599789|FG003|Overall Study|Adverse Event|3|||
130720509|NCT03233230|470599786|FG000|Overall Study|Protocol Violation|1|||
130720510|NCT03233230|470599787|FG001|Overall Study|Protocol Violation|2|||
130720511|NCT03233230|470599788|FG002|Overall Study|Protocol Violation|1|||
130720512|NCT03233230|470599789|FG003|Overall Study|Protocol Violation|1|||
130720513|NCT03233230|470599786|FG000|Overall Study|Lack of Efficacy|1|||
130720514|NCT03233230|470599787|FG001|Overall Study|Lack of Efficacy|0|||
130720515|NCT03233230|470599788|FG002|Overall Study|Lack of Efficacy|0|||
130720516|NCT03233230|470599789|FG003|Overall Study|Lack of Efficacy|0|||
130720517|NCT03233230|470599786|FG000|Overall Study|Other|5|||
130720518|NCT03233230|470599787|FG001|Overall Study|Other|5|||
130720519|NCT03233230|470599788|FG002|Overall Study|Other|5|||
130720520|NCT03233230|470599789|FG003|Overall Study|Other|3|||
130720521|NCT03233230|470599786|FG000|Overall Study|Withdrawal by Subject|2|||
130720522|NCT03233230|470599787|FG001|Overall Study|Withdrawal by Subject|2|||
130720523|NCT03233230|470599788|FG002|Overall Study|Withdrawal by Subject|0|||
130720524|NCT03233230|470599789|FG003|Overall Study|Withdrawal by Subject|1|||
130720525|NCT03233230|470599786|FG000|Overall Study|Lost to Follow-up|0|||
130720526|NCT03233230|470599787|FG001|Overall Study|Lost to Follow-up|3|||
130720527|NCT03233230|470599788|FG002|Overall Study|Lost to Follow-up|0|||
130314865|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130314866|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
130314867|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130314868|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130314869|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
130314870|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130314871|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130314872|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
130314873|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130314874|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130314875|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
130314876|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130314877|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130314878|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
130314879|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130314880|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130314881|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
130314882|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130314883|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130376075|NCT02899988|469343585|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376076|NCT02899988|469343586|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376077|NCT02899988|469343587|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376078|NCT02899988|469343588|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376079|NCT02899988|469343589|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130376080|NCT02899988|469343579|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
130376081|NCT02899988|469343580|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
130376082|NCT02899988|469343581|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
130376083|NCT02899988|469343582|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
130376084|NCT02899988|469343583|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130376085|NCT02899988|469343584|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130376086|NCT02899988|469343585|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130376087|NCT02899988|469343586|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
130376088|NCT02899988|469343587|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
130376089|NCT02899988|469343588|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
130376090|NCT02899988|469343589|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
130376091|NCT02899988|469343579|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
130376092|NCT02899988|469343580|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
130720528|NCT03233230|470599789|FG003|Overall Study|Lost to Follow-up|0|||
130720529|NCT02987959|470599790|FG000|Overall Study|Grantor stopped supply of drugs|6|||
130376093|NCT02899988|469343581|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
130376094|NCT02899988|469343582|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
130376095|NCT02899988|469343583|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
130376096|NCT02899988|469343584|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
130376097|NCT02899988|469343585|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
130376098|NCT02899988|469343586|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
130376099|NCT02899988|469343587|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
130559333|NCT01514136|470016472|FG002|Test Period 2; Test A*|Holiday|0|||
130559334|NCT01514136|470016473|FG003|Test Period 2; Test A*|Holiday|0|||
130559335|NCT01514136|470016474|FG004|Test Period 2; Test A*|Holiday|1|||
130559336|NCT01514136|470016475|FG005|Test Period 2; Test A*|Holiday|0|||
130559337|NCT01514136|470016476|FG006|Test Period 2; Test A*|Holiday|0|||
130559338|NCT01514136|470016477|FG007|Test Period 2; Test A*|Holiday|0|||
130559339|NCT01514136|470016470|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559340|NCT01514136|470016471|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559341|NCT01514136|470016472|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559342|NCT01514136|470016473|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559343|NCT01514136|470016474|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559344|NCT01514136|470016475|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
130559345|NCT01514136|470016476|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
130720530|NCT01898650|470599796|FG000|Overall Study|the subject would not lie still for imaging|1|||
130720531|NCT00911807|470599797|FG000|Overall Study|Adverse Event|2|||
130720532|NCT00911807|470599798|FG001|Overall Study|Adverse Event|1|||
130720533|NCT00911807|470599799|FG002|Overall Study|Adverse Event|5|||
130720534|NCT00911807|470599797|FG000|Overall Study|Death|0|||
130720535|NCT00911807|470599798|FG001|Overall Study|Death|0|||
130314884|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
130314885|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130314886|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130314887|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
130314888|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130314889|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130314890|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
130314891|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130314892|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130314893|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
130314894|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130314895|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130314896|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
130314897|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
130314898|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
130314899|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
130314900|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
130314901|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
130314902|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
130314903|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
130314904|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
130314905|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
130314906|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130314907|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130314908|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130314909|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130314910|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
130314911|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130314912|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
130314913|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130314914|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
130314915|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
130314916|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
130314917|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
130314918|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
130314919|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
130314920|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130314921|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
130314922|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130314923|NCT02910466|469118374|FG000|Overall Study|Adverse Event|1|||
130376100|NCT02899988|469343588|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
130376101|NCT02899988|469343589|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
130559346|NCT01514136|470016477|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
130559347|NCT01514136|470016470|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
130559348|NCT01514136|470016471|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
130466579|NCT04629950|469674846|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
130466580|NCT04629950|469674843|FG000|Extension Study|Withdrawal by Subject|0|||
130466581|NCT04629950|469674844|FG001|Extension Study|Withdrawal by Subject|0|||
130466582|NCT04629950|469674845|FG002|Extension Study|Withdrawal by Subject|1|||
130466583|NCT04629950|469674846|FG003|Extension Study|Withdrawal by Subject|0|||
130466584|NCT04629950|469674843|FG000|Extension Study|Adverse Event|0|||
130466585|NCT04629950|469674844|FG001|Extension Study|Adverse Event|0|||
130466586|NCT04629950|469674845|FG002|Extension Study|Adverse Event|0|||
130466587|NCT04629950|469674846|FG003|Extension Study|Adverse Event|1|||
130466588|NCT02088853|469674847|FG000|Overall Study|Pregnancy|1|||
130466589|NCT02088853|469674848|FG001|Overall Study|Pregnancy|0|||
130720536|NCT00911807|470599799|FG002|Overall Study|Death|1|||
130720537|NCT00911807|470599797|FG000|Overall Study|Protocol Violation|6|||
130720538|NCT00911807|470599798|FG001|Overall Study|Protocol Violation|4|||
130314924|NCT02910466|469118374|FG000|Overall Study|Withdrawal by Subject|3|||
130314925|NCT02910466|469118374|FG000|Overall Study|Lost to Follow-up|5|||
130314926|NCT02910466|469118374|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
130314927|NCT02910466|469118374|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
130314928|NCT04332107|469118383|FG000|Day 3|Lost to Follow-up|23|||
130314929|NCT04332107|469118384|FG001|Day 3|Lost to Follow-up|14|||
130314930|NCT04332107|469118383|FG000|Day 3|Missing outcome data|3|||
130314931|NCT04332107|469118384|FG001|Day 3|Missing outcome data|6|||
130314932|NCT04332107|469118383|FG000|Day 14|Lost to Follow-up|13|||
130314933|NCT04332107|469118384|FG001|Day 14|Lost to Follow-up|4|||
130314934|NCT04332107|469118383|FG000|Day 14|Missing outcome data|4|||
130314935|NCT04332107|469118384|FG001|Day 14|Missing outcome data|4|||
130314936|NCT04332107|469118383|FG000|Day 21|Lost to Follow-up|10|||
130314937|NCT04332107|469118384|FG001|Day 21|Lost to Follow-up|2|||
130314938|NCT00871871|469118389|FG000|Part I|Adverse Event|0|||
130314939|NCT00871871|469118390|FG001|Part I|Adverse Event|2|||
130314940|NCT00871871|469118391|FG002|Part I|Adverse Event|0|||
130314941|NCT00871871|469118392|FG003|Part I|Adverse Event|0|||
130314942|NCT00871871|469118389|FG000|Part I|Withdrawal by Subject|3|||
130314943|NCT00871871|469118390|FG001|Part I|Withdrawal by Subject|0|||
130314944|NCT00871871|469118391|FG002|Part I|Withdrawal by Subject|0|||
130314945|NCT00871871|469118392|FG003|Part I|Withdrawal by Subject|0|||
130314946|NCT00871871|469118389|FG000|Part I|Laboratory abnormality|0|||
130314947|NCT00871871|469118390|FG001|Part I|Laboratory abnormality|1|||
130314948|NCT00871871|469118391|FG002|Part I|Laboratory abnormality|0|||
130314949|NCT00871871|469118392|FG003|Part I|Laboratory abnormality|0|||
130314950|NCT00871871|469118389|FG000|Part II|Lack of Efficacy|0|||
130314951|NCT00871871|469118390|FG001|Part II|Lack of Efficacy|0|||
130314952|NCT00871871|469118391|FG002|Part II|Lack of Efficacy|1|||
130314953|NCT00871871|469118392|FG003|Part II|Lack of Efficacy|0|||
130314954|NCT00871871|469118389|FG000|Part II|Withdrawal by Subject|0|||
130314955|NCT00871871|469118390|FG001|Part II|Withdrawal by Subject|0|||
130314956|NCT00871871|469118391|FG002|Part II|Withdrawal by Subject|2|||
130314957|NCT00871871|469118392|FG003|Part II|Withdrawal by Subject|1|||
130314958|NCT00871871|469118389|FG000|Part II|Adverse Event|0|||
130314959|NCT00871871|469118390|FG001|Part II|Adverse Event|0|||
130376102|NCT02899988|469343579|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
130376103|NCT02899988|469343580|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
130376104|NCT02899988|469343581|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
130376105|NCT02899988|469343582|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
130376106|NCT02899988|469343583|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
130376107|NCT02899988|469343584|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
130376108|NCT02899988|469343585|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
130466590|NCT00396084|469674849|FG000|Overall Study|Adverse Event|0|||
130466591|NCT00396084|469674850|FG001|Overall Study|Adverse Event|0|||
130466592|NCT00396084|469674851|FG002|Overall Study|Adverse Event|0|||
130466593|NCT00396084|469674852|FG003|Overall Study|Adverse Event|0|||
130466594|NCT00396084|469674853|FG004|Overall Study|Adverse Event|1|||
130466595|NCT00396084|469674854|FG005|Overall Study|Adverse Event|2|||
130466596|NCT00396084|469674849|FG000|Overall Study|Withdrawal by Subject|0|||
130466597|NCT00396084|469674850|FG001|Overall Study|Withdrawal by Subject|0|||
130466598|NCT00396084|469674851|FG002|Overall Study|Withdrawal by Subject|0|||
130466599|NCT00396084|469674852|FG003|Overall Study|Withdrawal by Subject|1|||
130466600|NCT00396084|469674853|FG004|Overall Study|Withdrawal by Subject|0|||
130314960|NCT00871871|469118391|FG002|Part II|Adverse Event|1|||
130314961|NCT00871871|469118392|FG003|Part II|Adverse Event|2|||
130314962|NCT00871871|469118389|FG000|Part II|Protocol Violation|0|||
130376109|NCT02899988|469343586|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
130466601|NCT00396084|469674854|FG005|Overall Study|Withdrawal by Subject|0|||
130466602|NCT02708108|469674855|FG000|Overall Study|Death|1|||
130314963|NCT00871871|469118390|FG001|Part II|Protocol Violation|0|||
130314964|NCT00871871|469118391|FG002|Part II|Protocol Violation|0|||
130314965|NCT00871871|469118392|FG003|Part II|Protocol Violation|1|||
130314966|NCT01808196|469118396|FG000|Overall Study|Lost to Follow-up|1|||
130314967|NCT00479713|469118397|FG000|Overall Study|Adverse Event|8|||
130314968|NCT00479713|469118398|FG001|Overall Study|Adverse Event|6|||
130376110|NCT02899988|469343587|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
130376111|NCT02899988|469343588|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
130376112|NCT02899988|469343589|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
130376113|NCT02899988|469343579|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376114|NCT02899988|469343580|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376115|NCT02899988|469343581|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376116|NCT02899988|469343582|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376117|NCT02899988|469343583|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376118|NCT02899988|469343584|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
130376119|NCT02899988|469343585|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376120|NCT02899988|469343586|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
130376121|NCT02899988|469343587|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376122|NCT02899988|469343588|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376123|NCT02899988|469343589|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130376124|NCT02899988|469343579|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130376125|NCT02899988|469343580|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130376126|NCT02899988|469343581|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130376127|NCT02899988|469343582|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130314969|NCT00479713|469118397|FG000|Overall Study|Death|1|||
130314970|NCT00479713|469118398|FG001|Overall Study|Death|0|||
130314971|NCT00479713|469118397|FG000|Overall Study|Lost to Follow-up|0|||
130314972|NCT00479713|469118398|FG001|Overall Study|Lost to Follow-up|1|||
130314973|NCT00479713|469118397|FG000|Overall Study|Protocol Violation|0|||
130314974|NCT00479713|469118398|FG001|Overall Study|Protocol Violation|1|||
130314975|NCT00479713|469118397|FG000|Overall Study|Withdrawal by Subject|4|||
130314976|NCT00479713|469118398|FG001|Overall Study|Withdrawal by Subject|1|||
130314977|NCT03863509|469118401|FG000|Overall Study|COVID-19 shutdown period|0|||
130314978|NCT03863509|469118402|FG001|Overall Study|COVID-19 shutdown period|4|||
130314979|NCT03863509|469118403|FG002|Overall Study|COVID-19 shutdown period|0|||
130314980|NCT03863509|469118401|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
130314981|NCT03863509|469118402|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
130314982|NCT03863509|469118403|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
130314983|NCT03863509|469118401|FG000|Overall Study|Lost to Follow-up|8|||
130314984|NCT03863509|469118402|FG001|Overall Study|Lost to Follow-up|0|||
130314985|NCT03863509|469118403|FG002|Overall Study|Lost to Follow-up|2|||
130314986|NCT03863509|469118401|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
130314987|NCT03863509|469118402|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
130314988|NCT03863509|469118403|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
130314989|NCT03863509|469118401|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130314990|NCT03863509|469118402|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
130314991|NCT03863509|469118403|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130314992|NCT00141102|469118404|FG000|Overall Study|Adverse Event|233|||
130314993|NCT00141102|469118405|FG001|Overall Study|Adverse Event|305|||
130314994|NCT00141102|469118404|FG000|Overall Study|Laboratory Abnormality|9|||
130314995|NCT00141102|469118405|FG001|Overall Study|Laboratory Abnormality|33|||
130314996|NCT00141102|469118404|FG000|Overall Study|Lack of Efficacy|21|||
130314997|NCT00141102|469118405|FG001|Overall Study|Lack of Efficacy|26|||
130314998|NCT00141102|469118404|FG000|Overall Study|Lost to Follow-up|29|||
130314999|NCT00141102|469118405|FG001|Overall Study|Lost to Follow-up|32|||
130315000|NCT00141102|469118404|FG000|Overall Study|Other|87|||
130315001|NCT00141102|469118405|FG001|Overall Study|Other|76|||
130315002|NCT00141102|469118404|FG000|Overall Study|Withdrawal by Subject|112|||
130315003|NCT00141102|469118405|FG001|Overall Study|Withdrawal by Subject|142|||
130315004|NCT00141102|469118404|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
130315005|NCT00141102|469118405|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
130376128|NCT02899988|469343583|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
130376129|NCT02899988|469343584|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130376130|NCT02899988|469343585|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
130376131|NCT02899988|469343586|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
130376132|NCT02899988|469343587|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
130376133|NCT02899988|469343588|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130376134|NCT02899988|469343589|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
130376135|NCT01401283|469343590|FG000|Overall Study|surgery cancelled|5|||
130376136|NCT01401283|469343591|FG001|Overall Study|surgery cancelled|8|||
130376137|NCT01401283|469343590|FG000|Overall Study|preoperative arrhythmia|5|||
130376138|NCT01401283|469343591|FG001|Overall Study|preoperative arrhythmia|0|||
130466603|NCT02708108|469674856|FG001|Overall Study|Death|2|||
130466604|NCT02708108|469674855|FG000|Overall Study|Regimen change|1|||
130466605|NCT02708108|469674856|FG001|Overall Study|Regimen change|0|||
130720539|NCT00911807|470599799|FG002|Overall Study|Protocol Violation|9|||
130315006|NCT00141102|469118404|FG000|Overall Study|Death|2|||
130376139|NCT01401283|469343590|FG000|Overall Study|no central venous access|0|||
130315007|NCT00141102|469118405|FG001|Overall Study|Death|2|||
130315008|NCT01063153|469118409|FG000|Overall Study|Found Ineligible During Screening|2|||
130315009|NCT01063153|469118410|FG001|Overall Study|Found Ineligible During Screening|0|||
130315010|NCT01063153|469118409|FG000|Overall Study|Lost to Follow-up|0|||
130315011|NCT01063153|469118410|FG001|Overall Study|Lost to Follow-up|7|||
130315012|NCT01063153|469118409|FG000|Overall Study|Withdrawal by Subject|0|||
130315013|NCT01063153|469118410|FG001|Overall Study|Withdrawal by Subject|1|||
130315014|NCT01063153|469118409|FG000|Overall Study|Physician Decision|0|||
130315015|NCT01063153|469118410|FG001|Overall Study|Physician Decision|4|||
130315016|NCT00350844|469118411|FG000|Overall Study|Lost to Follow-up|1|||
130315017|NCT02775916|469118414|FG000|Overall Study|Adverse Event|1|||
130315018|NCT02775916|469118415|FG001|Overall Study|Adverse Event|0|||
130315019|NCT02775916|469118414|FG000|Overall Study|Subject/Guardian Decision|2|||
130315020|NCT02775916|469118415|FG001|Overall Study|Subject/Guardian Decision|0|||
130315021|NCT03737123|469120805|FG000|Study Treatment|Adverse Event|2|||
130315022|NCT03737123|469120806|FG001|Study Treatment|Adverse Event|0|||
130315023|NCT03737123|469120805|FG000|Study Treatment|Disease Progression|2|||
130315024|NCT03737123|469120806|FG001|Study Treatment|Disease Progression|0|||
130315025|NCT03737123|469120805|FG000|Study Treatment|Withdrawal by Subject|2|||
130315026|NCT03737123|469120806|FG001|Study Treatment|Withdrawal by Subject|0|||
130315027|NCT03737123|469120805|FG000|Follow up|Death|1|||
130315028|NCT03737123|469120806|FG001|Follow up|Death|0|||
130315029|NCT03737123|469120805|FG000|Follow up|Withdrawal by Subject|1|||
130315030|NCT03737123|469120806|FG001|Follow up|Withdrawal by Subject|0|||
130315031|NCT03737123|469120805|FG000|Follow up|Termination of study|4|||
130315032|NCT03737123|469120806|FG001|Follow up|Termination of study|0|||
130315033|NCT02173769|469120807|FG000|Overall Study|Protocol Violation|4|||
130315034|NCT03016312|469120814|FG000|Overall Study|discontinued before the treatment started|0|||
130315035|NCT03016312|469120815|FG001|Overall Study|discontinued before the treatment started|1|||
130315036|NCT03016312|469120814|FG000|Overall Study|Withdrawal by Subject|37|||
130315037|NCT03016312|469120815|FG001|Overall Study|Withdrawal by Subject|44|||
130315038|NCT03016312|469120814|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
130315039|NCT03016312|469120815|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
130315040|NCT03016312|469120814|FG000|Overall Study|Physician Decision|1|||
130315041|NCT03016312|469120815|FG001|Overall Study|Physician Decision|3|||
130315042|NCT03016312|469120814|FG000|Overall Study|Lost to Follow-up|12|||
130315043|NCT03016312|469120815|FG001|Overall Study|Lost to Follow-up|12|||
130315044|NCT03016312|469120814|FG000|Overall Study|Death|210|||
130315045|NCT03016312|469120815|FG001|Overall Study|Death|184|||
130315046|NCT03016312|469120814|FG000|Overall Study|loss to contact|1|||
130315047|NCT03016312|469120815|FG001|Overall Study|loss to contact|0|||
130315048|NCT03016312|469120814|FG000|Overall Study|started a new cancer therapy|1|||
130315049|NCT03016312|469120815|FG001|Overall Study|started a new cancer therapy|0|||
130315050|NCT00308139|469120817|FG000|Overall Study|Adverse Event|20|||
130315051|NCT00308139|469120818|FG001|Overall Study|Adverse Event|14|||
130315052|NCT00308139|469120817|FG000|Overall Study|Lost to Follow-up|13|||
130315053|NCT00308139|469120818|FG001|Overall Study|Lost to Follow-up|8|||
130315054|NCT00308139|469120817|FG000|Overall Study|Protocol Violation|3|||
130315055|NCT00308139|469120818|FG001|Overall Study|Protocol Violation|2|||
130315056|NCT00308139|469120817|FG000|Overall Study|Withdrawal of Consent|40|||
130315057|NCT00308139|469120818|FG001|Overall Study|Withdrawal of Consent|42|||
130315058|NCT00308139|469120817|FG000|Overall Study|Investigator Decision|11|||
130315059|NCT00308139|469120818|FG001|Overall Study|Investigator Decision|10|||
130315060|NCT00308139|469120817|FG000|Overall Study|Loss of Glucose Control|5|||
130315061|NCT00308139|469120818|FG001|Overall Study|Loss of Glucose Control|7|||
130315062|NCT00308139|469120817|FG000|Overall Study|Administrative|1|||
130315063|NCT00308139|469120818|FG001|Overall Study|Administrative|4|||
130315064|NCT00308139|469120817|FG000|Overall Study|Other|1|||
130315065|NCT00308139|469120818|FG001|Overall Study|Other|0|||
130315066|NCT01884077|469120819|FG000|Overall Study|screen fail|0|||
130315067|NCT01884077|469120820|FG001|Overall Study|screen fail|2|||
130315068|NCT01884077|469120819|FG000|Overall Study|canceled surgery|2|||
130315069|NCT01884077|469120820|FG001|Overall Study|canceled surgery|0|||
130315070|NCT01884077|469120819|FG000|Overall Study|Lost to Follow-up|0|||
130315071|NCT01884077|469120820|FG001|Overall Study|Lost to Follow-up|4|||
130315072|NCT01884077|469120819|FG000|Overall Study|study closed|6|||
130315073|NCT01884077|469120820|FG001|Overall Study|study closed|4|||
130720540|NCT00911807|470599797|FG000|Overall Study|Withdrawal by Subject|8|||
130315074|NCT00981149|469120821|FG000|Overall Study|Lost to Follow-up|1|||
130315075|NCT00981149|469120822|FG001|Overall Study|Lost to Follow-up|2|||
130315076|NCT00981149|469120821|FG000|Overall Study|Withdrawal by Subject|1|||
130315077|NCT00981149|469120822|FG001|Overall Study|Withdrawal by Subject|1|||
130315078|NCT01220167|469120826|FG000|Period 3|Urine positive for substance abuse|0|||
130315079|NCT01220167|469120827|FG001|Period 3|Urine positive for substance abuse|1|||
130315080|NCT01220167|469120828|FG002|Period 3|Urine positive for substance abuse|0|||
130315081|NCT05789745|469120829|FG000|Overall Study|Withdrawal by Subject|0|||
130315082|NCT05789745|469120830|FG001|Overall Study|Withdrawal by Subject|0|||
130720541|NCT00911807|470599798|FG001|Overall Study|Withdrawal by Subject|10|||
130720542|NCT00911807|470599799|FG002|Overall Study|Withdrawal by Subject|7|||
130720543|NCT00911807|470599797|FG000|Overall Study|Organizational reasons|1|||
130720544|NCT00911807|470599798|FG001|Overall Study|Organizational reasons|3|||
130720545|NCT00911807|470599799|FG002|Overall Study|Organizational reasons|1|||
130720546|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
130720547|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
130315083|NCT05789745|469120831|FG002|Overall Study|Withdrawal by Subject|0|||
130315084|NCT05789745|469120832|FG003|Overall Study|Withdrawal by Subject|0|||
130315085|NCT05789745|469120833|FG004|Overall Study|Withdrawal by Subject|1|||
130315086|NCT02634333|469120836|FG000|Overall Study|Completed out of Window|3|||
130315087|NCT02634333|469120837|FG001|Overall Study|Completed out of Window|2|||
130315088|NCT02634333|469120836|FG000|Overall Study|Missed Visit|5|||
130315089|NCT02634333|469120837|FG001|Overall Study|Missed Visit|2|||
130315090|NCT02634333|469120836|FG000|Overall Study|Lost to Follow-up|12|||
130315091|NCT02634333|469120837|FG001|Overall Study|Lost to Follow-up|7|||
130315092|NCT02634333|469120836|FG000|Overall Study|Withdrawal by Subject|9|||
130315093|NCT02634333|469120837|FG001|Overall Study|Withdrawal by Subject|13|||
130315094|NCT02634333|469120836|FG000|Overall Study|Death|11|||
130315095|NCT02634333|469120837|FG001|Overall Study|Death|8|||
130315096|NCT04537793|469120838|FG000|Part B (24 Weeks)|Adverse Event|0|||
130315097|NCT04537793|469120839|FG001|Part B (24 Weeks)|Adverse Event|1|||
130315098|NCT01255423|469120840|FG000|Overall Study|Abnormal Laboratory value|3|||
130315099|NCT01255423|469120841|FG001|Overall Study|Abnormal Laboratory value|2|||
130315100|NCT01255423|469120840|FG000|Overall Study|Use of prohibited medications|0|||
130315101|NCT01255423|469120841|FG001|Overall Study|Use of prohibited medications|1|||
130315102|NCT05470387|469120842|FG000|Overall Study|Protocol Violation|0|||
130315103|NCT05470387|469120843|FG001|Overall Study|Protocol Violation|3|||
130315104|NCT01858363|469120848|FG000|Overall Study|Death|35|||
130315105|NCT01858363|469120849|FG001|Overall Study|Death|9|||
130315106|NCT01858363|469120848|FG000|Overall Study|Withdrawal by Subject|28|||
130315107|NCT01858363|469120849|FG001|Overall Study|Withdrawal by Subject|14|||
130315108|NCT01858363|469120848|FG000|Overall Study|Lost to Follow-up|13|||
130315109|NCT01858363|469120849|FG001|Overall Study|Lost to Follow-up|3|||
130315110|NCT00101686|469120850|FG000|Overall Study|Progressive Disease|37|||
130315111|NCT00101686|469120851|FG001|Overall Study|Progressive Disease|28|||
130315112|NCT00101686|469120852|FG002|Overall Study|Progressive Disease|37|||
130315113|NCT00101686|469120853|FG003|Overall Study|Progressive Disease|38|||
130315114|NCT00101686|469120854|FG004|Overall Study|Progressive Disease|28|||
130315115|NCT00101686|469120855|FG005|Overall Study|Progressive Disease|25|||
130315116|NCT00101686|469120856|FG006|Overall Study|Progressive Disease|5|||
130315117|NCT00101686|469120857|FG007|Overall Study|Progressive Disease|7|||
130315118|NCT00101686|469120858|FG008|Overall Study|Progressive Disease|10|||
130315119|NCT00101686|469120859|FG009|Overall Study|Progressive Disease|8|||
130315120|NCT00101686|469120850|FG000|Overall Study|initiation other anti-cancer treatment|4|||
130315121|NCT00101686|469120851|FG001|Overall Study|initiation other anti-cancer treatment|3|||
130315122|NCT00101686|469120852|FG002|Overall Study|initiation other anti-cancer treatment|4|||
130315123|NCT00101686|469120853|FG003|Overall Study|initiation other anti-cancer treatment|3|||
130315124|NCT00101686|469120854|FG004|Overall Study|initiation other anti-cancer treatment|1|||
130315125|NCT00101686|469120855|FG005|Overall Study|initiation other anti-cancer treatment|1|||
130315126|NCT00101686|469120856|FG006|Overall Study|initiation other anti-cancer treatment|2|||
130315127|NCT00101686|469120857|FG007|Overall Study|initiation other anti-cancer treatment|2|||
130315128|NCT00101686|469120858|FG008|Overall Study|initiation other anti-cancer treatment|3|||
130315129|NCT00101686|469120859|FG009|Overall Study|initiation other anti-cancer treatment|3|||
130315130|NCT00101686|469120850|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
130315131|NCT00101686|469120851|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
130315132|NCT00101686|469120852|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
130315133|NCT00101686|469120853|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
130315134|NCT00101686|469120854|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
130315135|NCT00101686|469120855|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
130315136|NCT00101686|469120856|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
130315137|NCT00101686|469120857|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
130315138|NCT00101686|469120858|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
130315139|NCT00101686|469120859|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
130315140|NCT00101686|469120850|FG000|Overall Study|unacceptable toxicity|3|||
130315141|NCT00101686|469120851|FG001|Overall Study|unacceptable toxicity|9|||
130315142|NCT00101686|469120852|FG002|Overall Study|unacceptable toxicity|10|||
130315143|NCT00101686|469120853|FG003|Overall Study|unacceptable toxicity|6|||
130315144|NCT00101686|469120854|FG004|Overall Study|unacceptable toxicity|16|||
130315145|NCT00101686|469120855|FG005|Overall Study|unacceptable toxicity|10|||
130315146|NCT00101686|469120856|FG006|Overall Study|unacceptable toxicity|4|||
130315147|NCT00101686|469120857|FG007|Overall Study|unacceptable toxicity|2|||
130315148|NCT00101686|469120858|FG008|Overall Study|unacceptable toxicity|1|||
130315149|NCT00101686|469120859|FG009|Overall Study|unacceptable toxicity|4|||
130315150|NCT00101686|469120850|FG000|Overall Study|Randomized but did not receive treament|1|||
130315151|NCT00101686|469120851|FG001|Overall Study|Randomized but did not receive treament|6|||
130315152|NCT00101686|469120852|FG002|Overall Study|Randomized but did not receive treament|2|||
130315153|NCT00101686|469120853|FG003|Overall Study|Randomized but did not receive treament|2|||
130315154|NCT00101686|469120854|FG004|Overall Study|Randomized but did not receive treament|2|||
130315155|NCT00101686|469120855|FG005|Overall Study|Randomized but did not receive treament|2|||
130315156|NCT00101686|469120856|FG006|Overall Study|Randomized but did not receive treament|0|||
130315157|NCT00101686|469120857|FG007|Overall Study|Randomized but did not receive treament|1|||
130315158|NCT00101686|469120858|FG008|Overall Study|Randomized but did not receive treament|0|||
130315159|NCT00101686|469120859|FG009|Overall Study|Randomized but did not receive treament|1|||
130315160|NCT00101686|469120850|FG000|Overall Study|intercurrent non-cancer related illness|0|||
130315161|NCT00101686|469120851|FG001|Overall Study|intercurrent non-cancer related illness|0|||
130315162|NCT00101686|469120852|FG002|Overall Study|intercurrent non-cancer related illness|2|||
130315163|NCT00101686|469120853|FG003|Overall Study|intercurrent non-cancer related illness|0|||
130315164|NCT00101686|469120854|FG004|Overall Study|intercurrent non-cancer related illness|1|||
130315165|NCT00101686|469120855|FG005|Overall Study|intercurrent non-cancer related illness|3|||
130315166|NCT00101686|469120856|FG006|Overall Study|intercurrent non-cancer related illness|1|||
130315167|NCT00101686|469120857|FG007|Overall Study|intercurrent non-cancer related illness|0|||
130315168|NCT00101686|469120858|FG008|Overall Study|intercurrent non-cancer related illness|1|||
130315169|NCT00101686|469120859|FG009|Overall Study|intercurrent non-cancer related illness|1|||
130315170|NCT00101686|469120850|FG000|Overall Study|Physician Decision|10|||
130315171|NCT00101686|469120851|FG001|Overall Study|Physician Decision|13|||
130315172|NCT00101686|469120852|FG002|Overall Study|Physician Decision|6|||
130315173|NCT00101686|469120853|FG003|Overall Study|Physician Decision|7|||
130315174|NCT00101686|469120854|FG004|Overall Study|Physician Decision|8|||
130315175|NCT00101686|469120855|FG005|Overall Study|Physician Decision|9|||
130315176|NCT00101686|469120856|FG006|Overall Study|Physician Decision|5|||
130315177|NCT00101686|469120857|FG007|Overall Study|Physician Decision|5|||
130315178|NCT00101686|469120858|FG008|Overall Study|Physician Decision|1|||
130315179|NCT00101686|469120859|FG009|Overall Study|Physician Decision|1|||
130315180|NCT00101686|469120850|FG000|Overall Study|Other|1|||
130315181|NCT00101686|469120851|FG001|Overall Study|Other|4|||
130315182|NCT00101686|469120852|FG002|Overall Study|Other|1|||
130315183|NCT00101686|469120853|FG003|Overall Study|Other|6|||
130315184|NCT00101686|469120854|FG004|Overall Study|Other|2|||
130315185|NCT00101686|469120855|FG005|Overall Study|Other|12|||
130315186|NCT00101686|469120856|FG006|Overall Study|Other|1|||
130315187|NCT00101686|469120857|FG007|Overall Study|Other|5|||
130315188|NCT00101686|469120858|FG008|Overall Study|Other|3|||
130315189|NCT00101686|469120859|FG009|Overall Study|Other|3|||
130315190|NCT00101686|469120850|FG000|Overall Study|Withdrawal by Subject|9|||
130315191|NCT00101686|469120851|FG001|Overall Study|Withdrawal by Subject|8|||
130315192|NCT00101686|469120852|FG002|Overall Study|Withdrawal by Subject|6|||
130315193|NCT00101686|469120853|FG003|Overall Study|Withdrawal by Subject|8|||
130315194|NCT00101686|469120854|FG004|Overall Study|Withdrawal by Subject|8|||
130315195|NCT00101686|469120855|FG005|Overall Study|Withdrawal by Subject|7|||
130315196|NCT00101686|469120856|FG006|Overall Study|Withdrawal by Subject|7|||
130315197|NCT00101686|469120857|FG007|Overall Study|Withdrawal by Subject|7|||
130315198|NCT00101686|469120858|FG008|Overall Study|Withdrawal by Subject|8|||
130315199|NCT00101686|469120859|FG009|Overall Study|Withdrawal by Subject|9|||
130315200|NCT02525471|469120860|FG000|Overall Study|Screen Failure|6|||
130315201|NCT02525471|469120860|FG000|Overall Study|Withdrawal by Subject|4|||
130315202|NCT02525471|469120860|FG000|Overall Study|Death|1|||
130315203|NCT00867165|469120861|FG000|Overall Study|Adverse Event|3|||
130315204|NCT00867165|469120862|FG001|Overall Study|Adverse Event|0|||
130315205|NCT00867165|469120861|FG000|Overall Study|Withdrawal by Subject|1|||
130315206|NCT00867165|469120862|FG001|Overall Study|Withdrawal by Subject|0|||
130315207|NCT00890825|469120863|FG000|Overall Study|Withdrawal by Subject|1|||
130315208|NCT00890825|469120864|FG001|Overall Study|Withdrawal by Subject|0|||
130315209|NCT00890825|469120863|FG000|Overall Study|Alive at data cut off (DCO)|13|||
130315210|NCT00890825|469120864|FG001|Overall Study|Alive at data cut off (DCO)|14|||
130315211|NCT01054456|469120865|FG000|Overall Study|Other|1|||
130315212|NCT03935126|469120868|FG000|Overall Study|Study termination by sponsor|3|||
130315213|NCT03649217|469120869|FG000|Overall Study|subject had severe ataxia not initially found|1|||
130315214|NCT03649217|469120869|FG000|Overall Study|subject had cognitive issues not initially found|1|||
130315215|NCT02520726|469120870|FG000|Overall Study|Lost to Follow-up|3|||
130315216|NCT02520726|469120871|FG001|Overall Study|Lost to Follow-up|2|||
130315217|NCT01506271|469120872|FG000|Overall Study|Progressive disease|0|||
130315218|NCT01506271|469120873|FG001|Overall Study|Progressive disease|1|||
130315219|NCT01506271|469120874|FG002|Overall Study|Progressive disease|0|||
130315220|NCT01506271|469120872|FG000|Overall Study|Protocol Violation|3|||
130315221|NCT01506271|469120873|FG001|Overall Study|Protocol Violation|1|||
130315222|NCT01506271|469120874|FG002|Overall Study|Protocol Violation|0|||
130315223|NCT01506271|469120872|FG000|Overall Study|Death|0|||
130315224|NCT01506271|469120873|FG001|Overall Study|Death|1|||
130315225|NCT01506271|469120874|FG002|Overall Study|Death|0|||
130315226|NCT01506271|469120872|FG000|Overall Study|Adverse Event|0|||
130315227|NCT01506271|469120873|FG001|Overall Study|Adverse Event|2|||
130315228|NCT01506271|469120874|FG002|Overall Study|Adverse Event|0|||
130315229|NCT01506271|469120872|FG000|Overall Study|Insufficient supply of study drug|1|||
130315230|NCT01506271|469120873|FG001|Overall Study|Insufficient supply of study drug|0|||
130315231|NCT01506271|469120874|FG002|Overall Study|Insufficient supply of study drug|0|||
130315232|NCT01506271|469120872|FG000|Overall Study|Withdrawal by Subject|0|||
130315233|NCT01506271|469120873|FG001|Overall Study|Withdrawal by Subject|1|||
130315234|NCT01506271|469120874|FG002|Overall Study|Withdrawal by Subject|1|||
130315235|NCT01506271|469120872|FG000|Overall Study|Lost to Follow-up|0|||
130315236|NCT01506271|469120873|FG001|Overall Study|Lost to Follow-up|1|||
130315237|NCT01506271|469120874|FG002|Overall Study|Lost to Follow-up|2|||
130315238|NCT02021565|469120880|FG000|Baseline Through Intervention|Death|0|||
130315239|NCT02021565|469120881|FG001|Baseline Through Intervention|Death|1|||
130315240|NCT02021565|469120880|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
130315241|NCT02021565|469120881|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
130315242|NCT02021565|469120880|FG000|Baseline Through Intervention|Protocol Violation|0|||
130315243|NCT02021565|469120881|FG001|Baseline Through Intervention|Protocol Violation|7|||
130315244|NCT02021565|469120880|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
130315245|NCT02021565|469120881|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
130315246|NCT02021565|469120880|FG000|3-month Follow-up|Death|3|||
130315247|NCT02021565|469120881|FG001|3-month Follow-up|Death|0|||
130315248|NCT02021565|469120880|FG000|3-month Follow-up|Withdrawal by Subject|4|||
130315249|NCT02021565|469120881|FG001|3-month Follow-up|Withdrawal by Subject|0|||
130315250|NCT02021565|469120880|FG000|3-month Follow-up|Protocol Violation|3|||
130315251|NCT02021565|469120881|FG001|3-month Follow-up|Protocol Violation|2|||
130315252|NCT03040141|469120882|FG000|Overall Study|Death|1|||
130315253|NCT03040141|469120883|FG001|Overall Study|Death|2|||
130315254|NCT03040141|469120884|FG002|Overall Study|Death|3|||
130315255|NCT03040141|469120882|FG000|Overall Study|Withdrawal by Subject|3|||
130315256|NCT03040141|469120883|FG001|Overall Study|Withdrawal by Subject|1|||
130315257|NCT03040141|469120884|FG002|Overall Study|Withdrawal by Subject|1|||
130315258|NCT03040141|469120882|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130315259|NCT03040141|469120883|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
130315260|NCT03040141|469120884|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130315261|NCT03040141|469120882|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
130315262|NCT03040141|469120883|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130315263|NCT03040141|469120884|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130315264|NCT03318549|469120885|FG000|Overall Study|Withdrawal by Subject|5|||
130315265|NCT03318549|469120886|FG001|Overall Study|Withdrawal by Subject|19|||
130315266|NCT03318549|469120887|FG002|Overall Study|Withdrawal by Subject|2|||
130315267|NCT03318549|469120888|FG003|Overall Study|Withdrawal by Subject|0|||
130315268|NCT03318549|469120889|FG004|Overall Study|Withdrawal by Subject|0|||
130315269|NCT03318549|469120890|FG005|Overall Study|Withdrawal by Subject|0|||
130315270|NCT03318549|469120891|FG006|Overall Study|Withdrawal by Subject|0|||
130315271|NCT03318549|469120885|FG000|Overall Study|Physician Decision|0|||
130315272|NCT03318549|469120886|FG001|Overall Study|Physician Decision|4|||
130315273|NCT03318549|469120887|FG002|Overall Study|Physician Decision|1|||
130315274|NCT03318549|469120888|FG003|Overall Study|Physician Decision|0|||
130315275|NCT03318549|469120889|FG004|Overall Study|Physician Decision|0|||
130315276|NCT03318549|469120890|FG005|Overall Study|Physician Decision|0|||
130315277|NCT03318549|469120891|FG006|Overall Study|Physician Decision|0|||
130315278|NCT03318549|469120885|FG000|Overall Study|Lost to Follow-up|0|||
130315279|NCT03318549|469120886|FG001|Overall Study|Lost to Follow-up|3|||
130315280|NCT03318549|469120887|FG002|Overall Study|Lost to Follow-up|3|||
130315281|NCT03318549|469120888|FG003|Overall Study|Lost to Follow-up|0|||
130376140|NCT01401283|469343591|FG001|Overall Study|no central venous access|1|||
130376141|NCT01401283|469343590|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
130376142|NCT01401283|469343591|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
130376143|NCT02433483|469343592|FG000|Overall Study|Unacceptable toxicity|1|||
130315282|NCT03318549|469120889|FG004|Overall Study|Lost to Follow-up|0|||
130376144|NCT02433483|469343592|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
130315283|NCT03318549|469120890|FG005|Overall Study|Lost to Follow-up|0|||
130315284|NCT03318549|469120891|FG006|Overall Study|Lost to Follow-up|0|||
130315285|NCT01391663|469120892|FG000|Overall Study|Withdrawal by Subject|0|||
130315286|NCT01391663|469120893|FG001|Overall Study|Withdrawal by Subject|0|||
130315287|NCT01391663|469120894|FG002|Overall Study|Withdrawal by Subject|1|||
130315288|NCT01391663|469120895|FG003|Overall Study|Withdrawal by Subject|0|||
130315289|NCT00462306|469120896|FG000|Overall Study|insufficient data|0|||
130315290|NCT00462306|469120897|FG001|Overall Study|insufficient data|13|||
130315291|NCT03515824|469120898|FG000|Overall Study|Death|3|||
130315292|NCT03515824|469120899|FG001|Overall Study|Death|2|||
130315293|NCT03515824|469120900|FG002|Overall Study|Death|6|||
130466606|NCT02708108|469674855|FG000|Overall Study|No MRD and no imaging available|0|||
130466607|NCT02708108|469674856|FG001|Overall Study|No MRD and no imaging available|1|||
130466608|NCT01697969|469674859|FG000|Overall Study|Did not meet inc/exc criteria|3|||
130466609|NCT01561989|469674860|FG000|Overall Study|accural target not met.|5|||
130466610|NCT01561989|469674861|FG001|Overall Study|accural target not met.|6|||
130466611|NCT03447249|469674865|FG000|Overall Study|Adverse Event|1|||
130466612|NCT03447249|469674866|FG001|Overall Study|Adverse Event|0|||
130315294|NCT03515824|469120901|FG003|Overall Study|Death|0|||
130315295|NCT03515824|469120898|FG000|Overall Study|Lost to Follow-up|0|||
130315296|NCT03515824|469120899|FG001|Overall Study|Lost to Follow-up|1|||
130315297|NCT03515824|469120900|FG002|Overall Study|Lost to Follow-up|1|||
130315298|NCT03515824|469120901|FG003|Overall Study|Lost to Follow-up|0|||
130315299|NCT03515824|469120898|FG000|Overall Study|Study terminated by sponsor|0|||
130315300|NCT03515824|469120899|FG001|Overall Study|Study terminated by sponsor|1|||
130315301|NCT03515824|469120900|FG002|Overall Study|Study terminated by sponsor|6|||
130315302|NCT03515824|469120901|FG003|Overall Study|Study terminated by sponsor|0|||
130315303|NCT03515824|469120898|FG000|Overall Study|Status not recorded|0|||
130315304|NCT03515824|469120899|FG001|Overall Study|Status not recorded|0|||
130315305|NCT03515824|469120900|FG002|Overall Study|Status not recorded|2|||
130315306|NCT03515824|469120901|FG003|Overall Study|Status not recorded|0|||
130315307|NCT00920855|469120902|FG000|Overall Study|Adverse Event|1|||
130315308|NCT00920855|469120903|FG001|Overall Study|Adverse Event|1|||
130315309|NCT00920855|469120904|FG002|Overall Study|Adverse Event|4|||
130315310|NCT00920855|469120902|FG000|Overall Study|Withdrawal by Subject|2|||
130315311|NCT00920855|469120903|FG001|Overall Study|Withdrawal by Subject|1|||
130315312|NCT00920855|469120904|FG002|Overall Study|Withdrawal by Subject|6|||
130315313|NCT00920855|469120902|FG000|Overall Study|Disease progression|2|||
130315314|NCT00920855|469120903|FG001|Overall Study|Disease progression|1|||
130315315|NCT00920855|469120904|FG002|Overall Study|Disease progression|10|||
130315316|NCT00920855|469120902|FG000|Overall Study|Noncompliance to study medication|0|||
130315317|NCT00920855|469120903|FG001|Overall Study|Noncompliance to study medication|0|||
130315318|NCT00920855|469120904|FG002|Overall Study|Noncompliance to study medication|1|||
130315319|NCT00920855|469120902|FG000|Overall Study|Response plateau; started maintenance|0|||
130315320|NCT00920855|469120903|FG001|Overall Study|Response plateau; started maintenance|0|||
130315321|NCT00920855|469120904|FG002|Overall Study|Response plateau; started maintenance|1|||
130315322|NCT00539994|469120906|FG000|Overall Study|Lost to Follow-up|2|||
130315323|NCT00539994|469120907|FG001|Overall Study|Lost to Follow-up|1|||
130315324|NCT00539994|469120908|FG002|Overall Study|Lost to Follow-up|0|||
130315325|NCT00539994|469120906|FG000|Overall Study|Withdrawal by Subject|1|||
130315326|NCT00539994|469120907|FG001|Overall Study|Withdrawal by Subject|0|||
130315327|NCT00539994|469120908|FG002|Overall Study|Withdrawal by Subject|1|||
130315328|NCT00539994|469120906|FG000|Overall Study|Physician Decision|0|||
130315329|NCT00539994|469120907|FG001|Overall Study|Physician Decision|0|||
130315330|NCT00539994|469120908|FG002|Overall Study|Physician Decision|1|||
130315331|NCT00510835|469120910|FG000|Overall Study|Withdrawal by Subject|6|||
130315332|NCT00510835|469120911|FG001|Overall Study|Withdrawal by Subject|2|||
130315333|NCT00510835|469120912|FG002|Overall Study|Withdrawal by Subject|2|||
130315334|NCT03084796|469120913|FG000|Overall Study|Adverse Event|4|||
130315335|NCT03084796|469120914|FG001|Overall Study|Adverse Event|5|||
130315336|NCT03084796|469120915|FG002|Overall Study|Adverse Event|6|||
130315337|NCT03084796|469120916|FG003|Overall Study|Adverse Event|2|||
130315338|NCT03084796|469120917|FG004|Overall Study|Adverse Event|3|||
130315339|NCT03084796|469120918|FG005|Overall Study|Adverse Event|5|||
130315340|NCT03084796|469120913|FG000|Overall Study|Withdrawal by Subject|3|||
130315341|NCT03084796|469120914|FG001|Overall Study|Withdrawal by Subject|5|||
130315342|NCT03084796|469120915|FG002|Overall Study|Withdrawal by Subject|2|||
130315343|NCT03084796|469120916|FG003|Overall Study|Withdrawal by Subject|1|||
130315344|NCT03084796|469120917|FG004|Overall Study|Withdrawal by Subject|3|||
130315345|NCT03084796|469120918|FG005|Overall Study|Withdrawal by Subject|0|||
130315346|NCT03084796|469120913|FG000|Overall Study|Protocol Violation|0|||
130315347|NCT03084796|469120914|FG001|Overall Study|Protocol Violation|0|||
130315348|NCT03084796|469120915|FG002|Overall Study|Protocol Violation|1|||
130315349|NCT03084796|469120916|FG003|Overall Study|Protocol Violation|0|||
130315350|NCT03084796|469120917|FG004|Overall Study|Protocol Violation|1|||
130315351|NCT03084796|469120918|FG005|Overall Study|Protocol Violation|1|||
130315352|NCT03084796|469120913|FG000|Overall Study|Lack of Efficacy|0|||
130315353|NCT03084796|469120914|FG001|Overall Study|Lack of Efficacy|0|||
130315354|NCT03084796|469120915|FG002|Overall Study|Lack of Efficacy|1|||
130315355|NCT03084796|469120916|FG003|Overall Study|Lack of Efficacy|0|||
130315356|NCT03084796|469120917|FG004|Overall Study|Lack of Efficacy|1|||
130466613|NCT03447249|469674865|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130315357|NCT03084796|469120918|FG005|Overall Study|Lack of Efficacy|0|||
130315358|NCT03084796|469120913|FG000|Overall Study|Lost to Follow-up|0|||
130315359|NCT03084796|469120914|FG001|Overall Study|Lost to Follow-up|0|||
130315360|NCT03084796|469120915|FG002|Overall Study|Lost to Follow-up|1|||
130315361|NCT03084796|469120916|FG003|Overall Study|Lost to Follow-up|1|||
130315362|NCT03084796|469120917|FG004|Overall Study|Lost to Follow-up|3|||
130315363|NCT03084796|469120918|FG005|Overall Study|Lost to Follow-up|1|||
130315364|NCT03084796|469120913|FG000|Overall Study|Randomization error|0|||
130315365|NCT03084796|469120914|FG001|Overall Study|Randomization error|0|||
130315366|NCT03084796|469120915|FG002|Overall Study|Randomization error|1|||
130315367|NCT03084796|469120916|FG003|Overall Study|Randomization error|0|||
130315368|NCT03084796|469120917|FG004|Overall Study|Randomization error|0|||
130315369|NCT03084796|469120918|FG005|Overall Study|Randomization error|0|||
130315370|NCT05470985|469120919|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
130315371|NCT05470985|469120920|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
130315372|NCT05470985|469120919|FG000|Double Blind Treatment Period|Physician Decision|0|||
130315373|NCT05470985|469120920|FG001|Double Blind Treatment Period|Physician Decision|1|||
130315374|NCT05470985|469120919|FG000|Long Term Extension|Adverse Event|0|||
130315375|NCT05470985|469120920|FG001|Long Term Extension|Adverse Event|1|||
130315376|NCT05470985|469120919|FG000|Long Term Extension|Study terminated by sponsor|2|||
130315377|NCT05470985|469120920|FG001|Long Term Extension|Study terminated by sponsor|0|||
130315378|NCT02741245|469120924|FG000|Overall Study|Adverse Event|0|||
130315379|NCT02741245|469120925|FG001|Overall Study|Adverse Event|0|||
130315380|NCT02741245|469120926|FG002|Overall Study|Adverse Event|0|||
130315381|NCT02741245|469120927|FG003|Overall Study|Adverse Event|2|||
130315382|NCT02741245|469120928|FG004|Overall Study|Adverse Event|2|||
130315383|NCT02741245|469120924|FG000|Overall Study|Protocol Violation|0|||
130315384|NCT02741245|469120925|FG001|Overall Study|Protocol Violation|1|||
130315385|NCT02741245|469120926|FG002|Overall Study|Protocol Violation|0|||
130315386|NCT02741245|469120927|FG003|Overall Study|Protocol Violation|1|||
130315387|NCT02741245|469120928|FG004|Overall Study|Protocol Violation|0|||
130315388|NCT02741245|469120924|FG000|Overall Study|Withdrawal by Subject|0|||
130315389|NCT02741245|469120925|FG001|Overall Study|Withdrawal by Subject|0|||
130315390|NCT02741245|469120926|FG002|Overall Study|Withdrawal by Subject|0|||
130315391|NCT02741245|469120927|FG003|Overall Study|Withdrawal by Subject|1|||
130315392|NCT02741245|469120928|FG004|Overall Study|Withdrawal by Subject|0|||
130315393|NCT00607087|469120930|FG000|Overall Study|Withdrawal by Subject|9|||
130315394|NCT00607087|469120931|FG001|Overall Study|Withdrawal by Subject|4|||
130315395|NCT00607087|469120932|FG002|Overall Study|Withdrawal by Subject|4|||
130315396|NCT00607087|469120930|FG000|Overall Study|Adverse Event|3|||
130315397|NCT00607087|469120931|FG001|Overall Study|Adverse Event|2|||
130315398|NCT00607087|469120932|FG002|Overall Study|Adverse Event|3|||
130315399|NCT00607087|469120930|FG000|Overall Study|Other reason|1|||
130315400|NCT00607087|469120931|FG001|Overall Study|Other reason|5|||
130315401|NCT00607087|469120932|FG002|Overall Study|Other reason|2|||
130315402|NCT00607087|469120930|FG000|Overall Study|Poor compliance to protocol|1|||
130315403|NCT00607087|469120931|FG001|Overall Study|Poor compliance to protocol|0|||
130315404|NCT00607087|469120932|FG002|Overall Study|Poor compliance to protocol|1|||
130315405|NCT00607087|469120930|FG000|Overall Study|Lost to Follow-up|1|||
130315406|NCT00607087|469120931|FG001|Overall Study|Lost to Follow-up|0|||
130315407|NCT00607087|469120932|FG002|Overall Study|Lost to Follow-up|0|||
130315408|NCT00607087|469120930|FG000|Period 1|Withdrawal by Subject|7|||
130315409|NCT00607087|469120931|FG001|Period 1|Withdrawal by Subject|2|||
130315410|NCT00607087|469120932|FG002|Period 1|Withdrawal by Subject|3|||
130315411|NCT00607087|469120930|FG000|Period 1|Adverse Event|3|||
130315412|NCT00607087|469120931|FG001|Period 1|Adverse Event|0|||
130315413|NCT00607087|469120932|FG002|Period 1|Adverse Event|0|||
130315414|NCT00607087|469120930|FG000|Period 1|Poor compliance to protocol|1|||
130315415|NCT00607087|469120931|FG001|Period 1|Poor compliance to protocol|0|||
130315416|NCT00607087|469120932|FG002|Period 1|Poor compliance to protocol|0|||
130315417|NCT00607087|469120930|FG000|Period 1|Lost to Follow-up|1|||
130315418|NCT00607087|469120931|FG001|Period 1|Lost to Follow-up|0|||
130315419|NCT00607087|469120932|FG002|Period 1|Lost to Follow-up|0|||
130315420|NCT00607087|469120930|FG000|Period 1|Other reason|0|||
130315421|NCT00607087|469120931|FG001|Period 1|Other reason|4|||
130376145|NCT04271605|469343596|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
130376146|NCT03342690|469343597|FG000|Overall Study|Missing Information|9|||
130376147|NCT03342690|469343597|FG000|Overall Study|Protocol Violation|16|||
130376148|NCT00085631|469343598|FG000|Overall Study|Missing Data|4|||
130376149|NCT00085631|469343599|FG001|Overall Study|Missing Data|11|||
130315422|NCT00607087|469120932|FG002|Period 1|Other reason|2|||
130315423|NCT00607087|469120930|FG000|Period 2|Withdrawal by Subject|0|||
130315424|NCT00607087|469120931|FG001|Period 2|Withdrawal by Subject|1|||
130315425|NCT00607087|469120932|FG002|Period 2|Withdrawal by Subject|1|||
130315426|NCT00607087|469120930|FG000|Period 2|Other reason|1|||
130315427|NCT00607087|469120931|FG001|Period 2|Other reason|1|||
130315428|NCT00607087|469120932|FG002|Period 2|Other reason|0|||
130315429|NCT00607087|469120930|FG000|Period 2|Adverse Event|0|||
130315430|NCT00607087|469120931|FG001|Period 2|Adverse Event|1|||
130376150|NCT00085631|469343600|FG002|Overall Study|Missing Data|7|||
130315431|NCT00607087|469120932|FG002|Period 2|Adverse Event|3|||
130315432|NCT00607087|469120930|FG000|Period 2|Poor compliance to protocol|0|||
130315433|NCT00607087|469120931|FG001|Period 2|Poor compliance to protocol|0|||
130315434|NCT00607087|469120932|FG002|Period 2|Poor compliance to protocol|1|||
130315435|NCT00607087|469120930|FG000|Period 3|Withdrawal by Subject|2|||
130376151|NCT00411645|469343601|FG000|Overall Study|Consent Withdrawn|13|||
130720548|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
130720549|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
130720550|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
130720551|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
130315436|NCT00607087|469120931|FG001|Period 3|Withdrawal by Subject|1|||
130315437|NCT00607087|469120932|FG002|Period 3|Withdrawal by Subject|0|||
130315438|NCT00607087|469120930|FG000|Period 3|Adverse Event|0|||
130315439|NCT00607087|469120931|FG001|Period 3|Adverse Event|1|||
130315440|NCT00607087|469120932|FG002|Period 3|Adverse Event|0|||
130315441|NCT00154297|469120934|FG000|Overall Study|Death|5|||
130315442|NCT00154297|469120935|FG001|Overall Study|Death|2|||
130315443|NCT00154297|469120934|FG000|Overall Study|Withdrawal by Subject|0|||
130315444|NCT00154297|469120935|FG001|Overall Study|Withdrawal by Subject|5|||
130315445|NCT00154297|469120934|FG000|Overall Study|Lost to Follow-up|3|||
130720552|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
130720553|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
130720554|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Other|0|||
130720555|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Other|1|||
130720556|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
130720557|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
130720558|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
130720559|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
130376152|NCT00411645|469343602|FG001|Overall Study|Consent Withdrawn|22|||
130376153|NCT00411645|469343601|FG000|Overall Study|Death|56|||
130315446|NCT00154297|469120935|FG001|Overall Study|Lost to Follow-up|0|||
130315447|NCT00650767|469120936|FG000|Overall Study|Adverse Event|0|||
130315448|NCT00650767|469120937|FG001|Overall Study|Adverse Event|3|||
130315449|NCT00650767|469120938|FG002|Overall Study|Adverse Event|10|||
130315450|NCT00650767|469120939|FG003|Overall Study|Adverse Event|8|||
130315451|NCT00650767|469120936|FG000|Overall Study|Death|1|||
130315452|NCT00650767|469120937|FG001|Overall Study|Death|0|||
130315453|NCT00650767|469120938|FG002|Overall Study|Death|0|||
130315454|NCT00650767|469120939|FG003|Overall Study|Death|0|||
130315455|NCT00650767|469120936|FG000|Overall Study|Withdrawal by Subject|2|||
130315456|NCT00650767|469120937|FG001|Overall Study|Withdrawal by Subject|4|||
130315457|NCT00650767|469120938|FG002|Overall Study|Withdrawal by Subject|3|||
130315458|NCT00650767|469120939|FG003|Overall Study|Withdrawal by Subject|3|||
130315459|NCT00650767|469120936|FG000|Overall Study|Lost to Follow-up|1|||
130315460|NCT00650767|469120937|FG001|Overall Study|Lost to Follow-up|1|||
130315461|NCT00650767|469120938|FG002|Overall Study|Lost to Follow-up|1|||
130315462|NCT00650767|469120939|FG003|Overall Study|Lost to Follow-up|0|||
130315463|NCT00650767|469120936|FG000|Overall Study|Other|1|||
130315464|NCT00650767|469120937|FG001|Overall Study|Other|1|||
130315465|NCT00650767|469120938|FG002|Overall Study|Other|0|||
130315466|NCT00650767|469120939|FG003|Overall Study|Other|0|||
130315467|NCT01774799|469120940|FG000|Overall Study|Lost to Follow-up|1|||
130315468|NCT01774799|469120941|FG001|Overall Study|Lost to Follow-up|1|||
130315469|NCT01774799|469120942|FG002|Overall Study|Lost to Follow-up|0|||
130315470|NCT01774799|469120943|FG003|Overall Study|Lost to Follow-up|0|||
130315471|NCT00990106|469120944|FG000|Overall Study|"too busy to continue"|1|||
130315472|NCT00990106|469120945|FG001|Overall Study|"too busy to continue"|2|||
130315473|NCT00990106|469120944|FG000|Overall Study|Lost to Follow-up|1|||
130315474|NCT00990106|469120945|FG001|Overall Study|Lost to Follow-up|3|||
130315475|NCT00990106|469120944|FG000|Overall Study|Withdrawal by Subject|2|||
130315476|NCT00990106|469120945|FG001|Overall Study|Withdrawal by Subject|1|||
130315477|NCT00990106|469120944|FG000|Overall Study|opted for open label prazosin|1|||
130315478|NCT00990106|469120945|FG001|Overall Study|opted for open label prazosin|1|||
130315479|NCT00990106|469120944|FG000|Overall Study|relocation/deployment|4|||
130315480|NCT00990106|469120945|FG001|Overall Study|relocation/deployment|1|||
130315481|NCT00990106|469120944|FG000|Overall Study|started exclusionary medication|0|||
130720560|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
130720561|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
130720562|NCT01425723|470599804|FG000|Overall Study|Lack of Efficacy|0|||
130720563|NCT01425723|470599805|FG001|Overall Study|Lack of Efficacy|1|||
130720564|NCT01425723|470599804|FG000|Overall Study|Withdrawal by Subject|1|||
130720565|NCT01425723|470599805|FG001|Overall Study|Withdrawal by Subject|4|||
130315482|NCT00990106|469120945|FG001|Overall Study|started exclusionary medication|1|||
130376154|NCT00411645|469343602|FG001|Overall Study|Death|135|||
130376155|NCT00411645|469343601|FG000|Overall Study|Investigator/Sponsor Decision|10|||
130720566|NCT01425723|470599804|FG000|Overall Study|Lost to Follow-up|0|||
130720567|NCT01425723|470599805|FG001|Overall Study|Lost to Follow-up|3|||
130315483|NCT00990106|469120944|FG000|Overall Study|planned major surgery|0|||
130315484|NCT00990106|469120945|FG001|Overall Study|planned major surgery|1|||
130315485|NCT00990106|469120944|FG000|Overall Study|scheduling conflicts|0|||
130315486|NCT00990106|469120945|FG001|Overall Study|scheduling conflicts|2|||
130315487|NCT03064490|469120948|FG000|Overall Study|Physician Decision|5|||
130315488|NCT04158583|469120952|FG000|Overall Study|Withdrawal by Subject|1|||
130315489|NCT04158583|469120953|FG001|Overall Study|Withdrawal by Subject|1|||
130720568|NCT01425723|470599804|FG000|Overall Study|Physician Decision|2|||
130376156|NCT00411645|469343602|FG001|Overall Study|Investigator/Sponsor Decision|7|||
130376157|NCT00411645|469343601|FG000|Overall Study|Lost to Follow-up|2|||
130376158|NCT00411645|469343602|FG001|Overall Study|Lost to Follow-up|0|||
130376159|NCT05048784|469343603|FG000|Period 1|Adverse Event|3|||
130376160|NCT05048784|469343604|FG001|Period 1|Adverse Event|1|||
130376161|NCT05048784|469343605|FG002|Period 1|Adverse Event|0|||
130376162|NCT05048784|469343606|FG003|Period 1|Adverse Event|0|||
130376163|NCT05048784|469343603|FG000|Period 2|Lost to Follow-up|0|||
130376164|NCT05048784|469343604|FG001|Period 2|Lost to Follow-up|1|||
130376165|NCT05048784|469343605|FG002|Period 2|Lost to Follow-up|0|||
130376166|NCT05048784|469343606|FG003|Period 2|Lost to Follow-up|0|||
130376167|NCT04016285|469343607|FG000|Overall Study|Did not progress to surgery|2|||
130466614|NCT03447249|469674866|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130315490|NCT04158583|469120954|FG002|Overall Study|Withdrawal by Subject|0|||
130315491|NCT04158583|469120955|FG003|Overall Study|Withdrawal by Subject|0|||
130315492|NCT04158583|469120956|FG004|Overall Study|Withdrawal by Subject|1|||
130315493|NCT04158583|469120957|FG005|Overall Study|Withdrawal by Subject|0|||
130315494|NCT04158583|469120958|FG006|Overall Study|Withdrawal by Subject|0|||
130315495|NCT04158583|469120959|FG007|Overall Study|Withdrawal by Subject|0|||
130315496|NCT04158583|469120960|FG008|Overall Study|Withdrawal by Subject|2|||
130315497|NCT04158583|469120961|FG009|Overall Study|Withdrawal by Subject|0|||
130315498|NCT04158583|469120952|FG000|Overall Study|Study Terminated by Sponsor|0|||
130315499|NCT04158583|469120953|FG001|Overall Study|Study Terminated by Sponsor|0|||
130315500|NCT04158583|469120954|FG002|Overall Study|Study Terminated by Sponsor|0|||
130315501|NCT04158583|469120955|FG003|Overall Study|Study Terminated by Sponsor|1|||
130315502|NCT04158583|469120956|FG004|Overall Study|Study Terminated by Sponsor|0|||
130315503|NCT04158583|469120957|FG005|Overall Study|Study Terminated by Sponsor|0|||
130315504|NCT04158583|469120958|FG006|Overall Study|Study Terminated by Sponsor|0|||
130315505|NCT04158583|469120959|FG007|Overall Study|Study Terminated by Sponsor|0|||
130315506|NCT04158583|469120960|FG008|Overall Study|Study Terminated by Sponsor|0|||
130315507|NCT04158583|469120961|FG009|Overall Study|Study Terminated by Sponsor|0|||
130315508|NCT04158583|469120952|FG000|Overall Study|Progressive Disease|1|||
130315509|NCT04158583|469120953|FG001|Overall Study|Progressive Disease|0|||
130315510|NCT04158583|469120954|FG002|Overall Study|Progressive Disease|3|||
130315511|NCT04158583|469120955|FG003|Overall Study|Progressive Disease|5|||
130315512|NCT04158583|469120956|FG004|Overall Study|Progressive Disease|0|||
130315513|NCT04158583|469120957|FG005|Overall Study|Progressive Disease|1|||
130315514|NCT04158583|469120958|FG006|Overall Study|Progressive Disease|6|||
130315515|NCT04158583|469120959|FG007|Overall Study|Progressive Disease|2|||
130315516|NCT04158583|469120960|FG008|Overall Study|Progressive Disease|1|||
130315517|NCT04158583|469120961|FG009|Overall Study|Progressive Disease|2|||
130315518|NCT04158583|469120952|FG000|Overall Study|Lost to Follow-up|0|||
130315519|NCT04158583|469120953|FG001|Overall Study|Lost to Follow-up|0|||
130315520|NCT04158583|469120954|FG002|Overall Study|Lost to Follow-up|1|||
130315521|NCT04158583|469120955|FG003|Overall Study|Lost to Follow-up|1|||
130315522|NCT04158583|469120956|FG004|Overall Study|Lost to Follow-up|1|||
130315523|NCT04158583|469120957|FG005|Overall Study|Lost to Follow-up|0|||
130315524|NCT04158583|469120958|FG006|Overall Study|Lost to Follow-up|0|||
130315525|NCT04158583|469120959|FG007|Overall Study|Lost to Follow-up|0|||
130315526|NCT04158583|469120960|FG008|Overall Study|Lost to Follow-up|0|||
130315527|NCT04158583|469120961|FG009|Overall Study|Lost to Follow-up|0|||
130315528|NCT04158583|469120952|FG000|Overall Study|Due To Patient Status|0|||
130315529|NCT04158583|469120953|FG001|Overall Study|Due To Patient Status|0|||
130315530|NCT04158583|469120954|FG002|Overall Study|Due To Patient Status|0|||
130315531|NCT04158583|469120955|FG003|Overall Study|Due To Patient Status|0|||
130315532|NCT04158583|469120956|FG004|Overall Study|Due To Patient Status|0|||
130315533|NCT04158583|469120957|FG005|Overall Study|Due To Patient Status|0|||
130315534|NCT04158583|469120958|FG006|Overall Study|Due To Patient Status|0|||
130315535|NCT04158583|469120959|FG007|Overall Study|Due To Patient Status|0|||
130315536|NCT04158583|469120960|FG008|Overall Study|Due To Patient Status|1|||
130315537|NCT04158583|469120961|FG009|Overall Study|Due To Patient Status|0|||
130315538|NCT04158583|469120952|FG000|Overall Study|Death|3|||
130315539|NCT04158583|469120953|FG001|Overall Study|Death|4|||
130315540|NCT04158583|469120954|FG002|Overall Study|Death|2|||
130315541|NCT04158583|469120955|FG003|Overall Study|Death|2|||
130315542|NCT04158583|469120956|FG004|Overall Study|Death|4|||
130315543|NCT04158583|469120957|FG005|Overall Study|Death|3|||
130315544|NCT04158583|469120958|FG006|Overall Study|Death|5|||
130315545|NCT04158583|469120959|FG007|Overall Study|Death|2|||
130315546|NCT04158583|469120960|FG008|Overall Study|Death|0|||
130376168|NCT04016285|469343608|FG001|Overall Study|Did not progress to surgery|5|||
130315547|NCT04158583|469120961|FG009|Overall Study|Death|1|||
130315548|NCT04158583|469120952|FG000|Overall Study|Clinical Progression Disease|0|||
130315549|NCT04158583|469120953|FG001|Overall Study|Clinical Progression Disease|0|||
130315550|NCT04158583|469120954|FG002|Overall Study|Clinical Progression Disease|0|||
130315551|NCT04158583|469120955|FG003|Overall Study|Clinical Progression Disease|1|||
130315552|NCT04158583|469120956|FG004|Overall Study|Clinical Progression Disease|0|||
130376169|NCT04016285|469343607|FG000|Overall Study|Failed to collect outcome data|5|||
130466615|NCT03447249|469674865|FG000|Overall Study|Other|3|||
130720569|NCT01425723|470599805|FG001|Overall Study|Physician Decision|0|||
130720570|NCT01425723|470599804|FG000|Overall Study|Other|1|||
130720571|NCT01425723|470599805|FG001|Overall Study|Other|10|||
130720572|NCT00186043|470599806|FG000|Overall Study|Lack of Efficacy|1|||
130720573|NCT00186043|470599807|FG001|Overall Study|Lack of Efficacy|3|||
130720574|NCT00186043|470599806|FG000|Overall Study|Lost to Follow-up|4|||
130720575|NCT00186043|470599807|FG001|Overall Study|Lost to Follow-up|6|||
130720576|NCT00186043|470599806|FG000|Overall Study|Withdrawal by Subject|1|||
130720577|NCT00186043|470599807|FG001|Overall Study|Withdrawal by Subject|0|||
130720578|NCT00186043|470599806|FG000|Overall Study|Adverse Event|7|||
130720579|NCT00186043|470599807|FG001|Overall Study|Adverse Event|3|||
130720580|NCT00186043|470599806|FG000|Overall Study|Protocol Violation|2|||
130720581|NCT00186043|470599807|FG001|Overall Study|Protocol Violation|1|||
130720582|NCT04874636|470599808|FG000|Overall Study|Adverse Event|17|||
130720583|NCT04874636|470599809|FG001|Overall Study|Adverse Event|7|||
130720584|NCT04874636|470599808|FG000|Overall Study|Lost to Follow-up|1|||
130720585|NCT04874636|470599809|FG001|Overall Study|Lost to Follow-up|0|||
130720586|NCT04874636|470599808|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130720587|NCT04874636|470599809|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130720588|NCT04874636|470599808|FG000|Overall Study|Physician Decision|1|||
130720589|NCT04874636|470599809|FG001|Overall Study|Physician Decision|0|||
130720590|NCT04874636|470599808|FG000|Overall Study|Withdrawal by Subject|6|||
130720591|NCT04874636|470599809|FG001|Overall Study|Withdrawal by Subject|5|||
130720592|NCT01770392|470599810|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
130720593|NCT04639713|470599811|FG000|Overall Study|Protocol Noncompliance|2|||
130720594|NCT04639713|470599811|FG000|Overall Study|Withdrawal by Subject|1|||
130720595|NCT03870477|470599820|FG000|Overall Study|Early Study Termination|1|||
130720596|NCT03258853|470599821|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
130720597|NCT03258853|470599822|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
130720598|NCT00871741|470599827|FG000|Overall Study|Premature study termination|9|||
130720599|NCT00871741|470599828|FG001|Overall Study|Premature study termination|7|||
130720600|NCT03433755|470599833|FG000|Overall Study|Lost to Follow-up|1|||
130720601|NCT03433755|470599834|FG001|Overall Study|Lost to Follow-up|0|||
130315553|NCT04158583|469120957|FG005|Overall Study|Clinical Progression Disease|0|||
130315554|NCT04158583|469120958|FG006|Overall Study|Clinical Progression Disease|0|||
130315555|NCT04158583|469120959|FG007|Overall Study|Clinical Progression Disease|0|||
130315556|NCT04158583|469120960|FG008|Overall Study|Clinical Progression Disease|0|||
130315557|NCT04158583|469120961|FG009|Overall Study|Clinical Progression Disease|0|||
130315558|NCT04158583|469120952|FG000|Overall Study|Clinical Progression|0|||
130315559|NCT04158583|469120953|FG001|Overall Study|Clinical Progression|0|||
130315560|NCT04158583|469120954|FG002|Overall Study|Clinical Progression|0|||
130315561|NCT04158583|469120955|FG003|Overall Study|Clinical Progression|0|||
130315562|NCT04158583|469120956|FG004|Overall Study|Clinical Progression|1|||
130315563|NCT04158583|469120957|FG005|Overall Study|Clinical Progression|0|||
130315564|NCT04158583|469120958|FG006|Overall Study|Clinical Progression|2|||
130315565|NCT04158583|469120959|FG007|Overall Study|Clinical Progression|0|||
130315566|NCT04158583|469120960|FG008|Overall Study|Clinical Progression|0|||
130315567|NCT04158583|469120961|FG009|Overall Study|Clinical Progression|0|||
130315568|NCT04158583|469120952|FG000|Overall Study|Clinical Deterioration|0|||
130315569|NCT04158583|469120953|FG001|Overall Study|Clinical Deterioration|0|||
130315570|NCT04158583|469120954|FG002|Overall Study|Clinical Deterioration|0|||
130315571|NCT04158583|469120955|FG003|Overall Study|Clinical Deterioration|1|||
130315572|NCT04158583|469120956|FG004|Overall Study|Clinical Deterioration|0|||
130315573|NCT04158583|469120957|FG005|Overall Study|Clinical Deterioration|0|||
130315574|NCT04158583|469120958|FG006|Overall Study|Clinical Deterioration|0|||
130315575|NCT04158583|469120959|FG007|Overall Study|Clinical Deterioration|0|||
130315576|NCT04158583|469120960|FG008|Overall Study|Clinical Deterioration|0|||
130466616|NCT03447249|469674866|FG001|Overall Study|Other|0|||
130720602|NCT03433755|470599835|FG002|Overall Study|Lost to Follow-up|0|||
130720603|NCT03433755|470599836|FG003|Overall Study|Lost to Follow-up|0|||
130720604|NCT03433755|470599833|FG000|Overall Study|Decision by Sponsor|1|||
130315577|NCT04158583|469120961|FG009|Overall Study|Clinical Deterioration|1|||
130315578|NCT01871519|469120962|FG000|Overall Study|Death|26|||
130720605|NCT03433755|470599834|FG001|Overall Study|Decision by Sponsor|0|||
130720606|NCT03433755|470599835|FG002|Overall Study|Decision by Sponsor|0|||
130720607|NCT03433755|470599836|FG003|Overall Study|Decision by Sponsor|0|||
130315579|NCT01871519|469120962|FG000|Overall Study|Lost to Follow-up|15|||
130315580|NCT01871519|469120962|FG000|Overall Study|Withdrawal by Subject|49|||
130315581|NCT02485704|469120963|FG000|Overall Study|Lost to Follow-up|4|||
130315582|NCT02485704|469120964|FG001|Overall Study|Lost to Follow-up|5|||
130466617|NCT01248936|469674867|FG000|Overall Study|Sponsor Decision|259|||
130720608|NCT01565850|470599837|FG000|Overall Study|Adverse Event|0|||
130720609|NCT01565850|470599838|FG001|Overall Study|Adverse Event|1|||
130315583|NCT02485704|469120963|FG000|Overall Study|Withdrawal by Subject|0|||
130720610|NCT01565850|470599837|FG000|Overall Study|Lost to Follow-up|12|||
130720611|NCT01565850|470599838|FG001|Overall Study|Lost to Follow-up|4|||
130376170|NCT04016285|469343608|FG001|Overall Study|Failed to collect outcome data|3|||
130376171|NCT01750242|469343613|FG000|Overall Study|Unreadable Images|3|||
130376172|NCT01025752|469343625|FG000|Overall Study|Lost to Follow-up|7|||
130376173|NCT01025752|469343626|FG001|Overall Study|Lost to Follow-up|10|||
130376174|NCT01025752|469343625|FG000|Overall Study|Physician Decision|1|||
130376175|NCT01025752|469343626|FG001|Overall Study|Physician Decision|3|||
130376176|NCT01417234|469343629|FG000|Overall Study|Subject non-compliant|3|||
130376177|NCT00023764|469343630|FG000|Overall Study|Other|1|||
130376178|NCT00023764|469343630|FG000|Overall Study|Adverse Event|4|||
130376179|NCT00023764|469343630|FG000|Overall Study|Withdrawal by Subject|1|||
130376180|NCT00023764|469343630|FG000|Overall Study|Progression of disease|6|||
130376181|NCT00023764|469343630|FG000|Overall Study|patient received other treatment|1|||
130376182|NCT00023764|469343630|FG000|Overall Study|delay in obtaining staging images|1|||
130376183|NCT04294472|469343631|FG000|Overall Study|Adverse Event|0|||
130376184|NCT04294472|469343632|FG001|Overall Study|Adverse Event|1|||
130376185|NCT04294472|469343633|FG002|Overall Study|Adverse Event|1|||
130376186|NCT04294472|469343631|FG000|Overall Study|Randomized but not treated|0|||
130376187|NCT04294472|469343632|FG001|Overall Study|Randomized but not treated|1|||
130376188|NCT04294472|469343633|FG002|Overall Study|Randomized but not treated|1|||
130376189|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130376190|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130376191|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130376192|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
130376193|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130376194|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130376195|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
130376196|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
130376197|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Other|1|||
130376198|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Other|4|||
130376199|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Other|3|||
130376200|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Other|6|||
130376201|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
130376202|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
130376203|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
130376204|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
130376205|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
130376206|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
130376207|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
130376208|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
130376209|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130376210|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130376211|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130376212|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
130315584|NCT02485704|469120964|FG001|Overall Study|Withdrawal by Subject|3|||
130315585|NCT02485704|469120963|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
130315586|NCT02485704|469120964|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
130315587|NCT01777776|469120965|FG000|Overall Study|Adverse Event|2|||
130315588|NCT01777776|469120966|FG001|Overall Study|Adverse Event|4|||
130315589|NCT01777776|469120967|FG002|Overall Study|Adverse Event|0|||
130315590|NCT01777776|469120968|FG003|Overall Study|Adverse Event|0|||
130315591|NCT01777776|469120965|FG000|Overall Study|Disease Progression|4|||
130315592|NCT01777776|469120966|FG001|Overall Study|Disease Progression|8|||
130315593|NCT01777776|469120967|FG002|Overall Study|Disease Progression|6|||
130315594|NCT01777776|469120968|FG003|Overall Study|Disease Progression|3|||
130315595|NCT01777776|469120965|FG000|Overall Study|Withdrawal by Subject|0|||
130315596|NCT01777776|469120966|FG001|Overall Study|Withdrawal by Subject|0|||
130315597|NCT01777776|469120967|FG002|Overall Study|Withdrawal by Subject|0|||
130315598|NCT01777776|469120968|FG003|Overall Study|Withdrawal by Subject|1|||
130315599|NCT04617782|469122508|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
130315600|NCT04617782|469122508|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
130315601|NCT04617782|469122508|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
130315602|NCT04617782|469122508|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
130315603|NCT04617782|469122508|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
130315604|NCT04617782|469122508|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
130315605|NCT04233801|469122518|FG000|Overall Study|Other than listed|0|||
130315606|NCT04233801|469122519|FG001|Overall Study|Other than listed|0|||
130315607|NCT04233801|469122520|FG002|Overall Study|Other than listed|1|||
130315608|NCT04233801|469122518|FG000|Overall Study|Withdrawal by Subject|0|||
130315609|NCT04233801|469122519|FG001|Overall Study|Withdrawal by Subject|2|||
130315610|NCT04233801|469122520|FG002|Overall Study|Withdrawal by Subject|3|||
130376213|NCT02925494|469343640|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
130376214|NCT02925494|469343641|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
130376215|NCT02925494|469343642|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
130720612|NCT01565850|470599837|FG000|Overall Study|Investigator's Discretion|2|||
130720613|NCT01565850|470599838|FG001|Overall Study|Investigator's Discretion|1|||
130720614|NCT01565850|470599837|FG000|Overall Study|Participant noncompliance|2|||
130720615|NCT01565850|470599838|FG001|Overall Study|Participant noncompliance|0|||
130720616|NCT01565850|470599837|FG000|Overall Study|Withdrew Consent|4|||
130720617|NCT01565850|470599838|FG001|Overall Study|Withdrew Consent|2|||
130720618|NCT04941729|470601476|FG000|Overall Study|Death|0|||
130720619|NCT04941729|470601477|FG001|Overall Study|Death|1|||
130720620|NCT04941729|470601476|FG000|Overall Study|Study terminated by sponsor|11|||
130720621|NCT04941729|470601477|FG001|Overall Study|Study terminated by sponsor|10|||
130720622|NCT04994483|470601478|FG000|Overall Study|Adverse Event|26|||
130720623|NCT04994483|470601479|FG001|Overall Study|Adverse Event|17|||
130720624|NCT04994483|470601478|FG000|Overall Study|Lost to Follow-up|6|||
130720625|NCT04994483|470601479|FG001|Overall Study|Lost to Follow-up|10|||
130720626|NCT04994483|470601478|FG000|Overall Study|Noncompliance with study drug|8|||
130720627|NCT04994483|470601479|FG001|Overall Study|Noncompliance with study drug|5|||
130720628|NCT04994483|470601478|FG000|Overall Study|Physician Decision|5|||
130720629|NCT04994483|470601479|FG001|Overall Study|Physician Decision|0|||
130376216|NCT02925494|469343643|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
130376217|NCT06149247|469343648|FG000|Overall Study|Adverse Event|0|||
130376218|NCT06149247|469343649|FG001|Overall Study|Adverse Event|1|||
130376219|NCT02289417|469343650|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
130376220|NCT02289417|469343651|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376221|NCT02289417|469343652|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
130376222|NCT02289417|469343653|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376223|NCT02289417|469343654|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376224|NCT02289417|469343655|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376225|NCT02289417|469343656|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376226|NCT02289417|469343657|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376227|NCT02289417|469343658|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130376228|NCT02289417|469343650|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
130376229|NCT02289417|469343651|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
130376230|NCT02289417|469343652|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
130376231|NCT02289417|469343653|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376232|NCT02289417|469343654|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376233|NCT02289417|469343655|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376234|NCT02289417|469343656|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376235|NCT02289417|469343657|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376236|NCT02289417|469343658|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130376237|NCT02289417|469343650|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376238|NCT02289417|469343651|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
130376239|NCT02289417|469343652|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376240|NCT02289417|469343653|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376241|NCT02289417|469343654|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376242|NCT02289417|469343655|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376243|NCT02289417|469343656|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376244|NCT02289417|469343657|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376245|NCT02289417|469343658|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130376246|NCT02289417|469343650|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
130376247|NCT02289417|469343651|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376248|NCT02289417|469343652|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130720630|NCT04994483|470601478|FG000|Overall Study|Withdrawal by Subject|41|||
130720631|NCT04994483|470601479|FG001|Overall Study|Withdrawal by Subject|38|||
130376249|NCT02289417|469343653|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376250|NCT02289417|469343654|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376251|NCT02289417|469343655|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376252|NCT02289417|469343656|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376253|NCT02289417|469343657|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376254|NCT02289417|469343658|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130376255|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130720632|NCT04994483|470601478|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
130720633|NCT04994483|470601479|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
130376256|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
130376257|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
130376258|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
130720634|NCT04994483|470601478|FG000|Overall Study|Met stopping criteria|1|||
130720635|NCT04994483|470601479|FG001|Overall Study|Met stopping criteria|0|||
130720636|NCT04994483|470601478|FG000|Overall Study|Randomized in error, not treated|4|||
130376259|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
130720637|NCT04994483|470601479|FG001|Overall Study|Randomized in error, not treated|3|||
130466618|NCT01248936|469674867|FG000|Overall Study|Progression of Disease|50|||
130466619|NCT01248936|469674867|FG000|Overall Study|Death|26|||
130315611|NCT00928486|469122521|FG000|Overall Study|Adverse Event|2|||
130315612|NCT00928486|469122521|FG000|Overall Study|Disease Progression|7|||
130315613|NCT00928486|469122521|FG000|Overall Study|Withdrawal by Subject|1|||
130315614|NCT01342913|469122522|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
130315615|NCT01342913|469122523|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130315616|NCT01342913|469122524|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130315617|NCT01342913|469122522|FG000|2-week Run-in Period|Physician Decision|6|||
130315618|NCT01342913|469122523|FG001|2-week Run-in Period|Physician Decision|0|||
130315619|NCT01342913|469122524|FG002|2-week Run-in Period|Physician Decision|0|||
130315620|NCT01342913|469122522|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
130315621|NCT01342913|469122523|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130315622|NCT01342913|469122524|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130315623|NCT01342913|469122522|FG000|2-week Run-in Period|Adverse Event|2|||
130315624|NCT01342913|469122523|FG001|2-week Run-in Period|Adverse Event|0|||
130315625|NCT01342913|469122524|FG002|2-week Run-in Period|Adverse Event|0|||
130315626|NCT01342913|469122522|FG000|2-week Run-in Period|Protocol Violation|5|||
130315627|NCT01342913|469122523|FG001|2-week Run-in Period|Protocol Violation|0|||
130315628|NCT01342913|469122524|FG002|2-week Run-in Period|Protocol Violation|0|||
130315629|NCT01342913|469122522|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
130315630|NCT01342913|469122523|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
130315631|NCT01342913|469122524|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
130315632|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130315633|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Adverse Event|3|||
130315634|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Adverse Event|6|||
130315635|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130315636|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
130315637|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
130315638|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130315639|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
130315640|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
130315641|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130315642|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130315643|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
130315644|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130315645|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Physician Decision|2|||
130315646|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Physician Decision|0|||
130315647|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130315648|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130315649|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130315650|NCT04024891|469122528|FG000|Overall Study|Pregnancy|0|||
130315651|NCT04024891|469122529|FG001|Overall Study|Pregnancy|1|||
130315652|NCT01474317|469122540|FG000|Overall Study|Adverse Event|1|||
130315653|NCT01474317|469122540|FG000|Overall Study|Subject ineligible for study|1|||
130315654|NCT00453154|469122543|FG000|Double BIind Maintenance|Adverse Event|0|||
130315655|NCT00453154|469122544|FG001|Double BIind Maintenance|Adverse Event|0|||
130315656|NCT00453154|469122545|FG002|Double BIind Maintenance|Adverse Event|3|||
130315657|NCT00453154|469122546|FG003|Double BIind Maintenance|Adverse Event|12|||
130315658|NCT00453154|469122543|FG000|Double BIind Maintenance|Death|0|||
130315659|NCT00453154|469122544|FG001|Double BIind Maintenance|Death|0|||
130315660|NCT00453154|469122545|FG002|Double BIind Maintenance|Death|2|||
130315661|NCT00453154|469122546|FG003|Double BIind Maintenance|Death|1|||
130315662|NCT00453154|469122543|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
130315663|NCT00453154|469122544|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
130315664|NCT00453154|469122545|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
130315665|NCT00453154|469122546|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
130315666|NCT00453154|469122543|FG000|Double BIind Maintenance|Progression|0|||
130315667|NCT00453154|469122544|FG001|Double BIind Maintenance|Progression|0|||
130315668|NCT00453154|469122545|FG002|Double BIind Maintenance|Progression|29|||
130315669|NCT00453154|469122546|FG003|Double BIind Maintenance|Progression|26|||
130315670|NCT00453154|469122543|FG000|Double BIind Maintenance|Medical Issues|0|||
130315671|NCT00453154|469122544|FG001|Double BIind Maintenance|Medical Issues|0|||
130315672|NCT00453154|469122545|FG002|Double BIind Maintenance|Medical Issues|3|||
130315673|NCT00453154|469122546|FG003|Double BIind Maintenance|Medical Issues|1|||
130315674|NCT00453154|469122543|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130315675|NCT00453154|469122544|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130315676|NCT00453154|469122545|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130315677|NCT00453154|469122546|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130315678|NCT02152631|469122548|FG000|Overall Study|Adverse Event|32|||
130315679|NCT02152631|469122549|FG001|Overall Study|Adverse Event|4|||
130315680|NCT02152631|469122548|FG000|Overall Study|Withdrawal by Subject|13|||
130315681|NCT02152631|469122549|FG001|Overall Study|Withdrawal by Subject|16|||
130315682|NCT02152631|469122548|FG000|Overall Study|Noncompliance with study drug|1|||
130315683|NCT02152631|469122549|FG001|Overall Study|Noncompliance with study drug|0|||
130315684|NCT02152631|469122548|FG000|Overall Study|Physician Decision|1|||
130315685|NCT02152631|469122549|FG001|Overall Study|Physician Decision|2|||
130315686|NCT02152631|469122548|FG000|Overall Study|Lost to Follow-up|0|||
130315687|NCT02152631|469122549|FG001|Overall Study|Lost to Follow-up|1|||
130315688|NCT02152631|469122548|FG000|Overall Study|On Treatment|19|||
130315689|NCT02152631|469122549|FG001|Overall Study|On Treatment|3|||
130315690|NCT05473026|469122550|FG000|Overall Study|Lost to Follow-up|5|||
130315691|NCT05473026|469122551|FG001|Overall Study|Lost to Follow-up|2|||
130315692|NCT01693029|469122562|FG000|Overall Study|Withdrawal by Subject|15|||
130315693|NCT01693029|469122563|FG001|Overall Study|Withdrawal by Subject|22|||
130315694|NCT01693029|469122562|FG000|Overall Study|Kidney transplantation|7|||
130315695|NCT01693029|469122563|FG001|Overall Study|Kidney transplantation|7|||
130315696|NCT01693029|469122562|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
130315697|NCT01693029|469122563|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
130315698|NCT01693029|469122562|FG000|Overall Study|Protocol Violation|6|||
130315699|NCT01693029|469122563|FG001|Overall Study|Protocol Violation|7|||
130315700|NCT01693029|469122562|FG000|Overall Study|Change in dialysis modality|2|||
130315701|NCT01693029|469122563|FG001|Overall Study|Change in dialysis modality|1|||
130315702|NCT01693029|469122562|FG000|Overall Study|Physician Decision|0|||
130315703|NCT01693029|469122563|FG001|Overall Study|Physician Decision|2|||
130315704|NCT01693029|469122562|FG000|Overall Study|Lost to Follow-up|0|||
130315705|NCT01693029|469122563|FG001|Overall Study|Lost to Follow-up|1|||
130315706|NCT01693029|469122562|FG000|Overall Study|Adverse Event|1|||
130315707|NCT01693029|469122563|FG001|Overall Study|Adverse Event|6|||
130315708|NCT01693029|469122562|FG000|Overall Study|Death|5|||
130315709|NCT01693029|469122563|FG001|Overall Study|Death|8|||
130315710|NCT01693029|469122562|FG000|Overall Study|Non-compliance|2|||
130315711|NCT01693029|469122563|FG001|Overall Study|Non-compliance|1|||
130315712|NCT03683173|469122564|FG000|Completed Follow-up|Unavailable|235|||
130315713|NCT03683173|469122565|FG001|Completed Follow-up|Unavailable|217|||
130315714|NCT03683173|469122564|FG000|Completed Follow-up|Refused|69|||
130315715|NCT03683173|469122565|FG001|Completed Follow-up|Refused|59|||
130315716|NCT03683173|469122564|FG000|Completed Follow-up|Disconnected phone|65|||
130315717|NCT03683173|469122565|FG001|Completed Follow-up|Disconnected phone|95|||
130315718|NCT03683173|469122564|FG000|Completed Follow-up|Health issue/deceased|10|||
130315719|NCT03683173|469122565|FG001|Completed Follow-up|Health issue/deceased|4|||
130315720|NCT03683173|469122564|FG000|Completed Follow-up|Moved away|8|||
130315721|NCT03683173|469122565|FG001|Completed Follow-up|Moved away|1|||
130315722|NCT02647281|469122566|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315723|NCT02647281|469122567|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315724|NCT02647281|469122568|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315725|NCT02647281|469122569|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315726|NCT02647281|469122570|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315727|NCT02647281|469122571|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315728|NCT02647281|469122572|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315729|NCT02647281|469122573|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315730|NCT02647281|469122574|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
130315731|NCT05801991|469122575|FG000|Overall Study|Lost to Follow-up|1|||
130315732|NCT05801991|469122576|FG001|Overall Study|Lost to Follow-up|0|||
130315733|NCT02210000|469122577|FG000|Overall Study|Study Terminated|11|||
130315734|NCT02210000|469122578|FG001|Overall Study|Study Terminated|12|||
130315735|NCT02210000|469122577|FG000|Overall Study|Withdrawal by Subject|7|||
130315736|NCT02210000|469122578|FG001|Overall Study|Withdrawal by Subject|1|||
130315737|NCT02210000|469122577|FG000|Overall Study|Adverse Event|1|||
130315738|NCT02210000|469122578|FG001|Overall Study|Adverse Event|5|||
130376260|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
130376261|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130376262|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130376263|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130376264|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130376265|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130376266|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
130376267|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130315739|NCT02210000|469122577|FG000|Overall Study|Lost to Follow-up|0|||
130315740|NCT02210000|469122578|FG001|Overall Study|Lost to Follow-up|2|||
130315741|NCT02210000|469122577|FG000|Overall Study|Physician Decision|0|||
130315742|NCT02210000|469122578|FG001|Overall Study|Physician Decision|1|||
130315743|NCT01329263|469122581|FG000|Overall Study|Lost to Follow-up|4|||
130315744|NCT01329263|469122582|FG001|Overall Study|Lost to Follow-up|21|||
130315745|NCT01329263|469122581|FG000|Overall Study|Withdrawal by Subject|1|||
130315746|NCT01329263|469122582|FG001|Overall Study|Withdrawal by Subject|2|||
130376268|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130315747|NCT01421017|469122583|FG000|Overall Study|Withdrawal by Subject|2|||
130315748|NCT01421017|469122584|FG001|Overall Study|Withdrawal by Subject|0|||
130315749|NCT01421017|469122585|FG002|Overall Study|Withdrawal by Subject|0|||
130315750|NCT01421017|469122583|FG000|Overall Study|POD|0|||
130315751|NCT01421017|469122584|FG001|Overall Study|POD|6|||
130315752|NCT01421017|469122585|FG002|Overall Study|POD|3|||
130315753|NCT00833040|469122588|FG000|Overall Study|Adverse Event|0|||
130315754|NCT00833040|469122589|FG001|Overall Study|Adverse Event|0|||
130315755|NCT00833040|469122590|FG002|Overall Study|Adverse Event|0|||
130315756|NCT00833040|469122591|FG003|Overall Study|Adverse Event|0|||
130315757|NCT00833040|469122592|FG004|Overall Study|Adverse Event|0|||
130315758|NCT00833040|469122593|FG005|Overall Study|Adverse Event|1|||
130315759|NCT02313766|469122594|FG000|Overall Study|surgery cancelled|1|||
130315760|NCT02313766|469122595|FG001|Overall Study|surgery cancelled|0|||
130315761|NCT02313766|469122596|FG002|Overall Study|surgery cancelled|0|||
130315762|NCT02313766|469122594|FG000|Overall Study|Lost to Follow-up|0|||
130315763|NCT02313766|469122595|FG001|Overall Study|Lost to Follow-up|2|||
130315764|NCT02313766|469122596|FG002|Overall Study|Lost to Follow-up|0|||
130315765|NCT02313766|469122594|FG000|Overall Study|Adverse Event|0|||
130315766|NCT02313766|469122595|FG001|Overall Study|Adverse Event|1|||
130315767|NCT02313766|469122596|FG002|Overall Study|Adverse Event|0|||
130315768|NCT03489863|469122598|FG000|Overall Study|Withdrawal by Subject|0|||
130315769|NCT03489863|469122599|FG001|Overall Study|Withdrawal by Subject|1|||
130315770|NCT02193776|469122600|FG000|Overall Study|Consent withdrawn|1|||
130315771|NCT02193776|469122601|FG001|Overall Study|Consent withdrawn|0|||
130315772|NCT02193776|469122602|FG002|Overall Study|Consent withdrawn|0|||
130315773|NCT02193776|469122603|FG003|Overall Study|Consent withdrawn|0|||
130315774|NCT02193776|469122600|FG000|Overall Study|Failure to comply with protocol|0|||
130315775|NCT02193776|469122601|FG001|Overall Study|Failure to comply with protocol|1|||
130315776|NCT02193776|469122602|FG002|Overall Study|Failure to comply with protocol|0|||
130315777|NCT02193776|469122603|FG003|Overall Study|Failure to comply with protocol|0|||
130315778|NCT02193776|469122600|FG000|Overall Study|Investigator/Sponsor decision|1|||
130315779|NCT02193776|469122601|FG001|Overall Study|Investigator/Sponsor decision|1|||
130315780|NCT02193776|469122602|FG002|Overall Study|Investigator/Sponsor decision|0|||
130315781|NCT02193776|469122603|FG003|Overall Study|Investigator/Sponsor decision|0|||
130315782|NCT02193776|469122600|FG000|Overall Study|Death|1|||
130315783|NCT02193776|469122601|FG001|Overall Study|Death|0|||
130315784|NCT02193776|469122602|FG002|Overall Study|Death|0|||
130315785|NCT02193776|469122603|FG003|Overall Study|Death|0|||
130315786|NCT02193776|469122600|FG000|Overall Study|Adverse event/Specific toxicity|5|||
130315787|NCT02193776|469122601|FG001|Overall Study|Adverse event/Specific toxicity|5|||
130315788|NCT02193776|469122602|FG002|Overall Study|Adverse event/Specific toxicity|2|||
130315789|NCT02193776|469122603|FG003|Overall Study|Adverse event/Specific toxicity|2|||
130315790|NCT00962208|469122605|FG000|Overall Study|Could not achieve good vision|9|||
130315791|NCT00962208|469122606|FG001|Overall Study|Could not achieve good vision|0|||
130315792|NCT00962208|469122605|FG000|Overall Study|Contraindicated to continue study|5|||
130315793|NCT00962208|469122606|FG001|Overall Study|Contraindicated to continue study|1|||
130315794|NCT00962208|469122605|FG000|Overall Study|Lost to Follow-up|0|||
130315795|NCT00962208|469122606|FG001|Overall Study|Lost to Follow-up|9|||
130315796|NCT00791388|469122607|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315797|NCT00791388|469122608|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
130315798|NCT00791388|469122609|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315799|NCT00791388|469122610|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315800|NCT00791388|469122611|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315801|NCT00791388|469122607|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
130315802|NCT00791388|469122608|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315803|NCT00791388|469122609|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315804|NCT00791388|469122610|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315805|NCT00791388|469122611|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315806|NCT00791388|469122607|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315807|NCT00791388|469122608|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315808|NCT00791388|469122609|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315809|NCT00791388|469122610|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315810|NCT00791388|469122611|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
130315811|NCT02995980|469122612|FG000|Overall Study|Lost to Follow-up|14|||
130315812|NCT00657540|469122614|FG000|Overall Study|Lost to Follow-up|1|||
130315813|NCT00657540|469122615|FG001|Overall Study|Lost to Follow-up|4|||
130466620|NCT01248936|469674867|FG000|Overall Study|Withdrawal of Consent|20|||
130466621|NCT01248936|469674867|FG000|Overall Study|Adverse Event|8|||
130315814|NCT01458639|469122617|FG000|Overall Study|Physician Decision|4|||
130315815|NCT01458639|469122617|FG000|Overall Study|Equipment issue|1|||
130315816|NCT01458639|469122617|FG000|Overall Study|Inability to obtain subject blood sample|1|||
130315817|NCT02656017|469122618|FG000|Overall Study|Study burden|3|||
130315818|NCT02656017|469122619|FG001|Overall Study|Study burden|3|||
130315819|NCT02656017|469122618|FG000|Overall Study|Adverse Event|2|||
130315820|NCT02656017|469122619|FG001|Overall Study|Adverse Event|1|||
130315821|NCT02656017|469122618|FG000|Overall Study|Unable/unwilling to take study medication|2|||
130315822|NCT02656017|469122619|FG001|Overall Study|Unable/unwilling to take study medication|1|||
130315823|NCT02656017|469122618|FG000|Overall Study|Began Tolvaptan|1|||
130315824|NCT02656017|469122619|FG001|Overall Study|Began Tolvaptan|1|||
130315825|NCT02656017|469122618|FG000|Overall Study|Withdrawal by Subject|1|||
130315826|NCT02656017|469122619|FG001|Overall Study|Withdrawal by Subject|0|||
130315827|NCT02792231|469122620|FG000|Overall Study|Patient/guardian decision|32|||
130315828|NCT02792231|469122621|FG001|Overall Study|Patient/guardian decision|42|||
130315829|NCT02792231|469122620|FG000|Overall Study|Adverse Event|15|||
130315830|NCT02792231|469122621|FG001|Overall Study|Adverse Event|11|||
130315831|NCT02792231|469122620|FG000|Overall Study|Physician Decision|14|||
130315832|NCT02792231|469122621|FG001|Overall Study|Physician Decision|12|||
130315833|NCT02792231|469122620|FG000|Overall Study|Lack of Efficacy|7|||
130315834|NCT02792231|469122621|FG001|Overall Study|Lack of Efficacy|9|||
130315835|NCT02792231|469122620|FG000|Overall Study|Lost to Follow-up|9|||
130315836|NCT02792231|469122621|FG001|Overall Study|Lost to Follow-up|5|||
130315837|NCT02792231|469122620|FG000|Overall Study|Pregnancy|1|||
130315838|NCT02792231|469122621|FG001|Overall Study|Pregnancy|3|||
130315839|NCT02792231|469122620|FG000|Overall Study|Non-compliance with study treatment|2|||
130315840|NCT02792231|469122621|FG001|Overall Study|Non-compliance with study treatment|1|||
130315841|NCT02792231|469122620|FG000|Overall Study|Protocol deviation|2|||
130315842|NCT02792231|469122621|FG001|Overall Study|Protocol deviation|0|||
130315843|NCT02792231|469122620|FG000|Overall Study|Technical problems|0|||
130315844|NCT02792231|469122621|FG001|Overall Study|Technical problems|1|||
130315845|NCT05196828|469122622|FG000|Overall Study|Withdrawal by Subject|2|||
130315846|NCT05196828|469122623|FG001|Overall Study|Withdrawal by Subject|0|||
130315847|NCT05196828|469122622|FG000|Overall Study|Lost to Follow-up|0|||
130315848|NCT05196828|469122623|FG001|Overall Study|Lost to Follow-up|4|||
130315849|NCT05196828|469122622|FG000|Overall Study|Adverse Event|1|||
130315850|NCT05196828|469122623|FG001|Overall Study|Adverse Event|0|||
130315851|NCT03309878|469122624|FG000|Overall Study|Adverse Event|1|||
130315852|NCT03309878|469122625|FG001|Overall Study|Adverse Event|0|||
130315853|NCT03309878|469122626|FG002|Overall Study|Adverse Event|0|||
130315854|NCT03309878|469122627|FG003|Overall Study|Adverse Event|0|||
130315855|NCT03309878|469122624|FG000|Overall Study|Did not maintain eligibility|2|||
130315856|NCT03309878|469122625|FG001|Overall Study|Did not maintain eligibility|1|||
130315857|NCT03309878|469122626|FG002|Overall Study|Did not maintain eligibility|0|||
130315858|NCT03309878|469122627|FG003|Overall Study|Did not maintain eligibility|0|||
130315859|NCT03309878|469122624|FG000|Overall Study|Withdrawal by Subject|0|||
130315860|NCT03309878|469122625|FG001|Overall Study|Withdrawal by Subject|1|||
130315861|NCT03309878|469122626|FG002|Overall Study|Withdrawal by Subject|0|||
130315862|NCT03309878|469122627|FG003|Overall Study|Withdrawal by Subject|0|||
130315863|NCT01096316|469122628|FG000|Overall Study|Lost to Follow-up|15|||
130315864|NCT01096316|469122629|FG001|Overall Study|Lost to Follow-up|9|||
130315865|NCT02836652|469122630|FG000|Overall Study|Death|3|||
130315866|NCT02836652|469122631|FG001|Overall Study|Death|3|||
130315867|NCT02836652|469122630|FG000|Overall Study|Transplant/Explant|3|||
130315868|NCT02836652|469122631|FG001|Overall Study|Transplant/Explant|4|||
130315869|NCT02836652|469122630|FG000|Overall Study|Withdrawn|9|||
130315870|NCT02836652|469122631|FG001|Overall Study|Withdrawn|9|||
130315871|NCT02836652|469122630|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
130315872|NCT02836652|469122631|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
130315873|NCT02349633|469122633|FG000|Overall Study|Death|0|||
130315874|NCT02349633|469122634|FG001|Overall Study|Death|1|||
130315875|NCT02349633|469122635|FG002|Overall Study|Death|0|||
130315876|NCT02349633|469122636|FG003|Overall Study|Death|0|||
130315877|NCT02349633|469122637|FG004|Overall Study|Death|0|||
130315878|NCT02349633|469122638|FG005|Overall Study|Death|1|||
130315879|NCT02349633|469122639|FG006|Overall Study|Death|1|||
130315880|NCT02349633|469122640|FG007|Overall Study|Death|1|||
130315881|NCT02349633|469122641|FG008|Overall Study|Death|0|||
130315882|NCT02349633|469122642|FG009|Overall Study|Death|1|||
130315883|NCT02349633|469122643|FG010|Overall Study|Death|0|||
130315884|NCT02349633|469122644|FG011|Overall Study|Death|0|||
130315885|NCT02349633|469122645|FG012|Overall Study|Death|0|||
130315886|NCT02349633|469122646|FG013|Overall Study|Death|0|||
130315887|NCT02349633|469122633|FG000|Overall Study|Withdrawal by Subject|0|||
130315888|NCT02349633|469122634|FG001|Overall Study|Withdrawal by Subject|0|||
130315889|NCT02349633|469122635|FG002|Overall Study|Withdrawal by Subject|0|||
130315890|NCT02349633|469122636|FG003|Overall Study|Withdrawal by Subject|1|||
130315891|NCT02349633|469122637|FG004|Overall Study|Withdrawal by Subject|0|||
130315892|NCT02349633|469122638|FG005|Overall Study|Withdrawal by Subject|0|||
130315893|NCT02349633|469122639|FG006|Overall Study|Withdrawal by Subject|0|||
130315894|NCT02349633|469122640|FG007|Overall Study|Withdrawal by Subject|2|||
130466622|NCT01248936|469674867|FG000|Overall Study|Lost to Follow-up|7|||
130466623|NCT01248936|469674867|FG000|Overall Study|Refused Treatment|1|||
130466624|NCT01248936|469674867|FG000|Overall Study|Other reason|3|||
130466625|NCT04556981|469674868|FG000|Overall Study|Death|0|||
130315895|NCT02349633|469122641|FG008|Overall Study|Withdrawal by Subject|2|||
130466626|NCT04556981|469674869|FG001|Overall Study|Death|1|||
130720638|NCT04994483|470601478|FG000|Overall Study|Lack of a reliable study partner|0|||
130720639|NCT04994483|470601479|FG001|Overall Study|Lack of a reliable study partner|1|||
130720640|NCT04994483|470601478|FG000|Overall Study|Met MRI exclusion criteria|0|||
130720641|NCT04994483|470601479|FG001|Overall Study|Met MRI exclusion criteria|1|||
130720642|NCT01200992|470601480|FG000|Overall Study|Study terminated early|35|||
130720643|NCT01200992|470601481|FG001|Overall Study|Study terminated early|41|||
130720644|NCT01200992|470601480|FG000|Overall Study|Randomized but not treated|2|||
130720645|NCT01200992|470601481|FG001|Overall Study|Randomized but not treated|0|||
130720646|NCT00191113|470601490|FG000|Core Study|Withdrawal by Subject|25|||
130720647|NCT00191113|470601491|FG001|Core Study|Withdrawal by Subject|9|||
130720648|NCT00191113|470601490|FG000|Core Study|Protocol Violation|6|||
130720649|NCT00191113|470601491|FG001|Core Study|Protocol Violation|2|||
130720650|NCT00191113|470601490|FG000|Core Study|Lost to Follow-up|3|||
130720651|NCT00191113|470601491|FG001|Core Study|Lost to Follow-up|0|||
130720652|NCT00191113|470601490|FG000|Core Study|Adverse Event|0|||
130720653|NCT00191113|470601491|FG001|Core Study|Adverse Event|2|||
130720654|NCT00191113|470601490|FG000|Core Study|Lack of Efficacy|0|||
130720655|NCT00191113|470601491|FG001|Core Study|Lack of Efficacy|2|||
130720656|NCT00191113|470601490|FG000|Core Study|Death|1|||
130315896|NCT02349633|469122642|FG009|Overall Study|Withdrawal by Subject|1|||
130315897|NCT02349633|469122643|FG010|Overall Study|Withdrawal by Subject|0|||
130315898|NCT02349633|469122644|FG011|Overall Study|Withdrawal by Subject|0|||
130315899|NCT02349633|469122645|FG012|Overall Study|Withdrawal by Subject|0|||
130315900|NCT02349633|469122646|FG013|Overall Study|Withdrawal by Subject|0|||
130315901|NCT02349633|469122633|FG000|Overall Study|Withdrawal of informed consent|0|||
130315902|NCT02349633|469122634|FG001|Overall Study|Withdrawal of informed consent|0|||
130315903|NCT02349633|469122635|FG002|Overall Study|Withdrawal of informed consent|0|||
130315904|NCT02349633|469122636|FG003|Overall Study|Withdrawal of informed consent|1|||
130720657|NCT00191113|470601491|FG001|Core Study|Death|0|||
130720658|NCT00368979|470601497|FG000|Overall Study|Adverse Event|9|||
130720659|NCT00368979|470601498|FG001|Overall Study|Adverse Event|16|||
130720660|NCT00368979|470601497|FG000|Overall Study|Lack of Efficacy|5|||
130720661|NCT00368979|470601498|FG001|Overall Study|Lack of Efficacy|3|||
130720662|NCT00368979|470601497|FG000|Overall Study|Other|3|||
130720663|NCT00368979|470601498|FG001|Overall Study|Other|1|||
130720664|NCT00368979|470601497|FG000|Overall Study|Lost to Follow-up|1|||
130720665|NCT00368979|470601498|FG001|Overall Study|Lost to Follow-up|0|||
130720666|NCT00368979|470601497|FG000|Overall Study|Protocol Violation|2|||
130720667|NCT00368979|470601498|FG001|Overall Study|Protocol Violation|1|||
130720668|NCT00368979|470601497|FG000|Overall Study|Withdrawal by Subject|5|||
130720669|NCT00368979|470601498|FG001|Overall Study|Withdrawal by Subject|9|||
130720670|NCT00631657|470601501|FG000|6-Month Treatment Period|Adverse Event|47|||
130720671|NCT00631657|470601502|FG001|6-Month Treatment Period|Adverse Event|0|||
130720672|NCT00631657|470601503|FG002|6-Month Treatment Period|Adverse Event|7|||
130720673|NCT00631657|470601501|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
130720674|NCT00631657|470601502|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
130720675|NCT00631657|470601503|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
130720676|NCT00631657|470601501|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
130720677|NCT00631657|470601502|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
130720678|NCT00631657|470601503|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
130720679|NCT00631657|470601501|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
130720680|NCT00631657|470601502|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
130720681|NCT00631657|470601503|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
130720682|NCT00631657|470601501|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
130720683|NCT00631657|470601502|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
130720684|NCT00631657|470601503|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
130720685|NCT00631657|470601501|FG000|6-Month Treatment Period|Other|16|||
130315905|NCT02349633|469122637|FG004|Overall Study|Withdrawal of informed consent|1|||
130315906|NCT02349633|469122638|FG005|Overall Study|Withdrawal of informed consent|0|||
130315907|NCT02349633|469122639|FG006|Overall Study|Withdrawal of informed consent|0|||
130720686|NCT00631657|470601502|FG001|6-Month Treatment Period|Other|0|||
130376269|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130720687|NCT00631657|470601503|FG002|6-Month Treatment Period|Other|4|||
130376270|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130720688|NCT00631657|470601501|FG000|6-Month Treatment Period|Not Treated|2|||
130720689|NCT00631657|470601502|FG001|6-Month Treatment Period|Not Treated|0|||
130720690|NCT00631657|470601503|FG002|6-Month Treatment Period|Not Treated|1|||
130720691|NCT00631657|470601501|FG000|7-Day Discontinuation Period|Not Treated|1|||
130720692|NCT00631657|470601502|FG001|7-Day Discontinuation Period|Not Treated|1|||
130720693|NCT00631657|470601503|FG002|7-Day Discontinuation Period|Not Treated|1|||
130315908|NCT02349633|469122640|FG007|Overall Study|Withdrawal of informed consent|3|||
130376271|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130720694|NCT00631657|470601501|FG000|7-Day Discontinuation Period|Other|1|||
130720695|NCT00631657|470601502|FG001|7-Day Discontinuation Period|Other|0|||
130720696|NCT00631657|470601503|FG002|7-Day Discontinuation Period|Other|0|||
130720697|NCT00325195|470601504|FG000|Randomized|Not dosed|5|||
130376272|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130315909|NCT02349633|469122641|FG008|Overall Study|Withdrawal of informed consent|0|||
130315910|NCT02349633|469122642|FG009|Overall Study|Withdrawal of informed consent|0|||
130315911|NCT02349633|469122643|FG010|Overall Study|Withdrawal of informed consent|0|||
130315912|NCT02349633|469122644|FG011|Overall Study|Withdrawal of informed consent|0|||
130315913|NCT02349633|469122645|FG012|Overall Study|Withdrawal of informed consent|0|||
130315914|NCT02349633|469122646|FG013|Overall Study|Withdrawal of informed consent|0|||
130315915|NCT02349633|469122633|FG000|Overall Study|Transition to compassionate use|0|||
130315916|NCT02349633|469122634|FG001|Overall Study|Transition to compassionate use|0|||
130315917|NCT02349633|469122635|FG002|Overall Study|Transition to compassionate use|0|||
130315918|NCT02349633|469122636|FG003|Overall Study|Transition to compassionate use|0|||
130315919|NCT02349633|469122637|FG004|Overall Study|Transition to compassionate use|1|||
130315920|NCT02349633|469122638|FG005|Overall Study|Transition to compassionate use|0|||
130315921|NCT02349633|469122639|FG006|Overall Study|Transition to compassionate use|0|||
130315922|NCT02349633|469122640|FG007|Overall Study|Transition to compassionate use|3|||
130315923|NCT02349633|469122641|FG008|Overall Study|Transition to compassionate use|0|||
130315924|NCT02349633|469122642|FG009|Overall Study|Transition to compassionate use|1|||
130315925|NCT02349633|469122643|FG010|Overall Study|Transition to compassionate use|0|||
130315926|NCT02349633|469122644|FG011|Overall Study|Transition to compassionate use|0|||
130315927|NCT02349633|469122645|FG012|Overall Study|Transition to compassionate use|0|||
130315928|NCT02349633|469122646|FG013|Overall Study|Transition to compassionate use|0|||
130315929|NCT02349633|469122633|FG000|Overall Study|Early termination of survival follow-up|0|||
130315930|NCT02349633|469122634|FG001|Overall Study|Early termination of survival follow-up|0|||
130315931|NCT02349633|469122635|FG002|Overall Study|Early termination of survival follow-up|0|||
130315932|NCT02349633|469122636|FG003|Overall Study|Early termination of survival follow-up|0|||
130315933|NCT02349633|469122637|FG004|Overall Study|Early termination of survival follow-up|0|||
130315934|NCT02349633|469122638|FG005|Overall Study|Early termination of survival follow-up|0|||
130315935|NCT02349633|469122639|FG006|Overall Study|Early termination of survival follow-up|0|||
130315936|NCT02349633|469122640|FG007|Overall Study|Early termination of survival follow-up|4|||
130315937|NCT02349633|469122641|FG008|Overall Study|Early termination of survival follow-up|0|||
130315938|NCT02349633|469122642|FG009|Overall Study|Early termination of survival follow-up|0|||
130315939|NCT02349633|469122643|FG010|Overall Study|Early termination of survival follow-up|0|||
130315940|NCT02349633|469122644|FG011|Overall Study|Early termination of survival follow-up|0|||
130315941|NCT02349633|469122645|FG012|Overall Study|Early termination of survival follow-up|0|||
130315942|NCT02349633|469122646|FG013|Overall Study|Early termination of survival follow-up|0|||
130315943|NCT02349633|469122633|FG000|Overall Study|Termination by sponsor|0|||
130315944|NCT02349633|469122634|FG001|Overall Study|Termination by sponsor|0|||
130315945|NCT02349633|469122635|FG002|Overall Study|Termination by sponsor|0|||
130315946|NCT02349633|469122636|FG003|Overall Study|Termination by sponsor|0|||
130315947|NCT02349633|469122637|FG004|Overall Study|Termination by sponsor|0|||
130315948|NCT02349633|469122638|FG005|Overall Study|Termination by sponsor|0|||
130315949|NCT02349633|469122639|FG006|Overall Study|Termination by sponsor|0|||
130315950|NCT02349633|469122640|FG007|Overall Study|Termination by sponsor|1|||
130315951|NCT02349633|469122641|FG008|Overall Study|Termination by sponsor|0|||
130315952|NCT02349633|469122642|FG009|Overall Study|Termination by sponsor|2|||
130315953|NCT02349633|469122643|FG010|Overall Study|Termination by sponsor|0|||
130315954|NCT02349633|469122644|FG011|Overall Study|Termination by sponsor|0|||
130315955|NCT02349633|469122645|FG012|Overall Study|Termination by sponsor|0|||
130315956|NCT02349633|469122646|FG013|Overall Study|Termination by sponsor|0|||
130315957|NCT02349633|469122633|FG000|Overall Study|Other|0|||
130315958|NCT02349633|469122634|FG001|Overall Study|Other|0|||
130315959|NCT02349633|469122635|FG002|Overall Study|Other|0|||
130315960|NCT02349633|469122636|FG003|Overall Study|Other|0|||
130315961|NCT02349633|469122637|FG004|Overall Study|Other|0|||
130376273|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130376274|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
130376275|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
130376276|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
130376277|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
130376278|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
130376279|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130376280|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130376281|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130376282|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130376283|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130376284|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130376285|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130376286|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130376287|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130376288|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130315962|NCT02349633|469122638|FG005|Overall Study|Other|0|||
130315963|NCT02349633|469122639|FG006|Overall Study|Other|0|||
130315964|NCT02349633|469122640|FG007|Overall Study|Other|2|||
130315965|NCT02349633|469122641|FG008|Overall Study|Other|0|||
130315966|NCT02349633|469122642|FG009|Overall Study|Other|0|||
130315967|NCT02349633|469122643|FG010|Overall Study|Other|0|||
130315968|NCT02349633|469122644|FG011|Overall Study|Other|0|||
130315969|NCT02349633|469122645|FG012|Overall Study|Other|0|||
130315970|NCT02349633|469122646|FG013|Overall Study|Other|0|||
130315971|NCT01008943|469122648|FG000|Overall Study|Withdrawal by Subject|1|||
130315972|NCT04244253|469122649|FG000|Overall Study|Adverse Event|2|||
130315973|NCT04244253|469122650|FG001|Overall Study|Adverse Event|2|||
130315974|NCT04244253|469122651|FG002|Overall Study|Adverse Event|4|||
130315975|NCT04244253|469122649|FG000|Overall Study|Protocol Violation|1|||
130315976|NCT04244253|469122650|FG001|Overall Study|Protocol Violation|2|||
130315977|NCT04244253|469122651|FG002|Overall Study|Protocol Violation|1|||
130315978|NCT04244253|469122649|FG000|Overall Study|Withdrawal by Subject|0|||
130315979|NCT04244253|469122650|FG001|Overall Study|Withdrawal by Subject|1|||
130315980|NCT04244253|469122651|FG002|Overall Study|Withdrawal by Subject|6|||
130315981|NCT04244253|469122649|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130315982|NCT04244253|469122650|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130315983|NCT04244253|469122651|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130315984|NCT04663321|469122652|FG000|Overall Study|Study terminated by Sponsor|2|||
130315985|NCT04663321|469122653|FG001|Overall Study|Study terminated by Sponsor|1|||
130315986|NCT04663321|469122654|FG002|Overall Study|Study terminated by Sponsor|2|||
130315987|NCT04663321|469122652|FG000|Overall Study|Withdrawal by Subject|10|||
130315988|NCT04663321|469122653|FG001|Overall Study|Withdrawal by Subject|3|||
130315989|NCT04663321|469122654|FG002|Overall Study|Withdrawal by Subject|2|||
130315990|NCT04663321|469122652|FG000|Overall Study|Not provided|0|||
130315991|NCT04663321|469122653|FG001|Overall Study|Not provided|0|||
130315992|NCT04663321|469122654|FG002|Overall Study|Not provided|1|||
130315993|NCT02611479|469122655|FG000|Baseline Enrollment|Exited study|13|||
130315994|NCT02611479|469122655|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
130315995|NCT02611479|469122655|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
130315996|NCT02611479|469122655|FG000|Data Cleaning|No baseline function or pain metrics|2|||
130315997|NCT00423657|469122659|FG000|Overall Study|Withdrew consent|10|||
130315998|NCT00423657|469122660|FG001|Overall Study|Withdrew consent|8|||
130315999|NCT00423657|469122659|FG000|Overall Study|Non-compliance|0|||
130316000|NCT00423657|469122660|FG001|Overall Study|Non-compliance|1|||
130316001|NCT00423657|469122659|FG000|Overall Study|Other|15|||
130316002|NCT00423657|469122660|FG001|Overall Study|Other|16|||
130316003|NCT00423657|469122659|FG000|Overall Study|Request of sponsor/investigator|1|||
130316004|NCT00423657|469122660|FG001|Overall Study|Request of sponsor/investigator|0|||
130316005|NCT02748863|469122661|FG000|Treatment Period 1|Adverse Event|0|||
130316006|NCT02748863|469122662|FG001|Treatment Period 1|Adverse Event|1|||
130316007|NCT02748863|469122663|FG002|Treatment Period 1|Adverse Event|0|||
130316008|NCT02748863|469122664|FG003|Treatment Period 1|Adverse Event|0|||
130316009|NCT02748863|469122665|FG004|Treatment Period 1|Adverse Event|0|||
130316010|NCT02748863|469122661|FG000|Treatment Period 1|Lack of Efficacy|0|||
130316011|NCT02748863|469122662|FG001|Treatment Period 1|Lack of Efficacy|0|||
130316012|NCT02748863|469122663|FG002|Treatment Period 1|Lack of Efficacy|1|||
130316013|NCT02748863|469122664|FG003|Treatment Period 1|Lack of Efficacy|0|||
130316014|NCT02748863|469122665|FG004|Treatment Period 1|Lack of Efficacy|0|||
130316015|NCT02748863|469122661|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130316016|NCT02748863|469122662|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130316017|NCT02748863|469122663|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130316018|NCT02748863|469122664|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130316019|NCT02748863|469122665|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130316020|NCT02748863|469122661|FG000|Treatment Period 2|Lost to Follow-up|2|||
130316021|NCT02748863|469122662|FG001|Treatment Period 2|Lost to Follow-up|0|||
130316022|NCT02748863|469122663|FG002|Treatment Period 2|Lost to Follow-up|0|||
130316023|NCT02748863|469122664|FG003|Treatment Period 2|Lost to Follow-up|0|||
130316024|NCT02748863|469122665|FG004|Treatment Period 2|Lost to Follow-up|0|||
130316025|NCT02748863|469122661|FG000|Treatment Period 2|Adverse Event|3|||
130316026|NCT02748863|469122662|FG001|Treatment Period 2|Adverse Event|2|||
130376289|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130376290|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130376291|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376292|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376293|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376294|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376295|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376296|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376297|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
130316027|NCT02748863|469122663|FG002|Treatment Period 2|Adverse Event|0|||
130316028|NCT02748863|469122664|FG003|Treatment Period 2|Adverse Event|2|||
130376298|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376299|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130376300|NCT02289417|469343650|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376301|NCT02289417|469343651|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376302|NCT02289417|469343652|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376303|NCT02289417|469343653|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
130376304|NCT02289417|469343654|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376305|NCT02289417|469343655|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376306|NCT02289417|469343656|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
130376307|NCT02289417|469343657|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376308|NCT02289417|469343658|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130376309|NCT02289417|469343650|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
130376310|NCT02289417|469343651|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
130376311|NCT02289417|469343652|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
130376312|NCT02289417|469343653|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
130376313|NCT02289417|469343654|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
130376314|NCT02289417|469343655|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
130376315|NCT02289417|469343656|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
130376316|NCT02289417|469343657|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
130376317|NCT02289417|469343658|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
130376318|NCT02289417|469343650|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376319|NCT02289417|469343651|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376320|NCT02289417|469343652|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376321|NCT02289417|469343653|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376322|NCT02289417|469343654|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376323|NCT02289417|469343655|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376324|NCT02289417|469343656|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130376325|NCT02289417|469343657|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
130376326|NCT02289417|469343658|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
130376327|NCT02289417|469343650|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376328|NCT02289417|469343651|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376329|NCT02289417|469343652|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376330|NCT02289417|469343653|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376331|NCT02289417|469343654|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376332|NCT02289417|469343655|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376333|NCT02289417|469343656|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130376334|NCT02289417|469343657|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
130376335|NCT02289417|469343658|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
130376336|NCT02289417|469343650|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376337|NCT02289417|469343651|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376338|NCT02289417|469343652|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376339|NCT02289417|469343653|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376340|NCT02289417|469343654|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376341|NCT02289417|469343655|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376342|NCT02289417|469343656|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376343|NCT02289417|469343657|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
130376344|NCT02289417|469343658|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
130376345|NCT04786990|469343659|FG000|Overall Study|Withdrawal by Subject|1|||
130376346|NCT04786990|469343659|FG000|Overall Study|Adverse Event|1|||
130376347|NCT04786990|469343659|FG000|Overall Study|Lost to Follow-up|1|||
130376348|NCT04786990|469343659|FG000|Overall Study|Noncompliance|1|||
130376349|NCT04786990|469343659|FG000|Overall Study|Unable to complete site visits|1|||
130376350|NCT04786990|469343659|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130376351|NCT01782222|469343660|FG000|Overall Study|Adverse Event|4|||
130376352|NCT01782222|469343661|FG001|Overall Study|Adverse Event|5|||
130376353|NCT01782222|469343662|FG002|Overall Study|Adverse Event|3|||
130376354|NCT01782222|469343660|FG000|Overall Study|Lack of Efficacy|2|||
130376355|NCT01782222|469343661|FG001|Overall Study|Lack of Efficacy|1|||
130376356|NCT01782222|469343662|FG002|Overall Study|Lack of Efficacy|0|||
130376357|NCT01782222|469343660|FG000|Overall Study|Protocol Violation|1|||
130376358|NCT01782222|469343661|FG001|Overall Study|Protocol Violation|0|||
130376359|NCT01782222|469343662|FG002|Overall Study|Protocol Violation|0|||
130376360|NCT01782222|469343660|FG000|Overall Study|Withdrawal by Subject|1|||
130376361|NCT01782222|469343661|FG001|Overall Study|Withdrawal by Subject|4|||
130376362|NCT01782222|469343662|FG002|Overall Study|Withdrawal by Subject|1|||
130376363|NCT01782222|469343660|FG000|Overall Study|Moved to other state|0|||
130376364|NCT01782222|469343661|FG001|Overall Study|Moved to other state|1|||
130376365|NCT01782222|469343662|FG002|Overall Study|Moved to other state|0|||
130376366|NCT01500694|469343663|FG000|Overall Study|Adverse Event|4|||
130376367|NCT01500694|469343664|FG001|Overall Study|Adverse Event|3|||
130376368|NCT01500694|469343663|FG000|Overall Study|Protocol Violation|0|||
130376369|NCT01500694|469343664|FG001|Overall Study|Protocol Violation|1|||
130720698|NCT00325195|470601505|FG001|Randomized|Not dosed|5|||
130720699|NCT00325195|470601506|FG002|Randomized|Not dosed|3|||
130720700|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Adverse Event|15|||
130720701|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Adverse Event|17|||
130720702|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Adverse Event|1|||
130720703|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Death|3|||
130316029|NCT02748863|469122665|FG004|Treatment Period 2|Adverse Event|0|||
130316030|NCT02748863|469122661|FG000|Treatment Period 2|Lack of Efficacy|0|||
130316031|NCT02748863|469122662|FG001|Treatment Period 2|Lack of Efficacy|1|||
130316032|NCT02748863|469122663|FG002|Treatment Period 2|Lack of Efficacy|0|||
130316033|NCT02748863|469122664|FG003|Treatment Period 2|Lack of Efficacy|0|||
130316034|NCT02748863|469122665|FG004|Treatment Period 2|Lack of Efficacy|0|||
130316035|NCT02748863|469122661|FG000|Treatment Period 2|Pregnancy|0|||
130316036|NCT02748863|469122662|FG001|Treatment Period 2|Pregnancy|0|||
130316037|NCT02748863|469122663|FG002|Treatment Period 2|Pregnancy|0|||
130316038|NCT02748863|469122664|FG003|Treatment Period 2|Pregnancy|0|||
130316039|NCT02748863|469122665|FG004|Treatment Period 2|Pregnancy|1|||
130316040|NCT02422498|469122669|FG000|Overall Study|Inevaluable|4|||
130316041|NCT03206216|469122670|FG000|Overall Study|Withdrawal by Subject|0|||
130316042|NCT03206216|469122671|FG001|Overall Study|Withdrawal by Subject|1|||
130316043|NCT01960140|469122672|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
130316044|NCT00657046|469122674|FG000|Overall Study|Adverse Event|1|||
130316045|NCT00657046|469122675|FG001|Overall Study|Adverse Event|1|||
130316046|NCT00657046|469122676|FG002|Overall Study|Adverse Event|0|||
130316047|NCT00657046|469122674|FG000|Overall Study|Protocol Violation|2|||
130316048|NCT00657046|469122675|FG001|Overall Study|Protocol Violation|2|||
130316049|NCT00657046|469122676|FG002|Overall Study|Protocol Violation|0|||
130316050|NCT00657046|469122674|FG000|Overall Study|Withdrawal by Subject|1|||
130316051|NCT00657046|469122675|FG001|Overall Study|Withdrawal by Subject|0|||
130316052|NCT00657046|469122676|FG002|Overall Study|Withdrawal by Subject|0|||
130316053|NCT00657046|469122674|FG000|Overall Study|Death|0|||
130316054|NCT00657046|469122675|FG001|Overall Study|Death|0|||
130316055|NCT00657046|469122676|FG002|Overall Study|Death|1|||
130316056|NCT00657046|469122674|FG000|Overall Study|Surgery|0|||
130316057|NCT00657046|469122675|FG001|Overall Study|Surgery|0|||
130316058|NCT00657046|469122676|FG002|Overall Study|Surgery|1|||
130316059|NCT00377520|469122686|FG000|Overall Study|Ineligible (Prior radiation)|1|||
130376370|NCT01500694|469343663|FG000|Overall Study|Withdrawal by Subject|23|||
130376371|NCT01500694|469343664|FG001|Overall Study|Withdrawal by Subject|14|||
130376372|NCT01500694|469343663|FG000|Overall Study|Lost to Follow-up|2|||
130376373|NCT01500694|469343664|FG001|Overall Study|Lost to Follow-up|3|||
130720704|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Death|1|||
130720705|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Death|0|||
130720706|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
130720707|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
130720708|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
130720709|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
130720710|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
130720711|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
130720712|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130720713|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130720714|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
130720715|NCT01716715|470601507|FG000|Overall Study|Never Treated|2|||
130720716|NCT01716715|470601508|FG001|Overall Study|Never Treated|4|||
130720717|NCT04228783|470601509|FG000|Overall Study|Adverse Event|1|||
130720718|NCT04228783|470601510|FG001|Overall Study|Adverse Event|0|||
130720719|NCT04228783|470601511|FG002|Overall Study|Adverse Event|2|||
130720720|NCT04228783|470601512|FG003|Overall Study|Adverse Event|0|||
130376374|NCT01500694|469343663|FG000|Overall Study|Lack of Efficacy|14|||
130376375|NCT01500694|469343664|FG001|Overall Study|Lack of Efficacy|5|||
130376376|NCT01500694|469343663|FG000|Overall Study|Other|9|||
130316060|NCT00320515|469122691|FG000|Overall Study|Death|33|||
130316061|NCT00320515|469122691|FG000|Overall Study|Lost to Follow-up|6|||
130316062|NCT00320515|469122691|FG000|Overall Study|Physician Decision|2|||
130316063|NCT00320515|469122691|FG000|Overall Study|Withdrawal by Subject|8|||
130376377|NCT01500694|469343664|FG001|Overall Study|Other|3|||
130316064|NCT00851786|469122692|FG000|Overall Study|Withdrawal by Subject|0|||
130316065|NCT00851786|469122693|FG001|Overall Study|Withdrawal by Subject|1|||
130316066|NCT00851786|469122692|FG000|Overall Study|Protocol Violation|0|||
130316067|NCT00851786|469122693|FG001|Overall Study|Protocol Violation|1|||
130316068|NCT00851786|469122692|FG000|Overall Study|Lost to Follow-up|1|||
130376378|NCT00833794|469343665|FG000|Open-label Phase|Adverse Event|225|||
130720721|NCT04228783|470601513|FG004|Overall Study|Adverse Event|0|||
130720722|NCT04228783|470601514|FG005|Overall Study|Adverse Event|1|||
130720723|NCT04228783|470601509|FG000|Overall Study|Death|0|||
130720724|NCT04228783|470601510|FG001|Overall Study|Death|0|||
130720725|NCT04228783|470601511|FG002|Overall Study|Death|0|||
130466627|NCT04556981|469674868|FG000|Overall Study|Lost to Follow-up|2|||
130466628|NCT04556981|469674869|FG001|Overall Study|Lost to Follow-up|11|||
130466629|NCT04556981|469674868|FG000|Overall Study|Moved from the study area|1|||
130466630|NCT04556981|469674869|FG001|Overall Study|Moved from the study area|4|||
130466631|NCT04556981|469674868|FG000|Overall Study|Withdrawal by Subject|2|||
130466632|NCT04556981|469674869|FG001|Overall Study|Withdrawal by Subject|2|||
130466633|NCT04556981|469674868|FG000|Overall Study|Other|2|||
130466634|NCT04556981|469674869|FG001|Overall Study|Other|1|||
130466635|NCT01388361|469674870|FG000|Overall Study|Adverse Event|0|||
130466636|NCT01388361|469674871|FG001|Overall Study|Adverse Event|5|||
130466637|NCT01388361|469674872|FG002|Overall Study|Adverse Event|1|||
130466638|NCT01388361|469674870|FG000|Overall Study|Protocol Violation|0|||
130466639|NCT01388361|469674871|FG001|Overall Study|Protocol Violation|0|||
130466640|NCT01388361|469674872|FG002|Overall Study|Protocol Violation|2|||
130466641|NCT01388361|469674870|FG000|Overall Study|Withdrawal criteria|12|||
130466642|NCT01388361|469674871|FG001|Overall Study|Withdrawal criteria|7|||
130466643|NCT01388361|469674872|FG002|Overall Study|Withdrawal criteria|10|||
130466644|NCT01388361|469674870|FG000|Overall Study|Unclassified|0|||
130466645|NCT01388361|469674871|FG001|Overall Study|Unclassified|0|||
130466646|NCT01388361|469674872|FG002|Overall Study|Unclassified|1|||
130466647|NCT00068601|469674874|FG000|Overall Study|Ineligible|11|||
130466648|NCT00068601|469674875|FG001|Overall Study|Ineligible|13|||
130466649|NCT00068601|469674874|FG000|Overall Study|Not evaluable: withdrew consent|5|||
130466650|NCT00068601|469674875|FG001|Overall Study|Not evaluable: withdrew consent|4|||
130466651|NCT00068601|469674874|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
130466652|NCT00068601|469674875|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
130466653|NCT00068601|469674874|FG000|Overall Study|Death|11|||
130466654|NCT00068601|469674875|FG001|Overall Study|Death|3|||
130466655|NCT00068601|469674874|FG000|Overall Study|Lost to Follow-up|3|||
130466656|NCT00068601|469674875|FG001|Overall Study|Lost to Follow-up|2|||
130466657|NCT00068601|469674874|FG000|Overall Study|Missing primary outcome data|30|||
130466658|NCT00068601|469674875|FG001|Overall Study|Missing primary outcome data|34|||
130466659|NCT00440011|469674876|FG000|Overall Study|Adverse Event|2|||
130466660|NCT00440011|469674877|FG001|Overall Study|Adverse Event|0|||
130466661|NCT00440011|469674876|FG000|Overall Study|Lost to Follow-up|0|||
130466662|NCT00440011|469674877|FG001|Overall Study|Lost to Follow-up|2|||
130466663|NCT00440011|469674876|FG000|Overall Study|Protocol Violation|1|||
130466664|NCT00440011|469674877|FG001|Overall Study|Protocol Violation|1|||
130466665|NCT00440011|469674876|FG000|Overall Study|Withdrawal by Subject|1|||
130466666|NCT00440011|469674877|FG001|Overall Study|Withdrawal by Subject|0|||
130720726|NCT04228783|470601512|FG003|Overall Study|Death|0|||
130720727|NCT04228783|470601513|FG004|Overall Study|Death|1|||
130720728|NCT04228783|470601514|FG005|Overall Study|Death|0|||
130720729|NCT04228783|470601509|FG000|Overall Study|Lost to Follow-up|36|||
130720730|NCT04228783|470601510|FG001|Overall Study|Lost to Follow-up|36|||
130720731|NCT04228783|470601511|FG002|Overall Study|Lost to Follow-up|28|||
130720732|NCT04228783|470601512|FG003|Overall Study|Lost to Follow-up|6|||
130316069|NCT00851786|469122693|FG001|Overall Study|Lost to Follow-up|0|||
130316070|NCT00851786|469122692|FG000|Overall Study|Incarceration|1|||
130316071|NCT00851786|469122693|FG001|Overall Study|Incarceration|0|||
130316072|NCT00851786|469122692|FG000|Overall Study|Site Closure|1|||
130316073|NCT00851786|469122693|FG001|Overall Study|Site Closure|0|||
130316074|NCT00851786|469122692|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
130316075|NCT00851786|469122693|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
130316076|NCT00445549|469124288|FG000|Overall Study|progressive disease|12|||
130316077|NCT03858049|469124296|FG000|Overall Study|Adverse Event|16|||
130316078|NCT03858049|469124297|FG001|Overall Study|Adverse Event|9|||
130316079|NCT03858049|469124296|FG000|Overall Study|Other|1|||
130316080|NCT03858049|469124297|FG001|Overall Study|Other|1|||
130316081|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
130316082|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
130316083|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
130466667|NCT01803555|469674879|FG000|Overall Study|Adverse Event|3|||
130466668|NCT01803555|469674880|FG001|Overall Study|Adverse Event|2|||
130466669|NCT01803555|469674879|FG000|Overall Study|Withdrawal by Subject|3|||
130466670|NCT01803555|469674880|FG001|Overall Study|Withdrawal by Subject|3|||
130466671|NCT01803555|469674879|FG000|Overall Study|Non-compliance|1|||
130466672|NCT01803555|469674880|FG001|Overall Study|Non-compliance|1|||
130316084|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
130316085|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
130316086|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
130466673|NCT01803555|469674879|FG000|Overall Study|Protocol Violation|3|||
130466674|NCT01803555|469674880|FG001|Overall Study|Protocol Violation|5|||
130466675|NCT01803555|469674879|FG000|Overall Study|Lost to Follow-up|0|||
130466676|NCT01803555|469674880|FG001|Overall Study|Lost to Follow-up|2|||
130466677|NCT01803555|469674879|FG000|Overall Study|Other than specified|3|||
130466678|NCT01803555|469674880|FG001|Overall Study|Other than specified|5|||
130720733|NCT04228783|470601513|FG004|Overall Study|Lost to Follow-up|14|||
130720734|NCT04228783|470601514|FG005|Overall Study|Lost to Follow-up|3|||
130376379|NCT00833794|469343666|FG001|Open-label Phase|Adverse Event|0|||
130376380|NCT00833794|469343665|FG000|Open-label Phase|Lack of Efficacy|28|||
130376381|NCT00833794|469343666|FG001|Open-label Phase|Lack of Efficacy|0|||
130376382|NCT00833794|469343665|FG000|Open-label Phase|Withdrawal by Subject|48|||
130376383|NCT00833794|469343666|FG001|Open-label Phase|Withdrawal by Subject|0|||
130376384|NCT00833794|469343665|FG000|Open-label Phase|Physician Decision|20|||
130376385|NCT00833794|469343666|FG001|Open-label Phase|Physician Decision|0|||
130376386|NCT00833794|469343665|FG000|Open-label Phase|Administrative reason|1|||
130376387|NCT00833794|469343666|FG001|Open-label Phase|Administrative reason|0|||
130376388|NCT00833794|469343665|FG000|Open-label Phase|Protocol Violation|47|||
130376389|NCT00833794|469343666|FG001|Open-label Phase|Protocol Violation|0|||
130376390|NCT00833794|469343665|FG000|Open-label Phase|Did not complete wash-out period|12|||
130376391|NCT00833794|469343666|FG001|Open-label Phase|Did not complete wash-out period|0|||
130376392|NCT00833794|469343665|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
130376393|NCT00833794|469343666|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
130376394|NCT00833794|469343665|FG000|Double-blind Phase|Adverse Event|44|||
130376395|NCT00833794|469343666|FG001|Double-blind Phase|Adverse Event|11|||
130376396|NCT00833794|469343665|FG000|Double-blind Phase|Lack of Efficacy|34|||
130376397|NCT00833794|469343666|FG001|Double-blind Phase|Lack of Efficacy|22|||
130376398|NCT00833794|469343665|FG000|Double-blind Phase|Withdrawal by Subject|23|||
130376399|NCT00833794|469343666|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130376400|NCT00833794|469343665|FG000|Double-blind Phase|Physician Decision|4|||
130376401|NCT00833794|469343666|FG001|Double-blind Phase|Physician Decision|7|||
130376402|NCT00833794|469343665|FG000|Double-blind Phase|Administrative reason|1|||
130376403|NCT00833794|469343666|FG001|Double-blind Phase|Administrative reason|3|||
130376404|NCT04051008|469343669|FG000|Overall Study|Withdrawal by Subject|2|||
130376405|NCT04051008|469343670|FG001|Overall Study|Withdrawal by Subject|0|||
130376406|NCT04051008|469343671|FG002|Overall Study|Withdrawal by Subject|1|||
130376407|NCT03310775|469343681|FG000|Overall Study|Lost to Follow-up|2|||
130376408|NCT03310775|469343682|FG001|Overall Study|Lost to Follow-up|3|||
130376409|NCT03310775|469343681|FG000|Overall Study|aggravation of depression|0|||
130376410|NCT03310775|469343682|FG001|Overall Study|aggravation of depression|1|||
130376411|NCT00600483|469343683|FG000|Overall Study|Lost to Follow-up|26|||
130376412|NCT00600483|469343684|FG001|Overall Study|Lost to Follow-up|47|||
130376413|NCT00600483|469343683|FG000|Overall Study|Randomized but not treated|10|||
130376414|NCT00600483|469343684|FG001|Overall Study|Randomized but not treated|0|||
130376415|NCT01482884|469343685|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
130376416|NCT01482884|469343686|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
130376417|NCT01482884|469343685|FG000|Overall Study|Protocol Violation|1|||
130376418|NCT01482884|469343686|FG001|Overall Study|Protocol Violation|0|||
130376419|NCT01482884|469343685|FG000|Overall Study|Lost to Follow-up|2|||
130376420|NCT01482884|469343686|FG001|Overall Study|Lost to Follow-up|2|||
130376421|NCT01482884|469343685|FG000|Overall Study|Lack of Efficacy|0|||
130376422|NCT01482884|469343686|FG001|Overall Study|Lack of Efficacy|1|||
130376423|NCT01482884|469343685|FG000|Overall Study|Adverse Event|2|||
130376424|NCT01482884|469343686|FG001|Overall Study|Adverse Event|1|||
130376425|NCT01482884|469343685|FG000|Overall Study|Withdrawal by Subject|8|||
130376426|NCT01482884|469343686|FG001|Overall Study|Withdrawal by Subject|13|||
130376427|NCT00580606|469343687|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
130376428|NCT00580606|469343688|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
130376429|NCT00580606|469343687|FG000|Open Label (OL)|Withdrawal by Subject|4|||
130376430|NCT00580606|469343688|FG001|Open Label (OL)|Withdrawal by Subject|6|||
130376431|NCT00580606|469343687|FG000|Open Label (OL)|Dosing Symptoms|0|||
130376432|NCT00580606|469343688|FG001|Open Label (OL)|Dosing Symptoms|1|||
130376433|NCT00580606|469343687|FG000|Open Label (OL)|Lost to Follow-up|0|||
130376434|NCT00580606|469343688|FG001|Open Label (OL)|Lost to Follow-up|1|||
130376435|NCT00580606|469343687|FG000|Open Label (OL)|Pregnancy|0|||
130376436|NCT00580606|469343688|FG001|Open Label (OL)|Pregnancy|1|||
130466679|NCT01551355|469674881|FG000|Overall Study|Lost to Follow-up|51|||
130466680|NCT01551355|469674882|FG001|Overall Study|Lost to Follow-up|49|||
130466681|NCT01551355|469674883|FG002|Overall Study|Lost to Follow-up|34|||
130466682|NCT01551355|469674884|FG003|Overall Study|Lost to Follow-up|24|||
130376437|NCT00580606|469343687|FG000|Open Label (OL)|Non-compliance|2|||
130376438|NCT00580606|469343688|FG001|Open Label (OL)|Non-compliance|0|||
130376439|NCT00580606|469343687|FG000|Open Label (OL)|Physician Decision|1|||
130376440|NCT00580606|469343688|FG001|Open Label (OL)|Physician Decision|1|||
130376441|NCT00580606|469343687|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
130376442|NCT00580606|469343688|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
130466683|NCT01551355|469674885|FG004|Overall Study|Lost to Follow-up|9|||
130376443|NCT03655691|469343691|FG000|Overall Study|Adverse Event|0|||
130376444|NCT03655691|469343692|FG001|Overall Study|Adverse Event|0|||
130376445|NCT03655691|469343693|FG002|Overall Study|Adverse Event|1|||
130376446|NCT03655691|469343691|FG000|Overall Study|Lost to Follow-up|1|||
130376447|NCT03655691|469343692|FG001|Overall Study|Lost to Follow-up|1|||
130376448|NCT03655691|469343693|FG002|Overall Study|Lost to Follow-up|2|||
130376449|NCT03655691|469343691|FG000|Overall Study|Protocol Violation|0|||
130376450|NCT03655691|469343692|FG001|Overall Study|Protocol Violation|1|||
130316087|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
130316088|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
130316089|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
130316090|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
130316091|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
130316092|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
130316093|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
130316094|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
130316095|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
130316096|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
130720735|NCT04228783|470601509|FG000|Overall Study|Physician Decision|1|||
130720736|NCT04228783|470601510|FG001|Overall Study|Physician Decision|2|||
130720737|NCT04228783|470601511|FG002|Overall Study|Physician Decision|0|||
130720738|NCT04228783|470601512|FG003|Overall Study|Physician Decision|0|||
130720739|NCT04228783|470601513|FG004|Overall Study|Physician Decision|0|||
130720740|NCT04228783|470601514|FG005|Overall Study|Physician Decision|0|||
130720741|NCT04228783|470601509|FG000|Overall Study|Protocol Violation|0|||
130720742|NCT04228783|470601510|FG001|Overall Study|Protocol Violation|0|||
130720743|NCT04228783|470601511|FG002|Overall Study|Protocol Violation|0|||
130720744|NCT04228783|470601512|FG003|Overall Study|Protocol Violation|1|||
130720745|NCT04228783|470601513|FG004|Overall Study|Protocol Violation|0|||
130720746|NCT04228783|470601514|FG005|Overall Study|Protocol Violation|0|||
130720747|NCT04228783|470601509|FG000|Overall Study|Withdrawal by Subject|6|||
130720748|NCT04228783|470601510|FG001|Overall Study|Withdrawal by Subject|10|||
130720749|NCT04228783|470601511|FG002|Overall Study|Withdrawal by Subject|19|||
130720750|NCT04228783|470601512|FG003|Overall Study|Withdrawal by Subject|1|||
130720751|NCT04228783|470601513|FG004|Overall Study|Withdrawal by Subject|2|||
130720752|NCT04228783|470601514|FG005|Overall Study|Withdrawal by Subject|0|||
130720753|NCT04228783|470601509|FG000|Overall Study|Other|4|||
130720754|NCT04228783|470601510|FG001|Overall Study|Other|3|||
130720755|NCT04228783|470601511|FG002|Overall Study|Other|2|||
130720756|NCT04228783|470601512|FG003|Overall Study|Other|1|||
130720757|NCT04228783|470601513|FG004|Overall Study|Other|0|||
130720758|NCT04228783|470601514|FG005|Overall Study|Other|0|||
130720759|NCT03327792|470601515|FG000|Overall Study|Adverse Event|4|||
130720760|NCT03327792|470601516|FG001|Overall Study|Adverse Event|0|||
130720761|NCT03327792|470601515|FG000|Overall Study|Family/Personal issues|3|||
130720762|NCT03327792|470601516|FG001|Overall Study|Family/Personal issues|2|||
130720763|NCT03327792|470601515|FG000|Overall Study|Lost to Follow-up|0|||
130720764|NCT03327792|470601516|FG001|Overall Study|Lost to Follow-up|1|||
130720765|NCT00626392|470601517|FG000|Run-in Period|Adverse Event|0|||
130720766|NCT00626392|470601518|FG001|Run-in Period|Adverse Event|0|||
130720767|NCT00626392|470601519|FG002|Run-in Period|Adverse Event|1|||
130720768|NCT00626392|470601520|FG003|Run-in Period|Adverse Event|0|||
130720769|NCT00626392|470601521|FG004|Run-in Period|Adverse Event|1|||
130720770|NCT00626392|470601522|FG005|Run-in Period|Adverse Event|0|||
130720771|NCT00626392|470601517|FG000|Run-in Period|Withdrawal by Subject|0|||
130720772|NCT00626392|470601518|FG001|Run-in Period|Withdrawal by Subject|1|||
130720773|NCT00626392|470601519|FG002|Run-in Period|Withdrawal by Subject|1|||
130720774|NCT00626392|470601520|FG003|Run-in Period|Withdrawal by Subject|1|||
130720775|NCT00626392|470601521|FG004|Run-in Period|Withdrawal by Subject|3|||
130720776|NCT00626392|470601522|FG005|Run-in Period|Withdrawal by Subject|1|||
130720777|NCT00626392|470601517|FG000|Run-in Period|Noncompliance|1|||
130720778|NCT00626392|470601518|FG001|Run-in Period|Noncompliance|0|||
130720779|NCT00626392|470601519|FG002|Run-in Period|Noncompliance|1|||
130720780|NCT00626392|470601520|FG003|Run-in Period|Noncompliance|0|||
130720781|NCT00626392|470601521|FG004|Run-in Period|Noncompliance|0|||
130720782|NCT00626392|470601522|FG005|Run-in Period|Noncompliance|0|||
130720783|NCT00626392|470601517|FG000|Coadministration Period|Adverse Event|3|||
130466684|NCT01551355|469674886|FG005|Overall Study|Lost to Follow-up|6|||
130466685|NCT01925339|469674887|FG000|Overall Study|Adverse Event|2|||
130720784|NCT00626392|470601518|FG001|Coadministration Period|Adverse Event|1|||
130720785|NCT00626392|470601519|FG002|Coadministration Period|Adverse Event|7|||
130466686|NCT01925339|469674888|FG001|Overall Study|Adverse Event|0|||
130720786|NCT00626392|470601520|FG003|Coadministration Period|Adverse Event|4|||
130720787|NCT00626392|470601521|FG004|Coadministration Period|Adverse Event|3|||
130720788|NCT00626392|470601522|FG005|Coadministration Period|Adverse Event|4|||
130720789|NCT00626392|470601517|FG000|Coadministration Period|Withdrawal by Subject|1|||
130720790|NCT00626392|470601518|FG001|Coadministration Period|Withdrawal by Subject|1|||
130720791|NCT00626392|470601519|FG002|Coadministration Period|Withdrawal by Subject|0|||
130720792|NCT00626392|470601520|FG003|Coadministration Period|Withdrawal by Subject|1|||
130720793|NCT00626392|470601521|FG004|Coadministration Period|Withdrawal by Subject|0|||
130720794|NCT00626392|470601522|FG005|Coadministration Period|Withdrawal by Subject|1|||
130720795|NCT00626392|470601517|FG000|Coadministration Period|Protocol Violation|0|||
130720796|NCT00626392|470601518|FG001|Coadministration Period|Protocol Violation|1|||
130720797|NCT00626392|470601519|FG002|Coadministration Period|Protocol Violation|0|||
130376694|NCT03824912|469345901|FG002|Overall Study|Participation in another study|0|||
130376695|NCT02511184|469345902|FG000|Overall Study|Death|1|||
130376696|NCT02511184|469345903|FG001|Overall Study|Death|0|||
130376697|NCT02511184|469345902|FG000|Overall Study|Lost to Follow-up|0|||
130376698|NCT02511184|469345903|FG001|Overall Study|Lost to Follow-up|1|||
130376699|NCT02511184|469345902|FG000|Overall Study|Study terminated by sponsor|1|||
130376700|NCT02511184|469345903|FG001|Overall Study|Study terminated by sponsor|5|||
130376701|NCT02511184|469345902|FG000|Overall Study|Withdrawal by Subject|0|||
130376702|NCT02511184|469345903|FG001|Overall Study|Withdrawal by Subject|1|||
130376703|NCT01963403|469345906|FG000|Overall Study|Lost to Follow-up|2|||
130376704|NCT01963403|469345907|FG001|Overall Study|Lost to Follow-up|3|||
130376705|NCT01963403|469345906|FG000|Overall Study|Implant removal|0|||
130376706|NCT01963403|469345907|FG001|Overall Study|Implant removal|1|||
130376707|NCT00549302|469345910|FG000|Double-Blind|Death|2|||
130376708|NCT00549302|469345911|FG001|Double-Blind|Death|9|||
130376709|NCT00549302|469345912|FG002|Double-Blind|Death|0|||
130376710|NCT00549302|469345910|FG000|Double-Blind|Adverse Event|3|||
130376711|NCT00549302|469345911|FG001|Double-Blind|Adverse Event|16|||
130376712|NCT00549302|469345912|FG002|Double-Blind|Adverse Event|0|||
130376713|NCT00549302|469345910|FG000|Double-Blind|Withdrawal by Subject|3|||
130376714|NCT00549302|469345911|FG001|Double-Blind|Withdrawal by Subject|8|||
130376715|NCT00549302|469345912|FG002|Double-Blind|Withdrawal by Subject|0|||
130376716|NCT00549302|469345910|FG000|Double-Blind|Investigator Decision|1|||
130376717|NCT00549302|469345911|FG001|Double-Blind|Investigator Decision|5|||
130376718|NCT00549302|469345912|FG002|Double-Blind|Investigator Decision|0|||
130376719|NCT00549302|469345910|FG000|Double-Blind|Sponsor Decision|0|||
130316275|NCT04154943|469124355|FG000|Overall Study|Withdrawal by Subject|4|||
130316276|NCT01239381|469124356|FG000|Overall Study|Protocol Violation|1|||
130316277|NCT01239381|469124356|FG000|Overall Study|Withdrawal by Subject|1|||
130316278|NCT06237049|469124357|FG000|Overall Study|Death|0|||
130316279|NCT06237049|469124358|FG001|Overall Study|Death|0|||
130316280|NCT06237049|469124359|FG002|Overall Study|Death|0|||
130316281|NCT06237049|469124360|FG003|Overall Study|Death|1|||
130316282|NCT06237049|469124357|FG000|Overall Study|Lost to Follow-up|11|||
130316283|NCT06237049|469124358|FG001|Overall Study|Lost to Follow-up|5|||
130316284|NCT06237049|469124359|FG002|Overall Study|Lost to Follow-up|8|||
130316285|NCT06237049|469124360|FG003|Overall Study|Lost to Follow-up|8|||
130316286|NCT06237049|469124357|FG000|Overall Study|Protocol Violation|0|||
130316287|NCT06237049|469124358|FG001|Overall Study|Protocol Violation|1|||
130316288|NCT06237049|469124359|FG002|Overall Study|Protocol Violation|0|||
130316289|NCT06237049|469124360|FG003|Overall Study|Protocol Violation|1|||
130316290|NCT06237049|469124357|FG000|Overall Study|Withdrawal by Subject|4|||
130316291|NCT06237049|469124358|FG001|Overall Study|Withdrawal by Subject|2|||
130316292|NCT06237049|469124359|FG002|Overall Study|Withdrawal by Subject|1|||
130316293|NCT06237049|469124360|FG003|Overall Study|Withdrawal by Subject|0|||
130316294|NCT02738008|469124361|FG000|Overall Study|Study Terminated by Sponsor|1|||
130316295|NCT02738008|469124362|FG001|Overall Study|Study Terminated by Sponsor|5|||
130316296|NCT02738008|469124363|FG002|Overall Study|Study Terminated by Sponsor|3|||
130316297|NCT02738008|469124361|FG000|Overall Study|Adverse Event|0|||
130316298|NCT02738008|469124362|FG001|Overall Study|Adverse Event|1|||
130316299|NCT02738008|469124363|FG002|Overall Study|Adverse Event|2|||
130316300|NCT04621448|469124364|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130316301|NCT04621448|469124365|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130316302|NCT04621448|469124366|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130316303|NCT04621448|469124367|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130316304|NCT04621448|469124364|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
130316305|NCT04621448|469124365|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
130316306|NCT04621448|469124366|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
130316307|NCT04621448|469124367|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
130316308|NCT04621448|469124364|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
130316309|NCT04621448|469124365|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
130316310|NCT04621448|469124366|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
130316311|NCT04621448|469124367|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
130316312|NCT04621448|469124364|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
130316313|NCT04621448|469124365|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
130316314|NCT04621448|469124366|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
130376720|NCT00549302|469345911|FG001|Double-Blind|Sponsor Decision|1|||
130376721|NCT00549302|469345912|FG002|Double-Blind|Sponsor Decision|0|||
130376722|NCT00549302|469345910|FG000|Double-Blind|Lost to Follow-up|1|||
130376723|NCT00549302|469345911|FG001|Double-Blind|Lost to Follow-up|2|||
130376724|NCT00549302|469345912|FG002|Double-Blind|Lost to Follow-up|0|||
130376725|NCT00549302|469345910|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
130376726|NCT00549302|469345911|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
130316315|NCT04621448|469124367|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
130316316|NCT03550378|469124368|FG000|Overall Study|Death|0|||
130316317|NCT03550378|469124369|FG001|Overall Study|Death|1|||
130316318|NCT04590014|469124372|FG000|Overall Study|Withdrawal by Subject|1|||
130316319|NCT04590014|469124373|FG001|Overall Study|Withdrawal by Subject|0|||
130376727|NCT00549302|469345912|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
130376728|NCT00549302|469345910|FG000|Double-Blind|New condition or starts new therapy|0|||
130376729|NCT00549302|469345911|FG001|Double-Blind|New condition or starts new therapy|2|||
130376730|NCT00549302|469345912|FG002|Double-Blind|New condition or starts new therapy|0|||
130376731|NCT00549302|469345910|FG000|Open-Label|Adverse Event|0|||
130376732|NCT00549302|469345911|FG001|Open-Label|Adverse Event|0|||
130376733|NCT00549302|469345912|FG002|Open-Label|Adverse Event|11|||
130376734|NCT00549302|469345910|FG000|Open-Label|Death|0|||
130376735|NCT00549302|469345911|FG001|Open-Label|Death|0|||
130376736|NCT00549302|469345912|FG002|Open-Label|Death|40|||
130376737|NCT00549302|469345910|FG000|Open-Label|Investigator Decision|0|||
130376738|NCT00549302|469345911|FG001|Open-Label|Investigator Decision|0|||
130376739|NCT00549302|469345912|FG002|Open-Label|Investigator Decision|5|||
130376740|NCT00549302|469345910|FG000|Open-Label|Lost to Follow-up|0|||
130376741|NCT00549302|469345911|FG001|Open-Label|Lost to Follow-up|0|||
130376742|NCT00549302|469345912|FG002|Open-Label|Lost to Follow-up|2|||
130376743|NCT00549302|469345910|FG000|Open-Label|Other|0|||
130376744|NCT00549302|469345911|FG001|Open-Label|Other|0|||
130376745|NCT00549302|469345912|FG002|Open-Label|Other|3|||
130376746|NCT00549302|469345910|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
130376747|NCT00549302|469345911|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
130376748|NCT00549302|469345912|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
130376749|NCT00549302|469345910|FG000|Open-Label|Withdrawal by Subject|0|||
130376750|NCT00549302|469345911|FG001|Open-Label|Withdrawal by Subject|0|||
130376751|NCT00549302|469345912|FG002|Open-Label|Withdrawal by Subject|6|||
130376752|NCT03585504|469345913|FG000|Overall Study|Lost to Follow-up|26|||
130376753|NCT03585504|469345914|FG001|Overall Study|Lost to Follow-up|29|||
130376754|NCT01414114|469345915|FG000|Overall Study|Adverse Event|2|||
130376755|NCT01414114|469345915|FG000|Overall Study|Withdrawal by Subject|1|||
130376756|NCT01414114|469345915|FG000|Overall Study|Other|2|||
130376757|NCT00105482|469345916|FG000|Overall Study|Adverse Event|1|||
130376758|NCT00105482|469345917|FG001|Overall Study|Adverse Event|1|||
130376759|NCT00105482|469345916|FG000|Overall Study|Lost to Follow-up|26|||
130376760|NCT00105482|469345917|FG001|Overall Study|Lost to Follow-up|17|||
130376761|NCT00105482|469345916|FG000|Overall Study|Withdrawal by Subject|0|||
130376762|NCT00105482|469345917|FG001|Overall Study|Withdrawal by Subject|1|||
130376763|NCT00105482|469345916|FG000|Overall Study|Lost Interest|29|||
130376764|NCT00105482|469345917|FG001|Overall Study|Lost Interest|32|||
130376765|NCT00105482|469345916|FG000|Overall Study|Scheduling Conflict|2|||
130376766|NCT00105482|469345917|FG001|Overall Study|Scheduling Conflict|3|||
130720925|NCT00724048|470601563|FG002|Overall Study|Withdrawal by Subject|1|||
130720926|NCT00724048|470601564|FG003|Overall Study|Withdrawal by Subject|2|||
130720927|NCT00724048|470601561|FG000|Overall Study|Investigator decision|0|||
130720928|NCT00724048|470601562|FG001|Overall Study|Investigator decision|0|||
130720929|NCT00724048|470601563|FG002|Overall Study|Investigator decision|1|||
130720930|NCT00724048|470601564|FG003|Overall Study|Investigator decision|0|||
130376767|NCT00105482|469345916|FG000|Overall Study|Withdrawn by PI|1|||
130376768|NCT00105482|469345917|FG001|Overall Study|Withdrawn by PI|1|||
130376769|NCT05620563|469345918|FG000|Overall Study|Adverse Event|3|||
130376770|NCT05620563|469345919|FG001|Overall Study|Adverse Event|1|||
130376771|NCT05620563|469345918|FG000|Overall Study|Lost to Follow-up|0|||
130376772|NCT05620563|469345919|FG001|Overall Study|Lost to Follow-up|2|||
130720931|NCT00724048|470601561|FG000|Overall Study|Did not tolerate study drug|0|||
130720932|NCT00724048|470601562|FG001|Overall Study|Did not tolerate study drug|0|||
130720933|NCT00724048|470601563|FG002|Overall Study|Did not tolerate study drug|0|||
130376773|NCT05620563|469345918|FG000|Overall Study|Protocol Deviation|1|||
130376774|NCT05620563|469345919|FG001|Overall Study|Protocol Deviation|2|||
130376775|NCT05620563|469345918|FG000|Overall Study|Withdrawal by Subject|3|||
130376776|NCT05620563|469345919|FG001|Overall Study|Withdrawal by Subject|3|||
130376777|NCT05620563|469345918|FG000|Overall Study|Physician Decision|0|||
130720934|NCT00724048|470601564|FG003|Overall Study|Did not tolerate study drug|1|||
130720935|NCT00724048|470601561|FG000|Overall Study|Other than specified|1|||
130720936|NCT00724048|470601562|FG001|Overall Study|Other than specified|1|||
130720937|NCT00724048|470601563|FG002|Overall Study|Other than specified|0|||
130376778|NCT05620563|469345919|FG001|Overall Study|Physician Decision|1|||
130376779|NCT02085785|469345924|FG000|Overall Study|Withdrawal by Subject|2|||
130376780|NCT02085785|469345925|FG001|Overall Study|Withdrawal by Subject|1|||
130376781|NCT02085785|469345924|FG000|Overall Study|Lost to Follow-up|0|||
130376782|NCT02085785|469345925|FG001|Overall Study|Lost to Follow-up|1|||
130376783|NCT00779467|469345926|FG000|Overall Study|Lack of Efficacy|11|||
130376784|NCT00779467|469345927|FG001|Overall Study|Lack of Efficacy|2|||
130376785|NCT00779467|469345928|FG002|Overall Study|Lack of Efficacy|6|||
130376786|NCT00779467|469345929|FG003|Overall Study|Lack of Efficacy|11|||
130376787|NCT00779467|469345926|FG000|Overall Study|failed inclusion criteria|3|||
130376788|NCT00779467|469345927|FG001|Overall Study|failed inclusion criteria|3|||
130376789|NCT00779467|469345928|FG002|Overall Study|failed inclusion criteria|1|||
130376790|NCT00779467|469345929|FG003|Overall Study|failed inclusion criteria|2|||
130720938|NCT00724048|470601564|FG003|Overall Study|Other than specified|0|||
130720939|NCT00407758|470601565|FG000|Overall Study|ineligible -improper prior treatment|1|||
130376791|NCT00779467|469345926|FG000|Overall Study|missing data|1|||
130376792|NCT00779467|469345927|FG001|Overall Study|missing data|0|||
130376793|NCT00779467|469345928|FG002|Overall Study|missing data|1|||
130376794|NCT00779467|469345929|FG003|Overall Study|missing data|4|||
130376795|NCT00779467|469345926|FG000|Overall Study|technical issue|0|||
130376796|NCT00779467|469345927|FG001|Overall Study|technical issue|0|||
130376797|NCT00779467|469345928|FG002|Overall Study|technical issue|2|||
130376798|NCT00779467|469345929|FG003|Overall Study|technical issue|1|||
130376799|NCT00779467|469345926|FG000|Overall Study|unavailable research staff|0|||
130376800|NCT00779467|469345927|FG001|Overall Study|unavailable research staff|0|||
130376801|NCT00779467|469345928|FG002|Overall Study|unavailable research staff|0|||
130376802|NCT00779467|469345929|FG003|Overall Study|unavailable research staff|1|||
130376803|NCT02692703|469345930|FG000|Overall Study|Lost to Follow-up|1|||
130376804|NCT02692703|469345930|FG000|Overall Study|Other|1|||
130376805|NCT04118166|469345931|FG000|Overall Study|Adverse Event|1|||
130376806|NCT00284050|469345934|FG000|Overall Study|Adverse Event|1|||
130376807|NCT00284050|469345935|FG001|Overall Study|Adverse Event|1|||
130376808|NCT00284050|469345936|FG002|Overall Study|Adverse Event|1|||
130376809|NCT00284050|469345934|FG000|Overall Study|Lack of Efficacy|0|||
130376810|NCT00284050|469345935|FG001|Overall Study|Lack of Efficacy|1|||
130376811|NCT00284050|469345936|FG002|Overall Study|Lack of Efficacy|3|||
130376812|NCT00284050|469345934|FG000|Overall Study|Protocol Violation|0|||
130376813|NCT00284050|469345935|FG001|Overall Study|Protocol Violation|1|||
130376814|NCT00284050|469345936|FG002|Overall Study|Protocol Violation|2|||
130376815|NCT00284050|469345934|FG000|Overall Study|Withdrawal by Subject|2|||
130376816|NCT00284050|469345935|FG001|Overall Study|Withdrawal by Subject|2|||
130376817|NCT00284050|469345936|FG002|Overall Study|Withdrawal by Subject|2|||
130376818|NCT00284050|469345934|FG000|Overall Study|Lost to Follow-up|1|||
130376819|NCT00284050|469345935|FG001|Overall Study|Lost to Follow-up|0|||
130376820|NCT00284050|469345936|FG002|Overall Study|Lost to Follow-up|1|||
130376821|NCT00284050|469345934|FG000|Overall Study|Death|1|||
130376822|NCT00284050|469345935|FG001|Overall Study|Death|0|||
130376823|NCT00284050|469345936|FG002|Overall Study|Death|0|||
130376824|NCT02573350|469345939|FG000|Overall Study|Lost to Follow-up|2|||
130376825|NCT02573350|469345940|FG001|Overall Study|Lost to Follow-up|1|||
130376826|NCT02573350|469345939|FG000|Overall Study|Adverse Event|3|||
130376827|NCT02573350|469345940|FG001|Overall Study|Adverse Event|4|||
130376828|NCT02573350|469345939|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
130376829|NCT02573350|469345940|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
130376830|NCT02573350|469345939|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
130376831|NCT02573350|469345940|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
130376832|NCT02573350|469345939|FG000|Overall Study|Subject withdrew consent to participate|6|||
130376833|NCT02573350|469345940|FG001|Overall Study|Subject withdrew consent to participate|1|||
130376834|NCT02573350|469345939|FG000|Overall Study|Protocol Deviation|1|||
130376835|NCT02573350|469345940|FG001|Overall Study|Protocol Deviation|1|||
130376836|NCT02708121|469345941|FG000|Overall Study|Withdrawn by Study Team|1|||
130376837|NCT02708121|469345942|FG001|Overall Study|Withdrawn by Study Team|1|||
130376838|NCT02708121|469345941|FG000|Overall Study|Withdrawal by Subject|0|||
130720940|NCT01822275|470601566|FG000|Overall Study|Withdrawal by Subject|3|||
130376839|NCT02708121|469345942|FG001|Overall Study|Withdrawal by Subject|4|||
130376840|NCT01833520|469345943|FG000|Overall Study|Lack of Efficacy|3|||
130376841|NCT01833520|469345944|FG001|Overall Study|Lack of Efficacy|3|||
130376842|NCT01833520|469345945|FG002|Overall Study|Lack of Efficacy|8|||
130376843|NCT01833520|469345946|FG003|Overall Study|Lack of Efficacy|3|||
130376844|NCT02547649|469345947|FG000|Overall Study|Lost to Follow-up|3|||
130376845|NCT02547649|469345948|FG001|Overall Study|Lost to Follow-up|1|||
130376846|NCT02547649|469345949|FG002|Overall Study|Lost to Follow-up|1|||
130376847|NCT02547649|469345947|FG000|Overall Study|Not vaccinated|0|||
130376848|NCT02547649|469345948|FG001|Overall Study|Not vaccinated|0|||
130376849|NCT02547649|469345949|FG002|Overall Study|Not vaccinated|1|||
130376850|NCT02547649|469345947|FG000|Overall Study|Withdrawal by Subject|0|||
130376851|NCT02547649|469345948|FG001|Overall Study|Withdrawal by Subject|4|||
130376852|NCT02547649|469345949|FG002|Overall Study|Withdrawal by Subject|2|||
130376853|NCT03765918|469345952|FG000|Overall Study|Death|109|||
130376854|NCT03765918|469345953|FG001|Overall Study|Death|127|||
130376855|NCT03765918|469345952|FG000|Overall Study|Lost to Follow-up|2|||
130376856|NCT03765918|469345953|FG001|Overall Study|Lost to Follow-up|3|||
130376857|NCT03765918|469345952|FG000|Overall Study|Withdrawal by Subject|12|||
130376858|NCT03765918|469345953|FG001|Overall Study|Withdrawal by Subject|16|||
130376859|NCT03765918|469345952|FG000|Overall Study|Participants Ongoing|240|||
130376860|NCT03765918|469345953|FG001|Overall Study|Participants Ongoing|205|||
130376861|NCT00006903|469345954|FG000|Overall Study|Still receiving treatment|0|||
130376862|NCT00006903|469345955|FG001|Overall Study|Still receiving treatment|0|||
130376863|NCT00006903|469345956|FG002|Overall Study|Still receiving treatment|1|||
130376864|NCT00006903|469345954|FG000|Overall Study|Refused further treatment|0|||
130376865|NCT00006903|469345955|FG001|Overall Study|Refused further treatment|2|||
130376866|NCT00006903|469345956|FG002|Overall Study|Refused further treatment|1|||
130376867|NCT00006903|469345954|FG000|Overall Study|Adverse Event|0|||
130316320|NCT00468299|469124374|FG000|Overall Study|Withdrawal by Subject|0|||
130316321|NCT00468299|469124375|FG001|Overall Study|Withdrawal by Subject|1|||
130316322|NCT04264442|469124378|FG000|Overall Study|Lack of Efficacy|6|||
130316323|NCT04264442|469124378|FG000|Overall Study|Lost to Follow-up|2|||
130316324|NCT04264442|469124378|FG000|Overall Study|Sponsor Decision|23|||
130316325|NCT04264442|469124378|FG000|Overall Study|Withdrawal by Subject|11|||
130316326|NCT04264442|469124378|FG000|Overall Study|Study Termination|5|||
130316327|NCT01384734|469124380|FG000|Overall Study|Adverse Event|0|||
130376868|NCT00006903|469345955|FG001|Overall Study|Adverse Event|0|||
130376869|NCT00006903|469345956|FG002|Overall Study|Adverse Event|1|||
130316328|NCT01384734|469124381|FG001|Overall Study|Adverse Event|3|||
130316329|NCT01384734|469124382|FG002|Overall Study|Adverse Event|0|||
130316330|NCT01384734|469124383|FG003|Overall Study|Adverse Event|2|||
130316331|NCT01384734|469124384|FG004|Overall Study|Adverse Event|7|||
130316332|NCT01384734|469124380|FG000|Overall Study|Death|1|||
130316333|NCT01384734|469124381|FG001|Overall Study|Death|0|||
130316334|NCT01384734|469124382|FG002|Overall Study|Death|1|||
130316335|NCT01384734|469124383|FG003|Overall Study|Death|0|||
130316336|NCT01384734|469124384|FG004|Overall Study|Death|0|||
130316337|NCT01384734|469124380|FG000|Overall Study|Continuation criteria not met|0|||
130316338|NCT01384734|469124381|FG001|Overall Study|Continuation criteria not met|0|||
130316339|NCT01384734|469124382|FG002|Overall Study|Continuation criteria not met|1|||
130316340|NCT01384734|469124383|FG003|Overall Study|Continuation criteria not met|1|||
130316341|NCT01384734|469124384|FG004|Overall Study|Continuation criteria not met|0|||
130316342|NCT01384734|469124380|FG000|Overall Study|Lack of Efficacy|3|||
130316343|NCT01384734|469124381|FG001|Overall Study|Lack of Efficacy|7|||
130316344|NCT01384734|469124382|FG002|Overall Study|Lack of Efficacy|4|||
130316345|NCT01384734|469124383|FG003|Overall Study|Lack of Efficacy|4|||
130316346|NCT01384734|469124384|FG004|Overall Study|Lack of Efficacy|2|||
130316347|NCT01384734|469124380|FG000|Overall Study|Lost to Follow-up|5|||
130316348|NCT01384734|469124381|FG001|Overall Study|Lost to Follow-up|3|||
130316349|NCT01384734|469124382|FG002|Overall Study|Lost to Follow-up|3|||
130316350|NCT01384734|469124383|FG003|Overall Study|Lost to Follow-up|8|||
130316351|NCT01384734|469124384|FG004|Overall Study|Lost to Follow-up|5|||
130316352|NCT01384734|469124380|FG000|Overall Study|Non-compliance with study drug|1|||
130316353|NCT01384734|469124381|FG001|Overall Study|Non-compliance with study drug|2|||
130316354|NCT01384734|469124382|FG002|Overall Study|Non-compliance with study drug|6|||
130316355|NCT01384734|469124383|FG003|Overall Study|Non-compliance with study drug|0|||
130316356|NCT01384734|469124384|FG004|Overall Study|Non-compliance with study drug|2|||
130316357|NCT01384734|469124380|FG000|Overall Study|Pregnancy|0|||
130316358|NCT01384734|469124381|FG001|Overall Study|Pregnancy|1|||
130316359|NCT01384734|469124382|FG002|Overall Study|Pregnancy|0|||
130316360|NCT01384734|469124383|FG003|Overall Study|Pregnancy|0|||
130316361|NCT01384734|469124384|FG004|Overall Study|Pregnancy|1|||
130316362|NCT01384734|469124380|FG000|Overall Study|Sponsor terminated|0|||
130316363|NCT01384734|469124381|FG001|Overall Study|Sponsor terminated|0|||
130316364|NCT01384734|469124382|FG002|Overall Study|Sponsor terminated|0|||
130316365|NCT01384734|469124383|FG003|Overall Study|Sponsor terminated|0|||
130316366|NCT01384734|469124384|FG004|Overall Study|Sponsor terminated|1|||
130316367|NCT01384734|469124380|FG000|Overall Study|Withdrawal by Subject|5|||
130316368|NCT01384734|469124381|FG001|Overall Study|Withdrawal by Subject|5|||
130316369|NCT01384734|469124382|FG002|Overall Study|Withdrawal by Subject|6|||
130316370|NCT01384734|469124383|FG003|Overall Study|Withdrawal by Subject|7|||
130316371|NCT01384734|469124384|FG004|Overall Study|Withdrawal by Subject|9|||
130316372|NCT01384734|469124380|FG000|Overall Study|Investigator relocating|0|||
130316373|NCT01384734|469124381|FG001|Overall Study|Investigator relocating|2|||
130316374|NCT01384734|469124382|FG002|Overall Study|Investigator relocating|0|||
130316375|NCT01384734|469124383|FG003|Overall Study|Investigator relocating|3|||
130316376|NCT01384734|469124384|FG004|Overall Study|Investigator relocating|1|||
130316377|NCT01384734|469124380|FG000|Overall Study|Unable to come back for visit|1|||
130316378|NCT01384734|469124381|FG001|Overall Study|Unable to come back for visit|0|||
130316379|NCT01384734|469124382|FG002|Overall Study|Unable to come back for visit|1|||
130316380|NCT01384734|469124383|FG003|Overall Study|Unable to come back for visit|1|||
130316381|NCT01384734|469124384|FG004|Overall Study|Unable to come back for visit|0|||
130316382|NCT01384734|469124380|FG000|Overall Study|Prison|0|||
130316383|NCT01384734|469124381|FG001|Overall Study|Prison|0|||
130316384|NCT01384734|469124382|FG002|Overall Study|Prison|1|||
130316385|NCT01384734|469124383|FG003|Overall Study|Prison|0|||
130376870|NCT00006903|469345954|FG000|Overall Study|Death|0|||
130376871|NCT00006903|469345955|FG001|Overall Study|Death|1|||
130376872|NCT00006903|469345956|FG002|Overall Study|Death|0|||
130376873|NCT00006903|469345954|FG000|Overall Study|Patient never treated|0|||
130376874|NCT00006903|469345955|FG001|Overall Study|Patient never treated|0|||
130376875|NCT00006903|469345956|FG002|Overall Study|Patient never treated|1|||
130376876|NCT00006903|469345954|FG000|Overall Study|Ineligible|10|||
130376877|NCT00006903|469345955|FG001|Overall Study|Ineligible|1|||
130376878|NCT00006903|469345956|FG002|Overall Study|Ineligible|2|||
130376879|NCT01484197|469345959|FG000|Treatment Period 1|Adverse Event|1|||
130376880|NCT01484197|469345960|FG001|Treatment Period 1|Adverse Event|0|||
130376881|NCT01484197|469345961|FG002|Treatment Period 1|Adverse Event|0|||
130376882|NCT01484197|469345962|FG003|Treatment Period 1|Adverse Event|0|||
130376883|NCT01484197|469345959|FG000|Treatment Period 2|Subject withdrew consent|0|||
130376884|NCT01484197|469345960|FG001|Treatment Period 2|Subject withdrew consent|0|||
130376885|NCT01484197|469345961|FG002|Treatment Period 2|Subject withdrew consent|0|||
130376886|NCT01484197|469345962|FG003|Treatment Period 2|Subject withdrew consent|1|||
130376887|NCT02706691|469345966|FG000|Overall Study|Adverse Event|1|||
130376888|NCT01980992|469345967|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
130376889|NCT01980992|469345968|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
130376890|NCT01980992|469345967|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
130376891|NCT01980992|469345968|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
130376892|NCT01980992|469345967|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
130376893|NCT01980992|469345968|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
130376894|NCT01980992|469345967|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
130376895|NCT01980992|469345968|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
130376896|NCT01980992|469345967|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
130376897|NCT01980992|469345968|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
130376898|NCT01980992|469345967|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
130376899|NCT01980992|469345968|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
130376900|NCT05025241|469345972|FG000|Screening|Failed Screening|5|||
130376901|NCT05025241|469345972|FG000|Treatment and Follow Up|Adverse Event|3|||
130376902|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130376903|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
130376904|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130376905|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130376906|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130376907|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130376908|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
130376909|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
130376910|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
130376911|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
130376912|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
130376913|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
130376914|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
130376915|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130376916|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
130376917|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130376918|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
130376919|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130376920|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130376921|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130376922|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130466793|NCT00332241|469676413|FG001|Overall Study|Withdrawal by Subject|1|||
130466794|NCT00332241|469676412|FG000|Overall Study|Lost to Follow-up|4|||
130466795|NCT00332241|469676413|FG001|Overall Study|Lost to Follow-up|1|||
130466796|NCT00802464|469676415|FG000|Month 0 - Month 8|Adverse Event|0|||
130466797|NCT00802464|469676416|FG001|Month 0 - Month 8|Adverse Event|1|||
130466798|NCT00802464|469676417|FG002|Month 0 - Month 8|Adverse Event|1|||
130466799|NCT00802464|469676418|FG003|Month 0 - Month 8|Adverse Event|2|||
130466800|NCT00802464|469676415|FG000|Month 0 - Month 8|Protocol Violation|0|||
130466801|NCT00802464|469676416|FG001|Month 0 - Month 8|Protocol Violation|0|||
130466802|NCT00802464|469676417|FG002|Month 0 - Month 8|Protocol Violation|1|||
130466803|NCT00802464|469676418|FG003|Month 0 - Month 8|Protocol Violation|0|||
130466804|NCT00802464|469676415|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
130466805|NCT00802464|469676416|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
130466806|NCT00802464|469676417|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
130466807|NCT00802464|469676418|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
130466808|NCT00802464|469676415|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
130466809|NCT00802464|469676416|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
130466810|NCT00802464|469676417|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
130466811|NCT00802464|469676418|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
130466812|NCT00802464|469676415|FG000|Month 0 - Month 8|Other|0|||
130466813|NCT00802464|469676416|FG001|Month 0 - Month 8|Other|0|||
130466814|NCT00802464|469676417|FG002|Month 0 - Month 8|Other|1|||
130466815|NCT00802464|469676418|FG003|Month 0 - Month 8|Other|0|||
130466816|NCT00802464|469676415|FG000|Month 8 - Month 14|Adverse Event|0|||
130376923|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130376924|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
130466817|NCT00802464|469676416|FG001|Month 8 - Month 14|Adverse Event|1|||
130466818|NCT00802464|469676417|FG002|Month 8 - Month 14|Adverse Event|0|||
130466819|NCT00802464|469676418|FG003|Month 8 - Month 14|Adverse Event|0|||
130559418|NCT01621542|470016490|FG000|Overall Study|progression/treatment failure|2|||
130559419|NCT01621542|470016491|FG001|Overall Study|progression/treatment failure|4|||
130376925|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130376926|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130376927|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
130376928|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130376929|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130376930|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130376931|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130376932|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
130376933|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130376934|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130376935|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
130376936|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130376937|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
130376938|NCT02603419|469345974|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130376939|NCT02603419|469345975|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130376940|NCT02603419|469345976|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130376941|NCT02603419|469345977|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
130376942|NCT02603419|469345978|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130376943|NCT02603419|469345979|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130376944|NCT02603419|469345974|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130376945|NCT02603419|469345975|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130376946|NCT02603419|469345976|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130376947|NCT02603419|469345977|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130376948|NCT02603419|469345978|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130376949|NCT02603419|469345979|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
130376950|NCT02603419|469345974|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130376951|NCT02603419|469345975|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130376952|NCT02603419|469345976|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130376953|NCT02603419|469345977|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130376954|NCT02603419|469345978|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130376955|NCT02603419|469345979|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
130376956|NCT02603419|469345974|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130376957|NCT02603419|469345975|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130376958|NCT02603419|469345976|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130376959|NCT02603419|469345977|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130376960|NCT02603419|469345978|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130559420|NCT01621542|470016492|FG002|Overall Study|progression/treatment failure|3|||
130559421|NCT01621542|470016493|FG003|Overall Study|progression/treatment failure|7|||
130376961|NCT02603419|469345979|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
130376962|NCT02850965|469345980|FG000|Overall Study|Other than listed|3|||
130376963|NCT02850965|469345981|FG001|Overall Study|Other than listed|4|||
130376964|NCT02850965|469345980|FG000|Overall Study|Protocol Violation|0|||
130466820|NCT00802464|469676415|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
130466821|NCT00802464|469676416|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
130466822|NCT00802464|469676417|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
130466823|NCT00802464|469676418|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
130466824|NCT00802464|469676415|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
130466825|NCT00802464|469676416|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
130466826|NCT00802464|469676417|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
130466827|NCT00802464|469676418|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
130466828|NCT00402246|469676419|FG000|Overall Study|Death|62|||
130466829|NCT00402246|469676420|FG001|Overall Study|Death|58|||
130466830|NCT00402246|469676419|FG000|Overall Study|Lost to Follow-up|20|||
130466831|NCT00402246|469676420|FG001|Overall Study|Lost to Follow-up|28|||
130466832|NCT00402246|469676419|FG000|Overall Study|Withdrawal by Subject|72|||
130466833|NCT00402246|469676420|FG001|Overall Study|Withdrawal by Subject|87|||
130466834|NCT00402246|469676419|FG000|Overall Study|Physician Decision|24|||
130466835|NCT00402246|469676420|FG001|Overall Study|Physician Decision|26|||
130466836|NCT00402246|469676419|FG000|Overall Study|Protocol Violation|25|||
130466837|NCT00402246|469676420|FG001|Overall Study|Protocol Violation|24|||
130466838|NCT00402246|469676419|FG000|Overall Study|Missed Final Visit|1|||
130376965|NCT02850965|469345981|FG001|Overall Study|Protocol Violation|2|||
130376966|NCT02850965|469345980|FG000|Overall Study|Lost to Follow-up|5|||
130466839|NCT00402246|469676420|FG001|Overall Study|Missed Final Visit|2|||
130466840|NCT00402246|469676419|FG000|Overall Study|Insurance Issues|2|||
130466841|NCT00402246|469676420|FG001|Overall Study|Insurance Issues|1|||
130466842|NCT00402246|469676419|FG000|Overall Study|Heart Transplant|0|||
130720941|NCT01822275|470601566|FG000|Overall Study|Adverse Event|3|||
130720942|NCT01822275|470601566|FG000|Overall Study|Progression|14|||
130720943|NCT01822275|470601566|FG000|Overall Study|Physician Decision|2|||
130720944|NCT00073021|470601567|FG000|Overall Study|Protocol Violation|2|||
130720945|NCT00073021|470601568|FG001|Overall Study|Protocol Violation|1|||
130720946|NCT00073021|470601567|FG000|Overall Study|Adverse Event|4|||
130720947|NCT00073021|470601568|FG001|Overall Study|Adverse Event|4|||
130720948|NCT00073021|470601567|FG000|Overall Study|Withdrawal by Subject|6|||
130720949|NCT00073021|470601568|FG001|Overall Study|Withdrawal by Subject|5|||
130720950|NCT00073021|470601567|FG000|Overall Study|Physician Decision|3|||
130720951|NCT00073021|470601568|FG001|Overall Study|Physician Decision|1|||
130316386|NCT01384734|469124384|FG004|Overall Study|Prison|0|||
130316387|NCT01384734|469124380|FG000|Overall Study|As per Exclusion criteria|0|||
130316388|NCT01384734|469124381|FG001|Overall Study|As per Exclusion criteria|1|||
130316389|NCT01384734|469124382|FG002|Overall Study|As per Exclusion criteria|0|||
130316390|NCT01384734|469124383|FG003|Overall Study|As per Exclusion criteria|0|||
130316391|NCT01384734|469124384|FG004|Overall Study|As per Exclusion criteria|0|||
130316392|NCT01384734|469124380|FG000|Overall Study|Missed End of treatment visit|0|||
130316393|NCT01384734|469124381|FG001|Overall Study|Missed End of treatment visit|0|||
130316394|NCT01384734|469124382|FG002|Overall Study|Missed End of treatment visit|0|||
130316395|NCT01384734|469124383|FG003|Overall Study|Missed End of treatment visit|1|||
130316396|NCT01384734|469124384|FG004|Overall Study|Missed End of treatment visit|0|||
130316397|NCT01384734|469124380|FG000|Overall Study|Adhesion problem|0|||
130316398|NCT01384734|469124381|FG001|Overall Study|Adhesion problem|0|||
130316399|NCT01384734|469124382|FG002|Overall Study|Adhesion problem|0|||
130316400|NCT01384734|469124383|FG003|Overall Study|Adhesion problem|1|||
130316401|NCT01384734|469124384|FG004|Overall Study|Adhesion problem|0|||
130316402|NCT01384734|469124380|FG000|Overall Study|Early termination|0|||
130316403|NCT01384734|469124381|FG001|Overall Study|Early termination|0|||
130316404|NCT01384734|469124382|FG002|Overall Study|Early termination|0|||
130316405|NCT01384734|469124383|FG003|Overall Study|Early termination|0|||
130316406|NCT01384734|469124384|FG004|Overall Study|Early termination|1|||
130316407|NCT01384734|469124380|FG000|Overall Study|Physician Decision|1|||
130316408|NCT01384734|469124381|FG001|Overall Study|Physician Decision|0|||
130316409|NCT01384734|469124382|FG002|Overall Study|Physician Decision|0|||
130316410|NCT01384734|469124383|FG003|Overall Study|Physician Decision|0|||
130316411|NCT01384734|469124384|FG004|Overall Study|Physician Decision|0|||
130316412|NCT01290523|469124385|FG000|Overall Study|Death|3|||
130316413|NCT03071263|469124386|FG000|Overall Study|Adverse Event|1|||
130316414|NCT03071263|469124387|FG001|Overall Study|Adverse Event|3|||
130316415|NCT03071263|469124386|FG000|Overall Study|Withdrawal by Subject|1|||
130316416|NCT03071263|469124387|FG001|Overall Study|Withdrawal by Subject|3|||
130316417|NCT03071263|469124386|FG000|Overall Study|Physician Decision|1|||
130316418|NCT03071263|469124387|FG001|Overall Study|Physician Decision|0|||
130316419|NCT03071263|469124386|FG000|Overall Study|Participant moved to another city|0|||
130316420|NCT03071263|469124387|FG001|Overall Study|Participant moved to another city|1|||
130316421|NCT01917747|469124388|FG000|Overall Study|Withdrawal by Subject|1|||
130316422|NCT01917747|469124389|FG001|Overall Study|Withdrawal by Subject|2|||
130316423|NCT01917747|469124388|FG000|Overall Study|Lost to Follow-up|18|||
130316424|NCT01917747|469124389|FG001|Overall Study|Lost to Follow-up|9|||
130316425|NCT00152503|469124391|FG000|Overall Study|Adverse Event|4|||
130316426|NCT02922725|469124392|FG000|Overall Study|Withdrawal by Subject|1|||
130316427|NCT02922725|469124393|FG001|Overall Study|Withdrawal by Subject|0|||
130316428|NCT02922725|469124394|FG002|Overall Study|Withdrawal by Subject|0|||
130316429|NCT01300234|469124395|FG000|Overall Study|Adverse Event|1|||
130316430|NCT01300234|469124396|FG001|Overall Study|Adverse Event|1|||
130316431|NCT01300234|469124395|FG000|Overall Study|Protocol Violation|2|||
130316432|NCT01300234|469124396|FG001|Overall Study|Protocol Violation|3|||
130316433|NCT01300234|469124395|FG000|Overall Study|Withdrawal by Subject|5|||
130316434|NCT01300234|469124396|FG001|Overall Study|Withdrawal by Subject|9|||
130316435|NCT01300234|469124395|FG000|Overall Study|Lost to Follow-up|14|||
130316436|NCT01300234|469124396|FG001|Overall Study|Lost to Follow-up|12|||
130316437|NCT01300234|469124395|FG000|Overall Study|Pregnancy|2|||
130316438|NCT01300234|469124396|FG001|Overall Study|Pregnancy|1|||
130316439|NCT01300234|469124395|FG000|Overall Study|Participant reached stopping critera|2|||
130316440|NCT01300234|469124396|FG001|Overall Study|Participant reached stopping critera|0|||
130316441|NCT01300234|469124395|FG000|Overall Study|Participant stopped medication|1|||
130316442|NCT01300234|469124396|FG001|Overall Study|Participant stopped medication|1|||
130316443|NCT01300234|469124395|FG000|Overall Study|Participant refused return to hospital|1|||
130316444|NCT01300234|469124396|FG001|Overall Study|Participant refused return to hospital|0|||
130316445|NCT03253679|469124397|FG000|Overall Study|Screen Failure|1|||
130316446|NCT04816214|469124399|FG000|Overall Study|Progressive Disease|4|||
130316447|NCT04816214|469124400|FG001|Overall Study|Progressive Disease|0|||
130316448|NCT04816214|469124401|FG002|Overall Study|Progressive Disease|0|||
130316449|NCT04816214|469124399|FG000|Overall Study|Death|1|||
130316450|NCT04816214|469124400|FG001|Overall Study|Death|0|||
130316451|NCT04816214|469124401|FG002|Overall Study|Death|0|||
130316452|NCT04816214|469124399|FG000|Overall Study|Study Terminated by Sponsor|1|||
130316453|NCT04816214|469124400|FG001|Overall Study|Study Terminated by Sponsor|0|||
130316454|NCT04816214|469124401|FG002|Overall Study|Study Terminated by Sponsor|0|||
130316455|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
130316456|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130316457|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130316458|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
130316459|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130316460|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130316461|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
130316462|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130316463|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130316464|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
130316465|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130316466|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130316467|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
130316468|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130316469|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130316470|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
130316471|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130316472|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130316473|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
130316474|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130316475|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130316476|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
130316477|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130316478|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130316479|NCT00550407|469124402|FG000|26-Week Randomized Phase|Adverse Event|0|||
130316480|NCT00550407|469124403|FG001|26-Week Randomized Phase|Adverse Event|5|||
130316481|NCT00550407|469124404|FG002|26-Week Randomized Phase|Adverse Event|2|||
130316482|NCT00550407|469124402|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
130316483|NCT00550407|469124403|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
130316484|NCT00550407|469124404|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
130316485|NCT00550407|469124402|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
130316486|NCT00550407|469124403|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
130316487|NCT00550407|469124404|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
130316488|NCT00550407|469124402|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
130316489|NCT00550407|469124403|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
130316490|NCT00550407|469124404|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
130316491|NCT00584415|469124405|FG000|Overall Study|Adverse Event|7|||
130316492|NCT05051579|469124406|FG000|Overall Study|Withdrawal by Subject|3|||
130316493|NCT05051579|469124407|FG001|Overall Study|Withdrawal by Subject|5|||
130316494|NCT05051579|469124408|FG002|Overall Study|Withdrawal by Subject|2|||
130316495|NCT05051579|469124409|FG003|Overall Study|Withdrawal by Subject|1|||
130316496|NCT05051579|469124410|FG004|Overall Study|Withdrawal by Subject|4|||
130316497|NCT05051579|469124411|FG005|Overall Study|Withdrawal by Subject|0|||
130316498|NCT05051579|469124412|FG006|Overall Study|Withdrawal by Subject|4|||
130316499|NCT05051579|469124406|FG000|Overall Study|Lost to Follow-up|1|||
130316500|NCT05051579|469124407|FG001|Overall Study|Lost to Follow-up|0|||
130376967|NCT02850965|469345981|FG001|Overall Study|Lost to Follow-up|3|||
130376968|NCT02850965|469345980|FG000|Overall Study|Lack of Efficacy|4|||
130376969|NCT02850965|469345981|FG001|Overall Study|Lack of Efficacy|8|||
130376970|NCT02850965|469345980|FG000|Overall Study|Adverse Event|3|||
130376971|NCT02850965|469345981|FG001|Overall Study|Adverse Event|2|||
130376972|NCT02850965|469345980|FG000|Overall Study|Withdrawal by Subject|3|||
130376973|NCT02850965|469345981|FG001|Overall Study|Withdrawal by Subject|4|||
130376974|NCT02850965|469345980|FG000|Overall Study|Physician Decision|0|||
130376975|NCT02850965|469345981|FG001|Overall Study|Physician Decision|1|||
130376976|NCT02850965|469345980|FG000|Overall Study|Randomized but not treated|0|||
130376977|NCT02850965|469345981|FG001|Overall Study|Randomized but not treated|1|||
130559422|NCT01621542|470016494|FG004|Overall Study|progression/treatment failure|3|||
130559423|NCT01621542|470016495|FG005|Overall Study|progression/treatment failure|5|||
130316501|NCT05051579|469124408|FG002|Overall Study|Lost to Follow-up|0|||
130316502|NCT05051579|469124409|FG003|Overall Study|Lost to Follow-up|0|||
130316503|NCT05051579|469124410|FG004|Overall Study|Lost to Follow-up|1|||
130316504|NCT05051579|469124411|FG005|Overall Study|Lost to Follow-up|0|||
130559424|NCT01621542|470016490|FG000|Overall Study|Protocol Violation|0|||
130559425|NCT01621542|470016491|FG001|Overall Study|Protocol Violation|0|||
130316505|NCT05051579|469124412|FG006|Overall Study|Lost to Follow-up|1|||
130559426|NCT01621542|470016492|FG002|Overall Study|Protocol Violation|0|||
130559427|NCT01621542|470016493|FG003|Overall Study|Protocol Violation|1|||
130559428|NCT01621542|470016494|FG004|Overall Study|Protocol Violation|0|||
130376978|NCT02788357|469345982|FG000|Overall Study|Lost to Follow-up|3|||
130376979|NCT02788357|469345983|FG001|Overall Study|Lost to Follow-up|0|||
130376980|NCT02007109|469345989|FG000|Overall Study|Diary not returned or excluded|102|||
130316506|NCT05051579|469124406|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316507|NCT05051579|469124407|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316508|NCT05051579|469124408|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316509|NCT05051579|469124409|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316510|NCT05051579|469124410|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316511|NCT05051579|469124411|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316512|NCT05051579|469124412|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
130316513|NCT05051579|469124406|FG000|Overall Study|Adverse Event|2|||
130316514|NCT05051579|469124407|FG001|Overall Study|Adverse Event|1|||
130316515|NCT05051579|469124408|FG002|Overall Study|Adverse Event|0|||
130316516|NCT05051579|469124409|FG003|Overall Study|Adverse Event|4|||
130316517|NCT05051579|469124410|FG004|Overall Study|Adverse Event|1|||
130316518|NCT05051579|469124411|FG005|Overall Study|Adverse Event|2|||
130316519|NCT05051579|469124412|FG006|Overall Study|Adverse Event|0|||
130316520|NCT05051579|469124406|FG000|Overall Study|Inadvertent Enrollment|0|||
130316521|NCT05051579|469124407|FG001|Overall Study|Inadvertent Enrollment|0|||
130316522|NCT05051579|469124408|FG002|Overall Study|Inadvertent Enrollment|0|||
130316523|NCT05051579|469124409|FG003|Overall Study|Inadvertent Enrollment|0|||
130316524|NCT05051579|469124410|FG004|Overall Study|Inadvertent Enrollment|0|||
130316525|NCT05051579|469124411|FG005|Overall Study|Inadvertent Enrollment|0|||
130316526|NCT05051579|469124412|FG006|Overall Study|Inadvertent Enrollment|1|||
130316527|NCT05051579|469124406|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316528|NCT05051579|469124407|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
130316529|NCT05051579|469124408|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316530|NCT05051579|469124409|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316531|NCT05051579|469124410|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316532|NCT05051579|469124411|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316533|NCT05051579|469124412|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316534|NCT05051579|469124406|FG000|Overall Study|Sponsor Decision|0|||
130316535|NCT05051579|469124407|FG001|Overall Study|Sponsor Decision|0|||
130316536|NCT05051579|469124408|FG002|Overall Study|Sponsor Decision|0|||
130316537|NCT05051579|469124409|FG003|Overall Study|Sponsor Decision|0|||
130316538|NCT05051579|469124410|FG004|Overall Study|Sponsor Decision|1|||
130316539|NCT05051579|469124411|FG005|Overall Study|Sponsor Decision|0|||
130316540|NCT05051579|469124412|FG006|Overall Study|Sponsor Decision|0|||
130316541|NCT05051579|469124406|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316542|NCT05051579|469124407|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316543|NCT05051579|469124408|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316544|NCT05051579|469124409|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316545|NCT05051579|469124410|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
130316546|NCT05051579|469124411|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316547|NCT05051579|469124412|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316548|NCT00717249|469124413|FG000|Overall Study|Lens Discomfort|4|||
130316549|NCT00717249|469124414|FG001|Overall Study|Lens Discomfort|1|||
130316550|NCT00717249|469124413|FG000|Overall Study|Unsatisfactory visual Response|0|||
130316551|NCT00717249|469124414|FG001|Overall Study|Unsatisfactory visual Response|2|||
130316552|NCT00717249|469124413|FG000|Overall Study|Adverse Event|4|||
130316553|NCT00717249|469124414|FG001|Overall Study|Adverse Event|2|||
130316554|NCT00717249|469124413|FG000|Overall Study|Lost to Follow-up|2|||
130316555|NCT00717249|469124414|FG001|Overall Study|Lost to Follow-up|0|||
130316556|NCT00717249|469124413|FG000|Overall Study|Withdrawal by Subject|1|||
130316557|NCT00717249|469124414|FG001|Overall Study|Withdrawal by Subject|2|||
130316558|NCT00717249|469124413|FG000|Overall Study|Pregnancy|6|||
130316559|NCT00717249|469124414|FG001|Overall Study|Pregnancy|3|||
130316560|NCT00717249|469124413|FG000|Overall Study|Protocol Violation|0|||
130316561|NCT00717249|469124414|FG001|Overall Study|Protocol Violation|2|||
130316562|NCT00717249|469124413|FG000|Overall Study|Subject became Ineligible|1|||
130316563|NCT00717249|469124414|FG001|Overall Study|Subject became Ineligible|1|||
130316564|NCT00717249|469124413|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
130316565|NCT00717249|469124414|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
130316566|NCT00717249|469124413|FG000|Overall Study|Gastric Surgery|0|||
130316567|NCT00717249|469124414|FG001|Overall Study|Gastric Surgery|1|||
130376981|NCT02007109|469345989|FG000|Overall Study|Excluded - Age<7yo|9|||
130376982|NCT03572062|469345991|FG000|Overall Study|Adverse Event|0|||
130376983|NCT03572062|469345992|FG001|Overall Study|Adverse Event|0|||
130316568|NCT00717249|469124413|FG000|Overall Study|Diagnosed with Diabetes|1|||
130316569|NCT00717249|469124414|FG001|Overall Study|Diagnosed with Diabetes|0|||
130316570|NCT00717249|469124413|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
130316571|NCT00717249|469124414|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
130316572|NCT00717249|469124413|FG000|Overall Study|Subject relocated|1|||
130316573|NCT00717249|469124414|FG001|Overall Study|Subject relocated|0|||
130316574|NCT00717249|469124413|FG000|Overall Study|Headaches|1|||
130316575|NCT00717249|469124414|FG001|Overall Study|Headaches|0|||
130316576|NCT00360412|469124415|FG000|Overall Study|Adverse Event|37|||
130316577|NCT00360412|469124416|FG001|Overall Study|Adverse Event|65|||
130316578|NCT00360412|469124415|FG000|Overall Study|Protocol Violation|2|||
130316579|NCT00360412|469124416|FG001|Overall Study|Protocol Violation|5|||
130316580|NCT00360412|469124415|FG000|Overall Study|Patient withdrew consent|27|||
130316581|NCT00360412|469124416|FG001|Overall Study|Patient withdrew consent|52|||
130316582|NCT00360412|469124415|FG000|Overall Study|Lack of therapeutic efficacy|46|||
130316583|NCT00360412|469124416|FG001|Overall Study|Lack of therapeutic efficacy|61|||
130316584|NCT00360412|469124415|FG000|Overall Study|Physician Decision|2|||
130316585|NCT00360412|469124416|FG001|Overall Study|Physician Decision|4|||
130316586|NCT00360412|469124415|FG000|Overall Study|Other|5|||
130316587|NCT00360412|469124416|FG001|Overall Study|Other|6|||
130316588|NCT00360412|469124415|FG000|Overall Study|Study termination by Sponsor|214|||
130316589|NCT00360412|469124416|FG001|Overall Study|Study termination by Sponsor|469|||
130316590|NCT05148234|469124417|FG000|Phase I|Ineligible|0|||
130316591|NCT05148234|469124418|FG001|Phase I|Ineligible|0|||
130316592|NCT05148234|469124419|FG002|Phase I|Ineligible|0|||
130316593|NCT05148234|469124420|FG003|Phase I|Ineligible|0|||
130316594|NCT05148234|469124421|FG004|Phase I|Ineligible|0|||
130316595|NCT05148234|469124422|FG005|Phase I|Ineligible|0|||
130316596|NCT05148234|469124423|FG006|Phase I|Ineligible|0|||
130316597|NCT05148234|469124424|FG007|Phase I|Ineligible|1|||
130316598|NCT05148234|469124417|FG000|Phase I|Company closed the trial.|0|||
130316599|NCT05148234|469124418|FG001|Phase I|Company closed the trial.|1|||
130376984|NCT03572062|469345993|FG002|Overall Study|Adverse Event|0|||
130376985|NCT03572062|469345994|FG003|Overall Study|Adverse Event|0|||
130376986|NCT03572062|469345995|FG004|Overall Study|Adverse Event|0|||
130376987|NCT03572062|469345996|FG005|Overall Study|Adverse Event|0|||
130376988|NCT03572062|469345997|FG006|Overall Study|Adverse Event|0|||
130376989|NCT03572062|469345998|FG007|Overall Study|Adverse Event|0|||
130376990|NCT03572062|469345999|FG008|Overall Study|Adverse Event|1|||
130376991|NCT03572062|469346000|FG009|Overall Study|Adverse Event|3|||
130376992|NCT03572062|469345991|FG000|Overall Study|Death|0|||
130376993|NCT03572062|469345992|FG001|Overall Study|Death|0|||
130376994|NCT03572062|469345993|FG002|Overall Study|Death|0|||
130376995|NCT03572062|469345994|FG003|Overall Study|Death|0|||
130376996|NCT03572062|469345995|FG004|Overall Study|Death|0|||
130376997|NCT03572062|469345996|FG005|Overall Study|Death|1|||
130376998|NCT03572062|469345997|FG006|Overall Study|Death|0|||
130376999|NCT03572062|469345998|FG007|Overall Study|Death|0|||
130377000|NCT03572062|469345999|FG008|Overall Study|Death|0|||
130377001|NCT03572062|469346000|FG009|Overall Study|Death|0|||
130559429|NCT01621542|470016495|FG005|Overall Study|Protocol Violation|0|||
130559430|NCT01621542|470016490|FG000|Overall Study|study stopped by sponsor|0|||
130559431|NCT01621542|470016491|FG001|Overall Study|study stopped by sponsor|0|||
130559432|NCT01621542|470016492|FG002|Overall Study|study stopped by sponsor|0|||
130559433|NCT01621542|470016493|FG003|Overall Study|study stopped by sponsor|1|||
130559434|NCT01621542|470016494|FG004|Overall Study|study stopped by sponsor|0|||
130559435|NCT01621542|470016495|FG005|Overall Study|study stopped by sponsor|0|||
130559436|NCT01368042|470016496|FG000|Overall Study|Death|14|||
130559437|NCT01368042|470016496|FG000|Overall Study|Protocol Violation|11|||
130559438|NCT01368042|470016496|FG000|Overall Study|Lost to Follow-up|4|||
130316600|NCT05148234|469124419|FG002|Phase I|Company closed the trial.|0|||
130316601|NCT05148234|469124420|FG003|Phase I|Company closed the trial.|0|||
130316602|NCT05148234|469124421|FG004|Phase I|Company closed the trial.|0|||
130377002|NCT03572062|469345991|FG000|Overall Study|Lost to Follow-up|0|||
130377003|NCT03572062|469345992|FG001|Overall Study|Lost to Follow-up|0|||
130559439|NCT01368042|470016496|FG000|Overall Study|Transplanted|1|||
130559440|NCT00760669|470016497|FG000|Overall Study|Not assessed for overall improvement|18|||
130316603|NCT05148234|469124422|FG005|Phase I|Company closed the trial.|0|||
130377004|NCT03572062|469345993|FG002|Overall Study|Lost to Follow-up|0|||
130377005|NCT03572062|469345994|FG003|Overall Study|Lost to Follow-up|0|||
130377006|NCT03572062|469345995|FG004|Overall Study|Lost to Follow-up|0|||
130720952|NCT00073021|470601567|FG000|Overall Study|Lack of Efficacy|11|||
130316604|NCT05148234|469124423|FG006|Phase I|Company closed the trial.|0|||
130316605|NCT05148234|469124424|FG007|Phase I|Company closed the trial.|0|||
130316606|NCT03061201|469124425|FG000|Overall Study|Participants Terminated at Month 36|0|||
130316607|NCT03061201|469124426|FG001|Overall Study|Participants Terminated at Month 36|1|||
130377007|NCT03572062|469345996|FG005|Overall Study|Lost to Follow-up|1|||
130377008|NCT03572062|469345997|FG006|Overall Study|Lost to Follow-up|1|||
130377009|NCT03572062|469345998|FG007|Overall Study|Lost to Follow-up|0|||
130377010|NCT03572062|469345999|FG008|Overall Study|Lost to Follow-up|0|||
130377011|NCT03572062|469346000|FG009|Overall Study|Lost to Follow-up|0|||
130377012|NCT03572062|469345991|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377013|NCT03572062|469345992|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377014|NCT03572062|469345993|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130720953|NCT00073021|470601568|FG001|Overall Study|Lack of Efficacy|5|||
130720954|NCT01672970|470601570|FG000|Overall Study|Lack of Efficacy|12|||
130720955|NCT01672970|470601570|FG000|Overall Study|Adverse Event|18|||
130720956|NCT01672970|470601570|FG000|Overall Study|Withdrawal by Subject|2|||
130720957|NCT01672970|470601570|FG000|Overall Study|Lost to Follow-up|5|||
130720958|NCT01672970|470601570|FG000|Overall Study|Other|9|||
130720959|NCT01672970|470601570|FG000|Overall Study|Enrolled but not treated|1|||
130720960|NCT03276780|470601571|FG000|Overall Study|Withdrawal by Subject|5|||
130720961|NCT03276780|470601572|FG001|Overall Study|Withdrawal by Subject|3|||
130720962|NCT03276780|470601571|FG000|Overall Study|Lost to Follow-up|3|||
130720963|NCT03276780|470601572|FG001|Overall Study|Lost to Follow-up|5|||
130720964|NCT03276780|470601571|FG000|Overall Study|Moved out of state|1|||
130720965|NCT03276780|470601572|FG001|Overall Study|Moved out of state|1|||
130720966|NCT03276780|470601571|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
130720967|NCT03276780|470601572|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
130720968|NCT03276780|470601571|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
130720969|NCT03276780|470601572|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
130720970|NCT03835221|470601573|FG000|Methafilcon A|Withdrawal by Subject|1|||
130720971|NCT00390221|470601575|FG000|Overall Study|Lost to Follow-up|0|||
130720972|NCT00390221|470601576|FG001|Overall Study|Lost to Follow-up|3|||
130559441|NCT00760669|470016497|FG000|Overall Study|Participants missing efficacy assessment|6|||
130559442|NCT00760669|470016497|FG000|Overall Study|Participants with overlapping cases|1|||
130720973|NCT00390221|470601577|FG002|Overall Study|Lost to Follow-up|0|||
130377015|NCT03572062|469345994|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377016|NCT03572062|469345995|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377017|NCT03572062|469345996|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377018|NCT03572062|469345997|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377019|NCT03572062|469345998|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377020|NCT03572062|469345999|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
130377021|NCT03572062|469346000|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
130377022|NCT03572062|469345991|FG000|Overall Study|Study Terminated By Sponsor|0|||
130377023|NCT03572062|469345992|FG001|Overall Study|Study Terminated By Sponsor|0|||
130377024|NCT03572062|469345993|FG002|Overall Study|Study Terminated By Sponsor|0|||
130377025|NCT03572062|469345994|FG003|Overall Study|Study Terminated By Sponsor|0|||
130377026|NCT03572062|469345995|FG004|Overall Study|Study Terminated By Sponsor|0|||
130377027|NCT03572062|469345996|FG005|Overall Study|Study Terminated By Sponsor|0|||
130377028|NCT03572062|469345997|FG006|Overall Study|Study Terminated By Sponsor|0|||
130377029|NCT03572062|469345998|FG007|Overall Study|Study Terminated By Sponsor|0|||
130377030|NCT03572062|469345999|FG008|Overall Study|Study Terminated By Sponsor|29|||
130377031|NCT03572062|469346000|FG009|Overall Study|Study Terminated By Sponsor|27|||
130377032|NCT03572062|469345991|FG000|Overall Study|Physician Decision|0|||
130377033|NCT03572062|469345992|FG001|Overall Study|Physician Decision|0|||
130377034|NCT03572062|469345993|FG002|Overall Study|Physician Decision|0|||
130377035|NCT03572062|469345994|FG003|Overall Study|Physician Decision|0|||
130377036|NCT03572062|469345995|FG004|Overall Study|Physician Decision|0|||
130377037|NCT03572062|469345996|FG005|Overall Study|Physician Decision|0|||
130377038|NCT03572062|469345997|FG006|Overall Study|Physician Decision|0|||
130377039|NCT03572062|469345998|FG007|Overall Study|Physician Decision|0|||
130377040|NCT03572062|469345999|FG008|Overall Study|Physician Decision|1|||
130377041|NCT03572062|469346000|FG009|Overall Study|Physician Decision|0|||
130377042|NCT03572062|469345991|FG000|Overall Study|Withdrawal by Subject|0|||
130377043|NCT03572062|469345992|FG001|Overall Study|Withdrawal by Subject|0|||
130377044|NCT03572062|469345993|FG002|Overall Study|Withdrawal by Subject|0|||
130377045|NCT03572062|469345994|FG003|Overall Study|Withdrawal by Subject|0|||
130377046|NCT03572062|469345995|FG004|Overall Study|Withdrawal by Subject|0|||
130377047|NCT03572062|469345996|FG005|Overall Study|Withdrawal by Subject|0|||
130720974|NCT00390221|470601575|FG000|Overall Study|Adverse Event|1|||
130377048|NCT03572062|469345997|FG006|Overall Study|Withdrawal by Subject|0|||
130377049|NCT03572062|469345998|FG007|Overall Study|Withdrawal by Subject|0|||
130720975|NCT00390221|470601576|FG001|Overall Study|Adverse Event|4|||
130377050|NCT03572062|469345999|FG008|Overall Study|Withdrawal by Subject|0|||
130377051|NCT03572062|469346000|FG009|Overall Study|Withdrawal by Subject|1|||
130377052|NCT03572062|469345991|FG000|Overall Study|Randomized But Not Treated|0|||
130377053|NCT03572062|469345992|FG001|Overall Study|Randomized But Not Treated|0|||
130377054|NCT03572062|469345993|FG002|Overall Study|Randomized But Not Treated|0|||
130377055|NCT03572062|469345994|FG003|Overall Study|Randomized But Not Treated|0|||
130720976|NCT00390221|470601577|FG002|Overall Study|Adverse Event|3|||
130720977|NCT00390221|470601575|FG000|Overall Study|Investigator Decision|0|||
130377056|NCT03572062|469345995|FG004|Overall Study|Randomized But Not Treated|1|||
130377057|NCT03572062|469345996|FG005|Overall Study|Randomized But Not Treated|2|||
130377058|NCT03572062|469345997|FG006|Overall Study|Randomized But Not Treated|0|||
130377059|NCT03572062|469345998|FG007|Overall Study|Randomized But Not Treated|1|||
130377060|NCT03572062|469345999|FG008|Overall Study|Randomized But Not Treated|0|||
130377061|NCT03572062|469346000|FG009|Overall Study|Randomized But Not Treated|0|||
130377062|NCT01858389|469346001|FG000|Overall Study|Death|1|||
130377063|NCT01858389|469346002|FG001|Overall Study|Death|3|||
130377064|NCT01858389|469346001|FG000|Overall Study|Study terminated by sponsor|0|||
130377065|NCT01858389|469346002|FG001|Overall Study|Study terminated by sponsor|2|||
130377066|NCT01858389|469346001|FG000|Overall Study|Withdrawal by Subject|0|||
130377067|NCT01858389|469346002|FG001|Overall Study|Withdrawal by Subject|1|||
130377068|NCT01858389|469346001|FG000|Overall Study|Progressive disease|10|||
130377069|NCT01858389|469346002|FG001|Overall Study|Progressive disease|11|||
130377070|NCT01858389|469346001|FG000|Overall Study|Other|2|||
130377071|NCT01858389|469346002|FG001|Overall Study|Other|4|||
130377072|NCT01858389|469346001|FG000|Overall Study|Adverse Event|3|||
130377073|NCT01858389|469346002|FG001|Overall Study|Adverse Event|1|||
130377074|NCT01858389|469346001|FG000|Overall Study|Did not receive treatment|0|||
130377075|NCT01858389|469346002|FG001|Overall Study|Did not receive treatment|3|||
130377076|NCT00458211|469346003|FG000|Overall Study|Lack of Efficacy|12|||
130377077|NCT00458211|469346003|FG000|Overall Study|Withdrawal by Subject|2|||
130377078|NCT00458211|469346003|FG000|Overall Study|Protocol Violation|2|||
130377079|NCT00646776|469346006|FG000|Overall Study|Adverse Event|1|||
130377080|NCT00646776|469346007|FG001|Overall Study|Adverse Event|9|||
130377081|NCT00646776|469346006|FG000|Overall Study|Investigator discretion|0|||
130377082|NCT00646776|469346007|FG001|Overall Study|Investigator discretion|4|||
130377083|NCT00126568|469346008|FG000|Overall Study|Death|2|||
130377084|NCT03031678|469346010|FG000|Overall Study|Study closed prior to completion|1|||
130377085|NCT01753856|469346011|FG000|Overall Study|Adverse Event|1|||
130377086|NCT01753856|469346012|FG001|Overall Study|Adverse Event|0|||
130377087|NCT01753856|469346011|FG000|Overall Study|Withdrawal by Subject|0|||
130377088|NCT01753856|469346012|FG001|Overall Study|Withdrawal by Subject|2|||
130377089|NCT01753856|469346011|FG000|Overall Study|Sponsor Decision|2|||
130377090|NCT01753856|469346012|FG001|Overall Study|Sponsor Decision|0|||
130377091|NCT00434330|469346017|FG000|Overall Study|Adverse Event|0|||
130377092|NCT00434330|469346018|FG001|Overall Study|Adverse Event|0|||
130377093|NCT00434330|469346019|FG002|Overall Study|Adverse Event|1|||
130377094|NCT00434330|469346020|FG003|Overall Study|Adverse Event|0|||
130377095|NCT00434330|469346021|FG004|Overall Study|Adverse Event|0|||
130377096|NCT00434330|469346022|FG005|Overall Study|Adverse Event|0|||
130377097|NCT00434330|469346017|FG000|Overall Study|Death|1|||
130377098|NCT00434330|469346018|FG001|Overall Study|Death|0|||
130377099|NCT00434330|469346019|FG002|Overall Study|Death|0|||
130377100|NCT00434330|469346020|FG003|Overall Study|Death|0|||
130377101|NCT00434330|469346021|FG004|Overall Study|Death|1|||
130377102|NCT00434330|469346022|FG005|Overall Study|Death|1|||
130377103|NCT00434330|469346017|FG000|Overall Study|Withdrawal by Subject|0|||
130377104|NCT00434330|469346018|FG001|Overall Study|Withdrawal by Subject|0|||
130377105|NCT00434330|469346019|FG002|Overall Study|Withdrawal by Subject|1|||
130377106|NCT00434330|469346020|FG003|Overall Study|Withdrawal by Subject|1|||
130377107|NCT00434330|469346021|FG004|Overall Study|Withdrawal by Subject|0|||
130377108|NCT00434330|469346022|FG005|Overall Study|Withdrawal by Subject|0|||
130377109|NCT00434330|469346017|FG000|Overall Study|Renal transplant|0|||
130377110|NCT00434330|469346018|FG001|Overall Study|Renal transplant|0|||
130720978|NCT00390221|470601576|FG001|Overall Study|Investigator Decision|0|||
130377111|NCT00434330|469346019|FG002|Overall Study|Renal transplant|0|||
130377112|NCT00434330|469346020|FG003|Overall Study|Renal transplant|1|||
130377113|NCT00434330|469346021|FG004|Overall Study|Renal transplant|0|||
130377114|NCT00434330|469346022|FG005|Overall Study|Renal transplant|0|||
130377115|NCT00434330|469346017|FG000|Overall Study|Subject Not Compliant With Study|0|||
130377116|NCT00434330|469346018|FG001|Overall Study|Subject Not Compliant With Study|0|||
130466843|NCT00402246|469676420|FG001|Overall Study|Heart Transplant|1|||
130466844|NCT00402246|469676419|FG000|Overall Study|Patient's device explanted|6|||
130466845|NCT00402246|469676420|FG001|Overall Study|Patient's device explanted|2|||
130466846|NCT00402246|469676419|FG000|Overall Study|Center Closure|5|||
130466847|NCT00402246|469676420|FG001|Overall Study|Center Closure|3|||
130466848|NCT00402246|469676419|FG000|Overall Study|Deterioriating Condition|3|||
130466849|NCT00402246|469676420|FG001|Overall Study|Deterioriating Condition|2|||
130377117|NCT00434330|469346019|FG002|Overall Study|Subject Not Compliant With Study|1|||
130377118|NCT00434330|469346020|FG003|Overall Study|Subject Not Compliant With Study|0|||
130377119|NCT00434330|469346021|FG004|Overall Study|Subject Not Compliant With Study|0|||
130377120|NCT00434330|469346022|FG005|Overall Study|Subject Not Compliant With Study|0|||
130377121|NCT03278613|469346023|FG000|Overall Study|Lost to Follow-up|3|||
130377122|NCT03278613|469346024|FG001|Overall Study|Lost to Follow-up|1|||
130466850|NCT01471691|469676424|FG000|Overall Study|Lack of Efficacy|0|||
130377123|NCT01937559|469346025|FG000|Overall Study|Physician Decision|3|||
130377124|NCT01937559|469346026|FG001|Overall Study|Physician Decision|3|||
130720979|NCT00390221|470601577|FG002|Overall Study|Investigator Decision|1|||
130377125|NCT01937559|469346027|FG002|Overall Study|Physician Decision|0|||
130377126|NCT01937559|469346025|FG000|Overall Study|Withdrawal by Subject|6|||
130377127|NCT01937559|469346026|FG001|Overall Study|Withdrawal by Subject|4|||
130377128|NCT01937559|469346027|FG002|Overall Study|Withdrawal by Subject|0|||
130377129|NCT01937559|469346025|FG000|Overall Study|screen fail|2|||
130377130|NCT01937559|469346026|FG001|Overall Study|screen fail|4|||
130377131|NCT01937559|469346027|FG002|Overall Study|screen fail|0|||
130377132|NCT04847557|469346028|FG000|Overall Study|Adverse Event|1|||
130377133|NCT04847557|469346029|FG001|Overall Study|Adverse Event|0|||
130377134|NCT04847557|469346028|FG000|Overall Study|Death|19|||
130377135|NCT04847557|469346029|FG001|Overall Study|Death|15|||
130377136|NCT04847557|469346028|FG000|Overall Study|Lost to Follow-up|3|||
130377137|NCT04847557|469346029|FG001|Overall Study|Lost to Follow-up|6|||
130377138|NCT04847557|469346028|FG000|Overall Study|Physician Decision|1|||
130377139|NCT04847557|469346029|FG001|Overall Study|Physician Decision|0|||
130377140|NCT04847557|469346028|FG000|Overall Study|Protocol Violation|0|||
130377141|NCT04847557|469346029|FG001|Overall Study|Protocol Violation|1|||
130377142|NCT04847557|469346028|FG000|Overall Study|Withdrawal by Subject|8|||
130377143|NCT04847557|469346029|FG001|Overall Study|Withdrawal by Subject|14|||
130377144|NCT02154490|469348264|FG000|Overall Study|No tissue submitted|23|||
130377145|NCT02154490|469348264|FG000|Overall Study|No biomarker results|167|||
130377146|NCT02154490|469348264|FG000|Overall Study|Not assigned to a sub-study|270|||
130377147|NCT02154490|469348264|FG000|Overall Study|Did not register to a sub-study|749|||
130377148|NCT02961751|469348267|FG000|Overall Study|Lost to Follow-up|11|||
130377149|NCT02961751|469348267|FG000|Overall Study|Physician Decision|2|||
130316608|NCT03061201|469124427|FG002|Overall Study|Participants Terminated at Month 36|0|||
130316609|NCT03061201|469124428|FG003|Overall Study|Participants Terminated at Month 36|1|||
130316610|NCT03061201|469124425|FG000|Overall Study|Lost to Follow-up|1|||
130316611|NCT03061201|469124426|FG001|Overall Study|Lost to Follow-up|0|||
130316612|NCT03061201|469124427|FG002|Overall Study|Lost to Follow-up|0|||
130316613|NCT03061201|469124428|FG003|Overall Study|Lost to Follow-up|0|||
130316614|NCT03062358|469124429|FG000|Overall Study|Death|269|||
130316615|NCT03062358|469124430|FG001|Overall Study|Death|145|||
130316616|NCT03062358|469124429|FG000|Overall Study|Withdrawal by Subject|2|||
130316617|NCT03062358|469124430|FG001|Overall Study|Withdrawal by Subject|1|||
130316618|NCT03062358|469124429|FG000|Overall Study|Sponsor Decision|29|||
130316619|NCT03062358|469124430|FG001|Overall Study|Sponsor Decision|7|||
130316620|NCT03861273|469124431|FG000|Screening Phase (3 Weeks)|Other|1|||
130316621|NCT03861273|469124431|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
130316622|NCT03861273|469124431|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
130316623|NCT03861273|469124431|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
130316624|NCT03861273|469124431|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
130316625|NCT03799341|469124432|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130316626|NCT03799341|469124433|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130316627|NCT03799341|469124434|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
130316628|NCT03799341|469124432|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
130316629|NCT03799341|469124433|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
130316630|NCT03799341|469124434|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
130316631|NCT03799341|469124432|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130316632|NCT03799341|469124433|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130316633|NCT03799341|469124434|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
130316634|NCT03799341|469124432|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
130316635|NCT03799341|469124433|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
130316636|NCT03799341|469124434|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
130316637|NCT03799341|469124432|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
130316638|NCT03799341|469124433|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
130316639|NCT03799341|469124434|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
130377150|NCT02961751|469348267|FG000|Overall Study|Not Eligible at Enrollment|1|||
130316640|NCT03799341|469124432|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
130316641|NCT03799341|469124433|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130316642|NCT03799341|469124434|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130377151|NCT02961751|469348267|FG000|Overall Study|Protocol Violation|1|||
130377152|NCT01549860|469348269|FG000|Overall Study|Withdrawal by Subject|1|||
130377153|NCT01549860|469348270|FG001|Overall Study|Withdrawal by Subject|0|||
130316643|NCT01116648|469124435|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
130377154|NCT01549860|469348269|FG000|Overall Study|Physician Decision|1|||
130377155|NCT01549860|469348270|FG001|Overall Study|Physician Decision|1|||
130377156|NCT00720434|469348273|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130377157|NCT00720434|469348274|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
130377158|NCT00720434|469348275|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130466851|NCT01471691|469676425|FG001|Overall Study|Lack of Efficacy|1|||
130466852|NCT01808339|469676426|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466853|NCT01808339|469676427|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466854|NCT01808339|469676428|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130377159|NCT00720434|469348276|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130377160|NCT00720434|469348273|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
130377161|NCT00720434|469348274|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
130377162|NCT00720434|469348275|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
130377163|NCT00720434|469348276|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
130377164|NCT00720434|469348273|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
130377165|NCT00720434|469348274|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130377166|NCT00720434|469348275|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130377167|NCT00720434|469348276|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130377168|NCT00720434|469348273|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
130377169|NCT00720434|469348274|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
130377170|NCT00720434|469348275|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
130377171|NCT00720434|469348276|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
130377172|NCT00720434|469348273|FG000|Open-Label Period (Week 5-72)|Other|4|||
130377173|NCT00720434|469348274|FG001|Open-Label Period (Week 5-72)|Other|3|||
130377174|NCT00720434|469348275|FG002|Open-Label Period (Week 5-72)|Other|3|||
130377175|NCT00720434|469348276|FG003|Open-Label Period (Week 5-72)|Other|2|||
130377176|NCT01224431|469348277|FG000|Overall Study|not randomized|0|||
130377177|NCT01224431|469348278|FG001|Overall Study|not randomized|4|||
130377178|NCT01224431|469348277|FG000|Overall Study|no video record|0|||
130377179|NCT01224431|469348278|FG001|Overall Study|no video record|1|||
130377180|NCT02041286|469348283|FG000|Overall Study|Adverse Event|1|||
130377181|NCT01349790|469348299|FG000|Overall Study|Investigator Judgement|3|||
130377182|NCT01349790|469348299|FG000|Overall Study|Death|2|||
130377183|NCT01349790|469348299|FG000|Overall Study|Withdrawal by Patient|2|||
130377184|NCT01349790|469348299|FG000|Overall Study|Adverse Event|1|||
130377185|NCT01349790|469348299|FG000|Overall Study|Lost to Follow-up|1|||
130377186|NCT00885105|469348300|FG000|Overall Study|Withdrawal by Subject|0|||
130377187|NCT00885105|469348301|FG001|Overall Study|Withdrawal by Subject|8|||
130377188|NCT00885105|469348300|FG000|Overall Study|Adverse Event|1|||
130377189|NCT00885105|469348301|FG001|Overall Study|Adverse Event|0|||
130377190|NCT00885105|469348300|FG000|Overall Study|Protocol Violation|0|||
130377191|NCT00885105|469348301|FG001|Overall Study|Protocol Violation|2|||
130377192|NCT03519932|469348302|FG000|First Intervention|Adverse Event|1|||
130377193|NCT03519932|469348303|FG001|First Intervention|Adverse Event|3|||
130377194|NCT02254486|469348304|FG000|Overall Study|Adverse Event|1|||
130377195|NCT02254486|469348305|FG001|Overall Study|Adverse Event|1|||
130377196|NCT02254486|469348304|FG000|Overall Study|Lack of Efficacy|1|||
130377197|NCT02254486|469348305|FG001|Overall Study|Lack of Efficacy|0|||
130377198|NCT02254486|469348304|FG000|Overall Study|Lost to Follow-up|2|||
130377199|NCT02254486|469348305|FG001|Overall Study|Lost to Follow-up|4|||
130377200|NCT02254486|469348304|FG000|Overall Study|Protocol Violation|1|||
130377201|NCT02254486|469348305|FG001|Overall Study|Protocol Violation|2|||
130377202|NCT02254486|469348304|FG000|Overall Study|Withdrawal by Subject|17|||
130377203|NCT02254486|469348305|FG001|Overall Study|Withdrawal by Subject|15|||
130377204|NCT02254486|469348304|FG000|Overall Study|GFR<60mL/min|16|||
130377205|NCT02254486|469348305|FG001|Overall Study|GFR<60mL/min|21|||
130377206|NCT02254486|469348304|FG000|Overall Study|Various|12|||
130377207|NCT02254486|469348305|FG001|Overall Study|Various|12|||
130377208|NCT01350414|469348306|FG000|Overall Study|Lost to Follow-up|13|||
130377209|NCT01350414|469348306|FG000|Overall Study|Withdrawal by Subject|4|||
130377210|NCT01350414|469348306|FG000|Overall Study|Physician Decision|2|||
130377211|NCT02743520|469348307|FG000|Overall Study|Withdrawal by Subject|1|||
130377212|NCT01749514|469348308|FG000|Overall Study|Lost to Follow-up|0|||
130377213|NCT01749514|469348309|FG001|Overall Study|Lost to Follow-up|0|||
130377214|NCT01749514|469348310|FG002|Overall Study|Lost to Follow-up|0|||
130377215|NCT01749514|469348311|FG003|Overall Study|Lost to Follow-up|0|||
130377216|NCT01749514|469348312|FG004|Overall Study|Lost to Follow-up|0|||
130377217|NCT01749514|469348313|FG005|Overall Study|Lost to Follow-up|0|||
130466855|NCT01808339|469676429|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
130466856|NCT01808339|469676430|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
130466857|NCT01808339|469676431|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
130466858|NCT01808339|469676426|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130377218|NCT01749514|469348314|FG006|Overall Study|Lost to Follow-up|0|||
130377219|NCT01749514|469348315|FG007|Overall Study|Lost to Follow-up|1|||
130466859|NCT01808339|469676427|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130720980|NCT00390221|470601575|FG000|Overall Study|Withdrawal by Subject|13|||
130377220|NCT01749514|469348308|FG000|Overall Study|Withdrawal by Subject|0|||
130377221|NCT01749514|469348309|FG001|Overall Study|Withdrawal by Subject|0|||
130377222|NCT01749514|469348310|FG002|Overall Study|Withdrawal by Subject|0|||
130377223|NCT01749514|469348311|FG003|Overall Study|Withdrawal by Subject|0|||
130377224|NCT01749514|469348312|FG004|Overall Study|Withdrawal by Subject|0|||
130377225|NCT01749514|469348313|FG005|Overall Study|Withdrawal by Subject|1|||
130377226|NCT01749514|469348314|FG006|Overall Study|Withdrawal by Subject|0|||
130377227|NCT01749514|469348315|FG007|Overall Study|Withdrawal by Subject|1|||
130720981|NCT00390221|470601576|FG001|Overall Study|Withdrawal by Subject|9|||
130720982|NCT00390221|470601577|FG002|Overall Study|Withdrawal by Subject|7|||
130720983|NCT00390221|470601575|FG000|Overall Study|Subject Non-compliance|1|||
130377228|NCT01749514|469348308|FG000|Overall Study|Not Reported|0|||
130377229|NCT01749514|469348309|FG001|Overall Study|Not Reported|0|||
130377230|NCT01749514|469348310|FG002|Overall Study|Not Reported|0|||
130377231|NCT01749514|469348311|FG003|Overall Study|Not Reported|0|||
130377232|NCT01749514|469348312|FG004|Overall Study|Not Reported|0|||
130377233|NCT01749514|469348313|FG005|Overall Study|Not Reported|0|||
130377234|NCT01749514|469348314|FG006|Overall Study|Not Reported|0|||
130377235|NCT01749514|469348315|FG007|Overall Study|Not Reported|5|||
130377236|NCT01979016|469348317|FG000|Overall Study|Withdrawal by Subject|2|||
130377237|NCT01979016|469348318|FG001|Overall Study|Withdrawal by Subject|0|||
130377238|NCT01979016|469348317|FG000|Overall Study|Adverse Event|0|||
130720984|NCT00390221|470601576|FG001|Overall Study|Subject Non-compliance|0|||
130377239|NCT01979016|469348318|FG001|Overall Study|Adverse Event|1|||
130377240|NCT00938639|469348319|FG000|Overall Study|Moved away from study area|0|||
130377241|NCT00938639|469348320|FG001|Overall Study|Moved away from study area|1|||
130377242|NCT00938639|469348319|FG000|Overall Study|Lost to Follow-up|1|||
130377243|NCT00938639|469348320|FG001|Overall Study|Lost to Follow-up|2|||
130377244|NCT00938639|469348319|FG000|Overall Study|Family issues|1|||
130377245|NCT00938639|469348320|FG001|Overall Study|Family issues|1|||
130377246|NCT00938639|469348319|FG000|Overall Study|Participant noncompliance|1|||
130377247|NCT00938639|469348320|FG001|Overall Study|Participant noncompliance|0|||
130377248|NCT02509156|469348321|FG000|Randomized Phase|Death|1|||
130377249|NCT02509156|469348322|FG001|Randomized Phase|Death|0|||
130377250|NCT02509156|469348321|FG000|Randomized Phase|Withdrawal by Subject|1|||
130377251|NCT02509156|469348322|FG001|Randomized Phase|Withdrawal by Subject|1|||
130377252|NCT04326231|469348323|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
130377253|NCT04202965|469348326|FG000|Overall Study|Adverse Event|3|||
130377254|NCT04202965|469348326|FG000|Overall Study|Did not meet inclusion criteria|1|||
130377255|NCT01366209|469348329|FG000|Overall Study|Adverse Event|6|||
130377256|NCT01366209|469348330|FG001|Overall Study|Adverse Event|7|||
130377257|NCT01366209|469348329|FG000|Overall Study|Withdrawal by Subject|4|||
130377258|NCT01366209|469348330|FG001|Overall Study|Withdrawal by Subject|4|||
130377259|NCT01366209|469348329|FG000|Overall Study|Death|12|||
130377260|NCT01366209|469348330|FG001|Overall Study|Death|19|||
130377261|NCT01366209|469348329|FG000|Overall Study|Lung transplantation|6|||
130377262|NCT01366209|469348330|FG001|Overall Study|Lung transplantation|1|||
130377263|NCT01366209|469348329|FG000|Overall Study|Lost to Follow-up|2|||
130377264|NCT01366209|469348330|FG001|Overall Study|Lost to Follow-up|1|||
130377265|NCT01366209|469348329|FG000|Overall Study|Physician Decision|1|||
130377266|NCT01366209|469348330|FG001|Overall Study|Physician Decision|0|||
130377267|NCT01366209|469348329|FG000|Overall Study|Sponsors decision|0|||
130377268|NCT01366209|469348330|FG001|Overall Study|Sponsors decision|1|||
130377269|NCT01366209|469348329|FG000|Overall Study|Withdrew consent|4|||
130377270|NCT01366209|469348330|FG001|Overall Study|Withdrew consent|3|||
130377271|NCT02670837|469348331|FG000|Overall Study|Death|2|||
130377272|NCT02670837|469348332|FG001|Overall Study|Death|0|||
130377273|NCT02670837|469348333|FG002|Overall Study|Death|0|||
130377274|NCT01053221|469348334|FG000|Overall Study|The study was closed prematurely|5|||
130377275|NCT01053221|469348335|FG001|Overall Study|The study was closed prematurely|9|||
130377276|NCT00752232|469348336|FG000|Overall Study|Protocol Violation|0|||
130377277|NCT00752232|469348337|FG001|Overall Study|Protocol Violation|0|||
130377278|NCT00752232|469348338|FG002|Overall Study|Protocol Violation|0|||
130377279|NCT00752232|469348339|FG003|Overall Study|Protocol Violation|0|||
130377280|NCT00752232|469348340|FG004|Overall Study|Protocol Violation|0|||
130377281|NCT00752232|469348341|FG005|Overall Study|Protocol Violation|1|||
130377282|NCT00752232|469348342|FG006|Overall Study|Protocol Violation|0|||
130377283|NCT00752232|469348336|FG000|Overall Study|Caregiver request|2|||
130377284|NCT00752232|469348337|FG001|Overall Study|Caregiver request|0|||
130377285|NCT00752232|469348338|FG002|Overall Study|Caregiver request|0|||
130466860|NCT01808339|469676428|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130466861|NCT01808339|469676429|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130720985|NCT00390221|470601577|FG002|Overall Study|Subject Non-compliance|2|||
130720986|NCT00390221|470601575|FG000|Overall Study|Other|3|||
130377286|NCT00752232|469348339|FG003|Overall Study|Caregiver request|0|||
130377287|NCT00752232|469348340|FG004|Overall Study|Caregiver request|1|||
130377288|NCT00752232|469348341|FG005|Overall Study|Caregiver request|0|||
130720987|NCT00390221|470601576|FG001|Overall Study|Other|4|||
130720988|NCT00390221|470601577|FG002|Overall Study|Other|2|||
130377289|NCT00752232|469348342|FG006|Overall Study|Caregiver request|0|||
130377290|NCT00752232|469348336|FG000|Overall Study|Investigator request|0|||
130377291|NCT00752232|469348337|FG001|Overall Study|Investigator request|0|||
130377292|NCT00752232|469348338|FG002|Overall Study|Investigator request|0|||
130377293|NCT00752232|469348339|FG003|Overall Study|Investigator request|0|||
130377294|NCT00752232|469348340|FG004|Overall Study|Investigator request|1|||
130720989|NCT02533375|470601578|FG000|Overall Study|Lack of Efficacy|3|||
130720990|NCT02533375|470601578|FG000|Overall Study|Adverse Event|2|||
130377295|NCT00752232|469348341|FG005|Overall Study|Investigator request|0|||
130377296|NCT00752232|469348342|FG006|Overall Study|Investigator request|0|||
130377297|NCT00752232|469348336|FG000|Overall Study|Subject request|0|||
130377298|NCT00752232|469348337|FG001|Overall Study|Subject request|0|||
130559443|NCT00760669|470016497|FG000|Overall Study|Took drug before entering in contract|5|||
130559444|NCT02663271|470016498|FG000|Overall Study|Withdrawal by Subject|5|||
130559445|NCT02663271|470016498|FG000|Overall Study|Lack of Efficacy|1|||
130559446|NCT01572675|470016499|FG000|Overall Study|End of prescribed treatment|140|||
130559447|NCT01572675|470016500|FG001|Overall Study|End of prescribed treatment|118|||
130559448|NCT01572675|470016499|FG000|Overall Study|Recovery|16|||
130559449|NCT01572675|470016500|FG001|Overall Study|Recovery|23|||
130559450|NCT01572675|470016499|FG000|Overall Study|Lack of Efficacy|31|||
130559451|NCT01572675|470016500|FG001|Overall Study|Lack of Efficacy|31|||
130559452|NCT01572675|470016499|FG000|Overall Study|Intolerance|6|||
130559453|NCT01572675|470016500|FG001|Overall Study|Intolerance|5|||
130559454|NCT01572675|470016499|FG000|Overall Study|Improved symptoms|8|||
130559455|NCT01572675|470016500|FG001|Overall Study|Improved symptoms|2|||
130559456|NCT01572675|470016499|FG000|Overall Study|Surgical intervention|3|||
130559457|NCT01572675|470016500|FG001|Overall Study|Surgical intervention|6|||
130559458|NCT01572675|470016499|FG000|Overall Study|Withdrawal by Subject|5|||
130559459|NCT01572675|470016500|FG001|Overall Study|Withdrawal by Subject|1|||
130559460|NCT01572675|470016499|FG000|Overall Study|Physician Decision|2|||
130559461|NCT01572675|470016500|FG001|Overall Study|Physician Decision|2|||
130559462|NCT01572675|470016499|FG000|Overall Study|Death unrelated to coxibs|1|||
130559463|NCT01572675|470016500|FG001|Overall Study|Death unrelated to coxibs|1|||
130559464|NCT01572675|470016499|FG000|Overall Study|Other disease detected|1|||
130559465|NCT01572675|470016500|FG001|Overall Study|Other disease detected|1|||
130559466|NCT01572675|470016499|FG000|Overall Study|Unknown reason|1|||
130559467|NCT01572675|470016500|FG001|Overall Study|Unknown reason|1|||
130559468|NCT01572675|470016499|FG000|Overall Study|Rheumatologist new evaluation|0|||
130559469|NCT01572675|470016500|FG001|Overall Study|Rheumatologist new evaluation|1|||
130559470|NCT01572675|470016499|FG000|Overall Study|Missing data|1|||
130559471|NCT01572675|470016500|FG001|Overall Study|Missing data|4|||
130559472|NCT01572675|470016499|FG000|Overall Study|Lost to Follow-up|22|||
130559473|NCT01572675|470016500|FG001|Overall Study|Lost to Follow-up|27|||
130559474|NCT02921269|470016504|FG000|Overall Study|Did not complete DLT period|1|||
130559475|NCT00504153|470016514|FG000|Overall Study|Withdrawal by Subject|1|||
130559476|NCT00504153|470016514|FG000|Overall Study|Adverse Event|4|||
130559477|NCT00504153|470016514|FG000|Overall Study|Death|1|||
130559478|NCT02322229|470016515|FG000|Overall Study|Physician Decision|2|||
130559479|NCT00705432|470016516|FG000|Treatment Period|Adverse Event|45|||
130316644|NCT01116648|469124436|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
130316645|NCT01116648|469124437|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
130316646|NCT01116648|469124438|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
130316647|NCT01116648|469124439|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
130316648|NCT01116648|469124440|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
130316649|NCT01116648|469124441|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
130316650|NCT01116648|469124442|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
130316651|NCT01116648|469124443|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
130316652|NCT01116648|469124444|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
130316653|NCT01116648|469124445|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
130316654|NCT01116648|469124446|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
130316655|NCT01116648|469124447|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
130316656|NCT01116648|469124448|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
130316657|NCT01116648|469124449|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
130316658|NCT04539938|469124450|FG000|Overall Study|Death|30|||
130316659|NCT04539938|469124450|FG000|Overall Study|Withdrawal by Subject|4|||
130316660|NCT00410956|469124451|FG000|Overall Study|Adverse Event|1|||
130316661|NCT00410956|469124451|FG000|Overall Study|Death|2|||
130316662|NCT00410956|469124451|FG000|Overall Study|Lack of Efficacy|10|||
130316663|NCT00410956|469124451|FG000|Overall Study|Physician Decision|6|||
130316664|NCT01650194|469124452|FG000|Overall Study|Progressive Disease (PD)|35|||
130316665|NCT01650194|469124452|FG000|Overall Study|Withdrawal by Subject|2|||
130316666|NCT01650194|469124452|FG000|Overall Study|Miscellaneous|10|||
130316667|NCT00880698|469124455|FG000|Overall Study|Death|0|||
130559480|NCT00705432|470016517|FG001|Treatment Period|Adverse Event|37|||
130559481|NCT00705432|470016518|FG002|Treatment Period|Adverse Event|51|||
130559482|NCT00705432|470016519|FG003|Treatment Period|Adverse Event|12|||
130559483|NCT00705432|470016520|FG004|Treatment Period|Adverse Event|8|||
130559484|NCT00705432|470016521|FG005|Treatment Period|Adverse Event|9|||
130559485|NCT00705432|470016516|FG000|Treatment Period|Treatment failure|92|||
130559486|NCT00705432|470016517|FG001|Treatment Period|Treatment failure|42|||
130316668|NCT00880698|469124456|FG001|Overall Study|Death|0|||
130316669|NCT00880698|469124457|FG002|Overall Study|Death|1|||
130316670|NCT00880698|469124458|FG003|Overall Study|Death|2|||
130559487|NCT00705432|470016518|FG002|Treatment Period|Treatment failure|33|||
130559488|NCT00705432|470016519|FG003|Treatment Period|Treatment failure|25|||
130559489|NCT00705432|470016520|FG004|Treatment Period|Treatment failure|13|||
130720991|NCT02823652|470601586|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
130720992|NCT02823652|470601587|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
130316671|NCT00880698|469124455|FG000|Overall Study|Lost to Follow-up|1|||
130316672|NCT00880698|469124456|FG001|Overall Study|Lost to Follow-up|3|||
130316673|NCT00880698|469124457|FG002|Overall Study|Lost to Follow-up|0|||
130316674|NCT00880698|469124458|FG003|Overall Study|Lost to Follow-up|1|||
130316675|NCT00794950|469124459|FG000|BCG Induction|Withdrawal by Subject|2|||
130316676|NCT00794950|469124459|FG000|BCG Induction|ineligible|3|||
130316677|NCT00794950|469124459|FG000|BCG Induction|noncompliant w. BCG|1|||
130316678|NCT00794950|469124459|FG000|BCG Induction|Adverse Event|1|||
130316679|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
130316680|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
130316681|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
130316682|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
130316683|NCT00966654|469125401|FG000|Overall Study|Study was terminated,PI left institution|12|||
130316684|NCT01405768|469125406|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
130316685|NCT01405768|469125407|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
130316686|NCT02869633|469125410|FG000|Overall Study|Death|2|||
130316687|NCT02869633|469125411|FG001|Overall Study|Death|1|||
130316688|NCT02869633|469125410|FG000|Overall Study|Patient refused follow-up|1|||
130316689|NCT02869633|469125411|FG001|Overall Study|Patient refused follow-up|0|||
130316690|NCT02869633|469125410|FG000|Overall Study|Provider discretion|1|||
130316691|NCT02869633|469125411|FG001|Overall Study|Provider discretion|0|||
130316692|NCT02869633|469125410|FG000|Overall Study|Investigator decision|1|||
130316693|NCT02869633|469125411|FG001|Overall Study|Investigator decision|0|||
130316694|NCT02869633|469125410|FG000|Overall Study|Lost to Follow-up|0|||
130316695|NCT02869633|469125411|FG001|Overall Study|Lost to Follow-up|1|||
130316696|NCT02869633|469125410|FG000|Overall Study|Not eligible|6|||
130316697|NCT02869633|469125411|FG001|Overall Study|Not eligible|1|||
130316698|NCT02869633|469125410|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
130316699|NCT02869633|469125411|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
130316700|NCT02869633|469125410|FG000|Overall Study|Withdrawal by Subject|0|||
130316701|NCT02869633|469125411|FG001|Overall Study|Withdrawal by Subject|1|||
130316702|NCT01381016|469125412|FG000|Overall Study|Lost to Follow-up|1|||
130316703|NCT01381016|469125413|FG001|Overall Study|Lost to Follow-up|1|||
130316704|NCT01381016|469125412|FG000|Overall Study|Screen Failure|2|||
130316705|NCT01381016|469125413|FG001|Overall Study|Screen Failure|2|||
130316706|NCT01381016|469125412|FG000|Overall Study|Withdrawal by Subject|0|||
130316707|NCT01381016|469125413|FG001|Overall Study|Withdrawal by Subject|1|||
130316708|NCT01381016|469125412|FG000|Overall Study|Physician Decision|0|||
130316709|NCT01381016|469125413|FG001|Overall Study|Physician Decision|2|||
130316710|NCT01631435|469125414|FG000|Overall Study|Adverse Event|2|||
130316711|NCT01631435|469125414|FG000|Overall Study|Withdrawal by Subject|2|||
130316712|NCT01631435|469125414|FG000|Overall Study|incomplete study procedure|5|||
130316713|NCT01005251|469125418|FG000|Overall Study|Withdrawal by Subject|2|||
130316714|NCT01005251|469125419|FG001|Overall Study|Withdrawal by Subject|5|||
130316715|NCT01005251|469125420|FG002|Overall Study|Withdrawal by Subject|3|||
130316716|NCT01005251|469125421|FG003|Overall Study|Withdrawal by Subject|4|||
130316717|NCT01005251|469125422|FG004|Overall Study|Withdrawal by Subject|9|||
130316718|NCT01005251|469125418|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130316719|NCT01005251|469125419|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130316720|NCT01005251|469125420|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
130316721|NCT01005251|469125421|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130316722|NCT01005251|469125422|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130316723|NCT01005251|469125418|FG000|Overall Study|Adverse Event|2|||
130316724|NCT01005251|469125419|FG001|Overall Study|Adverse Event|6|||
130720993|NCT02823652|470601588|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
130316725|NCT01005251|469125420|FG002|Overall Study|Adverse Event|8|||
130316726|NCT01005251|469125421|FG003|Overall Study|Adverse Event|5|||
130316727|NCT01005251|469125422|FG004|Overall Study|Adverse Event|4|||
130316728|NCT01005251|469125418|FG000|Overall Study|Protocol Violation|1|||
130316729|NCT01005251|469125419|FG001|Overall Study|Protocol Violation|0|||
130316730|NCT01005251|469125420|FG002|Overall Study|Protocol Violation|0|||
130316731|NCT01005251|469125421|FG003|Overall Study|Protocol Violation|0|||
130316732|NCT01005251|469125422|FG004|Overall Study|Protocol Violation|2|||
130316733|NCT01005251|469125418|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
130316734|NCT01005251|469125419|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
130316735|NCT01005251|469125420|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
130316736|NCT01005251|469125421|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
130377299|NCT00752232|469348338|FG002|Overall Study|Subject request|1|||
130316737|NCT01005251|469125422|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
130316738|NCT01005251|469125418|FG000|Overall Study|Lost to Follow-up|1|||
130316739|NCT01005251|469125419|FG001|Overall Study|Lost to Follow-up|4|||
130316740|NCT01005251|469125420|FG002|Overall Study|Lost to Follow-up|2|||
130316741|NCT01005251|469125421|FG003|Overall Study|Lost to Follow-up|0|||
130559490|NCT00705432|470016521|FG005|Treatment Period|Treatment failure|14|||
130559491|NCT00705432|470016516|FG000|Treatment Period|Non medical reason|26|||
130559492|NCT00705432|470016517|FG001|Treatment Period|Non medical reason|32|||
130559493|NCT00705432|470016518|FG002|Treatment Period|Non medical reason|37|||
130559494|NCT00705432|470016519|FG003|Treatment Period|Non medical reason|4|||
130559495|NCT00705432|470016520|FG004|Treatment Period|Non medical reason|7|||
130559496|NCT00705432|470016521|FG005|Treatment Period|Non medical reason|7|||
130377300|NCT00752232|469348339|FG003|Overall Study|Subject request|0|||
130377301|NCT00752232|469348340|FG004|Overall Study|Subject request|0|||
130316742|NCT01005251|469125422|FG004|Overall Study|Lost to Follow-up|0|||
130316743|NCT01005251|469125418|FG000|Overall Study|Physician Decision|0|||
130316744|NCT01005251|469125419|FG001|Overall Study|Physician Decision|0|||
130316745|NCT01005251|469125420|FG002|Overall Study|Physician Decision|0|||
130316746|NCT01005251|469125421|FG003|Overall Study|Physician Decision|0|||
130316747|NCT01005251|469125422|FG004|Overall Study|Physician Decision|2|||
130377302|NCT00752232|469348341|FG005|Overall Study|Subject request|0|||
130377303|NCT00752232|469348342|FG006|Overall Study|Subject request|0|||
130377304|NCT00752232|469348336|FG000|Overall Study|Group home admission|0|||
130377305|NCT00752232|469348337|FG001|Overall Study|Group home admission|0|||
130377306|NCT00752232|469348338|FG002|Overall Study|Group home admission|0|||
130377307|NCT00752232|469348339|FG003|Overall Study|Group home admission|1|||
130316748|NCT01005251|469125418|FG000|Overall Study|Patient moved|1|||
130316749|NCT01005251|469125419|FG001|Overall Study|Patient moved|0|||
130316750|NCT01005251|469125420|FG002|Overall Study|Patient moved|0|||
130316751|NCT01005251|469125421|FG003|Overall Study|Patient moved|0|||
130316752|NCT01005251|469125422|FG004|Overall Study|Patient moved|0|||
130316753|NCT01005251|469125418|FG000|Overall Study|Wrong drug dispensed|0|||
130316754|NCT01005251|469125419|FG001|Overall Study|Wrong drug dispensed|1|||
130316755|NCT01005251|469125420|FG002|Overall Study|Wrong drug dispensed|0|||
130316756|NCT01005251|469125421|FG003|Overall Study|Wrong drug dispensed|0|||
130316757|NCT01005251|469125422|FG004|Overall Study|Wrong drug dispensed|0|||
130316758|NCT01005251|469125418|FG000|Overall Study|Randomized in error|0|||
130316759|NCT01005251|469125419|FG001|Overall Study|Randomized in error|0|||
130316760|NCT01005251|469125420|FG002|Overall Study|Randomized in error|1|||
130316761|NCT01005251|469125421|FG003|Overall Study|Randomized in error|1|||
130316762|NCT01005251|469125422|FG004|Overall Study|Randomized in error|0|||
130316763|NCT01005251|469125418|FG000|Overall Study|Lack of Efficacy|0|||
130316764|NCT01005251|469125419|FG001|Overall Study|Lack of Efficacy|0|||
130316765|NCT01005251|469125420|FG002|Overall Study|Lack of Efficacy|1|||
130316766|NCT01005251|469125421|FG003|Overall Study|Lack of Efficacy|1|||
130316767|NCT01005251|469125422|FG004|Overall Study|Lack of Efficacy|0|||
130316768|NCT01169103|469125429|FG000|Overall Study|Lost to Follow-up|3|||
130316769|NCT01169103|469125430|FG001|Overall Study|Lost to Follow-up|3|||
130377308|NCT00752232|469348340|FG004|Overall Study|Group home admission|0|||
130377309|NCT00752232|469348341|FG005|Overall Study|Group home admission|0|||
130377310|NCT00752232|469348342|FG006|Overall Study|Group home admission|0|||
130377311|NCT00752232|469348336|FG000|Overall Study|Caregiver could not attend the subject|0|||
130377312|NCT00752232|469348337|FG001|Overall Study|Caregiver could not attend the subject|0|||
130377313|NCT00752232|469348338|FG002|Overall Study|Caregiver could not attend the subject|0|||
130377314|NCT00752232|469348339|FG003|Overall Study|Caregiver could not attend the subject|0|||
130377315|NCT00752232|469348340|FG004|Overall Study|Caregiver could not attend the subject|1|||
130377316|NCT00752232|469348341|FG005|Overall Study|Caregiver could not attend the subject|0|||
130377317|NCT00752232|469348342|FG006|Overall Study|Caregiver could not attend the subject|0|||
130377318|NCT01919723|469348343|FG000|Overall Study|Blood Samples Hemolyzed|2|||
130377319|NCT01919723|469348344|FG001|Overall Study|Blood Samples Hemolyzed|2|||
130377320|NCT04502589|469348345|FG000|Overall Study|Physician Decision|1|||
130377321|NCT04502589|469348346|FG001|Overall Study|Physician Decision|0|||
130377322|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
130377323|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
130377324|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
130377325|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
130377326|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
130377327|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
130377328|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130377329|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
130377330|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130377331|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130377332|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Death|2|||
130377333|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Death|1|||
130316770|NCT01169103|469125429|FG000|Overall Study|Withdrawal by Subject|3|||
130316771|NCT01169103|469125430|FG001|Overall Study|Withdrawal by Subject|1|||
130316772|NCT00141453|469125431|FG000|Overall Study|Protocol Violation|6|||
130316773|NCT00141453|469125432|FG001|Overall Study|Protocol Violation|5|||
130316774|NCT06039579|469125433|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316775|NCT06039579|469125434|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316776|NCT06039579|469125435|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316777|NCT06039579|469125436|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316778|NCT06039579|469125437|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316779|NCT06039579|469125438|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316780|NCT06039579|469125439|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316781|NCT06039579|469125440|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
130316782|NCT02469623|469125445|FG000|Overall Study|Not consented for long-term follow-up|4|||
130316783|NCT02469623|469125445|FG000|Overall Study|Lost to Follow-up|4|||
130316784|NCT02469623|469125445|FG000|Overall Study|Withdrawal by Subject|2|||
130316785|NCT02469623|469125445|FG000|Overall Study|Death|3|||
130316786|NCT02763644|469125446|FG000|Overall Study|Patient/guardian decision|1|||
130316787|NCT02763644|469125447|FG001|Overall Study|Patient/guardian decision|0|||
130316788|NCT02763644|469125446|FG000|Overall Study|Death|1|||
130316789|NCT02763644|469125447|FG001|Overall Study|Death|1|||
130316790|NCT02763644|469125446|FG000|Overall Study|Adverse Event|1|||
130316791|NCT02763644|469125447|FG001|Overall Study|Adverse Event|1|||
130316792|NCT02356159|469125448|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316793|NCT02356159|469125449|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316794|NCT02356159|469125450|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316795|NCT02356159|469125451|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316796|NCT02356159|469125452|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316797|NCT02356159|469125453|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
130316798|NCT00861705|469125454|FG000|Overall Study|Never Began Treatment|7|||
130316799|NCT00861705|469125455|FG001|Overall Study|Never Began Treatment|3|||
130316800|NCT00861705|469125456|FG002|Overall Study|Never Began Treatment|0|||
130316801|NCT00861705|469125457|FG003|Overall Study|Never Began Treatment|1|||
130316802|NCT06418152|469125458|FG000|Overall Study|Frequent DBS setting changes|1|||
130316803|NCT06418152|469125458|FG000|Overall Study|Withdrawal by Subject|2|||
130316804|NCT00667628|469125459|FG000|Overall Study|Lost to Follow-up|1|||
130316805|NCT00667628|469125460|FG001|Overall Study|Lost to Follow-up|0|||
130316806|NCT00667628|469125459|FG000|Overall Study|Death|6|||
130316807|NCT00667628|469125460|FG001|Overall Study|Death|6|||
130316808|NCT00667628|469125459|FG000|Overall Study|Investigator Considers in Best Interest|1|||
130316809|NCT00667628|469125460|FG001|Overall Study|Investigator Considers in Best Interest|0|||
130316810|NCT00667628|469125459|FG000|Overall Study|Sponsor Terminated Study|17|||
130316811|NCT00667628|469125460|FG001|Overall Study|Sponsor Terminated Study|21|||
130316812|NCT03360682|469125461|FG000|Overall Study|Adverse Event|3|||
130316813|NCT01962441|469125464|FG000|Randomized Period|Randomized but Never Treated|4|||
130316814|NCT01962441|469125465|FG001|Randomized Period|Randomized but Never Treated|2|||
130316815|NCT01962441|469125466|FG002|Randomized Period|Randomized but Never Treated|3|||
130316816|NCT01962441|469125464|FG000|Randomized Period|Lost to Follow-up|2|||
130316817|NCT01962441|469125465|FG001|Randomized Period|Lost to Follow-up|4|||
130316818|NCT01962441|469125466|FG002|Randomized Period|Lost to Follow-up|4|||
130316819|NCT01962441|469125464|FG000|Randomized Period|Withdrew Consent|3|||
130316820|NCT01962441|469125465|FG001|Randomized Period|Withdrew Consent|3|||
130316821|NCT01962441|469125466|FG002|Randomized Period|Withdrew Consent|2|||
130316822|NCT01962441|469125464|FG000|Randomized Period|Adverse Event|1|||
130316823|NCT01962441|469125465|FG001|Randomized Period|Adverse Event|1|||
130316824|NCT01962441|469125466|FG002|Randomized Period|Adverse Event|0|||
130316825|NCT01962441|469125464|FG000|Randomized Period|Death|0|||
130316826|NCT01962441|469125465|FG001|Randomized Period|Death|0|||
130316827|NCT01962441|469125466|FG002|Randomized Period|Death|2|||
130316828|NCT01962441|469125464|FG000|Randomized Period|Protocol Violation|0|||
130316829|NCT01962441|469125465|FG001|Randomized Period|Protocol Violation|1|||
130316830|NCT01962441|469125466|FG002|Randomized Period|Protocol Violation|0|||
130316831|NCT01962441|469125464|FG000|Retreatment Substudy|Lack of Efficacy|1|||
130377334|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Death|4|||
130316832|NCT01962441|469125465|FG001|Retreatment Substudy|Lack of Efficacy|0|||
130316833|NCT01962441|469125466|FG002|Retreatment Substudy|Lack of Efficacy|0|||
130316834|NCT01962441|469125464|FG000|Retreatment Substudy|Lost to Follow-up|1|||
130377335|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Death|0|||
130720994|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
130720995|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130720996|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130720997|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
130720998|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
130316835|NCT01962441|469125465|FG001|Retreatment Substudy|Lost to Follow-up|0|||
130377336|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Death|0|||
130720999|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
130377337|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
130377338|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
130377339|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
130377340|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
130377341|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
130377342|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Other Reason|1|||
130377343|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Other Reason|3|||
130377344|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Other Reason|2|||
130377345|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Other Reason|0|||
130377346|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Other Reason|0|||
130377347|NCT00555321|469348347|FG000|Treatment Phase up to 12-months|Never treated|2|||
130377348|NCT00555321|469348348|FG001|Treatment Phase up to 12-months|Never treated|3|||
130377349|NCT00555321|469348349|FG002|Treatment Phase up to 12-months|Never treated|1|||
130377350|NCT00555321|469348350|FG003|Treatment Phase up to 12-months|Never treated|0|||
130377351|NCT00555321|469348351|FG004|Treatment Phase up to 12-months|Never treated|4|||
130377352|NCT00555321|469348347|FG000|Long-term Extension Phase|Adverse Event|2|||
130377353|NCT00555321|469348348|FG001|Long-term Extension Phase|Adverse Event|5|||
130377354|NCT00555321|469348349|FG002|Long-term Extension Phase|Adverse Event|2|||
130377355|NCT00555321|469348350|FG003|Long-term Extension Phase|Adverse Event|1|||
130377356|NCT00555321|469348351|FG004|Long-term Extension Phase|Adverse Event|0|||
130377357|NCT00555321|469348347|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
130377358|NCT00555321|469348348|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
130377359|NCT00555321|469348349|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
130377360|NCT00555321|469348350|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
130377361|NCT00555321|469348351|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
130721000|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
130721001|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
130377362|NCT00555321|469348347|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
130377363|NCT00555321|469348348|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
130466862|NCT01808339|469676430|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130466863|NCT01808339|469676431|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130466864|NCT01808339|469676426|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466865|NCT01808339|469676427|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466866|NCT01808339|469676428|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
130466867|NCT01808339|469676429|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466868|NCT01808339|469676430|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466869|NCT01808339|469676431|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
130466870|NCT02622568|469676432|FG000|Overall Study|Lost to Follow-up|5|||
130466871|NCT02622568|469676433|FG001|Overall Study|Lost to Follow-up|5|||
130466872|NCT00371787|469676436|FG000|Overall Study|Withdrawal by Subject|3|||
130466873|NCT00371787|469676437|FG001|Overall Study|Withdrawal by Subject|1|||
130466874|NCT01854385|469676438|FG000|Pre-Treatment|Withdrawal by Subject|4|||
130466875|NCT01854385|469676438|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
130466876|NCT01854385|469676438|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
130466877|NCT01854385|469676438|FG000|Pre-Treatment|Unable to come for study visits|1|||
130466878|NCT01854385|469676438|FG000|Treatment|Lost to Follow-up|1|||
130466879|NCT01266122|469676439|FG000|Overall Study|Lost to Follow-up|6|||
130466880|NCT01266122|469676440|FG001|Overall Study|Lost to Follow-up|6|||
130466881|NCT03756571|469676441|FG000|Overall Study|Lost to Follow-up|1|||
130466882|NCT03756571|469676442|FG001|Overall Study|Lost to Follow-up|1|||
130466883|NCT00421889|469676443|FG000|Overall Study|Adverse Event|1|||
130466884|NCT00421889|469676444|FG001|Overall Study|Adverse Event|0|||
130466885|NCT00421889|469676445|FG002|Overall Study|Adverse Event|1|||
130466886|NCT00421889|469676446|FG003|Overall Study|Adverse Event|1|||
130466887|NCT00421889|469676447|FG004|Overall Study|Adverse Event|1|||
130466888|NCT00421889|469676448|FG005|Overall Study|Adverse Event|4|||
130466889|NCT00421889|469676449|FG006|Overall Study|Adverse Event|1|||
130466890|NCT00421889|469676450|FG007|Overall Study|Adverse Event|0|||
130466891|NCT00421889|469676451|FG008|Overall Study|Adverse Event|2|||
130466892|NCT00421889|469676443|FG000|Overall Study|Withdrawal by Subject|1|||
130721002|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
130721003|NCT03567382|470601591|FG000|Overall Study|Lost to Follow-up|1|||
130721004|NCT03567382|470601592|FG001|Overall Study|Lost to Follow-up|21|||
130721005|NCT03567382|470601593|FG002|Overall Study|Lost to Follow-up|1|||
130721006|NCT03567382|470601594|FG003|Overall Study|Lost to Follow-up|21|||
130721007|NCT03567382|470601591|FG000|Overall Study|Withdrawal by Subject|2|||
130377364|NCT00555321|469348349|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
130466893|NCT00421889|469676444|FG001|Overall Study|Withdrawal by Subject|3|||
130466894|NCT00421889|469676445|FG002|Overall Study|Withdrawal by Subject|0|||
130466895|NCT00421889|469676446|FG003|Overall Study|Withdrawal by Subject|0|||
130721008|NCT03567382|470601592|FG001|Overall Study|Withdrawal by Subject|14|||
130721009|NCT03567382|470601593|FG002|Overall Study|Withdrawal by Subject|1|||
130377365|NCT00555321|469348350|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
130377366|NCT00555321|469348351|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
130377367|NCT00555321|469348347|FG000|Long-term Extension Phase|Death|2|||
130377368|NCT00555321|469348348|FG001|Long-term Extension Phase|Death|0|||
130377369|NCT00555321|469348349|FG002|Long-term Extension Phase|Death|0|||
130377370|NCT00555321|469348350|FG003|Long-term Extension Phase|Death|3|||
130377371|NCT00555321|469348351|FG004|Long-term Extension Phase|Death|0|||
130377372|NCT00555321|469348347|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
130377373|NCT00555321|469348348|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
130377374|NCT00555321|469348349|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
130377375|NCT00555321|469348350|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
130377376|NCT00555321|469348351|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
130377377|NCT00555321|469348347|FG000|Long-term Extension Phase|Other Reason|1|||
130377378|NCT00555321|469348348|FG001|Long-term Extension Phase|Other Reason|0|||
130377379|NCT00555321|469348349|FG002|Long-term Extension Phase|Other Reason|2|||
130377380|NCT00555321|469348350|FG003|Long-term Extension Phase|Other Reason|0|||
130377381|NCT00555321|469348351|FG004|Long-term Extension Phase|Other Reason|0|||
130377382|NCT00582166|469348354|FG000|Overall Study|Death|1|||
130377383|NCT00582166|469348354|FG000|Overall Study|Ineligible pathology|1|||
130377384|NCT02532972|469348355|FG000|Overall Study|Withdrawal by Subject|1|||
130377385|NCT01606436|469348356|FG000|Overall Study|Withdrawal by Subject|0|||
130377386|NCT01606436|469348357|FG001|Overall Study|Withdrawal by Subject|0|||
130377387|NCT01606436|469348358|FG002|Overall Study|Withdrawal by Subject|1|||
130377388|NCT01606436|469348359|FG003|Overall Study|Withdrawal by Subject|1|||
130377389|NCT01606436|469348360|FG004|Overall Study|Withdrawal by Subject|1|||
130377390|NCT01606436|469348361|FG005|Overall Study|Withdrawal by Subject|0|||
130377391|NCT01606436|469348356|FG000|Overall Study|Adverse Event|0|||
130377392|NCT01606436|469348357|FG001|Overall Study|Adverse Event|0|||
130377393|NCT01606436|469348358|FG002|Overall Study|Adverse Event|1|||
130466896|NCT00421889|469676447|FG004|Overall Study|Withdrawal by Subject|2|||
130466897|NCT00421889|469676448|FG005|Overall Study|Withdrawal by Subject|0|||
130466898|NCT00421889|469676449|FG006|Overall Study|Withdrawal by Subject|0|||
130721010|NCT03567382|470601594|FG003|Overall Study|Withdrawal by Subject|12|||
130721011|NCT00620659|470601595|FG000|Treatment Period 1|Adverse Event|1|||
130377394|NCT01606436|469348359|FG003|Overall Study|Adverse Event|0|||
130466899|NCT00421889|469676450|FG007|Overall Study|Withdrawal by Subject|0|||
130466900|NCT00421889|469676451|FG008|Overall Study|Withdrawal by Subject|0|||
130466901|NCT00421889|469676443|FG000|Overall Study|Death|0|||
130466902|NCT00421889|469676444|FG001|Overall Study|Death|0|||
130466903|NCT00421889|469676445|FG002|Overall Study|Death|0|||
130466904|NCT00421889|469676446|FG003|Overall Study|Death|0|||
130466905|NCT00421889|469676447|FG004|Overall Study|Death|1|||
130466906|NCT00421889|469676448|FG005|Overall Study|Death|1|||
130466907|NCT00421889|469676449|FG006|Overall Study|Death|0|||
130466908|NCT00421889|469676450|FG007|Overall Study|Death|0|||
130466909|NCT00421889|469676451|FG008|Overall Study|Death|0|||
130466910|NCT00421889|469676443|FG000|Overall Study|Progressive disease|3|||
130466911|NCT00421889|469676444|FG001|Overall Study|Progressive disease|2|||
130466912|NCT00421889|469676445|FG002|Overall Study|Progressive disease|2|||
130466913|NCT00421889|469676446|FG003|Overall Study|Progressive disease|3|||
130466914|NCT00421889|469676447|FG004|Overall Study|Progressive disease|2|||
130466915|NCT00421889|469676448|FG005|Overall Study|Progressive disease|21|||
130466916|NCT00421889|469676449|FG006|Overall Study|Progressive disease|3|||
130466917|NCT00421889|469676450|FG007|Overall Study|Progressive disease|1|||
130466918|NCT00421889|469676451|FG008|Overall Study|Progressive disease|5|||
130466919|NCT00421889|469676443|FG000|Overall Study|Patient/Investigator request|0|||
130466920|NCT00421889|469676444|FG001|Overall Study|Patient/Investigator request|0|||
130466921|NCT00421889|469676445|FG002|Overall Study|Patient/Investigator request|0|||
130466922|NCT00421889|469676446|FG003|Overall Study|Patient/Investigator request|0|||
130466923|NCT00421889|469676447|FG004|Overall Study|Patient/Investigator request|0|||
130466924|NCT00421889|469676448|FG005|Overall Study|Patient/Investigator request|9|||
130466925|NCT00421889|469676449|FG006|Overall Study|Patient/Investigator request|0|||
130466926|NCT00421889|469676450|FG007|Overall Study|Patient/Investigator request|1|||
130466927|NCT00421889|469676451|FG008|Overall Study|Patient/Investigator request|3|||
130466928|NCT00421889|469676443|FG000|Overall Study|Lost to Follow-up|0|||
130721012|NCT00620659|470601596|FG001|Treatment Period 1|Adverse Event|0|||
130377395|NCT01606436|469348360|FG004|Overall Study|Adverse Event|0|||
130721013|NCT00620659|470601597|FG002|Treatment Period 1|Adverse Event|0|||
130377396|NCT01606436|469348361|FG005|Overall Study|Adverse Event|0|||
130466929|NCT00421889|469676444|FG001|Overall Study|Lost to Follow-up|0|||
130466930|NCT00421889|469676445|FG002|Overall Study|Lost to Follow-up|0|||
130466931|NCT00421889|469676446|FG003|Overall Study|Lost to Follow-up|0|||
130466932|NCT00421889|469676447|FG004|Overall Study|Lost to Follow-up|0|||
130466933|NCT00421889|469676448|FG005|Overall Study|Lost to Follow-up|0|||
130466934|NCT00421889|469676449|FG006|Overall Study|Lost to Follow-up|0|||
130466935|NCT00421889|469676450|FG007|Overall Study|Lost to Follow-up|0|||
130721014|NCT00620659|470601598|FG003|Treatment Period 1|Adverse Event|3|||
130316836|NCT01962441|469125466|FG002|Retreatment Substudy|Lost to Follow-up|0|||
130316837|NCT04678115|469125469|FG000|Overall Study|Lost to Follow-up|1|||
130316838|NCT04678115|469125470|FG001|Overall Study|Lost to Follow-up|0|||
130316839|NCT04908397|469125471|FG000|Overall Study|Withdrawal by Subject|2|||
130316840|NCT03100149|469125476|FG000|Overall Study|Adverse Event|0|||
130316841|NCT03100149|469125477|FG001|Overall Study|Adverse Event|1|||
130316842|NCT03100149|469125478|FG002|Overall Study|Adverse Event|0|||
130316843|NCT03100149|469125476|FG000|Overall Study|Participant Moved out of Country|0|||
130316844|NCT03100149|469125477|FG001|Overall Study|Participant Moved out of Country|0|||
130316845|NCT03100149|469125478|FG002|Overall Study|Participant Moved out of Country|1|||
130316846|NCT03100149|469125476|FG000|Overall Study|Withdrawal by Subject|0|||
130316847|NCT03100149|469125477|FG001|Overall Study|Withdrawal by Subject|3|||
130316848|NCT03100149|469125478|FG002|Overall Study|Withdrawal by Subject|1|||
130316849|NCT04972162|469125479|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
130316850|NCT04972162|469125480|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
130316851|NCT01928927|469125481|FG000|Overall Study|Lost to Follow-up|1|||
130316852|NCT01928927|469125482|FG001|Overall Study|Lost to Follow-up|0|||
130316853|NCT01928927|469125481|FG000|Overall Study|Withdrawal by Subject|1|||
130316854|NCT01928927|469125482|FG001|Overall Study|Withdrawal by Subject|1|||
130316855|NCT00383552|469126386|FG000|Overall Study|Adverse Event|7|||
130316856|NCT00383552|469126387|FG001|Overall Study|Adverse Event|6|||
130316857|NCT00383552|469126388|FG002|Overall Study|Adverse Event|9|||
130316858|NCT00383552|469126389|FG003|Overall Study|Adverse Event|6|||
130316859|NCT00383552|469126386|FG000|Overall Study|Lack of Efficacy|4|||
130316860|NCT00383552|469126387|FG001|Overall Study|Lack of Efficacy|13|||
130316861|NCT00383552|469126388|FG002|Overall Study|Lack of Efficacy|29|||
130316862|NCT00383552|469126389|FG003|Overall Study|Lack of Efficacy|42|||
130316863|NCT00383552|469126386|FG000|Overall Study|Lost to Follow-up|0|||
130316864|NCT00383552|469126387|FG001|Overall Study|Lost to Follow-up|1|||
130316865|NCT00383552|469126388|FG002|Overall Study|Lost to Follow-up|5|||
130316866|NCT00383552|469126389|FG003|Overall Study|Lost to Follow-up|1|||
130316867|NCT00383552|469126386|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
130316868|NCT00383552|469126387|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
130316869|NCT00383552|469126388|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
130316870|NCT00383552|469126389|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
130316871|NCT00383552|469126386|FG000|Overall Study|Did not wish to continue (related)|1|||
130316872|NCT00383552|469126387|FG001|Overall Study|Did not wish to continue (related)|0|||
130316873|NCT00383552|469126388|FG002|Overall Study|Did not wish to continue (related)|2|||
130316874|NCT00383552|469126389|FG003|Overall Study|Did not wish to continue (related)|3|||
130316875|NCT00383552|469126386|FG000|Overall Study|Noncompliance with the protocol|11|||
130316876|NCT00383552|469126387|FG001|Overall Study|Noncompliance with the protocol|6|||
130316877|NCT00383552|469126388|FG002|Overall Study|Noncompliance with the protocol|8|||
130316878|NCT00383552|469126389|FG003|Overall Study|Noncompliance with the protocol|10|||
130316879|NCT00383552|469126386|FG000|Overall Study|Did not meet protocol eligibility|8|||
130316880|NCT00383552|469126387|FG001|Overall Study|Did not meet protocol eligibility|6|||
130316881|NCT00383552|469126388|FG002|Overall Study|Did not meet protocol eligibility|2|||
130316882|NCT00383552|469126389|FG003|Overall Study|Did not meet protocol eligibility|3|||
130316883|NCT00383552|469126386|FG000|Overall Study|Administrative|1|||
130316884|NCT00383552|469126387|FG001|Overall Study|Administrative|0|||
130316885|NCT00383552|469126388|FG002|Overall Study|Administrative|1|||
130316886|NCT00383552|469126389|FG003|Overall Study|Administrative|1|||
130316887|NCT01393158|469126392|FG000|Overall Study|Adverse Event|1|||
130316888|NCT01393158|469126393|FG001|Overall Study|Adverse Event|0|||
130316889|NCT02055898|469126394|FG000|First Intervention (5 Days)|Physician Decision|2|||
130316890|NCT02055898|469126395|FG001|First Intervention (5 Days)|Physician Decision|0|||
130316891|NCT02055898|469126394|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
130316892|NCT02055898|469126395|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
130316893|NCT01620060|469126396|FG000|Overall Study|Adverse Event|9|||
130316894|NCT01620060|469126396|FG000|Overall Study|Protocol Violation|1|||
130377397|NCT01606436|469348356|FG000|Overall Study|Sponsor Decision|0|||
130377398|NCT01606436|469348357|FG001|Overall Study|Sponsor Decision|0|||
130377399|NCT01606436|469348358|FG002|Overall Study|Sponsor Decision|0|||
130377400|NCT01606436|469348359|FG003|Overall Study|Sponsor Decision|1|||
130377401|NCT01606436|469348360|FG004|Overall Study|Sponsor Decision|0|||
130377402|NCT01606436|469348361|FG005|Overall Study|Sponsor Decision|0|||
130466936|NCT00421889|469676451|FG008|Overall Study|Lost to Follow-up|1|||
130316895|NCT01620060|469126396|FG000|Overall Study|Withdrawal by Subject|1|||
130316896|NCT01620060|469126396|FG000|Overall Study|Did not comply with Study Produre|1|||
130316897|NCT01620060|469126396|FG000|Overall Study|Family emergency|1|||
130316898|NCT01620060|469126396|FG000|Overall Study|Per Sponsor Decision|2|||
130316899|NCT00231777|469126397|FG000|Overall Study|Lost to Follow-up|3|||
130316900|NCT00231777|469126398|FG001|Overall Study|Lost to Follow-up|0|||
130377403|NCT02859454|469348362|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
130377404|NCT03944954|469348363|FG000|Overall Study|Withdrawal by Subject|22|||
130316901|NCT00231777|469126397|FG000|Overall Study|Other|3|||
130377405|NCT03944954|469348364|FG001|Overall Study|Withdrawal by Subject|4|||
130316902|NCT00231777|469126398|FG001|Overall Study|Other|2|||
130316903|NCT04551989|469126401|FG000|Overall Study|Adverse Event|4|||
130316904|NCT04551989|469126401|FG000|Overall Study|Protocol Violation|3|||
130316905|NCT04551989|469126401|FG000|Overall Study|Lost to Follow-up|1|||
130316906|NCT04551989|469126401|FG000|Overall Study|Physician Decision|3|||
130316907|NCT04698343|469126402|FG000|Overall Study|Withdrawal by Subject|6|||
130316908|NCT04698343|469126402|FG000|Overall Study|Physician Decision|2|||
130316909|NCT04698343|469126402|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
130316910|NCT04698343|469126402|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
130316911|NCT04698343|469126402|FG000|Overall Study|Personal reasons|3|||
130316912|NCT04698343|469126402|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
130316913|NCT00088530|469126403|FG000|Overall Study|Progressive/Relapsed Disease|28|||
130316914|NCT00088530|469126404|FG001|Overall Study|Progressive/Relapsed Disease|39|||
130316915|NCT00088530|469126403|FG000|Overall Study|Adverse Event|15|||
130316916|NCT00088530|469126404|FG001|Overall Study|Adverse Event|9|||
130316917|NCT00088530|469126403|FG000|Overall Study|Withdrawal by Subject|2|||
130316918|NCT00088530|469126404|FG001|Overall Study|Withdrawal by Subject|5|||
130316919|NCT00088530|469126403|FG000|Overall Study|Lost to Follow-up|2|||
130316920|NCT00088530|469126404|FG001|Overall Study|Lost to Follow-up|0|||
130316921|NCT00088530|469126403|FG000|Overall Study|Physician Decision|2|||
130316922|NCT00088530|469126404|FG001|Overall Study|Physician Decision|0|||
130316923|NCT00088530|469126403|FG000|Overall Study|Sponsor decision|0|||
130316924|NCT00088530|469126404|FG001|Overall Study|Sponsor decision|1|||
130316925|NCT00088530|469126403|FG000|Overall Study|Patient never treated|1|||
130316926|NCT00088530|469126404|FG001|Overall Study|Patient never treated|0|||
130316927|NCT00739401|469126405|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
130316928|NCT00739401|469126405|FG000|Overall Study|Death|3|||
130316929|NCT00739401|469126405|FG000|Overall Study|Withdrawal by Subject|4|||
130316930|NCT04575155|469126406|FG000|2 Month|Withdrawal by Subject|1|||
130316931|NCT04575155|469126407|FG001|2 Month|Withdrawal by Subject|1|||
130316932|NCT04575155|469126406|FG000|2 Month|Lost to Follow-up|5|||
130316933|NCT04575155|469126407|FG001|2 Month|Lost to Follow-up|3|||
130316934|NCT04575155|469126406|FG000|2 Month|Ineligible|1|||
130316935|NCT04575155|469126407|FG001|2 Month|Ineligible|0|||
130316936|NCT00467740|469126408|FG000|Overall Study|Adverse Event|0|||
130316937|NCT00467740|469126409|FG001|Overall Study|Adverse Event|0|||
130316938|NCT00467740|469126410|FG002|Overall Study|Adverse Event|1|||
130316939|NCT00467740|469126411|FG003|Overall Study|Adverse Event|0|||
130316940|NCT00467740|469126412|FG004|Overall Study|Adverse Event|0|||
130316941|NCT00467740|469126408|FG000|Overall Study|Protocol Violation|0|||
130316942|NCT00467740|469126409|FG001|Overall Study|Protocol Violation|0|||
130316943|NCT00467740|469126410|FG002|Overall Study|Protocol Violation|1|||
130316944|NCT00467740|469126411|FG003|Overall Study|Protocol Violation|0|||
130316945|NCT00467740|469126412|FG004|Overall Study|Protocol Violation|0|||
130316946|NCT00467740|469126408|FG000|Overall Study|Lost to Follow-up|0|||
130316947|NCT00467740|469126409|FG001|Overall Study|Lost to Follow-up|1|||
130316948|NCT00467740|469126410|FG002|Overall Study|Lost to Follow-up|0|||
130316949|NCT00467740|469126411|FG003|Overall Study|Lost to Follow-up|0|||
130316950|NCT00467740|469126412|FG004|Overall Study|Lost to Follow-up|0|||
130316951|NCT00467740|469126408|FG000|Overall Study|Withdrawal by Subject|1|||
130316952|NCT00467740|469126409|FG001|Overall Study|Withdrawal by Subject|1|||
130316953|NCT00467740|469126410|FG002|Overall Study|Withdrawal by Subject|0|||
130316954|NCT00467740|469126411|FG003|Overall Study|Withdrawal by Subject|1|||
130316955|NCT00467740|469126412|FG004|Overall Study|Withdrawal by Subject|0|||
130316956|NCT00467740|469126408|FG000|Overall Study|Lack of Efficacy|0|||
130316957|NCT00467740|469126409|FG001|Overall Study|Lack of Efficacy|1|||
130316958|NCT00467740|469126410|FG002|Overall Study|Lack of Efficacy|0|||
130316959|NCT00467740|469126411|FG003|Overall Study|Lack of Efficacy|0|||
130316960|NCT00467740|469126412|FG004|Overall Study|Lack of Efficacy|0|||
130316961|NCT02903160|469126413|FG000|Overall Study|Adverse Event|2|||
130316962|NCT02903160|469126413|FG000|Overall Study|Death|1|||
130316963|NCT02903160|469126413|FG000|Overall Study|Lost to Follow-up|2|||
130316964|NCT02903160|469126413|FG000|Overall Study|Withdrawal by Subject|1|||
130316965|NCT02903160|469126413|FG000|Overall Study|Medical Insurance Barriers|1|||
130316966|NCT00730158|469126417|FG000|Overall Study|Withdrawal by Subject|1|||
130316967|NCT00730158|469126418|FG001|Overall Study|Withdrawal by Subject|1|||
130316968|NCT00844376|469126419|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
130316969|NCT00844376|469126420|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
130316970|NCT00660192|469126421|FG000|Overall Study|Lost to Follow-up|2|||
130316971|NCT00660192|469126422|FG001|Overall Study|Lost to Follow-up|3|||
130316972|NCT00982735|469126423|FG000|Overall Study|Lost to Follow-up|6|||
130316973|NCT00982735|469126423|FG000|Overall Study|Patient ineligible for trial|224|||
130316974|NCT01601535|469126426|FG000|Phase 1|Adverse Event|1|||
130316975|NCT01601535|469126427|FG001|Phase 1|Adverse Event|0|||
130316976|NCT01601535|469126428|FG002|Phase 1|Adverse Event|2|||
130316977|NCT01601535|469126429|FG003|Phase 1|Adverse Event|1|||
130316978|NCT01601535|469126430|FG004|Phase 1|Adverse Event|0|||
130559497|NCT00705432|470016516|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
130377406|NCT03944954|469348363|FG000|Overall Study|Lost to Follow-up|18|||
130377407|NCT03944954|469348364|FG001|Overall Study|Lost to Follow-up|0|||
130377408|NCT03944954|469348363|FG000|Overall Study|Failed Medical Screening|7|||
130377409|NCT03944954|469348364|FG001|Overall Study|Failed Medical Screening|0|||
130377410|NCT02268084|469348367|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
130377411|NCT02268084|469348368|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
130377412|NCT02268084|469348367|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
130377413|NCT02268084|469348368|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
130377414|NCT05227027|469348369|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
130377415|NCT05227027|469348370|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
130377416|NCT03334448|469348374|FG000|Washout|Personal Reason|0|||
130377417|NCT03334448|469348375|FG001|Washout|Personal Reason|1|||
130377418|NCT03334448|469348376|FG002|Washout|Personal Reason|0|||
130377419|NCT03334448|469348377|FG003|Washout|Personal Reason|0|||
130377420|NCT03334448|469348374|FG000|Washout|Protocol Violation|0|||
130377421|NCT03334448|469348375|FG001|Washout|Protocol Violation|0|||
130377422|NCT03334448|469348376|FG002|Washout|Protocol Violation|0|||
130377423|NCT03334448|469348377|FG003|Washout|Protocol Violation|1|||
130377424|NCT01683383|469348379|FG000|Overall Study|Infant was not transported|1|||
130377425|NCT01683383|469348380|FG001|Overall Study|Infant was not transported|0|||
130377426|NCT00855920|469348381|FG000|Overall Study|Protocol Violation|0|||
130377427|NCT00855920|469348382|FG001|Overall Study|Protocol Violation|0|||
130377428|NCT00855920|469348383|FG002|Overall Study|Protocol Violation|2|||
130377429|NCT00855920|469348381|FG000|Overall Study|Adverse Event|2|||
130377430|NCT00855920|469348382|FG001|Overall Study|Adverse Event|1|||
130377431|NCT00855920|469348383|FG002|Overall Study|Adverse Event|1|||
130377432|NCT00855920|469348381|FG000|Overall Study|Lack of Efficacy|2|||
130377433|NCT00855920|469348382|FG001|Overall Study|Lack of Efficacy|2|||
130377434|NCT00855920|469348383|FG002|Overall Study|Lack of Efficacy|2|||
130377435|NCT00855920|469348381|FG000|Overall Study|Withdrawal by Subject|2|||
130377436|NCT00855920|469348382|FG001|Overall Study|Withdrawal by Subject|3|||
130377437|NCT00855920|469348383|FG002|Overall Study|Withdrawal by Subject|2|||
130377438|NCT00855920|469348381|FG000|Overall Study|Lost to Follow-up|1|||
130377439|NCT00855920|469348382|FG001|Overall Study|Lost to Follow-up|0|||
130377440|NCT00855920|469348383|FG002|Overall Study|Lost to Follow-up|2|||
130377441|NCT00855920|469348381|FG000|Overall Study|Death|0|||
130377442|NCT00855920|469348382|FG001|Overall Study|Death|1|||
130377443|NCT00855920|469348383|FG002|Overall Study|Death|0|||
130377444|NCT00855920|469348381|FG000|Overall Study|Decision by the sponsor|0|||
130377445|NCT00855920|469348382|FG001|Overall Study|Decision by the sponsor|1|||
130377446|NCT00855920|469348383|FG002|Overall Study|Decision by the sponsor|1|||
130377447|NCT00855920|469348381|FG000|Overall Study|Other than specified above|1|||
130377448|NCT00855920|469348382|FG001|Overall Study|Other than specified above|1|||
130377449|NCT00855920|469348383|FG002|Overall Study|Other than specified above|1|||
130377450|NCT00996307|469348384|FG000|Overall Study|Adverse Event|0|||
130377451|NCT00996307|469348385|FG001|Overall Study|Adverse Event|1|||
130377452|NCT00996307|469348386|FG002|Overall Study|Adverse Event|0|||
130377453|NCT00996307|469348387|FG003|Overall Study|Adverse Event|0|||
130377454|NCT00996307|469348384|FG000|Overall Study|Withdrawal by Subject|3|||
130377455|NCT00996307|469348385|FG001|Overall Study|Withdrawal by Subject|2|||
130377456|NCT00996307|469348386|FG002|Overall Study|Withdrawal by Subject|5|||
130377457|NCT00996307|469348387|FG003|Overall Study|Withdrawal by Subject|5|||
130377458|NCT00996307|469348384|FG000|Overall Study|Lost to Follow-up|13|||
130721015|NCT00620659|470601599|FG004|Treatment Period 1|Adverse Event|0|||
130721016|NCT00620659|470601600|FG005|Treatment Period 1|Adverse Event|0|||
130721017|NCT00620659|470601595|FG000|Treatment Period 1|Protocol Violation|1|||
130721018|NCT00620659|470601596|FG001|Treatment Period 1|Protocol Violation|0|||
130721019|NCT00620659|470601597|FG002|Treatment Period 1|Protocol Violation|0|||
130721020|NCT00620659|470601598|FG003|Treatment Period 1|Protocol Violation|0|||
130721021|NCT00620659|470601599|FG004|Treatment Period 1|Protocol Violation|0|||
130721022|NCT00620659|470601600|FG005|Treatment Period 1|Protocol Violation|0|||
130721023|NCT00620659|470601595|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130721024|NCT00620659|470601596|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130721025|NCT00620659|470601597|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130377459|NCT00996307|469348385|FG001|Overall Study|Lost to Follow-up|13|||
130377460|NCT00996307|469348386|FG002|Overall Study|Lost to Follow-up|7|||
130377461|NCT00996307|469348387|FG003|Overall Study|Lost to Follow-up|15|||
130377462|NCT00996307|469348384|FG000|Overall Study|Administrative reason|0|||
130377463|NCT00996307|469348385|FG001|Overall Study|Administrative reason|1|||
130377464|NCT00996307|469348386|FG002|Overall Study|Administrative reason|0|||
130377465|NCT00996307|469348387|FG003|Overall Study|Administrative reason|0|||
130377466|NCT00996307|469348384|FG000|Overall Study|Unable to classify|4|||
130721026|NCT00620659|470601598|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130721027|NCT00620659|470601599|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130466937|NCT00978042|469676452|FG000|Initial Treatment Period|Treated in Error|0|||
130466938|NCT00978042|469676453|FG001|Initial Treatment Period|Treated in Error|3|||
130466939|NCT00978042|469676452|FG000|Initial Treatment Period|Ineligibility|1|||
130466940|NCT00978042|469676453|FG001|Initial Treatment Period|Ineligibility|0|||
130466941|NCT00978042|469676452|FG000|Initial Treatment Period|Lost to Follow-up|21|||
130466942|NCT00978042|469676453|FG001|Initial Treatment Period|Lost to Follow-up|3|||
130466943|NCT00978042|469676452|FG000|Initial Treatment Period|Adverse Event|2|||
130466944|NCT00978042|469676453|FG001|Initial Treatment Period|Adverse Event|0|||
130466945|NCT00978042|469676452|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
130466946|NCT00978042|469676453|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
130466947|NCT00978042|469676452|FG000|Initial Treatment Period|Consent withdrawn|22|||
130466948|NCT00978042|469676453|FG001|Initial Treatment Period|Consent withdrawn|9|||
130466949|NCT00978042|469676452|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
130466950|NCT00978042|469676453|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
130466951|NCT00520546|469676454|FG000|Overall Study|Withdrawal by Subject|1|||
130466952|NCT00520546|469676454|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
130466953|NCT02101281|469676458|FG000|Overall Study|Adverse Event|0|||
130466954|NCT02101281|469676459|FG001|Overall Study|Adverse Event|1|||
130466955|NCT00296036|469676460|FG000|Overall Study|Withdrawal by Subject|1|||
130466956|NCT00296036|469676461|FG001|Overall Study|Withdrawal by Subject|0|||
130466957|NCT00296036|469676462|FG002|Overall Study|Withdrawal by Subject|2|||
130466958|NCT00296036|469676463|FG003|Overall Study|Withdrawal by Subject|1|||
130466959|NCT00296036|469676464|FG004|Overall Study|Withdrawal by Subject|2|||
130466960|NCT00296036|469676465|FG005|Overall Study|Withdrawal by Subject|1|||
130466961|NCT00296036|469676460|FG000|Overall Study|Protocol Violation|0|||
130466962|NCT00296036|469676461|FG001|Overall Study|Protocol Violation|0|||
130466963|NCT00296036|469676462|FG002|Overall Study|Protocol Violation|0|||
130466964|NCT00296036|469676463|FG003|Overall Study|Protocol Violation|0|||
130466965|NCT00296036|469676464|FG004|Overall Study|Protocol Violation|0|||
130466966|NCT00296036|469676465|FG005|Overall Study|Protocol Violation|3|||
130466967|NCT03403413|469676468|FG000|Overall Study|Lack of Efficacy|2|||
130466968|NCT04452318|469676469|FG000|Overall Study|Physician Decision|1|||
130466969|NCT04452318|469676470|FG001|Overall Study|Physician Decision|2|||
130466970|NCT04452318|469676471|FG002|Overall Study|Physician Decision|0|||
130466971|NCT04452318|469676472|FG003|Overall Study|Physician Decision|2|||
130466972|NCT04452318|469676473|FG004|Overall Study|Physician Decision|0|||
130466973|NCT04452318|469676474|FG005|Overall Study|Physician Decision|2|||
130466974|NCT04452318|469676475|FG006|Overall Study|Physician Decision|5|||
130466975|NCT04452318|469676469|FG000|Overall Study|Death|2|||
130377467|NCT00996307|469348385|FG001|Overall Study|Unable to classify|0|||
130377468|NCT00996307|469348386|FG002|Overall Study|Unable to classify|2|||
130377469|NCT00996307|469348387|FG003|Overall Study|Unable to classify|1|||
130377470|NCT02496611|469348390|FG000|Overall Study|Lost to Follow-up|2|||
130377471|NCT02496611|469348391|FG001|Overall Study|Lost to Follow-up|1|||
130377472|NCT02496611|469348390|FG000|Overall Study|Withdrawal by Subject|5|||
130377473|NCT02496611|469348391|FG001|Overall Study|Withdrawal by Subject|2|||
130377474|NCT01365910|469348395|FG000|Overall Study|Withdrawal by Subject|7|||
130377475|NCT01365910|469348395|FG000|Overall Study|disease progression|18|||
130377476|NCT01365910|469348395|FG000|Overall Study|Adverse Event|3|||
130377477|NCT01365910|469348395|FG000|Overall Study|other complicating disease|1|||
130377478|NCT01365910|469348395|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
130377479|NCT00371137|469348396|FG000|Overall Study|Adverse Event|20|||
130377480|NCT00371137|469348397|FG001|Overall Study|Adverse Event|35|||
130721028|NCT00620659|470601600|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130721029|NCT00620659|470601595|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721030|NCT00620659|470601596|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721031|NCT00620659|470601597|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721032|NCT00620659|470601598|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
130721033|NCT00620659|470601599|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721034|NCT00620659|470601600|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721035|NCT00620659|470601595|FG000|Treatment Period 2|Adverse Event|0|||
130721036|NCT00620659|470601596|FG001|Treatment Period 2|Adverse Event|3|||
130721037|NCT00620659|470601597|FG002|Treatment Period 2|Adverse Event|0|||
130721038|NCT00620659|470601598|FG003|Treatment Period 2|Adverse Event|0|||
130721039|NCT00620659|470601599|FG004|Treatment Period 2|Adverse Event|2|||
130466976|NCT04452318|469676470|FG001|Overall Study|Death|3|||
130466977|NCT04452318|469676471|FG002|Overall Study|Death|0|||
130466978|NCT04452318|469676472|FG003|Overall Study|Death|0|||
130466979|NCT04452318|469676473|FG004|Overall Study|Death|0|||
130466980|NCT04452318|469676474|FG005|Overall Study|Death|0|||
130377481|NCT00371137|469348398|FG002|Overall Study|Adverse Event|42|||
130377482|NCT00371137|469348396|FG000|Overall Study|Withdrawal by Subject|11|||
130377483|NCT00371137|469348397|FG001|Overall Study|Withdrawal by Subject|10|||
130377484|NCT00371137|469348398|FG002|Overall Study|Withdrawal by Subject|15|||
130377485|NCT00371137|469348396|FG000|Overall Study|Lost to Follow-up|6|||
130377486|NCT00371137|469348397|FG001|Overall Study|Lost to Follow-up|3|||
130377487|NCT00371137|469348398|FG002|Overall Study|Lost to Follow-up|5|||
130377488|NCT00371137|469348396|FG000|Overall Study|Lack of Efficacy|30|||
130377489|NCT00371137|469348397|FG001|Overall Study|Lack of Efficacy|12|||
130377490|NCT00371137|469348398|FG002|Overall Study|Lack of Efficacy|13|||
130377491|NCT00371137|469348396|FG000|Overall Study|Sponsor Decision|2|||
130377492|NCT00371137|469348397|FG001|Overall Study|Sponsor Decision|1|||
130377493|NCT00371137|469348398|FG002|Overall Study|Sponsor Decision|2|||
130377494|NCT00371137|469348396|FG000|Overall Study|Physician Decision|1|||
130377495|NCT00371137|469348397|FG001|Overall Study|Physician Decision|1|||
130377496|NCT00371137|469348398|FG002|Overall Study|Physician Decision|1|||
130377497|NCT00371137|469348396|FG000|Overall Study|Protocol Violation|2|||
130377498|NCT00371137|469348397|FG001|Overall Study|Protocol Violation|1|||
130377499|NCT00371137|469348398|FG002|Overall Study|Protocol Violation|1|||
130377500|NCT00536198|469348399|FG000|Overall Study|Lost to Follow-up|15|||
130377501|NCT00536198|469348400|FG001|Overall Study|Lost to Follow-up|14|||
130377502|NCT00536198|469348399|FG000|Overall Study|Withdrawal by Subject|16|||
130377503|NCT00536198|469348400|FG001|Overall Study|Withdrawal by Subject|12|||
130377504|NCT00536198|469348399|FG000|Overall Study|Adverse Event|2|||
130377505|NCT00536198|469348400|FG001|Overall Study|Adverse Event|2|||
130377506|NCT00536198|469348399|FG000|Overall Study|Rescue|3|||
130377507|NCT00536198|469348400|FG001|Overall Study|Rescue|9|||
130377508|NCT00536198|469348399|FG000|Overall Study|Pregnancy|1|||
130377509|NCT00536198|469348400|FG001|Overall Study|Pregnancy|1|||
130377510|NCT00536198|469348399|FG000|Overall Study|Protocol Violation|0|||
130377511|NCT00536198|469348400|FG001|Overall Study|Protocol Violation|1|||
130377512|NCT02013791|469348401|FG000|Period 1|Lost to Follow-up|0|||
130377513|NCT02013791|469348402|FG001|Period 1|Lost to Follow-up|0|||
130377514|NCT02013791|469348403|FG002|Period 1|Lost to Follow-up|0|||
130377515|NCT02013791|469348404|FG003|Period 1|Lost to Follow-up|1|||
130377516|NCT02013791|469348405|FG004|Period 1|Lost to Follow-up|0|||
130377517|NCT02013791|469348406|FG005|Period 1|Lost to Follow-up|0|||
130377518|NCT02013791|469348407|FG006|Period 1|Lost to Follow-up|1|||
130377519|NCT02013791|469348408|FG007|Period 1|Lost to Follow-up|1|||
130377520|NCT02013791|469348409|FG008|Period 1|Lost to Follow-up|0|||
130377521|NCT02013791|469348401|FG000|Period 1|Other Miscellaneous Reasons|0|||
130377522|NCT02013791|469348402|FG001|Period 1|Other Miscellaneous Reasons|2|||
130377523|NCT02013791|469348403|FG002|Period 1|Other Miscellaneous Reasons|0|||
130377524|NCT02013791|469348404|FG003|Period 1|Other Miscellaneous Reasons|0|||
130377525|NCT02013791|469348405|FG004|Period 1|Other Miscellaneous Reasons|0|||
130377526|NCT02013791|469348406|FG005|Period 1|Other Miscellaneous Reasons|0|||
130377527|NCT02013791|469348407|FG006|Period 1|Other Miscellaneous Reasons|0|||
130377528|NCT02013791|469348408|FG007|Period 1|Other Miscellaneous Reasons|0|||
130377529|NCT02013791|469348409|FG008|Period 1|Other Miscellaneous Reasons|0|||
130377530|NCT03798483|469348410|FG000|Overall Study|Lost to Follow-up|2|||
130377531|NCT01666782|469348411|FG000|Overall Study|Received 2 doses of vaccine|0|||
130377532|NCT01666782|469348412|FG001|Overall Study|Received 2 doses of vaccine|1|||
130377533|NCT01666782|469348411|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
130377534|NCT01666782|469348412|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
130377535|NCT01691781|469348424|FG000|Overall Study|Withdrawal by Subject|4|||
130377536|NCT01691781|469348425|FG001|Overall Study|Withdrawal by Subject|3|||
130721040|NCT00620659|470601600|FG005|Treatment Period 2|Adverse Event|0|||
130721041|NCT00620659|470601595|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130721042|NCT00620659|470601596|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130377537|NCT01691781|469348424|FG000|Overall Study|Physician Decision|1|||
130377538|NCT01691781|469348425|FG001|Overall Study|Physician Decision|1|||
130377539|NCT01691781|469348424|FG000|Overall Study|Protocol Violation|2|||
130377540|NCT01691781|469348425|FG001|Overall Study|Protocol Violation|2|||
130377541|NCT01691781|469348424|FG000|Overall Study|Adverse Event|0|||
130377542|NCT01691781|469348425|FG001|Overall Study|Adverse Event|1|||
130377543|NCT01605877|469348426|FG000|Overall Study|Withdrawal by Subject|1|||
130377544|NCT01918085|469348429|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
130377545|NCT01918085|469348430|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
130377546|NCT00687323|469348435|FG000|Overall Study|Death|25|||
130377547|NCT00687323|469348435|FG000|Overall Study|Withdrawal by Subject|1|||
130377548|NCT00687323|469348435|FG000|Overall Study|Excluded from efficacy evaluations|6|||
130721043|NCT00620659|470601597|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130377549|NCT00687323|469348435|FG000|Overall Study|Screen failure|148|||
130377550|NCT00679302|469348438|FG000|Overall Study|Lost to Follow-up|8|||
130377551|NCT00679302|469348439|FG001|Overall Study|Lost to Follow-up|4|||
130377552|NCT05109442|469348442|FG000|Overall Study|Withdrawal by Subject|0|||
130377553|NCT05109442|469348443|FG001|Overall Study|Withdrawal by Subject|0|||
130377554|NCT05109442|469348444|FG002|Overall Study|Withdrawal by Subject|1|||
130377555|NCT05109442|469348445|FG003|Overall Study|Withdrawal by Subject|0|||
130466981|NCT04452318|469676475|FG006|Overall Study|Death|0|||
130466982|NCT04452318|469676469|FG000|Overall Study|Lost to Follow-up|38|||
130377556|NCT05109442|469348446|FG004|Overall Study|Withdrawal by Subject|0|||
130377557|NCT05109442|469348447|FG005|Overall Study|Withdrawal by Subject|0|||
130377558|NCT05109442|469348442|FG000|Overall Study|Adverse Event|0|||
130316979|NCT01601535|469126431|FG005|Phase 1|Adverse Event|0|||
130316980|NCT01601535|469126426|FG000|Phase 1|Withdrawal by Subject|2|||
130316981|NCT01601535|469126427|FG001|Phase 1|Withdrawal by Subject|1|||
130316982|NCT01601535|469126428|FG002|Phase 1|Withdrawal by Subject|1|||
130316983|NCT01601535|469126429|FG003|Phase 1|Withdrawal by Subject|2|||
130316984|NCT01601535|469126430|FG004|Phase 1|Withdrawal by Subject|0|||
130316985|NCT01601535|469126431|FG005|Phase 1|Withdrawal by Subject|0|||
130316986|NCT01601535|469126426|FG000|Phase 1|Progressive Disease|2|||
130316987|NCT01601535|469126427|FG001|Phase 1|Progressive Disease|3|||
130316988|NCT01601535|469126428|FG002|Phase 1|Progressive Disease|2|||
130316989|NCT01601535|469126429|FG003|Phase 1|Progressive Disease|1|||
130316990|NCT01601535|469126430|FG004|Phase 1|Progressive Disease|0|||
130316991|NCT01601535|469126431|FG005|Phase 1|Progressive Disease|0|||
130316992|NCT01601535|469126426|FG000|Phase 1|Started Another Treatment|1|||
130316993|NCT01601535|469126427|FG001|Phase 1|Started Another Treatment|2|||
130316994|NCT01601535|469126428|FG002|Phase 1|Started Another Treatment|0|||
130316995|NCT01601535|469126429|FG003|Phase 1|Started Another Treatment|0|||
130316996|NCT01601535|469126430|FG004|Phase 1|Started Another Treatment|0|||
130316997|NCT01601535|469126431|FG005|Phase 1|Started Another Treatment|0|||
130316998|NCT01601535|469126426|FG000|Phase 2|Adverse Event|0|||
130316999|NCT01601535|469126427|FG001|Phase 2|Adverse Event|0|||
130317000|NCT01601535|469126428|FG002|Phase 2|Adverse Event|0|||
130317001|NCT01601535|469126429|FG003|Phase 2|Adverse Event|0|||
130317002|NCT01601535|469126430|FG004|Phase 2|Adverse Event|5|||
130317003|NCT01601535|469126431|FG005|Phase 2|Adverse Event|1|||
130317004|NCT01601535|469126426|FG000|Phase 2|Withdrawal by Subject|0|||
130317005|NCT01601535|469126427|FG001|Phase 2|Withdrawal by Subject|0|||
130317006|NCT01601535|469126428|FG002|Phase 2|Withdrawal by Subject|0|||
130317007|NCT01601535|469126429|FG003|Phase 2|Withdrawal by Subject|0|||
130317008|NCT01601535|469126430|FG004|Phase 2|Withdrawal by Subject|8|||
130317009|NCT01601535|469126431|FG005|Phase 2|Withdrawal by Subject|2|||
130317010|NCT01601535|469126426|FG000|Phase 2|Progressive Disease|0|||
130317011|NCT01601535|469126427|FG001|Phase 2|Progressive Disease|0|||
130317012|NCT01601535|469126428|FG002|Phase 2|Progressive Disease|0|||
130317013|NCT01601535|469126429|FG003|Phase 2|Progressive Disease|0|||
130317014|NCT01601535|469126430|FG004|Phase 2|Progressive Disease|5|||
130317015|NCT01601535|469126431|FG005|Phase 2|Progressive Disease|7|||
130317016|NCT01601535|469126426|FG000|Phase 2|Started Another Treatment|0|||
130317017|NCT01601535|469126427|FG001|Phase 2|Started Another Treatment|0|||
130317018|NCT01601535|469126428|FG002|Phase 2|Started Another Treatment|0|||
130317019|NCT01601535|469126429|FG003|Phase 2|Started Another Treatment|0|||
130317020|NCT01601535|469126430|FG004|Phase 2|Started Another Treatment|1|||
130317021|NCT01601535|469126431|FG005|Phase 2|Started Another Treatment|2|||
130317022|NCT01787461|469126434|FG000|Overall Study|Adverse Event|4|||
130317023|NCT01787461|469126435|FG001|Overall Study|Adverse Event|3|||
130317024|NCT01787461|469126434|FG000|Overall Study|Lost to Follow-up|3|||
130317025|NCT01787461|469126435|FG001|Overall Study|Lost to Follow-up|2|||
130317026|NCT01787461|469126434|FG000|Overall Study|No longer met eligibility criteria|1|||
130317027|NCT01787461|469126435|FG001|Overall Study|No longer met eligibility criteria|0|||
130317028|NCT01787461|469126434|FG000|Overall Study|Withdrawal by Subject|3|||
130317029|NCT01787461|469126435|FG001|Overall Study|Withdrawal by Subject|4|||
130317030|NCT01787461|469126434|FG000|Overall Study|Protocol Violation|3|||
130317031|NCT01787461|469126435|FG001|Overall Study|Protocol Violation|0|||
130317032|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317033|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317034|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
130317035|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317036|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317037|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317038|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
130317039|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317040|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317041|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317042|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317043|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
130317044|NCT04879628|469126436|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130377559|NCT05109442|469348443|FG001|Overall Study|Adverse Event|1|||
130377560|NCT05109442|469348444|FG002|Overall Study|Adverse Event|5|||
130377561|NCT05109442|469348445|FG003|Overall Study|Adverse Event|0|||
130317045|NCT04879628|469126437|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130317046|NCT04879628|469126438|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
130317047|NCT04879628|469126439|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
130317048|NCT03649074|469126440|FG000|Overall Study|Lost to Follow-up|2|||
130317049|NCT03649074|469126441|FG001|Overall Study|Lost to Follow-up|1|||
130317050|NCT03649074|469126440|FG000|Overall Study|Adverse Event|1|||
130377562|NCT05109442|469348446|FG004|Overall Study|Adverse Event|0|||
130377563|NCT05109442|469348447|FG005|Overall Study|Adverse Event|2|||
130377564|NCT05109442|469348442|FG000|Overall Study|Death|0|||
130377565|NCT05109442|469348443|FG001|Overall Study|Death|0|||
130377566|NCT05109442|469348444|FG002|Overall Study|Death|4|||
130377567|NCT05109442|469348445|FG003|Overall Study|Death|0|||
130377568|NCT05109442|469348446|FG004|Overall Study|Death|0|||
130377569|NCT05109442|469348447|FG005|Overall Study|Death|1|||
130377570|NCT05109442|469348442|FG000|Overall Study|Physician Decision|1|||
130377571|NCT05109442|469348443|FG001|Overall Study|Physician Decision|0|||
130377572|NCT05109442|469348444|FG002|Overall Study|Physician Decision|1|||
130377573|NCT05109442|469348445|FG003|Overall Study|Physician Decision|0|||
130377574|NCT05109442|469348446|FG004|Overall Study|Physician Decision|0|||
130377575|NCT05109442|469348447|FG005|Overall Study|Physician Decision|2|||
130377576|NCT05109442|469348442|FG000|Overall Study|Other than listed|0|||
130377577|NCT05109442|469348443|FG001|Overall Study|Other than listed|0|||
130377578|NCT05109442|469348444|FG002|Overall Study|Other than listed|9|||
130377579|NCT05109442|469348445|FG003|Overall Study|Other than listed|2|||
130377580|NCT05109442|469348446|FG004|Overall Study|Other than listed|0|||
130377581|NCT05109442|469348447|FG005|Overall Study|Other than listed|8|||
130377582|NCT05109442|469348442|FG000|Overall Study|Lack of Efficacy|3|||
130377583|NCT05109442|469348443|FG001|Overall Study|Lack of Efficacy|5|||
130377584|NCT05109442|469348444|FG002|Overall Study|Lack of Efficacy|29|||
130377585|NCT05109442|469348445|FG003|Overall Study|Lack of Efficacy|10|||
130377586|NCT05109442|469348446|FG004|Overall Study|Lack of Efficacy|11|||
130377587|NCT05109442|469348447|FG005|Overall Study|Lack of Efficacy|17|||
130377588|NCT04853225|469348448|FG000|Overall Study|Withdrawal by Subject|81|||
130377589|NCT04853225|469348449|FG001|Overall Study|Withdrawal by Subject|4|||
130377590|NCT04853225|469348450|FG002|Overall Study|Withdrawal by Subject|1|||
130377591|NCT04853225|469348448|FG000|Overall Study|Physician Decision|12|||
130377592|NCT04853225|469348449|FG001|Overall Study|Physician Decision|4|||
130377593|NCT04853225|469348450|FG002|Overall Study|Physician Decision|1|||
130377594|NCT04853225|469348448|FG000|Overall Study|Lost to Follow-up|50|||
130377595|NCT04853225|469348449|FG001|Overall Study|Lost to Follow-up|0|||
130377596|NCT04853225|469348450|FG002|Overall Study|Lost to Follow-up|0|||
130377597|NCT04853225|469348448|FG000|Overall Study|Other|102|||
130377598|NCT04853225|469348449|FG001|Overall Study|Other|11|||
130377599|NCT04853225|469348450|FG002|Overall Study|Other|5|||
130377600|NCT04853225|469348448|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
130377601|NCT04853225|469348449|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
130377602|NCT04853225|469348450|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
130377603|NCT04853225|469348448|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
130377604|NCT04853225|469348449|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
130377605|NCT04853225|469348450|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
130377606|NCT03918447|469348451|FG000|Overall Study|Death|1|||
130377607|NCT03918447|469348452|FG001|Overall Study|Death|0|||
130377608|NCT03918447|469348451|FG000|Overall Study|Lost to Follow-up|13|||
130377609|NCT03918447|469348452|FG001|Overall Study|Lost to Follow-up|6|||
130377610|NCT03918447|469348451|FG000|Overall Study|Withdrawal by Subject|19|||
130377611|NCT03918447|469348452|FG001|Overall Study|Withdrawal by Subject|17|||
130377612|NCT03918447|469348451|FG000|Overall Study|Study Terminated by Sponsor|195|||
130377613|NCT03918447|469348452|FG001|Overall Study|Study Terminated by Sponsor|197|||
130377614|NCT03918447|469348451|FG000|Overall Study|Reason not Specified|0|||
130377615|NCT03918447|469348452|FG001|Overall Study|Reason not Specified|1|||
130377616|NCT01405456|469348453|FG000|Overall Study|Lost to Follow-up|2|||
130377617|NCT01405456|469348454|FG001|Overall Study|Lost to Follow-up|1|||
130466983|NCT04452318|469676470|FG001|Overall Study|Lost to Follow-up|28|||
130721044|NCT00620659|470601598|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130721045|NCT00620659|470601599|FG004|Treatment Period 2|Withdrawal by Subject|3|||
130721046|NCT00620659|470601600|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130721047|NCT00620659|470601595|FG000|Placebo Washout Period 2|Adverse Event|2|||
130377618|NCT01405456|469348453|FG000|Overall Study|Physician Decision|1|||
130377619|NCT01405456|469348454|FG001|Overall Study|Physician Decision|0|||
130377620|NCT03909295|469349905|FG000|Overall Study|Adverse Event|2|||
130377621|NCT03909295|469349905|FG000|Overall Study|Study terminated by sponsor|50|||
130377622|NCT03138889|469349911|FG000|Overall Study|Withdrawal by Subject|5|||
130466984|NCT04452318|469676471|FG002|Overall Study|Lost to Follow-up|0|||
130466985|NCT04452318|469676472|FG003|Overall Study|Lost to Follow-up|3|||
130377623|NCT03138889|469349912|FG001|Overall Study|Withdrawal by Subject|5|||
130377624|NCT03138889|469349913|FG002|Overall Study|Withdrawal by Subject|0|||
130377625|NCT03138889|469349914|FG003|Overall Study|Withdrawal by Subject|2|||
130377626|NCT03138889|469349915|FG004|Overall Study|Withdrawal by Subject|1|||
130466986|NCT04452318|469676473|FG004|Overall Study|Lost to Follow-up|3|||
130377627|NCT03138889|469349916|FG005|Overall Study|Withdrawal by Subject|3|||
130377628|NCT03138889|469349917|FG006|Overall Study|Withdrawal by Subject|0|||
130377629|NCT03138889|469349918|FG007|Overall Study|Withdrawal by Subject|1|||
130377630|NCT02289690|469349921|FG000|Overall Study|Adverse Event Related to Progression|0|||
130317051|NCT03649074|469126441|FG001|Overall Study|Adverse Event|0|||
130317052|NCT03649074|469126440|FG000|Overall Study|Physician Decision|1|||
130317053|NCT03649074|469126441|FG001|Overall Study|Physician Decision|0|||
130317054|NCT03649074|469126440|FG000|Overall Study|Withdrawal by Subject|0|||
130317055|NCT03649074|469126441|FG001|Overall Study|Withdrawal by Subject|2|||
130317056|NCT03649074|469126440|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130317057|NCT03649074|469126441|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
130317058|NCT03649074|469126440|FG000|Overall Study|Other|1|||
130317059|NCT03649074|469126441|FG001|Overall Study|Other|0|||
130317060|NCT00556894|469126442|FG000|Overall Study|Adverse Event|2|||
130317061|NCT00556894|469126443|FG001|Overall Study|Adverse Event|3|||
130317062|NCT00556894|469126444|FG002|Overall Study|Adverse Event|3|||
130317063|NCT00556894|469126442|FG000|Overall Study|Death|1|||
130317064|NCT00556894|469126443|FG001|Overall Study|Death|0|||
130317065|NCT00556894|469126444|FG002|Overall Study|Death|0|||
130317066|NCT00556894|469126442|FG000|Overall Study|regulatory decision in Bulgaria|10|||
130317067|NCT00556894|469126443|FG001|Overall Study|regulatory decision in Bulgaria|14|||
130317068|NCT00556894|469126444|FG002|Overall Study|regulatory decision in Bulgaria|13|||
130317069|NCT00556894|469126442|FG000|Overall Study|Change in therapy|2|||
130317070|NCT00556894|469126443|FG001|Overall Study|Change in therapy|1|||
130317071|NCT00556894|469126444|FG002|Overall Study|Change in therapy|2|||
130317072|NCT00556894|469126442|FG000|Overall Study|Withdrawal by Subject|1|||
130317073|NCT00556894|469126443|FG001|Overall Study|Withdrawal by Subject|1|||
130317074|NCT00556894|469126444|FG002|Overall Study|Withdrawal by Subject|1|||
130317075|NCT04612725|469126447|FG000|Overall Study|Adverse Event|1|||
130317076|NCT04612725|469126448|FG001|Overall Study|Adverse Event|3|||
130317077|NCT04612725|469126449|FG002|Overall Study|Adverse Event|1|||
130317078|NCT04612725|469126450|FG003|Overall Study|Adverse Event|0|||
130317079|NCT04612725|469126451|FG004|Overall Study|Adverse Event|1|||
130317080|NCT04612725|469126447|FG000|Overall Study|Lost to Follow-up|0|||
130317081|NCT04612725|469126448|FG001|Overall Study|Lost to Follow-up|1|||
130317082|NCT04612725|469126449|FG002|Overall Study|Lost to Follow-up|0|||
130317083|NCT04612725|469126450|FG003|Overall Study|Lost to Follow-up|0|||
130317084|NCT04612725|469126451|FG004|Overall Study|Lost to Follow-up|0|||
130317085|NCT04612725|469126447|FG000|Overall Study|Physician Decision|2|||
130317086|NCT04612725|469126448|FG001|Overall Study|Physician Decision|0|||
130317087|NCT04612725|469126449|FG002|Overall Study|Physician Decision|0|||
130317088|NCT04612725|469126450|FG003|Overall Study|Physician Decision|0|||
130317089|NCT04612725|469126451|FG004|Overall Study|Physician Decision|0|||
130317090|NCT04612725|469126447|FG000|Overall Study|Study terminated by sponsor|3|||
130317091|NCT04612725|469126448|FG001|Overall Study|Study terminated by sponsor|1|||
130317092|NCT04612725|469126449|FG002|Overall Study|Study terminated by sponsor|2|||
130317093|NCT04612725|469126450|FG003|Overall Study|Study terminated by sponsor|4|||
130317094|NCT04612725|469126451|FG004|Overall Study|Study terminated by sponsor|5|||
130317095|NCT04612725|469126447|FG000|Overall Study|Withdrawal by Subject|8|||
130317096|NCT04612725|469126448|FG001|Overall Study|Withdrawal by Subject|3|||
130317097|NCT04612725|469126449|FG002|Overall Study|Withdrawal by Subject|5|||
130317098|NCT04612725|469126450|FG003|Overall Study|Withdrawal by Subject|1|||
130317099|NCT04612725|469126451|FG004|Overall Study|Withdrawal by Subject|9|||
130317100|NCT04612725|469126447|FG000|Overall Study|Other|0|||
130317101|NCT04612725|469126448|FG001|Overall Study|Other|0|||
130317102|NCT04612725|469126449|FG002|Overall Study|Other|0|||
130317103|NCT04612725|469126450|FG003|Overall Study|Other|0|||
130317104|NCT04612725|469126451|FG004|Overall Study|Other|1|||
130317105|NCT04875195|469126452|FG000|Overall Study|Death|9|||
130317106|NCT04875195|469126453|FG001|Overall Study|Death|3|||
130317107|NCT04875195|469126452|FG000|Overall Study|Withdrawal by Subject|2|||
130317108|NCT04875195|469126453|FG001|Overall Study|Withdrawal by Subject|1|||
130317109|NCT04875195|469126452|FG000|Overall Study|Ongoing in study|49|||
130317110|NCT04875195|469126453|FG001|Overall Study|Ongoing in study|2|||
130317111|NCT05190120|469126454|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130317112|NCT05190120|469126455|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130377631|NCT02289690|469349922|FG001|Overall Study|Adverse Event Related to Progression|1|||
130317113|NCT05190120|469126456|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130317114|NCT05190120|469126457|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
130317115|NCT05190120|469126454|FG000|Overall Study|Lost to Follow-up|5|||
130317116|NCT05190120|469126455|FG001|Overall Study|Lost to Follow-up|0|||
130317117|NCT05190120|469126456|FG002|Overall Study|Lost to Follow-up|2|||
130559498|NCT00705432|470016517|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
130559499|NCT00705432|470016518|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
130559500|NCT00705432|470016519|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130559501|NCT00705432|470016520|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130559502|NCT00705432|470016521|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130559503|NCT00705432|470016516|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
130559504|NCT00705432|470016517|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
130317118|NCT05190120|469126457|FG003|Overall Study|Lost to Follow-up|3|||
130317119|NCT02354235|469126458|FG000|Overall Study|Adverse Event|2|||
130317120|NCT02354235|469126459|FG001|Overall Study|Adverse Event|2|||
130317121|NCT02354235|469126458|FG000|Overall Study|Physician Decision|0|||
130317122|NCT02354235|469126459|FG001|Overall Study|Physician Decision|1|||
130317123|NCT02354235|469126458|FG000|Overall Study|Withdrawal by Subject|1|||
130317124|NCT02354235|469126459|FG001|Overall Study|Withdrawal by Subject|3|||
130317125|NCT02354235|469126458|FG000|Overall Study|Conflict with the stopping criteria|0|||
130317126|NCT02354235|469126459|FG001|Overall Study|Conflict with the stopping criteria|1|||
130317127|NCT03069352|469126460|FG000|Overall Study|Ongoing|12|||
130317128|NCT03069352|469126461|FG001|Overall Study|Ongoing|40|||
130317129|NCT02621424|469126462|FG000|Overall Study|Withdrawal by Subject|1|||
130377632|NCT02289690|469349923|FG002|Overall Study|Adverse Event Related to Progression|1|||
130317130|NCT02621424|469126463|FG001|Overall Study|Withdrawal by Subject|2|||
130317131|NCT04750642|469126466|FG000|Overall Study|Adverse Event|1|||
130317132|NCT04750642|469126467|FG001|Overall Study|Adverse Event|0|||
130317133|NCT04750642|469126466|FG000|Overall Study|Withdrawal by Subject|0|||
130377633|NCT02289690|469349924|FG003|Overall Study|Adverse Event Related to Progression|0|||
130377634|NCT02289690|469349925|FG004|Overall Study|Adverse Event Related to Progression|1|||
130377635|NCT02289690|469349926|FG005|Overall Study|Adverse Event Related to Progression|0|||
130377636|NCT02289690|469349927|FG006|Overall Study|Adverse Event Related to Progression|1|||
130377637|NCT02289690|469349928|FG007|Overall Study|Adverse Event Related to Progression|0|||
130377638|NCT02289690|469349929|FG008|Overall Study|Adverse Event Related to Progression|0|||
130377639|NCT02289690|469349930|FG009|Overall Study|Adverse Event Related to Progression|0|||
130377640|NCT02289690|469349921|FG000|Overall Study|Withdrawal by Subject|1|||
130377641|NCT02289690|469349922|FG001|Overall Study|Withdrawal by Subject|0|||
130377642|NCT02289690|469349923|FG002|Overall Study|Withdrawal by Subject|0|||
130377643|NCT02289690|469349924|FG003|Overall Study|Withdrawal by Subject|0|||
130377644|NCT02289690|469349925|FG004|Overall Study|Withdrawal by Subject|1|||
130377645|NCT02289690|469349926|FG005|Overall Study|Withdrawal by Subject|1|||
130377646|NCT02289690|469349927|FG006|Overall Study|Withdrawal by Subject|0|||
130377647|NCT02289690|469349928|FG007|Overall Study|Withdrawal by Subject|0|||
130377648|NCT02289690|469349929|FG008|Overall Study|Withdrawal by Subject|4|||
130377649|NCT02289690|469349930|FG009|Overall Study|Withdrawal by Subject|2|||
130377650|NCT02289690|469349921|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
130377651|NCT02289690|469349922|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
130377652|NCT02289690|469349923|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
130559505|NCT00705432|470016518|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
130559506|NCT00705432|470016519|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
130559507|NCT00705432|470016520|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
130559508|NCT00705432|470016521|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
130559509|NCT00521053|470016522|FG000|Observation Phase|Disease Progression|55|||
130559510|NCT00521053|470016522|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
130559511|NCT00521053|470016522|FG000|Observation Phase|Death|2|||
130559512|NCT00521053|470016522|FG000|Observation Phase|Adverse Event|1|||
130559513|NCT00521053|470016522|FG000|Observation Phase|Other non-study melanoma treatment|1|||
130559514|NCT00521053|470016522|FG000|Observation Phase|Physician Decision|1|||
130559515|NCT02281357|470016526|FG000|Overall Study|Adverse Event|2|||
130559516|NCT02281357|470016527|FG001|Overall Study|Adverse Event|1|||
130559517|NCT02281357|470016526|FG000|Overall Study|Lost to Follow-up|1|||
130559518|NCT02281357|470016527|FG001|Overall Study|Lost to Follow-up|0|||
130559519|NCT02281357|470016526|FG000|Overall Study|Withdrawal by Subject|4|||
130559520|NCT02281357|470016527|FG001|Overall Study|Withdrawal by Subject|3|||
130559521|NCT03007979|470016528|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
130559522|NCT00482703|470016529|FG000|Overall Study|Poor compliance|1|||
130559523|NCT00482703|470016530|FG001|Overall Study|Poor compliance|0|||
130559524|NCT04223791|470016532|FG000|Overall Study|Lost to Follow-up|0|||
130559525|NCT04223791|470016533|FG001|Overall Study|Lost to Follow-up|4|||
130559526|NCT04223791|470016532|FG000|Overall Study|Physician Decision|5|||
130559527|NCT04223791|470016533|FG001|Overall Study|Physician Decision|1|||
130559528|NCT04223791|470016532|FG000|Overall Study|Protocol Violation|1|||
130559529|NCT04223791|470016533|FG001|Overall Study|Protocol Violation|1|||
130559530|NCT04223791|470016532|FG000|Overall Study|Withdrawal by Subject|10|||
130559531|NCT04223791|470016533|FG001|Overall Study|Withdrawal by Subject|12|||
130559532|NCT04223791|470016532|FG000|Overall Study|Pregnancy|1|||
130559533|NCT04223791|470016533|FG001|Overall Study|Pregnancy|1|||
130559534|NCT04223791|470016532|FG000|Overall Study|Ongoing in Study|305|||
130559535|NCT04223791|470016533|FG001|Overall Study|Ongoing in Study|302|||
130559536|NCT00395863|470017798|FG000|Overall Study|Patients did not complete both exams|2|||
130317134|NCT04750642|469126467|FG001|Overall Study|Withdrawal by Subject|1|||
130317135|NCT04750642|469126466|FG000|Overall Study|Protocol Violation|0|||
130317136|NCT04750642|469126467|FG001|Overall Study|Protocol Violation|1|||
130377653|NCT02289690|469349924|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
130377654|NCT02289690|469349925|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
130377655|NCT02289690|469349926|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
130377656|NCT02289690|469349927|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
130377657|NCT02289690|469349928|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
130377658|NCT02289690|469349929|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
130377659|NCT02289690|469349930|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
130377660|NCT02289690|469349921|FG000|Overall Study|Lost to Follow-up|0|||
130377661|NCT02289690|469349922|FG001|Overall Study|Lost to Follow-up|0|||
130377662|NCT02289690|469349923|FG002|Overall Study|Lost to Follow-up|0|||
130377663|NCT02289690|469349924|FG003|Overall Study|Lost to Follow-up|0|||
130377664|NCT02289690|469349925|FG004|Overall Study|Lost to Follow-up|0|||
130377665|NCT02289690|469349926|FG005|Overall Study|Lost to Follow-up|0|||
130377666|NCT02289690|469349927|FG006|Overall Study|Lost to Follow-up|0|||
130377667|NCT02289690|469349928|FG007|Overall Study|Lost to Follow-up|1|||
130377668|NCT02289690|469349929|FG008|Overall Study|Lost to Follow-up|0|||
130377669|NCT02289690|469349930|FG009|Overall Study|Lost to Follow-up|2|||
130377670|NCT02289690|469349921|FG000|Overall Study|Death|0|||
130377671|NCT02289690|469349922|FG001|Overall Study|Death|0|||
130377672|NCT02289690|469349923|FG002|Overall Study|Death|0|||
130377673|NCT02289690|469349924|FG003|Overall Study|Death|0|||
130377674|NCT02289690|469349925|FG004|Overall Study|Death|0|||
130377675|NCT02289690|469349926|FG005|Overall Study|Death|0|||
130377676|NCT02289690|469349927|FG006|Overall Study|Death|0|||
130377677|NCT02289690|469349928|FG007|Overall Study|Death|49|||
130377678|NCT02289690|469349929|FG008|Overall Study|Death|45|||
130377679|NCT02289690|469349930|FG009|Overall Study|Death|41|||
130377680|NCT02289690|469349921|FG000|Overall Study|Sponsor Discontinued Study|0|||
130377681|NCT02289690|469349922|FG001|Overall Study|Sponsor Discontinued Study|0|||
130377682|NCT02289690|469349923|FG002|Overall Study|Sponsor Discontinued Study|0|||
130377683|NCT02289690|469349924|FG003|Overall Study|Sponsor Discontinued Study|0|||
130377684|NCT02289690|469349925|FG004|Overall Study|Sponsor Discontinued Study|0|||
130377685|NCT02289690|469349926|FG005|Overall Study|Sponsor Discontinued Study|0|||
130377686|NCT02289690|469349927|FG006|Overall Study|Sponsor Discontinued Study|0|||
130377687|NCT02289690|469349928|FG007|Overall Study|Sponsor Discontinued Study|9|||
130377688|NCT02289690|469349929|FG008|Overall Study|Sponsor Discontinued Study|7|||
130377689|NCT02289690|469349930|FG009|Overall Study|Sponsor Discontinued Study|15|||
130377690|NCT02289690|469349921|FG000|Overall Study|Other|0|||
130377691|NCT02289690|469349922|FG001|Overall Study|Other|0|||
130377692|NCT02289690|469349923|FG002|Overall Study|Other|0|||
130377693|NCT02289690|469349924|FG003|Overall Study|Other|1|||
130377694|NCT02289690|469349925|FG004|Overall Study|Other|1|||
130377695|NCT02289690|469349926|FG005|Overall Study|Other|0|||
130377696|NCT02289690|469349927|FG006|Overall Study|Other|1|||
130377697|NCT02289690|469349928|FG007|Overall Study|Other|2|||
130377698|NCT02289690|469349929|FG008|Overall Study|Other|3|||
130377699|NCT02289690|469349930|FG009|Overall Study|Other|1|||
130377700|NCT04166435|469349937|FG000|Overall Study|2 patients ineligible for response|2|||
130377701|NCT00267046|469349940|FG000|Overall Study|Disease progression|4|||
130377702|NCT00267046|469349941|FG001|Overall Study|Disease progression|2|||
130377703|NCT00267046|469349940|FG000|Overall Study|Chemotoxicity|2|||
130377704|NCT00267046|469349941|FG001|Overall Study|Chemotoxicity|0|||
130377705|NCT00267046|469349940|FG000|Overall Study|Open-label palifermin|2|||
130377706|NCT00267046|469349941|FG001|Overall Study|Open-label palifermin|7|||
130377707|NCT00267046|469349940|FG000|Overall Study|Surgery|3|||
130377708|NCT00267046|469349941|FG001|Overall Study|Surgery|1|||
130377709|NCT00267046|469349940|FG000|Overall Study|Withdrawal by Subject|1|||
130377710|NCT00267046|469349941|FG001|Overall Study|Withdrawal by Subject|0|||
130377711|NCT00267046|469349940|FG000|Overall Study|Radiation|0|||
130377712|NCT00267046|469349941|FG001|Overall Study|Radiation|1|||
130377713|NCT00865124|469349942|FG000|Overall Study|Physician Decision|2|||
130377714|NCT00865124|469349943|FG001|Overall Study|Physician Decision|1|||
130377715|NCT00865124|469349944|FG002|Overall Study|Physician Decision|0|||
130377716|NCT00865124|469349942|FG000|Overall Study|Withdrawn consent|2|||
130377717|NCT00865124|469349943|FG001|Overall Study|Withdrawn consent|0|||
130377718|NCT00865124|469349944|FG002|Overall Study|Withdrawn consent|0|||
130377719|NCT04983264|469349945|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
130377720|NCT04983264|469349946|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
130377721|NCT04983264|469349947|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
130377722|NCT04983264|469349945|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
130377723|NCT04983264|469349946|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
130377724|NCT04983264|469349947|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
130377725|NCT03042533|469349952|FG000|Overall Study|MD left program|1|||
130377726|NCT03042533|469349953|FG001|Overall Study|MD left program|4|||
130377727|NCT03042533|469349954|FG002|Overall Study|MD left program|1|||
130377728|NCT01111149|469349959|FG000|Overall Study|Protocol Violation|1|||
130377729|NCT01111149|469349960|FG001|Overall Study|Protocol Violation|1|||
130377730|NCT01111149|469349961|FG002|Overall Study|Protocol Violation|2|||
130377731|NCT01111149|469349959|FG000|Overall Study|Withdrawal by Subject|1|||
130377732|NCT01111149|469349960|FG001|Overall Study|Withdrawal by Subject|0|||
130377733|NCT01111149|469349961|FG002|Overall Study|Withdrawal by Subject|2|||
130377734|NCT02551731|469349966|FG000|Overall Study|Withdrawal by Subject|2|||
130377735|NCT01678911|469349973|FG000|Second Intervention|Lost to Follow-up|2|||
130377736|NCT01678911|469349974|FG001|Second Intervention|Lost to Follow-up|0|||
130559537|NCT00395863|470017799|FG001|Overall Study|Patients did not complete both exams|3|||
130559538|NCT02592551|470017802|FG000|Overall Study|Not evaluable|1|||
130559539|NCT02592551|470017803|FG001|Overall Study|Not evaluable|3|||
130559540|NCT02592551|470017804|FG002|Overall Study|Not evaluable|0|||
130559541|NCT01876251|470017805|FG000|Overall Study|Clinical progression|1|||
130559542|NCT01876251|470017806|FG001|Overall Study|Clinical progression|0|||
130377737|NCT00356369|469349975|FG000|Active Phase|Withdrawal by Subject|2|||
130377738|NCT00356369|469349976|FG001|Active Phase|Withdrawal by Subject|1|||
130377739|NCT02117648|469349980|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
130377740|NCT02117648|469349980|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
130377741|NCT02117648|469349980|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
130377742|NCT02117648|469349980|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
130377743|NCT02117648|469349980|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
130377744|NCT02117648|469349980|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
130377745|NCT02117648|469349980|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
130377746|NCT02117648|469349980|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
130377747|NCT02117648|469349980|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
130377748|NCT02117648|469349980|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
130377749|NCT02117648|469349980|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
130377750|NCT01985867|469349981|FG000|Overall Study|Lost to Follow-up|3|||
130377751|NCT01985867|469349982|FG001|Overall Study|Lost to Follow-up|4|||
130377752|NCT01985867|469349981|FG000|Overall Study|Adverse Event|3|||
130377753|NCT01985867|469349982|FG001|Overall Study|Adverse Event|2|||
130377754|NCT01985867|469349981|FG000|Overall Study|Lack of Efficacy|1|||
130377755|NCT01985867|469349982|FG001|Overall Study|Lack of Efficacy|0|||
130377756|NCT00553514|469349985|FG000|Overall Study|Protocol deviation|0|||
130377757|NCT00553514|469349986|FG001|Overall Study|Protocol deviation|0|||
130377758|NCT00553514|469349987|FG002|Overall Study|Protocol deviation|0|||
130377759|NCT00553514|469349988|FG003|Overall Study|Protocol deviation|1|||
130377760|NCT00553514|469349989|FG004|Overall Study|Protocol deviation|0|||
130377761|NCT00553514|469349985|FG000|Overall Study|Lack of ovarian response|4|||
130377762|NCT00553514|469349986|FG001|Overall Study|Lack of ovarian response|5|||
130377763|NCT00553514|469349987|FG002|Overall Study|Lack of ovarian response|5|||
130377764|NCT00553514|469349988|FG003|Overall Study|Lack of ovarian response|5|||
130377765|NCT00553514|469349989|FG004|Overall Study|Lack of ovarian response|6|||
130377766|NCT00553514|469349985|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130377767|NCT00553514|469349986|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130377768|NCT00553514|469349987|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130377769|NCT00553514|469349988|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130377770|NCT00553514|469349989|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130377771|NCT00553514|469349985|FG000|Overall Study|Risk of multiple pregnancy|0|||
130377772|NCT00553514|469349986|FG001|Overall Study|Risk of multiple pregnancy|2|||
130377773|NCT00553514|469349987|FG002|Overall Study|Risk of multiple pregnancy|0|||
130377774|NCT00553514|469349988|FG003|Overall Study|Risk of multiple pregnancy|1|||
130377775|NCT00553514|469349989|FG004|Overall Study|Risk of multiple pregnancy|0|||
130377776|NCT00553514|469349985|FG000|Overall Study|Other|1|||
130377777|NCT00553514|469349986|FG001|Overall Study|Other|1|||
130377778|NCT00553514|469349987|FG002|Overall Study|Other|0|||
130377779|NCT00553514|469349988|FG003|Overall Study|Other|0|||
130559543|NCT01876251|470017807|FG002|Overall Study|Clinical progression|0|||
130377780|NCT00553514|469349989|FG004|Overall Study|Other|1|||
130377781|NCT01442675|469349996|FG000|Overall Study|Protocol Violation|6|||
130377782|NCT01442675|469349996|FG000|Overall Study|Lost to Follow-up|2|||
130377783|NCT01442675|469349996|FG000|Overall Study|Withdrawal by Subject|4|||
130377784|NCT00137046|469350002|FG000|Overall Study|Death|2|||
130377785|NCT00137046|469350003|FG001|Overall Study|Death|1|||
130377786|NCT00137046|469350002|FG000|Overall Study|Adverse Event|16|||
130377787|NCT00137046|469350003|FG001|Overall Study|Adverse Event|5|||
130377788|NCT00137046|469350002|FG000|Overall Study|Laboratory Abnormality|2|||
130377789|NCT00137046|469350003|FG001|Overall Study|Laboratory Abnormality|0|||
130377790|NCT00137046|469350002|FG000|Overall Study|Lack of Efficacy|13|||
130377791|NCT00137046|469350003|FG001|Overall Study|Lack of Efficacy|1|||
130377792|NCT00137046|469350002|FG000|Overall Study|Lost to Follow-up|8|||
130377793|NCT00137046|469350003|FG001|Overall Study|Lost to Follow-up|24|||
130377794|NCT00137046|469350002|FG000|Overall Study|Other|23|||
130377795|NCT00137046|469350003|FG001|Overall Study|Other|19|||
130377796|NCT00137046|469350002|FG000|Overall Study|Withdrawal by Subject|33|||
130377797|NCT00137046|469350003|FG001|Overall Study|Withdrawal by Subject|42|||
130466987|NCT04452318|469676474|FG005|Overall Study|Lost to Follow-up|2|||
130466988|NCT04452318|469676475|FG006|Overall Study|Lost to Follow-up|1|||
130466989|NCT04452318|469676469|FG000|Overall Study|Withdrawal by Subject|46|||
130466990|NCT04452318|469676470|FG001|Overall Study|Withdrawal by Subject|40|||
130466991|NCT04452318|469676471|FG002|Overall Study|Withdrawal by Subject|0|||
130466992|NCT04452318|469676472|FG003|Overall Study|Withdrawal by Subject|18|||
130721048|NCT00620659|470601596|FG001|Placebo Washout Period 2|Adverse Event|0|||
130721049|NCT00620659|470601597|FG002|Placebo Washout Period 2|Adverse Event|0|||
130721050|NCT00620659|470601598|FG003|Placebo Washout Period 2|Adverse Event|0|||
130721051|NCT00620659|470601599|FG004|Placebo Washout Period 2|Adverse Event|0|||
130721052|NCT00620659|470601600|FG005|Placebo Washout Period 2|Adverse Event|0|||
130721053|NCT00620659|470601595|FG000|Treatment Period 3|Adverse Event|0|||
130721054|NCT00620659|470601596|FG001|Treatment Period 3|Adverse Event|2|||
130721055|NCT00620659|470601597|FG002|Treatment Period 3|Adverse Event|0|||
130721056|NCT00620659|470601598|FG003|Treatment Period 3|Adverse Event|0|||
130721057|NCT00620659|470601599|FG004|Treatment Period 3|Adverse Event|0|||
130721058|NCT00620659|470601600|FG005|Treatment Period 3|Adverse Event|0|||
130721059|NCT00620659|470601595|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130721060|NCT00620659|470601596|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130721061|NCT00620659|470601597|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130721062|NCT00620659|470601598|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130721063|NCT00620659|470601599|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130721064|NCT00620659|470601600|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130721065|NCT01193127|470601601|FG000|Randomized|Surgery Cancelled|0|||
130721066|NCT01193127|470601602|FG001|Randomized|Surgery Cancelled|0|||
130721067|NCT01193127|470601603|FG002|Randomized|Surgery Cancelled|0|||
130721068|NCT01193127|470601604|FG003|Randomized|Surgery Cancelled|1|||
130721069|NCT01193127|470601601|FG000|Treated|Withdrawal by Subject|0|||
130721070|NCT01193127|470601602|FG001|Treated|Withdrawal by Subject|0|||
130721071|NCT01193127|470601603|FG002|Treated|Withdrawal by Subject|0|||
130721072|NCT01193127|470601604|FG003|Treated|Withdrawal by Subject|1|||
130721073|NCT03246646|470601605|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
130721074|NCT03246646|470601606|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
130721075|NCT03246646|470601605|FG000|Overall Study|Withdrawal by Subject|3|||
130721076|NCT03246646|470601606|FG001|Overall Study|Withdrawal by Subject|0|||
130721077|NCT03246646|470601605|FG000|Overall Study|Lost to Follow-up|7|||
130721078|NCT03246646|470601606|FG001|Overall Study|Lost to Follow-up|0|||
130721079|NCT02352779|470601607|FG000|Overall Study|Personal Issues|1|||
130721080|NCT02352779|470601608|FG001|Overall Study|Personal Issues|1|||
130721081|NCT02352779|470601609|FG002|Overall Study|Personal Issues|0|||
130721082|NCT02352779|470601607|FG000|Overall Study|Too Many Forms|2|||
130721083|NCT02352779|470601608|FG001|Overall Study|Too Many Forms|0|||
130721084|NCT02352779|470601609|FG002|Overall Study|Too Many Forms|0|||
130721085|NCT02352779|470601607|FG000|Overall Study|Feeling Overwhelmed|1|||
130721086|NCT02352779|470601608|FG001|Overall Study|Feeling Overwhelmed|0|||
130721087|NCT02352779|470601609|FG002|Overall Study|Feeling Overwhelmed|0|||
130721088|NCT02352779|470601607|FG000|Overall Study|Disliked Intervention|1|||
130721089|NCT02352779|470601608|FG001|Overall Study|Disliked Intervention|0|||
130721090|NCT02352779|470601609|FG002|Overall Study|Disliked Intervention|0|||
130721091|NCT02352779|470601607|FG000|Overall Study|Changed Mind|1|||
130721092|NCT02352779|470601608|FG001|Overall Study|Changed Mind|0|||
130721093|NCT02352779|470601609|FG002|Overall Study|Changed Mind|0|||
130721094|NCT02352779|470601607|FG000|Overall Study|Study Related Symptoms|1|||
130721095|NCT02352779|470601608|FG001|Overall Study|Study Related Symptoms|0|||
130721096|NCT02352779|470601609|FG002|Overall Study|Study Related Symptoms|0|||
130721097|NCT02352779|470601607|FG000|Overall Study|Absence of Symptoms|1|||
130721098|NCT02352779|470601608|FG001|Overall Study|Absence of Symptoms|0|||
130721099|NCT02352779|470601609|FG002|Overall Study|Absence of Symptoms|0|||
130721100|NCT02352779|470601607|FG000|Overall Study|Other Medical Reason|0|||
130721101|NCT02352779|470601608|FG001|Overall Study|Other Medical Reason|0|||
130721102|NCT02352779|470601609|FG002|Overall Study|Other Medical Reason|1|||
130377798|NCT00137046|469350002|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
130377799|NCT00137046|469350003|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
130377800|NCT00137046|469350002|FG000|Overall Study|Withdrew prior to study treatment|1|||
130377801|NCT00137046|469350003|FG001|Overall Study|Withdrew prior to study treatment|1|||
130377802|NCT02725710|469350005|FG000|Overall Study|Lost to Follow-up|1|||
130377803|NCT02725710|469350006|FG001|Overall Study|Lost to Follow-up|0|||
130721103|NCT02352779|470601607|FG000|Overall Study|No Reason|0|||
130721104|NCT02352779|470601608|FG001|Overall Study|No Reason|0|||
130721105|NCT02352779|470601609|FG002|Overall Study|No Reason|1|||
130721106|NCT04555720|470601612|FG000|Overall Study|Lost to Follow-up|2|||
130721107|NCT04555720|470601613|FG001|Overall Study|Lost to Follow-up|0|||
130377804|NCT01927367|469350009|FG000|Overall Study|Withdrawal by Subject|7|||
130377805|NCT01927367|469350010|FG001|Overall Study|Withdrawal by Subject|4|||
130377806|NCT01927367|469350009|FG000|Overall Study|No baseline data|0|||
130377807|NCT01927367|469350010|FG001|Overall Study|No baseline data|1|||
130377808|NCT00598832|469350013|FG000|Overall Study|Lack of Efficacy|3|||
130377809|NCT00598832|469350014|FG001|Overall Study|Lack of Efficacy|7|||
130466993|NCT04452318|469676473|FG004|Overall Study|Withdrawal by Subject|6|||
130466994|NCT04452318|469676474|FG005|Overall Study|Withdrawal by Subject|8|||
130466995|NCT04452318|469676475|FG006|Overall Study|Withdrawal by Subject|6|||
130466996|NCT00595413|469676476|FG000|Overall Study|Adverse Event|0|||
130466997|NCT00595413|469676477|FG001|Overall Study|Adverse Event|2|||
130466998|NCT00595413|469676478|FG002|Overall Study|Adverse Event|1|||
130466999|NCT00595413|469676479|FG003|Overall Study|Adverse Event|1|||
130467000|NCT00595413|469676476|FG000|Overall Study|Lost to Follow-up|2|||
130467001|NCT00595413|469676477|FG001|Overall Study|Lost to Follow-up|2|||
130467002|NCT00595413|469676478|FG002|Overall Study|Lost to Follow-up|1|||
130467003|NCT00595413|469676479|FG003|Overall Study|Lost to Follow-up|3|||
130377810|NCT00598832|469350013|FG000|Overall Study|Adverse Event|6|||
130377811|NCT00598832|469350014|FG001|Overall Study|Adverse Event|2|||
130377812|NCT00598832|469350013|FG000|Overall Study|Withdrawal by Subject|25|||
130377813|NCT00598832|469350014|FG001|Overall Study|Withdrawal by Subject|36|||
130377814|NCT00598832|469350013|FG000|Overall Study|Protocol Violation|0|||
130377815|NCT00598832|469350014|FG001|Overall Study|Protocol Violation|2|||
130377816|NCT00598832|469350013|FG000|Overall Study|Lost to Follow-up|24|||
130377817|NCT00598832|469350014|FG001|Overall Study|Lost to Follow-up|29|||
130377818|NCT00598832|469350013|FG000|Overall Study|Pregnancy|2|||
130377819|NCT00598832|469350014|FG001|Overall Study|Pregnancy|2|||
130377820|NCT00598832|469350013|FG000|Overall Study|Physician Decision|1|||
130377821|NCT00598832|469350014|FG001|Overall Study|Physician Decision|4|||
130377822|NCT00598832|469350013|FG000|Overall Study|Non compliance|1|||
130377823|NCT00598832|469350014|FG001|Overall Study|Non compliance|0|||
130377824|NCT02760069|469350015|FG000|Overall Study|Withdrawal by Subject|0|||
130377825|NCT02760069|469350016|FG001|Overall Study|Withdrawal by Subject|1|||
130377826|NCT02760069|469350017|FG002|Overall Study|Withdrawal by Subject|1|||
130377827|NCT02142959|469350027|FG000|Overall Study|Adverse Event|1|||
130377828|NCT02142959|469350028|FG001|Overall Study|Adverse Event|0|||
130377829|NCT02142959|469350029|FG002|Overall Study|Adverse Event|0|||
130377830|NCT02142959|469350027|FG000|Overall Study|Death|0|||
130377831|NCT02142959|469350028|FG001|Overall Study|Death|1|||
130559544|NCT01876251|470017805|FG000|Overall Study|Death|2|||
130559545|NCT01876251|470017806|FG001|Overall Study|Death|0|||
130559546|NCT01876251|470017807|FG002|Overall Study|Death|1|||
130559547|NCT01876251|470017805|FG000|Overall Study|Participant started new treatment|1|||
130559548|NCT01876251|470017806|FG001|Overall Study|Participant started new treatment|0|||
130559549|NCT01876251|470017807|FG002|Overall Study|Participant started new treatment|1|||
130559550|NCT01876251|470017805|FG000|Overall Study|Participant refused further follow-up|0|||
130559551|NCT01876251|470017806|FG001|Overall Study|Participant refused further follow-up|0|||
130559552|NCT01876251|470017807|FG002|Overall Study|Participant refused further follow-up|1|||
130559553|NCT01876251|470017805|FG000|Overall Study|Study terminated|1|||
130559554|NCT01876251|470017806|FG001|Overall Study|Study terminated|0|||
130559555|NCT01876251|470017807|FG002|Overall Study|Study terminated|0|||
130559556|NCT01876251|470017805|FG000|Overall Study|Objective progression or relapse|10|||
130559557|NCT01876251|470017806|FG001|Overall Study|Objective progression or relapse|3|||
130559558|NCT01876251|470017807|FG002|Overall Study|Objective progression or relapse|8|||
130559559|NCT00268437|470017808|FG000|Overall Study|Ineligible|1|||
130559560|NCT03335163|470017811|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
130559561|NCT03335163|470017811|FG000|Overall Study|Withdrawal by Subject|18|||
130559562|NCT03945591|470017813|FG000|Overall Study|Participant not transplanted|1|||
130559563|NCT03945591|470017813|FG000|Overall Study|Change in treatment plan|3|||
130559564|NCT03945591|470017813|FG000|Overall Study|Adverse Event|1|||
130559565|NCT01986920|470017816|FG000|A- 101 25%|Withdrawal by Subject|1|||
130559566|NCT01986920|470017817|FG001|A- 101 25%|Withdrawal by Subject|0|||
130559567|NCT01986920|470017818|FG002|A- 101 25%|Withdrawal by Subject|0|||
130559568|NCT01986920|470017819|FG003|A- 101 25%|Withdrawal by Subject|0|||
130559569|NCT01986920|470017816|FG000|A-101 32.5%|Withdrawal by Subject|0|||
130559570|NCT01986920|470017817|FG001|A-101 32.5%|Withdrawal by Subject|1|||
130559571|NCT01986920|470017818|FG002|A-101 32.5%|Withdrawal by Subject|0|||
130559572|NCT01986920|470017819|FG003|A-101 32.5%|Withdrawal by Subject|0|||
130559573|NCT01986920|470017816|FG000|A-101 40%|Withdrawal by Subject|0|||
130559574|NCT01986920|470017817|FG001|A-101 40%|Withdrawal by Subject|0|||
130559575|NCT01986920|470017818|FG002|A-101 40%|Withdrawal by Subject|1|||
130559576|NCT01986920|470017819|FG003|A-101 40%|Withdrawal by Subject|0|||
130721108|NCT04555720|470601614|FG002|Overall Study|Lost to Follow-up|0|||
130377832|NCT02142959|469350029|FG002|Overall Study|Death|0|||
130377833|NCT02142959|469350027|FG000|Overall Study|Withdrawal by Subject|3|||
130467004|NCT00595413|469676476|FG000|Overall Study|Death|0|||
130467005|NCT00595413|469676477|FG001|Overall Study|Death|0|||
130467006|NCT00595413|469676478|FG002|Overall Study|Death|1|||
130467007|NCT00595413|469676479|FG003|Overall Study|Death|0|||
130377834|NCT02142959|469350028|FG001|Overall Study|Withdrawal by Subject|1|||
130377835|NCT02142959|469350029|FG002|Overall Study|Withdrawal by Subject|3|||
130377836|NCT02142959|469350027|FG000|Overall Study|Administrative Reasons|1|||
130377837|NCT02142959|469350028|FG001|Overall Study|Administrative Reasons|0|||
130377838|NCT02142959|469350029|FG002|Overall Study|Administrative Reasons|1|||
130377839|NCT02142959|469350027|FG000|Overall Study|Missing|0|||
130317151|NCT00644423|469128515|FG000|Overall Study|Lost to Follow-up|1|||
130317152|NCT00644423|469128516|FG001|Overall Study|Lost to Follow-up|1|||
130317153|NCT01519323|469128521|FG000|Overall Study|Death|3|||
130317154|NCT01519323|469128522|FG001|Overall Study|Death|2|||
130317155|NCT01519323|469128521|FG000|Overall Study|Study terminated by sponsor|0|||
130317156|NCT01519323|469128522|FG001|Overall Study|Study terminated by sponsor|1|||
130317157|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
130317158|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
130317159|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
130317160|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
130317161|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
130317162|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
130317163|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
130317164|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
130317165|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130317166|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130317167|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130317168|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130317169|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130317170|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130317171|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130317172|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130317173|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
130317174|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
130317175|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
130317176|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
130317177|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
130317178|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
130317179|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
130317180|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
130317181|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
130317182|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
130317183|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
130317184|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
130317185|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
130317186|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
130317187|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
130317188|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
130317189|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130317190|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130317191|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
130317192|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
130317193|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317194|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317195|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317196|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
130317197|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
130317198|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
130317199|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
130317200|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
130317201|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130377840|NCT02142959|469350028|FG001|Overall Study|Missing|1|||
130317202|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130317203|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
130317204|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130317205|NCT04416204|469128537|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130377841|NCT02142959|469350029|FG002|Overall Study|Missing|0|||
130377842|NCT02142959|469350027|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
130377843|NCT02142959|469350028|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
130377844|NCT02142959|469350029|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
130377845|NCT02142959|469350027|FG000|Overall Study|Patient didn't complete end of study visit|0|||
130377846|NCT02142959|469350028|FG001|Overall Study|Patient didn't complete end of study visit|0|||
130377847|NCT02142959|469350029|FG002|Overall Study|Patient didn't complete end of study visit|1|||
130377848|NCT03547687|469350030|FG000|Overall Study|Withdrawal by Subject|1|||
130467008|NCT00595413|469676476|FG000|Overall Study|Other|5|||
130377849|NCT03547687|469350030|FG000|Overall Study|Death|1|||
130377850|NCT02547454|469350034|FG000|Overall Study|Due to hemodialysis|53|||
130377851|NCT02547454|469350034|FG000|Overall Study|Due to transplantation|1|||
130377852|NCT02547454|469350034|FG000|Overall Study|Due to no further need to treat|4|||
130377853|NCT02547454|469350034|FG000|Overall Study|Death|38|||
130377854|NCT02547454|469350034|FG000|Overall Study|Lost to Follow-up|26|||
130377855|NCT02547454|469350034|FG000|Overall Study|Other|39|||
130377856|NCT02547454|469350034|FG000|Overall Study|No data|11|||
130377857|NCT03694821|469350036|FG000|Overall Study|Study terminated|4|||
130377858|NCT03694821|469350037|FG001|Overall Study|Study terminated|8|||
130377859|NCT03694821|469350038|FG002|Overall Study|Study terminated|4|||
130377860|NCT00203996|469350039|FG000|Overall Study|Lost to Follow-up|0|||
130377861|NCT00203996|469350040|FG001|Overall Study|Lost to Follow-up|0|||
130377862|NCT00203996|469350041|FG002|Overall Study|Lost to Follow-up|0|||
130377863|NCT00203996|469350042|FG003|Overall Study|Lost to Follow-up|1|||
130377864|NCT00203996|469350043|FG004|Overall Study|Lost to Follow-up|0|||
130377865|NCT00203996|469350044|FG005|Overall Study|Lost to Follow-up|0|||
130377866|NCT00203996|469350045|FG006|Overall Study|Lost to Follow-up|0|||
130377867|NCT00203996|469350046|FG007|Overall Study|Lost to Follow-up|0|||
130377868|NCT00203996|469350047|FG008|Overall Study|Lost to Follow-up|0|||
130377869|NCT00203996|469350048|FG009|Overall Study|Lost to Follow-up|0|||
130377870|NCT00203996|469350039|FG000|Overall Study|Protocol Violation|0|||
130377871|NCT00203996|469350040|FG001|Overall Study|Protocol Violation|0|||
130377872|NCT00203996|469350041|FG002|Overall Study|Protocol Violation|0|||
130377873|NCT00203996|469350042|FG003|Overall Study|Protocol Violation|6|||
130377874|NCT00203996|469350043|FG004|Overall Study|Protocol Violation|1|||
130377875|NCT00203996|469350044|FG005|Overall Study|Protocol Violation|0|||
130377876|NCT00203996|469350045|FG006|Overall Study|Protocol Violation|0|||
130377877|NCT00203996|469350046|FG007|Overall Study|Protocol Violation|0|||
130377878|NCT00203996|469350047|FG008|Overall Study|Protocol Violation|0|||
130467009|NCT00595413|469676477|FG001|Overall Study|Other|1|||
130377879|NCT00203996|469350048|FG009|Overall Study|Protocol Violation|0|||
130377880|NCT00203996|469350039|FG000|Overall Study|Physician Decision|0|||
130377881|NCT00203996|469350040|FG001|Overall Study|Physician Decision|0|||
130377882|NCT00203996|469350041|FG002|Overall Study|Physician Decision|0|||
130377883|NCT00203996|469350042|FG003|Overall Study|Physician Decision|2|||
130377884|NCT00203996|469350043|FG004|Overall Study|Physician Decision|0|||
130377885|NCT00203996|469350044|FG005|Overall Study|Physician Decision|0|||
130377886|NCT00203996|469350045|FG006|Overall Study|Physician Decision|0|||
130377887|NCT00203996|469350046|FG007|Overall Study|Physician Decision|0|||
130377888|NCT00203996|469350047|FG008|Overall Study|Physician Decision|0|||
130377889|NCT00203996|469350048|FG009|Overall Study|Physician Decision|1|||
130467010|NCT00595413|469676478|FG002|Overall Study|Other|5|||
130467011|NCT00595413|469676479|FG003|Overall Study|Other|0|||
130721109|NCT04555720|470601615|FG003|Overall Study|Lost to Follow-up|0|||
130721110|NCT04555720|470601612|FG000|Overall Study|Withdrawal by Subject|4|||
130721111|NCT04555720|470601613|FG001|Overall Study|Withdrawal by Subject|6|||
130721112|NCT04555720|470601614|FG002|Overall Study|Withdrawal by Subject|0|||
130721113|NCT04555720|470601615|FG003|Overall Study|Withdrawal by Subject|0|||
130721114|NCT00968799|470601616|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
130721115|NCT00719849|470601617|FG000|Overall Study|Death|0|||
130721116|NCT00719849|470601618|FG001|Overall Study|Death|1|||
130721117|NCT01372774|470601621|FG000|Overall Study|Withdrawal prior to treatment|4|||
130721118|NCT01372774|470601622|FG001|Overall Study|Withdrawal prior to treatment|5|||
130721119|NCT02201290|470601623|FG000|Overall Study|Withdrawal by Subject|2|||
130721120|NCT02201290|470601623|FG000|Overall Study|Lack of Efficacy|2|||
130721121|NCT02201290|470601623|FG000|Overall Study|Adverse Event|1|||
130721122|NCT03283319|470604205|FG000|Overall Study|Lost to Follow-up|5|||
130721123|NCT03283319|470604206|FG001|Overall Study|Lost to Follow-up|4|||
130721124|NCT03283319|470604207|FG002|Overall Study|Lost to Follow-up|5|||
130721125|NCT03283319|470604208|FG003|Overall Study|Lost to Follow-up|5|||
130721126|NCT03283319|470604209|FG004|Overall Study|Lost to Follow-up|4|||
130721127|NCT03283319|470604210|FG005|Overall Study|Lost to Follow-up|3|||
130721128|NCT03283319|470604205|FG000|Overall Study|Withdrawal by Subject|2|||
130721129|NCT03283319|470604206|FG001|Overall Study|Withdrawal by Subject|2|||
130721130|NCT03283319|470604207|FG002|Overall Study|Withdrawal by Subject|2|||
130721131|NCT03283319|470604208|FG003|Overall Study|Withdrawal by Subject|1|||
130721132|NCT03283319|470604209|FG004|Overall Study|Withdrawal by Subject|0|||
130721133|NCT03283319|470604210|FG005|Overall Study|Withdrawal by Subject|1|||
130721134|NCT03283319|470604205|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721135|NCT03283319|470604206|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721136|NCT03283319|470604207|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721137|NCT03283319|470604208|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
130721138|NCT03283319|470604209|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721139|NCT03283319|470604210|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721140|NCT00792935|470604211|FG000|Overall Study|Adverse Event|2|||
130721141|NCT00792935|470604212|FG001|Overall Study|Adverse Event|1|||
130721142|NCT00792935|470604211|FG000|Overall Study|Lost to Follow-up|0|||
130721143|NCT00792935|470604212|FG001|Overall Study|Lost to Follow-up|1|||
130721144|NCT00792935|470604211|FG000|Overall Study|Protocol Violation|2|||
130721145|NCT00792935|470604212|FG001|Overall Study|Protocol Violation|0|||
130721146|NCT00792935|470604211|FG000|Overall Study|Withdrawal by Subject|0|||
130721147|NCT00792935|470604212|FG001|Overall Study|Withdrawal by Subject|1|||
130721148|NCT03186781|470604213|FG000|Overall Study|Lost to Follow-up|0|||
130721149|NCT03186781|470604214|FG001|Overall Study|Lost to Follow-up|0|||
130721150|NCT03186781|470604215|FG002|Overall Study|Lost to Follow-up|1|||
130721151|NCT03186781|470604216|FG003|Overall Study|Lost to Follow-up|0|||
130721152|NCT03186781|470604217|FG004|Overall Study|Lost to Follow-up|1|||
130721153|NCT03186781|470604218|FG005|Overall Study|Lost to Follow-up|0|||
130721154|NCT03186781|470604213|FG000|Overall Study|Moved from Area|0|||
130721155|NCT03186781|470604214|FG001|Overall Study|Moved from Area|0|||
130721156|NCT03186781|470604215|FG002|Overall Study|Moved from Area|0|||
130721157|NCT03186781|470604216|FG003|Overall Study|Moved from Area|0|||
130377890|NCT00203996|469350039|FG000|Overall Study|CPAP machine malfunction|0|||
130377891|NCT00203996|469350040|FG001|Overall Study|CPAP machine malfunction|0|||
130377892|NCT00203996|469350041|FG002|Overall Study|CPAP machine malfunction|0|||
130377893|NCT00203996|469350042|FG003|Overall Study|CPAP machine malfunction|1|||
130377894|NCT00203996|469350043|FG004|Overall Study|CPAP machine malfunction|0|||
130377895|NCT00203996|469350044|FG005|Overall Study|CPAP machine malfunction|0|||
130377896|NCT00203996|469350045|FG006|Overall Study|CPAP machine malfunction|0|||
130467012|NCT04149002|469676480|FG000|Overall Study|Lost to Follow-up|1|||
130721158|NCT03186781|470604217|FG004|Overall Study|Moved from Area|1|||
130721159|NCT03186781|470604218|FG005|Overall Study|Moved from Area|0|||
130721160|NCT03186781|470604213|FG000|Overall Study|Withdrawal by Subject|0|||
130467013|NCT04149002|469676481|FG001|Overall Study|Lost to Follow-up|0|||
130721161|NCT03186781|470604214|FG001|Overall Study|Withdrawal by Subject|0|||
130721162|NCT03186781|470604215|FG002|Overall Study|Withdrawal by Subject|0|||
130721163|NCT03186781|470604216|FG003|Overall Study|Withdrawal by Subject|0|||
130721164|NCT03186781|470604217|FG004|Overall Study|Withdrawal by Subject|1|||
130317206|NCT04416204|469128538|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
130317207|NCT04416204|469128539|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130317208|NCT04416204|469128540|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130317209|NCT04456504|469128541|FG000|Overall Study|Lost to Follow-up|2|||
130317210|NCT01131507|469128542|FG000|Overall Study|Adverse Event|1|||
130721165|NCT03186781|470604218|FG005|Overall Study|Withdrawal by Subject|0|||
130721166|NCT04663295|470604219|FG000|Run-in Period|Withdrawal by Subject|3|||
130721167|NCT04663295|470604219|FG000|Overall Study Period|Pregnancy|1|||
130721168|NCT04663295|470604219|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
130721169|NCT03665441|470604220|FG000|Overall Study|survival follow up ongoing|23|||
130721170|NCT03665441|470604221|FG001|Overall Study|survival follow up ongoing|0|||
130721171|NCT03665441|470604220|FG000|Overall Study|Patients ongoing on treatment|9|||
130721172|NCT03665441|470604221|FG001|Overall Study|Patients ongoing on treatment|6|||
130721173|NCT03665441|470604220|FG000|Overall Study|Randomized but not treated|7|||
130721174|NCT03665441|470604221|FG001|Overall Study|Randomized but not treated|11|||
130721175|NCT03954834|470604222|FG000|Overall Study|Adverse Event|1|||
130721176|NCT03954834|470604223|FG001|Overall Study|Adverse Event|3|||
130721177|NCT03954834|470604224|FG002|Overall Study|Adverse Event|1|||
130721178|NCT03954834|470604225|FG003|Overall Study|Adverse Event|1|||
130721179|NCT03954834|470604222|FG000|Overall Study|Death|0|||
130721180|NCT03954834|470604223|FG001|Overall Study|Death|0|||
130721181|NCT03954834|470604224|FG002|Overall Study|Death|0|||
130721182|NCT03954834|470604225|FG003|Overall Study|Death|1|||
130721183|NCT03954834|470604222|FG000|Overall Study|Physician Decision|0|||
130317211|NCT01131507|469128542|FG000|Overall Study|Lost to Follow-up|1|||
130317212|NCT01131507|469128542|FG000|Overall Study|Withdrawal by Subject|1|||
130317213|NCT00762359|469128549|FG000|Overall Study|Adverse Event|20|||
130317214|NCT00762359|469128550|FG001|Overall Study|Adverse Event|23|||
130317215|NCT00762359|469128549|FG000|Overall Study|Protocol Violation|21|||
130317216|NCT00762359|469128550|FG001|Overall Study|Protocol Violation|13|||
130317217|NCT00762359|469128549|FG000|Overall Study|Withdrawal by Subject|13|||
130317218|NCT00762359|469128550|FG001|Overall Study|Withdrawal by Subject|10|||
130317219|NCT00762359|469128549|FG000|Overall Study|Lack of Efficacy|0|||
130317220|NCT00762359|469128550|FG001|Overall Study|Lack of Efficacy|4|||
130317221|NCT00762359|469128549|FG000|Overall Study|Institution closed|2|||
130317222|NCT00762359|469128550|FG001|Overall Study|Institution closed|3|||
130317223|NCT00762359|469128549|FG000|Overall Study|Physician Decision|2|||
130317224|NCT00762359|469128550|FG001|Overall Study|Physician Decision|3|||
130317225|NCT00762359|469128549|FG000|Overall Study|Removal|0|||
130317226|NCT00762359|469128550|FG001|Overall Study|Removal|1|||
130317227|NCT00762359|469128549|FG000|Overall Study|Withdrew consent|1|||
130317228|NCT00762359|469128550|FG001|Overall Study|Withdrew consent|0|||
130317229|NCT01453049|469128551|FG000|Overall Study|Protocol Violation|2|||
130317230|NCT01453049|469128552|FG001|Overall Study|Protocol Violation|5|||
130317231|NCT01453049|469128551|FG000|Overall Study|Lost to Follow-up|2|||
130317232|NCT01453049|469128552|FG001|Overall Study|Lost to Follow-up|1|||
130317233|NCT01453049|469128551|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
130317234|NCT01453049|469128552|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
130317235|NCT01453049|469128551|FG000|Overall Study|Withdrawal by Subject|1|||
130317236|NCT01453049|469128552|FG001|Overall Study|Withdrawal by Subject|0|||
130317237|NCT01453049|469128551|FG000|Overall Study|Randomized in Error|1|||
130317238|NCT01453049|469128552|FG001|Overall Study|Randomized in Error|0|||
130317239|NCT00882440|469128553|FG000|Overall Study|Adverse Event|2|||
130317240|NCT00882440|469128554|FG001|Overall Study|Adverse Event|2|||
130317241|NCT00882440|469128555|FG002|Overall Study|Adverse Event|2|||
130317242|NCT00882440|469128556|FG003|Overall Study|Adverse Event|1|||
130317243|NCT00882440|469128557|FG004|Overall Study|Adverse Event|1|||
130377897|NCT00203996|469350046|FG007|Overall Study|CPAP machine malfunction|0|||
130721184|NCT03954834|470604223|FG001|Overall Study|Physician Decision|1|||
130721185|NCT03954834|470604224|FG002|Overall Study|Physician Decision|0|||
130721186|NCT03954834|470604225|FG003|Overall Study|Physician Decision|2|||
130721187|NCT03954834|470604222|FG000|Overall Study|Protocol Violation|1|||
130721188|NCT03954834|470604223|FG001|Overall Study|Protocol Violation|0|||
130317244|NCT00882440|469128558|FG005|Overall Study|Adverse Event|4|||
130317245|NCT00882440|469128559|FG006|Overall Study|Adverse Event|2|||
130377898|NCT00203996|469350047|FG008|Overall Study|CPAP machine malfunction|0|||
130317246|NCT00882440|469128553|FG000|Overall Study|Lack of Efficacy|3|||
130317247|NCT00882440|469128554|FG001|Overall Study|Lack of Efficacy|5|||
130317248|NCT00882440|469128555|FG002|Overall Study|Lack of Efficacy|2|||
130317249|NCT00882440|469128556|FG003|Overall Study|Lack of Efficacy|0|||
130317250|NCT00882440|469128557|FG004|Overall Study|Lack of Efficacy|0|||
130721189|NCT03954834|470604224|FG002|Overall Study|Protocol Violation|0|||
130317251|NCT00882440|469128558|FG005|Overall Study|Lack of Efficacy|3|||
130377899|NCT00203996|469350048|FG009|Overall Study|CPAP machine malfunction|0|||
130721190|NCT03954834|470604225|FG003|Overall Study|Protocol Violation|1|||
130317252|NCT00882440|469128559|FG006|Overall Study|Lack of Efficacy|0|||
130317253|NCT00882440|469128553|FG000|Overall Study|Lost to Follow-up|2|||
130317254|NCT00882440|469128554|FG001|Overall Study|Lost to Follow-up|0|||
130317255|NCT00882440|469128555|FG002|Overall Study|Lost to Follow-up|1|||
130467014|NCT04149002|469676480|FG000|Overall Study|Withdrawal by Subject|1|||
130721191|NCT03954834|470604222|FG000|Overall Study|Withdrawal by Subject|2|||
130721192|NCT03954834|470604223|FG001|Overall Study|Withdrawal by Subject|3|||
130721193|NCT03954834|470604224|FG002|Overall Study|Withdrawal by Subject|13|||
130721194|NCT03954834|470604225|FG003|Overall Study|Withdrawal by Subject|6|||
130721195|NCT03954834|470604222|FG000|Overall Study|Participant left the country|0|||
130721196|NCT03954834|470604223|FG001|Overall Study|Participant left the country|0|||
130721197|NCT03954834|470604224|FG002|Overall Study|Participant left the country|1|||
130721198|NCT03954834|470604225|FG003|Overall Study|Participant left the country|0|||
130721199|NCT03954834|470604222|FG000|Overall Study|Lost to Follow-up|3|||
130721200|NCT03954834|470604223|FG001|Overall Study|Lost to Follow-up|2|||
130721201|NCT03954834|470604224|FG002|Overall Study|Lost to Follow-up|3|||
130721202|NCT03954834|470604225|FG003|Overall Study|Lost to Follow-up|5|||
130721203|NCT03047330|470604229|FG000|Sleep Block 1|Withdrawal by Subject|3|||
130721204|NCT00663026|470604230|FG000|Overall Study|Lost to Follow-up|1|||
130721205|NCT00663026|470604231|FG001|Overall Study|Lost to Follow-up|0|||
130721206|NCT00663026|470604232|FG002|Overall Study|Lost to Follow-up|0|||
130721207|NCT00663026|470604230|FG000|Overall Study|Other|1|||
130721208|NCT00663026|470604231|FG001|Overall Study|Other|2|||
130721209|NCT00663026|470604232|FG002|Overall Study|Other|0|||
130721210|NCT00663026|470604230|FG000|Overall Study|Adverse Event|0|||
130721211|NCT00663026|470604231|FG001|Overall Study|Adverse Event|2|||
130721212|NCT00663026|470604232|FG002|Overall Study|Adverse Event|3|||
130721213|NCT00663026|470604230|FG000|Overall Study|Caregiver Request|0|||
130721214|NCT00663026|470604231|FG001|Overall Study|Caregiver Request|2|||
130721215|NCT00663026|470604232|FG002|Overall Study|Caregiver Request|0|||
130721216|NCT00663026|470604230|FG000|Overall Study|Withdrawal by Subject|0|||
130721217|NCT00663026|470604231|FG001|Overall Study|Withdrawal by Subject|0|||
130721218|NCT00663026|470604232|FG002|Overall Study|Withdrawal by Subject|1|||
130721219|NCT01570686|470604233|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130721220|NCT01570686|470604234|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130721221|NCT01570686|470604233|FG000|Overall Study|Administrative problems|0|||
130721222|NCT01570686|470604234|FG001|Overall Study|Administrative problems|1|||
130721223|NCT01570686|470604233|FG000|Overall Study|Adverse Event|8|||
130721224|NCT01570686|470604234|FG001|Overall Study|Adverse Event|6|||
130721225|NCT01570686|470604233|FG000|Overall Study|Lost to Follow-up|4|||
130721226|NCT01570686|470604234|FG001|Overall Study|Lost to Follow-up|3|||
130721227|NCT01570686|470604233|FG000|Overall Study|Protocol Deviation|3|||
130721228|NCT01570686|470604234|FG001|Overall Study|Protocol Deviation|0|||
130721229|NCT01570686|470604233|FG000|Overall Study|Withdrawal by Subject|4|||
130721230|NCT01570686|470604234|FG001|Overall Study|Withdrawal by Subject|4|||
130721231|NCT01570686|470604233|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130721232|NCT01570686|470604234|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130721233|NCT00686075|470604236|FG000|Overall Study|Withdrawal by Subject|4|||
130721234|NCT00686075|470604237|FG001|Overall Study|Withdrawal by Subject|3|||
130721235|NCT00686075|470604238|FG002|Overall Study|Withdrawal by Subject|3|||
130721236|NCT00686075|470604239|FG003|Overall Study|Withdrawal by Subject|7|||
130721237|NCT00686075|470604240|FG004|Overall Study|Withdrawal by Subject|1|||
130721238|NCT00686075|470604241|FG005|Overall Study|Withdrawal by Subject|0|||
130721239|NCT00686075|470604242|FG006|Overall Study|Withdrawal by Subject|0|||
130721240|NCT00686075|470604243|FG007|Overall Study|Withdrawal by Subject|2|||
130721241|NCT00686075|470604244|FG008|Overall Study|Withdrawal by Subject|4|||
130721242|NCT00686075|470604245|FG009|Overall Study|Withdrawal by Subject|6|||
130721243|NCT00686075|470604236|FG000|Overall Study|Lost to Follow-up|3|||
130721244|NCT00686075|470604237|FG001|Overall Study|Lost to Follow-up|6|||
130721245|NCT00686075|470604238|FG002|Overall Study|Lost to Follow-up|3|||
130721246|NCT00686075|470604239|FG003|Overall Study|Lost to Follow-up|2|||
130721247|NCT00686075|470604240|FG004|Overall Study|Lost to Follow-up|3|||
130721248|NCT00686075|470604241|FG005|Overall Study|Lost to Follow-up|3|||
130721249|NCT00686075|470604242|FG006|Overall Study|Lost to Follow-up|0|||
130721250|NCT00686075|470604243|FG007|Overall Study|Lost to Follow-up|0|||
130721251|NCT00686075|470604244|FG008|Overall Study|Lost to Follow-up|2|||
130721252|NCT00686075|470604245|FG009|Overall Study|Lost to Follow-up|3|||
130721253|NCT00686075|470604236|FG000|Overall Study|Other|1|||
130721254|NCT00686075|470604237|FG001|Overall Study|Other|1|||
130721255|NCT00686075|470604238|FG002|Overall Study|Other|0|||
130721256|NCT00686075|470604239|FG003|Overall Study|Other|0|||
130721257|NCT00686075|470604240|FG004|Overall Study|Other|0|||
130721258|NCT00686075|470604241|FG005|Overall Study|Other|0|||
130721259|NCT00686075|470604242|FG006|Overall Study|Other|0|||
130721260|NCT00686075|470604243|FG007|Overall Study|Other|0|||
130721261|NCT00686075|470604244|FG008|Overall Study|Other|0|||
130721262|NCT00686075|470604245|FG009|Overall Study|Other|1|||
130721263|NCT04715932|470604246|FG000|Overall Study|Lost to Follow-up|1|||
130721264|NCT04715932|470604247|FG001|Overall Study|Lost to Follow-up|0|||
130721265|NCT03783039|470604260|FG000|Overall Study|Death|2|||
130721266|NCT03783039|470604261|FG001|Overall Study|Death|1|||
130721267|NCT01682863|470604262|FG000|Overall Study|Subject/guardian decision|19|||
130721268|NCT01682863|470604263|FG001|Overall Study|Subject/guardian decision|12|||
130721269|NCT01682863|470604264|FG002|Overall Study|Subject/guardian decision|10|||
130721270|NCT01682863|470604262|FG000|Overall Study|Lost to Follow-up|5|||
130721271|NCT01682863|470604263|FG001|Overall Study|Lost to Follow-up|1|||
130721272|NCT01682863|470604264|FG002|Overall Study|Lost to Follow-up|6|||
130721273|NCT01682863|470604262|FG000|Overall Study|Death|1|||
130721274|NCT01682863|470604263|FG001|Overall Study|Death|3|||
130721275|NCT01682863|470604264|FG002|Overall Study|Death|4|||
130721276|NCT01682863|470604262|FG000|Overall Study|Protocol deviation|1|||
130721277|NCT01682863|470604263|FG001|Overall Study|Protocol deviation|0|||
130721278|NCT01682863|470604264|FG002|Overall Study|Protocol deviation|1|||
130721279|NCT01682863|470604262|FG000|Overall Study|Technical problems|1|||
130721280|NCT01682863|470604263|FG001|Overall Study|Technical problems|0|||
130721281|NCT01682863|470604264|FG002|Overall Study|Technical problems|0|||
130721282|NCT01682863|470604262|FG000|Overall Study|Adverse Event|0|||
130721283|NCT01682863|470604263|FG001|Overall Study|Adverse Event|1|||
130377900|NCT00203996|469350039|FG000|Overall Study|Scheduling issue|0|||
130721284|NCT01682863|470604264|FG002|Overall Study|Adverse Event|2|||
130721285|NCT01682863|470604262|FG000|Overall Study|Physician Decision|0|||
130721286|NCT01682863|470604263|FG001|Overall Study|Physician Decision|0|||
130721287|NCT01682863|470604264|FG002|Overall Study|Physician Decision|1|||
130721288|NCT00918138|470604266|FG000|Overall Study|Subject withdrew consent|1|||
130721289|NCT00918138|470604267|FG001|Overall Study|Subject withdrew consent|1|||
130467015|NCT04149002|469676481|FG001|Overall Study|Withdrawal by Subject|0|||
130467016|NCT03233633|469676482|FG000|Overall Study|Adverse Event|2|||
130467017|NCT03233633|469676482|FG000|Overall Study|Less Than 3 Days of Data|6|||
130467018|NCT04583423|469676484|FG000|Overall Study|Lost to Follow-up|0|||
130467019|NCT04583423|469676485|FG001|Overall Study|Lost to Follow-up|1|||
130467020|NCT04583423|469676486|FG002|Overall Study|Lost to Follow-up|0|||
130467021|NCT04583423|469676487|FG003|Overall Study|Lost to Follow-up|2|||
130467022|NCT04583423|469676484|FG000|Overall Study|Study Terminated by Sponsor|32|||
130467023|NCT04583423|469676485|FG001|Overall Study|Study Terminated by Sponsor|35|||
130467024|NCT04583423|469676486|FG002|Overall Study|Study Terminated by Sponsor|36|||
130467025|NCT04583423|469676487|FG003|Overall Study|Study Terminated by Sponsor|33|||
130467026|NCT04583423|469676484|FG000|Overall Study|Withdrawal by Subject|3|||
130467027|NCT04583423|469676485|FG001|Overall Study|Withdrawal by Subject|1|||
130467028|NCT04583423|469676486|FG002|Overall Study|Withdrawal by Subject|2|||
130467029|NCT04583423|469676487|FG003|Overall Study|Withdrawal by Subject|1|||
130467030|NCT01198145|469676488|FG000|Overall Study|Withdrawal by Subject|1|||
130467031|NCT01198145|469676489|FG001|Overall Study|Withdrawal by Subject|1|||
130467032|NCT00603954|469676492|FG000|Overall Study|Protocol Violation|1|||
130467033|NCT00603954|469676493|FG001|Overall Study|Protocol Violation|2|||
130467034|NCT01736215|469676494|FG000|Overall Study|Early termination of erythropoietin use|1|||
130467035|NCT01736215|469676494|FG000|Overall Study|Adverse Event|4|||
130467036|NCT01736215|469676494|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
130467037|NCT01736215|469676494|FG000|Overall Study|Insufficient data to perform analysis|8|||
130467038|NCT01070069|469676495|FG000|Overall Study|Death|1|||
130467039|NCT01070069|469676496|FG001|Overall Study|Death|0|||
130467040|NCT01070069|469676497|FG002|Overall Study|Death|2|||
130467041|NCT01070069|469676498|FG003|Overall Study|Death|0|||
130467042|NCT01070069|469676499|FG004|Overall Study|Death|1|||
130467043|NCT01070069|469676495|FG000|Overall Study|Withdrawal by Subject|1|||
130467044|NCT01070069|469676496|FG001|Overall Study|Withdrawal by Subject|1|||
130467045|NCT01070069|469676497|FG002|Overall Study|Withdrawal by Subject|4|||
130467046|NCT01070069|469676498|FG003|Overall Study|Withdrawal by Subject|0|||
130467047|NCT01070069|469676499|FG004|Overall Study|Withdrawal by Subject|0|||
130467048|NCT01070069|469676495|FG000|Overall Study|Lost to Follow-up|4|||
130467049|NCT01070069|469676496|FG001|Overall Study|Lost to Follow-up|1|||
130467050|NCT01070069|469676497|FG002|Overall Study|Lost to Follow-up|0|||
130467051|NCT01070069|469676498|FG003|Overall Study|Lost to Follow-up|0|||
130467052|NCT01070069|469676499|FG004|Overall Study|Lost to Follow-up|3|||
130467053|NCT00419341|469676511|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
130467054|NCT00419341|469676511|FG000|Wash in/Wash Out Period|Adverse Event|2|||
130467055|NCT00419341|469676511|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
130467056|NCT00419341|469676511|FG000|Efficacy Period|Withdrawal by Subject|6|||
130467057|NCT00419341|469676511|FG000|Efficacy Period|Protocol Violation|1|||
130467058|NCT00419341|469676511|FG000|Efficacy Period|Lost to Follow-up|1|||
130467059|NCT00419341|469676511|FG000|Efficacy Period|Non-compliance|1|||
130467060|NCT00419341|469676511|FG000|Efficacy Period|Termination of study site|1|||
130467061|NCT01499199|469676513|FG000|Overall Study|Adverse Event|1|||
130467062|NCT01499199|469676513|FG000|Overall Study|Lack of Efficacy|1|||
130467063|NCT04732338|469676519|FG000|Overall Study|Lost to Follow-up|3|||
130467064|NCT04732338|469676520|FG001|Overall Study|Lost to Follow-up|3|||
130467065|NCT02539225|469676526|FG000|Part A|Adverse Event|13|||
130467066|NCT02539225|469676527|FG001|Part A|Adverse Event|4|||
130559577|NCT01986920|470017816|FG000|Placebo|Withdrawal by Subject|0|||
130721290|NCT00918138|470604266|FG000|Overall Study|Death|1|||
130721291|NCT00918138|470604267|FG001|Overall Study|Death|0|||
130721292|NCT00699374|470604268|FG000|Overall Study|Death|93|||
130721293|NCT00699374|470604269|FG001|Overall Study|Death|83|||
130721294|NCT00699374|470604268|FG000|Overall Study|Adverse Event|70|||
130467067|NCT02539225|469676526|FG000|Part A|Withdrawal by Subject|2|||
130467068|NCT02539225|469676527|FG001|Part A|Withdrawal by Subject|4|||
130467069|NCT02539225|469676526|FG000|Part A|Physician Decision|4|||
130467070|NCT02539225|469676527|FG001|Part A|Physician Decision|7|||
130467071|NCT02539225|469676526|FG000|Part A|Did Not Receive study Drug|1|||
130467072|NCT02539225|469676527|FG001|Part A|Did Not Receive study Drug|1|||
130467073|NCT02539225|469676526|FG000|Pre Treatment for Part B|Progressive disease|1|||
130467074|NCT02539225|469676527|FG001|Pre Treatment for Part B|Progressive disease|1|||
130467075|NCT02539225|469676526|FG000|Pre Treatment for Part B|Adverse Event|1|||
130721295|NCT00699374|470604269|FG001|Overall Study|Adverse Event|67|||
130467076|NCT02539225|469676527|FG001|Pre Treatment for Part B|Adverse Event|1|||
130467077|NCT02539225|469676526|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
130467078|NCT02539225|469676527|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
130467079|NCT02539225|469676526|FG000|Pre Treatment for Part B|Physician Decision|2|||
130467080|NCT02539225|469676527|FG001|Pre Treatment for Part B|Physician Decision|0|||
130467081|NCT02539225|469676526|FG000|Part B|Adverse Event|4|||
130467082|NCT02539225|469676527|FG001|Part B|Adverse Event|4|||
130559578|NCT01986920|470017817|FG001|Placebo|Withdrawal by Subject|0|||
130467083|NCT02539225|469676526|FG000|Part B|Withdrawal by Subject|0|||
130467084|NCT02539225|469676527|FG001|Part B|Withdrawal by Subject|3|||
130467085|NCT02539225|469676526|FG000|Part B|Physician Decision|0|||
130467086|NCT02539225|469676527|FG001|Part B|Physician Decision|9|||
130721296|NCT00699374|470604268|FG000|Overall Study|Global deterioration of health status|7|||
130721297|NCT00699374|470604269|FG001|Overall Study|Global deterioration of health status|8|||
130721298|NCT00699374|470604268|FG000|Overall Study|Lost to Follow-up|3|||
130721299|NCT00699374|470604269|FG001|Overall Study|Lost to Follow-up|5|||
130721300|NCT00699374|470604268|FG000|Overall Study|Withdrawal by Subject|34|||
130721301|NCT00699374|470604269|FG001|Overall Study|Withdrawal by Subject|44|||
130721302|NCT00699374|470604268|FG000|Overall Study|Objective progression or relapse|281|||
130721303|NCT00699374|470604269|FG001|Overall Study|Objective progression or relapse|277|||
130721304|NCT00699374|470604268|FG000|Overall Study|Other|18|||
130721305|NCT00699374|470604269|FG001|Overall Study|Other|15|||
130721306|NCT00699374|470604268|FG000|Overall Study|Protocol Violation|2|||
130721307|NCT00699374|470604269|FG001|Overall Study|Protocol Violation|6|||
130721308|NCT00699374|470604268|FG000|Overall Study|Study terminated by sponsor|13|||
130721309|NCT00699374|470604269|FG001|Overall Study|Study terminated by sponsor|28|||
130721310|NCT00699374|470604268|FG000|Overall Study|Randomized but not treated|4|||
130721311|NCT00699374|470604269|FG001|Overall Study|Randomized but not treated|2|||
130721312|NCT00699374|470604268|FG000|Overall Study|Died 28 days after last dose|5|||
130721313|NCT00699374|470604269|FG001|Overall Study|Died 28 days after last dose|9|||
130721314|NCT02885181|470604273|FG000|Overall Study|Investigator's Discretion|0|||
130721315|NCT02885181|470604274|FG001|Overall Study|Investigator's Discretion|1|||
130721316|NCT02885181|470604275|FG002|Overall Study|Investigator's Discretion|0|||
130721317|NCT02885181|470604276|FG003|Overall Study|Investigator's Discretion|1|||
130721318|NCT02885181|470604273|FG000|Overall Study|Adverse Event|0|||
130721319|NCT02885181|470604274|FG001|Overall Study|Adverse Event|0|||
130721320|NCT02885181|470604275|FG002|Overall Study|Adverse Event|0|||
130721321|NCT02885181|470604276|FG003|Overall Study|Adverse Event|1|||
130721322|NCT02885181|470604273|FG000|Overall Study|Withdrawal by Subject|0|||
130721323|NCT02885181|470604274|FG001|Overall Study|Withdrawal by Subject|0|||
130721324|NCT02885181|470604275|FG002|Overall Study|Withdrawal by Subject|0|||
130721325|NCT02885181|470604276|FG003|Overall Study|Withdrawal by Subject|1|||
130721326|NCT01517373|470604279|FG000|Run-in Period|Death|1|||
130721327|NCT01517373|470604280|FG001|Run-in Period|Death|0|||
130721328|NCT01517373|470604281|FG002|Run-in Period|Death|0|||
130721329|NCT01517373|470604282|FG003|Run-in Period|Death|0|||
130721330|NCT01517373|470604283|FG004|Run-in Period|Death|0|||
130721331|NCT01517373|470604284|FG005|Run-in Period|Death|0|||
130721332|NCT01517373|470604279|FG000|Run-in Period|Adverse Event|5|||
130721333|NCT01517373|470604280|FG001|Run-in Period|Adverse Event|0|||
130721334|NCT01517373|470604281|FG002|Run-in Period|Adverse Event|0|||
130721335|NCT01517373|470604282|FG003|Run-in Period|Adverse Event|0|||
130721336|NCT01517373|470604283|FG004|Run-in Period|Adverse Event|0|||
130721337|NCT01517373|470604284|FG005|Run-in Period|Adverse Event|0|||
130721338|NCT01517373|470604279|FG000|Run-in Period|Did not meet eligibility criteria|34|||
130721339|NCT01517373|470604280|FG001|Run-in Period|Did not meet eligibility criteria|0|||
130721340|NCT01517373|470604281|FG002|Run-in Period|Did not meet eligibility criteria|0|||
130721341|NCT01517373|470604282|FG003|Run-in Period|Did not meet eligibility criteria|0|||
130721342|NCT01517373|470604283|FG004|Run-in Period|Did not meet eligibility criteria|0|||
130721343|NCT01517373|470604284|FG005|Run-in Period|Did not meet eligibility criteria|0|||
130721344|NCT01517373|470604279|FG000|Run-in Period|Lost to Follow-up|1|||
130721345|NCT01517373|470604280|FG001|Run-in Period|Lost to Follow-up|0|||
130721346|NCT01517373|470604281|FG002|Run-in Period|Lost to Follow-up|0|||
130721347|NCT01517373|470604282|FG003|Run-in Period|Lost to Follow-up|0|||
130721348|NCT01517373|470604283|FG004|Run-in Period|Lost to Follow-up|0|||
130721349|NCT01517373|470604284|FG005|Run-in Period|Lost to Follow-up|0|||
130721350|NCT01517373|470604279|FG000|Run-in Period|Withdrawal by Subject|12|||
130721351|NCT01517373|470604280|FG001|Run-in Period|Withdrawal by Subject|0|||
130721352|NCT01517373|470604281|FG002|Run-in Period|Withdrawal by Subject|0|||
130721353|NCT01517373|470604282|FG003|Run-in Period|Withdrawal by Subject|0|||
130721354|NCT01517373|470604283|FG004|Run-in Period|Withdrawal by Subject|0|||
130721355|NCT01517373|470604284|FG005|Run-in Period|Withdrawal by Subject|0|||
130721356|NCT01517373|470604279|FG000|Run-in Period|Sponsor Decision|3|||
130721357|NCT01517373|470604280|FG001|Run-in Period|Sponsor Decision|0|||
130721358|NCT01517373|470604281|FG002|Run-in Period|Sponsor Decision|0|||
130721359|NCT01517373|470604282|FG003|Run-in Period|Sponsor Decision|0|||
130721360|NCT01517373|470604283|FG004|Run-in Period|Sponsor Decision|0|||
130721361|NCT01517373|470604284|FG005|Run-in Period|Sponsor Decision|0|||
130721362|NCT01517373|470604279|FG000|Run-in Period|Other|1|||
130721363|NCT01517373|470604280|FG001|Run-in Period|Other|0|||
130721364|NCT01517373|470604281|FG002|Run-in Period|Other|0|||
130721365|NCT01517373|470604282|FG003|Run-in Period|Other|0|||
130721366|NCT01517373|470604283|FG004|Run-in Period|Other|0|||
130317256|NCT00882440|469128556|FG003|Overall Study|Lost to Follow-up|1|||
130317257|NCT00882440|469128557|FG004|Overall Study|Lost to Follow-up|1|||
130317258|NCT00882440|469128558|FG005|Overall Study|Lost to Follow-up|0|||
130317259|NCT00882440|469128559|FG006|Overall Study|Lost to Follow-up|1|||
130317260|NCT00882440|469128553|FG000|Overall Study|Protocol Violation|0|||
130317261|NCT00882440|469128554|FG001|Overall Study|Protocol Violation|0|||
130317262|NCT00882440|469128555|FG002|Overall Study|Protocol Violation|1|||
130317263|NCT00882440|469128556|FG003|Overall Study|Protocol Violation|1|||
130317264|NCT00882440|469128557|FG004|Overall Study|Protocol Violation|1|||
130317265|NCT00882440|469128558|FG005|Overall Study|Protocol Violation|0|||
130317266|NCT00882440|469128559|FG006|Overall Study|Protocol Violation|0|||
130317267|NCT00882440|469128553|FG000|Overall Study|Withdrawal by Subject|2|||
130317268|NCT00882440|469128554|FG001|Overall Study|Withdrawal by Subject|1|||
130317269|NCT00882440|469128555|FG002|Overall Study|Withdrawal by Subject|1|||
130317270|NCT00882440|469128556|FG003|Overall Study|Withdrawal by Subject|0|||
130317271|NCT00882440|469128557|FG004|Overall Study|Withdrawal by Subject|6|||
130317272|NCT00882440|469128558|FG005|Overall Study|Withdrawal by Subject|0|||
130317273|NCT00882440|469128559|FG006|Overall Study|Withdrawal by Subject|1|||
130317274|NCT00882440|469128553|FG000|Overall Study|Patient Uncooperative|2|||
130317275|NCT00882440|469128554|FG001|Overall Study|Patient Uncooperative|0|||
130317276|NCT00882440|469128555|FG002|Overall Study|Patient Uncooperative|0|||
130317277|NCT00882440|469128556|FG003|Overall Study|Patient Uncooperative|0|||
130317278|NCT00882440|469128557|FG004|Overall Study|Patient Uncooperative|1|||
130317279|NCT00882440|469128558|FG005|Overall Study|Patient Uncooperative|0|||
130317280|NCT00882440|469128559|FG006|Overall Study|Patient Uncooperative|0|||
130317281|NCT05482308|469128563|FG000|Overall Study|Withdrawal by Subject|1|||
130317282|NCT05482308|469128564|FG001|Overall Study|Withdrawal by Subject|0|||
130317283|NCT05482308|469128563|FG000|Overall Study|No longer meets eligibility criteria|0|||
130317284|NCT05482308|469128564|FG001|Overall Study|No longer meets eligibility criteria|1|||
130317285|NCT01451723|469128566|FG000|Overall Study|study halted|6|||
130317286|NCT01451723|469128567|FG001|Overall Study|study halted|5|||
130317287|NCT00443040|469128570|FG000|Overall Study|Withdrawal by Subject|1|||
130317288|NCT00443040|469128571|FG001|Overall Study|Withdrawal by Subject|0|||
130467087|NCT04766034|469676530|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
130467088|NCT04766034|469676531|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
130467089|NCT04766034|469676532|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
130467090|NCT04766034|469676533|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
130467091|NCT04766034|469676534|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
130467092|NCT04766034|469676530|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
130467093|NCT04766034|469676531|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
130467094|NCT04766034|469676532|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
130467095|NCT04766034|469676533|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
130467096|NCT04766034|469676534|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
130467097|NCT04766034|469676530|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
130467098|NCT04766034|469676531|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
130467099|NCT04766034|469676532|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
130467100|NCT04766034|469676533|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
130467101|NCT04766034|469676534|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
130317289|NCT00443040|469128572|FG002|Overall Study|Withdrawal by Subject|0|||
130467102|NCT04766034|469676530|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
130317290|NCT00443040|469128570|FG000|Overall Study|Converted to an open laparotomy|3|||
130317291|NCT00443040|469128571|FG001|Overall Study|Converted to an open laparotomy|0|||
130317292|NCT00443040|469128572|FG002|Overall Study|Converted to an open laparotomy|1|||
130317293|NCT04245111|469128576|FG000|Overall Study|Lost to Follow-up|5|||
130317294|NCT04245111|469128577|FG001|Overall Study|Lost to Follow-up|1|||
130317295|NCT04245111|469128578|FG002|Overall Study|Lost to Follow-up|1|||
130317296|NCT03192176|469128584|FG000|Overall Study|Adverse Event|1|||
130467103|NCT04766034|469676531|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
130467104|NCT04766034|469676532|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
130317297|NCT03192176|469128585|FG001|Overall Study|Adverse Event|0|||
130317298|NCT03192176|469128586|FG002|Overall Study|Adverse Event|4|||
130317299|NCT03192176|469128587|FG003|Overall Study|Adverse Event|5|||
130317300|NCT03192176|469128588|FG004|Overall Study|Adverse Event|3|||
130317301|NCT03192176|469128589|FG005|Overall Study|Adverse Event|2|||
130317302|NCT03192176|469128590|FG006|Overall Study|Adverse Event|3|||
130317303|NCT03192176|469128591|FG007|Overall Study|Adverse Event|3|||
130317304|NCT03192176|469128584|FG000|Overall Study|Lost to Follow-up|0|||
130467105|NCT04766034|469676533|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
130467106|NCT04766034|469676534|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
130467107|NCT04814186|469678838|FG000|Treatment Phase|Adverse Event|1|||
130467108|NCT04814186|469678838|FG000|Treatment Phase|Death|6|||
130467109|NCT04814186|469678838|FG000|Treatment Phase|Withdrawal by Subject|2|||
130721367|NCT01517373|470604284|FG005|Run-in Period|Other|0|||
130721368|NCT01517373|470604279|FG000|Treatment Period|Adverse Event|0|||
130721369|NCT01517373|470604280|FG001|Treatment Period|Adverse Event|0|||
130721370|NCT01517373|470604281|FG002|Treatment Period|Adverse Event|0|||
130721371|NCT01517373|470604282|FG003|Treatment Period|Adverse Event|0|||
130721372|NCT01517373|470604283|FG004|Treatment Period|Adverse Event|0|||
130721373|NCT01517373|470604284|FG005|Treatment Period|Adverse Event|2|||
130721374|NCT01517373|470604279|FG000|Treatment Period|Lost to Follow-up|0|||
130721375|NCT01517373|470604280|FG001|Treatment Period|Lost to Follow-up|0|||
130721376|NCT01517373|470604281|FG002|Treatment Period|Lost to Follow-up|1|||
130721377|NCT01517373|470604282|FG003|Treatment Period|Lost to Follow-up|1|||
130721378|NCT01517373|470604283|FG004|Treatment Period|Lost to Follow-up|0|||
130721379|NCT01517373|470604284|FG005|Treatment Period|Lost to Follow-up|0|||
130721380|NCT01517373|470604279|FG000|Treatment Period|Withdrawal by Subject|0|||
130721381|NCT01517373|470604280|FG001|Treatment Period|Withdrawal by Subject|3|||
130721382|NCT01517373|470604281|FG002|Treatment Period|Withdrawal by Subject|2|||
130721383|NCT01517373|470604282|FG003|Treatment Period|Withdrawal by Subject|2|||
130721384|NCT01517373|470604283|FG004|Treatment Period|Withdrawal by Subject|2|||
130721385|NCT01517373|470604284|FG005|Treatment Period|Withdrawal by Subject|3|||
130721386|NCT01517373|470604279|FG000|Treatment Period|Other|0|||
130721387|NCT01517373|470604280|FG001|Treatment Period|Other|0|||
130721388|NCT01517373|470604281|FG002|Treatment Period|Other|0|||
130721389|NCT01517373|470604282|FG003|Treatment Period|Other|0|||
130317305|NCT03192176|469128585|FG001|Overall Study|Lost to Follow-up|0|||
130317306|NCT03192176|469128586|FG002|Overall Study|Lost to Follow-up|1|||
130317307|NCT03192176|469128587|FG003|Overall Study|Lost to Follow-up|2|||
130317308|NCT03192176|469128588|FG004|Overall Study|Lost to Follow-up|3|||
130721390|NCT01517373|470604283|FG004|Treatment Period|Other|1|||
130317309|NCT03192176|469128589|FG005|Overall Study|Lost to Follow-up|1|||
130317310|NCT03192176|469128590|FG006|Overall Study|Lost to Follow-up|1|||
130721391|NCT01517373|470604284|FG005|Treatment Period|Other|0|||
130721392|NCT01517373|470604279|FG000|Treatment Period|Protocol Violation|0|||
130721393|NCT01517373|470604280|FG001|Treatment Period|Protocol Violation|0|||
130721394|NCT01517373|470604281|FG002|Treatment Period|Protocol Violation|0|||
130721395|NCT01517373|470604282|FG003|Treatment Period|Protocol Violation|0|||
130721396|NCT01517373|470604283|FG004|Treatment Period|Protocol Violation|1|||
130721397|NCT01517373|470604284|FG005|Treatment Period|Protocol Violation|0|||
130721398|NCT01517373|470604279|FG000|Treatment Period|Lack of Efficacy|0|||
130721399|NCT01517373|470604280|FG001|Treatment Period|Lack of Efficacy|1|||
130721400|NCT01517373|470604281|FG002|Treatment Period|Lack of Efficacy|1|||
130721401|NCT01517373|470604282|FG003|Treatment Period|Lack of Efficacy|3|||
130721402|NCT01517373|470604283|FG004|Treatment Period|Lack of Efficacy|2|||
130721403|NCT01517373|470604284|FG005|Treatment Period|Lack of Efficacy|0|||
130721404|NCT01517373|470604279|FG000|Treatment Period|Medication error without AEs|0|||
130721405|NCT01517373|470604280|FG001|Treatment Period|Medication error without AEs|0|||
130721406|NCT01517373|470604281|FG002|Treatment Period|Medication error without AEs|2|||
130721407|NCT01517373|470604282|FG003|Treatment Period|Medication error without AEs|1|||
130721408|NCT01517373|470604283|FG004|Treatment Period|Medication error without AEs|0|||
130721409|NCT01517373|470604284|FG005|Treatment Period|Medication error without AEs|2|||
130721410|NCT04562155|470604288|FG000|Overall Study|COVID-19 pandemic|0|||
130721411|NCT04562155|470604289|FG001|Overall Study|COVID-19 pandemic|0|||
130721412|NCT04562155|470604290|FG002|Overall Study|COVID-19 pandemic|0|||
130721413|NCT04562155|470604291|FG003|Overall Study|COVID-19 pandemic|1|||
130721414|NCT04562155|470604288|FG000|Overall Study|Adverse Event|7|||
130721415|NCT04562155|470604289|FG001|Overall Study|Adverse Event|3|||
130721416|NCT04562155|470604290|FG002|Overall Study|Adverse Event|8|||
130721417|NCT04562155|470604291|FG003|Overall Study|Adverse Event|1|||
130721418|NCT04562155|470604288|FG000|Overall Study|Withdrawal by Subject|3|||
130721419|NCT04562155|470604289|FG001|Overall Study|Withdrawal by Subject|6|||
130721420|NCT04562155|470604290|FG002|Overall Study|Withdrawal by Subject|3|||
130721421|NCT04562155|470604291|FG003|Overall Study|Withdrawal by Subject|3|||
130317311|NCT03192176|469128591|FG007|Overall Study|Lost to Follow-up|1|||
130721422|NCT04562155|470604288|FG000|Overall Study|Participant personal reason|1|||
130721423|NCT04562155|470604289|FG001|Overall Study|Participant personal reason|0|||
130721424|NCT04562155|470604290|FG002|Overall Study|Participant personal reason|2|||
130721425|NCT04562155|470604291|FG003|Overall Study|Participant personal reason|1|||
130317312|NCT03192176|469128584|FG000|Overall Study|Physician Decision|1|||
130317313|NCT03192176|469128585|FG001|Overall Study|Physician Decision|0|||
130467110|NCT04814186|469678838|FG000|Treatment Phase|Other|1|||
130467111|NCT04814186|469678838|FG000|Follow-Up Phase|Adverse Event|1|||
130721426|NCT01085201|470604294|FG000|Overall Study|Scheduling conflict|1|||
130721427|NCT01085201|470604295|FG001|Overall Study|Scheduling conflict|0|||
130721428|NCT01085201|470604296|FG002|Overall Study|Scheduling conflict|1|||
130317314|NCT03192176|469128586|FG002|Overall Study|Physician Decision|0|||
130317315|NCT03192176|469128587|FG003|Overall Study|Physician Decision|0|||
130317316|NCT03192176|469128588|FG004|Overall Study|Physician Decision|0|||
130317317|NCT03192176|469128589|FG005|Overall Study|Physician Decision|2|||
130317318|NCT03192176|469128590|FG006|Overall Study|Physician Decision|1|||
130317319|NCT03192176|469128591|FG007|Overall Study|Physician Decision|0|||
130317320|NCT03192176|469128584|FG000|Overall Study|Protocol Deviation|1|||
130317321|NCT03192176|469128585|FG001|Overall Study|Protocol Deviation|1|||
130377901|NCT00203996|469350040|FG001|Overall Study|Scheduling issue|0|||
130377902|NCT00203996|469350041|FG002|Overall Study|Scheduling issue|0|||
130377903|NCT00203996|469350042|FG003|Overall Study|Scheduling issue|0|||
130377904|NCT00203996|469350043|FG004|Overall Study|Scheduling issue|0|||
130377905|NCT00203996|469350044|FG005|Overall Study|Scheduling issue|0|||
130377906|NCT00203996|469350045|FG006|Overall Study|Scheduling issue|0|||
130377907|NCT00203996|469350046|FG007|Overall Study|Scheduling issue|2|||
130377908|NCT00203996|469350047|FG008|Overall Study|Scheduling issue|0|||
130377909|NCT00203996|469350048|FG009|Overall Study|Scheduling issue|0|||
130377910|NCT03064451|469350049|FG000|Overall Study|Lost to Follow-up|1|||
130377911|NCT03064451|469350049|FG000|Overall Study|Mapping Failure|4|||
130377912|NCT03064451|469350049|FG000|Overall Study|Exited prior to procedure|8|||
130377913|NCT03064451|469350049|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
130377914|NCT00750204|469350050|FG000|Overall Study|study halted prematurely|1|||
130377915|NCT00750204|469350051|FG001|Overall Study|study halted prematurely|1|||
130377916|NCT00850564|469350052|FG000|Overall Study|Withdrawal by Subject|2|||
130377917|NCT01774968|469350053|FG000|Overall Study|Adverse Event|4|||
130467112|NCT04814186|469678838|FG000|Follow-Up Phase|Death|6|||
130467113|NCT04814186|469678838|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
130467114|NCT04814186|469678838|FG000|Follow-Up Phase|Other|1|||
130467115|NCT03960463|469678871|FG000|Overall Study|Withdrawal by Subject|2|||
130467116|NCT03960463|469678872|FG001|Overall Study|Withdrawal by Subject|0|||
130467117|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
130467118|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
130467119|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
130467120|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
130467121|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
130467122|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
130467123|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
130467124|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
130467125|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
130559579|NCT01986920|470017818|FG002|Placebo|Withdrawal by Subject|0|||
130721429|NCT01085201|470604297|FG003|Overall Study|Scheduling conflict|0|||
130721430|NCT01085201|470604298|FG004|Overall Study|Scheduling conflict|0|||
130721431|NCT01085201|470604294|FG000|Overall Study|Unknown- no study drug|2|||
130721432|NCT01085201|470604295|FG001|Overall Study|Unknown- no study drug|0|||
130721433|NCT01085201|470604296|FG002|Overall Study|Unknown- no study drug|0|||
130721434|NCT01085201|470604297|FG003|Overall Study|Unknown- no study drug|0|||
130721435|NCT01085201|470604298|FG004|Overall Study|Unknown- no study drug|0|||
130721436|NCT01085201|470604294|FG000|Overall Study|Fond ineligible after consent|0|||
130721437|NCT01085201|470604295|FG001|Overall Study|Fond ineligible after consent|1|||
130721438|NCT01085201|470604296|FG002|Overall Study|Fond ineligible after consent|1|||
130721439|NCT01085201|470604297|FG003|Overall Study|Fond ineligible after consent|0|||
130721440|NCT01085201|470604298|FG004|Overall Study|Fond ineligible after consent|0|||
130721441|NCT04516759|470604301|FG000|Overall Study|Withdrawal by Subject|1|||
130721442|NCT04516759|470604302|FG001|Overall Study|Withdrawal by Subject|1|||
130721443|NCT04516759|470604301|FG000|Overall Study|Other|0|||
130721444|NCT04516759|470604302|FG001|Overall Study|Other|1|||
130721445|NCT00528411|470604303|FG000|Overall Study|Adverse Event|4|||
130721446|NCT00528411|470604304|FG001|Overall Study|Adverse Event|0|||
130721447|NCT00528411|470604305|FG002|Overall Study|Adverse Event|1|||
130721448|NCT00528411|470604303|FG000|Overall Study|Incorrect Enrolment|1|||
130721449|NCT00528411|470604304|FG001|Overall Study|Incorrect Enrolment|1|||
130721450|NCT00528411|470604305|FG002|Overall Study|Incorrect Enrolment|0|||
130721451|NCT00528411|470604303|FG000|Overall Study|Severe non-compliance to protocol|0|||
130721452|NCT00528411|470604304|FG001|Overall Study|Severe non-compliance to protocol|1|||
130721453|NCT00528411|470604305|FG002|Overall Study|Severe non-compliance to protocol|0|||
130721454|NCT00528411|470604303|FG000|Overall Study|Prior commitment medication|0|||
130721455|NCT00528411|470604304|FG001|Overall Study|Prior commitment medication|1|||
130721456|NCT00528411|470604305|FG002|Overall Study|Prior commitment medication|0|||
130721457|NCT01221363|470604309|FG000|Overall Study|Pregnancy|1|||
130721458|NCT01221363|470604310|FG001|Overall Study|Pregnancy|0|||
130721459|NCT01221363|470604309|FG000|Overall Study|Withdrawal by Subject|11|||
130721460|NCT01221363|470604310|FG001|Overall Study|Withdrawal by Subject|5|||
130721461|NCT02695537|470604311|FG000|Overall Study|Adverse Event|3|||
130721462|NCT02695537|470604311|FG000|Overall Study|Lack of Efficacy|28|||
130721463|NCT02695537|470604311|FG000|Overall Study|Withdrawal by Subject|4|||
130317322|NCT03192176|469128586|FG002|Overall Study|Protocol Deviation|0|||
130377918|NCT01774968|469350054|FG001|Overall Study|Adverse Event|4|||
130377919|NCT01774968|469350053|FG000|Overall Study|Death|0|||
130377920|NCT01774968|469350054|FG001|Overall Study|Death|1|||
130721464|NCT02695537|470604311|FG000|Overall Study|Protocol Violation|3|||
130721465|NCT03597529|470604312|FG000|Overall Study|Lost to Follow-up|10|||
130721466|NCT03597529|470604313|FG001|Overall Study|Lost to Follow-up|12|||
130721467|NCT03597529|470604312|FG000|Overall Study|Physician Decision|3|||
130721468|NCT03597529|470604313|FG001|Overall Study|Physician Decision|1|||
130721469|NCT03597529|470604312|FG000|Overall Study|Withdrawal by Subject|6|||
130721470|NCT03597529|470604313|FG001|Overall Study|Withdrawal by Subject|3|||
130721471|NCT03597529|470604312|FG000|Overall Study|Non-compliant with study activities|1|||
130721472|NCT03597529|470604313|FG001|Overall Study|Non-compliant with study activities|2|||
130721473|NCT02865460|470604320|FG000|Overall Study|Adverse Event|1|||
130721474|NCT02865460|470604321|FG001|Overall Study|Adverse Event|0|||
130721475|NCT02865460|470604320|FG000|Overall Study|Withdrawal by Subject|1|||
130721476|NCT02865460|470604321|FG001|Overall Study|Withdrawal by Subject|1|||
130721477|NCT02865460|470604320|FG000|Overall Study|Lost to Follow-up|7|||
130721478|NCT02865460|470604321|FG001|Overall Study|Lost to Follow-up|4|||
130721479|NCT02865460|470604320|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130721480|NCT02865460|470604321|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130721481|NCT02238795|470604328|FG000|Overall Study|Patient without purpura fulminans|1|||
130721482|NCT01292226|470604332|FG000|Overall Study|Adverse Event|5|||
130721483|NCT01292226|470604332|FG000|Overall Study|Death|1|||
130721484|NCT01292226|470604332|FG000|Overall Study|Graft loss|1|||
130721485|NCT01292226|470604332|FG000|Overall Study|Protocol Violation|3|||
130721486|NCT01292226|470604332|FG000|Overall Study|Withdrawal by Subject|1|||
130721487|NCT01292226|470604332|FG000|Overall Study|Other|2|||
130721488|NCT01584843|470604333|FG000|First Treatment Period|Adverse Event|0|||
130721489|NCT01584843|470604334|FG001|First Treatment Period|Adverse Event|0|||
130721490|NCT01584843|470604335|FG002|First Treatment Period|Adverse Event|1|||
130721491|NCT01584843|470604336|FG003|First Treatment Period|Adverse Event|0|||
130721492|NCT01584843|470604337|FG004|First Treatment Period|Adverse Event|0|||
130721493|NCT01584843|470604338|FG005|First Treatment Period|Adverse Event|0|||
130721494|NCT01584843|470604333|FG000|First Treatment Period|Protocol Violation|0|||
130721495|NCT01584843|470604334|FG001|First Treatment Period|Protocol Violation|0|||
130721496|NCT01584843|470604335|FG002|First Treatment Period|Protocol Violation|0|||
130721497|NCT01584843|470604336|FG003|First Treatment Period|Protocol Violation|0|||
130721498|NCT01584843|470604337|FG004|First Treatment Period|Protocol Violation|0|||
130721499|NCT01584843|470604338|FG005|First Treatment Period|Protocol Violation|1|||
130377921|NCT01774968|469350053|FG000|Overall Study|Lost to Follow-up|1|||
130377922|NCT01774968|469350054|FG001|Overall Study|Lost to Follow-up|3|||
130377923|NCT01774968|469350053|FG000|Overall Study|Physician Decision|5|||
130377924|NCT01774968|469350054|FG001|Overall Study|Physician Decision|1|||
130377925|NCT01774968|469350053|FG000|Overall Study|Protocol Violation|14|||
130377926|NCT01774968|469350054|FG001|Overall Study|Protocol Violation|13|||
130377927|NCT01774968|469350053|FG000|Overall Study|Sponsor Decision|0|||
130377928|NCT01774968|469350054|FG001|Overall Study|Sponsor Decision|2|||
130377929|NCT01774968|469350053|FG000|Overall Study|Withdrawal by Subject|6|||
130377930|NCT01774968|469350054|FG001|Overall Study|Withdrawal by Subject|11|||
130377931|NCT05355805|469350057|FG000|Overall Study|Lost to Follow-up|6|||
130377932|NCT05355805|469350058|FG001|Overall Study|Lost to Follow-up|11|||
130377933|NCT05355805|469350059|FG002|Overall Study|Lost to Follow-up|10|||
130377934|NCT05355805|469350060|FG003|Overall Study|Lost to Follow-up|6|||
130377935|NCT05355805|469350057|FG000|Overall Study|Decision by Sponsor|0|||
130377936|NCT05355805|469350058|FG001|Overall Study|Decision by Sponsor|0|||
130377937|NCT05355805|469350059|FG002|Overall Study|Decision by Sponsor|1|||
130377938|NCT05355805|469350060|FG003|Overall Study|Decision by Sponsor|0|||
130377939|NCT05355805|469350057|FG000|Overall Study|Withdrawal by Subject|7|||
130377940|NCT05355805|469350058|FG001|Overall Study|Withdrawal by Subject|14|||
130377941|NCT05355805|469350059|FG002|Overall Study|Withdrawal by Subject|15|||
130377942|NCT05355805|469350060|FG003|Overall Study|Withdrawal by Subject|13|||
130377943|NCT02167893|469350061|FG000|Overall Study|Investigator transferred|85|||
130377944|NCT02167893|469350061|FG000|Overall Study|Investigator health reasons|10|||
130377945|NCT02167893|469350061|FG000|Overall Study|Case report forms not collected|68|||
130377946|NCT04818840|469350062|FG000|Overall Study|Lost to Follow-up|0|||
130377947|NCT04818840|469350063|FG001|Overall Study|Lost to Follow-up|5|||
130377948|NCT04818840|469350062|FG000|Overall Study|Physician Decision|1|||
130377949|NCT04818840|469350063|FG001|Overall Study|Physician Decision|0|||
130377950|NCT04818840|469350062|FG000|Overall Study|Site Terminated by Sponsor|0|||
130377951|NCT04818840|469350063|FG001|Overall Study|Site Terminated by Sponsor|3|||
130377952|NCT04818840|469350062|FG000|Overall Study|Study Terminated by Sponsor|43|||
130377953|NCT04818840|469350063|FG001|Overall Study|Study Terminated by Sponsor|7|||
130377954|NCT04818840|469350062|FG000|Overall Study|Withdrawal by Subject|0|||
130721500|NCT01584843|470604333|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721501|NCT01584843|470604334|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130377955|NCT04818840|469350063|FG001|Overall Study|Withdrawal by Subject|1|||
130377956|NCT00524368|469351673|FG000|Overall Study|Adverse Event|10|||
130377957|NCT00524368|469351674|FG001|Overall Study|Adverse Event|12|||
130721502|NCT01584843|470604335|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721503|NCT01584843|470604336|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721504|NCT01584843|470604337|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721505|NCT01584843|470604338|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
130721506|NCT01584843|470604333|FG000|Second Treatment Period|Withdrawal by Subject|0|||
130721507|NCT01584843|470604334|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130721508|NCT01584843|470604335|FG002|Second Treatment Period|Withdrawal by Subject|0|||
130721509|NCT01584843|470604336|FG003|Second Treatment Period|Withdrawal by Subject|0|||
130721510|NCT01584843|470604337|FG004|Second Treatment Period|Withdrawal by Subject|0|||
130721511|NCT01584843|470604338|FG005|Second Treatment Period|Withdrawal by Subject|1|||
130721512|NCT02196701|470604339|FG000|Overall Study|Adverse Event|1|||
130721513|NCT02196701|470604339|FG000|Overall Study|Lost to Follow-up|1|||
130721514|NCT02196701|470604339|FG000|Overall Study|Non-adherence to Protocol|1|||
130721515|NCT00311402|470604340|FG000|Overall Study|Adverse Event|118|||
130721516|NCT00311402|470604341|FG001|Overall Study|Adverse Event|105|||
130721517|NCT00311402|470604340|FG000|Overall Study|Lost to Follow-up|0|||
130721518|NCT00311402|470604341|FG001|Overall Study|Lost to Follow-up|3|||
130721519|NCT00311402|470604340|FG000|Overall Study|Withdrawal by Subject|17|||
130721520|NCT00311402|470604341|FG001|Overall Study|Withdrawal by Subject|18|||
130721521|NCT00311402|470604340|FG000|Overall Study|Lack of Efficacy|58|||
130721522|NCT00311402|470604341|FG001|Overall Study|Lack of Efficacy|42|||
130721523|NCT00311402|470604340|FG000|Overall Study|Protocol Violation|7|||
130721524|NCT00311402|470604341|FG001|Overall Study|Protocol Violation|6|||
130721525|NCT00311402|470604340|FG000|Overall Study|IRB's rejection etc.|10|||
130721526|NCT00311402|470604341|FG001|Overall Study|IRB's rejection etc.|3|||
130721527|NCT02640053|470604342|FG000|Overall Study|Withdrawal by Subject|2|||
130721528|NCT02640053|470604343|FG001|Overall Study|Withdrawal by Subject|1|||
130721529|NCT02640053|470604342|FG000|Overall Study|Adverse Event|1|||
130721530|NCT02640053|470604343|FG001|Overall Study|Adverse Event|1|||
130721531|NCT02640053|470604342|FG000|Overall Study|Alternative Therapy|1|||
130721532|NCT02640053|470604343|FG001|Overall Study|Alternative Therapy|1|||
130721533|NCT02640053|470604342|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
130721534|NCT02640053|470604343|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
130721535|NCT03283761|470604344|FG000|Study Treatment|Patient Non-Compliance|1|||
130721536|NCT03283761|470604344|FG000|Study Treatment|Alternative Cancer Therapy|7|||
130721537|NCT03283761|470604344|FG000|Study Treatment|Disease progression|21|||
130721538|NCT03283761|470604344|FG000|Study Treatment|Adverse Event|3|||
130721539|NCT03283761|470604344|FG000|Study Treatment|Withdrawal by Subject|4|||
130721540|NCT03283761|470604344|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
130317323|NCT03192176|469128587|FG003|Overall Study|Protocol Deviation|0|||
130317324|NCT03192176|469128588|FG004|Overall Study|Protocol Deviation|2|||
130317325|NCT03192176|469128589|FG005|Overall Study|Protocol Deviation|0|||
130317326|NCT03192176|469128590|FG006|Overall Study|Protocol Deviation|0|||
130317327|NCT03192176|469128591|FG007|Overall Study|Protocol Deviation|0|||
130317328|NCT03192176|469128584|FG000|Overall Study|Withdrawal by Subject|3|||
130317329|NCT03192176|469128585|FG001|Overall Study|Withdrawal by Subject|4|||
130317330|NCT03192176|469128586|FG002|Overall Study|Withdrawal by Subject|0|||
130317331|NCT03192176|469128587|FG003|Overall Study|Withdrawal by Subject|4|||
130317332|NCT03192176|469128588|FG004|Overall Study|Withdrawal by Subject|3|||
130317333|NCT03192176|469128589|FG005|Overall Study|Withdrawal by Subject|4|||
130317334|NCT03192176|469128590|FG006|Overall Study|Withdrawal by Subject|4|||
130317335|NCT03192176|469128591|FG007|Overall Study|Withdrawal by Subject|2|||
130317336|NCT03192176|469128584|FG000|Overall Study|Miscellaneous|1|||
130317337|NCT03192176|469128585|FG001|Overall Study|Miscellaneous|0|||
130317338|NCT03192176|469128586|FG002|Overall Study|Miscellaneous|1|||
130317339|NCT03192176|469128587|FG003|Overall Study|Miscellaneous|1|||
130317340|NCT03192176|469128588|FG004|Overall Study|Miscellaneous|1|||
130317341|NCT03192176|469128589|FG005|Overall Study|Miscellaneous|2|||
130317342|NCT03192176|469128590|FG006|Overall Study|Miscellaneous|0|||
130317343|NCT03192176|469128591|FG007|Overall Study|Miscellaneous|1|||
130317344|NCT03532542|469128594|FG000|Overall Study|Death|1|||
130317345|NCT03532542|469128595|FG001|Overall Study|Death|0|||
130317346|NCT03532542|469128594|FG000|Overall Study|Study Terminated by Sponsor|41|||
130317347|NCT03532542|469128595|FG001|Overall Study|Study Terminated by Sponsor|65|||
130317348|NCT03532542|469128594|FG000|Overall Study|Withdrawal by Subject|6|||
130317349|NCT03532542|469128595|FG001|Overall Study|Withdrawal by Subject|5|||
130317350|NCT00718510|469128597|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130377958|NCT00524368|469351673|FG000|Overall Study|Lost to Follow-up|9|||
130377959|NCT00524368|469351674|FG001|Overall Study|Lost to Follow-up|13|||
130377960|NCT00524368|469351673|FG000|Overall Study|Withdrawal by Subject|4|||
130377961|NCT00524368|469351674|FG001|Overall Study|Withdrawal by Subject|5|||
130721541|NCT03283761|470604344|FG000|Study Treatment|Symptomatic Deterioration|1|||
130721542|NCT03283761|470604344|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
130721543|NCT03283761|470604344|FG000|Follow up|Lost to Follow-up|1|||
130721544|NCT03283761|470604344|FG000|Follow up|Symptomatic Deterioration|1|||
130721545|NCT03283761|470604344|FG000|Follow up|Death|29|||
130721546|NCT03283761|470604344|FG000|Follow up|study terminated|4|||
130721547|NCT03283761|470604344|FG000|Follow up|Primary Investigator Withdrawal|1|||
130721548|NCT03283761|470604344|FG000|Follow up|Switched to alternative therapy|1|||
130721549|NCT03283761|470604344|FG000|Follow up|Subject is now in Hospice|1|||
130721550|NCT04159935|470604345|FG000|Overall Study|Study terminated due to COVID-19|1|||
130721551|NCT04159935|470604346|FG001|Overall Study|Study terminated due to COVID-19|3|||
130721552|NCT02036775|470604347|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721553|NCT02036775|470604348|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721554|NCT02036775|470604349|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721555|NCT02036775|470604350|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721556|NCT02036775|470604351|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721557|NCT02036775|470604352|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
130721558|NCT03923530|470604353|FG000|Overall Study|Withdrawal by Subject|1|||
130721559|NCT03923530|470604353|FG000|Overall Study|screen failure|3|||
130721560|NCT01458106|470604362|FG000|Overall Study|Withdrawal by Subject|2|||
130721561|NCT01458106|470604363|FG001|Overall Study|Withdrawal by Subject|0|||
130721562|NCT01458106|470604362|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
130721563|NCT01458106|470604363|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
130721564|NCT01458106|470604362|FG000|Overall Study|Withdrawn Per Protocol|0|||
130721565|NCT01458106|470604363|FG001|Overall Study|Withdrawn Per Protocol|1|||
130721566|NCT00855803|470604364|FG000|Overall Study|Death|2|||
130721567|NCT00855803|470604364|FG000|Overall Study|Lost to Follow-up|2|||
130721568|NCT00855803|470604364|FG000|Overall Study|Technical inability to undergo procedure|2|||
130721569|NCT00855803|470604364|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
130721570|NCT00855803|470604364|FG000|Overall Study|Withdrawal by Subject|3|||
130721571|NCT00855803|470604364|FG000|Overall Study|Physician Decision|3|||
130721572|NCT03050060|470604369|FG000|Overall Study|Adverse Event|7|||
130721573|NCT03050060|470604369|FG000|Overall Study|Withdrawal by Subject|1|||
130721574|NCT03050060|470604369|FG000|Overall Study|Progression|7|||
130721575|NCT02288182|470604370|FG000|Overall Study|Adverse Event|0|||
130721576|NCT02288182|470604371|FG001|Overall Study|Adverse Event|1|||
130721577|NCT02288182|470604370|FG000|Overall Study|Lost to Follow-up|0|||
130721578|NCT02288182|470604371|FG001|Overall Study|Lost to Follow-up|1|||
130721579|NCT02582866|470604372|FG000|Overall Study|Death|1|||
130721580|NCT02582866|470604372|FG000|Overall Study|Lack of Efficacy|2|||
130721581|NCT02582866|470604372|FG000|Overall Study|Lost to Follow-up|2|||
130721582|NCT02582866|470604372|FG000|Overall Study|Withdrawal by Subject|7|||
130721583|NCT02582866|470604372|FG000|Overall Study|Investigator decision|5|||
130721584|NCT02582866|470604372|FG000|Overall Study|Participant wants to get pregnant|1|||
130721585|NCT02582866|470604372|FG000|Overall Study|Pregnancy|2|||
130721586|NCT02582866|470604372|FG000|Overall Study|Sponsor decision|1|||
130317351|NCT00718510|469128598|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130317352|NCT00718510|469128597|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130317353|NCT00718510|469128598|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130317354|NCT02314052|469128599|FG000|Cycle One|Adverse Event|0|||
130317355|NCT02314052|469128600|FG001|Cycle One|Adverse Event|0|||
130317356|NCT02314052|469128601|FG002|Cycle One|Adverse Event|0|||
130317357|NCT02314052|469128602|FG003|Cycle One|Adverse Event|1|||
130317358|NCT02314052|469128603|FG004|Cycle One|Adverse Event|0|||
130317359|NCT02314052|469128604|FG005|Cycle One|Adverse Event|0|||
130317360|NCT00117637|469128605|FG000|First Intervention (Period 1)|Adverse Event|11|||
130317361|NCT00117637|469128606|FG001|First Intervention (Period 1)|Adverse Event|16|||
130317362|NCT00117637|469128605|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
130317363|NCT00117637|469128606|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
130317364|NCT00117637|469128605|FG000|First Intervention (Period 1)|Protocol Violation|1|||
130317365|NCT00117637|469128606|FG001|First Intervention (Period 1)|Protocol Violation|0|||
130317366|NCT00117637|469128605|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
130317367|NCT00117637|469128606|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
130317368|NCT00117637|469128605|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
130317369|NCT00117637|469128606|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
130317370|NCT00117637|469128605|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
130317371|NCT00117637|469128606|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
130377962|NCT00524368|469351673|FG000|Overall Study|Non-compliant|8|||
130721587|NCT02582866|470604372|FG000|Overall Study|Withdrawal due to personal reasons|1|||
130721588|NCT02056392|470604377|FG000|Overall Study|Lost to Follow-up|0|||
130721589|NCT02056392|470604378|FG001|Overall Study|Lost to Follow-up|1|||
130721590|NCT02056392|470604379|FG002|Overall Study|Lost to Follow-up|2|||
130721591|NCT02056392|470604380|FG003|Overall Study|Lost to Follow-up|0|||
130721592|NCT02056392|470604381|FG004|Overall Study|Lost to Follow-up|0|||
130721593|NCT02056392|470604382|FG005|Overall Study|Lost to Follow-up|0|||
130721594|NCT02056392|470604377|FG000|Overall Study|Protocol Violation|1|||
130721595|NCT02056392|470604378|FG001|Overall Study|Protocol Violation|0|||
130721596|NCT02056392|470604379|FG002|Overall Study|Protocol Violation|1|||
130721597|NCT02056392|470604380|FG003|Overall Study|Protocol Violation|0|||
130721598|NCT02056392|470604381|FG004|Overall Study|Protocol Violation|0|||
130721599|NCT02056392|470604382|FG005|Overall Study|Protocol Violation|0|||
130721600|NCT02056392|470604377|FG000|Overall Study|Withdrawal by Subject|1|||
130721601|NCT02056392|470604378|FG001|Overall Study|Withdrawal by Subject|0|||
130721602|NCT02056392|470604379|FG002|Overall Study|Withdrawal by Subject|0|||
130721603|NCT02056392|470604380|FG003|Overall Study|Withdrawal by Subject|0|||
130721604|NCT02056392|470604381|FG004|Overall Study|Withdrawal by Subject|1|||
130721605|NCT02056392|470604382|FG005|Overall Study|Withdrawal by Subject|0|||
130721606|NCT00633243|470606247|FG000|Overall Study|Withdrawal by Subject|0|||
130721607|NCT00633243|470606248|FG001|Overall Study|Withdrawal by Subject|1|||
130721608|NCT00633243|470606247|FG000|Overall Study|incarceration|0|||
130721609|NCT00633243|470606248|FG001|Overall Study|incarceration|2|||
130721610|NCT00633243|470606247|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
130721611|NCT00633243|470606248|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
130721612|NCT00633243|470606247|FG000|Overall Study|Not comfortable with self-injecting|0|||
130721613|NCT00633243|470606248|FG001|Overall Study|Not comfortable with self-injecting|1|||
130721614|NCT00633243|470606247|FG000|Overall Study|Mental Health--Depression|0|||
130721615|NCT00633243|470606248|FG001|Overall Study|Mental Health--Depression|1|||
130721616|NCT00633243|470606247|FG000|Overall Study|Couldn't tolerate side-effects|1|||
130721617|NCT00633243|470606248|FG001|Overall Study|Couldn't tolerate side-effects|1|||
130721618|NCT02022748|470606249|FG000|Overall Study|Adverse Event|1|||
130721619|NCT02022748|470606250|FG001|Overall Study|Adverse Event|1|||
130721620|NCT02022748|470606251|FG002|Overall Study|Adverse Event|0|||
130721621|NCT02022748|470606249|FG000|Overall Study|Withdrawal by Subject|0|||
130721622|NCT02022748|470606250|FG001|Overall Study|Withdrawal by Subject|1|||
130721623|NCT02022748|470606251|FG002|Overall Study|Withdrawal by Subject|0|||
130721624|NCT00461253|470606252|FG000|Overall Study|Death|985|||
130721625|NCT00461253|470606253|FG001|Overall Study|Death|0|||
130721626|NCT00461253|470606252|FG000|Overall Study|Protocol Violation|613|||
130721627|NCT00461253|470606253|FG001|Overall Study|Protocol Violation|236|||
130721628|NCT00461253|470606252|FG000|Overall Study|no response|2609|||
130721629|NCT00461253|470606253|FG001|Overall Study|no response|11789|||
130721630|NCT00461253|470606252|FG000|Overall Study|administrative|773|||
130721631|NCT00461253|470606253|FG001|Overall Study|administrative|7773|||
130721632|NCT04240392|470606254|FG000|Overall Study|Withdrawal by Subject|13|||
130721633|NCT04240392|470606255|FG001|Overall Study|Withdrawal by Subject|4|||
130721634|NCT04240392|470606254|FG000|Overall Study|Lost to Follow-up|11|||
130721635|NCT04240392|470606255|FG001|Overall Study|Lost to Follow-up|12|||
130721636|NCT01523457|470606256|FG000|Overall Study|Withdrawal by Subject|7|||
130721637|NCT01523457|470606257|FG001|Overall Study|Withdrawal by Subject|2|||
130721638|NCT00721630|470606258|FG000|Overall Study|Participant found to be ineligible|1|||
130721639|NCT03700385|470606261|FG000|Overall Study|Lost to Follow-up|1|||
130721640|NCT01555671|470606265|FG000|Overall Study|Physician Decision|20|||
130721641|NCT01555671|470606266|FG001|Overall Study|Physician Decision|25|||
130721642|NCT00372411|470606267|FG000|Overall Study|Withdrawal by Subject|3|||
130721643|NCT00372411|470606268|FG001|Overall Study|Withdrawal by Subject|4|||
130721644|NCT00372411|470606269|FG002|Overall Study|Withdrawal by Subject|1|||
130721645|NCT00372411|470606267|FG000|Overall Study|Death|0|||
130721646|NCT00372411|470606268|FG001|Overall Study|Death|2|||
130721647|NCT00372411|470606269|FG002|Overall Study|Death|1|||
130721648|NCT00372411|470606267|FG000|Overall Study|Lost to Follow-up|1|||
130721649|NCT00372411|470606268|FG001|Overall Study|Lost to Follow-up|1|||
130721650|NCT00372411|470606269|FG002|Overall Study|Lost to Follow-up|1|||
130721651|NCT00372411|470606267|FG000|Overall Study|Adverse Event|1|||
130721652|NCT00372411|470606268|FG001|Overall Study|Adverse Event|1|||
130317372|NCT00117637|469128605|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
130317373|NCT00117637|469128606|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
130317374|NCT00117637|469128605|FG000|First Intervention (Period 1)|reason not reported|0|||
130317375|NCT00117637|469128606|FG001|First Intervention (Period 1)|reason not reported|1|||
130317376|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Adverse Event|0|||
130317377|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Adverse Event|9|||
130317378|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
130317379|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
130317380|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
130317381|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
130317382|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
130317383|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
130317384|NCT00117637|469128605|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
130377963|NCT00524368|469351674|FG001|Overall Study|Non-compliant|9|||
130721653|NCT00372411|470606269|FG002|Overall Study|Adverse Event|0|||
130721654|NCT04590040|470606270|FG000|Treatment Period|Lost to Follow-up|2|||
130721655|NCT04590040|470606271|FG001|Treatment Period|Lost to Follow-up|5|||
130721656|NCT04590040|470606272|FG002|Treatment Period|Lost to Follow-up|0|||
130721657|NCT04590040|470606270|FG000|Treatment Period|Physician Decision|0|||
130721658|NCT04590040|470606271|FG001|Treatment Period|Physician Decision|0|||
130721659|NCT04590040|470606272|FG002|Treatment Period|Physician Decision|2|||
130317385|NCT00117637|469128606|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
130317386|NCT00117637|469128605|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
130317387|NCT00117637|469128606|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
130317388|NCT00117637|469128605|FG000|Second Intervention (Period 2)|reason not reported|1|||
130317389|NCT00117637|469128606|FG001|Second Intervention (Period 2)|reason not reported|0|||
130317390|NCT01582061|469128607|FG000|Overall Study|Lack of Efficacy|3|||
130317391|NCT01582061|469128608|FG001|Overall Study|Lack of Efficacy|23|||
130317392|NCT01582061|469128607|FG000|Overall Study|Adverse Event|12|||
130317393|NCT01582061|469128608|FG001|Overall Study|Adverse Event|8|||
130377964|NCT00524368|469351673|FG000|Overall Study|Reached a Virologic Endpoint|3|||
130377965|NCT00524368|469351674|FG001|Overall Study|Reached a Virologic Endpoint|2|||
130377966|NCT00524368|469351673|FG000|Overall Study|Sponsor's Decision|2|||
130377967|NCT00524368|469351674|FG001|Overall Study|Sponsor's Decision|0|||
130377968|NCT00524368|469351673|FG000|Overall Study|Ineligible to Continue the study|2|||
130377969|NCT00524368|469351674|FG001|Overall Study|Ineligible to Continue the study|5|||
130377970|NCT00524368|469351673|FG000|Overall Study|Other|3|||
130377971|NCT00524368|469351674|FG001|Overall Study|Other|2|||
130377972|NCT00793598|469351675|FG000|Overall Study|Patient Request|0|||
130377973|NCT00793598|469351676|FG001|Overall Study|Patient Request|1|||
130377974|NCT00793598|469351677|FG002|Overall Study|Patient Request|0|||
130377975|NCT00793598|469351678|FG003|Overall Study|Patient Request|0|||
130721660|NCT01284361|470606275|FG000|Overall Study|Withdrawal by Subject|1|||
130721661|NCT01284361|470606275|FG000|Overall Study|Protocol Violation|5|||
130721662|NCT01284361|470606275|FG000|Overall Study|Adverse Event|1|||
130721663|NCT01284361|470606275|FG000|Overall Study|Lost to Follow-up|2|||
130721664|NCT04003896|470606276|FG000|Overall Study|Withdrawal by Subject|3|||
130721665|NCT04003896|470606276|FG000|Overall Study|Physician Decision|1|||
130721666|NCT01957397|470606279|FG000|Test Period 1|sudden leakage/small bag|1|||
130377976|NCT00793598|469351679|FG004|Overall Study|Patient Request|0|||
130377977|NCT00793598|469351680|FG005|Overall Study|Patient Request|0|||
130721667|NCT01957397|470606280|FG001|Test Period 1|sudden leakage/small bag|1|||
130721668|NCT01957397|470606279|FG000|Test Period 1|Withdrawal by Subject|1|||
130721669|NCT01957397|470606280|FG001|Test Period 1|Withdrawal by Subject|0|||
130721670|NCT01957397|470606279|FG000|Test Period 2|Adverse Event|0|||
130721671|NCT01957397|470606280|FG001|Test Period 2|Adverse Event|1|||
130721672|NCT01957397|470606279|FG000|Test Period 3|Adverse Event|1|||
130721673|NCT01957397|470606280|FG001|Test Period 3|Adverse Event|2|||
130721674|NCT01957397|470606279|FG000|Test Period 3|the adhesive did not work|1|||
130721675|NCT01957397|470606280|FG001|Test Period 3|the adhesive did not work|0|||
130721676|NCT00324649|470606281|FG000|Overall Study|Adverse Event|1|||
130721677|NCT00324649|470606282|FG001|Overall Study|Adverse Event|4|||
130721678|NCT00324649|470606281|FG000|Overall Study|Withdrawal by Subject|0|||
130721679|NCT00324649|470606282|FG001|Overall Study|Withdrawal by Subject|1|||
130721680|NCT00324649|470606281|FG000|Overall Study|Noncompliance|1|||
130721681|NCT00324649|470606282|FG001|Overall Study|Noncompliance|0|||
130721682|NCT00540293|470606283|FG000|Overall Study|Adverse event related to study drug|10|||
130721683|NCT00540293|470606283|FG000|Overall Study|Adverse event not related to study drug|7|||
130721684|NCT00540293|470606283|FG000|Overall Study|Withdrawal by Subject|6|||
130721685|NCT00540293|470606283|FG000|Overall Study|Protocol violation, & subject schedule|12|||
130721686|NCT02740699|470606286|FG000|Overall Study|Lost to Follow-up|5|||
130721687|NCT02740699|470606286|FG000|Overall Study|Withdrawal by Subject|14|||
130721688|NCT02740699|470606286|FG000|Overall Study|Physician Decision|5|||
130721689|NCT04713553|470606287|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
130721690|NCT04713553|470606288|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
130721691|NCT04713553|470606289|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721692|NCT04713553|470606290|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721693|NCT04713553|470606291|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
130721694|NCT04713553|470606292|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721695|NCT04713553|470606293|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721696|NCT04713553|470606287|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721697|NCT04713553|470606288|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721698|NCT04713553|470606289|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721699|NCT04713553|470606290|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
130721700|NCT04713553|470606291|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721701|NCT04713553|470606292|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721702|NCT04713553|470606293|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721703|NCT04713553|470606287|FG000|Primary Study (2 Months)|Other|1|||
130721704|NCT04713553|470606288|FG001|Primary Study (2 Months)|Other|2|||
130721705|NCT04713553|470606289|FG002|Primary Study (2 Months)|Other|0|||
130721706|NCT04713553|470606290|FG003|Primary Study (2 Months)|Other|0|||
130721707|NCT04713553|470606291|FG004|Primary Study (2 Months)|Other|1|||
130377978|NCT00793598|469351681|FG006|Overall Study|Patient Request|0|||
130377979|NCT00793598|469351682|FG007|Overall Study|Patient Request|0|||
130317394|NCT01582061|469128607|FG000|Overall Study|Withdrawal by Subject|10|||
130317395|NCT01582061|469128608|FG001|Overall Study|Withdrawal by Subject|4|||
130317396|NCT01582061|469128607|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130317397|NCT01582061|469128608|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130317398|NCT01582061|469128607|FG000|Overall Study|Death|0|||
130317399|NCT01582061|469128608|FG001|Overall Study|Death|1|||
130317400|NCT01582061|469128607|FG000|Overall Study|condition no longer requires study drug|1|||
130317401|NCT01582061|469128608|FG001|Overall Study|condition no longer requires study drug|0|||
130317402|NCT01582061|469128607|FG000|Overall Study|Lost to Follow-up|1|||
130317403|NCT01582061|469128608|FG001|Overall Study|Lost to Follow-up|0|||
130317404|NCT02756338|469128609|FG000|Overall Study|Withdrawn by Investigator|1|||
130317405|NCT02756338|469128609|FG000|Overall Study|Device Replaced with Pacemaker|4|||
130317406|NCT00300755|469128614|FG000|Overall Study|Adverse Event|1|||
130317407|NCT00300755|469128615|FG001|Overall Study|Adverse Event|2|||
130317408|NCT00300755|469128616|FG002|Overall Study|Adverse Event|1|||
130317409|NCT00300755|469128614|FG000|Overall Study|Withdrawal by Subject|0|||
130317410|NCT00300755|469128615|FG001|Overall Study|Withdrawal by Subject|2|||
130317411|NCT00300755|469128616|FG002|Overall Study|Withdrawal by Subject|0|||
130317412|NCT00300755|469128614|FG000|Overall Study|Protocol Violation|0|||
130317413|NCT00300755|469128615|FG001|Overall Study|Protocol Violation|0|||
130317414|NCT00300755|469128616|FG002|Overall Study|Protocol Violation|1|||
130317415|NCT02694744|469128620|FG000|Overall Study|Adverse Event|2|||
130317416|NCT02694744|469128621|FG001|Overall Study|Adverse Event|1|||
130317417|NCT02694744|469128620|FG000|Overall Study|Withdrawal by Subject|2|||
130317418|NCT02694744|469128621|FG001|Overall Study|Withdrawal by Subject|1|||
130317419|NCT02694744|469128620|FG000|Overall Study|Physician Decision|1|||
130317420|NCT02694744|469128621|FG001|Overall Study|Physician Decision|2|||
130317421|NCT02694744|469128620|FG000|Overall Study|Lost to Follow-up|1|||
130317422|NCT02694744|469128621|FG001|Overall Study|Lost to Follow-up|0|||
130317423|NCT02694744|469128620|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
130317424|NCT02694744|469128621|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
130721708|NCT04713553|470606292|FG005|Primary Study (2 Months)|Other|0|||
130721709|NCT04713553|470606293|FG006|Primary Study (2 Months)|Other|0|||
130317425|NCT00686777|469128622|FG000|Overall Study|Adverse Event|2|||
130317426|NCT00686777|469128622|FG000|Overall Study|Pregnancy|1|||
130721710|NCT04713553|470606287|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
130721711|NCT04713553|470606288|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
130721712|NCT04713553|470606289|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
130721713|NCT04713553|470606290|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
130721714|NCT04713553|470606291|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
130721715|NCT04713553|470606292|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
130721716|NCT04713553|470606293|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
130721717|NCT04713553|470606287|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721718|NCT04713553|470606288|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721719|NCT04713553|470606289|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
130721720|NCT04713553|470606290|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721721|NCT04713553|470606291|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721722|NCT04713553|470606292|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721723|NCT04713553|470606293|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721724|NCT02315196|470606300|FG000|Overall Study|Withdrew consent|9|||
130721725|NCT04729309|470606301|FG000|Period 1|Subject unable to return for Period 2|3|||
130721726|NCT04729309|470606302|FG001|Period 1|Subject unable to return for Period 2|0|||
130721727|NCT04729309|470606301|FG000|Period 1|Lost to Follow-up|1|||
130721728|NCT04729309|470606302|FG001|Period 1|Lost to Follow-up|0|||
130721729|NCT00537303|470606303|FG000|Overall Study|Adverse Event|1|||
130721730|NCT00537303|470606304|FG001|Overall Study|Adverse Event|4|||
130721731|NCT00537303|470606303|FG000|Overall Study|Lack of Efficacy|6|||
130721732|NCT00537303|470606304|FG001|Overall Study|Lack of Efficacy|7|||
130721733|NCT00537303|470606303|FG000|Overall Study|Protocol Violation|8|||
130721734|NCT00537303|470606304|FG001|Overall Study|Protocol Violation|4|||
130721735|NCT00537303|470606303|FG000|Overall Study|Withdrawal criteria|3|||
130721736|NCT00537303|470606304|FG001|Overall Study|Withdrawal criteria|3|||
130317427|NCT00686777|469128622|FG000|Overall Study|Withdrawal by Subject|2|||
130317428|NCT00686777|469128622|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
130317429|NCT00686777|469128622|FG000|Overall Study|No Visit|1|||
130317430|NCT01945021|469128623|FG000|Overall Study|Adverse Event|1|||
130721737|NCT00537303|470606303|FG000|Overall Study|Unclassified|8|||
130317431|NCT01945021|469128623|FG000|Overall Study|Withdrawal of consent|12|||
130317432|NCT01945021|469128623|FG000|Overall Study|Lost to Follow-up|5|||
130317433|NCT01945021|469128623|FG000|Overall Study|Death|65|||
130317434|NCT03582215|469128624|FG000|Overall Study|Adverse Event|1|||
130317435|NCT03582215|469128625|FG001|Overall Study|Adverse Event|0|||
130317436|NCT03582215|469128626|FG002|Overall Study|Adverse Event|0|||
130317437|NCT03582215|469128627|FG003|Overall Study|Adverse Event|0|||
130317438|NCT03582215|469128628|FG004|Overall Study|Adverse Event|0|||
130317439|NCT03582215|469128629|FG005|Overall Study|Adverse Event|0|||
130317440|NCT03582215|469128630|FG006|Overall Study|Adverse Event|2|||
130377980|NCT00793598|469351675|FG000|Overall Study|Protocol Violation|0|||
130377981|NCT00793598|469351676|FG001|Overall Study|Protocol Violation|0|||
130377982|NCT00793598|469351677|FG002|Overall Study|Protocol Violation|0|||
130377983|NCT00793598|469351678|FG003|Overall Study|Protocol Violation|0|||
130377984|NCT00793598|469351679|FG004|Overall Study|Protocol Violation|0|||
130377985|NCT00793598|469351680|FG005|Overall Study|Protocol Violation|0|||
130377986|NCT00793598|469351681|FG006|Overall Study|Protocol Violation|0|||
130377987|NCT00793598|469351682|FG007|Overall Study|Protocol Violation|1|||
130377988|NCT00793598|469351675|FG000|Overall Study|Subject not dosed|0|||
130377989|NCT00793598|469351676|FG001|Overall Study|Subject not dosed|0|||
130377990|NCT00793598|469351677|FG002|Overall Study|Subject not dosed|0|||
130377991|NCT00793598|469351678|FG003|Overall Study|Subject not dosed|0|||
130377992|NCT00793598|469351679|FG004|Overall Study|Subject not dosed|0|||
130377993|NCT00793598|469351680|FG005|Overall Study|Subject not dosed|1|||
130377994|NCT00793598|469351681|FG006|Overall Study|Subject not dosed|0|||
130377995|NCT00793598|469351682|FG007|Overall Study|Subject not dosed|0|||
130377996|NCT02373202|469351693|FG000|Overall Study|Adverse Event|2|||
130377997|NCT02373202|469351694|FG001|Overall Study|Adverse Event|5|||
130377998|NCT02373202|469351695|FG002|Overall Study|Adverse Event|2|||
130377999|NCT02373202|469351696|FG003|Overall Study|Adverse Event|1|||
130378000|NCT02373202|469351693|FG000|Overall Study|Lack of Efficacy|0|||
130378001|NCT02373202|469351694|FG001|Overall Study|Lack of Efficacy|0|||
130378002|NCT02373202|469351695|FG002|Overall Study|Lack of Efficacy|1|||
130317441|NCT03582215|469128631|FG007|Overall Study|Adverse Event|2|||
130317442|NCT02163902|469128632|FG000|Overall Study|Subject's Request|3|||
130317443|NCT02163902|469128633|FG001|Overall Study|Subject's Request|4|||
130317444|NCT02163902|469128632|FG000|Overall Study|Lost to Follow-up|6|||
130317445|NCT02163902|469128633|FG001|Overall Study|Lost to Follow-up|7|||
130317446|NCT02163902|469128632|FG000|Overall Study|Administrative Decision|2|||
130317447|NCT02163902|469128633|FG001|Overall Study|Administrative Decision|2|||
130317448|NCT02174731|469128634|FG000|Overall Study|Participant decision|67|||
130317449|NCT02174731|469128635|FG001|Overall Study|Participant decision|64|||
130317450|NCT02174731|469128634|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130317451|NCT02174731|469128635|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130317452|NCT02174731|469128634|FG000|Overall Study|Missing|2|||
130317453|NCT02174731|469128635|FG001|Overall Study|Missing|0|||
130317454|NCT03119259|469128636|FG000|Overall Study|Withdrawn as no longer eligible|1|||
130317455|NCT03119259|469128637|FG001|Overall Study|Withdrawn as no longer eligible|0|||
130317456|NCT03119259|469128636|FG000|Overall Study|Withdrawal by Subject|4|||
130317457|NCT03119259|469128637|FG001|Overall Study|Withdrawal by Subject|2|||
130317458|NCT03119259|469128636|FG000|Overall Study|Lost to Follow-up|0|||
130317459|NCT03119259|469128637|FG001|Overall Study|Lost to Follow-up|1|||
130317460|NCT01168349|469128645|FG000|Overall Study|Death|157|||
130317461|NCT01168349|469128645|FG000|Overall Study|Lost to Follow-up|34|||
130317462|NCT01168349|469128645|FG000|Overall Study|Withdrawal by Subject|9|||
130317463|NCT01168349|469128645|FG000|Overall Study|Kidney transplantation|3|||
130317464|NCT01168349|469128645|FG000|Overall Study|Other|22|||
130317465|NCT01168349|469128645|FG000|Overall Study|Protocol Violation|76|||
130317466|NCT03535974|469128646|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130317467|NCT03535974|469128647|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
130317468|NCT03535974|469128648|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130317469|NCT03535974|469128646|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
130317470|NCT03535974|469128647|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
130317471|NCT03535974|469128648|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
130317472|NCT04059549|469128649|FG000|Overall Study|Withdrawal by Subject|2|||
130317473|NCT04059549|469128650|FG001|Overall Study|Withdrawal by Subject|0|||
130317474|NCT02678351|469128652|FG000|Overall Study|Withdrawal by Subject|1|||
130317475|NCT00988884|469128653|FG000|Overall Study|Adverse Event|0|||
130317476|NCT00988884|469128654|FG001|Overall Study|Adverse Event|1|||
130378003|NCT02373202|469351696|FG003|Overall Study|Lack of Efficacy|0|||
130378004|NCT02373202|469351693|FG000|Overall Study|Other|0|||
130317477|NCT00988884|469128653|FG000|Overall Study|Lost to Follow-up|20|||
130317478|NCT00988884|469128654|FG001|Overall Study|Lost to Follow-up|16|||
130317479|NCT00988884|469128653|FG000|Overall Study|Protocol Violation|0|||
130317480|NCT00988884|469128654|FG001|Overall Study|Protocol Violation|1|||
130378005|NCT02373202|469351694|FG001|Overall Study|Other|1|||
130378006|NCT02373202|469351695|FG002|Overall Study|Other|0|||
130378007|NCT02373202|469351696|FG003|Overall Study|Other|0|||
130378008|NCT01411228|469351698|FG000|Overall Study|Lost to Follow-up|0|||
130378009|NCT01411228|469351699|FG001|Overall Study|Lost to Follow-up|0|||
130378010|NCT01411228|469351700|FG002|Overall Study|Lost to Follow-up|1|||
130378011|NCT01411228|469351698|FG000|Overall Study|Withdrawal by Subject|1|||
130378012|NCT01411228|469351699|FG001|Overall Study|Withdrawal by Subject|0|||
130378013|NCT01411228|469351700|FG002|Overall Study|Withdrawal by Subject|0|||
130317481|NCT00988884|469128653|FG000|Overall Study|Withdrawal by Subject|15|||
130317482|NCT00988884|469128654|FG001|Overall Study|Withdrawal by Subject|18|||
130378014|NCT02141282|469351701|FG000|Overall Study|Adverse event, not related to progression|8|||
130378015|NCT02141282|469351702|FG001|Overall Study|Adverse event, not related to progression|1|||
130378016|NCT02141282|469351703|FG002|Overall Study|Adverse event, not related to progression|3|||
130378017|NCT02141282|469351704|FG003|Overall Study|Adverse event, not related to progression|1|||
130378018|NCT02141282|469351701|FG000|Overall Study|Adverse event, related to progression|1|||
130378019|NCT02141282|469351702|FG001|Overall Study|Adverse event, related to progression|0|||
130378020|NCT02141282|469351703|FG002|Overall Study|Adverse event, related to progression|2|||
130378021|NCT02141282|469351704|FG003|Overall Study|Adverse event, related to progression|0|||
130378022|NCT02141282|469351701|FG000|Overall Study|COVID-19 infection|1|||
130378023|NCT02141282|469351702|FG001|Overall Study|COVID-19 infection|0|||
130378024|NCT02141282|469351703|FG002|Overall Study|COVID-19 infection|0|||
130378025|NCT02141282|469351704|FG003|Overall Study|COVID-19 infection|0|||
130378026|NCT02141282|469351701|FG000|Overall Study|Lost to Follow-up|0|||
130378027|NCT02141282|469351702|FG001|Overall Study|Lost to Follow-up|0|||
130378028|NCT02141282|469351703|FG002|Overall Study|Lost to Follow-up|4|||
130378029|NCT02141282|469351704|FG003|Overall Study|Lost to Follow-up|2|||
130378030|NCT02141282|469351701|FG000|Overall Study|Other, not specified|14|||
130467126|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
130467127|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
130467128|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
130467129|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
130467130|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
130467131|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
130467132|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
130467133|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
130467134|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
130467135|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
130467136|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
130467137|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
130467138|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
130467139|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
130467140|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
130467141|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
130467142|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
130467143|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
130467144|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
130467145|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
130467146|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
130378031|NCT02141282|469351702|FG001|Overall Study|Other, not specified|11|||
130317483|NCT01919229|469128655|FG000|Overall Study|Subject/guardian decision|0|||
130317484|NCT01919229|469128656|FG001|Overall Study|Subject/guardian decision|0|||
130317485|NCT01919229|469128657|FG002|Overall Study|Subject/guardian decision|1|||
130317486|NCT00626275|469128658|FG000|Part A - Treatment Period 1|Adverse Event|1|||
130317487|NCT00626275|469128659|FG001|Part A - Treatment Period 1|Adverse Event|0|||
130317488|NCT00626275|469128660|FG002|Part A - Treatment Period 1|Adverse Event|0|||
130317489|NCT00626275|469128661|FG003|Part A - Treatment Period 1|Adverse Event|0|||
130317490|NCT00626275|469128662|FG004|Part A - Treatment Period 1|Adverse Event|0|||
130317491|NCT00626275|469128663|FG005|Part A - Treatment Period 1|Adverse Event|0|||
130317492|NCT00626275|469128664|FG006|Part A - Treatment Period 1|Adverse Event|0|||
130317493|NCT00626275|469128665|FG007|Part A - Treatment Period 1|Adverse Event|0|||
130317494|NCT00626275|469128658|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317495|NCT00626275|469128659|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317496|NCT00626275|469128660|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
130317497|NCT00626275|469128661|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317498|NCT00626275|469128662|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317499|NCT00626275|469128663|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317500|NCT00626275|469128664|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317501|NCT00626275|469128665|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317502|NCT00626275|469128658|FG000|Part B|Lost to Follow-up|0|||
130317503|NCT00626275|469128659|FG001|Part B|Lost to Follow-up|0|||
130317504|NCT00626275|469128660|FG002|Part B|Lost to Follow-up|0|||
130317505|NCT00626275|469128661|FG003|Part B|Lost to Follow-up|0|||
130317506|NCT00626275|469128662|FG004|Part B|Lost to Follow-up|0|||
130317507|NCT00626275|469128663|FG005|Part B|Lost to Follow-up|0|||
130317508|NCT00626275|469128664|FG006|Part B|Lost to Follow-up|1|||
130317509|NCT00626275|469128665|FG007|Part B|Lost to Follow-up|0|||
130317510|NCT00626275|469128658|FG000|Part B|Withdrawal by Subject|0|||
130317511|NCT00626275|469128659|FG001|Part B|Withdrawal by Subject|0|||
130317512|NCT00626275|469128660|FG002|Part B|Withdrawal by Subject|0|||
130317513|NCT00626275|469128661|FG003|Part B|Withdrawal by Subject|0|||
130317514|NCT00626275|469128662|FG004|Part B|Withdrawal by Subject|0|||
130317515|NCT00626275|469128663|FG005|Part B|Withdrawal by Subject|0|||
130317516|NCT00626275|469128664|FG006|Part B|Withdrawal by Subject|0|||
130721738|NCT00537303|470606304|FG001|Overall Study|Unclassified|7|||
130721739|NCT02085135|470606306|FG000|Overall Study|Adverse Event|4|||
130721740|NCT02085135|470606307|FG001|Overall Study|Adverse Event|7|||
130721741|NCT02085135|470606306|FG000|Overall Study|Lost to Follow-up|2|||
130721742|NCT02085135|470606307|FG001|Overall Study|Lost to Follow-up|2|||
130721743|NCT02085135|470606306|FG000|Overall Study|Withdrawal by Subject|3|||
130721744|NCT02085135|470606307|FG001|Overall Study|Withdrawal by Subject|0|||
130317517|NCT00626275|469128665|FG007|Part B|Withdrawal by Subject|1|||
130317518|NCT04999839|469128666|FG000|Overall Study|Adverse Event|1|||
130317519|NCT04999839|469128667|FG001|Overall Study|Adverse Event|1|||
130317520|NCT04999839|469128668|FG002|Overall Study|Adverse Event|1|||
130317521|NCT04999839|469128669|FG003|Overall Study|Adverse Event|1|||
130317522|NCT04999839|469128670|FG004|Overall Study|Adverse Event|1|||
130317523|NCT04999839|469128666|FG000|Overall Study|Lost to Follow-up|2|||
130317524|NCT04999839|469128667|FG001|Overall Study|Lost to Follow-up|0|||
130317525|NCT04999839|469128668|FG002|Overall Study|Lost to Follow-up|2|||
130317526|NCT04999839|469128669|FG003|Overall Study|Lost to Follow-up|4|||
130317527|NCT04999839|469128670|FG004|Overall Study|Lost to Follow-up|1|||
130317528|NCT04999839|469128666|FG000|Overall Study|Withdrawal by Subject|6|||
130317529|NCT04999839|469128667|FG001|Overall Study|Withdrawal by Subject|5|||
130317530|NCT04999839|469128668|FG002|Overall Study|Withdrawal by Subject|3|||
130317531|NCT04999839|469128669|FG003|Overall Study|Withdrawal by Subject|2|||
130317532|NCT04999839|469128670|FG004|Overall Study|Withdrawal by Subject|2|||
130317533|NCT04999839|469128666|FG000|Overall Study|Lack of Efficacy|0|||
130317534|NCT04999839|469128667|FG001|Overall Study|Lack of Efficacy|1|||
130317535|NCT04999839|469128668|FG002|Overall Study|Lack of Efficacy|0|||
130317536|NCT04999839|469128669|FG003|Overall Study|Lack of Efficacy|0|||
130317537|NCT04999839|469128670|FG004|Overall Study|Lack of Efficacy|0|||
130317538|NCT04999839|469128666|FG000|Overall Study|Physician Decision|0|||
130317539|NCT04999839|469128667|FG001|Overall Study|Physician Decision|0|||
130317540|NCT04999839|469128668|FG002|Overall Study|Physician Decision|0|||
130317541|NCT04999839|469128669|FG003|Overall Study|Physician Decision|0|||
130317542|NCT04999839|469128670|FG004|Overall Study|Physician Decision|1|||
130317543|NCT04999839|469128666|FG000|Overall Study|Sponsor request|0|||
130317544|NCT04999839|469128667|FG001|Overall Study|Sponsor request|1|||
130317545|NCT04999839|469128668|FG002|Overall Study|Sponsor request|0|||
130317546|NCT04999839|469128669|FG003|Overall Study|Sponsor request|0|||
130317547|NCT04999839|469128670|FG004|Overall Study|Sponsor request|0|||
130317548|NCT04999839|469128666|FG000|Overall Study|Other|0|||
130317549|NCT04999839|469128667|FG001|Overall Study|Other|0|||
130317550|NCT04999839|469128668|FG002|Overall Study|Other|1|||
130317551|NCT04999839|469128669|FG003|Overall Study|Other|0|||
130317552|NCT04999839|469128670|FG004|Overall Study|Other|0|||
130317553|NCT01362348|469128671|FG000|Overall Study|Protocol-defined stopping criteria|9|||
130317554|NCT01362348|469128671|FG000|Overall Study|Study closed/terminated|5|||
130317555|NCT02734693|469128674|FG000|Overall Study|Adverse Event|1|||
130317556|NCT02734693|469128675|FG001|Overall Study|Adverse Event|3|||
130317557|NCT02734693|469128676|FG002|Overall Study|Adverse Event|3|||
130317558|NCT02734693|469128674|FG000|Overall Study|Lack of Efficacy|1|||
130317559|NCT02734693|469128675|FG001|Overall Study|Lack of Efficacy|0|||
130317560|NCT02734693|469128676|FG002|Overall Study|Lack of Efficacy|0|||
130317561|NCT02734693|469128674|FG000|Overall Study|Lost to Follow-up|2|||
130317562|NCT02734693|469128675|FG001|Overall Study|Lost to Follow-up|0|||
130317563|NCT02734693|469128676|FG002|Overall Study|Lost to Follow-up|0|||
130317564|NCT02734693|469128674|FG000|Overall Study|Protocol Violation|1|||
130317565|NCT02734693|469128675|FG001|Overall Study|Protocol Violation|0|||
130317566|NCT02734693|469128676|FG002|Overall Study|Protocol Violation|0|||
130317567|NCT02734693|469128674|FG000|Overall Study|Withdrawal by Subject|1|||
130317568|NCT02734693|469128675|FG001|Overall Study|Withdrawal by Subject|0|||
130317569|NCT02734693|469128676|FG002|Overall Study|Withdrawal by Subject|0|||
130378032|NCT02141282|469351703|FG002|Overall Study|Other, not specified|23|||
130378033|NCT02141282|469351704|FG003|Overall Study|Other, not specified|9|||
130378034|NCT02141282|469351701|FG000|Overall Study|Progressive disease, Richter's|4|||
130721745|NCT02085135|470606306|FG000|Overall Study|Lack of Efficacy|2|||
130378035|NCT02141282|469351702|FG001|Overall Study|Progressive disease, Richter's|1|||
130378036|NCT02141282|469351703|FG002|Overall Study|Progressive disease, Richter's|1|||
130721746|NCT02085135|470606307|FG001|Overall Study|Lack of Efficacy|0|||
130317570|NCT02898454|469128682|FG000|Overall Study|Adverse Event|4|||
130378037|NCT02141282|469351704|FG003|Overall Study|Progressive disease, Richter's|1|||
130721747|NCT01136967|470606309|FG000|Overall Study|Adverse Event|9|||
130721748|NCT01136967|470606310|FG001|Overall Study|Adverse Event|12|||
130317571|NCT02898454|469128683|FG001|Overall Study|Adverse Event|1|||
130317572|NCT02898454|469128684|FG002|Overall Study|Adverse Event|2|||
130317573|NCT02898454|469128682|FG000|Overall Study|Protocol Violation|1|||
130317574|NCT02898454|469128683|FG001|Overall Study|Protocol Violation|0|||
130317575|NCT02898454|469128684|FG002|Overall Study|Protocol Violation|1|||
130721749|NCT01136967|470606309|FG000|Overall Study|Participant Choice|8|||
130317576|NCT02898454|469128682|FG000|Overall Study|Lack of Efficacy|4|||
130317577|NCT02898454|469128683|FG001|Overall Study|Lack of Efficacy|1|||
130317578|NCT02898454|469128684|FG002|Overall Study|Lack of Efficacy|0|||
130317579|NCT02898454|469128682|FG000|Overall Study|Withdrawal by Subject|6|||
130317580|NCT02898454|469128683|FG001|Overall Study|Withdrawal by Subject|3|||
130317581|NCT02898454|469128684|FG002|Overall Study|Withdrawal by Subject|3|||
130317582|NCT02898454|469128682|FG000|Overall Study|Lost to Follow-up|1|||
130317583|NCT02898454|469128683|FG001|Overall Study|Lost to Follow-up|0|||
130317584|NCT02898454|469128684|FG002|Overall Study|Lost to Follow-up|0|||
130467147|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
130467148|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
130467149|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
130467150|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
130467151|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
130467152|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
130467153|NCT04043455|469678873|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
130467154|NCT04043455|469678874|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
130467155|NCT04043455|469678875|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
130467156|NCT04043455|469678876|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
130467157|NCT04043455|469678877|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
130467158|NCT04043455|469678878|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
130467159|NCT04043455|469678873|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
130467160|NCT04043455|469678874|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
130467161|NCT04043455|469678875|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
130467162|NCT04043455|469678876|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
130467163|NCT04043455|469678877|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
130721750|NCT01136967|470606310|FG001|Overall Study|Participant Choice|3|||
130721751|NCT01136967|470606309|FG000|Overall Study|Lost to Follow-up|0|||
130721752|NCT01136967|470606310|FG001|Overall Study|Lost to Follow-up|1|||
130721753|NCT01136967|470606309|FG000|Overall Study|Withdrawal by Subject|1|||
130721754|NCT01136967|470606310|FG001|Overall Study|Withdrawal by Subject|2|||
130721755|NCT01136967|470606309|FG000|Overall Study|Clinical Progression|3|||
130721756|NCT01136967|470606310|FG001|Overall Study|Clinical Progression|5|||
130721757|NCT01136967|470606309|FG000|Overall Study|Radiation|1|||
130721758|NCT01136967|470606310|FG001|Overall Study|Radiation|0|||
130721759|NCT01136967|470606309|FG000|Overall Study|Non-compliance|1|||
130721760|NCT01136967|470606310|FG001|Overall Study|Non-compliance|0|||
130721761|NCT01136967|470606309|FG000|Overall Study|Investigator's Choice|1|||
130721762|NCT01136967|470606310|FG001|Overall Study|Investigator's Choice|1|||
130721763|NCT01136967|470606309|FG000|Overall Study|Increase in Lesion Size|0|||
130721764|NCT01136967|470606310|FG001|Overall Study|Increase in Lesion Size|2|||
130721765|NCT01136967|470606309|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
130721766|NCT01136967|470606310|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
130721767|NCT03839823|470606311|FG000|Overall Study|Adverse Event|8|||
130721768|NCT03839823|470606312|FG001|Overall Study|Adverse Event|4|||
130721769|NCT03839823|470606311|FG000|Overall Study|Death|1|||
130721770|NCT03839823|470606312|FG001|Overall Study|Death|0|||
130721771|NCT03839823|470606311|FG000|Overall Study|Physician Decision|1|||
130721772|NCT03839823|470606312|FG001|Overall Study|Physician Decision|5|||
130721773|NCT03839823|470606311|FG000|Overall Study|Progressive Disease (PD)|65|||
130721774|NCT03839823|470606312|FG001|Overall Study|Progressive Disease (PD)|65|||
130721775|NCT03839823|470606311|FG000|Overall Study|Subject Decision|2|||
130721776|NCT03839823|470606312|FG001|Overall Study|Subject Decision|9|||
130721777|NCT03839823|470606311|FG000|Overall Study|Not Treated|0|||
130721778|NCT03839823|470606312|FG001|Overall Study|Not Treated|10|||
130721779|NCT03151811|470606316|FG000|Overall Study|Randomized But Not Treated|18|||
130721780|NCT03151811|470606317|FG001|Overall Study|Randomized But Not Treated|3|||
130721781|NCT03151811|470606316|FG000|Overall Study|Progressive Disease|130|||
130721782|NCT03151811|470606317|FG001|Overall Study|Progressive Disease|170|||
130721783|NCT03151811|470606316|FG000|Overall Study|Adverse Event|49|||
130721784|NCT03151811|470606317|FG001|Overall Study|Adverse Event|40|||
130721785|NCT03151811|470606316|FG000|Overall Study|Lack of Efficacy|6|||
130721786|NCT03151811|470606317|FG001|Overall Study|Lack of Efficacy|8|||
130721787|NCT03151811|470606316|FG000|Overall Study|Physician Decision|21|||
130721788|NCT03151811|470606317|FG001|Overall Study|Physician Decision|9|||
130721789|NCT03151811|470606316|FG000|Overall Study|Withdrawal by Subject|17|||
130721790|NCT03151811|470606317|FG001|Overall Study|Withdrawal by Subject|7|||
130721791|NCT03151811|470606316|FG000|Overall Study|Lost to Follow-up|0|||
130721792|NCT03151811|470606317|FG001|Overall Study|Lost to Follow-up|1|||
130721793|NCT03151811|470606316|FG000|Overall Study|Study Terminated by Sponsor|5|||
130721794|NCT03151811|470606317|FG001|Overall Study|Study Terminated by Sponsor|11|||
130317585|NCT02898454|469128682|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
130317586|NCT02898454|469128683|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
130317587|NCT02898454|469128684|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
130317588|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130378038|NCT02141282|469351701|FG000|Overall Study|Progressive disease per protocol|12|||
130378039|NCT02141282|469351702|FG001|Overall Study|Progressive disease per protocol|7|||
130378040|NCT02141282|469351703|FG002|Overall Study|Progressive disease per protocol|9|||
130378041|NCT02141282|469351704|FG003|Overall Study|Progressive disease per protocol|2|||
130378042|NCT02141282|469351701|FG000|Overall Study|Stem cell transplant|1|||
130378043|NCT02141282|469351702|FG001|Overall Study|Stem cell transplant|0|||
130378044|NCT02141282|469351703|FG002|Overall Study|Stem cell transplant|1|||
130378045|NCT02141282|469351704|FG003|Overall Study|Stem cell transplant|0|||
130378046|NCT02141282|469351701|FG000|Overall Study|Study terminated by Sponsor|0|||
130378047|NCT02141282|469351702|FG001|Overall Study|Study terminated by Sponsor|1|||
130378048|NCT02141282|469351703|FG002|Overall Study|Study terminated by Sponsor|0|||
130378049|NCT02141282|469351704|FG003|Overall Study|Study terminated by Sponsor|0|||
130378050|NCT02141282|469351701|FG000|Overall Study|Subject non-compliance|0|||
130378051|NCT02141282|469351702|FG001|Overall Study|Subject non-compliance|0|||
130378052|NCT02141282|469351703|FG002|Overall Study|Subject non-compliance|1|||
130378053|NCT02141282|469351704|FG003|Overall Study|Subject non-compliance|0|||
130378054|NCT02141282|469351701|FG000|Overall Study|Withdrew consent|2|||
130378055|NCT02141282|469351702|FG001|Overall Study|Withdrew consent|0|||
130378056|NCT02141282|469351703|FG002|Overall Study|Withdrew consent|4|||
130378057|NCT02141282|469351704|FG003|Overall Study|Withdrew consent|0|||
130467164|NCT04043455|469678878|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
130467165|NCT04043455|469678873|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
130721795|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
130721796|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
130721797|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130721798|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130721799|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
130721800|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
130721801|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
130721802|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
130721803|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
130721804|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
130721805|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Death|1|||
130721806|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Death|0|||
130721807|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Death|0|||
130721808|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Death|0|||
130721809|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Death|0|||
130721810|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130721811|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130721812|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
130721813|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130721814|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130721815|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721816|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
130721817|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721818|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721819|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
130721820|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130721821|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130721822|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
130721823|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130721824|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130721825|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130721826|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
130721827|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130721828|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130721829|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130721830|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130721831|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721832|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721833|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721834|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130378058|NCT01752907|469351707|FG000|Overall Study|Withdrawal by Subject|4|||
130378059|NCT01752907|469351708|FG001|Overall Study|Withdrawal by Subject|10|||
130378060|NCT01752907|469351707|FG000|Overall Study|Lost to Follow-up|2|||
130378061|NCT01752907|469351708|FG001|Overall Study|Lost to Follow-up|1|||
130378062|NCT01752907|469351707|FG000|Overall Study|Decision by Sponsor|6|||
130378063|NCT01752907|469351708|FG001|Overall Study|Decision by Sponsor|9|||
130378064|NCT02670083|469351715|FG000|Overall Study|Adverse Event|16|||
130378065|NCT02670083|469351716|FG001|Overall Study|Adverse Event|13|||
130317589|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130317590|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130721835|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Other|4|||
130721836|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Other|4|||
130721837|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Other|3|||
130721838|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Other|1|||
130317591|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
130317592|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130317593|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130317594|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130317595|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130317596|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317597|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
130317598|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317599|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317600|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
130317601|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317602|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317603|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317604|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
130317605|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317606|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317607|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317608|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Death|3|||
130317609|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Death|0|||
130317610|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Death|0|||
130317611|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Death|0|||
130317612|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130317613|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
130317614|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130317615|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
130317616|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130317617|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
130317618|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130317619|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
130317620|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317621|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
130317622|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317623|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317624|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
130317625|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
130317626|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
130317627|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
130317628|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130317629|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130317630|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130317631|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130317632|NCT03883581|469128689|FG000|Overall Study|Withdrawal by Subject|4|||
130317633|NCT02926638|469128690|FG000|Overall Study|Progression|2|||
130317634|NCT02926638|469128691|FG001|Overall Study|Progression|5|||
130317635|NCT02926638|469128690|FG000|Overall Study|Ineligible|1|||
130317636|NCT02926638|469128691|FG001|Overall Study|Ineligible|0|||
130317637|NCT02926638|469128690|FG000|Overall Study|Not protocol specified|1|||
130317638|NCT02926638|469128691|FG001|Overall Study|Not protocol specified|0|||
130317639|NCT01908426|469129856|FG000|Overall Study|Adverse Event|98|||
130317640|NCT01908426|469129857|FG001|Overall Study|Adverse Event|11|||
130317641|NCT01908426|469129856|FG000|Overall Study|Clinical Deterioration|72|||
130317642|NCT01908426|469129857|FG001|Overall Study|Clinical Deterioration|38|||
130317643|NCT01908426|469129856|FG000|Overall Study|Lack of Efficacy|3|||
130317644|NCT01908426|469129857|FG001|Overall Study|Lack of Efficacy|0|||
130317645|NCT01908426|469129856|FG000|Overall Study|Lost to Follow-up|0|||
130378066|NCT02670083|469351715|FG000|Overall Study|Death|4|||
130721839|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Other|0|||
130721840|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
130721841|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130317646|NCT01908426|469129857|FG001|Overall Study|Lost to Follow-up|1|||
130317647|NCT01908426|469129856|FG000|Overall Study|Physician Decision|3|||
130317648|NCT01908426|469129857|FG001|Overall Study|Physician Decision|3|||
130378067|NCT02670083|469351716|FG001|Overall Study|Death|6|||
130721842|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130317649|NCT01908426|469129856|FG000|Overall Study|Withdrawal by Subject|11|||
130721843|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130317650|NCT01908426|469129857|FG001|Overall Study|Withdrawal by Subject|6|||
130317651|NCT01908426|469129856|FG000|Overall Study|Progressive Disease|206|||
130317652|NCT01908426|469129857|FG001|Overall Study|Progressive Disease|152|||
130317653|NCT01908426|469129856|FG000|Overall Study|Protocol Violation|1|||
130317654|NCT01908426|469129857|FG001|Overall Study|Protocol Violation|0|||
130317655|NCT01908426|469129856|FG000|Overall Study|No Study Treatment Given|3|||
130317656|NCT01908426|469129857|FG001|Overall Study|No Study Treatment Given|0|||
130317657|NCT02426580|469129858|FG000|Overall Study|Death|2|||
130317658|NCT02426580|469129859|FG001|Overall Study|Death|2|||
130317659|NCT02426580|469129858|FG000|Overall Study|Lost to Follow-up|0|||
130317660|NCT02426580|469129859|FG001|Overall Study|Lost to Follow-up|9|||
130317661|NCT02426580|469129858|FG000|Overall Study|transfer to hemodialysis|5|||
130317662|NCT02426580|469129859|FG001|Overall Study|transfer to hemodialysis|5|||
130317663|NCT02426580|469129858|FG000|Overall Study|Kidney transplant|3|||
130317664|NCT02426580|469129859|FG001|Overall Study|Kidney transplant|0|||
130317665|NCT02426580|469129858|FG000|Overall Study|Allergic to egg white|1|||
130317666|NCT02426580|469129859|FG001|Overall Study|Allergic to egg white|0|||
130317667|NCT00416624|469129868|FG000|Overall Study|Withdrawal by Subject|1|||
130317668|NCT00416624|469129869|FG001|Overall Study|Withdrawal by Subject|6|||
130317669|NCT00416624|469129870|FG002|Overall Study|Withdrawal by Subject|4|||
130317670|NCT00416624|469129871|FG003|Overall Study|Withdrawal by Subject|9|||
130317671|NCT00416624|469129868|FG000|Overall Study|Death|4|||
130317672|NCT00416624|469129869|FG001|Overall Study|Death|7|||
130317673|NCT00416624|469129870|FG002|Overall Study|Death|7|||
130317674|NCT00416624|469129871|FG003|Overall Study|Death|1|||
130317675|NCT00416624|469129868|FG000|Overall Study|Adverse Event|8|||
130317676|NCT00416624|469129869|FG001|Overall Study|Adverse Event|3|||
130317677|NCT00416624|469129870|FG002|Overall Study|Adverse Event|2|||
130317678|NCT00416624|469129871|FG003|Overall Study|Adverse Event|2|||
130317679|NCT00416624|469129868|FG000|Overall Study|Other|8|||
130317680|NCT00416624|469129869|FG001|Overall Study|Other|11|||
130317681|NCT00416624|469129870|FG002|Overall Study|Other|5|||
130317682|NCT00416624|469129871|FG003|Overall Study|Other|5|||
130317683|NCT00416624|469129868|FG000|Overall Study|Cancel|1|||
130317684|NCT00416624|469129869|FG001|Overall Study|Cancel|0|||
130317685|NCT00416624|469129870|FG002|Overall Study|Cancel|0|||
130317686|NCT00416624|469129871|FG003|Overall Study|Cancel|0|||
130317687|NCT00768989|469129874|FG000|Prior to Week 24|Withdrawal by Subject|1|||
130317688|NCT00768989|469129875|FG001|Prior to Week 24|Withdrawal by Subject|0|||
130317689|NCT00768989|469129874|FG000|Prior to Week 24|Adverse Event|3|||
130317690|NCT00768989|469129875|FG001|Prior to Week 24|Adverse Event|0|||
130317691|NCT00768989|469129874|FG000|Prior to Week 24|Lost to Follow-up|0|||
130317692|NCT00768989|469129875|FG001|Prior to Week 24|Lost to Follow-up|1|||
130317693|NCT00768989|469129874|FG000|Prior to Week 24|Protocol Violation|0|||
130317694|NCT00768989|469129875|FG001|Prior to Week 24|Protocol Violation|2|||
130317695|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
130317696|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
130317697|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
130317698|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
130317699|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
130317700|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
130317701|NCT00768989|469129874|FG000|On or After Week 36|Lack of Efficacy|1|||
130317702|NCT00768989|469129875|FG001|On or After Week 36|Lack of Efficacy|0|||
130317703|NCT00768989|469129874|FG000|On or After Week 36|Adverse Event|0|||
130317704|NCT00768989|469129875|FG001|On or After Week 36|Adverse Event|1|||
130317705|NCT00768989|469129874|FG000|On or After Week 36|Lost to Follow-up|1|||
130317706|NCT00768989|469129875|FG001|On or After Week 36|Lost to Follow-up|0|||
130317707|NCT00768989|469129874|FG000|On or After Week 36|Poor Compliance|1|||
130317708|NCT00768989|469129875|FG001|On or After Week 36|Poor Compliance|0|||
130317709|NCT00768989|469129874|FG000|On or After Week 36|Protocol Violation|1|||
130317710|NCT00768989|469129875|FG001|On or After Week 36|Protocol Violation|0|||
130317711|NCT00768989|469129874|FG000|On or After Week 36|Did not attend termination visit|2|||
130317712|NCT00768989|469129875|FG001|On or After Week 36|Did not attend termination visit|0|||
130317713|NCT00768989|469129874|FG000|On or After Week 36|Sponsor Termination|45|||
130317714|NCT00768989|469129875|FG001|On or After Week 36|Sponsor Termination|26|||
130317715|NCT03661723|469129876|FG000|Overall Study|Disease Progression|4|||
130317716|NCT03661723|469129877|FG001|Overall Study|Disease Progression|24|||
130317717|NCT03661723|469129878|FG002|Overall Study|Disease Progression|4|||
130317718|NCT03661723|469129879|FG003|Overall Study|Disease Progression|19|||
130317719|NCT03661723|469129876|FG000|Overall Study|Withdrawal by Subject|1|||
130317720|NCT03661723|469129877|FG001|Overall Study|Withdrawal by Subject|0|||
130317721|NCT03661723|469129878|FG002|Overall Study|Withdrawal by Subject|2|||
130317722|NCT03661723|469129879|FG003|Overall Study|Withdrawal by Subject|4|||
130317723|NCT03661723|469129876|FG000|Overall Study|Physician Decision|1|||
130317724|NCT03661723|469129877|FG001|Overall Study|Physician Decision|0|||
130317725|NCT03661723|469129878|FG002|Overall Study|Physician Decision|0|||
130317726|NCT03661723|469129879|FG003|Overall Study|Physician Decision|0|||
130378068|NCT02670083|469351715|FG000|Overall Study|Lost to Follow-up|2|||
130378069|NCT02670083|469351716|FG001|Overall Study|Lost to Follow-up|2|||
130721844|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130721845|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130721846|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721847|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721848|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130317727|NCT03661723|469129876|FG000|Overall Study|Clinical Deterioration|0|||
130317728|NCT03661723|469129877|FG001|Overall Study|Clinical Deterioration|0|||
130317729|NCT03661723|469129878|FG002|Overall Study|Clinical Deterioration|0|||
130317730|NCT03661723|469129879|FG003|Overall Study|Clinical Deterioration|1|||
130317731|NCT03452540|469129883|FG000|Overall Study|Adverse Event|1|||
130317732|NCT03452540|469129883|FG000|Overall Study|Withdrawal by Subject|1|||
130317733|NCT03452540|469129883|FG000|Overall Study|Other SAE and AE|2|||
130317734|NCT01045460|469129886|FG000|Overall Study|Physician Decision|3|||
130317735|NCT01045460|469129887|FG001|Overall Study|Physician Decision|2|||
130317736|NCT01045460|469129886|FG000|Overall Study|Lost to Follow-up|0|||
130317737|NCT01045460|469129887|FG001|Overall Study|Lost to Follow-up|1|||
130317738|NCT01045460|469129886|FG000|Overall Study|Lack of Efficacy|3|||
130317739|NCT01045460|469129887|FG001|Overall Study|Lack of Efficacy|0|||
130317740|NCT00524485|469129888|FG000|Overall Study|Withdrawal by Subject|5|||
130317741|NCT00436332|469129889|FG000|Overall Study|Adverse Event|9|||
130317742|NCT00436332|469129889|FG000|Overall Study|Withdrawal by Subject|2|||
130317743|NCT00436332|469129889|FG000|Overall Study|Progression|59|||
130317744|NCT00436332|469129889|FG000|Overall Study|Death|2|||
130317745|NCT00436332|469129889|FG000|Overall Study|Not Protocol Specified|6|||
130317746|NCT00436332|469129889|FG000|Overall Study|Ineligible|2|||
130317747|NCT00436332|469129889|FG000|Overall Study|Never Received Treatment|3|||
130317748|NCT00472108|469129890|FG000|Overall Study|Lost to Follow-up|0|||
130317749|NCT00472108|469129891|FG001|Overall Study|Lost to Follow-up|1|||
130317750|NCT01339689|469129894|FG000|Overall Study|Adverse Event|1|||
130317751|NCT01339689|469129895|FG001|Overall Study|Adverse Event|2|||
130317752|NCT01339689|469129894|FG000|Overall Study|Lost to Follow-up|9|||
130317753|NCT01339689|469129895|FG001|Overall Study|Lost to Follow-up|3|||
130317754|NCT01339689|469129894|FG000|Overall Study|Withdrawal by Subject|3|||
130317755|NCT01339689|469129895|FG001|Overall Study|Withdrawal by Subject|0|||
130317756|NCT01339689|469129894|FG000|Overall Study|Noncompliance|1|||
130317757|NCT01339689|469129895|FG001|Overall Study|Noncompliance|0|||
130317758|NCT01339689|469129894|FG000|Overall Study|Relocated out of area|0|||
130317759|NCT01339689|469129895|FG001|Overall Study|Relocated out of area|1|||
130317760|NCT01339689|469129894|FG000|Overall Study|Other|2|||
130317761|NCT01339689|469129895|FG001|Overall Study|Other|2|||
130317762|NCT01339689|469129894|FG000|Overall Study|multiple reasons|1|||
130317763|NCT01339689|469129895|FG001|Overall Study|multiple reasons|1|||
130317764|NCT00667888|469129896|FG000|Overall Study|Death|1|||
130317765|NCT00667888|469129897|FG001|Overall Study|Death|1|||
130317766|NCT00667888|469129896|FG000|Overall Study|Withdrawal by Subject|6|||
130721849|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721850|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Death|1|||
130721851|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130721852|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130721853|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Death|0|||
130721854|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Death|0|||
130721855|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
130317767|NCT00667888|469129897|FG001|Overall Study|Withdrawal by Subject|3|||
130378070|NCT02670083|469351715|FG000|Overall Study|Multiple Reasons|9|||
130378071|NCT02670083|469351716|FG001|Overall Study|Multiple Reasons|9|||
130378072|NCT02670083|469351715|FG000|Overall Study|Physician Decision|0|||
130378073|NCT02670083|469351716|FG001|Overall Study|Physician Decision|2|||
130378074|NCT02670083|469351715|FG000|Overall Study|Study Terminated By Sponsor|257|||
130378075|NCT02670083|469351716|FG001|Overall Study|Study Terminated By Sponsor|254|||
130467166|NCT04043455|469678874|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
130317768|NCT00667888|469129896|FG000|Overall Study|Proceed with other treatment|3|||
130317769|NCT00667888|469129897|FG001|Overall Study|Proceed with other treatment|3|||
130317770|NCT00667888|469129896|FG000|Overall Study|Ineligible after SIM|0|||
130317771|NCT00667888|469129897|FG001|Overall Study|Ineligible after SIM|2|||
130317772|NCT00499681|469129898|FG000|Overall Study|toxicity|0|||
130317773|NCT00499681|469129899|FG001|Overall Study|toxicity|1|||
130317774|NCT00499681|469129898|FG000|Overall Study|disease progression|0|||
130378076|NCT02670083|469351715|FG000|Overall Study|Symptomatic Deterioration|0|||
130378077|NCT02670083|469351716|FG001|Overall Study|Symptomatic Deterioration|2|||
130467167|NCT04043455|469678875|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
130559580|NCT01986920|470017819|FG003|Placebo|Withdrawal by Subject|1|||
130317775|NCT00499681|469129899|FG001|Overall Study|disease progression|1|||
130317776|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130317777|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130378078|NCT02670083|469351715|FG000|Overall Study|Withdrawal by Subject|32|||
130378079|NCT02670083|469351716|FG001|Overall Study|Withdrawal by Subject|31|||
130317778|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Disease progression|75|||
130317779|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Disease progression|59|||
130317780|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Adverse Event|16|||
130317781|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Adverse Event|16|||
130317782|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Death|2|||
130317783|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Death|3|||
130317784|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
130317785|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
130317786|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Other|3|||
130317787|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Other|0|||
130317788|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Adverse Event|2|||
130317789|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Adverse Event|3|||
130317790|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Death|1|||
130317791|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Death|3|||
130317792|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
130317793|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
130317794|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
130317795|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
130317796|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Disease progression|103|||
130317797|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Disease progression|122|||
130317798|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Other|3|||
130317799|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Other|0|||
130317800|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
130317801|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
130317802|NCT00883779|469129900|FG000|Off-study Phase|Death|185|||
130317803|NCT00883779|469129901|FG001|Off-study Phase|Death|174|||
130317804|NCT00883779|469129900|FG000|Off-study Phase|Refused treatment|1|||
130317805|NCT00883779|469129901|FG001|Off-study Phase|Refused treatment|1|||
130317806|NCT00883779|469129900|FG000|Off-study Phase|Failure to return|5|||
130317807|NCT00883779|469129901|FG001|Off-study Phase|Failure to return|6|||
130317808|NCT00883779|469129900|FG000|Off-study Phase|Other|18|||
130317809|NCT00883779|469129901|FG001|Off-study Phase|Other|21|||
130317810|NCT02140047|469129902|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130317811|NCT02140047|469129903|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130317812|NCT02140047|469129904|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130317813|NCT00079040|469129905|FG000|Overall Study|Withdrew before treatment|1|||
130317814|NCT00079040|469129905|FG000|Overall Study|Ineligible|1|||
130317815|NCT00325897|469129906|FG000|Overall Study|Lost to Follow-up|12|||
130317816|NCT00325897|469129907|FG001|Overall Study|Lost to Follow-up|13|||
130317817|NCT03915717|469129910|FG000|Overall Study|EchoMark Not Implanted|6|||
130317818|NCT03748823|469129912|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130317819|NCT03748823|469129913|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130317820|NCT03748823|469129912|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
130317821|NCT03748823|469129913|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
130317822|NCT03748823|469129912|FG000|Extension Period|Withdrawal by Subject|9|||
130317823|NCT03748823|469129913|FG001|Extension Period|Withdrawal by Subject|12|||
130317824|NCT03748823|469129912|FG000|Extension Period|Death|2|||
130317825|NCT03748823|469129913|FG001|Extension Period|Death|2|||
130317826|NCT03748823|469129912|FG000|Extension Period|Other than Specified|0|||
130317827|NCT03748823|469129913|FG001|Extension Period|Other than Specified|1|||
130467168|NCT04043455|469678876|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
130467169|NCT04043455|469678877|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
130467170|NCT04043455|469678878|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
130467171|NCT04043455|469678873|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
130467172|NCT04043455|469678874|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
130467173|NCT04043455|469678875|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
130467174|NCT04043455|469678876|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
130467175|NCT04043455|469678877|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
130467176|NCT04043455|469678878|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
130467177|NCT04043455|469678873|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
130467178|NCT04043455|469678874|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
130467179|NCT04043455|469678875|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
130467180|NCT04043455|469678876|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
130467181|NCT04043455|469678877|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
130467182|NCT04043455|469678878|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
130467183|NCT05568615|469678879|FG000|Overall Study|Death|1|||
130467184|NCT05568615|469678879|FG000|Overall Study|Physician Decision|1|||
130467185|NCT03529110|469678880|FG000|Overall Study|Progressive Disease|66|||
130467186|NCT03529110|469678881|FG001|Overall Study|Progressive Disease|158|||
130467187|NCT03529110|469678880|FG000|Overall Study|Clinical Progression|4|||
130467188|NCT03529110|469678881|FG001|Overall Study|Clinical Progression|12|||
130467189|NCT03529110|469678880|FG000|Overall Study|Adverse Event|35|||
130467190|NCT03529110|469678881|FG001|Overall Study|Adverse Event|17|||
130721856|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
130721857|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721858|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721859|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721860|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721861|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130721862|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721863|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721864|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721865|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130721866|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130721867|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130317828|NCT03748823|469129912|FG000|Extension Period|Protocol Violation|1|||
130317829|NCT03748823|469129913|FG001|Extension Period|Protocol Violation|0|||
130317830|NCT03748823|469129912|FG000|Extension Period|Lost to Follow-up|0|||
130317831|NCT03748823|469129913|FG001|Extension Period|Lost to Follow-up|1|||
130317832|NCT03748823|469129912|FG000|Extension Period|Lack of Efficacy|0|||
130317833|NCT03748823|469129913|FG001|Extension Period|Lack of Efficacy|1|||
130317834|NCT03748823|469129912|FG000|Extension Period|Physician Decision|1|||
130317835|NCT03748823|469129913|FG001|Extension Period|Physician Decision|2|||
130317836|NCT01664910|469129917|FG000|Overall Study|Adverse Event|0|||
130317837|NCT01664910|469129918|FG001|Overall Study|Adverse Event|0|||
130317838|NCT01664910|469129919|FG002|Overall Study|Adverse Event|1|||
130317839|NCT01011673|469129920|FG000|Randomized|Secondary headache|2|||
130317840|NCT01011673|469129921|FG001|Randomized|Secondary headache|1|||
130317841|NCT01011673|469129920|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
130317842|NCT01011673|469129921|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
130317843|NCT01632020|469129922|FG000|Overall Study|Withdrawal by Subject|1|||
130317844|NCT01632020|469129923|FG001|Overall Study|Withdrawal by Subject|0|||
130317845|NCT01632020|469129922|FG000|Overall Study|Adverse Event|1|||
130317846|NCT01632020|469129923|FG001|Overall Study|Adverse Event|0|||
130317847|NCT00549640|469129925|FG000|Overall Study|Withdrawal by Subject|6|||
130317848|NCT00549640|469129926|FG001|Overall Study|Withdrawal by Subject|12|||
130317849|NCT00549640|469129925|FG000|Overall Study|Adverse Event|5|||
130317850|NCT00549640|469129926|FG001|Overall Study|Adverse Event|0|||
130317851|NCT00549640|469129925|FG000|Overall Study|Lost to Follow-up|7|||
130467191|NCT03529110|469678880|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
130467192|NCT03529110|469678881|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
130467193|NCT03529110|469678880|FG000|Overall Study|Lack of Efficacy|3|||
130721868|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130721869|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130317852|NCT00549640|469129926|FG001|Overall Study|Lost to Follow-up|4|||
130317853|NCT00399516|469129935|FG000|Overall Study|Lost to Follow-up|2|||
130317854|NCT00539981|469129938|FG000|Overall Study|Adverse events (AE)|3|||
130317855|NCT00539981|469129939|FG001|Overall Study|Adverse events (AE)|3|||
130317856|NCT00539981|469129938|FG000|Overall Study|Lost to Follow-up|260|||
130317857|NCT00539981|469129939|FG001|Overall Study|Lost to Follow-up|251|||
130317858|NCT00539981|469129938|FG000|Overall Study|Withdrew consent|22|||
130317859|NCT00539981|469129939|FG001|Overall Study|Withdrew consent|14|||
130378080|NCT02670083|469351715|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130378081|NCT02670083|469351716|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130378082|NCT02057406|469351718|FG000|Overall Study|Physician Decision|0|||
130378083|NCT02057406|469351719|FG001|Overall Study|Physician Decision|0|||
130378084|NCT02057406|469351720|FG002|Overall Study|Physician Decision|2|||
130378085|NCT02057406|469351718|FG000|Overall Study|Withdrawal by Subject|0|||
130378086|NCT02057406|469351719|FG001|Overall Study|Withdrawal by Subject|2|||
130378087|NCT02057406|469351720|FG002|Overall Study|Withdrawal by Subject|0|||
130378088|NCT02057406|469351718|FG000|Overall Study|Lost to Follow-up|0|||
130378089|NCT02057406|469351719|FG001|Overall Study|Lost to Follow-up|0|||
130378090|NCT02057406|469351720|FG002|Overall Study|Lost to Follow-up|1|||
130317860|NCT00539981|469129938|FG000|Overall Study|Death|1|||
130317861|NCT00539981|469129939|FG001|Overall Study|Death|1|||
130317862|NCT00539981|469129938|FG000|Overall Study|Other reason-unspecified|9|||
130317863|NCT00539981|469129939|FG001|Overall Study|Other reason-unspecified|13|||
130317864|NCT02675907|469129940|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130317865|NCT02675907|469129941|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130317866|NCT02675907|469129940|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130317867|NCT02675907|469129941|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130317868|NCT02675907|469129940|FG000|Study Overall|Lack of Efficacy|1|||
130317869|NCT02675907|469129941|FG001|Study Overall|Lack of Efficacy|0|||
130317870|NCT02675907|469129940|FG000|Study Overall|Withdrawal by Subject|2|||
130317871|NCT02675907|469129941|FG001|Study Overall|Withdrawal by Subject|2|||
130317872|NCT02675907|469129940|FG000|Study Overall|Lost to Follow-up|0|||
130317873|NCT02675907|469129941|FG001|Study Overall|Lost to Follow-up|2|||
130317874|NCT01611792|469129942|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
130317875|NCT01611792|469129943|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
130317876|NCT01611792|469129942|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
130317877|NCT01611792|469129943|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
130317878|NCT01129622|469129944|FG000|Overall Study|Withdrawal by Subject|2|||
130317879|NCT00591006|469129945|FG000|Overall Study|Withdrawal by Subject|0|||
130317880|NCT00591006|469129946|FG001|Overall Study|Withdrawal by Subject|0|||
130317881|NCT00591006|469129947|FG002|Overall Study|Withdrawal by Subject|0|||
130317882|NCT00591006|469129948|FG003|Overall Study|Withdrawal by Subject|0|||
130317883|NCT00591006|469129949|FG004|Overall Study|Withdrawal by Subject|0|||
130317884|NCT00591006|469129950|FG005|Overall Study|Withdrawal by Subject|0|||
130317885|NCT00591006|469129951|FG006|Overall Study|Withdrawal by Subject|0|||
130317886|NCT00591006|469129952|FG007|Overall Study|Withdrawal by Subject|0|||
130378091|NCT02057406|469351718|FG000|Overall Study|Death|1|||
130378092|NCT02057406|469351719|FG001|Overall Study|Death|0|||
130378093|NCT02057406|469351720|FG002|Overall Study|Death|0|||
130378094|NCT02057406|469351718|FG000|Overall Study|Protocol Violation|0|||
130378095|NCT02057406|469351719|FG001|Overall Study|Protocol Violation|1|||
130378096|NCT02057406|469351720|FG002|Overall Study|Protocol Violation|0|||
130378097|NCT02057406|469351718|FG000|Overall Study|Patient transportation issues|0|||
130378098|NCT02057406|469351719|FG001|Overall Study|Patient transportation issues|0|||
130378099|NCT02057406|469351720|FG002|Overall Study|Patient transportation issues|1|||
130378100|NCT02425046|469351721|FG000|Overall Study|Lost to Follow-up|52|||
130378101|NCT02425046|469351722|FG001|Overall Study|Lost to Follow-up|50|||
130378102|NCT02425046|469351723|FG002|Overall Study|Lost to Follow-up|56|||
130378103|NCT02425046|469351721|FG000|Overall Study|Withdrawal by Subject|16|||
130378104|NCT02425046|469351722|FG001|Overall Study|Withdrawal by Subject|12|||
130378105|NCT02425046|469351723|FG002|Overall Study|Withdrawal by Subject|0|||
130378106|NCT03654651|469351724|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130378107|NCT03654651|469351725|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
130378108|NCT00856284|469351730|FG000|Overall Study|Hyperglycemic rescue|231|||
130378109|NCT00856284|469351731|FG001|Overall Study|Hyperglycemic rescue|201|||
130378110|NCT00856284|469351732|FG002|Overall Study|Hyperglycemic rescue|235|||
130378111|NCT00856284|469351730|FG000|Overall Study|Adverse Event|60|||
130378112|NCT00856284|469351731|FG001|Overall Study|Adverse Event|74|||
130378113|NCT00856284|469351732|FG002|Overall Study|Adverse Event|82|||
130378114|NCT00856284|469351730|FG000|Overall Study|Major protocol deviation|24|||
130378115|NCT00856284|469351731|FG001|Overall Study|Major protocol deviation|16|||
130378116|NCT00856284|469351732|FG002|Overall Study|Major protocol deviation|15|||
130378117|NCT00856284|469351730|FG000|Overall Study|Lost to Follow-up|20|||
130378118|NCT00856284|469351731|FG001|Overall Study|Lost to Follow-up|22|||
130467194|NCT03529110|469678881|FG001|Overall Study|Lack of Efficacy|3|||
130317887|NCT00591006|469129953|FG008|Overall Study|Withdrawal by Subject|0|||
130317888|NCT00591006|469129954|FG009|Overall Study|Withdrawal by Subject|0|||
130317889|NCT00591006|469129955|FG010|Overall Study|Withdrawal by Subject|0|||
130317890|NCT00591006|469129956|FG011|Overall Study|Withdrawal by Subject|0|||
130317891|NCT00591006|469129957|FG012|Overall Study|Withdrawal by Subject|0|||
130317892|NCT00591006|469129958|FG013|Overall Study|Withdrawal by Subject|0|||
130317893|NCT00591006|469129959|FG014|Overall Study|Withdrawal by Subject|0|||
130317894|NCT00591006|469129960|FG015|Overall Study|Withdrawal by Subject|1|||
130378119|NCT00856284|469351732|FG002|Overall Study|Lost to Follow-up|28|||
130378120|NCT00856284|469351730|FG000|Overall Study|Voluntary withdrawal|48|||
130378121|NCT00856284|469351731|FG001|Overall Study|Voluntary withdrawal|52|||
130378122|NCT00856284|469351732|FG002|Overall Study|Voluntary withdrawal|62|||
130378123|NCT00856284|469351730|FG000|Overall Study|Pregnancy|1|||
130378124|NCT00856284|469351731|FG001|Overall Study|Pregnancy|2|||
130378125|NCT00856284|469351732|FG002|Overall Study|Pregnancy|0|||
130378126|NCT00856284|469351730|FG000|Overall Study|Investigator discretion|9|||
130378127|NCT00856284|469351731|FG001|Overall Study|Investigator discretion|8|||
130378128|NCT00856284|469351732|FG002|Overall Study|Investigator discretion|10|||
130378129|NCT00856284|469351730|FG000|Overall Study|Other|15|||
130378130|NCT00856284|469351731|FG001|Overall Study|Other|17|||
130378131|NCT00856284|469351732|FG002|Overall Study|Other|14|||
130378132|NCT00856284|469351730|FG000|Overall Study|Randomized in error|0|||
130378133|NCT00856284|469351731|FG001|Overall Study|Randomized in error|0|||
130378134|NCT00856284|469351732|FG002|Overall Study|Randomized in error|1|||
130378135|NCT02904512|469351733|FG000|Overall Study|Withdrawal by Subject|1|||
130378136|NCT02904512|469351734|FG001|Overall Study|Withdrawal by Subject|0|||
130317895|NCT00591006|469129961|FG016|Overall Study|Withdrawal by Subject|0|||
130378137|NCT02904512|469351733|FG000|Overall Study|Transferred to ICU|1|||
130378138|NCT02904512|469351734|FG001|Overall Study|Transferred to ICU|0|||
130378139|NCT02904512|469351733|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
130378140|NCT02904512|469351734|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
130378141|NCT00460408|469351741|FG000|Overall Study|Adverse Event|1|||
130378142|NCT00460408|469351742|FG001|Overall Study|Adverse Event|0|||
130378143|NCT00460408|469351743|FG002|Overall Study|Adverse Event|0|||
130378144|NCT00460408|469351744|FG003|Overall Study|Adverse Event|0|||
130378145|NCT00460408|469351741|FG000|Overall Study|Death|7|||
130378146|NCT00460408|469351742|FG001|Overall Study|Death|0|||
130378147|NCT00460408|469351743|FG002|Overall Study|Death|0|||
130378148|NCT00460408|469351744|FG003|Overall Study|Death|0|||
130378149|NCT00460408|469351741|FG000|Overall Study|Lost to Follow-up|11|||
130378150|NCT00460408|469351742|FG001|Overall Study|Lost to Follow-up|0|||
130378151|NCT00460408|469351743|FG002|Overall Study|Lost to Follow-up|1|||
130378152|NCT00460408|469351744|FG003|Overall Study|Lost to Follow-up|0|||
130378153|NCT00460408|469351741|FG000|Overall Study|Withdrawal by Subject|31|||
130378154|NCT00460408|469351742|FG001|Overall Study|Withdrawal by Subject|0|||
130378155|NCT00460408|469351743|FG002|Overall Study|Withdrawal by Subject|0|||
130378156|NCT00460408|469351744|FG003|Overall Study|Withdrawal by Subject|0|||
130378157|NCT00460408|469351741|FG000|Overall Study|Insufficient clinical response|5|||
130378158|NCT00460408|469351742|FG001|Overall Study|Insufficient clinical response|1|||
130378159|NCT00460408|469351743|FG002|Overall Study|Insufficient clinical response|5|||
130378160|NCT00460408|469351744|FG003|Overall Study|Insufficient clinical response|0|||
130378161|NCT00460408|469351741|FG000|Overall Study|Other|12|||
130378162|NCT00460408|469351742|FG001|Overall Study|Other|2|||
130378163|NCT00460408|469351743|FG002|Overall Study|Other|0|||
130378164|NCT00460408|469351744|FG003|Overall Study|Other|0|||
130378165|NCT01986985|469351745|FG000|Overall Study|Withdrawal by Subject|4|||
130378166|NCT01986985|469351745|FG000|Overall Study|Scan not completed due to malfunction|3|||
130317896|NCT00591006|469129962|FG017|Overall Study|Withdrawal by Subject|0|||
130317897|NCT00591006|469129963|FG018|Overall Study|Withdrawal by Subject|0|||
130317898|NCT00591006|469129964|FG019|Overall Study|Withdrawal by Subject|0|||
130317899|NCT00591006|469129965|FG020|Overall Study|Withdrawal by Subject|0|||
130317900|NCT00591006|469129966|FG021|Overall Study|Withdrawal by Subject|0|||
130317901|NCT00591006|469129967|FG022|Overall Study|Withdrawal by Subject|0|||
130317902|NCT00591006|469129968|FG023|Overall Study|Withdrawal by Subject|1|||
130317903|NCT00591006|469129945|FG000|Overall Study|Adverse Event|0|||
130317904|NCT00591006|469129946|FG001|Overall Study|Adverse Event|0|||
130317905|NCT00591006|469129947|FG002|Overall Study|Adverse Event|0|||
130317906|NCT00591006|469129948|FG003|Overall Study|Adverse Event|0|||
130317907|NCT00591006|469129949|FG004|Overall Study|Adverse Event|0|||
130378167|NCT02288559|469351747|FG000|Overall Study|Adverse Event|1|||
130378168|NCT02288559|469351748|FG001|Overall Study|Adverse Event|1|||
130378169|NCT02288559|469351749|FG002|Overall Study|Adverse Event|5|||
130378170|NCT02288559|469351750|FG003|Overall Study|Adverse Event|0|||
130378171|NCT02288559|469351747|FG000|Overall Study|Death|0|||
130378172|NCT02288559|469351748|FG001|Overall Study|Death|0|||
130378173|NCT02288559|469351749|FG002|Overall Study|Death|1|||
130378174|NCT02288559|469351750|FG003|Overall Study|Death|0|||
130378175|NCT02288559|469351747|FG000|Overall Study|Lost to Follow-up|0|||
130378176|NCT02288559|469351748|FG001|Overall Study|Lost to Follow-up|0|||
130378177|NCT02288559|469351749|FG002|Overall Study|Lost to Follow-up|0|||
130378178|NCT02288559|469351750|FG003|Overall Study|Lost to Follow-up|1|||
130378179|NCT02288559|469351747|FG000|Overall Study|Withdrawal by Subject|0|||
130378180|NCT02288559|469351748|FG001|Overall Study|Withdrawal by Subject|0|||
130317908|NCT00591006|469129950|FG005|Overall Study|Adverse Event|0|||
130317909|NCT00591006|469129951|FG006|Overall Study|Adverse Event|0|||
130317910|NCT00591006|469129952|FG007|Overall Study|Adverse Event|0|||
130378181|NCT02288559|469351749|FG002|Overall Study|Withdrawal by Subject|2|||
130378182|NCT02288559|469351750|FG003|Overall Study|Withdrawal by Subject|1|||
130378183|NCT02288559|469351747|FG000|Overall Study|Reason Not Specified|0|||
130378184|NCT02288559|469351748|FG001|Overall Study|Reason Not Specified|0|||
130378185|NCT02288559|469351749|FG002|Overall Study|Reason Not Specified|3|||
130559581|NCT01338415|470017820|FG000|Core + Extension|Adverse Event|8|||
130559582|NCT01338415|470017821|FG001|Core + Extension|Adverse Event|6|||
130559583|NCT01338415|470017822|FG002|Core + Extension|Adverse Event|0|||
130559584|NCT01338415|470017820|FG000|Core + Extension|Withdrawal by Subject|1|||
130559585|NCT01338415|470017821|FG001|Core + Extension|Withdrawal by Subject|1|||
130559586|NCT01338415|470017822|FG002|Core + Extension|Withdrawal by Subject|0|||
130559587|NCT01338415|470017820|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
130559588|NCT01338415|470017821|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
130559589|NCT01338415|470017822|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
130559590|NCT01338415|470017820|FG000|Core + Extension|Other (administrative reason)|1|||
130378186|NCT02288559|469351750|FG003|Overall Study|Reason Not Specified|0|||
130378187|NCT03303079|469351751|FG000|Overall Study|Adverse Event|0|||
130378188|NCT03303079|469351752|FG001|Overall Study|Adverse Event|1|||
130378189|NCT03303079|469351753|FG002|Overall Study|Adverse Event|3|||
130378190|NCT03303079|469351751|FG000|Overall Study|Protocol Violation|5|||
130378191|NCT03303079|469351752|FG001|Overall Study|Protocol Violation|4|||
130317911|NCT00591006|469129953|FG008|Overall Study|Adverse Event|0|||
130317912|NCT00591006|469129954|FG009|Overall Study|Adverse Event|0|||
130317913|NCT00591006|469129955|FG010|Overall Study|Adverse Event|0|||
130317914|NCT00591006|469129956|FG011|Overall Study|Adverse Event|0|||
130317915|NCT00591006|469129957|FG012|Overall Study|Adverse Event|0|||
130317916|NCT00591006|469129958|FG013|Overall Study|Adverse Event|0|||
130317917|NCT00591006|469129959|FG014|Overall Study|Adverse Event|0|||
130317918|NCT00591006|469129960|FG015|Overall Study|Adverse Event|0|||
130317919|NCT00591006|469129961|FG016|Overall Study|Adverse Event|0|||
130317920|NCT00591006|469129962|FG017|Overall Study|Adverse Event|0|||
130317921|NCT00591006|469129963|FG018|Overall Study|Adverse Event|0|||
130317922|NCT00591006|469129964|FG019|Overall Study|Adverse Event|0|||
130317923|NCT00591006|469129965|FG020|Overall Study|Adverse Event|0|||
130317924|NCT00591006|469129966|FG021|Overall Study|Adverse Event|0|||
130317925|NCT00591006|469129967|FG022|Overall Study|Adverse Event|1|||
130317926|NCT00591006|469129968|FG023|Overall Study|Adverse Event|0|||
130317927|NCT00689390|469129969|FG000|Overall Study|Adverse Event|19|||
130317928|NCT00689390|469129970|FG001|Overall Study|Adverse Event|0|||
130317929|NCT00689390|469129969|FG000|Overall Study|Lost to Follow-up|179|||
130317930|NCT00689390|469129970|FG001|Overall Study|Lost to Follow-up|7|||
130317931|NCT00689390|469129969|FG000|Overall Study|Withdrawal by Subject|117|||
130317932|NCT00689390|469129970|FG001|Overall Study|Withdrawal by Subject|3|||
130317933|NCT00689390|469129969|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
130317934|NCT00689390|469129970|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
130317935|NCT00689390|469129969|FG000|Overall Study|Non-Compliance With Protocol|21|||
130317936|NCT00689390|469129970|FG001|Overall Study|Non-Compliance With Protocol|0|||
130317937|NCT00689390|469129969|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130317938|NCT00689390|469129970|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130317939|NCT00689390|469129969|FG000|Overall Study|Administrative|37|||
130317940|NCT00689390|469129970|FG001|Overall Study|Administrative|0|||
130317941|NCT02343263|469129971|FG000|Overall Study|Physician Decision|5|||
130317942|NCT02343263|469129972|FG001|Overall Study|Physician Decision|3|||
130317943|NCT02343263|469129973|FG002|Overall Study|Physician Decision|1|||
130317944|NCT00525512|469129991|FG000|Double-Blind Phase|Adverse Event|48|||
130317945|NCT00525512|469129992|FG001|Double-Blind Phase|Adverse Event|28|||
130317946|NCT00525512|469129993|FG002|Double-Blind Phase|Adverse Event|0|||
130317947|NCT00525512|469129994|FG003|Double-Blind Phase|Adverse Event|0|||
130721870|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130721871|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721872|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130721873|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721874|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721875|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130721876|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130721877|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721878|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721879|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721880|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Other|4|||
130721881|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130721882|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130467195|NCT03529110|469678880|FG000|Overall Study|Physician Decision|2|||
130467196|NCT03529110|469678881|FG001|Overall Study|Physician Decision|8|||
130467197|NCT03529110|469678880|FG000|Overall Study|Miscellaneous|2|||
130467198|NCT03529110|469678881|FG001|Overall Study|Miscellaneous|5|||
130467199|NCT05194917|469678882|FG000|Overall Study|Lost to Follow-up|7|||
130467200|NCT05194917|469678883|FG001|Overall Study|Lost to Follow-up|5|||
130467201|NCT05194917|469678884|FG002|Overall Study|Lost to Follow-up|6|||
130467202|NCT05194917|469678885|FG003|Overall Study|Lost to Follow-up|5|||
130467203|NCT04688450|469678890|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
130467204|NCT04688450|469678890|FG000|Overall Study|Withdrawal by Subject|1|||
130467205|NCT03189524|469678891|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
130467206|NCT03189524|469678892|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
130467207|NCT03189524|469678893|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
130317948|NCT00525512|469129991|FG000|Double-Blind Phase|Protocol Violation|3|||
130317949|NCT00525512|469129992|FG001|Double-Blind Phase|Protocol Violation|1|||
130317950|NCT00525512|469129993|FG002|Double-Blind Phase|Protocol Violation|0|||
130317951|NCT00525512|469129994|FG003|Double-Blind Phase|Protocol Violation|0|||
130317952|NCT00525512|469129991|FG000|Double-Blind Phase|Lost to Follow-up|3|||
130317953|NCT00525512|469129992|FG001|Double-Blind Phase|Lost to Follow-up|7|||
130317954|NCT00525512|469129993|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130317955|NCT00525512|469129994|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130467208|NCT03189524|469678891|FG000|Overall Study|Death|2|||
130467209|NCT03189524|469678892|FG001|Overall Study|Death|2|||
130467210|NCT03189524|469678893|FG002|Overall Study|Death|1|||
130467211|NCT03189524|469678891|FG000|Overall Study|Lost to Follow-up|1|||
130467212|NCT03189524|469678892|FG001|Overall Study|Lost to Follow-up|0|||
130721883|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Other|0|||
130721884|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Other|0|||
130721885|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
130721886|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
130721887|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721888|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721889|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721890|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721891|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130721892|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721893|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721894|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721895|NCT01475097|470606332|FG000|Overall Study|Protocol Violation|1|||
130721896|NCT01475097|470606333|FG001|Overall Study|Protocol Violation|1|||
130721897|NCT00851318|470606344|FG000|Overall Study|Withdrawal by Subject|7|||
130721898|NCT00851318|470606345|FG001|Overall Study|Withdrawal by Subject|1|||
130721899|NCT00851318|470606346|FG002|Overall Study|Withdrawal by Subject|5|||
130721900|NCT00851318|470606347|FG003|Overall Study|Withdrawal by Subject|3|||
130721901|NCT00851318|470606344|FG000|Overall Study|Adverse Event|13|||
130721902|NCT00851318|470606345|FG001|Overall Study|Adverse Event|2|||
130721903|NCT00851318|470606346|FG002|Overall Study|Adverse Event|9|||
130721904|NCT00851318|470606347|FG003|Overall Study|Adverse Event|12|||
130721905|NCT00851318|470606344|FG000|Overall Study|Pregnancy|0|||
130721906|NCT00851318|470606345|FG001|Overall Study|Pregnancy|0|||
130721907|NCT00851318|470606346|FG002|Overall Study|Pregnancy|1|||
130721908|NCT00851318|470606347|FG003|Overall Study|Pregnancy|1|||
130721909|NCT00851318|470606344|FG000|Overall Study|Lack of Efficacy|8|||
130721910|NCT00851318|470606345|FG001|Overall Study|Lack of Efficacy|2|||
130721911|NCT00851318|470606346|FG002|Overall Study|Lack of Efficacy|4|||
130721912|NCT00851318|470606347|FG003|Overall Study|Lack of Efficacy|2|||
130721913|NCT00851318|470606344|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130721914|NCT00851318|470606345|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130721915|NCT00851318|470606346|FG002|Overall Study|Non-compliance with Study Procedures|1|||
130721916|NCT00851318|470606347|FG003|Overall Study|Non-compliance with Study Procedures|0|||
130721917|NCT00851318|470606344|FG000|Overall Study|Physician Decision|0|||
130721918|NCT00851318|470606345|FG001|Overall Study|Physician Decision|0|||
130721919|NCT00851318|470606346|FG002|Overall Study|Physician Decision|1|||
130721920|NCT00851318|470606347|FG003|Overall Study|Physician Decision|1|||
130721921|NCT01844856|470606354|FG000|Overall Study|Lost to Follow-up|15|||
130721922|NCT01844856|470606355|FG001|Overall Study|Lost to Follow-up|3|||
130721923|NCT01844856|470606354|FG000|Overall Study|Adverse Event|3|||
130721924|NCT01844856|470606355|FG001|Overall Study|Adverse Event|6|||
130721925|NCT01844856|470606354|FG000|Overall Study|Withdrawal by Subject|3|||
130721926|NCT01844856|470606355|FG001|Overall Study|Withdrawal by Subject|2|||
130721927|NCT01844856|470606354|FG000|Overall Study|Noncompliance|2|||
130721928|NCT01844856|470606355|FG001|Overall Study|Noncompliance|3|||
130721929|NCT01844856|470606354|FG000|Overall Study|Enterococcus Resistant|0|||
130721930|NCT01844856|470606355|FG001|Overall Study|Enterococcus Resistant|1|||
130721931|NCT01844856|470606354|FG000|Overall Study|Inadvertently Not Scheduled|1|||
130721932|NCT01844856|470606355|FG001|Overall Study|Inadvertently Not Scheduled|0|||
130721933|NCT01844856|470606354|FG000|Overall Study|Randomized but was a Screen Failure|0|||
130721934|NCT01844856|470606355|FG001|Overall Study|Randomized but was a Screen Failure|1|||
130721935|NCT01001988|470606356|FG000|Overall Study|Protocol Violation|84|||
130721936|NCT01001988|470606356|FG000|Overall Study|Withdrawal by Subject|18|||
130721937|NCT01001988|470606356|FG000|Overall Study|Lost to Follow-up|15|||
130721938|NCT01442688|470606359|FG000|First Intervention|Withdrawal by Subject|1|||
130721939|NCT01442688|470606360|FG001|First Intervention|Withdrawal by Subject|0|||
130721940|NCT01442688|470606359|FG000|First Intervention|subject incarcerated|1|||
130467213|NCT03189524|469678893|FG002|Overall Study|Lost to Follow-up|8|||
130721941|NCT01442688|470606360|FG001|First Intervention|subject incarcerated|0|||
130721942|NCT01442688|470606359|FG000|Second Intervention|Adverse Event|1|||
130721943|NCT01442688|470606360|FG001|Second Intervention|Adverse Event|0|||
130721944|NCT00927394|470606361|FG000|Overall Study|Adverse Event|14|||
130721945|NCT00927394|470606362|FG001|Overall Study|Adverse Event|9|||
130721946|NCT00927394|470606361|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
130721947|NCT00927394|470606362|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
130317956|NCT00525512|469129991|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
130467214|NCT03189524|469678891|FG000|Overall Study|Withdrawal by Subject|1|||
130721948|NCT00927394|470606361|FG000|Overall Study|Withdrawal by Subject|20|||
130721949|NCT00927394|470606362|FG001|Overall Study|Withdrawal by Subject|24|||
130721950|NCT00927394|470606361|FG000|Overall Study|Lost to Follow-up|8|||
130721951|NCT00927394|470606362|FG001|Overall Study|Lost to Follow-up|14|||
130721952|NCT00927394|470606361|FG000|Overall Study|Administrative Problem|1|||
130721953|NCT00927394|470606362|FG001|Overall Study|Administrative Problem|0|||
130721954|NCT00927394|470606361|FG000|Overall Study|Death|1|||
130721955|NCT00927394|470606362|FG001|Overall Study|Death|1|||
130721956|NCT00927394|470606361|FG000|Overall Study|Protocol deviation|16|||
130721957|NCT00927394|470606362|FG001|Overall Study|Protocol deviation|13|||
130721958|NCT00927394|470606361|FG000|Overall Study|Randomized in error|0|||
130721959|NCT00927394|470606362|FG001|Overall Study|Randomized in error|1|||
130721960|NCT01329549|470606369|FG000|Overall Study|Withdrawal by Subject|1|||
130721961|NCT01329549|470606369|FG000|Overall Study|Adverse Event|1|||
130721962|NCT00998309|470606380|FG000|Overall Study|Protocol Violation|4|||
130721963|NCT04480021|470606383|FG000|Overall Study|Lost to Follow-up|3|||
130721964|NCT04480021|470606384|FG001|Overall Study|Lost to Follow-up|4|||
130721965|NCT01844505|470606387|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
130721966|NCT01844505|470606388|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
130317957|NCT00525512|469129992|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
130317958|NCT00525512|469129993|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130317959|NCT00525512|469129994|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130317960|NCT00525512|469129991|FG000|Double-Blind Phase|Lack of Efficacy|13|||
130467215|NCT03189524|469678892|FG001|Overall Study|Withdrawal by Subject|1|||
130467216|NCT03189524|469678893|FG002|Overall Study|Withdrawal by Subject|3|||
130467217|NCT03189524|469678891|FG000|Overall Study|Progressive Disease|0|||
130721967|NCT01844505|470606389|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
130317961|NCT00525512|469129992|FG001|Double-Blind Phase|Lack of Efficacy|5|||
130317962|NCT00525512|469129993|FG002|Double-Blind Phase|Lack of Efficacy|0|||
130317963|NCT00525512|469129994|FG003|Double-Blind Phase|Lack of Efficacy|0|||
130317964|NCT00525512|469129991|FG000|Double-Blind Phase|Other reason (not specified)|12|||
130317965|NCT00525512|469129992|FG001|Double-Blind Phase|Other reason (not specified)|13|||
130317966|NCT00525512|469129993|FG002|Double-Blind Phase|Other reason (not specified)|0|||
130317967|NCT00525512|469129994|FG003|Double-Blind Phase|Other reason (not specified)|0|||
130317968|NCT00525512|469129991|FG000|Open-Label Phase|Adverse Event|0|||
130317969|NCT00525512|469129992|FG001|Open-Label Phase|Adverse Event|0|||
130317970|NCT00525512|469129993|FG002|Open-Label Phase|Adverse Event|1|||
130317971|NCT00525512|469129994|FG003|Open-Label Phase|Adverse Event|0|||
130317972|NCT00525512|469129991|FG000|Open-Label Phase|Lost to Follow-up|0|||
130317973|NCT00525512|469129992|FG001|Open-Label Phase|Lost to Follow-up|0|||
130317974|NCT00525512|469129993|FG002|Open-Label Phase|Lost to Follow-up|1|||
130317975|NCT00525512|469129994|FG003|Open-Label Phase|Lost to Follow-up|0|||
130317976|NCT00525512|469129991|FG000|Open-Label Phase|Other reason (not specified)|0|||
130317977|NCT00525512|469129992|FG001|Open-Label Phase|Other reason (not specified)|0|||
130317978|NCT00525512|469129993|FG002|Open-Label Phase|Other reason (not specified)|4|||
130317979|NCT00525512|469129994|FG003|Open-Label Phase|Other reason (not specified)|5|||
130317980|NCT03289208|469129995|FG000|Overall Study|Adverse Event|1|||
130317981|NCT03289208|469129996|FG001|Overall Study|Adverse Event|0|||
130317982|NCT03289208|469129997|FG002|Overall Study|Adverse Event|0|||
130317983|NCT03353675|469130002|FG000|Overall Study|Adverse Event|4|||
130317984|NCT00395746|469130005|FG000|Overall Study|Adverse Event|5|||
130317985|NCT00395746|469130006|FG001|Overall Study|Adverse Event|2|||
130317986|NCT00395746|469130007|FG002|Overall Study|Adverse Event|2|||
130317987|NCT00395746|469130005|FG000|Overall Study|Protocol Violation|0|||
130317988|NCT00395746|469130006|FG001|Overall Study|Protocol Violation|1|||
130317989|NCT00395746|469130007|FG002|Overall Study|Protocol Violation|0|||
130317990|NCT00395746|469130005|FG000|Overall Study|Lack of Efficacy|2|||
130467218|NCT03189524|469678892|FG001|Overall Study|Progressive Disease|2|||
130467219|NCT03189524|469678893|FG002|Overall Study|Progressive Disease|0|||
130467220|NCT02980276|469678894|FG000|Overall Study|Withdrawal by Subject|4|||
130317991|NCT00395746|469130006|FG001|Overall Study|Lack of Efficacy|0|||
130317992|NCT00395746|469130007|FG002|Overall Study|Lack of Efficacy|17|||
130317993|NCT00395746|469130005|FG000|Overall Study|Hypoglycaemia|2|||
130317994|NCT00395746|469130006|FG001|Overall Study|Hypoglycaemia|1|||
130317995|NCT00395746|469130007|FG002|Overall Study|Hypoglycaemia|0|||
130317996|NCT00395746|469130005|FG000|Overall Study|Subject decision|0|||
130317997|NCT00395746|469130006|FG001|Overall Study|Subject decision|0|||
130317998|NCT00395746|469130007|FG002|Overall Study|Subject decision|1|||
130317999|NCT00395746|469130005|FG000|Overall Study|Withdrawal of consent|0|||
130721968|NCT01844505|470606387|FG000|Treatment Period|Other Reasons|120|||
130721969|NCT01844505|470606388|FG001|Treatment Period|Other Reasons|136|||
130721970|NCT01844505|470606389|FG002|Treatment Period|Other Reasons|58|||
130721971|NCT01844505|470606387|FG000|Treatment Period|Lost to Follow-up|9|||
130721972|NCT01844505|470606388|FG001|Treatment Period|Lost to Follow-up|11|||
130721973|NCT01844505|470606389|FG002|Treatment Period|Lost to Follow-up|6|||
130721974|NCT01844505|470606387|FG000|Treatment Period|Death|175|||
130378192|NCT03303079|469351753|FG002|Overall Study|Protocol Violation|7|||
130378193|NCT03303079|469351751|FG000|Overall Study|Withdrawal by Subject|2|||
130378194|NCT03303079|469351752|FG001|Overall Study|Withdrawal by Subject|4|||
130378195|NCT03303079|469351753|FG002|Overall Study|Withdrawal by Subject|2|||
130378196|NCT03303079|469351751|FG000|Overall Study|Other than specified|0|||
130378197|NCT03303079|469351752|FG001|Overall Study|Other than specified|2|||
130378198|NCT03303079|469351753|FG002|Overall Study|Other than specified|0|||
130378199|NCT02005445|469351754|FG000|Overall Study|Dual study enrollment|0|||
130378200|NCT02005445|469351755|FG001|Overall Study|Dual study enrollment|1|||
130378201|NCT00759954|469351756|FG000|Overall Study|Personal reason|1|||
130378202|NCT00759954|469351757|FG001|Overall Study|Personal reason|0|||
130378203|NCT00759954|469351756|FG000|Overall Study|Adverse Event|1|||
130378204|NCT00759954|469351757|FG001|Overall Study|Adverse Event|2|||
130378205|NCT01359449|469351758|FG000|Overall Study|Lost to Follow-up|1|||
130378206|NCT01359449|469351759|FG001|Overall Study|Lost to Follow-up|0|||
130378207|NCT01359449|469351758|FG000|Overall Study|Protocol Violation|0|||
130378208|NCT01359449|469351759|FG001|Overall Study|Protocol Violation|2|||
130378209|NCT01359449|469351758|FG000|Overall Study|Withdrawal by Subject|3|||
130378210|NCT01359449|469351759|FG001|Overall Study|Withdrawal by Subject|2|||
130378211|NCT00372112|469351760|FG000|Overall Study|Adverse Event|0|||
130378212|NCT00372112|469351761|FG001|Overall Study|Adverse Event|1|||
130378213|NCT00372112|469351762|FG002|Overall Study|Adverse Event|1|||
130378214|NCT00372112|469351763|FG003|Overall Study|Adverse Event|1|||
130378215|NCT00372112|469351760|FG000|Overall Study|Withdrawal by Subject|0|||
130378216|NCT00372112|469351761|FG001|Overall Study|Withdrawal by Subject|0|||
130378217|NCT00372112|469351762|FG002|Overall Study|Withdrawal by Subject|2|||
130378218|NCT00372112|469351763|FG003|Overall Study|Withdrawal by Subject|1|||
130378219|NCT00372112|469351760|FG000|Overall Study|Exacerbation|0|||
130378220|NCT00372112|469351761|FG001|Overall Study|Exacerbation|0|||
130378221|NCT00372112|469351762|FG002|Overall Study|Exacerbation|0|||
130378222|NCT00372112|469351763|FG003|Overall Study|Exacerbation|1|||
130378223|NCT00372112|469351760|FG000|Overall Study|PR >240 at Visit 3|0|||
130378224|NCT00372112|469351761|FG001|Overall Study|PR >240 at Visit 3|0|||
130378225|NCT00372112|469351762|FG002|Overall Study|PR >240 at Visit 3|0|||
130378226|NCT00372112|469351763|FG003|Overall Study|PR >240 at Visit 3|1|||
130378227|NCT00372112|469351760|FG000|Overall Study|Hepatitis B|1|||
130378228|NCT00372112|469351761|FG001|Overall Study|Hepatitis B|0|||
130378229|NCT00372112|469351762|FG002|Overall Study|Hepatitis B|0|||
130378230|NCT00372112|469351763|FG003|Overall Study|Hepatitis B|0|||
130378231|NCT00372112|469351760|FG000|Overall Study|Other-protocol violation|0|||
130378232|NCT00372112|469351761|FG001|Overall Study|Other-protocol violation|0|||
130378233|NCT00372112|469351762|FG002|Overall Study|Other-protocol violation|1|||
130378234|NCT00372112|469351763|FG003|Overall Study|Other-protocol violation|0|||
130378235|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
130378236|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
130378237|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
130378238|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
130378239|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
130378240|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
130378241|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
130378242|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
130378243|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Patient Request|1|||
130378244|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Patient Request|0|||
130378245|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
130378246|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
130378247|NCT04649060|469351778|FG000|Arm A/Arm B Treatment|Other|1|||
130378248|NCT04649060|469351779|FG001|Arm A/Arm B Treatment|Other|0|||
130467221|NCT02980276|469678895|FG001|Overall Study|Withdrawal by Subject|4|||
130467222|NCT02980276|469678894|FG000|Overall Study|Physician Decision|0|||
130467223|NCT02980276|469678895|FG001|Overall Study|Physician Decision|1|||
130467224|NCT02980276|469678894|FG000|Overall Study|Lost to Follow-up|18|||
130467225|NCT02980276|469678895|FG001|Overall Study|Lost to Follow-up|18|||
130467226|NCT02980276|469678894|FG000|Overall Study|Death|1|||
130378249|NCT04649060|469351778|FG000|Crossover (Arm B)|Adverse Event|0|||
130378250|NCT04649060|469351779|FG001|Crossover (Arm B)|Adverse Event|1|||
130378251|NCT04649060|469351778|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
130378252|NCT04649060|469351779|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
130467227|NCT02980276|469678895|FG001|Overall Study|Death|0|||
130467228|NCT02980276|469678894|FG000|Overall Study|Miscellaneous other|10|||
130378253|NCT00160251|469351782|FG000|Prior to Amendment 2|Adverse Event|2|||
130378254|NCT00160251|469351783|FG001|Prior to Amendment 2|Adverse Event|1|||
130378255|NCT00160251|469351784|FG002|Prior to Amendment 2|Adverse Event|3|||
130378256|NCT00160251|469351785|FG003|Prior to Amendment 2|Adverse Event|1|||
130378257|NCT00160251|469351786|FG004|Prior to Amendment 2|Adverse Event|1|||
130378258|NCT00160251|469351787|FG005|Prior to Amendment 2|Adverse Event|1|||
130378259|NCT00160251|469351788|FG006|Prior to Amendment 2|Adverse Event|1|||
130378260|NCT00160251|469351789|FG007|Prior to Amendment 2|Adverse Event|0|||
130467229|NCT02980276|469678895|FG001|Overall Study|Miscellaneous other|4|||
130378261|NCT00160251|469351782|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
130378262|NCT00160251|469351783|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
130378263|NCT00160251|469351784|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
130378264|NCT00160251|469351785|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
130378265|NCT00160251|469351786|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
130378266|NCT00160251|469351787|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
130378267|NCT00160251|469351788|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
130378268|NCT00160251|469351789|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
130378269|NCT00160251|469351782|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
130378270|NCT00160251|469351783|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
130378271|NCT00160251|469351784|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
130378272|NCT00160251|469351785|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
130378273|NCT00160251|469351786|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
130378274|NCT00160251|469351787|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
130378275|NCT00160251|469351788|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
130378276|NCT00160251|469351789|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
130378277|NCT00160251|469351782|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
130378278|NCT00160251|469351783|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
130378279|NCT00160251|469351784|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
130378280|NCT00160251|469351785|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
130378281|NCT00160251|469351786|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
130378282|NCT00160251|469351787|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
130378283|NCT00160251|469351788|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
130378284|NCT00160251|469351789|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
130378285|NCT00160251|469351782|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
130378286|NCT00160251|469351783|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
130378287|NCT00160251|469351784|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
130378288|NCT00160251|469351785|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
130378289|NCT00160251|469351786|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
130378290|NCT00160251|469351787|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
130378291|NCT00160251|469351788|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
130378292|NCT00160251|469351789|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
130378293|NCT00160251|469351782|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
130378294|NCT00160251|469351783|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
130378295|NCT00160251|469351784|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
130378296|NCT00160251|469351785|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
130378297|NCT00160251|469351786|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
130378298|NCT00160251|469351787|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
130378299|NCT00160251|469351788|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
130378300|NCT00160251|469351789|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
130378301|NCT00160251|469351782|FG000|Post-amendment 2|Adverse Event|0|||
130378302|NCT00160251|469351783|FG001|Post-amendment 2|Adverse Event|0|||
130378303|NCT00160251|469351784|FG002|Post-amendment 2|Adverse Event|0|||
130378304|NCT00160251|469351785|FG003|Post-amendment 2|Adverse Event|0|||
130378305|NCT00160251|469351786|FG004|Post-amendment 2|Adverse Event|0|||
130378306|NCT00160251|469351787|FG005|Post-amendment 2|Adverse Event|0|||
130378307|NCT00160251|469351788|FG006|Post-amendment 2|Adverse Event|0|||
130378308|NCT00160251|469351789|FG007|Post-amendment 2|Adverse Event|20|||
130378309|NCT00160251|469351782|FG000|Post-amendment 2|Lack of Efficacy|0|||
130378310|NCT00160251|469351783|FG001|Post-amendment 2|Lack of Efficacy|0|||
130378311|NCT00160251|469351784|FG002|Post-amendment 2|Lack of Efficacy|0|||
130378312|NCT00160251|469351785|FG003|Post-amendment 2|Lack of Efficacy|0|||
130378313|NCT00160251|469351786|FG004|Post-amendment 2|Lack of Efficacy|0|||
130378314|NCT00160251|469351787|FG005|Post-amendment 2|Lack of Efficacy|0|||
130378315|NCT00160251|469351788|FG006|Post-amendment 2|Lack of Efficacy|0|||
130378316|NCT00160251|469351789|FG007|Post-amendment 2|Lack of Efficacy|24|||
130378317|NCT00160251|469351782|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378318|NCT00160251|469351783|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378319|NCT00160251|469351784|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378320|NCT00160251|469351785|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378321|NCT00160251|469351786|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378322|NCT00160251|469351787|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378323|NCT00160251|469351788|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130378324|NCT00160251|469351789|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
130378325|NCT02730455|469351790|FG000|Overall Study|Death|5|||
130378326|NCT02730455|469351791|FG001|Overall Study|Death|6|||
130378327|NCT02730455|469351792|FG002|Overall Study|Death|4|||
130378328|NCT02730455|469351790|FG000|Overall Study|Consent withdrawn|2|||
130378329|NCT02730455|469351791|FG001|Overall Study|Consent withdrawn|4|||
130378330|NCT02730455|469351792|FG002|Overall Study|Consent withdrawn|1|||
130378331|NCT02730455|469351790|FG000|Overall Study|Lost to Follow-up|3|||
130378332|NCT02730455|469351791|FG001|Overall Study|Lost to Follow-up|1|||
130378333|NCT02730455|469351792|FG002|Overall Study|Lost to Follow-up|4|||
130378334|NCT02730455|469351790|FG000|Overall Study|Other|1|||
130378335|NCT02730455|469351791|FG001|Overall Study|Other|1|||
130378336|NCT02730455|469351792|FG002|Overall Study|Other|2|||
130378337|NCT02730455|469351790|FG000|Overall Study|Other|2|||
130378338|NCT02730455|469351791|FG001|Overall Study|Other|2|||
130378339|NCT02730455|469351792|FG002|Overall Study|Other|0|||
130378340|NCT01018186|469351799|FG000|2-week Run-in Period|Protocol Violation|1|||
130378341|NCT01018186|469351800|FG001|2-week Run-in Period|Protocol Violation|0|||
130378342|NCT01018186|469351801|FG002|2-week Run-in Period|Protocol Violation|0|||
130378343|NCT01018186|469351802|FG003|2-week Run-in Period|Protocol Violation|0|||
130378344|NCT01018186|469351799|FG000|2-week Run-in Period|Lost to Follow-up|2|||
130378345|NCT01018186|469351800|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130378346|NCT01018186|469351801|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130378347|NCT01018186|469351802|FG003|2-week Run-in Period|Lost to Follow-up|0|||
130378348|NCT01018186|469351799|FG000|2-week Run-in Period|Physician Decision|3|||
130378349|NCT01018186|469351800|FG001|2-week Run-in Period|Physician Decision|0|||
130378350|NCT01018186|469351801|FG002|2-week Run-in Period|Physician Decision|0|||
130378351|NCT01018186|469351802|FG003|2-week Run-in Period|Physician Decision|0|||
130378352|NCT01018186|469351799|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
130378353|NCT01018186|469351800|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130378354|NCT01018186|469351801|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130378355|NCT01018186|469351802|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
130378356|NCT01018186|469351799|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
130378357|NCT01018186|469351800|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130378358|NCT01018186|469351801|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130378359|NCT01018186|469351802|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130378360|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
130378361|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
130378362|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
130378363|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
130378364|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130378365|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
130378366|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
130378367|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
130378368|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
130378369|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
130378370|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
130378371|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
130378372|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
130378373|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
130378374|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
130378375|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
130378376|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
130378377|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
130378378|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
130378379|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
130378380|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
130378381|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
130378382|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
130378383|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
130378384|NCT01018186|469351799|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130378385|NCT01018186|469351800|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
130378386|NCT01018186|469351801|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
130378387|NCT01018186|469351802|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
130378388|NCT03049280|469351803|FG000|Overall Study|Physician Decision|1|||
130378389|NCT03552198|469351804|FG000|Overall Study|Lost to Follow-up|42|||
130378390|NCT03552198|469351805|FG001|Overall Study|Lost to Follow-up|48|||
130378391|NCT03552198|469351806|FG002|Overall Study|Lost to Follow-up|15|||
130378392|NCT03552198|469351807|FG003|Overall Study|Lost to Follow-up|19|||
130378393|NCT03552198|469351804|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
130378394|NCT03552198|469351805|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
130378395|NCT03552198|469351806|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
130721975|NCT01844505|470606388|FG001|Treatment Period|Death|154|||
130721976|NCT01844505|470606389|FG002|Treatment Period|Death|228|||
130721977|NCT03384654|470606390|FG000|Overall Study|Withdrawal by Subject|0|||
130378396|NCT03552198|469351807|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
130378397|NCT03552198|469351804|FG000|Overall Study|Did not receive air alerts|1|||
130378398|NCT03552198|469351805|FG001|Overall Study|Did not receive air alerts|0|||
130378399|NCT03552198|469351806|FG002|Overall Study|Did not receive air alerts|0|||
130378400|NCT03552198|469351807|FG003|Overall Study|Did not receive air alerts|1|||
130378401|NCT03235154|469351808|FG000|Overall Study|Withdrawal by Subject|1|||
130721978|NCT03384654|470606391|FG001|Overall Study|Withdrawal by Subject|0|||
130318000|NCT00395746|469130006|FG001|Overall Study|Withdrawal of consent|0|||
130318001|NCT00395746|469130007|FG002|Overall Study|Withdrawal of consent|1|||
130318002|NCT00395746|469130005|FG000|Overall Study|Difficultulty in use of device|0|||
130318003|NCT00395746|469130006|FG001|Overall Study|Difficultulty in use of device|0|||
130318004|NCT00395746|469130007|FG002|Overall Study|Difficultulty in use of device|1|||
130318005|NCT00395746|469130005|FG000|Overall Study|Unable to visit site on schedule|1|||
130318006|NCT00395746|469130006|FG001|Overall Study|Unable to visit site on schedule|0|||
130318007|NCT00395746|469130007|FG002|Overall Study|Unable to visit site on schedule|0|||
130318008|NCT03346434|469131891|FG000|Overall Study|Randomized in Error|0|||
130318009|NCT03346434|469131892|FG001|Overall Study|Randomized in Error|0|||
130318010|NCT03346434|469131893|FG002|Overall Study|Randomized in Error|0|||
130318011|NCT03346434|469131894|FG003|Overall Study|Randomized in Error|0|||
130318012|NCT03346434|469131895|FG004|Overall Study|Randomized in Error|1|||
130318013|NCT03346434|469131896|FG005|Overall Study|Randomized in Error|0|||
130318014|NCT03346434|469131891|FG000|Overall Study|Withdrawal by Subject|0|||
130318015|NCT03346434|469131892|FG001|Overall Study|Withdrawal by Subject|0|||
130318016|NCT03346434|469131893|FG002|Overall Study|Withdrawal by Subject|1|||
130318017|NCT03346434|469131894|FG003|Overall Study|Withdrawal by Subject|0|||
130318018|NCT03346434|469131895|FG004|Overall Study|Withdrawal by Subject|1|||
130318019|NCT03346434|469131896|FG005|Overall Study|Withdrawal by Subject|0|||
130318020|NCT03346434|469131891|FG000|Overall Study|Lost to Follow-up|0|||
130318021|NCT03346434|469131892|FG001|Overall Study|Lost to Follow-up|0|||
130318022|NCT03346434|469131893|FG002|Overall Study|Lost to Follow-up|0|||
130318023|NCT03346434|469131894|FG003|Overall Study|Lost to Follow-up|0|||
130318024|NCT03346434|469131895|FG004|Overall Study|Lost to Follow-up|1|||
130318025|NCT03346434|469131896|FG005|Overall Study|Lost to Follow-up|1|||
130318026|NCT03346434|469131891|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318027|NCT03346434|469131892|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318028|NCT03346434|469131893|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318029|NCT03346434|469131894|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318030|NCT03346434|469131895|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
130318031|NCT03346434|469131896|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
130318032|NCT03525444|469131897|FG000|Overall Study|Adverse Event|0|||
130318033|NCT03525444|469131898|FG001|Overall Study|Adverse Event|1|||
130318034|NCT03525444|469131897|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130318035|NCT03525444|469131898|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130318036|NCT03525444|469131897|FG000|Overall Study|Other|0|||
130318037|NCT03525444|469131898|FG001|Overall Study|Other|1|||
130318038|NCT01419236|469131902|FG000|Overall Study|Adverse Event|1|||
130318039|NCT01419236|469131903|FG001|Overall Study|Adverse Event|0|||
130318040|NCT01419236|469131902|FG000|Overall Study|Lack of Efficacy|0|||
130318041|NCT01419236|469131903|FG001|Overall Study|Lack of Efficacy|1|||
130318042|NCT01419236|469131902|FG000|Overall Study|Lost to Follow-up|1|||
130318043|NCT01419236|469131903|FG001|Overall Study|Lost to Follow-up|0|||
130318044|NCT01419236|469131902|FG000|Overall Study|Physician Decision|1|||
130318045|NCT01419236|469131903|FG001|Overall Study|Physician Decision|0|||
130318046|NCT01419236|469131902|FG000|Overall Study|Withdrawal by Subject|1|||
130318047|NCT01419236|469131903|FG001|Overall Study|Withdrawal by Subject|4|||
130318048|NCT01419236|469131902|FG000|Overall Study|Entry Criteria Not Met|1|||
130318049|NCT01419236|469131903|FG001|Overall Study|Entry Criteria Not Met|0|||
130318050|NCT02250326|469131904|FG000|Treatment|Death|1|||
130318051|NCT02250326|469131905|FG001|Treatment|Death|13|||
130318052|NCT02250326|469131906|FG002|Treatment|Death|2|||
130318053|NCT02250326|469131904|FG000|Treatment|Adverse Event|8|||
130318054|NCT02250326|469131905|FG001|Treatment|Adverse Event|8|||
130318055|NCT02250326|469131906|FG002|Treatment|Adverse Event|9|||
130318056|NCT02250326|469131904|FG000|Treatment|Progressive Disease|42|||
130318057|NCT02250326|469131905|FG001|Treatment|Progressive Disease|40|||
130318058|NCT02250326|469131906|FG002|Treatment|Progressive Disease|47|||
130318059|NCT02250326|469131904|FG000|Treatment|Symptomatic Deterioration|9|||
130318060|NCT02250326|469131905|FG001|Treatment|Symptomatic Deterioration|4|||
130318061|NCT02250326|469131906|FG002|Treatment|Symptomatic Deterioration|10|||
130318062|NCT02250326|469131904|FG000|Treatment|Withdrawal by Subject|11|||
130559591|NCT01338415|470017821|FG001|Core + Extension|Other (administrative reason)|0|||
130318063|NCT02250326|469131905|FG001|Treatment|Withdrawal by Subject|6|||
130318064|NCT02250326|469131906|FG002|Treatment|Withdrawal by Subject|4|||
130318065|NCT02250326|469131904|FG000|Treatment|Other reasons|8|||
130318066|NCT02250326|469131905|FG001|Treatment|Other reasons|7|||
130318067|NCT02250326|469131906|FG002|Treatment|Other reasons|7|||
130318068|NCT02250326|469131904|FG000|Extension Period|Progressive Disease|0|||
130318069|NCT02250326|469131905|FG001|Extension Period|Progressive Disease|2|||
130318070|NCT02250326|469131906|FG002|Extension Period|Progressive Disease|0|||
130318071|NCT02250326|469131904|FG000|Extension Period|Withdrawal by Subject|0|||
130318072|NCT02250326|469131905|FG001|Extension Period|Withdrawal by Subject|1|||
130318073|NCT02250326|469131906|FG002|Extension Period|Withdrawal by Subject|0|||
130318074|NCT02250326|469131904|FG000|Extension Period|Withdrawal by investigator|0|||
130318075|NCT02250326|469131905|FG001|Extension Period|Withdrawal by investigator|1|||
130721979|NCT03384654|470606392|FG002|Overall Study|Withdrawal by Subject|1|||
130721980|NCT03384654|470606393|FG003|Overall Study|Withdrawal by Subject|0|||
130721981|NCT00827632|470606394|FG000|Overall Study|Lost to Follow-up|8|||
130721982|NCT00827632|470606395|FG001|Overall Study|Lost to Follow-up|12|||
130318076|NCT02250326|469131906|FG002|Extension Period|Withdrawal by investigator|0|||
130318077|NCT00866177|469131907|FG000|Overall Study|Withdrawal by Subject|1|||
130318078|NCT00866177|469131907|FG000|Overall Study|Not Treated|151|||
130318079|NCT03585660|469131908|FG000|Overall Study|operator error|1|||
130318080|NCT03585660|469131908|FG000|Overall Study|technical error|2|||
130318081|NCT03585660|469131908|FG000|Overall Study|hip prosthesis|2|||
130318082|NCT03585660|469131908|FG000|Overall Study|did not undergo biopsy|8|||
130318083|NCT03585660|469131908|FG000|Overall Study|scanner problem|2|||
130318084|NCT00435409|469131909|FG000|Overall Study|Protocol Violation|1|||
130318085|NCT00435409|469131910|FG001|Overall Study|Protocol Violation|2|||
130318086|NCT00435409|469131911|FG002|Overall Study|Protocol Violation|0|||
130318087|NCT00435409|469131909|FG000|Overall Study|Lost to Follow-up|1|||
130318088|NCT00435409|469131910|FG001|Overall Study|Lost to Follow-up|2|||
130318089|NCT00435409|469131911|FG002|Overall Study|Lost to Follow-up|0|||
130318090|NCT00435409|469131909|FG000|Overall Study|Death|8|||
130318091|NCT00435409|469131910|FG001|Overall Study|Death|6|||
130318092|NCT00435409|469131911|FG002|Overall Study|Death|6|||
130318093|NCT00435409|469131909|FG000|Overall Study|Objective progression or relapse|158|||
130378402|NCT03235154|469351808|FG000|Overall Study|Adverse Event|1|||
130378403|NCT03235154|469351808|FG000|Overall Study|Lost to Follow-up|2|||
130378404|NCT00276744|469351809|FG000|PART A|Reason unknown|98|||
130378405|NCT00640601|469351815|FG000|Overall Study|Adverse Event|43|||
130378406|NCT00640601|469351815|FG000|Overall Study|Withdrawal by Subject|20|||
130378407|NCT00640601|469351815|FG000|Overall Study|Protocol Violation|6|||
130378408|NCT00640601|469351815|FG000|Overall Study|Lack of Efficacy|16|||
130378409|NCT00640601|469351815|FG000|Overall Study|Lost to Follow-up|9|||
130378410|NCT00640601|469351815|FG000|Overall Study|Physician Decision|8|||
130378411|NCT00640601|469351815|FG000|Overall Study|treatment naive, combination therapy|10|||
130378412|NCT03681405|469351816|FG000|Overall Study|Found to be ineligible after randomized|1|||
130378413|NCT03681405|469351817|FG001|Overall Study|Found to be ineligible after randomized|0|||
130378414|NCT03978520|469351818|FG000|Overall Study|Adverse Event|2|||
130378415|NCT03978520|469351819|FG001|Overall Study|Adverse Event|5|||
130378416|NCT03978520|469351820|FG002|Overall Study|Adverse Event|3|||
130378417|NCT03978520|469351821|FG003|Overall Study|Adverse Event|5|||
130378418|NCT03978520|469351822|FG004|Overall Study|Adverse Event|6|||
130378419|NCT03978520|469351818|FG000|Overall Study|Withdrawal by Subject|10|||
130378420|NCT03978520|469351819|FG001|Overall Study|Withdrawal by Subject|4|||
130378421|NCT03978520|469351820|FG002|Overall Study|Withdrawal by Subject|5|||
130378422|NCT03978520|469351821|FG003|Overall Study|Withdrawal by Subject|6|||
130378423|NCT03978520|469351822|FG004|Overall Study|Withdrawal by Subject|5|||
130378424|NCT03978520|469351818|FG000|Overall Study|Lost to Follow-up|2|||
130378425|NCT03978520|469351819|FG001|Overall Study|Lost to Follow-up|2|||
130378426|NCT03978520|469351820|FG002|Overall Study|Lost to Follow-up|2|||
130378427|NCT03978520|469351821|FG003|Overall Study|Lost to Follow-up|0|||
130378428|NCT03978520|469351822|FG004|Overall Study|Lost to Follow-up|1|||
130378429|NCT03978520|469351818|FG000|Overall Study|COVID-19 infection|0|||
130378430|NCT03978520|469351819|FG001|Overall Study|COVID-19 infection|1|||
130378431|NCT03978520|469351820|FG002|Overall Study|COVID-19 infection|0|||
130378432|NCT03978520|469351821|FG003|Overall Study|COVID-19 infection|0|||
130378433|NCT03978520|469351822|FG004|Overall Study|COVID-19 infection|0|||
130378434|NCT03978520|469351818|FG000|Overall Study|Other, not specified|9|||
130467230|NCT03025789|469678896|FG000|Overall Study|Lack of Efficacy|6|||
130467231|NCT03025789|469678897|FG001|Overall Study|Lack of Efficacy|1|||
130467232|NCT03025789|469678896|FG000|Overall Study|Death|1|||
130467233|NCT03025789|469678897|FG001|Overall Study|Death|0|||
130467234|NCT03025789|469678896|FG000|Overall Study|Withdrawal by Subject|0|||
130467235|NCT03025789|469678897|FG001|Overall Study|Withdrawal by Subject|2|||
130467236|NCT02723955|469678899|FG000|Escalation Phase|Death|1|||
130467237|NCT02723955|469678900|FG001|Escalation Phase|Death|1|||
130378435|NCT03978520|469351819|FG001|Overall Study|Other, not specified|4|||
130378436|NCT03978520|469351820|FG002|Overall Study|Other, not specified|1|||
130378437|NCT03978520|469351821|FG003|Overall Study|Other, not specified|1|||
130378438|NCT03978520|469351822|FG004|Overall Study|Other, not specified|2|||
130378439|NCT03978520|469351818|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
130378440|NCT03978520|469351819|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
130378441|NCT03978520|469351820|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
130378442|NCT03978520|469351821|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
130467238|NCT02723955|469678901|FG002|Escalation Phase|Death|2|||
130467239|NCT02723955|469678902|FG003|Escalation Phase|Death|7|||
130318094|NCT00435409|469131910|FG001|Overall Study|Objective progression or relapse|93|||
130318095|NCT00435409|469131911|FG002|Overall Study|Objective progression or relapse|58|||
130318096|NCT00435409|469131909|FG000|Overall Study|Global deterioration of health status|0|||
130467240|NCT02723955|469678903|FG004|Escalation Phase|Death|18|||
130721983|NCT00827632|470606394|FG000|Overall Study|Early withdrawal|14|||
130318097|NCT00435409|469131910|FG001|Overall Study|Global deterioration of health status|0|||
130318098|NCT00435409|469131911|FG002|Overall Study|Global deterioration of health status|4|||
130318099|NCT00435409|469131909|FG000|Overall Study|Withdrawal by Subject|8|||
130318100|NCT00435409|469131910|FG001|Overall Study|Withdrawal by Subject|7|||
130318101|NCT00435409|469131911|FG002|Overall Study|Withdrawal by Subject|1|||
130318102|NCT00435409|469131909|FG000|Overall Study|Other|45|||
130318103|NCT00435409|469131910|FG001|Overall Study|Other|30|||
130318104|NCT00435409|469131911|FG002|Overall Study|Other|1|||
130318105|NCT00435409|469131909|FG000|Overall Study|Adverse Event|0|||
130318106|NCT00435409|469131910|FG001|Overall Study|Adverse Event|0|||
130318107|NCT00435409|469131911|FG002|Overall Study|Adverse Event|8|||
130318108|NCT00435409|469131909|FG000|Overall Study|Sponsor decision|0|||
130318109|NCT00435409|469131910|FG001|Overall Study|Sponsor decision|3|||
130318110|NCT00435409|469131911|FG002|Overall Study|Sponsor decision|0|||
130318111|NCT05635461|469131914|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318112|NCT05635461|469131915|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318113|NCT05635461|469131916|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318114|NCT05635461|469131917|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318115|NCT05635461|469131918|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
130318116|NCT05635461|469131919|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318117|NCT05635461|469131914|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318118|NCT05635461|469131915|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
130318119|NCT05635461|469131916|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318120|NCT05635461|469131917|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318121|NCT05635461|469131918|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318122|NCT05635461|469131919|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318123|NCT05635461|469131914|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318124|NCT05635461|469131915|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318125|NCT05635461|469131916|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318126|NCT05635461|469131917|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
130318127|NCT05635461|469131918|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318128|NCT05635461|469131919|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318129|NCT03760029|469131922|FG000|Overall Study|Death|1|||
130318130|NCT03760029|469131923|FG001|Overall Study|Death|0|||
130318131|NCT03760029|469131924|FG002|Overall Study|Death|0|||
130318132|NCT03760029|469131922|FG000|Overall Study|Lost to Follow-up|0|||
130318133|NCT03760029|469131923|FG001|Overall Study|Lost to Follow-up|2|||
130318134|NCT03760029|469131924|FG002|Overall Study|Lost to Follow-up|1|||
130318135|NCT03760029|469131922|FG000|Overall Study|Withdrawal by Subject|1|||
130318136|NCT03760029|469131923|FG001|Overall Study|Withdrawal by Subject|4|||
130318137|NCT03760029|469131924|FG002|Overall Study|Withdrawal by Subject|1|||
130318138|NCT03760029|469131922|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130318139|NCT03760029|469131923|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130318140|NCT03760029|469131924|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130318141|NCT03760029|469131922|FG000|Overall Study|Other|2|||
130318142|NCT03760029|469131923|FG001|Overall Study|Other|1|||
130318143|NCT03760029|469131924|FG002|Overall Study|Other|0|||
130318144|NCT04890652|469131928|FG000|Overall Study|Withdrawal by Subject|2|||
130318145|NCT02269124|469131935|FG000|Overall Study|Lost to Follow-up|1|||
130318146|NCT02269124|469131936|FG001|Overall Study|Lost to Follow-up|0|||
130318147|NCT02269124|469131935|FG000|Overall Study|Withdrawal by Subject|0|||
130318148|NCT02269124|469131936|FG001|Overall Study|Withdrawal by Subject|2|||
130318149|NCT00614575|469131937|FG000|Overall Study|Adverse Event|106|||
130318150|NCT00614575|469131937|FG000|Overall Study|Lost to Follow-up|55|||
130318151|NCT00614575|469131937|FG000|Overall Study|Lack of Efficacy|14|||
130318152|NCT00614575|469131937|FG000|Overall Study|Withdrawal by Subject|6|||
130318153|NCT00614575|469131937|FG000|Overall Study|Death|3|||
130318154|NCT00614575|469131937|FG000|Overall Study|Physician Decision|2|||
130318155|NCT00614575|469131937|FG000|Overall Study|No data were collected.|18|||
130318156|NCT00614575|469131937|FG000|Overall Study|Irregularly enrolled patients|23|||
130318157|NCT00614575|469131937|FG000|Overall Study|No treatment|1|||
130318158|NCT01600885|469131938|FG000|First Period|Adverse Event|1|||
130318159|NCT01600885|469131939|FG001|First Period|Adverse Event|1|||
130318160|NCT01600885|469131938|FG000|First Period|moved out of area|1|||
130318161|NCT01600885|469131939|FG001|First Period|moved out of area|0|||
130318162|NCT00005906|469131946|FG000|Overall Study|Lack of Efficacy|3|||
130467241|NCT02723955|469678904|FG005|Escalation Phase|Death|17|||
130467242|NCT02723955|469678905|FG006|Escalation Phase|Death|11|||
130318163|NCT00286442|469131947|FG000|Overall Study|Hyperglycemic Rescue|19|||
130318164|NCT00286442|469131948|FG001|Overall Study|Hyperglycemic Rescue|17|||
130318165|NCT00286442|469131949|FG002|Overall Study|Hyperglycemic Rescue|25|||
130318166|NCT00286442|469131947|FG000|Overall Study|Adverse Event|7|||
130318167|NCT00286442|469131948|FG001|Overall Study|Adverse Event|6|||
130318168|NCT00286442|469131949|FG002|Overall Study|Adverse Event|1|||
130318169|NCT00286442|469131947|FG000|Overall Study|Protocol Violation|2|||
130318170|NCT00286442|469131948|FG001|Overall Study|Protocol Violation|4|||
130318171|NCT00286442|469131949|FG002|Overall Study|Protocol Violation|2|||
130318172|NCT00286442|469131947|FG000|Overall Study|Lost to Follow-up|5|||
130318173|NCT00286442|469131948|FG001|Overall Study|Lost to Follow-up|2|||
130318174|NCT00286442|469131949|FG002|Overall Study|Lost to Follow-up|1|||
130318175|NCT00286442|469131947|FG000|Overall Study|Physician Decision|1|||
130318176|NCT00286442|469131948|FG001|Overall Study|Physician Decision|1|||
130318177|NCT00286442|469131949|FG002|Overall Study|Physician Decision|1|||
130318178|NCT00286442|469131947|FG000|Overall Study|Administrative Error|1|||
130318179|NCT00286442|469131948|FG001|Overall Study|Administrative Error|1|||
130318180|NCT00286442|469131949|FG002|Overall Study|Administrative Error|0|||
130318181|NCT00286442|469131947|FG000|Overall Study|Withdrawal by Subject|2|||
130318182|NCT00286442|469131948|FG001|Overall Study|Withdrawal by Subject|14|||
130318183|NCT00286442|469131949|FG002|Overall Study|Withdrawal by Subject|2|||
130318184|NCT04571944|469131952|FG000|Overall Study|Death|1|||
130318185|NCT04571944|469131953|FG001|Overall Study|Death|0|||
130318186|NCT04571944|469131952|FG000|Overall Study|Withdrawal by Subject|3|||
130318187|NCT04571944|469131953|FG001|Overall Study|Withdrawal by Subject|0|||
130318188|NCT04571944|469131952|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
130318189|NCT04571944|469131953|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
130318190|NCT03740048|469131954|FG000|Overall Study|Withdrawal by Subject|1|||
130318191|NCT03740048|469131955|FG001|Overall Study|Withdrawal by Subject|1|||
130318192|NCT03740048|469131954|FG000|Overall Study|Death|1|||
130318193|NCT03740048|469131955|FG001|Overall Study|Death|6|||
130318194|NCT03740048|469131954|FG000|Overall Study|Switched to thrice-weekly HD|2|||
130318195|NCT03740048|469131955|FG001|Overall Study|Switched to thrice-weekly HD|0|||
130318196|NCT03740048|469131954|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
130318197|NCT03740048|469131955|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
130318198|NCT03740048|469131954|FG000|Overall Study|Lost to Follow-up|0|||
130318199|NCT03740048|469131955|FG001|Overall Study|Lost to Follow-up|1|||
130318200|NCT03740048|469131954|FG000|Overall Study|Non-compliance with HD|0|||
130318201|NCT03740048|469131955|FG001|Overall Study|Non-compliance with HD|1|||
130318202|NCT01476722|469131956|FG000|Overall Study|Adverse Event|1|||
130318203|NCT03261336|469131957|FG000|Overall Study|Adverse Event|1|||
130318204|NCT00292942|469131958|FG000|Overall Study|Withdrawal by Subject|0|||
130318205|NCT00292942|469131959|FG001|Overall Study|Withdrawal by Subject|0|||
130318206|NCT00292942|469131960|FG002|Overall Study|Withdrawal by Subject|1|||
130318207|NCT00292942|469131961|FG003|Overall Study|Withdrawal by Subject|0|||
130318208|NCT00292942|469131958|FG000|Overall Study|Adverse Event|0|||
130318209|NCT00292942|469131959|FG001|Overall Study|Adverse Event|0|||
130318210|NCT00292942|469131960|FG002|Overall Study|Adverse Event|0|||
130318211|NCT00292942|469131961|FG003|Overall Study|Adverse Event|1|||
130318212|NCT00651924|469131962|FG000|Overall Study|Withdrawal by PI|0|||
130318213|NCT00651924|469131963|FG001|Overall Study|Withdrawal by PI|2|||
130318214|NCT00651924|469131962|FG000|Overall Study|Withdrawal by Subject|0|||
130378443|NCT03978520|469351822|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
130378444|NCT02860169|469351823|FG000|Part A|Withdrawal by Subject|1|||
130378445|NCT02860169|469351823|FG000|Part A|Other (Screening failure)|6|||
130378446|NCT02860169|469351823|FG000|Part A|Other (Survey not completed)|3|||
130378447|NCT02860169|469351823|FG000|Part A|Other (did not completed consent)|1|||
130378448|NCT02860169|469351823|FG000|Part B|Other (Screening failure)|10|||
130378449|NCT02860169|469351823|FG000|Part B|Withdrawal by Subject|1|||
130378450|NCT02860169|469351823|FG000|Part C|Other (Screening failure)|1|||
130378451|NCT01648205|469351826|FG000|Placebo|Pregnancy|1|||
130378452|NCT01648205|469351826|FG000|Placebo|Withdrawal by Subject|1|||
130378453|NCT01648205|469351826|FG000|Placebo|Protocol Violation|2|||
130378454|NCT01648205|469351826|FG000|Ranolazine|Death|1|||
130378455|NCT01648205|469351826|FG000|Ranolazine|Withdrawal by Subject|1|||
130378456|NCT01648205|469351826|FG000|Ranolazine|Protocol Violation|3|||
130378457|NCT03667924|469351829|FG000|Baseline Completed|Lost to Follow-up|0|||
130378458|NCT03667924|469351830|FG001|Baseline Completed|Lost to Follow-up|2|||
130378459|NCT03667924|469351831|FG002|Baseline Completed|Lost to Follow-up|0|||
130378460|NCT03667924|469351829|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
130378461|NCT03667924|469351830|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
130378462|NCT03667924|469351831|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
130378463|NCT03667924|469351829|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
130378464|NCT03667924|469351830|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
130378465|NCT03667924|469351831|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
130378466|NCT03667924|469351829|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
130378467|NCT03667924|469351830|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
130378468|NCT03667924|469351831|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
130378469|NCT03667924|469351829|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
130378470|NCT03667924|469351830|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
130467243|NCT02723955|469678906|FG007|Escalation Phase|Death|21|||
130378471|NCT03667924|469351831|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
130378472|NCT03667924|469351829|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
130378473|NCT03667924|469351830|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
130378474|NCT03667924|469351831|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
130378475|NCT03667924|469351829|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
130378476|NCT03667924|469351830|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
130378477|NCT03667924|469351831|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
130378478|NCT04557371|469351837|FG000|Overall Study|Covid-19-related|0|||
130378479|NCT04557371|469351838|FG001|Overall Study|Covid-19-related|1|||
130378480|NCT04557371|469351839|FG002|Overall Study|Covid-19-related|0|||
130378481|NCT04557371|469351837|FG000|Overall Study|Withdrawal by Subject|0|||
130378482|NCT04557371|469351838|FG001|Overall Study|Withdrawal by Subject|1|||
130721984|NCT00827632|470606395|FG001|Overall Study|Early withdrawal|11|||
130721985|NCT01910389|470606397|FG000|Overall Study|Withdrawal by Subject|2|||
130721986|NCT01910389|470606398|FG001|Overall Study|Withdrawal by Subject|0|||
130721987|NCT01910389|470606397|FG000|Overall Study|Study Closed|13|||
130378483|NCT04557371|469351839|FG002|Overall Study|Withdrawal by Subject|0|||
130378484|NCT04557371|469351837|FG000|Overall Study|Adverse Event|1|||
130378485|NCT04557371|469351838|FG001|Overall Study|Adverse Event|0|||
130378486|NCT04557371|469351839|FG002|Overall Study|Adverse Event|0|||
130378487|NCT00897104|469351842|FG000|Overall Study|Lost to Follow-up|12|||
130378488|NCT00897104|469351843|FG001|Overall Study|Lost to Follow-up|17|||
130378489|NCT00897104|469351844|FG002|Overall Study|Lost to Follow-up|2|||
130378490|NCT00897104|469351842|FG000|Overall Study|Pregnancy|0|||
130378491|NCT00897104|469351843|FG001|Overall Study|Pregnancy|1|||
130378492|NCT00897104|469351844|FG002|Overall Study|Pregnancy|0|||
130378493|NCT00897104|469351842|FG000|Overall Study|Protocol Violation|0|||
130378494|NCT00897104|469351843|FG001|Overall Study|Protocol Violation|1|||
130378495|NCT00897104|469351844|FG002|Overall Study|Protocol Violation|0|||
130378496|NCT00897104|469351842|FG000|Overall Study|Withdrawal by Subject|23|||
130378497|NCT00897104|469351843|FG001|Overall Study|Withdrawal by Subject|27|||
130378498|NCT00897104|469351844|FG002|Overall Study|Withdrawal by Subject|3|||
130378499|NCT00897104|469351842|FG000|Overall Study|Abnormal Prestudy Labs|2|||
130378500|NCT00897104|469351843|FG001|Overall Study|Abnormal Prestudy Labs|0|||
130378501|NCT00897104|469351844|FG002|Overall Study|Abnormal Prestudy Labs|0|||
130378502|NCT00897104|469351842|FG000|Overall Study|Abnormal Baseline ECG|2|||
130378503|NCT00897104|469351843|FG001|Overall Study|Abnormal Baseline ECG|2|||
130378504|NCT00897104|469351844|FG002|Overall Study|Abnormal Baseline ECG|0|||
130378505|NCT00897104|469351842|FG000|Overall Study|Need for Concom. Med.|0|||
130378506|NCT00897104|469351843|FG001|Overall Study|Need for Concom. Med.|1|||
130378507|NCT00897104|469351844|FG002|Overall Study|Need for Concom. Med.|1|||
130378508|NCT00897104|469351842|FG000|Overall Study|Lack of Migraine Attack|20|||
130378509|NCT00897104|469351843|FG001|Overall Study|Lack of Migraine Attack|22|||
130378510|NCT00897104|469351844|FG002|Overall Study|Lack of Migraine Attack|1|||
130378511|NCT00897104|469351842|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130378512|NCT00897104|469351843|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130378513|NCT00897104|469351844|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130378514|NCT00897104|469351842|FG000|Overall Study|Other|3|||
130378515|NCT00897104|469351843|FG001|Overall Study|Other|0|||
130378516|NCT00897104|469351844|FG002|Overall Study|Other|0|||
130378517|NCT00897104|469351842|FG000|Overall Study|Protocol Violation|1|||
130378518|NCT00897104|469351843|FG001|Overall Study|Protocol Violation|0|||
130378519|NCT00897104|469351844|FG002|Overall Study|Protocol Violation|0|||
130378520|NCT00897104|469351842|FG000|Overall Study|Withdrawal by Subject|0|||
130378521|NCT00897104|469351843|FG001|Overall Study|Withdrawal by Subject|0|||
130378522|NCT00897104|469351844|FG002|Overall Study|Withdrawal by Subject|1|||
130378523|NCT00477971|469351845|FG000|Overall Study|Disease progression|6|||
130378524|NCT00477971|469351846|FG001|Overall Study|Disease progression|0|||
130378525|NCT00477971|469351845|FG000|Overall Study|Withdrawal by Subject|3|||
130378526|NCT00477971|469351846|FG001|Overall Study|Withdrawal by Subject|1|||
130378527|NCT00477971|469351845|FG000|Overall Study|Adverse Event|3|||
130378528|NCT00477971|469351846|FG001|Overall Study|Adverse Event|0|||
130378529|NCT00477971|469351845|FG000|Overall Study|Death|2|||
130378530|NCT00477971|469351846|FG001|Overall Study|Death|4|||
130378531|NCT00477971|469351845|FG000|Overall Study|Alternative treatment|3|||
130378532|NCT00477971|469351846|FG001|Overall Study|Alternative treatment|1|||
130378533|NCT00531232|469354117|FG000|Overall Study|Investigator decision|0|||
130378534|NCT00531232|469354118|FG001|Overall Study|Investigator decision|0|||
130378535|NCT00531232|469354119|FG002|Overall Study|Investigator decision|4|||
130378536|NCT00531232|469354117|FG000|Overall Study|Participants refused further treatment|0|||
130378537|NCT00531232|469354118|FG001|Overall Study|Participants refused further treatment|1|||
130378538|NCT00531232|469354119|FG002|Overall Study|Participants refused further treatment|2|||
130378539|NCT00531232|469354117|FG000|Overall Study|Adverse events (AEs)|1|||
130378540|NCT00531232|469354118|FG001|Overall Study|Adverse events (AEs)|2|||
130378541|NCT00531232|469354119|FG002|Overall Study|Adverse events (AEs)|2|||
130378542|NCT00531232|469354117|FG000|Overall Study|Treatment failure|1|||
130378543|NCT00531232|469354118|FG001|Overall Study|Treatment failure|3|||
130721988|NCT01910389|470606398|FG001|Overall Study|Study Closed|8|||
130378544|NCT00531232|469354119|FG002|Overall Study|Treatment failure|7|||
130378545|NCT00531232|469354117|FG000|Overall Study|Disease recurrence|0|||
130378546|NCT00531232|469354118|FG001|Overall Study|Disease recurrence|0|||
130378547|NCT00531232|469354119|FG002|Overall Study|Disease recurrence|1|||
130378548|NCT00531232|469354117|FG000|Overall Study|Deceased|2|||
130378549|NCT00531232|469354118|FG001|Overall Study|Deceased|2|||
130378550|NCT00531232|469354119|FG002|Overall Study|Deceased|2|||
130378551|NCT00531232|469354117|FG000|Overall Study|Withdrawal by Subject|0|||
130378552|NCT00531232|469354118|FG001|Overall Study|Withdrawal by Subject|1|||
130378553|NCT00531232|469354119|FG002|Overall Study|Withdrawal by Subject|2|||
130378554|NCT00531232|469354117|FG000|Overall Study|Other|0|||
130378555|NCT00531232|469354118|FG001|Overall Study|Other|0|||
130378556|NCT00531232|469354119|FG002|Overall Study|Other|5|||
130378557|NCT02345850|469354125|FG000|Overall Study|Not transplanted|10|||
130378558|NCT02345850|469354126|FG001|Overall Study|Not transplanted|5|||
130378559|NCT02345850|469354127|FG002|Overall Study|Not transplanted|4|||
130378560|NCT02345850|469354125|FG000|Overall Study|Lost to Follow-up|2|||
130378561|NCT02345850|469354126|FG001|Overall Study|Lost to Follow-up|3|||
130378562|NCT02345850|469354127|FG002|Overall Study|Lost to Follow-up|2|||
130378563|NCT02345850|469354125|FG000|Overall Study|Withdrawal by Subject|1|||
130378564|NCT02345850|469354126|FG001|Overall Study|Withdrawal by Subject|0|||
130378565|NCT02345850|469354127|FG002|Overall Study|Withdrawal by Subject|0|||
130378566|NCT01991067|469354134|FG000|Overall Study|Lost to Follow-up|6|||
130378567|NCT01991067|469354135|FG001|Overall Study|Lost to Follow-up|5|||
130378568|NCT00464087|469354139|FG000|Overall Study|No PCI per inclusion criteria|0|||
130378569|NCT00464087|469354140|FG001|Overall Study|No PCI per inclusion criteria|0|||
130378570|NCT00464087|469354141|FG002|Overall Study|No PCI per inclusion criteria|29|||
130378571|NCT00609492|469354142|FG000|Overall Study|Withdrawal by Subject|0|||
130378572|NCT00609492|469354143|FG001|Overall Study|Withdrawal by Subject|2|||
130378573|NCT00609492|469354144|FG002|Overall Study|Withdrawal by Subject|3|||
130378574|NCT00609492|469354142|FG000|Overall Study|Lost to Follow-up|1|||
130378575|NCT00609492|469354143|FG001|Overall Study|Lost to Follow-up|1|||
130378576|NCT00609492|469354144|FG002|Overall Study|Lost to Follow-up|4|||
130378577|NCT00418314|469354145|FG000|Overall Study|Withdrawal by Subject|1|||
130378578|NCT00418314|469354146|FG001|Overall Study|Withdrawal by Subject|2|||
130378579|NCT02692716|469354147|FG000|Overall Study|Lost to Follow-up|2|||
130378580|NCT02692716|469354148|FG001|Overall Study|Lost to Follow-up|5|||
130378581|NCT02692716|469354147|FG000|Overall Study|Withdrawal by Subject|3|||
130378582|NCT02692716|469354148|FG001|Overall Study|Withdrawal by Subject|1|||
130378583|NCT02782780|469354153|FG000|Overall Study|dropped out after randomization.|7|||
130378584|NCT02782780|469354154|FG001|Overall Study|dropped out after randomization.|5|||
130378585|NCT02782780|469354153|FG000|Overall Study|Protocol Violation|0|||
130378586|NCT02782780|469354154|FG001|Overall Study|Protocol Violation|2|||
130378587|NCT03562481|469354155|FG000|First Intervention|Lost to Follow-up|1|||
130378588|NCT03562481|469354156|FG001|First Intervention|Lost to Follow-up|0|||
130378589|NCT03247530|469354162|FG000|Overall Study|Withdrawal by caregiver|19|||
130378590|NCT03247530|469354163|FG001|Overall Study|Withdrawal by caregiver|8|||
130378591|NCT03247530|469354164|FG002|Overall Study|Withdrawal by caregiver|10|||
130721989|NCT04669691|470606403|FG000|Overall Study|Death|0|||
130721990|NCT04669691|470606404|FG001|Overall Study|Death|1|||
130721991|NCT04669691|470606405|FG002|Overall Study|Death|0|||
130721992|NCT04669691|470606406|FG003|Overall Study|Death|0|||
130721993|NCT04669691|470606407|FG004|Overall Study|Death|0|||
130721994|NCT04669691|470606408|FG005|Overall Study|Death|0|||
130378592|NCT03247530|469354162|FG000|Overall Study|Lost to Follow-up|3|||
130378593|NCT03247530|469354163|FG001|Overall Study|Lost to Follow-up|9|||
130378594|NCT03247530|469354164|FG002|Overall Study|Lost to Follow-up|6|||
130378595|NCT03247530|469354162|FG000|Overall Study|Adverse Event|2|||
130721995|NCT02304458|470606409|FG000|Overall Study|Adverse Event|0|||
130721996|NCT02304458|470606410|FG001|Overall Study|Adverse Event|0|||
130721997|NCT02304458|470606411|FG002|Overall Study|Adverse Event|7|||
130378596|NCT03247530|469354163|FG001|Overall Study|Adverse Event|5|||
130721998|NCT02304458|470606412|FG003|Overall Study|Adverse Event|0|||
130721999|NCT02304458|470606413|FG004|Overall Study|Adverse Event|0|||
130722000|NCT02304458|470606414|FG005|Overall Study|Adverse Event|0|||
130378597|NCT03247530|469354164|FG002|Overall Study|Adverse Event|2|||
130378598|NCT03247530|469354162|FG000|Overall Study|Failure to follow procedure|1|||
130378599|NCT03247530|469354163|FG001|Overall Study|Failure to follow procedure|1|||
130378600|NCT03247530|469354164|FG002|Overall Study|Failure to follow procedure|1|||
130378601|NCT03247530|469354162|FG000|Overall Study|Withdrawal by Subject|1|||
130378602|NCT03247530|469354163|FG001|Overall Study|Withdrawal by Subject|1|||
130378603|NCT03247530|469354164|FG002|Overall Study|Withdrawal by Subject|0|||
130378604|NCT03247530|469354162|FG000|Overall Study|Study medication misuse|0|||
130378605|NCT03247530|469354163|FG001|Overall Study|Study medication misuse|1|||
130722001|NCT02304458|470606415|FG006|Overall Study|Adverse Event|3|||
130467244|NCT02723955|469678907|FG008|Escalation Phase|Death|3|||
130722002|NCT02304458|470606416|FG007|Overall Study|Adverse Event|4|||
130318215|NCT00651924|469131963|FG001|Overall Study|Withdrawal by Subject|5|||
130318216|NCT00960063|469131964|FG000|Overall Study|Adverse Event|1|||
130318217|NCT00960063|469131965|FG001|Overall Study|Adverse Event|0|||
130318218|NCT00960063|469131966|FG002|Overall Study|Adverse Event|0|||
130318219|NCT00960063|469131964|FG000|Overall Study|Progression of Disease|0|||
130318220|NCT00960063|469131965|FG001|Overall Study|Progression of Disease|0|||
130318221|NCT00960063|469131966|FG002|Overall Study|Progression of Disease|3|||
130318222|NCT05083351|469131968|FG000|Overall Study|Adverse Event|3|||
130318223|NCT05083351|469131968|FG000|Overall Study|Did not meet data inclusion criteria|8|||
130318224|NCT05083351|469131968|FG000|Overall Study|Did not meet eligibility criteria|19|||
130318225|NCT05083351|469131968|FG000|Overall Study|Study Staff Decision|19|||
130318226|NCT01759420|469131970|FG000|Overall Study|Screen failure|5|||
130318227|NCT01759420|469131970|FG000|Overall Study|Inaccurate EKG machine readings|1|||
130318228|NCT04258423|469131979|FG000|Overall Study|Study Closure|2|||
130318229|NCT04258423|469131980|FG001|Overall Study|Study Closure|2|||
130318230|NCT00321789|469131981|FG000|Overall Study|Lost to Follow-up|4|||
130318231|NCT00321789|469131982|FG001|Overall Study|Lost to Follow-up|7|||
130318232|NCT00321789|469131981|FG000|Overall Study|Withdrawal by Subject|6|||
130318233|NCT00321789|469131982|FG001|Overall Study|Withdrawal by Subject|6|||
130318234|NCT00321789|469131981|FG000|Overall Study|Protocol Violation|5|||
130318235|NCT00321789|469131982|FG001|Overall Study|Protocol Violation|3|||
130318236|NCT03309020|469131985|FG000|Overall Study|Death|1|||
130318237|NCT03309020|469131986|FG001|Overall Study|Death|0|||
130318238|NCT03309020|469131985|FG000|Overall Study|Did not undergo surgery|2|||
130318239|NCT03309020|469131986|FG001|Overall Study|Did not undergo surgery|1|||
130318240|NCT02025179|469131987|FG000|Overall Study|Lost to Follow-up|0|||
130318241|NCT02025179|469131988|FG001|Overall Study|Lost to Follow-up|0|||
130318242|NCT02025179|469131989|FG002|Overall Study|Lost to Follow-up|1|||
130318243|NCT00402168|469131990|FG000|Randomized|Lost to Follow-up|1|||
130318244|NCT00402168|469131991|FG001|Randomized|Lost to Follow-up|0|||
130318245|NCT00402168|469131990|FG000|Randomized|Withdrawal by Subject|0|||
130318246|NCT00402168|469131991|FG001|Randomized|Withdrawal by Subject|1|||
130318247|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|Death|0|||
130318248|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|Death|1|||
130318249|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
130318250|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
130318251|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|non-specified|0|||
130318252|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|non-specified|1|||
130318253|NCT00402168|469131990|FG000|Long Term (LT)|Adverse Event|1|||
130318254|NCT00402168|469131991|FG001|Long Term (LT)|Adverse Event|5|||
130318255|NCT00402168|469131990|FG000|Long Term (LT)|Withdrawal by Subject|4|||
130318256|NCT00402168|469131991|FG001|Long Term (LT)|Withdrawal by Subject|7|||
130318257|NCT00402168|469131990|FG000|Long Term (LT)|Pregnancy|0|||
130318258|NCT00402168|469131991|FG001|Long Term (LT)|Pregnancy|1|||
130318259|NCT00402168|469131990|FG000|Long Term (LT)|Lost to Follow-up|1|||
130318260|NCT00402168|469131991|FG001|Long Term (LT)|Lost to Follow-up|0|||
130318261|NCT00402168|469131990|FG000|Long Term (LT)|Death|4|||
130318262|NCT00402168|469131991|FG001|Long Term (LT)|Death|0|||
130318263|NCT00402168|469131990|FG000|Long Term (LT)|Lack of Efficacy|0|||
130318264|NCT00402168|469131991|FG001|Long Term (LT)|Lack of Efficacy|2|||
130318265|NCT00402168|469131990|FG000|Long Term (LT)|non-specified|1|||
130318266|NCT00402168|469131991|FG001|Long Term (LT)|non-specified|2|||
130318267|NCT00402168|469131990|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
130318268|NCT00402168|469131991|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
130318269|NCT00402168|469131990|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
130318270|NCT00402168|469131991|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
130318271|NCT02362724|469131992|FG000|Overall Study|Withdrawal by Subject|3|||
130318272|NCT02362724|469131993|FG001|Overall Study|Withdrawal by Subject|1|||
130318273|NCT02362724|469131992|FG000|Overall Study|Adverse Event|3|||
130318274|NCT02362724|469131993|FG001|Overall Study|Adverse Event|0|||
130318275|NCT00601835|469131999|FG000|Overall Study|Withdrawal by Subject|9|||
130318276|NCT00601835|469132000|FG001|Overall Study|Withdrawal by Subject|6|||
130318277|NCT00601835|469131999|FG000|Overall Study|Physician Decision|1|||
130318278|NCT00601835|469132000|FG001|Overall Study|Physician Decision|0|||
130318279|NCT00601835|469131999|FG000|Overall Study|Lost to Follow-up|37|||
130318280|NCT00601835|469132000|FG001|Overall Study|Lost to Follow-up|5|||
130318281|NCT00601835|469131999|FG000|Overall Study|Adverse Event|1|||
130722003|NCT02304458|470606409|FG000|Overall Study|Death|0|||
130318282|NCT00601835|469132000|FG001|Overall Study|Adverse Event|1|||
130318283|NCT00601835|469131999|FG000|Overall Study|Relocate|12|||
130722004|NCT02304458|470606410|FG001|Overall Study|Death|0|||
130318284|NCT00601835|469132000|FG001|Overall Study|Relocate|2|||
130318285|NCT03137992|469132005|FG000|Washout Period 1|Adverse Event|1|||
130318286|NCT03137992|469132006|FG001|Washout Period 1|Adverse Event|1|||
130318287|NCT03137992|469132007|FG002|Washout Period 1|Adverse Event|0|||
130318288|NCT03137992|469132008|FG003|Washout Period 1|Adverse Event|0|||
130722005|NCT02304458|470606411|FG002|Overall Study|Death|2|||
130467245|NCT02723955|469678908|FG009|Escalation Phase|Death|0|||
130467246|NCT02723955|469678909|FG010|Escalation Phase|Death|0|||
130467247|NCT02723955|469678910|FG011|Escalation Phase|Death|0|||
130467248|NCT02723955|469678911|FG012|Escalation Phase|Death|2|||
130467249|NCT02723955|469678912|FG013|Escalation Phase|Death|4|||
130467250|NCT02723955|469678913|FG014|Escalation Phase|Death|5|||
130318289|NCT03137992|469132009|FG004|Washout Period 1|Adverse Event|0|||
130318290|NCT03137992|469132010|FG005|Washout Period 1|Adverse Event|1|||
130318291|NCT03137992|469132005|FG000|Washout Period 1|Withdrawal by Subject|0|||
130318292|NCT03137992|469132006|FG001|Washout Period 1|Withdrawal by Subject|1|||
130318293|NCT03137992|469132007|FG002|Washout Period 1|Withdrawal by Subject|1|||
130318294|NCT03137992|469132008|FG003|Washout Period 1|Withdrawal by Subject|0|||
130318295|NCT03137992|469132009|FG004|Washout Period 1|Withdrawal by Subject|0|||
130318296|NCT03137992|469132010|FG005|Washout Period 1|Withdrawal by Subject|0|||
130318297|NCT03137992|469132005|FG000|Washout Period 1|Principal Investigator Discretion|0|||
130318298|NCT03137992|469132006|FG001|Washout Period 1|Principal Investigator Discretion|1|||
130318299|NCT03137992|469132007|FG002|Washout Period 1|Principal Investigator Discretion|0|||
130318300|NCT03137992|469132008|FG003|Washout Period 1|Principal Investigator Discretion|0|||
130318301|NCT03137992|469132009|FG004|Washout Period 1|Principal Investigator Discretion|0|||
130318302|NCT03137992|469132010|FG005|Washout Period 1|Principal Investigator Discretion|0|||
130318303|NCT03137992|469132005|FG000|Washout Period 1|COPD Exacerbation|1|||
130318304|NCT03137992|469132006|FG001|Washout Period 1|COPD Exacerbation|1|||
130318305|NCT03137992|469132007|FG002|Washout Period 1|COPD Exacerbation|1|||
130318306|NCT03137992|469132008|FG003|Washout Period 1|COPD Exacerbation|0|||
130318307|NCT03137992|469132009|FG004|Washout Period 1|COPD Exacerbation|1|||
130318308|NCT03137992|469132010|FG005|Washout Period 1|COPD Exacerbation|1|||
130318309|NCT03137992|469132005|FG000|Washout Period 1|Subject Noncompliance|1|||
130318310|NCT03137992|469132006|FG001|Washout Period 1|Subject Noncompliance|0|||
130318311|NCT03137992|469132007|FG002|Washout Period 1|Subject Noncompliance|0|||
130318312|NCT03137992|469132008|FG003|Washout Period 1|Subject Noncompliance|0|||
130318313|NCT03137992|469132009|FG004|Washout Period 1|Subject Noncompliance|1|||
130318314|NCT03137992|469132010|FG005|Washout Period 1|Subject Noncompliance|0|||
130318315|NCT03137992|469132005|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318316|NCT03137992|469132006|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318317|NCT03137992|469132007|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318318|NCT03137992|469132008|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318319|NCT03137992|469132009|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318320|NCT03137992|469132010|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318321|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
130318322|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318323|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318324|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
130318325|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318326|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
130318327|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Adverse Event|0|||
130318328|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Adverse Event|1|||
130318329|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Adverse Event|0|||
130318330|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Adverse Event|0|||
130318331|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Adverse Event|0|||
130318332|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Adverse Event|0|||
130318333|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318334|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318335|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318336|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
130318337|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318338|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318339|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318340|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
130318341|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318342|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318343|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
130318344|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318345|NCT03137992|469132005|FG000|Washout Period 2|COPD Exacerbation|1|||
130318346|NCT03137992|469132006|FG001|Washout Period 2|COPD Exacerbation|1|||
130318347|NCT03137992|469132007|FG002|Washout Period 2|COPD Exacerbation|0|||
130318348|NCT03137992|469132008|FG003|Washout Period 2|COPD Exacerbation|0|||
130318349|NCT03137992|469132009|FG004|Washout Period 2|COPD Exacerbation|1|||
130318350|NCT03137992|469132010|FG005|Washout Period 2|COPD Exacerbation|0|||
130318351|NCT03137992|469132005|FG000|Washout Period 2|Subject Non-compliance|0|||
130318352|NCT03137992|469132006|FG001|Washout Period 2|Subject Non-compliance|1|||
130318353|NCT03137992|469132007|FG002|Washout Period 2|Subject Non-compliance|0|||
130318354|NCT03137992|469132008|FG003|Washout Period 2|Subject Non-compliance|0|||
130318355|NCT03137992|469132009|FG004|Washout Period 2|Subject Non-compliance|0|||
130467251|NCT02723955|469678914|FG015|Escalation Phase|Death|6|||
130378606|NCT03247530|469354164|FG002|Overall Study|Study medication misuse|0|||
130378607|NCT03247530|469354162|FG000|Overall Study|Other, multiple categories|1|||
130378608|NCT03247530|469354163|FG001|Overall Study|Other, multiple categories|3|||
130378609|NCT03247530|469354164|FG002|Overall Study|Other, multiple categories|1|||
130378610|NCT01442493|469354166|FG000|Overall Study|withdrawn from study|3|||
130378611|NCT01442493|469354167|FG001|Overall Study|withdrawn from study|2|||
130378612|NCT03315208|469354169|FG000|Overall Study|Lost to Follow-up|11|||
130378613|NCT03315208|469354170|FG001|Overall Study|Lost to Follow-up|6|||
130378614|NCT03315208|469354169|FG000|Overall Study|Withdrawal by Subject|2|||
130378615|NCT03315208|469354170|FG001|Overall Study|Withdrawal by Subject|0|||
130378616|NCT02875860|469354171|FG000|Overall Study|Withdrawal by Subject|0|||
130378617|NCT02875860|469354172|FG001|Overall Study|Withdrawal by Subject|1|||
130378618|NCT02320149|469354173|FG000|Overall Study|Adverse Event|3|||
130378619|NCT02320149|469354174|FG001|Overall Study|Adverse Event|7|||
130378620|NCT02320149|469354173|FG000|Overall Study|Withdrawal of Consent|28|||
130378621|NCT02320149|469354174|FG001|Overall Study|Withdrawal of Consent|32|||
130378622|NCT02320149|469354173|FG000|Overall Study|Lost to Follow-up|21|||
130378623|NCT02320149|469354174|FG001|Overall Study|Lost to Follow-up|34|||
130378624|NCT02320149|469354173|FG000|Overall Study|Protocol Violation|2|||
130378625|NCT02320149|469354174|FG001|Overall Study|Protocol Violation|1|||
130378626|NCT02320149|469354173|FG000|Overall Study|Noncompliance with Study Treatment|7|||
130378627|NCT02320149|469354174|FG001|Overall Study|Noncompliance with Study Treatment|2|||
130378628|NCT02320149|469354173|FG000|Overall Study|Lack of Efficacy|0|||
130378629|NCT02320149|469354174|FG001|Overall Study|Lack of Efficacy|1|||
130378630|NCT02320149|469354173|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130378631|NCT02320149|469354174|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130378632|NCT01156311|469354178|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
130378633|NCT01156311|469354179|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
130378634|NCT01156311|469354180|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
130378635|NCT01156311|469354181|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
130378636|NCT01156311|469354178|FG000|2-Month Monotherapy Period|Physician Decision|0|||
130378637|NCT01156311|469354179|FG001|2-Month Monotherapy Period|Physician Decision|1|||
130378638|NCT01156311|469354180|FG002|2-Month Monotherapy Period|Physician Decision|0|||
130378639|NCT01156311|469354181|FG003|2-Month Monotherapy Period|Physician Decision|0|||
130378640|NCT01156311|469354178|FG000|2-Month Monotherapy Period|Other|1|||
130378641|NCT01156311|469354179|FG001|2-Month Monotherapy Period|Other|0|||
130378642|NCT01156311|469354180|FG002|2-Month Monotherapy Period|Other|0|||
130378643|NCT01156311|469354181|FG003|2-Month Monotherapy Period|Other|0|||
130378644|NCT01156311|469354178|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
130378645|NCT01156311|469354179|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
130378646|NCT01156311|469354180|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
130378647|NCT01156311|469354181|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
130559592|NCT01338415|470017822|FG002|Core + Extension|Other (administrative reason)|0|||
130559593|NCT01338415|470017820|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
130559594|NCT01338415|470017821|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
130722006|NCT02304458|470606412|FG003|Overall Study|Death|0|||
130378648|NCT01156311|469354178|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130378649|NCT01156311|469354179|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130378650|NCT01156311|469354180|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
130378651|NCT01156311|469354181|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130318356|NCT03137992|469132010|FG005|Washout Period 2|Subject Non-compliance|0|||
130318357|NCT03137992|469132005|FG000|Washout Period 2|Adverse Event|0|||
130318358|NCT03137992|469132006|FG001|Washout Period 2|Adverse Event|0|||
130318359|NCT03137992|469132007|FG002|Washout Period 2|Adverse Event|0|||
130318360|NCT03137992|469132008|FG003|Washout Period 2|Adverse Event|1|||
130318361|NCT03137992|469132009|FG004|Washout Period 2|Adverse Event|1|||
130318362|NCT03137992|469132010|FG005|Washout Period 2|Adverse Event|0|||
130318363|NCT03137992|469132005|FG000|Washout Period 2|Withdrawal by Subject|1|||
130318364|NCT03137992|469132006|FG001|Washout Period 2|Withdrawal by Subject|0|||
130318365|NCT03137992|469132007|FG002|Washout Period 2|Withdrawal by Subject|0|||
130318366|NCT03137992|469132008|FG003|Washout Period 2|Withdrawal by Subject|0|||
130318367|NCT03137992|469132009|FG004|Washout Period 2|Withdrawal by Subject|1|||
130318368|NCT03137992|469132010|FG005|Washout Period 2|Withdrawal by Subject|0|||
130318369|NCT03137992|469132005|FG000|Washout Period 2|Sponsor Decision|0|||
130318370|NCT03137992|469132006|FG001|Washout Period 2|Sponsor Decision|0|||
130318371|NCT03137992|469132007|FG002|Washout Period 2|Sponsor Decision|0|||
130318372|NCT03137992|469132008|FG003|Washout Period 2|Sponsor Decision|0|||
130318373|NCT03137992|469132009|FG004|Washout Period 2|Sponsor Decision|0|||
130318374|NCT03137992|469132010|FG005|Washout Period 2|Sponsor Decision|1|||
130318375|NCT03137992|469132005|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
130318376|NCT03137992|469132006|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130318377|NCT03137992|469132007|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130318378|NCT03137992|469132008|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130378652|NCT01156311|469354178|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
130378653|NCT01156311|469354179|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
130722007|NCT02304458|470606413|FG004|Overall Study|Death|0|||
130722008|NCT02304458|470606414|FG005|Overall Study|Death|0|||
130722009|NCT02304458|470606415|FG006|Overall Study|Death|1|||
130722010|NCT02304458|470606416|FG007|Overall Study|Death|0|||
130722011|NCT02304458|470606409|FG000|Overall Study|Lack of Efficacy|4|||
130722012|NCT02304458|470606410|FG001|Overall Study|Lack of Efficacy|6|||
130722013|NCT02304458|470606411|FG002|Overall Study|Lack of Efficacy|38|||
130722014|NCT02304458|470606412|FG003|Overall Study|Lack of Efficacy|5|||
130722015|NCT02304458|470606413|FG004|Overall Study|Lack of Efficacy|6|||
130722016|NCT02304458|470606414|FG005|Overall Study|Lack of Efficacy|6|||
130722017|NCT02304458|470606415|FG006|Overall Study|Lack of Efficacy|21|||
130722018|NCT02304458|470606416|FG007|Overall Study|Lack of Efficacy|4|||
130722019|NCT02304458|470606409|FG000|Overall Study|Physician Decision|2|||
130722020|NCT02304458|470606410|FG001|Overall Study|Physician Decision|0|||
130722021|NCT02304458|470606411|FG002|Overall Study|Physician Decision|16|||
130378654|NCT01156311|469354180|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
130378655|NCT01156311|469354181|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
130378656|NCT01156311|469354178|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
130378657|NCT01156311|469354179|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
130378658|NCT01156311|469354180|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
130378659|NCT01156311|469354181|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
130378660|NCT01156311|469354178|FG000|6-month Add-on Therapy Period|Other|0|||
130378661|NCT01156311|469354179|FG001|6-month Add-on Therapy Period|Other|0|||
130378662|NCT01156311|469354180|FG002|6-month Add-on Therapy Period|Other|1|||
130378663|NCT01156311|469354181|FG003|6-month Add-on Therapy Period|Other|2|||
130378664|NCT01741701|469354182|FG000|Overall Study|Adverse Event|5|||
130378665|NCT01741701|469354183|FG001|Overall Study|Adverse Event|1|||
130378666|NCT01741701|469354182|FG000|Overall Study|Withdrawal by Subject|0|||
130378667|NCT01741701|469354183|FG001|Overall Study|Withdrawal by Subject|1|||
130378668|NCT03033394|469354188|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
130378669|NCT03033394|469354188|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
130378670|NCT03033394|469354188|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
130378671|NCT03033394|469354188|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
130378672|NCT03033394|469354188|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
130467252|NCT02723955|469678915|FG016|Escalation Phase|Death|6|||
130722022|NCT02304458|470606412|FG003|Overall Study|Physician Decision|1|||
130722023|NCT02304458|470606413|FG004|Overall Study|Physician Decision|0|||
130722024|NCT02304458|470606414|FG005|Overall Study|Physician Decision|0|||
130722025|NCT02304458|470606415|FG006|Overall Study|Physician Decision|3|||
130722026|NCT02304458|470606416|FG007|Overall Study|Physician Decision|0|||
130722027|NCT02304458|470606409|FG000|Overall Study|Protocol Violation|0|||
130722028|NCT02304458|470606410|FG001|Overall Study|Protocol Violation|0|||
130722029|NCT02304458|470606411|FG002|Overall Study|Protocol Violation|1|||
130378673|NCT02036294|469354189|FG000|Overall Study|Death|7|||
130378674|NCT02036294|469354190|FG001|Overall Study|Death|8|||
130467253|NCT02723955|469678916|FG017|Escalation Phase|Death|7|||
130467254|NCT02723955|469678917|FG018|Escalation Phase|Death|1|||
130467255|NCT02723955|469678918|FG019|Escalation Phase|Death|3|||
130467256|NCT02723955|469678919|FG020|Escalation Phase|Death|13|||
130467257|NCT02723955|469678920|FG021|Escalation Phase|Death|3|||
130467258|NCT02723955|469678921|FG022|Escalation Phase|Death|2|||
130467259|NCT02723955|469678922|FG023|Escalation Phase|Death|4|||
130467260|NCT02723955|469678923|FG024|Escalation Phase|Death|31|||
130467261|NCT02723955|469678924|FG025|Escalation Phase|Death|7|||
130467262|NCT02723955|469678925|FG026|Escalation Phase|Death|13|||
130467263|NCT02723955|469678926|FG027|Escalation Phase|Death|0|||
130467264|NCT02723955|469678927|FG028|Escalation Phase|Death|1|||
130467265|NCT02723955|469678928|FG029|Escalation Phase|Death|0|||
130467266|NCT02723955|469678929|FG030|Escalation Phase|Death|0|||
130467267|NCT02723955|469678930|FG031|Escalation Phase|Death|0|||
130467268|NCT02723955|469678931|FG032|Escalation Phase|Death|0|||
130467269|NCT02723955|469678932|FG033|Escalation Phase|Death|0|||
130467270|NCT02723955|469678933|FG034|Escalation Phase|Death|0|||
130467271|NCT02723955|469678934|FG035|Escalation Phase|Death|0|||
130467272|NCT02723955|469678935|FG036|Escalation Phase|Death|0|||
130467273|NCT02723955|469678936|FG037|Escalation Phase|Death|0|||
130467274|NCT02723955|469678937|FG038|Escalation Phase|Death|0|||
130467275|NCT02723955|469678938|FG039|Escalation Phase|Death|0|||
130722030|NCT02304458|470606412|FG003|Overall Study|Protocol Violation|0|||
130722031|NCT02304458|470606413|FG004|Overall Study|Protocol Violation|0|||
130722032|NCT02304458|470606414|FG005|Overall Study|Protocol Violation|0|||
130378675|NCT02036294|469354189|FG000|Overall Study|Withdrawal by Subject|2|||
130378676|NCT02036294|469354190|FG001|Overall Study|Withdrawal by Subject|3|||
130467276|NCT02723955|469678939|FG040|Escalation Phase|Death|0|||
130467277|NCT02723955|469678940|FG041|Escalation Phase|Death|0|||
130467278|NCT02723955|469678941|FG042|Escalation Phase|Death|0|||
130722033|NCT02304458|470606415|FG006|Overall Study|Protocol Violation|0|||
130722034|NCT02304458|470606416|FG007|Overall Study|Protocol Violation|0|||
130722035|NCT02304458|470606409|FG000|Overall Study|Withdrawal by Subject|1|||
130722036|NCT02304458|470606410|FG001|Overall Study|Withdrawal by Subject|0|||
130722037|NCT02304458|470606411|FG002|Overall Study|Withdrawal by Subject|7|||
130318379|NCT03137992|469132009|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130318380|NCT03137992|469132010|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
130318381|NCT03137992|469132005|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318382|NCT03137992|469132006|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
130318383|NCT03137992|469132007|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130318384|NCT03137992|469132008|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318385|NCT03137992|469132009|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130318386|NCT03137992|469132010|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318387|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130318388|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318389|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130318390|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318391|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318392|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318393|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318394|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318395|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318396|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
130318397|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318398|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318399|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Per study team|1|||
130318400|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Per study team|0|||
130318401|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Per study team|0|||
130318402|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Per study team|0|||
130318403|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Per study team|0|||
130318404|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Per study team|0|||
130318405|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318406|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318407|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318408|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318409|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318410|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
130318411|NCT02370420|469132011|FG000|Overall Study|Physician Decision|3|||
130318412|NCT02370420|469132012|FG001|Overall Study|Physician Decision|3|||
130318413|NCT02370420|469132011|FG000|Overall Study|Lost to Follow-up|11|||
130318414|NCT02370420|469132012|FG001|Overall Study|Lost to Follow-up|9|||
130318415|NCT03077542|469132013|FG000|Overall Study|Death|4|||
130318416|NCT03077542|469132014|FG001|Overall Study|Death|0|||
130318417|NCT03077542|469132013|FG000|Overall Study|Physician Decision|6|||
130318418|NCT03077542|469132014|FG001|Overall Study|Physician Decision|1|||
130318419|NCT03077542|469132013|FG000|Overall Study|Withdrawal by Subject|0|||
130318420|NCT03077542|469132014|FG001|Overall Study|Withdrawal by Subject|1|||
130318421|NCT00795704|469132015|FG000|Overall Study|Withdrawal by Subject|3|||
130318422|NCT00795704|469132016|FG001|Overall Study|Withdrawal by Subject|2|||
130318423|NCT00795704|469132015|FG000|Overall Study|Adverse Event|1|||
130318424|NCT00795704|469132016|FG001|Overall Study|Adverse Event|1|||
130318425|NCT03980730|469132017|FG000|Overall Study|Study Terminated by Sponsor|0|||
130318426|NCT03980730|469132018|FG001|Overall Study|Study Terminated by Sponsor|3|||
130318427|NCT03980730|469132017|FG000|Overall Study|Adverse Event|2|||
130318428|NCT03980730|469132018|FG001|Overall Study|Adverse Event|0|||
130318429|NCT03980730|469132017|FG000|Overall Study|Sponsor Request|0|||
130318430|NCT03980730|469132018|FG001|Overall Study|Sponsor Request|1|||
130318431|NCT01300728|469132019|FG000|Overall Study|Withdrawal by Subject|1|||
130318432|NCT01300728|469132020|FG001|Overall Study|Withdrawal by Subject|1|||
130318433|NCT01300728|469132019|FG000|Overall Study|Physician Decision|1|||
130318434|NCT01300728|469132020|FG001|Overall Study|Physician Decision|0|||
130378677|NCT01830972|469354191|FG000|Part II|Withdrawal by Subject|2|||
130378678|NCT01830972|469354192|FG001|Part II|Withdrawal by Subject|2|||
130378679|NCT01830972|469354191|FG000|Part III|Withdrawal by Subject|1|||
130378680|NCT01830972|469354192|FG001|Part III|Withdrawal by Subject|0|||
130378681|NCT01830972|469354191|FG000|Part III|Noncompliance|1|||
130378682|NCT01830972|469354192|FG001|Part III|Noncompliance|0|||
130378683|NCT01830972|469354191|FG000|Part IV|Withdrawal by Subject|2|||
130378684|NCT01830972|469354192|FG001|Part IV|Withdrawal by Subject|1|||
130722038|NCT02304458|470606412|FG003|Overall Study|Withdrawal by Subject|0|||
130378685|NCT01830972|469354191|FG000|Part IV|Non-Compliance|1|||
130467279|NCT02723955|469678899|FG000|Escalation Phase|Lost to Follow-up|0|||
130722039|NCT02304458|470606413|FG004|Overall Study|Withdrawal by Subject|0|||
130318435|NCT00880620|469132023|FG000|Overall Study|Adverse Event|4|||
130318436|NCT00880620|469132024|FG001|Overall Study|Adverse Event|5|||
130318437|NCT00880620|469132025|FG002|Overall Study|Adverse Event|15|||
130318438|NCT00880620|469132026|FG003|Overall Study|Adverse Event|15|||
130318439|NCT00880620|469132023|FG000|Overall Study|Death|0|||
130378686|NCT01830972|469354192|FG001|Part IV|Non-Compliance|0|||
130318440|NCT00880620|469132024|FG001|Overall Study|Death|0|||
130318441|NCT00880620|469132025|FG002|Overall Study|Death|1|||
130318442|NCT00880620|469132026|FG003|Overall Study|Death|0|||
130318443|NCT00880620|469132023|FG000|Overall Study|Lack of Efficacy|12|||
130318444|NCT00880620|469132024|FG001|Overall Study|Lack of Efficacy|4|||
130318445|NCT00880620|469132025|FG002|Overall Study|Lack of Efficacy|0|||
130318446|NCT00880620|469132026|FG003|Overall Study|Lack of Efficacy|1|||
130318447|NCT00880620|469132023|FG000|Overall Study|Lost to Follow-up|0|||
130318448|NCT00880620|469132024|FG001|Overall Study|Lost to Follow-up|1|||
130318449|NCT00880620|469132025|FG002|Overall Study|Lost to Follow-up|1|||
130318450|NCT00880620|469132026|FG003|Overall Study|Lost to Follow-up|0|||
130318451|NCT00880620|469132023|FG000|Overall Study|Protocol Violation|0|||
130318452|NCT00880620|469132024|FG001|Overall Study|Protocol Violation|1|||
130318453|NCT00880620|469132025|FG002|Overall Study|Protocol Violation|0|||
130318454|NCT00880620|469132026|FG003|Overall Study|Protocol Violation|2|||
130318455|NCT00880620|469132023|FG000|Overall Study|Withdrawal by Subject|4|||
130318456|NCT00880620|469132024|FG001|Overall Study|Withdrawal by Subject|3|||
130318457|NCT00880620|469132025|FG002|Overall Study|Withdrawal by Subject|1|||
130318458|NCT00880620|469132026|FG003|Overall Study|Withdrawal by Subject|3|||
130318459|NCT00880620|469132023|FG000|Overall Study|Noncompliance|0|||
130318460|NCT00880620|469132024|FG001|Overall Study|Noncompliance|0|||
130318461|NCT00880620|469132025|FG002|Overall Study|Noncompliance|1|||
130318462|NCT00880620|469132026|FG003|Overall Study|Noncompliance|1|||
130318463|NCT00880620|469132023|FG000|Overall Study|Other|1|||
130318464|NCT00880620|469132024|FG001|Overall Study|Other|1|||
130318465|NCT00880620|469132025|FG002|Overall Study|Other|2|||
130318466|NCT00880620|469132026|FG003|Overall Study|Other|2|||
130318467|NCT00301808|469132028|FG000|Overall Study|Adverse Event|5|||
130318468|NCT00301808|469132028|FG000|Overall Study|Death|3|||
130318469|NCT00301808|469132028|FG000|Overall Study|Lack of Efficacy|4|||
130318470|NCT05893862|469132035|FG000|Overall Study|Physician Decision|0|||
130318471|NCT05893862|469132036|FG001|Overall Study|Physician Decision|1|||
130318472|NCT05893862|469132037|FG002|Overall Study|Physician Decision|0|||
130318473|NCT05893862|469132038|FG003|Overall Study|Physician Decision|0|||
130318474|NCT05893862|469132039|FG004|Overall Study|Physician Decision|1|||
130318475|NCT05893862|469132040|FG005|Overall Study|Physician Decision|0|||
130318476|NCT05893862|469132035|FG000|Overall Study|Withdrawal by Subject|1|||
130318477|NCT05893862|469132036|FG001|Overall Study|Withdrawal by Subject|7|||
130318478|NCT05893862|469132037|FG002|Overall Study|Withdrawal by Subject|1|||
130318479|NCT05893862|469132038|FG003|Overall Study|Withdrawal by Subject|3|||
130318480|NCT05893862|469132039|FG004|Overall Study|Withdrawal by Subject|3|||
130318481|NCT05893862|469132040|FG005|Overall Study|Withdrawal by Subject|2|||
130318482|NCT05893862|469132035|FG000|Overall Study|Adverse Event|1|||
130318483|NCT05893862|469132036|FG001|Overall Study|Adverse Event|4|||
130318484|NCT05893862|469132037|FG002|Overall Study|Adverse Event|2|||
130318485|NCT05893862|469132038|FG003|Overall Study|Adverse Event|2|||
130318486|NCT05893862|469132039|FG004|Overall Study|Adverse Event|1|||
130318487|NCT05893862|469132040|FG005|Overall Study|Adverse Event|0|||
130318488|NCT02919761|469132041|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
130318489|NCT02919761|469132042|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
130318490|NCT02919761|469132043|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
130318491|NCT02919761|469132041|FG000|Part 1: Open Label|Adverse Event|1|||
130318492|NCT02919761|469132042|FG001|Part 1: Open Label|Adverse Event|0|||
130318493|NCT02919761|469132043|FG002|Part 1: Open Label|Adverse Event|0|||
130318494|NCT02919761|469132041|FG000|Part 1: Open Label|Lost to Follow-up|1|||
130318495|NCT02919761|469132042|FG001|Part 1: Open Label|Lost to Follow-up|0|||
130318496|NCT02919761|469132043|FG002|Part 1: Open Label|Lost to Follow-up|0|||
130318497|NCT02919761|469132041|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
130318498|NCT02919761|469132042|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
130318499|NCT02919761|469132043|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
130318500|NCT02919761|469132041|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
130318501|NCT02919761|469132042|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130318502|NCT02919761|469132043|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130318503|NCT02919761|469132041|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
130378687|NCT01426373|469354196|FG000|Overall Study|Adverse Event|6|||
130378688|NCT01426373|469354196|FG000|Overall Study|Lost to Follow-up|14|||
130378689|NCT01426373|469354196|FG000|Overall Study|Participant Convenience|10|||
130378690|NCT01426373|469354196|FG000|Overall Study|Miscellaneous Reasons|4|||
130378691|NCT04952402|469354197|FG000|Overall Study|Lost to Follow-up|1|||
130378692|NCT04952402|469354198|FG001|Overall Study|Lost to Follow-up|3|||
130378693|NCT04952402|469354197|FG000|Overall Study|Lack Of Venous Access|0|||
130378694|NCT04952402|469354198|FG001|Overall Study|Lack Of Venous Access|1|||
130378695|NCT00726661|469354199|FG000|Overall Study|Lost to Follow-up|36|||
130378696|NCT00726661|469354200|FG001|Overall Study|Lost to Follow-up|11|||
130378697|NCT00726661|469354199|FG000|Overall Study|Withdrawal by Subject|17|||
130318504|NCT02919761|469132042|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130318505|NCT02919761|469132043|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130318506|NCT02919761|469132041|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
130318507|NCT02919761|469132042|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130318508|NCT02919761|469132043|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130318509|NCT02919761|469132041|FG000|Part 1: Open Label|Termination by Sponsor|1|||
130318510|NCT02919761|469132042|FG001|Part 1: Open Label|Termination by Sponsor|0|||
130318511|NCT02919761|469132043|FG002|Part 1: Open Label|Termination by Sponsor|0|||
130318512|NCT02919761|469132041|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
130318513|NCT02919761|469132042|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
130318514|NCT02919761|469132043|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
130318515|NCT02919761|469132041|FG000|Part 2: Double-blind|Adverse Event|0|||
130318516|NCT02919761|469132042|FG001|Part 2: Double-blind|Adverse Event|1|||
130318517|NCT02919761|469132043|FG002|Part 2: Double-blind|Adverse Event|0|||
130318518|NCT02919761|469132041|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
130318519|NCT02919761|469132042|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
130318520|NCT02919761|469132043|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
130318521|NCT02919761|469132041|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
130318522|NCT02919761|469132042|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
130318523|NCT02919761|469132043|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
130318524|NCT02919761|469132041|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
130318525|NCT02919761|469132042|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
130318526|NCT02919761|469132043|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
130318527|NCT02919761|469132041|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130318528|NCT02919761|469132042|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130318529|NCT02919761|469132043|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
130318530|NCT02919761|469132041|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130318531|NCT02919761|469132042|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130318532|NCT02919761|469132043|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
130318533|NCT02919761|469132041|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
130318534|NCT02919761|469132042|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
130318535|NCT02919761|469132043|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
130318536|NCT02429830|469132046|FG000|Overall Study|Lost to Follow-up|1|||
130318537|NCT02429830|469132046|FG000|Overall Study|Device Explant|2|||
130378698|NCT00726661|469354200|FG001|Overall Study|Withdrawal by Subject|13|||
130378699|NCT00726661|469354199|FG000|Overall Study|Trial terminated by sponsor|214|||
130378700|NCT00726661|469354200|FG001|Overall Study|Trial terminated by sponsor|187|||
130378701|NCT00726661|469354199|FG000|Overall Study|Death|475|||
130378702|NCT00726661|469354200|FG001|Overall Study|Death|159|||
130378703|NCT00726661|469354199|FG000|Overall Study|Physician Decision|25|||
130378704|NCT00726661|469354200|FG001|Overall Study|Physician Decision|13|||
130378705|NCT00726661|469354199|FG000|Overall Study|Other|47|||
130378706|NCT00726661|469354200|FG001|Overall Study|Other|35|||
130378707|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
130378708|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
130378709|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
130378710|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
130378711|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
130378712|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
130378713|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
130378714|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
130378715|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
130378716|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
130378717|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
130378718|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130378719|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
130378720|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130378721|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130378722|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
130378723|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
130378724|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
130378725|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
130378726|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
130378727|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130722040|NCT02304458|470606414|FG005|Overall Study|Withdrawal by Subject|0|||
130722041|NCT02304458|470606415|FG006|Overall Study|Withdrawal by Subject|1|||
130378728|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
130378729|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
130378730|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130378731|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130378732|NCT01285310|469354201|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
130378733|NCT01285310|469354202|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
130722042|NCT02304458|470606416|FG007|Overall Study|Withdrawal by Subject|0|||
130722043|NCT03401450|470606417|FG000|Overall Study|Lost to Follow-up|4|||
130722044|NCT03401450|470606418|FG001|Overall Study|Lost to Follow-up|6|||
130722045|NCT03401450|470606417|FG000|Overall Study|Anesthesia plan changed|2|||
130378734|NCT01285310|469354203|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
130378735|NCT01285310|469354204|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
130378736|NCT01285310|469354205|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
130378737|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
130378738|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
130378739|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
130378740|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
130378741|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
130378742|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
130378743|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
130378744|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
130378745|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
130378746|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
130378747|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
130378748|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
130378749|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
130378750|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
130378751|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
130378752|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
130378753|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
130378754|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
130378755|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
130378756|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
130378757|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
130378758|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
130378759|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
130378760|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
130378761|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
130378762|NCT01285310|469354201|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
130378763|NCT01285310|469354202|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130378764|NCT01285310|469354203|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130378765|NCT01285310|469354204|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130378766|NCT01285310|469354205|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
130378767|NCT01574326|469354206|FG000|Overall Study|Randomized but not treated|0|||
130378768|NCT01574326|469354207|FG001|Overall Study|Randomized but not treated|1|||
130378769|NCT01574326|469354206|FG000|Overall Study|Withdrawal by Participant|2|||
130378770|NCT01574326|469354207|FG001|Overall Study|Withdrawal by Participant|4|||
130378771|NCT01574326|469354206|FG000|Overall Study|Physician Decision|5|||
130378772|NCT01574326|469354207|FG001|Overall Study|Physician Decision|3|||
130378773|NCT01574326|469354206|FG000|Overall Study|Adverse Event|1|||
130378774|NCT01574326|469354207|FG001|Overall Study|Adverse Event|3|||
130378775|NCT01574326|469354206|FG000|Overall Study|Other: Mainly kidney transplant|8|||
130378776|NCT01574326|469354207|FG001|Overall Study|Other: Mainly kidney transplant|8|||
130378777|NCT04997161|469354230|FG000|Overall Study|Study terminated by sponsor|3|||
130378778|NCT00005937|469354231|FG000|Overall Study|Lack of Efficacy|5|||
130378779|NCT01574612|469354232|FG000|Overall Study|Adverse Event|3|||
130378780|NCT01574612|469354232|FG000|Overall Study|non compliant with drug|2|||
130378781|NCT01574612|469354232|FG000|Overall Study|Withdrawal by Subject|1|||
130378782|NCT01574612|469354232|FG000|Overall Study|Lost to Follow-up|2|||
130378783|NCT02407704|469354235|FG000|Overall Study|Lost to Follow-up|0|||
130378784|NCT02407704|469354236|FG001|Overall Study|Lost to Follow-up|0|||
130378785|NCT02407704|469354237|FG002|Overall Study|Lost to Follow-up|0|||
130378786|NCT02407704|469354238|FG003|Overall Study|Lost to Follow-up|2|||
130378787|NCT02407704|469354235|FG000|Overall Study|Protocol Violation|0|||
130378788|NCT02407704|469354236|FG001|Overall Study|Protocol Violation|0|||
130378789|NCT02407704|469354237|FG002|Overall Study|Protocol Violation|0|||
130378790|NCT02407704|469354238|FG003|Overall Study|Protocol Violation|1|||
130378791|NCT02407704|469354235|FG000|Overall Study|Withdrawal by Subject|0|||
130378792|NCT02407704|469354236|FG001|Overall Study|Withdrawal by Subject|0|||
130378793|NCT02407704|469354237|FG002|Overall Study|Withdrawal by Subject|1|||
130378794|NCT02407704|469354238|FG003|Overall Study|Withdrawal by Subject|0|||
130378795|NCT01957644|469354241|FG000|Overall Study|Adverse Event|4|||
130378796|NCT01957644|469354242|FG001|Overall Study|Adverse Event|2|||
130378797|NCT01957644|469354243|FG002|Overall Study|Adverse Event|0|||
130378798|NCT01957644|469354244|FG003|Overall Study|Adverse Event|0|||
130378799|NCT01957644|469354245|FG004|Overall Study|Adverse Event|1|||
130378800|NCT01957644|469354241|FG000|Overall Study|Progressive disease / relapse|0|||
130378801|NCT01957644|469354242|FG001|Overall Study|Progressive disease / relapse|1|||
130378802|NCT01957644|469354243|FG002|Overall Study|Progressive disease / relapse|0|||
130378803|NCT01957644|469354244|FG003|Overall Study|Progressive disease / relapse|1|||
130378804|NCT01957644|469354245|FG004|Overall Study|Progressive disease / relapse|0|||
130378805|NCT01957644|469354241|FG000|Overall Study|Other reason|1|||
130378806|NCT01957644|469354242|FG001|Overall Study|Other reason|2|||
130378807|NCT01957644|469354243|FG002|Overall Study|Other reason|1|||
130378808|NCT01957644|469354244|FG003|Overall Study|Other reason|1|||
130378809|NCT01957644|469354245|FG004|Overall Study|Other reason|0|||
130378810|NCT01957644|469354241|FG000|Overall Study|Withdrawal by Subject|1|||
130378811|NCT01957644|469354242|FG001|Overall Study|Withdrawal by Subject|0|||
130378812|NCT01957644|469354243|FG002|Overall Study|Withdrawal by Subject|0|||
130378813|NCT01957644|469354244|FG003|Overall Study|Withdrawal by Subject|0|||
130378814|NCT01957644|469354245|FG004|Overall Study|Withdrawal by Subject|0|||
130378815|NCT01957644|469354241|FG000|Overall Study|Protocol Violation|0|||
130378816|NCT01957644|469354242|FG001|Overall Study|Protocol Violation|1|||
130378817|NCT01957644|469354243|FG002|Overall Study|Protocol Violation|0|||
130378818|NCT01957644|469354244|FG003|Overall Study|Protocol Violation|0|||
130378819|NCT01957644|469354245|FG004|Overall Study|Protocol Violation|0|||
130378820|NCT04044716|469354246|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
130378821|NCT04044716|469354247|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
130378822|NCT04044716|469354248|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
130378823|NCT04044716|469354246|FG000|Overall Study|Lost to Follow-up|2|||
130378824|NCT04044716|469354247|FG001|Overall Study|Lost to Follow-up|3|||
130378825|NCT04044716|469354248|FG002|Overall Study|Lost to Follow-up|0|||
130378826|NCT01324999|469354249|FG000|Overall Study|Adverse Event|3|||
130378827|NCT01324999|469354249|FG000|Overall Study|Withdrawal by Subject|2|||
130378828|NCT01714635|469354250|FG000|Overall Study|Discontinued|1|||
130378829|NCT01714635|469354251|FG001|Overall Study|Discontinued|0|||
130378830|NCT01714635|469354252|FG002|Overall Study|Discontinued|2|||
130378831|NCT01714635|469354250|FG000|Overall Study|Missed 6-month exam|1|||
130378832|NCT01714635|469354251|FG001|Overall Study|Missed 6-month exam|0|||
130378833|NCT01714635|469354252|FG002|Overall Study|Missed 6-month exam|0|||
130378834|NCT00230607|469354253|FG000|Overall Study|Other|3|||
130378835|NCT00071513|469354254|FG000|Intervention Component|Withdrawal by Subject|2|||
130378836|NCT00071513|469354255|FG001|Intervention Component|Withdrawal by Subject|3|||
130378837|NCT00071513|469354254|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
130378838|NCT00071513|469354255|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
130378839|NCT01244425|469354257|FG000|Overall Study|Withdrawal by Subject|2|||
130378840|NCT01244425|469354258|FG001|Overall Study|Withdrawal by Subject|2|||
130378841|NCT01244425|469354257|FG000|Overall Study|Adverse Event|1|||
130378842|NCT01244425|469354258|FG001|Overall Study|Adverse Event|1|||
130378843|NCT02743871|469354259|FG000|Overall Study|Lost to Follow-up|0|||
130378844|NCT02743871|469354260|FG001|Overall Study|Lost to Follow-up|0|||
130378845|NCT02743871|469354261|FG002|Overall Study|Lost to Follow-up|0|||
130378846|NCT02743871|469354262|FG003|Overall Study|Lost to Follow-up|1|||
130378847|NCT02743871|469354263|FG004|Overall Study|Lost to Follow-up|0|||
130378848|NCT02743871|469354264|FG005|Overall Study|Lost to Follow-up|0|||
130378849|NCT02743871|469354265|FG006|Overall Study|Lost to Follow-up|1|||
130378850|NCT02743871|469354266|FG007|Overall Study|Lost to Follow-up|0|||
130378851|NCT02743871|469354267|FG008|Overall Study|Lost to Follow-up|0|||
130378852|NCT02743871|469354268|FG009|Overall Study|Lost to Follow-up|0|||
130378853|NCT02743871|469354269|FG010|Overall Study|Lost to Follow-up|0|||
130378854|NCT02743871|469354270|FG011|Overall Study|Lost to Follow-up|2|||
130378855|NCT02743871|469354271|FG012|Overall Study|Lost to Follow-up|0|||
130378856|NCT02743871|469354272|FG013|Overall Study|Lost to Follow-up|0|||
130378857|NCT02743871|469354259|FG000|Overall Study|Withdrawal by Subject|0|||
130467280|NCT02723955|469678900|FG001|Escalation Phase|Lost to Follow-up|0|||
130467281|NCT02723955|469678901|FG002|Escalation Phase|Lost to Follow-up|0|||
130467282|NCT02723955|469678902|FG003|Escalation Phase|Lost to Follow-up|0|||
130467283|NCT02723955|469678903|FG004|Escalation Phase|Lost to Follow-up|0|||
130467284|NCT02723955|469678904|FG005|Escalation Phase|Lost to Follow-up|2|||
130467285|NCT02723955|469678905|FG006|Escalation Phase|Lost to Follow-up|1|||
130467286|NCT02723955|469678906|FG007|Escalation Phase|Lost to Follow-up|1|||
130467287|NCT02723955|469678907|FG008|Escalation Phase|Lost to Follow-up|1|||
130467288|NCT02723955|469678908|FG009|Escalation Phase|Lost to Follow-up|0|||
130467289|NCT02723955|469678909|FG010|Escalation Phase|Lost to Follow-up|0|||
130378858|NCT02743871|469354260|FG001|Overall Study|Withdrawal by Subject|0|||
130378859|NCT02743871|469354261|FG002|Overall Study|Withdrawal by Subject|0|||
130378860|NCT02743871|469354262|FG003|Overall Study|Withdrawal by Subject|0|||
130378861|NCT02743871|469354263|FG004|Overall Study|Withdrawal by Subject|0|||
130378862|NCT02743871|469354264|FG005|Overall Study|Withdrawal by Subject|0|||
130378863|NCT02743871|469354265|FG006|Overall Study|Withdrawal by Subject|0|||
130378864|NCT02743871|469354266|FG007|Overall Study|Withdrawal by Subject|0|||
130378865|NCT02743871|469354267|FG008|Overall Study|Withdrawal by Subject|0|||
130378866|NCT02743871|469354268|FG009|Overall Study|Withdrawal by Subject|0|||
130378867|NCT02743871|469354269|FG010|Overall Study|Withdrawal by Subject|1|||
130467290|NCT02723955|469678910|FG011|Escalation Phase|Lost to Follow-up|0|||
130378868|NCT02743871|469354270|FG011|Overall Study|Withdrawal by Subject|0|||
130378869|NCT02743871|469354271|FG012|Overall Study|Withdrawal by Subject|12|||
130378870|NCT02743871|469354272|FG013|Overall Study|Withdrawal by Subject|6|||
130378871|NCT02743871|469354259|FG000|Overall Study|Adverse Event|1|||
130378872|NCT02743871|469354260|FG001|Overall Study|Adverse Event|0|||
130378873|NCT02743871|469354261|FG002|Overall Study|Adverse Event|0|||
130378874|NCT02743871|469354262|FG003|Overall Study|Adverse Event|0|||
130378875|NCT02743871|469354263|FG004|Overall Study|Adverse Event|0|||
130378876|NCT02743871|469354264|FG005|Overall Study|Adverse Event|0|||
130378877|NCT02743871|469354265|FG006|Overall Study|Adverse Event|0|||
130378878|NCT02743871|469354266|FG007|Overall Study|Adverse Event|0|||
130378879|NCT02743871|469354267|FG008|Overall Study|Adverse Event|0|||
130378880|NCT02743871|469354268|FG009|Overall Study|Adverse Event|0|||
130378881|NCT02743871|469354269|FG010|Overall Study|Adverse Event|0|||
130378882|NCT02743871|469354270|FG011|Overall Study|Adverse Event|0|||
130378883|NCT02743871|469354271|FG012|Overall Study|Adverse Event|0|||
130378884|NCT02743871|469354272|FG013|Overall Study|Adverse Event|0|||
130378885|NCT02743871|469354259|FG000|Overall Study|Other|0|||
130378886|NCT02743871|469354260|FG001|Overall Study|Other|0|||
130378887|NCT02743871|469354261|FG002|Overall Study|Other|0|||
130378888|NCT02743871|469354262|FG003|Overall Study|Other|0|||
130378889|NCT02743871|469354263|FG004|Overall Study|Other|0|||
130378890|NCT02743871|469354264|FG005|Overall Study|Other|0|||
130378891|NCT02743871|469354265|FG006|Overall Study|Other|0|||
130378892|NCT02743871|469354266|FG007|Overall Study|Other|0|||
130378893|NCT02743871|469354267|FG008|Overall Study|Other|0|||
130378894|NCT02743871|469354268|FG009|Overall Study|Other|0|||
130378895|NCT02743871|469354269|FG010|Overall Study|Other|0|||
130378896|NCT02743871|469354270|FG011|Overall Study|Other|1|||
130378897|NCT02743871|469354271|FG012|Overall Study|Other|1|||
130378898|NCT02743871|469354272|FG013|Overall Study|Other|1|||
130378899|NCT02743871|469354259|FG000|Overall Study|Protocol Violation|0|||
130378900|NCT02743871|469354260|FG001|Overall Study|Protocol Violation|0|||
130378901|NCT02743871|469354261|FG002|Overall Study|Protocol Violation|0|||
130378902|NCT02743871|469354262|FG003|Overall Study|Protocol Violation|0|||
130378903|NCT02743871|469354263|FG004|Overall Study|Protocol Violation|0|||
130378904|NCT02743871|469354264|FG005|Overall Study|Protocol Violation|0|||
130378905|NCT02743871|469354265|FG006|Overall Study|Protocol Violation|0|||
130378906|NCT02743871|469354266|FG007|Overall Study|Protocol Violation|0|||
130378907|NCT02743871|469354267|FG008|Overall Study|Protocol Violation|0|||
130378908|NCT02743871|469354268|FG009|Overall Study|Protocol Violation|0|||
130378909|NCT02743871|469354269|FG010|Overall Study|Protocol Violation|0|||
130378910|NCT02743871|469354270|FG011|Overall Study|Protocol Violation|0|||
130378911|NCT02743871|469354271|FG012|Overall Study|Protocol Violation|2|||
130378912|NCT02743871|469354272|FG013|Overall Study|Protocol Violation|0|||
130378913|NCT02848651|469354273|FG000|Overall Study|Death|85|||
130378914|NCT02848651|469354273|FG000|Overall Study|Lost to Follow-up|1|||
130378915|NCT02848651|469354273|FG000|Overall Study|Non-Compliance|1|||
130378916|NCT02848651|469354273|FG000|Overall Study|Symptomatic Deterioration|1|||
130378917|NCT02848651|469354273|FG000|Overall Study|Physician Decision|4|||
130378918|NCT02848651|469354273|FG000|Overall Study|Withdrawal by Subject|14|||
130378919|NCT01059799|469354280|FG000|Overall Study|Adverse Event|2|||
130378920|NCT01059799|469354281|FG001|Overall Study|Adverse Event|3|||
130378921|NCT01059799|469354280|FG000|Overall Study|Lack of Efficacy|1|||
130378922|NCT01059799|469354281|FG001|Overall Study|Lack of Efficacy|0|||
130378923|NCT01059799|469354280|FG000|Overall Study|Protocol Violation|3|||
130378924|NCT01059799|469354281|FG001|Overall Study|Protocol Violation|2|||
130378925|NCT01059799|469354280|FG000|Overall Study|Withdrawal criteria|13|||
130378926|NCT01059799|469354281|FG001|Overall Study|Withdrawal criteria|2|||
130378927|NCT01059799|469354280|FG000|Overall Study|Other|12|||
130378928|NCT01059799|469354281|FG001|Overall Study|Other|3|||
130378929|NCT03789318|469354285|FG000|Overall Study|Adverse Event|0|||
130378930|NCT03789318|469354286|FG001|Overall Study|Adverse Event|0|||
130378931|NCT03789318|469354287|FG002|Overall Study|Adverse Event|1|||
130378932|NCT03789318|469354288|FG003|Overall Study|Adverse Event|1|||
130378933|NCT03789318|469354289|FG004|Overall Study|Adverse Event|0|||
130378934|NCT03789318|469354285|FG000|Overall Study|Lost to Follow-up|0|||
130378935|NCT03789318|469354286|FG001|Overall Study|Lost to Follow-up|0|||
130378936|NCT03789318|469354287|FG002|Overall Study|Lost to Follow-up|1|||
130378937|NCT03789318|469354288|FG003|Overall Study|Lost to Follow-up|0|||
130378938|NCT03789318|469354289|FG004|Overall Study|Lost to Follow-up|0|||
130378939|NCT03789318|469354285|FG000|Overall Study|Withdrawal by Subject|0|||
130378940|NCT03789318|469354286|FG001|Overall Study|Withdrawal by Subject|0|||
130378941|NCT03789318|469354287|FG002|Overall Study|Withdrawal by Subject|1|||
130378942|NCT03789318|469354288|FG003|Overall Study|Withdrawal by Subject|0|||
130378943|NCT03789318|469354289|FG004|Overall Study|Withdrawal by Subject|0|||
130378944|NCT02480114|469354290|FG000|Overall Study|Not completing surveys|3|||
130378945|NCT02480114|469354291|FG001|Overall Study|Not completing surveys|2|||
130378946|NCT02480114|469354290|FG000|Overall Study|Withdrawal by Subject|2|||
130378947|NCT02480114|469354291|FG001|Overall Study|Withdrawal by Subject|4|||
130378948|NCT02480114|469354290|FG000|Overall Study|Disease progression|3|||
130378949|NCT02480114|469354291|FG001|Overall Study|Disease progression|0|||
130378950|NCT02480114|469354290|FG000|Overall Study|Improper completion of survey|1|||
130378951|NCT02480114|469354291|FG001|Overall Study|Improper completion of survey|1|||
130378952|NCT02480114|469354290|FG000|Overall Study|Not eligible|0|||
130378953|NCT02480114|469354291|FG001|Overall Study|Not eligible|1|||
130378954|NCT01535053|469354292|FG000|Overall Study|Ineligible|1|||
130378955|NCT01535053|469354293|FG001|Overall Study|Ineligible|2|||
130378956|NCT00512707|469354294|FG000|Overall Study|Lost to Follow-up|5|||
130378957|NCT00512707|469354295|FG001|Overall Study|Lost to Follow-up|11|||
130378958|NCT00512707|469354294|FG000|Overall Study|Developed skin irritation|2|||
130378959|NCT00512707|469354295|FG001|Overall Study|Developed skin irritation|1|||
130378960|NCT00512707|469354294|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
130378961|NCT00512707|469354295|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
130378962|NCT00512707|469354294|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
130378963|NCT00512707|469354295|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
130378964|NCT03700671|469354296|FG000|Overall Study|Lack of Efficacy|1|||
130378965|NCT03700671|469354297|FG001|Overall Study|Lack of Efficacy|2|||
130378966|NCT01317160|469354298|FG000|Overall Study|Incorrect inclusion|1|||
130378967|NCT01317160|469354299|FG001|Overall Study|Incorrect inclusion|1|||
130378968|NCT01317160|469354298|FG000|Overall Study|Lost to Follow-up|3|||
130378969|NCT01317160|469354299|FG001|Overall Study|Lost to Follow-up|3|||
130378970|NCT01317160|469354298|FG000|Overall Study|Withdrawal by Subject|0|||
130378971|NCT01317160|469354299|FG001|Overall Study|Withdrawal by Subject|2|||
130378972|NCT04203238|469355997|FG000|Overall Study|Withdrawal by Subject|1|||
130378973|NCT04203238|469355998|FG001|Overall Study|Withdrawal by Subject|1|||
130378974|NCT04203238|469355997|FG000|Overall Study|Covid-19|3|||
130378975|NCT04203238|469355998|FG001|Overall Study|Covid-19|0|||
130378976|NCT01955733|469355999|FG000|Period 1|Lost to Follow-up|1|||
130378977|NCT01955733|469356000|FG001|Period 1|Lost to Follow-up|0|||
130378978|NCT01955733|469356001|FG002|Period 1|Lost to Follow-up|0|||
130378979|NCT01955733|469355999|FG000|Period 2|Adverse Event|1|||
130378980|NCT01955733|469356000|FG001|Period 2|Adverse Event|0|||
130378981|NCT01955733|469356001|FG002|Period 2|Adverse Event|0|||
130378982|NCT01955733|469355999|FG000|Period 2|Physician Decision|0|||
130378983|NCT01955733|469356000|FG001|Period 2|Physician Decision|0|||
130378984|NCT01955733|469356001|FG002|Period 2|Physician Decision|1|||
130378985|NCT01955733|469355999|FG000|Period 2|Withdrawal by Subject|1|||
130378986|NCT01955733|469356000|FG001|Period 2|Withdrawal by Subject|3|||
130378987|NCT01955733|469356001|FG002|Period 2|Withdrawal by Subject|2|||
130378988|NCT01955733|469355999|FG000|Period 2|Study terminated by sponsor|8|||
130378989|NCT01955733|469356000|FG001|Period 2|Study terminated by sponsor|14|||
130378990|NCT01955733|469356001|FG002|Period 2|Study terminated by sponsor|16|||
130378991|NCT01955733|469355999|FG000|Period 2|Lost to Follow-up|2|||
130378992|NCT01955733|469356000|FG001|Period 2|Lost to Follow-up|0|||
130378993|NCT01955733|469356001|FG002|Period 2|Lost to Follow-up|0|||
130378994|NCT01955733|469355999|FG000|Period 2|Other not defined above|0|||
130378995|NCT01955733|469356000|FG001|Period 2|Other not defined above|2|||
130378996|NCT01955733|469356001|FG002|Period 2|Other not defined above|2|||
130378997|NCT00733408|469356002|FG000|Overall Study|Adverse Event|4|||
130378998|NCT02762266|469356003|FG000|Overall Study|Physician Decision|2|||
130378999|NCT02762266|469356004|FG001|Overall Study|Physician Decision|0|||
130379000|NCT01438424|469356005|FG000|Overall Study|Continuing treatment|29|||
130379001|NCT01438424|469356005|FG000|Overall Study|Minimal virologic response|95|||
130379002|NCT01438424|469356005|FG000|Overall Study|Not identified|55|||
130379003|NCT01438424|469356005|FG000|Overall Study|Withdrawal by Subject|104|||
130379004|NCT01438424|469356005|FG000|Overall Study|Progression of chronic hepatitis B|22|||
130379005|NCT01438424|469356005|FG000|Overall Study|Death|22|||
130379006|NCT01438424|469356005|FG000|Overall Study|Adverse Event|17|||
130722046|NCT03401450|470606418|FG001|Overall Study|Anesthesia plan changed|2|||
130722047|NCT03401450|470606417|FG000|Overall Study|Did not complete medication diary|4|||
130722048|NCT03401450|470606418|FG001|Overall Study|Did not complete medication diary|2|||
130722049|NCT03401450|470606417|FG000|Overall Study|post surgery medication change|2|||
130722050|NCT03401450|470606418|FG001|Overall Study|post surgery medication change|1|||
130722051|NCT03401450|470606417|FG000|Overall Study|Cancelled surgery|0|||
130379007|NCT01438424|469356005|FG000|Overall Study|Lost to Follow-up|17|||
130722052|NCT03401450|470606418|FG001|Overall Study|Cancelled surgery|2|||
130379008|NCT01438424|469356005|FG000|Overall Study|Abnormal laboratory test result|14|||
130379009|NCT01438424|469356005|FG000|Overall Study|Need for drug prohibited by protocol|14|||
130379010|NCT01438424|469356005|FG000|Overall Study|Pregnancy|7|||
130379011|NCT01438424|469356005|FG000|Overall Study|No longer met inclusion criteria|1|||
130379012|NCT01438424|469356005|FG000|Overall Study|Participant noncompliance|20|||
130379013|NCT02064868|469356010|FG000|Overall Study|Lost to Follow-up|14|||
130379014|NCT02064868|469356011|FG001|Overall Study|Lost to Follow-up|8|||
130379015|NCT02064868|469356010|FG000|Overall Study|Physician Decision|1|||
130379016|NCT02064868|469356011|FG001|Overall Study|Physician Decision|0|||
130379017|NCT02064868|469356010|FG000|Overall Study|Withdrawal by Subject|14|||
130379018|NCT02064868|469356011|FG001|Overall Study|Withdrawal by Subject|3|||
130379019|NCT02064868|469356010|FG000|Overall Study|Technical Problems or Missing|5|||
130379020|NCT02064868|469356011|FG001|Overall Study|Technical Problems or Missing|2|||
130379021|NCT00931762|469356015|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
130379022|NCT00931762|469356015|FG000|Overall Study|Administrative Problems|5|||
130379023|NCT00931762|469356015|FG000|Overall Study|Death|1|||
130379024|NCT00931762|469356015|FG000|Overall Study|Disease Progression|3|||
130379025|NCT00931762|469356015|FG000|Overall Study|Adverse Event (s)|11|||
130379026|NCT00931762|469356015|FG000|Overall Study|Subject withdrew consent|13|||
130379027|NCT02664441|469356016|FG000|Randomization|Withdrawal by Subject|0|||
130379028|NCT02664441|469356017|FG001|Randomization|Withdrawal by Subject|1|||
130379029|NCT02664441|469356016|FG000|36-week Randomized Trial|Adverse Event|2|||
130379030|NCT02664441|469356017|FG001|36-week Randomized Trial|Adverse Event|0|||
130379031|NCT02664441|469356016|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
130379032|NCT02664441|469356017|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
130379033|NCT02664441|469356016|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
130379034|NCT02664441|469356017|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
130379035|NCT02664441|469356016|FG000|18-week Open Label Extension|Adverse Event|1|||
130379036|NCT02664441|469356017|FG001|18-week Open Label Extension|Adverse Event|0|||
130379037|NCT02664441|469356016|FG000|18-week Open Label Extension|Physician Decision|1|||
130379038|NCT02664441|469356017|FG001|18-week Open Label Extension|Physician Decision|0|||
130379039|NCT02664441|469356016|FG000|18-week Open Label Extension|Death|1|||
130379040|NCT02664441|469356017|FG001|18-week Open Label Extension|Death|0|||
130379041|NCT02664441|469356016|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
130379042|NCT02664441|469356017|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
130379043|NCT01413191|469356018|FG000|Overall Study|Lost to Follow-up|5|||
130379044|NCT01413191|469356018|FG000|Overall Study|Disease Progression|5|||
130379045|NCT01413191|469356018|FG000|Overall Study|Death|1|||
130379046|NCT01702454|469356019|FG000|Overall Study|Consent withdrawal|0|||
130379047|NCT01702454|469356020|FG001|Overall Study|Consent withdrawal|1|||
130379048|NCT01702454|469356019|FG000|Overall Study|Migrated/moved from study area|0|||
130379049|NCT01702454|469356020|FG001|Overall Study|Migrated/moved from study area|1|||
130379050|NCT01702454|469356019|FG000|Overall Study|Lost to Follow-up|3|||
130379051|NCT01702454|469356020|FG001|Overall Study|Lost to Follow-up|6|||
130379052|NCT00710710|469356021|FG000|Overall Study|Consent withdrawn|2|||
130379053|NCT00710710|469356022|FG001|Overall Study|Consent withdrawn|2|||
130379054|NCT00710710|469356021|FG000|Overall Study|Protocol Violation|0|||
130379055|NCT00710710|469356022|FG001|Overall Study|Protocol Violation|1|||
130379056|NCT00710710|469356021|FG000|Overall Study|Adverse Event|3|||
130379057|NCT00710710|469356022|FG001|Overall Study|Adverse Event|3|||
130379058|NCT00710710|469356021|FG000|Overall Study|Progressive disease|40|||
130379059|NCT00710710|469356022|FG001|Overall Study|Progressive disease|38|||
130379060|NCT03510884|469356023|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
130379061|NCT03510884|469356024|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
130379062|NCT03510884|469356025|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
130379063|NCT03510884|469356026|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
130379064|NCT03510884|469356023|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
130379065|NCT03510884|469356024|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
130379066|NCT03510884|469356025|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
130379067|NCT03510884|469356026|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
130379068|NCT03510884|469356023|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
130379069|NCT03510884|469356024|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
130722053|NCT01214915|470606420|FG000|Overall Study|Adverse Event|8|||
130379070|NCT03510884|469356025|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
130379071|NCT03510884|469356026|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
130379072|NCT03510884|469356023|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130379073|NCT03510884|469356024|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
130379074|NCT03510884|469356025|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130379075|NCT03510884|469356026|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130379076|NCT03510884|469356023|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
130379077|NCT03510884|469356024|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
130379078|NCT03510884|469356025|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
130379079|NCT03510884|469356026|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
130379080|NCT03510884|469356023|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
130379081|NCT03510884|469356024|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
130379082|NCT03510884|469356025|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
130379083|NCT03510884|469356026|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
130379084|NCT03510884|469356023|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130379085|NCT03510884|469356024|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
130379086|NCT03510884|469356025|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130379087|NCT03510884|469356026|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130379088|NCT03510884|469356023|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
130379089|NCT03510884|469356024|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
130379090|NCT03510884|469356025|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
130379091|NCT03510884|469356026|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
130379092|NCT03510884|469356023|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130379093|NCT03510884|469356024|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
130379094|NCT03510884|469356025|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130379095|NCT03510884|469356026|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130379096|NCT03510884|469356023|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
130379097|NCT03510884|469356024|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
130379098|NCT03510884|469356025|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
130379099|NCT03510884|469356026|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
130379100|NCT01529346|469356028|FG000|Overall Study|Lost to Follow-up|2|||
130379101|NCT01529346|469356029|FG001|Overall Study|Lost to Follow-up|0|||
130379102|NCT01529346|469356030|FG002|Overall Study|Lost to Follow-up|1|||
130379103|NCT01529346|469356031|FG003|Overall Study|Lost to Follow-up|0|||
130379104|NCT01529346|469356032|FG004|Overall Study|Lost to Follow-up|0|||
130379105|NCT01529346|469356028|FG000|Overall Study|Other|0|||
130379106|NCT01529346|469356029|FG001|Overall Study|Other|1|||
130379107|NCT01529346|469356030|FG002|Overall Study|Other|1|||
130379108|NCT01529346|469356031|FG003|Overall Study|Other|0|||
130379109|NCT01529346|469356032|FG004|Overall Study|Other|0|||
130379110|NCT00589914|469356038|FG000|Overall Study|Adverse Event|19|||
130379111|NCT00589914|469356039|FG001|Overall Study|Adverse Event|10|||
130379112|NCT00589914|469356038|FG000|Overall Study|Death|2|||
130379113|NCT00589914|469356039|FG001|Overall Study|Death|0|||
130379114|NCT00589914|469356038|FG000|Overall Study|Lack of Efficacy|40|||
130379115|NCT00589914|469356039|FG001|Overall Study|Lack of Efficacy|43|||
130379116|NCT00589914|469356038|FG000|Overall Study|Lost to Follow-up|11|||
130379117|NCT00589914|469356039|FG001|Overall Study|Lost to Follow-up|18|||
130379118|NCT00589914|469356038|FG000|Overall Study|Pregnancy|1|||
130379119|NCT00589914|469356039|FG001|Overall Study|Pregnancy|0|||
130379120|NCT00589914|469356038|FG000|Overall Study|Withdrawal by Subject|55|||
130379121|NCT00589914|469356039|FG001|Overall Study|Withdrawal by Subject|49|||
130379122|NCT00589914|469356038|FG000|Overall Study|Other|22|||
130379123|NCT00589914|469356039|FG001|Overall Study|Other|17|||
130379124|NCT01594125|469356044|FG000|Overall Study|Withdrawal by Subject|1|||
130379125|NCT01594125|469356045|FG001|Overall Study|Withdrawal by Subject|0|||
130379126|NCT01594125|469356046|FG002|Overall Study|Withdrawal by Subject|0|||
130379127|NCT01594125|469356047|FG003|Overall Study|Withdrawal by Subject|1|||
130379128|NCT01594125|469356048|FG004|Overall Study|Withdrawal by Subject|0|||
130379129|NCT01594125|469356044|FG000|Overall Study|Progressive Disease|3|||
130379130|NCT01594125|469356045|FG001|Overall Study|Progressive Disease|12|||
130379131|NCT01594125|469356046|FG002|Overall Study|Progressive Disease|3|||
130379132|NCT01594125|469356047|FG003|Overall Study|Progressive Disease|3|||
130379133|NCT01594125|469356048|FG004|Overall Study|Progressive Disease|7|||
130379134|NCT03590041|469356050|FG000|Overall Study|Protocol Violation|4|||
130379135|NCT03590041|469356051|FG001|Overall Study|Protocol Violation|3|||
130379136|NCT03590041|469356050|FG000|Overall Study|No session data recorded|14|||
130379137|NCT03590041|469356051|FG001|Overall Study|No session data recorded|2|||
130379138|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
130379139|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
130379140|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
130379141|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
130722054|NCT01214915|470606420|FG000|Overall Study|Lack of Efficacy|3|||
130722055|NCT03155945|470606421|FG000|Overall Study|Lost to Follow-up|0|||
130722056|NCT03155945|470606422|FG001|Overall Study|Lost to Follow-up|1|||
130379142|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
130379143|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
130379144|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
130379145|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
130379146|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
130379147|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
130379148|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
130379149|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
130722057|NCT03155945|470606421|FG000|Overall Study|Withdrawal by Subject|0|||
130379150|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
130379151|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
130379152|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
130379153|NCT01124422|469356053|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
130722058|NCT03155945|470606422|FG001|Overall Study|Withdrawal by Subject|1|||
130722059|NCT03155945|470606421|FG000|Overall Study|Other Reason|0|||
130722060|NCT03155945|470606422|FG001|Overall Study|Other Reason|1|||
130722061|NCT03395405|470608145|FG000|Overall Study|Death|0|||
130722062|NCT03395405|470608146|FG001|Overall Study|Death|2|||
130722063|NCT03395405|470608145|FG000|Overall Study|Lost to Follow-up|0|||
130722064|NCT03395405|470608146|FG001|Overall Study|Lost to Follow-up|1|||
130722065|NCT03395405|470608145|FG000|Overall Study|Protocol Violation|0|||
130722066|NCT03395405|470608146|FG001|Overall Study|Protocol Violation|1|||
130722067|NCT03395405|470608145|FG000|Overall Study|Withdrawal by Subject|3|||
130379154|NCT01124422|469356054|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
130379155|NCT01124422|469356055|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
130379156|NCT01124422|469356053|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
130379157|NCT01124422|469356054|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
130379158|NCT01124422|469356055|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
130379159|NCT01124422|469356053|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
130379160|NCT01124422|469356054|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
130467291|NCT02723955|469678911|FG012|Escalation Phase|Lost to Follow-up|1|||
130467292|NCT02723955|469678912|FG013|Escalation Phase|Lost to Follow-up|0|||
130467293|NCT02723955|469678913|FG014|Escalation Phase|Lost to Follow-up|0|||
130467294|NCT02723955|469678914|FG015|Escalation Phase|Lost to Follow-up|0|||
130467295|NCT02723955|469678915|FG016|Escalation Phase|Lost to Follow-up|1|||
130467296|NCT02723955|469678916|FG017|Escalation Phase|Lost to Follow-up|2|||
130467297|NCT02723955|469678917|FG018|Escalation Phase|Lost to Follow-up|0|||
130467298|NCT02723955|469678918|FG019|Escalation Phase|Lost to Follow-up|1|||
130467299|NCT02723955|469678919|FG020|Escalation Phase|Lost to Follow-up|2|||
130467300|NCT02723955|469678920|FG021|Escalation Phase|Lost to Follow-up|1|||
130467301|NCT02723955|469678921|FG022|Escalation Phase|Lost to Follow-up|0|||
130467302|NCT02723955|469678922|FG023|Escalation Phase|Lost to Follow-up|0|||
130467303|NCT02723955|469678923|FG024|Escalation Phase|Lost to Follow-up|1|||
130467304|NCT02723955|469678924|FG025|Escalation Phase|Lost to Follow-up|1|||
130467305|NCT02723955|469678925|FG026|Escalation Phase|Lost to Follow-up|3|||
130467306|NCT02723955|469678926|FG027|Escalation Phase|Lost to Follow-up|0|||
130467307|NCT02723955|469678927|FG028|Escalation Phase|Lost to Follow-up|1|||
130467308|NCT02723955|469678928|FG029|Escalation Phase|Lost to Follow-up|0|||
130467309|NCT02723955|469678929|FG030|Escalation Phase|Lost to Follow-up|0|||
130467310|NCT02723955|469678930|FG031|Escalation Phase|Lost to Follow-up|0|||
130467311|NCT02723955|469678931|FG032|Escalation Phase|Lost to Follow-up|0|||
130467312|NCT02723955|469678932|FG033|Escalation Phase|Lost to Follow-up|0|||
130467313|NCT02723955|469678933|FG034|Escalation Phase|Lost to Follow-up|0|||
130467314|NCT02723955|469678934|FG035|Escalation Phase|Lost to Follow-up|0|||
130467315|NCT02723955|469678935|FG036|Escalation Phase|Lost to Follow-up|0|||
130467316|NCT02723955|469678936|FG037|Escalation Phase|Lost to Follow-up|0|||
130467317|NCT02723955|469678937|FG038|Escalation Phase|Lost to Follow-up|0|||
130467318|NCT02723955|469678938|FG039|Escalation Phase|Lost to Follow-up|0|||
130467319|NCT02723955|469678939|FG040|Escalation Phase|Lost to Follow-up|0|||
130467320|NCT02723955|469678940|FG041|Escalation Phase|Lost to Follow-up|0|||
130467321|NCT02723955|469678941|FG042|Escalation Phase|Lost to Follow-up|0|||
130467322|NCT02723955|469678899|FG000|Escalation Phase|Physician Decision|0|||
130467323|NCT02723955|469678900|FG001|Escalation Phase|Physician Decision|0|||
130467324|NCT02723955|469678901|FG002|Escalation Phase|Physician Decision|0|||
130467325|NCT02723955|469678902|FG003|Escalation Phase|Physician Decision|0|||
130467326|NCT02723955|469678903|FG004|Escalation Phase|Physician Decision|0|||
130467327|NCT02723955|469678904|FG005|Escalation Phase|Physician Decision|2|||
130467328|NCT02723955|469678905|FG006|Escalation Phase|Physician Decision|0|||
130467329|NCT02723955|469678906|FG007|Escalation Phase|Physician Decision|0|||
130467330|NCT02723955|469678907|FG008|Escalation Phase|Physician Decision|0|||
130467331|NCT02723955|469678908|FG009|Escalation Phase|Physician Decision|0|||
130467332|NCT02723955|469678909|FG010|Escalation Phase|Physician Decision|0|||
130467333|NCT02723955|469678910|FG011|Escalation Phase|Physician Decision|0|||
130467334|NCT02723955|469678911|FG012|Escalation Phase|Physician Decision|0|||
130467335|NCT02723955|469678912|FG013|Escalation Phase|Physician Decision|0|||
130467336|NCT02723955|469678913|FG014|Escalation Phase|Physician Decision|0|||
130467337|NCT02723955|469678914|FG015|Escalation Phase|Physician Decision|0|||
130467338|NCT02723955|469678915|FG016|Escalation Phase|Physician Decision|0|||
130467339|NCT02723955|469678916|FG017|Escalation Phase|Physician Decision|0|||
130722068|NCT03395405|470608146|FG001|Overall Study|Withdrawal by Subject|1|||
130722069|NCT03395405|470608145|FG000|Overall Study|COVID-19 Pandemic|1|||
130379161|NCT01124422|469356055|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
130379162|NCT01124422|469356053|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
130379163|NCT01124422|469356054|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
130379164|NCT01124422|469356055|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
130379165|NCT01124422|469356053|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
130379166|NCT01124422|469356054|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
130379167|NCT01124422|469356055|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
130379168|NCT03454893|469356060|FG000|Overall Study|Study Terminated by the Sponsor|5|||
130379169|NCT03454893|469356060|FG000|Overall Study|Did not pass screening|4|||
130379170|NCT04876274|469356061|FG000|Overall Study|Lost to Follow-up|9|||
130379171|NCT04876274|469356062|FG001|Overall Study|Lost to Follow-up|12|||
130379172|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Death|3|||
130379173|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Death|3|||
130379174|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Death|0|||
130379175|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Death|0|||
130379176|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
130379177|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
130379178|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
130379179|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
130379180|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
130379181|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
130379182|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
130379183|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
130379184|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
130379185|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
130379186|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
130379187|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
130379188|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
130379189|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
130379190|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
130379191|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
130379192|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
130379193|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
130379194|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
130379195|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
130379196|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
130379197|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
130379198|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
130379199|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
130379200|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Other|6|||
130379201|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Other|3|||
130379202|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Other|0|||
130379203|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Other|0|||
130379204|NCT02051608|469356063|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
130379205|NCT02051608|469356064|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
130379206|NCT02051608|469356065|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
130379207|NCT02051608|469356066|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
130379208|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Adverse Event|0|||
130379209|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Adverse Event|0|||
130379210|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Adverse Event|6|||
130379211|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Adverse Event|8|||
130379212|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Death|0|||
130379213|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Death|0|||
130379214|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Death|7|||
130379215|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Death|4|||
130379216|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
130379217|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
130379218|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
130379219|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
130379220|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
130379221|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
130379222|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
130379223|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
130379224|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130379225|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130379226|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
130379227|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
130379228|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130379229|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130379230|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130379231|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
130379232|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Physician Decision|0|||
130379233|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Physician Decision|0|||
130379234|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Physician Decision|8|||
130379235|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Physician Decision|5|||
130379236|NCT02051608|469356063|FG000|Part 2: Open-label Extension|Other|0|||
130379237|NCT02051608|469356064|FG001|Part 2: Open-label Extension|Other|0|||
130379238|NCT02051608|469356065|FG002|Part 2: Open-label Extension|Other|9|||
130379239|NCT02051608|469356066|FG003|Part 2: Open-label Extension|Other|9|||
130379240|NCT01948050|469356069|FG000|Overall Study|Withdrawal by Subject|0|||
130379241|NCT01948050|469356070|FG001|Overall Study|Withdrawal by Subject|1|||
130379242|NCT00558025|469356071|FG000|Overall Study|Adverse Event|1|||
130379243|NCT00558025|469356072|FG001|Overall Study|Adverse Event|1|||
130379244|NCT00558025|469356071|FG000|Overall Study|Withdrawal by Subject|2|||
130379245|NCT00558025|469356072|FG001|Overall Study|Withdrawal by Subject|2|||
130379246|NCT00558025|469356071|FG000|Overall Study|Protocol Violation|1|||
130379247|NCT00558025|469356072|FG001|Overall Study|Protocol Violation|0|||
130467340|NCT02723955|469678917|FG018|Escalation Phase|Physician Decision|0|||
130467341|NCT02723955|469678918|FG019|Escalation Phase|Physician Decision|0|||
130467342|NCT02723955|469678919|FG020|Escalation Phase|Physician Decision|0|||
130467343|NCT02723955|469678920|FG021|Escalation Phase|Physician Decision|0|||
130467344|NCT02723955|469678921|FG022|Escalation Phase|Physician Decision|0|||
130467345|NCT02723955|469678922|FG023|Escalation Phase|Physician Decision|0|||
130467346|NCT02723955|469678923|FG024|Escalation Phase|Physician Decision|0|||
130467347|NCT02723955|469678924|FG025|Escalation Phase|Physician Decision|0|||
130467348|NCT02723955|469678925|FG026|Escalation Phase|Physician Decision|2|||
130467349|NCT02723955|469678926|FG027|Escalation Phase|Physician Decision|0|||
130467350|NCT02723955|469678927|FG028|Escalation Phase|Physician Decision|0|||
130467351|NCT02723955|469678928|FG029|Escalation Phase|Physician Decision|0|||
130467352|NCT02723955|469678929|FG030|Escalation Phase|Physician Decision|0|||
130467353|NCT02723955|469678930|FG031|Escalation Phase|Physician Decision|0|||
130467354|NCT02723955|469678931|FG032|Escalation Phase|Physician Decision|0|||
130467355|NCT02723955|469678932|FG033|Escalation Phase|Physician Decision|0|||
130467356|NCT02723955|469678933|FG034|Escalation Phase|Physician Decision|0|||
130467357|NCT02723955|469678934|FG035|Escalation Phase|Physician Decision|0|||
130467358|NCT02723955|469678935|FG036|Escalation Phase|Physician Decision|0|||
130467359|NCT02723955|469678936|FG037|Escalation Phase|Physician Decision|0|||
130467360|NCT02723955|469678937|FG038|Escalation Phase|Physician Decision|0|||
130467361|NCT02723955|469678938|FG039|Escalation Phase|Physician Decision|0|||
130467362|NCT02723955|469678939|FG040|Escalation Phase|Physician Decision|0|||
130467363|NCT02723955|469678940|FG041|Escalation Phase|Physician Decision|0|||
130467364|NCT02723955|469678941|FG042|Escalation Phase|Physician Decision|0|||
130467365|NCT02723955|469678899|FG000|Escalation Phase|Withdrawal by Subject|0|||
130467366|NCT02723955|469678900|FG001|Escalation Phase|Withdrawal by Subject|0|||
130467367|NCT02723955|469678901|FG002|Escalation Phase|Withdrawal by Subject|0|||
130467368|NCT02723955|469678902|FG003|Escalation Phase|Withdrawal by Subject|0|||
130467369|NCT02723955|469678903|FG004|Escalation Phase|Withdrawal by Subject|1|||
130467370|NCT02723955|469678904|FG005|Escalation Phase|Withdrawal by Subject|1|||
130467371|NCT02723955|469678905|FG006|Escalation Phase|Withdrawal by Subject|1|||
130467372|NCT02723955|469678906|FG007|Escalation Phase|Withdrawal by Subject|1|||
130467373|NCT02723955|469678907|FG008|Escalation Phase|Withdrawal by Subject|0|||
130467374|NCT02723955|469678908|FG009|Escalation Phase|Withdrawal by Subject|0|||
130467375|NCT02723955|469678909|FG010|Escalation Phase|Withdrawal by Subject|0|||
130467376|NCT02723955|469678910|FG011|Escalation Phase|Withdrawal by Subject|0|||
130467377|NCT02723955|469678911|FG012|Escalation Phase|Withdrawal by Subject|1|||
130467378|NCT02723955|469678912|FG013|Escalation Phase|Withdrawal by Subject|0|||
130467379|NCT02723955|469678913|FG014|Escalation Phase|Withdrawal by Subject|0|||
130467380|NCT02723955|469678914|FG015|Escalation Phase|Withdrawal by Subject|0|||
130467381|NCT02723955|469678915|FG016|Escalation Phase|Withdrawal by Subject|1|||
130467382|NCT02723955|469678916|FG017|Escalation Phase|Withdrawal by Subject|0|||
130467383|NCT02723955|469678917|FG018|Escalation Phase|Withdrawal by Subject|0|||
130467384|NCT02723955|469678918|FG019|Escalation Phase|Withdrawal by Subject|0|||
130467385|NCT02723955|469678919|FG020|Escalation Phase|Withdrawal by Subject|0|||
130467386|NCT02723955|469678920|FG021|Escalation Phase|Withdrawal by Subject|0|||
130467387|NCT02723955|469678921|FG022|Escalation Phase|Withdrawal by Subject|0|||
130467388|NCT02723955|469678922|FG023|Escalation Phase|Withdrawal by Subject|2|||
130467389|NCT02723955|469678923|FG024|Escalation Phase|Withdrawal by Subject|0|||
130467390|NCT02723955|469678924|FG025|Escalation Phase|Withdrawal by Subject|1|||
130467391|NCT02723955|469678925|FG026|Escalation Phase|Withdrawal by Subject|0|||
130467392|NCT02723955|469678926|FG027|Escalation Phase|Withdrawal by Subject|0|||
130467393|NCT02723955|469678927|FG028|Escalation Phase|Withdrawal by Subject|1|||
130467394|NCT02723955|469678928|FG029|Escalation Phase|Withdrawal by Subject|0|||
130467395|NCT02723955|469678929|FG030|Escalation Phase|Withdrawal by Subject|0|||
130467396|NCT02723955|469678930|FG031|Escalation Phase|Withdrawal by Subject|0|||
130467397|NCT02723955|469678931|FG032|Escalation Phase|Withdrawal by Subject|0|||
130467398|NCT02723955|469678932|FG033|Escalation Phase|Withdrawal by Subject|0|||
130467399|NCT02723955|469678933|FG034|Escalation Phase|Withdrawal by Subject|0|||
130467400|NCT02723955|469678934|FG035|Escalation Phase|Withdrawal by Subject|0|||
130467401|NCT02723955|469678935|FG036|Escalation Phase|Withdrawal by Subject|0|||
130467402|NCT02723955|469678936|FG037|Escalation Phase|Withdrawal by Subject|0|||
130467403|NCT02723955|469678937|FG038|Escalation Phase|Withdrawal by Subject|0|||
130467404|NCT02723955|469678938|FG039|Escalation Phase|Withdrawal by Subject|0|||
130467405|NCT02723955|469678939|FG040|Escalation Phase|Withdrawal by Subject|0|||
130379248|NCT01314443|469356073|FG000|Overall Study|Withdrawal by Subject|2|||
130379249|NCT01314443|469356074|FG001|Overall Study|Withdrawal by Subject|1|||
130379250|NCT01314443|469356075|FG002|Overall Study|Withdrawal by Subject|1|||
130379251|NCT01314443|469356076|FG003|Overall Study|Withdrawal by Subject|1|||
130379252|NCT01314443|469356073|FG000|Overall Study|Protocol Violation|2|||
130379253|NCT01314443|469356074|FG001|Overall Study|Protocol Violation|2|||
130379254|NCT01314443|469356075|FG002|Overall Study|Protocol Violation|1|||
130379255|NCT01314443|469356076|FG003|Overall Study|Protocol Violation|1|||
130379256|NCT00449540|469356078|FG000|Pretreatment Phase|No migraine experienced|66|||
130379257|NCT00449540|469356079|FG001|Pretreatment Phase|No migraine experienced|0|||
130379258|NCT00449540|469356080|FG002|Pretreatment Phase|No migraine experienced|0|||
130379259|NCT00449540|469356078|FG000|Treatment Phase|did not experience or treat migraine|0|||
130379260|NCT00449540|469356079|FG001|Treatment Phase|did not experience or treat migraine|20|||
130379261|NCT00449540|469356080|FG002|Treatment Phase|did not experience or treat migraine|17|||
130379262|NCT00010374|469356083|FG000|Overall Study|False positive phrenic nerve test|1|||
130379263|NCT01961323|469356084|FG000|Overall Study|Withdrawal by Subject|7|||
130379264|NCT01961323|469356084|FG000|Overall Study|Lost to Follow-up|8|||
130379265|NCT01961323|469356084|FG000|Overall Study|screen failure|34|||
130379266|NCT01881776|469356088|FG000|Overall Study|Lost to Follow-up|1|||
130379267|NCT01881776|469356089|FG001|Overall Study|Lost to Follow-up|2|||
130379268|NCT01881776|469356090|FG002|Overall Study|Lost to Follow-up|1|||
130379269|NCT01881776|469356088|FG000|Overall Study|Protocol Violation|0|||
130379270|NCT01881776|469356089|FG001|Overall Study|Protocol Violation|2|||
130379271|NCT01881776|469356090|FG002|Overall Study|Protocol Violation|1|||
130379272|NCT02393547|469356093|FG000|Overall Study|Adverse Event|2|||
130379273|NCT02393547|469356093|FG000|Overall Study|Withdrawal by Subject|3|||
130379274|NCT02393547|469356093|FG000|Overall Study|Lost to Follow-up|1|||
130379275|NCT02927431|469356094|FG000|Overall Study|Withdrawal by Subject|0|||
130379276|NCT02927431|469356095|FG001|Overall Study|Withdrawal by Subject|0|||
130379277|NCT02927431|469356096|FG002|Overall Study|Withdrawal by Subject|1|||
130379278|NCT01276353|469356097|FG000|Double-blind|Adverse Event|2|||
130379279|NCT01276353|469356098|FG001|Double-blind|Adverse Event|0|||
130379280|NCT01276353|469356097|FG000|Double-blind|Withdrawal by Subject|1|||
130379281|NCT01276353|469356098|FG001|Double-blind|Withdrawal by Subject|0|||
130379282|NCT01276353|469356097|FG000|Extension|Adverse Event|2|||
130379283|NCT01276353|469356098|FG001|Extension|Adverse Event|5|||
130379284|NCT01276353|469356097|FG000|Extension|Withdrawal by Subject|1|||
130379285|NCT01276353|469356098|FG001|Extension|Withdrawal by Subject|2|||
130379286|NCT01276353|469356097|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
130379287|NCT01276353|469356098|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
130379288|NCT01276353|469356097|FG000|Extension|Physician Decision|1|||
130379289|NCT01276353|469356098|FG001|Extension|Physician Decision|0|||
130379290|NCT01276353|469356097|FG000|Extension|Prohibited concomitant medications|0|||
130379291|NCT01276353|469356098|FG001|Extension|Prohibited concomitant medications|1|||
130379292|NCT02205814|469356099|FG000|Overall Study|Lost to Follow-up|0|||
130379293|NCT02205814|469356100|FG001|Overall Study|Lost to Follow-up|0|||
130379294|NCT02205814|469356101|FG002|Overall Study|Lost to Follow-up|0|||
130379295|NCT02205814|469356102|FG003|Overall Study|Lost to Follow-up|1|||
130379296|NCT02205814|469356099|FG000|Overall Study|Lack of Efficacy|1|||
130379297|NCT02205814|469356100|FG001|Overall Study|Lack of Efficacy|0|||
130379298|NCT02205814|469356101|FG002|Overall Study|Lack of Efficacy|1|||
130379299|NCT02205814|469356102|FG003|Overall Study|Lack of Efficacy|1|||
130379300|NCT02205814|469356099|FG000|Overall Study|Physician Decision|0|||
130379301|NCT02205814|469356100|FG001|Overall Study|Physician Decision|0|||
130379302|NCT02205814|469356101|FG002|Overall Study|Physician Decision|1|||
130379303|NCT02205814|469356102|FG003|Overall Study|Physician Decision|0|||
130379304|NCT02205814|469356099|FG000|Overall Study|Protocol Violation|1|||
130379305|NCT02205814|469356100|FG001|Overall Study|Protocol Violation|0|||
130379306|NCT02205814|469356101|FG002|Overall Study|Protocol Violation|0|||
130379307|NCT02205814|469356102|FG003|Overall Study|Protocol Violation|1|||
130379308|NCT02205814|469356099|FG000|Overall Study|Withdrawal by Subject|0|||
130379309|NCT02205814|469356100|FG001|Overall Study|Withdrawal by Subject|1|||
130379310|NCT02205814|469356101|FG002|Overall Study|Withdrawal by Subject|2|||
130379311|NCT02205814|469356102|FG003|Overall Study|Withdrawal by Subject|1|||
130379312|NCT02205814|469356099|FG000|Overall Study|not compliant with study procedures|0|||
130379313|NCT02205814|469356100|FG001|Overall Study|not compliant with study procedures|0|||
130379314|NCT02205814|469356101|FG002|Overall Study|not compliant with study procedures|1|||
130379315|NCT02205814|469356102|FG003|Overall Study|not compliant with study procedures|0|||
130379316|NCT00143403|469356103|FG000|Overall Study|Adverse Event|3|||
130379317|NCT00143403|469356104|FG001|Overall Study|Adverse Event|8|||
130379318|NCT00143403|469356103|FG000|Overall Study|Death|1|||
130379319|NCT00143403|469356104|FG001|Overall Study|Death|0|||
130379320|NCT00143403|469356103|FG000|Overall Study|Withdrawal by Subject|3|||
130379321|NCT00143403|469356104|FG001|Overall Study|Withdrawal by Subject|12|||
130379322|NCT00143403|469356103|FG000|Overall Study|Relapse|15|||
130379323|NCT00143403|469356104|FG001|Overall Study|Relapse|7|||
130379324|NCT00143403|469356103|FG000|Overall Study|Protocol Violation|2|||
130379325|NCT00143403|469356104|FG001|Overall Study|Protocol Violation|2|||
130379326|NCT00143403|469356103|FG000|Overall Study|specified by site|4|||
130379327|NCT00143403|469356104|FG001|Overall Study|specified by site|9|||
130379328|NCT00143403|469356103|FG000|Overall Study|Randomized Not Treated|7|||
130379329|NCT00143403|469356104|FG001|Overall Study|Randomized Not Treated|8|||
130379330|NCT00514540|469356105|FG000|First-Line Chemo|Withdrawal by Subject|1|||
130379331|NCT00514540|469356105|FG000|First-Line Chemo|Protocol Violation|7|||
130379332|NCT00514540|469356105|FG000|Second-Line|Physician/Patient Decision|31|||
130379333|NCT02326025|469356108|FG000|Overall Study|Adverse Event|3|||
130379334|NCT02326025|469356109|FG001|Overall Study|Adverse Event|0|||
130379335|NCT02326025|469356108|FG000|Overall Study|Physician Decision|1|||
130379336|NCT02326025|469356109|FG001|Overall Study|Physician Decision|2|||
130379337|NCT02326025|469356108|FG000|Overall Study|Physician and Participant Decision|1|||
130379338|NCT02326025|469356109|FG001|Overall Study|Physician and Participant Decision|0|||
130379339|NCT02326025|469356108|FG000|Overall Study|Withdrawal by Subject|0|||
130379340|NCT02326025|469356109|FG001|Overall Study|Withdrawal by Subject|2|||
130379341|NCT02326025|469356108|FG000|Overall Study|Protocol Violation|0|||
130379342|NCT02326025|469356109|FG001|Overall Study|Protocol Violation|1|||
130379343|NCT01846611|469356119|FG000|Overall Study|Lost to Follow-up|4|||
130379344|NCT01846611|469356120|FG001|Overall Study|Lost to Follow-up|6|||
130379345|NCT01846611|469356119|FG000|Overall Study|Withdrawal by Subject|15|||
130379346|NCT01846611|469356120|FG001|Overall Study|Withdrawal by Subject|19|||
130379347|NCT01846611|469356119|FG000|Overall Study|Other|19|||
130379348|NCT01846611|469356120|FG001|Overall Study|Other|18|||
130379349|NCT00662363|469356121|FG000|Overall Study|Withdrawal by Subject|6|||
130379350|NCT00662363|469356122|FG001|Overall Study|Withdrawal by Subject|5|||
130379351|NCT00662363|469356121|FG000|Overall Study|Adverse Event|0|||
130379352|NCT00662363|469356122|FG001|Overall Study|Adverse Event|3|||
130379353|NCT00662363|469356121|FG000|Overall Study|Discharged early from rehab|4|||
130379354|NCT00662363|469356122|FG001|Overall Study|Discharged early from rehab|1|||
130379355|NCT00662363|469356121|FG000|Overall Study|Protocol Violation|1|||
130379356|NCT00662363|469356122|FG001|Overall Study|Protocol Violation|1|||
130379357|NCT02744391|469356123|FG000|Overall Study|Lost to Follow-up|9|||
130379358|NCT02744391|469356123|FG000|Overall Study|Physician Decision|2|||
130379359|NCT02744391|469356123|FG000|Overall Study|Withdrawal by Subject|3|||
130379360|NCT01428453|469356124|FG000|Overall Study|Adverse Event|2|||
130379361|NCT01428453|469356125|FG001|Overall Study|Adverse Event|7|||
130379362|NCT01428453|469356124|FG000|Overall Study|Protocol Violation|1|||
130379363|NCT01428453|469356125|FG001|Overall Study|Protocol Violation|0|||
130379364|NCT01428453|469356124|FG000|Overall Study|Lost to Follow-up|0|||
130379365|NCT01428453|469356125|FG001|Overall Study|Lost to Follow-up|1|||
130379366|NCT01428453|469356124|FG000|Overall Study|Withdrawal by Subject|3|||
130379367|NCT01428453|469356125|FG001|Overall Study|Withdrawal by Subject|1|||
130379368|NCT01996709|469356126|FG000|Overall Study|Withdrawal by Subject|1|||
130379369|NCT01996709|469356127|FG001|Overall Study|Withdrawal by Subject|0|||
130379370|NCT01996709|469356126|FG000|Overall Study|Lost to Follow-up|3|||
130379371|NCT01996709|469356127|FG001|Overall Study|Lost to Follow-up|0|||
130379372|NCT01996709|469356126|FG000|Overall Study|Subject Non-Compliant|1|||
130379373|NCT01996709|469356127|FG001|Overall Study|Subject Non-Compliant|0|||
130379374|NCT01996709|469356126|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130379375|NCT01996709|469356127|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
130379376|NCT04405037|469356135|FG000|Overall Study|Withdrawal by Subject|1|||
130379377|NCT04405037|469356136|FG001|Overall Study|Withdrawal by Subject|0|||
130379378|NCT04405037|469356135|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
130379379|NCT04405037|469356136|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
130379380|NCT01134783|469357361|FG000|Overall Study|Pregnancy|16|||
130379381|NCT01134783|469357362|FG001|Overall Study|Pregnancy|8|||
130379382|NCT01134783|469357361|FG000|Overall Study|Withdrawal by Subject|15|||
130379383|NCT01134783|469357362|FG001|Overall Study|Withdrawal by Subject|9|||
130379384|NCT01134783|469357361|FG000|Overall Study|Lost to Follow-up|5|||
130379385|NCT01134783|469357362|FG001|Overall Study|Lost to Follow-up|20|||
130379386|NCT04221009|469357363|FG000|Overall Study|Withdrawal by Subject|4|||
130379387|NCT04232124|469357364|FG000|Overall Study|Lost to Follow-up|3|||
130379388|NCT02329730|469357365|FG000|Overall Study|Protocol Violation|0|||
130379389|NCT02329730|469357366|FG001|Overall Study|Protocol Violation|0|||
130379390|NCT02329730|469357367|FG002|Overall Study|Protocol Violation|0|||
130379391|NCT02329730|469357368|FG003|Overall Study|Protocol Violation|0|||
130379392|NCT02329730|469357369|FG004|Overall Study|Protocol Violation|2|||
130379393|NCT02329730|469357370|FG005|Overall Study|Protocol Violation|2|||
130379394|NCT02329730|469357371|FG006|Overall Study|Protocol Violation|0|||
130379395|NCT02329730|469357372|FG007|Overall Study|Protocol Violation|0|||
130379396|NCT02329730|469357373|FG008|Overall Study|Protocol Violation|0|||
130379397|NCT02329730|469357374|FG009|Overall Study|Protocol Violation|0|||
130379398|NCT02329730|469357375|FG010|Overall Study|Protocol Violation|0|||
130379399|NCT02329730|469357376|FG011|Overall Study|Protocol Violation|0|||
130379400|NCT02329730|469357365|FG000|Overall Study|Withdrawal by Subject|0|||
130379401|NCT02329730|469357366|FG001|Overall Study|Withdrawal by Subject|0|||
130379402|NCT02329730|469357367|FG002|Overall Study|Withdrawal by Subject|0|||
130379403|NCT02329730|469357368|FG003|Overall Study|Withdrawal by Subject|0|||
130379404|NCT02329730|469357369|FG004|Overall Study|Withdrawal by Subject|1|||
130379405|NCT02329730|469357370|FG005|Overall Study|Withdrawal by Subject|0|||
130379406|NCT02329730|469357371|FG006|Overall Study|Withdrawal by Subject|1|||
130379407|NCT02329730|469357372|FG007|Overall Study|Withdrawal by Subject|1|||
130379408|NCT02329730|469357373|FG008|Overall Study|Withdrawal by Subject|1|||
130379409|NCT02329730|469357374|FG009|Overall Study|Withdrawal by Subject|1|||
130379410|NCT02329730|469357375|FG010|Overall Study|Withdrawal by Subject|0|||
130379411|NCT02329730|469357376|FG011|Overall Study|Withdrawal by Subject|0|||
130379412|NCT02392247|469357381|FG000|Overall Study|Withdrawal by Subject|1|||
130379413|NCT02392247|469357381|FG000|Overall Study|Surgery cancelled; no data|1|||
130379414|NCT03010254|469357382|FG000|Overall Study|Adverse Event|0|||
130379415|NCT03010254|469357383|FG001|Overall Study|Adverse Event|1|||
130379416|NCT03010254|469357382|FG000|Overall Study|Lost to Follow-up|4|||
130379417|NCT03010254|469357383|FG001|Overall Study|Lost to Follow-up|0|||
130379418|NCT03010254|469357382|FG000|Overall Study|Withdrawal by Subject|1|||
130379419|NCT03010254|469357383|FG001|Overall Study|Withdrawal by Subject|1|||
130379420|NCT03010254|469357382|FG000|Overall Study|Other|2|||
130379421|NCT03010254|469357383|FG001|Overall Study|Other|3|||
130379422|NCT01404325|469357384|FG000|Overall Study|Lost to Follow-up|1|||
130379423|NCT01404325|469357385|FG001|Overall Study|Lost to Follow-up|0|||
130379424|NCT01404325|469357384|FG000|Overall Study|Death|2|||
130379425|NCT01404325|469357385|FG001|Overall Study|Death|0|||
130379426|NCT01404325|469357384|FG000|Overall Study|Graft loss/Retransplantation|1|||
130379427|NCT01404325|469357385|FG001|Overall Study|Graft loss/Retransplantation|0|||
130379428|NCT01404325|469357384|FG000|Overall Study|non-specified reason|0|||
130379429|NCT01404325|469357385|FG001|Overall Study|non-specified reason|2|||
130379430|NCT03312933|469357391|FG000|Overall Study|Protocol Violation|15|||
130379431|NCT03312933|469357391|FG000|Overall Study|Lost to Follow-up|36|||
130379432|NCT03312933|469357391|FG000|Overall Study|Withdrawal by Subject|3|||
130379433|NCT00224055|469357397|FG000|Overall Study|Adverse Event|9|||
130379434|NCT00224055|469357398|FG001|Overall Study|Adverse Event|3|||
130379435|NCT00224055|469357397|FG000|Overall Study|Lost to Follow-up|1|||
130379436|NCT00224055|469357398|FG001|Overall Study|Lost to Follow-up|2|||
130379437|NCT00224055|469357397|FG000|Overall Study|Protocol Violation|1|||
130379438|NCT00224055|469357398|FG001|Overall Study|Protocol Violation|1|||
130379439|NCT00224055|469357397|FG000|Overall Study|Inclusion Violation|3|||
130379440|NCT00224055|469357398|FG001|Overall Study|Inclusion Violation|6|||
130379441|NCT00224055|469357397|FG000|Overall Study|Withdrawal by Subject|0|||
130379442|NCT00224055|469357398|FG001|Overall Study|Withdrawal by Subject|2|||
130379443|NCT00224055|469357397|FG000|Overall Study|Other|1|||
130379444|NCT00224055|469357398|FG001|Overall Study|Other|0|||
130379445|NCT02068443|469357399|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130379446|NCT02068443|469357400|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
130379447|NCT02068443|469357401|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
130379448|NCT02068443|469357399|FG000|Overall Study|Voluntary Withdrawal|4|||
130379449|NCT02068443|469357400|FG001|Overall Study|Voluntary Withdrawal|0|||
130379450|NCT02068443|469357401|FG002|Overall Study|Voluntary Withdrawal|1|||
130379451|NCT02068443|469357399|FG000|Overall Study|Lack of Efficacy|2|||
130379452|NCT02068443|469357400|FG001|Overall Study|Lack of Efficacy|1|||
130379453|NCT02068443|469357401|FG002|Overall Study|Lack of Efficacy|0|||
130379454|NCT02068443|469357399|FG000|Overall Study|Other Reason Not Specified|1|||
130379455|NCT02068443|469357400|FG001|Overall Study|Other Reason Not Specified|0|||
130379456|NCT02068443|469357401|FG002|Overall Study|Other Reason Not Specified|0|||
130379457|NCT01986855|469357402|FG000|Overall Study|Adverse Event|1|||
130379458|NCT01986855|469357403|FG001|Overall Study|Adverse Event|0|||
130379459|NCT01986855|469357404|FG002|Overall Study|Adverse Event|0|||
130379460|NCT01986855|469357402|FG000|Overall Study|Death|3|||
130379461|NCT01986855|469357403|FG001|Overall Study|Death|4|||
130467406|NCT02723955|469678940|FG041|Escalation Phase|Withdrawal by Subject|0|||
130467407|NCT02723955|469678941|FG042|Escalation Phase|Withdrawal by Subject|0|||
130467408|NCT02723955|469678899|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467409|NCT02723955|469678900|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467410|NCT02723955|469678901|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467411|NCT02723955|469678902|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467412|NCT02723955|469678903|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
130467413|NCT02723955|469678904|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
130722070|NCT03395405|470608146|FG001|Overall Study|COVID-19 Pandemic|0|||
130379462|NCT01986855|469357404|FG002|Overall Study|Death|4|||
130379463|NCT01986855|469357402|FG000|Overall Study|Lost to Follow-up|2|||
130379464|NCT01986855|469357403|FG001|Overall Study|Lost to Follow-up|1|||
130379465|NCT01986855|469357404|FG002|Overall Study|Lost to Follow-up|0|||
130379466|NCT01986855|469357402|FG000|Overall Study|Screen Failure|0|||
130379467|NCT01986855|469357403|FG001|Overall Study|Screen Failure|1|||
130379468|NCT01986855|469357404|FG002|Overall Study|Screen Failure|0|||
130379469|NCT01986855|469357402|FG000|Overall Study|Participant Moved|0|||
130379470|NCT01986855|469357403|FG001|Overall Study|Participant Moved|0|||
130379471|NCT01986855|469357404|FG002|Overall Study|Participant Moved|2|||
130379472|NCT01986855|469357402|FG000|Overall Study|Withdrawal by Subject|7|||
130379473|NCT01986855|469357403|FG001|Overall Study|Withdrawal by Subject|8|||
130379474|NCT01986855|469357404|FG002|Overall Study|Withdrawal by Subject|5|||
130379475|NCT00664742|469357405|FG000|Overall Study|Withdrawn due to adverse events|3|||
130379476|NCT00664742|469357405|FG000|Overall Study|Withdrawal by Subject|31|||
130379477|NCT00664742|469357405|FG000|Overall Study|Lost to Follow-up|92|||
130379478|NCT04317066|469357406|FG000|Overall Study|Sponsor decision|5|||
130379479|NCT04317066|469357406|FG000|Overall Study|Death|2|||
130379480|NCT00848081|469357409|FG000|Overall Study|Adverse Event|6|||
130379481|NCT00848081|469357410|FG001|Overall Study|Adverse Event|7|||
130379482|NCT00848081|469357409|FG000|Overall Study|Protocol Violation|8|||
130379483|NCT00848081|469357410|FG001|Overall Study|Protocol Violation|5|||
130379484|NCT00848081|469357409|FG000|Overall Study|Lost to Follow-up|1|||
130379485|NCT00848081|469357410|FG001|Overall Study|Lost to Follow-up|0|||
130379486|NCT00848081|469357409|FG000|Overall Study|Physician Decision|0|||
130379487|NCT00848081|469357410|FG001|Overall Study|Physician Decision|3|||
130379488|NCT00848081|469357409|FG000|Overall Study|Withdrawal by Subject|5|||
130379489|NCT00848081|469357410|FG001|Overall Study|Withdrawal by Subject|3|||
130379490|NCT02014597|469357411|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
130379491|NCT02014597|469357412|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
130379492|NCT02825992|469357413|FG000|Overall Study|Withdrawal by Subject|4|||
130379493|NCT02825992|469357413|FG000|Overall Study|Lost to Follow-up|2|||
130379494|NCT02825992|469357413|FG000|Overall Study|Procedure terminated|2|||
130379495|NCT00754624|469357414|FG000|Overall Study|Adverse Event|16|||
130379496|NCT00754624|469357414|FG000|Overall Study|Death|1|||
130379497|NCT00754624|469357414|FG000|Overall Study|Physician Decision|8|||
130379498|NCT00754624|469357414|FG000|Overall Study|Protocol Violation|1|||
130379499|NCT00754624|469357414|FG000|Overall Study|Withdrawal by Subject|28|||
130379500|NCT00754624|469357414|FG000|Overall Study|Various|12|||
130379501|NCT00754624|469357414|FG000|Overall Study|Lost to Follow-up|3|||
130379502|NCT00715078|469357417|FG000|Overall Study|Death|29|||
130379503|NCT00715078|469357418|FG001|Overall Study|Death|36|||
130379504|NCT00715078|469357419|FG002|Overall Study|Death|36|||
130379505|NCT00715078|469357417|FG000|Overall Study|Withdrawal by Subject|1|||
130379506|NCT00715078|469357418|FG001|Overall Study|Withdrawal by Subject|0|||
130379507|NCT00715078|469357419|FG002|Overall Study|Withdrawal by Subject|1|||
130379508|NCT00715078|469357417|FG000|Overall Study|Unable to start due to disease prog.|0|||
130379509|NCT00715078|469357418|FG001|Overall Study|Unable to start due to disease prog.|0|||
130379510|NCT00715078|469357419|FG002|Overall Study|Unable to start due to disease prog.|1|||
130379511|NCT02618434|469357421|FG000|Overall Study|Withdrawal by Subject|0|||
130379512|NCT02618434|469357422|FG001|Overall Study|Withdrawal by Subject|2|||
130379513|NCT02618434|469357423|FG002|Overall Study|Withdrawal by Subject|3|||
130379514|NCT02618434|469357421|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
130379515|NCT02618434|469357422|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130379516|NCT02618434|469357423|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
130379517|NCT02618434|469357421|FG000|Overall Study|Lost to Follow-up|3|||
130379518|NCT02618434|469357422|FG001|Overall Study|Lost to Follow-up|1|||
130379519|NCT02618434|469357423|FG002|Overall Study|Lost to Follow-up|3|||
130379520|NCT02618434|469357421|FG000|Overall Study|Adverse Event|1|||
130379521|NCT02618434|469357422|FG001|Overall Study|Adverse Event|0|||
130379522|NCT02618434|469357423|FG002|Overall Study|Adverse Event|12|||
130379523|NCT02618434|469357421|FG000|Overall Study|Physician Decision|0|||
130379524|NCT02618434|469357422|FG001|Overall Study|Physician Decision|1|||
130379525|NCT02618434|469357423|FG002|Overall Study|Physician Decision|0|||
130379526|NCT02618434|469357421|FG000|Overall Study|Protocol Violation|0|||
130379527|NCT02618434|469357422|FG001|Overall Study|Protocol Violation|0|||
130379528|NCT02618434|469357423|FG002|Overall Study|Protocol Violation|1|||
130379529|NCT02618434|469357421|FG000|Overall Study|Other, Multiple categories|1|||
130379530|NCT02618434|469357422|FG001|Overall Study|Other, Multiple categories|1|||
130379531|NCT02618434|469357423|FG002|Overall Study|Other, Multiple categories|1|||
130379532|NCT01402544|469357424|FG000|Overall Study|Withdrawal by Subject|6|||
130379533|NCT00142584|469357425|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
130379534|NCT00142584|469357426|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
130379535|NCT00142584|469357425|FG000|Overall Study|Withdrawal by Subject|30|||
130379536|NCT00142584|469357426|FG001|Overall Study|Withdrawal by Subject|16|||
130379537|NCT00142584|469357425|FG000|Overall Study|Lost to Follow-up|22|||
130467414|NCT02723955|469678905|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
130467415|NCT02723955|469678906|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
130467416|NCT02723955|469678907|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
130379538|NCT00142584|469357426|FG001|Overall Study|Lost to Follow-up|12|||
130379539|NCT00142584|469357425|FG000|Overall Study|Adverse Event|14|||
130379540|NCT00142584|469357426|FG001|Overall Study|Adverse Event|5|||
130379541|NCT00142584|469357425|FG000|Overall Study|Protocol Violation|4|||
130379542|NCT00142584|469357426|FG001|Overall Study|Protocol Violation|7|||
130379543|NCT00142584|469357425|FG000|Overall Study|Treatment Failure|2|||
130379544|NCT00142584|469357426|FG001|Overall Study|Treatment Failure|0|||
130379545|NCT02709785|469357428|FG000|Overall Study|Withdrawal by Subject|1|||
130379546|NCT02709785|469357429|FG001|Overall Study|Withdrawal by Subject|2|||
130379547|NCT02709785|469357430|FG002|Overall Study|Withdrawal by Subject|1|||
130379548|NCT00276159|469357433|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
130379549|NCT00333866|469357434|FG000|Overall Study|Adverse Event|23|||
130379550|NCT00333866|469357435|FG001|Overall Study|Adverse Event|37|||
130379551|NCT00333866|469357436|FG002|Overall Study|Adverse Event|38|||
130379552|NCT00333866|469357437|FG003|Overall Study|Adverse Event|47|||
130379553|NCT00333866|469357434|FG000|Overall Study|Other|3|||
130379554|NCT00333866|469357435|FG001|Overall Study|Other|2|||
130379555|NCT00333866|469357436|FG002|Overall Study|Other|2|||
130379556|NCT00333866|469357437|FG003|Overall Study|Other|2|||
130379557|NCT00333866|469357434|FG000|Overall Study|Lack of Efficacy|8|||
130379558|NCT00333866|469357435|FG001|Overall Study|Lack of Efficacy|6|||
130379559|NCT00333866|469357436|FG002|Overall Study|Lack of Efficacy|3|||
130379560|NCT00333866|469357437|FG003|Overall Study|Lack of Efficacy|5|||
130379561|NCT00333866|469357434|FG000|Overall Study|Lost to Follow-up|1|||
130379562|NCT00333866|469357435|FG001|Overall Study|Lost to Follow-up|2|||
130379563|NCT00333866|469357436|FG002|Overall Study|Lost to Follow-up|2|||
130379564|NCT00333866|469357437|FG003|Overall Study|Lost to Follow-up|2|||
130379565|NCT00333866|469357434|FG000|Overall Study|Withdrawal by Subject|8|||
130379566|NCT00333866|469357435|FG001|Overall Study|Withdrawal by Subject|14|||
130379567|NCT00333866|469357436|FG002|Overall Study|Withdrawal by Subject|4|||
130379568|NCT00333866|469357437|FG003|Overall Study|Withdrawal by Subject|9|||
130379569|NCT00333866|469357434|FG000|Overall Study|Randomized but not Treated|5|||
130379570|NCT00333866|469357435|FG001|Overall Study|Randomized but not Treated|3|||
130379571|NCT00333866|469357436|FG002|Overall Study|Randomized but not Treated|2|||
130379572|NCT00333866|469357437|FG003|Overall Study|Randomized but not Treated|1|||
130379573|NCT00673465|469357443|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379574|NCT00673465|469357444|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379575|NCT00673465|469357445|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379576|NCT00673465|469357446|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379577|NCT00673465|469357447|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
130379578|NCT00673465|469357448|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
130379579|NCT00673465|469357449|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379580|NCT00673465|469357450|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379581|NCT00673465|469357451|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379582|NCT00673465|469357452|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379583|NCT00673465|469357453|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379584|NCT00673465|469357454|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
130379585|NCT00673465|469357443|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379586|NCT00673465|469357444|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379587|NCT00673465|469357445|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379588|NCT00673465|469357446|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379589|NCT00673465|469357447|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
130379590|NCT00673465|469357448|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379591|NCT00673465|469357449|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379592|NCT00673465|469357450|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379593|NCT00673465|469357451|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
130467417|NCT02723955|469678908|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467418|NCT02723955|469678909|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467419|NCT02723955|469678910|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467420|NCT02723955|469678911|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467421|NCT02723955|469678912|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467422|NCT02723955|469678913|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467423|NCT02723955|469678914|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467424|NCT02723955|469678915|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130559595|NCT01338415|470017822|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
130379594|NCT00673465|469357452|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379595|NCT00673465|469357453|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379596|NCT00673465|469357454|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
130379597|NCT00429104|469357455|FG000|Overall Study|Protocol Violation|1|||
130379598|NCT01829191|469357456|FG000|Overall Study|Relocation|0|||
130379599|NCT01829191|469357457|FG001|Overall Study|Relocation|1|||
130722071|NCT04345601|470608147|FG000|Overall Study|Death|0|||
130722072|NCT04345601|470608148|FG001|Overall Study|Death|3|||
130722073|NCT04345601|470608149|FG002|Overall Study|Death|2|||
130722074|NCT04345601|470608147|FG000|Overall Study|Lost to Follow-up|0|||
130722075|NCT04345601|470608148|FG001|Overall Study|Lost to Follow-up|0|||
130379600|NCT01829191|469357456|FG000|Overall Study|Lens discomfort|0|||
130379601|NCT01829191|469357457|FG001|Overall Study|Lens discomfort|3|||
130379602|NCT01829191|469357456|FG000|Overall Study|Lens handling difficulty|1|||
130379603|NCT01829191|469357457|FG001|Overall Study|Lens handling difficulty|4|||
130379604|NCT01829191|469357456|FG000|Overall Study|Protocol Violation|4|||
130379605|NCT01829191|469357457|FG001|Overall Study|Protocol Violation|1|||
130379606|NCT01829191|469357456|FG000|Overall Study|Withdrawal by Subject|2|||
130379607|NCT01829191|469357457|FG001|Overall Study|Withdrawal by Subject|3|||
130379608|NCT01829191|469357456|FG000|Overall Study|Lost to Follow-up|0|||
130379609|NCT01829191|469357457|FG001|Overall Study|Lost to Follow-up|1|||
130379610|NCT01829191|469357456|FG000|Overall Study|Subject was fit for ortho - k|0|||
130379611|NCT01829191|469357457|FG001|Overall Study|Subject was fit for ortho - k|1|||
130379612|NCT01907815|469357458|FG000|Overall Study|Withdrawal by Subject|1|||
130379613|NCT01907815|469357459|FG001|Overall Study|Withdrawal by Subject|0|||
130379614|NCT00587639|469357460|FG000|Overall Study|Withdrawal by Subject|1|||
130379615|NCT01996982|469357461|FG000|Overall Study|PI/team left institution|7|||
130379616|NCT01195415|469357462|FG000|Overall Study|No repeat biopsy due to progression|2|||
130379617|NCT00533845|469357463|FG000|Overall Study|Physician Decision|1|||
130379618|NCT00533845|469357464|FG001|Overall Study|Physician Decision|0|||
130379619|NCT01288469|469357470|FG000|Overall Study|Adverse Event|4|||
130379620|NCT01288469|469357471|FG001|Overall Study|Adverse Event|1|||
130379621|NCT01288469|469357472|FG002|Overall Study|Adverse Event|1|||
130379622|NCT01288469|469357470|FG000|Overall Study|Poor compliance to protocol|0|||
130379623|NCT01288469|469357471|FG001|Overall Study|Poor compliance to protocol|1|||
130379624|NCT01288469|469357472|FG002|Overall Study|Poor compliance to protocol|0|||
130379625|NCT01288469|469357470|FG000|Overall Study|Participant Moved|1|||
130379626|NCT01288469|469357471|FG001|Overall Study|Participant Moved|0|||
130379627|NCT01288469|469357472|FG002|Overall Study|Participant Moved|0|||
130379628|NCT01288469|469357470|FG000|Overall Study|Consent withdrawn by subject|1|||
130379629|NCT01288469|469357471|FG001|Overall Study|Consent withdrawn by subject|1|||
130379630|NCT01288469|469357472|FG002|Overall Study|Consent withdrawn by subject|1|||
130379631|NCT01288469|469357470|FG000|Overall Study|Exclusion criteria finally met|1|||
130379632|NCT01288469|469357471|FG001|Overall Study|Exclusion criteria finally met|0|||
130379633|NCT01288469|469357472|FG002|Overall Study|Exclusion criteria finally met|0|||
130379634|NCT00563381|469357473|FG000|Overall Study|Adverse Event|264|||
130379635|NCT00563381|469357474|FG001|Overall Study|Adverse Event|292|||
130379636|NCT00563381|469357473|FG000|Overall Study|Protocol Violation|66|||
130379637|NCT00563381|469357474|FG001|Overall Study|Protocol Violation|74|||
130379638|NCT00563381|469357473|FG000|Overall Study|Lost to Follow-up|7|||
130379639|NCT00563381|469357474|FG001|Overall Study|Lost to Follow-up|15|||
130379640|NCT00563381|469357473|FG000|Overall Study|Withdrawal by Subject|192|||
130379641|NCT00563381|469357474|FG001|Overall Study|Withdrawal by Subject|209|||
130379642|NCT00563381|469357473|FG000|Overall Study|Lack of Efficacy|32|||
130379643|NCT00563381|469357474|FG001|Overall Study|Lack of Efficacy|24|||
130379644|NCT00563381|469357473|FG000|Overall Study|Individual different reasons|24|||
130379645|NCT00563381|469357474|FG001|Overall Study|Individual different reasons|34|||
130379646|NCT00110149|469357475|FG000|Overall Study|Physician Decision|3|||
130379647|NCT02452398|469357478|FG000|Overall Study|Adverse Event|1|||
130379648|NCT02452398|469357478|FG000|Overall Study|Lost to Follow-up|28|||
130379649|NCT02452398|469357478|FG000|Overall Study|Physician Decision|2|||
130379650|NCT02452398|469357478|FG000|Overall Study|Withdrawal by Subject|6|||
130379651|NCT02452398|469357478|FG000|Overall Study|Moved away|4|||
130379652|NCT00001723|469357482|FG000|Overall Study|Lack of Efficacy|6|||
130379653|NCT00001723|469357483|FG001|Overall Study|Lack of Efficacy|7|||
130379654|NCT00001723|469357482|FG000|Overall Study|Lack of family interest|4|||
130379655|NCT00001723|469357483|FG001|Overall Study|Lack of family interest|5|||
130379656|NCT00001723|469357482|FG000|Overall Study|Lost to Follow-up|2|||
130379657|NCT00001723|469357483|FG001|Overall Study|Lost to Follow-up|2|||
130379658|NCT00001723|469357482|FG000|Overall Study|medication intolerance|1|||
130379659|NCT00001723|469357483|FG001|Overall Study|medication intolerance|2|||
130379660|NCT00927784|469357484|FG000|Overall Study|Death|1|||
130379661|NCT00927784|469357485|FG001|Overall Study|Death|0|||
130379662|NCT00927784|469357484|FG000|Overall Study|Withdrawal by Subject|1|||
130379663|NCT00927784|469357485|FG001|Overall Study|Withdrawal by Subject|0|||
130379664|NCT02170051|469357486|FG000|Overall Study|Withdrawal by Subject|10|||
130722076|NCT04345601|470608149|FG002|Overall Study|Lost to Follow-up|2|||
130722077|NCT00000378|470608150|FG000|Overall Study|Lack of Efficacy|16|||
130379665|NCT02170051|469357487|FG001|Overall Study|Withdrawal by Subject|10|||
130379666|NCT02170051|469357486|FG000|Overall Study|Lost to Follow-up|1|||
130379667|NCT02170051|469357487|FG001|Overall Study|Lost to Follow-up|3|||
130379668|NCT02643082|469357488|FG000|Period 1|Adverse Event|1|||
130722078|NCT00000378|470608151|FG001|Overall Study|Lack of Efficacy|14|||
130379669|NCT02643082|469357489|FG001|Period 1|Adverse Event|0|||
130379670|NCT01867021|469357490|FG000|Overall Study|Adverse Event|0|||
130379671|NCT01867021|469357491|FG001|Overall Study|Adverse Event|1|||
130379672|NCT01867021|469357490|FG000|Overall Study|Not Eligible|0|||
130379673|NCT01867021|469357491|FG001|Overall Study|Not Eligible|1|||
130379674|NCT01867021|469357490|FG000|Overall Study|Death|1|||
130379675|NCT01867021|469357491|FG001|Overall Study|Death|0|||
130379676|NCT01867021|469357490|FG000|Overall Study|Lost to Follow-up|0|||
130379677|NCT01867021|469357491|FG001|Overall Study|Lost to Follow-up|2|||
130379678|NCT01867021|469357490|FG000|Overall Study|Withdrawal by Subject|1|||
130379679|NCT01867021|469357491|FG001|Overall Study|Withdrawal by Subject|6|||
130379680|NCT00881712|469357492|FG000|Overall Study|Death|1|||
130379681|NCT00881712|469357493|FG001|Overall Study|Death|0|||
130379682|NCT00881712|469357494|FG002|Overall Study|Death|0|||
130379683|NCT00881712|469357492|FG000|Overall Study|Withdrawal by Subject|1|||
130379684|NCT00881712|469357493|FG001|Overall Study|Withdrawal by Subject|0|||
130379685|NCT00881712|469357494|FG002|Overall Study|Withdrawal by Subject|0|||
130379686|NCT02505867|469357497|FG000|Overall Study|Lack of Efficacy|6|||
130379687|NCT02505867|469357498|FG001|Overall Study|Lack of Efficacy|6|||
130379688|NCT01862874|469357499|FG000|Overall Study|Randomized not treated|1|||
130379689|NCT01862874|469357500|FG001|Overall Study|Randomized not treated|0|||
130379690|NCT01862874|469357499|FG000|Overall Study|Adverse Event|0|||
130379691|NCT01862874|469357500|FG001|Overall Study|Adverse Event|3|||
130379692|NCT01862874|469357499|FG000|Overall Study|Lost to Follow-up|26|||
130379693|NCT01862874|469357500|FG001|Overall Study|Lost to Follow-up|29|||
130379694|NCT01862874|469357499|FG000|Overall Study|Physician Decision|5|||
130379695|NCT01862874|469357500|FG001|Overall Study|Physician Decision|3|||
130379696|NCT01862874|469357499|FG000|Overall Study|Withdrawn by parent/guardian|1|||
130379697|NCT01862874|469357500|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130379698|NCT01862874|469357499|FG000|Overall Study|Withdrawal by Subject|46|||
130379699|NCT01862874|469357500|FG001|Overall Study|Withdrawal by Subject|40|||
130379700|NCT01862874|469357499|FG000|Overall Study|Death|0|||
130379701|NCT01862874|469357500|FG001|Overall Study|Death|1|||
130379702|NCT02260921|469357501|FG000|Overall Study|Adverse Event|1|||
130379703|NCT02260921|469357502|FG001|Overall Study|Adverse Event|0|||
130379704|NCT02260921|469357501|FG000|Overall Study|Lost to Follow-up|4|||
130379705|NCT02260921|469357502|FG001|Overall Study|Lost to Follow-up|3|||
130379706|NCT02260921|469357501|FG000|Overall Study|Withdraw Consent|4|||
130379707|NCT02260921|469357502|FG001|Overall Study|Withdraw Consent|1|||
130379708|NCT02260921|469357501|FG000|Overall Study|Death|1|||
130379709|NCT02260921|469357502|FG001|Overall Study|Death|0|||
130379710|NCT02260921|469357501|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
130379711|NCT02260921|469357502|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
130379712|NCT03241342|469357507|FG000|Overall Study|Adverse Event|5|||
130379713|NCT03241342|469357508|FG001|Overall Study|Adverse Event|8|||
130379714|NCT03241342|469357509|FG002|Overall Study|Adverse Event|4|||
130379715|NCT03241342|469357507|FG000|Overall Study|Lack of Efficacy|0|||
130379716|NCT03241342|469357508|FG001|Overall Study|Lack of Efficacy|0|||
130379717|NCT03241342|469357509|FG002|Overall Study|Lack of Efficacy|1|||
130379718|NCT03241342|469357507|FG000|Overall Study|noncompliance with study drug|2|||
130379719|NCT03241342|469357508|FG001|Overall Study|noncompliance with study drug|1|||
130379720|NCT03241342|469357509|FG002|Overall Study|noncompliance with study drug|1|||
130379721|NCT03241342|469357507|FG000|Overall Study|sponsor decision|0|||
130379722|NCT03241342|469357508|FG001|Overall Study|sponsor decision|1|||
130379723|NCT03241342|469357509|FG002|Overall Study|sponsor decision|2|||
130379724|NCT03241342|469357507|FG000|Overall Study|not reported|15|||
130379725|NCT03241342|469357508|FG001|Overall Study|not reported|21|||
130379726|NCT03241342|469357509|FG002|Overall Study|not reported|19|||
130379727|NCT02279173|469359383|FG000|Overall Study|Protocol-specified Criteria|67|||
130379728|NCT02279173|469359383|FG000|Overall Study|Withdrawal by Subject|20|||
130379729|NCT02279173|469359383|FG000|Overall Study|Decision by Sponsor|4|||
130379730|NCT02279173|469359383|FG000|Overall Study|Lost to Follow-up|3|||
130379731|NCT00157950|469359384|FG000|Overall Study|Death|1|||
130722079|NCT02448706|470608156|FG000|Overall Study|Withdrawal by Subject|4|||
130379732|NCT00157950|469359385|FG001|Overall Study|Death|0|||
130379733|NCT00386776|469359390|FG000|Overall Study|Withdrawal by Subject|8|||
130722080|NCT02448706|470608157|FG001|Overall Study|Withdrawal by Subject|3|||
130722081|NCT02448706|470608156|FG000|Overall Study|Protocol Violation|1|||
130722082|NCT02448706|470608157|FG001|Overall Study|Protocol Violation|1|||
130379734|NCT01500629|469359391|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
130379735|NCT01500629|469359392|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
130379736|NCT00588848|469359393|FG000|Overall Study|Physician Decision|0|||
130379737|NCT00588848|469359394|FG001|Overall Study|Physician Decision|3|||
130379738|NCT01499667|469359395|FG000|Overall Study|administrative problems|4|||
130379739|NCT01499667|469359396|FG001|Overall Study|administrative problems|5|||
130379740|NCT01499667|469359397|FG002|Overall Study|administrative problems|5|||
130379741|NCT01499667|469359395|FG000|Overall Study|Protocol Violation|1|||
130379742|NCT01499667|469359396|FG001|Overall Study|Protocol Violation|3|||
130379743|NCT01499667|469359397|FG002|Overall Study|Protocol Violation|2|||
130379744|NCT01499667|469359395|FG000|Overall Study|Adverse Event|0|||
130379745|NCT01499667|469359396|FG001|Overall Study|Adverse Event|2|||
130379746|NCT01499667|469359397|FG002|Overall Study|Adverse Event|2|||
130379747|NCT01499667|469359395|FG000|Overall Study|Withdrawal by Subject|2|||
130379748|NCT01499667|469359396|FG001|Overall Study|Withdrawal by Subject|1|||
130379749|NCT01499667|469359397|FG002|Overall Study|Withdrawal by Subject|1|||
130379750|NCT01499667|469359395|FG000|Overall Study|Lack of Efficacy|2|||
130379751|NCT01499667|469359396|FG001|Overall Study|Lack of Efficacy|0|||
130379752|NCT01499667|469359397|FG002|Overall Study|Lack of Efficacy|0|||
130379753|NCT02902965|469359398|FG000|Overall Study|Withdrawal by Subject|10|||
130379754|NCT02673489|469359399|FG000|Treatment Period|Lost to Follow-up|3|||
130379755|NCT02673489|469359400|FG001|Treatment Period|Lost to Follow-up|0|||
130379756|NCT02673489|469359399|FG000|Treatment Period|Participant request to discontinue|1|||
130379757|NCT02673489|469359400|FG001|Treatment Period|Participant request to discontinue|1|||
130379758|NCT02673489|469359399|FG000|Treatment Period|Participant moved to another province|1|||
130379759|NCT02673489|469359400|FG001|Treatment Period|Participant moved to another province|0|||
130379760|NCT02673489|469359399|FG000|Treatment Period|Participant was incarcerated|0|||
130379761|NCT02673489|469359400|FG001|Treatment Period|Participant was incarcerated|1|||
130379762|NCT02673489|469359399|FG000|Treatment Period|Adverse Event|0|||
130379763|NCT02673489|469359400|FG001|Treatment Period|Adverse Event|1|||
130379764|NCT02673489|469359399|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
130379765|NCT02673489|469359400|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
130379766|NCT02673489|469359399|FG000|Follow Up Period|Unable to return for follow-up|0|||
130379767|NCT02673489|469359400|FG001|Follow Up Period|Unable to return for follow-up|1|||
130379768|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
130379769|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
130379770|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
130379771|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130379772|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
130379773|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
130379774|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130379775|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130379776|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
130379777|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
130379778|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
130379779|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130379780|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
130379781|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
130379782|NCT00293254|469359401|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
130379783|NCT00293254|469359402|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
130379784|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
130379785|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
130379786|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Death|4|||
130379787|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Death|1|||
130379788|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
130379789|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
130379790|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
130379791|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
130379792|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
130379793|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
130379794|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
130379795|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
130379796|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
130379797|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
130379798|NCT00293254|469359401|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
130379799|NCT00293254|469359402|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
130379800|NCT00293254|469359401|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
130379801|NCT00293254|469359402|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
130379802|NCT00293254|469359401|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
130379803|NCT00293254|469359402|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
130379804|NCT00293254|469359401|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
130379805|NCT00293254|469359402|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
130379806|NCT00293254|469359401|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
130379807|NCT00293254|469359402|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
130379808|NCT00293254|469359401|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
130379809|NCT00293254|469359402|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
130379810|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
130379811|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
130379812|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
130379813|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
130379814|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
130379815|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
130379816|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
130379817|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
130379818|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
130379819|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
130379820|NCT00293254|469359401|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
130379821|NCT00293254|469359402|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
130379822|NCT02335489|469359403|FG000|Overall Study|Sponsor terminated study|4|||
130379823|NCT02335489|469359403|FG000|Overall Study|Lost to Follow-up|1|||
130379824|NCT02335489|469359403|FG000|Overall Study|Withdrawal by Subject|2|||
130379825|NCT02335489|469359403|FG000|Overall Study|Physician Decision|2|||
130379826|NCT02335489|469359403|FG000|Overall Study|Lack of Efficacy|1|||
130379827|NCT00503308|469359404|FG000|Overall Study|Protocol Violation|2|||
130379828|NCT00503308|469359405|FG001|Overall Study|Protocol Violation|1|||
130379829|NCT02233309|469359407|FG000|Overall Study|Physician Decision|5|||
130379830|NCT00232817|469359408|FG000|Overall Study|Protocol Violation|2|||
130379831|NCT00232817|469359409|FG001|Overall Study|Protocol Violation|1|||
130379832|NCT00799487|469359410|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
130379833|NCT00799487|469359411|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
130379834|NCT00799487|469359412|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
130379835|NCT00799487|469359410|FG000|Dose Adjustment Period|Adverse Event|2|||
130379836|NCT00799487|469359411|FG001|Dose Adjustment Period|Adverse Event|0|||
130379837|NCT00799487|469359412|FG002|Dose Adjustment Period|Adverse Event|0|||
130379838|NCT00799487|469359410|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
130379839|NCT00799487|469359411|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
130379840|NCT00799487|469359412|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
130379841|NCT00799487|469359410|FG000|Dose Adjustment Period|Investigator Discretion|2|||
130379842|NCT00799487|469359411|FG001|Dose Adjustment Period|Investigator Discretion|0|||
130379843|NCT00799487|469359412|FG002|Dose Adjustment Period|Investigator Discretion|0|||
130379844|NCT00799487|469359410|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
130379845|NCT00799487|469359411|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
130379846|NCT00799487|469359412|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
130379847|NCT00799487|469359410|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
130379848|NCT00799487|469359411|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
130379849|NCT00799487|469359412|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
130379850|NCT00799487|469359410|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
130467425|NCT02723955|469678916|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467426|NCT02723955|469678917|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467427|NCT02723955|469678918|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467428|NCT02723955|469678919|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467429|NCT02723955|469678920|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467430|NCT02723955|469678921|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467431|NCT02723955|469678922|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467432|NCT02723955|469678923|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467433|NCT02723955|469678924|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467434|NCT02723955|469678925|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467435|NCT02723955|469678926|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467436|NCT02723955|469678927|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467437|NCT02723955|469678928|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467438|NCT02723955|469678929|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467439|NCT02723955|469678930|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130648281|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648282|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648283|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
130648284|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648285|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130379851|NCT00799487|469359411|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
130648286|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130379852|NCT00799487|469359412|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
130379853|NCT00799487|469359410|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
130379854|NCT00799487|469359411|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
130467440|NCT02723955|469678931|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467441|NCT02723955|469678932|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467442|NCT02723955|469678933|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467443|NCT02723955|469678934|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467444|NCT02723955|469678935|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467445|NCT02723955|469678936|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467446|NCT02723955|469678937|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467447|NCT02723955|469678938|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467448|NCT02723955|469678939|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467449|NCT02723955|469678940|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467450|NCT02723955|469678941|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130467451|NCT02723955|469678899|FG000|Escalation Phase|Site Closed|0|||
130467452|NCT02723955|469678900|FG001|Escalation Phase|Site Closed|0|||
130467453|NCT02723955|469678901|FG002|Escalation Phase|Site Closed|0|||
130467454|NCT02723955|469678902|FG003|Escalation Phase|Site Closed|0|||
130467455|NCT02723955|469678903|FG004|Escalation Phase|Site Closed|0|||
130467456|NCT02723955|469678904|FG005|Escalation Phase|Site Closed|0|||
130467457|NCT02723955|469678905|FG006|Escalation Phase|Site Closed|0|||
130467458|NCT02723955|469678906|FG007|Escalation Phase|Site Closed|0|||
130467459|NCT02723955|469678907|FG008|Escalation Phase|Site Closed|0|||
130467460|NCT02723955|469678908|FG009|Escalation Phase|Site Closed|0|||
130467461|NCT02723955|469678909|FG010|Escalation Phase|Site Closed|0|||
130467462|NCT02723955|469678910|FG011|Escalation Phase|Site Closed|0|||
130467463|NCT02723955|469678911|FG012|Escalation Phase|Site Closed|0|||
130467464|NCT02723955|469678912|FG013|Escalation Phase|Site Closed|0|||
130467465|NCT02723955|469678913|FG014|Escalation Phase|Site Closed|0|||
130467466|NCT02723955|469678914|FG015|Escalation Phase|Site Closed|1|||
130467467|NCT02723955|469678915|FG016|Escalation Phase|Site Closed|0|||
130467468|NCT02723955|469678916|FG017|Escalation Phase|Site Closed|2|||
130467469|NCT02723955|469678917|FG018|Escalation Phase|Site Closed|0|||
130467470|NCT02723955|469678918|FG019|Escalation Phase|Site Closed|0|||
130467471|NCT02723955|469678919|FG020|Escalation Phase|Site Closed|1|||
130467472|NCT02723955|469678920|FG021|Escalation Phase|Site Closed|0|||
130467473|NCT02723955|469678921|FG022|Escalation Phase|Site Closed|0|||
130467474|NCT02723955|469678922|FG023|Escalation Phase|Site Closed|0|||
130467475|NCT02723955|469678923|FG024|Escalation Phase|Site Closed|3|||
130467476|NCT02723955|469678924|FG025|Escalation Phase|Site Closed|1|||
130467477|NCT02723955|469678925|FG026|Escalation Phase|Site Closed|3|||
130467478|NCT02723955|469678926|FG027|Escalation Phase|Site Closed|1|||
130467479|NCT02723955|469678927|FG028|Escalation Phase|Site Closed|1|||
130467480|NCT02723955|469678928|FG029|Escalation Phase|Site Closed|0|||
130467481|NCT02723955|469678929|FG030|Escalation Phase|Site Closed|0|||
130467482|NCT02723955|469678930|FG031|Escalation Phase|Site Closed|0|||
130467483|NCT02723955|469678931|FG032|Escalation Phase|Site Closed|0|||
130467484|NCT02723955|469678932|FG033|Escalation Phase|Site Closed|0|||
130467485|NCT02723955|469678933|FG034|Escalation Phase|Site Closed|0|||
130467486|NCT02723955|469678934|FG035|Escalation Phase|Site Closed|0|||
130467487|NCT02723955|469678935|FG036|Escalation Phase|Site Closed|0|||
130467488|NCT02723955|469678936|FG037|Escalation Phase|Site Closed|0|||
130467489|NCT02723955|469678937|FG038|Escalation Phase|Site Closed|0|||
130467490|NCT02723955|469678938|FG039|Escalation Phase|Site Closed|0|||
130467491|NCT02723955|469678939|FG040|Escalation Phase|Site Closed|0|||
130467492|NCT02723955|469678940|FG041|Escalation Phase|Site Closed|0|||
130467493|NCT02723955|469678941|FG042|Escalation Phase|Site Closed|0|||
130467494|NCT02723955|469678899|FG000|Expansion Phase|Death|0|||
130467495|NCT02723955|469678900|FG001|Expansion Phase|Death|0|||
130467496|NCT02723955|469678901|FG002|Expansion Phase|Death|0|||
130467497|NCT02723955|469678902|FG003|Expansion Phase|Death|0|||
130467498|NCT02723955|469678903|FG004|Expansion Phase|Death|0|||
130467499|NCT02723955|469678904|FG005|Expansion Phase|Death|0|||
130467500|NCT02723955|469678905|FG006|Expansion Phase|Death|0|||
130467501|NCT02723955|469678906|FG007|Expansion Phase|Death|0|||
130467502|NCT02723955|469678907|FG008|Expansion Phase|Death|0|||
130467503|NCT02723955|469678908|FG009|Expansion Phase|Death|25|||
130467504|NCT02723955|469678909|FG010|Expansion Phase|Death|69|||
130467505|NCT02723955|469678910|FG011|Expansion Phase|Death|48|||
130467506|NCT02723955|469678911|FG012|Expansion Phase|Death|0|||
130467507|NCT02723955|469678912|FG013|Expansion Phase|Death|0|||
130467508|NCT02723955|469678913|FG014|Expansion Phase|Death|0|||
130467509|NCT02723955|469678914|FG015|Expansion Phase|Death|0|||
130467510|NCT02723955|469678915|FG016|Expansion Phase|Death|0|||
130467511|NCT02723955|469678916|FG017|Expansion Phase|Death|0|||
130379855|NCT00799487|469359412|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
130379856|NCT00799487|469359410|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
130379857|NCT00799487|469359411|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
130379858|NCT00799487|469359412|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
130379859|NCT00799487|469359410|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
130379860|NCT00799487|469359411|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
130379861|NCT00799487|469359412|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
130379862|NCT00799487|469359410|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
130379863|NCT00799487|469359411|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
130379864|NCT00799487|469359412|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
130379865|NCT00799487|469359410|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
130379866|NCT00799487|469359411|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
130379867|NCT00799487|469359412|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
130379868|NCT04481750|469359413|FG000|Period 1 (Fasted)|Adverse Event|0|||
130379869|NCT04481750|469359414|FG001|Period 1 (Fasted)|Adverse Event|0|||
130379870|NCT04481750|469359415|FG002|Period 1 (Fasted)|Adverse Event|1|||
130379871|NCT04481750|469359416|FG003|Period 1 (Fasted)|Adverse Event|0|||
130379872|NCT04481750|469359417|FG004|Period 1 (Fasted)|Adverse Event|0|||
130379873|NCT04481750|469359418|FG005|Period 1 (Fasted)|Adverse Event|0|||
130379874|NCT04481750|469359419|FG006|Period 1 (Fasted)|Adverse Event|0|||
130379875|NCT04481750|469359420|FG007|Period 1 (Fasted)|Adverse Event|0|||
130379876|NCT04481750|469359421|FG008|Period 1 (Fasted)|Adverse Event|0|||
130379877|NCT04481750|469359422|FG009|Period 1 (Fasted)|Adverse Event|0|||
130379878|NCT04481750|469359423|FG010|Period 1 (Fasted)|Adverse Event|0|||
130379879|NCT03263442|469359424|FG000|Inpatient Phase|Death|1|||
130379880|NCT03263442|469359425|FG001|Inpatient Phase|Death|0|||
130379881|NCT03263442|469359424|FG000|Inpatient Phase|Withdrawal by Subject|1|||
130379882|NCT03263442|469359425|FG001|Inpatient Phase|Withdrawal by Subject|0|||
130379883|NCT03263442|469359424|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
130379884|NCT03263442|469359425|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
130379885|NCT03263442|469359424|FG000|1-month Follow-Up|Lost to Follow-up|1|||
130379886|NCT03263442|469359425|FG001|1-month Follow-Up|Lost to Follow-up|0|||
130379887|NCT03263442|469359424|FG000|3-month Follow-Up|Lost to Follow-up|1|||
130379888|NCT03263442|469359425|FG001|3-month Follow-Up|Lost to Follow-up|3|||
130379889|NCT03263442|469359424|FG000|6-month Follow-Up|Lost to Follow-up|2|||
130379890|NCT03263442|469359425|FG001|6-month Follow-Up|Lost to Follow-up|2|||
130379891|NCT01463878|469359426|FG000|Overall Study|no longer met criteria for tube feed|2|||
130379892|NCT01463878|469359427|FG001|Overall Study|no longer met criteria for tube feed|2|||
130379893|NCT02436889|469359428|FG000|Overall Study|No improvement in symptoms|1|||
130379894|NCT02436889|469359429|FG001|Overall Study|No improvement in symptoms|0|||
130379895|NCT02436889|469359428|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
130379896|NCT02436889|469359429|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
130379897|NCT01084174|469359430|FG000|Overall Study|gastrointestinal symptoms|1|||
130379898|NCT01084174|469359431|FG001|Overall Study|gastrointestinal symptoms|1|||
130379899|NCT01084174|469359430|FG000|Overall Study|Eosinophilic esophagitis|0|||
130379900|NCT01084174|469359431|FG001|Overall Study|Eosinophilic esophagitis|1|||
130379901|NCT01084174|469359430|FG000|Overall Study|Anaphylaxis|0|||
130379902|NCT01084174|469359431|FG001|Overall Study|Anaphylaxis|1|||
130379903|NCT01084174|469359430|FG000|Overall Study|Participant noncompliance|0|||
130379904|NCT01084174|469359431|FG001|Overall Study|Participant noncompliance|1|||
130379905|NCT01034462|469359432|FG000|Overall Study|Adverse Event|7|||
130379906|NCT01034462|469359433|FG001|Overall Study|Adverse Event|17|||
130379907|NCT01034462|469359432|FG000|Overall Study|Lack of Efficacy|4|||
130379908|NCT01034462|469359433|FG001|Overall Study|Lack of Efficacy|4|||
130379909|NCT01034462|469359432|FG000|Overall Study|Protocol Violation|10|||
130379910|NCT01034462|469359433|FG001|Overall Study|Protocol Violation|7|||
130379911|NCT01034462|469359432|FG000|Overall Study|Withdrawal by Subject|9|||
130379912|NCT01034462|469359433|FG001|Overall Study|Withdrawal by Subject|8|||
130379913|NCT01034462|469359432|FG000|Overall Study|Lost to Follow-up|14|||
130379914|NCT01034462|469359433|FG001|Overall Study|Lost to Follow-up|16|||
130379915|NCT01034462|469359432|FG000|Overall Study|Other reasons|1|||
130379916|NCT01034462|469359433|FG001|Overall Study|Other reasons|2|||
130379917|NCT01484873|469359434|FG000|Overall Study|Withdrawal by Subject|2|||
130467512|NCT02723955|469678917|FG018|Expansion Phase|Death|0|||
130467513|NCT02723955|469678918|FG019|Expansion Phase|Death|0|||
130379918|NCT02564042|469359435|FG000|Overall Study|Adverse Event|4|||
130379919|NCT02564042|469359436|FG001|Overall Study|Adverse Event|4|||
130379920|NCT02564042|469359437|FG002|Overall Study|Adverse Event|3|||
130379921|NCT02564042|469359438|FG003|Overall Study|Adverse Event|0|||
130379922|NCT02564042|469359439|FG004|Overall Study|Adverse Event|0|||
130379923|NCT02564042|469359440|FG005|Overall Study|Adverse Event|1|||
130379924|NCT02564042|469359435|FG000|Overall Study|Lost to Follow-up|1|||
130379925|NCT02564042|469359436|FG001|Overall Study|Lost to Follow-up|1|||
130379926|NCT02564042|469359437|FG002|Overall Study|Lost to Follow-up|1|||
130379927|NCT02564042|469359438|FG003|Overall Study|Lost to Follow-up|0|||
130467514|NCT02723955|469678919|FG020|Expansion Phase|Death|0|||
130379928|NCT02564042|469359439|FG004|Overall Study|Lost to Follow-up|1|||
130379929|NCT02564042|469359440|FG005|Overall Study|Lost to Follow-up|1|||
130379930|NCT02564042|469359435|FG000|Overall Study|Physician Decision|1|||
130379931|NCT02564042|469359436|FG001|Overall Study|Physician Decision|0|||
130379932|NCT02564042|469359437|FG002|Overall Study|Physician Decision|0|||
130379933|NCT02564042|469359438|FG003|Overall Study|Physician Decision|1|||
130379934|NCT02564042|469359439|FG004|Overall Study|Physician Decision|0|||
130379935|NCT02564042|469359440|FG005|Overall Study|Physician Decision|0|||
130379936|NCT02564042|469359435|FG000|Overall Study|Withdrawal by Subject|5|||
130379937|NCT02564042|469359436|FG001|Overall Study|Withdrawal by Subject|3|||
130379938|NCT02564042|469359437|FG002|Overall Study|Withdrawal by Subject|2|||
130379939|NCT02564042|469359438|FG003|Overall Study|Withdrawal by Subject|2|||
130379940|NCT02564042|469359439|FG004|Overall Study|Withdrawal by Subject|10|||
130379941|NCT02564042|469359440|FG005|Overall Study|Withdrawal by Subject|12|||
130379942|NCT01549392|469359441|FG000|Overall Study|Withdrawal by Subject|1|||
130379943|NCT01549392|469359442|FG001|Overall Study|Withdrawal by Subject|0|||
130379944|NCT01356966|469359443|FG000|Overall Study|Withdrawal by Subject|1|||
130379945|NCT01356966|469359444|FG001|Overall Study|Withdrawal by Subject|2|||
130379946|NCT01356966|469359443|FG000|Overall Study|Physician Decision|1|||
130379947|NCT01356966|469359444|FG001|Overall Study|Physician Decision|0|||
130379948|NCT02743806|469359445|FG000|Overall Study|Adverse Event|9|||
130379949|NCT02743806|469359445|FG000|Overall Study|Lost to Follow-up|8|||
130379950|NCT02743806|469359445|FG000|Overall Study|Voluntary Withdrawal|54|||
130379951|NCT02743806|469359445|FG000|Overall Study|Study Termination|65|||
130379952|NCT02743806|469359445|FG000|Overall Study|Pregnancy|6|||
130379953|NCT02743806|469359445|FG000|Overall Study|No Longer Clinically Benefiting|27|||
130379954|NCT02743806|469359445|FG000|Overall Study|Reason Not Specified|12|||
130379955|NCT00849381|469359446|FG000|Overall Study|Adverse Event|1|||
130379956|NCT00849381|469359446|FG000|Overall Study|Lost to Follow-up|129|||
130379957|NCT00849381|469359446|FG000|Overall Study|Protocol Violation|5|||
130379958|NCT00849381|469359446|FG000|Overall Study|Withdrawal by Subject|6|||
130379959|NCT00849381|469359446|FG000|Overall Study|Other|4|||
130379960|NCT02289898|469359451|FG000|Overall Study|Death|5|||
130379961|NCT02289898|469359452|FG001|Overall Study|Death|4|||
130379962|NCT02289898|469359453|FG002|Overall Study|Death|3|||
130379963|NCT02289898|469359451|FG000|Overall Study|Physician Decision|2|||
130379964|NCT02289898|469359452|FG001|Overall Study|Physician Decision|5|||
130379965|NCT02289898|469359453|FG002|Overall Study|Physician Decision|2|||
130379966|NCT02289898|469359451|FG000|Overall Study|Withdrawal by Subject|0|||
130379967|NCT02289898|469359452|FG001|Overall Study|Withdrawal by Subject|4|||
130379968|NCT02289898|469359453|FG002|Overall Study|Withdrawal by Subject|1|||
130379969|NCT02289898|469359451|FG000|Overall Study|Adverse Event|3|||
130379970|NCT02289898|469359452|FG001|Overall Study|Adverse Event|5|||
130379971|NCT02289898|469359453|FG002|Overall Study|Adverse Event|5|||
130379972|NCT02289898|469359451|FG000|Overall Study|Disease progression|34|||
130379973|NCT02289898|469359452|FG001|Overall Study|Disease progression|28|||
130379974|NCT02289898|469359453|FG002|Overall Study|Disease progression|34|||
130379975|NCT02289898|469359451|FG000|Overall Study|Use of another anticancer therapy|0|||
130379976|NCT02289898|469359452|FG001|Overall Study|Use of another anticancer therapy|0|||
130379977|NCT02289898|469359453|FG002|Overall Study|Use of another anticancer therapy|1|||
130379978|NCT02289898|469359451|FG000|Overall Study|Other|8|||
130379979|NCT02289898|469359452|FG001|Overall Study|Other|7|||
130379980|NCT02289898|469359453|FG002|Overall Study|Other|10|||
130379981|NCT01828281|469359454|FG000|Overall Study|Withdrawal by Subject|1|||
130379982|NCT01828281|469359455|FG001|Overall Study|Withdrawal by Subject|0|||
130379983|NCT03070782|469359456|FG000|Overall Study|Adverse Event|3|||
130379984|NCT03070782|469359457|FG001|Overall Study|Adverse Event|0|||
130379985|NCT03070782|469359458|FG002|Overall Study|Adverse Event|3|||
130379986|NCT03070782|469359459|FG003|Overall Study|Adverse Event|1|||
130379987|NCT03070782|469359460|FG004|Overall Study|Adverse Event|6|||
130379988|NCT03070782|469359461|FG005|Overall Study|Adverse Event|2|||
130379989|NCT03070782|469359456|FG000|Overall Study|Withdrawal by Subject|2|||
130379990|NCT03070782|469359457|FG001|Overall Study|Withdrawal by Subject|1|||
130379991|NCT03070782|469359458|FG002|Overall Study|Withdrawal by Subject|1|||
130379992|NCT03070782|469359459|FG003|Overall Study|Withdrawal by Subject|0|||
130379993|NCT03070782|469359460|FG004|Overall Study|Withdrawal by Subject|4|||
130379994|NCT03070782|469359461|FG005|Overall Study|Withdrawal by Subject|3|||
130379995|NCT03070782|469359456|FG000|Overall Study|Reason Not Specified|2|||
130379996|NCT03070782|469359457|FG001|Overall Study|Reason Not Specified|0|||
130379997|NCT03070782|469359458|FG002|Overall Study|Reason Not Specified|0|||
130379998|NCT03070782|469359459|FG003|Overall Study|Reason Not Specified|1|||
130379999|NCT03070782|469359460|FG004|Overall Study|Reason Not Specified|2|||
130380000|NCT03070782|469359461|FG005|Overall Study|Reason Not Specified|1|||
130380001|NCT03070782|469359456|FG000|Overall Study|Ineligibility|0|||
130380002|NCT03070782|469359457|FG001|Overall Study|Ineligibility|0|||
130380003|NCT03070782|469359458|FG002|Overall Study|Ineligibility|0|||
130380004|NCT03070782|469359459|FG003|Overall Study|Ineligibility|1|||
130380005|NCT03070782|469359460|FG004|Overall Study|Ineligibility|0|||
130380006|NCT03070782|469359461|FG005|Overall Study|Ineligibility|1|||
130380007|NCT03070782|469359456|FG000|Overall Study|Pregnancy|0|||
130380008|NCT03070782|469359457|FG001|Overall Study|Pregnancy|0|||
130380009|NCT03070782|469359458|FG002|Overall Study|Pregnancy|0|||
130380010|NCT03070782|469359459|FG003|Overall Study|Pregnancy|1|||
130380011|NCT03070782|469359460|FG004|Overall Study|Pregnancy|0|||
130380012|NCT03070782|469359461|FG005|Overall Study|Pregnancy|0|||
130380013|NCT03070782|469359456|FG000|Overall Study|Investigator Judgement|0|||
130380014|NCT03070782|469359457|FG001|Overall Study|Investigator Judgement|0|||
130380015|NCT03070782|469359458|FG002|Overall Study|Investigator Judgement|0|||
130380016|NCT03070782|469359459|FG003|Overall Study|Investigator Judgement|1|||
130380017|NCT03070782|469359460|FG004|Overall Study|Investigator Judgement|0|||
130380018|NCT03070782|469359461|FG005|Overall Study|Investigator Judgement|0|||
130380019|NCT01083576|469359462|FG000|Overall Study|Treatment Failure|6|||
130380020|NCT01083576|469359463|FG001|Overall Study|Treatment Failure|1|||
130380021|NCT03527966|469359464|FG000|Overall Study|Lost to Follow-up|3|||
130380022|NCT03527966|469359465|FG001|Overall Study|Lost to Follow-up|0|||
130380023|NCT02746874|469359466|FG000|Overall Study|Withdrawal by Subject|0|||
130380024|NCT02746874|469359467|FG001|Overall Study|Withdrawal by Subject|1|||
130380025|NCT02746874|469359466|FG000|Overall Study|Surgery Date Changed|0|||
130380026|NCT02746874|469359467|FG001|Overall Study|Surgery Date Changed|2|||
130380027|NCT00022633|469359470|FG000|Overall Study|Adverse Event|11|||
130380028|NCT00022633|469359471|FG001|Overall Study|Adverse Event|1|||
130380029|NCT00022633|469359470|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130380030|NCT00022633|469359471|FG001|Overall Study|Refusal unrelated to adverse event|0|||
130380031|NCT00022633|469359470|FG000|Overall Study|Progression/relapse|9|||
130380032|NCT00022633|469359471|FG001|Overall Study|Progression/relapse|2|||
130380033|NCT00022633|469359470|FG000|Overall Study|Death|4|||
130380034|NCT00022633|469359471|FG001|Overall Study|Death|0|||
130380035|NCT00022633|469359470|FG000|Overall Study|Other - not protocol specified|3|||
130380036|NCT00022633|469359471|FG001|Overall Study|Other - not protocol specified|2|||
130380037|NCT00022633|469359470|FG000|Overall Study|Ineligible|4|||
130380038|NCT00022633|469359471|FG001|Overall Study|Ineligible|0|||
130380039|NCT00487747|469359472|FG000|Overall Study|Adverse Event|1|||
130380040|NCT00487747|469359472|FG000|Overall Study|Lost to Follow-up|9|||
130380041|NCT00487747|469359472|FG000|Overall Study|Lack of Efficacy|1|||
130380042|NCT03402386|469359481|FG000|Overall Study|Adverse Event|3|||
130380043|NCT03402386|469359481|FG000|Overall Study|Physician Decision|1|||
130380044|NCT03402386|469359481|FG000|Overall Study|Difficult to control Hb|2|||
130380045|NCT02485574|469359490|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
130380046|NCT00255047|469359492|FG000|Overall Study|Serious Adverse Events|2|||
130380047|NCT00255047|469359493|FG001|Overall Study|Serious Adverse Events|1|||
130380048|NCT00255047|469359494|FG002|Overall Study|Serious Adverse Events|2|||
130380049|NCT00255047|469359495|FG003|Overall Study|Serious Adverse Events|1|||
130380050|NCT00255047|469359492|FG000|Overall Study|Adverse Event|0|||
130380051|NCT00255047|469359493|FG001|Overall Study|Adverse Event|3|||
130380052|NCT00255047|469359494|FG002|Overall Study|Adverse Event|2|||
130380053|NCT00255047|469359495|FG003|Overall Study|Adverse Event|1|||
130380054|NCT00255047|469359492|FG000|Overall Study|Protocol Violation|13|||
130380055|NCT00255047|469359493|FG001|Overall Study|Protocol Violation|13|||
130380056|NCT00255047|469359494|FG002|Overall Study|Protocol Violation|16|||
130380057|NCT00255047|469359495|FG003|Overall Study|Protocol Violation|20|||
130380058|NCT00255047|469359492|FG000|Overall Study|Lost to Follow-up|9|||
130380059|NCT00255047|469359493|FG001|Overall Study|Lost to Follow-up|8|||
130380060|NCT00255047|469359494|FG002|Overall Study|Lost to Follow-up|5|||
130380061|NCT00255047|469359495|FG003|Overall Study|Lost to Follow-up|6|||
130380062|NCT00255047|469359492|FG000|Overall Study|Withdrawal by Subject|24|||
130380063|NCT00255047|469359493|FG001|Overall Study|Withdrawal by Subject|23|||
130380064|NCT00255047|469359494|FG002|Overall Study|Withdrawal by Subject|25|||
130380065|NCT00255047|469359495|FG003|Overall Study|Withdrawal by Subject|18|||
130380066|NCT01957553|469359497|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
130380067|NCT01957553|469359498|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
130380068|NCT01957553|469359497|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
130380069|NCT01957553|469359498|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
130380070|NCT01957553|469359497|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
130722083|NCT01359969|470608161|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
130722084|NCT00470067|470608166|FG000|Overall Study|Death|1|||
130722085|NCT00470067|470608166|FG000|Overall Study|Disease Progression|6|||
130380071|NCT01957553|469359498|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
130380072|NCT01957553|469359497|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
130380073|NCT01957553|469359498|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
130380074|NCT01957553|469359497|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
130380075|NCT01957553|469359498|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
130380076|NCT01957553|469359497|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
130380077|NCT01957553|469359498|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
130380078|NCT01957553|469359497|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
130467515|NCT02723955|469678920|FG021|Expansion Phase|Death|0|||
130467516|NCT02723955|469678921|FG022|Expansion Phase|Death|0|||
130467517|NCT02723955|469678922|FG023|Expansion Phase|Death|0|||
130467518|NCT02723955|469678923|FG024|Expansion Phase|Death|0|||
130467519|NCT02723955|469678924|FG025|Expansion Phase|Death|0|||
130467520|NCT02723955|469678925|FG026|Expansion Phase|Death|0|||
130467521|NCT02723955|469678926|FG027|Expansion Phase|Death|0|||
130467522|NCT02723955|469678927|FG028|Expansion Phase|Death|0|||
130467523|NCT02723955|469678928|FG029|Expansion Phase|Death|12|||
130467524|NCT02723955|469678929|FG030|Expansion Phase|Death|202|||
130467525|NCT02723955|469678930|FG031|Expansion Phase|Death|31|||
130467526|NCT02723955|469678931|FG032|Expansion Phase|Death|17|||
130467527|NCT02723955|469678932|FG033|Expansion Phase|Death|2|||
130467528|NCT02723955|469678933|FG034|Expansion Phase|Death|3|||
130380079|NCT01957553|469359498|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
130380080|NCT01957553|469359497|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
130380081|NCT01957553|469359498|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
130380082|NCT01957553|469359497|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
130380083|NCT01957553|469359498|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
130380084|NCT01333059|469359499|FG000|Overall Study|Physician Decision|3|||
130467529|NCT02723955|469678934|FG035|Expansion Phase|Death|3|||
130467530|NCT02723955|469678935|FG036|Expansion Phase|Death|1|||
130467531|NCT02723955|469678936|FG037|Expansion Phase|Death|0|||
130467532|NCT02723955|469678937|FG038|Expansion Phase|Death|0|||
130467533|NCT02723955|469678938|FG039|Expansion Phase|Death|0|||
130467534|NCT02723955|469678939|FG040|Expansion Phase|Death|0|||
130467535|NCT02723955|469678940|FG041|Expansion Phase|Death|0|||
130467536|NCT02723955|469678941|FG042|Expansion Phase|Death|0|||
130467537|NCT02723955|469678899|FG000|Expansion Phase|Lost to Follow-up|0|||
130467538|NCT02723955|469678900|FG001|Expansion Phase|Lost to Follow-up|0|||
130467539|NCT02723955|469678901|FG002|Expansion Phase|Lost to Follow-up|0|||
130722086|NCT03400943|470608167|FG000|Treatment Period 1|Adverse Event|0|||
130722087|NCT03400943|470608168|FG001|Treatment Period 1|Adverse Event|0|||
130380085|NCT01333059|469359500|FG001|Overall Study|Physician Decision|3|||
130380086|NCT01333059|469359499|FG000|Overall Study|Protocol Violation|3|||
130380087|NCT01333059|469359500|FG001|Overall Study|Protocol Violation|0|||
130380088|NCT03566823|469359501|FG000|Overall Study|Lack of Efficacy|0|||
130380089|NCT03566823|469359502|FG001|Overall Study|Lack of Efficacy|1|||
130380090|NCT03566823|469359503|FG002|Overall Study|Lack of Efficacy|0|||
130380091|NCT03566823|469359501|FG000|Overall Study|Withdrawal by Subject|1|||
130380092|NCT03566823|469359502|FG001|Overall Study|Withdrawal by Subject|2|||
130380093|NCT03566823|469359503|FG002|Overall Study|Withdrawal by Subject|0|||
130380094|NCT03566823|469359501|FG000|Overall Study|Adverse Event|1|||
130380095|NCT03566823|469359502|FG001|Overall Study|Adverse Event|0|||
130380096|NCT03566823|469359503|FG002|Overall Study|Adverse Event|2|||
130380097|NCT02733367|469359504|FG000|Overall Study|Withdrawal by Subject|6|||
130380098|NCT01348347|469359505|FG000|Overall Study|Withdrawal by Subject|1|||
130380099|NCT01348347|469359506|FG001|Overall Study|Withdrawal by Subject|1|||
130380100|NCT01348347|469359507|FG002|Overall Study|Withdrawal by Subject|1|||
130380101|NCT01348347|469359505|FG000|Overall Study|Progressive disease|2|||
130380102|NCT01348347|469359506|FG001|Overall Study|Progressive disease|5|||
130380103|NCT01348347|469359507|FG002|Overall Study|Progressive disease|5|||
130380104|NCT00748033|469359508|FG000|Overall Study|Adverse Event|0|||
130380105|NCT00748033|469359509|FG001|Overall Study|Adverse Event|1|||
130380106|NCT03060629|469359515|FG000|Overall Study|Death|4|||
130380107|NCT03060629|469359516|FG001|Overall Study|Death|5|||
130380108|NCT03060629|469359515|FG000|Overall Study|Withdrawal by Subject|50|||
130380109|NCT03060629|469359516|FG001|Overall Study|Withdrawal by Subject|35|||
130380110|NCT03060629|469359515|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
130380111|NCT03060629|469359516|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
130380112|NCT03060629|469359515|FG000|Overall Study|Participant Relocate|15|||
130380113|NCT03060629|469359516|FG001|Overall Study|Participant Relocate|15|||
130380114|NCT03060629|469359515|FG000|Overall Study|Unable to Contact Participant|34|||
130380115|NCT03060629|469359516|FG001|Overall Study|Unable to Contact Participant|23|||
130380116|NCT03060629|469359515|FG000|Overall Study|Investigator Decision|7|||
130467540|NCT02723955|469678902|FG003|Expansion Phase|Lost to Follow-up|0|||
130467541|NCT02723955|469678903|FG004|Expansion Phase|Lost to Follow-up|0|||
130467542|NCT02723955|469678904|FG005|Expansion Phase|Lost to Follow-up|0|||
130467543|NCT02723955|469678905|FG006|Expansion Phase|Lost to Follow-up|0|||
130380117|NCT03060629|469359516|FG001|Overall Study|Investigator Decision|7|||
130380118|NCT03060629|469359515|FG000|Overall Study|Study Terminated by Sponsor|1100|||
130380119|NCT03060629|469359516|FG001|Overall Study|Study Terminated by Sponsor|1123|||
130380120|NCT03060629|469359515|FG000|Overall Study|Other|4|||
130380121|NCT03060629|469359516|FG001|Overall Study|Other|4|||
130467544|NCT02723955|469678906|FG007|Expansion Phase|Lost to Follow-up|0|||
130467545|NCT02723955|469678907|FG008|Expansion Phase|Lost to Follow-up|0|||
130467546|NCT02723955|469678908|FG009|Expansion Phase|Lost to Follow-up|0|||
130467547|NCT02723955|469678909|FG010|Expansion Phase|Lost to Follow-up|4|||
130467548|NCT02723955|469678910|FG011|Expansion Phase|Lost to Follow-up|1|||
130467549|NCT02723955|469678911|FG012|Expansion Phase|Lost to Follow-up|0|||
130722088|NCT03400943|470608169|FG002|Treatment Period 1|Adverse Event|0|||
130380122|NCT01405742|469359517|FG000|Overall Study|Lost to Follow-up|1|||
130380123|NCT01405742|469359518|FG001|Overall Study|Lost to Follow-up|0|||
130380124|NCT03672747|469359520|FG000|Overall Study|Lost to Follow-up|1|||
130380125|NCT03672747|469359521|FG001|Overall Study|Lost to Follow-up|1|||
130380126|NCT03672747|469359522|FG002|Overall Study|Lost to Follow-up|2|||
130380127|NCT03672747|469359523|FG003|Overall Study|Lost to Follow-up|2|||
130380128|NCT03672747|469359524|FG004|Overall Study|Lost to Follow-up|2|||
130380129|NCT03672747|469359525|FG005|Overall Study|Lost to Follow-up|1|||
130380130|NCT01782495|469359529|FG000|Overall Study|Adverse Event|0|||
130380131|NCT01782495|469359530|FG001|Overall Study|Adverse Event|0|||
130380132|NCT01782495|469359531|FG002|Overall Study|Adverse Event|0|||
130380133|NCT01782495|469359532|FG003|Overall Study|Adverse Event|0|||
130380134|NCT01782495|469359533|FG004|Overall Study|Adverse Event|0|||
130380135|NCT01782495|469359534|FG005|Overall Study|Adverse Event|0|||
130380136|NCT01782495|469359535|FG006|Overall Study|Adverse Event|0|||
130380137|NCT01782495|469359536|FG007|Overall Study|Adverse Event|2|||
130380138|NCT01782495|469359537|FG008|Overall Study|Adverse Event|0|||
130467550|NCT02723955|469678912|FG013|Expansion Phase|Lost to Follow-up|0|||
130467551|NCT02723955|469678913|FG014|Expansion Phase|Lost to Follow-up|0|||
130467552|NCT02723955|469678914|FG015|Expansion Phase|Lost to Follow-up|0|||
130467553|NCT02723955|469678915|FG016|Expansion Phase|Lost to Follow-up|0|||
130467554|NCT02723955|469678916|FG017|Expansion Phase|Lost to Follow-up|0|||
130467555|NCT02723955|469678917|FG018|Expansion Phase|Lost to Follow-up|0|||
130467556|NCT02723955|469678918|FG019|Expansion Phase|Lost to Follow-up|0|||
130467557|NCT02723955|469678919|FG020|Expansion Phase|Lost to Follow-up|0|||
130467558|NCT02723955|469678920|FG021|Expansion Phase|Lost to Follow-up|0|||
130467559|NCT02723955|469678921|FG022|Expansion Phase|Lost to Follow-up|0|||
130467560|NCT02723955|469678922|FG023|Expansion Phase|Lost to Follow-up|0|||
130467561|NCT02723955|469678923|FG024|Expansion Phase|Lost to Follow-up|0|||
130467562|NCT02723955|469678924|FG025|Expansion Phase|Lost to Follow-up|0|||
130467563|NCT02723955|469678925|FG026|Expansion Phase|Lost to Follow-up|0|||
130467564|NCT02723955|469678926|FG027|Expansion Phase|Lost to Follow-up|0|||
130467565|NCT02723955|469678927|FG028|Expansion Phase|Lost to Follow-up|0|||
130467566|NCT02723955|469678928|FG029|Expansion Phase|Lost to Follow-up|1|||
130467567|NCT02723955|469678929|FG030|Expansion Phase|Lost to Follow-up|19|||
130467568|NCT02723955|469678930|FG031|Expansion Phase|Lost to Follow-up|2|||
130467569|NCT02723955|469678931|FG032|Expansion Phase|Lost to Follow-up|1|||
130467570|NCT02723955|469678932|FG033|Expansion Phase|Lost to Follow-up|0|||
130467571|NCT02723955|469678933|FG034|Expansion Phase|Lost to Follow-up|0|||
130467572|NCT02723955|469678934|FG035|Expansion Phase|Lost to Follow-up|0|||
130467573|NCT02723955|469678935|FG036|Expansion Phase|Lost to Follow-up|0|||
130467574|NCT02723955|469678936|FG037|Expansion Phase|Lost to Follow-up|0|||
130467575|NCT02723955|469678937|FG038|Expansion Phase|Lost to Follow-up|0|||
130467576|NCT02723955|469678938|FG039|Expansion Phase|Lost to Follow-up|0|||
130467577|NCT02723955|469678939|FG040|Expansion Phase|Lost to Follow-up|0|||
130467578|NCT02723955|469678940|FG041|Expansion Phase|Lost to Follow-up|0|||
130467579|NCT02723955|469678941|FG042|Expansion Phase|Lost to Follow-up|0|||
130467580|NCT02723955|469678899|FG000|Expansion Phase|Physician Decision|0|||
130467581|NCT02723955|469678900|FG001|Expansion Phase|Physician Decision|0|||
130467582|NCT02723955|469678901|FG002|Expansion Phase|Physician Decision|0|||
130467583|NCT02723955|469678902|FG003|Expansion Phase|Physician Decision|0|||
130467584|NCT02723955|469678903|FG004|Expansion Phase|Physician Decision|0|||
130467585|NCT02723955|469678904|FG005|Expansion Phase|Physician Decision|0|||
130467586|NCT02723955|469678905|FG006|Expansion Phase|Physician Decision|0|||
130467587|NCT02723955|469678906|FG007|Expansion Phase|Physician Decision|0|||
130380139|NCT01782495|469359538|FG009|Overall Study|Adverse Event|0|||
130380140|NCT01782495|469359539|FG010|Overall Study|Adverse Event|0|||
130380141|NCT01782495|469359529|FG000|Overall Study|Withdrew Consent|0|||
130380142|NCT01782495|469359530|FG001|Overall Study|Withdrew Consent|1|||
130380143|NCT01782495|469359531|FG002|Overall Study|Withdrew Consent|0|||
130722089|NCT03400943|470608170|FG003|Treatment Period 1|Adverse Event|1|||
130380144|NCT01782495|469359532|FG003|Overall Study|Withdrew Consent|0|||
130722090|NCT03400943|470608167|FG000|Treatment Period 1|Lost to Follow-up|1|||
130380145|NCT01782495|469359533|FG004|Overall Study|Withdrew Consent|0|||
130380146|NCT01782495|469359534|FG005|Overall Study|Withdrew Consent|0|||
130380147|NCT01782495|469359535|FG006|Overall Study|Withdrew Consent|0|||
130380148|NCT01782495|469359536|FG007|Overall Study|Withdrew Consent|1|||
130380149|NCT01782495|469359537|FG008|Overall Study|Withdrew Consent|0|||
130380150|NCT01782495|469359538|FG009|Overall Study|Withdrew Consent|0|||
130380151|NCT01782495|469359539|FG010|Overall Study|Withdrew Consent|0|||
130380152|NCT03428360|469359540|FG000|Overall Study|Informed consent withdrawn|5|||
130380153|NCT03428360|469359540|FG000|Overall Study|Withdrawal by Subject|4|||
130380154|NCT03428360|469359540|FG000|Overall Study|Lost to Follow-up|5|||
130380155|NCT03428360|469359540|FG000|Overall Study|Physician Decision|2|||
130380156|NCT03428360|469359540|FG000|Overall Study|Informed consent withdrawn|5|||
130380157|NCT03428360|469359540|FG000|Overall Study|Study terminated by sponsor|10|||
130380158|NCT03428360|469359540|FG000|Overall Study|Non-compliant with study|1|||
130380159|NCT03428360|469359540|FG000|Overall Study|Non-compliant with study drug|3|||
130467588|NCT02723955|469678907|FG008|Expansion Phase|Physician Decision|0|||
130722091|NCT03400943|470608168|FG001|Treatment Period 1|Lost to Follow-up|0|||
130380160|NCT03428360|469359540|FG000|Overall Study|Death|3|||
130380161|NCT03428360|469359540|FG000|Overall Study|Adverse Event|1|||
130380162|NCT03428360|469359540|FG000|Overall Study|Not on antiepileptic drug|1|||
130380163|NCT03334903|469359544|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
130380164|NCT03334903|469359545|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
130380165|NCT03334903|469359544|FG000|Overall Study|Protocol Violation|1|||
130380166|NCT03334903|469359545|FG001|Overall Study|Protocol Violation|3|||
130380167|NCT03334903|469359544|FG000|Overall Study|Surgery postponed|1|||
130380168|NCT03334903|469359545|FG001|Overall Study|Surgery postponed|0|||
130380169|NCT03334903|469359544|FG000|Overall Study|Adverse Event|1|||
130380170|NCT03334903|469359545|FG001|Overall Study|Adverse Event|1|||
130380171|NCT03334903|469359544|FG000|Overall Study|Withdrawal by Subject|0|||
130380172|NCT03334903|469359545|FG001|Overall Study|Withdrawal by Subject|1|||
130380173|NCT03032705|469359546|FG000|Overall Study|Lost to Follow-up|16|||
130380174|NCT03032705|469359547|FG001|Overall Study|Lost to Follow-up|17|||
130380175|NCT03032705|469359546|FG000|Overall Study|did not quality|6|||
130380176|NCT03032705|469359547|FG001|Overall Study|did not quality|6|||
130380177|NCT02759471|469359548|FG000|Overall Study|discomfort|2|||
130380178|NCT02927080|469361149|FG000|Overall Study|Withdrawal by Subject|0|||
130380179|NCT02927080|469361150|FG001|Overall Study|Withdrawal by Subject|0|||
130380180|NCT02927080|469361151|FG002|Overall Study|Withdrawal by Subject|0|||
130380181|NCT02927080|469361152|FG003|Overall Study|Withdrawal by Subject|0|||
130380182|NCT02927080|469361153|FG004|Overall Study|Withdrawal by Subject|1|||
130380183|NCT02927080|469361154|FG005|Overall Study|Withdrawal by Subject|0|||
130380184|NCT02927080|469361155|FG006|Overall Study|Withdrawal by Subject|1|||
130380185|NCT02927080|469361156|FG007|Overall Study|Withdrawal by Subject|1|||
130380186|NCT02927080|469361157|FG008|Overall Study|Withdrawal by Subject|0|||
130380187|NCT02927080|469361158|FG009|Overall Study|Withdrawal by Subject|2|||
130380188|NCT02927080|469361149|FG000|Overall Study|Willingness to comply with protocol|0|||
130380189|NCT02927080|469361150|FG001|Overall Study|Willingness to comply with protocol|0|||
130380190|NCT02927080|469361151|FG002|Overall Study|Willingness to comply with protocol|0|||
130380191|NCT02927080|469361152|FG003|Overall Study|Willingness to comply with protocol|0|||
130380192|NCT02927080|469361153|FG004|Overall Study|Willingness to comply with protocol|0|||
130380193|NCT02927080|469361154|FG005|Overall Study|Willingness to comply with protocol|0|||
130380194|NCT02927080|469361155|FG006|Overall Study|Willingness to comply with protocol|0|||
130380195|NCT02927080|469361156|FG007|Overall Study|Willingness to comply with protocol|0|||
130380196|NCT02927080|469361157|FG008|Overall Study|Willingness to comply with protocol|0|||
130380197|NCT02927080|469361158|FG009|Overall Study|Willingness to comply with protocol|1|||
130380198|NCT02927080|469361149|FG000|Overall Study|Study terminated by Sponsor|0|||
130380199|NCT02927080|469361150|FG001|Overall Study|Study terminated by Sponsor|0|||
130380200|NCT02927080|469361151|FG002|Overall Study|Study terminated by Sponsor|0|||
130380201|NCT02927080|469361152|FG003|Overall Study|Study terminated by Sponsor|0|||
130380202|NCT02927080|469361153|FG004|Overall Study|Study terminated by Sponsor|0|||
130380203|NCT02927080|469361154|FG005|Overall Study|Study terminated by Sponsor|0|||
130380204|NCT02927080|469361155|FG006|Overall Study|Study terminated by Sponsor|6|||
130380205|NCT02927080|469361156|FG007|Overall Study|Study terminated by Sponsor|7|||
130380206|NCT02927080|469361157|FG008|Overall Study|Study terminated by Sponsor|2|||
130380207|NCT02927080|469361158|FG009|Overall Study|Study terminated by Sponsor|3|||
130380208|NCT02927080|469361149|FG000|Overall Study|Adverse Event|0|||
130380209|NCT02927080|469361150|FG001|Overall Study|Adverse Event|1|||
130467589|NCT02723955|469678908|FG009|Expansion Phase|Physician Decision|0|||
130467590|NCT02723955|469678909|FG010|Expansion Phase|Physician Decision|0|||
130467591|NCT02723955|469678910|FG011|Expansion Phase|Physician Decision|0|||
130467592|NCT02723955|469678911|FG012|Expansion Phase|Physician Decision|0|||
130467593|NCT02723955|469678912|FG013|Expansion Phase|Physician Decision|0|||
130467594|NCT02723955|469678913|FG014|Expansion Phase|Physician Decision|0|||
130467595|NCT02723955|469678914|FG015|Expansion Phase|Physician Decision|0|||
130467596|NCT02723955|469678915|FG016|Expansion Phase|Physician Decision|0|||
130467597|NCT02723955|469678916|FG017|Expansion Phase|Physician Decision|0|||
130467598|NCT02723955|469678917|FG018|Expansion Phase|Physician Decision|0|||
130467599|NCT02723955|469678918|FG019|Expansion Phase|Physician Decision|0|||
130467600|NCT02723955|469678919|FG020|Expansion Phase|Physician Decision|0|||
130467601|NCT02723955|469678920|FG021|Expansion Phase|Physician Decision|0|||
130380210|NCT02927080|469361151|FG002|Overall Study|Adverse Event|0|||
130467602|NCT02723955|469678921|FG022|Expansion Phase|Physician Decision|0|||
130467603|NCT02723955|469678922|FG023|Expansion Phase|Physician Decision|0|||
130467604|NCT02723955|469678923|FG024|Expansion Phase|Physician Decision|0|||
130467605|NCT02723955|469678924|FG025|Expansion Phase|Physician Decision|0|||
130467606|NCT02723955|469678925|FG026|Expansion Phase|Physician Decision|0|||
130467607|NCT02723955|469678926|FG027|Expansion Phase|Physician Decision|0|||
130380211|NCT02927080|469361152|FG003|Overall Study|Adverse Event|0|||
130380212|NCT02927080|469361153|FG004|Overall Study|Adverse Event|0|||
130380213|NCT02927080|469361154|FG005|Overall Study|Adverse Event|0|||
130380214|NCT02927080|469361155|FG006|Overall Study|Adverse Event|0|||
130467608|NCT02723955|469678927|FG028|Expansion Phase|Physician Decision|0|||
130380215|NCT02927080|469361156|FG007|Overall Study|Adverse Event|1|||
130380216|NCT02927080|469361157|FG008|Overall Study|Adverse Event|0|||
130380217|NCT02927080|469361158|FG009|Overall Study|Adverse Event|1|||
130380218|NCT02927080|469361149|FG000|Overall Study|Other|0|||
130380219|NCT02927080|469361150|FG001|Overall Study|Other|0|||
130380220|NCT02927080|469361151|FG002|Overall Study|Other|0|||
130380221|NCT02927080|469361152|FG003|Overall Study|Other|0|||
130380222|NCT02927080|469361153|FG004|Overall Study|Other|0|||
130380223|NCT02927080|469361154|FG005|Overall Study|Other|0|||
130380224|NCT02927080|469361155|FG006|Overall Study|Other|1|||
130380225|NCT02927080|469361156|FG007|Overall Study|Other|0|||
130380226|NCT02927080|469361157|FG008|Overall Study|Other|1|||
130380227|NCT02927080|469361158|FG009|Overall Study|Other|0|||
130380228|NCT02892760|469361159|FG000|Overall Study|Withdrawal by Subject|3|||
130380229|NCT02259582|469361160|FG000|Overall Study|Physician Decision|0|||
130380230|NCT02259582|469361161|FG001|Overall Study|Physician Decision|1|||
130380231|NCT02259582|469361162|FG002|Overall Study|Physician Decision|0|||
130380232|NCT02259582|469361160|FG000|Overall Study|Death|0|||
130380233|NCT02259582|469361161|FG001|Overall Study|Death|0|||
130380234|NCT02259582|469361162|FG002|Overall Study|Death|1|||
130380235|NCT02259582|469361160|FG000|Overall Study|Adverse Event|1|||
130380236|NCT02259582|469361161|FG001|Overall Study|Adverse Event|0|||
130380237|NCT02259582|469361162|FG002|Overall Study|Adverse Event|1|||
130380238|NCT02259582|469361160|FG000|Overall Study|Withdrawal by Subject|0|||
130380239|NCT02259582|469361161|FG001|Overall Study|Withdrawal by Subject|0|||
130380240|NCT02259582|469361162|FG002|Overall Study|Withdrawal by Subject|1|||
130380241|NCT02259582|469361160|FG000|Overall Study|Disease progression|14|||
130380242|NCT02259582|469361161|FG001|Overall Study|Disease progression|15|||
130380243|NCT02259582|469361162|FG002|Overall Study|Disease progression|17|||
130380244|NCT02259582|469361160|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
130380245|NCT02259582|469361161|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
130380246|NCT02259582|469361162|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
130380247|NCT00531050|469361166|FG000|Part 1: Period 1|Adverse Event|0|||
130380248|NCT00531050|469361167|FG001|Part 1: Period 1|Adverse Event|1|||
130380249|NCT00531050|469361168|FG002|Part 1: Period 1|Adverse Event|0|||
130380250|NCT00531050|469361169|FG003|Part 1: Period 1|Adverse Event|0|||
130380251|NCT00531050|469361170|FG004|Part 1: Period 1|Adverse Event|0|||
130380252|NCT00531050|469361171|FG005|Part 1: Period 1|Adverse Event|0|||
130380253|NCT00531050|469361166|FG000|Part 1: Period 1|Protocol Deviation|0|||
130380254|NCT00531050|469361167|FG001|Part 1: Period 1|Protocol Deviation|0|||
130380255|NCT00531050|469361168|FG002|Part 1: Period 1|Protocol Deviation|0|||
130380256|NCT00531050|469361169|FG003|Part 1: Period 1|Protocol Deviation|1|||
130380257|NCT00531050|469361170|FG004|Part 1: Period 1|Protocol Deviation|0|||
130380258|NCT00531050|469361171|FG005|Part 1: Period 1|Protocol Deviation|0|||
130380259|NCT00531050|469361166|FG000|Part 1: Period 3|Adverse Event|1|||
130380260|NCT00531050|469361167|FG001|Part 1: Period 3|Adverse Event|0|||
130380261|NCT00531050|469361168|FG002|Part 1: Period 3|Adverse Event|0|||
130380262|NCT00531050|469361169|FG003|Part 1: Period 3|Adverse Event|0|||
130380263|NCT00531050|469361170|FG004|Part 1: Period 3|Adverse Event|0|||
130380264|NCT00531050|469361171|FG005|Part 1: Period 3|Adverse Event|0|||
130380265|NCT00531050|469361166|FG000|Part 2: Period 1|Adverse Event|0|||
130380266|NCT00531050|469361167|FG001|Part 2: Period 1|Adverse Event|0|||
130380267|NCT00531050|469361168|FG002|Part 2: Period 1|Adverse Event|0|||
130380268|NCT00531050|469361169|FG003|Part 2: Period 1|Adverse Event|0|||
130380269|NCT00531050|469361170|FG004|Part 2: Period 1|Adverse Event|0|||
130722092|NCT03400943|470608169|FG002|Treatment Period 1|Lost to Follow-up|0|||
130722093|NCT03400943|470608170|FG003|Treatment Period 1|Lost to Follow-up|0|||
130380270|NCT00531050|469361171|FG005|Part 2: Period 1|Adverse Event|1|||
130380271|NCT00531050|469361166|FG000|Part 2: Period 3|Abnormal test procedure|1|||
130380272|NCT00531050|469361167|FG001|Part 2: Period 3|Abnormal test procedure|0|||
130380273|NCT00531050|469361168|FG002|Part 2: Period 3|Abnormal test procedure|0|||
130380274|NCT00531050|469361169|FG003|Part 2: Period 3|Abnormal test procedure|0|||
130380275|NCT00531050|469361170|FG004|Part 2: Period 3|Abnormal test procedure|0|||
130380276|NCT00531050|469361171|FG005|Part 2: Period 3|Abnormal test procedure|1|||
130380277|NCT00475176|469361174|FG000|Overall Study|Adverse Event|2|||
130380278|NCT00475176|469361174|FG000|Overall Study|Withdrawal by Subject|1|||
130380279|NCT00475176|469361174|FG000|Overall Study|Protocol Violation|1|||
130380280|NCT03804879|469361175|FG000|Overall Study|Adverse Event|3|||
130380281|NCT03804879|469361176|FG001|Overall Study|Adverse Event|0|||
130380282|NCT03804879|469361175|FG000|Overall Study|Study Terminated By Sponsor|10|||
130380283|NCT03804879|469361176|FG001|Overall Study|Study Terminated By Sponsor|12|||
130380284|NCT03804879|469361175|FG000|Overall Study|Withdrawal by Subject|3|||
130380285|NCT03804879|469361176|FG001|Overall Study|Withdrawal by Subject|1|||
130380286|NCT01585428|469361177|FG000|Overall Study|Death during treatment|1|||
130467609|NCT02723955|469678928|FG029|Expansion Phase|Physician Decision|0|||
130380287|NCT01585428|469361178|FG001|Overall Study|Death during treatment|0|||
130380288|NCT04273217|469361182|FG000|Overall Study|Lost to Follow-up|0|||
130380289|NCT04273217|469361183|FG001|Overall Study|Lost to Follow-up|0|||
130380290|NCT04273217|469361184|FG002|Overall Study|Lost to Follow-up|0|||
130380291|NCT04273217|469361185|FG003|Overall Study|Lost to Follow-up|0|||
130380292|NCT04273217|469361186|FG004|Overall Study|Lost to Follow-up|0|||
130380293|NCT04273217|469361187|FG005|Overall Study|Lost to Follow-up|1|||
130380294|NCT04273217|469361182|FG000|Overall Study|Participant non-compliance|0|||
130380295|NCT04273217|469361183|FG001|Overall Study|Participant non-compliance|0|||
130380296|NCT04273217|469361184|FG002|Overall Study|Participant non-compliance|0|||
130380297|NCT04273217|469361185|FG003|Overall Study|Participant non-compliance|0|||
130380298|NCT04273217|469361186|FG004|Overall Study|Participant non-compliance|1|||
130380299|NCT04273217|469361187|FG005|Overall Study|Participant non-compliance|0|||
130380300|NCT04273217|469361182|FG000|Overall Study|Positive urine drug screen|1|||
130380301|NCT04273217|469361183|FG001|Overall Study|Positive urine drug screen|0|||
130380302|NCT04273217|469361184|FG002|Overall Study|Positive urine drug screen|1|||
130380303|NCT04273217|469361185|FG003|Overall Study|Positive urine drug screen|0|||
130380304|NCT04273217|469361186|FG004|Overall Study|Positive urine drug screen|0|||
130380305|NCT04273217|469361187|FG005|Overall Study|Positive urine drug screen|1|||
130380306|NCT01988103|469361188|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
130380307|NCT01988103|469361189|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
130380308|NCT01988103|469361190|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
130380309|NCT01988103|469361191|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
130467610|NCT02723955|469678929|FG030|Expansion Phase|Physician Decision|1|||
130467611|NCT02723955|469678930|FG031|Expansion Phase|Physician Decision|1|||
130467612|NCT02723955|469678931|FG032|Expansion Phase|Physician Decision|0|||
130467613|NCT02723955|469678932|FG033|Expansion Phase|Physician Decision|0|||
130467614|NCT02723955|469678933|FG034|Expansion Phase|Physician Decision|0|||
130467615|NCT02723955|469678934|FG035|Expansion Phase|Physician Decision|0|||
130467616|NCT02723955|469678935|FG036|Expansion Phase|Physician Decision|0|||
130467617|NCT02723955|469678936|FG037|Expansion Phase|Physician Decision|0|||
130467618|NCT02723955|469678937|FG038|Expansion Phase|Physician Decision|0|||
130467619|NCT02723955|469678938|FG039|Expansion Phase|Physician Decision|0|||
130380310|NCT01988103|469361192|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
130380311|NCT01988103|469361188|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
130380312|NCT01988103|469361189|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
130380313|NCT01988103|469361190|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
130380314|NCT01988103|469361191|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
130380315|NCT01988103|469361192|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
130380316|NCT01988103|469361188|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
130380317|NCT01988103|469361189|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
130380318|NCT01988103|469361190|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
130380319|NCT01988103|469361191|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130380320|NCT01988103|469361192|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130380321|NCT01988103|469361188|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
130380322|NCT01988103|469361189|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
130380323|NCT01988103|469361190|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
130380324|NCT01988103|469361191|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
130380325|NCT01988103|469361192|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
130380326|NCT01988103|469361188|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130467620|NCT02723955|469678939|FG040|Expansion Phase|Physician Decision|0|||
130467621|NCT02723955|469678940|FG041|Expansion Phase|Physician Decision|0|||
130467622|NCT02723955|469678941|FG042|Expansion Phase|Physician Decision|0|||
130467623|NCT02723955|469678899|FG000|Expansion Phase|Withdrawal by Subject|0|||
130467624|NCT02723955|469678900|FG001|Expansion Phase|Withdrawal by Subject|0|||
130467625|NCT02723955|469678901|FG002|Expansion Phase|Withdrawal by Subject|0|||
130467626|NCT02723955|469678902|FG003|Expansion Phase|Withdrawal by Subject|0|||
130467627|NCT02723955|469678903|FG004|Expansion Phase|Withdrawal by Subject|0|||
130467628|NCT02723955|469678904|FG005|Expansion Phase|Withdrawal by Subject|0|||
130467629|NCT02723955|469678905|FG006|Expansion Phase|Withdrawal by Subject|0|||
130467630|NCT02723955|469678906|FG007|Expansion Phase|Withdrawal by Subject|0|||
130467631|NCT02723955|469678907|FG008|Expansion Phase|Withdrawal by Subject|0|||
130467632|NCT02723955|469678908|FG009|Expansion Phase|Withdrawal by Subject|2|||
130467633|NCT02723955|469678909|FG010|Expansion Phase|Withdrawal by Subject|1|||
130467634|NCT02723955|469678910|FG011|Expansion Phase|Withdrawal by Subject|0|||
130467635|NCT02723955|469678911|FG012|Expansion Phase|Withdrawal by Subject|0|||
130467636|NCT02723955|469678912|FG013|Expansion Phase|Withdrawal by Subject|0|||
130467637|NCT02723955|469678913|FG014|Expansion Phase|Withdrawal by Subject|0|||
130467638|NCT02723955|469678914|FG015|Expansion Phase|Withdrawal by Subject|0|||
130467639|NCT02723955|469678915|FG016|Expansion Phase|Withdrawal by Subject|0|||
130467640|NCT02723955|469678916|FG017|Expansion Phase|Withdrawal by Subject|0|||
130467641|NCT02723955|469678917|FG018|Expansion Phase|Withdrawal by Subject|0|||
130467642|NCT02723955|469678918|FG019|Expansion Phase|Withdrawal by Subject|0|||
130380327|NCT01988103|469361189|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
130380328|NCT01988103|469361190|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
130380329|NCT01988103|469361191|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130380330|NCT01988103|469361192|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130380331|NCT01988103|469361188|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
130380332|NCT01988103|469361189|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
130380333|NCT01988103|469361190|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
130380334|NCT01988103|469361191|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
130380335|NCT01988103|469361192|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
130380336|NCT01988103|469361188|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
130380337|NCT01988103|469361189|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
130380338|NCT01988103|469361190|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
130380339|NCT01988103|469361191|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
130380340|NCT01988103|469361192|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
130380341|NCT00311623|469361199|FG000|Overall Study|Physician Decision|0|||
130380342|NCT00311623|469361200|FG001|Overall Study|Physician Decision|0|||
130380343|NCT00311623|469361201|FG002|Overall Study|Physician Decision|2|||
130380344|NCT03998189|469361202|FG000|Overall Study|Lack of Efficacy|0|||
130380345|NCT03998189|469361203|FG001|Overall Study|Lack of Efficacy|1|||
130380346|NCT03414424|469361204|FG000|Overall Study|Screened out after consent|0|||
130380347|NCT03414424|469361205|FG001|Overall Study|Screened out after consent|2|||
130380348|NCT03414424|469361204|FG000|Overall Study|Lost to Follow-up|0|||
130380349|NCT03414424|469361205|FG001|Overall Study|Lost to Follow-up|1|||
130380350|NCT01949051|469361211|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
130380351|NCT01949051|469361212|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130380352|NCT01949051|469361213|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130467643|NCT02723955|469678919|FG020|Expansion Phase|Withdrawal by Subject|0|||
130467644|NCT02723955|469678920|FG021|Expansion Phase|Withdrawal by Subject|0|||
130467645|NCT02723955|469678921|FG022|Expansion Phase|Withdrawal by Subject|0|||
130467646|NCT02723955|469678922|FG023|Expansion Phase|Withdrawal by Subject|0|||
130467647|NCT02723955|469678923|FG024|Expansion Phase|Withdrawal by Subject|0|||
130467648|NCT02723955|469678924|FG025|Expansion Phase|Withdrawal by Subject|0|||
130467649|NCT02723955|469678925|FG026|Expansion Phase|Withdrawal by Subject|0|||
130467650|NCT02723955|469678926|FG027|Expansion Phase|Withdrawal by Subject|0|||
130467651|NCT02723955|469678927|FG028|Expansion Phase|Withdrawal by Subject|0|||
130467652|NCT02723955|469678928|FG029|Expansion Phase|Withdrawal by Subject|0|||
130467653|NCT02723955|469678929|FG030|Expansion Phase|Withdrawal by Subject|8|||
130467654|NCT02723955|469678930|FG031|Expansion Phase|Withdrawal by Subject|4|||
130467655|NCT02723955|469678931|FG032|Expansion Phase|Withdrawal by Subject|0|||
130467656|NCT02723955|469678932|FG033|Expansion Phase|Withdrawal by Subject|0|||
130467657|NCT02723955|469678933|FG034|Expansion Phase|Withdrawal by Subject|0|||
130467658|NCT02723955|469678934|FG035|Expansion Phase|Withdrawal by Subject|1|||
130467659|NCT02723955|469678935|FG036|Expansion Phase|Withdrawal by Subject|0|||
130467660|NCT02723955|469678936|FG037|Expansion Phase|Withdrawal by Subject|0|||
130467661|NCT02723955|469678937|FG038|Expansion Phase|Withdrawal by Subject|0|||
130467662|NCT02723955|469678938|FG039|Expansion Phase|Withdrawal by Subject|0|||
130467663|NCT02723955|469678939|FG040|Expansion Phase|Withdrawal by Subject|0|||
130467664|NCT02723955|469678940|FG041|Expansion Phase|Withdrawal by Subject|0|||
130467665|NCT02723955|469678941|FG042|Expansion Phase|Withdrawal by Subject|0|||
130467666|NCT02723955|469678899|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467667|NCT02723955|469678900|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467668|NCT02723955|469678901|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467669|NCT02723955|469678902|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467670|NCT02723955|469678903|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467671|NCT02723955|469678904|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467672|NCT02723955|469678905|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467673|NCT02723955|469678906|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467674|NCT02723955|469678907|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467675|NCT02723955|469678908|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
130380353|NCT01949051|469361214|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
130380354|NCT01949051|469361215|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130380355|NCT01949051|469361216|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130380356|NCT01949051|469361211|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
130467676|NCT02723955|469678909|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
130380357|NCT01949051|469361212|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130380358|NCT01949051|469361213|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130380359|NCT01949051|469361214|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130380360|NCT01949051|469361215|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130380361|NCT01949051|469361216|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130380362|NCT01949051|469361211|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130380363|NCT01949051|469361212|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130380364|NCT01949051|469361213|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130380365|NCT01949051|469361214|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130380366|NCT01949051|469361215|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130380367|NCT01949051|469361216|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
130380368|NCT01949051|469361211|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130380369|NCT01949051|469361212|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
130380370|NCT01949051|469361213|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130380371|NCT01949051|469361214|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130380372|NCT01949051|469361215|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130380373|NCT01949051|469361216|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130380374|NCT01949051|469361211|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130380375|NCT01949051|469361212|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130380376|NCT01949051|469361213|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
130380377|NCT01949051|469361214|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130380378|NCT01949051|469361215|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130380379|NCT01949051|469361216|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130380380|NCT02611778|469361218|FG000|Overall Study|Withdrawal by Subject|2|||
130380381|NCT02611778|469361219|FG001|Overall Study|Withdrawal by Subject|8|||
130380382|NCT02611778|469361218|FG000|Overall Study|Adverse Event|1|||
130380383|NCT02611778|469361219|FG001|Overall Study|Adverse Event|2|||
130380384|NCT02611778|469361218|FG000|Overall Study|Death|2|||
130380385|NCT02611778|469361219|FG001|Overall Study|Death|1|||
130380386|NCT02611778|469361218|FG000|Overall Study|Protocol Violation|1|||
130380387|NCT02611778|469361219|FG001|Overall Study|Protocol Violation|0|||
130380388|NCT02611778|469361218|FG000|Overall Study|Lost to Follow-up|3|||
130380389|NCT02611778|469361219|FG001|Overall Study|Lost to Follow-up|1|||
130380390|NCT02611778|469361218|FG000|Overall Study|Need for alternative treatment|1|||
130380391|NCT02611778|469361219|FG001|Overall Study|Need for alternative treatment|0|||
130380392|NCT02611778|469361218|FG000|Overall Study|Other Reason|2|||
130380393|NCT02611778|469361219|FG001|Overall Study|Other Reason|1|||
130380394|NCT02956486|469361234|FG000|Core Phase|Adverse Event|51|||
130380395|NCT02956486|469361235|FG001|Core Phase|Adverse Event|88|||
130380396|NCT02956486|469361236|FG002|Core Phase|Adverse Event|0|||
130380397|NCT02956486|469361234|FG000|Core Phase|Lost to Follow-up|8|||
130380398|NCT02956486|469361235|FG001|Core Phase|Lost to Follow-up|6|||
130380399|NCT02956486|469361236|FG002|Core Phase|Lost to Follow-up|0|||
130380400|NCT02956486|469361234|FG000|Core Phase|Inadequate therapeutic effect|4|||
130380401|NCT02956486|469361235|FG001|Core Phase|Inadequate therapeutic effect|5|||
130380402|NCT02956486|469361236|FG002|Core Phase|Inadequate therapeutic effect|0|||
130380403|NCT02956486|469361234|FG000|Core Phase|Withdrawal by Subject|101|||
130380404|NCT02956486|469361235|FG001|Core Phase|Withdrawal by Subject|104|||
130380405|NCT02956486|469361236|FG002|Core Phase|Withdrawal by Subject|0|||
130380406|NCT02956486|469361234|FG000|Core Phase|Study terminated by sponsor|888|||
130380407|NCT02956486|469361235|FG001|Core Phase|Study terminated by sponsor|848|||
130380408|NCT02956486|469361236|FG002|Core Phase|Study terminated by sponsor|0|||
130380409|NCT02956486|469361234|FG000|Core Phase|Other|27|||
130380410|NCT02956486|469361235|FG001|Core Phase|Other|18|||
130467677|NCT02723955|469678910|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
130467678|NCT02723955|469678911|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467679|NCT02723955|469678912|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130380411|NCT02956486|469361236|FG002|Core Phase|Other|0|||
130380412|NCT02956486|469361234|FG000|Core Phase|Not treated|0|||
130380413|NCT02956486|469361235|FG001|Core Phase|Not treated|3|||
130380414|NCT02956486|469361236|FG002|Core Phase|Not treated|0|||
130380415|NCT02956486|469361234|FG000|Extension Phase|Adverse Event|0|||
130467680|NCT02723955|469678913|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467681|NCT02723955|469678914|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467682|NCT02723955|469678915|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467683|NCT02723955|469678916|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467684|NCT02723955|469678917|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467685|NCT02723955|469678918|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467686|NCT02723955|469678919|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130380416|NCT02956486|469361235|FG001|Extension Phase|Adverse Event|0|||
130380417|NCT02956486|469361236|FG002|Extension Phase|Adverse Event|2|||
130380418|NCT02956486|469361234|FG000|Extension Phase|Study terminated by sponsor|0|||
130380419|NCT02956486|469361235|FG001|Extension Phase|Study terminated by sponsor|0|||
130380420|NCT02956486|469361236|FG002|Extension Phase|Study terminated by sponsor|16|||
130380421|NCT02956486|469361234|FG000|Extension Phase|Not Treated|0|||
130380422|NCT02956486|469361235|FG001|Extension Phase|Not Treated|0|||
130380423|NCT02956486|469361236|FG002|Extension Phase|Not Treated|1|||
130380424|NCT03325075|469361239|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
130380425|NCT03325075|469361240|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130380426|NCT03325075|469361241|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130380427|NCT03325075|469361242|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130380428|NCT03325075|469361239|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130380429|NCT03325075|469361240|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
130380430|NCT03325075|469361241|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130380431|NCT03325075|469361242|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130380432|NCT03325075|469361239|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
130380433|NCT03325075|469361240|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
130380434|NCT03325075|469361241|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
130380435|NCT03325075|469361242|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
130380436|NCT00422591|469361243|FG000|Overall Study|Physician Decision|4|||
130380437|NCT00422591|469361243|FG000|Overall Study|Withdrawal by Subject|2|||
130380438|NCT01408914|469361246|FG000|Overall Study|Could not complete tx in protocol period|5|||
130380439|NCT01408914|469361247|FG001|Overall Study|Could not complete tx in protocol period|5|||
130380440|NCT01408914|469361248|FG002|Overall Study|Could not complete tx in protocol period|6|||
130380441|NCT01408914|469361246|FG000|Overall Study|Lost to Follow-up|4|||
130380442|NCT01408914|469361247|FG001|Overall Study|Lost to Follow-up|1|||
130380443|NCT01408914|469361248|FG002|Overall Study|Lost to Follow-up|2|||
130380444|NCT01408914|469361246|FG000|Overall Study|Physician Decision|1|||
130380445|NCT01408914|469361247|FG001|Overall Study|Physician Decision|1|||
130380446|NCT01408914|469361248|FG002|Overall Study|Physician Decision|0|||
130380447|NCT01408914|469361246|FG000|Overall Study|Withdrawal by Subject|1|||
130380448|NCT01408914|469361247|FG001|Overall Study|Withdrawal by Subject|0|||
130380449|NCT01408914|469361248|FG002|Overall Study|Withdrawal by Subject|1|||
130380450|NCT01408914|469361246|FG000|Overall Study|Moved out of study jurisdiction|1|||
130380451|NCT01408914|469361247|FG001|Overall Study|Moved out of study jurisdiction|1|||
130380452|NCT01408914|469361248|FG002|Overall Study|Moved out of study jurisdiction|0|||
130380453|NCT01408914|469361246|FG000|Overall Study|Late exclusion|0|||
130380454|NCT01408914|469361247|FG001|Overall Study|Late exclusion|3|||
130380455|NCT01408914|469361248|FG002|Overall Study|Late exclusion|3|||
130380456|NCT01408914|469361246|FG000|Overall Study|Change in local TB/HIV norms|0|||
130380457|NCT01408914|469361247|FG001|Overall Study|Change in local TB/HIV norms|1|||
130380458|NCT01408914|469361248|FG002|Overall Study|Change in local TB/HIV norms|1|||
130380459|NCT00330616|469361249|FG000|Overall Study|Adverse Event|13|||
130380460|NCT00330616|469361249|FG000|Overall Study|Lack of Efficacy|1|||
130380461|NCT00330616|469361249|FG000|Overall Study|Lost to Follow-up|2|||
130380462|NCT00330616|469361249|FG000|Overall Study|Withdrawal by Subject|4|||
130380463|NCT00330616|469361249|FG000|Overall Study|Other|1|||
130380464|NCT00811473|469361252|FG000|Overall Study|Adverse Event|3|||
130380465|NCT00811473|469361253|FG001|Overall Study|Adverse Event|12|||
130380466|NCT00811473|469361252|FG000|Overall Study|Lost to Follow-up|5|||
130380467|NCT00811473|469361253|FG001|Overall Study|Lost to Follow-up|1|||
130380468|NCT00811473|469361252|FG000|Overall Study|Withdrawal by Subject|2|||
130380469|NCT00811473|469361253|FG001|Overall Study|Withdrawal by Subject|4|||
130380470|NCT00811473|469361252|FG000|Overall Study|Severe non-compliance to protocol|2|||
130380471|NCT00811473|469361253|FG001|Overall Study|Severe non-compliance to protocol|4|||
130380472|NCT00811473|469361252|FG000|Overall Study|Lack of therapeutic response|4|||
130380473|NCT00811473|469361253|FG001|Overall Study|Lack of therapeutic response|1|||
130380474|NCT00811473|469361252|FG000|Overall Study|Condition under investigation worsened|1|||
130380475|NCT00811473|469361253|FG001|Overall Study|Condition under investigation worsened|3|||
130380476|NCT00811473|469361252|FG000|Overall Study|Other 2|4|||
130380477|NCT00811473|469361253|FG001|Overall Study|Other 2|1|||
130467687|NCT02723955|469678920|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467688|NCT02723955|469678921|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467689|NCT02723955|469678922|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467690|NCT02723955|469678923|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467691|NCT02723955|469678924|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467692|NCT02723955|469678925|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467693|NCT02723955|469678926|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130380478|NCT00811473|469361252|FG000|Overall Study|Incorrect Enrollment|1|||
130380479|NCT00811473|469361253|FG001|Overall Study|Incorrect Enrollment|0|||
130380480|NCT00811473|469361252|FG000|Overall Study|Safety Reasons|1|||
130380481|NCT00811473|469361253|FG001|Overall Study|Safety Reasons|0|||
130380482|NCT00667368|469361263|FG000|Overall Study|Lost to Follow-up|176|||
130380483|NCT00667368|469361264|FG001|Overall Study|Lost to Follow-up|155|||
130380484|NCT00667368|469361263|FG000|Overall Study|Discontinued early|24|||
130380485|NCT00667368|469361264|FG001|Overall Study|Discontinued early|17|||
130380486|NCT01585194|469361265|FG000|Overall Study|Withdrawal by Subject|1|||
130380487|NCT01585194|469361265|FG000|Overall Study|Physician Decision|2|||
130467694|NCT02723955|469678927|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130380488|NCT01585194|469361265|FG000|Overall Study|Lack of insurance|1|||
130380489|NCT00732615|469361266|FG000|Overall Study|Withdrawal by Subject|3|||
130380490|NCT00732615|469361267|FG001|Overall Study|Withdrawal by Subject|1|||
130380491|NCT00732615|469361266|FG000|Overall Study|Lost to Follow-up|0|||
130380492|NCT00732615|469361267|FG001|Overall Study|Lost to Follow-up|1|||
130380493|NCT00732615|469361266|FG000|Overall Study|Adverse Event|0|||
130380494|NCT00732615|469361267|FG001|Overall Study|Adverse Event|2|||
130380495|NCT00732615|469361266|FG000|Overall Study|Physician Decision|3|||
130380496|NCT00732615|469361267|FG001|Overall Study|Physician Decision|0|||
130380497|NCT00732615|469361266|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
130380498|NCT00732615|469361267|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
130380499|NCT00191789|469361268|FG000|Overall Study|Adverse Event|5|||
130380500|NCT00191789|469361268|FG000|Overall Study|Patient: Satisfactory Response|5|||
130380501|NCT00191789|469361268|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
130380502|NCT00191789|469361268|FG000|Overall Study|Withdrawal by Subject|4|||
130380503|NCT00191789|469361268|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
130380504|NCT00191789|469361268|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
130380505|NCT00191789|469361268|FG000|Overall Study|Death - Not Study-Drug Related|1|||
130380506|NCT01922089|469361271|FG000|Overall Study|Adverse Event|18|||
130380507|NCT01922089|469361272|FG001|Overall Study|Adverse Event|13|||
130380508|NCT01922089|469361271|FG000|Overall Study|Protocol Deviation|10|||
130380509|NCT01922089|469361272|FG001|Overall Study|Protocol Deviation|7|||
130380510|NCT01922089|469361271|FG000|Overall Study|Withdrawal by Subject|3|||
130380511|NCT01922089|469361272|FG001|Overall Study|Withdrawal by Subject|4|||
130380512|NCT01922089|469361271|FG000|Overall Study|administrative problems|4|||
130380513|NCT01922089|469361272|FG001|Overall Study|administrative problems|1|||
130380514|NCT01922089|469361271|FG000|Overall Study|Physician Decision|2|||
130380515|NCT01922089|469361272|FG001|Overall Study|Physician Decision|3|||
130380516|NCT01922089|469361271|FG000|Overall Study|Death|2|||
130380517|NCT01922089|469361272|FG001|Overall Study|Death|1|||
130380518|NCT01922089|469361271|FG000|Overall Study|Lost to Follow-up|0|||
130380519|NCT01922089|469361272|FG001|Overall Study|Lost to Follow-up|1|||
130380520|NCT04903626|469361273|FG000|Overall Study|Lost to Follow-up|6|||
130380521|NCT04903626|469361273|FG000|Overall Study|Withdrawal by Subject|1|||
130380522|NCT04903626|469361273|FG000|Overall Study|Other, Not Specified|1|||
130380523|NCT00165776|469361277|FG000|Overall Study|Lack of Efficacy|0|||
130380524|NCT00165776|469361278|FG001|Overall Study|Lack of Efficacy|0|||
130380525|NCT00165776|469361279|FG002|Overall Study|Lack of Efficacy|0|||
130380526|NCT00165776|469361280|FG003|Overall Study|Lack of Efficacy|1|||
130380527|NCT00165776|469361277|FG000|Overall Study|Withdrawal by Subject|4|||
130722094|NCT03400943|470608167|FG000|Treatment Period 1|Protocol Violation|0|||
130722095|NCT03400943|470608168|FG001|Treatment Period 1|Protocol Violation|1|||
130722096|NCT03400943|470608169|FG002|Treatment Period 1|Protocol Violation|1|||
130722097|NCT03400943|470608170|FG003|Treatment Period 1|Protocol Violation|0|||
130722098|NCT03400943|470608167|FG000|Treatment Period 1|Study terminated by sponsor|2|||
130722099|NCT03400943|470608168|FG001|Treatment Period 1|Study terminated by sponsor|0|||
130722100|NCT03400943|470608169|FG002|Treatment Period 1|Study terminated by sponsor|0|||
130722101|NCT03400943|470608170|FG003|Treatment Period 1|Study terminated by sponsor|1|||
130722102|NCT03400943|470608167|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130722103|NCT03400943|470608168|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130722104|NCT03400943|470608169|FG002|Treatment Period 1|Withdrawal by Subject|3|||
130722105|NCT03400943|470608170|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130722106|NCT03400943|470608167|FG000|Treatment Period 1|Other|2|||
130380528|NCT00165776|469361278|FG001|Overall Study|Withdrawal by Subject|1|||
130380529|NCT00165776|469361279|FG002|Overall Study|Withdrawal by Subject|2|||
130380530|NCT00165776|469361280|FG003|Overall Study|Withdrawal by Subject|0|||
130380531|NCT00165776|469361277|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
130380532|NCT00165776|469361278|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
130380533|NCT00165776|469361279|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
130380534|NCT00165776|469361280|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
130380535|NCT02622321|469361283|FG000|Overall Study|Withdrawal by Subject|2|||
130380536|NCT02622321|469361284|FG001|Overall Study|Withdrawal by Subject|0|||
130380537|NCT02622321|469361285|FG002|Overall Study|Withdrawal by Subject|0|||
130380538|NCT02622321|469361286|FG003|Overall Study|Withdrawal by Subject|0|||
130380539|NCT02622321|469361283|FG000|Overall Study|Death|0|||
130380540|NCT02622321|469361284|FG001|Overall Study|Death|0|||
130380541|NCT02622321|469361285|FG002|Overall Study|Death|1|||
130380542|NCT02622321|469361286|FG003|Overall Study|Death|0|||
130380543|NCT02622321|469361283|FG000|Overall Study|Physician Decision|1|||
130380544|NCT02622321|469361284|FG001|Overall Study|Physician Decision|0|||
130380545|NCT02622321|469361285|FG002|Overall Study|Physician Decision|0|||
130380546|NCT02622321|469361286|FG003|Overall Study|Physician Decision|0|||
130380547|NCT00965718|469361288|FG000|Overall Study|Withdrawal by Subject|4|||
130380548|NCT00241280|469361289|FG000|Overall Study|Adverse Event|2|||
130380549|NCT00241280|469361290|FG001|Overall Study|Adverse Event|6|||
130380550|NCT00241280|469361289|FG000|Overall Study|Discomfort|11|||
130380551|NCT00241280|469361290|FG001|Overall Study|Discomfort|16|||
130380552|NCT00241280|469361289|FG000|Overall Study|Pregnancy|1|||
130380553|NCT00241280|469361290|FG001|Overall Study|Pregnancy|5|||
130380554|NCT00241280|469361289|FG000|Overall Study|Lost to Follow-up|5|||
130380555|NCT00241280|469361290|FG001|Overall Study|Lost to Follow-up|8|||
130380556|NCT00241280|469361289|FG000|Overall Study|Withdrawal by Subject|7|||
130380557|NCT00241280|469361290|FG001|Overall Study|Withdrawal by Subject|4|||
130380558|NCT00241280|469361289|FG000|Overall Study|Protocol Violation|4|||
130380559|NCT00241280|469361290|FG001|Overall Study|Protocol Violation|10|||
130380560|NCT00241280|469361289|FG000|Overall Study|Relocation|4|||
130380561|NCT00241280|469361290|FG001|Overall Study|Relocation|4|||
130380562|NCT00241280|469361289|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
130380563|NCT00241280|469361290|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
130380564|NCT00241280|469361289|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130380565|NCT00241280|469361290|FG001|Overall Study|Unsatisfactory Visual Response|1|||
130380566|NCT00241280|469361289|FG000|Overall Study|Diabetic|1|||
130380567|NCT00241280|469361290|FG001|Overall Study|Diabetic|0|||
130380568|NCT00241280|469361289|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
130380569|NCT00241280|469361290|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
130380570|NCT00241280|469361289|FG000|Overall Study|Dispensed incorrect test article|1|||
130380571|NCT00241280|469361290|FG001|Overall Study|Dispensed incorrect test article|2|||
130380572|NCT00241280|469361289|FG000|Overall Study|Unacceptable Fit|0|||
130380573|NCT00241280|469361290|FG001|Overall Study|Unacceptable Fit|1|||
130380574|NCT00241280|469361289|FG000|Overall Study|Scheduling Conflict|0|||
130380575|NCT00241280|469361290|FG001|Overall Study|Scheduling Conflict|2|||
130380576|NCT00241280|469361289|FG000|Overall Study|History of Ocular Surgery|0|||
130380577|NCT00241280|469361290|FG001|Overall Study|History of Ocular Surgery|1|||
130380578|NCT00241280|469361289|FG000|Overall Study|Coating on Lens|1|||
130380579|NCT00241280|469361290|FG001|Overall Study|Coating on Lens|0|||
130380580|NCT00241280|469361289|FG000|Overall Study|Excessive Dryness|0|||
130380581|NCT00241280|469361290|FG001|Overall Study|Excessive Dryness|1|||
130380582|NCT01850524|469361298|FG000|Overall Study|Lost to Follow-up|5|||
130380583|NCT01850524|469361299|FG001|Overall Study|Lost to Follow-up|10|||
130380584|NCT01850524|469361298|FG000|Overall Study|Withdrawal by Subject|24|||
130380585|NCT01850524|469361299|FG001|Overall Study|Withdrawal by Subject|22|||
130380586|NCT01850524|469361298|FG000|Overall Study|Reason not Specified|142|||
130380587|NCT01850524|469361299|FG001|Overall Study|Reason not Specified|141|||
130380588|NCT00368355|469361300|FG000|Overall Study|Adverse Event|1|||
130380589|NCT00368355|469361301|FG001|Overall Study|Adverse Event|0|||
130380590|NCT00368355|469361300|FG000|Overall Study|Death|2|||
130380591|NCT00368355|469361301|FG001|Overall Study|Death|4|||
130380592|NCT00368355|469361300|FG000|Overall Study|Relapse|6|||
130380593|NCT00368355|469361301|FG001|Overall Study|Relapse|10|||
130380594|NCT00368355|469361300|FG000|Overall Study|Subsequent transplant|0|||
130380595|NCT00368355|469361301|FG001|Overall Study|Subsequent transplant|3|||
130380596|NCT00368355|469361300|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
130380597|NCT00368355|469361301|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
130380598|NCT00396591|469361306|FG000|Overall Study|Disease Progression|13|||
130380599|NCT00396591|469361306|FG000|Overall Study|Adverse Event|2|||
130380600|NCT00396591|469361306|FG000|Overall Study|Participant request|1|||
130380601|NCT01013701|469361307|FG000|Overall Study|study prematurely terminated|7|||
130380602|NCT02671422|469361310|FG000|Overall Study|Lost to Follow-up|1|||
130380603|NCT02671422|469361310|FG000|Overall Study|Adverse Event|68|||
130380604|NCT02671422|469361310|FG000|Overall Study|Lack of Efficacy|1|||
130380605|NCT02671422|469361310|FG000|Overall Study|Lost to Follow-up|4|||
130380606|NCT02671422|469361310|FG000|Overall Study|Withdrawal by Subject|7|||
130380607|NCT02671422|469361310|FG000|Overall Study|Progressive Disease|156|||
130380608|NCT02671422|469361310|FG000|Overall Study|Worsening of Disease|4|||
130380609|NCT02671422|469361310|FG000|Overall Study|Sponsor decision|5|||
130380610|NCT02671422|469361310|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
130380611|NCT02671422|469361310|FG000|Overall Study|Not treated with Vargatef®|3|||
130380612|NCT02671422|469361310|FG000|Overall Study|Other not defined above|3|||
130380613|NCT04772755|469361311|FG000|Overall Study|Withdrawal by Subject|1|||
130380614|NCT04772755|469361312|FG001|Overall Study|Withdrawal by Subject|0|||
130380615|NCT04772755|469361311|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
130380616|NCT04772755|469361312|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
130380617|NCT01905657|469361313|FG000|Overall Study|Adverse Event|23|||
130467695|NCT02723955|469678928|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467696|NCT02723955|469678929|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
130467697|NCT02723955|469678930|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467698|NCT02723955|469678931|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467699|NCT02723955|469678932|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467700|NCT02723955|469678933|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467701|NCT02723955|469678934|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467702|NCT02723955|469678935|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467703|NCT02723955|469678936|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467704|NCT02723955|469678937|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467705|NCT02723955|469678938|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467706|NCT02723955|469678939|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467707|NCT02723955|469678940|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467708|NCT02723955|469678941|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130467709|NCT02723955|469678899|FG000|Expansion Phase|Site Closed|0|||
130467710|NCT02723955|469678900|FG001|Expansion Phase|Site Closed|0|||
130467711|NCT02723955|469678901|FG002|Expansion Phase|Site Closed|0|||
130467712|NCT02723955|469678902|FG003|Expansion Phase|Site Closed|0|||
130467713|NCT02723955|469678903|FG004|Expansion Phase|Site Closed|0|||
130467714|NCT02723955|469678904|FG005|Expansion Phase|Site Closed|0|||
130467715|NCT02723955|469678905|FG006|Expansion Phase|Site Closed|0|||
130467716|NCT02723955|469678906|FG007|Expansion Phase|Site Closed|0|||
130467717|NCT02723955|469678907|FG008|Expansion Phase|Site Closed|0|||
130467718|NCT02723955|469678908|FG009|Expansion Phase|Site Closed|1|||
130467719|NCT02723955|469678909|FG010|Expansion Phase|Site Closed|2|||
130467720|NCT02723955|469678910|FG011|Expansion Phase|Site Closed|6|||
130467721|NCT02723955|469678911|FG012|Expansion Phase|Site Closed|0|||
130467722|NCT02723955|469678912|FG013|Expansion Phase|Site Closed|0|||
130467723|NCT02723955|469678913|FG014|Expansion Phase|Site Closed|0|||
130467724|NCT02723955|469678914|FG015|Expansion Phase|Site Closed|0|||
130467725|NCT02723955|469678915|FG016|Expansion Phase|Site Closed|0|||
130467726|NCT02723955|469678916|FG017|Expansion Phase|Site Closed|0|||
130467727|NCT02723955|469678917|FG018|Expansion Phase|Site Closed|0|||
130467728|NCT02723955|469678918|FG019|Expansion Phase|Site Closed|0|||
130467729|NCT02723955|469678919|FG020|Expansion Phase|Site Closed|0|||
130467730|NCT02723955|469678920|FG021|Expansion Phase|Site Closed|0|||
130467731|NCT02723955|469678921|FG022|Expansion Phase|Site Closed|0|||
130467732|NCT02723955|469678922|FG023|Expansion Phase|Site Closed|0|||
130467733|NCT02723955|469678923|FG024|Expansion Phase|Site Closed|0|||
130467734|NCT02723955|469678924|FG025|Expansion Phase|Site Closed|0|||
130467735|NCT02723955|469678925|FG026|Expansion Phase|Site Closed|0|||
130467736|NCT02723955|469678926|FG027|Expansion Phase|Site Closed|0|||
130467737|NCT02723955|469678927|FG028|Expansion Phase|Site Closed|0|||
130467738|NCT02723955|469678928|FG029|Expansion Phase|Site Closed|0|||
130467739|NCT02723955|469678929|FG030|Expansion Phase|Site Closed|8|||
130467740|NCT02723955|469678930|FG031|Expansion Phase|Site Closed|4|||
130467741|NCT02723955|469678931|FG032|Expansion Phase|Site Closed|2|||
130467742|NCT02723955|469678932|FG033|Expansion Phase|Site Closed|2|||
130380618|NCT01905657|469361314|FG001|Overall Study|Adverse Event|17|||
130380619|NCT01905657|469361315|FG002|Overall Study|Adverse Event|18|||
130380620|NCT01905657|469361313|FG000|Overall Study|Clinical Progression|103|||
130380621|NCT01905657|469361314|FG001|Overall Study|Clinical Progression|78|||
130467743|NCT02723955|469678933|FG034|Expansion Phase|Site Closed|0|||
130467744|NCT02723955|469678934|FG035|Expansion Phase|Site Closed|0|||
130380622|NCT01905657|469361315|FG002|Overall Study|Clinical Progression|59|||
130467745|NCT02723955|469678935|FG036|Expansion Phase|Site Closed|0|||
130380623|NCT01905657|469361313|FG000|Overall Study|Death|40|||
130380624|NCT01905657|469361314|FG001|Overall Study|Death|43|||
130380625|NCT01905657|469361315|FG002|Overall Study|Death|47|||
130467746|NCT02723955|469678936|FG037|Expansion Phase|Site Closed|0|||
130467747|NCT02723955|469678937|FG038|Expansion Phase|Site Closed|0|||
130467748|NCT02723955|469678938|FG039|Expansion Phase|Site Closed|0|||
130380626|NCT01905657|469361313|FG000|Overall Study|Excluded Medication|13|||
130380627|NCT01905657|469361314|FG001|Overall Study|Excluded Medication|16|||
130380628|NCT01905657|469361315|FG002|Overall Study|Excluded Medication|9|||
130380629|NCT01905657|469361313|FG000|Overall Study|Lost to Follow-up|1|||
130380630|NCT01905657|469361314|FG001|Overall Study|Lost to Follow-up|2|||
130380631|NCT01905657|469361315|FG002|Overall Study|Lost to Follow-up|1|||
130380632|NCT01905657|469361313|FG000|Overall Study|Physician Decision|5|||
130380633|NCT01905657|469361314|FG001|Overall Study|Physician Decision|8|||
130380634|NCT01905657|469361315|FG002|Overall Study|Physician Decision|12|||
130380635|NCT01905657|469361313|FG000|Overall Study|Protocol Violation|2|||
130380636|NCT01905657|469361314|FG001|Overall Study|Protocol Violation|1|||
130380637|NCT01905657|469361315|FG002|Overall Study|Protocol Violation|1|||
130380638|NCT01905657|469361313|FG000|Overall Study|Screen Failure|0|||
130380639|NCT01905657|469361314|FG001|Overall Study|Screen Failure|1|||
130380640|NCT01905657|469361315|FG002|Overall Study|Screen Failure|0|||
130380641|NCT01905657|469361313|FG000|Overall Study|Withdrawal by Subject|15|||
130380642|NCT01905657|469361314|FG001|Overall Study|Withdrawal by Subject|21|||
130380643|NCT01905657|469361315|FG002|Overall Study|Withdrawal by Subject|53|||
130380644|NCT01905657|469361313|FG000|Overall Study|Sponsor Decision|1|||
130380645|NCT01905657|469361314|FG001|Overall Study|Sponsor Decision|0|||
130380646|NCT01905657|469361315|FG002|Overall Study|Sponsor Decision|0|||
130380647|NCT04702997|469361316|FG000|Overall Study|Withdrawal by Subject|1|||
130380648|NCT04702997|469361317|FG001|Overall Study|Withdrawal by Subject|1|||
130380649|NCT01386554|469361322|FG000|Overall Study|Lost to Follow-up|0|||
130380650|NCT01386554|469361323|FG001|Overall Study|Lost to Follow-up|0|||
130380651|NCT01386554|469361324|FG002|Overall Study|Lost to Follow-up|1|||
130380652|NCT01386554|469361322|FG000|Overall Study|Adverse Event|2|||
130380653|NCT01386554|469361323|FG001|Overall Study|Adverse Event|5|||
130380654|NCT01386554|469361324|FG002|Overall Study|Adverse Event|2|||
130380655|NCT01386554|469361322|FG000|Overall Study|Progressive disease|1|||
130380656|NCT01386554|469361323|FG001|Overall Study|Progressive disease|2|||
130380657|NCT01386554|469361324|FG002|Overall Study|Progressive disease|2|||
130380658|NCT01386554|469361322|FG000|Overall Study|Administration of live vaccines|0|||
130380659|NCT01386554|469361323|FG001|Overall Study|Administration of live vaccines|1|||
130380660|NCT01386554|469361324|FG002|Overall Study|Administration of live vaccines|0|||
130380661|NCT01386554|469361322|FG000|Overall Study|Investigator discretion|0|||
130380662|NCT01386554|469361323|FG001|Overall Study|Investigator discretion|0|||
130380663|NCT01386554|469361324|FG002|Overall Study|Investigator discretion|1|||
130380664|NCT01386554|469361322|FG000|Overall Study|Reason not collected|0|||
130380665|NCT01386554|469361323|FG001|Overall Study|Reason not collected|1|||
130380666|NCT01386554|469361324|FG002|Overall Study|Reason not collected|0|||
130380667|NCT02879305|469361326|FG000|Overall Study|Investigator Site Closed|55|||
130380668|NCT02879305|469361327|FG001|Overall Study|Investigator Site Closed|57|||
130380669|NCT02879305|469361326|FG000|Overall Study|Withdrawal by Subject|44|||
130380670|NCT02879305|469361327|FG001|Overall Study|Withdrawal by Subject|42|||
130380671|NCT02879305|469361326|FG000|Overall Study|Lost to Follow-up|17|||
130380672|NCT02879305|469361327|FG001|Overall Study|Lost to Follow-up|12|||
130380673|NCT02879305|469361326|FG000|Overall Study|Other|1|||
130380674|NCT02879305|469361327|FG001|Overall Study|Other|0|||
130380675|NCT00001596|469363341|FG000|Overall Study|Death|1|||
130380676|NCT00001596|469363342|FG001|Overall Study|Death|0|||
130380677|NCT00001596|469363341|FG000|Overall Study|Withdrawal by Subject|3|||
130380678|NCT00001596|469363342|FG001|Overall Study|Withdrawal by Subject|1|||
130380679|NCT00001596|469363341|FG000|Overall Study|Study Termination|12|||
130380680|NCT00001596|469363342|FG001|Overall Study|Study Termination|9|||
130380681|NCT00001596|469363341|FG000|Overall Study|Adverse Event|1|||
130380682|NCT00001596|469363342|FG001|Overall Study|Adverse Event|0|||
130380683|NCT00463346|469363344|FG000|Overall Study|Withdrawal by Subject|3|||
130380684|NCT00463346|469363345|FG001|Overall Study|Withdrawal by Subject|3|||
130380685|NCT04067544|469363347|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
130380686|NCT02282020|469363350|FG000|Overall Study|Objective Disease Progression|128|||
130380687|NCT02282020|469363351|FG001|Overall Study|Objective Disease Progression|30|||
130380688|NCT02282020|469363350|FG000|Overall Study|Adverse Event|18|||
130380689|NCT02282020|469363351|FG001|Overall Study|Adverse Event|15|||
130380690|NCT02282020|469363350|FG000|Overall Study|Withdrawal by Subject|7|||
130380691|NCT02282020|469363351|FG001|Overall Study|Withdrawal by Subject|10|||
130380692|NCT02282020|469363350|FG000|Overall Study|Miscellaneous|5|||
130380693|NCT02282020|469363351|FG001|Overall Study|Miscellaneous|19|||
130380694|NCT02282020|469363350|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
130380695|NCT02282020|469363351|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
130380696|NCT02282020|469363350|FG000|Overall Study|Developed Discontinuation Criteria|0|||
130380697|NCT02282020|469363351|FG001|Overall Study|Developed Discontinuation Criteria|2|||
130380698|NCT02282020|469363350|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
130380699|NCT02282020|469363351|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
130380700|NCT00082355|469363352|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
130380701|NCT00082355|469363352|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
130467749|NCT02723955|469678939|FG040|Expansion Phase|Site Closed|0|||
130380702|NCT00082355|469363352|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
130380703|NCT00759863|469363354|FG000|Overall Study|Death, moved, or lost contact|20|||
130380704|NCT00759863|469363355|FG001|Overall Study|Death, moved, or lost contact|18|||
130380705|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
130380706|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
130380707|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
130380708|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
130380709|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
130380710|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
130380711|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
130380712|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
130380713|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Other|4|||
130380714|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Other|1|||
130380715|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
130380716|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
130380717|NCT00303498|469363358|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
130380718|NCT00303498|469363359|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
130380719|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
130380720|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
130380721|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Death|1|||
130380722|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Death|0|||
130380723|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
130380724|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
130380725|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
130380726|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
130380727|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
130380728|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
130380729|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
130380730|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
130380731|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Other|1|||
130380732|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Other|0|||
130380733|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
130380734|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
130380735|NCT00303498|469363358|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
130380736|NCT00303498|469363359|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
130380737|NCT04532099|469363360|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
130380738|NCT04532099|469363361|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
130380739|NCT04532099|469363362|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
130380740|NCT00460031|469363363|FG000|Overall Study|Adverse Event|5|||
130380741|NCT00460031|469363363|FG000|Overall Study|Withdrawal by Subject|5|||
130380742|NCT00460031|469363363|FG000|Overall Study|Death|1|||
130380743|NCT00644995|469363373|FG000|Overall Study|Lost to Follow-up|1|||
130380744|NCT00644995|469363374|FG001|Overall Study|Lost to Follow-up|4|||
130380745|NCT00644995|469363373|FG000|Overall Study|Refused|1|||
130380746|NCT00644995|469363374|FG001|Overall Study|Refused|0|||
130380747|NCT02066233|469363380|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
130380748|NCT02066233|469363381|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
130380749|NCT00103142|469363382|FG000|Overall Study|Adverse Event|1|||
130380750|NCT00103142|469363383|FG001|Overall Study|Adverse Event|0|||
130380751|NCT00103142|469363382|FG000|Overall Study|Progression of disease|2|||
130380752|NCT00103142|469363383|FG001|Overall Study|Progression of disease|1|||
130380753|NCT02772081|469363384|FG000|Overall Study|Physician Decision|1|||
130380754|NCT02772081|469363385|FG001|Overall Study|Physician Decision|1|||
130380755|NCT02772081|469363384|FG000|Overall Study|Death|1|||
130380756|NCT02772081|469363385|FG001|Overall Study|Death|1|||
130380757|NCT02598076|469363386|FG000|Overall Study|Lost to Follow-up|2|||
130380758|NCT02598076|469363387|FG001|Overall Study|Lost to Follow-up|3|||
130380759|NCT01946425|469363388|FG000|Overall Study|Protocol Violation|1|||
130380760|NCT01946425|469363389|FG001|Overall Study|Protocol Violation|0|||
130380761|NCT01946425|469363388|FG000|Overall Study|Withdrawal by Subject|1|||
130380762|NCT01946425|469363389|FG001|Overall Study|Withdrawal by Subject|0|||
130380763|NCT03227029|469363390|FG000|Overall Study|Child Wheezed (no treatment)|0|||
130380764|NCT03227029|469363391|FG001|Overall Study|Child Wheezed (no treatment)|1|||
130380765|NCT03227029|469363392|FG002|Overall Study|Child Wheezed (no treatment)|0|||
130380766|NCT03227029|469363390|FG000|Overall Study|No post RSV season visit due to COVID|3|||
130380767|NCT03227029|469363391|FG001|Overall Study|No post RSV season visit due to COVID|3|||
130380768|NCT03227029|469363392|FG002|Overall Study|No post RSV season visit due to COVID|2|||
130380769|NCT03227029|469363390|FG000|Overall Study|Not able to get to clinic|0|||
130380770|NCT03227029|469363391|FG001|Overall Study|Not able to get to clinic|0|||
130380771|NCT03227029|469363392|FG002|Overall Study|Not able to get to clinic|1|||
130380772|NCT03227029|469363390|FG000|Overall Study|Withdrawal by Subject|1|||
130380773|NCT03227029|469363391|FG001|Overall Study|Withdrawal by Subject|0|||
130380774|NCT03227029|469363392|FG002|Overall Study|Withdrawal by Subject|0|||
130380775|NCT03227029|469363390|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
130380776|NCT03227029|469363391|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
130380777|NCT03227029|469363392|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
130380778|NCT00390858|469363393|FG000|Overall Study|Adverse Event|6|||
130380779|NCT00390858|469363394|FG001|Overall Study|Adverse Event|2|||
130380780|NCT00390858|469363393|FG000|Overall Study|Lack of Efficacy|0|||
130380781|NCT00390858|469363394|FG001|Overall Study|Lack of Efficacy|1|||
130380782|NCT00390858|469363393|FG000|Overall Study|Withdrawal by Subject|3|||
130380783|NCT00390858|469363394|FG001|Overall Study|Withdrawal by Subject|4|||
130380784|NCT01113801|469363395|FG000|Overall Study|Adverse Event|4|||
130380785|NCT01113801|469363396|FG001|Overall Study|Adverse Event|0|||
130380786|NCT01113801|469363397|FG002|Overall Study|Adverse Event|2|||
130380787|NCT01113801|469363398|FG003|Overall Study|Adverse Event|6|||
130380788|NCT01113801|469363395|FG000|Overall Study|Death|4|||
130380789|NCT01113801|469363396|FG001|Overall Study|Death|5|||
130380790|NCT01113801|469363397|FG002|Overall Study|Death|3|||
130380791|NCT01113801|469363398|FG003|Overall Study|Death|4|||
130380792|NCT01113801|469363395|FG000|Overall Study|Protocol Violation|0|||
130380793|NCT01113801|469363396|FG001|Overall Study|Protocol Violation|1|||
130380794|NCT01113801|469363397|FG002|Overall Study|Protocol Violation|0|||
130380795|NCT01113801|469363398|FG003|Overall Study|Protocol Violation|0|||
130380796|NCT01113801|469363395|FG000|Overall Study|Withdrawal by Subject|9|||
130380797|NCT01113801|469363396|FG001|Overall Study|Withdrawal by Subject|7|||
130380798|NCT01113801|469363397|FG002|Overall Study|Withdrawal by Subject|7|||
130380799|NCT01113801|469363398|FG003|Overall Study|Withdrawal by Subject|8|||
130380800|NCT01113801|469363395|FG000|Overall Study|Physician Decision|2|||
130380801|NCT01113801|469363396|FG001|Overall Study|Physician Decision|2|||
130380802|NCT01113801|469363397|FG002|Overall Study|Physician Decision|3|||
130380803|NCT01113801|469363398|FG003|Overall Study|Physician Decision|3|||
130380804|NCT01113801|469363395|FG000|Overall Study|Sponsor Decision|15|||
130380805|NCT01113801|469363396|FG001|Overall Study|Sponsor Decision|21|||
130380806|NCT01113801|469363397|FG002|Overall Study|Sponsor Decision|20|||
130380807|NCT01113801|469363398|FG003|Overall Study|Sponsor Decision|15|||
130380808|NCT01113801|469363395|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
130380809|NCT01113801|469363396|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
130380810|NCT01113801|469363397|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
130380811|NCT01113801|469363398|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
130380812|NCT01506479|469363399|FG000|Overall Study|Lost to Follow-up|1|||
130380813|NCT01506479|469363400|FG001|Overall Study|Lost to Follow-up|2|||
130380814|NCT01506479|469363401|FG002|Overall Study|Lost to Follow-up|2|||
130380815|NCT01506479|469363399|FG000|Overall Study|Withdrawal by Subject|1|||
130380816|NCT01506479|469363400|FG001|Overall Study|Withdrawal by Subject|2|||
130380817|NCT01506479|469363401|FG002|Overall Study|Withdrawal by Subject|1|||
130380818|NCT01506479|469363399|FG000|Overall Study|Missing assessment|1|||
130380819|NCT01506479|469363400|FG001|Overall Study|Missing assessment|0|||
130380820|NCT01506479|469363401|FG002|Overall Study|Missing assessment|0|||
130380821|NCT01506479|469363399|FG000|Overall Study|Adverse Event|0|||
130380822|NCT01506479|469363400|FG001|Overall Study|Adverse Event|1|||
130380823|NCT01506479|469363401|FG002|Overall Study|Adverse Event|0|||
130380824|NCT01782859|469363402|FG000|Overall Study|Protocol Violation|6|||
130380825|NCT01782859|469363403|FG001|Overall Study|Protocol Violation|6|||
130467750|NCT02723955|469678940|FG041|Expansion Phase|Site Closed|0|||
130467751|NCT02723955|469678941|FG042|Expansion Phase|Site Closed|0|||
130467752|NCT02723955|469678899|FG000|Crossover/ Re-treatment Phase|Death|0|||
130467753|NCT02723955|469678900|FG001|Crossover/ Re-treatment Phase|Death|0|||
130467754|NCT02723955|469678901|FG002|Crossover/ Re-treatment Phase|Death|0|||
130467755|NCT02723955|469678902|FG003|Crossover/ Re-treatment Phase|Death|0|||
130467756|NCT02723955|469678903|FG004|Crossover/ Re-treatment Phase|Death|0|||
130380826|NCT01782859|469363402|FG000|Overall Study|Withdrawal by Subject|0|||
130380827|NCT01782859|469363403|FG001|Overall Study|Withdrawal by Subject|1|||
130380828|NCT03318315|469363406|FG000|Overall Study|Lost to Follow-up|3|||
130380829|NCT03318315|469363407|FG001|Overall Study|Lost to Follow-up|2|||
130380830|NCT03318315|469363408|FG002|Overall Study|Lost to Follow-up|1|||
130380831|NCT03318315|469363406|FG000|Overall Study|Protocol Violation|1|||
130380832|NCT03318315|469363407|FG001|Overall Study|Protocol Violation|1|||
130380833|NCT03318315|469363408|FG002|Overall Study|Protocol Violation|1|||
130380834|NCT03318315|469363406|FG000|Overall Study|Withdrawal by Subject|0|||
130380835|NCT03318315|469363407|FG001|Overall Study|Withdrawal by Subject|0|||
130380836|NCT03318315|469363408|FG002|Overall Study|Withdrawal by Subject|2|||
130380837|NCT01896531|469363409|FG000|Overall Study|Death|57|||
130467757|NCT02723955|469678904|FG005|Crossover/ Re-treatment Phase|Death|0|||
130722107|NCT03400943|470608168|FG001|Treatment Period 1|Other|1|||
130380838|NCT01896531|469363410|FG001|Overall Study|Death|59|||
130380839|NCT01896531|469363409|FG000|Overall Study|Lost to Follow-up|3|||
130380840|NCT01896531|469363410|FG001|Overall Study|Lost to Follow-up|0|||
130380841|NCT01896531|469363409|FG000|Overall Study|Non-compliance|0|||
130380842|NCT01896531|469363410|FG001|Overall Study|Non-compliance|1|||
130722108|NCT03400943|470608169|FG002|Treatment Period 1|Other|2|||
130467758|NCT02723955|469678905|FG006|Crossover/ Re-treatment Phase|Death|0|||
130467759|NCT02723955|469678906|FG007|Crossover/ Re-treatment Phase|Death|0|||
130467760|NCT02723955|469678907|FG008|Crossover/ Re-treatment Phase|Death|0|||
130467761|NCT02723955|469678908|FG009|Crossover/ Re-treatment Phase|Death|0|||
130467762|NCT02723955|469678909|FG010|Crossover/ Re-treatment Phase|Death|0|||
130467763|NCT02723955|469678910|FG011|Crossover/ Re-treatment Phase|Death|0|||
130467764|NCT02723955|469678911|FG012|Crossover/ Re-treatment Phase|Death|0|||
130467765|NCT02723955|469678912|FG013|Crossover/ Re-treatment Phase|Death|0|||
130467766|NCT02723955|469678913|FG014|Crossover/ Re-treatment Phase|Death|0|||
130467767|NCT02723955|469678914|FG015|Crossover/ Re-treatment Phase|Death|0|||
130467768|NCT02723955|469678915|FG016|Crossover/ Re-treatment Phase|Death|0|||
130467769|NCT02723955|469678916|FG017|Crossover/ Re-treatment Phase|Death|0|||
130467770|NCT02723955|469678917|FG018|Crossover/ Re-treatment Phase|Death|0|||
130467771|NCT02723955|469678918|FG019|Crossover/ Re-treatment Phase|Death|0|||
130467772|NCT02723955|469678919|FG020|Crossover/ Re-treatment Phase|Death|0|||
130467773|NCT02723955|469678920|FG021|Crossover/ Re-treatment Phase|Death|0|||
130467774|NCT02723955|469678921|FG022|Crossover/ Re-treatment Phase|Death|0|||
130467775|NCT02723955|469678922|FG023|Crossover/ Re-treatment Phase|Death|0|||
130467776|NCT02723955|469678923|FG024|Crossover/ Re-treatment Phase|Death|0|||
130467777|NCT02723955|469678924|FG025|Crossover/ Re-treatment Phase|Death|0|||
130380843|NCT01896531|469363409|FG000|Overall Study|Study Ended by Sponsor|7|||
130380844|NCT01896531|469363410|FG001|Overall Study|Study Ended by Sponsor|20|||
130722109|NCT03400943|470608170|FG003|Treatment Period 1|Other|2|||
130722110|NCT03400943|470608167|FG000|Post-treatment Period 1|Adverse Event|2|||
130380845|NCT01896531|469363409|FG000|Overall Study|Withdrawal by Subject|3|||
130380846|NCT01896531|469363410|FG001|Overall Study|Withdrawal by Subject|2|||
130380847|NCT01896531|469363409|FG000|Overall Study|Death Prior to Treatment|1|||
130380848|NCT01896531|469363410|FG001|Overall Study|Death Prior to Treatment|0|||
130380849|NCT00770289|469363413|FG000|Overall Study|Other|6|||
130380850|NCT02659631|469363414|FG000|Overall Study|Lost to Follow-up|0|||
130380851|NCT02659631|469363415|FG001|Overall Study|Lost to Follow-up|0|||
130380852|NCT02659631|469363416|FG002|Overall Study|Lost to Follow-up|2|||
130380853|NCT02659631|469363417|FG003|Overall Study|Lost to Follow-up|0|||
130380854|NCT02659631|469363418|FG004|Overall Study|Lost to Follow-up|0|||
130380855|NCT02659631|469363419|FG005|Overall Study|Lost to Follow-up|1|||
130380856|NCT02659631|469363420|FG006|Overall Study|Lost to Follow-up|0|||
130380857|NCT02659631|469363421|FG007|Overall Study|Lost to Follow-up|0|||
130380858|NCT02659631|469363422|FG008|Overall Study|Lost to Follow-up|0|||
130380859|NCT02659631|469363423|FG009|Overall Study|Lost to Follow-up|0|||
130380860|NCT02659631|469363414|FG000|Overall Study|Withdrawal prior to treatment|0|||
130380861|NCT02659631|469363415|FG001|Overall Study|Withdrawal prior to treatment|0|||
130380862|NCT02659631|469363416|FG002|Overall Study|Withdrawal prior to treatment|0|||
130380863|NCT02659631|469363417|FG003|Overall Study|Withdrawal prior to treatment|0|||
130380864|NCT02659631|469363418|FG004|Overall Study|Withdrawal prior to treatment|1|||
130380865|NCT02659631|469363419|FG005|Overall Study|Withdrawal prior to treatment|0|||
130380866|NCT02659631|469363420|FG006|Overall Study|Withdrawal prior to treatment|0|||
130380867|NCT02659631|469363421|FG007|Overall Study|Withdrawal prior to treatment|0|||
130380868|NCT02659631|469363422|FG008|Overall Study|Withdrawal prior to treatment|0|||
130380869|NCT02659631|469363423|FG009|Overall Study|Withdrawal prior to treatment|0|||
130380870|NCT02659631|469363414|FG000|Overall Study|Participant refused further follow-up|0|||
130380871|NCT02659631|469363415|FG001|Overall Study|Participant refused further follow-up|0|||
130380872|NCT02659631|469363416|FG002|Overall Study|Participant refused further follow-up|0|||
130380873|NCT02659631|469363417|FG003|Overall Study|Participant refused further follow-up|1|||
130380874|NCT02659631|469363418|FG004|Overall Study|Participant refused further follow-up|0|||
130380875|NCT02659631|469363419|FG005|Overall Study|Participant refused further follow-up|0|||
130380876|NCT02659631|469363420|FG006|Overall Study|Participant refused further follow-up|0|||
130380877|NCT02659631|469363421|FG007|Overall Study|Participant refused further follow-up|0|||
130380878|NCT02659631|469363422|FG008|Overall Study|Participant refused further follow-up|1|||
130380879|NCT02659631|469363423|FG009|Overall Study|Participant refused further follow-up|0|||
130380880|NCT02659631|469363414|FG000|Overall Study|Death (follow-up phase)|1|||
130380881|NCT02659631|469363415|FG001|Overall Study|Death (follow-up phase)|2|||
130380882|NCT02659631|469363416|FG002|Overall Study|Death (follow-up phase)|1|||
130380883|NCT02659631|469363417|FG003|Overall Study|Death (follow-up phase)|1|||
130380884|NCT02659631|469363418|FG004|Overall Study|Death (follow-up phase)|3|||
130380885|NCT02659631|469363419|FG005|Overall Study|Death (follow-up phase)|2|||
130467778|NCT02723955|469678925|FG026|Crossover/ Re-treatment Phase|Death|0|||
130467779|NCT02723955|469678926|FG027|Crossover/ Re-treatment Phase|Death|0|||
130467780|NCT02723955|469678927|FG028|Crossover/ Re-treatment Phase|Death|0|||
130467781|NCT02723955|469678928|FG029|Crossover/ Re-treatment Phase|Death|0|||
130467782|NCT02723955|469678929|FG030|Crossover/ Re-treatment Phase|Death|0|||
130467783|NCT02723955|469678930|FG031|Crossover/ Re-treatment Phase|Death|0|||
130467784|NCT02723955|469678931|FG032|Crossover/ Re-treatment Phase|Death|0|||
130467785|NCT02723955|469678932|FG033|Crossover/ Re-treatment Phase|Death|0|||
130467786|NCT02723955|469678933|FG034|Crossover/ Re-treatment Phase|Death|0|||
130467787|NCT02723955|469678934|FG035|Crossover/ Re-treatment Phase|Death|0|||
130467788|NCT02723955|469678935|FG036|Crossover/ Re-treatment Phase|Death|0|||
130467789|NCT02723955|469678936|FG037|Crossover/ Re-treatment Phase|Death|1|||
130467790|NCT02723955|469678937|FG038|Crossover/ Re-treatment Phase|Death|14|||
130467791|NCT02723955|469678938|FG039|Crossover/ Re-treatment Phase|Death|32|||
130467792|NCT02723955|469678939|FG040|Crossover/ Re-treatment Phase|Death|2|||
130467793|NCT02723955|469678940|FG041|Crossover/ Re-treatment Phase|Death|1|||
130467794|NCT02723955|469678941|FG042|Crossover/ Re-treatment Phase|Death|0|||
130467795|NCT02723955|469678899|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467796|NCT02723955|469678900|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467797|NCT02723955|469678901|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467798|NCT02723955|469678902|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467799|NCT02723955|469678903|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467800|NCT02723955|469678904|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467801|NCT02723955|469678905|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130722111|NCT03400943|470608168|FG001|Post-treatment Period 1|Adverse Event|0|||
130467802|NCT02723955|469678906|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467803|NCT02723955|469678907|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467804|NCT02723955|469678908|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467805|NCT02723955|469678909|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467806|NCT02723955|469678910|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467807|NCT02723955|469678911|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467808|NCT02723955|469678912|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467809|NCT02723955|469678913|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467810|NCT02723955|469678914|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467811|NCT02723955|469678915|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467812|NCT02723955|469678916|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467813|NCT02723955|469678917|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467814|NCT02723955|469678918|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467815|NCT02723955|469678919|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467816|NCT02723955|469678920|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467817|NCT02723955|469678921|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467818|NCT02723955|469678922|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467819|NCT02723955|469678923|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467820|NCT02723955|469678924|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467821|NCT02723955|469678925|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467822|NCT02723955|469678926|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467823|NCT02723955|469678927|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467824|NCT02723955|469678928|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467825|NCT02723955|469678929|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467826|NCT02723955|469678930|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467827|NCT02723955|469678931|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467828|NCT02723955|469678932|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467829|NCT02723955|469678933|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467830|NCT02723955|469678934|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467831|NCT02723955|469678935|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467832|NCT02723955|469678936|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467833|NCT02723955|469678937|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467834|NCT02723955|469678938|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
130467835|NCT02723955|469678939|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467836|NCT02723955|469678940|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467837|NCT02723955|469678941|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130467838|NCT02723955|469678899|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467839|NCT02723955|469678900|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467840|NCT02723955|469678901|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467841|NCT02723955|469678902|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467842|NCT02723955|469678903|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467843|NCT02723955|469678904|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
130722112|NCT03400943|470608169|FG002|Post-treatment Period 1|Adverse Event|0|||
130722113|NCT03400943|470608170|FG003|Post-treatment Period 1|Adverse Event|0|||
130722114|NCT03400943|470608167|FG000|Post-treatment Period 1|Protocol Violation|1|||
130722115|NCT03400943|470608168|FG001|Post-treatment Period 1|Protocol Violation|0|||
130722116|NCT03400943|470608169|FG002|Post-treatment Period 1|Protocol Violation|0|||
130467844|NCT02723955|469678905|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467845|NCT02723955|469678906|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467846|NCT02723955|469678907|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467847|NCT02723955|469678908|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467848|NCT02723955|469678909|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467849|NCT02723955|469678910|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467850|NCT02723955|469678911|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467851|NCT02723955|469678912|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
130380886|NCT02659631|469363420|FG006|Overall Study|Death (follow-up phase)|0|||
130380887|NCT02659631|469363421|FG007|Overall Study|Death (follow-up phase)|3|||
130380888|NCT02659631|469363422|FG008|Overall Study|Death (follow-up phase)|1|||
130380889|NCT02659631|469363423|FG009|Overall Study|Death (follow-up phase)|0|||
130380890|NCT02659631|469363414|FG000|Overall Study|Death (treatment phase)|0|||
130380891|NCT02659631|469363415|FG001|Overall Study|Death (treatment phase)|0|||
130380892|NCT02659631|469363416|FG002|Overall Study|Death (treatment phase)|0|||
130380893|NCT02659631|469363417|FG003|Overall Study|Death (treatment phase)|0|||
130380894|NCT02659631|469363418|FG004|Overall Study|Death (treatment phase)|1|||
130380895|NCT02659631|469363419|FG005|Overall Study|Death (treatment phase)|0|||
130380896|NCT02659631|469363420|FG006|Overall Study|Death (treatment phase)|1|||
130380897|NCT02659631|469363421|FG007|Overall Study|Death (treatment phase)|0|||
130380898|NCT02659631|469363422|FG008|Overall Study|Death (treatment phase)|0|||
130380899|NCT02659631|469363423|FG009|Overall Study|Death (treatment phase)|0|||
130380900|NCT02377466|469363424|FG000|Overall Study|Other: Randomized and not treated|0|||
130380901|NCT02377466|469363425|FG001|Overall Study|Other: Randomized and not treated|2|||
130380902|NCT00495170|469363426|FG000|Overall Study|Lost to Follow-up|9|||
130380903|NCT00495170|469363426|FG000|Overall Study|Withdrawal by Subject|3|||
130380904|NCT00495170|469363426|FG000|Overall Study|Inappropriate staging|8|||
130380905|NCT04210310|469363427|FG000|Overall Study|Lost to Follow-up|32|||
130380906|NCT04210310|469363428|FG001|Overall Study|Lost to Follow-up|1|||
130380907|NCT02049957|469363437|FG000|Overall Study|Progressive Disease|5|||
130380908|NCT02049957|469363438|FG001|Overall Study|Progressive Disease|4|||
130380909|NCT02049957|469363439|FG002|Overall Study|Progressive Disease|2|||
130380910|NCT02049957|469363440|FG003|Overall Study|Progressive Disease|2|||
130380911|NCT02049957|469363441|FG004|Overall Study|Progressive Disease|6|||
130380912|NCT02049957|469363442|FG005|Overall Study|Progressive Disease|35|||
130380913|NCT02049957|469363443|FG006|Overall Study|Progressive Disease|7|||
130380914|NCT02049957|469363444|FG007|Overall Study|Progressive Disease|26|||
130380915|NCT02049957|469363445|FG008|Overall Study|Progressive Disease|6|||
130380916|NCT02049957|469363437|FG000|Overall Study|Adverse Event|1|||
130380917|NCT02049957|469363438|FG001|Overall Study|Adverse Event|1|||
130380918|NCT02049957|469363439|FG002|Overall Study|Adverse Event|1|||
130380919|NCT02049957|469363440|FG003|Overall Study|Adverse Event|0|||
130380920|NCT02049957|469363441|FG004|Overall Study|Adverse Event|0|||
130380921|NCT02049957|469363442|FG005|Overall Study|Adverse Event|5|||
130380922|NCT02049957|469363443|FG006|Overall Study|Adverse Event|0|||
130380923|NCT02049957|469363444|FG007|Overall Study|Adverse Event|6|||
130380924|NCT02049957|469363445|FG008|Overall Study|Adverse Event|1|||
130380925|NCT02049957|469363437|FG000|Overall Study|Study Terminated by Sponsor|0|||
130380926|NCT02049957|469363438|FG001|Overall Study|Study Terminated by Sponsor|1|||
130380927|NCT02049957|469363439|FG002|Overall Study|Study Terminated by Sponsor|0|||
130380928|NCT02049957|469363440|FG003|Overall Study|Study Terminated by Sponsor|0|||
130380929|NCT02049957|469363441|FG004|Overall Study|Study Terminated by Sponsor|0|||
130380930|NCT02049957|469363442|FG005|Overall Study|Study Terminated by Sponsor|0|||
130380931|NCT02049957|469363443|FG006|Overall Study|Study Terminated by Sponsor|1|||
130380932|NCT02049957|469363444|FG007|Overall Study|Study Terminated by Sponsor|0|||
130380933|NCT02049957|469363445|FG008|Overall Study|Study Terminated by Sponsor|0|||
130380934|NCT02049957|469363437|FG000|Overall Study|Withdrawal by Subject|0|||
130380935|NCT02049957|469363438|FG001|Overall Study|Withdrawal by Subject|0|||
130380936|NCT02049957|469363439|FG002|Overall Study|Withdrawal by Subject|0|||
130380937|NCT02049957|469363440|FG003|Overall Study|Withdrawal by Subject|1|||
130380938|NCT02049957|469363441|FG004|Overall Study|Withdrawal by Subject|0|||
130380939|NCT02049957|469363442|FG005|Overall Study|Withdrawal by Subject|2|||
130380940|NCT02049957|469363443|FG006|Overall Study|Withdrawal by Subject|0|||
130380941|NCT02049957|469363444|FG007|Overall Study|Withdrawal by Subject|3|||
130380942|NCT02049957|469363445|FG008|Overall Study|Withdrawal by Subject|1|||
130380943|NCT02049957|469363437|FG000|Overall Study|Physician Decision|0|||
130380944|NCT02049957|469363438|FG001|Overall Study|Physician Decision|0|||
130380945|NCT02049957|469363439|FG002|Overall Study|Physician Decision|0|||
130380946|NCT02049957|469363440|FG003|Overall Study|Physician Decision|0|||
130380947|NCT02049957|469363441|FG004|Overall Study|Physician Decision|0|||
130380948|NCT02049957|469363442|FG005|Overall Study|Physician Decision|1|||
130380949|NCT02049957|469363443|FG006|Overall Study|Physician Decision|0|||
130380950|NCT02049957|469363444|FG007|Overall Study|Physician Decision|0|||
130467852|NCT02723955|469678913|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467853|NCT02723955|469678914|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
130380951|NCT02049957|469363445|FG008|Overall Study|Physician Decision|0|||
130467854|NCT02723955|469678915|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
130380952|NCT01958008|469363446|FG000|Overall Study|Worsening of disease under study|0|||
130380953|NCT01958008|469363447|FG001|Overall Study|Worsening of disease under study|0|||
130380954|NCT01958008|469363448|FG002|Overall Study|Worsening of disease under study|1|||
130380955|NCT01958008|469363449|FG003|Overall Study|Worsening of disease under study|0|||
130380956|NCT01958008|469363446|FG000|Overall Study|Other adverse event|1|||
130467855|NCT02723955|469678916|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
130380957|NCT01958008|469363447|FG001|Overall Study|Other adverse event|0|||
130380958|NCT01958008|469363448|FG002|Overall Study|Other adverse event|0|||
130467856|NCT02723955|469678917|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467857|NCT02723955|469678918|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467858|NCT02723955|469678919|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467859|NCT02723955|469678920|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467860|NCT02723955|469678921|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467861|NCT02723955|469678922|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467862|NCT02723955|469678923|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467863|NCT02723955|469678924|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467864|NCT02723955|469678925|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467865|NCT02723955|469678926|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467866|NCT02723955|469678927|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467867|NCT02723955|469678928|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467868|NCT02723955|469678929|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467869|NCT02723955|469678930|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467870|NCT02723955|469678931|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467871|NCT02723955|469678932|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467872|NCT02723955|469678933|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467873|NCT02723955|469678934|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467874|NCT02723955|469678935|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467875|NCT02723955|469678936|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467876|NCT02723955|469678937|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
130467877|NCT02723955|469678938|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
130467878|NCT02723955|469678939|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467879|NCT02723955|469678940|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
130467880|NCT02723955|469678941|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
130467881|NCT02723955|469678899|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
130467882|NCT02723955|469678900|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
130467883|NCT02723955|469678901|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
130467884|NCT02723955|469678902|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
130467885|NCT02723955|469678903|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
130467886|NCT02723955|469678904|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
130467887|NCT02723955|469678905|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
130467888|NCT02723955|469678906|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
130467889|NCT02723955|469678907|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
130467890|NCT02723955|469678908|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
130467891|NCT02723955|469678909|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
130467892|NCT02723955|469678910|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
130467893|NCT02723955|469678911|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
130467894|NCT02723955|469678912|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
130467895|NCT02723955|469678913|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
130467896|NCT02723955|469678914|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
130467897|NCT02723955|469678915|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
130467898|NCT02723955|469678916|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
130467899|NCT02723955|469678917|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
130722117|NCT03400943|470608170|FG003|Post-treatment Period 1|Protocol Violation|0|||
130380959|NCT01958008|469363449|FG003|Overall Study|Other adverse event|0|||
130380960|NCT01634360|469363450|FG000|Overall Study|Adverse Event|10|||
130380961|NCT01634360|469363451|FG001|Overall Study|Adverse Event|34|||
130380962|NCT01634360|469363450|FG000|Overall Study|subject withdrew consent|13|||
130380963|NCT01634360|469363451|FG001|Overall Study|subject withdrew consent|23|||
130380964|NCT01634360|469363450|FG000|Overall Study|Protocol Violation|1|||
130380965|NCT01634360|469363451|FG001|Overall Study|Protocol Violation|1|||
130380966|NCT01634360|469363450|FG000|Overall Study|Lack of Efficacy|4|||
130380967|NCT01634360|469363451|FG001|Overall Study|Lack of Efficacy|14|||
130380968|NCT01634360|469363450|FG000|Overall Study|Other|3|||
130380969|NCT01634360|469363451|FG001|Overall Study|Other|20|||
130380970|NCT01634360|469363450|FG000|Overall Study|Study termination by sponsor|18|||
130380971|NCT01634360|469363451|FG001|Overall Study|Study termination by sponsor|44|||
130380972|NCT02028065|469363452|FG000|Randomization Through Start Treatment|Not treated|1|||
130380973|NCT02028065|469363453|FG001|Randomization Through Start Treatment|Not treated|3|||
130380974|NCT02028065|469363454|FG002|Randomization Through Start Treatment|Not treated|3|||
130380975|NCT02028065|469363452|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
130380976|NCT02028065|469363453|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
130380977|NCT02028065|469363454|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
130380978|NCT02028065|469363452|FG000|Treatment Through Study Completion|Physician Decision|1|||
130380979|NCT02028065|469363453|FG001|Treatment Through Study Completion|Physician Decision|0|||
130380980|NCT02028065|469363454|FG002|Treatment Through Study Completion|Physician Decision|0|||
130380981|NCT02028065|469363452|FG000|Treatment Through Study Completion|Protocol Violation|1|||
130380982|NCT02028065|469363453|FG001|Treatment Through Study Completion|Protocol Violation|4|||
130380983|NCT02028065|469363454|FG002|Treatment Through Study Completion|Protocol Violation|0|||
130380984|NCT02028065|469363452|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
130467900|NCT02723955|469678918|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
130467901|NCT02723955|469678919|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
130467902|NCT02723955|469678920|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
130467903|NCT02723955|469678921|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
130467904|NCT02723955|469678922|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
130467905|NCT02723955|469678923|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
130467906|NCT02723955|469678924|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
130467907|NCT02723955|469678925|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
130467908|NCT02723955|469678926|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
130467909|NCT02723955|469678927|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
130467910|NCT02723955|469678928|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
130467911|NCT02723955|469678929|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
130467912|NCT02723955|469678930|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
130467913|NCT02723955|469678931|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
130467914|NCT02723955|469678932|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
130467915|NCT02723955|469678933|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
130467916|NCT02723955|469678934|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
130467917|NCT02723955|469678935|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
130467918|NCT02723955|469678936|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
130467919|NCT02723955|469678937|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
130467920|NCT02723955|469678938|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
130467921|NCT02723955|469678939|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
130467922|NCT02723955|469678940|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
130467923|NCT02723955|469678941|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
130380985|NCT02028065|469363453|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
130467924|NCT04300647|469678942|FG000|Pre-Crossover|Death|19|||
130467925|NCT04300647|469678943|FG001|Pre-Crossover|Death|58|||
130467926|NCT04300647|469678944|FG002|Pre-Crossover|Death|0|||
130467927|NCT04300647|469678942|FG000|Pre-Crossover|Lost to Follow-up|0|||
130467928|NCT04300647|469678943|FG001|Pre-Crossover|Lost to Follow-up|3|||
130467929|NCT04300647|469678944|FG002|Pre-Crossover|Lost to Follow-up|0|||
130467930|NCT04300647|469678942|FG000|Pre-Crossover|Withdrawal by Subject|2|||
130467931|NCT04300647|469678943|FG001|Pre-Crossover|Withdrawal by Subject|4|||
130467932|NCT04300647|469678944|FG002|Pre-Crossover|Withdrawal by Subject|0|||
130467933|NCT04300647|469678942|FG000|Pre-Crossover|On-going in Study|24|||
130467934|NCT04300647|469678943|FG001|Pre-Crossover|On-going in Study|61|||
130467935|NCT04300647|469678944|FG002|Pre-Crossover|On-going in Study|0|||
130467936|NCT04300647|469678942|FG000|Post-Crossover|Death|0|||
130467937|NCT04300647|469678943|FG001|Post-Crossover|Death|0|||
130467938|NCT04300647|469678944|FG002|Post-Crossover|Death|3|||
130380986|NCT02028065|469363454|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
130380987|NCT02028065|469363452|FG000|Treatment Through Study Completion|Adverse Event|3|||
130380988|NCT02028065|469363453|FG001|Treatment Through Study Completion|Adverse Event|3|||
130380989|NCT02028065|469363454|FG002|Treatment Through Study Completion|Adverse Event|5|||
130380990|NCT01414855|469363457|FG000|Overall Study|Death|17|||
130380991|NCT01414855|469363457|FG000|Overall Study|Lost to Follow-up|5|||
130380992|NCT01414855|469363457|FG000|Overall Study|Withdrawal by Subject|7|||
130380993|NCT00877383|469363461|FG000|Overall Study|Adverse Event|13|||
130380994|NCT00877383|469363462|FG001|Overall Study|Adverse Event|14|||
130380995|NCT00877383|469363461|FG000|Overall Study|Lost to Follow-up|5|||
130380996|NCT00877383|469363462|FG001|Overall Study|Lost to Follow-up|3|||
130380997|NCT00877383|469363461|FG000|Overall Study|Subject withdrew consent|3|||
130380998|NCT00877383|469363462|FG001|Overall Study|Subject withdrew consent|12|||
130380999|NCT00877383|469363461|FG000|Overall Study|Subject no longer requires study drug|2|||
130381000|NCT00877383|469363462|FG001|Overall Study|Subject no longer requires study drug|0|||
130381001|NCT00877383|469363461|FG000|Overall Study|Administrative problems|2|||
130381002|NCT00877383|469363462|FG001|Overall Study|Administrative problems|0|||
130381003|NCT00877383|469363461|FG000|Overall Study|Protocol deviation|2|||
130381004|NCT00877383|469363462|FG001|Overall Study|Protocol deviation|6|||
130381005|NCT00877383|469363461|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130381006|NCT00877383|469363462|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130467939|NCT04300647|469678942|FG000|Post-Crossover|Lost to Follow-up|0|||
130467940|NCT04300647|469678943|FG001|Post-Crossover|Lost to Follow-up|0|||
130467941|NCT04300647|469678944|FG002|Post-Crossover|Lost to Follow-up|1|||
130467942|NCT04300647|469678942|FG000|Post-Crossover|Withdrawal by Subject|0|||
130381007|NCT00877383|469363461|FG000|Overall Study|Death|1|||
130381008|NCT00877383|469363462|FG001|Overall Study|Death|2|||
130467943|NCT04300647|469678943|FG001|Post-Crossover|Withdrawal by Subject|0|||
130467944|NCT04300647|469678944|FG002|Post-Crossover|Withdrawal by Subject|1|||
130467945|NCT04300647|469678942|FG000|Post-Crossover|On-going in Study|0|||
130467946|NCT04300647|469678943|FG001|Post-Crossover|On-going in Study|0|||
130467947|NCT04300647|469678944|FG002|Post-Crossover|On-going in Study|8|||
130381009|NCT04851314|469363463|FG000|Overall Study|Unable to complete research set-up procedures|0|||
130467948|NCT04999085|469678947|FG000|Overall Study|Death|1|||
130467949|NCT03346538|469678949|FG000|Overall Study|Physician Decision|0|||
130467950|NCT03346538|469678950|FG001|Overall Study|Physician Decision|1|||
130381010|NCT04851314|469363464|FG001|Overall Study|Unable to complete research set-up procedures|2|||
130467951|NCT03346538|469678951|FG002|Overall Study|Physician Decision|0|||
130381011|NCT04851314|469363463|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
130381012|NCT04851314|469363464|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
130381013|NCT02107482|469363471|FG000|Overall Study|inconveinence|2|||
130381014|NCT02107482|469363471|FG000|Overall Study|Lost to Follow-up|1|||
130381015|NCT02107482|469363471|FG000|Overall Study|Lack of Efficacy|1|||
130381016|NCT04868890|469363472|FG000|Overall Study|Death|2|||
130381017|NCT04868890|469363473|FG001|Overall Study|Death|1|||
130381018|NCT04868890|469363472|FG000|Overall Study|Withdrawal by Subject|1|||
130467952|NCT03346538|469678949|FG000|Overall Study|Withdrawal by Subject|3|||
130467953|NCT03346538|469678950|FG001|Overall Study|Withdrawal by Subject|2|||
130467954|NCT03346538|469678951|FG002|Overall Study|Withdrawal by Subject|0|||
130467955|NCT03346538|469678949|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
130467956|NCT03346538|469678950|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
130467957|NCT03346538|469678951|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
130467958|NCT01353313|469678952|FG000|Overall Study|Lost to Follow-up|22|||
130467959|NCT01353313|469678953|FG001|Overall Study|Lost to Follow-up|23|||
130467960|NCT01353313|469678952|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
130467961|NCT01353313|469678953|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
130467962|NCT02824029|469678955|FG000|Overall Study|Didn't receive treatment|2|||
130467963|NCT02824029|469678955|FG000|Overall Study|Patient decision to discontinue treatment|3|||
130467964|NCT02824029|469678955|FG000|Overall Study|Non-compliant|5|||
130467965|NCT02824029|469678955|FG000|Overall Study|Progression of disease|15|||
130467966|NCT02824029|469678955|FG000|Overall Study|Inadequate response to therapy|2|||
130467967|NCT02824029|469678955|FG000|Overall Study|Possible progression per treating physician|1|||
130467968|NCT04524390|469678956|FG000|Double Blind|Consent Withdrawal by subject|2|||
130467969|NCT04524390|469678957|FG001|Double Blind|Consent Withdrawal by subject|1|||
130467970|NCT04524390|469678958|FG002|Double Blind|Consent Withdrawal by subject|0|||
130467971|NCT04524390|469678956|FG000|Double Blind|Adverse Event|5|||
130467972|NCT04524390|469678957|FG001|Double Blind|Adverse Event|3|||
130467973|NCT04524390|469678958|FG002|Double Blind|Adverse Event|0|||
130467974|NCT04524390|469678956|FG000|Double Blind|Liver Transplant|5|||
130467975|NCT04524390|469678957|FG001|Double Blind|Liver Transplant|6|||
130467976|NCT04524390|469678958|FG002|Double Blind|Liver Transplant|0|||
130467977|NCT04524390|469678956|FG000|Double Blind|Disease Progression|0|||
130467978|NCT04524390|469678957|FG001|Double Blind|Disease Progression|1|||
130467979|NCT04524390|469678958|FG002|Double Blind|Disease Progression|0|||
130467980|NCT04524390|469678956|FG000|Open-Label|Drug interruption criteria|0|||
130467981|NCT04524390|469678957|FG001|Open-Label|Drug interruption criteria|0|||
130467982|NCT04524390|469678958|FG002|Open-Label|Drug interruption criteria|1|||
130467983|NCT04524390|469678956|FG000|Open-Label|Liver Transplant|0|||
130467984|NCT04524390|469678957|FG001|Open-Label|Liver Transplant|0|||
130467985|NCT04524390|469678958|FG002|Open-Label|Liver Transplant|1|||
130467986|NCT04524390|469678956|FG000|Open-Label|Disease Progression|0|||
130467987|NCT04524390|469678957|FG001|Open-Label|Disease Progression|0|||
130467988|NCT04524390|469678958|FG002|Open-Label|Disease Progression|1|||
130467989|NCT04524390|469678956|FG000|Open-Label|Adverse Event|0|||
130467990|NCT04524390|469678957|FG001|Open-Label|Adverse Event|0|||
130467991|NCT04524390|469678958|FG002|Open-Label|Adverse Event|3|||
130467992|NCT04524390|469678956|FG000|Open-Label|Study Termination by sponsor|0|||
130467993|NCT04524390|469678957|FG001|Open-Label|Study Termination by sponsor|0|||
130467994|NCT04524390|469678958|FG002|Open-Label|Study Termination by sponsor|45|||
130467995|NCT00174382|469678966|FG000|Overall Study|Death|2|||
130467996|NCT00174382|469678966|FG000|Overall Study|Adverse Event|19|||
130467997|NCT00174382|469678966|FG000|Overall Study|Withdrawal by Subject|6|||
130467998|NCT00174382|469678966|FG000|Overall Study|Protocol Violation|3|||
130467999|NCT00174382|469678966|FG000|Overall Study|Arrived early for last visit in error|1|||
130468000|NCT00174382|469678966|FG000|Overall Study|Subject felt pill not effective enough|1|||
130468001|NCT00174382|469678966|FG000|Overall Study|Lost to Follow-up|1|||
130468002|NCT03655262|469678967|FG000|Overall Study|Withdrawal by Subject|0|||
130468003|NCT03655262|469678968|FG001|Overall Study|Withdrawal by Subject|0|||
130468004|NCT03655262|469678969|FG002|Overall Study|Withdrawal by Subject|1|||
130468005|NCT03951805|469678971|FG000|Overall Study|Adverse Event|1|||
130468006|NCT03951805|469678972|FG001|Overall Study|Adverse Event|0|||
130468007|NCT03951805|469678973|FG002|Overall Study|Adverse Event|0|||
130468008|NCT03951805|469678974|FG003|Overall Study|Adverse Event|0|||
130468009|NCT00604669|469678975|FG000|Overall Study|lack of information in chart|7|||
130468010|NCT01695954|469678976|FG000|Overall Study|Withdrawal by Subject|4|||
130468011|NCT01695954|469678977|FG001|Overall Study|Withdrawal by Subject|0|||
130468012|NCT01695954|469678976|FG000|Overall Study|Adverse Event|0|||
130468013|NCT01695954|469678977|FG001|Overall Study|Adverse Event|2|||
130468014|NCT04328727|469678979|FG000|Overall Study|Guardian Decision|1|||
130468015|NCT04328727|469678979|FG000|Overall Study|Participant decision|4|||
130468016|NCT04328727|469678979|FG000|Overall Study|Death|3|||
130468017|NCT03684044|469678980|FG000|Overall Study|Adverse Event|3|||
130468018|NCT03684044|469678981|FG001|Overall Study|Adverse Event|0|||
130468019|NCT03684044|469678980|FG000|Overall Study|Death|4|||
130468020|NCT03684044|469678981|FG001|Overall Study|Death|7|||
130468021|NCT03684044|469678980|FG000|Overall Study|Lost to Follow-up|3|||
130468022|NCT03684044|469678981|FG001|Overall Study|Lost to Follow-up|2|||
130468023|NCT03684044|469678980|FG000|Overall Study|Patient Not Available|0|||
130468024|NCT03684044|469678981|FG001|Overall Study|Patient Not Available|2|||
130468025|NCT03684044|469678980|FG000|Overall Study|Physician Decision|1|||
130468026|NCT03684044|469678981|FG001|Overall Study|Physician Decision|0|||
130468027|NCT03684044|469678980|FG000|Overall Study|Withdrawal by Subject|11|||
130468028|NCT03684044|469678981|FG001|Overall Study|Withdrawal by Subject|9|||
130468029|NCT03703336|469678982|FG000|Overall Study|Parent withdrew consent|29|||
130468030|NCT03703336|469678983|FG001|Overall Study|Parent withdrew consent|8|||
130468031|NCT03703336|469678982|FG000|Overall Study|Migration|3|||
130468032|NCT03703336|469678983|FG001|Overall Study|Migration|3|||
130468033|NCT03703336|469678982|FG000|Overall Study|Protocol Violation|3|||
130468034|NCT03703336|469678983|FG001|Overall Study|Protocol Violation|1|||
130468035|NCT03703336|469678982|FG000|Overall Study|Physician Decision|2|||
130468036|NCT03703336|469678983|FG001|Overall Study|Physician Decision|0|||
130468037|NCT03703336|469678982|FG000|Overall Study|Adverse Event|0|||
130468038|NCT03703336|469678983|FG001|Overall Study|Adverse Event|2|||
130468039|NCT03703336|469678982|FG000|Overall Study|Lost to Follow-up|1|||
130468040|NCT03703336|469678983|FG001|Overall Study|Lost to Follow-up|0|||
130468041|NCT03930420|469678985|FG000|Overall Study|Withdrawal by Subject|7|||
130468042|NCT03930420|469678986|FG001|Overall Study|Withdrawal by Subject|9|||
130468043|NCT00580866|469678987|FG000|Overall Study|Lost to Follow-up|2|||
130468044|NCT00580866|469678988|FG001|Overall Study|Lost to Follow-up|2|||
130468045|NCT00609336|469678989|FG000|Overall Study|Protocol Violation|3|||
130468046|NCT00609336|469678989|FG000|Overall Study|Death|1|||
130468047|NCT00609336|469678989|FG000|Overall Study|LA or Met at Surgery|9|||
130468048|NCT02238483|469678990|FG000|Overall Study|Withdrawal by Subject|2|||
130468049|NCT02238483|469678991|FG001|Overall Study|Withdrawal by Subject|7|||
130468050|NCT02238483|469678990|FG000|Overall Study|Lost to Follow-up|1|||
130468051|NCT02238483|469678991|FG001|Overall Study|Lost to Follow-up|1|||
130468052|NCT02238483|469678990|FG000|Overall Study|Protocol Violation|1|||
130468053|NCT02238483|469678991|FG001|Overall Study|Protocol Violation|2|||
130468054|NCT02238483|469678990|FG000|Overall Study|Death|1|||
130468055|NCT02238483|469678991|FG001|Overall Study|Death|0|||
130468056|NCT02238483|469678990|FG000|Overall Study|Adverse Event|7|||
130468057|NCT02238483|469678991|FG001|Overall Study|Adverse Event|3|||
130468058|NCT02238483|469678990|FG000|Overall Study|Withdrawn due to physician decision|1|||
130468059|NCT02238483|469678991|FG001|Overall Study|Withdrawn due to physician decision|0|||
130468060|NCT02238483|469678990|FG000|Overall Study|Completion status not recorded|1|||
130468061|NCT02238483|469678991|FG001|Overall Study|Completion status not recorded|1|||
130468062|NCT02238483|469678990|FG000|Overall Study|Illness in family member|1|||
130468063|NCT02238483|469678991|FG001|Overall Study|Illness in family member|0|||
130468064|NCT02477605|469678992|FG000|Overall Study|Discontinued prior to treatment|1|||
130468065|NCT02477605|469678993|FG001|Overall Study|Discontinued prior to treatment|0|||
130468066|NCT02477605|469678992|FG000|Overall Study|Lost to Follow-up|0|||
130468067|NCT02477605|469678993|FG001|Overall Study|Lost to Follow-up|2|||
130468068|NCT02477605|469678992|FG000|Overall Study|Withdrawal by Subject|0|||
130468069|NCT02477605|469678993|FG001|Overall Study|Withdrawal by Subject|1|||
130468070|NCT02477605|469678992|FG000|Overall Study|Administered gas during surgery|0|||
130468071|NCT02477605|469678993|FG001|Overall Study|Administered gas during surgery|1|||
130468072|NCT02574455|469678994|FG000|Overall Study|Death|197|||
130468073|NCT02574455|469678995|FG001|Overall Study|Death|210|||
130468074|NCT02574455|469678994|FG000|Overall Study|Withdrawal of Consent|11|||
130468075|NCT02574455|469678995|FG001|Overall Study|Withdrawal of Consent|28|||
130468076|NCT02574455|469678994|FG000|Overall Study|Lost to Follow-up|4|||
130468077|NCT02574455|469678995|FG001|Overall Study|Lost to Follow-up|4|||
130468078|NCT02574455|469678994|FG000|Overall Study|Sponsor's Decision|55|||
130468079|NCT02574455|469678995|FG001|Overall Study|Sponsor's Decision|20|||
130468080|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Death|117|||
130468081|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Death|197|||
130468082|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
130468083|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
130468084|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
130468085|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
130468086|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
130722118|NCT03400943|470608167|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
130722119|NCT03400943|470608168|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
130722120|NCT03400943|470608169|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
130722121|NCT03400943|470608170|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
130722122|NCT03400943|470608167|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
130722123|NCT03400943|470608168|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130722124|NCT03400943|470608169|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
130381019|NCT04868890|469363473|FG001|Overall Study|Withdrawal by Subject|5|||
130381020|NCT00867009|469363474|FG000|Induction Period|Nonserious Adverse Event|5|||
130381021|NCT00867009|469363474|FG000|Induction Period|Serious Adverse Event|10|||
130381022|NCT00867009|469363474|FG000|Induction Period|Death due to serious adverse event|6|||
130381023|NCT00867009|469363474|FG000|Induction Period|Death due to Study Disease|4|||
130381024|NCT00867009|469363474|FG000|Induction Period|Protocol Violation|1|||
130381025|NCT00867009|469363474|FG000|Induction Period|Withdrawal by Subject|8|||
130381026|NCT00867009|469363474|FG000|Induction Period|Physician Decision|3|||
130381027|NCT00867009|469363474|FG000|Induction Period|Progressive Disease (PD)|25|||
130381028|NCT00867009|469363474|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
130381029|NCT03358290|469363476|FG000|Overall Study|Study discontinued by Sponsor|0|||
130381030|NCT03358290|469363477|FG001|Overall Study|Study discontinued by Sponsor|1|||
130381031|NCT03358290|469363478|FG002|Overall Study|Study discontinued by Sponsor|1|||
130381032|NCT03358290|469363479|FG003|Overall Study|Study discontinued by Sponsor|0|||
130381033|NCT03358290|469363480|FG004|Overall Study|Study discontinued by Sponsor|0|||
130381034|NCT03358290|469363476|FG000|Overall Study|Adverse Event|0|||
130381035|NCT03358290|469363477|FG001|Overall Study|Adverse Event|0|||
130381036|NCT03358290|469363478|FG002|Overall Study|Adverse Event|1|||
130381037|NCT03358290|469363479|FG003|Overall Study|Adverse Event|2|||
130381038|NCT03358290|469363480|FG004|Overall Study|Adverse Event|0|||
130381039|NCT03358290|469363476|FG000|Overall Study|Withdrawal by Subject|0|||
130381040|NCT03358290|469363477|FG001|Overall Study|Withdrawal by Subject|0|||
130381041|NCT03358290|469363478|FG002|Overall Study|Withdrawal by Subject|0|||
130381042|NCT03358290|469363479|FG003|Overall Study|Withdrawal by Subject|0|||
130381043|NCT03358290|469363480|FG004|Overall Study|Withdrawal by Subject|1|||
130381044|NCT01339429|469363481|FG000|Overall Study|Withdrawal by Subject|1|||
130381045|NCT01339429|469363481|FG000|Overall Study|Physician Decision|3|||
130381046|NCT00459667|469363482|FG000|Overall Study|Adverse Event|9|||
130381047|NCT00459667|469363483|FG001|Overall Study|Adverse Event|12|||
130381048|NCT00459667|469363484|FG002|Overall Study|Adverse Event|8|||
130381049|NCT00459667|469363482|FG000|Overall Study|Lost to Follow-up|5|||
130381050|NCT00459667|469363483|FG001|Overall Study|Lost to Follow-up|9|||
130381051|NCT00459667|469363484|FG002|Overall Study|Lost to Follow-up|3|||
130381052|NCT00459667|469363482|FG000|Overall Study|Pregnancy|1|||
130381053|NCT00459667|469363483|FG001|Overall Study|Pregnancy|1|||
130381054|NCT00459667|469363484|FG002|Overall Study|Pregnancy|1|||
130381055|NCT00459667|469363482|FG000|Overall Study|Protocol Violation|1|||
130381056|NCT00459667|469363483|FG001|Overall Study|Protocol Violation|0|||
130381057|NCT00459667|469363484|FG002|Overall Study|Protocol Violation|0|||
130381058|NCT00459667|469363482|FG000|Overall Study|Withdrawal by Subject|3|||
130381059|NCT00459667|469363483|FG001|Overall Study|Withdrawal by Subject|5|||
130381060|NCT00459667|469363484|FG002|Overall Study|Withdrawal by Subject|5|||
130381061|NCT00459667|469363482|FG000|Overall Study|Other disease modifying treatment|1|||
130381062|NCT00459667|469363483|FG001|Overall Study|Other disease modifying treatment|2|||
130381063|NCT00459667|469363484|FG002|Overall Study|Other disease modifying treatment|1|||
130381064|NCT00459667|469363482|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
130381065|NCT00459667|469363483|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
130381066|NCT00459667|469363484|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
130381067|NCT00459667|469363482|FG000|Overall Study|No treatment administered|6|||
130381068|NCT00459667|469363483|FG001|Overall Study|No treatment administered|3|||
130381069|NCT00459667|469363484|FG002|Overall Study|No treatment administered|1|||
130381070|NCT04140292|469363485|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
130381071|NCT04140292|469363486|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
130381072|NCT00556712|469363487|FG000|Overall Study|Adverse Event|7|||
130381073|NCT00556712|469363488|FG001|Overall Study|Adverse Event|19|||
130381074|NCT00556712|469363487|FG000|Overall Study|Death|5|||
130381075|NCT00556712|469363488|FG001|Overall Study|Death|10|||
130381076|NCT00556712|469363487|FG000|Overall Study|Progressive Disease|383|||
130381077|NCT00556712|469363488|FG001|Overall Study|Progressive Disease|320|||
130381078|NCT00556712|469363487|FG000|Overall Study|Protocol Violation|3|||
130381079|NCT00556712|469363488|FG001|Overall Study|Protocol Violation|2|||
130381080|NCT00556712|469363487|FG000|Overall Study|Refused Treatment|17|||
130381081|NCT00556712|469363488|FG001|Overall Study|Refused Treatment|16|||
130381082|NCT00556712|469363487|FG000|Overall Study|Failure to Return|2|||
130381083|NCT00556712|469363488|FG001|Overall Study|Failure to Return|3|||
130381084|NCT00556712|469363487|FG000|Overall Study|Other|2|||
130381085|NCT00556712|469363488|FG001|Overall Study|Other|2|||
130381086|NCT00556712|469363487|FG000|Overall Study|Ongoing at Data Cutoff|32|||
130381087|NCT00556712|469363488|FG001|Overall Study|Ongoing at Data Cutoff|66|||
130381088|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
130381089|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
130722125|NCT03400943|470608170|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
130722126|NCT03400943|470608167|FG000|Post-treatment Period 1|Other|2|||
130722127|NCT03400943|470608168|FG001|Post-treatment Period 1|Other|0|||
130722128|NCT03400943|470608169|FG002|Post-treatment Period 1|Other|4|||
130381090|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
130381091|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
130381092|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
130381093|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
130381094|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
130381095|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
130381096|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
130381097|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
130381098|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
130381099|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
130381100|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
130381101|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
130381102|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
130381103|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
130381104|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
130381105|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
130381106|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
130381107|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
130381108|NCT01962207|469363489|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
130381109|NCT01962207|469363490|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
130381110|NCT01962207|469363491|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
130381111|NCT01962207|469363492|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
130381112|NCT00847704|469363493|FG000|Overall Study|Withdrawal by Subject|1|||
130381113|NCT04080297|469363495|FG000|Overall Study|Adverse Event|1|||
130381114|NCT04080297|469363496|FG001|Overall Study|Adverse Event|3|||
130381115|NCT04080297|469363495|FG000|Overall Study|concurrent illness|1|||
130381116|NCT04080297|469363496|FG001|Overall Study|concurrent illness|0|||
130381117|NCT02200445|469363497|FG000|Overall Study|Lack of Efficacy|1|||
130381118|NCT02200445|469363498|FG001|Overall Study|Lack of Efficacy|2|||
130381119|NCT02200445|469363499|FG002|Overall Study|Lack of Efficacy|2|||
130381120|NCT02200445|469363497|FG000|Overall Study|Adverse Event|0|||
130381121|NCT02200445|469363498|FG001|Overall Study|Adverse Event|2|||
130381122|NCT02200445|469363499|FG002|Overall Study|Adverse Event|0|||
130381123|NCT01031069|469363500|FG000|Overall Study|Serious Adverse Event|0|||
130381124|NCT01031069|469363501|FG001|Overall Study|Serious Adverse Event|1|||
130381125|NCT01031069|469363502|FG002|Overall Study|Serious Adverse Event|0|||
130381126|NCT01031069|469363503|FG003|Overall Study|Serious Adverse Event|0|||
130381127|NCT01031069|469363500|FG000|Overall Study|Withdrawal by Subject|2|||
130381128|NCT01031069|469363501|FG001|Overall Study|Withdrawal by Subject|3|||
130381129|NCT01031069|469363502|FG002|Overall Study|Withdrawal by Subject|18|||
130381130|NCT01031069|469363503|FG003|Overall Study|Withdrawal by Subject|18|||
130381131|NCT01031069|469363500|FG000|Overall Study|Migrated/moved from study area|1|||
130381132|NCT01031069|469363501|FG001|Overall Study|Migrated/moved from study area|2|||
130381133|NCT01031069|469363502|FG002|Overall Study|Migrated/moved from study area|1|||
130381134|NCT01031069|469363503|FG003|Overall Study|Migrated/moved from study area|1|||
130381135|NCT01031069|469363500|FG000|Overall Study|Lost to Follow-up|9|||
130381136|NCT01031069|469363501|FG001|Overall Study|Lost to Follow-up|5|||
130468087|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
130468088|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
130468089|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
130468090|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
130468091|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
130468092|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
130468093|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
130468094|NCT02677896|469678996|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
130468095|NCT02677896|469678997|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
130468096|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
130468097|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
130468098|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
130468099|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
130468100|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
130468101|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
130722129|NCT03400943|470608170|FG003|Post-treatment Period 1|Other|5|||
130381137|NCT01031069|469363502|FG002|Overall Study|Lost to Follow-up|21|||
130381138|NCT01031069|469363503|FG003|Overall Study|Lost to Follow-up|15|||
130381139|NCT01031069|469363500|FG000|Overall Study|Other|0|||
130381140|NCT01031069|469363501|FG001|Overall Study|Other|0|||
130381141|NCT01031069|469363502|FG002|Overall Study|Other|1|||
130381142|NCT01031069|469363503|FG003|Overall Study|Other|0|||
130381143|NCT00353262|469363507|FG000|Overall Study|Adverse Event|8|||
130381144|NCT00353262|469363507|FG000|Overall Study|Withdrawal by Subject|2|||
130381145|NCT00353262|469363507|FG000|Overall Study|Insufficient Therapeutic Response|13|||
130381146|NCT00353262|469363507|FG000|Overall Study|Progression|1|||
130381147|NCT00353262|469363507|FG000|Overall Study|Surgery|4|||
130381148|NCT00353262|469363507|FG000|Overall Study|Break from Chemotherapy|1|||
130381149|NCT05286307|469363508|FG000|Overall Study|Incomplete outcome assessments|2|||
130381150|NCT05286307|469363509|FG001|Overall Study|Incomplete outcome assessments|1|||
130381151|NCT05286307|469363508|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
130381152|NCT05286307|469363509|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
130381153|NCT05286307|469363508|FG000|Overall Study|Lost to follow up at 6 months|25|||
130381154|NCT05286307|469363509|FG001|Overall Study|Lost to follow up at 6 months|35|||
130381155|NCT05286307|469363508|FG000|Overall Study|Study medication not available|1|||
130381156|NCT05286307|469363509|FG001|Overall Study|Study medication not available|1|||
130381157|NCT01103284|469363510|FG000|Overall Study|Death|2|||
130381158|NCT01103284|469363511|FG001|Overall Study|Death|0|||
130381159|NCT01103284|469363510|FG000|Overall Study|Lost to Follow-up|9|||
130381160|NCT01103284|469363511|FG001|Overall Study|Lost to Follow-up|10|||
130381161|NCT01103284|469363510|FG000|Overall Study|Pregnancy|3|||
130381162|NCT01103284|469363511|FG001|Overall Study|Pregnancy|1|||
130381163|NCT01103284|469363510|FG000|Overall Study|Protocol Violation|12|||
130381164|NCT01103284|469363511|FG001|Overall Study|Protocol Violation|5|||
130381165|NCT01103284|469363510|FG000|Overall Study|Adverse Event|0|||
130381166|NCT01103284|469363511|FG001|Overall Study|Adverse Event|5|||
130381167|NCT01103284|469363510|FG000|Overall Study|Withdrawal by Subject|14|||
130381168|NCT01103284|469363511|FG001|Overall Study|Withdrawal by Subject|18|||
130381169|NCT01103284|469363510|FG000|Overall Study|Dermal Hypersensitivity|0|||
130381170|NCT01103284|469363511|FG001|Overall Study|Dermal Hypersensitivity|1|||
130381171|NCT01103284|469363510|FG000|Overall Study|Termination by the Sponsor|0|||
130381172|NCT01103284|469363511|FG001|Overall Study|Termination by the Sponsor|1|||
130381173|NCT01103284|469363510|FG000|Overall Study|Not described|2|||
130381174|NCT01103284|469363511|FG001|Overall Study|Not described|1|||
130381175|NCT01103284|469363510|FG000|Overall Study|Missing CRF entries for study completion|0|||
130381176|NCT01103284|469363511|FG001|Overall Study|Missing CRF entries for study completion|2|||
130381177|NCT01853826|469365642|FG000|Overall Study|Patients who switched to commercial drug|11|||
130381178|NCT01853826|469365642|FG000|Overall Study|Patient refused to continue medication|21|||
130381179|NCT01853826|469365642|FG000|Overall Study|Lost to Follow-up|2|||
130381180|NCT01853826|469365642|FG000|Overall Study|Non-compliant with protocol|4|||
130381181|NCT01853826|469365642|FG000|Overall Study|Other adverse events (AE)|62|||
130381182|NCT01853826|469365642|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
130381183|NCT01853826|469365642|FG000|Overall Study|Progressive disease|342|||
130381184|NCT01853826|469365642|FG000|Overall Study|Other than listed|13|||
130381185|NCT01853826|469365642|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
130381186|NCT00982488|469365646|FG000|Overall Study|Administrative reason by sponsor|81|||
130381187|NCT00982488|469365647|FG001|Overall Study|Administrative reason by sponsor|3|||
130381188|NCT00982488|469365648|FG002|Overall Study|Administrative reason by sponsor|11|||
130381189|NCT00982488|469365649|FG003|Overall Study|Administrative reason by sponsor|0|||
130381190|NCT00982488|469365650|FG004|Overall Study|Administrative reason by sponsor|0|||
130381191|NCT00982488|469365646|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130381192|NCT00982488|469365647|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130381193|NCT00982488|469365648|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130381194|NCT00982488|469365649|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130381195|NCT00982488|469365650|FG004|Overall Study|Adverse event unrelated to study drug|0|||
130381196|NCT00982488|469365646|FG000|Overall Study|Death|11|||
130381197|NCT00982488|469365647|FG001|Overall Study|Death|0|||
130381198|NCT00982488|469365648|FG002|Overall Study|Death|2|||
130381199|NCT00982488|469365649|FG003|Overall Study|Death|0|||
130381200|NCT00982488|469365650|FG004|Overall Study|Death|0|||
130381201|NCT00982488|469365646|FG000|Overall Study|Disease progression|30|||
130381202|NCT00982488|469365647|FG001|Overall Study|Disease progression|5|||
130381203|NCT00982488|469365648|FG002|Overall Study|Disease progression|10|||
130381204|NCT00982488|469365649|FG003|Overall Study|Disease progression|1|||
130381205|NCT00982488|469365650|FG004|Overall Study|Disease progression|1|||
130381206|NCT00982488|469365646|FG000|Overall Study|Lost to Follow-up|1|||
130381207|NCT00982488|469365647|FG001|Overall Study|Lost to Follow-up|0|||
130381208|NCT00982488|469365648|FG002|Overall Study|Lost to Follow-up|0|||
130381209|NCT00982488|469365649|FG003|Overall Study|Lost to Follow-up|0|||
130381210|NCT00982488|469365650|FG004|Overall Study|Lost to Follow-up|0|||
130381211|NCT00982488|469365646|FG000|Overall Study|Maximum clinical benefit|1|||
130381212|NCT00982488|469365647|FG001|Overall Study|Maximum clinical benefit|1|||
130381213|NCT00982488|469365648|FG002|Overall Study|Maximum clinical benefit|1|||
130381214|NCT00982488|469365649|FG003|Overall Study|Maximum clinical benefit|0|||
130381215|NCT00982488|469365650|FG004|Overall Study|Maximum clinical benefit|0|||
130381216|NCT00982488|469365646|FG000|Overall Study|Other|15|||
130381217|NCT00982488|469365647|FG001|Overall Study|Other|1|||
130381218|NCT00982488|469365648|FG002|Overall Study|Other|3|||
130381219|NCT00982488|469365649|FG003|Overall Study|Other|1|||
130381220|NCT00982488|469365650|FG004|Overall Study|Other|0|||
130381221|NCT00982488|469365646|FG000|Overall Study|Poor compliance/noncompliance|0|||
130381222|NCT00982488|469365647|FG001|Overall Study|Poor compliance/noncompliance|1|||
130381223|NCT00982488|469365648|FG002|Overall Study|Poor compliance/noncompliance|0|||
130381224|NCT00982488|469365649|FG003|Overall Study|Poor compliance/noncompliance|0|||
130381225|NCT00982488|469365650|FG004|Overall Study|Poor compliance/noncompliance|0|||
130381226|NCT00982488|469365646|FG000|Overall Study|Stem cell transplant|2|||
130381227|NCT00982488|469365647|FG001|Overall Study|Stem cell transplant|0|||
130381228|NCT00982488|469365648|FG002|Overall Study|Stem cell transplant|0|||
130381229|NCT00982488|469365649|FG003|Overall Study|Stem cell transplant|1|||
130381230|NCT00982488|469365650|FG004|Overall Study|Stem cell transplant|0|||
130381231|NCT00982488|469365646|FG000|Overall Study|Study drug toxicity|34|||
130381232|NCT00982488|469365647|FG001|Overall Study|Study drug toxicity|1|||
130381233|NCT00982488|469365648|FG002|Overall Study|Study drug toxicity|6|||
130381234|NCT00982488|469365649|FG003|Overall Study|Study drug toxicity|0|||
130381235|NCT00982488|469365650|FG004|Overall Study|Study drug toxicity|0|||
130381236|NCT00982488|469365646|FG000|Overall Study|Withdrawal by Subject|5|||
130381237|NCT00982488|469365647|FG001|Overall Study|Withdrawal by Subject|1|||
130381238|NCT00982488|469365648|FG002|Overall Study|Withdrawal by Subject|1|||
130381239|NCT00982488|469365649|FG003|Overall Study|Withdrawal by Subject|0|||
130381240|NCT00982488|469365650|FG004|Overall Study|Withdrawal by Subject|0|||
130381241|NCT00180414|469365659|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
130381242|NCT00180414|469365660|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
130381243|NCT01572909|469365661|FG000|Overall Study|Adverse Event|7|||
130722130|NCT03400943|470608167|FG000|Treatment Period 2|Study terminated by sponsor|0|||
130722131|NCT03400943|470608168|FG001|Treatment Period 2|Study terminated by sponsor|1|||
130722132|NCT03400943|470608169|FG002|Treatment Period 2|Study terminated by sponsor|0|||
130381244|NCT01572909|469365662|FG001|Overall Study|Adverse Event|2|||
130722133|NCT03400943|470608170|FG003|Treatment Period 2|Study terminated by sponsor|0|||
130381245|NCT01572909|469365661|FG000|Overall Study|Death|3|||
130381246|NCT01572909|469365662|FG001|Overall Study|Death|1|||
130381247|NCT01572909|469365661|FG000|Overall Study|Lost to Follow-up|8|||
130381248|NCT01572909|469365662|FG001|Overall Study|Lost to Follow-up|7|||
130381249|NCT01572909|469365661|FG000|Overall Study|Physician Decision|1|||
130381250|NCT01572909|469365662|FG001|Overall Study|Physician Decision|1|||
130381251|NCT01572909|469365661|FG000|Overall Study|Technical Issues|1|||
130381252|NCT01572909|469365662|FG001|Overall Study|Technical Issues|0|||
130381253|NCT01572909|469365661|FG000|Overall Study|Withdrawal by Subject|12|||
130381254|NCT01572909|469365662|FG001|Overall Study|Withdrawal by Subject|11|||
130381255|NCT01572909|469365661|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
130381256|NCT01572909|469365662|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
130381257|NCT03641651|469365663|FG000|Overall Study|organizational issues at one study site|1|||
130381258|NCT04779489|469365664|FG000|Overall Study|Physician Decision|1|||
130381259|NCT00623727|469365665|FG000|Double Blind (DB)|Adverse Event|1|||
130381260|NCT00623727|469365666|FG001|Double Blind (DB)|Adverse Event|3|||
130381261|NCT00623727|469365665|FG000|Double Blind (DB)|Physician Decision|0|||
130381262|NCT00623727|469365666|FG001|Double Blind (DB)|Physician Decision|1|||
130381263|NCT00623727|469365665|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
130381264|NCT00623727|469365666|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
130381265|NCT00623727|469365665|FG000|Double Blind (DB)|Lack of Efficacy|2|||
130381266|NCT00623727|469365666|FG001|Double Blind (DB)|Lack of Efficacy|2|||
130381267|NCT00623727|469365665|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
130381268|NCT00623727|469365666|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
130381269|NCT00623727|469365665|FG000|Double Blind (DB)|Lost to Follow-up|1|||
130381270|NCT00623727|469365666|FG001|Double Blind (DB)|Lost to Follow-up|1|||
130381271|NCT00623727|469365665|FG000|Double Blind (DB)|Protocol Violation|2|||
130381272|NCT00623727|469365666|FG001|Double Blind (DB)|Protocol Violation|2|||
130381273|NCT00623727|469365665|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
130381274|NCT00623727|469365666|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
130381275|NCT00623727|469365665|FG000|Open Label Follow-up|Study termination|0|||
130381276|NCT00623727|469365666|FG001|Open Label Follow-up|Study termination|6|||
130381277|NCT00623727|469365665|FG000|Open Label Follow-up|Participant convenience|0|||
130381278|NCT00623727|469365666|FG001|Open Label Follow-up|Participant convenience|1|||
130381279|NCT00951665|469365667|FG000|Phase 1b|Adverse Event|2|||
130381280|NCT00951665|469365668|FG001|Phase 1b|Adverse Event|1|||
130381281|NCT00951665|469365669|FG002|Phase 1b|Adverse Event|0|||
130381282|NCT00951665|469365670|FG003|Phase 1b|Adverse Event|1|||
130381283|NCT00951665|469365671|FG004|Phase 1b|Adverse Event|0|||
130722134|NCT03400943|470608167|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130722135|NCT03400943|470608168|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130722136|NCT03400943|470608169|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130722137|NCT03400943|470608170|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130722138|NCT03400943|470608167|FG000|Treatment Period 2|Other|1|||
130722139|NCT03400943|470608168|FG001|Treatment Period 2|Other|6|||
130722140|NCT03400943|470608169|FG002|Treatment Period 2|Other|0|||
130722141|NCT03400943|470608170|FG003|Treatment Period 2|Other|0|||
130722142|NCT03400943|470608167|FG000|Follow-up Period|Withdrawal by Subject|1|||
130722143|NCT03400943|470608168|FG001|Follow-up Period|Withdrawal by Subject|0|||
130722144|NCT03400943|470608169|FG002|Follow-up Period|Withdrawal by Subject|0|||
130722145|NCT03400943|470608170|FG003|Follow-up Period|Withdrawal by Subject|0|||
130381284|NCT00951665|469365672|FG005|Phase 1b|Adverse Event|0|||
130381285|NCT00951665|469365667|FG000|Phase 1b|Death|1|||
130381286|NCT00951665|469365668|FG001|Phase 1b|Death|0|||
130381287|NCT00951665|469365669|FG002|Phase 1b|Death|2|||
130381288|NCT00951665|469365670|FG003|Phase 1b|Death|0|||
130381289|NCT00951665|469365671|FG004|Phase 1b|Death|0|||
130381290|NCT00951665|469365672|FG005|Phase 1b|Death|0|||
130381291|NCT00951665|469365667|FG000|Phase 1b|Physician Decision|4|||
130381292|NCT00951665|469365668|FG001|Phase 1b|Physician Decision|0|||
130381293|NCT00951665|469365669|FG002|Phase 1b|Physician Decision|1|||
130381294|NCT00951665|469365670|FG003|Phase 1b|Physician Decision|0|||
130381295|NCT00951665|469365671|FG004|Phase 1b|Physician Decision|0|||
130381296|NCT00951665|469365672|FG005|Phase 1b|Physician Decision|0|||
130381297|NCT00951665|469365667|FG000|Phase 1b|Withdrawal by Subject|0|||
130381298|NCT00951665|469365668|FG001|Phase 1b|Withdrawal by Subject|1|||
130381299|NCT00951665|469365669|FG002|Phase 1b|Withdrawal by Subject|0|||
130381300|NCT00951665|469365670|FG003|Phase 1b|Withdrawal by Subject|0|||
130381301|NCT00951665|469365671|FG004|Phase 1b|Withdrawal by Subject|0|||
130381302|NCT00951665|469365672|FG005|Phase 1b|Withdrawal by Subject|0|||
130381303|NCT00951665|469365667|FG000|Phase 1b|Disease Progression|13|||
130381304|NCT00951665|469365668|FG001|Phase 1b|Disease Progression|2|||
130381305|NCT00951665|469365669|FG002|Phase 1b|Disease Progression|14|||
130381306|NCT00951665|469365670|FG003|Phase 1b|Disease Progression|0|||
130381307|NCT00951665|469365671|FG004|Phase 1b|Disease Progression|0|||
130381308|NCT00951665|469365672|FG005|Phase 1b|Disease Progression|0|||
130381309|NCT00951665|469365667|FG000|Phase 1b|Protocol Violation|2|||
130381310|NCT00951665|469365668|FG001|Phase 1b|Protocol Violation|0|||
130381311|NCT00951665|469365669|FG002|Phase 1b|Protocol Violation|0|||
130381312|NCT00951665|469365670|FG003|Phase 1b|Protocol Violation|0|||
130381313|NCT00951665|469365671|FG004|Phase 1b|Protocol Violation|0|||
130468102|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
130468103|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
130468104|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
130468105|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
130468106|NCT02677896|469678996|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
130468107|NCT02677896|469678997|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
130468108|NCT00567489|469678998|FG000|Overall Study|Adverse Event|6|||
130468109|NCT00567489|469678999|FG001|Overall Study|Adverse Event|14|||
130468110|NCT00567489|469678998|FG000|Overall Study|Physician Decision|0|||
130468111|NCT00567489|469678999|FG001|Overall Study|Physician Decision|4|||
130468112|NCT00567489|469678998|FG000|Overall Study|Withdrawal by Subject|0|||
130468113|NCT00567489|469678999|FG001|Overall Study|Withdrawal by Subject|2|||
130468114|NCT00567489|469678998|FG000|Overall Study|Renal Transplantation|0|||
130468115|NCT00567489|469678999|FG001|Overall Study|Renal Transplantation|3|||
130468116|NCT00567489|469678998|FG000|Overall Study|Other|1|||
130468117|NCT00567489|469678999|FG001|Overall Study|Other|0|||
130468118|NCT03565315|469679003|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
130468119|NCT03565315|469679004|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
130468120|NCT03565315|469679005|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
130468121|NCT03565315|469679006|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
130722146|NCT02563106|470608171|FG000|Overall Study|Withdrawal by Subject|7|||
130722147|NCT02563106|470608172|FG001|Overall Study|Withdrawal by Subject|8|||
130722148|NCT02563106|470608171|FG000|Overall Study|Adverse Event|17|||
130468122|NCT01083316|469679007|FG000|Overall Study|Adverse Event|2|||
130468123|NCT01083316|469679007|FG000|Overall Study|Withdrawal by Subject|1|||
130722149|NCT02563106|470608172|FG001|Overall Study|Adverse Event|15|||
130722150|NCT02563106|470608171|FG000|Overall Study|Protocol Violation|1|||
130381314|NCT00951665|469365672|FG005|Phase 1b|Protocol Violation|0|||
130722151|NCT02563106|470608172|FG001|Overall Study|Protocol Violation|0|||
130722152|NCT02563106|470608171|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
130381315|NCT00951665|469365667|FG000|Phase 2a|Adverse Event|0|||
130381316|NCT00951665|469365668|FG001|Phase 2a|Adverse Event|0|||
130381317|NCT00951665|469365669|FG002|Phase 2a|Adverse Event|0|||
130381318|NCT00951665|469365670|FG003|Phase 2a|Adverse Event|0|||
130381319|NCT00951665|469365671|FG004|Phase 2a|Adverse Event|2|||
130381320|NCT00951665|469365672|FG005|Phase 2a|Adverse Event|0|||
130468124|NCT04200365|469679008|FG000|Overall Study|Adverse Event|2|||
130381321|NCT00951665|469365667|FG000|Phase 2a|Death|0|||
130381322|NCT00951665|469365668|FG001|Phase 2a|Death|0|||
130381323|NCT00951665|469365669|FG002|Phase 2a|Death|0|||
130381324|NCT00951665|469365670|FG003|Phase 2a|Death|0|||
130381325|NCT00951665|469365671|FG004|Phase 2a|Death|1|||
130381326|NCT00951665|469365672|FG005|Phase 2a|Death|1|||
130381327|NCT00951665|469365667|FG000|Phase 2a|Lost to Follow-up|0|||
130381328|NCT00951665|469365668|FG001|Phase 2a|Lost to Follow-up|0|||
130381329|NCT00951665|469365669|FG002|Phase 2a|Lost to Follow-up|0|||
130381330|NCT00951665|469365670|FG003|Phase 2a|Lost to Follow-up|0|||
130381331|NCT00951665|469365671|FG004|Phase 2a|Lost to Follow-up|1|||
130381332|NCT00951665|469365672|FG005|Phase 2a|Lost to Follow-up|0|||
130381333|NCT00951665|469365667|FG000|Phase 2a|Physician Decision|0|||
130381334|NCT00951665|469365668|FG001|Phase 2a|Physician Decision|0|||
130381335|NCT00951665|469365669|FG002|Phase 2a|Physician Decision|0|||
130381336|NCT00951665|469365670|FG003|Phase 2a|Physician Decision|0|||
130381337|NCT00951665|469365671|FG004|Phase 2a|Physician Decision|0|||
130381338|NCT00951665|469365672|FG005|Phase 2a|Physician Decision|1|||
130381339|NCT00951665|469365667|FG000|Phase 2a|Withdrawal by Subject|0|||
130381340|NCT00951665|469365668|FG001|Phase 2a|Withdrawal by Subject|0|||
130381341|NCT00951665|469365669|FG002|Phase 2a|Withdrawal by Subject|0|||
130381342|NCT00951665|469365670|FG003|Phase 2a|Withdrawal by Subject|0|||
130381343|NCT00951665|469365671|FG004|Phase 2a|Withdrawal by Subject|2|||
130381344|NCT00951665|469365672|FG005|Phase 2a|Withdrawal by Subject|0|||
130381345|NCT00951665|469365667|FG000|Phase 2a|Disease Progression|0|||
130381346|NCT00951665|469365668|FG001|Phase 2a|Disease Progression|0|||
130381347|NCT00951665|469365669|FG002|Phase 2a|Disease Progression|0|||
130381348|NCT00951665|469365670|FG003|Phase 2a|Disease Progression|0|||
130381349|NCT00951665|469365671|FG004|Phase 2a|Disease Progression|6|||
130381350|NCT00951665|469365672|FG005|Phase 2a|Disease Progression|5|||
130381351|NCT01199289|469365673|FG000|Overall Study|Ineligibility determined|2|||
130722153|NCT02563106|470608172|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
130722154|NCT02563106|470608171|FG000|Overall Study|Lost to Follow-up|3|||
130722155|NCT02563106|470608172|FG001|Overall Study|Lost to Follow-up|2|||
130722156|NCT02563106|470608171|FG000|Overall Study|Physician Decision|3|||
130722157|NCT02563106|470608172|FG001|Overall Study|Physician Decision|1|||
130381352|NCT01199289|469365674|FG001|Overall Study|Ineligibility determined|1|||
130381353|NCT01199289|469365675|FG002|Overall Study|Ineligibility determined|0|||
130381354|NCT01199289|469365676|FG003|Overall Study|Ineligibility determined|0|||
130381355|NCT01199289|469365673|FG000|Overall Study|Protocol Violation|1|||
130381356|NCT01199289|469365674|FG001|Overall Study|Protocol Violation|0|||
130381357|NCT01199289|469365675|FG002|Overall Study|Protocol Violation|0|||
130381358|NCT01199289|469365676|FG003|Overall Study|Protocol Violation|1|||
130381359|NCT01199289|469365673|FG000|Overall Study|Noncompliance|1|||
130468125|NCT04200365|469679008|FG000|Overall Study|Progressive Disease|4|||
130468126|NCT04200365|469679008|FG000|Overall Study|Lack of Efficacy|1|||
130468127|NCT04200365|469679008|FG000|Overall Study|Study Closure|4|||
130468128|NCT02318134|469679015|FG000|Overall Study|Withdrawal by Subject|2|||
130468129|NCT02318134|469679016|FG001|Overall Study|Withdrawal by Subject|1|||
130468130|NCT01976312|469679017|FG000|Overall Study|Pregnancy|0|||
130468131|NCT01976312|469679018|FG001|Overall Study|Pregnancy|1|||
130468132|NCT01976312|469679017|FG000|Overall Study|Lost to Follow-up|2|||
130468133|NCT01976312|469679018|FG001|Overall Study|Lost to Follow-up|0|||
130468134|NCT01976312|469679017|FG000|Overall Study|Withdrawal by Subject|7|||
130468135|NCT01976312|469679018|FG001|Overall Study|Withdrawal by Subject|2|||
130468136|NCT01976312|469679017|FG000|Overall Study|Adverse Event|6|||
130468137|NCT01976312|469679018|FG001|Overall Study|Adverse Event|6|||
130468138|NCT01976312|469679017|FG000|Overall Study|Protocol Violation|2|||
130468139|NCT01976312|469679018|FG001|Overall Study|Protocol Violation|0|||
130468140|NCT01609218|469679025|FG000|Period 1|Adverse Event|3|||
130722158|NCT02563106|470608171|FG000|Overall Study|Other reason - not specified|2|||
130381360|NCT01199289|469365674|FG001|Overall Study|Noncompliance|0|||
130468141|NCT01609218|469679026|FG001|Period 1|Adverse Event|5|||
130381361|NCT01199289|469365675|FG002|Overall Study|Noncompliance|2|||
130468142|NCT01609218|469679025|FG000|Period 1|Sponsor Decision|0|||
130468143|NCT01609218|469679026|FG001|Period 1|Sponsor Decision|1|||
130722159|NCT02563106|470608172|FG001|Overall Study|Other reason - not specified|1|||
130381362|NCT01199289|469365676|FG003|Overall Study|Noncompliance|0|||
130381363|NCT01199289|469365673|FG000|Overall Study|Adverse Event|0|||
130381364|NCT01199289|469365674|FG001|Overall Study|Adverse Event|3|||
130381365|NCT01199289|469365675|FG002|Overall Study|Adverse Event|1|||
130381366|NCT01199289|469365676|FG003|Overall Study|Adverse Event|4|||
130381367|NCT01199289|469365673|FG000|Overall Study|Full consent withdrawn|2|||
130381368|NCT01199289|469365674|FG001|Overall Study|Full consent withdrawn|2|||
130381369|NCT01199289|469365675|FG002|Overall Study|Full consent withdrawn|2|||
130468144|NCT01609218|469679025|FG000|Period 2|Adverse Event|1|||
130468145|NCT01609218|469679026|FG001|Period 2|Adverse Event|0|||
130468146|NCT04428112|469679032|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
130468147|NCT04428112|469679033|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
130722160|NCT01059539|470608173|FG000|Overall Study|Adverse Event|66|||
130468148|NCT04428112|469679032|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
130468149|NCT04428112|469679033|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
130468150|NCT04428112|469679032|FG000|Overall Study|Withdrawal by Subject|9|||
130468151|NCT04428112|469679033|FG001|Overall Study|Withdrawal by Subject|4|||
130468152|NCT04428112|469679032|FG000|Overall Study|Lost to Follow-up|27|||
130468153|NCT04428112|469679033|FG001|Overall Study|Lost to Follow-up|7|||
130468154|NCT01207492|469679034|FG000|Overall Study|Still on study|1|||
130468155|NCT01207492|469679034|FG000|Overall Study|Withdrawal by Subject|9|||
130468156|NCT01207492|469679034|FG000|Overall Study|Physician Decision|1|||
130468157|NCT01207492|469679034|FG000|Overall Study|Progressive disease|3|||
130468158|NCT01207492|469679034|FG000|Overall Study|Toxicity|1|||
130468159|NCT02769858|469679035|FG000|Overall Study|Withdrawal by Subject|2|||
130468160|NCT04755660|469680245|FG000|Overall Study|Lost to Follow-up|1|||
130468161|NCT04755660|469680246|FG001|Overall Study|Lost to Follow-up|1|||
130468162|NCT04755660|469680247|FG002|Overall Study|Lost to Follow-up|0|||
130468163|NCT04755660|469680245|FG000|Overall Study|Withdrawal by Subject|0|||
130722161|NCT01059539|470608173|FG000|Overall Study|Insufficient Therapeutic Response|26|||
130381370|NCT01199289|469365676|FG003|Overall Study|Full consent withdrawn|3|||
130381371|NCT01199289|469365673|FG000|Overall Study|Administrative decision|0|||
130468164|NCT04755660|469680246|FG001|Overall Study|Withdrawal by Subject|1|||
130468165|NCT04755660|469680247|FG002|Overall Study|Withdrawal by Subject|1|||
130468166|NCT04755660|469680245|FG000|Overall Study|Physician Decision|0|||
130468167|NCT04755660|469680246|FG001|Overall Study|Physician Decision|0|||
130468168|NCT04755660|469680247|FG002|Overall Study|Physician Decision|1|||
130468169|NCT03088813|469680249|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
130468170|NCT03088813|469680250|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
130468171|NCT03088813|469680251|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
130468172|NCT03088813|469680252|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
130381372|NCT01199289|469365674|FG001|Overall Study|Administrative decision|0|||
130381373|NCT01199289|469365675|FG002|Overall Study|Administrative decision|0|||
130468173|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
130468174|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
130468175|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
130468176|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
130468177|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
130468178|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
130468179|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
130468180|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
130468181|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
130381374|NCT01199289|469365676|FG003|Overall Study|Administrative decision|1|||
130381375|NCT01199289|469365673|FG000|Overall Study|Lost to Follow-up|0|||
130381376|NCT01199289|469365674|FG001|Overall Study|Lost to Follow-up|0|||
130381377|NCT01199289|469365675|FG002|Overall Study|Lost to Follow-up|0|||
130381378|NCT01199289|469365676|FG003|Overall Study|Lost to Follow-up|1|||
130381379|NCT01199289|469365673|FG000|Overall Study|Protocol-specified criteria|3|||
130381380|NCT01199289|469365674|FG001|Overall Study|Protocol-specified criteria|0|||
130381381|NCT01199289|469365675|FG002|Overall Study|Protocol-specified criteria|0|||
130381382|NCT01199289|469365676|FG003|Overall Study|Protocol-specified criteria|1|||
130381383|NCT01199289|469365673|FG000|Overall Study|Pregnancy|0|||
130381384|NCT01199289|469365674|FG001|Overall Study|Pregnancy|1|||
130381385|NCT01199289|469365675|FG002|Overall Study|Pregnancy|0|||
130381386|NCT01199289|469365676|FG003|Overall Study|Pregnancy|1|||
130381387|NCT02723084|469365677|FG000|Overall Study|Withdrawal by Subject|1|||
130381388|NCT02723084|469365678|FG001|Overall Study|Withdrawal by Subject|1|||
130381389|NCT02723084|469365677|FG000|Overall Study|Lost to Follow-up|3|||
130381390|NCT02723084|469365678|FG001|Overall Study|Lost to Follow-up|0|||
130381391|NCT00127712|469365684|FG000|Overall Study|Adverse Event|3|||
130381392|NCT00127712|469365685|FG001|Overall Study|Adverse Event|0|||
130381393|NCT00127712|469365684|FG000|Overall Study|Lack of GI access to continue|2|||
130381394|NCT00127712|469365685|FG001|Overall Study|Lack of GI access to continue|0|||
130381395|NCT02642614|469365686|FG000|Overall Study|Adverse Event|1|||
130381396|NCT02642614|469365687|FG001|Overall Study|Adverse Event|1|||
130468182|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
130468183|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
130468184|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
130468185|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
130468186|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
130722162|NCT01059539|470608173|FG000|Overall Study|Protocol Violation|55|||
130381397|NCT02642614|469365688|FG002|Overall Study|Adverse Event|2|||
130381398|NCT02642614|469365689|FG003|Overall Study|Adverse Event|2|||
130381399|NCT02642614|469365686|FG000|Overall Study|Lost to Follow-up|1|||
130381400|NCT02642614|469365687|FG001|Overall Study|Lost to Follow-up|0|||
130381401|NCT02642614|469365688|FG002|Overall Study|Lost to Follow-up|0|||
130381402|NCT02642614|469365689|FG003|Overall Study|Lost to Follow-up|0|||
130381403|NCT02642614|469365686|FG000|Overall Study|Withdrawal by Subject|1|||
130381404|NCT02642614|469365687|FG001|Overall Study|Withdrawal by Subject|1|||
130381405|NCT02642614|469365688|FG002|Overall Study|Withdrawal by Subject|0|||
130381406|NCT02642614|469365689|FG003|Overall Study|Withdrawal by Subject|0|||
130381407|NCT02450903|469365690|FG000|Overall Study|Adverse Event|3|||
130381408|NCT02450903|469365690|FG000|Overall Study|Progressive disease|15|||
130381409|NCT02450903|469365690|FG000|Overall Study|Switched to commercial drug|1|||
130381410|NCT02450903|469365690|FG000|Overall Study|Subject/guardian decision|1|||
130381411|NCT01164956|469365691|FG000|Overall Study|Side Effects|1|||
130381412|NCT01164956|469365692|FG001|Overall Study|Side Effects|0|||
130381413|NCT01164956|469365693|FG002|Overall Study|Side Effects|1|||
130381414|NCT01320085|469365694|FG000|Overall Study|Disease Progression|26|||
130381415|NCT01320085|469365695|FG001|Overall Study|Disease Progression|93|||
130381416|NCT01320085|469365696|FG002|Overall Study|Disease Progression|17|||
130381417|NCT01320085|469365694|FG000|Overall Study|Adverse Event|12|||
130381418|NCT01320085|469365695|FG001|Overall Study|Adverse Event|20|||
130381419|NCT01320085|469365696|FG002|Overall Study|Adverse Event|5|||
130381420|NCT01320085|469365694|FG000|Overall Study|Withdrawal by Subject|2|||
130381421|NCT01320085|469365695|FG001|Overall Study|Withdrawal by Subject|4|||
130722163|NCT01059539|470608173|FG000|Overall Study|Withdrawal of Consent|80|||
130722164|NCT01059539|470608173|FG000|Overall Study|Lost to Follow-up|42|||
130722165|NCT01059539|470608173|FG000|Overall Study|Reason Not Specified|2|||
130722166|NCT04091659|470608174|FG000|Overall Study|Protocol Violation|3|||
130722167|NCT04091659|470608175|FG001|Overall Study|Protocol Violation|0|||
130722168|NCT04091659|470608174|FG000|Overall Study|Lost to Follow-up|0|||
130381422|NCT01320085|469365696|FG002|Overall Study|Withdrawal by Subject|1|||
130381423|NCT01320085|469365694|FG000|Overall Study|Protocol Deviation|1|||
130381424|NCT01320085|469365695|FG001|Overall Study|Protocol Deviation|0|||
130381425|NCT01320085|469365696|FG002|Overall Study|Protocol Deviation|1|||
130381426|NCT01320085|469365694|FG000|Overall Study|Administrative problems|0|||
130381427|NCT01320085|469365695|FG001|Overall Study|Administrative problems|0|||
130381428|NCT01320085|469365696|FG002|Overall Study|Administrative problems|1|||
130381429|NCT03020407|469365705|FG000|Overall Study|Withdrawal by Subject|2|||
130381430|NCT03020407|469365706|FG001|Overall Study|Withdrawal by Subject|1|||
130381431|NCT03020407|469365705|FG000|Overall Study|Lost to Follow-up|2|||
130381432|NCT03020407|469365706|FG001|Overall Study|Lost to Follow-up|3|||
130381433|NCT03020407|469365705|FG000|Overall Study|Protocol Violation|0|||
130381434|NCT03020407|469365706|FG001|Overall Study|Protocol Violation|1|||
130381435|NCT00708162|469365707|FG000|Randomized Phase|Randomized but Not Treated|7|||
130381436|NCT00708162|469365708|FG001|Randomized Phase|Randomized but Not Treated|5|||
130381437|NCT00708162|469365707|FG000|Randomized Phase|Participant Noncompliance|40|||
130381438|NCT00708162|469365708|FG001|Randomized Phase|Participant Noncompliance|32|||
130381439|NCT00708162|469365707|FG000|Randomized Phase|Lost to Follow-up|34|||
130381440|NCT00708162|469365708|FG001|Randomized Phase|Lost to Follow-up|34|||
130381441|NCT00708162|469365707|FG000|Randomized Phase|Withdrew Consent|31|||
130381442|NCT00708162|469365708|FG001|Randomized Phase|Withdrew Consent|22|||
130381443|NCT00708162|469365707|FG000|Randomized Phase|Lack of Efficacy|14|||
130381444|NCT00708162|469365708|FG001|Randomized Phase|Lack of Efficacy|19|||
130381445|NCT00708162|469365707|FG000|Randomized Phase|Protocol Violation|10|||
130381446|NCT00708162|469365708|FG001|Randomized Phase|Protocol Violation|11|||
130381447|NCT00708162|469365707|FG000|Randomized Phase|Adverse Event|8|||
130381448|NCT00708162|469365708|FG001|Randomized Phase|Adverse Event|12|||
130381449|NCT00708162|469365707|FG000|Randomized Phase|Investigator's Discretion|7|||
130381450|NCT00708162|469365708|FG001|Randomized Phase|Investigator's Discretion|10|||
130381451|NCT00708162|469365707|FG000|Randomized Phase|Death|2|||
130381452|NCT00708162|469365708|FG001|Randomized Phase|Death|9|||
130381453|NCT00708162|469365707|FG000|Randomized Phase|Pregnancy|3|||
130381454|NCT00708162|469365708|FG001|Randomized Phase|Pregnancy|0|||
130381455|NCT00708162|469365707|FG000|Open-Label Phase|Lost to Follow-up|10|||
130381456|NCT00708162|469365708|FG001|Open-Label Phase|Lost to Follow-up|8|||
130381457|NCT00708162|469365707|FG000|Open-Label Phase|Withdrew Consent|12|||
130381458|NCT00708162|469365708|FG001|Open-Label Phase|Withdrew Consent|6|||
130381459|NCT00708162|469365707|FG000|Open-Label Phase|Participant Noncompliance|7|||
130381460|NCT00708162|469365708|FG001|Open-Label Phase|Participant Noncompliance|7|||
130381461|NCT00708162|469365707|FG000|Open-Label Phase|Lack of Efficacy|7|||
130381462|NCT00708162|469365708|FG001|Open-Label Phase|Lack of Efficacy|4|||
130381463|NCT00708162|469365707|FG000|Open-Label Phase|Investigator's Discretion|3|||
130381464|NCT00708162|469365708|FG001|Open-Label Phase|Investigator's Discretion|2|||
130381465|NCT00708162|469365707|FG000|Open-Label Phase|Death|3|||
130381466|NCT00708162|469365708|FG001|Open-Label Phase|Death|1|||
130381467|NCT00708162|469365707|FG000|Open-Label Phase|Adverse Event|1|||
130381468|NCT00708162|469365708|FG001|Open-Label Phase|Adverse Event|2|||
130381469|NCT00708162|469365707|FG000|Open-Label Phase|Other|1|||
130381470|NCT00708162|469365708|FG001|Open-Label Phase|Other|0|||
130381471|NCT02699554|469365709|FG000|Overall Study|Lost to Follow-up|9|||
130722169|NCT04091659|470608175|FG001|Overall Study|Lost to Follow-up|1|||
130722170|NCT03678285|470608180|FG000|Overall Study|Adverse Event|2|||
130722171|NCT03678285|470608180|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
130722172|NCT03678285|470608180|FG000|Overall Study|Dehydrated prior to start of workout|1|||
130722173|NCT00616629|470608181|FG000|Overall Study|Protocol Violation|1|||
130381472|NCT00708643|469365710|FG000|Overall Study|Adverse Event|0|||
130381473|NCT00708643|469365711|FG001|Overall Study|Adverse Event|1|||
130381474|NCT00788151|469365712|FG000|Overall Study|Other adverse event|0|||
130381475|NCT00788151|469365713|FG001|Overall Study|Other adverse event|2|||
130381476|NCT00788151|469365712|FG000|Overall Study|Protocol Violation|0|||
130381477|NCT00788151|469365713|FG001|Overall Study|Protocol Violation|1|||
130381478|NCT00788151|469365712|FG000|Overall Study|Withdrawal by Subject|13|||
130381479|NCT00788151|469365713|FG001|Overall Study|Withdrawal by Subject|6|||
130381480|NCT00788151|469365712|FG000|Overall Study|Enrolled but not treated|1|||
130381481|NCT00788151|469365713|FG001|Overall Study|Enrolled but not treated|1|||
130381482|NCT00503009|469365714|FG000|Overall Study|Protocol Violation|1|||
130381483|NCT00503009|469365715|FG001|Overall Study|Protocol Violation|0|||
130381484|NCT00503009|469365716|FG002|Overall Study|Protocol Violation|1|||
130381485|NCT00503009|469365714|FG000|Overall Study|Withdrawal by Subject|0|||
130381486|NCT00503009|469365715|FG001|Overall Study|Withdrawal by Subject|1|||
130381487|NCT00503009|469365716|FG002|Overall Study|Withdrawal by Subject|1|||
130381488|NCT00503009|469365714|FG000|Overall Study|Physician Decision|0|||
130381489|NCT00503009|469365715|FG001|Overall Study|Physician Decision|1|||
130381490|NCT00503009|469365716|FG002|Overall Study|Physician Decision|1|||
130381491|NCT01349803|469365717|FG000|Overall Study|Adverse Event|0|||
130381492|NCT01349803|469365718|FG001|Overall Study|Adverse Event|0|||
130381493|NCT01349803|469365719|FG002|Overall Study|Adverse Event|0|||
130381494|NCT01349803|469365720|FG003|Overall Study|Adverse Event|2|||
130381495|NCT01349803|469365717|FG000|Overall Study|Withdrawal by Subject|1|||
130381496|NCT01349803|469365718|FG001|Overall Study|Withdrawal by Subject|0|||
130381497|NCT01349803|469365719|FG002|Overall Study|Withdrawal by Subject|0|||
130381498|NCT01349803|469365720|FG003|Overall Study|Withdrawal by Subject|0|||
130381499|NCT01349803|469365717|FG000|Overall Study|Protocol-specified criteria|0|||
130381500|NCT01349803|469365718|FG001|Overall Study|Protocol-specified criteria|1|||
130381501|NCT01349803|469365719|FG002|Overall Study|Protocol-specified criteria|3|||
130381502|NCT01349803|469365720|FG003|Overall Study|Protocol-specified criteria|0|||
130381503|NCT00100815|469365721|FG000|Overall Study|Progression|24|||
130381504|NCT00100815|469365721|FG000|Overall Study|Adverse Event|18|||
130381505|NCT00100815|469365721|FG000|Overall Study|Death|4|||
130381506|NCT00100815|469365721|FG000|Overall Study|Other|3|||
130381507|NCT01710033|469365722|FG000|Stage 2|Adverse Event|0|||
130381508|NCT01710033|469365723|FG001|Stage 2|Adverse Event|0|||
130381509|NCT01710033|469365724|FG002|Stage 2|Adverse Event|0|||
130381510|NCT01710033|469365725|FG003|Stage 2|Adverse Event|0|||
130381511|NCT01710033|469365726|FG004|Stage 2|Adverse Event|1|||
130381512|NCT01647282|469365728|FG000|Overall Study|Physician Decision|7|||
130381513|NCT01647282|469365729|FG001|Overall Study|Physician Decision|5|||
130381514|NCT01244906|469365731|FG000|Overall Study|Death|2|||
130381515|NCT01244906|469365731|FG000|Overall Study|Progression of disease post treatment|6|||
130381516|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
130381517|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
130468187|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
130468188|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
130468189|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
130468190|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
130381518|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
130381519|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
130381520|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
130381521|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
130381522|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130381523|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130381524|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130381525|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
130381526|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130381527|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
130381528|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
130381529|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
130722174|NCT00616629|470608182|FG001|Overall Study|Protocol Violation|2|||
130381530|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
130381531|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
130381532|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
130381533|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
130381534|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130381535|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130381536|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130381537|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130381538|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
130381539|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
130381540|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130381541|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
130381542|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
130381543|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130381544|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130381545|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
130381546|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
130381547|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
130381548|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
130381549|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
130381550|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
130381551|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
130381552|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130381553|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130381554|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130381555|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
130381556|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
130381557|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130381558|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
130381559|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
130381560|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
130381561|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
130381562|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
130381563|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
130381564|NCT03720470|469365732|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130381565|NCT03720470|469365733|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130381566|NCT03720470|469365734|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130381567|NCT03720470|469365735|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130381568|NCT03720470|469365736|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130381569|NCT03720470|469365737|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
130381570|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130381571|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130381572|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130381573|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
130381574|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
130381575|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
130381576|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130381577|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130381578|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
130381579|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130381580|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130381581|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130381582|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130381583|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130381584|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130381585|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
130381586|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130381587|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
130381588|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130381589|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130381590|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130381591|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130381592|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130381593|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
130381594|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130381595|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130381596|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
130722175|NCT00616629|470608183|FG002|Overall Study|Protocol Violation|1|||
130722176|NCT00616629|470608184|FG003|Overall Study|Protocol Violation|0|||
130722177|NCT00616629|470608185|FG004|Overall Study|Protocol Violation|0|||
130722178|NCT00616629|470608181|FG000|Overall Study|AV-block|1|||
130722179|NCT00616629|470608182|FG001|Overall Study|AV-block|0|||
130722180|NCT00616629|470608183|FG002|Overall Study|AV-block|0|||
130722181|NCT00616629|470608184|FG003|Overall Study|AV-block|0|||
130381597|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130381598|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130381599|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130381600|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
130381601|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
130381602|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
130381603|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130381604|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130381605|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130381606|NCT03720470|469365732|FG000|Treatment Period: Final 4 Weeks|Other|0|||
130381607|NCT03720470|469365733|FG001|Treatment Period: Final 4 Weeks|Other|1|||
130381608|NCT03720470|469365734|FG002|Treatment Period: Final 4 Weeks|Other|0|||
130559596|NCT01338415|470017820|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
130559597|NCT01338415|470017821|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
130559598|NCT01338415|470017822|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
130559599|NCT01338415|470017820|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
130381609|NCT03720470|469365735|FG003|Treatment Period: Final 4 Weeks|Other|2|||
130381610|NCT03720470|469365736|FG004|Treatment Period: Final 4 Weeks|Other|1|||
130381611|NCT03720470|469365737|FG005|Treatment Period: Final 4 Weeks|Other|0|||
130381612|NCT00453921|469365738|FG000|Overall Study|Withdrawal by Subject|1|||
130381613|NCT00453921|469365739|FG001|Overall Study|Withdrawal by Subject|1|||
130381614|NCT00453921|469365740|FG002|Overall Study|Withdrawal by Subject|1|||
130381615|NCT00453921|469365741|FG003|Overall Study|Withdrawal by Subject|1|||
130381616|NCT00453921|469365738|FG000|Overall Study|Lost to Follow-up|0|||
130381617|NCT00453921|469365739|FG001|Overall Study|Lost to Follow-up|0|||
130381618|NCT00453921|469365740|FG002|Overall Study|Lost to Follow-up|1|||
130381619|NCT00453921|469365741|FG003|Overall Study|Lost to Follow-up|0|||
130381620|NCT00993291|469365745|FG000|Overall Study|Withdrawal by Subject|1|||
130381621|NCT02763189|469365746|FG000|Overall Study|Device failure|0|||
130381622|NCT02763189|469365747|FG001|Overall Study|Device failure|2|||
130381623|NCT00573534|469365752|FG000|Overall Study|oppositional behavior|3|||
130381624|NCT00467259|469365757|FG000|Overall Study|Adverse Event|24|||
130381625|NCT00467259|469365758|FG001|Overall Study|Adverse Event|90|||
130381626|NCT00467259|469365757|FG000|Overall Study|Protocol Violation|1|||
130381627|NCT00467259|469365758|FG001|Overall Study|Protocol Violation|7|||
130381628|NCT00467259|469365757|FG000|Overall Study|Withdrawal by Subject|34|||
130381629|NCT00467259|469365758|FG001|Overall Study|Withdrawal by Subject|108|||
130381630|NCT00467259|469365757|FG000|Overall Study|Physician Decision|0|||
130381631|NCT00467259|469365758|FG001|Overall Study|Physician Decision|2|||
130381632|NCT00467259|469365757|FG000|Overall Study|Lost to Follow-up|14|||
130381633|NCT00467259|469365758|FG001|Overall Study|Lost to Follow-up|34|||
130381634|NCT00467259|469365757|FG000|Overall Study|Site Closed|2|||
130381635|NCT00467259|469365758|FG001|Overall Study|Site Closed|1|||
130468191|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
130468192|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
130468193|NCT03088813|469680249|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
130468194|NCT03088813|469680250|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
130468195|NCT03088813|469680251|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
130468196|NCT03088813|469680252|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
130468197|NCT01903811|469680253|FG000|Overall Study|No measurable disease|1|||
130468198|NCT01903811|469680254|FG001|Overall Study|No measurable disease|1|||
130468199|NCT01903811|469680253|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
130468200|NCT01903811|469680254|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
130468201|NCT01903811|469680253|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
130468202|NCT01903811|469680254|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
130468203|NCT01903811|469680253|FG000|Overall Study|Withdrawal by Subject|0|||
130468204|NCT01903811|469680254|FG001|Overall Study|Withdrawal by Subject|1|||
130381636|NCT01129960|469365766|FG000|Overall Study|Withdrawal by Subject|3|||
130381637|NCT01129960|469365767|FG001|Overall Study|Withdrawal by Subject|0|||
130381638|NCT01129960|469365768|FG002|Overall Study|Withdrawal by Subject|3|||
130381639|NCT01129960|469365769|FG003|Overall Study|Withdrawal by Subject|2|||
130381640|NCT01129960|469365766|FG000|Overall Study|Lack of Efficacy|1|||
130559600|NCT01338415|470017821|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
130722182|NCT00616629|470608185|FG004|Overall Study|AV-block|0|||
130722183|NCT01777620|470608186|FG000|Overall Study|Subject Withdrawal|1|||
130722184|NCT01777620|470608187|FG001|Overall Study|Subject Withdrawal|0|||
130722185|NCT04005352|470608189|FG000|Overall Study|Adverse Event|4|||
130722186|NCT04005352|470608190|FG001|Overall Study|Adverse Event|5|||
130722187|NCT04005352|470608189|FG000|Overall Study|Death|4|||
130381641|NCT01129960|469365767|FG001|Overall Study|Lack of Efficacy|1|||
130381642|NCT01129960|469365768|FG002|Overall Study|Lack of Efficacy|1|||
130381643|NCT01129960|469365769|FG003|Overall Study|Lack of Efficacy|1|||
130381644|NCT01129960|469365766|FG000|Overall Study|Adverse Event|23|||
130722188|NCT04005352|470608190|FG001|Overall Study|Death|2|||
130468205|NCT04540913|469680255|FG000|Overall Study|Withdrawal by Subject|14|||
130468206|NCT04540913|469680256|FG001|Overall Study|Withdrawal by Subject|3|||
130722189|NCT04005352|470608189|FG000|Overall Study|Lost to Follow-up|6|||
130722190|NCT04005352|470608190|FG001|Overall Study|Lost to Follow-up|2|||
130468207|NCT03613740|469680257|FG000|Overall Study|Lost to Follow-up|1|||
130468208|NCT03613740|469680258|FG001|Overall Study|Lost to Follow-up|1|||
130468209|NCT01693120|469680260|FG000|Enrollment|Lost to Follow-up|1|||
130468210|NCT01693120|469680260|FG000|Enrollment|Withdrawal by Subject|10|||
130468211|NCT01693120|469680260|FG000|Enrollment|Protocol Violation|46|||
130468212|NCT01693120|469680260|FG000|Enrollment|Physician Decision|3|||
130722191|NCT04005352|470608189|FG000|Overall Study|Physician Decision|7|||
130722192|NCT04005352|470608190|FG001|Overall Study|Physician Decision|13|||
130722193|NCT04005352|470608189|FG000|Overall Study|Protocol Violation|0|||
130722194|NCT04005352|470608190|FG001|Overall Study|Protocol Violation|1|||
130381645|NCT01129960|469365767|FG001|Overall Study|Adverse Event|16|||
130381646|NCT01129960|469365768|FG002|Overall Study|Adverse Event|16|||
130381647|NCT01129960|469365769|FG003|Overall Study|Adverse Event|7|||
130381648|NCT01129960|469365766|FG000|Overall Study|Protocol Violation|1|||
130381649|NCT01129960|469365767|FG001|Overall Study|Protocol Violation|2|||
130381650|NCT01129960|469365768|FG002|Overall Study|Protocol Violation|3|||
130381651|NCT01129960|469365769|FG003|Overall Study|Protocol Violation|0|||
130381652|NCT01129960|469365766|FG000|Overall Study|Lost to Follow-up|0|||
130381653|NCT01129960|469365767|FG001|Overall Study|Lost to Follow-up|2|||
130381654|NCT01129960|469365768|FG002|Overall Study|Lost to Follow-up|3|||
130381655|NCT01129960|469365769|FG003|Overall Study|Lost to Follow-up|3|||
130381656|NCT01129960|469365766|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
130381657|NCT01129960|469365767|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
130381658|NCT01129960|469365768|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
130381659|NCT01129960|469365769|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
130381660|NCT01129960|469365766|FG000|Overall Study|Physician Decision|1|||
130381661|NCT01129960|469365767|FG001|Overall Study|Physician Decision|0|||
130381662|NCT01129960|469365768|FG002|Overall Study|Physician Decision|0|||
130381663|NCT01129960|469365769|FG003|Overall Study|Physician Decision|0|||
130381664|NCT01129960|469365766|FG000|Overall Study|Pregnancy|1|||
130381665|NCT01129960|469365767|FG001|Overall Study|Pregnancy|0|||
130381666|NCT01129960|469365768|FG002|Overall Study|Pregnancy|0|||
130381667|NCT01129960|469365769|FG003|Overall Study|Pregnancy|0|||
130381668|NCT04285879|469365770|FG000|Overall Study|Lost to Follow-up|1|||
130381669|NCT04285879|469365771|FG001|Overall Study|Lost to Follow-up|8|||
130381670|NCT04285879|469365770|FG000|Overall Study|medical/surgical exclusion|16|||
130381671|NCT04285879|469365771|FG001|Overall Study|medical/surgical exclusion|0|||
130381672|NCT02056340|469365772|FG000|Overall Study|Lost to Follow-up|5|||
130381673|NCT02056340|469365773|FG001|Overall Study|Lost to Follow-up|5|||
130381674|NCT02056340|469365772|FG000|Overall Study|Withdrawal by Subject|2|||
130381675|NCT02056340|469365773|FG001|Overall Study|Withdrawal by Subject|6|||
130381676|NCT04900220|469365775|FG000|Overall Study|Lost to Follow-up|1|||
130381677|NCT04900220|469365776|FG001|Overall Study|Lost to Follow-up|1|||
130381678|NCT02999854|469365782|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
130381679|NCT02999854|469365783|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
130381680|NCT02999854|469365782|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
130381681|NCT02999854|469365783|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
130381682|NCT02999854|469365782|FG000|Active Study Phase (up to 18 Months)|Death|7|||
130381683|NCT02999854|469365783|FG001|Active Study Phase (up to 18 Months)|Death|5|||
130381684|NCT02999854|469365782|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
130381685|NCT02999854|469365783|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
130381686|NCT02999854|469365782|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
130381687|NCT02999854|469365783|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
130381688|NCT02999854|469365782|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
130381689|NCT02999854|469365783|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
130381690|NCT02999854|469365782|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
130381691|NCT02999854|469365783|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
130381692|NCT02999854|469365782|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
130381693|NCT02999854|469365783|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
130381694|NCT01085591|469365784|FG000|Overall Study|Adverse Event|0|||
130381695|NCT01085591|469365785|FG001|Overall Study|Adverse Event|1|||
130722195|NCT04005352|470608189|FG000|Overall Study|Withdrawal by Subject|28|||
130468213|NCT01693120|469680260|FG000|Enrollment|Adverse Event|1|||
130722196|NCT04005352|470608190|FG001|Overall Study|Withdrawal by Subject|38|||
130381696|NCT01085591|469365786|FG002|Overall Study|Adverse Event|3|||
130381697|NCT01085591|469365784|FG000|Overall Study|Physician Decision|1|||
130381698|NCT01085591|469365785|FG001|Overall Study|Physician Decision|0|||
130381699|NCT01085591|469365786|FG002|Overall Study|Physician Decision|1|||
130381700|NCT01085591|469365784|FG000|Overall Study|Withdrawal by Subject|0|||
130468214|NCT01693120|469680260|FG000|Enrollment|Study closed|8|||
130468215|NCT01693120|469680260|FG000|Enrollment|Other|1|||
130468216|NCT01693120|469680260|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
130468217|NCT01693120|469680260|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
130468218|NCT01693120|469680260|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
130468219|NCT01693120|469680260|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
130468220|NCT01693120|469680260|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
130468221|NCT04153565|469680261|FG000|Overall Study|Death|13|||
130468222|NCT01443845|469680268|FG000|Overall Study|Protocol Violation|43|||
130468223|NCT01443845|469680269|FG001|Overall Study|Protocol Violation|45|||
130468224|NCT01443845|469680268|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
130468225|NCT01443845|469680269|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
130468226|NCT01443845|469680268|FG000|Overall Study|Deterioration in pulmonary function|1|||
130468227|NCT01443845|469680269|FG001|Overall Study|Deterioration in pulmonary function|4|||
130468228|NCT01443845|469680268|FG000|Overall Study|Lack of Efficacy|10|||
130468229|NCT01443845|469680269|FG001|Overall Study|Lack of Efficacy|5|||
130468230|NCT01443845|469680268|FG000|Overall Study|Adverse Event|64|||
130468231|NCT01443845|469680269|FG001|Overall Study|Adverse Event|138|||
130381701|NCT01085591|469365785|FG001|Overall Study|Withdrawal by Subject|2|||
130381702|NCT01085591|469365786|FG002|Overall Study|Withdrawal by Subject|1|||
130381703|NCT01085591|469365784|FG000|Overall Study|Lost to Follow-up|0|||
130381704|NCT01085591|469365785|FG001|Overall Study|Lost to Follow-up|1|||
130381705|NCT01085591|469365786|FG002|Overall Study|Lost to Follow-up|1|||
130381706|NCT01085591|469365784|FG000|Overall Study|Protocol Violation|1|||
130381707|NCT01085591|469365785|FG001|Overall Study|Protocol Violation|1|||
130381708|NCT01085591|469365786|FG002|Overall Study|Protocol Violation|1|||
130381709|NCT01085591|469365784|FG000|Overall Study|Other|0|||
130381710|NCT01085591|469365785|FG001|Overall Study|Other|1|||
130381711|NCT01085591|469365786|FG002|Overall Study|Other|0|||
130381712|NCT01085591|469365784|FG000|Overall Study|Not Properly Consented|1|||
130381713|NCT01085591|469365785|FG001|Overall Study|Not Properly Consented|0|||
130381714|NCT01085591|469365786|FG002|Overall Study|Not Properly Consented|0|||
130381715|NCT03036072|469365789|FG000|Overall Study|Death|0|||
130381716|NCT03036072|469365790|FG001|Overall Study|Death|1|||
130381717|NCT03036072|469365789|FG000|Overall Study|Withdrawal by Subject|0|||
130381718|NCT03036072|469365790|FG001|Overall Study|Withdrawal by Subject|1|||
130381719|NCT03036072|469365789|FG000|Overall Study|Physician Decision|0|||
130381720|NCT03036072|469365790|FG001|Overall Study|Physician Decision|1|||
130381721|NCT02484729|469365791|FG000|Overall Study|Failure of IntelliCap Error|0|||
130381722|NCT02484729|469365792|FG001|Overall Study|Failure of IntelliCap Error|0|||
130381723|NCT02484729|469365793|FG002|Overall Study|Failure of IntelliCap Error|0|||
130381724|NCT02484729|469365794|FG003|Overall Study|Failure of IntelliCap Error|0|||
130381725|NCT02484729|469365795|FG004|Overall Study|Failure of IntelliCap Error|0|||
130381726|NCT02484729|469365796|FG005|Overall Study|Failure of IntelliCap Error|0|||
130381727|NCT02484729|469365797|FG006|Overall Study|Failure of IntelliCap Error|0|||
130381728|NCT02484729|469365798|FG007|Overall Study|Failure of IntelliCap Error|0|||
130381729|NCT02484729|469365799|FG008|Overall Study|Failure of IntelliCap Error|0|||
130381730|NCT02484729|469365800|FG009|Overall Study|Failure of IntelliCap Error|1|||
130381731|NCT02111850|469365803|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381732|NCT02111850|469365804|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381733|NCT02111850|469365805|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381734|NCT02111850|469365806|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381735|NCT02111850|469365807|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
130381736|NCT02111850|469365808|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381737|NCT02111850|469365809|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381738|NCT02111850|469365810|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381739|NCT02111850|469365811|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381740|NCT02111850|469365812|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381741|NCT02111850|469365813|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130381742|NCT00665847|469365814|FG000|Overall Study|Adverse Event|8|||
130381743|NCT00665847|469365814|FG000|Overall Study|Withdrawal by Subject|2|||
130381744|NCT00665847|469365814|FG000|Overall Study|Subject non-compliant|8|||
130381745|NCT00665847|469365814|FG000|Overall Study|Subject reached a virologic endpoint|4|||
130381746|NCT00665847|469365814|FG000|Overall Study|Resistance to TMC125|1|||
130381747|NCT00665847|469365814|FG000|Overall Study|Subject ineligible to continue the trial|1|||
130381748|NCT00665847|469365814|FG000|Overall Study|Switch to Commercial Medication|1|||
130381749|NCT03605303|469365815|FG000|Period 1|Study Terminated|2|||
130381750|NCT03605303|469365816|FG001|Period 1|Study Terminated|1|||
130381751|NCT02626520|469365819|FG000|Overall Study|Physician Decision|1|||
130381752|NCT02626520|469365820|FG001|Overall Study|Physician Decision|1|||
130381753|NCT02626520|469365819|FG000|Overall Study|Adverse Event|0|||
130381754|NCT02626520|469365820|FG001|Overall Study|Adverse Event|4|||
130381755|NCT02626520|469365819|FG000|Overall Study|Lack of Efficacy|0|||
130381756|NCT02626520|469365820|FG001|Overall Study|Lack of Efficacy|2|||
130381757|NCT02626520|469365819|FG000|Overall Study|Did not start protocol therapy|0|||
130381758|NCT02626520|469365820|FG001|Overall Study|Did not start protocol therapy|2|||
130381759|NCT02626520|469365819|FG000|Overall Study|Study terminated|0|||
130381760|NCT02626520|469365820|FG001|Overall Study|Study terminated|1|||
130381761|NCT00492115|469365821|FG000|Overall Study|Withdrawal by Subject|3|||
130381762|NCT00492115|469365822|FG001|Overall Study|Withdrawal by Subject|4|||
130381763|NCT03564145|469365823|FG000|Overall Study|Adverse Event|4|||
130381764|NCT03564145|469365823|FG000|Overall Study|Lost to Follow-up|21|||
130381765|NCT03564145|469365823|FG000|Overall Study|Protocol Violation|2|||
130381766|NCT03564145|469365823|FG000|Overall Study|Withdrawal by Subject|48|||
130381767|NCT03564145|469365823|FG000|Overall Study|Study Terminated by Sponsor|146|||
130381768|NCT03564145|469365823|FG000|Overall Study|Physician Decision|1|||
130381769|NCT03564145|469365823|FG000|Overall Study|Other Than Specified|1|||
130381770|NCT03564145|469365823|FG000|Overall Study|Pregnancy|1|||
130381771|NCT03915496|469365826|FG000|Overall Study|Adverse Event|2|||
130381772|NCT03915496|469365827|FG001|Overall Study|Adverse Event|1|||
130381773|NCT03915496|469365828|FG002|Overall Study|Adverse Event|2|||
130381774|NCT05024058|469367382|FG000|Treatment|Study terminated by sponsor|5|||
130381775|NCT05024058|469367383|FG001|Treatment|Study terminated by sponsor|6|||
130381776|NCT05024058|469367384|FG002|Treatment|Study terminated by sponsor|4|||
130381777|NCT05024058|469367385|FG003|Treatment|Study terminated by sponsor|2|||
130381778|NCT05024058|469367386|FG004|Treatment|Study terminated by sponsor|3|||
130381779|NCT05024058|469367387|FG005|Treatment|Study terminated by sponsor|3|||
130381780|NCT05024058|469367388|FG006|Treatment|Study terminated by sponsor|1|||
130381781|NCT05024058|469367389|FG007|Treatment|Study terminated by sponsor|3|||
130381782|NCT05024058|469367390|FG008|Treatment|Study terminated by sponsor|6|||
130381783|NCT05024058|469367391|FG009|Treatment|Study terminated by sponsor|6|||
130381784|NCT05024058|469367382|FG000|Follow-up|Withdrawal by Subject|1|||
130381785|NCT05024058|469367383|FG001|Follow-up|Withdrawal by Subject|0|||
130381786|NCT05024058|469367384|FG002|Follow-up|Withdrawal by Subject|1|||
130381787|NCT05024058|469367385|FG003|Follow-up|Withdrawal by Subject|0|||
130381788|NCT05024058|469367386|FG004|Follow-up|Withdrawal by Subject|0|||
130381789|NCT05024058|469367387|FG005|Follow-up|Withdrawal by Subject|0|||
130381790|NCT05024058|469367388|FG006|Follow-up|Withdrawal by Subject|0|||
130381791|NCT05024058|469367389|FG007|Follow-up|Withdrawal by Subject|1|||
130381792|NCT05024058|469367390|FG008|Follow-up|Withdrawal by Subject|0|||
130381793|NCT05024058|469367391|FG009|Follow-up|Withdrawal by Subject|1|||
130381794|NCT00501293|469367392|FG000|Optimization Period|Enrolled in error|1|||
130381795|NCT00501293|469367393|FG001|Optimization Period|Enrolled in error|0|||
130381796|NCT00501293|469367392|FG000|Maintenance Period|Withdrawal by Subject|14|||
130722197|NCT00936897|470608193|FG000|Overall Study|Withdrawal by Subject|9|||
130722198|NCT00936897|470608194|FG001|Overall Study|Withdrawal by Subject|19|||
130722199|NCT00936897|470608193|FG000|Overall Study|Adverse Event|4|||
130381797|NCT00501293|469367393|FG001|Maintenance Period|Withdrawal by Subject|13|||
130381798|NCT00501293|469367392|FG000|Maintenance Period|Lost to Follow-up|12|||
130381799|NCT00501293|469367393|FG001|Maintenance Period|Lost to Follow-up|7|||
130381800|NCT00501293|469367392|FG000|Maintenance Period|Adverse Event|6|||
130381801|NCT00501293|469367393|FG001|Maintenance Period|Adverse Event|6|||
130381802|NCT00501293|469367392|FG000|Maintenance Period|Protocol Violation|2|||
130381803|NCT00501293|469367393|FG001|Maintenance Period|Protocol Violation|1|||
130381804|NCT00501293|469367392|FG000|Maintenance Period|Lack of Efficacy|4|||
130381805|NCT00501293|469367393|FG001|Maintenance Period|Lack of Efficacy|1|||
130381806|NCT00501293|469367392|FG000|Maintenance Period|Noncompliant with study medication|5|||
130381807|NCT00501293|469367393|FG001|Maintenance Period|Noncompliant with study medication|0|||
130381808|NCT00501293|469367392|FG000|Maintenance Period|Went into rehabilitation|1|||
130381809|NCT00501293|469367393|FG001|Maintenance Period|Went into rehabilitation|0|||
130381810|NCT00501293|469367392|FG000|Maintenance Period|Would not wear patch|1|||
130381811|NCT00501293|469367393|FG001|Maintenance Period|Would not wear patch|0|||
130381812|NCT00501293|469367392|FG000|Maintenance Period|Application site reaction|1|||
130381813|NCT00501293|469367393|FG001|Maintenance Period|Application site reaction|0|||
130381814|NCT00967798|469367394|FG000|Overall Study|Withdrawal by Subject|5|||
130468232|NCT01443845|469680268|FG000|Overall Study|Withdrawal by Subject|63|||
130468233|NCT01443845|469680269|FG001|Overall Study|Withdrawal by Subject|67|||
130381815|NCT00967798|469367395|FG001|Overall Study|Withdrawal by Subject|2|||
130381816|NCT00967798|469367394|FG000|Overall Study|Lost to Follow-up|4|||
130381817|NCT00967798|469367395|FG001|Overall Study|Lost to Follow-up|1|||
130381818|NCT03316131|469367396|FG000|Treatment Period 2|Protocol deviation|1|||
130381819|NCT03316131|469367397|FG001|Treatment Period 2|Protocol deviation|0|||
130722200|NCT00936897|470608194|FG001|Overall Study|Adverse Event|13|||
130381820|NCT01409564|469367398|FG000|Overall Study|low medication compliance|4|||
130381821|NCT01409564|469367399|FG001|Overall Study|low medication compliance|3|||
130381822|NCT01409564|469367398|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
130722201|NCT00936897|470608193|FG000|Overall Study|Other|3|||
130381823|NCT01409564|469367399|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
130381824|NCT00350636|469367403|FG000|Overall Study|Adverse Event|19|||
130381825|NCT00350636|469367404|FG001|Overall Study|Adverse Event|13|||
130381826|NCT00350636|469367403|FG000|Overall Study|Protocol Violation|1|||
130381827|NCT00350636|469367404|FG001|Overall Study|Protocol Violation|3|||
130381828|NCT00350636|469367403|FG000|Overall Study|Withdrawal by Subject|13|||
130381829|NCT00350636|469367404|FG001|Overall Study|Withdrawal by Subject|17|||
130381830|NCT00350636|469367403|FG000|Overall Study|Lost to Follow-up|9|||
130381831|NCT00350636|469367404|FG001|Overall Study|Lost to Follow-up|8|||
130381832|NCT00350636|469367403|FG000|Overall Study|Physician Decision|0|||
130381833|NCT00350636|469367404|FG001|Overall Study|Physician Decision|2|||
130381834|NCT00350636|469367403|FG000|Overall Study|Other|1|||
130381835|NCT00350636|469367404|FG001|Overall Study|Other|2|||
130381836|NCT01042236|469367407|FG000|Treatment Period 1|Adverse Event|0|||
130381837|NCT01042236|469367408|FG001|Treatment Period 1|Adverse Event|1|||
130381838|NCT01042236|469367409|FG002|Treatment Period 1|Adverse Event|0|||
130381839|NCT01042236|469367410|FG003|Treatment Period 1|Adverse Event|0|||
130381840|NCT01042236|469367411|FG004|Treatment Period 1|Adverse Event|1|||
130381841|NCT01042236|469367412|FG005|Treatment Period 1|Adverse Event|0|||
130381842|NCT01042236|469367407|FG000|Treatment Period 3|Adverse Event|0|||
130381843|NCT01042236|469367408|FG001|Treatment Period 3|Adverse Event|0|||
130381844|NCT01042236|469367409|FG002|Treatment Period 3|Adverse Event|0|||
130381845|NCT01042236|469367410|FG003|Treatment Period 3|Adverse Event|1|||
130381846|NCT01042236|469367411|FG004|Treatment Period 3|Adverse Event|0|||
130381847|NCT01042236|469367412|FG005|Treatment Period 3|Adverse Event|0|||
130381848|NCT01042236|469367407|FG000|Treatment Period 3|Protocol Violation|0|||
130381849|NCT01042236|469367408|FG001|Treatment Period 3|Protocol Violation|0|||
130381850|NCT01042236|469367409|FG002|Treatment Period 3|Protocol Violation|0|||
130381851|NCT01042236|469367410|FG003|Treatment Period 3|Protocol Violation|1|||
130381852|NCT01042236|469367411|FG004|Treatment Period 3|Protocol Violation|0|||
130381853|NCT01042236|469367412|FG005|Treatment Period 3|Protocol Violation|0|||
130381854|NCT01525550|469367413|FG000|Overall Study|Lost to Follow-up|8|||
130381855|NCT01525550|469367414|FG001|Overall Study|Lost to Follow-up|2|||
130381856|NCT01525550|469367413|FG000|Overall Study|Death|19|||
130381857|NCT01525550|469367414|FG001|Overall Study|Death|28|||
130381858|NCT01525550|469367413|FG000|Overall Study|Other|0|||
130381859|NCT01525550|469367414|FG001|Overall Study|Other|4|||
130381860|NCT01525550|469367413|FG000|Overall Study|Sponsor's Decision|30|||
130381861|NCT01525550|469367414|FG001|Overall Study|Sponsor's Decision|11|||
130381862|NCT01525550|469367413|FG000|Overall Study|Withdrawal by Subject|4|||
130381863|NCT01525550|469367414|FG001|Overall Study|Withdrawal by Subject|0|||
130381864|NCT00723892|469367421|FG000|Overall Study|Participant not tracked|33|||
130381865|NCT00723892|469367422|FG001|Overall Study|Participant not tracked|35|||
130381866|NCT00723892|469367421|FG000|Overall Study|Virological criterion|24|||
130381867|NCT00723892|469367422|FG001|Overall Study|Virological criterion|9|||
130381868|NCT00723892|469367421|FG000|Overall Study|Withdrawal by Subject|6|||
130381869|NCT00723892|469367422|FG001|Overall Study|Withdrawal by Subject|9|||
130381870|NCT00723892|469367421|FG000|Overall Study|End planned|11|||
130381871|NCT00723892|469367422|FG001|Overall Study|End planned|7|||
130381872|NCT00723892|469367421|FG000|Overall Study|Bad tolerance|5|||
130381873|NCT00723892|469367422|FG001|Overall Study|Bad tolerance|5|||
130381874|NCT00723892|469367421|FG000|Overall Study|Multiple reasons|17|||
130381875|NCT00723892|469367422|FG001|Overall Study|Multiple reasons|12|||
130468234|NCT01443845|469680268|FG000|Overall Study|Military Conflict - Site Terminated|20|||
130468235|NCT01443845|469680269|FG001|Overall Study|Military Conflict - Site Terminated|21|||
130468236|NCT01443845|469680268|FG000|Overall Study|Lost to Follow-up|9|||
130468237|NCT01443845|469680269|FG001|Overall Study|Lost to Follow-up|13|||
130468238|NCT01610297|469680271|FG000|Overall Study|Lost to Follow-up|1|||
130468239|NCT01007396|469680272|FG000|Overall Study|Lost to Follow-up|47|||
130468240|NCT03283371|469680273|FG000|Placebo-controlled|Adverse Event|1|||
130381876|NCT00723892|469367421|FG000|Overall Study|Other|6|||
130381877|NCT00723892|469367422|FG001|Overall Study|Other|3|||
130381878|NCT00723892|469367421|FG000|Overall Study|Study end|1|||
130381879|NCT00723892|469367422|FG001|Overall Study|Study end|3|||
130381880|NCT00723892|469367421|FG000|Overall Study|Weight loss|1|||
130468241|NCT03283371|469680274|FG001|Placebo-controlled|Adverse Event|1|||
130468242|NCT03283371|469680275|FG002|Placebo-controlled|Adverse Event|0|||
130468243|NCT03283371|469680276|FG003|Placebo-controlled|Adverse Event|0|||
130468244|NCT03283371|469680273|FG000|Placebo-controlled|Lack of Efficacy|1|||
130468245|NCT03283371|469680274|FG001|Placebo-controlled|Lack of Efficacy|0|||
130468246|NCT03283371|469680275|FG002|Placebo-controlled|Lack of Efficacy|0|||
130381881|NCT00723892|469367422|FG001|Overall Study|Weight loss|3|||
130381882|NCT00723892|469367421|FG000|Overall Study|Alcohol abuse|0|||
130381883|NCT00723892|469367422|FG001|Overall Study|Alcohol abuse|1|||
130468247|NCT03283371|469680276|FG003|Placebo-controlled|Lack of Efficacy|0|||
130468248|NCT03283371|469680273|FG000|Placebo-controlled|Withdrawal by Subject|1|||
130468249|NCT03283371|469680274|FG001|Placebo-controlled|Withdrawal by Subject|1|||
130381884|NCT00723892|469367421|FG000|Overall Study|Intercurrent infection|2|||
130381885|NCT00723892|469367422|FG001|Overall Study|Intercurrent infection|0|||
130381886|NCT00723892|469367421|FG000|Overall Study|Drug addiction|1|||
130381887|NCT00723892|469367422|FG001|Overall Study|Drug addiction|0|||
130722202|NCT00936897|470608194|FG001|Overall Study|Other|9|||
130722203|NCT00936897|470608193|FG000|Overall Study|Lost to Follow-up|1|||
130722204|NCT00936897|470608194|FG001|Overall Study|Lost to Follow-up|10|||
130381888|NCT02411292|469367426|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
130381889|NCT02411292|469367426|FG000|Overall Study|Death|2|||
130381890|NCT02411292|469367426|FG000|Overall Study|Lost to Follow-up|3|||
130381891|NCT02232425|469367427|FG000|Overall Study|Lost to Follow-up|6|||
130381892|NCT02232425|469367428|FG001|Overall Study|Lost to Follow-up|2|||
130381893|NCT02232425|469367427|FG000|Overall Study|Adverse Event|2|||
130381894|NCT02232425|469367428|FG001|Overall Study|Adverse Event|0|||
130381895|NCT02232425|469367427|FG000|Overall Study|Withdrawal by Subject|5|||
130381896|NCT02232425|469367428|FG001|Overall Study|Withdrawal by Subject|6|||
130381897|NCT02232425|469367427|FG000|Overall Study|Lack of Efficacy|1|||
130381898|NCT02232425|469367428|FG001|Overall Study|Lack of Efficacy|0|||
130381899|NCT00665353|469367429|FG000|Study Step 1|Adverse Event|1|||
130381900|NCT00665353|469367429|FG000|Study Step 1|Withdrawal by Subject|2|||
130381901|NCT00665353|469367429|FG000|Study Step 2|Lost to Follow-up|2|||
130381902|NCT00665353|469367429|FG000|Study Step 2|Lack of Efficacy|12|||
130381903|NCT00498602|469367430|FG000|Overall Study|Death|0|||
130381904|NCT00498602|469367431|FG001|Overall Study|Death|0|||
130381905|NCT00498602|469367432|FG002|Overall Study|Death|0|||
130381906|NCT00498602|469367433|FG003|Overall Study|Death|0|||
130381907|NCT00498602|469367434|FG004|Overall Study|Death|0|||
130381908|NCT00498602|469367435|FG005|Overall Study|Death|1|||
130381909|NCT00498602|469367436|FG006|Overall Study|Death|0|||
130381910|NCT00498602|469367430|FG000|Overall Study|Lack of Efficacy|1|||
130381911|NCT00498602|469367431|FG001|Overall Study|Lack of Efficacy|0|||
130381912|NCT00498602|469367432|FG002|Overall Study|Lack of Efficacy|0|||
130381913|NCT00498602|469367433|FG003|Overall Study|Lack of Efficacy|0|||
130381914|NCT00498602|469367434|FG004|Overall Study|Lack of Efficacy|0|||
130381915|NCT00498602|469367435|FG005|Overall Study|Lack of Efficacy|0|||
130381916|NCT00498602|469367436|FG006|Overall Study|Lack of Efficacy|0|||
130381917|NCT00498602|469367430|FG000|Overall Study|Lost to Follow-up|0|||
130381918|NCT00498602|469367431|FG001|Overall Study|Lost to Follow-up|2|||
130722205|NCT00936897|470608193|FG000|Overall Study|Administrative Decision|1|||
130722206|NCT00936897|470608194|FG001|Overall Study|Administrative Decision|2|||
130722207|NCT00936897|470608193|FG000|Overall Study|Protocol Violation|1|||
130722208|NCT00936897|470608194|FG001|Overall Study|Protocol Violation|1|||
130381919|NCT00498602|469367432|FG002|Overall Study|Lost to Follow-up|0|||
130381920|NCT00498602|469367433|FG003|Overall Study|Lost to Follow-up|2|||
130381921|NCT00498602|469367434|FG004|Overall Study|Lost to Follow-up|0|||
130381922|NCT00498602|469367435|FG005|Overall Study|Lost to Follow-up|0|||
130722209|NCT00936897|470608193|FG000|Overall Study|Ineligibility Determined|0|||
130722210|NCT00936897|470608194|FG001|Overall Study|Ineligibility Determined|3|||
130722211|NCT00936897|470608193|FG000|Overall Study|Noncompliance|0|||
130722212|NCT00936897|470608194|FG001|Overall Study|Noncompliance|2|||
130722213|NCT00936897|470608193|FG000|Overall Study|Death|0|||
130722214|NCT00936897|470608194|FG001|Overall Study|Death|1|||
130722215|NCT04058067|470608195|FG000|Overall Study|Adverse Event|2|||
130722216|NCT04058067|470608196|FG001|Overall Study|Adverse Event|0|||
130722217|NCT04058067|470608195|FG000|Overall Study|Death|0|||
130722218|NCT04058067|470608196|FG001|Overall Study|Death|1|||
130722219|NCT04058067|470608195|FG000|Overall Study|Physician Decision|3|||
130722220|NCT04058067|470608196|FG001|Overall Study|Physician Decision|1|||
130722221|NCT04058067|470608195|FG000|Overall Study|Protocol Violation|0|||
130722222|NCT04058067|470608196|FG001|Overall Study|Protocol Violation|1|||
130722223|NCT04058067|470608195|FG000|Overall Study|Withdrawal by Subject|7|||
130722224|NCT04058067|470608196|FG001|Overall Study|Withdrawal by Subject|8|||
130722225|NCT00417170|470608197|FG000|Overall Study|Adverse Event|1|||
130381923|NCT00498602|469367436|FG006|Overall Study|Lost to Follow-up|0|||
130381924|NCT00498602|469367430|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130381925|NCT00498602|469367431|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130381926|NCT00498602|469367432|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
130381927|NCT00498602|469367433|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
130722226|NCT00417170|470608198|FG001|Overall Study|Adverse Event|1|||
130722227|NCT00417170|470608197|FG000|Overall Study|Withdrawal by Subject|1|||
130381928|NCT00498602|469367434|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130381929|NCT00498602|469367435|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130381930|NCT00498602|469367436|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130381931|NCT00498602|469367430|FG000|Overall Study|AE not related to Study Drug|1|||
130381932|NCT00498602|469367431|FG001|Overall Study|AE not related to Study Drug|3|||
130381933|NCT00498602|469367432|FG002|Overall Study|AE not related to Study Drug|0|||
130381934|NCT00498602|469367433|FG003|Overall Study|AE not related to Study Drug|0|||
130381935|NCT00498602|469367434|FG004|Overall Study|AE not related to Study Drug|2|||
130381936|NCT00498602|469367435|FG005|Overall Study|AE not related to Study Drug|2|||
130381937|NCT00498602|469367436|FG006|Overall Study|AE not related to Study Drug|1|||
130381938|NCT00498602|469367430|FG000|Overall Study|Caregiver Request|2|||
130381939|NCT00498602|469367431|FG001|Overall Study|Caregiver Request|2|||
130381940|NCT00498602|469367432|FG002|Overall Study|Caregiver Request|2|||
130381941|NCT00498602|469367433|FG003|Overall Study|Caregiver Request|0|||
130381942|NCT00498602|469367434|FG004|Overall Study|Caregiver Request|1|||
130381943|NCT00498602|469367435|FG005|Overall Study|Caregiver Request|2|||
130381944|NCT00498602|469367436|FG006|Overall Study|Caregiver Request|0|||
130381945|NCT00498602|469367430|FG000|Overall Study|Investigator Request|0|||
130381946|NCT00498602|469367431|FG001|Overall Study|Investigator Request|0|||
130381947|NCT00498602|469367432|FG002|Overall Study|Investigator Request|1|||
130381948|NCT00498602|469367433|FG003|Overall Study|Investigator Request|0|||
130381949|NCT00498602|469367434|FG004|Overall Study|Investigator Request|0|||
130381950|NCT00498602|469367435|FG005|Overall Study|Investigator Request|0|||
130381951|NCT00498602|469367436|FG006|Overall Study|Investigator Request|0|||
130381952|NCT00498602|469367430|FG000|Overall Study|Subject Request|3|||
130381953|NCT00498602|469367431|FG001|Overall Study|Subject Request|0|||
130381954|NCT00498602|469367432|FG002|Overall Study|Subject Request|1|||
130381955|NCT00498602|469367433|FG003|Overall Study|Subject Request|1|||
130381956|NCT00498602|469367434|FG004|Overall Study|Subject Request|1|||
130381957|NCT00498602|469367435|FG005|Overall Study|Subject Request|4|||
130381958|NCT00498602|469367436|FG006|Overall Study|Subject Request|1|||
130381959|NCT00498602|469367430|FG000|Overall Study|Other|2|||
130381960|NCT00498602|469367431|FG001|Overall Study|Other|3|||
130381961|NCT00498602|469367432|FG002|Overall Study|Other|1|||
130381962|NCT00498602|469367433|FG003|Overall Study|Other|0|||
130381963|NCT00498602|469367434|FG004|Overall Study|Other|0|||
130381964|NCT00498602|469367435|FG005|Overall Study|Other|3|||
130381965|NCT00498602|469367436|FG006|Overall Study|Other|0|||
130381966|NCT03103919|469367440|FG000|Overall Study|Adverse Event|2|||
130381967|NCT03103919|469367441|FG001|Overall Study|Adverse Event|2|||
130468250|NCT03283371|469680275|FG002|Placebo-controlled|Withdrawal by Subject|0|||
130468251|NCT03283371|469680276|FG003|Placebo-controlled|Withdrawal by Subject|0|||
130468252|NCT03283371|469680273|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
130468253|NCT03283371|469680274|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
130468254|NCT03283371|469680275|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
130468255|NCT03283371|469680276|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
130468256|NCT03283371|469680273|FG000|Open-label Phase|Adverse Event|0|||
130468257|NCT03283371|469680274|FG001|Open-label Phase|Adverse Event|0|||
130468258|NCT03283371|469680275|FG002|Open-label Phase|Adverse Event|2|||
130468259|NCT03283371|469680276|FG003|Open-label Phase|Adverse Event|0|||
130468260|NCT03283371|469680273|FG000|Open-label Phase|Withdrawal by Subject|0|||
130468261|NCT03283371|469680274|FG001|Open-label Phase|Withdrawal by Subject|0|||
130468262|NCT03283371|469680275|FG002|Open-label Phase|Withdrawal by Subject|1|||
130468263|NCT03283371|469680276|FG003|Open-label Phase|Withdrawal by Subject|0|||
130468264|NCT03283371|469680273|FG000|Open-label Phase|Other|0|||
130468265|NCT03283371|469680274|FG001|Open-label Phase|Other|0|||
130468266|NCT03283371|469680275|FG002|Open-label Phase|Other|1|||
130381968|NCT01291173|469367442|FG000|Overall Study|Adverse Event|0|||
130381969|NCT01291173|469367443|FG001|Overall Study|Adverse Event|3|||
130381970|NCT01291173|469367444|FG002|Overall Study|Adverse Event|1|||
130381971|NCT01291173|469367445|FG003|Overall Study|Adverse Event|3|||
130381972|NCT01291173|469367442|FG000|Overall Study|Protocol Violation|7|||
130381973|NCT01291173|469367443|FG001|Overall Study|Protocol Violation|2|||
130381974|NCT01291173|469367444|FG002|Overall Study|Protocol Violation|2|||
130381975|NCT01291173|469367445|FG003|Overall Study|Protocol Violation|5|||
130381976|NCT01291173|469367442|FG000|Overall Study|Withdrawal by Subject|6|||
130381977|NCT01291173|469367443|FG001|Overall Study|Withdrawal by Subject|4|||
130381978|NCT01291173|469367444|FG002|Overall Study|Withdrawal by Subject|4|||
130381979|NCT01291173|469367445|FG003|Overall Study|Withdrawal by Subject|2|||
130468267|NCT03283371|469680276|FG003|Open-label Phase|Other|1|||
130381980|NCT01291173|469367442|FG000|Overall Study|Lost to Follow-up|4|||
130381981|NCT01291173|469367443|FG001|Overall Study|Lost to Follow-up|6|||
130381982|NCT01291173|469367444|FG002|Overall Study|Lost to Follow-up|3|||
130381983|NCT01291173|469367445|FG003|Overall Study|Lost to Follow-up|2|||
130381984|NCT01291173|469367442|FG000|Overall Study|Unable to meet visit schedule|0|||
130381985|NCT01291173|469367443|FG001|Overall Study|Unable to meet visit schedule|0|||
130381986|NCT01291173|469367444|FG002|Overall Study|Unable to meet visit schedule|1|||
130381987|NCT01291173|469367445|FG003|Overall Study|Unable to meet visit schedule|0|||
130381988|NCT01291173|469367442|FG000|Overall Study|Lack of compliance|0|||
130381989|NCT01291173|469367443|FG001|Overall Study|Lack of compliance|0|||
130381990|NCT01291173|469367444|FG002|Overall Study|Lack of compliance|0|||
130381991|NCT01291173|469367445|FG003|Overall Study|Lack of compliance|1|||
130381992|NCT01291173|469367442|FG000|Overall Study|Subject was unblinded|0|||
130381993|NCT01291173|469367443|FG001|Overall Study|Subject was unblinded|0|||
130381994|NCT01291173|469367444|FG002|Overall Study|Subject was unblinded|1|||
130381995|NCT01291173|469367445|FG003|Overall Study|Subject was unblinded|0|||
130381996|NCT01291173|469367442|FG000|Overall Study|Excluded therapy|0|||
130381997|NCT01291173|469367443|FG001|Overall Study|Excluded therapy|0|||
130381998|NCT01291173|469367444|FG002|Overall Study|Excluded therapy|1|||
130381999|NCT01291173|469367445|FG003|Overall Study|Excluded therapy|0|||
130382000|NCT01846507|469367446|FG000|Overall Study|Lost to Follow-up|4|||
130382001|NCT01846507|469367446|FG000|Overall Study|Protocol Violation|1|||
130382002|NCT01846507|469367446|FG000|Overall Study|Missing data|2|||
130382003|NCT02436356|469367447|FG000|Overall Study|Excluded by MRI Screening|0|||
130382004|NCT02436356|469367448|FG001|Overall Study|Excluded by MRI Screening|0|||
130382005|NCT02436356|469367449|FG002|Overall Study|Excluded by MRI Screening|2|||
130382006|NCT02436356|469367447|FG000|Overall Study|Lost to Follow-up|0|||
130382007|NCT02436356|469367448|FG001|Overall Study|Lost to Follow-up|1|||
130382008|NCT02436356|469367449|FG002|Overall Study|Lost to Follow-up|0|||
130382009|NCT02436356|469367447|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
130382010|NCT02436356|469367448|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
130382011|NCT02436356|469367449|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
130382012|NCT02436356|469367447|FG000|Overall Study|Excluded due to other medical conditions|3|||
130382013|NCT02436356|469367448|FG001|Overall Study|Excluded due to other medical conditions|0|||
130382014|NCT02436356|469367449|FG002|Overall Study|Excluded due to other medical conditions|0|||
130722228|NCT00417170|470608198|FG001|Overall Study|Withdrawal by Subject|1|||
130722229|NCT00417170|470608197|FG000|Overall Study|Lost to Follow-up|0|||
130722230|NCT00417170|470608198|FG001|Overall Study|Lost to Follow-up|1|||
130382015|NCT02436356|469367447|FG000|Overall Study|Withdrawal by Subject|1|||
130382016|NCT02436356|469367448|FG001|Overall Study|Withdrawal by Subject|0|||
130382017|NCT02436356|469367449|FG002|Overall Study|Withdrawal by Subject|0|||
130382018|NCT04577118|469367450|FG000|Overall Study|Withdrawal by Subject|4|||
130382019|NCT00810407|469367451|FG000|Overall Study|Protocol Violation|3|||
130382020|NCT00810407|469367451|FG000|Overall Study|No Visit After First Day of Treatment|3|||
130468268|NCT03076515|469680278|FG000|Overall Study|DMC decision based on interim analysis|25|||
130468269|NCT03076515|469680279|FG001|Overall Study|DMC decision based on interim analysis|29|||
130468270|NCT02554786|469680282|FG000|Overall Study|Subject/guardian decision|29|||
130468271|NCT02554786|469680283|FG001|Overall Study|Subject/guardian decision|17|||
130468272|NCT02554786|469680284|FG002|Overall Study|Subject/guardian decision|18|||
130468273|NCT02554786|469680285|FG003|Overall Study|Subject/guardian decision|30|||
130468274|NCT02554786|469680286|FG004|Overall Study|Subject/guardian decision|20|||
130468275|NCT02554786|469680282|FG000|Overall Study|Lost to Follow-up|4|||
130468276|NCT02554786|469680283|FG001|Overall Study|Lost to Follow-up|3|||
130468277|NCT02554786|469680284|FG002|Overall Study|Lost to Follow-up|4|||
130468278|NCT02554786|469680285|FG003|Overall Study|Lost to Follow-up|2|||
130468279|NCT02554786|469680286|FG004|Overall Study|Lost to Follow-up|2|||
130468280|NCT02554786|469680282|FG000|Overall Study|Protocol deviation|1|||
130468281|NCT02554786|469680283|FG001|Overall Study|Protocol deviation|3|||
130468282|NCT02554786|469680284|FG002|Overall Study|Protocol deviation|3|||
130382021|NCT00674661|469367452|FG000|Overall Study|Other|5|||
130382022|NCT00674661|469367453|FG001|Overall Study|Other|7|||
130468283|NCT02554786|469680285|FG003|Overall Study|Protocol deviation|4|||
130468284|NCT02554786|469680286|FG004|Overall Study|Protocol deviation|2|||
130722231|NCT05005312|470608199|FG000|Overall Study|Enrolled, but not treated|0|||
130468285|NCT02554786|469680282|FG000|Overall Study|Technical problems|1|||
130468286|NCT02554786|469680283|FG001|Overall Study|Technical problems|1|||
130468287|NCT02554786|469680284|FG002|Overall Study|Technical problems|0|||
130468288|NCT02554786|469680285|FG003|Overall Study|Technical problems|2|||
130468289|NCT02554786|469680286|FG004|Overall Study|Technical problems|1|||
130468290|NCT02554786|469680282|FG000|Overall Study|Adverse Event|0|||
130468291|NCT02554786|469680283|FG001|Overall Study|Adverse Event|0|||
130468292|NCT02554786|469680284|FG002|Overall Study|Adverse Event|0|||
130559601|NCT01338415|470017822|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
130559602|NCT01338415|470017820|FG000|Exceptional Use Treatment Period|Death|0|||
130559603|NCT01338415|470017821|FG001|Exceptional Use Treatment Period|Death|0|||
130559604|NCT01338415|470017822|FG002|Exceptional Use Treatment Period|Death|1|||
130722232|NCT05005312|470608200|FG001|Overall Study|Enrolled, but not treated|1|||
130559605|NCT05215262|470017825|FG000|Overall Study|Lost to Follow-up|12|||
130559606|NCT05215262|470017826|FG001|Overall Study|Lost to Follow-up|0|||
130382023|NCT00674661|469367452|FG000|Overall Study|Lost to Follow-up|6|||
130722233|NCT01283035|470608201|FG000|Overall Study|Subject later found ineligible|1|||
130722234|NCT00867503|470608203|FG000|Overall Study|Withdrawal by Subject|1|||
130722235|NCT02704403|470608204|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
130722236|NCT02704403|470608205|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
130722237|NCT02704403|470608204|FG000|Overall Study|Administrative reasons by sponsor|1251|||
130722238|NCT02704403|470608205|FG001|Overall Study|Administrative reasons by sponsor|616|||
130722239|NCT02704403|470608204|FG000|Overall Study|Death|4|||
130722240|NCT02704403|470608205|FG001|Overall Study|Death|3|||
130722241|NCT02704403|470608204|FG000|Overall Study|Endpoint event|52|||
130722242|NCT02704403|470608205|FG001|Overall Study|Endpoint event|24|||
130722243|NCT02704403|470608204|FG000|Overall Study|Lost to Follow-up|22|||
130722244|NCT02704403|470608205|FG001|Overall Study|Lost to Follow-up|11|||
130722245|NCT02704403|470608204|FG000|Overall Study|Protocol Violation|15|||
130722246|NCT02704403|470608205|FG001|Overall Study|Protocol Violation|15|||
130722247|NCT02704403|470608204|FG000|Overall Study|Adverse Event|2|||
130722248|NCT02704403|470608205|FG001|Overall Study|Adverse Event|0|||
130722249|NCT02704403|470608204|FG000|Overall Study|Withdrawal by Subject|85|||
130722250|NCT02704403|470608205|FG001|Overall Study|Withdrawal by Subject|45|||
130722251|NCT02704403|470608204|FG000|Overall Study|Investigator decision|1|||
130722252|NCT02704403|470608205|FG001|Overall Study|Investigator decision|1|||
130722253|NCT02704403|470608204|FG000|Overall Study|Follow-up not possible|1|||
130722254|NCT02704403|470608205|FG001|Overall Study|Follow-up not possible|2|||
130722255|NCT02792699|470608206|FG000|Overall Study|Adverse Event|1|||
130722256|NCT02792699|470608207|FG001|Overall Study|Adverse Event|2|||
130722257|NCT02792699|470608208|FG002|Overall Study|Adverse Event|4|||
130722258|NCT02792699|470608206|FG000|Overall Study|Withdrawal by Subject|4|||
130722259|NCT02792699|470608207|FG001|Overall Study|Withdrawal by Subject|4|||
130722260|NCT02792699|470608208|FG002|Overall Study|Withdrawal by Subject|3|||
130722261|NCT02792699|470608206|FG000|Overall Study|Lost to Follow-up|0|||
130722262|NCT02792699|470608207|FG001|Overall Study|Lost to Follow-up|1|||
130722263|NCT02792699|470608208|FG002|Overall Study|Lost to Follow-up|2|||
130722264|NCT02792699|470608206|FG000|Overall Study|Physician Decision|2|||
130722265|NCT02792699|470608207|FG001|Overall Study|Physician Decision|0|||
130722266|NCT02792699|470608208|FG002|Overall Study|Physician Decision|0|||
130722267|NCT02792699|470608206|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130722268|NCT02792699|470608207|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
130722269|NCT02792699|470608208|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130722270|NCT02792699|470608206|FG000|Overall Study|Other|1|||
130722271|NCT02792699|470608207|FG001|Overall Study|Other|0|||
130468293|NCT02554786|469680285|FG003|Overall Study|Adverse Event|0|||
130468294|NCT02554786|469680286|FG004|Overall Study|Adverse Event|2|||
130468295|NCT02554786|469680282|FG000|Overall Study|Death|0|||
130468296|NCT02554786|469680283|FG001|Overall Study|Death|0|||
130468297|NCT02554786|469680284|FG002|Overall Study|Death|0|||
130468298|NCT02554786|469680285|FG003|Overall Study|Death|1|||
130468299|NCT02554786|469680286|FG004|Overall Study|Death|0|||
130468300|NCT02554786|469680282|FG000|Overall Study|Non-compliance with study treatment|0|||
130468301|NCT02554786|469680283|FG001|Overall Study|Non-compliance with study treatment|1|||
130468302|NCT02554786|469680284|FG002|Overall Study|Non-compliance with study treatment|1|||
130468303|NCT02554786|469680285|FG003|Overall Study|Non-compliance with study treatment|0|||
130468304|NCT02554786|469680286|FG004|Overall Study|Non-compliance with study treatment|1|||
130468305|NCT02554786|469680282|FG000|Overall Study|Physician Decision|0|||
130468306|NCT02554786|469680283|FG001|Overall Study|Physician Decision|1|||
130722272|NCT02792699|470608208|FG002|Overall Study|Other|0|||
130722273|NCT01755767|470608209|FG000|Overall Study|Progressive Disease|8|||
130722274|NCT01755767|470608210|FG001|Overall Study|Progressive Disease|7|||
130722275|NCT01755767|470608211|FG002|Overall Study|Progressive Disease|91|||
130722276|NCT01755767|470608212|FG003|Overall Study|Progressive Disease|43|||
130722277|NCT01755767|470608209|FG000|Overall Study|Clinical Disease Progression|4|||
130722278|NCT01755767|470608210|FG001|Overall Study|Clinical Disease Progression|2|||
130722279|NCT01755767|470608211|FG002|Overall Study|Clinical Disease Progression|29|||
130722280|NCT01755767|470608212|FG003|Overall Study|Clinical Disease Progression|20|||
130722281|NCT01755767|470608209|FG000|Overall Study|Radiographic Disease Progression|9|||
130722282|NCT01755767|470608210|FG001|Overall Study|Radiographic Disease Progression|4|||
130722283|NCT01755767|470608211|FG002|Overall Study|Radiographic Disease Progression|44|||
130722284|NCT01755767|470608212|FG003|Overall Study|Radiographic Disease Progression|27|||
130468307|NCT02554786|469680284|FG002|Overall Study|Physician Decision|4|||
130468308|NCT02554786|469680285|FG003|Overall Study|Physician Decision|1|||
130468309|NCT02554786|469680286|FG004|Overall Study|Physician Decision|1|||
130468310|NCT02554786|469680282|FG000|Overall Study|Pregnancy|0|||
130468311|NCT02554786|469680283|FG001|Overall Study|Pregnancy|0|||
130468312|NCT02554786|469680284|FG002|Overall Study|Pregnancy|0|||
130468313|NCT02554786|469680285|FG003|Overall Study|Pregnancy|1|||
130722285|NCT01755767|470608209|FG000|Overall Study|Adverse Event|6|||
130722286|NCT01755767|470608210|FG001|Overall Study|Adverse Event|0|||
130468314|NCT02554786|469680286|FG004|Overall Study|Pregnancy|1|||
130722287|NCT01755767|470608211|FG002|Overall Study|Adverse Event|28|||
130468315|NCT04704284|469680287|FG000|Overall Study|Withdrawal by Subject|1|||
130468316|NCT00539734|469680289|FG000|Overall Study|Protocol Violation|1|||
130468317|NCT02692417|469680292|FG000|Overall Study|Withdrawal by Subject|5|||
130468318|NCT02692417|469680293|FG001|Overall Study|Withdrawal by Subject|1|||
130468319|NCT02692417|469680292|FG000|Overall Study|Adverse Event|1|||
130468320|NCT02692417|469680293|FG001|Overall Study|Adverse Event|0|||
130468321|NCT02372253|469680294|FG000|Overall Study|Non Compliance|2|||
130468322|NCT02372253|469680295|FG001|Overall Study|Non Compliance|0|||
130468323|NCT02178098|469680301|FG000|Overall Study|Withdrawal by Subject|0|||
130468324|NCT02178098|469680302|FG001|Overall Study|Withdrawal by Subject|6|||
130468325|NCT02178098|469680301|FG000|Overall Study|Adverse Event|1|||
130468326|NCT02178098|469680302|FG001|Overall Study|Adverse Event|2|||
130468327|NCT02178098|469680301|FG000|Overall Study|Protocol Violation|1|||
130468328|NCT02178098|469680302|FG001|Overall Study|Protocol Violation|1|||
130468329|NCT02178098|469680301|FG000|Overall Study|Lost to Follow-up|0|||
130468330|NCT02178098|469680302|FG001|Overall Study|Lost to Follow-up|1|||
130468331|NCT02178098|469680301|FG000|Overall Study|Sponsor Request|1|||
130468332|NCT02178098|469680302|FG001|Overall Study|Sponsor Request|0|||
130468333|NCT02178098|469680301|FG000|Overall Study|Other|2|||
130468334|NCT02178098|469680302|FG001|Overall Study|Other|2|||
130468335|NCT01044303|469680305|FG000|Overall Study|Lost to Follow-up|2|||
130468336|NCT01109524|469680306|FG000|Overall Study|Disease Progression|29|||
130468337|NCT01109524|469680306|FG000|Overall Study|Study Drug toxicity|6|||
130468338|NCT01109524|469680306|FG000|Overall Study|Adverse Event|4|||
130468339|NCT01109524|469680306|FG000|Overall Study|Withdrawal by Subject|2|||
130468340|NCT01109524|469680306|FG000|Overall Study|Maximum clinical benefit|3|||
130468341|NCT01109524|469680306|FG000|Overall Study|Death|2|||
130468342|NCT01109524|469680306|FG000|Overall Study|No longer meets criteria|2|||
130468343|NCT01109524|469680306|FG000|Overall Study|Participant requested to end treatment|4|||
130468344|NCT01109524|469680306|FG000|Overall Study|Other|5|||
130468345|NCT00031694|469680322|FG000|Overall Study|Adverse Event|12|||
130468346|NCT00031694|469680322|FG000|Overall Study|Death|2|||
130468347|NCT00031694|469680322|FG000|Overall Study|Withdrawal by Subject|5|||
130468348|NCT04048382|469680323|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
130559607|NCT04880447|470017828|FG000|Overall Study|No vaccination information|1|||
130559608|NCT04880447|470017828|FG000|Overall Study|No adverse event information (missing information)|1|||
130559609|NCT04880447|470017828|FG000|Overall Study|Disease not covered in this study|35|||
130382024|NCT00674661|469367453|FG001|Overall Study|Lost to Follow-up|3|||
130382025|NCT00674661|469367452|FG000|Overall Study|Withdrawal by Subject|0|||
130382026|NCT00674661|469367453|FG001|Overall Study|Withdrawal by Subject|5|||
130382027|NCT03108027|469367455|FG000|Period 1|Subject/Guardian Decision|0|||
130382028|NCT03108027|469367456|FG001|Period 1|Subject/Guardian Decision|0|||
130382029|NCT03108027|469367457|FG002|Period 1|Subject/Guardian Decision|0|||
130382030|NCT03108027|469367458|FG003|Period 1|Subject/Guardian Decision|2|||
130382031|NCT03108027|469367459|FG004|Period 1|Subject/Guardian Decision|0|||
130382032|NCT03108027|469367460|FG005|Period 1|Subject/Guardian Decision|0|||
130382033|NCT03108027|469367455|FG000|Period 3|Adverse Event|0|||
130382034|NCT03108027|469367456|FG001|Period 3|Adverse Event|1|||
130382035|NCT03108027|469367457|FG002|Period 3|Adverse Event|0|||
130382036|NCT03108027|469367458|FG003|Period 3|Adverse Event|0|||
130382037|NCT03108027|469367459|FG004|Period 3|Adverse Event|0|||
130382038|NCT03108027|469367460|FG005|Period 3|Adverse Event|0|||
130382039|NCT02426892|469367461|FG000|Overall Study|Adverse Event|2|||
130382040|NCT02426892|469367461|FG000|Overall Study|Lack of Efficacy|17|||
130382041|NCT02426892|469367461|FG000|Overall Study|Withdrawal by Subject|1|||
130382042|NCT00268996|469367462|FG000|Overall Study|Adverse Event|11|||
130382043|NCT00268996|469367463|FG001|Overall Study|Adverse Event|7|||
130382044|NCT00268996|469367462|FG000|Overall Study|Lost to Follow-up|3|||
130382045|NCT00268996|469367463|FG001|Overall Study|Lost to Follow-up|1|||
130382046|NCT00268996|469367462|FG000|Overall Study|Withdrawal by Subject|5|||
130382047|NCT00268996|469367463|FG001|Overall Study|Withdrawal by Subject|11|||
130382048|NCT00268996|469367462|FG000|Overall Study|Non-compliance|1|||
130382049|NCT00268996|469367463|FG001|Overall Study|Non-compliance|0|||
130382050|NCT00268996|469367462|FG000|Overall Study|Other|1|||
130382051|NCT00268996|469367463|FG001|Overall Study|Other|1|||
130468349|NCT04048382|469680324|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
130382052|NCT00451321|469367466|FG000|Overall Study|Lost to Follow-up|3|||
130468350|NCT04048382|469680323|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
130382053|NCT00451321|469367467|FG001|Overall Study|Lost to Follow-up|3|||
130382054|NCT00451321|469367468|FG002|Overall Study|Lost to Follow-up|1|||
130382055|NCT00451321|469367469|FG003|Overall Study|Lost to Follow-up|3|||
130468351|NCT04048382|469680324|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
130468352|NCT04048382|469680323|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
130468353|NCT04048382|469680324|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
130468354|NCT01205048|469680326|FG000|Overall Study|Withdrawal by Subject|14|||
130559610|NCT00718549|470017829|FG000|Induction Phase|Disease Progression|1|||
130382056|NCT00451321|469367470|FG004|Overall Study|Lost to Follow-up|0|||
130382057|NCT00451321|469367471|FG005|Overall Study|Lost to Follow-up|1|||
130382058|NCT00451321|469367472|FG006|Overall Study|Lost to Follow-up|0|||
130468355|NCT01205048|469680326|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
130468356|NCT01205048|469680326|FG000|Overall Study|Lost to Follow-up|4|||
130468357|NCT01205048|469680326|FG000|Overall Study|Other|2|||
130468358|NCT01255670|469680327|FG000|Overall Study|Adverse Event|10|||
130468359|NCT01255670|469680328|FG001|Overall Study|Adverse Event|10|||
130468360|NCT01255670|469680327|FG000|Overall Study|Lost to Follow-up|16|||
130468361|NCT01255670|469680328|FG001|Overall Study|Lost to Follow-up|10|||
130468362|NCT01037985|469680329|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
130468363|NCT01037985|469680330|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
130468364|NCT01037985|469680329|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
130468365|NCT01037985|469680330|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
130468366|NCT01037985|469680329|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
130468367|NCT01037985|469680330|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
130468368|NCT01037985|469680329|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
130468369|NCT01037985|469680330|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
130468370|NCT02269475|469680331|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
130468371|NCT02269475|469680332|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
130468372|NCT02269475|469680331|FG000|Overall Study|Withdrawal by Subject|0|||
130468373|NCT02269475|469680332|FG001|Overall Study|Withdrawal by Subject|1|||
130468374|NCT02730871|469680333|FG000|Overall Study|Adverse Event|6|||
130468375|NCT02730871|469680334|FG001|Overall Study|Adverse Event|0|||
130468376|NCT00823472|469680335|FG000|Overall Study|Physician Decision|24|||
130468377|NCT00823472|469680336|FG001|Overall Study|Physician Decision|28|||
130468378|NCT04992390|469680337|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
130468379|NCT04992390|469680338|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
130468380|NCT04992390|469680339|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
130468381|NCT04992390|469680337|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
130468382|NCT04992390|469680338|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
130468383|NCT04992390|469680339|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
130468384|NCT04992390|469680337|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
130468385|NCT04992390|469680338|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
130468386|NCT04992390|469680339|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
130468387|NCT04992390|469680337|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
130468388|NCT04992390|469680338|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
130468389|NCT04992390|469680339|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
130468390|NCT04992390|469680337|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
130468391|NCT04992390|469680338|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
130468392|NCT04992390|469680339|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
130468393|NCT04992390|469680337|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
130468394|NCT04992390|469680338|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
130468395|NCT04992390|469680339|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
130468396|NCT04992390|469680337|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
130468397|NCT04992390|469680338|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
130468398|NCT04992390|469680339|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
130468399|NCT04992390|469680337|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
130468400|NCT04992390|469680338|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
130468401|NCT04992390|469680339|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
130468402|NCT04992390|469680337|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
130468403|NCT04992390|469680338|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
130468404|NCT04992390|469680339|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
130468405|NCT04992390|469680337|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
130468406|NCT04992390|469680338|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
130468407|NCT04992390|469680339|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
130468408|NCT04992390|469680337|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
130468409|NCT04992390|469680338|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
130468410|NCT04992390|469680339|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
130468411|NCT04992390|469680337|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
130382059|NCT00451321|469367473|FG007|Overall Study|Lost to Follow-up|0|||
130382060|NCT00451321|469367466|FG000|Overall Study|Withdrawal by Subject|3|||
130382061|NCT00451321|469367467|FG001|Overall Study|Withdrawal by Subject|1|||
130382062|NCT00451321|469367468|FG002|Overall Study|Withdrawal by Subject|0|||
130382063|NCT00451321|469367469|FG003|Overall Study|Withdrawal by Subject|4|||
130382064|NCT00451321|469367470|FG004|Overall Study|Withdrawal by Subject|0|||
130382065|NCT00451321|469367471|FG005|Overall Study|Withdrawal by Subject|0|||
130382066|NCT00451321|469367472|FG006|Overall Study|Withdrawal by Subject|0|||
130382067|NCT00451321|469367473|FG007|Overall Study|Withdrawal by Subject|0|||
130382068|NCT00451321|469367466|FG000|Overall Study|Study closed/terminated|1|||
130382069|NCT00451321|469367467|FG001|Overall Study|Study closed/terminated|1|||
130382070|NCT00451321|469367468|FG002|Overall Study|Study closed/terminated|17|||
130382071|NCT00451321|469367469|FG003|Overall Study|Study closed/terminated|5|||
130722288|NCT01755767|470608212|FG003|Overall Study|Adverse Event|11|||
130722289|NCT01755767|470608209|FG000|Overall Study|Death|1|||
130722290|NCT01755767|470608210|FG001|Overall Study|Death|2|||
130382072|NCT00451321|469367470|FG004|Overall Study|Study closed/terminated|7|||
130382073|NCT00451321|469367471|FG005|Overall Study|Study closed/terminated|7|||
130382074|NCT00451321|469367472|FG006|Overall Study|Study closed/terminated|5|||
130382075|NCT00451321|469367473|FG007|Overall Study|Study closed/terminated|3|||
130382076|NCT00451321|469367466|FG000|Overall Study|Sponsor decision to amend protocol|0|||
130382077|NCT00451321|469367467|FG001|Overall Study|Sponsor decision to amend protocol|0|||
130382078|NCT00451321|469367468|FG002|Overall Study|Sponsor decision to amend protocol|0|||
130382079|NCT00451321|469367469|FG003|Overall Study|Sponsor decision to amend protocol|0|||
130382080|NCT00451321|469367470|FG004|Overall Study|Sponsor decision to amend protocol|0|||
130382081|NCT00451321|469367471|FG005|Overall Study|Sponsor decision to amend protocol|1|||
130382082|NCT00451321|469367472|FG006|Overall Study|Sponsor decision to amend protocol|1|||
130382083|NCT00451321|469367473|FG007|Overall Study|Sponsor decision to amend protocol|3|||
130382084|NCT01528254|469367476|FG000|Overall Study|Administrative problems|96|||
130382085|NCT01528254|469367477|FG001|Overall Study|Administrative problems|94|||
130382086|NCT01528254|469367476|FG000|Overall Study|Adverse Event|28|||
130382087|NCT01528254|469367477|FG001|Overall Study|Adverse Event|44|||
130382088|NCT01528254|469367476|FG000|Overall Study|Lost to Follow-up|17|||
130382089|NCT01528254|469367477|FG001|Overall Study|Lost to Follow-up|24|||
130382090|NCT01528254|469367476|FG000|Overall Study|Death|13|||
130382091|NCT01528254|469367477|FG001|Overall Study|Death|9|||
130468412|NCT04992390|469680338|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
130468413|NCT04992390|469680339|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
130468414|NCT04992390|469680337|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
130468415|NCT04992390|469680338|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
130468416|NCT04992390|469680339|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
130468417|NCT04992390|469680337|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
130468418|NCT04992390|469680338|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
130468419|NCT04992390|469680339|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
130468420|NCT04992390|469680337|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
130468421|NCT04992390|469680338|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
130468422|NCT04992390|469680339|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
130468423|NCT04992390|469680337|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
130468424|NCT04992390|469680338|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
130468425|NCT04992390|469680339|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
130468426|NCT02807779|469680340|FG000|Overall Study|Lost to Follow-up|1|||
130468427|NCT02807779|469680341|FG001|Overall Study|Lost to Follow-up|0|||
130468428|NCT02807779|469680342|FG002|Overall Study|Lost to Follow-up|0|||
130468429|NCT02807779|469680340|FG000|Overall Study|Physician Decision|2|||
130468430|NCT02807779|469680341|FG001|Overall Study|Physician Decision|0|||
130468431|NCT02807779|469680342|FG002|Overall Study|Physician Decision|1|||
130468432|NCT02807779|469680340|FG000|Overall Study|Death|1|||
130468433|NCT02807779|469680341|FG001|Overall Study|Death|1|||
130468434|NCT02807779|469680342|FG002|Overall Study|Death|0|||
130468435|NCT03783026|469681626|FG000|Treatment Phase|Adverse Event|15|||
130468436|NCT03783026|469681626|FG000|Treatment Phase|Lack of Efficacy|11|||
130468437|NCT03783026|469681626|FG000|Treatment Phase|Withdrawal by Subject|6|||
130382092|NCT01528254|469367476|FG000|Overall Study|Protocol deviation|9|||
130382093|NCT01528254|469367477|FG001|Overall Study|Protocol deviation|19|||
130382094|NCT01528254|469367476|FG000|Overall Study|New therapy for study indication|8|||
130468438|NCT03783026|469681626|FG000|Treatment Phase|Lost to Follow-up|2|||
130382095|NCT01528254|469367477|FG001|Overall Study|New therapy for study indication|6|||
130382096|NCT01528254|469367476|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130382097|NCT01528254|469367477|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130382098|NCT01528254|469367476|FG000|Overall Study|Withdrawal by Subject|5|||
130382099|NCT01528254|469367477|FG001|Overall Study|Withdrawal by Subject|4|||
130382100|NCT01528254|469367476|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130468439|NCT03783026|469681626|FG000|Treatment Phase|Protocol Deviation|8|||
130468440|NCT03783026|469681626|FG000|Treatment Phase|Did Not Receive Treatment|1|||
130468441|NCT03783026|469681626|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
130468442|NCT01853748|469681627|FG000|Allocation|Withdrawal by Subject|1|||
130468443|NCT01853748|469681628|FG001|Allocation|Withdrawal by Subject|13|||
130468444|NCT01853748|469681627|FG000|Allocation|not sufficient to receive intervention|0|||
130468445|NCT01853748|469681628|FG001|Allocation|not sufficient to receive intervention|1|||
130468446|NCT01853748|469681627|FG000|Follow-Up|Withdrawal by Subject|7|||
130468447|NCT01853748|469681628|FG001|Follow-Up|Withdrawal by Subject|6|||
130468448|NCT01853748|469681627|FG000|Follow-Up|Adverse Event|67|||
130468449|NCT01853748|469681628|FG001|Follow-Up|Adverse Event|7|||
130468450|NCT01853748|469681627|FG000|Follow-Up|not available for data collection|16|||
130468451|NCT01853748|469681628|FG001|Follow-Up|not available for data collection|4|||
130468452|NCT02576509|469681635|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
130382101|NCT01528254|469367477|FG001|Overall Study|Abnormal laboratory value(s)|7|||
130382102|NCT01528254|469367476|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130382103|NCT01528254|469367477|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130382104|NCT01528254|469367476|FG000|Overall Study|No longer requires study drug|1|||
130382105|NCT01528254|469367477|FG001|Overall Study|No longer requires study drug|1|||
130382106|NCT02196558|469367483|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
130382107|NCT02196558|469367484|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
130382108|NCT02196558|469367485|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
130382109|NCT02196558|469367483|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
130382110|NCT02196558|469367484|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
130382111|NCT02196558|469367485|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
130382112|NCT02196558|469367483|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
130382113|NCT02196558|469367484|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
130382114|NCT02196558|469367485|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
130382115|NCT02196558|469367483|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
130382116|NCT02196558|469367484|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
130382117|NCT02196558|469367485|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
130382118|NCT02196558|469367483|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130382119|NCT02196558|469367484|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130382120|NCT02196558|469367485|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130382121|NCT02669433|469367489|FG000|Overall Study|Protocol Violation|0|||
130382122|NCT02669433|469367490|FG001|Overall Study|Protocol Violation|4|||
130382123|NCT02669433|469367491|FG002|Overall Study|Protocol Violation|1|||
130382124|NCT02669433|469367489|FG000|Overall Study|Disease Progression|1|||
130382125|NCT02669433|469367490|FG001|Overall Study|Disease Progression|0|||
130382126|NCT02669433|469367491|FG002|Overall Study|Disease Progression|0|||
130382127|NCT02669433|469367489|FG000|Overall Study|Physician Decision|1|||
130382128|NCT02669433|469367490|FG001|Overall Study|Physician Decision|1|||
130382129|NCT02669433|469367491|FG002|Overall Study|Physician Decision|0|||
130382130|NCT02669433|469367489|FG000|Overall Study|Adverse Event|6|||
130382131|NCT02669433|469367490|FG001|Overall Study|Adverse Event|7|||
130382132|NCT02669433|469367491|FG002|Overall Study|Adverse Event|10|||
130382133|NCT02669433|469367489|FG000|Overall Study|Sponsor Termination|1|||
130382134|NCT02669433|469367490|FG001|Overall Study|Sponsor Termination|0|||
130382135|NCT02669433|469367491|FG002|Overall Study|Sponsor Termination|1|||
130382136|NCT02669433|469367489|FG000|Overall Study|Withdrawal by Subject|5|||
130382137|NCT02669433|469367490|FG001|Overall Study|Withdrawal by Subject|1|||
130382138|NCT02669433|469367491|FG002|Overall Study|Withdrawal by Subject|0|||
130382139|NCT02669433|469367489|FG000|Overall Study|Withdrawal by Caregiver|1|||
130382140|NCT02669433|469367490|FG001|Overall Study|Withdrawal by Caregiver|0|||
130382141|NCT02669433|469367491|FG002|Overall Study|Withdrawal by Caregiver|2|||
130382142|NCT02669433|469367489|FG000|Overall Study|Death|0|||
130382143|NCT02669433|469367490|FG001|Overall Study|Death|1|||
130382144|NCT02669433|469367491|FG002|Overall Study|Death|1|||
130382145|NCT00576927|469367492|FG000|Clinical Assessment|Lack of Efficacy|24|||
130382146|NCT00576927|469367492|FG000|Clinical Assessment|Death|1|||
130382147|NCT00576927|469367492|FG000|Clinical Assessment|Withdrawal by Subject|10|||
130382148|NCT00576927|469367492|FG000|Clinical Assessment|Physician Decision|1|||
130382149|NCT00576927|469367492|FG000|Baseline|Physician Decision|9|||
130382150|NCT00576927|469367492|FG000|Baseline|Medication Change by PCP of subject|1|||
130382151|NCT00576927|469367492|FG000|Baseline|Withdrawal by Subject|3|||
130382152|NCT00576927|469367492|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
130382153|NCT00576927|469367492|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
130382154|NCT00576927|469367492|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
130382155|NCT00576927|469367492|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
130382156|NCT00576927|469367492|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
130382157|NCT03266094|469367493|FG000|Overall Study|Lost to Follow-up|1|||
130382158|NCT03266094|469367493|FG000|Overall Study|Withdrawal by Subject|1|||
130382159|NCT03128892|469367494|FG000|Overall Study|Withdrawal by Subject|2|||
130382160|NCT03128892|469367494|FG000|Overall Study|Physician Decision|1|||
130382161|NCT00459108|469367496|FG000|Overall Study|Withdrawal by Subject|5|||
130382162|NCT00459108|469367496|FG000|Overall Study|Adverse Event|3|||
130382163|NCT00459108|469367496|FG000|Overall Study|Death|2|||
130382164|NCT00459108|469367496|FG000|Overall Study|Progression|1|||
130382165|NCT03473808|469367501|FG000|Overall Study|Withdrawal by Subject|1|||
130382166|NCT02157298|469367502|FG000|Overall Study|Adverse Event|1|||
130382167|NCT02157298|469367503|FG001|Overall Study|Adverse Event|0|||
130382168|NCT02157298|469367502|FG000|Overall Study|Subject no longer meets study criteria|1|||
130382169|NCT02157298|469367503|FG001|Overall Study|Subject no longer meets study criteria|2|||
130382170|NCT02157298|469367502|FG000|Overall Study|Poor/Non-compliance|1|||
130382171|NCT02157298|469367503|FG001|Overall Study|Poor/Non-compliance|0|||
130382172|NCT02157298|469367502|FG000|Overall Study|Withdrawal by Subject|1|||
130382173|NCT02157298|469367503|FG001|Overall Study|Withdrawal by Subject|0|||
130382174|NCT03171415|469367504|FG000|Overall Study|Lost to Follow-up|0|||
130382175|NCT03171415|469367505|FG001|Overall Study|Lost to Follow-up|0|||
130382176|NCT03171415|469367506|FG002|Overall Study|Lost to Follow-up|0|||
130382177|NCT03171415|469367507|FG003|Overall Study|Lost to Follow-up|0|||
130382178|NCT03171415|469367508|FG004|Overall Study|Lost to Follow-up|2|||
130382179|NCT04059094|469367509|FG000|Overall Study|Adverse Event|0|||
130382180|NCT04059094|469367510|FG001|Overall Study|Adverse Event|0|||
130382181|NCT04059094|469367511|FG002|Overall Study|Adverse Event|0|||
130382182|NCT04059094|469367512|FG003|Overall Study|Adverse Event|0|||
130382183|NCT04059094|469367513|FG004|Overall Study|Adverse Event|1|||
130559611|NCT00718549|470017830|FG001|Induction Phase|Disease Progression|0|||
130559612|NCT00718549|470017831|FG002|Induction Phase|Disease Progression|0|||
130559613|NCT00718549|470017829|FG000|Induction Phase|Eligibility Criteria Violation|2|||
130559614|NCT00718549|470017830|FG001|Induction Phase|Eligibility Criteria Violation|0|||
130559615|NCT00718549|470017831|FG002|Induction Phase|Eligibility Criteria Violation|0|||
130559616|NCT00718549|470017829|FG000|Induction Phase|Early Termination - No Additional Info|59|||
130559617|NCT00718549|470017830|FG001|Induction Phase|Early Termination - No Additional Info|0|||
130559618|NCT00718549|470017831|FG002|Induction Phase|Early Termination - No Additional Info|0|||
130382184|NCT04059094|469367509|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130382185|NCT04059094|469367510|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
130382186|NCT04059094|469367511|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130382187|NCT04059094|469367512|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130382188|NCT04059094|469367513|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130382189|NCT00883116|469367518|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130382190|NCT00883116|469367519|FG001|Overall Study|Adverse event unrelated to study drug|10|||
130382191|NCT00883116|469367518|FG000|Overall Study|Death|6|||
130382192|NCT00883116|469367519|FG001|Overall Study|Death|2|||
130382193|NCT00883116|469367518|FG000|Overall Study|Disease progression|130|||
130382194|NCT00883116|469367519|FG001|Overall Study|Disease progression|128|||
130382195|NCT00883116|469367518|FG000|Overall Study|Lost to Follow-up|0|||
130382196|NCT00883116|469367519|FG001|Overall Study|Lost to Follow-up|1|||
130382197|NCT00883116|469367518|FG000|Overall Study|Maximum clinical benefit|13|||
130382198|NCT00883116|469367519|FG001|Overall Study|Maximum clinical benefit|46|||
130382199|NCT00883116|469367518|FG000|Overall Study|Not identified|3|||
130382200|NCT00883116|469367519|FG001|Overall Study|Not identified|6|||
130382201|NCT00883116|469367518|FG000|Overall Study|Study drug toxicity|36|||
130382202|NCT00883116|469367519|FG001|Overall Study|Study drug toxicity|16|||
130382203|NCT00883116|469367518|FG000|Overall Study|Withdrawal by Subject|14|||
130382204|NCT00883116|469367519|FG001|Overall Study|Withdrawal by Subject|8|||
130382205|NCT00883116|469367518|FG000|Overall Study|No longer meets study criteria|2|||
130382206|NCT00883116|469367519|FG001|Overall Study|No longer meets study criteria|2|||
130382207|NCT03715764|469367520|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
130382208|NCT03715764|469367521|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
130382209|NCT03715764|469367520|FG000|3 Month Follow-up|Lost to Follow-up|2|||
130382210|NCT03715764|469367521|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130382211|NCT03715764|469367520|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
130382212|NCT03715764|469367521|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
130382213|NCT03715764|469367520|FG000|6 Month Follow-up|Lost to Follow-up|3|||
130382214|NCT03715764|469367521|FG001|6 Month Follow-up|Lost to Follow-up|0|||
130382215|NCT03715764|469367520|FG000|12 Month Follow-up|Lost to Follow-up|2|||
130382216|NCT03715764|469367521|FG001|12 Month Follow-up|Lost to Follow-up|3|||
130382217|NCT03715764|469367520|FG000|12 Month Follow-up|Pregnancy|0|||
130382218|NCT03715764|469367521|FG001|12 Month Follow-up|Pregnancy|1|||
130382219|NCT03715764|469367520|FG000|12 Month Follow-up|Surgery|2|||
130382220|NCT03715764|469367521|FG001|12 Month Follow-up|Surgery|0|||
130382221|NCT03715764|469367520|FG000|12 Month Follow-up|Wrong address|1|||
130382222|NCT03715764|469367521|FG001|12 Month Follow-up|Wrong address|0|||
130382223|NCT03715764|469367520|FG000|12 Month Follow-up|No symptoms|1|||
130382224|NCT03715764|469367521|FG001|12 Month Follow-up|No symptoms|0|||
130382225|NCT03715764|469367520|FG000|12 Month Follow-up|Changed primary care centre|0|||
130559619|NCT00718549|470017829|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
130559620|NCT00718549|470017830|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
130559621|NCT00718549|470017831|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
130722291|NCT01755767|470608211|FG002|Overall Study|Death|15|||
130382226|NCT03715764|469367521|FG001|12 Month Follow-up|Changed primary care centre|1|||
130382227|NCT00818662|469367527|FG000|Overall Study|Adverse Event|5|||
130382228|NCT00818662|469367528|FG001|Overall Study|Adverse Event|14|||
130382229|NCT00818662|469367529|FG002|Overall Study|Adverse Event|4|||
130382230|NCT00818662|469367530|FG003|Overall Study|Adverse Event|3|||
130382231|NCT00818662|469367527|FG000|Overall Study|Withdrawal by Subject|5|||
130382232|NCT00818662|469367528|FG001|Overall Study|Withdrawal by Subject|4|||
130382233|NCT00818662|469367529|FG002|Overall Study|Withdrawal by Subject|2|||
130382234|NCT00818662|469367530|FG003|Overall Study|Withdrawal by Subject|2|||
130382235|NCT00818662|469367527|FG000|Overall Study|Death|1|||
130382236|NCT00818662|469367528|FG001|Overall Study|Death|3|||
130722292|NCT01755767|470608212|FG003|Overall Study|Death|4|||
130722293|NCT01755767|470608209|FG000|Overall Study|Subject Decision|0|||
130559622|NCT00718549|470017829|FG000|Maintenance/ Observation Phase|Death|0|||
130559623|NCT00718549|470017830|FG001|Maintenance/ Observation Phase|Death|1|||
130559624|NCT00718549|470017831|FG002|Maintenance/ Observation Phase|Death|2|||
130559625|NCT00718549|470017829|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
130559626|NCT00718549|470017830|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
130559627|NCT00718549|470017831|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
130559628|NCT00718549|470017829|FG000|Maintenance/ Observation Phase|Progression|0|||
130559629|NCT00718549|470017830|FG001|Maintenance/ Observation Phase|Progression|5|||
130559630|NCT00718549|470017831|FG002|Maintenance/ Observation Phase|Progression|14|||
130559631|NCT00718549|470017829|FG000|Maintenance/ Observation Phase|Relapse|0|||
130559632|NCT00718549|470017830|FG001|Maintenance/ Observation Phase|Relapse|3|||
130559633|NCT00718549|470017831|FG002|Maintenance/ Observation Phase|Relapse|2|||
130559634|NCT01353508|470017832|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130559635|NCT01353508|470017833|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130559636|NCT01353508|470017834|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130559637|NCT01353508|470017835|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
130559638|NCT01353508|470017832|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
130559639|NCT01353508|470017833|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130559640|NCT01353508|470017834|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130559641|NCT01353508|470017835|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130559642|NCT02606461|470017836|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130559643|NCT02606461|470017837|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130559644|NCT02606461|470017838|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
130559645|NCT02606461|470017839|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130559646|NCT02606461|470017840|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130559647|NCT02606461|470017841|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130559648|NCT01970488|470017846|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
130559649|NCT01970488|470017847|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
130559650|NCT01970488|470017848|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130559651|NCT01970488|470017849|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130559652|NCT01970488|470017850|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130559653|NCT01970488|470017846|FG000|Part 1: Through Week 16|Protocol Violation|1|||
130559654|NCT01970488|470017847|FG001|Part 1: Through Week 16|Protocol Violation|2|||
130559655|NCT01970488|470017848|FG002|Part 1: Through Week 16|Protocol Violation|0|||
130559656|NCT01970488|470017849|FG003|Part 1: Through Week 16|Protocol Violation|0|||
130559657|NCT01970488|470017850|FG004|Part 1: Through Week 16|Protocol Violation|0|||
130559658|NCT01970488|470017846|FG000|Part 1: Through Week 16|Adverse Event|6|||
130559659|NCT01970488|470017847|FG001|Part 1: Through Week 16|Adverse Event|5|||
130559660|NCT01970488|470017848|FG002|Part 1: Through Week 16|Adverse Event|0|||
130559661|NCT01970488|470017849|FG003|Part 1: Through Week 16|Adverse Event|0|||
130559662|NCT01970488|470017850|FG004|Part 1: Through Week 16|Adverse Event|0|||
130559663|NCT01970488|470017846|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
130559664|NCT01970488|470017847|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
130559665|NCT01970488|470017848|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
130559666|NCT01970488|470017849|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
130559667|NCT01970488|470017850|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
130559668|NCT01970488|470017846|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
130559669|NCT01970488|470017847|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
130559670|NCT01970488|470017848|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
130559671|NCT01970488|470017849|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
130559672|NCT01970488|470017850|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
130382237|NCT00818662|469367529|FG002|Overall Study|Death|0|||
130382238|NCT00818662|469367530|FG003|Overall Study|Death|0|||
130382239|NCT00818662|469367527|FG000|Overall Study|Physician Decision|1|||
130382240|NCT00818662|469367528|FG001|Overall Study|Physician Decision|0|||
130382241|NCT00818662|469367529|FG002|Overall Study|Physician Decision|0|||
130382242|NCT00818662|469367530|FG003|Overall Study|Physician Decision|0|||
130382243|NCT00818662|469367527|FG000|Overall Study|Lost to Follow-up|0|||
130382244|NCT00818662|469367528|FG001|Overall Study|Lost to Follow-up|0|||
130382245|NCT00818662|469367529|FG002|Overall Study|Lost to Follow-up|0|||
130382246|NCT00818662|469367530|FG003|Overall Study|Lost to Follow-up|1|||
130382247|NCT00818662|469367527|FG000|Overall Study|Unwilling or Unable to Participate|4|||
130722294|NCT01755767|470608210|FG001|Overall Study|Subject Decision|0|||
130382248|NCT00818662|469367528|FG001|Overall Study|Unwilling or Unable to Participate|6|||
130382249|NCT00818662|469367529|FG002|Overall Study|Unwilling or Unable to Participate|2|||
130382250|NCT00818662|469367530|FG003|Overall Study|Unwilling or Unable to Participate|4|||
130559673|NCT01970488|470017846|FG000|Part 2: Post Week 16|Physician Decision|0|||
130559674|NCT01970488|470017847|FG001|Part 2: Post Week 16|Physician Decision|0|||
130559675|NCT01970488|470017848|FG002|Part 2: Post Week 16|Physician Decision|0|||
130559676|NCT01970488|470017849|FG003|Part 2: Post Week 16|Physician Decision|0|||
130722295|NCT01755767|470608211|FG002|Overall Study|Subject Decision|10|||
130722296|NCT01755767|470608212|FG003|Overall Study|Subject Decision|3|||
130722297|NCT01755767|470608209|FG000|Overall Study|Withdrawal by Subject|0|||
130722298|NCT01755767|470608210|FG001|Overall Study|Withdrawal by Subject|0|||
130722299|NCT01755767|470608211|FG002|Overall Study|Withdrawal by Subject|2|||
130722300|NCT01755767|470608212|FG003|Overall Study|Withdrawal by Subject|1|||
130382251|NCT00818662|469367527|FG000|Overall Study|Protocol Violation|1|||
130382252|NCT00818662|469367528|FG001|Overall Study|Protocol Violation|1|||
130382253|NCT00818662|469367529|FG002|Overall Study|Protocol Violation|0|||
130382254|NCT00818662|469367530|FG003|Overall Study|Protocol Violation|0|||
130382255|NCT00818662|469367527|FG000|Overall Study|Requires a Prohibited Medication|1|||
130382256|NCT00818662|469367528|FG001|Overall Study|Requires a Prohibited Medication|0|||
130382257|NCT00818662|469367529|FG002|Overall Study|Requires a Prohibited Medication|0|||
130382258|NCT00818662|469367530|FG003|Overall Study|Requires a Prohibited Medication|0|||
130382259|NCT00818662|469367527|FG000|Overall Study|Safety Risk|1|||
130382260|NCT00818662|469367528|FG001|Overall Study|Safety Risk|1|||
130382261|NCT00818662|469367529|FG002|Overall Study|Safety Risk|0|||
130382262|NCT00818662|469367530|FG003|Overall Study|Safety Risk|1|||
130382263|NCT00818662|469367527|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
130382264|NCT00818662|469367528|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
130382265|NCT00818662|469367529|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
130382266|NCT00818662|469367530|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
130382267|NCT00818662|469367527|FG000|Overall Study|Participant's health declined|0|||
130382268|NCT00818662|469367528|FG001|Overall Study|Participant's health declined|0|||
130382269|NCT00818662|469367529|FG002|Overall Study|Participant's health declined|0|||
130382270|NCT00818662|469367530|FG003|Overall Study|Participant's health declined|1|||
130382271|NCT00818662|469367527|FG000|Overall Study|Caregiver to pursue other treatment|0|||
130382272|NCT00818662|469367528|FG001|Overall Study|Caregiver to pursue other treatment|1|||
130382273|NCT00818662|469367529|FG002|Overall Study|Caregiver to pursue other treatment|0|||
130382274|NCT00818662|469367530|FG003|Overall Study|Caregiver to pursue other treatment|0|||
130382275|NCT00818662|469367527|FG000|Overall Study|Moving out of state|0|||
130382276|NCT00818662|469367528|FG001|Overall Study|Moving out of state|0|||
130382277|NCT00818662|469367529|FG002|Overall Study|Moving out of state|0|||
130382278|NCT00818662|469367530|FG003|Overall Study|Moving out of state|1|||
130382279|NCT00818662|469367527|FG000|Overall Study|Declined move to another study site|1|||
130382280|NCT00818662|469367528|FG001|Overall Study|Declined move to another study site|0|||
130382281|NCT00818662|469367529|FG002|Overall Study|Declined move to another study site|0|||
130382282|NCT00818662|469367530|FG003|Overall Study|Declined move to another study site|0|||
130382283|NCT00818662|469367527|FG000|Overall Study|Change in living situation|0|||
130382284|NCT00818662|469367528|FG001|Overall Study|Change in living situation|0|||
130382285|NCT00818662|469367529|FG002|Overall Study|Change in living situation|0|||
130382286|NCT00818662|469367530|FG003|Overall Study|Change in living situation|1|||
130382287|NCT00818662|469367527|FG000|Overall Study|Study partner decision|0|||
130382288|NCT00818662|469367528|FG001|Overall Study|Study partner decision|0|||
130382289|NCT00818662|469367529|FG002|Overall Study|Study partner decision|0|||
130382290|NCT00818662|469367530|FG003|Overall Study|Study partner decision|1|||
130382291|NCT00818662|469367527|FG000|Overall Study|Admitted to long term nursing care|0|||
130382292|NCT00818662|469367528|FG001|Overall Study|Admitted to long term nursing care|1|||
130382293|NCT00818662|469367529|FG002|Overall Study|Admitted to long term nursing care|0|||
130382294|NCT00818662|469367530|FG003|Overall Study|Admitted to long term nursing care|0|||
130382295|NCT01472081|469367531|FG000|Overall Study|Continuing treatment at time of analysis|1|||
130382296|NCT01472081|469367532|FG001|Overall Study|Continuing treatment at time of analysis|4|||
130382297|NCT01472081|469367533|FG002|Overall Study|Continuing treatment at time of analysis|1|||
130382298|NCT01472081|469367534|FG003|Overall Study|Continuing treatment at time of analysis|8|||
130382299|NCT01472081|469367535|FG004|Overall Study|Continuing treatment at time of analysis|9|||
130382300|NCT01472081|469367536|FG005|Overall Study|Continuing treatment at time of analysis|0|||
130382301|NCT01472081|469367531|FG000|Overall Study|Disease Progression|4|||
130382302|NCT01472081|469367532|FG001|Overall Study|Disease Progression|10|||
130382303|NCT01472081|469367533|FG002|Overall Study|Disease Progression|12|||
130382304|NCT01472081|469367534|FG003|Overall Study|Disease Progression|31|||
130382305|NCT01472081|469367535|FG004|Overall Study|Disease Progression|22|||
130382306|NCT01472081|469367536|FG005|Overall Study|Disease Progression|3|||
130382307|NCT01472081|469367531|FG000|Overall Study|Study drug toxicity|2|||
130382308|NCT01472081|469367532|FG001|Overall Study|Study drug toxicity|9|||
130382309|NCT01472081|469367533|FG002|Overall Study|Study drug toxicity|4|||
130382310|NCT01472081|469367534|FG003|Overall Study|Study drug toxicity|6|||
130382311|NCT01472081|469367535|FG004|Overall Study|Study drug toxicity|13|||
130382312|NCT01472081|469367536|FG005|Overall Study|Study drug toxicity|2|||
130382313|NCT01472081|469367531|FG000|Overall Study|Death|0|||
130382314|NCT01472081|469367532|FG001|Overall Study|Death|0|||
130382315|NCT01472081|469367533|FG002|Overall Study|Death|0|||
130382316|NCT01472081|469367534|FG003|Overall Study|Death|0|||
130382317|NCT01472081|469367535|FG004|Overall Study|Death|1|||
130382318|NCT01472081|469367536|FG005|Overall Study|Death|0|||
130382319|NCT01472081|469367531|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130722301|NCT01755767|470608209|FG000|Overall Study|Other|0|||
130722302|NCT01755767|470608210|FG001|Overall Study|Other|0|||
130382320|NCT01472081|469367532|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
130382321|NCT01472081|469367533|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
130382322|NCT01472081|469367534|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
130722303|NCT01755767|470608211|FG002|Overall Study|Other|2|||
130722304|NCT01755767|470608212|FG003|Overall Study|Other|3|||
130722305|NCT01755767|470608209|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
130722306|NCT01755767|470608210|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
130382323|NCT01472081|469367535|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
130382324|NCT01472081|469367536|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
130382325|NCT01472081|469367531|FG000|Overall Study|Withdrawal by Subject|0|||
130382326|NCT01472081|469367532|FG001|Overall Study|Withdrawal by Subject|0|||
130382327|NCT01472081|469367533|FG002|Overall Study|Withdrawal by Subject|0|||
130382328|NCT01472081|469367534|FG003|Overall Study|Withdrawal by Subject|0|||
130382329|NCT01472081|469367535|FG004|Overall Study|Withdrawal by Subject|0|||
130382330|NCT01472081|469367536|FG005|Overall Study|Withdrawal by Subject|1|||
130382331|NCT01472081|469367531|FG000|Overall Study|Poor/non-compliance|0|||
130382332|NCT01472081|469367532|FG001|Overall Study|Poor/non-compliance|0|||
130382333|NCT01472081|469367533|FG002|Overall Study|Poor/non-compliance|1|||
130382334|NCT01472081|469367534|FG003|Overall Study|Poor/non-compliance|0|||
130382335|NCT01472081|469367535|FG004|Overall Study|Poor/non-compliance|1|||
130382336|NCT01472081|469367536|FG005|Overall Study|Poor/non-compliance|0|||
130382337|NCT01472081|469367531|FG000|Overall Study|No longer meets study criteria|0|||
130382338|NCT01472081|469367532|FG001|Overall Study|No longer meets study criteria|0|||
130382339|NCT01472081|469367533|FG002|Overall Study|No longer meets study criteria|1|||
130382340|NCT01472081|469367534|FG003|Overall Study|No longer meets study criteria|0|||
130382341|NCT01472081|469367535|FG004|Overall Study|No longer meets study criteria|0|||
130382342|NCT01472081|469367536|FG005|Overall Study|No longer meets study criteria|0|||
130382343|NCT01472081|469367531|FG000|Overall Study|Subject request to discontinue treatment|0|||
130382344|NCT01472081|469367532|FG001|Overall Study|Subject request to discontinue treatment|3|||
130382345|NCT01472081|469367533|FG002|Overall Study|Subject request to discontinue treatment|1|||
130382346|NCT01472081|469367534|FG003|Overall Study|Subject request to discontinue treatment|1|||
130382347|NCT01472081|469367535|FG004|Overall Study|Subject request to discontinue treatment|0|||
130382348|NCT01472081|469367536|FG005|Overall Study|Subject request to discontinue treatment|0|||
130382349|NCT01705652|469367538|FG000|Overall Study|Adverse Event|1|||
130382350|NCT01705652|469367539|FG001|Overall Study|Adverse Event|0|||
130382351|NCT01705652|469367538|FG000|Overall Study|Withdrawal by Subject|1|||
130382352|NCT01705652|469367539|FG001|Overall Study|Withdrawal by Subject|2|||
130382353|NCT01705652|469367538|FG000|Overall Study|non-compliance|1|||
130382354|NCT01705652|469367539|FG001|Overall Study|non-compliance|1|||
130382355|NCT01686633|469367540|FG000|Overall Study|Lack of Efficacy|33|||
130382356|NCT01686633|469367541|FG001|Overall Study|Lack of Efficacy|13|||
130382357|NCT01686633|469367542|FG002|Overall Study|Lack of Efficacy|11|||
130382358|NCT01686633|469367540|FG000|Overall Study|Withdrawal by Subject|8|||
130382359|NCT01686633|469367541|FG001|Overall Study|Withdrawal by Subject|8|||
130382360|NCT01686633|469367542|FG002|Overall Study|Withdrawal by Subject|5|||
130382361|NCT01686633|469367540|FG000|Overall Study|Physician Decision|3|||
130382362|NCT01686633|469367541|FG001|Overall Study|Physician Decision|4|||
130382363|NCT01686633|469367542|FG002|Overall Study|Physician Decision|4|||
130382364|NCT01686633|469367540|FG000|Overall Study|Adverse Event|4|||
130382365|NCT01686633|469367541|FG001|Overall Study|Adverse Event|3|||
130382366|NCT01686633|469367542|FG002|Overall Study|Adverse Event|3|||
130382367|NCT01686633|469367540|FG000|Overall Study|Protocol Violation|2|||
130382368|NCT01686633|469367541|FG001|Overall Study|Protocol Violation|3|||
130382369|NCT01686633|469367542|FG002|Overall Study|Protocol Violation|0|||
130382370|NCT01686633|469367540|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
130382371|NCT01686633|469367541|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
130382372|NCT01686633|469367542|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
130382373|NCT01686633|469367540|FG000|Overall Study|Lost to Follow-up|0|||
130382374|NCT01686633|469367541|FG001|Overall Study|Lost to Follow-up|1|||
130722307|NCT01755767|470608211|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
130722308|NCT01755767|470608212|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
130382375|NCT01686633|469367542|FG002|Overall Study|Lost to Follow-up|1|||
130382376|NCT00397982|469370042|FG000|Overall Study|Withdrawal by Subject|1|||
130382377|NCT00397982|469370042|FG000|Overall Study|Adverse Event|1|||
130382378|NCT00397982|469370042|FG000|Overall Study|noncompliance|1|||
130382379|NCT00397982|469370042|FG000|Overall Study|Unrelated health issues|1|||
130382380|NCT04244786|469370043|FG000|Overall Study|Adverse Event|0|||
130382381|NCT04244786|469370044|FG001|Overall Study|Adverse Event|0|||
130382382|NCT04244786|469370045|FG002|Overall Study|Adverse Event|2|||
130382383|NCT04244786|469370043|FG000|Overall Study|Withdrawal by Subject|0|||
130382384|NCT04244786|469370044|FG001|Overall Study|Withdrawal by Subject|0|||
130382385|NCT04244786|469370045|FG002|Overall Study|Withdrawal by Subject|5|||
130382386|NCT00613938|469370052|FG000|Overall Study|Withdrawal by Subject|2|||
130382387|NCT00613938|469370053|FG001|Overall Study|Withdrawal by Subject|4|||
130382388|NCT00613938|469370054|FG002|Overall Study|Withdrawal by Subject|9|||
130382389|NCT00613938|469370055|FG003|Overall Study|Withdrawal by Subject|9|||
130382390|NCT00613938|469370052|FG000|Overall Study|Adverse Event|1|||
130382391|NCT00613938|469370053|FG001|Overall Study|Adverse Event|4|||
130382392|NCT00613938|469370054|FG002|Overall Study|Adverse Event|8|||
130382393|NCT00613938|469370055|FG003|Overall Study|Adverse Event|5|||
130382394|NCT00613938|469370052|FG000|Overall Study|Lack of Efficacy|16|||
130382395|NCT00613938|469370053|FG001|Overall Study|Lack of Efficacy|18|||
130382396|NCT00613938|469370054|FG002|Overall Study|Lack of Efficacy|5|||
130382397|NCT00613938|469370055|FG003|Overall Study|Lack of Efficacy|9|||
130382398|NCT00613938|469370052|FG000|Overall Study|Other|1|||
130382399|NCT00613938|469370053|FG001|Overall Study|Other|2|||
130382400|NCT00613938|469370054|FG002|Overall Study|Other|1|||
130382401|NCT00613938|469370055|FG003|Overall Study|Other|3|||
130382402|NCT02636868|469370056|FG000|Overall Study|Death|0|||
130382403|NCT02636868|469370057|FG001|Overall Study|Death|1|||
130382404|NCT02636868|469370058|FG002|Overall Study|Death|2|||
130382405|NCT03220217|469370059|FG000|Overall Study|Withdrawal by Subject|0|||
130382406|NCT03220217|469370060|FG001|Overall Study|Withdrawal by Subject|1|||
130382407|NCT03220217|469370061|FG002|Overall Study|Withdrawal by Subject|0|||
130382408|NCT03220217|469370059|FG000|Overall Study|Subject Missed Procedure|0|||
130382409|NCT03220217|469370060|FG001|Overall Study|Subject Missed Procedure|0|||
130382410|NCT03220217|469370061|FG002|Overall Study|Subject Missed Procedure|1|||
130382411|NCT03025542|469370062|FG000|Overall Study|Adverse Event|0|||
130382412|NCT03025542|469370063|FG001|Overall Study|Adverse Event|2|||
130382413|NCT03025542|469370062|FG000|Overall Study|Lost to Follow-up|1|||
130382414|NCT03025542|469370063|FG001|Overall Study|Lost to Follow-up|0|||
130382415|NCT03025542|469370062|FG000|Overall Study|Withdrawal by Subject|1|||
130382416|NCT03025542|469370063|FG001|Overall Study|Withdrawal by Subject|0|||
130382417|NCT03745937|469370065|FG000|Overall Study|Withdrawal by Subject|0|||
130382418|NCT03745937|469370066|FG001|Overall Study|Withdrawal by Subject|0|||
130382419|NCT03745937|469370067|FG002|Overall Study|Withdrawal by Subject|0|||
130382420|NCT03745937|469370068|FG003|Overall Study|Withdrawal by Subject|1|||
130382421|NCT03745937|469370065|FG000|Overall Study|Not-specifed|0|||
130382422|NCT03745937|469370066|FG001|Overall Study|Not-specifed|1|||
130382423|NCT03745937|469370067|FG002|Overall Study|Not-specifed|0|||
130382424|NCT03745937|469370068|FG003|Overall Study|Not-specifed|1|||
130382425|NCT00696696|469370074|FG000|Overall Study|Adverse Event|5|||
130382426|NCT00696696|469370074|FG000|Overall Study|Withdrawal by Subject|8|||
130382427|NCT00696696|469370074|FG000|Overall Study|Physician Decision|2|||
130382428|NCT00696696|469370074|FG000|Overall Study|Death|3|||
130382429|NCT02507505|469370075|FG000|Overall Study|Withdrawal by Subject|13|||
130382430|NCT02507505|469370076|FG001|Overall Study|Withdrawal by Subject|11|||
130382431|NCT02507505|469370075|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
130382432|NCT02507505|469370076|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
130382433|NCT02507505|469370075|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
130382434|NCT02507505|469370076|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
130382435|NCT02507505|469370075|FG000|Overall Study|Death before receipt of anesthesia|0|||
130382436|NCT02507505|469370076|FG001|Overall Study|Death before receipt of anesthesia|1|||
130382437|NCT03182829|469370077|FG000|Overall Study|Protocol Violation|12|||
130382438|NCT03182829|469370078|FG001|Overall Study|Protocol Violation|12|||
130382439|NCT03182829|469370077|FG000|Overall Study|Other|4|||
130382440|NCT03182829|469370078|FG001|Overall Study|Other|3|||
130382441|NCT00254540|469370079|FG000|Overall Study|Adverse Event|6|||
130382442|NCT00254540|469370080|FG001|Overall Study|Adverse Event|7|||
130382443|NCT00254540|469370079|FG000|Overall Study|Lack of Efficacy|13|||
130382444|NCT00254540|469370080|FG001|Overall Study|Lack of Efficacy|13|||
130382445|NCT00254540|469370079|FG000|Overall Study|Death|0|||
130382446|NCT00254540|469370080|FG001|Overall Study|Death|1|||
130382447|NCT00254540|469370079|FG000|Overall Study|Laboratory Test Abnormality|0|||
130382448|NCT00254540|469370080|FG001|Overall Study|Laboratory Test Abnormality|1|||
130382449|NCT00225251|469370081|FG000|Overall Study|Withdrawal by Subject|1|||
130382450|NCT00225251|469370082|FG001|Overall Study|Withdrawal by Subject|1|||
130382451|NCT03045328|469370088|FG000|Overall Study|Withdrawal by Subject|2|||
130382452|NCT01313767|469370089|FG000|Overall Study|Adverse Event|1|||
130382453|NCT01313767|469370090|FG001|Overall Study|Adverse Event|0|||
130382454|NCT01313767|469370089|FG000|Overall Study|Lost to Follow-up|1|||
130382455|NCT01313767|469370090|FG001|Overall Study|Lost to Follow-up|0|||
130382456|NCT01313767|469370089|FG000|Overall Study|Withdrawal by Subject|2|||
130382457|NCT01313767|469370090|FG001|Overall Study|Withdrawal by Subject|1|||
130382458|NCT01313767|469370089|FG000|Overall Study|Protocol Violation|3|||
130382459|NCT01313767|469370090|FG001|Overall Study|Protocol Violation|1|||
130382460|NCT01287897|469370091|FG000|Overall Study|Adverse Event|5|||
130382461|NCT01287897|469370092|FG001|Overall Study|Adverse Event|3|||
130382462|NCT01287897|469370093|FG002|Overall Study|Adverse Event|6|||
130382463|NCT01287897|469370094|FG003|Overall Study|Adverse Event|4|||
130382464|NCT01287897|469370091|FG000|Overall Study|Lack of Efficacy|2|||
130382465|NCT01287897|469370092|FG001|Overall Study|Lack of Efficacy|0|||
130382466|NCT01287897|469370093|FG002|Overall Study|Lack of Efficacy|0|||
130468453|NCT02576509|469681636|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
130468454|NCT02576509|469681635|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130468455|NCT02576509|469681636|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
130468456|NCT02576509|469681635|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
130468457|NCT02576509|469681636|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
130468458|NCT02576509|469681635|FG000|Treatment Period|Disease progression|263|||
130468459|NCT02576509|469681636|FG001|Treatment Period|Disease progression|244|||
130468460|NCT02576509|469681635|FG000|Treatment Period|Study drug toxicity|37|||
130468461|NCT02576509|469681636|FG001|Treatment Period|Study drug toxicity|41|||
130468462|NCT02576509|469681635|FG000|Treatment Period|Death|1|||
130468463|NCT02576509|469681636|FG001|Treatment Period|Death|1|||
130468464|NCT02576509|469681635|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
130468465|NCT02576509|469681636|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
130468466|NCT02576509|469681635|FG000|Treatment Period|Participant request to stop treatment|8|||
130468467|NCT02576509|469681636|FG001|Treatment Period|Participant request to stop treatment|18|||
130468468|NCT02576509|469681635|FG000|Treatment Period|Participant withdrew consent|3|||
130468469|NCT02576509|469681636|FG001|Treatment Period|Participant withdrew consent|7|||
130468470|NCT02576509|469681635|FG000|Treatment Period|Lost to Follow-up|0|||
130382467|NCT01287897|469370094|FG003|Overall Study|Lack of Efficacy|0|||
130382468|NCT01287897|469370091|FG000|Overall Study|Protocol Violation|1|||
130382469|NCT01287897|469370092|FG001|Overall Study|Protocol Violation|1|||
130382470|NCT01287897|469370093|FG002|Overall Study|Protocol Violation|0|||
130382471|NCT01287897|469370094|FG003|Overall Study|Protocol Violation|1|||
130382472|NCT01287897|469370091|FG000|Overall Study|Lost to Follow-up|0|||
130382473|NCT01287897|469370092|FG001|Overall Study|Lost to Follow-up|0|||
130382474|NCT01287897|469370093|FG002|Overall Study|Lost to Follow-up|2|||
130382475|NCT01287897|469370094|FG003|Overall Study|Lost to Follow-up|0|||
130382476|NCT01287897|469370091|FG000|Overall Study|Withdrawal by Subject|1|||
130382477|NCT01287897|469370092|FG001|Overall Study|Withdrawal by Subject|5|||
130382478|NCT01287897|469370093|FG002|Overall Study|Withdrawal by Subject|3|||
130382479|NCT01287897|469370094|FG003|Overall Study|Withdrawal by Subject|2|||
130382480|NCT01287897|469370091|FG000|Overall Study|Not consented properly|0|||
130382481|NCT01287897|469370092|FG001|Overall Study|Not consented properly|1|||
130382482|NCT01287897|469370093|FG002|Overall Study|Not consented properly|0|||
130382483|NCT01287897|469370094|FG003|Overall Study|Not consented properly|0|||
130382484|NCT01287897|469370091|FG000|Overall Study|Not meeting entrance criteria|1|||
130382485|NCT01287897|469370092|FG001|Overall Study|Not meeting entrance criteria|1|||
130382486|NCT01287897|469370093|FG002|Overall Study|Not meeting entrance criteria|0|||
130382487|NCT01287897|469370094|FG003|Overall Study|Not meeting entrance criteria|0|||
130382488|NCT01287897|469370091|FG000|Overall Study|Other|1|||
130382489|NCT01287897|469370092|FG001|Overall Study|Other|0|||
130382490|NCT01287897|469370093|FG002|Overall Study|Other|1|||
130382491|NCT01287897|469370094|FG003|Overall Study|Other|0|||
130382492|NCT00065507|469370095|FG000|Overall Study|Death|16|||
130382493|NCT00065507|469370096|FG001|Overall Study|Death|17|||
130382494|NCT00065507|469370095|FG000|Overall Study|Adverse Event|4|||
130382495|NCT00065507|469370096|FG001|Overall Study|Adverse Event|3|||
130382496|NCT00065507|469370095|FG000|Overall Study|Lack of Efficacy|0|||
130382497|NCT00065507|469370096|FG001|Overall Study|Lack of Efficacy|6|||
130382498|NCT00065507|469370095|FG000|Overall Study|Poor/Non-compliance|3|||
130382499|NCT00065507|469370096|FG001|Overall Study|Poor/Non-compliance|2|||
130382500|NCT00065507|469370095|FG000|Overall Study|Lost to Follow-up|3|||
130382501|NCT00065507|469370096|FG001|Overall Study|Lost to Follow-up|0|||
130382502|NCT00065507|469370095|FG000|Overall Study|Subject Withdrew Consent|2|||
130382503|NCT00065507|469370096|FG001|Overall Study|Subject Withdrew Consent|1|||
130382504|NCT00065507|469370095|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
130382505|NCT00065507|469370096|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
130382506|NCT02169739|469370097|FG000|Overall Study|Lost to Follow-up|0|||
130382507|NCT02169739|469370098|FG001|Overall Study|Lost to Follow-up|4|||
130382508|NCT03635957|469370099|FG000|Run-In Period|Lost to Follow-up|1|||
130382509|NCT03635957|469370099|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
130382510|NCT00227903|469370102|FG000|Overall Study|Withdrawal by Subject|2|||
130382511|NCT00227903|469370103|FG001|Overall Study|Withdrawal by Subject|5|||
130382512|NCT00227903|469370102|FG000|Overall Study|Subject moved out of area|1|||
130382513|NCT00227903|469370103|FG001|Overall Study|Subject moved out of area|2|||
130382514|NCT00227903|469370102|FG000|Overall Study|Lost to Follow-up|1|||
130468471|NCT02576509|469681636|FG001|Treatment Period|Lost to Follow-up|1|||
130382515|NCT00227903|469370103|FG001|Overall Study|Lost to Follow-up|3|||
130382516|NCT00227903|469370102|FG000|Overall Study|Miscarriage|1|||
130382517|NCT00227903|469370103|FG001|Overall Study|Miscarriage|0|||
130382518|NCT01475331|469370104|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
130382519|NCT01475331|469370105|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
130382520|NCT01475331|469370104|FG000|Overall Study|excessive main duct communication|1|||
130382521|NCT01475331|469370105|FG001|Overall Study|excessive main duct communication|1|||
130382522|NCT01475331|469370104|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
130382523|NCT01475331|469370105|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
130468472|NCT02576509|469681635|FG000|Treatment Period|Maximum clinical benefit|1|||
130468473|NCT02576509|469681636|FG001|Treatment Period|Maximum clinical benefit|0|||
130468474|NCT02576509|469681635|FG000|Treatment Period|Poor/non-compliance|1|||
130468475|NCT02576509|469681636|FG001|Treatment Period|Poor/non-compliance|1|||
130468476|NCT02576509|469681635|FG000|Treatment Period|Participant no longer meets criteria|1|||
130468477|NCT02576509|469681636|FG001|Treatment Period|Participant no longer meets criteria|0|||
130468478|NCT02576509|469681635|FG000|Treatment Period|Other reason|12|||
130468479|NCT02576509|469681636|FG001|Treatment Period|Other reason|8|||
130468480|NCT02576509|469681635|FG000|Treatment Period|NOT REPORTED|1|||
130468481|NCT02576509|469681636|FG001|Treatment Period|NOT REPORTED|0|||
130468482|NCT02576509|469681635|FG000|Treatment Period|Administrative reason by sponsor|0|||
130468483|NCT02576509|469681636|FG001|Treatment Period|Administrative reason by sponsor|1|||
130468484|NCT03725722|469681642|FG000|Overall Study|Lack of Efficacy|2|||
130468485|NCT03725722|469681643|FG001|Overall Study|Lack of Efficacy|1|||
130468486|NCT03725722|469681644|FG002|Overall Study|Lack of Efficacy|2|||
130468487|NCT03725722|469681645|FG003|Overall Study|Lack of Efficacy|0|||
130468488|NCT03725722|469681646|FG004|Overall Study|Lack of Efficacy|2|||
130468489|NCT03725722|469681642|FG000|Overall Study|Adverse Event|2|||
130468490|NCT03725722|469681643|FG001|Overall Study|Adverse Event|2|||
130468491|NCT03725722|469681644|FG002|Overall Study|Adverse Event|1|||
130468492|NCT03725722|469681645|FG003|Overall Study|Adverse Event|0|||
130468493|NCT03725722|469681646|FG004|Overall Study|Adverse Event|6|||
130468494|NCT03725722|469681642|FG000|Overall Study|Withdrawal by Subject|4|||
130468495|NCT03725722|469681643|FG001|Overall Study|Withdrawal by Subject|1|||
130468496|NCT03725722|469681644|FG002|Overall Study|Withdrawal by Subject|0|||
130468497|NCT03725722|469681645|FG003|Overall Study|Withdrawal by Subject|4|||
130468498|NCT03725722|469681646|FG004|Overall Study|Withdrawal by Subject|4|||
130468499|NCT03725722|469681642|FG000|Overall Study|Lost to Follow-up|3|||
130468500|NCT03725722|469681643|FG001|Overall Study|Lost to Follow-up|1|||
130468501|NCT03725722|469681644|FG002|Overall Study|Lost to Follow-up|2|||
130468502|NCT03725722|469681645|FG003|Overall Study|Lost to Follow-up|2|||
130468503|NCT03725722|469681646|FG004|Overall Study|Lost to Follow-up|1|||
130468504|NCT03725722|469681642|FG000|Overall Study|Personal reasons|0|||
130468505|NCT03725722|469681643|FG001|Overall Study|Personal reasons|0|||
130468506|NCT03725722|469681644|FG002|Overall Study|Personal reasons|1|||
130468507|NCT03725722|469681645|FG003|Overall Study|Personal reasons|0|||
130468508|NCT03725722|469681646|FG004|Overall Study|Personal reasons|1|||
130468509|NCT03725722|469681642|FG000|Overall Study|COVID-19 situation|0|||
130468510|NCT03725722|469681643|FG001|Overall Study|COVID-19 situation|1|||
130468511|NCT03725722|469681644|FG002|Overall Study|COVID-19 situation|0|||
130468512|NCT03725722|469681645|FG003|Overall Study|COVID-19 situation|0|||
130468513|NCT03725722|469681646|FG004|Overall Study|COVID-19 situation|0|||
130468514|NCT05505045|469681647|FG000|Overall Study|Withdrawal by Subject|2|||
130468515|NCT05505045|469681648|FG001|Overall Study|Withdrawal by Subject|1|||
130468516|NCT03397108|469681650|FG000|Overall Study|Lost to Follow-up|15|||
130468517|NCT03397108|469681651|FG001|Overall Study|Lost to Follow-up|0|||
130468518|NCT03397108|469681650|FG000|Overall Study|Insufficient milk production|3|||
130468519|NCT03397108|469681651|FG001|Overall Study|Insufficient milk production|2|||
130468520|NCT03397108|469681650|FG000|Overall Study|Withdrawal by Subject|2|||
130468521|NCT03397108|469681651|FG001|Overall Study|Withdrawal by Subject|0|||
130468522|NCT03554265|469681652|FG000|Overall Study|Withdrawal by Subject|2|||
130468523|NCT03554265|469681653|FG001|Overall Study|Withdrawal by Subject|2|||
130468524|NCT03554265|469681654|FG002|Overall Study|Withdrawal by Subject|3|||
130468525|NCT03554265|469681652|FG000|Overall Study|Physician Decision|0|||
130468526|NCT03554265|469681653|FG001|Overall Study|Physician Decision|0|||
130468527|NCT03554265|469681654|FG002|Overall Study|Physician Decision|1|||
130468528|NCT05386238|469681655|FG000|Overall Study|Lost to Follow-up|3|||
130468529|NCT05386238|469681656|FG001|Overall Study|Lost to Follow-up|2|||
130468530|NCT05386238|469681655|FG000|Overall Study|Withdrawal by Subject|0|||
130468531|NCT05386238|469681656|FG001|Overall Study|Withdrawal by Subject|1|||
130468532|NCT05672667|469681657|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
130468533|NCT03575052|469681665|FG000|Overall Study|Adverse Event|6|||
130468534|NCT03575052|469681666|FG001|Overall Study|Adverse Event|10|||
130468535|NCT03575052|469681665|FG000|Overall Study|Not further specified|5|||
130468536|NCT03575052|469681666|FG001|Overall Study|Not further specified|7|||
130468537|NCT03575052|469681665|FG000|Overall Study|Withdrawal by Subject|5|||
130468538|NCT03575052|469681666|FG001|Overall Study|Withdrawal by Subject|6|||
130468539|NCT03575052|469681665|FG000|Overall Study|Lost to Follow-up|3|||
130468540|NCT03575052|469681666|FG001|Overall Study|Lost to Follow-up|0|||
130468541|NCT03575052|469681665|FG000|Overall Study|Death|2|||
130468542|NCT03575052|469681666|FG001|Overall Study|Death|1|||
130468543|NCT03575052|469681665|FG000|Overall Study|Lack of Efficacy|2|||
130468544|NCT03575052|469681666|FG001|Overall Study|Lack of Efficacy|1|||
130468545|NCT03575052|469681665|FG000|Overall Study|Study drug noncompliance|1|||
130468546|NCT03575052|469681666|FG001|Overall Study|Study drug noncompliance|2|||
130468547|NCT03575052|469681665|FG000|Overall Study|Protocol Violation|0|||
130559677|NCT01970488|470017850|FG004|Part 2: Post Week 16|Physician Decision|1|||
130722309|NCT03464630|470608213|FG000|Overall Study|Lost to Follow-up|62|||
130382524|NCT01475331|469370104|FG000|Overall Study|Sign of malignancy during the procedure|2|||
130382525|NCT01475331|469370105|FG001|Overall Study|Sign of malignancy during the procedure|0|||
130722310|NCT03464630|470608214|FG001|Overall Study|Lost to Follow-up|52|||
130722311|NCT03464630|470608213|FG000|Overall Study|Withdrawal by Subject|16|||
130722312|NCT03464630|470608214|FG001|Overall Study|Withdrawal by Subject|10|||
130722313|NCT03464630|470608213|FG000|Overall Study|Passive Disengagement|8|||
130722314|NCT03464630|470608214|FG001|Overall Study|Passive Disengagement|4|||
130722315|NCT00191165|470608215|FG000|Overall Study|Adverse Event|2|||
130722316|NCT00191165|470608216|FG001|Overall Study|Adverse Event|0|||
130382526|NCT01475331|469370104|FG000|Overall Study|cyst found to be prohibitively small|0|||
130382527|NCT01475331|469370105|FG001|Overall Study|cyst found to be prohibitively small|1|||
130382528|NCT03683758|469370106|FG000|Overall Study|Non-study commitment conflict|1|||
130382529|NCT03683758|469370107|FG001|Overall Study|Non-study commitment conflict|3|||
130382530|NCT03683758|469370106|FG000|Overall Study|Illness preventing participation|1|||
130382531|NCT03683758|469370107|FG001|Overall Study|Illness preventing participation|0|||
130382532|NCT03683758|469370106|FG000|Overall Study|Adverse Event|1|||
130382533|NCT03683758|469370107|FG001|Overall Study|Adverse Event|0|||
130382534|NCT01172847|469370108|FG000|Overall Study|Withdrawal by Subject|3|||
130382535|NCT01163279|469370109|FG000|Overall Study|Withdrawal by Subject|2|||
130382536|NCT01163279|469370110|FG001|Overall Study|Withdrawal by Subject|0|||
130382537|NCT01601626|469370111|FG000|Overall Study|Death|1|||
130382538|NCT01601626|469370112|FG001|Overall Study|Death|1|||
130382539|NCT01601626|469370113|FG002|Overall Study|Death|1|||
130382540|NCT01601626|469370111|FG000|Overall Study|Lost to Follow-up|1|||
130382541|NCT01601626|469370112|FG001|Overall Study|Lost to Follow-up|2|||
130382542|NCT01601626|469370113|FG002|Overall Study|Lost to Follow-up|0|||
130382543|NCT01601626|469370111|FG000|Overall Study|Unable to Get to Clinic|0|||
130382544|NCT01601626|469370112|FG001|Overall Study|Unable to Get to Clinic|1|||
130382545|NCT01601626|469370113|FG002|Overall Study|Unable to Get to Clinic|0|||
130382546|NCT01601626|469370111|FG000|Overall Study|Withdrawal by Subject|0|||
130382547|NCT01601626|469370112|FG001|Overall Study|Withdrawal by Subject|1|||
130382548|NCT01601626|469370113|FG002|Overall Study|Withdrawal by Subject|1|||
130382549|NCT01601626|469370111|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
130382550|NCT01601626|469370112|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
130382551|NCT01601626|469370113|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
130382552|NCT02632552|469370117|FG000|Overall Study|Lost to Follow-up|14|||
130382553|NCT02632552|469370118|FG001|Overall Study|Lost to Follow-up|8|||
130382554|NCT02632552|469370117|FG000|Overall Study|Withdrawal by Subject|2|||
130382555|NCT02632552|469370118|FG001|Overall Study|Withdrawal by Subject|0|||
130382556|NCT02632552|469370117|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
130382557|NCT02632552|469370118|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
130382558|NCT02728895|469370119|FG000|Overall Study|Other|1|||
130382559|NCT02728895|469370120|FG001|Overall Study|Other|2|||
130382560|NCT02728895|469370119|FG000|Overall Study|Withdrawal by Subject|0|||
130382561|NCT02728895|469370120|FG001|Overall Study|Withdrawal by Subject|3|||
130382562|NCT02968563|469370127|FG000|Overall Study|Adverse Event|0|||
130382563|NCT02968563|469370128|FG001|Overall Study|Adverse Event|6|||
130382564|NCT02968563|469370127|FG000|Overall Study|Death|1|||
130382565|NCT02968563|469370128|FG001|Overall Study|Death|1|||
130382566|NCT02968563|469370127|FG000|Overall Study|Lost to Follow-up|0|||
130382567|NCT02968563|469370128|FG001|Overall Study|Lost to Follow-up|1|||
130382568|NCT02574247|469370129|FG000|Overall Study|Withdrawal by Subject|1|||
130382569|NCT02574247|469370130|FG001|Overall Study|Withdrawal by Subject|0|||
130382570|NCT02574247|469370131|FG002|Overall Study|Withdrawal by Subject|0|||
130382571|NCT02574247|469370129|FG000|Overall Study|Did not meet inclusion criteria|4|||
130382572|NCT02574247|469370130|FG001|Overall Study|Did not meet inclusion criteria|3|||
130382573|NCT02574247|469370131|FG002|Overall Study|Did not meet inclusion criteria|5|||
130382574|NCT03178773|469370132|FG000|Overall Study|Death|0|||
130382575|NCT03178773|469370133|FG001|Overall Study|Death|1|||
130382576|NCT03178773|469370132|FG000|Overall Study|Lost to Follow-up|29|||
130722317|NCT00191165|470608215|FG000|Overall Study|Protocol Violation|0|||
130722318|NCT00191165|470608216|FG001|Overall Study|Protocol Violation|1|||
130382577|NCT03178773|469370133|FG001|Overall Study|Lost to Follow-up|25|||
130382578|NCT03178773|469370132|FG000|Overall Study|Withdrawal by Subject|10|||
130382579|NCT03178773|469370133|FG001|Overall Study|Withdrawal by Subject|14|||
130382580|NCT01382446|469370134|FG000|Overall Study|Withdrawal by Subject|0|||
130382581|NCT01382446|469370135|FG001|Overall Study|Withdrawal by Subject|1|||
130382582|NCT01382446|469370134|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
130382583|NCT01382446|469370135|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
130382584|NCT02604212|469370144|FG000|Overall Study|Study Terminated by Sponsor|2|||
130382585|NCT02604212|469370145|FG001|Overall Study|Study Terminated by Sponsor|1|||
130382586|NCT02604212|469370146|FG002|Overall Study|Study Terminated by Sponsor|3|||
130382587|NCT02604212|469370147|FG003|Overall Study|Study Terminated by Sponsor|3|||
130382588|NCT02604212|469370144|FG000|Overall Study|Withdrawal by Subject|0|||
130722319|NCT00191165|470608215|FG000|Overall Study|Participant Moved Away|0|||
130468548|NCT03575052|469681666|FG001|Overall Study|Protocol Violation|2|||
130468549|NCT03575052|469681665|FG000|Overall Study|Physician Decision|1|||
130382589|NCT02604212|469370145|FG001|Overall Study|Withdrawal by Subject|0|||
130382590|NCT02604212|469370146|FG002|Overall Study|Withdrawal by Subject|1|||
130382591|NCT02604212|469370147|FG003|Overall Study|Withdrawal by Subject|0|||
130382592|NCT01119131|469370148|FG000|Overall Study|Adverse Event|1|||
130382593|NCT01119131|469370149|FG001|Overall Study|Adverse Event|1|||
130382594|NCT01119131|469370150|FG002|Overall Study|Adverse Event|1|||
130468550|NCT03575052|469681666|FG001|Overall Study|Physician Decision|0|||
130468551|NCT03438188|469681667|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
130468552|NCT03438188|469681668|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
130468553|NCT03438188|469681669|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
130468554|NCT03438188|469681667|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
130468555|NCT03438188|469681668|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
130468556|NCT03438188|469681669|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
130468557|NCT03438188|469681667|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
130468558|NCT03438188|469681668|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
130468559|NCT03438188|469681669|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
130468560|NCT03438188|469681667|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
130468561|NCT03438188|469681668|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
130468562|NCT03438188|469681669|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
130468563|NCT03438188|469681667|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
130468564|NCT03438188|469681668|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
130468565|NCT03438188|469681669|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
130468566|NCT04300231|469681670|FG000|Overall Study|Protocol Violation|4|||
130468567|NCT04300231|469681671|FG001|Overall Study|Protocol Violation|3|||
130468568|NCT04300231|469681672|FG002|Overall Study|Protocol Violation|0|||
130468569|NCT04300231|469681673|FG003|Overall Study|Protocol Violation|2|||
130468570|NCT00670046|469681680|FG000|Overall Study|Lost to Follow-up|1|||
130468571|NCT00670046|469681681|FG001|Overall Study|Lost to Follow-up|1|||
130468572|NCT00670046|469681680|FG000|Overall Study|Withdrawal by Subject|0|||
130468573|NCT00670046|469681681|FG001|Overall Study|Withdrawal by Subject|1|||
130468574|NCT02300298|469681684|FG000|Disposition for Nintedanib|Progressive disease|10|||
130468575|NCT02300298|469681685|FG001|Disposition for Nintedanib|Progressive disease|0|||
130468576|NCT02300298|469681684|FG000|Disposition for Docetaxel|Progressive disease|0|||
130468577|NCT02300298|469681685|FG001|Disposition for Docetaxel|Progressive disease|6|||
130382595|NCT01119131|469370148|FG000|Overall Study|Non-Compliance|1|||
130382596|NCT01119131|469370149|FG001|Overall Study|Non-Compliance|0|||
130382597|NCT01119131|469370150|FG002|Overall Study|Non-Compliance|4|||
130382598|NCT01119131|469370148|FG000|Overall Study|Physician Decision|0|||
130382599|NCT01119131|469370149|FG001|Overall Study|Physician Decision|0|||
130382600|NCT01119131|469370150|FG002|Overall Study|Physician Decision|1|||
130382601|NCT01166763|469370151|FG000|Overall Study|Withdrawal by Subject|3|||
130382602|NCT04339296|469370152|FG000|Overall Study|Refuse to participate after allocation|1|||
130382603|NCT04339296|469370153|FG001|Overall Study|Refuse to participate after allocation|1|||
130382604|NCT04339296|469370152|FG000|Overall Study|Withdrew after completion of baseline|2|||
130382605|NCT04339296|469370153|FG001|Overall Study|Withdrew after completion of baseline|1|||
130382606|NCT04339296|469370152|FG000|Overall Study|Lost to Follow-up|0|||
130382607|NCT04339296|469370153|FG001|Overall Study|Lost to Follow-up|4|||
130382608|NCT04339296|469370152|FG000|Overall Study|Discontinued intervention|5|||
130382609|NCT04339296|469370153|FG001|Overall Study|Discontinued intervention|3|||
130382610|NCT01909479|469370154|FG000|From Baseline to Week 26|Adverse Event|3|||
130382611|NCT01909479|469370155|FG001|From Baseline to Week 26|Adverse Event|2|||
130382612|NCT01909479|469370154|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
130382613|NCT01909479|469370155|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
130382614|NCT01909479|469370154|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
130382615|NCT01909479|469370155|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
130382616|NCT01909479|469370154|FG000|26 - 52 Weeks|Adverse Event|0|||
130382617|NCT01909479|469370155|FG001|26 - 52 Weeks|Adverse Event|1|||
130382618|NCT01909479|469370154|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
130468578|NCT02300298|469681684|FG000|Disposition for Docetaxel|other adverse event|0|||
130468579|NCT02300298|469681685|FG001|Disposition for Docetaxel|other adverse event|4|||
130468580|NCT03285763|469681686|FG000|Overall Study|Death|470|||
130468581|NCT03285763|469681686|FG000|Overall Study|Lost to Follow-up|18|||
130468582|NCT03285763|469681686|FG000|Overall Study|Physician Decision|2|||
130468583|NCT03285763|469681686|FG000|Overall Study|Study Terminated By Sponsor|79|||
130468584|NCT03285763|469681686|FG000|Overall Study|Withdrawal by Subject|33|||
130468585|NCT03624972|469681687|FG000|Overall Study|Lost to Follow-up|2|||
130468586|NCT03624972|469681688|FG001|Overall Study|Lost to Follow-up|0|||
130382619|NCT01909479|469370155|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
130382620|NCT01909479|469370154|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
130382621|NCT01909479|469370155|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
130382622|NCT01909479|469370154|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
130382623|NCT01909479|469370155|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
130382624|NCT01909479|469370154|FG000|52 Weeks to End of Study|Adverse Event|2|||
130382625|NCT01909479|469370155|FG001|52 Weeks to End of Study|Adverse Event|1|||
130382626|NCT01909479|469370154|FG000|52 Weeks to End of Study|Death|0|||
130382627|NCT01909479|469370155|FG001|52 Weeks to End of Study|Death|1|||
130382628|NCT01909479|469370154|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
130468587|NCT03624972|469681689|FG002|Overall Study|Lost to Follow-up|0|||
130468588|NCT03624972|469681687|FG000|Overall Study|Withdrawal by Subject|0|||
130468589|NCT03624972|469681688|FG001|Overall Study|Withdrawal by Subject|2|||
130468590|NCT03624972|469681689|FG002|Overall Study|Withdrawal by Subject|0|||
130468591|NCT03456076|469681694|FG000|Overall Study|Withdrawal by Subject|5|||
130468592|NCT03456076|469681695|FG001|Overall Study|Withdrawal by Subject|9|||
130468593|NCT03456076|469681694|FG000|Overall Study|Protocol deviation|0|||
130468594|NCT03456076|469681695|FG001|Overall Study|Protocol deviation|1|||
130468595|NCT03456076|469681694|FG000|Overall Study|Lost to Follow-up|0|||
130468596|NCT03456076|469681695|FG001|Overall Study|Lost to Follow-up|1|||
130468597|NCT03456076|469681694|FG000|Overall Study|Death|2|||
130468598|NCT03456076|469681695|FG001|Overall Study|Death|5|||
130468599|NCT03456076|469681694|FG000|Overall Study|Study ongoing|123|||
130468600|NCT03456076|469681695|FG001|Overall Study|Study ongoing|111|||
130468601|NCT03990649|469681699|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
130468602|NCT03990649|469681700|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
130468603|NCT03990649|469681701|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
130468604|NCT03990649|469681699|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
130468605|NCT03990649|469681700|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
130468606|NCT03990649|469681701|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
130468607|NCT03990649|469681699|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
130468608|NCT03990649|469681700|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
130468609|NCT03990649|469681701|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
130468610|NCT03990649|469681699|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
130468611|NCT03990649|469681700|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
130382629|NCT01909479|469370155|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
130382630|NCT01909479|469370154|FG000|52 Weeks to End of Study|Protocol Violation|1|||
130382631|NCT01909479|469370155|FG001|52 Weeks to End of Study|Protocol Violation|0|||
130382632|NCT01909479|469370154|FG000|52 Weeks to End of Study|Progressive disease|1|||
130382633|NCT01909479|469370155|FG001|52 Weeks to End of Study|Progressive disease|1|||
130382634|NCT01909479|469370154|FG000|52 Weeks to End of Study|Personal reasons|2|||
130382635|NCT01909479|469370155|FG001|52 Weeks to End of Study|Personal reasons|1|||
130382636|NCT01909479|469370154|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
130382637|NCT01909479|469370155|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
130382638|NCT01909479|469370154|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
130382639|NCT01909479|469370155|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
130382640|NCT01909479|469370154|FG000|52 Weeks to End of Study|Lack of contact|1|||
130382641|NCT01909479|469370155|FG001|52 Weeks to End of Study|Lack of contact|0|||
130382642|NCT01909479|469370154|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
130382643|NCT01909479|469370155|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
130382644|NCT01909479|469370154|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
130382645|NCT01909479|469370155|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
130382646|NCT04446377|469370156|FG000|Overall Study|Withdrawal by Subject|6|||
130382647|NCT04446377|469370157|FG001|Overall Study|Withdrawal by Subject|1|||
130382648|NCT04446377|469370156|FG000|Overall Study|Physician Decision|1|||
130382649|NCT04446377|469370157|FG001|Overall Study|Physician Decision|1|||
130382650|NCT04446377|469370156|FG000|Overall Study|Lost to Follow-up|0|||
130382651|NCT04446377|469370157|FG001|Overall Study|Lost to Follow-up|2|||
130468612|NCT03990649|469681701|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
130468613|NCT03990649|469681699|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
130468614|NCT03990649|469681700|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
130468615|NCT03990649|469681701|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
130468616|NCT03990649|469681699|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
130468617|NCT03990649|469681700|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
130468618|NCT03990649|469681701|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
130468619|NCT03990649|469681699|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
130468620|NCT03990649|469681700|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
130468621|NCT03990649|469681701|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
130468622|NCT00431834|469681706|FG000|Overall Study|Withdrawal by Subject|7|||
130468623|NCT00431834|469681706|FG000|Overall Study|Death|3|||
130382652|NCT04446377|469370156|FG000|Overall Study|Not eligible|0|||
130382653|NCT04446377|469370157|FG001|Overall Study|Not eligible|1|||
130382654|NCT03557151|469370160|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
130468624|NCT00431834|469681706|FG000|Overall Study|Missed Endpoint Visit|2|||
130468625|NCT00431834|469681706|FG000|Overall Study|Lost to Follow-up|1|||
130382655|NCT03557151|469370161|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
130382656|NCT03557151|469370160|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
130382657|NCT03557151|469370161|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
130382658|NCT03557151|469370160|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
130382659|NCT03557151|469370161|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
130382660|NCT01414075|469370162|FG000|Overall Study|Adverse Event|1|||
130382661|NCT01414075|469370163|FG001|Overall Study|Adverse Event|0|||
130382662|NCT01414075|469370164|FG002|Overall Study|Adverse Event|1|||
130382663|NCT01414075|469370165|FG003|Overall Study|Adverse Event|0|||
130382664|NCT01414075|469370162|FG000|Overall Study|Death|1|||
130382665|NCT01414075|469370163|FG001|Overall Study|Death|0|||
130382666|NCT01414075|469370164|FG002|Overall Study|Death|0|||
130382667|NCT01414075|469370165|FG003|Overall Study|Death|1|||
130382668|NCT01414075|469370162|FG000|Overall Study|Withdrawal by Subject|0|||
130382669|NCT01414075|469370163|FG001|Overall Study|Withdrawal by Subject|0|||
130382670|NCT01414075|469370164|FG002|Overall Study|Withdrawal by Subject|0|||
130382671|NCT01414075|469370165|FG003|Overall Study|Withdrawal by Subject|1|||
130382672|NCT01414075|469370162|FG000|Overall Study|Other than specified|1|||
130382673|NCT01414075|469370163|FG001|Overall Study|Other than specified|0|||
130382674|NCT01414075|469370164|FG002|Overall Study|Other than specified|1|||
130382675|NCT01414075|469370165|FG003|Overall Study|Other than specified|0|||
130382676|NCT01187043|469370167|FG000|Overall Study|Adverse Event|0|||
130382677|NCT01187043|469370168|FG001|Overall Study|Adverse Event|0|||
130382678|NCT01187043|469370169|FG002|Overall Study|Adverse Event|0|||
130382679|NCT01187043|469370170|FG003|Overall Study|Adverse Event|0|||
130382680|NCT01187043|469370171|FG004|Overall Study|Adverse Event|1|||
130382681|NCT01187043|469370167|FG000|Overall Study|Unable to make scheduled visits|1|||
130382682|NCT01187043|469370168|FG001|Overall Study|Unable to make scheduled visits|0|||
130468626|NCT02461628|469681712|FG000|Overall Study|Refused to complete survey|4|||
130468627|NCT02461628|469681713|FG001|Overall Study|Refused to complete survey|7|||
130468628|NCT02647905|469681718|FG000|Overall Study|Lost to Follow-up|1|||
130468629|NCT02647905|469681718|FG000|Overall Study|Withdrawal by Subject|2|||
130468630|NCT02015520|469681719|FG000|Overall Study|Lack of Efficacy|1|||
130382683|NCT01187043|469370169|FG002|Overall Study|Unable to make scheduled visits|4|||
130382684|NCT01187043|469370170|FG003|Overall Study|Unable to make scheduled visits|0|||
130382685|NCT01187043|469370171|FG004|Overall Study|Unable to make scheduled visits|1|||
130382686|NCT03198234|469370173|FG000|Overall Study|Relapse of primary disease|0|||
130382687|NCT03198234|469370174|FG001|Overall Study|Relapse of primary disease|1|||
130382688|NCT03198234|469370175|FG002|Overall Study|Relapse of primary disease|0|||
130382689|NCT01361464|469370176|FG000|Overall Study|Death|1|||
130382690|NCT01361464|469370176|FG000|Overall Study|Withdrawal by Subject|2|||
130382691|NCT01106898|469370180|FG000|Overall Study|Adverse Event|6|||
130382692|NCT01722071|469370181|FG000|Overall Study|Protocol Violation|1|||
130382693|NCT01722071|469370182|FG001|Overall Study|Protocol Violation|0|||
130382694|NCT00541034|469370183|FG000|Overall Study|Non-Compliance|3|||
130382695|NCT01505868|469370184|FG000|Overall Study|Withdrawal by Subject|1|||
130382696|NCT01505868|469370185|FG001|Overall Study|Withdrawal by Subject|0|||
130382697|NCT01505868|469370186|FG002|Overall Study|Withdrawal by Subject|0|||
130382698|NCT01505868|469370187|FG003|Overall Study|Withdrawal by Subject|0|||
130382699|NCT01505868|469370188|FG004|Overall Study|Withdrawal by Subject|0|||
130382700|NCT02062879|469370189|FG000|Overall Study|Withdrawal by Subject|4|||
130382701|NCT02062879|469370190|FG001|Overall Study|Withdrawal by Subject|1|||
130382702|NCT02289079|469370191|FG000|Overall Study|Physician Decision|2|||
130382703|NCT02289079|469370192|FG001|Overall Study|Physician Decision|0|||
130382704|NCT02289079|469370191|FG000|Overall Study|Lost to Follow-up|0|||
130382705|NCT02289079|469370192|FG001|Overall Study|Lost to Follow-up|1|||
130382706|NCT00680043|469370193|FG000|Overall Study|Withdrawal by Subject|1|||
130382707|NCT00680043|469370194|FG001|Overall Study|Withdrawal by Subject|0|||
130382708|NCT00680043|469370195|FG002|Overall Study|Withdrawal by Subject|0|||
130382709|NCT00680043|469370193|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
130382710|NCT00680043|469370194|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
130468631|NCT02015520|469681720|FG001|Overall Study|Lack of Efficacy|0|||
130468632|NCT02015520|469681721|FG002|Overall Study|Lack of Efficacy|3|||
130468633|NCT02015520|469681722|FG003|Overall Study|Lack of Efficacy|2|||
130468634|NCT02015520|469681719|FG000|Overall Study|Adverse Event|0|||
130382711|NCT00680043|469370195|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
130382712|NCT00680043|469370193|FG000|Overall Study|Renal Transplant|1|||
130382713|NCT00680043|469370194|FG001|Overall Study|Renal Transplant|0|||
130382714|NCT00680043|469370195|FG002|Overall Study|Renal Transplant|4|||
130468635|NCT02015520|469681720|FG001|Overall Study|Adverse Event|0|||
130468636|NCT02015520|469681721|FG002|Overall Study|Adverse Event|0|||
130382715|NCT00553150|469370196|FG000|Overall Study|Withdrawal by Subject|0|||
130382716|NCT00553150|469370197|FG001|Overall Study|Withdrawal by Subject|0|||
130382717|NCT00553150|469370198|FG002|Overall Study|Withdrawal by Subject|0|||
130382718|NCT00553150|469370199|FG003|Overall Study|Withdrawal by Subject|2|||
130468637|NCT02015520|469681722|FG003|Overall Study|Adverse Event|1|||
130722320|NCT00191165|470608216|FG001|Overall Study|Participant Moved Away|1|||
130382719|NCT00553150|469370196|FG000|Overall Study|Protocol Violation|0|||
130382720|NCT00553150|469370197|FG001|Overall Study|Protocol Violation|0|||
130382721|NCT00553150|469370198|FG002|Overall Study|Protocol Violation|0|||
130382722|NCT00553150|469370199|FG003|Overall Study|Protocol Violation|1|||
130382723|NCT00553150|469370196|FG000|Overall Study|Ineligible|0|||
130382724|NCT00553150|469370197|FG001|Overall Study|Ineligible|0|||
130382725|NCT00553150|469370198|FG002|Overall Study|Ineligible|0|||
130382726|NCT00553150|469370199|FG003|Overall Study|Ineligible|1|||
130382727|NCT03061331|469370200|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
130722321|NCT03196635|470608217|FG000|Overall Study|Withdrawal by Subject|1|||
130722322|NCT00380744|470608221|FG000|Overall Study|Death|0|||
130722323|NCT00380744|470608222|FG001|Overall Study|Death|0|||
130722324|NCT00380744|470608223|FG002|Overall Study|Death|0|||
130722325|NCT00380744|470608224|FG003|Overall Study|Death|0|||
130722326|NCT00380744|470608225|FG004|Overall Study|Death|0|||
130722327|NCT00380744|470608226|FG005|Overall Study|Death|0|||
130722328|NCT00380744|470608227|FG006|Overall Study|Death|1|||
130722329|NCT00380744|470608221|FG000|Overall Study|Withdrawal by Subject|1|||
130722330|NCT00380744|470608222|FG001|Overall Study|Withdrawal by Subject|0|||
130722331|NCT00380744|470608223|FG002|Overall Study|Withdrawal by Subject|0|||
130722332|NCT00380744|470608224|FG003|Overall Study|Withdrawal by Subject|0|||
130382728|NCT03061331|469370201|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
130382729|NCT02998840|469370202|FG000|Overall Study|Lost to Follow-up|1|||
130382730|NCT02998840|469370203|FG001|Overall Study|Lost to Follow-up|1|||
130382731|NCT02998840|469370204|FG002|Overall Study|Lost to Follow-up|2|||
130382732|NCT02998840|469370205|FG003|Overall Study|Lost to Follow-up|3|||
130382733|NCT02998840|469370202|FG000|Overall Study|Withdrawal by Subject|1|||
130382734|NCT02998840|469370203|FG001|Overall Study|Withdrawal by Subject|1|||
130382735|NCT02998840|469370204|FG002|Overall Study|Withdrawal by Subject|0|||
130382736|NCT02998840|469370205|FG003|Overall Study|Withdrawal by Subject|1|||
130382737|NCT02998840|469370202|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
130382738|NCT02998840|469370203|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
130382739|NCT02998840|469370204|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
130382740|NCT02998840|469370205|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
130382741|NCT01980875|469370206|FG000|Overall Study|Withdrew Consent|1|||
130382742|NCT01980875|469370207|FG001|Overall Study|Withdrew Consent|1|||
130382743|NCT01980875|469370208|FG002|Overall Study|Withdrew Consent|1|||
130382744|NCT01980875|469370206|FG000|Overall Study|Study Terminated by Sponsor|7|||
130382745|NCT01980875|469370207|FG001|Overall Study|Study Terminated by Sponsor|24|||
130382746|NCT01980875|469370208|FG002|Overall Study|Study Terminated by Sponsor|22|||
130382747|NCT01980875|469370206|FG000|Overall Study|Lost to Follow-up|0|||
130382748|NCT01980875|469370207|FG001|Overall Study|Lost to Follow-up|0|||
130382749|NCT01980875|469370208|FG002|Overall Study|Lost to Follow-up|1|||
130382750|NCT02625259|469370212|FG000|First Intervention (Day 1)|Other|0|||
130382751|NCT02625259|469370213|FG001|First Intervention (Day 1)|Other|0|||
130382752|NCT02625259|469370214|FG002|First Intervention (Day 1)|Other|1|||
130382753|NCT02625259|469370215|FG003|First Intervention (Day 1)|Other|0|||
130382754|NCT02625259|469370216|FG004|First Intervention (Day 1)|Other|0|||
130382755|NCT02625259|469370212|FG000|First Intervention (Day 1)|Adverse Event|2|||
130382756|NCT02625259|469370213|FG001|First Intervention (Day 1)|Adverse Event|1|||
130382757|NCT02625259|469370214|FG002|First Intervention (Day 1)|Adverse Event|0|||
130382758|NCT02625259|469370215|FG003|First Intervention (Day 1)|Adverse Event|0|||
130382759|NCT02625259|469370216|FG004|First Intervention (Day 1)|Adverse Event|0|||
130382760|NCT02625259|469370212|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
130382761|NCT02625259|469370213|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130382762|NCT02625259|469370214|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130382763|NCT02625259|469370215|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
130382764|NCT02625259|469370216|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
130722333|NCT00380744|470608225|FG004|Overall Study|Withdrawal by Subject|0|||
130722334|NCT00380744|470608226|FG005|Overall Study|Withdrawal by Subject|0|||
130722335|NCT00380744|470608227|FG006|Overall Study|Withdrawal by Subject|0|||
130722336|NCT01338870|470608228|FG000|Overall Study|Lost to Follow-up|0|||
130722337|NCT01338870|470608229|FG001|Overall Study|Lost to Follow-up|0|||
130722338|NCT01338870|470608230|FG002|Overall Study|Lost to Follow-up|1|||
130382765|NCT00513474|469370217|FG000|Overall Study|Death|6|||
130382766|NCT00513474|469370218|FG001|Overall Study|Death|9|||
130382767|NCT00513474|469370217|FG000|Overall Study|Participant Withdrew Consent|1|||
130382768|NCT00513474|469370218|FG001|Overall Study|Participant Withdrew Consent|0|||
130722339|NCT01338870|470608231|FG003|Overall Study|Lost to Follow-up|0|||
130722340|NCT01338870|470608232|FG004|Overall Study|Lost to Follow-up|1|||
130382769|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Adverse Event|82|||
130382770|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Death|6|||
130382771|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
130382772|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
130382773|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
130722341|NCT01338870|470608233|FG005|Overall Study|Lost to Follow-up|0|||
130382774|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
130382775|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
130382776|NCT00195676|469370224|FG000|Period O - Open-label Treatment|Other reasons|68|||
130382777|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
130382778|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
130382779|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
130382780|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
130382781|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
130382782|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
130382783|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
130382784|NCT00195676|469370224|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
130382785|NCT00195676|469370224|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
130382786|NCT00195676|469370224|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
130382787|NCT00195676|469370224|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
130382788|NCT00195676|469370224|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
130382789|NCT00195676|469370224|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
130382790|NCT01189812|469370225|FG000|Overall Study|Withdrawal by Subject|2|||
130382791|NCT01189812|469370226|FG001|Overall Study|Withdrawal by Subject|3|||
130382792|NCT01189812|469370225|FG000|Overall Study|Adverse Event|1|||
130382793|NCT01189812|469370226|FG001|Overall Study|Adverse Event|0|||
130382794|NCT01189812|469370225|FG000|Overall Study|Out of Window|4|||
130382795|NCT01189812|469370226|FG001|Overall Study|Out of Window|3|||
130382796|NCT01189812|469370225|FG000|Overall Study|Moved out of State|1|||
130382797|NCT01189812|469370226|FG001|Overall Study|Moved out of State|2|||
130382798|NCT00535223|469370228|FG000|Overall Study|Withdrawal by Subject|4|||
130382799|NCT00535223|469370229|FG001|Overall Study|Withdrawal by Subject|1|||
130722342|NCT01338870|470608228|FG000|Overall Study|Withdrawal by Subject|2|||
130722343|NCT01338870|470608229|FG001|Overall Study|Withdrawal by Subject|3|||
130722344|NCT01338870|470608230|FG002|Overall Study|Withdrawal by Subject|4|||
130382800|NCT02953314|469370230|FG000|Overall Study|Adverse Event|0|||
130382801|NCT02953314|469370231|FG001|Overall Study|Adverse Event|1|||
130382802|NCT02953314|469370230|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130382803|NCT02953314|469370231|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130382804|NCT01765153|469370232|FG000|Training Phase 1|Format of intervention differed|1|||
130382805|NCT01765153|469370233|FG001|Training Phase 1|Format of intervention differed|0|||
130382806|NCT01765153|469370232|FG000|Training Phase 1|Poor participation in intervention|0|||
130382807|NCT01765153|469370233|FG001|Training Phase 1|Poor participation in intervention|1|||
130382808|NCT01765153|469370232|FG000|Rest Phase 1|Withdrawal by Subject|0|||
130382809|NCT01765153|469370233|FG001|Rest Phase 1|Withdrawal by Subject|1|||
130382810|NCT01765153|469370232|FG000|Training Phase 2|Withdrawal by Subject|0|||
130382811|NCT01765153|469370233|FG001|Training Phase 2|Withdrawal by Subject|1|||
130382812|NCT01765153|469370232|FG000|Rest Phase 2|Lost to Follow-up|2|||
130382813|NCT01765153|469370233|FG001|Rest Phase 2|Lost to Follow-up|1|||
130382814|NCT02554812|469370234|FG000|Overall Study|Adverse Event|2|||
130382815|NCT02554812|469370235|FG001|Overall Study|Adverse Event|5|||
130382816|NCT02554812|469370236|FG002|Overall Study|Adverse Event|3|||
130382817|NCT02554812|469370237|FG003|Overall Study|Adverse Event|0|||
130382818|NCT02554812|469370238|FG004|Overall Study|Adverse Event|5|||
130382819|NCT02554812|469370239|FG005|Overall Study|Adverse Event|0|||
130382820|NCT02554812|469370240|FG006|Overall Study|Adverse Event|1|||
130382821|NCT02554812|469370241|FG007|Overall Study|Adverse Event|6|||
130382822|NCT02554812|469370242|FG008|Overall Study|Adverse Event|2|||
130382823|NCT02554812|469370243|FG009|Overall Study|Adverse Event|2|||
130382824|NCT02554812|469370244|FG010|Overall Study|Adverse Event|1|||
130382825|NCT02554812|469370245|FG011|Overall Study|Adverse Event|2|||
130382826|NCT02554812|469370246|FG012|Overall Study|Adverse Event|0|||
130382827|NCT02554812|469370247|FG013|Overall Study|Adverse Event|3|||
130382828|NCT02554812|469370248|FG014|Overall Study|Adverse Event|2|||
130382829|NCT02554812|469370249|FG015|Overall Study|Adverse Event|1|||
130382830|NCT02554812|469370250|FG016|Overall Study|Adverse Event|0|||
130382831|NCT02554812|469370251|FG017|Overall Study|Adverse Event|1|||
130382832|NCT02554812|469370252|FG018|Overall Study|Adverse Event|0|||
130382833|NCT02554812|469370253|FG019|Overall Study|Adverse Event|0|||
130382834|NCT02554812|469370254|FG020|Overall Study|Adverse Event|0|||
130382835|NCT02554812|469370255|FG021|Overall Study|Adverse Event|2|||
130382836|NCT02554812|469370256|FG022|Overall Study|Adverse Event|1|||
130722345|NCT01338870|470608231|FG003|Overall Study|Withdrawal by Subject|0|||
130722346|NCT01338870|470608232|FG004|Overall Study|Withdrawal by Subject|0|||
130382837|NCT02554812|469370257|FG023|Overall Study|Adverse Event|1|||
130382838|NCT02554812|469370258|FG024|Overall Study|Adverse Event|1|||
130382839|NCT02554812|469370259|FG025|Overall Study|Adverse Event|2|||
130382840|NCT02554812|469370260|FG026|Overall Study|Adverse Event|1|||
130382841|NCT02554812|469370234|FG000|Overall Study|Death|1|||
130382842|NCT02554812|469370235|FG001|Overall Study|Death|2|||
130382843|NCT02554812|469370236|FG002|Overall Study|Death|2|||
130382844|NCT02554812|469370237|FG003|Overall Study|Death|2|||
130382845|NCT02554812|469370238|FG004|Overall Study|Death|0|||
130382846|NCT02554812|469370239|FG005|Overall Study|Death|1|||
130382847|NCT02554812|469370240|FG006|Overall Study|Death|1|||
130382848|NCT02554812|469370241|FG007|Overall Study|Death|1|||
130382849|NCT02554812|469370242|FG008|Overall Study|Death|0|||
130382850|NCT02554812|469370243|FG009|Overall Study|Death|0|||
130382851|NCT02554812|469370244|FG010|Overall Study|Death|0|||
130382852|NCT02554812|469370245|FG011|Overall Study|Death|0|||
130382853|NCT02554812|469370246|FG012|Overall Study|Death|0|||
130382854|NCT02554812|469370247|FG013|Overall Study|Death|0|||
130382855|NCT02554812|469370248|FG014|Overall Study|Death|1|||
130382856|NCT02554812|469370249|FG015|Overall Study|Death|1|||
130382857|NCT02554812|469370250|FG016|Overall Study|Death|1|||
130382858|NCT02554812|469370251|FG017|Overall Study|Death|0|||
130382859|NCT02554812|469370252|FG018|Overall Study|Death|1|||
130382860|NCT02554812|469370253|FG019|Overall Study|Death|2|||
130382861|NCT02554812|469370254|FG020|Overall Study|Death|0|||
130382862|NCT02554812|469370255|FG021|Overall Study|Death|1|||
130382863|NCT02554812|469370256|FG022|Overall Study|Death|1|||
130382864|NCT02554812|469370257|FG023|Overall Study|Death|0|||
130382865|NCT02554812|469370258|FG024|Overall Study|Death|0|||
130382866|NCT02554812|469370259|FG025|Overall Study|Death|0|||
130382867|NCT02554812|469370260|FG026|Overall Study|Death|0|||
130382868|NCT02554812|469370234|FG000|Overall Study|Lost to Follow-up|0|||
130382869|NCT02554812|469370235|FG001|Overall Study|Lost to Follow-up|1|||
130382870|NCT02554812|469370236|FG002|Overall Study|Lost to Follow-up|0|||
130382871|NCT02554812|469370237|FG003|Overall Study|Lost to Follow-up|0|||
130382872|NCT02554812|469370238|FG004|Overall Study|Lost to Follow-up|0|||
130382873|NCT02554812|469370239|FG005|Overall Study|Lost to Follow-up|0|||
130382874|NCT02554812|469370240|FG006|Overall Study|Lost to Follow-up|0|||
130382875|NCT02554812|469370241|FG007|Overall Study|Lost to Follow-up|0|||
130382876|NCT02554812|469370242|FG008|Overall Study|Lost to Follow-up|0|||
130382877|NCT02554812|469370243|FG009|Overall Study|Lost to Follow-up|0|||
130382878|NCT02554812|469370244|FG010|Overall Study|Lost to Follow-up|0|||
130382879|NCT02554812|469370245|FG011|Overall Study|Lost to Follow-up|0|||
130382880|NCT02554812|469370246|FG012|Overall Study|Lost to Follow-up|0|||
130382881|NCT02554812|469370247|FG013|Overall Study|Lost to Follow-up|0|||
130382882|NCT02554812|469370248|FG014|Overall Study|Lost to Follow-up|0|||
130382883|NCT02554812|469370249|FG015|Overall Study|Lost to Follow-up|0|||
130382884|NCT02554812|469370250|FG016|Overall Study|Lost to Follow-up|0|||
130382885|NCT02554812|469370251|FG017|Overall Study|Lost to Follow-up|0|||
130382886|NCT02554812|469370252|FG018|Overall Study|Lost to Follow-up|0|||
130382887|NCT02554812|469370253|FG019|Overall Study|Lost to Follow-up|0|||
130382888|NCT02554812|469370254|FG020|Overall Study|Lost to Follow-up|0|||
130382889|NCT02554812|469370255|FG021|Overall Study|Lost to Follow-up|0|||
130382890|NCT02554812|469370256|FG022|Overall Study|Lost to Follow-up|0|||
130382891|NCT02554812|469370257|FG023|Overall Study|Lost to Follow-up|0|||
130382892|NCT02554812|469370258|FG024|Overall Study|Lost to Follow-up|0|||
130382893|NCT02554812|469370259|FG025|Overall Study|Lost to Follow-up|0|||
130382894|NCT02554812|469370260|FG026|Overall Study|Lost to Follow-up|0|||
130382895|NCT02554812|469370234|FG000|Overall Study|Global deterioration of health status|4|||
130382896|NCT02554812|469370235|FG001|Overall Study|Global deterioration of health status|3|||
130382897|NCT02554812|469370236|FG002|Overall Study|Global deterioration of health status|3|||
130382898|NCT02554812|469370237|FG003|Overall Study|Global deterioration of health status|2|||
130382899|NCT02554812|469370238|FG004|Overall Study|Global deterioration of health status|5|||
130382900|NCT02554812|469370239|FG005|Overall Study|Global deterioration of health status|0|||
130382901|NCT02554812|469370240|FG006|Overall Study|Global deterioration of health status|2|||
130382902|NCT02554812|469370241|FG007|Overall Study|Global deterioration of health status|1|||
130382903|NCT02554812|469370242|FG008|Overall Study|Global deterioration of health status|1|||
130382904|NCT02554812|469370243|FG009|Overall Study|Global deterioration of health status|1|||
130382905|NCT02554812|469370244|FG010|Overall Study|Global deterioration of health status|2|||
130382906|NCT02554812|469370245|FG011|Overall Study|Global deterioration of health status|1|||
130382907|NCT02554812|469370246|FG012|Overall Study|Global deterioration of health status|0|||
130382908|NCT02554812|469370247|FG013|Overall Study|Global deterioration of health status|0|||
130382909|NCT02554812|469370248|FG014|Overall Study|Global deterioration of health status|0|||
130382910|NCT02554812|469370249|FG015|Overall Study|Global deterioration of health status|1|||
130382911|NCT02554812|469370250|FG016|Overall Study|Global deterioration of health status|0|||
130382912|NCT02554812|469370251|FG017|Overall Study|Global deterioration of health status|0|||
130382913|NCT02554812|469370252|FG018|Overall Study|Global deterioration of health status|0|||
130382914|NCT02554812|469370253|FG019|Overall Study|Global deterioration of health status|0|||
130382915|NCT02554812|469370254|FG020|Overall Study|Global deterioration of health status|0|||
130382916|NCT02554812|469370255|FG021|Overall Study|Global deterioration of health status|0|||
130382917|NCT02554812|469370256|FG022|Overall Study|Global deterioration of health status|0|||
130382918|NCT02554812|469370257|FG023|Overall Study|Global deterioration of health status|0|||
130382919|NCT02554812|469370258|FG024|Overall Study|Global deterioration of health status|0|||
130382920|NCT02554812|469370259|FG025|Overall Study|Global deterioration of health status|0|||
130382921|NCT02554812|469370260|FG026|Overall Study|Global deterioration of health status|0|||
130722347|NCT01338870|470608233|FG005|Overall Study|Withdrawal by Subject|2|||
130722348|NCT01338870|470608228|FG000|Overall Study|Other|3|||
130722349|NCT01338870|470608229|FG001|Overall Study|Other|3|||
130722350|NCT01338870|470608230|FG002|Overall Study|Other|3|||
130722351|NCT01338870|470608231|FG003|Overall Study|Other|2|||
130722352|NCT01338870|470608232|FG004|Overall Study|Other|0|||
130382922|NCT02554812|469370234|FG000|Overall Study|Progressive disease|20|||
130382923|NCT02554812|469370235|FG001|Overall Study|Progressive disease|16|||
130382924|NCT02554812|469370236|FG002|Overall Study|Progressive disease|19|||
130382925|NCT02554812|469370237|FG003|Overall Study|Progressive disease|18|||
130382926|NCT02554812|469370238|FG004|Overall Study|Progressive disease|21|||
130382927|NCT02554812|469370239|FG005|Overall Study|Progressive disease|15|||
130382928|NCT02554812|469370240|FG006|Overall Study|Progressive disease|6|||
130382929|NCT02554812|469370241|FG007|Overall Study|Progressive disease|13|||
130382930|NCT02554812|469370242|FG008|Overall Study|Progressive disease|6|||
130382931|NCT02554812|469370243|FG009|Overall Study|Progressive disease|6|||
130382932|NCT02554812|469370244|FG010|Overall Study|Progressive disease|8|||
130382933|NCT02554812|469370245|FG011|Overall Study|Progressive disease|8|||
130382934|NCT02554812|469370246|FG012|Overall Study|Progressive disease|6|||
130382935|NCT02554812|469370247|FG013|Overall Study|Progressive disease|10|||
130382936|NCT02554812|469370248|FG014|Overall Study|Progressive disease|20|||
130382937|NCT02554812|469370249|FG015|Overall Study|Progressive disease|6|||
130382938|NCT02554812|469370250|FG016|Overall Study|Progressive disease|3|||
130382939|NCT02554812|469370251|FG017|Overall Study|Progressive disease|3|||
130382940|NCT02554812|469370252|FG018|Overall Study|Progressive disease|11|||
130382941|NCT02554812|469370253|FG019|Overall Study|Progressive disease|7|||
130382942|NCT02554812|469370254|FG020|Overall Study|Progressive disease|11|||
130382943|NCT02554812|469370255|FG021|Overall Study|Progressive disease|6|||
130382944|NCT02554812|469370256|FG022|Overall Study|Progressive disease|9|||
130382945|NCT02554812|469370257|FG023|Overall Study|Progressive disease|9|||
130382946|NCT02554812|469370258|FG024|Overall Study|Progressive disease|4|||
130382947|NCT02554812|469370259|FG025|Overall Study|Progressive disease|5|||
130382948|NCT02554812|469370260|FG026|Overall Study|Progressive disease|5|||
130382949|NCT02554812|469370234|FG000|Overall Study|Other|0|||
130382950|NCT02554812|469370235|FG001|Overall Study|Other|0|||
130382951|NCT02554812|469370236|FG002|Overall Study|Other|2|||
130382952|NCT02554812|469370237|FG003|Overall Study|Other|3|||
130382953|NCT02554812|469370238|FG004|Overall Study|Other|2|||
130382954|NCT02554812|469370239|FG005|Overall Study|Other|1|||
130382955|NCT02554812|469370240|FG006|Overall Study|Other|0|||
130382956|NCT02554812|469370241|FG007|Overall Study|Other|0|||
130382957|NCT02554812|469370242|FG008|Overall Study|Other|1|||
130382958|NCT02554812|469370243|FG009|Overall Study|Other|1|||
130382959|NCT02554812|469370244|FG010|Overall Study|Other|0|||
130382960|NCT02554812|469370245|FG011|Overall Study|Other|0|||
130382961|NCT02554812|469370246|FG012|Overall Study|Other|1|||
130382962|NCT02554812|469370247|FG013|Overall Study|Other|0|||
130382963|NCT02554812|469370248|FG014|Overall Study|Other|1|||
130382964|NCT02554812|469370249|FG015|Overall Study|Other|0|||
130382965|NCT02554812|469370250|FG016|Overall Study|Other|0|||
130382966|NCT02554812|469370251|FG017|Overall Study|Other|0|||
130382967|NCT02554812|469370252|FG018|Overall Study|Other|0|||
130382968|NCT02554812|469370253|FG019|Overall Study|Other|0|||
130382969|NCT02554812|469370254|FG020|Overall Study|Other|0|||
130382970|NCT02554812|469370255|FG021|Overall Study|Other|2|||
130382971|NCT02554812|469370256|FG022|Overall Study|Other|0|||
130382972|NCT02554812|469370257|FG023|Overall Study|Other|0|||
130382973|NCT02554812|469370258|FG024|Overall Study|Other|0|||
130382974|NCT02554812|469370259|FG025|Overall Study|Other|0|||
130382975|NCT02554812|469370260|FG026|Overall Study|Other|0|||
130382976|NCT02554812|469370234|FG000|Overall Study|Withdrawal by Subject|1|||
130722353|NCT01338870|470608233|FG005|Overall Study|Other|2|||
130382977|NCT02554812|469370235|FG001|Overall Study|Withdrawal by Subject|0|||
130382978|NCT02554812|469370236|FG002|Overall Study|Withdrawal by Subject|0|||
130382979|NCT02554812|469370237|FG003|Overall Study|Withdrawal by Subject|2|||
130382980|NCT02554812|469370238|FG004|Overall Study|Withdrawal by Subject|2|||
130382981|NCT02554812|469370239|FG005|Overall Study|Withdrawal by Subject|3|||
130382982|NCT02554812|469370240|FG006|Overall Study|Withdrawal by Subject|0|||
130382983|NCT02554812|469370241|FG007|Overall Study|Withdrawal by Subject|0|||
130382984|NCT02554812|469370242|FG008|Overall Study|Withdrawal by Subject|1|||
130722354|NCT01338870|470608228|FG000|Overall Study|Protocol Violation|0|||
130382985|NCT02554812|469370243|FG009|Overall Study|Withdrawal by Subject|1|||
130382986|NCT02554812|469370244|FG010|Overall Study|Withdrawal by Subject|0|||
130382987|NCT02554812|469370245|FG011|Overall Study|Withdrawal by Subject|1|||
130382988|NCT02554812|469370246|FG012|Overall Study|Withdrawal by Subject|1|||
130382989|NCT02554812|469370247|FG013|Overall Study|Withdrawal by Subject|1|||
130382990|NCT02554812|469370248|FG014|Overall Study|Withdrawal by Subject|1|||
130382991|NCT02554812|469370249|FG015|Overall Study|Withdrawal by Subject|1|||
130382992|NCT02554812|469370250|FG016|Overall Study|Withdrawal by Subject|3|||
130382993|NCT02554812|469370251|FG017|Overall Study|Withdrawal by Subject|1|||
130722355|NCT01338870|470608229|FG001|Overall Study|Protocol Violation|2|||
130722356|NCT01338870|470608230|FG002|Overall Study|Protocol Violation|2|||
130468638|NCT02015520|469681719|FG000|Overall Study|Withdrawal by Subject|2|||
130468639|NCT02015520|469681720|FG001|Overall Study|Withdrawal by Subject|2|||
130468640|NCT02015520|469681721|FG002|Overall Study|Withdrawal by Subject|1|||
130468641|NCT02015520|469681722|FG003|Overall Study|Withdrawal by Subject|0|||
130468642|NCT02015520|469681719|FG000|Overall Study|Death|1|||
130468643|NCT02015520|469681720|FG001|Overall Study|Death|0|||
130468644|NCT02015520|469681721|FG002|Overall Study|Death|0|||
130468645|NCT02015520|469681722|FG003|Overall Study|Death|0|||
130468646|NCT02015520|469681719|FG000|Overall Study|Lost to Follow-up|0|||
130468647|NCT02015520|469681720|FG001|Overall Study|Lost to Follow-up|0|||
130468648|NCT02015520|469681721|FG002|Overall Study|Lost to Follow-up|1|||
130468649|NCT02015520|469681722|FG003|Overall Study|Lost to Follow-up|0|||
130468650|NCT02015520|469681719|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
130468651|NCT02015520|469681720|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
130468652|NCT02015520|469681721|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
130468653|NCT02015520|469681722|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
130468654|NCT02015520|469681719|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
130468655|NCT02015520|469681720|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
130468656|NCT02015520|469681721|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
130468657|NCT02015520|469681722|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
130722357|NCT01338870|470608231|FG003|Overall Study|Protocol Violation|2|||
130722358|NCT01338870|470608232|FG004|Overall Study|Protocol Violation|1|||
130722359|NCT01338870|470608233|FG005|Overall Study|Protocol Violation|1|||
130722360|NCT01338870|470608228|FG000|Overall Study|Adverse Event|4|||
130722361|NCT01338870|470608229|FG001|Overall Study|Adverse Event|4|||
130382994|NCT02554812|469370252|FG018|Overall Study|Withdrawal by Subject|0|||
130382995|NCT02554812|469370253|FG019|Overall Study|Withdrawal by Subject|2|||
130382996|NCT02554812|469370254|FG020|Overall Study|Withdrawal by Subject|0|||
130382997|NCT02554812|469370255|FG021|Overall Study|Withdrawal by Subject|1|||
130382998|NCT02554812|469370256|FG022|Overall Study|Withdrawal by Subject|0|||
130382999|NCT02554812|469370257|FG023|Overall Study|Withdrawal by Subject|1|||
130383000|NCT02554812|469370258|FG024|Overall Study|Withdrawal by Subject|0|||
130383001|NCT02554812|469370259|FG025|Overall Study|Withdrawal by Subject|0|||
130383002|NCT02554812|469370260|FG026|Overall Study|Withdrawal by Subject|1|||
130383003|NCT02554812|469370234|FG000|Overall Study|Physician Decision|1|||
130383004|NCT02554812|469370235|FG001|Overall Study|Physician Decision|0|||
130383005|NCT02554812|469370236|FG002|Overall Study|Physician Decision|0|||
130383006|NCT02554812|469370237|FG003|Overall Study|Physician Decision|1|||
130383007|NCT02554812|469370238|FG004|Overall Study|Physician Decision|0|||
130383008|NCT02554812|469370239|FG005|Overall Study|Physician Decision|1|||
130383009|NCT02554812|469370240|FG006|Overall Study|Physician Decision|0|||
130383010|NCT02554812|469370241|FG007|Overall Study|Physician Decision|0|||
130383011|NCT02554812|469370242|FG008|Overall Study|Physician Decision|0|||
130383012|NCT02554812|469370243|FG009|Overall Study|Physician Decision|0|||
130383013|NCT02554812|469370244|FG010|Overall Study|Physician Decision|1|||
130383014|NCT02554812|469370245|FG011|Overall Study|Physician Decision|0|||
130383015|NCT02554812|469370246|FG012|Overall Study|Physician Decision|0|||
130383016|NCT02554812|469370247|FG013|Overall Study|Physician Decision|0|||
130383017|NCT02554812|469370248|FG014|Overall Study|Physician Decision|0|||
130383018|NCT02554812|469370249|FG015|Overall Study|Physician Decision|0|||
130383019|NCT02554812|469370250|FG016|Overall Study|Physician Decision|1|||
130383020|NCT02554812|469370251|FG017|Overall Study|Physician Decision|1|||
130383021|NCT02554812|469370252|FG018|Overall Study|Physician Decision|0|||
130383022|NCT02554812|469370253|FG019|Overall Study|Physician Decision|1|||
130383023|NCT02554812|469370254|FG020|Overall Study|Physician Decision|1|||
130383024|NCT02554812|469370255|FG021|Overall Study|Physician Decision|0|||
130383025|NCT02554812|469370256|FG022|Overall Study|Physician Decision|1|||
130383026|NCT02554812|469370257|FG023|Overall Study|Physician Decision|0|||
130383027|NCT02554812|469370258|FG024|Overall Study|Physician Decision|0|||
130383028|NCT02554812|469370259|FG025|Overall Study|Physician Decision|0|||
130383029|NCT02554812|469370260|FG026|Overall Study|Physician Decision|0|||
130383030|NCT02554812|469370234|FG000|Overall Study|Study terminated by sponsor|0|||
130383031|NCT02554812|469370235|FG001|Overall Study|Study terminated by sponsor|0|||
130383032|NCT02554812|469370236|FG002|Overall Study|Study terminated by sponsor|0|||
130383033|NCT02554812|469370237|FG003|Overall Study|Study terminated by sponsor|0|||
130383034|NCT02554812|469370238|FG004|Overall Study|Study terminated by sponsor|0|||
130383035|NCT02554812|469370239|FG005|Overall Study|Study terminated by sponsor|0|||
130383036|NCT02554812|469370240|FG006|Overall Study|Study terminated by sponsor|0|||
130383037|NCT02554812|469370241|FG007|Overall Study|Study terminated by sponsor|0|||
130383038|NCT02554812|469370242|FG008|Overall Study|Study terminated by sponsor|0|||
130383039|NCT02554812|469370243|FG009|Overall Study|Study terminated by sponsor|0|||
130468658|NCT05119855|469681724|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
130722362|NCT01338870|470608230|FG002|Overall Study|Adverse Event|1|||
130383040|NCT02554812|469370244|FG010|Overall Study|Study terminated by sponsor|0|||
130383041|NCT02554812|469370245|FG011|Overall Study|Study terminated by sponsor|0|||
130383042|NCT02554812|469370246|FG012|Overall Study|Study terminated by sponsor|0|||
130722363|NCT01338870|470608231|FG003|Overall Study|Adverse Event|5|||
130468659|NCT05119855|469681725|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
130468660|NCT05119855|469681724|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
130468661|NCT05119855|469681725|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
130468662|NCT05119855|469681724|FG000|Overall Study|Lost to Follow-up|6|||
130468663|NCT05119855|469681725|FG001|Overall Study|Lost to Follow-up|8|||
130468664|NCT02932579|469681726|FG000|Overall Study|Withdrawal by Subject|4|||
130468665|NCT02932579|469681727|FG001|Overall Study|Withdrawal by Subject|1|||
130468666|NCT01972724|469681728|FG000|Double-Blind|Rescue Criteria Met|1|||
130468667|NCT01972724|469681729|FG001|Double-Blind|Rescue Criteria Met|0|||
130383043|NCT02554812|469370247|FG013|Overall Study|Study terminated by sponsor|0|||
130383044|NCT02554812|469370248|FG014|Overall Study|Study terminated by sponsor|0|||
130383045|NCT02554812|469370249|FG015|Overall Study|Study terminated by sponsor|0|||
130383046|NCT02554812|469370250|FG016|Overall Study|Study terminated by sponsor|0|||
130383047|NCT02554812|469370251|FG017|Overall Study|Study terminated by sponsor|0|||
130383048|NCT02554812|469370252|FG018|Overall Study|Study terminated by sponsor|0|||
130383049|NCT02554812|469370253|FG019|Overall Study|Study terminated by sponsor|0|||
130383050|NCT02554812|469370254|FG020|Overall Study|Study terminated by sponsor|0|||
130383051|NCT02554812|469370255|FG021|Overall Study|Study terminated by sponsor|0|||
130383052|NCT02554812|469370256|FG022|Overall Study|Study terminated by sponsor|0|||
130383053|NCT02554812|469370257|FG023|Overall Study|Study terminated by sponsor|0|||
130383054|NCT02554812|469370258|FG024|Overall Study|Study terminated by sponsor|1|||
130383055|NCT02554812|469370259|FG025|Overall Study|Study terminated by sponsor|0|||
130383056|NCT02554812|469370260|FG026|Overall Study|Study terminated by sponsor|0|||
130383057|NCT02554812|469370234|FG000|Overall Study|No longer meets eligibility criteria|0|||
130383058|NCT02554812|469370235|FG001|Overall Study|No longer meets eligibility criteria|1|||
130383059|NCT02554812|469370236|FG002|Overall Study|No longer meets eligibility criteria|0|||
130383060|NCT02554812|469370237|FG003|Overall Study|No longer meets eligibility criteria|0|||
130383061|NCT02554812|469370238|FG004|Overall Study|No longer meets eligibility criteria|0|||
130383062|NCT02554812|469370239|FG005|Overall Study|No longer meets eligibility criteria|0|||
130383063|NCT02554812|469370240|FG006|Overall Study|No longer meets eligibility criteria|0|||
130383064|NCT02554812|469370241|FG007|Overall Study|No longer meets eligibility criteria|0|||
130468668|NCT01972724|469681730|FG002|Double-Blind|Rescue Criteria Met|0|||
130468669|NCT01972724|469681728|FG000|Double-Blind|Adverse Event|1|||
130468670|NCT01972724|469681729|FG001|Double-Blind|Adverse Event|0|||
130468671|NCT01972724|469681730|FG002|Double-Blind|Adverse Event|0|||
130468672|NCT01972724|469681728|FG000|Double-Blind|Withdrawal of Consent|2|||
130468673|NCT01972724|469681729|FG001|Double-Blind|Withdrawal of Consent|1|||
130468674|NCT01972724|469681730|FG002|Double-Blind|Withdrawal of Consent|0|||
130468675|NCT01972724|469681728|FG000|Double-Blind|Significant Protocol Deviation|5|||
130468676|NCT01972724|469681729|FG001|Double-Blind|Significant Protocol Deviation|8|||
130468677|NCT01972724|469681730|FG002|Double-Blind|Significant Protocol Deviation|0|||
130468678|NCT01972724|469681728|FG000|Open-Label|Withdrew Consent|0|||
130468679|NCT01972724|469681729|FG001|Open-Label|Withdrew Consent|0|||
130468680|NCT01972724|469681730|FG002|Open-Label|Withdrew Consent|3|||
130468681|NCT01972724|469681728|FG000|Open-Label|Significant Protocol Deviation|0|||
130468682|NCT01972724|469681729|FG001|Open-Label|Significant Protocol Deviation|0|||
130468683|NCT01972724|469681730|FG002|Open-Label|Significant Protocol Deviation|2|||
130468684|NCT00111813|469681737|FG000|Overall Study|Adverse Event|1|||
130468685|NCT00111813|469681738|FG001|Overall Study|Adverse Event|2|||
130468686|NCT00111813|469681739|FG002|Overall Study|Adverse Event|4|||
130468687|NCT00111813|469681740|FG003|Overall Study|Adverse Event|2|||
130468688|NCT00111813|469681741|FG004|Overall Study|Adverse Event|2|||
130468689|NCT00111813|469681742|FG005|Overall Study|Adverse Event|2|||
130468690|NCT00111813|469681737|FG000|Overall Study|Progressive disease|2|||
130468691|NCT00111813|469681738|FG001|Overall Study|Progressive disease|1|||
130468692|NCT00111813|469681739|FG002|Overall Study|Progressive disease|5|||
130468693|NCT00111813|469681740|FG003|Overall Study|Progressive disease|3|||
130468694|NCT00111813|469681741|FG004|Overall Study|Progressive disease|4|||
130468695|NCT00111813|469681742|FG005|Overall Study|Progressive disease|3|||
130468696|NCT00111813|469681737|FG000|Overall Study|Lack of Efficacy|0|||
130468697|NCT00111813|469681738|FG001|Overall Study|Lack of Efficacy|0|||
130468698|NCT00111813|469681739|FG002|Overall Study|Lack of Efficacy|0|||
130468699|NCT00111813|469681740|FG003|Overall Study|Lack of Efficacy|0|||
130383065|NCT02554812|469370242|FG008|Overall Study|No longer meets eligibility criteria|0|||
130383066|NCT02554812|469370243|FG009|Overall Study|No longer meets eligibility criteria|0|||
130468700|NCT00111813|469681741|FG004|Overall Study|Lack of Efficacy|0|||
130468701|NCT00111813|469681742|FG005|Overall Study|Lack of Efficacy|1|||
130468702|NCT00111813|469681737|FG000|Overall Study|Other|0|||
130468703|NCT00111813|469681738|FG001|Overall Study|Other|0|||
130468704|NCT00111813|469681739|FG002|Overall Study|Other|1|||
130468705|NCT00111813|469681740|FG003|Overall Study|Other|0|||
130468706|NCT00111813|469681741|FG004|Overall Study|Other|0|||
130468707|NCT00111813|469681742|FG005|Overall Study|Other|0|||
130468708|NCT03201562|469681751|FG000|Overall Study|Physician Decision|0|||
130468709|NCT03201562|469681752|FG001|Overall Study|Physician Decision|0|||
130559678|NCT01970488|470017846|FG000|Part 2: Post Week 16|Non-compliance|0|||
130383067|NCT02554812|469370244|FG010|Overall Study|No longer meets eligibility criteria|0|||
130383068|NCT02554812|469370245|FG011|Overall Study|No longer meets eligibility criteria|0|||
130383069|NCT02554812|469370246|FG012|Overall Study|No longer meets eligibility criteria|0|||
130383070|NCT02554812|469370247|FG013|Overall Study|No longer meets eligibility criteria|0|||
130383071|NCT02554812|469370248|FG014|Overall Study|No longer meets eligibility criteria|0|||
130383072|NCT02554812|469370249|FG015|Overall Study|No longer meets eligibility criteria|0|||
130383073|NCT02554812|469370250|FG016|Overall Study|No longer meets eligibility criteria|0|||
130383074|NCT02554812|469370251|FG017|Overall Study|No longer meets eligibility criteria|0|||
130383075|NCT02554812|469370252|FG018|Overall Study|No longer meets eligibility criteria|0|||
130383076|NCT02554812|469370253|FG019|Overall Study|No longer meets eligibility criteria|0|||
130383077|NCT02554812|469370254|FG020|Overall Study|No longer meets eligibility criteria|0|||
130383078|NCT02554812|469370255|FG021|Overall Study|No longer meets eligibility criteria|0|||
130383079|NCT02554812|469370256|FG022|Overall Study|No longer meets eligibility criteria|0|||
130383080|NCT02554812|469370257|FG023|Overall Study|No longer meets eligibility criteria|0|||
130383081|NCT02554812|469370258|FG024|Overall Study|No longer meets eligibility criteria|0|||
130383082|NCT02554812|469370259|FG025|Overall Study|No longer meets eligibility criteria|0|||
130383083|NCT02554812|469370260|FG026|Overall Study|No longer meets eligibility criteria|0|||
130383084|NCT02081690|469372301|FG000|Overall Study|Death|3|||
130383085|NCT02081690|469372301|FG000|Overall Study|Physician Decision|3|||
130383086|NCT02081690|469372301|FG000|Overall Study|Withdrawal by Subject|1|||
130383087|NCT03204981|469372303|FG000|Overall Study|Physician Decision|2|||
130383088|NCT03204981|469372303|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
130383089|NCT00312494|469372306|FG000|Overall Study|Randomized; not treated with study drug|9|||
130383090|NCT00312494|469372307|FG001|Overall Study|Randomized; not treated with study drug|10|||
130383091|NCT00312494|469372308|FG002|Overall Study|Randomized; not treated with study drug|5|||
130383092|NCT00312494|469372306|FG000|Overall Study|Adverse Event|33|||
130383093|NCT00312494|469372307|FG001|Overall Study|Adverse Event|15|||
130383094|NCT00312494|469372308|FG002|Overall Study|Adverse Event|11|||
130383095|NCT00312494|469372306|FG000|Overall Study|Lack of Efficacy|4|||
130383096|NCT00312494|469372307|FG001|Overall Study|Lack of Efficacy|6|||
130383097|NCT00312494|469372308|FG002|Overall Study|Lack of Efficacy|8|||
130383098|NCT00312494|469372306|FG000|Overall Study|Laboratory abnormality|1|||
130383099|NCT00312494|469372307|FG001|Overall Study|Laboratory abnormality|0|||
130383100|NCT00312494|469372308|FG002|Overall Study|Laboratory abnormality|0|||
130383101|NCT00312494|469372306|FG000|Overall Study|Lost to Follow-up|8|||
130383102|NCT00312494|469372307|FG001|Overall Study|Lost to Follow-up|8|||
130383103|NCT00312494|469372308|FG002|Overall Study|Lost to Follow-up|8|||
130383104|NCT00312494|469372306|FG000|Overall Study|Withdrawal by Subject|6|||
130383105|NCT00312494|469372307|FG001|Overall Study|Withdrawal by Subject|9|||
130383106|NCT00312494|469372308|FG002|Overall Study|Withdrawal by Subject|10|||
130383107|NCT00312494|469372306|FG000|Overall Study|Other|10|||
130383108|NCT00312494|469372307|FG001|Overall Study|Other|10|||
130383109|NCT00312494|469372308|FG002|Overall Study|Other|1|||
130383110|NCT02734810|469372310|FG000|Overall Study|Adverse Event|1|||
130383111|NCT02734810|469372311|FG001|Overall Study|Adverse Event|0|||
130383112|NCT02734810|469372310|FG000|Overall Study|Lack of Efficacy|1|||
130383113|NCT02734810|469372311|FG001|Overall Study|Lack of Efficacy|0|||
130383114|NCT00488345|469372313|FG000|Overall Study|Adverse Event|0|||
130383115|NCT00488345|469372314|FG001|Overall Study|Adverse Event|1|||
130383116|NCT00488345|469372315|FG002|Overall Study|Adverse Event|1|||
130383117|NCT00488345|469372313|FG000|Overall Study|Unable to administer antibiotics at home|0|||
130383118|NCT00488345|469372314|FG001|Overall Study|Unable to administer antibiotics at home|1|||
130383119|NCT00488345|469372315|FG002|Overall Study|Unable to administer antibiotics at home|0|||
130383120|NCT00488345|469372313|FG000|Overall Study|Institutional Review Board review|0|||
130383121|NCT00488345|469372314|FG001|Overall Study|Institutional Review Board review|0|||
130383122|NCT00488345|469372315|FG002|Overall Study|Institutional Review Board review|1|||
130383123|NCT00488345|469372313|FG000|Overall Study|Surgical team recommendation|0|||
130383124|NCT00488345|469372314|FG001|Overall Study|Surgical team recommendation|1|||
130383125|NCT00488345|469372315|FG002|Overall Study|Surgical team recommendation|0|||
130383126|NCT00488345|469372313|FG000|Overall Study|Parent/legal guardian request|0|||
130383127|NCT00488345|469372314|FG001|Overall Study|Parent/legal guardian request|1|||
130722364|NCT01338870|470608232|FG004|Overall Study|Adverse Event|4|||
130722365|NCT01338870|470608233|FG005|Overall Study|Adverse Event|1|||
130383128|NCT00488345|469372315|FG002|Overall Study|Parent/legal guardian request|1|||
130383129|NCT00903617|469372321|FG000|Overall Study|Adverse Event|0|||
130383130|NCT00903617|469372322|FG001|Overall Study|Adverse Event|1|||
130383131|NCT00903617|469372323|FG002|Overall Study|Adverse Event|1|||
130383132|NCT00903617|469372324|FG003|Overall Study|Adverse Event|0|||
130383133|NCT00903617|469372321|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130383134|NCT00903617|469372322|FG001|Overall Study|Protocol-defined stopping criteria|2|||
130383135|NCT00903617|469372323|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130383136|NCT00903617|469372324|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130722366|NCT00077857|470608236|FG000|Overall Study|Adverse Event|30|||
130383137|NCT00903617|469372321|FG000|Overall Study|Lost to Follow-up|2|||
130383138|NCT00903617|469372322|FG001|Overall Study|Lost to Follow-up|0|||
130383139|NCT00903617|469372323|FG002|Overall Study|Lost to Follow-up|1|||
130383140|NCT00903617|469372324|FG003|Overall Study|Lost to Follow-up|1|||
130383141|NCT00903617|469372321|FG000|Overall Study|Withdrawal by Subject|1|||
130383142|NCT00903617|469372322|FG001|Overall Study|Withdrawal by Subject|2|||
130383143|NCT00903617|469372323|FG002|Overall Study|Withdrawal by Subject|3|||
130383144|NCT00903617|469372324|FG003|Overall Study|Withdrawal by Subject|0|||
130383145|NCT01104636|469372325|FG000|Overall Study|Lack of Efficacy|43|||
130383146|NCT01104636|469372325|FG000|Overall Study|Lost to Follow-up|24|||
130383147|NCT01104636|469372325|FG000|Overall Study|Withdrawal by Subject|4|||
130383148|NCT01104636|469372325|FG000|Overall Study|Other|43|||
130383149|NCT01104636|469372325|FG000|Overall Study|Study terminated by sponsor|1|||
130383150|NCT01104636|469372325|FG000|Overall Study|Pregnancy|2|||
130383151|NCT01104636|469372325|FG000|Overall Study|Adverse Event|40|||
130383152|NCT01104636|469372325|FG000|Overall Study|Ongoing|21|||
130383153|NCT01706003|469372326|FG000|Overall Study|Withdrawal by Subject|2|||
130383154|NCT01706003|469372327|FG001|Overall Study|Withdrawal by Subject|0|||
130383155|NCT01706003|469372326|FG000|Overall Study|Not scheduled|3|||
130383156|NCT01706003|469372327|FG001|Overall Study|Not scheduled|0|||
130383157|NCT01706003|469372326|FG000|Overall Study|Lost to Follow-up|6|||
130383158|NCT01706003|469372327|FG001|Overall Study|Lost to Follow-up|4|||
130383159|NCT00407563|469372328|FG000|Overall Study|Patient continues on treatment|1|||
130383160|NCT03055260|469372329|FG000|Overall Study|Withdrawal by Subject|1|||
130383161|NCT03055260|469372330|FG001|Overall Study|Withdrawal by Subject|0|||
130383162|NCT00592839|469372331|FG000|Overall Study|Withdrawal by Subject|1|||
130383163|NCT00592839|469372332|FG001|Overall Study|Withdrawal by Subject|1|||
130383164|NCT00592839|469372333|FG002|Overall Study|Withdrawal by Subject|3|||
130383165|NCT00592839|469372331|FG000|Overall Study|Protocol Violation|1|||
130383166|NCT00592839|469372332|FG001|Overall Study|Protocol Violation|1|||
130383167|NCT00592839|469372333|FG002|Overall Study|Protocol Violation|2|||
130383168|NCT00592839|469372331|FG000|Overall Study|Adverse Event|0|||
130383169|NCT00592839|469372332|FG001|Overall Study|Adverse Event|1|||
130383170|NCT00592839|469372333|FG002|Overall Study|Adverse Event|0|||
130383171|NCT00592839|469372331|FG000|Overall Study|Lost to Follow-up|0|||
130383172|NCT00592839|469372332|FG001|Overall Study|Lost to Follow-up|1|||
130383173|NCT00592839|469372333|FG002|Overall Study|Lost to Follow-up|1|||
130383174|NCT00249444|469372339|FG000|Overall Study|Lost to Follow-up|2|||
130383175|NCT00249444|469372340|FG001|Overall Study|Lost to Follow-up|2|||
130383176|NCT00249444|469372339|FG000|Overall Study|non-compliant|9|||
130383177|NCT00249444|469372340|FG001|Overall Study|non-compliant|11|||
130383178|NCT00249444|469372339|FG000|Overall Study|Adverse Event|1|||
130383179|NCT00249444|469372340|FG001|Overall Study|Adverse Event|1|||
130383180|NCT00249444|469372339|FG000|Overall Study|life event|0|||
130383181|NCT00249444|469372340|FG001|Overall Study|life event|1|||
130383182|NCT00936910|469372343|FG000|Overall Study|Lack of Efficacy|3|||
130383183|NCT00412854|469372344|FG000|Overall Study|Withdrawn due to adverse events|1|||
130383184|NCT00412854|469372345|FG001|Overall Study|Withdrawn due to adverse events|5|||
130383185|NCT00412854|469372344|FG000|Overall Study|Withdrawn for other reasons|13|||
130383186|NCT00412854|469372345|FG001|Overall Study|Withdrawn for other reasons|11|||
130383187|NCT04483011|469372349|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130383188|NCT04483011|469372350|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130383189|NCT03518073|469372351|FG000|Overall Study|Adverse Event|2|||
130383190|NCT03518073|469372352|FG001|Overall Study|Adverse Event|4|||
130383191|NCT03518073|469372353|FG002|Overall Study|Adverse Event|2|||
130383192|NCT03518073|469372351|FG000|Overall Study|Death|2|||
130383193|NCT03518073|469372352|FG001|Overall Study|Death|1|||
130383194|NCT03518073|469372353|FG002|Overall Study|Death|3|||
130383195|NCT03518073|469372351|FG000|Overall Study|Lost to Follow-up|1|||
130383196|NCT03518073|469372352|FG001|Overall Study|Lost to Follow-up|0|||
130383197|NCT03518073|469372353|FG002|Overall Study|Lost to Follow-up|1|||
130383198|NCT03518073|469372351|FG000|Overall Study|Physician Decision|5|||
130722367|NCT00077857|470608237|FG001|Overall Study|Adverse Event|32|||
130383199|NCT03518073|469372352|FG001|Overall Study|Physician Decision|0|||
130383200|NCT03518073|469372353|FG002|Overall Study|Physician Decision|2|||
130383201|NCT03518073|469372351|FG000|Overall Study|Progressive disease|1|||
130383202|NCT03518073|469372352|FG001|Overall Study|Progressive disease|1|||
130383203|NCT03518073|469372353|FG002|Overall Study|Progressive disease|1|||
130383204|NCT03518073|469372351|FG000|Overall Study|Protocol Violation|1|||
130722368|NCT00077857|470608236|FG000|Overall Study|Death|7|||
130722369|NCT00077857|470608237|FG001|Overall Study|Death|3|||
130722370|NCT00077857|470608236|FG000|Overall Study|Insufficient therapeutic response|112|||
130722371|NCT00077857|470608237|FG001|Overall Study|Insufficient therapeutic response|128|||
130383205|NCT03518073|469372352|FG001|Overall Study|Protocol Violation|0|||
130383206|NCT03518073|469372353|FG002|Overall Study|Protocol Violation|0|||
130383207|NCT03518073|469372351|FG000|Overall Study|Withdrawal by Subject|30|||
130383208|NCT03518073|469372352|FG001|Overall Study|Withdrawal by Subject|34|||
130383209|NCT03518073|469372353|FG002|Overall Study|Withdrawal by Subject|29|||
130468710|NCT03201562|469681753|FG002|Overall Study|Physician Decision|1|||
130383210|NCT03518073|469372351|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130383211|NCT03518073|469372352|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
130383212|NCT03518073|469372353|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
130383213|NCT03518073|469372351|FG000|Overall Study|Covid-19|1|||
130383214|NCT03518073|469372352|FG001|Overall Study|Covid-19|2|||
130383215|NCT03518073|469372353|FG002|Overall Study|Covid-19|1|||
130383216|NCT03045081|469372354|FG000|Overall Study|Withdrawal by Subject|6|||
130383217|NCT03045081|469372355|FG001|Overall Study|Withdrawal by Subject|11|||
130383218|NCT01485640|469372356|FG000|Overall Study|Adverse Event|10|||
130383219|NCT01485640|469372356|FG000|Overall Study|Lack of Efficacy|2|||
130383220|NCT01485640|469372356|FG000|Overall Study|Protocol Violation|1|||
130383221|NCT01485640|469372356|FG000|Overall Study|Withdrawal by Subject|14|||
130383222|NCT01485640|469372356|FG000|Overall Study|Terminated by Sponsor|95|||
130722372|NCT00077857|470608236|FG000|Overall Study|Violation of selection criteria at entry|3|||
130383223|NCT01853046|469372357|FG000|Overall Study|Withdrawal by Subject|1|||
130383224|NCT01853046|469372358|FG001|Overall Study|Withdrawal by Subject|1|||
130383225|NCT01853046|469372357|FG000|Overall Study|Adverse Event|4|||
130383226|NCT01853046|469372358|FG001|Overall Study|Adverse Event|2|||
130383227|NCT01853046|469372357|FG000|Overall Study|Disease progression|13|||
130383228|NCT01853046|469372358|FG001|Overall Study|Disease progression|3|||
130383229|NCT02057198|469372364|FG000|Overall Study|Death|0|||
130383230|NCT02057198|469372365|FG001|Overall Study|Death|0|||
130383231|NCT02057198|469372366|FG002|Overall Study|Death|1|||
130383232|NCT02057198|469372364|FG000|Overall Study|Discharged early; lost to followup|0|||
130383233|NCT02057198|469372365|FG001|Overall Study|Discharged early; lost to followup|1|||
130383234|NCT02057198|469372366|FG002|Overall Study|Discharged early; lost to followup|0|||
130383235|NCT02489344|469372371|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
130383236|NCT02489344|469372371|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
130383237|NCT02489344|469372371|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
130383238|NCT02489344|469372371|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
130383239|NCT00546637|469372374|FG000|Overall Study|Adverse Event|46|||
130383240|NCT00546637|469372375|FG001|Overall Study|Adverse Event|20|||
130383241|NCT00546637|469372374|FG000|Overall Study|Lack of Efficacy|5|||
130383242|NCT00546637|469372375|FG001|Overall Study|Lack of Efficacy|5|||
130383243|NCT00546637|469372374|FG000|Overall Study|Lost to Follow-up|2|||
130383244|NCT00546637|469372375|FG001|Overall Study|Lost to Follow-up|2|||
130383245|NCT00546637|469372374|FG000|Overall Study|Other|10|||
130383246|NCT00546637|469372375|FG001|Overall Study|Other|12|||
130383247|NCT00546637|469372374|FG000|Overall Study|Withdrawal by Subject|7|||
130383248|NCT00546637|469372375|FG001|Overall Study|Withdrawal by Subject|9|||
130383249|NCT00546637|469372374|FG000|Overall Study|Randomized, but not treated|3|||
130383250|NCT00546637|469372375|FG001|Overall Study|Randomized, but not treated|1|||
130383251|NCT01074450|469372376|FG000|First Intervention|Emesis in Dosing Interval|0|||
130383252|NCT01074450|469372377|FG001|First Intervention|Emesis in Dosing Interval|2|||
130383253|NCT01074450|469372376|FG000|Second Intervention|Protocol Violation|1|||
130383254|NCT01074450|469372377|FG001|Second Intervention|Protocol Violation|0|||
130383255|NCT01074450|469372376|FG000|Second Intervention|Physician Decision|0|||
130383256|NCT01074450|469372377|FG001|Second Intervention|Physician Decision|1|||
130383257|NCT00680745|469372378|FG000|Overall Study|Withdrawal by Subject|8|||
130383258|NCT00680745|469372379|FG001|Overall Study|Withdrawal by Subject|3|||
130383259|NCT00680745|469372380|FG002|Overall Study|Withdrawal by Subject|2|||
130383260|NCT00680745|469372381|FG003|Overall Study|Withdrawal by Subject|8|||
130383261|NCT00680745|469372378|FG000|Overall Study|Lost to Follow-up|0|||
130383262|NCT00680745|469372379|FG001|Overall Study|Lost to Follow-up|1|||
130383263|NCT00680745|469372380|FG002|Overall Study|Lost to Follow-up|1|||
130383264|NCT00680745|469372381|FG003|Overall Study|Lost to Follow-up|0|||
130383265|NCT00680745|469372378|FG000|Overall Study|Death|1|||
130383266|NCT00680745|469372379|FG001|Overall Study|Death|0|||
130383267|NCT00680745|469372380|FG002|Overall Study|Death|1|||
130383268|NCT00680745|469372381|FG003|Overall Study|Death|0|||
130383269|NCT00680745|469372378|FG000|Overall Study|Adverse Event|5|||
130722373|NCT00077857|470608237|FG001|Overall Study|Violation of selection criteria at entry|1|||
130383270|NCT00680745|469372379|FG001|Overall Study|Adverse Event|3|||
130383271|NCT00680745|469372380|FG002|Overall Study|Adverse Event|3|||
130383272|NCT00680745|469372381|FG003|Overall Study|Adverse Event|3|||
130383273|NCT00680745|469372378|FG000|Overall Study|Poor/Non-compliance|0|||
130383274|NCT00680745|469372379|FG001|Overall Study|Poor/Non-compliance|3|||
130383275|NCT00680745|469372380|FG002|Overall Study|Poor/Non-compliance|0|||
130383276|NCT00680745|469372381|FG003|Overall Study|Poor/Non-compliance|0|||
130383277|NCT00680745|469372378|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130383278|NCT00680745|469372379|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130383279|NCT00680745|469372380|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130383280|NCT00680745|469372381|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
130383281|NCT00680745|469372378|FG000|Overall Study|False Treatment|0|||
130383282|NCT00680745|469372379|FG001|Overall Study|False Treatment|1|||
130383283|NCT00680745|469372380|FG002|Overall Study|False Treatment|3|||
130383284|NCT00680745|469372381|FG003|Overall Study|False Treatment|0|||
130383285|NCT02612428|469372382|FG000|VTL-308|Death|14|||
130383286|NCT02612428|469372383|FG001|VTL-308|Death|16|||
130383287|NCT02612428|469372382|FG000|VTL-308|Withdrawal by Subject|0|||
130383288|NCT02612428|469372383|FG001|VTL-308|Withdrawal by Subject|1|||
130383289|NCT02612428|469372382|FG000|VTL-308E|Death|9|||
130383290|NCT02612428|469372383|FG001|VTL-308E|Death|7|||
130383291|NCT02612428|469372382|FG000|VTL-308E|Lost to Follow-up|2|||
130383292|NCT02612428|469372383|FG001|VTL-308E|Lost to Follow-up|0|||
130383293|NCT00742001|469372384|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
130383294|NCT00742001|469372385|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
130383295|NCT00742001|469372386|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
130383296|NCT00137423|469372387|FG000|Overall Study|Adverse Event|7|||
130383297|NCT00137423|469372388|FG001|Overall Study|Adverse Event|9|||
130722374|NCT00077857|470608236|FG000|Overall Study|Other protocol violation|0|||
130722375|NCT00077857|470608237|FG001|Overall Study|Other protocol violation|1|||
130722376|NCT00077857|470608236|FG000|Overall Study|Refused treatment|29|||
130383298|NCT00137423|469372387|FG000|Overall Study|consent withdrawn|1|||
130383299|NCT00137423|469372388|FG001|Overall Study|consent withdrawn|1|||
130383300|NCT00137423|469372387|FG000|Overall Study|Lack of Efficacy|31|||
130383301|NCT00137423|469372388|FG001|Overall Study|Lack of Efficacy|33|||
130383302|NCT00137423|469372387|FG000|Overall Study|Death|0|||
130383303|NCT00137423|469372388|FG001|Overall Study|Death|1|||
130383304|NCT01928329|469372389|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
130383305|NCT01928329|469372390|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
130383306|NCT01928329|469372389|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
130383307|NCT01928329|469372390|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
130383308|NCT01928329|469372389|FG000|Overall Study|Adverse Event|5|||
130383309|NCT01928329|469372390|FG001|Overall Study|Adverse Event|3|||
130383310|NCT01928329|469372389|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
130383311|NCT01928329|469372390|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
130383312|NCT01928329|469372389|FG000|Overall Study|Withdrawal by Subject|1|||
130383313|NCT01928329|469372390|FG001|Overall Study|Withdrawal by Subject|5|||
130383314|NCT01928329|469372389|FG000|Overall Study|Physician Decision|1|||
130383315|NCT01928329|469372390|FG001|Overall Study|Physician Decision|1|||
130383316|NCT03187262|469372391|FG000|Induction|Lack of Efficacy|2|||
130383317|NCT03187262|469372391|FG000|Induction|Progressive Disease|4|||
130383318|NCT03187262|469372391|FG000|Consolidation|Progressive Disease|5|||
130383319|NCT02617511|469372393|FG000|Overall Study|Withdrawal by Subject|1|||
130383320|NCT02617511|469372394|FG001|Overall Study|Withdrawal by Subject|0|||
130383321|NCT00909389|469372397|FG000|Overall Study|Adverse Event|6|||
130383322|NCT00909389|469372397|FG000|Overall Study|Death|4|||
130383323|NCT00909389|469372397|FG000|Overall Study|Poor Compliance|16|||
130383324|NCT00909389|469372397|FG000|Overall Study|Lost to Follow-up|4|||
130383325|NCT00909389|469372397|FG000|Overall Study|No Information|103|||
130383326|NCT00003492|469372398|FG000|Overall Study|Not evaluable|6|||
130383327|NCT00597766|469372401|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
130383328|NCT00597766|469372402|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
130383329|NCT00597766|469372403|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
130383330|NCT00597766|469372401|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
130383331|NCT00597766|469372402|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
130383332|NCT00597766|469372403|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
130383333|NCT00737282|469372405|FG000|Overall Study|Study prematurely terminated|175|||
130383334|NCT02810392|469372407|FG000|Overall Study|Subject too ill to continue|1|||
130383335|NCT02810392|469372408|FG001|Overall Study|Subject too ill to continue|0|||
130383336|NCT02810392|469372407|FG000|Overall Study|COVID 19 research restrictions|0|||
130383337|NCT02810392|469372408|FG001|Overall Study|COVID 19 research restrictions|1|||
130383338|NCT00840294|469372409|FG000|Overall Study|Withdrawal by Subject|2|||
130383339|NCT00840294|469372410|FG001|Overall Study|Withdrawal by Subject|1|||
130383340|NCT00840294|469372409|FG000|Overall Study|Protocol Violation|1|||
130383341|NCT00840294|469372410|FG001|Overall Study|Protocol Violation|3|||
130383342|NCT00840294|469372409|FG000|Overall Study|Illness|0|||
130383343|NCT00840294|469372410|FG001|Overall Study|Illness|1|||
130383344|NCT00453544|469372413|FG000|Overall Study|Withdrawal by Subject|1|||
130383345|NCT00453544|469372414|FG001|Overall Study|Withdrawal by Subject|0|||
130383346|NCT00453544|469372415|FG002|Overall Study|Withdrawal by Subject|0|||
130383347|NCT00453544|469372416|FG003|Overall Study|Withdrawal by Subject|0|||
130722377|NCT00077857|470608237|FG001|Overall Study|Refused treatment|21|||
130383348|NCT00453544|469372413|FG000|Overall Study|Primary outcome measure not completed|1|||
130383349|NCT00453544|469372414|FG001|Overall Study|Primary outcome measure not completed|1|||
130383350|NCT00453544|469372415|FG002|Overall Study|Primary outcome measure not completed|0|||
130383351|NCT00453544|469372416|FG003|Overall Study|Primary outcome measure not completed|1|||
130383352|NCT02457910|469372417|FG000|Overall Study|Withdrawal by Subject|0|||
130383353|NCT02457910|469372418|FG001|Overall Study|Withdrawal by Subject|0|||
130383354|NCT02457910|469372419|FG002|Overall Study|Withdrawal by Subject|0|||
130383355|NCT02457910|469372420|FG003|Overall Study|Withdrawal by Subject|0|||
130383356|NCT02457910|469372421|FG004|Overall Study|Withdrawal by Subject|0|||
130722378|NCT00077857|470608236|FG000|Overall Study|Failure to return|5|||
130383357|NCT02457910|469372422|FG005|Overall Study|Withdrawal by Subject|1|||
130383358|NCT02457910|469372417|FG000|Overall Study|Adverse Event|0|||
130383359|NCT02457910|469372418|FG001|Overall Study|Adverse Event|2|||
130383360|NCT02457910|469372419|FG002|Overall Study|Adverse Event|1|||
130383361|NCT02457910|469372420|FG003|Overall Study|Adverse Event|1|||
130383362|NCT02457910|469372421|FG004|Overall Study|Adverse Event|1|||
130383363|NCT02457910|469372422|FG005|Overall Study|Adverse Event|3|||
130383364|NCT02457910|469372417|FG000|Overall Study|Disease progression|3|||
130383365|NCT02457910|469372418|FG001|Overall Study|Disease progression|3|||
130468711|NCT03201562|469681751|FG000|Overall Study|Adverse Event|0|||
130468712|NCT03201562|469681752|FG001|Overall Study|Adverse Event|0|||
130468713|NCT03201562|469681753|FG002|Overall Study|Adverse Event|1|||
130468714|NCT03201562|469681751|FG000|Overall Study|Lost to Follow-up|0|||
130468715|NCT03201562|469681752|FG001|Overall Study|Lost to Follow-up|1|||
130468716|NCT03201562|469681753|FG002|Overall Study|Lost to Follow-up|2|||
130468717|NCT00393484|469681754|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
130468718|NCT00393484|469681755|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
130468719|NCT00393484|469681754|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
130468720|NCT00393484|469681755|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
130468721|NCT00393484|469681754|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
130468722|NCT00393484|469681755|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
130468723|NCT00393484|469681754|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
130468724|NCT00393484|469681755|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
130468725|NCT00393484|469681754|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
130468726|NCT00393484|469681755|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
130468727|NCT00393484|469681754|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
130468728|NCT00393484|469681755|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
130468729|NCT00393484|469681754|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
130468730|NCT00393484|469681755|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
130468731|NCT00393484|469681754|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
130468732|NCT00393484|469681755|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
130468733|NCT00393484|469681754|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
130468734|NCT00393484|469681755|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
130468735|NCT00393484|469681754|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
130468736|NCT00393484|469681755|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
130468737|NCT02556138|469681761|FG000|Overall Study|Withdrawal by Subject|1|||
130468738|NCT04939246|469681762|FG000|After Treatment|Death|4|||
130468739|NCT04939246|469681762|FG000|After Treatment|Lost to Follow-up|1|||
130468740|NCT04939246|469681762|FG000|After Treatment|Discharged to hospice|2|||
130468741|NCT04994509|469681763|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
130468742|NCT04994509|469681764|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
130468743|NCT04994509|469681765|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
130468744|NCT04994509|469681763|FG000|Overall Study|Withdrew Consent|73|||
130468745|NCT04994509|469681764|FG001|Overall Study|Withdrew Consent|72|||
130468746|NCT04994509|469681765|FG002|Overall Study|Withdrew Consent|46|||
130468747|NCT04994509|469681763|FG000|Overall Study|Lost to Follow-up|39|||
130468748|NCT04994509|469681764|FG001|Overall Study|Lost to Follow-up|36|||
130468749|NCT04994509|469681765|FG002|Overall Study|Lost to Follow-up|26|||
130468750|NCT04994509|469681763|FG000|Overall Study|HIV-1 Infection|4|||
130468751|NCT04994509|469681764|FG001|Overall Study|HIV-1 Infection|20|||
130468752|NCT04994509|469681765|FG002|Overall Study|HIV-1 Infection|12|||
130468753|NCT04994509|469681763|FG000|Overall Study|Investigator's Discretion|9|||
130468754|NCT04994509|469681764|FG001|Overall Study|Investigator's Discretion|8|||
130468755|NCT04994509|469681765|FG002|Overall Study|Investigator's Discretion|11|||
130468756|NCT04994509|469681763|FG000|Overall Study|Randomized but Never Treated|10|||
130468757|NCT04994509|469681764|FG001|Overall Study|Randomized but Never Treated|10|||
130468758|NCT04994509|469681765|FG002|Overall Study|Randomized but Never Treated|3|||
130468759|NCT04994509|469681763|FG000|Overall Study|Pregnancy|5|||
130468760|NCT04994509|469681764|FG001|Overall Study|Pregnancy|5|||
130468761|NCT04994509|469681765|FG002|Overall Study|Pregnancy|0|||
130468762|NCT04994509|469681763|FG000|Overall Study|Death|0|||
130383366|NCT02457910|469372419|FG002|Overall Study|Disease progression|1|||
130383367|NCT02457910|469372420|FG003|Overall Study|Disease progression|1|||
130468763|NCT04994509|469681764|FG001|Overall Study|Death|5|||
130468764|NCT04994509|469681765|FG002|Overall Study|Death|0|||
130468765|NCT04994509|469681763|FG000|Overall Study|Adverse Event|2|||
130468766|NCT04994509|469681764|FG001|Overall Study|Adverse Event|1|||
130468767|NCT04994509|469681765|FG002|Overall Study|Adverse Event|0|||
130468768|NCT04994509|469681763|FG000|Overall Study|Non-compliance With Study Drug|1|||
130383368|NCT02457910|469372421|FG004|Overall Study|Disease progression|4|||
130383369|NCT02457910|469372422|FG005|Overall Study|Disease progression|6|||
130383370|NCT02457910|469372417|FG000|Overall Study|Other complicating illness|0|||
130383371|NCT02457910|469372418|FG001|Overall Study|Other complicating illness|0|||
130383372|NCT02457910|469372419|FG002|Overall Study|Other complicating illness|0|||
130383373|NCT02457910|469372420|FG003|Overall Study|Other complicating illness|0|||
130383374|NCT02457910|469372421|FG004|Overall Study|Other complicating illness|0|||
130383375|NCT02457910|469372422|FG005|Overall Study|Other complicating illness|1|||
130383376|NCT02457910|469372417|FG000|Overall Study|Death|0|||
130383377|NCT02457910|469372418|FG001|Overall Study|Death|0|||
130383378|NCT02457910|469372419|FG002|Overall Study|Death|1|||
130383379|NCT02457910|469372420|FG003|Overall Study|Death|0|||
130383380|NCT02457910|469372421|FG004|Overall Study|Death|0|||
130383381|NCT02457910|469372422|FG005|Overall Study|Death|0|||
130383382|NCT00619801|469372425|FG000|Overall Study|Lack of Efficacy|0|||
130383383|NCT00619801|469372426|FG001|Overall Study|Lack of Efficacy|1|||
130383384|NCT00619801|469372425|FG000|Overall Study|Withdrawal by Subject|1|||
130383385|NCT00619801|469372426|FG001|Overall Study|Withdrawal by Subject|1|||
130383386|NCT00619801|469372425|FG000|Overall Study|Loss of efficacy|0|||
130383387|NCT00619801|469372426|FG001|Overall Study|Loss of efficacy|1|||
130383388|NCT03721276|469372427|FG000|Overall Study|Lost to Follow-up|5|||
130383389|NCT03721276|469372428|FG001|Overall Study|Lost to Follow-up|3|||
130383390|NCT03721276|469372427|FG000|Overall Study|Adverse Event|0|||
130383391|NCT03721276|469372428|FG001|Overall Study|Adverse Event|1|||
130383392|NCT01340898|469372429|FG000|Primary Phase|Serious Adverse Events|0|||
130383393|NCT01340898|469372430|FG001|Primary Phase|Serious Adverse Events|0|||
130383394|NCT01340898|469372431|FG002|Primary Phase|Serious Adverse Events|1|||
130383395|NCT01340898|469372429|FG000|Primary Phase|Withdrawal by Subject|8|||
130383396|NCT01340898|469372430|FG001|Primary Phase|Withdrawal by Subject|7|||
130383397|NCT01340898|469372431|FG002|Primary Phase|Withdrawal by Subject|5|||
130383398|NCT01340898|469372429|FG000|Primary Phase|Migrated/moved from study area|4|||
130383399|NCT01340898|469372430|FG001|Primary Phase|Migrated/moved from study area|1|||
130383400|NCT01340898|469372431|FG002|Primary Phase|Migrated/moved from study area|0|||
130383401|NCT01340898|469372429|FG000|Primary Phase|Lost to Follow-up|4|||
130383402|NCT01340898|469372430|FG001|Primary Phase|Lost to Follow-up|1|||
130383403|NCT01340898|469372431|FG002|Primary Phase|Lost to Follow-up|0|||
130383404|NCT01340898|469372429|FG000|Booster Phase|Withdrawal by Subject|3|||
130383405|NCT01340898|469372430|FG001|Booster Phase|Withdrawal by Subject|0|||
130383406|NCT01340898|469372431|FG002|Booster Phase|Withdrawal by Subject|4|||
130383407|NCT01340898|469372429|FG000|Booster Phase|Migrated/moved from study area|3|||
130383408|NCT01340898|469372430|FG001|Booster Phase|Migrated/moved from study area|0|||
130383409|NCT01340898|469372431|FG002|Booster Phase|Migrated/moved from study area|0|||
130383410|NCT01340898|469372429|FG000|Booster Phase|Lost to Follow-up|4|||
130383411|NCT01340898|469372430|FG001|Booster Phase|Lost to Follow-up|2|||
130383412|NCT01340898|469372431|FG002|Booster Phase|Lost to Follow-up|3|||
130383413|NCT01214629|469372433|FG000|Overall Study|Progressive Disease|1|||
130383414|NCT01214629|469372434|FG001|Overall Study|Progressive Disease|1|||
130383415|NCT01214629|469372435|FG002|Overall Study|Progressive Disease|0|||
130383416|NCT01214629|469372436|FG003|Overall Study|Progressive Disease|1|||
130383417|NCT01214629|469372437|FG004|Overall Study|Progressive Disease|2|||
130383418|NCT01214629|469372438|FG005|Overall Study|Progressive Disease|3|||
130383419|NCT01214629|469372439|FG006|Overall Study|Progressive Disease|1|||
130383420|NCT01214629|469372440|FG007|Overall Study|Progressive Disease|1|||
130383421|NCT01214629|469372441|FG008|Overall Study|Progressive Disease|1|||
130383422|NCT01214629|469372442|FG009|Overall Study|Progressive Disease|5|||
130468769|NCT04994509|469681764|FG001|Overall Study|Non-compliance With Study Drug|1|||
130468770|NCT04994509|469681765|FG002|Overall Study|Non-compliance With Study Drug|1|||
130722379|NCT00077857|470608237|FG001|Overall Study|Failure to return|5|||
130722380|NCT00077857|470608236|FG000|Overall Study|Other|15|||
130722381|NCT00077857|470608237|FG001|Overall Study|Other|13|||
130722382|NCT00423319|470608238|FG000|Overall Study|Death|2|||
130383423|NCT01214629|469372443|FG010|Overall Study|Progressive Disease|1|||
130383424|NCT01214629|469372433|FG000|Overall Study|Adverse Event|0|||
130468771|NCT04994509|469681763|FG000|Overall Study|Withdrew Assent|3|||
130468772|NCT04994509|469681764|FG001|Overall Study|Withdrew Assent|0|||
130383425|NCT01214629|469372434|FG001|Overall Study|Adverse Event|0|||
130383426|NCT01214629|469372435|FG002|Overall Study|Adverse Event|0|||
130468773|NCT04994509|469681765|FG002|Overall Study|Withdrew Assent|0|||
130468774|NCT04994509|469681763|FG000|Overall Study|Protocol Violation|1|||
130383427|NCT01214629|469372436|FG003|Overall Study|Adverse Event|1|||
130383428|NCT01214629|469372437|FG004|Overall Study|Adverse Event|0|||
130383429|NCT01214629|469372438|FG005|Overall Study|Adverse Event|1|||
130383430|NCT01214629|469372439|FG006|Overall Study|Adverse Event|0|||
130383431|NCT01214629|469372440|FG007|Overall Study|Adverse Event|0|||
130383432|NCT01214629|469372441|FG008|Overall Study|Adverse Event|0|||
130383433|NCT01214629|469372442|FG009|Overall Study|Adverse Event|1|||
130383434|NCT01214629|469372443|FG010|Overall Study|Adverse Event|0|||
130468775|NCT04994509|469681764|FG001|Overall Study|Protocol Violation|0|||
130383435|NCT01214629|469372433|FG000|Overall Study|Physician Decision|0|||
130383436|NCT01214629|469372434|FG001|Overall Study|Physician Decision|0|||
130383437|NCT01214629|469372435|FG002|Overall Study|Physician Decision|0|||
130383438|NCT01214629|469372436|FG003|Overall Study|Physician Decision|0|||
130383439|NCT01214629|469372437|FG004|Overall Study|Physician Decision|0|||
130383440|NCT01214629|469372438|FG005|Overall Study|Physician Decision|0|||
130383441|NCT01214629|469372439|FG006|Overall Study|Physician Decision|0|||
130383442|NCT01214629|469372440|FG007|Overall Study|Physician Decision|0|||
130383443|NCT01214629|469372441|FG008|Overall Study|Physician Decision|0|||
130383444|NCT01214629|469372442|FG009|Overall Study|Physician Decision|0|||
130383445|NCT01214629|469372443|FG010|Overall Study|Physician Decision|1|||
130383446|NCT01214629|469372433|FG000|Overall Study|Withdrawal by Subject|0|||
130383447|NCT01214629|469372434|FG001|Overall Study|Withdrawal by Subject|0|||
130383448|NCT01214629|469372435|FG002|Overall Study|Withdrawal by Subject|0|||
130383449|NCT01214629|469372436|FG003|Overall Study|Withdrawal by Subject|0|||
130383450|NCT01214629|469372437|FG004|Overall Study|Withdrawal by Subject|0|||
130383451|NCT01214629|469372438|FG005|Overall Study|Withdrawal by Subject|0|||
130383452|NCT01214629|469372439|FG006|Overall Study|Withdrawal by Subject|0|||
130383453|NCT01214629|469372440|FG007|Overall Study|Withdrawal by Subject|0|||
130383454|NCT01214629|469372441|FG008|Overall Study|Withdrawal by Subject|0|||
130383455|NCT01214629|469372442|FG009|Overall Study|Withdrawal by Subject|1|||
130383456|NCT01214629|469372443|FG010|Overall Study|Withdrawal by Subject|0|||
130383457|NCT01829230|469372444|FG000|Overall Study|Protocol Violation|0|||
130383458|NCT01829230|469372445|FG001|Overall Study|Protocol Violation|2|||
130383459|NCT01829230|469372444|FG000|Overall Study|Withdrawal by Subject|0|||
130383460|NCT01829230|469372445|FG001|Overall Study|Withdrawal by Subject|1|||
130383461|NCT01829230|469372444|FG000|Overall Study|Lost to Follow-up|1|||
130383462|NCT01829230|469372445|FG001|Overall Study|Lost to Follow-up|1|||
130383463|NCT04501666|469372446|FG000|Overall Study|Physician Decision|0|||
130383464|NCT04501666|469372447|FG001|Overall Study|Physician Decision|1|||
130383465|NCT04501666|469372446|FG000|Overall Study|Adverse Event|12|||
130383466|NCT04501666|469372447|FG001|Overall Study|Adverse Event|4|||
130383467|NCT04501666|469372446|FG000|Overall Study|Subject's request|10|||
130383468|NCT04501666|469372447|FG001|Overall Study|Subject's request|6|||
130383469|NCT04501666|469372446|FG000|Overall Study|Protocol Deviation|2|||
130383470|NCT04501666|469372447|FG001|Overall Study|Protocol Deviation|1|||
130383471|NCT04501666|469372446|FG000|Overall Study|Other-- site permanently closing|0|||
130383472|NCT04501666|469372447|FG001|Overall Study|Other-- site permanently closing|1|||
130383473|NCT03021265|469372448|FG000|Overall Study|Adverse Event|29|||
130383474|NCT03021265|469372448|FG000|Overall Study|Lack of Efficacy|3|||
130383475|NCT03021265|469372448|FG000|Overall Study|Improved|17|||
130383476|NCT03021265|469372448|FG000|Overall Study|Lost to Follow-up|67|||
130383477|NCT03021265|469372448|FG000|Overall Study|No reason given|2|||
130383478|NCT03021265|469372448|FG000|Overall Study|No visit since the first visit|4|||
130383479|NCT00642941|469372449|FG000|Overall Study|Physician Decision|3|||
130383480|NCT00642941|469372450|FG001|Overall Study|Physician Decision|1|||
130383481|NCT00642941|469372451|FG002|Overall Study|Physician Decision|0|||
130383482|NCT00642941|469372452|FG003|Overall Study|Physician Decision|0|||
130383483|NCT00642941|469372453|FG004|Overall Study|Physician Decision|0|||
130383484|NCT00642941|469372454|FG005|Overall Study|Physician Decision|0|||
130383485|NCT00642941|469372455|FG006|Overall Study|Physician Decision|1|||
130383486|NCT00642941|469372456|FG007|Overall Study|Physician Decision|0|||
130383487|NCT00642941|469372457|FG008|Overall Study|Physician Decision|0|||
130383488|NCT00642941|469372458|FG009|Overall Study|Physician Decision|1|||
130383489|NCT00642941|469372459|FG010|Overall Study|Physician Decision|0|||
130383490|NCT00642941|469372460|FG011|Overall Study|Physician Decision|1|||
130383491|NCT00642941|469372449|FG000|Overall Study|Death|4|||
130383492|NCT00642941|469372450|FG001|Overall Study|Death|0|||
130383493|NCT00642941|469372451|FG002|Overall Study|Death|1|||
130468776|NCT04994509|469681765|FG002|Overall Study|Protocol Violation|0|||
130468777|NCT01643070|469683540|FG000|Overall Study|Withdrawal by Subject|3|||
130383494|NCT00642941|469372452|FG003|Overall Study|Death|1|||
130383495|NCT00642941|469372453|FG004|Overall Study|Death|2|||
130383496|NCT00642941|469372454|FG005|Overall Study|Death|1|||
130383497|NCT00642941|469372455|FG006|Overall Study|Death|0|||
130383498|NCT00642941|469372456|FG007|Overall Study|Death|0|||
130383499|NCT00642941|469372457|FG008|Overall Study|Death|0|||
130383500|NCT00642941|469372458|FG009|Overall Study|Death|0|||
130468778|NCT01643070|469683541|FG001|Overall Study|Withdrawal by Subject|1|||
130468779|NCT01643070|469683540|FG000|Overall Study|Death|1|||
130468780|NCT01643070|469683541|FG001|Overall Study|Death|0|||
130468781|NCT01643070|469683540|FG000|Overall Study|Pregressive disease|0|||
130383501|NCT00642941|469372459|FG010|Overall Study|Death|0|||
130383502|NCT00642941|469372460|FG011|Overall Study|Death|1|||
130383503|NCT00642941|469372449|FG000|Overall Study|Study closed by Sponsor|0|||
130383504|NCT00642941|469372450|FG001|Overall Study|Study closed by Sponsor|1|||
130383505|NCT00642941|469372451|FG002|Overall Study|Study closed by Sponsor|0|||
130383506|NCT00642941|469372452|FG003|Overall Study|Study closed by Sponsor|0|||
130383507|NCT00642941|469372453|FG004|Overall Study|Study closed by Sponsor|0|||
130383508|NCT00642941|469372454|FG005|Overall Study|Study closed by Sponsor|0|||
130383509|NCT00642941|469372455|FG006|Overall Study|Study closed by Sponsor|0|||
130383510|NCT00642941|469372456|FG007|Overall Study|Study closed by Sponsor|0|||
130468782|NCT01643070|469683541|FG001|Overall Study|Pregressive disease|2|||
130468783|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
130468784|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
130468785|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
130468786|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
130468787|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
130468788|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
130468789|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
130468790|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
130468791|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
130468792|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
130468793|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
130468794|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
130468795|NCT01600014|469683542|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
130468796|NCT01600014|469683543|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
130468797|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
130468798|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
130383511|NCT00642941|469372457|FG008|Overall Study|Study closed by Sponsor|0|||
130383512|NCT00642941|469372458|FG009|Overall Study|Study closed by Sponsor|0|||
130383513|NCT00642941|469372459|FG010|Overall Study|Study closed by Sponsor|0|||
130383514|NCT00642941|469372460|FG011|Overall Study|Study closed by Sponsor|0|||
130383515|NCT00642941|469372449|FG000|Overall Study|Withdrawal by Subject|1|||
130383516|NCT00642941|469372450|FG001|Overall Study|Withdrawal by Subject|0|||
130383517|NCT00642941|469372451|FG002|Overall Study|Withdrawal by Subject|0|||
130383518|NCT00642941|469372452|FG003|Overall Study|Withdrawal by Subject|2|||
130383519|NCT00642941|469372453|FG004|Overall Study|Withdrawal by Subject|0|||
130383520|NCT00642941|469372454|FG005|Overall Study|Withdrawal by Subject|0|||
130383521|NCT00642941|469372455|FG006|Overall Study|Withdrawal by Subject|2|||
130383522|NCT00642941|469372456|FG007|Overall Study|Withdrawal by Subject|0|||
130383523|NCT00642941|469372457|FG008|Overall Study|Withdrawal by Subject|1|||
130383524|NCT00642941|469372458|FG009|Overall Study|Withdrawal by Subject|0|||
130383525|NCT00642941|469372459|FG010|Overall Study|Withdrawal by Subject|0|||
130383526|NCT00642941|469372460|FG011|Overall Study|Withdrawal by Subject|1|||
130383527|NCT00642941|469372449|FG000|Overall Study|Protocol Violation|0|||
130383528|NCT00642941|469372450|FG001|Overall Study|Protocol Violation|0|||
130383529|NCT00642941|469372451|FG002|Overall Study|Protocol Violation|0|||
130383530|NCT00642941|469372452|FG003|Overall Study|Protocol Violation|0|||
130383531|NCT00642941|469372453|FG004|Overall Study|Protocol Violation|0|||
130383532|NCT00642941|469372454|FG005|Overall Study|Protocol Violation|0|||
130383533|NCT00642941|469372455|FG006|Overall Study|Protocol Violation|1|||
130383534|NCT00642941|469372456|FG007|Overall Study|Protocol Violation|0|||
130383535|NCT00642941|469372457|FG008|Overall Study|Protocol Violation|0|||
130383536|NCT00642941|469372458|FG009|Overall Study|Protocol Violation|0|||
130383537|NCT00642941|469372459|FG010|Overall Study|Protocol Violation|0|||
130383538|NCT00642941|469372460|FG011|Overall Study|Protocol Violation|0|||
130383539|NCT00642941|469372449|FG000|Overall Study|Adverse Event|1|||
130383540|NCT00642941|469372450|FG001|Overall Study|Adverse Event|1|||
130468799|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
130468800|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
130468801|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
130468802|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
130468803|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
130468804|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
130468805|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
130468806|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
130468807|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
130468808|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
130468809|NCT01600014|469683542|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
130559679|NCT01970488|470017847|FG001|Part 2: Post Week 16|Non-compliance|0|||
130722383|NCT00423319|470608239|FG001|Overall Study|Death|0|||
130722384|NCT00423319|470608238|FG000|Overall Study|Adverse Event|93|||
130722385|NCT00423319|470608239|FG001|Overall Study|Adverse Event|112|||
130383541|NCT00642941|469372451|FG002|Overall Study|Adverse Event|0|||
130722386|NCT00423319|470608238|FG000|Overall Study|Withdrawal by Subject|86|||
130383542|NCT00642941|469372452|FG003|Overall Study|Adverse Event|0|||
130383543|NCT00642941|469372453|FG004|Overall Study|Adverse Event|0|||
130559680|NCT01970488|470017848|FG002|Part 2: Post Week 16|Non-compliance|1|||
130722387|NCT00423319|470608239|FG001|Overall Study|Withdrawal by Subject|99|||
130722388|NCT00423319|470608238|FG000|Overall Study|Lost to Follow-up|4|||
130383544|NCT00642941|469372454|FG005|Overall Study|Adverse Event|0|||
130383545|NCT00642941|469372455|FG006|Overall Study|Adverse Event|1|||
130383546|NCT00642941|469372456|FG007|Overall Study|Adverse Event|1|||
130383547|NCT00642941|469372457|FG008|Overall Study|Adverse Event|0|||
130383548|NCT00642941|469372458|FG009|Overall Study|Adverse Event|1|||
130383549|NCT00642941|469372459|FG010|Overall Study|Adverse Event|0|||
130383550|NCT00642941|469372460|FG011|Overall Study|Adverse Event|0|||
130383551|NCT00642941|469372449|FG000|Overall Study|Other|1|||
130383552|NCT00642941|469372450|FG001|Overall Study|Other|1|||
130383553|NCT00642941|469372451|FG002|Overall Study|Other|1|||
130383554|NCT00642941|469372452|FG003|Overall Study|Other|1|||
130383555|NCT00642941|469372453|FG004|Overall Study|Other|0|||
130383556|NCT00642941|469372454|FG005|Overall Study|Other|1|||
130383557|NCT00642941|469372455|FG006|Overall Study|Other|0|||
130383558|NCT00642941|469372456|FG007|Overall Study|Other|1|||
130383559|NCT00642941|469372457|FG008|Overall Study|Other|0|||
130383560|NCT00642941|469372458|FG009|Overall Study|Other|0|||
130383561|NCT00642941|469372459|FG010|Overall Study|Other|0|||
130383562|NCT00642941|469372460|FG011|Overall Study|Other|1|||
130383563|NCT00642941|469372449|FG000|Overall Study|Disease progression|60|||
130383564|NCT00642941|469372450|FG001|Overall Study|Disease progression|50|||
130383565|NCT00642941|469372451|FG002|Overall Study|Disease progression|5|||
130383566|NCT00642941|469372452|FG003|Overall Study|Disease progression|36|||
130383567|NCT00642941|469372453|FG004|Overall Study|Disease progression|23|||
130383568|NCT00642941|469372454|FG005|Overall Study|Disease progression|39|||
130383569|NCT00642941|469372455|FG006|Overall Study|Disease progression|18|||
130383570|NCT00642941|469372456|FG007|Overall Study|Disease progression|12|||
130383571|NCT00642941|469372457|FG008|Overall Study|Disease progression|10|||
130383572|NCT00642941|469372458|FG009|Overall Study|Disease progression|7|||
130383573|NCT00642941|469372459|FG010|Overall Study|Disease progression|12|||
130383574|NCT00642941|469372460|FG011|Overall Study|Disease progression|7|||
130383575|NCT01338493|469372461|FG000|Enrolled|Withdrawal by Subject|1|||
130383576|NCT01338493|469372461|FG000|Enrolled|Patient not implanted|4|||
130383577|NCT01338493|469372461|FG000|Discharge|Death|1|||
130383578|NCT01338493|469372461|FG000|Discharge|Missed visit|1|||
130383579|NCT01338493|469372461|FG000|6 Months Follow up|Lost to Follow-up|11|||
130383580|NCT01338493|469372461|FG000|6 Months Follow up|Missed visit|8|||
130383581|NCT01338493|469372461|FG000|12 Months Follow up|Lost to Follow-up|9|||
130383582|NCT00656474|469372462|FG000|Overall Study|Other Reason|1|||
130383583|NCT01614067|469372464|FG000|Overall Study|Pregnancy|1|||
130383584|NCT01614067|469372465|FG001|Overall Study|Pregnancy|0|||
130383585|NCT01614067|469372464|FG000|Overall Study|Physician Decision|6|||
130383586|NCT01614067|469372465|FG001|Overall Study|Physician Decision|5|||
130383587|NCT01614067|469372464|FG000|Overall Study|Withdrawal by Subject|0|||
130383588|NCT01614067|469372465|FG001|Overall Study|Withdrawal by Subject|1|||
130383589|NCT01614067|469372464|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
130383590|NCT01614067|469372465|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
130383591|NCT00056407|469372466|FG000|Overall Study|Adverse Event|282|||
130383592|NCT00056407|469372467|FG001|Overall Study|Adverse Event|364|||
130383593|NCT00056407|469372466|FG000|Overall Study|Withdrawal by Subject|377|||
130383594|NCT00056407|469372467|FG001|Overall Study|Withdrawal by Subject|361|||
130383595|NCT00056407|469372466|FG000|Overall Study|Lost to Follow-up|123|||
130383596|NCT00056407|469372467|FG001|Overall Study|Lost to Follow-up|113|||
130383597|NCT00056407|469372466|FG000|Overall Study|Protocol Violation|104|||
130383598|NCT00056407|469372467|FG001|Overall Study|Protocol Violation|95|||
130383599|NCT00056407|469372466|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
130383600|NCT00056407|469372467|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
130383601|NCT00056407|469372466|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
130383602|NCT00056407|469372467|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
130383603|NCT00056407|469372466|FG000|Overall Study|Missing|25|||
130383604|NCT00056407|469372467|FG001|Overall Study|Missing|34|||
130383605|NCT00616655|469372468|FG000|Overall Study|Adverse Event|10|||
130383606|NCT00616655|469372469|FG001|Overall Study|Adverse Event|7|||
130383607|NCT00616655|469372470|FG002|Overall Study|Adverse Event|12|||
130383608|NCT00616655|469372468|FG000|Overall Study|Lack of Efficacy|5|||
130383609|NCT00616655|469372469|FG001|Overall Study|Lack of Efficacy|5|||
130383610|NCT00616655|469372470|FG002|Overall Study|Lack of Efficacy|5|||
130722389|NCT00423319|470608239|FG001|Overall Study|Lost to Follow-up|3|||
130383611|NCT00616655|469372468|FG000|Overall Study|Lost to Follow-up|3|||
130383612|NCT00616655|469372469|FG001|Overall Study|Lost to Follow-up|12|||
130383613|NCT00616655|469372470|FG002|Overall Study|Lost to Follow-up|10|||
130383614|NCT00616655|469372468|FG000|Overall Study|Protocol Violation|2|||
130383615|NCT00616655|469372469|FG001|Overall Study|Protocol Violation|4|||
130383616|NCT00616655|469372470|FG002|Overall Study|Protocol Violation|3|||
130383617|NCT00616655|469372468|FG000|Overall Study|Withdrawal by Subject|9|||
130383618|NCT00616655|469372469|FG001|Overall Study|Withdrawal by Subject|7|||
130383619|NCT00616655|469372470|FG002|Overall Study|Withdrawal by Subject|11|||
130383620|NCT00616655|469372468|FG000|Overall Study|Does not meet in/ex criteria|0|||
130383621|NCT00616655|469372469|FG001|Overall Study|Does not meet in/ex criteria|0|||
130383622|NCT00616655|469372470|FG002|Overall Study|Does not meet in/ex criteria|2|||
130383623|NCT00616655|469372468|FG000|Overall Study|Other|6|||
130383624|NCT00616655|469372469|FG001|Overall Study|Other|6|||
130383625|NCT00616655|469372470|FG002|Overall Study|Other|5|||
130383626|NCT02663674|469372473|FG000|Overall Study|Lost to Follow-up|5|||
130383627|NCT02663674|469372474|FG001|Overall Study|Lost to Follow-up|4|||
130383628|NCT02663674|469372473|FG000|Overall Study|Withdrawal by Subject|1|||
130383629|NCT02663674|469372474|FG001|Overall Study|Withdrawal by Subject|4|||
130383630|NCT02663674|469372473|FG000|Overall Study|Physician Decision|1|||
130383631|NCT02663674|469372474|FG001|Overall Study|Physician Decision|1|||
130383632|NCT02663674|469372473|FG000|Overall Study|Other Event (Health Related)|0|||
130383633|NCT02663674|469372474|FG001|Overall Study|Other Event (Health Related)|1|||
130383634|NCT00415909|469373493|FG000|Overall Study|Withdrawal by Subject|2|||
130383635|NCT00415909|469373493|FG000|Overall Study|Death|1|||
130383636|NCT02355691|469373498|FG000|Overall Study|Loss of Research Personnel|7|||
130383637|NCT02355691|469373499|FG001|Overall Study|Loss of Research Personnel|9|||
130383638|NCT00462761|469373502|FG000|Overall Study|Adverse Event|6|||
130383639|NCT00462761|469373502|FG000|Overall Study|Withdrawal by Subject|9|||
130383640|NCT00462761|469373502|FG000|Overall Study|Physician Decision|5|||
130383641|NCT00462761|469373502|FG000|Overall Study|Disease progression|43|||
130383642|NCT00462761|469373502|FG000|Overall Study|Death|12|||
130383643|NCT00462761|469373502|FG000|Overall Study|Other|1|||
130383644|NCT02345811|469373503|FG000|First Intervention|Withdrawal by Subject|1|||
130383645|NCT02345811|469373504|FG001|First Intervention|Withdrawal by Subject|1|||
130383646|NCT02877082|469373505|FG000|Overall Study|Trial was closed early|5|||
130383647|NCT02522286|469373506|FG000|Overall Study|Withdrawal by Subject|3|||
130383648|NCT02522286|469373507|FG001|Overall Study|Withdrawal by Subject|0|||
130383649|NCT02522286|469373508|FG002|Overall Study|Withdrawal by Subject|0|||
130383650|NCT02522286|469373509|FG003|Overall Study|Withdrawal by Subject|3|||
130383651|NCT03480750|469373510|FG000|Overall Study|Withdrawal by Subject|0|||
130383652|NCT03480750|469373511|FG001|Overall Study|Withdrawal by Subject|1|||
130383653|NCT03480750|469373512|FG002|Overall Study|Withdrawal by Subject|0|||
130383654|NCT03480750|469373513|FG003|Overall Study|Withdrawal by Subject|0|||
130383655|NCT03480750|469373514|FG004|Overall Study|Withdrawal by Subject|0|||
130383656|NCT03480750|469373515|FG005|Overall Study|Withdrawal by Subject|0|||
130383657|NCT03480750|469373510|FG000|Overall Study|The interruption in Trientine shippment|0|||
130383658|NCT03480750|469373511|FG001|Overall Study|The interruption in Trientine shippment|0|||
130383659|NCT03480750|469373512|FG002|Overall Study|The interruption in Trientine shippment|0|||
130383660|NCT03480750|469373513|FG003|Overall Study|The interruption in Trientine shippment|0|||
130383661|NCT03480750|469373514|FG004|Overall Study|The interruption in Trientine shippment|0|||
130383662|NCT03480750|469373515|FG005|Overall Study|The interruption in Trientine shippment|1|||
130383663|NCT00605813|469373516|FG000|Overall Study|Protocol Violation|25|||
130383664|NCT01132482|469373517|FG000|Overall Study|Adverse Event|1|||
130383665|NCT01132482|469373518|FG001|Overall Study|Adverse Event|0|||
130383666|NCT00174915|469373523|FG000|Overall Study|Lost to Follow-up|19|||
130383667|NCT00174915|469373524|FG001|Overall Study|Lost to Follow-up|17|||
130383668|NCT00174915|469373525|FG002|Overall Study|Lost to Follow-up|9|||
130383669|NCT00174915|469373526|FG003|Overall Study|Lost to Follow-up|17|||
130383670|NCT00174915|469373527|FG004|Overall Study|Lost to Follow-up|10|||
130383671|NCT00174915|469373523|FG000|Overall Study|Adverse Event|18|||
130383672|NCT00174915|469373524|FG001|Overall Study|Adverse Event|16|||
130383673|NCT00174915|469373525|FG002|Overall Study|Adverse Event|11|||
130383674|NCT00174915|469373526|FG003|Overall Study|Adverse Event|18|||
130383675|NCT00174915|469373527|FG004|Overall Study|Adverse Event|5|||
130383676|NCT00174915|469373523|FG000|Overall Study|Personal Reason(s)|16|||
130383677|NCT00174915|469373524|FG001|Overall Study|Personal Reason(s)|16|||
130383678|NCT00174915|469373525|FG002|Overall Study|Personal Reason(s)|9|||
130383679|NCT00174915|469373526|FG003|Overall Study|Personal Reason(s)|9|||
130383680|NCT00174915|469373527|FG004|Overall Study|Personal Reason(s)|9|||
130383681|NCT00174915|469373523|FG000|Overall Study|Other|15|||
130383682|NCT00174915|469373524|FG001|Overall Study|Other|8|||
130383683|NCT00174915|469373525|FG002|Overall Study|Other|6|||
130383684|NCT00174915|469373526|FG003|Overall Study|Other|5|||
130383685|NCT00174915|469373527|FG004|Overall Study|Other|3|||
130383686|NCT00174915|469373523|FG000|Overall Study|Gout Flare|13|||
130383687|NCT00174915|469373524|FG001|Overall Study|Gout Flare|6|||
130383688|NCT00174915|469373525|FG002|Overall Study|Gout Flare|8|||
130383689|NCT00174915|469373526|FG003|Overall Study|Gout Flare|1|||
130383690|NCT00174915|469373527|FG004|Overall Study|Gout Flare|0|||
130383691|NCT00174915|469373523|FG000|Overall Study|Protocol Violation|6|||
130383692|NCT00174915|469373524|FG001|Overall Study|Protocol Violation|3|||
130383693|NCT00174915|469373525|FG002|Overall Study|Protocol Violation|3|||
130383694|NCT00174915|469373526|FG003|Overall Study|Protocol Violation|6|||
130383695|NCT00174915|469373527|FG004|Overall Study|Protocol Violation|3|||
130383696|NCT00174915|469373523|FG000|Overall Study|Therapeutic Failure|6|||
130383697|NCT00174915|469373524|FG001|Overall Study|Therapeutic Failure|3|||
130383698|NCT00174915|469373525|FG002|Overall Study|Therapeutic Failure|2|||
130383699|NCT00174915|469373526|FG003|Overall Study|Therapeutic Failure|1|||
130383700|NCT00174915|469373527|FG004|Overall Study|Therapeutic Failure|3|||
130383701|NCT03060447|469373532|FG000|Overall Study|Withdrawal by Subject|2|||
130383702|NCT03060447|469373533|FG001|Overall Study|Withdrawal by Subject|0|||
130383703|NCT00573755|469373534|FG000|Overall Study|Still receiving treatment|1|||
130383704|NCT00573755|469373535|FG001|Overall Study|Still receiving treatment|0|||
130383705|NCT03274440|469373539|FG000|Overall Study|Time commitment too great|1|||
130383706|NCT03274440|469373540|FG001|Overall Study|Time commitment too great|0|||
130383707|NCT03274440|469373541|FG002|Overall Study|Time commitment too great|0|||
130383708|NCT03274440|469373542|FG003|Overall Study|Time commitment too great|1|||
130383709|NCT03274440|469373543|FG004|Overall Study|Time commitment too great|0|||
130383710|NCT03274440|469373544|FG005|Overall Study|Time commitment too great|0|||
130383711|NCT00450450|469373545|FG000|Overall Study|Death|1|||
130383712|NCT00450450|469373546|FG001|Overall Study|Death|3|||
130383713|NCT00450450|469373545|FG000|Overall Study|Relapse|2|||
130383714|NCT00450450|469373546|FG001|Overall Study|Relapse|0|||
130383715|NCT00450450|469373545|FG000|Overall Study|Missing Data|2|||
130383716|NCT00450450|469373546|FG001|Overall Study|Missing Data|0|||
130383717|NCT04984993|469373547|FG000|Overall Study|Withdrawal by Subject|8|||
130383718|NCT04984993|469373548|FG001|Overall Study|Withdrawal by Subject|2|||
130383719|NCT04984993|469373547|FG000|Overall Study|Lost to Follow-up|2|||
130383720|NCT04984993|469373548|FG001|Overall Study|Lost to Follow-up|2|||
130383721|NCT04984993|469373547|FG000|Overall Study|Both patients moved to another country|4|||
130383722|NCT04984993|469373548|FG001|Overall Study|Both patients moved to another country|0|||
130722390|NCT00423319|470608238|FG000|Overall Study|Poor compliance or noncompliance|1|||
130722391|NCT00423319|470608239|FG001|Overall Study|Poor compliance or noncompliance|1|||
130722392|NCT00423319|470608238|FG000|Overall Study|No longer meets study criteria|15|||
130722393|NCT00423319|470608239|FG001|Overall Study|No longer meets study criteria|15|||
130722394|NCT00423319|470608238|FG000|Overall Study|Other|23|||
130383723|NCT02865187|469373549|FG000|Overall Study|Lost to Follow-up|12|||
130383724|NCT02865187|469373550|FG001|Overall Study|Lost to Follow-up|7|||
130383725|NCT02865187|469373549|FG000|Overall Study|Adverse Event|1|||
130383726|NCT02865187|469373550|FG001|Overall Study|Adverse Event|0|||
130383727|NCT01110707|469373551|FG000|Overall Study|Protocol Violation|0|||
130383728|NCT01110707|469373552|FG001|Overall Study|Protocol Violation|3|||
130383729|NCT02369341|469373553|FG000|Overall Study|Migrated/moved from study area|1|||
130383730|NCT02369341|469373554|FG001|Overall Study|Migrated/moved from study area|0|||
130383731|NCT03287804|469373555|FG000|Overall Study|Death|1|||
130383732|NCT03287804|469373555|FG000|Overall Study|Physician Decision|2|||
130383733|NCT03287804|469373555|FG000|Overall Study|Progressive disease|8|||
130383734|NCT02710045|469373561|FG000|Overall Study|Death|1|||
130383735|NCT02710045|469373562|FG001|Overall Study|Death|2|||
130722395|NCT00423319|470608239|FG001|Overall Study|Other|22|||
130383736|NCT02710045|469373563|FG002|Overall Study|Death|0|||
130383737|NCT02710045|469373561|FG000|Overall Study|Withdrawal by Subject|6|||
130383738|NCT02710045|469373562|FG001|Overall Study|Withdrawal by Subject|6|||
130383739|NCT02710045|469373563|FG002|Overall Study|Withdrawal by Subject|2|||
130383740|NCT02710045|469373561|FG000|Overall Study|Protocol Violation|1|||
130383741|NCT02710045|469373562|FG001|Overall Study|Protocol Violation|2|||
130383742|NCT02710045|469373563|FG002|Overall Study|Protocol Violation|3|||
130383743|NCT02710045|469373561|FG000|Overall Study|Lost to Follow-up|3|||
130383744|NCT02710045|469373562|FG001|Overall Study|Lost to Follow-up|6|||
130383745|NCT02710045|469373563|FG002|Overall Study|Lost to Follow-up|7|||
130383746|NCT02710045|469373561|FG000|Overall Study|Physician Decision|0|||
130383747|NCT02710045|469373562|FG001|Overall Study|Physician Decision|0|||
130383748|NCT02710045|469373563|FG002|Overall Study|Physician Decision|1|||
130383749|NCT02710045|469373561|FG000|Overall Study|Poor Attendance|0|||
130383750|NCT02710045|469373562|FG001|Overall Study|Poor Attendance|1|||
130722396|NCT02348723|470608241|FG000|Overall Study|No ablation|21|||
130383751|NCT02710045|469373563|FG002|Overall Study|Poor Attendance|0|||
130383752|NCT01275833|469373564|FG000|Overall Study|Study terminated|1|||
130722397|NCT02348723|470608242|FG001|Overall Study|No ablation|20|||
130722398|NCT02348723|470608241|FG000|Overall Study|Non-compliant with Protocol|1|||
130722399|NCT02348723|470608242|FG001|Overall Study|Non-compliant with Protocol|0|||
130722400|NCT02348723|470608241|FG000|Overall Study|Lost to Follow-up|1|||
130722401|NCT02348723|470608242|FG001|Overall Study|Lost to Follow-up|1|||
130722402|NCT02348723|470608241|FG000|Overall Study|Consent withdrawn|1|||
130383753|NCT01275833|469373565|FG001|Overall Study|Study terminated|1|||
130383754|NCT02707991|469373567|FG000|Overall Study|Protocol Violation|1|||
130383755|NCT02707991|469373568|FG001|Overall Study|Protocol Violation|0|||
130383756|NCT02707991|469373567|FG000|Overall Study|Became ineligible|0|||
130383757|NCT02707991|469373568|FG001|Overall Study|Became ineligible|1|||
130383758|NCT02733991|469373569|FG000|Overall Study|Adverse Event|1|||
130468810|NCT01600014|469683543|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
130722403|NCT02348723|470608242|FG001|Overall Study|Consent withdrawn|3|||
130722404|NCT02348723|470608241|FG000|Overall Study|Reason other than specified|1|||
130383759|NCT02733991|469373570|FG001|Overall Study|Adverse Event|0|||
130383760|NCT02733991|469373569|FG000|Overall Study|Withdrawal by Subject|0|||
130383761|NCT02733991|469373570|FG001|Overall Study|Withdrawal by Subject|5|||
130383762|NCT04191499|469373571|FG000|Overall Study|Adverse Event|1|||
130383763|NCT04191499|469373572|FG001|Overall Study|Adverse Event|0|||
130722405|NCT02348723|470608242|FG001|Overall Study|Reason other than specified|1|||
130722406|NCT02348723|470608241|FG000|Overall Study|Adverse Event|3|||
130383764|NCT04191499|469373571|FG000|Overall Study|Death|42|||
130383765|NCT04191499|469373572|FG001|Overall Study|Death|55|||
130383766|NCT04191499|469373571|FG000|Overall Study|Lost to Follow-up|4|||
130383767|NCT04191499|469373572|FG001|Overall Study|Lost to Follow-up|1|||
130383768|NCT04191499|469373571|FG000|Overall Study|Physician Decision|1|||
130383769|NCT04191499|469373572|FG001|Overall Study|Physician Decision|0|||
130383770|NCT04191499|469373571|FG000|Overall Study|Progressive Disease|1|||
130383771|NCT04191499|469373572|FG001|Overall Study|Progressive Disease|0|||
130383772|NCT04191499|469373571|FG000|Overall Study|Symptomatic Deterioration|1|||
130383773|NCT04191499|469373572|FG001|Overall Study|Symptomatic Deterioration|0|||
130383774|NCT04191499|469373571|FG000|Overall Study|Withdrawal by Subject|7|||
130383775|NCT04191499|469373572|FG001|Overall Study|Withdrawal by Subject|11|||
130383776|NCT04191499|469373571|FG000|Overall Study|Ongoing in the study|104|||
130383777|NCT04191499|469373572|FG001|Overall Study|Ongoing in the study|97|||
130383778|NCT02141997|469373573|FG000|Overall Study|Adverse Event|0|||
130383779|NCT02141997|469373574|FG001|Overall Study|Adverse Event|2|||
130383780|NCT02141997|469373575|FG002|Overall Study|Adverse Event|0|||
130383781|NCT02141997|469373576|FG003|Overall Study|Adverse Event|1|||
130383782|NCT02141997|469373573|FG000|Overall Study|Participant noncompliance|1|||
130383783|NCT02141997|469373574|FG001|Overall Study|Participant noncompliance|0|||
130383784|NCT02141997|469373575|FG002|Overall Study|Participant noncompliance|0|||
130383785|NCT02141997|469373576|FG003|Overall Study|Participant noncompliance|0|||
130383786|NCT02141997|469373573|FG000|Overall Study|Withdrew consent|1|||
130383787|NCT02141997|469373574|FG001|Overall Study|Withdrew consent|0|||
130383788|NCT02141997|469373575|FG002|Overall Study|Withdrew consent|3|||
130383789|NCT02141997|469373576|FG003|Overall Study|Withdrew consent|0|||
130383790|NCT02141997|469373573|FG000|Overall Study|Other|1|||
130383791|NCT02141997|469373574|FG001|Overall Study|Other|4|||
130383792|NCT02141997|469373575|FG002|Overall Study|Other|0|||
130383793|NCT02141997|469373576|FG003|Overall Study|Other|0|||
130383794|NCT04105998|469373579|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
130383795|NCT04105998|469373580|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
130383796|NCT00383149|469373582|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
130383797|NCT00383149|469373582|FG000|Overall Study|Death|2|||
130383798|NCT00383149|469373582|FG000|Overall Study|Disease Progression|38|||
130383799|NCT00383149|469373582|FG000|Overall Study|Lost to Follow-up|1|||
130383800|NCT00383149|469373582|FG000|Overall Study|Other|1|||
130383801|NCT00383149|469373582|FG000|Overall Study|Study Drug Toxicity|4|||
130383802|NCT00383149|469373582|FG000|Overall Study|Request to Discontinue Treatment|4|||
130383803|NCT00383149|469373582|FG000|Overall Study|Participant Withdrew Consent|1|||
130383804|NCT00450333|469373583|FG000|Overall Study|Study terminated|47|||
130383805|NCT00450333|469373584|FG001|Overall Study|Study terminated|54|||
130383806|NCT00450333|469373585|FG002|Overall Study|Study terminated|16|||
130383807|NCT00450333|469373586|FG003|Overall Study|Study terminated|21|||
130383808|NCT00450333|469373583|FG000|Overall Study|Adverse Event|1|||
130383809|NCT00450333|469373584|FG001|Overall Study|Adverse Event|7|||
130383810|NCT00450333|469373585|FG002|Overall Study|Adverse Event|2|||
130383811|NCT00450333|469373586|FG003|Overall Study|Adverse Event|2|||
130383812|NCT00450333|469373583|FG000|Overall Study|Protocol Violation|1|||
130383813|NCT00450333|469373584|FG001|Overall Study|Protocol Violation|0|||
130383814|NCT00450333|469373585|FG002|Overall Study|Protocol Violation|1|||
130383815|NCT00450333|469373586|FG003|Overall Study|Protocol Violation|0|||
130383816|NCT00450333|469373583|FG000|Overall Study|Withdrawal by Subject|1|||
130383817|NCT00450333|469373584|FG001|Overall Study|Withdrawal by Subject|0|||
130383818|NCT00450333|469373585|FG002|Overall Study|Withdrawal by Subject|3|||
130383819|NCT00450333|469373586|FG003|Overall Study|Withdrawal by Subject|0|||
130383820|NCT00450333|469373583|FG000|Overall Study|Kidney transplant|1|||
130383821|NCT00450333|469373584|FG001|Overall Study|Kidney transplant|0|||
130383822|NCT00450333|469373585|FG002|Overall Study|Kidney transplant|1|||
130383823|NCT00450333|469373586|FG003|Overall Study|Kidney transplant|3|||
130383824|NCT00450333|469373583|FG000|Overall Study|Death|3|||
130383825|NCT00450333|469373584|FG001|Overall Study|Death|2|||
130383826|NCT00450333|469373585|FG002|Overall Study|Death|2|||
130383827|NCT00450333|469373586|FG003|Overall Study|Death|2|||
130383828|NCT00416078|469373587|FG000|Overall Study|Death|3|||
130383829|NCT00416078|469373588|FG001|Overall Study|Death|4|||
130383830|NCT00416078|469373587|FG000|Overall Study|Withdrawal by Subject|3|||
130383831|NCT00416078|469373588|FG001|Overall Study|Withdrawal by Subject|2|||
130383832|NCT00416078|469373587|FG000|Overall Study|Physician Decision|1|||
130383833|NCT00416078|469373588|FG001|Overall Study|Physician Decision|0|||
130383834|NCT00416078|469373587|FG000|Overall Study|Lost to Follow-up|4|||
130383835|NCT00416078|469373588|FG001|Overall Study|Lost to Follow-up|2|||
130383836|NCT00461682|469373592|FG000|Overall Study|Protocol Violation|1|||
130383837|NCT04128267|469373596|FG000|Overall Study|Withdrawal by Subject|6|||
130383838|NCT04128267|469373596|FG000|Overall Study|Death|2|||
130383839|NCT04128267|469373596|FG000|Overall Study|Disease progression|1|||
130383840|NCT04128267|469373596|FG000|Overall Study|Participant had other medical issues|4|||
130383841|NCT04128267|469373596|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
130383842|NCT01698801|469373599|FG000|Treatment Phase|Adverse Event|4|||
130383843|NCT01698801|469373599|FG000|Treatment Phase|Protocol Violation|1|||
130383844|NCT01698801|469373599|FG000|Treatment Phase|Other|4|||
130383845|NCT01698801|469373599|FG000|Treatment Phase|Withdrawal by Subject|1|||
130383846|NCT01698801|469373599|FG000|Treatment Phase|Disease progression|1|||
130383847|NCT01698801|469373599|FG000|Follow Up Phase|Withdrawal by Subject|1|||
130383848|NCT01698801|469373599|FG000|Follow Up Phase|Death|4|||
130383849|NCT03761147|469373600|FG000|Overall Study|Withdrawal by Subject|6|||
130383850|NCT03761147|469373601|FG001|Overall Study|Withdrawal by Subject|1|||
130383851|NCT03761147|469373600|FG000|Overall Study|Adverse Event|1|||
130383852|NCT03761147|469373601|FG001|Overall Study|Adverse Event|3|||
130383853|NCT03232281|469374755|FG000|Overall Study|Adverse Event|1|||
130383854|NCT03232281|469374756|FG001|Overall Study|Adverse Event|1|||
130383855|NCT03232281|469374755|FG000|Overall Study|Withdrawal by Subject|5|||
130383856|NCT03232281|469374756|FG001|Overall Study|Withdrawal by Subject|4|||
130383857|NCT03232281|469374755|FG000|Overall Study|Protocol Deviation|1|||
130383858|NCT03232281|469374756|FG001|Overall Study|Protocol Deviation|1|||
130383859|NCT02132767|469374758|FG000|Overall Study|Death|3|||
130383860|NCT02132767|469374759|FG001|Overall Study|Death|2|||
130383861|NCT02132767|469374758|FG000|Overall Study|Withdrawal by Subject|10|||
130383862|NCT02132767|469374759|FG001|Overall Study|Withdrawal by Subject|9|||
130383863|NCT02132767|469374758|FG000|Overall Study|Lost to Follow-up|4|||
130383864|NCT02132767|469374759|FG001|Overall Study|Lost to Follow-up|4|||
130383865|NCT00778700|469374762|FG000|Overall Study|Adverse Event|6|||
130383866|NCT00778700|469374763|FG001|Overall Study|Adverse Event|1|||
130383867|NCT00778700|469374764|FG002|Overall Study|Adverse Event|3|||
130383868|NCT00778700|469374765|FG003|Overall Study|Adverse Event|5|||
130383869|NCT00778700|469374762|FG000|Overall Study|Protocol Violation|1|||
130383870|NCT00778700|469374763|FG001|Overall Study|Protocol Violation|1|||
130383871|NCT00778700|469374764|FG002|Overall Study|Protocol Violation|0|||
130383872|NCT00778700|469374765|FG003|Overall Study|Protocol Violation|0|||
130383873|NCT00778700|469374762|FG000|Overall Study|Subject Withdrew Consent|6|||
130383874|NCT00778700|469374763|FG001|Overall Study|Subject Withdrew Consent|4|||
130383875|NCT00778700|469374764|FG002|Overall Study|Subject Withdrew Consent|1|||
130383876|NCT00778700|469374765|FG003|Overall Study|Subject Withdrew Consent|4|||
130383877|NCT00778700|469374762|FG000|Overall Study|Lost to Follow-up|3|||
130383878|NCT00778700|469374763|FG001|Overall Study|Lost to Follow-up|1|||
130383879|NCT00778700|469374764|FG002|Overall Study|Lost to Follow-up|0|||
130383880|NCT00778700|469374765|FG003|Overall Study|Lost to Follow-up|1|||
130383881|NCT00778700|469374762|FG000|Overall Study|Reason not Specified|2|||
130383882|NCT00778700|469374763|FG001|Overall Study|Reason not Specified|0|||
130383883|NCT00778700|469374764|FG002|Overall Study|Reason not Specified|1|||
130383884|NCT00778700|469374765|FG003|Overall Study|Reason not Specified|3|||
130383885|NCT00778700|469374762|FG000|Overall Study|Other|0|||
130383886|NCT00778700|469374763|FG001|Overall Study|Other|0|||
130383887|NCT00778700|469374764|FG002|Overall Study|Other|1|||
130383888|NCT00778700|469374765|FG003|Overall Study|Other|0|||
130383889|NCT04267133|469374766|FG000|Overall Study|Withdrawal by Subject|1|||
130383890|NCT04267133|469374766|FG000|Overall Study|Adverse Event|4|||
130383891|NCT04008030|469374768|FG000|Pre-Treatment|Withdrawal by Subject|0|||
130383892|NCT04008030|469374769|FG001|Pre-Treatment|Withdrawal by Subject|0|||
130383893|NCT04008030|469374770|FG002|Pre-Treatment|Withdrawal by Subject|9|||
130468811|NCT01600014|469683542|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
130468812|NCT01600014|469683543|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
130468813|NCT01600014|469683542|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
130468814|NCT01600014|469683543|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
130468815|NCT01600014|469683542|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
130468816|NCT01600014|469683543|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
130468817|NCT03398148|469683544|FG000|Substudy 1 Period 1|Adverse Event|5|||
130468818|NCT03398148|469683545|FG001|Substudy 1 Period 1|Adverse Event|2|||
130468819|NCT03398148|469683546|FG002|Substudy 1 Period 1|Adverse Event|2|||
130468820|NCT03398148|469683547|FG003|Substudy 1 Period 1|Adverse Event|0|||
130468821|NCT03398148|469683548|FG004|Substudy 1 Period 1|Adverse Event|8|||
130722407|NCT02348723|470608242|FG001|Overall Study|Adverse Event|1|||
130383894|NCT04008030|469374768|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130383895|NCT04008030|469374769|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
130383896|NCT04008030|469374770|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
130383897|NCT04008030|469374768|FG000|Pre-Treatment|Other reasons|0|||
130383898|NCT04008030|469374769|FG001|Pre-Treatment|Other reasons|1|||
130383899|NCT04008030|469374770|FG002|Pre-Treatment|Other reasons|6|||
130383900|NCT04008030|469374768|FG000|Treatment|Withdrawal by Subject|1|||
130383901|NCT04008030|469374769|FG001|Treatment|Withdrawal by Subject|1|||
130468822|NCT03398148|469683549|FG005|Substudy 1 Period 1|Adverse Event|0|||
130559681|NCT01970488|470017849|FG003|Part 2: Post Week 16|Non-compliance|0|||
130722408|NCT01268501|470608243|FG000|Overall Study|Lost to Follow-up|1|||
130383902|NCT04008030|469374770|FG002|Treatment|Withdrawal by Subject|1|||
130383903|NCT04008030|469374768|FG000|Treatment|Death|2|||
130383904|NCT04008030|469374769|FG001|Treatment|Death|4|||
130383905|NCT04008030|469374770|FG002|Treatment|Death|0|||
130383906|NCT04008030|469374768|FG000|Treatment|Pregnancy|0|||
130383907|NCT04008030|469374769|FG001|Treatment|Pregnancy|1|||
130383908|NCT04008030|469374770|FG002|Treatment|Pregnancy|0|||
130383909|NCT04008030|469374768|FG000|Treatment|Participant no longer meets study criteria|0|||
130383910|NCT04008030|469374769|FG001|Treatment|Participant no longer meets study criteria|1|||
130383911|NCT04008030|469374770|FG002|Treatment|Participant no longer meets study criteria|0|||
130383912|NCT04008030|469374768|FG000|Treatment|Other reasons|5|||
130383913|NCT04008030|469374769|FG001|Treatment|Other reasons|13|||
130383914|NCT04008030|469374770|FG002|Treatment|Other reasons|6|||
130383915|NCT04008030|469374768|FG000|Treatment|Disease Progression|137|||
130383916|NCT04008030|469374769|FG001|Treatment|Disease Progression|82|||
130383917|NCT04008030|469374770|FG002|Treatment|Disease Progression|85|||
130383918|NCT04008030|469374768|FG000|Treatment|Study drug toxicity|28|||
130383919|NCT04008030|469374769|FG001|Treatment|Study drug toxicity|48|||
130383920|NCT04008030|469374770|FG002|Treatment|Study drug toxicity|8|||
130383921|NCT04008030|469374768|FG000|Treatment|Adverse Event unrelated to study drug|28|||
130383922|NCT04008030|469374769|FG001|Treatment|Adverse Event unrelated to study drug|22|||
130383923|NCT04008030|469374770|FG002|Treatment|Adverse Event unrelated to study drug|6|||
130383924|NCT04008030|469374768|FG000|Treatment|Maximum Clinical Benefit|0|||
130383925|NCT04008030|469374769|FG001|Treatment|Maximum Clinical Benefit|1|||
130383926|NCT04008030|469374770|FG002|Treatment|Maximum Clinical Benefit|9|||
130383927|NCT04008030|469374768|FG000|Treatment|On-going treatment|13|||
130383928|NCT04008030|469374769|FG001|Treatment|On-going treatment|20|||
130383929|NCT04008030|469374770|FG002|Treatment|On-going treatment|0|||
130383930|NCT00003901|469374774|FG000|Overall Study|Adverse Event|1|||
130383931|NCT00003901|469374774|FG000|Overall Study|Withdrawal by Subject|1|||
130383932|NCT00003901|469374774|FG000|Overall Study|Ineligible|6|||
130383933|NCT00003901|469374774|FG000|Overall Study|CT Scan not within protocol requirement|2|||
130383934|NCT00003901|469374774|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
130383935|NCT00003901|469374774|FG000|Overall Study|Medical problems|6|||
130383936|NCT01496313|469374781|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
130383937|NCT01496313|469374782|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
130383938|NCT01496313|469374783|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
130383939|NCT01496313|469374784|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
130383940|NCT01496313|469374785|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
130383941|NCT01496313|469374786|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
130383942|NCT01496313|469374781|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
130383943|NCT01496313|469374782|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
130383944|NCT01496313|469374783|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130383945|NCT01496313|469374784|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130383946|NCT01496313|469374785|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130383947|NCT01496313|469374786|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130383948|NCT01496313|469374781|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130383949|NCT01496313|469374782|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
130383950|NCT01496313|469374783|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130383951|NCT01496313|469374784|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130383952|NCT01496313|469374785|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130383953|NCT01496313|469374786|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130383954|NCT01496313|469374781|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
130383955|NCT01496313|469374782|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
130383956|NCT01496313|469374783|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
130383957|NCT01496313|469374784|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
130383958|NCT01496313|469374785|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
130383959|NCT01496313|469374786|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
130468823|NCT03398148|469683550|FG006|Substudy 1 Period 1|Adverse Event|0|||
130468824|NCT03398148|469683551|FG007|Substudy 1 Period 1|Adverse Event|0|||
130468825|NCT03398148|469683552|FG008|Substudy 1 Period 1|Adverse Event|0|||
130468826|NCT03398148|469683553|FG009|Substudy 1 Period 1|Adverse Event|0|||
130468827|NCT03398148|469683554|FG010|Substudy 1 Period 1|Adverse Event|0|||
130468828|NCT03398148|469683555|FG011|Substudy 1 Period 1|Adverse Event|0|||
130468829|NCT03398148|469683556|FG012|Substudy 1 Period 1|Adverse Event|0|||
130383960|NCT01496313|469374781|FG000|Randomized Period (up to 14 Months)|Other|1|||
130468830|NCT03398148|469683557|FG013|Substudy 1 Period 1|Adverse Event|0|||
130559682|NCT01970488|470017850|FG004|Part 2: Post Week 16|Non-compliance|0|||
130383961|NCT01496313|469374782|FG001|Randomized Period (up to 14 Months)|Other|2|||
130383962|NCT01496313|469374783|FG002|Randomized Period (up to 14 Months)|Other|0|||
130383963|NCT01496313|469374784|FG003|Randomized Period (up to 14 Months)|Other|0|||
130383964|NCT01496313|469374785|FG004|Randomized Period (up to 14 Months)|Other|0|||
130383965|NCT01496313|469374786|FG005|Randomized Period (up to 14 Months)|Other|0|||
130468831|NCT03398148|469683558|FG014|Substudy 1 Period 1|Adverse Event|0|||
130468832|NCT03398148|469683544|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
130468833|NCT03398148|469683545|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
130468834|NCT03398148|469683546|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130383966|NCT01496313|469374781|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130383967|NCT01496313|469374782|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130383968|NCT01496313|469374783|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130383969|NCT01496313|469374784|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130383970|NCT01496313|469374785|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130383971|NCT01496313|469374786|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
130383972|NCT01496313|469374781|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130383973|NCT01496313|469374782|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130383974|NCT01496313|469374783|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130383975|NCT01496313|469374784|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130383976|NCT01496313|469374785|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130383977|NCT01496313|469374786|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
130383978|NCT01496313|469374781|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
130383979|NCT01496313|469374782|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
130383980|NCT01496313|469374783|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
130383981|NCT01496313|469374784|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
130383982|NCT01496313|469374785|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
130383983|NCT01496313|469374786|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
130383984|NCT01050257|469374787|FG000|Overall Study|Adverse Event|4|||
130383985|NCT01050257|469374788|FG001|Overall Study|Adverse Event|4|||
130383986|NCT01050257|469374789|FG002|Overall Study|Adverse Event|2|||
130383987|NCT01050257|469374787|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
130383988|NCT01050257|469374788|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
130383989|NCT01050257|469374789|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
130383990|NCT01050257|469374787|FG000|Overall Study|Withdrawal by Subject|0|||
130383991|NCT01050257|469374788|FG001|Overall Study|Withdrawal by Subject|3|||
130383992|NCT01050257|469374789|FG002|Overall Study|Withdrawal by Subject|0|||
130383993|NCT01050257|469374787|FG000|Overall Study|No reason specified|0|||
130383994|NCT01050257|469374788|FG001|Overall Study|No reason specified|0|||
130383995|NCT01050257|469374789|FG002|Overall Study|No reason specified|2|||
130383996|NCT01050257|469374787|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
130383997|NCT01050257|469374788|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
130383998|NCT01050257|469374789|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
130383999|NCT01050257|469374787|FG000|Overall Study|Violation criteria|0|||
130384000|NCT01050257|469374788|FG001|Overall Study|Violation criteria|1|||
130384001|NCT01050257|469374789|FG002|Overall Study|Violation criteria|0|||
130384002|NCT01050257|469374787|FG000|Overall Study|Failure to return|0|||
130384003|NCT01050257|469374788|FG001|Overall Study|Failure to return|2|||
130384004|NCT01050257|469374789|FG002|Overall Study|Failure to return|0|||
130384005|NCT01050257|469374787|FG000|Overall Study|Death|0|||
130384006|NCT01050257|469374788|FG001|Overall Study|Death|0|||
130384007|NCT01050257|469374789|FG002|Overall Study|Death|1|||
130384008|NCT00278109|469374791|FG000|Overall Study|Adverse Event|3|||
130384009|NCT00278109|469374791|FG000|Overall Study|social circumstances|1|||
130384010|NCT02580357|469374792|FG000|Overall Study|Lost to Follow-up|2|||
130384011|NCT02580357|469374793|FG001|Overall Study|Lost to Follow-up|0|||
130384012|NCT02580357|469374794|FG002|Overall Study|Lost to Follow-up|0|||
130384013|NCT02580357|469374792|FG000|Overall Study|Protocol Violation|1|||
130468835|NCT03398148|469683547|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
130468836|NCT03398148|469683548|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
130384014|NCT02580357|469374793|FG001|Overall Study|Protocol Violation|0|||
130384015|NCT02580357|469374794|FG002|Overall Study|Protocol Violation|0|||
130384016|NCT02064166|469374795|FG000|Overall Study|Adverse Event|1|||
130384017|NCT02064166|469374796|FG001|Overall Study|Adverse Event|0|||
130384018|NCT04519645|469374799|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
130384019|NCT04519645|469374800|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
130384020|NCT04519645|469374801|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
130384021|NCT04519645|469374799|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
130468837|NCT03398148|469683549|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468838|NCT03398148|469683550|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468839|NCT03398148|469683551|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468840|NCT03398148|469683552|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130384022|NCT04519645|469374800|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
130384023|NCT04519645|469374801|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
130384024|NCT04519645|469374799|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
130384025|NCT04519645|469374800|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
130384026|NCT04519645|469374801|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
130468841|NCT03398148|469683553|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468842|NCT03398148|469683554|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130384027|NCT04519645|469374799|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
130384028|NCT04519645|469374800|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
130384029|NCT04519645|469374801|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
130384030|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384031|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
130384032|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384033|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384034|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384035|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384036|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130384037|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
130384038|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
130384039|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
130384040|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
130384041|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
130384042|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
130384043|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
130384044|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
130384045|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
130384046|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
130384047|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
130384048|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
130384049|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
130384050|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
130384051|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130384052|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
130384053|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130384054|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130384055|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130384056|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
130384057|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130384058|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
130384059|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
130384060|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
130384061|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
130384062|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
130384063|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
130384064|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
130384065|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384066|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384067|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384068|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384069|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384070|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
130384071|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130384072|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130384073|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130384074|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130384075|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130384076|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130384077|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130384078|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
130384079|NCT03742037|469374802|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384080|NCT03742037|469374803|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384081|NCT03742037|469374804|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384082|NCT03742037|469374805|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384083|NCT03742037|469374806|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384084|NCT03742037|469374807|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130384085|NCT03742037|469374808|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
130384086|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
130384087|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
130384088|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
130384089|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
130468843|NCT03398148|469683555|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468844|NCT03398148|469683556|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468845|NCT03398148|469683557|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468846|NCT03398148|469683558|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130468847|NCT03398148|469683544|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
130468848|NCT03398148|469683545|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
130468849|NCT03398148|469683546|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
130468850|NCT03398148|469683547|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
130468851|NCT03398148|469683548|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
130468852|NCT03398148|469683549|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
130468853|NCT03398148|469683550|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
130468854|NCT03398148|469683551|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
130468855|NCT03398148|469683552|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
130468856|NCT03398148|469683553|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
130468857|NCT03398148|469683554|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
130468858|NCT03398148|469683555|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
130468859|NCT03398148|469683556|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
130468860|NCT03398148|469683557|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
130468861|NCT03398148|469683558|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
130468862|NCT03398148|469683544|FG000|Substudy 1 Period 1|Other|0|||
130468863|NCT03398148|469683545|FG001|Substudy 1 Period 1|Other|1|||
130468864|NCT03398148|469683546|FG002|Substudy 1 Period 1|Other|0|||
130468865|NCT03398148|469683547|FG003|Substudy 1 Period 1|Other|0|||
130468866|NCT03398148|469683548|FG004|Substudy 1 Period 1|Other|3|||
130468867|NCT03398148|469683549|FG005|Substudy 1 Period 1|Other|0|||
130468868|NCT03398148|469683550|FG006|Substudy 1 Period 1|Other|0|||
130468869|NCT03398148|469683551|FG007|Substudy 1 Period 1|Other|0|||
130468870|NCT03398148|469683552|FG008|Substudy 1 Period 1|Other|0|||
130468871|NCT03398148|469683553|FG009|Substudy 1 Period 1|Other|0|||
130468872|NCT03398148|469683554|FG010|Substudy 1 Period 1|Other|0|||
130468873|NCT03398148|469683555|FG011|Substudy 1 Period 1|Other|0|||
130468874|NCT03398148|469683556|FG012|Substudy 1 Period 1|Other|0|||
130468875|NCT03398148|469683557|FG013|Substudy 1 Period 1|Other|0|||
130468876|NCT03398148|469683558|FG014|Substudy 1 Period 1|Other|0|||
130468877|NCT03398148|469683544|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468878|NCT03398148|469683545|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468879|NCT03398148|469683546|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468880|NCT03398148|469683547|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468881|NCT03398148|469683548|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
130468882|NCT03398148|469683549|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468883|NCT03398148|469683550|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468884|NCT03398148|469683551|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468885|NCT03398148|469683552|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
130722409|NCT01268501|470608243|FG000|Overall Study|Withdrawal by Subject|3|||
130722410|NCT01268501|470608243|FG000|Overall Study|Unacceptable Subjective Vision|3|||
130384090|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
130384091|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
130384092|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
130384093|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130384094|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130384095|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
130384096|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
130384097|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130384098|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130384099|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
130384100|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130384101|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
130384102|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
130384103|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130384104|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130384105|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130384106|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130384107|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
130722411|NCT01268501|470608243|FG000|Overall Study|Handling Difficulties|2|||
130722412|NCT00678886|470608244|FG000|Overall Study|Withdrawal by Subject|0|||
130468886|NCT03398148|469683553|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468887|NCT03398148|469683554|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468888|NCT03398148|469683555|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468889|NCT03398148|469683556|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468890|NCT03398148|469683557|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468891|NCT03398148|469683558|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
130468892|NCT03398148|469683544|FG000|Substudy 1 Period 2|Adverse Event|0|||
130468893|NCT03398148|469683545|FG001|Substudy 1 Period 2|Adverse Event|0|||
130384108|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130384109|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130384110|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130384111|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130384112|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130384113|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
130384114|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130384115|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
130384116|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
130384117|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
130384118|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130384119|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130384120|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
130384121|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
130384122|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130384123|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
130384124|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130384125|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130384126|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130384127|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
130384128|NCT03742037|469374802|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384129|NCT03742037|469374803|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384130|NCT03742037|469374804|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
130384131|NCT03742037|469374805|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384132|NCT03742037|469374806|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384133|NCT03742037|469374807|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384134|NCT03742037|469374808|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130384135|NCT00969150|469374837|FG000|Overall Study|Adverse Event|4|||
130384136|NCT00969150|469374838|FG001|Overall Study|Adverse Event|14|||
130384137|NCT00969150|469374837|FG000|Overall Study|Lack of Efficacy|1|||
130384138|NCT00969150|469374838|FG001|Overall Study|Lack of Efficacy|1|||
130384139|NCT00969150|469374837|FG000|Overall Study|Protocol Violation|9|||
130384140|NCT00969150|469374838|FG001|Overall Study|Protocol Violation|12|||
130384141|NCT00969150|469374837|FG000|Overall Study|Withdrawal by Subject|13|||
130384142|NCT00969150|469374838|FG001|Overall Study|Withdrawal by Subject|9|||
130384143|NCT00969150|469374837|FG000|Overall Study|Lost to Follow-up|5|||
130384144|NCT00969150|469374838|FG001|Overall Study|Lost to Follow-up|4|||
130384145|NCT00969150|469374837|FG000|Overall Study|Other reasons|1|||
130384146|NCT00969150|469374838|FG001|Overall Study|Other reasons|0|||
130384147|NCT01026792|469374842|FG000|Overall Study|Protocol Violation|1|||
130384148|NCT00309842|469374843|FG000|Overall Study|Lost to Follow-up|1|||
130384149|NCT00423150|469374844|FG000|Overall Study|Adverse Event|11|||
130384150|NCT00423150|469374844|FG000|Overall Study|Progression of disease being studied|69|||
130384151|NCT00423150|469374844|FG000|Overall Study|Withdrawal by Subject|1|||
130384152|NCT00423150|469374844|FG000|Overall Study|Non-compliance with protocol|1|||
130384153|NCT00423150|469374844|FG000|Overall Study|Administrative|4|||
130384154|NCT03204305|469374845|FG000|Overall Study|Lost to Follow-up|6|||
130384155|NCT03204305|469374846|FG001|Overall Study|Lost to Follow-up|4|||
130384156|NCT03204305|469374847|FG002|Overall Study|Lost to Follow-up|0|||
130384157|NCT03204305|469374848|FG003|Overall Study|Lost to Follow-up|0|||
130384158|NCT03204305|469374845|FG000|Overall Study|Physician Decision|1|||
130384159|NCT03204305|469374846|FG001|Overall Study|Physician Decision|0|||
130384160|NCT03204305|469374847|FG002|Overall Study|Physician Decision|0|||
130468894|NCT03398148|469683546|FG002|Substudy 1 Period 2|Adverse Event|0|||
130468895|NCT03398148|469683547|FG003|Substudy 1 Period 2|Adverse Event|0|||
130468896|NCT03398148|469683548|FG004|Substudy 1 Period 2|Adverse Event|0|||
130468897|NCT03398148|469683549|FG005|Substudy 1 Period 2|Adverse Event|2|||
130468898|NCT03398148|469683550|FG006|Substudy 1 Period 2|Adverse Event|4|||
130468899|NCT03398148|469683551|FG007|Substudy 1 Period 2|Adverse Event|0|||
130468900|NCT03398148|469683552|FG008|Substudy 1 Period 2|Adverse Event|0|||
130384161|NCT03204305|469374848|FG003|Overall Study|Physician Decision|0|||
130384162|NCT03204305|469374845|FG000|Overall Study|failure to place arterial line|2|||
130384163|NCT03204305|469374846|FG001|Overall Study|failure to place arterial line|1|||
130384164|NCT03204305|469374847|FG002|Overall Study|failure to place arterial line|0|||
130468901|NCT03398148|469683553|FG009|Substudy 1 Period 2|Adverse Event|0|||
130468902|NCT03398148|469683554|FG010|Substudy 1 Period 2|Adverse Event|0|||
130468903|NCT03398148|469683555|FG011|Substudy 1 Period 2|Adverse Event|0|||
130722413|NCT00678886|470608245|FG001|Overall Study|Withdrawal by Subject|0|||
130722414|NCT00678886|470608246|FG002|Overall Study|Withdrawal by Subject|4|||
130468904|NCT03398148|469683556|FG012|Substudy 1 Period 2|Adverse Event|0|||
130468905|NCT03398148|469683557|FG013|Substudy 1 Period 2|Adverse Event|0|||
130468906|NCT03398148|469683558|FG014|Substudy 1 Period 2|Adverse Event|0|||
130468907|NCT03398148|469683544|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468908|NCT03398148|469683545|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468909|NCT03398148|469683546|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468910|NCT03398148|469683547|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468911|NCT03398148|469683548|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468912|NCT03398148|469683549|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468913|NCT03398148|469683550|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
130468914|NCT03398148|469683551|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
130468915|NCT03398148|469683552|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130722415|NCT00678886|470608247|FG003|Overall Study|Withdrawal by Subject|6|||
130722416|NCT00678886|470608244|FG000|Overall Study|Physician Decision|0|||
130722417|NCT00678886|470608245|FG001|Overall Study|Physician Decision|0|||
130722418|NCT00678886|470608246|FG002|Overall Study|Physician Decision|1|||
130722419|NCT00678886|470608247|FG003|Overall Study|Physician Decision|1|||
130384165|NCT03204305|469374848|FG003|Overall Study|failure to place arterial line|0|||
130384166|NCT03204305|469374845|FG000|Overall Study|Withdrawal by Subject|2|||
130384167|NCT03204305|469374846|FG001|Overall Study|Withdrawal by Subject|0|||
130384168|NCT03204305|469374847|FG002|Overall Study|Withdrawal by Subject|0|||
130384169|NCT03204305|469374848|FG003|Overall Study|Withdrawal by Subject|0|||
130384170|NCT02045797|469374849|FG000|Overall Study|Adverse Event|3|||
130384171|NCT02045797|469374850|FG001|Overall Study|Adverse Event|1|||
130384172|NCT02045797|469374851|FG002|Overall Study|Adverse Event|0|||
130384173|NCT02045797|469374849|FG000|Overall Study|Lack of Efficacy|1|||
130384174|NCT02045797|469374850|FG001|Overall Study|Lack of Efficacy|0|||
130384175|NCT02045797|469374851|FG002|Overall Study|Lack of Efficacy|0|||
130384176|NCT02045797|469374849|FG000|Overall Study|Lost to Follow-up|2|||
130384177|NCT02045797|469374850|FG001|Overall Study|Lost to Follow-up|3|||
130384178|NCT02045797|469374851|FG002|Overall Study|Lost to Follow-up|1|||
130384179|NCT02045797|469374849|FG000|Overall Study|Physician Decision|0|||
130384180|NCT02045797|469374850|FG001|Overall Study|Physician Decision|1|||
130384181|NCT02045797|469374851|FG002|Overall Study|Physician Decision|0|||
130384182|NCT02045797|469374849|FG000|Overall Study|Withdrawal by Subject|1|||
130468916|NCT03398148|469683553|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468917|NCT03398148|469683554|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468918|NCT03398148|469683555|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468919|NCT03398148|469683556|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468920|NCT03398148|469683557|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468921|NCT03398148|469683558|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130468922|NCT03398148|469683544|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
130468923|NCT03398148|469683545|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
130468924|NCT03398148|469683546|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
130468925|NCT03398148|469683547|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
130384183|NCT02045797|469374850|FG001|Overall Study|Withdrawal by Subject|2|||
130384184|NCT02045797|469374851|FG002|Overall Study|Withdrawal by Subject|0|||
130384185|NCT00101907|469374855|FG000|Overall Study|Adverse Event|1|||
130384186|NCT00101907|469374856|FG001|Overall Study|Adverse Event|0|||
130384187|NCT00101907|469374857|FG002|Overall Study|Adverse Event|0|||
130384188|NCT00101907|469374858|FG003|Overall Study|Adverse Event|0|||
130384189|NCT00101907|469374859|FG004|Overall Study|Adverse Event|0|||
130384190|NCT00101907|469374860|FG005|Overall Study|Adverse Event|0|||
130384191|NCT00101907|469374855|FG000|Overall Study|Death|0|||
130468926|NCT03398148|469683548|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
130468927|NCT03398148|469683549|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
130384192|NCT00101907|469374856|FG001|Overall Study|Death|1|||
130384193|NCT00101907|469374857|FG002|Overall Study|Death|0|||
130384194|NCT00101907|469374858|FG003|Overall Study|Death|0|||
130384195|NCT00101907|469374859|FG004|Overall Study|Death|3|||
130384196|NCT00101907|469374860|FG005|Overall Study|Death|0|||
130384197|NCT00101907|469374855|FG000|Overall Study|Physician Decision|0|||
130384198|NCT00101907|469374856|FG001|Overall Study|Physician Decision|0|||
130384199|NCT00101907|469374857|FG002|Overall Study|Physician Decision|0|||
130384200|NCT00101907|469374858|FG003|Overall Study|Physician Decision|1|||
130384201|NCT00101907|469374859|FG004|Overall Study|Physician Decision|1|||
130384202|NCT00101907|469374860|FG005|Overall Study|Physician Decision|0|||
130384203|NCT00101907|469374855|FG000|Overall Study|Withdrawal by Subject|1|||
130384204|NCT00101907|469374856|FG001|Overall Study|Withdrawal by Subject|0|||
130384205|NCT00101907|469374857|FG002|Overall Study|Withdrawal by Subject|1|||
130384206|NCT00101907|469374858|FG003|Overall Study|Withdrawal by Subject|0|||
130384207|NCT00101907|469374859|FG004|Overall Study|Withdrawal by Subject|1|||
130384208|NCT00101907|469374860|FG005|Overall Study|Withdrawal by Subject|0|||
130384209|NCT03279692|469374863|FG000|Overall Study|Withdrawal by Subject|1|||
130384210|NCT04219891|469374867|FG000|Overall Study|Lost to Follow-up|3|||
130384211|NCT04219891|469374867|FG000|Overall Study|Withdrawal by Subject|2|||
130384212|NCT04958785|469375893|FG000|Overall Study|Study Terminated by Sponsor|4|||
130384213|NCT04958785|469375894|FG001|Overall Study|Study Terminated by Sponsor|10|||
130384214|NCT04958785|469375895|FG002|Overall Study|Study Terminated by Sponsor|7|||
130384215|NCT04958785|469375896|FG003|Overall Study|Study Terminated by Sponsor|6|||
130384216|NCT04958785|469375897|FG004|Overall Study|Study Terminated by Sponsor|34|||
130384217|NCT04958785|469375893|FG000|Overall Study|Death|2|||
130384218|NCT04958785|469375894|FG001|Overall Study|Death|3|||
130384219|NCT04958785|469375895|FG002|Overall Study|Death|4|||
130384220|NCT04958785|469375896|FG003|Overall Study|Death|5|||
130384221|NCT04958785|469375897|FG004|Overall Study|Death|5|||
130384222|NCT04958785|469375893|FG000|Overall Study|Withdrew consent|2|||
130384223|NCT04958785|469375894|FG001|Overall Study|Withdrew consent|0|||
130384224|NCT04958785|469375895|FG002|Overall Study|Withdrew consent|3|||
130384225|NCT04958785|469375896|FG003|Overall Study|Withdrew consent|1|||
130384226|NCT04958785|469375897|FG004|Overall Study|Withdrew consent|0|||
130384227|NCT04958785|469375893|FG000|Overall Study|Investigator's discretion|0|||
130384228|NCT04958785|469375894|FG001|Overall Study|Investigator's discretion|1|||
130384229|NCT04958785|469375895|FG002|Overall Study|Investigator's discretion|0|||
130384230|NCT04958785|469375896|FG003|Overall Study|Investigator's discretion|1|||
130384231|NCT04958785|469375897|FG004|Overall Study|Investigator's discretion|2|||
130384232|NCT04958785|469375893|FG000|Overall Study|Adverse Event|0|||
130384233|NCT04958785|469375894|FG001|Overall Study|Adverse Event|0|||
130384234|NCT04958785|469375895|FG002|Overall Study|Adverse Event|0|||
130384235|NCT04958785|469375896|FG003|Overall Study|Adverse Event|0|||
130384236|NCT04958785|469375897|FG004|Overall Study|Adverse Event|1|||
130384237|NCT04958785|469375893|FG000|Overall Study|Lost to Follow-up|0|||
130384238|NCT04958785|469375894|FG001|Overall Study|Lost to Follow-up|0|||
130384239|NCT04958785|469375895|FG002|Overall Study|Lost to Follow-up|0|||
130384240|NCT04958785|469375896|FG003|Overall Study|Lost to Follow-up|0|||
130384241|NCT04958785|469375897|FG004|Overall Study|Lost to Follow-up|1|||
130384242|NCT03274687|469375898|FG000|Overall Study|Protocol Violation|1|||
130384243|NCT03274687|469375899|FG001|Overall Study|Protocol Violation|1|||
130384244|NCT04734652|469375904|FG000|Overall Study|Withdrawal by Subject|2|||
130384245|NCT04734652|469375905|FG001|Overall Study|Withdrawal by Subject|0|||
130384246|NCT04734652|469375904|FG000|Overall Study|Death|0|||
130384247|NCT04734652|469375905|FG001|Overall Study|Death|1|||
130384248|NCT05104476|469375915|FG000|Overall Study|Randomized But Not Treated|1|||
130384249|NCT05104476|469375916|FG001|Overall Study|Randomized But Not Treated|2|||
130384250|NCT05104476|469375915|FG000|Overall Study|Adverse Event|2|||
130384251|NCT05104476|469375916|FG001|Overall Study|Adverse Event|2|||
130384252|NCT05104476|469375915|FG000|Overall Study|Withdrawal by Subject|3|||
130384253|NCT05104476|469375916|FG001|Overall Study|Withdrawal by Subject|3|||
130384254|NCT05104476|469375915|FG000|Overall Study|Other Than Specified|0|||
130384255|NCT05104476|469375916|FG001|Overall Study|Other Than Specified|3|||
130384256|NCT04447755|469375917|FG000|Overall Study|Death|9|||
130384257|NCT04447755|469375918|FG001|Overall Study|Death|16|||
130384258|NCT04447755|469375919|FG002|Overall Study|Death|8|||
130384259|NCT04447755|469375920|FG003|Overall Study|Death|9|||
130384260|NCT04447755|469375921|FG004|Overall Study|Death|8|||
130384261|NCT04447755|469375922|FG005|Overall Study|Death|9|||
130384262|NCT04447755|469375923|FG006|Overall Study|Death|55|||
130384263|NCT04447755|469375917|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130384264|NCT04447755|469375918|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130384265|NCT04447755|469375919|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130384266|NCT04447755|469375920|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130384267|NCT04447755|469375921|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130384268|NCT04447755|469375922|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130384269|NCT04447755|469375923|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130384270|NCT04447755|469375917|FG000|Overall Study|Sponsor Decision|0|||
130722420|NCT00678886|470608244|FG000|Overall Study|Lost to Follow-up|0|||
130384271|NCT04447755|469375918|FG001|Overall Study|Sponsor Decision|0|||
130384272|NCT04447755|469375919|FG002|Overall Study|Sponsor Decision|0|||
130384273|NCT04447755|469375920|FG003|Overall Study|Sponsor Decision|0|||
130384274|NCT04447755|469375921|FG004|Overall Study|Sponsor Decision|1|||
130384275|NCT04447755|469375922|FG005|Overall Study|Sponsor Decision|0|||
130384276|NCT04447755|469375923|FG006|Overall Study|Sponsor Decision|10|||
130384277|NCT04447755|469375917|FG000|Overall Study|Lost to Follow-up|0|||
130384278|NCT04447755|469375918|FG001|Overall Study|Lost to Follow-up|0|||
130384279|NCT04447755|469375919|FG002|Overall Study|Lost to Follow-up|0|||
130384280|NCT04447755|469375920|FG003|Overall Study|Lost to Follow-up|0|||
130384281|NCT04447755|469375921|FG004|Overall Study|Lost to Follow-up|0|||
130384282|NCT04447755|469375922|FG005|Overall Study|Lost to Follow-up|0|||
130384283|NCT04447755|469375923|FG006|Overall Study|Lost to Follow-up|1|||
130384284|NCT02375113|469375926|FG000|Overall Study|Undisclosed Reason(s).|1|||
130384285|NCT02375113|469375927|FG001|Overall Study|Undisclosed Reason(s).|1|||
130384286|NCT02375113|469375926|FG000|Overall Study|Poor adherence (<70%).|1|||
130384287|NCT02375113|469375927|FG001|Overall Study|Poor adherence (<70%).|0|||
130384288|NCT02375113|469375926|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
130384289|NCT02375113|469375927|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
130384290|NCT04387435|469375933|FG000|Overall Study|Physician Decision|1|||
130384291|NCT03855280|469375934|FG000|Treatment Phase|Adverse Event|1|||
130384292|NCT03855280|469375934|FG000|Treatment Phase|Withdrawal by Subject|1|||
130384293|NCT03855280|469375934|FG000|Continuation Phase|Protocol Violation|1|||
130384294|NCT03855280|469375934|FG000|Continuation Phase|Adverse Event|1|||
130384295|NCT03855280|469375934|FG000|Continuation Phase|Sponsor Concluded Study|1|||
130384296|NCT03338855|469375937|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
130384297|NCT03338855|469375938|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
130384298|NCT00511667|469375939|FG000|Overall Study|Adverse Event|1|||
130384299|NCT00511667|469375940|FG001|Overall Study|Adverse Event|0|||
130384300|NCT00511667|469375939|FG000|Overall Study|Protocol Violation|1|||
130384301|NCT00511667|469375940|FG001|Overall Study|Protocol Violation|1|||
130384302|NCT00511667|469375939|FG000|Overall Study|Withdrawal by Subject|2|||
130384303|NCT00511667|469375940|FG001|Overall Study|Withdrawal by Subject|0|||
130384304|NCT00511667|469375939|FG000|Overall Study|Site terminated|6|||
130384305|NCT00511667|469375940|FG001|Overall Study|Site terminated|1|||
130384306|NCT00511667|469375939|FG000|Overall Study|Other|2|||
130384307|NCT00511667|469375940|FG001|Overall Study|Other|1|||
130384308|NCT02335099|469375941|FG000|Treatment|Withdrawal by Subject|1|||
130384309|NCT02335099|469375942|FG001|Treatment|Withdrawal by Subject|3|||
130384310|NCT02335099|469375941|FG000|Treatment|Lost to Follow-up|2|||
130384311|NCT02335099|469375942|FG001|Treatment|Lost to Follow-up|0|||
130384312|NCT02335099|469375941|FG000|Treatment|Death|1|||
130384313|NCT02335099|469375942|FG001|Treatment|Death|0|||
130384314|NCT02335099|469375941|FG000|Treatment|Adverse Event|1|||
130384315|NCT02335099|469375942|FG001|Treatment|Adverse Event|2|||
130384316|NCT02335099|469375941|FG000|Follow-up|Death|0|||
130384317|NCT02335099|469375942|FG001|Follow-up|Death|1|||
130468928|NCT03398148|469683550|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
130468929|NCT03398148|469683551|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
130468930|NCT03398148|469683552|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
130468931|NCT03398148|469683553|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
130468932|NCT03398148|469683554|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
130468933|NCT03398148|469683555|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
130468934|NCT03398148|469683556|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
130468935|NCT03398148|469683557|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
130468936|NCT03398148|469683558|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
130468937|NCT03398148|469683544|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468938|NCT03398148|469683545|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468939|NCT03398148|469683546|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468940|NCT03398148|469683547|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130559683|NCT01970488|470017846|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
130384318|NCT00484939|469375945|FG000|Overall Study|Death|9|||
130384319|NCT00484939|469375946|FG001|Overall Study|Death|13|||
130468941|NCT03398148|469683548|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468942|NCT03398148|469683549|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468943|NCT03398148|469683550|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
130468944|NCT03398148|469683551|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468945|NCT03398148|469683552|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130559684|NCT01970488|470017847|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
130384320|NCT00484939|469375945|FG000|Overall Study|Adverse Event|22|||
130384321|NCT00484939|469375946|FG001|Overall Study|Adverse Event|12|||
130384322|NCT00484939|469375945|FG000|Overall Study|Patient Withdrew Consent|19|||
130384323|NCT00484939|469375946|FG001|Overall Study|Patient Withdrew Consent|10|||
130384324|NCT00484939|469375945|FG000|Overall Study|Protocol Violation|3|||
130384325|NCT00484939|469375946|FG001|Overall Study|Protocol Violation|3|||
130384326|NCT00484939|469375945|FG000|Overall Study|Lost to Follow-up|0|||
130384327|NCT00484939|469375946|FG001|Overall Study|Lost to Follow-up|3|||
130384328|NCT00484939|469375945|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
130384329|NCT00484939|469375946|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
130384330|NCT00484939|469375945|FG000|Overall Study|Disease progression|67|||
130384331|NCT00484939|469375946|FG001|Overall Study|Disease progression|88|||
130384332|NCT00484939|469375945|FG000|Overall Study|Screen Failure|2|||
130384333|NCT00484939|469375946|FG001|Overall Study|Screen Failure|2|||
130384334|NCT00484939|469375945|FG000|Overall Study|Reason Not Specified|11|||
130384335|NCT00484939|469375946|FG001|Overall Study|Reason Not Specified|6|||
130384336|NCT01474876|469375949|FG000|Overall Study|Adverse Event|11|||
130384337|NCT01474876|469375950|FG001|Overall Study|Adverse Event|5|||
130384338|NCT01474876|469375951|FG002|Overall Study|Adverse Event|0|||
130384339|NCT01474876|469375949|FG000|Overall Study|Serious Adverse Event|2|||
130384340|NCT01474876|469375950|FG001|Overall Study|Serious Adverse Event|3|||
130384341|NCT01474876|469375951|FG002|Overall Study|Serious Adverse Event|0|||
130384342|NCT01474876|469375949|FG000|Overall Study|Lost to Follow-up|5|||
130384343|NCT01474876|469375950|FG001|Overall Study|Lost to Follow-up|4|||
130384344|NCT01474876|469375951|FG002|Overall Study|Lost to Follow-up|0|||
130384345|NCT01474876|469375949|FG000|Overall Study|Investigator's decision|28|||
130384346|NCT01474876|469375950|FG001|Overall Study|Investigator's decision|6|||
130384347|NCT01474876|469375951|FG002|Overall Study|Investigator's decision|0|||
130384348|NCT01474876|469375949|FG000|Overall Study|Patient's request|19|||
130384349|NCT01474876|469375950|FG001|Overall Study|Patient's request|5|||
130384350|NCT01474876|469375951|FG002|Overall Study|Patient's request|0|||
130384351|NCT01474876|469375949|FG000|Overall Study|Investigator's decision and pt request|1|||
130384352|NCT01474876|469375950|FG001|Overall Study|Investigator's decision and pt request|0|||
130384353|NCT01474876|469375951|FG002|Overall Study|Investigator's decision and pt request|0|||
130384354|NCT01523886|469375952|FG000|Overall Study|surgery cancelled|0|||
130384355|NCT01523886|469375953|FG001|Overall Study|surgery cancelled|1|||
130384356|NCT01173718|469375963|FG000|Overall Study|Death|17|||
130384357|NCT01173718|469375963|FG000|Overall Study|Abandonment of study graft|27|||
130384358|NCT01367158|469375964|FG000|Overall Study|Withdrew consent|0|||
130384359|NCT01367158|469375965|FG001|Overall Study|Withdrew consent|2|||
130384360|NCT01367158|469375966|FG002|Overall Study|Withdrew consent|1|||
130384361|NCT01367158|469375967|FG003|Overall Study|Withdrew consent|0|||
130384362|NCT01367158|469375968|FG004|Overall Study|Withdrew consent|2|||
130384363|NCT01367158|469375969|FG005|Overall Study|Withdrew consent|0|||
130384364|NCT01367158|469375970|FG006|Overall Study|Withdrew consent|0|||
130384365|NCT01367158|469375971|FG007|Overall Study|Withdrew consent|1|||
130384366|NCT01367158|469375972|FG008|Overall Study|Withdrew consent|0|||
130384367|NCT01367158|469375973|FG009|Overall Study|Withdrew consent|0|||
130384368|NCT01367158|469375974|FG010|Overall Study|Withdrew consent|0|||
130384369|NCT01367158|469375964|FG000|Overall Study|Lost to Follow-up|0|||
130384370|NCT01367158|469375965|FG001|Overall Study|Lost to Follow-up|0|||
130384371|NCT01367158|469375966|FG002|Overall Study|Lost to Follow-up|0|||
130384372|NCT01367158|469375967|FG003|Overall Study|Lost to Follow-up|1|||
130384373|NCT01367158|469375968|FG004|Overall Study|Lost to Follow-up|0|||
130384374|NCT01367158|469375969|FG005|Overall Study|Lost to Follow-up|2|||
130384375|NCT01367158|469375970|FG006|Overall Study|Lost to Follow-up|0|||
130384376|NCT01367158|469375971|FG007|Overall Study|Lost to Follow-up|1|||
130384377|NCT01367158|469375972|FG008|Overall Study|Lost to Follow-up|0|||
130384378|NCT01367158|469375973|FG009|Overall Study|Lost to Follow-up|0|||
130384379|NCT01367158|469375974|FG010|Overall Study|Lost to Follow-up|1|||
130384380|NCT01367158|469375964|FG000|Overall Study|Protocol Violation|0|||
130384381|NCT01367158|469375965|FG001|Overall Study|Protocol Violation|1|||
130384382|NCT01367158|469375966|FG002|Overall Study|Protocol Violation|0|||
130384383|NCT01367158|469375967|FG003|Overall Study|Protocol Violation|0|||
130384384|NCT01367158|469375968|FG004|Overall Study|Protocol Violation|0|||
130384385|NCT01367158|469375969|FG005|Overall Study|Protocol Violation|0|||
130384386|NCT01367158|469375970|FG006|Overall Study|Protocol Violation|0|||
130384387|NCT01367158|469375971|FG007|Overall Study|Protocol Violation|0|||
130384388|NCT01367158|469375972|FG008|Overall Study|Protocol Violation|0|||
130384389|NCT01367158|469375973|FG009|Overall Study|Protocol Violation|0|||
130384390|NCT01367158|469375974|FG010|Overall Study|Protocol Violation|0|||
130384391|NCT02226003|469375975|FG000|Overall Study|Lost to Follow-up|2|||
130384392|NCT02226003|469375976|FG001|Overall Study|Lost to Follow-up|1|||
130384393|NCT02226003|469375977|FG002|Overall Study|Lost to Follow-up|3|||
130384394|NCT02226003|469375975|FG000|Overall Study|Withdrawal by Subject|0|||
130384395|NCT02226003|469375976|FG001|Overall Study|Withdrawal by Subject|0|||
130384396|NCT02226003|469375977|FG002|Overall Study|Withdrawal by Subject|3|||
130384397|NCT01499563|469375980|FG000|Overall Study|Withdrawal by Subject|10|||
130384398|NCT01499563|469375981|FG001|Overall Study|Withdrawal by Subject|11|||
130384399|NCT01499563|469375982|FG002|Overall Study|Withdrawal by Subject|7|||
130384400|NCT01499563|469375983|FG003|Overall Study|Withdrawal by Subject|8|||
130384401|NCT01499563|469375980|FG000|Overall Study|Physician Decision|2|||
130384402|NCT01499563|469375981|FG001|Overall Study|Physician Decision|1|||
130384403|NCT01499563|469375982|FG002|Overall Study|Physician Decision|3|||
130384404|NCT01499563|469375983|FG003|Overall Study|Physician Decision|0|||
130384405|NCT01499563|469375980|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
130384406|NCT01499563|469375981|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
130384407|NCT01499563|469375982|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
130384408|NCT01499563|469375983|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
130384409|NCT01499563|469375980|FG000|Overall Study|Adverse Event|2|||
130384410|NCT01499563|469375981|FG001|Overall Study|Adverse Event|0|||
130384411|NCT01499563|469375982|FG002|Overall Study|Adverse Event|1|||
130384412|NCT01499563|469375983|FG003|Overall Study|Adverse Event|3|||
130384413|NCT01499563|469375980|FG000|Overall Study|Lack of Efficacy|0|||
130384414|NCT01499563|469375981|FG001|Overall Study|Lack of Efficacy|1|||
130384415|NCT01499563|469375982|FG002|Overall Study|Lack of Efficacy|6|||
130384416|NCT01499563|469375983|FG003|Overall Study|Lack of Efficacy|3|||
130384417|NCT01499563|469375980|FG000|Overall Study|Other|8|||
130384418|NCT01499563|469375981|FG001|Overall Study|Other|6|||
130384419|NCT01499563|469375982|FG002|Overall Study|Other|6|||
130384420|NCT01499563|469375983|FG003|Overall Study|Other|4|||
130384421|NCT00597012|469375988|FG000|Overall Study|Death|1|||
130384422|NCT00597012|469375989|FG001|Overall Study|Death|1|||
130384423|NCT00597012|469375988|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
130384424|NCT00597012|469375989|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
130384425|NCT00597012|469375988|FG000|Overall Study|Withdrawal by Subject|7|||
130384426|NCT00597012|469375989|FG001|Overall Study|Withdrawal by Subject|4|||
130384427|NCT00597012|469375988|FG000|Overall Study|Ineligible|2|||
130384428|NCT00597012|469375989|FG001|Overall Study|Ineligible|0|||
130384429|NCT00597012|469375988|FG000|Overall Study|Lost to Follow-up|0|||
130384430|NCT00597012|469375989|FG001|Overall Study|Lost to Follow-up|2|||
130384431|NCT00587561|469376523|FG000|Overall Study|Lost to Follow-up|6|||
130384432|NCT00587561|469376524|FG001|Overall Study|Lost to Follow-up|4|||
130384433|NCT00410761|469376525|FG000|Randomized Treatment Period|Adverse Event|34|||
130384434|NCT00410761|469376526|FG001|Randomized Treatment Period|Adverse Event|3|||
130384435|NCT00410761|469376525|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
130384436|NCT00410761|469376526|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
130384437|NCT00410761|469376525|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
130384438|NCT00410761|469376526|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
130384439|NCT00410761|469376525|FG000|Randomized Treatment Period|Other|69|||
130384440|NCT00410761|469376526|FG001|Randomized Treatment Period|Other|21|||
130384441|NCT00410761|469376525|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
130384442|NCT00410761|469376526|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
130384443|NCT00410761|469376525|FG000|Open-Label Treatment Period|Adverse Event|13|||
130384444|NCT00410761|469376526|FG001|Open-Label Treatment Period|Adverse Event|15|||
130384445|NCT00410761|469376525|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
130384446|NCT00410761|469376526|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
130384447|NCT00410761|469376525|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
130384448|NCT00410761|469376526|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
130384449|NCT00410761|469376525|FG000|Open-Label Treatment Period|Other|18|||
130384450|NCT00410761|469376526|FG001|Open-Label Treatment Period|Other|9|||
130384451|NCT02926924|469376528|FG000|Overall Study|withdrawal - reason unknown|0|||
130384452|NCT02926924|469376529|FG001|Overall Study|withdrawal - reason unknown|1|||
130384453|NCT04568590|469376532|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
130384454|NCT00202644|469376533|FG000|Overall Study|Adverse Event|12|||
130384455|NCT00202644|469376534|FG001|Overall Study|Adverse Event|13|||
130384456|NCT00202644|469376533|FG000|Overall Study|Withdrawal by Subject|8|||
130384457|NCT00202644|469376534|FG001|Overall Study|Withdrawal by Subject|6|||
130384458|NCT00202644|469376533|FG000|Overall Study|Lack of Efficacy|6|||
130384459|NCT00202644|469376534|FG001|Overall Study|Lack of Efficacy|6|||
130384460|NCT00202644|469376533|FG000|Overall Study|Lost to Follow-up|0|||
130384461|NCT00202644|469376534|FG001|Overall Study|Lost to Follow-up|1|||
130384462|NCT00202644|469376533|FG000|Overall Study|Other|9|||
130384463|NCT00202644|469376534|FG001|Overall Study|Other|1|||
130384464|NCT03724812|469376541|FG000|Overall Study|Missed Visit|1|||
130384465|NCT03724812|469376541|FG000|Overall Study|Death|2|||
130384466|NCT03724812|469376541|FG000|Overall Study|Withdrawal by Subject|1|||
130384467|NCT02268864|469376542|FG000|Overall Study|Withdrawal by Subject|2|||
130384468|NCT02268864|469376543|FG001|Overall Study|Withdrawal by Subject|0|||
130384469|NCT02268864|469376544|FG002|Overall Study|Withdrawal by Subject|0|||
130384470|NCT02268864|469376542|FG000|Overall Study|Death|0|||
130384471|NCT02268864|469376543|FG001|Overall Study|Death|1|||
130384472|NCT02268864|469376544|FG002|Overall Study|Death|0|||
130384473|NCT05407675|469376545|FG000|Overall Study|Withdrawal by Subject|0|||
130384474|NCT05407675|469376546|FG001|Overall Study|Withdrawal by Subject|2|||
130384475|NCT05407675|469376547|FG002|Overall Study|Withdrawal by Subject|3|||
130384476|NCT05407675|469376548|FG003|Overall Study|Withdrawal by Subject|5|||
130384477|NCT05407675|469376549|FG004|Overall Study|Withdrawal by Subject|0|||
130384478|NCT05407675|469376550|FG005|Overall Study|Withdrawal by Subject|2|||
130384479|NCT05407675|469376551|FG006|Overall Study|Withdrawal by Subject|0|||
130384480|NCT05407675|469376552|FG007|Overall Study|Withdrawal by Subject|0|||
130384481|NCT05407675|469376553|FG008|Overall Study|Withdrawal by Subject|2|||
130384482|NCT05407675|469376554|FG009|Overall Study|Withdrawal by Subject|0|||
130384483|NCT05407675|469376555|FG010|Overall Study|Withdrawal by Subject|1|||
130384484|NCT05407675|469376556|FG011|Overall Study|Withdrawal by Subject|0|||
130384485|NCT05407675|469376557|FG012|Overall Study|Withdrawal by Subject|0|||
130384486|NCT05407675|469376545|FG000|Overall Study|Site terminated by sponsor|0|||
130384487|NCT05407675|469376546|FG001|Overall Study|Site terminated by sponsor|0|||
130384488|NCT05407675|469376547|FG002|Overall Study|Site terminated by sponsor|1|||
130384489|NCT05407675|469376548|FG003|Overall Study|Site terminated by sponsor|0|||
130384490|NCT05407675|469376549|FG004|Overall Study|Site terminated by sponsor|2|||
130384491|NCT05407675|469376550|FG005|Overall Study|Site terminated by sponsor|0|||
130384492|NCT05407675|469376551|FG006|Overall Study|Site terminated by sponsor|1|||
130384493|NCT05407675|469376552|FG007|Overall Study|Site terminated by sponsor|0|||
130384494|NCT05407675|469376553|FG008|Overall Study|Site terminated by sponsor|0|||
130384495|NCT05407675|469376554|FG009|Overall Study|Site terminated by sponsor|2|||
130384496|NCT05407675|469376555|FG010|Overall Study|Site terminated by sponsor|2|||
130384497|NCT05407675|469376556|FG011|Overall Study|Site terminated by sponsor|2|||
130384498|NCT05407675|469376557|FG012|Overall Study|Site terminated by sponsor|1|||
130384499|NCT05407675|469376545|FG000|Overall Study|Disease Progression|0|||
130384500|NCT05407675|469376546|FG001|Overall Study|Disease Progression|0|||
130384501|NCT05407675|469376547|FG002|Overall Study|Disease Progression|0|||
130384502|NCT05407675|469376548|FG003|Overall Study|Disease Progression|0|||
130384503|NCT05407675|469376549|FG004|Overall Study|Disease Progression|0|||
130384504|NCT05407675|469376550|FG005|Overall Study|Disease Progression|0|||
130384505|NCT05407675|469376551|FG006|Overall Study|Disease Progression|0|||
130384506|NCT05407675|469376552|FG007|Overall Study|Disease Progression|0|||
130384507|NCT05407675|469376553|FG008|Overall Study|Disease Progression|0|||
130384508|NCT05407675|469376554|FG009|Overall Study|Disease Progression|0|||
130384509|NCT05407675|469376555|FG010|Overall Study|Disease Progression|1|||
130384510|NCT05407675|469376556|FG011|Overall Study|Disease Progression|0|||
130384511|NCT05407675|469376557|FG012|Overall Study|Disease Progression|0|||
130384512|NCT05407675|469376545|FG000|Overall Study|Physician Decision|0|||
130384513|NCT05407675|469376546|FG001|Overall Study|Physician Decision|0|||
130384514|NCT05407675|469376547|FG002|Overall Study|Physician Decision|0|||
130384515|NCT05407675|469376548|FG003|Overall Study|Physician Decision|0|||
130384516|NCT05407675|469376549|FG004|Overall Study|Physician Decision|0|||
130384517|NCT05407675|469376550|FG005|Overall Study|Physician Decision|0|||
130384518|NCT05407675|469376551|FG006|Overall Study|Physician Decision|0|||
130384519|NCT05407675|469376552|FG007|Overall Study|Physician Decision|0|||
130384520|NCT05407675|469376553|FG008|Overall Study|Physician Decision|0|||
130384521|NCT05407675|469376554|FG009|Overall Study|Physician Decision|0|||
130384522|NCT05407675|469376555|FG010|Overall Study|Physician Decision|1|||
130384523|NCT05407675|469376556|FG011|Overall Study|Physician Decision|0|||
130384524|NCT05407675|469376557|FG012|Overall Study|Physician Decision|0|||
130384525|NCT05407675|469376545|FG000|Overall Study|Other reasons|0|||
130384526|NCT05407675|469376546|FG001|Overall Study|Other reasons|0|||
130384527|NCT05407675|469376547|FG002|Overall Study|Other reasons|0|||
130384528|NCT05407675|469376548|FG003|Overall Study|Other reasons|0|||
130384529|NCT05407675|469376549|FG004|Overall Study|Other reasons|0|||
130384530|NCT05407675|469376550|FG005|Overall Study|Other reasons|0|||
130384531|NCT05407675|469376551|FG006|Overall Study|Other reasons|0|||
130384532|NCT05407675|469376552|FG007|Overall Study|Other reasons|0|||
130384533|NCT05407675|469376553|FG008|Overall Study|Other reasons|1|||
130384534|NCT05407675|469376554|FG009|Overall Study|Other reasons|1|||
130384535|NCT05407675|469376555|FG010|Overall Study|Other reasons|1|||
130384536|NCT05407675|469376556|FG011|Overall Study|Other reasons|1|||
130384537|NCT05407675|469376557|FG012|Overall Study|Other reasons|0|||
130384538|NCT05407675|469376545|FG000|Overall Study|Death|3|||
130384539|NCT05407675|469376546|FG001|Overall Study|Death|4|||
130384540|NCT05407675|469376547|FG002|Overall Study|Death|3|||
130384541|NCT05407675|469376548|FG003|Overall Study|Death|6|||
130384542|NCT05407675|469376549|FG004|Overall Study|Death|0|||
130384543|NCT05407675|469376550|FG005|Overall Study|Death|2|||
130384544|NCT05407675|469376551|FG006|Overall Study|Death|4|||
130384545|NCT05407675|469376552|FG007|Overall Study|Death|2|||
130384546|NCT05407675|469376553|FG008|Overall Study|Death|2|||
130384547|NCT05407675|469376554|FG009|Overall Study|Death|4|||
130384548|NCT05407675|469376555|FG010|Overall Study|Death|2|||
130384549|NCT05407675|469376556|FG011|Overall Study|Death|1|||
130384550|NCT05407675|469376557|FG012|Overall Study|Death|0|||
130384551|NCT05407675|469376545|FG000|Overall Study|Adverse Event|0|||
130384552|NCT05407675|469376546|FG001|Overall Study|Adverse Event|0|||
130384553|NCT05407675|469376547|FG002|Overall Study|Adverse Event|0|||
130384554|NCT05407675|469376548|FG003|Overall Study|Adverse Event|0|||
130384555|NCT05407675|469376549|FG004|Overall Study|Adverse Event|1|||
130384556|NCT05407675|469376550|FG005|Overall Study|Adverse Event|0|||
130384557|NCT05407675|469376551|FG006|Overall Study|Adverse Event|0|||
130384558|NCT05407675|469376552|FG007|Overall Study|Adverse Event|0|||
130468946|NCT03398148|469683553|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468947|NCT03398148|469683554|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468948|NCT03398148|469683555|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468949|NCT03398148|469683556|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468950|NCT03398148|469683557|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468951|NCT03398148|469683558|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130468952|NCT03398148|469683544|FG000|Substudy 1 Period 2|Other|0|||
130468953|NCT03398148|469683545|FG001|Substudy 1 Period 2|Other|0|||
130468954|NCT03398148|469683546|FG002|Substudy 1 Period 2|Other|0|||
130468955|NCT03398148|469683547|FG003|Substudy 1 Period 2|Other|0|||
130468956|NCT03398148|469683548|FG004|Substudy 1 Period 2|Other|0|||
130468957|NCT03398148|469683549|FG005|Substudy 1 Period 2|Other|0|||
130468958|NCT03398148|469683550|FG006|Substudy 1 Period 2|Other|1|||
130468959|NCT03398148|469683551|FG007|Substudy 1 Period 2|Other|0|||
130468960|NCT03398148|469683552|FG008|Substudy 1 Period 2|Other|0|||
130468961|NCT03398148|469683553|FG009|Substudy 1 Period 2|Other|0|||
130468962|NCT03398148|469683554|FG010|Substudy 1 Period 2|Other|0|||
130468963|NCT03398148|469683555|FG011|Substudy 1 Period 2|Other|0|||
130468964|NCT03398148|469683556|FG012|Substudy 1 Period 2|Other|0|||
130468965|NCT03398148|469683557|FG013|Substudy 1 Period 2|Other|0|||
130384559|NCT05407675|469376553|FG008|Overall Study|Adverse Event|0|||
130384560|NCT05407675|469376554|FG009|Overall Study|Adverse Event|0|||
130384561|NCT05407675|469376555|FG010|Overall Study|Adverse Event|0|||
130384562|NCT05407675|469376556|FG011|Overall Study|Adverse Event|1|||
130384563|NCT05407675|469376557|FG012|Overall Study|Adverse Event|0|||
130384564|NCT05407675|469376545|FG000|Overall Study|Ongoing Treatment|0|||
130384565|NCT05407675|469376546|FG001|Overall Study|Ongoing Treatment|0|||
130384566|NCT05407675|469376547|FG002|Overall Study|Ongoing Treatment|0|||
130384567|NCT05407675|469376548|FG003|Overall Study|Ongoing Treatment|0|||
130384568|NCT05407675|469376549|FG004|Overall Study|Ongoing Treatment|0|||
130384569|NCT05407675|469376550|FG005|Overall Study|Ongoing Treatment|0|||
130384570|NCT05407675|469376551|FG006|Overall Study|Ongoing Treatment|0|||
130384571|NCT05407675|469376552|FG007|Overall Study|Ongoing Treatment|0|||
130384572|NCT05407675|469376553|FG008|Overall Study|Ongoing Treatment|1|||
130384573|NCT05407675|469376554|FG009|Overall Study|Ongoing Treatment|0|||
130384574|NCT05407675|469376555|FG010|Overall Study|Ongoing Treatment|0|||
130384575|NCT05407675|469376556|FG011|Overall Study|Ongoing Treatment|0|||
130384576|NCT05407675|469376557|FG012|Overall Study|Ongoing Treatment|0|||
130384577|NCT00857220|469376558|FG000|Overall Study|Adverse Event|35|||
130384578|NCT00857220|469376558|FG000|Overall Study|Death|1|||
130384579|NCT00857220|469376558|FG000|Overall Study|Lack of Efficacy|11|||
130384580|NCT00857220|469376558|FG000|Overall Study|Lost to Follow-up|30|||
130384581|NCT00857220|469376558|FG000|Overall Study|Physician Decision|4|||
130384582|NCT00857220|469376558|FG000|Overall Study|Protocol Violation|16|||
130384583|NCT00857220|469376558|FG000|Overall Study|Withdrawal by Subject|67|||
130384584|NCT00857220|469376558|FG000|Overall Study|Clinical Hold|6|||
130384585|NCT00857220|469376558|FG000|Overall Study|Site Closed|5|||
130384586|NCT00857220|469376558|FG000|Overall Study|Miscellaneous|8|||
130384587|NCT03698994|469376559|FG000|Overall Study|Adverse Event|2|||
130384588|NCT03698994|469376559|FG000|Overall Study|Death|1|||
130384589|NCT03698994|469376559|FG000|Overall Study|Physician Decision|1|||
130384590|NCT03698994|469376559|FG000|Overall Study|Withdrawal by Subject|3|||
130384591|NCT03698994|469376559|FG000|Overall Study|Progressive Disease|12|||
130384592|NCT03251079|469376563|FG000|Overall Study|Withdrawal by Subject|1|||
130384593|NCT02472795|469376570|FG000|Overall Study|Adverse Event|0|||
130384594|NCT02472795|469376571|FG001|Overall Study|Adverse Event|1|||
130384595|NCT02472795|469376572|FG002|Overall Study|Adverse Event|0|||
130384596|NCT02472795|469376573|FG003|Overall Study|Adverse Event|0|||
130384597|NCT02472795|469376574|FG004|Overall Study|Adverse Event|2|||
130384598|NCT02472795|469376570|FG000|Overall Study|Withdrawal by Subject|0|||
130384599|NCT02472795|469376571|FG001|Overall Study|Withdrawal by Subject|0|||
130384600|NCT02472795|469376572|FG002|Overall Study|Withdrawal by Subject|0|||
130384601|NCT02472795|469376573|FG003|Overall Study|Withdrawal by Subject|0|||
130384602|NCT02472795|469376574|FG004|Overall Study|Withdrawal by Subject|1|||
130384603|NCT04166513|469376575|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
130384604|NCT04166513|469376576|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
130468966|NCT03398148|469683558|FG014|Substudy 1 Period 2|Other|0|||
130468967|NCT03398148|469683544|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
130384605|NCT04166513|469376577|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
130384606|NCT04166513|469376578|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
130384607|NCT04166513|469376575|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
130384608|NCT04166513|469376576|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
130384609|NCT04166513|469376577|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
130468968|NCT03398148|469683545|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468969|NCT03398148|469683546|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
130384610|NCT04166513|469376578|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
130384611|NCT04166513|469376575|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
130468970|NCT03398148|469683547|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
130722421|NCT00678886|470608245|FG001|Overall Study|Lost to Follow-up|0|||
130384612|NCT04166513|469376576|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
130384613|NCT04166513|469376577|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
130384614|NCT04166513|469376578|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
130384615|NCT04166513|469376575|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
130384616|NCT04166513|469376576|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
130384617|NCT04166513|469376577|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
130384618|NCT04166513|469376578|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
130384619|NCT04166513|469376575|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
130384620|NCT04166513|469376576|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
130384621|NCT04166513|469376577|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
130384622|NCT04166513|469376578|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
130384623|NCT01851720|469378231|FG000|Overall Study|Lost to Follow-up|0|||
130384624|NCT01851720|469378232|FG001|Overall Study|Lost to Follow-up|1|||
130384625|NCT01870583|469378235|FG000|Overall Study|Protocol Violation|0|||
130384626|NCT01870583|469378236|FG001|Overall Study|Protocol Violation|5|||
130384627|NCT01870583|469378237|FG002|Overall Study|Protocol Violation|3|||
130384628|NCT01870583|469378235|FG000|Overall Study|Lost to Follow-up|11|||
130384629|NCT01870583|469378236|FG001|Overall Study|Lost to Follow-up|13|||
130384630|NCT01870583|469378237|FG002|Overall Study|Lost to Follow-up|5|||
130384631|NCT04741074|469378238|FG000|Overall Study|Withdrawal by Subject|1|||
130384632|NCT04741074|469378239|FG001|Overall Study|Withdrawal by Subject|1|||
130384633|NCT04741074|469378238|FG000|Overall Study|Study terminated prematurely|1|||
130384634|NCT04741074|469378239|FG001|Overall Study|Study terminated prematurely|0|||
130384635|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Death|3|||
130384636|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Death|2|||
130384637|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Death|4|||
130384638|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Death|3|||
130384639|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Death|0|||
130384640|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Death|0|||
130384641|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130384642|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
130384643|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
130384644|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130384645|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130384646|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130384647|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
130384648|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130384649|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130384650|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130384651|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130384652|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130384653|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
130384654|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130384655|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
130384656|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
130384657|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130384658|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130384659|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130384660|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130384661|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
130384662|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
130384663|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130384664|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130384665|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
130384666|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
130384667|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
130384668|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
130384669|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
130384670|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
130384671|NCT02432846|469378240|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130384672|NCT02432846|469378241|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130384673|NCT02432846|469378242|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
130384674|NCT02432846|469378243|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130384675|NCT02432846|469378244|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130384676|NCT02432846|469378245|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130384677|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
130384678|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
130384679|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
130384680|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
130468971|NCT03398148|469683548|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468972|NCT03398148|469683549|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
130384681|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
130384682|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
130384683|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130384684|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130384685|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130384686|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130384687|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
130384688|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
130384689|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130384690|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130384691|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130384692|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130384693|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
130384694|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130384695|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130468973|NCT03398148|469683550|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
130468974|NCT03398148|469683551|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468975|NCT03398148|469683552|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468976|NCT03398148|469683553|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468977|NCT03398148|469683554|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468978|NCT03398148|469683555|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468979|NCT03398148|469683556|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468980|NCT03398148|469683557|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468981|NCT03398148|469683558|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
130468982|NCT03398148|469683544|FG000|Substudy 2 Period 1|Adverse Event|0|||
130468983|NCT03398148|469683545|FG001|Substudy 2 Period 1|Adverse Event|0|||
130468984|NCT03398148|469683546|FG002|Substudy 2 Period 1|Adverse Event|0|||
130468985|NCT03398148|469683547|FG003|Substudy 2 Period 1|Adverse Event|0|||
130468986|NCT03398148|469683548|FG004|Substudy 2 Period 1|Adverse Event|0|||
130468987|NCT03398148|469683549|FG005|Substudy 2 Period 1|Adverse Event|0|||
130468988|NCT03398148|469683550|FG006|Substudy 2 Period 1|Adverse Event|0|||
130468989|NCT03398148|469683551|FG007|Substudy 2 Period 1|Adverse Event|0|||
130468990|NCT03398148|469683552|FG008|Substudy 2 Period 1|Adverse Event|0|||
130468991|NCT03398148|469683553|FG009|Substudy 2 Period 1|Adverse Event|12|||
130468992|NCT03398148|469683554|FG010|Substudy 2 Period 1|Adverse Event|2|||
130468993|NCT03398148|469683555|FG011|Substudy 2 Period 1|Adverse Event|0|||
130468994|NCT03398148|469683556|FG012|Substudy 2 Period 1|Adverse Event|0|||
130468995|NCT03398148|469683557|FG013|Substudy 2 Period 1|Adverse Event|0|||
130468996|NCT03398148|469683558|FG014|Substudy 2 Period 1|Adverse Event|0|||
130468997|NCT03398148|469683544|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130384696|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130384697|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130384698|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130384699|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
130384700|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
130384701|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130384702|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130384703|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130384704|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130384705|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
130384706|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
130384707|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130384708|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130384709|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130384710|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130384711|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
130384712|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
130384713|NCT02432846|469378240|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130384714|NCT02432846|469378241|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130384715|NCT02432846|469378242|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130468998|NCT03398148|469683545|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130468999|NCT03398148|469683546|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469000|NCT03398148|469683547|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469001|NCT03398148|469683548|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469002|NCT03398148|469683549|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469003|NCT03398148|469683550|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469004|NCT03398148|469683551|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469005|NCT03398148|469683552|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469006|NCT03398148|469683553|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
130469007|NCT03398148|469683554|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
130469008|NCT03398148|469683555|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469009|NCT03398148|469683556|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469010|NCT03398148|469683557|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469011|NCT03398148|469683558|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
130469012|NCT03398148|469683544|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
130469013|NCT03398148|469683545|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
130469014|NCT03398148|469683546|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
130469015|NCT03398148|469683547|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
130722422|NCT00678886|470608246|FG002|Overall Study|Lost to Follow-up|3|||
130722423|NCT00678886|470608247|FG003|Overall Study|Lost to Follow-up|2|||
130722424|NCT00678886|470608244|FG000|Overall Study|Other|0|||
130384716|NCT02432846|469378243|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130384717|NCT02432846|469378244|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
130384718|NCT02432846|469378245|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130384719|NCT01770379|469378246|FG000|Overall Study|Technical issues|1|||
130384720|NCT01770379|469378247|FG001|Overall Study|Technical issues|0|||
130384721|NCT01770379|469378248|FG002|Overall Study|Technical issues|0|||
130384722|NCT01770379|469378246|FG000|Overall Study|Withdrawal by Subject|7|||
130384723|NCT01770379|469378247|FG001|Overall Study|Withdrawal by Subject|10|||
130384724|NCT01770379|469378248|FG002|Overall Study|Withdrawal by Subject|7|||
130384725|NCT01770379|469378246|FG000|Overall Study|study terminated by sponsor|22|||
130384726|NCT01770379|469378247|FG001|Overall Study|study terminated by sponsor|23|||
130384727|NCT01770379|469378248|FG002|Overall Study|study terminated by sponsor|22|||
130384728|NCT01770379|469378246|FG000|Overall Study|Protocol Violation|0|||
130384729|NCT01770379|469378247|FG001|Overall Study|Protocol Violation|1|||
130384730|NCT01770379|469378248|FG002|Overall Study|Protocol Violation|1|||
130384731|NCT01770379|469378246|FG000|Overall Study|Physician Decision|0|||
130384732|NCT01770379|469378247|FG001|Overall Study|Physician Decision|1|||
130384733|NCT01770379|469378248|FG002|Overall Study|Physician Decision|2|||
130384734|NCT01770379|469378246|FG000|Overall Study|Lost to Follow-up|0|||
130384735|NCT01770379|469378247|FG001|Overall Study|Lost to Follow-up|0|||
130384736|NCT01770379|469378248|FG002|Overall Study|Lost to Follow-up|2|||
130384737|NCT01770379|469378246|FG000|Overall Study|Lack of Efficacy|8|||
130384738|NCT01770379|469378247|FG001|Overall Study|Lack of Efficacy|6|||
130384739|NCT01770379|469378248|FG002|Overall Study|Lack of Efficacy|6|||
130384740|NCT01770379|469378246|FG000|Overall Study|Adverse Event|1|||
130384741|NCT01770379|469378247|FG001|Overall Study|Adverse Event|3|||
130384742|NCT01770379|469378248|FG002|Overall Study|Adverse Event|2|||
130384743|NCT03045887|469378249|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
130384744|NCT03045887|469378250|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384745|NCT03045887|469378251|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384746|NCT03045887|469378252|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384747|NCT03045887|469378253|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384748|NCT03045887|469378254|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384749|NCT03045887|469378255|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384750|NCT03045887|469378256|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384751|NCT03045887|469378257|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384752|NCT03045887|469378258|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130384753|NCT03045887|469378249|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384754|NCT03045887|469378250|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384755|NCT03045887|469378251|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384756|NCT03045887|469378252|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
130384757|NCT03045887|469378253|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384758|NCT03045887|469378254|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384759|NCT03045887|469378255|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130722425|NCT00678886|470608245|FG001|Overall Study|Other|0|||
130722426|NCT00678886|470608246|FG002|Overall Study|Other|1|||
130722427|NCT00678886|470608247|FG003|Overall Study|Other|0|||
130722428|NCT00206323|470608248|FG000|Overall Study|Lack of Efficacy|4|||
130384760|NCT03045887|469378256|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130722429|NCT00206323|470608249|FG001|Overall Study|Lack of Efficacy|1|||
130722430|NCT00206323|470608248|FG000|Overall Study|Adverse Event|1|||
130722431|NCT00206323|470608249|FG001|Overall Study|Adverse Event|1|||
130384761|NCT03045887|469378257|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384762|NCT03045887|469378258|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130384763|NCT03045887|469378249|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
130384764|NCT03045887|469378250|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384765|NCT03045887|469378251|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
130469016|NCT03398148|469683548|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
130469017|NCT03398148|469683549|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
130469018|NCT03398148|469683550|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
130384766|NCT03045887|469378252|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384767|NCT03045887|469378253|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384768|NCT03045887|469378254|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384769|NCT03045887|469378255|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
130469019|NCT03398148|469683551|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
130469020|NCT03398148|469683552|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
130469021|NCT03398148|469683553|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
130469022|NCT03398148|469683554|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
130469023|NCT03398148|469683555|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
130469024|NCT03398148|469683556|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
130469025|NCT03398148|469683557|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
130469026|NCT03398148|469683558|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
130469027|NCT03398148|469683544|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469028|NCT03398148|469683545|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469029|NCT03398148|469683546|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469030|NCT03398148|469683547|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469031|NCT03398148|469683548|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469032|NCT03398148|469683549|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469033|NCT03398148|469683550|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469034|NCT03398148|469683551|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469035|NCT03398148|469683552|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469036|NCT03398148|469683553|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469037|NCT03398148|469683554|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
130469038|NCT03398148|469683555|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469039|NCT03398148|469683556|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469040|NCT03398148|469683557|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469041|NCT03398148|469683558|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130469042|NCT03398148|469683544|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469043|NCT03398148|469683545|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469044|NCT03398148|469683546|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469045|NCT03398148|469683547|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469046|NCT03398148|469683548|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469047|NCT03398148|469683549|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469048|NCT03398148|469683550|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469049|NCT03398148|469683551|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469050|NCT03398148|469683552|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469051|NCT03398148|469683553|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469052|NCT03398148|469683554|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
130384770|NCT03045887|469378256|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384771|NCT03045887|469378257|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384772|NCT03045887|469378258|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
130384773|NCT03045887|469378249|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384774|NCT03045887|469378250|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384775|NCT03045887|469378251|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
130384776|NCT03045887|469378252|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
130384777|NCT03045887|469378253|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384778|NCT03045887|469378254|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384779|NCT03045887|469378255|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384780|NCT03045887|469378256|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384781|NCT03045887|469378257|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384782|NCT03045887|469378258|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130384783|NCT03045887|469378249|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384784|NCT03045887|469378250|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384785|NCT03045887|469378251|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384786|NCT03045887|469378252|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
130384787|NCT03045887|469378253|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130469053|NCT03398148|469683555|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469054|NCT03398148|469683556|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469055|NCT03398148|469683557|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469056|NCT03398148|469683558|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130469057|NCT03398148|469683544|FG000|Substudy 2 Period 1|Other|0|||
130469058|NCT03398148|469683545|FG001|Substudy 2 Period 1|Other|0|||
130469059|NCT03398148|469683546|FG002|Substudy 2 Period 1|Other|0|||
130469060|NCT03398148|469683547|FG003|Substudy 2 Period 1|Other|0|||
130469061|NCT03398148|469683548|FG004|Substudy 2 Period 1|Other|0|||
130469062|NCT03398148|469683549|FG005|Substudy 2 Period 1|Other|0|||
130469063|NCT03398148|469683550|FG006|Substudy 2 Period 1|Other|0|||
130469064|NCT03398148|469683551|FG007|Substudy 2 Period 1|Other|0|||
130469065|NCT03398148|469683552|FG008|Substudy 2 Period 1|Other|0|||
130469066|NCT03398148|469683553|FG009|Substudy 2 Period 1|Other|4|||
130469067|NCT03398148|469683554|FG010|Substudy 2 Period 1|Other|4|||
130384788|NCT03045887|469378254|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384789|NCT03045887|469378255|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384790|NCT03045887|469378256|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384791|NCT03045887|469378257|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384792|NCT03045887|469378258|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130384793|NCT01912287|469378260|FG000|Overall Study|Ineligible|1|||
130384794|NCT01912287|469378261|FG001|Overall Study|Ineligible|0|||
130384795|NCT01912287|469378262|FG002|Overall Study|Ineligible|1|||
130384796|NCT01912287|469378260|FG000|Overall Study|No-show|0|||
130384797|NCT01912287|469378261|FG001|Overall Study|No-show|0|||
130384798|NCT01912287|469378262|FG002|Overall Study|No-show|1|||
130384799|NCT01912287|469378260|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
130384800|NCT01912287|469378261|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
130384801|NCT01912287|469378262|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
130384802|NCT01912287|469378260|FG000|Overall Study|Felt treatment no longer needed|0|||
130384803|NCT01912287|469378261|FG001|Overall Study|Felt treatment no longer needed|1|||
130384804|NCT01912287|469378262|FG002|Overall Study|Felt treatment no longer needed|0|||
130384805|NCT01912287|469378260|FG000|Overall Study|Life circumstances|4|||
130384806|NCT01912287|469378261|FG001|Overall Study|Life circumstances|2|||
130384807|NCT01912287|469378262|FG002|Overall Study|Life circumstances|0|||
130384808|NCT01912287|469378260|FG000|Overall Study|Lost Interest|1|||
130384809|NCT01912287|469378261|FG001|Overall Study|Lost Interest|0|||
130384810|NCT01912287|469378262|FG002|Overall Study|Lost Interest|0|||
130384811|NCT01912287|469378260|FG000|Overall Study|Uknown reason - subject drop out|5|||
130384812|NCT01912287|469378261|FG001|Overall Study|Uknown reason - subject drop out|7|||
130384813|NCT01912287|469378262|FG002|Overall Study|Uknown reason - subject drop out|3|||
130384814|NCT01912287|469378260|FG000|Overall Study|Missed Assesment|1|||
130384815|NCT01912287|469378261|FG001|Overall Study|Missed Assesment|1|||
130384816|NCT01912287|469378262|FG002|Overall Study|Missed Assesment|1|||
130384817|NCT01912287|469378260|FG000|Overall Study|Scheduling/change in availability|17|||
130384818|NCT01912287|469378261|FG001|Overall Study|Scheduling/change in availability|10|||
130384819|NCT01912287|469378262|FG002|Overall Study|Scheduling/change in availability|8|||
130384820|NCT03914326|469378265|FG000|Overall Study|Withdrawal by Subject|27|||
130384821|NCT03914326|469378266|FG001|Overall Study|Withdrawal by Subject|34|||
130384822|NCT03914326|469378265|FG000|Overall Study|Lost to Follow-up|43|||
130384823|NCT03914326|469378266|FG001|Overall Study|Lost to Follow-up|51|||
130384824|NCT03914326|469378265|FG000|Overall Study|Randomised more than once|0|||
130384825|NCT03914326|469378266|FG001|Overall Study|Randomised more than once|1|||
130384826|NCT03226392|469378271|FG000|Overall Study|Protocol Deviation|1|||
130384827|NCT03226392|469378272|FG001|Overall Study|Protocol Deviation|0|||
130384828|NCT03226392|469378271|FG000|Overall Study|Physician Decision|1|||
130384829|NCT03226392|469378272|FG001|Overall Study|Physician Decision|0|||
130384830|NCT03226392|469378271|FG000|Overall Study|Lost to Follow-up|1|||
130384831|NCT03226392|469378272|FG001|Overall Study|Lost to Follow-up|0|||
130384832|NCT03226392|469378271|FG000|Overall Study|Adverse Event|1|||
130384833|NCT03226392|469378272|FG001|Overall Study|Adverse Event|0|||
130384834|NCT03226392|469378271|FG000|Overall Study|Technical Problems|0|||
130384835|NCT03226392|469378272|FG001|Overall Study|Technical Problems|2|||
130384836|NCT03226392|469378271|FG000|Overall Study|Subject/Guardian Decision|7|||
130384837|NCT03226392|469378272|FG001|Overall Study|Subject/Guardian Decision|6|||
130384838|NCT04788953|469378273|FG000|Overall Study|Adverse Event|1|||
130384839|NCT04788953|469378274|FG001|Overall Study|Adverse Event|1|||
130384840|NCT04788953|469378273|FG000|Overall Study|Withdrawal by Subject|1|||
130384841|NCT04788953|469378274|FG001|Overall Study|Withdrawal by Subject|0|||
130384842|NCT04788953|469378273|FG000|Overall Study|Protocol Violation|0|||
130384843|NCT04788953|469378274|FG001|Overall Study|Protocol Violation|1|||
130384844|NCT00937157|469378275|FG000|Overall Study|Pregnancy|1|||
130384845|NCT00937157|469378275|FG000|Overall Study|Lost to Follow-up|3|||
130384846|NCT00469092|469378276|FG000|Overall Study|Adverse Event|5|||
130384847|NCT00469092|469378277|FG001|Overall Study|Adverse Event|4|||
130384848|NCT00469092|469378276|FG000|Overall Study|Lack of Efficacy|1|||
130384849|NCT00469092|469378277|FG001|Overall Study|Lack of Efficacy|0|||
130384850|NCT00469092|469378276|FG000|Overall Study|Lost to Follow-up|1|||
130384851|NCT00469092|469378277|FG001|Overall Study|Lost to Follow-up|2|||
130384852|NCT00469092|469378276|FG000|Overall Study|Protocol Violation|3|||
130384853|NCT00469092|469378277|FG001|Overall Study|Protocol Violation|3|||
130722432|NCT00206323|470608248|FG000|Overall Study|Lost to Follow-up|1|||
130722433|NCT00206323|470608249|FG001|Overall Study|Lost to Follow-up|1|||
130722434|NCT03918109|470608262|FG000|Overall Study|Withdrawal by Subject|0|||
130384854|NCT00469092|469378276|FG000|Overall Study|Withdrawal by Subject|4|||
130384855|NCT00469092|469378277|FG001|Overall Study|Withdrawal by Subject|4|||
130384856|NCT00469092|469378276|FG000|Overall Study|Withdrawal Criteria|3|||
130384857|NCT00469092|469378277|FG001|Overall Study|Withdrawal Criteria|4|||
130384858|NCT00469092|469378276|FG000|Overall Study|Incorrectly Randomised|4|||
130384859|NCT00469092|469378277|FG001|Overall Study|Incorrectly Randomised|3|||
130384860|NCT00469092|469378276|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
130384861|NCT00469092|469378277|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
130469068|NCT03398148|469683555|FG011|Substudy 2 Period 1|Other|0|||
130469069|NCT03398148|469683556|FG012|Substudy 2 Period 1|Other|0|||
130469070|NCT03398148|469683557|FG013|Substudy 2 Period 1|Other|0|||
130469071|NCT03398148|469683558|FG014|Substudy 2 Period 1|Other|0|||
130469072|NCT03398148|469683544|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469073|NCT03398148|469683545|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469074|NCT03398148|469683546|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469075|NCT03398148|469683547|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469076|NCT03398148|469683548|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469077|NCT03398148|469683549|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469078|NCT03398148|469683550|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469079|NCT03398148|469683551|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469080|NCT03398148|469683552|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469081|NCT03398148|469683553|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469082|NCT03398148|469683554|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
130469083|NCT03398148|469683555|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469084|NCT03398148|469683556|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469085|NCT03398148|469683557|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469086|NCT03398148|469683558|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
130469087|NCT03398148|469683544|FG000|Substudy 2 Period 2|Adverse Event|0|||
130469088|NCT03398148|469683545|FG001|Substudy 2 Period 2|Adverse Event|0|||
130469089|NCT03398148|469683546|FG002|Substudy 2 Period 2|Adverse Event|0|||
130469090|NCT03398148|469683547|FG003|Substudy 2 Period 2|Adverse Event|0|||
130469091|NCT03398148|469683548|FG004|Substudy 2 Period 2|Adverse Event|0|||
130469092|NCT03398148|469683549|FG005|Substudy 2 Period 2|Adverse Event|0|||
130469093|NCT03398148|469683550|FG006|Substudy 2 Period 2|Adverse Event|0|||
130469094|NCT03398148|469683551|FG007|Substudy 2 Period 2|Adverse Event|0|||
130469095|NCT03398148|469683552|FG008|Substudy 2 Period 2|Adverse Event|0|||
130469096|NCT03398148|469683553|FG009|Substudy 2 Period 2|Adverse Event|0|||
130469097|NCT03398148|469683554|FG010|Substudy 2 Period 2|Adverse Event|0|||
130469098|NCT03398148|469683555|FG011|Substudy 2 Period 2|Adverse Event|0|||
130469099|NCT03398148|469683556|FG012|Substudy 2 Period 2|Adverse Event|0|||
130384862|NCT00469092|469378276|FG000|Overall Study|Use of lipid lowering drug|1|||
130384863|NCT00469092|469378277|FG001|Overall Study|Use of lipid lowering drug|0|||
130384864|NCT00469092|469378276|FG000|Overall Study|Hypoglycaemic Episodes|1|||
130384865|NCT00469092|469378277|FG001|Overall Study|Hypoglycaemic Episodes|1|||
130384866|NCT00469092|469378276|FG000|Overall Study|Abnormal lab value|1|||
130384867|NCT00469092|469378277|FG001|Overall Study|Abnormal lab value|0|||
130384868|NCT00469092|469378276|FG000|Overall Study|Use of Corticosteroid|1|||
130384869|NCT00469092|469378277|FG001|Overall Study|Use of Corticosteroid|0|||
130384870|NCT02024867|469378278|FG000|Overall Study|Protocol Violation|3|||
130384871|NCT02024867|469378279|FG001|Overall Study|Protocol Violation|3|||
130384872|NCT02024867|469378278|FG000|Overall Study|Lost to Follow-up|6|||
130384873|NCT02024867|469378279|FG001|Overall Study|Lost to Follow-up|4|||
130384874|NCT02150954|469378280|FG000|Overall Study|Protocol Violation|1|||
130384875|NCT02150954|469378281|FG001|Overall Study|Protocol Violation|0|||
130384876|NCT01998633|469378283|FG000|Overall Study|Death|1|||
130384877|NCT00413192|469378284|FG000|Overall Study|Disease progression|26|||
130384878|NCT00413192|469378285|FG001|Overall Study|Disease progression|31|||
130384879|NCT00413192|469378286|FG002|Overall Study|Disease progression|16|||
130469100|NCT03398148|469683557|FG013|Substudy 2 Period 2|Adverse Event|1|||
130469101|NCT03398148|469683558|FG014|Substudy 2 Period 2|Adverse Event|3|||
130469102|NCT03398148|469683544|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
130469103|NCT03398148|469683545|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
130469104|NCT03398148|469683546|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
130469105|NCT03398148|469683547|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
130469106|NCT03398148|469683548|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
130469107|NCT03398148|469683549|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
130469108|NCT03398148|469683550|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
130469109|NCT03398148|469683551|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
130469110|NCT03398148|469683552|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
130469111|NCT03398148|469683553|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
130469112|NCT03398148|469683554|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
130469113|NCT03398148|469683555|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
130384880|NCT00413192|469378287|FG003|Overall Study|Disease progression|25|||
130469114|NCT03398148|469683556|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
130469115|NCT03398148|469683557|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
130469116|NCT03398148|469683558|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
130469117|NCT03398148|469683544|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469118|NCT03398148|469683545|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130722435|NCT03918109|470608263|FG001|Overall Study|Withdrawal by Subject|0|||
130722436|NCT03918109|470608264|FG002|Overall Study|Withdrawal by Subject|2|||
130384881|NCT00413192|469378284|FG000|Overall Study|Toxicity|3|||
130384882|NCT00413192|469378285|FG001|Overall Study|Toxicity|2|||
130384883|NCT00413192|469378286|FG002|Overall Study|Toxicity|2|||
130384884|NCT00413192|469378287|FG003|Overall Study|Toxicity|2|||
130469119|NCT03398148|469683546|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130559685|NCT01970488|470017848|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
130559686|NCT01970488|470017849|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
130559687|NCT01970488|470017850|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
130559688|NCT01970488|470017846|FG000|Part 2: Post Week 16|Adverse Event|0|||
130559689|NCT01970488|470017847|FG001|Part 2: Post Week 16|Adverse Event|0|||
130559690|NCT01970488|470017848|FG002|Part 2: Post Week 16|Adverse Event|5|||
130722437|NCT03918109|470608265|FG003|Overall Study|Withdrawal by Subject|1|||
130722438|NCT03918109|470608262|FG000|Overall Study|Lost to Follow-up|0|||
130384885|NCT00413192|469378284|FG000|Overall Study|Withdrawal by Subject|3|||
130384886|NCT00413192|469378285|FG001|Overall Study|Withdrawal by Subject|5|||
130384887|NCT00413192|469378286|FG002|Overall Study|Withdrawal by Subject|0|||
130384888|NCT00413192|469378287|FG003|Overall Study|Withdrawal by Subject|1|||
130384889|NCT00413192|469378284|FG000|Overall Study|Intercurrent illness|0|||
130384890|NCT00413192|469378285|FG001|Overall Study|Intercurrent illness|0|||
130384891|NCT00413192|469378286|FG002|Overall Study|Intercurrent illness|0|||
130384892|NCT00413192|469378287|FG003|Overall Study|Intercurrent illness|1|||
130384893|NCT00413192|469378284|FG000|Overall Study|Intercurrent death|0|||
130384894|NCT00413192|469378285|FG001|Overall Study|Intercurrent death|1|||
130384895|NCT00413192|469378286|FG002|Overall Study|Intercurrent death|0|||
130384896|NCT00413192|469378287|FG003|Overall Study|Intercurrent death|0|||
130384897|NCT00413192|469378284|FG000|Overall Study|Other|5|||
130384898|NCT00413192|469378285|FG001|Overall Study|Other|1|||
130384899|NCT00413192|469378286|FG002|Overall Study|Other|1|||
130384900|NCT00413192|469378287|FG003|Overall Study|Other|2|||
130384901|NCT00413192|469378284|FG000|Overall Study|Not treated|0|||
130384902|NCT00413192|469378285|FG001|Overall Study|Not treated|0|||
130384903|NCT00413192|469378286|FG002|Overall Study|Not treated|0|||
130384904|NCT00413192|469378287|FG003|Overall Study|Not treated|1|||
130384905|NCT02631850|469378288|FG000|Treatment Period|Lost to Follow-up|0|||
130384906|NCT02631850|469378289|FG001|Treatment Period|Lost to Follow-up|1|||
130384907|NCT02631850|469378290|FG002|Treatment Period|Lost to Follow-up|0|||
130384908|NCT02631850|469378291|FG003|Treatment Period|Lost to Follow-up|0|||
130384909|NCT02631850|469378288|FG000|Treatment Period|Protocol Violation|1|||
130384910|NCT02631850|469378289|FG001|Treatment Period|Protocol Violation|0|||
130384911|NCT02631850|469378290|FG002|Treatment Period|Protocol Violation|0|||
130384912|NCT02631850|469378291|FG003|Treatment Period|Protocol Violation|0|||
130384913|NCT02631850|469378288|FG000|Treatment Period|Withdrawal by Subject|0|||
130384914|NCT02631850|469378289|FG001|Treatment Period|Withdrawal by Subject|5|||
130384915|NCT02631850|469378290|FG002|Treatment Period|Withdrawal by Subject|2|||
130384916|NCT02631850|469378291|FG003|Treatment Period|Withdrawal by Subject|2|||
130384917|NCT02631850|469378288|FG000|Treatment Period|Adverse Event|1|||
130384918|NCT02631850|469378289|FG001|Treatment Period|Adverse Event|0|||
130384919|NCT02631850|469378290|FG002|Treatment Period|Adverse Event|2|||
130384920|NCT02631850|469378291|FG003|Treatment Period|Adverse Event|3|||
130384921|NCT02631850|469378288|FG000|Treatment Period|Family medical issue|1|||
130384922|NCT02631850|469378289|FG001|Treatment Period|Family medical issue|0|||
130384923|NCT02631850|469378290|FG002|Treatment Period|Family medical issue|0|||
130384924|NCT02631850|469378291|FG003|Treatment Period|Family medical issue|0|||
130384925|NCT02631850|469378288|FG000|6 Month Follow up|Lost to Follow-up|5|||
130384926|NCT02631850|469378289|FG001|6 Month Follow up|Lost to Follow-up|8|||
130384927|NCT02631850|469378290|FG002|6 Month Follow up|Lost to Follow-up|3|||
130384928|NCT02631850|469378291|FG003|6 Month Follow up|Lost to Follow-up|5|||
130384929|NCT02631850|469378288|FG000|6 Month Follow up|Withdrawal by Subject|1|||
130384930|NCT02631850|469378289|FG001|6 Month Follow up|Withdrawal by Subject|0|||
130384931|NCT02631850|469378290|FG002|6 Month Follow up|Withdrawal by Subject|0|||
130384932|NCT02631850|469378291|FG003|6 Month Follow up|Withdrawal by Subject|2|||
130384933|NCT02631850|469378288|FG000|6 Month Follow up|Adverse Event|1|||
130384934|NCT02631850|469378289|FG001|6 Month Follow up|Adverse Event|4|||
130384935|NCT02631850|469378290|FG002|6 Month Follow up|Adverse Event|1|||
130384936|NCT02631850|469378291|FG003|6 Month Follow up|Adverse Event|3|||
130384937|NCT02631850|469378288|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
130559691|NCT01970488|470017849|FG003|Part 2: Post Week 16|Adverse Event|1|||
130559692|NCT01970488|470017850|FG004|Part 2: Post Week 16|Adverse Event|1|||
130722439|NCT03918109|470608263|FG001|Overall Study|Lost to Follow-up|0|||
130722440|NCT03918109|470608264|FG002|Overall Study|Lost to Follow-up|0|||
130722441|NCT03918109|470608265|FG003|Overall Study|Lost to Follow-up|1|||
130722442|NCT00758680|470608268|FG000|Overall Study|Adverse Event|0|||
130384938|NCT02631850|469378289|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
130384939|NCT02631850|469378290|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
130384940|NCT02631850|469378291|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
130384941|NCT03992781|469378297|FG000|Overall Study|Lost to Follow-up|5|||
130384942|NCT03992781|469378297|FG000|Overall Study|Adverse Event|1|||
130384943|NCT03992781|469378297|FG000|Overall Study|Lack of Efficacy|5|||
130384944|NCT03164928|469378298|FG000|Overall Study|Lost to Follow-up|1|||
130384945|NCT03164928|469378299|FG001|Overall Study|Lost to Follow-up|0|||
130384946|NCT02278263|469378300|FG000|Overall Study|Protocol Violation|7|||
130384947|NCT02278263|469378301|FG001|Overall Study|Protocol Violation|0|||
130384948|NCT02278263|469378302|FG002|Overall Study|Protocol Violation|9|||
130384949|NCT01998737|469378303|FG000|Overall Study|Corrupted database|23|||
130384950|NCT01998737|469378304|FG001|Overall Study|Corrupted database|0|||
130384951|NCT03997383|469378305|FG000|Double-blind Treatment Period|Adverse Event|4|||
130384952|NCT03997383|469378306|FG001|Double-blind Treatment Period|Adverse Event|3|||
130384953|NCT03997383|469378305|FG000|Double-blind Treatment Period|Death|4|||
130384954|NCT03997383|469378306|FG001|Double-blind Treatment Period|Death|4|||
130384955|NCT03997383|469378305|FG000|Double-blind Treatment Period|Physician Decision|2|||
130384956|NCT03997383|469378306|FG001|Double-blind Treatment Period|Physician Decision|0|||
130384957|NCT03997383|469378305|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
130384958|NCT03997383|469378306|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
130384959|NCT03997383|469378305|FG000|Open-label Extension Period|Ongoing|148|||
130384960|NCT03997383|469378306|FG001|Open-label Extension Period|Ongoing|151|||
130384961|NCT03997383|469378305|FG000|Open-label Extension Period|Adverse Event|4|||
130384962|NCT03997383|469378306|FG001|Open-label Extension Period|Adverse Event|1|||
130384963|NCT03997383|469378305|FG000|Open-label Extension Period|Death|8|||
130384964|NCT03997383|469378306|FG001|Open-label Extension Period|Death|9|||
130384965|NCT03997383|469378305|FG000|Open-label Extension Period|Physician Decision|1|||
130384966|NCT03997383|469378306|FG001|Open-label Extension Period|Physician Decision|1|||
130384967|NCT03997383|469378305|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
130384968|NCT03997383|469378306|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
130384969|NCT03997383|469378305|FG000|Open-label Extension Period|Reason Not Specified|2|||
130384970|NCT03997383|469378306|FG001|Open-label Extension Period|Reason Not Specified|0|||
130384971|NCT02118012|469378307|FG000|Overall Study|Adverse Event|0|||
130384972|NCT02118012|469378308|FG001|Overall Study|Adverse Event|1|||
130384973|NCT02118012|469378307|FG000|Overall Study|Physician Decision|0|||
130384974|NCT02118012|469378308|FG001|Overall Study|Physician Decision|1|||
130384975|NCT00171223|469378309|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
130384976|NCT00171223|469378310|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
130384977|NCT00171223|469378311|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
130384978|NCT00171223|469378309|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
130384979|NCT00171223|469378310|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
130384980|NCT00171223|469378311|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
130384981|NCT00171223|469378309|FG000|Overall Study|Abnormal Procedure|1|||
130384982|NCT00171223|469378310|FG001|Overall Study|Abnormal Procedure|0|||
130384983|NCT00171223|469378311|FG002|Overall Study|Abnormal Procedure|0|||
130384984|NCT00171223|469378309|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
130384985|NCT00171223|469378310|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
130384986|NCT00171223|469378311|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
130384987|NCT00171223|469378309|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
130384988|NCT00171223|469378310|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
130384989|NCT00171223|469378311|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
130384990|NCT00171223|469378309|FG000|Overall Study|Protocol Violation|2|||
130384991|NCT00171223|469378310|FG001|Overall Study|Protocol Violation|2|||
130384992|NCT00171223|469378311|FG002|Overall Study|Protocol Violation|3|||
130384993|NCT00171223|469378309|FG000|Overall Study|Participant Withdrew Consent|12|||
130384994|NCT00171223|469378310|FG001|Overall Study|Participant Withdrew Consent|21|||
130384995|NCT00171223|469378311|FG002|Overall Study|Participant Withdrew Consent|15|||
130384996|NCT00171223|469378309|FG000|Overall Study|Lost to Follow-up|5|||
130384997|NCT00171223|469378310|FG001|Overall Study|Lost to Follow-up|2|||
130384998|NCT00171223|469378311|FG002|Overall Study|Lost to Follow-up|3|||
130384999|NCT00171223|469378309|FG000|Overall Study|Administrative Problems|4|||
130385000|NCT00171223|469378310|FG001|Overall Study|Administrative Problems|7|||
130385001|NCT00171223|469378311|FG002|Overall Study|Administrative Problems|6|||
130469120|NCT03398148|469683547|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469121|NCT03398148|469683548|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469122|NCT03398148|469683549|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469123|NCT03398148|469683550|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469124|NCT03398148|469683551|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130385002|NCT00171223|469378309|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
130385003|NCT00171223|469378310|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
130385004|NCT00171223|469378311|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
130385005|NCT00171223|469378309|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
130385006|NCT00171223|469378310|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
130385007|NCT00171223|469378311|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
130385008|NCT00455429|469378320|FG000|Overall Study|Study Terminated by Sponsor|0|||
130385009|NCT00455429|469378321|FG001|Overall Study|Study Terminated by Sponsor|0|||
130469125|NCT03398148|469683552|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130385010|NCT00455429|469378322|FG002|Overall Study|Study Terminated by Sponsor|0|||
130385011|NCT00455429|469378323|FG003|Overall Study|Study Terminated by Sponsor|3|||
130385012|NCT00455429|469378320|FG000|Overall Study|Lost to Follow-up|1|||
130385013|NCT00455429|469378321|FG001|Overall Study|Lost to Follow-up|0|||
130385014|NCT00455429|469378322|FG002|Overall Study|Lost to Follow-up|0|||
130722443|NCT00758680|470608269|FG001|Overall Study|Adverse Event|0|||
130722444|NCT00758680|470608270|FG002|Overall Study|Adverse Event|0|||
130722445|NCT00758680|470608271|FG003|Overall Study|Adverse Event|0|||
130722446|NCT00758680|470608272|FG004|Overall Study|Adverse Event|0|||
130722447|NCT00758680|470608273|FG005|Overall Study|Adverse Event|0|||
130469126|NCT03398148|469683553|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469127|NCT03398148|469683554|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469128|NCT03398148|469683555|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
130469129|NCT03398148|469683556|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
130469130|NCT03398148|469683557|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
130469131|NCT03398148|469683558|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
130469132|NCT03398148|469683544|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
130469133|NCT03398148|469683545|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
130469134|NCT03398148|469683546|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
130469135|NCT03398148|469683547|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
130469136|NCT03398148|469683548|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
130469137|NCT03398148|469683549|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
130469138|NCT03398148|469683550|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
130469139|NCT03398148|469683551|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
130469140|NCT03398148|469683552|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
130469141|NCT03398148|469683553|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
130469142|NCT03398148|469683554|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
130469143|NCT03398148|469683555|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
130469144|NCT03398148|469683556|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
130469145|NCT03398148|469683557|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
130469146|NCT03398148|469683558|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
130469147|NCT03398148|469683544|FG000|Substudy 2 Period 2|Other|0|||
130469148|NCT03398148|469683545|FG001|Substudy 2 Period 2|Other|0|||
130469149|NCT03398148|469683546|FG002|Substudy 2 Period 2|Other|0|||
130469150|NCT03398148|469683547|FG003|Substudy 2 Period 2|Other|0|||
130469151|NCT03398148|469683548|FG004|Substudy 2 Period 2|Other|0|||
130559693|NCT01970488|470017846|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
130722448|NCT00758680|470608274|FG006|Overall Study|Adverse Event|0|||
130385015|NCT00455429|469378323|FG003|Overall Study|Lost to Follow-up|3|||
130385016|NCT00455429|469378320|FG000|Overall Study|Withdrawal by Subject|0|||
130722449|NCT00758680|470608275|FG007|Overall Study|Adverse Event|1|||
130722450|NCT00758680|470608276|FG008|Overall Study|Adverse Event|0|||
130385017|NCT00455429|469378321|FG001|Overall Study|Withdrawal by Subject|1|||
130385018|NCT00455429|469378322|FG002|Overall Study|Withdrawal by Subject|1|||
130385019|NCT00455429|469378323|FG003|Overall Study|Withdrawal by Subject|0|||
130385020|NCT00455429|469378320|FG000|Overall Study|Lack of Efficacy|0|||
130385021|NCT00455429|469378321|FG001|Overall Study|Lack of Efficacy|1|||
130385022|NCT00455429|469378322|FG002|Overall Study|Lack of Efficacy|0|||
130385023|NCT00455429|469378323|FG003|Overall Study|Lack of Efficacy|1|||
130385024|NCT00455429|469378320|FG000|Overall Study|Adverse Event|0|||
130385025|NCT00455429|469378321|FG001|Overall Study|Adverse Event|1|||
130385026|NCT00455429|469378322|FG002|Overall Study|Adverse Event|0|||
130385027|NCT00455429|469378323|FG003|Overall Study|Adverse Event|3|||
130385028|NCT00455429|469378320|FG000|Overall Study|Randomly assigned but not treated|0|||
130385029|NCT00455429|469378321|FG001|Overall Study|Randomly assigned but not treated|0|||
130385030|NCT00455429|469378322|FG002|Overall Study|Randomly assigned but not treated|0|||
130385031|NCT00455429|469378323|FG003|Overall Study|Randomly assigned but not treated|2|||
130385032|NCT00455429|469378320|FG000|Overall Study|Personal Reason|1|||
130385033|NCT00455429|469378321|FG001|Overall Study|Personal Reason|0|||
130385034|NCT00455429|469378322|FG002|Overall Study|Personal Reason|0|||
130385035|NCT00455429|469378323|FG003|Overall Study|Personal Reason|0|||
130385036|NCT00455429|469378320|FG000|Overall Study|Non-compliance|0|||
130385037|NCT00455429|469378321|FG001|Overall Study|Non-compliance|0|||
130385038|NCT00455429|469378322|FG002|Overall Study|Non-compliance|0|||
130385039|NCT00455429|469378323|FG003|Overall Study|Non-compliance|1|||
130385040|NCT00455429|469378320|FG000|Overall Study|Other|0|||
130385041|NCT00455429|469378321|FG001|Overall Study|Other|2|||
130722451|NCT00758680|470608277|FG009|Overall Study|Adverse Event|1|||
130385042|NCT00455429|469378322|FG002|Overall Study|Other|0|||
130385043|NCT00455429|469378323|FG003|Overall Study|Other|1|||
130469152|NCT03398148|469683549|FG005|Substudy 2 Period 2|Other|0|||
130469153|NCT03398148|469683550|FG006|Substudy 2 Period 2|Other|0|||
130469154|NCT03398148|469683551|FG007|Substudy 2 Period 2|Other|0|||
130469155|NCT03398148|469683552|FG008|Substudy 2 Period 2|Other|0|||
130559694|NCT01970488|470017847|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
130469156|NCT03398148|469683553|FG009|Substudy 2 Period 2|Other|0|||
130385044|NCT01165554|469378330|FG000|Overall Study|Withdrawal by Subject|23|||
130385045|NCT02951156|469378331|FG000|Overall Study|Death|3|||
130385046|NCT02951156|469378332|FG001|Overall Study|Death|8|||
130385047|NCT02951156|469378333|FG002|Overall Study|Death|5|||
130385048|NCT02951156|469378331|FG000|Overall Study|Progressive disease|1|||
130469157|NCT03398148|469683554|FG010|Substudy 2 Period 2|Other|0|||
130722452|NCT00758680|470608268|FG000|Overall Study|Laboratory Adverse Event|0|||
130385049|NCT02951156|469378332|FG001|Overall Study|Progressive disease|0|||
130385050|NCT02951156|469378333|FG002|Overall Study|Progressive disease|1|||
130385051|NCT02951156|469378331|FG000|Overall Study|Withdrawal by Subject|0|||
130385052|NCT02951156|469378332|FG001|Overall Study|Withdrawal by Subject|0|||
130385053|NCT02951156|469378333|FG002|Overall Study|Withdrawal by Subject|1|||
130385054|NCT02951156|469378331|FG000|Overall Study|Study terminated by sponsor|0|||
130469158|NCT03398148|469683555|FG011|Substudy 2 Period 2|Other|0|||
130469159|NCT03398148|469683556|FG012|Substudy 2 Period 2|Other|0|||
130469160|NCT03398148|469683557|FG013|Substudy 2 Period 2|Other|1|||
130469161|NCT03398148|469683558|FG014|Substudy 2 Period 2|Other|1|||
130469162|NCT03398148|469683544|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469163|NCT03398148|469683545|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469164|NCT03398148|469683546|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469165|NCT03398148|469683547|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469166|NCT03398148|469683548|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469167|NCT03398148|469683549|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469168|NCT03398148|469683550|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469169|NCT03398148|469683551|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469170|NCT03398148|469683552|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469171|NCT03398148|469683553|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469172|NCT03398148|469683554|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469173|NCT03398148|469683555|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469174|NCT03398148|469683556|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
130469175|NCT03398148|469683557|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
130469176|NCT03398148|469683558|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
130469177|NCT04278586|469683559|FG000|Overall Study|Withdrawal by Subject|13|||
130469178|NCT04278586|469683560|FG001|Overall Study|Withdrawal by Subject|6|||
130469179|NCT04278586|469683559|FG000|Overall Study|Lost to Follow-up|37|||
130469180|NCT04278586|469683560|FG001|Overall Study|Lost to Follow-up|24|||
130469181|NCT02791230|469683561|FG000|Overall Study|Adverse Event|10|||
130469182|NCT02791230|469683562|FG001|Overall Study|Adverse Event|9|||
130469183|NCT02791230|469683563|FG002|Overall Study|Adverse Event|66|||
130469184|NCT02791230|469683561|FG000|Overall Study|Death|38|||
130469185|NCT02791230|469683562|FG001|Overall Study|Death|25|||
130469186|NCT02791230|469683563|FG002|Overall Study|Death|184|||
130722453|NCT00758680|470608269|FG001|Overall Study|Laboratory Adverse Event|0|||
130722454|NCT00758680|470608270|FG002|Overall Study|Laboratory Adverse Event|0|||
130722455|NCT00758680|470608271|FG003|Overall Study|Laboratory Adverse Event|0|||
130385055|NCT02951156|469378332|FG001|Overall Study|Study terminated by sponsor|0|||
130385056|NCT02951156|469378333|FG002|Overall Study|Study terminated by sponsor|1|||
130385057|NCT02951156|469378331|FG000|Overall Study|Other|5|||
130385058|NCT02951156|469378332|FG001|Overall Study|Other|1|||
130385059|NCT02951156|469378333|FG002|Overall Study|Other|2|||
130385060|NCT04351087|469378334|FG000|Overall Study|Lost to Follow-up|7|||
130385061|NCT04351087|469378335|FG001|Overall Study|Lost to Follow-up|3|||
130385062|NCT04351087|469378334|FG000|Overall Study|Withdrawal by Subject|3|||
130385063|NCT04351087|469378335|FG001|Overall Study|Withdrawal by Subject|4|||
130385064|NCT04351087|469378334|FG000|Overall Study|Lack of Efficacy|3|||
130385065|NCT04351087|469378335|FG001|Overall Study|Lack of Efficacy|2|||
130385066|NCT01603459|469378338|FG000|Overall Study|Adverse Event|5|||
130385067|NCT01603459|469378338|FG000|Overall Study|Withdrawal by Subject|5|||
130385068|NCT01603459|469378338|FG000|Overall Study|Lost to Follow-up|3|||
130385069|NCT01603459|469378338|FG000|Overall Study|Predefined discontinuation criteria|3|||
130385070|NCT01603459|469378338|FG000|Overall Study|Non-compliance|1|||
130385071|NCT01603459|469378338|FG000|Overall Study|Administrative reason|1|||
130385072|NCT03519347|469378341|FG000|Interventional Crossover Period 1|Death|0|||
130385073|NCT03519347|469378342|FG001|Interventional Crossover Period 1|Death|0|||
130469187|NCT02791230|469683561|FG000|Overall Study|Lack of Efficacy|1|||
130469188|NCT02791230|469683562|FG001|Overall Study|Lack of Efficacy|0|||
130469189|NCT02791230|469683563|FG002|Overall Study|Lack of Efficacy|3|||
130469190|NCT02791230|469683561|FG000|Overall Study|Lost to Follow-up|0|||
130469191|NCT02791230|469683562|FG001|Overall Study|Lost to Follow-up|0|||
130469192|NCT02791230|469683563|FG002|Overall Study|Lost to Follow-up|10|||
130469193|NCT02791230|469683561|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
130469194|NCT02791230|469683562|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130469195|NCT02791230|469683563|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
130469196|NCT02791230|469683561|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
130469197|NCT02791230|469683562|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
130469198|NCT02791230|469683563|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
130469199|NCT02791230|469683561|FG000|Overall Study|Study sites terminated by sponsor|1|||
130469200|NCT02791230|469683562|FG001|Overall Study|Study sites terminated by sponsor|0|||
130469201|NCT02791230|469683563|FG002|Overall Study|Study sites terminated by sponsor|5|||
130469202|NCT02791230|469683561|FG000|Overall Study|Other|9|||
130385074|NCT03519347|469378343|FG002|Interventional Crossover Period 1|Death|0|||
130385075|NCT03519347|469378344|FG003|Interventional Crossover Period 1|Death|1|||
130385076|NCT05517382|469378345|FG000|Overall Study|Lost to Follow-up|0|||
130469203|NCT02791230|469683562|FG001|Overall Study|Other|1|||
130469204|NCT02791230|469683563|FG002|Overall Study|Other|28|||
130469205|NCT02791230|469683561|FG000|Overall Study|Protocol Violation|0|||
130469206|NCT02791230|469683562|FG001|Overall Study|Protocol Violation|0|||
130469207|NCT02791230|469683563|FG002|Overall Study|Protocol Violation|4|||
130469208|NCT02791230|469683561|FG000|Overall Study|Withdrawal by Subject|24|||
130469209|NCT02791230|469683562|FG001|Overall Study|Withdrawal by Subject|13|||
130469210|NCT02791230|469683563|FG002|Overall Study|Withdrawal by Subject|172|||
130469211|NCT02791230|469683561|FG000|Overall Study|Enrolled but not treated|0|||
130469212|NCT02791230|469683562|FG001|Overall Study|Enrolled but not treated|0|||
130469213|NCT02791230|469683563|FG002|Overall Study|Enrolled but not treated|5|||
130469214|NCT04201834|469683571|FG000|Overall Study|Screen fail|1|||
130469215|NCT04310735|469683579|FG000|Overall Study|Withdrawal by Subject|1|||
130469216|NCT04310735|469683580|FG001|Overall Study|Withdrawal by Subject|3|||
130385077|NCT05517382|469378346|FG001|Overall Study|Lost to Follow-up|1|||
130385078|NCT01641692|469378347|FG000|Treatment Period 1|Adverse Event|1|||
130385079|NCT01641692|469378348|FG001|Treatment Period 1|Adverse Event|0|||
130385080|NCT01641692|469378349|FG002|Treatment Period 1|Adverse Event|0|||
130385081|NCT01641692|469378350|FG003|Treatment Period 1|Adverse Event|0|||
130385082|NCT01641692|469378351|FG004|Treatment Period 1|Adverse Event|0|||
130385083|NCT01641692|469378352|FG005|Treatment Period 1|Adverse Event|0|||
130385084|NCT01641692|469378353|FG006|Treatment Period 1|Adverse Event|0|||
130385085|NCT01641692|469378354|FG007|Treatment Period 1|Adverse Event|0|||
130385086|NCT01641692|469378347|FG000|Treatment Period 1|Lack of Efficacy|0|||
130385087|NCT01641692|469378348|FG001|Treatment Period 1|Lack of Efficacy|0|||
130385088|NCT01641692|469378349|FG002|Treatment Period 1|Lack of Efficacy|0|||
130385089|NCT01641692|469378350|FG003|Treatment Period 1|Lack of Efficacy|0|||
130385090|NCT01641692|469378351|FG004|Treatment Period 1|Lack of Efficacy|0|||
130385091|NCT01641692|469378352|FG005|Treatment Period 1|Lack of Efficacy|0|||
130385092|NCT01641692|469378353|FG006|Treatment Period 1|Lack of Efficacy|0|||
130385093|NCT01641692|469378354|FG007|Treatment Period 1|Lack of Efficacy|1|||
130385094|NCT01641692|469378347|FG000|Treatment Period 1|Protocol Violation|1|||
130385095|NCT01641692|469378348|FG001|Treatment Period 1|Protocol Violation|0|||
130385096|NCT01641692|469378349|FG002|Treatment Period 1|Protocol Violation|0|||
130385097|NCT01641692|469378350|FG003|Treatment Period 1|Protocol Violation|0|||
130385098|NCT01641692|469378351|FG004|Treatment Period 1|Protocol Violation|2|||
130385099|NCT01641692|469378352|FG005|Treatment Period 1|Protocol Violation|0|||
130385100|NCT01641692|469378353|FG006|Treatment Period 1|Protocol Violation|0|||
130385101|NCT01641692|469378354|FG007|Treatment Period 1|Protocol Violation|0|||
130385102|NCT01641692|469378347|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385103|NCT01641692|469378348|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385104|NCT01641692|469378349|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385105|NCT01641692|469378350|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385106|NCT01641692|469378351|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
130385107|NCT01641692|469378352|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385108|NCT01641692|469378353|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130385109|NCT01641692|469378354|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
130469217|NCT04310735|469683581|FG002|Overall Study|Withdrawal by Subject|8|||
130469218|NCT04310735|469683579|FG000|Overall Study|Equipment malfunction|0|||
130469219|NCT04310735|469683580|FG001|Overall Study|Equipment malfunction|1|||
130722456|NCT00758680|470608272|FG004|Overall Study|Laboratory Adverse Event|0|||
130722457|NCT00758680|470608273|FG005|Overall Study|Laboratory Adverse Event|0|||
130385110|NCT01641692|469378347|FG000|Treatment Period 1|Lost to Follow-up|0|||
130385111|NCT01641692|469378348|FG001|Treatment Period 1|Lost to Follow-up|0|||
130385112|NCT01641692|469378349|FG002|Treatment Period 1|Lost to Follow-up|1|||
130722458|NCT00758680|470608274|FG006|Overall Study|Laboratory Adverse Event|0|||
130385113|NCT01641692|469378350|FG003|Treatment Period 1|Lost to Follow-up|0|||
130385114|NCT01641692|469378351|FG004|Treatment Period 1|Lost to Follow-up|0|||
130385115|NCT01641692|469378352|FG005|Treatment Period 1|Lost to Follow-up|0|||
130385116|NCT01641692|469378353|FG006|Treatment Period 1|Lost to Follow-up|0|||
130385117|NCT01641692|469378354|FG007|Treatment Period 1|Lost to Follow-up|0|||
130385118|NCT01641692|469378347|FG000|Treatment Period 1|Physician Decision|0|||
130385119|NCT01641692|469378348|FG001|Treatment Period 1|Physician Decision|0|||
130469220|NCT04310735|469683581|FG002|Overall Study|Equipment malfunction|0|||
130469221|NCT04104321|469683582|FG000|Overall Study|didn't take the study drug|3|||
130469222|NCT03481777|469683583|FG000|Overall Study|Withdrawal by Subject|36|||
130469223|NCT03481777|469683584|FG001|Overall Study|Withdrawal by Subject|31|||
130469224|NCT03481777|469683583|FG000|Overall Study|Non stroke = non target population|277|||
130469225|NCT03481777|469683584|FG001|Overall Study|Non stroke = non target population|254|||
130469226|NCT05696080|469683585|FG000|Overall Study|Lost to Follow-up|2|||
130469227|NCT05696080|469683586|FG001|Overall Study|Lost to Follow-up|1|||
130469228|NCT05696080|469683585|FG000|Overall Study|Physician Decision|1|||
130469229|NCT05696080|469683586|FG001|Overall Study|Physician Decision|0|||
130469230|NCT05696080|469683585|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130559695|NCT01970488|470017848|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
130722459|NCT00758680|470608275|FG007|Overall Study|Laboratory Adverse Event|0|||
130722460|NCT00758680|470608276|FG008|Overall Study|Laboratory Adverse Event|1|||
130722461|NCT00758680|470608277|FG009|Overall Study|Laboratory Adverse Event|0|||
130722462|NCT00758680|470608268|FG000|Overall Study|Withdrawal by Subject|0|||
130385120|NCT01641692|469378349|FG002|Treatment Period 1|Physician Decision|0|||
130385121|NCT01641692|469378350|FG003|Treatment Period 1|Physician Decision|0|||
130385122|NCT01641692|469378351|FG004|Treatment Period 1|Physician Decision|1|||
130385123|NCT01641692|469378352|FG005|Treatment Period 1|Physician Decision|0|||
130385124|NCT01641692|469378353|FG006|Treatment Period 1|Physician Decision|0|||
130385125|NCT01641692|469378354|FG007|Treatment Period 1|Physician Decision|0|||
130385126|NCT01641692|469378347|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130385127|NCT01641692|469378348|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130385128|NCT01641692|469378349|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130385129|NCT01641692|469378350|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130385130|NCT01641692|469378351|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130385131|NCT01641692|469378352|FG005|Treatment Period 1|Withdrawal by Subject|2|||
130385132|NCT01641692|469378353|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130385133|NCT01641692|469378354|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130385134|NCT01641692|469378347|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
130385135|NCT01641692|469378348|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385136|NCT01641692|469378349|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385137|NCT01641692|469378350|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385138|NCT01641692|469378351|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385139|NCT01641692|469378352|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385140|NCT01641692|469378353|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385141|NCT01641692|469378354|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130385142|NCT01641692|469378347|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385143|NCT01641692|469378348|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385144|NCT01641692|469378349|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385145|NCT01641692|469378350|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385146|NCT01641692|469378351|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385147|NCT01641692|469378352|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385148|NCT01641692|469378353|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130385149|NCT01641692|469378354|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130385150|NCT01641692|469378347|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130385151|NCT01641692|469378348|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385152|NCT01641692|469378349|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130385153|NCT01641692|469378350|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130385154|NCT01641692|469378351|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130385155|NCT01641692|469378352|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385156|NCT01641692|469378353|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385157|NCT01641692|469378354|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130385158|NCT01641692|469378347|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130385159|NCT01641692|469378348|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130385160|NCT01641692|469378349|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130385161|NCT01641692|469378350|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130385162|NCT01641692|469378351|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130385163|NCT01641692|469378352|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130385164|NCT01641692|469378353|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130385165|NCT01641692|469378354|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130385166|NCT01641692|469378347|FG000|Treatment Period 2|Lack of Efficacy|1|||
130385167|NCT01641692|469378348|FG001|Treatment Period 2|Lack of Efficacy|0|||
130385168|NCT01641692|469378349|FG002|Treatment Period 2|Lack of Efficacy|0|||
130385169|NCT01641692|469378350|FG003|Treatment Period 2|Lack of Efficacy|0|||
130385170|NCT01641692|469378351|FG004|Treatment Period 2|Lack of Efficacy|0|||
130385171|NCT01641692|469378352|FG005|Treatment Period 2|Lack of Efficacy|0|||
130385172|NCT01641692|469378353|FG006|Treatment Period 2|Lack of Efficacy|0|||
130385173|NCT01641692|469378354|FG007|Treatment Period 2|Lack of Efficacy|0|||
130385174|NCT01641692|469378347|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
130385175|NCT01641692|469378348|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385176|NCT01641692|469378349|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130722463|NCT00758680|470608269|FG001|Overall Study|Withdrawal by Subject|0|||
130385177|NCT01641692|469378350|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385178|NCT01641692|469378351|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385179|NCT01641692|469378352|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385180|NCT01641692|469378353|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385181|NCT01641692|469378354|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130385182|NCT01641692|469378347|FG000|Treatment Period 2|Lost to Follow-up|0|||
130385183|NCT01641692|469378348|FG001|Treatment Period 2|Lost to Follow-up|0|||
130385184|NCT01641692|469378349|FG002|Treatment Period 2|Lost to Follow-up|0|||
130385185|NCT01641692|469378350|FG003|Treatment Period 2|Lost to Follow-up|0|||
130385186|NCT01641692|469378351|FG004|Treatment Period 2|Lost to Follow-up|0|||
130385187|NCT01641692|469378352|FG005|Treatment Period 2|Lost to Follow-up|1|||
130385188|NCT01641692|469378353|FG006|Treatment Period 2|Lost to Follow-up|0|||
130385189|NCT01641692|469378354|FG007|Treatment Period 2|Lost to Follow-up|0|||
130385190|NCT01641692|469378347|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130385191|NCT01641692|469378348|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130385192|NCT01641692|469378349|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130385193|NCT01641692|469378350|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130385194|NCT01641692|469378351|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130385195|NCT01641692|469378352|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130385196|NCT01641692|469378353|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130385197|NCT01641692|469378354|FG007|Treatment Period 2|Withdrawal by Subject|1|||
130385198|NCT01641692|469378347|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385199|NCT01641692|469378348|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385200|NCT01641692|469378349|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385201|NCT01641692|469378350|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385202|NCT01641692|469378351|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130385203|NCT01641692|469378352|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385204|NCT01641692|469378353|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130385205|NCT01641692|469378354|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130385206|NCT01641692|469378347|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130385207|NCT01641692|469378348|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130385208|NCT01641692|469378349|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130385209|NCT01641692|469378350|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130385210|NCT01641692|469378351|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130385211|NCT01641692|469378352|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130385212|NCT01641692|469378353|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130385213|NCT01641692|469378354|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130385214|NCT01641692|469378347|FG000|Treatment Period 3|Adverse Event|0|||
130385215|NCT01641692|469378348|FG001|Treatment Period 3|Adverse Event|0|||
130385216|NCT01641692|469378349|FG002|Treatment Period 3|Adverse Event|0|||
130385217|NCT01641692|469378350|FG003|Treatment Period 3|Adverse Event|0|||
130385218|NCT01641692|469378351|FG004|Treatment Period 3|Adverse Event|0|||
130385219|NCT01641692|469378352|FG005|Treatment Period 3|Adverse Event|0|||
130385220|NCT01641692|469378353|FG006|Treatment Period 3|Adverse Event|1|||
130385221|NCT01641692|469378354|FG007|Treatment Period 3|Adverse Event|0|||
130385222|NCT01641692|469378347|FG000|Treatment Period 3|Protocol Violation|0|||
130385223|NCT01641692|469378348|FG001|Treatment Period 3|Protocol Violation|0|||
130385224|NCT01641692|469378349|FG002|Treatment Period 3|Protocol Violation|1|||
130385225|NCT01641692|469378350|FG003|Treatment Period 3|Protocol Violation|0|||
130385226|NCT01641692|469378351|FG004|Treatment Period 3|Protocol Violation|0|||
130385227|NCT01641692|469378352|FG005|Treatment Period 3|Protocol Violation|0|||
130385228|NCT01641692|469378353|FG006|Treatment Period 3|Protocol Violation|0|||
130385229|NCT01641692|469378354|FG007|Treatment Period 3|Protocol Violation|0|||
130385230|NCT01641692|469378347|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385231|NCT01641692|469378348|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385232|NCT01641692|469378349|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385233|NCT01641692|469378350|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385234|NCT01641692|469378351|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385235|NCT01641692|469378352|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385236|NCT01641692|469378353|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130385237|NCT01641692|469378354|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130385238|NCT01641692|469378347|FG000|Treatment Period 3|Lost to Follow-up|0|||
130385239|NCT01641692|469378348|FG001|Treatment Period 3|Lost to Follow-up|1|||
130385240|NCT01641692|469378349|FG002|Treatment Period 3|Lost to Follow-up|0|||
130385241|NCT01641692|469378350|FG003|Treatment Period 3|Lost to Follow-up|0|||
130385242|NCT01641692|469378351|FG004|Treatment Period 3|Lost to Follow-up|0|||
130385243|NCT01641692|469378352|FG005|Treatment Period 3|Lost to Follow-up|0|||
130722464|NCT00758680|470608270|FG002|Overall Study|Withdrawal by Subject|0|||
130722465|NCT00758680|470608271|FG003|Overall Study|Withdrawal by Subject|0|||
130722466|NCT00758680|470608272|FG004|Overall Study|Withdrawal by Subject|0|||
130385244|NCT01641692|469378353|FG006|Treatment Period 3|Lost to Follow-up|0|||
130385245|NCT01641692|469378354|FG007|Treatment Period 3|Lost to Follow-up|0|||
130385246|NCT01641692|469378347|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385247|NCT01641692|469378348|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385248|NCT01641692|469378349|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385249|NCT01641692|469378350|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385250|NCT01641692|469378351|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385251|NCT01641692|469378352|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
130385252|NCT01641692|469378353|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385253|NCT01641692|469378354|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
130385254|NCT01641692|469378347|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130385255|NCT01641692|469378348|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130385256|NCT01641692|469378349|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130385257|NCT01641692|469378350|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130385258|NCT01641692|469378351|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130385259|NCT01641692|469378352|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130385260|NCT01641692|469378353|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130385261|NCT01641692|469378354|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130385262|NCT04948450|469378359|FG000|Overall Study|Return home|1|||
130385263|NCT04948450|469378360|FG001|Overall Study|Return home|3|||
130385264|NCT05198843|469378363|FG000|Overall Study|Lack of Efficacy|1|||
130385265|NCT00296374|469378364|FG000|Overall Study|Adverse Event|14|||
130385266|NCT00296374|469378365|FG001|Overall Study|Adverse Event|10|||
130385267|NCT00296374|469378366|FG002|Overall Study|Adverse Event|7|||
130385268|NCT00296374|469378364|FG000|Overall Study|Withdrawal by Subject|3|||
130385269|NCT00296374|469378365|FG001|Overall Study|Withdrawal by Subject|5|||
130385270|NCT00296374|469378366|FG002|Overall Study|Withdrawal by Subject|11|||
130385271|NCT00296374|469378364|FG000|Overall Study|Incorrect enrollment|3|||
130385272|NCT00296374|469378365|FG001|Overall Study|Incorrect enrollment|3|||
130385273|NCT00296374|469378366|FG002|Overall Study|Incorrect enrollment|4|||
130385274|NCT00296374|469378364|FG000|Overall Study|Protocol Violation|1|||
130385275|NCT00296374|469378365|FG001|Overall Study|Protocol Violation|2|||
130385276|NCT00296374|469378366|FG002|Overall Study|Protocol Violation|3|||
130385277|NCT00296374|469378364|FG000|Overall Study|Lost to Follow-up|3|||
130385278|NCT00296374|469378365|FG001|Overall Study|Lost to Follow-up|1|||
130385279|NCT00296374|469378366|FG002|Overall Study|Lost to Follow-up|1|||
130385280|NCT00296374|469378364|FG000|Overall Study|Relocated to another state|1|||
130385281|NCT00296374|469378365|FG001|Overall Study|Relocated to another state|0|||
130385282|NCT00296374|469378366|FG002|Overall Study|Relocated to another state|0|||
130385283|NCT00296374|469378364|FG000|Overall Study|Stopped drug before end of study visit|0|||
130385284|NCT00296374|469378365|FG001|Overall Study|Stopped drug before end of study visit|1|||
130385285|NCT00296374|469378366|FG002|Overall Study|Stopped drug before end of study visit|0|||
130385286|NCT00296374|469378364|FG000|Overall Study|Nephrologist introduced ACE|0|||
130385287|NCT00296374|469378365|FG001|Overall Study|Nephrologist introduced ACE|1|||
130385288|NCT00296374|469378366|FG002|Overall Study|Nephrologist introduced ACE|0|||
130385289|NCT00296374|469378364|FG000|Overall Study|Pregnancy|0|||
130385290|NCT00296374|469378365|FG001|Overall Study|Pregnancy|0|||
130385291|NCT00296374|469378366|FG002|Overall Study|Pregnancy|2|||
130385292|NCT00296374|469378364|FG000|Overall Study|Other|0|||
130385293|NCT00296374|469378365|FG001|Overall Study|Other|0|||
130385294|NCT00296374|469378366|FG002|Overall Study|Other|1|||
130385295|NCT01721330|469378367|FG000|Overall Study|Withdrawal by Subject|0|||
130385296|NCT01721330|469378368|FG001|Overall Study|Withdrawal by Subject|1|||
130385297|NCT01786629|469379941|FG000|Overall Study|Lack of Efficacy|0|||
130385298|NCT01786629|469379942|FG001|Overall Study|Lack of Efficacy|4|||
130385299|NCT01786629|469379941|FG000|Overall Study|Adverse Event|0|||
130385300|NCT01786629|469379942|FG001|Overall Study|Adverse Event|1|||
130385301|NCT02750592|469379947|FG000|Overall Study|Adverse Event|3|||
130385302|NCT02750592|469379947|FG000|Overall Study|Lack of Efficacy|2|||
130385303|NCT02981342|469379950|FG000|Overall Study|Adverse Event|0|||
130385304|NCT02981342|469379951|FG001|Overall Study|Adverse Event|0|||
130385305|NCT02981342|469379952|FG002|Overall Study|Adverse Event|0|||
130385306|NCT02981342|469379953|FG003|Overall Study|Adverse Event|1|||
130385307|NCT02981342|469379950|FG000|Overall Study|Death|0|||
130385308|NCT02981342|469379951|FG001|Overall Study|Death|9|||
130385309|NCT02981342|469379952|FG002|Overall Study|Death|9|||
130385310|NCT02981342|469379953|FG003|Overall Study|Death|4|||
130385311|NCT02981342|469379950|FG000|Overall Study|Withdrawal by Subject|0|||
130385312|NCT02981342|469379951|FG001|Overall Study|Withdrawal by Subject|0|||
130385313|NCT02981342|469379952|FG002|Overall Study|Withdrawal by Subject|3|||
130385314|NCT02981342|469379953|FG003|Overall Study|Withdrawal by Subject|1|||
130385315|NCT02981342|469379950|FG000|Overall Study|Study closed by sponsor|0|||
130385316|NCT02981342|469379951|FG001|Overall Study|Study closed by sponsor|0|||
130385317|NCT02981342|469379952|FG002|Overall Study|Study closed by sponsor|1|||
130385318|NCT02981342|469379953|FG003|Overall Study|Study closed by sponsor|1|||
130385319|NCT02981342|469379950|FG000|Overall Study|Randomized, Never Treated|0|||
130385320|NCT02981342|469379951|FG001|Overall Study|Randomized, Never Treated|1|||
130385321|NCT02981342|469379952|FG002|Overall Study|Randomized, Never Treated|0|||
130385322|NCT02981342|469379953|FG003|Overall Study|Randomized, Never Treated|7|||
130385323|NCT02981342|469379950|FG000|Overall Study|Lost to Follow-up|0|||
130385324|NCT02981342|469379951|FG001|Overall Study|Lost to Follow-up|1|||
130385325|NCT02981342|469379952|FG002|Overall Study|Lost to Follow-up|0|||
130385326|NCT02981342|469379953|FG003|Overall Study|Lost to Follow-up|0|||
130385327|NCT05333900|469379954|FG000|Overall Study|Protocol Violation|0|||
130385328|NCT05333900|469379955|FG001|Overall Study|Protocol Violation|1|||
130385329|NCT05333900|469379954|FG000|Overall Study|Withdrawal by Subject|0|||
130559696|NCT01970488|470017849|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
130385330|NCT05333900|469379955|FG001|Overall Study|Withdrawal by Subject|1|||
130385331|NCT05333900|469379954|FG000|Overall Study|COVID-19 Pandemic|1|||
130385332|NCT05333900|469379955|FG001|Overall Study|COVID-19 Pandemic|1|||
130385333|NCT01394523|469379958|FG000|Overall Study|Unable to place block|1|||
130385334|NCT01394523|469379959|FG001|Overall Study|Unable to place block|0|||
130385335|NCT01394523|469379960|FG002|Overall Study|Unable to place block|0|||
130385336|NCT02389998|469379961|FG000|Overall Study|car accident|1|||
130385337|NCT02389998|469379962|FG001|Overall Study|car accident|0|||
130385338|NCT03525574|469379963|FG000|Overall Study|Adverse Event|15|||
130385339|NCT03525574|469379964|FG001|Overall Study|Adverse Event|0|||
130385340|NCT03525574|469379963|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
130385341|NCT03525574|469379964|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130385342|NCT03525574|469379963|FG000|Overall Study|Lost to Follow-up|4|||
130385343|NCT03525574|469379964|FG001|Overall Study|Lost to Follow-up|0|||
130385344|NCT03525574|469379963|FG000|Overall Study|Commercial drug is Available for participant|48|||
130385345|NCT03525574|469379964|FG001|Overall Study|Commercial drug is Available for participant|0|||
130385346|NCT03525574|469379963|FG000|Overall Study|Death|1|||
130385347|NCT03525574|469379964|FG001|Overall Study|Death|0|||
130385348|NCT03525574|469379963|FG000|Overall Study|Other non-compliance|2|||
130385349|NCT03525574|469379964|FG001|Overall Study|Other non-compliance|0|||
130385350|NCT03525574|469379963|FG000|Overall Study|Physician Decision|6|||
130385351|NCT03525574|469379964|FG001|Overall Study|Physician Decision|0|||
130385352|NCT03525574|469379963|FG000|Overall Study|Other|58|||
130385353|NCT03525574|469379964|FG001|Overall Study|Other|0|||
130385354|NCT03525574|469379963|FG000|Overall Study|Enrolled but never dosed|1|||
130385355|NCT03525574|469379964|FG001|Overall Study|Enrolled but never dosed|0|||
130385356|NCT03525574|469379963|FG000|Overall Study|Not enrolled in 105 study|0|||
130385357|NCT03525574|469379964|FG001|Overall Study|Not enrolled in 105 study|3|||
130385358|NCT03814746|469379967|FG000|Overall Study|Participant decision|9|||
130385359|NCT03814746|469379968|FG001|Overall Study|Participant decision|6|||
130385360|NCT03814746|469379969|FG002|Overall Study|Participant decision|15|||
130385361|NCT03814746|469379967|FG000|Overall Study|Physician Decision|2|||
130385362|NCT03814746|469379968|FG001|Overall Study|Physician Decision|2|||
130385363|NCT03814746|469379969|FG002|Overall Study|Physician Decision|4|||
130559697|NCT01970488|470017850|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
130559698|NCT01970488|470017846|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
130559699|NCT01970488|470017847|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
130559700|NCT01970488|470017848|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
130559701|NCT01970488|470017849|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
130559702|NCT01970488|470017850|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
130559703|NCT02092350|470017851|FG000|Overall Study|Adverse Event|0|||
130559704|NCT02092350|470017852|FG001|Overall Study|Adverse Event|3|||
130559705|NCT02092350|470017851|FG000|Overall Study|Death|2|||
130559706|NCT02092350|470017852|FG001|Overall Study|Death|5|||
130559707|NCT02092350|470017851|FG000|Overall Study|Lost to Follow-up|3|||
130559708|NCT02092350|470017852|FG001|Overall Study|Lost to Follow-up|1|||
130559709|NCT02092350|470017851|FG000|Overall Study|Protocol Violation|1|||
130559710|NCT02092350|470017852|FG001|Overall Study|Protocol Violation|0|||
130559711|NCT02092350|470017851|FG000|Overall Study|Physician Decision|1|||
130559712|NCT02092350|470017852|FG001|Overall Study|Physician Decision|1|||
130559713|NCT02092350|470017851|FG000|Overall Study|Screen Failure|1|||
130385364|NCT03814746|469379967|FG000|Overall Study|Death|2|||
130385365|NCT03814746|469379968|FG001|Overall Study|Death|2|||
130559714|NCT02092350|470017852|FG001|Overall Study|Screen Failure|0|||
130559715|NCT02092350|470017851|FG000|Overall Study|Withdrawal by Subject|2|||
130559716|NCT02092350|470017852|FG001|Overall Study|Withdrawal by Subject|2|||
130385366|NCT03814746|469379969|FG002|Overall Study|Death|2|||
130385367|NCT03814746|469379967|FG000|Overall Study|Adverse Event|2|||
130385368|NCT03814746|469379968|FG001|Overall Study|Adverse Event|2|||
130385369|NCT03814746|469379969|FG002|Overall Study|Adverse Event|1|||
130385370|NCT03814746|469379967|FG000|Overall Study|Lost to Follow-up|2|||
130385371|NCT03814746|469379968|FG001|Overall Study|Lost to Follow-up|1|||
130385372|NCT03814746|469379969|FG002|Overall Study|Lost to Follow-up|2|||
130385373|NCT03814746|469379967|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130385374|NCT03814746|469379968|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130385375|NCT03814746|469379969|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130385376|NCT03814746|469379967|FG000|Overall Study|Pregnancy|0|||
130385377|NCT03814746|469379968|FG001|Overall Study|Pregnancy|1|||
130385378|NCT03814746|469379969|FG002|Overall Study|Pregnancy|1|||
130385379|NCT03814746|469379967|FG000|Overall Study|Protocol Violation|1|||
130385380|NCT03814746|469379968|FG001|Overall Study|Protocol Violation|0|||
130385381|NCT03814746|469379969|FG002|Overall Study|Protocol Violation|0|||
130385382|NCT00518323|469379975|FG000|Overall Study|Lack of Efficacy|14|||
130385383|NCT00518323|469379976|FG001|Overall Study|Lack of Efficacy|2|||
130385384|NCT00518323|469379977|FG002|Overall Study|Lack of Efficacy|4|||
130385385|NCT00518323|469379978|FG003|Overall Study|Lack of Efficacy|20|||
130385386|NCT00518323|469379975|FG000|Overall Study|Withdrawal by Subject|1|||
130722467|NCT00758680|470608273|FG005|Overall Study|Withdrawal by Subject|0|||
130722468|NCT00758680|470608274|FG006|Overall Study|Withdrawal by Subject|1|||
130722469|NCT00758680|470608275|FG007|Overall Study|Withdrawal by Subject|0|||
130722470|NCT00758680|470608276|FG008|Overall Study|Withdrawal by Subject|1|||
130722471|NCT00758680|470608277|FG009|Overall Study|Withdrawal by Subject|0|||
130722472|NCT00761865|470608278|FG000|Overall Study|Lost to Follow-up|8|||
130722473|NCT00761865|470608279|FG001|Overall Study|Lost to Follow-up|7|||
130722474|NCT00319982|470608280|FG000|Overall Study|Withdrawal by Subject|1|||
130385387|NCT00518323|469379976|FG001|Overall Study|Withdrawal by Subject|2|||
130385388|NCT00518323|469379977|FG002|Overall Study|Withdrawal by Subject|4|||
130385389|NCT00518323|469379978|FG003|Overall Study|Withdrawal by Subject|2|||
130385390|NCT00518323|469379975|FG000|Overall Study|Lost to Follow-up|0|||
130385391|NCT00518323|469379976|FG001|Overall Study|Lost to Follow-up|2|||
130385392|NCT00518323|469379977|FG002|Overall Study|Lost to Follow-up|1|||
130385393|NCT00518323|469379978|FG003|Overall Study|Lost to Follow-up|3|||
130385394|NCT00518323|469379975|FG000|Overall Study|Adverse Event|1|||
130385395|NCT00518323|469379976|FG001|Overall Study|Adverse Event|1|||
130385396|NCT00518323|469379977|FG002|Overall Study|Adverse Event|1|||
130385397|NCT00518323|469379978|FG003|Overall Study|Adverse Event|0|||
130385398|NCT00518323|469379975|FG000|Overall Study|Prohibited medication and others|3|||
130385399|NCT00518323|469379976|FG001|Overall Study|Prohibited medication and others|1|||
130385400|NCT00518323|469379977|FG002|Overall Study|Prohibited medication and others|1|||
130385401|NCT00518323|469379978|FG003|Overall Study|Prohibited medication and others|0|||
130385402|NCT01086540|469379979|FG000|Overall Study|Death|3|||
130385403|NCT01086540|469379980|FG001|Overall Study|Death|1|||
130385404|NCT01086540|469379979|FG000|Overall Study|Physician Decision|2|||
130385405|NCT01086540|469379980|FG001|Overall Study|Physician Decision|1|||
130385406|NCT01086540|469379979|FG000|Overall Study|Addition of new therapy for PAH|1|||
130385407|NCT01086540|469379980|FG001|Overall Study|Addition of new therapy for PAH|0|||
130385408|NCT03880019|469379983|FG000|Overall Study|Competing disease|1|||
130385409|NCT00326950|469379984|FG000|Overall Study|Progressive Disease|1|||
130385410|NCT01266460|469379990|FG000|Overall Study|Adverse Event|3|||
130385411|NCT01266460|469379990|FG000|Overall Study|Withdrawal by Subject|5|||
130385412|NCT01266460|469379990|FG000|Overall Study|Disease Progression|18|||
130385413|NCT01266460|469379990|FG000|Overall Study|Not otherwise specified|8|||
130385414|NCT01132547|469379995|FG000|Overall Study|Withdrawal by Subject|3|||
130385415|NCT01132547|469379996|FG001|Overall Study|Withdrawal by Subject|1|||
130385416|NCT01132547|469379995|FG000|Overall Study|Death|1|||
130385417|NCT01132547|469379996|FG001|Overall Study|Death|0|||
130385418|NCT05811234|469379997|FG000|Overall Study|Loss of Effectiveness|2|||
130385419|NCT05811234|469379997|FG000|Overall Study|Adverse Event|4|||
130385420|NCT05811234|469379997|FG000|Overall Study|Pregnancy|1|||
130385421|NCT05811234|469379997|FG000|Overall Study|Disease progression|1|||
130385422|NCT05811234|469379997|FG000|Overall Study|Withdrawal by Subject|4|||
130385423|NCT05811234|469379997|FG000|Overall Study|Lost to Follow-up|13|||
130385424|NCT05811234|469379997|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
130385425|NCT04499781|469379998|FG000|Overall Study|Lost to Follow-up|2|||
130385426|NCT04499781|469379999|FG001|Overall Study|Lost to Follow-up|3|||
130385427|NCT04499781|469379998|FG000|Overall Study|Withdrawal by Subject|2|||
130385428|NCT04499781|469379999|FG001|Overall Study|Withdrawal by Subject|0|||
130385429|NCT00730912|469380017|FG000|Overall Study|Discontinued|0|||
130385430|NCT00730912|469380018|FG001|Overall Study|Discontinued|0|||
130385431|NCT00730912|469380019|FG002|Overall Study|Discontinued|1|||
130385432|NCT03311659|469380020|FG000|Overall Study|Protocol Violation|1|||
130385433|NCT04053023|469380021|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
130385434|NCT04053023|469380022|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
130385435|NCT00071760|469380023|FG000|Overall Study|Adverse Event|2|||
130385436|NCT00071760|469380024|FG001|Overall Study|Adverse Event|1|||
130385437|NCT00071760|469380023|FG000|Overall Study|Lost to Follow-up|0|||
130385438|NCT00071760|469380024|FG001|Overall Study|Lost to Follow-up|3|||
130385439|NCT00071760|469380023|FG000|Overall Study|Protocol Violation|1|||
130385440|NCT00071760|469380024|FG001|Overall Study|Protocol Violation|0|||
130385441|NCT00071760|469380023|FG000|Overall Study|Withdrawal by Subject|0|||
130385442|NCT00071760|469380024|FG001|Overall Study|Withdrawal by Subject|1|||
130385443|NCT00071760|469380023|FG000|Overall Study|Insufficient Viral Load Response|1|||
130385444|NCT00071760|469380024|FG001|Overall Study|Insufficient Viral Load Response|1|||
130385445|NCT00071760|469380023|FG000|Overall Study|Lack of availability of RTV|1|||
130385446|NCT00071760|469380024|FG001|Overall Study|Lack of availability of RTV|0|||
130385447|NCT00071760|469380023|FG000|Overall Study|Physician Decision|2|||
130385448|NCT00071760|469380024|FG001|Overall Study|Physician Decision|1|||
130385449|NCT00071760|469380023|FG000|Overall Study|Relocation|0|||
130385450|NCT00071760|469380024|FG001|Overall Study|Relocation|1|||
130385451|NCT01994629|469380025|FG000|Overall Study|Withdrawal by Subject|1|||
130385452|NCT01994629|469380026|FG001|Overall Study|Withdrawal by Subject|0|||
130385453|NCT01994629|469380025|FG000|Overall Study|Lost to Follow-up|0|||
130385454|NCT01994629|469380026|FG001|Overall Study|Lost to Follow-up|3|||
130385455|NCT03424265|469380027|FG000|Overall Study|screening failure|1|||
130385456|NCT03424265|469380028|FG001|Overall Study|screening failure|0|||
130385457|NCT03424265|469380027|FG000|Overall Study|Withdrawal by Subject|0|||
130385458|NCT03424265|469380028|FG001|Overall Study|Withdrawal by Subject|2|||
130385459|NCT00894322|469380036|FG000|Overall Study|Withdrawal by Subject|1|||
130385460|NCT00894322|469380037|FG001|Overall Study|Withdrawal by Subject|0|||
130385461|NCT00894322|469380038|FG002|Overall Study|Withdrawal by Subject|0|||
130385462|NCT03447990|469380046|FG000|Overall Study|Withdrawal by Subject|0|||
130385463|NCT03447990|469380047|FG001|Overall Study|Withdrawal by Subject|0|||
130385464|NCT03447990|469380048|FG002|Overall Study|Withdrawal by Subject|0|||
130385465|NCT03447990|469380049|FG003|Overall Study|Withdrawal by Subject|0|||
130385466|NCT03447990|469380050|FG004|Overall Study|Withdrawal by Subject|0|||
130385467|NCT03447990|469380051|FG005|Overall Study|Withdrawal by Subject|0|||
130385468|NCT03447990|469380052|FG006|Overall Study|Withdrawal by Subject|1|||
130385469|NCT02738450|469380053|FG000|Overall Study|Withdrawal by Subject|0|||
130385470|NCT02738450|469380054|FG001|Overall Study|Withdrawal by Subject|2|||
130385471|NCT02738450|469380055|FG002|Overall Study|Withdrawal by Subject|0|||
130385472|NCT00399360|469380058|FG000|Overall Study|Lost to Follow-up|2|||
130385473|NCT00399360|469380059|FG001|Overall Study|Lost to Follow-up|1|||
130385474|NCT00399360|469380060|FG002|Overall Study|Lost to Follow-up|2|||
130385475|NCT00399360|469380061|FG003|Overall Study|Lost to Follow-up|4|||
130385476|NCT00399360|469380058|FG000|Overall Study|Adverse Event|0|||
130385477|NCT00399360|469380059|FG001|Overall Study|Adverse Event|0|||
130385478|NCT00399360|469380060|FG002|Overall Study|Adverse Event|1|||
130385479|NCT00399360|469380061|FG003|Overall Study|Adverse Event|0|||
130385480|NCT00399360|469380058|FG000|Overall Study|Withdrawal by Subject|0|||
130385481|NCT00399360|469380059|FG001|Overall Study|Withdrawal by Subject|2|||
130385482|NCT00399360|469380060|FG002|Overall Study|Withdrawal by Subject|0|||
130385483|NCT00399360|469380061|FG003|Overall Study|Withdrawal by Subject|2|||
130385484|NCT01412021|469380062|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
130385485|NCT01412021|469380062|FG000|Overall Study|Treatment Prior to Approval|3|||
130385486|NCT01412021|469380062|FG000|Overall Study|Transferred to Other Hospital|9|||
130385487|NCT01166178|469380063|FG000|Overall Study|Withdrawal by Subject|1|||
130385488|NCT01166178|469380064|FG001|Overall Study|Withdrawal by Subject|0|||
130385489|NCT01166178|469380063|FG000|Overall Study|Study was terminated|20|||
130385490|NCT01166178|469380064|FG001|Overall Study|Study was terminated|8|||
130385491|NCT04537234|469380071|FG000|Overall Study|Withdrawal by Subject|2|||
130385492|NCT04537234|469380072|FG001|Overall Study|Withdrawal by Subject|0|||
130385493|NCT07114198|469380073|FG000|Overall Study|Protocol Violation|1|||
130385494|NCT07114198|469380074|FG001|Overall Study|Protocol Violation|1|||
130385495|NCT00670800|469381959|FG000|Overall Study|2 controls were insulin resistant|0|||
130385496|NCT00670800|469381960|FG001|Overall Study|2 controls were insulin resistant|2|||
130385497|NCT04736199|469381961|FG000|Overall Study|Adverse Event|28|||
130385498|NCT04736199|469381962|FG001|Overall Study|Adverse Event|22|||
130385499|NCT04736199|469381961|FG000|Overall Study|Death|9|||
130385500|NCT04736199|469381962|FG001|Overall Study|Death|3|||
130385501|NCT04736199|469381961|FG000|Overall Study|Lost to Follow-up|4|||
130385502|NCT04736199|469381962|FG001|Overall Study|Lost to Follow-up|1|||
130385503|NCT04736199|469381961|FG000|Overall Study|Physician Decision|5|||
130385504|NCT04736199|469381962|FG001|Overall Study|Physician Decision|9|||
130385505|NCT04736199|469381961|FG000|Overall Study|Withdrawal by Subject|21|||
130385506|NCT04736199|469381962|FG001|Overall Study|Withdrawal by Subject|9|||
130385507|NCT04736199|469381961|FG000|Overall Study|Progressive disease|120|||
130385508|NCT04736199|469381962|FG001|Overall Study|Progressive disease|101|||
130385509|NCT04736199|469381961|FG000|Overall Study|Subject decision|13|||
130385510|NCT04736199|469381962|FG001|Overall Study|Subject decision|13|||
130385511|NCT04736199|469381961|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
130385512|NCT04736199|469381962|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
130385513|NCT04736199|469381961|FG000|Overall Study|Additional primary malignancy|1|||
130385514|NCT04736199|469381962|FG001|Overall Study|Additional primary malignancy|0|||
130385515|NCT04736199|469381961|FG000|Overall Study|Non-compliance with study drug|0|||
130385516|NCT04736199|469381962|FG001|Overall Study|Non-compliance with study drug|1|||
130385517|NCT04736199|469381961|FG000|Overall Study|Other reason|0|||
130385518|NCT04736199|469381962|FG001|Overall Study|Other reason|1|||
130385519|NCT04736199|469381961|FG000|Overall Study|Ongoing with study drug|240|||
130385520|NCT04736199|469381962|FG001|Overall Study|Ongoing with study drug|63|||
130385521|NCT04736199|469381961|FG000|Overall Study|Study drug never administered|3|||
130385522|NCT04736199|469381962|FG001|Overall Study|Study drug never administered|0|||
130385523|NCT04318080|469381963|FG000|Overall Study|Study closed by sponsor|10|||
130385524|NCT04318080|469381964|FG001|Overall Study|Study closed by sponsor|22|||
130385525|NCT04318080|469381963|FG000|Overall Study|Death|3|||
130385526|NCT04318080|469381964|FG001|Overall Study|Death|9|||
130385527|NCT04318080|469381963|FG000|Overall Study|Withdrawal by Subject|1|||
130385528|NCT04318080|469381964|FG001|Overall Study|Withdrawal by Subject|0|||
130385529|NCT04318080|469381963|FG000|Overall Study|Protocol Deviation|1|||
130385530|NCT04318080|469381964|FG001|Overall Study|Protocol Deviation|0|||
130385531|NCT06308822|469381965|FG000|Overall Study|Mutation Status Not Confirmed|17|||
130385532|NCT06308822|469381965|FG000|Overall Study|Adverse Event|1|||
130385533|NCT06308822|469381965|FG000|Overall Study|Death|5|||
130385534|NCT06308822|469381965|FG000|Overall Study|Disease progression|8|||
130385535|NCT06308822|469381965|FG000|Overall Study|Withdrawal by Subject|1|||
130385536|NCT06308822|469381965|FG000|Overall Study|Physician Decision|3|||
130385537|NCT03712904|469381966|FG000|Overall Study|Death|0|||
130385538|NCT03712904|469381967|FG001|Overall Study|Death|1|||
130385539|NCT03712904|469381966|FG000|Overall Study|Withdrawal by Subject|0|||
130385540|NCT03712904|469381967|FG001|Overall Study|Withdrawal by Subject|1|||
130385541|NCT03712904|469381966|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
130385542|NCT03712904|469381967|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
130385543|NCT01852942|469381968|FG000|Overall Study|Physician Decision|1|||
130385544|NCT01852942|469381969|FG001|Overall Study|Physician Decision|0|||
130385545|NCT01852942|469381968|FG000|Overall Study|Death|1|||
130385546|NCT01852942|469381969|FG001|Overall Study|Death|1|||
130385547|NCT01852942|469381968|FG000|Overall Study|Withdrawal by Subject|2|||
130385548|NCT01852942|469381969|FG001|Overall Study|Withdrawal by Subject|3|||
130385549|NCT01852942|469381968|FG000|Overall Study|Lost to Follow-up|1|||
130385550|NCT01852942|469381969|FG001|Overall Study|Lost to Follow-up|2|||
130385551|NCT01921179|469381970|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
130385552|NCT01921179|469381971|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
130385553|NCT01921179|469381970|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
130385554|NCT01921179|469381971|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
130385555|NCT05608005|469381978|FG000|Overall Study|Adverse Event|2|||
130385556|NCT05608005|469381979|FG001|Overall Study|Adverse Event|1|||
130385557|NCT05608005|469381980|FG002|Overall Study|Adverse Event|3|||
130385558|NCT05608005|469381978|FG000|Overall Study|Protocol Violation|2|||
130385559|NCT05608005|469381979|FG001|Overall Study|Protocol Violation|3|||
130385560|NCT05608005|469381980|FG002|Overall Study|Protocol Violation|0|||
130385561|NCT05608005|469381978|FG000|Overall Study|Withdrawal by Subject|10|||
130385562|NCT05608005|469381979|FG001|Overall Study|Withdrawal by Subject|12|||
130385563|NCT05608005|469381980|FG002|Overall Study|Withdrawal by Subject|4|||
130385564|NCT05608005|469381978|FG000|Overall Study|Lost to Follow-up|25|||
130385565|NCT05608005|469381979|FG001|Overall Study|Lost to Follow-up|27|||
130385566|NCT05608005|469381980|FG002|Overall Study|Lost to Follow-up|15|||
130385567|NCT05608005|469381978|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
130385568|NCT05608005|469381979|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
130385569|NCT05608005|469381980|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
130385570|NCT04708886|469381981|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
130385571|NCT04708886|469381981|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
130385572|NCT01372501|469381982|FG000|Overall Study|Adverse Event|4|||
130385573|NCT01372501|469381982|FG000|Overall Study|Device migration|1|||
130385574|NCT01466348|469381983|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
130385575|NCT01466348|469381984|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
130385576|NCT03989440|469381985|FG000|Overall Study|COVID-19 travel restrictions|0|||
130385577|NCT03989440|469381986|FG001|Overall Study|COVID-19 travel restrictions|0|||
130385578|NCT03989440|469381987|FG002|Overall Study|COVID-19 travel restrictions|1|||
130385579|NCT03989440|469381988|FG003|Overall Study|COVID-19 travel restrictions|0|||
130385580|NCT03989440|469381989|FG004|Overall Study|COVID-19 travel restrictions|0|||
130385581|NCT03989440|469381990|FG005|Overall Study|COVID-19 travel restrictions|0|||
130385582|NCT03989440|469381985|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
130385583|NCT03989440|469381986|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
130385584|NCT03989440|469381987|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
130385585|NCT03989440|469381988|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
130385586|NCT03989440|469381989|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
130385587|NCT03989440|469381990|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
130385588|NCT03970733|469381993|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130385589|NCT03970733|469381994|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
130385590|NCT03970733|469381995|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
130385591|NCT03970733|469381996|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130385592|NCT03970733|469381997|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130385593|NCT03970733|469381993|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
130385594|NCT03970733|469381994|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
130385595|NCT03970733|469381995|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
130385596|NCT03970733|469381996|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
130385597|NCT03970733|469381997|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
130385598|NCT03970733|469381993|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
130385599|NCT03970733|469381994|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
130385600|NCT03970733|469381995|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
130722475|NCT00319982|470608281|FG001|Overall Study|Withdrawal by Subject|0|||
130722476|NCT01094886|470608282|FG000|Overall Study|Adverse Event|2|||
130722477|NCT01094886|470608282|FG000|Overall Study|Withdrawal by Subject|5|||
130722478|NCT03866902|470608283|FG000|Overall Study|Lost to Follow-up|98|||
130385601|NCT03970733|469381996|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
130385602|NCT03970733|469381997|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
130385603|NCT03970733|469381993|FG000|Main Study Phase (18 Months)|Other|1|||
130385604|NCT03970733|469381994|FG001|Main Study Phase (18 Months)|Other|1|||
130385605|NCT03970733|469381995|FG002|Main Study Phase (18 Months)|Other|0|||
130385606|NCT03970733|469381996|FG003|Main Study Phase (18 Months)|Other|0|||
130385607|NCT03970733|469381997|FG004|Main Study Phase (18 Months)|Other|0|||
130385608|NCT03970733|469381993|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130385609|NCT03970733|469381994|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130385610|NCT03970733|469381995|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130385611|NCT03970733|469381996|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130385612|NCT03970733|469381997|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
130385613|NCT02189473|469382001|FG000|Overall Study|Death|22|||
130385614|NCT02189473|469382002|FG001|Overall Study|Death|23|||
130385615|NCT02189473|469382001|FG000|Overall Study|Lost to Follow-up|1|||
130385616|NCT02189473|469382002|FG001|Overall Study|Lost to Follow-up|2|||
130385617|NCT01955161|469382003|FG000|Overall Study|Withdrawal before treatment|2|||
130385618|NCT01955161|469382004|FG001|Overall Study|Withdrawal before treatment|0|||
130385619|NCT01955161|469382005|FG002|Overall Study|Withdrawal before treatment|1|||
130385620|NCT01955161|469382003|FG000|Overall Study|Adverse Event|10|||
130385621|NCT01955161|469382004|FG001|Overall Study|Adverse Event|14|||
130385622|NCT01955161|469382005|FG002|Overall Study|Adverse Event|15|||
130385623|NCT01955161|469382003|FG000|Overall Study|Death|1|||
130385624|NCT01955161|469382004|FG001|Overall Study|Death|1|||
130385625|NCT01955161|469382005|FG002|Overall Study|Death|3|||
130385626|NCT01955161|469382003|FG000|Overall Study|Withdrawal by Subject|9|||
130385627|NCT01955161|469382004|FG001|Overall Study|Withdrawal by Subject|8|||
130385628|NCT01955161|469382005|FG002|Overall Study|Withdrawal by Subject|12|||
130385629|NCT01955161|469382003|FG000|Overall Study|Protocol Violation|2|||
130385630|NCT01955161|469382004|FG001|Overall Study|Protocol Violation|0|||
130385631|NCT01955161|469382005|FG002|Overall Study|Protocol Violation|0|||
130385632|NCT01955161|469382003|FG000|Overall Study|Other reason: physician decision|0|||
130385633|NCT01955161|469382004|FG001|Overall Study|Other reason: physician decision|1|||
130385634|NCT01955161|469382005|FG002|Overall Study|Other reason: physician decision|1|||
130385635|NCT01955161|469382003|FG000|Overall Study|Other reason: disallowed medication|1|||
130385636|NCT01955161|469382004|FG001|Overall Study|Other reason: disallowed medication|0|||
130385637|NCT01955161|469382005|FG002|Overall Study|Other reason: disallowed medication|1|||
130385638|NCT01955161|469382003|FG000|Overall Study|Other reason: caregiver unavailable|1|||
130385639|NCT01955161|469382004|FG001|Overall Study|Other reason: caregiver unavailable|0|||
130385640|NCT01955161|469382005|FG002|Overall Study|Other reason: caregiver unavailable|0|||
130385641|NCT01955161|469382003|FG000|Overall Study|Other reason: moved to nursing home|0|||
130385642|NCT01955161|469382004|FG001|Overall Study|Other reason: moved to nursing home|1|||
130385643|NCT01955161|469382005|FG002|Overall Study|Other reason: moved to nursing home|0|||
130385644|NCT01955161|469382003|FG000|Overall Study|Other reason: insufficient compliance|0|||
130385645|NCT01955161|469382004|FG001|Overall Study|Other reason: insufficient compliance|0|||
130385646|NCT01955161|469382005|FG002|Overall Study|Other reason: insufficient compliance|1|||
130385647|NCT01955161|469382003|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
130385648|NCT01955161|469382004|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
130385649|NCT01955161|469382005|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
130385650|NCT01955161|469382003|FG000|Overall Study|Other reason: patient's will|0|||
130385651|NCT01955161|469382004|FG001|Overall Study|Other reason: patient's will|0|||
130385652|NCT01955161|469382005|FG002|Overall Study|Other reason: patient's will|1|||
130385653|NCT02784821|469382008|FG000|Overall Study|Death|0|||
130385654|NCT02784821|469382009|FG001|Overall Study|Death|5|||
130385655|NCT02784821|469382010|FG002|Overall Study|Death|4|||
130469231|NCT05696080|469683586|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130469232|NCT05696080|469683585|FG000|Overall Study|Withdrawal by Subject|12|||
130469233|NCT05696080|469683586|FG001|Overall Study|Withdrawal by Subject|0|||
130469234|NCT04038957|469683592|FG000|Overall Study|Withdrawal by Subject|1|||
130385656|NCT02784821|469382011|FG003|Overall Study|Death|5|||
130385657|NCT01277523|469382012|FG000|Overall Study|Adverse Event|1|||
130385658|NCT01277523|469382013|FG001|Overall Study|Adverse Event|0|||
130385659|NCT01277523|469382014|FG002|Overall Study|Adverse Event|0|||
130385660|NCT01277523|469382012|FG000|Overall Study|Protocol Violation|2|||
130385661|NCT01277523|469382013|FG001|Overall Study|Protocol Violation|0|||
130385662|NCT01277523|469382014|FG002|Overall Study|Protocol Violation|0|||
130385663|NCT01277523|469382012|FG000|Overall Study|Other Reason not Defined|0|||
130385664|NCT01277523|469382013|FG001|Overall Study|Other Reason not Defined|1|||
130385665|NCT01277523|469382014|FG002|Overall Study|Other Reason not Defined|0|||
130385666|NCT01881230|469382020|FG000|Overall Study|Death|2|||
130385667|NCT01881230|469382021|FG001|Overall Study|Death|0|||
130385668|NCT01881230|469382022|FG002|Overall Study|Death|1|||
130385669|NCT01881230|469382020|FG000|Overall Study|Adverse Event|9|||
130469235|NCT04038957|469683592|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
130469236|NCT01998984|469683597|FG000|Overall Study|Adverse Event|0|||
130385670|NCT01881230|469382021|FG001|Overall Study|Adverse Event|13|||
130385671|NCT01881230|469382022|FG002|Overall Study|Adverse Event|12|||
130385672|NCT01881230|469382020|FG000|Overall Study|Progressive Disease|31|||
130385673|NCT01881230|469382021|FG001|Overall Study|Progressive Disease|35|||
130385674|NCT01881230|469382022|FG002|Overall Study|Progressive Disease|36|||
130385675|NCT01881230|469382020|FG000|Overall Study|Symptomatic Deterioration|3|||
130385676|NCT01881230|469382021|FG001|Overall Study|Symptomatic Deterioration|3|||
130469237|NCT01998984|469683598|FG001|Overall Study|Adverse Event|0|||
130469238|NCT01998984|469683599|FG002|Overall Study|Adverse Event|0|||
130385677|NCT01881230|469382022|FG002|Overall Study|Symptomatic Deterioration|1|||
130385678|NCT01881230|469382020|FG000|Overall Study|Withdrawal by Subject|6|||
130385679|NCT01881230|469382021|FG001|Overall Study|Withdrawal by Subject|4|||
130385680|NCT01881230|469382022|FG002|Overall Study|Withdrawal by Subject|6|||
130385681|NCT01881230|469382020|FG000|Overall Study|Physician Decision|4|||
130385682|NCT01881230|469382021|FG001|Overall Study|Physician Decision|3|||
130385683|NCT01881230|469382022|FG002|Overall Study|Physician Decision|6|||
130385684|NCT01881230|469382020|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130385685|NCT01881230|469382021|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130385686|NCT01881230|469382022|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130385687|NCT01881230|469382020|FG000|Overall Study|Given Commercially Available Drug|0|||
130385688|NCT01881230|469382021|FG001|Overall Study|Given Commercially Available Drug|0|||
130385689|NCT01881230|469382022|FG002|Overall Study|Given Commercially Available Drug|2|||
130385690|NCT01881230|469382020|FG000|Overall Study|Protocol Violation|1|||
130385691|NCT01881230|469382021|FG001|Overall Study|Protocol Violation|1|||
130385692|NCT01881230|469382022|FG002|Overall Study|Protocol Violation|0|||
130385693|NCT01881230|469382020|FG000|Overall Study|Miscellaneous|3|||
130385694|NCT01881230|469382021|FG001|Overall Study|Miscellaneous|3|||
130385695|NCT01881230|469382022|FG002|Overall Study|Miscellaneous|0|||
130385696|NCT01881230|469382020|FG000|Overall Study|Untreated: Other|0|||
130385697|NCT01881230|469382021|FG001|Overall Study|Untreated: Other|0|||
130385698|NCT01881230|469382022|FG002|Overall Study|Untreated: Other|1|||
130385699|NCT01881230|469382020|FG000|Overall Study|Untreated: Death|0|||
130385700|NCT01881230|469382021|FG001|Overall Study|Untreated: Death|0|||
130385701|NCT01881230|469382022|FG002|Overall Study|Untreated: Death|1|||
130385702|NCT01881230|469382020|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
130385703|NCT01881230|469382021|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
130385704|NCT01881230|469382022|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
130385705|NCT00112502|469382023|FG000|Overall Study|Withdrawal by Subject|0|||
130385706|NCT00112502|469382024|FG001|Overall Study|Withdrawal by Subject|1|||
130385707|NCT00112502|469382025|FG002|Overall Study|Withdrawal by Subject|1|||
130385708|NCT00112502|469382026|FG003|Overall Study|Withdrawal by Subject|4|||
130469239|NCT01998984|469683600|FG003|Overall Study|Adverse Event|1|||
130469240|NCT01998984|469683597|FG000|Overall Study|Lost to Follow-up|0|||
130469241|NCT01998984|469683598|FG001|Overall Study|Lost to Follow-up|1|||
130385709|NCT00112502|469382027|FG004|Overall Study|Withdrawal by Subject|2|||
130385710|NCT00112502|469382028|FG005|Overall Study|Withdrawal by Subject|5|||
130385711|NCT00112502|469382029|FG006|Overall Study|Withdrawal by Subject|3|||
130385712|NCT00112502|469382030|FG007|Overall Study|Withdrawal by Subject|7|||
130385713|NCT02385266|469382031|FG000|Overall Study|Withdrawal by Subject|1|||
130385714|NCT02385266|469382032|FG001|Overall Study|Withdrawal by Subject|3|||
130385715|NCT01030523|469382033|FG000|Initial Study (5 Years)|Death|1|||
130385716|NCT01030523|469382034|FG001|Initial Study (5 Years)|Death|0|||
130385717|NCT01030523|469382033|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
130385718|NCT01030523|469382034|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
130385719|NCT01030523|469382033|FG000|Initial Study (5 Years)|Implant failure|1|||
130385720|NCT01030523|469382034|FG001|Initial Study (5 Years)|Implant failure|0|||
130385721|NCT01030523|469382033|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
130385722|NCT01030523|469382034|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
130385723|NCT01030523|469382033|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
130385724|NCT01030523|469382034|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
130469242|NCT01998984|469683599|FG002|Overall Study|Lost to Follow-up|0|||
130469243|NCT01998984|469683600|FG003|Overall Study|Lost to Follow-up|1|||
130469244|NCT01998984|469683597|FG000|Overall Study|Withdrawal by Subject|0|||
130385725|NCT01030523|469382033|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
130385726|NCT01030523|469382034|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
130385727|NCT02357901|469382041|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
130385728|NCT02357901|469382042|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130385729|NCT02357901|469382043|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130385730|NCT02357901|469382044|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130385731|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
130385732|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
130385733|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
130385734|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
130385735|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
130722479|NCT03866902|470608284|FG001|Overall Study|Lost to Follow-up|82|||
130385736|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
130385737|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
130385738|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
130385739|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130385740|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
130385741|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
130385742|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
130385743|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
130385744|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
130385745|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
130385746|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
130385747|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
130385748|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
130385749|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
130385750|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
130385751|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
130385752|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
130385753|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
130385754|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
130385755|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
130469245|NCT01998984|469683598|FG001|Overall Study|Withdrawal by Subject|0|||
130469246|NCT01998984|469683599|FG002|Overall Study|Withdrawal by Subject|1|||
130469247|NCT01998984|469683600|FG003|Overall Study|Withdrawal by Subject|0|||
130559717|NCT00239226|470017853|FG000|Overall Study|permAF during stabilization period|0|||
130559718|NCT00239226|470017854|FG001|Overall Study|permAF during stabilization period|0|||
130559719|NCT00239226|470017855|FG002|Overall Study|permAF during stabilization period|0|||
130559720|NCT00239226|470017856|FG003|Overall Study|permAF during stabilization period|3|||
130559721|NCT00239226|470017853|FG000|Overall Study|Lost to Follow-up|1|||
130385756|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
130385757|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
130385758|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
130385759|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
130385760|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
130385761|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
130469248|NCT01998984|469683597|FG000|Overall Study|Other|0|||
130469249|NCT01998984|469683598|FG001|Overall Study|Other|0|||
130469250|NCT01998984|469683599|FG002|Overall Study|Other|0|||
130469251|NCT01998984|469683600|FG003|Overall Study|Other|1|||
130559722|NCT00239226|470017854|FG001|Overall Study|Lost to Follow-up|0|||
130385762|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
130385763|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
130385764|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
130385765|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
130385766|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
130469252|NCT01843374|469683601|FG000|Overall Study|Death|155|||
130559723|NCT00239226|470017855|FG002|Overall Study|Lost to Follow-up|1|||
130559724|NCT00239226|470017856|FG003|Overall Study|Lost to Follow-up|0|||
130559725|NCT00646906|470017858|FG000|Crossover Period 1|Withdrawal by Subject|1|||
130722480|NCT03866902|470608283|FG000|Overall Study|Pregnancy|18|||
130722481|NCT03866902|470608284|FG001|Overall Study|Pregnancy|24|||
130722482|NCT04730349|470608287|FG000|Overall Study|Participant withdrew consent|1|||
130722483|NCT04730349|470608288|FG001|Overall Study|Participant withdrew consent|0|||
130722484|NCT04730349|470608287|FG000|Overall Study|Disease progression|6|||
130722485|NCT04730349|470608288|FG001|Overall Study|Disease progression|4|||
130722486|NCT04730349|470608287|FG000|Overall Study|Study drug toxicity|0|||
130722487|NCT04730349|470608288|FG001|Overall Study|Study drug toxicity|1|||
130722488|NCT00638027|470608290|FG000|Overall Study|Adverse Event|0|||
130722489|NCT00638027|470608291|FG001|Overall Study|Adverse Event|2|||
130722490|NCT00371397|470608292|FG000|Session 1|Withdrawal by Subject|1|||
130722491|NCT00371397|470608293|FG001|Session 1|Withdrawal by Subject|0|||
130722492|NCT00371397|470608294|FG002|Session 1|Withdrawal by Subject|0|||
130722493|NCT00371397|470608295|FG003|Session 1|Withdrawal by Subject|0|||
130722494|NCT00371397|470608296|FG004|Session 1|Withdrawal by Subject|0|||
130722495|NCT00371397|470608297|FG005|Session 1|Withdrawal by Subject|0|||
130722496|NCT00371397|470608298|FG006|Session 1|Withdrawal by Subject|0|||
130722497|NCT00371397|470608299|FG007|Session 1|Withdrawal by Subject|1|||
130722498|NCT00371397|470608300|FG008|Session 1|Withdrawal by Subject|0|||
130722499|NCT00371397|470608301|FG009|Session 1|Withdrawal by Subject|0|||
130722500|NCT00371397|470608302|FG010|Session 1|Withdrawal by Subject|0|||
130385767|NCT02357901|469382041|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
130385768|NCT02357901|469382042|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
130385769|NCT02357901|469382043|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
130385770|NCT02357901|469382044|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
130385771|NCT00491387|469382050|FG000|Overall Study|study terminated|20|||
130385772|NCT00227305|469382054|FG000|Overall Study|Adverse Event|40|||
130385773|NCT00227305|469382054|FG000|Overall Study|Withdrawal by Subject|42|||
130385774|NCT00227305|469382054|FG000|Overall Study|Lost to Follow-up|33|||
130385775|NCT00227305|469382054|FG000|Overall Study|Study specific discontinuation|13|||
130385776|NCT00227305|469382054|FG000|Overall Study|MOVED OUT OF AREA|3|||
130385777|NCT00227305|469382054|FG000|Overall Study|Lack of Efficacy|7|||
130385778|NCT00227305|469382054|FG000|Overall Study|Physician Decision|3|||
130385779|NCT00227305|469382054|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
130385780|NCT00227305|469382054|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
130385781|NCT00227305|469382054|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
130385782|NCT00483379|469382055|FG000|Treatment Period|Adverse Event|1|||
130385783|NCT00483379|469382056|FG001|Treatment Period|Adverse Event|0|||
130385784|NCT00483379|469382055|FG000|Treatment Period|Withdrawal by Subject|1|||
130385785|NCT00483379|469382056|FG001|Treatment Period|Withdrawal by Subject|0|||
130385786|NCT03338062|469382057|FG000|Overall Study|Alternative Therapy|1|||
130385787|NCT03338062|469382058|FG001|Overall Study|Alternative Therapy|0|||
130385788|NCT01558752|469382059|FG000|Overall Study|Physician Decision|2|||
130385789|NCT01558752|469382060|FG001|Overall Study|Physician Decision|0|||
130385790|NCT04340362|469382064|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
130385791|NCT01170091|469382065|FG000|Overall Study|Missing efficacy evaluation|3|||
130385792|NCT01170091|469382065|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
130385793|NCT00391274|469382073|FG000|Overall Study|Death Due to Study Disease|55|||
130385794|NCT00391274|469382074|FG001|Overall Study|Death Due to Study Disease|45|||
130385795|NCT00391274|469382073|FG000|Overall Study|Lost to Follow-up|0|||
130385796|NCT00391274|469382074|FG001|Overall Study|Lost to Follow-up|3|||
130385797|NCT00391274|469382073|FG000|Overall Study|Physician Decision|4|||
130385798|NCT00391274|469382074|FG001|Overall Study|Physician Decision|2|||
130385799|NCT00391274|469382073|FG000|Overall Study|Withdrawal by Subject|0|||
130385800|NCT00391274|469382074|FG001|Overall Study|Withdrawal by Subject|3|||
130385801|NCT00391274|469382073|FG000|Overall Study|Death Due to Adverse Event|1|||
130385802|NCT00391274|469382074|FG001|Overall Study|Death Due to Adverse Event|3|||
130385803|NCT00391274|469382073|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
130385804|NCT00391274|469382074|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
130385805|NCT00391274|469382073|FG000|Overall Study|Death Not Study Related|0|||
130385806|NCT00391274|469382074|FG001|Overall Study|Death Not Study Related|1|||
130385807|NCT03051607|469382075|FG000|Overall Study|Adverse Event|66|||
130385808|NCT03341533|469382076|FG000|Overall Study|Withdrawal by Subject|1|||
130385809|NCT03341533|469382077|FG001|Overall Study|Withdrawal by Subject|1|||
130385810|NCT03341533|469382076|FG000|Overall Study|Not eligible after randomization|2|||
130385811|NCT03341533|469382077|FG001|Overall Study|Not eligible after randomization|1|||
130385812|NCT05104567|469382082|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385813|NCT05104567|469382083|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
130385814|NCT05104567|469382084|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385815|NCT05104567|469382085|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385816|NCT05104567|469382086|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385817|NCT05104567|469382087|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385818|NCT05104567|469382088|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130385819|NCT05104567|469382082|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
130385820|NCT05104567|469382083|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
130385821|NCT05104567|469382084|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
130385822|NCT05104567|469382085|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
130385823|NCT05104567|469382086|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
130385824|NCT05104567|469382087|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
130385825|NCT05104567|469382088|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
130385826|NCT05104567|469382082|FG000|Overall Study|Progressive disease|3|||
130385827|NCT05104567|469382083|FG001|Overall Study|Progressive disease|13|||
130385828|NCT05104567|469382084|FG002|Overall Study|Progressive disease|13|||
130385829|NCT05104567|469382085|FG003|Overall Study|Progressive disease|17|||
130469253|NCT01843374|469683602|FG001|Overall Study|Death|313|||
130469254|NCT01843374|469683601|FG000|Overall Study|Withdrawal by Subject|14|||
130469255|NCT01843374|469683602|FG001|Overall Study|Withdrawal by Subject|20|||
130469256|NCT01843374|469683601|FG000|Overall Study|Withdrawing due to Other reason|20|||
130469257|NCT01843374|469683602|FG001|Overall Study|Withdrawing due to Other reason|46|||
130469258|NCT02605837|469683603|FG000|Overall Study|Adverse Event|3|||
130469259|NCT02605837|469683604|FG001|Overall Study|Adverse Event|1|||
130469260|NCT02605837|469683603|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130385830|NCT05104567|469382086|FG004|Overall Study|Progressive disease|17|||
130385831|NCT05104567|469382087|FG005|Overall Study|Progressive disease|28|||
130385832|NCT05104567|469382088|FG006|Overall Study|Progressive disease|24|||
130385833|NCT05104567|469382082|FG000|Overall Study|Withdrawal by Subject|1|||
130385834|NCT05104567|469382083|FG001|Overall Study|Withdrawal by Subject|1|||
130385835|NCT05104567|469382084|FG002|Overall Study|Withdrawal by Subject|2|||
130385836|NCT05104567|469382085|FG003|Overall Study|Withdrawal by Subject|0|||
130385837|NCT05104567|469382086|FG004|Overall Study|Withdrawal by Subject|0|||
130385838|NCT05104567|469382087|FG005|Overall Study|Withdrawal by Subject|0|||
130385839|NCT05104567|469382088|FG006|Overall Study|Withdrawal by Subject|0|||
130385840|NCT05104567|469382082|FG000|Overall Study|Other|1|||
130385841|NCT05104567|469382083|FG001|Overall Study|Other|1|||
130385842|NCT05104567|469382084|FG002|Overall Study|Other|1|||
130385843|NCT05104567|469382085|FG003|Overall Study|Other|0|||
130385844|NCT05104567|469382086|FG004|Overall Study|Other|0|||
130385845|NCT05104567|469382087|FG005|Overall Study|Other|0|||
130385846|NCT05104567|469382088|FG006|Overall Study|Other|0|||
130385847|NCT00733746|469382093|FG000|Overall Study|Ineligible|5|||
130385848|NCT05778786|469382094|FG000|Period 1|COVID-19 Related|3|||
130385849|NCT05778786|469382095|FG001|Period 1|COVID-19 Related|3|||
130385850|NCT05778786|469382094|FG000|Period 1|Withdrew Consent during Study|1|||
130385851|NCT05778786|469382095|FG001|Period 1|Withdrew Consent during Study|0|||
130385852|NCT05778786|469382094|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
130385853|NCT05778786|469382095|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
130385854|NCT05778786|469382094|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
130385855|NCT05778786|469382095|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
130385856|NCT03658538|469382097|FG000|Overall Study|Death|2|||
130385857|NCT03658538|469382098|FG001|Overall Study|Death|1|||
130385858|NCT03658538|469382097|FG000|Overall Study|Cancer diagnosis|1|||
130385859|NCT03658538|469382098|FG001|Overall Study|Cancer diagnosis|0|||
130385860|NCT03658538|469382097|FG000|Overall Study|Change residence|1|||
130385861|NCT03658538|469382098|FG001|Overall Study|Change residence|2|||
130385862|NCT03658538|469382097|FG000|Overall Study|Lost to Follow-up|3|||
130385863|NCT03658538|469382098|FG001|Overall Study|Lost to Follow-up|3|||
130385864|NCT03658538|469382097|FG000|Overall Study|Unblinded|2|||
130385865|NCT03658538|469382098|FG001|Overall Study|Unblinded|3|||
130385866|NCT03658538|469382097|FG000|Overall Study|Physician Decision|0|||
130385867|NCT03658538|469382098|FG001|Overall Study|Physician Decision|1|||
130385868|NCT03658538|469382097|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
130385869|NCT03658538|469382098|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
130385870|NCT03658538|469382097|FG000|Overall Study|Evicted from home|1|||
130385871|NCT03658538|469382098|FG001|Overall Study|Evicted from home|0|||
130385872|NCT02446990|469382099|FG000|Overall Study|Death|485|||
130385873|NCT02446990|469382100|FG001|Overall Study|Death|458|||
130385874|NCT02446990|469382099|FG000|Overall Study|Lost to Follow-up|3|||
130385875|NCT02446990|469382100|FG001|Overall Study|Lost to Follow-up|1|||
130385876|NCT02446990|469382099|FG000|Overall Study|Physician Decision|1|||
130385877|NCT02446990|469382100|FG001|Overall Study|Physician Decision|0|||
130385878|NCT02446990|469382099|FG000|Overall Study|Withdrawal by Subject|231|||
130385879|NCT02446990|469382100|FG001|Overall Study|Withdrawal by Subject|199|||
130385880|NCT01064401|469382101|FG000|Overall Study|Adverse Event|47|||
130385881|NCT01064401|469382102|FG001|Overall Study|Adverse Event|56|||
130385882|NCT01064401|469382101|FG000|Overall Study|Lack of Efficacy|46|||
130385883|NCT01064401|469382102|FG001|Overall Study|Lack of Efficacy|23|||
130385884|NCT01064401|469382101|FG000|Overall Study|Lost to Follow-up|12|||
130385885|NCT01064401|469382102|FG001|Overall Study|Lost to Follow-up|9|||
130385886|NCT01064401|469382101|FG000|Overall Study|Consent Withdrawn|98|||
130385887|NCT01064401|469382102|FG001|Overall Study|Consent Withdrawn|80|||
130385888|NCT01064401|469382101|FG000|Overall Study|Investigator Decision|4|||
130385889|NCT01064401|469382102|FG001|Overall Study|Investigator Decision|6|||
130385890|NCT01064401|469382101|FG000|Overall Study|Death|4|||
130385891|NCT01064401|469382102|FG001|Overall Study|Death|0|||
130385892|NCT01064401|469382101|FG000|Overall Study|Pregnancy|4|||
130385893|NCT01064401|469382102|FG001|Overall Study|Pregnancy|7|||
130385894|NCT01064401|469382101|FG000|Overall Study|Noncompliance|7|||
130385895|NCT01064401|469382102|FG001|Overall Study|Noncompliance|8|||
130385896|NCT01064401|469382101|FG000|Overall Study|Site Closure|4|||
130385897|NCT01064401|469382102|FG001|Overall Study|Site Closure|5|||
130385898|NCT01064401|469382101|FG000|Overall Study|Other|2|||
130385899|NCT01064401|469382102|FG001|Overall Study|Other|1|||
130385900|NCT03158051|469382103|FG000|Overall Study|Lost to Follow-up|41|||
130385901|NCT03158051|469382104|FG001|Overall Study|Lost to Follow-up|47|||
130385902|NCT03158051|469382103|FG000|Overall Study|Physician Decision|6|||
130385903|NCT03158051|469382104|FG001|Overall Study|Physician Decision|7|||
130385904|NCT03158051|469382103|FG000|Overall Study|Withdrawal by Subject|24|||
130385905|NCT03158051|469382104|FG001|Overall Study|Withdrawal by Subject|15|||
130385906|NCT03158051|469382103|FG000|Overall Study|Death|0|||
130385907|NCT03158051|469382104|FG001|Overall Study|Death|1|||
130385908|NCT02588833|469382105|FG000|Part 1|Withdrawal by Subject|1|||
130385909|NCT02588833|469382106|FG001|Part 1|Withdrawal by Subject|0|||
130469261|NCT02605837|469683604|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130469262|NCT02605837|469683603|FG000|Overall Study|Withdrawal by Subject|8|||
130469263|NCT02605837|469683604|FG001|Overall Study|Withdrawal by Subject|8|||
130469264|NCT02605837|469683603|FG000|Overall Study|Physician Decision|0|||
130469265|NCT02605837|469683604|FG001|Overall Study|Physician Decision|1|||
130469266|NCT02652260|469683605|FG000|Base Study|Pregnancy|0|||
130469267|NCT02652260|469683606|FG001|Base Study|Pregnancy|1|||
130469268|NCT02652260|469683605|FG000|Base Study|Withdrawal by Subject|0|||
130469269|NCT02652260|469683606|FG001|Base Study|Withdrawal by Subject|1|||
130469270|NCT02652260|469683605|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
130469271|NCT02652260|469683606|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
130469272|NCT02652260|469683605|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
130469273|NCT02652260|469683606|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
130385910|NCT02588833|469382105|FG000|Part 2A|Physician Decision|0|||
130469274|NCT02652260|469683605|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
130469275|NCT02652260|469683606|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
130469276|NCT02652260|469683605|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
130469277|NCT02652260|469683606|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
130469278|NCT02652260|469683605|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
130469279|NCT02652260|469683606|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
130469280|NCT02652260|469683605|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
130469281|NCT02652260|469683606|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
130469282|NCT02652260|469683605|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
130469283|NCT02652260|469683606|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
130469284|NCT02652260|469683605|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
130469285|NCT02652260|469683606|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
130469286|NCT02652260|469683605|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
130469287|NCT02652260|469683606|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
130469288|NCT02652260|469683605|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
130469289|NCT02652260|469683606|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
130469290|NCT02652260|469683605|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
130469291|NCT02652260|469683606|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
130469292|NCT02652260|469683605|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
130469293|NCT02652260|469683606|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
130469294|NCT05056246|469683607|FG000|Overall Study|Adverse Event|0|||
130559726|NCT00646906|470017859|FG001|Crossover Period 1|Withdrawal by Subject|0|||
130559727|NCT00646906|470017860|FG002|Crossover Period 1|Withdrawal by Subject|0|||
130559728|NCT00646906|470017861|FG003|Crossover Period 1|Withdrawal by Subject|0|||
130559729|NCT00646906|470017862|FG004|Crossover Period 1|Withdrawal by Subject|0|||
130559730|NCT00646906|470017863|FG005|Crossover Period 1|Withdrawal by Subject|1|||
130559731|NCT00646906|470017864|FG006|Crossover Period 1|Withdrawal by Subject|0|||
130559732|NCT00646906|470017858|FG000|Crossover Period 2|Withdrawal by Subject|0|||
130559733|NCT00646906|470017859|FG001|Crossover Period 2|Withdrawal by Subject|1|||
130559734|NCT00646906|470017860|FG002|Crossover Period 2|Withdrawal by Subject|2|||
130559735|NCT00646906|470017861|FG003|Crossover Period 2|Withdrawal by Subject|1|||
130385911|NCT02588833|469382106|FG001|Part 2A|Physician Decision|1|||
130385912|NCT02588833|469382105|FG000|Part 2A|Withdrawal by Subject|0|||
130385913|NCT02588833|469382106|FG001|Part 2A|Withdrawal by Subject|1|||
130385914|NCT02588833|469382105|FG000|Part 2B|Adverse Event|0|||
130385915|NCT02588833|469382106|FG001|Part 2B|Adverse Event|1|||
130385916|NCT02588833|469382105|FG000|Part 2C|Adverse Event|0|||
130385917|NCT02588833|469382106|FG001|Part 2C|Adverse Event|1|||
130385918|NCT02588833|469382105|FG000|Part 2C|Withdrawal by Subject|0|||
130385919|NCT02588833|469382106|FG001|Part 2C|Withdrawal by Subject|1|||
130385920|NCT02588833|469382105|FG000|Part 3 (Safety Follow-up)|Other|0|||
130385921|NCT02588833|469382106|FG001|Part 3 (Safety Follow-up)|Other|2|||
130385922|NCT02738151|469382107|FG000|Overall Study|Randomized but not treated|4|||
130385923|NCT02738151|469382108|FG001|Overall Study|Randomized but not treated|1|||
130385924|NCT02738151|469382107|FG000|Overall Study|Adverse Event|4|||
130385925|NCT02738151|469382108|FG001|Overall Study|Adverse Event|5|||
130385926|NCT02738151|469382107|FG000|Overall Study|Hypoglycemia|0|||
130385927|NCT02738151|469382108|FG001|Overall Study|Hypoglycemia|1|||
130385928|NCT02738151|469382107|FG000|Overall Study|Poor Compliance to Protocol|4|||
130469295|NCT05056246|469683608|FG001|Overall Study|Adverse Event|0|||
130559736|NCT00646906|470017862|FG004|Crossover Period 2|Withdrawal by Subject|0|||
130559737|NCT00646906|470017863|FG005|Crossover Period 2|Withdrawal by Subject|0|||
130559738|NCT00646906|470017864|FG006|Crossover Period 2|Withdrawal by Subject|0|||
130559739|NCT00646906|470017858|FG000|Crossover Period 2|Physician Decision|0|||
130559740|NCT00646906|470017859|FG001|Crossover Period 2|Physician Decision|0|||
130559741|NCT00646906|470017860|FG002|Crossover Period 2|Physician Decision|0|||
130385929|NCT02738151|469382108|FG001|Overall Study|Poor Compliance to Protocol|3|||
130469296|NCT05056246|469683609|FG002|Overall Study|Adverse Event|0|||
130469297|NCT05056246|469683610|FG003|Overall Study|Adverse Event|0|||
130559742|NCT00646906|470017861|FG003|Crossover Period 2|Physician Decision|0|||
130559743|NCT00646906|470017862|FG004|Crossover Period 2|Physician Decision|0|||
130722501|NCT00371397|470608303|FG011|Session 1|Withdrawal by Subject|0|||
130722502|NCT03014180|470608304|FG000|Overall Study|Protocol Violation|2|||
130722503|NCT01284621|470608305|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722504|NCT01284621|470608306|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130385930|NCT02738151|469382107|FG000|Overall Study|Other than specified above|11|||
130385931|NCT02738151|469382108|FG001|Overall Study|Other than specified above|21|||
130385932|NCT03333044|469382112|FG000|Overall Study|Pregnancy|1|||
130385933|NCT03333044|469382113|FG001|Overall Study|Pregnancy|0|||
130385934|NCT03333044|469382114|FG002|Overall Study|Pregnancy|0|||
130385935|NCT03333044|469382112|FG000|Overall Study|Lost to Follow-up|0|||
130385936|NCT03333044|469382113|FG001|Overall Study|Lost to Follow-up|14|||
130385937|NCT03333044|469382114|FG002|Overall Study|Lost to Follow-up|6|||
130385938|NCT03649711|469382117|FG000|Overall Study|Adverse Event|0|||
130385939|NCT03649711|469382118|FG001|Overall Study|Adverse Event|1|||
130385940|NCT03649711|469382119|FG002|Overall Study|Adverse Event|0|||
130385941|NCT03649711|469382117|FG000|Overall Study|Kidney Transplant|1|||
130385942|NCT03649711|469382118|FG001|Overall Study|Kidney Transplant|0|||
130385943|NCT03649711|469382119|FG002|Overall Study|Kidney Transplant|0|||
130385944|NCT03188094|469382124|FG000|Overall Study|Screen failure|1|||
130385945|NCT03188094|469382125|FG001|Overall Study|Screen failure|0|||
130385946|NCT03188094|469382126|FG002|Overall Study|Screen failure|0|||
130385947|NCT03188094|469382124|FG000|Overall Study|Pregnancy|3|||
130385948|NCT03188094|469382125|FG001|Overall Study|Pregnancy|0|||
130385949|NCT03188094|469382126|FG002|Overall Study|Pregnancy|0|||
130385950|NCT03188094|469382124|FG000|Overall Study|Ineligible|1|||
130385951|NCT03188094|469382125|FG001|Overall Study|Ineligible|0|||
130385952|NCT03188094|469382126|FG002|Overall Study|Ineligible|0|||
130385953|NCT03188094|469382124|FG000|Overall Study|Lost to Follow-up|0|||
130385954|NCT03188094|469382125|FG001|Overall Study|Lost to Follow-up|0|||
130385955|NCT03188094|469382126|FG002|Overall Study|Lost to Follow-up|17|||
130385956|NCT05478252|469382127|FG000|Overall Study|Withdrawal by Subject|2|||
130385957|NCT05478252|469382128|FG001|Overall Study|Withdrawal by Subject|3|||
130385958|NCT05478252|469382127|FG000|Overall Study|Lost to Follow-up|4|||
130385959|NCT05478252|469382128|FG001|Overall Study|Lost to Follow-up|2|||
130385960|NCT05478252|469382127|FG000|Overall Study|Physician Decision|1|||
130385961|NCT05478252|469382128|FG001|Overall Study|Physician Decision|1|||
130385962|NCT05478252|469382127|FG000|Overall Study|Death|1|||
130385963|NCT05478252|469382128|FG001|Overall Study|Death|0|||
130385964|NCT00858442|469383793|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
130385965|NCT00858442|469383794|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
130385966|NCT03329690|469383798|FG000|Overall Study|Progressive disease per RECIST|85|||
130385967|NCT03329690|469383799|FG001|Overall Study|Progressive disease per RECIST|44|||
130385968|NCT03329690|469383800|FG002|Overall Study|Progressive disease per RECIST|6|||
130385969|NCT03329690|469383801|FG003|Overall Study|Progressive disease per RECIST|16|||
130385970|NCT03329690|469383802|FG004|Overall Study|Progressive disease per RECIST|20|||
130385971|NCT03329690|469383798|FG000|Overall Study|Clinical progression|7|||
130385972|NCT03329690|469383799|FG001|Overall Study|Clinical progression|4|||
130385973|NCT03329690|469383800|FG002|Overall Study|Clinical progression|1|||
130385974|NCT03329690|469383801|FG003|Overall Study|Clinical progression|1|||
130385975|NCT03329690|469383802|FG004|Overall Study|Clinical progression|1|||
130385976|NCT03329690|469383798|FG000|Overall Study|Adverse Event|22|||
130385977|NCT03329690|469383799|FG001|Overall Study|Adverse Event|4|||
130385978|NCT03329690|469383800|FG002|Overall Study|Adverse Event|0|||
130385979|NCT03329690|469383801|FG003|Overall Study|Adverse Event|1|||
130385980|NCT03329690|469383802|FG004|Overall Study|Adverse Event|2|||
130385981|NCT03329690|469383798|FG000|Overall Study|Death|2|||
130385982|NCT03329690|469383799|FG001|Overall Study|Death|0|||
130385983|NCT03329690|469383800|FG002|Overall Study|Death|0|||
130385984|NCT03329690|469383801|FG003|Overall Study|Death|1|||
130385985|NCT03329690|469383802|FG004|Overall Study|Death|0|||
130385986|NCT03329690|469383798|FG000|Overall Study|Withdrawal by Subject|2|||
130385987|NCT03329690|469383799|FG001|Overall Study|Withdrawal by Subject|3|||
130385988|NCT03329690|469383800|FG002|Overall Study|Withdrawal by Subject|0|||
130385989|NCT03329690|469383801|FG003|Overall Study|Withdrawal by Subject|1|||
130385990|NCT03329690|469383802|FG004|Overall Study|Withdrawal by Subject|0|||
130385991|NCT03329690|469383798|FG000|Overall Study|Physician Decision|1|||
130385992|NCT03329690|469383799|FG001|Overall Study|Physician Decision|0|||
130385993|NCT03329690|469383800|FG002|Overall Study|Physician Decision|0|||
130469298|NCT05056246|469683611|FG004|Overall Study|Adverse Event|1|||
130385994|NCT03329690|469383801|FG003|Overall Study|Physician Decision|0|||
130385995|NCT03329690|469383802|FG004|Overall Study|Physician Decision|1|||
130469299|NCT05056246|469683607|FG000|Overall Study|Lost to Follow-up|0|||
130385996|NCT03329690|469383798|FG000|Overall Study|Miscellaneous|6|||
130469300|NCT05056246|469683608|FG001|Overall Study|Lost to Follow-up|0|||
130385997|NCT03329690|469383799|FG001|Overall Study|Miscellaneous|0|||
130385998|NCT03329690|469383800|FG002|Overall Study|Miscellaneous|0|||
130385999|NCT03329690|469383801|FG003|Overall Study|Miscellaneous|0|||
130386000|NCT03329690|469383802|FG004|Overall Study|Miscellaneous|0|||
130469301|NCT05056246|469683609|FG002|Overall Study|Lost to Follow-up|0|||
130386001|NCT03329690|469383798|FG000|Overall Study|Did not receive treatment|1|||
130386002|NCT03329690|469383799|FG001|Overall Study|Did not receive treatment|0|||
130386003|NCT03329690|469383800|FG002|Overall Study|Did not receive treatment|0|||
130386004|NCT03329690|469383801|FG003|Overall Study|Did not receive treatment|1|||
130386005|NCT03329690|469383802|FG004|Overall Study|Did not receive treatment|0|||
130386006|NCT02337907|469383804|FG000|Overall Study|Other than listed|1|||
130386007|NCT02337907|469383805|FG001|Overall Study|Other than listed|0|||
130469302|NCT05056246|469683610|FG003|Overall Study|Lost to Follow-up|2|||
130469303|NCT05056246|469683611|FG004|Overall Study|Lost to Follow-up|0|||
130469304|NCT05056246|469683607|FG000|Overall Study|Withdrawal by Subject|0|||
130469305|NCT05056246|469683608|FG001|Overall Study|Withdrawal by Subject|1|||
130469306|NCT05056246|469683609|FG002|Overall Study|Withdrawal by Subject|0|||
130469307|NCT05056246|469683610|FG003|Overall Study|Withdrawal by Subject|0|||
130469308|NCT05056246|469683611|FG004|Overall Study|Withdrawal by Subject|0|||
130469309|NCT04714320|469683613|FG000|Overall Study|Voluntary Withdrawal|4|||
130469310|NCT04714320|469683614|FG001|Overall Study|Voluntary Withdrawal|1|||
130469311|NCT04714320|469683615|FG002|Overall Study|Voluntary Withdrawal|2|||
130469312|NCT04714320|469683613|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
130469313|NCT04714320|469683614|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
130469314|NCT04714320|469683615|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
130469315|NCT04714320|469683613|FG000|Overall Study|Reason Not Specified|1|||
130469316|NCT04714320|469683614|FG001|Overall Study|Reason Not Specified|3|||
130469317|NCT04714320|469683615|FG002|Overall Study|Reason Not Specified|3|||
130469318|NCT05057897|469683616|FG000|Overall Study|Site closure|2|||
130469319|NCT05057897|469683617|FG001|Overall Study|Site closure|2|||
130469320|NCT05057897|469683616|FG000|Overall Study|Death|1|||
130469321|NCT05057897|469683617|FG001|Overall Study|Death|0|||
130469322|NCT00505934|469683626|FG000|Overall Study|Adverse Event|1|||
130469323|NCT00505934|469683626|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
130469324|NCT00505934|469683626|FG000|Overall Study|Other: IV dose needed to be changed|1|||
130469325|NCT03050814|469683627|FG000|Overall Study|Screen failures|0|||
130469326|NCT03050814|469683628|FG001|Overall Study|Screen failures|0|||
130469327|NCT03050814|469683629|FG002|Overall Study|Screen failures|4|||
130469328|NCT05137236|469683633|FG000|Part A|Other than Specified|1|||
130469329|NCT05137236|469683634|FG001|Part A|Other than Specified|0|||
130469330|NCT05137236|469683635|FG002|Part A|Other than Specified|0|||
130469331|NCT05137236|469683636|FG003|Part A|Other than Specified|0|||
130469332|NCT05137236|469683637|FG004|Part A|Other than Specified|0|||
130469333|NCT05137236|469683638|FG005|Part A|Other than Specified|0|||
130469334|NCT05137236|469683639|FG006|Part A|Other than Specified|0|||
130469335|NCT05137236|469683640|FG007|Part A|Other than Specified|0|||
130469336|NCT05137236|469683633|FG000|Part A|Withdrawal by Subject|0|||
130559744|NCT00646906|470017863|FG005|Crossover Period 2|Physician Decision|0|||
130386008|NCT02337907|469383806|FG002|Overall Study|Other than listed|0|||
130386009|NCT02337907|469383807|FG003|Overall Study|Other than listed|1|||
130386010|NCT02337907|469383808|FG004|Overall Study|Other than listed|1|||
130386011|NCT02337907|469383809|FG005|Overall Study|Other than listed|0|||
130386012|NCT02337907|469383804|FG000|Overall Study|Withdrawal by Subject|2|||
130386013|NCT02337907|469383805|FG001|Overall Study|Withdrawal by Subject|3|||
130386014|NCT02337907|469383806|FG002|Overall Study|Withdrawal by Subject|0|||
130386015|NCT02337907|469383807|FG003|Overall Study|Withdrawal by Subject|2|||
130386016|NCT02337907|469383808|FG004|Overall Study|Withdrawal by Subject|5|||
130386017|NCT02337907|469383809|FG005|Overall Study|Withdrawal by Subject|0|||
130386018|NCT02337907|469383804|FG000|Overall Study|Lost to Follow-up|0|||
130386019|NCT02337907|469383805|FG001|Overall Study|Lost to Follow-up|0|||
130386020|NCT02337907|469383806|FG002|Overall Study|Lost to Follow-up|0|||
130386021|NCT02337907|469383807|FG003|Overall Study|Lost to Follow-up|0|||
130386022|NCT02337907|469383808|FG004|Overall Study|Lost to Follow-up|0|||
130386023|NCT02337907|469383809|FG005|Overall Study|Lost to Follow-up|1|||
130386024|NCT02337907|469383804|FG000|Overall Study|Adverse Event|1|||
130386025|NCT02337907|469383805|FG001|Overall Study|Adverse Event|1|||
130386026|NCT02337907|469383806|FG002|Overall Study|Adverse Event|1|||
130559745|NCT00646906|470017864|FG006|Crossover Period 2|Physician Decision|1|||
130559746|NCT02448225|470017865|FG000|Overall Study|Withdrawal by Subject|1|||
130559747|NCT02448225|470017865|FG000|Overall Study|Did not get FSPG scan|18|||
130559748|NCT02448225|470017865|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
130559749|NCT02486653|470017868|FG000|Overall Study|Withdrawal by Subject|1|||
130469337|NCT05137236|469683634|FG001|Part A|Withdrawal by Subject|4|||
130386027|NCT02337907|469383807|FG003|Overall Study|Adverse Event|1|||
130386028|NCT02337907|469383808|FG004|Overall Study|Adverse Event|4|||
130386029|NCT02337907|469383809|FG005|Overall Study|Adverse Event|0|||
130386030|NCT02488681|469383816|FG000|Overall Study|Implant unsuccessful|7|||
130469338|NCT05137236|469683635|FG002|Part A|Withdrawal by Subject|1|||
130469339|NCT05137236|469683636|FG003|Part A|Withdrawal by Subject|1|||
130469340|NCT05137236|469683637|FG004|Part A|Withdrawal by Subject|3|||
130469341|NCT05137236|469683638|FG005|Part A|Withdrawal by Subject|2|||
130469342|NCT05137236|469683639|FG006|Part A|Withdrawal by Subject|0|||
130386031|NCT02809677|469383817|FG000|Overall Study|Withdrawal by Subject|8|||
130386032|NCT03165110|469383818|FG000|Overall Study|Anroid phone software incompatibility|1|||
130386033|NCT05533632|469383819|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
130386034|NCT05533632|469383819|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
130386035|NCT05533632|469383819|FG000|Overall Study|Lost to Follow-up|1|||
130386036|NCT05533632|469383819|FG000|Overall Study|Withdrawal by Subject|4|||
130386037|NCT05533632|469383819|FG000|Overall Study|Adverse Event|4|||
130386038|NCT04327388|469383822|FG000|Overall Study|Adverse Event|17|||
130386039|NCT04327388|469383823|FG001|Overall Study|Adverse Event|18|||
130386040|NCT04327388|469383824|FG002|Overall Study|Adverse Event|9|||
130386041|NCT04327388|469383822|FG000|Overall Study|Other|1|||
130386042|NCT04327388|469383823|FG001|Overall Study|Other|2|||
130386043|NCT04327388|469383824|FG002|Overall Study|Other|0|||
130386044|NCT04327388|469383822|FG000|Overall Study|Randomized and not treated|2|||
130386045|NCT04327388|469383823|FG001|Overall Study|Randomized and not treated|0|||
130386046|NCT04327388|469383824|FG002|Overall Study|Randomized and not treated|2|||
130386047|NCT04120974|469383825|FG000|Overall Study|Death|1|||
130386048|NCT04120974|469383825|FG000|Overall Study|Physician Decision|1|||
130386049|NCT04120974|469383825|FG000|Overall Study|Lost to Follow-up|6|||
130386050|NCT03559257|469383826|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
130386051|NCT03559257|469383827|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130386052|NCT03559257|469383826|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130386053|NCT03559257|469383827|FG001|Double Blind Treatment Period|Protocol Violation|4|||
130386054|NCT03559257|469383826|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130386055|NCT03559257|469383827|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
130386056|NCT03559257|469383826|FG000|Double Blind Treatment Period|Adverse Event|0|||
130386057|NCT03559257|469383827|FG001|Double Blind Treatment Period|Adverse Event|1|||
130386058|NCT03559257|469383826|FG000|Double Blind Treatment Period|Screen Failure|0|||
130386059|NCT03559257|469383827|FG001|Double Blind Treatment Period|Screen Failure|1|||
130386060|NCT03559257|469383826|FG000|Open-label Treatment Period|Adverse Event|1|||
130386061|NCT03559257|469383827|FG001|Open-label Treatment Period|Adverse Event|4|||
130386062|NCT03559257|469383826|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
130386063|NCT03559257|469383827|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
130386064|NCT03559257|469383826|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
130386065|NCT03559257|469383827|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130386066|NCT03559257|469383826|FG000|Open-label Treatment Period|Protocol Violation|2|||
130386067|NCT03559257|469383827|FG001|Open-label Treatment Period|Protocol Violation|0|||
130722505|NCT01284621|470608307|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722506|NCT01284621|470608308|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722507|NCT01284621|470608309|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
130722508|NCT01284621|470608310|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722509|NCT02802631|470608313|FG000|Overall Study|Withdrawal by Subject|1|||
130722510|NCT02802631|470608314|FG001|Overall Study|Withdrawal by Subject|0|||
130722511|NCT02802631|470608315|FG002|Overall Study|Withdrawal by Subject|0|||
130722512|NCT02802631|470608316|FG003|Overall Study|Withdrawal by Subject|0|||
130386068|NCT03559257|469383826|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
130386069|NCT03559257|469383827|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130386070|NCT03559257|469383826|FG000|Open-label Treatment Period|Physician Decision|0|||
130386071|NCT03559257|469383827|FG001|Open-label Treatment Period|Physician Decision|1|||
130386072|NCT01519960|469383828|FG000|Overall Study|Withdrawal from the study|26|||
130386073|NCT01519960|469383829|FG001|Overall Study|Withdrawal from the study|22|||
130386074|NCT01519960|469383830|FG002|Overall Study|Withdrawal from the study|5|||
130386075|NCT01387347|469383831|FG000|Overall Study|Lost to Follow-up|2|||
130386076|NCT01387347|469383832|FG001|Overall Study|Lost to Follow-up|1|||
130386077|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
130386078|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
130386079|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
130386080|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
130386081|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
130386082|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
130386083|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
130386084|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
130386085|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
130386086|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
130386087|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
130386088|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
130386089|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
130386090|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
130386091|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
130386092|NCT00561080|469383835|FG000|Vaccination Period (up to Month 4)|Other|0|||
130386093|NCT00561080|469383836|FG001|Vaccination Period (up to Month 4)|Other|2|||
130469343|NCT05137236|469683640|FG007|Part A|Withdrawal by Subject|0|||
130469344|NCT05137236|469683633|FG000|Part A|Lost to Follow-up|5|||
130469345|NCT05137236|469683634|FG001|Part A|Lost to Follow-up|7|||
130469346|NCT05137236|469683635|FG002|Part A|Lost to Follow-up|1|||
130469347|NCT05137236|469683636|FG003|Part A|Lost to Follow-up|3|||
130469348|NCT05137236|469683637|FG004|Part A|Lost to Follow-up|3|||
130469349|NCT05137236|469683638|FG005|Part A|Lost to Follow-up|8|||
130469350|NCT05137236|469683639|FG006|Part A|Lost to Follow-up|0|||
130469351|NCT05137236|469683640|FG007|Part A|Lost to Follow-up|0|||
130469352|NCT05137236|469683633|FG000|Part B|Withdrawal by Subject|0|||
130469353|NCT05137236|469683634|FG001|Part B|Withdrawal by Subject|0|||
130469354|NCT05137236|469683635|FG002|Part B|Withdrawal by Subject|0|||
130559750|NCT02486653|470017869|FG001|Overall Study|Withdrawal by Subject|3|||
130559751|NCT02486653|470017868|FG000|Overall Study|Protocol Violation|1|||
130386094|NCT00561080|469383837|FG002|Vaccination Period (up to Month 4)|Other|1|||
130386095|NCT00561080|469383835|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
130386096|NCT00561080|469383836|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
130386097|NCT00561080|469383837|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
130386098|NCT00561080|469383835|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
130386099|NCT00561080|469383836|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
130386100|NCT00561080|469383837|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
130386101|NCT00561080|469383835|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
130386102|NCT00561080|469383836|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
130386103|NCT00561080|469383837|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
130386104|NCT00561080|469383835|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
130386105|NCT00561080|469383836|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
130386106|NCT00561080|469383837|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
130386107|NCT01288287|469383838|FG000|Overall Study|Lost to Follow-up|8|||
130386108|NCT01288287|469383838|FG000|Overall Study|Withdrawal by Subject|4|||
130386109|NCT01288287|469383838|FG000|Overall Study|Lack of Efficacy|13|||
130386110|NCT01288287|469383838|FG000|Overall Study|Other Reason|13|||
130386111|NCT01288287|469383838|FG000|Overall Study|Unknown Reason|1|||
130386112|NCT01288287|469383838|FG000|Overall Study|Unknown Status|7|||
130386113|NCT01092182|469383839|FG000|Overall Study|Death|0|||
130386114|NCT01092182|469383840|FG001|Overall Study|Death|5|||
130386115|NCT01092182|469383841|FG002|Overall Study|Death|3|||
130386116|NCT01092182|469383839|FG000|Overall Study|participant safety|1|||
130386117|NCT01092182|469383840|FG001|Overall Study|participant safety|2|||
130386118|NCT01092182|469383841|FG002|Overall Study|participant safety|0|||
130386119|NCT01092182|469383839|FG000|Overall Study|Physician Decision|0|||
130386120|NCT01092182|469383840|FG001|Overall Study|Physician Decision|6|||
130386121|NCT01092182|469383841|FG002|Overall Study|Physician Decision|0|||
130386122|NCT01092182|469383839|FG000|Overall Study|Did not meet criteria|0|||
130386123|NCT01092182|469383840|FG001|Overall Study|Did not meet criteria|0|||
130386124|NCT01092182|469383841|FG002|Overall Study|Did not meet criteria|25|||
130386125|NCT01092182|469383839|FG000|Overall Study|Non-compliance|0|||
130386126|NCT01092182|469383840|FG001|Overall Study|Non-compliance|3|||
130386127|NCT01092182|469383841|FG002|Overall Study|Non-compliance|0|||
130386128|NCT01092182|469383839|FG000|Overall Study|Participant refused follow-up|0|||
130386129|NCT01092182|469383840|FG001|Overall Study|Participant refused follow-up|2|||
130386130|NCT01092182|469383841|FG002|Overall Study|Participant refused follow-up|0|||
130386131|NCT02515045|469383848|FG000|Overall Study|Adverse Event|0|||
130386132|NCT02515045|469383849|FG001|Overall Study|Adverse Event|3|||
130386133|NCT02515045|469383850|FG002|Overall Study|Adverse Event|3|||
130386134|NCT02515045|469383848|FG000|Overall Study|Lost to Follow-up|0|||
130386135|NCT02515045|469383849|FG001|Overall Study|Lost to Follow-up|1|||
130386136|NCT02515045|469383850|FG002|Overall Study|Lost to Follow-up|1|||
130386137|NCT00238121|469383851|FG000|Overall Study|Withdrawal by Subject|1|||
130386138|NCT00238121|469383852|FG001|Overall Study|Withdrawal by Subject|1|||
130386139|NCT00238121|469383851|FG000|Overall Study|Adverse Event|2|||
130386140|NCT00238121|469383852|FG001|Overall Study|Adverse Event|1|||
130386141|NCT03255382|469383855|FG000|Overall Study|Adverse Event|3|||
130386142|NCT03255382|469383856|FG001|Overall Study|Adverse Event|0|||
130469355|NCT05137236|469683636|FG003|Part B|Withdrawal by Subject|0|||
130469356|NCT05137236|469683637|FG004|Part B|Withdrawal by Subject|0|||
130559752|NCT02486653|470017869|FG001|Overall Study|Protocol Violation|0|||
130559753|NCT02486653|470017868|FG000|Overall Study|surgery cancelled|4|||
130386143|NCT03255382|469383855|FG000|Overall Study|Lost to Follow-up|2|||
130386144|NCT03255382|469383856|FG001|Overall Study|Lost to Follow-up|0|||
130386145|NCT03255382|469383855|FG000|Overall Study|Withdrawal by Subject|2|||
130386146|NCT03255382|469383856|FG001|Overall Study|Withdrawal by Subject|0|||
130559754|NCT02486653|470017869|FG001|Overall Study|surgery cancelled|1|||
130386147|NCT03255382|469383855|FG000|Overall Study|Other|6|||
130469357|NCT05137236|469683638|FG005|Part B|Withdrawal by Subject|0|||
130559755|NCT01177384|470017871|FG000|Overall Study|Adverse Event|6|||
130386148|NCT03255382|469383856|FG001|Overall Study|Other|0|||
130469358|NCT05137236|469683639|FG006|Part B|Withdrawal by Subject|0|||
130469359|NCT05137236|469683640|FG007|Part B|Withdrawal by Subject|2|||
130722513|NCT02802631|470608317|FG004|Overall Study|Withdrawal by Subject|0|||
130722514|NCT02802631|470608318|FG005|Overall Study|Withdrawal by Subject|0|||
130722515|NCT02802631|470608319|FG006|Overall Study|Withdrawal by Subject|0|||
130722516|NCT02802631|470608320|FG007|Overall Study|Withdrawal by Subject|0|||
130722517|NCT02802631|470608313|FG000|Overall Study|Physician Decision|1|||
130722518|NCT02802631|470608314|FG001|Overall Study|Physician Decision|0|||
130722519|NCT02802631|470608315|FG002|Overall Study|Physician Decision|0|||
130722520|NCT02802631|470608316|FG003|Overall Study|Physician Decision|0|||
130722521|NCT02802631|470608317|FG004|Overall Study|Physician Decision|0|||
130722522|NCT02802631|470608318|FG005|Overall Study|Physician Decision|0|||
130722523|NCT02802631|470608319|FG006|Overall Study|Physician Decision|1|||
130722524|NCT02802631|470608320|FG007|Overall Study|Physician Decision|0|||
130722525|NCT02802631|470608313|FG000|Overall Study|Adverse Event|0|||
130722526|NCT02802631|470608314|FG001|Overall Study|Adverse Event|2|||
130722527|NCT02802631|470608315|FG002|Overall Study|Adverse Event|0|||
130722528|NCT02802631|470608316|FG003|Overall Study|Adverse Event|1|||
130386149|NCT02221284|469383859|FG000|Overall Study|Case Report Forms Uncollected|56|||
130386150|NCT02221284|469383859|FG000|Overall Study|Protocol Deviation|5|||
130386151|NCT01675128|469383862|FG000|Overall Study|Disease progression on study|1|||
130386152|NCT01675128|469383863|FG001|Overall Study|Disease progression on study|1|||
130386153|NCT01675128|469383864|FG002|Overall Study|Disease progression on study|1|||
130386154|NCT01675128|469383862|FG000|Overall Study|Refused further treatment|1|||
130386155|NCT01675128|469383863|FG001|Overall Study|Refused further treatment|0|||
130386156|NCT01675128|469383864|FG002|Overall Study|Refused further treatment|0|||
130386157|NCT01675128|469383862|FG000|Overall Study|Pulmonary complication; off study|0|||
130386158|NCT01675128|469383863|FG001|Overall Study|Pulmonary complication; off study|1|||
130386159|NCT01675128|469383864|FG002|Overall Study|Pulmonary complication; off study|0|||
130386160|NCT03526458|469383874|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
130386161|NCT03526458|469383875|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
130386162|NCT03526458|469383874|FG000|Overall Study|Stone passed, surgery cancelled|2|||
130386163|NCT03526458|469383875|FG001|Overall Study|Stone passed, surgery cancelled|1|||
130386164|NCT03526458|469383874|FG000|Overall Study|Withdrawal by Subject|1|||
130386165|NCT03526458|469383875|FG001|Overall Study|Withdrawal by Subject|0|||
130386166|NCT03526458|469383874|FG000|Overall Study|Physician Decision|2|||
130386167|NCT03526458|469383875|FG001|Overall Study|Physician Decision|1|||
130386168|NCT03526458|469383874|FG000|Overall Study|Lack of equipment|1|||
130386169|NCT03526458|469383875|FG001|Overall Study|Lack of equipment|1|||
130386170|NCT00529542|469383876|FG000|Overall Study|Withdrawal by Subject|1|||
130386171|NCT00529542|469383877|FG001|Overall Study|Withdrawal by Subject|0|||
130386172|NCT00529542|469383876|FG000|Overall Study|Lost to Follow-up|0|||
130386173|NCT00529542|469383877|FG001|Overall Study|Lost to Follow-up|1|||
130386174|NCT02587065|469383878|FG000|Overall Study|Adverse Event|14|||
130386175|NCT02587065|469383878|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
130386176|NCT02587065|469383878|FG000|Overall Study|Non-adherence to the Protocol|3|||
130386177|NCT02587065|469383878|FG000|Overall Study|Discontinuation of Study Medication|2|||
130386178|NCT02587065|469383878|FG000|Overall Study|Reason not Specified|3|||
130386179|NCT02113956|469383883|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
130386180|NCT02113956|469383884|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
130386181|NCT02113956|469383883|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
130386182|NCT02113956|469383884|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
130386183|NCT02113956|469383883|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
130386184|NCT02113956|469383884|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
130386185|NCT01602380|469383885|FG000|Overall Study|Death|147|||
130386186|NCT01602380|469383886|FG001|Overall Study|Death|145|||
130386187|NCT01602380|469383885|FG000|Overall Study|Withdrawal by Subject|39|||
130386188|NCT01602380|469383886|FG001|Overall Study|Withdrawal by Subject|41|||
130386189|NCT01602380|469383885|FG000|Overall Study|Lost to Follow-up|15|||
130386190|NCT01602380|469383886|FG001|Overall Study|Lost to Follow-up|12|||
130386191|NCT01602380|469383885|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130386192|NCT01602380|469383886|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
130386193|NCT01602380|469383885|FG000|Overall Study|Other|2|||
130386194|NCT01602380|469383886|FG001|Overall Study|Other|0|||
130386195|NCT02005250|469383888|FG000|Overall Study|Lost to Follow-up|15|||
130386196|NCT02005250|469383889|FG001|Overall Study|Lost to Follow-up|5|||
130386197|NCT04007094|469383890|FG000|Overall Study|Lost to Follow-up|1|||
130386198|NCT04007094|469383891|FG001|Overall Study|Lost to Follow-up|1|||
130386199|NCT02921776|469383892|FG000|Overall Study|patient deterioration, fatigue|2|||
130386200|NCT02921776|469383893|FG001|Overall Study|patient deterioration, fatigue|6|||
130386201|NCT02921776|469383894|FG002|Overall Study|patient deterioration, fatigue|0|||
130386202|NCT02921776|469383895|FG003|Overall Study|patient deterioration, fatigue|0|||
130386203|NCT02921776|469383896|FG004|Overall Study|patient deterioration, fatigue|0|||
130386204|NCT02921776|469383897|FG005|Overall Study|patient deterioration, fatigue|0|||
130386205|NCT02921776|469383898|FG006|Overall Study|patient deterioration, fatigue|0|||
130722529|NCT02802631|470608317|FG004|Overall Study|Adverse Event|6|||
130386206|NCT02921776|469383899|FG007|Overall Study|patient deterioration, fatigue|0|||
130386207|NCT02921776|469383892|FG000|Overall Study|Withdrawal by Subject|0|||
130386208|NCT02921776|469383893|FG001|Overall Study|Withdrawal by Subject|2|||
130386209|NCT02921776|469383894|FG002|Overall Study|Withdrawal by Subject|0|||
130386210|NCT02921776|469383895|FG003|Overall Study|Withdrawal by Subject|1|||
130386211|NCT02921776|469383896|FG004|Overall Study|Withdrawal by Subject|1|||
130386212|NCT02921776|469383897|FG005|Overall Study|Withdrawal by Subject|0|||
130386213|NCT02921776|469383898|FG006|Overall Study|Withdrawal by Subject|8|||
130386214|NCT02921776|469383899|FG007|Overall Study|Withdrawal by Subject|1|||
130386215|NCT02921776|469383892|FG000|Overall Study|Death|0|||
130386216|NCT02921776|469383893|FG001|Overall Study|Death|0|||
130386217|NCT02921776|469383894|FG002|Overall Study|Death|0|||
130386218|NCT02921776|469383895|FG003|Overall Study|Death|2|||
130386219|NCT02921776|469383896|FG004|Overall Study|Death|0|||
130386220|NCT02921776|469383897|FG005|Overall Study|Death|0|||
130386221|NCT02921776|469383898|FG006|Overall Study|Death|0|||
130386222|NCT02921776|469383899|FG007|Overall Study|Death|0|||
130386223|NCT02921776|469383892|FG000|Overall Study|extubation or early discharge|0|||
130386224|NCT02921776|469383893|FG001|Overall Study|extubation or early discharge|0|||
130386225|NCT02921776|469383894|FG002|Overall Study|extubation or early discharge|0|||
130386226|NCT02921776|469383895|FG003|Overall Study|extubation or early discharge|5|||
130386227|NCT02921776|469383896|FG004|Overall Study|extubation or early discharge|5|||
130386228|NCT02921776|469383897|FG005|Overall Study|extubation or early discharge|0|||
130386229|NCT02921776|469383898|FG006|Overall Study|extubation or early discharge|0|||
130386230|NCT02921776|469383899|FG007|Overall Study|extubation or early discharge|0|||
130386231|NCT02921776|469383892|FG000|Overall Study|Lost to Follow-up|0|||
130386232|NCT02921776|469383893|FG001|Overall Study|Lost to Follow-up|0|||
130386233|NCT02921776|469383894|FG002|Overall Study|Lost to Follow-up|0|||
130386234|NCT02921776|469383895|FG003|Overall Study|Lost to Follow-up|0|||
130386235|NCT02921776|469383896|FG004|Overall Study|Lost to Follow-up|0|||
130386236|NCT02921776|469383897|FG005|Overall Study|Lost to Follow-up|2|||
130386237|NCT02921776|469383898|FG006|Overall Study|Lost to Follow-up|3|||
130386238|NCT02921776|469383899|FG007|Overall Study|Lost to Follow-up|6|||
130386239|NCT02070744|469383905|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130386240|NCT02070744|469383906|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130386241|NCT02070744|469383907|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130386242|NCT02070744|469383908|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
130386243|NCT02070744|469383909|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130386244|NCT02070744|469383905|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130386245|NCT02070744|469383906|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130386246|NCT02070744|469383907|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130386247|NCT02070744|469383908|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130386248|NCT02070744|469383909|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
130386249|NCT02070744|469383905|FG000|OLE Phase (48 Weeks)|Other|0|||
130386250|NCT02070744|469383906|FG001|OLE Phase (48 Weeks)|Other|0|||
130386251|NCT02070744|469383907|FG002|OLE Phase (48 Weeks)|Other|0|||
130386252|NCT02070744|469383908|FG003|OLE Phase (48 Weeks)|Other|0|||
130386253|NCT02070744|469383909|FG004|OLE Phase (48 Weeks)|Other|1|||
130386254|NCT04199117|469383910|FG000|Overall Study|Withdrawal by Subject|3|||
130386255|NCT04199117|469383911|FG001|Overall Study|Withdrawal by Subject|0|||
130386256|NCT04199117|469383912|FG002|Overall Study|Withdrawal by Subject|0|||
130386257|NCT04199117|469383913|FG003|Overall Study|Withdrawal by Subject|1|||
130386258|NCT04199117|469383914|FG004|Overall Study|Withdrawal by Subject|1|||
130386259|NCT04199117|469383915|FG005|Overall Study|Withdrawal by Subject|0|||
130386260|NCT04199117|469383916|FG006|Overall Study|Withdrawal by Subject|0|||
130386261|NCT04199117|469383917|FG007|Overall Study|Withdrawal by Subject|2|||
130386262|NCT04199117|469383918|FG008|Overall Study|Withdrawal by Subject|0|||
130386263|NCT04199117|469383919|FG009|Overall Study|Withdrawal by Subject|0|||
130386264|NCT04199117|469383920|FG010|Overall Study|Withdrawal by Subject|1|||
130386265|NCT04199117|469383921|FG011|Overall Study|Withdrawal by Subject|1|||
130386266|NCT04199117|469383922|FG012|Overall Study|Withdrawal by Subject|2|||
130386267|NCT04199117|469383923|FG013|Overall Study|Withdrawal by Subject|1|||
130386268|NCT04199117|469383924|FG014|Overall Study|Withdrawal by Subject|1|||
130386269|NCT04199117|469383925|FG015|Overall Study|Withdrawal by Subject|1|||
130386270|NCT04199117|469383910|FG000|Overall Study|Death|1|||
130386271|NCT04199117|469383911|FG001|Overall Study|Death|1|||
130386272|NCT04199117|469383912|FG002|Overall Study|Death|0|||
130386273|NCT04199117|469383913|FG003|Overall Study|Death|0|||
130386274|NCT04199117|469383914|FG004|Overall Study|Death|0|||
130386275|NCT04199117|469383915|FG005|Overall Study|Death|0|||
130386276|NCT04199117|469383916|FG006|Overall Study|Death|0|||
130386277|NCT04199117|469383917|FG007|Overall Study|Death|0|||
130386278|NCT04199117|469383918|FG008|Overall Study|Death|0|||
130386279|NCT04199117|469383919|FG009|Overall Study|Death|0|||
130386280|NCT04199117|469383920|FG010|Overall Study|Death|0|||
130386281|NCT04199117|469383921|FG011|Overall Study|Death|1|||
130386282|NCT04199117|469383922|FG012|Overall Study|Death|0|||
130386283|NCT04199117|469383923|FG013|Overall Study|Death|1|||
130386284|NCT04199117|469383924|FG014|Overall Study|Death|0|||
130386285|NCT04199117|469383925|FG015|Overall Study|Death|0|||
130386286|NCT04199117|469383910|FG000|Overall Study|Withdrawal by PI|0|||
130386287|NCT04199117|469383911|FG001|Overall Study|Withdrawal by PI|0|||
130386288|NCT04199117|469383912|FG002|Overall Study|Withdrawal by PI|0|||
130386289|NCT04199117|469383913|FG003|Overall Study|Withdrawal by PI|0|||
130386290|NCT04199117|469383914|FG004|Overall Study|Withdrawal by PI|0|||
130386291|NCT04199117|469383915|FG005|Overall Study|Withdrawal by PI|0|||
130386292|NCT04199117|469383916|FG006|Overall Study|Withdrawal by PI|0|||
130386293|NCT04199117|469383917|FG007|Overall Study|Withdrawal by PI|0|||
130386294|NCT04199117|469383918|FG008|Overall Study|Withdrawal by PI|0|||
130386295|NCT04199117|469383919|FG009|Overall Study|Withdrawal by PI|0|||
130386296|NCT04199117|469383920|FG010|Overall Study|Withdrawal by PI|0|||
130386297|NCT04199117|469383921|FG011|Overall Study|Withdrawal by PI|0|||
130386298|NCT04199117|469383922|FG012|Overall Study|Withdrawal by PI|1|||
130386299|NCT04199117|469383923|FG013|Overall Study|Withdrawal by PI|0|||
130386300|NCT04199117|469383924|FG014|Overall Study|Withdrawal by PI|0|||
130386301|NCT04199117|469383925|FG015|Overall Study|Withdrawal by PI|0|||
130386302|NCT04439253|469385636|FG000|Overall Study|Adverse Event|1|||
130386303|NCT04439253|469385636|FG000|Overall Study|Disease progression|2|||
130386304|NCT04439253|469385636|FG000|Overall Study|Complicating disease|1|||
130386305|NCT00702403|469385637|FG000|From Consent to Engraftment|Progressive leukemia|6|||
130386306|NCT00702403|469385637|FG000|From Consent to Engraftment|Critically ill|2|||
130386307|NCT00702403|469385637|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
130386308|NCT00702403|469385637|FG000|From Consent to Engraftment|Myocardial infarction|1|||
130386309|NCT00702403|469385637|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
130386310|NCT00702403|469385637|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
130386311|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
130386312|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
130386313|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Non-compliance|2|||
130386314|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
130386315|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
130386316|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Suicide|1|||
130386317|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
130386318|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
130386319|NCT00702403|469385637|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
130386320|NCT00380978|469385639|FG000|Overall Study|Refused allocated intervention|0|||
130386321|NCT00380978|469385640|FG001|Overall Study|Refused allocated intervention|6|||
130386322|NCT00380978|469385639|FG000|Overall Study|Wrong study envelope|0|||
130386323|NCT00380978|469385640|FG001|Overall Study|Wrong study envelope|2|||
130386324|NCT00380978|469385639|FG000|Overall Study|Allocation prior to analgesia request|1|||
130386325|NCT00380978|469385640|FG001|Overall Study|Allocation prior to analgesia request|2|||
130386326|NCT00380978|469385639|FG000|Overall Study|Parous patient|1|||
130386327|NCT00380978|469385640|FG001|Overall Study|Parous patient|0|||
130386328|NCT04146545|469385641|FG000|Overall Study|deemed ineligible after randomization|1|||
130386329|NCT04146545|469385642|FG001|Overall Study|deemed ineligible after randomization|0|||
130386330|NCT01729754|469385643|FG000|Part 1|Adverse Event|2|||
130386331|NCT01729754|469385644|FG001|Part 1|Adverse Event|0|||
130386332|NCT01729754|469385645|FG002|Part 1|Adverse Event|0|||
130386333|NCT01729754|469385646|FG003|Part 1|Adverse Event|1|||
130386334|NCT01729754|469385647|FG004|Part 1|Adverse Event|0|||
130386335|NCT01729754|469385648|FG005|Part 1|Adverse Event|0|||
130386336|NCT01729754|469385649|FG006|Part 1|Adverse Event|2|||
130386337|NCT01729754|469385650|FG007|Part 1|Adverse Event|0|||
130386338|NCT01729754|469385651|FG008|Part 1|Adverse Event|0|||
130386339|NCT01729754|469385652|FG009|Part 1|Adverse Event|5|||
130386340|NCT01729754|469385643|FG000|Part 1|Lack of Efficacy|1|||
130386341|NCT01729754|469385644|FG001|Part 1|Lack of Efficacy|0|||
130386342|NCT01729754|469385645|FG002|Part 1|Lack of Efficacy|0|||
130386343|NCT01729754|469385646|FG003|Part 1|Lack of Efficacy|0|||
130386344|NCT01729754|469385647|FG004|Part 1|Lack of Efficacy|0|||
130386345|NCT01729754|469385648|FG005|Part 1|Lack of Efficacy|0|||
130386346|NCT01729754|469385649|FG006|Part 1|Lack of Efficacy|2|||
130386347|NCT01729754|469385650|FG007|Part 1|Lack of Efficacy|0|||
130386348|NCT01729754|469385651|FG008|Part 1|Lack of Efficacy|0|||
130386349|NCT01729754|469385652|FG009|Part 1|Lack of Efficacy|0|||
130386350|NCT01729754|469385643|FG000|Part 1|Lost to Follow-up|1|||
130386351|NCT01729754|469385644|FG001|Part 1|Lost to Follow-up|0|||
130386352|NCT01729754|469385645|FG002|Part 1|Lost to Follow-up|0|||
130386353|NCT01729754|469385646|FG003|Part 1|Lost to Follow-up|2|||
130386354|NCT01729754|469385647|FG004|Part 1|Lost to Follow-up|0|||
130386355|NCT01729754|469385648|FG005|Part 1|Lost to Follow-up|0|||
130386356|NCT01729754|469385649|FG006|Part 1|Lost to Follow-up|3|||
130386357|NCT01729754|469385650|FG007|Part 1|Lost to Follow-up|0|||
130386358|NCT01729754|469385651|FG008|Part 1|Lost to Follow-up|0|||
130386359|NCT01729754|469385652|FG009|Part 1|Lost to Follow-up|3|||
130386360|NCT01729754|469385643|FG000|Part 1|Non-compliance with Study Drug|1|||
130386361|NCT01729754|469385644|FG001|Part 1|Non-compliance with Study Drug|0|||
130386362|NCT01729754|469385645|FG002|Part 1|Non-compliance with Study Drug|0|||
130386363|NCT01729754|469385646|FG003|Part 1|Non-compliance with Study Drug|0|||
130386364|NCT01729754|469385647|FG004|Part 1|Non-compliance with Study Drug|0|||
130386365|NCT01729754|469385648|FG005|Part 1|Non-compliance with Study Drug|0|||
130386366|NCT01729754|469385649|FG006|Part 1|Non-compliance with Study Drug|0|||
130386367|NCT01729754|469385650|FG007|Part 1|Non-compliance with Study Drug|0|||
130386368|NCT01729754|469385651|FG008|Part 1|Non-compliance with Study Drug|0|||
130386369|NCT01729754|469385652|FG009|Part 1|Non-compliance with Study Drug|0|||
130386370|NCT01729754|469385643|FG000|Part 1|Physician Decision|0|||
130386371|NCT01729754|469385644|FG001|Part 1|Physician Decision|0|||
130386372|NCT01729754|469385645|FG002|Part 1|Physician Decision|0|||
130386373|NCT01729754|469385646|FG003|Part 1|Physician Decision|0|||
130386374|NCT01729754|469385647|FG004|Part 1|Physician Decision|0|||
130386375|NCT01729754|469385648|FG005|Part 1|Physician Decision|0|||
130386376|NCT01729754|469385649|FG006|Part 1|Physician Decision|0|||
130386377|NCT01729754|469385650|FG007|Part 1|Physician Decision|0|||
130386378|NCT01729754|469385651|FG008|Part 1|Physician Decision|0|||
130386379|NCT01729754|469385652|FG009|Part 1|Physician Decision|4|||
130386380|NCT01729754|469385643|FG000|Part 1|Pregnancy|0|||
130386381|NCT01729754|469385644|FG001|Part 1|Pregnancy|0|||
130386382|NCT01729754|469385645|FG002|Part 1|Pregnancy|0|||
130386383|NCT01729754|469385646|FG003|Part 1|Pregnancy|1|||
130386384|NCT01729754|469385647|FG004|Part 1|Pregnancy|0|||
130386385|NCT01729754|469385648|FG005|Part 1|Pregnancy|0|||
130386386|NCT01729754|469385649|FG006|Part 1|Pregnancy|0|||
130386387|NCT01729754|469385650|FG007|Part 1|Pregnancy|0|||
130386388|NCT01729754|469385651|FG008|Part 1|Pregnancy|0|||
130386389|NCT01729754|469385652|FG009|Part 1|Pregnancy|1|||
130386390|NCT01729754|469385643|FG000|Part 1|Progressive Disease|0|||
130386391|NCT01729754|469385644|FG001|Part 1|Progressive Disease|0|||
130386392|NCT01729754|469385645|FG002|Part 1|Progressive Disease|0|||
130386393|NCT01729754|469385646|FG003|Part 1|Progressive Disease|0|||
130386394|NCT01729754|469385647|FG004|Part 1|Progressive Disease|0|||
130386395|NCT01729754|469385648|FG005|Part 1|Progressive Disease|0|||
130386396|NCT01729754|469385649|FG006|Part 1|Progressive Disease|0|||
130386397|NCT01729754|469385650|FG007|Part 1|Progressive Disease|0|||
130386398|NCT01729754|469385651|FG008|Part 1|Progressive Disease|0|||
130386399|NCT01729754|469385652|FG009|Part 1|Progressive Disease|1|||
130386400|NCT01729754|469385643|FG000|Part 1|Protocol Violation|2|||
130386401|NCT01729754|469385644|FG001|Part 1|Protocol Violation|0|||
130386402|NCT01729754|469385645|FG002|Part 1|Protocol Violation|0|||
130386403|NCT01729754|469385646|FG003|Part 1|Protocol Violation|1|||
130386404|NCT01729754|469385647|FG004|Part 1|Protocol Violation|0|||
130386405|NCT01729754|469385648|FG005|Part 1|Protocol Violation|0|||
130469360|NCT05137236|469683633|FG000|Part B|Lost to Follow-up|0|||
130469361|NCT05137236|469683634|FG001|Part B|Lost to Follow-up|0|||
130469362|NCT05137236|469683635|FG002|Part B|Lost to Follow-up|0|||
130469363|NCT05137236|469683636|FG003|Part B|Lost to Follow-up|0|||
130469364|NCT05137236|469683637|FG004|Part B|Lost to Follow-up|0|||
130469365|NCT05137236|469683638|FG005|Part B|Lost to Follow-up|0|||
130469366|NCT05137236|469683639|FG006|Part B|Lost to Follow-up|5|||
130469367|NCT05137236|469683640|FG007|Part B|Lost to Follow-up|5|||
130469368|NCT05137236|469683633|FG000|Part B|Death|0|||
130469369|NCT05137236|469683634|FG001|Part B|Death|0|||
130469370|NCT05137236|469683635|FG002|Part B|Death|0|||
130386406|NCT01729754|469385649|FG006|Part 1|Protocol Violation|1|||
130386407|NCT01729754|469385650|FG007|Part 1|Protocol Violation|0|||
130386408|NCT01729754|469385651|FG008|Part 1|Protocol Violation|0|||
130386409|NCT01729754|469385652|FG009|Part 1|Protocol Violation|0|||
130386410|NCT01729754|469385643|FG000|Part 1|Withdrawal by Subject|5|||
130386411|NCT01729754|469385644|FG001|Part 1|Withdrawal by Subject|0|||
130386412|NCT01729754|469385645|FG002|Part 1|Withdrawal by Subject|0|||
130386413|NCT01729754|469385646|FG003|Part 1|Withdrawal by Subject|7|||
130386414|NCT01729754|469385647|FG004|Part 1|Withdrawal by Subject|0|||
130386415|NCT01729754|469385648|FG005|Part 1|Withdrawal by Subject|0|||
130386416|NCT01729754|469385649|FG006|Part 1|Withdrawal by Subject|5|||
130386417|NCT01729754|469385650|FG007|Part 1|Withdrawal by Subject|0|||
130386418|NCT01729754|469385651|FG008|Part 1|Withdrawal by Subject|0|||
130386419|NCT01729754|469385652|FG009|Part 1|Withdrawal by Subject|6|||
130386420|NCT01729754|469385643|FG000|Part 1|Other Protocol Specified Criteria|2|||
130386421|NCT01729754|469385644|FG001|Part 1|Other Protocol Specified Criteria|0|||
130386422|NCT01729754|469385645|FG002|Part 1|Other Protocol Specified Criteria|0|||
130386423|NCT01729754|469385646|FG003|Part 1|Other Protocol Specified Criteria|0|||
130386424|NCT01729754|469385647|FG004|Part 1|Other Protocol Specified Criteria|0|||
130386425|NCT01729754|469385648|FG005|Part 1|Other Protocol Specified Criteria|0|||
130469371|NCT05137236|469683636|FG003|Part B|Death|0|||
130469372|NCT05137236|469683637|FG004|Part B|Death|0|||
130469373|NCT05137236|469683638|FG005|Part B|Death|0|||
130469374|NCT05137236|469683639|FG006|Part B|Death|0|||
130469375|NCT05137236|469683640|FG007|Part B|Death|2|||
130386426|NCT01729754|469385649|FG006|Part 1|Other Protocol Specified Criteria|1|||
130386427|NCT01729754|469385650|FG007|Part 1|Other Protocol Specified Criteria|0|||
130386428|NCT01729754|469385651|FG008|Part 1|Other Protocol Specified Criteria|0|||
130386429|NCT01729754|469385652|FG009|Part 1|Other Protocol Specified Criteria|4|||
130386430|NCT01729754|469385643|FG000|Part 2|Adverse Event|2|||
130386431|NCT01729754|469385644|FG001|Part 2|Adverse Event|0|||
130386432|NCT01729754|469385645|FG002|Part 2|Adverse Event|0|||
130386433|NCT01729754|469385646|FG003|Part 2|Adverse Event|0|||
130386434|NCT01729754|469385647|FG004|Part 2|Adverse Event|0|||
130386435|NCT01729754|469385648|FG005|Part 2|Adverse Event|0|||
130386436|NCT01729754|469385649|FG006|Part 2|Adverse Event|0|||
130386437|NCT01729754|469385650|FG007|Part 2|Adverse Event|0|||
130386438|NCT01729754|469385651|FG008|Part 2|Adverse Event|1|||
130386439|NCT01729754|469385652|FG009|Part 2|Adverse Event|2|||
130386440|NCT01729754|469385643|FG000|Part 2|Lack of Efficacy|0|||
130386441|NCT01729754|469385644|FG001|Part 2|Lack of Efficacy|0|||
130386442|NCT01729754|469385645|FG002|Part 2|Lack of Efficacy|0|||
130386443|NCT01729754|469385646|FG003|Part 2|Lack of Efficacy|0|||
130386444|NCT01729754|469385647|FG004|Part 2|Lack of Efficacy|0|||
130386445|NCT01729754|469385648|FG005|Part 2|Lack of Efficacy|0|||
130386446|NCT01729754|469385649|FG006|Part 2|Lack of Efficacy|0|||
130386447|NCT01729754|469385650|FG007|Part 2|Lack of Efficacy|0|||
130386448|NCT01729754|469385651|FG008|Part 2|Lack of Efficacy|2|||
130386449|NCT01729754|469385652|FG009|Part 2|Lack of Efficacy|2|||
130386450|NCT01729754|469385643|FG000|Part 2|Lost to Follow-up|0|||
130386451|NCT01729754|469385644|FG001|Part 2|Lost to Follow-up|0|||
130386452|NCT01729754|469385645|FG002|Part 2|Lost to Follow-up|0|||
130386453|NCT01729754|469385646|FG003|Part 2|Lost to Follow-up|2|||
130386454|NCT01729754|469385647|FG004|Part 2|Lost to Follow-up|0|||
130386455|NCT01729754|469385648|FG005|Part 2|Lost to Follow-up|0|||
130386456|NCT01729754|469385649|FG006|Part 2|Lost to Follow-up|0|||
130386457|NCT01729754|469385650|FG007|Part 2|Lost to Follow-up|1|||
130386458|NCT01729754|469385651|FG008|Part 2|Lost to Follow-up|0|||
130386459|NCT01729754|469385652|FG009|Part 2|Lost to Follow-up|2|||
130386460|NCT01729754|469385643|FG000|Part 2|Non-Compliance with Study Drug|0|||
130386461|NCT01729754|469385644|FG001|Part 2|Non-Compliance with Study Drug|0|||
130386462|NCT01729754|469385645|FG002|Part 2|Non-Compliance with Study Drug|0|||
130386463|NCT01729754|469385646|FG003|Part 2|Non-Compliance with Study Drug|0|||
130386464|NCT01729754|469385647|FG004|Part 2|Non-Compliance with Study Drug|0|||
130386465|NCT01729754|469385648|FG005|Part 2|Non-Compliance with Study Drug|0|||
130386466|NCT01729754|469385649|FG006|Part 2|Non-Compliance with Study Drug|0|||
130386467|NCT01729754|469385650|FG007|Part 2|Non-Compliance with Study Drug|0|||
130386468|NCT01729754|469385651|FG008|Part 2|Non-Compliance with Study Drug|0|||
130386469|NCT01729754|469385652|FG009|Part 2|Non-Compliance with Study Drug|1|||
130386470|NCT01729754|469385643|FG000|Part 2|Pregnancy|0|||
130386471|NCT01729754|469385644|FG001|Part 2|Pregnancy|0|||
130386472|NCT01729754|469385645|FG002|Part 2|Pregnancy|0|||
130386473|NCT01729754|469385646|FG003|Part 2|Pregnancy|1|||
130386474|NCT01729754|469385647|FG004|Part 2|Pregnancy|0|||
130386475|NCT01729754|469385648|FG005|Part 2|Pregnancy|0|||
130386476|NCT01729754|469385649|FG006|Part 2|Pregnancy|0|||
130386477|NCT01729754|469385650|FG007|Part 2|Pregnancy|0|||
130386478|NCT01729754|469385651|FG008|Part 2|Pregnancy|0|||
130386479|NCT01729754|469385652|FG009|Part 2|Pregnancy|1|||
130386480|NCT01729754|469385643|FG000|Part 2|Withdrawal by Subject|3|||
130386481|NCT01729754|469385644|FG001|Part 2|Withdrawal by Subject|0|||
130386482|NCT01729754|469385645|FG002|Part 2|Withdrawal by Subject|0|||
130386483|NCT01729754|469385646|FG003|Part 2|Withdrawal by Subject|2|||
130386484|NCT01729754|469385647|FG004|Part 2|Withdrawal by Subject|0|||
130386485|NCT01729754|469385648|FG005|Part 2|Withdrawal by Subject|0|||
130386486|NCT01729754|469385649|FG006|Part 2|Withdrawal by Subject|0|||
130386487|NCT01729754|469385650|FG007|Part 2|Withdrawal by Subject|1|||
130386488|NCT01729754|469385651|FG008|Part 2|Withdrawal by Subject|1|||
130386489|NCT01729754|469385652|FG009|Part 2|Withdrawal by Subject|4|||
130386490|NCT01729754|469385643|FG000|Part 2|Other Protocol Specified Criteria|1|||
130386491|NCT01729754|469385644|FG001|Part 2|Other Protocol Specified Criteria|0|||
130386492|NCT01729754|469385645|FG002|Part 2|Other Protocol Specified Criteria|0|||
130386493|NCT01729754|469385646|FG003|Part 2|Other Protocol Specified Criteria|0|||
130386494|NCT01729754|469385647|FG004|Part 2|Other Protocol Specified Criteria|0|||
130386495|NCT01729754|469385648|FG005|Part 2|Other Protocol Specified Criteria|0|||
130386496|NCT01729754|469385649|FG006|Part 2|Other Protocol Specified Criteria|0|||
130386497|NCT01729754|469385650|FG007|Part 2|Other Protocol Specified Criteria|1|||
130386498|NCT01729754|469385651|FG008|Part 2|Other Protocol Specified Criteria|0|||
130386499|NCT01729754|469385652|FG009|Part 2|Other Protocol Specified Criteria|0|||
130386500|NCT01729754|469385643|FG000|Part 3|Adverse Event|0|||
130386501|NCT01729754|469385644|FG001|Part 3|Adverse Event|0|||
130386502|NCT01729754|469385645|FG002|Part 3|Adverse Event|1|||
130386503|NCT01729754|469385646|FG003|Part 3|Adverse Event|0|||
130386504|NCT01729754|469385647|FG004|Part 3|Adverse Event|0|||
130386505|NCT01729754|469385648|FG005|Part 3|Adverse Event|5|||
130386506|NCT01729754|469385649|FG006|Part 3|Adverse Event|0|||
130386507|NCT01729754|469385650|FG007|Part 3|Adverse Event|0|||
130386508|NCT01729754|469385651|FG008|Part 3|Adverse Event|0|||
130469376|NCT02724956|469683641|FG000|Overall Study|Physician Decision|1|||
130469377|NCT02724956|469683642|FG001|Overall Study|Physician Decision|0|||
130469378|NCT02724956|469683641|FG000|Overall Study|Lack of Efficacy|0|||
130469379|NCT02724956|469683642|FG001|Overall Study|Lack of Efficacy|1|||
130469380|NCT02724956|469683641|FG000|Overall Study|Withdrawal by Subject|0|||
130469381|NCT02724956|469683642|FG001|Overall Study|Withdrawal by Subject|1|||
130469382|NCT02121002|469683651|FG000|Overall Study|Physician Decision|2|||
130469383|NCT02121002|469683652|FG001|Overall Study|Physician Decision|0|||
130469384|NCT02121002|469683653|FG002|Overall Study|Physician Decision|0|||
130469385|NCT02121002|469683651|FG000|Overall Study|Withdrawal by Subject|3|||
130469386|NCT02121002|469683652|FG001|Overall Study|Withdrawal by Subject|1|||
130469387|NCT02121002|469683653|FG002|Overall Study|Withdrawal by Subject|4|||
130469388|NCT02121002|469683651|FG000|Overall Study|Protocol Violation|1|||
130469389|NCT02121002|469683652|FG001|Overall Study|Protocol Violation|2|||
130469390|NCT02121002|469683653|FG002|Overall Study|Protocol Violation|4|||
130559756|NCT01177384|470017872|FG001|Overall Study|Adverse Event|4|||
130559757|NCT01177384|470017871|FG000|Overall Study|Lack of Efficacy|0|||
130559758|NCT01177384|470017872|FG001|Overall Study|Lack of Efficacy|1|||
130559759|NCT01177384|470017871|FG000|Overall Study|Lost to Follow-up|3|||
130386509|NCT01729754|469385652|FG009|Part 3|Adverse Event|3|||
130386510|NCT01729754|469385643|FG000|Part 3|Death|0|||
130386511|NCT01729754|469385644|FG001|Part 3|Death|0|||
130386512|NCT01729754|469385645|FG002|Part 3|Death|0|||
130386513|NCT01729754|469385646|FG003|Part 3|Death|0|||
130386514|NCT01729754|469385647|FG004|Part 3|Death|0|||
130386515|NCT01729754|469385648|FG005|Part 3|Death|2|||
130386516|NCT01729754|469385649|FG006|Part 3|Death|0|||
130386517|NCT01729754|469385650|FG007|Part 3|Death|0|||
130386518|NCT01729754|469385651|FG008|Part 3|Death|0|||
130386519|NCT01729754|469385652|FG009|Part 3|Death|0|||
130386520|NCT01729754|469385643|FG000|Part 3|Lack of Efficacy|0|||
130386521|NCT01729754|469385644|FG001|Part 3|Lack of Efficacy|0|||
130386522|NCT01729754|469385645|FG002|Part 3|Lack of Efficacy|0|||
130386523|NCT01729754|469385646|FG003|Part 3|Lack of Efficacy|0|||
130386524|NCT01729754|469385647|FG004|Part 3|Lack of Efficacy|2|||
130386525|NCT01729754|469385648|FG005|Part 3|Lack of Efficacy|0|||
130386526|NCT01729754|469385649|FG006|Part 3|Lack of Efficacy|0|||
130386527|NCT01729754|469385650|FG007|Part 3|Lack of Efficacy|0|||
130386528|NCT01729754|469385651|FG008|Part 3|Lack of Efficacy|0|||
130386529|NCT01729754|469385652|FG009|Part 3|Lack of Efficacy|4|||
130386530|NCT01729754|469385643|FG000|Part 3|Lost to Follow-up|0|||
130386531|NCT01729754|469385644|FG001|Part 3|Lost to Follow-up|1|||
130386532|NCT01729754|469385645|FG002|Part 3|Lost to Follow-up|2|||
130386533|NCT01729754|469385646|FG003|Part 3|Lost to Follow-up|0|||
130386534|NCT01729754|469385647|FG004|Part 3|Lost to Follow-up|0|||
130386535|NCT01729754|469385648|FG005|Part 3|Lost to Follow-up|3|||
130386536|NCT01729754|469385649|FG006|Part 3|Lost to Follow-up|0|||
130386537|NCT01729754|469385650|FG007|Part 3|Lost to Follow-up|0|||
130386538|NCT01729754|469385651|FG008|Part 3|Lost to Follow-up|1|||
130386539|NCT01729754|469385652|FG009|Part 3|Lost to Follow-up|0|||
130386540|NCT01729754|469385643|FG000|Part 3|Physician Decision|0|||
130386541|NCT01729754|469385644|FG001|Part 3|Physician Decision|0|||
130386542|NCT01729754|469385645|FG002|Part 3|Physician Decision|1|||
130386543|NCT01729754|469385646|FG003|Part 3|Physician Decision|0|||
130386544|NCT01729754|469385647|FG004|Part 3|Physician Decision|0|||
130386545|NCT01729754|469385648|FG005|Part 3|Physician Decision|0|||
130386546|NCT01729754|469385649|FG006|Part 3|Physician Decision|0|||
130386547|NCT01729754|469385650|FG007|Part 3|Physician Decision|0|||
130386548|NCT01729754|469385651|FG008|Part 3|Physician Decision|0|||
130386549|NCT01729754|469385652|FG009|Part 3|Physician Decision|0|||
130386550|NCT01729754|469385643|FG000|Part 3|Withdrawal by Subject|0|||
130386551|NCT01729754|469385644|FG001|Part 3|Withdrawal by Subject|4|||
130386552|NCT01729754|469385645|FG002|Part 3|Withdrawal by Subject|1|||
130386553|NCT01729754|469385646|FG003|Part 3|Withdrawal by Subject|0|||
130386554|NCT01729754|469385647|FG004|Part 3|Withdrawal by Subject|2|||
130386555|NCT01729754|469385648|FG005|Part 3|Withdrawal by Subject|1|||
130386556|NCT01729754|469385649|FG006|Part 3|Withdrawal by Subject|0|||
130386557|NCT01729754|469385650|FG007|Part 3|Withdrawal by Subject|2|||
130386558|NCT01729754|469385651|FG008|Part 3|Withdrawal by Subject|0|||
130386559|NCT01729754|469385652|FG009|Part 3|Withdrawal by Subject|0|||
130386560|NCT01729754|469385643|FG000|Part 3|Other Protocol Specified Criteria|0|||
130386561|NCT01729754|469385644|FG001|Part 3|Other Protocol Specified Criteria|0|||
130386562|NCT01729754|469385645|FG002|Part 3|Other Protocol Specified Criteria|0|||
130386563|NCT01729754|469385646|FG003|Part 3|Other Protocol Specified Criteria|0|||
130386564|NCT01729754|469385647|FG004|Part 3|Other Protocol Specified Criteria|0|||
130386565|NCT01729754|469385648|FG005|Part 3|Other Protocol Specified Criteria|2|||
130386566|NCT01729754|469385649|FG006|Part 3|Other Protocol Specified Criteria|0|||
130386567|NCT01729754|469385650|FG007|Part 3|Other Protocol Specified Criteria|1|||
130386568|NCT01729754|469385651|FG008|Part 3|Other Protocol Specified Criteria|0|||
130469391|NCT02121002|469683651|FG000|Overall Study|Concomitant therapy|0|||
130469392|NCT02121002|469683652|FG001|Overall Study|Concomitant therapy|1|||
130469393|NCT02121002|469683653|FG002|Overall Study|Concomitant therapy|1|||
130469394|NCT02121002|469683651|FG000|Overall Study|Others|1|||
130469395|NCT02121002|469683652|FG001|Overall Study|Others|0|||
130469396|NCT02121002|469683653|FG002|Overall Study|Others|1|||
130469397|NCT02590432|469683654|FG000|Open-label Treatment Period|Adverse Event|97|||
130469398|NCT02590432|469683655|FG001|Open-label Treatment Period|Adverse Event|79|||
130469399|NCT02590432|469683656|FG002|Open-label Treatment Period|Adverse Event|0|||
130386569|NCT01729754|469385652|FG009|Part 3|Other Protocol Specified Criteria|0|||
130386570|NCT00773292|469385653|FG000|Treatment 48 Weeks|Adverse Event|1|||
130386571|NCT00773292|469385653|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
130386572|NCT02794103|469385654|FG000|Overall Study|Loss to follow up due to high sedation|3|||
130386573|NCT04608500|469385655|FG000|Overall Study|Adverse Event|2|||
130386574|NCT04608500|469385656|FG001|Overall Study|Adverse Event|0|||
130386575|NCT04608500|469385655|FG000|Overall Study|Lost to Follow-up|15|||
130386576|NCT04608500|469385656|FG001|Overall Study|Lost to Follow-up|9|||
130386577|NCT04608500|469385655|FG000|Overall Study|Participant request|11|||
130386578|NCT04608500|469385656|FG001|Overall Study|Participant request|7|||
130386579|NCT04608500|469385655|FG000|Overall Study|Protocol Violation|1|||
130386580|NCT04608500|469385656|FG001|Overall Study|Protocol Violation|0|||
130386581|NCT04608500|469385655|FG000|Overall Study|Other|6|||
130386582|NCT04608500|469385656|FG001|Overall Study|Other|2|||
130386583|NCT00542919|469385657|FG000|Overall Study|Adverse Event|1|||
130386584|NCT00542919|469385658|FG001|Overall Study|Adverse Event|5|||
130386585|NCT00542919|469385659|FG002|Overall Study|Adverse Event|1|||
130386586|NCT00542919|469385657|FG000|Overall Study|Withdrawal by Subject|1|||
130386587|NCT00542919|469385658|FG001|Overall Study|Withdrawal by Subject|0|||
130386588|NCT00542919|469385659|FG002|Overall Study|Withdrawal by Subject|3|||
130386589|NCT00542919|469385657|FG000|Overall Study|Physician Decision|2|||
130386590|NCT00542919|469385658|FG001|Overall Study|Physician Decision|2|||
130386591|NCT00542919|469385659|FG002|Overall Study|Physician Decision|1|||
130386592|NCT00542919|469385657|FG000|Overall Study|Sponsor Decision|1|||
130386593|NCT00542919|469385658|FG001|Overall Study|Sponsor Decision|0|||
130386594|NCT00542919|469385659|FG002|Overall Study|Sponsor Decision|0|||
130386595|NCT00542919|469385657|FG000|Overall Study|Lost to Follow-up|2|||
130386596|NCT00542919|469385658|FG001|Overall Study|Lost to Follow-up|0|||
130386597|NCT00542919|469385659|FG002|Overall Study|Lost to Follow-up|1|||
130386598|NCT02747420|469385660|FG000|Overall Study|Lost to Follow-up|4|||
130386599|NCT02747420|469385661|FG001|Overall Study|Lost to Follow-up|2|||
130386600|NCT02747420|469385660|FG000|Overall Study|Withdrawal by Subject|3|||
130386601|NCT02747420|469385661|FG001|Overall Study|Withdrawal by Subject|2|||
130386602|NCT03662542|469385662|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
130386603|NCT03662542|469385663|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386604|NCT03662542|469385664|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386605|NCT03662542|469385665|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386606|NCT03662542|469385666|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386607|NCT03662542|469385667|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386608|NCT03662542|469385668|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386609|NCT03662542|469385669|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386610|NCT03662542|469385670|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130386611|NCT03662542|469385662|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386612|NCT03662542|469385663|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
130386613|NCT03662542|469385664|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386614|NCT03662542|469385665|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386615|NCT03662542|469385666|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386616|NCT03662542|469385667|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386617|NCT03662542|469385668|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386618|NCT03662542|469385669|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130386619|NCT03662542|469385670|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130469400|NCT02590432|469683657|FG003|Open-label Treatment Period|Adverse Event|0|||
130469401|NCT02590432|469683658|FG004|Open-label Treatment Period|Adverse Event|0|||
130469402|NCT02590432|469683659|FG005|Open-label Treatment Period|Adverse Event|0|||
130469403|NCT02590432|469683660|FG006|Open-label Treatment Period|Adverse Event|0|||
130469404|NCT02590432|469683661|FG007|Open-label Treatment Period|Adverse Event|0|||
130469405|NCT02590432|469683662|FG008|Open-label Treatment Period|Adverse Event|0|||
130469406|NCT02590432|469683654|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
130386620|NCT03662542|469385662|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
130386621|NCT03662542|469385663|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
130386622|NCT03662542|469385664|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
130386623|NCT03662542|469385665|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
130386624|NCT03662542|469385666|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
130386625|NCT03662542|469385667|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
130386626|NCT03662542|469385668|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
130386627|NCT03662542|469385669|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
130386628|NCT03662542|469385670|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
130469407|NCT02590432|469683655|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
130469408|NCT02590432|469683656|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
130469409|NCT02590432|469683657|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
130469410|NCT02590432|469683658|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
130469411|NCT02590432|469683659|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
130469412|NCT02590432|469683660|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
130469413|NCT02590432|469683661|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
130469414|NCT02590432|469683662|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
130469415|NCT02590432|469683654|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
130469416|NCT02590432|469683655|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
130469417|NCT02590432|469683656|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
130469418|NCT02590432|469683657|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
130469419|NCT02590432|469683658|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
130469420|NCT02590432|469683659|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
130469421|NCT02590432|469683660|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
130469422|NCT02590432|469683661|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
130469423|NCT02590432|469683662|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
130469424|NCT02590432|469683654|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
130469425|NCT02590432|469683655|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
130469426|NCT02590432|469683656|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130469427|NCT02590432|469683657|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
130469428|NCT02590432|469683658|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
130469429|NCT02590432|469683659|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
130469430|NCT02590432|469683660|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
130469431|NCT02590432|469683661|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
130469432|NCT02590432|469683662|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
130469433|NCT02590432|469683654|FG000|Open-label Treatment Period|Protocol Violation|10|||
130469434|NCT02590432|469683655|FG001|Open-label Treatment Period|Protocol Violation|4|||
130469435|NCT02590432|469683656|FG002|Open-label Treatment Period|Protocol Violation|0|||
130469436|NCT02590432|469683657|FG003|Open-label Treatment Period|Protocol Violation|0|||
130469437|NCT02590432|469683658|FG004|Open-label Treatment Period|Protocol Violation|0|||
130469438|NCT02590432|469683659|FG005|Open-label Treatment Period|Protocol Violation|0|||
130469439|NCT02590432|469683660|FG006|Open-label Treatment Period|Protocol Violation|0|||
130469440|NCT02590432|469683661|FG007|Open-label Treatment Period|Protocol Violation|0|||
130469441|NCT02590432|469683662|FG008|Open-label Treatment Period|Protocol Violation|0|||
130469442|NCT02590432|469683654|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
130469443|NCT02590432|469683655|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
130469444|NCT02590432|469683656|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469445|NCT02590432|469683657|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469446|NCT02590432|469683658|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469447|NCT02590432|469683659|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469448|NCT02590432|469683660|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469449|NCT02590432|469683661|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130469450|NCT02590432|469683662|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
130386629|NCT03662542|469385662|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
130386630|NCT03662542|469385663|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386631|NCT03662542|469385664|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386632|NCT03662542|469385665|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386633|NCT03662542|469385666|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386634|NCT03662542|469385667|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386635|NCT03662542|469385668|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386636|NCT03662542|469385669|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386637|NCT03662542|469385670|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130386638|NCT03662542|469385662|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386639|NCT03662542|469385663|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386640|NCT03662542|469385664|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386641|NCT03662542|469385665|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386642|NCT03662542|469385666|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386643|NCT03662542|469385667|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
130386644|NCT03662542|469385668|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386645|NCT03662542|469385669|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386646|NCT03662542|469385670|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130386647|NCT03662542|469385662|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386648|NCT03662542|469385663|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386649|NCT03662542|469385664|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386650|NCT03662542|469385665|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
130386651|NCT03662542|469385666|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
130386652|NCT03662542|469385667|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386653|NCT03662542|469385668|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386654|NCT03662542|469385669|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386655|NCT03662542|469385670|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130386656|NCT03662542|469385662|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386657|NCT03662542|469385663|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386658|NCT03662542|469385664|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386659|NCT03662542|469385665|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
130386660|NCT03662542|469385666|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
130386661|NCT03662542|469385667|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
130386662|NCT03662542|469385668|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386663|NCT03662542|469385669|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386664|NCT03662542|469385670|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130386665|NCT03662542|469385662|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386666|NCT03662542|469385663|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386667|NCT03662542|469385664|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386668|NCT03662542|469385665|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386669|NCT03662542|469385666|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
130386670|NCT03662542|469385667|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
130386671|NCT03662542|469385668|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386672|NCT03662542|469385669|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386673|NCT03662542|469385670|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130386674|NCT03662542|469385662|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386675|NCT03662542|469385663|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386676|NCT03662542|469385664|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386677|NCT03662542|469385665|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386678|NCT03662542|469385666|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386679|NCT03662542|469385667|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
130386680|NCT03662542|469385668|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386681|NCT03662542|469385669|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386682|NCT03662542|469385670|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130386683|NCT03662542|469385662|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386684|NCT03662542|469385663|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386685|NCT03662542|469385664|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386686|NCT03662542|469385665|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386687|NCT03662542|469385666|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386688|NCT03662542|469385667|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386689|NCT03662542|469385668|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386690|NCT03662542|469385669|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
130386691|NCT03662542|469385670|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
130386692|NCT03662542|469385662|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386693|NCT03662542|469385663|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386694|NCT03662542|469385664|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386695|NCT03662542|469385665|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386696|NCT03662542|469385666|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386697|NCT03662542|469385667|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386698|NCT03662542|469385668|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
130386699|NCT03662542|469385669|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130386700|NCT03662542|469385670|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
130386701|NCT03662542|469385662|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386702|NCT03662542|469385663|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386703|NCT03662542|469385664|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386704|NCT03662542|469385665|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386705|NCT03662542|469385666|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386706|NCT03662542|469385667|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386707|NCT03662542|469385668|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
130386708|NCT03662542|469385669|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130386709|NCT03662542|469385670|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
130386710|NCT03662542|469385662|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386711|NCT03662542|469385663|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386712|NCT03662542|469385664|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386713|NCT03662542|469385665|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386714|NCT03662542|469385666|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386715|NCT03662542|469385667|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
130386716|NCT03662542|469385668|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
130386717|NCT03662542|469385669|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
130386718|NCT03662542|469385670|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
130386719|NCT01217060|469385672|FG000|Overall Study|Withdrawal by Subject|1|||
130559760|NCT01177384|470017872|FG001|Overall Study|Lost to Follow-up|4|||
130559761|NCT01177384|470017871|FG000|Overall Study|Physician Decision|0|||
130559762|NCT01177384|470017872|FG001|Overall Study|Physician Decision|3|||
130559763|NCT01177384|470017871|FG000|Overall Study|Protocol Violation|0|||
130386720|NCT03388138|469385676|FG000|Overall Study|Protocol Violation|1|||
130386721|NCT03388138|469385677|FG001|Overall Study|Protocol Violation|0|||
130386722|NCT01528072|469385680|FG000|Overall Study|Withdrawal by Subject|5|||
130386723|NCT01528072|469385680|FG000|Overall Study|Physician Decision|1|||
130386724|NCT01528072|469385680|FG000|Overall Study|Determined not eligible by AEAC|1|||
130386725|NCT01528072|469385680|FG000|Overall Study|Missed Visit|2|||
130386726|NCT01528072|469385680|FG000|Overall Study|Lost to Follow-up|5|||
130386727|NCT01528072|469385680|FG000|Overall Study|Explanted|2|||
130386728|NCT01528072|469385680|FG000|Overall Study|Site Closure|4|||
130386729|NCT01528072|469385680|FG000|Overall Study|Death|2|||
130386730|NCT01528072|469385680|FG000|Overall Study|Early Termination of Study|52|||
130386731|NCT01859494|469385683|FG000|Overall Study|Adverse Event|1|||
130386732|NCT02769247|469385695|FG000|Overall Study|Withdrawal by Subject|1|||
130386733|NCT02769247|469385696|FG001|Overall Study|Withdrawal by Subject|0|||
130386734|NCT02769247|469385697|FG002|Overall Study|Withdrawal by Subject|0|||
130386735|NCT02769247|469385698|FG003|Overall Study|Withdrawal by Subject|1|||
130386736|NCT02769247|469385695|FG000|Overall Study|Protocol Violation|0|||
130386737|NCT02769247|469385696|FG001|Overall Study|Protocol Violation|0|||
130386738|NCT02769247|469385697|FG002|Overall Study|Protocol Violation|1|||
130386739|NCT02769247|469385698|FG003|Overall Study|Protocol Violation|0|||
130386740|NCT02769247|469385695|FG000|Overall Study|Physician Decision|1|||
130386741|NCT02769247|469385696|FG001|Overall Study|Physician Decision|0|||
130386742|NCT02769247|469385697|FG002|Overall Study|Physician Decision|0|||
130386743|NCT02769247|469385698|FG003|Overall Study|Physician Decision|0|||
130386744|NCT01462084|469385701|FG000|Overall Study|Withdrawal by Subject|1|||
130386745|NCT01462084|469385702|FG001|Overall Study|Withdrawal by Subject|0|||
130386746|NCT01462084|469385701|FG000|Overall Study|Protocol Violation|1|||
130386747|NCT01462084|469385702|FG001|Overall Study|Protocol Violation|1|||
130386748|NCT05089682|469385703|FG000|Overall Study|Withdrawal by Subject|2|||
130386749|NCT01996826|469385704|FG000|Overall Study|Lost to Follow-up|6|||
130386750|NCT01996826|469385705|FG001|Overall Study|Lost to Follow-up|2|||
130386751|NCT01996826|469385704|FG000|Overall Study|Physician Decision|1|||
130386752|NCT01996826|469385705|FG001|Overall Study|Physician Decision|1|||
130386753|NCT00695396|469385706|FG000|Overall Study|Study Closed Prematurely|5|||
130386754|NCT00695396|469385707|FG001|Overall Study|Study Closed Prematurely|6|||
130386755|NCT00695396|469385708|FG002|Overall Study|Study Closed Prematurely|8|||
130386756|NCT00695396|469385706|FG000|Overall Study|Withdrawal by Subject|2|||
130386757|NCT00695396|469385707|FG001|Overall Study|Withdrawal by Subject|2|||
130386758|NCT00695396|469385708|FG002|Overall Study|Withdrawal by Subject|0|||
130386759|NCT01514760|469385710|FG000|Overall Study|Lost to Follow-up|2|||
130386760|NCT02092662|469385711|FG000|Overall Study|Lost to Follow-up|13|||
130386761|NCT02092662|469385712|FG001|Overall Study|Lost to Follow-up|0|||
130386762|NCT02418468|469385713|FG000|Overall Study|Adverse Event|1|||
130386763|NCT02418468|469385714|FG001|Overall Study|Adverse Event|0|||
130386764|NCT02418468|469385713|FG000|Overall Study|Withdrawal of informed consent|1|||
130386765|NCT02418468|469385714|FG001|Overall Study|Withdrawal of informed consent|1|||
130386766|NCT02914769|469385715|FG000|Overall Study|Protocol Violation|3|||
130386767|NCT02914769|469385716|FG001|Overall Study|Protocol Violation|2|||
130386768|NCT02914769|469385715|FG000|Overall Study|Withdrawal by Subject|0|||
130386769|NCT02914769|469385716|FG001|Overall Study|Withdrawal by Subject|1|||
130386770|NCT01592344|469385717|FG000|Overall Study|Adverse Event|1|||
130386771|NCT01592344|469385718|FG001|Overall Study|Adverse Event|1|||
130386772|NCT01592344|469385717|FG000|Overall Study|Lack of Efficacy|1|||
130386773|NCT01592344|469385718|FG001|Overall Study|Lack of Efficacy|0|||
130386774|NCT01592344|469385717|FG000|Overall Study|not available at primary outcome visit|2|||
130386775|NCT01592344|469385718|FG001|Overall Study|not available at primary outcome visit|4|||
130386776|NCT00099437|469385719|FG000|Overall Study|Lost to Follow-up|30|||
130386777|NCT00099437|469385720|FG001|Overall Study|Lost to Follow-up|33|||
130386778|NCT00099437|469385719|FG000|Overall Study|Death|293|||
130386779|NCT00099437|469385720|FG001|Overall Study|Death|261|||
130386780|NCT00099437|469385719|FG000|Overall Study|Withdrawal by Subject|6|||
130386781|NCT00099437|469385720|FG001|Overall Study|Withdrawal by Subject|10|||
130386782|NCT00099437|469385719|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
130386783|NCT00099437|469385720|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
130386784|NCT04969224|469385721|FG000|Overall Study|Adverse Event|1|||
130386785|NCT04969224|469385721|FG000|Overall Study|Enrolled but never dosed|1|||
130386786|NCT02726074|469385722|FG000|Overall Study|Withdrawal by Subject|4|||
130386787|NCT02726074|469385722|FG000|Overall Study|Adverse Event|14|||
130386788|NCT02726074|469385722|FG000|Overall Study|Protocol Violation|3|||
130559764|NCT01177384|470017872|FG001|Overall Study|Protocol Violation|2|||
130386789|NCT02726074|469385722|FG000|Overall Study|Lost to Follow-up|2|||
130386790|NCT02726074|469385722|FG000|Overall Study|Others|3|||
130386791|NCT00613015|469385723|FG000|Overall Study|Lost to Follow-up|0|||
130386792|NCT00613015|469385724|FG001|Overall Study|Lost to Follow-up|1|||
130559765|NCT01177384|470017871|FG000|Overall Study|Withdrawal by Subject|5|||
130722530|NCT02802631|470608318|FG005|Overall Study|Adverse Event|1|||
130722531|NCT02802631|470608319|FG006|Overall Study|Adverse Event|4|||
130722532|NCT02802631|470608320|FG007|Overall Study|Adverse Event|0|||
130722533|NCT02802631|470608313|FG000|Overall Study|Sponsor Decision|0|||
130386793|NCT00613015|469385725|FG002|Overall Study|Lost to Follow-up|3|||
130386794|NCT00613015|469385726|FG003|Overall Study|Lost to Follow-up|3|||
130386795|NCT00613015|469385727|FG004|Overall Study|Lost to Follow-up|2|||
130386796|NCT00613015|469385728|FG005|Overall Study|Lost to Follow-up|3|||
130386797|NCT04256785|469385729|FG000|Overall Study|Adverse Event|8|||
130386798|NCT04256785|469385730|FG001|Overall Study|Adverse Event|6|||
130386799|NCT04256785|469385729|FG000|Overall Study|Lack of Efficacy|3|||
130386800|NCT04256785|469385730|FG001|Overall Study|Lack of Efficacy|4|||
130386801|NCT04256785|469385729|FG000|Overall Study|Lost to Follow-up|7|||
130386802|NCT04256785|469385730|FG001|Overall Study|Lost to Follow-up|7|||
130386803|NCT04256785|469385729|FG000|Overall Study|Protocol Violation|1|||
130469451|NCT02590432|469683654|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
130386804|NCT04256785|469385730|FG001|Overall Study|Protocol Violation|0|||
130386805|NCT04256785|469385729|FG000|Overall Study|Withdrawal by Subject|4|||
130386806|NCT04256785|469385730|FG001|Overall Study|Withdrawal by Subject|1|||
130386807|NCT04256785|469385729|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
130386808|NCT04256785|469385730|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
130386809|NCT02153112|469385736|FG000|Overall Study|Adverse Event|0|||
130386810|NCT02153112|469385737|FG001|Overall Study|Adverse Event|0|||
130386811|NCT02153112|469385738|FG002|Overall Study|Adverse Event|1|||
130386812|NCT02153112|469385739|FG003|Overall Study|Adverse Event|0|||
130386813|NCT02153112|469385740|FG004|Overall Study|Adverse Event|0|||
130386814|NCT02153112|469385741|FG005|Overall Study|Adverse Event|0|||
130386815|NCT02153112|469385742|FG006|Overall Study|Adverse Event|0|||
130386816|NCT02153112|469385743|FG007|Overall Study|Adverse Event|0|||
130386817|NCT02153112|469385744|FG008|Overall Study|Adverse Event|0|||
130386818|NCT02153112|469385745|FG009|Overall Study|Adverse Event|0|||
130386819|NCT02153112|469385736|FG000|Overall Study|Lost to Follow-up|1|||
130386820|NCT02153112|469385737|FG001|Overall Study|Lost to Follow-up|1|||
130386821|NCT02153112|469385738|FG002|Overall Study|Lost to Follow-up|0|||
130386822|NCT02153112|469385739|FG003|Overall Study|Lost to Follow-up|0|||
130386823|NCT02153112|469385740|FG004|Overall Study|Lost to Follow-up|2|||
130386824|NCT02153112|469385741|FG005|Overall Study|Lost to Follow-up|1|||
130386825|NCT02153112|469385742|FG006|Overall Study|Lost to Follow-up|1|||
130386826|NCT02153112|469385743|FG007|Overall Study|Lost to Follow-up|0|||
130386827|NCT02153112|469385744|FG008|Overall Study|Lost to Follow-up|1|||
130386828|NCT02153112|469385745|FG009|Overall Study|Lost to Follow-up|1|||
130386829|NCT02153112|469385736|FG000|Overall Study|Withdrawal by Subject|3|||
130386830|NCT02153112|469385737|FG001|Overall Study|Withdrawal by Subject|1|||
130386831|NCT02153112|469385738|FG002|Overall Study|Withdrawal by Subject|2|||
130386832|NCT02153112|469385739|FG003|Overall Study|Withdrawal by Subject|2|||
130386833|NCT02153112|469385740|FG004|Overall Study|Withdrawal by Subject|1|||
130386834|NCT02153112|469385741|FG005|Overall Study|Withdrawal by Subject|1|||
130386835|NCT02153112|469385742|FG006|Overall Study|Withdrawal by Subject|7|||
130386836|NCT02153112|469385743|FG007|Overall Study|Withdrawal by Subject|2|||
130386837|NCT02153112|469385744|FG008|Overall Study|Withdrawal by Subject|13|||
130386838|NCT02153112|469385745|FG009|Overall Study|Withdrawal by Subject|12|||
130386839|NCT02153112|469385736|FG000|Overall Study|Reason not Specified|0|||
130386840|NCT02153112|469385737|FG001|Overall Study|Reason not Specified|0|||
130386841|NCT02153112|469385738|FG002|Overall Study|Reason not Specified|0|||
130386842|NCT02153112|469385739|FG003|Overall Study|Reason not Specified|0|||
130386843|NCT02153112|469385740|FG004|Overall Study|Reason not Specified|0|||
130722534|NCT02802631|470608314|FG001|Overall Study|Sponsor Decision|0|||
130386844|NCT02153112|469385741|FG005|Overall Study|Reason not Specified|0|||
130386845|NCT02153112|469385742|FG006|Overall Study|Reason not Specified|0|||
130386846|NCT02153112|469385743|FG007|Overall Study|Reason not Specified|0|||
130722535|NCT02802631|470608315|FG002|Overall Study|Sponsor Decision|6|||
130722536|NCT02802631|470608316|FG003|Overall Study|Sponsor Decision|0|||
130722537|NCT02802631|470608317|FG004|Overall Study|Sponsor Decision|2|||
130722538|NCT02802631|470608318|FG005|Overall Study|Sponsor Decision|0|||
130722539|NCT02802631|470608319|FG006|Overall Study|Sponsor Decision|0|||
130386847|NCT02153112|469385744|FG008|Overall Study|Reason not Specified|1|||
130386848|NCT02153112|469385745|FG009|Overall Study|Reason not Specified|1|||
130386849|NCT00832585|469385751|FG000|Overall Study|Withdrawal by Subject|1|||
130386850|NCT00832585|469385751|FG000|Overall Study|Lost to Follow-up|1|||
130386851|NCT01374087|469385756|FG000|Overall Study|Adverse Event|1|||
130386852|NCT01374087|469385757|FG001|Overall Study|Adverse Event|0|||
130386853|NCT01374087|469385756|FG000|Overall Study|Disease progression|2|||
130386854|NCT01374087|469385757|FG001|Overall Study|Disease progression|2|||
130386855|NCT01374087|469385756|FG000|Overall Study|Study discontinued|13|||
130386856|NCT01374087|469385757|FG001|Overall Study|Study discontinued|13|||
130469452|NCT02590432|469683655|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
130722540|NCT02802631|470608320|FG007|Overall Study|Sponsor Decision|4|||
130722541|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Physician Decision|1|||
130386857|NCT03011307|469385758|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
130386858|NCT03011307|469385759|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
130386859|NCT03011307|469385758|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
130386860|NCT03011307|469385759|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
130386861|NCT03011307|469385758|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
130386862|NCT03011307|469385759|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
130386863|NCT00271947|469385760|FG000|Overall Study|Lost to Follow-up|1|||
130386864|NCT02677987|469385761|FG000|Overall Study|Withdrawal by Subject|3|||
130386865|NCT02677987|469385762|FG001|Overall Study|Withdrawal by Subject|0|||
130386866|NCT02677987|469385761|FG000|Overall Study|Lost to Follow-up|1|||
130386867|NCT02677987|469385762|FG001|Overall Study|Lost to Follow-up|0|||
130386868|NCT01522365|469385765|FG000|Overall Study|Withdrawal by Subject|1|||
130386869|NCT01522365|469385766|FG001|Overall Study|Withdrawal by Subject|1|||
130386870|NCT01522365|469385765|FG000|Overall Study|Lost to Follow-up|1|||
130386871|NCT01522365|469385766|FG001|Overall Study|Lost to Follow-up|1|||
130386872|NCT00673179|469385767|FG000|Overall Study|Toxicity/Complications|3|||
130386873|NCT00673179|469385768|FG001|Overall Study|Toxicity/Complications|0|||
130386874|NCT02466555|469385769|FG000|Overall Study|Lost to Follow-up|2|||
130386875|NCT04170348|469385770|FG000|Overall Study|Lost to Follow-up|2|||
130386876|NCT04170348|469385771|FG001|Overall Study|Lost to Follow-up|2|||
130386877|NCT04170348|469385770|FG000|Overall Study|Withdrawal by Subject|1|||
130386878|NCT04170348|469385771|FG001|Overall Study|Withdrawal by Subject|5|||
130386879|NCT04170348|469385770|FG000|Overall Study|Non-adherence|1|||
130386880|NCT04170348|469385771|FG001|Overall Study|Non-adherence|1|||
130386881|NCT04170348|469385770|FG000|Overall Study|Adverse Event|1|||
130386882|NCT04170348|469385771|FG001|Overall Study|Adverse Event|0|||
130386883|NCT01120756|469385772|FG000|Overall Study|Withdrawal by Subject|1|||
130386884|NCT01120756|469385773|FG001|Overall Study|Withdrawal by Subject|1|||
130386885|NCT03760146|469385779|FG000|Overall Study|Adverse Event|11|||
130386886|NCT03760146|469385780|FG001|Overall Study|Adverse Event|8|||
130386887|NCT03760146|469385781|FG002|Overall Study|Adverse Event|0|||
130386888|NCT03760146|469385782|FG003|Overall Study|Adverse Event|0|||
130386889|NCT03760146|469385783|FG004|Overall Study|Adverse Event|0|||
130386890|NCT03760146|469385784|FG005|Overall Study|Adverse Event|0|||
130386891|NCT03760146|469385779|FG000|Overall Study|Death|1|||
130386892|NCT03760146|469385780|FG001|Overall Study|Death|0|||
130386893|NCT03760146|469385781|FG002|Overall Study|Death|0|||
130386894|NCT03760146|469385782|FG003|Overall Study|Death|0|||
130386895|NCT03760146|469385783|FG004|Overall Study|Death|0|||
130386896|NCT03760146|469385784|FG005|Overall Study|Death|0|||
130386897|NCT03760146|469385779|FG000|Overall Study|Lost to Follow-up|41|||
130386898|NCT03760146|469385780|FG001|Overall Study|Lost to Follow-up|28|||
130386899|NCT03760146|469385781|FG002|Overall Study|Lost to Follow-up|9|||
130386900|NCT03760146|469385782|FG003|Overall Study|Lost to Follow-up|2|||
130386901|NCT03760146|469385783|FG004|Overall Study|Lost to Follow-up|14|||
130386902|NCT03760146|469385784|FG005|Overall Study|Lost to Follow-up|8|||
130386903|NCT03760146|469385779|FG000|Overall Study|No longer met eligibility criteria|3|||
130386904|NCT03760146|469385780|FG001|Overall Study|No longer met eligibility criteria|9|||
130386905|NCT03760146|469385781|FG002|Overall Study|No longer met eligibility criteria|0|||
130386906|NCT03760146|469385782|FG003|Overall Study|No longer met eligibility criteria|0|||
130386907|NCT03760146|469385783|FG004|Overall Study|No longer met eligibility criteria|1|||
130386908|NCT03760146|469385784|FG005|Overall Study|No longer met eligibility criteria|0|||
130386909|NCT03760146|469385779|FG000|Overall Study|Protocol Violation|21|||
130386910|NCT03760146|469385780|FG001|Overall Study|Protocol Violation|13|||
130386911|NCT03760146|469385781|FG002|Overall Study|Protocol Violation|1|||
130386912|NCT03760146|469385782|FG003|Overall Study|Protocol Violation|0|||
130386913|NCT03760146|469385783|FG004|Overall Study|Protocol Violation|1|||
130386914|NCT03760146|469385784|FG005|Overall Study|Protocol Violation|0|||
130386915|NCT03760146|469385779|FG000|Overall Study|Withdrawal by Subject|19|||
130386916|NCT03760146|469385780|FG001|Overall Study|Withdrawal by Subject|20|||
130386917|NCT03760146|469385781|FG002|Overall Study|Withdrawal by Subject|1|||
130386918|NCT03760146|469385782|FG003|Overall Study|Withdrawal by Subject|0|||
130386919|NCT03760146|469385783|FG004|Overall Study|Withdrawal by Subject|1|||
130386920|NCT03760146|469385784|FG005|Overall Study|Withdrawal by Subject|0|||
130386921|NCT00449644|469385785|FG000|Overall Study|Adverse Event|0|||
130386922|NCT00449644|469385786|FG001|Overall Study|Adverse Event|0|||
130386923|NCT00449644|469385787|FG002|Overall Study|Adverse Event|3|||
130386924|NCT00449644|469385788|FG003|Overall Study|Adverse Event|5|||
130386925|NCT00449644|469385785|FG000|Overall Study|Death|1|||
130386926|NCT00449644|469385786|FG001|Overall Study|Death|0|||
130386927|NCT00449644|469385787|FG002|Overall Study|Death|6|||
130386928|NCT00449644|469385788|FG003|Overall Study|Death|1|||
130386929|NCT00449644|469385785|FG000|Overall Study|Lost to Follow-up|1|||
130386930|NCT00449644|469385786|FG001|Overall Study|Lost to Follow-up|1|||
130386931|NCT00449644|469385787|FG002|Overall Study|Lost to Follow-up|5|||
130386932|NCT00449644|469385788|FG003|Overall Study|Lost to Follow-up|3|||
130386933|NCT00449644|469385785|FG000|Overall Study|Pregnancy|0|||
130386934|NCT00449644|469385786|FG001|Overall Study|Pregnancy|0|||
130386935|NCT00449644|469385787|FG002|Overall Study|Pregnancy|3|||
130386936|NCT00449644|469385788|FG003|Overall Study|Pregnancy|2|||
130386937|NCT00449644|469385785|FG000|Overall Study|Protocol Violation|4|||
130386938|NCT00449644|469385786|FG001|Overall Study|Protocol Violation|4|||
130386939|NCT00449644|469385787|FG002|Overall Study|Protocol Violation|3|||
130386940|NCT00449644|469385788|FG003|Overall Study|Protocol Violation|7|||
130386941|NCT00449644|469385785|FG000|Overall Study|Withdrawal by Subject|3|||
130386942|NCT00449644|469385786|FG001|Overall Study|Withdrawal by Subject|4|||
130386943|NCT00449644|469385787|FG002|Overall Study|Withdrawal by Subject|6|||
130386944|NCT00449644|469385788|FG003|Overall Study|Withdrawal by Subject|7|||
130386945|NCT00449644|469385785|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130386946|NCT00449644|469385786|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
130386947|NCT00449644|469385787|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
130386948|NCT00449644|469385788|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
130386949|NCT00449644|469385785|FG000|Overall Study|Other|1|||
130386950|NCT00449644|469385786|FG001|Overall Study|Other|4|||
130386951|NCT00449644|469385787|FG002|Overall Study|Other|1|||
130386952|NCT00449644|469385788|FG003|Overall Study|Other|0|||
130386953|NCT00449644|469385785|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
130386954|NCT00449644|469385786|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
130386955|NCT00449644|469385787|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
130386956|NCT00449644|469385788|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
130386957|NCT01082965|469385789|FG000|Overall Study|Protocol Violation|0|||
130386958|NCT01082965|469385790|FG001|Overall Study|Protocol Violation|1|||
130386959|NCT01082965|469385789|FG000|Overall Study|Other|1|||
130386960|NCT01082965|469385790|FG001|Overall Study|Other|1|||
130386961|NCT01559012|469385793|FG000|Overall Study|Withdrawal by Subject|0|||
130386962|NCT01559012|469385794|FG001|Overall Study|Withdrawal by Subject|1|||
130386963|NCT02291055|469385795|FG000|Overall Study|Death|2|||
130386964|NCT02291055|469385796|FG001|Overall Study|Death|2|||
130386965|NCT02291055|469385797|FG002|Overall Study|Death|5|||
130386966|NCT02291055|469385798|FG003|Overall Study|Death|8|||
130386967|NCT02291055|469385799|FG004|Overall Study|Death|12|||
130386968|NCT02291055|469385795|FG000|Overall Study|Lost to Follow-up|0|||
130386969|NCT02291055|469385796|FG001|Overall Study|Lost to Follow-up|0|||
130386970|NCT02291055|469385797|FG002|Overall Study|Lost to Follow-up|0|||
130386971|NCT02291055|469385798|FG003|Overall Study|Lost to Follow-up|1|||
130386972|NCT02291055|469385799|FG004|Overall Study|Lost to Follow-up|2|||
130386973|NCT02291055|469385795|FG000|Overall Study|Withdrawal by Subject|3|||
130386974|NCT02291055|469385796|FG001|Overall Study|Withdrawal by Subject|1|||
130386975|NCT02291055|469385797|FG002|Overall Study|Withdrawal by Subject|1|||
130386976|NCT02291055|469385798|FG003|Overall Study|Withdrawal by Subject|5|||
130386977|NCT02291055|469385799|FG004|Overall Study|Withdrawal by Subject|10|||
130386978|NCT02291055|469385795|FG000|Overall Study|Progressive Disease|0|||
130386979|NCT02291055|469385796|FG001|Overall Study|Progressive Disease|0|||
130386980|NCT02291055|469385797|FG002|Overall Study|Progressive Disease|1|||
130386981|NCT02291055|469385798|FG003|Overall Study|Progressive Disease|4|||
130386982|NCT02291055|469385799|FG004|Overall Study|Progressive Disease|2|||
130386983|NCT02291055|469385795|FG000|Overall Study|Study Terminated by Sponsor|0|||
130386984|NCT02291055|469385796|FG001|Overall Study|Study Terminated by Sponsor|0|||
130386985|NCT02291055|469385797|FG002|Overall Study|Study Terminated by Sponsor|0|||
130386986|NCT02291055|469385798|FG003|Overall Study|Study Terminated by Sponsor|5|||
130386987|NCT02291055|469385799|FG004|Overall Study|Study Terminated by Sponsor|1|||
130386988|NCT02291055|469385795|FG000|Overall Study|Other|0|||
130386989|NCT02291055|469385796|FG001|Overall Study|Other|2|||
130386990|NCT02291055|469385797|FG002|Overall Study|Other|1|||
130386991|NCT02291055|469385798|FG003|Overall Study|Other|4|||
130386992|NCT02291055|469385799|FG004|Overall Study|Other|0|||
130386993|NCT00853723|469385801|FG000|Overall Study|Adverse Event|3|||
130386994|NCT00853723|469385802|FG001|Overall Study|Adverse Event|4|||
130386995|NCT00853723|469385803|FG002|Overall Study|Adverse Event|1|||
130386996|NCT00853723|469385801|FG000|Overall Study|Withdrawal by Subject|2|||
130386997|NCT00853723|469385802|FG001|Overall Study|Withdrawal by Subject|1|||
130386998|NCT00853723|469385803|FG002|Overall Study|Withdrawal by Subject|0|||
130386999|NCT00853723|469385801|FG000|Overall Study|Protocol Violation|1|||
130387000|NCT00853723|469385802|FG001|Overall Study|Protocol Violation|2|||
130387001|NCT00853723|469385803|FG002|Overall Study|Protocol Violation|1|||
130387002|NCT03839212|469385804|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
130387003|NCT00445965|469385805|FG000|Overall Study|Adverse Event|2|||
130387004|NCT00445965|469385805|FG000|Overall Study|Physician Decision|1|||
130387005|NCT00445965|469385805|FG000|Overall Study|Enrolled but not treated|1|||
130387006|NCT00445965|469385805|FG000|Overall Study|Removed due to progressive disease|29|||
130387007|NCT00679263|469385806|FG000|Visit 2/Dose 1|Adverse Event|1|||
130387008|NCT00679263|469385807|FG001|Visit 2/Dose 1|Adverse Event|0|||
130387009|NCT00679263|469385808|FG002|Visit 2/Dose 1|Adverse Event|0|||
130387010|NCT00679263|469385806|FG000|Visit 2/Dose 1|subject not compliance|1|||
130387011|NCT00679263|469385807|FG001|Visit 2/Dose 1|subject not compliance|1|||
130387012|NCT00679263|469385808|FG002|Visit 2/Dose 1|subject not compliance|0|||
130387013|NCT01464346|469385812|FG000|Overall Study|Withdrawal by Subject|0|||
130387014|NCT01464346|469385813|FG001|Overall Study|Withdrawal by Subject|0|||
130387015|NCT01464346|469385814|FG002|Overall Study|Withdrawal by Subject|1|||
130387016|NCT03999892|469385815|FG000|Overall Study|Lost to Follow-up|1|||
130387017|NCT02295995|469385816|FG000|Overall Study|Lost to Follow-up|5|||
130387018|NCT02295995|469385817|FG001|Overall Study|Lost to Follow-up|1|||
130387019|NCT02447081|469385818|FG000|Overall Study|Death|161|||
130387020|NCT02447081|469385818|FG000|Overall Study|Lost to Follow-up|36|||
130387021|NCT02447081|469385818|FG000|Overall Study|Visit not completed|17|||
130387022|NCT02447081|469385818|FG000|Overall Study|unsuccessful implant procedure|10|||
130387023|NCT02406651|469385821|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
130387024|NCT02946047|469385822|FG000|Overall Study|Adverse Event|1|||
130387025|NCT02946047|469385823|FG001|Overall Study|Adverse Event|0|||
130387026|NCT02946047|469385824|FG002|Overall Study|Adverse Event|0|||
130387027|NCT02946047|469385825|FG003|Overall Study|Adverse Event|0|||
130387028|NCT04350788|469385833|FG000|Overall Study|Lost to Follow-up|6|||
130387029|NCT04350788|469385834|FG001|Overall Study|Lost to Follow-up|2|||
130387030|NCT04350788|469385833|FG000|Overall Study|Withdrawal by Subject|2|||
130387031|NCT04350788|469385834|FG001|Overall Study|Withdrawal by Subject|4|||
130387032|NCT04350788|469385833|FG000|Overall Study|Protocol Violation|4|||
130387033|NCT04350788|469385834|FG001|Overall Study|Protocol Violation|0|||
130387034|NCT02255981|469387158|FG000|Overall Study|Lost to Follow-up|3|||
130387035|NCT02255981|469387158|FG000|Overall Study|Withdrawal by Subject|1|||
130469453|NCT02590432|469683656|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469454|NCT02590432|469683657|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469455|NCT02590432|469683658|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469456|NCT02590432|469683659|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469457|NCT02590432|469683660|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469458|NCT02590432|469683661|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469459|NCT02590432|469683662|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
130469460|NCT02590432|469683654|FG000|Double-blind Treatment Period|Adverse Event|0|||
130469461|NCT02590432|469683655|FG001|Double-blind Treatment Period|Adverse Event|0|||
130469462|NCT02590432|469683656|FG002|Double-blind Treatment Period|Adverse Event|14|||
130469463|NCT02590432|469683657|FG003|Double-blind Treatment Period|Adverse Event|12|||
130469464|NCT02590432|469683658|FG004|Double-blind Treatment Period|Adverse Event|6|||
130469465|NCT02590432|469683659|FG005|Double-blind Treatment Period|Adverse Event|22|||
130469466|NCT02590432|469683660|FG006|Double-blind Treatment Period|Adverse Event|20|||
130469467|NCT02590432|469683661|FG007|Double-blind Treatment Period|Adverse Event|0|||
130469468|NCT02590432|469683662|FG008|Double-blind Treatment Period|Adverse Event|0|||
130469469|NCT02590432|469683654|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130469470|NCT02590432|469683655|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130559766|NCT01177384|470017872|FG001|Overall Study|Withdrawal by Subject|12|||
130559767|NCT01849497|470017873|FG000|Overall Study|Withdrawal by Subject|1|||
130387036|NCT01046682|469387161|FG000|Overall Study|Adverse Event|2|||
130387037|NCT01046682|469387162|FG001|Overall Study|Adverse Event|0|||
130387038|NCT00371254|469387163|FG000|Overall Study|Disease progression|13|||
130387039|NCT00371254|469387164|FG001|Overall Study|Disease progression|13|||
130387040|NCT00371254|469387163|FG000|Overall Study|Study drug toxicity|3|||
130387041|NCT00371254|469387164|FG001|Overall Study|Study drug toxicity|5|||
130387042|NCT00371254|469387163|FG000|Overall Study|Subject request|5|||
130387043|NCT00371254|469387164|FG001|Overall Study|Subject request|0|||
130387044|NCT00371254|469387163|FG000|Overall Study|Investigator Decision|2|||
130387045|NCT00371254|469387164|FG001|Overall Study|Investigator Decision|0|||
130387046|NCT00371254|469387163|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130387047|NCT00371254|469387164|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130387048|NCT00371254|469387163|FG000|Overall Study|Lost to Follow-up|0|||
130387049|NCT00371254|469387164|FG001|Overall Study|Lost to Follow-up|1|||
130559768|NCT01849497|470017874|FG001|Overall Study|Withdrawal by Subject|2|||
130559769|NCT01849497|470017873|FG000|Overall Study|Sponsor Decision|0|||
130559770|NCT01849497|470017874|FG001|Overall Study|Sponsor Decision|1|||
130387050|NCT00371254|469387163|FG000|Overall Study|Withdrawal by Subject|0|||
130387051|NCT00371254|469387164|FG001|Overall Study|Withdrawal by Subject|1|||
130387052|NCT02246673|469387167|FG000|Overall Study|Sponsor Decision|1|||
130387053|NCT02246673|469387168|FG001|Overall Study|Sponsor Decision|0|||
130387054|NCT02246673|469387169|FG002|Overall Study|Sponsor Decision|0|||
130387055|NCT02246673|469387170|FG003|Overall Study|Sponsor Decision|0|||
130469471|NCT02590432|469683656|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130469472|NCT02590432|469683657|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
130559771|NCT01849497|470017873|FG000|Overall Study|Lost to Follow-up|0|||
130559772|NCT01849497|470017874|FG001|Overall Study|Lost to Follow-up|1|||
130387056|NCT02246673|469387171|FG004|Overall Study|Sponsor Decision|0|||
130387057|NCT02246673|469387167|FG000|Overall Study|Withdrawal by Subject|0|||
130387058|NCT02246673|469387168|FG001|Overall Study|Withdrawal by Subject|0|||
130387059|NCT02246673|469387169|FG002|Overall Study|Withdrawal by Subject|0|||
130469473|NCT02590432|469683658|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
130469474|NCT02590432|469683659|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
130469475|NCT02590432|469683660|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
130469476|NCT02590432|469683661|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
130469477|NCT02590432|469683662|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
130469478|NCT02590432|469683654|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
130469479|NCT02590432|469683655|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
130469480|NCT02590432|469683656|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
130469481|NCT02590432|469683657|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
130469482|NCT02590432|469683658|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
130469483|NCT02590432|469683659|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
130469484|NCT02590432|469683660|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
130469485|NCT02590432|469683661|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
130469486|NCT02590432|469683662|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
130469487|NCT02590432|469683654|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130469488|NCT02590432|469683655|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130469489|NCT02590432|469683656|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130469490|NCT02590432|469683657|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130469491|NCT02590432|469683658|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
130469492|NCT02590432|469683659|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
130469493|NCT02590432|469683660|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
130469494|NCT02590432|469683661|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
130469495|NCT02590432|469683662|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
130469496|NCT02590432|469683654|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469497|NCT02590432|469683655|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469498|NCT02590432|469683656|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469499|NCT02590432|469683657|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469500|NCT02590432|469683658|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469501|NCT02590432|469683659|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
130469502|NCT02590432|469683660|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469503|NCT02590432|469683661|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469504|NCT02590432|469683662|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130469505|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130469506|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130387060|NCT02246673|469387170|FG003|Overall Study|Withdrawal by Subject|0|||
130387061|NCT02246673|469387171|FG004|Overall Study|Withdrawal by Subject|1|||
130387062|NCT02246673|469387167|FG000|Overall Study|Lost to Follow-up|0|||
130387063|NCT02246673|469387168|FG001|Overall Study|Lost to Follow-up|0|||
130387064|NCT02246673|469387169|FG002|Overall Study|Lost to Follow-up|0|||
130387065|NCT02246673|469387170|FG003|Overall Study|Lost to Follow-up|1|||
130387066|NCT02246673|469387171|FG004|Overall Study|Lost to Follow-up|0|||
130387067|NCT02246673|469387167|FG000|Overall Study|Protocol Violation|0|||
130387068|NCT02246673|469387168|FG001|Overall Study|Protocol Violation|0|||
130387069|NCT02246673|469387169|FG002|Overall Study|Protocol Violation|0|||
130387070|NCT02246673|469387170|FG003|Overall Study|Protocol Violation|1|||
130387071|NCT02246673|469387171|FG004|Overall Study|Protocol Violation|0|||
130387072|NCT05413369|469387176|FG000|Overall Study|Adverse Event|1|||
130387073|NCT05413369|469387177|FG001|Overall Study|Adverse Event|1|||
130387074|NCT05413369|469387176|FG000|Overall Study|Withdrawal by Subject|13|||
130387075|NCT05413369|469387177|FG001|Overall Study|Withdrawal by Subject|4|||
130387076|NCT05413369|469387176|FG000|Overall Study|Non-compliance with study schedule|2|||
130387077|NCT05413369|469387177|FG001|Overall Study|Non-compliance with study schedule|1|||
130387078|NCT05413369|469387176|FG000|Overall Study|Other|1|||
130387079|NCT05413369|469387177|FG001|Overall Study|Other|1|||
130387080|NCT00720057|469387178|FG000|Overall Study|Lost to Follow-up|0|||
130387081|NCT00720057|469387179|FG001|Overall Study|Lost to Follow-up|2|||
130387082|NCT00720057|469387178|FG000|Overall Study|Protocol Violation|1|||
130387083|NCT00720057|469387179|FG001|Overall Study|Protocol Violation|0|||
130387084|NCT00720057|469387178|FG000|Overall Study|Withdrawal by Subject|0|||
130387085|NCT00720057|469387179|FG001|Overall Study|Withdrawal by Subject|1|||
130387086|NCT01679002|469387183|FG000|Overall Study|Adverse Event|1|||
130387087|NCT01679002|469387184|FG001|Overall Study|Adverse Event|1|||
130469507|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130469508|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130469509|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130469510|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130387088|NCT01679002|469387185|FG002|Overall Study|Adverse Event|0|||
130387089|NCT01179477|469387189|FG000|Overall Study|Death|542|||
130387090|NCT01179477|469387189|FG000|Overall Study|Unsuccessful implant|80|||
130387091|NCT01179477|469387189|FG000|Overall Study|Non-death withdrawal|438|||
130387092|NCT01179477|469387189|FG000|Overall Study|Did not complete final visit|27|||
130387093|NCT00975481|469387196|FG000|Second Intervention Period|Adverse Event|2|||
130387094|NCT00975481|469387197|FG001|Second Intervention Period|Adverse Event|1|||
130387095|NCT00975481|469387198|FG002|Second Intervention Period|Adverse Event|0|||
130387096|NCT00975481|469387199|FG003|Second Intervention Period|Adverse Event|0|||
130387097|NCT00975481|469387200|FG004|Second Intervention Period|Adverse Event|0|||
130387098|NCT00975481|469387201|FG005|Second Intervention Period|Adverse Event|0|||
130387099|NCT00975481|469387196|FG000|Second Intervention Period|Withdrawal by Subject|0|||
130387100|NCT00975481|469387197|FG001|Second Intervention Period|Withdrawal by Subject|0|||
130387101|NCT00975481|469387198|FG002|Second Intervention Period|Withdrawal by Subject|1|||
130387102|NCT00975481|469387199|FG003|Second Intervention Period|Withdrawal by Subject|0|||
130387103|NCT00975481|469387200|FG004|Second Intervention Period|Withdrawal by Subject|0|||
130387104|NCT00975481|469387201|FG005|Second Intervention Period|Withdrawal by Subject|0|||
130387105|NCT00975481|469387196|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
130387106|NCT00975481|469387197|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
130387107|NCT00975481|469387198|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
130387108|NCT00975481|469387199|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
130387109|NCT00975481|469387200|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
130387110|NCT00975481|469387201|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
130387111|NCT00975481|469387196|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
130387112|NCT00975481|469387197|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
130387113|NCT00975481|469387198|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
130387114|NCT00975481|469387199|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
130387115|NCT00975481|469387200|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
130387116|NCT00975481|469387201|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
130387117|NCT00643682|469387202|FG000|Overall Study|did not keep appointment|522|||
130387118|NCT00643682|469387203|FG001|Overall Study|did not keep appointment|509|||
130387119|NCT03630120|469387207|FG000|Overall Study|Disease progression|0|||
130387120|NCT03630120|469387208|FG001|Overall Study|Disease progression|1|||
130387121|NCT03630120|469387209|FG002|Overall Study|Disease progression|1|||
130387122|NCT03630120|469387210|FG003|Overall Study|Disease progression|1|||
130387123|NCT03755414|469387212|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
130387124|NCT03755414|469387213|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
130387125|NCT03755414|469387214|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
130387126|NCT03755414|469387212|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
130387127|NCT03755414|469387213|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
130387128|NCT03755414|469387214|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
130387129|NCT03755414|469387212|FG000|Overall Study|Non-compliance|0|||
130387130|NCT03755414|469387213|FG001|Overall Study|Non-compliance|1|||
130387131|NCT03755414|469387214|FG002|Overall Study|Non-compliance|0|||
130387132|NCT00281684|469387215|FG000|Overall Study|Lost to Follow-up|0|||
130387133|NCT00281684|469387216|FG001|Overall Study|Lost to Follow-up|0|||
130387134|NCT00281684|469387217|FG002|Overall Study|Lost to Follow-up|1|||
130387135|NCT00281684|469387218|FG003|Overall Study|Lost to Follow-up|0|||
130387136|NCT00281684|469387215|FG000|Overall Study|Withdrawal by Subject|1|||
130387137|NCT00281684|469387216|FG001|Overall Study|Withdrawal by Subject|0|||
130387138|NCT00281684|469387217|FG002|Overall Study|Withdrawal by Subject|0|||
130387139|NCT00281684|469387218|FG003|Overall Study|Withdrawal by Subject|0|||
130387140|NCT03642717|469387221|FG000|Overall Study|Lost to Follow-up|2|||
130387141|NCT03642717|469387221|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
130387142|NCT03642717|469387221|FG000|Overall Study|Taken study drug prior to contract date|3|||
130387143|NCT00302458|469387222|FG000|Overall Study|Lost to Follow-up|1|||
130387144|NCT00302458|469387222|FG000|Overall Study|Ineligible after screening|1|||
130387145|NCT00302458|469387222|FG000|Overall Study|Withdrawal by Subject|1|||
130387146|NCT00946712|469387223|FG000|Overall Study|Adverse Event|118|||
130387147|NCT00946712|469387224|FG001|Overall Study|Adverse Event|124|||
130387148|NCT00946712|469387223|FG000|Overall Study|Disease progression|308|||
130387149|NCT00946712|469387224|FG001|Overall Study|Disease progression|404|||
130387150|NCT00946712|469387223|FG000|Overall Study|Death|21|||
130387151|NCT00946712|469387224|FG001|Overall Study|Death|22|||
130387152|NCT00946712|469387223|FG000|Overall Study|No treatment given|25|||
130387153|NCT00946712|469387224|FG001|Overall Study|No treatment given|29|||
130387154|NCT00946712|469387223|FG000|Overall Study|Other reasons|61|||
130387155|NCT00946712|469387224|FG001|Overall Study|Other reasons|73|||
130387156|NCT00946712|469387223|FG000|Overall Study|On Treatment|0|||
130387157|NCT00946712|469387224|FG001|Overall Study|On Treatment|4|||
130387158|NCT00946712|469387223|FG000|Overall Study|Ineligible|14|||
130387159|NCT00946712|469387224|FG001|Overall Study|Ineligible|6|||
130387160|NCT01531387|469387227|FG000|Overall Study|Early termination of study|11|||
130387161|NCT01531387|469387228|FG001|Overall Study|Early termination of study|11|||
130387162|NCT02642432|469387231|FG000|Overall Study|Adverse Event|2|||
130387163|NCT02642432|469387231|FG000|Overall Study|Withdrew Consent|1|||
130387164|NCT02642432|469387231|FG000|Overall Study|Lost to Follow-up|2|||
130387165|NCT02642432|469387231|FG000|Overall Study|Other|3|||
130387166|NCT01848756|469387232|FG000|Overall Study|Adverse Event|1|||
130387167|NCT01848756|469387232|FG000|Overall Study|Withdrawal by Subject|1|||
130387168|NCT01848756|469387232|FG000|Overall Study|Enrolled in Error|1|||
130387169|NCT03245008|469387233|FG000|Overall Study|Adverse Event|15|||
130387170|NCT03245008|469387234|FG001|Overall Study|Adverse Event|18|||
130387171|NCT03245008|469387235|FG002|Overall Study|Adverse Event|15|||
130387172|NCT03245008|469387236|FG003|Overall Study|Adverse Event|0|||
130387173|NCT03245008|469387237|FG004|Overall Study|Adverse Event|1|||
130387174|NCT03245008|469387233|FG000|Overall Study|Lack of Efficacy|0|||
130387175|NCT03245008|469387234|FG001|Overall Study|Lack of Efficacy|1|||
130387176|NCT03245008|469387235|FG002|Overall Study|Lack of Efficacy|0|||
130387177|NCT03245008|469387236|FG003|Overall Study|Lack of Efficacy|0|||
130387178|NCT03245008|469387237|FG004|Overall Study|Lack of Efficacy|0|||
130387179|NCT03245008|469387233|FG000|Overall Study|Lost to Follow-up|4|||
130387180|NCT03245008|469387234|FG001|Overall Study|Lost to Follow-up|1|||
130387181|NCT03245008|469387235|FG002|Overall Study|Lost to Follow-up|0|||
130387182|NCT03245008|469387236|FG003|Overall Study|Lost to Follow-up|0|||
130387183|NCT03245008|469387237|FG004|Overall Study|Lost to Follow-up|1|||
130387184|NCT03245008|469387233|FG000|Overall Study|Physician Decision|1|||
130387185|NCT03245008|469387234|FG001|Overall Study|Physician Decision|3|||
130387186|NCT03245008|469387235|FG002|Overall Study|Physician Decision|4|||
130387187|NCT03245008|469387236|FG003|Overall Study|Physician Decision|0|||
130387188|NCT03245008|469387237|FG004|Overall Study|Physician Decision|0|||
130387189|NCT03245008|469387233|FG000|Overall Study|Protocol Violation|0|||
130387190|NCT03245008|469387234|FG001|Overall Study|Protocol Violation|1|||
130387191|NCT03245008|469387235|FG002|Overall Study|Protocol Violation|0|||
130387192|NCT03245008|469387236|FG003|Overall Study|Protocol Violation|0|||
130387193|NCT03245008|469387237|FG004|Overall Study|Protocol Violation|0|||
130387194|NCT03245008|469387233|FG000|Overall Study|Withdrawal by Subject|20|||
130387195|NCT03245008|469387234|FG001|Overall Study|Withdrawal by Subject|19|||
130387196|NCT03245008|469387235|FG002|Overall Study|Withdrawal by Subject|11|||
130387197|NCT03245008|469387236|FG003|Overall Study|Withdrawal by Subject|0|||
130387198|NCT03245008|469387237|FG004|Overall Study|Withdrawal by Subject|0|||
130387199|NCT03245008|469387233|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130387200|NCT03245008|469387234|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130387201|NCT03245008|469387235|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130387202|NCT03245008|469387236|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
130387203|NCT03245008|469387237|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
130387204|NCT03245008|469387233|FG000|Overall Study|Failure to meet randomization criteria|0|||
130387205|NCT03245008|469387234|FG001|Overall Study|Failure to meet randomization criteria|1|||
130469511|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130469512|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
130469513|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
130469514|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469515|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469516|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469517|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469518|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469519|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469520|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469521|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
130469522|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130469523|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469524|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469525|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469526|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469527|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469528|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469529|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
130469530|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
130469531|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
130469532|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130387206|NCT03245008|469387235|FG002|Overall Study|Failure to meet randomization criteria|0|||
130387207|NCT03245008|469387236|FG003|Overall Study|Failure to meet randomization criteria|1|||
130387208|NCT03245008|469387237|FG004|Overall Study|Failure to meet randomization criteria|0|||
130387209|NCT02075658|469387238|FG000|Overall Study|Physician Decision|2|||
130387210|NCT02075658|469387239|FG001|Overall Study|Physician Decision|2|||
130387211|NCT01498458|469387240|FG000|Overall Study|Adverse Event|4|||
130469533|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130559773|NCT02941926|470017875|FG000|Core Phase|Progressive disease|1109|||
130387212|NCT01498458|469387240|FG000|Overall Study|Physician Decision|3|||
130387213|NCT00718328|469387241|FG000|Overall Study|Lost to Follow-up|1|||
130387214|NCT00718328|469387242|FG001|Overall Study|Lost to Follow-up|0|||
130387215|NCT02865915|469387243|FG000|Overall Study|Pregnancy|1|||
130387216|NCT02865915|469387244|FG001|Overall Study|Pregnancy|0|||
130387217|NCT02865915|469387243|FG000|Overall Study|Withdrawal by Subject|1|||
130387218|NCT02865915|469387244|FG001|Overall Study|Withdrawal by Subject|1|||
130387219|NCT02865915|469387243|FG000|Overall Study|Adverse Event|0|||
130387220|NCT02865915|469387244|FG001|Overall Study|Adverse Event|4|||
130387221|NCT02865915|469387243|FG000|Overall Study|Lost to Follow-up|0|||
130387222|NCT02865915|469387244|FG001|Overall Study|Lost to Follow-up|1|||
130387223|NCT02865915|469387243|FG000|Overall Study|Protocol Violation|0|||
130387224|NCT02865915|469387244|FG001|Overall Study|Protocol Violation|1|||
130387225|NCT02865915|469387243|FG000|Overall Study|Study terminated by sponsor|23|||
130387226|NCT02865915|469387244|FG001|Overall Study|Study terminated by sponsor|18|||
130387227|NCT02865915|469387243|FG000|Overall Study|Dosing group discontinued|0|||
130387228|NCT02865915|469387244|FG001|Overall Study|Dosing group discontinued|5|||
130387229|NCT05760300|469387250|FG000|Overall Study|Adverse Event|0|||
130387230|NCT05760300|469387251|FG001|Overall Study|Adverse Event|0|||
130387231|NCT05760300|469387252|FG002|Overall Study|Adverse Event|1|||
130387232|NCT05760300|469387253|FG003|Overall Study|Adverse Event|0|||
130387233|NCT05760300|469387250|FG000|Overall Study|Participant Decision|1|||
130387234|NCT05760300|469387251|FG001|Overall Study|Participant Decision|0|||
130387235|NCT05760300|469387252|FG002|Overall Study|Participant Decision|0|||
130387236|NCT05760300|469387253|FG003|Overall Study|Participant Decision|0|||
130387237|NCT01581307|469387261|FG000|Overall Study|Withdrawal by Subject|1|||
130387238|NCT00378209|469387266|FG000|Overall Study|Progressive disease|11|||
130387239|NCT00378209|469387266|FG000|Overall Study|Adverse Event|3|||
130387240|NCT00378209|469387266|FG000|Overall Study|Initiation of non-protocol therapy|3|||
130387241|NCT00378209|469387266|FG000|Overall Study|Physician Decision|3|||
130387242|NCT00378209|469387266|FG000|Overall Study|Death|1|||
130387243|NCT00378209|469387266|FG000|Overall Study|Treatment delay|1|||
130387244|NCT01894581|469387267|FG000|Overall Study|Withdrawal by Subject|2|||
130387245|NCT01894581|469387268|FG001|Overall Study|Withdrawal by Subject|3|||
130387246|NCT01894581|469387267|FG000|Overall Study|Screen Failure|3|||
130387247|NCT01894581|469387268|FG001|Overall Study|Screen Failure|4|||
130387248|NCT03313804|469387272|FG000|Treatment|Death|5|||
130387249|NCT03313804|469387272|FG000|Treatment|still on treatment|2|||
130387250|NCT03313804|469387272|FG000|Follow Up|still on follow up|3|||
130387251|NCT03795298|469387273|FG000|Overall Study|Death|34|||
130387252|NCT03795298|469387274|FG001|Overall Study|Death|29|||
130387253|NCT03795298|469387273|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
130387254|NCT03795298|469387274|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
130387255|NCT03795298|469387273|FG000|Overall Study|Lost to Follow-up|28|||
130387256|NCT03795298|469387274|FG001|Overall Study|Lost to Follow-up|17|||
130387257|NCT03795298|469387273|FG000|Overall Study|Physician Decision|5|||
130387258|NCT03795298|469387274|FG001|Overall Study|Physician Decision|4|||
130387259|NCT03795298|469387273|FG000|Overall Study|Withdrawal by Subject|43|||
130387260|NCT03795298|469387274|FG001|Overall Study|Withdrawal by Subject|28|||
130387261|NCT03795298|469387273|FG000|Overall Study|Reason not reported|7|||
130387262|NCT03795298|469387274|FG001|Overall Study|Reason not reported|9|||
130387263|NCT01252940|469387275|FG000|Main Study Phase|Randomized but not treated|4|||
130387264|NCT01252940|469387276|FG001|Main Study Phase|Randomized but not treated|2|||
130387265|NCT01252940|469387275|FG000|Main Study Phase|Adverse Event|3|||
130387266|NCT01252940|469387276|FG001|Main Study Phase|Adverse Event|1|||
130387267|NCT01252940|469387275|FG000|Main Study Phase|Lack of Efficacy|1|||
130387268|NCT01252940|469387276|FG001|Main Study Phase|Lack of Efficacy|0|||
130387269|NCT01252940|469387275|FG000|Main Study Phase|Lost to Follow-up|6|||
130387270|NCT01252940|469387276|FG001|Main Study Phase|Lost to Follow-up|1|||
130387271|NCT01252940|469387275|FG000|Main Study Phase|Physician Decision|1|||
130387272|NCT01252940|469387276|FG001|Main Study Phase|Physician Decision|0|||
130387273|NCT01252940|469387275|FG000|Main Study Phase|Protocol Violation|4|||
130387274|NCT01252940|469387276|FG001|Main Study Phase|Protocol Violation|2|||
130387275|NCT01252940|469387275|FG000|Main Study Phase|Withdrawal by Subject|6|||
130387276|NCT01252940|469387276|FG001|Main Study Phase|Withdrawal by Subject|5|||
130387277|NCT01252940|469387275|FG000|Main Study Phase|Subject Non-compliance|1|||
130387278|NCT01252940|469387276|FG001|Main Study Phase|Subject Non-compliance|1|||
130387279|NCT01252940|469387275|FG000|Extension Phase|Adverse Event|2|||
130387280|NCT01252940|469387276|FG001|Extension Phase|Adverse Event|1|||
130387281|NCT01252940|469387275|FG000|Extension Phase|Lack of Efficacy|1|||
130387282|NCT01252940|469387276|FG001|Extension Phase|Lack of Efficacy|0|||
130387283|NCT01252940|469387275|FG000|Extension Phase|Lost to Follow-up|5|||
130387284|NCT01252940|469387276|FG001|Extension Phase|Lost to Follow-up|0|||
130387285|NCT01252940|469387275|FG000|Extension Phase|Physician Decision|0|||
130387286|NCT01252940|469387276|FG001|Extension Phase|Physician Decision|1|||
130387287|NCT01252940|469387275|FG000|Extension Phase|Subject Non-compliance|1|||
130387288|NCT01252940|469387276|FG001|Extension Phase|Subject Non-compliance|0|||
130387289|NCT01252940|469387275|FG000|Extension Phase|Withdrawal by Subject|1|||
130722542|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Physician Decision|0|||
130387290|NCT01252940|469387276|FG001|Extension Phase|Withdrawal by Subject|1|||
130387291|NCT04814433|469387279|FG000|Overall Study|Survey not returned|4|||
130387292|NCT04814433|469387280|FG001|Overall Study|Survey not returned|8|||
130387293|NCT04814433|469387281|FG002|Overall Study|Survey not returned|4|||
130387294|NCT04814433|469387282|FG003|Overall Study|Survey not returned|5|||
130387295|NCT02496533|469387285|FG000|Overall Study|Lack of data on outcome|3|||
130387296|NCT02496533|469387286|FG001|Overall Study|Lack of data on outcome|0|||
130387297|NCT02496533|469387285|FG000|Overall Study|Patient did not complete all measures|0|||
130387298|NCT02496533|469387286|FG001|Overall Study|Patient did not complete all measures|4|||
130387299|NCT02496533|469387285|FG000|Overall Study|Late for radiologic testing|0|||
130387300|NCT02496533|469387286|FG001|Overall Study|Late for radiologic testing|2|||
130387301|NCT01816893|469387289|FG000|Washout Period|Withdrawal by Subject|2|||
130387302|NCT01816893|469387290|FG001|Washout Period|Withdrawal by Subject|0|||
130387303|NCT02016625|469388892|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
130387304|NCT02016625|469388893|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
130387305|NCT02016625|469388892|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
130387306|NCT02016625|469388893|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
130387307|NCT02016625|469388892|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
130387308|NCT02016625|469388893|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
130387309|NCT02155738|469388894|FG000|Overall Study|Missing critical information|1|||
130387310|NCT02155738|469388895|FG001|Overall Study|Missing critical information|0|||
130387311|NCT02155738|469388896|FG002|Overall Study|Missing critical information|0|||
130387312|NCT02155738|469388897|FG003|Overall Study|Missing critical information|1|||
130387313|NCT01190254|469388898|FG000|Overall Study|Adverse Event|3|||
130387314|NCT01190254|469388899|FG001|Overall Study|Adverse Event|6|||
130387315|NCT01190254|469388900|FG002|Overall Study|Adverse Event|8|||
130387316|NCT01190254|469388898|FG000|Overall Study|Lack of Efficacy|7|||
130722543|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Physician Decision|0|||
130387317|NCT01190254|469388899|FG001|Overall Study|Lack of Efficacy|4|||
130387318|NCT01190254|469388900|FG002|Overall Study|Lack of Efficacy|5|||
130387319|NCT01190254|469388898|FG000|Overall Study|Lost to Follow-up|4|||
130559774|NCT02941926|470017875|FG000|Core Phase|Adverse Event|504|||
130387320|NCT01190254|469388899|FG001|Overall Study|Lost to Follow-up|2|||
130387321|NCT01190254|469388900|FG002|Overall Study|Lost to Follow-up|0|||
130387322|NCT01190254|469388898|FG000|Overall Study|Withdrawal by Subject|4|||
130387323|NCT01190254|469388899|FG001|Overall Study|Withdrawal by Subject|5|||
130387324|NCT01190254|469388900|FG002|Overall Study|Withdrawal by Subject|7|||
130387325|NCT01190254|469388898|FG000|Overall Study|Protocol Violation|2|||
130387326|NCT01190254|469388899|FG001|Overall Study|Protocol Violation|0|||
130387327|NCT01190254|469388900|FG002|Overall Study|Protocol Violation|2|||
130387328|NCT01190254|469388898|FG000|Overall Study|Did not meet protocol eligibility|1|||
130387329|NCT01190254|469388899|FG001|Overall Study|Did not meet protocol eligibility|0|||
130387330|NCT01190254|469388900|FG002|Overall Study|Did not meet protocol eligibility|0|||
130387331|NCT02603809|469388901|FG000|Overall Study|Withdrawal by Subject|4|||
130387332|NCT02603809|469388902|FG001|Overall Study|Withdrawal by Subject|1|||
130387333|NCT02603809|469388903|FG002|Overall Study|Withdrawal by Subject|2|||
130387334|NCT02603809|469388904|FG003|Overall Study|Withdrawal by Subject|3|||
130387335|NCT02603809|469388905|FG004|Overall Study|Withdrawal by Subject|3|||
130387336|NCT02603809|469388906|FG005|Overall Study|Withdrawal by Subject|4|||
130387337|NCT02603809|469388901|FG000|Overall Study|Lost to Follow-up|2|||
130387338|NCT02603809|469388902|FG001|Overall Study|Lost to Follow-up|3|||
130387339|NCT02603809|469388903|FG002|Overall Study|Lost to Follow-up|1|||
130387340|NCT02603809|469388904|FG003|Overall Study|Lost to Follow-up|4|||
130387341|NCT02603809|469388905|FG004|Overall Study|Lost to Follow-up|2|||
130387342|NCT02603809|469388906|FG005|Overall Study|Lost to Follow-up|2|||
130387343|NCT02603809|469388901|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
130387344|NCT02603809|469388902|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
130387345|NCT02603809|469388903|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
130387346|NCT02603809|469388904|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
130387347|NCT02603809|469388905|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
130387348|NCT02603809|469388906|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
130387349|NCT02603809|469388901|FG000|Overall Study|Physician Decision|0|||
130387350|NCT02603809|469388902|FG001|Overall Study|Physician Decision|0|||
130387351|NCT02603809|469388903|FG002|Overall Study|Physician Decision|0|||
130387352|NCT02603809|469388904|FG003|Overall Study|Physician Decision|1|||
130387353|NCT02603809|469388905|FG004|Overall Study|Physician Decision|2|||
130387354|NCT02603809|469388906|FG005|Overall Study|Physician Decision|1|||
130387355|NCT02603809|469388901|FG000|Overall Study|Adverse Event|3|||
130559775|NCT02941926|470017875|FG000|Core Phase|Subject/guardian decision|127|||
130387356|NCT02603809|469388902|FG001|Overall Study|Adverse Event|0|||
130559776|NCT02941926|470017875|FG000|Core Phase|Physician Decision|112|||
130387357|NCT02603809|469388903|FG002|Overall Study|Adverse Event|2|||
130387358|NCT02603809|469388904|FG003|Overall Study|Adverse Event|2|||
130387359|NCT02603809|469388905|FG004|Overall Study|Adverse Event|1|||
130387360|NCT02603809|469388906|FG005|Overall Study|Adverse Event|1|||
130469534|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130469535|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130469536|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130722544|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Physician Decision|0|||
130722545|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Physician Decision|0|||
130387361|NCT02603809|469388901|FG000|Overall Study|Lack of Efficacy|0|||
130387362|NCT02603809|469388902|FG001|Overall Study|Lack of Efficacy|1|||
130387363|NCT02603809|469388903|FG002|Overall Study|Lack of Efficacy|0|||
130387364|NCT02603809|469388904|FG003|Overall Study|Lack of Efficacy|0|||
130387365|NCT02603809|469388905|FG004|Overall Study|Lack of Efficacy|0|||
130387366|NCT02603809|469388906|FG005|Overall Study|Lack of Efficacy|1|||
130387367|NCT04729127|469388907|FG000|Overall Study|Suspended/Terminated EI Services|4|||
130387368|NCT04729127|469388908|FG001|Overall Study|Suspended/Terminated EI Services|0|||
130387369|NCT04729127|469388909|FG002|Overall Study|Suspended/Terminated EI Services|4|||
130387370|NCT04729127|469388910|FG003|Overall Study|Suspended/Terminated EI Services|6|||
130387371|NCT04729127|469388911|FG004|Overall Study|Suspended/Terminated EI Services|0|||
130387372|NCT04729127|469388912|FG005|Overall Study|Suspended/Terminated EI Services|6|||
130387373|NCT04729127|469388913|FG006|Overall Study|Suspended/Terminated EI Services|2|||
130387374|NCT04729127|469388914|FG007|Overall Study|Suspended/Terminated EI Services|0|||
130387375|NCT04729127|469388915|FG008|Overall Study|Suspended/Terminated EI Services|2|||
130387376|NCT04729127|469388907|FG000|Overall Study|Withdrawal by Subject|1|||
130387377|NCT04729127|469388908|FG001|Overall Study|Withdrawal by Subject|0|||
130387378|NCT04729127|469388909|FG002|Overall Study|Withdrawal by Subject|1|||
130387379|NCT04729127|469388910|FG003|Overall Study|Withdrawal by Subject|0|||
130387380|NCT04729127|469388911|FG004|Overall Study|Withdrawal by Subject|0|||
130387381|NCT04729127|469388912|FG005|Overall Study|Withdrawal by Subject|0|||
130387382|NCT04729127|469388913|FG006|Overall Study|Withdrawal by Subject|0|||
130387383|NCT04729127|469388914|FG007|Overall Study|Withdrawal by Subject|0|||
130387384|NCT04729127|469388915|FG008|Overall Study|Withdrawal by Subject|0|||
130387385|NCT04729127|469388907|FG000|Overall Study|Switched Agency/Setting|1|||
130387386|NCT04729127|469388908|FG001|Overall Study|Switched Agency/Setting|0|||
130387387|NCT04729127|469388909|FG002|Overall Study|Switched Agency/Setting|1|||
130387388|NCT04729127|469388910|FG003|Overall Study|Switched Agency/Setting|1|||
130387389|NCT04729127|469388911|FG004|Overall Study|Switched Agency/Setting|0|||
130387390|NCT04729127|469388912|FG005|Overall Study|Switched Agency/Setting|1|||
130387391|NCT04729127|469388913|FG006|Overall Study|Switched Agency/Setting|1|||
130387392|NCT04729127|469388914|FG007|Overall Study|Switched Agency/Setting|0|||
130387393|NCT04729127|469388915|FG008|Overall Study|Switched Agency/Setting|1|||
130387394|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
130387395|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
130387396|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
130387397|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
130387398|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
130387399|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
130387400|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
130387401|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
130387402|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
130387403|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
130387404|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
130387405|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
130387406|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
130387407|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
130387408|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
130387409|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
130387410|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
130387411|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
130387412|NCT00887354|469388916|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
130387413|NCT00887354|469388917|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
130387414|NCT00887354|469388916|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
130387415|NCT00887354|469388917|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
130469537|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130469538|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130387416|NCT00887354|469388916|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
130387417|NCT00887354|469388917|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
130559777|NCT02941926|470017875|FG000|Core Phase|Death|46|||
130387418|NCT00887354|469388916|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
130387419|NCT00887354|469388917|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
130387420|NCT00887354|469388916|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
130387421|NCT00887354|469388917|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
130469539|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130469540|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
130469541|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469542|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469543|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469544|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469545|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469546|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469547|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469548|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
130469549|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
130469550|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469551|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469552|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469553|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469554|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469555|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469556|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469557|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
130469558|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
130469559|NCT02590432|469683654|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469560|NCT02590432|469683655|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469561|NCT02590432|469683656|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469562|NCT02590432|469683657|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469563|NCT02590432|469683658|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469564|NCT02590432|469683659|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469565|NCT02590432|469683660|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469566|NCT02590432|469683661|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
130469567|NCT02590432|469683662|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
130469568|NCT02006758|469683663|FG000|Overall Study|Protocol Violation|1|||
130469569|NCT02006758|469683663|FG000|Overall Study|Death|1|||
130469570|NCT02006758|469683663|FG000|Overall Study|Lost to Follow-up|4|||
130469571|NCT02006758|469683663|FG000|Overall Study|Withdrawal by Subject|4|||
130469572|NCT02006758|469683663|FG000|Overall Study|Procedurally excluded|1|||
130469573|NCT02006758|469683663|FG000|Overall Study|Other|2|||
130469574|NCT04788641|469683668|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
130469575|NCT04788641|469683669|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
130469576|NCT04788641|469683670|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
130559778|NCT02941926|470017875|FG000|Core Phase|Protocol deviation|34|||
130387422|NCT00887354|469388916|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
130387423|NCT00887354|469388917|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
130387424|NCT00192504|469388920|FG000|Overall Study|Lost to Follow-up|1|||
130387425|NCT00192504|469388921|FG001|Overall Study|Lost to Follow-up|0|||
130387426|NCT00192504|469388922|FG002|Overall Study|Lost to Follow-up|0|||
130387427|NCT00192504|469388923|FG003|Overall Study|Lost to Follow-up|0|||
130387428|NCT00192504|469388920|FG000|Overall Study|Dosing window missed|0|||
130387429|NCT00192504|469388921|FG001|Overall Study|Dosing window missed|0|||
130387430|NCT00192504|469388922|FG002|Overall Study|Dosing window missed|1|||
130387431|NCT00192504|469388923|FG003|Overall Study|Dosing window missed|0|||
130387432|NCT01139450|469388924|FG000|Overall Study|Withdrawal by Subject|7|||
130387433|NCT01139450|469388925|FG001|Overall Study|Withdrawal by Subject|10|||
130387434|NCT01139450|469388926|FG002|Overall Study|Withdrawal by Subject|13|||
130387435|NCT01139450|469388924|FG000|Overall Study|Lack of Efficacy|3|||
130387436|NCT01139450|469388925|FG001|Overall Study|Lack of Efficacy|1|||
130387437|NCT01139450|469388926|FG002|Overall Study|Lack of Efficacy|8|||
130387438|NCT01139450|469388924|FG000|Overall Study|Protocol Violation|6|||
130387439|NCT01139450|469388925|FG001|Overall Study|Protocol Violation|5|||
130387440|NCT01139450|469388926|FG002|Overall Study|Protocol Violation|2|||
130387441|NCT01139450|469388924|FG000|Overall Study|Lost to Follow-up|9|||
130387442|NCT01139450|469388925|FG001|Overall Study|Lost to Follow-up|7|||
130387443|NCT01139450|469388926|FG002|Overall Study|Lost to Follow-up|11|||
130387444|NCT01139450|469388924|FG000|Overall Study|Administrative|0|||
130387445|NCT01139450|469388925|FG001|Overall Study|Administrative|0|||
130387446|NCT01139450|469388926|FG002|Overall Study|Administrative|1|||
130387447|NCT01139450|469388924|FG000|Overall Study|Adverse Event|2|||
130387448|NCT01139450|469388925|FG001|Overall Study|Adverse Event|2|||
130387449|NCT01139450|469388926|FG002|Overall Study|Adverse Event|3|||
130387450|NCT00914810|469388935|FG000|Overall Study|Withdrawal by Subject|1|||
130387451|NCT00914810|469388936|FG001|Overall Study|Withdrawal by Subject|0|||
130722546|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
130387452|NCT00914810|469388935|FG000|Overall Study|Relocated out of state|1|||
130387453|NCT00914810|469388936|FG001|Overall Study|Relocated out of state|0|||
130387454|NCT00914810|469388935|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
130387455|NCT00914810|469388936|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
130387456|NCT05129488|469388937|FG000|Overall Study|Protocol Violation|3|||
130387457|NCT04782856|469388938|FG000|Overall Study|Withdrawal by Subject|0|||
130387458|NCT04782856|469388939|FG001|Overall Study|Withdrawal by Subject|1|||
130387459|NCT01465022|469388940|FG000|Overall Study|Lost to Follow-up|15|||
130387460|NCT01465022|469388941|FG001|Overall Study|Lost to Follow-up|14|||
130387461|NCT01465022|469388942|FG002|Overall Study|Lost to Follow-up|0|||
130387462|NCT01465022|469388940|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
130387463|NCT01465022|469388941|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
130387464|NCT01465022|469388942|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
130387465|NCT01465022|469388940|FG000|Overall Study|Not Randomized|0|||
130387466|NCT01465022|469388941|FG001|Overall Study|Not Randomized|0|||
130387467|NCT01465022|469388942|FG002|Overall Study|Not Randomized|70|||
130387468|NCT01327300|469388943|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
130387469|NCT01327300|469388944|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
130387470|NCT03257631|469388958|FG000|Overall Study|Death|1|||
130387471|NCT03257631|469388959|FG001|Overall Study|Death|0|||
130387472|NCT03257631|469388960|FG002|Overall Study|Death|1|||
130387473|NCT03257631|469388961|FG003|Overall Study|Death|1|||
130387474|NCT03257631|469388958|FG000|Overall Study|Progressive Disease|10|||
130387475|NCT03257631|469388959|FG001|Overall Study|Progressive Disease|9|||
130387476|NCT03257631|469388960|FG002|Overall Study|Progressive Disease|17|||
130387477|NCT03257631|469388961|FG003|Overall Study|Progressive Disease|8|||
130387478|NCT03257631|469388958|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130387479|NCT03257631|469388959|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130387480|NCT03257631|469388960|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130387481|NCT03257631|469388961|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
130387482|NCT03257631|469388958|FG000|Overall Study|Adverse Event|0|||
130387483|NCT03257631|469388959|FG001|Overall Study|Adverse Event|0|||
130387484|NCT03257631|469388960|FG002|Overall Study|Adverse Event|2|||
130387485|NCT03257631|469388961|FG003|Overall Study|Adverse Event|0|||
130387486|NCT02529137|469388962|FG000|Overall Study|Discontinuation for different reasons|8|||
130387487|NCT01290666|469388966|FG000|Overall Study|Lost to Follow-up|11|||
130387488|NCT01290666|469388966|FG000|Overall Study|Withdrawal by Subject|23|||
130387489|NCT01290666|469388966|FG000|Overall Study|Early Termination of Study|4|||
130387490|NCT03036098|469388967|FG000|Pre-Treatment|Other Reasons|1|||
130387491|NCT03036098|469388968|FG001|Pre-Treatment|Other Reasons|2|||
130387492|NCT03036098|469388969|FG002|Pre-Treatment|Other Reasons|0|||
130387493|NCT03036098|469388970|FG003|Pre-Treatment|Other Reasons|5|||
130387494|NCT03036098|469388967|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
130387495|NCT03036098|469388968|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
130387496|NCT03036098|469388969|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
130387497|NCT03036098|469388970|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
130387498|NCT03036098|469388967|FG000|Pre-Treatment|Withdrawal by Subject|1|||
130387499|NCT03036098|469388968|FG001|Pre-Treatment|Withdrawal by Subject|14|||
130387500|NCT03036098|469388969|FG002|Pre-Treatment|Withdrawal by Subject|0|||
130387501|NCT03036098|469388970|FG003|Pre-Treatment|Withdrawal by Subject|5|||
130387502|NCT03036098|469388967|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
130387503|NCT03036098|469388968|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
130387504|NCT03036098|469388969|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
130387505|NCT03036098|469388970|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
130387506|NCT03036098|469388967|FG000|Treatment|Disease Progression|130|||
130387507|NCT03036098|469388968|FG001|Treatment|Disease Progression|77|||
130387508|NCT03036098|469388969|FG002|Treatment|Disease Progression|168|||
130387509|NCT03036098|469388970|FG003|Treatment|Disease Progression|50|||
130387510|NCT03036098|469388967|FG000|Treatment|Study Drug Toxicity|95|||
130387511|NCT03036098|469388968|FG001|Treatment|Study Drug Toxicity|45|||
130387512|NCT03036098|469388969|FG002|Treatment|Study Drug Toxicity|26|||
130387513|NCT03036098|469388970|FG003|Treatment|Study Drug Toxicity|22|||
130387514|NCT03036098|469388967|FG000|Treatment|Death|9|||
130387515|NCT03036098|469388968|FG001|Treatment|Death|3|||
130387516|NCT03036098|469388969|FG002|Treatment|Death|1|||
130387517|NCT03036098|469388970|FG003|Treatment|Death|2|||
130387518|NCT03036098|469388967|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
130387519|NCT03036098|469388968|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
130387520|NCT03036098|469388969|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
130387521|NCT03036098|469388970|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
130559779|NCT02941926|470017875|FG000|Core Phase|Lost to Follow-up|8|||
130387522|NCT03036098|469388967|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
130387523|NCT03036098|469388968|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
130722547|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130469577|NCT04788641|469683671|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
130469578|NCT04788641|469683668|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
130469579|NCT04788641|469683669|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
130469580|NCT04788641|469683670|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
130469581|NCT04788641|469683671|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
130469582|NCT04788641|469683668|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
130469583|NCT04788641|469683669|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
130469584|NCT04788641|469683670|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
130469585|NCT04788641|469683671|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
130469586|NCT01250769|469683672|FG000|Overall Study|Withdrawal by Subject|0|||
130469587|NCT01250769|469683673|FG001|Overall Study|Withdrawal by Subject|1|||
130469588|NCT01250769|469683674|FG002|Overall Study|Withdrawal by Subject|1|||
130469589|NCT01250769|469683675|FG003|Overall Study|Withdrawal by Subject|0|||
130469590|NCT01250769|469683672|FG000|Overall Study|Adverse Event|0|||
130469591|NCT01250769|469683673|FG001|Overall Study|Adverse Event|0|||
130469592|NCT01250769|469683674|FG002|Overall Study|Adverse Event|1|||
130469593|NCT01250769|469683675|FG003|Overall Study|Adverse Event|0|||
130469594|NCT02740231|469683676|FG000|Overall Study|Withdrawal by Subject|1|||
130469595|NCT02740231|469683677|FG001|Overall Study|Withdrawal by Subject|1|||
130469596|NCT02740231|469683678|FG002|Overall Study|Withdrawal by Subject|1|||
130387524|NCT03036098|469388969|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
130387525|NCT03036098|469388970|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
130387526|NCT03036098|469388967|FG000|Treatment|Withdrawal by Subject|2|||
130387527|NCT03036098|469388968|FG001|Treatment|Withdrawal by Subject|9|||
130387528|NCT03036098|469388969|FG002|Treatment|Withdrawal by Subject|2|||
130387529|NCT03036098|469388970|FG003|Treatment|Withdrawal by Subject|4|||
130387530|NCT03036098|469388967|FG000|Treatment|Maximum Clinical Benefit|6|||
130387531|NCT03036098|469388968|FG001|Treatment|Maximum Clinical Benefit|1|||
130387532|NCT03036098|469388969|FG002|Treatment|Maximum Clinical Benefit|6|||
130387533|NCT03036098|469388970|FG003|Treatment|Maximum Clinical Benefit|10|||
130387534|NCT03036098|469388967|FG000|Treatment|Poor/Non Compliance|1|||
130387535|NCT03036098|469388968|FG001|Treatment|Poor/Non Compliance|2|||
130387536|NCT03036098|469388969|FG002|Treatment|Poor/Non Compliance|0|||
130387537|NCT03036098|469388970|FG003|Treatment|Poor/Non Compliance|1|||
130387538|NCT03036098|469388967|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
130387539|NCT03036098|469388968|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
130387540|NCT03036098|469388969|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
130387541|NCT03036098|469388970|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
130387542|NCT03036098|469388967|FG000|Treatment|Administrative Reason by Sponsor|1|||
130387543|NCT03036098|469388968|FG001|Treatment|Administrative Reason by Sponsor|0|||
130387544|NCT03036098|469388969|FG002|Treatment|Administrative Reason by Sponsor|2|||
130387545|NCT03036098|469388970|FG003|Treatment|Administrative Reason by Sponsor|1|||
130387546|NCT03036098|469388967|FG000|Treatment|Other Reasons|31|||
130387547|NCT03036098|469388968|FG001|Treatment|Other Reasons|5|||
130387548|NCT03036098|469388969|FG002|Treatment|Other Reasons|21|||
130387549|NCT03036098|469388970|FG003|Treatment|Other Reasons|8|||
130387550|NCT03036098|469388967|FG000|Treatment|Ongoing Treatment|0|||
130387551|NCT03036098|469388968|FG001|Treatment|Ongoing Treatment|0|||
130387552|NCT03036098|469388969|FG002|Treatment|Ongoing Treatment|23|||
130387553|NCT03036098|469388970|FG003|Treatment|Ongoing Treatment|0|||
130387554|NCT02063854|469388972|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
130387555|NCT02063854|469388973|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130469597|NCT02740231|469683679|FG003|Overall Study|Withdrawal by Subject|0|||
130469598|NCT02740231|469683676|FG000|Overall Study|Lack of Efficacy|0|||
130469599|NCT02740231|469683677|FG001|Overall Study|Lack of Efficacy|1|||
130469600|NCT02740231|469683678|FG002|Overall Study|Lack of Efficacy|0|||
130469601|NCT02740231|469683679|FG003|Overall Study|Lack of Efficacy|4|||
130469602|NCT02740231|469683676|FG000|Overall Study|Lost to Follow-up|1|||
130387556|NCT02063854|469388974|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
130387557|NCT02063854|469388975|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
130387558|NCT02063854|469388976|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
130387559|NCT02063854|469388977|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
130387560|NCT02063854|469388978|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
130469603|NCT02740231|469683677|FG001|Overall Study|Lost to Follow-up|3|||
130559780|NCT02941926|470017875|FG000|Core Phase|Technical problems|5|||
130387561|NCT02063854|469388972|FG000|Overall Study|Major Protocol Deviation|0|||
130387562|NCT02063854|469388973|FG001|Overall Study|Major Protocol Deviation|0|||
130387563|NCT02063854|469388974|FG002|Overall Study|Major Protocol Deviation|3|||
130387564|NCT02063854|469388975|FG003|Overall Study|Major Protocol Deviation|0|||
130469604|NCT02740231|469683678|FG002|Overall Study|Lost to Follow-up|0|||
130469605|NCT02740231|469683679|FG003|Overall Study|Lost to Follow-up|3|||
130469606|NCT02740231|469683676|FG000|Overall Study|Adverse Event|0|||
130559781|NCT02941926|470017875|FG000|Extension Phase|Physician Decision|155|||
130469607|NCT02740231|469683677|FG001|Overall Study|Adverse Event|1|||
130387565|NCT02063854|469388976|FG004|Overall Study|Major Protocol Deviation|0|||
130387566|NCT02063854|469388977|FG005|Overall Study|Major Protocol Deviation|0|||
130387567|NCT02063854|469388978|FG006|Overall Study|Major Protocol Deviation|0|||
130387568|NCT02063854|469388972|FG000|Overall Study|Voluntary Withdrawal|2|||
130387569|NCT02063854|469388973|FG001|Overall Study|Voluntary Withdrawal|0|||
130387570|NCT02063854|469388974|FG002|Overall Study|Voluntary Withdrawal|8|||
130387571|NCT02063854|469388975|FG003|Overall Study|Voluntary Withdrawal|1|||
130387572|NCT02063854|469388976|FG004|Overall Study|Voluntary Withdrawal|3|||
130387573|NCT02063854|469388977|FG005|Overall Study|Voluntary Withdrawal|6|||
130387574|NCT02063854|469388978|FG006|Overall Study|Voluntary Withdrawal|1|||
130387575|NCT02063854|469388972|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
130387576|NCT02063854|469388973|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
130387577|NCT02063854|469388974|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
130387578|NCT02063854|469388975|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
130387579|NCT02063854|469388976|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
130387580|NCT02063854|469388977|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
130387581|NCT02063854|469388978|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
130387582|NCT02063854|469388972|FG000|Overall Study|Reason Not Specified|1|||
130387583|NCT02063854|469388973|FG001|Overall Study|Reason Not Specified|0|||
130387584|NCT02063854|469388974|FG002|Overall Study|Reason Not Specified|0|||
130387585|NCT02063854|469388975|FG003|Overall Study|Reason Not Specified|0|||
130387586|NCT02063854|469388976|FG004|Overall Study|Reason Not Specified|0|||
130387587|NCT02063854|469388977|FG005|Overall Study|Reason Not Specified|0|||
130387588|NCT02063854|469388978|FG006|Overall Study|Reason Not Specified|0|||
130387589|NCT02063854|469388972|FG000|Overall Study|Did Not Receive Study Drug|0|||
130387590|NCT02063854|469388973|FG001|Overall Study|Did Not Receive Study Drug|0|||
130387591|NCT02063854|469388974|FG002|Overall Study|Did Not Receive Study Drug|0|||
130387592|NCT02063854|469388975|FG003|Overall Study|Did Not Receive Study Drug|0|||
130387593|NCT02063854|469388976|FG004|Overall Study|Did Not Receive Study Drug|0|||
130387594|NCT02063854|469388977|FG005|Overall Study|Did Not Receive Study Drug|1|||
130387595|NCT02063854|469388978|FG006|Overall Study|Did Not Receive Study Drug|0|||
130387596|NCT03538158|469388979|FG000|Overall Study|Lost to Follow-up|13|||
130387597|NCT03538158|469388980|FG001|Overall Study|Lost to Follow-up|7|||
130387598|NCT03538158|469388979|FG000|Overall Study|Withdrawal by Subject|2|||
130387599|NCT03538158|469388980|FG001|Overall Study|Withdrawal by Subject|1|||
130387600|NCT00772707|469388981|FG000|Overall Study|Withdrawn|3|||
130387601|NCT01454570|469388982|FG000|Overall Study|Withdrawal by Subject|2|||
130387602|NCT01454570|469388982|FG000|Overall Study|Screen Failure|7|||
130387603|NCT04356963|469388984|FG000|First Session|Withdrawal by Subject|1|||
130387604|NCT04356963|469388984|FG000|Second Session|Withdrawal by Subject|3|||
130387605|NCT04356963|469388984|FG000|Second Session|Lost to Follow-up|1|||
130387606|NCT04356963|469388984|FG000|Third Session|Lost to Follow-up|6|||
130387607|NCT04356963|469388984|FG000|Third Session|Withdrawal by Subject|1|||
130387608|NCT01176266|469388991|FG000|Overall Study|Death|6|||
130387609|NCT01176266|469388991|FG000|Overall Study|Withdrawal by Subject|3|||
130722548|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722549|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722550|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722551|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
130722552|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130387610|NCT05075850|469388992|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
130387611|NCT00271609|469388993|FG000|Overall Study|Adverse Event|11|||
130387612|NCT00271609|469388994|FG001|Overall Study|Adverse Event|3|||
130387613|NCT00271609|469388993|FG000|Overall Study|Withdrawal by Subject|2|||
130387614|NCT00271609|469388994|FG001|Overall Study|Withdrawal by Subject|0|||
130387615|NCT02188589|469388995|FG000|Overall Study|Withdrawal by Subject|5|||
130387616|NCT00741039|469388999|FG000|Overall Study|Patient non-compliance|2|||
130387617|NCT00741039|469389000|FG001|Overall Study|Patient non-compliance|0|||
130469608|NCT02740231|469683678|FG002|Overall Study|Adverse Event|0|||
130469609|NCT02740231|469683679|FG003|Overall Study|Adverse Event|1|||
130722553|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130469610|NCT02462759|469683680|FG000|Part 1: Double Blind|Death|1|||
130722554|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130387618|NCT00878709|469389001|FG000|Overall Study|Withdrawal by Subject|197|||
130387619|NCT00878709|469389002|FG001|Overall Study|Withdrawal by Subject|120|||
130387620|NCT00878709|469389001|FG000|Overall Study|Lost to Follow-up|35|||
130387621|NCT00878709|469389002|FG001|Overall Study|Lost to Follow-up|33|||
130387622|NCT00878709|469389001|FG000|Overall Study|Other Reasons|93|||
130387623|NCT00878709|469389002|FG001|Overall Study|Other Reasons|84|||
130387624|NCT01712854|469389003|FG000|Overall Study|Physician Decision|1|||
130387625|NCT00768300|469389008|FG000|Overall Study|Randomized but not treated|1|||
130387626|NCT00768300|469389009|FG001|Overall Study|Randomized but not treated|1|||
130469611|NCT02462759|469683681|FG001|Part 1: Double Blind|Death|0|||
130469612|NCT02462759|469683682|FG002|Part 1: Double Blind|Death|0|||
130469613|NCT00243503|469683683|FG000|Overall Study|Adverse Event|11|||
130387627|NCT00768300|469389008|FG000|Overall Study|Adverse Event|10|||
130387628|NCT00768300|469389009|FG001|Overall Study|Adverse Event|2|||
130387629|NCT00768300|469389008|FG000|Overall Study|Protocol Violation|6|||
130387630|NCT00768300|469389009|FG001|Overall Study|Protocol Violation|1|||
130387631|NCT00768300|469389008|FG000|Overall Study|Withdrawal by Subject|13|||
130387632|NCT00768300|469389009|FG001|Overall Study|Withdrawal by Subject|7|||
130387633|NCT00768300|469389008|FG000|Overall Study|Physician Decision|2|||
130387634|NCT00768300|469389009|FG001|Overall Study|Physician Decision|3|||
130387635|NCT00768300|469389008|FG000|Overall Study|Study discontinued by Sponsor|271|||
130387636|NCT00768300|469389009|FG001|Overall Study|Study discontinued by Sponsor|140|||
130387637|NCT00768300|469389008|FG000|Overall Study|Death|21|||
130387638|NCT00768300|469389009|FG001|Overall Study|Death|5|||
130387639|NCT00768300|469389008|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
130387640|NCT00768300|469389009|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
130387641|NCT00768300|469389008|FG000|Overall Study|Screen failure following randomization|1|||
130387642|NCT00768300|469389009|FG001|Overall Study|Screen failure following randomization|0|||
130387643|NCT00768300|469389008|FG000|Overall Study|Received lung transplant|1|||
130387644|NCT00768300|469389009|FG001|Overall Study|Received lung transplant|1|||
130387645|NCT00768300|469389008|FG000|Overall Study|Lost to Follow-up|0|||
130387646|NCT00768300|469389009|FG001|Overall Study|Lost to Follow-up|1|||
130387647|NCT00768300|469389008|FG000|Overall Study|Began prohibited concomitant medication|0|||
130387648|NCT00768300|469389009|FG001|Overall Study|Began prohibited concomitant medication|1|||
130387649|NCT00768300|469389008|FG000|Overall Study|Treated but never dosed with Study drug|1|||
130387650|NCT00768300|469389009|FG001|Overall Study|Treated but never dosed with Study drug|0|||
130387651|NCT00768300|469389008|FG000|Overall Study|Missing data|1|||
130387652|NCT00768300|469389009|FG001|Overall Study|Missing data|0|||
130387653|NCT00322842|469389012|FG000|Overall Study|Withdrawal by Subject|0|||
130387654|NCT00322842|469389013|FG001|Overall Study|Withdrawal by Subject|1|||
130387655|NCT00322842|469389012|FG000|Overall Study|Lost to Follow-up|0|||
130387656|NCT00322842|469389013|FG001|Overall Study|Lost to Follow-up|1|||
130387657|NCT00322842|469389012|FG000|Overall Study|Refused transplant|1|||
130387658|NCT00322842|469389013|FG001|Overall Study|Refused transplant|0|||
130387659|NCT00322842|469389012|FG000|Overall Study|Death|1|||
130387660|NCT00322842|469389013|FG001|Overall Study|Death|0|||
130387661|NCT02068222|469389016|FG000|Overall Study|Lost to Follow-up|1|||
130387662|NCT01782664|469389018|FG000|Overall Study|Adverse Event|2|||
130387663|NCT01782664|469389019|FG001|Overall Study|Adverse Event|2|||
130387664|NCT01782664|469389020|FG002|Overall Study|Adverse Event|2|||
130387665|NCT01782664|469389021|FG003|Overall Study|Adverse Event|2|||
130387666|NCT01782664|469389022|FG004|Overall Study|Adverse Event|0|||
130387667|NCT01782664|469389023|FG005|Overall Study|Adverse Event|0|||
130387668|NCT01782664|469389018|FG000|Overall Study|Lack of Efficacy|2|||
130387669|NCT01782664|469389019|FG001|Overall Study|Lack of Efficacy|0|||
130387670|NCT01782664|469389020|FG002|Overall Study|Lack of Efficacy|2|||
130387671|NCT01782664|469389021|FG003|Overall Study|Lack of Efficacy|2|||
130387672|NCT01782664|469389022|FG004|Overall Study|Lack of Efficacy|0|||
130387673|NCT01782664|469389023|FG005|Overall Study|Lack of Efficacy|0|||
130387674|NCT01782664|469389018|FG000|Overall Study|Protocol Violation|0|||
130387675|NCT01782664|469389019|FG001|Overall Study|Protocol Violation|1|||
130387676|NCT01782664|469389020|FG002|Overall Study|Protocol Violation|0|||
130387677|NCT01782664|469389021|FG003|Overall Study|Protocol Violation|1|||
130387678|NCT01782664|469389022|FG004|Overall Study|Protocol Violation|0|||
130387679|NCT01782664|469389023|FG005|Overall Study|Protocol Violation|0|||
130387680|NCT01782664|469389018|FG000|Overall Study|Withdrawal by Subject|2|||
130387681|NCT01782664|469389019|FG001|Overall Study|Withdrawal by Subject|2|||
130387682|NCT01782664|469389020|FG002|Overall Study|Withdrawal by Subject|0|||
130387683|NCT01782664|469389021|FG003|Overall Study|Withdrawal by Subject|0|||
130387684|NCT01782664|469389022|FG004|Overall Study|Withdrawal by Subject|0|||
130387685|NCT01782664|469389023|FG005|Overall Study|Withdrawal by Subject|0|||
130387686|NCT00651755|469389025|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
130387687|NCT00651755|469389026|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
130387688|NCT00651755|469389025|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
130387689|NCT00651755|469389026|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
130387690|NCT00624052|469389029|FG000|Overall Study|Adverse Event|7|||
130387691|NCT00624052|469389030|FG001|Overall Study|Adverse Event|6|||
130387692|NCT00624052|469389031|FG002|Overall Study|Adverse Event|0|||
130387693|NCT00624052|469389032|FG003|Overall Study|Adverse Event|3|||
130387694|NCT00624052|469389029|FG000|Overall Study|Lack of Efficacy|1|||
130387695|NCT00624052|469389030|FG001|Overall Study|Lack of Efficacy|1|||
130387696|NCT00624052|469389031|FG002|Overall Study|Lack of Efficacy|0|||
130387697|NCT00624052|469389032|FG003|Overall Study|Lack of Efficacy|0|||
130387698|NCT00624052|469389029|FG000|Overall Study|Lost to Follow-up|2|||
130387699|NCT00624052|469389030|FG001|Overall Study|Lost to Follow-up|3|||
130387700|NCT00624052|469389031|FG002|Overall Study|Lost to Follow-up|1|||
130387701|NCT00624052|469389032|FG003|Overall Study|Lost to Follow-up|0|||
130387702|NCT00624052|469389029|FG000|Overall Study|Non compliant with the protocol|2|||
130387703|NCT00624052|469389030|FG001|Overall Study|Non compliant with the protocol|1|||
130387704|NCT00624052|469389031|FG002|Overall Study|Non compliant with the protocol|1|||
130387705|NCT00624052|469389032|FG003|Overall Study|Non compliant with the protocol|1|||
130469614|NCT00243503|469683683|FG000|Overall Study|Withdrawal by Subject|1|||
130469615|NCT00243503|469683683|FG000|Overall Study|Lack of Efficacy|44|||
130469616|NCT00243503|469683683|FG000|Overall Study|Death|1|||
130469617|NCT00243503|469683683|FG000|Overall Study|Other|1|||
130469618|NCT01000480|469683687|FG000|Induction Phase|Adverse Event|2|||
130469619|NCT01000480|469683687|FG000|Induction Phase|Lost to Follow-up|1|||
130469620|NCT01000480|469683687|FG000|Induction Phase|Physician Decision|1|||
130469621|NCT01000480|469683687|FG000|Induction Phase|Entry Criteria Not Met|3|||
130469622|NCT01000480|469683687|FG000|Concurrent Therapy Phase|Adverse Event|4|||
130387706|NCT00624052|469389029|FG000|Overall Study|Consent withdrawn|3|||
130387707|NCT00624052|469389030|FG001|Overall Study|Consent withdrawn|1|||
130469623|NCT01000480|469683687|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
130469624|NCT01000480|469683687|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
130469625|NCT01000480|469683687|FG000|Concurrent Therapy Phase|Physician Decision|1|||
130469626|NCT04600752|469683692|FG000|Overall Study|Physician Decision|0|||
130469627|NCT04600752|469683693|FG001|Overall Study|Physician Decision|0|||
130469628|NCT04600752|469683694|FG002|Overall Study|Physician Decision|1|||
130469629|NCT04600752|469683692|FG000|Overall Study|Adverse Event|0|||
130469630|NCT04600752|469683693|FG001|Overall Study|Adverse Event|1|||
130469631|NCT04600752|469683694|FG002|Overall Study|Adverse Event|0|||
130469632|NCT04600752|469683692|FG000|Overall Study|Withdrawal by Subject|2|||
130469633|NCT04600752|469683693|FG001|Overall Study|Withdrawal by Subject|1|||
130469634|NCT04600752|469683694|FG002|Overall Study|Withdrawal by Subject|0|||
130469635|NCT04600752|469683692|FG000|Overall Study|Lack of Efficacy|1|||
130469636|NCT04600752|469683693|FG001|Overall Study|Lack of Efficacy|0|||
130469637|NCT04600752|469683694|FG002|Overall Study|Lack of Efficacy|0|||
130469638|NCT02374307|469683695|FG000|3-months Follow-up|Lost to Follow-up|1|||
130469639|NCT02374307|469683696|FG001|3-months Follow-up|Lost to Follow-up|2|||
130469640|NCT02374307|469683695|FG000|3-months Follow-up|Withdrawal by Subject|1|||
130469641|NCT02374307|469683696|FG001|3-months Follow-up|Withdrawal by Subject|4|||
130469642|NCT02374307|469683695|FG000|3-months Follow-up|Death|1|||
130469643|NCT02374307|469683696|FG001|3-months Follow-up|Death|2|||
130722555|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130722556|NCT02377427|470608321|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722557|NCT02377427|470608322|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722558|NCT02377427|470608323|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
130387708|NCT00624052|469389031|FG002|Overall Study|Consent withdrawn|1|||
130387709|NCT00624052|469389032|FG003|Overall Study|Consent withdrawn|0|||
130387710|NCT00624052|469389029|FG000|Overall Study|Changed job/ran out if meds|0|||
130387711|NCT00624052|469389030|FG001|Overall Study|Changed job/ran out if meds|2|||
130387712|NCT00624052|469389031|FG002|Overall Study|Changed job/ran out if meds|0|||
130387713|NCT00624052|469389032|FG003|Overall Study|Changed job/ran out if meds|0|||
130387714|NCT00698581|469389033|FG000|Overall Study|Lack of Efficacy|23|||
130387715|NCT00698581|469389034|FG001|Overall Study|Lack of Efficacy|11|||
130387716|NCT00698581|469389033|FG000|Overall Study|Withdrawal by Subject|6|||
130387717|NCT00698581|469389034|FG001|Overall Study|Withdrawal by Subject|0|||
130387718|NCT00698581|469389033|FG000|Overall Study|Other reason|9|||
130387719|NCT00698581|469389034|FG001|Overall Study|Other reason|1|||
130387720|NCT00698581|469389033|FG000|Overall Study|SAE, non-fatal|1|||
130387721|NCT00698581|469389034|FG001|Overall Study|SAE, non-fatal|0|||
130387722|NCT00698581|469389033|FG000|Overall Study|AE, non-serious non-fatal|4|||
130469644|NCT02374307|469683695|FG000|3-months Follow-up|Missed first follow-up|5|||
130387723|NCT00698581|469389034|FG001|Overall Study|AE, non-serious non-fatal|0|||
130387724|NCT00698581|469389033|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130469645|NCT02374307|469683696|FG001|3-months Follow-up|Missed first follow-up|1|||
130387725|NCT00698581|469389034|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130469646|NCT02374307|469683695|FG000|6-months Follow-up|Lost to Follow-up|1|||
130469647|NCT02374307|469683696|FG001|6-months Follow-up|Lost to Follow-up|2|||
130469648|NCT02374307|469683695|FG000|6-months Follow-up|Death|2|||
130469649|NCT02374307|469683696|FG001|6-months Follow-up|Death|1|||
130469650|NCT02374307|469683695|FG000|6-months Follow-up|Withdrawal by Subject|0|||
130469651|NCT02374307|469683696|FG001|6-months Follow-up|Withdrawal by Subject|3|||
130469652|NCT01747486|469683711|FG000|Stage 1|Physician Decision|3|||
130469653|NCT01747486|469683712|FG001|Stage 1|Physician Decision|0|||
130469654|NCT01747486|469683711|FG000|Stage 1|Withdrawal by Subject|4|||
130469655|NCT01747486|469683712|FG001|Stage 1|Withdrawal by Subject|3|||
130469656|NCT01747486|469683711|FG000|Stage 1|Disease progression|4|||
130469657|NCT01747486|469683712|FG001|Stage 1|Disease progression|9|||
130469658|NCT01747486|469683711|FG000|Stage 1|Death|1|||
130469659|NCT01747486|469683712|FG001|Stage 1|Death|1|||
130469660|NCT01747486|469683711|FG000|Stage 2|Physician Decision|2|||
130469661|NCT01747486|469683712|FG001|Stage 2|Physician Decision|0|||
130469662|NCT01747486|469683711|FG000|Stage 2|Withdrawal by Subject|1|||
130469663|NCT01747486|469683712|FG001|Stage 2|Withdrawal by Subject|0|||
130469664|NCT01747486|469683711|FG000|Stage 2|New Cancer Therapy|3|||
130387726|NCT00698581|469389033|FG000|Overall Study|AE of unknown type|1|||
130387727|NCT00698581|469389034|FG001|Overall Study|AE of unknown type|0|||
130387728|NCT01286012|469389035|FG000|Overall Study|Adverse Event|3|||
130387729|NCT01286012|469389036|FG001|Overall Study|Adverse Event|3|||
130387730|NCT01286012|469389035|FG000|Overall Study|Death|2|||
130387731|NCT01286012|469389036|FG001|Overall Study|Death|3|||
130387732|NCT01286012|469389035|FG000|Overall Study|Protocol Violation|1|||
130387733|NCT01286012|469389036|FG001|Overall Study|Protocol Violation|1|||
130387734|NCT01286012|469389035|FG000|Overall Study|Withdrawal by Subject|4|||
130387735|NCT01286012|469389036|FG001|Overall Study|Withdrawal by Subject|4|||
130387736|NCT01286012|469389035|FG000|Overall Study|Physician Decision|2|||
130387737|NCT01286012|469389036|FG001|Overall Study|Physician Decision|0|||
130387738|NCT01286012|469389035|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
130387739|NCT01286012|469389036|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
130387740|NCT00663052|469389040|FG000|Overall Study|Adverse Event|6|||
130387741|NCT00663052|469389041|FG001|Overall Study|Adverse Event|3|||
130387742|NCT00663052|469389040|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
130387743|NCT00663052|469389041|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130387744|NCT00663052|469389040|FG000|Overall Study|Protocol Violation|1|||
130387745|NCT00663052|469389041|FG001|Overall Study|Protocol Violation|0|||
130387746|NCT00663052|469389040|FG000|Overall Study|Withdrawal by Subject|2|||
130387747|NCT00663052|469389041|FG001|Overall Study|Withdrawal by Subject|5|||
130387748|NCT00663052|469389040|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
130387749|NCT00663052|469389041|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
130387750|NCT00663052|469389040|FG000|Overall Study|Other|0|||
130387751|NCT00663052|469389041|FG001|Overall Study|Other|1|||
130387752|NCT04690751|469389047|FG000|Overall Study|Protocol Violation|0|||
130387753|NCT04690751|469389048|FG001|Overall Study|Protocol Violation|1|||
130387754|NCT04690751|469389049|FG002|Overall Study|Protocol Violation|0|||
130387755|NCT04690751|469389050|FG003|Overall Study|Protocol Violation|1|||
130387756|NCT04690751|469389051|FG004|Overall Study|Protocol Violation|2|||
130387757|NCT04690751|469389052|FG005|Overall Study|Protocol Violation|0|||
130387758|NCT04690751|469389047|FG000|Overall Study|Adverse Event|0|||
130387759|NCT04690751|469389048|FG001|Overall Study|Adverse Event|0|||
130387760|NCT04690751|469389049|FG002|Overall Study|Adverse Event|1|||
130387761|NCT04690751|469389050|FG003|Overall Study|Adverse Event|0|||
130387762|NCT04690751|469389051|FG004|Overall Study|Adverse Event|0|||
130387763|NCT04690751|469389052|FG005|Overall Study|Adverse Event|0|||
130387764|NCT04690751|469389047|FG000|Overall Study|Positive urine drug screen test|0|||
130387765|NCT04690751|469389048|FG001|Overall Study|Positive urine drug screen test|0|||
130387766|NCT04690751|469389049|FG002|Overall Study|Positive urine drug screen test|0|||
130387767|NCT04690751|469389050|FG003|Overall Study|Positive urine drug screen test|0|||
130387768|NCT04690751|469389051|FG004|Overall Study|Positive urine drug screen test|1|||
130387769|NCT04690751|469389052|FG005|Overall Study|Positive urine drug screen test|0|||
130387770|NCT04364620|469389053|FG000|Overall Study|Disease Progression|20|||
130387771|NCT04364620|469389053|FG000|Overall Study|Adverse Event|5|||
130387772|NCT04364620|469389053|FG000|Overall Study|Physician Decision|4|||
130387773|NCT04364620|469389053|FG000|Overall Study|Death|3|||
130387774|NCT04364620|469389053|FG000|Overall Study|Other|2|||
130387775|NCT04364620|469389053|FG000|Overall Study|Withdrawal by Subject|1|||
130387776|NCT03971695|469390249|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387777|NCT03971695|469390250|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387778|NCT03971695|469390251|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387779|NCT03971695|469390252|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
130387780|NCT03971695|469390253|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
130387781|NCT03971695|469390254|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387782|NCT03971695|469390255|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387783|NCT03971695|469390256|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387784|NCT03971695|469390257|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
130387785|NCT03971695|469390258|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130387786|NCT03971695|469390259|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130387787|NCT03971695|469390260|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130387788|NCT03971695|469390261|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130387789|NCT02356783|469390264|FG000|Overall Study|Lost to Follow-up|1|||
130387790|NCT02356783|469390265|FG001|Overall Study|Lost to Follow-up|3|||
130387791|NCT01365507|469390266|FG000|Overall Study|Withdrawal Criteria|8|||
130387792|NCT01365507|469390267|FG001|Overall Study|Withdrawal Criteria|5|||
130387793|NCT01365507|469390266|FG000|Overall Study|Unclassified|1|||
130387794|NCT01365507|469390267|FG001|Overall Study|Unclassified|4|||
130387795|NCT03020823|469390270|FG000|Overall Study|Physician Decision|4|||
130387796|NCT03020823|469390270|FG000|Overall Study|Lack of Efficacy|4|||
130722559|NCT02377427|470608324|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130387797|NCT03020823|469390270|FG000|Overall Study|Adverse Event|2|||
130387798|NCT03739112|469390271|FG000|Overall Study|Adverse Event|2|||
130387799|NCT03739112|469390272|FG001|Overall Study|Adverse Event|2|||
130387800|NCT03739112|469390271|FG000|Overall Study|Withdrawal by Subject|38|||
130387801|NCT03739112|469390272|FG001|Overall Study|Withdrawal by Subject|19|||
130387802|NCT03739112|469390271|FG000|Overall Study|Lost to Follow-up|31|||
130387803|NCT03739112|469390272|FG001|Overall Study|Lost to Follow-up|33|||
130387804|NCT03739112|469390271|FG000|Overall Study|Protocol Deviation|12|||
130387805|NCT03739112|469390272|FG001|Overall Study|Protocol Deviation|9|||
130387806|NCT03739112|469390271|FG000|Overall Study|Physician Decision|1|||
130387807|NCT03739112|469390272|FG001|Overall Study|Physician Decision|0|||
130387808|NCT03739112|469390271|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
130387809|NCT03739112|469390272|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
130387810|NCT03739112|469390271|FG000|Overall Study|Site went on hold|65|||
130387811|NCT03739112|469390272|FG001|Overall Study|Site went on hold|67|||
130387812|NCT03739112|469390271|FG000|Overall Study|Other than specified|8|||
130387813|NCT03739112|469390272|FG001|Overall Study|Other than specified|5|||
130387814|NCT03739112|469390271|FG000|Overall Study|Randomized but not vaccinated|31|||
130387815|NCT03739112|469390272|FG001|Overall Study|Randomized but not vaccinated|25|||
130387816|NCT04307446|469390273|FG000|Overall Study|Lost to Follow-up|2|||
130387817|NCT04307446|469390274|FG001|Overall Study|Lost to Follow-up|0|||
130387818|NCT01652664|469390277|FG000|Overall Study|Treatment Failure|5|||
130387819|NCT01652664|469390278|FG001|Overall Study|Treatment Failure|1|||
130387820|NCT01652664|469390277|FG000|Overall Study|Inadequate IOP control|1|||
130387821|NCT01652664|469390278|FG001|Overall Study|Inadequate IOP control|0|||
130387822|NCT00297037|469390279|FG000|Overall Study|Withdrawal by Subject|2|||
130387823|NCT00297037|469390280|FG001|Overall Study|Withdrawal by Subject|0|||
130387824|NCT00464568|469390281|FG000|Overall Study|Adverse Event|2|||
130387825|NCT00405587|469390284|FG000|Overall Study|Death|0|||
130387826|NCT00405587|469390285|FG001|Overall Study|Death|0|||
130387827|NCT00405587|469390286|FG002|Overall Study|Death|0|||
130387828|NCT00405587|469390287|FG003|Overall Study|Death|1|||
130387829|NCT00405587|469390284|FG000|Overall Study|Disease Progression|22|||
130387830|NCT00405587|469390285|FG001|Overall Study|Disease Progression|23|||
130387831|NCT00405587|469390286|FG002|Overall Study|Disease Progression|21|||
130387832|NCT00405587|469390287|FG003|Overall Study|Disease Progression|17|||
130387833|NCT00405587|469390284|FG000|Overall Study|Physician Decision|3|||
130387834|NCT00405587|469390285|FG001|Overall Study|Physician Decision|2|||
130387835|NCT00405587|469390286|FG002|Overall Study|Physician Decision|0|||
130387836|NCT00405587|469390287|FG003|Overall Study|Physician Decision|0|||
130387837|NCT00405587|469390284|FG000|Overall Study|Adverse Event|1|||
130387838|NCT00405587|469390285|FG001|Overall Study|Adverse Event|0|||
130387839|NCT00405587|469390286|FG002|Overall Study|Adverse Event|0|||
130387840|NCT00405587|469390287|FG003|Overall Study|Adverse Event|0|||
130387841|NCT00405587|469390284|FG000|Overall Study|Lost to Follow-up|0|||
130387842|NCT00405587|469390285|FG001|Overall Study|Lost to Follow-up|1|||
130387843|NCT00405587|469390286|FG002|Overall Study|Lost to Follow-up|1|||
130387844|NCT00405587|469390287|FG003|Overall Study|Lost to Follow-up|0|||
130387845|NCT00405587|469390284|FG000|Overall Study|Radiation induced necrosis|0|||
130387846|NCT00405587|469390285|FG001|Overall Study|Radiation induced necrosis|1|||
130387847|NCT00405587|469390286|FG002|Overall Study|Radiation induced necrosis|0|||
130387848|NCT00405587|469390287|FG003|Overall Study|Radiation induced necrosis|0|||
130387849|NCT00405587|469390284|FG000|Overall Study|Withdrawal by Subject|0|||
130387850|NCT00405587|469390285|FG001|Overall Study|Withdrawal by Subject|0|||
130387851|NCT00405587|469390286|FG002|Overall Study|Withdrawal by Subject|0|||
130387852|NCT00405587|469390287|FG003|Overall Study|Withdrawal by Subject|2|||
130387853|NCT00405587|469390284|FG000|Overall Study|Participant not dosed|0|||
130387854|NCT00405587|469390285|FG001|Overall Study|Participant not dosed|1|||
130387855|NCT00405587|469390286|FG002|Overall Study|Participant not dosed|0|||
130387856|NCT00405587|469390287|FG003|Overall Study|Participant not dosed|0|||
130387857|NCT06027866|469390288|FG000|Overall Study|Withdrawal by Subject|2|||
130387858|NCT00930579|469390291|FG000|Overall Study|Withdrawal by Subject|1|||
130387859|NCT00930579|469390291|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
130387860|NCT00507442|469390292|FG000|Overall Study|Adverse Event|8|||
130387861|NCT00507442|469390293|FG001|Overall Study|Adverse Event|11|||
130387862|NCT00507442|469390294|FG002|Overall Study|Adverse Event|4|||
130387863|NCT00507442|469390295|FG003|Overall Study|Adverse Event|1|||
130387864|NCT00507442|469390292|FG000|Overall Study|Protocol Violation|0|||
130387865|NCT00507442|469390293|FG001|Overall Study|Protocol Violation|1|||
130387866|NCT00507442|469390294|FG002|Overall Study|Protocol Violation|0|||
130387867|NCT00507442|469390295|FG003|Overall Study|Protocol Violation|0|||
130387868|NCT00507442|469390292|FG000|Overall Study|Lost to Follow-up|0|||
130387869|NCT00507442|469390293|FG001|Overall Study|Lost to Follow-up|0|||
130387870|NCT00507442|469390294|FG002|Overall Study|Lost to Follow-up|1|||
130387871|NCT00507442|469390295|FG003|Overall Study|Lost to Follow-up|0|||
130387872|NCT00507442|469390292|FG000|Overall Study|Physician Decision|0|||
130387873|NCT00507442|469390293|FG001|Overall Study|Physician Decision|2|||
130387874|NCT00507442|469390294|FG002|Overall Study|Physician Decision|4|||
130387875|NCT00507442|469390295|FG003|Overall Study|Physician Decision|1|||
130387876|NCT00507442|469390292|FG000|Overall Study|Progressive Disease|2|||
130387877|NCT00507442|469390293|FG001|Overall Study|Progressive Disease|4|||
130387878|NCT00507442|469390294|FG002|Overall Study|Progressive Disease|2|||
130387879|NCT00507442|469390295|FG003|Overall Study|Progressive Disease|0|||
130387880|NCT00507442|469390292|FG000|Overall Study|Withdrawal by Subject|4|||
130387881|NCT00507442|469390293|FG001|Overall Study|Withdrawal by Subject|4|||
130387882|NCT00507442|469390294|FG002|Overall Study|Withdrawal by Subject|2|||
130387883|NCT00507442|469390295|FG003|Overall Study|Withdrawal by Subject|1|||
130387884|NCT00507442|469390292|FG000|Overall Study|Other|2|||
130387885|NCT00507442|469390293|FG001|Overall Study|Other|5|||
130387886|NCT00507442|469390294|FG002|Overall Study|Other|2|||
130387887|NCT00507442|469390295|FG003|Overall Study|Other|2|||
130387888|NCT02672423|469390296|FG000|Period 1|Adverse Event|0|||
130387889|NCT02672423|469390297|FG001|Period 1|Adverse Event|0|||
130387890|NCT02672423|469390298|FG002|Period 1|Adverse Event|0|||
130387891|NCT02672423|469390299|FG003|Period 1|Adverse Event|0|||
130387892|NCT02672423|469390300|FG004|Period 1|Adverse Event|1|||
130387893|NCT02672423|469390301|FG005|Period 1|Adverse Event|0|||
130387894|NCT02672423|469390302|FG006|Period 1|Adverse Event|0|||
130387895|NCT02672423|469390303|FG007|Period 1|Adverse Event|0|||
130387896|NCT02672423|469390304|FG008|Period 1|Adverse Event|0|||
130387897|NCT02672423|469390305|FG009|Period 1|Adverse Event|0|||
130387898|NCT02672423|469390296|FG000|Period 2|Withdrawal by Subject|0|||
130387899|NCT02672423|469390297|FG001|Period 2|Withdrawal by Subject|0|||
130387900|NCT02672423|469390298|FG002|Period 2|Withdrawal by Subject|1|||
130387901|NCT02672423|469390299|FG003|Period 2|Withdrawal by Subject|0|||
130387902|NCT02672423|469390300|FG004|Period 2|Withdrawal by Subject|0|||
130387903|NCT02672423|469390301|FG005|Period 2|Withdrawal by Subject|0|||
130387904|NCT02672423|469390302|FG006|Period 2|Withdrawal by Subject|0|||
130387905|NCT02672423|469390303|FG007|Period 2|Withdrawal by Subject|0|||
130387906|NCT02672423|469390304|FG008|Period 2|Withdrawal by Subject|0|||
130387907|NCT02672423|469390305|FG009|Period 2|Withdrawal by Subject|0|||
130387908|NCT02672423|469390296|FG000|Period 3|Withdrawal by Subject|0|||
130387909|NCT02672423|469390297|FG001|Period 3|Withdrawal by Subject|0|||
130387910|NCT02672423|469390298|FG002|Period 3|Withdrawal by Subject|0|||
130387911|NCT02672423|469390299|FG003|Period 3|Withdrawal by Subject|0|||
130387912|NCT02672423|469390300|FG004|Period 3|Withdrawal by Subject|0|||
130387913|NCT02672423|469390301|FG005|Period 3|Withdrawal by Subject|0|||
130387914|NCT02672423|469390302|FG006|Period 3|Withdrawal by Subject|0|||
130387915|NCT02672423|469390303|FG007|Period 3|Withdrawal by Subject|1|||
130387916|NCT02672423|469390304|FG008|Period 3|Withdrawal by Subject|0|||
130387917|NCT02672423|469390305|FG009|Period 3|Withdrawal by Subject|0|||
130387918|NCT02672423|469390296|FG000|Period 3|Physician Decision|0|||
130387919|NCT02672423|469390297|FG001|Period 3|Physician Decision|0|||
130387920|NCT02672423|469390298|FG002|Period 3|Physician Decision|0|||
130387921|NCT02672423|469390299|FG003|Period 3|Physician Decision|0|||
130387922|NCT02672423|469390300|FG004|Period 3|Physician Decision|0|||
130387923|NCT02672423|469390301|FG005|Period 3|Physician Decision|1|||
130387924|NCT02672423|469390302|FG006|Period 3|Physician Decision|0|||
130387925|NCT02672423|469390303|FG007|Period 3|Physician Decision|0|||
130387926|NCT02672423|469390304|FG008|Period 3|Physician Decision|0|||
130387927|NCT02672423|469390305|FG009|Period 3|Physician Decision|0|||
130387928|NCT00536107|469390309|FG000|Overall Study|Death|5|||
130387929|NCT00536107|469390310|FG001|Overall Study|Death|1|||
130469665|NCT01747486|469683712|FG001|Stage 2|New Cancer Therapy|0|||
130469666|NCT01747486|469683711|FG000|Stage 2|Disease Progression|3|||
130469667|NCT01747486|469683712|FG001|Stage 2|Disease Progression|0|||
130469668|NCT01771731|469683713|FG000|Overall Study|Physician Decision|1|||
130469669|NCT01771731|469683714|FG001|Overall Study|Physician Decision|0|||
130469670|NCT01771731|469683713|FG000|Overall Study|Protocol Violation|0|||
130387930|NCT00536107|469390309|FG000|Overall Study|Incorrect enrolment|1|||
130387931|NCT00536107|469390310|FG001|Overall Study|Incorrect enrolment|0|||
130469671|NCT01771731|469683714|FG001|Overall Study|Protocol Violation|1|||
130387932|NCT00536107|469390309|FG000|Overall Study|Withdrawal by Subject|0|||
130387933|NCT00536107|469390310|FG001|Overall Study|Withdrawal by Subject|1|||
130387934|NCT00536107|469390309|FG000|Overall Study|Study Termination|2|||
130469672|NCT01771731|469683713|FG000|Overall Study|Adverse event: Pain Crisis|1|||
130469673|NCT01771731|469683714|FG001|Overall Study|Adverse event: Pain Crisis|1|||
130469674|NCT00087139|469683715|FG000|Overall Study|Adverse Event|18|||
130722560|NCT02377427|470608325|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722561|NCT02342639|470608326|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
130387935|NCT00536107|469390310|FG001|Overall Study|Study Termination|4|||
130469675|NCT00087139|469683716|FG001|Overall Study|Adverse Event|17|||
130469676|NCT00087139|469683717|FG002|Overall Study|Adverse Event|13|||
130387936|NCT02410954|469390311|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
130387937|NCT02410954|469390312|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
130387938|NCT02410954|469390311|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
130387939|NCT02410954|469390312|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
130387940|NCT00949325|469390313|FG000|Overall Study|Adverse Event|0|||
130387941|NCT00949325|469390314|FG001|Overall Study|Adverse Event|2|||
130387942|NCT00949325|469390315|FG002|Overall Study|Adverse Event|0|||
130387943|NCT00791518|469390316|FG000|Overall Study|Protocol Violation|93|||
130387944|NCT01520363|469390317|FG000|Overall Study|Withdrawal by Subject|2|||
130387945|NCT01520363|469390318|FG001|Overall Study|Withdrawal by Subject|0|||
130387946|NCT05172544|469390319|FG000|Overall Study|Withdrawal by Subject|1|||
130387947|NCT05172544|469390320|FG001|Overall Study|Withdrawal by Subject|0|||
130387948|NCT05172544|469390321|FG002|Overall Study|Withdrawal by Subject|0|||
130387949|NCT05172544|469390319|FG000|Overall Study|Physician Decision|0|||
130387950|NCT05172544|469390320|FG001|Overall Study|Physician Decision|0|||
130387951|NCT05172544|469390321|FG002|Overall Study|Physician Decision|1|||
130387952|NCT04829318|469390322|FG000|Overall Study|Adverse Event|6|||
130387953|NCT04829318|469390322|FG000|Overall Study|Death|1|||
130387954|NCT04829318|469390322|FG000|Overall Study|Lost to Follow-up|1|||
130387955|NCT04829318|469390322|FG000|Overall Study|Physician Decision|1|||
130387956|NCT04829318|469390322|FG000|Overall Study|Withdrawal by Subject|19|||
130387957|NCT04829318|469390322|FG000|Overall Study|Site terminated by sponsor|1|||
130387958|NCT04829318|469390322|FG000|Overall Study|Sponsor decision|5|||
130387959|NCT04829318|469390322|FG000|Overall Study|Other|1|||
130387960|NCT00728130|469390323|FG000|Overall Study|Withdrawal by Subject|1|||
130387961|NCT00728130|469390323|FG000|Overall Study|Paperwork not completed in time|1|||
130387962|NCT00728130|469390323|FG000|Overall Study|Physician Decision|1|||
130387963|NCT02073279|469390326|FG000|Double-blind Period|Adverse Event|1|||
130387964|NCT02073279|469390327|FG001|Double-blind Period|Adverse Event|1|||
130387965|NCT02073279|469390326|FG000|Double-blind Period|Switched to another treatment|1|||
130387966|NCT02073279|469390327|FG001|Double-blind Period|Switched to another treatment|2|||
130387967|NCT02073279|469390326|FG000|Double-blind Period|Protocol Violation|0|||
130387968|NCT02073279|469390327|FG001|Double-blind Period|Protocol Violation|1|||
130387969|NCT02073279|469390326|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
130387970|NCT02073279|469390327|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
130387971|NCT02073279|469390326|FG000|Double-blind Period|Withdrawal by Subject|2|||
130387972|NCT02073279|469390327|FG001|Double-blind Period|Withdrawal by Subject|2|||
130387973|NCT02073279|469390326|FG000|Open-label Extension Period|Adverse Event|1|||
130387974|NCT02073279|469390327|FG001|Open-label Extension Period|Adverse Event|0|||
130559782|NCT02941926|470017875|FG000|Extension Phase|Progressive disease|115|||
130559783|NCT02941926|470017875|FG000|Extension Phase|Adverse Event|13|||
130559784|NCT02941926|470017875|FG000|Extension Phase|Subject/Guardian decision|12|||
130559785|NCT02941926|470017875|FG000|Extension Phase|Death|6|||
130387975|NCT02073279|469390326|FG000|Open-label Extension Period|Lack of Efficacy|1|||
130387976|NCT02073279|469390327|FG001|Open-label Extension Period|Lack of Efficacy|0|||
130559786|NCT00307333|470017876|FG000|Overall Study|Lost to Follow-up|11|||
130559787|NCT00307333|470017877|FG001|Overall Study|Lost to Follow-up|3|||
130559788|NCT00698932|470017878|FG000|Overall Study|Adverse Event|0|||
130559789|NCT00698932|470017879|FG001|Overall Study|Adverse Event|2|||
130559790|NCT00698932|470017878|FG000|Overall Study|Incorrect enrollment|0|||
130559791|NCT00698932|470017879|FG001|Overall Study|Incorrect enrollment|2|||
130559792|NCT00698932|470017878|FG000|Overall Study|Study specific discontinuation criteria|3|||
130559793|NCT00698932|470017879|FG001|Overall Study|Study specific discontinuation criteria|4|||
130559794|NCT00698932|470017878|FG000|Overall Study|Withdrawal by Subject|11|||
130559795|NCT00698932|470017879|FG001|Overall Study|Withdrawal by Subject|23|||
130559796|NCT00698932|470017878|FG000|Overall Study|Lost to Follow-up|6|||
130559797|NCT00698932|470017879|FG001|Overall Study|Lost to Follow-up|1|||
130559798|NCT00698932|470017878|FG000|Overall Study|Severe non-compliance to protocol|1|||
130559799|NCT00698932|470017879|FG001|Overall Study|Severe non-compliance to protocol|2|||
130387977|NCT02073279|469390326|FG000|Open-label Extension Period|Lost to Follow-up|0|||
130387978|NCT02073279|469390327|FG001|Open-label Extension Period|Lost to Follow-up|4|||
130387979|NCT02073279|469390326|FG000|Open-label Extension Period|Switched to another treatment|1|||
130387980|NCT02073279|469390327|FG001|Open-label Extension Period|Switched to another treatment|4|||
130387981|NCT02073279|469390326|FG000|Open-label Extension Period|Protocol Violation|0|||
130387982|NCT02073279|469390327|FG001|Open-label Extension Period|Protocol Violation|1|||
130387983|NCT02073279|469390326|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
130387984|NCT02073279|469390327|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
130387985|NCT02073279|469390326|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
130387986|NCT02073279|469390327|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
130387987|NCT01265849|469390333|FG000|Overall Study|Randomized//Treatment not initiated|1|||
130387988|NCT01265849|469390334|FG001|Overall Study|Randomized//Treatment not initiated|4|||
130387989|NCT01265849|469390335|FG002|Overall Study|Randomized//Treatment not initiated|0|||
130387990|NCT01265849|469390333|FG000|Overall Study|Physician Decision|1|||
130387991|NCT01265849|469390334|FG001|Overall Study|Physician Decision|2|||
130387992|NCT01265849|469390335|FG002|Overall Study|Physician Decision|0|||
130387993|NCT01265849|469390333|FG000|Overall Study|Lost to Follow-up|18|||
130387994|NCT01265849|469390334|FG001|Overall Study|Lost to Follow-up|15|||
130559800|NCT00698932|470017878|FG000|Overall Study|Safety reasons|0|||
130559801|NCT00698932|470017879|FG001|Overall Study|Safety reasons|2|||
130387995|NCT01265849|469390335|FG002|Overall Study|Lost to Follow-up|5|||
130387996|NCT01265849|469390333|FG000|Overall Study|Not otherwise specified|1|||
130387997|NCT01265849|469390334|FG001|Overall Study|Not otherwise specified|6|||
130387998|NCT01265849|469390335|FG002|Overall Study|Not otherwise specified|1|||
130387999|NCT01265849|469390333|FG000|Overall Study|Withdrawal by Subject|25|||
130388000|NCT01265849|469390334|FG001|Overall Study|Withdrawal by Subject|34|||
130388001|NCT01265849|469390335|FG002|Overall Study|Withdrawal by Subject|13|||
130388002|NCT03194321|469390337|FG000|Overall Study|Withdrawal by Subject|1|||
130388003|NCT03194321|469390337|FG000|Overall Study|Lost to Follow-up|1|||
130388004|NCT03194321|469390337|FG000|Overall Study|Travel for Follow-up|1|||
130388005|NCT03803774|469390338|FG000|Dose Escalation|Withdrawal by Subject|0|||
130388006|NCT03803774|469390339|FG001|Dose Escalation|Withdrawal by Subject|0|||
130388007|NCT03803774|469390340|FG002|Dose Escalation|Withdrawal by Subject|0|||
130388008|NCT03803774|469390341|FG003|Dose Escalation|Withdrawal by Subject|1|||
130388009|NCT03803774|469390342|FG004|Dose Escalation|Withdrawal by Subject|0|||
130388010|NCT00003641|469390345|FG000|Overall Study|Withdrawal by Subject|0|||
130388011|NCT00003641|469390346|FG001|Overall Study|Withdrawal by Subject|100|||
130388012|NCT00003641|469390345|FG000|Overall Study|Adverse Event|0|||
130388013|NCT00003641|469390346|FG001|Overall Study|Adverse Event|38|||
130388014|NCT00003641|469390345|FG000|Overall Study|Disease progression|0|||
130722562|NCT02342639|470608327|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
130722563|NCT02342639|470608326|FG000|Overall Study|Protocol Violation|0|||
130388015|NCT00003641|469390346|FG001|Overall Study|Disease progression|2|||
130388016|NCT00003641|469390345|FG000|Overall Study|Unknown/missing|0|||
130388017|NCT00003641|469390346|FG001|Overall Study|Unknown/missing|22|||
130388018|NCT00003641|469390345|FG000|Overall Study|Should not receive interferon therapy|2|||
130388019|NCT00003641|469390346|FG001|Overall Study|Should not receive interferon therapy|0|||
130388020|NCT00003641|469390345|FG000|Overall Study|Never started interferon|567|||
130388021|NCT00003641|469390346|FG001|Overall Study|Never started interferon|12|||
130388022|NCT02154581|469390347|FG000|Overall Study|Lost to Follow-up|7|||
130388023|NCT02154581|469390348|FG001|Overall Study|Lost to Follow-up|8|||
130388024|NCT03659916|469390349|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
130388025|NCT03659916|469390350|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
130388026|NCT03659916|469390351|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
130388027|NCT03659916|469390349|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
130388028|NCT03659916|469390350|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
130388029|NCT03659916|469390351|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
130388030|NCT03659916|469390349|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
130388031|NCT03659916|469390350|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
130388032|NCT03659916|469390351|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
130388033|NCT03659916|469390349|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
130388034|NCT03659916|469390350|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
130388035|NCT03659916|469390351|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
130388036|NCT03659916|469390349|FG000|Treatment Period (72 Weeks)|Other|1|||
130388037|NCT03659916|469390350|FG001|Treatment Period (72 Weeks)|Other|3|||
130388038|NCT03659916|469390351|FG002|Treatment Period (72 Weeks)|Other|9|||
130388039|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
130388040|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
130388041|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
130469677|NCT00087139|469683715|FG000|Overall Study|Death|2|||
130469678|NCT00087139|469683716|FG001|Overall Study|Death|1|||
130469679|NCT00087139|469683717|FG002|Overall Study|Death|0|||
130469680|NCT00087139|469683715|FG000|Overall Study|Withdrawal by Subject|3|||
130469681|NCT00087139|469683716|FG001|Overall Study|Withdrawal by Subject|2|||
130722564|NCT02342639|470608327|FG001|Overall Study|Protocol Violation|2|||
130388042|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
130469682|NCT00087139|469683717|FG002|Overall Study|Withdrawal by Subject|2|||
130722565|NCT02212379|470608328|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
130722566|NCT02212379|470608328|FG000|From Baseline to Week 48|Adverse Event|7|||
130388043|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
130388044|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
130469683|NCT00087139|469683715|FG000|Overall Study|Physician Decision|1|||
130469684|NCT00087139|469683716|FG001|Overall Study|Physician Decision|1|||
130469685|NCT00087139|469683717|FG002|Overall Study|Physician Decision|1|||
130469686|NCT00087139|469683715|FG000|Overall Study|Disease progression|9|||
130469687|NCT00087139|469683716|FG001|Overall Study|Disease progression|19|||
130722567|NCT02212379|470608328|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
130722568|NCT02212379|470608328|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
130388045|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
130388046|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
130388047|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
130388048|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
130722569|NCT02212379|470608328|FG000|From Week 48 to Week 96|Adverse Event|1|||
130722570|NCT02212379|470608328|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
130388049|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
130388050|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
130388051|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
130388052|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
130388053|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
130388054|NCT03659916|469390349|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
130388055|NCT03659916|469390350|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
130388056|NCT03659916|469390351|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
130388057|NCT03886220|469390352|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
130388058|NCT03886220|469390353|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
130388059|NCT03886220|469390352|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130388060|NCT03886220|469390353|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130388061|NCT03886220|469390352|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130388062|NCT03886220|469390353|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130388063|NCT03615105|469390356|FG000|Overall Study|Protocol Violation|1|||
130388064|NCT03615105|469390357|FG001|Overall Study|Protocol Violation|0|||
130388065|NCT03615105|469390358|FG002|Overall Study|Protocol Violation|0|||
130388066|NCT03615105|469390356|FG000|Overall Study|Death|0|||
130388067|NCT03615105|469390357|FG001|Overall Study|Death|2|||
130388068|NCT03615105|469390358|FG002|Overall Study|Death|0|||
130388069|NCT03482791|469390359|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
130388070|NCT03482791|469390360|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
130388071|NCT01344161|469390362|FG000|Overall Study|Lost to Follow-up|4|||
130388072|NCT01344161|469390363|FG001|Overall Study|Lost to Follow-up|1|||
130388073|NCT01344161|469390362|FG000|Overall Study|Pregnancy|0|||
130388074|NCT01344161|469390363|FG001|Overall Study|Pregnancy|1|||
130388075|NCT01344161|469390362|FG000|Overall Study|Protocol Violation|1|||
130388076|NCT01344161|469390363|FG001|Overall Study|Protocol Violation|1|||
130388077|NCT03759379|469393124|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
130388078|NCT03759379|469393125|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
130388079|NCT03759379|469393124|FG000|Treatment Period|Death|2|||
130388080|NCT03759379|469393125|FG001|Treatment Period|Death|3|||
130388081|NCT03759379|469393124|FG000|Treatment Period|Lost to Follow-up|1|||
130388082|NCT03759379|469393125|FG001|Treatment Period|Lost to Follow-up|0|||
130388083|NCT03759379|469393124|FG000|Treatment Period|Physician Decision|0|||
130388084|NCT03759379|469393125|FG001|Treatment Period|Physician Decision|1|||
130388085|NCT04579380|469393127|FG000|Overall Study|Death|9|||
130388086|NCT04579380|469393128|FG001|Overall Study|Death|22|||
130388087|NCT04579380|469393129|FG002|Overall Study|Death|22|||
130388088|NCT04579380|469393130|FG003|Overall Study|Death|17|||
130388089|NCT04579380|469393131|FG004|Overall Study|Death|6|||
130388090|NCT04579380|469393132|FG005|Overall Study|Death|21|||
130388091|NCT04579380|469393133|FG006|Overall Study|Death|10|||
130388092|NCT04579380|469393134|FG007|Overall Study|Death|11|||
130388093|NCT04579380|469393135|FG008|Overall Study|Death|25|||
130388094|NCT04579380|469393127|FG000|Overall Study|Withdrawal by Subject|0|||
130388095|NCT04579380|469393128|FG001|Overall Study|Withdrawal by Subject|3|||
130388096|NCT04579380|469393129|FG002|Overall Study|Withdrawal by Subject|4|||
130388097|NCT04579380|469393130|FG003|Overall Study|Withdrawal by Subject|0|||
130388098|NCT04579380|469393131|FG004|Overall Study|Withdrawal by Subject|1|||
130388099|NCT04579380|469393132|FG005|Overall Study|Withdrawal by Subject|2|||
130388100|NCT04579380|469393133|FG006|Overall Study|Withdrawal by Subject|0|||
130388101|NCT04579380|469393134|FG007|Overall Study|Withdrawal by Subject|1|||
130388102|NCT04579380|469393135|FG008|Overall Study|Withdrawal by Subject|2|||
130388103|NCT04579380|469393127|FG000|Overall Study|Ongoing|2|||
130388104|NCT04579380|469393128|FG001|Overall Study|Ongoing|6|||
130388105|NCT04579380|469393129|FG002|Overall Study|Ongoing|4|||
130388106|NCT04579380|469393130|FG003|Overall Study|Ongoing|8|||
130388107|NCT04579380|469393131|FG004|Overall Study|Ongoing|5|||
130388108|NCT04579380|469393132|FG005|Overall Study|Ongoing|8|||
130388109|NCT04579380|469393133|FG006|Overall Study|Ongoing|3|||
130388110|NCT04579380|469393134|FG007|Overall Study|Ongoing|19|||
130388111|NCT04579380|469393135|FG008|Overall Study|Ongoing|6|||
130469688|NCT00087139|469683717|FG002|Overall Study|Disease progression|12|||
130388112|NCT02967692|469393136|FG000|Overall Study|Progressive disease|3|||
130388113|NCT02967692|469393137|FG001|Overall Study|Progressive disease|15|||
130388114|NCT02967692|469393138|FG002|Overall Study|Progressive disease|114|||
130388115|NCT02967692|469393139|FG003|Overall Study|Progressive disease|151|||
130469689|NCT00087139|469683715|FG000|Overall Study|Ineligible|4|||
130469690|NCT00087139|469683716|FG001|Overall Study|Ineligible|7|||
130469691|NCT00087139|469683717|FG002|Overall Study|Ineligible|4|||
130388116|NCT02967692|469393136|FG000|Overall Study|Subject/guardian decision|1|||
130388117|NCT02967692|469393137|FG001|Overall Study|Subject/guardian decision|1|||
130388118|NCT02967692|469393138|FG002|Overall Study|Subject/guardian decision|14|||
130388119|NCT02967692|469393139|FG003|Overall Study|Subject/guardian decision|22|||
130388120|NCT02967692|469393136|FG000|Overall Study|Death|0|||
130469692|NCT00087139|469683715|FG000|Overall Study|Symptomatic deterioration|1|||
130469693|NCT00087139|469683716|FG001|Overall Study|Symptomatic deterioration|1|||
130388121|NCT02967692|469393137|FG001|Overall Study|Death|1|||
130388122|NCT02967692|469393138|FG002|Overall Study|Death|13|||
130388123|NCT02967692|469393139|FG003|Overall Study|Death|13|||
130388124|NCT02967692|469393136|FG000|Overall Study|Protocol deviation|1|||
130388125|NCT02967692|469393137|FG001|Overall Study|Protocol deviation|0|||
130388126|NCT02967692|469393138|FG002|Overall Study|Protocol deviation|1|||
130388127|NCT02967692|469393139|FG003|Overall Study|Protocol deviation|1|||
130388128|NCT02967692|469393136|FG000|Overall Study|Lost to Follow-up|0|||
130388129|NCT02967692|469393137|FG001|Overall Study|Lost to Follow-up|0|||
130388130|NCT02967692|469393138|FG002|Overall Study|Lost to Follow-up|1|||
130388131|NCT02967692|469393139|FG003|Overall Study|Lost to Follow-up|0|||
130388132|NCT02967692|469393136|FG000|Overall Study|Physician Decision|0|||
130388133|NCT02967692|469393137|FG001|Overall Study|Physician Decision|0|||
130388134|NCT02967692|469393138|FG002|Overall Study|Physician Decision|22|||
130388135|NCT02967692|469393139|FG003|Overall Study|Physician Decision|13|||
130388136|NCT02967692|469393136|FG000|Overall Study|Adverse Event|2|||
130388137|NCT02967692|469393137|FG001|Overall Study|Adverse Event|9|||
130388138|NCT02967692|469393138|FG002|Overall Study|Adverse Event|60|||
130388139|NCT02967692|469393139|FG003|Overall Study|Adverse Event|28|||
130388140|NCT02967692|469393136|FG000|Overall Study|Study terminated by sponsor|2|||
130388141|NCT02967692|469393137|FG001|Overall Study|Study terminated by sponsor|1|||
130388142|NCT02967692|469393138|FG002|Overall Study|Study terminated by sponsor|42|||
130388143|NCT02967692|469393139|FG003|Overall Study|Study terminated by sponsor|37|||
130388144|NCT01536379|469393140|FG000|Overall Study|Adverse Event|1|||
130388145|NCT01536379|469393141|FG001|Overall Study|Adverse Event|2|||
130388146|NCT01536379|469393140|FG000|Overall Study|Withdrawal by Subject|1|||
130388147|NCT01536379|469393141|FG001|Overall Study|Withdrawal by Subject|1|||
130388148|NCT00939809|469393147|FG000|Overall Study|Adverse Event|2|||
130388149|NCT00939809|469393147|FG000|Overall Study|Death|1|||
130388150|NCT04447417|469393148|FG000|Overall Study|Withdrawal by Subject|1|||
130388151|NCT04447417|469393149|FG001|Overall Study|Withdrawal by Subject|0|||
130388152|NCT04447417|469393148|FG000|Overall Study|Failure to meet inclusion criteria|1|||
130388153|NCT04447417|469393149|FG001|Overall Study|Failure to meet inclusion criteria|0|||
130388154|NCT04447417|469393148|FG000|Overall Study|Lost to Follow-up|1|||
130388155|NCT04447417|469393149|FG001|Overall Study|Lost to Follow-up|0|||
130388156|NCT00066066|469393150|FG000|Overall Study|Lost to Follow-up|6|||
130388157|NCT00066066|469393151|FG001|Overall Study|Lost to Follow-up|4|||
130388158|NCT00066066|469393152|FG002|Overall Study|Lost to Follow-up|7|||
130388159|NCT00066066|469393153|FG003|Overall Study|Lost to Follow-up|4|||
130388160|NCT00066066|469393154|FG004|Overall Study|Lost to Follow-up|3|||
130388161|NCT00066066|469393155|FG005|Overall Study|Lost to Follow-up|5|||
130388162|NCT02268409|469393156|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
130388163|NCT02268409|469393156|FG000|Overall Study|Death|1|||
130388164|NCT02268409|469393156|FG000|Overall Study|Lost to Follow-up|1|||
130388165|NCT02268409|469393156|FG000|Overall Study|Protocol Violation|3|||
130388166|NCT02268409|469393156|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
130388167|NCT02268409|469393156|FG000|Overall Study|Withdrawal by Subject|5|||
130388168|NCT00156533|469393160|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
130388169|NCT00156533|469393161|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
130388170|NCT00156533|469393162|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
130388171|NCT00156533|469393163|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
130388172|NCT00156533|469393160|FG000|Overall Study|Withdrawal by Subject|1|||
130388173|NCT00156533|469393161|FG001|Overall Study|Withdrawal by Subject|0|||
130388174|NCT00156533|469393162|FG002|Overall Study|Withdrawal by Subject|0|||
130388175|NCT00156533|469393163|FG003|Overall Study|Withdrawal by Subject|1|||
130388176|NCT00156533|469393160|FG000|Overall Study|Failed Screening|1|||
130388177|NCT00156533|469393161|FG001|Overall Study|Failed Screening|0|||
130388178|NCT00156533|469393162|FG002|Overall Study|Failed Screening|1|||
130388179|NCT00156533|469393163|FG003|Overall Study|Failed Screening|1|||
130388180|NCT02608268|469393164|FG000|Overall Study|Adverse Event|0|||
130388181|NCT02608268|469393165|FG001|Overall Study|Adverse Event|0|||
130388182|NCT02608268|469393166|FG002|Overall Study|Adverse Event|1|||
130388183|NCT02608268|469393167|FG003|Overall Study|Adverse Event|0|||
130388184|NCT02608268|469393168|FG004|Overall Study|Adverse Event|0|||
130388185|NCT02608268|469393169|FG005|Overall Study|Adverse Event|0|||
130388186|NCT02608268|469393170|FG006|Overall Study|Adverse Event|0|||
130388187|NCT02608268|469393171|FG007|Overall Study|Adverse Event|0|||
130388188|NCT02608268|469393172|FG008|Overall Study|Adverse Event|0|||
130388189|NCT02608268|469393173|FG009|Overall Study|Adverse Event|0|||
130388190|NCT02608268|469393174|FG010|Overall Study|Adverse Event|0|||
130388191|NCT02608268|469393175|FG011|Overall Study|Adverse Event|0|||
130388192|NCT02608268|469393176|FG012|Overall Study|Adverse Event|2|||
130388193|NCT02608268|469393177|FG013|Overall Study|Adverse Event|0|||
130388194|NCT02608268|469393178|FG014|Overall Study|Adverse Event|0|||
130388195|NCT02608268|469393179|FG015|Overall Study|Adverse Event|0|||
130388196|NCT02608268|469393180|FG016|Overall Study|Adverse Event|0|||
130388197|NCT02608268|469393181|FG017|Overall Study|Adverse Event|0|||
130388198|NCT02608268|469393182|FG018|Overall Study|Adverse Event|0|||
130388199|NCT02608268|469393183|FG019|Overall Study|Adverse Event|0|||
130388200|NCT02608268|469393184|FG020|Overall Study|Adverse Event|1|||
130388201|NCT02608268|469393185|FG021|Overall Study|Adverse Event|1|||
130388202|NCT02608268|469393186|FG022|Overall Study|Adverse Event|0|||
130388203|NCT02608268|469393187|FG023|Overall Study|Adverse Event|0|||
130388204|NCT02608268|469393188|FG024|Overall Study|Adverse Event|1|||
130388205|NCT02608268|469393189|FG025|Overall Study|Adverse Event|0|||
130388206|NCT02608268|469393190|FG026|Overall Study|Adverse Event|0|||
130388207|NCT02608268|469393191|FG027|Overall Study|Adverse Event|0|||
130388208|NCT02608268|469393192|FG028|Overall Study|Adverse Event|1|||
130388209|NCT02608268|469393193|FG029|Overall Study|Adverse Event|0|||
130388210|NCT02608268|469393164|FG000|Overall Study|Death|1|||
130388211|NCT02608268|469393165|FG001|Overall Study|Death|0|||
130388212|NCT02608268|469393166|FG002|Overall Study|Death|0|||
130388213|NCT02608268|469393167|FG003|Overall Study|Death|0|||
130388214|NCT02608268|469393168|FG004|Overall Study|Death|0|||
130388215|NCT02608268|469393169|FG005|Overall Study|Death|0|||
130388216|NCT02608268|469393170|FG006|Overall Study|Death|0|||
130388217|NCT02608268|469393171|FG007|Overall Study|Death|0|||
130388218|NCT02608268|469393172|FG008|Overall Study|Death|1|||
130388219|NCT02608268|469393173|FG009|Overall Study|Death|1|||
130388220|NCT02608268|469393174|FG010|Overall Study|Death|0|||
130388221|NCT02608268|469393175|FG011|Overall Study|Death|0|||
130388222|NCT02608268|469393176|FG012|Overall Study|Death|0|||
130388223|NCT02608268|469393177|FG013|Overall Study|Death|0|||
130388224|NCT02608268|469393178|FG014|Overall Study|Death|0|||
130388225|NCT02608268|469393179|FG015|Overall Study|Death|1|||
130388226|NCT02608268|469393180|FG016|Overall Study|Death|0|||
130388227|NCT02608268|469393181|FG017|Overall Study|Death|1|||
130388228|NCT02608268|469393182|FG018|Overall Study|Death|0|||
130388229|NCT02608268|469393183|FG019|Overall Study|Death|1|||
130388230|NCT02608268|469393184|FG020|Overall Study|Death|1|||
130388231|NCT02608268|469393185|FG021|Overall Study|Death|0|||
130388232|NCT02608268|469393186|FG022|Overall Study|Death|0|||
130388233|NCT02608268|469393187|FG023|Overall Study|Death|0|||
130388234|NCT02608268|469393188|FG024|Overall Study|Death|1|||
130388235|NCT02608268|469393189|FG025|Overall Study|Death|2|||
130388236|NCT02608268|469393190|FG026|Overall Study|Death|0|||
130388237|NCT02608268|469393191|FG027|Overall Study|Death|1|||
130388238|NCT02608268|469393192|FG028|Overall Study|Death|4|||
130388239|NCT02608268|469393193|FG029|Overall Study|Death|0|||
130388240|NCT02608268|469393164|FG000|Overall Study|Physician Decision|0|||
130388241|NCT02608268|469393165|FG001|Overall Study|Physician Decision|0|||
130388242|NCT02608268|469393166|FG002|Overall Study|Physician Decision|0|||
130388243|NCT02608268|469393167|FG003|Overall Study|Physician Decision|0|||
130388244|NCT02608268|469393168|FG004|Overall Study|Physician Decision|0|||
130388245|NCT02608268|469393169|FG005|Overall Study|Physician Decision|0|||
130388246|NCT02608268|469393170|FG006|Overall Study|Physician Decision|0|||
130388247|NCT02608268|469393171|FG007|Overall Study|Physician Decision|0|||
130388248|NCT02608268|469393172|FG008|Overall Study|Physician Decision|0|||
130388249|NCT02608268|469393173|FG009|Overall Study|Physician Decision|0|||
130388250|NCT02608268|469393174|FG010|Overall Study|Physician Decision|1|||
130388251|NCT02608268|469393175|FG011|Overall Study|Physician Decision|0|||
130388252|NCT02608268|469393176|FG012|Overall Study|Physician Decision|0|||
130388253|NCT02608268|469393177|FG013|Overall Study|Physician Decision|1|||
130388254|NCT02608268|469393178|FG014|Overall Study|Physician Decision|0|||
130388255|NCT02608268|469393179|FG015|Overall Study|Physician Decision|0|||
130388256|NCT02608268|469393180|FG016|Overall Study|Physician Decision|0|||
130388257|NCT02608268|469393181|FG017|Overall Study|Physician Decision|0|||
130388258|NCT02608268|469393182|FG018|Overall Study|Physician Decision|0|||
130388259|NCT02608268|469393183|FG019|Overall Study|Physician Decision|0|||
130388260|NCT02608268|469393184|FG020|Overall Study|Physician Decision|0|||
130388261|NCT02608268|469393185|FG021|Overall Study|Physician Decision|0|||
130388262|NCT02608268|469393186|FG022|Overall Study|Physician Decision|1|||
130388263|NCT02608268|469393187|FG023|Overall Study|Physician Decision|1|||
130388264|NCT02608268|469393188|FG024|Overall Study|Physician Decision|1|||
130388265|NCT02608268|469393189|FG025|Overall Study|Physician Decision|0|||
130388266|NCT02608268|469393190|FG026|Overall Study|Physician Decision|0|||
130388267|NCT02608268|469393191|FG027|Overall Study|Physician Decision|2|||
130388268|NCT02608268|469393192|FG028|Overall Study|Physician Decision|1|||
130388269|NCT02608268|469393193|FG029|Overall Study|Physician Decision|1|||
130388270|NCT02608268|469393164|FG000|Overall Study|Progressive disease|12|||
130388271|NCT02608268|469393165|FG001|Overall Study|Progressive disease|8|||
130388272|NCT02608268|469393166|FG002|Overall Study|Progressive disease|13|||
130388273|NCT02608268|469393167|FG003|Overall Study|Progressive disease|5|||
130388274|NCT02608268|469393168|FG004|Overall Study|Progressive disease|2|||
130388275|NCT02608268|469393169|FG005|Overall Study|Progressive disease|4|||
130388276|NCT02608268|469393170|FG006|Overall Study|Progressive disease|6|||
130388277|NCT02608268|469393171|FG007|Overall Study|Progressive disease|2|||
130388278|NCT02608268|469393172|FG008|Overall Study|Progressive disease|5|||
130388279|NCT02608268|469393173|FG009|Overall Study|Progressive disease|6|||
130388280|NCT02608268|469393174|FG010|Overall Study|Progressive disease|5|||
130722571|NCT02105974|470608329|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
130722572|NCT02105974|470608330|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130722573|NCT02105974|470608331|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130722574|NCT02105974|470608329|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
130388281|NCT02608268|469393175|FG011|Overall Study|Progressive disease|5|||
130388282|NCT02608268|469393176|FG012|Overall Study|Progressive disease|4|||
130388283|NCT02608268|469393177|FG013|Overall Study|Progressive disease|11|||
130388284|NCT02608268|469393178|FG014|Overall Study|Progressive disease|6|||
130388285|NCT02608268|469393179|FG015|Overall Study|Progressive disease|3|||
130388286|NCT02608268|469393180|FG016|Overall Study|Progressive disease|5|||
130388287|NCT02608268|469393181|FG017|Overall Study|Progressive disease|5|||
130388288|NCT02608268|469393182|FG018|Overall Study|Progressive disease|5|||
130388289|NCT02608268|469393183|FG019|Overall Study|Progressive disease|2|||
130388290|NCT02608268|469393184|FG020|Overall Study|Progressive disease|10|||
130388291|NCT02608268|469393185|FG021|Overall Study|Progressive disease|4|||
130388292|NCT02608268|469393186|FG022|Overall Study|Progressive disease|5|||
130388293|NCT02608268|469393187|FG023|Overall Study|Progressive disease|5|||
130388294|NCT02608268|469393188|FG024|Overall Study|Progressive disease|3|||
130388295|NCT02608268|469393189|FG025|Overall Study|Progressive disease|11|||
130388296|NCT02608268|469393190|FG026|Overall Study|Progressive disease|16|||
130388297|NCT02608268|469393191|FG027|Overall Study|Progressive disease|11|||
130388298|NCT02608268|469393192|FG028|Overall Study|Progressive disease|10|||
130388299|NCT02608268|469393193|FG029|Overall Study|Progressive disease|15|||
130388300|NCT02608268|469393164|FG000|Overall Study|Subject/guardian decision|1|||
130388301|NCT02608268|469393165|FG001|Overall Study|Subject/guardian decision|1|||
130388302|NCT02608268|469393166|FG002|Overall Study|Subject/guardian decision|2|||
130388303|NCT02608268|469393167|FG003|Overall Study|Subject/guardian decision|0|||
130388304|NCT02608268|469393168|FG004|Overall Study|Subject/guardian decision|0|||
130388305|NCT02608268|469393169|FG005|Overall Study|Subject/guardian decision|0|||
130388306|NCT02608268|469393170|FG006|Overall Study|Subject/guardian decision|0|||
130388307|NCT02608268|469393171|FG007|Overall Study|Subject/guardian decision|0|||
130388308|NCT02608268|469393172|FG008|Overall Study|Subject/guardian decision|2|||
130388309|NCT02608268|469393173|FG009|Overall Study|Subject/guardian decision|2|||
130388310|NCT02608268|469393174|FG010|Overall Study|Subject/guardian decision|0|||
130388311|NCT02608268|469393175|FG011|Overall Study|Subject/guardian decision|1|||
130388312|NCT02608268|469393176|FG012|Overall Study|Subject/guardian decision|0|||
130388313|NCT02608268|469393177|FG013|Overall Study|Subject/guardian decision|1|||
130388314|NCT02608268|469393178|FG014|Overall Study|Subject/guardian decision|0|||
130388315|NCT02608268|469393179|FG015|Overall Study|Subject/guardian decision|1|||
130388316|NCT02608268|469393180|FG016|Overall Study|Subject/guardian decision|0|||
130388317|NCT02608268|469393181|FG017|Overall Study|Subject/guardian decision|0|||
130388318|NCT02608268|469393182|FG018|Overall Study|Subject/guardian decision|1|||
130388319|NCT02608268|469393183|FG019|Overall Study|Subject/guardian decision|0|||
130388320|NCT02608268|469393184|FG020|Overall Study|Subject/guardian decision|0|||
130388321|NCT02608268|469393185|FG021|Overall Study|Subject/guardian decision|0|||
130388322|NCT02608268|469393186|FG022|Overall Study|Subject/guardian decision|1|||
130388323|NCT02608268|469393187|FG023|Overall Study|Subject/guardian decision|0|||
130388324|NCT02608268|469393188|FG024|Overall Study|Subject/guardian decision|0|||
130388325|NCT02608268|469393189|FG025|Overall Study|Subject/guardian decision|1|||
130388326|NCT02608268|469393190|FG026|Overall Study|Subject/guardian decision|1|||
130388327|NCT02608268|469393191|FG027|Overall Study|Subject/guardian decision|1|||
130388328|NCT02608268|469393192|FG028|Overall Study|Subject/guardian decision|1|||
130388329|NCT02608268|469393193|FG029|Overall Study|Subject/guardian decision|0|||
130388330|NCT03873987|469393194|FG000|Overall Study|Adverse Event|1|||
130388331|NCT03873987|469393195|FG001|Overall Study|Adverse Event|0|||
130388332|NCT03873987|469393194|FG000|Overall Study|staff was unable to start a new IV line|1|||
130388333|NCT03873987|469393195|FG001|Overall Study|staff was unable to start a new IV line|0|||
130388334|NCT03873987|469393194|FG000|Overall Study|Lost to Follow-up|0|||
130388335|NCT03873987|469393195|FG001|Overall Study|Lost to Follow-up|1|||
130722575|NCT02105974|470608330|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
130722576|NCT02105974|470608331|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
130388336|NCT02520011|469393197|FG000|Overall Study|Adverse Event|0|||
130388337|NCT02520011|469393198|FG001|Overall Study|Adverse Event|1|||
130722577|NCT02105974|470608329|FG000|2 Week Run-in Period|Adverse Event|6|||
130722578|NCT02105974|470608330|FG001|2 Week Run-in Period|Adverse Event|0|||
130388338|NCT02520011|469393199|FG002|Overall Study|Adverse Event|2|||
130388339|NCT02520011|469393197|FG000|Overall Study|Death|0|||
130388340|NCT02520011|469393198|FG001|Overall Study|Death|8|||
130388341|NCT02520011|469393199|FG002|Overall Study|Death|1|||
130722579|NCT02105974|470608331|FG002|2 Week Run-in Period|Adverse Event|0|||
130388342|NCT02520011|469393197|FG000|Overall Study|Lack of Efficacy|4|||
130388343|NCT02520011|469393198|FG001|Overall Study|Lack of Efficacy|26|||
130388344|NCT02520011|469393199|FG002|Overall Study|Lack of Efficacy|4|||
130388345|NCT02520011|469393197|FG000|Overall Study|Physician Decision|0|||
130388346|NCT02520011|469393198|FG001|Overall Study|Physician Decision|2|||
130388347|NCT02520011|469393199|FG002|Overall Study|Physician Decision|0|||
130388348|NCT02520011|469393197|FG000|Overall Study|Withdrawal by Subject|1|||
130469694|NCT00087139|469683717|FG002|Overall Study|Symptomatic deterioration|3|||
130469695|NCT00087139|469683715|FG000|Overall Study|Use of coumadin|1|||
130469696|NCT00087139|469683716|FG001|Overall Study|Use of coumadin|0|||
130469697|NCT00087139|469683717|FG002|Overall Study|Use of coumadin|0|||
130469698|NCT00087139|469683715|FG000|Overall Study|Response achieved|0|||
130469699|NCT00087139|469683716|FG001|Overall Study|Response achieved|1|||
130469700|NCT00087139|469683717|FG002|Overall Study|Response achieved|0|||
130469701|NCT00087139|469683715|FG000|Overall Study|Extradural disease|0|||
130388349|NCT02520011|469393198|FG001|Overall Study|Withdrawal by Subject|3|||
130388350|NCT02520011|469393199|FG002|Overall Study|Withdrawal by Subject|0|||
130388351|NCT02520011|469393197|FG000|Overall Study|Protocol Deviation|0|||
130388352|NCT02520011|469393198|FG001|Overall Study|Protocol Deviation|1|||
130388353|NCT02520011|469393199|FG002|Overall Study|Protocol Deviation|0|||
130388354|NCT02520011|469393197|FG000|Overall Study|Patient went to hospice|0|||
130388355|NCT02520011|469393198|FG001|Overall Study|Patient went to hospice|1|||
130388356|NCT02520011|469393199|FG002|Overall Study|Patient went to hospice|0|||
130388357|NCT02520011|469393197|FG000|Overall Study|Progressive disease following response|0|||
130388358|NCT02520011|469393198|FG001|Overall Study|Progressive disease following response|4|||
130388359|NCT02520011|469393199|FG002|Overall Study|Progressive disease following response|2|||
130388360|NCT01063764|469393200|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
130388361|NCT01063764|469393200|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
130388362|NCT01063764|469393200|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
130388363|NCT01063764|469393200|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
130388364|NCT01063764|469393200|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
130388365|NCT01063764|469393200|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
130388366|NCT01063764|469393200|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
130388367|NCT00697515|469393201|FG000|Dose Optimization Period|Adverse Event|4|||
130388368|NCT00697515|469393202|FG001|Dose Optimization Period|Adverse Event|0|||
130388369|NCT00697515|469393201|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
130388370|NCT00697515|469393202|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
130388371|NCT00697515|469393201|FG000|Dose Optimization Period|Lost to Follow-up|2|||
130388372|NCT00697515|469393202|FG001|Dose Optimization Period|Lost to Follow-up|0|||
130388373|NCT00697515|469393201|FG000|Dose Optimization Period|sponsor request|2|||
130388374|NCT00697515|469393202|FG001|Dose Optimization Period|sponsor request|0|||
130388375|NCT00697515|469393201|FG000|Dose Optimization Period|called to active duty|1|||
130388376|NCT00697515|469393202|FG001|Dose Optimization Period|called to active duty|0|||
130388377|NCT00697515|469393201|FG000|Dose Optimization Period|elevated QTc|1|||
130388378|NCT00697515|469393202|FG001|Dose Optimization Period|elevated QTc|0|||
130388379|NCT00697515|469393201|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
130388380|NCT00697515|469393202|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
130388381|NCT00697515|469393201|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
130469702|NCT00087139|469683716|FG001|Overall Study|Extradural disease|0|||
130469703|NCT00087139|469683717|FG002|Overall Study|Extradural disease|1|||
130469704|NCT00001277|469683720|FG000|Overall Study|Adverse Event|0|||
130469705|NCT00001277|469683721|FG001|Overall Study|Adverse Event|0|||
130469706|NCT00001277|469683722|FG002|Overall Study|Adverse Event|1|||
130469707|NCT00001277|469683720|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
130469708|NCT00001277|469683721|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
130388382|NCT00697515|469393202|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
130388383|NCT00697515|469393201|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
130388384|NCT00697515|469393202|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
130388385|NCT00697515|469393201|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
130388386|NCT00697515|469393202|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
130388387|NCT01727141|469393204|FG000|Overall Study|Physician Decision|0|||
130388388|NCT01727141|469393205|FG001|Overall Study|Physician Decision|1|||
130388389|NCT01727141|469393206|FG002|Overall Study|Physician Decision|0|||
130388390|NCT01727141|469393207|FG003|Overall Study|Physician Decision|2|||
130388391|NCT01727141|469393204|FG000|Overall Study|Lost to Follow-up|0|||
130469709|NCT00001277|469683722|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
130469710|NCT00065260|469683723|FG000|Overall Study|Death|0|||
130469711|NCT00065260|469683724|FG001|Overall Study|Death|1|||
130559802|NCT00698932|470017878|FG000|Overall Study|Death|1|||
130388392|NCT01727141|469393205|FG001|Overall Study|Lost to Follow-up|2|||
130388393|NCT01727141|469393206|FG002|Overall Study|Lost to Follow-up|0|||
130388394|NCT01727141|469393207|FG003|Overall Study|Lost to Follow-up|0|||
130469712|NCT03101371|469683727|FG000|Overall Study|Physician Decision|0|||
130469713|NCT03101371|469683728|FG001|Overall Study|Physician Decision|1|||
130388395|NCT01727141|469393204|FG000|Overall Study|Death|0|||
130388396|NCT01727141|469393205|FG001|Overall Study|Death|1|||
130388397|NCT01727141|469393206|FG002|Overall Study|Death|1|||
130388398|NCT01727141|469393207|FG003|Overall Study|Death|1|||
130469714|NCT03101371|469683727|FG000|Overall Study|Lost to Follow-up|1|||
130469715|NCT03101371|469683728|FG001|Overall Study|Lost to Follow-up|4|||
130559803|NCT00698932|470017879|FG001|Overall Study|Death|0|||
130722580|NCT02105974|470608329|FG000|2 Week Run-in Period|Study closed/terminated|1|||
130722581|NCT02105974|470608330|FG001|2 Week Run-in Period|Study closed/terminated|0|||
130722582|NCT02105974|470608331|FG002|2 Week Run-in Period|Study closed/terminated|0|||
130722583|NCT02105974|470608329|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
130722584|NCT02105974|470608330|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
130722585|NCT02105974|470608331|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
130722586|NCT02105974|470608329|FG000|2 Week Run-in Period|Withdrew consent|23|||
130722587|NCT02105974|470608330|FG001|2 Week Run-in Period|Withdrew consent|0|||
130722588|NCT02105974|470608331|FG002|2 Week Run-in Period|Withdrew consent|0|||
130722589|NCT02105974|470608329|FG000|2 Week Run-in Period|Investigator discretion|8|||
130722590|NCT02105974|470608330|FG001|2 Week Run-in Period|Investigator discretion|0|||
130722591|NCT02105974|470608331|FG002|2 Week Run-in Period|Investigator discretion|0|||
130722592|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
130722593|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
130722594|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
130722595|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
130722596|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
130722597|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
130722598|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
130722599|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
130722600|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
130722601|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
130722602|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
130722603|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
130388399|NCT01727141|469393204|FG000|Overall Study|Protocol deviation|1|||
130388400|NCT01727141|469393205|FG001|Overall Study|Protocol deviation|1|||
130388401|NCT01727141|469393206|FG002|Overall Study|Protocol deviation|0|||
130388402|NCT01727141|469393207|FG003|Overall Study|Protocol deviation|1|||
130388403|NCT01727141|469393204|FG000|Overall Study|Withdrawal by Subject|4|||
130388404|NCT01727141|469393205|FG001|Overall Study|Withdrawal by Subject|4|||
130388405|NCT01727141|469393206|FG002|Overall Study|Withdrawal by Subject|2|||
130388406|NCT01727141|469393207|FG003|Overall Study|Withdrawal by Subject|11|||
130388407|NCT02603432|469393210|FG000|Overall Study|Adverse Event|1|||
130388408|NCT02603432|469393211|FG001|Overall Study|Adverse Event|0|||
130388409|NCT02603432|469393210|FG000|Overall Study|Death|221|||
130388410|NCT02603432|469393211|FG001|Overall Study|Death|242|||
130388411|NCT02603432|469393210|FG000|Overall Study|Lost to Follow-up|3|||
130388412|NCT02603432|469393211|FG001|Overall Study|Lost to Follow-up|9|||
130388413|NCT02603432|469393210|FG000|Overall Study|Progressive Disease|7|||
130388414|NCT02603432|469393211|FG001|Overall Study|Progressive Disease|5|||
130388415|NCT02603432|469393210|FG000|Overall Study|Withdrawal by Subject|12|||
130388416|NCT02603432|469393211|FG001|Overall Study|Withdrawal by Subject|18|||
130388417|NCT02603432|469393210|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
130388418|NCT02603432|469393211|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130388419|NCT02603432|469393210|FG000|Overall Study|Study terminated by sponsor|74|||
130388420|NCT02603432|469393211|FG001|Overall Study|Study terminated by sponsor|75|||
130388421|NCT02603432|469393210|FG000|Overall Study|Other|13|||
130388422|NCT02603432|469393211|FG001|Overall Study|Other|0|||
130388423|NCT04014075|469393212|FG000|Overall Study|Progressive Disease|53|||
130388424|NCT04014075|469393212|FG000|Overall Study|Adverse Event|15|||
130388425|NCT04014075|469393212|FG000|Overall Study|Clinical Progression|4|||
130388426|NCT04014075|469393212|FG000|Overall Study|Death|2|||
130388427|NCT04014075|469393212|FG000|Overall Study|Withdrawal by Subject|2|||
130388428|NCT04014075|469393212|FG000|Overall Study|Miscellaneous|2|||
130388429|NCT04014075|469393212|FG000|Overall Study|Physician Decision|1|||
130388430|NCT01957462|469393216|FG000|Test Period 1|Withdrawal by Subject|1|||
130388431|NCT01957462|469393217|FG001|Test Period 1|Withdrawal by Subject|0|||
130388432|NCT01957462|469393216|FG000|Test Period 1|Adverse Event|1|||
130388433|NCT01957462|469393217|FG001|Test Period 1|Adverse Event|0|||
130388434|NCT05954052|469393218|FG000|Overall Study|Adverse Event|1|||
130388435|NCT02584504|469393219|FG000|Double-blind Treatment|Participant withdrew consent|0|||
130388436|NCT02584504|469393220|FG001|Double-blind Treatment|Participant withdrew consent|0|||
130388437|NCT02584504|469393221|FG002|Double-blind Treatment|Participant withdrew consent|1|||
130722604|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130722605|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130722606|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
130388438|NCT02584504|469393219|FG000|Double-blind Treatment|Adverse Event|0|||
130388439|NCT02584504|469393220|FG001|Double-blind Treatment|Adverse Event|1|||
130388440|NCT02584504|469393221|FG002|Double-blind Treatment|Adverse Event|0|||
130388441|NCT02584504|469393219|FG000|Double-blind Treatment|Family Matter|0|||
130388442|NCT02584504|469393220|FG001|Double-blind Treatment|Family Matter|1|||
130388443|NCT02584504|469393221|FG002|Double-blind Treatment|Family Matter|0|||
130388444|NCT02584504|469393219|FG000|Open-label Treatment|Participant withdrew consent|0|||
130388445|NCT02584504|469393220|FG001|Open-label Treatment|Participant withdrew consent|0|||
130388446|NCT02584504|469393221|FG002|Open-label Treatment|Participant withdrew consent|4|||
130388447|NCT02584504|469393219|FG000|Open-label Treatment|Adverse Event|2|||
130388448|NCT02584504|469393220|FG001|Open-label Treatment|Adverse Event|2|||
130388449|NCT02584504|469393221|FG002|Open-label Treatment|Adverse Event|3|||
130388450|NCT02584504|469393219|FG000|Open-label Treatment|Physician Decision|0|||
130388451|NCT02584504|469393220|FG001|Open-label Treatment|Physician Decision|1|||
130388452|NCT02584504|469393221|FG002|Open-label Treatment|Physician Decision|0|||
130388453|NCT02584504|469393219|FG000|Open-label Treatment|Entered but not treated|0|||
130388454|NCT02584504|469393220|FG001|Open-label Treatment|Entered but not treated|1|||
130388455|NCT02584504|469393221|FG002|Open-label Treatment|Entered but not treated|1|||
130388456|NCT03102918|469393222|FG000|Overall Study|Protocol Violation|1|||
130388457|NCT03102918|469393223|FG001|Overall Study|Protocol Violation|0|||
130388458|NCT04765358|469393226|FG000|Overall Study|Withdrawal by Subject|1|||
130388459|NCT02731729|469393227|FG000|Overall Study|Death|2|||
130388460|NCT02731729|469393228|FG001|Overall Study|Death|2|||
130388461|NCT02731729|469393227|FG000|Overall Study|Study terminated by Sponsor|6|||
130388462|NCT02731729|469393228|FG001|Overall Study|Study terminated by Sponsor|6|||
130388463|NCT02731729|469393227|FG000|Overall Study|Withdrawal by Subject|1|||
130388464|NCT02731729|469393228|FG001|Overall Study|Withdrawal by Subject|0|||
130388465|NCT03446040|469393231|FG000|Overall Study|Disease progression|3|||
130388466|NCT03446040|469393232|FG001|Overall Study|Disease progression|3|||
130388467|NCT03446040|469393233|FG002|Overall Study|Disease progression|3|||
130388468|NCT03446040|469393234|FG003|Overall Study|Disease progression|4|||
130388469|NCT03446040|469393235|FG004|Overall Study|Disease progression|4|||
130388470|NCT03446040|469393236|FG005|Overall Study|Disease progression|6|||
130388471|NCT03446040|469393237|FG006|Overall Study|Disease progression|3|||
130388472|NCT03446040|469393238|FG007|Overall Study|Disease progression|4|||
130388473|NCT03446040|469393239|FG008|Overall Study|Disease progression|2|||
130388474|NCT03446040|469393240|FG009|Overall Study|Disease progression|4|||
130388475|NCT03446040|469393241|FG010|Overall Study|Disease progression|9|||
130388476|NCT03446040|469393242|FG011|Overall Study|Disease progression|3|||
130388477|NCT03446040|469393243|FG012|Overall Study|Disease progression|7|||
130388478|NCT03446040|469393244|FG013|Overall Study|Disease progression|7|||
130388479|NCT03446040|469393231|FG000|Overall Study|Study drug toxicity|0|||
130388480|NCT03446040|469393232|FG001|Overall Study|Study drug toxicity|0|||
130388481|NCT03446040|469393233|FG002|Overall Study|Study drug toxicity|0|||
130388482|NCT03446040|469393234|FG003|Overall Study|Study drug toxicity|0|||
130388483|NCT03446040|469393235|FG004|Overall Study|Study drug toxicity|0|||
130388484|NCT03446040|469393236|FG005|Overall Study|Study drug toxicity|0|||
130388485|NCT03446040|469393237|FG006|Overall Study|Study drug toxicity|0|||
130388486|NCT03446040|469393238|FG007|Overall Study|Study drug toxicity|0|||
130388487|NCT03446040|469393239|FG008|Overall Study|Study drug toxicity|1|||
130388488|NCT03446040|469393240|FG009|Overall Study|Study drug toxicity|0|||
130388489|NCT03446040|469393241|FG010|Overall Study|Study drug toxicity|0|||
130388490|NCT03446040|469393242|FG011|Overall Study|Study drug toxicity|0|||
130388491|NCT03446040|469393243|FG012|Overall Study|Study drug toxicity|0|||
130388492|NCT03446040|469393244|FG013|Overall Study|Study drug toxicity|0|||
130388493|NCT03446040|469393231|FG000|Overall Study|Adverse Event|0|||
130388494|NCT03446040|469393232|FG001|Overall Study|Adverse Event|0|||
130388495|NCT03446040|469393233|FG002|Overall Study|Adverse Event|0|||
130388496|NCT03446040|469393234|FG003|Overall Study|Adverse Event|0|||
130388497|NCT03446040|469393235|FG004|Overall Study|Adverse Event|0|||
130388498|NCT03446040|469393236|FG005|Overall Study|Adverse Event|2|||
130388499|NCT03446040|469393237|FG006|Overall Study|Adverse Event|0|||
130388500|NCT03446040|469393238|FG007|Overall Study|Adverse Event|0|||
130388501|NCT03446040|469393239|FG008|Overall Study|Adverse Event|1|||
130388502|NCT03446040|469393240|FG009|Overall Study|Adverse Event|0|||
130469716|NCT03101371|469683727|FG000|Overall Study|Did not meet eligibility criteria|2|||
130388503|NCT03446040|469393241|FG010|Overall Study|Adverse Event|0|||
130388504|NCT03446040|469393242|FG011|Overall Study|Adverse Event|0|||
130469717|NCT03101371|469683728|FG001|Overall Study|Did not meet eligibility criteria|1|||
130469718|NCT04019444|469683730|FG000|Overall Study|Withdrawal by Subject|0|||
130722607|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
130388505|NCT03446040|469393243|FG012|Overall Study|Adverse Event|0|||
130388506|NCT03446040|469393244|FG013|Overall Study|Adverse Event|0|||
130388507|NCT03446040|469393231|FG000|Overall Study|Death|0|||
130388508|NCT03446040|469393232|FG001|Overall Study|Death|0|||
130388509|NCT03446040|469393233|FG002|Overall Study|Death|0|||
130388510|NCT03446040|469393234|FG003|Overall Study|Death|0|||
130388511|NCT03446040|469393235|FG004|Overall Study|Death|0|||
130469719|NCT04019444|469683731|FG001|Overall Study|Withdrawal by Subject|1|||
130388512|NCT03446040|469393236|FG005|Overall Study|Death|0|||
130388513|NCT03446040|469393237|FG006|Overall Study|Death|0|||
130388514|NCT03446040|469393238|FG007|Overall Study|Death|0|||
130388515|NCT03446040|469393239|FG008|Overall Study|Death|0|||
130388516|NCT03446040|469393240|FG009|Overall Study|Death|0|||
130388517|NCT03446040|469393241|FG010|Overall Study|Death|1|||
130388518|NCT03446040|469393242|FG011|Overall Study|Death|0|||
130388519|NCT03446040|469393243|FG012|Overall Study|Death|0|||
130388520|NCT03446040|469393244|FG013|Overall Study|Death|2|||
130388521|NCT03446040|469393231|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130388522|NCT03446040|469393232|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
130388523|NCT03446040|469393233|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130388524|NCT03446040|469393234|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
130388525|NCT03446040|469393235|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
130388526|NCT03446040|469393236|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
130388527|NCT03446040|469393237|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
130388528|NCT03446040|469393238|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
130388529|NCT03446040|469393239|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
130388530|NCT03446040|469393240|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
130388531|NCT03446040|469393241|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
130388532|NCT03446040|469393242|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
130388533|NCT03446040|469393243|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
130388534|NCT03446040|469393244|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
130388535|NCT03446040|469393231|FG000|Overall Study|Participant withdrew consent|0|||
130388536|NCT03446040|469393232|FG001|Overall Study|Participant withdrew consent|0|||
130388537|NCT03446040|469393233|FG002|Overall Study|Participant withdrew consent|0|||
130388538|NCT03446040|469393234|FG003|Overall Study|Participant withdrew consent|0|||
130388539|NCT03446040|469393235|FG004|Overall Study|Participant withdrew consent|0|||
130388540|NCT03446040|469393236|FG005|Overall Study|Participant withdrew consent|1|||
130388541|NCT03446040|469393237|FG006|Overall Study|Participant withdrew consent|0|||
130388542|NCT03446040|469393238|FG007|Overall Study|Participant withdrew consent|1|||
130388543|NCT03446040|469393239|FG008|Overall Study|Participant withdrew consent|0|||
130388544|NCT03446040|469393240|FG009|Overall Study|Participant withdrew consent|0|||
130388545|NCT03446040|469393241|FG010|Overall Study|Participant withdrew consent|0|||
130388546|NCT03446040|469393242|FG011|Overall Study|Participant withdrew consent|0|||
130388547|NCT03446040|469393243|FG012|Overall Study|Participant withdrew consent|0|||
130388548|NCT03446040|469393244|FG013|Overall Study|Participant withdrew consent|0|||
130388549|NCT03446040|469393231|FG000|Overall Study|Not reported|0|||
130388550|NCT03446040|469393232|FG001|Overall Study|Not reported|0|||
130388551|NCT03446040|469393233|FG002|Overall Study|Not reported|1|||
130388552|NCT03446040|469393234|FG003|Overall Study|Not reported|0|||
130469720|NCT04019444|469683732|FG002|Overall Study|Withdrawal by Subject|0|||
130469721|NCT04019444|469683733|FG003|Overall Study|Withdrawal by Subject|1|||
130469722|NCT04019444|469683730|FG000|Overall Study|Solicited Event|0|||
130469723|NCT04019444|469683731|FG001|Overall Study|Solicited Event|0|||
130469724|NCT04019444|469683732|FG002|Overall Study|Solicited Event|2|||
130469725|NCT04019444|469683733|FG003|Overall Study|Solicited Event|0|||
130469726|NCT01303445|469683745|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
130469727|NCT01303445|469683746|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
130469728|NCT01303445|469683745|FG000|Second Intervention (7 Days)|Adverse Event|0|||
130388553|NCT03446040|469393235|FG004|Overall Study|Not reported|0|||
130388554|NCT03446040|469393236|FG005|Overall Study|Not reported|0|||
130388555|NCT03446040|469393237|FG006|Overall Study|Not reported|0|||
130388556|NCT03446040|469393238|FG007|Overall Study|Not reported|0|||
130469729|NCT01303445|469683746|FG001|Second Intervention (7 Days)|Adverse Event|2|||
130388557|NCT03446040|469393239|FG008|Overall Study|Not reported|0|||
130388558|NCT03446040|469393240|FG009|Overall Study|Not reported|0|||
130388559|NCT03446040|469393241|FG010|Overall Study|Not reported|0|||
130388560|NCT03446040|469393242|FG011|Overall Study|Not reported|0|||
130388561|NCT03446040|469393243|FG012|Overall Study|Not reported|0|||
130388562|NCT03446040|469393244|FG013|Overall Study|Not reported|0|||
130388563|NCT02066467|469393245|FG000|Overall Study|Did not undergo implant procedure|24|||
130388564|NCT02066467|469393245|FG000|Overall Study|Attempted to implant withoput success|43|||
130388565|NCT02066467|469393245|FG000|Overall Study|Consent ineligible|1|||
130388566|NCT02066467|469393245|FG000|Overall Study|Death|54|||
130388567|NCT02066467|469393245|FG000|Overall Study|Lost to Follow-up|51|||
130388568|NCT02066467|469393245|FG000|Overall Study|Adverse Event|20|||
130388569|NCT02066467|469393245|FG000|Overall Study|Withdrawal by Subject|16|||
130388570|NCT02066467|469393245|FG000|Overall Study|Physician Decision|2|||
130388571|NCT02066467|469393245|FG000|Overall Study|Not defined|4|||
130388572|NCT00456521|469393246|FG000|Overall Study|Adverse Event|150|||
130388573|NCT00456521|469393247|FG001|Overall Study|Adverse Event|25|||
130388574|NCT00456521|469393246|FG000|Overall Study|Withdrawal by Subject|43|||
130388575|NCT00456521|469393247|FG001|Overall Study|Withdrawal by Subject|24|||
130388576|NCT00456521|469393246|FG000|Overall Study|Lost to Follow-up|22|||
130388577|NCT00456521|469393247|FG001|Overall Study|Lost to Follow-up|17|||
130388578|NCT00456521|469393246|FG000|Overall Study|Lack of Efficacy|3|||
130388579|NCT00456521|469393247|FG001|Overall Study|Lack of Efficacy|6|||
130388580|NCT00456521|469393246|FG000|Overall Study|Protocol Violation|4|||
130388581|NCT00456521|469393247|FG001|Overall Study|Protocol Violation|0|||
130388582|NCT00456521|469393246|FG000|Overall Study|Pregnancy|1|||
130388583|NCT00456521|469393247|FG001|Overall Study|Pregnancy|1|||
130388584|NCT00456521|469393246|FG000|Overall Study|Drug non-compliance, moved, other|26|||
130388585|NCT00456521|469393247|FG001|Overall Study|Drug non-compliance, moved, other|11|||
130388586|NCT01316276|469393248|FG000|Overall Study|Death|1|||
130388587|NCT01316276|469393248|FG000|Overall Study|Adverse Event|19|||
130388588|NCT01316276|469393248|FG000|Overall Study|Withdrawal of consent|24|||
130388589|NCT01316276|469393248|FG000|Overall Study|Lost to Follow-up|1|||
130388590|NCT01316276|469393248|FG000|Overall Study|Other|22|||
130388591|NCT00605475|469393249|FG000|Overall Study|Abnormal Laboratory Values|0|||
130388592|NCT00605475|469393250|FG001|Overall Study|Abnormal Laboratory Values|0|||
130388593|NCT00605475|469393251|FG002|Overall Study|Abnormal Laboratory Values|0|||
130388594|NCT00605475|469393252|FG003|Overall Study|Abnormal Laboratory Values|0|||
130388595|NCT00605475|469393253|FG004|Overall Study|Abnormal Laboratory Values|0|||
130388596|NCT00605475|469393254|FG005|Overall Study|Abnormal Laboratory Values|0|||
130388597|NCT00605475|469393255|FG006|Overall Study|Abnormal Laboratory Values|0|||
130388598|NCT00605475|469393256|FG007|Overall Study|Abnormal Laboratory Values|0|||
130388599|NCT00605475|469393257|FG008|Overall Study|Abnormal Laboratory Values|1|||
130388600|NCT00605475|469393258|FG009|Overall Study|Abnormal Laboratory Values|0|||
130388601|NCT00605475|469393249|FG000|Overall Study|Administrative problems|0|||
130388602|NCT00605475|469393250|FG001|Overall Study|Administrative problems|0|||
130722608|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
130722609|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
130722610|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
130722611|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
130722612|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
130722613|NCT01177059|470608333|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
130722614|NCT01177059|470608333|FG000|Overall Study|Withdrew consent|2|||
130722615|NCT01177059|470608333|FG000|Overall Study|Lost to Follow-up|18|||
130722616|NCT02585934|470609655|FG000|Overall Study|Lost to Follow-up|2|||
130722617|NCT02585934|470609656|FG001|Overall Study|Lost to Follow-up|2|||
130722618|NCT02585934|470609655|FG000|Overall Study|Protocol Violation|14|||
130722619|NCT02585934|470609656|FG001|Overall Study|Protocol Violation|11|||
130722620|NCT02585934|470609655|FG000|Overall Study|Adverse Event|21|||
130388603|NCT00605475|469393251|FG002|Overall Study|Administrative problems|0|||
130388604|NCT00605475|469393252|FG003|Overall Study|Administrative problems|0|||
130722621|NCT02585934|470609656|FG001|Overall Study|Adverse Event|22|||
130388605|NCT00605475|469393253|FG004|Overall Study|Administrative problems|0|||
130388606|NCT00605475|469393254|FG005|Overall Study|Administrative problems|0|||
130388607|NCT00605475|469393255|FG006|Overall Study|Administrative problems|1|||
130388608|NCT00605475|469393256|FG007|Overall Study|Administrative problems|0|||
130388609|NCT00605475|469393257|FG008|Overall Study|Administrative problems|0|||
130388610|NCT00605475|469393258|FG009|Overall Study|Administrative problems|0|||
130388611|NCT00605475|469393249|FG000|Overall Study|Lost to Follow-up|0|||
130388612|NCT00605475|469393250|FG001|Overall Study|Lost to Follow-up|0|||
130388613|NCT00605475|469393251|FG002|Overall Study|Lost to Follow-up|0|||
130388614|NCT00605475|469393252|FG003|Overall Study|Lost to Follow-up|0|||
130388615|NCT00605475|469393253|FG004|Overall Study|Lost to Follow-up|0|||
130388616|NCT00605475|469393254|FG005|Overall Study|Lost to Follow-up|0|||
130388617|NCT00605475|469393255|FG006|Overall Study|Lost to Follow-up|0|||
130388618|NCT00605475|469393256|FG007|Overall Study|Lost to Follow-up|0|||
130388619|NCT00605475|469393257|FG008|Overall Study|Lost to Follow-up|1|||
130388620|NCT00605475|469393258|FG009|Overall Study|Lost to Follow-up|1|||
130388621|NCT00605475|469393249|FG000|Overall Study|Protocol Violation|0|||
130388622|NCT00605475|469393250|FG001|Overall Study|Protocol Violation|0|||
130388623|NCT00605475|469393251|FG002|Overall Study|Protocol Violation|0|||
130388624|NCT00605475|469393252|FG003|Overall Study|Protocol Violation|0|||
130388625|NCT00605475|469393253|FG004|Overall Study|Protocol Violation|1|||
130388626|NCT00605475|469393254|FG005|Overall Study|Protocol Violation|0|||
130388627|NCT00605475|469393255|FG006|Overall Study|Protocol Violation|0|||
130388628|NCT00605475|469393256|FG007|Overall Study|Protocol Violation|0|||
130388629|NCT00605475|469393257|FG008|Overall Study|Protocol Violation|0|||
130388630|NCT00605475|469393258|FG009|Overall Study|Protocol Violation|0|||
130388631|NCT00605475|469393249|FG000|Overall Study|Withdrawal by Subject|0|||
130388632|NCT00605475|469393250|FG001|Overall Study|Withdrawal by Subject|0|||
130388633|NCT00605475|469393251|FG002|Overall Study|Withdrawal by Subject|0|||
130388634|NCT00605475|469393252|FG003|Overall Study|Withdrawal by Subject|0|||
130388635|NCT00605475|469393253|FG004|Overall Study|Withdrawal by Subject|0|||
130388636|NCT00605475|469393254|FG005|Overall Study|Withdrawal by Subject|2|||
130388637|NCT00605475|469393255|FG006|Overall Study|Withdrawal by Subject|0|||
130388638|NCT00605475|469393256|FG007|Overall Study|Withdrawal by Subject|0|||
130388639|NCT00605475|469393257|FG008|Overall Study|Withdrawal by Subject|0|||
130388640|NCT00605475|469393258|FG009|Overall Study|Withdrawal by Subject|1|||
130388641|NCT02596854|469393259|FG000|Overall Study|Withdrawn|8|||
130388642|NCT00076011|469393260|FG000|Overall Study|Death|1|||
130388643|NCT00076011|469393260|FG000|Overall Study|Adverse Event|10|||
130388644|NCT00076011|469393260|FG000|Overall Study|Lack of Efficacy|25|||
130388645|NCT00076011|469393260|FG000|Overall Study|Withdrawal by Subject|1|||
130388646|NCT00076011|469393260|FG000|Overall Study|Study terminated by sponsor|3|||
130388647|NCT00076011|469393260|FG000|Overall Study|Other|11|||
130388648|NCT00076011|469393260|FG000|Overall Study|Ongoing|1|||
130388649|NCT00581776|469393261|FG000|Overall Study|Disease progression or no response|3|||
130388650|NCT03615326|469393266|FG000|Overall Study|Death|266|||
130388651|NCT03615326|469393267|FG001|Overall Study|Death|286|||
130388652|NCT03615326|469393268|FG002|Overall Study|Death|14|||
130388653|NCT03615326|469393269|FG003|Overall Study|Death|17|||
130388654|NCT03615326|469393266|FG000|Overall Study|Lost to Follow-up|0|||
130388655|NCT03615326|469393267|FG001|Overall Study|Lost to Follow-up|1|||
130388656|NCT03615326|469393268|FG002|Overall Study|Lost to Follow-up|0|||
130388657|NCT03615326|469393269|FG003|Overall Study|Lost to Follow-up|0|||
130388658|NCT03615326|469393266|FG000|Overall Study|Withdrawal by Subject|1|||
130388659|NCT03615326|469393267|FG001|Overall Study|Withdrawal by Subject|3|||
130388660|NCT03615326|469393268|FG002|Overall Study|Withdrawal by Subject|0|||
130388661|NCT03615326|469393269|FG003|Overall Study|Withdrawal by Subject|0|||
130388662|NCT03615326|469393266|FG000|Overall Study|Participants Ongoing|83|||
130388663|NCT03615326|469393267|FG001|Overall Study|Participants Ongoing|58|||
130388664|NCT03615326|469393268|FG002|Overall Study|Participants Ongoing|6|||
130388665|NCT03615326|469393269|FG003|Overall Study|Participants Ongoing|3|||
130388666|NCT03425331|469393272|FG000|Overall Study|Withdrawal by Subject|1|||
130388667|NCT03425331|469393272|FG000|Overall Study|Death|1|||
130388668|NCT03425331|469393272|FG000|Overall Study|Adverse Event|1|||
130388669|NCT03425331|469393272|FG000|Overall Study|Disease Progression|2|||
130469730|NCT01303445|469683745|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
130469731|NCT01303445|469683746|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
130469732|NCT01303445|469683745|FG000|Washout (14 Days)|Protocol Violation|1|||
130469733|NCT01303445|469683746|FG001|Washout (14 Days)|Protocol Violation|0|||
130469734|NCT01303445|469683745|FG000|Washout (14 Days)|Lost to Follow-up|0|||
130469735|NCT01303445|469683746|FG001|Washout (14 Days)|Lost to Follow-up|2|||
130469736|NCT01303445|469683745|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
130469737|NCT01303445|469683746|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
130469738|NCT01303445|469683745|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
130469739|NCT01303445|469683746|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
130469740|NCT03481660|469685718|FG000|Overall Study|Adverse Event|5|||
130388670|NCT02864251|469393274|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
130469741|NCT03481660|469685719|FG001|Overall Study|Adverse Event|4|||
130388671|NCT02864251|469393275|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
130388672|NCT02864251|469393276|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
130388673|NCT02864251|469393274|FG000|Pre-Treatment|Withdrawal by Participant|0|||
130388674|NCT02864251|469393275|FG001|Pre-Treatment|Withdrawal by Participant|0|||
130388675|NCT02864251|469393276|FG002|Pre-Treatment|Withdrawal by Participant|4|||
130388676|NCT02864251|469393274|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
130388677|NCT02864251|469393275|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
130388678|NCT02864251|469393276|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
130388679|NCT02864251|469393274|FG000|Pre-Treatment|Other Reasons|0|||
130388680|NCT02864251|469393275|FG001|Pre-Treatment|Other Reasons|1|||
130388681|NCT02864251|469393276|FG002|Pre-Treatment|Other Reasons|1|||
130388682|NCT02864251|469393274|FG000|Treatment|Disease Progression|109|||
130469742|NCT03481660|469685718|FG000|Overall Study|Death|13|||
130469743|NCT03481660|469685719|FG001|Overall Study|Death|9|||
130469744|NCT03481660|469685718|FG000|Overall Study|Lost to Follow-up|2|||
130469745|NCT03481660|469685719|FG001|Overall Study|Lost to Follow-up|2|||
130469746|NCT03481660|469685718|FG000|Overall Study|Physician Decision|2|||
130469747|NCT03481660|469685719|FG001|Overall Study|Physician Decision|3|||
130388683|NCT02864251|469393275|FG001|Treatment|Disease Progression|52|||
130388684|NCT02864251|469393276|FG002|Treatment|Disease Progression|101|||
130388685|NCT02864251|469393274|FG000|Treatment|Study Drug Toxicity|9|||
130388686|NCT02864251|469393275|FG001|Treatment|Study Drug Toxicity|4|||
130388687|NCT02864251|469393276|FG002|Treatment|Study Drug Toxicity|10|||
130388688|NCT02864251|469393274|FG000|Treatment|Death|0|||
130388689|NCT02864251|469393275|FG001|Treatment|Death|2|||
130388690|NCT02864251|469393276|FG002|Treatment|Death|3|||
130388691|NCT02864251|469393274|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
130388692|NCT02864251|469393275|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
130388693|NCT02864251|469393276|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
130388694|NCT02864251|469393274|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
130388695|NCT02864251|469393275|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
130388696|NCT02864251|469393276|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
130388697|NCT02864251|469393274|FG000|Treatment|Withdrawal by Participant|8|||
130388698|NCT02864251|469393275|FG001|Treatment|Withdrawal by Participant|5|||
130388699|NCT02864251|469393276|FG002|Treatment|Withdrawal by Participant|13|||
130388700|NCT02864251|469393274|FG000|Treatment|Maximum Clinical Benefit|1|||
130388701|NCT02864251|469393275|FG001|Treatment|Maximum Clinical Benefit|0|||
130388702|NCT02864251|469393276|FG002|Treatment|Maximum Clinical Benefit|1|||
130388703|NCT02864251|469393274|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
130388704|NCT02864251|469393275|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
130388705|NCT02864251|469393276|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
130388706|NCT02864251|469393274|FG000|Treatment|Other Reasons|1|||
130388707|NCT02864251|469393275|FG001|Treatment|Other Reasons|1|||
130388708|NCT02864251|469393276|FG002|Treatment|Other Reasons|4|||
130388709|NCT02864251|469393274|FG000|Treatment|Administrative Reason by Sponsor|1|||
130388710|NCT02864251|469393275|FG001|Treatment|Administrative Reason by Sponsor|0|||
130388711|NCT02864251|469393276|FG002|Treatment|Administrative Reason by Sponsor|0|||
130388712|NCT00973479|469393283|FG000|Overall Study|Lost to Follow-up|0|||
130722622|NCT02585934|470609655|FG000|Overall Study|Physician Decision|3|||
130722623|NCT02585934|470609656|FG001|Overall Study|Physician Decision|2|||
130722624|NCT02585934|470609655|FG000|Overall Study|Withdrawal by Subject|7|||
130722625|NCT02585934|470609656|FG001|Overall Study|Withdrawal by Subject|21|||
130722626|NCT02585934|470609655|FG000|Overall Study|Lack of Efficacy|2|||
130722627|NCT02585934|470609656|FG001|Overall Study|Lack of Efficacy|1|||
130722628|NCT02585934|470609655|FG000|Overall Study|Death|2|||
130722629|NCT02585934|470609656|FG001|Overall Study|Death|0|||
130722630|NCT02585934|470609655|FG000|Overall Study|Caregiver Withdrew Consent|7|||
130722631|NCT02585934|470609656|FG001|Overall Study|Caregiver Withdrew Consent|7|||
130388713|NCT00973479|469393284|FG001|Overall Study|Lost to Follow-up|3|||
130469748|NCT03481660|469685718|FG000|Overall Study|Withdrawal by Subject|14|||
130469749|NCT03481660|469685719|FG001|Overall Study|Withdrawal by Subject|7|||
130469750|NCT01259401|469685720|FG000|4-month Follow-up|Death|0|||
130469751|NCT01259401|469685721|FG001|4-month Follow-up|Death|1|||
130469752|NCT01259401|469685720|FG000|4-month Follow-up|Lost to Follow-up|0|||
130469753|NCT01259401|469685721|FG001|4-month Follow-up|Lost to Follow-up|1|||
130469754|NCT03954184|469685724|FG000|Overall Study|Lost to Follow-up|500|||
130469755|NCT03954184|469685725|FG001|Overall Study|Lost to Follow-up|0|||
130722632|NCT02585934|470609655|FG000|Overall Study|Sponsor Termination|1|||
130722633|NCT02585934|470609656|FG001|Overall Study|Sponsor Termination|2|||
130722634|NCT02585934|470609655|FG000|Overall Study|Another Reason|10|||
130722635|NCT02585934|470609656|FG001|Overall Study|Another Reason|5|||
130388714|NCT00973479|469393283|FG000|Overall Study|Death|2|||
130388715|NCT00973479|469393284|FG001|Overall Study|Death|2|||
130469756|NCT03398200|469685726|FG000|Overall Study|Withdrawal by Subject|0|||
130722636|NCT03972163|470609657|FG000|Overall Study|Death|0|||
130388716|NCT00973479|469393283|FG000|Overall Study|Withdrawal by Subject|15|||
130388717|NCT00973479|469393284|FG001|Overall Study|Withdrawal by Subject|16|||
130388718|NCT00973479|469393283|FG000|Overall Study|Lack of Efficacy|5|||
130388719|NCT00973479|469393284|FG001|Overall Study|Lack of Efficacy|7|||
130388720|NCT00973479|469393283|FG000|Overall Study|Adverse Event|12|||
130388721|NCT00973479|469393284|FG001|Overall Study|Adverse Event|32|||
130388722|NCT00973479|469393283|FG000|Overall Study|Protocol Violation|2|||
130388723|NCT00973479|469393284|FG001|Overall Study|Protocol Violation|2|||
130388724|NCT00973479|469393283|FG000|Overall Study|Other|1|||
130388725|NCT00973479|469393284|FG001|Overall Study|Other|7|||
130388726|NCT00362115|469393285|FG000|Overall Study|Adverse Event|0|||
130388727|NCT00362115|469393286|FG001|Overall Study|Adverse Event|1|||
130388728|NCT00362115|469393287|FG002|Overall Study|Adverse Event|1|||
130388729|NCT00362115|469393288|FG003|Overall Study|Adverse Event|1|||
130388730|NCT00362115|469393289|FG004|Overall Study|Adverse Event|2|||
130388731|NCT00362115|469393290|FG005|Overall Study|Adverse Event|2|||
130388732|NCT00362115|469393291|FG006|Overall Study|Adverse Event|1|||
130388733|NCT00362115|469393285|FG000|Overall Study|Protocol Violation|0|||
130388734|NCT00362115|469393286|FG001|Overall Study|Protocol Violation|0|||
130388735|NCT00362115|469393287|FG002|Overall Study|Protocol Violation|0|||
130388736|NCT00362115|469393288|FG003|Overall Study|Protocol Violation|0|||
130388737|NCT00362115|469393289|FG004|Overall Study|Protocol Violation|0|||
130388738|NCT00362115|469393290|FG005|Overall Study|Protocol Violation|1|||
130388739|NCT00362115|469393291|FG006|Overall Study|Protocol Violation|0|||
130388740|NCT00362115|469393285|FG000|Overall Study|Lost to Follow-up|0|||
130388741|NCT00362115|469393286|FG001|Overall Study|Lost to Follow-up|1|||
130388742|NCT00362115|469393287|FG002|Overall Study|Lost to Follow-up|0|||
130388743|NCT00362115|469393288|FG003|Overall Study|Lost to Follow-up|0|||
130388744|NCT00362115|469393289|FG004|Overall Study|Lost to Follow-up|2|||
130388745|NCT00362115|469393290|FG005|Overall Study|Lost to Follow-up|0|||
130388746|NCT00362115|469393291|FG006|Overall Study|Lost to Follow-up|1|||
130388747|NCT00362115|469393285|FG000|Overall Study|Withdrawal by Subject|1|||
130388748|NCT00362115|469393286|FG001|Overall Study|Withdrawal by Subject|3|||
130388749|NCT00362115|469393287|FG002|Overall Study|Withdrawal by Subject|1|||
130388750|NCT00362115|469393288|FG003|Overall Study|Withdrawal by Subject|0|||
130388751|NCT00362115|469393289|FG004|Overall Study|Withdrawal by Subject|1|||
130388752|NCT00362115|469393290|FG005|Overall Study|Withdrawal by Subject|3|||
130388753|NCT00362115|469393291|FG006|Overall Study|Withdrawal by Subject|4|||
130388754|NCT00362115|469393285|FG000|Overall Study|Lack of Efficacy|1|||
130388755|NCT00362115|469393286|FG001|Overall Study|Lack of Efficacy|0|||
130388756|NCT00362115|469393287|FG002|Overall Study|Lack of Efficacy|5|||
130388757|NCT00362115|469393288|FG003|Overall Study|Lack of Efficacy|2|||
130388758|NCT00362115|469393289|FG004|Overall Study|Lack of Efficacy|2|||
130388759|NCT00362115|469393290|FG005|Overall Study|Lack of Efficacy|0|||
130388760|NCT00362115|469393291|FG006|Overall Study|Lack of Efficacy|3|||
130388761|NCT00362115|469393285|FG000|Overall Study|Physician Decision|0|||
130388762|NCT00362115|469393286|FG001|Overall Study|Physician Decision|0|||
130388763|NCT00362115|469393287|FG002|Overall Study|Physician Decision|0|||
130388764|NCT00362115|469393288|FG003|Overall Study|Physician Decision|0|||
130469757|NCT03398200|469685727|FG001|Overall Study|Withdrawal by Subject|1|||
130469758|NCT05478525|469685728|FG000|Overall Study|Withdrawal by Subject|0|||
130469759|NCT05478525|469685729|FG001|Overall Study|Withdrawal by Subject|1|||
130722637|NCT03972163|470609658|FG001|Overall Study|Death|1|||
130722638|NCT01161407|470609661|FG000|Overall Study|Protocol Violation|3|||
130722639|NCT01161407|470609662|FG001|Overall Study|Protocol Violation|1|||
130722640|NCT00849186|470609665|FG000|Overall Study|Adverse Event|2|||
130388765|NCT00362115|469393289|FG004|Overall Study|Physician Decision|0|||
130469760|NCT05478525|469685730|FG002|Overall Study|Withdrawal by Subject|2|||
130469761|NCT05478525|469685731|FG003|Overall Study|Withdrawal by Subject|0|||
130469762|NCT05478525|469685728|FG000|Overall Study|COVID-19 Infection|2|||
130469763|NCT05478525|469685729|FG001|Overall Study|COVID-19 Infection|0|||
130469764|NCT05478525|469685730|FG002|Overall Study|COVID-19 Infection|1|||
130469765|NCT05478525|469685731|FG003|Overall Study|COVID-19 Infection|1|||
130469766|NCT01649271|469685732|FG000|Overall Study|Progressive disease|4|||
130388766|NCT00362115|469393290|FG005|Overall Study|Physician Decision|0|||
130388767|NCT00362115|469393291|FG006|Overall Study|Physician Decision|3|||
130469767|NCT01649271|469685733|FG001|Overall Study|Progressive disease|5|||
130722641|NCT00849186|470609665|FG000|Overall Study|Withdrawal by Subject|1|||
130722642|NCT00849186|470609665|FG000|Overall Study|not treated|6|||
130388768|NCT00362115|469393285|FG000|Overall Study|Other|0|||
130388769|NCT00362115|469393286|FG001|Overall Study|Other|1|||
130388770|NCT00362115|469393287|FG002|Overall Study|Other|0|||
130388771|NCT00362115|469393288|FG003|Overall Study|Other|1|||
130388772|NCT00362115|469393289|FG004|Overall Study|Other|0|||
130388773|NCT00362115|469393290|FG005|Overall Study|Other|1|||
130388774|NCT00362115|469393291|FG006|Overall Study|Other|0|||
130469768|NCT01649271|469685732|FG000|Overall Study|Other Adverse Event|0|||
130559804|NCT03044249|470017884|FG000|Overall Study|Adverse Event|4|||
130388775|NCT03965962|469393292|FG000|Overall Study|Adverse Event|1|||
130388776|NCT03965962|469393293|FG001|Overall Study|Adverse Event|0|||
130469769|NCT01649271|469685733|FG001|Overall Study|Other Adverse Event|2|||
130559805|NCT03044249|470017885|FG001|Overall Study|Adverse Event|9|||
130559806|NCT03044249|470017884|FG000|Overall Study|Lost to Follow-up|1|||
130559807|NCT03044249|470017885|FG001|Overall Study|Lost to Follow-up|0|||
130722643|NCT00849186|470609665|FG000|Overall Study|Other|1|||
130722644|NCT00492024|470609666|FG000|Treatment|Adverse Event|3|||
130722645|NCT00492024|470609667|FG001|Treatment|Adverse Event|1|||
130722646|NCT00492024|470609666|FG000|Treatment|Lack of Efficacy|21|||
130722647|NCT00492024|470609667|FG001|Treatment|Lack of Efficacy|20|||
130722648|NCT00492024|470609666|FG000|Treatment|Lost to Follow-up|3|||
130469770|NCT01649271|469685732|FG000|Overall Study|Withdrawal by Subject|1|||
130469771|NCT01649271|469685733|FG001|Overall Study|Withdrawal by Subject|0|||
130469772|NCT01649271|469685732|FG000|Overall Study|Other than stated above|1|||
130469773|NCT01649271|469685733|FG001|Overall Study|Other than stated above|0|||
130469774|NCT05644002|469685734|FG000|Overall Study|Lost to Follow-up|1|||
130469775|NCT05644002|469685735|FG001|Overall Study|Lost to Follow-up|2|||
130469776|NCT05644002|469685734|FG000|Overall Study|Withdrawal by Subject|0|||
130469777|NCT05644002|469685735|FG001|Overall Study|Withdrawal by Subject|1|||
130469778|NCT04842500|469685736|FG000|Overall Study|Withdrawal by Subject|4|||
130469779|NCT04842500|469685737|FG001|Overall Study|Withdrawal by Subject|1|||
130469780|NCT04842500|469685738|FG002|Overall Study|Withdrawal by Subject|2|||
130469781|NCT04842500|469685739|FG003|Overall Study|Withdrawal by Subject|3|||
130469782|NCT04842500|469685736|FG000|Overall Study|Protocol Violation|1|||
130469783|NCT04842500|469685737|FG001|Overall Study|Protocol Violation|0|||
130469784|NCT04842500|469685738|FG002|Overall Study|Protocol Violation|0|||
130469785|NCT04842500|469685739|FG003|Overall Study|Protocol Violation|1|||
130469786|NCT05756075|469685742|FG000|Overall Study|Withdrawal by Subject|16|||
130469787|NCT05756075|469685743|FG001|Overall Study|Withdrawal by Subject|9|||
130469788|NCT03821844|469685744|FG000|Overall Study|Death|37|||
130469789|NCT03821844|469685745|FG001|Overall Study|Death|31|||
130469790|NCT03821844|469685744|FG000|Overall Study|Discharged|10|||
130469791|NCT03821844|469685745|FG001|Overall Study|Discharged|14|||
130469792|NCT03821844|469685744|FG000|Overall Study|Not present in facility at followup|2|||
130469793|NCT03821844|469685745|FG001|Overall Study|Not present in facility at followup|3|||
130469794|NCT04065048|469685746|FG000|Overall Study|Withdrawal by Subject|1|||
130469795|NCT04065048|469685747|FG001|Overall Study|Withdrawal by Subject|2|||
130469796|NCT04065048|469685748|FG002|Overall Study|Withdrawal by Subject|1|||
130469797|NCT04065048|469685749|FG003|Overall Study|Withdrawal by Subject|1|||
130469798|NCT04065048|469685746|FG000|Overall Study|Adverse Event|1|||
130469799|NCT04065048|469685747|FG001|Overall Study|Adverse Event|0|||
130469800|NCT04065048|469685748|FG002|Overall Study|Adverse Event|1|||
130469801|NCT04065048|469685749|FG003|Overall Study|Adverse Event|0|||
130469802|NCT05104697|469685751|FG000|Overall Study|Withdrawal by Subject|0|||
130469803|NCT05104697|469685752|FG001|Overall Study|Withdrawal by Subject|1|||
130469804|NCT03845465|469685753|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
130469805|NCT03845465|469685754|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
130469806|NCT03845465|469685753|FG000|6-month Data Collection|Withdrawal by Subject|0|||
130469807|NCT03845465|469685754|FG001|6-month Data Collection|Withdrawal by Subject|2|||
130469808|NCT03845465|469685753|FG000|12-month Data Collection|Withdrawal by Subject|0|||
130469809|NCT03845465|469685754|FG001|12-month Data Collection|Withdrawal by Subject|2|||
130722649|NCT00492024|470609667|FG001|Treatment|Lost to Follow-up|1|||
130722650|NCT00492024|470609666|FG000|Treatment|Withdrawal by Subject|2|||
130722651|NCT00492024|470609667|FG001|Treatment|Withdrawal by Subject|0|||
130388777|NCT03965962|469393294|FG002|Overall Study|Adverse Event|0|||
130388778|NCT03965962|469393295|FG003|Overall Study|Adverse Event|0|||
130388779|NCT03965962|469393292|FG000|Overall Study|Protocol Violation|21|||
130388780|NCT03965962|469393293|FG001|Overall Study|Protocol Violation|4|||
130388781|NCT03965962|469393294|FG002|Overall Study|Protocol Violation|10|||
130388782|NCT03965962|469393295|FG003|Overall Study|Protocol Violation|5|||
130388783|NCT03965962|469393292|FG000|Overall Study|Lost to Follow-up|0|||
130388784|NCT03965962|469393293|FG001|Overall Study|Lost to Follow-up|1|||
130388785|NCT03965962|469393294|FG002|Overall Study|Lost to Follow-up|0|||
130388786|NCT03965962|469393295|FG003|Overall Study|Lost to Follow-up|0|||
130388787|NCT03965962|469393292|FG000|Overall Study|Withdrawal by Subject|3|||
130388788|NCT03965962|469393293|FG001|Overall Study|Withdrawal by Subject|0|||
130388789|NCT03965962|469393294|FG002|Overall Study|Withdrawal by Subject|0|||
130388790|NCT03965962|469393295|FG003|Overall Study|Withdrawal by Subject|1|||
130388791|NCT01408030|469393300|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
130388792|NCT01408030|469393301|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
130388793|NCT01408030|469393302|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
130388794|NCT01408030|469393303|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
130388795|NCT01408030|469393300|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
130469810|NCT03899961|469685762|FG000|Overall Study|-delivery prior to|2|||
130388796|NCT01408030|469393301|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
130469811|NCT03899961|469685763|FG001|Overall Study|-delivery prior to|7|||
130469812|NCT03899961|469685762|FG000|Overall Study|req general anesth|1|||
130559808|NCT03044249|470017884|FG000|Overall Study|Non-compliance with Study Drug|1|||
130559809|NCT03044249|470017885|FG001|Overall Study|Non-compliance with Study Drug|0|||
130388797|NCT01408030|469393302|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
130388798|NCT01408030|469393303|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
130388799|NCT01408030|469393300|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
130388800|NCT01408030|469393301|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
130388801|NCT01408030|469393302|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
130388802|NCT01408030|469393303|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
130388803|NCT01408030|469393300|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
130388804|NCT01408030|469393301|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
130388805|NCT01408030|469393302|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
130388806|NCT01408030|469393303|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
130388807|NCT01408030|469393300|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
130388808|NCT01408030|469393301|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
130388809|NCT01408030|469393302|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
130388810|NCT01408030|469393303|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
130388811|NCT01408030|469393300|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
130388812|NCT01408030|469393301|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
130388813|NCT01408030|469393302|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
130388814|NCT01408030|469393303|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
130388815|NCT01408030|469393300|FG000|Observation Phase (Off Drug)|Other|1|||
130388816|NCT01408030|469393301|FG001|Observation Phase (Off Drug)|Other|1|||
130388817|NCT01408030|469393302|FG002|Observation Phase (Off Drug)|Other|1|||
130388818|NCT01408030|469393303|FG003|Observation Phase (Off Drug)|Other|1|||
130388819|NCT00729183|469393304|FG000|Overall Study|Adverse Event|11|||
130388820|NCT00729183|469393305|FG001|Overall Study|Adverse Event|5|||
130388821|NCT00729183|469393304|FG000|Overall Study|Lack of Efficacy|0|||
130388822|NCT00729183|469393305|FG001|Overall Study|Lack of Efficacy|1|||
130388823|NCT00729183|469393304|FG000|Overall Study|Lost to Follow-up|3|||
130388824|NCT00729183|469393305|FG001|Overall Study|Lost to Follow-up|1|||
130388825|NCT00729183|469393304|FG000|Overall Study|Physician Decision|1|||
130388826|NCT00729183|469393305|FG001|Overall Study|Physician Decision|1|||
130469813|NCT03899961|469685763|FG001|Overall Study|req general anesth|2|||
130469814|NCT03899961|469685762|FG000|Overall Study|capacity|5|||
130469815|NCT03899961|469685763|FG001|Overall Study|capacity|6|||
130469816|NCT03899961|469685762|FG000|Overall Study|Withdrawal by Subject|1|||
130469817|NCT03899961|469685763|FG001|Overall Study|Withdrawal by Subject|1|||
130469818|NCT05307978|469685768|FG000|Overall Study|Lost to Follow-up|0|||
130469819|NCT05307978|469685769|FG001|Overall Study|Lost to Follow-up|1|||
130469820|NCT05307978|469685770|FG002|Overall Study|Lost to Follow-up|0|||
130469821|NCT05307978|469685771|FG003|Overall Study|Lost to Follow-up|4|||
130469822|NCT05307978|469685772|FG004|Overall Study|Lost to Follow-up|0|||
130469823|NCT05307978|469685773|FG005|Overall Study|Lost to Follow-up|0|||
130469824|NCT05307978|469685774|FG006|Overall Study|Lost to Follow-up|1|||
130469825|NCT03324984|469685775|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
130469826|NCT03324984|469685776|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
130469827|NCT05656911|469685777|FG000|Treatment Phase|Physician Decision|2|||
130469828|NCT05656911|469685778|FG001|Treatment Phase|Physician Decision|0|||
130469829|NCT05656911|469685777|FG000|Treatment Phase|Lack of Efficacy|6|||
130469830|NCT05656911|469685778|FG001|Treatment Phase|Lack of Efficacy|3|||
130469831|NCT05656911|469685777|FG000|Treatment Phase|Subject Decision|4|||
130469832|NCT05656911|469685778|FG001|Treatment Phase|Subject Decision|2|||
130469833|NCT05656911|469685777|FG000|Treatment Phase|Other Reasons|1|||
130469834|NCT05656911|469685778|FG001|Treatment Phase|Other Reasons|0|||
130469835|NCT05656911|469685777|FG000|Treatment Phase|Adverse Event|3|||
130469836|NCT05656911|469685778|FG001|Treatment Phase|Adverse Event|1|||
130469837|NCT05656911|469685777|FG000|Follow-up Phase|Subject Decision|0|||
130469838|NCT05656911|469685778|FG001|Follow-up Phase|Subject Decision|1|||
130469839|NCT05656911|469685777|FG000|Follow-up Phase|Missing|1|||
130469840|NCT05656911|469685778|FG001|Follow-up Phase|Missing|0|||
130469841|NCT05075408|469685779|FG000|Overall Study|Withdrawal by Subject|5|||
130469842|NCT05075408|469685780|FG001|Overall Study|Withdrawal by Subject|3|||
130469843|NCT05075408|469685781|FG002|Overall Study|Withdrawal by Subject|4|||
130469844|NCT05075408|469685779|FG000|Overall Study|Adverse Event|5|||
130469845|NCT05075408|469685780|FG001|Overall Study|Adverse Event|7|||
130469846|NCT05075408|469685781|FG002|Overall Study|Adverse Event|8|||
130469847|NCT05075408|469685779|FG000|Overall Study|Protocol Violation|0|||
130469848|NCT05075408|469685780|FG001|Overall Study|Protocol Violation|1|||
130469849|NCT05075408|469685781|FG002|Overall Study|Protocol Violation|0|||
130469850|NCT05075408|469685779|FG000|Overall Study|Lost to Follow-up|2|||
130469851|NCT05075408|469685780|FG001|Overall Study|Lost to Follow-up|1|||
130469852|NCT05075408|469685781|FG002|Overall Study|Lost to Follow-up|1|||
130469853|NCT05075408|469685779|FG000|Overall Study|Physician Decision|1|||
130469854|NCT05075408|469685780|FG001|Overall Study|Physician Decision|0|||
130388827|NCT00729183|469393304|FG000|Overall Study|Protocol Violation|1|||
130469855|NCT05075408|469685781|FG002|Overall Study|Physician Decision|0|||
130469856|NCT05075408|469685779|FG000|Overall Study|Other-unspecified|3|||
130388828|NCT00729183|469393305|FG001|Overall Study|Protocol Violation|0|||
130388829|NCT00729183|469393304|FG000|Overall Study|Withdrawal by Subject|9|||
130388830|NCT00729183|469393305|FG001|Overall Study|Withdrawal by Subject|7|||
130388831|NCT02867709|469393306|FG000|Treatment Period|Adverse Event|1|||
130388832|NCT02867709|469393307|FG001|Treatment Period|Adverse Event|1|||
130388833|NCT02867709|469393308|FG002|Treatment Period|Adverse Event|2|||
130388834|NCT02867709|469393306|FG000|Treatment Period|Withdrawal of Consent|7|||
130388835|NCT02867709|469393307|FG001|Treatment Period|Withdrawal of Consent|9|||
130388836|NCT02867709|469393308|FG002|Treatment Period|Withdrawal of Consent|8|||
130388837|NCT02867709|469393306|FG000|Treatment Period|Lost to Follow-up|17|||
130388838|NCT02867709|469393307|FG001|Treatment Period|Lost to Follow-up|20|||
130388839|NCT02867709|469393308|FG002|Treatment Period|Lost to Follow-up|20|||
130388840|NCT02867709|469393306|FG000|Treatment Period|Lack of Qualifying Event|42|||
130388841|NCT02867709|469393307|FG001|Treatment Period|Lack of Qualifying Event|55|||
130388842|NCT02867709|469393308|FG002|Treatment Period|Lack of Qualifying Event|42|||
130388843|NCT02867709|469393306|FG000|Treatment Period|Protocol Violation|3|||
130388844|NCT02867709|469393307|FG001|Treatment Period|Protocol Violation|2|||
130388845|NCT02867709|469393308|FG002|Treatment Period|Protocol Violation|3|||
130388846|NCT02867709|469393306|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
130388847|NCT02867709|469393307|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
130388848|NCT02867709|469393308|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
130388849|NCT02867709|469393306|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
130388850|NCT02867709|469393307|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
130388851|NCT02867709|469393308|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
130388852|NCT02867709|469393306|FG000|Safety Follow-up Period|Pregnancy|0|||
130388853|NCT02867709|469393307|FG001|Safety Follow-up Period|Pregnancy|1|||
130388854|NCT02867709|469393308|FG002|Safety Follow-up Period|Pregnancy|0|||
130388855|NCT02867709|469393306|FG000|Safety Follow-up Period|Protocol Violation|0|||
130388856|NCT02867709|469393307|FG001|Safety Follow-up Period|Protocol Violation|1|||
130388857|NCT02867709|469393308|FG002|Safety Follow-up Period|Protocol Violation|1|||
130388858|NCT05497284|469393309|FG000|Overall Study|Adverse Event|1|||
130388859|NCT05497284|469393310|FG001|Overall Study|Adverse Event|0|||
130388860|NCT05497284|469393309|FG000|Overall Study|Physician Decision|0|||
130388861|NCT05497284|469393310|FG001|Overall Study|Physician Decision|1|||
130388862|NCT05497284|469393309|FG000|Overall Study|Study terminated by sponsor|7|||
130388863|NCT05497284|469393310|FG001|Overall Study|Study terminated by sponsor|4|||
130469857|NCT05075408|469685780|FG001|Overall Study|Other-unspecified|2|||
130469858|NCT05075408|469685781|FG002|Overall Study|Other-unspecified|0|||
130469859|NCT02837510|469685782|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
130469860|NCT02837510|469685783|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
130469861|NCT02837510|469685782|FG000|Washout (2 Weeks)|Adverse Event|0|||
130469862|NCT02837510|469685783|FG001|Washout (2 Weeks)|Adverse Event|1|||
130469863|NCT02837510|469685782|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
130469864|NCT02837510|469685783|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
130469865|NCT02837510|469685782|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
130469866|NCT02837510|469685783|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
130469867|NCT02837510|469685782|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
130469868|NCT02837510|469685783|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
130469869|NCT02837510|469685782|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
130469870|NCT02837510|469685783|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
130469871|NCT05419505|469685784|FG000|Overall Study|Adverse Event|0|||
130469872|NCT05419505|469685785|FG001|Overall Study|Adverse Event|0|||
130469873|NCT05419505|469685786|FG002|Overall Study|Adverse Event|0|||
130469874|NCT05419505|469685787|FG003|Overall Study|Adverse Event|1|||
130469875|NCT05419505|469685788|FG004|Overall Study|Adverse Event|0|||
130469876|NCT05419505|469685789|FG005|Overall Study|Adverse Event|0|||
130469877|NCT05419505|469685790|FG006|Overall Study|Adverse Event|0|||
130469878|NCT05419505|469685791|FG007|Overall Study|Adverse Event|0|||
130469879|NCT05419505|469685784|FG000|Overall Study|Withdrawal by Subject|1|||
130469880|NCT05419505|469685785|FG001|Overall Study|Withdrawal by Subject|2|||
130469881|NCT05419505|469685786|FG002|Overall Study|Withdrawal by Subject|0|||
130469882|NCT05419505|469685787|FG003|Overall Study|Withdrawal by Subject|0|||
130469883|NCT05419505|469685788|FG004|Overall Study|Withdrawal by Subject|0|||
130388864|NCT05497284|469393309|FG000|Overall Study|Subject Decision|0|||
130388865|NCT05497284|469393310|FG001|Overall Study|Subject Decision|1|||
130388866|NCT03878446|469393311|FG000|Overall Study|Withdrawn by parent or guardian|1|||
130469884|NCT05419505|469685789|FG005|Overall Study|Withdrawal by Subject|0|||
130469885|NCT05419505|469685790|FG006|Overall Study|Withdrawal by Subject|1|||
130469886|NCT05419505|469685791|FG007|Overall Study|Withdrawal by Subject|0|||
130469887|NCT05419505|469685784|FG000|Overall Study|Lost to Follow-up|2|||
130469888|NCT05419505|469685785|FG001|Overall Study|Lost to Follow-up|1|||
130469889|NCT05419505|469685786|FG002|Overall Study|Lost to Follow-up|0|||
130469890|NCT05419505|469685787|FG003|Overall Study|Lost to Follow-up|0|||
130469891|NCT05419505|469685788|FG004|Overall Study|Lost to Follow-up|1|||
130469892|NCT05419505|469685789|FG005|Overall Study|Lost to Follow-up|2|||
130388867|NCT03878446|469393312|FG001|Overall Study|Withdrawn by parent or guardian|0|||
130388868|NCT03878446|469393313|FG002|Overall Study|Withdrawn by parent or guardian|0|||
130388869|NCT03878446|469393314|FG003|Overall Study|Withdrawn by parent or guardian|0|||
130388870|NCT03878446|469393315|FG004|Overall Study|Withdrawn by parent or guardian|0|||
130388871|NCT05214768|469393316|FG000|Induction Period|Withdrawal by Subject|1|||
130388872|NCT05214768|469393317|FG001|Induction Period|Withdrawal by Subject|0|||
130388873|NCT05214768|469393318|FG002|Induction Period|Withdrawal by Subject|0|||
130388874|NCT05214768|469393319|FG003|Induction Period|Withdrawal by Subject|0|||
130388875|NCT05214768|469393320|FG004|Induction Period|Withdrawal by Subject|0|||
130388876|NCT05214768|469393321|FG005|Induction Period|Withdrawal by Subject|0|||
130388877|NCT05214768|469393316|FG000|Induction Period|Physician Decision|1|||
130388878|NCT05214768|469393317|FG001|Induction Period|Physician Decision|0|||
130388879|NCT05214768|469393318|FG002|Induction Period|Physician Decision|0|||
130388880|NCT05214768|469393319|FG003|Induction Period|Physician Decision|0|||
130388881|NCT05214768|469393320|FG004|Induction Period|Physician Decision|0|||
130388882|NCT05214768|469393321|FG005|Induction Period|Physician Decision|0|||
130388883|NCT05214768|469393316|FG000|Maintenance Period|Other Reasons|0|||
130388884|NCT05214768|469393317|FG001|Maintenance Period|Other Reasons|0|||
130388885|NCT05214768|469393318|FG002|Maintenance Period|Other Reasons|1|||
130388886|NCT05214768|469393319|FG003|Maintenance Period|Other Reasons|1|||
130388887|NCT05214768|469393320|FG004|Maintenance Period|Other Reasons|0|||
130388888|NCT05214768|469393321|FG005|Maintenance Period|Other Reasons|0|||
130388889|NCT05214768|469393316|FG000|Maintenance Period|Withdrawal by Subject|0|||
130388890|NCT05214768|469393317|FG001|Maintenance Period|Withdrawal by Subject|0|||
130388891|NCT05214768|469393318|FG002|Maintenance Period|Withdrawal by Subject|0|||
130388892|NCT05214768|469393319|FG003|Maintenance Period|Withdrawal by Subject|1|||
130388893|NCT05214768|469393320|FG004|Maintenance Period|Withdrawal by Subject|0|||
130388894|NCT05214768|469393321|FG005|Maintenance Period|Withdrawal by Subject|0|||
130388895|NCT05214768|469393316|FG000|Maintenance Period|Lack of Efficacy|0|||
130388896|NCT05214768|469393317|FG001|Maintenance Period|Lack of Efficacy|0|||
130388897|NCT05214768|469393318|FG002|Maintenance Period|Lack of Efficacy|1|||
130388898|NCT05214768|469393319|FG003|Maintenance Period|Lack of Efficacy|0|||
130388899|NCT05214768|469393320|FG004|Maintenance Period|Lack of Efficacy|1|||
130388900|NCT05214768|469393321|FG005|Maintenance Period|Lack of Efficacy|0|||
130388901|NCT05214768|469393316|FG000|Open Label Extension Period|Physician Decision|0|||
130388902|NCT05214768|469393317|FG001|Open Label Extension Period|Physician Decision|0|||
130388903|NCT05214768|469393318|FG002|Open Label Extension Period|Physician Decision|0|||
130388904|NCT05214768|469393319|FG003|Open Label Extension Period|Physician Decision|0|||
130388905|NCT05214768|469393320|FG004|Open Label Extension Period|Physician Decision|0|||
130388906|NCT05214768|469393321|FG005|Open Label Extension Period|Physician Decision|1|||
130388907|NCT05214768|469393316|FG000|Open Label Extension Period|Lack of Efficacy|0|||
130388908|NCT05214768|469393317|FG001|Open Label Extension Period|Lack of Efficacy|0|||
130388909|NCT05214768|469393318|FG002|Open Label Extension Period|Lack of Efficacy|0|||
130388910|NCT05214768|469393319|FG003|Open Label Extension Period|Lack of Efficacy|0|||
130388911|NCT05214768|469393320|FG004|Open Label Extension Period|Lack of Efficacy|0|||
130388912|NCT05214768|469393321|FG005|Open Label Extension Period|Lack of Efficacy|1|||
130388913|NCT05214768|469393316|FG000|Open Label Extension Period|Ongoing Study|0|||
130388914|NCT05214768|469393317|FG001|Open Label Extension Period|Ongoing Study|0|||
130469893|NCT05419505|469685790|FG006|Overall Study|Lost to Follow-up|0|||
130469894|NCT05419505|469685791|FG007|Overall Study|Lost to Follow-up|1|||
130469895|NCT02780388|469685794|FG000|Overall Study|Lost to Follow-up|0|||
130469896|NCT02780388|469685795|FG001|Overall Study|Lost to Follow-up|1|||
130469897|NCT02780388|469685796|FG002|Overall Study|Lost to Follow-up|0|||
130469898|NCT02780388|469685797|FG003|Overall Study|Lost to Follow-up|0|||
130469899|NCT02780388|469685798|FG004|Overall Study|Lost to Follow-up|0|||
130469900|NCT02780388|469685794|FG000|Overall Study|Withdrawal by Subject|1|||
130469901|NCT02780388|469685795|FG001|Overall Study|Withdrawal by Subject|1|||
130469902|NCT02780388|469685796|FG002|Overall Study|Withdrawal by Subject|0|||
130469903|NCT02780388|469685797|FG003|Overall Study|Withdrawal by Subject|0|||
130469904|NCT02780388|469685798|FG004|Overall Study|Withdrawal by Subject|0|||
130469905|NCT02058108|469685799|FG000|Overall Study|Abnormal Laboratory Values|0|||
130469906|NCT02058108|469685800|FG001|Overall Study|Abnormal Laboratory Values|1|||
130388915|NCT05214768|469393318|FG002|Open Label Extension Period|Ongoing Study|0|||
130388916|NCT05214768|469393319|FG003|Open Label Extension Period|Ongoing Study|0|||
130388917|NCT05214768|469393320|FG004|Open Label Extension Period|Ongoing Study|0|||
130388918|NCT05214768|469393321|FG005|Open Label Extension Period|Ongoing Study|42|||
130388919|NCT05041322|469393322|FG000|Baseline|Withdrawal by Subject|1|||
130388920|NCT05041322|469393323|FG001|Baseline|Withdrawal by Subject|0|||
130388921|NCT05041322|469393322|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
130388922|NCT05041322|469393323|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
130388923|NCT05041322|469393322|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
130388924|NCT05041322|469393323|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
130388925|NCT01502423|469393324|FG000|Overall Study|Withdrawal by Subject|0|||
130388926|NCT01502423|469393325|FG001|Overall Study|Withdrawal by Subject|1|||
130388927|NCT00567892|469393326|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130469907|NCT02058108|469685799|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
130388928|NCT00567892|469393327|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130388929|NCT00567892|469393328|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
130388930|NCT00567892|469393329|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
130388931|NCT00567892|469393326|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130388932|NCT00567892|469393327|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130388933|NCT00567892|469393328|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130388934|NCT00567892|469393329|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
130388935|NCT04383743|469393330|FG000|Overall Study|Withdrawal by Subject|1|||
130388936|NCT04383743|469393330|FG000|Overall Study|Adverse Event|1|||
130388937|NCT01239368|469394743|FG000|Overall Study|Principal investigator discretion|1|||
130388938|NCT01239368|469394744|FG001|Overall Study|Principal investigator discretion|0|||
130388939|NCT01239368|469394745|FG002|Overall Study|Principal investigator discretion|0|||
130388940|NCT01239368|469394746|FG003|Overall Study|Principal investigator discretion|0|||
130388941|NCT01239368|469394747|FG004|Overall Study|Principal investigator discretion|1|||
130388942|NCT01239368|469394748|FG005|Overall Study|Principal investigator discretion|2|||
130388943|NCT01239368|469394749|FG006|Overall Study|Principal investigator discretion|0|||
130388944|NCT01239368|469394750|FG007|Overall Study|Principal investigator discretion|0|||
130388945|NCT01239368|469394751|FG008|Overall Study|Principal investigator discretion|0|||
130388946|NCT01239368|469394752|FG009|Overall Study|Principal investigator discretion|1|||
130388947|NCT01239368|469394743|FG000|Overall Study|Disease progression on study|1|||
130388948|NCT01239368|469394744|FG001|Overall Study|Disease progression on study|1|||
130388949|NCT01239368|469394745|FG002|Overall Study|Disease progression on study|1|||
130388950|NCT01239368|469394746|FG003|Overall Study|Disease progression on study|1|||
130388951|NCT01239368|469394747|FG004|Overall Study|Disease progression on study|4|||
130388952|NCT01239368|469394748|FG005|Overall Study|Disease progression on study|2|||
130388953|NCT01239368|469394749|FG006|Overall Study|Disease progression on study|5|||
130388954|NCT01239368|469394750|FG007|Overall Study|Disease progression on study|0|||
130388955|NCT01239368|469394751|FG008|Overall Study|Disease progression on study|0|||
130388956|NCT01239368|469394752|FG009|Overall Study|Disease progression on study|2|||
130388957|NCT01239368|469394743|FG000|Overall Study|Refused further treatment|0|||
130388958|NCT01239368|469394744|FG001|Overall Study|Refused further treatment|0|||
130388959|NCT01239368|469394745|FG002|Overall Study|Refused further treatment|0|||
130388960|NCT01239368|469394746|FG003|Overall Study|Refused further treatment|0|||
130388961|NCT01239368|469394747|FG004|Overall Study|Refused further treatment|0|||
130388962|NCT01239368|469394748|FG005|Overall Study|Refused further treatment|0|||
130388963|NCT01239368|469394749|FG006|Overall Study|Refused further treatment|0|||
130388964|NCT01239368|469394750|FG007|Overall Study|Refused further treatment|0|||
130388965|NCT01239368|469394751|FG008|Overall Study|Refused further treatment|0|||
130388966|NCT01239368|469394752|FG009|Overall Study|Refused further treatment|1|||
130388967|NCT01239368|469394743|FG000|Overall Study|Death|0|||
130388968|NCT01239368|469394744|FG001|Overall Study|Death|0|||
130388969|NCT01239368|469394745|FG002|Overall Study|Death|0|||
130388970|NCT01239368|469394746|FG003|Overall Study|Death|0|||
130388971|NCT01239368|469394747|FG004|Overall Study|Death|0|||
130388972|NCT01239368|469394748|FG005|Overall Study|Death|0|||
130388973|NCT01239368|469394749|FG006|Overall Study|Death|1|||
130388974|NCT01239368|469394750|FG007|Overall Study|Death|0|||
130388975|NCT01239368|469394751|FG008|Overall Study|Death|0|||
130388976|NCT01239368|469394752|FG009|Overall Study|Death|0|||
130388977|NCT01254227|469394757|FG000|Overall Study|Withdrawal by Subject|6|||
130388978|NCT01254227|469394757|FG000|Overall Study|Lost to Follow-up|6|||
130388979|NCT01254227|469394757|FG000|Overall Study|Adverse Event|5|||
130388980|NCT01254227|469394757|FG000|Overall Study|Abnormal test procedure result|5|||
130388981|NCT01254227|469394757|FG000|Overall Study|Administrative problems|2|||
130388982|NCT01254227|469394757|FG000|Overall Study|Death|1|||
130388983|NCT01254227|469394757|FG000|Overall Study|Protocol deviation|1|||
130388984|NCT03265249|469394760|FG000|Overall Study|Withdrawal by Subject|0|||
130388985|NCT03265249|469394761|FG001|Overall Study|Withdrawal by Subject|1|||
130388986|NCT01614990|469394762|FG000|Overall Study|Protocol Violation|1|||
130388987|NCT01614990|469394763|FG001|Overall Study|Protocol Violation|1|||
130388988|NCT01012622|469394768|FG000|Overall Study|Withdrawal by Subject|6|||
130388989|NCT01012622|469394768|FG000|Overall Study|Lost to Follow-up|5|||
130469908|NCT02058108|469685800|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130469909|NCT02058108|469685799|FG000|Overall Study|No longer requires study drug|0|||
130469910|NCT02058108|469685800|FG001|Overall Study|No longer requires study drug|1|||
130469911|NCT02058108|469685799|FG000|Overall Study|Withdrawal by Subject|1|||
130469912|NCT02058108|469685800|FG001|Overall Study|Withdrawal by Subject|0|||
130722652|NCT00492024|470609666|FG000|Follow up|Lack of Efficacy|0|||
130388990|NCT01012622|469394768|FG000|Overall Study|Adverse Event|7|||
130388991|NCT01012622|469394768|FG000|Overall Study|non-compliance with the drug|9|||
130388992|NCT01012622|469394768|FG000|Overall Study|Other|1|||
130388993|NCT01012622|469394768|FG000|Overall Study|screening failure|1|||
130388994|NCT01012622|469394768|FG000|Overall Study|withdrawal of consent by a parent|2|||
130388995|NCT00706641|469394770|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
130722653|NCT00492024|470609667|FG001|Follow up|Lack of Efficacy|1|||
130559810|NCT03044249|470017884|FG000|Overall Study|Study Terminated by Sponsor|2|||
130559811|NCT03044249|470017885|FG001|Overall Study|Study Terminated by Sponsor|0|||
130559812|NCT03044249|470017884|FG000|Overall Study|Withdrawal by Subject|2|||
130559813|NCT03044249|470017885|FG001|Overall Study|Withdrawal by Subject|5|||
130559814|NCT00955279|470017886|FG000|Overall Study|Other|0|||
130559815|NCT00955279|470017887|FG001|Overall Study|Other|0|||
130559816|NCT00955279|470017888|FG002|Overall Study|Other|3|||
130559817|NCT00955279|470017886|FG000|Overall Study|Death|1|||
130559818|NCT00955279|470017887|FG001|Overall Study|Death|1|||
130559819|NCT00955279|470017888|FG002|Overall Study|Death|1|||
130559820|NCT00955279|470017886|FG000|Overall Study|Lost to Follow-up|0|||
130559821|NCT00955279|470017887|FG001|Overall Study|Lost to Follow-up|3|||
130559822|NCT00955279|470017888|FG002|Overall Study|Lost to Follow-up|1|||
130559823|NCT00955279|470017886|FG000|Overall Study|Withdrawal by Subject|2|||
130559824|NCT00955279|470017887|FG001|Overall Study|Withdrawal by Subject|0|||
130559825|NCT00955279|470017888|FG002|Overall Study|Withdrawal by Subject|3|||
130559826|NCT02632721|470017890|FG000|Overall Study|Adverse Event|0|||
130559827|NCT02632721|470017891|FG001|Overall Study|Adverse Event|0|||
130559828|NCT02632721|470017892|FG002|Overall Study|Adverse Event|2|||
130559829|NCT02632721|470017893|FG003|Overall Study|Adverse Event|5|||
130559830|NCT02632721|470017894|FG004|Overall Study|Adverse Event|3|||
130559831|NCT02632721|470017890|FG000|Overall Study|Dose limiting toxicity|0|||
130559832|NCT02632721|470017891|FG001|Overall Study|Dose limiting toxicity|0|||
130559833|NCT02632721|470017892|FG002|Overall Study|Dose limiting toxicity|0|||
130559834|NCT02632721|470017893|FG003|Overall Study|Dose limiting toxicity|1|||
130559835|NCT02632721|470017894|FG004|Overall Study|Dose limiting toxicity|0|||
130388996|NCT00706641|469394770|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
130388997|NCT00706641|469394770|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
130388998|NCT02535741|469394771|FG000|Overall Study|Adverse Event|3|||
130388999|NCT02535741|469394771|FG000|Overall Study|Withdrawal by Subject|9|||
130389000|NCT02535741|469394771|FG000|Overall Study|Lost to Follow-up|10|||
130389001|NCT02535741|469394771|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
130389002|NCT02535741|469394771|FG000|Overall Study|Missing data|6|||
130389003|NCT00798369|469394772|FG000|Overall Study|Subject withdrew consent|0|||
130389004|NCT00798369|469394773|FG001|Overall Study|Subject withdrew consent|0|||
130389005|NCT00798369|469394774|FG002|Overall Study|Subject withdrew consent|1|||
130389006|NCT00798369|469394775|FG003|Overall Study|Subject withdrew consent|1|||
130389007|NCT00798369|469394776|FG004|Overall Study|Subject withdrew consent|0|||
130389008|NCT00798369|469394777|FG005|Overall Study|Subject withdrew consent|2|||
130389009|NCT00798369|469394772|FG000|Overall Study|Lost to Follow-up|1|||
130389010|NCT00798369|469394773|FG001|Overall Study|Lost to Follow-up|1|||
130389011|NCT00798369|469394774|FG002|Overall Study|Lost to Follow-up|1|||
130389012|NCT00798369|469394775|FG003|Overall Study|Lost to Follow-up|0|||
130389013|NCT00798369|469394776|FG004|Overall Study|Lost to Follow-up|1|||
130389014|NCT00798369|469394777|FG005|Overall Study|Lost to Follow-up|0|||
130389015|NCT00798369|469394772|FG000|Overall Study|Adminstrative problems|0|||
130389016|NCT00798369|469394773|FG001|Overall Study|Adminstrative problems|0|||
130389017|NCT00798369|469394774|FG002|Overall Study|Adminstrative problems|0|||
130389018|NCT00798369|469394775|FG003|Overall Study|Adminstrative problems|0|||
130389019|NCT00798369|469394776|FG004|Overall Study|Adminstrative problems|0|||
130389020|NCT00798369|469394777|FG005|Overall Study|Adminstrative problems|1|||
130389021|NCT04475588|469394778|FG000|Overall Study|Adverse Event|2|||
130389022|NCT04475588|469394779|FG001|Overall Study|Adverse Event|0|||
130389023|NCT04762680|469394780|FG000|Phase 2|Adverse Event|0|||
130389024|NCT04762680|469394781|FG001|Phase 2|Adverse Event|1|||
130389025|NCT04762680|469394782|FG002|Phase 2|Adverse Event|0|||
130389026|NCT04762680|469394783|FG003|Phase 2|Adverse Event|0|||
130559836|NCT02632721|470017890|FG000|Overall Study|Progressive disease|3|||
130559837|NCT02632721|470017891|FG001|Overall Study|Progressive disease|0|||
130559838|NCT02632721|470017892|FG002|Overall Study|Progressive disease|4|||
130559839|NCT02632721|470017893|FG003|Overall Study|Progressive disease|6|||
130559840|NCT02632721|470017894|FG004|Overall Study|Progressive disease|5|||
130559841|NCT02632721|470017890|FG000|Overall Study|Refused to continue taking trial medication|0|||
130559842|NCT02632721|470017891|FG001|Overall Study|Refused to continue taking trial medication|1|||
130559843|NCT02632721|470017892|FG002|Overall Study|Refused to continue taking trial medication|1|||
130559844|NCT02632721|470017893|FG003|Overall Study|Refused to continue taking trial medication|1|||
130559845|NCT02632721|470017894|FG004|Overall Study|Refused to continue taking trial medication|2|||
130559846|NCT02632721|470017890|FG000|Overall Study|Inadequate clinical condition|0|||
130559847|NCT02632721|470017891|FG001|Overall Study|Inadequate clinical condition|0|||
130559848|NCT02632721|470017892|FG002|Overall Study|Inadequate clinical condition|0|||
130559849|NCT02632721|470017893|FG003|Overall Study|Inadequate clinical condition|0|||
130559850|NCT02632721|470017894|FG004|Overall Study|Inadequate clinical condition|1|||
130559851|NCT02632721|470017890|FG000|Overall Study|No meet eligibility|0|||
130559852|NCT02632721|470017891|FG001|Overall Study|No meet eligibility|0|||
130559853|NCT02632721|470017892|FG002|Overall Study|No meet eligibility|0|||
130559854|NCT02632721|470017893|FG003|Overall Study|No meet eligibility|0|||
130559855|NCT02632721|470017894|FG004|Overall Study|No meet eligibility|1|||
130722654|NCT00492024|470609666|FG000|Follow up|Lost to Follow-up|1|||
130722655|NCT00492024|470609667|FG001|Follow up|Lost to Follow-up|1|||
130722656|NCT03247816|470609672|FG000|Overall Study|Adverse Event|12|||
130722657|NCT03247816|470609672|FG000|Overall Study|Physician Decision|3|||
130722658|NCT03247816|470609672|FG000|Overall Study|Lack of Efficacy|1|||
130722659|NCT03247816|470609672|FG000|Overall Study|Lost to Follow-up|10|||
130722660|NCT03247816|470609672|FG000|Overall Study|Missing Feraccru stop date|3|||
130389027|NCT04762680|469394784|FG004|Phase 2|Adverse Event|0|||
130389028|NCT04762680|469394785|FG005|Phase 2|Adverse Event|0|||
130389029|NCT04762680|469394786|FG006|Phase 2|Adverse Event|0|||
130389030|NCT04762680|469394787|FG007|Phase 2|Adverse Event|0|||
130389031|NCT04762680|469394788|FG008|Phase 2|Adverse Event|0|||
130389032|NCT04762680|469394789|FG009|Phase 2|Adverse Event|0|||
130389033|NCT04762680|469394790|FG010|Phase 2|Adverse Event|0|||
130389034|NCT04762680|469394791|FG011|Phase 2|Adverse Event|0|||
130389035|NCT04762680|469394792|FG012|Phase 2|Adverse Event|0|||
130389036|NCT04762680|469394793|FG013|Phase 2|Adverse Event|0|||
130389037|NCT04762680|469394794|FG014|Phase 2|Adverse Event|0|||
130389038|NCT04762680|469394795|FG015|Phase 2|Adverse Event|0|||
130389039|NCT04762680|469394796|FG016|Phase 2|Adverse Event|0|||
130389040|NCT04762680|469394797|FG017|Phase 2|Adverse Event|0|||
130389041|NCT04762680|469394798|FG018|Phase 2|Adverse Event|0|||
130389042|NCT04762680|469394799|FG019|Phase 2|Adverse Event|0|||
130389043|NCT04762680|469394800|FG020|Phase 2|Adverse Event|0|||
130389044|NCT04762680|469394801|FG021|Phase 2|Adverse Event|0|||
130389045|NCT04762680|469394780|FG000|Phase 2|Protocol Violation|5|||
130389046|NCT04762680|469394781|FG001|Phase 2|Protocol Violation|5|||
130389047|NCT04762680|469394782|FG002|Phase 2|Protocol Violation|1|||
130389048|NCT04762680|469394783|FG003|Phase 2|Protocol Violation|0|||
130389049|NCT04762680|469394784|FG004|Phase 2|Protocol Violation|0|||
130389050|NCT04762680|469394785|FG005|Phase 2|Protocol Violation|0|||
130389051|NCT04762680|469394786|FG006|Phase 2|Protocol Violation|0|||
130389052|NCT04762680|469394787|FG007|Phase 2|Protocol Violation|0|||
130389053|NCT04762680|469394788|FG008|Phase 2|Protocol Violation|0|||
130389054|NCT04762680|469394789|FG009|Phase 2|Protocol Violation|0|||
130389055|NCT04762680|469394790|FG010|Phase 2|Protocol Violation|0|||
130389056|NCT04762680|469394791|FG011|Phase 2|Protocol Violation|0|||
130389057|NCT04762680|469394792|FG012|Phase 2|Protocol Violation|0|||
130389058|NCT04762680|469394793|FG013|Phase 2|Protocol Violation|0|||
130389059|NCT04762680|469394794|FG014|Phase 2|Protocol Violation|0|||
130389060|NCT04762680|469394795|FG015|Phase 2|Protocol Violation|0|||
130389061|NCT04762680|469394796|FG016|Phase 2|Protocol Violation|0|||
130389062|NCT04762680|469394797|FG017|Phase 2|Protocol Violation|0|||
130389063|NCT04762680|469394798|FG018|Phase 2|Protocol Violation|0|||
130389064|NCT04762680|469394799|FG019|Phase 2|Protocol Violation|0|||
130389065|NCT04762680|469394800|FG020|Phase 2|Protocol Violation|0|||
130389066|NCT04762680|469394801|FG021|Phase 2|Protocol Violation|0|||
130389067|NCT04762680|469394780|FG000|Phase 2|Withdrawal by Subject|23|||
130389068|NCT04762680|469394781|FG001|Phase 2|Withdrawal by Subject|21|||
130389069|NCT04762680|469394782|FG002|Phase 2|Withdrawal by Subject|28|||
130389070|NCT04762680|469394783|FG003|Phase 2|Withdrawal by Subject|0|||
130389071|NCT04762680|469394784|FG004|Phase 2|Withdrawal by Subject|0|||
130389072|NCT04762680|469394785|FG005|Phase 2|Withdrawal by Subject|0|||
130389073|NCT04762680|469394786|FG006|Phase 2|Withdrawal by Subject|0|||
130389074|NCT04762680|469394787|FG007|Phase 2|Withdrawal by Subject|0|||
130389075|NCT04762680|469394788|FG008|Phase 2|Withdrawal by Subject|0|||
130389076|NCT04762680|469394789|FG009|Phase 2|Withdrawal by Subject|0|||
130389077|NCT04762680|469394790|FG010|Phase 2|Withdrawal by Subject|0|||
130389078|NCT04762680|469394791|FG011|Phase 2|Withdrawal by Subject|0|||
130389079|NCT04762680|469394792|FG012|Phase 2|Withdrawal by Subject|0|||
130389080|NCT04762680|469394793|FG013|Phase 2|Withdrawal by Subject|0|||
130389081|NCT04762680|469394794|FG014|Phase 2|Withdrawal by Subject|0|||
130389082|NCT04762680|469394795|FG015|Phase 2|Withdrawal by Subject|0|||
130389083|NCT04762680|469394796|FG016|Phase 2|Withdrawal by Subject|0|||
130389084|NCT04762680|469394797|FG017|Phase 2|Withdrawal by Subject|0|||
130722661|NCT04623086|470609673|FG000|Overall Study|Withdrawal by Subject|0|||
130389085|NCT04762680|469394798|FG018|Phase 2|Withdrawal by Subject|0|||
130389086|NCT04762680|469394799|FG019|Phase 2|Withdrawal by Subject|0|||
130389087|NCT04762680|469394800|FG020|Phase 2|Withdrawal by Subject|0|||
130389088|NCT04762680|469394801|FG021|Phase 2|Withdrawal by Subject|0|||
130389089|NCT04762680|469394780|FG000|Phase 2|Lost to Follow-up|14|||
130389090|NCT04762680|469394781|FG001|Phase 2|Lost to Follow-up|8|||
130722662|NCT04623086|470609674|FG001|Overall Study|Withdrawal by Subject|0|||
130389091|NCT04762680|469394782|FG002|Phase 2|Lost to Follow-up|9|||
130389092|NCT04762680|469394783|FG003|Phase 2|Lost to Follow-up|0|||
130389093|NCT04762680|469394784|FG004|Phase 2|Lost to Follow-up|0|||
130389094|NCT04762680|469394785|FG005|Phase 2|Lost to Follow-up|0|||
130389095|NCT04762680|469394786|FG006|Phase 2|Lost to Follow-up|0|||
130389096|NCT04762680|469394787|FG007|Phase 2|Lost to Follow-up|0|||
130389097|NCT04762680|469394788|FG008|Phase 2|Lost to Follow-up|0|||
130389098|NCT04762680|469394789|FG009|Phase 2|Lost to Follow-up|0|||
130389099|NCT04762680|469394790|FG010|Phase 2|Lost to Follow-up|0|||
130722663|NCT04623086|470609675|FG002|Overall Study|Withdrawal by Subject|10|||
130389100|NCT04762680|469394791|FG011|Phase 2|Lost to Follow-up|0|||
130389101|NCT04762680|469394792|FG012|Phase 2|Lost to Follow-up|0|||
130722664|NCT04546724|470609676|FG000|Overall Study|Withdrawal by Subject|145|||
130722665|NCT04546724|470609677|FG001|Overall Study|Withdrawal by Subject|41|||
130722666|NCT04546724|470609676|FG000|Overall Study|Adverse Event|1|||
130722667|NCT04546724|470609677|FG001|Overall Study|Adverse Event|1|||
130722668|NCT04546724|470609676|FG000|Overall Study|Lost to Follow-up|186|||
130722669|NCT04546724|470609677|FG001|Overall Study|Lost to Follow-up|63|||
130722670|NCT04546724|470609676|FG000|Overall Study|Physician Decision|8|||
130722671|NCT04546724|470609677|FG001|Overall Study|Physician Decision|2|||
130722672|NCT04546724|470609676|FG000|Overall Study|Death|2|||
130389102|NCT04762680|469394793|FG013|Phase 2|Lost to Follow-up|0|||
130389103|NCT04762680|469394794|FG014|Phase 2|Lost to Follow-up|0|||
130389104|NCT04762680|469394795|FG015|Phase 2|Lost to Follow-up|0|||
130389105|NCT04762680|469394796|FG016|Phase 2|Lost to Follow-up|0|||
130389106|NCT04762680|469394797|FG017|Phase 2|Lost to Follow-up|0|||
130389107|NCT04762680|469394798|FG018|Phase 2|Lost to Follow-up|0|||
130389108|NCT04762680|469394799|FG019|Phase 2|Lost to Follow-up|0|||
130389109|NCT04762680|469394800|FG020|Phase 2|Lost to Follow-up|0|||
130389110|NCT04762680|469394801|FG021|Phase 2|Lost to Follow-up|0|||
130389111|NCT04762680|469394780|FG000|Phase 3|Adverse Event|0|||
130389112|NCT04762680|469394781|FG001|Phase 3|Adverse Event|0|||
130389113|NCT04762680|469394782|FG002|Phase 3|Adverse Event|0|||
130389114|NCT04762680|469394783|FG003|Phase 3|Adverse Event|1|||
130389115|NCT04762680|469394784|FG004|Phase 3|Adverse Event|0|||
130389116|NCT04762680|469394785|FG005|Phase 3|Adverse Event|0|||
130389117|NCT04762680|469394786|FG006|Phase 3|Adverse Event|0|||
130389118|NCT04762680|469394787|FG007|Phase 3|Adverse Event|0|||
130389119|NCT04762680|469394788|FG008|Phase 3|Adverse Event|0|||
130389120|NCT04762680|469394789|FG009|Phase 3|Adverse Event|0|||
130389121|NCT04762680|469394790|FG010|Phase 3|Adverse Event|0|||
130389122|NCT04762680|469394791|FG011|Phase 3|Adverse Event|0|||
130389123|NCT04762680|469394792|FG012|Phase 3|Adverse Event|0|||
130389124|NCT04762680|469394793|FG013|Phase 3|Adverse Event|0|||
130389125|NCT04762680|469394794|FG014|Phase 3|Adverse Event|0|||
130389126|NCT04762680|469394795|FG015|Phase 3|Adverse Event|0|||
130389127|NCT04762680|469394796|FG016|Phase 3|Adverse Event|0|||
130389128|NCT04762680|469394797|FG017|Phase 3|Adverse Event|3|||
130389129|NCT04762680|469394798|FG018|Phase 3|Adverse Event|0|||
130389130|NCT04762680|469394799|FG019|Phase 3|Adverse Event|0|||
130389131|NCT04762680|469394800|FG020|Phase 3|Adverse Event|0|||
130389132|NCT04762680|469394801|FG021|Phase 3|Adverse Event|0|||
130389133|NCT04762680|469394780|FG000|Phase 3|Protocol Violation|0|||
130389134|NCT04762680|469394781|FG001|Phase 3|Protocol Violation|0|||
130389135|NCT04762680|469394782|FG002|Phase 3|Protocol Violation|0|||
130389136|NCT04762680|469394783|FG003|Phase 3|Protocol Violation|4|||
130389137|NCT04762680|469394784|FG004|Phase 3|Protocol Violation|1|||
130389138|NCT04762680|469394785|FG005|Phase 3|Protocol Violation|5|||
130389139|NCT04762680|469394786|FG006|Phase 3|Protocol Violation|1|||
130389140|NCT04762680|469394787|FG007|Phase 3|Protocol Violation|0|||
130389141|NCT04762680|469394788|FG008|Phase 3|Protocol Violation|0|||
130389142|NCT04762680|469394789|FG009|Phase 3|Protocol Violation|0|||
130389143|NCT04762680|469394790|FG010|Phase 3|Protocol Violation|0|||
130389144|NCT04762680|469394791|FG011|Phase 3|Protocol Violation|2|||
130389145|NCT04762680|469394792|FG012|Phase 3|Protocol Violation|3|||
130389146|NCT04762680|469394793|FG013|Phase 3|Protocol Violation|0|||
130389147|NCT04762680|469394794|FG014|Phase 3|Protocol Violation|0|||
130389148|NCT04762680|469394795|FG015|Phase 3|Protocol Violation|1|||
130389149|NCT04762680|469394796|FG016|Phase 3|Protocol Violation|0|||
130389150|NCT04762680|469394797|FG017|Phase 3|Protocol Violation|10|||
130389151|NCT04762680|469394798|FG018|Phase 3|Protocol Violation|0|||
130389152|NCT04762680|469394799|FG019|Phase 3|Protocol Violation|0|||
130389153|NCT04762680|469394800|FG020|Phase 3|Protocol Violation|0|||
130389154|NCT04762680|469394801|FG021|Phase 3|Protocol Violation|0|||
130389155|NCT04762680|469394780|FG000|Phase 3|Withdrawal by Subject|0|||
130389156|NCT04762680|469394781|FG001|Phase 3|Withdrawal by Subject|0|||
130389157|NCT04762680|469394782|FG002|Phase 3|Withdrawal by Subject|0|||
130389158|NCT04762680|469394783|FG003|Phase 3|Withdrawal by Subject|13|||
130389159|NCT04762680|469394784|FG004|Phase 3|Withdrawal by Subject|17|||
130389160|NCT04762680|469394785|FG005|Phase 3|Withdrawal by Subject|12|||
130389161|NCT04762680|469394786|FG006|Phase 3|Withdrawal by Subject|8|||
130389162|NCT04762680|469394787|FG007|Phase 3|Withdrawal by Subject|3|||
130389163|NCT04762680|469394788|FG008|Phase 3|Withdrawal by Subject|2|||
130389164|NCT04762680|469394789|FG009|Phase 3|Withdrawal by Subject|4|||
130389165|NCT04762680|469394790|FG010|Phase 3|Withdrawal by Subject|3|||
130389166|NCT04762680|469394791|FG011|Phase 3|Withdrawal by Subject|1|||
130389167|NCT04762680|469394792|FG012|Phase 3|Withdrawal by Subject|3|||
130389168|NCT04762680|469394793|FG013|Phase 3|Withdrawal by Subject|2|||
130389169|NCT04762680|469394794|FG014|Phase 3|Withdrawal by Subject|1|||
130389170|NCT04762680|469394795|FG015|Phase 3|Withdrawal by Subject|4|||
130389171|NCT04762680|469394796|FG016|Phase 3|Withdrawal by Subject|6|||
130389172|NCT04762680|469394797|FG017|Phase 3|Withdrawal by Subject|32|||
130389173|NCT04762680|469394798|FG018|Phase 3|Withdrawal by Subject|0|||
130722673|NCT04546724|470609677|FG001|Overall Study|Death|1|||
130389174|NCT04762680|469394799|FG019|Phase 3|Withdrawal by Subject|0|||
130389175|NCT04762680|469394800|FG020|Phase 3|Withdrawal by Subject|0|||
130469913|NCT02058108|469685799|FG000|Overall Study|Administrative problems|3|||
130469914|NCT02058108|469685800|FG001|Overall Study|Administrative problems|3|||
130469915|NCT02058108|469685799|FG000|Overall Study|Protocol Violation|0|||
130469916|NCT02058108|469685800|FG001|Overall Study|Protocol Violation|1|||
130469917|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
130469918|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
130469919|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
130469920|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
130469921|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
130469922|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
130469923|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
130469924|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
130469925|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
130469926|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
130469927|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
130469928|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
130469929|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
130469930|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
130469931|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
130469932|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
130469933|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
130469934|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
130469935|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
130469936|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
130469937|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
130389176|NCT04762680|469394801|FG021|Phase 3|Withdrawal by Subject|0|||
130389177|NCT04762680|469394780|FG000|Phase 3|Lost to Follow-up|0|||
130389178|NCT04762680|469394781|FG001|Phase 3|Lost to Follow-up|0|||
130389179|NCT04762680|469394782|FG002|Phase 3|Lost to Follow-up|0|||
130389180|NCT04762680|469394783|FG003|Phase 3|Lost to Follow-up|9|||
130389181|NCT04762680|469394784|FG004|Phase 3|Lost to Follow-up|22|||
130389182|NCT04762680|469394785|FG005|Phase 3|Lost to Follow-up|24|||
130389183|NCT04762680|469394786|FG006|Phase 3|Lost to Follow-up|2|||
130389184|NCT04762680|469394787|FG007|Phase 3|Lost to Follow-up|4|||
130389185|NCT04762680|469394788|FG008|Phase 3|Lost to Follow-up|6|||
130389186|NCT04762680|469394789|FG009|Phase 3|Lost to Follow-up|4|||
130389187|NCT04762680|469394790|FG010|Phase 3|Lost to Follow-up|3|||
130389188|NCT04762680|469394791|FG011|Phase 3|Lost to Follow-up|0|||
130389189|NCT04762680|469394792|FG012|Phase 3|Lost to Follow-up|5|||
130389190|NCT04762680|469394793|FG013|Phase 3|Lost to Follow-up|4|||
130389191|NCT04762680|469394794|FG014|Phase 3|Lost to Follow-up|6|||
130389192|NCT04762680|469394795|FG015|Phase 3|Lost to Follow-up|1|||
130389193|NCT04762680|469394796|FG016|Phase 3|Lost to Follow-up|1|||
130389194|NCT04762680|469394797|FG017|Phase 3|Lost to Follow-up|66|||
130389195|NCT04762680|469394798|FG018|Phase 3|Lost to Follow-up|0|||
130389196|NCT04762680|469394799|FG019|Phase 3|Lost to Follow-up|0|||
130389197|NCT04762680|469394800|FG020|Phase 3|Lost to Follow-up|0|||
130389198|NCT04762680|469394801|FG021|Phase 3|Lost to Follow-up|0|||
130389199|NCT04762680|469394780|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389200|NCT04762680|469394781|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389201|NCT04762680|469394782|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389202|NCT04762680|469394783|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389203|NCT04762680|469394784|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389204|NCT04762680|469394785|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389205|NCT04762680|469394786|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389206|NCT04762680|469394787|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389207|NCT04762680|469394788|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130469938|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
130559856|NCT02632721|470017890|FG000|Overall Study|Allergic reaction|0|||
130389208|NCT04762680|469394789|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389209|NCT04762680|469394790|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389210|NCT04762680|469394791|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389211|NCT04762680|469394792|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389212|NCT04762680|469394793|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389213|NCT04762680|469394794|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389214|NCT04762680|469394795|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389215|NCT04762680|469394796|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389216|NCT04762680|469394797|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130469939|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
130469940|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
130469941|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
130469942|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
130469943|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
130389217|NCT04762680|469394798|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389218|NCT04762680|469394799|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389219|NCT04762680|469394800|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130389220|NCT04762680|469394801|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
130389221|NCT04762680|469394780|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389222|NCT04762680|469394781|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389223|NCT04762680|469394782|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389224|NCT04762680|469394783|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389225|NCT04762680|469394784|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389226|NCT04762680|469394785|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389227|NCT04762680|469394786|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389228|NCT04762680|469394787|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389229|NCT04762680|469394788|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389230|NCT04762680|469394789|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389231|NCT04762680|469394790|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389232|NCT04762680|469394791|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389233|NCT04762680|469394792|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389234|NCT04762680|469394793|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389235|NCT04762680|469394794|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389236|NCT04762680|469394795|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389237|NCT04762680|469394796|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389238|NCT04762680|469394797|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389239|NCT04762680|469394798|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389240|NCT04762680|469394799|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
130389241|NCT04762680|469394800|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389242|NCT04762680|469394801|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
130389243|NCT02082210|469394802|FG000|Overall Study|Death|0|||
130389244|NCT02082210|469394803|FG001|Overall Study|Death|0|||
130389245|NCT02082210|469394804|FG002|Overall Study|Death|1|||
130389246|NCT02082210|469394805|FG003|Overall Study|Death|1|||
130389247|NCT02082210|469394806|FG004|Overall Study|Death|1|||
130389248|NCT02082210|469394807|FG005|Overall Study|Death|0|||
130389249|NCT02082210|469394802|FG000|Overall Study|Withdrawal by Subject|0|||
130389250|NCT02082210|469394803|FG001|Overall Study|Withdrawal by Subject|0|||
130389251|NCT02082210|469394804|FG002|Overall Study|Withdrawal by Subject|0|||
130389252|NCT02082210|469394805|FG003|Overall Study|Withdrawal by Subject|1|||
130389253|NCT02082210|469394806|FG004|Overall Study|Withdrawal by Subject|2|||
130389254|NCT02082210|469394807|FG005|Overall Study|Withdrawal by Subject|2|||
130389255|NCT02082210|469394802|FG000|Overall Study|Clinical Progression|0|||
130389256|NCT02082210|469394803|FG001|Overall Study|Clinical Progression|0|||
130389257|NCT02082210|469394804|FG002|Overall Study|Clinical Progression|0|||
130389258|NCT02082210|469394805|FG003|Overall Study|Clinical Progression|1|||
130389259|NCT02082210|469394806|FG004|Overall Study|Clinical Progression|0|||
130389260|NCT02082210|469394807|FG005|Overall Study|Clinical Progression|0|||
130389261|NCT02082210|469394802|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
130389262|NCT02082210|469394803|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
130389263|NCT02082210|469394804|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
130389264|NCT02082210|469394805|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
130389265|NCT02082210|469394806|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
130389266|NCT02082210|469394807|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
130389267|NCT02082210|469394802|FG000|Overall Study|Physician Decision|0|||
130389268|NCT02082210|469394803|FG001|Overall Study|Physician Decision|0|||
130389269|NCT02082210|469394804|FG002|Overall Study|Physician Decision|1|||
130389270|NCT02082210|469394805|FG003|Overall Study|Physician Decision|1|||
130389271|NCT02082210|469394806|FG004|Overall Study|Physician Decision|0|||
130389272|NCT02082210|469394807|FG005|Overall Study|Physician Decision|0|||
130389273|NCT04461015|469394821|FG000|Overall Study|IV access lost during the study|0|||
130389274|NCT04461015|469394822|FG001|Overall Study|IV access lost during the study|1|||
130389275|NCT04461015|469394821|FG000|Overall Study|Withdrawal by Subject|0|||
130389276|NCT04461015|469394822|FG001|Overall Study|Withdrawal by Subject|1|||
130389277|NCT03506373|469394835|FG000|Overall Study|Adverse Event|6|||
130389278|NCT03506373|469394835|FG000|Overall Study|Withdrawal by Subject|2|||
130389279|NCT03506373|469394835|FG000|Overall Study|Disease progression|5|||
130389280|NCT03506373|469394835|FG000|Overall Study|Other|3|||
130389281|NCT00885755|469394836|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
130389282|NCT00885755|469394837|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
130389283|NCT00885755|469394838|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
130389284|NCT00885755|469394836|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
130389285|NCT00885755|469394837|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
130389286|NCT00885755|469394838|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
130389287|NCT00885755|469394836|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
130389288|NCT00885755|469394837|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
130389289|NCT00885755|469394838|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
130389290|NCT00885755|469394836|FG000|Part I: Trastuzumab+Taxane|Death|0|||
130389291|NCT00885755|469394837|FG001|Part I: Trastuzumab+Taxane|Death|0|||
130389292|NCT00885755|469394838|FG002|Part I: Trastuzumab+Taxane|Death|1|||
130389293|NCT00885755|469394836|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
130389294|NCT00885755|469394837|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
130389295|NCT00885755|469394838|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
130389296|NCT05442554|469394839|FG000|Overall Study|Adverse Event|1|||
130389297|NCT01817725|469394840|FG000|Overall Study|Withdrawal by Subject|1|||
130389298|NCT01852812|469394841|FG000|Overall Study|Adverse Event|0|||
130389299|NCT01852812|469394842|FG001|Overall Study|Adverse Event|0|||
130389300|NCT01852812|469394843|FG002|Overall Study|Adverse Event|1|||
130389301|NCT01852812|469394841|FG000|Overall Study|Non-compliance With Study Drug|0|||
130389302|NCT01852812|469394842|FG001|Overall Study|Non-compliance With Study Drug|1|||
130389303|NCT01852812|469394843|FG002|Overall Study|Non-compliance With Study Drug|0|||
130389304|NCT02250443|469394844|FG000|Overall Study|Administrative problems|7|||
130389305|NCT02250443|469394844|FG000|Overall Study|Adverse Event|3|||
130389306|NCT01549964|469394845|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
130389307|NCT01549964|469394846|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
130389308|NCT01549964|469394847|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
130389309|NCT01549964|469394848|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
130389310|NCT01549964|469394845|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
130389311|NCT01549964|469394846|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
130469944|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
130469945|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
130469946|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
130469947|NCT04759833|469685804|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
130469948|NCT04759833|469685805|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
130469949|NCT04759833|469685806|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
130389312|NCT01549964|469394847|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
130389313|NCT01549964|469394848|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
130389314|NCT01549964|469394845|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
130389315|NCT01549964|469394846|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130389316|NCT01549964|469394847|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130389317|NCT01549964|469394848|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130389318|NCT01549964|469394845|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
130389319|NCT01549964|469394846|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
130389320|NCT01549964|469394847|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
130389321|NCT01549964|469394848|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
130389322|NCT01549964|469394845|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
130389323|NCT01549964|469394846|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
130389324|NCT01549964|469394847|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
130389325|NCT01549964|469394848|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
130389326|NCT01549964|469394845|FG000|24-Week Treatment Period|Other|1|||
130389327|NCT01549964|469394846|FG001|24-Week Treatment Period|Other|0|||
130389328|NCT01549964|469394847|FG002|24-Week Treatment Period|Other|1|||
130559857|NCT02632721|470017891|FG001|Overall Study|Allergic reaction|0|||
130559858|NCT02632721|470017892|FG002|Overall Study|Allergic reaction|0|||
130559859|NCT02632721|470017893|FG003|Overall Study|Allergic reaction|1|||
130559860|NCT02632721|470017894|FG004|Overall Study|Allergic reaction|0|||
130389329|NCT01549964|469394848|FG003|24-Week Treatment Period|Other|0|||
130389330|NCT01549964|469394845|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130389331|NCT01549964|469394846|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130469950|NCT04759833|469685807|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
130469951|NCT04759833|469685808|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
130559861|NCT02632721|470017890|FG000|Overall Study|Receiving Decitabine locally|0|||
130389332|NCT01549964|469394847|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
130389333|NCT01549964|469394848|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130389334|NCT01549964|469394845|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
130389335|NCT01549964|469394846|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
130559862|NCT02632721|470017891|FG001|Overall Study|Receiving Decitabine locally|0|||
130389336|NCT01549964|469394847|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
130389337|NCT01549964|469394848|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
130559863|NCT02632721|470017892|FG002|Overall Study|Receiving Decitabine locally|1|||
130389338|NCT01549964|469394845|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
130389339|NCT01549964|469394846|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
130722674|NCT04546724|470609676|FG000|Overall Study|subject has been out of town|1|||
130722675|NCT04546724|470609677|FG001|Overall Study|subject has been out of town|0|||
130722676|NCT04546724|470609676|FG000|Overall Study|subject is incarcerated|2|||
130722677|NCT04546724|470609677|FG001|Overall Study|subject is incarcerated|0|||
130722678|NCT04546724|470609676|FG000|Overall Study|subject is relocating|12|||
130722679|NCT04546724|470609677|FG001|Overall Study|subject is relocating|4|||
130722680|NCT04546724|470609676|FG000|Overall Study|Subject in another study|1|||
130722681|NCT04546724|470609677|FG001|Overall Study|Subject in another study|1|||
130722682|NCT04874155|470609680|FG000|Overall Study|Lost to Follow-up|1|||
130389340|NCT01549964|469394847|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
130389341|NCT01549964|469394848|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
130389342|NCT01549964|469394845|FG000|80-Week Extension Period|Pregnancy|0|||
130389343|NCT01549964|469394846|FG001|80-Week Extension Period|Pregnancy|0|||
130389344|NCT01549964|469394847|FG002|80-Week Extension Period|Pregnancy|1|||
130389345|NCT01549964|469394848|FG003|80-Week Extension Period|Pregnancy|0|||
130389346|NCT01549964|469394845|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
130389347|NCT01549964|469394846|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
130389348|NCT01549964|469394847|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
130389349|NCT01549964|469394848|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
130389350|NCT01549964|469394845|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
130389351|NCT01549964|469394846|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
130389352|NCT01549964|469394847|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
130389353|NCT01549964|469394848|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
130389354|NCT01549964|469394845|FG000|80-Week Extension Period|Lost to Follow-up|1|||
130389355|NCT01549964|469394846|FG001|80-Week Extension Period|Lost to Follow-up|0|||
130389356|NCT01549964|469394847|FG002|80-Week Extension Period|Lost to Follow-up|2|||
130389357|NCT01549964|469394848|FG003|80-Week Extension Period|Lost to Follow-up|1|||
130389358|NCT01549964|469394845|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
130389359|NCT01549964|469394846|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
130389360|NCT01549964|469394847|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
130389361|NCT01549964|469394848|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
130389362|NCT02290821|469394849|FG000|Overall Study|Withdrawal by Subject|1|||
130389363|NCT02290821|469394850|FG001|Overall Study|Withdrawal by Subject|1|||
130389364|NCT02290821|469394849|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
130389365|NCT02290821|469394850|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
130389366|NCT02290821|469394849|FG000|Overall Study|Lost to Follow-up|3|||
130389367|NCT02290821|469394850|FG001|Overall Study|Lost to Follow-up|2|||
130389368|NCT00751348|469394855|FG000|Overall Study|Withdrawal by Subject|5|||
130389369|NCT00751348|469394856|FG001|Overall Study|Withdrawal by Subject|2|||
130389370|NCT00751348|469394855|FG000|Overall Study|Migration from study area|1|||
130389371|NCT00751348|469394856|FG001|Overall Study|Migration from study area|0|||
130389372|NCT02039674|469394859|FG000|Overall Study|Adverse Event|0|||
130389373|NCT02039674|469394860|FG001|Overall Study|Adverse Event|0|||
130389374|NCT02039674|469394861|FG002|Overall Study|Adverse Event|0|||
130389375|NCT02039674|469394862|FG003|Overall Study|Adverse Event|1|||
130389376|NCT02039674|469394863|FG004|Overall Study|Adverse Event|0|||
130389377|NCT02039674|469394864|FG005|Overall Study|Adverse Event|0|||
130389378|NCT02039674|469394865|FG006|Overall Study|Adverse Event|0|||
130389379|NCT02039674|469394866|FG007|Overall Study|Adverse Event|0|||
130389380|NCT02039674|469394867|FG008|Overall Study|Adverse Event|2|||
130389381|NCT02039674|469394868|FG009|Overall Study|Adverse Event|1|||
130389382|NCT02039674|469394869|FG010|Overall Study|Adverse Event|0|||
130389383|NCT02039674|469394870|FG011|Overall Study|Adverse Event|2|||
130389384|NCT02039674|469394871|FG012|Overall Study|Adverse Event|3|||
130389385|NCT02039674|469394872|FG013|Overall Study|Adverse Event|1|||
130389386|NCT02039674|469394859|FG000|Overall Study|Death|2|||
130389387|NCT02039674|469394860|FG001|Overall Study|Death|0|||
130389388|NCT02039674|469394861|FG002|Overall Study|Death|2|||
130389389|NCT02039674|469394862|FG003|Overall Study|Death|3|||
130389390|NCT02039674|469394863|FG004|Overall Study|Death|0|||
130389391|NCT02039674|469394864|FG005|Overall Study|Death|0|||
130389392|NCT02039674|469394865|FG006|Overall Study|Death|1|||
130389393|NCT02039674|469394866|FG007|Overall Study|Death|0|||
130389394|NCT02039674|469394867|FG008|Overall Study|Death|2|||
130389395|NCT02039674|469394868|FG009|Overall Study|Death|0|||
130389396|NCT02039674|469394869|FG010|Overall Study|Death|1|||
130389397|NCT02039674|469394870|FG011|Overall Study|Death|3|||
130389398|NCT02039674|469394871|FG012|Overall Study|Death|2|||
130389399|NCT02039674|469394872|FG013|Overall Study|Death|8|||
130389400|NCT02039674|469394859|FG000|Overall Study|Excluded Medication|1|||
130389401|NCT02039674|469394860|FG001|Overall Study|Excluded Medication|1|||
130389402|NCT02039674|469394861|FG002|Overall Study|Excluded Medication|0|||
130389403|NCT02039674|469394862|FG003|Overall Study|Excluded Medication|1|||
130389404|NCT02039674|469394863|FG004|Overall Study|Excluded Medication|0|||
130389405|NCT02039674|469394864|FG005|Overall Study|Excluded Medication|1|||
130389406|NCT02039674|469394865|FG006|Overall Study|Excluded Medication|0|||
130722683|NCT04874155|470609681|FG001|Overall Study|Lost to Follow-up|1|||
130469952|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
130722684|NCT04874155|470609680|FG000|Overall Study|Withdrawal by Subject|2|||
130722685|NCT04874155|470609681|FG001|Overall Study|Withdrawal by Subject|2|||
130722686|NCT01147107|470609688|FG000|Overall Study|Lack of Efficacy|5|||
130722687|NCT01147107|470609689|FG001|Overall Study|Lack of Efficacy|0|||
130722688|NCT01147107|470609688|FG000|Overall Study|Withdrawal by Subject|1|||
130722689|NCT01147107|470609689|FG001|Overall Study|Withdrawal by Subject|1|||
130722690|NCT03201965|470609692|FG000|Overall Study|Death|5|||
130722691|NCT03201965|470609693|FG001|Overall Study|Death|27|||
130722692|NCT03201965|470609694|FG002|Overall Study|Death|27|||
130722693|NCT03201965|470609692|FG000|Overall Study|Lost to Follow-up|0|||
130722694|NCT03201965|470609693|FG001|Overall Study|Lost to Follow-up|1|||
130722695|NCT03201965|470609694|FG002|Overall Study|Lost to Follow-up|0|||
130722696|NCT03201965|470609692|FG000|Overall Study|Withdrawal by Subject|3|||
130722697|NCT03201965|470609693|FG001|Overall Study|Withdrawal by Subject|13|||
130722698|NCT03201965|470609694|FG002|Overall Study|Withdrawal by Subject|4|||
130722699|NCT03201965|470609692|FG000|Overall Study|Ongoing|20|||
130722700|NCT03201965|470609693|FG001|Overall Study|Ongoing|152|||
130722701|NCT03201965|470609694|FG002|Overall Study|Ongoing|164|||
130389407|NCT02039674|469394866|FG007|Overall Study|Excluded Medication|0|||
130389408|NCT02039674|469394867|FG008|Overall Study|Excluded Medication|2|||
130389409|NCT02039674|469394868|FG009|Overall Study|Excluded Medication|3|||
130389410|NCT02039674|469394869|FG010|Overall Study|Excluded Medication|5|||
130389411|NCT02039674|469394870|FG011|Overall Study|Excluded Medication|6|||
130389412|NCT02039674|469394871|FG012|Overall Study|Excluded Medication|8|||
130389413|NCT02039674|469394872|FG013|Overall Study|Excluded Medication|3|||
130389414|NCT02039674|469394859|FG000|Overall Study|Lost to Follow-up|0|||
130389415|NCT02039674|469394860|FG001|Overall Study|Lost to Follow-up|0|||
130389416|NCT02039674|469394861|FG002|Overall Study|Lost to Follow-up|0|||
130389417|NCT02039674|469394862|FG003|Overall Study|Lost to Follow-up|0|||
130389418|NCT02039674|469394863|FG004|Overall Study|Lost to Follow-up|1|||
130389419|NCT02039674|469394864|FG005|Overall Study|Lost to Follow-up|1|||
130389420|NCT02039674|469394865|FG006|Overall Study|Lost to Follow-up|0|||
130389421|NCT02039674|469394866|FG007|Overall Study|Lost to Follow-up|0|||
130389422|NCT02039674|469394867|FG008|Overall Study|Lost to Follow-up|0|||
130389423|NCT02039674|469394868|FG009|Overall Study|Lost to Follow-up|0|||
130389424|NCT02039674|469394869|FG010|Overall Study|Lost to Follow-up|0|||
130389425|NCT02039674|469394870|FG011|Overall Study|Lost to Follow-up|2|||
130389426|NCT02039674|469394871|FG012|Overall Study|Lost to Follow-up|2|||
130389427|NCT02039674|469394872|FG013|Overall Study|Lost to Follow-up|1|||
130389428|NCT02039674|469394859|FG000|Overall Study|Physician Decision|0|||
130389429|NCT02039674|469394860|FG001|Overall Study|Physician Decision|0|||
130389430|NCT02039674|469394861|FG002|Overall Study|Physician Decision|0|||
130389431|NCT02039674|469394862|FG003|Overall Study|Physician Decision|0|||
130389432|NCT02039674|469394863|FG004|Overall Study|Physician Decision|0|||
130389433|NCT02039674|469394864|FG005|Overall Study|Physician Decision|0|||
130389434|NCT02039674|469394865|FG006|Overall Study|Physician Decision|0|||
130389435|NCT02039674|469394866|FG007|Overall Study|Physician Decision|0|||
130389436|NCT02039674|469394867|FG008|Overall Study|Physician Decision|0|||
130389437|NCT02039674|469394868|FG009|Overall Study|Physician Decision|0|||
130389438|NCT02039674|469394869|FG010|Overall Study|Physician Decision|0|||
130389439|NCT02039674|469394870|FG011|Overall Study|Physician Decision|1|||
130389440|NCT02039674|469394871|FG012|Overall Study|Physician Decision|1|||
130389441|NCT02039674|469394872|FG013|Overall Study|Physician Decision|0|||
130389442|NCT02039674|469394859|FG000|Overall Study|Progressive Disease|8|||
130389443|NCT02039674|469394860|FG001|Overall Study|Progressive Disease|8|||
130389444|NCT02039674|469394861|FG002|Overall Study|Progressive Disease|6|||
130389445|NCT02039674|469394862|FG003|Overall Study|Progressive Disease|7|||
130389446|NCT02039674|469394863|FG004|Overall Study|Progressive Disease|9|||
130389447|NCT02039674|469394864|FG005|Overall Study|Progressive Disease|10|||
130389448|NCT02039674|469394865|FG006|Overall Study|Progressive Disease|1|||
130389449|NCT02039674|469394866|FG007|Overall Study|Progressive Disease|3|||
130389450|NCT02039674|469394867|FG008|Overall Study|Progressive Disease|6|||
130469953|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
130722702|NCT02329847|470609695|FG000|Overall Study|Death|4|||
130389451|NCT02039674|469394868|FG009|Overall Study|Progressive Disease|4|||
130389452|NCT02039674|469394869|FG010|Overall Study|Progressive Disease|0|||
130389453|NCT02039674|469394870|FG011|Overall Study|Progressive Disease|34|||
130389454|NCT02039674|469394871|FG012|Overall Study|Progressive Disease|34|||
130389455|NCT02039674|469394872|FG013|Overall Study|Progressive Disease|18|||
130389456|NCT02039674|469394859|FG000|Overall Study|Withdrawal by Subject|1|||
130389457|NCT02039674|469394860|FG001|Overall Study|Withdrawal by Subject|2|||
130389458|NCT02039674|469394861|FG002|Overall Study|Withdrawal by Subject|3|||
130389459|NCT02039674|469394862|FG003|Overall Study|Withdrawal by Subject|0|||
130389460|NCT02039674|469394863|FG004|Overall Study|Withdrawal by Subject|1|||
130722703|NCT02329847|470609696|FG001|Overall Study|Death|4|||
130722704|NCT02329847|470609697|FG002|Overall Study|Death|22|||
130722705|NCT02329847|470609698|FG003|Overall Study|Death|12|||
130722706|NCT02329847|470609699|FG004|Overall Study|Death|20|||
130722707|NCT02329847|470609700|FG005|Overall Study|Death|13|||
130389461|NCT02039674|469394864|FG005|Overall Study|Withdrawal by Subject|0|||
130389462|NCT02039674|469394865|FG006|Overall Study|Withdrawal by Subject|0|||
130389463|NCT02039674|469394866|FG007|Overall Study|Withdrawal by Subject|0|||
130389464|NCT02039674|469394867|FG008|Overall Study|Withdrawal by Subject|0|||
130389465|NCT02039674|469394868|FG009|Overall Study|Withdrawal by Subject|1|||
130389466|NCT02039674|469394869|FG010|Overall Study|Withdrawal by Subject|1|||
130389467|NCT02039674|469394870|FG011|Overall Study|Withdrawal by Subject|4|||
130389468|NCT02039674|469394871|FG012|Overall Study|Withdrawal by Subject|6|||
130389469|NCT02039674|469394872|FG013|Overall Study|Withdrawal by Subject|2|||
130389470|NCT02039674|469394859|FG000|Overall Study|Clinical Progression|0|||
130389471|NCT02039674|469394860|FG001|Overall Study|Clinical Progression|0|||
130389472|NCT02039674|469394861|FG002|Overall Study|Clinical Progression|0|||
130389473|NCT02039674|469394862|FG003|Overall Study|Clinical Progression|0|||
130389474|NCT02039674|469394863|FG004|Overall Study|Clinical Progression|0|||
130389475|NCT02039674|469394864|FG005|Overall Study|Clinical Progression|0|||
130389476|NCT02039674|469394865|FG006|Overall Study|Clinical Progression|1|||
130389477|NCT02039674|469394866|FG007|Overall Study|Clinical Progression|0|||
130389478|NCT02039674|469394867|FG008|Overall Study|Clinical Progression|0|||
130389479|NCT02039674|469394868|FG009|Overall Study|Clinical Progression|0|||
130389480|NCT02039674|469394869|FG010|Overall Study|Clinical Progression|0|||
130389481|NCT02039674|469394870|FG011|Overall Study|Clinical Progression|0|||
130389482|NCT02039674|469394871|FG012|Overall Study|Clinical Progression|1|||
130389483|NCT02039674|469394872|FG013|Overall Study|Clinical Progression|0|||
130389484|NCT02039674|469394859|FG000|Overall Study|Sponsor Decision|1|||
130389485|NCT02039674|469394860|FG001|Overall Study|Sponsor Decision|1|||
130389486|NCT02039674|469394861|FG002|Overall Study|Sponsor Decision|1|||
130389487|NCT02039674|469394862|FG003|Overall Study|Sponsor Decision|1|||
130389488|NCT02039674|469394863|FG004|Overall Study|Sponsor Decision|1|||
130389489|NCT02039674|469394864|FG005|Overall Study|Sponsor Decision|0|||
130389490|NCT02039674|469394865|FG006|Overall Study|Sponsor Decision|0|||
130389491|NCT02039674|469394866|FG007|Overall Study|Sponsor Decision|0|||
130389492|NCT02039674|469394867|FG008|Overall Study|Sponsor Decision|0|||
130389493|NCT02039674|469394868|FG009|Overall Study|Sponsor Decision|3|||
130389494|NCT02039674|469394869|FG010|Overall Study|Sponsor Decision|0|||
130389495|NCT02039674|469394870|FG011|Overall Study|Sponsor Decision|8|||
130389496|NCT02039674|469394871|FG012|Overall Study|Sponsor Decision|5|||
130389497|NCT02039674|469394872|FG013|Overall Study|Sponsor Decision|0|||
130389498|NCT02039674|469394859|FG000|Overall Study|Other|0|||
130389499|NCT02039674|469394860|FG001|Overall Study|Other|0|||
130389500|NCT02039674|469394861|FG002|Overall Study|Other|0|||
130389501|NCT02039674|469394862|FG003|Overall Study|Other|0|||
130389502|NCT02039674|469394863|FG004|Overall Study|Other|0|||
130389503|NCT02039674|469394864|FG005|Overall Study|Other|0|||
130469954|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
130469955|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
130469956|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
130469957|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130469958|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130469959|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130469960|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130469961|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
130469962|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
130469963|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
130722708|NCT02329847|470609695|FG000|Overall Study|Lost to Follow-up|0|||
130722709|NCT02329847|470609696|FG001|Overall Study|Lost to Follow-up|0|||
130722710|NCT02329847|470609697|FG002|Overall Study|Lost to Follow-up|2|||
130722711|NCT02329847|470609698|FG003|Overall Study|Lost to Follow-up|3|||
130722712|NCT02329847|470609699|FG004|Overall Study|Lost to Follow-up|0|||
130722713|NCT02329847|470609700|FG005|Overall Study|Lost to Follow-up|1|||
130722714|NCT02329847|470609695|FG000|Overall Study|Physician Decision|0|||
130722715|NCT02329847|470609696|FG001|Overall Study|Physician Decision|0|||
130722716|NCT02329847|470609697|FG002|Overall Study|Physician Decision|0|||
130722717|NCT02329847|470609698|FG003|Overall Study|Physician Decision|0|||
130722718|NCT02329847|470609699|FG004|Overall Study|Physician Decision|1|||
130722719|NCT02329847|470609700|FG005|Overall Study|Physician Decision|0|||
130722720|NCT02329847|470609695|FG000|Overall Study|Withdrawal by Subject|2|||
130722721|NCT02329847|470609696|FG001|Overall Study|Withdrawal by Subject|1|||
130389504|NCT02039674|469394865|FG006|Overall Study|Other|0|||
130389505|NCT02039674|469394866|FG007|Overall Study|Other|0|||
130389506|NCT02039674|469394867|FG008|Overall Study|Other|0|||
130389507|NCT02039674|469394868|FG009|Overall Study|Other|0|||
130389508|NCT02039674|469394869|FG010|Overall Study|Other|0|||
130389509|NCT02039674|469394870|FG011|Overall Study|Other|0|||
130389510|NCT02039674|469394871|FG012|Overall Study|Other|1|||
130389511|NCT02039674|469394872|FG013|Overall Study|Other|0|||
130389512|NCT01358357|469394873|FG000|Open Label Phase|Adverse Event|0|||
130389513|NCT01358357|469394874|FG001|Open Label Phase|Adverse Event|0|||
130389514|NCT01358357|469394875|FG002|Open Label Phase|Adverse Event|59|||
130389515|NCT01358357|469394873|FG000|Open Label Phase|Lack of Efficacy|0|||
130389516|NCT01358357|469394874|FG001|Open Label Phase|Lack of Efficacy|0|||
130389517|NCT01358357|469394875|FG002|Open Label Phase|Lack of Efficacy|107|||
130389518|NCT01358357|469394873|FG000|Open Label Phase|Lost to Follow-up|0|||
130389519|NCT01358357|469394874|FG001|Open Label Phase|Lost to Follow-up|0|||
130389520|NCT01358357|469394875|FG002|Open Label Phase|Lost to Follow-up|76|||
130389521|NCT01358357|469394873|FG000|Open Label Phase|Protocol Violation|0|||
130389522|NCT01358357|469394874|FG001|Open Label Phase|Protocol Violation|0|||
130389523|NCT01358357|469394875|FG002|Open Label Phase|Protocol Violation|45|||
130389524|NCT01358357|469394873|FG000|Open Label Phase|Withdrawal by Subject|0|||
130389525|NCT01358357|469394874|FG001|Open Label Phase|Withdrawal by Subject|0|||
130389526|NCT01358357|469394875|FG002|Open Label Phase|Withdrawal by Subject|112|||
130389527|NCT01358357|469394873|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
130389528|NCT01358357|469394874|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
130389529|NCT01358357|469394875|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
130389530|NCT01358357|469394873|FG000|Open Label Phase|Terminated at study completion|0|||
130389531|NCT01358357|469394874|FG001|Open Label Phase|Terminated at study completion|0|||
130389532|NCT01358357|469394875|FG002|Open Label Phase|Terminated at study completion|5|||
130389533|NCT01358357|469394873|FG000|Open Label Phase|Mood episode|0|||
130389534|NCT01358357|469394874|FG001|Open Label Phase|Mood episode|0|||
130389535|NCT01358357|469394875|FG002|Open Label Phase|Mood episode|42|||
130389536|NCT01358357|469394873|FG000|Double-Blind Phase|Adverse Event|8|||
130389537|NCT01358357|469394874|FG001|Double-Blind Phase|Adverse Event|5|||
130389538|NCT01358357|469394875|FG002|Double-Blind Phase|Adverse Event|0|||
130389539|NCT01358357|469394873|FG000|Double-Blind Phase|Lost to Follow-up|5|||
130389540|NCT01358357|469394874|FG001|Double-Blind Phase|Lost to Follow-up|7|||
130389541|NCT01358357|469394875|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130389542|NCT01358357|469394873|FG000|Double-Blind Phase|Protocol Violation|1|||
130389543|NCT01358357|469394874|FG001|Double-Blind Phase|Protocol Violation|11|||
130389544|NCT01358357|469394875|FG002|Double-Blind Phase|Protocol Violation|0|||
130389545|NCT01358357|469394873|FG000|Double-Blind Phase|Protocol Violation|16|||
130389546|NCT01358357|469394874|FG001|Double-Blind Phase|Protocol Violation|12|||
130389547|NCT01358357|469394875|FG002|Double-Blind Phase|Protocol Violation|0|||
130389548|NCT01358357|469394873|FG000|Double-Blind Phase|Terminated at study completion|2|||
130389549|NCT01358357|469394874|FG001|Double-Blind Phase|Terminated at study completion|0|||
130389550|NCT01358357|469394875|FG002|Double-Blind Phase|Terminated at study completion|0|||
130389551|NCT01358357|469394873|FG000|Double-Blind Phase|Recurrence of mood event|48|||
130389552|NCT01358357|469394874|FG001|Double-Blind Phase|Recurrence of mood event|64|||
130389553|NCT01358357|469394875|FG002|Double-Blind Phase|Recurrence of mood event|0|||
130389554|NCT01358357|469394873|FG000|Double-Blind Phase|Administrative|0|||
130389555|NCT01358357|469394874|FG001|Double-Blind Phase|Administrative|1|||
130389556|NCT01358357|469394875|FG002|Double-Blind Phase|Administrative|0|||
130389557|NCT01826487|469394876|FG000|Overall Study|Adverse Event|1|||
130389558|NCT01826487|469394877|FG001|Overall Study|Adverse Event|1|||
130389559|NCT01826487|469394876|FG000|Overall Study|Lost to Follow-up|1|||
130389560|NCT01826487|469394877|FG001|Overall Study|Lost to Follow-up|0|||
130389561|NCT01826487|469394876|FG000|Overall Study|Withdrawal by Subject|1|||
130389562|NCT01826487|469394877|FG001|Overall Study|Withdrawal by Subject|3|||
130389563|NCT01826487|469394876|FG000|Overall Study|Protocol Violation|1|||
130389564|NCT01826487|469394877|FG001|Overall Study|Protocol Violation|1|||
130389565|NCT02136576|469394878|FG000|Overall Study|Lost to Follow-up|2|||
130389566|NCT02136576|469394879|FG001|Overall Study|Lost to Follow-up|0|||
130389567|NCT02136576|469394880|FG002|Overall Study|Lost to Follow-up|0|||
130389568|NCT00537381|469394881|FG000|Overall Study|Adverse Event|13|||
130389569|NCT00537381|469394882|FG001|Overall Study|Adverse Event|9|||
130389570|NCT00537381|469394881|FG000|Overall Study|Death|3|||
130722722|NCT02329847|470609697|FG002|Overall Study|Withdrawal by Subject|5|||
130722723|NCT02329847|470609698|FG003|Overall Study|Withdrawal by Subject|7|||
130722724|NCT02329847|470609699|FG004|Overall Study|Withdrawal by Subject|8|||
130389571|NCT00537381|469394882|FG001|Overall Study|Death|3|||
130389572|NCT00537381|469394881|FG000|Overall Study|Withdrawal by Subject|5|||
130389573|NCT00537381|469394882|FG001|Overall Study|Withdrawal by Subject|14|||
130389574|NCT00537381|469394881|FG000|Overall Study|Physician Decision|7|||
130389575|NCT00537381|469394882|FG001|Overall Study|Physician Decision|6|||
130389576|NCT00537381|469394881|FG000|Overall Study|Disease Progression|9|||
130389577|NCT00537381|469394882|FG001|Overall Study|Disease Progression|18|||
130389578|NCT00537381|469394881|FG000|Overall Study|Sponsor decision|14|||
130389579|NCT00537381|469394882|FG001|Overall Study|Sponsor decision|9|||
130389580|NCT00537381|469394881|FG000|Overall Study|Other|5|||
130389581|NCT00537381|469394882|FG001|Overall Study|Other|3|||
130389582|NCT02590939|469394883|FG000|Overall Study|Withdrawal by Subject|3|||
130389583|NCT02590939|469394884|FG001|Overall Study|Withdrawal by Subject|1|||
130559864|NCT02632721|470017893|FG003|Overall Study|Receiving Decitabine locally|0|||
130389584|NCT02590939|469394883|FG000|Overall Study|Failed the nociceptive test|2|||
130389585|NCT02590939|469394884|FG001|Overall Study|Failed the nociceptive test|1|||
130389586|NCT02081079|469394886|FG000|Overall Study|Lack of Efficacy|3|||
130389587|NCT02081079|469394887|FG001|Overall Study|Lack of Efficacy|2|||
130722725|NCT02329847|470609700|FG005|Overall Study|Withdrawal by Subject|3|||
130722726|NCT02329847|470609695|FG000|Overall Study|Other|1|||
130722727|NCT02329847|470609696|FG001|Overall Study|Other|2|||
130722728|NCT02329847|470609697|FG002|Overall Study|Other|6|||
130722729|NCT02329847|470609698|FG003|Overall Study|Other|13|||
130722730|NCT02329847|470609699|FG004|Overall Study|Other|10|||
130722731|NCT02329847|470609700|FG005|Overall Study|Other|3|||
130722732|NCT05293639|470609701|FG000|Overall Study|Withdrawal by Subject|1|||
130722733|NCT05293639|470609702|FG001|Overall Study|Withdrawal by Subject|1|||
130722734|NCT05293639|470609703|FG002|Overall Study|Withdrawal by Subject|2|||
130722735|NCT05293639|470609701|FG000|Overall Study|Death|0|||
130722736|NCT05293639|470609702|FG001|Overall Study|Death|1|||
130722737|NCT05293639|470609703|FG002|Overall Study|Death|0|||
130722738|NCT05293639|470609701|FG000|Overall Study|Lost to Follow-up|0|||
130722739|NCT05293639|470609702|FG001|Overall Study|Lost to Follow-up|0|||
130722740|NCT05293639|470609703|FG002|Overall Study|Lost to Follow-up|5|||
130722741|NCT05293639|470609701|FG000|Overall Study|Other|0|||
130722742|NCT05293639|470609702|FG001|Overall Study|Other|0|||
130722743|NCT05293639|470609703|FG002|Overall Study|Other|1|||
130722744|NCT02365558|470609707|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
130722745|NCT02365558|470609708|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
130722746|NCT02365558|470609707|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
130722747|NCT02365558|470609708|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
130722748|NCT00369317|470609709|FG000|Overall Study|Adverse Event|3|||
130722749|NCT00369317|470609709|FG000|Overall Study|Death|1|||
130722750|NCT00369317|470609709|FG000|Overall Study|Lack of Efficacy|5|||
130722751|NCT00369317|470609709|FG000|Overall Study|Physician Decision|2|||
130722752|NCT00369317|470609709|FG000|Overall Study|Withdrawal by Subject|8|||
130722753|NCT00369317|470609709|FG000|Overall Study|Ineligible|1|||
130722754|NCT02828241|470609718|FG000|Overall Study|Adverse Event|7|||
130389588|NCT02081079|469394886|FG000|Overall Study|Lost to Follow-up|1|||
130389589|NCT02081079|469394887|FG001|Overall Study|Lost to Follow-up|0|||
130389590|NCT02225743|469394888|FG000|Overall Study|Withdrawal by Subject|18|||
130389591|NCT04837131|469394896|FG000|Overall Study|Death|1|||
130389592|NCT04837131|469394896|FG000|Overall Study|Withdrawal by Subject|1|||
130389593|NCT04837131|469394896|FG000|Overall Study|Adverse Event|1|||
130389594|NCT04837131|469394896|FG000|Overall Study|Protocol Violation|1|||
130389595|NCT04709575|469396689|FG000|Overall Study|Withdrawal by Subject|6|||
130389596|NCT04709575|469396690|FG001|Overall Study|Withdrawal by Subject|2|||
130389597|NCT04709575|469396689|FG000|Overall Study|Lost to Follow-up|2|||
130389598|NCT04709575|469396690|FG001|Overall Study|Lost to Follow-up|2|||
130389599|NCT04709575|469396689|FG000|Overall Study|Adverse Event|1|||
130389600|NCT04709575|469396690|FG001|Overall Study|Adverse Event|0|||
130389601|NCT04709575|469396689|FG000|Overall Study|Protocol Violation|1|||
130389602|NCT04709575|469396690|FG001|Overall Study|Protocol Violation|1|||
130389603|NCT03181399|469396691|FG000|6 Months on Treatment|Protocol non-compliance|7|||
130389604|NCT03181399|469396691|FG000|6 Months on Treatment|Adverse Event|4|||
130389605|NCT03181399|469396691|FG000|6 Months on Treatment|Tried alternative treatment|2|||
130389606|NCT03181399|469396691|FG000|6 Months on Treatment|Lost to Follow-up|2|||
130389607|NCT03181399|469396691|FG000|6 Months on Treatment|Personal reasons|1|||
130389608|NCT03181399|469396691|FG000|3 Months Off-treatment|Parent unable to travel|1|||
130389609|NCT00489853|469396696|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
130389610|NCT00489853|469396697|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
130389611|NCT00489853|469396698|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
130389612|NCT00489853|469396696|FG000|Wash-out Period 1|Adverse Event|0|||
130389613|NCT00489853|469396697|FG001|Wash-out Period 1|Adverse Event|1|||
130389614|NCT00489853|469396698|FG002|Wash-out Period 1|Adverse Event|1|||
130389615|NCT00489853|469396696|FG000|Wash-out Period 1|Protocol Violation|0|||
130389616|NCT00489853|469396697|FG001|Wash-out Period 1|Protocol Violation|1|||
130389617|NCT00489853|469396698|FG002|Wash-out Period 1|Protocol Violation|1|||
130389618|NCT00489853|469396696|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
130389619|NCT00489853|469396697|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
130389620|NCT00489853|469396698|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
130389621|NCT00489853|469396696|FG000|Wash-out Period 2|Adverse Event|1|||
130389622|NCT00489853|469396697|FG001|Wash-out Period 2|Adverse Event|1|||
130389623|NCT00489853|469396698|FG002|Wash-out Period 2|Adverse Event|0|||
130722755|NCT02828241|470609719|FG001|Overall Study|Adverse Event|2|||
130722756|NCT02828241|470609718|FG000|Overall Study|Protocol Violation|1|||
130389624|NCT00489853|469396696|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
130389625|NCT00489853|469396697|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
130389626|NCT00489853|469396698|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
130389627|NCT00489853|469396696|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
130389628|NCT00489853|469396697|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
130389629|NCT00489853|469396698|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
130722757|NCT02828241|470609719|FG001|Overall Study|Protocol Violation|0|||
130722758|NCT03185013|470609724|FG000|Overall Study|Withdrawal by Subject|5|||
130722759|NCT03185013|470609725|FG001|Overall Study|Withdrawal by Subject|3|||
130389630|NCT01541969|469396703|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
130389631|NCT01541969|469396704|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
130389632|NCT01541969|469396703|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
130389633|NCT01541969|469396704|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
130389634|NCT01541969|469396703|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
130389635|NCT01541969|469396704|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
130389636|NCT01541969|469396703|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
130389637|NCT01541969|469396704|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
130389638|NCT01541969|469396703|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
130389639|NCT01541969|469396704|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
130389640|NCT01541969|469396703|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
130389641|NCT01541969|469396704|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
130389642|NCT01541969|469396703|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
130389643|NCT01541969|469396704|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
130389644|NCT01541969|469396703|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
130389645|NCT01541969|469396704|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
130389646|NCT01541969|469396703|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
130389647|NCT01541969|469396704|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
130389648|NCT01541969|469396703|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
130389649|NCT01541969|469396704|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
130389650|NCT05123222|469396705|FG000|Overall Study|Lost to Follow-up|2|||
130389651|NCT05123222|469396706|FG001|Overall Study|Lost to Follow-up|0|||
130389652|NCT05123222|469396707|FG002|Overall Study|Lost to Follow-up|0|||
130389653|NCT05123222|469396708|FG003|Overall Study|Lost to Follow-up|0|||
130389654|NCT05123222|469396705|FG000|Overall Study|Protocol Violation|0|||
130389655|NCT05123222|469396706|FG001|Overall Study|Protocol Violation|0|||
130389656|NCT05123222|469396707|FG002|Overall Study|Protocol Violation|1|||
130389657|NCT05123222|469396708|FG003|Overall Study|Protocol Violation|0|||
130389658|NCT02255500|469396713|FG000|Overall Study|Withdrawal by Subject|1|||
130389659|NCT02255500|469396714|FG001|Overall Study|Withdrawal by Subject|0|||
130389660|NCT00265343|469396715|FG000|Overall Study|Adverse Event|10|||
130389661|NCT00265343|469396716|FG001|Overall Study|Adverse Event|7|||
130389662|NCT00265343|469396715|FG000|Overall Study|Withdrawal by Subject|3|||
130722760|NCT03185013|470609724|FG000|Overall Study|Adverse Event|1|||
130722761|NCT03185013|470609725|FG001|Overall Study|Adverse Event|0|||
130722762|NCT03185013|470609724|FG000|Overall Study|Progressive Disease|1|||
130722763|NCT03185013|470609725|FG001|Overall Study|Progressive Disease|0|||
130722764|NCT03185013|470609724|FG000|Overall Study|Lost to Follow-up|8|||
130722765|NCT03185013|470609725|FG001|Overall Study|Lost to Follow-up|2|||
130722766|NCT03185013|470609724|FG000|Overall Study|Physician Decision|1|||
130722767|NCT03185013|470609725|FG001|Overall Study|Physician Decision|0|||
130722768|NCT03185013|470609724|FG000|Overall Study|Protocol Deviation|2|||
130722769|NCT03185013|470609725|FG001|Overall Study|Protocol Deviation|0|||
130722770|NCT03185013|470609724|FG000|Overall Study|Reason not Specified|3|||
130722771|NCT03185013|470609725|FG001|Overall Study|Reason not Specified|2|||
130722772|NCT03185013|470609724|FG000|Overall Study|Death|1|||
130722773|NCT03185013|470609725|FG001|Overall Study|Death|0|||
130722774|NCT00510289|470609729|FG000|Overall Study|Withdrawal by Subject|7|||
130722775|NCT00510289|470609729|FG000|Overall Study|Refused bone marrow biopsy|2|||
130722776|NCT00510289|470609729|FG000|Overall Study|Lost to Follow-up|1|||
130722777|NCT00510289|470609729|FG000|Overall Study|Progressed prior to starting drug|2|||
130722778|NCT00673387|470609732|FG000|Overall Study|Withdrawal by Subject|15|||
130722779|NCT00673387|470609733|FG001|Overall Study|Withdrawal by Subject|16|||
130722780|NCT00673387|470609734|FG002|Overall Study|Withdrawal by Subject|20|||
130722781|NCT00673387|470609735|FG003|Overall Study|Withdrawal by Subject|16|||
130722782|NCT00673387|470609736|FG004|Overall Study|Withdrawal by Subject|18|||
130722783|NCT00673387|470609737|FG005|Overall Study|Withdrawal by Subject|21|||
130722784|NCT00673387|470609738|FG006|Overall Study|Withdrawal by Subject|15|||
130389663|NCT00265343|469396716|FG001|Overall Study|Withdrawal by Subject|9|||
130389664|NCT00265343|469396715|FG000|Overall Study|Other|8|||
130722785|NCT00673387|470609739|FG007|Overall Study|Withdrawal by Subject|21|||
130722786|NCT00673387|470609732|FG000|Overall Study|Adverse Event|3|||
130722787|NCT00673387|470609733|FG001|Overall Study|Adverse Event|1|||
130722788|NCT00673387|470609734|FG002|Overall Study|Adverse Event|5|||
130389665|NCT00265343|469396716|FG001|Overall Study|Other|3|||
130389666|NCT04865354|469396717|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
130389667|NCT04865354|469396718|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
130389668|NCT04865354|469396717|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
130389669|NCT04865354|469396718|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
130389670|NCT04865354|469396717|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
130722789|NCT00673387|470609735|FG003|Overall Study|Adverse Event|2|||
130722790|NCT00673387|470609736|FG004|Overall Study|Adverse Event|6|||
130389671|NCT04865354|469396718|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
130389672|NCT00588822|469396723|FG000|Overall Study|progression of disease|8|||
130389673|NCT04254978|469396725|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
130389674|NCT04254978|469396725|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
130389675|NCT04254978|469396725|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
130389676|NCT04254978|469396725|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
130389677|NCT04254978|469396725|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
130389678|NCT04254978|469396725|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
130389679|NCT02515942|469396729|FG000|Overall Study|Adverse Event|5|||
130389680|NCT02515942|469396730|FG001|Overall Study|Adverse Event|0|||
130389681|NCT02515942|469396731|FG002|Overall Study|Adverse Event|0|||
130389682|NCT02515942|469396729|FG000|Overall Study|Death|0|||
130389683|NCT02515942|469396730|FG001|Overall Study|Death|0|||
130389684|NCT02515942|469396731|FG002|Overall Study|Death|1|||
130389685|NCT02515942|469396729|FG000|Overall Study|Lack of Efficacy|0|||
130389686|NCT02515942|469396730|FG001|Overall Study|Lack of Efficacy|0|||
130389687|NCT02515942|469396731|FG002|Overall Study|Lack of Efficacy|1|||
130389688|NCT02515942|469396729|FG000|Overall Study|Lost to Follow-up|2|||
130389689|NCT02515942|469396730|FG001|Overall Study|Lost to Follow-up|0|||
130389690|NCT02515942|469396731|FG002|Overall Study|Lost to Follow-up|0|||
130389691|NCT02515942|469396729|FG000|Overall Study|Withdrawal by Subject|0|||
130389692|NCT02515942|469396730|FG001|Overall Study|Withdrawal by Subject|3|||
130389693|NCT02515942|469396731|FG002|Overall Study|Withdrawal by Subject|2|||
130389694|NCT02436759|469396734|FG000|Overall Study|Adverse Event|3|||
130389695|NCT02436759|469396735|FG001|Overall Study|Adverse Event|0|||
130389696|NCT02436759|469396734|FG000|Overall Study|Protocol Violation|1|||
130389697|NCT02436759|469396735|FG001|Overall Study|Protocol Violation|0|||
130389698|NCT02436759|469396734|FG000|Overall Study|Withdrawal by Subject|0|||
130389699|NCT02436759|469396735|FG001|Overall Study|Withdrawal by Subject|1|||
130389700|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
130389701|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
130389702|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
130389703|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
130389704|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
130389705|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
130389706|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
130389707|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
130389708|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
130389709|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
130389710|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
130389711|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
130389712|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
130389713|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
130389714|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
130389715|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
130389716|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
130389717|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
130389718|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
130389719|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
130389720|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
130389721|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
130389722|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
130389723|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
130389724|NCT00277212|469396736|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
130389725|NCT00277212|469396737|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
130389726|NCT00277212|469396738|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
130389727|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
130389728|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
130389729|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
130389730|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
130389731|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
130469964|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
130469965|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
130469966|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
130389732|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
130389733|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
130389734|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
130389735|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
130389736|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
130389737|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
130559865|NCT02632721|470017894|FG004|Overall Study|Receiving Decitabine locally|0|||
130559866|NCT02632721|470017890|FG000|Overall Study|No benefit from study treatment|1|||
130559867|NCT02632721|470017891|FG001|Overall Study|No benefit from study treatment|1|||
130559868|NCT02632721|470017892|FG002|Overall Study|No benefit from study treatment|0|||
130559869|NCT02632721|470017893|FG003|Overall Study|No benefit from study treatment|0|||
130559870|NCT02632721|470017894|FG004|Overall Study|No benefit from study treatment|1|||
130559871|NCT02632721|470017890|FG000|Overall Study|Patient wish for other treatment|0|||
130559872|NCT02632721|470017891|FG001|Overall Study|Patient wish for other treatment|1|||
130559873|NCT02632721|470017892|FG002|Overall Study|Patient wish for other treatment|0|||
130389738|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
130389739|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
130389740|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
130389741|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
130389742|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
130389743|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
130389744|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
130389745|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
130559874|NCT02632721|470017893|FG003|Overall Study|Patient wish for other treatment|0|||
130559875|NCT02632721|470017894|FG004|Overall Study|Patient wish for other treatment|0|||
130389746|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
130389747|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
130389748|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
130389749|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
130389750|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
130389751|NCT00277212|469396736|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
130389752|NCT00277212|469396737|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
130389753|NCT00277212|469396738|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
130389754|NCT00902564|469396739|FG000|Overall Study|Withdrawal by Subject|2|||
130389755|NCT03336216|469396740|FG000|Randomization|Not reported|2|||
130389756|NCT03336216|469396741|FG001|Randomization|Not reported|0|||
130389757|NCT03336216|469396742|FG002|Randomization|Not reported|1|||
130389758|NCT03336216|469396743|FG003|Randomization|Not reported|0|||
130389759|NCT03336216|469396740|FG000|Randomization|Other reasons|1|||
130389760|NCT03336216|469396741|FG001|Randomization|Other reasons|1|||
130389761|NCT03336216|469396742|FG002|Randomization|Other reasons|1|||
130389762|NCT03336216|469396743|FG003|Randomization|Other reasons|0|||
130389763|NCT03336216|469396740|FG000|Randomization|Participant no longer meets study criteria|0|||
130389764|NCT03336216|469396741|FG001|Randomization|Participant no longer meets study criteria|2|||
130389765|NCT03336216|469396742|FG002|Randomization|Participant no longer meets study criteria|4|||
130389766|NCT03336216|469396743|FG003|Randomization|Participant no longer meets study criteria|1|||
130389767|NCT03336216|469396740|FG000|Randomization|Lost to Follow-up|1|||
130389768|NCT03336216|469396741|FG001|Randomization|Lost to Follow-up|0|||
130389769|NCT03336216|469396742|FG002|Randomization|Lost to Follow-up|0|||
130389770|NCT03336216|469396743|FG003|Randomization|Lost to Follow-up|0|||
130389771|NCT03336216|469396740|FG000|Randomization|Participant withdrew consent|9|||
130389772|NCT03336216|469396741|FG001|Randomization|Participant withdrew consent|1|||
130389773|NCT03336216|469396742|FG002|Randomization|Participant withdrew consent|0|||
130389774|NCT03336216|469396743|FG003|Randomization|Participant withdrew consent|0|||
130389775|NCT03336216|469396740|FG000|Randomization|Adverse Event|1|||
130389776|NCT03336216|469396741|FG001|Randomization|Adverse Event|1|||
130389777|NCT03336216|469396742|FG002|Randomization|Adverse Event|0|||
130389778|NCT03336216|469396743|FG003|Randomization|Adverse Event|0|||
130389779|NCT03336216|469396740|FG000|Treatment|Adverse Event|2|||
130389780|NCT03336216|469396741|FG001|Treatment|Adverse Event|3|||
130389781|NCT03336216|469396742|FG002|Treatment|Adverse Event|4|||
130389782|NCT03336216|469396743|FG003|Treatment|Adverse Event|4|||
130389783|NCT03336216|469396740|FG000|Treatment|Participant request to discontinue treatment|2|||
130389784|NCT03336216|469396741|FG001|Treatment|Participant request to discontinue treatment|1|||
130389785|NCT03336216|469396742|FG002|Treatment|Participant request to discontinue treatment|2|||
130389786|NCT03336216|469396743|FG003|Treatment|Participant request to discontinue treatment|2|||
130389787|NCT03336216|469396740|FG000|Treatment|Participant withdrew consent|7|||
130389788|NCT03336216|469396741|FG001|Treatment|Participant withdrew consent|2|||
130389789|NCT03336216|469396742|FG002|Treatment|Participant withdrew consent|3|||
130722791|NCT00673387|470609737|FG005|Overall Study|Adverse Event|2|||
130389790|NCT03336216|469396743|FG003|Treatment|Participant withdrew consent|2|||
130389791|NCT03336216|469396740|FG000|Treatment|Death|2|||
130389792|NCT03336216|469396741|FG001|Treatment|Death|3|||
130389793|NCT03336216|469396742|FG002|Treatment|Death|3|||
130389794|NCT03336216|469396743|FG003|Treatment|Death|4|||
130389795|NCT03336216|469396740|FG000|Treatment|Participant no longer meets study criteria|0|||
130389796|NCT03336216|469396741|FG001|Treatment|Participant no longer meets study criteria|1|||
130389797|NCT03336216|469396742|FG002|Treatment|Participant no longer meets study criteria|0|||
130469967|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
130469968|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
130469969|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
130469970|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
130469971|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
130469972|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
130469973|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
130389798|NCT03336216|469396743|FG003|Treatment|Participant no longer meets study criteria|0|||
130389799|NCT03336216|469396740|FG000|Treatment|Other reasons|2|||
130389800|NCT03336216|469396741|FG001|Treatment|Other reasons|0|||
130389801|NCT03336216|469396742|FG002|Treatment|Other reasons|0|||
130389802|NCT03336216|469396743|FG003|Treatment|Other reasons|3|||
130389803|NCT03336216|469396740|FG000|Treatment|Disease progression|23|||
130389804|NCT03336216|469396741|FG001|Treatment|Disease progression|34|||
130389805|NCT03336216|469396742|FG002|Treatment|Disease progression|33|||
130389806|NCT03336216|469396743|FG003|Treatment|Disease progression|26|||
130389807|NCT03336216|469396740|FG000|Treatment|Study drug toxicity|0|||
130389808|NCT03336216|469396741|FG001|Treatment|Study drug toxicity|3|||
130389809|NCT03336216|469396742|FG002|Treatment|Study drug toxicity|2|||
130389810|NCT03336216|469396743|FG003|Treatment|Study drug toxicity|0|||
130389811|NCT03336216|469396740|FG000|Treatment|Adverse Event unrelated to study drug|1|||
130389812|NCT03336216|469396741|FG001|Treatment|Adverse Event unrelated to study drug|1|||
130389813|NCT03336216|469396742|FG002|Treatment|Adverse Event unrelated to study drug|1|||
130722792|NCT00673387|470609738|FG006|Overall Study|Adverse Event|5|||
130722793|NCT00673387|470609739|FG007|Overall Study|Adverse Event|5|||
130722794|NCT00673387|470609732|FG000|Overall Study|Physician Decision|0|||
130722795|NCT00673387|470609733|FG001|Overall Study|Physician Decision|0|||
130722796|NCT00673387|470609734|FG002|Overall Study|Physician Decision|0|||
130722797|NCT00673387|470609735|FG003|Overall Study|Physician Decision|0|||
130722798|NCT00673387|470609736|FG004|Overall Study|Physician Decision|0|||
130722799|NCT00673387|470609737|FG005|Overall Study|Physician Decision|5|||
130722800|NCT00673387|470609738|FG006|Overall Study|Physician Decision|1|||
130722801|NCT00673387|470609739|FG007|Overall Study|Physician Decision|1|||
130722802|NCT00673387|470609732|FG000|Overall Study|Protocol Violation|3|||
130722803|NCT00673387|470609733|FG001|Overall Study|Protocol Violation|0|||
130722804|NCT00673387|470609734|FG002|Overall Study|Protocol Violation|1|||
130722805|NCT00673387|470609735|FG003|Overall Study|Protocol Violation|2|||
130722806|NCT00673387|470609736|FG004|Overall Study|Protocol Violation|0|||
130722807|NCT00673387|470609737|FG005|Overall Study|Protocol Violation|1|||
130722808|NCT00673387|470609738|FG006|Overall Study|Protocol Violation|1|||
130722809|NCT00673387|470609739|FG007|Overall Study|Protocol Violation|3|||
130389814|NCT03336216|469396743|FG003|Treatment|Adverse Event unrelated to study drug|0|||
130389815|NCT03336216|469396740|FG000|Treatment|Disease Recurrence|1|||
130389816|NCT03336216|469396741|FG001|Treatment|Disease Recurrence|0|||
130389817|NCT03336216|469396742|FG002|Treatment|Disease Recurrence|0|||
130389818|NCT03336216|469396743|FG003|Treatment|Disease Recurrence|0|||
130389819|NCT03239470|469396744|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
130389820|NCT03239470|469396745|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
130389821|NCT00922766|469396746|FG000|Overall Study|Death|3|||
130389822|NCT00922766|469396746|FG000|Overall Study|Withdrawal by Subject|2|||
130389823|NCT00922766|469396746|FG000|Overall Study|Other|1|||
130389824|NCT00922766|469396746|FG000|Overall Study|Adverse Event|1|||
130389825|NCT01231581|469396749|FG000|Overall Study|Lost to Follow-up|2|||
130389826|NCT01231581|469396750|FG001|Overall Study|Lost to Follow-up|2|||
130389827|NCT01231581|469396749|FG000|Overall Study|Withdrawal by Subject|6|||
130389828|NCT01231581|469396750|FG001|Overall Study|Withdrawal by Subject|9|||
130389829|NCT01231581|469396749|FG000|Overall Study|Study Closed/Terminated|6|||
130389830|NCT01231581|469396750|FG001|Overall Study|Study Closed/Terminated|5|||
130389831|NCT01231581|469396749|FG000|Overall Study|Death|65|||
130389832|NCT01231581|469396750|FG001|Overall Study|Death|64|||
130389833|NCT01231581|469396749|FG000|Overall Study|Ongoing|1|||
130389834|NCT01231581|469396750|FG001|Overall Study|Ongoing|0|||
130469974|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
130722810|NCT00673387|470609732|FG000|Overall Study|Lost to Follow-up|8|||
130722811|NCT00673387|470609733|FG001|Overall Study|Lost to Follow-up|6|||
130389835|NCT03616912|469396751|FG000|Overall Study|Adverse Event|17|||
130389836|NCT03616912|469396752|FG001|Overall Study|Adverse Event|21|||
130722812|NCT00673387|470609734|FG002|Overall Study|Lost to Follow-up|5|||
130722813|NCT00673387|470609735|FG003|Overall Study|Lost to Follow-up|6|||
130722814|NCT00673387|470609736|FG004|Overall Study|Lost to Follow-up|6|||
130722815|NCT00673387|470609737|FG005|Overall Study|Lost to Follow-up|5|||
130389837|NCT03616912|469396753|FG002|Overall Study|Adverse Event|9|||
130389838|NCT03616912|469396754|FG003|Overall Study|Adverse Event|0|||
130389839|NCT03616912|469396755|FG004|Overall Study|Adverse Event|0|||
130389840|NCT03616912|469396756|FG005|Overall Study|Adverse Event|0|||
130389841|NCT03616912|469396751|FG000|Overall Study|Death|1|||
130389842|NCT03616912|469396752|FG001|Overall Study|Death|1|||
130389843|NCT03616912|469396753|FG002|Overall Study|Death|0|||
130389844|NCT03616912|469396754|FG003|Overall Study|Death|0|||
130389845|NCT03616912|469396755|FG004|Overall Study|Death|0|||
130389846|NCT03616912|469396756|FG005|Overall Study|Death|0|||
130389847|NCT03616912|469396751|FG000|Overall Study|Lack of Efficacy|13|||
130389848|NCT03616912|469396752|FG001|Overall Study|Lack of Efficacy|6|||
130389849|NCT03616912|469396753|FG002|Overall Study|Lack of Efficacy|8|||
130389850|NCT03616912|469396754|FG003|Overall Study|Lack of Efficacy|4|||
130389851|NCT03616912|469396755|FG004|Overall Study|Lack of Efficacy|5|||
130389852|NCT03616912|469396756|FG005|Overall Study|Lack of Efficacy|1|||
130389853|NCT03616912|469396751|FG000|Overall Study|Lost to Follow-up|1|||
130389854|NCT03616912|469396752|FG001|Overall Study|Lost to Follow-up|2|||
130389855|NCT03616912|469396753|FG002|Overall Study|Lost to Follow-up|3|||
130389856|NCT03616912|469396754|FG003|Overall Study|Lost to Follow-up|0|||
130389857|NCT03616912|469396755|FG004|Overall Study|Lost to Follow-up|0|||
130389858|NCT03616912|469396756|FG005|Overall Study|Lost to Follow-up|0|||
130389859|NCT03616912|469396751|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
130389860|NCT03616912|469396752|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
130389861|NCT03616912|469396753|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
130389862|NCT03616912|469396754|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
130389863|NCT03616912|469396755|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
130389864|NCT03616912|469396756|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
130389865|NCT03616912|469396751|FG000|Overall Study|Withdrawal by Subject|12|||
130389866|NCT03616912|469396752|FG001|Overall Study|Withdrawal by Subject|12|||
130389867|NCT03616912|469396753|FG002|Overall Study|Withdrawal by Subject|15|||
130389868|NCT03616912|469396754|FG003|Overall Study|Withdrawal by Subject|2|||
130389869|NCT03616912|469396755|FG004|Overall Study|Withdrawal by Subject|0|||
130389870|NCT03616912|469396756|FG005|Overall Study|Withdrawal by Subject|2|||
130389871|NCT03616912|469396751|FG000|Overall Study|Study Terminated by Sponsor|0|||
130389872|NCT03616912|469396752|FG001|Overall Study|Study Terminated by Sponsor|0|||
130389873|NCT03616912|469396753|FG002|Overall Study|Study Terminated by Sponsor|0|||
130389874|NCT03616912|469396754|FG003|Overall Study|Study Terminated by Sponsor|10|||
130389875|NCT03616912|469396755|FG004|Overall Study|Study Terminated by Sponsor|9|||
130389876|NCT03616912|469396756|FG005|Overall Study|Study Terminated by Sponsor|11|||
130389877|NCT03616912|469396751|FG000|Overall Study|Protocol Deviation|1|||
130389878|NCT03616912|469396752|FG001|Overall Study|Protocol Deviation|1|||
130389879|NCT03616912|469396753|FG002|Overall Study|Protocol Deviation|0|||
130389880|NCT03616912|469396754|FG003|Overall Study|Protocol Deviation|0|||
130389881|NCT03616912|469396755|FG004|Overall Study|Protocol Deviation|0|||
130389882|NCT03616912|469396756|FG005|Overall Study|Protocol Deviation|0|||
130389883|NCT03616912|469396751|FG000|Overall Study|Pregnancy|1|||
130389884|NCT03616912|469396752|FG001|Overall Study|Pregnancy|0|||
130389885|NCT03616912|469396753|FG002|Overall Study|Pregnancy|4|||
130389886|NCT03616912|469396754|FG003|Overall Study|Pregnancy|0|||
130389887|NCT03616912|469396755|FG004|Overall Study|Pregnancy|0|||
130389888|NCT03616912|469396756|FG005|Overall Study|Pregnancy|0|||
130389889|NCT03616912|469396751|FG000|Overall Study|Protocol Violation|1|||
130389890|NCT03616912|469396752|FG001|Overall Study|Protocol Violation|0|||
130389891|NCT03616912|469396753|FG002|Overall Study|Protocol Violation|2|||
130389892|NCT03616912|469396754|FG003|Overall Study|Protocol Violation|0|||
130389893|NCT03616912|469396755|FG004|Overall Study|Protocol Violation|0|||
130389894|NCT03616912|469396756|FG005|Overall Study|Protocol Violation|0|||
130389895|NCT03616912|469396751|FG000|Overall Study|Physician Decision|2|||
130389896|NCT03616912|469396752|FG001|Overall Study|Physician Decision|0|||
130389897|NCT03616912|469396753|FG002|Overall Study|Physician Decision|0|||
130389898|NCT03616912|469396754|FG003|Overall Study|Physician Decision|0|||
130389899|NCT03616912|469396755|FG004|Overall Study|Physician Decision|1|||
130389900|NCT03616912|469396756|FG005|Overall Study|Physician Decision|0|||
130389901|NCT03616912|469396751|FG000|Overall Study|Randomized But Never Treated|0|||
130389902|NCT03616912|469396752|FG001|Overall Study|Randomized But Never Treated|2|||
130559876|NCT02632721|470017890|FG000|Overall Study|Relapsed Pneumonia|0|||
130559877|NCT02632721|470017891|FG001|Overall Study|Relapsed Pneumonia|0|||
130389903|NCT03616912|469396753|FG002|Overall Study|Randomized But Never Treated|0|||
130389904|NCT03616912|469396754|FG003|Overall Study|Randomized But Never Treated|0|||
130389905|NCT03616912|469396755|FG004|Overall Study|Randomized But Never Treated|0|||
130389906|NCT03616912|469396756|FG005|Overall Study|Randomized But Never Treated|0|||
130389907|NCT02510794|469396757|FG000|Overall Study|Adverse Event|0|||
130389908|NCT02510794|469396758|FG001|Overall Study|Adverse Event|1|||
130389909|NCT02510794|469396759|FG002|Overall Study|Adverse Event|0|||
130389910|NCT02510794|469396760|FG003|Overall Study|Adverse Event|0|||
130389911|NCT02510794|469396757|FG000|Overall Study|Death|1|||
130389912|NCT02510794|469396758|FG001|Overall Study|Death|2|||
130389913|NCT02510794|469396759|FG002|Overall Study|Death|1|||
130389914|NCT02510794|469396760|FG003|Overall Study|Death|1|||
130389915|NCT02510794|469396757|FG000|Overall Study|Lack of Efficacy|3|||
130389916|NCT02510794|469396758|FG001|Overall Study|Lack of Efficacy|1|||
130389917|NCT02510794|469396759|FG002|Overall Study|Lack of Efficacy|1|||
130389918|NCT02510794|469396760|FG003|Overall Study|Lack of Efficacy|0|||
130469975|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
130469976|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
130469977|NCT04759833|469685804|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
130469978|NCT04759833|469685805|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
130469979|NCT04759833|469685806|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
130469980|NCT04759833|469685807|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
130469981|NCT04759833|469685808|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
130469982|NCT04711135|469685809|FG000|Overall Study|Physician Decision|0|||
130469983|NCT04711135|469685810|FG001|Overall Study|Physician Decision|1|||
130469984|NCT04711135|469685809|FG000|Overall Study|Ongoing treatment|0|||
130469985|NCT04711135|469685810|FG001|Overall Study|Ongoing treatment|1|||
130469986|NCT00998881|469685813|FG000|Overall Study|Adverse Event|2|||
130469987|NCT00998881|469685814|FG001|Overall Study|Adverse Event|2|||
130469988|NCT00998881|469685813|FG000|Overall Study|Lack of Efficacy|1|||
130469989|NCT00998881|469685814|FG001|Overall Study|Lack of Efficacy|0|||
130469990|NCT00998881|469685813|FG000|Overall Study|Physician Decision|3|||
130469991|NCT00998881|469685814|FG001|Overall Study|Physician Decision|0|||
130469992|NCT00998881|469685813|FG000|Overall Study|Withdrawal by Subject|1|||
130469993|NCT00998881|469685814|FG001|Overall Study|Withdrawal by Subject|0|||
130469994|NCT00998881|469685813|FG000|Overall Study|Personal matter|1|||
130469995|NCT00998881|469685814|FG001|Overall Study|Personal matter|0|||
130389919|NCT02510794|469396757|FG000|Overall Study|Participant moved out of the area|0|||
130389920|NCT02510794|469396758|FG001|Overall Study|Participant moved out of the area|0|||
130389921|NCT02510794|469396759|FG002|Overall Study|Participant moved out of the area|0|||
130389922|NCT02510794|469396760|FG003|Overall Study|Participant moved out of the area|1|||
130389923|NCT02510794|469396757|FG000|Overall Study|Physician Decision|3|||
130389924|NCT02510794|469396758|FG001|Overall Study|Physician Decision|0|||
130389925|NCT02510794|469396759|FG002|Overall Study|Physician Decision|0|||
130389926|NCT02510794|469396760|FG003|Overall Study|Physician Decision|0|||
130389927|NCT02510794|469396757|FG000|Overall Study|Protocol Violation|0|||
130389928|NCT02510794|469396758|FG001|Overall Study|Protocol Violation|0|||
130389929|NCT02510794|469396759|FG002|Overall Study|Protocol Violation|1|||
130389930|NCT02510794|469396760|FG003|Overall Study|Protocol Violation|0|||
130389931|NCT02510794|469396757|FG000|Overall Study|Withdrawal by Subject|1|||
130389932|NCT02510794|469396758|FG001|Overall Study|Withdrawal by Subject|2|||
130389933|NCT02510794|469396759|FG002|Overall Study|Withdrawal by Subject|4|||
130389934|NCT02510794|469396760|FG003|Overall Study|Withdrawal by Subject|3|||
130389935|NCT01649375|469396761|FG000|Up to Week 16|Adverse Event|2|||
130389936|NCT01649375|469396762|FG001|Up to Week 16|Adverse Event|5|||
130389937|NCT01649375|469396763|FG002|Up to Week 16|Adverse Event|4|||
130389938|NCT01649375|469396764|FG003|Up to Week 16|Adverse Event|0|||
130389939|NCT01649375|469396765|FG004|Up to Week 16|Adverse Event|0|||
130389940|NCT01649375|469396761|FG000|Up to Week 16|Lack of Efficacy|0|||
130389941|NCT01649375|469396762|FG001|Up to Week 16|Lack of Efficacy|0|||
130389942|NCT01649375|469396763|FG002|Up to Week 16|Lack of Efficacy|1|||
130389943|NCT01649375|469396764|FG003|Up to Week 16|Lack of Efficacy|0|||
130389944|NCT01649375|469396765|FG004|Up to Week 16|Lack of Efficacy|0|||
130389945|NCT01649375|469396761|FG000|Up to Week 16|Physician Decision|0|||
130389946|NCT01649375|469396762|FG001|Up to Week 16|Physician Decision|0|||
130389947|NCT01649375|469396763|FG002|Up to Week 16|Physician Decision|1|||
130389948|NCT01649375|469396764|FG003|Up to Week 16|Physician Decision|0|||
130389949|NCT01649375|469396765|FG004|Up to Week 16|Physician Decision|0|||
130389950|NCT01649375|469396761|FG000|Up to Week 16|Withdrawal by Subject|2|||
130389951|NCT01649375|469396762|FG001|Up to Week 16|Withdrawal by Subject|1|||
130389952|NCT01649375|469396763|FG002|Up to Week 16|Withdrawal by Subject|2|||
130389953|NCT01649375|469396764|FG003|Up to Week 16|Withdrawal by Subject|0|||
130389954|NCT01649375|469396765|FG004|Up to Week 16|Withdrawal by Subject|0|||
130389955|NCT01649375|469396761|FG000|Up to Week 16|Death|1|||
130389956|NCT01649375|469396762|FG001|Up to Week 16|Death|0|||
130389957|NCT01649375|469396763|FG002|Up to Week 16|Death|0|||
130389958|NCT01649375|469396764|FG003|Up to Week 16|Death|0|||
130469996|NCT00818246|469685815|FG000|Overall Study|Impossible to match pictures|5|||
130469997|NCT01121991|469685816|FG000|Overall Study|Lack of Ovarian Response|2|||
130469998|NCT01121991|469685816|FG000|Overall Study|No Oocytes Retrieved|3|||
130389959|NCT01649375|469396765|FG004|Up to Week 16|Death|0|||
130469999|NCT01121991|469685816|FG000|Overall Study|No Fertilization|1|||
130470000|NCT00409838|469685817|FG000|Short-term Period|Adverse Event|0|||
130389960|NCT01649375|469396761|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
130389961|NCT01649375|469396762|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
130389962|NCT01649375|469396763|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
130389963|NCT01649375|469396764|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
130389964|NCT01649375|469396765|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
130389965|NCT01649375|469396761|FG000|Week 16 up to Week 260|Non-compliance|0|||
130389966|NCT01649375|469396762|FG001|Week 16 up to Week 260|Non-compliance|1|||
130389967|NCT01649375|469396763|FG002|Week 16 up to Week 260|Non-compliance|0|||
130389968|NCT01649375|469396764|FG003|Week 16 up to Week 260|Non-compliance|1|||
130389969|NCT01649375|469396765|FG004|Week 16 up to Week 260|Non-compliance|0|||
130389970|NCT01649375|469396761|FG000|Week 16 up to Week 260|Physician Decision|0|||
130389971|NCT01649375|469396762|FG001|Week 16 up to Week 260|Physician Decision|2|||
130389972|NCT01649375|469396763|FG002|Week 16 up to Week 260|Physician Decision|0|||
130389973|NCT01649375|469396764|FG003|Week 16 up to Week 260|Physician Decision|0|||
130389974|NCT01649375|469396765|FG004|Week 16 up to Week 260|Physician Decision|0|||
130389975|NCT01649375|469396761|FG000|Week 16 up to Week 260|Technical issues|0|||
130389976|NCT01649375|469396762|FG001|Week 16 up to Week 260|Technical issues|1|||
130389977|NCT01649375|469396763|FG002|Week 16 up to Week 260|Technical issues|0|||
130389978|NCT01649375|469396764|FG003|Week 16 up to Week 260|Technical issues|1|||
130389979|NCT01649375|469396765|FG004|Week 16 up to Week 260|Technical issues|0|||
130389980|NCT01649375|469396761|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
130389981|NCT01649375|469396762|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
130389982|NCT01649375|469396763|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
130389983|NCT01649375|469396764|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
130389984|NCT01649375|469396765|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
130389985|NCT01649375|469396761|FG000|Week 16 up to Week 260|Death|1|||
130389986|NCT01649375|469396762|FG001|Week 16 up to Week 260|Death|1|||
130389987|NCT01649375|469396763|FG002|Week 16 up to Week 260|Death|0|||
130389988|NCT01649375|469396764|FG003|Week 16 up to Week 260|Death|0|||
130389989|NCT01649375|469396765|FG004|Week 16 up to Week 260|Death|0|||
130389990|NCT01649375|469396761|FG000|Week 16 up to Week 260|Adverse Event|5|||
130389991|NCT01649375|469396762|FG001|Week 16 up to Week 260|Adverse Event|2|||
130389992|NCT01649375|469396763|FG002|Week 16 up to Week 260|Adverse Event|0|||
130389993|NCT01649375|469396764|FG003|Week 16 up to Week 260|Adverse Event|3|||
130389994|NCT01649375|469396765|FG004|Week 16 up to Week 260|Adverse Event|2|||
130389995|NCT01124604|469396768|FG000|Overall Study|Adverse Event|10|||
130389996|NCT01124604|469396769|FG001|Overall Study|Adverse Event|1|||
130389997|NCT01124604|469396768|FG000|Overall Study|Lack of Efficacy|1|||
130389998|NCT01124604|469396769|FG001|Overall Study|Lack of Efficacy|0|||
130389999|NCT01124604|469396768|FG000|Overall Study|Withdrawal by Subject|4|||
130390000|NCT01124604|469396769|FG001|Overall Study|Withdrawal by Subject|0|||
130390001|NCT01124604|469396768|FG000|Overall Study|Disease Progression|0|||
130390002|NCT01124604|469396769|FG001|Overall Study|Disease Progression|1|||
130390003|NCT01856790|469396770|FG000|Closed Loop Control|Withdrawal by Subject|2|||
130390004|NCT01856790|469396770|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
130390005|NCT04091646|469396771|FG000|Overall Study|Adverse Event|2|||
130390006|NCT04091646|469396772|FG001|Overall Study|Adverse Event|1|||
130390007|NCT04091646|469396771|FG000|Overall Study|Lost to Follow-up|6|||
130390008|NCT04091646|469396772|FG001|Overall Study|Lost to Follow-up|2|||
130390009|NCT04091646|469396771|FG000|Overall Study|Protocol Violation|0|||
130390010|NCT04091646|469396772|FG001|Overall Study|Protocol Violation|1|||
130470001|NCT00409838|469685818|FG001|Short-term Period|Adverse Event|1|||
130470002|NCT00409838|469685817|FG000|Short-term Period|Lost to Follow-up|0|||
130470003|NCT00409838|469685818|FG001|Short-term Period|Lost to Follow-up|1|||
130470004|NCT00409838|469685817|FG000|Short-term Period|Withdrawal by Subject|2|||
130470005|NCT00409838|469685818|FG001|Short-term Period|Withdrawal by Subject|3|||
130470006|NCT00409838|469685817|FG000|Short-term Period|Never Treated|1|||
130470007|NCT00409838|469685818|FG001|Short-term Period|Never Treated|0|||
130470008|NCT00409838|469685817|FG000|Long-term Extension Period|Adverse Event|10|||
130470009|NCT00409838|469685818|FG001|Long-term Extension Period|Adverse Event|0|||
130470010|NCT00409838|469685817|FG000|Long-term Extension Period|Death|1|||
130470011|NCT00409838|469685818|FG001|Long-term Extension Period|Death|0|||
130470012|NCT00409838|469685817|FG000|Long-term Extension Period|Lack of Efficacy|2|||
130470013|NCT00409838|469685818|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130470014|NCT00409838|469685817|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
130470015|NCT00409838|469685818|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
130470016|NCT00409838|469685817|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
130470017|NCT00409838|469685818|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
130470018|NCT00409838|469685817|FG000|Long-term Extension Period|Pregnancy|1|||
130470019|NCT00409838|469685818|FG001|Long-term Extension Period|Pregnancy|0|||
130470020|NCT01619410|469685819|FG000|Overall Study|Lost to Follow-up|7|||
130470021|NCT01619410|469685820|FG001|Overall Study|Lost to Follow-up|4|||
130470022|NCT00999167|469685822|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
130390011|NCT04091646|469396771|FG000|Overall Study|Withdrawal by Subject|4|||
130390012|NCT04091646|469396772|FG001|Overall Study|Withdrawal by Subject|1|||
130390013|NCT04091646|469396771|FG000|Overall Study|Participant Incarcerated|1|||
130390014|NCT04091646|469396772|FG001|Overall Study|Participant Incarcerated|0|||
130390015|NCT01762943|469396773|FG000|Overall Study|Physician Decision|1|||
130390016|NCT01762943|469396774|FG001|Overall Study|Physician Decision|1|||
130390017|NCT01762943|469396773|FG000|Overall Study|Protocol Violation|1|||
130390018|NCT01762943|469396774|FG001|Overall Study|Protocol Violation|0|||
130470023|NCT00999167|469685823|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
130470024|NCT00999167|469685824|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
130470025|NCT00999167|469685822|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
130390019|NCT01762943|469396773|FG000|Overall Study|Withdrawal by Subject|2|||
130390020|NCT01762943|469396774|FG001|Overall Study|Withdrawal by Subject|1|||
130390021|NCT00539838|469396775|FG000|Overall Study|Fail to return|2|||
130390022|NCT00539838|469396776|FG001|Overall Study|Fail to return|0|||
130390023|NCT00539838|469396777|FG002|Overall Study|Fail to return|0|||
130390024|NCT00539838|469396775|FG000|Overall Study|Withdrawal by Subject|0|||
130390025|NCT00539838|469396776|FG001|Overall Study|Withdrawal by Subject|4|||
130390026|NCT00539838|469396777|FG002|Overall Study|Withdrawal by Subject|0|||
130390027|NCT00539838|469396775|FG000|Overall Study|Death|0|||
130390028|NCT00539838|469396776|FG001|Overall Study|Death|2|||
130390029|NCT00539838|469396777|FG002|Overall Study|Death|0|||
130390030|NCT00539838|469396775|FG000|Overall Study|Did not cooperate|1|||
130390031|NCT00539838|469396776|FG001|Overall Study|Did not cooperate|0|||
130390032|NCT00539838|469396777|FG002|Overall Study|Did not cooperate|1|||
130390033|NCT00539838|469396775|FG000|Overall Study|Administrative|4|||
130390034|NCT00539838|469396776|FG001|Overall Study|Administrative|0|||
130390035|NCT00539838|469396777|FG002|Overall Study|Administrative|8|||
130390036|NCT04343521|469396778|FG000|Overall Study|Adverse Event|0|||
130390037|NCT04343521|469396779|FG001|Overall Study|Adverse Event|2|||
130390038|NCT04343521|469396778|FG000|Overall Study|Death|1|||
130390039|NCT04343521|469396779|FG001|Overall Study|Death|2|||
130390040|NCT04343521|469396778|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
130390041|NCT04343521|469396779|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
130390042|NCT04343521|469396778|FG000|Overall Study|Withdrawal by Subject|70|||
130390043|NCT04343521|469396779|FG001|Overall Study|Withdrawal by Subject|95|||
130390044|NCT04343521|469396778|FG000|Overall Study|Withdrawal by study team|6|||
130390045|NCT04343521|469396779|FG001|Overall Study|Withdrawal by study team|12|||
130390046|NCT00107198|469396780|FG000|Overall Study|Lack of Efficacy|28|||
130390047|NCT00107198|469396780|FG000|Overall Study|Lost to Follow-up|12|||
130390048|NCT00107198|469396780|FG000|Overall Study|Protocol Violation|1|||
130390049|NCT00107198|469396780|FG000|Overall Study|Withdrawal by Subject|6|||
130390050|NCT00107198|469396780|FG000|Overall Study|Ineligible|5|||
130390051|NCT02120950|469396781|FG000|Overall Study|Adverse Event|5|||
130390052|NCT02120950|469396782|FG001|Overall Study|Adverse Event|4|||
130390053|NCT02120950|469396783|FG002|Overall Study|Adverse Event|3|||
130390054|NCT02120950|469396781|FG000|Overall Study|Death|3|||
130390055|NCT02120950|469396782|FG001|Overall Study|Death|0|||
130390056|NCT02120950|469396783|FG002|Overall Study|Death|1|||
130390057|NCT02120950|469396781|FG000|Overall Study|Withdrawal by Subject|6|||
130390058|NCT02120950|469396782|FG001|Overall Study|Withdrawal by Subject|3|||
130390059|NCT02120950|469396783|FG002|Overall Study|Withdrawal by Subject|2|||
130390060|NCT02120950|469396781|FG000|Overall Study|Protocol Violation|1|||
130390061|NCT02120950|469396782|FG001|Overall Study|Protocol Violation|1|||
130390062|NCT02120950|469396783|FG002|Overall Study|Protocol Violation|7|||
130390063|NCT02120950|469396781|FG000|Overall Study|Other reasons|5|||
130390064|NCT02120950|469396782|FG001|Overall Study|Other reasons|4|||
130390065|NCT02120950|469396783|FG002|Overall Study|Other reasons|1|||
130390066|NCT02120950|469396781|FG000|Overall Study|Lost to Follow-up|0|||
130390067|NCT02120950|469396782|FG001|Overall Study|Lost to Follow-up|2|||
130390068|NCT02120950|469396783|FG002|Overall Study|Lost to Follow-up|1|||
130390069|NCT02424383|469396784|FG000|Overall Study|Withdrawal by Subject|32|||
130390070|NCT02424383|469396784|FG000|Overall Study|Death|170|||
130390071|NCT02424383|469396784|FG000|Overall Study|Sponsor's decision|3|||
130390072|NCT02424383|469396784|FG000|Overall Study|Investigator's decision|44|||
130390073|NCT02424383|469396784|FG000|Overall Study|Lost to Follow-up|81|||
130390074|NCT02424383|469396784|FG000|Overall Study|Other|7|||
130390075|NCT02424383|469396784|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
130390076|NCT02438722|469396787|FG000|Overall Study|Adverse Event|12|||
130390077|NCT02438722|469396788|FG001|Overall Study|Adverse Event|9|||
130390078|NCT02438722|469396787|FG000|Overall Study|Refusal unrelated to AE|2|||
130390079|NCT02438722|469396788|FG001|Overall Study|Refusal unrelated to AE|5|||
130390080|NCT02438722|469396787|FG000|Overall Study|Disease progression/relapse|46|||
130390081|NCT02438722|469396788|FG001|Overall Study|Disease progression/relapse|51|||
130390082|NCT02438722|469396787|FG000|Overall Study|Death|0|||
130390083|NCT02438722|469396788|FG001|Overall Study|Death|3|||
130390084|NCT02438722|469396787|FG000|Overall Study|Physician Decision|2|||
130390085|NCT02438722|469396788|FG001|Overall Study|Physician Decision|2|||
130390086|NCT02438722|469396787|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
130390087|NCT02438722|469396788|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
130390088|NCT02438722|469396787|FG000|Overall Study|Withdrawal by Subject|0|||
130390089|NCT02438722|469396788|FG001|Overall Study|Withdrawal by Subject|1|||
130390090|NCT02438722|469396787|FG000|Overall Study|On protocol treatment|15|||
130390091|NCT02438722|469396788|FG001|Overall Study|On protocol treatment|14|||
130390092|NCT02438722|469396787|FG000|Overall Study|Did not receive protocol treatment|5|||
130722816|NCT00673387|470609738|FG006|Overall Study|Lost to Follow-up|8|||
130390093|NCT02438722|469396788|FG001|Overall Study|Did not receive protocol treatment|0|||
130390094|NCT00909779|469396789|FG000|Overall Study|Adverse Event|53|||
130390095|NCT00909779|469396790|FG001|Overall Study|Adverse Event|55|||
130390096|NCT00909779|469396789|FG000|Overall Study|Lack of Efficacy|7|||
130390097|NCT00909779|469396790|FG001|Overall Study|Lack of Efficacy|4|||
130390098|NCT00909779|469396789|FG000|Overall Study|Lost to Follow-up|19|||
130390099|NCT00909779|469396790|FG001|Overall Study|Lost to Follow-up|15|||
130390100|NCT00909779|469396789|FG000|Overall Study|Physician Decision|8|||
130390101|NCT00909779|469396790|FG001|Overall Study|Physician Decision|2|||
130390102|NCT00909779|469396789|FG000|Overall Study|Protocol Violation|2|||
130390103|NCT00909779|469396790|FG001|Overall Study|Protocol Violation|5|||
130390104|NCT00909779|469396789|FG000|Overall Study|Withdrawal by Subject|116|||
130390105|NCT00909779|469396790|FG001|Overall Study|Withdrawal by Subject|80|||
130390106|NCT00909779|469396789|FG000|Overall Study|Site Ceasing Operation|2|||
130390107|NCT00909779|469396790|FG001|Overall Study|Site Ceasing Operation|2|||
130390108|NCT00909779|469396789|FG000|Overall Study|Medical Monitor Decision|1|||
130390109|NCT00909779|469396790|FG001|Overall Study|Medical Monitor Decision|0|||
130390110|NCT00909779|469396789|FG000|Overall Study|Noncompliance|1|||
130390111|NCT00909779|469396790|FG001|Overall Study|Noncompliance|1|||
130390112|NCT00909779|469396789|FG000|Overall Study|Randomized in error|1|||
130390113|NCT00909779|469396790|FG001|Overall Study|Randomized in error|1|||
130390114|NCT02738333|469396794|FG000|Overall Study|Death|1|||
130390115|NCT02738333|469396795|FG001|Overall Study|Death|0|||
130390116|NCT02738333|469396796|FG002|Overall Study|Death|0|||
130390117|NCT02738333|469396794|FG000|Overall Study|Lost to Follow-up|1|||
130390118|NCT02738333|469396795|FG001|Overall Study|Lost to Follow-up|0|||
130390119|NCT02738333|469396796|FG002|Overall Study|Lost to Follow-up|0|||
130390120|NCT01498952|469396798|FG000|Overall Study|Death|2|||
130390121|NCT01498952|469396799|FG001|Overall Study|Death|2|||
130390122|NCT01498952|469396800|FG002|Overall Study|Death|0|||
130390123|NCT01498952|469396801|FG003|Overall Study|Death|0|||
130390124|NCT01498952|469396802|FG004|Overall Study|Death|0|||
130390125|NCT00579826|469396803|FG000|Overall Study|Withdrawal by Subject|5|||
130390126|NCT00579826|469396804|FG001|Overall Study|Withdrawal by Subject|3|||
130390127|NCT04191382|469396805|FG000|Overall Study|Withdrawal by Subject|1|||
130390128|NCT04191382|469396806|FG001|Overall Study|Withdrawal by Subject|0|||
130390129|NCT04191382|469396807|FG002|Overall Study|Withdrawal by Subject|0|||
130390130|NCT05237206|469396808|FG000|Overall Study|screen failure-did not receive treatment|8|||
130390131|NCT05237206|469396808|FG000|Overall Study|did not receive treatment|3|||
130390132|NCT00454987|469396814|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
130390133|NCT00454987|469396815|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
130390134|NCT00454987|469396816|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
130390135|NCT00454987|469396814|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
130390136|NCT00454987|469396815|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
130390137|NCT00454987|469396816|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
130390138|NCT00454987|469396814|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
130390139|NCT00454987|469396815|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
130390140|NCT00454987|469396816|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
130390141|NCT02205333|469396817|FG000|Overall Study|Death|5|||
130390142|NCT02205333|469396818|FG001|Overall Study|Death|6|||
130390143|NCT02205333|469396819|FG002|Overall Study|Death|2|||
130390144|NCT02205333|469396820|FG003|Overall Study|Death|6|||
130390145|NCT02205333|469396821|FG004|Overall Study|Death|5|||
130390146|NCT02205333|469396822|FG005|Overall Study|Death|3|||
130390147|NCT02205333|469396823|FG006|Overall Study|Death|3|||
130390148|NCT02205333|469396824|FG007|Overall Study|Death|2|||
130390149|NCT02205333|469396825|FG008|Overall Study|Death|0|||
130390150|NCT02205333|469396817|FG000|Overall Study|Withdrawal by Subject|1|||
130722817|NCT00673387|470609739|FG007|Overall Study|Lost to Follow-up|5|||
130390151|NCT02205333|469396818|FG001|Overall Study|Withdrawal by Subject|0|||
130722818|NCT00960115|470609742|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
130722819|NCT00960115|470609743|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
130390152|NCT02205333|469396819|FG002|Overall Study|Withdrawal by Subject|0|||
130390153|NCT02205333|469396820|FG003|Overall Study|Withdrawal by Subject|1|||
130390154|NCT02205333|469396821|FG004|Overall Study|Withdrawal by Subject|0|||
130722820|NCT00861198|470609744|FG000|Overall Study|SpyGlass Failed|5|||
130722821|NCT02011386|470609745|FG000|Overall Study|Non-compliance|2|||
130390155|NCT02205333|469396822|FG005|Overall Study|Withdrawal by Subject|0|||
130390156|NCT02205333|469396823|FG006|Overall Study|Withdrawal by Subject|2|||
130390157|NCT02205333|469396824|FG007|Overall Study|Withdrawal by Subject|0|||
130390158|NCT02205333|469396825|FG008|Overall Study|Withdrawal by Subject|0|||
130390159|NCT01476696|469396826|FG000|Overall Study|Sponsor decision|2|||
130390160|NCT01476696|469396827|FG001|Overall Study|Sponsor decision|1|||
130390161|NCT01476696|469396828|FG002|Overall Study|Sponsor decision|0|||
130390162|NCT01476696|469396826|FG000|Overall Study|Withdrawal by Subject|1|||
130390163|NCT01476696|469396827|FG001|Overall Study|Withdrawal by Subject|0|||
130390164|NCT01476696|469396828|FG002|Overall Study|Withdrawal by Subject|0|||
130390165|NCT02009046|469396829|FG000|Overall Study|Lost to Follow-up|256|||
130390166|NCT02009046|469396830|FG001|Overall Study|Lost to Follow-up|206|||
130390167|NCT00304356|469396836|FG000|Nitazoxanide|Physician Decision|5|||
130390168|NCT00304356|469396836|FG000|Nitazoxanide|Physician Decision|1|||
130390169|NCT00304356|469396836|FG000|Nitazoxanide|number is 0|1|||
130390170|NCT00304356|469396836|FG000|Nitazoxanide|Physician Decision|1|||
130390171|NCT00304356|469396836|FG000|Nitazoxanide|Physician Decision|1|||
130390172|NCT00304356|469396836|FG000|Nitazoxanide|Physician Decision|1|||
130390173|NCT01737047|469396837|FG000|Overall Study|Death|10|||
130390174|NCT01737047|469396838|FG001|Overall Study|Death|0|||
130390175|NCT01737047|469396839|FG002|Overall Study|Death|1|||
130390176|NCT01737047|469396837|FG000|Overall Study|Withdrawal by Subject|17|||
130390177|NCT01737047|469396838|FG001|Overall Study|Withdrawal by Subject|11|||
130390178|NCT01737047|469396839|FG002|Overall Study|Withdrawal by Subject|4|||
130390179|NCT00335972|469396840|FG000|Overall Study|not given treatments|0|||
130390180|NCT00335972|469396841|FG001|Overall Study|not given treatments|3|||
130390181|NCT03082599|469396844|FG000|Overall Study|Lost to Follow-up|1|||
130390182|NCT03082599|469396845|FG001|Overall Study|Lost to Follow-up|0|||
130390183|NCT00323115|469396846|FG000|Vaccine Administration|Adverse Event|1|||
130390184|NCT00323115|469396846|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
130390185|NCT02658890|469398785|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390186|NCT02658890|469398786|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390187|NCT02658890|469398787|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390188|NCT02658890|469398788|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390189|NCT02658890|469398789|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390190|NCT02658890|469398790|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390191|NCT02658890|469398791|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390192|NCT02658890|469398792|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390193|NCT02658890|469398793|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130390194|NCT02658890|469398794|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390195|NCT02658890|469398795|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390196|NCT02658890|469398796|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390197|NCT02658890|469398797|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390198|NCT02658890|469398798|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390199|NCT02658890|469398799|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390200|NCT02658890|469398800|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390201|NCT02658890|469398801|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390202|NCT02658890|469398802|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390203|NCT02658890|469398803|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390204|NCT02658890|469398804|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390205|NCT02658890|469398805|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390206|NCT02658890|469398806|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390207|NCT02658890|469398807|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390208|NCT02658890|469398808|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390209|NCT02658890|469398809|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390210|NCT02658890|469398810|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390211|NCT02658890|469398811|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390212|NCT02658890|469398785|FG000|Treatment Phase|Adverse Event|0|||
130390213|NCT02658890|469398786|FG001|Treatment Phase|Adverse Event|1|||
130390214|NCT02658890|469398787|FG002|Treatment Phase|Adverse Event|2|||
130390215|NCT02658890|469398788|FG003|Treatment Phase|Adverse Event|2|||
130390216|NCT02658890|469398789|FG004|Treatment Phase|Adverse Event|1|||
130390217|NCT02658890|469398790|FG005|Treatment Phase|Adverse Event|0|||
130390218|NCT02658890|469398791|FG006|Treatment Phase|Adverse Event|0|||
130390219|NCT02658890|469398792|FG007|Treatment Phase|Adverse Event|2|||
130390220|NCT02658890|469398793|FG008|Treatment Phase|Adverse Event|1|||
130390221|NCT02658890|469398794|FG009|Treatment Phase|Adverse Event|2|||
130390222|NCT02658890|469398795|FG010|Treatment Phase|Adverse Event|3|||
130470026|NCT00999167|469685823|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
130470027|NCT00999167|469685824|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
130470028|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
130470029|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
130470030|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
130470031|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
130470032|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
130470033|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
130390223|NCT02658890|469398796|FG011|Treatment Phase|Adverse Event|0|||
130390224|NCT02658890|469398797|FG012|Treatment Phase|Adverse Event|1|||
130390225|NCT02658890|469398798|FG013|Treatment Phase|Adverse Event|4|||
130390226|NCT02658890|469398799|FG014|Treatment Phase|Adverse Event|0|||
130390227|NCT02658890|469398800|FG015|Treatment Phase|Adverse Event|0|||
130390228|NCT02658890|469398801|FG016|Treatment Phase|Adverse Event|0|||
130390229|NCT02658890|469398802|FG017|Treatment Phase|Adverse Event|0|||
130390230|NCT02658890|469398803|FG018|Treatment Phase|Adverse Event|5|||
130470034|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
130470035|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
130390231|NCT02658890|469398804|FG019|Treatment Phase|Adverse Event|1|||
130390232|NCT02658890|469398805|FG020|Treatment Phase|Adverse Event|3|||
130390233|NCT02658890|469398806|FG021|Treatment Phase|Adverse Event|0|||
130390234|NCT02658890|469398807|FG022|Treatment Phase|Adverse Event|5|||
130390235|NCT02658890|469398808|FG023|Treatment Phase|Adverse Event|0|||
130390236|NCT02658890|469398809|FG024|Treatment Phase|Adverse Event|0|||
130390237|NCT02658890|469398810|FG025|Treatment Phase|Adverse Event|2|||
130390238|NCT02658890|469398811|FG026|Treatment Phase|Adverse Event|1|||
130390239|NCT02658890|469398785|FG000|Treatment Phase|Death|0|||
130390240|NCT02658890|469398786|FG001|Treatment Phase|Death|0|||
130390241|NCT02658890|469398787|FG002|Treatment Phase|Death|0|||
130390242|NCT02658890|469398788|FG003|Treatment Phase|Death|0|||
130390243|NCT02658890|469398789|FG004|Treatment Phase|Death|0|||
130390244|NCT02658890|469398790|FG005|Treatment Phase|Death|0|||
130390245|NCT02658890|469398791|FG006|Treatment Phase|Death|0|||
130390246|NCT02658890|469398792|FG007|Treatment Phase|Death|0|||
130390247|NCT02658890|469398793|FG008|Treatment Phase|Death|0|||
130390248|NCT02658890|469398794|FG009|Treatment Phase|Death|0|||
130390249|NCT02658890|469398795|FG010|Treatment Phase|Death|0|||
130390250|NCT02658890|469398796|FG011|Treatment Phase|Death|0|||
130390251|NCT02658890|469398797|FG012|Treatment Phase|Death|0|||
130390252|NCT02658890|469398798|FG013|Treatment Phase|Death|0|||
130390253|NCT02658890|469398799|FG014|Treatment Phase|Death|0|||
130390254|NCT02658890|469398800|FG015|Treatment Phase|Death|0|||
130390255|NCT02658890|469398801|FG016|Treatment Phase|Death|0|||
130390256|NCT02658890|469398802|FG017|Treatment Phase|Death|0|||
130390257|NCT02658890|469398803|FG018|Treatment Phase|Death|1|||
130390258|NCT02658890|469398804|FG019|Treatment Phase|Death|0|||
130390259|NCT02658890|469398805|FG020|Treatment Phase|Death|0|||
130390260|NCT02658890|469398806|FG021|Treatment Phase|Death|0|||
130390261|NCT02658890|469398807|FG022|Treatment Phase|Death|0|||
130390262|NCT02658890|469398808|FG023|Treatment Phase|Death|0|||
130390263|NCT02658890|469398809|FG024|Treatment Phase|Death|0|||
130390264|NCT02658890|469398810|FG025|Treatment Phase|Death|0|||
130390265|NCT02658890|469398811|FG026|Treatment Phase|Death|0|||
130390266|NCT02658890|469398785|FG000|Treatment Phase|Lost to Follow-up|0|||
130390267|NCT02658890|469398786|FG001|Treatment Phase|Lost to Follow-up|0|||
130390268|NCT02658890|469398787|FG002|Treatment Phase|Lost to Follow-up|0|||
130390269|NCT02658890|469398788|FG003|Treatment Phase|Lost to Follow-up|0|||
130390270|NCT02658890|469398789|FG004|Treatment Phase|Lost to Follow-up|0|||
130390271|NCT02658890|469398790|FG005|Treatment Phase|Lost to Follow-up|0|||
130390272|NCT02658890|469398791|FG006|Treatment Phase|Lost to Follow-up|1|||
130390273|NCT02658890|469398792|FG007|Treatment Phase|Lost to Follow-up|0|||
130390274|NCT02658890|469398793|FG008|Treatment Phase|Lost to Follow-up|0|||
130390275|NCT02658890|469398794|FG009|Treatment Phase|Lost to Follow-up|0|||
130390276|NCT02658890|469398795|FG010|Treatment Phase|Lost to Follow-up|0|||
130390277|NCT02658890|469398796|FG011|Treatment Phase|Lost to Follow-up|0|||
130390278|NCT02658890|469398797|FG012|Treatment Phase|Lost to Follow-up|0|||
130390279|NCT02658890|469398798|FG013|Treatment Phase|Lost to Follow-up|0|||
130390280|NCT02658890|469398799|FG014|Treatment Phase|Lost to Follow-up|0|||
130390281|NCT02658890|469398800|FG015|Treatment Phase|Lost to Follow-up|0|||
130390282|NCT02658890|469398801|FG016|Treatment Phase|Lost to Follow-up|0|||
130390283|NCT02658890|469398802|FG017|Treatment Phase|Lost to Follow-up|0|||
130390284|NCT02658890|469398803|FG018|Treatment Phase|Lost to Follow-up|0|||
130390285|NCT02658890|469398804|FG019|Treatment Phase|Lost to Follow-up|0|||
130390286|NCT02658890|469398805|FG020|Treatment Phase|Lost to Follow-up|0|||
130470036|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
130390287|NCT02658890|469398806|FG021|Treatment Phase|Lost to Follow-up|0|||
130390288|NCT02658890|469398807|FG022|Treatment Phase|Lost to Follow-up|0|||
130390289|NCT02658890|469398808|FG023|Treatment Phase|Lost to Follow-up|0|||
130390290|NCT02658890|469398809|FG024|Treatment Phase|Lost to Follow-up|0|||
130390291|NCT02658890|469398810|FG025|Treatment Phase|Lost to Follow-up|0|||
130390292|NCT02658890|469398811|FG026|Treatment Phase|Lost to Follow-up|0|||
130470037|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
130470038|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
130390293|NCT02658890|469398785|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
130390294|NCT02658890|469398786|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
130390295|NCT02658890|469398787|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
130470039|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
130390296|NCT02658890|469398788|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
130390297|NCT02658890|469398789|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
130390298|NCT02658890|469398790|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
130390299|NCT02658890|469398791|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
130390300|NCT02658890|469398792|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
130390301|NCT02658890|469398793|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
130390302|NCT02658890|469398794|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
130390303|NCT02658890|469398795|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
130390304|NCT02658890|469398796|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
130390305|NCT02658890|469398797|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
130390306|NCT02658890|469398798|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
130390307|NCT02658890|469398799|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
130390308|NCT02658890|469398800|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
130390309|NCT02658890|469398801|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
130390310|NCT02658890|469398802|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
130390311|NCT02658890|469398803|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
130390312|NCT02658890|469398804|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
130390313|NCT02658890|469398805|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
130390314|NCT02658890|469398806|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
130390315|NCT02658890|469398807|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
130390316|NCT02658890|469398808|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
130390317|NCT02658890|469398809|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
130390318|NCT02658890|469398810|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
130390319|NCT02658890|469398811|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
130390320|NCT02658890|469398785|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
130390321|NCT02658890|469398786|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
130390322|NCT02658890|469398787|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
130390323|NCT02658890|469398788|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
130390324|NCT02658890|469398789|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
130390325|NCT02658890|469398790|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
130390326|NCT02658890|469398791|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
130390327|NCT02658890|469398792|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
130390328|NCT02658890|469398793|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
130390329|NCT02658890|469398794|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
130390330|NCT02658890|469398795|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
130390331|NCT02658890|469398796|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
130390332|NCT02658890|469398797|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
130390333|NCT02658890|469398798|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
130390334|NCT02658890|469398799|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
130390335|NCT02658890|469398800|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
130390336|NCT02658890|469398801|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
130390337|NCT02658890|469398802|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
130390338|NCT02658890|469398803|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
130390339|NCT02658890|469398804|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
130390340|NCT02658890|469398805|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
130390341|NCT02658890|469398806|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
130390342|NCT02658890|469398807|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
130390343|NCT02658890|469398808|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
130390344|NCT02658890|469398809|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
130390345|NCT02658890|469398810|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
130390346|NCT02658890|469398811|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
130390347|NCT02658890|469398785|FG000|Treatment Phase|Other Reasons|0|||
130390348|NCT02658890|469398786|FG001|Treatment Phase|Other Reasons|0|||
130390349|NCT02658890|469398787|FG002|Treatment Phase|Other Reasons|0|||
130390350|NCT02658890|469398788|FG003|Treatment Phase|Other Reasons|0|||
130390351|NCT02658890|469398789|FG004|Treatment Phase|Other Reasons|0|||
130390352|NCT02658890|469398790|FG005|Treatment Phase|Other Reasons|0|||
130390353|NCT02658890|469398791|FG006|Treatment Phase|Other Reasons|1|||
130390354|NCT02658890|469398792|FG007|Treatment Phase|Other Reasons|0|||
130390355|NCT02658890|469398793|FG008|Treatment Phase|Other Reasons|1|||
130390356|NCT02658890|469398794|FG009|Treatment Phase|Other Reasons|0|||
130390357|NCT02658890|469398795|FG010|Treatment Phase|Other Reasons|0|||
130390358|NCT02658890|469398796|FG011|Treatment Phase|Other Reasons|0|||
130390359|NCT02658890|469398797|FG012|Treatment Phase|Other Reasons|0|||
130390360|NCT02658890|469398798|FG013|Treatment Phase|Other Reasons|2|||
130390361|NCT02658890|469398799|FG014|Treatment Phase|Other Reasons|0|||
130390362|NCT02658890|469398800|FG015|Treatment Phase|Other Reasons|0|||
130390363|NCT02658890|469398801|FG016|Treatment Phase|Other Reasons|0|||
130390364|NCT02658890|469398802|FG017|Treatment Phase|Other Reasons|0|||
130470040|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
130470041|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
130390365|NCT02658890|469398803|FG018|Treatment Phase|Other Reasons|1|||
130390366|NCT02658890|469398804|FG019|Treatment Phase|Other Reasons|0|||
130390367|NCT02658890|469398805|FG020|Treatment Phase|Other Reasons|0|||
130390368|NCT02658890|469398806|FG021|Treatment Phase|Other Reasons|0|||
130390369|NCT02658890|469398807|FG022|Treatment Phase|Other Reasons|0|||
130390370|NCT02658890|469398808|FG023|Treatment Phase|Other Reasons|0|||
130390371|NCT02658890|469398809|FG024|Treatment Phase|Other Reasons|1|||
130390372|NCT02658890|469398810|FG025|Treatment Phase|Other Reasons|0|||
130390373|NCT02658890|469398811|FG026|Treatment Phase|Other Reasons|1|||
130390374|NCT02658890|469398785|FG000|Treatment Phase|Progressive Disease|6|||
130390375|NCT02658890|469398786|FG001|Treatment Phase|Progressive Disease|7|||
130390376|NCT02658890|469398787|FG002|Treatment Phase|Progressive Disease|6|||
130390377|NCT02658890|469398788|FG003|Treatment Phase|Progressive Disease|12|||
130390378|NCT02658890|469398789|FG004|Treatment Phase|Progressive Disease|6|||
130390379|NCT02658890|469398790|FG005|Treatment Phase|Progressive Disease|18|||
130390380|NCT02658890|469398791|FG006|Treatment Phase|Progressive Disease|12|||
130390381|NCT02658890|469398792|FG007|Treatment Phase|Progressive Disease|19|||
130390382|NCT02658890|469398793|FG008|Treatment Phase|Progressive Disease|26|||
130390383|NCT02658890|469398794|FG009|Treatment Phase|Progressive Disease|8|||
130390384|NCT02658890|469398795|FG010|Treatment Phase|Progressive Disease|7|||
130390385|NCT02658890|469398796|FG011|Treatment Phase|Progressive Disease|9|||
130390386|NCT02658890|469398797|FG012|Treatment Phase|Progressive Disease|8|||
130390387|NCT02658890|469398798|FG013|Treatment Phase|Progressive Disease|29|||
130390388|NCT02658890|469398799|FG014|Treatment Phase|Progressive Disease|6|||
130390389|NCT02658890|469398800|FG015|Treatment Phase|Progressive Disease|2|||
130390390|NCT02658890|469398801|FG016|Treatment Phase|Progressive Disease|32|||
130390391|NCT02658890|469398802|FG017|Treatment Phase|Progressive Disease|14|||
130390392|NCT02658890|469398803|FG018|Treatment Phase|Progressive Disease|40|||
130390393|NCT02658890|469398804|FG019|Treatment Phase|Progressive Disease|32|||
130390394|NCT02658890|469398805|FG020|Treatment Phase|Progressive Disease|19|||
130390395|NCT02658890|469398806|FG021|Treatment Phase|Progressive Disease|30|||
130390396|NCT02658890|469398807|FG022|Treatment Phase|Progressive Disease|15|||
130390397|NCT02658890|469398808|FG023|Treatment Phase|Progressive Disease|0|||
130390398|NCT02658890|469398809|FG024|Treatment Phase|Progressive Disease|0|||
130390399|NCT02658890|469398810|FG025|Treatment Phase|Progressive Disease|14|||
130390400|NCT02658890|469398811|FG026|Treatment Phase|Progressive Disease|11|||
130390401|NCT02658890|469398785|FG000|Treatment Phase|Study Drug Toxicity|0|||
130390402|NCT02658890|469398786|FG001|Treatment Phase|Study Drug Toxicity|0|||
130390403|NCT02658890|469398787|FG002|Treatment Phase|Study Drug Toxicity|2|||
130390404|NCT02658890|469398788|FG003|Treatment Phase|Study Drug Toxicity|0|||
130390405|NCT02658890|469398789|FG004|Treatment Phase|Study Drug Toxicity|0|||
130390406|NCT02658890|469398790|FG005|Treatment Phase|Study Drug Toxicity|0|||
130390407|NCT02658890|469398791|FG006|Treatment Phase|Study Drug Toxicity|0|||
130390408|NCT02658890|469398792|FG007|Treatment Phase|Study Drug Toxicity|0|||
130390409|NCT02658890|469398793|FG008|Treatment Phase|Study Drug Toxicity|3|||
130390410|NCT02658890|469398794|FG009|Treatment Phase|Study Drug Toxicity|0|||
130390411|NCT02658890|469398795|FG010|Treatment Phase|Study Drug Toxicity|1|||
130390412|NCT02658890|469398796|FG011|Treatment Phase|Study Drug Toxicity|1|||
130390413|NCT02658890|469398797|FG012|Treatment Phase|Study Drug Toxicity|2|||
130390414|NCT02658890|469398798|FG013|Treatment Phase|Study Drug Toxicity|9|||
130390415|NCT02658890|469398799|FG014|Treatment Phase|Study Drug Toxicity|0|||
130390416|NCT02658890|469398800|FG015|Treatment Phase|Study Drug Toxicity|1|||
130390417|NCT02658890|469398801|FG016|Treatment Phase|Study Drug Toxicity|1|||
130390418|NCT02658890|469398802|FG017|Treatment Phase|Study Drug Toxicity|0|||
130390419|NCT02658890|469398803|FG018|Treatment Phase|Study Drug Toxicity|8|||
130390420|NCT02658890|469398804|FG019|Treatment Phase|Study Drug Toxicity|3|||
130390421|NCT02658890|469398805|FG020|Treatment Phase|Study Drug Toxicity|2|||
130390422|NCT02658890|469398806|FG021|Treatment Phase|Study Drug Toxicity|0|||
130390423|NCT02658890|469398807|FG022|Treatment Phase|Study Drug Toxicity|8|||
130390424|NCT02658890|469398808|FG023|Treatment Phase|Study Drug Toxicity|0|||
130390425|NCT02658890|469398809|FG024|Treatment Phase|Study Drug Toxicity|0|||
130390426|NCT02658890|469398810|FG025|Treatment Phase|Study Drug Toxicity|2|||
130390427|NCT02658890|469398811|FG026|Treatment Phase|Study Drug Toxicity|0|||
130390428|NCT02658890|469398785|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390429|NCT02658890|469398786|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390430|NCT02658890|469398787|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390431|NCT02658890|469398788|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130390432|NCT02658890|469398789|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390433|NCT02658890|469398790|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390434|NCT02658890|469398791|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390435|NCT02658890|469398792|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390436|NCT02658890|469398793|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390437|NCT02658890|469398794|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130390438|NCT02658890|469398795|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130470042|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
130470043|NCT00999167|469685822|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
130390439|NCT02658890|469398796|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390440|NCT02658890|469398797|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390441|NCT02658890|469398798|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390442|NCT02658890|469398799|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390443|NCT02658890|469398800|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390444|NCT02658890|469398801|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390445|NCT02658890|469398802|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130470044|NCT00999167|469685823|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
130390446|NCT02658890|469398803|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130390447|NCT02658890|469398804|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390448|NCT02658890|469398805|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390449|NCT02658890|469398806|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390450|NCT02658890|469398807|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130390451|NCT02658890|469398808|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390452|NCT02658890|469398809|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390453|NCT02658890|469398810|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390454|NCT02658890|469398811|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130390455|NCT02658890|469398785|FG000|Treatment Phase|Withdrawal by Subject|0|||
130390456|NCT02658890|469398786|FG001|Treatment Phase|Withdrawal by Subject|1|||
130390457|NCT02658890|469398787|FG002|Treatment Phase|Withdrawal by Subject|0|||
130390458|NCT02658890|469398788|FG003|Treatment Phase|Withdrawal by Subject|0|||
130390459|NCT02658890|469398789|FG004|Treatment Phase|Withdrawal by Subject|0|||
130390460|NCT02658890|469398790|FG005|Treatment Phase|Withdrawal by Subject|0|||
130390461|NCT02658890|469398791|FG006|Treatment Phase|Withdrawal by Subject|1|||
130390462|NCT02658890|469398792|FG007|Treatment Phase|Withdrawal by Subject|0|||
130390463|NCT02658890|469398793|FG008|Treatment Phase|Withdrawal by Subject|0|||
130390464|NCT02658890|469398794|FG009|Treatment Phase|Withdrawal by Subject|1|||
130390465|NCT02658890|469398795|FG010|Treatment Phase|Withdrawal by Subject|0|||
130390466|NCT02658890|469398796|FG011|Treatment Phase|Withdrawal by Subject|0|||
130390467|NCT02658890|469398797|FG012|Treatment Phase|Withdrawal by Subject|1|||
130390468|NCT02658890|469398798|FG013|Treatment Phase|Withdrawal by Subject|3|||
130390469|NCT02658890|469398799|FG014|Treatment Phase|Withdrawal by Subject|0|||
130390470|NCT02658890|469398800|FG015|Treatment Phase|Withdrawal by Subject|0|||
130390471|NCT02658890|469398801|FG016|Treatment Phase|Withdrawal by Subject|1|||
130390472|NCT02658890|469398802|FG017|Treatment Phase|Withdrawal by Subject|0|||
130390473|NCT02658890|469398803|FG018|Treatment Phase|Withdrawal by Subject|4|||
130390474|NCT02658890|469398804|FG019|Treatment Phase|Withdrawal by Subject|3|||
130390475|NCT02658890|469398805|FG020|Treatment Phase|Withdrawal by Subject|0|||
130390476|NCT02658890|469398806|FG021|Treatment Phase|Withdrawal by Subject|4|||
130390477|NCT02658890|469398807|FG022|Treatment Phase|Withdrawal by Subject|1|||
130390478|NCT02658890|469398808|FG023|Treatment Phase|Withdrawal by Subject|1|||
130390479|NCT02658890|469398809|FG024|Treatment Phase|Withdrawal by Subject|0|||
130390480|NCT02658890|469398810|FG025|Treatment Phase|Withdrawal by Subject|0|||
130390481|NCT02658890|469398811|FG026|Treatment Phase|Withdrawal by Subject|0|||
130390482|NCT02474199|469398812|FG000|Overall Study|Lost to Follow-up|1|||
130390483|NCT02474199|469398813|FG001|Overall Study|Lost to Follow-up|0|||
130390484|NCT02474199|469398814|FG002|Overall Study|Lost to Follow-up|0|||
130390485|NCT02474199|469398815|FG003|Overall Study|Lost to Follow-up|0|||
130390486|NCT02474199|469398812|FG000|Overall Study|Withdrawal by Subject|1|||
130390487|NCT02474199|469398813|FG001|Overall Study|Withdrawal by Subject|2|||
130390488|NCT02474199|469398814|FG002|Overall Study|Withdrawal by Subject|0|||
130390489|NCT02474199|469398815|FG003|Overall Study|Withdrawal by Subject|1|||
130390490|NCT02474199|469398812|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130390491|NCT02474199|469398813|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
130390492|NCT02474199|469398814|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130390493|NCT02474199|469398815|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130390494|NCT02474199|469398812|FG000|Overall Study|Did not meet eligibility criteria|0|||
130390495|NCT02474199|469398813|FG001|Overall Study|Did not meet eligibility criteria|0|||
130390496|NCT02474199|469398814|FG002|Overall Study|Did not meet eligibility criteria|2|||
130390497|NCT02474199|469398815|FG003|Overall Study|Did not meet eligibility criteria|2|||
130390498|NCT03090100|469398816|FG000|Overall Study|Adverse Event|9|||
130390499|NCT03090100|469398817|FG001|Overall Study|Adverse Event|11|||
130390500|NCT03090100|469398816|FG000|Overall Study|Pregnancy|1|||
130390501|NCT03090100|469398817|FG001|Overall Study|Pregnancy|1|||
130390502|NCT03090100|469398816|FG000|Overall Study|Lack of Efficacy|2|||
130390503|NCT03090100|469398817|FG001|Overall Study|Lack of Efficacy|7|||
130390504|NCT03090100|469398816|FG000|Overall Study|Lost to Follow-up|2|||
130470045|NCT00999167|469685824|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
130470046|NCT05052996|469685827|FG000|Overall Study|Still on study|0|||
130470047|NCT05052996|469685828|FG001|Overall Study|Still on study|0|||
130470048|NCT05052996|469685829|FG002|Overall Study|Still on study|47|||
130390505|NCT03090100|469398817|FG001|Overall Study|Lost to Follow-up|2|||
130390506|NCT03090100|469398816|FG000|Overall Study|Withdrawal by Subject|7|||
130390507|NCT03090100|469398817|FG001|Overall Study|Withdrawal by Subject|19|||
130390508|NCT03090100|469398816|FG000|Overall Study|Protocol Violation|2|||
130390509|NCT03090100|469398817|FG001|Overall Study|Protocol Violation|6|||
130470049|NCT05052996|469685830|FG003|Overall Study|Still on study|44|||
130470050|NCT05052996|469685827|FG000|Overall Study|Cohort terminated by sponsor|21|||
130390510|NCT03090100|469398816|FG000|Overall Study|Non-compliance|2|||
130390511|NCT03090100|469398817|FG001|Overall Study|Non-compliance|0|||
130390512|NCT03090100|469398816|FG000|Overall Study|Other|2|||
130390513|NCT03090100|469398817|FG001|Overall Study|Other|2|||
130390514|NCT00159588|469398818|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
130390515|NCT00159588|469398819|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
130390516|NCT00159588|469398820|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
130390517|NCT01660711|469398821|FG000|Overall Study|Adverse Event|7|||
130390518|NCT01660711|469398821|FG000|Overall Study|Withdrawal by Subject|1|||
130390519|NCT04920123|469398823|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130390520|NCT04920123|469398824|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130390521|NCT04920123|469398825|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130390522|NCT03253848|469398826|FG000|Overall Study|Adverse Event|7|||
130390523|NCT03253848|469398826|FG000|Overall Study|Death|5|||
130390524|NCT03253848|469398826|FG000|Overall Study|initiation of other treatments|3|||
130390525|NCT03253848|469398826|FG000|Overall Study|Other complicating disease|1|||
130390526|NCT03253848|469398826|FG000|Overall Study|Withdrawal by Subject|1|||
130390527|NCT03253848|469398826|FG000|Overall Study|Declining health|1|||
130390528|NCT05352815|469398827|FG000|Overall Study|Withdrawal by Subject|28|||
130390529|NCT05352815|469398828|FG001|Overall Study|Withdrawal by Subject|24|||
130390530|NCT05352815|469398827|FG000|Overall Study|Lost to Follow-up|4|||
130390531|NCT05352815|469398828|FG001|Overall Study|Lost to Follow-up|7|||
130390532|NCT05352815|469398827|FG000|Overall Study|Death|2|||
130390533|NCT05352815|469398828|FG001|Overall Study|Death|3|||
130390534|NCT05352815|469398827|FG000|Overall Study|Site closure|1|||
130390535|NCT05352815|469398828|FG001|Overall Study|Site closure|0|||
130390536|NCT02759120|469398829|FG000|Overall Study|Death|34|||
130390537|NCT02759120|469398830|FG001|Overall Study|Death|36|||
130390538|NCT02759120|469398829|FG000|Overall Study|Lost to Follow-up|4|||
130390539|NCT02759120|469398830|FG001|Overall Study|Lost to Follow-up|7|||
130390540|NCT02759120|469398829|FG000|Overall Study|Physician Decision|3|||
130390541|NCT02759120|469398830|FG001|Overall Study|Physician Decision|0|||
130390542|NCT02759120|469398829|FG000|Overall Study|Withdrawal by Subject|28|||
130390543|NCT02759120|469398830|FG001|Overall Study|Withdrawal by Subject|15|||
130390544|NCT02759120|469398829|FG000|Overall Study|Moved out of area|3|||
130390545|NCT02759120|469398830|FG001|Overall Study|Moved out of area|4|||
130390546|NCT02759120|469398829|FG000|Overall Study|Lung transplant|3|||
130390547|NCT02759120|469398830|FG001|Overall Study|Lung transplant|5|||
130390548|NCT02759120|469398829|FG000|Overall Study|Other reason not completed|10|||
130390549|NCT02759120|469398830|FG001|Overall Study|Other reason not completed|12|||
130390550|NCT03056755|469398832|FG000|Treatment- Core Phase|Progressive disease|89|||
130390551|NCT03056755|469398833|FG001|Treatment- Core Phase|Progressive disease|88|||
130390552|NCT03056755|469398834|FG002|Treatment- Core Phase|Progressive disease|90|||
130390553|NCT03056755|469398832|FG000|Treatment- Core Phase|Adverse Event|20|||
130390554|NCT03056755|469398833|FG001|Treatment- Core Phase|Adverse Event|14|||
130390555|NCT03056755|469398834|FG002|Treatment- Core Phase|Adverse Event|13|||
130390556|NCT03056755|469398832|FG000|Treatment- Core Phase|Physician Decision|7|||
130390557|NCT03056755|469398833|FG001|Treatment- Core Phase|Physician Decision|13|||
130390558|NCT03056755|469398834|FG002|Treatment- Core Phase|Physician Decision|5|||
130390559|NCT03056755|469398832|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
130390560|NCT03056755|469398833|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
130390561|NCT03056755|469398834|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
130390562|NCT03056755|469398832|FG000|Treatment- Core Phase|Death|3|||
130390563|NCT03056755|469398833|FG001|Treatment- Core Phase|Death|2|||
130390564|NCT03056755|469398834|FG002|Treatment- Core Phase|Death|4|||
130390565|NCT03056755|469398832|FG000|Treatment- Core Phase|Protocol deviation|1|||
130390566|NCT03056755|469398833|FG001|Treatment- Core Phase|Protocol deviation|1|||
130390567|NCT03056755|469398834|FG002|Treatment- Core Phase|Protocol deviation|0|||
130390568|NCT03056755|469398832|FG000|Treatment- Core Phase|Technical problems|1|||
130390569|NCT03056755|469398833|FG001|Treatment- Core Phase|Technical problems|0|||
130390570|NCT03056755|469398834|FG002|Treatment- Core Phase|Technical problems|0|||
130390571|NCT03056755|469398832|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
130390572|NCT03056755|469398833|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
130390573|NCT03056755|469398834|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
130390574|NCT03056755|469398832|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
130390575|NCT03056755|469398833|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
130390576|NCT03056755|469398834|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
130390577|NCT03056755|469398832|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
130390578|NCT03056755|469398833|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
130390579|NCT03056755|469398834|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
130390580|NCT03056755|469398832|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
130390581|NCT03056755|469398833|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
130390582|NCT03056755|469398834|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
130390583|NCT00278954|469398835|FG000|Overall Study|Adverse Event|3|||
130390584|NCT00278954|469398835|FG000|Overall Study|Lost to Follow-up|1|||
130390585|NCT00278954|469398835|FG000|Overall Study|Withdrawal by Subject|1|||
130390586|NCT03406858|469398836|FG000|Overall Study|Failure to receive treatment drug.|1|||
130390587|NCT03406858|469398836|FG000|Overall Study|ineligible|1|||
130390588|NCT02419742|469398837|FG000|Overall Study|Adverse Event|2|||
130390589|NCT02419742|469398838|FG001|Overall Study|Adverse Event|0|||
130390590|NCT02419742|469398837|FG000|Overall Study|Disease Progression|0|||
130390591|NCT02419742|469398838|FG001|Overall Study|Disease Progression|1|||
130390592|NCT02419742|469398837|FG000|Overall Study|Withdrew Consent|2|||
130390593|NCT02419742|469398838|FG001|Overall Study|Withdrew Consent|1|||
130390594|NCT02419742|469398837|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
130390595|NCT02419742|469398838|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
130390596|NCT05071183|469398847|FG000|Overall Study|Death|1|||
130390597|NCT05071183|469398848|FG001|Overall Study|Death|2|||
130390598|NCT05071183|469398849|FG002|Overall Study|Death|0|||
130390599|NCT05071183|469398847|FG000|Overall Study|Other Reasons|1|||
130390600|NCT05071183|469398848|FG001|Overall Study|Other Reasons|3|||
130390601|NCT05071183|469398849|FG002|Overall Study|Other Reasons|2|||
130390602|NCT02532647|469398857|FG000|Overall Study|Did not receive trial medication|1|||
130390603|NCT02532647|469398858|FG001|Overall Study|Did not receive trial medication|0|||
130390604|NCT02532647|469398859|FG002|Overall Study|Did not receive trial medication|1|||
130390605|NCT02211131|469398860|FG000|Overall Study|Death|26|||
130390606|NCT02211131|469398861|FG001|Overall Study|Death|16|||
130390607|NCT02211131|469398860|FG000|Overall Study|Lost to Follow-up|4|||
130390608|NCT02211131|469398861|FG001|Overall Study|Lost to Follow-up|3|||
130390609|NCT02211131|469398860|FG000|Overall Study|Decision by Sponsor|1|||
130390610|NCT02211131|469398861|FG001|Overall Study|Decision by Sponsor|1|||
130390611|NCT02211131|469398860|FG000|Overall Study|Withdrawal by Subject|3|||
130390612|NCT02211131|469398861|FG001|Overall Study|Withdrawal by Subject|8|||
130390613|NCT02939560|469398866|FG000|Overall Study|Withdrawal by Subject|2|||
130390614|NCT02939560|469398866|FG000|Overall Study|Protocol Violation|1|||
130390615|NCT03340025|469398869|FG000|Overall Study|Lost to Follow-up|2|||
130390616|NCT03340025|469398870|FG001|Overall Study|Lost to Follow-up|2|||
130390617|NCT02420691|469398873|FG000|Overall Study|Adverse Event|3|||
130390618|NCT02420691|469398873|FG000|Overall Study|Withdrawal by Subject|3|||
130390619|NCT03897179|469398879|FG000|Overall Study|Withdrawal by Subject|1|||
130390620|NCT00704535|469398880|FG000|Overall Study|Adverse Event|2|||
130390621|NCT00704535|469398880|FG000|Overall Study|Death|2|||
130390622|NCT00704535|469398880|FG000|Overall Study|Lost to Follow-up|8|||
130390623|NCT00704535|469398880|FG000|Overall Study|Protocol Violation|10|||
130390624|NCT00704535|469398880|FG000|Overall Study|Completed status not on Case Report Form|124|||
130390625|NCT01480076|469398881|FG000|Overall Study|Run-in Failure|52|||
130390626|NCT01480076|469398881|FG000|Overall Study|Adverse Event|39|||
130390627|NCT01480076|469398881|FG000|Overall Study|Death|2|||
130390628|NCT01480076|469398881|FG000|Overall Study|Disease Progression|5|||
130390629|NCT01480076|469398881|FG000|Overall Study|Non-compliance With Study Protocol|15|||
130390630|NCT01480076|469398881|FG000|Overall Study|Withdrawal by Subject|105|||
130390631|NCT01480076|469398881|FG000|Overall Study|Lost to Follow-up|7|||
130390632|NCT01480076|469398881|FG000|Overall Study|Investigator Decision|13|||
130390633|NCT01480076|469398881|FG000|Overall Study|Other|52|||
130390634|NCT02503332|469398883|FG000|Overall Study|Adverse Event|17|||
130390635|NCT02503332|469398884|FG001|Overall Study|Adverse Event|5|||
130390636|NCT02503332|469398885|FG002|Overall Study|Adverse Event|3|||
130390637|NCT02503332|469398886|FG003|Overall Study|Adverse Event|1|||
130390638|NCT02503332|469398883|FG000|Overall Study|Investigator's Decision|5|||
130390639|NCT02503332|469398884|FG001|Overall Study|Investigator's Decision|1|||
130390640|NCT02503332|469398885|FG002|Overall Study|Investigator's Decision|0|||
130390641|NCT02503332|469398886|FG003|Overall Study|Investigator's Decision|0|||
130390642|NCT02503332|469398883|FG000|Overall Study|Sponsor's Decision|1|||
130390643|NCT02503332|469398884|FG001|Overall Study|Sponsor's Decision|0|||
130390644|NCT02503332|469398885|FG002|Overall Study|Sponsor's Decision|0|||
130390645|NCT02503332|469398886|FG003|Overall Study|Sponsor's Decision|1|||
130390646|NCT02503332|469398883|FG000|Overall Study|Subject Request|6|||
130390647|NCT02503332|469398884|FG001|Overall Study|Subject Request|5|||
130390648|NCT02503332|469398885|FG002|Overall Study|Subject Request|2|||
130390649|NCT02503332|469398886|FG003|Overall Study|Subject Request|1|||
130390650|NCT02503332|469398883|FG000|Overall Study|Death|0|||
130390651|NCT02503332|469398884|FG001|Overall Study|Death|2|||
130390652|NCT02503332|469398885|FG002|Overall Study|Death|2|||
130390653|NCT02503332|469398886|FG003|Overall Study|Death|0|||
130390654|NCT02503332|469398883|FG000|Overall Study|Other|5|||
130390655|NCT02503332|469398884|FG001|Overall Study|Other|6|||
130390656|NCT02503332|469398885|FG002|Overall Study|Other|1|||
130390657|NCT02503332|469398886|FG003|Overall Study|Other|1|||
130390658|NCT02625090|469398892|FG000|Overall Study|Participant wants to be pregnant|2|||
130390659|NCT02625090|469398892|FG000|Overall Study|For the Promoter|1|||
130390660|NCT02625090|469398892|FG000|Overall Study|Sponsor's Decision|9|||
130390661|NCT02625090|469398892|FG000|Overall Study|Somnolence|1|||
130390662|NCT02625090|469398892|FG000|Overall Study|Study terminated by Sponsor|7|||
130390663|NCT02625090|469398892|FG000|Overall Study|Negative Benefit/Risk|1|||
130390664|NCT02625090|469398892|FG000|Overall Study|Protocol Deviation|2|||
130390665|NCT02625090|469398892|FG000|Overall Study|Lack of Efficacy|16|||
130390666|NCT02625090|469398892|FG000|Overall Study|Adverse Event|3|||
130470051|NCT05052996|469685828|FG001|Overall Study|Cohort terminated by sponsor|12|||
130470052|NCT05052996|469685829|FG002|Overall Study|Cohort terminated by sponsor|0|||
130470053|NCT05052996|469685830|FG003|Overall Study|Cohort terminated by sponsor|0|||
130470054|NCT05052996|469685827|FG000|Overall Study|Withdrew consent|1|||
130390667|NCT02439320|469398893|FG000|Overall Study|Adverse Event|0|||
130390668|NCT02439320|469398894|FG001|Overall Study|Adverse Event|2|||
130390669|NCT02439320|469398895|FG002|Overall Study|Adverse Event|0|||
130390670|NCT02439320|469398893|FG000|Overall Study|Lost to Follow-up|37|||
130390671|NCT02439320|469398894|FG001|Overall Study|Lost to Follow-up|34|||
130390672|NCT02439320|469398895|FG002|Overall Study|Lost to Follow-up|42|||
130390673|NCT02439320|469398893|FG000|Overall Study|Death|0|||
130390674|NCT02439320|469398894|FG001|Overall Study|Death|1|||
130390675|NCT02439320|469398895|FG002|Overall Study|Death|0|||
130390676|NCT02439320|469398893|FG000|Overall Study|Noncompliance with Protocol|10|||
130390677|NCT02439320|469398894|FG001|Overall Study|Noncompliance with Protocol|11|||
130390678|NCT02439320|469398895|FG002|Overall Study|Noncompliance with Protocol|7|||
130390679|NCT02439320|469398893|FG000|Overall Study|Pregnancy|0|||
130390680|NCT02439320|469398894|FG001|Overall Study|Pregnancy|1|||
130390681|NCT02439320|469398895|FG002|Overall Study|Pregnancy|1|||
130390682|NCT02439320|469398893|FG000|Overall Study|Withdrawal by Subject|12|||
130390683|NCT02439320|469398894|FG001|Overall Study|Withdrawal by Subject|16|||
130390684|NCT02439320|469398895|FG002|Overall Study|Withdrawal by Subject|14|||
130390685|NCT02439320|469398893|FG000|Overall Study|Physician Decision|2|||
130390686|NCT02439320|469398894|FG001|Overall Study|Physician Decision|1|||
130390687|NCT02439320|469398895|FG002|Overall Study|Physician Decision|0|||
130390688|NCT02439320|469398893|FG000|Overall Study|Sponsor Request|0|||
130390689|NCT02439320|469398894|FG001|Overall Study|Sponsor Request|2|||
130390690|NCT02439320|469398895|FG002|Overall Study|Sponsor Request|1|||
130390691|NCT02439320|469398893|FG000|Overall Study|Randomization Failure|35|||
130390692|NCT02439320|469398894|FG001|Overall Study|Randomization Failure|46|||
130390693|NCT02439320|469398895|FG002|Overall Study|Randomization Failure|34|||
130390694|NCT02972632|469398896|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130390695|NCT02972632|469398896|FG000|Overall Study|Lost to Follow-up|4|||
130390696|NCT02972632|469398896|FG000|Overall Study|Voluntary Withdrawal|10|||
130390697|NCT01251380|469398901|FG000|Overall Study|Other (Not otherwise specified)|12|||
130390698|NCT01251380|469398901|FG000|Overall Study|Withdrawal by Subject|6|||
130390699|NCT01251380|469398901|FG000|Overall Study|Lack of Efficacy|1|||
130390700|NCT01251380|469398901|FG000|Overall Study|Adverse Event|1|||
130390701|NCT01251380|469398901|FG000|Overall Study|Lost to Follow-up|2|||
130390702|NCT03054870|469398905|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
130390703|NCT03054870|469398905|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
130390704|NCT01154218|469398906|FG000|Third Intervention Period|Adverse Event|0|||
130390705|NCT01154218|469398907|FG001|Third Intervention Period|Adverse Event|1|||
130390706|NCT01154218|469398908|FG002|Third Intervention Period|Adverse Event|0|||
130390707|NCT01154218|469398909|FG003|Third Intervention Period|Adverse Event|0|||
130390708|NCT01154218|469398906|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130390709|NCT01154218|469398907|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130390710|NCT01154218|469398908|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130390711|NCT01154218|469398909|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
130390712|NCT01154218|469398906|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
130390713|NCT01154218|469398907|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
130390714|NCT01154218|469398908|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
130390715|NCT01154218|469398909|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
130390716|NCT00129129|469398910|FG000|Primary Phase|Adverse Event|2|||
130390717|NCT00129129|469398911|FG001|Primary Phase|Adverse Event|1|||
130390718|NCT00129129|469398912|FG002|Primary Phase|Adverse Event|0|||
130390719|NCT00129129|469398913|FG003|Primary Phase|Adverse Event|0|||
130390720|NCT00129129|469398914|FG004|Primary Phase|Adverse Event|0|||
130390721|NCT00129129|469398910|FG000|Primary Phase|Withdrawal by Subject|12|||
130390722|NCT00129129|469398911|FG001|Primary Phase|Withdrawal by Subject|10|||
130390723|NCT00129129|469398912|FG002|Primary Phase|Withdrawal by Subject|0|||
130390724|NCT00129129|469398913|FG003|Primary Phase|Withdrawal by Subject|0|||
130470055|NCT05052996|469685828|FG001|Overall Study|Withdrew consent|0|||
130470056|NCT05052996|469685829|FG002|Overall Study|Withdrew consent|1|||
130470057|NCT05052996|469685830|FG003|Overall Study|Withdrew consent|2|||
130470058|NCT05052996|469685827|FG000|Overall Study|Lost to Follow-up|1|||
130559878|NCT02632721|470017892|FG002|Overall Study|Relapsed Pneumonia|0|||
130390725|NCT00129129|469398914|FG004|Primary Phase|Withdrawal by Subject|0|||
130390726|NCT00129129|469398910|FG000|Primary Phase|Migration from study area|1|||
130390727|NCT00129129|469398911|FG001|Primary Phase|Migration from study area|3|||
130390728|NCT00129129|469398912|FG002|Primary Phase|Migration from study area|0|||
130390729|NCT00129129|469398913|FG003|Primary Phase|Migration from study area|0|||
130390730|NCT00129129|469398914|FG004|Primary Phase|Migration from study area|0|||
130390731|NCT00129129|469398910|FG000|Primary Phase|Lost to Follow-up|8|||
130390732|NCT00129129|469398911|FG001|Primary Phase|Lost to Follow-up|6|||
130390733|NCT00129129|469398912|FG002|Primary Phase|Lost to Follow-up|0|||
130390734|NCT00129129|469398913|FG003|Primary Phase|Lost to Follow-up|0|||
130390735|NCT00129129|469398914|FG004|Primary Phase|Lost to Follow-up|0|||
130390736|NCT00129129|469398910|FG000|Primary Phase|Other|2|||
130390737|NCT00129129|469398911|FG001|Primary Phase|Other|5|||
130390738|NCT00129129|469398912|FG002|Primary Phase|Other|0|||
130390739|NCT00129129|469398913|FG003|Primary Phase|Other|0|||
130390740|NCT00129129|469398914|FG004|Primary Phase|Other|0|||
130390741|NCT00129129|469398910|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
130390742|NCT00129129|469398911|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
130390743|NCT00129129|469398912|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
130390744|NCT00129129|469398913|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
130390745|NCT00129129|469398914|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
130390746|NCT00129129|469398910|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
130390747|NCT00129129|469398911|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
130390748|NCT00129129|469398912|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
130390749|NCT00129129|469398913|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
130390750|NCT00129129|469398914|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
130390751|NCT00129129|469398910|FG000|Fourth Dose Phase|Migration from study area|0|||
130390752|NCT00129129|469398911|FG001|Fourth Dose Phase|Migration from study area|0|||
130390753|NCT00129129|469398912|FG002|Fourth Dose Phase|Migration from study area|0|||
130390754|NCT00129129|469398913|FG003|Fourth Dose Phase|Migration from study area|0|||
130390755|NCT00129129|469398914|FG004|Fourth Dose Phase|Migration from study area|2|||
130390756|NCT00129129|469398910|FG000|Fourth Dose Phase|Other|0|||
130390757|NCT00129129|469398911|FG001|Fourth Dose Phase|Other|0|||
130390758|NCT00129129|469398912|FG002|Fourth Dose Phase|Other|0|||
130390759|NCT00129129|469398913|FG003|Fourth Dose Phase|Other|1|||
130390760|NCT00129129|469398914|FG004|Fourth Dose Phase|Other|1|||
130390761|NCT00129129|469398910|FG000|Fourth Dose Phase|Protocol Violation|0|||
130390762|NCT00129129|469398911|FG001|Fourth Dose Phase|Protocol Violation|0|||
130390763|NCT00129129|469398912|FG002|Fourth Dose Phase|Protocol Violation|0|||
130390764|NCT00129129|469398913|FG003|Fourth Dose Phase|Protocol Violation|1|||
130390765|NCT00129129|469398914|FG004|Fourth Dose Phase|Protocol Violation|0|||
130390766|NCT02140567|469398917|FG000|Overall Study|Problems with recording equipment|6|||
130390767|NCT02882854|469398918|FG000|Overall Study|Lost to Follow-up|1|||
130390768|NCT02882854|469398919|FG001|Overall Study|Lost to Follow-up|2|||
130390769|NCT02882854|469398918|FG000|Overall Study|Physician Decision|0|||
130390770|NCT02882854|469398919|FG001|Overall Study|Physician Decision|1|||
130390771|NCT03774433|469398925|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
130390772|NCT00108160|469398926|FG000|Overall Study|Lost to Follow-up|25|||
130390773|NCT00108160|469398927|FG001|Overall Study|Lost to Follow-up|12|||
130390774|NCT00108160|469398926|FG000|Overall Study|Death|1|||
130390775|NCT00108160|469398927|FG001|Overall Study|Death|2|||
130390776|NCT00108160|469398926|FG000|Overall Study|Withdrawal by Subject|4|||
130390777|NCT00108160|469398927|FG001|Overall Study|Withdrawal by Subject|2|||
130390778|NCT00108160|469398926|FG000|Overall Study|Protocol Violation|9|||
130390779|NCT00108160|469398927|FG001|Overall Study|Protocol Violation|5|||
130390780|NCT00578942|469398935|FG000|Overall Study|Lost to Follow-up|1|||
130390781|NCT00600938|469398936|FG000|Core Study|Abnormal test procedure result(s)|3|||
130390782|NCT00600938|469398937|FG001|Core Study|Abnormal test procedure result(s)|2|||
130390783|NCT00600938|469398938|FG002|Core Study|Abnormal test procedure result(s)|0|||
130390784|NCT00600938|469398939|FG003|Core Study|Abnormal test procedure result(s)|0|||
130390785|NCT00600938|469398936|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
130390786|NCT00600938|469398937|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
130390787|NCT00600938|469398938|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
130390788|NCT00600938|469398939|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
130390789|NCT00600938|469398936|FG000|Core Study|Patient withdrew consent|7|||
130390790|NCT00600938|469398937|FG001|Core Study|Patient withdrew consent|12|||
130390791|NCT00600938|469398938|FG002|Core Study|Patient withdrew consent|0|||
130390792|NCT00600938|469398939|FG003|Core Study|Patient withdrew consent|0|||
130390793|NCT00600938|469398936|FG000|Core Study|Lost to Follow-up|3|||
130390794|NCT00600938|469398937|FG001|Core Study|Lost to Follow-up|2|||
130390795|NCT00600938|469398938|FG002|Core Study|Lost to Follow-up|0|||
130390796|NCT00600938|469398939|FG003|Core Study|Lost to Follow-up|0|||
130390797|NCT00600938|469398936|FG000|Core Study|Death|1|||
130390798|NCT00600938|469398937|FG001|Core Study|Death|1|||
130390799|NCT00600938|469398938|FG002|Core Study|Death|0|||
130390800|NCT00600938|469398939|FG003|Core Study|Death|0|||
130390801|NCT00600938|469398936|FG000|Core Study|Protocol Violation|1|||
130390802|NCT00600938|469398937|FG001|Core Study|Protocol Violation|2|||
130390803|NCT00600938|469398938|FG002|Core Study|Protocol Violation|0|||
130390804|NCT00600938|469398939|FG003|Core Study|Protocol Violation|0|||
130390805|NCT00600938|469398936|FG000|Extension Study|Adverse Event|1|||
130390806|NCT00600938|469398937|FG001|Extension Study|Adverse Event|0|||
130390807|NCT00600938|469398938|FG002|Extension Study|Adverse Event|2|||
130390808|NCT00600938|469398939|FG003|Extension Study|Adverse Event|0|||
130390809|NCT00600938|469398936|FG000|Extension Study|Abnormal test procedure results|0|||
130390810|NCT00600938|469398937|FG001|Extension Study|Abnormal test procedure results|1|||
130390811|NCT00600938|469398938|FG002|Extension Study|Abnormal test procedure results|1|||
130390812|NCT00600938|469398939|FG003|Extension Study|Abnormal test procedure results|1|||
130390813|NCT00600938|469398936|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
130390814|NCT00600938|469398937|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
130390815|NCT00600938|469398938|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
130390816|NCT00600938|469398939|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
130390817|NCT00600938|469398936|FG000|Extension Study|Withdrawal by Subject|2|||
130470059|NCT05052996|469685828|FG001|Overall Study|Lost to Follow-up|0|||
130470060|NCT05052996|469685829|FG002|Overall Study|Lost to Follow-up|0|||
130470061|NCT05052996|469685830|FG003|Overall Study|Lost to Follow-up|2|||
130470062|NCT05052996|469685827|FG000|Overall Study|Adverse Event|0|||
130470063|NCT05052996|469685828|FG001|Overall Study|Adverse Event|0|||
130470064|NCT05052996|469685829|FG002|Overall Study|Adverse Event|2|||
130470065|NCT05052996|469685830|FG003|Overall Study|Adverse Event|0|||
130470066|NCT05052996|469685827|FG000|Overall Study|Randomized but never treated|0|||
130470067|NCT05052996|469685828|FG001|Overall Study|Randomized but never treated|0|||
130470068|NCT05052996|469685829|FG002|Overall Study|Randomized but never treated|1|||
130470069|NCT05052996|469685830|FG003|Overall Study|Randomized but never treated|1|||
130470070|NCT05052996|469685827|FG000|Overall Study|Protocol Violation|1|||
130470071|NCT05052996|469685828|FG001|Overall Study|Protocol Violation|0|||
130470072|NCT05052996|469685829|FG002|Overall Study|Protocol Violation|0|||
130470073|NCT05052996|469685830|FG003|Overall Study|Protocol Violation|0|||
130470074|NCT00522951|469685831|FG000|Period 1|body motion|0|||
130390818|NCT00600938|469398937|FG001|Extension Study|Withdrawal by Subject|2|||
130390819|NCT00600938|469398938|FG002|Extension Study|Withdrawal by Subject|3|||
130390820|NCT00600938|469398939|FG003|Extension Study|Withdrawal by Subject|0|||
130390821|NCT00600938|469398936|FG000|Extension Study|Lost to Follow-up|1|||
130390822|NCT00600938|469398937|FG001|Extension Study|Lost to Follow-up|1|||
130390823|NCT00600938|469398938|FG002|Extension Study|Lost to Follow-up|2|||
130390824|NCT00600938|469398939|FG003|Extension Study|Lost to Follow-up|0|||
130390825|NCT00600938|469398936|FG000|Extension Study|Death|1|||
130390826|NCT00600938|469398937|FG001|Extension Study|Death|0|||
130390827|NCT00600938|469398938|FG002|Extension Study|Death|0|||
130390828|NCT00600938|469398939|FG003|Extension Study|Death|0|||
130390829|NCT04056195|469398940|FG000|Overall Study|Adverse Event|1|||
130390830|NCT04056195|469398941|FG001|Overall Study|Adverse Event|0|||
130390831|NCT04056195|469398942|FG002|Overall Study|Adverse Event|0|||
130390832|NCT04056195|469398940|FG000|Overall Study|Withdrawal by Subject|0|||
130390833|NCT04056195|469398941|FG001|Overall Study|Withdrawal by Subject|1|||
130390834|NCT04056195|469398942|FG002|Overall Study|Withdrawal by Subject|1|||
130390835|NCT04056195|469398940|FG000|Overall Study|Physician Decision|1|||
130390836|NCT04056195|469398941|FG001|Overall Study|Physician Decision|1|||
130390837|NCT04056195|469398942|FG002|Overall Study|Physician Decision|1|||
130390838|NCT00549562|469398943|FG000|Overall Study|Adverse Event|1|||
130390839|NCT00549562|469398943|FG000|Overall Study|Lack of Efficacy|1|||
130390840|NCT00004888|469400618|FG000|Overall Study|Adverse Event|5|||
130390841|NCT00004888|469400619|FG001|Overall Study|Adverse Event|10|||
130390842|NCT00004888|469400618|FG000|Overall Study|Withdrawal by Subject|0|||
130390843|NCT00004888|469400619|FG001|Overall Study|Withdrawal by Subject|3|||
130390844|NCT00004888|469400618|FG000|Overall Study|Physician Decision|1|||
130390845|NCT00004888|469400619|FG001|Overall Study|Physician Decision|1|||
130390846|NCT00004888|469400618|FG000|Overall Study|Progressive Disease|4|||
130390847|NCT00004888|469400619|FG001|Overall Study|Progressive Disease|9|||
130390848|NCT00004888|469400618|FG000|Overall Study|Death without progressive disease|0|||
130390849|NCT00004888|469400619|FG001|Overall Study|Death without progressive disease|1|||
130390850|NCT00004888|469400618|FG000|Overall Study|Toxic death|1|||
130390851|NCT00004888|469400619|FG001|Overall Study|Toxic death|0|||
130390852|NCT02579265|469400620|FG000|Overall Study|Weaned off earlier than 28 days|44|||
130390853|NCT02579265|469400621|FG001|Overall Study|Weaned off earlier than 28 days|43|||
130390854|NCT02579265|469400620|FG000|Overall Study|Adverse Event|2|||
130390855|NCT02579265|469400621|FG001|Overall Study|Adverse Event|0|||
130390856|NCT02579265|469400620|FG000|Overall Study|Any other reason not specified|0|||
130390857|NCT02579265|469400621|FG001|Overall Study|Any other reason not specified|2|||
130470075|NCT00522951|469685832|FG001|Period 1|body motion|1|||
130470076|NCT00522951|469685831|FG000|Washout Period|Adverse Event|0|||
130470077|NCT00522951|469685832|FG001|Washout Period|Adverse Event|1|||
130470078|NCT00522951|469685831|FG000|Washout Period|Death|0|||
130470079|NCT00522951|469685832|FG001|Washout Period|Death|1|||
130470080|NCT00522951|469685831|FG000|Period 2|Withdrawal by Subject|1|||
130470081|NCT00522951|469685832|FG001|Period 2|Withdrawal by Subject|0|||
130390858|NCT02579265|469400620|FG000|Overall Study|Withdrawal by Subject|2|||
130390859|NCT02579265|469400621|FG001|Overall Study|Withdrawal by Subject|0|||
130390860|NCT02579265|469400620|FG000|Overall Study|Physician Decision|1|||
130390861|NCT02579265|469400621|FG001|Overall Study|Physician Decision|0|||
130390862|NCT02579265|469400620|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
130390863|NCT02579265|469400621|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
130390864|NCT02174848|469400622|FG000|Overall Study|Adverse Event|2|||
130470082|NCT00522951|469685831|FG000|Period 2|residual contrast medium|1|||
130470083|NCT00522951|469685832|FG001|Period 2|residual contrast medium|1|||
130390865|NCT02174848|469400623|FG001|Overall Study|Adverse Event|1|||
130390866|NCT02174848|469400622|FG000|Overall Study|Withdrawal by Subject|3|||
130390867|NCT02174848|469400623|FG001|Overall Study|Withdrawal by Subject|3|||
130390868|NCT02174848|469400622|FG000|Overall Study|Lost to Follow-up|0|||
130390869|NCT02174848|469400623|FG001|Overall Study|Lost to Follow-up|1|||
130390870|NCT02174848|469400622|FG000|Overall Study|Worsening of disease|1|||
130390871|NCT02174848|469400623|FG001|Overall Study|Worsening of disease|1|||
130390872|NCT02174848|469400622|FG000|Overall Study|Unable to comply with study requirements|1|||
130390873|NCT02174848|469400623|FG001|Overall Study|Unable to comply with study requirements|0|||
130390874|NCT00644969|469400627|FG000|Treatment Phase|Randomized, not treated|1|||
130390875|NCT00644969|469400628|FG001|Treatment Phase|Randomized, not treated|0|||
130390876|NCT00644969|469400627|FG000|Treatment Phase|Adverse Event|3|||
130390877|NCT00644969|469400628|FG001|Treatment Phase|Adverse Event|0|||
130390878|NCT00644969|469400627|FG000|Treatment Phase|Withdrawal by Subject|4|||
130390879|NCT00644969|469400628|FG001|Treatment Phase|Withdrawal by Subject|0|||
130390880|NCT00644969|469400627|FG000|Treatment Phase|Lost to Follow-up|2|||
130390881|NCT00644969|469400628|FG001|Treatment Phase|Lost to Follow-up|2|||
130390882|NCT00644969|469400627|FG000|Treatment Phase|Other|4|||
130390883|NCT00644969|469400628|FG001|Treatment Phase|Other|1|||
130390884|NCT00644969|469400627|FG000|Post Treatment Phase|Death|1|||
130390885|NCT00644969|469400628|FG001|Post Treatment Phase|Death|0|||
130390886|NCT00644969|469400627|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
130390887|NCT00644969|469400628|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
130390888|NCT00644969|469400627|FG000|Post Treatment Phase|Lost to Follow-up|4|||
130390889|NCT00644969|469400628|FG001|Post Treatment Phase|Lost to Follow-up|1|||
130390890|NCT00644969|469400627|FG000|Post Treatment Phase|Other|1|||
130390891|NCT00644969|469400628|FG001|Post Treatment Phase|Other|0|||
130390892|NCT00666757|469400637|FG000|Overall Study|Lost to Follow-up|39|||
130390893|NCT00666757|469400638|FG001|Overall Study|Lost to Follow-up|35|||
130390894|NCT00666757|469400637|FG000|Overall Study|Protocol Violation|23|||
130390895|NCT00666757|469400638|FG001|Overall Study|Protocol Violation|24|||
130390896|NCT00666757|469400637|FG000|Overall Study|Adverse Event|22|||
130390897|NCT00666757|469400638|FG001|Overall Study|Adverse Event|12|||
130390898|NCT00666757|469400637|FG000|Overall Study|Withdrawal by Subject|13|||
130390899|NCT00666757|469400638|FG001|Overall Study|Withdrawal by Subject|17|||
130390900|NCT00666757|469400637|FG000|Overall Study|Lack of Efficacy|3|||
130390901|NCT00666757|469400638|FG001|Overall Study|Lack of Efficacy|6|||
130390902|NCT00666757|469400637|FG000|Overall Study|Physician Decision|0|||
130390903|NCT00666757|469400638|FG001|Overall Study|Physician Decision|2|||
130390904|NCT00666757|469400637|FG000|Overall Study|Sponsor decision|0|||
130390905|NCT00666757|469400638|FG001|Overall Study|Sponsor decision|1|||
130390906|NCT00952341|469400643|FG000|Cycle 1|Adverse Event|4|||
130390907|NCT00952341|469400644|FG001|Cycle 1|Adverse Event|1|||
130390908|NCT00952341|469400643|FG000|Cycle 1|Withdrawal by Subject|3|||
130390909|NCT00952341|469400644|FG001|Cycle 1|Withdrawal by Subject|8|||
130390910|NCT00952341|469400643|FG000|Cycle 1|Protocol Violation|2|||
130390911|NCT00952341|469400644|FG001|Cycle 1|Protocol Violation|1|||
130390912|NCT00952341|469400643|FG000|Cycle 1|Lost to Follow-up|11|||
130390913|NCT00952341|469400644|FG001|Cycle 1|Lost to Follow-up|2|||
130390914|NCT00952341|469400643|FG000|Cycle 1|Physician Decision|0|||
130390915|NCT00952341|469400644|FG001|Cycle 1|Physician Decision|1|||
130390916|NCT00952341|469400643|FG000|Cycle 2|Withdrawal by Subject|1|||
130390917|NCT00952341|469400644|FG001|Cycle 2|Withdrawal by Subject|1|||
130390918|NCT00952341|469400643|FG000|Cycle 2|Protocol Violation|1|||
130390919|NCT00952341|469400644|FG001|Cycle 2|Protocol Violation|0|||
130390920|NCT00952341|469400643|FG000|Cycle 2|Lost to Follow-up|6|||
130390921|NCT00952341|469400644|FG001|Cycle 2|Lost to Follow-up|9|||
130390922|NCT00952341|469400643|FG000|Cycle 2|Physician Decision|1|||
130390923|NCT00952341|469400644|FG001|Cycle 2|Physician Decision|1|||
130390924|NCT00952341|469400643|FG000|Cycle 2|Progressive Disease|0|||
130390925|NCT00952341|469400644|FG001|Cycle 2|Progressive Disease|1|||
130390926|NCT01413360|469400649|FG000|Overall Study|Lost to Follow-up|2|||
130390927|NCT01413360|469400649|FG000|Overall Study|Adverse Event|1|||
130390928|NCT05694546|469400652|FG000|Overall Study|Lost to Follow-up|11|||
130390929|NCT01589445|469400653|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
130390930|NCT01589445|469400653|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
130390931|NCT01589445|469400653|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
130390932|NCT01589445|469400653|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
130390933|NCT01589445|469400653|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
130390934|NCT01589445|469400653|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
130390935|NCT01589445|469400653|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
130390936|NCT01589445|469400653|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
130390937|NCT01589445|469400653|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
130390938|NCT01589445|469400653|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
130390939|NCT01488097|469400665|FG000|Overall Study|Lost to Follow-up|1|||
130390940|NCT02016482|469400669|FG000|Period A|Adverse Event|3|||
130390941|NCT02016482|469400670|FG001|Period A|Adverse Event|5|||
130390942|NCT02016482|469400669|FG000|Period A|Withdrawal by Subject|3|||
130722822|NCT02011386|470609745|FG000|Overall Study|Lack of Efficacy|3|||
130390943|NCT02016482|469400670|FG001|Period A|Withdrawal by Subject|4|||
130390944|NCT02016482|469400669|FG000|Period A|Lost to Follow-up|3|||
130390945|NCT02016482|469400670|FG001|Period A|Lost to Follow-up|3|||
130390946|NCT02016482|469400669|FG000|Period A|Lack of Efficacy|2|||
130390947|NCT02016482|469400670|FG001|Period A|Lack of Efficacy|1|||
130390948|NCT02016482|469400669|FG000|Period A|Other|3|||
130390949|NCT02016482|469400670|FG001|Period A|Other|0|||
130390950|NCT02016482|469400669|FG000|Period A|Protocol Violation|0|||
130390951|NCT02016482|469400670|FG001|Period A|Protocol Violation|1|||
130390952|NCT02016482|469400669|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
130390953|NCT02016482|469400670|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
130390954|NCT02016482|469400669|FG000|Period B|Withdrawal by Subject|1|||
130390955|NCT02016482|469400670|FG001|Period B|Withdrawal by Subject|1|||
130390956|NCT02016482|469400669|FG000|Period B|Lost to Follow-up|2|||
130390957|NCT02016482|469400670|FG001|Period B|Lost to Follow-up|0|||
130390958|NCT02016482|469400669|FG000|Period B|Lack of Efficacy|6|||
130390959|NCT02016482|469400670|FG001|Period B|Lack of Efficacy|4|||
130390960|NCT02016482|469400669|FG000|Period B|Other|4|||
130390961|NCT02016482|469400670|FG001|Period B|Other|0|||
130390962|NCT02016482|469400669|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
130390963|NCT02016482|469400670|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
130390964|NCT02872116|469400681|FG000|Pre-Treatment|Disease Progression|0|||
130390965|NCT02872116|469400682|FG001|Pre-Treatment|Disease Progression|1|||
130390966|NCT02872116|469400683|FG002|Pre-Treatment|Disease Progression|0|||
130390967|NCT02872116|469400681|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
130390968|NCT02872116|469400682|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
130390969|NCT02872116|469400683|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
130390970|NCT02872116|469400681|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
130390971|NCT02872116|469400682|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
130390972|NCT02872116|469400683|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
130390973|NCT02872116|469400681|FG000|Pre-Treatment|Participant withdrew consent|2|||
130390974|NCT02872116|469400682|FG001|Pre-Treatment|Participant withdrew consent|20|||
130390975|NCT02872116|469400683|FG002|Pre-Treatment|Participant withdrew consent|3|||
130390976|NCT02872116|469400681|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
130390977|NCT02872116|469400682|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
130390978|NCT02872116|469400683|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
130390979|NCT02872116|469400681|FG000|Pre-Treatment|Other reasons|1|||
130390980|NCT02872116|469400682|FG001|Pre-Treatment|Other reasons|2|||
130390981|NCT02872116|469400683|FG002|Pre-Treatment|Other reasons|2|||
130390982|NCT02872116|469400681|FG000|Treatment|Death|121|||
130390983|NCT02872116|469400682|FG001|Treatment|Death|94|||
130390984|NCT02872116|469400683|FG002|Treatment|Death|68|||
130390985|NCT02872116|469400681|FG000|Treatment|Lost to Follow-up|5|||
130390986|NCT02872116|469400682|FG001|Treatment|Lost to Follow-up|7|||
130390987|NCT02872116|469400683|FG002|Treatment|Lost to Follow-up|3|||
130390988|NCT02872116|469400681|FG000|Treatment|Participant withdrew consent|20|||
130390989|NCT02872116|469400682|FG001|Treatment|Participant withdrew consent|40|||
130390990|NCT02872116|469400683|FG002|Treatment|Participant withdrew consent|8|||
130390991|NCT02872116|469400681|FG000|Treatment|Other reasons|13|||
130390992|NCT02872116|469400682|FG001|Treatment|Other reasons|12|||
130390993|NCT02872116|469400683|FG002|Treatment|Other reasons|5|||
130390994|NCT03089606|469400689|FG000|Overall Study|Progression after Cycle 1|1|||
130390995|NCT01709695|469400693|FG000|Overall Study|Withdrawal by Subject|1|||
130390996|NCT01709695|469400694|FG001|Overall Study|Withdrawal by Subject|1|||
130390997|NCT02802592|469400695|FG000|Overall Study|Study terminated due to loss of funding|4|||
130390998|NCT01150123|469400697|FG000|Overall Study|Withdrawal by Subject|1|||
130390999|NCT01150123|469400698|FG001|Overall Study|Withdrawal by Subject|1|||
130391000|NCT01150123|469400699|FG002|Overall Study|Withdrawal by Subject|2|||
130391001|NCT01150123|469400700|FG003|Overall Study|Withdrawal by Subject|1|||
130391002|NCT01150123|469400701|FG004|Overall Study|Withdrawal by Subject|1|||
130470084|NCT03101930|469685833|FG000|Overall Study|Withdrawal by Subject|2|||
130470085|NCT03101930|469685834|FG001|Overall Study|Withdrawal by Subject|1|||
130391003|NCT01150123|469400702|FG005|Overall Study|Withdrawal by Subject|1|||
130391004|NCT01150123|469400703|FG006|Overall Study|Withdrawal by Subject|0|||
130391005|NCT01150123|469400704|FG007|Overall Study|Withdrawal by Subject|3|||
130391006|NCT01150123|469400705|FG008|Overall Study|Withdrawal by Subject|2|||
130391007|NCT01150123|469400706|FG009|Overall Study|Withdrawal by Subject|0|||
130391008|NCT01150123|469400707|FG010|Overall Study|Withdrawal by Subject|1|||
130391009|NCT01150123|469400708|FG011|Overall Study|Withdrawal by Subject|0|||
130391010|NCT01150123|469400709|FG012|Overall Study|Withdrawal by Subject|1|||
130391011|NCT01150123|469400710|FG013|Overall Study|Withdrawal by Subject|0|||
130391012|NCT01150123|469400711|FG014|Overall Study|Withdrawal by Subject|0|||
130391013|NCT01150123|469400712|FG015|Overall Study|Withdrawal by Subject|1|||
130391014|NCT01150123|469400713|FG016|Overall Study|Withdrawal by Subject|0|||
130470086|NCT03101930|469685835|FG002|Overall Study|Withdrawal by Subject|2|||
130470087|NCT00976495|469685836|FG000|Overall Study|Withdrawal by Subject|0|||
130391015|NCT01150123|469400714|FG017|Overall Study|Withdrawal by Subject|1|||
130391016|NCT01150123|469400697|FG000|Overall Study|Lost to Follow-up|2|||
130391017|NCT01150123|469400698|FG001|Overall Study|Lost to Follow-up|1|||
130391018|NCT01150123|469400699|FG002|Overall Study|Lost to Follow-up|2|||
130391019|NCT01150123|469400700|FG003|Overall Study|Lost to Follow-up|2|||
130391020|NCT01150123|469400701|FG004|Overall Study|Lost to Follow-up|2|||
130391021|NCT01150123|469400702|FG005|Overall Study|Lost to Follow-up|5|||
130391022|NCT01150123|469400703|FG006|Overall Study|Lost to Follow-up|0|||
130391023|NCT01150123|469400704|FG007|Overall Study|Lost to Follow-up|0|||
130391024|NCT01150123|469400705|FG008|Overall Study|Lost to Follow-up|3|||
130391025|NCT01150123|469400706|FG009|Overall Study|Lost to Follow-up|1|||
130391026|NCT01150123|469400707|FG010|Overall Study|Lost to Follow-up|1|||
130391027|NCT01150123|469400708|FG011|Overall Study|Lost to Follow-up|1|||
130391028|NCT01150123|469400709|FG012|Overall Study|Lost to Follow-up|2|||
130391029|NCT01150123|469400710|FG013|Overall Study|Lost to Follow-up|0|||
130391030|NCT01150123|469400711|FG014|Overall Study|Lost to Follow-up|0|||
130391031|NCT01150123|469400712|FG015|Overall Study|Lost to Follow-up|0|||
130391032|NCT01150123|469400713|FG016|Overall Study|Lost to Follow-up|0|||
130391033|NCT01150123|469400714|FG017|Overall Study|Lost to Follow-up|0|||
130391034|NCT02486042|469400715|FG000|Overall Study|Physician Decision|1|||
130391035|NCT02486042|469400716|FG001|Overall Study|Physician Decision|7|||
130391036|NCT02486042|469400715|FG000|Overall Study|Hospital transfer|2|||
130391037|NCT02486042|469400716|FG001|Overall Study|Hospital transfer|2|||
130391038|NCT02486042|469400715|FG000|Overall Study|Withdrawal by Subject|0|||
130391039|NCT02486042|469400716|FG001|Overall Study|Withdrawal by Subject|2|||
130391040|NCT02347189|469400721|FG000|Overall Study|No implant attempted of study device|9|||
130391041|NCT02347189|469400721|FG000|Overall Study|No primary outcome data available|2|||
130391042|NCT04404855|469400722|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
130391043|NCT04404855|469400723|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
130391044|NCT00735878|469400724|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
130391045|NCT00735878|469400725|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
130391046|NCT00735878|469400726|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
130391047|NCT00994240|469400727|FG000|Overall Study|Lost to Follow-up|3|||
130391048|NCT00994240|469400728|FG001|Overall Study|Lost to Follow-up|2|||
130391049|NCT00994240|469400727|FG000|Overall Study|Withdrawal by Subject|1|||
130391050|NCT00994240|469400728|FG001|Overall Study|Withdrawal by Subject|0|||
130391051|NCT00994240|469400727|FG000|Overall Study|study termination|2|||
130391052|NCT00994240|469400728|FG001|Overall Study|study termination|3|||
130391053|NCT03320564|469400729|FG000|Overall Study|Protocol Violation|1|||
130391054|NCT00352846|469400730|FG000|Overall Study|Disease progression|0|||
130391055|NCT00352846|469400731|FG001|Overall Study|Disease progression|2|||
130391056|NCT00352846|469400730|FG000|Overall Study|Withdrawal by Subject|3|||
130391057|NCT00352846|469400731|FG001|Overall Study|Withdrawal by Subject|8|||
130391058|NCT00352846|469400730|FG000|Overall Study|Ineligible|3|||
130391059|NCT00352846|469400731|FG001|Overall Study|Ineligible|2|||
130391060|NCT00352846|469400730|FG000|Overall Study|Non-compliance|2|||
130391061|NCT00352846|469400731|FG001|Overall Study|Non-compliance|0|||
130391062|NCT00352846|469400730|FG000|Overall Study|Death|0|||
130391063|NCT00352846|469400731|FG001|Overall Study|Death|1|||
130391064|NCT00788827|469400732|FG000|Overall Study|Lack of Efficacy|2|||
130391065|NCT01527682|469400739|FG000|Overall Study|Protocol Violation|8|||
130391066|NCT01586819|469400740|FG000|Overall Study|Withdrawal by Subject|1|||
130391067|NCT01586819|469400741|FG001|Overall Study|Withdrawal by Subject|0|||
130391068|NCT01359254|469400742|FG000|Overall Study|Death|1|||
130391069|NCT01359254|469400743|FG001|Overall Study|Death|0|||
130391070|NCT03979638|469400747|FG000|Period 1|Physician Decision|1|||
130391071|NCT03979638|469400748|FG001|Period 1|Physician Decision|1|||
130391072|NCT03979638|469400747|FG000|Period 1|Withdrawal by Subject|4|||
130391073|NCT03979638|469400748|FG001|Period 1|Withdrawal by Subject|3|||
130391074|NCT03979638|469400747|FG000|Period 1|Study terminated by Sponsor|1|||
130391075|NCT03979638|469400748|FG001|Period 1|Study terminated by Sponsor|3|||
130391076|NCT03979638|469400747|FG000|Period 1|Protocol Violation|1|||
130391077|NCT03979638|469400748|FG001|Period 1|Protocol Violation|0|||
130391078|NCT03979638|469400747|FG000|Period 2|Study terminated by Sponsor|1|||
130391079|NCT03979638|469400748|FG001|Period 2|Study terminated by Sponsor|1|||
130559879|NCT02632721|470017893|FG003|Overall Study|Relapsed Pneumonia|0|||
130391080|NCT04248933|469400749|FG000|Overall Study|Lost to Follow-up|9|||
130391081|NCT04248933|469400749|FG000|Overall Study|Withdrawal by Subject|2|||
130391082|NCT04220411|469400760|FG000|Overall Study|Adverse Event|0|||
130391083|NCT04220411|469400761|FG001|Overall Study|Adverse Event|0|||
130391084|NCT04220411|469400762|FG002|Overall Study|Adverse Event|0|||
130391085|NCT04220411|469400763|FG003|Overall Study|Adverse Event|1|||
130391086|NCT02028988|469400764|FG000|Overall Study|Withdrawal by Subject|2|||
130391087|NCT02680639|469400765|FG000|Screening Period|Screen Failure|7|||
130391088|NCT02680639|469400766|FG001|Screening Period|Screen Failure|0|||
130391089|NCT02680639|469400767|FG002|Screening Period|Screen Failure|0|||
130391090|NCT01063595|469400768|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
130391091|NCT01063595|469400769|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
130391092|NCT01063595|469400768|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
130391093|NCT01063595|469400769|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
130391094|NCT01063595|469400768|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
130391095|NCT01063595|469400769|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
130391096|NCT01063595|469400768|FG000|First Intervention|Adverse Event|1|||
130391097|NCT01063595|469400769|FG001|First Intervention|Adverse Event|4|||
130391098|NCT01063595|469400768|FG000|First Intervention|Withdrawal by Subject|1|||
130391099|NCT01063595|469400769|FG001|First Intervention|Withdrawal by Subject|0|||
130391100|NCT01063595|469400768|FG000|First Intervention|Reason not Specified|0|||
130391101|NCT01063595|469400769|FG001|First Intervention|Reason not Specified|1|||
130391102|NCT00851799|469400770|FG000|Overall Study|Death|1|||
130391103|NCT00851799|469400771|FG001|Overall Study|Death|0|||
130391104|NCT00851799|469400772|FG002|Overall Study|Death|1|||
130391105|NCT00851799|469400770|FG000|Overall Study|Lost to Follow-up|5|||
130391106|NCT00851799|469400771|FG001|Overall Study|Lost to Follow-up|3|||
130391107|NCT00851799|469400772|FG002|Overall Study|Lost to Follow-up|10|||
130391108|NCT00851799|469400770|FG000|Overall Study|Not able to get to clinic|8|||
130391109|NCT00851799|469400771|FG001|Overall Study|Not able to get to clinic|5|||
130391110|NCT00851799|469400772|FG002|Overall Study|Not able to get to clinic|9|||
130391111|NCT00851799|469400770|FG000|Overall Study|Not willing to adhere to requirements|1|||
130391112|NCT00851799|469400771|FG001|Overall Study|Not willing to adhere to requirements|2|||
130391113|NCT00851799|469400772|FG002|Overall Study|Not willing to adhere to requirements|2|||
130391114|NCT00851799|469400770|FG000|Overall Study|Withdrew consent prior study completion|1|||
130391115|NCT00851799|469400771|FG001|Overall Study|Withdrew consent prior study completion|2|||
130391116|NCT00851799|469400772|FG002|Overall Study|Withdrew consent prior study completion|1|||
130391117|NCT00851799|469400770|FG000|Overall Study|Severe Debilitation|0|||
130391118|NCT00851799|469400771|FG001|Overall Study|Severe Debilitation|1|||
130391119|NCT00851799|469400772|FG002|Overall Study|Severe Debilitation|0|||
130391120|NCT00851799|469400770|FG000|Overall Study|Completed protocol due to pregnancy|0|||
130391121|NCT00851799|469400771|FG001|Overall Study|Completed protocol due to pregnancy|0|||
130391122|NCT00851799|469400772|FG002|Overall Study|Completed protocol due to pregnancy|1|||
130391123|NCT04365556|469400786|FG000|Overall Study|No longer eligible due to treatment plan|1|||
130391124|NCT04365556|469400787|FG001|Overall Study|No longer eligible due to treatment plan|0|||
130391125|NCT04365556|469400786|FG000|Overall Study|Lost to Follow-up|3|||
130391126|NCT04365556|469400787|FG001|Overall Study|Lost to Follow-up|2|||
130391127|NCT04439318|469400790|FG000|Overall Study|Ineligible|1|||
130391128|NCT04439318|469400790|FG000|Overall Study|Never Started Treatment|3|||
130391129|NCT04439318|469400790|FG000|Overall Study|Adverse Event|10|||
130391130|NCT04439318|469400790|FG000|Overall Study|Death|2|||
130391131|NCT04439318|469400790|FG000|Overall Study|Disease Progression|25|||
130391132|NCT04439318|469400790|FG000|Overall Study|Other Complicating Disease|2|||
130391133|NCT04439318|469400790|FG000|Overall Study|Withdrawal by Subject|4|||
130391134|NCT04439318|469400790|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
130391135|NCT04439318|469400790|FG000|Overall Study|Non-Compliance|1|||
130391136|NCT04439318|469400790|FG000|Overall Study|Still on Treatment|1|||
130391137|NCT00699972|469402226|FG000|Overall Study|Adverse Event|7|||
130391138|NCT00699972|469402227|FG001|Overall Study|Adverse Event|9|||
130391139|NCT00699972|469402228|FG002|Overall Study|Adverse Event|24|||
130391140|NCT00699972|469402226|FG000|Overall Study|Lost to Follow-up|0|||
130391141|NCT00699972|469402227|FG001|Overall Study|Lost to Follow-up|2|||
130391142|NCT00699972|469402228|FG002|Overall Study|Lost to Follow-up|0|||
130391143|NCT00699972|469402226|FG000|Overall Study|Withdrawal by Subject|3|||
130391144|NCT00699972|469402227|FG001|Overall Study|Withdrawal by Subject|7|||
130391145|NCT00699972|469402228|FG002|Overall Study|Withdrawal by Subject|4|||
130391146|NCT00699972|469402226|FG000|Overall Study|Lack of Efficacy|2|||
130391147|NCT00699972|469402227|FG001|Overall Study|Lack of Efficacy|0|||
130391148|NCT00699972|469402228|FG002|Overall Study|Lack of Efficacy|2|||
130391149|NCT00699972|469402226|FG000|Overall Study|Administrative/Other|3|||
130391150|NCT00699972|469402227|FG001|Overall Study|Administrative/Other|1|||
130391151|NCT00699972|469402228|FG002|Overall Study|Administrative/Other|4|||
130391152|NCT00699972|469402226|FG000|Overall Study|Randomized, Not Treated|1|||
130470088|NCT00976495|469685837|FG001|Overall Study|Withdrawal by Subject|1|||
130470089|NCT00976495|469685838|FG002|Overall Study|Withdrawal by Subject|0|||
130470090|NCT02538341|469685839|FG000|Overall Study|Lost to Follow-up|51|||
130391153|NCT00699972|469402227|FG001|Overall Study|Randomized, Not Treated|0|||
130391154|NCT00699972|469402228|FG002|Overall Study|Randomized, Not Treated|1|||
130391155|NCT03509675|469402229|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
130391156|NCT03509675|469402230|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
130391157|NCT03509675|469402229|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
130391158|NCT03509675|469402230|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
130391159|NCT03509675|469402229|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
130391160|NCT03509675|469402230|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
130391161|NCT03509675|469402229|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
130470091|NCT02538341|469685840|FG001|Overall Study|Lost to Follow-up|46|||
130470092|NCT02538341|469685839|FG000|Overall Study|Withdrawal by Subject|3|||
130470093|NCT02538341|469685840|FG001|Overall Study|Withdrawal by Subject|1|||
130470094|NCT02538341|469685839|FG000|Overall Study|Death|2|||
130470095|NCT02538341|469685840|FG001|Overall Study|Death|0|||
130470096|NCT00331136|469685841|FG000|Overall Study|Adverse Event|3|||
130470097|NCT00331136|469685842|FG001|Overall Study|Adverse Event|5|||
130470098|NCT00331136|469685843|FG002|Overall Study|Adverse Event|0|||
130470099|NCT00331136|469685844|FG003|Overall Study|Adverse Event|1|||
130470100|NCT00331136|469685841|FG000|Overall Study|Withdrawal by Subject|0|||
130470101|NCT00331136|469685842|FG001|Overall Study|Withdrawal by Subject|1|||
130470102|NCT00331136|469685843|FG002|Overall Study|Withdrawal by Subject|0|||
130470103|NCT00331136|469685844|FG003|Overall Study|Withdrawal by Subject|0|||
130470104|NCT00331136|469685841|FG000|Overall Study|Lost to Follow-up|0|||
130470105|NCT00331136|469685842|FG001|Overall Study|Lost to Follow-up|1|||
130470106|NCT00331136|469685843|FG002|Overall Study|Lost to Follow-up|0|||
130470107|NCT00331136|469685844|FG003|Overall Study|Lost to Follow-up|0|||
130470108|NCT00331136|469685841|FG000|Overall Study|Protocol Violation|1|||
130470109|NCT00331136|469685842|FG001|Overall Study|Protocol Violation|0|||
130470110|NCT00331136|469685843|FG002|Overall Study|Protocol Violation|0|||
130470111|NCT00331136|469685844|FG003|Overall Study|Protocol Violation|0|||
130470112|NCT00331136|469685841|FG000|Overall Study|Not treated|1|||
130470113|NCT00331136|469685842|FG001|Overall Study|Not treated|0|||
130470114|NCT00331136|469685843|FG002|Overall Study|Not treated|0|||
130470115|NCT00331136|469685844|FG003|Overall Study|Not treated|0|||
130470116|NCT02321514|469685845|FG000|Overall Study|Death|15|||
130470117|NCT02321514|469685845|FG000|Overall Study|Missed Visit|7|||
130470118|NCT02321514|469685845|FG000|Overall Study|Study Exit|3|||
130470119|NCT04484935|469685850|FG000|Overall Study|Other|0|||
130470120|NCT04484935|469685851|FG001|Overall Study|Other|1|||
130470121|NCT04484935|469685850|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130470122|NCT04484935|469685851|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130470123|NCT04484935|469685850|FG000|Overall Study|Lost to Follow-up|1|||
130470124|NCT04484935|469685851|FG001|Overall Study|Lost to Follow-up|0|||
130470125|NCT04484935|469685850|FG000|Overall Study|Death|2|||
130470126|NCT04484935|469685851|FG001|Overall Study|Death|1|||
130470127|NCT03432858|469685852|FG000|Overall Study|Protocol Violation|2|||
130470128|NCT03432858|469685853|FG001|Overall Study|Protocol Violation|1|||
130391162|NCT03509675|469402230|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
130391163|NCT01023581|469402233|FG000|Overall Study|Adverse Event|4|||
130391164|NCT01023581|469402234|FG001|Overall Study|Adverse Event|4|||
130391165|NCT01023581|469402235|FG002|Overall Study|Adverse Event|7|||
130391166|NCT01023581|469402236|FG003|Overall Study|Adverse Event|3|||
130391167|NCT01023581|469402237|FG004|Overall Study|Adverse Event|2|||
130391168|NCT01023581|469402238|FG005|Overall Study|Adverse Event|5|||
130391169|NCT01023581|469402239|FG006|Overall Study|Adverse Event|11|||
130391170|NCT01023581|469402233|FG000|Overall Study|Major protocol deviation|2|||
130391171|NCT01023581|469402234|FG001|Overall Study|Major protocol deviation|0|||
130391172|NCT01023581|469402235|FG002|Overall Study|Major protocol deviation|3|||
130391173|NCT01023581|469402236|FG003|Overall Study|Major protocol deviation|0|||
130391174|NCT01023581|469402237|FG004|Overall Study|Major protocol deviation|0|||
130391175|NCT01023581|469402238|FG005|Overall Study|Major protocol deviation|0|||
130391176|NCT01023581|469402239|FG006|Overall Study|Major protocol deviation|0|||
130391177|NCT01023581|469402233|FG000|Overall Study|Lost to Follow-up|4|||
130391178|NCT01023581|469402234|FG001|Overall Study|Lost to Follow-up|8|||
130391179|NCT01023581|469402235|FG002|Overall Study|Lost to Follow-up|7|||
130391180|NCT01023581|469402236|FG003|Overall Study|Lost to Follow-up|2|||
130391181|NCT01023581|469402237|FG004|Overall Study|Lost to Follow-up|5|||
130391182|NCT01023581|469402238|FG005|Overall Study|Lost to Follow-up|2|||
130391183|NCT01023581|469402239|FG006|Overall Study|Lost to Follow-up|2|||
130391184|NCT01023581|469402233|FG000|Overall Study|Withdrawal by Subject|13|||
130391185|NCT01023581|469402234|FG001|Overall Study|Withdrawal by Subject|8|||
130391186|NCT01023581|469402235|FG002|Overall Study|Withdrawal by Subject|16|||
130391187|NCT01023581|469402236|FG003|Overall Study|Withdrawal by Subject|10|||
130391188|NCT01023581|469402237|FG004|Overall Study|Withdrawal by Subject|6|||
130391189|NCT01023581|469402238|FG005|Overall Study|Withdrawal by Subject|8|||
130470129|NCT03432858|469685854|FG002|Overall Study|Protocol Violation|9|||
130470130|NCT03432858|469685852|FG000|Overall Study|Withdrawal by Subject|0|||
130470131|NCT03432858|469685853|FG001|Overall Study|Withdrawal by Subject|1|||
130391190|NCT01023581|469402239|FG006|Overall Study|Withdrawal by Subject|5|||
130470132|NCT03432858|469685854|FG002|Overall Study|Withdrawal by Subject|1|||
130470133|NCT03432858|469685852|FG000|Overall Study|Procedure canceled/rescheduled|0|||
130470134|NCT03432858|469685853|FG001|Overall Study|Procedure canceled/rescheduled|9|||
130391191|NCT01023581|469402233|FG000|Overall Study|Pregnancy|0|||
130391192|NCT01023581|469402234|FG001|Overall Study|Pregnancy|0|||
130391193|NCT01023581|469402235|FG002|Overall Study|Pregnancy|0|||
130391194|NCT01023581|469402236|FG003|Overall Study|Pregnancy|2|||
130391195|NCT01023581|469402237|FG004|Overall Study|Pregnancy|0|||
130391196|NCT01023581|469402238|FG005|Overall Study|Pregnancy|1|||
130470135|NCT03432858|469685854|FG002|Overall Study|Procedure canceled/rescheduled|6|||
130470136|NCT03432858|469685852|FG000|Overall Study|Required postop mobilization with splinting|0|||
130391197|NCT01023581|469402239|FG006|Overall Study|Pregnancy|0|||
130391198|NCT01023581|469402233|FG000|Overall Study|Lack of Efficacy|9|||
130391199|NCT01023581|469402234|FG001|Overall Study|Lack of Efficacy|3|||
130391200|NCT01023581|469402235|FG002|Overall Study|Lack of Efficacy|6|||
130391201|NCT01023581|469402236|FG003|Overall Study|Lack of Efficacy|2|||
130391202|NCT01023581|469402237|FG004|Overall Study|Lack of Efficacy|1|||
130391203|NCT01023581|469402238|FG005|Overall Study|Lack of Efficacy|2|||
130722823|NCT01197755|470609746|FG000|Overall Study|Adverse Event|8|||
130722824|NCT01197755|470609747|FG001|Overall Study|Adverse Event|10|||
130722825|NCT01197755|470609748|FG002|Overall Study|Adverse Event|10|||
130391204|NCT01023581|469402239|FG006|Overall Study|Lack of Efficacy|1|||
130391205|NCT01023581|469402233|FG000|Overall Study|Physician Decision|2|||
130391206|NCT01023581|469402234|FG001|Overall Study|Physician Decision|0|||
130391207|NCT01023581|469402235|FG002|Overall Study|Physician Decision|2|||
130391208|NCT01023581|469402236|FG003|Overall Study|Physician Decision|1|||
130391209|NCT01023581|469402237|FG004|Overall Study|Physician Decision|1|||
130391210|NCT01023581|469402238|FG005|Overall Study|Physician Decision|1|||
130391211|NCT01023581|469402239|FG006|Overall Study|Physician Decision|1|||
130391212|NCT01023581|469402233|FG000|Overall Study|Other|1|||
130391213|NCT01023581|469402234|FG001|Overall Study|Other|0|||
130391214|NCT01023581|469402235|FG002|Overall Study|Other|1|||
130391215|NCT01023581|469402236|FG003|Overall Study|Other|0|||
130559880|NCT02632721|470017894|FG004|Overall Study|Relapsed Pneumonia|1|||
130559881|NCT02632721|470017890|FG000|Overall Study|Therapy refractory AML|0|||
130559882|NCT02632721|470017891|FG001|Overall Study|Therapy refractory AML|0|||
130559883|NCT02632721|470017892|FG002|Overall Study|Therapy refractory AML|0|||
130559884|NCT02632721|470017893|FG003|Overall Study|Therapy refractory AML|0|||
130559885|NCT02632721|470017894|FG004|Overall Study|Therapy refractory AML|1|||
130559886|NCT02632721|470017890|FG000|Overall Study|Increase of white blood cell count|0|||
130559887|NCT02632721|470017891|FG001|Overall Study|Increase of white blood cell count|0|||
130559888|NCT02632721|470017892|FG002|Overall Study|Increase of white blood cell count|0|||
130559889|NCT02632721|470017893|FG003|Overall Study|Increase of white blood cell count|0|||
130559890|NCT02632721|470017894|FG004|Overall Study|Increase of white blood cell count|1|||
130559891|NCT02632721|470017890|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130559892|NCT02632721|470017891|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130559893|NCT02632721|470017892|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
130559894|NCT02632721|470017893|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130559895|NCT02632721|470017894|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130559896|NCT00544648|470017897|FG000|Overall Study|Withdrawal by Subject|1|||
130559897|NCT00544648|470017898|FG001|Overall Study|Withdrawal by Subject|0|||
130559898|NCT00544648|470017897|FG000|Overall Study|Adverse Event|1|||
130559899|NCT00544648|470017898|FG001|Overall Study|Adverse Event|1|||
130559900|NCT00544648|470017897|FG000|Overall Study|progression of disease|1|||
130559901|NCT00544648|470017898|FG001|Overall Study|progression of disease|0|||
130559902|NCT04166383|470017900|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
130559903|NCT04166383|470017900|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
130559904|NCT04166383|470017900|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
130559905|NCT03346057|470017901|FG000|Overall Study|Death|1|||
130559906|NCT03346057|470017902|FG001|Overall Study|Death|2|||
130391216|NCT01023581|469402237|FG004|Overall Study|Other|1|||
130391217|NCT01023581|469402238|FG005|Overall Study|Other|0|||
130391218|NCT01023581|469402239|FG006|Overall Study|Other|0|||
130391219|NCT01723163|469402240|FG000|Treatment Phase|Withdrawal by Subject|14|||
130391220|NCT01723163|469402241|FG001|Treatment Phase|Withdrawal by Subject|6|||
130391221|NCT01723163|469402240|FG000|Treatment Phase|Withdrawal by PI|5|||
130391222|NCT01723163|469402241|FG001|Treatment Phase|Withdrawal by PI|1|||
130391223|NCT01723163|469402240|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
130391224|NCT01723163|469402241|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
130391225|NCT01723163|469402240|FG000|3-Month Follow-up|Unable to Contact|12|||
130391226|NCT01723163|469402241|FG001|3-Month Follow-up|Unable to Contact|19|||
130391227|NCT01723163|469402240|FG000|6-Month Follow-up|Death|1|||
130391228|NCT01723163|469402241|FG001|6-Month Follow-up|Death|0|||
130391229|NCT01723163|469402240|FG000|6-Month Follow-up|Unable to Contact|17|||
130391230|NCT01723163|469402241|FG001|6-Month Follow-up|Unable to Contact|15|||
130559907|NCT03346057|470017903|FG002|Overall Study|Death|0|||
130559908|NCT03346057|470017904|FG003|Overall Study|Death|0|||
130559909|NCT03346057|470017901|FG000|Overall Study|Lost to Follow-up|0|||
130722826|NCT01197755|470609746|FG000|Overall Study|Study-specific discontinuation criteria|2|||
130391231|NCT01723163|469402240|FG000|12-Month Follow-up|Death|1|||
130391232|NCT01723163|469402241|FG001|12-Month Follow-up|Death|0|||
130391233|NCT01723163|469402240|FG000|12-Month Follow-up|Unable to Contact|23|||
130391234|NCT01723163|469402241|FG001|12-Month Follow-up|Unable to Contact|28|||
130391235|NCT05664490|469402249|FG000|Overall Study|Withdrawal by Subject|0|||
130391236|NCT05664490|469402250|FG001|Overall Study|Withdrawal by Subject|1|||
130391237|NCT05664490|469402249|FG000|Overall Study|Lost to Follow-up|14|||
130391238|NCT05664490|469402250|FG001|Overall Study|Lost to Follow-up|22|||
130391239|NCT00325754|469402251|FG000|Overall Study|Adverse Event|4|||
130391240|NCT00325754|469402252|FG001|Overall Study|Adverse Event|1|||
130391241|NCT03412084|469402255|FG000|Overall Study|Withdrawal by Subject|2|||
130391242|NCT03412084|469402256|FG001|Overall Study|Withdrawal by Subject|0|||
130391243|NCT03412084|469402255|FG000|Overall Study|Participant moved|1|||
130391244|NCT03412084|469402256|FG001|Overall Study|Participant moved|0|||
130391245|NCT03412084|469402255|FG000|Overall Study|Lost to Follow-up|1|||
130391246|NCT03412084|469402256|FG001|Overall Study|Lost to Follow-up|1|||
130391247|NCT01289847|469402263|FG000|Overall Study|Patient could not comply with visits|1|||
130391248|NCT01324388|469402268|FG000|Part 1 of Study|Adverse Event|2|||
130391249|NCT01324388|469402269|FG001|Part 1 of Study|Adverse Event|0|||
130391250|NCT01324388|469402270|FG002|Part 1 of Study|Adverse Event|0|||
130391251|NCT01324388|469402271|FG003|Part 1 of Study|Adverse Event|0|||
130391252|NCT01324388|469402268|FG000|Part 1 of Study|Protocol Violation|1|||
130391253|NCT01324388|469402269|FG001|Part 1 of Study|Protocol Violation|2|||
130391254|NCT01324388|469402270|FG002|Part 1 of Study|Protocol Violation|0|||
130391255|NCT01324388|469402271|FG003|Part 1 of Study|Protocol Violation|0|||
130391256|NCT01324388|469402268|FG000|Part 1 of Study|Physician Decision|1|||
130391257|NCT01324388|469402269|FG001|Part 1 of Study|Physician Decision|0|||
130391258|NCT01324388|469402270|FG002|Part 1 of Study|Physician Decision|0|||
130391259|NCT01324388|469402271|FG003|Part 1 of Study|Physician Decision|0|||
130391260|NCT01324388|469402268|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
130391261|NCT01324388|469402269|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
130391262|NCT01324388|469402270|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
130391263|NCT01324388|469402271|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
130391264|NCT01324388|469402268|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130391265|NCT01324388|469402269|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130391266|NCT01324388|469402270|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
130391267|NCT01324388|469402271|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130391268|NCT01405963|469402272|FG000|Overall Study|Moved Away|2|||
130391269|NCT01405963|469402273|FG001|Overall Study|Moved Away|0|||
130391270|NCT01405963|469402272|FG000|Overall Study|Adverse Event|0|||
130391271|NCT01405963|469402273|FG001|Overall Study|Adverse Event|1|||
130391272|NCT01405963|469402272|FG000|Overall Study|Lost to Follow-up|0|||
130391273|NCT01405963|469402273|FG001|Overall Study|Lost to Follow-up|1|||
130391274|NCT01894152|469402277|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
130391275|NCT01708174|469402278|FG000|Treatment Period|Withdrawal by Subject|1|||
130391276|NCT01708174|469402279|FG001|Treatment Period|Withdrawal by Subject|0|||
130391277|NCT01708174|469402280|FG002|Treatment Period|Withdrawal by Subject|0|||
130391278|NCT01708174|469402278|FG000|Treatment Period|Progressive disease|0|||
130391279|NCT01708174|469402279|FG001|Treatment Period|Progressive disease|1|||
130391280|NCT01708174|469402280|FG002|Treatment Period|Progressive disease|0|||
130391281|NCT01708174|469402278|FG000|Treatment Period|Death|0|||
130391282|NCT01708174|469402279|FG001|Treatment Period|Death|0|||
130391283|NCT01708174|469402280|FG002|Treatment Period|Death|1|||
130391284|NCT01708174|469402278|FG000|Treatment Period|Adverse Event|0|||
130391285|NCT01708174|469402279|FG001|Treatment Period|Adverse Event|1|||
130391286|NCT01708174|469402280|FG002|Treatment Period|Adverse Event|0|||
130391287|NCT00075582|469402281|FG000|Overall Study|Adverse Event|3|||
130391288|NCT00075582|469402282|FG001|Overall Study|Adverse Event|1|||
130391289|NCT00075582|469402281|FG000|Overall Study|Lack of Efficacy|4|||
130391290|NCT00075582|469402282|FG001|Overall Study|Lack of Efficacy|8|||
130391291|NCT00075582|469402281|FG000|Overall Study|Physician Decision|5|||
130391292|NCT00075582|469402282|FG001|Overall Study|Physician Decision|8|||
130391293|NCT00075582|469402281|FG000|Overall Study|Withdrawal by Subject|2|||
130391294|NCT00075582|469402282|FG001|Overall Study|Withdrawal by Subject|2|||
130391295|NCT00075582|469402281|FG000|Overall Study|Ineligible for study|36|||
130391296|NCT00075582|469402282|FG001|Overall Study|Ineligible for study|16|||
130391297|NCT02268812|469402283|FG000|Overall Study|Adverse Event|8|||
130391298|NCT02268812|469402284|FG001|Overall Study|Adverse Event|26|||
130391299|NCT02268812|469402285|FG002|Overall Study|Adverse Event|7|||
130391300|NCT02268812|469402286|FG003|Overall Study|Adverse Event|10|||
130391301|NCT02268812|469402283|FG000|Overall Study|Protocol deviation|0|||
130391302|NCT02268812|469402284|FG001|Overall Study|Protocol deviation|0|||
130391303|NCT02268812|469402285|FG002|Overall Study|Protocol deviation|1|||
130391304|NCT02268812|469402286|FG003|Overall Study|Protocol deviation|0|||
130391305|NCT02268812|469402283|FG000|Overall Study|Withdrawal by Subject|0|||
130391306|NCT02268812|469402284|FG001|Overall Study|Withdrawal by Subject|1|||
130391307|NCT02268812|469402285|FG002|Overall Study|Withdrawal by Subject|0|||
130391308|NCT02268812|469402286|FG003|Overall Study|Withdrawal by Subject|0|||
130391309|NCT02268812|469402283|FG000|Overall Study|Physician Decision|3|||
130391310|NCT02268812|469402284|FG001|Overall Study|Physician Decision|1|||
130391311|NCT02268812|469402285|FG002|Overall Study|Physician Decision|0|||
130391312|NCT02268812|469402286|FG003|Overall Study|Physician Decision|1|||
130391313|NCT02268812|469402283|FG000|Overall Study|Other|5|||
130391314|NCT02268812|469402284|FG001|Overall Study|Other|4|||
130391315|NCT02268812|469402285|FG002|Overall Study|Other|1|||
130391316|NCT02268812|469402286|FG003|Overall Study|Other|3|||
130391317|NCT05045144|469402287|FG000|Overall Study|Lost to Follow-up|3|||
130391318|NCT05045144|469402288|FG001|Overall Study|Lost to Follow-up|2|||
130391319|NCT05045144|469402289|FG002|Overall Study|Lost to Follow-up|3|||
130391320|NCT05045144|469402290|FG003|Overall Study|Lost to Follow-up|5|||
130391321|NCT05045144|469402291|FG004|Overall Study|Lost to Follow-up|13|||
130391322|NCT05045144|469402287|FG000|Overall Study|Withdrawal by Subject|0|||
130391323|NCT05045144|469402288|FG001|Overall Study|Withdrawal by Subject|1|||
130391324|NCT05045144|469402289|FG002|Overall Study|Withdrawal by Subject|0|||
130391325|NCT05045144|469402290|FG003|Overall Study|Withdrawal by Subject|0|||
130391326|NCT05045144|469402291|FG004|Overall Study|Withdrawal by Subject|0|||
130391327|NCT05045144|469402287|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130391328|NCT05045144|469402288|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130470137|NCT03432858|469685853|FG001|Overall Study|Required postop mobilization with splinting|0|||
130470138|NCT03432858|469685854|FG002|Overall Study|Required postop mobilization with splinting|1|||
130470139|NCT01094184|469685858|FG000|Overall Study|Death|35|||
130470140|NCT01094184|469685859|FG001|Overall Study|Death|11|||
130470141|NCT03892564|469685860|FG000|Overall Study|Withdrawal by Subject|2|||
130470142|NCT04402294|469685861|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
130470143|NCT04402294|469685862|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
130391329|NCT05045144|469402289|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130391330|NCT05045144|469402290|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130391331|NCT05045144|469402291|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130391332|NCT02385084|469402292|FG000|Period 2|Protocol Violation|0|||
130391333|NCT02385084|469402293|FG001|Period 2|Protocol Violation|0|||
130391334|NCT02385084|469402294|FG002|Period 2|Protocol Violation|1|||
130391335|NCT02385084|469402295|FG003|Period 2|Protocol Violation|0|||
130391336|NCT02385084|469402296|FG004|Period 2|Protocol Violation|0|||
130391337|NCT02385084|469402297|FG005|Period 2|Protocol Violation|0|||
130391338|NCT02171260|469402298|FG000|Overall Study|Death|0|||
130391339|NCT02171260|469402299|FG001|Overall Study|Death|0|||
130391340|NCT02171260|469402300|FG002|Overall Study|Death|0|||
130391341|NCT02171260|469402301|FG003|Overall Study|Death|1|||
130391342|NCT02171260|469402298|FG000|Overall Study|Physician Decision|1|||
130391343|NCT02171260|469402299|FG001|Overall Study|Physician Decision|0|||
130391344|NCT02171260|469402300|FG002|Overall Study|Physician Decision|1|||
130391345|NCT02171260|469402301|FG003|Overall Study|Physician Decision|0|||
130391346|NCT02171260|469402298|FG000|Overall Study|Withdrawal by Subject|1|||
130391347|NCT02171260|469402299|FG001|Overall Study|Withdrawal by Subject|0|||
130391348|NCT02171260|469402300|FG002|Overall Study|Withdrawal by Subject|0|||
130391349|NCT02171260|469402301|FG003|Overall Study|Withdrawal by Subject|0|||
130391350|NCT02171260|469402298|FG000|Overall Study|Evidence of progressive disease|4|||
130391351|NCT02171260|469402299|FG001|Overall Study|Evidence of progressive disease|6|||
130391352|NCT02171260|469402300|FG002|Overall Study|Evidence of progressive disease|4|||
130391353|NCT02171260|469402301|FG003|Overall Study|Evidence of progressive disease|4|||
130391354|NCT00323492|469402302|FG000|Study Phase 1|Adverse Event|2|||
130391355|NCT00323492|469402303|FG001|Study Phase 1|Adverse Event|0|||
130391356|NCT00323492|469402304|FG002|Study Phase 1|Adverse Event|0|||
130391357|NCT00323492|469402302|FG000|Study Phase 2|Adverse Event|1|||
130391358|NCT00323492|469402303|FG001|Study Phase 2|Adverse Event|0|||
130391359|NCT00323492|469402304|FG002|Study Phase 2|Adverse Event|0|||
130391360|NCT00323492|469402302|FG000|Study Phase 2|Physician Decision|1|||
130391361|NCT00323492|469402303|FG001|Study Phase 2|Physician Decision|0|||
130391362|NCT00323492|469402304|FG002|Study Phase 2|Physician Decision|0|||
130391363|NCT00323492|469402302|FG000|Study Phase 2|Lost to Follow-up|1|||
130391364|NCT00323492|469402303|FG001|Study Phase 2|Lost to Follow-up|0|||
130391365|NCT00323492|469402304|FG002|Study Phase 2|Lost to Follow-up|0|||
130391366|NCT00323492|469402302|FG000|Study Phase 2|Withdrawal by Subject|0|||
130391367|NCT00323492|469402303|FG001|Study Phase 2|Withdrawal by Subject|1|||
130391368|NCT00323492|469402304|FG002|Study Phase 2|Withdrawal by Subject|0|||
130391369|NCT00323492|469402302|FG000|Study Phase 2|Noncompliance with study schedule|0|||
130391370|NCT00323492|469402303|FG001|Study Phase 2|Noncompliance with study schedule|0|||
130391371|NCT00323492|469402304|FG002|Study Phase 2|Noncompliance with study schedule|1|||
130391372|NCT00323492|469402302|FG000|Study Phase 2|Protocol Violation|1|||
130391373|NCT00323492|469402303|FG001|Study Phase 2|Protocol Violation|0|||
130391374|NCT00323492|469402304|FG002|Study Phase 2|Protocol Violation|0|||
130391375|NCT01466387|469402305|FG000|Overall Study|Adverse Event|0|||
130391376|NCT01466387|469402306|FG001|Overall Study|Adverse Event|0|||
130391377|NCT01466387|469402307|FG002|Overall Study|Adverse Event|1|||
130391378|NCT01466387|469402308|FG003|Overall Study|Adverse Event|1|||
130391379|NCT01466387|469402309|FG004|Overall Study|Adverse Event|0|||
130391380|NCT01466387|469402310|FG005|Overall Study|Adverse Event|0|||
130391381|NCT01466387|469402305|FG000|Overall Study|Lost to Follow-up|0|||
130391382|NCT01466387|469402306|FG001|Overall Study|Lost to Follow-up|0|||
130391383|NCT01466387|469402307|FG002|Overall Study|Lost to Follow-up|0|||
130391384|NCT01466387|469402308|FG003|Overall Study|Lost to Follow-up|0|||
130391385|NCT01466387|469402309|FG004|Overall Study|Lost to Follow-up|0|||
130391386|NCT01466387|469402310|FG005|Overall Study|Lost to Follow-up|1|||
130391387|NCT01466387|469402305|FG000|Overall Study|Protocol Violation|1|||
130391388|NCT01466387|469402306|FG001|Overall Study|Protocol Violation|0|||
130391389|NCT01466387|469402307|FG002|Overall Study|Protocol Violation|0|||
130391390|NCT01466387|469402308|FG003|Overall Study|Protocol Violation|1|||
130391391|NCT01466387|469402309|FG004|Overall Study|Protocol Violation|0|||
130391392|NCT01466387|469402310|FG005|Overall Study|Protocol Violation|0|||
130391393|NCT01319877|469402311|FG000|Overall Study|Lost to Follow-up|100|||
130391394|NCT01319877|469402312|FG001|Overall Study|Lost to Follow-up|37|||
130391395|NCT01319877|469402311|FG000|Overall Study|Physician Decision|2|||
130391396|NCT01319877|469402312|FG001|Overall Study|Physician Decision|0|||
130391397|NCT01319877|469402311|FG000|Overall Study|Disease Progression|2|||
130391398|NCT01319877|469402312|FG001|Overall Study|Disease Progression|2|||
130391399|NCT01319877|469402311|FG000|Overall Study|Withdrawal by Subject|0|||
130391400|NCT01319877|469402312|FG001|Overall Study|Withdrawal by Subject|1|||
130391401|NCT01319877|469402311|FG000|Overall Study|Reason Not Specified|4|||
130391402|NCT01319877|469402312|FG001|Overall Study|Reason Not Specified|5|||
130391403|NCT02968979|469402313|FG000|Overall Study|Protocol Violation|7|||
130391404|NCT02968979|469402313|FG000|Overall Study|Withdrawal by Subject|1|||
130391405|NCT00896337|469402315|FG000|Overall Study|Death|7|||
130391406|NCT00896337|469402315|FG000|Overall Study|Withdrawal by Subject|7|||
130391407|NCT00896337|469402315|FG000|Overall Study|Lost to Follow-up|11|||
130391408|NCT01124643|469402316|FG000|Overall Study|Death|1|||
130391409|NCT02678676|469402319|FG000|Overall Study|Death|619|||
130391410|NCT02678676|469402320|FG001|Overall Study|Death|649|||
130391411|NCT02678676|469402319|FG000|Overall Study|Withdrawal by Subject|13|||
130391412|NCT02678676|469402320|FG001|Overall Study|Withdrawal by Subject|5|||
130391413|NCT02678676|469402319|FG000|Overall Study|Lost to Follow-up|171|||
130391414|NCT02678676|469402320|FG001|Overall Study|Lost to Follow-up|151|||
130391415|NCT02678676|469402319|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
130391416|NCT02678676|469402320|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
130391417|NCT00747435|469402321|FG000|Overall Study|Lost to Follow-up|2|||
130391418|NCT00747435|469402321|FG000|Overall Study|Withdrawal by Subject|3|||
130391419|NCT00747435|469402321|FG000|Overall Study|Still undergoing follow up|1|||
130391420|NCT01342510|469402324|FG000|Overall Study|Protocol Violation|12|||
130391421|NCT01342510|469402325|FG001|Overall Study|Protocol Violation|6|||
130391422|NCT01342510|469402326|FG002|Overall Study|Protocol Violation|13|||
130391423|NCT01342510|469402327|FG003|Overall Study|Protocol Violation|11|||
130391424|NCT01449526|469402328|FG000|Overall Study|Lost to Follow-up|1|||
130391425|NCT01449526|469402329|FG001|Overall Study|Lost to Follow-up|2|||
130391426|NCT01449526|469402328|FG000|Overall Study|Withdrawal by Subject|1|||
130391427|NCT01449526|469402329|FG001|Overall Study|Withdrawal by Subject|1|||
130391428|NCT01449526|469402328|FG000|Overall Study|Symptoms/complaints|0|||
130391429|NCT01449526|469402329|FG001|Overall Study|Symptoms/complaints|1|||
130391430|NCT01449526|469402328|FG000|Overall Study|Lack of Motivation|0|||
130391431|NCT01449526|469402329|FG001|Overall Study|Lack of Motivation|1|||
130391432|NCT01449526|469402328|FG000|Overall Study|Cannot maintain visits|0|||
130391433|NCT01449526|469402329|FG001|Overall Study|Cannot maintain visits|1|||
130391434|NCT01400516|469402331|FG000|Primary Trial|Withdrawal by Subject|0|||
130391435|NCT01400516|469402332|FG001|Primary Trial|Withdrawal by Subject|2|||
130391436|NCT01132495|469402338|FG000|Overall Study|Various reasons|40|||
130391437|NCT01132495|469402339|FG001|Overall Study|Various reasons|38|||
130391438|NCT01132495|469402340|FG002|Overall Study|Various reasons|20|||
130470144|NCT04402294|469685861|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
130391439|NCT01132495|469402341|FG003|Overall Study|Various reasons|12|||
130391440|NCT00082433|469402345|FG000|Overall Study|Adverse Event|12|||
130391441|NCT00082433|469402346|FG001|Overall Study|Adverse Event|17|||
130470145|NCT04402294|469685862|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
130470146|NCT01216176|469688182|FG000|Overall Study|Adverse Event|0|||
130470147|NCT01216176|469688183|FG001|Overall Study|Adverse Event|8|||
130391442|NCT00082433|469402345|FG000|Overall Study|Death|8|||
130391443|NCT00082433|469402346|FG001|Overall Study|Death|18|||
130391444|NCT00082433|469402345|FG000|Overall Study|Disease Progression/Relapse|270|||
130391445|NCT00082433|469402346|FG001|Overall Study|Disease Progression/Relapse|388|||
130470148|NCT01216176|469688184|FG002|Overall Study|Adverse Event|0|||
130391446|NCT00082433|469402345|FG000|Overall Study|Physician Decision|50|||
130391447|NCT00082433|469402346|FG001|Overall Study|Physician Decision|61|||
130391448|NCT00082433|469402345|FG000|Overall Study|Lost to Follow-up|1|||
130391449|NCT00082433|469402346|FG001|Overall Study|Lost to Follow-up|2|||
130391450|NCT00082433|469402345|FG000|Overall Study|Study Drug Toxicity|179|||
130391451|NCT00082433|469402346|FG001|Overall Study|Study Drug Toxicity|66|||
130391452|NCT00082433|469402345|FG000|Overall Study|Withdrawal by Subject|55|||
130391453|NCT00082433|469402346|FG001|Overall Study|Withdrawal by Subject|30|||
130391454|NCT00082433|469402345|FG000|Overall Study|Still On Treatment|2|||
130391455|NCT00082433|469402346|FG001|Overall Study|Still On Treatment|1|||
130391456|NCT00082433|469402345|FG000|Overall Study|Not Treated|12|||
130391457|NCT00082433|469402346|FG001|Overall Study|Not Treated|11|||
130391458|NCT00082433|469402345|FG000|Overall Study|Ineligible|2|||
130391459|NCT00082433|469402346|FG001|Overall Study|Ineligible|1|||
130391460|NCT00082433|469402345|FG000|Overall Study|Noncompliance|2|||
130391461|NCT00082433|469402346|FG001|Overall Study|Noncompliance|1|||
130391462|NCT00082433|469402345|FG000|Overall Study|New primary cancer|1|||
130391463|NCT00082433|469402346|FG001|Overall Study|New primary cancer|0|||
130391464|NCT00082433|469402345|FG000|Overall Study|Impending surgery|0|||
130391465|NCT00082433|469402346|FG001|Overall Study|Impending surgery|1|||
130391466|NCT01796197|469402349|FG000|Overall Study|Lost to Follow-up|1|||
130391467|NCT01796197|469402349|FG000|Overall Study|Lack of Efficacy|1|||
130391468|NCT01380184|469402350|FG000|Part 1 (19 Days)|Adverse Event|1|||
130391469|NCT01380184|469402350|FG000|Part 2|Adverse Event|5|||
130391470|NCT01380184|469402350|FG000|Part 2|Disease Progression|8|||
130391471|NCT01380184|469402350|FG000|Part 2|Lost to Follow-up|1|||
130391472|NCT04097821|469402351|FG000|Overall Study|Subject Decision|0|||
130391473|NCT04097821|469402352|FG001|Overall Study|Subject Decision|0|||
130391474|NCT04097821|469402353|FG002|Overall Study|Subject Decision|0|||
130391475|NCT04097821|469402354|FG003|Overall Study|Subject Decision|1|||
130391476|NCT04097821|469402355|FG004|Overall Study|Subject Decision|2|||
130391477|NCT04097821|469402356|FG005|Overall Study|Subject Decision|2|||
130391478|NCT04097821|469402357|FG006|Overall Study|Subject Decision|0|||
130391479|NCT04097821|469402358|FG007|Overall Study|Subject Decision|1|||
130391480|NCT04097821|469402351|FG000|Overall Study|Death|0|||
130391481|NCT04097821|469402352|FG001|Overall Study|Death|0|||
130391482|NCT04097821|469402353|FG002|Overall Study|Death|3|||
130391483|NCT04097821|469402354|FG003|Overall Study|Death|1|||
130391484|NCT04097821|469402355|FG004|Overall Study|Death|0|||
130470149|NCT01216176|469688182|FG000|Overall Study|Physician Decision|0|||
130470150|NCT01216176|469688183|FG001|Overall Study|Physician Decision|0|||
130470151|NCT01216176|469688184|FG002|Overall Study|Physician Decision|1|||
130470152|NCT00212355|469688187|FG000|Overall Study|Adverse Event|1|||
130470153|NCT00212355|469688187|FG000|Overall Study|Withdrawal by Subject|1|||
130470154|NCT00212355|469688187|FG000|Overall Study|A change of address|1|||
130391485|NCT04097821|469402356|FG005|Overall Study|Death|0|||
130391486|NCT04097821|469402357|FG006|Overall Study|Death|0|||
130391487|NCT04097821|469402358|FG007|Overall Study|Death|0|||
130391488|NCT04097821|469402351|FG000|Overall Study|Physician Decision|1|||
130391489|NCT04097821|469402352|FG001|Overall Study|Physician Decision|2|||
130391490|NCT04097821|469402353|FG002|Overall Study|Physician Decision|0|||
130391491|NCT04097821|469402354|FG003|Overall Study|Physician Decision|0|||
130391492|NCT04097821|469402355|FG004|Overall Study|Physician Decision|0|||
130391493|NCT04097821|469402356|FG005|Overall Study|Physician Decision|0|||
130391494|NCT04097821|469402357|FG006|Overall Study|Physician Decision|0|||
130391495|NCT04097821|469402358|FG007|Overall Study|Physician Decision|0|||
130391496|NCT04097821|469402351|FG000|Overall Study|Adverse Event|0|||
130391497|NCT04097821|469402352|FG001|Overall Study|Adverse Event|0|||
130391498|NCT04097821|469402353|FG002|Overall Study|Adverse Event|1|||
130391499|NCT04097821|469402354|FG003|Overall Study|Adverse Event|1|||
130391500|NCT04097821|469402355|FG004|Overall Study|Adverse Event|0|||
130391501|NCT04097821|469402356|FG005|Overall Study|Adverse Event|0|||
130391502|NCT04097821|469402357|FG006|Overall Study|Adverse Event|0|||
130391503|NCT04097821|469402358|FG007|Overall Study|Adverse Event|0|||
130391504|NCT04097821|469402351|FG000|Overall Study|New Therapy For Study Indication|0|||
130391505|NCT04097821|469402352|FG001|Overall Study|New Therapy For Study Indication|0|||
130391506|NCT04097821|469402353|FG002|Overall Study|New Therapy For Study Indication|0|||
130391507|NCT04097821|469402354|FG003|Overall Study|New Therapy For Study Indication|0|||
130391508|NCT04097821|469402355|FG004|Overall Study|New Therapy For Study Indication|0|||
130391509|NCT04097821|469402356|FG005|Overall Study|New Therapy For Study Indication|0|||
130391510|NCT04097821|469402357|FG006|Overall Study|New Therapy For Study Indication|1|||
130391511|NCT04097821|469402358|FG007|Overall Study|New Therapy For Study Indication|0|||
130391512|NCT04243538|469402359|FG000|Overall Study|Withdrawal by Subject|0|||
130391513|NCT04243538|469402360|FG001|Overall Study|Withdrawal by Subject|2|||
130470155|NCT00186992|469688191|FG000|Overall Study|Withdrawal by Subject|5|||
130470156|NCT00186992|469688191|FG000|Overall Study|Physician's discretion|13|||
130470157|NCT00186992|469688191|FG000|Overall Study|PI Discretion|4|||
130470158|NCT00186992|469688191|FG000|Overall Study|Ineligible|2|||
130470159|NCT00186992|469688191|FG000|Overall Study|Lost to Follow-up|2|||
130470160|NCT00186992|469688191|FG000|Overall Study|Still on Study|9|||
130470161|NCT03683069|469688192|FG000|Overall Study|see limitations|12|||
130391514|NCT04243538|469402359|FG000|Overall Study|Lost to Follow-up|0|||
130391515|NCT04243538|469402360|FG001|Overall Study|Lost to Follow-up|3|||
130391516|NCT03532295|469402361|FG000|Overall Study|Did not start treatment|0|||
130391517|NCT03532295|469402362|FG001|Overall Study|Did not start treatment|2|||
130391518|NCT02776917|469402363|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
130391519|NCT05756790|469402364|FG000|Overall Study|Withdrawal by Subject|1|||
130391520|NCT05756790|469402365|FG001|Overall Study|Withdrawal by Subject|1|||
130391521|NCT05756790|469402366|FG002|Overall Study|Withdrawal by Subject|1|||
130391522|NCT05756790|469402367|FG003|Overall Study|Withdrawal by Subject|1|||
130391523|NCT05756790|469402368|FG004|Overall Study|Withdrawal by Subject|0|||
130470162|NCT03683069|469688193|FG001|Overall Study|see limitations|13|||
130391524|NCT05756790|469402369|FG005|Overall Study|Withdrawal by Subject|0|||
130391525|NCT05756790|469402364|FG000|Overall Study|Protocol Violation|0|||
130391526|NCT05756790|469402365|FG001|Overall Study|Protocol Violation|0|||
130391527|NCT05756790|469402366|FG002|Overall Study|Protocol Violation|1|||
130391528|NCT05756790|469402367|FG003|Overall Study|Protocol Violation|1|||
130391529|NCT05756790|469402368|FG004|Overall Study|Protocol Violation|0|||
130391530|NCT05756790|469402369|FG005|Overall Study|Protocol Violation|0|||
130391531|NCT05756790|469402364|FG000|Overall Study|Ineligible|0|||
130391532|NCT05756790|469402365|FG001|Overall Study|Ineligible|0|||
130391533|NCT05756790|469402366|FG002|Overall Study|Ineligible|0|||
130391534|NCT05756790|469402367|FG003|Overall Study|Ineligible|0|||
130391535|NCT05756790|469402368|FG004|Overall Study|Ineligible|2|||
130391536|NCT05756790|469402369|FG005|Overall Study|Ineligible|2|||
130391537|NCT02449239|469403722|FG000|Induction Phase|Lack of Efficacy|64|||
130391538|NCT02449239|469403722|FG000|Induction Phase|Adverse Event|1|||
130391539|NCT02449239|469403722|FG000|Induction Phase|Lost to Follow-up|1|||
130391540|NCT02449239|469403722|FG000|Induction Phase|Protocol Violation|1|||
130391541|NCT02449239|469403722|FG000|Induction Phase|Physician Decision|1|||
130391542|NCT02449239|469403722|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
130391543|NCT02449239|469403722|FG000|Induction Phase|Withdrawal by Subject|1|||
130391544|NCT02449239|469403722|FG000|Maintenance Month 3|Lack of Efficacy|14|||
130391545|NCT02449239|469403722|FG000|Maintenance Month 6|Lack of Efficacy|10|||
130391546|NCT02449239|469403722|FG000|Maintenance Month 6|Adverse Event|2|||
130391547|NCT02449239|469403722|FG000|Maintenance Month 6|Physician Decision|1|||
130391548|NCT02449239|469403722|FG000|Maintenance Month 9|Lack of Efficacy|2|||
130391549|NCT02449239|469403722|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
130391550|NCT02449239|469403722|FG000|Maintenance Month 12|Lack of Efficacy|5|||
130391551|NCT02449239|469403722|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
130391552|NCT02449239|469403722|FG000|Maintenance Month 12|Subject moved from area|1|||
130391553|NCT02449239|469403722|FG000|Maintenance Month 15|Lack of Efficacy|1|||
130391554|NCT02449239|469403722|FG000|Maintenance Month 21|Lack of Efficacy|1|||
130391555|NCT02449239|469403722|FG000|Maintenance Month 21|Sponsor decision|1|||
130391556|NCT03314584|469403729|FG000|Overall Study|Withdrawal by Subject|3|||
130391557|NCT03314584|469403730|FG001|Overall Study|Withdrawal by Subject|3|||
130391558|NCT03314584|469403729|FG000|Overall Study|Lost to Follow-up|4|||
130391559|NCT03314584|469403730|FG001|Overall Study|Lost to Follow-up|0|||
130391560|NCT06134817|469403731|FG000|Overall Study|Physician Departure - termination of study|1|||
130391561|NCT04214288|469403735|FG000|Overall Study|Ongoing in the study|41|||
130391562|NCT04214288|469403736|FG001|Overall Study|Ongoing in the study|51|||
130391563|NCT04214288|469403737|FG002|Overall Study|Ongoing in the study|12|||
130391564|NCT04214288|469403738|FG003|Overall Study|Ongoing in the study|39|||
130391565|NCT04214288|469403735|FG000|Overall Study|Adverse Event|1|||
130391566|NCT04214288|469403736|FG001|Overall Study|Adverse Event|0|||
130391567|NCT04214288|469403737|FG002|Overall Study|Adverse Event|0|||
130391568|NCT04214288|469403738|FG003|Overall Study|Adverse Event|0|||
130391569|NCT04214288|469403735|FG000|Overall Study|Death|22|||
130391570|NCT04214288|469403736|FG001|Overall Study|Death|13|||
130391571|NCT04214288|469403737|FG002|Overall Study|Death|7|||
130391572|NCT04214288|469403738|FG003|Overall Study|Death|19|||
130391573|NCT04214288|469403735|FG000|Overall Study|Lost to Follow-up|1|||
130391574|NCT04214288|469403736|FG001|Overall Study|Lost to Follow-up|2|||
130391575|NCT04214288|469403737|FG002|Overall Study|Lost to Follow-up|1|||
130391576|NCT04214288|469403738|FG003|Overall Study|Lost to Follow-up|0|||
130391577|NCT04214288|469403735|FG000|Overall Study|Other|1|||
130391578|NCT04214288|469403736|FG001|Overall Study|Other|2|||
130391579|NCT04214288|469403737|FG002|Overall Study|Other|0|||
130391580|NCT04214288|469403738|FG003|Overall Study|Other|6|||
130391581|NCT04214288|469403735|FG000|Overall Study|Protocol Violation|0|||
130391582|NCT04214288|469403736|FG001|Overall Study|Protocol Violation|1|||
130391583|NCT04214288|469403737|FG002|Overall Study|Protocol Violation|0|||
130391584|NCT04214288|469403738|FG003|Overall Study|Protocol Violation|0|||
130391585|NCT04214288|469403735|FG000|Overall Study|Withdrawal by Subject|8|||
130391586|NCT04214288|469403736|FG001|Overall Study|Withdrawal by Subject|4|||
130391587|NCT04214288|469403737|FG002|Overall Study|Withdrawal by Subject|0|||
130391588|NCT04214288|469403738|FG003|Overall Study|Withdrawal by Subject|9|||
130391589|NCT01990495|469403748|FG000|Overall Study|Physician Decision|5|||
130391590|NCT01990495|469403749|FG001|Overall Study|Physician Decision|4|||
130391591|NCT01928862|469403755|FG000|Overall Study|Lost to Follow-up|1|||
130391592|NCT01928862|469403756|FG001|Overall Study|Lost to Follow-up|0|||
130391593|NCT01928862|469403757|FG002|Overall Study|Lost to Follow-up|0|||
130391594|NCT01928862|469403758|FG003|Overall Study|Lost to Follow-up|0|||
130391595|NCT01928862|469403759|FG004|Overall Study|Lost to Follow-up|1|||
130391596|NCT04649164|469403760|FG000|Overall Study|Withdrawal by Subject|1|||
130391597|NCT04649164|469403761|FG001|Overall Study|Withdrawal by Subject|1|||
130391598|NCT04649164|469403762|FG002|Overall Study|Withdrawal by Subject|2|||
130391599|NCT04649164|469403760|FG000|Overall Study|Participant's care recipient expired|0|||
130391600|NCT04649164|469403761|FG001|Overall Study|Participant's care recipient expired|0|||
130391601|NCT04649164|469403762|FG002|Overall Study|Participant's care recipient expired|2|||
130391602|NCT03168464|469403763|FG000|Overall Study|Death|9|||
130391603|NCT03168464|469403763|FG000|Overall Study|Progression of disease|6|||
130391604|NCT02053753|469403764|FG000|Overall Study|Withdrawal by Subject|2|||
130391605|NCT02053753|469403765|FG001|Overall Study|Withdrawal by Subject|4|||
130391606|NCT02053753|469403764|FG000|Overall Study|Decision by Sponsor|1|||
130391607|NCT02053753|469403765|FG001|Overall Study|Decision by Sponsor|1|||
130391608|NCT02053753|469403764|FG000|Overall Study|Lost to Follow-up|4|||
130391609|NCT02053753|469403765|FG001|Overall Study|Lost to Follow-up|3|||
130391610|NCT02023151|469403772|FG000|Overall Study|Lost to Follow-up|4|||
130391611|NCT04064294|469403773|FG000|Overall Study|Adverse Event|1|||
130391612|NCT04064294|469403774|FG001|Overall Study|Adverse Event|0|||
130391613|NCT04064294|469403775|FG002|Overall Study|Adverse Event|0|||
130391614|NCT03450707|469403776|FG000|Overall Study|Outside enrollment window|4|||
130391615|NCT03450707|469403777|FG001|Overall Study|Outside enrollment window|1|||
130391616|NCT03450707|469403776|FG000|Overall Study|Death|1|||
130391617|NCT03450707|469403777|FG001|Overall Study|Death|0|||
130391618|NCT03450707|469403776|FG000|Overall Study|Indication for thiamine|1|||
130391619|NCT03450707|469403777|FG001|Overall Study|Indication for thiamine|1|||
130391620|NCT03450707|469403776|FG000|Overall Study|Evidence of traumatic brain injury|1|||
130391621|NCT03450707|469403777|FG001|Overall Study|Evidence of traumatic brain injury|0|||
130391622|NCT03450707|469403776|FG000|Overall Study|Following commands|0|||
130391623|NCT03450707|469403777|FG001|Overall Study|Following commands|3|||
130391624|NCT03450707|469403776|FG000|Overall Study|Lactate < 3.5|0|||
130391625|NCT03450707|469403777|FG001|Overall Study|Lactate < 3.5|2|||
130391626|NCT03450707|469403776|FG000|Overall Study|Rearrest with ECMO|0|||
130391627|NCT03450707|469403777|FG001|Overall Study|Rearrest with ECMO|1|||
130391628|NCT03450707|469403776|FG000|Overall Study|Indication for thiamine + head CT results|0|||
130391629|NCT03450707|469403777|FG001|Overall Study|Indication for thiamine + head CT results|1|||
130391630|NCT03450707|469403776|FG000|Overall Study|Family/patient goals of care|0|||
130391631|NCT03450707|469403777|FG001|Overall Study|Family/patient goals of care|1|||
130391632|NCT00481195|469403778|FG000|Overall Study|Adverse Event|16|||
130391633|NCT00481195|469403779|FG001|Overall Study|Adverse Event|11|||
130391634|NCT00481195|469403778|FG000|Overall Study|Lack of Efficacy|1|||
130391635|NCT00481195|469403779|FG001|Overall Study|Lack of Efficacy|3|||
130391636|NCT00481195|469403778|FG000|Overall Study|Lost to Follow-up|4|||
130391637|NCT00481195|469403779|FG001|Overall Study|Lost to Follow-up|6|||
130391638|NCT00481195|469403778|FG000|Overall Study|Physician Decision|3|||
130391639|NCT00481195|469403779|FG001|Overall Study|Physician Decision|1|||
130391640|NCT00481195|469403778|FG000|Overall Study|Protocol Violation|10|||
130391641|NCT00481195|469403779|FG001|Overall Study|Protocol Violation|7|||
130391642|NCT00481195|469403778|FG000|Overall Study|Withdrawal by Subject|3|||
130391643|NCT00481195|469403779|FG001|Overall Study|Withdrawal by Subject|9|||
130391644|NCT00481195|469403778|FG000|Overall Study|Miscellaneous|2|||
130391645|NCT00481195|469403779|FG001|Overall Study|Miscellaneous|2|||
130391646|NCT03343483|469403780|FG000|Overall Study|Death|0|||
130391647|NCT03343483|469403781|FG001|Overall Study|Death|3|||
130391648|NCT03343483|469403780|FG000|Overall Study|Lost to Follow-up|9|||
130391649|NCT03343483|469403781|FG001|Overall Study|Lost to Follow-up|13|||
130391650|NCT03343483|469403780|FG000|Overall Study|Withdrawal by Subject|8|||
130391651|NCT03343483|469403781|FG001|Overall Study|Withdrawal by Subject|17|||
130391652|NCT01505608|469403782|FG000|Phase I|Lack of Efficacy|0|||
130391653|NCT01505608|469403783|FG001|Phase I|Lack of Efficacy|4|||
130391654|NCT01505608|469403782|FG000|Phase I|Adverse Event|0|||
130391655|NCT01505608|469403783|FG001|Phase I|Adverse Event|1|||
130391656|NCT01505608|469403782|FG000|Phase I|Withdrawal by Subject|0|||
130391657|NCT01505608|469403783|FG001|Phase I|Withdrawal by Subject|1|||
130391658|NCT01505608|469403782|FG000|Phase II|Lack of Efficacy|2|||
130391659|NCT01505608|469403783|FG001|Phase II|Lack of Efficacy|1|||
130391660|NCT01505608|469403782|FG000|Phase II|Protocol Violation|0|||
130391661|NCT01505608|469403783|FG001|Phase II|Protocol Violation|1|||
130391662|NCT03975647|469403784|FG000|Overall Study|Death|71|||
130391663|NCT03975647|469403785|FG001|Overall Study|Death|63|||
130391664|NCT03975647|469403784|FG000|Overall Study|Lost to Follow-up|2|||
130391665|NCT03975647|469403785|FG001|Overall Study|Lost to Follow-up|2|||
130391666|NCT03975647|469403784|FG000|Overall Study|Subject withdrawal of consent|7|||
130722827|NCT01197755|470609747|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130391667|NCT03975647|469403785|FG001|Overall Study|Subject withdrawal of consent|11|||
130391668|NCT02404350|469403786|FG000|Overall Study|Adverse Event|2|||
130391669|NCT02404350|469403787|FG001|Overall Study|Adverse Event|2|||
130391670|NCT02404350|469403788|FG002|Overall Study|Adverse Event|3|||
130391671|NCT02404350|469403789|FG003|Overall Study|Adverse Event|9|||
130391672|NCT02404350|469403786|FG000|Overall Study|Lack of Efficacy|3|||
130391673|NCT02404350|469403787|FG001|Overall Study|Lack of Efficacy|1|||
130391674|NCT02404350|469403788|FG002|Overall Study|Lack of Efficacy|0|||
130391675|NCT02404350|469403789|FG003|Overall Study|Lack of Efficacy|3|||
130391676|NCT02404350|469403786|FG000|Overall Study|Lost to Follow-up|2|||
130391677|NCT02404350|469403787|FG001|Overall Study|Lost to Follow-up|0|||
130391678|NCT02404350|469403788|FG002|Overall Study|Lost to Follow-up|0|||
130391679|NCT02404350|469403789|FG003|Overall Study|Lost to Follow-up|1|||
130391680|NCT02404350|469403786|FG000|Overall Study|Physician Decision|1|||
130391681|NCT02404350|469403787|FG001|Overall Study|Physician Decision|0|||
130391682|NCT02404350|469403788|FG002|Overall Study|Physician Decision|0|||
130391683|NCT02404350|469403789|FG003|Overall Study|Physician Decision|2|||
130391684|NCT02404350|469403786|FG000|Overall Study|Pregnancy|0|||
130391685|NCT02404350|469403787|FG001|Overall Study|Pregnancy|0|||
130391686|NCT02404350|469403788|FG002|Overall Study|Pregnancy|0|||
130391687|NCT02404350|469403789|FG003|Overall Study|Pregnancy|1|||
130391688|NCT02404350|469403786|FG000|Overall Study|Withdrawal by Subject|7|||
130391689|NCT02404350|469403787|FG001|Overall Study|Withdrawal by Subject|3|||
130391690|NCT02404350|469403788|FG002|Overall Study|Withdrawal by Subject|3|||
130391691|NCT02404350|469403789|FG003|Overall Study|Withdrawal by Subject|19|||
130391692|NCT02404350|469403786|FG000|Overall Study|Due to Non-compliance with treatment|0|||
130391693|NCT02404350|469403787|FG001|Overall Study|Due to Non-compliance with treatment|0|||
130391694|NCT02404350|469403788|FG002|Overall Study|Due to Non-compliance with treatment|0|||
130391695|NCT02404350|469403789|FG003|Overall Study|Due to Non-compliance with treatment|1|||
130391696|NCT02404350|469403786|FG000|Overall Study|Due to Technical problems|0|||
130391697|NCT02404350|469403787|FG001|Overall Study|Due to Technical problems|0|||
130391698|NCT02404350|469403788|FG002|Overall Study|Due to Technical problems|0|||
130391699|NCT02404350|469403789|FG003|Overall Study|Due to Technical problems|1|||
130391700|NCT00600756|469403790|FG000|Analysis After 6 Months|Adverse Event|43|||
130391701|NCT00600756|469403791|FG001|Analysis After 6 Months|Adverse Event|33|||
130391702|NCT00600756|469403790|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
130391703|NCT00600756|469403791|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
130391704|NCT00600756|469403790|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
130391705|NCT00600756|469403791|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
130391706|NCT00600756|469403790|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
130391707|NCT00600756|469403791|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
130391708|NCT00600756|469403790|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
130391709|NCT00600756|469403791|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
130391710|NCT00600756|469403790|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
130391711|NCT00600756|469403791|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
130391712|NCT00600756|469403790|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
130391713|NCT00600756|469403791|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
130391714|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
130391715|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
130391716|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
130391717|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
130391718|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
130391719|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
130391720|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
130391721|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
130391722|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
130391723|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
130391724|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
130391725|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
130391726|NCT00600756|469403790|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
130391727|NCT00600756|469403791|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
130391728|NCT02319031|469403792|FG000|Treatment Period|Death|1|||
130391729|NCT02319031|469403793|FG001|Treatment Period|Death|0|||
130391730|NCT00439556|469403794|FG000|Overall Study|Patient was taken off study for non-comp|0|||
130391731|NCT00439556|469403795|FG001|Overall Study|Patient was taken off study for non-comp|1|||
130391732|NCT00439556|469403796|FG002|Overall Study|Patient was taken off study for non-comp|0|||
130391733|NCT02871739|469403797|FG000|Overall Study|Lost to Follow-up|3|||
130391734|NCT02871739|469403798|FG001|Overall Study|Lost to Follow-up|2|||
130391735|NCT02871739|469403799|FG002|Overall Study|Lost to Follow-up|0|||
130391736|NCT02871739|469403800|FG003|Overall Study|Lost to Follow-up|2|||
130391737|NCT01085097|469403803|FG000|Overall Study|Adverse Event|0|||
130391738|NCT01085097|469403804|FG001|Overall Study|Adverse Event|0|||
130391739|NCT01085097|469403805|FG002|Overall Study|Adverse Event|2|||
130391740|NCT01085097|469403803|FG000|Overall Study|Treatment failure|2|||
130391741|NCT01085097|469403804|FG001|Overall Study|Treatment failure|0|||
130391742|NCT01085097|469403805|FG002|Overall Study|Treatment failure|0|||
130391743|NCT01498640|469403808|FG000|Overall Study|Lost to Follow-up|1|||
130391744|NCT01498640|469403808|FG000|Overall Study|Death|1|||
130470163|NCT03769168|469688194|FG000|Overall Study|Adverse Event|0|||
130470164|NCT03769168|469688195|FG001|Overall Study|Adverse Event|1|||
130391745|NCT01498640|469403808|FG000|Overall Study|Other|3|||
130391746|NCT01524692|469403813|FG000|Overall Study|Withdrawal by Subject|3|||
130391747|NCT04007523|469403815|FG000|Overall Study|Withdrawal by Subject|0|||
130391748|NCT04007523|469403816|FG001|Overall Study|Withdrawal by Subject|1|||
130470165|NCT03769168|469688194|FG000|Overall Study|Lack of Efficacy|2|||
130470166|NCT03769168|469688195|FG001|Overall Study|Lack of Efficacy|4|||
130470167|NCT03769168|469688194|FG000|Overall Study|Post study access to treatment|3|||
130391749|NCT04007523|469403817|FG002|Overall Study|Withdrawal by Subject|1|||
130391750|NCT04007523|469403818|FG003|Overall Study|Withdrawal by Subject|0|||
130391751|NCT04007523|469403815|FG000|Overall Study|ICU Transfer|0|||
130391752|NCT04007523|469403816|FG001|Overall Study|ICU Transfer|1|||
130391753|NCT04007523|469403817|FG002|Overall Study|ICU Transfer|0|||
130391754|NCT04007523|469403818|FG003|Overall Study|ICU Transfer|0|||
130391755|NCT04007523|469403815|FG000|Overall Study|COVID hospital closure|0|||
130391756|NCT04007523|469403816|FG001|Overall Study|COVID hospital closure|0|||
130391757|NCT04007523|469403817|FG002|Overall Study|COVID hospital closure|1|||
130391758|NCT04007523|469403818|FG003|Overall Study|COVID hospital closure|2|||
130391759|NCT04007523|469403815|FG000|Overall Study|Surgery cancelled|0|||
130391760|NCT04007523|469403816|FG001|Overall Study|Surgery cancelled|0|||
130391761|NCT04007523|469403817|FG002|Overall Study|Surgery cancelled|1|||
130391762|NCT04007523|469403818|FG003|Overall Study|Surgery cancelled|1|||
130391763|NCT02197806|469403823|FG000|Overall Study|Adverse Event|0|||
130391764|NCT02197806|469403824|FG001|Overall Study|Adverse Event|1|||
130391765|NCT02197806|469403825|FG002|Overall Study|Adverse Event|0|||
130391766|NCT02197806|469403826|FG003|Overall Study|Adverse Event|1|||
130391767|NCT03065244|469403833|FG000|Overall Study|Lost to Follow-up|1|||
130391768|NCT03065244|469403834|FG001|Overall Study|Lost to Follow-up|1|||
130391769|NCT03065244|469403833|FG000|Overall Study|Diagnosed with a different disease|1|||
130391770|NCT03065244|469403834|FG001|Overall Study|Diagnosed with a different disease|1|||
130391771|NCT03065244|469403833|FG000|Overall Study|Protocol Violation|0|||
130391772|NCT03065244|469403834|FG001|Overall Study|Protocol Violation|1|||
130391773|NCT03065244|469403833|FG000|Overall Study|Withdrawal by Subject|1|||
130391774|NCT03065244|469403834|FG001|Overall Study|Withdrawal by Subject|1|||
130391775|NCT03717480|469403835|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
130391776|NCT01774786|469403838|FG000|Overall Study|Death|300|||
130391777|NCT01774786|469403839|FG001|Overall Study|Death|319|||
130391778|NCT01774786|469403838|FG000|Overall Study|Lost to Follow-up|6|||
130391779|NCT01774786|469403839|FG001|Overall Study|Lost to Follow-up|7|||
130391780|NCT01774786|469403838|FG000|Overall Study|Withdrawal by Subject|18|||
130391781|NCT01774786|469403839|FG001|Overall Study|Withdrawal by Subject|14|||
130391782|NCT01774786|469403838|FG000|Overall Study|Physician Decision|2|||
130391783|NCT01774786|469403839|FG001|Overall Study|Physician Decision|0|||
130391784|NCT01774786|469403838|FG000|Overall Study|Non-compliance|0|||
130391785|NCT01774786|469403839|FG001|Overall Study|Non-compliance|1|||
130391786|NCT01774786|469403838|FG000|Overall Study|Reason Not Specified|2|||
130391787|NCT01774786|469403839|FG001|Overall Study|Reason Not Specified|5|||
130391788|NCT02965703|469403844|FG000|Overall Study|Withdrawal by Subject|6|||
130391789|NCT02965703|469403845|FG001|Overall Study|Withdrawal by Subject|3|||
130391790|NCT02965703|469403846|FG002|Overall Study|Withdrawal by Subject|1|||
130391791|NCT02965703|469403844|FG000|Overall Study|Protocol Violation|1|||
130391792|NCT02965703|469403845|FG001|Overall Study|Protocol Violation|0|||
130391793|NCT02965703|469403846|FG002|Overall Study|Protocol Violation|0|||
130391794|NCT02965703|469403844|FG000|Overall Study|Adverse Event|1|||
130391795|NCT02965703|469403845|FG001|Overall Study|Adverse Event|1|||
130391796|NCT02965703|469403846|FG002|Overall Study|Adverse Event|0|||
130391797|NCT02965703|469403844|FG000|Overall Study|Lost to Follow-up|2|||
130391798|NCT02965703|469403845|FG001|Overall Study|Lost to Follow-up|1|||
130391799|NCT02965703|469403846|FG002|Overall Study|Lost to Follow-up|1|||
130391800|NCT00768144|469403847|FG000|Overall Study|Adverse Event|13|||
130391801|NCT00768144|469403847|FG000|Overall Study|Progressive Disease|21|||
130391802|NCT00768144|469403847|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
130391803|NCT00768144|469403847|FG000|Overall Study|Pt Withdrew Consent|1|||
130391804|NCT02268786|469403848|FG000|Overall Study|No Euploid Embryos available|42|||
130391805|NCT02268786|469403849|FG001|Overall Study|No Euploid Embryos available|0|||
130391806|NCT02268786|469403848|FG000|Overall Study|Withdrawal by Subject|7|||
130391807|NCT02268786|469403849|FG001|Overall Study|Withdrawal by Subject|14|||
130391808|NCT02268786|469403848|FG000|Overall Study|Thaw Failure|6|||
130391809|NCT02268786|469403849|FG001|Overall Study|Thaw Failure|4|||
130391810|NCT02268786|469403848|FG000|Overall Study|Protocol Violation|1|||
130391811|NCT02268786|469403849|FG001|Overall Study|Protocol Violation|0|||
130391812|NCT00744627|469403850|FG000|Overall Study|Adverse Event|6|||
130391813|NCT00744627|469403851|FG001|Overall Study|Adverse Event|9|||
130722828|NCT01197755|470609748|FG002|Overall Study|Study-specific discontinuation criteria|0|||
130391814|NCT00744627|469403850|FG000|Overall Study|Lack of Efficacy|7|||
130391815|NCT00744627|469403851|FG001|Overall Study|Lack of Efficacy|3|||
130391816|NCT00744627|469403850|FG000|Overall Study|Noncompliance|0|||
130391817|NCT00744627|469403851|FG001|Overall Study|Noncompliance|1|||
130391818|NCT00744627|469403850|FG000|Overall Study|Protocol Deviations|0|||
130391819|NCT00744627|469403851|FG001|Overall Study|Protocol Deviations|2|||
130391820|NCT00744627|469403850|FG000|Overall Study|Voluntary Withdrawal|9|||
130391821|NCT00744627|469403851|FG001|Overall Study|Voluntary Withdrawal|6|||
130391822|NCT00744627|469403850|FG000|Overall Study|Lost to Follow-up|2|||
130391823|NCT00744627|469403851|FG001|Overall Study|Lost to Follow-up|1|||
130391824|NCT00744627|469403850|FG000|Overall Study|Other|1|||
130391825|NCT00744627|469403851|FG001|Overall Study|Other|0|||
130470168|NCT03769168|469688195|FG001|Overall Study|Post study access to treatment|11|||
130470169|NCT03769168|469688194|FG000|Overall Study|Physician Decision|1|||
130470170|NCT03769168|469688195|FG001|Overall Study|Physician Decision|4|||
130470171|NCT03769168|469688194|FG000|Overall Study|Subject Decision|2|||
130470172|NCT03769168|469688195|FG001|Overall Study|Subject Decision|4|||
130470173|NCT03769168|469688194|FG000|Overall Study|Guardian decision|1|||
130470174|NCT03769168|469688195|FG001|Overall Study|Guardian decision|0|||
130391826|NCT04251221|469403852|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
130391827|NCT04251221|469403853|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
130391828|NCT03745144|469403854|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
130391829|NCT03745144|469403855|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
130391830|NCT03745144|469403856|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
130391831|NCT03745144|469403854|FG000|Period 1|Other|0|||
130391832|NCT03745144|469403855|FG001|Period 1|Other|0|||
130391833|NCT03745144|469403856|FG002|Period 1|Other|1|||
130391834|NCT04668950|469403857|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
130391835|NCT04668950|469403858|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
130391836|NCT04668950|469403857|FG000|Overall Study|Could not confirm started study medication|15|||
130391837|NCT04668950|469403858|FG001|Overall Study|Could not confirm started study medication|15|||
130391838|NCT04668950|469403857|FG000|Overall Study|Could not confirm baseline status|6|||
130391839|NCT04668950|469403858|FG001|Overall Study|Could not confirm baseline status|2|||
130391840|NCT04668950|469403857|FG000|Overall Study|Drop out and did not start medication|15|||
130391841|NCT04668950|469403858|FG001|Overall Study|Drop out and did not start medication|17|||
130391842|NCT04668950|469403857|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
130391843|NCT04668950|469403858|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
130391844|NCT04668950|469403857|FG000|Overall Study|Other|2|||
130391845|NCT04668950|469403858|FG001|Overall Study|Other|4|||
130391846|NCT04059146|469403864|FG000|Overall Study|Withdrawal by Subject|0|||
130391847|NCT04059146|469403865|FG001|Overall Study|Withdrawal by Subject|1|||
130391848|NCT00502697|469405145|FG000|Overall Study|Withdrawal by Subject|3|||
130391849|NCT00502697|469405146|FG001|Overall Study|Withdrawal by Subject|1|||
130391850|NCT00502697|469405145|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
130391851|NCT00502697|469405146|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
130391852|NCT00502697|469405145|FG000|Overall Study|found not to meet eligibility criteria|3|||
130391853|NCT00502697|469405146|FG001|Overall Study|found not to meet eligibility criteria|4|||
130391854|NCT00502697|469405145|FG000|Overall Study|did not meet assignment criteria|4|||
130391855|NCT00502697|469405146|FG001|Overall Study|did not meet assignment criteria|2|||
130391856|NCT01545817|469405148|FG000|Pazopanib|Disease progression|51|||
130391857|NCT01545817|469405149|FG001|Pazopanib|Disease progression|0|||
130391858|NCT01545817|469405148|FG000|Pazopanib|Adverse Event|19|||
130391859|NCT01545817|469405149|FG001|Pazopanib|Adverse Event|0|||
130391860|NCT01545817|469405148|FG000|Pazopanib|Other reason|4|||
130391861|NCT01545817|469405149|FG001|Pazopanib|Other reason|0|||
130391862|NCT01545817|469405148|FG000|Everolimus|Other reason|0|||
130391863|NCT01545817|469405149|FG001|Everolimus|Other reason|7|||
130391864|NCT01545817|469405148|FG000|Everolimus|Disease progression|0|||
130391865|NCT01545817|469405149|FG001|Everolimus|Disease progression|25|||
130391866|NCT01545817|469405148|FG000|Everolimus|Adverse Event|0|||
130391867|NCT01545817|469405149|FG001|Everolimus|Adverse Event|6|||
130391868|NCT00589108|469405155|FG000|Overall Study|Lost to Follow-up|1|||
130391869|NCT00589108|469405156|FG001|Overall Study|Lost to Follow-up|1|||
130391870|NCT00589108|469405157|FG002|Overall Study|Lost to Follow-up|1|||
130391871|NCT00589108|469405155|FG000|Overall Study|Death|3|||
130391872|NCT00589108|469405156|FG001|Overall Study|Death|3|||
130391873|NCT00589108|469405157|FG002|Overall Study|Death|4|||
130391874|NCT03256552|469405158|FG000|Overall Study|Protocol Violation|1|||
130391875|NCT03256552|469405158|FG000|Overall Study|Physician Decision|1|||
130391876|NCT03256552|469405158|FG000|Overall Study|Adverse Event|1|||
130391877|NCT03256552|469405158|FG000|Overall Study|Withdrawal by Subject|2|||
130391878|NCT03026257|469405163|FG000|Overall Study|Adverse Event|3|||
130391879|NCT03026257|469405164|FG001|Overall Study|Adverse Event|0|||
130391880|NCT03026257|469405165|FG002|Overall Study|Adverse Event|0|||
130391881|NCT03026257|469405166|FG003|Overall Study|Adverse Event|0|||
130391882|NCT03026257|469405167|FG004|Overall Study|Adverse Event|0|||
130391883|NCT03026257|469405168|FG005|Overall Study|Adverse Event|0|||
130391884|NCT03026257|469405163|FG000|Overall Study|Lost to Follow-up|1|||
130391885|NCT03026257|469405164|FG001|Overall Study|Lost to Follow-up|0|||
130722829|NCT01197755|470609746|FG000|Overall Study|Entered the long-term extension study|18|||
130391886|NCT03026257|469405165|FG002|Overall Study|Lost to Follow-up|0|||
130470175|NCT04941287|469688196|FG000|Overall Study|Rapid decline before starting treatment|3|||
130391887|NCT03026257|469405166|FG003|Overall Study|Lost to Follow-up|0|||
130391888|NCT03026257|469405167|FG004|Overall Study|Lost to Follow-up|0|||
130391889|NCT03026257|469405168|FG005|Overall Study|Lost to Follow-up|0|||
130391890|NCT03026257|469405163|FG000|Overall Study|Protocol Violation|1|||
130391891|NCT03026257|469405164|FG001|Overall Study|Protocol Violation|0|||
130391892|NCT03026257|469405165|FG002|Overall Study|Protocol Violation|0|||
130391893|NCT03026257|469405166|FG003|Overall Study|Protocol Violation|1|||
130391894|NCT03026257|469405167|FG004|Overall Study|Protocol Violation|1|||
130391895|NCT03026257|469405168|FG005|Overall Study|Protocol Violation|0|||
130391896|NCT03026257|469405163|FG000|Overall Study|Withdrawal by Subject|1|||
130391897|NCT03026257|469405164|FG001|Overall Study|Withdrawal by Subject|1|||
130391898|NCT03026257|469405165|FG002|Overall Study|Withdrawal by Subject|0|||
130391899|NCT03026257|469405166|FG003|Overall Study|Withdrawal by Subject|0|||
130391900|NCT03026257|469405167|FG004|Overall Study|Withdrawal by Subject|0|||
130391901|NCT03026257|469405168|FG005|Overall Study|Withdrawal by Subject|0|||
130391902|NCT04380857|469405169|FG000|Overall Study|Lost to Follow-up|3|||
130391903|NCT04380857|469405170|FG001|Overall Study|Lost to Follow-up|3|||
130391904|NCT00838201|469405171|FG000|Overall Study|Investigator decision, or other reasons|2|||
130391905|NCT00838201|469405172|FG001|Overall Study|Investigator decision, or other reasons|3|||
130391906|NCT00838201|469405171|FG000|Overall Study|Noncompliance|0|||
130391907|NCT00838201|469405172|FG001|Overall Study|Noncompliance|1|||
130391908|NCT00838201|469405171|FG000|Overall Study|Administrative decision|1|||
130391909|NCT00838201|469405172|FG001|Overall Study|Administrative decision|2|||
130391910|NCT00838201|469405171|FG000|Overall Study|Disease progression|3|||
130391911|NCT00838201|469405172|FG001|Overall Study|Disease progression|3|||
130391912|NCT00838201|469405171|FG000|Overall Study|Consent withdrawn|16|||
130391913|NCT00838201|469405172|FG001|Overall Study|Consent withdrawn|19|||
130391914|NCT00838201|469405171|FG000|Overall Study|Lost to Follow-up|4|||
130391915|NCT00838201|469405172|FG001|Overall Study|Lost to Follow-up|3|||
130391916|NCT00838201|469405171|FG000|Overall Study|Adverse Event|5|||
130391917|NCT00838201|469405172|FG001|Overall Study|Adverse Event|9|||
130391918|NCT00838201|469405171|FG000|Overall Study|Death|11|||
130391919|NCT00838201|469405172|FG001|Overall Study|Death|13|||
130391920|NCT02558790|469405173|FG000|Overall Study|Lost to Follow-up|2|||
130391921|NCT02558790|469405173|FG000|Overall Study|Physician Decision|1|||
130391922|NCT02558790|469405173|FG000|Overall Study|Withdrawal by Subject|1|||
130391923|NCT02558790|469405173|FG000|Overall Study|Screen Fail|3|||
130391924|NCT05228470|469405176|FG000|Overall Study|Death|6|||
130391925|NCT05228470|469405177|FG001|Overall Study|Death|11|||
130391926|NCT05228470|469405176|FG000|Overall Study|Withdrawal by Subject|1|||
130391927|NCT05228470|469405177|FG001|Overall Study|Withdrawal by Subject|8|||
130391928|NCT05228470|469405176|FG000|Overall Study|Ongoing|1|||
130391929|NCT05228470|469405177|FG001|Overall Study|Ongoing|11|||
130391930|NCT05620576|469405178|FG000|Overall Study|Adverse Event|1|||
130391931|NCT05620576|469405179|FG001|Overall Study|Adverse Event|1|||
130391932|NCT05620576|469405178|FG000|Overall Study|Lost to Follow-up|3|||
130391933|NCT05620576|469405179|FG001|Overall Study|Lost to Follow-up|1|||
130391934|NCT05620576|469405178|FG000|Overall Study|Physician Decision|0|||
130391935|NCT05620576|469405179|FG001|Overall Study|Physician Decision|1|||
130391936|NCT05620576|469405178|FG000|Overall Study|Protocol Deviation|1|||
130391937|NCT05620576|469405179|FG001|Overall Study|Protocol Deviation|1|||
130391938|NCT05620576|469405178|FG000|Overall Study|Withdrawal by Subject|2|||
130391939|NCT05620576|469405179|FG001|Overall Study|Withdrawal by Subject|3|||
130391940|NCT02622828|469405180|FG000|Overall Study|participant withdrew|3|||
130391941|NCT02780804|469405183|FG000|Overall Study|Death|1|||
130391942|NCT02780804|469405184|FG001|Overall Study|Death|0|||
130391943|NCT02780804|469405185|FG002|Overall Study|Death|0|||
130391944|NCT02780804|469405183|FG000|Overall Study|Lack of Efficacy|5|||
130391945|NCT02780804|469405184|FG001|Overall Study|Lack of Efficacy|8|||
130391946|NCT02780804|469405185|FG002|Overall Study|Lack of Efficacy|4|||
130391947|NCT02780804|469405183|FG000|Overall Study|Physician Decision|0|||
130391948|NCT02780804|469405184|FG001|Overall Study|Physician Decision|0|||
130391949|NCT02780804|469405185|FG002|Overall Study|Physician Decision|2|||
130391950|NCT02780804|469405183|FG000|Overall Study|Withdrawal by Subject|0|||
130391951|NCT02780804|469405184|FG001|Overall Study|Withdrawal by Subject|1|||
130391952|NCT02780804|469405185|FG002|Overall Study|Withdrawal by Subject|0|||
130391953|NCT01921829|469405188|FG000|Overall Study|Withdrawal by Subject|0|||
130391954|NCT01921829|469405189|FG001|Overall Study|Withdrawal by Subject|1|||
130391955|NCT04476030|469405190|FG000|Overall Study|Withdrawal by Subject|20|||
130391956|NCT04476030|469405191|FG001|Overall Study|Withdrawal by Subject|16|||
130391957|NCT04476030|469405190|FG000|Overall Study|Adverse Event|10|||
130391958|NCT04476030|469405191|FG001|Overall Study|Adverse Event|11|||
130391959|NCT04476030|469405190|FG000|Overall Study|Lost to Follow-up|7|||
130391960|NCT04476030|469405191|FG001|Overall Study|Lost to Follow-up|4|||
130391961|NCT04476030|469405190|FG000|Overall Study|Physician Decision|1|||
130391962|NCT04476030|469405191|FG001|Overall Study|Physician Decision|1|||
130391963|NCT04476030|469405190|FG000|Overall Study|Protocol Deviation|2|||
130391964|NCT04476030|469405191|FG001|Overall Study|Protocol Deviation|0|||
130391965|NCT04476030|469405190|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
130391966|NCT04476030|469405191|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
130391967|NCT04476030|469405190|FG000|Overall Study|Randomized but not Dosed|2|||
130391968|NCT04476030|469405191|FG001|Overall Study|Randomized but not Dosed|8|||
130391969|NCT02256891|469405198|FG000|Overall Study|Death|0|||
130391970|NCT02256891|469405199|FG001|Overall Study|Death|2|||
130391971|NCT02256891|469405198|FG000|Overall Study|Lost to Follow-up|0|||
130391972|NCT02256891|469405199|FG001|Overall Study|Lost to Follow-up|3|||
130391973|NCT02256891|469405198|FG000|Overall Study|Physician Decision|7|||
130391974|NCT02256891|469405199|FG001|Overall Study|Physician Decision|3|||
130391975|NCT02256891|469405198|FG000|Overall Study|Screen Fail|5|||
130391976|NCT02256891|469405199|FG001|Overall Study|Screen Fail|4|||
130391977|NCT02256891|469405198|FG000|Overall Study|Equipment Malfunction|0|||
130391978|NCT02256891|469405199|FG001|Overall Study|Equipment Malfunction|1|||
130391979|NCT01344447|469405200|FG000|Overall Study|Adverse Event|1|||
130391980|NCT01344447|469405200|FG000|Overall Study|Protocol Violation|1|||
130391981|NCT01344447|469405200|FG000|Overall Study|Withdrawal by Subject|1|||
130391982|NCT01344447|469405200|FG000|Overall Study|The contrast was not seen|1|||
130391983|NCT01344447|469405200|FG000|Overall Study|Physician Decision|1|||
130391984|NCT01344447|469405200|FG000|Overall Study|MRA unsuccessful|1|||
130391985|NCT01344447|469405200|FG000|Overall Study|Bolus tracking failed|1|||
130391986|NCT01344447|469405200|FG000|Overall Study|Error of power injector|1|||
130391987|NCT02286193|469405211|FG000|Overall Study|Referred: CRS unable to make contact|62|||
130391988|NCT02286193|469405211|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
130391989|NCT02286193|469405211|FG000|Overall Study|Referred: Declined service|38|||
130391990|NCT02932904|469405212|FG000|Overall Study|Reason not Specified|1|||
130391991|NCT02932904|469405213|FG001|Overall Study|Reason not Specified|0|||
130391992|NCT02932904|469405214|FG002|Overall Study|Reason not Specified|2|||
130391993|NCT02932904|469405215|FG003|Overall Study|Reason not Specified|2|||
130391994|NCT02932904|469405212|FG000|Overall Study|Noncompliance with Study Drug|2|||
130391995|NCT02932904|469405213|FG001|Overall Study|Noncompliance with Study Drug|3|||
130470176|NCT04941287|469688197|FG001|Overall Study|Rapid decline before starting treatment|1|||
130470177|NCT04527146|469688202|FG000|Overall Study|Withdrawal by Subject|12|||
130470178|NCT04527146|469688203|FG001|Overall Study|Withdrawal by Subject|15|||
130470179|NCT04527146|469688204|FG002|Overall Study|Withdrawal by Subject|7|||
130470180|NCT04527146|469688205|FG003|Overall Study|Withdrawal by Subject|16|||
130470181|NCT04527146|469688202|FG000|Overall Study|Lost to Follow-up|13|||
130470182|NCT04527146|469688203|FG001|Overall Study|Lost to Follow-up|9|||
130470183|NCT04527146|469688204|FG002|Overall Study|Lost to Follow-up|16|||
130470184|NCT04527146|469688205|FG003|Overall Study|Lost to Follow-up|13|||
130470185|NCT04527146|469688202|FG000|Overall Study|Death|0|||
130470186|NCT04527146|469688203|FG001|Overall Study|Death|1|||
130470187|NCT04527146|469688204|FG002|Overall Study|Death|1|||
130470188|NCT04527146|469688205|FG003|Overall Study|Death|0|||
130470189|NCT04527146|469688202|FG000|Overall Study|Adverse Event|0|||
130470190|NCT04527146|469688203|FG001|Overall Study|Adverse Event|0|||
130470191|NCT04527146|469688204|FG002|Overall Study|Adverse Event|1|||
130470192|NCT04527146|469688205|FG003|Overall Study|Adverse Event|0|||
130470193|NCT04527146|469688202|FG000|Overall Study|Ineligible after randomization|2|||
130470194|NCT04527146|469688203|FG001|Overall Study|Ineligible after randomization|0|||
130470195|NCT04527146|469688204|FG002|Overall Study|Ineligible after randomization|2|||
130470196|NCT04527146|469688205|FG003|Overall Study|Ineligible after randomization|2|||
130470197|NCT04527146|469688202|FG000|Overall Study|Moved to a different group|6|||
130470198|NCT04527146|469688203|FG001|Overall Study|Moved to a different group|3|||
130470199|NCT04527146|469688204|FG002|Overall Study|Moved to a different group|0|||
130470200|NCT04527146|469688205|FG003|Overall Study|Moved to a different group|2|||
130470201|NCT05107401|469688206|FG000|Overall Study|Lost to Follow-up|13|||
130470202|NCT05107401|469688207|FG001|Overall Study|Lost to Follow-up|12|||
130470203|NCT05687903|469688214|FG000|Overall Study|Protocol Deviation|1|||
130470204|NCT05687903|469688215|FG001|Overall Study|Protocol Deviation|1|||
130470205|NCT05687903|469688216|FG002|Overall Study|Protocol Deviation|0|||
130470206|NCT05687903|469688217|FG003|Overall Study|Protocol Deviation|1|||
130470207|NCT05687903|469688218|FG004|Overall Study|Protocol Deviation|0|||
130470208|NCT04468776|469688219|FG000|Overall Study|Lost to Follow-up|4|||
130470209|NCT04468776|469688220|FG001|Overall Study|Lost to Follow-up|3|||
130470210|NCT04468776|469688221|FG002|Overall Study|Lost to Follow-up|4|||
130470211|NCT04468776|469688219|FG000|Overall Study|Withdrawal by Subject|1|||
130470212|NCT04468776|469688220|FG001|Overall Study|Withdrawal by Subject|10|||
130470213|NCT04468776|469688221|FG002|Overall Study|Withdrawal by Subject|4|||
130470214|NCT04468776|469688219|FG000|Overall Study|Physician Decision|0|||
130470215|NCT04468776|469688220|FG001|Overall Study|Physician Decision|1|||
130470216|NCT04468776|469688221|FG002|Overall Study|Physician Decision|1|||
130470217|NCT05613205|469688222|FG000|Overall Study|Lost to Follow-up|0|||
130470218|NCT05613205|469688223|FG001|Overall Study|Lost to Follow-up|0|||
130470219|NCT05613205|469688224|FG002|Overall Study|Lost to Follow-up|1|||
130470220|NCT05613205|469688225|FG003|Overall Study|Lost to Follow-up|1|||
130470221|NCT05613205|469688226|FG004|Overall Study|Lost to Follow-up|0|||
130470222|NCT05613205|469688222|FG000|Overall Study|Withdrawal by Subject|0|||
130470223|NCT05613205|469688223|FG001|Overall Study|Withdrawal by Subject|0|||
130391996|NCT02932904|469405214|FG002|Overall Study|Noncompliance with Study Drug|3|||
130470224|NCT05613205|469688224|FG002|Overall Study|Withdrawal by Subject|1|||
130470225|NCT05613205|469688225|FG003|Overall Study|Withdrawal by Subject|1|||
130391997|NCT02932904|469405215|FG003|Overall Study|Noncompliance with Study Drug|4|||
130391998|NCT02932904|469405212|FG000|Overall Study|Pregnancy|0|||
130391999|NCT02932904|469405213|FG001|Overall Study|Pregnancy|1|||
130392000|NCT02932904|469405214|FG002|Overall Study|Pregnancy|1|||
130392001|NCT02932904|469405215|FG003|Overall Study|Pregnancy|0|||
130392002|NCT02932904|469405212|FG000|Overall Study|Study Termination|0|||
130392003|NCT02932904|469405213|FG001|Overall Study|Study Termination|1|||
130392004|NCT02932904|469405214|FG002|Overall Study|Study Termination|0|||
130392005|NCT02932904|469405215|FG003|Overall Study|Study Termination|0|||
130392006|NCT02932904|469405212|FG000|Overall Study|Voluntary Withdrawal|2|||
130392007|NCT02932904|469405213|FG001|Overall Study|Voluntary Withdrawal|1|||
130392008|NCT02932904|469405214|FG002|Overall Study|Voluntary Withdrawal|4|||
130392009|NCT02932904|469405215|FG003|Overall Study|Voluntary Withdrawal|2|||
130392010|NCT02932904|469405212|FG000|Overall Study|Lost to Follow-up|5|||
130392011|NCT02932904|469405213|FG001|Overall Study|Lost to Follow-up|3|||
130392012|NCT02932904|469405214|FG002|Overall Study|Lost to Follow-up|6|||
130392013|NCT02932904|469405215|FG003|Overall Study|Lost to Follow-up|0|||
130392014|NCT02932904|469405212|FG000|Overall Study|Significant Protocol Deviation|2|||
130392015|NCT02932904|469405213|FG001|Overall Study|Significant Protocol Deviation|3|||
130392016|NCT02932904|469405214|FG002|Overall Study|Significant Protocol Deviation|6|||
130392017|NCT02932904|469405215|FG003|Overall Study|Significant Protocol Deviation|1|||
130392018|NCT02932904|469405212|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130392019|NCT02932904|469405213|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
130392020|NCT02932904|469405214|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130392021|NCT02932904|469405215|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
130392022|NCT02932904|469405212|FG000|Overall Study|Randomized But Not Treated|1|||
130392023|NCT02932904|469405213|FG001|Overall Study|Randomized But Not Treated|1|||
130392024|NCT02932904|469405214|FG002|Overall Study|Randomized But Not Treated|0|||
130392025|NCT02932904|469405215|FG003|Overall Study|Randomized But Not Treated|2|||
130392026|NCT00337103|469405216|FG000|Overall Study|Progressive Disease|414|||
130392027|NCT00337103|469405217|FG001|Overall Study|Progressive Disease|410|||
130392028|NCT00337103|469405216|FG000|Overall Study|Adverse Event|45|||
130392029|NCT00337103|469405217|FG001|Overall Study|Adverse Event|59|||
130392030|NCT00337103|469405216|FG000|Overall Study|Subject Choice|34|||
130392031|NCT00337103|469405217|FG001|Overall Study|Subject Choice|27|||
130392032|NCT00337103|469405216|FG000|Overall Study|Clinical Progression|27|||
130392033|NCT00337103|469405217|FG001|Overall Study|Clinical Progression|24|||
130392034|NCT00337103|469405216|FG000|Overall Study|Physician Decision|15|||
130392035|NCT00337103|469405217|FG001|Overall Study|Physician Decision|14|||
130392036|NCT00337103|469405216|FG000|Overall Study|Withdrawal by Subject|8|||
130392037|NCT00337103|469405217|FG001|Overall Study|Withdrawal by Subject|5|||
130392038|NCT00337103|469405216|FG000|Overall Study|Other|5|||
130470226|NCT05613205|469688226|FG004|Overall Study|Withdrawal by Subject|0|||
130470227|NCT04440176|469688229|FG000|Overall Study|Withdrawal by Subject|5|||
130470228|NCT04440176|469688230|FG001|Overall Study|Withdrawal by Subject|3|||
130470229|NCT04440176|469688229|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130470230|NCT04440176|469688230|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130470231|NCT04440176|469688229|FG000|Overall Study|Adverse Event|2|||
130470232|NCT04440176|469688230|FG001|Overall Study|Adverse Event|6|||
130470233|NCT04440176|469688229|FG000|Overall Study|Lost to Follow-up|22|||
130470234|NCT04440176|469688230|FG001|Overall Study|Lost to Follow-up|23|||
130470235|NCT04440176|469688229|FG000|Overall Study|Medication error without associated adverse event|0|||
130470236|NCT04440176|469688230|FG001|Overall Study|Medication error without associated adverse event|1|||
130470237|NCT04440176|469688229|FG000|Overall Study|No longer met eligibility criteria|7|||
130470238|NCT04440176|469688230|FG001|Overall Study|No longer met eligibility criteria|1|||
130470239|NCT04440176|469688229|FG000|Overall Study|Other|1|||
130470240|NCT04440176|469688230|FG001|Overall Study|Other|2|||
130470241|NCT04440176|469688229|FG000|Overall Study|Protocol deviation|6|||
130470242|NCT04440176|469688230|FG001|Overall Study|Protocol deviation|8|||
130470243|NCT04440176|469688229|FG000|Overall Study|Randomized but not vaccinated|6|||
130470244|NCT04440176|469688230|FG001|Overall Study|Randomized but not vaccinated|3|||
130470245|NCT04608045|469688237|FG000|Overall Study|Physician Decision|1|||
130470246|NCT03103321|469688239|FG000|Overall Study|Protocol Violation|1|||
130470247|NCT03103321|469688240|FG001|Overall Study|Protocol Violation|1|||
130392039|NCT00337103|469405217|FG001|Overall Study|Other|6|||
130392040|NCT00337103|469405216|FG000|Overall Study|Entry Criteria Not Met|4|||
130392041|NCT00337103|469405217|FG001|Overall Study|Entry Criteria Not Met|1|||
130392042|NCT00337103|469405216|FG000|Overall Study|Lost to Follow-up|1|||
130392043|NCT00337103|469405217|FG001|Overall Study|Lost to Follow-up|2|||
130392044|NCT00337103|469405216|FG000|Overall Study|Death|1|||
130392045|NCT00337103|469405217|FG001|Overall Study|Death|0|||
130392046|NCT01577758|469405218|FG000|Dose Escalation Phase|Adverse Event|0|||
130392047|NCT01577758|469405219|FG001|Dose Escalation Phase|Adverse Event|0|||
130392048|NCT01577758|469405220|FG002|Dose Escalation Phase|Adverse Event|0|||
130392049|NCT01577758|469405221|FG003|Dose Escalation Phase|Adverse Event|0|||
130392050|NCT01577758|469405222|FG004|Dose Escalation Phase|Adverse Event|0|||
130722830|NCT01197755|470609747|FG001|Overall Study|Entered the long-term extension study|21|||
130392051|NCT01577758|469405223|FG005|Dose Escalation Phase|Adverse Event|2|||
130392052|NCT01577758|469405224|FG006|Dose Escalation Phase|Adverse Event|1|||
130392053|NCT01577758|469405225|FG007|Dose Escalation Phase|Adverse Event|0|||
130392054|NCT01577758|469405218|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
130392055|NCT01577758|469405219|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
130392056|NCT01577758|469405220|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
130392057|NCT01577758|469405221|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
130392058|NCT01577758|469405222|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
130392059|NCT01577758|469405223|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
130392060|NCT01577758|469405224|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
130392061|NCT01577758|469405225|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
130392062|NCT01577758|469405218|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130392063|NCT01577758|469405219|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130392064|NCT01577758|469405220|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130392065|NCT01577758|469405221|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130392066|NCT01577758|469405222|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130392067|NCT01577758|469405223|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
130392068|NCT01577758|469405224|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
130392069|NCT01577758|469405225|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
130392070|NCT01577758|469405218|FG000|Dose Escalation Phase|Progression Disease|2|||
130392071|NCT01577758|469405219|FG001|Dose Escalation Phase|Progression Disease|2|||
130392072|NCT01577758|469405220|FG002|Dose Escalation Phase|Progression Disease|1|||
130392073|NCT01577758|469405221|FG003|Dose Escalation Phase|Progression Disease|2|||
130392074|NCT01577758|469405222|FG004|Dose Escalation Phase|Progression Disease|5|||
130392075|NCT01577758|469405223|FG005|Dose Escalation Phase|Progression Disease|0|||
130392076|NCT01577758|469405224|FG006|Dose Escalation Phase|Progression Disease|0|||
130392077|NCT01577758|469405225|FG007|Dose Escalation Phase|Progression Disease|0|||
130392078|NCT01577758|469405218|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392079|NCT01577758|469405219|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392080|NCT01577758|469405220|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392081|NCT01577758|469405221|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392082|NCT01577758|469405222|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392083|NCT01577758|469405223|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392084|NCT01577758|469405224|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130392085|NCT01577758|469405225|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
130392086|NCT01577758|469405218|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392087|NCT01577758|469405219|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392088|NCT01577758|469405220|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392089|NCT01577758|469405221|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392090|NCT01577758|469405222|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392091|NCT01577758|469405223|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392092|NCT01577758|469405224|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
130392093|NCT01577758|469405225|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
130392094|NCT01577758|469405218|FG000|mCRC Expansion Phase|Progression Disease|0|||
130392095|NCT01577758|469405219|FG001|mCRC Expansion Phase|Progression Disease|0|||
130392096|NCT01577758|469405220|FG002|mCRC Expansion Phase|Progression Disease|0|||
130392097|NCT01577758|469405221|FG003|mCRC Expansion Phase|Progression Disease|0|||
130392098|NCT01577758|469405222|FG004|mCRC Expansion Phase|Progression Disease|0|||
130392099|NCT01577758|469405223|FG005|mCRC Expansion Phase|Progression Disease|0|||
130392100|NCT01577758|469405224|FG006|mCRC Expansion Phase|Progression Disease|0|||
130392101|NCT01577758|469405225|FG007|mCRC Expansion Phase|Progression Disease|19|||
130392102|NCT01256593|469405231|FG000|Overall Study|Protocol Violation|26|||
130392103|NCT01256593|469405231|FG000|Overall Study|No Drug Administration Information|2|||
130392104|NCT01256593|469405231|FG000|Overall Study|No Visit After Treatment|186|||
130392105|NCT04414553|469405232|FG000|Overall Study|Lost to Follow-up|20|||
130392106|NCT03969992|469405236|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
130392107|NCT03969992|469405237|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
130392108|NCT03969992|469405238|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
130392109|NCT03969992|469405236|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
130392110|NCT03969992|469405237|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
130470248|NCT03103321|469688241|FG002|Overall Study|Protocol Violation|1|||
130392111|NCT03969992|469405238|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
130392112|NCT03969992|469405236|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
130392113|NCT03969992|469405237|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
130392114|NCT03969992|469405238|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
130392115|NCT03969992|469405236|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
130392116|NCT03969992|469405237|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
130392117|NCT03969992|469405238|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
130470249|NCT03103321|469688242|FG003|Overall Study|Protocol Violation|0|||
130470250|NCT04247542|469688243|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
130722831|NCT01197755|470609748|FG002|Overall Study|Entered the long-term extension study|35|||
130722832|NCT01197755|470609746|FG000|Overall Study|Lack of therapeutic response|0|||
130722833|NCT01197755|470609747|FG001|Overall Study|Lack of therapeutic response|7|||
130722834|NCT01197755|470609748|FG002|Overall Study|Lack of therapeutic response|4|||
130722835|NCT01197755|470609746|FG000|Overall Study|Severe non-compliance to the protocol|2|||
130722836|NCT01197755|470609747|FG001|Overall Study|Severe non-compliance to the protocol|1|||
130722837|NCT01197755|470609748|FG002|Overall Study|Severe non-compliance to the protocol|2|||
130722838|NCT01197755|470609746|FG000|Overall Study|Withdrawal by Subject|1|||
130722839|NCT01197755|470609747|FG001|Overall Study|Withdrawal by Subject|0|||
130392118|NCT03969992|469405236|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
130392119|NCT03969992|469405237|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
130392120|NCT03969992|469405238|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
130392121|NCT03519971|469405255|FG000|Overall Study|Death|142|||
130392122|NCT03519971|469405256|FG001|Overall Study|Death|69|||
130392123|NCT03519971|469405255|FG000|Overall Study|Lost to Follow-up|0|||
130392124|NCT03519971|469405256|FG001|Overall Study|Lost to Follow-up|1|||
130392125|NCT03519971|469405255|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
130392126|NCT03519971|469405256|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
130392127|NCT03519971|469405255|FG000|Overall Study|Withdrawal by Subject|3|||
130392128|NCT03519971|469405256|FG001|Overall Study|Withdrawal by Subject|2|||
130392129|NCT03519971|469405255|FG000|Overall Study|Other|1|||
130392130|NCT03519971|469405256|FG001|Overall Study|Other|0|||
130392131|NCT04544293|469405262|FG000|Double-blind|Adverse Event|2|||
130392132|NCT04544293|469405263|FG001|Double-blind|Adverse Event|1|||
130392133|NCT04544293|469405262|FG000|Double-blind|Pregnancy|0|||
130392134|NCT04544293|469405263|FG001|Double-blind|Pregnancy|1|||
130392135|NCT04544293|469405262|FG000|Double-blind|Lost to Follow-up|0|||
130392136|NCT04544293|469405263|FG001|Double-blind|Lost to Follow-up|1|||
130392137|NCT04544293|469405262|FG000|Open-Label Extension|Study ongoing|79|||
130392138|NCT04544293|469405263|FG001|Open-Label Extension|Study ongoing|81|||
130392139|NCT00642668|469405269|FG000|Overall Study|Lost to Follow-up|1|||
130392140|NCT00642668|469405269|FG000|Overall Study|Adverse Event|2|||
130392141|NCT00642668|469405269|FG000|Overall Study|Death|2|||
130392142|NCT00642668|469405269|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130392143|NCT00642668|469405269|FG000|Overall Study|Failure to Return|1|||
130392144|NCT00642668|469405269|FG000|Overall Study|Dialysis Initiation|5|||
130392145|NCT00642668|469405269|FG000|Overall Study|Blood Transfusion|2|||
130392146|NCT03608774|469405270|FG000|Overall Study|Lost to Follow-up|5|||
130392147|NCT03608774|469405271|FG001|Overall Study|Lost to Follow-up|5|||
130392148|NCT03608774|469405270|FG000|Overall Study|Withdrawal by Subject|1|||
130392149|NCT03608774|469405271|FG001|Overall Study|Withdrawal by Subject|0|||
130392150|NCT03608774|469405270|FG000|Overall Study|Protocol Violation|1|||
130392151|NCT03608774|469405271|FG001|Overall Study|Protocol Violation|0|||
130392152|NCT03608774|469405270|FG000|Overall Study|Not eligible at enrollment|0|||
130392153|NCT03608774|469405271|FG001|Overall Study|Not eligible at enrollment|1|||
130392154|NCT03608774|469405270|FG000|Overall Study|Health related event|0|||
130392155|NCT03608774|469405271|FG001|Overall Study|Health related event|1|||
130392156|NCT01177540|469405272|FG000|Overall Study|Adverse Event|1|||
130392157|NCT01177540|469405273|FG001|Overall Study|Adverse Event|0|||
130392158|NCT02910167|469405274|FG000|Overall Study|Adverse Event|1|||
130392159|NCT02910167|469405274|FG000|Overall Study|Lost to Follow-up|18|||
130392160|NCT03913091|469405275|FG000|Overall Study|Lost to Follow-up|18|||
130392161|NCT03913091|469405276|FG001|Overall Study|Lost to Follow-up|11|||
130392162|NCT03913091|469405275|FG000|Overall Study|Required additional meds/surgery|1|||
130392163|NCT03913091|469405276|FG001|Overall Study|Required additional meds/surgery|2|||
130392164|NCT03913091|469405275|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
130392165|NCT03913091|469405276|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
130392166|NCT04477304|469405277|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
130392167|NCT04477304|469405278|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
130392168|NCT05083442|469407065|FG000|Overall Study|Lost to Follow-up|1|||
130392169|NCT05083442|469407066|FG001|Overall Study|Lost to Follow-up|0|||
130392170|NCT05083442|469407065|FG000|Overall Study|Lack of Efficacy|0|||
130392171|NCT05083442|469407066|FG001|Overall Study|Lack of Efficacy|1|||
130392172|NCT05083442|469407065|FG000|Overall Study|Withdrawal by Subject|1|||
130392173|NCT05083442|469407066|FG001|Overall Study|Withdrawal by Subject|3|||
130392174|NCT05083442|469407065|FG000|Overall Study|scheduling difficulties|1|||
130722840|NCT01197755|470609748|FG002|Overall Study|Withdrawal by Subject|0|||
130722841|NCT01197755|470609746|FG000|Overall Study|Lost to Follow-up|0|||
130392175|NCT05083442|469407066|FG001|Overall Study|scheduling difficulties|2|||
130392176|NCT03387813|469407074|FG000|Overall Study|Death|40|||
130392177|NCT03387813|469407075|FG001|Overall Study|Death|37|||
130392178|NCT03387813|469407076|FG002|Overall Study|Death|190|||
130392179|NCT03387813|469407074|FG000|Overall Study|Withdrawal by Subject|9|||
130392180|NCT03387813|469407075|FG001|Overall Study|Withdrawal by Subject|19|||
130392181|NCT03387813|469407076|FG002|Overall Study|Withdrawal by Subject|32|||
130392182|NCT03387813|469407074|FG000|Overall Study|Lost to Follow-up|3|||
130392183|NCT03387813|469407075|FG001|Overall Study|Lost to Follow-up|9|||
130392184|NCT03387813|469407076|FG002|Overall Study|Lost to Follow-up|15|||
130392185|NCT03387813|469407074|FG000|Overall Study|Non-Compliance|6|||
130392186|NCT03387813|469407075|FG001|Overall Study|Non-Compliance|6|||
130392187|NCT03387813|469407076|FG002|Overall Study|Non-Compliance|31|||
130392188|NCT03387813|469407074|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
130392189|NCT03387813|469407075|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
130392190|NCT03387813|469407076|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
130392191|NCT04327999|469407077|FG000|Overall Study|Protocol Violation|1|||
130392192|NCT01293240|469407078|FG000|Overall Study|Noncompliance|2|||
130392193|NCT03792672|469407080|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
130392194|NCT03792672|469407081|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130392195|NCT03792672|469407082|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130392196|NCT03792672|469407083|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
130392197|NCT03792672|469407084|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130392198|NCT03792672|469407085|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130392199|NCT03792672|469407080|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
130392200|NCT03792672|469407081|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
130392201|NCT03792672|469407082|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
130392202|NCT03792672|469407083|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
130392203|NCT03792672|469407084|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
130392204|NCT03792672|469407085|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
130392205|NCT03792672|469407080|FG000|Treatment Period 4 (2 Days)|Other|1|||
130392206|NCT03792672|469407081|FG001|Treatment Period 4 (2 Days)|Other|0|||
130392207|NCT03792672|469407082|FG002|Treatment Period 4 (2 Days)|Other|0|||
130392208|NCT03792672|469407083|FG003|Treatment Period 4 (2 Days)|Other|0|||
130470251|NCT04247542|469688244|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
130470252|NCT04247542|469688245|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
130470253|NCT04247542|469688243|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
130470254|NCT04247542|469688244|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
130470255|NCT04247542|469688245|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
130470256|NCT04118452|469688246|FG000|Overall Study|Lost to Follow-up|5|||
130470257|NCT04118452|469688247|FG001|Overall Study|Lost to Follow-up|5|||
130470258|NCT04118452|469688246|FG000|Overall Study|Withdrawal by Subject|17|||
130470259|NCT04118452|469688247|FG001|Overall Study|Withdrawal by Subject|17|||
130470260|NCT04847999|469688248|FG000|Overall Study|Lost to Follow-up|0|||
130470261|NCT04847999|469688249|FG001|Overall Study|Lost to Follow-up|1|||
130470262|NCT02879448|469688250|FG000|Overall Study|Death|251|||
130470263|NCT02879448|469688251|FG001|Overall Study|Death|263|||
130470264|NCT02879448|469688250|FG000|Overall Study|Lost to Follow-up|23|||
130470265|NCT02879448|469688251|FG001|Overall Study|Lost to Follow-up|28|||
130722842|NCT01197755|470609747|FG001|Overall Study|Lost to Follow-up|0|||
130722843|NCT01197755|470609748|FG002|Overall Study|Lost to Follow-up|1|||
130722844|NCT01197755|470609746|FG000|Overall Study|eg, change in circumstances|7|||
130392209|NCT03792672|469407084|FG004|Treatment Period 4 (2 Days)|Other|0|||
130392210|NCT03792672|469407085|FG005|Treatment Period 4 (2 Days)|Other|0|||
130392211|NCT00006478|469407087|FG000|Overall Study|Vaccine could not be produced|1|||
130392212|NCT00006478|469407087|FG000|Overall Study|Physician Decision|6|||
130392213|NCT03161483|469407091|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130392214|NCT03161483|469407092|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
130392215|NCT03161483|469407093|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130392216|NCT03161483|469407094|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130470266|NCT02879448|469688250|FG000|Overall Study|Withdrawal by Subject|42|||
130470267|NCT02879448|469688251|FG001|Overall Study|Withdrawal by Subject|79|||
130559910|NCT03346057|470017902|FG001|Overall Study|Lost to Follow-up|2|||
130722845|NCT01197755|470609747|FG001|Overall Study|eg, change in circumstances|3|||
130722846|NCT01197755|470609748|FG002|Overall Study|eg, change in circumstances|2|||
130392217|NCT03161483|469407091|FG000|Treatment Period|Death|1|||
130722847|NCT03365011|470609749|FG000|Overall Study|Withdrawal by Subject|1|||
130392218|NCT03161483|469407092|FG001|Treatment Period|Death|0|||
130392219|NCT03161483|469407093|FG002|Treatment Period|Death|0|||
130392220|NCT03161483|469407094|FG003|Treatment Period|Death|0|||
130392221|NCT03161483|469407091|FG000|Treatment Period|Adverse Event|5|||
130392222|NCT03161483|469407092|FG001|Treatment Period|Adverse Event|2|||
130392223|NCT03161483|469407093|FG002|Treatment Period|Adverse Event|1|||
130470268|NCT02879448|469688250|FG000|Overall Study|Other Reasons|8|||
130470269|NCT02879448|469688251|FG001|Overall Study|Other Reasons|12|||
130470270|NCT05952076|469688252|FG000|Overall Study|Death|1|||
130392224|NCT03161483|469407094|FG003|Treatment Period|Adverse Event|11|||
130392225|NCT03161483|469407091|FG000|Treatment Period|Pregnancy|1|||
130392226|NCT03161483|469407092|FG001|Treatment Period|Pregnancy|0|||
130392227|NCT03161483|469407093|FG002|Treatment Period|Pregnancy|0|||
130392228|NCT03161483|469407094|FG003|Treatment Period|Pregnancy|0|||
130392229|NCT03161483|469407091|FG000|Treatment Period|Lack of Efficacy|0|||
130392230|NCT03161483|469407092|FG001|Treatment Period|Lack of Efficacy|0|||
130392231|NCT03161483|469407093|FG002|Treatment Period|Lack of Efficacy|0|||
130392232|NCT03161483|469407094|FG003|Treatment Period|Lack of Efficacy|1|||
130392233|NCT03161483|469407091|FG000|Treatment Period|Withdrawal by Subject|2|||
130392234|NCT03161483|469407092|FG001|Treatment Period|Withdrawal by Subject|5|||
130392235|NCT03161483|469407093|FG002|Treatment Period|Withdrawal by Subject|2|||
130392236|NCT03161483|469407094|FG003|Treatment Period|Withdrawal by Subject|6|||
130392237|NCT03161483|469407091|FG000|Treatment Period|Lost to Follow-up|0|||
130392238|NCT03161483|469407092|FG001|Treatment Period|Lost to Follow-up|0|||
130392239|NCT03161483|469407093|FG002|Treatment Period|Lost to Follow-up|0|||
130392240|NCT03161483|469407094|FG003|Treatment Period|Lost to Follow-up|1|||
130392241|NCT03161483|469407091|FG000|Treatment Period|Protocol Violation|0|||
130392242|NCT03161483|469407092|FG001|Treatment Period|Protocol Violation|0|||
130392243|NCT03161483|469407093|FG002|Treatment Period|Protocol Violation|0|||
130392244|NCT03161483|469407094|FG003|Treatment Period|Protocol Violation|1|||
130392245|NCT03161483|469407091|FG000|Treatment Period|Other reasons|1|||
130392246|NCT03161483|469407092|FG001|Treatment Period|Other reasons|1|||
130392247|NCT03161483|469407093|FG002|Treatment Period|Other reasons|0|||
130392248|NCT03161483|469407094|FG003|Treatment Period|Other reasons|0|||
130392249|NCT04238728|469407105|FG000|Overall Study|Withdrawal by Subject|1|||
130392250|NCT04238728|469407105|FG000|Overall Study|Lost to Follow-up|2|||
130392251|NCT05389657|469407107|FG000|Overall Study|Lost to Follow-up|7|||
130392252|NCT05389657|469407108|FG001|Overall Study|Lost to Follow-up|8|||
130392253|NCT01907828|469407109|FG000|Overall Study|Exclusion criteria not met|0|||
130392254|NCT01907828|469407110|FG001|Overall Study|Exclusion criteria not met|1|||
130392255|NCT01907828|469407109|FG000|Overall Study|Withdrawal by Subject|3|||
130392256|NCT01907828|469407110|FG001|Overall Study|Withdrawal by Subject|4|||
130392257|NCT01907828|469407109|FG000|Overall Study|Lost to Follow-up|3|||
130392258|NCT01907828|469407110|FG001|Overall Study|Lost to Follow-up|0|||
130392259|NCT01907828|469407109|FG000|Overall Study|Participant refused 24-month follow-up|1|||
130392260|NCT01907828|469407110|FG001|Overall Study|Participant refused 24-month follow-up|0|||
130392261|NCT01907828|469407109|FG000|Overall Study|Participant met exclusion criteria|0|||
130392262|NCT01907828|469407110|FG001|Overall Study|Participant met exclusion criteria|1|||
130392263|NCT01073865|469407116|FG000|Overall Study|Reasons other than below|19|||
130392264|NCT01073865|469407117|FG001|Overall Study|Reasons other than below|31|||
130392265|NCT01073865|469407116|FG000|Overall Study|Lost to Follow-up|1|||
130392266|NCT01073865|469407117|FG001|Overall Study|Lost to Follow-up|1|||
130392267|NCT01073865|469407116|FG000|Overall Study|Death|3|||
130392268|NCT01073865|469407117|FG001|Overall Study|Death|2|||
130392269|NCT01073865|469407116|FG000|Overall Study|Withdrawal by Subject|5|||
130392270|NCT01073865|469407117|FG001|Overall Study|Withdrawal by Subject|5|||
130392271|NCT03261947|469407121|FG000|Overall Study|Death|10|||
130559911|NCT03346057|470017903|FG002|Overall Study|Lost to Follow-up|1|||
130559912|NCT03346057|470017904|FG003|Overall Study|Lost to Follow-up|0|||
130559913|NCT03346057|470017901|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
130722848|NCT03365011|470609750|FG001|Overall Study|Withdrawal by Subject|2|||
130392272|NCT03261947|469407122|FG001|Overall Study|Death|13|||
130392273|NCT03261947|469407123|FG002|Overall Study|Death|17|||
130392274|NCT03261947|469407124|FG003|Overall Study|Death|12|||
130392275|NCT03261947|469407125|FG004|Overall Study|Death|8|||
130392276|NCT03261947|469407121|FG000|Overall Study|Lost to Follow-up|0|||
130392277|NCT03261947|469407122|FG001|Overall Study|Lost to Follow-up|0|||
130392278|NCT03261947|469407123|FG002|Overall Study|Lost to Follow-up|2|||
130392279|NCT03261947|469407124|FG003|Overall Study|Lost to Follow-up|1|||
130392280|NCT03261947|469407125|FG004|Overall Study|Lost to Follow-up|0|||
130392281|NCT03261947|469407121|FG000|Overall Study|Withdrawal by Subject|0|||
130392282|NCT03261947|469407122|FG001|Overall Study|Withdrawal by Subject|0|||
130392283|NCT03261947|469407123|FG002|Overall Study|Withdrawal by Subject|3|||
130392284|NCT03261947|469407124|FG003|Overall Study|Withdrawal by Subject|0|||
130392285|NCT03261947|469407125|FG004|Overall Study|Withdrawal by Subject|1|||
130392286|NCT03261947|469407121|FG000|Overall Study|Site Terminated by Sponsor|0|||
130392287|NCT03261947|469407122|FG001|Overall Study|Site Terminated by Sponsor|0|||
130392288|NCT03261947|469407123|FG002|Overall Study|Site Terminated by Sponsor|4|||
130392289|NCT03261947|469407124|FG003|Overall Study|Site Terminated by Sponsor|7|||
130392290|NCT03261947|469407125|FG004|Overall Study|Site Terminated by Sponsor|5|||
130392291|NCT03261947|469407121|FG000|Overall Study|Reason not Specified|2|||
130392292|NCT03261947|469407122|FG001|Overall Study|Reason not Specified|0|||
130392293|NCT03261947|469407123|FG002|Overall Study|Reason not Specified|4|||
130559914|NCT03346057|470017902|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
130722849|NCT00499174|470609751|FG000|Overall Study|Physician Decision|78|||
130392294|NCT03261947|469407124|FG003|Overall Study|Reason not Specified|1|||
130392295|NCT03261947|469407125|FG004|Overall Study|Reason not Specified|3|||
130392296|NCT00228917|469407126|FG000|Overall Study|Migrated/moved from study area|0|||
130392297|NCT00228917|469407127|FG001|Overall Study|Migrated/moved from study area|0|||
130392298|NCT00228917|469407128|FG002|Overall Study|Migrated/moved from study area|0|||
130392299|NCT00228917|469407129|FG003|Overall Study|Migrated/moved from study area|0|||
130392300|NCT00228917|469407130|FG004|Overall Study|Migrated/moved from study area|0|||
130392301|NCT00228917|469407131|FG005|Overall Study|Migrated/moved from study area|2|||
130392302|NCT00228917|469407132|FG006|Overall Study|Migrated/moved from study area|0|||
130392303|NCT00228917|469407133|FG007|Overall Study|Migrated/moved from study area|0|||
130392304|NCT00409617|469407134|FG000|Overall Study|Adverse Event|57|||
130392305|NCT00409617|469407134|FG000|Overall Study|Lack of Efficacy|54|||
130392306|NCT00409617|469407134|FG000|Overall Study|Lost to Follow-up|2|||
130392307|NCT00409617|469407134|FG000|Overall Study|Protocol Violation|24|||
130392308|NCT00409617|469407134|FG000|Overall Study|Withdrawal by Subject|8|||
130392309|NCT00409617|469407134|FG000|Overall Study|Administrative reasons|1|||
130392310|NCT00409617|469407134|FG000|Overall Study|Not described|14|||
130392311|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
130392312|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
130392313|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
130392314|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
130392315|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
130392316|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
130392317|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
130392318|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130392319|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130392320|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130392321|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
130392322|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
130392323|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
130392324|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
130392325|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
130392326|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
130392327|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130392328|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130392329|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130392330|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130392331|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
130392332|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130392333|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
130392334|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130392335|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130392336|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130392337|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
130392338|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130392339|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130392340|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130392341|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
130392342|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
130392343|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
130392344|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
130392345|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
130392346|NCT03373383|469407138|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
130392347|NCT03373383|469407139|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
130392348|NCT03373383|469407140|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
130392349|NCT03373383|469407141|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
130470271|NCT05952076|469688253|FG001|Overall Study|Death|1|||
130470272|NCT05952076|469688252|FG000|Overall Study|Lost to Follow-up|0|||
130470273|NCT05952076|469688253|FG001|Overall Study|Lost to Follow-up|1|||
130470274|NCT05288283|469688254|FG000|Overall Study|Study Terminated Early|1|||
130392350|NCT03373383|469407142|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
130392351|NCT03373383|469407138|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
130392352|NCT03373383|469407139|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130392353|NCT03373383|469407140|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130392354|NCT03373383|469407141|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130392355|NCT03373383|469407142|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130470275|NCT05288283|469688255|FG001|Overall Study|Study Terminated Early|1|||
130470276|NCT05086744|469688256|FG000|Part A|Adverse Event|0|||
130470277|NCT05086744|469688257|FG001|Part A|Adverse Event|1|||
130470278|NCT05086744|469688256|FG000|Part A|Lack of Efficacy|3|||
130392356|NCT03818516|469407143|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
130392357|NCT04372602|469407144|FG000|Overall Study|Withdrawal by Subject|1|||
130470279|NCT05086744|469688257|FG001|Part A|Lack of Efficacy|0|||
130470280|NCT05086744|469688256|FG000|Part A|Protocol deviation|1|||
130392358|NCT04372602|469407145|FG001|Overall Study|Withdrawal by Subject|1|||
130392359|NCT04372602|469407144|FG000|Overall Study|Adverse Event|0|||
130392360|NCT04372602|469407145|FG001|Overall Study|Adverse Event|1|||
130392361|NCT04372602|469407144|FG000|Overall Study|Transitioned to comfort care|0|||
130392362|NCT04372602|469407145|FG001|Overall Study|Transitioned to comfort care|1|||
130392363|NCT02907359|469407146|FG000|Overall Study|Death|234|||
130392364|NCT02907359|469407147|FG001|Overall Study|Death|117|||
130392365|NCT02907359|469407146|FG000|Overall Study|Withdrawal by Subject|6|||
130392366|NCT02907359|469407147|FG001|Overall Study|Withdrawal by Subject|11|||
130392367|NCT02907359|469407146|FG000|Overall Study|Lost to Follow-up|1|||
130392368|NCT02907359|469407147|FG001|Overall Study|Lost to Follow-up|0|||
130392369|NCT02739269|469407148|FG000|Overall Study|Protocol Violation|5|||
130392370|NCT02739269|469407149|FG001|Overall Study|Protocol Violation|0|||
130392371|NCT02739269|469407148|FG000|Overall Study|Cycle cancellation|2|||
130392372|NCT02739269|469407149|FG001|Overall Study|Cycle cancellation|2|||
130392373|NCT02739269|469407148|FG000|Overall Study|Withdrawal by Subject|0|||
130392374|NCT02739269|469407149|FG001|Overall Study|Withdrawal by Subject|2|||
130392375|NCT00923559|469407150|FG000|Overall Study|Lost to Follow-up|2|||
130392376|NCT00923559|469407151|FG001|Overall Study|Lost to Follow-up|3|||
130392377|NCT01951157|469407152|FG000|Overall Study|Progressive Disease|12|||
130392378|NCT01951157|469407153|FG001|Overall Study|Progressive Disease|13|||
130392379|NCT01951157|469407154|FG002|Overall Study|Progressive Disease|10|||
130392380|NCT01951157|469407152|FG000|Overall Study|Treatment-unrelated AE|1|||
130392381|NCT01951157|469407153|FG001|Overall Study|Treatment-unrelated AE|0|||
130392382|NCT01951157|469407154|FG002|Overall Study|Treatment-unrelated AE|3|||
130392383|NCT01951157|469407152|FG000|Overall Study|Study Termination|0|||
130392384|NCT01951157|469407153|FG001|Overall Study|Study Termination|0|||
130392385|NCT01951157|469407154|FG002|Overall Study|Study Termination|1|||
130392386|NCT01951157|469407152|FG000|Overall Study|Physician Decision|5|||
130392387|NCT01951157|469407153|FG001|Overall Study|Physician Decision|3|||
130392388|NCT01951157|469407154|FG002|Overall Study|Physician Decision|2|||
130392389|NCT01951157|469407152|FG000|Overall Study|Non-treatmentrelated death|2|||
130392390|NCT01951157|469407153|FG001|Overall Study|Non-treatmentrelated death|2|||
130392391|NCT01951157|469407154|FG002|Overall Study|Non-treatmentrelated death|2|||
130392392|NCT01951157|469407152|FG000|Overall Study|No treated|0|||
130392393|NCT01951157|469407153|FG001|Overall Study|No treated|1|||
130392394|NCT01951157|469407154|FG002|Overall Study|No treated|0|||
130392395|NCT01951157|469407152|FG000|Overall Study|Treatment-related AE|2|||
130392396|NCT01951157|469407153|FG001|Overall Study|Treatment-related AE|0|||
130392397|NCT01951157|469407154|FG002|Overall Study|Treatment-related AE|4|||
130392398|NCT01951157|469407152|FG000|Overall Study|Consent withdrawn by subject|0|||
130392399|NCT01951157|469407153|FG001|Overall Study|Consent withdrawn by subject|1|||
130392400|NCT01951157|469407154|FG002|Overall Study|Consent withdrawn by subject|3|||
130392401|NCT01951157|469407152|FG000|Overall Study|Treatment-related death|0|||
130392402|NCT01951157|469407153|FG001|Overall Study|Treatment-related death|2|||
130392403|NCT01951157|469407154|FG002|Overall Study|Treatment-related death|0|||
130392404|NCT00329407|469407160|FG000|Overall Study|Withdrawal by Subject|1|||
130392405|NCT00978068|469407161|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
130392406|NCT00978068|469407162|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
130392407|NCT00978068|469407161|FG000|Overall Study|Death|1|||
130392408|NCT00978068|469407162|FG001|Overall Study|Death|2|||
130470281|NCT05086744|469688257|FG001|Part A|Protocol deviation|0|||
130470282|NCT05086744|469688256|FG000|Part A|Subject decision|1|||
130470283|NCT05086744|469688257|FG001|Part A|Subject decision|0|||
130470284|NCT05086744|469688256|FG000|Part B|Adverse Event|0|||
130470285|NCT05086744|469688257|FG001|Part B|Adverse Event|1|||
130470286|NCT05086744|469688256|FG000|Part B|Lack of Efficacy|0|||
130392409|NCT00978068|469407161|FG000|Overall Study|Lost to Follow-up|1|||
130392410|NCT00978068|469407162|FG001|Overall Study|Lost to Follow-up|2|||
130470287|NCT05086744|469688257|FG001|Part B|Lack of Efficacy|1|||
130722850|NCT00499174|470609752|FG001|Overall Study|Physician Decision|9|||
130392411|NCT00978068|469407161|FG000|Overall Study|Physician Decision|0|||
130392412|NCT00978068|469407162|FG001|Overall Study|Physician Decision|1|||
130392413|NCT00978068|469407161|FG000|Overall Study|Unable to Comply with Study|0|||
130392414|NCT00978068|469407162|FG001|Overall Study|Unable to Comply with Study|2|||
130392415|NCT03560531|469407163|FG000|Overall Study|Death|4|||
130392416|NCT03560531|469407164|FG001|Overall Study|Death|1|||
130392417|NCT03560531|469407165|FG002|Overall Study|Death|1|||
130392418|NCT03560531|469407166|FG003|Overall Study|Death|2|||
130392419|NCT03560531|469407167|FG004|Overall Study|Death|6|||
130392420|NCT03560531|469407168|FG005|Overall Study|Death|1|||
130392421|NCT03560531|469407169|FG006|Overall Study|Death|4|||
130392422|NCT03560531|469407170|FG007|Overall Study|Death|8|||
130392423|NCT03560531|469407171|FG008|Overall Study|Death|1|||
130392424|NCT03560531|469407172|FG009|Overall Study|Death|3|||
130392425|NCT03560531|469407173|FG010|Overall Study|Death|2|||
130470288|NCT05086744|469688256|FG000|Part B|Study terminated by sponsor|1|||
130470289|NCT05086744|469688257|FG001|Part B|Study terminated by sponsor|6|||
130392426|NCT03560531|469407174|FG011|Overall Study|Death|0|||
130392427|NCT03560531|469407175|FG012|Overall Study|Death|4|||
130392428|NCT03560531|469407176|FG013|Overall Study|Death|1|||
130392429|NCT03560531|469407163|FG000|Overall Study|Lost to Follow-up|1|||
130392430|NCT03560531|469407164|FG001|Overall Study|Lost to Follow-up|1|||
130392431|NCT03560531|469407165|FG002|Overall Study|Lost to Follow-up|0|||
130392432|NCT03560531|469407166|FG003|Overall Study|Lost to Follow-up|0|||
130392433|NCT03560531|469407167|FG004|Overall Study|Lost to Follow-up|0|||
130392434|NCT03560531|469407168|FG005|Overall Study|Lost to Follow-up|0|||
130392435|NCT03560531|469407169|FG006|Overall Study|Lost to Follow-up|1|||
130392436|NCT03560531|469407170|FG007|Overall Study|Lost to Follow-up|0|||
130392437|NCT03560531|469407171|FG008|Overall Study|Lost to Follow-up|0|||
130392438|NCT03560531|469407172|FG009|Overall Study|Lost to Follow-up|0|||
130392439|NCT03560531|469407173|FG010|Overall Study|Lost to Follow-up|0|||
130392440|NCT03560531|469407174|FG011|Overall Study|Lost to Follow-up|0|||
130392441|NCT03560531|469407175|FG012|Overall Study|Lost to Follow-up|0|||
130392442|NCT03560531|469407176|FG013|Overall Study|Lost to Follow-up|0|||
130392443|NCT03560531|469407163|FG000|Overall Study|Withdrawal by Subject|1|||
130392444|NCT03560531|469407164|FG001|Overall Study|Withdrawal by Subject|0|||
130392445|NCT03560531|469407165|FG002|Overall Study|Withdrawal by Subject|0|||
130392446|NCT03560531|469407166|FG003|Overall Study|Withdrawal by Subject|0|||
130392447|NCT03560531|469407167|FG004|Overall Study|Withdrawal by Subject|0|||
130392448|NCT03560531|469407168|FG005|Overall Study|Withdrawal by Subject|0|||
130392449|NCT03560531|469407169|FG006|Overall Study|Withdrawal by Subject|0|||
130392450|NCT03560531|469407170|FG007|Overall Study|Withdrawal by Subject|3|||
130392451|NCT03560531|469407171|FG008|Overall Study|Withdrawal by Subject|2|||
130392452|NCT03560531|469407172|FG009|Overall Study|Withdrawal by Subject|0|||
130392453|NCT03560531|469407173|FG010|Overall Study|Withdrawal by Subject|0|||
130392454|NCT03560531|469407174|FG011|Overall Study|Withdrawal by Subject|0|||
130392455|NCT03560531|469407175|FG012|Overall Study|Withdrawal by Subject|2|||
130392456|NCT03560531|469407176|FG013|Overall Study|Withdrawal by Subject|0|||
130392457|NCT03560531|469407163|FG000|Overall Study|Study end per-protocol|1|||
130392458|NCT03560531|469407164|FG001|Overall Study|Study end per-protocol|1|||
130392459|NCT03560531|469407165|FG002|Overall Study|Study end per-protocol|2|||
130392460|NCT03560531|469407166|FG003|Overall Study|Study end per-protocol|0|||
130392461|NCT03560531|469407167|FG004|Overall Study|Study end per-protocol|1|||
130392462|NCT03560531|469407168|FG005|Overall Study|Study end per-protocol|0|||
130392463|NCT03560531|469407169|FG006|Overall Study|Study end per-protocol|0|||
130392464|NCT03560531|469407170|FG007|Overall Study|Study end per-protocol|0|||
130392465|NCT03560531|469407171|FG008|Overall Study|Study end per-protocol|0|||
130392466|NCT03560531|469407172|FG009|Overall Study|Study end per-protocol|0|||
130392467|NCT03560531|469407173|FG010|Overall Study|Study end per-protocol|0|||
130392468|NCT03560531|469407174|FG011|Overall Study|Study end per-protocol|0|||
130392469|NCT03560531|469407175|FG012|Overall Study|Study end per-protocol|0|||
130392470|NCT03560531|469407176|FG013|Overall Study|Study end per-protocol|0|||
130392471|NCT03560531|469407163|FG000|Overall Study|Early study termination by sponsor|9|||
130392472|NCT03560531|469407164|FG001|Overall Study|Early study termination by sponsor|0|||
130392473|NCT03560531|469407165|FG002|Overall Study|Early study termination by sponsor|0|||
130392474|NCT03560531|469407166|FG003|Overall Study|Early study termination by sponsor|4|||
130392475|NCT03560531|469407167|FG004|Overall Study|Early study termination by sponsor|8|||
130392476|NCT03560531|469407168|FG005|Overall Study|Early study termination by sponsor|2|||
130392477|NCT03560531|469407169|FG006|Overall Study|Early study termination by sponsor|5|||
130392478|NCT03560531|469407170|FG007|Overall Study|Early study termination by sponsor|64|||
130392479|NCT03560531|469407171|FG008|Overall Study|Early study termination by sponsor|7|||
130392480|NCT03560531|469407172|FG009|Overall Study|Early study termination by sponsor|2|||
130392481|NCT03560531|469407173|FG010|Overall Study|Early study termination by sponsor|16|||
130392482|NCT03560531|469407174|FG011|Overall Study|Early study termination by sponsor|2|||
130392483|NCT03560531|469407175|FG012|Overall Study|Early study termination by sponsor|6|||
130392484|NCT03560531|469407176|FG013|Overall Study|Early study termination by sponsor|2|||
130392485|NCT01471379|469407179|FG000|Overall Study|Adverse Event|1|||
130392486|NCT01471379|469407180|FG001|Overall Study|Adverse Event|0|||
130392487|NCT01471379|469407181|FG002|Overall Study|Adverse Event|0|||
130392488|NCT01471379|469407179|FG000|Overall Study|Study terminated|0|||
130392489|NCT01471379|469407180|FG001|Overall Study|Study terminated|1|||
130392490|NCT01471379|469407181|FG002|Overall Study|Study terminated|0|||
130392491|NCT02120794|469407182|FG000|Overall Study|Withdrawal by Subject|43|||
130470290|NCT01704079|469688258|FG000|Overall Study|Withdrawal by Subject|5|||
130470291|NCT01704079|469688259|FG001|Overall Study|Withdrawal by Subject|7|||
130392492|NCT02120794|469407182|FG000|Overall Study|Adverse Event|10|||
130392493|NCT02120794|469407182|FG000|Overall Study|Physician Decision|4|||
130392494|NCT02120794|469407182|FG000|Overall Study|Due to insurance coverage|1|||
130392495|NCT01200797|469407183|FG000|Overall Study|symptomatic deterioration|2|||
130392496|NCT01200797|469407183|FG000|Overall Study|Adverse Event|4|||
130392497|NCT01200797|469407183|FG000|Overall Study|Disease Progression|13|||
130392498|NCT01644175|469407184|FG000|Overall Study|Randomized But Not Treated|0|||
130392499|NCT01644175|469407185|FG001|Overall Study|Randomized But Not Treated|2|||
130470292|NCT01704079|469688258|FG000|Overall Study|Lost to Follow-up|2|||
130470293|NCT01704079|469688259|FG001|Overall Study|Lost to Follow-up|5|||
130392500|NCT01644175|469407184|FG000|Overall Study|Adverse Event|8|||
130392501|NCT01644175|469407185|FG001|Overall Study|Adverse Event|13|||
130392502|NCT01644175|469407184|FG000|Overall Study|Death|1|||
130392503|NCT01644175|469407185|FG001|Overall Study|Death|2|||
130392504|NCT01644175|469407184|FG000|Overall Study|Poor compliance to protocol|9|||
130392505|NCT01644175|469407185|FG001|Overall Study|Poor compliance to protocol|10|||
130392506|NCT01644175|469407184|FG000|Overall Study|Physician Decision|1|||
130392507|NCT01644175|469407185|FG001|Overall Study|Physician Decision|2|||
130392508|NCT01644175|469407184|FG000|Overall Study|Participant Moved|1|||
130392509|NCT01644175|469407185|FG001|Overall Study|Participant Moved|2|||
130392510|NCT01644175|469407184|FG000|Overall Study|Consent withdrawn by participant|3|||
130392511|NCT01644175|469407185|FG001|Overall Study|Consent withdrawn by participant|4|||
130392512|NCT01644175|469407184|FG000|Overall Study|Related to Autoinjector Administration|2|||
130392513|NCT01644175|469407185|FG001|Overall Study|Related to Autoinjector Administration|1|||
130392514|NCT01644175|469407184|FG000|Overall Study|Last visit outside protocol visit window|4|||
130392515|NCT01644175|469407185|FG001|Overall Study|Last visit outside protocol visit window|11|||
130392516|NCT01644175|469407184|FG000|Overall Study|Selection criteria finally not met|0|||
130392517|NCT01644175|469407185|FG001|Overall Study|Selection criteria finally not met|1|||
130392518|NCT01644175|469407184|FG000|Overall Study|Site closure|2|||
130392519|NCT01644175|469407185|FG001|Overall Study|Site closure|2|||
130392520|NCT01644175|469407184|FG000|Overall Study|Lost to Follow-up|1|||
130392521|NCT01644175|469407185|FG001|Overall Study|Lost to Follow-up|0|||
130392522|NCT01644175|469407184|FG000|Overall Study|Other than specified above|0|||
130392523|NCT01644175|469407185|FG001|Overall Study|Other than specified above|3|||
130392524|NCT02818777|469407193|FG000|Overall Study|Adverse Event|3|||
130392525|NCT01623596|469407203|FG000|Overall Study|Abnormal laboratory values|2|||
130392526|NCT01623596|469407204|FG001|Overall Study|Abnormal laboratory values|0|||
130392527|NCT01623596|469407203|FG000|Overall Study|Administrative problems|9|||
130392528|NCT01623596|469407204|FG001|Overall Study|Administrative problems|13|||
130392529|NCT01623596|469407203|FG000|Overall Study|Adverse Event|20|||
130392530|NCT01623596|469407204|FG001|Overall Study|Adverse Event|29|||
130392531|NCT01623596|469407203|FG000|Overall Study|Death|0|||
130392532|NCT01623596|469407204|FG001|Overall Study|Death|2|||
130392533|NCT01623596|469407203|FG000|Overall Study|Lost to Follow-up|12|||
130392534|NCT01623596|469407204|FG001|Overall Study|Lost to Follow-up|16|||
130392535|NCT01623596|469407203|FG000|Overall Study|Withdrawal by Subject|13|||
130392536|NCT01623596|469407204|FG001|Overall Study|Withdrawal by Subject|31|||
130470294|NCT01704079|469688258|FG000|Overall Study|Adverse Event|4|||
130470295|NCT01704079|469688259|FG001|Overall Study|Adverse Event|7|||
130470296|NCT01704079|469688258|FG000|Overall Study|Protocol Violation|1|||
130470297|NCT01704079|469688259|FG001|Overall Study|Protocol Violation|0|||
130470298|NCT01704079|469688258|FG000|Overall Study|Subject noncompliance|2|||
130470299|NCT01704079|469688259|FG001|Overall Study|Subject noncompliance|3|||
130470300|NCT01704079|469688258|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
130470301|NCT01704079|469688259|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
130470302|NCT05986565|469688260|FG000|Overall Study|Lost to Follow-up|8|||
130470303|NCT05986565|469688261|FG001|Overall Study|Lost to Follow-up|3|||
130470304|NCT05986565|469688260|FG000|Overall Study|Withdrawal by Subject|0|||
130470305|NCT05986565|469688261|FG001|Overall Study|Withdrawal by Subject|1|||
130470306|NCT02991807|469688263|FG000|Overall Study|Withdrawal by Subject|2|||
130470307|NCT02991807|469688264|FG001|Overall Study|Withdrawal by Subject|1|||
130470308|NCT02991807|469688263|FG000|Overall Study|Physician Decision|0|||
130470309|NCT02991807|469688264|FG001|Overall Study|Physician Decision|1|||
130470310|NCT02991807|469688263|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
130470311|NCT02991807|469688264|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
130470312|NCT00792636|469688266|FG000|Overall Study|Protocol Violation|17|||
130470313|NCT00792636|469688267|FG001|Overall Study|Protocol Violation|23|||
130470314|NCT00792636|469688268|FG002|Overall Study|Protocol Violation|20|||
130470315|NCT00792636|469688266|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
130392537|NCT01623596|469407203|FG000|Overall Study|Patient no longer requires study drug|1|||
130392538|NCT01623596|469407204|FG001|Overall Study|Patient no longer requires study drug|0|||
130392539|NCT01623596|469407203|FG000|Overall Study|Protocol Violation|0|||
130392540|NCT01623596|469407204|FG001|Overall Study|Protocol Violation|6|||
130470316|NCT00792636|469688267|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
130392541|NCT01623596|469407203|FG000|Overall Study|Lack of Efficacy|5|||
130392542|NCT01623596|469407204|FG001|Overall Study|Lack of Efficacy|3|||
130392543|NCT01324349|469407205|FG000|Overall Study|Death|1|||
130392544|NCT01324349|469407206|FG001|Overall Study|Death|1|||
130392545|NCT01324349|469407205|FG000|Overall Study|Withdrawal by Subject|0|||
130392546|NCT01324349|469407206|FG001|Overall Study|Withdrawal by Subject|1|||
130392547|NCT00748215|469407209|FG000|Overall Study|Withdrawal by Subject|7|||
130470317|NCT00792636|469688268|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
130470318|NCT00792636|469688266|FG000|Overall Study|Lost to Follow-up|13|||
130392548|NCT00748215|469407210|FG001|Overall Study|Withdrawal by Subject|7|||
130392549|NCT00748215|469407209|FG000|Overall Study|Treatment change|2|||
130392550|NCT00748215|469407210|FG001|Overall Study|Treatment change|1|||
130392551|NCT00748215|469407209|FG000|Overall Study|Change in patient condition|0|||
130392552|NCT00748215|469407210|FG001|Overall Study|Change in patient condition|3|||
130392553|NCT00748215|469407209|FG000|Overall Study|Non-compliant|0|||
130392554|NCT00748215|469407210|FG001|Overall Study|Non-compliant|2|||
130392555|NCT00748215|469407209|FG000|Overall Study|Adverse Event|0|||
130392556|NCT00748215|469407210|FG001|Overall Study|Adverse Event|5|||
130392557|NCT03200899|469407215|FG000|Overall Study|Lost to Follow-up|10|||
130392558|NCT03200899|469407216|FG001|Overall Study|Lost to Follow-up|23|||
130392559|NCT00026793|469407218|FG000|Overall Study|Death on study due to underlying disease|4|||
130392560|NCT00026793|469407218|FG000|Overall Study|Physician Decision|2|||
130392561|NCT00026793|469407218|FG000|Overall Study|Off study|2|||
130392562|NCT04151290|469407219|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
130392563|NCT00969553|469407220|FG000|Overall Study|Progressive disease (PD)|2|||
130392564|NCT00969553|469407221|FG001|Overall Study|Progressive disease (PD)|2|||
130392565|NCT00969553|469407222|FG002|Overall Study|Progressive disease (PD)|6|||
130392566|NCT00969553|469407223|FG003|Overall Study|Progressive disease (PD)|9|||
130392567|NCT00969553|469407224|FG004|Overall Study|Progressive disease (PD)|2|||
130392568|NCT00969553|469407225|FG005|Overall Study|Progressive disease (PD)|4|||
130392569|NCT00969553|469407226|FG006|Overall Study|Progressive disease (PD)|2|||
130392570|NCT00969553|469407227|FG007|Overall Study|Progressive disease (PD)|12|||
130392571|NCT00969553|469407228|FG008|Overall Study|Progressive disease (PD)|3|||
130392572|NCT00969553|469407220|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392573|NCT00969553|469407221|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392574|NCT00969553|469407222|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392575|NCT00969553|469407223|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392576|NCT00969553|469407224|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
130392577|NCT00969553|469407225|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392578|NCT00969553|469407226|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392579|NCT00969553|469407227|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392580|NCT00969553|469407228|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
130392581|NCT00969553|469407220|FG000|Overall Study|Other Adverse Event|0|||
130392582|NCT00969553|469407221|FG001|Overall Study|Other Adverse Event|0|||
130392583|NCT00969553|469407222|FG002|Overall Study|Other Adverse Event|0|||
130392584|NCT00969553|469407223|FG003|Overall Study|Other Adverse Event|1|||
130392585|NCT00969553|469407224|FG004|Overall Study|Other Adverse Event|0|||
130392586|NCT00969553|469407225|FG005|Overall Study|Other Adverse Event|0|||
130392587|NCT00969553|469407226|FG006|Overall Study|Other Adverse Event|1|||
130392588|NCT00969553|469407227|FG007|Overall Study|Other Adverse Event|0|||
130392589|NCT00969553|469407228|FG008|Overall Study|Other Adverse Event|0|||
130392590|NCT00969553|469407220|FG000|Overall Study|Refused cont. medication|1|||
130392591|NCT00969553|469407221|FG001|Overall Study|Refused cont. medication|1|||
130392592|NCT00969553|469407222|FG002|Overall Study|Refused cont. medication|0|||
130392593|NCT00969553|469407223|FG003|Overall Study|Refused cont. medication|2|||
130392594|NCT00969553|469407224|FG004|Overall Study|Refused cont. medication|0|||
130392595|NCT00969553|469407225|FG005|Overall Study|Refused cont. medication|0|||
130392596|NCT00969553|469407226|FG006|Overall Study|Refused cont. medication|0|||
130392597|NCT00969553|469407227|FG007|Overall Study|Refused cont. medication|1|||
130392598|NCT00969553|469407228|FG008|Overall Study|Refused cont. medication|0|||
130392599|NCT00969553|469407220|FG000|Overall Study|Not specified above|0|||
130392600|NCT00969553|469407221|FG001|Overall Study|Not specified above|0|||
130392601|NCT00969553|469407222|FG002|Overall Study|Not specified above|0|||
130722851|NCT02351960|470609755|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
130392602|NCT00969553|469407223|FG003|Overall Study|Not specified above|4|||
130392603|NCT00969553|469407224|FG004|Overall Study|Not specified above|0|||
130392604|NCT00969553|469407225|FG005|Overall Study|Not specified above|0|||
130392605|NCT00969553|469407226|FG006|Overall Study|Not specified above|1|||
130392606|NCT00969553|469407227|FG007|Overall Study|Not specified above|1|||
130392607|NCT00969553|469407228|FG008|Overall Study|Not specified above|0|||
130392608|NCT04248816|469407230|FG000|Overall Study|Ineligible post-randomization|7|||
130392609|NCT04248816|469407231|FG001|Overall Study|Ineligible post-randomization|21|||
130392610|NCT04248816|469407232|FG002|Overall Study|Ineligible post-randomization|25|||
130392611|NCT01077804|469407234|FG000|Overall Study|Unreachable|102|||
130392612|NCT01077804|469407234|FG000|Overall Study|Refused to continue|79|||
130392613|NCT01077804|469407234|FG000|Overall Study|Other|18|||
130392614|NCT02620046|469407236|FG000|Overall Study|Adverse Event|22|||
130392615|NCT02620046|469407237|FG001|Overall Study|Adverse Event|42|||
130392616|NCT02620046|469407236|FG000|Overall Study|Lost to Follow-up|4|||
130392617|NCT02620046|469407237|FG001|Overall Study|Lost to Follow-up|10|||
130392618|NCT02620046|469407236|FG000|Overall Study|Withdrawal by Subject|36|||
130392619|NCT02620046|469407237|FG001|Overall Study|Withdrawal by Subject|66|||
130392620|NCT02620046|469407236|FG000|Overall Study|Site Termination|3|||
130392621|NCT02620046|469407237|FG001|Overall Study|Site Termination|3|||
130392622|NCT02620046|469407236|FG000|Overall Study|Pregnancy|3|||
130392623|NCT02620046|469407237|FG001|Overall Study|Pregnancy|7|||
130392624|NCT02620046|469407236|FG000|Overall Study|Lack of Efficacy|81|||
130470319|NCT00792636|469688267|FG001|Overall Study|Lost to Follow-up|19|||
130392625|NCT02620046|469407237|FG001|Overall Study|Lack of Efficacy|146|||
130392626|NCT02620046|469407236|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
130392627|NCT02620046|469407237|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
130392628|NCT02620046|469407236|FG000|Overall Study|Reason Not Specified|13|||
130392629|NCT02620046|469407237|FG001|Overall Study|Reason Not Specified|21|||
130392630|NCT02620046|469407236|FG000|Overall Study|Significant Protocol Deviation|0|||
130392631|NCT02620046|469407237|FG001|Overall Study|Significant Protocol Deviation|1|||
130392632|NCT00136084|469408945|FG000|Overall Study|Death|12|||
130392633|NCT00136084|469408946|FG001|Overall Study|Death|5|||
130392634|NCT00136084|469408945|FG000|Overall Study|Unacceptable toxicity|8|||
130392635|NCT00136084|469408946|FG001|Overall Study|Unacceptable toxicity|11|||
130392636|NCT00136084|469408945|FG000|Overall Study|Relapse|20|||
130392637|NCT00136084|469408946|FG001|Overall Study|Relapse|23|||
130392638|NCT00136084|469408945|FG000|Overall Study|Lost to Follow-up|2|||
130392639|NCT00136084|469408946|FG001|Overall Study|Lost to Follow-up|0|||
130392640|NCT00136084|469408945|FG000|Overall Study|No Response|1|||
130392641|NCT00136084|469408946|FG001|Overall Study|No Response|2|||
130392642|NCT00136084|469408945|FG000|Overall Study|Withdrawal by Subject|5|||
130392643|NCT00136084|469408946|FG001|Overall Study|Withdrawal by Subject|1|||
130392644|NCT00997503|469408947|FG000|Overall Study|Death|53|||
130392645|NCT00997503|469408947|FG000|Overall Study|Withdrawal by Subject|76|||
130559915|NCT03346057|470017903|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
130559916|NCT03346057|470017904|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
130722852|NCT02351960|470609756|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130722853|NCT02351960|470609755|FG000|Overall Study|Voluntary Withdrawal|5|||
130722854|NCT02351960|470609756|FG001|Overall Study|Voluntary Withdrawal|4|||
130722855|NCT02351960|470609755|FG000|Overall Study|Significant Protocol Deviation|0|||
130722856|NCT02351960|470609756|FG001|Overall Study|Significant Protocol Deviation|5|||
130392646|NCT00997503|469408947|FG000|Overall Study|Lost to Follow-up|33|||
130392647|NCT00997503|469408947|FG000|Overall Study|Adverse Event|3|||
130392648|NCT00997503|469408947|FG000|Overall Study|Physician Decision|10|||
130392649|NCT00997503|469408947|FG000|Overall Study|Missed 12-month follow-up|85|||
130392650|NCT00997503|469408947|FG000|Overall Study|Other reason|13|||
130392651|NCT00116831|469408948|FG000|Overall Study|Adverse Event|14|||
130392652|NCT00116831|469408949|FG001|Overall Study|Adverse Event|16|||
130392653|NCT00116831|469408948|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
130392654|NCT00116831|469408949|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
130392655|NCT00116831|469408948|FG000|Overall Study|Lost to Follow-up|8|||
130392656|NCT00116831|469408949|FG001|Overall Study|Lost to Follow-up|6|||
130392657|NCT00116831|469408948|FG000|Overall Study|Protocol Violation|3|||
130392658|NCT00116831|469408949|FG001|Overall Study|Protocol Violation|6|||
130392659|NCT00116831|469408948|FG000|Overall Study|Hypoglycaemic events|1|||
130392660|NCT00116831|469408949|FG001|Overall Study|Hypoglycaemic events|0|||
130392661|NCT00116831|469408948|FG000|Overall Study|Low haemoglobin on screening|1|||
130392662|NCT00116831|469408949|FG001|Overall Study|Low haemoglobin on screening|0|||
130392663|NCT00116831|469408948|FG000|Overall Study|Withdrawn investigational product|1|||
130392664|NCT00116831|469408949|FG001|Overall Study|Withdrawn investigational product|0|||
130392665|NCT00116831|469408948|FG000|Overall Study|Withdrawal by Subject|32|||
130392666|NCT00116831|469408949|FG001|Overall Study|Withdrawal by Subject|32|||
130392667|NCT00116831|469408948|FG000|Overall Study|Insufficient therapeutic effect|0|||
130392668|NCT00116831|469408949|FG001|Overall Study|Insufficient therapeutic effect|1|||
130392669|NCT00116831|469408948|FG000|Overall Study|Missing data for participant|1|||
130392670|NCT00116831|469408949|FG001|Overall Study|Missing data for participant|0|||
130392671|NCT00380393|469408950|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
130392672|NCT00380393|469408951|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
130392673|NCT00380393|469408950|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
130392674|NCT00380393|469408951|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
130392675|NCT00380393|469408950|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
130392676|NCT00380393|469408951|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
130392677|NCT00380393|469408950|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
130392678|NCT00380393|469408951|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
130392679|NCT00380393|469408950|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
130392680|NCT00380393|469408951|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
130392681|NCT00380393|469408950|FG000|Month 14|Withdrawal by Subject|9|||
130392682|NCT00380393|469408951|FG001|Month 14|Withdrawal by Subject|7|||
130392683|NCT00380393|469408950|FG000|Month 14|Death|1|||
130392684|NCT00380393|469408951|FG001|Month 14|Death|0|||
130392685|NCT00380393|469408950|FG000|Month 14|Lost to Follow-up|0|||
130392686|NCT00380393|469408951|FG001|Month 14|Lost to Follow-up|1|||
130392687|NCT00380393|469408950|FG000|Month 14|Migrated/moved from study area|39|||
130392688|NCT00380393|469408951|FG001|Month 14|Migrated/moved from study area|42|||
130392689|NCT00380393|469408950|FG000|Month 14|Protocol Violation|2|||
130392690|NCT00380393|469408951|FG001|Month 14|Protocol Violation|0|||
130392691|NCT00380393|469408950|FG000|Month 14|Others|6|||
130392692|NCT00380393|469408951|FG001|Month 14|Others|6|||
130392693|NCT01933048|469408952|FG000|Overall Study|Lost to Follow-up|15|||
130392694|NCT01933048|469408953|FG001|Overall Study|Lost to Follow-up|18|||
130392695|NCT01933048|469408952|FG000|Overall Study|personal reasons|1|||
130392696|NCT01933048|469408953|FG001|Overall Study|personal reasons|1|||
130392697|NCT01933048|469408952|FG000|Overall Study|Protocol Violation|7|||
130392698|NCT01933048|469408953|FG001|Overall Study|Protocol Violation|8|||
130392699|NCT01933048|469408952|FG000|Overall Study|Physician Decision|1|||
130392700|NCT01933048|469408953|FG001|Overall Study|Physician Decision|0|||
130392701|NCT01933048|469408952|FG000|Overall Study|unknown reasons|1|||
130392702|NCT01933048|469408953|FG001|Overall Study|unknown reasons|1|||
130392703|NCT02476968|469408954|FG000|Overall Study|Other|0|||
130392704|NCT02476968|469408955|FG001|Overall Study|Other|2|||
130392705|NCT02476968|469408956|FG002|Overall Study|Other|0|||
130392706|NCT02476968|469408954|FG000|Overall Study|Lost to Follow-up|10|||
130392707|NCT02476968|469408955|FG001|Overall Study|Lost to Follow-up|0|||
130392708|NCT02476968|469408956|FG002|Overall Study|Lost to Follow-up|1|||
130392709|NCT02476968|469408954|FG000|Overall Study|Death|48|||
130392710|NCT02476968|469408955|FG001|Overall Study|Death|8|||
130392711|NCT02476968|469408956|FG002|Overall Study|Death|1|||
130392712|NCT02476968|469408954|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130392713|NCT02476968|469408955|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130392714|NCT02476968|469408956|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130392715|NCT02476968|469408954|FG000|Overall Study|Patient decision|37|||
130392716|NCT02476968|469408955|FG001|Overall Study|Patient decision|8|||
130392717|NCT02476968|469408956|FG002|Overall Study|Patient decision|0|||
130392718|NCT01859507|469408957|FG000|Overall Study|left the country|4|||
130392719|NCT02404311|469408958|FG000|Part A: Month 0-18|Death|2|||
130392720|NCT02404311|469408959|FG001|Part A: Month 0-18|Death|0|||
130392721|NCT02404311|469408960|FG002|Part A: Month 0-18|Death|0|||
130392722|NCT02404311|469408961|FG003|Part A: Month 0-18|Death|0|||
130392723|NCT02404311|469408962|FG004|Part A: Month 0-18|Death|0|||
130392724|NCT02404311|469408958|FG000|Part A: Month 0-18|Physician Decision|1|||
130392725|NCT02404311|469408959|FG001|Part A: Month 0-18|Physician Decision|0|||
130392726|NCT02404311|469408960|FG002|Part A: Month 0-18|Physician Decision|0|||
130392727|NCT02404311|469408961|FG003|Part A: Month 0-18|Physician Decision|0|||
130392728|NCT02404311|469408962|FG004|Part A: Month 0-18|Physician Decision|0|||
130392729|NCT02404311|469408958|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
130392730|NCT02404311|469408959|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
130392731|NCT02404311|469408960|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
130392732|NCT02404311|469408961|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
130392733|NCT02404311|469408962|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
130392734|NCT02404311|469408958|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
130392735|NCT02404311|469408959|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
130392736|NCT02404311|469408960|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
130392737|NCT02404311|469408961|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
130392738|NCT02404311|469408962|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
130392739|NCT02404311|469408958|FG000|Part A: Month 0-18|HIV Infection|6|||
130392740|NCT02404311|469408959|FG001|Part A: Month 0-18|HIV Infection|2|||
130392741|NCT02404311|469408960|FG002|Part A: Month 0-18|HIV Infection|0|||
130392742|NCT02404311|469408961|FG003|Part A: Month 0-18|HIV Infection|0|||
130392743|NCT02404311|469408962|FG004|Part A: Month 0-18|HIV Infection|0|||
130392744|NCT02404311|469408958|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
130392745|NCT02404311|469408959|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
130392746|NCT02404311|469408960|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
130392747|NCT02404311|469408961|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
130392748|NCT02404311|469408962|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
130392749|NCT00218296|469408970|FG000|Overall Study|Lost to Follow-up|9|||
130392750|NCT00218296|469408971|FG001|Overall Study|Lost to Follow-up|7|||
130392751|NCT00218296|469408970|FG000|Overall Study|Withdrawal by Subject|36|||
130392752|NCT00218296|469408971|FG001|Overall Study|Withdrawal by Subject|47|||
130392753|NCT00218296|469408970|FG000|Overall Study|Randomized but did not enter treatment|66|||
130392754|NCT00218296|469408971|FG001|Overall Study|Randomized but did not enter treatment|67|||
130392755|NCT00097721|469408972|FG000|Overall Study|Adverse Event|8|||
130392756|NCT00097721|469408973|FG001|Overall Study|Adverse Event|1|||
130392757|NCT00097721|469408972|FG000|Overall Study|Withdrawal by Subject|6|||
130392758|NCT00097721|469408973|FG001|Overall Study|Withdrawal by Subject|1|||
130392759|NCT00097721|469408972|FG000|Overall Study|Progressive Disease|55|||
130392760|NCT00097721|469408973|FG001|Overall Study|Progressive Disease|27|||
130392761|NCT00097721|469408972|FG000|Overall Study|Physician Decision|1|||
130392762|NCT00097721|469408973|FG001|Overall Study|Physician Decision|3|||
130392763|NCT00097721|469408972|FG000|Overall Study|Reason not given|1|||
130392764|NCT00097721|469408973|FG001|Overall Study|Reason not given|1|||
130392765|NCT01752855|469408977|FG000|Overall Study|Adverse Event|1|||
130392766|NCT01752855|469408978|FG001|Overall Study|Adverse Event|0|||
130392767|NCT01752855|469408977|FG000|Overall Study|Withdrew Consent|0|||
130392768|NCT01752855|469408978|FG001|Overall Study|Withdrew Consent|2|||
130392769|NCT01752855|469408977|FG000|Overall Study|Lack of Efficacy|0|||
130392770|NCT01752855|469408978|FG001|Overall Study|Lack of Efficacy|2|||
130392771|NCT01478321|469408979|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
130392772|NCT01478321|469408979|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
130392773|NCT01478321|469408979|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
130392774|NCT01478321|469408979|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
130392775|NCT01478321|469408979|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
130392776|NCT01478321|469408979|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
130392777|NCT01478321|469408979|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
130392778|NCT01478321|469408979|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
130392779|NCT00634088|469408982|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
130392780|NCT00634088|469408983|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
130392781|NCT00634088|469408984|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
130392782|NCT00634088|469408985|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
130392783|NCT00634088|469408982|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
130392784|NCT00634088|469408983|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
130470320|NCT00792636|469688268|FG002|Overall Study|Lost to Follow-up|14|||
130470321|NCT00792636|469688266|FG000|Overall Study|Withdrew Consent|10|||
130470322|NCT00792636|469688267|FG001|Overall Study|Withdrew Consent|13|||
130470323|NCT00792636|469688268|FG002|Overall Study|Withdrew Consent|9|||
130470324|NCT00792636|469688266|FG000|Overall Study|Lack of Efficacy|3|||
130470325|NCT00792636|469688267|FG001|Overall Study|Lack of Efficacy|4|||
130470326|NCT00792636|469688268|FG002|Overall Study|Lack of Efficacy|13|||
130470327|NCT00792636|469688266|FG000|Overall Study|Adverse Event|4|||
130470328|NCT00792636|469688267|FG001|Overall Study|Adverse Event|2|||
130470329|NCT00792636|469688268|FG002|Overall Study|Adverse Event|3|||
130470330|NCT00792636|469688266|FG000|Overall Study|Investigator Discretion|2|||
130470331|NCT00792636|469688267|FG001|Overall Study|Investigator Discretion|0|||
130470332|NCT00792636|469688268|FG002|Overall Study|Investigator Discretion|2|||
130470333|NCT01046136|469688269|FG000|Overall Study|Withdrawal by Subject|0|||
130470334|NCT01046136|469688270|FG001|Overall Study|Withdrawal by Subject|4|||
130470335|NCT01046136|469688269|FG000|Overall Study|Physician Decision|1|||
130470336|NCT01046136|469688270|FG001|Overall Study|Physician Decision|1|||
130470337|NCT01046136|469688269|FG000|Overall Study|Lost to Follow-up|3|||
130470338|NCT01046136|469688270|FG001|Overall Study|Lost to Follow-up|3|||
130470339|NCT04579250|469688271|FG000|Overall Study|Withdrawal by Subject|1|||
130470340|NCT04579250|469688272|FG001|Overall Study|Withdrawal by Subject|1|||
130470341|NCT04579250|469688273|FG002|Overall Study|Withdrawal by Subject|0|||
130470342|NCT04579250|469688271|FG000|Overall Study|Lost to Follow-up|1|||
130470343|NCT04579250|469688272|FG001|Overall Study|Lost to Follow-up|1|||
130470344|NCT04579250|469688273|FG002|Overall Study|Lost to Follow-up|0|||
130470345|NCT04579250|469688271|FG000|Overall Study|Moved from area|0|||
130470346|NCT04579250|469688272|FG001|Overall Study|Moved from area|1|||
130470347|NCT04579250|469688273|FG002|Overall Study|Moved from area|2|||
130470348|NCT00727909|469688274|FG000|Overall Study|Withdrawal by Subject|5|||
130470349|NCT00727909|469688275|FG001|Overall Study|Withdrawal by Subject|11|||
130470350|NCT00727909|469688276|FG002|Overall Study|Withdrawal by Subject|8|||
130470351|NCT00727909|469688277|FG003|Overall Study|Withdrawal by Subject|5|||
130470352|NCT00727909|469688274|FG000|Overall Study|Death|0|||
130470353|NCT00727909|469688275|FG001|Overall Study|Death|0|||
130470354|NCT00727909|469688276|FG002|Overall Study|Death|1|||
130470355|NCT00727909|469688277|FG003|Overall Study|Death|0|||
130470356|NCT03446157|469688278|FG000|Overall Study|Death|11|||
130470357|NCT03446157|469688279|FG001|Overall Study|Death|9|||
130470358|NCT03446157|469688278|FG000|Overall Study|Lost to Follow-up|0|||
130470359|NCT03446157|469688279|FG001|Overall Study|Lost to Follow-up|1|||
130470360|NCT03446157|469688278|FG000|Overall Study|Withdrawal by Subject|2|||
130470361|NCT03446157|469688279|FG001|Overall Study|Withdrawal by Subject|1|||
130470362|NCT00411151|469688280|FG000|Overall Study|Death|38|||
130470363|NCT00411151|469688280|FG000|Overall Study|Withdrawal by Subject|2|||
130470364|NCT00411151|469688280|FG000|Overall Study|Lost to Follow-up|2|||
130470365|NCT00411151|469688280|FG000|Overall Study|Protocol Violation|1|||
130470366|NCT00411151|469688280|FG000|Overall Study|Trial prematurely closed|4|||
130392785|NCT00634088|469408984|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
130392786|NCT00634088|469408985|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
130470367|NCT04110054|469688281|FG000|Overall Study|COVID-19 reason other than AE|0|||
130470368|NCT04110054|469688282|FG001|Overall Study|COVID-19 reason other than AE|0|||
130470369|NCT04110054|469688283|FG002|Overall Study|COVID-19 reason other than AE|2|||
130722857|NCT02968849|470609761|FG000|Overall Study|Death|8|||
130470370|NCT04110054|469688284|FG003|Overall Study|COVID-19 reason other than AE|0|||
130470371|NCT04110054|469688281|FG000|Overall Study|Withdrawal by Subject|0|||
130470372|NCT04110054|469688282|FG001|Overall Study|Withdrawal by Subject|3|||
130470373|NCT04110054|469688283|FG002|Overall Study|Withdrawal by Subject|2|||
130470374|NCT04110054|469688284|FG003|Overall Study|Withdrawal by Subject|0|||
130470375|NCT04110054|469688281|FG000|Overall Study|Adverse Event|1|||
130470376|NCT04110054|469688282|FG001|Overall Study|Adverse Event|1|||
130470377|NCT04110054|469688283|FG002|Overall Study|Adverse Event|4|||
130722858|NCT02968849|470609762|FG001|Overall Study|Death|10|||
130470378|NCT04110054|469688284|FG003|Overall Study|Adverse Event|3|||
130470379|NCT00093015|469688285|FG000|Overall Study|Withdrawal by Subject|194|||
130470380|NCT00093015|469688286|FG001|Overall Study|Withdrawal by Subject|171|||
130470381|NCT00093015|469688285|FG000|Overall Study|Lost to Follow-up|96|||
130470382|NCT00093015|469688286|FG001|Overall Study|Lost to Follow-up|108|||
130470383|NCT00093015|469688285|FG000|Overall Study|Death|375|||
130470384|NCT00093015|469688286|FG001|Overall Study|Death|385|||
130470385|NCT00632203|469688288|FG000|Overall Study|Did not start study treatment|1|||
130470386|NCT00632203|469688289|FG001|Overall Study|Did not start study treatment|0|||
130470387|NCT00448669|469688297|FG000|Overall Study|Lost to Follow-up|52|||
130470388|NCT00448669|469688298|FG001|Overall Study|Lost to Follow-up|63|||
130470389|NCT00448669|469688297|FG000|Overall Study|Withdrawal by Subject|90|||
130470390|NCT00448669|469688298|FG001|Overall Study|Withdrawal by Subject|74|||
130470391|NCT00448669|469688297|FG000|Overall Study|Relocated|49|||
130470392|NCT00448669|469688298|FG001|Overall Study|Relocated|36|||
130392787|NCT00634088|469408982|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
130392788|NCT00634088|469408983|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
130392789|NCT00634088|469408984|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
130392790|NCT00634088|469408985|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
130392791|NCT00634088|469408982|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
130392792|NCT00634088|469408983|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
130392793|NCT00634088|469408984|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
130392794|NCT00634088|469408985|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
130392795|NCT00634088|469408982|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
130392796|NCT00634088|469408983|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
130392797|NCT00634088|469408984|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
130392798|NCT00634088|469408985|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
130392799|NCT00634088|469408982|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
130392800|NCT00634088|469408983|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
130392801|NCT00634088|469408984|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
130392802|NCT00634088|469408985|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
130392803|NCT01203072|469408988|FG000|Overall Study|Adverse Event|5|||
130392804|NCT01203072|469408989|FG001|Overall Study|Adverse Event|3|||
130392805|NCT01203072|469408990|FG002|Overall Study|Adverse Event|2|||
130392806|NCT01203072|469408991|FG003|Overall Study|Adverse Event|4|||
130392807|NCT01203072|469408992|FG004|Overall Study|Adverse Event|2|||
130392808|NCT01203072|469408988|FG000|Overall Study|Lack of Efficacy|1|||
130392809|NCT01203072|469408989|FG001|Overall Study|Lack of Efficacy|0|||
130392810|NCT01203072|469408990|FG002|Overall Study|Lack of Efficacy|0|||
130392811|NCT01203072|469408991|FG003|Overall Study|Lack of Efficacy|0|||
130392812|NCT01203072|469408992|FG004|Overall Study|Lack of Efficacy|0|||
130392813|NCT01203072|469408988|FG000|Overall Study|Lost to Follow-up|0|||
130392814|NCT01203072|469408989|FG001|Overall Study|Lost to Follow-up|1|||
130392815|NCT01203072|469408990|FG002|Overall Study|Lost to Follow-up|0|||
130392816|NCT01203072|469408991|FG003|Overall Study|Lost to Follow-up|0|||
130392817|NCT01203072|469408992|FG004|Overall Study|Lost to Follow-up|0|||
130392818|NCT01203072|469408988|FG000|Overall Study|Protocol Violation|2|||
130392819|NCT01203072|469408989|FG001|Overall Study|Protocol Violation|0|||
130392820|NCT01203072|469408990|FG002|Overall Study|Protocol Violation|0|||
130392821|NCT01203072|469408991|FG003|Overall Study|Protocol Violation|0|||
130392822|NCT01203072|469408992|FG004|Overall Study|Protocol Violation|1|||
130392823|NCT01203072|469408988|FG000|Overall Study|Withdrawal by Subject|2|||
130392824|NCT01203072|469408989|FG001|Overall Study|Withdrawal by Subject|2|||
130392825|NCT01203072|469408990|FG002|Overall Study|Withdrawal by Subject|1|||
130392826|NCT01203072|469408991|FG003|Overall Study|Withdrawal by Subject|2|||
130392827|NCT01203072|469408992|FG004|Overall Study|Withdrawal by Subject|3|||
130392828|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
130392829|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
130392830|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
130392831|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
130392832|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
130392833|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
130392834|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
130392835|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
130392836|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
130470393|NCT00448669|469688297|FG000|Overall Study|Were withdrawn by investigator|10|||
130470394|NCT00448669|469688298|FG001|Overall Study|Were withdrawn by investigator|6|||
130470395|NCT00448669|469688297|FG000|Overall Study|Death|2|||
130392837|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
130392838|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
130392839|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
130392840|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
130392841|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
130392842|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
130392843|NCT03735667|469409003|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
130470396|NCT00448669|469688298|FG001|Overall Study|Death|4|||
130470397|NCT00448669|469688297|FG000|Overall Study|Had other reasons|5|||
130470398|NCT00448669|469688298|FG001|Overall Study|Had other reasons|6|||
130392844|NCT03735667|469409004|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
130392845|NCT03735667|469409005|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
130392846|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
130392847|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
130392848|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
130392849|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
130392850|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
130392851|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
130392852|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
130392853|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
130392854|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
130392855|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
130392856|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
130392857|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
130392858|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
130392859|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
130392860|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
130392861|NCT03735667|469409003|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
130392862|NCT03735667|469409004|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
130392863|NCT03735667|469409005|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
130392864|NCT01987427|469409008|FG000|Overall Study|Adverse Event|4|||
130392865|NCT01987427|469409009|FG001|Overall Study|Adverse Event|2|||
130392866|NCT01987427|469409010|FG002|Overall Study|Adverse Event|8|||
130722859|NCT02968849|470609761|FG000|Overall Study|Lost to Follow-up|31|||
130392867|NCT01987427|469409008|FG000|Overall Study|Lost to Follow-up|6|||
130392868|NCT01987427|469409009|FG001|Overall Study|Lost to Follow-up|6|||
130392869|NCT01987427|469409010|FG002|Overall Study|Lost to Follow-up|9|||
130392870|NCT01987427|469409008|FG000|Overall Study|Withdrawal by Subject|2|||
130392871|NCT01987427|469409009|FG001|Overall Study|Withdrawal by Subject|1|||
130392872|NCT01987427|469409010|FG002|Overall Study|Withdrawal by Subject|3|||
130392873|NCT01987427|469409008|FG000|Overall Study|Lack of Efficacy|1|||
130392874|NCT01987427|469409009|FG001|Overall Study|Lack of Efficacy|0|||
130392875|NCT01987427|469409010|FG002|Overall Study|Lack of Efficacy|0|||
130392876|NCT01987427|469409008|FG000|Overall Study|Other|1|||
130392877|NCT01987427|469409009|FG001|Overall Study|Other|1|||
130392878|NCT01987427|469409010|FG002|Overall Study|Other|0|||
130392879|NCT02547129|469409014|FG000|Overall Study|Difficulty with ongoing infection|1|||
130392880|NCT02547129|469409015|FG001|Overall Study|Difficulty with ongoing infection|0|||
130392881|NCT00805766|469409016|FG000|Screening Period|Adverse Event|1|||
130392882|NCT00805766|469409016|FG000|Screening Period|Lack of Efficacy|2|||
130392883|NCT00805766|469409016|FG000|Screening Period|Pregnancy|1|||
130392884|NCT00805766|469409016|FG000|Screening Period|Responder|2|||
130392885|NCT00805766|469409016|FG000|Increased Dose Period|Adverse Event|4|||
130392886|NCT00805766|469409016|FG000|Increased Dose Period|Lack of Efficacy|7|||
130392887|NCT00805766|469409016|FG000|Increased Dose Period|Pregnancy|1|||
130392888|NCT00805766|469409016|FG000|Increased Dose Period|Withdrawal by Subject|1|||
130392889|NCT03925324|469409017|FG000|Overall Study|Death|1|||
130392890|NCT03925324|469409018|FG001|Overall Study|Death|1|||
130392891|NCT02063737|469409021|FG000|Overall Study|Lost to Follow-up|11|||
130392892|NCT02063737|469409022|FG001|Overall Study|Lost to Follow-up|4|||
130392893|NCT02159521|469409023|FG000|Overall Study|Enrolled but not treated|3|||
130392894|NCT02159521|469409023|FG000|Overall Study|Withdrawal by Subject|7|||
130392895|NCT02159521|469409023|FG000|Overall Study|Lost to Follow-up|6|||
130392896|NCT02159521|469409023|FG000|Overall Study|Death|1|||
130392897|NCT02159521|469409023|FG000|Overall Study|Other than specified|1|||
130392898|NCT00694369|469409026|FG000|Overall Study|Adverse Event|0|||
130392899|NCT00694369|469409027|FG001|Overall Study|Adverse Event|1|||
130392900|NCT00694369|469409028|FG002|Overall Study|Adverse Event|0|||
130392901|NCT00694369|469409029|FG003|Overall Study|Adverse Event|1|||
130722860|NCT02968849|470609762|FG001|Overall Study|Lost to Follow-up|29|||
130722861|NCT02968849|470609761|FG000|Overall Study|Withdrawal by Subject|73|||
130722862|NCT02968849|470609762|FG001|Overall Study|Withdrawal by Subject|64|||
130392902|NCT00694369|469409030|FG004|Overall Study|Adverse Event|3|||
130392903|NCT00694369|469409026|FG000|Overall Study|Lost to Follow-up|0|||
130392904|NCT00694369|469409027|FG001|Overall Study|Lost to Follow-up|0|||
130392905|NCT00694369|469409028|FG002|Overall Study|Lost to Follow-up|1|||
130392906|NCT00694369|469409029|FG003|Overall Study|Lost to Follow-up|1|||
130392907|NCT00694369|469409030|FG004|Overall Study|Lost to Follow-up|0|||
130392908|NCT00694369|469409026|FG000|Overall Study|Physician Decision|0|||
130392909|NCT00694369|469409027|FG001|Overall Study|Physician Decision|0|||
130392910|NCT00694369|469409028|FG002|Overall Study|Physician Decision|0|||
130392911|NCT00694369|469409029|FG003|Overall Study|Physician Decision|0|||
130392912|NCT00694369|469409030|FG004|Overall Study|Physician Decision|1|||
130392913|NCT00694369|469409026|FG000|Overall Study|Protocol Violation|0|||
130392914|NCT00694369|469409027|FG001|Overall Study|Protocol Violation|1|||
130392915|NCT00694369|469409028|FG002|Overall Study|Protocol Violation|0|||
130392916|NCT00694369|469409029|FG003|Overall Study|Protocol Violation|0|||
130722863|NCT02968849|470609761|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
130392917|NCT00694369|469409030|FG004|Overall Study|Protocol Violation|0|||
130392918|NCT00694369|469409026|FG000|Overall Study|Withdrawal by Subject|1|||
130392919|NCT00694369|469409027|FG001|Overall Study|Withdrawal by Subject|1|||
130392920|NCT00694369|469409028|FG002|Overall Study|Withdrawal by Subject|1|||
130392921|NCT00694369|469409029|FG003|Overall Study|Withdrawal by Subject|1|||
130392922|NCT00694369|469409030|FG004|Overall Study|Withdrawal by Subject|2|||
130722864|NCT02968849|470609762|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
130722865|NCT02968849|470609761|FG000|Overall Study|Physician Decision|6|||
130722866|NCT02968849|470609762|FG001|Overall Study|Physician Decision|9|||
130722867|NCT02968849|470609761|FG000|Overall Study|Other|16|||
130722868|NCT02968849|470609762|FG001|Overall Study|Other|10|||
130722869|NCT02013674|470609765|FG000|Overall Study|Death|0|||
130722870|NCT02013674|470609766|FG001|Overall Study|Death|1|||
130722871|NCT02013674|470609765|FG000|Overall Study|Lost to Follow-up|1|||
130722872|NCT02013674|470609766|FG001|Overall Study|Lost to Follow-up|0|||
130722873|NCT00416884|470609767|FG000|Overall Study|Study terminated due to low accrual|1|||
130722874|NCT02203331|470609768|FG000|Overall Study|Pregnancy|1|||
130722875|NCT02203331|470609769|FG001|Overall Study|Pregnancy|0|||
130722876|NCT02203331|470609770|FG002|Overall Study|Pregnancy|0|||
130722877|NCT02203331|470609771|FG003|Overall Study|Pregnancy|0|||
130722878|NCT02203331|470609772|FG004|Overall Study|Pregnancy|2|||
130722879|NCT02203331|470609773|FG005|Overall Study|Pregnancy|0|||
130722880|NCT02203331|470609768|FG000|Overall Study|Withdrawal by Subject|1|||
130722881|NCT02203331|470609769|FG001|Overall Study|Withdrawal by Subject|0|||
130722882|NCT02203331|470609770|FG002|Overall Study|Withdrawal by Subject|1|||
130722883|NCT02203331|470609771|FG003|Overall Study|Withdrawal by Subject|0|||
130722884|NCT02203331|470609772|FG004|Overall Study|Withdrawal by Subject|0|||
130722885|NCT02203331|470609773|FG005|Overall Study|Withdrawal by Subject|3|||
130722886|NCT02203331|470609768|FG000|Overall Study|Adverse Event|4|||
130722887|NCT02203331|470609769|FG001|Overall Study|Adverse Event|8|||
130722888|NCT02203331|470609770|FG002|Overall Study|Adverse Event|3|||
130722889|NCT02203331|470609771|FG003|Overall Study|Adverse Event|4|||
130722890|NCT02203331|470609772|FG004|Overall Study|Adverse Event|3|||
130722891|NCT02203331|470609773|FG005|Overall Study|Adverse Event|3|||
130722892|NCT02203331|470609768|FG000|Overall Study|Other Reasons|1|||
130722893|NCT02203331|470609769|FG001|Overall Study|Other Reasons|2|||
130722894|NCT02203331|470609770|FG002|Overall Study|Other Reasons|0|||
130722895|NCT02203331|470609771|FG003|Overall Study|Other Reasons|2|||
130722896|NCT02203331|470609772|FG004|Overall Study|Other Reasons|0|||
130722897|NCT02203331|470609773|FG005|Overall Study|Other Reasons|0|||
130722898|NCT02203331|470609768|FG000|Overall Study|Lack of Efficacy|0|||
130722899|NCT02203331|470609769|FG001|Overall Study|Lack of Efficacy|2|||
130722900|NCT02203331|470609770|FG002|Overall Study|Lack of Efficacy|1|||
130722901|NCT02203331|470609771|FG003|Overall Study|Lack of Efficacy|0|||
130722902|NCT02203331|470609772|FG004|Overall Study|Lack of Efficacy|0|||
130722903|NCT02203331|470609773|FG005|Overall Study|Lack of Efficacy|1|||
130722904|NCT02203331|470609768|FG000|Overall Study|Protocol Violation|0|||
130722905|NCT02203331|470609769|FG001|Overall Study|Protocol Violation|2|||
130722906|NCT02203331|470609770|FG002|Overall Study|Protocol Violation|0|||
130722907|NCT02203331|470609771|FG003|Overall Study|Protocol Violation|1|||
130722908|NCT02203331|470609772|FG004|Overall Study|Protocol Violation|1|||
130722909|NCT02203331|470609773|FG005|Overall Study|Protocol Violation|0|||
130722910|NCT02203331|470609768|FG000|Overall Study|Lost to Follow-up|0|||
130722911|NCT02203331|470609769|FG001|Overall Study|Lost to Follow-up|0|||
130722912|NCT02203331|470609770|FG002|Overall Study|Lost to Follow-up|0|||
130722913|NCT02203331|470609771|FG003|Overall Study|Lost to Follow-up|0|||
130722914|NCT02203331|470609772|FG004|Overall Study|Lost to Follow-up|1|||
130722915|NCT02203331|470609773|FG005|Overall Study|Lost to Follow-up|0|||
130722916|NCT00704730|470609780|FG000|Overall Study|Adverse Event|35|||
130722917|NCT00704730|470609781|FG001|Overall Study|Adverse Event|9|||
130722918|NCT00704730|470609780|FG000|Overall Study|Death|11|||
130722919|NCT00704730|470609781|FG001|Overall Study|Death|5|||
130722920|NCT00704730|470609780|FG000|Overall Study|Physician Decision|2|||
130722921|NCT00704730|470609781|FG001|Overall Study|Physician Decision|0|||
130722922|NCT00704730|470609780|FG000|Overall Study|Did not receive drug|5|||
130722923|NCT00704730|470609781|FG001|Overall Study|Did not receive drug|2|||
130722924|NCT00704730|470609780|FG000|Overall Study|Disease progression per PI|58|||
130722925|NCT00704730|470609781|FG001|Overall Study|Disease progression per PI|67|||
130722926|NCT00704730|470609780|FG000|Overall Study|data unavailable|1|||
130722927|NCT00704730|470609781|FG001|Overall Study|data unavailable|0|||
130722928|NCT00704730|470609780|FG000|Overall Study|Withdrawal by Subject|9|||
130722929|NCT00704730|470609781|FG001|Overall Study|Withdrawal by Subject|13|||
130392923|NCT00907374|469409033|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
130392924|NCT00907374|469409034|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
130722930|NCT05065567|470609783|FG000|Overall Study|Lost to Follow-up|10|||
130722931|NCT05065567|470609784|FG001|Overall Study|Lost to Follow-up|9|||
130722932|NCT05065567|470609785|FG002|Overall Study|Lost to Follow-up|6|||
130722933|NCT04051619|470609786|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
130722934|NCT04051619|470609787|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
130722935|NCT04051619|470609786|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130722936|NCT04051619|470609787|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130722937|NCT03510598|470611256|FG000|Overall Study|Withdrawal by Subject|1|||
130722938|NCT02886624|470611259|FG000|12-week Post Treatment Follow-up|Death|1|||
130722939|NCT02886624|470611259|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
130722940|NCT01664130|470611264|FG000|Overall Study|competing secondary disease|2|||
130722941|NCT00554606|470611265|FG000|Overall Study|Adverse Event|3|||
130722942|NCT00554606|470611265|FG000|Overall Study|Abnormal laboratory values|1|||
130722943|NCT00554606|470611265|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
130722944|NCT00554606|470611265|FG000|Overall Study|Subject withdrew consent|2|||
130722945|NCT00554606|470611265|FG000|Overall Study|Lost to Follow-up|2|||
130722946|NCT00554606|470611265|FG000|Overall Study|Administrative problems|60|||
130722947|NCT00554606|470611265|FG000|Overall Study|Death|1|||
130722948|NCT00554606|470611265|FG000|Overall Study|Protocol deviation|2|||
130722949|NCT03323437|470611266|FG000|Overall Study|Withdrawal by Subject|0|||
130722950|NCT03323437|470611267|FG001|Overall Study|Withdrawal by Subject|4|||
130722951|NCT01305044|470611273|FG000|Overall Study|Withdrawal by Subject|3|||
130722952|NCT01305044|470611274|FG001|Overall Study|Withdrawal by Subject|6|||
130722953|NCT03257865|470611281|FG000|Overall Study|Adverse Event|4|||
130722954|NCT03257865|470611282|FG001|Overall Study|Adverse Event|8|||
130722955|NCT03257865|470611281|FG000|Overall Study|Lack of Efficacy|1|||
130392925|NCT00594464|469409037|FG000|Overall Study|Withdrawal by Subject|1|||
130392926|NCT00594464|469409037|FG000|Overall Study|Delay in operation|2|||
130392927|NCT00775437|469409038|FG000|Overall Study|Loss of efficacy|2|||
130392928|NCT00775437|469409038|FG000|Overall Study|Withdrawal by Subject|3|||
130392929|NCT00775437|469409038|FG000|Overall Study|Lost to Follow-up|1|||
130392930|NCT03131440|469409039|FG000|Overall Study|Withdrawal by Subject|1|||
130392931|NCT03131440|469409040|FG001|Overall Study|Withdrawal by Subject|3|||
130392932|NCT03131440|469409041|FG002|Overall Study|Withdrawal by Subject|0|||
130392933|NCT03131440|469409042|FG003|Overall Study|Withdrawal by Subject|0|||
130392934|NCT03131440|469409043|FG004|Overall Study|Withdrawal by Subject|1|||
130392935|NCT03131440|469409044|FG005|Overall Study|Withdrawal by Subject|0|||
130392936|NCT03131440|469409045|FG006|Overall Study|Withdrawal by Subject|0|||
130392937|NCT03131440|469409046|FG007|Overall Study|Withdrawal by Subject|1|||
130392938|NCT03131440|469409047|FG008|Overall Study|Withdrawal by Subject|1|||
130392939|NCT03131440|469409048|FG009|Overall Study|Withdrawal by Subject|1|||
130392940|NCT03131440|469409049|FG010|Overall Study|Withdrawal by Subject|0|||
130392941|NCT03131440|469409050|FG011|Overall Study|Withdrawal by Subject|1|||
130392942|NCT03131440|469409051|FG012|Overall Study|Withdrawal by Subject|1|||
130392943|NCT03131440|469409052|FG013|Overall Study|Withdrawal by Subject|0|||
130392944|NCT03131440|469409053|FG014|Overall Study|Withdrawal by Subject|1|||
130392945|NCT03131440|469409054|FG015|Overall Study|Withdrawal by Subject|0|||
130392946|NCT03131440|469409055|FG016|Overall Study|Withdrawal by Subject|0|||
130392947|NCT03131440|469409056|FG017|Overall Study|Withdrawal by Subject|0|||
130392948|NCT03131440|469409057|FG018|Overall Study|Withdrawal by Subject|1|||
130392949|NCT03131440|469409058|FG019|Overall Study|Withdrawal by Subject|0|||
130392950|NCT03131440|469409059|FG020|Overall Study|Withdrawal by Subject|1|||
130392951|NCT03131440|469409060|FG021|Overall Study|Withdrawal by Subject|1|||
130392952|NCT03131440|469409061|FG022|Overall Study|Withdrawal by Subject|1|||
130392953|NCT03131440|469409062|FG023|Overall Study|Withdrawal by Subject|0|||
130392954|NCT03131440|469409063|FG024|Overall Study|Withdrawal by Subject|0|||
130392955|NCT03131440|469409064|FG025|Overall Study|Withdrawal by Subject|0|||
130392956|NCT03131440|469409065|FG026|Overall Study|Withdrawal by Subject|0|||
130392957|NCT03131440|469409066|FG027|Overall Study|Withdrawal by Subject|0|||
130392958|NCT03131440|469409067|FG028|Overall Study|Withdrawal by Subject|0|||
130392959|NCT03131440|469409068|FG029|Overall Study|Withdrawal by Subject|0|||
130392960|NCT03131440|469409069|FG030|Overall Study|Withdrawal by Subject|1|||
130470399|NCT00448669|469688297|FG000|Overall Study|HIV-infected at enrollment|1|||
130470400|NCT00448669|469688298|FG001|Overall Study|HIV-infected at enrollment|2|||
130722956|NCT03257865|470611282|FG001|Overall Study|Lack of Efficacy|2|||
130722957|NCT03257865|470611281|FG000|Overall Study|Non-compliance with Study Drug|0|||
130722958|NCT03257865|470611282|FG001|Overall Study|Non-compliance with Study Drug|2|||
130722959|NCT03257865|470611281|FG000|Overall Study|Withdrawal by Subject|23|||
130722960|NCT03257865|470611282|FG001|Overall Study|Withdrawal by Subject|17|||
130722961|NCT03257865|470611281|FG000|Overall Study|Physician Decision|3|||
130722962|NCT03257865|470611282|FG001|Overall Study|Physician Decision|1|||
130392961|NCT03131440|469409070|FG031|Overall Study|Withdrawal by Subject|0|||
130392962|NCT03131440|469409039|FG000|Overall Study|Lost to Follow-up|0|||
130392963|NCT03131440|469409040|FG001|Overall Study|Lost to Follow-up|0|||
130392964|NCT03131440|469409041|FG002|Overall Study|Lost to Follow-up|0|||
130392965|NCT03131440|469409042|FG003|Overall Study|Lost to Follow-up|0|||
130392966|NCT03131440|469409043|FG004|Overall Study|Lost to Follow-up|0|||
130392967|NCT03131440|469409044|FG005|Overall Study|Lost to Follow-up|1|||
130722963|NCT03257865|470611281|FG000|Overall Study|Other|0|||
130722964|NCT03257865|470611282|FG001|Overall Study|Other|1|||
130392968|NCT03131440|469409045|FG006|Overall Study|Lost to Follow-up|0|||
130392969|NCT03131440|469409046|FG007|Overall Study|Lost to Follow-up|0|||
130392970|NCT03131440|469409047|FG008|Overall Study|Lost to Follow-up|0|||
130392971|NCT03131440|469409048|FG009|Overall Study|Lost to Follow-up|0|||
130392972|NCT03131440|469409049|FG010|Overall Study|Lost to Follow-up|0|||
130392973|NCT03131440|469409050|FG011|Overall Study|Lost to Follow-up|0|||
130392974|NCT03131440|469409051|FG012|Overall Study|Lost to Follow-up|0|||
130392975|NCT03131440|469409052|FG013|Overall Study|Lost to Follow-up|0|||
130392976|NCT03131440|469409053|FG014|Overall Study|Lost to Follow-up|0|||
130392977|NCT03131440|469409054|FG015|Overall Study|Lost to Follow-up|0|||
130392978|NCT03131440|469409055|FG016|Overall Study|Lost to Follow-up|0|||
130392979|NCT03131440|469409056|FG017|Overall Study|Lost to Follow-up|0|||
130392980|NCT03131440|469409057|FG018|Overall Study|Lost to Follow-up|0|||
130392981|NCT03131440|469409058|FG019|Overall Study|Lost to Follow-up|2|||
130392982|NCT03131440|469409059|FG020|Overall Study|Lost to Follow-up|1|||
130392983|NCT03131440|469409060|FG021|Overall Study|Lost to Follow-up|0|||
130392984|NCT03131440|469409061|FG022|Overall Study|Lost to Follow-up|1|||
130392985|NCT03131440|469409062|FG023|Overall Study|Lost to Follow-up|0|||
130392986|NCT03131440|469409063|FG024|Overall Study|Lost to Follow-up|1|||
130392987|NCT03131440|469409064|FG025|Overall Study|Lost to Follow-up|0|||
130392988|NCT03131440|469409065|FG026|Overall Study|Lost to Follow-up|0|||
130392989|NCT03131440|469409066|FG027|Overall Study|Lost to Follow-up|2|||
130392990|NCT03131440|469409067|FG028|Overall Study|Lost to Follow-up|0|||
130392991|NCT03131440|469409068|FG029|Overall Study|Lost to Follow-up|2|||
130392992|NCT03131440|469409069|FG030|Overall Study|Lost to Follow-up|0|||
130392993|NCT03131440|469409070|FG031|Overall Study|Lost to Follow-up|0|||
130392994|NCT03131440|469409039|FG000|Overall Study|Death|0|||
130392995|NCT03131440|469409040|FG001|Overall Study|Death|0|||
130392996|NCT03131440|469409041|FG002|Overall Study|Death|0|||
130392997|NCT03131440|469409042|FG003|Overall Study|Death|0|||
130392998|NCT03131440|469409043|FG004|Overall Study|Death|0|||
130392999|NCT03131440|469409044|FG005|Overall Study|Death|0|||
130393000|NCT03131440|469409045|FG006|Overall Study|Death|0|||
130393001|NCT03131440|469409046|FG007|Overall Study|Death|0|||
130393002|NCT03131440|469409047|FG008|Overall Study|Death|0|||
130393003|NCT03131440|469409048|FG009|Overall Study|Death|0|||
130393004|NCT03131440|469409049|FG010|Overall Study|Death|0|||
130393005|NCT03131440|469409050|FG011|Overall Study|Death|0|||
130393006|NCT03131440|469409051|FG012|Overall Study|Death|0|||
130393007|NCT03131440|469409052|FG013|Overall Study|Death|0|||
130722965|NCT03257865|470611281|FG000|Overall Study|Lost to Follow-up|4|||
130722966|NCT03257865|470611282|FG001|Overall Study|Lost to Follow-up|4|||
130722967|NCT02677714|470611283|FG000|Overall Study|Withdrawal by Subject|2|||
130722968|NCT02677714|470611284|FG001|Overall Study|Withdrawal by Subject|0|||
130722969|NCT04628793|470611285|FG000|Overall Study|Study terminated by sponsor|0|||
130722970|NCT04628793|470611286|FG001|Overall Study|Study terminated by sponsor|0|||
130722971|NCT04628793|470611287|FG002|Overall Study|Study terminated by sponsor|8|||
130722972|NCT04628793|470611285|FG000|Overall Study|Withdrawal by Subject|2|||
130722973|NCT04628793|470611286|FG001|Overall Study|Withdrawal by Subject|3|||
130722974|NCT04628793|470611287|FG002|Overall Study|Withdrawal by Subject|0|||
130722975|NCT04628793|470611285|FG000|Overall Study|Lost to Follow-up|0|||
130722976|NCT04628793|470611286|FG001|Overall Study|Lost to Follow-up|1|||
130722977|NCT04628793|470611287|FG002|Overall Study|Lost to Follow-up|0|||
130722978|NCT04015908|470611290|FG000|Overall Study|Lost to Follow-up|0|||
130722979|NCT04015908|470611291|FG001|Overall Study|Lost to Follow-up|1|||
130722980|NCT02538965|470611292|FG000|Treatment Period|Other = Death due to disease progression|1|||
130722981|NCT02538965|470611292|FG000|Treatment Period|Adverse Event|2|||
130722982|NCT02538965|470611292|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130722983|NCT02538965|470611292|FG000|Treatment Period|Treatment Failure|9|||
130722984|NCT02538965|470611292|FG000|Treatment Period|Disease Progression|1|||
130722985|NCT02538965|470611292|FG000|Treatment Period|Physician Decision|2|||
130722986|NCT02538965|470611292|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
130722987|NCT02538965|470611292|FG000|Follow-Up Period|Withdrawal by Parent|4|||
130722988|NCT03200912|470611293|FG000|Overall Study|Adverse Event|3|||
130722989|NCT03200912|470611294|FG001|Overall Study|Adverse Event|0|||
130722990|NCT03200912|470611295|FG002|Overall Study|Adverse Event|0|||
130393008|NCT03131440|469409053|FG014|Overall Study|Death|0|||
130393009|NCT03131440|469409054|FG015|Overall Study|Death|0|||
130393010|NCT03131440|469409055|FG016|Overall Study|Death|0|||
130393011|NCT03131440|469409056|FG017|Overall Study|Death|0|||
130722991|NCT03200912|470611293|FG000|Overall Study|Withdrawal by Subject|1|||
130722992|NCT03200912|470611294|FG001|Overall Study|Withdrawal by Subject|2|||
130393012|NCT03131440|469409057|FG018|Overall Study|Death|0|||
130393013|NCT03131440|469409058|FG019|Overall Study|Death|0|||
130393014|NCT03131440|469409059|FG020|Overall Study|Death|0|||
130393015|NCT03131440|469409060|FG021|Overall Study|Death|0|||
130393016|NCT03131440|469409061|FG022|Overall Study|Death|0|||
130393017|NCT03131440|469409062|FG023|Overall Study|Death|0|||
130393018|NCT03131440|469409063|FG024|Overall Study|Death|0|||
130393019|NCT03131440|469409064|FG025|Overall Study|Death|1|||
130393020|NCT03131440|469409065|FG026|Overall Study|Death|0|||
130393021|NCT03131440|469409066|FG027|Overall Study|Death|0|||
130393022|NCT03131440|469409067|FG028|Overall Study|Death|0|||
130393023|NCT03131440|469409068|FG029|Overall Study|Death|0|||
130393024|NCT03131440|469409069|FG030|Overall Study|Death|0|||
130393025|NCT03131440|469409070|FG031|Overall Study|Death|0|||
130393026|NCT00746941|469409073|FG000|Overall Study|Death|2|||
130393027|NCT00746941|469409074|FG001|Overall Study|Death|0|||
130393028|NCT00746941|469409075|FG002|Overall Study|Death|0|||
130393029|NCT00746941|469409076|FG003|Overall Study|Death|6|||
130393030|NCT00746941|469409073|FG000|Overall Study|Physician Decision|0|||
130393031|NCT00746941|469409074|FG001|Overall Study|Physician Decision|0|||
130393032|NCT00746941|469409075|FG002|Overall Study|Physician Decision|2|||
130393033|NCT00746941|469409076|FG003|Overall Study|Physician Decision|0|||
130393034|NCT00746941|469409073|FG000|Overall Study|Withdrawal by Subject|3|||
130393035|NCT00746941|469409074|FG001|Overall Study|Withdrawal by Subject|0|||
130393036|NCT00746941|469409075|FG002|Overall Study|Withdrawal by Subject|0|||
130393037|NCT00746941|469409076|FG003|Overall Study|Withdrawal by Subject|2|||
130393038|NCT00746941|469409073|FG000|Overall Study|Other, reason not provided|2|||
130393039|NCT00746941|469409074|FG001|Overall Study|Other, reason not provided|4|||
130393040|NCT00746941|469409075|FG002|Overall Study|Other, reason not provided|0|||
130393041|NCT00746941|469409076|FG003|Overall Study|Other, reason not provided|4|||
130393042|NCT00746941|469409073|FG000|Overall Study|Adverse Event|0|||
130393043|NCT00746941|469409074|FG001|Overall Study|Adverse Event|0|||
130393044|NCT00746941|469409075|FG002|Overall Study|Adverse Event|0|||
130393045|NCT00746941|469409076|FG003|Overall Study|Adverse Event|1|||
130393046|NCT03316885|469409077|FG000|Overall Study|Adverse Event|1|||
130393047|NCT03316885|469409077|FG000|Overall Study|Death|10|||
130393048|NCT03316885|469409077|FG000|Overall Study|Lost to Follow-up|4|||
130393049|NCT03316885|469409077|FG000|Overall Study|Withdrawal by Subject|9|||
130393050|NCT03316885|469409077|FG000|Overall Study|COVID related|8|||
130393051|NCT04371380|469409078|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
130393052|NCT04371380|469409079|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
130393053|NCT04371380|469409080|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
130393054|NCT00680901|469409089|FG000|Overall Study|Ongoing: On Study Treatment|1|||
130393055|NCT00680901|469409090|FG001|Overall Study|Ongoing: On Study Treatment|0|||
130393056|NCT00680901|469409089|FG000|Overall Study|Ongoing: In Follow Up|1|||
130393057|NCT00680901|469409090|FG001|Overall Study|Ongoing: In Follow Up|0|||
130393058|NCT00680901|469409089|FG000|Overall Study|Adverse Event|1|||
130393059|NCT00680901|469409090|FG001|Overall Study|Adverse Event|1|||
130393060|NCT00680901|469409089|FG000|Overall Study|Lost to Follow-up|3|||
130393061|NCT00680901|469409090|FG001|Overall Study|Lost to Follow-up|5|||
130393062|NCT00680901|469409089|FG000|Overall Study|Subject decided to withdraw from the study|4|||
130393063|NCT00680901|469409090|FG001|Overall Study|Subject decided to withdraw from the study|15|||
130393064|NCT00680901|469409089|FG000|Overall Study|Sponsor decision|1|||
130393065|NCT00680901|469409090|FG001|Overall Study|Sponsor decision|0|||
130393066|NCT00680901|469409089|FG000|Overall Study|Physician Decision|0|||
130393067|NCT00680901|469409090|FG001|Overall Study|Physician Decision|2|||
130393068|NCT00680901|469409089|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
130393069|NCT00680901|469409090|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
130393070|NCT00680901|469409089|FG000|Overall Study|Other protocol defined stopping criteria|17|||
130393071|NCT00680901|469409090|FG001|Overall Study|Other protocol defined stopping criteria|17|||
130393072|NCT04809220|469409093|FG000|Overall Study|Adverse Event|4|||
130393073|NCT04809220|469409094|FG001|Overall Study|Adverse Event|0|||
130393074|NCT04809220|469409093|FG000|Overall Study|Death|1|||
130393075|NCT04809220|469409094|FG001|Overall Study|Death|0|||
130393076|NCT04809220|469409093|FG000|Overall Study|Lost to Follow-up|3|||
130393077|NCT04809220|469409094|FG001|Overall Study|Lost to Follow-up|0|||
130393078|NCT04809220|469409093|FG000|Overall Study|Physician Decision|0|||
130393079|NCT04809220|469409094|FG001|Overall Study|Physician Decision|1|||
130393080|NCT04809220|469409093|FG000|Overall Study|Withdrawal by Subject|9|||
130393081|NCT04809220|469409094|FG001|Overall Study|Withdrawal by Subject|5|||
130393082|NCT04809220|469409093|FG000|Overall Study|Due to long-term overseas business trips|1|||
130393083|NCT04809220|469409094|FG001|Overall Study|Due to long-term overseas business trips|0|||
130393084|NCT01062555|469409095|FG000|Phase 1|Death|10|||
130393085|NCT01062555|469409096|FG001|Phase 1|Death|17|||
130393086|NCT01062555|469409097|FG002|Phase 1|Death|0|||
130393087|NCT01062555|469409098|FG003|Phase 1|Death|0|||
130393088|NCT01062555|469409095|FG000|Phase 1|Graft Failure|12|||
130393089|NCT01062555|469409096|FG001|Phase 1|Graft Failure|8|||
130393090|NCT01062555|469409097|FG002|Phase 1|Graft Failure|0|||
130393091|NCT01062555|469409098|FG003|Phase 1|Graft Failure|0|||
130393092|NCT01062555|469409095|FG000|Phase 1|Withdrawal by Subject|1|||
130393093|NCT01062555|469409096|FG001|Phase 1|Withdrawal by Subject|1|||
130393094|NCT01062555|469409097|FG002|Phase 1|Withdrawal by Subject|0|||
130393095|NCT01062555|469409098|FG003|Phase 1|Withdrawal by Subject|0|||
130393096|NCT01062555|469409095|FG000|Phase 2|Death|0|||
130393097|NCT01062555|469409096|FG001|Phase 2|Death|0|||
130393098|NCT01062555|469409097|FG002|Phase 2|Death|8|||
130393099|NCT01062555|469409098|FG003|Phase 2|Death|3|||
130393100|NCT01062555|469409095|FG000|Phase 2|Graft failure|0|||
130393101|NCT01062555|469409096|FG001|Phase 2|Graft failure|0|||
130393102|NCT01062555|469409097|FG002|Phase 2|Graft failure|7|||
130393103|NCT01062555|469409098|FG003|Phase 2|Graft failure|4|||
130393104|NCT01062555|469409095|FG000|Phase 2|Withdrawal by Subject|0|||
130393105|NCT01062555|469409096|FG001|Phase 2|Withdrawal by Subject|0|||
130393106|NCT01062555|469409097|FG002|Phase 2|Withdrawal by Subject|0|||
130393107|NCT01062555|469409098|FG003|Phase 2|Withdrawal by Subject|7|||
130393108|NCT01062555|469409095|FG000|Phase 2|Protocol Violation|0|||
130393109|NCT01062555|469409096|FG001|Phase 2|Protocol Violation|0|||
130393110|NCT01062555|469409097|FG002|Phase 2|Protocol Violation|0|||
130393111|NCT01062555|469409098|FG003|Phase 2|Protocol Violation|3|||
130393112|NCT01062555|469409095|FG000|Phase 2|Physician Decision|0|||
130393113|NCT01062555|469409096|FG001|Phase 2|Physician Decision|0|||
130393114|NCT01062555|469409097|FG002|Phase 2|Physician Decision|0|||
130393115|NCT01062555|469409098|FG003|Phase 2|Physician Decision|17|||
130393116|NCT02641379|469409101|FG000|Overall Study|Exclusion criterion during screening|1|||
130393117|NCT02641379|469409102|FG001|Overall Study|Exclusion criterion during screening|0|||
130393118|NCT02641379|469409103|FG002|Overall Study|Exclusion criterion during screening|0|||
130393119|NCT02641379|469409104|FG003|Overall Study|Exclusion criterion during screening|1|||
130393120|NCT02641379|469409105|FG004|Overall Study|Exclusion criterion during screening|2|||
130393121|NCT02641379|469409106|FG005|Overall Study|Exclusion criterion during screening|0|||
130393122|NCT02641379|469409107|FG006|Overall Study|Exclusion criterion during screening|0|||
130393123|NCT02641379|469409108|FG007|Overall Study|Exclusion criterion during screening|0|||
130393124|NCT02641379|469409109|FG008|Overall Study|Exclusion criterion during screening|0|||
130393125|NCT02641379|469409110|FG009|Overall Study|Exclusion criterion during screening|0|||
130393126|NCT02641379|469409111|FG010|Overall Study|Exclusion criterion during screening|0|||
130393127|NCT02641379|469409101|FG000|Overall Study|Withdrawal of informed consent|0|||
130393128|NCT02641379|469409102|FG001|Overall Study|Withdrawal of informed consent|1|||
130393129|NCT02641379|469409103|FG002|Overall Study|Withdrawal of informed consent|0|||
130393130|NCT02641379|469409104|FG003|Overall Study|Withdrawal of informed consent|0|||
130393131|NCT02641379|469409105|FG004|Overall Study|Withdrawal of informed consent|0|||
130393132|NCT02641379|469409106|FG005|Overall Study|Withdrawal of informed consent|0|||
130393133|NCT02641379|469409107|FG006|Overall Study|Withdrawal of informed consent|0|||
130393134|NCT02641379|469409108|FG007|Overall Study|Withdrawal of informed consent|1|||
130393135|NCT02641379|469409109|FG008|Overall Study|Withdrawal of informed consent|0|||
130393136|NCT02641379|469409110|FG009|Overall Study|Withdrawal of informed consent|0|||
130393137|NCT02641379|469409111|FG010|Overall Study|Withdrawal of informed consent|0|||
130393138|NCT02641379|469409101|FG000|Overall Study|Adverse Event|7|||
130393139|NCT02641379|469409102|FG001|Overall Study|Adverse Event|8|||
130393140|NCT02641379|469409103|FG002|Overall Study|Adverse Event|2|||
130393141|NCT02641379|469409104|FG003|Overall Study|Adverse Event|2|||
130393142|NCT02641379|469409105|FG004|Overall Study|Adverse Event|5|||
130393143|NCT02641379|469409106|FG005|Overall Study|Adverse Event|1|||
130393144|NCT02641379|469409107|FG006|Overall Study|Adverse Event|5|||
130470401|NCT00448669|469688297|FG000|Overall Study|Never started drug|9|||
130470402|NCT00448669|469688298|FG001|Overall Study|Never started drug|7|||
130470403|NCT04287985|469688299|FG000|Overall Study|Adverse Event|1|||
130470404|NCT04287985|469688300|FG001|Overall Study|Adverse Event|0|||
130470405|NCT04287985|469688301|FG002|Overall Study|Adverse Event|0|||
130470406|NCT04287985|469688302|FG003|Overall Study|Adverse Event|0|||
130470407|NCT04287985|469688299|FG000|Overall Study|Protocol Violation|0|||
130470408|NCT04287985|469688300|FG001|Overall Study|Protocol Violation|1|||
130470409|NCT04287985|469688301|FG002|Overall Study|Protocol Violation|0|||
130470410|NCT04287985|469688302|FG003|Overall Study|Protocol Violation|0|||
130470411|NCT04287985|469688299|FG000|Overall Study|Physician Decision|0|||
130470412|NCT04287985|469688300|FG001|Overall Study|Physician Decision|0|||
130470413|NCT04287985|469688301|FG002|Overall Study|Physician Decision|0|||
130470414|NCT04287985|469688302|FG003|Overall Study|Physician Decision|1|||
130470415|NCT04287985|469688299|FG000|Overall Study|Withdrawal by Subject|2|||
130470416|NCT04287985|469688300|FG001|Overall Study|Withdrawal by Subject|1|||
130470417|NCT04287985|469688301|FG002|Overall Study|Withdrawal by Subject|1|||
130470418|NCT04287985|469688302|FG003|Overall Study|Withdrawal by Subject|2|||
130470419|NCT01340066|469688307|FG000|Placebo Run in Period|Screen Failures|27|||
130470420|NCT01340066|469688308|FG001|Placebo Run in Period|Screen Failures|0|||
130393145|NCT02641379|469409108|FG007|Overall Study|Adverse Event|0|||
130393146|NCT02641379|469409109|FG008|Overall Study|Adverse Event|1|||
130393147|NCT02641379|469409110|FG009|Overall Study|Adverse Event|1|||
130393148|NCT02641379|469409111|FG010|Overall Study|Adverse Event|5|||
130393149|NCT02641379|469409101|FG000|Overall Study|Lack of Efficacy|0|||
130470421|NCT01340066|469688309|FG002|Placebo Run in Period|Screen Failures|0|||
130470422|NCT01340066|469688307|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
130393150|NCT02641379|469409102|FG001|Overall Study|Lack of Efficacy|0|||
130393151|NCT02641379|469409103|FG002|Overall Study|Lack of Efficacy|2|||
130722993|NCT03200912|470611295|FG002|Overall Study|Withdrawal by Subject|4|||
130722994|NCT03200912|470611293|FG000|Overall Study|Non-compliance with study drug|0|||
130722995|NCT03200912|470611294|FG001|Overall Study|Non-compliance with study drug|1|||
130722996|NCT03200912|470611295|FG002|Overall Study|Non-compliance with study drug|0|||
130722997|NCT02309138|470611296|FG000|Overall Study|Withdrawal by Subject|44|||
130722998|NCT02309138|470611297|FG001|Overall Study|Withdrawal by Subject|15|||
130722999|NCT02309138|470611296|FG000|Overall Study|Protocol Violation|4|||
130723000|NCT02309138|470611297|FG001|Overall Study|Protocol Violation|2|||
130723001|NCT02309138|470611296|FG000|Overall Study|delivered before visit 2|0|||
130723002|NCT02309138|470611297|FG001|Overall Study|delivered before visit 2|1|||
130393152|NCT02641379|469409104|FG003|Overall Study|Lack of Efficacy|0|||
130393153|NCT02641379|469409105|FG004|Overall Study|Lack of Efficacy|0|||
130393154|NCT02641379|469409106|FG005|Overall Study|Lack of Efficacy|2|||
130393155|NCT02641379|469409107|FG006|Overall Study|Lack of Efficacy|0|||
130393156|NCT02641379|469409108|FG007|Overall Study|Lack of Efficacy|5|||
130393157|NCT02641379|469409109|FG008|Overall Study|Lack of Efficacy|0|||
130393158|NCT02641379|469409110|FG009|Overall Study|Lack of Efficacy|0|||
130393159|NCT02641379|469409111|FG010|Overall Study|Lack of Efficacy|0|||
130393160|NCT02641379|469409101|FG000|Overall Study|Participant unable to attend study visit|4|||
130393161|NCT02641379|469409102|FG001|Overall Study|Participant unable to attend study visit|10|||
130393162|NCT02641379|469409103|FG002|Overall Study|Participant unable to attend study visit|1|||
130393163|NCT02641379|469409104|FG003|Overall Study|Participant unable to attend study visit|2|||
130393164|NCT02641379|469409105|FG004|Overall Study|Participant unable to attend study visit|5|||
130393165|NCT02641379|469409106|FG005|Overall Study|Participant unable to attend study visit|1|||
130393166|NCT02641379|469409107|FG006|Overall Study|Participant unable to attend study visit|1|||
130393167|NCT02641379|469409108|FG007|Overall Study|Participant unable to attend study visit|1|||
130393168|NCT02641379|469409109|FG008|Overall Study|Participant unable to attend study visit|0|||
130393169|NCT02641379|469409110|FG009|Overall Study|Participant unable to attend study visit|2|||
130393170|NCT02641379|469409111|FG010|Overall Study|Participant unable to attend study visit|0|||
130393171|NCT02641379|469409101|FG000|Overall Study|Participant's compliance|0|||
130393172|NCT02641379|469409102|FG001|Overall Study|Participant's compliance|1|||
130393173|NCT02641379|469409103|FG002|Overall Study|Participant's compliance|0|||
130393174|NCT02641379|469409104|FG003|Overall Study|Participant's compliance|1|||
130393175|NCT02641379|469409105|FG004|Overall Study|Participant's compliance|0|||
130393176|NCT02641379|469409106|FG005|Overall Study|Participant's compliance|2|||
130393177|NCT02641379|469409107|FG006|Overall Study|Participant's compliance|0|||
130393178|NCT02641379|469409108|FG007|Overall Study|Participant's compliance|0|||
130393179|NCT02641379|469409109|FG008|Overall Study|Participant's compliance|1|||
130393180|NCT02641379|469409110|FG009|Overall Study|Participant's compliance|1|||
130393181|NCT02641379|469409111|FG010|Overall Study|Participant's compliance|1|||
130393182|NCT02641379|469409101|FG000|Overall Study|Participant cannot be reached|4|||
130393183|NCT02641379|469409102|FG001|Overall Study|Participant cannot be reached|4|||
130393184|NCT02641379|469409103|FG002|Overall Study|Participant cannot be reached|0|||
130393185|NCT02641379|469409104|FG003|Overall Study|Participant cannot be reached|8|||
130393186|NCT02641379|469409105|FG004|Overall Study|Participant cannot be reached|2|||
130393187|NCT02641379|469409106|FG005|Overall Study|Participant cannot be reached|1|||
130393188|NCT02641379|469409107|FG006|Overall Study|Participant cannot be reached|0|||
130393189|NCT02641379|469409108|FG007|Overall Study|Participant cannot be reached|1|||
130393190|NCT02641379|469409109|FG008|Overall Study|Participant cannot be reached|0|||
130393191|NCT02641379|469409110|FG009|Overall Study|Participant cannot be reached|2|||
130393192|NCT02641379|469409111|FG010|Overall Study|Participant cannot be reached|1|||
130393193|NCT02641379|469409101|FG000|Overall Study|PCR positive at Week 24|15|||
130393194|NCT02641379|469409102|FG001|Overall Study|PCR positive at Week 24|21|||
130393195|NCT02641379|469409103|FG002|Overall Study|PCR positive at Week 24|62|||
130393196|NCT02641379|469409104|FG003|Overall Study|PCR positive at Week 24|0|||
130393197|NCT02641379|469409105|FG004|Overall Study|PCR positive at Week 24|0|||
130393198|NCT02641379|469409106|FG005|Overall Study|PCR positive at Week 24|6|||
130393199|NCT02641379|469409107|FG006|Overall Study|PCR positive at Week 24|3|||
130393200|NCT02641379|469409108|FG007|Overall Study|PCR positive at Week 24|8|||
130470423|NCT01340066|469688308|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
130470424|NCT01340066|469688309|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
130723003|NCT03421730|470611306|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723004|NCT03421730|470611307|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
130393201|NCT02641379|469409109|FG008|Overall Study|PCR positive at Week 24|0|||
130393202|NCT02641379|469409110|FG009|Overall Study|PCR positive at Week 24|1|||
130393203|NCT02641379|469409111|FG010|Overall Study|PCR positive at Week 24|0|||
130393204|NCT02641379|469409101|FG000|Overall Study|PCR positive at follow up 2|1|||
130393205|NCT02641379|469409102|FG001|Overall Study|PCR positive at follow up 2|0|||
130393206|NCT02641379|469409103|FG002|Overall Study|PCR positive at follow up 2|0|||
130393207|NCT02641379|469409104|FG003|Overall Study|PCR positive at follow up 2|0|||
130393208|NCT02641379|469409105|FG004|Overall Study|PCR positive at follow up 2|0|||
130393209|NCT02641379|469409106|FG005|Overall Study|PCR positive at follow up 2|0|||
130393210|NCT02641379|469409107|FG006|Overall Study|PCR positive at follow up 2|0|||
130393211|NCT02641379|469409108|FG007|Overall Study|PCR positive at follow up 2|0|||
130393212|NCT02641379|469409109|FG008|Overall Study|PCR positive at follow up 2|0|||
130393213|NCT02641379|469409110|FG009|Overall Study|PCR positive at follow up 2|0|||
130393214|NCT02641379|469409111|FG010|Overall Study|PCR positive at follow up 2|0|||
130393215|NCT02641379|469409101|FG000|Overall Study|Participant showed relapse|1|||
130393216|NCT02641379|469409102|FG001|Overall Study|Participant showed relapse|0|||
130393217|NCT02641379|469409103|FG002|Overall Study|Participant showed relapse|0|||
130393218|NCT02641379|469409104|FG003|Overall Study|Participant showed relapse|0|||
130393219|NCT02641379|469409105|FG004|Overall Study|Participant showed relapse|0|||
130393220|NCT02641379|469409106|FG005|Overall Study|Participant showed relapse|0|||
130393221|NCT02641379|469409107|FG006|Overall Study|Participant showed relapse|1|||
130393222|NCT02641379|469409108|FG007|Overall Study|Participant showed relapse|0|||
130393223|NCT02641379|469409109|FG008|Overall Study|Participant showed relapse|0|||
130393224|NCT02641379|469409110|FG009|Overall Study|Participant showed relapse|0|||
130393225|NCT02641379|469409111|FG010|Overall Study|Participant showed relapse|0|||
130393226|NCT02641379|469409101|FG000|Overall Study|Participant stopped study/treatment|1|||
130393227|NCT02641379|469409102|FG001|Overall Study|Participant stopped study/treatment|3|||
130393228|NCT02641379|469409103|FG002|Overall Study|Participant stopped study/treatment|1|||
130393229|NCT02641379|469409104|FG003|Overall Study|Participant stopped study/treatment|0|||
130393230|NCT02641379|469409105|FG004|Overall Study|Participant stopped study/treatment|0|||
130393231|NCT02641379|469409106|FG005|Overall Study|Participant stopped study/treatment|1|||
130393232|NCT02641379|469409107|FG006|Overall Study|Participant stopped study/treatment|2|||
130393233|NCT02641379|469409108|FG007|Overall Study|Participant stopped study/treatment|0|||
130393234|NCT02641379|469409109|FG008|Overall Study|Participant stopped study/treatment|1|||
130393235|NCT02641379|469409110|FG009|Overall Study|Participant stopped study/treatment|0|||
130393236|NCT02641379|469409111|FG010|Overall Study|Participant stopped study/treatment|0|||
130393237|NCT02641379|469409101|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
130393238|NCT02641379|469409102|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
130393239|NCT02641379|469409103|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
130393240|NCT02641379|469409104|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
130393241|NCT02641379|469409105|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
130393242|NCT02641379|469409106|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
130393243|NCT02641379|469409107|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
130393244|NCT02641379|469409108|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
130393245|NCT02641379|469409109|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
130393246|NCT02641379|469409110|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
130393247|NCT02641379|469409111|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
130393248|NCT02641379|469409101|FG000|Overall Study|Financial problems|0|||
130393249|NCT02641379|469409102|FG001|Overall Study|Financial problems|1|||
130393250|NCT02641379|469409103|FG002|Overall Study|Financial problems|0|||
130393251|NCT02641379|469409104|FG003|Overall Study|Financial problems|0|||
130393252|NCT02641379|469409105|FG004|Overall Study|Financial problems|0|||
130393253|NCT02641379|469409106|FG005|Overall Study|Financial problems|0|||
130393254|NCT02641379|469409107|FG006|Overall Study|Financial problems|0|||
130393255|NCT02641379|469409108|FG007|Overall Study|Financial problems|0|||
130393256|NCT02641379|469409109|FG008|Overall Study|Financial problems|0|||
130393257|NCT02641379|469409110|FG009|Overall Study|Financial problems|0|||
130393258|NCT02641379|469409111|FG010|Overall Study|Financial problems|0|||
130393259|NCT02641379|469409101|FG000|Overall Study|PCR positive at Week 68|0|||
130393260|NCT02641379|469409102|FG001|Overall Study|PCR positive at Week 68|1|||
130393261|NCT02641379|469409103|FG002|Overall Study|PCR positive at Week 68|0|||
130393262|NCT02641379|469409104|FG003|Overall Study|PCR positive at Week 68|0|||
130723005|NCT03421730|470611308|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723006|NCT03421730|470611309|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723007|NCT03421730|470611310|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723008|NCT03421730|470611311|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723009|NCT03421730|470611312|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130393263|NCT02641379|469409105|FG004|Overall Study|PCR positive at Week 68|0|||
130393264|NCT02641379|469409106|FG005|Overall Study|PCR positive at Week 68|0|||
130393265|NCT02641379|469409107|FG006|Overall Study|PCR positive at Week 68|0|||
130723010|NCT03421730|470611313|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723011|NCT03421730|470611314|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723012|NCT03421730|470611315|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130393266|NCT02641379|469409108|FG007|Overall Study|PCR positive at Week 68|0|||
130393267|NCT02641379|469409109|FG008|Overall Study|PCR positive at Week 68|0|||
130470425|NCT01340066|469688307|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
130393268|NCT02641379|469409110|FG009|Overall Study|PCR positive at Week 68|0|||
130393269|NCT02641379|469409111|FG010|Overall Study|PCR positive at Week 68|0|||
130393270|NCT02641379|469409101|FG000|Overall Study|PCR positive at Week 48|0|||
130393271|NCT02641379|469409102|FG001|Overall Study|PCR positive at Week 48|1|||
130393272|NCT02641379|469409103|FG002|Overall Study|PCR positive at Week 48|0|||
130393273|NCT02641379|469409104|FG003|Overall Study|PCR positive at Week 48|0|||
130393274|NCT02641379|469409105|FG004|Overall Study|PCR positive at Week 48|0|||
130393275|NCT02641379|469409106|FG005|Overall Study|PCR positive at Week 48|0|||
130393276|NCT02641379|469409107|FG006|Overall Study|PCR positive at Week 48|0|||
130393277|NCT02641379|469409108|FG007|Overall Study|PCR positive at Week 48|0|||
130393278|NCT02641379|469409109|FG008|Overall Study|PCR positive at Week 48|0|||
130393279|NCT02641379|469409110|FG009|Overall Study|PCR positive at Week 48|0|||
130393280|NCT02641379|469409111|FG010|Overall Study|PCR positive at Week 48|0|||
130393281|NCT02641379|469409101|FG000|Overall Study|PCR not performed at Week 12|0|||
130393282|NCT02641379|469409102|FG001|Overall Study|PCR not performed at Week 12|0|||
130393283|NCT02641379|469409103|FG002|Overall Study|PCR not performed at Week 12|1|||
130393284|NCT02641379|469409104|FG003|Overall Study|PCR not performed at Week 12|0|||
130393285|NCT02641379|469409105|FG004|Overall Study|PCR not performed at Week 12|0|||
130393286|NCT02641379|469409106|FG005|Overall Study|PCR not performed at Week 12|0|||
130393287|NCT02641379|469409107|FG006|Overall Study|PCR not performed at Week 12|0|||
130393288|NCT02641379|469409108|FG007|Overall Study|PCR not performed at Week 12|0|||
130393289|NCT02641379|469409109|FG008|Overall Study|PCR not performed at Week 12|0|||
130393290|NCT02641379|469409110|FG009|Overall Study|PCR not performed at Week 12|0|||
130393291|NCT02641379|469409111|FG010|Overall Study|PCR not performed at Week 12|0|||
130393292|NCT02641379|469409101|FG000|Overall Study|No PCR at baseline|0|||
130393293|NCT02641379|469409102|FG001|Overall Study|No PCR at baseline|0|||
130393294|NCT02641379|469409103|FG002|Overall Study|No PCR at baseline|1|||
130393295|NCT02641379|469409104|FG003|Overall Study|No PCR at baseline|0|||
130393296|NCT02641379|469409105|FG004|Overall Study|No PCR at baseline|0|||
130393297|NCT02641379|469409106|FG005|Overall Study|No PCR at baseline|0|||
130393298|NCT02641379|469409107|FG006|Overall Study|No PCR at baseline|0|||
130393299|NCT02641379|469409108|FG007|Overall Study|No PCR at baseline|0|||
130393300|NCT02641379|469409109|FG008|Overall Study|No PCR at baseline|0|||
130393301|NCT02641379|469409110|FG009|Overall Study|No PCR at baseline|0|||
130393302|NCT02641379|469409111|FG010|Overall Study|No PCR at baseline|0|||
130393303|NCT02641379|469409101|FG000|Overall Study|PCR positive at Week 28|0|||
130393304|NCT02641379|469409102|FG001|Overall Study|PCR positive at Week 28|0|||
130393305|NCT02641379|469409103|FG002|Overall Study|PCR positive at Week 28|1|||
130393306|NCT02641379|469409104|FG003|Overall Study|PCR positive at Week 28|0|||
130393307|NCT02641379|469409105|FG004|Overall Study|PCR positive at Week 28|0|||
130393308|NCT02641379|469409106|FG005|Overall Study|PCR positive at Week 28|0|||
130393309|NCT02641379|469409107|FG006|Overall Study|PCR positive at Week 28|0|||
130393310|NCT02641379|469409108|FG007|Overall Study|PCR positive at Week 28|0|||
130393311|NCT02641379|469409109|FG008|Overall Study|PCR positive at Week 28|0|||
130393312|NCT02641379|469409110|FG009|Overall Study|PCR positive at Week 28|0|||
130393313|NCT02641379|469409111|FG010|Overall Study|PCR positive at Week 28|0|||
130393314|NCT02641379|469409101|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
130393315|NCT02641379|469409102|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
130393316|NCT02641379|469409103|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
130393317|NCT02641379|469409104|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
130393318|NCT02641379|469409105|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
130393319|NCT02641379|469409106|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
130393320|NCT02641379|469409107|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
130393321|NCT02641379|469409108|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
130393322|NCT02641379|469409109|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
130393323|NCT02641379|469409110|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
130393324|NCT02641379|469409111|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
130393325|NCT02641379|469409101|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
130393326|NCT02641379|469409102|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
130393327|NCT02641379|469409103|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
130393328|NCT02641379|469409104|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
130393329|NCT02641379|469409105|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
130393330|NCT02641379|469409106|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
130393331|NCT02641379|469409107|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
130393332|NCT02641379|469409108|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
130393333|NCT02641379|469409109|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
130393334|NCT02641379|469409110|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
130393335|NCT02641379|469409111|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
130393336|NCT02641379|469409101|FG000|Overall Study|Baseline viral load unavailable|0|||
130393337|NCT02641379|469409102|FG001|Overall Study|Baseline viral load unavailable|0|||
130393338|NCT02641379|469409103|FG002|Overall Study|Baseline viral load unavailable|0|||
130393339|NCT02641379|469409104|FG003|Overall Study|Baseline viral load unavailable|1|||
130393340|NCT02641379|469409105|FG004|Overall Study|Baseline viral load unavailable|0|||
130393341|NCT02641379|469409106|FG005|Overall Study|Baseline viral load unavailable|0|||
130393342|NCT02641379|469409107|FG006|Overall Study|Baseline viral load unavailable|0|||
130393343|NCT02641379|469409108|FG007|Overall Study|Baseline viral load unavailable|0|||
130393344|NCT02641379|469409109|FG008|Overall Study|Baseline viral load unavailable|0|||
130393345|NCT02641379|469409110|FG009|Overall Study|Baseline viral load unavailable|0|||
130393346|NCT02641379|469409111|FG010|Overall Study|Baseline viral load unavailable|0|||
130393347|NCT02641379|469409101|FG000|Overall Study|Blood could not be drawn|0|||
130393348|NCT02641379|469409102|FG001|Overall Study|Blood could not be drawn|0|||
130393349|NCT02641379|469409103|FG002|Overall Study|Blood could not be drawn|0|||
130393350|NCT02641379|469409104|FG003|Overall Study|Blood could not be drawn|0|||
130393351|NCT02641379|469409105|FG004|Overall Study|Blood could not be drawn|1|||
130393352|NCT02641379|469409106|FG005|Overall Study|Blood could not be drawn|0|||
130393353|NCT02641379|469409107|FG006|Overall Study|Blood could not be drawn|0|||
130393354|NCT02641379|469409108|FG007|Overall Study|Blood could not be drawn|0|||
130393355|NCT02641379|469409109|FG008|Overall Study|Blood could not be drawn|0|||
130393356|NCT02641379|469409110|FG009|Overall Study|Blood could not be drawn|0|||
130393357|NCT02641379|469409111|FG010|Overall Study|Blood could not be drawn|0|||
130393358|NCT02641379|469409101|FG000|Overall Study|Protocol Violation|0|||
130393359|NCT02641379|469409102|FG001|Overall Study|Protocol Violation|0|||
130393360|NCT02641379|469409103|FG002|Overall Study|Protocol Violation|0|||
130393361|NCT02641379|469409104|FG003|Overall Study|Protocol Violation|0|||
130393362|NCT02641379|469409105|FG004|Overall Study|Protocol Violation|2|||
130393363|NCT02641379|469409106|FG005|Overall Study|Protocol Violation|0|||
130393364|NCT02641379|469409107|FG006|Overall Study|Protocol Violation|0|||
130393365|NCT02641379|469409108|FG007|Overall Study|Protocol Violation|0|||
130393366|NCT02641379|469409109|FG008|Overall Study|Protocol Violation|1|||
130393367|NCT02641379|469409110|FG009|Overall Study|Protocol Violation|0|||
130393368|NCT02641379|469409111|FG010|Overall Study|Protocol Violation|0|||
130393369|NCT02641379|469409101|FG000|Overall Study|Participation in sili rescue study|0|||
130393370|NCT02641379|469409102|FG001|Overall Study|Participation in sili rescue study|0|||
130393371|NCT02641379|469409103|FG002|Overall Study|Participation in sili rescue study|0|||
130393372|NCT02641379|469409104|FG003|Overall Study|Participation in sili rescue study|0|||
130393373|NCT02641379|469409105|FG004|Overall Study|Participation in sili rescue study|0|||
130393374|NCT02641379|469409106|FG005|Overall Study|Participation in sili rescue study|1|||
130393375|NCT02641379|469409107|FG006|Overall Study|Participation in sili rescue study|0|||
130393376|NCT02641379|469409108|FG007|Overall Study|Participation in sili rescue study|0|||
130393377|NCT02641379|469409109|FG008|Overall Study|Participation in sili rescue study|0|||
130393378|NCT02641379|469409110|FG009|Overall Study|Participation in sili rescue study|0|||
130393379|NCT02641379|469409111|FG010|Overall Study|Participation in sili rescue study|0|||
130393380|NCT02641379|469409101|FG000|Overall Study|Lost to Follow-up|0|||
130393381|NCT02641379|469409102|FG001|Overall Study|Lost to Follow-up|0|||
130393382|NCT02641379|469409103|FG002|Overall Study|Lost to Follow-up|0|||
130393383|NCT02641379|469409104|FG003|Overall Study|Lost to Follow-up|0|||
130393384|NCT02641379|469409105|FG004|Overall Study|Lost to Follow-up|0|||
130393385|NCT02641379|469409106|FG005|Overall Study|Lost to Follow-up|0|||
130393386|NCT02641379|469409107|FG006|Overall Study|Lost to Follow-up|0|||
130393387|NCT02641379|469409108|FG007|Overall Study|Lost to Follow-up|0|||
130393388|NCT02641379|469409109|FG008|Overall Study|Lost to Follow-up|1|||
130393389|NCT02641379|469409110|FG009|Overall Study|Lost to Follow-up|0|||
130393390|NCT02641379|469409111|FG010|Overall Study|Lost to Follow-up|0|||
130393391|NCT02641379|469409101|FG000|Overall Study|Source data not found|0|||
130393392|NCT02641379|469409102|FG001|Overall Study|Source data not found|0|||
130393393|NCT02641379|469409103|FG002|Overall Study|Source data not found|0|||
130393394|NCT02641379|469409104|FG003|Overall Study|Source data not found|0|||
130393395|NCT02641379|469409105|FG004|Overall Study|Source data not found|0|||
130393396|NCT02641379|469409106|FG005|Overall Study|Source data not found|1|||
130393397|NCT02641379|469409107|FG006|Overall Study|Source data not found|0|||
130393398|NCT02641379|469409108|FG007|Overall Study|Source data not found|0|||
130393399|NCT02641379|469409109|FG008|Overall Study|Source data not found|0|||
130393400|NCT02641379|469409110|FG009|Overall Study|Source data not found|0|||
130393401|NCT02641379|469409111|FG010|Overall Study|Source data not found|0|||
130393402|NCT02641379|469409101|FG000|Overall Study|Participant showed weight reduction|0|||
130393403|NCT02641379|469409102|FG001|Overall Study|Participant showed weight reduction|0|||
130393404|NCT02641379|469409103|FG002|Overall Study|Participant showed weight reduction|0|||
130393405|NCT02641379|469409104|FG003|Overall Study|Participant showed weight reduction|0|||
130393406|NCT02641379|469409105|FG004|Overall Study|Participant showed weight reduction|0|||
130470426|NCT01340066|469688308|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
130470427|NCT01340066|469688309|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
130470428|NCT01340066|469688307|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
130393407|NCT02641379|469409106|FG005|Overall Study|Participant showed weight reduction|0|||
130393408|NCT02641379|469409107|FG006|Overall Study|Participant showed weight reduction|0|||
130393409|NCT02641379|469409108|FG007|Overall Study|Participant showed weight reduction|1|||
130393410|NCT02641379|469409109|FG008|Overall Study|Participant showed weight reduction|0|||
130393411|NCT02641379|469409110|FG009|Overall Study|Participant showed weight reduction|0|||
130393412|NCT02641379|469409111|FG010|Overall Study|Participant showed weight reduction|0|||
130470429|NCT01340066|469688308|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
130393413|NCT02641379|469409101|FG000|Overall Study|Non-response Week 12|0|||
130393414|NCT02641379|469409102|FG001|Overall Study|Non-response Week 12|0|||
130393415|NCT02641379|469409103|FG002|Overall Study|Non-response Week 12|0|||
130393416|NCT02641379|469409104|FG003|Overall Study|Non-response Week 12|0|||
130393417|NCT02641379|469409105|FG004|Overall Study|Non-response Week 12|0|||
130393418|NCT02641379|469409106|FG005|Overall Study|Non-response Week 12|0|||
130393419|NCT02641379|469409107|FG006|Overall Study|Non-response Week 12|0|||
130393420|NCT02641379|469409108|FG007|Overall Study|Non-response Week 12|1|||
130393421|NCT02641379|469409109|FG008|Overall Study|Non-response Week 12|0|||
130393422|NCT02641379|469409110|FG009|Overall Study|Non-response Week 12|0|||
130393423|NCT02641379|469409111|FG010|Overall Study|Non-response Week 12|0|||
130393424|NCT02641379|469409101|FG000|Overall Study|No 2 Log drop at Week 12|0|||
130393425|NCT02641379|469409102|FG001|Overall Study|No 2 Log drop at Week 12|0|||
130393426|NCT02641379|469409103|FG002|Overall Study|No 2 Log drop at Week 12|0|||
130393427|NCT02641379|469409104|FG003|Overall Study|No 2 Log drop at Week 12|0|||
130393428|NCT02641379|469409105|FG004|Overall Study|No 2 Log drop at Week 12|0|||
130393429|NCT02641379|469409106|FG005|Overall Study|No 2 Log drop at Week 12|0|||
130393430|NCT02641379|469409107|FG006|Overall Study|No 2 Log drop at Week 12|0|||
130393431|NCT02641379|469409108|FG007|Overall Study|No 2 Log drop at Week 12|0|||
130393432|NCT02641379|469409109|FG008|Overall Study|No 2 Log drop at Week 12|0|||
130393433|NCT02641379|469409110|FG009|Overall Study|No 2 Log drop at Week 12|0|||
130393434|NCT02641379|469409111|FG010|Overall Study|No 2 Log drop at Week 12|1|||
130393435|NCT02641379|469409101|FG000|Overall Study|Negative PCR result|0|||
130393436|NCT02641379|469409102|FG001|Overall Study|Negative PCR result|0|||
130393437|NCT02641379|469409103|FG002|Overall Study|Negative PCR result|0|||
130393438|NCT02641379|469409104|FG003|Overall Study|Negative PCR result|0|||
130393439|NCT02641379|469409105|FG004|Overall Study|Negative PCR result|0|||
130393440|NCT02641379|469409106|FG005|Overall Study|Negative PCR result|0|||
130393441|NCT02641379|469409107|FG006|Overall Study|Negative PCR result|0|||
130393442|NCT02641379|469409108|FG007|Overall Study|Negative PCR result|0|||
130393443|NCT02641379|469409109|FG008|Overall Study|Negative PCR result|0|||
130393444|NCT02641379|469409110|FG009|Overall Study|Negative PCR result|1|||
130393445|NCT02641379|469409111|FG010|Overall Study|Negative PCR result|0|||
130393446|NCT02641379|469409101|FG000|Overall Study|Participant's PCR high|0|||
130393447|NCT02641379|469409102|FG001|Overall Study|Participant's PCR high|0|||
130393448|NCT02641379|469409103|FG002|Overall Study|Participant's PCR high|0|||
130393449|NCT02641379|469409104|FG003|Overall Study|Participant's PCR high|0|||
130393450|NCT02641379|469409105|FG004|Overall Study|Participant's PCR high|0|||
130393451|NCT02641379|469409106|FG005|Overall Study|Participant's PCR high|0|||
130393452|NCT02641379|469409107|FG006|Overall Study|Participant's PCR high|0|||
130393453|NCT02641379|469409108|FG007|Overall Study|Participant's PCR high|1|||
130393454|NCT02641379|469409109|FG008|Overall Study|Participant's PCR high|0|||
130393455|NCT02641379|469409110|FG009|Overall Study|Participant's PCR high|0|||
130393456|NCT02641379|469409111|FG010|Overall Study|Participant's PCR high|0|||
130393457|NCT02641379|469409101|FG000|Overall Study|Participant treated after Week 24|0|||
130393458|NCT02641379|469409102|FG001|Overall Study|Participant treated after Week 24|0|||
130393459|NCT02641379|469409103|FG002|Overall Study|Participant treated after Week 24|0|||
130393460|NCT02641379|469409104|FG003|Overall Study|Participant treated after Week 24|0|||
130393461|NCT02641379|469409105|FG004|Overall Study|Participant treated after Week 24|0|||
130393462|NCT02641379|469409106|FG005|Overall Study|Participant treated after Week 24|0|||
130393463|NCT02641379|469409107|FG006|Overall Study|Participant treated after Week 24|0|||
130393464|NCT02641379|469409108|FG007|Overall Study|Participant treated after Week 24|0|||
130393465|NCT02641379|469409109|FG008|Overall Study|Participant treated after Week 24|1|||
130393466|NCT02641379|469409110|FG009|Overall Study|Participant treated after Week 24|0|||
130393467|NCT02641379|469409111|FG010|Overall Study|Participant treated after Week 24|0|||
130393468|NCT02641379|469409101|FG000|Overall Study|Missing PCR result at Week 8|0|||
130393469|NCT02641379|469409102|FG001|Overall Study|Missing PCR result at Week 8|0|||
130393470|NCT02641379|469409103|FG002|Overall Study|Missing PCR result at Week 8|0|||
130393471|NCT02641379|469409104|FG003|Overall Study|Missing PCR result at Week 8|0|||
130393472|NCT02641379|469409105|FG004|Overall Study|Missing PCR result at Week 8|0|||
130393473|NCT02641379|469409106|FG005|Overall Study|Missing PCR result at Week 8|0|||
130470430|NCT01340066|469688309|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
130470431|NCT02789020|469688310|FG000|Overall Study|Withdrawal by Subject|6|||
130393474|NCT02641379|469409107|FG006|Overall Study|Missing PCR result at Week 8|0|||
130393475|NCT02641379|469409108|FG007|Overall Study|Missing PCR result at Week 8|0|||
130393476|NCT02641379|469409109|FG008|Overall Study|Missing PCR result at Week 8|0|||
130393477|NCT02641379|469409110|FG009|Overall Study|Missing PCR result at Week 8|1|||
130393478|NCT02641379|469409111|FG010|Overall Study|Missing PCR result at Week 8|0|||
130393479|NCT02641379|469409101|FG000|Overall Study|PCR positive|0|||
130393480|NCT02641379|469409102|FG001|Overall Study|PCR positive|0|||
130393481|NCT02641379|469409103|FG002|Overall Study|PCR positive|0|||
130393482|NCT02641379|469409104|FG003|Overall Study|PCR positive|0|||
130393483|NCT02641379|469409105|FG004|Overall Study|PCR positive|0|||
130470432|NCT02789020|469688311|FG001|Overall Study|Withdrawal by Subject|5|||
130393484|NCT02641379|469409106|FG005|Overall Study|PCR positive|0|||
130393485|NCT02641379|469409107|FG006|Overall Study|PCR positive|1|||
130393486|NCT02641379|469409108|FG007|Overall Study|PCR positive|0|||
130393487|NCT02641379|469409109|FG008|Overall Study|PCR positive|0|||
130393488|NCT02641379|469409110|FG009|Overall Study|PCR positive|0|||
130393489|NCT02641379|469409111|FG010|Overall Study|PCR positive|0|||
130393490|NCT04964128|469409112|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
130393491|NCT04964128|469409112|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
130393492|NCT01070316|469409123|FG000|Extension Phase|Lack of Efficacy|3|||
130393493|NCT01070316|469409123|FG000|Extension Phase|Withdrawal by Subject|1|||
130393494|NCT00692770|469409126|FG000|Overall Study|Protocol Violation|2|||
130393495|NCT00692770|469409127|FG001|Overall Study|Protocol Violation|7|||
130393496|NCT00692770|469409126|FG000|Overall Study|Withdrawal by Subject|97|||
130393497|NCT00692770|469409127|FG001|Overall Study|Withdrawal by Subject|36|||
130393498|NCT00692770|469409126|FG000|Overall Study|Adverse Event|136|||
130393499|NCT00692770|469409127|FG001|Overall Study|Adverse Event|41|||
130393500|NCT00692770|469409126|FG000|Overall Study|Death|10|||
130393501|NCT00692770|469409127|FG001|Overall Study|Death|5|||
130393502|NCT00692770|469409126|FG000|Overall Study|Lost to Follow-up|7|||
130393503|NCT00692770|469409127|FG001|Overall Study|Lost to Follow-up|3|||
130393504|NCT00692770|469409126|FG000|Overall Study|Non-compliant with study medication|11|||
130393505|NCT00692770|469409127|FG001|Overall Study|Non-compliant with study medication|5|||
130393506|NCT00692770|469409126|FG000|Overall Study|Progression by clinical judgment|2|||
130393507|NCT00692770|469409127|FG001|Overall Study|Progression by clinical judgment|3|||
130393508|NCT00692770|469409126|FG000|Overall Study|Physician decision not protocol driven|10|||
130393509|NCT00692770|469409127|FG001|Overall Study|Physician decision not protocol driven|14|||
130393510|NCT00692770|469409126|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
130393511|NCT00692770|469409127|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
130393512|NCT00692770|469409126|FG000|Overall Study|Protocol driven decision point|3|||
130393513|NCT00692770|469409127|FG001|Overall Study|Protocol driven decision point|7|||
130393514|NCT00692770|469409126|FG000|Overall Study|Completed all planned assessments|79|||
130393515|NCT00692770|469409127|FG001|Overall Study|Completed all planned assessments|101|||
130393516|NCT00692770|469409126|FG000|Overall Study|Radiological and clinical progression|8|||
130393517|NCT00692770|469409127|FG001|Overall Study|Radiological and clinical progression|8|||
130393518|NCT00692770|469409126|FG000|Overall Study|Clinical endpoint reached|16|||
130393519|NCT00692770|469409127|FG001|Overall Study|Clinical endpoint reached|43|||
130723013|NCT03421730|470611316|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723014|NCT03421730|470611317|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723015|NCT03421730|470611306|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723016|NCT03421730|470611307|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723017|NCT03421730|470611308|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723018|NCT03421730|470611309|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723019|NCT03421730|470611310|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
130723020|NCT03421730|470611311|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723021|NCT03421730|470611312|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723022|NCT03421730|470611313|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723023|NCT03421730|470611314|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723024|NCT03421730|470611315|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723025|NCT03421730|470611316|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723026|NCT03421730|470611317|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723027|NCT02901548|470611322|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
130723028|NCT01955083|470611323|FG000|Overall Study|Lost to Follow-up|1|||
130723029|NCT01955083|470611324|FG001|Overall Study|Lost to Follow-up|1|||
130723030|NCT02871492|470611333|FG000|Overall Study|Lost to Follow-up|6|||
130723031|NCT02871492|470611334|FG001|Overall Study|Lost to Follow-up|3|||
130723032|NCT02871492|470611335|FG002|Overall Study|Lost to Follow-up|5|||
130723033|NCT02871492|470611333|FG000|Overall Study|Withdrawal by Subject|0|||
130723034|NCT02871492|470611334|FG001|Overall Study|Withdrawal by Subject|0|||
130723035|NCT02871492|470611335|FG002|Overall Study|Withdrawal by Subject|1|||
130393520|NCT00692770|469409126|FG000|Overall Study|Study terminated by sponsor|2|||
130393521|NCT00692770|469409127|FG001|Overall Study|Study terminated by sponsor|2|||
130393522|NCT00692770|469409126|FG000|Overall Study|Randomized but not treated|3|||
130393523|NCT00692770|469409127|FG001|Overall Study|Randomized but not treated|4|||
130393524|NCT04327986|469409128|FG000|Overall Study|Physician Decision|2|||
130470433|NCT03771352|469688322|FG000|Overall Study|Screen failure|2|||
130393525|NCT04327986|469409129|FG001|Overall Study|Physician Decision|0|||
130393526|NCT04327986|469409130|FG002|Overall Study|Physician Decision|0|||
130393527|NCT04327986|469409128|FG000|Overall Study|Death|1|||
130393528|NCT04327986|469409129|FG001|Overall Study|Death|0|||
130393529|NCT04327986|469409130|FG002|Overall Study|Death|0|||
130393530|NCT00655564|469409131|FG000|Overall Study|Adverse Event|1|||
130470434|NCT03771352|469688322|FG000|Overall Study|Withdrawal by Subject|2|||
130393531|NCT00655564|469409131|FG000|Overall Study|Lost to Follow-up|1|||
130393532|NCT00655564|469409131|FG000|Overall Study|Desired Alternate Therapy|1|||
130393533|NCT00560950|469409133|FG000|Overall Study|Lost to Follow-up|1|||
130393534|NCT00560950|469409134|FG001|Overall Study|Lost to Follow-up|0|||
130393535|NCT02917031|469409138|FG000|Overall Study|Reason not specified|7|||
130393536|NCT02917031|469409139|FG001|Overall Study|Reason not specified|5|||
130393537|NCT02917031|469409140|FG002|Overall Study|Reason not specified|6|||
130393538|NCT02917031|469409138|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
130393539|NCT02917031|469409139|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
130393540|NCT02917031|469409140|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
130393541|NCT02917031|469409138|FG000|Overall Study|Withdrawal by Subject|3|||
130393542|NCT02917031|469409139|FG001|Overall Study|Withdrawal by Subject|3|||
130393543|NCT02917031|469409140|FG002|Overall Study|Withdrawal by Subject|0|||
130393544|NCT02917031|469409138|FG000|Overall Study|Physician Decision|1|||
130393545|NCT02917031|469409139|FG001|Overall Study|Physician Decision|0|||
130393546|NCT02917031|469409140|FG002|Overall Study|Physician Decision|0|||
130393547|NCT02917031|469409138|FG000|Overall Study|Adverse Event|4|||
130393548|NCT02917031|469409139|FG001|Overall Study|Adverse Event|1|||
130393549|NCT02917031|469409140|FG002|Overall Study|Adverse Event|5|||
130393550|NCT02917031|469409138|FG000|Overall Study|Death|2|||
130393551|NCT02917031|469409139|FG001|Overall Study|Death|3|||
130393552|NCT02917031|469409140|FG002|Overall Study|Death|4|||
130393553|NCT00427635|469410422|FG000|Treatment Phase|Withdrawal by Subject|1|||
130393554|NCT00427635|469410423|FG001|Treatment Phase|Withdrawal by Subject|0|||
130393555|NCT00427635|469410422|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
130393556|NCT00427635|469410423|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
130393557|NCT03711162|469410426|FG000|Overall Study|Adverse Event|5|||
130393558|NCT03711162|469410427|FG001|Overall Study|Adverse Event|2|||
130393559|NCT03711162|469410428|FG002|Overall Study|Adverse Event|4|||
130393560|NCT03711162|469410426|FG000|Overall Study|Death|11|||
130393561|NCT03711162|469410427|FG001|Overall Study|Death|7|||
130393562|NCT03711162|469410428|FG002|Overall Study|Death|8|||
130393563|NCT03711162|469410426|FG000|Overall Study|Lost to Follow-up|1|||
130393564|NCT03711162|469410427|FG001|Overall Study|Lost to Follow-up|0|||
130393565|NCT03711162|469410428|FG002|Overall Study|Lost to Follow-up|1|||
130393566|NCT03711162|469410426|FG000|Overall Study|Study Terminated by Sponsor|139|||
130393567|NCT03711162|469410427|FG001|Overall Study|Study Terminated by Sponsor|152|||
130393568|NCT03711162|469410428|FG002|Overall Study|Study Terminated by Sponsor|146|||
130393569|NCT03711162|469410426|FG000|Overall Study|Withdrawal by Subject|17|||
130393570|NCT03711162|469410427|FG001|Overall Study|Withdrawal by Subject|10|||
130393571|NCT03711162|469410428|FG002|Overall Study|Withdrawal by Subject|10|||
130393572|NCT03711162|469410426|FG000|Overall Study|Miscellaneous|1|||
130393573|NCT03711162|469410427|FG001|Overall Study|Miscellaneous|2|||
130393574|NCT03711162|469410428|FG002|Overall Study|Miscellaneous|2|||
130393575|NCT03711162|469410426|FG000|Overall Study|Not Treated|1|||
130393576|NCT03711162|469410427|FG001|Overall Study|Not Treated|0|||
130393577|NCT03711162|469410428|FG002|Overall Study|Not Treated|1|||
130393578|NCT03711162|469410426|FG000|Overall Study|Physician Decision|0|||
130393579|NCT03711162|469410427|FG001|Overall Study|Physician Decision|2|||
130393580|NCT03711162|469410428|FG002|Overall Study|Physician Decision|0|||
130393581|NCT03711162|469410426|FG000|Overall Study|Lack of Efficacy|0|||
130723036|NCT02256436|470611336|FG000|Overall Study|Adverse Event|9|||
130723037|NCT02256436|470611337|FG001|Overall Study|Adverse Event|14|||
130723038|NCT02256436|470611336|FG000|Overall Study|Death|216|||
130393582|NCT03711162|469410427|FG001|Overall Study|Lack of Efficacy|0|||
130393583|NCT03711162|469410428|FG002|Overall Study|Lack of Efficacy|2|||
130723039|NCT02256436|470611337|FG001|Overall Study|Death|208|||
130723040|NCT02256436|470611336|FG000|Overall Study|Lost to Follow-up|1|||
130723041|NCT02256436|470611337|FG001|Overall Study|Lost to Follow-up|2|||
130723042|NCT02256436|470611336|FG000|Overall Study|Physician Decision|1|||
130723043|NCT02256436|470611337|FG001|Overall Study|Physician Decision|0|||
130723044|NCT02256436|470611336|FG000|Overall Study|Protocol Violation|0|||
130393584|NCT03711162|469410426|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
130393585|NCT03711162|469410427|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
130393586|NCT03711162|469410428|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130723045|NCT02256436|470611337|FG001|Overall Study|Protocol Violation|1|||
130723046|NCT02256436|470611336|FG000|Overall Study|Withdrawal by Subject|26|||
130723047|NCT02256436|470611337|FG001|Overall Study|Withdrawal by Subject|10|||
130393587|NCT00394212|469410431|FG000|Overall Study|Lost to Follow-up|3|||
130393588|NCT00394212|469410432|FG001|Overall Study|Lost to Follow-up|0|||
130393589|NCT00394212|469410431|FG000|Overall Study|Withdrawal by Subject|4|||
130393590|NCT00394212|469410432|FG001|Overall Study|Withdrawal by Subject|1|||
130393591|NCT00588445|469410433|FG000|Overall Study|Protocol Violation|1|||
130393592|NCT00588445|469410433|FG000|Overall Study|Withdrawal by Subject|3|||
130723048|NCT02256436|470611336|FG000|Overall Study|Transferred to Extension Study|11|||
130393593|NCT00588445|469410433|FG000|Overall Study|Disease Progression|1|||
130393594|NCT00588445|469410433|FG000|Overall Study|Not Treated|10|||
130393595|NCT03240133|469410434|FG000|Overall Study|Withdrawal by Subject|0|||
130393596|NCT03240133|469410435|FG001|Overall Study|Withdrawal by Subject|1|||
130393597|NCT03240133|469410436|FG002|Overall Study|Withdrawal by Subject|0|||
130393598|NCT03240133|469410434|FG000|Overall Study|Adverse Event|1|||
130393599|NCT03240133|469410435|FG001|Overall Study|Adverse Event|1|||
130393600|NCT03240133|469410436|FG002|Overall Study|Adverse Event|0|||
130393601|NCT03240133|469410434|FG000|Overall Study|Rash|1|||
130393602|NCT03240133|469410435|FG001|Overall Study|Rash|0|||
130393603|NCT03240133|469410436|FG002|Overall Study|Rash|0|||
130393604|NCT03240133|469410434|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
130393605|NCT03240133|469410435|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
130393606|NCT03240133|469410436|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
130393607|NCT03240133|469410434|FG000|Overall Study|Intercurrent illness.|0|||
130393608|NCT03240133|469410435|FG001|Overall Study|Intercurrent illness.|1|||
130393609|NCT03240133|469410436|FG002|Overall Study|Intercurrent illness.|0|||
130393610|NCT03240133|469410434|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
130393611|NCT03240133|469410435|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
130393612|NCT03240133|469410436|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
130393613|NCT01176292|469410440|FG000|Overall Study|Lost to Follow-up|2|||
130393614|NCT01176292|469410441|FG001|Overall Study|Lost to Follow-up|4|||
130393615|NCT01176292|469410440|FG000|Overall Study|Adverse Event|1|||
130393616|NCT01176292|469410441|FG001|Overall Study|Adverse Event|1|||
130393617|NCT01176292|469410440|FG000|Overall Study|Physician Decision|0|||
130393618|NCT01176292|469410441|FG001|Overall Study|Physician Decision|2|||
130393619|NCT01176292|469410440|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
130393620|NCT01176292|469410441|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
130393621|NCT00110812|469410442|FG000|Main Study|Death|0|||
130393622|NCT00110812|469410443|FG001|Main Study|Death|0|||
130393623|NCT00110812|469410444|FG002|Main Study|Death|2|||
130393624|NCT00110812|469410442|FG000|Main Study|Withdrawal by Subject|0|||
130393625|NCT00110812|469410443|FG001|Main Study|Withdrawal by Subject|0|||
130393626|NCT00110812|469410444|FG002|Main Study|Withdrawal by Subject|1|||
130393627|NCT00110812|469410442|FG000|Main Study|Lost to Follow-up|8|||
130393628|NCT00110812|469410443|FG001|Main Study|Lost to Follow-up|11|||
130393629|NCT00110812|469410444|FG002|Main Study|Lost to Follow-up|10|||
130393630|NCT00110812|469410442|FG000|Extended Follow-up|Death|1|||
130393631|NCT00110812|469410443|FG001|Extended Follow-up|Death|0|||
130393632|NCT00110812|469410444|FG002|Extended Follow-up|Death|3|||
130393633|NCT00110812|469410442|FG000|Extended Follow-up|Withdrawal by Subject|0|||
130723049|NCT02256436|470611337|FG001|Overall Study|Transferred to Extension Study|23|||
130723050|NCT02256436|470611336|FG000|Overall Study|Did Not Continue on Extension Study|8|||
130723051|NCT02256436|470611337|FG001|Overall Study|Did Not Continue on Extension Study|12|||
130723052|NCT03583086|470611338|FG000|Overall Study|Death|2|||
130723053|NCT03583086|470611339|FG001|Overall Study|Death|6|||
130723054|NCT03583086|470611340|FG002|Overall Study|Death|12|||
130723055|NCT03583086|470611341|FG003|Overall Study|Death|10|||
130723056|NCT03583086|470611342|FG004|Overall Study|Death|14|||
130723057|NCT03583086|470611343|FG005|Overall Study|Death|14|||
130723058|NCT03583086|470611344|FG006|Overall Study|Death|4|||
130723059|NCT03583086|470611338|FG000|Overall Study|Withdrawal by Subject|0|||
130723060|NCT03583086|470611339|FG001|Overall Study|Withdrawal by Subject|0|||
130723061|NCT03583086|470611340|FG002|Overall Study|Withdrawal by Subject|1|||
130723062|NCT03583086|470611341|FG003|Overall Study|Withdrawal by Subject|0|||
130723063|NCT03583086|470611342|FG004|Overall Study|Withdrawal by Subject|0|||
130723064|NCT03583086|470611343|FG005|Overall Study|Withdrawal by Subject|0|||
130723065|NCT03583086|470611344|FG006|Overall Study|Withdrawal by Subject|1|||
130723066|NCT03583086|470611338|FG000|Overall Study|Refused follow-up|0|||
130723067|NCT03583086|470611339|FG001|Overall Study|Refused follow-up|0|||
130723068|NCT03583086|470611340|FG002|Overall Study|Refused follow-up|1|||
130723069|NCT03583086|470611341|FG003|Overall Study|Refused follow-up|0|||
130723070|NCT03583086|470611342|FG004|Overall Study|Refused follow-up|1|||
130723071|NCT03583086|470611343|FG005|Overall Study|Refused follow-up|0|||
130723072|NCT03583086|470611344|FG006|Overall Study|Refused follow-up|0|||
130393634|NCT00110812|469410443|FG001|Extended Follow-up|Withdrawal by Subject|1|||
130393635|NCT00110812|469410444|FG002|Extended Follow-up|Withdrawal by Subject|0|||
130393636|NCT00110812|469410442|FG000|Extended Follow-up|Lost to Follow-up|1|||
130393637|NCT00110812|469410443|FG001|Extended Follow-up|Lost to Follow-up|3|||
130393638|NCT00110812|469410444|FG002|Extended Follow-up|Lost to Follow-up|1|||
130393639|NCT01446965|469410446|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
130393640|NCT01446965|469410447|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
130393641|NCT01446965|469410446|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
130723073|NCT03583086|470611338|FG000|Overall Study|Declining Performance Status|0|||
130723074|NCT03583086|470611339|FG001|Overall Study|Declining Performance Status|0|||
130393642|NCT01446965|469410447|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
130723075|NCT03583086|470611340|FG002|Overall Study|Declining Performance Status|1|||
130723076|NCT03583086|470611341|FG003|Overall Study|Declining Performance Status|0|||
130393643|NCT02852265|469410448|FG000|3-month Follow-up|Lost to Follow-up|1|||
130393644|NCT02852265|469410449|FG001|3-month Follow-up|Lost to Follow-up|1|||
130393645|NCT01828034|469410452|FG000|Overall Study|Withdrawal by Subject|0|||
130393646|NCT01828034|469410453|FG001|Overall Study|Withdrawal by Subject|0|||
130393647|NCT01828034|469410454|FG002|Overall Study|Withdrawal by Subject|0|||
130393648|NCT01828034|469410455|FG003|Overall Study|Withdrawal by Subject|1|||
130393649|NCT02871375|469410456|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
130393650|NCT02871375|469410457|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
130393651|NCT01988571|469410460|FG000|Overall Study|Death|3|||
130393652|NCT01988571|469410461|FG001|Overall Study|Death|1|||
130393653|NCT01988571|469410460|FG000|Overall Study|Physician Decision|2|||
130393654|NCT01988571|469410461|FG001|Overall Study|Physician Decision|1|||
130393655|NCT01988571|469410460|FG000|Overall Study|Lost to Follow-up|3|||
130393656|NCT01988571|469410461|FG001|Overall Study|Lost to Follow-up|0|||
130393657|NCT01988571|469410460|FG000|Overall Study|Withdrawal by Subject|31|||
130393658|NCT01988571|469410461|FG001|Overall Study|Withdrawal by Subject|33|||
130393659|NCT00004412|469410462|FG000|Randomized Period|Moved to Crossover Period|3|||
130393660|NCT00004412|469410463|FG001|Randomized Period|Moved to Crossover Period|0|||
130393661|NCT00004412|469410464|FG002|Randomized Period|Moved to Crossover Period|0|||
130393662|NCT02346136|469410467|FG000|Overall Study|Withdrawal by Subject|7|||
130393663|NCT02346136|469410468|FG001|Overall Study|Withdrawal by Subject|5|||
130393664|NCT02346136|469410467|FG000|Overall Study|Death|1|||
130393665|NCT02346136|469410468|FG001|Overall Study|Death|0|||
130393666|NCT02346136|469410467|FG000|Overall Study|Study termination|14|||
130393667|NCT02346136|469410468|FG001|Overall Study|Study termination|18|||
130393668|NCT00453999|469410472|FG000|Overall Study|Adverse Event|1|||
130393669|NCT00453999|469410473|FG001|Overall Study|Adverse Event|2|||
130393670|NCT00453999|469410474|FG002|Overall Study|Adverse Event|1|||
130393671|NCT00453999|469410472|FG000|Overall Study|Lost to Follow-up|0|||
130393672|NCT00453999|469410473|FG001|Overall Study|Lost to Follow-up|1|||
130393673|NCT00453999|469410474|FG002|Overall Study|Lost to Follow-up|1|||
130393674|NCT00453999|469410472|FG000|Overall Study|Withdrawal by Subject|2|||
130393675|NCT00453999|469410473|FG001|Overall Study|Withdrawal by Subject|1|||
130393676|NCT00453999|469410474|FG002|Overall Study|Withdrawal by Subject|1|||
130393677|NCT00453999|469410472|FG000|Overall Study|Subject Request|2|||
130393678|NCT00453999|469410473|FG001|Overall Study|Subject Request|1|||
130393679|NCT00453999|469410474|FG002|Overall Study|Subject Request|0|||
130393680|NCT01364428|469410484|FG000|Overall Study|Adverse Event|1|||
130393681|NCT01364428|469410485|FG001|Overall Study|Adverse Event|2|||
130393682|NCT01364428|469410484|FG000|Overall Study|Protocol Violation|2|||
130393683|NCT01364428|469410485|FG001|Overall Study|Protocol Violation|0|||
130393684|NCT01364428|469410484|FG000|Overall Study|Withdrawal Criteria|14|||
130393685|NCT01364428|469410485|FG001|Overall Study|Withdrawal Criteria|10|||
130393686|NCT01364428|469410484|FG000|Overall Study|Other|3|||
130393687|NCT01364428|469410485|FG001|Overall Study|Other|3|||
130393688|NCT00743652|469410486|FG000|Overall Study|Parent/Legal Guardian Request|3|||
130393689|NCT00743652|469410487|FG001|Overall Study|Parent/Legal Guardian Request|2|||
130393690|NCT00743652|469410488|FG002|Overall Study|Parent/Legal Guardian Request|2|||
130393691|NCT00743652|469410489|FG003|Overall Study|Parent/Legal Guardian Request|2|||
130393692|NCT00743652|469410490|FG004|Overall Study|Parent/Legal Guardian Request|0|||
130393693|NCT00743652|469410486|FG000|Overall Study|Adverse Event|3|||
130393694|NCT00743652|469410487|FG001|Overall Study|Adverse Event|0|||
130393695|NCT00743652|469410488|FG002|Overall Study|Adverse Event|0|||
130393696|NCT00743652|469410489|FG003|Overall Study|Adverse Event|0|||
130393697|NCT00743652|469410490|FG004|Overall Study|Adverse Event|0|||
130393698|NCT00743652|469410486|FG000|Overall Study|Death|2|||
130393699|NCT00743652|469410487|FG001|Overall Study|Death|0|||
130393700|NCT00743652|469410488|FG002|Overall Study|Death|0|||
130393701|NCT00743652|469410489|FG003|Overall Study|Death|0|||
130393702|NCT00743652|469410490|FG004|Overall Study|Death|0|||
130559917|NCT03346057|470017901|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
130559918|NCT03346057|470017902|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
130723077|NCT03583086|470611342|FG004|Overall Study|Declining Performance Status|0|||
130723078|NCT03583086|470611343|FG005|Overall Study|Declining Performance Status|0|||
130393703|NCT00743652|469410486|FG000|Overall Study|Investigator Request|0|||
130393704|NCT00743652|469410487|FG001|Overall Study|Investigator Request|0|||
130393705|NCT00743652|469410488|FG002|Overall Study|Investigator Request|0|||
130393706|NCT00743652|469410489|FG003|Overall Study|Investigator Request|2|||
130393707|NCT00743652|469410490|FG004|Overall Study|Investigator Request|0|||
130559919|NCT03346057|470017903|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
130723079|NCT03583086|470611344|FG006|Overall Study|Declining Performance Status|0|||
130393708|NCT00743652|469410486|FG000|Overall Study|Other|1|||
130393709|NCT00743652|469410487|FG001|Overall Study|Other|1|||
130393710|NCT00743652|469410488|FG002|Overall Study|Other|0|||
130393711|NCT00743652|469410489|FG003|Overall Study|Other|0|||
130723080|NCT03583086|470611338|FG000|Overall Study|Still on study|0|||
130723081|NCT03583086|470611339|FG001|Overall Study|Still on study|0|||
130393712|NCT00743652|469410490|FG004|Overall Study|Other|0|||
130393713|NCT00743652|469410486|FG000|Overall Study|Lost to Follow-up|1|||
130393714|NCT00743652|469410487|FG001|Overall Study|Lost to Follow-up|0|||
130393715|NCT00743652|469410488|FG002|Overall Study|Lost to Follow-up|0|||
130393716|NCT00743652|469410489|FG003|Overall Study|Lost to Follow-up|0|||
130393717|NCT00743652|469410490|FG004|Overall Study|Lost to Follow-up|0|||
130393718|NCT02129803|469410493|FG000|Overall Study|Protocol Violation|4|||
130393719|NCT02129803|469410494|FG001|Overall Study|Protocol Violation|0|||
130393720|NCT02129803|469410493|FG000|Overall Study|Physician Decision|0|||
130393721|NCT02129803|469410494|FG001|Overall Study|Physician Decision|1|||
130393722|NCT02129803|469410493|FG000|Overall Study|Difficulty sleeping|1|||
130393723|NCT02129803|469410494|FG001|Overall Study|Difficulty sleeping|0|||
130393724|NCT02129803|469410493|FG000|Overall Study|Morning headache|0|||
130393725|NCT02129803|469410494|FG001|Overall Study|Morning headache|1|||
130393726|NCT02129803|469410493|FG000|Overall Study|Withdrawal by Subject|1|||
130393727|NCT02129803|469410494|FG001|Overall Study|Withdrawal by Subject|1|||
130393728|NCT02689258|469410495|FG000|Overall Study|Subject Non-Compliance|0|||
130393729|NCT02689258|469410496|FG001|Overall Study|Subject Non-Compliance|1|||
130393730|NCT02689258|469410497|FG002|Overall Study|Subject Non-Compliance|0|||
130393731|NCT02689258|469410498|FG003|Overall Study|Subject Non-Compliance|0|||
130393732|NCT02689258|469410499|FG004|Overall Study|Subject Non-Compliance|0|||
130393733|NCT02689258|469410500|FG005|Overall Study|Subject Non-Compliance|0|||
130393734|NCT02689258|469410501|FG006|Overall Study|Subject Non-Compliance|0|||
130393735|NCT02689258|469410502|FG007|Overall Study|Subject Non-Compliance|0|||
130393736|NCT02689258|469410503|FG008|Overall Study|Subject Non-Compliance|0|||
130393737|NCT02689258|469410504|FG009|Overall Study|Subject Non-Compliance|0|||
130393738|NCT02689258|469410505|FG010|Overall Study|Subject Non-Compliance|0|||
130393739|NCT02689258|469410506|FG011|Overall Study|Subject Non-Compliance|0|||
130393740|NCT02689258|469410495|FG000|Overall Study|Subject Refusal to Continue|0|||
130393741|NCT02689258|469410496|FG001|Overall Study|Subject Refusal to Continue|1|||
130393742|NCT02689258|469410497|FG002|Overall Study|Subject Refusal to Continue|0|||
130393743|NCT02689258|469410498|FG003|Overall Study|Subject Refusal to Continue|0|||
130393744|NCT02689258|469410499|FG004|Overall Study|Subject Refusal to Continue|0|||
130393745|NCT02689258|469410500|FG005|Overall Study|Subject Refusal to Continue|0|||
130559920|NCT03346057|470017904|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
130559921|NCT03346057|470017901|FG000|Overall Study|Physician Decision|3|||
130559922|NCT03346057|470017902|FG001|Overall Study|Physician Decision|2|||
130559923|NCT03346057|470017903|FG002|Overall Study|Physician Decision|0|||
130559924|NCT03346057|470017904|FG003|Overall Study|Physician Decision|2|||
130559925|NCT03346057|470017901|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
130393746|NCT02689258|469410501|FG006|Overall Study|Subject Refusal to Continue|0|||
130393747|NCT02689258|469410502|FG007|Overall Study|Subject Refusal to Continue|0|||
130393748|NCT02689258|469410503|FG008|Overall Study|Subject Refusal to Continue|1|||
130393749|NCT02689258|469410504|FG009|Overall Study|Subject Refusal to Continue|0|||
130393750|NCT02689258|469410505|FG010|Overall Study|Subject Refusal to Continue|0|||
130393751|NCT02689258|469410506|FG011|Overall Study|Subject Refusal to Continue|1|||
130393752|NCT02689258|469410495|FG000|Overall Study|Other|0|||
130393753|NCT02689258|469410496|FG001|Overall Study|Other|2|||
130393754|NCT02689258|469410497|FG002|Overall Study|Other|0|||
130393755|NCT02689258|469410498|FG003|Overall Study|Other|0|||
130393756|NCT02689258|469410499|FG004|Overall Study|Other|1|||
130393757|NCT02689258|469410500|FG005|Overall Study|Other|0|||
130393758|NCT02689258|469410501|FG006|Overall Study|Other|0|||
130393759|NCT02689258|469410502|FG007|Overall Study|Other|0|||
130393760|NCT02689258|469410503|FG008|Overall Study|Other|1|||
130393761|NCT02689258|469410504|FG009|Overall Study|Other|0|||
130393762|NCT02689258|469410505|FG010|Overall Study|Other|0|||
130393763|NCT02689258|469410506|FG011|Overall Study|Other|0|||
130393764|NCT03742141|469410512|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
130393765|NCT06049043|469410517|FG000|Overall Study|Lost to Follow-up|11|||
130393766|NCT06049043|469410518|FG001|Overall Study|Lost to Follow-up|9|||
130393767|NCT01354496|469410522|FG000|Period 1|Adverse Event|0|||
130393768|NCT01354496|469410523|FG001|Period 1|Adverse Event|0|||
130393769|NCT01354496|469410524|FG002|Period 1|Adverse Event|1|||
130393770|NCT01354496|469410525|FG003|Period 1|Adverse Event|0|||
130393771|NCT01354496|469410526|FG004|Period 1|Adverse Event|0|||
130393772|NCT01354496|469410527|FG005|Period 1|Adverse Event|0|||
130393773|NCT01354496|469410522|FG000|Period 1|Physician Decision|0|||
130393774|NCT01354496|469410523|FG001|Period 1|Physician Decision|0|||
130393775|NCT01354496|469410524|FG002|Period 1|Physician Decision|1|||
130393776|NCT01354496|469410525|FG003|Period 1|Physician Decision|0|||
130559926|NCT03346057|470017902|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
130723082|NCT03583086|470611340|FG002|Overall Study|Still on study|0|||
130393777|NCT01354496|469410526|FG004|Period 1|Physician Decision|0|||
130393778|NCT01354496|469410527|FG005|Period 1|Physician Decision|0|||
130559927|NCT03346057|470017903|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
130393779|NCT01354496|469410522|FG000|Period 2|Adverse Event|0|||
130393780|NCT01354496|469410523|FG001|Period 2|Adverse Event|0|||
130393781|NCT01354496|469410524|FG002|Period 2|Adverse Event|0|||
130393782|NCT01354496|469410525|FG003|Period 2|Adverse Event|1|||
130393783|NCT01354496|469410526|FG004|Period 2|Adverse Event|0|||
130393784|NCT01354496|469410527|FG005|Period 2|Adverse Event|0|||
130393785|NCT01354496|469410522|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130393786|NCT01354496|469410523|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
130393787|NCT01354496|469410524|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130393788|NCT01354496|469410525|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
130393789|NCT01354496|469410526|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130393790|NCT01354496|469410527|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130393791|NCT03216850|469410528|FG000|Overall Study|Pre-analytical error|6|||
130393792|NCT03190889|469410529|FG000|Overall Study|Lost to Follow-up|7|||
130393793|NCT03190889|469410530|FG001|Overall Study|Lost to Follow-up|7|||
130393794|NCT03190889|469410531|FG002|Overall Study|Lost to Follow-up|3|||
130393795|NCT03190889|469410529|FG000|Overall Study|Withdrawal by Subject|1|||
130393796|NCT03190889|469410530|FG001|Overall Study|Withdrawal by Subject|1|||
130393797|NCT03190889|469410531|FG002|Overall Study|Withdrawal by Subject|2|||
130393798|NCT03190889|469410529|FG000|Overall Study|Did not complete protocol|4|||
130393799|NCT03190889|469410530|FG001|Overall Study|Did not complete protocol|9|||
130393800|NCT03190889|469410531|FG002|Overall Study|Did not complete protocol|0|||
130393801|NCT03190889|469410529|FG000|Overall Study|COVID-19|1|||
130393802|NCT03190889|469410530|FG001|Overall Study|COVID-19|0|||
130393803|NCT03190889|469410531|FG002|Overall Study|COVID-19|2|||
130393804|NCT01228747|469410532|FG000|Overall Study|Adverse Event|8|||
130393805|NCT01228747|469410533|FG001|Overall Study|Adverse Event|4|||
130393806|NCT01228747|469410532|FG000|Overall Study|Lack of Efficacy|40|||
130393807|NCT01228747|469410533|FG001|Overall Study|Lack of Efficacy|27|||
130393808|NCT01228747|469410532|FG000|Overall Study|Protocol Violation|6|||
130393809|NCT01228747|469410533|FG001|Overall Study|Protocol Violation|5|||
130393810|NCT01228747|469410532|FG000|Overall Study|Lost to Follow-up|4|||
130393811|NCT01228747|469410533|FG001|Overall Study|Lost to Follow-up|3|||
130393812|NCT01228747|469410532|FG000|Overall Study|Withdrawal by Subject|5|||
130393813|NCT01228747|469410533|FG001|Overall Study|Withdrawal by Subject|1|||
130393814|NCT01228747|469410532|FG000|Overall Study|Other Reason|2|||
130393815|NCT01228747|469410533|FG001|Overall Study|Other Reason|5|||
130393816|NCT00500292|469410537|FG000|Overall Study|Adverse Event|3|||
130393817|NCT00500292|469410538|FG001|Overall Study|Adverse Event|6|||
130393818|NCT00500292|469410539|FG002|Overall Study|Adverse Event|4|||
130393819|NCT00500292|469410537|FG000|Overall Study|Condition under investigation worsened|21|||
130393820|NCT00500292|469410538|FG001|Overall Study|Condition under investigation worsened|23|||
130393821|NCT00500292|469410539|FG002|Overall Study|Condition under investigation worsened|19|||
130393822|NCT00500292|469410537|FG000|Overall Study|Withdrawal by Subject|0|||
130393823|NCT00500292|469410538|FG001|Overall Study|Withdrawal by Subject|1|||
130393824|NCT00500292|469410539|FG002|Overall Study|Withdrawal by Subject|0|||
130393825|NCT00500292|469410537|FG000|Overall Study|Other|1|||
130393826|NCT00500292|469410538|FG001|Overall Study|Other|1|||
130393827|NCT00500292|469410539|FG002|Overall Study|Other|4|||
130393828|NCT04982250|469410542|FG000|Overall Study|Lost to Follow-up|0|||
130393829|NCT04982250|469410543|FG001|Overall Study|Lost to Follow-up|26|||
130393830|NCT04982250|469410544|FG002|Overall Study|Lost to Follow-up|0|||
130393831|NCT04982250|469410545|FG003|Overall Study|Lost to Follow-up|0|||
130393832|NCT04982250|469410546|FG004|Overall Study|Lost to Follow-up|72|||
130723083|NCT03583086|470611341|FG003|Overall Study|Still on study|1|||
130723084|NCT03583086|470611342|FG004|Overall Study|Still on study|0|||
130723085|NCT03583086|470611343|FG005|Overall Study|Still on study|0|||
130723086|NCT03583086|470611344|FG006|Overall Study|Still on study|1|||
130723087|NCT03583086|470611338|FG000|Overall Study|Disease progression|0|||
130723088|NCT03583086|470611339|FG001|Overall Study|Disease progression|0|||
130723089|NCT03583086|470611340|FG002|Overall Study|Disease progression|0|||
130723090|NCT03583086|470611341|FG003|Overall Study|Disease progression|0|||
130723091|NCT03583086|470611342|FG004|Overall Study|Disease progression|0|||
130723092|NCT03583086|470611343|FG005|Overall Study|Disease progression|0|||
130723093|NCT03583086|470611344|FG006|Overall Study|Disease progression|1|||
130723094|NCT03583086|470611338|FG000|Overall Study|Undergoing radiation therapy|0|||
130723095|NCT03583086|470611339|FG001|Overall Study|Undergoing radiation therapy|0|||
130393833|NCT04982250|469410547|FG005|Overall Study|Lost to Follow-up|69|||
130393834|NCT04982250|469410542|FG000|Overall Study|Not Eligible to Enroll|0|||
130470435|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
130393835|NCT04982250|469410543|FG001|Overall Study|Not Eligible to Enroll|0|||
130393836|NCT04982250|469410544|FG002|Overall Study|Not Eligible to Enroll|0|||
130723096|NCT03583086|470611340|FG002|Overall Study|Undergoing radiation therapy|0|||
130723097|NCT03583086|470611341|FG003|Overall Study|Undergoing radiation therapy|0|||
130393837|NCT04982250|469410545|FG003|Overall Study|Not Eligible to Enroll|0|||
130393838|NCT04982250|469410546|FG004|Overall Study|Not Eligible to Enroll|10|||
130393839|NCT04982250|469410547|FG005|Overall Study|Not Eligible to Enroll|7|||
130393840|NCT01148511|469410549|FG000|Exposed to Study Drug|Protocol Violation|2|||
130393841|NCT01148511|469410550|FG001|Exposed to Study Drug|Protocol Violation|0|||
130723098|NCT03583086|470611342|FG004|Overall Study|Undergoing radiation therapy|0|||
130393842|NCT01148511|469410551|FG002|Exposed to Study Drug|Protocol Violation|0|||
130393843|NCT01148511|469410549|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
130723099|NCT03583086|470611343|FG005|Overall Study|Undergoing radiation therapy|0|||
130393844|NCT01148511|469410550|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
130393845|NCT01148511|469410551|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
130393846|NCT01148511|469410549|FG000|Randomized|Adverse Event|0|||
130393847|NCT01148511|469410550|FG001|Randomized|Adverse Event|1|||
130393848|NCT01148511|469410551|FG002|Randomized|Adverse Event|0|||
130393849|NCT01148511|469410549|FG000|Randomized|Protocol Violation|0|||
130393850|NCT01148511|469410550|FG001|Randomized|Protocol Violation|2|||
130393851|NCT01148511|469410551|FG002|Randomized|Protocol Violation|1|||
130393852|NCT01148511|469410549|FG000|Randomized|Lost to Follow-up|0|||
130393853|NCT01148511|469410550|FG001|Randomized|Lost to Follow-up|1|||
130393854|NCT01148511|469410551|FG002|Randomized|Lost to Follow-up|1|||
130393855|NCT01148511|469410549|FG000|Randomized|Consent withdrawal|0|||
130393856|NCT01148511|469410550|FG001|Randomized|Consent withdrawal|5|||
130393857|NCT01148511|469410551|FG002|Randomized|Consent withdrawal|3|||
130393858|NCT01148511|469410549|FG000|Randomized|Other|0|||
130393859|NCT01148511|469410550|FG001|Randomized|Other|1|||
130393860|NCT01148511|469410551|FG002|Randomized|Other|1|||
130393861|NCT04258605|469410553|FG000|Overall Study|Death|1|||
130393862|NCT04258605|469410554|FG001|Overall Study|Death|0|||
130393863|NCT04258605|469410553|FG000|Overall Study|Early study termination|21|||
130393864|NCT04258605|469410554|FG001|Overall Study|Early study termination|2|||
130393865|NCT00856908|469410571|FG000|Overall Study|Lost to Follow-up|1|||
130393866|NCT00856908|469410572|FG001|Overall Study|Lost to Follow-up|0|||
130393867|NCT01712256|469410575|FG000|Overall Study|Lost to Follow-up|1|||
130393868|NCT02196324|469410578|FG000|Overall Study|Withdrawal by Subject|8|||
130393869|NCT02196324|469410579|FG001|Overall Study|Withdrawal by Subject|4|||
130393870|NCT02196324|469410578|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
130393871|NCT02196324|469410579|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
130393872|NCT02196324|469410578|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
130393873|NCT02196324|469410579|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
130393874|NCT02196324|469410578|FG000|Overall Study|Other|1|||
130393875|NCT02196324|469410579|FG001|Overall Study|Other|0|||
130470436|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
130470437|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
130470438|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
130470439|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
130470440|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
130470441|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
130470442|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
130470443|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
130470444|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
130470445|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
130470446|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
130470447|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
130470448|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
130470449|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
130470450|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
130470451|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
130470452|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
130470453|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
130470454|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
130470455|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
130470456|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
130470457|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
130470458|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
130470459|NCT03338816|469688332|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
130470460|NCT03338816|469688333|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
130470461|NCT03338816|469688334|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
130723100|NCT03583086|470611344|FG006|Overall Study|Undergoing radiation therapy|1|||
130723101|NCT03583086|470611338|FG000|Overall Study|Lost to Follow-up|0|||
130723102|NCT03583086|470611339|FG001|Overall Study|Lost to Follow-up|0|||
130393876|NCT02181556|469412495|FG000|Overall Study|Withdrawal by Subject|1|||
130393877|NCT01940120|469412496|FG000|Overall Study|Death|40|||
130393878|NCT01940120|469412496|FG000|Overall Study|Withdrawal by Subject|8|||
130393879|NCT01572038|469412498|FG000|Overall Study|Death|648|||
130393880|NCT01572038|469412498|FG000|Overall Study|Withdrawal by Subject|204|||
130723103|NCT03583086|470611340|FG002|Overall Study|Lost to Follow-up|0|||
130393881|NCT01572038|469412498|FG000|Overall Study|Lost to Follow-up|81|||
130393882|NCT01572038|469412498|FG000|Overall Study|Physician Decision|20|||
130393883|NCT01572038|469412498|FG000|Overall Study|Patient Decision|14|||
130393884|NCT01572038|469412498|FG000|Overall Study|Progressive Disease|8|||
130470462|NCT03338816|469688335|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
130723104|NCT03583086|470611341|FG003|Overall Study|Lost to Follow-up|0|||
130470463|NCT04238247|469688341|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
130470464|NCT04238247|469688342|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
130470465|NCT04238247|469688343|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
130470466|NCT04238247|469688344|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
130470467|NCT04238247|469688341|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
130470468|NCT04238247|469688342|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
130470469|NCT04238247|469688343|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
130470470|NCT04238247|469688344|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
130470471|NCT04238247|469688341|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
130470472|NCT04238247|469688342|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
130470473|NCT04238247|469688343|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
130470474|NCT04238247|469688344|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
130470475|NCT04238247|469688341|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
130470476|NCT04238247|469688342|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
130470477|NCT04238247|469688343|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
130470478|NCT04238247|469688344|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
130470479|NCT03092726|469688345|FG000|Overall Study|Adverse Event|3|||
130470480|NCT03092726|469688346|FG001|Overall Study|Adverse Event|10|||
130470481|NCT03092726|469688345|FG000|Overall Study|Lack of Efficacy|0|||
130559928|NCT03346057|470017904|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
130559929|NCT03346057|470017901|FG000|Overall Study|Withdrawal by Subject|1|||
130559930|NCT03346057|470017902|FG001|Overall Study|Withdrawal by Subject|0|||
130559931|NCT03346057|470017903|FG002|Overall Study|Withdrawal by Subject|0|||
130559932|NCT03346057|470017904|FG003|Overall Study|Withdrawal by Subject|0|||
130559933|NCT03044886|470017905|FG000|Overall Study|Lost to Follow-up|15|||
130559934|NCT03044886|470017906|FG001|Overall Study|Lost to Follow-up|10|||
130559935|NCT03044886|470017907|FG002|Overall Study|Lost to Follow-up|12|||
130723105|NCT03583086|470611342|FG004|Overall Study|Lost to Follow-up|0|||
130393885|NCT01572038|469412498|FG000|Overall Study|Site Closed Before Completing Form|6|||
130393886|NCT01572038|469412498|FG000|Overall Study|Enrolled into Another Trial|3|||
130393887|NCT01572038|469412498|FG000|Overall Study|Participated in Another Trial|3|||
130393888|NCT01572038|469412498|FG000|Overall Study|Termination by Sponsor|2|||
130393889|NCT01572038|469412498|FG000|Overall Study|Patient Deterioration|1|||
130393890|NCT01572038|469412498|FG000|Overall Study|Sponsor Decision|1|||
130393891|NCT01888497|469412499|FG000|Washout Period 1|Withdrawal by Subject|0|||
130393892|NCT01888497|469412500|FG001|Washout Period 1|Withdrawal by Subject|0|||
130393893|NCT01888497|469412501|FG002|Washout Period 1|Withdrawal by Subject|1|||
130393894|NCT01888497|469412502|FG003|Washout Period 1|Withdrawal by Subject|1|||
130393895|NCT01888497|469412499|FG000|Washout Period 2|Adverse Event|0|||
130393896|NCT01888497|469412500|FG001|Washout Period 2|Adverse Event|0|||
130393897|NCT01888497|469412501|FG002|Washout Period 2|Adverse Event|0|||
130393898|NCT01888497|469412502|FG003|Washout Period 2|Adverse Event|1|||
130393899|NCT01888497|469412499|FG000|Washout Period 2|Withdrawal by Subject|0|||
130393900|NCT01888497|469412500|FG001|Washout Period 2|Withdrawal by Subject|0|||
130393901|NCT01888497|469412501|FG002|Washout Period 2|Withdrawal by Subject|0|||
130393902|NCT01888497|469412502|FG003|Washout Period 2|Withdrawal by Subject|1|||
130393903|NCT04152447|469412503|FG000|Overall Study|Lost to Follow-up|1|||
130393904|NCT04152447|469412504|FG001|Overall Study|Lost to Follow-up|0|||
130393905|NCT04152447|469412503|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
130393906|NCT04152447|469412504|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
130393907|NCT04152447|469412503|FG000|Overall Study|Withdrawal by Subject|0|||
130393908|NCT04152447|469412504|FG001|Overall Study|Withdrawal by Subject|1|||
130393909|NCT04152447|469412503|FG000|Overall Study|Found ineligible after enrolling|1|||
130393910|NCT04152447|469412504|FG001|Overall Study|Found ineligible after enrolling|1|||
130393911|NCT04152447|469412503|FG000|Overall Study|Did not receive VR headset in time.|0|||
130393912|NCT04152447|469412504|FG001|Overall Study|Did not receive VR headset in time.|2|||
130393913|NCT03034954|469412505|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
130393914|NCT03034954|469412506|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
130393915|NCT04200248|469412511|FG000|Overall Study|Personal reasons|0|||
130393916|NCT04200248|469412512|FG001|Overall Study|Personal reasons|0|||
130393917|NCT04200248|469412513|FG002|Overall Study|Personal reasons|1|||
130393918|NCT04200248|469412511|FG000|Overall Study|Discontinued prior to treatment|3|||
130470482|NCT03092726|469688346|FG001|Overall Study|Lack of Efficacy|1|||
130470483|NCT03092726|469688345|FG000|Overall Study|Lost to Follow-up|1|||
130470484|NCT03092726|469688346|FG001|Overall Study|Lost to Follow-up|0|||
130470485|NCT03092726|469688345|FG000|Overall Study|Withdrawal by Subject|5|||
130470486|NCT03092726|469688346|FG001|Overall Study|Withdrawal by Subject|3|||
130470487|NCT04950127|469688347|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
130470488|NCT04950127|469688348|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
130470489|NCT04950127|469688349|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
130470490|NCT04950127|469688350|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
130559936|NCT02003014|470017908|FG000|Overall Study|Case report forms uncollected|9|||
130723106|NCT03583086|470611343|FG005|Overall Study|Lost to Follow-up|1|||
130393919|NCT04200248|469412512|FG001|Overall Study|Discontinued prior to treatment|3|||
130393920|NCT04200248|469412513|FG002|Overall Study|Discontinued prior to treatment|2|||
130393921|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
130393922|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
130393923|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
130393924|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
130393925|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130393926|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
130393927|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130393928|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130393929|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
130393930|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
130393931|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
130393932|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
130393933|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
130393934|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130393935|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130393936|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130393937|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
130393938|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
130393939|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
130393940|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
130393941|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130393942|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
130393943|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130393944|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130393945|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130393946|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
130393947|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130393948|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130393949|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130393950|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
130393951|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130393952|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130470491|NCT04950127|469688351|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
130470492|NCT04950127|469688352|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
130470493|NCT04950127|469688347|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
130470494|NCT04950127|469688348|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
130470495|NCT04950127|469688349|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
130470496|NCT04950127|469688350|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
130470497|NCT04950127|469688351|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
130470498|NCT04950127|469688352|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
130470499|NCT04950127|469688347|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
130470500|NCT04950127|469688348|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
130723107|NCT03583086|470611344|FG006|Overall Study|Lost to Follow-up|0|||
130723108|NCT03583086|470611338|FG000|Overall Study|Adverse Event|0|||
130723109|NCT03583086|470611339|FG001|Overall Study|Adverse Event|0|||
130723110|NCT03583086|470611340|FG002|Overall Study|Adverse Event|0|||
130723111|NCT03583086|470611341|FG003|Overall Study|Adverse Event|0|||
130393953|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
130393954|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
130393955|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
130393956|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
130393957|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130393958|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
130393959|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130393960|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130393961|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
130470501|NCT04950127|469688349|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
130470502|NCT04950127|469688350|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
130470503|NCT04950127|469688351|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
130470504|NCT04950127|469688352|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
130470505|NCT04950127|469688347|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
130470506|NCT04950127|469688348|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
130470507|NCT04950127|469688349|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
130393962|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
130393963|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
130393964|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
130393965|NCT01218516|469412516|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
130393966|NCT01218516|469412517|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
130393967|NCT01218516|469412518|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
130393968|NCT01218516|469412519|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
130393969|NCT04171414|469412520|FG000|Overall Study|Death|1|||
130393970|NCT04171414|469412520|FG000|Overall Study|Withdrawal by Subject|1|||
130393971|NCT01714310|469412521|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
130393972|NCT01714310|469412522|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
130393973|NCT01714310|469412523|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
130393974|NCT01714310|469412521|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
130393975|NCT01714310|469412522|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
130393976|NCT01714310|469412523|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
130393977|NCT01714310|469412521|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
130393978|NCT01714310|469412522|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
130393979|NCT01714310|469412523|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
130393980|NCT01714310|469412521|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
130393981|NCT01714310|469412522|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
130393982|NCT01714310|469412523|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
130393983|NCT02586493|469412528|FG000|Overall Study|Adverse Event|4|||
130393984|NCT02586493|469412528|FG000|Overall Study|Protocol Violation|6|||
130393985|NCT02586493|469412528|FG000|Overall Study|Lost to Follow-up|1|||
130393986|NCT02586493|469412528|FG000|Overall Study|Withdrawal by Subject|1|||
130393987|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
130393988|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
130393989|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
130393990|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
130393991|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
130393992|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
130393993|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
130393994|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
130393995|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
130393996|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
130393997|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
130393998|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
130393999|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
130394000|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
130394001|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
130394002|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Death|5|||
130394003|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Death|0|||
130394004|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Death|2|||
130394005|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Death|0|||
130394006|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Death|4|||
130394007|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
130394008|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
130394009|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
130394010|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
130394011|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
130394012|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
130394013|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
130394014|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
130394015|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
130394016|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
130394017|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
130394018|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130394019|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
130394020|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130394021|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130394022|NCT01604343|469412532|FG000|Prior to W52 Administration(Through W52)|Other|15|||
130394023|NCT01604343|469412533|FG001|Prior to W52 Administration(Through W52)|Other|0|||
130394024|NCT01604343|469412534|FG002|Prior to W52 Administration(Through W52)|Other|10|||
130394025|NCT01604343|469412535|FG003|Prior to W52 Administration(Through W52)|Other|0|||
130394026|NCT01604343|469412536|FG004|Prior to W52 Administration(Through W52)|Other|6|||
130394027|NCT01604343|469412532|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
130394028|NCT01604343|469412533|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
130394029|NCT01604343|469412534|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
130394030|NCT01604343|469412535|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
130394031|NCT01604343|469412536|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
130394032|NCT01604343|469412532|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
130394033|NCT01604343|469412533|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
130394034|NCT01604343|469412534|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
130394035|NCT01604343|469412535|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
130394036|NCT01604343|469412536|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
130394037|NCT01604343|469412532|FG000|Week 52 to Week 104|Adverse Event|0|||
130394038|NCT01604343|469412533|FG001|Week 52 to Week 104|Adverse Event|12|||
130394039|NCT01604343|469412534|FG002|Week 52 to Week 104|Adverse Event|26|||
130394040|NCT01604343|469412535|FG003|Week 52 to Week 104|Adverse Event|21|||
130394041|NCT01604343|469412536|FG004|Week 52 to Week 104|Adverse Event|27|||
130394042|NCT01604343|469412532|FG000|Week 52 to Week 104|Death|0|||
130394043|NCT01604343|469412533|FG001|Week 52 to Week 104|Death|4|||
130394044|NCT01604343|469412534|FG002|Week 52 to Week 104|Death|2|||
130394045|NCT01604343|469412535|FG003|Week 52 to Week 104|Death|5|||
130394046|NCT01604343|469412536|FG004|Week 52 to Week 104|Death|0|||
130394047|NCT01604343|469412532|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
130394048|NCT01604343|469412533|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
130394049|NCT01604343|469412534|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
130394050|NCT01604343|469412535|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
130394051|NCT01604343|469412536|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
130394052|NCT01604343|469412532|FG000|Week 52 to Week 104|Physician Decision|0|||
130394053|NCT01604343|469412533|FG001|Week 52 to Week 104|Physician Decision|1|||
130394054|NCT01604343|469412534|FG002|Week 52 to Week 104|Physician Decision|0|||
130394055|NCT01604343|469412535|FG003|Week 52 to Week 104|Physician Decision|0|||
130394056|NCT01604343|469412536|FG004|Week 52 to Week 104|Physician Decision|2|||
130394057|NCT01604343|469412532|FG000|Week 52 to Week 104|Pregnancy|0|||
130394058|NCT01604343|469412533|FG001|Week 52 to Week 104|Pregnancy|0|||
130394059|NCT01604343|469412534|FG002|Week 52 to Week 104|Pregnancy|1|||
130394060|NCT01604343|469412535|FG003|Week 52 to Week 104|Pregnancy|2|||
130394061|NCT01604343|469412536|FG004|Week 52 to Week 104|Pregnancy|1|||
130394062|NCT01604343|469412532|FG000|Week 52 to Week 104|Other|0|||
130394063|NCT01604343|469412533|FG001|Week 52 to Week 104|Other|11|||
130394064|NCT01604343|469412534|FG002|Week 52 to Week 104|Other|11|||
130394065|NCT01604343|469412535|FG003|Week 52 to Week 104|Other|6|||
130394066|NCT01604343|469412536|FG004|Week 52 to Week 104|Other|3|||
130394067|NCT01604343|469412532|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
130394068|NCT01604343|469412533|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130394069|NCT01604343|469412534|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
130394070|NCT01604343|469412535|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130394071|NCT01604343|469412536|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130394072|NCT01604343|469412532|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
130394073|NCT01604343|469412533|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
130394074|NCT01604343|469412534|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
130394075|NCT01604343|469412535|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
130394076|NCT01604343|469412536|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
130394077|NCT01604343|469412532|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
130394078|NCT01604343|469412533|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
130394079|NCT01604343|469412534|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
130394080|NCT01604343|469412535|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
130394081|NCT01604343|469412536|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
130394082|NCT03144180|469412550|FG000|Overall Study|STAT Delivery|1|||
130394083|NCT03144180|469412551|FG001|Overall Study|STAT Delivery|1|||
130394084|NCT03144180|469412550|FG000|Overall Study|Provider forgot to fill out forms|1|||
130394085|NCT03144180|469412551|FG001|Overall Study|Provider forgot to fill out forms|3|||
130394086|NCT03144180|469412550|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
130394087|NCT03144180|469412551|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
130394088|NCT03144180|469412550|FG000|Overall Study|Scrub tech removed tube cap|0|||
130394089|NCT03144180|469412551|FG001|Overall Study|Scrub tech removed tube cap|1|||
130394090|NCT02308735|469412556|FG000|Overall Study|Physician Decision|2|||
130394091|NCT02308735|469412557|FG001|Overall Study|Physician Decision|0|||
130394092|NCT02308735|469412558|FG002|Overall Study|Physician Decision|0|||
130394093|NCT02308735|469412559|FG003|Overall Study|Physician Decision|2|||
130394094|NCT00606892|469412560|FG000|First Intervention|Protocol Violation|1|||
130394095|NCT00606892|469412561|FG001|First Intervention|Protocol Violation|4|||
130394096|NCT04960228|469412566|FG000|Overall Study|Withdrawal by Subject|216|||
130394097|NCT04960228|469412567|FG001|Overall Study|Withdrawal by Subject|35|||
130394098|NCT04960228|469412566|FG000|Overall Study|Failed attention check|69|||
130394099|NCT04960228|469412567|FG001|Overall Study|Failed attention check|148|||
130394100|NCT04960228|469412566|FG000|Overall Study|Flagged for response quality by Dynata|3|||
130394101|NCT04960228|469412567|FG001|Overall Study|Flagged for response quality by Dynata|3|||
130394102|NCT00794196|469412569|FG000|Overall Study|Lost to Follow-up|5|||
130394103|NCT00794196|469412570|FG001|Overall Study|Lost to Follow-up|23|||
130394104|NCT00149747|469412571|FG000|Overall Study|Death|1|||
130394105|NCT00149747|469412572|FG001|Overall Study|Death|0|||
130394106|NCT00149747|469412571|FG000|Overall Study|Withdrawal by Subject|3|||
130394107|NCT00149747|469412572|FG001|Overall Study|Withdrawal by Subject|3|||
130394108|NCT04753164|469412573|FG000|Overall Study|Adverse Event|0|||
130394109|NCT04753164|469412574|FG001|Overall Study|Adverse Event|2|||
130394110|NCT04753164|469412573|FG000|Overall Study|Withdrawal by Subject|9|||
130394111|NCT04753164|469412574|FG001|Overall Study|Withdrawal by Subject|7|||
130394112|NCT04753164|469412573|FG000|Overall Study|Lost to Follow-up|6|||
130394113|NCT04753164|469412574|FG001|Overall Study|Lost to Follow-up|6|||
130394114|NCT04753164|469412573|FG000|Overall Study|Other|12|||
130394115|NCT04753164|469412574|FG001|Overall Study|Other|5|||
130394116|NCT01183975|469412580|FG000|Overall Study|Lost to Follow-up|73|||
130394117|NCT00850395|469412587|FG000|Overall Study|Death|1|||
130394118|NCT00850395|469412587|FG000|Overall Study|Adverse Event|1|||
130394119|NCT00850395|469412587|FG000|Overall Study|Insufficient clinical response|3|||
130394120|NCT00850395|469412587|FG000|Overall Study|Other|5|||
130394121|NCT02376166|469412588|FG000|Overall Study|Adverse Event|1|||
130394122|NCT02376166|469412588|FG000|Overall Study|Discontinued metformin early|2|||
130394123|NCT04180020|469412589|FG000|Overall Study|missed visit|18|||
130394124|NCT04180020|469412590|FG001|Overall Study|missed visit|16|||
130394125|NCT04180020|469412589|FG000|Overall Study|Death|2|||
130394126|NCT04180020|469412590|FG001|Overall Study|Death|3|||
130394127|NCT04180020|469412589|FG000|Overall Study|Withdrawal by Subject|1|||
130394128|NCT04180020|469412590|FG001|Overall Study|Withdrawal by Subject|5|||
130394129|NCT04180020|469412589|FG000|Overall Study|incarcerated|1|||
130394130|NCT04180020|469412590|FG001|Overall Study|incarcerated|1|||
130394131|NCT04180020|469412589|FG000|Overall Study|Physician Decision|0|||
130394132|NCT04180020|469412590|FG001|Overall Study|Physician Decision|2|||
130394133|NCT00405548|469412591|FG000|Overall Study|Cognitive Memory problems on study day|1|||
130394134|NCT00405548|469412592|FG001|Overall Study|Cognitive Memory problems on study day|0|||
130394135|NCT00405548|469412591|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
130394136|NCT00405548|469412592|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
130394137|NCT00405548|469412591|FG000|Overall Study|Unable to self-administer shots|1|||
130394138|NCT00405548|469412592|FG001|Overall Study|Unable to self-administer shots|0|||
130394139|NCT00405548|469412591|FG000|Overall Study|Venous access failed during study day|1|||
130394140|NCT00405548|469412592|FG001|Overall Study|Venous access failed during study day|0|||
130394141|NCT00405548|469412591|FG000|Overall Study|Withdrawal by Subject|1|||
130394142|NCT00405548|469412592|FG001|Overall Study|Withdrawal by Subject|0|||
130394143|NCT03554291|469412593|FG000|Overall Study|Death|2|||
130394144|NCT03554291|469412594|FG001|Overall Study|Death|1|||
130394145|NCT03554291|469412593|FG000|Overall Study|Lost to Follow-up|1|||
130394146|NCT03554291|469412594|FG001|Overall Study|Lost to Follow-up|0|||
130394147|NCT03554291|469412593|FG000|Overall Study|Withdrawal by Subject|1|||
130394148|NCT03554291|469412594|FG001|Overall Study|Withdrawal by Subject|0|||
130394149|NCT03554291|469412593|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
130394150|NCT03554291|469412594|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
130394151|NCT02036502|469412595|FG000|Part 1:Dose Determination/Escalation|Death|3|||
130394152|NCT02036502|469412596|FG001|Part 1:Dose Determination/Escalation|Death|2|||
130394153|NCT02036502|469412597|FG002|Part 1:Dose Determination/Escalation|Death|0|||
130394154|NCT02036502|469412598|FG003|Part 1:Dose Determination/Escalation|Death|0|||
130394155|NCT02036502|469412599|FG004|Part 1:Dose Determination/Escalation|Death|0|||
130394156|NCT02036502|469412600|FG005|Part 1:Dose Determination/Escalation|Death|0|||
130394157|NCT02036502|469412601|FG006|Part 1:Dose Determination/Escalation|Death|0|||
130394158|NCT02036502|469412602|FG007|Part 1:Dose Determination/Escalation|Death|0|||
130394159|NCT02036502|469412595|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
130394160|NCT02036502|469412596|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130394161|NCT02036502|469412597|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130394162|NCT02036502|469412598|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130723112|NCT03583086|470611342|FG004|Overall Study|Adverse Event|0|||
130723113|NCT03583086|470611343|FG005|Overall Study|Adverse Event|1|||
130723114|NCT03583086|470611344|FG006|Overall Study|Adverse Event|0|||
130394163|NCT02036502|469412599|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130394164|NCT02036502|469412600|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130394165|NCT02036502|469412601|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130723115|NCT01696279|470611345|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
130723116|NCT01696279|470611346|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130559937|NCT02003014|470017908|FG000|Overall Study|Treatment started after contract period|1|||
130559938|NCT02003014|470017908|FG000|Overall Study|Patient did not visit the study site|5|||
130559939|NCT02003014|470017908|FG000|Overall Study|Investigator's transfer|4|||
130559940|NCT01660451|470017909|FG000|Overall Study|Protocol Violation|0|||
130559941|NCT01660451|470017910|FG001|Overall Study|Protocol Violation|1|||
130559942|NCT01660451|470017911|FG002|Overall Study|Protocol Violation|1|||
130559943|NCT01660451|470017909|FG000|Overall Study|AE not associated with clinical disease progression|13|||
130559944|NCT01660451|470017910|FG001|Overall Study|AE not associated with clinical disease progression|10|||
130559945|NCT01660451|470017911|FG002|Overall Study|AE not associated with clinical disease progression|40|||
130559946|NCT01660451|470017909|FG000|Overall Study|AE associated with clinical disease progression|1|||
130559947|NCT01660451|470017910|FG001|Overall Study|AE associated with clinical disease progression|3|||
130559948|NCT01660451|470017911|FG002|Overall Study|AE associated with clinical disease progression|11|||
130559949|NCT01660451|470017909|FG000|Overall Study|Sponsor Decision|0|||
130559950|NCT01660451|470017910|FG001|Overall Study|Sponsor Decision|0|||
130559951|NCT01660451|470017911|FG002|Overall Study|Sponsor Decision|1|||
130559952|NCT01660451|470017909|FG000|Overall Study|Protocol Deviation|0|||
130559953|NCT01660451|470017910|FG001|Overall Study|Protocol Deviation|0|||
130559954|NCT01660451|470017911|FG002|Overall Study|Protocol Deviation|1|||
130559955|NCT01660451|470017909|FG000|Overall Study|Physician Decision|1|||
130559956|NCT01660451|470017910|FG001|Overall Study|Physician Decision|2|||
130723117|NCT01696279|470611347|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130723118|NCT01696279|470611348|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130723119|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130559957|NCT01660451|470017911|FG002|Overall Study|Physician Decision|5|||
130559958|NCT01660451|470017909|FG000|Overall Study|Withdrawal by Subject|1|||
130559959|NCT01660451|470017910|FG001|Overall Study|Withdrawal by Subject|1|||
130559960|NCT01660451|470017911|FG002|Overall Study|Withdrawal by Subject|20|||
130559961|NCT01660451|470017909|FG000|Overall Study|Trial closure.|0|||
130559962|NCT01660451|470017910|FG001|Overall Study|Trial closure.|0|||
130559963|NCT01660451|470017911|FG002|Overall Study|Trial closure.|1|||
130559964|NCT01660451|470017909|FG000|Overall Study|Switching to other therapy|0|||
130723120|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
130394166|NCT02036502|469412602|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130394167|NCT02036502|469412595|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394168|NCT02036502|469412596|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
130394169|NCT02036502|469412597|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394170|NCT02036502|469412598|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394171|NCT02036502|469412599|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394172|NCT02036502|469412600|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394173|NCT02036502|469412601|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394174|NCT02036502|469412602|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130394175|NCT02036502|469412595|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
130394176|NCT02036502|469412596|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
130394177|NCT02036502|469412597|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
130394178|NCT02036502|469412598|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
130394179|NCT02036502|469412599|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
130394180|NCT02036502|469412600|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
130394181|NCT02036502|469412601|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
130394182|NCT02036502|469412602|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
130394183|NCT02036502|469412595|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130394184|NCT02036502|469412596|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130394185|NCT02036502|469412597|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
130394186|NCT02036502|469412598|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
130394187|NCT02036502|469412599|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
130394188|NCT02036502|469412600|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130723121|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130394189|NCT02036502|469412601|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130394190|NCT02036502|469412602|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130394191|NCT02036502|469412595|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130559965|NCT01660451|470017910|FG001|Overall Study|Switching to other therapy|1|||
130559966|NCT01660451|470017911|FG002|Overall Study|Switching to other therapy|1|||
130559967|NCT01660451|470017909|FG000|Overall Study|Progressive disease - clinical progression|4|||
130723122|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130559968|NCT01660451|470017910|FG001|Overall Study|Progressive disease - clinical progression|10|||
130559969|NCT01660451|470017911|FG002|Overall Study|Progressive disease - clinical progression|9|||
130559970|NCT01660451|470017909|FG000|Overall Study|Progressive disease - radiological progression|12|||
130559971|NCT01660451|470017910|FG001|Overall Study|Progressive disease - radiological progression|23|||
130559972|NCT01660451|470017911|FG002|Overall Study|Progressive disease - radiological progression|50|||
130559973|NCT01660451|470017909|FG000|Overall Study|Death|1|||
130723123|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130723124|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
130723125|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130394192|NCT02036502|469412596|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394193|NCT02036502|469412597|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
130394194|NCT02036502|469412598|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394195|NCT02036502|469412599|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394196|NCT02036502|469412600|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394197|NCT02036502|469412601|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394198|NCT02036502|469412602|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130394199|NCT02036502|469412595|FG000|Part 2:Dose Confirmation|Death|0|||
130394200|NCT02036502|469412596|FG001|Part 2:Dose Confirmation|Death|0|||
130394201|NCT02036502|469412597|FG002|Part 2:Dose Confirmation|Death|1|||
130394202|NCT02036502|469412598|FG003|Part 2:Dose Confirmation|Death|0|||
130394203|NCT02036502|469412599|FG004|Part 2:Dose Confirmation|Death|0|||
130394204|NCT02036502|469412600|FG005|Part 2:Dose Confirmation|Death|0|||
130394205|NCT02036502|469412601|FG006|Part 2:Dose Confirmation|Death|0|||
130394206|NCT02036502|469412602|FG007|Part 2:Dose Confirmation|Death|0|||
130394207|NCT02036502|469412595|FG000|Part 2:Dose Confirmation|Not treated|0|||
130394208|NCT02036502|469412596|FG001|Part 2:Dose Confirmation|Not treated|0|||
130394209|NCT02036502|469412597|FG002|Part 2:Dose Confirmation|Not treated|0|||
130394210|NCT02036502|469412598|FG003|Part 2:Dose Confirmation|Not treated|1|||
130394211|NCT02036502|469412599|FG004|Part 2:Dose Confirmation|Not treated|0|||
130394212|NCT02036502|469412600|FG005|Part 2:Dose Confirmation|Not treated|0|||
130394213|NCT02036502|469412601|FG006|Part 2:Dose Confirmation|Not treated|0|||
130394214|NCT02036502|469412602|FG007|Part 2:Dose Confirmation|Not treated|0|||
130394215|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Adverse Event|0|||
130394216|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Adverse Event|0|||
130394217|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Adverse Event|0|||
130394218|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Adverse Event|0|||
130394219|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Adverse Event|0|||
130394220|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Adverse Event|4|||
130394221|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Adverse Event|0|||
130394222|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Adverse Event|2|||
130394223|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Death|0|||
130394224|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Death|0|||
130394225|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Death|0|||
130394226|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Death|0|||
130394227|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Death|0|||
130394228|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Death|24|||
130394229|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Death|0|||
130394230|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Death|3|||
130394231|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394232|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394233|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394234|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394235|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394236|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394237|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
130394238|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
130394239|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Physician Decision|0|||
130394240|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Physician Decision|0|||
130394241|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Physician Decision|0|||
130394242|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Physician Decision|0|||
130394243|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Physician Decision|0|||
130394244|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Physician Decision|1|||
130394245|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Physician Decision|0|||
130394246|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Physician Decision|0|||
130394247|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
130394248|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
130394249|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
130394250|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
130394251|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
130394252|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
130394253|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
130394254|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
130394255|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130559974|NCT01660451|470017910|FG001|Overall Study|Death|0|||
130394256|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130394257|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130394258|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130394259|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130394260|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
130394261|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130559975|NCT01660451|470017911|FG002|Overall Study|Death|1|||
130394262|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
130394263|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130394264|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130394265|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130394266|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130394267|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130394268|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
130394269|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
130394270|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
130394271|NCT02036502|469412595|FG000|Part 3:Dose Expansion|Not Treated|0|||
130394272|NCT02036502|469412596|FG001|Part 3:Dose Expansion|Not Treated|0|||
130394273|NCT02036502|469412597|FG002|Part 3:Dose Expansion|Not Treated|0|||
130394274|NCT02036502|469412598|FG003|Part 3:Dose Expansion|Not Treated|0|||
130394275|NCT02036502|469412599|FG004|Part 3:Dose Expansion|Not Treated|0|||
130394276|NCT02036502|469412600|FG005|Part 3:Dose Expansion|Not Treated|2|||
130394277|NCT02036502|469412601|FG006|Part 3:Dose Expansion|Not Treated|0|||
130394278|NCT02036502|469412602|FG007|Part 3:Dose Expansion|Not Treated|0|||
130394279|NCT02741700|469412603|FG000|Overall Study|Lost to Follow-up|17|||
130394280|NCT02741700|469412604|FG001|Overall Study|Lost to Follow-up|8|||
130394281|NCT02741700|469412603|FG000|Overall Study|Withdrawal by Subject|2|||
130394282|NCT02741700|469412604|FG001|Overall Study|Withdrawal by Subject|5|||
130394283|NCT02741700|469412603|FG000|Overall Study|Physician Decision|3|||
130394284|NCT02741700|469412604|FG001|Overall Study|Physician Decision|0|||
130394285|NCT02741700|469412603|FG000|Overall Study|Moved out of State|0|||
130394286|NCT02741700|469412604|FG001|Overall Study|Moved out of State|1|||
130394287|NCT02741700|469412603|FG000|Overall Study|Death|4|||
130394288|NCT02741700|469412604|FG001|Overall Study|Death|5|||
130394289|NCT00811577|469412605|FG000|Overall Study|Lost to Follow-up|7|||
130394290|NCT00811577|469412606|FG001|Overall Study|Lost to Follow-up|1|||
130394291|NCT00811577|469412605|FG000|Overall Study|Withdrawal by Subject|3|||
130394292|NCT00811577|469412606|FG001|Overall Study|Withdrawal by Subject|0|||
130394293|NCT01068509|469412607|FG000|Overall Study|Death|0|||
130394294|NCT01068509|469412608|FG001|Overall Study|Death|0|||
130394295|NCT01068509|469412609|FG002|Overall Study|Death|1|||
130394296|NCT01068509|469412607|FG000|Overall Study|Disease Progression|5|||
130394297|NCT01068509|469412608|FG001|Overall Study|Disease Progression|20|||
130394298|NCT01068509|469412609|FG002|Overall Study|Disease Progression|18|||
130394299|NCT01068509|469412607|FG000|Overall Study|Lost to Follow-up|1|||
130394300|NCT01068509|469412608|FG001|Overall Study|Lost to Follow-up|0|||
130394301|NCT01068509|469412609|FG002|Overall Study|Lost to Follow-up|0|||
130394302|NCT01068509|469412607|FG000|Overall Study|Withdrew Consent|0|||
130394303|NCT01068509|469412608|FG001|Overall Study|Withdrew Consent|1|||
130394304|NCT01068509|469412609|FG002|Overall Study|Withdrew Consent|2|||
130394305|NCT01068509|469412607|FG000|Overall Study|Reason Not Specified|0|||
130394306|NCT01068509|469412608|FG001|Overall Study|Reason Not Specified|1|||
130394307|NCT01068509|469412609|FG002|Overall Study|Reason Not Specified|0|||
130394308|NCT02442778|469412611|FG000|Overall Study|Adverse Event|2|||
130394309|NCT02442778|469412612|FG001|Overall Study|Adverse Event|6|||
130394310|NCT02442778|469412613|FG002|Overall Study|Adverse Event|6|||
130394311|NCT02442778|469412611|FG000|Overall Study|Death|0|||
130394312|NCT02442778|469412612|FG001|Overall Study|Death|2|||
130394313|NCT02442778|469412613|FG002|Overall Study|Death|0|||
130394314|NCT02442778|469412611|FG000|Overall Study|Lack of Efficacy|1|||
130394315|NCT02442778|469412612|FG001|Overall Study|Lack of Efficacy|0|||
130394316|NCT02442778|469412613|FG002|Overall Study|Lack of Efficacy|0|||
130394317|NCT02442778|469412611|FG000|Overall Study|Lost to Follow-up|1|||
130394318|NCT02442778|469412612|FG001|Overall Study|Lost to Follow-up|1|||
130394319|NCT02442778|469412613|FG002|Overall Study|Lost to Follow-up|1|||
130394320|NCT02442778|469412611|FG000|Overall Study|Non-compliance with study drug|2|||
130394321|NCT02442778|469412612|FG001|Overall Study|Non-compliance with study drug|0|||
130394322|NCT02442778|469412613|FG002|Overall Study|Non-compliance with study drug|1|||
130394323|NCT02442778|469412611|FG000|Overall Study|Physician Decision|1|||
130394324|NCT02442778|469412612|FG001|Overall Study|Physician Decision|1|||
130394325|NCT02442778|469412613|FG002|Overall Study|Physician Decision|1|||
130394326|NCT02442778|469412611|FG000|Overall Study|Protocol Deviation|3|||
130394327|NCT02442778|469412612|FG001|Overall Study|Protocol Deviation|0|||
130394328|NCT02442778|469412613|FG002|Overall Study|Protocol Deviation|1|||
130394329|NCT02442778|469412611|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
130394330|NCT02442778|469412612|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
130394331|NCT02442778|469412613|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
130394332|NCT02442778|469412611|FG000|Overall Study|Withdrawal by Subject|4|||
130394333|NCT02442778|469412612|FG001|Overall Study|Withdrawal by Subject|4|||
130394334|NCT02442778|469412613|FG002|Overall Study|Withdrawal by Subject|3|||
130394335|NCT02442778|469412611|FG000|Overall Study|Reason not specified|1|||
130394336|NCT02442778|469412612|FG001|Overall Study|Reason not specified|4|||
130394337|NCT02442778|469412613|FG002|Overall Study|Reason not specified|0|||
130394338|NCT01165138|469412614|FG000|Overall Study|Adverse Event|0|||
130394339|NCT01165138|469412615|FG001|Overall Study|Adverse Event|1|||
130394340|NCT01165138|469412616|FG002|Overall Study|Adverse Event|0|||
130394341|NCT01165138|469412617|FG003|Overall Study|Adverse Event|2|||
130394342|NCT01165138|469412614|FG000|Overall Study|Lack of Efficacy|0|||
130394343|NCT01165138|469412615|FG001|Overall Study|Lack of Efficacy|32|||
130394344|NCT01165138|469412616|FG002|Overall Study|Lack of Efficacy|6|||
130394345|NCT01165138|469412617|FG003|Overall Study|Lack of Efficacy|7|||
130394346|NCT01165138|469412614|FG000|Overall Study|Protocol Violation|0|||
130394347|NCT01165138|469412615|FG001|Overall Study|Protocol Violation|7|||
130394348|NCT01165138|469412616|FG002|Overall Study|Protocol Violation|0|||
130394349|NCT01165138|469412617|FG003|Overall Study|Protocol Violation|2|||
130394350|NCT01165138|469412614|FG000|Overall Study|Lost to Follow-up|0|||
130394351|NCT01165138|469412615|FG001|Overall Study|Lost to Follow-up|0|||
130394352|NCT01165138|469412616|FG002|Overall Study|Lost to Follow-up|1|||
130394353|NCT01165138|469412617|FG003|Overall Study|Lost to Follow-up|2|||
130394354|NCT01165138|469412614|FG000|Overall Study|Physician Decision|0|||
130394355|NCT01165138|469412615|FG001|Overall Study|Physician Decision|6|||
130394356|NCT01165138|469412616|FG002|Overall Study|Physician Decision|7|||
130394357|NCT01165138|469412617|FG003|Overall Study|Physician Decision|6|||
130394358|NCT01165138|469412614|FG000|Overall Study|Withdrawal by Subject|0|||
130394359|NCT01165138|469412615|FG001|Overall Study|Withdrawal by Subject|6|||
130394360|NCT01165138|469412616|FG002|Overall Study|Withdrawal by Subject|6|||
130394361|NCT01165138|469412617|FG003|Overall Study|Withdrawal by Subject|3|||
130394362|NCT01418937|469412618|FG000|Overall Study|Lost to Follow-up|5|||
130394363|NCT01418937|469412618|FG000|Overall Study|Protocol Violation|1|||
130394364|NCT01418937|469412618|FG000|Overall Study|Pregnancy|1|||
130394365|NCT01418937|469412618|FG000|Overall Study|Withdrawal by Subject|1|||
130394366|NCT00962104|469412619|FG000|Overall Study|Adverse Event|10|||
130394367|NCT00962104|469412620|FG001|Overall Study|Adverse Event|3|||
130394368|NCT00962104|469412619|FG000|Overall Study|Entry Criteria Not Met|1|||
130394369|NCT00962104|469412620|FG001|Overall Study|Entry Criteria Not Met|2|||
130394370|NCT00962104|469412619|FG000|Overall Study|Lack of Efficacy|0|||
130394371|NCT00962104|469412620|FG001|Overall Study|Lack of Efficacy|1|||
130394372|NCT00962104|469412619|FG000|Overall Study|Lost to Follow-up|10|||
130394373|NCT00962104|469412620|FG001|Overall Study|Lost to Follow-up|4|||
130394374|NCT00962104|469412619|FG000|Overall Study|Physician Decision|1|||
130394375|NCT00962104|469412620|FG001|Overall Study|Physician Decision|0|||
130394376|NCT00962104|469412619|FG000|Overall Study|Protocol Violation|6|||
130394377|NCT00962104|469412620|FG001|Overall Study|Protocol Violation|8|||
130394378|NCT00962104|469412619|FG000|Overall Study|Sponsor Decision|0|||
130394379|NCT00962104|469412620|FG001|Overall Study|Sponsor Decision|1|||
130394380|NCT00962104|469412619|FG000|Overall Study|Withdrawal by Subject|10|||
130394381|NCT00962104|469412620|FG001|Overall Study|Withdrawal by Subject|6|||
130394382|NCT00962104|469412619|FG000|Overall Study|Other|2|||
130394383|NCT00962104|469412620|FG001|Overall Study|Other|0|||
130394384|NCT02013167|469412621|FG000|Overall Study|Withdrawal by Subject|15|||
130394385|NCT02013167|469412622|FG001|Overall Study|Withdrawal by Subject|14|||
130394386|NCT02013167|469412621|FG000|Overall Study|Sponsor Decision|1|||
130394387|NCT02013167|469412622|FG001|Overall Study|Sponsor Decision|3|||
130394388|NCT02013167|469412621|FG000|Overall Study|Lost to Follow-up|0|||
130394389|NCT02013167|469412622|FG001|Overall Study|Lost to Follow-up|1|||
130394390|NCT02013167|469412621|FG000|Overall Study|Death|85|||
130394391|NCT02013167|469412622|FG001|Overall Study|Death|160|||
130394392|NCT00603746|469412623|FG000|Overall Study|Adverse Event|2|||
130394393|NCT00603746|469412624|FG001|Overall Study|Adverse Event|3|||
130394394|NCT00603746|469412625|FG002|Overall Study|Adverse Event|0|||
130394395|NCT00603746|469412626|FG003|Overall Study|Adverse Event|1|||
130394396|NCT00603746|469412627|FG004|Overall Study|Adverse Event|0|||
130394397|NCT00603746|469412628|FG005|Overall Study|Adverse Event|4|||
130394398|NCT00603746|469412623|FG000|Overall Study|Lack of Efficacy|34|||
130394399|NCT00603746|469412624|FG001|Overall Study|Lack of Efficacy|11|||
130394400|NCT00603746|469412625|FG002|Overall Study|Lack of Efficacy|6|||
130394401|NCT00603746|469412626|FG003|Overall Study|Lack of Efficacy|11|||
130394402|NCT00603746|469412627|FG004|Overall Study|Lack of Efficacy|12|||
130394403|NCT00603746|469412628|FG005|Overall Study|Lack of Efficacy|8|||
130394404|NCT00603746|469412623|FG000|Overall Study|Protocol Violation|0|||
130394405|NCT00603746|469412624|FG001|Overall Study|Protocol Violation|3|||
130394406|NCT00603746|469412625|FG002|Overall Study|Protocol Violation|1|||
130394407|NCT00603746|469412626|FG003|Overall Study|Protocol Violation|0|||
130394408|NCT00603746|469412627|FG004|Overall Study|Protocol Violation|1|||
130394409|NCT00603746|469412628|FG005|Overall Study|Protocol Violation|0|||
130394410|NCT00603746|469412623|FG000|Overall Study|Lost to Follow-up|0|||
130394411|NCT00603746|469412624|FG001|Overall Study|Lost to Follow-up|1|||
130394412|NCT00603746|469412625|FG002|Overall Study|Lost to Follow-up|1|||
130394413|NCT00603746|469412626|FG003|Overall Study|Lost to Follow-up|0|||
130394414|NCT00603746|469412627|FG004|Overall Study|Lost to Follow-up|0|||
130394415|NCT00603746|469412628|FG005|Overall Study|Lost to Follow-up|0|||
130394416|NCT00603746|469412623|FG000|Overall Study|Physician Decision|1|||
130394417|NCT00603746|469412624|FG001|Overall Study|Physician Decision|0|||
130394418|NCT00603746|469412625|FG002|Overall Study|Physician Decision|0|||
130394419|NCT00603746|469412626|FG003|Overall Study|Physician Decision|0|||
130394420|NCT00603746|469412627|FG004|Overall Study|Physician Decision|1|||
130394421|NCT00603746|469412628|FG005|Overall Study|Physician Decision|0|||
130394422|NCT00603746|469412623|FG000|Overall Study|Withdrawal by Subject|1|||
130394423|NCT00603746|469412624|FG001|Overall Study|Withdrawal by Subject|0|||
130394424|NCT00603746|469412625|FG002|Overall Study|Withdrawal by Subject|0|||
130394425|NCT00603746|469412626|FG003|Overall Study|Withdrawal by Subject|1|||
130394426|NCT00603746|469412627|FG004|Overall Study|Withdrawal by Subject|3|||
130394427|NCT00603746|469412628|FG005|Overall Study|Withdrawal by Subject|1|||
130394428|NCT01113879|469412631|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
130394429|NCT01113879|469412632|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
130394430|NCT03323658|469412634|FG000|Overall Study|Adverse Event|0|||
130394431|NCT03323658|469412635|FG001|Overall Study|Adverse Event|1|||
130394432|NCT03323658|469412636|FG002|Overall Study|Adverse Event|0|||
130394433|NCT00615056|469412637|FG000|Overall Study|Death|31|||
130394434|NCT00615056|469412638|FG001|Overall Study|Death|31|||
130394435|NCT00615056|469412639|FG002|Overall Study|Death|21|||
130394436|NCT00615056|469412640|FG003|Overall Study|Death|23|||
130394437|NCT00615056|469412637|FG000|Overall Study|Lost to Follow-up|1|||
130394438|NCT00615056|469412638|FG001|Overall Study|Lost to Follow-up|2|||
130394439|NCT00615056|469412639|FG002|Overall Study|Lost to Follow-up|4|||
130394440|NCT00615056|469412640|FG003|Overall Study|Lost to Follow-up|5|||
130394441|NCT00615056|469412637|FG000|Overall Study|Other|13|||
130394442|NCT00615056|469412638|FG001|Overall Study|Other|15|||
130394443|NCT00615056|469412639|FG002|Overall Study|Other|10|||
130394444|NCT00615056|469412640|FG003|Overall Study|Other|7|||
130394445|NCT00615056|469412637|FG000|Overall Study|Objective progression or relapse|0|||
130394446|NCT00615056|469412638|FG001|Overall Study|Objective progression or relapse|2|||
130394447|NCT00615056|469412639|FG002|Overall Study|Objective progression or relapse|0|||
130394448|NCT00615056|469412640|FG003|Overall Study|Objective progression or relapse|0|||
130394449|NCT00615056|469412637|FG000|Overall Study|Withdrawal by Subject|0|||
130394450|NCT00615056|469412638|FG001|Overall Study|Withdrawal by Subject|1|||
130394451|NCT00615056|469412639|FG002|Overall Study|Withdrawal by Subject|1|||
130394452|NCT00615056|469412640|FG003|Overall Study|Withdrawal by Subject|0|||
130394453|NCT00615056|469412637|FG000|Overall Study|Discontinued by Sponsor|1|||
130394454|NCT00615056|469412638|FG001|Overall Study|Discontinued by Sponsor|0|||
130394455|NCT00615056|469412639|FG002|Overall Study|Discontinued by Sponsor|0|||
130394456|NCT00615056|469412640|FG003|Overall Study|Discontinued by Sponsor|0|||
130394457|NCT00615056|469412637|FG000|Overall Study|Randomized but not treated|3|||
130394458|NCT00615056|469412638|FG001|Overall Study|Randomized but not treated|0|||
130394459|NCT00615056|469412639|FG002|Overall Study|Randomized but not treated|0|||
130394460|NCT00615056|469412640|FG003|Overall Study|Randomized but not treated|0|||
130394461|NCT00717769|469412641|FG000|Overall Study|Adverse Event|9|||
130394462|NCT00717769|469412642|FG001|Overall Study|Adverse Event|6|||
130394463|NCT00717769|469412643|FG002|Overall Study|Adverse Event|1|||
130394464|NCT00717769|469412641|FG000|Overall Study|Lack of compliance|0|||
130394465|NCT00717769|469412642|FG001|Overall Study|Lack of compliance|2|||
130394466|NCT00717769|469412643|FG002|Overall Study|Lack of compliance|0|||
130394467|NCT00717769|469412641|FG000|Overall Study|Lost to Follow-up|3|||
130394468|NCT00717769|469412642|FG001|Overall Study|Lost to Follow-up|4|||
130394469|NCT00717769|469412643|FG002|Overall Study|Lost to Follow-up|0|||
130394470|NCT00717769|469412641|FG000|Overall Study|Lack of Efficacy|1|||
130394471|NCT00717769|469412642|FG001|Overall Study|Lack of Efficacy|2|||
130394472|NCT00717769|469412643|FG002|Overall Study|Lack of Efficacy|0|||
130394473|NCT00717769|469412641|FG000|Overall Study|Protocol Violation|0|||
130394474|NCT00717769|469412642|FG001|Overall Study|Protocol Violation|2|||
130394475|NCT00717769|469412643|FG002|Overall Study|Protocol Violation|0|||
130394476|NCT00717769|469412641|FG000|Overall Study|Sponsor decision|1|||
130394477|NCT00717769|469412642|FG001|Overall Study|Sponsor decision|0|||
130394478|NCT00717769|469412643|FG002|Overall Study|Sponsor decision|10|||
130394479|NCT00717769|469412641|FG000|Overall Study|Withdrew consent|2|||
130394480|NCT00717769|469412642|FG001|Overall Study|Withdrew consent|2|||
130394481|NCT00717769|469412643|FG002|Overall Study|Withdrew consent|0|||
130394482|NCT02276612|469412644|FG000|Overall Study|Death|1|||
130394483|NCT02276612|469412645|FG001|Overall Study|Death|0|||
130394484|NCT02276612|469412644|FG000|Overall Study|Pregnancy|1|||
130394485|NCT02276612|469412645|FG001|Overall Study|Pregnancy|0|||
130394486|NCT02276612|469412644|FG000|Overall Study|Withdrew Consent|1|||
130394487|NCT02276612|469412645|FG001|Overall Study|Withdrew Consent|0|||
130394488|NCT02276612|469412644|FG000|Overall Study|Lost to Follow-up|1|||
130394489|NCT02276612|469412645|FG001|Overall Study|Lost to Follow-up|0|||
130394490|NCT00262067|469412646|FG000|Overall Study|Death|190|||
130394491|NCT00262067|469412647|FG001|Overall Study|Death|89|||
130394492|NCT00262067|469412648|FG002|Overall Study|Death|186|||
130394493|NCT00262067|469412649|FG003|Overall Study|Death|99|||
130394494|NCT00262067|469412646|FG000|Overall Study|Lost to Follow-up|5|||
130394495|NCT00262067|469412647|FG001|Overall Study|Lost to Follow-up|4|||
130394496|NCT00262067|469412648|FG002|Overall Study|Lost to Follow-up|7|||
130394497|NCT00262067|469412649|FG003|Overall Study|Lost to Follow-up|5|||
130394498|NCT00262067|469412646|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
130394499|NCT00262067|469412647|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
130394500|NCT00262067|469412648|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
130394501|NCT00262067|469412649|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
130394502|NCT00262067|469412646|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
130394503|NCT00262067|469412647|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
130394504|NCT00262067|469412648|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
130394505|NCT00262067|469412649|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
130394506|NCT02849548|469412650|FG000|Overall Study|Lost to Follow-up|1|||
130394507|NCT02849548|469412651|FG001|Overall Study|Lost to Follow-up|2|||
130394508|NCT02849548|469412650|FG000|Overall Study|Protocol Violation|1|||
130394509|NCT02849548|469412651|FG001|Overall Study|Protocol Violation|0|||
130394510|NCT02357147|469412653|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
130394511|NCT02357147|469412654|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
130394512|NCT02357147|469412653|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
130394513|NCT02357147|469412654|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
130394514|NCT02357147|469412653|FG000|Combination Treatment Phase|Investigator Discretion|1|||
130394515|NCT02357147|469412654|FG001|Combination Treatment Phase|Investigator Discretion|1|||
130394516|NCT02357147|469412653|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
130394517|NCT02357147|469412654|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
130394518|NCT02357147|469412653|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
130394519|NCT02357147|469412654|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
130394520|NCT02357147|469412653|FG000|Combination Treatment Phase|Adverse Event|12|||
130394521|NCT02357147|469412654|FG001|Combination Treatment Phase|Adverse Event|4|||
130394522|NCT02357147|469412653|FG000|Combination Treatment Phase|Death|1|||
130394523|NCT02357147|469412654|FG001|Combination Treatment Phase|Death|1|||
130394524|NCT02357147|469412653|FG000|Combination Treatment Phase|Sponsor Decision|0|||
130394525|NCT02357147|469412654|FG001|Combination Treatment Phase|Sponsor Decision|12|||
130394526|NCT02357147|469412653|FG000|Combination Treatment Phase|Other|1|||
130394527|NCT02357147|469412654|FG001|Combination Treatment Phase|Other|0|||
130394528|NCT02357147|469412653|FG000|Combination Treatment Phase|Not treated|0|||
130394529|NCT02357147|469412654|FG001|Combination Treatment Phase|Not treated|2|||
130394530|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
130394531|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
130394532|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130394533|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
130394534|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
130394535|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
130394536|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130394537|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Adverse Event|3|||
130394538|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
130394539|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
130394540|NCT02357147|469412653|FG000|Maintenance Treatment Phase|Not Treated|1|||
130394541|NCT02357147|469412654|FG001|Maintenance Treatment Phase|Not Treated|0|||
130394542|NCT00256698|469412655|FG000|Overall Study|Withdrawal by Subject|7|||
130394543|NCT00256698|469412656|FG001|Overall Study|Withdrawal by Subject|7|||
130394544|NCT00256698|469412655|FG000|Overall Study|Adverse Event|13|||
130394545|NCT00256698|469412656|FG001|Overall Study|Adverse Event|6|||
130394546|NCT00256698|469412655|FG000|Overall Study|Protocol Violation|6|||
130394547|NCT00256698|469412656|FG001|Overall Study|Protocol Violation|5|||
130394548|NCT00256698|469412655|FG000|Overall Study|Lost to Follow-up|1|||
130394549|NCT00256698|469412656|FG001|Overall Study|Lost to Follow-up|3|||
130394550|NCT00256698|469412655|FG000|Overall Study|disease progression|97|||
130394551|NCT00256698|469412656|FG001|Overall Study|disease progression|105|||
130394552|NCT00256698|469412655|FG000|Overall Study|still ongoing at data cut-off|41|||
130394553|NCT00256698|469412656|FG001|Overall Study|still ongoing at data cut-off|46|||
130394554|NCT00256698|469412655|FG000|Overall Study|withdrawn due to osteoporosis|1|||
130394555|NCT00256698|469412656|FG001|Overall Study|withdrawn due to osteoporosis|0|||
130394556|NCT00256698|469412655|FG000|Overall Study|Prematurely Discontinued|1|||
130394557|NCT00256698|469412656|FG001|Overall Study|Prematurely Discontinued|0|||
130394558|NCT03962543|469412657|FG000|Treatment Phase|Death|0|||
130394559|NCT03962543|469412658|FG001|Treatment Phase|Death|1|||
130394560|NCT03962543|469412657|FG000|Treatment Phase|Withdrawal by Subject|3|||
130394561|NCT03962543|469412658|FG001|Treatment Phase|Withdrawal by Subject|0|||
130394562|NCT03962543|469412657|FG000|Treatment Phase|Adverse Event|3|||
130394563|NCT03962543|469412658|FG001|Treatment Phase|Adverse Event|12|||
130394564|NCT03962543|469412657|FG000|Treatment Phase|Lost to Follow-up|1|||
130394565|NCT03962543|469412658|FG001|Treatment Phase|Lost to Follow-up|2|||
130394566|NCT03962543|469412657|FG000|Treatment Phase|Radiographic PD|9|||
130394567|NCT03962543|469412658|FG001|Treatment Phase|Radiographic PD|3|||
130723126|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130394568|NCT03962543|469412657|FG000|Treatment Phase|Participant Decision|3|||
130394569|NCT03962543|469412658|FG001|Treatment Phase|Participant Decision|8|||
130723127|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130470508|NCT04950127|469688350|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
130470509|NCT04950127|469688351|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
130470510|NCT04950127|469688352|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
130470511|NCT04950127|469688347|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
130723128|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
130723129|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130394570|NCT03962543|469412657|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
130394571|NCT03962543|469412658|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
130394572|NCT03962543|469412657|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
130394573|NCT03962543|469412658|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
130394574|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
130394575|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
130394576|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
130394577|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
130394578|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
130394579|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
130394580|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
130394581|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
130394582|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
130394583|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
130394584|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
130394585|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
130394586|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
130394587|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
130394588|NCT03962543|469412657|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
130394589|NCT03962543|469412658|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
130394590|NCT03264404|469414366|FG000|Overall Study|Death|2|||
130394591|NCT03264404|469414366|FG000|Overall Study|Physician Decision|1|||
130394592|NCT03264404|469414366|FG000|Overall Study|Disease Progression|28|||
130394593|NCT03264404|469414366|FG000|Overall Study|Adverse Event|1|||
130394594|NCT03264404|469414366|FG000|Overall Study|Off study prior to treatment|2|||
130394595|NCT03036566|469414369|FG000|Overall Study|Lost to Follow-up|3|||
130394596|NCT01852292|469414373|FG000|Overall Study|Untreated - did not receive study drug|3|||
130394597|NCT01852292|469414374|FG001|Overall Study|Untreated - did not receive study drug|1|||
130394598|NCT01852292|469414373|FG000|Overall Study|Death|9|||
130394599|NCT01852292|469414374|FG001|Overall Study|Death|8|||
130394600|NCT01852292|469414373|FG000|Overall Study|Patient/guardian decision|8|||
130394601|NCT01852292|469414374|FG001|Overall Study|Patient/guardian decision|4|||
130394602|NCT01852292|469414373|FG000|Overall Study|Adverse Event|8|||
130394603|NCT01852292|469414374|FG001|Overall Study|Adverse Event|11|||
130394604|NCT01852292|469414373|FG000|Overall Study|Physician Decision|6|||
130394605|NCT01852292|469414374|FG001|Overall Study|Physician Decision|2|||
130394606|NCT01852292|469414373|FG000|Overall Study|Protocol Violation|2|||
130394607|NCT01852292|469414374|FG001|Overall Study|Protocol Violation|0|||
130394608|NCT01852292|469414373|FG000|Overall Study|Non-compliance with study treatment|1|||
130394609|NCT01852292|469414374|FG001|Overall Study|Non-compliance with study treatment|0|||
130394610|NCT01852292|469414373|FG000|Overall Study|Study terminated by Sponsor|0|||
130394611|NCT01852292|469414374|FG001|Overall Study|Study terminated by Sponsor|1|||
130394612|NCT01852292|469414373|FG000|Overall Study|Progressive disease|42|||
130394613|NCT01852292|469414374|FG001|Overall Study|Progressive disease|52|||
130394614|NCT01914666|469414377|FG000|Treatment Period|Lack of Efficacy|0|||
130394615|NCT01914666|469414378|FG001|Treatment Period|Lack of Efficacy|0|||
130394616|NCT01914666|469414379|FG002|Treatment Period|Lack of Efficacy|2|||
130394617|NCT01914666|469414377|FG000|Treatment Period|Adverse Event|10|||
130394618|NCT01914666|469414378|FG001|Treatment Period|Adverse Event|4|||
130394619|NCT01914666|469414379|FG002|Treatment Period|Adverse Event|2|||
130394620|NCT01914666|469414377|FG000|Treatment Period|Withdrawal by Subject|3|||
130394621|NCT01914666|469414378|FG001|Treatment Period|Withdrawal by Subject|2|||
130394622|NCT01914666|469414379|FG002|Treatment Period|Withdrawal by Subject|2|||
130394623|NCT01914666|469414377|FG000|Treatment Period|Physician Decision|0|||
130394624|NCT01914666|469414378|FG001|Treatment Period|Physician Decision|0|||
130394625|NCT01914666|469414379|FG002|Treatment Period|Physician Decision|2|||
130394626|NCT02586012|469414380|FG000|Overall Study|Withdrawal by Subject|1|||
130394627|NCT02586012|469414381|FG001|Overall Study|Withdrawal by Subject|1|||
130394628|NCT02586012|469414382|FG002|Overall Study|Withdrawal by Subject|0|||
130394629|NCT02586012|469414383|FG003|Overall Study|Withdrawal by Subject|1|||
130394630|NCT02586012|469414384|FG004|Overall Study|Withdrawal by Subject|0|||
130394631|NCT02586012|469414385|FG005|Overall Study|Withdrawal by Subject|2|||
130394632|NCT02586012|469414380|FG000|Overall Study|Protocol Violation|0|||
130394633|NCT02586012|469414381|FG001|Overall Study|Protocol Violation|0|||
130394634|NCT02586012|469414382|FG002|Overall Study|Protocol Violation|0|||
130470512|NCT04950127|469688348|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
130470513|NCT04950127|469688349|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
130470514|NCT04950127|469688350|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
130394635|NCT02586012|469414383|FG003|Overall Study|Protocol Violation|0|||
130394636|NCT02586012|469414384|FG004|Overall Study|Protocol Violation|0|||
130394637|NCT02586012|469414385|FG005|Overall Study|Protocol Violation|1|||
130394638|NCT02586012|469414380|FG000|Overall Study|study terminated|0|||
130394639|NCT02586012|469414381|FG001|Overall Study|study terminated|2|||
130394640|NCT02586012|469414382|FG002|Overall Study|study terminated|1|||
130394641|NCT02586012|469414383|FG003|Overall Study|study terminated|1|||
130394642|NCT02586012|469414384|FG004|Overall Study|study terminated|1|||
130394643|NCT02586012|469414385|FG005|Overall Study|study terminated|0|||
130394644|NCT03277846|469414386|FG000|Overall Study|Inpatient stay too brief|12|||
130394645|NCT03277846|469414387|FG001|Overall Study|Inpatient stay too brief|11|||
130394646|NCT04013191|469414388|FG000|Overall Study|Adverse Event|1|||
130394647|NCT04013191|469414389|FG001|Overall Study|Adverse Event|0|||
130394648|NCT01275066|469414398|FG000|Overall Study|Withdrawal by Subject|0|||
130394649|NCT01275066|469414399|FG001|Overall Study|Withdrawal by Subject|0|||
130394650|NCT01275066|469414400|FG002|Overall Study|Withdrawal by Subject|1|||
130394651|NCT01275066|469414398|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
130394652|NCT01275066|469414399|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
130394653|NCT01275066|469414400|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
130394654|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
130394655|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
130394656|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
130394657|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
130394658|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
130394659|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
130394660|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
130394661|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
130394662|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
130394663|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
130394664|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
130394665|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
130394666|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
130394667|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
130394668|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
130394669|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
130394670|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
130394671|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
130394672|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
130394673|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
130394674|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
130394675|NCT00934544|469414406|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
130394676|NCT00934544|469414407|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
130394677|NCT00934544|469414408|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
130394678|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
130394679|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
130394680|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
130394681|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
130394682|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
130394683|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
130394684|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
130394685|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
130394686|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
130394687|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
130394688|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
130394689|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
130394690|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
130394691|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
130394692|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
130394693|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
130394694|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
130394695|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
130394696|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
130394697|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
130394698|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
130394699|NCT00934544|469414406|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
130394700|NCT00934544|469414407|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
130394701|NCT00934544|469414408|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
130394702|NCT04033003|469414410|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
130394703|NCT04033003|469414411|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
130394704|NCT04033003|469414410|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
130394705|NCT04033003|469414411|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
130394706|NCT04033003|469414410|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
130394707|NCT04033003|469414411|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
130394708|NCT04033003|469414410|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
130394709|NCT04033003|469414411|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
130394710|NCT04033003|469414410|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
130394711|NCT04033003|469414411|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
130394712|NCT04033003|469414410|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
130394713|NCT04033003|469414411|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
130394714|NCT04033003|469414410|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
130394715|NCT04033003|469414411|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
130394716|NCT04033003|469414410|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
130394717|NCT04033003|469414411|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
130394718|NCT04033003|469414410|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
130394719|NCT04033003|469414411|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
130394720|NCT04033003|469414410|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
130394721|NCT04033003|469414411|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
130394722|NCT04033003|469414410|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
130394723|NCT04033003|469414411|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
130394724|NCT04033003|469414410|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
130394725|NCT04033003|469414411|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
130394726|NCT04033003|469414410|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
130394727|NCT04033003|469414411|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
130394728|NCT02487394|469414416|FG000|Phase 1|Withdrawal by Subject|0|||
130394729|NCT02487394|469414417|FG001|Phase 1|Withdrawal by Subject|1|||
130394730|NCT00782210|469414422|FG000|Overall Study|Adverse Event|21|||
130394731|NCT00782210|469414423|FG001|Overall Study|Adverse Event|17|||
130394732|NCT00782210|469414424|FG002|Overall Study|Adverse Event|16|||
130394733|NCT00782210|469414422|FG000|Overall Study|Lost to Follow-up|2|||
130394734|NCT00782210|469414423|FG001|Overall Study|Lost to Follow-up|1|||
130394735|NCT00782210|469414424|FG002|Overall Study|Lost to Follow-up|2|||
130394736|NCT00782210|469414422|FG000|Overall Study|Withdrawal by Subject|11|||
130394737|NCT00782210|469414423|FG001|Overall Study|Withdrawal by Subject|8|||
130394738|NCT00782210|469414424|FG002|Overall Study|Withdrawal by Subject|11|||
130394739|NCT00782210|469414422|FG000|Overall Study|Non compliance with protocol|0|||
130394740|NCT00782210|469414423|FG001|Overall Study|Non compliance with protocol|3|||
130394741|NCT00782210|469414424|FG002|Overall Study|Non compliance with protocol|2|||
130394742|NCT00782210|469414422|FG000|Overall Study|Lack of Efficacy|13|||
130394743|NCT00782210|469414423|FG001|Overall Study|Lack of Efficacy|4|||
130394744|NCT00782210|469414424|FG002|Overall Study|Lack of Efficacy|1|||
130394745|NCT00782210|469414422|FG000|Overall Study|Other reason not described above|3|||
130394746|NCT00782210|469414423|FG001|Overall Study|Other reason not described above|2|||
130394747|NCT00782210|469414424|FG002|Overall Study|Other reason not described above|3|||
130394748|NCT00654381|469414427|FG000|1st Stage|Adverse Event|3|||
130394749|NCT00654381|469414428|FG001|1st Stage|Adverse Event|3|||
130394750|NCT00654381|469414429|FG002|1st Stage|Adverse Event|3|||
130394751|NCT00654381|469414430|FG003|1st Stage|Adverse Event|3|||
130394752|NCT00654381|469414431|FG004|1st Stage|Adverse Event|2|||
130394753|NCT00654381|469414432|FG005|1st Stage|Adverse Event|1|||
130394754|NCT00654381|469414427|FG000|1st Stage|Withdrawal by Subject|0|||
130394755|NCT00654381|469414428|FG001|1st Stage|Withdrawal by Subject|0|||
130394756|NCT00654381|469414429|FG002|1st Stage|Withdrawal by Subject|0|||
130394757|NCT00654381|469414430|FG003|1st Stage|Withdrawal by Subject|1|||
130394758|NCT00654381|469414431|FG004|1st Stage|Withdrawal by Subject|0|||
130394759|NCT00654381|469414432|FG005|1st Stage|Withdrawal by Subject|1|||
130723130|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130723131|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130394760|NCT00654381|469414427|FG000|1st Stage|Investigator's decision|0|||
130394761|NCT00654381|469414428|FG001|1st Stage|Investigator's decision|0|||
130394762|NCT00654381|469414429|FG002|1st Stage|Investigator's decision|0|||
130394763|NCT00654381|469414430|FG003|1st Stage|Investigator's decision|1|||
130559976|NCT01660451|470017909|FG000|Overall Study|Other|0|||
130394764|NCT00654381|469414431|FG004|1st Stage|Investigator's decision|0|||
130394765|NCT00654381|469414432|FG005|1st Stage|Investigator's decision|0|||
130394766|NCT00654381|469414427|FG000|2nd Stage|Adverse Event|2|||
130394767|NCT00654381|469414428|FG001|2nd Stage|Adverse Event|0|||
130394768|NCT00654381|469414429|FG002|2nd Stage|Adverse Event|2|||
130394769|NCT00654381|469414430|FG003|2nd Stage|Adverse Event|3|||
130394770|NCT00654381|469414431|FG004|2nd Stage|Adverse Event|7|||
130394771|NCT00654381|469414432|FG005|2nd Stage|Adverse Event|2|||
130394772|NCT00654381|469414427|FG000|2nd Stage|Withdrawal by Subject|0|||
130394773|NCT00654381|469414428|FG001|2nd Stage|Withdrawal by Subject|0|||
130394774|NCT00654381|469414429|FG002|2nd Stage|Withdrawal by Subject|0|||
130394775|NCT00654381|469414430|FG003|2nd Stage|Withdrawal by Subject|0|||
130394776|NCT00654381|469414431|FG004|2nd Stage|Withdrawal by Subject|1|||
130394777|NCT00654381|469414432|FG005|2nd Stage|Withdrawal by Subject|1|||
130394778|NCT00654381|469414427|FG000|2nd Stage|Investigator's decision|0|||
130394779|NCT00654381|469414428|FG001|2nd Stage|Investigator's decision|0|||
130394780|NCT00654381|469414429|FG002|2nd Stage|Investigator's decision|1|||
130394781|NCT00654381|469414430|FG003|2nd Stage|Investigator's decision|1|||
130394782|NCT00654381|469414431|FG004|2nd Stage|Investigator's decision|0|||
130394783|NCT00654381|469414432|FG005|2nd Stage|Investigator's decision|0|||
130394784|NCT00654381|469414427|FG000|Extension Stage|Adverse Event|1|||
130394785|NCT00654381|469414428|FG001|Extension Stage|Adverse Event|2|||
130394786|NCT00654381|469414429|FG002|Extension Stage|Adverse Event|9|||
130394787|NCT00654381|469414430|FG003|Extension Stage|Adverse Event|7|||
130394788|NCT00654381|469414431|FG004|Extension Stage|Adverse Event|1|||
130394789|NCT00654381|469414432|FG005|Extension Stage|Adverse Event|1|||
130394790|NCT00654381|469414427|FG000|Extension Stage|Protocol Violation|0|||
130394791|NCT00654381|469414428|FG001|Extension Stage|Protocol Violation|0|||
130394792|NCT00654381|469414429|FG002|Extension Stage|Protocol Violation|0|||
130394793|NCT00654381|469414430|FG003|Extension Stage|Protocol Violation|1|||
130394794|NCT00654381|469414431|FG004|Extension Stage|Protocol Violation|0|||
130394795|NCT00654381|469414432|FG005|Extension Stage|Protocol Violation|0|||
130394796|NCT00654381|469414427|FG000|Extension Stage|Lack of Efficacy|0|||
130394797|NCT00654381|469414428|FG001|Extension Stage|Lack of Efficacy|0|||
130394798|NCT00654381|469414429|FG002|Extension Stage|Lack of Efficacy|1|||
130394799|NCT00654381|469414430|FG003|Extension Stage|Lack of Efficacy|0|||
130394800|NCT00654381|469414431|FG004|Extension Stage|Lack of Efficacy|0|||
130394801|NCT00654381|469414432|FG005|Extension Stage|Lack of Efficacy|0|||
130394802|NCT00654381|469414427|FG000|Extension Stage|Withdrawal by Subject|0|||
130394803|NCT00654381|469414428|FG001|Extension Stage|Withdrawal by Subject|0|||
130394804|NCT00654381|469414429|FG002|Extension Stage|Withdrawal by Subject|1|||
130394805|NCT00654381|469414430|FG003|Extension Stage|Withdrawal by Subject|1|||
130394806|NCT00654381|469414431|FG004|Extension Stage|Withdrawal by Subject|1|||
130394807|NCT00654381|469414432|FG005|Extension Stage|Withdrawal by Subject|1|||
130470515|NCT04950127|469688351|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
130470516|NCT04950127|469688352|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
130470517|NCT03833167|469688357|FG000|Overall Study|Withdrawal by Subject|4|||
130470518|NCT03833167|469688358|FG001|Overall Study|Withdrawal by Subject|6|||
130470519|NCT03833167|469688357|FG000|Overall Study|Ongoing|186|||
130470520|NCT03833167|469688358|FG001|Overall Study|Ongoing|194|||
130470521|NCT03833167|469688357|FG000|Overall Study|Lost to Follow-up|1|||
130470522|NCT03833167|469688358|FG001|Overall Study|Lost to Follow-up|1|||
130470523|NCT03833167|469688357|FG000|Overall Study|Physician Decision|0|||
130470524|NCT03833167|469688358|FG001|Overall Study|Physician Decision|2|||
130470525|NCT03833167|469688357|FG000|Overall Study|Death|34|||
130470526|NCT03833167|469688358|FG001|Overall Study|Death|22|||
130470527|NCT01948661|469688360|FG000|Overall Study|Withdrawal by Subject|2|||
130470528|NCT01948661|469688361|FG001|Overall Study|Withdrawal by Subject|4|||
130470529|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Adverse Event|4|||
130559977|NCT01660451|470017910|FG001|Overall Study|Other|0|||
130559978|NCT01660451|470017911|FG002|Overall Study|Other|1|||
130394808|NCT00654381|469414427|FG000|Extension Stage|Closure of the trial site|0|||
130394809|NCT00654381|469414428|FG001|Extension Stage|Closure of the trial site|0|||
130394810|NCT00654381|469414429|FG002|Extension Stage|Closure of the trial site|0|||
130394811|NCT00654381|469414430|FG003|Extension Stage|Closure of the trial site|0|||
130394812|NCT00654381|469414431|FG004|Extension Stage|Closure of the trial site|1|||
130394813|NCT00654381|469414432|FG005|Extension Stage|Closure of the trial site|1|||
130394814|NCT00826267|469414435|FG000|Overall Study|Other Adverse Event|1|||
130394815|NCT00826267|469414436|FG001|Overall Study|Other Adverse Event|0|||
130394816|NCT00826267|469414437|FG002|Overall Study|Other Adverse Event|0|||
130394817|NCT01675882|469414450|FG000|Overall Study|Adverse Event|0|||
130394818|NCT01675882|469414451|FG001|Overall Study|Adverse Event|2|||
130394819|NCT01675882|469414452|FG002|Overall Study|Adverse Event|1|||
130394820|NCT01675882|469414453|FG003|Overall Study|Adverse Event|0|||
130470530|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Adverse Event|1|||
130470531|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
130470532|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
130470533|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
130470534|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
130470535|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
130470536|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
130470537|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
130470538|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
130559979|NCT02456662|470017913|FG000|Overall Study|Lost to Follow-up|2|||
130394821|NCT01675882|469414450|FG000|Overall Study|Participant unwilling to continue|2|||
130394822|NCT01675882|469414451|FG001|Overall Study|Participant unwilling to continue|4|||
130394823|NCT01675882|469414452|FG002|Overall Study|Participant unwilling to continue|2|||
130394824|NCT01675882|469414453|FG003|Overall Study|Participant unwilling to continue|1|||
130394825|NCT01675882|469414450|FG000|Overall Study|Lost to Follow-up|0|||
130394826|NCT01675882|469414451|FG001|Overall Study|Lost to Follow-up|1|||
130394827|NCT01675882|469414452|FG002|Overall Study|Lost to Follow-up|0|||
130394828|NCT01675882|469414453|FG003|Overall Study|Lost to Follow-up|0|||
130394829|NCT01675882|469414450|FG000|Overall Study|Non-compliance|0|||
130394830|NCT01675882|469414451|FG001|Overall Study|Non-compliance|0|||
130394831|NCT01675882|469414452|FG002|Overall Study|Non-compliance|0|||
130394832|NCT01675882|469414453|FG003|Overall Study|Non-compliance|1|||
130394833|NCT00735371|469414456|FG000|Overall Study|Adverse Event|3|||
130394834|NCT00735371|469414457|FG001|Overall Study|Adverse Event|3|||
130394835|NCT00735371|469414458|FG002|Overall Study|Adverse Event|4|||
130394836|NCT00735371|469414459|FG003|Overall Study|Adverse Event|1|||
130394837|NCT00735371|469414456|FG000|Overall Study|Protocol Violation|2|||
130394838|NCT00735371|469414457|FG001|Overall Study|Protocol Violation|2|||
130394839|NCT00735371|469414458|FG002|Overall Study|Protocol Violation|0|||
130394840|NCT00735371|469414459|FG003|Overall Study|Protocol Violation|3|||
130394841|NCT00735371|469414456|FG000|Overall Study|Withdrawal by Subject|0|||
130394842|NCT00735371|469414457|FG001|Overall Study|Withdrawal by Subject|2|||
130394843|NCT00735371|469414458|FG002|Overall Study|Withdrawal by Subject|2|||
130394844|NCT00735371|469414459|FG003|Overall Study|Withdrawal by Subject|0|||
130394845|NCT00735371|469414456|FG000|Overall Study|Lost to Follow-up|1|||
130394846|NCT00735371|469414457|FG001|Overall Study|Lost to Follow-up|1|||
130394847|NCT00735371|469414458|FG002|Overall Study|Lost to Follow-up|3|||
130394848|NCT00735371|469414459|FG003|Overall Study|Lost to Follow-up|1|||
130394849|NCT00735371|469414456|FG000|Overall Study|Lack of Efficacy|4|||
130394850|NCT00735371|469414457|FG001|Overall Study|Lack of Efficacy|2|||
130394851|NCT00735371|469414458|FG002|Overall Study|Lack of Efficacy|0|||
130394852|NCT00735371|469414459|FG003|Overall Study|Lack of Efficacy|4|||
130394853|NCT00735371|469414456|FG000|Overall Study|Sponsor Decision|3|||
130394854|NCT00735371|469414457|FG001|Overall Study|Sponsor Decision|1|||
130394855|NCT00735371|469414458|FG002|Overall Study|Sponsor Decision|0|||
130394856|NCT00735371|469414459|FG003|Overall Study|Sponsor Decision|1|||
130394857|NCT00735371|469414456|FG000|Overall Study|Protocol Violation|0|||
130394858|NCT00735371|469414457|FG001|Overall Study|Protocol Violation|1|||
130394859|NCT00735371|469414458|FG002|Overall Study|Protocol Violation|2|||
130394860|NCT00735371|469414459|FG003|Overall Study|Protocol Violation|0|||
130394861|NCT00735371|469414456|FG000|Overall Study|Prior Vyvanse Exposure|1|||
130394862|NCT00735371|469414457|FG001|Overall Study|Prior Vyvanse Exposure|1|||
130394863|NCT00735371|469414458|FG002|Overall Study|Prior Vyvanse Exposure|0|||
130394864|NCT00735371|469414459|FG003|Overall Study|Prior Vyvanse Exposure|0|||
130394865|NCT00735371|469414456|FG000|Overall Study|Exclusion criteria|1|||
130394866|NCT00735371|469414457|FG001|Overall Study|Exclusion criteria|0|||
130394867|NCT00735371|469414458|FG002|Overall Study|Exclusion criteria|0|||
130394868|NCT00735371|469414459|FG003|Overall Study|Exclusion criteria|0|||
130394869|NCT00994448|469414460|FG000|Overall Study|Adverse Event|1|||
130394870|NCT00994448|469414461|FG001|Overall Study|Adverse Event|0|||
130394871|NCT00994448|469414460|FG000|Overall Study|Lost to Follow-up|5|||
130394872|NCT00994448|469414461|FG001|Overall Study|Lost to Follow-up|1|||
130394873|NCT00994448|469414460|FG000|Overall Study|Withdrawal by Subject|1|||
130394874|NCT00994448|469414461|FG001|Overall Study|Withdrawal by Subject|1|||
130394875|NCT00994448|469414460|FG000|Overall Study|Physician Decision|1|||
130394876|NCT00994448|469414461|FG001|Overall Study|Physician Decision|0|||
130394877|NCT00436748|469414466|FG000|Overall Study|Ineligibility Determined|1|||
130394878|NCT00436748|469414467|FG001|Overall Study|Ineligibility Determined|1|||
130394879|NCT00436748|469414466|FG000|Overall Study|Adverse Event|0|||
130394880|NCT00436748|469414467|FG001|Overall Study|Adverse Event|2|||
130394881|NCT00436748|469414466|FG000|Overall Study|Consent Withdrawn|1|||
130394882|NCT00436748|469414467|FG001|Overall Study|Consent Withdrawn|4|||
130394883|NCT00436748|469414466|FG000|Overall Study|Administrative Decision|1|||
130394884|NCT00436748|469414467|FG001|Overall Study|Administrative Decision|0|||
130723132|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
130723133|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130723134|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130723135|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130394885|NCT00436748|469414466|FG000|Overall Study|Lost to Follow-up|0|||
130394886|NCT00436748|469414467|FG001|Overall Study|Lost to Follow-up|1|||
130394887|NCT00436748|469414466|FG000|Overall Study|Protocol-specified Criteria|5|||
130394888|NCT00436748|469414467|FG001|Overall Study|Protocol-specified Criteria|4|||
130394889|NCT00436748|469414466|FG000|Overall Study|Other|3|||
130394890|NCT00436748|469414467|FG001|Overall Study|Other|0|||
130394891|NCT01610791|469414468|FG000|Overall Study|Lost to Follow-up|7|||
130394892|NCT01610791|469414468|FG000|Overall Study|Adverse Event|6|||
130394893|NCT01610791|469414468|FG000|Overall Study|Physician Decision|1|||
130394894|NCT01610791|469414468|FG000|Overall Study|Adverse event and Investigator decision|1|||
130394895|NCT01610791|469414468|FG000|Overall Study|Death|1|||
130394896|NCT01610791|469414468|FG000|Overall Study|Not determined|5|||
130394897|NCT00850200|469414471|FG000|Overall Study|Physician Decision|2|||
130394898|NCT00850200|469414471|FG000|Overall Study|Did not recieve treatment|2|||
130394899|NCT00850200|469414471|FG000|Overall Study|Withdrawal by Subject|1|||
130394900|NCT02711800|469414472|FG000|Overall Study|Lost to Follow-up|1|||
130394901|NCT02711800|469414472|FG000|Overall Study|Withdrawal by Subject|1|||
130394902|NCT04164901|469414476|FG000|Overall Study|Withdrawal by Subject|4|||
130394903|NCT04164901|469414477|FG001|Overall Study|Withdrawal by Subject|4|||
130394904|NCT05040152|469414482|FG000|Overall Study|Withdrawal by Subject|5|||
130394905|NCT05040152|469414483|FG001|Overall Study|Withdrawal by Subject|0|||
130394906|NCT05040152|469414482|FG000|Overall Study|Lost to Follow-up|0|||
130394907|NCT05040152|469414483|FG001|Overall Study|Lost to Follow-up|2|||
130394908|NCT02046148|469414491|FG000|Overall Study|Lost to Follow-up|1|||
130394909|NCT02046148|469414492|FG001|Overall Study|Lost to Follow-up|1|||
130394910|NCT02046148|469414491|FG000|Overall Study|Withdrawal by Subject|0|||
130394911|NCT02046148|469414492|FG001|Overall Study|Withdrawal by Subject|2|||
130394912|NCT00314574|469414493|FG000|Overall Study|Death|3|||
130394913|NCT00314574|469414494|FG001|Overall Study|Death|0|||
130394914|NCT00314574|469414493|FG000|Overall Study|Adverse Event|11|||
130394915|NCT00314574|469414494|FG001|Overall Study|Adverse Event|16|||
130394916|NCT00314574|469414493|FG000|Overall Study|Lost to Follow-up|19|||
130394917|NCT00314574|469414494|FG001|Overall Study|Lost to Follow-up|25|||
130394918|NCT00314574|469414493|FG000|Overall Study|Withdrawal by Subject|33|||
130394919|NCT00314574|469414494|FG001|Overall Study|Withdrawal by Subject|22|||
130394920|NCT00314574|469414493|FG000|Overall Study|Physician Decision|22|||
130394921|NCT00314574|469414494|FG001|Overall Study|Physician Decision|15|||
130394922|NCT00314574|469414493|FG000|Overall Study|Pregnancy|6|||
130394923|NCT00314574|469414494|FG001|Overall Study|Pregnancy|4|||
130394924|NCT00314574|469414493|FG000|Overall Study|Data unknown at database lock|0|||
130394925|NCT00314574|469414494|FG001|Overall Study|Data unknown at database lock|1|||
130394926|NCT00449956|469414495|FG000|Overall Study|Adverse Event|7|||
130394927|NCT00449956|469414496|FG001|Overall Study|Adverse Event|1|||
130394928|NCT00449956|469414497|FG002|Overall Study|Adverse Event|6|||
130394929|NCT00449956|469414495|FG000|Overall Study|Lack of Efficacy|0|||
130394930|NCT00449956|469414496|FG001|Overall Study|Lack of Efficacy|0|||
130394931|NCT00449956|469414497|FG002|Overall Study|Lack of Efficacy|1|||
130394932|NCT00449956|469414495|FG000|Overall Study|Protocol Violation|1|||
130394933|NCT00449956|469414496|FG001|Overall Study|Protocol Violation|1|||
130394934|NCT00449956|469414497|FG002|Overall Study|Protocol Violation|1|||
130394935|NCT00449956|469414495|FG000|Overall Study|Withdrawal by Subject|0|||
130394936|NCT00449956|469414496|FG001|Overall Study|Withdrawal by Subject|1|||
130394937|NCT00449956|469414497|FG002|Overall Study|Withdrawal by Subject|0|||
130394938|NCT00449956|469414495|FG000|Overall Study|Physician Decision|2|||
130394939|NCT00449956|469414496|FG001|Overall Study|Physician Decision|1|||
130394940|NCT00449956|469414497|FG002|Overall Study|Physician Decision|1|||
130394941|NCT02086110|469414498|FG000|Overall Study|Withdrawal by Subject|1|||
130394942|NCT02086110|469414499|FG001|Overall Study|Withdrawal by Subject|1|||
130394943|NCT00235872|469414504|FG000|Overall Study|Adverse Event|34|||
130394944|NCT00235872|469414504|FG000|Overall Study|Death|1|||
130394945|NCT00235872|469414504|FG000|Overall Study|Lost to Follow-up|1|||
130394946|NCT00235872|469414504|FG000|Overall Study|Withdrawal by Subject|50|||
130394947|NCT00235872|469414504|FG000|Overall Study|Administrative reason|61|||
130394948|NCT02272413|469414505|FG000|Randomized Through Treatment Start|Not treated|3|||
130394949|NCT02272413|469414506|FG001|Randomized Through Treatment Start|Not treated|5|||
130394950|NCT02272413|469414505|FG000|Pre-switch Period|Adverse Event|38|||
130394951|NCT02272413|469414506|FG001|Pre-switch Period|Adverse Event|37|||
130470539|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Other|6|||
130470540|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Other|1|||
130394952|NCT02272413|469414505|FG000|Pre-switch Period|Death|26|||
130394953|NCT02272413|469414506|FG001|Pre-switch Period|Death|26|||
130394954|NCT02272413|469414505|FG000|Pre-switch Period|Withdrawal by Subject|27|||
130394955|NCT02272413|469414506|FG001|Pre-switch Period|Withdrawal by Subject|15|||
130394956|NCT02272413|469414505|FG000|Pre-switch Period|Physician Decision|6|||
130394957|NCT02272413|469414506|FG001|Pre-switch Period|Physician Decision|18|||
130394958|NCT02272413|469414505|FG000|Pre-switch Period|Progressive disease|185|||
130394959|NCT02272413|469414506|FG001|Pre-switch Period|Progressive disease|173|||
130394960|NCT02272413|469414505|FG000|Pre-switch Period|Lost to Follow-up|0|||
130394961|NCT02272413|469414506|FG001|Pre-switch Period|Lost to Follow-up|2|||
130394962|NCT02272413|469414505|FG000|Pre-switch Period|Protocol Violation|1|||
130394963|NCT02272413|469414506|FG001|Pre-switch Period|Protocol Violation|0|||
130394964|NCT02272413|469414505|FG000|Pre-switch Period|Other than listed|10|||
130394965|NCT02272413|469414506|FG001|Pre-switch Period|Other than listed|11|||
130394966|NCT02272413|469414505|FG000|Post-switch Period|Adverse Event|4|||
130394967|NCT02272413|469414506|FG001|Post-switch Period|Adverse Event|4|||
130394968|NCT02272413|469414505|FG000|Post-switch Period|Death|3|||
130470541|NCT03271489|469688362|FG000|Double-Blind (DB) Period|Missing|1|||
130470542|NCT03271489|469688363|FG001|Double-Blind (DB) Period|Missing|0|||
130470543|NCT03271489|469688362|FG000|Open-Label (OL) Period|Adverse Event|2|||
130394969|NCT02272413|469414506|FG001|Post-switch Period|Death|2|||
130394970|NCT02272413|469414505|FG000|Post-switch Period|Withdrawal by Subject|1|||
130394971|NCT02272413|469414506|FG001|Post-switch Period|Withdrawal by Subject|2|||
130394972|NCT02272413|469414505|FG000|Post-switch Period|Physician Decision|1|||
130394973|NCT02272413|469414506|FG001|Post-switch Period|Physician Decision|1|||
130394974|NCT02272413|469414505|FG000|Post-switch Period|Progressive disease|21|||
130394975|NCT02272413|469414506|FG001|Post-switch Period|Progressive disease|21|||
130394976|NCT02272413|469414505|FG000|Post-switch Period|Study terminated by sponsor|8|||
130394977|NCT02272413|469414506|FG001|Post-switch Period|Study terminated by sponsor|11|||
130394978|NCT02272413|469414505|FG000|Post-switch Period|Other than listed|4|||
130394979|NCT02272413|469414506|FG001|Post-switch Period|Other than listed|5|||
130394980|NCT04116710|469414521|FG000|Overall Study|Death|4|||
130394981|NCT04116710|469414522|FG001|Overall Study|Death|6|||
130394982|NCT04116710|469414523|FG002|Overall Study|Death|3|||
130394983|NCT04116710|469414524|FG003|Overall Study|Death|1|||
130394984|NCT04116710|469414521|FG000|Overall Study|Withdrawal by Subject|0|||
130394985|NCT04116710|469414522|FG001|Overall Study|Withdrawal by Subject|0|||
130394986|NCT04116710|469414523|FG002|Overall Study|Withdrawal by Subject|0|||
130394987|NCT04116710|469414524|FG003|Overall Study|Withdrawal by Subject|1|||
130394988|NCT00582933|469414525|FG000|Overall Study|Physician Decision|3|||
130394989|NCT00696137|469414526|FG000|Overall Study|Withdrawal by Subject|2|||
130394990|NCT00842348|469414529|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
130394991|NCT00842348|469414530|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
130394992|NCT00842348|469414529|FG000|Study 729|Disease progression/death|19|||
130394993|NCT00842348|469414530|FG001|Study 729|Disease progression/death|30|||
130394994|NCT00842348|469414529|FG000|Study 729|Adverse Event|1|||
130394995|NCT00842348|469414530|FG001|Study 729|Adverse Event|1|||
130394996|NCT00842348|469414529|FG000|Study 729|Protocol Violation|1|||
130394997|NCT00842348|469414530|FG001|Study 729|Protocol Violation|1|||
130394998|NCT00842348|469414529|FG000|Study 729|Withdrawal by Subject|2|||
130394999|NCT00842348|469414530|FG001|Study 729|Withdrawal by Subject|4|||
130395000|NCT00842348|469414529|FG000|Study 729|Due to Sponsor stopping the study|1|||
130395001|NCT00842348|469414530|FG001|Study 729|Due to Sponsor stopping the study|1|||
130395002|NCT00842348|469414529|FG000|Study 729|Due to non-availability of IP|0|||
130395003|NCT00842348|469414530|FG001|Study 729|Due to non-availability of IP|1|||
130395004|NCT00842348|469414529|FG000|Study 729|Sponsor's decision|1|||
130395005|NCT00842348|469414530|FG001|Study 729|Sponsor's decision|0|||
130395006|NCT00842348|469414529|FG000|Study 729|Surgical resection|1|||
130395007|NCT00842348|469414530|FG001|Study 729|Surgical resection|0|||
130395008|NCT01524627|469414533|FG000|Overall Study|Physician Decision|0|||
130395009|NCT01524627|469414534|FG001|Overall Study|Physician Decision|1|||
130395010|NCT01524627|469414533|FG000|Overall Study|Lost to Follow-up|1|||
130395011|NCT01524627|469414534|FG001|Overall Study|Lost to Follow-up|1|||
130395012|NCT02388737|469416476|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
130395013|NCT02388737|469416477|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
130395014|NCT02388737|469416478|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
130395015|NCT02388737|469416476|FG000|Overall Study|Major Protocol Deviation|18|||
130395016|NCT02388737|469416477|FG001|Overall Study|Major Protocol Deviation|25|||
130395017|NCT02388737|469416478|FG002|Overall Study|Major Protocol Deviation|22|||
130470544|NCT03271489|469688363|FG001|Open-Label (OL) Period|Adverse Event|0|||
130470545|NCT03271489|469688362|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
130470546|NCT03271489|469688363|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
130470547|NCT03271489|469688362|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
130470548|NCT03271489|469688363|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
130559980|NCT02456662|470017914|FG001|Overall Study|Lost to Follow-up|1|||
130723136|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
130723137|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130723138|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130723139|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130723140|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
130723141|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130395018|NCT02388737|469416476|FG000|Overall Study|Lost to Follow-up|5|||
130395019|NCT02388737|469416477|FG001|Overall Study|Lost to Follow-up|1|||
130395020|NCT02388737|469416478|FG002|Overall Study|Lost to Follow-up|4|||
130395021|NCT02388737|469416476|FG000|Overall Study|Voluntary Withdrawal|10|||
130395022|NCT02388737|469416477|FG001|Overall Study|Voluntary Withdrawal|18|||
130395023|NCT02388737|469416478|FG002|Overall Study|Voluntary Withdrawal|17|||
130395024|NCT02388737|469416476|FG000|Overall Study|Lack of Efficacy|3|||
130395025|NCT02388737|469416477|FG001|Overall Study|Lack of Efficacy|0|||
130395026|NCT02388737|469416478|FG002|Overall Study|Lack of Efficacy|3|||
130395027|NCT02388737|469416476|FG000|Overall Study|Reason Not Specified|5|||
130395028|NCT02388737|469416477|FG001|Overall Study|Reason Not Specified|5|||
130470549|NCT03271489|469688362|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
130470550|NCT03271489|469688363|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
130470551|NCT03271489|469688362|FG000|Open-Label (OL) Period|No Specified|2|||
130395029|NCT02388737|469416478|FG002|Overall Study|Reason Not Specified|4|||
130395030|NCT03252522|469416479|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
130395031|NCT03252522|469416480|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
130395032|NCT03252522|469416481|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
130395033|NCT03252522|469416479|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
130395034|NCT03252522|469416480|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
130395035|NCT03252522|469416481|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
130395036|NCT03252522|469416479|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
130395037|NCT03252522|469416480|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
130395038|NCT03252522|469416481|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
130395039|NCT03252522|469416479|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
130395040|NCT03252522|469416480|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
130395041|NCT03252522|469416481|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
130395042|NCT03252522|469416479|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
130395043|NCT03252522|469416480|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
130395044|NCT03252522|469416481|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
130395045|NCT03252522|469416479|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
130395046|NCT03252522|469416480|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
130395047|NCT03252522|469416481|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
130395048|NCT03252522|469416479|FG000|Phase 2: Open Label|Adverse Event|0|||
130395049|NCT03252522|469416480|FG001|Phase 2: Open Label|Adverse Event|0|||
130395050|NCT03252522|469416481|FG002|Phase 2: Open Label|Adverse Event|2|||
130395051|NCT03252522|469416479|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
130395052|NCT03252522|469416480|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
130395053|NCT03252522|469416481|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
130395054|NCT03299842|469416483|FG000|Overall Study|Caregiver withdrew consent|2|||
130395055|NCT03299842|469416483|FG000|Overall Study|Child would not keep the watch on|3|||
130395056|NCT01344369|469416486|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130395057|NCT01344369|469416487|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
130395058|NCT01344369|469416486|FG000|Washout of 28 Days|Physician Decision|0|||
130395059|NCT01344369|469416487|FG001|Washout of 28 Days|Physician Decision|1|||
130395060|NCT01344369|469416486|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
130395061|NCT01344369|469416487|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
130395062|NCT01454726|469416491|FG000|Overall Study|Withdrawal by Subject|0|||
130395063|NCT01454726|469416492|FG001|Overall Study|Withdrawal by Subject|1|||
130395064|NCT03848845|469416493|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130395065|NCT03848845|469416494|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
130395066|NCT03848845|469416495|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130395067|NCT03848845|469416496|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130395068|NCT03848845|469416493|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
130395069|NCT03848845|469416494|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
130395070|NCT03848845|469416495|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
130395071|NCT03848845|469416496|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
130395072|NCT03848845|469416493|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
130395073|NCT03848845|469416494|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
130395074|NCT03848845|469416495|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
130395075|NCT03848845|469416496|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
130395076|NCT03848845|469416493|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
130395077|NCT03848845|469416494|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
130395078|NCT03848845|469416495|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
130395079|NCT03848845|469416496|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
130395080|NCT01886833|469416497|FG000|Overall Study|IgA not available from both periods|204|||
130395081|NCT02223767|469416505|FG000|Overall Study|Withdrawal by Subject|4|||
130395082|NCT02223767|469416506|FG001|Overall Study|Withdrawal by Subject|4|||
130395083|NCT02342704|469416507|FG000|Overall Study|Physician Decision|0|||
130395084|NCT02342704|469416508|FG001|Overall Study|Physician Decision|3|||
130395085|NCT02342704|469416507|FG000|Overall Study|Sponsor Termination|49|||
130395086|NCT02342704|469416508|FG001|Overall Study|Sponsor Termination|43|||
130395087|NCT02342704|469416507|FG000|Overall Study|Other|0|||
130470552|NCT03271489|469688363|FG001|Open-Label (OL) Period|No Specified|2|||
130395088|NCT02342704|469416508|FG001|Overall Study|Other|1|||
130395089|NCT02342704|469416507|FG000|Overall Study|Withdrawal by Subject|1|||
130395090|NCT02342704|469416508|FG001|Overall Study|Withdrawal by Subject|0|||
130395091|NCT02342704|469416507|FG000|Overall Study|Lost to Follow-up|2|||
130395092|NCT02342704|469416508|FG001|Overall Study|Lost to Follow-up|1|||
130470553|NCT03271489|469688362|FG000|Open-Label (OL) Period|Missing|2|||
130470554|NCT03271489|469688363|FG001|Open-Label (OL) Period|Missing|0|||
130470555|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
130470556|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
130470557|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
130559981|NCT00074581|470017916|FG000|Overall Study|Death|15|||
130395093|NCT02342704|469416507|FG000|Overall Study|Adverse Event|1|||
130395094|NCT02342704|469416508|FG001|Overall Study|Adverse Event|3|||
130395095|NCT02347527|469416510|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
130395096|NCT02347527|469416511|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
130395097|NCT02347527|469416512|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
130395098|NCT02347527|469416513|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
130395099|NCT02347527|469416510|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
130395100|NCT02347527|469416511|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
130395101|NCT02347527|469416512|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
130395102|NCT02347527|469416513|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
130395103|NCT02347527|469416510|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
130395104|NCT02347527|469416511|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
130395105|NCT02347527|469416512|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
130395106|NCT02347527|469416513|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
130395107|NCT02347527|469416510|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
130395108|NCT02347527|469416511|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
130395109|NCT02347527|469416512|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
130395110|NCT02347527|469416513|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
130395111|NCT02347527|469416510|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130395112|NCT02347527|469416511|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
130395113|NCT02347527|469416512|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130395114|NCT02347527|469416513|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130395115|NCT00302003|469416514|FG000|Overall Study|Lack of Efficacy|62|||
130395116|NCT00302003|469416514|FG000|Overall Study|Lost to Follow-up|1|||
130395117|NCT00302003|469416514|FG000|Overall Study|Physician Decision|2|||
130395118|NCT00302003|469416514|FG000|Overall Study|Withdrawal by Subject|5|||
130395119|NCT00302003|469416514|FG000|Overall Study|Ineligible|9|||
130395120|NCT00302003|469416514|FG000|Overall Study|Protocol Violation|1|||
130395121|NCT00283439|469416515|FG000|Overall Study|Adverse Event|0|||
130395122|NCT00283439|469416516|FG001|Overall Study|Adverse Event|0|||
130395123|NCT00283439|469416517|FG002|Overall Study|Adverse Event|0|||
130395124|NCT00283439|469416518|FG003|Overall Study|Adverse Event|1|||
130395125|NCT00283439|469416515|FG000|Overall Study|Death|0|||
130395126|NCT00283439|469416516|FG001|Overall Study|Death|0|||
130395127|NCT00283439|469416517|FG002|Overall Study|Death|1|||
130395128|NCT00283439|469416518|FG003|Overall Study|Death|0|||
130395129|NCT00283439|469416515|FG000|Overall Study|Disease progression|0|||
130395130|NCT00283439|469416516|FG001|Overall Study|Disease progression|1|||
130395131|NCT00283439|469416517|FG002|Overall Study|Disease progression|0|||
130395132|NCT00283439|469416518|FG003|Overall Study|Disease progression|0|||
130395133|NCT00283439|469416515|FG000|Overall Study|Requirement for alternative therapy|1|||
130395134|NCT00283439|469416516|FG001|Overall Study|Requirement for alternative therapy|2|||
130395135|NCT00283439|469416517|FG002|Overall Study|Requirement for alternative therapy|5|||
130395136|NCT00283439|469416518|FG003|Overall Study|Requirement for alternative therapy|2|||
130395137|NCT00283439|469416515|FG000|Overall Study|Stem cell transplant|6|||
130395138|NCT00283439|469416516|FG001|Overall Study|Stem cell transplant|6|||
130395139|NCT00283439|469416517|FG002|Overall Study|Stem cell transplant|4|||
130395140|NCT00283439|469416518|FG003|Overall Study|Stem cell transplant|3|||
130395141|NCT00283439|469416515|FG000|Overall Study|Treatment discontinued|0|||
130395142|NCT00283439|469416516|FG001|Overall Study|Treatment discontinued|2|||
130395143|NCT00283439|469416517|FG002|Overall Study|Treatment discontinued|1|||
130395144|NCT00283439|469416518|FG003|Overall Study|Treatment discontinued|3|||
130395145|NCT00283439|469416515|FG000|Overall Study|Other|1|||
130395146|NCT00283439|469416516|FG001|Overall Study|Other|0|||
130395147|NCT00283439|469416517|FG002|Overall Study|Other|0|||
130395148|NCT00283439|469416518|FG003|Overall Study|Other|0|||
130395149|NCT02042924|469416519|FG000|Overall Study|Early Death|1|||
130395150|NCT01632891|469416520|FG000|Overall Study|Lost to Follow-up|0|||
130395151|NCT01632891|469416521|FG001|Overall Study|Lost to Follow-up|1|||
130395152|NCT01632891|469416520|FG000|Overall Study|Withdrawal by Subject|1|||
130395153|NCT01632891|469416521|FG001|Overall Study|Withdrawal by Subject|0|||
130395154|NCT02919670|469416522|FG000|Overall Study|Only 17 participants met compliance|43|||
130395155|NCT02919670|469416523|FG001|Overall Study|Only 17 participants met compliance|39|||
130395156|NCT00240071|469416524|FG000|Overall Study|Withdrawal by Subject|3|||
130559982|NCT00074581|470017917|FG001|Overall Study|Death|16|||
130395157|NCT01466270|469416525|FG000|Overall Study|Withdrawal by Subject|4|||
130395158|NCT01466270|469416526|FG001|Overall Study|Withdrawal by Subject|1|||
130395159|NCT01466270|469416525|FG000|Overall Study|Physician Decision|1|||
130559983|NCT00074581|470017916|FG000|Overall Study|Withdrawal by Subject|50|||
130559984|NCT00074581|470017917|FG001|Overall Study|Withdrawal by Subject|49|||
130395160|NCT01466270|469416526|FG001|Overall Study|Physician Decision|0|||
130395161|NCT01466270|469416525|FG000|Overall Study|Lost to Follow-up|1|||
130395162|NCT01466270|469416526|FG001|Overall Study|Lost to Follow-up|3|||
130395163|NCT01466270|469416525|FG000|Overall Study|Progression|1|||
130395164|NCT01466270|469416526|FG001|Overall Study|Progression|0|||
130395165|NCT01466270|469416525|FG000|Overall Study|Toxicity|4|||
130395166|NCT01466270|469416526|FG001|Overall Study|Toxicity|1|||
130395167|NCT01466270|469416525|FG000|Overall Study|Multiple|1|||
130395168|NCT01466270|469416526|FG001|Overall Study|Multiple|1|||
130395169|NCT04206293|469416531|FG000|Overall Study|Consent withdrawal|1|||
130395170|NCT01454934|469416536|FG000|Overall Study|Clinical progression|28|||
130395171|NCT01454934|469416537|FG001|Overall Study|Clinical progression|25|||
130395172|NCT01454934|469416536|FG000|Overall Study|Other|6|||
130395173|NCT01454934|469416537|FG001|Overall Study|Other|17|||
130395174|NCT01454934|469416536|FG000|Overall Study|Adverse Event|28|||
130395175|NCT01454934|469416537|FG001|Overall Study|Adverse Event|24|||
130395176|NCT01454934|469416536|FG000|Overall Study|Withdrawn consent|2|||
130395177|NCT01454934|469416537|FG001|Overall Study|Withdrawn consent|5|||
130395178|NCT01454934|469416536|FG000|Overall Study|Withdrawal by Subject|11|||
130395179|NCT01454934|469416537|FG001|Overall Study|Withdrawal by Subject|15|||
130395180|NCT01454934|469416536|FG000|Overall Study|Disease progression|194|||
130395181|NCT01454934|469416537|FG001|Overall Study|Disease progression|181|||
130395182|NCT01454934|469416536|FG000|Overall Study|Lost to Follow-up|0|||
130395183|NCT01454934|469416537|FG001|Overall Study|Lost to Follow-up|1|||
130395184|NCT01454934|469416536|FG000|Overall Study|Not treated|1|||
130395185|NCT01454934|469416537|FG001|Overall Study|Not treated|2|||
130395186|NCT00430092|469416538|FG000|Overall Study|Adverse Event|0|||
130395187|NCT00430092|469416539|FG001|Overall Study|Adverse Event|0|||
130395188|NCT00430092|469416540|FG002|Overall Study|Adverse Event|1|||
130395189|NCT00430092|469416538|FG000|Overall Study|Lack of Efficacy|5|||
130395190|NCT00430092|469416539|FG001|Overall Study|Lack of Efficacy|2|||
130395191|NCT00430092|469416540|FG002|Overall Study|Lack of Efficacy|54|||
130395192|NCT00430092|469416538|FG000|Overall Study|Lost to Follow-up|1|||
130395193|NCT00430092|469416539|FG001|Overall Study|Lost to Follow-up|0|||
130395194|NCT00430092|469416540|FG002|Overall Study|Lost to Follow-up|0|||
130395195|NCT00430092|469416538|FG000|Overall Study|Protocol Violation|0|||
130395196|NCT00430092|469416539|FG001|Overall Study|Protocol Violation|1|||
130395197|NCT00430092|469416540|FG002|Overall Study|Protocol Violation|1|||
130395198|NCT00430092|469416538|FG000|Overall Study|Withdrawal by Subject|0|||
130395199|NCT00430092|469416539|FG001|Overall Study|Withdrawal by Subject|1|||
130395200|NCT00430092|469416540|FG002|Overall Study|Withdrawal by Subject|1|||
130395201|NCT02118428|469416541|FG000|Overall Study|Physician Decision|0|||
130395202|NCT02118428|469416542|FG001|Overall Study|Physician Decision|1|||
130395203|NCT02118428|469416543|FG002|Overall Study|Physician Decision|0|||
130395204|NCT02118428|469416541|FG000|Overall Study|Withdrawal by Subject|2|||
130395205|NCT02118428|469416542|FG001|Overall Study|Withdrawal by Subject|2|||
130395206|NCT02118428|469416543|FG002|Overall Study|Withdrawal by Subject|0|||
130395207|NCT02118428|469416541|FG000|Overall Study|Death|7|||
130395208|NCT02118428|469416542|FG001|Overall Study|Death|5|||
130395209|NCT02118428|469416543|FG002|Overall Study|Death|0|||
130395210|NCT02118428|469416541|FG000|Overall Study|Lost to Follow-up|3|||
130395211|NCT02118428|469416542|FG001|Overall Study|Lost to Follow-up|1|||
130395212|NCT02118428|469416543|FG002|Overall Study|Lost to Follow-up|0|||
130395213|NCT02118428|469416541|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
130395214|NCT02118428|469416542|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
130395215|NCT02118428|469416543|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
130395216|NCT00706966|469416553|FG000|Overall Study|Adverse Event|1|||
130559985|NCT00074581|470017916|FG000|Overall Study|Unable to adhere to visit schedule|13|||
130395217|NCT02884089|469416556|FG000|Period 1|Dosing error|2|||
130395218|NCT02884089|469416557|FG001|Period 1|Dosing error|2|||
130395219|NCT02884089|469416558|FG002|Period 1|Dosing error|0|||
130395220|NCT02884089|469416559|FG003|Period 1|Dosing error|0|||
130395221|NCT02884089|469416556|FG000|Washout Period 1|Lost to Follow-up|0|||
130395222|NCT02884089|469416557|FG001|Washout Period 1|Lost to Follow-up|1|||
130395223|NCT02884089|469416558|FG002|Washout Period 1|Lost to Follow-up|0|||
130559986|NCT00074581|470017917|FG001|Overall Study|Unable to adhere to visit schedule|14|||
130559987|NCT00074581|470017916|FG000|Overall Study|Relocated|14|||
130559988|NCT00074581|470017917|FG001|Overall Study|Relocated|9|||
130395224|NCT02884089|469416559|FG003|Washout Period 1|Lost to Follow-up|1|||
130395225|NCT02884089|469416556|FG000|Washout Period 1|Withdrawal by Subject|0|||
130395226|NCT02884089|469416557|FG001|Washout Period 1|Withdrawal by Subject|1|||
130395227|NCT02884089|469416558|FG002|Washout Period 1|Withdrawal by Subject|0|||
130395228|NCT02884089|469416559|FG003|Washout Period 1|Withdrawal by Subject|0|||
130395229|NCT02884089|469416556|FG000|Period 2|Adverse Event|1|||
130395230|NCT02884089|469416557|FG001|Period 2|Adverse Event|0|||
130395231|NCT02884089|469416558|FG002|Period 2|Adverse Event|0|||
130395232|NCT02884089|469416559|FG003|Period 2|Adverse Event|0|||
130395233|NCT02884089|469416556|FG000|Period 3|Withdrawal by Subject|0|||
130395234|NCT02884089|469416557|FG001|Period 3|Withdrawal by Subject|0|||
130395235|NCT02884089|469416558|FG002|Period 3|Withdrawal by Subject|1|||
130395236|NCT02884089|469416559|FG003|Period 3|Withdrawal by Subject|0|||
130395237|NCT02884089|469416556|FG000|Washout Period 3|Withdrawal by Subject|0|||
130395238|NCT02884089|469416557|FG001|Washout Period 3|Withdrawal by Subject|0|||
130395239|NCT02884089|469416558|FG002|Washout Period 3|Withdrawal by Subject|1|||
130395240|NCT02884089|469416559|FG003|Washout Period 3|Withdrawal by Subject|0|||
130395241|NCT02884089|469416556|FG000|Washout Period 3|Lost to Follow-up|0|||
130395242|NCT02884089|469416557|FG001|Washout Period 3|Lost to Follow-up|0|||
130395243|NCT02884089|469416558|FG002|Washout Period 3|Lost to Follow-up|0|||
130395244|NCT02884089|469416559|FG003|Washout Period 3|Lost to Follow-up|1|||
130395245|NCT02884089|469416556|FG000|Period 4|Withdrawal by Subject|0|||
130395246|NCT02884089|469416557|FG001|Period 4|Withdrawal by Subject|1|||
130395247|NCT02884089|469416558|FG002|Period 4|Withdrawal by Subject|0|||
130395248|NCT02884089|469416559|FG003|Period 4|Withdrawal by Subject|0|||
130395249|NCT02884089|469416556|FG000|Period 4|Lost to Follow-up|1|||
130395250|NCT02884089|469416557|FG001|Period 4|Lost to Follow-up|0|||
130395251|NCT02884089|469416558|FG002|Period 4|Lost to Follow-up|0|||
130395252|NCT02884089|469416559|FG003|Period 4|Lost to Follow-up|0|||
130395253|NCT02884089|469416556|FG000|Follow-up Visit|Withdrawal by Subject|1|||
130395254|NCT02884089|469416557|FG001|Follow-up Visit|Withdrawal by Subject|0|||
130395255|NCT02884089|469416558|FG002|Follow-up Visit|Withdrawal by Subject|0|||
130395256|NCT02884089|469416559|FG003|Follow-up Visit|Withdrawal by Subject|1|||
130395257|NCT01631474|469416560|FG000|Overall Study|Lost to Follow-up|8|||
130395258|NCT01631474|469416561|FG001|Overall Study|Lost to Follow-up|5|||
130395259|NCT01631474|469416562|FG002|Overall Study|Lost to Follow-up|7|||
130395260|NCT01631474|469416563|FG003|Overall Study|Lost to Follow-up|5|||
130395261|NCT01631474|469416564|FG004|Overall Study|Lost to Follow-up|5|||
130395262|NCT01631474|469416560|FG000|Overall Study|Withdrawal by Subject|4|||
130395263|NCT01631474|469416561|FG001|Overall Study|Withdrawal by Subject|4|||
130395264|NCT01631474|469416562|FG002|Overall Study|Withdrawal by Subject|2|||
130395265|NCT01631474|469416563|FG003|Overall Study|Withdrawal by Subject|6|||
130395266|NCT01631474|469416564|FG004|Overall Study|Withdrawal by Subject|5|||
130395267|NCT01631474|469416560|FG000|Overall Study|Lack of Efficacy|2|||
130395268|NCT01631474|469416561|FG001|Overall Study|Lack of Efficacy|2|||
130395269|NCT01631474|469416562|FG002|Overall Study|Lack of Efficacy|0|||
130395270|NCT01631474|469416563|FG003|Overall Study|Lack of Efficacy|0|||
130395271|NCT01631474|469416564|FG004|Overall Study|Lack of Efficacy|2|||
130395272|NCT01631474|469416560|FG000|Overall Study|Noncompliance with Study Drug|0|||
130395273|NCT01631474|469416561|FG001|Overall Study|Noncompliance with Study Drug|0|||
130395274|NCT01631474|469416562|FG002|Overall Study|Noncompliance with Study Drug|0|||
130395275|NCT01631474|469416563|FG003|Overall Study|Noncompliance with Study Drug|0|||
130395276|NCT01631474|469416564|FG004|Overall Study|Noncompliance with Study Drug|1|||
130395277|NCT01631474|469416560|FG000|Overall Study|Adverse Event|0|||
130395278|NCT01631474|469416561|FG001|Overall Study|Adverse Event|1|||
130395279|NCT01631474|469416562|FG002|Overall Study|Adverse Event|0|||
130395280|NCT01631474|469416563|FG003|Overall Study|Adverse Event|0|||
130395281|NCT01631474|469416564|FG004|Overall Study|Adverse Event|0|||
130395282|NCT02624284|469416565|FG000|Overall Study|Withdrawal by Subject|3|||
130395283|NCT02624284|469416566|FG001|Overall Study|Withdrawal by Subject|6|||
130395284|NCT02624284|469416567|FG002|Overall Study|Withdrawal by Subject|3|||
130395285|NCT02624284|469416565|FG000|Overall Study|Protocol Violation|9|||
130395286|NCT02624284|469416566|FG001|Overall Study|Protocol Violation|10|||
130395287|NCT02624284|469416567|FG002|Overall Study|Protocol Violation|7|||
130395288|NCT02624284|469416565|FG000|Overall Study|Revealed exclusionary condition|2|||
130395289|NCT02624284|469416566|FG001|Overall Study|Revealed exclusionary condition|2|||
130395290|NCT02624284|469416567|FG002|Overall Study|Revealed exclusionary condition|0|||
130395291|NCT02624284|469416565|FG000|Overall Study|Adverse Event|0|||
130395292|NCT02624284|469416566|FG001|Overall Study|Adverse Event|0|||
130395293|NCT02624284|469416567|FG002|Overall Study|Adverse Event|1|||
130395294|NCT01641367|469416570|FG000|Cohorts|Death|18|||
130395295|NCT01641367|469416571|FG001|Cohorts|Death|1|||
130395296|NCT01641367|469416572|FG002|Cohorts|Death|2|||
130395297|NCT01641367|469416573|FG003|Cohorts|Death|0|||
130395298|NCT01641367|469416574|FG004|Cohorts|Death|1|||
130470558|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
130470559|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
130470560|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
130470561|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
130470562|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
130470563|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
130559989|NCT00074581|470017916|FG000|Overall Study|Were withdrawn by investigator|5|||
130395299|NCT01641367|469416575|FG005|Cohorts|Death|1|||
130395300|NCT01641367|469416576|FG006|Cohorts|Death|0|||
130395301|NCT01641367|469416577|FG007|Cohorts|Death|0|||
130395302|NCT01641367|469416570|FG000|Cohorts|Lost to Follow-up|16|||
130395303|NCT01641367|469416571|FG001|Cohorts|Lost to Follow-up|0|||
130395304|NCT01641367|469416572|FG002|Cohorts|Lost to Follow-up|2|||
130395305|NCT01641367|469416573|FG003|Cohorts|Lost to Follow-up|0|||
130395306|NCT01641367|469416574|FG004|Cohorts|Lost to Follow-up|2|||
130395307|NCT01641367|469416575|FG005|Cohorts|Lost to Follow-up|0|||
130395308|NCT01641367|469416576|FG006|Cohorts|Lost to Follow-up|0|||
130395309|NCT01641367|469416577|FG007|Cohorts|Lost to Follow-up|0|||
130395310|NCT01641367|469416570|FG000|Randomized Adherence Intervention|Death|0|||
130395311|NCT01641367|469416571|FG001|Randomized Adherence Intervention|Death|0|||
130395312|NCT01641367|469416572|FG002|Randomized Adherence Intervention|Death|0|||
130395313|NCT01641367|469416573|FG003|Randomized Adherence Intervention|Death|0|||
130395314|NCT01641367|469416574|FG004|Randomized Adherence Intervention|Death|0|||
130395315|NCT01641367|469416575|FG005|Randomized Adherence Intervention|Death|0|||
130395316|NCT01641367|469416576|FG006|Randomized Adherence Intervention|Death|11|||
130395317|NCT01641367|469416577|FG007|Randomized Adherence Intervention|Death|12|||
130395318|NCT01641367|469416570|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395319|NCT01641367|469416571|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395320|NCT01641367|469416572|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395321|NCT01641367|469416573|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395322|NCT01641367|469416574|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395323|NCT01641367|469416575|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
130395324|NCT01641367|469416576|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
130395325|NCT01641367|469416577|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
130395326|NCT03100825|469416580|FG000|Overall Study|Participant/Guardian Decision|7|||
130395327|NCT03100825|469416580|FG000|Overall Study|Physician Decision|1|||
130395328|NCT00048542|469416589|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130395329|NCT00048542|469416590|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130395330|NCT00048542|469416591|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130395331|NCT00048542|469416592|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130395332|NCT00048542|469416593|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130395333|NCT00048542|469416594|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
130395334|NCT00048542|469416595|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
130395335|NCT00048542|469416596|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
130395336|NCT00048542|469416589|FG000|Double-Blind Phase|Protocol Violation|0|||
130395337|NCT00048542|469416590|FG001|Double-Blind Phase|Protocol Violation|0|||
130395338|NCT00048542|469416591|FG002|Double-Blind Phase|Protocol Violation|1|||
130395339|NCT00048542|469416592|FG003|Double-Blind Phase|Protocol Violation|0|||
130395340|NCT00048542|469416593|FG004|Double-Blind Phase|Protocol Violation|0|||
130395341|NCT00048542|469416594|FG005|Double-Blind Phase|Protocol Violation|0|||
130395342|NCT00048542|469416595|FG006|Double-Blind Phase|Protocol Violation|0|||
130395343|NCT00048542|469416596|FG007|Double-Blind Phase|Protocol Violation|0|||
130395344|NCT00048542|469416589|FG000|Double-Blind Phase|Sponsor request or decision|2|||
130395345|NCT00048542|469416590|FG001|Double-Blind Phase|Sponsor request or decision|0|||
130395346|NCT00048542|469416591|FG002|Double-Blind Phase|Sponsor request or decision|0|||
130395347|NCT00048542|469416592|FG003|Double-Blind Phase|Sponsor request or decision|0|||
130395348|NCT00048542|469416593|FG004|Double-Blind Phase|Sponsor request or decision|0|||
130395349|NCT00048542|469416594|FG005|Double-Blind Phase|Sponsor request or decision|0|||
130395350|NCT00048542|469416595|FG006|Double-Blind Phase|Sponsor request or decision|0|||
130395351|NCT00048542|469416596|FG007|Double-Blind Phase|Sponsor request or decision|0|||
130395352|NCT00048542|469416589|FG000|Double-Blind Phase|Randomized in error|1|||
130395353|NCT00048542|469416590|FG001|Double-Blind Phase|Randomized in error|0|||
130723142|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130723143|NCT01696279|470611345|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723144|NCT01696279|470611346|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723145|NCT01696279|470611347|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
130723146|NCT01696279|470611348|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723147|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130723148|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130723149|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130395354|NCT00048542|469416591|FG002|Double-Blind Phase|Randomized in error|0|||
130395355|NCT00048542|469416592|FG003|Double-Blind Phase|Randomized in error|0|||
130395356|NCT00048542|469416593|FG004|Double-Blind Phase|Randomized in error|0|||
130395357|NCT00048542|469416594|FG005|Double-Blind Phase|Randomized in error|0|||
130395358|NCT00048542|469416595|FG006|Double-Blind Phase|Randomized in error|0|||
130395359|NCT00048542|469416596|FG007|Double-Blind Phase|Randomized in error|0|||
130395360|NCT00048542|469416589|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130559990|NCT00074581|470017917|FG001|Overall Study|Were withdrawn by investigator|2|||
130395361|NCT00048542|469416590|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130395362|NCT00048542|469416591|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130395363|NCT00048542|469416592|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130395364|NCT00048542|469416593|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
130395365|NCT00048542|469416594|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
130559991|NCT00074581|470017916|FG000|Overall Study|Lost to Follow-up|16|||
130395366|NCT00048542|469416595|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130395367|NCT00048542|469416596|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130395368|NCT00048542|469416589|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395369|NCT00048542|469416590|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395370|NCT00048542|469416591|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395371|NCT00048542|469416592|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395372|NCT00048542|469416593|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395373|NCT00048542|469416594|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
130395374|NCT00048542|469416595|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395375|NCT00048542|469416596|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
130395376|NCT00048542|469416589|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395377|NCT00048542|469416590|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395378|NCT00048542|469416591|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395379|NCT00048542|469416592|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395380|NCT00048542|469416593|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
130395381|NCT00048542|469416594|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
130395382|NCT00048542|469416595|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395383|NCT00048542|469416596|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130395384|NCT00048542|469416589|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
130395385|NCT00048542|469416590|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
130395386|NCT00048542|469416591|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
130395387|NCT00048542|469416592|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
130395388|NCT00048542|469416593|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
130395389|NCT00048542|469416594|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
130395390|NCT00048542|469416595|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
130395391|NCT00048542|469416596|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
130395392|NCT00048542|469416589|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395393|NCT00048542|469416590|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395394|NCT00048542|469416591|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395395|NCT00048542|469416592|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395396|NCT00048542|469416593|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
130395397|NCT00048542|469416594|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
130395398|NCT00048542|469416595|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395399|NCT00048542|469416596|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130395400|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395401|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395402|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395403|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395404|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395405|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130395406|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
130395407|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
130395408|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395409|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395410|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395411|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395412|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395413|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130395414|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
130395415|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
130395416|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395417|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395418|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395419|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395420|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395421|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130395422|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
130395423|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
130395424|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395425|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395426|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395427|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395428|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395429|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130395430|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
130559992|NCT00074581|470017917|FG001|Overall Study|Lost to Follow-up|11|||
130395431|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
130395432|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395433|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395434|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395435|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395436|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395437|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130395438|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
130395439|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
130395440|NCT00048542|469416589|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395441|NCT00048542|469416590|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395442|NCT00048542|469416591|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395443|NCT00048542|469416592|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395444|NCT00048542|469416593|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395445|NCT00048542|469416594|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130395446|NCT00048542|469416595|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
130395447|NCT00048542|469416596|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
130395448|NCT00578175|469416597|FG000|Overall Study|Adverse Event|0|||
130395449|NCT00578175|469416598|FG001|Overall Study|Adverse Event|1|||
130395450|NCT00578175|469416599|FG002|Overall Study|Adverse Event|1|||
130395451|NCT00578175|469416597|FG000|Overall Study|Other reasons|70|||
130395452|NCT00578175|469416598|FG001|Overall Study|Other reasons|42|||
130395453|NCT00578175|469416599|FG002|Overall Study|Other reasons|23|||
130395454|NCT01869192|469416600|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
130395455|NCT01869192|469416601|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
130395456|NCT01869192|469416600|FG000|Postoperative Chemotherapy|Physician Decision|0|||
130395457|NCT01869192|469416601|FG001|Postoperative Chemotherapy|Physician Decision|2|||
130395458|NCT02126969|469416606|FG000|Overall Study|Withdrawal by Subject|1|||
130395459|NCT02126969|469416607|FG001|Overall Study|Withdrawal by Subject|2|||
130395460|NCT00423891|469416608|FG000|Enrolled|Withdrawal by Subject|0|||
130395461|NCT00423891|469416609|FG001|Enrolled|Withdrawal by Subject|0|||
130395462|NCT00423891|469416610|FG002|Enrolled|Withdrawal by Subject|1|||
130395463|NCT00423891|469416608|FG000|Enrolled|Lost to Follow-up|0|||
130395464|NCT00423891|469416609|FG001|Enrolled|Lost to Follow-up|0|||
130395465|NCT00423891|469416610|FG002|Enrolled|Lost to Follow-up|1|||
130395466|NCT00423891|469416608|FG000|Enrolled|No longer met criteria|11|||
130395467|NCT00423891|469416609|FG001|Enrolled|No longer met criteria|2|||
130395468|NCT00423891|469416610|FG002|Enrolled|No longer met criteria|1|||
130395469|NCT00423891|469416608|FG000|Treatment|Withdrawal by Subject|1|||
130395470|NCT00423891|469416609|FG001|Treatment|Withdrawal by Subject|0|||
130395471|NCT00423891|469416610|FG002|Treatment|Withdrawal by Subject|0|||
130395472|NCT00423891|469416608|FG000|Treatment|Lost to Follow-up|1|||
130395473|NCT00423891|469416609|FG001|Treatment|Lost to Follow-up|0|||
130395474|NCT00423891|469416610|FG002|Treatment|Lost to Follow-up|0|||
130395475|NCT00423891|469416608|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
130395476|NCT00423891|469416609|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
130395477|NCT00423891|469416610|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
130395478|NCT00423891|469416608|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
130395479|NCT00423891|469416609|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
130395480|NCT00423891|469416610|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
130395481|NCT00785486|469416615|FG000|Midazolam Alone|Withdrawal by Subject|1|||
130395482|NCT01640366|469416619|FG000|Overall Study|Withdrawal by Subject|1|||
130395483|NCT01640366|469416619|FG000|Overall Study|Protocol Violation|16|||
130395484|NCT01640366|469416619|FG000|Overall Study|Lost to Follow-up|5|||
130395485|NCT01116232|469416622|FG000|Overall Study|Progressive diease|4|||
130395486|NCT02357940|469416625|FG000|Overall Study|Adverse Event|0|||
130395487|NCT02357940|469416626|FG001|Overall Study|Adverse Event|1|||
130470564|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
130470565|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
130470566|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
130470567|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
130395488|NCT02357940|469416625|FG000|Overall Study|Investigator's judgement|0|||
130395489|NCT02357940|469416626|FG001|Overall Study|Investigator's judgement|1|||
130470568|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
130470569|NCT03271489|469688362|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
130470570|NCT03271489|469688363|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
130723150|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
130723151|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130395490|NCT02275481|469416627|FG000|Overall Study|Death|2|||
130395491|NCT02275481|469416628|FG001|Overall Study|Death|1|||
130395492|NCT02275481|469416627|FG000|Overall Study|Lost to Follow-up|2|||
130395493|NCT02275481|469416628|FG001|Overall Study|Lost to Follow-up|0|||
130395494|NCT02275481|469416627|FG000|Overall Study|Withdrawal by Subject|3|||
130395495|NCT02275481|469416628|FG001|Overall Study|Withdrawal by Subject|0|||
130395496|NCT02275481|469416627|FG000|Overall Study|all other reasons combined|2|||
130395497|NCT02275481|469416628|FG001|Overall Study|all other reasons combined|1|||
130395498|NCT02275481|469416627|FG000|Overall Study|Physician Decision|0|||
130395499|NCT02275481|469416628|FG001|Overall Study|Physician Decision|1|||
130395500|NCT03274986|469416629|FG000|Overall Study|Withdrawal by Subject|0|||
130395501|NCT03274986|469416630|FG001|Overall Study|Withdrawal by Subject|1|||
130395502|NCT03274986|469416629|FG000|Overall Study|Lost to Follow-up|0|||
130395503|NCT03274986|469416630|FG001|Overall Study|Lost to Follow-up|1|||
130395504|NCT00344773|469416639|FG000|Overall Study|Adverse Event|2|||
130395505|NCT00344773|469416639|FG000|Overall Study|Objective Disease Progression|16|||
130395506|NCT00344773|469416639|FG000|Overall Study|Withdrawal by Subject|1|||
130723152|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130723153|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130395507|NCT00344773|469416639|FG000|Overall Study|Not Eligible for the study|2|||
130395508|NCT00714259|469416641|FG000|Overall Study|Death|2|||
130395509|NCT02141074|469416642|FG000|Pre-prophylaxis|Adverse Event|3|||
130395510|NCT02141074|469416643|FG001|Pre-prophylaxis|Adverse Event|0|||
130395511|NCT02141074|469416642|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
130395512|NCT02141074|469416643|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
130395513|NCT02141074|469416642|FG000|Prophylaxis|Adverse Event|0|||
130395514|NCT02141074|469416643|FG001|Prophylaxis|Adverse Event|4|||
130395515|NCT02141074|469416642|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
130395516|NCT02141074|469416643|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
130395517|NCT02141074|469416642|FG000|Prophylaxis|Withdrawal by Subject|0|||
130395518|NCT02141074|469416643|FG001|Prophylaxis|Withdrawal by Subject|1|||
130395519|NCT00403273|469418562|FG000|Overall Study|Lost to Follow-up|3|||
130395520|NCT00403273|469418563|FG001|Overall Study|Lost to Follow-up|2|||
130395521|NCT00403273|469418562|FG000|Overall Study|Physician Decision|0|||
130395522|NCT00403273|469418563|FG001|Overall Study|Physician Decision|1|||
130395523|NCT00403273|469418562|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
130395524|NCT00403273|469418563|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
130395525|NCT00574405|469418564|FG000|Overall Study|Withdrawal by Subject|3|||
130395526|NCT00574405|469418565|FG001|Overall Study|Withdrawal by Subject|2|||
130395527|NCT01336738|469418566|FG000|Overall Study|Adverse Event|0|||
130395528|NCT01336738|469418567|FG001|Overall Study|Adverse Event|3|||
130395529|NCT01336738|469418568|FG002|Overall Study|Adverse Event|2|||
130395530|NCT01336738|469418569|FG003|Overall Study|Adverse Event|1|||
130395531|NCT01336738|469418570|FG004|Overall Study|Adverse Event|3|||
130395532|NCT01336738|469418566|FG000|Overall Study|Lost to Follow-up|2|||
130395533|NCT01336738|469418567|FG001|Overall Study|Lost to Follow-up|1|||
130395534|NCT01336738|469418568|FG002|Overall Study|Lost to Follow-up|2|||
130395535|NCT01336738|469418569|FG003|Overall Study|Lost to Follow-up|2|||
130395536|NCT01336738|469418570|FG004|Overall Study|Lost to Follow-up|2|||
130395537|NCT01336738|469418566|FG000|Overall Study|Did not meet entrance criteria|0|||
130395538|NCT01336738|469418567|FG001|Overall Study|Did not meet entrance criteria|1|||
130395539|NCT01336738|469418568|FG002|Overall Study|Did not meet entrance criteria|0|||
130395540|NCT01336738|469418569|FG003|Overall Study|Did not meet entrance criteria|0|||
130395541|NCT01336738|469418570|FG004|Overall Study|Did not meet entrance criteria|0|||
130395542|NCT01336738|469418566|FG000|Overall Study|Protocol Violation|0|||
130395543|NCT01336738|469418567|FG001|Overall Study|Protocol Violation|1|||
130395544|NCT01336738|469418568|FG002|Overall Study|Protocol Violation|0|||
130395545|NCT01336738|469418569|FG003|Overall Study|Protocol Violation|0|||
130395546|NCT01336738|469418570|FG004|Overall Study|Protocol Violation|0|||
130395547|NCT01336738|469418566|FG000|Overall Study|Withdrawal by Subject|2|||
130395548|NCT01336738|469418567|FG001|Overall Study|Withdrawal by Subject|0|||
130395549|NCT01336738|469418568|FG002|Overall Study|Withdrawal by Subject|2|||
130395550|NCT01336738|469418569|FG003|Overall Study|Withdrawal by Subject|1|||
130395551|NCT01336738|469418570|FG004|Overall Study|Withdrawal by Subject|1|||
130395552|NCT01336738|469418566|FG000|Overall Study|Other|3|||
130395553|NCT01336738|469418567|FG001|Overall Study|Other|3|||
130395554|NCT01336738|469418568|FG002|Overall Study|Other|2|||
130395555|NCT01336738|469418569|FG003|Overall Study|Other|3|||
130395556|NCT01336738|469418570|FG004|Overall Study|Other|4|||
130395557|NCT03003520|469418571|FG000|Overall Study|Adverse Event|9|||
130395558|NCT03003520|469418572|FG001|Overall Study|Adverse Event|0|||
130395559|NCT03003520|469418571|FG000|Overall Study|Death|1|||
130395560|NCT03003520|469418572|FG001|Overall Study|Death|0|||
130395561|NCT03003520|469418571|FG000|Overall Study|Other reasons|4|||
130395562|NCT03003520|469418572|FG001|Overall Study|Other reasons|0|||
130395563|NCT03003520|469418571|FG000|Overall Study|Withdrawal by Subject|6|||
130395564|NCT03003520|469418572|FG001|Overall Study|Withdrawal by Subject|0|||
130395565|NCT03003520|469418571|FG000|Overall Study|Progressive disease|9|||
130395566|NCT03003520|469418572|FG001|Overall Study|Progressive disease|1|||
130395567|NCT01332149|469418573|FG000|Overall Study|Adverse Event|11|||
130395568|NCT01332149|469418574|FG001|Overall Study|Adverse Event|9|||
130395569|NCT01332149|469418573|FG000|Overall Study|Other unspecified|5|||
130395570|NCT01332149|469418574|FG001|Overall Study|Other unspecified|7|||
130395571|NCT01332149|469418573|FG000|Overall Study|Protocol Violation|1|||
130395572|NCT01332149|469418574|FG001|Overall Study|Protocol Violation|3|||
130395573|NCT01332149|469418573|FG000|Overall Study|Withdrawal by Subject|4|||
130395574|NCT01332149|469418574|FG001|Overall Study|Withdrawal by Subject|5|||
130395575|NCT01332149|469418573|FG000|Overall Study|Lost to Follow-up|1|||
130395576|NCT01332149|469418574|FG001|Overall Study|Lost to Follow-up|1|||
130395577|NCT01332149|469418573|FG000|Overall Study|Insufficient clinical response|4|||
130395578|NCT01332149|469418574|FG001|Overall Study|Insufficient clinical response|7|||
130395579|NCT01332149|469418573|FG000|Overall Study|Did not meet entrance criteria|3|||
130395580|NCT01332149|469418574|FG001|Overall Study|Did not meet entrance criteria|4|||
130395581|NCT01332149|469418573|FG000|Overall Study|Randomized but not treated|1|||
130395582|NCT01332149|469418574|FG001|Overall Study|Randomized but not treated|2|||
130395583|NCT04615949|469418575|FG000|Overall Study|Withdrawal by Subject|2|||
130395584|NCT04615949|469418576|FG001|Overall Study|Withdrawal by Subject|4|||
130395585|NCT04615949|469418575|FG000|Overall Study|Lost to Follow-up|2|||
130395586|NCT04615949|469418576|FG001|Overall Study|Lost to Follow-up|2|||
130395587|NCT04615949|469418575|FG000|Overall Study|Death|0|||
130395588|NCT04615949|469418576|FG001|Overall Study|Death|2|||
130395589|NCT01920932|469418578|FG000|Overall Study|Death|1|||
130395590|NCT01920932|469418578|FG000|Overall Study|Withdrawal of consent|1|||
130395591|NCT01816139|469418579|FG000|Overall Study|Adverse Event|6|||
130395592|NCT01816139|469418580|FG001|Overall Study|Adverse Event|8|||
130395593|NCT01816139|469418579|FG000|Overall Study|Lack of Efficacy|1|||
130395594|NCT01816139|469418580|FG001|Overall Study|Lack of Efficacy|2|||
130395595|NCT01816139|469418579|FG000|Overall Study|Lost to Follow-up|5|||
130395596|NCT01816139|469418580|FG001|Overall Study|Lost to Follow-up|3|||
130395597|NCT01816139|469418579|FG000|Overall Study|Withdrew Consent|6|||
130395598|NCT01816139|469418580|FG001|Overall Study|Withdrew Consent|4|||
130395599|NCT01816139|469418579|FG000|Overall Study|Protocol Violation|6|||
130395600|NCT01816139|469418580|FG001|Overall Study|Protocol Violation|3|||
130395601|NCT01816139|469418579|FG000|Overall Study|Reason not Specified|4|||
130395602|NCT01816139|469418580|FG001|Overall Study|Reason not Specified|2|||
130395603|NCT02554656|469418583|FG000|Overall Study|Protocol Violation|3|||
130395604|NCT03240575|469418584|FG000|Overall Study|Adverse Event|0|||
130395605|NCT03240575|469418585|FG001|Overall Study|Adverse Event|2|||
130395606|NCT03240575|469418586|FG002|Overall Study|Adverse Event|0|||
130395607|NCT03240575|469418587|FG003|Overall Study|Adverse Event|1|||
130395608|NCT03240575|469418584|FG000|Overall Study|Withdrawal by Subject|2|||
130395609|NCT03240575|469418585|FG001|Overall Study|Withdrawal by Subject|11|||
130395610|NCT03240575|469418586|FG002|Overall Study|Withdrawal by Subject|0|||
130395611|NCT03240575|469418587|FG003|Overall Study|Withdrawal by Subject|1|||
130395612|NCT03240575|469418584|FG000|Overall Study|Other|0|||
130395613|NCT03240575|469418585|FG001|Overall Study|Other|1|||
130395614|NCT03240575|469418586|FG002|Overall Study|Other|0|||
130395615|NCT03240575|469418587|FG003|Overall Study|Other|0|||
130395616|NCT00697346|469418592|FG000|Overall Study|Adverse Event|4|||
130395617|NCT00697346|469418593|FG001|Overall Study|Adverse Event|5|||
130395618|NCT00697346|469418594|FG002|Overall Study|Adverse Event|0|||
130395619|NCT00697346|469418592|FG000|Overall Study|Progressive Disease|19|||
130395620|NCT00697346|469418593|FG001|Overall Study|Progressive Disease|18|||
130395621|NCT00697346|469418594|FG002|Overall Study|Progressive Disease|0|||
130395622|NCT00697346|469418592|FG000|Overall Study|Symptomatic Deterioration|0|||
130395623|NCT00697346|469418593|FG001|Overall Study|Symptomatic Deterioration|1|||
130395624|NCT00697346|469418594|FG002|Overall Study|Symptomatic Deterioration|0|||
130395625|NCT00697346|469418592|FG000|Overall Study|Withdrawal by Subject|2|||
130395626|NCT00697346|469418593|FG001|Overall Study|Withdrawal by Subject|2|||
130395627|NCT00697346|469418594|FG002|Overall Study|Withdrawal by Subject|0|||
130395628|NCT00697346|469418592|FG000|Overall Study|Reason not Specified|3|||
130395629|NCT00697346|469418593|FG001|Overall Study|Reason not Specified|0|||
130395630|NCT00697346|469418594|FG002|Overall Study|Reason not Specified|1|||
130395631|NCT03643562|469418596|FG000|Overall Study|Adverse Event|1|||
130395632|NCT03643562|469418597|FG001|Overall Study|Adverse Event|0|||
130395633|NCT03643562|469418596|FG000|Overall Study|Lack of Efficacy|0|||
130395634|NCT03643562|469418597|FG001|Overall Study|Lack of Efficacy|1|||
130395635|NCT03643562|469418596|FG000|Overall Study|Physician Decision|0|||
130395636|NCT03643562|469418597|FG001|Overall Study|Physician Decision|1|||
130395637|NCT03643562|469418596|FG000|Overall Study|Study Terminated by Sponsor|2|||
130395638|NCT03643562|469418597|FG001|Overall Study|Study Terminated by Sponsor|10|||
130395639|NCT03643562|469418596|FG000|Overall Study|Withdrawal by Subject|2|||
130395640|NCT03643562|469418597|FG001|Overall Study|Withdrawal by Subject|2|||
130395641|NCT03643562|469418596|FG000|Overall Study|Other than specified|3|||
130395642|NCT03643562|469418597|FG001|Overall Study|Other than specified|2|||
130395643|NCT01982253|469418600|FG000|Overall Study|Withdrawal by Subject|1|||
130395644|NCT01982253|469418601|FG001|Overall Study|Withdrawal by Subject|0|||
130395645|NCT01982253|469418602|FG002|Overall Study|Withdrawal by Subject|0|||
130395646|NCT01982253|469418600|FG000|Overall Study|Study terminated by sponsor|1|||
130395647|NCT01982253|469418601|FG001|Overall Study|Study terminated by sponsor|4|||
130395648|NCT01982253|469418602|FG002|Overall Study|Study terminated by sponsor|4|||
130395649|NCT00913744|469418604|FG000|Overall Study|Adverse Event|2|||
130395650|NCT00913744|469418605|FG001|Overall Study|Adverse Event|0|||
130395651|NCT00913744|469418604|FG000|Overall Study|Withdrawal by Subject|2|||
130395652|NCT00913744|469418605|FG001|Overall Study|Withdrawal by Subject|1|||
130395653|NCT00913744|469418604|FG000|Overall Study|Death|1|||
130395654|NCT00913744|469418605|FG001|Overall Study|Death|0|||
130395655|NCT02945410|469418606|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130395656|NCT02945410|469418607|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
130395657|NCT02945410|469418608|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130395658|NCT02945410|469418609|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130395659|NCT02945410|469418610|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130395660|NCT02945410|469418611|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130395661|NCT02945410|469418606|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
130395662|NCT02945410|469418607|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
130395663|NCT02945410|469418608|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
130395664|NCT02945410|469418609|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
130395665|NCT02945410|469418610|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
130395666|NCT02945410|469418611|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
130395667|NCT02945410|469418606|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130395668|NCT02945410|469418607|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130395669|NCT02945410|469418608|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
130395670|NCT02945410|469418609|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130395671|NCT02945410|469418610|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
130395672|NCT02945410|469418611|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130395673|NCT01539226|469418612|FG000|Overall Study|Withdrawal by Subject|24|||
130395674|NCT01539226|469418613|FG001|Overall Study|Withdrawal by Subject|54|||
130395675|NCT01539226|469418612|FG000|Overall Study|Lost to Follow-up|20|||
130395676|NCT01539226|469418613|FG001|Overall Study|Lost to Follow-up|54|||
130395677|NCT01539226|469418612|FG000|Overall Study|Death|1|||
130395678|NCT01539226|469418613|FG001|Overall Study|Death|2|||
130395679|NCT01539226|469418612|FG000|Overall Study|Adverse Event|2|||
130395680|NCT01539226|469418613|FG001|Overall Study|Adverse Event|0|||
130395681|NCT01539226|469418612|FG000|Overall Study|Pregnancy|13|||
130395682|NCT01539226|469418613|FG001|Overall Study|Pregnancy|29|||
130395683|NCT01539226|469418612|FG000|Overall Study|inappropriate enrollment|0|||
130395684|NCT01539226|469418613|FG001|Overall Study|inappropriate enrollment|1|||
130395685|NCT01539226|469418612|FG000|Overall Study|Multiple Reasons|3|||
130395686|NCT01539226|469418613|FG001|Overall Study|Multiple Reasons|1|||
130395687|NCT01539226|469418612|FG000|Overall Study|not HIV seroconversion-related|93|||
130395688|NCT01539226|469418613|FG001|Overall Study|not HIV seroconversion-related|176|||
130395689|NCT01539226|469418612|FG000|Overall Study|HIV seroconversion-related|55|||
130395690|NCT01539226|469418613|FG001|Overall Study|HIV seroconversion-related|80|||
130395691|NCT01539226|469418612|FG000|Overall Study|Non-compliance|6|||
130395692|NCT01539226|469418613|FG001|Overall Study|Non-compliance|8|||
130395693|NCT00414661|469418618|FG000|Overall Study|Death|2|||
130395694|NCT00414661|469418619|FG001|Overall Study|Death|5|||
130395695|NCT00414661|469418620|FG002|Overall Study|Death|0|||
130395696|NCT00414661|469418621|FG003|Overall Study|Death|0|||
130395697|NCT00414661|469418618|FG000|Overall Study|Lost to Follow-up|1|||
130395698|NCT00414661|469418619|FG001|Overall Study|Lost to Follow-up|4|||
130395699|NCT00414661|469418620|FG002|Overall Study|Lost to Follow-up|0|||
130395700|NCT00414661|469418621|FG003|Overall Study|Lost to Follow-up|1|||
130395701|NCT00414661|469418618|FG000|Overall Study|Withdrawal by Subject|5|||
130395702|NCT00414661|469418619|FG001|Overall Study|Withdrawal by Subject|2|||
130395703|NCT00414661|469418620|FG002|Overall Study|Withdrawal by Subject|2|||
130395704|NCT00414661|469418621|FG003|Overall Study|Withdrawal by Subject|2|||
130395705|NCT00414661|469418618|FG000|Overall Study|Other|6|||
130395706|NCT00414661|469418619|FG001|Overall Study|Other|3|||
130395707|NCT00414661|469418620|FG002|Overall Study|Other|0|||
130395708|NCT00414661|469418621|FG003|Overall Study|Other|0|||
130395709|NCT00357370|469418622|FG000|Cohort 2|Lack of Efficacy|0|||
130395710|NCT00357370|469418623|FG001|Cohort 2|Lack of Efficacy|2|||
130395711|NCT00357370|469418624|FG002|Cohort 2|Lack of Efficacy|1|||
130395712|NCT00357370|469418622|FG000|Cohort 2|Adverse Event|1|||
130395713|NCT00357370|469418623|FG001|Cohort 2|Adverse Event|1|||
130395714|NCT00357370|469418624|FG002|Cohort 2|Adverse Event|1|||
130395715|NCT00357370|469418622|FG000|Cohort 2|Lost to Follow-up|0|||
130395716|NCT00357370|469418623|FG001|Cohort 2|Lost to Follow-up|1|||
130395717|NCT00357370|469418624|FG002|Cohort 2|Lost to Follow-up|0|||
130395718|NCT00357370|469418622|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
130395719|NCT00357370|469418623|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
130395720|NCT00357370|469418624|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
130470571|NCT03330795|469688364|FG000|Overall Study|Death|3|||
130395721|NCT00357370|469418622|FG000|Cohort 2|Withdrawal by Subject|0|||
130395722|NCT00357370|469418623|FG001|Cohort 2|Withdrawal by Subject|2|||
130395723|NCT00357370|469418624|FG002|Cohort 2|Withdrawal by Subject|0|||
130395724|NCT01143090|469418625|FG000|Overall Study|Lack of Efficacy|2|||
130395725|NCT01143090|469418625|FG000|Overall Study|Adverse Event|17|||
130395726|NCT01143090|469418625|FG000|Overall Study|Lost to Follow-up|9|||
130395727|NCT01143090|469418625|FG000|Overall Study|Protocol Violation|2|||
130395728|NCT01143090|469418625|FG000|Overall Study|Withdrawal by Subject|18|||
130395729|NCT01143090|469418625|FG000|Overall Study|Non-compliance with study drug|1|||
130395730|NCT01143090|469418625|FG000|Overall Study|Failure to meet eligibility criteria|1|||
130395731|NCT01143090|469418625|FG000|Overall Study|Administrative|1|||
130395732|NCT01800916|469418626|FG000|Test Period 1 (1 Week)|Convex product user|0|||
130395733|NCT01800916|469418627|FG001|Test Period 1 (1 Week)|Convex product user|0|||
130395734|NCT01800916|469418628|FG002|Test Period 1 (1 Week)|Convex product user|0|||
130395735|NCT01800916|469418629|FG003|Test Period 1 (1 Week)|Convex product user|1|||
130395736|NCT01800916|469418630|FG004|Test Period 1 (1 Week)|Convex product user|0|||
130395737|NCT01800916|469418631|FG005|Test Period 1 (1 Week)|Convex product user|0|||
130395738|NCT01800916|469418632|FG006|Test Period 1 (1 Week)|Convex product user|0|||
130395739|NCT01800916|469418633|FG007|Test Period 1 (1 Week)|Convex product user|0|||
130395740|NCT01800916|469418634|FG008|Test Period 1 (1 Week)|Convex product user|0|||
130395741|NCT01800916|469418626|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
130395742|NCT01800916|469418627|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
130395743|NCT01800916|469418628|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
130395744|NCT01800916|469418629|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
130395745|NCT01800916|469418630|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
130395746|NCT01800916|469418631|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
130395747|NCT01800916|469418632|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
130395748|NCT01800916|469418633|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
130395749|NCT01800916|469418634|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
130395750|NCT01232296|469418635|FG000|Overall Study|Adverse Event|24|||
130395751|NCT01232296|469418636|FG001|Overall Study|Adverse Event|12|||
130395752|NCT01232296|469418635|FG000|Overall Study|Physician Decision|1|||
130395753|NCT01232296|469418636|FG001|Overall Study|Physician Decision|1|||
130395754|NCT01232296|469418635|FG000|Overall Study|Progressive disease|43|||
130395755|NCT01232296|469418636|FG001|Overall Study|Progressive disease|61|||
130395756|NCT01232296|469418635|FG000|Overall Study|Study terminated by sponsor|0|||
130395757|NCT01232296|469418636|FG001|Overall Study|Study terminated by sponsor|1|||
130395758|NCT01232296|469418635|FG000|Overall Study|Technical problems|3|||
130395759|NCT01232296|469418636|FG001|Overall Study|Technical problems|0|||
130395760|NCT01232296|469418635|FG000|Overall Study|Subject/guardian decision|10|||
130395761|NCT01232296|469418636|FG001|Overall Study|Subject/guardian decision|2|||
130395762|NCT01232296|469418635|FG000|Overall Study|Death|1|||
130395763|NCT01232296|469418636|FG001|Overall Study|Death|6|||
130395764|NCT00727714|469418639|FG000|Overall Study|Lost to Follow-up|2|||
130395765|NCT00937547|469418640|FG000|Overall Study|misdiagnosis|1|||
130395766|NCT00937547|469418641|FG001|Overall Study|misdiagnosis|6|||
130395767|NCT00937547|469418642|FG002|Overall Study|misdiagnosis|7|||
130395768|NCT00325234|469418643|FG000|Overall Study|Adverse Event|10|||
130395769|NCT00325234|469418644|FG001|Overall Study|Adverse Event|7|||
130395770|NCT00325234|469418643|FG000|Overall Study|Death due to Study Disease|1|||
130395771|NCT00325234|469418644|FG001|Overall Study|Death due to Study Disease|0|||
130395772|NCT00325234|469418643|FG000|Overall Study|Entry Criteria Not Met|1|||
130395773|NCT00325234|469418644|FG001|Overall Study|Entry Criteria Not Met|2|||
130395774|NCT00325234|469418643|FG000|Overall Study|Subject Decision|6|||
130395775|NCT00325234|469418644|FG001|Overall Study|Subject Decision|8|||
130395776|NCT00325234|469418643|FG000|Overall Study|Physician Decision|17|||
130395777|NCT00325234|469418644|FG001|Overall Study|Physician Decision|12|||
130395778|NCT00325234|469418643|FG000|Overall Study|Progressive Disease|34|||
130395779|NCT00325234|469418644|FG001|Overall Study|Progressive Disease|37|||
130395780|NCT01234467|469418645|FG000|Overall Study|Adverse Event|3|||
130470572|NCT03330795|469688364|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
130395781|NCT01234467|469418645|FG000|Overall Study|Death|2|||
130395782|NCT01234467|469418645|FG000|Overall Study|Withdrawal by Subject|2|||
130395783|NCT01234467|469418645|FG000|Overall Study|Disease Progression|2|||
130395784|NCT01234467|469418645|FG000|Overall Study|Clinical deterioration|1|||
130395785|NCT01234467|469418645|FG000|Overall Study|Physician Decision|1|||
130395786|NCT01234467|469418645|FG000|Overall Study|Other complicating disease (stroke)|1|||
130395787|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
130395788|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
130395789|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
130395790|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
130395791|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
130395792|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
130470573|NCT05064735|469688365|FG000|Overall Study|Withdrawal by Subject|7|||
130470574|NCT05064735|469688366|FG001|Overall Study|Withdrawal by Subject|8|||
130470575|NCT05064735|469688365|FG000|Overall Study|Lost to Follow-up|7|||
130470576|NCT05064735|469688366|FG001|Overall Study|Lost to Follow-up|2|||
130470577|NCT05064735|469688365|FG000|Overall Study|Physician Decision|2|||
130470578|NCT05064735|469688366|FG001|Overall Study|Physician Decision|1|||
130470579|NCT05064735|469688365|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
130470580|NCT05064735|469688366|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
130470581|NCT05064735|469688365|FG000|Overall Study|Site Closure|7|||
130470582|NCT05064735|469688366|FG001|Overall Study|Site Closure|2|||
130470583|NCT02886286|469688367|FG000|Overall Study|pump motor stall|0|||
130470584|NCT02886286|469688368|FG001|Overall Study|pump motor stall|1|||
130470585|NCT05096819|469690763|FG000|Overall Study|Withdrawal by Subject|3|||
130470586|NCT05096819|469690764|FG001|Overall Study|Withdrawal by Subject|0|||
130470587|NCT03547908|469690765|FG000|Blinded Phase|Lost to Follow-up|3|||
130470588|NCT03547908|469690766|FG001|Blinded Phase|Lost to Follow-up|3|||
130470589|NCT03547908|469690767|FG002|Blinded Phase|Lost to Follow-up|0|||
130470590|NCT03547908|469690768|FG003|Blinded Phase|Lost to Follow-up|0|||
130470591|NCT03547908|469690765|FG000|Blinded Phase|Withdrew Consent|2|||
130470592|NCT03547908|469690766|FG001|Blinded Phase|Withdrew Consent|3|||
130470593|NCT03547908|469690767|FG002|Blinded Phase|Withdrew Consent|0|||
130470594|NCT03547908|469690768|FG003|Blinded Phase|Withdrew Consent|0|||
130470595|NCT03547908|469690765|FG000|Blinded Phase|Investigator's Discretion|2|||
130470596|NCT03547908|469690766|FG001|Blinded Phase|Investigator's Discretion|1|||
130470597|NCT03547908|469690767|FG002|Blinded Phase|Investigator's Discretion|0|||
130470598|NCT03547908|469690768|FG003|Blinded Phase|Investigator's Discretion|0|||
130470599|NCT03547908|469690765|FG000|Blinded Phase|Death|2|||
130470600|NCT03547908|469690766|FG001|Blinded Phase|Death|0|||
130395793|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
130395794|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
130395795|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
130395796|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
130395797|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
130395798|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
130395799|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
130395800|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
130395801|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
130395802|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
130395803|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
130395804|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
130395805|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Death|0|||
130395806|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Death|0|||
130395807|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Death|1|||
130395808|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Death|0|||
130395809|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Death|0|||
130395810|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Death|0|||
130395811|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Death|0|||
130395812|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Death|0|||
130395813|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Death|0|||
130395814|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
130395815|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
130395816|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
130395817|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395818|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395819|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395820|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395821|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395822|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130395823|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
130395824|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
130395825|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
130470601|NCT03547908|469690767|FG002|Blinded Phase|Death|0|||
130470602|NCT03547908|469690768|FG003|Blinded Phase|Death|0|||
130470603|NCT03547908|469690765|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
130470604|NCT03547908|469690766|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
130470605|NCT03547908|469690767|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
130470606|NCT03547908|469690768|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
130395826|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395827|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395828|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395829|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395830|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395831|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130395832|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
130395833|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
130395834|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
130395835|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
130395836|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
130395837|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
130395838|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
130395839|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
130395840|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
130395841|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
130395842|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
130395843|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
130395844|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
130395845|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
130395846|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
130395847|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
130395848|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
130395849|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
130395850|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
130395851|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
130395852|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
130395853|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395854|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395855|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395856|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395857|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395858|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130395859|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395860|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
130395861|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395862|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395863|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395864|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395865|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395866|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395867|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130395868|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
130395869|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
130395870|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
130395871|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
130395872|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
130395873|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
130395874|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
130395875|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
130395876|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
130395877|NCT00404352|469418646|FG000|Double Blind (up to 24 Month)|Other|0|||
130395878|NCT00404352|469418647|FG001|Double Blind (up to 24 Month)|Other|1|||
130395879|NCT00404352|469418648|FG002|Double Blind (up to 24 Month)|Other|0|||
130395880|NCT00404352|469418649|FG003|Double Blind (up to 24 Month)|Other|0|||
130395881|NCT00404352|469418650|FG004|Double Blind (up to 24 Month)|Other|0|||
130395882|NCT00404352|469418651|FG005|Double Blind (up to 24 Month)|Other|0|||
130395883|NCT00404352|469418652|FG006|Double Blind (up to 24 Month)|Other|0|||
130395884|NCT00404352|469418653|FG007|Double Blind (up to 24 Month)|Other|0|||
130395885|NCT00404352|469418654|FG008|Double Blind (up to 24 Month)|Other|0|||
130395886|NCT00404352|469418646|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
130395887|NCT00404352|469418647|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
130395888|NCT00404352|469418648|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
130395889|NCT00404352|469418649|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
130470607|NCT03547908|469690765|FG000|Blinded Phase|Adverse Event|1|||
130395890|NCT00404352|469418650|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
130395891|NCT00404352|469418651|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
130559993|NCT00074581|470017916|FG000|Overall Study|Ended relationship w. index participant|117|||
130559994|NCT00074581|470017917|FG001|Overall Study|Ended relationship w. index participant|106|||
130559995|NCT00074581|470017916|FG000|Overall Study|Other|14|||
130559996|NCT00074581|470017917|FG001|Overall Study|Other|19|||
130559997|NCT04411628|470017922|FG000|Overall Study|Withdrawal by Subject|1|||
130723154|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
130723155|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723156|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723157|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723158|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
130723159|NCT01441947|470611351|FG000|Overall Study|Withdrawal by Subject|3|||
130723160|NCT01441947|470611352|FG001|Overall Study|Withdrawal by Subject|0|||
130723161|NCT04106661|470611354|FG000|Overall Study|Protocol Violation|3|||
130723162|NCT04106661|470611355|FG001|Overall Study|Protocol Violation|0|||
130723163|NCT04106661|470611354|FG000|Overall Study|Scheduling difficulties|1|||
130723164|NCT04106661|470611355|FG001|Overall Study|Scheduling difficulties|1|||
130723165|NCT00468650|470611356|FG000|Overall Study|Lost to Follow-up|4|||
130723166|NCT00468650|470611356|FG000|Overall Study|Withdrawal by Subject|2|||
130723167|NCT00468650|470611356|FG000|Overall Study|Protocol Violation|1|||
130723168|NCT02639052|470611357|FG000|Overall Study|Lost to Follow-up|1|||
130723169|NCT02730351|470611359|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
130723170|NCT02730351|470611360|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
130723171|NCT02730351|470611359|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
130723172|NCT02730351|470611360|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
130723173|NCT02730351|470611359|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
130723174|NCT02730351|470611360|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
130723175|NCT02730351|470611359|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
130723176|NCT02730351|470611360|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
130723177|NCT02730351|470611359|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
130723178|NCT02730351|470611360|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
130723179|NCT00128830|470611361|FG000|Overall Study|Adverse Event|10|||
130723180|NCT00128830|470611361|FG000|Overall Study|Withdrawal by Subject|14|||
130723181|NCT00128830|470611361|FG000|Overall Study|Lost to Follow-up|4|||
130723182|NCT00128830|470611361|FG000|Overall Study|Reached a virologic endpoint|29|||
130723183|NCT00128830|470611361|FG000|Overall Study|Non-compliant|4|||
130723184|NCT00128830|470611361|FG000|Overall Study|Discontinued or ineligible for study|2|||
130723185|NCT00128830|470611361|FG000|Overall Study|Other|9|||
130723186|NCT00838435|470611362|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
130395892|NCT00404352|469418652|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
130395893|NCT00404352|469418653|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
130395894|NCT00404352|469418654|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
130395895|NCT00404352|469418646|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
130395896|NCT00404352|469418647|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
130395897|NCT00404352|469418648|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
130395898|NCT00404352|469418649|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
130395899|NCT00404352|469418650|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
130395900|NCT00404352|469418651|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
130395901|NCT00404352|469418652|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
130395902|NCT00404352|469418653|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
130395903|NCT00404352|469418654|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
130395904|NCT00404352|469418646|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395905|NCT00404352|469418647|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395906|NCT00404352|469418648|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395907|NCT00404352|469418649|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395908|NCT00404352|469418650|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
130395909|NCT00404352|469418651|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395910|NCT00404352|469418652|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395911|NCT00404352|469418653|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130395912|NCT00404352|469418654|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130559998|NCT04411628|470017923|FG001|Overall Study|Withdrawal by Subject|1|||
130559999|NCT04411628|470017924|FG002|Overall Study|Withdrawal by Subject|2|||
130560000|NCT04411628|470017925|FG003|Overall Study|Withdrawal by Subject|0|||
130723187|NCT00838435|470611362|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
130723188|NCT00838435|470611362|FG000|Part 2 (7 Years)|Adverse Event|2|||
130395913|NCT00404352|469418646|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395914|NCT00404352|469418647|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395915|NCT00404352|469418648|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395916|NCT00404352|469418649|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130723189|NCT00838435|470611362|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
130723190|NCT00838435|470611362|FG000|Part 2 (7 Years)|Physician Decision|1|||
130723191|NCT00838435|470611362|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
130723192|NCT00838435|470611362|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
130395917|NCT00404352|469418650|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395918|NCT00404352|469418651|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
130395919|NCT00404352|469418652|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395920|NCT00404352|469418653|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395921|NCT00404352|469418654|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130395922|NCT00404352|469418646|FG000|Open Label (up to 24 Month)|Disease progression|0|||
130395923|NCT00404352|469418647|FG001|Open Label (up to 24 Month)|Disease progression|0|||
130395924|NCT00404352|469418648|FG002|Open Label (up to 24 Month)|Disease progression|0|||
130395925|NCT00404352|469418649|FG003|Open Label (up to 24 Month)|Disease progression|1|||
130395926|NCT00404352|469418650|FG004|Open Label (up to 24 Month)|Disease progression|0|||
130395927|NCT00404352|469418651|FG005|Open Label (up to 24 Month)|Disease progression|0|||
130395928|NCT00404352|469418652|FG006|Open Label (up to 24 Month)|Disease progression|0|||
130395929|NCT00404352|469418653|FG007|Open Label (up to 24 Month)|Disease progression|0|||
130395930|NCT00404352|469418654|FG008|Open Label (up to 24 Month)|Disease progression|0|||
130395931|NCT00404352|469418646|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395932|NCT00404352|469418647|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395933|NCT00404352|469418648|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395934|NCT00404352|469418649|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395935|NCT00404352|469418650|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130723193|NCT03796039|470611364|FG000|Overall Study|Death|2|||
130723194|NCT03796039|470611365|FG001|Overall Study|Death|1|||
130395936|NCT00404352|469418651|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395937|NCT00404352|469418652|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
130395938|NCT00404352|469418653|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
130395939|NCT00404352|469418654|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130395940|NCT00404352|469418646|FG000|Open Label Extension (up to 36 Months)|Other|0|||
130395941|NCT00404352|469418647|FG001|Open Label Extension (up to 36 Months)|Other|0|||
130395942|NCT00404352|469418648|FG002|Open Label Extension (up to 36 Months)|Other|0|||
130395943|NCT00404352|469418649|FG003|Open Label Extension (up to 36 Months)|Other|0|||
130395944|NCT00404352|469418650|FG004|Open Label Extension (up to 36 Months)|Other|0|||
130395945|NCT00404352|469418651|FG005|Open Label Extension (up to 36 Months)|Other|0|||
130395946|NCT00404352|469418652|FG006|Open Label Extension (up to 36 Months)|Other|0|||
130395947|NCT00404352|469418653|FG007|Open Label Extension (up to 36 Months)|Other|0|||
130395948|NCT00404352|469418654|FG008|Open Label Extension (up to 36 Months)|Other|2|||
130395949|NCT04370691|469418655|FG000|Overall Study|Pending visit|48|||
130395950|NCT04370691|469418655|FG000|Overall Study|Have Not Reached Lower Window|15|||
130395951|NCT04370691|469418655|FG000|Overall Study|Termination|14|||
130395952|NCT04370691|469418655|FG000|Overall Study|Missed or Overdue|10|||
130395953|NCT00486265|469418656|FG000|Overall Study|Adverse Event|1|||
130395954|NCT00486265|469418656|FG000|Overall Study|Lack of Efficacy|8|||
130395955|NCT04225923|469418660|FG000|Overall Study|Protocol Violation|1|||
130395956|NCT04225923|469418661|FG001|Overall Study|Protocol Violation|0|||
130395957|NCT04225923|469418662|FG002|Overall Study|Protocol Violation|1|||
130395958|NCT04225923|469418660|FG000|Overall Study|Withdrawal by Subject|4|||
130395959|NCT04225923|469418661|FG001|Overall Study|Withdrawal by Subject|1|||
130395960|NCT04225923|469418662|FG002|Overall Study|Withdrawal by Subject|3|||
130395961|NCT04225923|469418660|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
130395962|NCT04225923|469418661|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
130395963|NCT04225923|469418662|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
130395964|NCT00855309|469418663|FG000|Overall Study|patient never recieved drug|1|||
130395965|NCT00855309|469418664|FG001|Overall Study|patient never recieved drug|0|||
130395966|NCT01417481|469418665|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130395967|NCT01417481|469418666|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130395968|NCT00829296|469418667|FG000|Overall Study|Adverse Event|5|||
130395969|NCT00829296|469418668|FG001|Overall Study|Adverse Event|4|||
130395970|NCT03029624|469418669|FG000|Overall Study|Adverse Event|1|||
130395971|NCT03029624|469418669|FG000|Overall Study|Withdrawal by Subject|1|||
130395972|NCT03029624|469418669|FG000|Overall Study|Lack of Efficacy|1|||
130395973|NCT03029624|469418669|FG000|Overall Study|MRI need|2|||
130395974|NCT01077960|469418673|FG000|Overall Study|Adverse Event|6|||
130395975|NCT01077960|469418673|FG000|Overall Study|Protocol Violation|3|||
130395976|NCT01077960|469418673|FG000|Overall Study|Lost to Follow-up|5|||
130395977|NCT01077960|469418673|FG000|Overall Study|Subject decision|1|||
130395978|NCT01077960|469418673|FG000|Overall Study|Reason unspecified|1|||
130395979|NCT03837899|469418674|FG000|Overall Study|Death|6|||
130395980|NCT03837899|469418675|FG001|Overall Study|Death|8|||
130395981|NCT03837899|469418676|FG002|Overall Study|Death|3|||
130395982|NCT03837899|469418677|FG003|Overall Study|Death|7|||
130395983|NCT03837899|469418678|FG004|Overall Study|Death|8|||
130395984|NCT03837899|469418679|FG005|Overall Study|Death|7|||
130395985|NCT03837899|469418674|FG000|Overall Study|Moved to post-trial access program|0|||
130395986|NCT03837899|469418675|FG001|Overall Study|Moved to post-trial access program|1|||
130723195|NCT03796039|470611364|FG000|Overall Study|Withdrawal by Subject|7|||
130723196|NCT03796039|470611365|FG001|Overall Study|Withdrawal by Subject|4|||
130723197|NCT02927366|470611366|FG000|Overall Study|Adverse Event|1|||
130723198|NCT02927366|470611367|FG001|Overall Study|Adverse Event|0|||
130723199|NCT02927366|470611366|FG000|Overall Study|Patient schedule|1|||
130723200|NCT02927366|470611367|FG001|Overall Study|Patient schedule|0|||
130723201|NCT00587990|470611372|FG000|Overall Study|Death|0|||
130395987|NCT03837899|469418676|FG002|Overall Study|Moved to post-trial access program|0|||
130395988|NCT03837899|469418677|FG003|Overall Study|Moved to post-trial access program|0|||
130395989|NCT03837899|469418678|FG004|Overall Study|Moved to post-trial access program|0|||
130395990|NCT03837899|469418679|FG005|Overall Study|Moved to post-trial access program|0|||
130395991|NCT03837899|469418674|FG000|Overall Study|Other|0|||
130395992|NCT03837899|469418675|FG001|Overall Study|Other|0|||
130395993|NCT03837899|469418676|FG002|Overall Study|Other|0|||
130395994|NCT03837899|469418677|FG003|Overall Study|Other|0|||
130395995|NCT03837899|469418678|FG004|Overall Study|Other|0|||
130395996|NCT03837899|469418679|FG005|Overall Study|Other|2|||
130395997|NCT03837899|469418674|FG000|Overall Study|Lost to Follow-up|0|||
130395998|NCT03837899|469418675|FG001|Overall Study|Lost to Follow-up|1|||
130395999|NCT03837899|469418676|FG002|Overall Study|Lost to Follow-up|0|||
130396000|NCT03837899|469418677|FG003|Overall Study|Lost to Follow-up|0|||
130396001|NCT03837899|469418678|FG004|Overall Study|Lost to Follow-up|0|||
130396002|NCT03837899|469418679|FG005|Overall Study|Lost to Follow-up|0|||
130396003|NCT03837899|469418674|FG000|Overall Study|Withdrawal by Subject|0|||
130396004|NCT03837899|469418675|FG001|Overall Study|Withdrawal by Subject|0|||
130396005|NCT03837899|469418676|FG002|Overall Study|Withdrawal by Subject|0|||
130396006|NCT03837899|469418677|FG003|Overall Study|Withdrawal by Subject|1|||
130396007|NCT03837899|469418678|FG004|Overall Study|Withdrawal by Subject|0|||
130396008|NCT03837899|469418679|FG005|Overall Study|Withdrawal by Subject|0|||
130396009|NCT03837899|469418674|FG000|Overall Study|Study specific discontinuation criteria|0|||
130396010|NCT03837899|469418675|FG001|Overall Study|Study specific discontinuation criteria|1|||
130396011|NCT03837899|469418676|FG002|Overall Study|Study specific discontinuation criteria|0|||
130396012|NCT03837899|469418677|FG003|Overall Study|Study specific discontinuation criteria|0|||
130396013|NCT03837899|469418678|FG004|Overall Study|Study specific discontinuation criteria|3|||
130396014|NCT03837899|469418679|FG005|Overall Study|Study specific discontinuation criteria|1|||
130396015|NCT01371656|469418680|FG000|Overall Study|Death|7|||
130396016|NCT01371656|469418681|FG001|Overall Study|Death|4|||
130396017|NCT01371656|469418680|FG000|Overall Study|Physician Decision|46|||
130396018|NCT01371656|469418681|FG001|Overall Study|Physician Decision|7|||
130396019|NCT01371656|469418680|FG000|Overall Study|Withdrawal by Subject|7|||
130396020|NCT01371656|469418681|FG001|Overall Study|Withdrawal by Subject|0|||
130396021|NCT01371656|469418680|FG000|Overall Study|Ineligible|4|||
130396022|NCT01371656|469418681|FG001|Overall Study|Ineligible|3|||
130396023|NCT01465464|469418682|FG000|Overall Study|Adverse Event|96|||
130396024|NCT01465464|469418683|FG001|Overall Study|Adverse Event|49|||
130396025|NCT01465464|469418682|FG000|Overall Study|Lack of Efficacy|139|||
130396026|NCT01465464|469418683|FG001|Overall Study|Lack of Efficacy|190|||
130396027|NCT01465464|469418682|FG000|Overall Study|Physician Decision|13|||
130396028|NCT01465464|469418683|FG001|Overall Study|Physician Decision|5|||
130396029|NCT01465464|469418682|FG000|Overall Study|Protocol Violation|1|||
130396030|NCT01465464|469418683|FG001|Overall Study|Protocol Violation|1|||
130396031|NCT01465464|469418682|FG000|Overall Study|Withdrawal by Subject|46|||
130396032|NCT01465464|469418683|FG001|Overall Study|Withdrawal by Subject|30|||
130396033|NCT01465464|469418682|FG000|Overall Study|Other|9|||
130396034|NCT01465464|469418683|FG001|Overall Study|Other|3|||
130396035|NCT01465464|469418682|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
130396036|NCT01465464|469418683|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
130396037|NCT01554618|469418684|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
130396038|NCT01554618|469418685|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
130396039|NCT01554618|469418684|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
130396040|NCT01554618|469418685|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
130396041|NCT01554618|469418684|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
130396042|NCT01554618|469418685|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
130396043|NCT01554618|469418684|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
130396044|NCT01554618|469418685|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
130396045|NCT01554618|469418684|FG000|Open-Label Extension Period|Physician Decision|0|||
130396046|NCT01554618|469418685|FG001|Open-Label Extension Period|Physician Decision|1|||
130396047|NCT01554618|469418684|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130396048|NCT01554618|469418685|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
130396049|NCT02244580|469418687|FG000|Overall Study|No cancer tissues available|241|||
130396050|NCT04011410|469418688|FG000|Overall Study|Withdrawal by Subject|1|||
130396051|NCT00291668|469418694|FG000|Overall Study|Lack of Efficacy|1|||
130396052|NCT00291668|469418695|FG001|Overall Study|Lack of Efficacy|0|||
130396053|NCT00291668|469418696|FG002|Overall Study|Lack of Efficacy|0|||
130396054|NCT00291668|469418694|FG000|Overall Study|SAE, non-fatal|1|||
130396055|NCT00291668|469418695|FG001|Overall Study|SAE, non-fatal|1|||
130723202|NCT00587990|470611373|FG001|Overall Study|Death|0|||
130723203|NCT00587990|470611374|FG002|Overall Study|Death|1|||
130396056|NCT00291668|469418696|FG002|Overall Study|SAE, non-fatal|1|||
130396057|NCT00291668|469418694|FG000|Overall Study|AE, non-serious non-fatal|1|||
130396058|NCT00291668|469418695|FG001|Overall Study|AE, non-serious non-fatal|0|||
130396059|NCT00291668|469418696|FG002|Overall Study|AE, non-serious non-fatal|0|||
130396060|NCT00291668|469418694|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130396061|NCT00291668|469418695|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130396062|NCT00291668|469418696|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130396063|NCT00313612|469418699|FG000|Overall Study|Patient never received treatment|0|||
130396064|NCT00313612|469418700|FG001|Overall Study|Patient never received treatment|1|||
130396065|NCT00451035|469418701|FG000|Overall Study|Disease progression|11|||
130396066|NCT00451035|469418701|FG000|Overall Study|Death|3|||
130396067|NCT00451035|469418701|FG000|Overall Study|New anti-neoplastic therapy|3|||
130396068|NCT01393405|469418704|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
130396069|NCT01393405|469418705|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
130396070|NCT01393405|469418706|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
130396071|NCT01393405|469418704|FG000|Induction Period (week1-16)|Adverse Event|16|||
130396072|NCT01393405|469418705|FG001|Induction Period (week1-16)|Adverse Event|0|||
130396073|NCT01393405|469418706|FG002|Induction Period (week1-16)|Adverse Event|0|||
130396074|NCT01393405|469418704|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
130396075|NCT01393405|469418705|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
130396076|NCT01393405|469418706|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
130396077|NCT01393405|469418704|FG000|Maintenance Period Week|Lack of Efficacy|0|||
130396078|NCT01393405|469418705|FG001|Maintenance Period Week|Lack of Efficacy|22|||
130396079|NCT01393405|469418706|FG002|Maintenance Period Week|Lack of Efficacy|22|||
130396080|NCT01393405|469418704|FG000|Maintenance Period Week|Adverse Event|0|||
130396081|NCT01393405|469418705|FG001|Maintenance Period Week|Adverse Event|5|||
130396082|NCT01393405|469418706|FG002|Maintenance Period Week|Adverse Event|2|||
130396083|NCT01393405|469418704|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
130396084|NCT01393405|469418705|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
130396085|NCT01393405|469418706|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
130396086|NCT01393405|469418704|FG000|Maintenance Period Week|Lost to Follow-up|0|||
130396087|NCT01393405|469418705|FG001|Maintenance Period Week|Lost to Follow-up|1|||
130396088|NCT01393405|469418706|FG002|Maintenance Period Week|Lost to Follow-up|0|||
130396089|NCT03350503|469418710|FG000|Overall Study|Adverse Event|5|||
130396090|NCT03350503|469418710|FG000|Overall Study|Withdrawal by Subject|5|||
130396091|NCT03350503|469418710|FG000|Overall Study|Continuation impossible due to move|4|||
130396092|NCT03350503|469418710|FG000|Overall Study|Physician Decision|3|||
130396093|NCT04536727|469418711|FG000|Overall Study|Lost to Follow-up|1|||
130396094|NCT04536727|469418712|FG001|Overall Study|Lost to Follow-up|1|||
130396095|NCT04536727|469418711|FG000|Overall Study|Death|0|||
130396096|NCT04536727|469418712|FG001|Overall Study|Death|1|||
130396097|NCT01399593|469418713|FG000|Overall Study|Physician Decision|1|||
130396098|NCT01399593|469418714|FG001|Overall Study|Physician Decision|0|||
130396099|NCT01399593|469418713|FG000|Overall Study|Adverse Event|1|||
130396100|NCT01399593|469418714|FG001|Overall Study|Adverse Event|0|||
130396101|NCT01399593|469418713|FG000|Overall Study|Death|1|||
130396102|NCT01399593|469418714|FG001|Overall Study|Death|1|||
130396103|NCT01399593|469418713|FG000|Overall Study|Transplantectomy|0|||
130396104|NCT01399593|469418714|FG001|Overall Study|Transplantectomy|1|||
130396105|NCT00244712|469418723|FG000|Overall Study|Adverse Event|20|||
130396106|NCT00244712|469418724|FG001|Overall Study|Adverse Event|21|||
130396107|NCT00244712|469418723|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
130396108|NCT00244712|469418724|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
130396109|NCT00244712|469418723|FG000|Overall Study|Lack of Compliance|10|||
130396110|NCT00244712|469418724|FG001|Overall Study|Lack of Compliance|11|||
130396111|NCT00244712|469418723|FG000|Overall Study|Lost to Follow-up|45|||
130396112|NCT00244712|469418724|FG001|Overall Study|Lost to Follow-up|52|||
130396113|NCT00244712|469418723|FG000|Overall Study|Withdrawal by Subject|13|||
130396114|NCT00244712|469418724|FG001|Overall Study|Withdrawal by Subject|23|||
130396115|NCT00244712|469418723|FG000|Overall Study|Protocol Violation, disease progression|13|||
130396116|NCT00244712|469418724|FG001|Overall Study|Protocol Violation, disease progression|11|||
130396117|NCT00500370|469418727|FG000|Overall Study|Adverse Event|9|||
130396118|NCT00500370|469418728|FG001|Overall Study|Adverse Event|3|||
130396119|NCT00500370|469418727|FG000|Overall Study|Lost to Follow-up|10|||
130396120|NCT00500370|469418728|FG001|Overall Study|Lost to Follow-up|10|||
130396121|NCT00500370|469418727|FG000|Overall Study|Protocol Violation|2|||
130396122|NCT00500370|469418728|FG001|Overall Study|Protocol Violation|4|||
130396123|NCT00500370|469418727|FG000|Overall Study|Sponsor Decision|2|||
130396124|NCT00500370|469418728|FG001|Overall Study|Sponsor Decision|0|||
130396125|NCT00500370|469418727|FG000|Overall Study|Subject Decision|10|||
130396126|NCT00500370|469418728|FG001|Overall Study|Subject Decision|17|||
130396127|NCT04804813|469418729|FG000|Overall Study|Protocol Violation|2|||
130396128|NCT04804813|469418730|FG001|Overall Study|Protocol Violation|0|||
130396129|NCT04804813|469418729|FG000|Overall Study|Withdrawal by Subject|1|||
130470608|NCT03547908|469690766|FG001|Blinded Phase|Adverse Event|0|||
130396130|NCT04804813|469418730|FG001|Overall Study|Withdrawal by Subject|0|||
130396131|NCT05627518|469418731|FG000|Treatment Period 1|Adverse Event|0|||
130396132|NCT05627518|469418732|FG001|Treatment Period 1|Adverse Event|0|||
130396133|NCT05627518|469418733|FG002|Treatment Period 1|Adverse Event|1|||
130396134|NCT05627518|469418734|FG003|Treatment Period 1|Adverse Event|0|||
130396135|NCT05627518|469418735|FG004|Treatment Period 1|Adverse Event|0|||
130396136|NCT05627518|469418736|FG005|Treatment Period 1|Adverse Event|0|||
130396137|NCT05627518|469418737|FG006|Treatment Period 1|Adverse Event|0|||
130396138|NCT05627518|469418738|FG007|Treatment Period 1|Adverse Event|1|||
130396139|NCT05627518|469418731|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130396140|NCT05627518|469418732|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130396141|NCT05627518|469418733|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130396142|NCT05627518|469418734|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130396143|NCT05627518|469418735|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130396144|NCT05627518|469418736|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130396145|NCT05627518|469418737|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130396146|NCT05627518|469418738|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130396147|NCT05627518|469418731|FG000|Treatment Period 1|Protocol Violation|0|||
130396148|NCT05627518|469418732|FG001|Treatment Period 1|Protocol Violation|0|||
130396149|NCT05627518|469418733|FG002|Treatment Period 1|Protocol Violation|0|||
130396150|NCT05627518|469418734|FG003|Treatment Period 1|Protocol Violation|0|||
130396151|NCT05627518|469418735|FG004|Treatment Period 1|Protocol Violation|0|||
130396152|NCT05627518|469418736|FG005|Treatment Period 1|Protocol Violation|0|||
130396153|NCT05627518|469418737|FG006|Treatment Period 1|Protocol Violation|6|||
130396154|NCT05627518|469418738|FG007|Treatment Period 1|Protocol Violation|6|||
130396155|NCT05627518|469418731|FG000|Treatment Period 2|Adverse Event|1|||
130396156|NCT05627518|469418732|FG001|Treatment Period 2|Adverse Event|0|||
130396157|NCT05627518|469418733|FG002|Treatment Period 2|Adverse Event|0|||
130396158|NCT05627518|469418734|FG003|Treatment Period 2|Adverse Event|0|||
130396159|NCT05627518|469418735|FG004|Treatment Period 2|Adverse Event|0|||
130396160|NCT05627518|469418736|FG005|Treatment Period 2|Adverse Event|0|||
130396161|NCT05627518|469418737|FG006|Treatment Period 2|Adverse Event|0|||
130396162|NCT05627518|469418738|FG007|Treatment Period 2|Adverse Event|0|||
130396163|NCT05627518|469418731|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130396164|NCT05627518|469418732|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130396165|NCT05627518|469418733|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130396166|NCT05627518|469418734|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130396167|NCT05627518|469418735|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130396168|NCT05627518|469418736|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130396169|NCT05627518|469418737|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130396170|NCT05627518|469418738|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130396171|NCT02777125|469418742|FG000|Overall Study|Consent form violation|14|||
130396172|NCT02777125|469418743|FG001|Overall Study|Consent form violation|12|||
130396173|NCT02777125|469418742|FG000|Overall Study|Assent form violation|21|||
130396174|NCT02777125|469418743|FG001|Overall Study|Assent form violation|23|||
130396175|NCT02777125|469418742|FG000|Overall Study|Protocol Violation|8|||
130396176|NCT02777125|469418743|FG001|Overall Study|Protocol Violation|12|||
130396177|NCT06023394|469418744|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
130396178|NCT06023394|469418745|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
130396179|NCT06023394|469418744|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
130396180|NCT06023394|469418745|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
130396181|NCT06023394|469418744|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
130396182|NCT06023394|469418745|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
130396183|NCT06023394|469418744|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
130396184|NCT06023394|469418745|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
130396185|NCT01581593|469420190|FG000|Overall Study|Withdrawal by Subject|1|||
130396186|NCT02970968|469420192|FG000|Overall Study|Withdrawal by Subject|3|||
130396187|NCT02970968|469420193|FG001|Overall Study|Withdrawal by Subject|3|||
130396188|NCT02970968|469420192|FG000|Overall Study|Adverse Event|1|||
130396189|NCT02970968|469420193|FG001|Overall Study|Adverse Event|2|||
130396190|NCT02970968|469420192|FG000|Overall Study|Lost to Follow-up|1|||
130396191|NCT02970968|469420193|FG001|Overall Study|Lost to Follow-up|1|||
130396192|NCT02970968|469420192|FG000|Overall Study|Non-Compliance|0|||
130396193|NCT02970968|469420193|FG001|Overall Study|Non-Compliance|1|||
130396194|NCT02565381|469420194|FG000|Overall Study|Lost to Follow-up|1|||
130396195|NCT02565381|469420195|FG001|Overall Study|Lost to Follow-up|0|||
130396196|NCT02565381|469420196|FG002|Overall Study|Lost to Follow-up|1|||
130396197|NCT05084053|469420199|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
130396198|NCT05084053|469420200|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130396199|NCT05084053|469420201|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130396200|NCT05084053|469420202|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130396201|NCT05084053|469420199|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
130396202|NCT05084053|469420200|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
130396203|NCT05084053|469420201|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
130470609|NCT03547908|469690767|FG002|Blinded Phase|Adverse Event|0|||
130396204|NCT05084053|469420202|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
130396205|NCT05084053|469420199|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
130396206|NCT05084053|469420200|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
130396207|NCT05084053|469420201|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
130396208|NCT05084053|469420202|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
130396209|NCT00071812|469420203|FG000|24-Week Double-Blind Period|Adverse Event|2|||
130396210|NCT00071812|469420204|FG001|24-Week Double-Blind Period|Adverse Event|3|||
130396211|NCT00071812|469420205|FG002|24-Week Double-Blind Period|Adverse Event|4|||
130396212|NCT00071812|469420206|FG003|24-Week Double-Blind Period|Adverse Event|4|||
130396213|NCT00071812|469420203|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
130396214|NCT00071812|469420204|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
130396215|NCT00071812|469420205|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
130396216|NCT00071812|469420206|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
130396217|NCT00071812|469420203|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
130396218|NCT00071812|469420204|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
130396219|NCT00071812|469420205|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
130396220|NCT00071812|469420206|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130396221|NCT00071812|469420203|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
130396222|NCT00071812|469420204|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
130396223|NCT00071812|469420205|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
130396224|NCT00071812|469420206|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
130396225|NCT00071812|469420203|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
130396226|NCT00071812|469420204|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
130396227|NCT00071812|469420205|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
130396228|NCT00071812|469420206|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
130396229|NCT00071812|469420203|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
130396230|NCT00071812|469420204|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
130396231|NCT00071812|469420205|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
130396232|NCT00071812|469420206|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
130396233|NCT00071812|469420203|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130396234|NCT00071812|469420204|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130396235|NCT00071812|469420205|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130396236|NCT00071812|469420206|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
130396237|NCT00071812|469420203|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130396238|NCT00071812|469420204|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130396239|NCT00071812|469420205|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130396240|NCT00071812|469420206|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
130396241|NCT00071812|469420203|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130396242|NCT00071812|469420204|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130396243|NCT00071812|469420205|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130396244|NCT00071812|469420206|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
130396245|NCT00071812|469420203|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130396246|NCT00071812|469420204|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130396247|NCT00071812|469420205|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
130396248|NCT00071812|469420206|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
130396249|NCT04127786|469420211|FG000|Primary Series|Adverse Event|1|||
130396250|NCT04127786|469420212|FG001|Primary Series|Adverse Event|0|||
130396251|NCT04127786|469420213|FG002|Primary Series|Adverse Event|0|||
130396252|NCT04127786|469420214|FG003|Primary Series|Adverse Event|1|||
130396253|NCT04127786|469420215|FG004|Primary Series|Adverse Event|0|||
130396254|NCT04127786|469420216|FG005|Primary Series|Adverse Event|1|||
130396255|NCT04127786|469420211|FG000|Primary Series|Protocol Violation|5|||
130396256|NCT04127786|469420212|FG001|Primary Series|Protocol Violation|3|||
130396257|NCT04127786|469420213|FG002|Primary Series|Protocol Violation|4|||
130396258|NCT04127786|469420214|FG003|Primary Series|Protocol Violation|3|||
130396259|NCT04127786|469420215|FG004|Primary Series|Protocol Violation|2|||
130396260|NCT04127786|469420216|FG005|Primary Series|Protocol Violation|0|||
130396261|NCT04127786|469420211|FG000|Primary Series|Withdrawal by Subject|0|||
130723204|NCT02754856|470611375|FG000|Overall Study|Withdrawal by Subject|1|||
130723205|NCT00530218|470611376|FG000|Overall Study|CMV Not Detected|13|||
130723206|NCT00530218|470611376|FG000|Overall Study|Death|12|||
130723207|NCT03477903|470611377|FG000|Overall Study|Study Terminated by Sponsor|1|||
130723208|NCT00426361|470611378|FG000|Overall Study|Lost to Follow-up|3|||
130723209|NCT00426361|470611379|FG001|Overall Study|Lost to Follow-up|2|||
130723210|NCT00426361|470611380|FG002|Overall Study|Lost to Follow-up|5|||
130723211|NCT00426361|470611378|FG000|Overall Study|Withdrawal by Subject|1|||
130723212|NCT00426361|470611379|FG001|Overall Study|Withdrawal by Subject|3|||
130396262|NCT04127786|469420212|FG001|Primary Series|Withdrawal by Subject|0|||
130396263|NCT04127786|469420213|FG002|Primary Series|Withdrawal by Subject|0|||
130396264|NCT04127786|469420214|FG003|Primary Series|Withdrawal by Subject|1|||
130396265|NCT04127786|469420215|FG004|Primary Series|Withdrawal by Subject|0|||
130723213|NCT00426361|470611380|FG002|Overall Study|Withdrawal by Subject|0|||
130396266|NCT04127786|469420216|FG005|Primary Series|Withdrawal by Subject|0|||
130396267|NCT04127786|469420211|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
130396268|NCT04127786|469420212|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
130396269|NCT04127786|469420213|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
130396270|NCT04127786|469420214|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
130396271|NCT04127786|469420215|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
130396272|NCT04127786|469420216|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
130396273|NCT04127786|469420211|FG000|Booster Phase|Withdrawal by Subject|2|||
130396274|NCT04127786|469420212|FG001|Booster Phase|Withdrawal by Subject|0|||
130396275|NCT04127786|469420213|FG002|Booster Phase|Withdrawal by Subject|0|||
130396276|NCT04127786|469420214|FG003|Booster Phase|Withdrawal by Subject|0|||
130396277|NCT04127786|469420215|FG004|Booster Phase|Withdrawal by Subject|0|||
130396278|NCT04127786|469420216|FG005|Booster Phase|Withdrawal by Subject|0|||
130396279|NCT03568942|469420219|FG000|Overall Study|Family emergency|1|||
130396280|NCT03568942|469420219|FG000|Overall Study|Lost to Follow-up|1|||
130396281|NCT01945489|469420220|FG000|Cycle 1|Adverse Event|2|||
130396282|NCT01945489|469420221|FG001|Cycle 1|Adverse Event|0|||
130396283|NCT01945489|469420220|FG000|Cycle 1|Lost to Follow-up|4|||
130396284|NCT01945489|469420221|FG001|Cycle 1|Lost to Follow-up|0|||
130396285|NCT01945489|469420220|FG000|Cycle 1|Personal Reasons|4|||
130396286|NCT01945489|469420221|FG001|Cycle 1|Personal Reasons|2|||
130396287|NCT01945489|469420220|FG000|Cycle 1|Protocol Violation|0|||
130396288|NCT01945489|469420221|FG001|Cycle 1|Protocol Violation|1|||
130396289|NCT01945489|469420220|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
130396290|NCT01945489|469420221|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
130396291|NCT01945489|469420220|FG000|Cycle 2|Adverse Event|1|||
130396292|NCT01945489|469420221|FG001|Cycle 2|Adverse Event|0|||
130396293|NCT01945489|469420220|FG000|Cycle 2|Lost to Follow-up|0|||
130396294|NCT01945489|469420221|FG001|Cycle 2|Lost to Follow-up|1|||
130396295|NCT00358527|469420222|FG000|Overall Study|Adverse Event|4|||
130396296|NCT00358527|469420223|FG001|Overall Study|Adverse Event|0|||
130396297|NCT00358527|469420222|FG000|Overall Study|Withdrawal by Subject|1|||
130396298|NCT00358527|469420223|FG001|Overall Study|Withdrawal by Subject|1|||
130396299|NCT00358527|469420222|FG000|Overall Study|Non-compliance with protocol|6|||
130396300|NCT00358527|469420223|FG001|Overall Study|Non-compliance with protocol|1|||
130396301|NCT00358527|469420222|FG000|Overall Study|Administrative|2|||
130396302|NCT00358527|469420223|FG001|Overall Study|Administrative|1|||
130396303|NCT04144166|469420226|FG000|Overall Study|Discharged before study start|1|||
130396304|NCT04144166|469420226|FG000|Overall Study|Pregnancy|1|||
130396305|NCT04144166|469420226|FG000|Overall Study|Nail polish could not be removed from finger|1|||
130396306|NCT00749463|469420227|FG000|Overall Study|Adverse Event|0|||
130396307|NCT00749463|469420228|FG001|Overall Study|Adverse Event|4|||
130396308|NCT00749463|469420229|FG002|Overall Study|Adverse Event|1|||
130396309|NCT00749463|469420227|FG000|Overall Study|Withdrawal by Subject|1|||
130396310|NCT00749463|469420228|FG001|Overall Study|Withdrawal by Subject|0|||
130396311|NCT00749463|469420229|FG002|Overall Study|Withdrawal by Subject|0|||
130396312|NCT03569371|469420230|FG000|Overall Study|Lack of Efficacy|1|||
130396313|NCT03569371|469420230|FG000|Overall Study|Lost to Follow-up|1|||
130396314|NCT03569371|469420230|FG000|Overall Study|Adverse Event|1|||
130723214|NCT02478320|470611381|FG000|Overall Study|Adverse Event|2|||
130396315|NCT04145895|469420231|FG000|Overall Study|Physician Decision|2|||
130396316|NCT04145895|469420232|FG001|Overall Study|Physician Decision|0|||
130396317|NCT04145895|469420231|FG000|Overall Study|Withdrawal by Subject|0|||
130396318|NCT04145895|469420232|FG001|Overall Study|Withdrawal by Subject|2|||
130396319|NCT01236755|469420233|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
130723215|NCT02478320|470611382|FG001|Overall Study|Adverse Event|0|||
130723216|NCT02478320|470611381|FG000|Overall Study|Death|1|||
130723217|NCT02478320|470611382|FG001|Overall Study|Death|0|||
130723218|NCT02478320|470611381|FG000|Overall Study|Lack of Efficacy|4|||
130396320|NCT01236755|469420233|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
130396321|NCT01236755|469420233|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
130396322|NCT01236755|469420233|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
130723219|NCT02478320|470611382|FG001|Overall Study|Lack of Efficacy|0|||
130723220|NCT02478320|470611381|FG000|Overall Study|Withdrawal by Subject|2|||
130723221|NCT02478320|470611382|FG001|Overall Study|Withdrawal by Subject|0|||
130396323|NCT00805935|469420234|FG000|Overall Study|Stimulation Failure|1|||
130396324|NCT00805935|469420235|FG001|Overall Study|Stimulation Failure|5|||
130396325|NCT00805935|469420236|FG002|Overall Study|Stimulation Failure|2|||
130396326|NCT00805935|469420237|FG003|Overall Study|Stimulation Failure|2|||
130396327|NCT00805935|469420234|FG000|Overall Study|Cycle cancelled|0|||
130396328|NCT00805935|469420235|FG001|Overall Study|Cycle cancelled|0|||
130396329|NCT00805935|469420236|FG002|Overall Study|Cycle cancelled|2|||
130723222|NCT02478320|470611381|FG000|Overall Study|Screen Failure|3|||
130723223|NCT02478320|470611382|FG001|Overall Study|Screen Failure|0|||
130396330|NCT00805935|469420237|FG003|Overall Study|Cycle cancelled|0|||
130396331|NCT00805935|469420234|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
130396332|NCT00805935|469420235|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
130396333|NCT00805935|469420236|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
130396334|NCT00805935|469420237|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
130396335|NCT00805935|469420234|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130396336|NCT00805935|469420235|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130396337|NCT00805935|469420236|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130396338|NCT00805935|469420237|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
130396339|NCT00805935|469420234|FG000|Overall Study|Lost to Follow-up|1|||
130396340|NCT00805935|469420235|FG001|Overall Study|Lost to Follow-up|0|||
130396341|NCT00805935|469420236|FG002|Overall Study|Lost to Follow-up|0|||
130396342|NCT00805935|469420237|FG003|Overall Study|Lost to Follow-up|0|||
130396343|NCT00805935|469420234|FG000|Overall Study|No positive serum pregnancy|8|||
130396344|NCT00805935|469420235|FG001|Overall Study|No positive serum pregnancy|7|||
130396345|NCT00805935|469420236|FG002|Overall Study|No positive serum pregnancy|6|||
130396346|NCT00805935|469420237|FG003|Overall Study|No positive serum pregnancy|5|||
130396347|NCT00805935|469420234|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130396348|NCT00805935|469420235|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130396349|NCT00805935|469420236|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130396350|NCT00805935|469420237|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130396351|NCT00805935|469420234|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
130396352|NCT00805935|469420235|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
130723224|NCT03255655|470611383|FG000|Overall Study|Lost to Follow-up|7|||
130723225|NCT03255655|470611384|FG001|Overall Study|Lost to Follow-up|4|||
130723226|NCT04428333|470611387|FG000|Overall Study|Physician Decision|5|||
130723227|NCT04428333|470611388|FG001|Overall Study|Physician Decision|6|||
130723228|NCT04428333|470611387|FG000|Overall Study|Withdrawal by Subject|1|||
130723229|NCT04428333|470611388|FG001|Overall Study|Withdrawal by Subject|3|||
130723230|NCT04428333|470611387|FG000|Overall Study|Study Terminated By Sponsor|14|||
130723231|NCT04428333|470611388|FG001|Overall Study|Study Terminated By Sponsor|16|||
130723232|NCT04853992|470611389|FG000|Treatment Period A|Adverse Event|0|||
130723233|NCT04853992|470611390|FG001|Treatment Period A|Adverse Event|1|||
130723234|NCT04853992|470611389|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
130723235|NCT04853992|470611390|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
130723236|NCT03582826|470611391|FG000|Overall Study|Lost to Follow-up|39|||
130723237|NCT03582826|470611392|FG001|Overall Study|Lost to Follow-up|0|||
130723238|NCT03582826|470611391|FG000|Overall Study|Withdrawal by Subject|2|||
130723239|NCT03582826|470611392|FG001|Overall Study|Withdrawal by Subject|0|||
130723240|NCT02269163|470611393|FG000|Overall Study|Lost to Follow-up|1|||
130723241|NCT02269163|470611394|FG001|Overall Study|Lost to Follow-up|0|||
130723242|NCT02269163|470611393|FG000|Overall Study|Major protocol violation|0|||
130723243|NCT02269163|470611394|FG001|Overall Study|Major protocol violation|1|||
130723244|NCT02269163|470611393|FG000|Overall Study|Other|2|||
130723245|NCT02269163|470611394|FG001|Overall Study|Other|2|||
130723246|NCT02269163|470611393|FG000|Overall Study|Withdrawal by Subject|0|||
130723247|NCT02269163|470611394|FG001|Overall Study|Withdrawal by Subject|3|||
130723248|NCT02269163|470611393|FG000|Overall Study|Physician Decision|0|||
130723249|NCT02269163|470611394|FG001|Overall Study|Physician Decision|1|||
130723250|NCT03480386|470611395|FG000|Overall Study|Did not complete measures at 3-months|17|||
130396353|NCT00805935|469420236|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
130396354|NCT00805935|469420237|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
130396355|NCT00805935|469420234|FG000|Overall Study|Biochemical pregnancy|0|||
130396356|NCT00805935|469420235|FG001|Overall Study|Biochemical pregnancy|1|||
130396357|NCT00805935|469420236|FG002|Overall Study|Biochemical pregnancy|0|||
130396358|NCT00805935|469420237|FG003|Overall Study|Biochemical pregnancy|0|||
130396359|NCT00805935|469420234|FG000|Overall Study|Chemical pregnancy|0|||
130396360|NCT00805935|469420235|FG001|Overall Study|Chemical pregnancy|5|||
130396361|NCT00805935|469420236|FG002|Overall Study|Chemical pregnancy|3|||
130396362|NCT00805935|469420237|FG003|Overall Study|Chemical pregnancy|2|||
130723251|NCT03480386|470611396|FG001|Overall Study|Did not complete measures at 3-months|14|||
130396363|NCT00805935|469420234|FG000|Overall Study|Ectopic pregnancy|0|||
130396364|NCT00805935|469420235|FG001|Overall Study|Ectopic pregnancy|0|||
130396365|NCT00805935|469420236|FG002|Overall Study|Ectopic pregnancy|1|||
130396366|NCT00805935|469420237|FG003|Overall Study|Ectopic pregnancy|0|||
130396367|NCT00805935|469420234|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130396368|NCT00805935|469420235|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
130396369|NCT00805935|469420236|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130396370|NCT00805935|469420237|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130396371|NCT04904185|469420238|FG000|Overall Study|Expansion failure|1|||
130723252|NCT03480386|470611395|FG000|Overall Study|No baseline measures|11|||
130723253|NCT03480386|470611396|FG001|Overall Study|No baseline measures|14|||
130723254|NCT03480386|470611395|FG000|Overall Study|Death|0|||
130723255|NCT03480386|470611396|FG001|Overall Study|Death|5|||
130723256|NCT03480386|470611395|FG000|Overall Study|Withdrawal by Subject|12|||
130723257|NCT03480386|470611396|FG001|Overall Study|Withdrawal by Subject|8|||
130396372|NCT04904185|469420239|FG001|Overall Study|Expansion failure|0|||
130396373|NCT04904185|469420238|FG000|Overall Study|Late response on prior treatment|1|||
130396374|NCT04904185|469420239|FG001|Overall Study|Late response on prior treatment|0|||
130396375|NCT02433834|469420243|FG000|Overall Study|Protocol-specified criteria|7|||
130396376|NCT02433834|469420243|FG000|Overall Study|Protocol Violation|3|||
130396377|NCT02433834|469420243|FG000|Overall Study|Lost to Follow-up|6|||
130396378|NCT02433834|469420243|FG000|Overall Study|Withdrawal by Subject|14|||
130396379|NCT02433834|469420243|FG000|Overall Study|Adverse Event|6|||
130396380|NCT02433834|469420243|FG000|Overall Study|Physician Decision|1|||
130396381|NCT05288556|469420251|FG000|Overall Study|Protocol Violation|1|||
130396382|NCT05288556|469420251|FG000|Overall Study|Withdrawal by Subject|1|||
130396383|NCT02775344|469420252|FG000|Overall Study|No ovarian cyst identified|3|||
130396384|NCT02775344|469420253|FG001|Overall Study|No ovarian cyst identified|2|||
130396385|NCT04627064|469420254|FG000|Overall Study|Progressive disease|8|||
130396386|NCT04627064|469420255|FG001|Overall Study|Progressive disease|0|||
130396387|NCT04627064|469420254|FG000|Overall Study|Withdrawal by Subject|2|||
130396388|NCT04627064|469420255|FG001|Overall Study|Withdrawal by Subject|0|||
130396389|NCT04627064|469420254|FG000|Overall Study|Physician Decision|1|||
130396390|NCT04627064|469420255|FG001|Overall Study|Physician Decision|0|||
130396391|NCT00559962|469420260|FG000|Overall Study|Adverse Event|1|||
130396392|NCT00559962|469420261|FG001|Overall Study|Adverse Event|7|||
130396393|NCT00559962|469420262|FG002|Overall Study|Adverse Event|8|||
130396394|NCT00559962|469420263|FG003|Overall Study|Adverse Event|5|||
130396395|NCT00559962|469420264|FG004|Overall Study|Adverse Event|11|||
130396396|NCT00559962|469420265|FG005|Overall Study|Adverse Event|4|||
130396397|NCT00559962|469420266|FG006|Overall Study|Adverse Event|4|||
130396398|NCT00559962|469420267|FG007|Overall Study|Adverse Event|2|||
130396399|NCT00559962|469420260|FG000|Overall Study|Lost to Follow-up|0|||
130396400|NCT00559962|469420261|FG001|Overall Study|Lost to Follow-up|1|||
130396401|NCT00559962|469420262|FG002|Overall Study|Lost to Follow-up|0|||
130396402|NCT00559962|469420263|FG003|Overall Study|Lost to Follow-up|0|||
130396403|NCT00559962|469420264|FG004|Overall Study|Lost to Follow-up|0|||
130396404|NCT00559962|469420265|FG005|Overall Study|Lost to Follow-up|0|||
130396405|NCT00559962|469420266|FG006|Overall Study|Lost to Follow-up|0|||
130396406|NCT00559962|469420267|FG007|Overall Study|Lost to Follow-up|0|||
130396407|NCT00559962|469420260|FG000|Overall Study|Withdrawal by Subject|1|||
130396408|NCT00559962|469420261|FG001|Overall Study|Withdrawal by Subject|1|||
130396409|NCT00559962|469420262|FG002|Overall Study|Withdrawal by Subject|2|||
130396410|NCT00559962|469420263|FG003|Overall Study|Withdrawal by Subject|0|||
130396411|NCT00559962|469420264|FG004|Overall Study|Withdrawal by Subject|3|||
130396412|NCT00559962|469420265|FG005|Overall Study|Withdrawal by Subject|1|||
130396413|NCT00559962|469420266|FG006|Overall Study|Withdrawal by Subject|0|||
130396414|NCT00559962|469420267|FG007|Overall Study|Withdrawal by Subject|2|||
130396415|NCT00559962|469420260|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130396416|NCT00559962|469420261|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
130396417|NCT00559962|469420262|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130396418|NCT00559962|469420263|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
130396419|NCT00559962|469420264|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
130396420|NCT00559962|469420265|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
130396421|NCT00559962|469420266|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
130396422|NCT00559962|469420267|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
130396423|NCT01461096|469420268|FG000|Overall Study|Death|3|||
130396424|NCT01461096|469420269|FG001|Overall Study|Death|6|||
130396425|NCT01461096|469420268|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130396426|NCT01461096|469420269|FG001|Overall Study|Severe debilitation, unable to continue|1|||
130396427|NCT01461096|469420268|FG000|Overall Study|Subj not able to get to clinic|15|||
130396428|NCT01461096|469420269|FG001|Overall Study|Subj not able to get to clinic|13|||
130396429|NCT01461096|469420268|FG000|Overall Study|Site is closing|27|||
130396430|NCT01461096|469420269|FG001|Overall Study|Site is closing|30|||
130396431|NCT01461096|469420268|FG000|Overall Study|Withdrawal by Subject|5|||
130396432|NCT01461096|469420269|FG001|Overall Study|Withdrawal by Subject|3|||
130396433|NCT01461096|469420268|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
130396434|NCT01461096|469420269|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
130396435|NCT01461096|469420268|FG000|Overall Study|Lost to Follow-up|8|||
130396436|NCT01461096|469420269|FG001|Overall Study|Lost to Follow-up|4|||
130396437|NCT01452412|469420275|FG000|Overall Study|Withdrawal by Subject|15|||
130396438|NCT01452412|469420276|FG001|Overall Study|Withdrawal by Subject|11|||
130396439|NCT01452412|469420275|FG000|Overall Study|Adverse Event|4|||
130560001|NCT04411628|470017922|FG000|Overall Study|Lost to Follow-up|0|||
130396440|NCT01452412|469420276|FG001|Overall Study|Adverse Event|3|||
130396441|NCT01452412|469420275|FG000|Overall Study|Lost to Follow-up|5|||
130396442|NCT01452412|469420276|FG001|Overall Study|Lost to Follow-up|3|||
130396443|NCT01452412|469420275|FG000|Overall Study|Death|1|||
130396444|NCT01452412|469420276|FG001|Overall Study|Death|0|||
130396445|NCT01452412|469420275|FG000|Overall Study|Initiated dialysis|1|||
130396446|NCT01452412|469420276|FG001|Overall Study|Initiated dialysis|0|||
130560002|NCT04411628|470017923|FG001|Overall Study|Lost to Follow-up|1|||
130396447|NCT01452412|469420275|FG000|Overall Study|Other|2|||
130396448|NCT01452412|469420276|FG001|Overall Study|Other|0|||
130396449|NCT03047135|469420277|FG000|Overall Study|Still being treated|3|||
130396450|NCT03013543|469420278|FG000|Overall Study|Withdrawal by Subject|0|||
130396451|NCT03013543|469420279|FG001|Overall Study|Withdrawal by Subject|2|||
130396452|NCT03013543|469420280|FG002|Overall Study|Withdrawal by Subject|0|||
130396453|NCT03013543|469420281|FG003|Overall Study|Withdrawal by Subject|5|||
130396454|NCT03013543|469420282|FG004|Overall Study|Withdrawal by Subject|6|||
130396455|NCT03013543|469420283|FG005|Overall Study|Withdrawal by Subject|2|||
130396456|NCT03013543|469420284|FG006|Overall Study|Withdrawal by Subject|3|||
130396457|NCT03013543|469420285|FG007|Overall Study|Withdrawal by Subject|1|||
130396458|NCT03013543|469420286|FG008|Overall Study|Withdrawal by Subject|0|||
130396459|NCT03013543|469420287|FG009|Overall Study|Withdrawal by Subject|4|||
130396460|NCT03013543|469420278|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130396461|NCT03013543|469420279|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130396462|NCT03013543|469420280|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130396463|NCT03013543|469420281|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
130396464|NCT03013543|469420282|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
130396465|NCT03013543|469420283|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130396466|NCT03013543|469420284|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
130396467|NCT03013543|469420285|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
130396468|NCT03013543|469420286|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
130396469|NCT03013543|469420287|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
130396470|NCT03013543|469420278|FG000|Overall Study|Other|0|||
130396471|NCT03013543|469420279|FG001|Overall Study|Other|0|||
130396472|NCT03013543|469420280|FG002|Overall Study|Other|2|||
130396473|NCT03013543|469420281|FG003|Overall Study|Other|0|||
130723258|NCT03480386|470611395|FG000|Overall Study|Lost to Follow-up|2|||
130723259|NCT03480386|470611396|FG001|Overall Study|Lost to Follow-up|1|||
130396474|NCT03013543|469420282|FG004|Overall Study|Other|2|||
130396475|NCT03013543|469420283|FG005|Overall Study|Other|0|||
130396476|NCT03013543|469420284|FG006|Overall Study|Other|0|||
130396477|NCT03013543|469420285|FG007|Overall Study|Other|0|||
130396478|NCT03013543|469420286|FG008|Overall Study|Other|1|||
130396479|NCT03013543|469420287|FG009|Overall Study|Other|0|||
130396480|NCT03013543|469420278|FG000|Overall Study|Adverse Event|0|||
130396481|NCT03013543|469420279|FG001|Overall Study|Adverse Event|0|||
130396482|NCT03013543|469420280|FG002|Overall Study|Adverse Event|0|||
130396483|NCT03013543|469420281|FG003|Overall Study|Adverse Event|3|||
130396484|NCT03013543|469420282|FG004|Overall Study|Adverse Event|2|||
130396485|NCT03013543|469420283|FG005|Overall Study|Adverse Event|1|||
130396486|NCT03013543|469420284|FG006|Overall Study|Adverse Event|3|||
130396487|NCT03013543|469420285|FG007|Overall Study|Adverse Event|8|||
130396488|NCT03013543|469420286|FG008|Overall Study|Adverse Event|0|||
130396489|NCT03013543|469420287|FG009|Overall Study|Adverse Event|2|||
130396490|NCT03013543|469420278|FG000|Overall Study|Death|0|||
130396491|NCT03013543|469420279|FG001|Overall Study|Death|0|||
130396492|NCT03013543|469420280|FG002|Overall Study|Death|0|||
130396493|NCT03013543|469420281|FG003|Overall Study|Death|1|||
130396494|NCT03013543|469420282|FG004|Overall Study|Death|0|||
130396495|NCT03013543|469420283|FG005|Overall Study|Death|0|||
130396496|NCT03013543|469420284|FG006|Overall Study|Death|0|||
130396497|NCT03013543|469420285|FG007|Overall Study|Death|0|||
130396498|NCT03013543|469420286|FG008|Overall Study|Death|0|||
130396499|NCT03013543|469420287|FG009|Overall Study|Death|0|||
130396500|NCT03013543|469420278|FG000|Overall Study|Lack of Efficacy|0|||
130396501|NCT03013543|469420279|FG001|Overall Study|Lack of Efficacy|0|||
130396502|NCT03013543|469420280|FG002|Overall Study|Lack of Efficacy|0|||
130396503|NCT03013543|469420281|FG003|Overall Study|Lack of Efficacy|1|||
130396504|NCT03013543|469420282|FG004|Overall Study|Lack of Efficacy|0|||
130396505|NCT03013543|469420283|FG005|Overall Study|Lack of Efficacy|0|||
130396506|NCT03013543|469420284|FG006|Overall Study|Lack of Efficacy|0|||
130396507|NCT03013543|469420285|FG007|Overall Study|Lack of Efficacy|0|||
130396508|NCT03013543|469420286|FG008|Overall Study|Lack of Efficacy|0|||
130396509|NCT03013543|469420287|FG009|Overall Study|Lack of Efficacy|0|||
130396510|NCT03013543|469420278|FG000|Overall Study|Lost to Follow-up|0|||
130396511|NCT03013543|469420279|FG001|Overall Study|Lost to Follow-up|0|||
130470610|NCT03547908|469690768|FG003|Blinded Phase|Adverse Event|0|||
130470611|NCT03547908|469690765|FG000|Blinded Phase|Randomized But Never Treated|1|||
130470612|NCT03547908|469690766|FG001|Blinded Phase|Randomized But Never Treated|0|||
130470613|NCT03547908|469690767|FG002|Blinded Phase|Randomized But Never Treated|0|||
130470614|NCT03547908|469690768|FG003|Blinded Phase|Randomized But Never Treated|0|||
130470615|NCT03547908|469690765|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
130470616|NCT03547908|469690766|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
130470617|NCT03547908|469690767|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
130470618|NCT03547908|469690768|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
130470619|NCT03547908|469690765|FG000|Open-label Extension Phase|Death|0|||
130470620|NCT03547908|469690766|FG001|Open-label Extension Phase|Death|0|||
130396512|NCT03013543|469420280|FG002|Overall Study|Lost to Follow-up|0|||
130396513|NCT03013543|469420281|FG003|Overall Study|Lost to Follow-up|1|||
130396514|NCT03013543|469420282|FG004|Overall Study|Lost to Follow-up|0|||
130396515|NCT03013543|469420283|FG005|Overall Study|Lost to Follow-up|0|||
130396516|NCT03013543|469420284|FG006|Overall Study|Lost to Follow-up|1|||
130396517|NCT03013543|469420285|FG007|Overall Study|Lost to Follow-up|0|||
130396518|NCT03013543|469420286|FG008|Overall Study|Lost to Follow-up|0|||
130396519|NCT03013543|469420287|FG009|Overall Study|Lost to Follow-up|2|||
130396520|NCT03013543|469420278|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130396521|NCT03013543|469420279|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130396522|NCT03013543|469420280|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130396523|NCT03013543|469420281|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130396524|NCT03013543|469420282|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130396525|NCT03013543|469420283|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130396526|NCT03013543|469420284|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130396527|NCT03013543|469420285|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130396528|NCT03013543|469420286|FG008|Overall Study|Non-Compliance With Study Drug|1|||
130396529|NCT03013543|469420287|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130396530|NCT03013543|469420278|FG000|Overall Study|Physician Decision|0|||
130396531|NCT03013543|469420279|FG001|Overall Study|Physician Decision|0|||
130396532|NCT03013543|469420280|FG002|Overall Study|Physician Decision|0|||
130396533|NCT03013543|469420281|FG003|Overall Study|Physician Decision|0|||
130396534|NCT03013543|469420282|FG004|Overall Study|Physician Decision|1|||
130396535|NCT03013543|469420283|FG005|Overall Study|Physician Decision|0|||
130396536|NCT03013543|469420284|FG006|Overall Study|Physician Decision|0|||
130396537|NCT03013543|469420285|FG007|Overall Study|Physician Decision|0|||
130396538|NCT03013543|469420286|FG008|Overall Study|Physician Decision|0|||
130396539|NCT03013543|469420287|FG009|Overall Study|Physician Decision|0|||
130396540|NCT03013543|469420278|FG000|Overall Study|Protocol Violation|0|||
130396541|NCT03013543|469420279|FG001|Overall Study|Protocol Violation|0|||
130396542|NCT03013543|469420280|FG002|Overall Study|Protocol Violation|0|||
130396543|NCT03013543|469420281|FG003|Overall Study|Protocol Violation|0|||
130396544|NCT03013543|469420282|FG004|Overall Study|Protocol Violation|0|||
130396545|NCT03013543|469420283|FG005|Overall Study|Protocol Violation|0|||
130396546|NCT03013543|469420284|FG006|Overall Study|Protocol Violation|0|||
130396547|NCT03013543|469420285|FG007|Overall Study|Protocol Violation|0|||
130396548|NCT03013543|469420286|FG008|Overall Study|Protocol Violation|0|||
130396549|NCT03013543|469420287|FG009|Overall Study|Protocol Violation|1|||
130396550|NCT01537783|469420294|FG000|Overall Study|Lost to Follow-up|11|||
130396551|NCT01537783|469420295|FG001|Overall Study|Lost to Follow-up|2|||
130396552|NCT02722928|469420298|FG000|Overall Study|Standard CT was not as required per prot|5|||
130396553|NCT02722928|469420299|FG001|Overall Study|Standard CT was not as required per prot|13|||
130396554|NCT02722928|469420298|FG000|Overall Study|Required Intraoperative MRI|5|||
130396555|NCT02722928|469420299|FG001|Overall Study|Required Intraoperative MRI|7|||
130396556|NCT01838642|469420300|FG000|Overall Study|Died on study|1|||
130396557|NCT01398956|469420301|FG000|Overall Study|Withdrawal by Subject|4|||
130396558|NCT01398956|469420301|FG000|Overall Study|AE, non-serious non-fatal|4|||
130396559|NCT01398956|469420301|FG000|Overall Study|Withdrawal Criteria No.3|1|||
130396560|NCT01398956|469420301|FG000|Overall Study|Subject moved a long distance|1|||
130396561|NCT01557400|469420302|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
130396562|NCT01557400|469420302|FG000|Overall Study|Adverse Event|3|||
130396563|NCT01557400|469420302|FG000|Overall Study|Lost to Follow-up|5|||
130396564|NCT01557400|469420302|FG000|Overall Study|Withdrawal by Subject|9|||
130396565|NCT02281552|469420305|FG000|Overall Study|Medication error|1|||
130396566|NCT02281552|469420306|FG001|Overall Study|Medication error|0|||
130396567|NCT02281552|469420305|FG000|Overall Study|Insufficient clinical response|0|||
130396568|NCT02281552|469420306|FG001|Overall Study|Insufficient clinical response|1|||
130396569|NCT02281552|469420305|FG000|Overall Study|Adverse Event|3|||
130396570|NCT02281552|469420306|FG001|Overall Study|Adverse Event|9|||
130396571|NCT01224639|469420307|FG000|Overall Study|Withdrawal by Subject|0|||
130396572|NCT01224639|469420308|FG001|Overall Study|Withdrawal by Subject|0|||
130396573|NCT01224639|469420309|FG002|Overall Study|Withdrawal by Subject|0|||
130396574|NCT01224639|469420310|FG003|Overall Study|Withdrawal by Subject|0|||
130396575|NCT01224639|469420311|FG004|Overall Study|Withdrawal by Subject|2|||
130396576|NCT01224639|469420312|FG005|Overall Study|Withdrawal by Subject|0|||
130396577|NCT01224639|469420313|FG006|Overall Study|Withdrawal by Subject|1|||
130396578|NCT01224639|469420314|FG007|Overall Study|Withdrawal by Subject|1|||
130396579|NCT01224639|469420307|FG000|Overall Study|Adverse Event|0|||
130396580|NCT01224639|469420308|FG001|Overall Study|Adverse Event|0|||
130396581|NCT01224639|469420309|FG002|Overall Study|Adverse Event|0|||
130396582|NCT01224639|469420310|FG003|Overall Study|Adverse Event|0|||
130396583|NCT01224639|469420311|FG004|Overall Study|Adverse Event|0|||
130396584|NCT01224639|469420312|FG005|Overall Study|Adverse Event|0|||
130396585|NCT01224639|469420313|FG006|Overall Study|Adverse Event|0|||
130396586|NCT01224639|469420314|FG007|Overall Study|Adverse Event|1|||
130396587|NCT03465878|469420315|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130470621|NCT03547908|469690767|FG002|Open-label Extension Phase|Death|1|||
130396588|NCT03465878|469420316|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
130396589|NCT03465878|469420317|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130396590|NCT03465878|469420318|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130396591|NCT03465878|469420315|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130396592|NCT03465878|469420316|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130396593|NCT03465878|469420317|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130396594|NCT03465878|469420318|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
130396595|NCT03465878|469420315|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130396596|NCT03465878|469420316|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130396597|NCT03465878|469420317|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130396598|NCT03465878|469420318|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
130396599|NCT04656132|469420319|FG000|Overall Study|Lost to Follow-up|4|||
130396600|NCT04656132|469420319|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
130396601|NCT04365699|469420320|FG000|Overall Study|Death|2|||
130396602|NCT04365699|469420321|FG001|Overall Study|Death|5|||
130396603|NCT04365699|469420322|FG002|Overall Study|Death|15|||
130396604|NCT02540954|469420323|FG000|Overall Study|Physician Decision|3|||
130396605|NCT02540954|469420324|FG001|Overall Study|Physician Decision|1|||
130396606|NCT02540954|469420323|FG000|Overall Study|Withdrawal by Subject|6|||
130396607|NCT02540954|469420324|FG001|Overall Study|Withdrawal by Subject|5|||
130396608|NCT02540954|469420323|FG000|Overall Study|Lost to Follow-up|1|||
130396609|NCT02540954|469420324|FG001|Overall Study|Lost to Follow-up|1|||
130396610|NCT02540954|469420323|FG000|Overall Study|Adverse Event|4|||
130396611|NCT02540954|469420324|FG001|Overall Study|Adverse Event|2|||
130396612|NCT02540954|469420323|FG000|Overall Study|Death|0|||
130396613|NCT02540954|469420324|FG001|Overall Study|Death|3|||
130396614|NCT02540954|469420323|FG000|Overall Study|Treatment failure|1|||
130396615|NCT02540954|469420324|FG001|Overall Study|Treatment failure|0|||
130396616|NCT02540954|469420323|FG000|Overall Study|Other reason|4|||
130396617|NCT02540954|469420324|FG001|Overall Study|Other reason|2|||
130396618|NCT00834912|469420327|FG000|Treatment Period 1|Adverse Event|0|||
130396619|NCT00834912|469420328|FG001|Treatment Period 1|Adverse Event|1|||
130396620|NCT00834912|469420329|FG002|Treatment Period 1|Adverse Event|0|||
130396621|NCT00834912|469420330|FG003|Treatment Period 1|Adverse Event|1|||
130396622|NCT00834912|469420331|FG004|Treatment Period 1|Adverse Event|0|||
130396623|NCT00834912|469420332|FG005|Treatment Period 1|Adverse Event|0|||
130396624|NCT00834912|469420327|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130396625|NCT00834912|469420328|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130396626|NCT00834912|469420329|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130396627|NCT00834912|469420330|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130396628|NCT00834912|469420331|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130396629|NCT00834912|469420332|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130396630|NCT03829046|469420333|FG000|Overall Study|Withdrawal by Subject|1|||
130396631|NCT03829046|469420334|FG001|Overall Study|Withdrawal by Subject|0|||
130396632|NCT02643251|469421643|FG000|Overall Study|Adverse Event|3|||
130396633|NCT02643251|469421644|FG001|Overall Study|Adverse Event|1|||
130396634|NCT02643251|469421643|FG000|Overall Study|Withdrawal by Subject|2|||
130396635|NCT02643251|469421644|FG001|Overall Study|Withdrawal by Subject|0|||
130396636|NCT02643251|469421643|FG000|Overall Study|Lost to Follow-up|4|||
130470622|NCT03547908|469690768|FG003|Open-label Extension Phase|Death|0|||
130470623|NCT02152137|469690770|FG000|Overall Study|Withdrawal by Subject|1|||
130470624|NCT02152137|469690770|FG000|Overall Study|Originally assigned to Arm B|3|||
130470625|NCT03358875|469690771|FG000|Overall Study|Death|409|||
130470626|NCT03358875|469690772|FG001|Overall Study|Death|223|||
130470627|NCT03358875|469690771|FG000|Overall Study|Study Closed by Sponsor|66|||
130470628|NCT03358875|469690772|FG001|Overall Study|Study Closed by Sponsor|29|||
130396637|NCT02643251|469421644|FG001|Overall Study|Lost to Follow-up|1|||
130396638|NCT02643251|469421643|FG000|Overall Study|Protocol Violation|1|||
130396639|NCT02643251|469421644|FG001|Overall Study|Protocol Violation|0|||
130396640|NCT02643251|469421643|FG000|Overall Study|PI Decision to terminate patient|1|||
130396641|NCT02643251|469421644|FG001|Overall Study|PI Decision to terminate patient|0|||
130396642|NCT00333229|469421647|FG000|Overall Study|Lack of Efficacy|0|||
130396643|NCT00333229|469421648|FG001|Overall Study|Lack of Efficacy|1|||
130396644|NCT00348556|469421649|FG000|Overall Study|Adverse Event|1|||
130396645|NCT01944059|469421650|FG000|Overall Study|Lost to Follow-up|1|||
130396646|NCT01944059|469421650|FG000|Overall Study|Physician Decision|3|||
130470629|NCT03358875|469690771|FG000|Overall Study|Withdrawal by Subject|13|||
130396647|NCT01944059|469421650|FG000|Overall Study|Withdrawal by Subject|1|||
130396648|NCT01944059|469421650|FG000|Overall Study|Adverse Event|2|||
130396649|NCT02365636|469421651|FG000|Overall Study|Adverse Event|3|||
130396650|NCT02365636|469421652|FG001|Overall Study|Adverse Event|3|||
130396651|NCT02365636|469421653|FG002|Overall Study|Adverse Event|2|||
130396652|NCT02365636|469421651|FG000|Overall Study|Protocol Violation|1|||
130396653|NCT02365636|469421652|FG001|Overall Study|Protocol Violation|4|||
130396654|NCT02365636|469421653|FG002|Overall Study|Protocol Violation|0|||
130396655|NCT02365636|469421651|FG000|Overall Study|Lost to Follow-up|0|||
130396656|NCT02365636|469421652|FG001|Overall Study|Lost to Follow-up|0|||
130396657|NCT02365636|469421653|FG002|Overall Study|Lost to Follow-up|1|||
130396658|NCT02365636|469421651|FG000|Overall Study|Other|2|||
130396659|NCT02365636|469421652|FG001|Overall Study|Other|0|||
130396660|NCT02365636|469421653|FG002|Overall Study|Other|0|||
130396661|NCT00463060|469421656|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
130396662|NCT00463060|469421656|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
130396663|NCT01802775|469421659|FG000|Overall Study|Death|0|||
130396664|NCT01802775|469421660|FG001|Overall Study|Death|3|||
130396665|NCT01802775|469421659|FG000|Overall Study|Reason not provided|0|||
130396666|NCT01802775|469421660|FG001|Overall Study|Reason not provided|1|||
130396667|NCT01802775|469421659|FG000|Overall Study|Physician Decision|1|||
130396668|NCT01802775|469421660|FG001|Overall Study|Physician Decision|0|||
130396669|NCT01802775|469421659|FG000|Overall Study|Adverse Event|1|||
130396670|NCT01802775|469421660|FG001|Overall Study|Adverse Event|1|||
130396671|NCT01802775|469421659|FG000|Overall Study|Withdrawal by Subject|3|||
130396672|NCT01802775|469421660|FG001|Overall Study|Withdrawal by Subject|5|||
130396673|NCT01802775|469421659|FG000|Overall Study|Lost to Follow-up|1|||
130396674|NCT01802775|469421660|FG001|Overall Study|Lost to Follow-up|2|||
130396675|NCT01067352|469421665|FG000|Overall Study|Withdrawal by Subject|1|||
130396676|NCT01067352|469421666|FG001|Overall Study|Withdrawal by Subject|2|||
130396677|NCT01067352|469421667|FG002|Overall Study|Withdrawal by Subject|1|||
130396678|NCT01067352|469421665|FG000|Overall Study|Physician Decision|0|||
130396679|NCT01067352|469421666|FG001|Overall Study|Physician Decision|1|||
130396680|NCT01067352|469421667|FG002|Overall Study|Physician Decision|0|||
130396681|NCT01096784|469421668|FG000|Overall Study|Withdrawal by Subject|2|||
130396682|NCT01096784|469421669|FG001|Overall Study|Withdrawal by Subject|1|||
130396683|NCT01096784|469421668|FG000|Overall Study|Adverse Event|11|||
130396684|NCT01096784|469421669|FG001|Overall Study|Adverse Event|9|||
130396685|NCT01096784|469421668|FG000|Overall Study|Protocol Deviation|2|||
130396686|NCT01096784|469421669|FG001|Overall Study|Protocol Deviation|2|||
130396687|NCT01096784|469421668|FG000|Overall Study|Administrative Decision|0|||
130396688|NCT01096784|469421669|FG001|Overall Study|Administrative Decision|1|||
130396689|NCT01096784|469421668|FG000|Overall Study|Other Unspecified|0|||
130396690|NCT01096784|469421669|FG001|Overall Study|Other Unspecified|1|||
130396691|NCT05923229|469421670|FG000|Overall Study|Withdrawal by Subject|3|||
130396692|NCT05923229|469421671|FG001|Overall Study|Withdrawal by Subject|0|||
130396693|NCT05923229|469421670|FG000|Overall Study|Health related|2|||
130396694|NCT05923229|469421671|FG001|Overall Study|Health related|1|||
130396695|NCT03064126|469421672|FG000|Overall Study|Death|40|||
130396696|NCT03064126|469421673|FG001|Overall Study|Death|16|||
130396697|NCT03064126|469421674|FG002|Overall Study|Death|4|||
130396698|NCT03064126|469421675|FG003|Overall Study|Death|2|||
130396699|NCT03064126|469421672|FG000|Overall Study|Withdrawal by Subject|17|||
130396700|NCT03064126|469421673|FG001|Overall Study|Withdrawal by Subject|9|||
130396701|NCT03064126|469421674|FG002|Overall Study|Withdrawal by Subject|0|||
130396702|NCT03064126|469421675|FG003|Overall Study|Withdrawal by Subject|2|||
130396703|NCT03064126|469421672|FG000|Overall Study|Lost to Follow-up|7|||
130396704|NCT03064126|469421673|FG001|Overall Study|Lost to Follow-up|3|||
130396705|NCT03064126|469421674|FG002|Overall Study|Lost to Follow-up|0|||
130396706|NCT03064126|469421675|FG003|Overall Study|Lost to Follow-up|0|||
130396707|NCT03064126|469421672|FG000|Overall Study|Adverse Event|2|||
130396708|NCT03064126|469421673|FG001|Overall Study|Adverse Event|0|||
130396709|NCT03064126|469421674|FG002|Overall Study|Adverse Event|0|||
130396710|NCT03064126|469421675|FG003|Overall Study|Adverse Event|0|||
130396711|NCT03064126|469421672|FG000|Overall Study|Physician Decision|3|||
130560003|NCT04411628|470017924|FG002|Overall Study|Lost to Follow-up|0|||
130396712|NCT03064126|469421673|FG001|Overall Study|Physician Decision|0|||
130396713|NCT03064126|469421674|FG002|Overall Study|Physician Decision|0|||
130396714|NCT03064126|469421675|FG003|Overall Study|Physician Decision|0|||
130396715|NCT03064126|469421672|FG000|Overall Study|Other reason for early termination|3|||
130396716|NCT03064126|469421673|FG001|Overall Study|Other reason for early termination|2|||
130396717|NCT03064126|469421674|FG002|Overall Study|Other reason for early termination|0|||
130396718|NCT03064126|469421675|FG003|Overall Study|Other reason for early termination|0|||
130396719|NCT03064126|469421672|FG000|Overall Study|Missed Visit|3|||
130396720|NCT03064126|469421673|FG001|Overall Study|Missed Visit|1|||
130396721|NCT03064126|469421674|FG002|Overall Study|Missed Visit|0|||
130396722|NCT03064126|469421675|FG003|Overall Study|Missed Visit|0|||
130396723|NCT02465528|469421676|FG000|Overall Study|Progressive disease|0|||
130396724|NCT02465528|469421677|FG001|Overall Study|Progressive disease|2|||
130396725|NCT02465528|469421678|FG002|Overall Study|Progressive disease|9|||
130396726|NCT02465528|469421679|FG003|Overall Study|Progressive disease|4|||
130396727|NCT02465528|469421676|FG000|Overall Study|Study terminated by sponsor|1|||
130396728|NCT02465528|469421677|FG001|Overall Study|Study terminated by sponsor|2|||
130396729|NCT02465528|469421678|FG002|Overall Study|Study terminated by sponsor|0|||
130396730|NCT02465528|469421679|FG003|Overall Study|Study terminated by sponsor|0|||
130396731|NCT02465528|469421676|FG000|Overall Study|Withdrawal by Subject|0|||
130396732|NCT02465528|469421677|FG001|Overall Study|Withdrawal by Subject|0|||
130396733|NCT02465528|469421678|FG002|Overall Study|Withdrawal by Subject|2|||
130396734|NCT02465528|469421679|FG003|Overall Study|Withdrawal by Subject|0|||
130396735|NCT02465528|469421676|FG000|Overall Study|Adverse Event|0|||
130396736|NCT02465528|469421677|FG001|Overall Study|Adverse Event|0|||
130396737|NCT02465528|469421678|FG002|Overall Study|Adverse Event|0|||
130396738|NCT02465528|469421679|FG003|Overall Study|Adverse Event|1|||
130396739|NCT02465528|469421676|FG000|Overall Study|Physician Decision|0|||
130396740|NCT02465528|469421677|FG001|Overall Study|Physician Decision|0|||
130396741|NCT02465528|469421678|FG002|Overall Study|Physician Decision|1|||
130396742|NCT02465528|469421679|FG003|Overall Study|Physician Decision|0|||
130396743|NCT00846742|469421682|FG000|Overall Study|Withdrawal by Subject|1|||
130396744|NCT03795610|469421684|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
130396745|NCT03795610|469421684|FG000|Overall Study|Withdrawal by Subject|1|||
130396746|NCT03795610|469421684|FG000|Overall Study|Screen Failure (Unknown)|1|||
130396747|NCT03909165|469421689|FG000|Overall Study|Physician Decision|0|||
130396748|NCT03909165|469421690|FG001|Overall Study|Physician Decision|1|||
130396749|NCT03909165|469421691|FG002|Overall Study|Physician Decision|0|||
130396750|NCT03909165|469421692|FG003|Overall Study|Physician Decision|0|||
130396751|NCT03909165|469421693|FG004|Overall Study|Physician Decision|0|||
130396752|NCT03909165|469421689|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130396753|NCT03909165|469421690|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130396754|NCT03909165|469421691|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130723260|NCT03480386|470611395|FG000|Overall Study|Complicating disease|0|||
130396755|NCT03909165|469421692|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130396756|NCT03909165|469421693|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130723261|NCT03480386|470611396|FG001|Overall Study|Complicating disease|1|||
130396757|NCT03909165|469421689|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130396758|NCT03909165|469421690|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130396759|NCT03909165|469421691|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130396760|NCT03909165|469421692|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
130396761|NCT03909165|469421693|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
130396762|NCT03909165|469421689|FG000|Overall Study|Previous Drug Exposure|0|||
130396763|NCT03909165|469421690|FG001|Overall Study|Previous Drug Exposure|0|||
130396764|NCT03909165|469421691|FG002|Overall Study|Previous Drug Exposure|1|||
130396765|NCT03909165|469421692|FG003|Overall Study|Previous Drug Exposure|0|||
130396766|NCT03909165|469421693|FG004|Overall Study|Previous Drug Exposure|0|||
130396767|NCT03909165|469421689|FG000|Overall Study|Early Discharge|1|||
130396768|NCT03909165|469421690|FG001|Overall Study|Early Discharge|0|||
130396769|NCT03909165|469421691|FG002|Overall Study|Early Discharge|0|||
130396770|NCT03909165|469421692|FG003|Overall Study|Early Discharge|0|||
130396771|NCT03909165|469421693|FG004|Overall Study|Early Discharge|0|||
130396772|NCT04098458|469421697|FG000|Overall Study|Death|1|||
130396773|NCT04098458|469421697|FG000|Overall Study|did not meet study inclusion criteria|3|||
130396774|NCT00006489|469421698|FG000|Overall Study|Adverse Event|3|||
130396775|NCT00006489|469421699|FG001|Overall Study|Adverse Event|2|||
130396776|NCT00006489|469421700|FG002|Overall Study|Adverse Event|4|||
130396777|NCT00006489|469421701|FG003|Overall Study|Adverse Event|3|||
130396778|NCT00006489|469421698|FG000|Overall Study|Withdrawal by Subject|10|||
130396779|NCT00006489|469421699|FG001|Overall Study|Withdrawal by Subject|9|||
130396780|NCT00006489|469421700|FG002|Overall Study|Withdrawal by Subject|9|||
130396781|NCT00006489|469421701|FG003|Overall Study|Withdrawal by Subject|6|||
130396782|NCT00006489|469421698|FG000|Overall Study|Scheduling Conflict|0|||
130396783|NCT00006489|469421699|FG001|Overall Study|Scheduling Conflict|3|||
130396784|NCT00006489|469421700|FG002|Overall Study|Scheduling Conflict|2|||
130396785|NCT00006489|469421701|FG003|Overall Study|Scheduling Conflict|1|||
130396786|NCT00006489|469421698|FG000|Overall Study|Death|0|||
130396787|NCT00006489|469421699|FG001|Overall Study|Death|0|||
130396788|NCT00006489|469421700|FG002|Overall Study|Death|0|||
130470630|NCT03358875|469690772|FG001|Overall Study|Withdrawal by Subject|16|||
130470631|NCT03358875|469690771|FG000|Overall Study|Lost to Follow-up|13|||
130396789|NCT00006489|469421701|FG003|Overall Study|Death|1|||
130396790|NCT01533246|469421704|FG000|Overall Study|Adverse Event|1|||
130396791|NCT01533246|469421704|FG000|Overall Study|Withdrawal by Subject|1|||
130470632|NCT03358875|469690772|FG001|Overall Study|Lost to Follow-up|2|||
130396792|NCT03491150|469421705|FG000|Overall Study|Adverse Event|1|||
130396793|NCT03491150|469421706|FG001|Overall Study|Adverse Event|0|||
130396794|NCT03491150|469421705|FG000|Overall Study|Study Terminated by Sponsor|74|||
130396795|NCT03491150|469421706|FG001|Overall Study|Study Terminated by Sponsor|70|||
130723262|NCT03480386|470611395|FG000|Overall Study|Disease progression|3|||
130723263|NCT03480386|470611396|FG001|Overall Study|Disease progression|0|||
130396796|NCT03491150|469421705|FG000|Overall Study|Other|0|||
130396797|NCT03491150|469421706|FG001|Overall Study|Other|1|||
130396798|NCT03491150|469421705|FG000|Overall Study|Withdrawal by Subject|1|||
130396799|NCT03491150|469421706|FG001|Overall Study|Withdrawal by Subject|2|||
130396800|NCT05179421|469421708|FG000|First Infusion Day|Adverse Event|1|||
130396801|NCT05179421|469421709|FG001|First Infusion Day|Adverse Event|0|||
130396802|NCT03746522|469421719|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
130396803|NCT03746522|469421720|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
130396804|NCT03746522|469421721|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
130396805|NCT03746522|469421719|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
130396806|NCT03746522|469421720|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
130396807|NCT03746522|469421721|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
130396808|NCT03746522|469421719|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
130396809|NCT03746522|469421720|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
130396810|NCT03746522|469421721|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
130396811|NCT03746522|469421719|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
130396812|NCT03746522|469421720|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
130396813|NCT03746522|469421721|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
130396814|NCT03746522|469421719|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
130396815|NCT03746522|469421720|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
130396816|NCT03746522|469421721|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
130396817|NCT01479621|469421722|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
130396818|NCT01479621|469421723|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396819|NCT01479621|469421724|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396820|NCT01479621|469421725|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396821|NCT01479621|469421726|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396822|NCT01479621|469421727|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396823|NCT01479621|469421728|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130396824|NCT01479621|469421722|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
130396825|NCT01479621|469421723|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396826|NCT01479621|469421724|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396827|NCT01479621|469421725|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396828|NCT01479621|469421726|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396829|NCT01479621|469421727|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396830|NCT01479621|469421728|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130396831|NCT01479621|469421722|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
130396832|NCT01479621|469421723|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396833|NCT01479621|469421724|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396834|NCT01479621|469421725|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396835|NCT01479621|469421726|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396836|NCT01479621|469421727|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396837|NCT01479621|469421728|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130396838|NCT01479621|469421722|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
130396839|NCT01479621|469421723|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396840|NCT01479621|469421724|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396841|NCT01479621|469421725|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396842|NCT01479621|469421726|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396843|NCT01479621|469421727|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396844|NCT01479621|469421728|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130396845|NCT01479621|469421722|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
130396846|NCT01479621|469421723|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396847|NCT01479621|469421724|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396848|NCT01479621|469421725|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396849|NCT01479621|469421726|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396850|NCT01479621|469421727|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396851|NCT01479621|469421728|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130396852|NCT01479621|469421722|FG000|Treatment Period|Adverse Event|0|||
130396853|NCT01479621|469421723|FG001|Treatment Period|Adverse Event|0|||
130396854|NCT01479621|469421724|FG002|Treatment Period|Adverse Event|0|||
130396855|NCT01479621|469421725|FG003|Treatment Period|Adverse Event|0|||
130396856|NCT01479621|469421726|FG004|Treatment Period|Adverse Event|1|||
130396857|NCT01479621|469421727|FG005|Treatment Period|Adverse Event|2|||
130396858|NCT01479621|469421728|FG006|Treatment Period|Adverse Event|2|||
130396859|NCT01479621|469421722|FG000|Treatment Period|Withdrawal by Subject|0|||
130396860|NCT01479621|469421723|FG001|Treatment Period|Withdrawal by Subject|4|||
130396861|NCT01479621|469421724|FG002|Treatment Period|Withdrawal by Subject|2|||
130396862|NCT01479621|469421725|FG003|Treatment Period|Withdrawal by Subject|2|||
130396863|NCT01479621|469421726|FG004|Treatment Period|Withdrawal by Subject|5|||
130396864|NCT01479621|469421727|FG005|Treatment Period|Withdrawal by Subject|5|||
130396865|NCT01479621|469421728|FG006|Treatment Period|Withdrawal by Subject|1|||
130396866|NCT01479621|469421722|FG000|Treatment Period|Physician Decision|0|||
130396867|NCT01479621|469421723|FG001|Treatment Period|Physician Decision|0|||
130396868|NCT01479621|469421724|FG002|Treatment Period|Physician Decision|0|||
130396869|NCT01479621|469421725|FG003|Treatment Period|Physician Decision|0|||
130396870|NCT01479621|469421726|FG004|Treatment Period|Physician Decision|1|||
130396871|NCT01479621|469421727|FG005|Treatment Period|Physician Decision|1|||
130396872|NCT01479621|469421728|FG006|Treatment Period|Physician Decision|0|||
130396873|NCT01479621|469421722|FG000|Treatment Period|Non-compliance to study drug|0|||
130396874|NCT01479621|469421723|FG001|Treatment Period|Non-compliance to study drug|1|||
130396875|NCT01479621|469421724|FG002|Treatment Period|Non-compliance to study drug|0|||
130396876|NCT01479621|469421725|FG003|Treatment Period|Non-compliance to study drug|0|||
130396877|NCT01479621|469421726|FG004|Treatment Period|Non-compliance to study drug|0|||
130396878|NCT01479621|469421727|FG005|Treatment Period|Non-compliance to study drug|0|||
130396879|NCT01479621|469421728|FG006|Treatment Period|Non-compliance to study drug|1|||
130396880|NCT01479621|469421722|FG000|Treatment Period|Protocol Violation|0|||
130396881|NCT01479621|469421723|FG001|Treatment Period|Protocol Violation|9|||
130396882|NCT01479621|469421724|FG002|Treatment Period|Protocol Violation|6|||
130396883|NCT01479621|469421725|FG003|Treatment Period|Protocol Violation|5|||
130396884|NCT01479621|469421726|FG004|Treatment Period|Protocol Violation|2|||
130396885|NCT01479621|469421727|FG005|Treatment Period|Protocol Violation|10|||
130396886|NCT01479621|469421728|FG006|Treatment Period|Protocol Violation|6|||
130396887|NCT01479621|469421722|FG000|Treatment Period|Pregnancy|0|||
130396888|NCT01479621|469421723|FG001|Treatment Period|Pregnancy|0|||
130396889|NCT01479621|469421724|FG002|Treatment Period|Pregnancy|2|||
130396890|NCT01479621|469421725|FG003|Treatment Period|Pregnancy|0|||
130396891|NCT01479621|469421726|FG004|Treatment Period|Pregnancy|0|||
130396892|NCT01479621|469421727|FG005|Treatment Period|Pregnancy|0|||
130396893|NCT01479621|469421728|FG006|Treatment Period|Pregnancy|0|||
130396894|NCT01479621|469421722|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
130396895|NCT01479621|469421723|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
130396896|NCT01479621|469421724|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
130396897|NCT01479621|469421725|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
130396898|NCT01479621|469421726|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
130396899|NCT01479621|469421727|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
130396900|NCT01479621|469421728|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
130396901|NCT01479621|469421722|FG000|Treatment Period|Lost to Follow-up|0|||
130396902|NCT01479621|469421723|FG001|Treatment Period|Lost to Follow-up|0|||
130396903|NCT01479621|469421724|FG002|Treatment Period|Lost to Follow-up|1|||
130396904|NCT01479621|469421725|FG003|Treatment Period|Lost to Follow-up|0|||
130396905|NCT01479621|469421726|FG004|Treatment Period|Lost to Follow-up|2|||
130396906|NCT01479621|469421727|FG005|Treatment Period|Lost to Follow-up|2|||
130396907|NCT01479621|469421728|FG006|Treatment Period|Lost to Follow-up|1|||
130396908|NCT01479621|469421722|FG000|Treatment Period|Met stopping criteria|0|||
130396909|NCT01479621|469421723|FG001|Treatment Period|Met stopping criteria|8|||
130396910|NCT01479621|469421724|FG002|Treatment Period|Met stopping criteria|7|||
130396911|NCT01479621|469421725|FG003|Treatment Period|Met stopping criteria|4|||
130396912|NCT01479621|469421726|FG004|Treatment Period|Met stopping criteria|9|||
130396913|NCT01479621|469421727|FG005|Treatment Period|Met stopping criteria|20|||
130396914|NCT01479621|469421728|FG006|Treatment Period|Met stopping criteria|6|||
130396915|NCT00323414|469421732|FG000|Overall Study|Withdrawal by Subject|0|||
130396916|NCT00323414|469421733|FG001|Overall Study|Withdrawal by Subject|1|||
130396917|NCT00677807|469421744|FG000|Overall Study|Adverse Event|4|||
130396918|NCT00677807|469421745|FG001|Overall Study|Adverse Event|1|||
130396919|NCT00677807|469421746|FG002|Overall Study|Adverse Event|6|||
130396920|NCT00677807|469421744|FG000|Overall Study|Lack of Efficacy|0|||
130396921|NCT00677807|469421745|FG001|Overall Study|Lack of Efficacy|0|||
130396922|NCT00677807|469421746|FG002|Overall Study|Lack of Efficacy|2|||
130396923|NCT00677807|469421744|FG000|Overall Study|Participant no longer needs study drug|0|||
130396924|NCT00677807|469421745|FG001|Overall Study|Participant no longer needs study drug|0|||
130396925|NCT00677807|469421746|FG002|Overall Study|Participant no longer needs study drug|1|||
130396926|NCT00677807|469421744|FG000|Overall Study|Withdrawal by Subject|10|||
130396927|NCT00677807|469421745|FG001|Overall Study|Withdrawal by Subject|3|||
130396928|NCT00677807|469421746|FG002|Overall Study|Withdrawal by Subject|6|||
130396929|NCT00677807|469421744|FG000|Overall Study|Lost to Follow-up|2|||
130723264|NCT03480386|470611395|FG000|Overall Study|Became ineligible|0|||
130723265|NCT03480386|470611396|FG001|Overall Study|Became ineligible|2|||
130723266|NCT00574912|470611397|FG000|Overall Study|Could not place IV lines.|3|||
130396930|NCT00677807|469421745|FG001|Overall Study|Lost to Follow-up|2|||
130396931|NCT00677807|469421746|FG002|Overall Study|Lost to Follow-up|2|||
130396932|NCT00677807|469421744|FG000|Overall Study|Administrative problems|1|||
130396933|NCT00677807|469421745|FG001|Overall Study|Administrative problems|1|||
130470633|NCT03358875|469690771|FG000|Overall Study|Miscellaneous|33|||
130470634|NCT03358875|469690772|FG001|Overall Study|Miscellaneous|0|||
130470635|NCT03358875|469690771|FG000|Overall Study|Remained on Study|1|||
130560004|NCT04411628|470017925|FG003|Overall Study|Lost to Follow-up|0|||
130560005|NCT00732251|470017926|FG000|Overall Study|Lost to Follow-up|3|||
130560006|NCT00732251|470017926|FG000|Overall Study|Withdrawal by Subject|3|||
130560007|NCT00732251|470017926|FG000|Overall Study|Early Term due to Site Closure|1|||
130560008|NCT01034540|470017927|FG000|Overall Study|Adverse Event|0|||
130560009|NCT01034540|470017928|FG001|Overall Study|Adverse Event|1|||
130560010|NCT03519867|470017931|FG000|Overall Study|Adverse Event|1|||
130560011|NCT03519867|470017932|FG001|Overall Study|Adverse Event|1|||
130560012|NCT03519867|470017933|FG002|Overall Study|Adverse Event|0|||
130560013|NCT03519867|470017934|FG003|Overall Study|Adverse Event|0|||
130560014|NCT03519867|470017935|FG004|Overall Study|Adverse Event|0|||
130560015|NCT03519867|470017936|FG005|Overall Study|Adverse Event|0|||
130560016|NCT03519867|470017937|FG006|Overall Study|Adverse Event|0|||
130560017|NCT03519867|470017938|FG007|Overall Study|Adverse Event|0|||
130560018|NCT03519867|470017939|FG008|Overall Study|Adverse Event|0|||
130560019|NCT03519867|470017940|FG009|Overall Study|Adverse Event|0|||
130560020|NCT03519867|470017931|FG000|Overall Study|Protocol Violation|0|||
130560021|NCT03519867|470017932|FG001|Overall Study|Protocol Violation|0|||
130560022|NCT03519867|470017933|FG002|Overall Study|Protocol Violation|0|||
130560023|NCT03519867|470017934|FG003|Overall Study|Protocol Violation|0|||
130560024|NCT03519867|470017935|FG004|Overall Study|Protocol Violation|0|||
130560025|NCT03519867|470017936|FG005|Overall Study|Protocol Violation|1|||
130560026|NCT03519867|470017937|FG006|Overall Study|Protocol Violation|0|||
130560027|NCT03519867|470017938|FG007|Overall Study|Protocol Violation|0|||
130560028|NCT03519867|470017939|FG008|Overall Study|Protocol Violation|0|||
130560029|NCT03519867|470017940|FG009|Overall Study|Protocol Violation|0|||
130560030|NCT03519867|470017931|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560031|NCT03519867|470017932|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560032|NCT03519867|470017933|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560033|NCT03519867|470017934|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560034|NCT03519867|470017935|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560035|NCT03519867|470017936|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560036|NCT03519867|470017937|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
130560037|NCT03519867|470017938|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560038|NCT03519867|470017939|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560039|NCT03519867|470017940|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130560040|NCT03519867|470017931|FG000|Overall Study|Admin. of other reversal agent|1|||
130560041|NCT03519867|470017932|FG001|Overall Study|Admin. of other reversal agent|1|||
130560042|NCT03519867|470017933|FG002|Overall Study|Admin. of other reversal agent|0|||
130560043|NCT03519867|470017934|FG003|Overall Study|Admin. of other reversal agent|0|||
130560044|NCT03519867|470017935|FG004|Overall Study|Admin. of other reversal agent|0|||
130560045|NCT03519867|470017936|FG005|Overall Study|Admin. of other reversal agent|1|||
130560046|NCT03519867|470017937|FG006|Overall Study|Admin. of other reversal agent|0|||
130560047|NCT03519867|470017938|FG007|Overall Study|Admin. of other reversal agent|0|||
130560048|NCT03519867|470017939|FG008|Overall Study|Admin. of other reversal agent|0|||
130560049|NCT03519867|470017940|FG009|Overall Study|Admin. of other reversal agent|0|||
130560050|NCT03519867|470017931|FG000|Overall Study|Reason not provided|1|||
130560051|NCT03519867|470017932|FG001|Overall Study|Reason not provided|1|||
130560052|NCT03519867|470017933|FG002|Overall Study|Reason not provided|1|||
130560053|NCT03519867|470017934|FG003|Overall Study|Reason not provided|1|||
130560054|NCT03519867|470017935|FG004|Overall Study|Reason not provided|0|||
130560055|NCT03519867|470017936|FG005|Overall Study|Reason not provided|1|||
130560056|NCT03519867|470017937|FG006|Overall Study|Reason not provided|0|||
130560057|NCT03519867|470017938|FG007|Overall Study|Reason not provided|1|||
130560058|NCT03519867|470017939|FG008|Overall Study|Reason not provided|1|||
130560059|NCT03519867|470017940|FG009|Overall Study|Reason not provided|0|||
130723267|NCT00574912|470611397|FG000|Overall Study|scheduling conflicts|3|||
130723268|NCT00574912|470611397|FG000|Overall Study|Physician Decision|2|||
130396934|NCT00677807|469421746|FG002|Overall Study|Administrative problems|2|||
130723269|NCT02099682|470611402|FG000|Overall Study|Data Not Available|51|||
130723270|NCT02099682|470611402|FG000|Overall Study|Lost to Follow-up|31|||
130396935|NCT00677807|469421744|FG000|Overall Study|Death|0|||
130396936|NCT00677807|469421745|FG001|Overall Study|Death|1|||
130396937|NCT00677807|469421746|FG002|Overall Study|Death|1|||
130396938|NCT00677807|469421744|FG000|Overall Study|Protocol Deviation|1|||
130560060|NCT01252810|470017941|FG000|Overall Study|Withdrawal by Subject|4|||
130560061|NCT01252810|470017942|FG001|Overall Study|Withdrawal by Subject|1|||
130560062|NCT01252810|470017941|FG000|Overall Study|Lost to Follow-up|0|||
130560063|NCT01252810|470017942|FG001|Overall Study|Lost to Follow-up|1|||
130560064|NCT01252810|470017941|FG000|Overall Study|Physician Decision|2|||
130560065|NCT01252810|470017942|FG001|Overall Study|Physician Decision|1|||
130560066|NCT01252810|470017941|FG000|Overall Study|Various reasons|8|||
130560067|NCT01252810|470017942|FG001|Overall Study|Various reasons|0|||
130560068|NCT04376827|470017947|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
130723271|NCT02099682|470611402|FG000|Overall Study|Other|29|||
130396939|NCT00677807|469421745|FG001|Overall Study|Protocol Deviation|3|||
130396940|NCT00677807|469421746|FG002|Overall Study|Protocol Deviation|0|||
130723272|NCT02551666|470611403|FG000|Overall Study|Withdrawal by Subject|1|||
130723273|NCT02551666|470611404|FG001|Overall Study|Withdrawal by Subject|3|||
130723274|NCT00805467|470613410|FG000|Overall Study|Lack of Efficacy|0|||
130723275|NCT00805467|470613411|FG001|Overall Study|Lack of Efficacy|8|||
130723276|NCT00805467|470613412|FG002|Overall Study|Lack of Efficacy|13|||
130723277|NCT00805467|470613413|FG003|Overall Study|Lack of Efficacy|86|||
130396941|NCT04019041|469421747|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
130396942|NCT04019041|469421748|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
130470636|NCT03358875|469690772|FG001|Overall Study|Remained on Study|0|||
130470637|NCT06194214|469690776|FG000|Overall Study|Adverse Event|1|||
130470638|NCT03433339|469690777|FG000|Overall Study|Lost to Follow-up|2|||
130470639|NCT03433339|469690778|FG001|Overall Study|Lost to Follow-up|0|||
130470640|NCT03433339|469690777|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
130470641|NCT03433339|469690778|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
130470642|NCT03433339|469690777|FG000|Overall Study|Withdrawal by Subject|0|||
130470643|NCT03433339|469690778|FG001|Overall Study|Withdrawal by Subject|2|||
130470644|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
130470645|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
130470646|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
130470647|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
130470648|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
130470649|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
130470650|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
130470651|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
130470652|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
130470653|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
130470654|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
130470655|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
130470656|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
130470657|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
130470658|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
130470659|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
130470660|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
130470661|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
130470662|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
130470663|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
130470664|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130470665|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130470666|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130470667|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130470668|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
130470669|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130470670|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130470671|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130470672|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130470673|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
130470674|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
130470675|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
130470676|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
130470677|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
130470678|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
130470679|NCT01898494|469690794|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
130470680|NCT01898494|469690795|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
130470681|NCT01898494|469690796|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
130470682|NCT01898494|469690797|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
130470683|NCT01898494|469690798|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
130470684|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
130470685|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
130470686|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
130470687|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
130470688|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
130470689|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
130470690|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
130470691|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
130470692|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
130470693|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
130723278|NCT00805467|470613410|FG000|Overall Study|Lost to Follow-up|0|||
130723279|NCT00805467|470613411|FG001|Overall Study|Lost to Follow-up|1|||
130723280|NCT00805467|470613412|FG002|Overall Study|Lost to Follow-up|7|||
130396943|NCT04019041|469421749|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130396944|NCT04019041|469421750|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130396945|NCT04019041|469421751|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130396946|NCT04019041|469421752|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130396947|NCT04019041|469421747|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130396948|NCT04019041|469421748|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130396949|NCT04019041|469421749|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
130396950|NCT04019041|469421750|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130396951|NCT04019041|469421751|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130396952|NCT04019041|469421752|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130396953|NCT04019041|469421747|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
130396954|NCT04019041|469421748|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
130396955|NCT04019041|469421749|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
130396956|NCT04019041|469421750|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130396957|NCT04019041|469421751|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130396958|NCT04019041|469421752|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130396959|NCT04019041|469421747|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130470694|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
130470695|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
130470696|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
130470697|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
130470698|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
130470699|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
130470700|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
130470701|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
130470702|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
130470703|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
130470704|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
130470705|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
130470706|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
130470707|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
130470708|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
130470709|NCT01898494|469690794|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
130470710|NCT01898494|469690795|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
130470711|NCT01898494|469690796|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
130470712|NCT01898494|469690797|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
130470713|NCT01898494|469690798|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
130470714|NCT03289039|469690801|FG000|Overall Study|Withdrawal by Subject|0|||
130470715|NCT03289039|469690802|FG001|Overall Study|Withdrawal by Subject|1|||
130470716|NCT03289039|469690801|FG000|Overall Study|Became ineligible prior to treatment start|0|||
130470717|NCT03289039|469690802|FG001|Overall Study|Became ineligible prior to treatment start|1|||
130470718|NCT03289039|469690801|FG000|Overall Study|progressed before treatment start|1|||
130470719|NCT03289039|469690802|FG001|Overall Study|progressed before treatment start|0|||
130470720|NCT04732494|469690803|FG000|Overall Study|Death|39|||
130470721|NCT04732494|469690804|FG001|Overall Study|Death|36|||
130470722|NCT04732494|469690803|FG000|Overall Study|Study Closed by Sponsor|20|||
130470723|NCT04732494|469690804|FG001|Overall Study|Study Closed by Sponsor|15|||
130470724|NCT04732494|469690803|FG000|Overall Study|Withdrawal by Subject|2|||
130470725|NCT04732494|469690804|FG001|Overall Study|Withdrawal by Subject|7|||
130470726|NCT04732494|469690803|FG000|Overall Study|Lost to Follow-up|1|||
130470727|NCT04732494|469690804|FG001|Overall Study|Lost to Follow-up|5|||
130470728|NCT05136404|469690807|FG000|Period 1|Adverse Event|0|||
130470729|NCT05136404|469690808|FG001|Period 1|Adverse Event|1|||
130470730|NCT05136404|469690809|FG002|Period 1|Adverse Event|1|||
130470731|NCT05136404|469690807|FG000|Period 2|Inappropriate Behavior|0|||
130470732|NCT05136404|469690808|FG001|Period 2|Inappropriate Behavior|0|||
130470733|NCT05136404|469690809|FG002|Period 2|Inappropriate Behavior|1|||
130470734|NCT05136404|469690807|FG000|Period 3|Adverse Event|0|||
130470735|NCT05136404|469690808|FG001|Period 3|Adverse Event|0|||
130470736|NCT05136404|469690809|FG002|Period 3|Adverse Event|1|||
130470737|NCT05512962|469690811|FG000|Overall Study|Withdrawal by Subject|1|||
130470738|NCT05512962|469690812|FG001|Overall Study|Withdrawal by Subject|0|||
130470739|NCT02860130|469690813|FG000|Overall Study|Adverse Event|2|||
130470740|NCT02860130|469690814|FG001|Overall Study|Adverse Event|3|||
130470741|NCT02860130|469690813|FG000|Overall Study|Protocol Violation|1|||
130470742|NCT02860130|469690814|FG001|Overall Study|Protocol Violation|1|||
130470743|NCT02860130|469690813|FG000|Overall Study|Withdrawal by Subject|0|||
130470744|NCT02860130|469690814|FG001|Overall Study|Withdrawal by Subject|2|||
130723281|NCT00805467|470613413|FG003|Overall Study|Lost to Follow-up|21|||
130470745|NCT02860130|469690813|FG000|Overall Study|Physician Decision|2|||
130396960|NCT04019041|469421748|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130396961|NCT04019041|469421749|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
130396962|NCT04019041|469421750|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130396963|NCT04019041|469421751|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130396964|NCT04019041|469421752|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130396965|NCT04019041|469421747|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130396966|NCT04019041|469421748|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130396967|NCT04019041|469421749|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130396968|NCT04019041|469421750|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
130396969|NCT04019041|469421751|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
130396970|NCT04019041|469421752|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
130396971|NCT04019041|469421747|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130396972|NCT04019041|469421748|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130396973|NCT04019041|469421749|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130396974|NCT04019041|469421750|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
130396975|NCT04019041|469421751|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130396976|NCT04019041|469421752|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130396977|NCT04019041|469421747|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130396978|NCT04019041|469421748|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130396979|NCT04019041|469421749|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130396980|NCT04019041|469421750|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130396981|NCT04019041|469421751|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
130396982|NCT04019041|469421752|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130396983|NCT04019041|469421747|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130396984|NCT04019041|469421748|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130396985|NCT04019041|469421749|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130396986|NCT04019041|469421750|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
130396987|NCT04019041|469421751|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
130396988|NCT04019041|469421752|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130396989|NCT04019041|469421747|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130396990|NCT04019041|469421748|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130396991|NCT04019041|469421749|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130396992|NCT04019041|469421750|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130396993|NCT04019041|469421751|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
130396994|NCT04019041|469421752|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
130396995|NCT03925727|469421753|FG000|Overall Study|Adverse Event|4|||
130396996|NCT03925727|469421754|FG001|Overall Study|Adverse Event|0|||
130396997|NCT03925727|469421755|FG002|Overall Study|Adverse Event|3|||
130396998|NCT03925727|469421753|FG000|Overall Study|Protocol Violation|1|||
130396999|NCT03925727|469421754|FG001|Overall Study|Protocol Violation|2|||
130397000|NCT03925727|469421755|FG002|Overall Study|Protocol Violation|2|||
130397001|NCT03925727|469421753|FG000|Overall Study|Withdrawal by Subject|3|||
130397002|NCT03925727|469421754|FG001|Overall Study|Withdrawal by Subject|2|||
130397003|NCT03925727|469421755|FG002|Overall Study|Withdrawal by Subject|4|||
130397004|NCT03925727|469421753|FG000|Overall Study|Administrative Reasons|3|||
130397005|NCT03925727|469421754|FG001|Overall Study|Administrative Reasons|1|||
130397006|NCT03925727|469421755|FG002|Overall Study|Administrative Reasons|2|||
130397007|NCT03925727|469421753|FG000|Overall Study|Randomized in error or Disqualified|8|||
130397008|NCT03925727|469421754|FG001|Overall Study|Randomized in error or Disqualified|1|||
130397009|NCT03925727|469421755|FG002|Overall Study|Randomized in error or Disqualified|7|||
130397010|NCT00314366|469421756|FG000|Overall Study|not treated due to patient medical condi|1|||
130397011|NCT00314366|469421757|FG001|Overall Study|not treated due to patient medical condi|0|||
130397012|NCT01393743|469421758|FG000|Core Study|Adverse Event|5|||
130397013|NCT01393743|469421759|FG001|Core Study|Adverse Event|9|||
130397014|NCT01393743|469421760|FG002|Core Study|Adverse Event|0|||
130397015|NCT01393743|469421758|FG000|Core Study|Lost to Follow-up|1|||
130397016|NCT01393743|469421759|FG001|Core Study|Lost to Follow-up|1|||
130397017|NCT01393743|469421760|FG002|Core Study|Lost to Follow-up|0|||
130397018|NCT01393743|469421758|FG000|Core Study|Participant's Choice|2|||
130397019|NCT01393743|469421759|FG001|Core Study|Participant's Choice|3|||
130397020|NCT01393743|469421760|FG002|Core Study|Participant's Choice|0|||
130397021|NCT01393743|469421758|FG000|Core Study|Inadequate therapeutic effect|2|||
130397022|NCT01393743|469421759|FG001|Core Study|Inadequate therapeutic effect|0|||
130470746|NCT02860130|469690814|FG001|Overall Study|Physician Decision|2|||
130397023|NCT01393743|469421760|FG002|Core Study|Inadequate therapeutic effect|0|||
130397024|NCT01393743|469421758|FG000|Extension Phase|Adverse Event|0|||
130397025|NCT01393743|469421759|FG001|Extension Phase|Adverse Event|0|||
130397026|NCT01393743|469421760|FG002|Extension Phase|Adverse Event|12|||
130470747|NCT02860130|469690813|FG000|Overall Study|Other|2|||
130470748|NCT02860130|469690814|FG001|Overall Study|Other|1|||
130470749|NCT05575076|469690815|FG000|Overall Study|Adverse Event|24|||
130397027|NCT01393743|469421758|FG000|Extension Phase|Lost to Follow-up|0|||
130397028|NCT01393743|469421759|FG001|Extension Phase|Lost to Follow-up|0|||
130397029|NCT01393743|469421760|FG002|Extension Phase|Lost to Follow-up|2|||
130397030|NCT01393743|469421758|FG000|Extension Phase|Participant choice|0|||
130397031|NCT01393743|469421759|FG001|Extension Phase|Participant choice|0|||
130397032|NCT01393743|469421760|FG002|Extension Phase|Participant choice|16|||
130397033|NCT01393743|469421758|FG000|Extension Phase|Inadequate therapeutic effect|0|||
130397034|NCT01393743|469421759|FG001|Extension Phase|Inadequate therapeutic effect|0|||
130397035|NCT01393743|469421760|FG002|Extension Phase|Inadequate therapeutic effect|7|||
130397036|NCT01393743|469421758|FG000|Extension Phase|Withdrawal by Subject|0|||
130397037|NCT01393743|469421759|FG001|Extension Phase|Withdrawal by Subject|0|||
130397038|NCT01393743|469421760|FG002|Extension Phase|Withdrawal by Subject|8|||
130397039|NCT01393743|469421758|FG000|Extension Phase|Pregnancy|0|||
130397040|NCT01393743|469421759|FG001|Extension Phase|Pregnancy|0|||
130397041|NCT01393743|469421760|FG002|Extension Phase|Pregnancy|1|||
130560069|NCT04376827|470017948|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
130560070|NCT04376827|470017947|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
130560071|NCT04376827|470017948|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
130560072|NCT04376827|470017947|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
130397042|NCT01393743|469421758|FG000|Extension Phase|Other|0|||
130397043|NCT01393743|469421759|FG001|Extension Phase|Other|0|||
130397044|NCT01393743|469421760|FG002|Extension Phase|Other|14|||
130560073|NCT04376827|470017948|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
130560074|NCT04376827|470017947|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
130723282|NCT00805467|470613410|FG000|Overall Study|Withdrawal by Subject|0|||
130723283|NCT00805467|470613411|FG001|Overall Study|Withdrawal by Subject|6|||
130397045|NCT02321462|469421764|FG000|Overall Study|Withdrawal by Subject|5|||
130397046|NCT02321462|469421765|FG001|Overall Study|Withdrawal by Subject|2|||
130397047|NCT02321462|469421764|FG000|Overall Study|Subject withdrawn before any treatment|1|||
130397048|NCT02321462|469421765|FG001|Overall Study|Subject withdrawn before any treatment|1|||
130397049|NCT01574352|469421778|FG000|Overall Study|Withdrawal by Subject|6|||
130397050|NCT01574352|469421779|FG001|Overall Study|Withdrawal by Subject|13|||
130397051|NCT01574352|469421778|FG000|Overall Study|Injury in non-camp related sport|1|||
130397052|NCT01574352|469421779|FG001|Overall Study|Injury in non-camp related sport|0|||
130397053|NCT01282424|469421780|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
130397054|NCT01282424|469421780|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
130397055|NCT01282424|469421780|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
130397056|NCT01282424|469421780|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
130397057|NCT01282424|469421780|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
130397058|NCT01282424|469421780|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
130397059|NCT01282424|469421780|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
130397060|NCT01282424|469421780|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
130397061|NCT02283788|469421787|FG000|Overall Study|Adverse Event|1|||
130397062|NCT02283788|469421788|FG001|Overall Study|Adverse Event|3|||
130397063|NCT02283788|469421789|FG002|Overall Study|Adverse Event|5|||
130397064|NCT02283788|469421790|FG003|Overall Study|Adverse Event|1|||
130397065|NCT02283788|469421787|FG000|Overall Study|Withdrawal by Subject|0|||
130397066|NCT02283788|469421788|FG001|Overall Study|Withdrawal by Subject|1|||
130397067|NCT02283788|469421789|FG002|Overall Study|Withdrawal by Subject|0|||
130397068|NCT02283788|469421790|FG003|Overall Study|Withdrawal by Subject|1|||
130397069|NCT01083433|469423941|FG000|Overall Study|Lost to Follow-up|2|||
130397070|NCT01083433|469423942|FG001|Overall Study|Lost to Follow-up|1|||
130397071|NCT01083433|469423943|FG002|Overall Study|Lost to Follow-up|1|||
130397072|NCT01083433|469423941|FG000|Overall Study|Withdrawal by Subject|0|||
130397073|NCT01083433|469423942|FG001|Overall Study|Withdrawal by Subject|5|||
130397074|NCT01083433|469423943|FG002|Overall Study|Withdrawal by Subject|3|||
130397075|NCT01083433|469423941|FG000|Overall Study|Pregnancy|0|||
130397076|NCT01083433|469423942|FG001|Overall Study|Pregnancy|0|||
130397077|NCT01083433|469423943|FG002|Overall Study|Pregnancy|1|||
130397078|NCT04982029|469423944|FG000|Overall Study|Lost to Follow-up|2|||
130397079|NCT04982029|469423945|FG001|Overall Study|Lost to Follow-up|3|||
130397080|NCT05458856|469423946|FG000|Overall Study|Withdrawal by Subject|5|||
130397081|NCT05458856|469423946|FG000|Overall Study|Death|4|||
130723284|NCT00805467|470613412|FG002|Overall Study|Withdrawal by Subject|45|||
130723285|NCT00805467|470613413|FG003|Overall Study|Withdrawal by Subject|50|||
130397082|NCT05458856|469423946|FG000|Overall Study|Protocol Deviation|3|||
130397083|NCT05458856|469423946|FG000|Overall Study|Physician Decision|1|||
130397084|NCT05168475|469423947|FG000|Period 1|Protocol Violation|1|||
130397085|NCT05168475|469423947|FG000|Period 1|IMP shortage|2|||
130397086|NCT05168475|469423947|FG000|Period 1|Not randomised|2|||
130397087|NCT05168475|469423947|FG000|Period 2|IMP shortage|1|||
130397088|NCT01589822|469423948|FG000|Overall Study|Withdrawal by Subject|1|||
130397089|NCT01589822|469423949|FG001|Overall Study|Withdrawal by Subject|2|||
130397090|NCT01589822|469423950|FG002|Overall Study|Withdrawal by Subject|0|||
130397091|NCT01589822|469423948|FG000|Overall Study|Death|1|||
130560075|NCT04376827|470017948|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
130560076|NCT04376827|470017947|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
130560077|NCT04376827|470017948|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
130560078|NCT00729378|470019705|FG000|Baseline|Did not complete study measurements|72|||
130560079|NCT00729378|470019706|FG001|Baseline|Did not complete study measurements|33|||
130560080|NCT00729378|470019705|FG000|Baseline|Withdrawal by Subject|66|||
130560081|NCT00729378|470019706|FG001|Baseline|Withdrawal by Subject|59|||
130560082|NCT00729378|470019705|FG000|12-months|Lost to Follow-up|100|||
130560083|NCT00729378|470019706|FG001|12-months|Lost to Follow-up|65|||
130560084|NCT00729378|470019705|FG000|24-months|Lost to Follow-up|72|||
130560085|NCT00729378|470019706|FG001|24-months|Lost to Follow-up|51|||
130560086|NCT00729378|470019705|FG000|36-months|Lost to Follow-up|15|||
130560087|NCT00729378|470019706|FG001|36-months|Lost to Follow-up|6|||
130560088|NCT02246582|470019707|FG000|Overall Study|Withdrawal by Subject|3|||
130560089|NCT02246582|470019708|FG001|Overall Study|Withdrawal by Subject|4|||
130560090|NCT02060383|470019709|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
130560091|NCT02060383|470019710|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
130560092|NCT02060383|470019711|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
130560093|NCT02060383|470019712|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
130560094|NCT02060383|470019713|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
130560095|NCT02060383|470019709|FG000|Core Phase|Adverse Event|2|||
130560096|NCT02060383|470019710|FG001|Core Phase|Adverse Event|0|||
130560097|NCT02060383|470019711|FG002|Core Phase|Adverse Event|0|||
130560098|NCT02060383|470019712|FG003|Core Phase|Adverse Event|2|||
130560099|NCT02060383|470019713|FG004|Core Phase|Adverse Event|6|||
130560100|NCT02060383|470019709|FG000|Core Phase|Administrative problems|0|||
130560101|NCT02060383|470019710|FG001|Core Phase|Administrative problems|1|||
130560102|NCT02060383|470019711|FG002|Core Phase|Administrative problems|0|||
130560103|NCT02060383|470019712|FG003|Core Phase|Administrative problems|0|||
130560104|NCT02060383|470019713|FG004|Core Phase|Administrative problems|0|||
130397092|NCT01589822|469423949|FG001|Overall Study|Death|0|||
130397093|NCT01589822|469423950|FG002|Overall Study|Death|0|||
130560105|NCT02060383|470019709|FG000|Core Phase|Protocol Violation|0|||
130560106|NCT02060383|470019710|FG001|Core Phase|Protocol Violation|0|||
130560107|NCT02060383|470019711|FG002|Core Phase|Protocol Violation|0|||
130560108|NCT02060383|470019712|FG003|Core Phase|Protocol Violation|1|||
130560109|NCT02060383|470019713|FG004|Core Phase|Protocol Violation|0|||
130560110|NCT02060383|470019709|FG000|Core Phase|Withdrawal by Subject|0|||
130560111|NCT02060383|470019710|FG001|Core Phase|Withdrawal by Subject|0|||
130560112|NCT02060383|470019711|FG002|Core Phase|Withdrawal by Subject|0|||
130723286|NCT00805467|470613410|FG000|Overall Study|Protocol Violation|0|||
130723287|NCT00805467|470613411|FG001|Overall Study|Protocol Violation|3|||
130723288|NCT00805467|470613412|FG002|Overall Study|Protocol Violation|0|||
130397094|NCT01589822|469423948|FG000|Overall Study|Missed 90 day visit|2|||
130397095|NCT01589822|469423949|FG001|Overall Study|Missed 90 day visit|1|||
130397096|NCT01589822|469423950|FG002|Overall Study|Missed 90 day visit|1|||
130397097|NCT01140477|469423951|FG000|Overall Study|Lost to Follow-up|4|||
130397098|NCT01140477|469423952|FG001|Overall Study|Lost to Follow-up|0|||
130397099|NCT01140477|469423951|FG000|Overall Study|Withdrawal by Subject|1|||
130397100|NCT01140477|469423952|FG001|Overall Study|Withdrawal by Subject|4|||
130397101|NCT01140477|469423951|FG000|Overall Study|Surgical complication preventing implant|2|||
130397102|NCT01140477|469423952|FG001|Overall Study|Surgical complication preventing implant|0|||
130397103|NCT01140477|469423951|FG000|Overall Study|Death|1|||
130397104|NCT01140477|469423952|FG001|Overall Study|Death|1|||
130397105|NCT01140477|469423951|FG000|Overall Study|Subject explanted|0|||
130397106|NCT01140477|469423952|FG001|Overall Study|Subject explanted|1|||
130397107|NCT00773175|469423953|FG000|Overall Study|Adverse Event|2|||
130397108|NCT00773175|469423954|FG001|Overall Study|Adverse Event|0|||
130397109|NCT00773175|469423953|FG000|Overall Study|Consent Withdrawn|0|||
130723289|NCT00805467|470613413|FG003|Overall Study|Protocol Violation|5|||
130723290|NCT00805467|470613410|FG000|Overall Study|Adverse Event|0|||
130723291|NCT00805467|470613411|FG001|Overall Study|Adverse Event|13|||
130397110|NCT00773175|469423954|FG001|Overall Study|Consent Withdrawn|2|||
130397111|NCT01904604|469423961|FG000|Overall Study|Withdrew before receiving dosing|0|||
130397112|NCT01904604|469423962|FG001|Overall Study|Withdrew before receiving dosing|1|||
130397113|NCT01904604|469423963|FG002|Overall Study|Withdrew before receiving dosing|0|||
130397114|NCT01904604|469423961|FG000|Overall Study|Non-compliance|1|||
130397115|NCT01904604|469423962|FG001|Overall Study|Non-compliance|0|||
130560113|NCT02060383|470019712|FG003|Core Phase|Withdrawal by Subject|4|||
130560114|NCT02060383|470019713|FG004|Core Phase|Withdrawal by Subject|2|||
130560115|NCT02060383|470019709|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
130560116|NCT02060383|470019710|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
130397116|NCT01904604|469423963|FG002|Overall Study|Non-compliance|0|||
130560117|NCT02060383|470019711|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130723292|NCT00805467|470613412|FG002|Overall Study|Adverse Event|26|||
130723293|NCT00805467|470613413|FG003|Overall Study|Adverse Event|57|||
130397117|NCT01904604|469423961|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
130397118|NCT01904604|469423962|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
130397119|NCT01904604|469423963|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
130397120|NCT01904604|469423961|FG000|Overall Study|Patch site reactions|1|||
130397121|NCT01904604|469423962|FG001|Overall Study|Patch site reactions|1|||
130397122|NCT01904604|469423963|FG002|Overall Study|Patch site reactions|0|||
130397123|NCT01904604|469423961|FG000|Overall Study|Increased syncope|0|||
130397124|NCT01904604|469423962|FG001|Overall Study|Increased syncope|1|||
130397125|NCT01904604|469423963|FG002|Overall Study|Increased syncope|0|||
130397126|NCT01904604|469423961|FG000|Overall Study|Unrelated illness|0|||
130397127|NCT01904604|469423962|FG001|Overall Study|Unrelated illness|1|||
130397128|NCT01904604|469423963|FG002|Overall Study|Unrelated illness|0|||
130397129|NCT01904604|469423961|FG000|Overall Study|Passed Week 52 OFC|1|||
130397130|NCT01904604|469423962|FG001|Overall Study|Passed Week 52 OFC|0|||
130397131|NCT01904604|469423963|FG002|Overall Study|Passed Week 52 OFC|0|||
130397132|NCT01904604|469423961|FG000|Overall Study|Withdrawal by Subject|1|||
130397133|NCT01904604|469423962|FG001|Overall Study|Withdrawal by Subject|2|||
130397134|NCT01904604|469423963|FG002|Overall Study|Withdrawal by Subject|0|||
130397135|NCT01904604|469423961|FG000|Overall Study|Participant Relocated|1|||
130397136|NCT01904604|469423962|FG001|Overall Study|Participant Relocated|1|||
130397137|NCT01904604|469423963|FG002|Overall Study|Participant Relocated|1|||
130397138|NCT01904604|469423961|FG000|Overall Study|Lost to Follow-up|0|||
130397139|NCT01904604|469423962|FG001|Overall Study|Lost to Follow-up|0|||
130397140|NCT01904604|469423963|FG002|Overall Study|Lost to Follow-up|1|||
130397141|NCT01481116|469423968|FG000|Overall Study|Adverse Event|26|||
130397142|NCT01481116|469423969|FG001|Overall Study|Adverse Event|26|||
130397143|NCT01481116|469423970|FG002|Overall Study|Adverse Event|42|||
130397144|NCT01481116|469423968|FG000|Overall Study|Major Protocol Deviation|3|||
130397145|NCT01481116|469423969|FG001|Overall Study|Major Protocol Deviation|7|||
130397146|NCT01481116|469423970|FG002|Overall Study|Major Protocol Deviation|1|||
130397147|NCT01481116|469423968|FG000|Overall Study|Lost to Follow-up|8|||
130397148|NCT01481116|469423969|FG001|Overall Study|Lost to Follow-up|12|||
130397149|NCT01481116|469423970|FG002|Overall Study|Lost to Follow-up|11|||
130397150|NCT01481116|469423968|FG000|Overall Study|Withdrawal by Subject|37|||
130397151|NCT01481116|469423969|FG001|Overall Study|Withdrawal by Subject|33|||
130397152|NCT01481116|469423970|FG002|Overall Study|Withdrawal by Subject|37|||
130397153|NCT01481116|469423968|FG000|Overall Study|Study Termination|730|||
130397154|NCT01481116|469423969|FG001|Overall Study|Study Termination|729|||
130397155|NCT01481116|469423970|FG002|Overall Study|Study Termination|713|||
130397156|NCT01481116|469423968|FG000|Overall Study|Pregnancy|0|||
130397157|NCT01481116|469423969|FG001|Overall Study|Pregnancy|0|||
130397158|NCT01481116|469423970|FG002|Overall Study|Pregnancy|1|||
130397159|NCT01481116|469423968|FG000|Overall Study|Lack of Efficacy|3|||
130397160|NCT01481116|469423969|FG001|Overall Study|Lack of Efficacy|3|||
130397161|NCT01481116|469423970|FG002|Overall Study|Lack of Efficacy|1|||
130397162|NCT01481116|469423968|FG000|Overall Study|Contraindications|1|||
130397163|NCT01481116|469423969|FG001|Overall Study|Contraindications|1|||
130397164|NCT01481116|469423970|FG002|Overall Study|Contraindications|0|||
130397165|NCT01481116|469423968|FG000|Overall Study|Other|1|||
130397166|NCT01481116|469423969|FG001|Overall Study|Other|1|||
130397167|NCT01481116|469423970|FG002|Overall Study|Other|0|||
130397168|NCT01481116|469423968|FG000|Overall Study|Participant Started Taking Glipizide|1|||
130397169|NCT01481116|469423969|FG001|Overall Study|Participant Started Taking Glipizide|0|||
130397170|NCT01481116|469423970|FG002|Overall Study|Participant Started Taking Glipizide|0|||
130397171|NCT01481116|469423968|FG000|Overall Study|Participant Moved Out of Area|2|||
130397172|NCT01481116|469423969|FG001|Overall Study|Participant Moved Out of Area|0|||
130397173|NCT01481116|469423970|FG002|Overall Study|Participant Moved Out of Area|1|||
130397174|NCT01481116|469423968|FG000|Overall Study|Participant Moved Out of Country|1|||
130397175|NCT01481116|469423969|FG001|Overall Study|Participant Moved Out of Country|0|||
130397176|NCT01481116|469423970|FG002|Overall Study|Participant Moved Out of Country|1|||
130397177|NCT01481116|469423968|FG000|Overall Study|Investigator Decision|3|||
130397178|NCT01481116|469423969|FG001|Overall Study|Investigator Decision|2|||
130397179|NCT01481116|469423970|FG002|Overall Study|Investigator Decision|1|||
130397180|NCT01481116|469423968|FG000|Overall Study|Sponsor Decision|0|||
130397181|NCT01481116|469423969|FG001|Overall Study|Sponsor Decision|1|||
130397182|NCT01481116|469423970|FG002|Overall Study|Sponsor Decision|3|||
130560118|NCT02060383|470019712|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
130723294|NCT00805467|470613410|FG000|Overall Study|Death|0|||
130397183|NCT01481116|469423968|FG000|Overall Study|Non-Compliant With Study Drug|0|||
130397184|NCT01481116|469423969|FG001|Overall Study|Non-Compliant With Study Drug|1|||
130397185|NCT01481116|469423970|FG002|Overall Study|Non-Compliant With Study Drug|1|||
130397186|NCT01481116|469423968|FG000|Overall Study|Investigator's Discretion|2|||
130397187|NCT01481116|469423969|FG001|Overall Study|Investigator's Discretion|0|||
130397188|NCT01481116|469423970|FG002|Overall Study|Investigator's Discretion|0|||
130397189|NCT01481116|469423968|FG000|Overall Study|Death|2|||
130397190|NCT01481116|469423969|FG001|Overall Study|Death|1|||
130397191|NCT01481116|469423970|FG002|Overall Study|Death|0|||
130397192|NCT01481116|469423968|FG000|Overall Study|Hypoglycemic Event|4|||
130397193|NCT01481116|469423969|FG001|Overall Study|Hypoglycemic Event|0|||
130397194|NCT01481116|469423970|FG002|Overall Study|Hypoglycemic Event|0|||
130397195|NCT01782313|469423988|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
130397196|NCT01782313|469423988|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
130397197|NCT01782313|469423988|FG000|Treated Cycle 3|Progressive Disease|21|||
130560119|NCT02060383|470019713|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
130560120|NCT02060383|470019709|FG000|Extension Phase|Adverse Event|1|||
130560121|NCT02060383|470019710|FG001|Extension Phase|Adverse Event|1|||
130560122|NCT02060383|470019711|FG002|Extension Phase|Adverse Event|2|||
130723295|NCT00805467|470613411|FG001|Overall Study|Death|2|||
130723296|NCT00805467|470613412|FG002|Overall Study|Death|7|||
130723297|NCT00805467|470613413|FG003|Overall Study|Death|5|||
130723298|NCT00805467|470613410|FG000|Overall Study|Physician Decision|0|||
130723299|NCT00805467|470613411|FG001|Overall Study|Physician Decision|1|||
130723300|NCT00805467|470613412|FG002|Overall Study|Physician Decision|2|||
130397198|NCT01782313|469423988|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
130397199|NCT01782313|469423988|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
130397200|NCT01782313|469423988|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
130397201|NCT01782313|469423988|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
130397202|NCT01782313|469423988|FG000|Survival Follow up|Lost to Follow-up|1|||
130397203|NCT04476017|469423992|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
130397204|NCT04476017|469423993|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
130397205|NCT02704364|469423994|FG000|Overall Study|Adverse Event|1|||
130397206|NCT02704364|469423995|FG001|Overall Study|Adverse Event|1|||
130397207|NCT02704364|469423996|FG002|Overall Study|Adverse Event|0|||
130397208|NCT02704364|469423994|FG000|Overall Study|Noncompliance with study drug|1|||
130397209|NCT02704364|469423995|FG001|Overall Study|Noncompliance with study drug|1|||
130397210|NCT02704364|469423996|FG002|Overall Study|Noncompliance with study drug|0|||
130397211|NCT02704364|469423994|FG000|Overall Study|Other|0|||
130397212|NCT02704364|469423995|FG001|Overall Study|Other|1|||
130397213|NCT02704364|469423996|FG002|Overall Study|Other|1|||
130397214|NCT02975934|469423997|FG000|Treatment Phase|Never initiated study drug|0|||
130397215|NCT02975934|469423998|FG001|Treatment Phase|Never initiated study drug|5|||
130397216|NCT02975934|469423999|FG002|Treatment Phase|Never initiated study drug|0|||
130397217|NCT03362502|469424000|FG000|Overall Study|Death|0|||
130397218|NCT03362502|469424001|FG001|Overall Study|Death|0|||
130397219|NCT03362502|469424002|FG002|Overall Study|Death|1|||
130397220|NCT02075840|469424003|FG000|Overall Study|Withdrawal by Subject|13|||
130397221|NCT02075840|469424004|FG001|Overall Study|Withdrawal by Subject|22|||
130397222|NCT02075840|469424003|FG000|Overall Study|Reason not specified|1|||
130397223|NCT02075840|469424004|FG001|Overall Study|Reason not specified|0|||
130397224|NCT02075840|469424003|FG000|Overall Study|Adverse Event|0|||
130397225|NCT02075840|469424004|FG001|Overall Study|Adverse Event|2|||
130397226|NCT02075840|469424003|FG000|Overall Study|Death|35|||
130397227|NCT02075840|469424004|FG001|Overall Study|Death|40|||
130397228|NCT02075840|469424003|FG000|Overall Study|Lost to Follow-up|3|||
130397229|NCT02075840|469424004|FG001|Overall Study|Lost to Follow-up|2|||
130397230|NCT02075840|469424003|FG000|Overall Study|Physician Decision|1|||
130397231|NCT02075840|469424004|FG001|Overall Study|Physician Decision|3|||
130397232|NCT02075840|469424003|FG000|Overall Study|Ongoing at CCOD|99|||
130397233|NCT02075840|469424004|FG001|Overall Study|Ongoing at CCOD|82|||
130397234|NCT04889625|469424017|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
130397235|NCT04889625|469424018|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
130397236|NCT04889625|469424017|FG000|Period 1|Subject out of window|0|||
130397237|NCT04889625|469424018|FG001|Period 1|Subject out of window|1|||
130397238|NCT04889625|469424017|FG000|Period 1|Wrong add power dispensed|0|||
130397239|NCT04889625|469424018|FG001|Period 1|Wrong add power dispensed|1|||
130397240|NCT04889625|469424017|FG000|Period 1|Discontinued due to fitting guide error|1|||
130397241|NCT04889625|469424018|FG001|Period 1|Discontinued due to fitting guide error|1|||
130397242|NCT04889625|469424017|FG000|Period 2|Test article no longer available|1|||
130397243|NCT04889625|469424018|FG001|Period 2|Test article no longer available|0|||
130397244|NCT04889625|469424017|FG000|Period 2|Incorrect lens dispensed|1|||
130397245|NCT04889625|469424018|FG001|Period 2|Incorrect lens dispensed|0|||
130397246|NCT04889625|469424017|FG000|Period 2|Wrong add power dispensed|0|||
130397247|NCT04889625|469424018|FG001|Period 2|Wrong add power dispensed|1|||
130397248|NCT03473743|469424021|FG000|Overall Study|Withdrawal by Subject|0|||
130397249|NCT03473743|469424022|FG001|Overall Study|Withdrawal by Subject|0|||
130397250|NCT03473743|469424023|FG002|Overall Study|Withdrawal by Subject|0|||
130397251|NCT03473743|469424024|FG003|Overall Study|Withdrawal by Subject|0|||
130397252|NCT03473743|469424025|FG004|Overall Study|Withdrawal by Subject|0|||
130397253|NCT03473743|469424026|FG005|Overall Study|Withdrawal by Subject|0|||
130397254|NCT03473743|469424027|FG006|Overall Study|Withdrawal by Subject|0|||
130397255|NCT03473743|469424028|FG007|Overall Study|Withdrawal by Subject|3|||
130560123|NCT02060383|470019712|FG003|Extension Phase|Adverse Event|0|||
130560124|NCT02060383|470019713|FG004|Extension Phase|Adverse Event|1|||
130723301|NCT00805467|470613413|FG003|Overall Study|Physician Decision|6|||
130723302|NCT00805467|470613410|FG000|Overall Study|Not reported|0|||
130397256|NCT03473743|469424021|FG000|Overall Study|Other|0|||
130397257|NCT03473743|469424022|FG001|Overall Study|Other|0|||
130397258|NCT03473743|469424023|FG002|Overall Study|Other|0|||
130397259|NCT03473743|469424024|FG003|Overall Study|Other|1|||
130397260|NCT03473743|469424025|FG004|Overall Study|Other|0|||
130397261|NCT03473743|469424026|FG005|Overall Study|Other|0|||
130397262|NCT03473743|469424027|FG006|Overall Study|Other|0|||
130397263|NCT03473743|469424028|FG007|Overall Study|Other|0|||
130397264|NCT03473743|469424021|FG000|Overall Study|Ongoing|0|||
130560125|NCT02060383|470019709|FG000|Extension Phase|Withdrawal by Subject|0|||
130560126|NCT02060383|470019710|FG001|Extension Phase|Withdrawal by Subject|1|||
130560127|NCT02060383|470019711|FG002|Extension Phase|Withdrawal by Subject|0|||
130560128|NCT02060383|470019712|FG003|Extension Phase|Withdrawal by Subject|0|||
130560129|NCT02060383|470019713|FG004|Extension Phase|Withdrawal by Subject|2|||
130560130|NCT02060383|470019709|FG000|Extension Phase|Administrative problems|1|||
130560131|NCT02060383|470019710|FG001|Extension Phase|Administrative problems|0|||
130560132|NCT02060383|470019711|FG002|Extension Phase|Administrative problems|0|||
130560133|NCT02060383|470019712|FG003|Extension Phase|Administrative problems|0|||
130560134|NCT02060383|470019713|FG004|Extension Phase|Administrative problems|0|||
130560135|NCT02060383|470019709|FG000|Extension Phase|Death|0|||
130560136|NCT02060383|470019710|FG001|Extension Phase|Death|0|||
130560137|NCT02060383|470019711|FG002|Extension Phase|Death|1|||
130560138|NCT02060383|470019712|FG003|Extension Phase|Death|0|||
130560139|NCT02060383|470019713|FG004|Extension Phase|Death|1|||
130723303|NCT00805467|470613411|FG001|Overall Study|Not reported|0|||
130397265|NCT03473743|469424022|FG001|Overall Study|Ongoing|0|||
130397266|NCT03473743|469424023|FG002|Overall Study|Ongoing|6|||
130397267|NCT03473743|469424024|FG003|Overall Study|Ongoing|8|||
130397268|NCT03473743|469424025|FG004|Overall Study|Ongoing|1|||
130397269|NCT03473743|469424026|FG005|Overall Study|Ongoing|1|||
130397270|NCT03473743|469424027|FG006|Overall Study|Ongoing|22|||
130397271|NCT03473743|469424028|FG007|Overall Study|Ongoing|24|||
130397272|NCT03473743|469424021|FG000|Overall Study|Randomized but not treated|0|||
130397273|NCT03473743|469424022|FG001|Overall Study|Randomized but not treated|0|||
130397274|NCT03473743|469424023|FG002|Overall Study|Randomized but not treated|0|||
130397275|NCT03473743|469424024|FG003|Overall Study|Randomized but not treated|0|||
130397276|NCT03473743|469424025|FG004|Overall Study|Randomized but not treated|0|||
130397277|NCT03473743|469424026|FG005|Overall Study|Randomized but not treated|0|||
130397278|NCT03473743|469424027|FG006|Overall Study|Randomized but not treated|1|||
130397279|NCT03473743|469424028|FG007|Overall Study|Randomized but not treated|1|||
130397280|NCT02552316|469424030|FG000|Overall Study|Withdrawal by Subject|1|||
130397281|NCT02552316|469424030|FG000|Overall Study|Withdrawal due to non-compliance|1|||
130397282|NCT02659020|469424031|FG000|Overall Study|Adverse Event|0|||
130397283|NCT02659020|469424032|FG001|Overall Study|Adverse Event|0|||
130397284|NCT02659020|469424033|FG002|Overall Study|Adverse Event|0|||
130397285|NCT02659020|469424034|FG003|Overall Study|Adverse Event|2|||
130397286|NCT02659020|469424035|FG004|Overall Study|Adverse Event|0|||
130397287|NCT02659020|469424036|FG005|Overall Study|Adverse Event|0|||
130397288|NCT02659020|469424037|FG006|Overall Study|Adverse Event|2|||
130397289|NCT02659020|469424031|FG000|Overall Study|Lost to Follow-up|1|||
130397290|NCT02659020|469424032|FG001|Overall Study|Lost to Follow-up|2|||
130397291|NCT02659020|469424033|FG002|Overall Study|Lost to Follow-up|1|||
130397292|NCT02659020|469424034|FG003|Overall Study|Lost to Follow-up|6|||
130397293|NCT02659020|469424035|FG004|Overall Study|Lost to Follow-up|1|||
130723304|NCT00805467|470613412|FG002|Overall Study|Not reported|3|||
130723305|NCT00805467|470613413|FG003|Overall Study|Not reported|7|||
130397294|NCT02659020|469424036|FG005|Overall Study|Lost to Follow-up|5|||
130397295|NCT02659020|469424037|FG006|Overall Study|Lost to Follow-up|0|||
130397296|NCT02659020|469424031|FG000|Overall Study|Physician Decision|0|||
130397297|NCT02659020|469424032|FG001|Overall Study|Physician Decision|0|||
130397298|NCT02659020|469424033|FG002|Overall Study|Physician Decision|0|||
130397299|NCT02659020|469424034|FG003|Overall Study|Physician Decision|1|||
130397300|NCT02659020|469424035|FG004|Overall Study|Physician Decision|1|||
130397301|NCT02659020|469424036|FG005|Overall Study|Physician Decision|0|||
130397302|NCT02659020|469424037|FG006|Overall Study|Physician Decision|1|||
130397303|NCT02659020|469424031|FG000|Overall Study|Withdrawal by Subject|2|||
130397304|NCT02659020|469424032|FG001|Overall Study|Withdrawal by Subject|1|||
130397305|NCT02659020|469424033|FG002|Overall Study|Withdrawal by Subject|0|||
130397306|NCT02659020|469424034|FG003|Overall Study|Withdrawal by Subject|3|||
130397307|NCT02659020|469424035|FG004|Overall Study|Withdrawal by Subject|3|||
130397308|NCT02659020|469424036|FG005|Overall Study|Withdrawal by Subject|6|||
130397309|NCT02659020|469424037|FG006|Overall Study|Withdrawal by Subject|3|||
130397310|NCT02659020|469424031|FG000|Overall Study|Progressive Disease|0|||
130397311|NCT02659020|469424032|FG001|Overall Study|Progressive Disease|0|||
130397312|NCT02659020|469424033|FG002|Overall Study|Progressive Disease|0|||
130397313|NCT02659020|469424034|FG003|Overall Study|Progressive Disease|4|||
130397314|NCT02659020|469424035|FG004|Overall Study|Progressive Disease|1|||
130560140|NCT02060383|470019709|FG000|Extension Phase|Protocol Violation|0|||
130560141|NCT02060383|470019710|FG001|Extension Phase|Protocol Violation|0|||
130560142|NCT02060383|470019711|FG002|Extension Phase|Protocol Violation|0|||
130723306|NCT05307510|470613416|FG000|Overall Study|Lost to Follow-up|3|||
130397315|NCT02659020|469424036|FG005|Overall Study|Progressive Disease|0|||
130397316|NCT02659020|469424037|FG006|Overall Study|Progressive Disease|2|||
130397317|NCT04382911|469424038|FG000|Overall Study|unable to be imaged prior to surgery|2|||
130397318|NCT01585766|469424044|FG000|Overall Study|Withdrawal by Subject|0|||
130397319|NCT01585766|469424045|FG001|Overall Study|Withdrawal by Subject|1|||
130397320|NCT01585766|469424046|FG002|Overall Study|Withdrawal by Subject|1|||
130397321|NCT01585766|469424047|FG003|Overall Study|Withdrawal by Subject|0|||
130397322|NCT01585766|469424048|FG004|Overall Study|Withdrawal by Subject|0|||
130397323|NCT01585766|469424049|FG005|Overall Study|Withdrawal by Subject|0|||
130397324|NCT01585766|469424044|FG000|Overall Study|Death|0|||
130397325|NCT01585766|469424045|FG001|Overall Study|Death|1|||
130397326|NCT01585766|469424046|FG002|Overall Study|Death|0|||
130397327|NCT01585766|469424047|FG003|Overall Study|Death|0|||
130397328|NCT01585766|469424048|FG004|Overall Study|Death|0|||
130397329|NCT01585766|469424049|FG005|Overall Study|Death|0|||
130397330|NCT01585766|469424044|FG000|Overall Study|Physician Decision|0|||
130397331|NCT01585766|469424045|FG001|Overall Study|Physician Decision|0|||
130397332|NCT01585766|469424046|FG002|Overall Study|Physician Decision|1|||
130397333|NCT01585766|469424047|FG003|Overall Study|Physician Decision|0|||
130397334|NCT01585766|469424048|FG004|Overall Study|Physician Decision|0|||
130397335|NCT01585766|469424049|FG005|Overall Study|Physician Decision|0|||
130397336|NCT01120210|469424050|FG000|MAIN INFUSION|Adverse Event|1|||
130397337|NCT01120210|469424051|FG001|MAIN INFUSION|Adverse Event|0|||
130397338|NCT01120210|469424050|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
130397339|NCT01120210|469424051|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
130397340|NCT02052739|469424052|FG000|Overall Study|Withdrew due to Adverse Event|3|||
130397341|NCT02052739|469424053|FG001|Overall Study|Withdrew due to Adverse Event|0|||
130397342|NCT02052739|469424052|FG000|Overall Study|Participant Died|2|||
130397343|NCT02052739|469424053|FG001|Overall Study|Participant Died|1|||
130397344|NCT02043015|469424064|FG000|Overall Study|Lost to Follow-up|4|||
130397345|NCT02043015|469424064|FG000|Overall Study|Withdrawal by Subject|4|||
130397346|NCT02043015|469424064|FG000|Overall Study|Removed once target enrollment reached|15|||
130397347|NCT02043015|469424064|FG000|Overall Study|Participant moved away from study city|4|||
130397348|NCT02043015|469424064|FG000|Overall Study|Incarceration|1|||
130397349|NCT04049760|469424066|FG000|Overall Study|Withdrawal by Subject|1|||
130397350|NCT01526889|469424067|FG000|Treatment Period|Adverse Event|2|||
130397351|NCT01526889|469424068|FG001|Treatment Period|Adverse Event|0|||
130397352|NCT01526889|469424067|FG000|Treatment Extension Period|Administrative problems|1|||
130397353|NCT01526889|469424068|FG001|Treatment Extension Period|Administrative problems|0|||
130397354|NCT00974571|469424071|FG000|Overall Study|Adverse Event|31|||
130397355|NCT00974571|469424072|FG001|Overall Study|Adverse Event|4|||
130397356|NCT00974571|469424073|FG002|Overall Study|Adverse Event|27|||
130397357|NCT00974571|469424071|FG000|Overall Study|Lack of Efficacy|3|||
130397358|NCT00974571|469424072|FG001|Overall Study|Lack of Efficacy|2|||
130397359|NCT00974571|469424073|FG002|Overall Study|Lack of Efficacy|9|||
130397360|NCT00974571|469424071|FG000|Overall Study|Lost to Follow-up|2|||
130397361|NCT00974571|469424072|FG001|Overall Study|Lost to Follow-up|1|||
130397362|NCT00974571|469424073|FG002|Overall Study|Lost to Follow-up|2|||
130397363|NCT00974571|469424071|FG000|Overall Study|Protocol Violation|13|||
130397364|NCT00974571|469424072|FG001|Overall Study|Protocol Violation|4|||
130397365|NCT00974571|469424073|FG002|Overall Study|Protocol Violation|18|||
130397366|NCT00974571|469424071|FG000|Overall Study|Withdrawal by Subject|14|||
130397367|NCT00974571|469424072|FG001|Overall Study|Withdrawal by Subject|5|||
130397368|NCT00974571|469424073|FG002|Overall Study|Withdrawal by Subject|16|||
130397369|NCT00974571|469424071|FG000|Overall Study|Patient Moved|1|||
130397370|NCT00974571|469424072|FG001|Overall Study|Patient Moved|0|||
130397371|NCT00974571|469424073|FG002|Overall Study|Patient Moved|1|||
130397372|NCT00974571|469424071|FG000|Overall Study|Other|4|||
130397373|NCT00974571|469424072|FG001|Overall Study|Other|0|||
130397374|NCT00974571|469424073|FG002|Overall Study|Other|10|||
130397375|NCT01494610|469424091|FG000|Period 1|Withdrawal by Subject|1|||
130397376|NCT01494610|469424092|FG001|Period 1|Withdrawal by Subject|1|||
130397377|NCT01494610|469424091|FG000|Period 3|Adverse Event|1|||
130397378|NCT01494610|469424092|FG001|Period 3|Adverse Event|0|||
130397379|NCT01494610|469424091|FG000|Period 3|Withdrawal by Subject|1|||
130397380|NCT01494610|469424092|FG001|Period 3|Withdrawal by Subject|0|||
130397381|NCT01494610|469424091|FG000|Period 4|Protocol Violation|1|||
130397382|NCT01494610|469424092|FG001|Period 4|Protocol Violation|0|||
130397383|NCT02385799|469424095|FG000|Overall Study|Lost to Follow-up|1|||
130397384|NCT02385799|469424096|FG001|Overall Study|Lost to Follow-up|2|||
130397385|NCT02385799|469424095|FG000|Overall Study|Adverse Event|4|||
130397386|NCT02385799|469424096|FG001|Overall Study|Adverse Event|2|||
130397387|NCT02385799|469424095|FG000|Overall Study|Withdrawal by Subject|0|||
130397388|NCT02385799|469424096|FG001|Overall Study|Withdrawal by Subject|4|||
130723307|NCT05307510|470613417|FG001|Overall Study|Lost to Follow-up|6|||
130723308|NCT05307510|470613416|FG000|Overall Study|Withdrawal by Subject|0|||
130397389|NCT00477672|469424100|FG000|Overall Study|Adverse Event|3|||
130397390|NCT00477672|469424101|FG001|Overall Study|Adverse Event|5|||
130397391|NCT00477672|469424102|FG002|Overall Study|Adverse Event|6|||
130397392|NCT00477672|469424100|FG000|Overall Study|Death|0|||
130397393|NCT00477672|469424101|FG001|Overall Study|Death|1|||
130397394|NCT00477672|469424102|FG002|Overall Study|Death|0|||
130397395|NCT00477672|469424100|FG000|Overall Study|Disease progression|0|||
130397396|NCT00477672|469424101|FG001|Overall Study|Disease progression|1|||
130397397|NCT00477672|469424102|FG002|Overall Study|Disease progression|0|||
130397398|NCT00477672|469424100|FG000|Overall Study|Physician Decision|1|||
130397399|NCT00477672|469424101|FG001|Overall Study|Physician Decision|0|||
130397400|NCT00477672|469424102|FG002|Overall Study|Physician Decision|0|||
130397401|NCT00477672|469424100|FG000|Overall Study|Protocol noncompliance|0|||
130397402|NCT00477672|469424101|FG001|Overall Study|Protocol noncompliance|2|||
130397403|NCT00477672|469424102|FG002|Overall Study|Protocol noncompliance|0|||
130397404|NCT00477672|469424100|FG000|Overall Study|Consent withdrawn|2|||
130397405|NCT00477672|469424101|FG001|Overall Study|Consent withdrawn|5|||
130397406|NCT00477672|469424102|FG002|Overall Study|Consent withdrawn|10|||
130397407|NCT00477672|469424100|FG000|Overall Study|Discretion of Sponsor|1|||
130397408|NCT00477672|469424101|FG001|Overall Study|Discretion of Sponsor|2|||
130397409|NCT00477672|469424102|FG002|Overall Study|Discretion of Sponsor|0|||
130397410|NCT03571516|469424103|FG000|Overall Study|Severe diarrhea|1|||
130397411|NCT03571516|469424104|FG001|Overall Study|Severe diarrhea|0|||
130397412|NCT03571516|469424103|FG000|Overall Study|Withdrawal by Subject|0|||
130397413|NCT03571516|469424104|FG001|Overall Study|Withdrawal by Subject|1|||
130397414|NCT03044197|469424107|FG000|Overall Study|Withdrawal by Subject|3|||
130397415|NCT03044197|469424108|FG001|Overall Study|Withdrawal by Subject|1|||
130397416|NCT00989833|469424113|FG000|Overall Study|Lost to Follow-up|0|||
130397417|NCT00989833|469424114|FG001|Overall Study|Lost to Follow-up|1|||
130397418|NCT00989833|469424115|FG002|Overall Study|Lost to Follow-up|0|||
130397419|NCT00989833|469424113|FG000|Overall Study|Protocol Violation|1|||
130397420|NCT00989833|469424114|FG001|Overall Study|Protocol Violation|2|||
130397421|NCT00989833|469424115|FG002|Overall Study|Protocol Violation|1|||
130397422|NCT00989833|469424113|FG000|Overall Study|Withdrawal by Subject|0|||
130397423|NCT00989833|469424114|FG001|Overall Study|Withdrawal by Subject|0|||
130397424|NCT00989833|469424115|FG002|Overall Study|Withdrawal by Subject|1|||
130397425|NCT00989833|469424113|FG000|Overall Study|Incorrectly randomized|1|||
130397426|NCT00989833|469424114|FG001|Overall Study|Incorrectly randomized|0|||
130397427|NCT00989833|469424115|FG002|Overall Study|Incorrectly randomized|0|||
130397428|NCT02469610|469424116|FG000|Overall Study|Death|1|||
130397429|NCT02469610|469424117|FG001|Overall Study|Death|0|||
130397430|NCT02469610|469424116|FG000|Overall Study|Lost to Follow-up|1|||
130397431|NCT02469610|469424117|FG001|Overall Study|Lost to Follow-up|0|||
130397432|NCT02469610|469424116|FG000|Overall Study|exclusion criteria|2|||
130397433|NCT02469610|469424117|FG001|Overall Study|exclusion criteria|1|||
130397434|NCT01806896|469424118|FG000|Overall Study|Adverse Event|2|||
130397435|NCT01806896|469424119|FG001|Overall Study|Adverse Event|0|||
130397436|NCT01806896|469424118|FG000|Overall Study|Other|1|||
130397437|NCT01806896|469424119|FG001|Overall Study|Other|0|||
130397438|NCT02434770|469424120|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
130397439|NCT02434770|469424121|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
130397440|NCT02434770|469424122|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
130397441|NCT02434770|469424120|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
130397442|NCT02434770|469424121|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
130397443|NCT02434770|469424122|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
130397444|NCT02434770|469424120|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
130723309|NCT05307510|470613417|FG001|Overall Study|Withdrawal by Subject|1|||
130723310|NCT03610516|470613420|FG000|Treatment Epoch|Adverse Event|3|||
130723311|NCT03610516|470613421|FG001|Treatment Epoch|Adverse Event|1|||
130723312|NCT03610516|470613420|FG000|Treatment Epoch|Death|1|||
130723313|NCT03610516|470613421|FG001|Treatment Epoch|Death|0|||
130723314|NCT03610516|470613420|FG000|Treatment Epoch|Lack of Efficacy|0|||
130397445|NCT02434770|469424121|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
130397446|NCT02434770|469424122|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
130397447|NCT02434770|469424120|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
130397448|NCT02434770|469424121|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
130397449|NCT02434770|469424122|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
130397450|NCT02434770|469424120|FG000|Week 1 to Week 18|Death|1|||
130397451|NCT02434770|469424121|FG001|Week 1 to Week 18|Death|0|||
130397452|NCT02434770|469424122|FG002|Week 1 to Week 18|Death|0|||
130397453|NCT02434770|469424120|FG000|Week 18 to Week|Lost to Follow-up|2|||
130397454|NCT02434770|469424121|FG001|Week 18 to Week|Lost to Follow-up|2|||
130397455|NCT02434770|469424122|FG002|Week 18 to Week|Lost to Follow-up|1|||
130397456|NCT02434770|469424120|FG000|Week 18 to Week|Withdrawal by Subject|0|||
130397457|NCT02434770|469424121|FG001|Week 18 to Week|Withdrawal by Subject|0|||
130397458|NCT02434770|469424122|FG002|Week 18 to Week|Withdrawal by Subject|2|||
130723315|NCT03610516|470613421|FG001|Treatment Epoch|Lack of Efficacy|1|||
130723316|NCT03610516|470613420|FG000|Treatment Epoch|No longer requires treatment|1|||
130397459|NCT02434770|469424120|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
130397460|NCT02434770|469424121|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
130397461|NCT02434770|469424122|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
130397462|NCT00245765|469424123|FG000|Overall Study|Adverse Event|1|||
130397463|NCT00245765|469424124|FG001|Overall Study|Adverse Event|1|||
130397464|NCT00245765|469424125|FG002|Overall Study|Adverse Event|0|||
130397465|NCT00245765|469424123|FG000|Overall Study|Lack of Efficacy|14|||
130397466|NCT00245765|469424124|FG001|Overall Study|Lack of Efficacy|7|||
130397467|NCT00245765|469424125|FG002|Overall Study|Lack of Efficacy|0|||
130397468|NCT00245765|469424123|FG000|Overall Study|Lost to Follow-up|1|||
130397469|NCT00245765|469424124|FG001|Overall Study|Lost to Follow-up|2|||
130397470|NCT00245765|469424125|FG002|Overall Study|Lost to Follow-up|0|||
130397471|NCT00245765|469424123|FG000|Overall Study|Withdrawal by Subject|1|||
130397472|NCT00245765|469424124|FG001|Overall Study|Withdrawal by Subject|0|||
130397473|NCT00245765|469424125|FG002|Overall Study|Withdrawal by Subject|3|||
130397474|NCT00245765|469424123|FG000|Overall Study|Other reason|2|||
130397475|NCT00245765|469424124|FG001|Overall Study|Other reason|0|||
130397476|NCT00245765|469424125|FG002|Overall Study|Other reason|1|||
130397477|NCT00245765|469424123|FG000|Overall Study|Other|13|||
130397478|NCT00245765|469424124|FG001|Overall Study|Other|4|||
130397479|NCT00245765|469424125|FG002|Overall Study|Other|4|||
130397480|NCT00660348|469424126|FG000|Overall Study|Withdrawal by Subject|1|||
130397481|NCT00660348|469424127|FG001|Overall Study|Withdrawal by Subject|0|||
130397482|NCT03316872|469424131|FG000|Overall Study|Death|1|||
130397483|NCT04074317|469424135|FG000|Third Period|Withdrawal by Subject|0|||
130397484|NCT04074317|469424136|FG001|Third Period|Withdrawal by Subject|0|||
130397485|NCT04074317|469424137|FG002|Third Period|Withdrawal by Subject|0|||
130397486|NCT04074317|469424138|FG003|Third Period|Withdrawal by Subject|1|||
130397487|NCT04074317|469424139|FG004|Third Period|Withdrawal by Subject|0|||
130397488|NCT04074317|469424140|FG005|Third Period|Withdrawal by Subject|0|||
130397489|NCT01101841|469426251|FG000|Overall Study|Adverse Event|15|||
130397490|NCT01101841|469426252|FG001|Overall Study|Adverse Event|15|||
130397491|NCT01101841|469426251|FG000|Overall Study|Lost to Follow-up|9|||
130397492|NCT01101841|469426252|FG001|Overall Study|Lost to Follow-up|3|||
130397493|NCT01101841|469426251|FG000|Overall Study|Withdrawal by Subject|21|||
130397494|NCT01101841|469426252|FG001|Overall Study|Withdrawal by Subject|40|||
130397495|NCT01101841|469426251|FG000|Overall Study|Protocol Violation|1|||
130397496|NCT01101841|469426252|FG001|Overall Study|Protocol Violation|1|||
130397497|NCT01101841|469426251|FG000|Overall Study|Physician Decision|0|||
130397498|NCT01101841|469426252|FG001|Overall Study|Physician Decision|2|||
130397499|NCT01101841|469426251|FG000|Overall Study|Lack of Efficacy|0|||
130397500|NCT01101841|469426252|FG001|Overall Study|Lack of Efficacy|2|||
130397501|NCT01101841|469426251|FG000|Overall Study|Other|0|||
130397502|NCT01101841|469426252|FG001|Overall Study|Other|1|||
130397503|NCT01101841|469426251|FG000|Overall Study|Suicidality Tracking Scale|3|||
130397504|NCT01101841|469426252|FG001|Overall Study|Suicidality Tracking Scale|1|||
130397505|NCT01101841|469426251|FG000|Overall Study|Eligibility Criteria|1|||
130397506|NCT01101841|469426252|FG001|Overall Study|Eligibility Criteria|2|||
130397507|NCT00653224|469426257|FG000|Overall Study|Adverse Event|2|||
130397508|NCT00653224|469426258|FG001|Overall Study|Adverse Event|1|||
130397509|NCT00653224|469426257|FG000|Overall Study|Lack of Efficacy|1|||
130397510|NCT00653224|469426258|FG001|Overall Study|Lack of Efficacy|2|||
130397511|NCT00653224|469426257|FG000|Overall Study|Loss of efficacy|1|||
130397512|NCT00653224|469426258|FG001|Overall Study|Loss of efficacy|0|||
130397513|NCT00653224|469426257|FG000|Overall Study|Lost to Follow-up|1|||
130397514|NCT00653224|469426258|FG001|Overall Study|Lost to Follow-up|0|||
130397515|NCT00653224|469426257|FG000|Overall Study|Other|2|||
130397516|NCT00653224|469426258|FG001|Overall Study|Other|4|||
130397517|NCT05308901|469426261|FG000|Overall Study|Death|6|||
130397518|NCT00640510|469426262|FG000|Overall Study|Lack of Efficacy|0|||
130397519|NCT00640510|469426263|FG001|Overall Study|Lack of Efficacy|1|||
130723317|NCT03610516|470613421|FG001|Treatment Epoch|No longer requires treatment|0|||
130723318|NCT03610516|470613420|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
130397520|NCT00640510|469426262|FG000|Overall Study|Protocol Violation|1|||
130397521|NCT00640510|469426263|FG001|Overall Study|Protocol Violation|0|||
130470750|NCT05575076|469690815|FG000|Overall Study|Death|7|||
130470751|NCT05575076|469690815|FG000|Overall Study|Lost to Follow-up|16|||
130470752|NCT05575076|469690815|FG000|Overall Study|Non-Compliance|3|||
130470753|NCT05575076|469690815|FG000|Overall Study|Physician Decision|6|||
130397522|NCT00640510|469426262|FG000|Overall Study|Physician Decision|0|||
130470754|NCT05575076|469690815|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
130397523|NCT00640510|469426263|FG001|Overall Study|Physician Decision|1|||
130397524|NCT00192075|469426264|FG000|Overall Study|Disease Progression|23|||
130397525|NCT00192075|469426265|FG001|Overall Study|Disease Progression|6|||
130397526|NCT00192075|469426264|FG000|Overall Study|Adverse Event|1|||
130397527|NCT00192075|469426265|FG001|Overall Study|Adverse Event|3|||
130397528|NCT00192075|469426264|FG000|Overall Study|Death|0|||
130397529|NCT00192075|469426265|FG001|Overall Study|Death|1|||
130397530|NCT00192075|469426264|FG000|Overall Study|Lack of Efficacy|0|||
130397531|NCT00192075|469426265|FG001|Overall Study|Lack of Efficacy|0|||
130397532|NCT00192075|469426264|FG000|Overall Study|Physician Decision|3|||
130397533|NCT00192075|469426265|FG001|Overall Study|Physician Decision|0|||
130397534|NCT00192075|469426264|FG000|Overall Study|Withdrawal by Subject|5|||
130397535|NCT00192075|469426265|FG001|Overall Study|Withdrawal by Subject|5|||
130397536|NCT00192075|469426264|FG000|Overall Study|Patient Non-Compliance|0|||
130397537|NCT00192075|469426265|FG001|Overall Study|Patient Non-Compliance|1|||
130397538|NCT00192075|469426264|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
130397539|NCT00192075|469426265|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
130397540|NCT00192075|469426264|FG000|Overall Study|Other|5|||
130397541|NCT00192075|469426265|FG001|Overall Study|Other|2|||
130397542|NCT00355238|469426267|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130397543|NCT00355238|469426268|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130397544|NCT00355238|469426269|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130397545|NCT00355238|469426270|FG003|Overall Study|Adverse event unrelated to study drug|1|||
130397546|NCT00355238|469426267|FG000|Overall Study|Death|1|||
130397547|NCT00355238|469426268|FG001|Overall Study|Death|0|||
130397548|NCT00355238|469426269|FG002|Overall Study|Death|0|||
130397549|NCT00355238|469426270|FG003|Overall Study|Death|0|||
130397550|NCT00355238|469426267|FG000|Overall Study|Disease progression|37|||
130397551|NCT00355238|469426268|FG001|Overall Study|Disease progression|36|||
130397552|NCT00355238|469426269|FG002|Overall Study|Disease progression|16|||
130397553|NCT00355238|469426270|FG003|Overall Study|Disease progression|11|||
130397554|NCT00355238|469426267|FG000|Overall Study|Study drug toxicity|11|||
130397555|NCT00355238|469426268|FG001|Overall Study|Study drug toxicity|7|||
130397556|NCT00355238|469426269|FG002|Overall Study|Study drug toxicity|5|||
130397557|NCT00355238|469426270|FG003|Overall Study|Study drug toxicity|2|||
130397558|NCT00355238|469426267|FG000|Overall Study|Participant withdrew consent|3|||
130397559|NCT00355238|469426268|FG001|Overall Study|Participant withdrew consent|1|||
130397560|NCT00355238|469426269|FG002|Overall Study|Participant withdrew consent|0|||
130397561|NCT00355238|469426270|FG003|Overall Study|Participant withdrew consent|0|||
130397562|NCT00355238|469426267|FG000|Overall Study|Participant request to discontinue study treatment|1|||
130397563|NCT00355238|469426268|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130397564|NCT00355238|469426269|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130397565|NCT00355238|469426270|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130397566|NCT01956110|469426271|FG000|Overall Study|Protocol Violation|25|||
130397567|NCT01956110|469426272|FG001|Overall Study|Protocol Violation|11|||
130397568|NCT01956110|469426271|FG000|Overall Study|Adverse Event|9|||
130397569|NCT01956110|469426272|FG001|Overall Study|Adverse Event|10|||
130397570|NCT01956110|469426271|FG000|Overall Study|Personal reasons|1|||
130723319|NCT03610516|470613421|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
130723320|NCT03610516|470613420|FG000|Treatment Epoch|Physician Decision|8|||
130397571|NCT01956110|469426272|FG001|Overall Study|Personal reasons|1|||
130397572|NCT03325166|469426277|FG000|Overall Study|Adverse Event|1|||
130397573|NCT01400841|469426281|FG000|Initial Study Phase (6 Months)|Death|1|||
130397574|NCT01400841|469426281|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
130397575|NCT00910715|469426282|FG000|Overall Study|Lost to Follow-up|22|||
130397576|NCT00910715|469426283|FG001|Overall Study|Lost to Follow-up|26|||
130397577|NCT00910715|469426284|FG002|Overall Study|Lost to Follow-up|0|||
130397578|NCT00770120|469426287|FG000|Overall Study|Progression|31|||
130397579|NCT00770120|469426287|FG000|Overall Study|Adverse Event|11|||
130397580|NCT00770120|469426287|FG000|Overall Study|Not Protocol Specified|11|||
130397581|NCT00770120|469426287|FG000|Overall Study|Death|3|||
130397582|NCT00770120|469426287|FG000|Overall Study|Withdrawal by Subject|2|||
130397583|NCT00770120|469426287|FG000|Overall Study|Ineligible|1|||
130397584|NCT00770120|469426287|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
130397585|NCT00770120|469426287|FG000|Overall Study|Reason under Review|1|||
130723321|NCT03610516|470613421|FG001|Treatment Epoch|Physician Decision|5|||
130723322|NCT03610516|470613420|FG000|Treatment Epoch|Protocol Deviation|1|||
130397586|NCT01467076|469426288|FG000|Overall Study|Lost to Follow-up|1|||
130397587|NCT01467076|469426289|FG001|Overall Study|Lost to Follow-up|0|||
130397588|NCT01467076|469426290|FG002|Overall Study|Lost to Follow-up|0|||
130397589|NCT02506816|469426299|FG000|Overall Study|Adverse Event|3|||
130723323|NCT03610516|470613421|FG001|Treatment Epoch|Protocol Deviation|0|||
130723324|NCT03610516|470613420|FG000|Treatment Epoch|Withdrawal by Subject|3|||
130397590|NCT03761628|469426301|FG000|Overall Study|Withdrawal by Subject|3|||
130397591|NCT03761628|469426301|FG000|Overall Study|Physician Decision|1|||
130397592|NCT03761628|469426301|FG000|Overall Study|Pregnancy|1|||
130397593|NCT03761628|469426301|FG000|Overall Study|Lost to Follow-up|1|||
130397594|NCT05358821|469426304|FG000|Overall Study|Withdrawal by Subject|0|||
130397595|NCT05358821|469426305|FG001|Overall Study|Withdrawal by Subject|1|||
130397596|NCT05358821|469426306|FG002|Overall Study|Withdrawal by Subject|0|||
130397597|NCT05358821|469426304|FG000|Overall Study|Withdrawal of Consent|0|||
130397598|NCT05358821|469426305|FG001|Overall Study|Withdrawal of Consent|0|||
130397599|NCT05358821|469426306|FG002|Overall Study|Withdrawal of Consent|1|||
130397600|NCT04649151|469426307|FG000|Overall Study|Pregnancy|0|||
130397601|NCT04649151|469426308|FG001|Overall Study|Pregnancy|0|||
130397602|NCT04649151|469426309|FG002|Overall Study|Pregnancy|0|||
130397603|NCT04649151|469426310|FG003|Overall Study|Pregnancy|0|||
130397604|NCT04649151|469426311|FG004|Overall Study|Pregnancy|3|||
130397605|NCT04649151|469426307|FG000|Overall Study|Physician Decision|10|||
130397606|NCT04649151|469426308|FG001|Overall Study|Physician Decision|0|||
130397607|NCT04649151|469426309|FG002|Overall Study|Physician Decision|0|||
130397608|NCT04649151|469426310|FG003|Overall Study|Physician Decision|1|||
130397609|NCT04649151|469426311|FG004|Overall Study|Physician Decision|1|||
130397610|NCT04649151|469426307|FG000|Overall Study|Protocol Deviation|25|||
130397611|NCT04649151|469426308|FG001|Overall Study|Protocol Deviation|3|||
130397612|NCT04649151|469426309|FG002|Overall Study|Protocol Deviation|0|||
130397613|NCT04649151|469426310|FG003|Overall Study|Protocol Deviation|0|||
130397614|NCT04649151|469426311|FG004|Overall Study|Protocol Deviation|0|||
130397615|NCT04649151|469426307|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
130397616|NCT04649151|469426308|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
130397617|NCT04649151|469426309|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130397618|NCT04649151|469426310|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130397619|NCT04649151|469426311|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130397620|NCT04649151|469426307|FG000|Overall Study|Withdrawal by Subject|370|||
130397621|NCT04649151|469426308|FG001|Overall Study|Withdrawal by Subject|113|||
130397622|NCT04649151|469426309|FG002|Overall Study|Withdrawal by Subject|2|||
130397623|NCT04649151|469426310|FG003|Overall Study|Withdrawal by Subject|7|||
130397624|NCT04649151|469426311|FG004|Overall Study|Withdrawal by Subject|15|||
130397625|NCT04649151|469426307|FG000|Overall Study|Adverse Event|1|||
130397626|NCT04649151|469426308|FG001|Overall Study|Adverse Event|0|||
130397627|NCT04649151|469426309|FG002|Overall Study|Adverse Event|0|||
130397628|NCT04649151|469426310|FG003|Overall Study|Adverse Event|0|||
130397629|NCT04649151|469426311|FG004|Overall Study|Adverse Event|0|||
130397630|NCT04649151|469426307|FG000|Overall Study|Lost to Follow-up|256|||
130397631|NCT04649151|469426308|FG001|Overall Study|Lost to Follow-up|29|||
130397632|NCT04649151|469426309|FG002|Overall Study|Lost to Follow-up|10|||
130397633|NCT04649151|469426310|FG003|Overall Study|Lost to Follow-up|3|||
130397634|NCT04649151|469426311|FG004|Overall Study|Lost to Follow-up|6|||
130397635|NCT04649151|469426307|FG000|Overall Study|Other than specified|59|||
130397636|NCT04649151|469426308|FG001|Overall Study|Other than specified|294|||
130397637|NCT04649151|469426309|FG002|Overall Study|Other than specified|0|||
130397638|NCT04649151|469426310|FG003|Overall Study|Other than specified|0|||
130397639|NCT04649151|469426311|FG004|Overall Study|Other than specified|4|||
130397640|NCT04649151|469426307|FG000|Overall Study|Death|0|||
130397641|NCT04649151|469426308|FG001|Overall Study|Death|0|||
130397642|NCT04649151|469426309|FG002|Overall Study|Death|0|||
130397643|NCT04649151|469426310|FG003|Overall Study|Death|0|||
130397644|NCT04649151|469426311|FG004|Overall Study|Death|1|||
130397645|NCT03752619|469426312|FG000|Overall Study|Lost to Follow-up|2|||
130397646|NCT03752619|469426313|FG001|Overall Study|Lost to Follow-up|1|||
130397647|NCT03752619|469426312|FG000|Overall Study|Withdrawal by Subject|1|||
130397648|NCT03752619|469426313|FG001|Overall Study|Withdrawal by Subject|1|||
130397649|NCT03752619|469426312|FG000|Overall Study|Adverse Event|0|||
130397650|NCT03752619|469426313|FG001|Overall Study|Adverse Event|1|||
130397651|NCT03907683|469426314|FG000|Overall Study|Pregnancy|1|||
130397652|NCT03907683|469426314|FG000|Overall Study|Withdrawal by Subject|1|||
130397653|NCT03400332|469426315|FG000|Pre-Treatment|Other reasons|0|||
130397654|NCT03400332|469426316|FG001|Pre-Treatment|Other reasons|0|||
130397655|NCT03400332|469426317|FG002|Pre-Treatment|Other reasons|0|||
130397656|NCT03400332|469426318|FG003|Pre-Treatment|Other reasons|0|||
130397657|NCT03400332|469426319|FG004|Pre-Treatment|Other reasons|0|||
130397658|NCT03400332|469426320|FG005|Pre-Treatment|Other reasons|0|||
130397659|NCT03400332|469426321|FG006|Pre-Treatment|Other reasons|0|||
130397660|NCT03400332|469426322|FG007|Pre-Treatment|Other reasons|0|||
130397661|NCT03400332|469426323|FG008|Pre-Treatment|Other reasons|1|||
130723325|NCT03610516|470613421|FG001|Treatment Epoch|Withdrawal by Subject|1|||
130723326|NCT03610516|470613420|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
130723327|NCT03610516|470613421|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
130723328|NCT03610516|470613420|FG000|Post-Treatment Follow-up|Death|1|||
130723329|NCT03610516|470613421|FG001|Post-Treatment Follow-up|Death|0|||
130397662|NCT03400332|469426315|FG000|Pre-Treatment|No longer met study criteria|0|||
130723330|NCT01056289|470613424|FG000|Open-label Phase|Adverse Event|29|||
130397663|NCT03400332|469426316|FG001|Pre-Treatment|No longer met study criteria|0|||
130397664|NCT03400332|469426317|FG002|Pre-Treatment|No longer met study criteria|0|||
130397665|NCT03400332|469426318|FG003|Pre-Treatment|No longer met study criteria|0|||
130397666|NCT03400332|469426319|FG004|Pre-Treatment|No longer met study criteria|0|||
130397667|NCT03400332|469426320|FG005|Pre-Treatment|No longer met study criteria|0|||
130397668|NCT03400332|469426321|FG006|Pre-Treatment|No longer met study criteria|0|||
130397669|NCT03400332|469426322|FG007|Pre-Treatment|No longer met study criteria|0|||
130397670|NCT03400332|469426323|FG008|Pre-Treatment|No longer met study criteria|1|||
130397671|NCT03400332|469426315|FG000|Pre-Treatment|Withdrawal by Subject|0|||
130397672|NCT03400332|469426316|FG001|Pre-Treatment|Withdrawal by Subject|0|||
130397673|NCT03400332|469426317|FG002|Pre-Treatment|Withdrawal by Subject|0|||
130397674|NCT03400332|469426318|FG003|Pre-Treatment|Withdrawal by Subject|0|||
130397675|NCT03400332|469426319|FG004|Pre-Treatment|Withdrawal by Subject|0|||
130560143|NCT02060383|470019712|FG003|Extension Phase|Protocol Violation|0|||
130560144|NCT02060383|470019713|FG004|Extension Phase|Protocol Violation|1|||
130560145|NCT00761306|470019716|FG000|Overall Study|Adverse Event|5|||
130560146|NCT00761306|470019716|FG000|Overall Study|Lack of Efficacy|4|||
130397676|NCT03400332|469426320|FG005|Pre-Treatment|Withdrawal by Subject|0|||
130397677|NCT03400332|469426321|FG006|Pre-Treatment|Withdrawal by Subject|0|||
130397678|NCT03400332|469426322|FG007|Pre-Treatment|Withdrawal by Subject|0|||
130397679|NCT03400332|469426323|FG008|Pre-Treatment|Withdrawal by Subject|1|||
130397680|NCT03400332|469426315|FG000|Treatment|Participant withdrew consent|2|||
130397681|NCT03400332|469426316|FG001|Treatment|Participant withdrew consent|2|||
130397682|NCT03400332|469426317|FG002|Treatment|Participant withdrew consent|0|||
130397683|NCT03400332|469426318|FG003|Treatment|Participant withdrew consent|0|||
130397684|NCT03400332|469426319|FG004|Treatment|Participant withdrew consent|3|||
130397685|NCT03400332|469426320|FG005|Treatment|Participant withdrew consent|3|||
130397686|NCT03400332|469426321|FG006|Treatment|Participant withdrew consent|1|||
130397687|NCT03400332|469426322|FG007|Treatment|Participant withdrew consent|1|||
130397688|NCT03400332|469426323|FG008|Treatment|Participant withdrew consent|1|||
130397689|NCT03400332|469426315|FG000|Treatment|Other reasons|0|||
130397690|NCT03400332|469426316|FG001|Treatment|Other reasons|1|||
130397691|NCT03400332|469426317|FG002|Treatment|Other reasons|1|||
130397692|NCT03400332|469426318|FG003|Treatment|Other reasons|0|||
130397693|NCT03400332|469426319|FG004|Treatment|Other reasons|3|||
130397694|NCT03400332|469426320|FG005|Treatment|Other reasons|1|||
130397695|NCT03400332|469426321|FG006|Treatment|Other reasons|2|||
130397696|NCT03400332|469426322|FG007|Treatment|Other reasons|0|||
130397697|NCT03400332|469426323|FG008|Treatment|Other reasons|1|||
130397698|NCT03400332|469426315|FG000|Treatment|Lost to Follow-up|0|||
130397699|NCT03400332|469426316|FG001|Treatment|Lost to Follow-up|1|||
130397700|NCT03400332|469426317|FG002|Treatment|Lost to Follow-up|0|||
130397701|NCT03400332|469426318|FG003|Treatment|Lost to Follow-up|0|||
130397702|NCT03400332|469426319|FG004|Treatment|Lost to Follow-up|0|||
130397703|NCT03400332|469426320|FG005|Treatment|Lost to Follow-up|0|||
130397704|NCT03400332|469426321|FG006|Treatment|Lost to Follow-up|0|||
130397705|NCT03400332|469426322|FG007|Treatment|Lost to Follow-up|0|||
130397706|NCT03400332|469426323|FG008|Treatment|Lost to Follow-up|0|||
130397707|NCT03400332|469426315|FG000|Treatment|Death|3|||
130397708|NCT03400332|469426316|FG001|Treatment|Death|1|||
130397709|NCT03400332|469426317|FG002|Treatment|Death|2|||
130397710|NCT03400332|469426318|FG003|Treatment|Death|3|||
130397711|NCT03400332|469426319|FG004|Treatment|Death|6|||
130397712|NCT03400332|469426320|FG005|Treatment|Death|2|||
130397713|NCT03400332|469426321|FG006|Treatment|Death|1|||
130397714|NCT03400332|469426322|FG007|Treatment|Death|3|||
130397715|NCT03400332|469426323|FG008|Treatment|Death|6|||
130397716|NCT03901963|469426324|FG000|Overall Study|Lost to Follow-up|1|||
130397717|NCT03901963|469426325|FG001|Overall Study|Lost to Follow-up|1|||
130397718|NCT03901963|469426324|FG000|Overall Study|Physician Decision|1|||
130397719|NCT03901963|469426325|FG001|Overall Study|Physician Decision|2|||
130397720|NCT03901963|469426324|FG000|Overall Study|Protocol Violation|1|||
130397721|NCT03901963|469426325|FG001|Overall Study|Protocol Violation|1|||
130397722|NCT03901963|469426324|FG000|Overall Study|Withdrawal by Subject|4|||
130397723|NCT03901963|469426325|FG001|Overall Study|Withdrawal by Subject|11|||
130397724|NCT03901963|469426324|FG000|Overall Study|Ongoing|84|||
130397725|NCT03901963|469426325|FG001|Overall Study|Ongoing|73|||
130397726|NCT03901963|469426324|FG000|Overall Study|Randomized but not treated|3|||
130397727|NCT03901963|469426325|FG001|Overall Study|Randomized but not treated|3|||
130397728|NCT02018458|469426332|FG000|Overall Study|Death|4|||
130397729|NCT04033159|469426356|FG000|Washout Period|Physician Decision|0|||
130397730|NCT04033159|469426357|FG001|Washout Period|Physician Decision|1|||
130397731|NCT04033159|469426358|FG002|Washout Period|Physician Decision|0|||
130397732|NCT04033159|469426356|FG000|Washout Period|Study terminated by Sponsor|0|||
130397733|NCT04033159|469426357|FG001|Washout Period|Study terminated by Sponsor|7|||
130397734|NCT04033159|469426358|FG002|Washout Period|Study terminated by Sponsor|0|||
130397735|NCT04033159|469426356|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
130397736|NCT04033159|469426357|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
130397737|NCT04033159|469426358|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
130397738|NCT00116558|469426359|FG000|Overall Study|Death|11|||
130397739|NCT00116558|469426360|FG001|Overall Study|Death|5|||
130397740|NCT00116558|469426361|FG002|Overall Study|Death|3|||
130397741|NCT00116558|469426359|FG000|Overall Study|Withdrawal by Subject|17|||
130397742|NCT00116558|469426360|FG001|Overall Study|Withdrawal by Subject|3|||
130560147|NCT00761306|470019716|FG000|Overall Study|Protocol Violation|2|||
130397743|NCT00116558|469426361|FG002|Overall Study|Withdrawal by Subject|12|||
130397744|NCT00116558|469426359|FG000|Overall Study|disease progression|3|||
130397745|NCT00116558|469426360|FG001|Overall Study|disease progression|7|||
130397746|NCT00116558|469426361|FG002|Overall Study|disease progression|18|||
130397747|NCT02027844|469426362|FG000|Overall Study|Withdrawal by Subject|3|||
130397748|NCT02027844|469426363|FG001|Overall Study|Withdrawal by Subject|2|||
130397749|NCT02027844|469426364|FG002|Overall Study|Withdrawal by Subject|1|||
130397750|NCT02027844|469426362|FG000|Overall Study|Lost to Follow-up|0|||
130397751|NCT02027844|469426363|FG001|Overall Study|Lost to Follow-up|2|||
130397752|NCT02027844|469426364|FG002|Overall Study|Lost to Follow-up|1|||
130397753|NCT02027844|469426362|FG000|Overall Study|Protocol Violation|0|||
130397754|NCT02027844|469426363|FG001|Overall Study|Protocol Violation|2|||
130397755|NCT02027844|469426364|FG002|Overall Study|Protocol Violation|0|||
130397756|NCT02027844|469426362|FG000|Overall Study|Incomlete data|2|||
130397757|NCT02027844|469426363|FG001|Overall Study|Incomlete data|0|||
130397758|NCT02027844|469426364|FG002|Overall Study|Incomlete data|0|||
130397759|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
130397760|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
130397761|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Graft loss|1|||
130397762|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Graft loss|2|||
130397763|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Death|5|||
130397764|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Death|3|||
130397765|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
130397766|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
130397767|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
130397768|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
130397769|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
130397770|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
130397771|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
130397772|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
130397773|NCT00378014|469426365|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
130397774|NCT00378014|469426366|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
130397775|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
130397776|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
130397777|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Death|1|||
130397778|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Death|2|||
130397779|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
130397780|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
130397781|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
130397782|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
130397783|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
130397784|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
130397785|NCT00378014|469426365|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
130397786|NCT00378014|469426366|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
130397787|NCT00354172|469426367|FG000|Overall Study|Did not receive transplant|1|||
130397788|NCT02287896|469426373|FG000|Second Injection Visit|Withdrawal by Subject|0|||
130397789|NCT02287896|469426374|FG001|Second Injection Visit|Withdrawal by Subject|1|||
130397790|NCT01639040|469426375|FG000|Overall Study|Adverse Event|1|||
130397791|NCT01639040|469426376|FG001|Overall Study|Adverse Event|0|||
130397792|NCT05619692|469426377|FG000|Overall Study|Adverse Event|2|||
130397793|NCT05619692|469426378|FG001|Overall Study|Adverse Event|2|||
130397794|NCT05619692|469426377|FG000|Overall Study|Withdrawal by Participant|3|||
130397795|NCT05619692|469426378|FG001|Overall Study|Withdrawal by Participant|4|||
130397796|NCT05619692|469426377|FG000|Overall Study|Lost to Follow-up|2|||
130397797|NCT05619692|469426378|FG001|Overall Study|Lost to Follow-up|1|||
130397798|NCT05619692|469426377|FG000|Overall Study|Randomized but not treated|1|||
130397799|NCT05619692|469426378|FG001|Overall Study|Randomized but not treated|3|||
130397800|NCT05267054|469426379|FG000|Overall Study|Death|13|||
130397801|NCT05267054|469426380|FG001|Overall Study|Death|14|||
130397802|NCT05267054|469426379|FG000|Overall Study|Study Ended by Sponsor|9|||
130397803|NCT05267054|469426380|FG001|Overall Study|Study Ended by Sponsor|13|||
130397804|NCT05267054|469426379|FG000|Overall Study|Lost to Follow-up|1|||
130397805|NCT05267054|469426380|FG001|Overall Study|Lost to Follow-up|1|||
130397806|NCT05267054|469426379|FG000|Overall Study|Withdrawal by Subject|1|||
130397807|NCT05267054|469426380|FG001|Overall Study|Withdrawal by Subject|1|||
130397808|NCT02457598|469426381|FG000|Overall Study|Progressive Disease|2|||
130397809|NCT02457598|469426382|FG001|Overall Study|Progressive Disease|2|||
130397810|NCT02457598|469426383|FG002|Overall Study|Progressive Disease|1|||
130397811|NCT02457598|469426384|FG003|Overall Study|Progressive Disease|11|||
130397812|NCT02457598|469426385|FG004|Overall Study|Progressive Disease|7|||
130397813|NCT02457598|469426386|FG005|Overall Study|Progressive Disease|3|||
130397814|NCT02457598|469426387|FG006|Overall Study|Progressive Disease|2|||
130397815|NCT02457598|469426388|FG007|Overall Study|Progressive Disease|1|||
130397816|NCT02457598|469426389|FG008|Overall Study|Progressive Disease|1|||
130397817|NCT02457598|469426390|FG009|Overall Study|Progressive Disease|2|||
130397818|NCT02457598|469426391|FG010|Overall Study|Progressive Disease|45|||
130397819|NCT02457598|469426392|FG011|Overall Study|Progressive Disease|6|||
130397820|NCT02457598|469426393|FG012|Overall Study|Progressive Disease|2|||
130397821|NCT02457598|469426394|FG013|Overall Study|Progressive Disease|2|||
130397822|NCT02457598|469426395|FG014|Overall Study|Progressive Disease|10|||
130397823|NCT02457598|469426396|FG015|Overall Study|Progressive Disease|1|||
130397824|NCT02457598|469426397|FG016|Overall Study|Progressive Disease|1|||
130397825|NCT02457598|469426381|FG000|Overall Study|Investigator's Discretion|0|||
130560148|NCT00761306|470019716|FG000|Overall Study|Withdrawal of Consent|3|||
130560149|NCT00761306|470019716|FG000|Overall Study|Lost to Follow-up|1|||
130560150|NCT00761306|470019716|FG000|Overall Study|Administrative or Other Reasons|5|||
130560151|NCT05162027|470019717|FG000|Overall Study|Adverse Event|1|||
130560152|NCT05162027|470019718|FG001|Overall Study|Adverse Event|0|||
130560153|NCT03713034|470019719|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
130560154|NCT03713034|470019720|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
130560155|NCT02982239|470019723|FG000|Overall Study|Lost to Follow-up|3|||
130560156|NCT02982239|470019724|FG001|Overall Study|Lost to Follow-up|2|||
130560157|NCT02767323|470019731|FG000|Overall Study|Withdrawal by Subject|17|||
130560158|NCT02767323|470019732|FG001|Overall Study|Withdrawal by Subject|5|||
130560159|NCT02767323|470019733|FG002|Overall Study|Withdrawal by Subject|13|||
130560160|NCT02767323|470019734|FG003|Overall Study|Withdrawal by Subject|0|||
130560161|NCT02767323|470019731|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
130560162|NCT02767323|470019732|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
130560163|NCT02767323|470019733|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
130560164|NCT02767323|470019734|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
130560165|NCT04479436|470019744|FG000|Overall Study|Progressive disease|26|||
130560166|NCT04479436|470019745|FG001|Overall Study|Progressive disease|1|||
130397826|NCT02457598|469426382|FG001|Overall Study|Investigator's Discretion|2|||
130397827|NCT02457598|469426383|FG002|Overall Study|Investigator's Discretion|2|||
130397828|NCT02457598|469426384|FG003|Overall Study|Investigator's Discretion|2|||
130397829|NCT02457598|469426385|FG004|Overall Study|Investigator's Discretion|0|||
130397830|NCT02457598|469426386|FG005|Overall Study|Investigator's Discretion|0|||
130397831|NCT02457598|469426387|FG006|Overall Study|Investigator's Discretion|0|||
130397832|NCT02457598|469426388|FG007|Overall Study|Investigator's Discretion|1|||
130397833|NCT02457598|469426389|FG008|Overall Study|Investigator's Discretion|2|||
130397834|NCT02457598|469426390|FG009|Overall Study|Investigator's Discretion|0|||
130397835|NCT02457598|469426391|FG010|Overall Study|Investigator's Discretion|10|||
130397836|NCT02457598|469426392|FG011|Overall Study|Investigator's Discretion|2|||
130397837|NCT02457598|469426393|FG012|Overall Study|Investigator's Discretion|2|||
130397838|NCT02457598|469426394|FG013|Overall Study|Investigator's Discretion|1|||
130397839|NCT02457598|469426395|FG014|Overall Study|Investigator's Discretion|5|||
130397840|NCT02457598|469426396|FG015|Overall Study|Investigator's Discretion|0|||
130560167|NCT04479436|470019744|FG000|Overall Study|Adverse Event|6|||
130560168|NCT04479436|470019745|FG001|Overall Study|Adverse Event|0|||
130397841|NCT02457598|469426397|FG016|Overall Study|Investigator's Discretion|0|||
130397842|NCT02457598|469426381|FG000|Overall Study|Study Terminated by Sponsor|0|||
130397843|NCT02457598|469426382|FG001|Overall Study|Study Terminated by Sponsor|1|||
130397844|NCT02457598|469426383|FG002|Overall Study|Study Terminated by Sponsor|0|||
130397845|NCT02457598|469426384|FG003|Overall Study|Study Terminated by Sponsor|4|||
130397846|NCT02457598|469426385|FG004|Overall Study|Study Terminated by Sponsor|1|||
130397847|NCT02457598|469426386|FG005|Overall Study|Study Terminated by Sponsor|0|||
130397848|NCT02457598|469426387|FG006|Overall Study|Study Terminated by Sponsor|1|||
130397849|NCT02457598|469426388|FG007|Overall Study|Study Terminated by Sponsor|0|||
130397850|NCT02457598|469426389|FG008|Overall Study|Study Terminated by Sponsor|0|||
130397851|NCT02457598|469426390|FG009|Overall Study|Study Terminated by Sponsor|0|||
130397852|NCT02457598|469426391|FG010|Overall Study|Study Terminated by Sponsor|4|||
130397853|NCT02457598|469426392|FG011|Overall Study|Study Terminated by Sponsor|0|||
130397854|NCT02457598|469426393|FG012|Overall Study|Study Terminated by Sponsor|1|||
130397855|NCT02457598|469426394|FG013|Overall Study|Study Terminated by Sponsor|0|||
130397856|NCT02457598|469426395|FG014|Overall Study|Study Terminated by Sponsor|8|||
130397857|NCT02457598|469426396|FG015|Overall Study|Study Terminated by Sponsor|1|||
130397858|NCT02457598|469426397|FG016|Overall Study|Study Terminated by Sponsor|0|||
130397859|NCT02457598|469426381|FG000|Overall Study|Adverse Event|0|||
130397860|NCT02457598|469426382|FG001|Overall Study|Adverse Event|1|||
130397861|NCT02457598|469426383|FG002|Overall Study|Adverse Event|1|||
130397862|NCT02457598|469426384|FG003|Overall Study|Adverse Event|4|||
130397863|NCT02457598|469426385|FG004|Overall Study|Adverse Event|1|||
130397864|NCT02457598|469426386|FG005|Overall Study|Adverse Event|0|||
130397865|NCT02457598|469426387|FG006|Overall Study|Adverse Event|0|||
130397866|NCT02457598|469426388|FG007|Overall Study|Adverse Event|1|||
130560169|NCT04479436|470019744|FG000|Overall Study|Withdrawal by Subject|5|||
130560170|NCT04479436|470019745|FG001|Overall Study|Withdrawal by Subject|0|||
130397867|NCT02457598|469426389|FG008|Overall Study|Adverse Event|0|||
130397868|NCT02457598|469426390|FG009|Overall Study|Adverse Event|1|||
130397869|NCT02457598|469426391|FG010|Overall Study|Adverse Event|6|||
130560171|NCT04479436|470019744|FG000|Overall Study|Clinical progression|1|||
130560172|NCT04479436|470019745|FG001|Overall Study|Clinical progression|0|||
130560173|NCT04479436|470019744|FG000|Overall Study|Physician Decision|1|||
130560174|NCT04479436|470019745|FG001|Overall Study|Physician Decision|0|||
130397870|NCT02457598|469426392|FG011|Overall Study|Adverse Event|0|||
130397871|NCT02457598|469426393|FG012|Overall Study|Adverse Event|0|||
130397872|NCT02457598|469426394|FG013|Overall Study|Adverse Event|1|||
130397873|NCT02457598|469426395|FG014|Overall Study|Adverse Event|2|||
130397874|NCT02457598|469426396|FG015|Overall Study|Adverse Event|0|||
130397875|NCT02457598|469426397|FG016|Overall Study|Adverse Event|0|||
130397876|NCT02457598|469426381|FG000|Overall Study|Death|0|||
130397877|NCT02457598|469426382|FG001|Overall Study|Death|0|||
130397878|NCT02457598|469426383|FG002|Overall Study|Death|0|||
130397879|NCT02457598|469426384|FG003|Overall Study|Death|3|||
130397880|NCT02457598|469426385|FG004|Overall Study|Death|0|||
130397881|NCT02457598|469426386|FG005|Overall Study|Death|1|||
130397882|NCT02457598|469426387|FG006|Overall Study|Death|0|||
130397883|NCT02457598|469426388|FG007|Overall Study|Death|0|||
130397884|NCT02457598|469426389|FG008|Overall Study|Death|0|||
130397885|NCT02457598|469426390|FG009|Overall Study|Death|0|||
130397886|NCT02457598|469426391|FG010|Overall Study|Death|3|||
130397887|NCT02457598|469426392|FG011|Overall Study|Death|0|||
130397888|NCT02457598|469426393|FG012|Overall Study|Death|0|||
130397889|NCT02457598|469426394|FG013|Overall Study|Death|1|||
130397890|NCT02457598|469426395|FG014|Overall Study|Death|2|||
130397891|NCT02457598|469426396|FG015|Overall Study|Death|0|||
130397892|NCT02457598|469426397|FG016|Overall Study|Death|1|||
130397893|NCT02457598|469426381|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397894|NCT02457598|469426382|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
130397895|NCT02457598|469426383|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397896|NCT02457598|469426384|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
130397897|NCT02457598|469426385|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397898|NCT02457598|469426386|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397899|NCT02457598|469426387|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397900|NCT02457598|469426388|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
130397901|NCT02457598|469426389|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397902|NCT02457598|469426390|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397903|NCT02457598|469426391|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
130397904|NCT02457598|469426392|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397905|NCT02457598|469426393|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397906|NCT02457598|469426394|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
130397907|NCT02457598|469426395|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
130397908|NCT02457598|469426396|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
130397909|NCT02457598|469426397|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
130397910|NCT02457598|469426381|FG000|Overall Study|Withdrew Consent|0|||
130397911|NCT02457598|469426382|FG001|Overall Study|Withdrew Consent|0|||
130397912|NCT02457598|469426383|FG002|Overall Study|Withdrew Consent|0|||
130397913|NCT02457598|469426384|FG003|Overall Study|Withdrew Consent|0|||
130397914|NCT02457598|469426385|FG004|Overall Study|Withdrew Consent|0|||
130397915|NCT02457598|469426386|FG005|Overall Study|Withdrew Consent|0|||
130397916|NCT02457598|469426387|FG006|Overall Study|Withdrew Consent|0|||
130397917|NCT02457598|469426388|FG007|Overall Study|Withdrew Consent|2|||
130397918|NCT02457598|469426389|FG008|Overall Study|Withdrew Consent|0|||
130397919|NCT02457598|469426390|FG009|Overall Study|Withdrew Consent|0|||
130397920|NCT02457598|469426391|FG010|Overall Study|Withdrew Consent|3|||
130397921|NCT02457598|469426392|FG011|Overall Study|Withdrew Consent|0|||
130397922|NCT02457598|469426393|FG012|Overall Study|Withdrew Consent|0|||
130397923|NCT02457598|469426394|FG013|Overall Study|Withdrew Consent|1|||
130397924|NCT02457598|469426395|FG014|Overall Study|Withdrew Consent|0|||
130397925|NCT02457598|469426396|FG015|Overall Study|Withdrew Consent|0|||
130397926|NCT02457598|469426397|FG016|Overall Study|Withdrew Consent|0|||
130397927|NCT02457598|469426381|FG000|Overall Study|Unacceptable Toxicity|0|||
130397928|NCT02457598|469426382|FG001|Overall Study|Unacceptable Toxicity|0|||
130397929|NCT02457598|469426383|FG002|Overall Study|Unacceptable Toxicity|0|||
130397930|NCT02457598|469426384|FG003|Overall Study|Unacceptable Toxicity|0|||
130397931|NCT02457598|469426385|FG004|Overall Study|Unacceptable Toxicity|0|||
130397932|NCT02457598|469426386|FG005|Overall Study|Unacceptable Toxicity|0|||
130397933|NCT02457598|469426387|FG006|Overall Study|Unacceptable Toxicity|0|||
130397934|NCT02457598|469426388|FG007|Overall Study|Unacceptable Toxicity|0|||
130397935|NCT02457598|469426389|FG008|Overall Study|Unacceptable Toxicity|0|||
130397936|NCT02457598|469426390|FG009|Overall Study|Unacceptable Toxicity|0|||
130397937|NCT02457598|469426391|FG010|Overall Study|Unacceptable Toxicity|1|||
130397938|NCT02457598|469426392|FG011|Overall Study|Unacceptable Toxicity|0|||
130397939|NCT02457598|469426393|FG012|Overall Study|Unacceptable Toxicity|1|||
130397940|NCT02457598|469426394|FG013|Overall Study|Unacceptable Toxicity|1|||
130397941|NCT02457598|469426395|FG014|Overall Study|Unacceptable Toxicity|1|||
130397942|NCT02457598|469426396|FG015|Overall Study|Unacceptable Toxicity|0|||
130397943|NCT02457598|469426397|FG016|Overall Study|Unacceptable Toxicity|0|||
130397944|NCT02457598|469426381|FG000|Overall Study|Intercurrent Illness|0|||
130397945|NCT02457598|469426382|FG001|Overall Study|Intercurrent Illness|0|||
130397946|NCT02457598|469426383|FG002|Overall Study|Intercurrent Illness|0|||
130397947|NCT02457598|469426384|FG003|Overall Study|Intercurrent Illness|0|||
130397948|NCT02457598|469426385|FG004|Overall Study|Intercurrent Illness|0|||
130397949|NCT02457598|469426386|FG005|Overall Study|Intercurrent Illness|0|||
130397950|NCT02457598|469426387|FG006|Overall Study|Intercurrent Illness|0|||
130560175|NCT00791258|470019752|FG000|Overall Study|Adverse Event|87|||
130560176|NCT00791258|470019752|FG000|Overall Study|Lost to Follow-up|18|||
130560177|NCT00791258|470019752|FG000|Overall Study|Protocol Violation|109|||
130560178|NCT00791258|470019752|FG000|Overall Study|Withdrawal by Subject|40|||
130560179|NCT00791258|470019752|FG000|Overall Study|Did not take medication for >3 days|1|||
130560180|NCT00791258|470019752|FG000|Overall Study|subject left area|2|||
130560181|NCT00791258|470019752|FG000|Overall Study|non-compliance|3|||
130560182|NCT00791258|470019752|FG000|Overall Study|Subject incarcerated|1|||
130560183|NCT00791258|470019752|FG000|Overall Study|Subject required restricted medication|1|||
130560184|NCT00791258|470019752|FG000|Overall Study|Lack of Efficacy|1|||
130560185|NCT00058552|470019753|FG000|Overall Study|Died prior to receiving treatment|4|||
130560186|NCT00058552|470019754|FG001|Overall Study|Died prior to receiving treatment|2|||
130560187|NCT00058552|470019753|FG000|Overall Study|Disease progression|52|||
130560188|NCT00058552|470019754|FG001|Overall Study|Disease progression|44|||
130560189|NCT00058552|470019753|FG000|Overall Study|Adverse Event|4|||
130560190|NCT00058552|470019754|FG001|Overall Study|Adverse Event|2|||
130560191|NCT00058552|470019753|FG000|Overall Study|Withdrawal by Subject|3|||
130560192|NCT00058552|470019754|FG001|Overall Study|Withdrawal by Subject|5|||
130560193|NCT00058552|470019753|FG000|Overall Study|Physician Decision|2|||
130560194|NCT00058552|470019754|FG001|Overall Study|Physician Decision|5|||
130560195|NCT00058552|470019753|FG000|Overall Study|Clinical disease progression|0|||
130560196|NCT00058552|470019754|FG001|Overall Study|Clinical disease progression|4|||
130560197|NCT02319668|470019755|FG000|Overall Study|Other (Not specified)|0|||
130560198|NCT02319668|470019756|FG001|Overall Study|Other (Not specified)|2|||
130560199|NCT01372150|470019757|FG000|Overall Study|Lack of Efficacy|3|||
130560200|NCT01372150|470019758|FG001|Overall Study|Lack of Efficacy|0|||
130560201|NCT01372150|470019759|FG002|Overall Study|Lack of Efficacy|1|||
130560202|NCT01372150|470019757|FG000|Overall Study|Lost to Follow-up|4|||
130560203|NCT01372150|470019758|FG001|Overall Study|Lost to Follow-up|5|||
130560204|NCT01372150|470019759|FG002|Overall Study|Lost to Follow-up|6|||
130560205|NCT01372150|470019757|FG000|Overall Study|Protocol Violation|1|||
130560206|NCT01372150|470019758|FG001|Overall Study|Protocol Violation|0|||
130560207|NCT01372150|470019759|FG002|Overall Study|Protocol Violation|3|||
130560208|NCT01372150|470019757|FG000|Overall Study|Withdrawal by Subject|2|||
130560209|NCT01372150|470019758|FG001|Overall Study|Withdrawal by Subject|7|||
130560210|NCT01372150|470019759|FG002|Overall Study|Withdrawal by Subject|2|||
130560211|NCT01372150|470019757|FG000|Overall Study|Other|1|||
130560212|NCT01372150|470019758|FG001|Overall Study|Other|0|||
130560213|NCT01372150|470019759|FG002|Overall Study|Other|2|||
130560214|NCT01372150|470019757|FG000|Overall Study|Adverse Event|2|||
130560215|NCT01372150|470019758|FG001|Overall Study|Adverse Event|1|||
130560216|NCT01372150|470019759|FG002|Overall Study|Adverse Event|2|||
130560217|NCT01372150|470019757|FG000|Overall Study|Randomized but not treated|0|||
130560218|NCT01372150|470019758|FG001|Overall Study|Randomized but not treated|1|||
130560219|NCT01372150|470019759|FG002|Overall Study|Randomized but not treated|0|||
130560220|NCT02316340|470019760|FG000|First Progression|Clinical progression|2|||
130560221|NCT02316340|470019761|FG001|First Progression|Clinical progression|1|||
130560222|NCT02316340|470019760|FG000|First Progression|Withdrawal by Subject|1|||
130560223|NCT02316340|470019761|FG001|First Progression|Withdrawal by Subject|0|||
130560224|NCT03781323|470019762|FG000|Overall Study|Withdrawal by Subject|1|||
130560225|NCT01526551|470019763|FG000|Overall Study|Lack of returned parental consent form|424|||
130560226|NCT04422990|470019771|FG000|Overall Study|Withdrawal by Subject|0|||
130560227|NCT04422990|470019772|FG001|Overall Study|Withdrawal by Subject|1|||
130560228|NCT04422990|470019771|FG000|Overall Study|Travel|3|||
130723331|NCT01056289|470613425|FG001|Open-label Phase|Adverse Event|0|||
130397951|NCT02457598|469426388|FG007|Overall Study|Intercurrent Illness|0|||
130397952|NCT02457598|469426389|FG008|Overall Study|Intercurrent Illness|0|||
130397953|NCT02457598|469426390|FG009|Overall Study|Intercurrent Illness|0|||
130397954|NCT02457598|469426391|FG010|Overall Study|Intercurrent Illness|1|||
130397955|NCT02457598|469426392|FG011|Overall Study|Intercurrent Illness|0|||
130397956|NCT02457598|469426393|FG012|Overall Study|Intercurrent Illness|0|||
130560229|NCT04422990|470019772|FG001|Overall Study|Travel|0|||
130723332|NCT01056289|470613426|FG002|Open-label Phase|Adverse Event|0|||
130560230|NCT00433914|470019773|FG000|Overall Study|Withdrawal by Subject|0|||
130723333|NCT01056289|470613427|FG003|Open-label Phase|Adverse Event|0|||
130560231|NCT00433914|470019774|FG001|Overall Study|Withdrawal by Subject|2|||
130560232|NCT00433914|470019773|FG000|Overall Study|Lost to Follow-up|0|||
130560233|NCT00433914|470019774|FG001|Overall Study|Lost to Follow-up|1|||
130723334|NCT01056289|470613424|FG000|Open-label Phase|Lost to Follow-up|30|||
130723335|NCT01056289|470613425|FG001|Open-label Phase|Lost to Follow-up|0|||
130723336|NCT01056289|470613426|FG002|Open-label Phase|Lost to Follow-up|0|||
130560234|NCT02844920|470019777|FG000|Overall Study|Lost to Follow-up|2|||
130560235|NCT00800436|470019788|FG000|Overall Study|Withdrawal by Subject|0|||
130560236|NCT00800436|470019789|FG001|Overall Study|Withdrawal by Subject|0|||
130560237|NCT00800436|470019790|FG002|Overall Study|Withdrawal by Subject|1|||
130560238|NCT00800436|470019791|FG003|Overall Study|Withdrawal by Subject|1|||
130723337|NCT01056289|470613427|FG003|Open-label Phase|Lost to Follow-up|0|||
130723338|NCT01056289|470613424|FG000|Open-label Phase|Other|9|||
130397957|NCT02457598|469426394|FG013|Overall Study|Intercurrent Illness|0|||
130397958|NCT02457598|469426395|FG014|Overall Study|Intercurrent Illness|0|||
130397959|NCT02457598|469426396|FG015|Overall Study|Intercurrent Illness|0|||
130397960|NCT02457598|469426397|FG016|Overall Study|Intercurrent Illness|0|||
130397961|NCT02457598|469426381|FG000|Overall Study|Protocol Violation|0|||
130397962|NCT02457598|469426382|FG001|Overall Study|Protocol Violation|0|||
130397963|NCT02457598|469426383|FG002|Overall Study|Protocol Violation|0|||
130397964|NCT02457598|469426384|FG003|Overall Study|Protocol Violation|0|||
130397965|NCT02457598|469426385|FG004|Overall Study|Protocol Violation|0|||
130397966|NCT02457598|469426386|FG005|Overall Study|Protocol Violation|0|||
130397967|NCT02457598|469426387|FG006|Overall Study|Protocol Violation|0|||
130397968|NCT02457598|469426388|FG007|Overall Study|Protocol Violation|0|||
130397969|NCT02457598|469426389|FG008|Overall Study|Protocol Violation|0|||
130397970|NCT02457598|469426390|FG009|Overall Study|Protocol Violation|0|||
130397971|NCT02457598|469426391|FG010|Overall Study|Protocol Violation|1|||
130397972|NCT02457598|469426392|FG011|Overall Study|Protocol Violation|0|||
130397973|NCT02457598|469426393|FG012|Overall Study|Protocol Violation|0|||
130397974|NCT02457598|469426394|FG013|Overall Study|Protocol Violation|0|||
130397975|NCT02457598|469426395|FG014|Overall Study|Protocol Violation|0|||
130397976|NCT02457598|469426396|FG015|Overall Study|Protocol Violation|0|||
130397977|NCT02457598|469426397|FG016|Overall Study|Protocol Violation|0|||
130397978|NCT01403974|469426398|FG000|Overall Study|Progressive disease according to RECIST|3|||
130397979|NCT01403974|469426399|FG001|Overall Study|Progressive disease according to RECIST|3|||
130397980|NCT01403974|469426400|FG002|Overall Study|Progressive disease according to RECIST|2|||
130397981|NCT01403974|469426401|FG003|Overall Study|Progressive disease according to RECIST|3|||
130397982|NCT01403974|469426402|FG004|Overall Study|Progressive disease according to RECIST|3|||
130397983|NCT01403974|469426403|FG005|Overall Study|Progressive disease according to RECIST|2|||
130397984|NCT01403974|469426404|FG006|Overall Study|Progressive disease according to RECIST|3|||
130397985|NCT01403974|469426405|FG007|Overall Study|Progressive disease according to RECIST|2|||
130397986|NCT01403974|469426406|FG008|Overall Study|Progressive disease according to RECIST|6|||
130397987|NCT01403974|469426407|FG009|Overall Study|Progressive disease according to RECIST|2|||
130397988|NCT01403974|469426408|FG010|Overall Study|Progressive disease according to RECIST|3|||
130397989|NCT01403974|469426409|FG011|Overall Study|Progressive disease according to RECIST|2|||
130397990|NCT01403974|469426410|FG012|Overall Study|Progressive disease according to RECIST|2|||
130397991|NCT01403974|469426411|FG013|Overall Study|Progressive disease according to RECIST|3|||
130397992|NCT01403974|469426412|FG014|Overall Study|Progressive disease according to RECIST|1|||
130397993|NCT01403974|469426413|FG015|Overall Study|Progressive disease according to RECIST|8|||
130397994|NCT01403974|469426398|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130397995|NCT01403974|469426399|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130397996|NCT01403974|469426400|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130397997|NCT01403974|469426401|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
130397998|NCT01403974|469426402|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
130397999|NCT01403974|469426403|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
130398000|NCT01403974|469426404|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130398001|NCT01403974|469426405|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130398002|NCT01403974|469426406|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
130398003|NCT01403974|469426407|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
130398004|NCT01403974|469426408|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
130398005|NCT01403974|469426409|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
130398006|NCT01403974|469426410|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
130398007|NCT01403974|469426411|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
130398008|NCT01403974|469426412|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
130398009|NCT01403974|469426413|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
130398010|NCT01403974|469426398|FG000|Overall Study|Refused to continue study medication|0|||
130398011|NCT01403974|469426399|FG001|Overall Study|Refused to continue study medication|0|||
130398012|NCT01403974|469426400|FG002|Overall Study|Refused to continue study medication|0|||
130398013|NCT01403974|469426401|FG003|Overall Study|Refused to continue study medication|0|||
130398014|NCT01403974|469426402|FG004|Overall Study|Refused to continue study medication|0|||
130398015|NCT01403974|469426403|FG005|Overall Study|Refused to continue study medication|1|||
130398016|NCT01403974|469426404|FG006|Overall Study|Refused to continue study medication|0|||
130560239|NCT00800436|470019792|FG004|Overall Study|Withdrawal by Subject|0|||
130398017|NCT01403974|469426405|FG007|Overall Study|Refused to continue study medication|0|||
130560240|NCT00800436|470019793|FG005|Overall Study|Withdrawal by Subject|0|||
130723339|NCT01056289|470613425|FG001|Open-label Phase|Other|0|||
130398018|NCT01403974|469426406|FG008|Overall Study|Refused to continue study medication|1|||
130398019|NCT01403974|469426407|FG009|Overall Study|Refused to continue study medication|0|||
130398020|NCT01403974|469426408|FG010|Overall Study|Refused to continue study medication|1|||
130398021|NCT01403974|469426409|FG011|Overall Study|Refused to continue study medication|0|||
130398022|NCT01403974|469426410|FG012|Overall Study|Refused to continue study medication|0|||
130398023|NCT01403974|469426411|FG013|Overall Study|Refused to continue study medication|0|||
130398024|NCT01403974|469426412|FG014|Overall Study|Refused to continue study medication|0|||
130398025|NCT01403974|469426413|FG015|Overall Study|Refused to continue study medication|4|||
130398026|NCT01403974|469426398|FG000|Overall Study|Adverse Event|0|||
130398027|NCT01403974|469426399|FG001|Overall Study|Adverse Event|0|||
130398028|NCT01403974|469426400|FG002|Overall Study|Adverse Event|1|||
130398029|NCT01403974|469426401|FG003|Overall Study|Adverse Event|0|||
130398030|NCT01403974|469426402|FG004|Overall Study|Adverse Event|0|||
130398031|NCT01403974|469426403|FG005|Overall Study|Adverse Event|0|||
130398032|NCT01403974|469426404|FG006|Overall Study|Adverse Event|0|||
130398033|NCT01403974|469426405|FG007|Overall Study|Adverse Event|1|||
130398034|NCT01403974|469426406|FG008|Overall Study|Adverse Event|0|||
130398035|NCT01403974|469426407|FG009|Overall Study|Adverse Event|0|||
130398036|NCT01403974|469426408|FG010|Overall Study|Adverse Event|0|||
130398037|NCT01403974|469426409|FG011|Overall Study|Adverse Event|0|||
130398038|NCT01403974|469426410|FG012|Overall Study|Adverse Event|1|||
130398039|NCT01403974|469426411|FG013|Overall Study|Adverse Event|0|||
130398040|NCT01403974|469426412|FG014|Overall Study|Adverse Event|0|||
130398041|NCT01403974|469426413|FG015|Overall Study|Adverse Event|0|||
130398042|NCT01403974|469426398|FG000|Overall Study|Other than specified|0|||
130398043|NCT01403974|469426399|FG001|Overall Study|Other than specified|0|||
130398044|NCT01403974|469426400|FG002|Overall Study|Other than specified|0|||
130398045|NCT01403974|469426401|FG003|Overall Study|Other than specified|0|||
130398046|NCT01403974|469426402|FG004|Overall Study|Other than specified|0|||
130398047|NCT01403974|469426403|FG005|Overall Study|Other than specified|0|||
130398048|NCT01403974|469426404|FG006|Overall Study|Other than specified|0|||
130398049|NCT01403974|469426405|FG007|Overall Study|Other than specified|0|||
130398050|NCT01403974|469426406|FG008|Overall Study|Other than specified|0|||
130398051|NCT01403974|469426407|FG009|Overall Study|Other than specified|1|||
130398052|NCT01403974|469426408|FG010|Overall Study|Other than specified|0|||
130398053|NCT01403974|469426409|FG011|Overall Study|Other than specified|1|||
130398054|NCT01403974|469426410|FG012|Overall Study|Other than specified|0|||
130398055|NCT01403974|469426411|FG013|Overall Study|Other than specified|0|||
130398056|NCT01403974|469426412|FG014|Overall Study|Other than specified|0|||
130398057|NCT01403974|469426413|FG015|Overall Study|Other than specified|0|||
130398058|NCT04334460|469426414|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
130398059|NCT04334460|469426415|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
130398060|NCT04334460|469426414|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
130398061|NCT04334460|469426415|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
130398062|NCT00547703|469426416|FG000|Overall Study|Lost to Follow-up|1|||
130398063|NCT00547703|469426417|FG001|Overall Study|Lost to Follow-up|0|||
130398064|NCT03995953|469426420|FG000|Overall Study|Death|3|||
130398065|NCT03995953|469426421|FG001|Overall Study|Death|0|||
130398066|NCT03995953|469426422|FG002|Overall Study|Death|3|||
130398067|NCT03995953|469426423|FG003|Overall Study|Death|0|||
130398068|NCT03995953|469426424|FG004|Overall Study|Death|3|||
130398069|NCT03995953|469426425|FG005|Overall Study|Death|0|||
130398070|NCT03995953|469426426|FG006|Overall Study|Death|0|||
130398071|NCT03995953|469426427|FG007|Overall Study|Death|0|||
130398072|NCT03995953|469426428|FG008|Overall Study|Death|1|||
130398073|NCT03995953|469426429|FG009|Overall Study|Death|0|||
130398074|NCT03995953|469426430|FG010|Overall Study|Death|0|||
130398075|NCT03995953|469426431|FG011|Overall Study|Death|0|||
130398076|NCT03995953|469426420|FG000|Overall Study|Lost to Follow-up|6|||
130398077|NCT03995953|469426421|FG001|Overall Study|Lost to Follow-up|54|||
130398078|NCT03995953|469426422|FG002|Overall Study|Lost to Follow-up|3|||
130398079|NCT03995953|469426423|FG003|Overall Study|Lost to Follow-up|32|||
130398080|NCT03995953|469426424|FG004|Overall Study|Lost to Follow-up|5|||
130398081|NCT03995953|469426425|FG005|Overall Study|Lost to Follow-up|44|||
130398082|NCT03995953|469426426|FG006|Overall Study|Lost to Follow-up|0|||
130398083|NCT03995953|469426427|FG007|Overall Study|Lost to Follow-up|31|||
130398084|NCT03995953|469426428|FG008|Overall Study|Lost to Follow-up|8|||
130398085|NCT03995953|469426429|FG009|Overall Study|Lost to Follow-up|36|||
130398086|NCT03995953|469426430|FG010|Overall Study|Lost to Follow-up|5|||
130398087|NCT03995953|469426431|FG011|Overall Study|Lost to Follow-up|41|||
130398088|NCT03995953|469426420|FG000|Overall Study|Withdrawal by Subject|4|||
130398089|NCT03995953|469426421|FG001|Overall Study|Withdrawal by Subject|0|||
130398090|NCT03995953|469426422|FG002|Overall Study|Withdrawal by Subject|1|||
130398091|NCT03995953|469426423|FG003|Overall Study|Withdrawal by Subject|0|||
130398092|NCT03995953|469426424|FG004|Overall Study|Withdrawal by Subject|1|||
130398093|NCT03995953|469426425|FG005|Overall Study|Withdrawal by Subject|0|||
130398094|NCT03995953|469426426|FG006|Overall Study|Withdrawal by Subject|1|||
130398095|NCT03995953|469426427|FG007|Overall Study|Withdrawal by Subject|0|||
130398096|NCT03995953|469426428|FG008|Overall Study|Withdrawal by Subject|3|||
130398097|NCT03995953|469426429|FG009|Overall Study|Withdrawal by Subject|0|||
130398098|NCT03995953|469426430|FG010|Overall Study|Withdrawal by Subject|3|||
130398099|NCT03995953|469426431|FG011|Overall Study|Withdrawal by Subject|0|||
130398100|NCT03995953|469426420|FG000|Overall Study|Health Issues|0|||
130398101|NCT03995953|469426421|FG001|Overall Study|Health Issues|0|||
130398102|NCT03995953|469426422|FG002|Overall Study|Health Issues|0|||
130398103|NCT03995953|469426423|FG003|Overall Study|Health Issues|0|||
130398104|NCT03995953|469426424|FG004|Overall Study|Health Issues|1|||
130398105|NCT03995953|469426425|FG005|Overall Study|Health Issues|0|||
130398106|NCT03995953|469426426|FG006|Overall Study|Health Issues|0|||
130398107|NCT03995953|469426427|FG007|Overall Study|Health Issues|0|||
130398108|NCT03995953|469426428|FG008|Overall Study|Health Issues|4|||
130398109|NCT03995953|469426429|FG009|Overall Study|Health Issues|0|||
130398110|NCT03995953|469426430|FG010|Overall Study|Health Issues|0|||
130398111|NCT03995953|469426431|FG011|Overall Study|Health Issues|0|||
130398112|NCT03995953|469426420|FG000|Overall Study|Relocated|11|||
130398113|NCT03995953|469426421|FG001|Overall Study|Relocated|0|||
130398114|NCT03995953|469426422|FG002|Overall Study|Relocated|16|||
130398115|NCT03995953|469426423|FG003|Overall Study|Relocated|0|||
130398116|NCT03995953|469426424|FG004|Overall Study|Relocated|14|||
130398117|NCT03995953|469426425|FG005|Overall Study|Relocated|0|||
130398118|NCT03995953|469426426|FG006|Overall Study|Relocated|16|||
130398119|NCT03995953|469426427|FG007|Overall Study|Relocated|0|||
130398120|NCT03995953|469426428|FG008|Overall Study|Relocated|14|||
130398121|NCT03995953|469426429|FG009|Overall Study|Relocated|0|||
130398122|NCT03995953|469426430|FG010|Overall Study|Relocated|15|||
130398123|NCT03995953|469426431|FG011|Overall Study|Relocated|0|||
130398124|NCT02130765|469426432|FG000|Overall Study|Did not receive treatment|4|||
130398125|NCT02130765|469426433|FG001|Overall Study|Did not receive treatment|0|||
130398126|NCT02130765|469426434|FG002|Overall Study|Did not receive treatment|0|||
130398127|NCT02130765|469426435|FG003|Overall Study|Did not receive treatment|0|||
130398128|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
130398129|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
130398130|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
130398131|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
130398132|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
130398133|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
130398134|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
130398135|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
130398136|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
130398137|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
130398138|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
130398139|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
130398140|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
130398141|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
130398142|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
130398143|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
130398144|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
130398145|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
130398146|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
130398147|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
130398148|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
130398149|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
130398150|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
130398151|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
130398152|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
130398153|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
130398154|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
130398155|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
130398156|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
130398157|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
130398158|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
130398159|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
130398160|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
130398161|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
130398162|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
130398163|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
130398164|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
130398165|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
130398166|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
130398167|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
130398168|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
130398169|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
130398170|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
130398171|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
130398172|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
130398173|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
130398174|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
130398175|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
130398176|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
130398177|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
130398178|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
130398179|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
130398180|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
130398181|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
130398182|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
130398183|NCT04951622|469426445|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
130398184|NCT04951622|469426446|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
130398185|NCT04951622|469426447|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
130398186|NCT04951622|469426448|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
130398187|NCT04951622|469426449|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
130398188|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
130398189|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
130398190|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
130398191|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
130398192|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
130398193|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
130398194|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
130398195|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
130398196|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
130398197|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
130398198|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
130398199|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
130398200|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
130398201|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
130398202|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
130398203|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
130398204|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
130398205|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
130398206|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
130398207|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
130398208|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
130398209|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
130398210|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
130398211|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
130398212|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
130398213|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
130398214|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
130398215|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
130398216|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
130398217|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
130398218|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
130398219|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
130398220|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
130398221|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
130398222|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
130398223|NCT04951622|469426445|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
130398224|NCT04951622|469426446|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
130398225|NCT04951622|469426447|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
130398226|NCT04951622|469426448|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
130398227|NCT04951622|469426449|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
130398228|NCT01455012|469426454|FG000|Overall Study|Adverse Event|0|||
130398229|NCT01455012|469426455|FG001|Overall Study|Adverse Event|2|||
130398230|NCT01455012|469426454|FG000|Overall Study|Lack of Efficacy|6|||
130398231|NCT01455012|469426455|FG001|Overall Study|Lack of Efficacy|1|||
130398232|NCT01455012|469426454|FG000|Overall Study|Withdrawal by Subject|3|||
130398233|NCT01455012|469426455|FG001|Overall Study|Withdrawal by Subject|1|||
130398234|NCT01455012|469426454|FG000|Overall Study|Unknown reason|2|||
130398235|NCT01455012|469426455|FG001|Overall Study|Unknown reason|0|||
130398236|NCT01215227|469426456|FG000|Overall Study|Adverse Event|11|||
130398237|NCT01215227|469426457|FG001|Overall Study|Adverse Event|11|||
130398238|NCT01215227|469426458|FG002|Overall Study|Adverse Event|4|||
130398239|NCT01215227|469426459|FG003|Overall Study|Adverse Event|8|||
130398240|NCT01215227|469426460|FG004|Overall Study|Adverse Event|7|||
130398241|NCT01215227|469426461|FG005|Overall Study|Adverse Event|6|||
130398242|NCT01215227|469426456|FG000|Overall Study|Treatment Failure|8|||
130398243|NCT01215227|469426457|FG001|Overall Study|Treatment Failure|4|||
130398244|NCT01215227|469426458|FG002|Overall Study|Treatment Failure|1|||
130398245|NCT01215227|469426459|FG003|Overall Study|Treatment Failure|5|||
130398246|NCT01215227|469426460|FG004|Overall Study|Treatment Failure|1|||
130398247|NCT01215227|469426461|FG005|Overall Study|Treatment Failure|1|||
130398248|NCT01215227|469426456|FG000|Overall Study|Lost to Follow-up|1|||
130398249|NCT01215227|469426457|FG001|Overall Study|Lost to Follow-up|4|||
130398250|NCT01215227|469426458|FG002|Overall Study|Lost to Follow-up|1|||
130398251|NCT01215227|469426459|FG003|Overall Study|Lost to Follow-up|1|||
130398252|NCT01215227|469426460|FG004|Overall Study|Lost to Follow-up|1|||
130398253|NCT01215227|469426461|FG005|Overall Study|Lost to Follow-up|2|||
130398254|NCT01215227|469426456|FG000|Overall Study|Subject Withdrew Consent|16|||
130398255|NCT01215227|469426457|FG001|Overall Study|Subject Withdrew Consent|20|||
130398256|NCT01215227|469426458|FG002|Overall Study|Subject Withdrew Consent|7|||
130398257|NCT01215227|469426459|FG003|Overall Study|Subject Withdrew Consent|10|||
130398258|NCT01215227|469426460|FG004|Overall Study|Subject Withdrew Consent|11|||
130398259|NCT01215227|469426461|FG005|Overall Study|Subject Withdrew Consent|8|||
130398260|NCT01215227|469426456|FG000|Overall Study|Non-Compliance With Protocol|2|||
130398261|NCT01215227|469426457|FG001|Overall Study|Non-Compliance With Protocol|6|||
130398262|NCT01215227|469426458|FG002|Overall Study|Non-Compliance With Protocol|1|||
130398263|NCT01215227|469426459|FG003|Overall Study|Non-Compliance With Protocol|0|||
130398264|NCT01215227|469426460|FG004|Overall Study|Non-Compliance With Protocol|0|||
130398265|NCT01215227|469426461|FG005|Overall Study|Non-Compliance With Protocol|0|||
130398266|NCT01215227|469426456|FG000|Overall Study|Administrative|83|||
130398267|NCT01215227|469426457|FG001|Overall Study|Administrative|73|||
130398268|NCT01215227|469426458|FG002|Overall Study|Administrative|42|||
130398269|NCT01215227|469426459|FG003|Overall Study|Administrative|24|||
130398270|NCT01215227|469426460|FG004|Overall Study|Administrative|28|||
130398271|NCT01215227|469426461|FG005|Overall Study|Administrative|40|||
130398272|NCT01215227|469426456|FG000|Overall Study|Missing Status|0|||
130398273|NCT01215227|469426457|FG001|Overall Study|Missing Status|1|||
130398274|NCT01215227|469426458|FG002|Overall Study|Missing Status|0|||
130398275|NCT01215227|469426459|FG003|Overall Study|Missing Status|0|||
130398276|NCT01215227|469426460|FG004|Overall Study|Missing Status|0|||
130398277|NCT01215227|469426461|FG005|Overall Study|Missing Status|0|||
130398278|NCT01215227|469426456|FG000|Overall Study|Randomized but not treated|0|||
130398279|NCT01215227|469426457|FG001|Overall Study|Randomized but not treated|0|||
130398280|NCT01215227|469426458|FG002|Overall Study|Randomized but not treated|1|||
130398281|NCT01215227|469426459|FG003|Overall Study|Randomized but not treated|1|||
130398282|NCT01215227|469426460|FG004|Overall Study|Randomized but not treated|0|||
130398283|NCT01215227|469426461|FG005|Overall Study|Randomized but not treated|1|||
130398284|NCT02253810|469426462|FG000|Overall Study|Withdrawal by Subject|2|||
130398285|NCT02253810|469426463|FG001|Overall Study|Withdrawal by Subject|1|||
130398286|NCT02253810|469426462|FG000|Overall Study|Unknown concomitant procedure|3|||
130398287|NCT02253810|469426463|FG001|Overall Study|Unknown concomitant procedure|2|||
130398288|NCT01434290|469426464|FG000|Overall Study|Protocol Violation|6|||
130398289|NCT01434290|469426465|FG001|Overall Study|Protocol Violation|3|||
130398290|NCT01434290|469426464|FG000|Overall Study|No protocol treatment|2|||
130398291|NCT01434290|469426465|FG001|Overall Study|No protocol treatment|4|||
130398292|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
130398293|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
130723340|NCT01056289|470613426|FG002|Open-label Phase|Other|0|||
130723341|NCT01056289|470613427|FG003|Open-label Phase|Other|0|||
130398294|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
130723342|NCT01056289|470613424|FG000|Open-label Phase|Protocol Violation|6|||
130398295|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
130398296|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
130723343|NCT01056289|470613425|FG001|Open-label Phase|Protocol Violation|0|||
130398297|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
130398298|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
130398299|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
130398300|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
130398301|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
130398302|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
130398303|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
130723344|NCT01056289|470613426|FG002|Open-label Phase|Protocol Violation|0|||
130398304|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
130723345|NCT01056289|470613427|FG003|Open-label Phase|Protocol Violation|0|||
130723346|NCT01056289|470613424|FG000|Open-label Phase|Withdrawal by Subject|26|||
130723347|NCT01056289|470613425|FG001|Open-label Phase|Withdrawal by Subject|0|||
130723348|NCT01056289|470613426|FG002|Open-label Phase|Withdrawal by Subject|0|||
130723349|NCT01056289|470613427|FG003|Open-label Phase|Withdrawal by Subject|0|||
130723350|NCT01056289|470613424|FG000|Open-label Phase|Lack of Efficacy|18|||
130723351|NCT01056289|470613425|FG001|Open-label Phase|Lack of Efficacy|0|||
130723352|NCT01056289|470613426|FG002|Open-label Phase|Lack of Efficacy|0|||
130723353|NCT01056289|470613427|FG003|Open-label Phase|Lack of Efficacy|0|||
130723354|NCT01056289|470613424|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
130398305|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
130723355|NCT01056289|470613425|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
130398306|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
130398307|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
130398308|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
130398309|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
130398310|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
130398311|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
130398312|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Other|3|||
130398313|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Other|0|||
130398314|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Other|2|||
130398315|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Other|2|||
130398316|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Other|7|||
130398317|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398318|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398319|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398320|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
130398321|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398322|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398323|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398324|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398325|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398326|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
130398327|NCT00213148|469426467|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
130398328|NCT00213148|469426468|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
130723356|NCT01056289|470613426|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
130723357|NCT01056289|470613427|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
130723358|NCT01056289|470613424|FG000|Double-blind Phase|Adverse Event|0|||
130723359|NCT01056289|470613425|FG001|Double-blind Phase|Adverse Event|1|||
130398329|NCT00213148|469426469|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
130398330|NCT00213148|469426470|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
130398331|NCT00213148|469426471|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
130398332|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
130398333|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
130398334|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
130398335|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
130398336|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
130398337|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
130398338|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
130398339|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
130398340|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
130398341|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
130398342|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Other|2|||
130398343|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Other|1|||
130398344|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Other|2|||
130398345|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Other|8|||
130398346|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Other|7|||
130398347|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398348|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
130398349|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398350|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398351|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130398352|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
130398353|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398354|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398355|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130398356|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130723360|NCT01056289|470613426|FG002|Double-blind Phase|Adverse Event|2|||
130723361|NCT01056289|470613427|FG003|Double-blind Phase|Adverse Event|1|||
130398357|NCT00213148|469426467|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
130398358|NCT00213148|469426468|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
130398359|NCT00213148|469426469|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
130398360|NCT00213148|469426470|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
130398361|NCT00213148|469426471|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
130398362|NCT00213148|469426467|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130398363|NCT00213148|469426468|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
130398364|NCT00213148|469426469|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130398365|NCT00213148|469426470|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130398366|NCT00213148|469426471|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
130398367|NCT00213148|469426467|FG000|Cycle 3 (1 Month)|Other|0|||
130398368|NCT00213148|469426468|FG001|Cycle 3 (1 Month)|Other|0|||
130398369|NCT00213148|469426469|FG002|Cycle 3 (1 Month)|Other|1|||
130398370|NCT00213148|469426470|FG003|Cycle 3 (1 Month)|Other|1|||
130398371|NCT00213148|469426471|FG004|Cycle 3 (1 Month)|Other|0|||
130398372|NCT00558103|469426472|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
130398373|NCT00558103|469426473|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
130398374|NCT00558103|469426474|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
130398375|NCT00558103|469426475|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
130398376|NCT00558103|469426476|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
130398377|NCT00558103|469426477|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
130398378|NCT00558103|469426472|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
130398379|NCT00558103|469426473|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
130398380|NCT00558103|469426474|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
130398381|NCT00558103|469426475|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
130398382|NCT00558103|469426476|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
130398383|NCT00558103|469426477|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
130398384|NCT00558103|469426472|FG000|Randomized Treatment Phase|Disease Progression|1|||
130398385|NCT00558103|469426473|FG001|Randomized Treatment Phase|Disease Progression|0|||
130398386|NCT00558103|469426474|FG002|Randomized Treatment Phase|Disease Progression|1|||
130398387|NCT00558103|469426475|FG003|Randomized Treatment Phase|Disease Progression|0|||
130398388|NCT00558103|469426476|FG004|Randomized Treatment Phase|Disease Progression|0|||
130398389|NCT00558103|469426477|FG005|Randomized Treatment Phase|Disease Progression|0|||
130398390|NCT00558103|469426472|FG000|Randomized Treatment Phase|Adverse Event|0|||
130398391|NCT00558103|469426473|FG001|Randomized Treatment Phase|Adverse Event|0|||
130398392|NCT00558103|469426474|FG002|Randomized Treatment Phase|Adverse Event|0|||
130398393|NCT00558103|469426475|FG003|Randomized Treatment Phase|Adverse Event|1|||
130398394|NCT00558103|469426476|FG004|Randomized Treatment Phase|Adverse Event|1|||
130398395|NCT00558103|469426477|FG005|Randomized Treatment Phase|Adverse Event|0|||
130398396|NCT00558103|469426472|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
130398397|NCT00558103|469426473|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
130398398|NCT00558103|469426474|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
130723362|NCT01056289|470613424|FG000|Double-blind Phase|Lost to Follow-up|0|||
130723363|NCT01056289|470613425|FG001|Double-blind Phase|Lost to Follow-up|2|||
130723364|NCT01056289|470613426|FG002|Double-blind Phase|Lost to Follow-up|2|||
130723365|NCT01056289|470613427|FG003|Double-blind Phase|Lost to Follow-up|2|||
130398399|NCT00558103|469426475|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
130398400|NCT00558103|469426476|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
130398401|NCT00558103|469426477|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
130398402|NCT00558103|469426472|FG000|Monotherapy Extension Phase|Disease Progression|0|||
130398403|NCT00558103|469426473|FG001|Monotherapy Extension Phase|Disease Progression|0|||
130398404|NCT00558103|469426474|FG002|Monotherapy Extension Phase|Disease Progression|0|||
130398405|NCT00558103|469426475|FG003|Monotherapy Extension Phase|Disease Progression|0|||
130398406|NCT00558103|469426476|FG004|Monotherapy Extension Phase|Disease Progression|0|||
130398407|NCT00558103|469426477|FG005|Monotherapy Extension Phase|Disease Progression|8|||
130723366|NCT01056289|470613424|FG000|Double-blind Phase|Other|0|||
130723367|NCT01056289|470613425|FG001|Double-blind Phase|Other|0|||
130723368|NCT01056289|470613426|FG002|Double-blind Phase|Other|1|||
130398408|NCT03548584|469428412|FG000|Overall Study|Lost to Follow-up|0|||
130398409|NCT03548584|469428413|FG001|Overall Study|Lost to Follow-up|0|||
130398410|NCT03548584|469428414|FG002|Overall Study|Lost to Follow-up|1|||
130398411|NCT03548584|469428412|FG000|Overall Study|Adverse Event|1|||
130398412|NCT03548584|469428413|FG001|Overall Study|Adverse Event|11|||
130398413|NCT03548584|469428414|FG002|Overall Study|Adverse Event|5|||
130398414|NCT03548584|469428412|FG000|Overall Study|Site Terminated by Sponsor|1|||
130398415|NCT03548584|469428413|FG001|Overall Study|Site Terminated by Sponsor|3|||
130398416|NCT03548584|469428414|FG002|Overall Study|Site Terminated by Sponsor|2|||
130398417|NCT03548584|469428412|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
130398418|NCT03548584|469428413|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
130723369|NCT01056289|470613427|FG003|Double-blind Phase|Other|2|||
130723370|NCT01056289|470613424|FG000|Double-blind Phase|Protocol Violation|0|||
130398419|NCT03548584|469428414|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
130398420|NCT03548584|469428412|FG000|Overall Study|Lack of Efficacy|0|||
130723371|NCT01056289|470613425|FG001|Double-blind Phase|Protocol Violation|0|||
130398421|NCT03548584|469428413|FG001|Overall Study|Lack of Efficacy|1|||
130398422|NCT03548584|469428414|FG002|Overall Study|Lack of Efficacy|0|||
130398423|NCT03548584|469428412|FG000|Overall Study|Non-compliance with Study Drug|0|||
130398424|NCT03548584|469428413|FG001|Overall Study|Non-compliance with Study Drug|1|||
130398425|NCT03548584|469428414|FG002|Overall Study|Non-compliance with Study Drug|0|||
130398426|NCT03548584|469428412|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
130398427|NCT03548584|469428413|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
130398428|NCT03548584|469428414|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
130398429|NCT03633396|469428421|FG000|Overall Study|Withdrawal by Subject|4|||
130398430|NCT03633396|469428422|FG001|Overall Study|Withdrawal by Subject|4|||
130398431|NCT03633396|469428421|FG000|Overall Study|Adverse Event|1|||
130398432|NCT03633396|469428422|FG001|Overall Study|Adverse Event|1|||
130398433|NCT03633396|469428421|FG000|Overall Study|Lack of Efficacy|1|||
130398434|NCT03633396|469428422|FG001|Overall Study|Lack of Efficacy|0|||
130398435|NCT03633396|469428421|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
130398436|NCT03633396|469428422|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
130398437|NCT01012817|469428423|FG000|Overall Study|Withdrawal by Subject|0|||
130398438|NCT01012817|469428424|FG001|Overall Study|Withdrawal by Subject|0|||
130398439|NCT01012817|469428425|FG002|Overall Study|Withdrawal by Subject|0|||
130398440|NCT01012817|469428426|FG003|Overall Study|Withdrawal by Subject|1|||
130398441|NCT01012817|469428427|FG004|Overall Study|Withdrawal by Subject|0|||
130398442|NCT01012817|469428428|FG005|Overall Study|Withdrawal by Subject|0|||
130398443|NCT01012817|469428429|FG006|Overall Study|Withdrawal by Subject|0|||
130398444|NCT01012817|469428430|FG007|Overall Study|Withdrawal by Subject|1|||
130398445|NCT01012817|469428431|FG008|Overall Study|Withdrawal by Subject|0|||
130398446|NCT01012817|469428432|FG009|Overall Study|Withdrawal by Subject|0|||
130398447|NCT01012817|469428433|FG010|Overall Study|Withdrawal by Subject|1|||
130398448|NCT01012817|469428434|FG011|Overall Study|Withdrawal by Subject|1|||
130398449|NCT01012817|469428435|FG012|Overall Study|Withdrawal by Subject|0|||
130398450|NCT01012817|469428436|FG013|Overall Study|Withdrawal by Subject|1|||
130398451|NCT01012817|469428423|FG000|Overall Study|Adverse Event|0|||
130398452|NCT01012817|469428424|FG001|Overall Study|Adverse Event|0|||
130398453|NCT01012817|469428425|FG002|Overall Study|Adverse Event|0|||
130398454|NCT01012817|469428426|FG003|Overall Study|Adverse Event|0|||
130398455|NCT01012817|469428427|FG004|Overall Study|Adverse Event|0|||
130398456|NCT01012817|469428428|FG005|Overall Study|Adverse Event|1|||
130398457|NCT01012817|469428429|FG006|Overall Study|Adverse Event|0|||
130398458|NCT01012817|469428430|FG007|Overall Study|Adverse Event|0|||
130398459|NCT01012817|469428431|FG008|Overall Study|Adverse Event|0|||
130398460|NCT01012817|469428432|FG009|Overall Study|Adverse Event|0|||
130398461|NCT01012817|469428433|FG010|Overall Study|Adverse Event|1|||
130398462|NCT01012817|469428434|FG011|Overall Study|Adverse Event|0|||
130398463|NCT01012817|469428435|FG012|Overall Study|Adverse Event|0|||
130398464|NCT01012817|469428436|FG013|Overall Study|Adverse Event|1|||
130723372|NCT01056289|470613426|FG002|Double-blind Phase|Protocol Violation|1|||
130723373|NCT01056289|470613427|FG003|Double-blind Phase|Protocol Violation|1|||
130723374|NCT01056289|470613424|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130723375|NCT01056289|470613425|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130723376|NCT01056289|470613426|FG002|Double-blind Phase|Withdrawal by Subject|4|||
130723377|NCT01056289|470613427|FG003|Double-blind Phase|Withdrawal by Subject|2|||
130723378|NCT01056289|470613424|FG000|Double-blind Phase|Discontinuation symptom|0|||
130723379|NCT01056289|470613425|FG001|Double-blind Phase|Discontinuation symptom|1|||
130723380|NCT01056289|470613426|FG002|Double-blind Phase|Discontinuation symptom|2|||
130398465|NCT03756558|469428437|FG000|Overall Study|Death|1|||
130398466|NCT03756558|469428437|FG000|Overall Study|Lost to Follow-up|2|||
130398467|NCT03756558|469428437|FG000|Overall Study|Withdrawal by Subject|2|||
130398468|NCT00978731|469428438|FG000|Overall Study|Death|4|||
130398469|NCT00978731|469428439|FG001|Overall Study|Death|1|||
130398470|NCT00978731|469428440|FG002|Overall Study|Death|1|||
130560241|NCT00800436|470019794|FG006|Overall Study|Withdrawal by Subject|0|||
130560242|NCT00766090|470019795|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560243|NCT00766090|470019796|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560244|NCT00766090|470019797|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560245|NCT00766090|470019798|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560246|NCT00766090|470019799|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560247|NCT00766090|470019800|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560248|NCT00766090|470019801|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560249|NCT00766090|470019802|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130723381|NCT01056289|470613427|FG003|Double-blind Phase|Discontinuation symptom|2|||
130398471|NCT00978731|469428441|FG003|Overall Study|Death|0|||
130398472|NCT00978731|469428438|FG000|Overall Study|Lost to Follow-up|0|||
130398473|NCT00978731|469428439|FG001|Overall Study|Lost to Follow-up|0|||
130398474|NCT00978731|469428440|FG002|Overall Study|Lost to Follow-up|0|||
130398475|NCT00978731|469428441|FG003|Overall Study|Lost to Follow-up|1|||
130398476|NCT00978731|469428438|FG000|Overall Study|Adverse Event|5|||
130560250|NCT00766090|470019803|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
130560251|NCT00766090|470019804|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560252|NCT00766090|470019805|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560253|NCT00766090|470019806|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130560254|NCT00766090|470019795|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
130560255|NCT00766090|470019796|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560256|NCT00766090|470019797|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560257|NCT00766090|470019798|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130723382|NCT01056289|470613424|FG000|Double-blind Phase|Physician Decision|0|||
130723383|NCT01056289|470613425|FG001|Double-blind Phase|Physician Decision|0|||
130723384|NCT01056289|470613426|FG002|Double-blind Phase|Physician Decision|1|||
130723385|NCT01056289|470613427|FG003|Double-blind Phase|Physician Decision|0|||
130723386|NCT01199471|470613430|FG000|Overall Study|Protocol Violation|4|||
130723387|NCT01199471|470613430|FG000|Overall Study|Withdrawal by Subject|1|||
130723388|NCT01199471|470613430|FG000|Overall Study|Physician Decision|1|||
130723389|NCT03511326|470613438|FG000|Overall Study|Withdrawal by Subject|1|||
130723390|NCT04746794|470613441|FG000|Overall Study|Did not complete any study assessment|50303|||
130723391|NCT04746794|470613442|FG001|Overall Study|Did not complete any study assessment|44997|||
130398477|NCT00978731|469428439|FG001|Overall Study|Adverse Event|2|||
130398478|NCT00978731|469428440|FG002|Overall Study|Adverse Event|0|||
130398479|NCT00978731|469428441|FG003|Overall Study|Adverse Event|0|||
130398480|NCT00978731|469428438|FG000|Overall Study|Participant's request|1|||
130398481|NCT00978731|469428439|FG001|Overall Study|Participant's request|0|||
130398482|NCT00978731|469428440|FG002|Overall Study|Participant's request|0|||
130398483|NCT00978731|469428441|FG003|Overall Study|Participant's request|0|||
130398484|NCT00978731|469428438|FG000|Overall Study|Administrative reason|3|||
130398485|NCT00978731|469428439|FG001|Overall Study|Administrative reason|3|||
130398486|NCT00978731|469428440|FG002|Overall Study|Administrative reason|1|||
130398487|NCT00978731|469428441|FG003|Overall Study|Administrative reason|0|||
130398488|NCT00978731|469428438|FG000|Overall Study|Deterioration without progression|0|||
130398489|NCT00978731|469428439|FG001|Overall Study|Deterioration without progression|1|||
130398490|NCT00978731|469428440|FG002|Overall Study|Deterioration without progression|0|||
130398491|NCT00978731|469428441|FG003|Overall Study|Deterioration without progression|0|||
130398492|NCT00978731|469428438|FG000|Overall Study|Disease progression/relapse|5|||
130398493|NCT00978731|469428439|FG001|Overall Study|Disease progression/relapse|4|||
130398494|NCT00978731|469428440|FG002|Overall Study|Disease progression/relapse|2|||
130398495|NCT00978731|469428441|FG003|Overall Study|Disease progression/relapse|2|||
130398496|NCT00978731|469428438|FG000|Overall Study|Study closure|3|||
130398497|NCT00978731|469428439|FG001|Overall Study|Study closure|4|||
130398498|NCT00978731|469428440|FG002|Overall Study|Study closure|1|||
130398499|NCT00978731|469428441|FG003|Overall Study|Study closure|1|||
130398500|NCT00978731|469428438|FG000|Overall Study|No response|1|||
130398501|NCT00978731|469428439|FG001|Overall Study|No response|0|||
130398502|NCT00978731|469428440|FG002|Overall Study|No response|0|||
130398503|NCT00978731|469428441|FG003|Overall Study|No response|0|||
130398504|NCT01896895|469428444|FG000|Double-blind MP|Physician Decision|0|||
130398505|NCT01896895|469428445|FG001|Double-blind MP|Physician Decision|0|||
130398506|NCT01896895|469428446|FG002|Double-blind MP|Physician Decision|1|||
130398507|NCT01896895|469428447|FG003|Double-blind MP|Physician Decision|0|||
130398508|NCT01896895|469428444|FG000|Double-blind MP|Withdrawal by Subject|0|||
130398509|NCT01896895|469428445|FG001|Double-blind MP|Withdrawal by Subject|2|||
130398510|NCT01896895|469428446|FG002|Double-blind MP|Withdrawal by Subject|1|||
130398511|NCT01896895|469428447|FG003|Double-blind MP|Withdrawal by Subject|0|||
130398512|NCT01896895|469428444|FG000|Double-blind MP|Lost to Follow-up|1|||
130398513|NCT01896895|469428445|FG001|Double-blind MP|Lost to Follow-up|0|||
130398514|NCT01896895|469428446|FG002|Double-blind MP|Lost to Follow-up|1|||
130398515|NCT01896895|469428447|FG003|Double-blind MP|Lost to Follow-up|0|||
130398516|NCT00293384|469428448|FG000|Overall Study|Non-compliance|2|||
130398517|NCT00293384|469428448|FG000|Overall Study|Missed dosage/study drug|1|||
130398518|NCT00293384|469428448|FG000|Overall Study|Ineligible|2|||
130398519|NCT04482179|469428449|FG000|Overall Study|Death|1|||
130398520|NCT04482179|469428450|FG001|Overall Study|Death|0|||
130398521|NCT04482179|469428449|FG000|Overall Study|Withdrawal by Subject|1|||
130398522|NCT04482179|469428450|FG001|Overall Study|Withdrawal by Subject|0|||
130398523|NCT00145509|469428451|FG000|Overall Study|Adverse Event|10|||
130398524|NCT00145509|469428452|FG001|Overall Study|Adverse Event|3|||
130723392|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
130723393|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
130723394|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
130398525|NCT00145509|469428451|FG000|Overall Study|Lack of Efficacy|3|||
130398526|NCT00145509|469428452|FG001|Overall Study|Lack of Efficacy|1|||
130398527|NCT00145509|469428451|FG000|Overall Study|Lost to Follow-up|5|||
130398528|NCT00145509|469428452|FG001|Overall Study|Lost to Follow-up|9|||
130398529|NCT00145509|469428451|FG000|Overall Study|Withdrew Consent|2|||
130398530|NCT00145509|469428452|FG001|Overall Study|Withdrew Consent|7|||
130723395|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
130723396|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130723397|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130723398|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
130723399|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
130723400|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
130398531|NCT00145509|469428451|FG000|Overall Study|Reason not provided|2|||
130398532|NCT00145509|469428452|FG001|Overall Study|Reason not provided|1|||
130398533|NCT00419562|469428453|FG000|Overall Study|Lost to Follow-up|12|||
130398534|NCT00419562|469428454|FG001|Overall Study|Lost to Follow-up|13|||
130398535|NCT00419562|469428453|FG000|Overall Study|Withdrawal by Subject|20|||
130398536|NCT00419562|469428454|FG001|Overall Study|Withdrawal by Subject|18|||
130398537|NCT00419562|469428453|FG000|Overall Study|Participant Institutionalized|1|||
130398538|NCT00419562|469428454|FG001|Overall Study|Participant Institutionalized|0|||
130723401|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
130398539|NCT02789176|469428455|FG000|Overall Study|Death|0|||
130398540|NCT02789176|469428456|FG001|Overall Study|Death|0|||
130398541|NCT02789176|469428457|FG002|Overall Study|Death|3|||
130398542|NCT02789176|469428458|FG003|Overall Study|Death|0|||
130398543|NCT02789176|469428455|FG000|Overall Study|Withdrawal by Subject|0|||
130398544|NCT02789176|469428456|FG001|Overall Study|Withdrawal by Subject|0|||
130398545|NCT02789176|469428457|FG002|Overall Study|Withdrawal by Subject|1|||
130398546|NCT02789176|469428458|FG003|Overall Study|Withdrawal by Subject|0|||
130398547|NCT02789176|469428455|FG000|Overall Study|Lost to Follow-up|8|||
130398548|NCT02789176|469428456|FG001|Overall Study|Lost to Follow-up|2|||
130398549|NCT02789176|469428457|FG002|Overall Study|Lost to Follow-up|6|||
130398550|NCT02789176|469428458|FG003|Overall Study|Lost to Follow-up|1|||
130398551|NCT00596011|469428459|FG000|Overall Study|Withdrawal by Subject|2|||
130398552|NCT00596011|469428460|FG001|Overall Study|Withdrawal by Subject|3|||
130398553|NCT00596011|469428459|FG000|Overall Study|Adverse Event|11|||
130398554|NCT00596011|469428460|FG001|Overall Study|Adverse Event|7|||
130398555|NCT01633944|469428461|FG000|Open-label Titration Phase|Adverse Event|109|||
130398556|NCT01633944|469428462|FG001|Open-label Titration Phase|Adverse Event|0|||
130398557|NCT01633944|469428463|FG002|Open-label Titration Phase|Adverse Event|0|||
130398558|NCT01633944|469428461|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
130398559|NCT01633944|469428462|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
130398560|NCT01633944|469428463|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
130398561|NCT01633944|469428461|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
130398562|NCT01633944|469428462|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
130398563|NCT01633944|469428463|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
130398564|NCT01633944|469428461|FG000|Open-label Titration Phase|Protocol Violation|24|||
130398565|NCT01633944|469428462|FG001|Open-label Titration Phase|Protocol Violation|0|||
130398566|NCT01633944|469428463|FG002|Open-label Titration Phase|Protocol Violation|0|||
130398567|NCT01633944|469428461|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
130398568|NCT01633944|469428462|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
130398569|NCT01633944|469428463|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
130398570|NCT01633944|469428461|FG000|Open-label Titration Phase|Other|68|||
130398571|NCT01633944|469428462|FG001|Open-label Titration Phase|Other|0|||
130398572|NCT01633944|469428463|FG002|Open-label Titration Phase|Other|0|||
130398573|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130398574|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Adverse Event|13|||
130398575|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Adverse Event|7|||
130398576|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130398577|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
130398578|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
130398579|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130398580|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130398581|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
130398582|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130398583|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
130398584|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
130398585|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130398586|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
130398587|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
130398588|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
130398589|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
130398590|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
130398591|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
130398592|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
130398593|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
130398594|NCT01633944|469428461|FG000|Double-blind Treatment Phase|Other|0|||
130398595|NCT01633944|469428462|FG001|Double-blind Treatment Phase|Other|7|||
130398596|NCT01633944|469428463|FG002|Double-blind Treatment Phase|Other|0|||
130398597|NCT02583256|469428464|FG000|Overall Study|Withdrawal by Subject|0|||
130398598|NCT02583256|469428465|FG001|Overall Study|Withdrawal by Subject|1|||
130398599|NCT02583256|469428466|FG002|Overall Study|Withdrawal by Subject|1|||
130398600|NCT02583256|469428467|FG003|Overall Study|Withdrawal by Subject|0|||
130398601|NCT02583256|469428464|FG000|Overall Study|Lost to Follow-up|1|||
130398602|NCT02583256|469428465|FG001|Overall Study|Lost to Follow-up|1|||
130398603|NCT02583256|469428466|FG002|Overall Study|Lost to Follow-up|0|||
130398604|NCT02583256|469428467|FG003|Overall Study|Lost to Follow-up|1|||
130398605|NCT02583256|469428464|FG000|Overall Study|Administrative/Other|2|||
130398606|NCT02583256|469428465|FG001|Overall Study|Administrative/Other|0|||
130398607|NCT02583256|469428466|FG002|Overall Study|Administrative/Other|1|||
130398608|NCT02583256|469428467|FG003|Overall Study|Administrative/Other|2|||
130398609|NCT03364049|469428468|FG000|Overall Study|Death|6|||
130398610|NCT03364049|469428469|FG001|Overall Study|Death|4|||
130398611|NCT03364049|469428470|FG002|Overall Study|Death|5|||
130398612|NCT03364049|469428471|FG003|Overall Study|Death|14|||
130398613|NCT03364049|469428468|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
130398614|NCT03364049|469428469|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
130398615|NCT03364049|469428470|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
130398616|NCT03364049|469428471|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
130398617|NCT03364049|469428468|FG000|Overall Study|Withdrawal by Subject|0|||
130398618|NCT03364049|469428469|FG001|Overall Study|Withdrawal by Subject|1|||
130398619|NCT03364049|469428470|FG002|Overall Study|Withdrawal by Subject|1|||
130398620|NCT03364049|469428471|FG003|Overall Study|Withdrawal by Subject|1|||
130398621|NCT00418691|469428472|FG000|Overall Study|Lost to Follow-up|1|||
130398622|NCT00418691|469428473|FG001|Overall Study|Lost to Follow-up|2|||
130398623|NCT00418691|469428474|FG002|Overall Study|Lost to Follow-up|3|||
130398624|NCT00418691|469428472|FG000|Overall Study|Started new medication voiding entry|0|||
130398625|NCT00418691|469428473|FG001|Overall Study|Started new medication voiding entry|0|||
130398626|NCT00418691|469428474|FG002|Overall Study|Started new medication voiding entry|1|||
130723402|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130723403|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130723404|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
130723405|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
130723406|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
130398627|NCT00418691|469428472|FG000|Overall Study|Progressive Disease|1|||
130398628|NCT00418691|469428473|FG001|Overall Study|Progressive Disease|0|||
130398629|NCT00418691|469428474|FG002|Overall Study|Progressive Disease|1|||
130398630|NCT02103478|469428475|FG000|Overall Study|Adverse Event|0|||
130398631|NCT02103478|469428476|FG001|Overall Study|Adverse Event|0|||
130398632|NCT02103478|469428477|FG002|Overall Study|Adverse Event|1|||
130398633|NCT02103478|469428478|FG003|Overall Study|Adverse Event|1|||
130398634|NCT02103478|469428479|FG004|Overall Study|Adverse Event|2|||
130398635|NCT02103478|469428480|FG005|Overall Study|Adverse Event|1|||
130398636|NCT02103478|469428481|FG006|Overall Study|Adverse Event|0|||
130398637|NCT02103478|469428482|FG007|Overall Study|Adverse Event|0|||
130398638|NCT02103478|469428483|FG008|Overall Study|Adverse Event|0|||
130398639|NCT02103478|469428475|FG000|Overall Study|Death|2|||
130398640|NCT02103478|469428476|FG001|Overall Study|Death|2|||
130398641|NCT02103478|469428477|FG002|Overall Study|Death|1|||
130398642|NCT02103478|469428478|FG003|Overall Study|Death|1|||
130398643|NCT02103478|469428479|FG004|Overall Study|Death|5|||
130398644|NCT02103478|469428480|FG005|Overall Study|Death|15|||
130398645|NCT02103478|469428481|FG006|Overall Study|Death|14|||
130398646|NCT02103478|469428482|FG007|Overall Study|Death|10|||
130398647|NCT02103478|469428483|FG008|Overall Study|Death|11|||
130398648|NCT02103478|469428475|FG000|Overall Study|Progressive Disease|2|||
130398649|NCT02103478|469428476|FG001|Overall Study|Progressive Disease|1|||
130398650|NCT02103478|469428477|FG002|Overall Study|Progressive Disease|2|||
130398651|NCT02103478|469428478|FG003|Overall Study|Progressive Disease|0|||
130398652|NCT02103478|469428479|FG004|Overall Study|Progressive Disease|9|||
130398653|NCT02103478|469428480|FG005|Overall Study|Progressive Disease|1|||
130398654|NCT02103478|469428481|FG006|Overall Study|Progressive Disease|2|||
130398655|NCT02103478|469428482|FG007|Overall Study|Progressive Disease|0|||
130398656|NCT02103478|469428483|FG008|Overall Study|Progressive Disease|1|||
130398657|NCT02103478|469428475|FG000|Overall Study|Withdrawal by Subject|2|||
130398658|NCT02103478|469428476|FG001|Overall Study|Withdrawal by Subject|0|||
130398659|NCT02103478|469428477|FG002|Overall Study|Withdrawal by Subject|0|||
130398660|NCT02103478|469428478|FG003|Overall Study|Withdrawal by Subject|4|||
130398661|NCT02103478|469428479|FG004|Overall Study|Withdrawal by Subject|0|||
130398662|NCT02103478|469428480|FG005|Overall Study|Withdrawal by Subject|0|||
130398663|NCT02103478|469428481|FG006|Overall Study|Withdrawal by Subject|1|||
130398664|NCT02103478|469428482|FG007|Overall Study|Withdrawal by Subject|1|||
130398665|NCT02103478|469428483|FG008|Overall Study|Withdrawal by Subject|0|||
130398666|NCT02103478|469428475|FG000|Overall Study|Lost to Follow-up|0|||
130398667|NCT02103478|469428476|FG001|Overall Study|Lost to Follow-up|0|||
130398668|NCT02103478|469428477|FG002|Overall Study|Lost to Follow-up|0|||
130398669|NCT02103478|469428478|FG003|Overall Study|Lost to Follow-up|0|||
130398670|NCT02103478|469428479|FG004|Overall Study|Lost to Follow-up|0|||
130398671|NCT02103478|469428480|FG005|Overall Study|Lost to Follow-up|0|||
130398672|NCT02103478|469428481|FG006|Overall Study|Lost to Follow-up|0|||
130398673|NCT02103478|469428482|FG007|Overall Study|Lost to Follow-up|1|||
130398674|NCT02103478|469428483|FG008|Overall Study|Lost to Follow-up|0|||
130398675|NCT02103478|469428475|FG000|Overall Study|Other|1|||
130398676|NCT02103478|469428476|FG001|Overall Study|Other|3|||
130398677|NCT02103478|469428477|FG002|Overall Study|Other|2|||
130398678|NCT02103478|469428478|FG003|Overall Study|Other|0|||
130398679|NCT02103478|469428479|FG004|Overall Study|Other|3|||
130398680|NCT02103478|469428480|FG005|Overall Study|Other|8|||
130398681|NCT02103478|469428481|FG006|Overall Study|Other|8|||
130398682|NCT02103478|469428482|FG007|Overall Study|Other|4|||
130398683|NCT02103478|469428483|FG008|Overall Study|Other|2|||
130398684|NCT04182100|469428484|FG000|Overall Study|Adverse Event|1|||
130398685|NCT04182100|469428484|FG000|Overall Study|Withdrawal by Subject|1|||
130398686|NCT04988295|469428485|FG000|Overall Study|Withdrawal by Subject|9|||
130398687|NCT04988295|469428486|FG001|Overall Study|Withdrawal by Subject|29|||
130398688|NCT04988295|469428487|FG002|Overall Study|Withdrawal by Subject|6|||
130398689|NCT04988295|469428488|FG003|Overall Study|Withdrawal by Subject|0|||
130398690|NCT04988295|469428485|FG000|Overall Study|Lost to Follow-up|1|||
130398691|NCT04988295|469428486|FG001|Overall Study|Lost to Follow-up|0|||
130398692|NCT04988295|469428487|FG002|Overall Study|Lost to Follow-up|0|||
130398693|NCT04988295|469428488|FG003|Overall Study|Lost to Follow-up|0|||
130398694|NCT04988295|469428485|FG000|Overall Study|Study participation ongoing|186|||
130398695|NCT04988295|469428486|FG001|Overall Study|Study participation ongoing|169|||
130398696|NCT04988295|469428487|FG002|Overall Study|Study participation ongoing|99|||
130398697|NCT04988295|469428488|FG003|Overall Study|Study participation ongoing|119|||
130398698|NCT00433654|469428493|FG000|Overall Study|Death|4|||
130398699|NCT00433654|469428494|FG001|Overall Study|Death|0|||
130398700|NCT00433654|469428493|FG000|Overall Study|Missed visit|6|||
130398701|NCT00433654|469428494|FG001|Overall Study|Missed visit|3|||
130398702|NCT00433654|469428493|FG000|Overall Study|Subject not yet due for visit|4|||
130398703|NCT00433654|469428494|FG001|Overall Study|Subject not yet due for visit|0|||
130398704|NCT00433654|469428493|FG000|Overall Study|Withdrawal by Subject|1|||
130398705|NCT00433654|469428494|FG001|Overall Study|Withdrawal by Subject|2|||
130398706|NCT03748641|469428495|FG000|Overall Study|Ongoing|155|||
130398707|NCT03748641|469428496|FG001|Overall Study|Ongoing|148|||
130398708|NCT03748641|469428497|FG002|Overall Study|Ongoing|66|||
130398709|NCT03748641|469428498|FG003|Overall Study|Ongoing|79|||
130398710|NCT03748641|469428499|FG004|Overall Study|Ongoing|84|||
130398711|NCT03748641|469428495|FG000|Overall Study|Death|54|||
130398712|NCT03748641|469428496|FG001|Overall Study|Death|59|||
130398713|NCT03748641|469428497|FG002|Overall Study|Death|51|||
130398714|NCT03748641|469428498|FG003|Overall Study|Death|42|||
130398715|NCT03748641|469428499|FG004|Overall Study|Death|9|||
130398716|NCT03748641|469428495|FG000|Overall Study|Lost to Follow-up|0|||
130398717|NCT03748641|469428496|FG001|Overall Study|Lost to Follow-up|2|||
130398718|NCT03748641|469428497|FG002|Overall Study|Lost to Follow-up|1|||
130398719|NCT03748641|469428498|FG003|Overall Study|Lost to Follow-up|0|||
130398720|NCT03748641|469428499|FG004|Overall Study|Lost to Follow-up|0|||
130398721|NCT03748641|469428495|FG000|Overall Study|Withdrawal by Subject|3|||
130398722|NCT03748641|469428496|FG001|Overall Study|Withdrawal by Subject|2|||
130398723|NCT03748641|469428497|FG002|Overall Study|Withdrawal by Subject|5|||
130398724|NCT03748641|469428498|FG003|Overall Study|Withdrawal by Subject|3|||
130398725|NCT03748641|469428499|FG004|Overall Study|Withdrawal by Subject|2|||
130398726|NCT04397263|469428500|FG000|Overall Study|Withdrawal by Subject|2|||
130398727|NCT01428193|469428501|FG000|Overall Study|Physician Decision|1|||
130398728|NCT01428193|469428501|FG000|Overall Study|Elevated screening liver enzymes|1|||
130398729|NCT03762083|469428502|FG000|Overall Study|Withdrawal by Subject|2|||
130398730|NCT03762083|469428502|FG000|Overall Study|Physician Decision|1|||
130398731|NCT04697628|469428503|FG000|Overall Study|Withdrawal by Subject|17|||
130398732|NCT04697628|469428504|FG001|Overall Study|Withdrawal by Subject|23|||
130398733|NCT04697628|469428503|FG000|Overall Study|Lost to Follow-up|0|||
130398734|NCT04697628|469428504|FG001|Overall Study|Lost to Follow-up|4|||
130398735|NCT04697628|469428503|FG000|Overall Study|On-going in study|122|||
130398736|NCT04697628|469428504|FG001|Overall Study|On-going in study|91|||
130398737|NCT02703636|469428505|FG000|Overall Study|Adverse Event|14|||
130398738|NCT02703636|469428505|FG000|Overall Study|Study stopped by sponsor|1|||
130398739|NCT02703636|469428505|FG000|Overall Study|Withdrawal by Subject|1|||
130398740|NCT00393939|469428506|FG000|Overall Study|Protocol Violation|1|||
130398741|NCT00393939|469428507|FG001|Overall Study|Protocol Violation|1|||
130398742|NCT00393939|469428506|FG000|Overall Study|Lost to Follow-up|2|||
130398743|NCT00393939|469428507|FG001|Overall Study|Lost to Follow-up|4|||
130398744|NCT00393939|469428506|FG000|Overall Study|Death|10|||
130398745|NCT00393939|469428507|FG001|Overall Study|Death|4|||
130398746|NCT00393939|469428506|FG000|Overall Study|Sponsor|5|||
130398747|NCT00393939|469428507|FG001|Overall Study|Sponsor|13|||
130398748|NCT00393939|469428506|FG000|Overall Study|Objective progression or relapse|239|||
130398749|NCT00393939|469428507|FG001|Overall Study|Objective progression or relapse|223|||
130398750|NCT00393939|469428506|FG000|Overall Study|Withdrawal by Subject|2|||
130398751|NCT00393939|469428507|FG001|Overall Study|Withdrawal by Subject|7|||
130398752|NCT00393939|469428506|FG000|Overall Study|Other|37|||
130398753|NCT00393939|469428507|FG001|Overall Study|Other|45|||
130398754|NCT03778931|469428508|FG000|Overall Study|Withdrawal by Subject|12|||
130398755|NCT03778931|469428509|FG001|Overall Study|Withdrawal by Subject|25|||
130398756|NCT03778931|469428508|FG000|Overall Study|Physician Decision|1|||
130398757|NCT03778931|469428509|FG001|Overall Study|Physician Decision|3|||
130398758|NCT03778931|469428508|FG000|Overall Study|Participant Noncompliance|1|||
130398759|NCT03778931|469428509|FG001|Overall Study|Participant Noncompliance|1|||
130398760|NCT03778931|469428508|FG000|Overall Study|Lost to Follow-up|4|||
130398761|NCT03778931|469428509|FG001|Overall Study|Lost to Follow-up|1|||
130398762|NCT03778931|469428508|FG000|Overall Study|Death|69|||
130398763|NCT03778931|469428509|FG001|Overall Study|Death|79|||
130398764|NCT00006184|469428510|FG000|Overall Study|Death|1|||
130398765|NCT00006184|469428511|FG001|Overall Study|Death|0|||
130398766|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
130398767|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
130398768|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
130398769|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
130398770|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
130398771|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
130398772|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
130398773|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
130398774|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
130398775|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
130398776|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
130398777|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
130398778|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
130398779|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
130398780|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
130398781|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
130398782|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
130398783|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
130398784|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
130398785|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
130398786|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
130398787|NCT02161718|469428516|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
130398788|NCT02161718|469428517|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
130398789|NCT02161718|469428518|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
130398790|NCT02161718|469428516|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
130398791|NCT02161718|469428517|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
130398792|NCT02161718|469428518|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
130398793|NCT02161718|469428516|FG000|Post- Randomization Period|Lost to Follow-up|0|||
130398794|NCT02161718|469428517|FG001|Post- Randomization Period|Lost to Follow-up|9|||
130398795|NCT02161718|469428518|FG002|Post- Randomization Period|Lost to Follow-up|15|||
130398796|NCT02161718|469428516|FG000|Post- Randomization Period|Adverse Event|0|||
130398797|NCT02161718|469428517|FG001|Post- Randomization Period|Adverse Event|9|||
130398798|NCT02161718|469428518|FG002|Post- Randomization Period|Adverse Event|10|||
130398799|NCT02161718|469428516|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
130398800|NCT02161718|469428517|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
130398801|NCT02161718|469428518|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
130398802|NCT02161718|469428516|FG000|Post- Randomization Period|Physician Decision|0|||
130398803|NCT02161718|469428517|FG001|Post- Randomization Period|Physician Decision|2|||
130398804|NCT02161718|469428518|FG002|Post- Randomization Period|Physician Decision|4|||
130398805|NCT02161718|469428516|FG000|Post- Randomization Period|Protocol Violation|0|||
130398806|NCT02161718|469428517|FG001|Post- Randomization Period|Protocol Violation|2|||
130398807|NCT02161718|469428518|FG002|Post- Randomization Period|Protocol Violation|3|||
130398808|NCT02161718|469428516|FG000|Post- Randomization Period|Lack of Efficacy|0|||
130398809|NCT02161718|469428517|FG001|Post- Randomization Period|Lack of Efficacy|0|||
130398810|NCT02161718|469428518|FG002|Post- Randomization Period|Lack of Efficacy|1|||
130723407|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
130398811|NCT02161718|469428516|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
130398812|NCT02161718|469428517|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
130398813|NCT02161718|469428518|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
130398814|NCT02161718|469428516|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
130398815|NCT02161718|469428517|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
130560258|NCT00766090|470019799|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560259|NCT00766090|470019800|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560260|NCT00766090|470019801|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560261|NCT00766090|470019802|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560262|NCT00766090|470019803|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560263|NCT00766090|470019804|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560264|NCT00766090|470019805|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560265|NCT00766090|470019806|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130560266|NCT00766090|470019795|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130560267|NCT00766090|470019796|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560268|NCT00766090|470019797|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560269|NCT00766090|470019798|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130560270|NCT00766090|470019799|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560271|NCT00766090|470019800|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560272|NCT00766090|470019801|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560273|NCT00766090|470019802|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560274|NCT00766090|470019803|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560275|NCT00766090|470019804|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560276|NCT00766090|470019805|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560277|NCT00766090|470019806|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130560278|NCT00766090|470019795|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560279|NCT00766090|470019796|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560280|NCT00766090|470019797|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
130398816|NCT02161718|469428518|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
130398817|NCT02161718|469428516|FG000|Post- Randomization Period|Relocation|0|||
130398818|NCT02161718|469428517|FG001|Post- Randomization Period|Relocation|3|||
130398819|NCT02161718|469428518|FG002|Post- Randomization Period|Relocation|0|||
130560281|NCT00766090|470019798|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560282|NCT00766090|470019799|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560283|NCT00766090|470019800|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
130723408|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
130398820|NCT04108208|469428519|FG000|Overall Study|Withdrawal by Subject|2|||
130398821|NCT04108208|469428520|FG001|Overall Study|Withdrawal by Subject|6|||
130398822|NCT04108208|469428519|FG000|Overall Study|other-ongoing|20|||
130398823|NCT04108208|469428520|FG001|Overall Study|other-ongoing|40|||
130398824|NCT04108208|469428519|FG000|Overall Study|Death|1|||
130398825|NCT04108208|469428520|FG001|Overall Study|Death|4|||
130398826|NCT04108208|469428519|FG000|Overall Study|Lost to Follow-up|2|||
130398827|NCT04108208|469428520|FG001|Overall Study|Lost to Follow-up|0|||
130398828|NCT02948842|469428523|FG000|Overall Study|Withdrawal by Subject|4|||
130398829|NCT02350309|469428525|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
130398830|NCT02350309|469428526|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
130398831|NCT02350309|469428527|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
130398832|NCT02350309|469428528|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
130398833|NCT02350309|469428529|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
130398834|NCT02350309|469428530|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
130398835|NCT02350309|469428525|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
130398836|NCT02350309|469428526|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
130398837|NCT02350309|469428527|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
130398838|NCT02350309|469428528|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
130398839|NCT02350309|469428529|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
130398840|NCT02350309|469428530|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
130398841|NCT01256710|469428531|FG000|Overall Study|Death|449|||
130398842|NCT01256710|469428531|FG000|Overall Study|System Explant|67|||
130398843|NCT01256710|469428531|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
130398844|NCT01256710|469428531|FG000|Overall Study|Lost to Follow-up|67|||
130398845|NCT01256710|469428531|FG000|Overall Study|Withdrawal by Subject|29|||
130398846|NCT01256710|469428531|FG000|Overall Study|Physician Decision|9|||
130398847|NCT01256710|469428531|FG000|Overall Study|Subject Noncompliance|2|||
130398848|NCT01256710|469428531|FG000|Overall Study|Study Terminated by Sponsor|273|||
130398849|NCT00058825|469428532|FG000|Overall Study|Relapse|9|||
130398850|NCT00058825|469428532|FG000|Overall Study|Progressive Disease|5|||
130398851|NCT00058825|469428532|FG000|Overall Study|Graft Failure|5|||
130398852|NCT00058825|469428532|FG000|Overall Study|Death|3|||
130560284|NCT00766090|470019801|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
130723409|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
130723410|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
130398853|NCT01205165|469428533|FG000|Overall Study|Lost to Follow-up|2|||
130398854|NCT02942017|469428534|FG000|Overall Study|Adverse Event|0|||
130398855|NCT02942017|469428535|FG001|Overall Study|Adverse Event|1|||
130398856|NCT02942017|469428534|FG000|Overall Study|Withdrawal by Subject|0|||
130560285|NCT00766090|470019802|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560286|NCT00766090|470019803|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560287|NCT00766090|470019804|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560288|NCT00766090|470019805|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560289|NCT00766090|470019806|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
130560290|NCT00766090|470019795|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560291|NCT00766090|470019796|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560292|NCT00766090|470019797|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560293|NCT00766090|470019798|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560294|NCT00766090|470019799|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
130560295|NCT00766090|470019800|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560296|NCT00766090|470019801|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560297|NCT00766090|470019802|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560298|NCT00766090|470019803|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560299|NCT00766090|470019804|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560300|NCT00766090|470019805|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560301|NCT00766090|470019806|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130560302|NCT00766090|470019795|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560303|NCT00766090|470019796|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560304|NCT00766090|470019797|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
130560305|NCT00766090|470019798|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560306|NCT00766090|470019799|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560307|NCT00766090|470019800|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560308|NCT00766090|470019801|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560309|NCT00766090|470019802|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560310|NCT00766090|470019803|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560311|NCT00766090|470019804|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560312|NCT00766090|470019805|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560313|NCT00766090|470019806|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130560314|NCT00766090|470019795|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
130560315|NCT00766090|470019796|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
130560316|NCT00766090|470019797|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
130560317|NCT00766090|470019798|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
130560318|NCT00766090|470019799|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
130560319|NCT00766090|470019800|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
130560320|NCT00766090|470019801|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
130560321|NCT00766090|470019802|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
130560322|NCT00766090|470019803|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
130560323|NCT00766090|470019804|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
130560324|NCT00766090|470019805|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
130560325|NCT00766090|470019806|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
130560326|NCT00766090|470019795|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560327|NCT00766090|470019796|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560328|NCT00766090|470019797|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560329|NCT00766090|470019798|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560330|NCT00766090|470019799|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560331|NCT00766090|470019800|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
130560332|NCT00766090|470019801|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560333|NCT00766090|470019802|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560334|NCT00766090|470019803|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560335|NCT00766090|470019804|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560336|NCT00766090|470019805|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560337|NCT00766090|470019806|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130560338|NCT00766090|470019795|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560339|NCT00766090|470019796|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130560340|NCT00766090|470019797|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560341|NCT00766090|470019798|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130560342|NCT00766090|470019799|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560343|NCT00766090|470019800|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560344|NCT00766090|470019801|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560345|NCT00766090|470019802|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560346|NCT00766090|470019803|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560347|NCT00766090|470019804|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560348|NCT00766090|470019805|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130560349|NCT00766090|470019806|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130560350|NCT00766090|470019795|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560351|NCT00766090|470019796|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560352|NCT00766090|470019797|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130398857|NCT02942017|469428535|FG001|Overall Study|Withdrawal by Subject|1|||
130398858|NCT02942017|469428534|FG000|Overall Study|Lost to Follow-up|1|||
130398859|NCT02942017|469428535|FG001|Overall Study|Lost to Follow-up|1|||
130398860|NCT02942017|469428534|FG000|Overall Study|Randomized but not dosed|1|||
130398861|NCT02942017|469428535|FG001|Overall Study|Randomized but not dosed|3|||
130398862|NCT04399161|469428536|FG000|Overall Study|Withdrawal by Subject|1|||
130398863|NCT04399161|469428537|FG001|Overall Study|Withdrawal by Subject|0|||
130398864|NCT04399161|469428538|FG002|Overall Study|Withdrawal by Subject|2|||
130398865|NCT04399161|469428536|FG000|Overall Study|Protocol Violation|1|||
130398866|NCT04399161|469428537|FG001|Overall Study|Protocol Violation|2|||
130398867|NCT04399161|469428538|FG002|Overall Study|Protocol Violation|0|||
130398868|NCT01736696|469428541|FG000|Overall Study|Withdrawal by Subject|0|||
130398869|NCT01736696|469428542|FG001|Overall Study|Withdrawal by Subject|0|||
130398870|NCT01736696|469428543|FG002|Overall Study|Withdrawal by Subject|1|||
130398871|NCT01736696|469428544|FG003|Overall Study|Withdrawal by Subject|0|||
130398872|NCT01736696|469428545|FG004|Overall Study|Withdrawal by Subject|0|||
130398873|NCT01736696|469428546|FG005|Overall Study|Withdrawal by Subject|0|||
130398874|NCT01736696|469428547|FG006|Overall Study|Withdrawal by Subject|0|||
130398875|NCT00838565|469428548|FG000|Overall Study|Withdrawal by Subject|0|||
130398876|NCT00838565|469428549|FG001|Overall Study|Withdrawal by Subject|0|||
130398877|NCT00838565|469428550|FG002|Overall Study|Withdrawal by Subject|1|||
130398878|NCT00838565|469428551|FG003|Overall Study|Withdrawal by Subject|0|||
130398879|NCT00838565|469428552|FG004|Overall Study|Withdrawal by Subject|0|||
130398880|NCT00838565|469428553|FG005|Overall Study|Withdrawal by Subject|2|||
130398881|NCT00838565|469428548|FG000|Overall Study|Other|0|||
130398882|NCT00838565|469428549|FG001|Overall Study|Other|2|||
130398883|NCT00838565|469428550|FG002|Overall Study|Other|0|||
130398884|NCT00838565|469428551|FG003|Overall Study|Other|0|||
130398885|NCT00838565|469428552|FG004|Overall Study|Other|0|||
130398886|NCT00838565|469428553|FG005|Overall Study|Other|0|||
130398887|NCT00838565|469428548|FG000|Overall Study|Randomized but not Treated|0|||
130398888|NCT00838565|469428549|FG001|Overall Study|Randomized but not Treated|1|||
130398889|NCT00838565|469428550|FG002|Overall Study|Randomized but not Treated|0|||
130398890|NCT00838565|469428551|FG003|Overall Study|Randomized but not Treated|0|||
130398891|NCT00838565|469428552|FG004|Overall Study|Randomized but not Treated|0|||
130398892|NCT00838565|469428553|FG005|Overall Study|Randomized but not Treated|0|||
130398893|NCT02114879|469428554|FG000|Overall Study|Withdrawal by Subject|9|||
130398894|NCT02114879|469428555|FG001|Overall Study|Withdrawal by Subject|5|||
130398895|NCT02114879|469428554|FG000|Overall Study|Death|6|||
130398896|NCT02114879|469428555|FG001|Overall Study|Death|11|||
130398897|NCT02114879|469428554|FG000|Overall Study|Lost to Follow-up|4|||
130398898|NCT02114879|469428555|FG001|Overall Study|Lost to Follow-up|6|||
130398899|NCT02114879|469428554|FG000|Overall Study|Physician Decision|0|||
130398900|NCT02114879|469428555|FG001|Overall Study|Physician Decision|2|||
130398901|NCT00458484|469428556|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
130398902|NCT00458484|469428557|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
130398903|NCT00458484|469428558|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
130398904|NCT00458484|469428559|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
130398905|NCT00458484|469428560|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
130398906|NCT00458484|469428561|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
130398907|NCT00458484|469428562|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
130398908|NCT05059600|469428563|FG000|Overall Study|Enrolled but not Treated|10|||
130398909|NCT04538664|469428564|FG000|Overall Study|Withdrawal by Subject|5|||
130398910|NCT04538664|469428565|FG001|Overall Study|Withdrawal by Subject|9|||
130398911|NCT04538664|469428564|FG000|Overall Study|Lost to Follow-up|2|||
130398912|NCT04538664|469428565|FG001|Overall Study|Lost to Follow-up|1|||
130398913|NCT04538664|469428564|FG000|Overall Study|Ongoing|106|||
130398914|NCT04538664|469428565|FG001|Overall Study|Ongoing|115|||
130398915|NCT04552587|469428566|FG000|Overall Study|Lost to Follow-up|4|||
130398916|NCT03400033|469428569|FG000|Overall Study|Withdrawal by Subject|1|||
130398917|NCT03400033|469428570|FG001|Overall Study|Withdrawal by Subject|2|||
130398918|NCT02741115|469428576|FG000|Overall Study|Adverse Event|1|||
130398919|NCT02741115|469428577|FG001|Overall Study|Adverse Event|0|||
130398920|NCT02741115|469428576|FG000|Overall Study|Lost to Follow-up|7|||
130398921|NCT02741115|469428577|FG001|Overall Study|Lost to Follow-up|4|||
130398922|NCT02741115|469428576|FG000|Overall Study|Withdrawal by Subject|4|||
130398923|NCT02741115|469428577|FG001|Overall Study|Withdrawal by Subject|2|||
130398924|NCT06425458|469428578|FG000|Overall Study|Removed by study team|2|||
130398925|NCT06425458|469428578|FG000|Overall Study|Lost to Follow-up|5|||
130398926|NCT00445328|469428579|FG000|Overall Study|Death|0|||
130398927|NCT00445328|469428580|FG001|Overall Study|Death|1|||
130398928|NCT00445328|469428579|FG000|Overall Study|Adverse Event|0|||
130398929|NCT00445328|469428580|FG001|Overall Study|Adverse Event|3|||
130398930|NCT00445328|469428579|FG000|Overall Study|Other|0|||
130398931|NCT00445328|469428580|FG001|Overall Study|Other|2|||
130398932|NCT00445328|469428579|FG000|Overall Study|Withdrawal by Subject|2|||
130398933|NCT00445328|469428580|FG001|Overall Study|Withdrawal by Subject|0|||
130398934|NCT00445328|469428579|FG000|Overall Study|Protocol Violation|1|||
130398935|NCT00445328|469428580|FG001|Overall Study|Protocol Violation|0|||
130723411|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130723412|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130723413|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
130398936|NCT02782949|469428584|FG000|Overall Study|Protocol Violation|1|||
130398937|NCT02782949|469428585|FG001|Overall Study|Protocol Violation|0|||
130398938|NCT02782949|469428584|FG000|Overall Study|Withdrawal by Subject|0|||
130398939|NCT02782949|469428585|FG001|Overall Study|Withdrawal by Subject|1|||
130398940|NCT01433263|469429789|FG000|Overall Study|Adverse Event|3|||
130398941|NCT01433263|469429790|FG001|Overall Study|Adverse Event|1|||
130398942|NCT01433263|469429789|FG000|Overall Study|Death|5|||
130398943|NCT01433263|469429790|FG001|Overall Study|Death|3|||
130398944|NCT01433263|469429789|FG000|Overall Study|Lost to Follow-up|0|||
130398945|NCT01433263|469429790|FG001|Overall Study|Lost to Follow-up|1|||
130398946|NCT01433263|469429789|FG000|Overall Study|Protocol Deviation|1|||
130398947|NCT01433263|469429790|FG001|Overall Study|Protocol Deviation|0|||
130398948|NCT01433263|469429789|FG000|Overall Study|Withdrawal by Subject|10|||
130398949|NCT01433263|469429790|FG001|Overall Study|Withdrawal by Subject|7|||
130398950|NCT04709237|469429791|FG000|Overall Study|Lost to Follow-up|1|||
130398951|NCT04709237|469429792|FG001|Overall Study|Lost to Follow-up|0|||
130398952|NCT04709237|469429793|FG002|Overall Study|Lost to Follow-up|0|||
130398953|NCT01302964|469429795|FG000|Overall Study|Adverse Event|1|||
130398954|NCT01302964|469429796|FG001|Overall Study|Adverse Event|0|||
130398955|NCT02489318|469429797|FG000|Randomized|Withdrawal by Subject|0|||
130398956|NCT02489318|469429798|FG001|Randomized|Withdrawal by Subject|1|||
130398957|NCT02489318|469429797|FG000|Treated|Adverse Event|19|||
130398958|NCT02489318|469429798|FG001|Treated|Adverse Event|62|||
130398959|NCT02489318|469429797|FG000|Treated|Death|13|||
130398960|NCT02489318|469429798|FG001|Treated|Death|11|||
130398961|NCT02489318|469429797|FG000|Treated|Physician Decision|4|||
130398962|NCT02489318|469429798|FG001|Treated|Physician Decision|6|||
130398963|NCT02489318|469429797|FG000|Treated|Protocol Violation|1|||
130398964|NCT02489318|469429798|FG001|Treated|Protocol Violation|2|||
130398965|NCT02489318|469429797|FG000|Treated|Withdrawal by Subject|37|||
130398966|NCT02489318|469429798|FG001|Treated|Withdrawal by Subject|36|||
130398967|NCT02489318|469429797|FG000|Treated|Other: Progressive Disease|245|||
130398968|NCT02489318|469429798|FG001|Treated|Other: Progressive Disease|138|||
130398969|NCT02489318|469429797|FG000|Treated|Other|0|||
130398970|NCT02489318|469429798|FG001|Treated|Other|2|||
130398971|NCT02489318|469429797|FG000|Treated|Ongoing|0|||
130398972|NCT02489318|469429798|FG001|Treated|Ongoing|267|||
130398973|NCT05723770|469429799|FG000|Overall Study|Lost to Follow-up|4|||
130398974|NCT05723770|469429799|FG000|Overall Study|Withdrawal by Subject|2|||
130723414|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130723415|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130723416|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
130723417|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
130723418|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
130398999|NCT01359592|469429807|FG000|Initial Registration|Adverse Event|1|||
130399000|NCT01359592|469429808|FG001|Initial Registration|Adverse Event|0|||
130399001|NCT01359592|469429809|FG002|Initial Registration|Adverse Event|0|||
130399002|NCT01359592|469429810|FG003|Initial Registration|Adverse Event|0|||
130399003|NCT01359592|469429807|FG000|Initial Registration|Death|1|||
130399004|NCT01359592|469429808|FG001|Initial Registration|Death|0|||
130399005|NCT01359592|469429809|FG002|Initial Registration|Death|0|||
130399006|NCT01359592|469429810|FG003|Initial Registration|Death|0|||
130399007|NCT01359592|469429807|FG000|Initial Registration|Other reason not protocol specified|1|||
130399008|NCT01359592|469429808|FG001|Initial Registration|Other reason not protocol specified|0|||
130399009|NCT01359592|469429809|FG002|Initial Registration|Other reason not protocol specified|0|||
130399010|NCT01359592|469429810|FG003|Initial Registration|Other reason not protocol specified|0|||
130399011|NCT01359592|469429807|FG000|Initial Registration|Ineligible|26|||
130399012|NCT01359592|469429808|FG001|Initial Registration|Ineligible|0|||
130399013|NCT01359592|469429809|FG002|Initial Registration|Ineligible|0|||
130399014|NCT01359592|469429810|FG003|Initial Registration|Ineligible|0|||
130399015|NCT01359592|469429807|FG000|PET-Directed Therapy|Adverse Event|0|||
130399016|NCT01359592|469429808|FG001|PET-Directed Therapy|Adverse Event|0|||
130399017|NCT01359592|469429809|FG002|PET-Directed Therapy|Adverse Event|1|||
130399018|NCT01359592|469429810|FG003|PET-Directed Therapy|Adverse Event|0|||
130399019|NCT01359592|469429807|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130399020|NCT01359592|469429808|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130399021|NCT01359592|469429809|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
130399022|NCT01359592|469429810|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130560353|NCT00766090|470019798|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560354|NCT00766090|470019799|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
130560355|NCT00766090|470019800|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560356|NCT00766090|470019801|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560357|NCT00766090|470019802|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560358|NCT00766090|470019803|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560359|NCT00766090|470019804|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560360|NCT00766090|470019805|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560361|NCT00766090|470019806|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130560362|NCT01106027|470019813|FG000|Overall Study|Lost graft early, discontinued|1|||
130560363|NCT02871778|470019814|FG000|Part A: Treatment Period 1|Adverse Event|1|||
130399023|NCT01359592|469429807|FG000|PET-Directed Therapy|Ineligible|0|||
130399024|NCT01359592|469429808|FG001|PET-Directed Therapy|Ineligible|0|||
130399025|NCT01359592|469429809|FG002|PET-Directed Therapy|Ineligible|24|||
130399026|NCT01359592|469429810|FG003|PET-Directed Therapy|Ineligible|0|||
130399027|NCT00779675|469429820|FG000|Treatment Period|Adverse Event|87|||
130399028|NCT00779675|469429820|FG000|Treatment Period|Treatment Failure|80|||
130399029|NCT00779675|469429820|FG000|Treatment Period|Transferred to Another Study|38|||
130399030|NCT00779675|469429820|FG000|Treatment Period|Lost to Follow-up|23|||
130399031|NCT00779675|469429820|FG000|Treatment Period|Withdrawal by Subject|46|||
130399032|NCT00779675|469429820|FG000|Treatment Period|Protocol Violation|54|||
130399033|NCT00779675|469429820|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
130399034|NCT00779675|469429820|FG000|Treatment Period|Administrative|3|||
130399035|NCT00779675|469429820|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
130399036|NCT00779675|469429820|FG000|Extended Treatment Period|Protocol Violation|13|||
130399037|NCT00779675|469429820|FG000|Extended Treatment Period|Adverse Event|6|||
130399038|NCT00779675|469429820|FG000|Extended Treatment Period|Treatment Failure|11|||
130560364|NCT02871778|470019815|FG001|Part A: Treatment Period 1|Adverse Event|1|||
130560365|NCT02871778|470019816|FG002|Part A: Treatment Period 1|Adverse Event|1|||
130560366|NCT02871778|470019817|FG003|Part A: Treatment Period 1|Adverse Event|0|||
130560367|NCT02871778|470019818|FG004|Part A: Treatment Period 1|Adverse Event|0|||
130560368|NCT02871778|470019819|FG005|Part A: Treatment Period 1|Adverse Event|0|||
130560369|NCT02871778|470019820|FG006|Part A: Treatment Period 1|Adverse Event|0|||
130560370|NCT02871778|470019821|FG007|Part A: Treatment Period 1|Adverse Event|0|||
130560371|NCT02871778|470019814|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130560372|NCT02871778|470019815|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130399039|NCT00779675|469429820|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
130399040|NCT00779675|469429820|FG000|Extended Treatment Period|Lost to Follow-up|6|||
130399041|NCT02821962|469429821|FG000|Overall Study|Lost to Follow-up|2|||
130399042|NCT02821962|469429822|FG001|Overall Study|Lost to Follow-up|0|||
130399043|NCT00749775|469429827|FG000|Overall Study|Protocol Violation|24|||
130399044|NCT00749775|469429827|FG000|Overall Study|Lost to Follow-up|36|||
130399045|NCT00749775|469429827|FG000|Overall Study|No visit after first day of treatment|44|||
130399046|NCT00749775|469429827|FG000|Overall Study|No drug administration|3|||
130399047|NCT04300296|469429828|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
130399048|NCT04300296|469429829|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130399049|NCT04300296|469429830|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130399050|NCT04300296|469429831|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130399051|NCT04300296|469429832|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130399052|NCT04300296|469429833|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130399053|NCT04300296|469429828|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130723419|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
130723420|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
130560373|NCT02871778|470019816|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130399054|NCT04300296|469429829|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130399055|NCT04300296|469429830|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130399056|NCT04300296|469429831|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130399057|NCT04300296|469429832|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
130399058|NCT04300296|469429833|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130399059|NCT04300296|469429828|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
130399060|NCT04300296|469429829|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
130399061|NCT04300296|469429830|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130399062|NCT04300296|469429831|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130399063|NCT04300296|469429832|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130399064|NCT04300296|469429833|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
130399065|NCT04300296|469429828|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
130399066|NCT04300296|469429829|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130399067|NCT04300296|469429830|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
130399068|NCT04300296|469429831|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130399069|NCT04300296|469429832|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
130399070|NCT04300296|469429833|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130399071|NCT04300296|469429828|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
130399072|NCT04300296|469429829|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130399073|NCT04300296|469429830|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
130399074|NCT04300296|469429831|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130399075|NCT04300296|469429832|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
130399076|NCT04300296|469429833|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130399077|NCT04300296|469429828|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130399078|NCT04300296|469429829|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
130399079|NCT04300296|469429830|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130399080|NCT04300296|469429831|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130399081|NCT04300296|469429832|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130399082|NCT04300296|469429833|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130399083|NCT04300296|469429828|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
130560374|NCT02871778|470019817|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130399084|NCT04300296|469429829|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
130399085|NCT04300296|469429830|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
130399086|NCT04300296|469429831|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
130399087|NCT04300296|469429832|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
130399088|NCT04300296|469429833|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
130399089|NCT00701129|469429834|FG000|Overall Study|Death|2|||
130399090|NCT02412631|469429835|FG000|Overall Study|Adverse Event|1|||
130399091|NCT02412631|469429836|FG001|Overall Study|Adverse Event|2|||
130399092|NCT02412631|469429835|FG000|Overall Study|Lost to Follow-up|5|||
130399093|NCT02412631|469429836|FG001|Overall Study|Lost to Follow-up|9|||
130399094|NCT02412631|469429835|FG000|Overall Study|Withdrawal by Subject|9|||
130399095|NCT02412631|469429836|FG001|Overall Study|Withdrawal by Subject|3|||
130399096|NCT02412631|469429835|FG000|Overall Study|Early stop by FDA|5|||
130399097|NCT02412631|469429836|FG001|Overall Study|Early stop by FDA|2|||
130399098|NCT02412631|469429835|FG000|Overall Study|Unspecified reason|6|||
130399099|NCT02412631|469429836|FG001|Overall Study|Unspecified reason|8|||
130399100|NCT00958776|469429837|FG000|Overall Study|Adverse Event|0|||
130399101|NCT00958776|469429838|FG001|Overall Study|Adverse Event|1|||
130399102|NCT00958776|469429837|FG000|Overall Study|Physician Decision|1|||
130648287|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648288|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648289|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648290|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648291|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648292|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648293|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130648294|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
130648295|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
130648296|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
130648297|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
130648298|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
130560375|NCT02871778|470019818|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130560376|NCT02871778|470019819|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130560377|NCT02871778|470019820|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130560378|NCT02871778|470019821|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130560379|NCT02871778|470019814|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560380|NCT02871778|470019815|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560381|NCT02871778|470019816|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
130560382|NCT02871778|470019817|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560383|NCT02871778|470019818|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560384|NCT02871778|470019819|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560385|NCT02871778|470019820|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560386|NCT02871778|470019821|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130560387|NCT02871778|470019814|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560388|NCT02871778|470019815|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560389|NCT02871778|470019816|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
130560390|NCT02871778|470019817|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560391|NCT02871778|470019818|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560392|NCT02871778|470019819|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560393|NCT02871778|470019820|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560394|NCT02871778|470019821|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130560395|NCT02871778|470019814|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560396|NCT02871778|470019815|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
130560397|NCT02871778|470019816|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
130399103|NCT00958776|469429838|FG001|Overall Study|Physician Decision|0|||
130399104|NCT00958776|469429837|FG000|Overall Study|Lost to Follow-up|2|||
130399105|NCT00958776|469429838|FG001|Overall Study|Lost to Follow-up|6|||
130399106|NCT00958776|469429837|FG000|Overall Study|Withdrawal by Subject|7|||
130399107|NCT00958776|469429838|FG001|Overall Study|Withdrawal by Subject|16|||
130399108|NCT00958776|469429837|FG000|Overall Study|Protocol Violation|1|||
130399109|NCT00958776|469429838|FG001|Overall Study|Protocol Violation|1|||
130399110|NCT00958776|469429837|FG000|Overall Study|Death|2|||
130399111|NCT00958776|469429838|FG001|Overall Study|Death|1|||
130399112|NCT00958776|469429837|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
130399113|NCT00958776|469429838|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
130399114|NCT00958776|469429837|FG000|Overall Study|Missing|1|||
130399115|NCT00958776|469429838|FG001|Overall Study|Missing|1|||
130399116|NCT00480636|469429839|FG000|Overall Study|Death|12|||
130399117|NCT00480636|469429839|FG000|Overall Study|Lost to Follow-up|4|||
130399118|NCT00480636|469429839|FG000|Overall Study|Other|2|||
130399119|NCT00480636|469429839|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
130399120|NCT00326911|469429842|FG000|Overall Study|Hospitalization prior to treatment|0|||
130560398|NCT02871778|470019817|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560399|NCT02871778|470019818|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560400|NCT02871778|470019819|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560401|NCT02871778|470019820|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560402|NCT02871778|470019821|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
130560403|NCT02871778|470019814|FG000|Part A: Treatment Period 2|Adverse Event|2|||
130560404|NCT02871778|470019815|FG001|Part A: Treatment Period 2|Adverse Event|2|||
130560405|NCT02871778|470019816|FG002|Part A: Treatment Period 2|Adverse Event|0|||
130560406|NCT02871778|470019817|FG003|Part A: Treatment Period 2|Adverse Event|0|||
130560407|NCT02871778|470019818|FG004|Part A: Treatment Period 2|Adverse Event|0|||
130560408|NCT02871778|470019819|FG005|Part A: Treatment Period 2|Adverse Event|0|||
130560409|NCT02871778|470019820|FG006|Part A: Treatment Period 2|Adverse Event|0|||
130560410|NCT02871778|470019821|FG007|Part A: Treatment Period 2|Adverse Event|0|||
130560411|NCT02871778|470019814|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560412|NCT02871778|470019815|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560413|NCT02871778|470019816|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560414|NCT02871778|470019817|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
130399121|NCT00326911|469429843|FG001|Overall Study|Hospitalization prior to treatment|1|||
130560415|NCT02871778|470019818|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560416|NCT02871778|470019819|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560417|NCT02871778|470019820|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560418|NCT02871778|470019821|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
130560419|NCT02871778|470019814|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
130560420|NCT02871778|470019815|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130399122|NCT00326911|469429842|FG000|Overall Study|Physician decision prior to treatment|1|||
130399123|NCT00326911|469429843|FG001|Overall Study|Physician decision prior to treatment|0|||
130399124|NCT00326911|469429842|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
130560421|NCT02871778|470019816|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
130560422|NCT02871778|470019817|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130560423|NCT02871778|470019818|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130560424|NCT02871778|470019819|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130560425|NCT02871778|470019820|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130560426|NCT02871778|470019821|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130560427|NCT02871778|470019814|FG000|Part B: Treatment Period 3|Adverse Event|0|||
130560428|NCT02871778|470019815|FG001|Part B: Treatment Period 3|Adverse Event|0|||
130560429|NCT02871778|470019816|FG002|Part B: Treatment Period 3|Adverse Event|0|||
130560430|NCT02871778|470019817|FG003|Part B: Treatment Period 3|Adverse Event|0|||
130560431|NCT02871778|470019818|FG004|Part B: Treatment Period 3|Adverse Event|1|||
130560432|NCT02871778|470019819|FG005|Part B: Treatment Period 3|Adverse Event|1|||
130560433|NCT02871778|470019820|FG006|Part B: Treatment Period 3|Adverse Event|1|||
130560434|NCT02871778|470019821|FG007|Part B: Treatment Period 3|Adverse Event|0|||
130560435|NCT02653300|470019823|FG000|Overall Study|Withdrawal by Subject|2|||
130560436|NCT00800683|470019843|FG000|Overall Study|Adverse Event|11|||
130560437|NCT00800683|470019844|FG001|Overall Study|Adverse Event|8|||
130560438|NCT00800683|470019843|FG000|Overall Study|Lost to Follow-up|3|||
130560439|NCT00800683|470019844|FG001|Overall Study|Lost to Follow-up|1|||
130560440|NCT00800683|470019843|FG000|Overall Study|Withdrawal by Subject|1|||
130560441|NCT00800683|470019844|FG001|Overall Study|Withdrawal by Subject|7|||
130560442|NCT00800683|470019843|FG000|Overall Study|Lack of Efficacy|1|||
130560443|NCT00800683|470019844|FG001|Overall Study|Lack of Efficacy|1|||
130560444|NCT00800683|470019843|FG000|Overall Study|Other|1|||
130560445|NCT00800683|470019844|FG001|Overall Study|Other|2|||
130560446|NCT01478360|470019845|FG000|Overall Study|Lost to Follow-up|1|||
130560447|NCT01478360|470019846|FG001|Overall Study|Lost to Follow-up|0|||
130560448|NCT01478360|470019845|FG000|Overall Study|Adverse Event|0|||
130560449|NCT01478360|470019846|FG001|Overall Study|Adverse Event|1|||
130560450|NCT01478360|470019845|FG000|Overall Study|Administrative problems|1|||
130560451|NCT01478360|470019846|FG001|Overall Study|Administrative problems|2|||
130560452|NCT02289352|470019847|FG000|Overall Study|Withdrawal by Subject|1|||
130560453|NCT02289352|470019848|FG001|Overall Study|Withdrawal by Subject|1|||
130560454|NCT02289352|470019849|FG002|Overall Study|Withdrawal by Subject|0|||
130560455|NCT00911625|470019850|FG000|Overall Study|Lost to Follow-up|7|||
130560456|NCT00911625|470019851|FG001|Overall Study|Lost to Follow-up|0|||
130560457|NCT01289821|470019852|FG000|Treatment Period|Withdrawal by Subject|1|||
130560458|NCT01289821|470019852|FG000|Treatment Period|Physician Decision|3|||
130560459|NCT01289821|470019852|FG000|Treatment Period|Adverse Event|4|||
130560460|NCT01289821|470019852|FG000|Treatment Period|Radiological Progression|43|||
130560461|NCT01289821|470019852|FG000|Treatment Period|Clinical Progression|2|||
130560462|NCT01289821|470019852|FG000|Treatment Period|Therapeutic procedure required|1|||
130560463|NCT01289821|470019852|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
130560464|NCT01289821|470019852|FG000|Safety Follow-up Period|Protocol Violation|3|||
130560465|NCT01289821|470019852|FG000|Safety Follow-up Period|Unspecified reason|1|||
130560466|NCT01289821|470019852|FG000|Survival Follow-up Period|Protocol Violation|1|||
130560467|NCT01289821|470019852|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
130560468|NCT01289821|470019852|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
130560469|NCT01245387|470019856|FG000|Overall Study|Lost to Follow-up|106|||
130560470|NCT01245387|470019856|FG000|Overall Study|Lack of Efficacy|195|||
130560471|NCT01245387|470019856|FG000|Overall Study|Adverse Event|9|||
130560472|NCT01245387|470019856|FG000|Overall Study|Death|3|||
130560473|NCT01245387|470019856|FG000|Overall Study|Other|131|||
130560474|NCT01245387|470019856|FG000|Overall Study|Missing discontinuation status|369|||
130560475|NCT00757003|470019857|FG000|Overall Study|Death|33|||
130560476|NCT00757003|470019857|FG000|Overall Study|Lost to Follow-up|9|||
130560477|NCT00757003|470019857|FG000|Overall Study|Withdrawal by Subject|4|||
130560478|NCT00757003|470019857|FG000|Overall Study|Surgically explanted|2|||
130560479|NCT00757003|470019857|FG000|Overall Study|Not implanted|1|||
130560480|NCT02146599|470019873|FG000|Overall Study|Failed to meet inclusion criteria|5|||
130560481|NCT03061175|470019877|FG000|Baseline|Participant was deemed ineligible|1|||
130560482|NCT03061175|470019878|FG001|Baseline|Participant was deemed ineligible|0|||
130560483|NCT03061175|470019877|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
130560484|NCT03061175|470019878|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
130560485|NCT03061175|470019877|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
130560486|NCT03061175|470019878|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
130560487|NCT03061175|470019877|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
130560488|NCT03061175|470019878|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
130560489|NCT02243865|470019879|FG000|Overall Study|Protocol Violation|1|||
130560490|NCT02243865|470019880|FG001|Overall Study|Protocol Violation|3|||
130560491|NCT02243865|470019879|FG000|Overall Study|Lost to Follow-up|1|||
130560492|NCT02243865|470019880|FG001|Overall Study|Lost to Follow-up|1|||
130560493|NCT02243865|470019879|FG000|Overall Study|Withdrawal by Subject|1|||
130560494|NCT02243865|470019880|FG001|Overall Study|Withdrawal by Subject|0|||
130560495|NCT02243865|470019879|FG000|Overall Study|Adverse Event|1|||
130399125|NCT00326911|469429843|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
130399126|NCT04537806|469429847|FG000|Overall Study|Randomized but not treated|1|||
130399127|NCT04537806|469429848|FG001|Overall Study|Randomized but not treated|0|||
130399128|NCT04537806|469429847|FG000|Overall Study|Adverse Event|1|||
130399129|NCT04537806|469429848|FG001|Overall Study|Adverse Event|1|||
130399130|NCT03019627|469429849|FG000|Overall Study|Adverse Event|8|||
130399131|NCT03019627|469429850|FG001|Overall Study|Adverse Event|0|||
130399132|NCT03019627|469429849|FG000|Overall Study|Unrelated to adverse event|1|||
130399133|NCT03019627|469429850|FG001|Overall Study|Unrelated to adverse event|3|||
130399134|NCT03019627|469429849|FG000|Overall Study|Lost to Follow-up|2|||
130399135|NCT03019627|469429850|FG001|Overall Study|Lost to Follow-up|1|||
130399136|NCT03019627|469429849|FG000|Overall Study|not compliance|2|||
130399137|NCT03019627|469429850|FG001|Overall Study|not compliance|2|||
130399138|NCT03019627|469429849|FG000|Overall Study|Other|2|||
130399139|NCT03019627|469429850|FG001|Overall Study|Other|2|||
130399140|NCT02953821|469429851|FG000|Overall Study|Adverse Event|0|||
130399141|NCT02953821|469429852|FG001|Overall Study|Adverse Event|4|||
130399142|NCT02953821|469429851|FG000|Overall Study|Death|1|||
130399143|NCT02953821|469429852|FG001|Overall Study|Death|0|||
130399144|NCT02953821|469429851|FG000|Overall Study|Progressive Disease|5|||
130399145|NCT02953821|469429852|FG001|Overall Study|Progressive Disease|1|||
130399146|NCT02953821|469429851|FG000|Overall Study|Lost to Follow-up|2|||
130399147|NCT02953821|469429852|FG001|Overall Study|Lost to Follow-up|0|||
130399148|NCT02953821|469429851|FG000|Overall Study|Physician Decision|1|||
130399149|NCT02953821|469429852|FG001|Overall Study|Physician Decision|1|||
130399150|NCT02953821|469429851|FG000|Overall Study|Withdrawal by Subject|3|||
130399151|NCT02953821|469429852|FG001|Overall Study|Withdrawal by Subject|3|||
130399152|NCT02953821|469429851|FG000|Overall Study|Change of address|0|||
130399153|NCT02953821|469429852|FG001|Overall Study|Change of address|1|||
130399154|NCT02953821|469429851|FG000|Overall Study|Lack of Efficacy|1|||
130399155|NCT02953821|469429852|FG001|Overall Study|Lack of Efficacy|0|||
130399156|NCT02953821|469429851|FG000|Overall Study|Out of state for indeterminate time|0|||
130399157|NCT02953821|469429852|FG001|Overall Study|Out of state for indeterminate time|1|||
130399158|NCT02953821|469429851|FG000|Overall Study|No improvement|0|||
130399159|NCT02953821|469429852|FG001|Overall Study|No improvement|1|||
130399160|NCT02953821|469429851|FG000|Overall Study|Refused follow-up visit|2|||
130399161|NCT02953821|469429852|FG001|Overall Study|Refused follow-up visit|1|||
130399162|NCT03219333|469429853|FG000|Overall Study|Withdrawal by Subject|9|||
130399163|NCT03219333|469429854|FG001|Overall Study|Withdrawal by Subject|4|||
130399164|NCT03219333|469429853|FG000|Overall Study|Lost to Follow-up|1|||
130399165|NCT03219333|469429854|FG001|Overall Study|Lost to Follow-up|1|||
130399166|NCT03219333|469429853|FG000|Overall Study|Death|104|||
130399167|NCT03219333|469429854|FG001|Overall Study|Death|72|||
130399168|NCT03219333|469429853|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
130399169|NCT03219333|469429854|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
130399170|NCT03219333|469429853|FG000|Overall Study|Other|2|||
130399171|NCT03219333|469429854|FG001|Overall Study|Other|2|||
130399172|NCT00723606|469429855|FG000|Overall Study|Adverse Event|2|||
130399173|NCT00723606|469429856|FG001|Overall Study|Adverse Event|5|||
130399174|NCT00723606|469429855|FG000|Overall Study|Other|2|||
130399175|NCT00723606|469429856|FG001|Overall Study|Other|0|||
130399176|NCT00723606|469429855|FG000|Overall Study|Withdrawal by Subject|0|||
130399177|NCT00723606|469429856|FG001|Overall Study|Withdrawal by Subject|2|||
130399178|NCT05107128|469429857|FG000|Overall Study|Adverse Event|2|||
130399179|NCT05107128|469429858|FG001|Overall Study|Adverse Event|0|||
130399180|NCT05107128|469429857|FG000|Overall Study|Withdrawal by Subject|3|||
130399181|NCT05107128|469429858|FG001|Overall Study|Withdrawal by Subject|3|||
130399182|NCT05107128|469429857|FG000|Overall Study|Withdrawal of Consent|0|||
130399183|NCT05107128|469429858|FG001|Overall Study|Withdrawal of Consent|1|||
130399184|NCT05107128|469429857|FG000|Overall Study|Reason Not Specified|2|||
130399185|NCT05107128|469429858|FG001|Overall Study|Reason Not Specified|0|||
130399186|NCT01470469|469429859|FG000|Overall Study|Withdrawal by Subject|4|||
130399187|NCT01470469|469429860|FG001|Overall Study|Withdrawal by Subject|6|||
130399188|NCT01470469|469429859|FG000|Overall Study|Lack of Efficacy|1|||
130399189|NCT01470469|469429860|FG001|Overall Study|Lack of Efficacy|7|||
130399190|NCT01470469|469429859|FG000|Overall Study|Adverse Event|0|||
130399191|NCT01470469|469429860|FG001|Overall Study|Adverse Event|7|||
130399192|NCT01470469|469429859|FG000|Overall Study|Lost to Follow-up|2|||
130399193|NCT01470469|469429860|FG001|Overall Study|Lost to Follow-up|2|||
130399194|NCT01470469|469429859|FG000|Overall Study|Protocol Violation|1|||
130399195|NCT01470469|469429860|FG001|Overall Study|Protocol Violation|1|||
130399196|NCT01470469|469429859|FG000|Overall Study|Other|2|||
130399197|NCT01470469|469429860|FG001|Overall Study|Other|1|||
130399198|NCT05459129|469429861|FG000|Overall Study|Death|1|||
130399199|NCT05459129|469429862|FG001|Overall Study|Death|0|||
130399200|NCT05459129|469429861|FG000|Overall Study|Study Terminated By Sponsor|5|||
130399201|NCT05459129|469429862|FG001|Overall Study|Study Terminated By Sponsor|6|||
130399202|NCT04083976|469429864|FG000|Overall Study|Lost to Follow-up|3|||
130399203|NCT04083976|469429865|FG001|Overall Study|Lost to Follow-up|0|||
130399204|NCT04083976|469429866|FG002|Overall Study|Lost to Follow-up|0|||
130399205|NCT04083976|469429867|FG003|Overall Study|Lost to Follow-up|1|||
130399206|NCT04083976|469429864|FG000|Overall Study|Withdrawal by Subject|16|||
130399207|NCT04083976|469429865|FG001|Overall Study|Withdrawal by Subject|1|||
130399208|NCT04083976|469429866|FG002|Overall Study|Withdrawal by Subject|9|||
130399209|NCT04083976|469429867|FG003|Overall Study|Withdrawal by Subject|0|||
130399210|NCT04083976|469429864|FG000|Overall Study|Sponsor Decision|14|||
130399211|NCT04083976|469429865|FG001|Overall Study|Sponsor Decision|0|||
130399212|NCT04083976|469429866|FG002|Overall Study|Sponsor Decision|0|||
130399213|NCT04083976|469429867|FG003|Overall Study|Sponsor Decision|7|||
130399214|NCT04083976|469429864|FG000|Overall Study|Other|1|||
130399215|NCT04083976|469429865|FG001|Overall Study|Other|0|||
130399216|NCT04083976|469429866|FG002|Overall Study|Other|1|||
130399217|NCT04083976|469429867|FG003|Overall Study|Other|0|||
130399218|NCT02504372|469429868|FG000|Overall Study|Death|136|||
130399219|NCT02504372|469429869|FG001|Overall Study|Death|154|||
130399220|NCT02504372|469429868|FG000|Overall Study|Lost to Follow-up|0|||
130399221|NCT02504372|469429869|FG001|Overall Study|Lost to Follow-up|2|||
130399222|NCT02504372|469429868|FG000|Overall Study|Withdrawal of consent|25|||
130399223|NCT02504372|469429869|FG001|Overall Study|Withdrawal of consent|16|||
130399224|NCT02504372|469429868|FG000|Overall Study|Participants ongoing|429|||
130399225|NCT02504372|469429869|FG001|Overall Study|Participants ongoing|415|||
130399226|NCT04530552|469429873|FG000|Overall Study|Physician Decision|0|||
130399227|NCT04530552|469429874|FG001|Overall Study|Physician Decision|1|||
130399228|NCT04530552|469429873|FG000|Overall Study|Withdrawal by Subject|0|||
130399229|NCT04530552|469429874|FG001|Overall Study|Withdrawal by Subject|1|||
130399230|NCT04530552|469429873|FG000|Overall Study|Adverse Event|0|||
130399231|NCT04530552|469429874|FG001|Overall Study|Adverse Event|1|||
130560496|NCT02243865|470019880|FG001|Overall Study|Adverse Event|1|||
130560497|NCT01235793|470019884|FG000|Overall Study|Death|6|||
130560498|NCT01159912|470019888|FG000|Overall Study|Adverse Event|2|||
130560499|NCT01159912|470019889|FG001|Overall Study|Adverse Event|2|||
130560500|NCT01159912|470019890|FG002|Overall Study|Adverse Event|3|||
130560501|NCT01159912|470019888|FG000|Overall Study|Lack of Efficacy|23|||
130560502|NCT01159912|470019889|FG001|Overall Study|Lack of Efficacy|15|||
130560503|NCT01159912|470019890|FG002|Overall Study|Lack of Efficacy|14|||
130560504|NCT01159912|470019888|FG000|Overall Study|Protocol Violation|1|||
130399232|NCT04530552|469429873|FG000|Overall Study|No surgery|0|||
130399233|NCT04530552|469429874|FG001|Overall Study|No surgery|1|||
130399234|NCT05132127|469429881|FG000|Overall Study|Adverse Event|1|||
130399235|NCT05220397|469429882|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130399236|NCT05220397|469429883|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130399237|NCT05220397|469429884|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
130399238|NCT05220397|469429885|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130399239|NCT05220397|469429886|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130399240|NCT01946204|469429889|FG000|Overall Study|Death|38|||
130399241|NCT01946204|469429890|FG001|Overall Study|Death|59|||
130399242|NCT01946204|469429889|FG000|Overall Study|Withdrawal by Subject|37|||
130399243|NCT01946204|469429890|FG001|Overall Study|Withdrawal by Subject|50|||
130399244|NCT01946204|469429889|FG000|Overall Study|Lost to Follow-up|3|||
130399245|NCT01946204|469429890|FG001|Overall Study|Lost to Follow-up|7|||
130399246|NCT01946204|469429889|FG000|Overall Study|Ongoing|316|||
130399247|NCT01946204|469429890|FG001|Overall Study|Ongoing|687|||
130399248|NCT01946204|469429889|FG000|Overall Study|Other|7|||
130399249|NCT01946204|469429890|FG001|Overall Study|Other|3|||
130399250|NCT00376168|469429895|FG000|Overall Study|Adverse Event|1|||
130399251|NCT00376168|469429896|FG001|Overall Study|Adverse Event|1|||
130560505|NCT01159912|470019889|FG001|Overall Study|Protocol Violation|2|||
130560506|NCT01159912|470019890|FG002|Overall Study|Protocol Violation|3|||
130560507|NCT01159912|470019888|FG000|Overall Study|Lost to Follow-up|4|||
130560508|NCT01159912|470019889|FG001|Overall Study|Lost to Follow-up|0|||
130560509|NCT01159912|470019890|FG002|Overall Study|Lost to Follow-up|0|||
130560510|NCT01159912|470019888|FG000|Overall Study|Physician Decision|0|||
130560511|NCT01159912|470019889|FG001|Overall Study|Physician Decision|0|||
130560512|NCT01159912|470019890|FG002|Overall Study|Physician Decision|3|||
130560513|NCT01159912|470019888|FG000|Overall Study|Withdrawal by Subject|10|||
130560514|NCT01159912|470019889|FG001|Overall Study|Withdrawal by Subject|3|||
130399252|NCT00376168|469429895|FG000|Overall Study|Pregnancy|1|||
130399253|NCT00376168|469429896|FG001|Overall Study|Pregnancy|0|||
130399254|NCT04181827|469429897|FG000|Overall Study|Ongoing|124|||
130399255|NCT04181827|469429898|FG001|Overall Study|Ongoing|157|||
130399256|NCT04181827|469429897|FG000|Overall Study|Death|82|||
130399257|NCT04181827|469429898|FG001|Overall Study|Death|50|||
130399258|NCT04181827|469429897|FG000|Overall Study|Lost to Follow-up|0|||
130399259|NCT04181827|469429898|FG001|Overall Study|Lost to Follow-up|1|||
130560515|NCT01159912|470019890|FG002|Overall Study|Withdrawal by Subject|3|||
130560516|NCT01428661|470019898|FG000|Double-Masked Phase|Protocol Violation|9|||
130560517|NCT01428661|470019899|FG001|Double-Masked Phase|Protocol Violation|4|||
130560518|NCT01428661|470019900|FG002|Double-Masked Phase|Protocol Violation|0|||
130399260|NCT04181827|469429897|FG000|Overall Study|Withdrawal by Subject|5|||
130399261|NCT04181827|469429898|FG001|Overall Study|Withdrawal by Subject|0|||
130399262|NCT05091528|469429899|FG000|Overall Study|Study Termination by Sponsor|0|||
130399263|NCT05091528|469429900|FG001|Overall Study|Study Termination by Sponsor|1|||
130399264|NCT05091528|469429901|FG002|Overall Study|Study Termination by Sponsor|0|||
130399265|NCT05091528|469429902|FG003|Overall Study|Study Termination by Sponsor|1|||
130399266|NCT01857063|469429903|FG000|Period 1 (7 Days)|Adverse Event|0|||
130399267|NCT01857063|469429904|FG001|Period 1 (7 Days)|Adverse Event|1|||
130399268|NCT01857063|469429903|FG000|Period 1 (7 Days)|Physician Decision|1|||
130399269|NCT01857063|469429904|FG001|Period 1 (7 Days)|Physician Decision|0|||
130399270|NCT01857063|469429903|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
130399271|NCT01857063|469429904|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
130399272|NCT01857063|469429903|FG000|Period 2 (7 Days)|Adverse Event|2|||
130399273|NCT01857063|469429904|FG001|Period 2 (7 Days)|Adverse Event|1|||
130399274|NCT01857063|469429903|FG000|Period 2 (7 Days)|Physician Decision|1|||
130399275|NCT01857063|469429904|FG001|Period 2 (7 Days)|Physician Decision|1|||
130399276|NCT01857063|469429903|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
130399277|NCT01857063|469429904|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
130399278|NCT02448875|469429909|FG000|Overall Study|Adverse Event|2|||
130399279|NCT02448875|469429910|FG001|Overall Study|Adverse Event|1|||
130399280|NCT02448875|469429911|FG002|Overall Study|Adverse Event|0|||
130399281|NCT02448875|469429909|FG000|Overall Study|Lost to Follow-up|1|||
130399282|NCT02448875|469429910|FG001|Overall Study|Lost to Follow-up|0|||
130399283|NCT02448875|469429911|FG002|Overall Study|Lost to Follow-up|0|||
130399284|NCT02448875|469429909|FG000|Overall Study|Investigator Decision|3|||
130399285|NCT02448875|469429910|FG001|Overall Study|Investigator Decision|0|||
130399286|NCT02448875|469429911|FG002|Overall Study|Investigator Decision|1|||
130399287|NCT02448875|469429909|FG000|Overall Study|Withdrawal by Subject|1|||
130399288|NCT02448875|469429910|FG001|Overall Study|Withdrawal by Subject|0|||
130399289|NCT02448875|469429911|FG002|Overall Study|Withdrawal by Subject|0|||
130399290|NCT00689481|469429912|FG000|Overall Study|Adverse Event|7|||
130399291|NCT00689481|469429913|FG001|Overall Study|Adverse Event|1|||
130399292|NCT00689481|469429912|FG000|Overall Study|Lost to Follow-up|4|||
130399293|NCT00689481|469429913|FG001|Overall Study|Lost to Follow-up|3|||
130399294|NCT00689481|469429912|FG000|Overall Study|Lack of Efficacy|4|||
130399295|NCT00689481|469429913|FG001|Overall Study|Lack of Efficacy|3|||
130399296|NCT00689481|469429912|FG000|Overall Study|Non-compliance with study treatment|1|||
130399297|NCT00689481|469429913|FG001|Overall Study|Non-compliance with study treatment|1|||
130399298|NCT00689481|469429912|FG000|Overall Study|Withdrawal by Subject|8|||
130399299|NCT00689481|469429913|FG001|Overall Study|Withdrawal by Subject|4|||
130399300|NCT00689481|469429912|FG000|Overall Study|Excluded medication started during study|0|||
130399301|NCT00689481|469429913|FG001|Overall Study|Excluded medication started during study|1|||
130399302|NCT00689481|469429912|FG000|Overall Study|Subject early term, left on vacation|0|||
130399303|NCT00689481|469429913|FG001|Overall Study|Subject early term, left on vacation|1|||
130399304|NCT00316199|469429914|FG000|Overall Study|Adverse Event|2|||
130399305|NCT00316199|469429914|FG000|Overall Study|Death|8|||
130399306|NCT00316199|469429914|FG000|Overall Study|Lost to Follow-up|2|||
130399307|NCT00590954|469429915|FG000|Overall Study|Inevaluable|2|||
130399308|NCT00634647|469431364|FG000|Overall Study|death on study|3|||
130399309|NCT00634647|469431364|FG000|Overall Study|refused further treatment|3|||
130399310|NCT00634647|469431364|FG000|Overall Study|declined to participate before treatment|1|||
130399311|NCT00976898|469431367|FG000|Overall Study|Protocol Violation|1|||
130399312|NCT00976898|469431367|FG000|Overall Study|Adverse Event|1|||
130399313|NCT00976898|469431367|FG000|Overall Study|Physician Decision|1|||
130399314|NCT00976898|469431367|FG000|Overall Study|Liver Transplant|1|||
130399315|NCT00976898|469431367|FG000|Overall Study|Progressive Disease|1|||
130399316|NCT06034496|469431368|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
130399317|NCT06034496|469431369|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
130399318|NCT06034496|469431368|FG000|Overall Study|Withdrawal by Subject|5|||
130399319|NCT06034496|469431369|FG001|Overall Study|Withdrawal by Subject|4|||
130399320|NCT03277261|469431372|FG000|Overall Study|Adverse Event|17|||
130399321|NCT03277261|469431373|FG001|Overall Study|Adverse Event|1|||
130399322|NCT03277261|469431372|FG000|Overall Study|Participant Withdrawal of Consent|6|||
130399323|NCT03277261|469431373|FG001|Overall Study|Participant Withdrawal of Consent|15|||
130399324|NCT03277261|469431372|FG000|Overall Study|Investigator / Sponsor Decision|4|||
130399325|NCT03277261|469431373|FG001|Overall Study|Investigator / Sponsor Decision|2|||
130399326|NCT03277261|469431372|FG000|Overall Study|Pregnancy|2|||
130399327|NCT03277261|469431373|FG001|Overall Study|Pregnancy|0|||
130399328|NCT03277261|469431372|FG000|Overall Study|Lost to Follow-up|2|||
130399329|NCT03277261|469431373|FG001|Overall Study|Lost to Follow-up|2|||
130399330|NCT03277261|469431372|FG000|Overall Study|Lack of Efficacy|2|||
130399331|NCT03277261|469431373|FG001|Overall Study|Lack of Efficacy|2|||
130399332|NCT03277261|469431372|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
130399333|NCT03277261|469431373|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
130399334|NCT02365597|469431377|FG000|Overall Study|Lost to Follow-up|0|||
130399335|NCT02365597|469431378|FG001|Overall Study|Lost to Follow-up|1|||
130723421|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
130723422|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130723423|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130723424|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
130723425|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
130723426|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
130399336|NCT02365597|469431379|FG002|Overall Study|Lost to Follow-up|0|||
130399337|NCT02365597|469431380|FG003|Overall Study|Lost to Follow-up|1|||
130399338|NCT02365597|469431377|FG000|Overall Study|Withdrawal by Subject|1|||
130399339|NCT02365597|469431378|FG001|Overall Study|Withdrawal by Subject|8|||
130399340|NCT02365597|469431379|FG002|Overall Study|Withdrawal by Subject|5|||
130399341|NCT02365597|469431380|FG003|Overall Study|Withdrawal by Subject|1|||
130399342|NCT02365597|469431377|FG000|Overall Study|Sponsor's decision|1|||
130399343|NCT02365597|469431378|FG001|Overall Study|Sponsor's decision|3|||
130399344|NCT02365597|469431379|FG002|Overall Study|Sponsor's decision|13|||
130399345|NCT02365597|469431380|FG003|Overall Study|Sponsor's decision|0|||
130399346|NCT02365597|469431377|FG000|Overall Study|Other|0|||
130399347|NCT02365597|469431378|FG001|Overall Study|Other|4|||
130399348|NCT02365597|469431379|FG002|Overall Study|Other|0|||
130399349|NCT02365597|469431380|FG003|Overall Study|Other|0|||
130399350|NCT02365597|469431377|FG000|Overall Study|Enrolled but not treated|0|||
130399351|NCT02365597|469431378|FG001|Overall Study|Enrolled but not treated|1|||
130399352|NCT02365597|469431379|FG002|Overall Study|Enrolled but not treated|1|||
130399353|NCT02365597|469431380|FG003|Overall Study|Enrolled but not treated|0|||
130399354|NCT02365597|469431377|FG000|Overall Study|Ongoing|0|||
130399355|NCT02365597|469431378|FG001|Overall Study|Ongoing|0|||
130399356|NCT02365597|469431379|FG002|Overall Study|Ongoing|0|||
130399357|NCT02365597|469431380|FG003|Overall Study|Ongoing|17|||
130399358|NCT00499603|469431381|FG000|Overall Study|Adverse Event|0|||
130399359|NCT00499603|469431382|FG001|Overall Study|Adverse Event|1|||
130399360|NCT03323099|469431383|FG000|Overall Study|Withdrawal by Subject|6|||
130399361|NCT03323099|469431384|FG001|Overall Study|Withdrawal by Subject|12|||
130399362|NCT03323099|469431383|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
130399363|NCT03323099|469431384|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
130399364|NCT03604692|469431385|FG000|Overall Study|Investigator's Decision|0|||
130399365|NCT03604692|469431386|FG001|Overall Study|Investigator's Decision|0|||
130399366|NCT03604692|469431387|FG002|Overall Study|Investigator's Decision|0|||
130399367|NCT03604692|469431388|FG003|Overall Study|Investigator's Decision|1|||
130399368|NCT03604692|469431389|FG004|Overall Study|Investigator's Decision|0|||
130399369|NCT03604692|469431390|FG005|Overall Study|Investigator's Decision|7|||
130399370|NCT03604692|469431385|FG000|Overall Study|Withdrawal by Subject|0|||
130399371|NCT03604692|469431386|FG001|Overall Study|Withdrawal by Subject|0|||
130399372|NCT03604692|469431387|FG002|Overall Study|Withdrawal by Subject|0|||
130399373|NCT03604692|469431388|FG003|Overall Study|Withdrawal by Subject|0|||
130399374|NCT03604692|469431389|FG004|Overall Study|Withdrawal by Subject|0|||
130399375|NCT03604692|469431390|FG005|Overall Study|Withdrawal by Subject|2|||
130399376|NCT03604692|469431385|FG000|Overall Study|Progressive Disease|1|||
130399377|NCT03604692|469431386|FG001|Overall Study|Progressive Disease|0|||
130399378|NCT03604692|469431387|FG002|Overall Study|Progressive Disease|1|||
130399379|NCT03604692|469431388|FG003|Overall Study|Progressive Disease|0|||
130399380|NCT03604692|469431389|FG004|Overall Study|Progressive Disease|3|||
130399381|NCT03604692|469431390|FG005|Overall Study|Progressive Disease|4|||
130399382|NCT03604692|469431385|FG000|Overall Study|Difficulty Coming into Site|0|||
130399383|NCT03604692|469431386|FG001|Overall Study|Difficulty Coming into Site|0|||
130399384|NCT03604692|469431387|FG002|Overall Study|Difficulty Coming into Site|0|||
130399385|NCT03604692|469431388|FG003|Overall Study|Difficulty Coming into Site|0|||
130399386|NCT03604692|469431389|FG004|Overall Study|Difficulty Coming into Site|0|||
130399387|NCT03604692|469431390|FG005|Overall Study|Difficulty Coming into Site|1|||
130399388|NCT03604692|469431385|FG000|Overall Study|Death|0|||
130399389|NCT03604692|469431386|FG001|Overall Study|Death|0|||
130399390|NCT03604692|469431387|FG002|Overall Study|Death|1|||
130399391|NCT03604692|469431388|FG003|Overall Study|Death|0|||
130399392|NCT03604692|469431389|FG004|Overall Study|Death|0|||
130399393|NCT03604692|469431390|FG005|Overall Study|Death|0|||
130723427|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
130399394|NCT03604692|469431385|FG000|Overall Study|Drug Intolerance|0|||
130399395|NCT03604692|469431386|FG001|Overall Study|Drug Intolerance|0|||
130399396|NCT03604692|469431387|FG002|Overall Study|Drug Intolerance|0|||
130399397|NCT03604692|469431388|FG003|Overall Study|Drug Intolerance|1|||
130399398|NCT03604692|469431389|FG004|Overall Study|Drug Intolerance|0|||
130399399|NCT03604692|469431390|FG005|Overall Study|Drug Intolerance|0|||
130399400|NCT03604692|469431385|FG000|Overall Study|Noncompliance with follow-up visit|0|||
130399401|NCT03604692|469431386|FG001|Overall Study|Noncompliance with follow-up visit|0|||
130399402|NCT03604692|469431387|FG002|Overall Study|Noncompliance with follow-up visit|0|||
130399403|NCT03604692|469431388|FG003|Overall Study|Noncompliance with follow-up visit|1|||
130399404|NCT03604692|469431389|FG004|Overall Study|Noncompliance with follow-up visit|0|||
130399405|NCT03604692|469431390|FG005|Overall Study|Noncompliance with follow-up visit|0|||
130399406|NCT03604692|469431385|FG000|Overall Study|Not Treated|0|||
130399407|NCT03604692|469431386|FG001|Overall Study|Not Treated|0|||
130399408|NCT03604692|469431387|FG002|Overall Study|Not Treated|0|||
130399409|NCT03604692|469431388|FG003|Overall Study|Not Treated|0|||
130399410|NCT03604692|469431389|FG004|Overall Study|Not Treated|1|||
130399411|NCT03604692|469431390|FG005|Overall Study|Not Treated|0|||
130399412|NCT03466411|469431391|FG000|Overall Study|Lost to Follow-up|0|||
130399413|NCT03466411|469431392|FG001|Overall Study|Lost to Follow-up|1|||
130399414|NCT03466411|469431393|FG002|Overall Study|Lost to Follow-up|1|||
130399415|NCT03466411|469431394|FG003|Overall Study|Lost to Follow-up|0|||
130399416|NCT03466411|469431395|FG004|Overall Study|Lost to Follow-up|0|||
130399417|NCT03466411|469431396|FG005|Overall Study|Lost to Follow-up|0|||
130399418|NCT03466411|469431397|FG006|Overall Study|Lost to Follow-up|1|||
130399419|NCT03466411|469431398|FG007|Overall Study|Lost to Follow-up|1|||
130399420|NCT03466411|469431399|FG008|Overall Study|Lost to Follow-up|0|||
130399421|NCT03466411|469431400|FG009|Overall Study|Lost to Follow-up|1|||
130399422|NCT03466411|469431401|FG010|Overall Study|Lost to Follow-up|1|||
130399423|NCT03466411|469431402|FG011|Overall Study|Lost to Follow-up|1|||
130399424|NCT03466411|469431403|FG012|Overall Study|Lost to Follow-up|0|||
130399425|NCT03466411|469431391|FG000|Overall Study|Withdrawal by Subject|14|||
130399426|NCT03466411|469431392|FG001|Overall Study|Withdrawal by Subject|7|||
130399427|NCT03466411|469431393|FG002|Overall Study|Withdrawal by Subject|8|||
130399428|NCT03466411|469431394|FG003|Overall Study|Withdrawal by Subject|4|||
130399429|NCT03466411|469431395|FG004|Overall Study|Withdrawal by Subject|6|||
130399430|NCT03466411|469431396|FG005|Overall Study|Withdrawal by Subject|3|||
130399431|NCT03466411|469431397|FG006|Overall Study|Withdrawal by Subject|6|||
130399432|NCT03466411|469431398|FG007|Overall Study|Withdrawal by Subject|9|||
130399433|NCT03466411|469431399|FG008|Overall Study|Withdrawal by Subject|6|||
130399434|NCT03466411|469431400|FG009|Overall Study|Withdrawal by Subject|11|||
130399435|NCT03466411|469431401|FG010|Overall Study|Withdrawal by Subject|14|||
130399436|NCT03466411|469431402|FG011|Overall Study|Withdrawal by Subject|12|||
130399437|NCT03466411|469431403|FG012|Overall Study|Withdrawal by Subject|7|||
130399438|NCT03466411|469431391|FG000|Overall Study|Other|1|||
130399439|NCT03466411|469431392|FG001|Overall Study|Other|1|||
130399440|NCT03466411|469431393|FG002|Overall Study|Other|0|||
130399441|NCT03466411|469431394|FG003|Overall Study|Other|1|||
130399442|NCT03466411|469431395|FG004|Overall Study|Other|2|||
130399443|NCT03466411|469431396|FG005|Overall Study|Other|0|||
130399444|NCT03466411|469431397|FG006|Overall Study|Other|0|||
130399445|NCT03466411|469431398|FG007|Overall Study|Other|0|||
130399446|NCT03466411|469431399|FG008|Overall Study|Other|0|||
130399447|NCT03466411|469431400|FG009|Overall Study|Other|1|||
130399448|NCT03466411|469431401|FG010|Overall Study|Other|2|||
130399449|NCT03466411|469431402|FG011|Overall Study|Other|0|||
130399450|NCT03466411|469431403|FG012|Overall Study|Other|0|||
130399451|NCT03466411|469431391|FG000|Overall Study|Randomized but not Treated|0|||
130399452|NCT03466411|469431392|FG001|Overall Study|Randomized but not Treated|0|||
130399453|NCT03466411|469431393|FG002|Overall Study|Randomized but not Treated|0|||
130399454|NCT03466411|469431394|FG003|Overall Study|Randomized but not Treated|0|||
130399455|NCT03466411|469431395|FG004|Overall Study|Randomized but not Treated|0|||
130399456|NCT03466411|469431396|FG005|Overall Study|Randomized but not Treated|0|||
130399457|NCT03466411|469431397|FG006|Overall Study|Randomized but not Treated|1|||
130399458|NCT03466411|469431398|FG007|Overall Study|Randomized but not Treated|0|||
130399459|NCT03466411|469431399|FG008|Overall Study|Randomized but not Treated|0|||
130399460|NCT03466411|469431400|FG009|Overall Study|Randomized but not Treated|0|||
130399461|NCT03466411|469431401|FG010|Overall Study|Randomized but not Treated|0|||
130399462|NCT03466411|469431402|FG011|Overall Study|Randomized but not Treated|0|||
130399463|NCT03466411|469431403|FG012|Overall Study|Randomized but not Treated|0|||
130399464|NCT02375672|469431404|FG000|Overall Study|remain on follow up|20|||
130399465|NCT04115358|469431405|FG000|Overall Study|exfoliation|0|||
130399466|NCT04115358|469431406|FG001|Overall Study|exfoliation|0|||
130399467|NCT04115358|469431407|FG002|Overall Study|exfoliation|1|||
130399468|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399469|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
130399470|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
130399471|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
130399472|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399473|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399474|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399475|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399476|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399477|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399478|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399479|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399480|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399481|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399482|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399483|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399484|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399485|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399486|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399487|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399488|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399489|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399490|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399491|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130399492|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399493|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
130399494|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399495|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399496|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399497|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399498|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399499|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399500|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399501|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399502|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399503|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399504|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399505|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399506|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399507|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399508|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399509|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399510|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399511|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399512|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399513|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399514|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399515|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130399516|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399517|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
130399518|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399519|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399520|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399521|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399522|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399523|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399524|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399525|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399526|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399527|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399528|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399529|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399530|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399531|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399532|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399533|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399534|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399535|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399536|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399537|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399538|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399539|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130399540|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
130399541|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
130399542|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
130399543|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
130399544|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130560519|NCT01428661|470019898|FG000|Double-Masked Phase|Adverse Event|13|||
130399545|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399546|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399547|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399548|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399549|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399550|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399551|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399552|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399553|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399554|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399555|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399556|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399557|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399558|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399559|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399560|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399561|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399562|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399563|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130399564|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
130399565|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
130399566|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
130399567|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
130399568|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399569|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399570|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399571|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399572|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399573|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399574|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399575|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399576|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399577|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399578|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399579|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399580|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399581|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399582|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399583|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399584|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399585|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399586|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399587|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130399588|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399589|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
130399590|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399591|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
130399592|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130723428|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130723429|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
130723430|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
130723431|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
130723432|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
130723433|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
130399593|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399594|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399595|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399596|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399597|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399598|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130723434|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
130723435|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
130723436|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
130723437|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
130399599|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399600|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399601|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399602|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399603|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399604|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399605|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399606|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399607|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399608|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399609|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399610|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399611|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130399612|NCT02346240|469431409|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399613|NCT02346240|469431410|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399614|NCT02346240|469431411|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
130399615|NCT02346240|469431412|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399616|NCT02346240|469431413|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399617|NCT02346240|469431414|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399618|NCT02346240|469431415|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399619|NCT02346240|469431416|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399620|NCT02346240|469431417|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399621|NCT02346240|469431418|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399622|NCT02346240|469431419|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399623|NCT02346240|469431420|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399624|NCT02346240|469431421|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399625|NCT02346240|469431422|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399626|NCT02346240|469431423|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399627|NCT02346240|469431424|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399628|NCT02346240|469431425|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399629|NCT02346240|469431426|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399630|NCT02346240|469431427|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399631|NCT02346240|469431428|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399632|NCT02346240|469431429|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399633|NCT02346240|469431430|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399634|NCT02346240|469431431|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399635|NCT02346240|469431432|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130399636|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399637|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399638|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399639|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399640|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399641|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399642|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399643|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130399644|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130399645|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399646|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399647|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399648|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399649|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130399650|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
130399651|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130399652|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130399653|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399654|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399655|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399656|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399657|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399658|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399659|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130399660|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399661|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399662|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399663|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399664|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399665|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399666|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399667|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399668|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399669|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399670|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399671|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399672|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399673|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130399674|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399675|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
130399676|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399677|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399678|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399679|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399680|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399681|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399682|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399683|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130399684|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399685|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399686|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399687|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399688|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399689|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399690|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399691|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399692|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399693|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399694|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399695|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399696|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399697|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399698|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
130399699|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399700|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399701|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399702|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399703|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399704|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399705|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399706|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399707|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130399708|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399709|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399710|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399711|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399712|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399713|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399714|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399715|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399716|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399717|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399718|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399719|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130723438|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
130723439|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
130723440|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
130723441|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
130723442|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
130723443|NCT01422187|470613450|FG000|Overall Study|Personal reason|1|||
130723444|NCT01422187|470613451|FG001|Overall Study|Personal reason|0|||
130560520|NCT01428661|470019899|FG001|Double-Masked Phase|Adverse Event|4|||
130560521|NCT01428661|470019900|FG002|Double-Masked Phase|Adverse Event|0|||
130399720|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399721|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130399722|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
130399723|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130399724|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130399725|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399726|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399727|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399728|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399729|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399730|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399731|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130399732|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399733|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399734|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399735|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399736|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399737|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399738|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399739|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399740|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399741|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399742|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399743|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399744|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399745|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
130399746|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
130399747|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
130399748|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
130399749|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399750|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399751|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399752|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399753|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399754|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399755|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130399756|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399757|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399758|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399759|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399760|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399761|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399762|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
130399763|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399764|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399765|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399766|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399767|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399768|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399769|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399770|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399771|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399772|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399773|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399774|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399775|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399776|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130560522|NCT01428661|470019898|FG000|Double-Masked Phase|Lost to Follow-up|14|||
130560523|NCT01428661|470019899|FG001|Double-Masked Phase|Lost to Follow-up|14|||
130560524|NCT01428661|470019900|FG002|Double-Masked Phase|Lost to Follow-up|0|||
130560525|NCT01428661|470019898|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
130399777|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399778|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130399779|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130723445|NCT01422187|470613452|FG002|Overall Study|Personal reason|0|||
130723446|NCT01422187|470613450|FG000|Overall Study|Lost to Follow-up|0|||
130723447|NCT01422187|470613451|FG001|Overall Study|Lost to Follow-up|1|||
130723448|NCT01422187|470613452|FG002|Overall Study|Lost to Follow-up|0|||
130723449|NCT02227446|470613453|FG000|Overall Study|not eligible post randomization|18|||
130723450|NCT02227446|470613454|FG001|Overall Study|not eligible post randomization|29|||
130723451|NCT02227446|470613453|FG000|Overall Study|Withdrawal by Subject|4|||
130723452|NCT02227446|470613454|FG001|Overall Study|Withdrawal by Subject|5|||
130723453|NCT00875797|470613455|FG000|Overall Study|Protocol Violation|6|||
130723454|NCT00875797|470613456|FG001|Overall Study|Protocol Violation|3|||
130723455|NCT00715624|470613457|FG000|Overall Study|Adverse Event|12|||
130723456|NCT00715624|470613458|FG001|Overall Study|Adverse Event|37|||
130723457|NCT00715624|470613457|FG000|Overall Study|Lack of Efficacy|11|||
130723458|NCT00715624|470613458|FG001|Overall Study|Lack of Efficacy|11|||
130723459|NCT00715624|470613457|FG000|Overall Study|Lost to Follow-up|1|||
130723460|NCT00715624|470613458|FG001|Overall Study|Lost to Follow-up|2|||
130723461|NCT00715624|470613457|FG000|Overall Study|Protocol Violation|1|||
130723462|NCT00715624|470613458|FG001|Overall Study|Protocol Violation|0|||
130723463|NCT00715624|470613457|FG000|Overall Study|Withdrawal by Subject|11|||
130723464|NCT00715624|470613458|FG001|Overall Study|Withdrawal by Subject|25|||
130723465|NCT00715624|470613457|FG000|Overall Study|Familial and personal reasons|10|||
130723466|NCT00715624|470613458|FG001|Overall Study|Familial and personal reasons|22|||
130723467|NCT00715624|470613457|FG000|Overall Study|Poor compliance|6|||
130723468|NCT00715624|470613458|FG001|Overall Study|Poor compliance|13|||
130723469|NCT00715624|470613457|FG000|Overall Study|Sponsor decision|0|||
130723470|NCT00715624|470613458|FG001|Overall Study|Sponsor decision|4|||
130723471|NCT00715624|470613457|FG000|Overall Study|Incorrect randomization (not treated)|0|||
130723472|NCT00715624|470613458|FG001|Overall Study|Incorrect randomization (not treated)|1|||
130399780|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399781|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399782|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399783|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399784|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399785|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399786|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399787|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399788|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130399789|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399790|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399791|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130399792|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399793|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130399794|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130399795|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399796|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399797|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399798|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399799|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399800|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399801|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399802|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399803|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130399804|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399805|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399806|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399807|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399808|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130723473|NCT00715624|470613457|FG000|Overall Study|Other|0|||
130723474|NCT00715624|470613458|FG001|Overall Study|Other|1|||
130723475|NCT00229723|470613459|FG000|Concomitant Phase|Adverse Event|4|||
130723476|NCT00229723|470613460|FG001|Concomitant Phase|Adverse Event|2|||
130723477|NCT00229723|470613461|FG002|Concomitant Phase|Adverse Event|5|||
130399809|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399810|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399811|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399812|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399813|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
130399814|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399815|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399816|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399817|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399818|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399819|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399820|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399821|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399822|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399823|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399824|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399825|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399826|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399827|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130399828|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399829|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399830|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399831|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399832|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399833|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399834|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399835|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399836|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399837|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399838|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
130399839|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399840|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399841|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399842|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399843|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399844|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399845|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399846|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399847|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399848|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399849|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399850|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399851|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130399852|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399853|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399854|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399855|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399856|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399857|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130560526|NCT01428661|470019899|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
130560527|NCT01428661|470019900|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
130560528|NCT01428661|470019898|FG000|Double-Masked Phase|Lack of Efficacy|2|||
130560529|NCT01428661|470019899|FG001|Double-Masked Phase|Lack of Efficacy|1|||
130399858|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130560530|NCT01428661|470019900|FG002|Double-Masked Phase|Lack of Efficacy|0|||
130560531|NCT01428661|470019898|FG000|Double-Masked Phase|*Various|1|||
130723478|NCT00229723|470613462|FG003|Concomitant Phase|Adverse Event|2|||
130723479|NCT00229723|470613463|FG004|Concomitant Phase|Adverse Event|0|||
130723480|NCT00229723|470613464|FG005|Concomitant Phase|Adverse Event|1|||
130723481|NCT00229723|470613465|FG006|Concomitant Phase|Adverse Event|2|||
130399859|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399860|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399861|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399862|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399863|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399864|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399865|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399866|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
130399867|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399868|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399869|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399870|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399871|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399872|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399873|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399874|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399875|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130399876|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399877|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399878|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399879|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399880|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399881|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399882|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399883|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399884|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399885|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399886|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399887|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399888|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399889|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399890|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
130399891|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399892|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399893|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399894|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399895|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399896|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399897|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399898|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399899|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130399900|NCT02346240|469431409|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399901|NCT02346240|469431410|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399902|NCT02346240|469431411|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399903|NCT02346240|469431412|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399904|NCT02346240|469431413|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399905|NCT02346240|469431414|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399906|NCT02346240|469431415|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399907|NCT02346240|469431416|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399908|NCT02346240|469431417|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399909|NCT02346240|469431418|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399910|NCT02346240|469431419|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399911|NCT02346240|469431420|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399912|NCT02346240|469431421|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130560532|NCT01428661|470019899|FG001|Double-Masked Phase|*Various|6|||
130399913|NCT02346240|469431422|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399914|NCT02346240|469431423|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
130399915|NCT02346240|469431424|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399916|NCT02346240|469431425|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399917|NCT02346240|469431426|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399918|NCT02346240|469431427|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399919|NCT02346240|469431428|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399920|NCT02346240|469431429|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399921|NCT02346240|469431430|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399922|NCT02346240|469431431|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399923|NCT02346240|469431432|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130399924|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399925|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399926|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130560533|NCT01428661|470019900|FG002|Double-Masked Phase|*Various|0|||
130560534|NCT01428661|470019898|FG000|Open Label Extension|Protocol Violation|0|||
130560535|NCT01428661|470019899|FG001|Open Label Extension|Protocol Violation|0|||
130560536|NCT01428661|470019900|FG002|Open Label Extension|Protocol Violation|9|||
130560537|NCT01428661|470019898|FG000|Open Label Extension|Adverse Event|0|||
130560538|NCT01428661|470019899|FG001|Open Label Extension|Adverse Event|0|||
130560539|NCT01428661|470019900|FG002|Open Label Extension|Adverse Event|15|||
130560540|NCT01428661|470019898|FG000|Open Label Extension|Lost to Follow-up|0|||
130560541|NCT01428661|470019899|FG001|Open Label Extension|Lost to Follow-up|0|||
130560542|NCT01428661|470019900|FG002|Open Label Extension|Lost to Follow-up|38|||
130560543|NCT01428661|470019898|FG000|Open Label Extension|Withdrawal by Subject|0|||
130560544|NCT01428661|470019899|FG001|Open Label Extension|Withdrawal by Subject|0|||
130560545|NCT01428661|470019900|FG002|Open Label Extension|Withdrawal by Subject|49|||
130560546|NCT01428661|470019898|FG000|Open Label Extension|Lack of Efficacy|0|||
130560547|NCT01428661|470019899|FG001|Open Label Extension|Lack of Efficacy|0|||
130560548|NCT01428661|470019900|FG002|Open Label Extension|Lack of Efficacy|24|||
130560549|NCT01428661|470019898|FG000|Open Label Extension|**Various|0|||
130560550|NCT01428661|470019899|FG001|Open Label Extension|**Various|0|||
130560551|NCT01428661|470019900|FG002|Open Label Extension|**Various|185|||
130560552|NCT02229539|470022576|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
130560553|NCT02229539|470022577|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
130560554|NCT02229539|470022578|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
130560555|NCT02229539|470022576|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
130560556|NCT02229539|470022577|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
130560557|NCT02229539|470022578|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
130399927|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399928|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399929|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399930|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399931|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399932|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399933|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399934|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399935|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399936|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399937|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399938|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399939|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399940|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130399941|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
130399942|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
130399943|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
130399944|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130399945|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
130399946|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130399947|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130560558|NCT02229539|470022576|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
130560559|NCT02229539|470022577|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
130560560|NCT02229539|470022578|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
130560561|NCT02229539|470022576|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
130560562|NCT02229539|470022577|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
130560563|NCT02229539|470022578|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
130399948|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399949|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399950|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399951|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399952|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399953|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399954|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399955|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399956|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399957|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399958|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399959|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399960|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399961|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399962|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399963|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399964|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399965|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399966|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
130399967|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
130399968|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399969|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
130399970|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399971|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
130399972|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399973|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399974|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399975|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399976|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399977|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399978|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399979|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399980|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399981|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399982|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399983|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399984|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399985|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399986|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399987|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399988|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399989|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399990|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130399991|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399992|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399993|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130399994|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399995|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130399996|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130399997|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130399998|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130399999|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400000|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400001|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400002|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400003|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400004|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400005|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400006|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400007|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400008|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400009|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400010|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400011|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400012|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130560564|NCT02229539|470022576|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
130723482|NCT00229723|470613459|FG000|Concomitant Phase|Objective disease progression|0|||
130400013|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400014|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400015|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400016|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400017|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
130400018|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400019|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130400020|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400021|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400022|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400023|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400024|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400025|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400026|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400027|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400028|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400029|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400030|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400031|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400032|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400033|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400034|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400035|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400036|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400037|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130400038|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130400039|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130400040|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130400041|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130400042|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130400043|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130400044|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400045|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400046|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400047|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400048|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400049|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400050|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400051|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400052|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400053|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400054|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400055|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400056|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400057|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400058|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400059|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400060|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400061|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400062|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
130400063|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130400064|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130400065|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
130400066|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130400067|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130400068|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400069|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130723483|NCT00229723|470613460|FG001|Concomitant Phase|Objective disease progression|0|||
130723484|NCT00229723|470613461|FG002|Concomitant Phase|Objective disease progression|0|||
130723485|NCT00229723|470613462|FG003|Concomitant Phase|Objective disease progression|0|||
130723486|NCT00229723|470613463|FG004|Concomitant Phase|Objective disease progression|0|||
130400070|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130723487|NCT00229723|470613464|FG005|Concomitant Phase|Objective disease progression|0|||
130723488|NCT00229723|470613465|FG006|Concomitant Phase|Objective disease progression|0|||
130723489|NCT00229723|470613459|FG000|Concomitant Phase|Clinical progression|0|||
130723490|NCT00229723|470613460|FG001|Concomitant Phase|Clinical progression|0|||
130723491|NCT00229723|470613461|FG002|Concomitant Phase|Clinical progression|0|||
130723492|NCT00229723|470613462|FG003|Concomitant Phase|Clinical progression|0|||
130723493|NCT00229723|470613463|FG004|Concomitant Phase|Clinical progression|0|||
130723494|NCT00229723|470613464|FG005|Concomitant Phase|Clinical progression|0|||
130723495|NCT00229723|470613465|FG006|Concomitant Phase|Clinical progression|1|||
130723496|NCT00229723|470613459|FG000|Concomitant Phase|Lost to Follow-up|0|||
130723497|NCT00229723|470613460|FG001|Concomitant Phase|Lost to Follow-up|0|||
130723498|NCT00229723|470613461|FG002|Concomitant Phase|Lost to Follow-up|0|||
130723499|NCT00229723|470613462|FG003|Concomitant Phase|Lost to Follow-up|0|||
130723500|NCT00229723|470613463|FG004|Concomitant Phase|Lost to Follow-up|1|||
130723501|NCT00229723|470613464|FG005|Concomitant Phase|Lost to Follow-up|0|||
130723502|NCT00229723|470613465|FG006|Concomitant Phase|Lost to Follow-up|0|||
130723503|NCT00229723|470613459|FG000|Concomitant Phase|Informed consent withdrawn|3|||
130723504|NCT00229723|470613460|FG001|Concomitant Phase|Informed consent withdrawn|2|||
130723505|NCT00229723|470613461|FG002|Concomitant Phase|Informed consent withdrawn|0|||
130723506|NCT00229723|470613462|FG003|Concomitant Phase|Informed consent withdrawn|2|||
130723507|NCT00229723|470613463|FG004|Concomitant Phase|Informed consent withdrawn|0|||
130723508|NCT00229723|470613464|FG005|Concomitant Phase|Informed consent withdrawn|0|||
130723509|NCT00229723|470613465|FG006|Concomitant Phase|Informed consent withdrawn|0|||
130723510|NCT00229723|470613459|FG000|Concomitant Phase|Severe non-compliance|0|||
130723511|NCT00229723|470613460|FG001|Concomitant Phase|Severe non-compliance|1|||
130723512|NCT00229723|470613461|FG002|Concomitant Phase|Severe non-compliance|0|||
130723513|NCT00229723|470613462|FG003|Concomitant Phase|Severe non-compliance|0|||
130723514|NCT00229723|470613463|FG004|Concomitant Phase|Severe non-compliance|1|||
130723515|NCT00229723|470613464|FG005|Concomitant Phase|Severe non-compliance|0|||
130400071|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400072|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400073|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400074|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400075|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400076|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400077|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400078|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400079|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400080|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400081|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400082|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400083|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400084|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400085|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400086|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
130400087|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400088|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130400089|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
130400090|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
130400091|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
130723516|NCT00229723|470613465|FG006|Concomitant Phase|Severe non-compliance|0|||
130723517|NCT00229723|470613459|FG000|Concomitant Phase|Other|3|||
130723518|NCT00229723|470613460|FG001|Concomitant Phase|Other|0|||
130723519|NCT00229723|470613461|FG002|Concomitant Phase|Other|1|||
130723520|NCT00229723|470613462|FG003|Concomitant Phase|Other|1|||
130723521|NCT00229723|470613463|FG004|Concomitant Phase|Other|0|||
130723522|NCT00229723|470613464|FG005|Concomitant Phase|Other|2|||
130723523|NCT00229723|470613465|FG006|Concomitant Phase|Other|0|||
130723524|NCT00229723|470613459|FG000|Maintenance Phase|Adverse Event|7|||
130723525|NCT00229723|470613460|FG001|Maintenance Phase|Adverse Event|2|||
130723526|NCT00229723|470613461|FG002|Maintenance Phase|Adverse Event|1|||
130723527|NCT00229723|470613462|FG003|Maintenance Phase|Adverse Event|4|||
130723528|NCT00229723|470613463|FG004|Maintenance Phase|Adverse Event|7|||
130400092|NCT02346240|469431409|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400093|NCT02346240|469431410|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130723529|NCT00229723|470613464|FG005|Maintenance Phase|Adverse Event|5|||
130723530|NCT00229723|470613465|FG006|Maintenance Phase|Adverse Event|2|||
130723531|NCT00229723|470613459|FG000|Maintenance Phase|Objective disease progression|5|||
130723532|NCT00229723|470613460|FG001|Maintenance Phase|Objective disease progression|5|||
130723533|NCT00229723|470613461|FG002|Maintenance Phase|Objective disease progression|3|||
130723534|NCT00229723|470613462|FG003|Maintenance Phase|Objective disease progression|6|||
130400094|NCT02346240|469431411|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400095|NCT02346240|469431412|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400096|NCT02346240|469431413|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400097|NCT02346240|469431414|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400098|NCT02346240|469431415|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400099|NCT02346240|469431416|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400100|NCT02346240|469431417|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400101|NCT02346240|469431418|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400102|NCT02346240|469431419|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400103|NCT02346240|469431420|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400104|NCT02346240|469431421|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400105|NCT02346240|469431422|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400106|NCT02346240|469431423|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400107|NCT02346240|469431424|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400108|NCT02346240|469431425|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400109|NCT02346240|469431426|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400110|NCT02346240|469431427|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
130400111|NCT02346240|469431428|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400112|NCT02346240|469431429|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400113|NCT02346240|469431430|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400114|NCT02346240|469431431|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400115|NCT02346240|469431432|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130400116|NCT01573624|469431433|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130400117|NCT01573624|469431434|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130400118|NCT01573624|469431435|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
130400119|NCT01573624|469431436|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130400120|NCT01573624|469431437|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130400121|NCT01573624|469431438|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
130400122|NCT01573624|469431439|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130400123|NCT01573624|469431433|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
130400124|NCT01573624|469431434|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
130400125|NCT01573624|469431435|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
130400126|NCT01573624|469431436|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130400127|NCT01573624|469431437|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
130400128|NCT01573624|469431438|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130400129|NCT01573624|469431439|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130400130|NCT01573624|469431433|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
130400131|NCT01573624|469431434|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400132|NCT01573624|469431435|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400133|NCT01573624|469431436|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400134|NCT01573624|469431437|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400135|NCT01573624|469431438|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400136|NCT01573624|469431439|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130400137|NCT01573624|469431433|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130400138|NCT01573624|469431434|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130400139|NCT01573624|469431435|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130400140|NCT01573624|469431436|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130400141|NCT01573624|469431437|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130400142|NCT01573624|469431438|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
130400143|NCT01573624|469431439|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130400144|NCT01573624|469431433|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130400145|NCT01573624|469431434|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130400146|NCT01573624|469431435|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130400147|NCT01573624|469431436|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130400148|NCT01573624|469431437|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130400149|NCT01573624|469431438|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130723535|NCT00229723|470613463|FG004|Maintenance Phase|Objective disease progression|2|||
130723536|NCT00229723|470613464|FG005|Maintenance Phase|Objective disease progression|9|||
130723537|NCT00229723|470613465|FG006|Maintenance Phase|Objective disease progression|5|||
130723538|NCT00229723|470613459|FG000|Maintenance Phase|Clinical progression|4|||
130723539|NCT00229723|470613460|FG001|Maintenance Phase|Clinical progression|1|||
130400150|NCT01573624|469431439|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130400151|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400152|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400153|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400154|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400155|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400156|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
130400157|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130400158|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130400159|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130400160|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130400161|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130400162|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130400163|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130400164|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130400165|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130400166|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130400167|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
130400168|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130400169|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130400170|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130400171|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130400172|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400173|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400174|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400175|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400176|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400177|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
130400178|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130400179|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130400180|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130400181|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130400182|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
130400183|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130400184|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130400185|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130400186|NCT01573624|469431433|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400187|NCT01573624|469431434|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400188|NCT01573624|469431435|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400189|NCT01573624|469431436|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400190|NCT01573624|469431437|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400191|NCT01573624|469431438|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400192|NCT01573624|469431439|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400193|NCT01573624|469431433|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
130400194|NCT01573624|469431434|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
130400195|NCT01573624|469431435|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
130400196|NCT01573624|469431436|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
130400197|NCT01573624|469431437|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
130400198|NCT01573624|469431438|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
130400199|NCT01573624|469431439|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
130400200|NCT01573624|469431433|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130400201|NCT01573624|469431434|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
130400202|NCT01573624|469431435|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130400203|NCT01573624|469431436|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130723540|NCT00229723|470613461|FG002|Maintenance Phase|Clinical progression|2|||
130723541|NCT00229723|470613462|FG003|Maintenance Phase|Clinical progression|2|||
130723542|NCT00229723|470613463|FG004|Maintenance Phase|Clinical progression|1|||
130723543|NCT00229723|470613464|FG005|Maintenance Phase|Clinical progression|1|||
130723544|NCT00229723|470613465|FG006|Maintenance Phase|Clinical progression|1|||
130723545|NCT00229723|470613459|FG000|Maintenance Phase|Lost to Follow-up|0|||
130723546|NCT00229723|470613460|FG001|Maintenance Phase|Lost to Follow-up|1|||
130400204|NCT01573624|469431437|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130723547|NCT00229723|470613461|FG002|Maintenance Phase|Lost to Follow-up|2|||
130400205|NCT01573624|469431438|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
130400206|NCT01573624|469431439|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130400207|NCT01573624|469431433|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
130400208|NCT01573624|469431434|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400209|NCT01573624|469431435|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400210|NCT01573624|469431436|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400211|NCT01573624|469431437|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400212|NCT01573624|469431438|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400213|NCT01573624|469431439|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130400214|NCT01573624|469431433|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130400215|NCT01573624|469431434|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130400216|NCT01573624|469431435|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130400217|NCT01573624|469431436|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130400218|NCT01573624|469431437|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130400219|NCT01573624|469431438|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130400220|NCT01573624|469431439|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130400221|NCT01573624|469431433|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
130400222|NCT01573624|469431434|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400223|NCT01573624|469431435|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400224|NCT01573624|469431436|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400225|NCT01573624|469431437|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400226|NCT01573624|469431438|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400227|NCT01573624|469431439|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130400228|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
130400229|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130400230|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130400231|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130400232|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130400233|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130400234|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
130400235|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
130400236|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130400237|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130400238|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130400239|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130400240|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
130400241|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130400242|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400243|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
130400244|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400245|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400246|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400247|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400248|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130400249|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400250|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
130400251|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400252|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400253|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400254|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400255|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130400256|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130400257|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130400258|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130400259|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130400260|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130400261|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130400262|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130400263|NCT01573624|469431433|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400264|NCT01573624|469431434|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400265|NCT01573624|469431435|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400266|NCT01573624|469431436|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400267|NCT01573624|469431437|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400268|NCT01573624|469431438|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130400269|NCT01573624|469431439|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130400270|NCT01573624|469431433|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
130400271|NCT01573624|469431434|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130400272|NCT01573624|469431435|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130400273|NCT01573624|469431436|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130400274|NCT01573624|469431437|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130400275|NCT01573624|469431438|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130400276|NCT01573624|469431439|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
130400277|NCT01573624|469431433|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130400278|NCT01573624|469431434|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
130400279|NCT01573624|469431435|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130400280|NCT01573624|469431436|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130400281|NCT01573624|469431437|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130400282|NCT01573624|469431438|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
130400283|NCT01573624|469431439|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130400284|NCT01573624|469431433|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
130400285|NCT01573624|469431434|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400286|NCT01573624|469431435|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400287|NCT01573624|469431436|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400288|NCT01573624|469431437|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400289|NCT01573624|469431438|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400290|NCT01573624|469431439|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130400291|NCT01573624|469431433|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130400292|NCT01573624|469431434|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130400293|NCT01573624|469431435|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130400294|NCT01573624|469431436|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130400295|NCT01573624|469431437|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
130400296|NCT01573624|469431438|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
130400297|NCT01573624|469431439|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130400298|NCT01573624|469431433|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
130400299|NCT01573624|469431434|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400300|NCT01573624|469431435|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400301|NCT01573624|469431436|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400302|NCT01573624|469431437|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400303|NCT01573624|469431438|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400304|NCT01573624|469431439|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130400305|NCT02681302|469431440|FG000|Overall Study|Withdrawal by Subject|1|||
130400306|NCT02681302|469431441|FG001|Overall Study|Withdrawal by Subject|1|||
130400307|NCT02681302|469431442|FG002|Overall Study|Withdrawal by Subject|0|||
130400308|NCT02681302|469431443|FG003|Overall Study|Withdrawal by Subject|0|||
130400309|NCT02681302|469431444|FG004|Overall Study|Withdrawal by Subject|1|||
130400310|NCT02681302|469431445|FG005|Overall Study|Withdrawal by Subject|0|||
130400311|NCT02681302|469431440|FG000|Overall Study|Screen Failure|2|||
130400312|NCT02681302|469431441|FG001|Overall Study|Screen Failure|4|||
130400313|NCT02681302|469431442|FG002|Overall Study|Screen Failure|2|||
130400314|NCT02681302|469431443|FG003|Overall Study|Screen Failure|0|||
130400315|NCT02681302|469431444|FG004|Overall Study|Screen Failure|1|||
130400316|NCT02681302|469431445|FG005|Overall Study|Screen Failure|1|||
130400317|NCT02681302|469431440|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130400318|NCT02681302|469431441|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130400319|NCT02681302|469431442|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130400320|NCT02681302|469431443|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130400321|NCT02681302|469431444|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130400322|NCT02681302|469431445|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
130400323|NCT02115282|469431446|FG000|Overall Study|Disease progression during treatment|216|||
130400324|NCT02115282|469431447|FG001|Overall Study|Disease progression during treatment|229|||
130400325|NCT02115282|469431446|FG000|Overall Study|Adverse Event|49|||
130400326|NCT02115282|469431447|FG001|Overall Study|Adverse Event|23|||
130400327|NCT02115282|469431446|FG000|Overall Study|Death|1|||
130400328|NCT02115282|469431447|FG001|Overall Study|Death|3|||
130400329|NCT02115282|469431446|FG000|Overall Study|Alternative therapy|1|||
130400330|NCT02115282|469431447|FG001|Overall Study|Alternative therapy|1|||
130400331|NCT02115282|469431446|FG000|Overall Study|Complicating disease|0|||
130400332|NCT02115282|469431447|FG001|Overall Study|Complicating disease|3|||
130400333|NCT02115282|469431446|FG000|Overall Study|Withdrawal by Subject|12|||
130400334|NCT02115282|469431447|FG001|Overall Study|Withdrawal by Subject|10|||
130400335|NCT02115282|469431446|FG000|Overall Study|Symptomatic progression/deterioration|7|||
130400336|NCT02115282|469431447|FG001|Overall Study|Symptomatic progression/deterioration|18|||
130400337|NCT02115282|469431446|FG000|Overall Study|Non-compliance|5|||
130400338|NCT02115282|469431447|FG001|Overall Study|Non-compliance|1|||
130400339|NCT02115282|469431446|FG000|Overall Study|Protocol Violation|2|||
130400340|NCT02115282|469431447|FG001|Overall Study|Protocol Violation|2|||
130400341|NCT02115282|469431446|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
130400342|NCT02115282|469431447|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
130400343|NCT02115282|469431446|FG000|Overall Study|Not start protocol therapy|9|||
130400344|NCT02115282|469431447|FG001|Overall Study|Not start protocol therapy|10|||
130400345|NCT02152995|469431452|FG000|Overall Study|Withdrawal by Subject|1|||
130400346|NCT02152995|469431453|FG001|Overall Study|Withdrawal by Subject|0|||
130400347|NCT00480779|469431455|FG000|Overall Study|Other|2|||
130400348|NCT00480779|469431456|FG001|Overall Study|Other|0|||
130400349|NCT00480779|469431455|FG000|Overall Study|Job and Health-related|0|||
130400350|NCT00480779|469431456|FG001|Overall Study|Job and Health-related|3|||
130400351|NCT04907032|469431457|FG000|Overall Study|Withdrawal by Subject|7|||
130400352|NCT04907032|469431458|FG001|Overall Study|Withdrawal by Subject|1|||
130400353|NCT00613509|469431460|FG000|Cycle 1|Adverse Event|2|||
130400354|NCT00613509|469431461|FG001|Cycle 1|Adverse Event|1|||
130400355|NCT00613509|469431460|FG000|Cycle 1|Disease Progression|2|||
130400356|NCT00613509|469431461|FG001|Cycle 1|Disease Progression|6|||
130400357|NCT00613509|469431460|FG000|Cycle 1|Unacceptable Toxicity|1|||
130400358|NCT00613509|469431461|FG001|Cycle 1|Unacceptable Toxicity|0|||
130400359|NCT00613509|469431460|FG000|Cycle 1|Other administrative reason|0|||
130400360|NCT00613509|469431461|FG001|Cycle 1|Other administrative reason|1|||
130400361|NCT02257736|469431471|FG000|Overall Study|Progressive disease|365|||
130400362|NCT02257736|469431472|FG001|Overall Study|Progressive disease|327|||
130400363|NCT02257736|469431471|FG000|Overall Study|Adverse Event|45|||
130400364|NCT02257736|469431472|FG001|Overall Study|Adverse Event|56|||
130400365|NCT02257736|469431471|FG000|Overall Study|Withdrawal by Subject|21|||
130400366|NCT02257736|469431472|FG001|Overall Study|Withdrawal by Subject|38|||
130400367|NCT02257736|469431471|FG000|Overall Study|Death|11|||
130400368|NCT02257736|469431472|FG001|Overall Study|Death|6|||
130400369|NCT02257736|469431471|FG000|Overall Study|Physician Decision|5|||
130400370|NCT02257736|469431472|FG001|Overall Study|Physician Decision|9|||
130400371|NCT02257736|469431471|FG000|Overall Study|Non-Compliance with study drug|1|||
130400372|NCT02257736|469431472|FG001|Overall Study|Non-Compliance with study drug|2|||
130400373|NCT02257736|469431471|FG000|Overall Study|Protocol Violation|1|||
130400374|NCT02257736|469431472|FG001|Overall Study|Protocol Violation|0|||
130400375|NCT02257736|469431471|FG000|Overall Study|Other|1|||
130400376|NCT02257736|469431472|FG001|Overall Study|Other|7|||
130400377|NCT02257736|469431471|FG000|Overall Study|Randomized, not treated|1|||
130400378|NCT02257736|469431472|FG001|Overall Study|Randomized, not treated|2|||
130400379|NCT00308711|469431481|FG000|Overall Study|Withdrawal by Subject|1|||
130400380|NCT00308711|469431482|FG001|Overall Study|Withdrawal by Subject|0|||
130400381|NCT00308711|469431483|FG002|Overall Study|Withdrawal by Subject|1|||
130400382|NCT00308711|469431481|FG000|Overall Study|Protocol Violation|0|||
130400383|NCT00308711|469431482|FG001|Overall Study|Protocol Violation|1|||
130400384|NCT00308711|469431483|FG002|Overall Study|Protocol Violation|1|||
130400385|NCT00308711|469431481|FG000|Overall Study|Lost to Follow-up|0|||
130400386|NCT00308711|469431482|FG001|Overall Study|Lost to Follow-up|1|||
130400387|NCT00308711|469431483|FG002|Overall Study|Lost to Follow-up|0|||
130400388|NCT00308711|469431481|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
130400389|NCT00308711|469431482|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
130400390|NCT00308711|469431483|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
130400391|NCT00308711|469431481|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
130400392|NCT00308711|469431482|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
130400393|NCT00308711|469431483|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
130723548|NCT00229723|470613462|FG003|Maintenance Phase|Lost to Follow-up|2|||
130400394|NCT02167256|469431484|FG000|Overall Study|Adverse Event|13|||
130400395|NCT02167256|469431485|FG001|Overall Study|Adverse Event|6|||
130400396|NCT02167256|469431484|FG000|Overall Study|Withdrawal by Subject|4|||
130400397|NCT02167256|469431485|FG001|Overall Study|Withdrawal by Subject|4|||
130400398|NCT02167256|469431484|FG000|Overall Study|non-compliance|3|||
130400399|NCT02167256|469431485|FG001|Overall Study|non-compliance|0|||
130400400|NCT02167256|469431484|FG000|Overall Study|Study partner unable to participate|1|||
130723549|NCT00229723|470613463|FG004|Maintenance Phase|Lost to Follow-up|0|||
130400401|NCT02167256|469431485|FG001|Overall Study|Study partner unable to participate|0|||
130400402|NCT01420081|469431486|FG000|Overall Study|Death|1|||
130400403|NCT01420081|469431487|FG001|Overall Study|Death|0|||
130400404|NCT01420081|469431488|FG002|Overall Study|Death|8|||
130400405|NCT01420081|469431489|FG003|Overall Study|Death|0|||
130400406|NCT01420081|469431490|FG004|Overall Study|Death|7|||
130400407|NCT01420081|469431491|FG005|Overall Study|Death|12|||
130400408|NCT01420081|469431492|FG006|Overall Study|Death|0|||
130723550|NCT00229723|470613464|FG005|Maintenance Phase|Lost to Follow-up|0|||
130723551|NCT00229723|470613465|FG006|Maintenance Phase|Lost to Follow-up|1|||
130723552|NCT00229723|470613459|FG000|Maintenance Phase|Informed consent withdrawn|1|||
130400409|NCT01420081|469431493|FG007|Overall Study|Death|1|||
130400410|NCT01420081|469431494|FG008|Overall Study|Death|1|||
130400411|NCT01420081|469431486|FG000|Overall Study|Lost to Follow-up|0|||
130400412|NCT01420081|469431487|FG001|Overall Study|Lost to Follow-up|0|||
130400413|NCT01420081|469431488|FG002|Overall Study|Lost to Follow-up|0|||
130400414|NCT01420081|469431489|FG003|Overall Study|Lost to Follow-up|0|||
130400415|NCT01420081|469431490|FG004|Overall Study|Lost to Follow-up|1|||
130400416|NCT01420081|469431491|FG005|Overall Study|Lost to Follow-up|1|||
130400417|NCT01420081|469431492|FG006|Overall Study|Lost to Follow-up|0|||
130400418|NCT01420081|469431493|FG007|Overall Study|Lost to Follow-up|0|||
130400419|NCT01420081|469431494|FG008|Overall Study|Lost to Follow-up|0|||
130400420|NCT01420081|469431486|FG000|Overall Study|Study Terminated by Sponsor|2|||
130400421|NCT01420081|469431487|FG001|Overall Study|Study Terminated by Sponsor|1|||
130400422|NCT01420081|469431488|FG002|Overall Study|Study Terminated by Sponsor|1|||
130400423|NCT01420081|469431489|FG003|Overall Study|Study Terminated by Sponsor|3|||
130400424|NCT01420081|469431490|FG004|Overall Study|Study Terminated by Sponsor|11|||
130400425|NCT01420081|469431491|FG005|Overall Study|Study Terminated by Sponsor|7|||
130400426|NCT01420081|469431492|FG006|Overall Study|Study Terminated by Sponsor|3|||
130400427|NCT01420081|469431493|FG007|Overall Study|Study Terminated by Sponsor|2|||
130400428|NCT01420081|469431494|FG008|Overall Study|Study Terminated by Sponsor|2|||
130400429|NCT01420081|469431486|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
130400430|NCT01420081|469431487|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
130400431|NCT01420081|469431488|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
130400432|NCT01420081|469431489|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
130400433|NCT01420081|469431490|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
130400434|NCT01420081|469431491|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
130400435|NCT01420081|469431492|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
130400436|NCT01420081|469431493|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
130400437|NCT01420081|469431494|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
130400438|NCT01420081|469431486|FG000|Overall Study|Other Reasons|0|||
130400439|NCT01420081|469431487|FG001|Overall Study|Other Reasons|0|||
130400440|NCT01420081|469431488|FG002|Overall Study|Other Reasons|1|||
130400441|NCT01420081|469431489|FG003|Overall Study|Other Reasons|0|||
130400442|NCT01420081|469431490|FG004|Overall Study|Other Reasons|0|||
130400443|NCT01420081|469431491|FG005|Overall Study|Other Reasons|0|||
130400444|NCT01420081|469431492|FG006|Overall Study|Other Reasons|0|||
130400445|NCT01420081|469431493|FG007|Overall Study|Other Reasons|0|||
130400446|NCT01420081|469431494|FG008|Overall Study|Other Reasons|0|||
130400447|NCT01723228|469431495|FG000|Overall Study|Adverse Event|2|||
130400448|NCT01723228|469431496|FG001|Overall Study|Adverse Event|6|||
130400449|NCT01723228|469431495|FG000|Overall Study|Withdrawal by Subject|2|||
130400450|NCT01723228|469431496|FG001|Overall Study|Withdrawal by Subject|1|||
130400451|NCT01723228|469431495|FG000|Overall Study|Protocol Violation|0|||
130400452|NCT01723228|469431496|FG001|Overall Study|Protocol Violation|2|||
130400453|NCT01723228|469431495|FG000|Overall Study|Lost to Follow-up|2|||
130400454|NCT01723228|469431496|FG001|Overall Study|Lost to Follow-up|1|||
130400455|NCT01723228|469431495|FG000|Overall Study|Other|2|||
130400456|NCT01723228|469431496|FG001|Overall Study|Other|1|||
130400457|NCT01451424|469431499|FG000|Overall Study|Withdrawal by Subject|1|||
130400458|NCT01451424|469431500|FG001|Overall Study|Withdrawal by Subject|1|||
130400459|NCT01451424|469431501|FG002|Overall Study|Withdrawal by Subject|0|||
130400460|NCT01451424|469431502|FG003|Overall Study|Withdrawal by Subject|2|||
130400461|NCT01451424|469431499|FG000|Overall Study|Lost to Follow-up|0|||
130400462|NCT01451424|469431500|FG001|Overall Study|Lost to Follow-up|1|||
130400463|NCT01451424|469431501|FG002|Overall Study|Lost to Follow-up|0|||
130400464|NCT01451424|469431502|FG003|Overall Study|Lost to Follow-up|1|||
130400465|NCT01451424|469431499|FG000|Overall Study|Physician Decision|0|||
130400466|NCT01451424|469431500|FG001|Overall Study|Physician Decision|0|||
130400467|NCT01451424|469431501|FG002|Overall Study|Physician Decision|1|||
130400468|NCT01451424|469431502|FG003|Overall Study|Physician Decision|1|||
130400469|NCT01451424|469431499|FG000|Overall Study|Adverse Event|0|||
130400470|NCT01451424|469431500|FG001|Overall Study|Adverse Event|0|||
130400471|NCT01451424|469431501|FG002|Overall Study|Adverse Event|0|||
130400472|NCT01451424|469431502|FG003|Overall Study|Adverse Event|1|||
130400473|NCT00528528|469431508|FG000|Overall Study|Lost to Follow-up|0|||
130400474|NCT00528528|469431509|FG001|Overall Study|Lost to Follow-up|0|||
130400475|NCT00528528|469431510|FG002|Overall Study|Lost to Follow-up|1|||
130400476|NCT00528528|469431511|FG003|Overall Study|Lost to Follow-up|1|||
130400477|NCT00528528|469431508|FG000|Overall Study|Ineligible to continue the trial|0|||
130400478|NCT00528528|469431509|FG001|Overall Study|Ineligible to continue the trial|0|||
130400479|NCT00528528|469431510|FG002|Overall Study|Ineligible to continue the trial|0|||
130400480|NCT00528528|469431511|FG003|Overall Study|Ineligible to continue the trial|1|||
130400481|NCT00528528|469431508|FG000|Overall Study|Other|0|||
130400482|NCT00528528|469431509|FG001|Overall Study|Other|1|||
130400483|NCT00528528|469431510|FG002|Overall Study|Other|0|||
130400484|NCT00528528|469431511|FG003|Overall Study|Other|0|||
130400485|NCT00528528|469431508|FG000|Overall Study|Withdrawal by Subject|3|||
130400486|NCT00528528|469431509|FG001|Overall Study|Withdrawal by Subject|2|||
130400487|NCT00528528|469431510|FG002|Overall Study|Withdrawal by Subject|1|||
130400488|NCT00528528|469431511|FG003|Overall Study|Withdrawal by Subject|1|||
130400489|NCT00528528|469431508|FG000|Overall Study|Ongoing participant|0|||
130400490|NCT00528528|469431509|FG001|Overall Study|Ongoing participant|0|||
130400491|NCT00528528|469431510|FG002|Overall Study|Ongoing participant|1|||
130400492|NCT00528528|469431511|FG003|Overall Study|Ongoing participant|0|||
130400493|NCT04325828|469431512|FG000|Overall Study|Ongoing|26|||
130400494|NCT04602624|469431513|FG000|Overall Study|Protocol Deviation|1|||
130400495|NCT04602624|469431513|FG000|Overall Study|Withdrawal by Participant|1|||
130400496|NCT04084769|469431514|FG000|Overall Study|Protocol Violation|1|||
130400497|NCT04084769|469431515|FG001|Overall Study|Protocol Violation|3|||
130400498|NCT04084769|469431516|FG002|Overall Study|Protocol Violation|0|||
130400499|NCT04084769|469431517|FG003|Overall Study|Protocol Violation|1|||
130400500|NCT04084769|469431514|FG000|Overall Study|Withdrawal by Subject|0|||
130400501|NCT04084769|469431515|FG001|Overall Study|Withdrawal by Subject|1|||
130400502|NCT04084769|469431516|FG002|Overall Study|Withdrawal by Subject|0|||
130400503|NCT04084769|469431517|FG003|Overall Study|Withdrawal by Subject|0|||
130400504|NCT04084769|469431514|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130400505|NCT04084769|469431515|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130400506|NCT04084769|469431516|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130400507|NCT04084769|469431517|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130400508|NCT04084769|469431514|FG000|Overall Study|Lost to Follow-up|2|||
130400509|NCT04084769|469431515|FG001|Overall Study|Lost to Follow-up|0|||
130400510|NCT04084769|469431516|FG002|Overall Study|Lost to Follow-up|0|||
130400511|NCT04084769|469431517|FG003|Overall Study|Lost to Follow-up|0|||
130400512|NCT03390504|469431518|FG000|Overall Study|Lost to Follow-up|2|||
130400513|NCT03390504|469431519|FG001|Overall Study|Lost to Follow-up|4|||
130400514|NCT03390504|469431520|FG002|Overall Study|Lost to Follow-up|0|||
130400515|NCT03390504|469431521|FG003|Overall Study|Lost to Follow-up|1|||
130400516|NCT03390504|469431518|FG000|Overall Study|Withdrawal by Subject|3|||
130400517|NCT03390504|469431519|FG001|Overall Study|Withdrawal by Subject|15|||
130400518|NCT03390504|469431520|FG002|Overall Study|Withdrawal by Subject|5|||
130400519|NCT03390504|469431521|FG003|Overall Study|Withdrawal by Subject|2|||
130400520|NCT03390504|469431518|FG000|Overall Study|Other|1|||
130400521|NCT03390504|469431519|FG001|Overall Study|Other|2|||
130400522|NCT03390504|469431520|FG002|Overall Study|Other|2|||
130400523|NCT03390504|469431521|FG003|Overall Study|Other|6|||
130400524|NCT03508219|469431522|FG000|Overall Study|Death|2|||
130400525|NCT03508219|469431522|FG000|Overall Study|Withdrawal by Subject|1|||
130400526|NCT03508219|469431522|FG000|Overall Study|Lost to Follow-up|4|||
130400527|NCT03508219|469431522|FG000|Overall Study|Missed visit|2|||
130400528|NCT03945981|469431523|FG000|Overall Study|Lost to Follow-up|12|||
130400529|NCT03945981|469431523|FG000|Overall Study|Physician Decision|4|||
130400530|NCT03945981|469431523|FG000|Overall Study|Withdrawal by Subject|6|||
130400531|NCT03945981|469431523|FG000|Overall Study|Protocol Violation|1|||
130400532|NCT04466891|469431524|FG000|Overall Study|Death|60|||
130400533|NCT04466891|469431525|FG001|Overall Study|Death|6|||
130400534|NCT04466891|469431524|FG000|Overall Study|Withdrawal by Subject|8|||
130400535|NCT04466891|469431525|FG001|Overall Study|Withdrawal by Subject|1|||
130400536|NCT04466891|469431524|FG000|Overall Study|Study terminated by sponsor|5|||
130400537|NCT04466891|469431525|FG001|Overall Study|Study terminated by sponsor|0|||
130400538|NCT04466891|469431524|FG000|Overall Study|Lost to Follow-up|2|||
130400539|NCT04466891|469431525|FG001|Overall Study|Lost to Follow-up|0|||
130400540|NCT04466891|469431524|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
130400541|NCT04466891|469431525|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
130400542|NCT03091192|469431526|FG000|Overall Study|Study terminated by sponsor|21|||
130400543|NCT03091192|469431527|FG001|Overall Study|Study terminated by sponsor|14|||
130400544|NCT03091192|469431526|FG000|Overall Study|Death|9|||
130400545|NCT03091192|469431527|FG001|Overall Study|Death|13|||
130400546|NCT03091192|469431526|FG000|Overall Study|Withdrawal by Subject|2|||
130400547|NCT03091192|469431527|FG001|Overall Study|Withdrawal by Subject|0|||
130400548|NCT03091192|469431526|FG000|Overall Study|Lost to Follow-up|1|||
130400549|NCT03091192|469431527|FG001|Overall Study|Lost to Follow-up|0|||
130400550|NCT04487080|469431530|FG000|Overall Study|Withdrawal by Subject|19|||
130400551|NCT04487080|469431531|FG001|Overall Study|Withdrawal by Subject|18|||
130400552|NCT04487080|469431532|FG002|Overall Study|Withdrawal by Subject|13|||
130400553|NCT04487080|469431530|FG000|Overall Study|Lost to Follow-up|3|||
130400554|NCT04487080|469431531|FG001|Overall Study|Lost to Follow-up|1|||
130400555|NCT04487080|469431532|FG002|Overall Study|Lost to Follow-up|0|||
130400556|NCT04487080|469431530|FG000|Overall Study|Ongoing|313|||
130400557|NCT04487080|469431531|FG001|Overall Study|Ongoing|297|||
130400558|NCT04487080|469431532|FG002|Overall Study|Ongoing|149|||
130723553|NCT00229723|470613460|FG001|Maintenance Phase|Informed consent withdrawn|0|||
130400559|NCT05645432|469431533|FG000|Overall Study|Withdrawal by Subject|1|||
130400560|NCT03195478|469431534|FG000|Overall Study|Disease Progression|5|||
130400561|NCT03195478|469431535|FG001|Overall Study|Disease Progression|4|||
130560565|NCT02229539|470022577|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
130560566|NCT02229539|470022578|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
130560567|NCT02229539|470022576|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
130560568|NCT02229539|470022577|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
130560569|NCT02229539|470022578|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
130560570|NCT04050670|470022581|FG000|Period 3|Physician Decision|0|||
130560571|NCT04050670|470022582|FG001|Period 3|Physician Decision|1|||
130560572|NCT04050670|470022583|FG002|Period 3|Physician Decision|0|||
130560573|NCT00880555|470022594|FG000|Overall Study|Physician Decision|0|||
130560574|NCT00880555|470022595|FG001|Overall Study|Physician Decision|8|||
130560575|NCT00880555|470022596|FG002|Overall Study|Physician Decision|0|||
130560576|NCT00880555|470022597|FG003|Overall Study|Physician Decision|2|||
130560577|NCT00880555|470022598|FG004|Overall Study|Physician Decision|1|||
130560578|NCT00880555|470022599|FG005|Overall Study|Physician Decision|0|||
130560579|NCT00880555|470022594|FG000|Overall Study|Withdrawal by Subject|1|||
130560580|NCT00880555|470022595|FG001|Overall Study|Withdrawal by Subject|1|||
130560581|NCT00880555|470022596|FG002|Overall Study|Withdrawal by Subject|0|||
130560582|NCT00880555|470022597|FG003|Overall Study|Withdrawal by Subject|0|||
130560583|NCT00880555|470022598|FG004|Overall Study|Withdrawal by Subject|0|||
130560584|NCT00880555|470022599|FG005|Overall Study|Withdrawal by Subject|0|||
130560585|NCT00880555|470022594|FG000|Overall Study|Lack of resources (hired rater)|9|||
130560586|NCT00880555|470022595|FG001|Overall Study|Lack of resources (hired rater)|7|||
130560587|NCT00880555|470022596|FG002|Overall Study|Lack of resources (hired rater)|5|||
130560588|NCT00880555|470022597|FG003|Overall Study|Lack of resources (hired rater)|0|||
130560589|NCT00880555|470022598|FG004|Overall Study|Lack of resources (hired rater)|0|||
130560590|NCT00880555|470022599|FG005|Overall Study|Lack of resources (hired rater)|0|||
130560591|NCT00880555|470022594|FG000|Overall Study|Death|0|||
130560592|NCT00880555|470022595|FG001|Overall Study|Death|0|||
130560593|NCT00880555|470022596|FG002|Overall Study|Death|0|||
130560594|NCT00880555|470022597|FG003|Overall Study|Death|0|||
130560595|NCT00880555|470022598|FG004|Overall Study|Death|0|||
130560596|NCT00880555|470022599|FG005|Overall Study|Death|1|||
130560597|NCT00880555|470022594|FG000|Overall Study|Lost to Follow-up|0|||
130560598|NCT00880555|470022595|FG001|Overall Study|Lost to Follow-up|1|||
130560599|NCT00880555|470022596|FG002|Overall Study|Lost to Follow-up|0|||
130560600|NCT00880555|470022597|FG003|Overall Study|Lost to Follow-up|0|||
130560601|NCT00880555|470022598|FG004|Overall Study|Lost to Follow-up|0|||
130560602|NCT00880555|470022599|FG005|Overall Study|Lost to Follow-up|0|||
130560603|NCT02982590|470022601|FG000|Overall Study|Lost to Follow-up|0|||
130560604|NCT02982590|470022602|FG001|Overall Study|Lost to Follow-up|1|||
130560605|NCT02982590|470022601|FG000|Overall Study|Death|4|||
130560606|NCT02982590|470022602|FG001|Overall Study|Death|0|||
130560607|NCT01168973|470022603|FG000|Overall Study|Progressive Disease|341|||
130400562|NCT03195478|469431536|FG002|Overall Study|Disease Progression|6|||
130400563|NCT03195478|469431537|FG003|Overall Study|Disease Progression|1|||
130400564|NCT03195478|469431534|FG000|Overall Study|Study Drug Toxicity|2|||
130400565|NCT03195478|469431535|FG001|Overall Study|Study Drug Toxicity|0|||
130400566|NCT03195478|469431536|FG002|Overall Study|Study Drug Toxicity|0|||
130400567|NCT03195478|469431537|FG003|Overall Study|Study Drug Toxicity|1|||
130400568|NCT03195478|469431534|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130400569|NCT03195478|469431535|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
130400570|NCT03195478|469431536|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130560608|NCT01168973|470022604|FG001|Overall Study|Progressive Disease|429|||
130560609|NCT01168973|470022603|FG000|Overall Study|Adverse Event|94|||
130723554|NCT00229723|470613461|FG002|Maintenance Phase|Informed consent withdrawn|0|||
130723555|NCT00229723|470613462|FG003|Maintenance Phase|Informed consent withdrawn|1|||
130723556|NCT00229723|470613463|FG004|Maintenance Phase|Informed consent withdrawn|1|||
130723557|NCT00229723|470613464|FG005|Maintenance Phase|Informed consent withdrawn|1|||
130723558|NCT00229723|470613465|FG006|Maintenance Phase|Informed consent withdrawn|0|||
130723559|NCT00229723|470613459|FG000|Maintenance Phase|Severe non-compliance|3|||
130400571|NCT03195478|469431537|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
130560610|NCT01168973|470022604|FG001|Overall Study|Adverse Event|55|||
130560611|NCT01168973|470022603|FG000|Overall Study|Withdrawal by Subject|90|||
130560612|NCT01168973|470022604|FG001|Overall Study|Withdrawal by Subject|53|||
130560613|NCT01168973|470022603|FG000|Overall Study|Death|42|||
130560614|NCT01168973|470022604|FG001|Overall Study|Death|45|||
130560615|NCT01168973|470022603|FG000|Overall Study|Physician Decision|37|||
130560616|NCT01168973|470022604|FG001|Overall Study|Physician Decision|19|||
130560617|NCT01168973|470022603|FG000|Overall Study|Sponsor Decision|2|||
130560618|NCT01168973|470022604|FG001|Overall Study|Sponsor Decision|1|||
130560619|NCT01168973|470022603|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
130560620|NCT01168973|470022604|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
130560621|NCT02230254|470022605|FG000|Overall Study|Lost to Follow-up|3|||
130560622|NCT02023242|470022606|FG000|Overall Study|Lost to Follow-up|3|||
130560623|NCT02023242|470022607|FG001|Overall Study|Lost to Follow-up|1|||
130560624|NCT02023242|470022606|FG000|Overall Study|Death|0|||
130400572|NCT03195478|469431534|FG000|Overall Study|Participant Withdrew Consent|1|||
130400573|NCT03195478|469431535|FG001|Overall Study|Participant Withdrew Consent|0|||
130400574|NCT03195478|469431536|FG002|Overall Study|Participant Withdrew Consent|0|||
130400575|NCT03195478|469431537|FG003|Overall Study|Participant Withdrew Consent|0|||
130400576|NCT03195478|469431534|FG000|Overall Study|Maximum Clinical benefit|0|||
130400577|NCT03195478|469431535|FG001|Overall Study|Maximum Clinical benefit|0|||
130400578|NCT03195478|469431536|FG002|Overall Study|Maximum Clinical benefit|1|||
130400579|NCT03195478|469431537|FG003|Overall Study|Maximum Clinical benefit|0|||
130400580|NCT03195478|469431534|FG000|Overall Study|Other Reasons|0|||
130400581|NCT03195478|469431535|FG001|Overall Study|Other Reasons|0|||
130400582|NCT03195478|469431536|FG002|Overall Study|Other Reasons|1|||
130400583|NCT03195478|469431537|FG003|Overall Study|Other Reasons|0|||
130400584|NCT03890367|469431538|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130400585|NCT03890367|469431539|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130400586|NCT03890367|469431540|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130400587|NCT03890367|469431538|FG000|Overall Study|Protocol deviation|2|||
130400588|NCT03890367|469431539|FG001|Overall Study|Protocol deviation|2|||
130400589|NCT03890367|469431540|FG002|Overall Study|Protocol deviation|1|||
130400590|NCT03890367|469431538|FG000|Overall Study|Lost to Follow-up|1|||
130400591|NCT03890367|469431539|FG001|Overall Study|Lost to Follow-up|1|||
130400592|NCT03890367|469431540|FG002|Overall Study|Lost to Follow-up|0|||
130400593|NCT04346615|469432927|FG000|Overall Study|Lost to Follow-up|0|||
130400594|NCT04346615|469432928|FG001|Overall Study|Lost to Follow-up|2|||
130400595|NCT04346615|469432927|FG000|Overall Study|Withdrawal by Subject|1|||
130400596|NCT04346615|469432928|FG001|Overall Study|Withdrawal by Subject|0|||
130400597|NCT04346615|469432927|FG000|Overall Study|Death|5|||
130400598|NCT04346615|469432928|FG001|Overall Study|Death|1|||
130400599|NCT04346615|469432927|FG000|Overall Study|Other|0|||
130400600|NCT04346615|469432928|FG001|Overall Study|Other|2|||
130400601|NCT04346615|469432927|FG000|Overall Study|Randomized not treated|1|||
130400602|NCT04346615|469432928|FG001|Overall Study|Randomized not treated|0|||
130400603|NCT03370341|469432929|FG000|Overall Study|Lost to Follow-up|0|||
130400604|NCT03370341|469432930|FG001|Overall Study|Lost to Follow-up|1|||
130400605|NCT01707004|469432933|FG000|Overall Study|Physician Decision|3|||
130400606|NCT00533949|469432934|FG000|Overall Study|Protocol Violation|12|||
130400607|NCT00533949|469432935|FG001|Overall Study|Protocol Violation|12|||
130400608|NCT00533949|469432936|FG002|Overall Study|Protocol Violation|9|||
130400609|NCT00533949|469432937|FG003|Overall Study|Protocol Violation|9|||
130400610|NCT00533949|469432934|FG000|Overall Study|Withdrawal by Subject|3|||
130400611|NCT00533949|469432935|FG001|Overall Study|Withdrawal by Subject|2|||
130400612|NCT00533949|469432936|FG002|Overall Study|Withdrawal by Subject|1|||
130400613|NCT00533949|469432937|FG003|Overall Study|Withdrawal by Subject|1|||
130400614|NCT00727194|469432938|FG000|Screening Period|Low QMG scores|0|||
130723560|NCT00229723|470613460|FG001|Maintenance Phase|Severe non-compliance|1|||
130723561|NCT00229723|470613461|FG002|Maintenance Phase|Severe non-compliance|0|||
130400615|NCT00727194|469432939|FG001|Screening Period|Low QMG scores|0|||
130400616|NCT00727194|469432940|FG002|Screening Period|Low QMG scores|6|||
130400617|NCT00727194|469432938|FG000|Screening Period|Lacked AChR antibodies|0|||
130400618|NCT00727194|469432939|FG001|Screening Period|Lacked AChR antibodies|0|||
130400619|NCT00727194|469432940|FG002|Screening Period|Lacked AChR antibodies|5|||
130400620|NCT00727194|469432938|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
130400621|NCT00727194|469432939|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
130400622|NCT00727194|469432940|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
130400623|NCT00727194|469432938|FG000|Screening Period|Severe infections|0|||
130400624|NCT00727194|469432939|FG001|Screening Period|Severe infections|0|||
130400625|NCT00727194|469432940|FG002|Screening Period|Severe infections|2|||
130400626|NCT00727194|469432938|FG000|Screening Period|History of thymoma|0|||
130400627|NCT00727194|469432939|FG001|Screening Period|History of thymoma|0|||
130400628|NCT00727194|469432940|FG002|Screening Period|History of thymoma|1|||
130400629|NCT00727194|469432938|FG000|Treatment Period 2|Lack of Efficacy|0|||
130400630|NCT00727194|469432939|FG001|Treatment Period 2|Lack of Efficacy|1|||
130723562|NCT00229723|470613462|FG003|Maintenance Phase|Severe non-compliance|0|||
130723563|NCT00229723|470613463|FG004|Maintenance Phase|Severe non-compliance|1|||
130400631|NCT00727194|469432940|FG002|Treatment Period 2|Lack of Efficacy|0|||
130400632|NCT04269161|469432946|FG000|Overall Study|Change of modality and no longer eligible|3|||
130400633|NCT04269161|469432947|FG001|Overall Study|Change of modality and no longer eligible|3|||
130400634|NCT04269161|469432946|FG000|Overall Study|Required procedure outside of NICU|1|||
130400635|NCT04269161|469432947|FG001|Overall Study|Required procedure outside of NICU|0|||
130400636|NCT04269161|469432946|FG000|Overall Study|Equipment issue|1|||
130400637|NCT04269161|469432947|FG001|Overall Study|Equipment issue|1|||
130400638|NCT01677195|469432948|FG000|Overall Study|Lost to Follow-up|14|||
130400639|NCT01677195|469432949|FG001|Overall Study|Lost to Follow-up|22|||
130400640|NCT01677195|469432950|FG002|Overall Study|Lost to Follow-up|22|||
130400641|NCT01677195|469432948|FG000|Overall Study|Withdrawal by Subject|1|||
130400642|NCT01677195|469432949|FG001|Overall Study|Withdrawal by Subject|0|||
130400643|NCT01677195|469432950|FG002|Overall Study|Withdrawal by Subject|1|||
130400644|NCT01677195|469432948|FG000|Overall Study|Adverse Event|6|||
130400645|NCT01677195|469432949|FG001|Overall Study|Adverse Event|4|||
130400646|NCT01677195|469432950|FG002|Overall Study|Adverse Event|1|||
130400647|NCT01677195|469432948|FG000|Overall Study|Physician Decision|1|||
130400648|NCT01677195|469432949|FG001|Overall Study|Physician Decision|2|||
130400649|NCT01677195|469432950|FG002|Overall Study|Physician Decision|2|||
130400650|NCT01677195|469432948|FG000|Overall Study|Pregnancy|0|||
130400651|NCT01677195|469432949|FG001|Overall Study|Pregnancy|1|||
130400652|NCT01677195|469432950|FG002|Overall Study|Pregnancy|0|||
130400653|NCT01677195|469432948|FG000|Overall Study|Protocol Violation|7|||
130400654|NCT01677195|469432949|FG001|Overall Study|Protocol Violation|3|||
130560625|NCT02023242|470022607|FG001|Overall Study|Death|1|||
130560626|NCT00388505|470022611|FG000|Overall Study|Adverse Event or Death|43|||
130560627|NCT00388505|470022612|FG001|Overall Study|Adverse Event or Death|17|||
130560628|NCT00388505|470022611|FG000|Overall Study|Withdrawal by Subject|24|||
130560629|NCT00388505|470022612|FG001|Overall Study|Withdrawal by Subject|9|||
130560630|NCT00388505|470022611|FG000|Overall Study|Lost to Follow-up|5|||
130560631|NCT00388505|470022612|FG001|Overall Study|Lost to Follow-up|3|||
130400655|NCT01677195|469432950|FG002|Overall Study|Protocol Violation|4|||
130400656|NCT04368429|469432951|FG000|Overall Study|Adverse Event|1|||
130400657|NCT04368429|469432952|FG001|Overall Study|Adverse Event|0|||
130400658|NCT02472756|469432954|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
130400659|NCT02472756|469432954|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
130400660|NCT02472756|469432954|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
130400661|NCT02472756|469432954|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
130400662|NCT02472756|469432954|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
130400663|NCT02143414|469432955|FG000|Induction|Adverse Event|1|||
130400664|NCT02143414|469432956|FG001|Induction|Adverse Event|2|||
130400665|NCT02143414|469432955|FG000|Induction|Death|1|||
130560632|NCT00388505|470022611|FG000|Overall Study|Inappropriate Enrollment|0|||
130560633|NCT00388505|470022612|FG001|Overall Study|Inappropriate Enrollment|1|||
130400666|NCT02143414|469432956|FG001|Induction|Death|2|||
130400667|NCT02143414|469432955|FG000|Induction|Patient refusal|1|||
130560634|NCT00388505|470022611|FG000|Overall Study|Administrative Reason|1|||
130560635|NCT00388505|470022612|FG001|Overall Study|Administrative Reason|0|||
130560636|NCT00388505|470022611|FG000|Overall Study|Protocol Violation|6|||
130560637|NCT00388505|470022612|FG001|Overall Study|Protocol Violation|5|||
130560638|NCT00388505|470022611|FG000|Overall Study|Unable to classify|4|||
130560639|NCT00388505|470022612|FG001|Overall Study|Unable to classify|3|||
130560640|NCT04854434|470022615|FG000|Overall Study|Death|1|||
130560641|NCT04854434|470022616|FG001|Overall Study|Death|3|||
130560642|NCT04854434|470022617|FG002|Overall Study|Death|4|||
130560643|NCT04854434|470022615|FG000|Overall Study|Study Terminated by Sponsor|2|||
130560644|NCT04854434|470022616|FG001|Overall Study|Study Terminated by Sponsor|0|||
130560645|NCT04854434|470022617|FG002|Overall Study|Study Terminated by Sponsor|0|||
130560646|NCT04854434|470022615|FG000|Overall Study|Other|1|||
130560647|NCT04854434|470022616|FG001|Overall Study|Other|1|||
130560648|NCT04854434|470022617|FG002|Overall Study|Other|0|||
130560649|NCT01274715|470022618|FG000|Overall Study|Lost to Follow-up|1|||
130560650|NCT01274715|470022618|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130560651|NCT01274715|470022618|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130560652|NCT01274715|470022618|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130560653|NCT02285920|470022620|FG000|Overall Study|Kidney transplantation|2|||
130560654|NCT02285920|470022621|FG001|Overall Study|Kidney transplantation|2|||
130560655|NCT02285920|470022622|FG002|Overall Study|Kidney transplantation|2|||
130560656|NCT02285920|470022623|FG003|Overall Study|Kidney transplantation|0|||
130560657|NCT02285920|470022620|FG000|Overall Study|Change to peritoneal dialysis|0|||
130560658|NCT02285920|470022621|FG001|Overall Study|Change to peritoneal dialysis|0|||
130560659|NCT02285920|470022622|FG002|Overall Study|Change to peritoneal dialysis|1|||
130560660|NCT02285920|470022623|FG003|Overall Study|Change to peritoneal dialysis|0|||
130400668|NCT02143414|469432956|FG001|Induction|Patient refusal|1|||
130560661|NCT02285920|470022620|FG000|Overall Study|Transfer to non-participating unit|0|||
130400669|NCT02143414|469432955|FG000|Induction|Refractory|1|||
130400670|NCT02143414|469432956|FG001|Induction|Refractory|0|||
130400671|NCT02143414|469432955|FG000|Induction|Began alternative treatment|1|||
130400672|NCT02143414|469432956|FG001|Induction|Began alternative treatment|0|||
130560662|NCT02285920|470022621|FG001|Overall Study|Transfer to non-participating unit|1|||
130560663|NCT02285920|470022622|FG002|Overall Study|Transfer to non-participating unit|0|||
130560664|NCT02285920|470022623|FG003|Overall Study|Transfer to non-participating unit|0|||
130560665|NCT02285920|470022620|FG000|Overall Study|Dialysis discontinuation|0|||
130560666|NCT02285920|470022621|FG001|Overall Study|Dialysis discontinuation|1|||
130560667|NCT02285920|470022622|FG002|Overall Study|Dialysis discontinuation|0|||
130560668|NCT02285920|470022623|FG003|Overall Study|Dialysis discontinuation|0|||
130400673|NCT02143414|469432955|FG000|Induction|Ineligible for postremission|5|||
130400674|NCT02143414|469432956|FG001|Induction|Ineligible for postremission|1|||
130400675|NCT02143414|469432955|FG000|Post-remission|Adverse Event|0|||
130400676|NCT02143414|469432956|FG001|Post-remission|Adverse Event|2|||
130400677|NCT02143414|469432955|FG000|Post-remission|Disease progression/relapse|5|||
130400678|NCT02143414|469432956|FG001|Post-remission|Disease progression/relapse|0|||
130400679|NCT02143414|469432955|FG000|Maintenance|Adverse Event|4|||
130400680|NCT02143414|469432956|FG001|Maintenance|Adverse Event|6|||
130400681|NCT02143414|469432955|FG000|Maintenance|Disease progression/relapse|3|||
130400682|NCT02143414|469432956|FG001|Maintenance|Disease progression/relapse|2|||
130400683|NCT02143414|469432955|FG000|Maintenance|Patient refusal|2|||
130400684|NCT02143414|469432956|FG001|Maintenance|Patient refusal|1|||
130400685|NCT02143414|469432955|FG000|Maintenance|Physician Decision|1|||
130400686|NCT02143414|469432956|FG001|Maintenance|Physician Decision|0|||
130400687|NCT02143414|469432955|FG000|Maintenance|Death|0|||
130400688|NCT02143414|469432956|FG001|Maintenance|Death|1|||
130400689|NCT02143414|469432955|FG000|Maintenance|On protocol treatment|0|||
130400690|NCT02143414|469432956|FG001|Maintenance|On protocol treatment|6|||
130400691|NCT00110266|469432958|FG000|Overall Study|Adverse Event|27|||
130400692|NCT00110266|469432958|FG000|Overall Study|Abnormal laboratory value|15|||
130400693|NCT00110266|469432958|FG000|Overall Study|Withdrawal by Subject|16|||
130400694|NCT00110266|469432958|FG000|Overall Study|Death|17|||
130400695|NCT00110266|469432958|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130400696|NCT00110266|469432958|FG000|Overall Study|Participant condition no longer requires study drug|1|||
130400697|NCT02896400|469432959|FG000|1 Month Follow-up|Lost to Follow-up|7|||
130400698|NCT02896400|469432960|FG001|1 Month Follow-up|Lost to Follow-up|7|||
130400699|NCT02896400|469432961|FG002|1 Month Follow-up|Lost to Follow-up|5|||
130400700|NCT02896400|469432962|FG003|1 Month Follow-up|Lost to Follow-up|8|||
130400701|NCT02896400|469432963|FG004|1 Month Follow-up|Lost to Follow-up|9|||
130400702|NCT02896400|469432964|FG005|1 Month Follow-up|Lost to Follow-up|6|||
130400703|NCT02896400|469432965|FG006|1 Month Follow-up|Lost to Follow-up|5|||
130400704|NCT02896400|469432966|FG007|1 Month Follow-up|Lost to Follow-up|6|||
130400705|NCT02896400|469432967|FG008|1 Month Follow-up|Lost to Follow-up|4|||
130400706|NCT02896400|469432968|FG009|1 Month Follow-up|Lost to Follow-up|7|||
130400707|NCT02896400|469432969|FG010|1 Month Follow-up|Lost to Follow-up|5|||
130400708|NCT02896400|469432970|FG011|1 Month Follow-up|Lost to Follow-up|5|||
130400709|NCT02896400|469432971|FG012|1 Month Follow-up|Lost to Follow-up|3|||
130400710|NCT02896400|469432972|FG013|1 Month Follow-up|Lost to Follow-up|4|||
130400711|NCT02896400|469432973|FG014|1 Month Follow-up|Lost to Follow-up|1|||
130400712|NCT02896400|469432974|FG015|1 Month Follow-up|Lost to Follow-up|2|||
130400713|NCT02896400|469432959|FG000|1 Month Follow-up|Death|0|||
130400714|NCT02896400|469432960|FG001|1 Month Follow-up|Death|0|||
130400715|NCT02896400|469432961|FG002|1 Month Follow-up|Death|0|||
130400716|NCT02896400|469432962|FG003|1 Month Follow-up|Death|0|||
130400717|NCT02896400|469432963|FG004|1 Month Follow-up|Death|0|||
130400718|NCT02896400|469432964|FG005|1 Month Follow-up|Death|0|||
130400719|NCT02896400|469432965|FG006|1 Month Follow-up|Death|0|||
130400720|NCT02896400|469432966|FG007|1 Month Follow-up|Death|0|||
130400721|NCT02896400|469432967|FG008|1 Month Follow-up|Death|0|||
130400722|NCT02896400|469432968|FG009|1 Month Follow-up|Death|0|||
130400723|NCT02896400|469432969|FG010|1 Month Follow-up|Death|0|||
130400724|NCT02896400|469432970|FG011|1 Month Follow-up|Death|0|||
130400725|NCT02896400|469432971|FG012|1 Month Follow-up|Death|0|||
130400726|NCT02896400|469432972|FG013|1 Month Follow-up|Death|0|||
130400727|NCT02896400|469432973|FG014|1 Month Follow-up|Death|0|||
130400728|NCT02896400|469432974|FG015|1 Month Follow-up|Death|1|||
130400729|NCT02896400|469432959|FG000|3 Month Follow-up|Lost to Follow-up|6|||
130400730|NCT02896400|469432960|FG001|3 Month Follow-up|Lost to Follow-up|3|||
130400731|NCT02896400|469432961|FG002|3 Month Follow-up|Lost to Follow-up|6|||
130400732|NCT02896400|469432962|FG003|3 Month Follow-up|Lost to Follow-up|11|||
130400733|NCT02896400|469432963|FG004|3 Month Follow-up|Lost to Follow-up|12|||
130400734|NCT02896400|469432964|FG005|3 Month Follow-up|Lost to Follow-up|6|||
130400735|NCT02896400|469432965|FG006|3 Month Follow-up|Lost to Follow-up|4|||
130400736|NCT02896400|469432966|FG007|3 Month Follow-up|Lost to Follow-up|3|||
130400737|NCT02896400|469432967|FG008|3 Month Follow-up|Lost to Follow-up|6|||
130400738|NCT02896400|469432968|FG009|3 Month Follow-up|Lost to Follow-up|5|||
130400739|NCT02896400|469432969|FG010|3 Month Follow-up|Lost to Follow-up|6|||
130400740|NCT02896400|469432970|FG011|3 Month Follow-up|Lost to Follow-up|6|||
130400741|NCT02896400|469432971|FG012|3 Month Follow-up|Lost to Follow-up|3|||
130400742|NCT02896400|469432972|FG013|3 Month Follow-up|Lost to Follow-up|5|||
130400743|NCT02896400|469432973|FG014|3 Month Follow-up|Lost to Follow-up|3|||
130400744|NCT02896400|469432974|FG015|3 Month Follow-up|Lost to Follow-up|2|||
130400745|NCT02896400|469432959|FG000|3 Month Follow-up|Death|0|||
130400746|NCT02896400|469432960|FG001|3 Month Follow-up|Death|0|||
130400747|NCT02896400|469432961|FG002|3 Month Follow-up|Death|0|||
130400748|NCT02896400|469432962|FG003|3 Month Follow-up|Death|0|||
130400749|NCT02896400|469432963|FG004|3 Month Follow-up|Death|0|||
130400750|NCT02896400|469432964|FG005|3 Month Follow-up|Death|0|||
130400751|NCT02896400|469432965|FG006|3 Month Follow-up|Death|0|||
130400752|NCT02896400|469432966|FG007|3 Month Follow-up|Death|0|||
130400753|NCT02896400|469432967|FG008|3 Month Follow-up|Death|0|||
130400754|NCT02896400|469432968|FG009|3 Month Follow-up|Death|0|||
130400755|NCT02896400|469432969|FG010|3 Month Follow-up|Death|0|||
130400756|NCT02896400|469432970|FG011|3 Month Follow-up|Death|0|||
130400757|NCT02896400|469432971|FG012|3 Month Follow-up|Death|0|||
130400758|NCT02896400|469432972|FG013|3 Month Follow-up|Death|1|||
130560669|NCT02285920|470022620|FG000|Overall Study|Death|2|||
130560670|NCT02285920|470022621|FG001|Overall Study|Death|0|||
130560671|NCT02285920|470022622|FG002|Overall Study|Death|2|||
130560672|NCT02285920|470022623|FG003|Overall Study|Death|1|||
130560673|NCT01480284|470022624|FG000|Overall Study|Withdrawal by Subject|2|||
130560674|NCT01480284|470022625|FG001|Overall Study|Withdrawal by Subject|0|||
130560675|NCT01480284|470022624|FG000|Overall Study|Adverse Event|1|||
130560676|NCT01480284|470022625|FG001|Overall Study|Adverse Event|0|||
130560677|NCT01480284|470022624|FG000|Overall Study|Study closed/terminated|3|||
130560678|NCT01480284|470022625|FG001|Overall Study|Study closed/terminated|0|||
130560679|NCT01480284|470022624|FG000|Overall Study|Lost to Follow-up|1|||
130560680|NCT01480284|470022625|FG001|Overall Study|Lost to Follow-up|0|||
130560681|NCT01480284|470022624|FG000|Overall Study|Physician Decision|1|||
130560682|NCT01480284|470022625|FG001|Overall Study|Physician Decision|0|||
130560683|NCT01641237|470022638|FG000|Period II|Withdrawal by Subject|1|||
130560684|NCT01641237|470022639|FG001|Period II|Withdrawal by Subject|0|||
130560685|NCT01641237|470022640|FG002|Period II|Withdrawal by Subject|0|||
130560686|NCT01641237|470022641|FG003|Period II|Withdrawal by Subject|0|||
130560687|NCT01641237|470022638|FG000|Period III|Lost to Follow-up|1|||
130560688|NCT01641237|470022639|FG001|Period III|Lost to Follow-up|0|||
130560689|NCT01641237|470022640|FG002|Period III|Lost to Follow-up|0|||
130560690|NCT01641237|470022641|FG003|Period III|Lost to Follow-up|0|||
130560691|NCT02716675|470022642|FG000|Overall Study|Death|2|||
130560692|NCT02716675|470022643|FG001|Overall Study|Death|3|||
130560693|NCT02716675|470022644|FG002|Overall Study|Death|0|||
130560694|NCT02716675|470022642|FG000|Overall Study|Physician Decision|2|||
130560695|NCT02716675|470022643|FG001|Overall Study|Physician Decision|1|||
130560696|NCT02716675|470022644|FG002|Overall Study|Physician Decision|1|||
130560697|NCT02716675|470022642|FG000|Overall Study|Lost to Follow-up|100|||
130560698|NCT02716675|470022643|FG001|Overall Study|Lost to Follow-up|87|||
130560699|NCT02716675|470022644|FG002|Overall Study|Lost to Follow-up|99|||
130560700|NCT02716675|470022642|FG000|Overall Study|Withdrawal by Subject|22|||
130560701|NCT02716675|470022643|FG001|Overall Study|Withdrawal by Subject|25|||
130560702|NCT02716675|470022644|FG002|Overall Study|Withdrawal by Subject|20|||
130560703|NCT02716675|470022642|FG000|Overall Study|Protocol Violation|0|||
130723564|NCT00229723|470613464|FG005|Maintenance Phase|Severe non-compliance|0|||
130723565|NCT00229723|470613465|FG006|Maintenance Phase|Severe non-compliance|0|||
130723566|NCT00229723|470613459|FG000|Maintenance Phase|Other|5|||
130723567|NCT00229723|470613460|FG001|Maintenance Phase|Other|4|||
130723568|NCT00229723|470613461|FG002|Maintenance Phase|Other|1|||
130723569|NCT00229723|470613462|FG003|Maintenance Phase|Other|2|||
130723570|NCT00229723|470613463|FG004|Maintenance Phase|Other|3|||
130723571|NCT00229723|470613464|FG005|Maintenance Phase|Other|3|||
130723572|NCT00229723|470613465|FG006|Maintenance Phase|Other|1|||
130723573|NCT00735397|470613468|FG000|Overall Study|Adverse Event|194|||
130400759|NCT02896400|469432973|FG014|3 Month Follow-up|Death|1|||
130400760|NCT02896400|469432974|FG015|3 Month Follow-up|Death|0|||
130400761|NCT02896400|469432959|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400762|NCT02896400|469432960|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130400763|NCT02896400|469432961|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400764|NCT02896400|469432962|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400765|NCT02896400|469432963|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130400766|NCT02896400|469432964|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400767|NCT02896400|469432965|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
130400768|NCT02896400|469432966|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
130400769|NCT02896400|469432967|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400770|NCT02896400|469432968|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400771|NCT02896400|469432969|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130400772|NCT02896400|469432970|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130400773|NCT02896400|469432971|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400774|NCT02896400|469432972|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130400775|NCT02896400|469432973|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
130400776|NCT02896400|469432974|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130400777|NCT02896400|469432959|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
130560704|NCT02716675|470022643|FG001|Overall Study|Protocol Violation|3|||
130560705|NCT02716675|470022644|FG002|Overall Study|Protocol Violation|1|||
130560706|NCT02716675|470022642|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
130560707|NCT02716675|470022643|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
130560708|NCT02716675|470022644|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
130560709|NCT02716675|470022642|FG000|Overall Study|Other|38|||
130560710|NCT02716675|470022643|FG001|Overall Study|Other|47|||
130560711|NCT02716675|470022644|FG002|Overall Study|Other|48|||
130560712|NCT00709111|470022645|FG000|Overall Study|Withdrawal by Subject|1|||
130560713|NCT00709111|470022645|FG000|Overall Study|Unable to attend clinic visits|1|||
130723574|NCT00735397|470613468|FG000|Overall Study|Lost to Follow-up|33|||
130723575|NCT00735397|470613468|FG000|Overall Study|Participant choice|252|||
130400778|NCT02896400|469432960|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130400779|NCT02896400|469432961|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
130400780|NCT02896400|469432962|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
130400781|NCT02896400|469432963|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
130400782|NCT02896400|469432964|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130400783|NCT02896400|469432965|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130400784|NCT02896400|469432966|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
130400785|NCT02896400|469432967|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
130400786|NCT02896400|469432968|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
130400787|NCT02896400|469432969|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
130400788|NCT02896400|469432970|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
130400789|NCT02896400|469432971|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
130400790|NCT02896400|469432972|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130400791|NCT02896400|469432973|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
130400792|NCT02896400|469432974|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
130400793|NCT02984020|469432975|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
130400794|NCT02984020|469432975|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
130400795|NCT02984020|469432975|FG000|Overall Study|Other significant protocol violation|2|||
130400796|NCT01207778|469432976|FG000|Overall Study|Lost to Follow-up|0|||
130400797|NCT01207778|469432977|FG001|Overall Study|Lost to Follow-up|3|||
130400798|NCT01207778|469432978|FG002|Overall Study|Lost to Follow-up|3|||
130400799|NCT00646204|469432979|FG000|Overall Study|Adverse Event|3|||
130400800|NCT00646204|469432980|FG001|Overall Study|Adverse Event|0|||
130400801|NCT00646204|469432979|FG000|Overall Study|Withdrawal by Subject|1|||
130400802|NCT00646204|469432980|FG001|Overall Study|Withdrawal by Subject|0|||
130400803|NCT03107988|469432984|FG000|Overall Study|Adverse Event|0|||
130400804|NCT03107988|469432985|FG001|Overall Study|Adverse Event|0|||
130400805|NCT03107988|469432986|FG002|Overall Study|Adverse Event|0|||
130400806|NCT03107988|469432987|FG003|Overall Study|Adverse Event|1|||
130400807|NCT03107988|469432988|FG004|Overall Study|Adverse Event|0|||
130400808|NCT03107988|469432989|FG005|Overall Study|Adverse Event|1|||
130400809|NCT03107988|469432990|FG006|Overall Study|Adverse Event|0|||
130400810|NCT03107988|469432991|FG007|Overall Study|Adverse Event|1|||
130400811|NCT03107988|469432992|FG008|Overall Study|Adverse Event|0|||
130400812|NCT03107988|469432993|FG009|Overall Study|Adverse Event|0|||
130400813|NCT03107988|469432994|FG010|Overall Study|Adverse Event|0|||
130400814|NCT03107988|469432995|FG011|Overall Study|Adverse Event|0|||
130400815|NCT03107988|469432996|FG012|Overall Study|Adverse Event|0|||
130400816|NCT03107988|469432984|FG000|Overall Study|Disease Progression or Relapse|1|||
130400817|NCT03107988|469432985|FG001|Overall Study|Disease Progression or Relapse|2|||
130400818|NCT03107988|469432986|FG002|Overall Study|Disease Progression or Relapse|2|||
130400819|NCT03107988|469432987|FG003|Overall Study|Disease Progression or Relapse|5|||
130400820|NCT03107988|469432988|FG004|Overall Study|Disease Progression or Relapse|1|||
130400821|NCT03107988|469432989|FG005|Overall Study|Disease Progression or Relapse|1|||
130400822|NCT03107988|469432990|FG006|Overall Study|Disease Progression or Relapse|0|||
130400823|NCT03107988|469432991|FG007|Overall Study|Disease Progression or Relapse|0|||
130400824|NCT03107988|469432992|FG008|Overall Study|Disease Progression or Relapse|0|||
130400825|NCT03107988|469432993|FG009|Overall Study|Disease Progression or Relapse|1|||
130400826|NCT03107988|469432994|FG010|Overall Study|Disease Progression or Relapse|4|||
130400827|NCT03107988|469432995|FG011|Overall Study|Disease Progression or Relapse|0|||
130400828|NCT03107988|469432996|FG012|Overall Study|Disease Progression or Relapse|0|||
130470755|NCT05575076|469690815|FG000|Overall Study|Withdrawal by Subject|71|||
130400829|NCT03107988|469432984|FG000|Overall Study|Ineligible|0|||
130400830|NCT03107988|469432985|FG001|Overall Study|Ineligible|0|||
130400831|NCT03107988|469432986|FG002|Overall Study|Ineligible|0|||
130400832|NCT03107988|469432987|FG003|Overall Study|Ineligible|0|||
130400833|NCT03107988|469432988|FG004|Overall Study|Ineligible|0|||
130400834|NCT03107988|469432989|FG005|Overall Study|Ineligible|0|||
130400835|NCT03107988|469432990|FG006|Overall Study|Ineligible|0|||
130400836|NCT03107988|469432991|FG007|Overall Study|Ineligible|0|||
130400837|NCT03107988|469432992|FG008|Overall Study|Ineligible|1|||
130400838|NCT03107988|469432993|FG009|Overall Study|Ineligible|0|||
130400839|NCT03107988|469432994|FG010|Overall Study|Ineligible|0|||
130400840|NCT03107988|469432995|FG011|Overall Study|Ineligible|0|||
130400841|NCT03107988|469432996|FG012|Overall Study|Ineligible|0|||
130400842|NCT02610192|469432998|FG000|Overall Study|Received other treatment|8|||
130400843|NCT02610192|469432998|FG000|Overall Study|Physician Decision|1|||
130400844|NCT00503841|469432999|FG000|Overall Study|All screen failures|44|||
130400845|NCT00326612|469433000|FG000|Overall Study|They did not have a seizure requiring tx|129|||
130400846|NCT00326612|469433001|FG001|Overall Study|They did not have a seizure requiring tx|137|||
130400847|NCT00548808|469433003|FG000|Overall Study|Lost to Follow-up|9|||
130400848|NCT00548808|469433004|FG001|Overall Study|Lost to Follow-up|3|||
130400849|NCT00548808|469433003|FG000|Overall Study|Protocol Violation|8|||
130400850|NCT00548808|469433004|FG001|Overall Study|Protocol Violation|8|||
130400851|NCT00548808|469433003|FG000|Overall Study|Withdrawal by Subject|8|||
130400852|NCT00548808|469433004|FG001|Overall Study|Withdrawal by Subject|4|||
130400853|NCT00548808|469433003|FG000|Overall Study|Physician Decision|6|||
130400854|NCT00548808|469433004|FG001|Overall Study|Physician Decision|3|||
130400855|NCT00548808|469433003|FG000|Overall Study|Adverse Event|4|||
130400856|NCT00548808|469433004|FG001|Overall Study|Adverse Event|5|||
130400857|NCT00548808|469433003|FG000|Overall Study|Death|2|||
130400858|NCT00548808|469433004|FG001|Overall Study|Death|0|||
130400859|NCT00548808|469433003|FG000|Overall Study|Entry Criteria Not Met|2|||
130400860|NCT00548808|469433004|FG001|Overall Study|Entry Criteria Not Met|2|||
130400861|NCT00548808|469433003|FG000|Overall Study|Lack of Efficacy|2|||
130400862|NCT00548808|469433004|FG001|Overall Study|Lack of Efficacy|0|||
130400863|NCT00548808|469433003|FG000|Overall Study|Sponsor Decision|1|||
130400864|NCT00548808|469433004|FG001|Overall Study|Sponsor Decision|1|||
130400865|NCT02177266|469433005|FG000|Overall Study|Adverse Event|0|||
130400866|NCT02177266|469433006|FG001|Overall Study|Adverse Event|1|||
130400867|NCT02177266|469433005|FG000|Overall Study|Withdrawal by Subject|1|||
130400868|NCT02177266|469433006|FG001|Overall Study|Withdrawal by Subject|0|||
130400869|NCT00546715|469433008|FG000|Overall Study|Withdrawal by Subject|0|||
130400870|NCT00546715|469433009|FG001|Overall Study|Withdrawal by Subject|1|||
130400871|NCT00546715|469433010|FG002|Overall Study|Withdrawal by Subject|0|||
130400872|NCT00546715|469433011|FG003|Overall Study|Withdrawal by Subject|0|||
130400873|NCT02331446|469433012|FG000|Overall Study|Lost to Follow-up|2|||
130400874|NCT02331446|469433013|FG001|Overall Study|Lost to Follow-up|1|||
130400875|NCT02331446|469433014|FG002|Overall Study|Lost to Follow-up|0|||
130400876|NCT02331446|469433015|FG003|Overall Study|Lost to Follow-up|1|||
130400877|NCT02331446|469433012|FG000|Overall Study|Personal Problem|2|||
130400878|NCT02331446|469433013|FG001|Overall Study|Personal Problem|0|||
130400879|NCT02331446|469433014|FG002|Overall Study|Personal Problem|0|||
130400880|NCT02331446|469433015|FG003|Overall Study|Personal Problem|0|||
130400881|NCT02331446|469433012|FG000|Overall Study|Disease|0|||
130400882|NCT02331446|469433013|FG001|Overall Study|Disease|2|||
130400883|NCT02331446|469433014|FG002|Overall Study|Disease|2|||
130400884|NCT02331446|469433015|FG003|Overall Study|Disease|1|||
130400885|NCT02331446|469433012|FG000|Overall Study|Physician Decision|0|||
130400886|NCT02331446|469433013|FG001|Overall Study|Physician Decision|1|||
130400887|NCT02331446|469433014|FG002|Overall Study|Physician Decision|0|||
130400888|NCT02331446|469433015|FG003|Overall Study|Physician Decision|1|||
130400889|NCT02331446|469433012|FG000|Overall Study|Lost before baseline analysis|0|||
130400890|NCT02331446|469433013|FG001|Overall Study|Lost before baseline analysis|1|||
130400891|NCT02331446|469433014|FG002|Overall Study|Lost before baseline analysis|1|||
130400892|NCT02331446|469433015|FG003|Overall Study|Lost before baseline analysis|0|||
130400893|NCT03670810|469433024|FG000|Main Study|Adverse Event|37|||
130400894|NCT03670810|469433025|FG001|Main Study|Adverse Event|38|||
130400895|NCT03670810|469433026|FG002|Main Study|Adverse Event|3|||
130400896|NCT03670810|469433027|FG003|Main Study|Adverse Event|4|||
130400897|NCT03670810|469433028|FG004|Main Study|Adverse Event|4|||
130400898|NCT03670810|469433029|FG005|Main Study|Adverse Event|5|||
130400899|NCT03670810|469433030|FG006|Main Study|Adverse Event|0|||
130400900|NCT03670810|469433031|FG007|Main Study|Adverse Event|0|||
130400901|NCT03670810|469433032|FG008|Main Study|Adverse Event|0|||
130400902|NCT03670810|469433024|FG000|Main Study|Lack of Efficacy|8|||
130400903|NCT03670810|469433025|FG001|Main Study|Lack of Efficacy|9|||
130400904|NCT03670810|469433026|FG002|Main Study|Lack of Efficacy|3|||
130400905|NCT03670810|469433027|FG003|Main Study|Lack of Efficacy|4|||
130400906|NCT03670810|469433028|FG004|Main Study|Lack of Efficacy|0|||
130400907|NCT03670810|469433029|FG005|Main Study|Lack of Efficacy|0|||
130400908|NCT03670810|469433030|FG006|Main Study|Lack of Efficacy|0|||
130400909|NCT03670810|469433031|FG007|Main Study|Lack of Efficacy|0|||
130400910|NCT03670810|469433032|FG008|Main Study|Lack of Efficacy|0|||
130400911|NCT03670810|469433024|FG000|Main Study|Lost to Follow-up|9|||
130400912|NCT03670810|469433025|FG001|Main Study|Lost to Follow-up|7|||
130400913|NCT03670810|469433026|FG002|Main Study|Lost to Follow-up|4|||
130400914|NCT03670810|469433027|FG003|Main Study|Lost to Follow-up|6|||
130400915|NCT03670810|469433028|FG004|Main Study|Lost to Follow-up|1|||
130400916|NCT03670810|469433029|FG005|Main Study|Lost to Follow-up|0|||
130400917|NCT03670810|469433030|FG006|Main Study|Lost to Follow-up|0|||
130400918|NCT03670810|469433031|FG007|Main Study|Lost to Follow-up|0|||
130400919|NCT03670810|469433032|FG008|Main Study|Lost to Follow-up|0|||
130400920|NCT03670810|469433024|FG000|Main Study|Non-compliance with Study Drug|0|||
130400921|NCT03670810|469433025|FG001|Main Study|Non-compliance with Study Drug|2|||
130400922|NCT03670810|469433026|FG002|Main Study|Non-compliance with Study Drug|3|||
130400923|NCT03670810|469433027|FG003|Main Study|Non-compliance with Study Drug|0|||
130400924|NCT03670810|469433028|FG004|Main Study|Non-compliance with Study Drug|0|||
130400925|NCT03670810|469433029|FG005|Main Study|Non-compliance with Study Drug|0|||
130400926|NCT03670810|469433030|FG006|Main Study|Non-compliance with Study Drug|0|||
130560714|NCT01301456|470022650|FG000|Stage 1|Withdrawal by Subject|0|||
130560715|NCT01301456|470022651|FG001|Stage 1|Withdrawal by Subject|0|||
130560716|NCT01301456|470022652|FG002|Stage 1|Withdrawal by Subject|1|||
130560717|NCT01301456|470022653|FG003|Stage 1|Withdrawal by Subject|0|||
130560718|NCT01301456|470022654|FG004|Stage 1|Withdrawal by Subject|1|||
130560719|NCT01301456|470022655|FG005|Stage 1|Withdrawal by Subject|0|||
130560720|NCT01301456|470022656|FG006|Stage 1|Withdrawal by Subject|0|||
130560721|NCT01301456|470022657|FG007|Stage 1|Withdrawal by Subject|0|||
130560722|NCT01301456|470022658|FG008|Stage 1|Withdrawal by Subject|0|||
130560723|NCT01301456|470022659|FG009|Stage 1|Withdrawal by Subject|0|||
130560724|NCT01301456|470022660|FG010|Stage 1|Withdrawal by Subject|0|||
130560725|NCT01301456|470022661|FG011|Stage 1|Withdrawal by Subject|0|||
130560726|NCT01301456|470022650|FG000|Stage 1|Randomized but not treated|0|||
130560727|NCT01301456|470022651|FG001|Stage 1|Randomized but not treated|0|||
130560728|NCT01301456|470022652|FG002|Stage 1|Randomized but not treated|0|||
130560729|NCT01301456|470022653|FG003|Stage 1|Randomized but not treated|0|||
130723576|NCT00735397|470613468|FG000|Overall Study|Inadequate therapeutic effect|202|||
130723577|NCT00735397|470613468|FG000|Overall Study|Administrative/Other|502|||
130723578|NCT03016975|470613473|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
130723579|NCT03016975|470613474|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
130400927|NCT03670810|469433031|FG007|Main Study|Non-compliance with Study Drug|1|||
130400928|NCT03670810|469433032|FG008|Main Study|Non-compliance with Study Drug|0|||
130400929|NCT03670810|469433024|FG000|Main Study|Physician Decision|3|||
130400930|NCT03670810|469433025|FG001|Main Study|Physician Decision|0|||
130400931|NCT03670810|469433026|FG002|Main Study|Physician Decision|1|||
130400932|NCT03670810|469433027|FG003|Main Study|Physician Decision|0|||
130400933|NCT03670810|469433028|FG004|Main Study|Physician Decision|0|||
130400934|NCT03670810|469433029|FG005|Main Study|Physician Decision|0|||
130400935|NCT03670810|469433030|FG006|Main Study|Physician Decision|1|||
130400936|NCT03670810|469433031|FG007|Main Study|Physician Decision|1|||
130400937|NCT03670810|469433032|FG008|Main Study|Physician Decision|0|||
130400938|NCT03670810|469433024|FG000|Main Study|Pregnancy|1|||
130400939|NCT03670810|469433025|FG001|Main Study|Pregnancy|2|||
130400940|NCT03670810|469433026|FG002|Main Study|Pregnancy|0|||
130400941|NCT03670810|469433027|FG003|Main Study|Pregnancy|0|||
130400942|NCT03670810|469433028|FG004|Main Study|Pregnancy|0|||
130400943|NCT03670810|469433029|FG005|Main Study|Pregnancy|0|||
130400944|NCT03670810|469433030|FG006|Main Study|Pregnancy|0|||
130400945|NCT03670810|469433031|FG007|Main Study|Pregnancy|0|||
130400946|NCT03670810|469433032|FG008|Main Study|Pregnancy|0|||
130400947|NCT03670810|469433024|FG000|Main Study|Protocol Deviation|2|||
130400948|NCT03670810|469433025|FG001|Main Study|Protocol Deviation|12|||
130400949|NCT03670810|469433026|FG002|Main Study|Protocol Deviation|8|||
130400950|NCT03670810|469433027|FG003|Main Study|Protocol Deviation|4|||
130400951|NCT03670810|469433028|FG004|Main Study|Protocol Deviation|0|||
130400952|NCT03670810|469433029|FG005|Main Study|Protocol Deviation|0|||
130400953|NCT03670810|469433030|FG006|Main Study|Protocol Deviation|0|||
130400954|NCT03670810|469433031|FG007|Main Study|Protocol Deviation|0|||
130400955|NCT03670810|469433032|FG008|Main Study|Protocol Deviation|0|||
130400956|NCT03670810|469433024|FG000|Main Study|Withdrawal by Subject|21|||
130400957|NCT03670810|469433025|FG001|Main Study|Withdrawal by Subject|21|||
130400958|NCT03670810|469433026|FG002|Main Study|Withdrawal by Subject|8|||
130400959|NCT03670810|469433027|FG003|Main Study|Withdrawal by Subject|9|||
130400960|NCT03670810|469433028|FG004|Main Study|Withdrawal by Subject|5|||
130400961|NCT03670810|469433029|FG005|Main Study|Withdrawal by Subject|2|||
130400962|NCT03670810|469433030|FG006|Main Study|Withdrawal by Subject|1|||
130400963|NCT03670810|469433031|FG007|Main Study|Withdrawal by Subject|1|||
130400964|NCT03670810|469433032|FG008|Main Study|Withdrawal by Subject|0|||
130400965|NCT03670810|469433024|FG000|Main Study|Participant did not want to take the three other treatments|1|||
130400966|NCT03670810|469433025|FG001|Main Study|Participant did not want to take the three other treatments|0|||
130560730|NCT01301456|470022654|FG004|Stage 1|Randomized but not treated|0|||
130400967|NCT03670810|469433026|FG002|Main Study|Participant did not want to take the three other treatments|0|||
130400968|NCT03670810|469433027|FG003|Main Study|Participant did not want to take the three other treatments|0|||
130400969|NCT03670810|469433028|FG004|Main Study|Participant did not want to take the three other treatments|0|||
130400970|NCT03670810|469433029|FG005|Main Study|Participant did not want to take the three other treatments|0|||
130400971|NCT03670810|469433030|FG006|Main Study|Participant did not want to take the three other treatments|0|||
130400972|NCT03670810|469433031|FG007|Main Study|Participant did not want to take the three other treatments|0|||
130400973|NCT03670810|469433032|FG008|Main Study|Participant did not want to take the three other treatments|0|||
130400974|NCT03670810|469433024|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130560731|NCT01301456|470022655|FG005|Stage 1|Randomized but not treated|0|||
130400975|NCT03670810|469433025|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
130560732|NCT01301456|470022656|FG006|Stage 1|Randomized but not treated|1|||
130560733|NCT01301456|470022657|FG007|Stage 1|Randomized but not treated|0|||
130560734|NCT01301456|470022658|FG008|Stage 1|Randomized but not treated|0|||
130723580|NCT03016975|470613475|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
130723581|NCT03016975|470613473|FG000|At 6 Months Follow-up|Death|2|||
130400976|NCT03670810|469433026|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400977|NCT03670810|469433027|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400978|NCT03670810|469433028|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400979|NCT03670810|469433029|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400980|NCT03670810|469433030|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400981|NCT03670810|469433031|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400982|NCT03670810|469433032|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130400983|NCT03670810|469433024|FG000|Main Study|Travel and Coronavirus issues|0|||
130400984|NCT03670810|469433025|FG001|Main Study|Travel and Coronavirus issues|0|||
130400985|NCT03670810|469433026|FG002|Main Study|Travel and Coronavirus issues|0|||
130400986|NCT03670810|469433027|FG003|Main Study|Travel and Coronavirus issues|1|||
130400987|NCT03670810|469433028|FG004|Main Study|Travel and Coronavirus issues|0|||
130400988|NCT03670810|469433029|FG005|Main Study|Travel and Coronavirus issues|0|||
130400989|NCT03670810|469433030|FG006|Main Study|Travel and Coronavirus issues|0|||
130400990|NCT03670810|469433031|FG007|Main Study|Travel and Coronavirus issues|0|||
130400991|NCT03670810|469433032|FG008|Main Study|Travel and Coronavirus issues|0|||
130400992|NCT03670810|469433024|FG000|Open Label Extension|Protocol Deviation|0|||
130400993|NCT03670810|469433025|FG001|Open Label Extension|Protocol Deviation|0|||
130400994|NCT03670810|469433026|FG002|Open Label Extension|Protocol Deviation|0|||
130400995|NCT03670810|469433027|FG003|Open Label Extension|Protocol Deviation|0|||
130400996|NCT03670810|469433028|FG004|Open Label Extension|Protocol Deviation|0|||
130400997|NCT03670810|469433029|FG005|Open Label Extension|Protocol Deviation|0|||
130560735|NCT01301456|470022659|FG009|Stage 1|Randomized but not treated|0|||
130560736|NCT01301456|470022660|FG010|Stage 1|Randomized but not treated|0|||
130400998|NCT03670810|469433030|FG006|Open Label Extension|Protocol Deviation|0|||
130400999|NCT03670810|469433031|FG007|Open Label Extension|Protocol Deviation|0|||
130401000|NCT03670810|469433032|FG008|Open Label Extension|Protocol Deviation|5|||
130401001|NCT03670810|469433024|FG000|Open Label Extension|Death|0|||
130401002|NCT03670810|469433025|FG001|Open Label Extension|Death|0|||
130401003|NCT03670810|469433026|FG002|Open Label Extension|Death|0|||
130401004|NCT03670810|469433027|FG003|Open Label Extension|Death|0|||
130401005|NCT03670810|469433028|FG004|Open Label Extension|Death|0|||
130401006|NCT03670810|469433029|FG005|Open Label Extension|Death|0|||
130401007|NCT03670810|469433030|FG006|Open Label Extension|Death|0|||
130401008|NCT03670810|469433031|FG007|Open Label Extension|Death|0|||
130401009|NCT03670810|469433032|FG008|Open Label Extension|Death|1|||
130401010|NCT03670810|469433024|FG000|Open Label Extension|COVID-19|0|||
130401011|NCT03670810|469433025|FG001|Open Label Extension|COVID-19|0|||
130401012|NCT03670810|469433026|FG002|Open Label Extension|COVID-19|0|||
130401013|NCT03670810|469433027|FG003|Open Label Extension|COVID-19|0|||
130401014|NCT03670810|469433028|FG004|Open Label Extension|COVID-19|0|||
130401015|NCT03670810|469433029|FG005|Open Label Extension|COVID-19|0|||
130401016|NCT03670810|469433030|FG006|Open Label Extension|COVID-19|0|||
130401017|NCT03670810|469433031|FG007|Open Label Extension|COVID-19|0|||
130401018|NCT03670810|469433032|FG008|Open Label Extension|COVID-19|1|||
130401019|NCT03670810|469433024|FG000|Open Label Extension|Lack of Efficacy|0|||
130401020|NCT03670810|469433025|FG001|Open Label Extension|Lack of Efficacy|0|||
130401021|NCT03670810|469433026|FG002|Open Label Extension|Lack of Efficacy|0|||
130401022|NCT03670810|469433027|FG003|Open Label Extension|Lack of Efficacy|0|||
130401023|NCT03670810|469433028|FG004|Open Label Extension|Lack of Efficacy|0|||
130401024|NCT03670810|469433029|FG005|Open Label Extension|Lack of Efficacy|0|||
130401025|NCT03670810|469433030|FG006|Open Label Extension|Lack of Efficacy|0|||
130401026|NCT03670810|469433031|FG007|Open Label Extension|Lack of Efficacy|0|||
130401027|NCT03670810|469433032|FG008|Open Label Extension|Lack of Efficacy|39|||
130401028|NCT03670810|469433024|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
130401029|NCT03670810|469433025|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
130401030|NCT03670810|469433026|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
130560737|NCT01301456|470022661|FG011|Stage 1|Randomized but not treated|0|||
130560738|NCT01301456|470022650|FG000|Stage 2|Adverse Event|0|||
130560739|NCT01301456|470022651|FG001|Stage 2|Adverse Event|0|||
130560740|NCT01301456|470022652|FG002|Stage 2|Adverse Event|0|||
130560741|NCT01301456|470022653|FG003|Stage 2|Adverse Event|0|||
130560742|NCT01301456|470022654|FG004|Stage 2|Adverse Event|0|||
130560743|NCT01301456|470022655|FG005|Stage 2|Adverse Event|0|||
130560744|NCT01301456|470022656|FG006|Stage 2|Adverse Event|0|||
130401031|NCT03670810|469433027|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
130401032|NCT03670810|469433028|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
130401033|NCT03670810|469433029|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
130401034|NCT03670810|469433030|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
130401035|NCT03670810|469433031|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
130401036|NCT03670810|469433032|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
130401037|NCT03670810|469433024|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130560745|NCT01301456|470022657|FG007|Stage 2|Adverse Event|0|||
130401038|NCT03670810|469433025|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401039|NCT03670810|469433026|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401040|NCT03670810|469433027|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401041|NCT03670810|469433028|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401042|NCT03670810|469433029|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401043|NCT03670810|469433030|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401044|NCT03670810|469433031|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130401045|NCT03670810|469433032|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
130401046|NCT03670810|469433024|FG000|Open Label Extension|Withdrawal by Subject|0|||
130401047|NCT03670810|469433025|FG001|Open Label Extension|Withdrawal by Subject|0|||
130401048|NCT03670810|469433026|FG002|Open Label Extension|Withdrawal by Subject|0|||
130401049|NCT03670810|469433027|FG003|Open Label Extension|Withdrawal by Subject|0|||
130401050|NCT03670810|469433028|FG004|Open Label Extension|Withdrawal by Subject|0|||
130401051|NCT03670810|469433029|FG005|Open Label Extension|Withdrawal by Subject|0|||
130401052|NCT03670810|469433030|FG006|Open Label Extension|Withdrawal by Subject|0|||
130401053|NCT03670810|469433031|FG007|Open Label Extension|Withdrawal by Subject|0|||
130401054|NCT03670810|469433032|FG008|Open Label Extension|Withdrawal by Subject|46|||
130401055|NCT03670810|469433024|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401056|NCT03670810|469433025|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401057|NCT03670810|469433026|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401058|NCT03670810|469433027|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401059|NCT03670810|469433028|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401060|NCT03670810|469433029|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401061|NCT03670810|469433030|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401062|NCT03670810|469433031|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130401063|NCT03670810|469433032|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
130401064|NCT03670810|469433024|FG000|Open Label Extension|Physician Decision|0|||
130401065|NCT03670810|469433025|FG001|Open Label Extension|Physician Decision|0|||
130401066|NCT03670810|469433026|FG002|Open Label Extension|Physician Decision|0|||
130401067|NCT03670810|469433027|FG003|Open Label Extension|Physician Decision|0|||
130401068|NCT03670810|469433028|FG004|Open Label Extension|Physician Decision|0|||
130401069|NCT03670810|469433029|FG005|Open Label Extension|Physician Decision|0|||
130401070|NCT03670810|469433030|FG006|Open Label Extension|Physician Decision|0|||
130401071|NCT03670810|469433031|FG007|Open Label Extension|Physician Decision|0|||
130401072|NCT03670810|469433032|FG008|Open Label Extension|Physician Decision|2|||
130401073|NCT03670810|469433024|FG000|Open Label Extension|Non-compliance with study drug|0|||
130401074|NCT03670810|469433025|FG001|Open Label Extension|Non-compliance with study drug|0|||
130401075|NCT03670810|469433026|FG002|Open Label Extension|Non-compliance with study drug|0|||
130401076|NCT03670810|469433027|FG003|Open Label Extension|Non-compliance with study drug|0|||
130401077|NCT03670810|469433028|FG004|Open Label Extension|Non-compliance with study drug|0|||
130401078|NCT03670810|469433029|FG005|Open Label Extension|Non-compliance with study drug|0|||
130401079|NCT03670810|469433030|FG006|Open Label Extension|Non-compliance with study drug|0|||
130401080|NCT03670810|469433031|FG007|Open Label Extension|Non-compliance with study drug|0|||
130401081|NCT03670810|469433032|FG008|Open Label Extension|Non-compliance with study drug|5|||
130401082|NCT03670810|469433024|FG000|Open Label Extension|Pregnancy|0|||
130401083|NCT03670810|469433025|FG001|Open Label Extension|Pregnancy|0|||
130401084|NCT03670810|469433026|FG002|Open Label Extension|Pregnancy|0|||
130401085|NCT03670810|469433027|FG003|Open Label Extension|Pregnancy|0|||
130401086|NCT03670810|469433028|FG004|Open Label Extension|Pregnancy|0|||
130401087|NCT03670810|469433029|FG005|Open Label Extension|Pregnancy|0|||
130401088|NCT03670810|469433030|FG006|Open Label Extension|Pregnancy|0|||
130401089|NCT03670810|469433031|FG007|Open Label Extension|Pregnancy|0|||
130401090|NCT03670810|469433032|FG008|Open Label Extension|Pregnancy|3|||
130401091|NCT03670810|469433024|FG000|Open Label Extension|Adverse Event|0|||
130401092|NCT03670810|469433025|FG001|Open Label Extension|Adverse Event|0|||
130401093|NCT03670810|469433026|FG002|Open Label Extension|Adverse Event|0|||
130401094|NCT03670810|469433027|FG003|Open Label Extension|Adverse Event|0|||
130401095|NCT03670810|469433028|FG004|Open Label Extension|Adverse Event|0|||
130401096|NCT03670810|469433029|FG005|Open Label Extension|Adverse Event|0|||
130401097|NCT03670810|469433030|FG006|Open Label Extension|Adverse Event|0|||
130401098|NCT03670810|469433031|FG007|Open Label Extension|Adverse Event|0|||
130401099|NCT03670810|469433032|FG008|Open Label Extension|Adverse Event|24|||
130401100|NCT03670810|469433024|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
130401101|NCT03670810|469433025|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
130401102|NCT03670810|469433026|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
130401103|NCT03670810|469433027|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
130401104|NCT03670810|469433028|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
130401105|NCT03670810|469433029|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
130401106|NCT03670810|469433030|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
130401107|NCT03670810|469433031|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
130401108|NCT03670810|469433032|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
130401109|NCT03670810|469433024|FG000|Open Label Extension|Lost to Follow-up|0|||
130401110|NCT03670810|469433025|FG001|Open Label Extension|Lost to Follow-up|0|||
130401111|NCT03670810|469433026|FG002|Open Label Extension|Lost to Follow-up|0|||
130401112|NCT03670810|469433027|FG003|Open Label Extension|Lost to Follow-up|0|||
130401113|NCT03670810|469433028|FG004|Open Label Extension|Lost to Follow-up|0|||
130401114|NCT03670810|469433029|FG005|Open Label Extension|Lost to Follow-up|0|||
130401115|NCT03670810|469433030|FG006|Open Label Extension|Lost to Follow-up|0|||
130401116|NCT03670810|469433031|FG007|Open Label Extension|Lost to Follow-up|0|||
130401117|NCT03670810|469433032|FG008|Open Label Extension|Lost to Follow-up|23|||
130401118|NCT02644967|469433034|FG000|Overall Study|Death|26|||
130401119|NCT02644967|469433034|FG000|Overall Study|Physician Decision|1|||
130401120|NCT02644967|469433034|FG000|Overall Study|Withdrawal by Subject|2|||
130401121|NCT02644967|469433034|FG000|Overall Study|Protocol Violation|1|||
130401122|NCT02644967|469433034|FG000|Overall Study|Progressive Disease|1|||
130401123|NCT02644967|469433034|FG000|Overall Study|Study Terminated by Sponsor|4|||
130401124|NCT01502644|469433035|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
130401125|NCT01502644|469433036|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130401126|NCT01502644|469433037|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130401127|NCT01502644|469433038|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130401128|NCT01502644|469433035|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
130401129|NCT01502644|469433036|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130401130|NCT01502644|469433037|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130401131|NCT01502644|469433038|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130401132|NCT01502644|469433035|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
130401133|NCT01502644|469433036|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130401134|NCT01502644|469433037|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130401135|NCT01502644|469433038|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130401136|NCT01502644|469433035|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
130401137|NCT01502644|469433036|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
130401138|NCT01502644|469433037|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
130401139|NCT01502644|469433038|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
130401140|NCT01502644|469433035|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
130401141|NCT01502644|469433036|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
130401142|NCT01502644|469433037|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
130401143|NCT01502644|469433038|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
130401144|NCT01552226|469433039|FG000|Overall Study|Withdrawal by Subject|4|||
130401145|NCT01552226|469433040|FG001|Overall Study|Withdrawal by Subject|4|||
130401146|NCT00637195|469433041|FG000|Overall Study|Lost to Follow-up|1|||
130401147|NCT00637195|469433042|FG001|Overall Study|Lost to Follow-up|0|||
130401148|NCT00637195|469433041|FG000|Overall Study|Other|2|||
130401149|NCT00637195|469433042|FG001|Overall Study|Other|0|||
130401150|NCT00637195|469433041|FG000|Overall Study|Withdrawal by Subject|0|||
130401151|NCT00637195|469433042|FG001|Overall Study|Withdrawal by Subject|1|||
130401152|NCT02388997|469433043|FG000|Overall Study|Adverse Event|1|||
130401153|NCT02388997|469433044|FG001|Overall Study|Adverse Event|2|||
130401154|NCT02388997|469433043|FG000|Overall Study|Withdrawal by Subject|2|||
130401155|NCT02388997|469433044|FG001|Overall Study|Withdrawal by Subject|1|||
130401156|NCT02388997|469433043|FG000|Overall Study|Lung function exclusion criteria|0|||
130401157|NCT02388997|469433044|FG001|Overall Study|Lung function exclusion criteria|2|||
130401158|NCT02388997|469433043|FG000|Overall Study|Tested positive for virus during run-in|0|||
130401159|NCT02388997|469433044|FG001|Overall Study|Tested positive for virus during run-in|1|||
130401160|NCT01110915|469433045|FG000|Overall Study|Death|2|||
130401161|NCT01110915|469433046|FG001|Overall Study|Death|1|||
130401162|NCT01110915|469433045|FG000|Overall Study|Lost to Follow-up|1|||
130401163|NCT01110915|469433046|FG001|Overall Study|Lost to Follow-up|0|||
130401164|NCT01110915|469433045|FG000|Overall Study|Withdrawal by Subject|7|||
130401165|NCT01110915|469433046|FG001|Overall Study|Withdrawal by Subject|1|||
130401166|NCT00207142|469433047|FG000|Induction Phase|Adverse Event|9|||
130401167|NCT00207142|469433048|FG001|Induction Phase|Adverse Event|0|||
130401168|NCT00207142|469433049|FG002|Induction Phase|Adverse Event|0|||
130401169|NCT00207142|469433050|FG003|Induction Phase|Adverse Event|0|||
130401170|NCT00207142|469433047|FG000|Induction Phase|Death|1|||
130401171|NCT00207142|469433048|FG001|Induction Phase|Death|0|||
130401172|NCT00207142|469433049|FG002|Induction Phase|Death|0|||
130401173|NCT00207142|469433050|FG003|Induction Phase|Death|0|||
130401174|NCT00207142|469433047|FG000|Induction Phase|Lack of Efficacy|1|||
130401175|NCT00207142|469433048|FG001|Induction Phase|Lack of Efficacy|0|||
130401176|NCT00207142|469433049|FG002|Induction Phase|Lack of Efficacy|0|||
130401177|NCT00207142|469433050|FG003|Induction Phase|Lack of Efficacy|0|||
130401178|NCT00207142|469433047|FG000|Induction Phase|Lost to Follow-up|5|||
130401179|NCT00207142|469433048|FG001|Induction Phase|Lost to Follow-up|0|||
130401180|NCT00207142|469433049|FG002|Induction Phase|Lost to Follow-up|0|||
130401181|NCT00207142|469433050|FG003|Induction Phase|Lost to Follow-up|0|||
130401182|NCT00207142|469433047|FG000|Induction Phase|Physician Decision|2|||
130401183|NCT00207142|469433048|FG001|Induction Phase|Physician Decision|0|||
130401184|NCT00207142|469433049|FG002|Induction Phase|Physician Decision|0|||
130401185|NCT00207142|469433050|FG003|Induction Phase|Physician Decision|0|||
130401186|NCT00207142|469433047|FG000|Induction Phase|Poor/noncompliance|2|||
130401187|NCT00207142|469433048|FG001|Induction Phase|Poor/noncompliance|0|||
130401188|NCT00207142|469433049|FG002|Induction Phase|Poor/noncompliance|0|||
130401189|NCT00207142|469433050|FG003|Induction Phase|Poor/noncompliance|0|||
130401190|NCT00207142|469433047|FG000|Induction Phase|Pregnancy|1|||
130401191|NCT00207142|469433048|FG001|Induction Phase|Pregnancy|0|||
130401192|NCT00207142|469433049|FG002|Induction Phase|Pregnancy|0|||
130401193|NCT00207142|469433050|FG003|Induction Phase|Pregnancy|0|||
130401194|NCT00207142|469433047|FG000|Induction Phase|Subject no longer meets study criteria|3|||
130401195|NCT00207142|469433048|FG001|Induction Phase|Subject no longer meets study criteria|0|||
130401196|NCT00207142|469433049|FG002|Induction Phase|Subject no longer meets study criteria|0|||
130401197|NCT00207142|469433050|FG003|Induction Phase|Subject no longer meets study criteria|0|||
130401198|NCT00207142|469433047|FG000|Induction Phase|Withdrawal by Subject|4|||
130401199|NCT00207142|469433048|FG001|Induction Phase|Withdrawal by Subject|0|||
130401200|NCT00207142|469433049|FG002|Induction Phase|Withdrawal by Subject|0|||
130401201|NCT00207142|469433050|FG003|Induction Phase|Withdrawal by Subject|0|||
130401202|NCT00207142|469433047|FG000|Induction Phase|Incarceration|1|||
130401203|NCT00207142|469433048|FG001|Induction Phase|Incarceration|0|||
130401204|NCT00207142|469433049|FG002|Induction Phase|Incarceration|0|||
130401205|NCT00207142|469433050|FG003|Induction Phase|Incarceration|0|||
130401206|NCT00207142|469433047|FG000|Induction Phase|Missing lab data|1|||
130401207|NCT00207142|469433048|FG001|Induction Phase|Missing lab data|0|||
130401208|NCT00207142|469433049|FG002|Induction Phase|Missing lab data|0|||
130401209|NCT00207142|469433050|FG003|Induction Phase|Missing lab data|0|||
130401210|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
130401211|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
130401212|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
130401213|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
130401214|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
130401215|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
130401216|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
130401217|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
130401218|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130401219|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130401220|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
130401221|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130401222|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
130401223|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
130401224|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
130401225|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
130401226|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
130401227|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
130401228|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
130401229|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
130401230|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130401231|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130401232|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
130401233|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130401234|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
130401235|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
130401236|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
130401237|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
130401238|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Death|0|||
130401239|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Death|0|||
130401240|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Death|0|||
130401241|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Death|1|||
130401242|NCT00207142|469433047|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130401243|NCT00207142|469433048|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130401244|NCT00207142|469433049|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130401245|NCT00207142|469433050|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
130401246|NCT03306264|469433051|FG000|Overall Study|Death|33|||
130401247|NCT03306264|469433052|FG001|Overall Study|Death|25|||
130401248|NCT03306264|469433053|FG002|Overall Study|Death|34|||
130401249|NCT03306264|469433054|FG003|Overall Study|Death|34|||
130401250|NCT03306264|469433051|FG000|Overall Study|Complete Consent Withdrawal|4|||
130401251|NCT03306264|469433052|FG001|Overall Study|Complete Consent Withdrawal|4|||
130401252|NCT03306264|469433053|FG002|Overall Study|Complete Consent Withdrawal|1|||
130401253|NCT03306264|469433054|FG003|Overall Study|Complete Consent Withdrawal|8|||
130401254|NCT03306264|469433051|FG000|Overall Study|Lost to Follow-up|1|||
130401255|NCT03306264|469433052|FG001|Overall Study|Lost to Follow-up|0|||
130401256|NCT03306264|469433053|FG002|Overall Study|Lost to Follow-up|1|||
130401257|NCT03306264|469433054|FG003|Overall Study|Lost to Follow-up|0|||
130401258|NCT03306264|469433051|FG000|Overall Study|Rollover to ASTX727-06|10|||
130401259|NCT03306264|469433052|FG001|Overall Study|Rollover to ASTX727-06|18|||
130401260|NCT03306264|469433053|FG002|Overall Study|Rollover to ASTX727-06|4|||
130401261|NCT03306264|469433054|FG003|Overall Study|Rollover to ASTX727-06|2|||
130401262|NCT03306264|469433051|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
130401263|NCT03306264|469433052|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
130401264|NCT03306264|469433053|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
130401265|NCT03306264|469433054|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
130401266|NCT01822132|469433055|FG000|Overall Study|Lost to Follow-up|4|||
130401267|NCT01822132|469433056|FG001|Overall Study|Lost to Follow-up|2|||
130401268|NCT02519712|469433057|FG000|Overall Study|Disease Relapse|1|||
130401269|NCT02519712|469433057|FG000|Overall Study|Disease Progression|1|||
130401270|NCT02519712|469433057|FG000|Overall Study|Accruals are donors|2|||
130401271|NCT01247090|469433060|FG000|Overall Study|Physician Decision|1|||
130401272|NCT01247090|469433061|FG001|Overall Study|Physician Decision|0|||
130401273|NCT01247090|469433062|FG002|Overall Study|Physician Decision|0|||
130401274|NCT01247090|469433060|FG000|Overall Study|Withdrawal by Subject|0|||
130401275|NCT01247090|469433061|FG001|Overall Study|Withdrawal by Subject|1|||
130401276|NCT01247090|469433062|FG002|Overall Study|Withdrawal by Subject|0|||
130401277|NCT00006916|469433064|FG000|Overall Study|Device not inserted|4|||
130401278|NCT00006916|469433064|FG000|Overall Study|Complication of device insertion|1|||
130401279|NCT03431350|469433068|FG000|Overall Study|ONGOING|0|||
130401280|NCT03431350|469433069|FG001|Overall Study|ONGOING|0|||
130401281|NCT03431350|469433070|FG002|Overall Study|ONGOING|2|||
130401282|NCT03431350|469433071|FG003|Overall Study|ONGOING|0|||
130401283|NCT03431350|469433072|FG004|Overall Study|ONGOING|1|||
130401284|NCT03431350|469433073|FG005|Overall Study|ONGOING|3|||
130401285|NCT03431350|469433074|FG006|Overall Study|ONGOING|0|||
130401286|NCT03431350|469433075|FG007|Overall Study|ONGOING|1|||
130401287|NCT03431350|469433076|FG008|Overall Study|ONGOING|3|||
130401288|NCT03431350|469433077|FG009|Overall Study|ONGOING|4|||
130401289|NCT03431350|469433078|FG010|Overall Study|ONGOING|2|||
130401290|NCT03431350|469433079|FG011|Overall Study|ONGOING|1|||
130401291|NCT03431350|469433068|FG000|Overall Study|Death|6|||
130401292|NCT03431350|469433069|FG001|Overall Study|Death|5|||
130401293|NCT03431350|469433070|FG002|Overall Study|Death|18|||
130401294|NCT03431350|469433071|FG003|Overall Study|Death|7|||
130401295|NCT03431350|469433072|FG004|Overall Study|Death|4|||
130401296|NCT03431350|469433073|FG005|Overall Study|Death|3|||
130401297|NCT03431350|469433074|FG006|Overall Study|Death|2|||
130401298|NCT03431350|469433075|FG007|Overall Study|Death|0|||
130401299|NCT03431350|469433076|FG008|Overall Study|Death|0|||
130401300|NCT03431350|469433077|FG009|Overall Study|Death|0|||
130401301|NCT03431350|469433078|FG010|Overall Study|Death|4|||
130401302|NCT03431350|469433079|FG011|Overall Study|Death|0|||
130401303|NCT03431350|469433068|FG000|Overall Study|Lost to Follow-up|0|||
130401304|NCT03431350|469433069|FG001|Overall Study|Lost to Follow-up|1|||
130401305|NCT03431350|469433070|FG002|Overall Study|Lost to Follow-up|0|||
130401306|NCT03431350|469433071|FG003|Overall Study|Lost to Follow-up|0|||
130401307|NCT03431350|469433072|FG004|Overall Study|Lost to Follow-up|0|||
130401308|NCT03431350|469433073|FG005|Overall Study|Lost to Follow-up|0|||
130401309|NCT03431350|469433074|FG006|Overall Study|Lost to Follow-up|0|||
130401310|NCT03431350|469433075|FG007|Overall Study|Lost to Follow-up|0|||
130401311|NCT03431350|469433076|FG008|Overall Study|Lost to Follow-up|0|||
130401312|NCT03431350|469433077|FG009|Overall Study|Lost to Follow-up|0|||
130401313|NCT03431350|469433078|FG010|Overall Study|Lost to Follow-up|0|||
130401314|NCT03431350|469433079|FG011|Overall Study|Lost to Follow-up|0|||
130401315|NCT03431350|469433068|FG000|Overall Study|Withdrawal by Subject|0|||
130401316|NCT03431350|469433069|FG001|Overall Study|Withdrawal by Subject|0|||
130401317|NCT03431350|469433070|FG002|Overall Study|Withdrawal by Subject|0|||
130401318|NCT03431350|469433071|FG003|Overall Study|Withdrawal by Subject|1|||
130401319|NCT03431350|469433072|FG004|Overall Study|Withdrawal by Subject|1|||
130401320|NCT03431350|469433073|FG005|Overall Study|Withdrawal by Subject|1|||
130401321|NCT03431350|469433074|FG006|Overall Study|Withdrawal by Subject|0|||
130401322|NCT03431350|469433075|FG007|Overall Study|Withdrawal by Subject|0|||
130401323|NCT03431350|469433076|FG008|Overall Study|Withdrawal by Subject|0|||
130401324|NCT03431350|469433077|FG009|Overall Study|Withdrawal by Subject|2|||
130401325|NCT03431350|469433078|FG010|Overall Study|Withdrawal by Subject|0|||
130401326|NCT03431350|469433079|FG011|Overall Study|Withdrawal by Subject|1|||
130401327|NCT03431350|469433068|FG000|Overall Study|Other|0|||
130401328|NCT03431350|469433069|FG001|Overall Study|Other|0|||
130401329|NCT03431350|469433070|FG002|Overall Study|Other|1|||
130401330|NCT03431350|469433071|FG003|Overall Study|Other|3|||
130401331|NCT03431350|469433072|FG004|Overall Study|Other|2|||
130401332|NCT03431350|469433073|FG005|Overall Study|Other|2|||
130401333|NCT03431350|469433074|FG006|Overall Study|Other|4|||
130401334|NCT03431350|469433075|FG007|Overall Study|Other|0|||
130401335|NCT03431350|469433076|FG008|Overall Study|Other|14|||
130401336|NCT03431350|469433077|FG009|Overall Study|Other|11|||
130401337|NCT03431350|469433078|FG010|Overall Study|Other|11|||
130401338|NCT03431350|469433079|FG011|Overall Study|Other|15|||
130401339|NCT00414388|469433080|FG000|Overall Study|Adverse Event|1|||
130401340|NCT03591575|469433082|FG000|Overall Study|Adverse Event|2|||
130401341|NCT03591575|469433083|FG001|Overall Study|Adverse Event|0|||
130401342|NCT03591575|469433082|FG000|Overall Study|Withdrawal by Subject|4|||
130401343|NCT03591575|469433083|FG001|Overall Study|Withdrawal by Subject|1|||
130401344|NCT00218543|469433084|FG000|Overall Study|Lost to Follow-up|8|||
130401345|NCT00218543|469433084|FG000|Overall Study|relocated|1|||
130401346|NCT00218543|469433084|FG000|Overall Study|Withdrawal by Subject|1|||
130401347|NCT00218543|469433084|FG000|Overall Study|Physician Decision|3|||
130401348|NCT00218543|469433084|FG000|Overall Study|Adverse Event|2|||
130401349|NCT01864291|469433085|FG000|Overall Study|need for revision surgery|2|||
130401350|NCT01387607|469433086|FG000|Overall Study|Adverse Event|23|||
130401351|NCT01387607|469433087|FG001|Overall Study|Adverse Event|11|||
130401352|NCT01387607|469433086|FG000|Overall Study|Lack of Efficacy|8|||
130401353|NCT01387607|469433087|FG001|Overall Study|Lack of Efficacy|6|||
130401354|NCT01387607|469433086|FG000|Overall Study|Lost to Follow-up|2|||
130401355|NCT01387607|469433087|FG001|Overall Study|Lost to Follow-up|1|||
130401356|NCT01387607|469433086|FG000|Overall Study|No longer meets eligibility criteria|0|||
130401357|NCT01387607|469433087|FG001|Overall Study|No longer meets eligibility criteria|1|||
130401358|NCT01387607|469433086|FG000|Overall Study|Protocol Violation|1|||
130401359|NCT01387607|469433087|FG001|Overall Study|Protocol Violation|5|||
130401360|NCT01387607|469433086|FG000|Overall Study|Withdrawal by Subject|13|||
130401361|NCT01387607|469433087|FG001|Overall Study|Withdrawal by Subject|14|||
130401362|NCT01387607|469433086|FG000|Overall Study|Other|1|||
130401363|NCT01387607|469433087|FG001|Overall Study|Other|1|||
130401364|NCT01387607|469433086|FG000|Overall Study|Randomized, not treated|3|||
130401365|NCT01387607|469433087|FG001|Overall Study|Randomized, not treated|6|||
130401366|NCT03080961|469433088|FG000|Overall Study|Withdrawal by Subject|3|||
130401367|NCT03665038|469433091|FG000|Overall Study|Lost to Follow-up|0|||
130401368|NCT03665038|469433092|FG001|Overall Study|Lost to Follow-up|0|||
130401369|NCT03665038|469433093|FG002|Overall Study|Lost to Follow-up|1|||
130401370|NCT04579679|469433094|FG000|Overall Study|New Antitumor Therapy|6|||
130401371|NCT04579679|469433095|FG001|Overall Study|New Antitumor Therapy|4|||
130401372|NCT04579679|469433096|FG002|Overall Study|New Antitumor Therapy|7|||
130401373|NCT04579679|469433097|FG003|Overall Study|New Antitumor Therapy|0|||
130401374|NCT04579679|469433094|FG000|Overall Study|Withdrawal of Consent|1|||
130401375|NCT04579679|469433095|FG001|Overall Study|Withdrawal of Consent|1|||
130401376|NCT04579679|469433096|FG002|Overall Study|Withdrawal of Consent|2|||
130401377|NCT04579679|469433097|FG003|Overall Study|Withdrawal of Consent|4|||
130401378|NCT04579679|469433094|FG000|Overall Study|Death|2|||
130401379|NCT04579679|469433095|FG001|Overall Study|Death|2|||
130401380|NCT04579679|469433096|FG002|Overall Study|Death|2|||
130401381|NCT04579679|469433097|FG003|Overall Study|Death|0|||
130401382|NCT04579679|469433094|FG000|Overall Study|Adverse Event|0|||
130401383|NCT04579679|469433095|FG001|Overall Study|Adverse Event|4|||
130401384|NCT04579679|469433096|FG002|Overall Study|Adverse Event|0|||
130401385|NCT04579679|469433097|FG003|Overall Study|Adverse Event|0|||
130401386|NCT04579679|469433094|FG000|Overall Study|Disease Progression|9|||
130401387|NCT04579679|469433095|FG001|Overall Study|Disease Progression|13|||
130401388|NCT04579679|469433096|FG002|Overall Study|Disease Progression|7|||
130401389|NCT04579679|469433097|FG003|Overall Study|Disease Progression|0|||
130401390|NCT04579679|469433094|FG000|Overall Study|Physician Decision|0|||
130401391|NCT04579679|469433095|FG001|Overall Study|Physician Decision|0|||
130401392|NCT04579679|469433096|FG002|Overall Study|Physician Decision|1|||
130401393|NCT04579679|469433097|FG003|Overall Study|Physician Decision|0|||
130401394|NCT04579679|469433094|FG000|Overall Study|Study Terminated by Sponsor|2|||
130401395|NCT04579679|469433095|FG001|Overall Study|Study Terminated by Sponsor|7|||
130723582|NCT03016975|470613474|FG001|At 6 Months Follow-up|Death|0|||
130723583|NCT03016975|470613475|FG002|At 6 Months Follow-up|Death|0|||
130401396|NCT04579679|469433096|FG002|Overall Study|Study Terminated by Sponsor|1|||
130401397|NCT04579679|469433097|FG003|Overall Study|Study Terminated by Sponsor|0|||
130401398|NCT01700179|469434385|FG000|Overall Study|Physician Decision|2|||
130723584|NCT03016975|470613473|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
130723585|NCT03016975|470613474|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130723586|NCT03016975|470613475|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130723587|NCT03016975|470613473|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
130723588|NCT03016975|470613474|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
130723589|NCT03016975|470613475|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
130723590|NCT03016975|470613473|FG000|At 6 Months Follow-up|Aborted implant|1|||
130723591|NCT03016975|470613474|FG001|At 6 Months Follow-up|Aborted implant|0|||
130723592|NCT03016975|470613475|FG002|At 6 Months Follow-up|Aborted implant|0|||
130723593|NCT03016975|470613473|FG000|At 2 Year Follow-up|Death|1|||
130723594|NCT03016975|470613474|FG001|At 2 Year Follow-up|Death|0|||
130723595|NCT03016975|470613475|FG002|At 2 Year Follow-up|Death|0|||
130723596|NCT03016975|470613473|FG000|At 3 Year Follow-up|Death|1|||
130723597|NCT03016975|470613474|FG001|At 3 Year Follow-up|Death|0|||
130723598|NCT03016975|470613475|FG002|At 3 Year Follow-up|Death|0|||
130723599|NCT03016975|470613473|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
130723600|NCT03016975|470613474|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
130723601|NCT03016975|470613475|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
130723602|NCT03016975|470613473|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
130723603|NCT03016975|470613474|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
130723604|NCT03016975|470613475|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
130723605|NCT01590797|470613476|FG000|Overall Study|Adverse Event|4|||
130723606|NCT01590797|470613477|FG001|Overall Study|Adverse Event|3|||
130723607|NCT01590797|470613476|FG000|Overall Study|Lack of Efficacy|0|||
130723608|NCT01590797|470613477|FG001|Overall Study|Lack of Efficacy|2|||
130723609|NCT01590797|470613476|FG000|Overall Study|Lost to Follow-up|0|||
130723610|NCT01590797|470613477|FG001|Overall Study|Lost to Follow-up|1|||
130723611|NCT01590797|470613476|FG000|Overall Study|Protocol Violation|4|||
130723612|NCT01590797|470613477|FG001|Overall Study|Protocol Violation|1|||
130723613|NCT01590797|470613476|FG000|Overall Study|Withdrawal by Subject|7|||
130723614|NCT01590797|470613477|FG001|Overall Study|Withdrawal by Subject|5|||
130723615|NCT01590797|470613476|FG000|Overall Study|Other Protocol Specified Criteria|2|||
130723616|NCT01590797|470613477|FG001|Overall Study|Other Protocol Specified Criteria|4|||
130401399|NCT00679341|469434386|FG000|Overall Study|Disease progression|42|||
130401400|NCT00679341|469434387|FG001|Overall Study|Disease progression|36|||
130401401|NCT00679341|469434386|FG000|Overall Study|Adverse Event|5|||
130401402|NCT00679341|469434387|FG001|Overall Study|Adverse Event|6|||
130401403|NCT00679341|469434386|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
130401404|NCT00679341|469434387|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
130401405|NCT00679341|469434386|FG000|Overall Study|Death|1|||
130401406|NCT00679341|469434387|FG001|Overall Study|Death|1|||
130401407|NCT00679341|469434386|FG000|Overall Study|Other|1|||
130401408|NCT00679341|469434387|FG001|Overall Study|Other|0|||
130401409|NCT00679341|469434386|FG000|Overall Study|Physician Decision|1|||
130470756|NCT05575076|469690815|FG000|Overall Study|Study Terminated by Sponsor|630|||
130470757|NCT05575076|469690815|FG000|Overall Study|Other|17|||
130470758|NCT01127373|469690816|FG000|Overall Study|Not Treated|3|||
130470759|NCT01127373|469690816|FG000|Overall Study|Lost to Follow-up|7|||
130470760|NCT01127373|469690816|FG000|Overall Study|Withdrawal by Subject|1|||
130470761|NCT01127373|469690816|FG000|Overall Study|Disease progression|1|||
130560746|NCT01301456|470022658|FG008|Stage 2|Adverse Event|0|||
130560747|NCT01301456|470022659|FG009|Stage 2|Adverse Event|0|||
130560748|NCT01301456|470022660|FG010|Stage 2|Adverse Event|1|||
130560749|NCT01301456|470022661|FG011|Stage 2|Adverse Event|0|||
130470762|NCT02376790|469690823|FG000|Overall Study|Withdrawal by Subject|43|||
130470763|NCT02376790|469690824|FG001|Overall Study|Withdrawal by Subject|36|||
130470764|NCT02376790|469690825|FG002|Overall Study|Withdrawal by Subject|37|||
130470765|NCT02376790|469690823|FG000|Overall Study|Decision by Sponsor|2|||
130470766|NCT02376790|469690824|FG001|Overall Study|Decision by Sponsor|1|||
130470767|NCT02376790|469690825|FG002|Overall Study|Decision by Sponsor|4|||
130470768|NCT02376790|469690823|FG000|Overall Study|Lost to Follow-up|15|||
130470769|NCT02376790|469690824|FG001|Overall Study|Lost to Follow-up|10|||
130470770|NCT02376790|469690825|FG002|Overall Study|Lost to Follow-up|12|||
130470771|NCT03014453|469690826|FG000|Overall Study|Lost to Follow-up|12|||
130560750|NCT00915772|470022662|FG000|Overall Study|Adverse Event|12|||
130723617|NCT00901576|470613485|FG000|Second Intervention|Withdrawal by Subject|0|||
130723618|NCT00901576|470613486|FG001|Second Intervention|Withdrawal by Subject|0|||
130723619|NCT00901576|470613487|FG002|Second Intervention|Withdrawal by Subject|0|||
130723620|NCT00901576|470613488|FG003|Second Intervention|Withdrawal by Subject|1|||
130470772|NCT03014453|469690826|FG000|Overall Study|Discontinued GER|3|||
130560751|NCT00915772|470022663|FG001|Overall Study|Adverse Event|13|||
130560752|NCT00915772|470022664|FG002|Overall Study|Adverse Event|11|||
130723621|NCT00901576|470613489|FG004|Second Intervention|Withdrawal by Subject|0|||
130560753|NCT00915772|470022662|FG000|Overall Study|Protocol Violation|4|||
130560754|NCT00915772|470022663|FG001|Overall Study|Protocol Violation|1|||
130560755|NCT00915772|470022664|FG002|Overall Study|Protocol Violation|2|||
130560756|NCT00915772|470022662|FG000|Overall Study|Lost to Follow-up|1|||
130560757|NCT00915772|470022663|FG001|Overall Study|Lost to Follow-up|2|||
130560758|NCT00915772|470022664|FG002|Overall Study|Lost to Follow-up|2|||
130560759|NCT00915772|470022662|FG000|Overall Study|Lack of Efficacy|9|||
130560760|NCT00915772|470022663|FG001|Overall Study|Lack of Efficacy|15|||
130560761|NCT00915772|470022664|FG002|Overall Study|Lack of Efficacy|3|||
130560762|NCT00915772|470022662|FG000|Overall Study|Refused to continue trial medication|6|||
130560763|NCT00915772|470022663|FG001|Overall Study|Refused to continue trial medication|8|||
130560764|NCT00915772|470022664|FG002|Overall Study|Refused to continue trial medication|4|||
130560765|NCT00915772|470022662|FG000|Overall Study|Any other reason|4|||
130560766|NCT00915772|470022663|FG001|Overall Study|Any other reason|7|||
130560767|NCT00915772|470022664|FG002|Overall Study|Any other reason|7|||
130560768|NCT01383096|470022667|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130560769|NCT01383096|470022668|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130560770|NCT01383096|470022669|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
130560771|NCT01383096|470022667|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130560772|NCT01383096|470022668|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130560773|NCT01383096|470022669|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130560774|NCT01383096|470022667|FG000|Third Intervention (8 Days)|Elevated AST|0|||
130560775|NCT01383096|470022668|FG001|Third Intervention (8 Days)|Elevated AST|1|||
130560776|NCT01383096|470022669|FG002|Third Intervention (8 Days)|Elevated AST|0|||
130560777|NCT01383096|470022667|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
130560778|NCT01383096|470022668|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
130560779|NCT01383096|470022669|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130560780|NCT01383096|470022667|FG000|Third Intervention (8 Days)|Adverse Event|1|||
130560781|NCT01383096|470022668|FG001|Third Intervention (8 Days)|Adverse Event|0|||
130560782|NCT01383096|470022669|FG002|Third Intervention (8 Days)|Adverse Event|0|||
130560783|NCT01383096|470022667|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
130560784|NCT01383096|470022668|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
130560785|NCT01383096|470022669|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
130560786|NCT01383096|470022667|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
130560787|NCT01383096|470022668|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130723622|NCT00901576|470613490|FG005|Second Intervention|Withdrawal by Subject|1|||
130723623|NCT00901576|470613485|FG000|Second Intervention|Physician Decision|1|||
130723624|NCT00901576|470613486|FG001|Second Intervention|Physician Decision|0|||
130723625|NCT00901576|470613487|FG002|Second Intervention|Physician Decision|0|||
130723626|NCT00901576|470613488|FG003|Second Intervention|Physician Decision|0|||
130723627|NCT00901576|470613489|FG004|Second Intervention|Physician Decision|0|||
130723628|NCT00901576|470613490|FG005|Second Intervention|Physician Decision|0|||
130723629|NCT01559389|470613491|FG000|Overall Study|Withdrawal by Subject|20|||
130723630|NCT01559389|470613492|FG001|Overall Study|Withdrawal by Subject|20|||
130723631|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
130723632|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
130723633|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
130723634|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
130723635|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
130723636|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
130401410|NCT00679341|469434387|FG001|Overall Study|Physician Decision|0|||
130401411|NCT00679341|469434386|FG000|Overall Study|Not treated|0|||
130723637|NCT03201445|470613493|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
130723638|NCT03201445|470613494|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
130401412|NCT00679341|469434387|FG001|Overall Study|Not treated|2|||
130401413|NCT00679341|469434386|FG000|Overall Study|Physician/patient decision to withdraw|0|||
130401414|NCT00679341|469434387|FG001|Overall Study|Physician/patient decision to withdraw|6|||
130401415|NCT00667342|469434388|FG000|Overall Study|Protocol Violation|1|||
130401416|NCT00667342|469434389|FG001|Overall Study|Protocol Violation|0|||
130401417|NCT00667342|469434390|FG002|Overall Study|Protocol Violation|0|||
130401418|NCT00667342|469434388|FG000|Overall Study|Withdrawal by Subject|1|||
130401419|NCT00667342|469434389|FG001|Overall Study|Withdrawal by Subject|0|||
130560788|NCT01383096|470022669|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130401420|NCT00667342|469434390|FG002|Overall Study|Withdrawal by Subject|0|||
130401421|NCT00667342|469434388|FG000|Overall Study|Physician Decision|3|||
130401422|NCT00667342|469434389|FG001|Overall Study|Physician Decision|0|||
130560789|NCT01383096|470022667|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130560790|NCT01383096|470022668|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130560791|NCT01383096|470022669|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130560792|NCT01383096|470022667|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
130401423|NCT00667342|469434390|FG002|Overall Study|Physician Decision|0|||
130401424|NCT00667342|469434388|FG000|Overall Study|Relapse or tumor progression|9|||
130401425|NCT00667342|469434389|FG001|Overall Study|Relapse or tumor progression|0|||
130401426|NCT00667342|469434390|FG002|Overall Study|Relapse or tumor progression|7|||
130401427|NCT00667342|469434388|FG000|Overall Study|Adverse Event|0|||
130401428|NCT00667342|469434389|FG001|Overall Study|Adverse Event|0|||
130401429|NCT00667342|469434390|FG002|Overall Study|Adverse Event|1|||
130401430|NCT00667342|469434388|FG000|Overall Study|Ineligible|0|||
130401431|NCT00667342|469434389|FG001|Overall Study|Ineligible|0|||
130401432|NCT00667342|469434390|FG002|Overall Study|Ineligible|1|||
130401433|NCT01440322|469434393|FG000|Overall Study|Discomfort|2|||
130401434|NCT01440322|469434394|FG001|Overall Study|Discomfort|0|||
130401435|NCT01440322|469434393|FG000|Overall Study|Biomicroscopy|1|||
130401436|NCT01440322|469434394|FG001|Overall Study|Biomicroscopy|0|||
130401437|NCT01440322|469434393|FG000|Overall Study|Symptoms and Problems|1|||
130401438|NCT01440322|469434394|FG001|Overall Study|Symptoms and Problems|0|||
130401439|NCT01440322|469434393|FG000|Overall Study|Unacceptable Subjective Vision|1|||
130401440|NCT01440322|469434394|FG001|Overall Study|Unacceptable Subjective Vision|0|||
130401441|NCT01440322|469434393|FG000|Overall Study|Other Product Related|1|||
130401442|NCT01440322|469434394|FG001|Overall Study|Other Product Related|0|||
130401443|NCT01440322|469434393|FG000|Overall Study|Unrelated Medical Problem|0|||
130401444|NCT01440322|469434394|FG001|Overall Study|Unrelated Medical Problem|1|||
130401445|NCT01440322|469434393|FG000|Overall Study|Other Non-Product Related|1|||
130401446|NCT01440322|469434394|FG001|Overall Study|Other Non-Product Related|0|||
130401447|NCT05044234|469434396|FG000|Overall Study|Lost to Follow-up|2|||
130401448|NCT05044234|469434397|FG001|Overall Study|Lost to Follow-up|1|||
130401449|NCT05044234|469434398|FG002|Overall Study|Lost to Follow-up|1|||
130401450|NCT05044234|469434399|FG003|Overall Study|Lost to Follow-up|2|||
130401451|NCT05044234|469434396|FG000|Overall Study|Withdrawal by Subject|6|||
130401452|NCT05044234|469434397|FG001|Overall Study|Withdrawal by Subject|4|||
130401453|NCT05044234|469434398|FG002|Overall Study|Withdrawal by Subject|5|||
130401454|NCT05044234|469434399|FG003|Overall Study|Withdrawal by Subject|8|||
130401455|NCT05044234|469434396|FG000|Overall Study|Study terminated by Sponsor|21|||
130401456|NCT05044234|469434397|FG001|Overall Study|Study terminated by Sponsor|21|||
130401457|NCT05044234|469434398|FG002|Overall Study|Study terminated by Sponsor|20|||
130401458|NCT05044234|469434399|FG003|Overall Study|Study terminated by Sponsor|14|||
130401459|NCT05044234|469434396|FG000|Overall Study|Other, not specified|0|||
130401460|NCT05044234|469434397|FG001|Overall Study|Other, not specified|0|||
130401461|NCT05044234|469434398|FG002|Overall Study|Other, not specified|1|||
130401462|NCT05044234|469434399|FG003|Overall Study|Other, not specified|2|||
130401463|NCT05044234|469434396|FG000|Overall Study|Delayed data entry|0|||
130401464|NCT05044234|469434397|FG001|Overall Study|Delayed data entry|0|||
130401465|NCT05044234|469434398|FG002|Overall Study|Delayed data entry|0|||
130401466|NCT05044234|469434399|FG003|Overall Study|Delayed data entry|1|||
130401467|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Adverse Event|9|||
130401468|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Adverse Event|2|||
130401469|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
130401470|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
130401471|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
130401472|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
130401473|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Physician Decision|1|||
130401474|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Physician Decision|1|||
130401475|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Pregnancy|2|||
130401476|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Pregnancy|0|||
130401477|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
130401478|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
130401479|NCT02896127|469434400|FG000|COMPLETED WEEK 52|Technical problems|1|||
130401480|NCT02896127|469434401|FG001|COMPLETED WEEK 52|Technical problems|0|||
130401481|NCT02896127|469434400|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
130401482|NCT02896127|469434401|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
130401483|NCT02896127|469434400|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
130401484|NCT02896127|469434401|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
130401485|NCT02896127|469434400|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
130401486|NCT02896127|469434401|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
130401487|NCT02896127|469434400|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
130401488|NCT02896127|469434401|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
130401489|NCT02896127|469434400|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
130401490|NCT02896127|469434401|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
130401491|NCT00279708|469434402|FG000|Overall Study|Withdrawal by Subject|2|||
130470773|NCT03014453|469690826|FG000|Overall Study|Excluded|19|||
130723639|NCT03201445|470613493|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
130723640|NCT03201445|470613494|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
130723641|NCT03201445|470613493|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
130723642|NCT03201445|470613494|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
130723643|NCT03201445|470613493|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
130723644|NCT03201445|470613494|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
130560793|NCT01383096|470022668|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130560794|NCT01383096|470022669|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130560795|NCT01383096|470022667|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
130560796|NCT01383096|470022668|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
130560797|NCT01383096|470022669|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
130560798|NCT01383096|470022667|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
130560799|NCT01383096|470022668|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
130560800|NCT01383096|470022669|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
130401492|NCT00279708|469434403|FG001|Overall Study|Withdrawal by Subject|3|||
130401493|NCT00279708|469434402|FG000|Overall Study|Adverse Event|1|||
130401494|NCT00279708|469434403|FG001|Overall Study|Adverse Event|1|||
130401495|NCT03354429|469434404|FG000|Overall Study|Withdrawal by Subject|8|||
130401496|NCT03354429|469434405|FG001|Overall Study|Withdrawal by Subject|7|||
130401497|NCT03354429|469434404|FG000|Overall Study|Lost to Follow-up|1|||
130401498|NCT03354429|469434405|FG001|Overall Study|Lost to Follow-up|0|||
130401499|NCT02488629|469434406|FG000|Overall Study|Lack of Efficacy|3|||
130401500|NCT02488629|469434407|FG001|Overall Study|Lack of Efficacy|1|||
130401501|NCT02488629|469434408|FG002|Overall Study|Lack of Efficacy|0|||
130401502|NCT02488629|469434409|FG003|Overall Study|Lack of Efficacy|0|||
130401503|NCT02488629|469434406|FG000|Overall Study|Withdrawal by Subject|0|||
130401504|NCT02488629|469434407|FG001|Overall Study|Withdrawal by Subject|1|||
130401505|NCT02488629|469434408|FG002|Overall Study|Withdrawal by Subject|0|||
130401506|NCT02488629|469434409|FG003|Overall Study|Withdrawal by Subject|0|||
130401507|NCT02940691|469434410|FG000|Overall Study|Lost to Follow-up|5|||
130401508|NCT02940691|469434410|FG000|Overall Study|Incarceration|1|||
130401509|NCT03912233|469434411|FG000|Overall Study|Adverse Event|1|||
130401510|NCT03912233|469434412|FG001|Overall Study|Adverse Event|0|||
130401511|NCT03912233|469434413|FG002|Overall Study|Adverse Event|0|||
130401512|NCT03912233|469434414|FG003|Overall Study|Adverse Event|0|||
130401513|NCT03912233|469434415|FG004|Overall Study|Adverse Event|0|||
130401514|NCT03912233|469434416|FG005|Overall Study|Adverse Event|0|||
130401515|NCT03912233|469434411|FG000|Overall Study|Physician Decision|1|||
130401516|NCT03912233|469434412|FG001|Overall Study|Physician Decision|0|||
130401517|NCT03912233|469434413|FG002|Overall Study|Physician Decision|0|||
130401518|NCT03912233|469434414|FG003|Overall Study|Physician Decision|0|||
130401519|NCT03912233|469434415|FG004|Overall Study|Physician Decision|0|||
130401520|NCT03912233|469434416|FG005|Overall Study|Physician Decision|0|||
130401521|NCT03912233|469434411|FG000|Overall Study|Other|0|||
130401522|NCT03912233|469434412|FG001|Overall Study|Other|0|||
130401523|NCT03912233|469434413|FG002|Overall Study|Other|0|||
130560801|NCT01211535|470022670|FG000|Overall Study|Adverse Event|0|||
130560802|NCT01211535|470022671|FG001|Overall Study|Adverse Event|1|||
130401524|NCT03912233|469434414|FG003|Overall Study|Other|0|||
130401525|NCT03912233|469434415|FG004|Overall Study|Other|7|||
130401526|NCT03912233|469434416|FG005|Overall Study|Other|12|||
130401527|NCT00654628|469434417|FG000|6-week Active Treatment Period|Adverse Event|9|||
130401528|NCT00654628|469434417|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
130401529|NCT00654628|469434417|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
130401530|NCT00654628|469434417|FG000|6-week Active Treatment Period|Out of window period|1|||
130401531|NCT00654628|469434417|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
130401532|NCT00654628|469434417|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
130401533|NCT00953329|469434422|FG000|Overall Study|Lack of Efficacy|1|||
130401534|NCT02477020|469434425|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
130401535|NCT02477020|469434426|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130401536|NCT02477020|469434425|FG000|Overall Study|Voluntary Withdrawal|7|||
130401537|NCT02477020|469434426|FG001|Overall Study|Voluntary Withdrawal|16|||
130401538|NCT02477020|469434425|FG000|Overall Study|Reason not Specified|3|||
130401539|NCT02477020|469434426|FG001|Overall Study|Reason not Specified|1|||
130401540|NCT02477020|469434425|FG000|Overall Study|Lack of Efficacy|14|||
130401541|NCT02477020|469434426|FG001|Overall Study|Lack of Efficacy|5|||
130401542|NCT01465802|469434428|FG000|Overall Study|Study terminated by sponsor|1|||
130401543|NCT01465802|469434429|FG001|Overall Study|Study terminated by sponsor|0|||
130401544|NCT01465802|469434430|FG002|Overall Study|Study terminated by sponsor|0|||
130401545|NCT01465802|469434431|FG003|Overall Study|Study terminated by sponsor|1|||
130401546|NCT01465802|469434432|FG004|Overall Study|Study terminated by sponsor|7|||
130401547|NCT01465802|469434428|FG000|Overall Study|Withdrawal by Subject|7|||
130401548|NCT01465802|469434429|FG001|Overall Study|Withdrawal by Subject|7|||
130401549|NCT01465802|469434430|FG002|Overall Study|Withdrawal by Subject|0|||
130401550|NCT01465802|469434431|FG003|Overall Study|Withdrawal by Subject|8|||
130401551|NCT01465802|469434432|FG004|Overall Study|Withdrawal by Subject|1|||
130401552|NCT01465802|469434428|FG000|Overall Study|Lost to Follow-up|1|||
130401553|NCT01465802|469434429|FG001|Overall Study|Lost to Follow-up|1|||
130401554|NCT01465802|469434430|FG002|Overall Study|Lost to Follow-up|0|||
130401555|NCT01465802|469434431|FG003|Overall Study|Lost to Follow-up|0|||
130401556|NCT01465802|469434432|FG004|Overall Study|Lost to Follow-up|0|||
130401557|NCT01465802|469434428|FG000|Overall Study|Reason not specified|9|||
130401558|NCT01465802|469434429|FG001|Overall Study|Reason not specified|4|||
130401559|NCT01465802|469434430|FG002|Overall Study|Reason not specified|0|||
130401560|NCT01465802|469434431|FG003|Overall Study|Reason not specified|10|||
130401561|NCT01465802|469434432|FG004|Overall Study|Reason not specified|2|||
130401562|NCT01465802|469434428|FG000|Overall Study|Death|15|||
130401563|NCT01465802|469434429|FG001|Overall Study|Death|12|||
130401564|NCT01465802|469434430|FG002|Overall Study|Death|0|||
130401565|NCT01465802|469434431|FG003|Overall Study|Death|10|||
130401566|NCT01465802|469434432|FG004|Overall Study|Death|2|||
130401567|NCT01340976|469434433|FG000|Overall Study|Physician Decision|2|||
130401568|NCT01340976|469434434|FG001|Overall Study|Physician Decision|0|||
130401569|NCT01340976|469434435|FG002|Overall Study|Physician Decision|1|||
130401570|NCT01340976|469434436|FG003|Overall Study|Physician Decision|1|||
130401571|NCT01340976|469434437|FG004|Overall Study|Physician Decision|1|||
130401572|NCT01340976|469434438|FG005|Overall Study|Physician Decision|0|||
130401573|NCT01340976|469434433|FG000|Overall Study|Death|0|||
130401574|NCT01340976|469434434|FG001|Overall Study|Death|1|||
130401575|NCT01340976|469434435|FG002|Overall Study|Death|0|||
130401576|NCT01340976|469434436|FG003|Overall Study|Death|0|||
130401577|NCT01340976|469434437|FG004|Overall Study|Death|0|||
130401578|NCT01340976|469434438|FG005|Overall Study|Death|0|||
130401579|NCT01340976|469434433|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
130401580|NCT01340976|469434434|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130401581|NCT01340976|469434435|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130401582|NCT01340976|469434436|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130401583|NCT01340976|469434437|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130401584|NCT01340976|469434438|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130401585|NCT01340976|469434433|FG000|Overall Study|Withdrawal by Subject|0|||
130401586|NCT01340976|469434434|FG001|Overall Study|Withdrawal by Subject|0|||
130401587|NCT01340976|469434435|FG002|Overall Study|Withdrawal by Subject|0|||
130401588|NCT01340976|469434436|FG003|Overall Study|Withdrawal by Subject|1|||
130401589|NCT01340976|469434437|FG004|Overall Study|Withdrawal by Subject|1|||
130401590|NCT01340976|469434438|FG005|Overall Study|Withdrawal by Subject|0|||
130401591|NCT01340976|469434433|FG000|Overall Study|Other anemia treatment|1|||
130401592|NCT01340976|469434434|FG001|Overall Study|Other anemia treatment|0|||
130401593|NCT01340976|469434435|FG002|Overall Study|Other anemia treatment|2|||
130401594|NCT01340976|469434436|FG003|Overall Study|Other anemia treatment|1|||
130401595|NCT01340976|469434437|FG004|Overall Study|Other anemia treatment|0|||
130401596|NCT01340976|469434438|FG005|Overall Study|Other anemia treatment|1|||
130401597|NCT01340976|469434433|FG000|Overall Study|Adverse Event|0|||
130401598|NCT01340976|469434434|FG001|Overall Study|Adverse Event|1|||
130401599|NCT01340976|469434435|FG002|Overall Study|Adverse Event|0|||
130401600|NCT01340976|469434436|FG003|Overall Study|Adverse Event|0|||
130401601|NCT01340976|469434437|FG004|Overall Study|Adverse Event|0|||
130401602|NCT01340976|469434438|FG005|Overall Study|Adverse Event|0|||
130401603|NCT01358981|469434439|FG000|Period 1|Withdrawal by Subject|0|||
130401604|NCT01358981|469434440|FG001|Period 1|Withdrawal by Subject|0|||
130401605|NCT01358981|469434441|FG002|Period 1|Withdrawal by Subject|0|||
130401606|NCT01358981|469434442|FG003|Period 1|Withdrawal by Subject|1|||
130401607|NCT01358981|469434443|FG004|Period 1|Withdrawal by Subject|0|||
130401608|NCT01358981|469434444|FG005|Period 1|Withdrawal by Subject|0|||
130401609|NCT01358981|469434445|FG006|Period 1|Withdrawal by Subject|0|||
130401610|NCT03025828|469434455|FG000|Overall Study|Lost to Follow-up|1|||
130401611|NCT01020019|469434456|FG000|Overall Study|Lost to Follow-up|21|||
130401612|NCT01020019|469434457|FG001|Overall Study|Lost to Follow-up|18|||
130401613|NCT01020019|469434456|FG000|Overall Study|Adverse Event|1|||
130401614|NCT01020019|469434457|FG001|Overall Study|Adverse Event|5|||
130401615|NCT01020019|469434456|FG000|Overall Study|not interested in treatment|4|||
130401616|NCT01020019|469434457|FG001|Overall Study|not interested in treatment|4|||
130401617|NCT01020019|469434456|FG000|Overall Study|moving|0|||
130401618|NCT01020019|469434457|FG001|Overall Study|moving|2|||
130401619|NCT04958109|469434458|FG000|Overall Study|Withdrawal by Subject|0|||
130401620|NCT04958109|469434459|FG001|Overall Study|Withdrawal by Subject|1|||
130401621|NCT04958109|469434458|FG000|Overall Study|Lost to Follow-up|0|||
130401622|NCT04958109|469434459|FG001|Overall Study|Lost to Follow-up|1|||
130401623|NCT02214121|469434460|FG000|Part A|Patient decision|2|||
130401624|NCT02214121|469434461|FG001|Part A|Patient decision|0|||
130401625|NCT02214121|469434462|FG002|Part A|Patient decision|0|||
130401626|NCT02214121|469434460|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
130401627|NCT02214121|469434461|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
130401628|NCT02214121|469434462|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
130401629|NCT02214121|469434460|FG000|Part A|Other|1|||
130401630|NCT02214121|469434461|FG001|Part A|Other|0|||
130401631|NCT02214121|469434462|FG002|Part A|Other|0|||
130401632|NCT02214121|469434460|FG000|Part B|Patient decision|0|||
130401633|NCT02214121|469434461|FG001|Part B|Patient decision|1|||
130401634|NCT02214121|469434462|FG002|Part B|Patient decision|0|||
130401635|NCT02214121|469434460|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
130401636|NCT02214121|469434461|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
130723645|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
130401637|NCT02214121|469434462|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
130401638|NCT02214121|469434460|FG000|Part B|Lost to Follow-up|0|||
130401639|NCT02214121|469434461|FG001|Part B|Lost to Follow-up|0|||
130401640|NCT02214121|469434462|FG002|Part B|Lost to Follow-up|1|||
130401641|NCT00715793|469434463|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
130401642|NCT00715793|469434464|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
130401643|NCT00715793|469434463|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
130401644|NCT00715793|469434464|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
130401645|NCT01849588|469434467|FG000|Overall Study|Lack of Efficacy|3|||
130401646|NCT03417141|469434469|FG000|Overall Study|Withdrawal by Subject|1|||
130723646|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
130723647|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
130723648|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
130723649|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
130723650|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
130723651|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130723652|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130723653|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
130723654|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
130723655|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
130723656|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
130723657|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
130723658|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
130723659|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
130723660|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
130723661|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130723662|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130723663|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
130723664|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
130723665|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
130723666|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
130723667|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130723668|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130723669|NCT03201445|470613493|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130723670|NCT03201445|470613494|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130723671|NCT03201445|470613493|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
130723672|NCT03201445|470613494|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
130723673|NCT01228019|470613495|FG000|Overall Study|Dose Violation|70|||
130723674|NCT01228019|470613495|FG000|Overall Study|Duplicate enrollment|1|||
130723675|NCT01228019|470613495|FG000|Overall Study|Missing pre-treatment data|72|||
130723676|NCT01228019|470613495|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
130723677|NCT01228019|470613495|FG000|Overall Study|Violation of Entry Criterion|9|||
130723678|NCT01346293|470613498|FG000|Overall Study|Protocol Violation|30|||
130723679|NCT01346293|470613499|FG001|Overall Study|Protocol Violation|9|||
130723680|NCT01346293|470613498|FG000|Overall Study|Lost to Follow-up|21|||
130723681|NCT01346293|470613499|FG001|Overall Study|Lost to Follow-up|8|||
130723682|NCT01346293|470613498|FG000|Overall Study|Withdrawal by Subject|15|||
130401647|NCT03417141|469434469|FG000|Overall Study|Protocol Violation|3|||
130401648|NCT03706690|469434471|FG000|Overall Study|Withdrawal by Subject|8|||
130401649|NCT03706690|469434472|FG001|Overall Study|Withdrawal by Subject|8|||
130401650|NCT03706690|469434471|FG000|Overall Study|Death|143|||
130401651|NCT03706690|469434472|FG001|Overall Study|Death|75|||
130401652|NCT03706690|469434471|FG000|Overall Study|Ongoing at DCO|121|||
130401653|NCT03706690|469434472|FG001|Overall Study|Ongoing at DCO|52|||
130401654|NCT02098109|469434473|FG000|Overall Study|Protocol Violation|3|||
130401655|NCT02098109|469434474|FG001|Overall Study|Protocol Violation|0|||
130401656|NCT02143843|469434475|FG000|Overall Study|Adverse Event|8|||
130401657|NCT02143843|469434475|FG000|Overall Study|Lack of Efficacy|2|||
130401658|NCT02143843|469434475|FG000|Overall Study|Withdrawal by Subject|2|||
130401659|NCT03385239|469434485|FG000|Overall Study|Voluntary Withdrawal|2|||
130401660|NCT03385239|469434486|FG001|Overall Study|Voluntary Withdrawal|3|||
130401661|NCT03385239|469434487|FG002|Overall Study|Voluntary Withdrawal|2|||
130560803|NCT03593850|470022674|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
130401662|NCT03385239|469434488|FG003|Overall Study|Voluntary Withdrawal|3|||
130401663|NCT03385239|469434489|FG004|Overall Study|Voluntary Withdrawal|0|||
130401664|NCT03385239|469434485|FG000|Overall Study|Adverse Event|0|||
130401665|NCT03385239|469434486|FG001|Overall Study|Adverse Event|0|||
130401666|NCT03385239|469434487|FG002|Overall Study|Adverse Event|1|||
130401667|NCT03385239|469434488|FG003|Overall Study|Adverse Event|0|||
130401668|NCT03385239|469434489|FG004|Overall Study|Adverse Event|0|||
130401669|NCT03385239|469434485|FG000|Overall Study|Other|0|||
130401670|NCT03385239|469434486|FG001|Overall Study|Other|0|||
130401671|NCT03385239|469434487|FG002|Overall Study|Other|0|||
130401672|NCT03385239|469434488|FG003|Overall Study|Other|1|||
130401673|NCT03385239|469434489|FG004|Overall Study|Other|0|||
130401674|NCT01574703|469434490|FG000|Overall Study|Adverse Event|0|||
130401675|NCT01574703|469434491|FG001|Overall Study|Adverse Event|2|||
130401676|NCT01574703|469434492|FG002|Overall Study|Adverse Event|1|||
130401677|NCT01574703|469434493|FG003|Overall Study|Adverse Event|1|||
130401678|NCT01574703|469434490|FG000|Overall Study|Protocol Violation|0|||
130401679|NCT01574703|469434491|FG001|Overall Study|Protocol Violation|0|||
130401680|NCT01574703|469434492|FG002|Overall Study|Protocol Violation|0|||
130401681|NCT01574703|469434493|FG003|Overall Study|Protocol Violation|1|||
130401682|NCT01574703|469434490|FG000|Overall Study|Unspecified Reason|27|||
130401683|NCT01574703|469434491|FG001|Overall Study|Unspecified Reason|15|||
130401684|NCT01574703|469434492|FG002|Overall Study|Unspecified Reason|20|||
130401685|NCT01574703|469434493|FG003|Overall Study|Unspecified Reason|16|||
130401686|NCT01574703|469434490|FG000|Overall Study|Withdrawal by Subject|53|||
130401687|NCT01574703|469434491|FG001|Overall Study|Withdrawal by Subject|52|||
130401688|NCT01574703|469434492|FG002|Overall Study|Withdrawal by Subject|36|||
130401689|NCT01574703|469434493|FG003|Overall Study|Withdrawal by Subject|61|||
130401690|NCT01574703|469434490|FG000|Overall Study|Met Withdrawal Criteria|0|||
130401691|NCT01574703|469434491|FG001|Overall Study|Met Withdrawal Criteria|1|||
130401692|NCT01574703|469434492|FG002|Overall Study|Met Withdrawal Criteria|1|||
130401693|NCT01574703|469434493|FG003|Overall Study|Met Withdrawal Criteria|0|||
130401694|NCT01574703|469434490|FG000|Overall Study|Lost to Follow-up|43|||
130401695|NCT01574703|469434491|FG001|Overall Study|Lost to Follow-up|41|||
130401696|NCT01574703|469434492|FG002|Overall Study|Lost to Follow-up|46|||
130401697|NCT01574703|469434493|FG003|Overall Study|Lost to Follow-up|35|||
130401698|NCT01574703|469434490|FG000|Overall Study|Death|2|||
130401699|NCT01574703|469434491|FG001|Overall Study|Death|1|||
130401700|NCT01574703|469434492|FG002|Overall Study|Death|1|||
130401701|NCT01574703|469434493|FG003|Overall Study|Death|0|||
130401702|NCT01524770|469434494|FG000|First Intervention|Withdrawal by Subject|1|||
130401703|NCT01524770|469434495|FG001|First Intervention|Withdrawal by Subject|0|||
130401704|NCT01524770|469434494|FG000|First Intervention|Adverse Event|1|||
130401705|NCT01524770|469434495|FG001|First Intervention|Adverse Event|1|||
130401706|NCT01524770|469434494|FG000|First Intervention|Protocol Violation|1|||
130401707|NCT01524770|469434495|FG001|First Intervention|Protocol Violation|0|||
130401708|NCT03467425|469434496|FG000|Overall Study|Adverse Event|9|||
130401709|NCT03467425|469434497|FG001|Overall Study|Adverse Event|9|||
130401710|NCT03467425|469434496|FG000|Overall Study|Lack of Efficacy|3|||
130401711|NCT03467425|469434497|FG001|Overall Study|Lack of Efficacy|1|||
130401712|NCT03467425|469434496|FG000|Overall Study|Protocol Violation|0|||
130401713|NCT03467425|469434497|FG001|Overall Study|Protocol Violation|1|||
130401714|NCT03467425|469434496|FG000|Overall Study|Lost to Follow-up|18|||
130401715|NCT03467425|469434497|FG001|Overall Study|Lost to Follow-up|25|||
130401716|NCT03467425|469434496|FG000|Overall Study|Physician Decision|2|||
130401717|NCT03467425|469434497|FG001|Overall Study|Physician Decision|1|||
130401718|NCT03467425|469434496|FG000|Overall Study|Withdrawal by Subject|15|||
130401719|NCT03467425|469434497|FG001|Overall Study|Withdrawal by Subject|17|||
130401720|NCT02318693|469434498|FG000|Overall Study|Protocol Violation|0|||
130401721|NCT02318693|469434499|FG001|Overall Study|Protocol Violation|1|||
130401722|NCT01282216|469434500|FG000|Overall Study|Graft failure|0|||
130401723|NCT01282216|469434501|FG001|Overall Study|Graft failure|0|||
130401724|NCT01282216|469434502|FG002|Overall Study|Graft failure|3|||
130401725|NCT01282216|469434503|FG003|Overall Study|Graft failure|2|||
130401726|NCT01282216|469434500|FG000|Overall Study|Physician Decision|0|||
130401727|NCT01282216|469434501|FG001|Overall Study|Physician Decision|0|||
130401728|NCT01282216|469434502|FG002|Overall Study|Physician Decision|11|||
130401729|NCT01282216|469434503|FG003|Overall Study|Physician Decision|0|||
130401730|NCT01282216|469434500|FG000|Overall Study|Relapse|0|||
130401731|NCT01282216|469434501|FG001|Overall Study|Relapse|0|||
130401732|NCT01282216|469434502|FG002|Overall Study|Relapse|17|||
130401733|NCT01282216|469434503|FG003|Overall Study|Relapse|6|||
130401734|NCT01282216|469434500|FG000|Overall Study|Death|0|||
130401735|NCT01282216|469434501|FG001|Overall Study|Death|0|||
130401736|NCT01282216|469434502|FG002|Overall Study|Death|2|||
130401737|NCT01282216|469434503|FG003|Overall Study|Death|0|||
130401738|NCT03492177|469434508|FG000|Overall Study|Adverse Event|1|||
130401739|NCT03492177|469434509|FG001|Overall Study|Adverse Event|0|||
130401740|NCT03492177|469434510|FG002|Overall Study|Adverse Event|0|||
130401741|NCT03492177|469434508|FG000|Overall Study|Death|3|||
130401742|NCT03492177|469434509|FG001|Overall Study|Death|0|||
130401743|NCT03492177|469434510|FG002|Overall Study|Death|3|||
130401744|NCT03492177|469434508|FG000|Overall Study|Lack of Efficacy|1|||
130401745|NCT03492177|469434509|FG001|Overall Study|Lack of Efficacy|2|||
130401746|NCT03492177|469434510|FG002|Overall Study|Lack of Efficacy|0|||
130401747|NCT03492177|469434508|FG000|Overall Study|Other|1|||
130401748|NCT03492177|469434509|FG001|Overall Study|Other|0|||
130401749|NCT03492177|469434510|FG002|Overall Study|Other|0|||
130401750|NCT03492177|469434508|FG000|Overall Study|Ongoing|16|||
130401751|NCT03492177|469434509|FG001|Overall Study|Ongoing|19|||
130401752|NCT03492177|469434510|FG002|Overall Study|Ongoing|17|||
130401753|NCT04745689|469434511|FG000|Overall Study|Death|9|||
130401754|NCT04745689|469434512|FG001|Overall Study|Death|6|||
130401755|NCT04745689|469434511|FG000|Overall Study|Lost to Follow-up|1|||
130401756|NCT04745689|469434512|FG001|Overall Study|Lost to Follow-up|0|||
130401757|NCT04745689|469434511|FG000|Overall Study|Withdrawal by Subject|2|||
130401758|NCT04745689|469434512|FG001|Overall Study|Withdrawal by Subject|0|||
130401759|NCT04745689|469434511|FG000|Overall Study|Study terminated by sponsor|10|||
130401760|NCT04745689|469434512|FG001|Overall Study|Study terminated by sponsor|3|||
130401761|NCT03238911|469434513|FG000|Overall Study|Withdrawal by Subject|1|||
130401762|NCT03238911|469434514|FG001|Overall Study|Withdrawal by Subject|2|||
130401763|NCT03238911|469434513|FG000|Overall Study|Lost to Follow-up|2|||
130401764|NCT03238911|469434514|FG001|Overall Study|Lost to Follow-up|1|||
130401765|NCT02239536|469434515|FG000|Overall Study|Non-neoplastic polyp|23|||
130401766|NCT02239536|469434516|FG001|Overall Study|Non-neoplastic polyp|17|||
130401767|NCT01038778|469434517|FG000|Overall Study|Withdrawal by Subject|0|||
130401768|NCT01038778|469434518|FG001|Overall Study|Withdrawal by Subject|2|||
130401769|NCT01038778|469434519|FG002|Overall Study|Withdrawal by Subject|3|||
130401770|NCT03285646|469436260|FG000|Overall Study|Adverse Event|1|||
130401771|NCT03285646|469436261|FG001|Overall Study|Adverse Event|0|||
130401772|NCT03285646|469436260|FG000|Overall Study|Withdrawal by Subject|10|||
130401773|NCT03285646|469436261|FG001|Overall Study|Withdrawal by Subject|2|||
130401774|NCT03285646|469436260|FG000|Overall Study|Lost to Follow-up|2|||
130401775|NCT03285646|469436261|FG001|Overall Study|Lost to Follow-up|1|||
130401776|NCT03285646|469436260|FG000|Overall Study|Investigator/Sponsor Decision|0|||
130401777|NCT03285646|469436261|FG001|Overall Study|Investigator/Sponsor Decision|1|||
130401778|NCT01344057|469436262|FG000|Overall Study|Premature Withdrawal|1|||
130401779|NCT00306592|469436263|FG000|Overall Study|Adverse Event|8|||
130401780|NCT00306592|469436264|FG001|Overall Study|Adverse Event|15|||
130401781|NCT00306592|469436263|FG000|Overall Study|Lost to Follow-up|1|||
130401782|NCT00306592|469436264|FG001|Overall Study|Lost to Follow-up|0|||
130401783|NCT00306592|469436263|FG000|Overall Study|Noncompliance|0|||
130401784|NCT00306592|469436264|FG001|Overall Study|Noncompliance|2|||
130401785|NCT00306592|469436263|FG000|Overall Study|Persistent Antibodies|6|||
130401786|NCT00306592|469436264|FG001|Overall Study|Persistent Antibodies|3|||
130401787|NCT00306592|469436263|FG000|Overall Study|Voluntary|10|||
130401788|NCT00306592|469436264|FG001|Overall Study|Voluntary|6|||
130401789|NCT00306592|469436263|FG000|Overall Study|Other|5|||
130401790|NCT00306592|469436264|FG001|Overall Study|Other|10|||
130401791|NCT00306592|469436263|FG000|Overall Study|Other|1|||
130401792|NCT00306592|469436264|FG001|Overall Study|Other|2|||
130401793|NCT00306592|469436263|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
130401794|NCT00306592|469436264|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
130401795|NCT03592641|469436267|FG000|Overall Study|Withdrawal by Subject|1|||
130401796|NCT00436280|469436268|FG000|Period 1: Induction|Adverse Event|8|||
130401797|NCT00436280|469436268|FG000|Period 1: Induction|Progressive Disease|12|||
130401798|NCT00436280|469436268|FG000|Period 1: Induction|Stable Disease|6|||
130401799|NCT00436280|469436268|FG000|Period 1: Induction|Withdrawal by Subject|1|||
130401800|NCT00436280|469436268|FG000|Period 1: Induction|Death|1|||
130401801|NCT00436280|469436268|FG000|Period 2: Consolidation|Adverse Event|1|||
130401802|NCT00436280|469436268|FG000|Period 2: Consolidation|Progressive Disease|10|||
130401803|NCT00436280|469436268|FG000|Period 2: Consolidation|Stable Disease|1|||
130401804|NCT00436280|469436268|FG000|Period 2: Consolidation|Physician Decision|2|||
130401805|NCT00436280|469436268|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
130401806|NCT00436280|469436268|FG000|Period 2: Consolidation|Death|1|||
130401807|NCT00436280|469436268|FG000|Period 3: Maintenance|Adverse Event|6|||
130401808|NCT00436280|469436268|FG000|Period 3: Maintenance|Progressive Disease|12|||
130401809|NCT01049919|469436272|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
130401810|NCT01049919|469436273|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
130401811|NCT01049919|469436272|FG000|Overall Study|Withdrawal by Subject|5|||
130401812|NCT01049919|469436273|FG001|Overall Study|Withdrawal by Subject|0|||
130401813|NCT01049919|469436272|FG000|Overall Study|Lost to Follow-up|6|||
130401814|NCT01049919|469436273|FG001|Overall Study|Lost to Follow-up|1|||
130401815|NCT01049919|469436272|FG000|Overall Study|Physician Decision|2|||
130401816|NCT01049919|469436273|FG001|Overall Study|Physician Decision|0|||
130401817|NCT01049919|469436272|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
130401818|NCT01049919|469436273|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
130401819|NCT01049919|469436272|FG000|Overall Study|Early study termination by sponsor.|2|||
130401820|NCT01049919|469436273|FG001|Overall Study|Early study termination by sponsor.|0|||
130401821|NCT02566759|469436277|FG000|All Parts|Withdrawal by Subject|0|||
130401822|NCT02566759|469436278|FG001|All Parts|Withdrawal by Subject|1|||
130401823|NCT02566759|469436279|FG002|All Parts|Withdrawal by Subject|0|||
130401824|NCT02566759|469436280|FG003|All Parts|Withdrawal by Subject|0|||
130723683|NCT01346293|470613499|FG001|Overall Study|Withdrawal by Subject|4|||
130401825|NCT02566759|469436281|FG004|All Parts|Withdrawal by Subject|0|||
130401826|NCT02566759|469436282|FG005|All Parts|Withdrawal by Subject|0|||
130401827|NCT02566759|469436283|FG006|All Parts|Withdrawal by Subject|0|||
130401828|NCT02566759|469436284|FG007|All Parts|Withdrawal by Subject|0|||
130401829|NCT02566759|469436285|FG008|All Parts|Withdrawal by Subject|0|||
130401830|NCT02566759|469436286|FG009|All Parts|Withdrawal by Subject|0|||
130401831|NCT02566759|469436287|FG010|All Parts|Withdrawal by Subject|0|||
130401832|NCT02566759|469436288|FG011|All Parts|Withdrawal by Subject|0|||
130401833|NCT02566759|469436289|FG012|All Parts|Withdrawal by Subject|0|||
130401834|NCT02566759|469436290|FG013|All Parts|Withdrawal by Subject|0|||
130401835|NCT02566759|469436291|FG014|All Parts|Withdrawal by Subject|0|||
130401836|NCT02566759|469436292|FG015|All Parts|Withdrawal by Subject|0|||
130401837|NCT02566759|469436293|FG016|All Parts|Withdrawal by Subject|0|||
130401838|NCT02566759|469436277|FG000|All Parts|Adverse Event|0|||
130401839|NCT02566759|469436278|FG001|All Parts|Adverse Event|0|||
130401840|NCT02566759|469436279|FG002|All Parts|Adverse Event|0|||
130401841|NCT02566759|469436280|FG003|All Parts|Adverse Event|0|||
130401842|NCT02566759|469436281|FG004|All Parts|Adverse Event|0|||
130401843|NCT02566759|469436282|FG005|All Parts|Adverse Event|0|||
130401844|NCT02566759|469436283|FG006|All Parts|Adverse Event|0|||
130401845|NCT02566759|469436284|FG007|All Parts|Adverse Event|0|||
130401846|NCT02566759|469436285|FG008|All Parts|Adverse Event|0|||
130401847|NCT02566759|469436286|FG009|All Parts|Adverse Event|0|||
130401848|NCT02566759|469436287|FG010|All Parts|Adverse Event|0|||
130401849|NCT02566759|469436288|FG011|All Parts|Adverse Event|0|||
130401850|NCT02566759|469436289|FG012|All Parts|Adverse Event|1|||
130401851|NCT02566759|469436290|FG013|All Parts|Adverse Event|3|||
130401852|NCT02566759|469436291|FG014|All Parts|Adverse Event|0|||
130401853|NCT02566759|469436292|FG015|All Parts|Adverse Event|0|||
130401854|NCT02566759|469436293|FG016|All Parts|Adverse Event|0|||
130401855|NCT02566759|469436277|FG000|All Parts|Other|0|||
130401856|NCT02566759|469436278|FG001|All Parts|Other|0|||
130401857|NCT02566759|469436279|FG002|All Parts|Other|0|||
130401858|NCT02566759|469436280|FG003|All Parts|Other|0|||
130401859|NCT02566759|469436281|FG004|All Parts|Other|0|||
130401860|NCT02566759|469436282|FG005|All Parts|Other|0|||
130401861|NCT02566759|469436283|FG006|All Parts|Other|0|||
130401862|NCT02566759|469436284|FG007|All Parts|Other|0|||
130401863|NCT02566759|469436285|FG008|All Parts|Other|0|||
130401864|NCT02566759|469436286|FG009|All Parts|Other|0|||
130401865|NCT02566759|469436287|FG010|All Parts|Other|0|||
130401866|NCT02566759|469436288|FG011|All Parts|Other|0|||
130401867|NCT02566759|469436289|FG012|All Parts|Other|0|||
130401868|NCT02566759|469436290|FG013|All Parts|Other|2|||
130401869|NCT02566759|469436291|FG014|All Parts|Other|0|||
130401870|NCT02566759|469436292|FG015|All Parts|Other|0|||
130401871|NCT02566759|469436293|FG016|All Parts|Other|0|||
130401872|NCT02566759|469436277|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401873|NCT02566759|469436278|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401874|NCT02566759|469436279|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401875|NCT02566759|469436280|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401876|NCT02566759|469436281|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401877|NCT02566759|469436282|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401878|NCT02566759|469436283|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401879|NCT02566759|469436284|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401880|NCT02566759|469436285|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401881|NCT02566759|469436286|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401882|NCT02566759|469436287|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401883|NCT02566759|469436288|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401884|NCT02566759|469436289|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401885|NCT02566759|469436290|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401886|NCT02566759|469436291|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401887|NCT02566759|469436292|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130401888|NCT02566759|469436293|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
130401889|NCT01126541|469436294|FG000|Overall Study|Adverse Event|0|||
130401890|NCT01126541|469436295|FG001|Overall Study|Adverse Event|2|||
130560804|NCT03593850|470022675|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
130560805|NCT01735279|470022676|FG000|Overall Study|Lost to Follow-up|11|||
130723684|NCT01346293|470613498|FG000|Overall Study|Other|1|||
130401891|NCT01126541|469436296|FG002|Overall Study|Adverse Event|4|||
130401892|NCT01126541|469436294|FG000|Overall Study|Death|0|||
130401893|NCT01126541|469436295|FG001|Overall Study|Death|1|||
130401894|NCT01126541|469436296|FG002|Overall Study|Death|0|||
130401895|NCT01126541|469436294|FG000|Overall Study|Lack of Efficacy|6|||
130401896|NCT01126541|469436295|FG001|Overall Study|Lack of Efficacy|1|||
130401897|NCT01126541|469436296|FG002|Overall Study|Lack of Efficacy|11|||
130401898|NCT01126541|469436294|FG000|Overall Study|Lost to Follow-up|1|||
130401899|NCT01126541|469436295|FG001|Overall Study|Lost to Follow-up|2|||
130401900|NCT01126541|469436296|FG002|Overall Study|Lost to Follow-up|2|||
130401901|NCT01126541|469436294|FG000|Overall Study|Withdrawal by Subject|2|||
130401902|NCT01126541|469436295|FG001|Overall Study|Withdrawal by Subject|5|||
130401903|NCT01126541|469436296|FG002|Overall Study|Withdrawal by Subject|6|||
130401904|NCT01126541|469436294|FG000|Overall Study|Protocol Violation|0|||
130401905|NCT01126541|469436295|FG001|Overall Study|Protocol Violation|0|||
130401906|NCT01126541|469436296|FG002|Overall Study|Protocol Violation|1|||
130401907|NCT01126541|469436294|FG000|Overall Study|Administrative reason or other|1|||
130401908|NCT01126541|469436295|FG001|Overall Study|Administrative reason or other|1|||
130401909|NCT01126541|469436296|FG002|Overall Study|Administrative reason or other|2|||
130401910|NCT01532687|469436297|FG000|Overall Study|Death|2|||
130401911|NCT01532687|469436298|FG001|Overall Study|Death|0|||
130401912|NCT01532687|469436297|FG000|Overall Study|Adverse Event|6|||
130401913|NCT01532687|469436298|FG001|Overall Study|Adverse Event|1|||
130401914|NCT01532687|469436297|FG000|Overall Study|Withdrawal by Subject|1|||
130401915|NCT01532687|469436298|FG001|Overall Study|Withdrawal by Subject|0|||
130401916|NCT01532687|469436297|FG000|Overall Study|Physician Decision|2|||
130401917|NCT01532687|469436298|FG001|Overall Study|Physician Decision|1|||
130401918|NCT01532687|469436297|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
130401919|NCT01532687|469436298|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
130401920|NCT03160703|469436299|FG000|Overall Study|Withdrawal by Subject|0|||
130401921|NCT03160703|469436300|FG001|Overall Study|Withdrawal by Subject|0|||
130401922|NCT03160703|469436301|FG002|Overall Study|Withdrawal by Subject|0|||
130401923|NCT03160703|469436302|FG003|Overall Study|Withdrawal by Subject|1|||
130401924|NCT00226941|469436303|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
130401925|NCT00226941|469436304|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
130401926|NCT00226941|469436305|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
130401927|NCT00226941|469436306|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
130560806|NCT01735279|470022677|FG001|Overall Study|Lost to Follow-up|8|||
130560807|NCT02170779|470022678|FG000|Overall Study|Withdrawal by Subject|1|||
130560808|NCT02170779|470022679|FG001|Overall Study|Withdrawal by Subject|0|||
130560809|NCT02170779|470022678|FG000|Overall Study|Lost to Follow-up|0|||
130560810|NCT02170779|470022679|FG001|Overall Study|Lost to Follow-up|1|||
130560811|NCT00369785|470022680|FG000|Overall Study|Physician Decision|3|||
130560812|NCT00369785|470022681|FG001|Overall Study|Physician Decision|2|||
130560813|NCT00369785|470022680|FG000|Overall Study|Death|1|||
130560814|NCT00369785|470022681|FG001|Overall Study|Death|2|||
130560815|NCT00369785|470022680|FG000|Overall Study|Withdrawal by Subject|7|||
130560816|NCT00369785|470022681|FG001|Overall Study|Withdrawal by Subject|6|||
130560817|NCT00369785|470022680|FG000|Overall Study|Toxicity|6|||
130560818|NCT00369785|470022681|FG001|Overall Study|Toxicity|4|||
130560819|NCT00369785|470022680|FG000|Overall Study|Never started|0|||
130560820|NCT00369785|470022681|FG001|Overall Study|Never started|2|||
130560821|NCT00369785|470022680|FG000|Overall Study|Progression|4|||
130560822|NCT00369785|470022681|FG001|Overall Study|Progression|4|||
130560823|NCT00369785|470022680|FG000|Overall Study|Multiple reasons|6|||
130560824|NCT00369785|470022681|FG001|Overall Study|Multiple reasons|5|||
130560825|NCT04556136|470022689|FG000|Overall Study|Lost to Follow-up|6|||
130560826|NCT04556136|470022690|FG001|Overall Study|Lost to Follow-up|6|||
130560827|NCT04556136|470022689|FG000|Overall Study|Physician Decision|2|||
130560828|NCT04556136|470022690|FG001|Overall Study|Physician Decision|1|||
130560829|NCT04556136|470022689|FG000|Overall Study|Withdrawal by Subject|2|||
130560830|NCT04556136|470022690|FG001|Overall Study|Withdrawal by Subject|1|||
130560831|NCT02678416|470022691|FG000|Part 1|Withdrawal by Subject|1|||
130723685|NCT01346293|470613499|FG001|Overall Study|Other|0|||
130723686|NCT03503864|470613502|FG000|Overall Study|Protocol Violation|6|||
130401928|NCT00226941|469436303|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130401929|NCT00226941|469436304|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130401930|NCT00226941|469436305|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130401931|NCT00226941|469436306|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
130401932|NCT01513291|469436307|FG000|Treatment Period|Adverse Event|8|||
130401933|NCT01513291|469436308|FG001|Treatment Period|Adverse Event|4|||
130401934|NCT01513291|469436309|FG002|Treatment Period|Adverse Event|0|||
130401935|NCT01513291|469436310|FG003|Treatment Period|Adverse Event|0|||
130560832|NCT02678416|470022691|FG000|Part 2|Adverse Event|2|||
130560833|NCT02678416|470022691|FG000|Part 2|Withdrawal by Subject|1|||
130723687|NCT03503864|470613502|FG000|Overall Study|Withdrawal by Subject|7|||
130560834|NCT01848353|470022692|FG000|Phase 1|Withdrawal by Subject|3|||
130560835|NCT01848353|470022693|FG001|Phase 1|Withdrawal by Subject|1|||
130560836|NCT01848353|470022694|FG002|Phase 1|Withdrawal by Subject|0|||
130560837|NCT01848353|470022695|FG003|Phase 1|Withdrawal by Subject|0|||
130560838|NCT01848353|470022692|FG000|Phase 2|Withdrawal by Subject|3|||
130560839|NCT01848353|470022693|FG001|Phase 2|Withdrawal by Subject|2|||
130560840|NCT01848353|470022694|FG002|Phase 2|Withdrawal by Subject|0|||
130401936|NCT01513291|469436311|FG004|Treatment Period|Adverse Event|0|||
130401937|NCT01513291|469436307|FG000|Treatment Period|Lack of Efficacy|3|||
130401938|NCT01513291|469436308|FG001|Treatment Period|Lack of Efficacy|0|||
130401939|NCT01513291|469436309|FG002|Treatment Period|Lack of Efficacy|0|||
130401940|NCT01513291|469436310|FG003|Treatment Period|Lack of Efficacy|0|||
130560841|NCT01848353|470022695|FG003|Phase 2|Withdrawal by Subject|0|||
130723688|NCT02910063|470613504|FG000|Phase 2|Withdrawal by Subject|3|||
130723689|NCT02910063|470613505|FG001|Phase 2|Withdrawal by Subject|0|||
130723690|NCT02910063|470613506|FG002|Phase 2|Withdrawal by Subject|0|||
130723691|NCT02910063|470613504|FG000|Phase 2|Lost to Follow-up|1|||
130723692|NCT02910063|470613505|FG001|Phase 2|Lost to Follow-up|0|||
130723693|NCT02910063|470613506|FG002|Phase 2|Lost to Follow-up|0|||
130723694|NCT02910063|470613504|FG000|Phase 2|Death|24|||
130723695|NCT02910063|470613505|FG001|Phase 2|Death|0|||
130723696|NCT02910063|470613506|FG002|Phase 2|Death|0|||
130723697|NCT04693416|470613507|FG000|Overall Study|Lost to Follow-up|13|||
130723698|NCT04693416|470613508|FG001|Overall Study|Lost to Follow-up|0|||
130723699|NCT00474266|470613509|FG000|Overall Study|Withdrawal by Subject|7|||
130723700|NCT00474266|470613510|FG001|Overall Study|Withdrawal by Subject|20|||
130401941|NCT01513291|469436311|FG004|Treatment Period|Lack of Efficacy|0|||
130401942|NCT01513291|469436307|FG000|Treatment Period|Lost to Follow-up|2|||
130401943|NCT01513291|469436308|FG001|Treatment Period|Lost to Follow-up|3|||
130401944|NCT01513291|469436309|FG002|Treatment Period|Lost to Follow-up|0|||
130401945|NCT01513291|469436310|FG003|Treatment Period|Lost to Follow-up|0|||
130401946|NCT01513291|469436311|FG004|Treatment Period|Lost to Follow-up|0|||
130401947|NCT01513291|469436307|FG000|Treatment Period|Physician Decision|1|||
130401948|NCT01513291|469436308|FG001|Treatment Period|Physician Decision|0|||
130401949|NCT01513291|469436309|FG002|Treatment Period|Physician Decision|0|||
130401950|NCT01513291|469436310|FG003|Treatment Period|Physician Decision|0|||
130401951|NCT01513291|469436311|FG004|Treatment Period|Physician Decision|0|||
130401952|NCT01513291|469436307|FG000|Treatment Period|Protocol Violation|1|||
130401953|NCT01513291|469436308|FG001|Treatment Period|Protocol Violation|2|||
130401954|NCT01513291|469436309|FG002|Treatment Period|Protocol Violation|0|||
130401955|NCT01513291|469436310|FG003|Treatment Period|Protocol Violation|0|||
130401956|NCT01513291|469436311|FG004|Treatment Period|Protocol Violation|0|||
130401957|NCT01513291|469436307|FG000|Treatment Period|Withdrawal by Subject|8|||
130401958|NCT01513291|469436308|FG001|Treatment Period|Withdrawal by Subject|5|||
130401959|NCT01513291|469436309|FG002|Treatment Period|Withdrawal by Subject|0|||
130401960|NCT01513291|469436310|FG003|Treatment Period|Withdrawal by Subject|0|||
130401961|NCT01513291|469436311|FG004|Treatment Period|Withdrawal by Subject|0|||
130401962|NCT01513291|469436307|FG000|Treatment Period|Randomized not treated|0|||
130401963|NCT01513291|469436308|FG001|Treatment Period|Randomized not treated|2|||
130401964|NCT01513291|469436309|FG002|Treatment Period|Randomized not treated|0|||
130401965|NCT01513291|469436310|FG003|Treatment Period|Randomized not treated|0|||
130401966|NCT01513291|469436311|FG004|Treatment Period|Randomized not treated|0|||
130401967|NCT01513291|469436307|FG000|Run-out Period|Lost to Follow-up|0|||
130401968|NCT01513291|469436308|FG001|Run-out Period|Lost to Follow-up|0|||
130401969|NCT01513291|469436309|FG002|Run-out Period|Lost to Follow-up|0|||
130401970|NCT01513291|469436310|FG003|Run-out Period|Lost to Follow-up|1|||
130401971|NCT01513291|469436311|FG004|Run-out Period|Lost to Follow-up|0|||
130401972|NCT01513291|469436307|FG000|Run-out Period|Withdrawal by Subject|0|||
130401973|NCT01513291|469436308|FG001|Run-out Period|Withdrawal by Subject|0|||
130401974|NCT01513291|469436309|FG002|Run-out Period|Withdrawal by Subject|0|||
130401975|NCT01513291|469436310|FG003|Run-out Period|Withdrawal by Subject|1|||
130401976|NCT01513291|469436311|FG004|Run-out Period|Withdrawal by Subject|0|||
130401977|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
130401978|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
130401979|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
130401980|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
130401981|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
130401982|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
130401983|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
130401984|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
130401985|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
130723701|NCT00474266|470613511|FG002|Overall Study|Withdrawal by Subject|4|||
130723702|NCT00474266|470613512|FG003|Overall Study|Withdrawal by Subject|7|||
130723703|NCT02774642|470613513|FG000|Overall Study|Lost to Follow-up|9|||
130723704|NCT02774642|470613514|FG001|Overall Study|Lost to Follow-up|7|||
130723705|NCT04642365|470613524|FG000|Overall Study|Death|3|||
130723706|NCT04642365|470613525|FG001|Overall Study|Death|2|||
130723707|NCT04642365|470613526|FG002|Overall Study|Death|4|||
130723708|NCT04642365|470613527|FG003|Overall Study|Death|5|||
130723709|NCT04642365|470613528|FG004|Overall Study|Death|5|||
130723710|NCT04642365|470613529|FG005|Overall Study|Death|3|||
130401986|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
130401987|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
130401988|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
130401989|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
130401990|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
130401991|NCT03732638|469436312|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
130401992|NCT03732638|469436313|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
130401993|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
130723711|NCT04642365|470613530|FG006|Overall Study|Death|2|||
130401994|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
130401995|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
130401996|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
130401997|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
130401998|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
130401999|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
130402000|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
130402001|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
130402002|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
130402003|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
130402004|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
130402005|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
130402006|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
130402007|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
130402008|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
130402009|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
130402010|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
130402011|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
130402012|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
130402013|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
130402014|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
130402015|NCT03732638|469436312|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
130402016|NCT03732638|469436313|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
130402017|NCT03732638|469436312|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
130402018|NCT03732638|469436313|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
130402019|NCT03732638|469436312|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
130402020|NCT03732638|469436313|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
130402021|NCT03732638|469436312|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
130402022|NCT03732638|469436313|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
130402023|NCT03732638|469436312|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
130402024|NCT03732638|469436313|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
130402025|NCT03728582|469436314|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
130402026|NCT03728582|469436315|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
130402027|NCT03728582|469436314|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
130402028|NCT03728582|469436315|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
130402029|NCT01034397|469436316|FG000|Overall Study|Lack of compliance|0|||
130402030|NCT01034397|469436317|FG001|Overall Study|Lack of compliance|1|||
130402031|NCT01034397|469436316|FG000|Overall Study|Lack of Efficacy|3|||
130402032|NCT01034397|469436317|FG001|Overall Study|Lack of Efficacy|0|||
130402033|NCT01034397|469436316|FG000|Overall Study|Adverse Event|4|||
130402034|NCT01034397|469436317|FG001|Overall Study|Adverse Event|0|||
130402035|NCT01034397|469436316|FG000|Overall Study|Other|0|||
130402036|NCT01034397|469436317|FG001|Overall Study|Other|1|||
130402037|NCT01018264|469436318|FG000|Overall Study|Withdrawal by Subject|1|||
130402038|NCT01018264|469436319|FG001|Overall Study|Withdrawal by Subject|0|||
130402039|NCT01018264|469436318|FG000|Overall Study|Lost to Follow-up|0|||
130402040|NCT01018264|469436319|FG001|Overall Study|Lost to Follow-up|1|||
130402041|NCT01785524|469436320|FG000|Overall Study|Withdrawal by Subject|2|||
130402042|NCT01785524|469436321|FG001|Overall Study|Withdrawal by Subject|2|||
130402043|NCT03217136|469436326|FG000|Overall Study|Lost to Follow-up|2|||
130402044|NCT03217136|469436327|FG001|Overall Study|Lost to Follow-up|1|||
130402045|NCT03217136|469436326|FG000|Overall Study|Site Randomized Participant in Error|0|||
130560842|NCT01848353|470022692|FG000|Phase 3|Withdrawal by Subject|1|||
130560843|NCT01848353|470022693|FG001|Phase 3|Withdrawal by Subject|1|||
130560844|NCT01848353|470022694|FG002|Phase 3|Withdrawal by Subject|0|||
130402046|NCT03217136|469436327|FG001|Overall Study|Site Randomized Participant in Error|1|||
130402047|NCT03217136|469436326|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
130402048|NCT03217136|469436327|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
130402049|NCT03217136|469436326|FG000|Overall Study|Dispensing Error|1|||
130402050|NCT03217136|469436327|FG001|Overall Study|Dispensing Error|0|||
130402051|NCT03217136|469436326|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130402052|NCT03217136|469436327|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130402053|NCT03192150|469436328|FG000|Overall Study|Adverse Event|14|||
130402054|NCT03192150|469436329|FG001|Overall Study|Adverse Event|12|||
130402055|NCT03192150|469436328|FG000|Overall Study|Lack of Efficacy|23|||
130402056|NCT03192150|469436329|FG001|Overall Study|Lack of Efficacy|30|||
130402057|NCT03192150|469436328|FG000|Overall Study|Lost to Follow-up|1|||
130402058|NCT03192150|469436329|FG001|Overall Study|Lost to Follow-up|1|||
130402059|NCT03192150|469436328|FG000|Overall Study|Withdrawal by Subject|4|||
130560845|NCT01848353|470022695|FG003|Phase 3|Withdrawal by Subject|0|||
130402060|NCT03192150|469436329|FG001|Overall Study|Withdrawal by Subject|2|||
130402061|NCT03192150|469436328|FG000|Overall Study|Protocol Violation|5|||
130560846|NCT00935272|470022696|FG000|Overall Study|Lost to Follow-up|10|||
130402062|NCT03192150|469436329|FG001|Overall Study|Protocol Violation|2|||
130402063|NCT03192150|469436328|FG000|Overall Study|Surgery Canceled|6|||
130402064|NCT03192150|469436329|FG001|Overall Study|Surgery Canceled|2|||
130402065|NCT03192150|469436328|FG000|Overall Study|Other-Various Administrative Reasons|2|||
130402066|NCT03192150|469436329|FG001|Overall Study|Other-Various Administrative Reasons|5|||
130402067|NCT02579616|469436330|FG000|Overall Study|Participants did not receive treatment|3|||
130402068|NCT00261716|469436338|FG000|Overall Study|Withdrawal by Subject|6|||
130402069|NCT00261716|469436339|FG001|Overall Study|Withdrawal by Subject|8|||
130402070|NCT00261716|469436338|FG000|Overall Study|Lost to Follow-up|0|||
130402071|NCT00261716|469436339|FG001|Overall Study|Lost to Follow-up|2|||
130402072|NCT00767676|469436340|FG000|Overall Study|Investigator error|54|||
130402073|NCT00617240|469436341|FG000|Overall Study|Lack of Efficacy|1|||
130402074|NCT00617240|469436342|FG001|Overall Study|Lack of Efficacy|0|||
130402075|NCT01611259|469436343|FG000|Overall Study|Physician Decision|1|||
130402076|NCT01611259|469436343|FG000|Overall Study|Lack of Efficacy|2|||
130402077|NCT01611259|469436343|FG000|Overall Study|Adverse Event|4|||
130402078|NCT01611259|469436343|FG000|Overall Study|Withdrawal by Subject|7|||
130402079|NCT04936685|469436344|FG000|Overall Study|Protocol Violation|1|||
130402080|NCT04936685|469436345|FG001|Overall Study|Protocol Violation|0|||
130402081|NCT03969212|469436348|FG000|Overall Study|Adverse Event|1|||
130402082|NCT03969212|469436349|FG001|Overall Study|Adverse Event|0|||
130402083|NCT03969212|469436350|FG002|Overall Study|Adverse Event|0|||
130402084|NCT03969212|469436351|FG003|Overall Study|Adverse Event|0|||
130402085|NCT03969212|469436348|FG000|Overall Study|Lost to Follow-up|2|||
130402086|NCT03969212|469436349|FG001|Overall Study|Lost to Follow-up|2|||
130402087|NCT03969212|469436350|FG002|Overall Study|Lost to Follow-up|2|||
130402088|NCT03969212|469436351|FG003|Overall Study|Lost to Follow-up|2|||
130402089|NCT03969212|469436348|FG000|Overall Study|Protocol Violation|0|||
130402090|NCT03969212|469436349|FG001|Overall Study|Protocol Violation|0|||
130402091|NCT03969212|469436350|FG002|Overall Study|Protocol Violation|0|||
130402092|NCT03969212|469436351|FG003|Overall Study|Protocol Violation|1|||
130402093|NCT03969212|469436348|FG000|Overall Study|Withdrawal by Subject|7|||
130402094|NCT03969212|469436349|FG001|Overall Study|Withdrawal by Subject|13|||
130402095|NCT03969212|469436350|FG002|Overall Study|Withdrawal by Subject|5|||
130402096|NCT03969212|469436351|FG003|Overall Study|Withdrawal by Subject|11|||
130402097|NCT03969212|469436348|FG000|Overall Study|Physician Decision|0|||
130402098|NCT03969212|469436349|FG001|Overall Study|Physician Decision|0|||
130402099|NCT03969212|469436350|FG002|Overall Study|Physician Decision|1|||
130402100|NCT03969212|469436351|FG003|Overall Study|Physician Decision|0|||
130402101|NCT03969212|469436348|FG000|Overall Study|Reason not Specified|22|||
130402102|NCT03969212|469436349|FG001|Overall Study|Reason not Specified|23|||
130402103|NCT03969212|469436350|FG002|Overall Study|Reason not Specified|28|||
130402104|NCT03969212|469436351|FG003|Overall Study|Reason not Specified|26|||
130402105|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
130402106|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
130402107|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
130402108|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
130402109|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
130402110|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
130402111|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
130402112|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
130402113|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
130402114|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
130402115|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
130402116|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
130402117|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
130402118|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
130402119|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
130402120|NCT00280566|469436354|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
130402121|NCT00280566|469436355|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
130402122|NCT00280566|469436356|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
130402123|NCT00280566|469436354|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
130402124|NCT00280566|469436355|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
130402125|NCT00280566|469436356|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
130402126|NCT00280566|469436354|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
130402127|NCT00280566|469436355|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
130402128|NCT00280566|469436356|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
130402129|NCT00280566|469436354|FG000|Period 2 Double Blind|Adverse Event|0|||
130402130|NCT00280566|469436355|FG001|Period 2 Double Blind|Adverse Event|11|||
130402131|NCT00280566|469436356|FG002|Period 2 Double Blind|Adverse Event|15|||
130402132|NCT00280566|469436354|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
130402133|NCT00280566|469436355|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
130402134|NCT00280566|469436356|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
130402135|NCT00280566|469436354|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
130402136|NCT00280566|469436355|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
130402137|NCT00280566|469436356|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
130402138|NCT00280566|469436354|FG000|Period 2 Double Blind|miscellaneous|0|||
130402139|NCT00280566|469436355|FG001|Period 2 Double Blind|miscellaneous|10|||
130402140|NCT00280566|469436356|FG002|Period 2 Double Blind|miscellaneous|5|||
130402141|NCT01147653|469436357|FG000|Year 2|Withdrawal by Subject|2|||
130402142|NCT01147653|469436358|FG001|Year 2|Withdrawal by Subject|3|||
130402143|NCT00353366|469436359|FG000|Overall Study|Adverse Event|8|||
130402144|NCT00353366|469436359|FG000|Overall Study|Protocol Violation|12|||
130402145|NCT00353366|469436359|FG000|Overall Study|Withdrawal by Subject|12|||
130402146|NCT00353366|469436359|FG000|Overall Study|Lost to Follow-up|92|||
130402147|NCT00353366|469436359|FG000|Overall Study|Other|19|||
130402148|NCT01302392|469436362|FG000|Overall Study|Lost to Follow-up|1|||
130402149|NCT01302392|469436363|FG001|Overall Study|Lost to Follow-up|0|||
130402150|NCT01302392|469436362|FG000|Overall Study|Withdrawal by Subject|6|||
130402151|NCT01302392|469436363|FG001|Overall Study|Withdrawal by Subject|1|||
130402152|NCT00259857|469436364|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
130402153|NCT00259857|469436365|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
130402154|NCT00259857|469436364|FG000|24 Months Treatment|Lost to Follow-up|0|||
130470774|NCT03014453|469690826|FG000|Overall Study|Refused to take part in|37|||
130470775|NCT05450458|469690827|FG000|Overall Study|Lost to Follow-up|4|||
130470776|NCT02794480|469690828|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
130470777|NCT02794480|469690829|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
130470778|NCT02794480|469690830|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
130470779|NCT02794480|469690831|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
130470780|NCT02794480|469690828|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
130470781|NCT02794480|469690829|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
130470782|NCT02794480|469690830|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
130470783|NCT02794480|469690831|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
130470784|NCT02794480|469690828|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130470785|NCT02794480|469690829|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130470786|NCT02794480|469690830|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130470787|NCT02794480|469690831|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
130470788|NCT02794480|469690828|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130470789|NCT02794480|469690829|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
130470790|NCT02794480|469690830|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130470791|NCT02794480|469690831|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130470792|NCT02794480|469690828|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
130470793|NCT02794480|469690829|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130470794|NCT02794480|469690830|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130470795|NCT02794480|469690831|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
130470796|NCT00262301|469690832|FG000|Double-blind Phase|Lost to Follow-up|1|||
130470797|NCT00262301|469690833|FG001|Double-blind Phase|Lost to Follow-up|0|||
130470798|NCT00262301|469690834|FG002|Double-blind Phase|Lost to Follow-up|0|||
130470799|NCT00262301|469690832|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
130470800|NCT00262301|469690833|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
130470801|NCT00262301|469690834|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
130470802|NCT01017146|469690835|FG000|Overall Study|Adverse Event|11|||
130470803|NCT01017146|469690836|FG001|Overall Study|Adverse Event|1|||
130470804|NCT01017146|469690835|FG000|Overall Study|Lost to Follow-up|14|||
130470805|NCT01017146|469690836|FG001|Overall Study|Lost to Follow-up|14|||
130470806|NCT01017146|469690835|FG000|Overall Study|Noncompliance with Study Product|1|||
130470807|NCT01017146|469690836|FG001|Overall Study|Noncompliance with Study Product|1|||
130470808|NCT01017146|469690835|FG000|Overall Study|Withdrawal by Subject|32|||
130470809|NCT01017146|469690836|FG001|Overall Study|Withdrawal by Subject|16|||
130470810|NCT01017146|469690835|FG000|Overall Study|Relocation|0|||
130470811|NCT01017146|469690836|FG001|Overall Study|Relocation|4|||
130470812|NCT01017146|469690835|FG000|Overall Study|Pregnancy|2|||
130470813|NCT01017146|469690836|FG001|Overall Study|Pregnancy|1|||
130470814|NCT01017146|469690835|FG000|Overall Study|Protocol Violation|2|||
130402155|NCT00259857|469436365|FG001|24 Months Treatment|Lost to Follow-up|3|||
130402156|NCT00670228|469436366|FG000|Overall Study|Adverse Event|1|||
130402157|NCT00670228|469436367|FG001|Overall Study|Adverse Event|0|||
130402158|NCT00670228|469436366|FG000|Overall Study|Death or MACE|0|||
130402159|NCT00670228|469436367|FG001|Overall Study|Death or MACE|1|||
130402160|NCT00670228|469436366|FG000|Overall Study|Not treated|2|||
130402161|NCT00670228|469436367|FG001|Overall Study|Not treated|2|||
130402162|NCT00670228|469436366|FG000|Overall Study|Not meeting the selection criteria|2|||
130402163|NCT00670228|469436367|FG001|Overall Study|Not meeting the selection criteria|0|||
130402164|NCT01813019|469436375|FG000|Overall Study|Adverse Event|0|||
130402165|NCT01813019|469436376|FG001|Overall Study|Adverse Event|3|||
130402166|NCT01813019|469436375|FG000|Overall Study|Withdrawal by Subject|3|||
130402167|NCT01813019|469436376|FG001|Overall Study|Withdrawal by Subject|2|||
130402168|NCT01813019|469436375|FG000|Overall Study|administrative problems|2|||
130402169|NCT01813019|469436376|FG001|Overall Study|administrative problems|0|||
130402170|NCT01813019|469436375|FG000|Overall Study|Protocol Deviation|2|||
130402171|NCT01813019|469436376|FG001|Overall Study|Protocol Deviation|1|||
130402172|NCT01559311|469436377|FG000|Overall Study|Protocol Violation|0|||
130402173|NCT01559311|469436378|FG001|Overall Study|Protocol Violation|0|||
130402174|NCT01559311|469436379|FG002|Overall Study|Protocol Violation|2|||
130402175|NCT01559311|469436377|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
130402176|NCT01559311|469436378|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
130402177|NCT01559311|469436379|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
130402178|NCT01559311|469436377|FG000|Overall Study|Withdrawal by Subject|2|||
130402179|NCT01559311|469436378|FG001|Overall Study|Withdrawal by Subject|1|||
130402180|NCT01559311|469436379|FG002|Overall Study|Withdrawal by Subject|0|||
130402181|NCT01559311|469436377|FG000|Overall Study|Death|0|||
130402182|NCT01559311|469436378|FG001|Overall Study|Death|2|||
130402183|NCT01559311|469436379|FG002|Overall Study|Death|3|||
130402184|NCT01559311|469436377|FG000|Overall Study|Lost to Follow-up|0|||
130402185|NCT01559311|469436378|FG001|Overall Study|Lost to Follow-up|3|||
130402186|NCT01559311|469436379|FG002|Overall Study|Lost to Follow-up|2|||
130402187|NCT01559311|469436377|FG000|Overall Study|Adverse Event|0|||
130402188|NCT01559311|469436378|FG001|Overall Study|Adverse Event|0|||
130402189|NCT01559311|469436379|FG002|Overall Study|Adverse Event|1|||
130402190|NCT01462357|469436380|FG000|Overall Study|Death|0|||
130402191|NCT01462357|469436381|FG001|Overall Study|Death|0|||
130402192|NCT01462357|469436382|FG002|Overall Study|Death|1|||
130402193|NCT01462357|469436380|FG000|Overall Study|Withdrawal by Subject|3|||
130402194|NCT01462357|469436381|FG001|Overall Study|Withdrawal by Subject|11|||
130402195|NCT01462357|469436382|FG002|Overall Study|Withdrawal by Subject|3|||
130402196|NCT01462357|469436380|FG000|Overall Study|Migrated/moved from study area|2|||
130402197|NCT01462357|469436381|FG001|Overall Study|Migrated/moved from study area|3|||
130402198|NCT01462357|469436382|FG002|Overall Study|Migrated/moved from study area|1|||
130402199|NCT01462357|469436380|FG000|Overall Study|Lost to Follow-up|3|||
130402200|NCT01462357|469436381|FG001|Overall Study|Lost to Follow-up|5|||
130402201|NCT01462357|469436382|FG002|Overall Study|Lost to Follow-up|7|||
130402202|NCT01482767|469436384|FG000|Overall Study|Death|1|||
130402203|NCT01482767|469436385|FG001|Overall Study|Death|1|||
130402204|NCT01482767|469436384|FG000|Overall Study|Withdrawal by Subject|7|||
130402205|NCT01482767|469436385|FG001|Overall Study|Withdrawal by Subject|5|||
130402206|NCT01482767|469436384|FG000|Overall Study|Lost to Follow-up|12|||
130402207|NCT01482767|469436385|FG001|Overall Study|Lost to Follow-up|6|||
130402208|NCT01482767|469436384|FG000|Overall Study|Adverse Event|0|||
130402209|NCT01482767|469436385|FG001|Overall Study|Adverse Event|3|||
130402210|NCT01482767|469436384|FG000|Overall Study|Site closure|22|||
130402211|NCT01482767|469436385|FG001|Overall Study|Site closure|14|||
130402212|NCT01482767|469436384|FG000|Overall Study|Non-adherence to study requirements|4|||
130402213|NCT01482767|469436385|FG001|Overall Study|Non-adherence to study requirements|7|||
130402214|NCT01482767|469436384|FG000|Overall Study|Alternate HCV treatment|7|||
130402215|NCT01482767|469436385|FG001|Overall Study|Alternate HCV treatment|8|||
130402216|NCT01482767|469436384|FG000|Overall Study|Ineligible|0|||
130402217|NCT01482767|469436385|FG001|Overall Study|Ineligible|5|||
130402218|NCT01482767|469436384|FG000|Overall Study|Nurse error|1|||
130402219|NCT01482767|469436385|FG001|Overall Study|Nurse error|0|||
130402220|NCT00025883|469436386|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
130402221|NCT00025883|469436386|FG000|Overall Study|no baseline data|1|||
130402222|NCT00025883|469436386|FG000|Overall Study|Death|1|||
130402223|NCT00025883|469436386|FG000|Overall Study|Adverse Event|1|||
130402224|NCT00025883|469436386|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
130402225|NCT02908529|469436388|FG000|Overall Study|Lost to Follow-up|0|||
130402226|NCT02908529|469436389|FG001|Overall Study|Lost to Follow-up|2|||
130723712|NCT04642365|470613531|FG007|Overall Study|Death|1|||
130402227|NCT02553421|469436390|FG000|Overall Study|Lost to Follow-up|21|||
130402228|NCT02553421|469436391|FG001|Overall Study|Lost to Follow-up|1|||
130402229|NCT02553421|469436390|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
130402230|NCT02553421|469436391|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
130470815|NCT01017146|469690836|FG001|Overall Study|Protocol Violation|0|||
130402231|NCT02553421|469436390|FG000|Overall Study|Improper Device Placement|3|||
130402232|NCT02553421|469436391|FG001|Overall Study|Improper Device Placement|0|||
130402233|NCT04197713|469436394|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
130402234|NCT04197713|469436395|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
130402235|NCT05569954|469436396|FG000|Overall Study|Lost to Follow-up|3|||
130402236|NCT05569954|469436397|FG001|Overall Study|Lost to Follow-up|4|||
130402237|NCT05569954|469436396|FG000|Overall Study|Protocol Violation|1|||
130402238|NCT05569954|469436397|FG001|Overall Study|Protocol Violation|2|||
130402239|NCT05569954|469436396|FG000|Overall Study|Withdrawal by Subject|4|||
130402240|NCT05569954|469436397|FG001|Overall Study|Withdrawal by Subject|2|||
130402241|NCT01660412|469436398|FG000|Overall Study|Protocol Violation|0|||
130402242|NCT01660412|469436399|FG001|Overall Study|Protocol Violation|3|||
130402243|NCT03013491|469436400|FG000|Main Study|Death|2|||
130402244|NCT03013491|469436401|FG001|Main Study|Death|2|||
130402245|NCT03013491|469436402|FG002|Main Study|Death|5|||
130402246|NCT03013491|469436403|FG003|Main Study|Death|3|||
130402247|NCT03013491|469436404|FG004|Main Study|Death|9|||
130402248|NCT03013491|469436405|FG005|Main Study|Death|12|||
130402249|NCT03013491|469436406|FG006|Main Study|Death|3|||
130402250|NCT03013491|469436407|FG007|Main Study|Death|5|||
130402251|NCT03013491|469436408|FG008|Main Study|Death|1|||
130402252|NCT03013491|469436409|FG009|Main Study|Death|2|||
130402253|NCT03013491|469436410|FG010|Main Study|Death|4|||
130402254|NCT03013491|469436411|FG011|Main Study|Death|1|||
130402255|NCT03013491|469436412|FG012|Main Study|Death|1|||
130402256|NCT03013491|469436413|FG013|Main Study|Death|4|||
130402257|NCT03013491|469436414|FG014|Main Study|Death|0|||
130402258|NCT03013491|469436415|FG015|Main Study|Death|3|||
130402259|NCT03013491|469436416|FG016|Main Study|Death|5|||
130402260|NCT03013491|469436417|FG017|Main Study|Death|1|||
130402261|NCT03013491|469436418|FG018|Main Study|Death|47|||
130402262|NCT03013491|469436400|FG000|Main Study|Lost to Follow-up|0|||
130402263|NCT03013491|469436401|FG001|Main Study|Lost to Follow-up|0|||
130402264|NCT03013491|469436402|FG002|Main Study|Lost to Follow-up|1|||
130402265|NCT03013491|469436403|FG003|Main Study|Lost to Follow-up|0|||
130402266|NCT03013491|469436404|FG004|Main Study|Lost to Follow-up|1|||
130402267|NCT03013491|469436405|FG005|Main Study|Lost to Follow-up|0|||
130402268|NCT03013491|469436406|FG006|Main Study|Lost to Follow-up|0|||
130402269|NCT03013491|469436407|FG007|Main Study|Lost to Follow-up|0|||
130402270|NCT03013491|469436408|FG008|Main Study|Lost to Follow-up|0|||
130402271|NCT03013491|469436409|FG009|Main Study|Lost to Follow-up|0|||
130402272|NCT03013491|469436410|FG010|Main Study|Lost to Follow-up|0|||
130402273|NCT03013491|469436411|FG011|Main Study|Lost to Follow-up|0|||
130402274|NCT03013491|469436412|FG012|Main Study|Lost to Follow-up|0|||
130402275|NCT03013491|469436413|FG013|Main Study|Lost to Follow-up|0|||
130402276|NCT03013491|469436414|FG014|Main Study|Lost to Follow-up|0|||
130402277|NCT03013491|469436415|FG015|Main Study|Lost to Follow-up|0|||
130402278|NCT03013491|469436416|FG016|Main Study|Lost to Follow-up|0|||
130402279|NCT03013491|469436417|FG017|Main Study|Lost to Follow-up|0|||
130402280|NCT03013491|469436418|FG018|Main Study|Lost to Follow-up|3|||
130402281|NCT03013491|469436400|FG000|Main Study|Termination of the study by Sponsor|0|||
130402282|NCT03013491|469436401|FG001|Main Study|Termination of the study by Sponsor|0|||
130402283|NCT03013491|469436402|FG002|Main Study|Termination of the study by Sponsor|2|||
130402284|NCT03013491|469436403|FG003|Main Study|Termination of the study by Sponsor|0|||
130402285|NCT03013491|469436404|FG004|Main Study|Termination of the study by Sponsor|1|||
130402286|NCT03013491|469436405|FG005|Main Study|Termination of the study by Sponsor|2|||
130402287|NCT03013491|469436406|FG006|Main Study|Termination of the study by Sponsor|0|||
130402288|NCT03013491|469436407|FG007|Main Study|Termination of the study by Sponsor|0|||
130402289|NCT03013491|469436408|FG008|Main Study|Termination of the study by Sponsor|1|||
130402290|NCT03013491|469436409|FG009|Main Study|Termination of the study by Sponsor|1|||
130402291|NCT03013491|469436410|FG010|Main Study|Termination of the study by Sponsor|1|||
130402292|NCT03013491|469436411|FG011|Main Study|Termination of the study by Sponsor|2|||
130402293|NCT03013491|469436412|FG012|Main Study|Termination of the study by Sponsor|0|||
130402294|NCT03013491|469436413|FG013|Main Study|Termination of the study by Sponsor|0|||
130402295|NCT03013491|469436414|FG014|Main Study|Termination of the study by Sponsor|0|||
130402296|NCT03013491|469436415|FG015|Main Study|Termination of the study by Sponsor|0|||
130402297|NCT03013491|469436416|FG016|Main Study|Termination of the study by Sponsor|0|||
130402298|NCT03013491|469436417|FG017|Main Study|Termination of the study by Sponsor|1|||
130402299|NCT03013491|469436418|FG018|Main Study|Termination of the study by Sponsor|13|||
130402300|NCT03013491|469436400|FG000|Main Study|Withdrawal by Subject|0|||
130402301|NCT03013491|469436401|FG001|Main Study|Withdrawal by Subject|0|||
130402302|NCT03013491|469436402|FG002|Main Study|Withdrawal by Subject|0|||
130560847|NCT00935272|470022697|FG001|Overall Study|Lost to Follow-up|3|||
130402303|NCT03013491|469436403|FG003|Main Study|Withdrawal by Subject|4|||
130402304|NCT03013491|469436404|FG004|Main Study|Withdrawal by Subject|2|||
130402305|NCT03013491|469436405|FG005|Main Study|Withdrawal by Subject|1|||
130402306|NCT03013491|469436406|FG006|Main Study|Withdrawal by Subject|0|||
130402307|NCT03013491|469436407|FG007|Main Study|Withdrawal by Subject|0|||
130402308|NCT03013491|469436408|FG008|Main Study|Withdrawal by Subject|0|||
130723713|NCT04642365|470613524|FG000|Overall Study|Physician Decision|1|||
130723714|NCT04642365|470613525|FG001|Overall Study|Physician Decision|0|||
130723715|NCT04642365|470613526|FG002|Overall Study|Physician Decision|0|||
130723716|NCT04642365|470613527|FG003|Overall Study|Physician Decision|0|||
130723717|NCT04642365|470613528|FG004|Overall Study|Physician Decision|0|||
130723718|NCT04642365|470613529|FG005|Overall Study|Physician Decision|0|||
130723719|NCT04642365|470613530|FG006|Overall Study|Physician Decision|0|||
130723720|NCT04642365|470613531|FG007|Overall Study|Physician Decision|0|||
130723721|NCT04642365|470613524|FG000|Overall Study|Progressive Disease|1|||
130723722|NCT04642365|470613525|FG001|Overall Study|Progressive Disease|1|||
130723723|NCT04642365|470613526|FG002|Overall Study|Progressive Disease|1|||
130723724|NCT04642365|470613527|FG003|Overall Study|Progressive Disease|0|||
130723725|NCT04642365|470613528|FG004|Overall Study|Progressive Disease|0|||
130723726|NCT04642365|470613529|FG005|Overall Study|Progressive Disease|0|||
130723727|NCT04642365|470613530|FG006|Overall Study|Progressive Disease|1|||
130723728|NCT04642365|470613531|FG007|Overall Study|Progressive Disease|0|||
130723729|NCT04642365|470613524|FG000|Overall Study|Study Terminated By Sponsor|0|||
130723730|NCT04642365|470613525|FG001|Overall Study|Study Terminated By Sponsor|2|||
130723731|NCT04642365|470613526|FG002|Overall Study|Study Terminated By Sponsor|1|||
130723732|NCT04642365|470613527|FG003|Overall Study|Study Terminated By Sponsor|1|||
130723733|NCT04642365|470613528|FG004|Overall Study|Study Terminated By Sponsor|1|||
130723734|NCT04642365|470613529|FG005|Overall Study|Study Terminated By Sponsor|2|||
130723735|NCT04642365|470613530|FG006|Overall Study|Study Terminated By Sponsor|2|||
130723736|NCT04642365|470613531|FG007|Overall Study|Study Terminated By Sponsor|1|||
130723737|NCT04642365|470613524|FG000|Overall Study|Symptomatic Deterioration|1|||
130723738|NCT04642365|470613525|FG001|Overall Study|Symptomatic Deterioration|1|||
130402309|NCT03013491|469436409|FG009|Main Study|Withdrawal by Subject|0|||
130402310|NCT03013491|469436410|FG010|Main Study|Withdrawal by Subject|1|||
130402311|NCT03013491|469436411|FG011|Main Study|Withdrawal by Subject|2|||
130402312|NCT03013491|469436412|FG012|Main Study|Withdrawal by Subject|0|||
130402313|NCT03013491|469436413|FG013|Main Study|Withdrawal by Subject|2|||
130723739|NCT04642365|470613526|FG002|Overall Study|Symptomatic Deterioration|0|||
130723740|NCT04642365|470613527|FG003|Overall Study|Symptomatic Deterioration|0|||
130723741|NCT04642365|470613528|FG004|Overall Study|Symptomatic Deterioration|0|||
130723742|NCT04642365|470613529|FG005|Overall Study|Symptomatic Deterioration|1|||
130723743|NCT04642365|470613530|FG006|Overall Study|Symptomatic Deterioration|0|||
130723744|NCT04642365|470613531|FG007|Overall Study|Symptomatic Deterioration|0|||
130723745|NCT04642365|470613524|FG000|Overall Study|Withdrawal by Subject|0|||
130723746|NCT04642365|470613525|FG001|Overall Study|Withdrawal by Subject|0|||
130723747|NCT04642365|470613526|FG002|Overall Study|Withdrawal by Subject|1|||
130723748|NCT04642365|470613527|FG003|Overall Study|Withdrawal by Subject|1|||
130723749|NCT04642365|470613528|FG004|Overall Study|Withdrawal by Subject|0|||
130723750|NCT04642365|470613529|FG005|Overall Study|Withdrawal by Subject|0|||
130723751|NCT04642365|470613530|FG006|Overall Study|Withdrawal by Subject|2|||
130723752|NCT04642365|470613531|FG007|Overall Study|Withdrawal by Subject|0|||
130723753|NCT04642365|470613524|FG000|Overall Study|Adverse Event|0|||
130723754|NCT04642365|470613525|FG001|Overall Study|Adverse Event|0|||
130723755|NCT04642365|470613526|FG002|Overall Study|Adverse Event|0|||
130402314|NCT03013491|469436414|FG014|Main Study|Withdrawal by Subject|0|||
130723756|NCT04642365|470613527|FG003|Overall Study|Adverse Event|0|||
130723757|NCT04642365|470613528|FG004|Overall Study|Adverse Event|0|||
130723758|NCT04642365|470613529|FG005|Overall Study|Adverse Event|0|||
130723759|NCT04642365|470613530|FG006|Overall Study|Adverse Event|0|||
130723760|NCT04642365|470613531|FG007|Overall Study|Adverse Event|1|||
130723761|NCT01144715|470613532|FG000|Overall Study|Lost to Follow-up|2|||
130723762|NCT01144715|470613533|FG001|Overall Study|Lost to Follow-up|1|||
130723763|NCT01144715|470613532|FG000|Overall Study|Withdrawal by Subject|2|||
130723764|NCT01144715|470613533|FG001|Overall Study|Withdrawal by Subject|1|||
130723765|NCT01144715|470613532|FG000|Overall Study|Adverse Event|0|||
130723766|NCT01144715|470613533|FG001|Overall Study|Adverse Event|1|||
130402315|NCT03013491|469436415|FG015|Main Study|Withdrawal by Subject|0|||
130402316|NCT03013491|469436416|FG016|Main Study|Withdrawal by Subject|0|||
130402317|NCT03013491|469436417|FG017|Main Study|Withdrawal by Subject|0|||
130402318|NCT03013491|469436418|FG018|Main Study|Withdrawal by Subject|18|||
130723767|NCT06281171|470613534|FG000|Timepoint 2|Lost to Follow-up|6|||
130723768|NCT06281171|470613535|FG001|Timepoint 2|Lost to Follow-up|4|||
130723769|NCT06281171|470613534|FG000|Timepoint 3|Lost to Follow-up|0|||
130723770|NCT06281171|470613535|FG001|Timepoint 3|Lost to Follow-up|5|||
130402319|NCT03013491|469436400|FG000|Main Study|Disease progression|0|||
130402320|NCT03013491|469436401|FG001|Main Study|Disease progression|0|||
130402321|NCT03013491|469436402|FG002|Main Study|Disease progression|0|||
130723771|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
130723772|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
130402322|NCT03013491|469436403|FG003|Main Study|Disease progression|1|||
130402323|NCT03013491|469436404|FG004|Main Study|Disease progression|0|||
130402324|NCT03013491|469436405|FG005|Main Study|Disease progression|0|||
130402325|NCT03013491|469436406|FG006|Main Study|Disease progression|0|||
130402326|NCT03013491|469436407|FG007|Main Study|Disease progression|0|||
130402327|NCT03013491|469436408|FG008|Main Study|Disease progression|1|||
130402328|NCT03013491|469436409|FG009|Main Study|Disease progression|0|||
130402329|NCT03013491|469436410|FG010|Main Study|Disease progression|1|||
130402330|NCT03013491|469436411|FG011|Main Study|Disease progression|0|||
130402331|NCT03013491|469436412|FG012|Main Study|Disease progression|0|||
130402332|NCT03013491|469436413|FG013|Main Study|Disease progression|0|||
130402333|NCT03013491|469436414|FG014|Main Study|Disease progression|0|||
130402334|NCT03013491|469436415|FG015|Main Study|Disease progression|0|||
130402335|NCT03013491|469436416|FG016|Main Study|Disease progression|0|||
130402336|NCT03013491|469436417|FG017|Main Study|Disease progression|0|||
130402337|NCT03013491|469436418|FG018|Main Study|Disease progression|4|||
130402338|NCT03013491|469436400|FG000|Main Study|Symptomatic deterioration|0|||
130402339|NCT03013491|469436401|FG001|Main Study|Symptomatic deterioration|0|||
130402340|NCT03013491|469436402|FG002|Main Study|Symptomatic deterioration|0|||
130402341|NCT03013491|469436403|FG003|Main Study|Symptomatic deterioration|0|||
130402342|NCT03013491|469436404|FG004|Main Study|Symptomatic deterioration|0|||
130402343|NCT03013491|469436405|FG005|Main Study|Symptomatic deterioration|1|||
130402344|NCT03013491|469436406|FG006|Main Study|Symptomatic deterioration|0|||
130402345|NCT03013491|469436407|FG007|Main Study|Symptomatic deterioration|0|||
130402346|NCT03013491|469436408|FG008|Main Study|Symptomatic deterioration|0|||
130402347|NCT03013491|469436409|FG009|Main Study|Symptomatic deterioration|0|||
130402348|NCT03013491|469436410|FG010|Main Study|Symptomatic deterioration|0|||
130402349|NCT03013491|469436411|FG011|Main Study|Symptomatic deterioration|0|||
130402350|NCT03013491|469436412|FG012|Main Study|Symptomatic deterioration|0|||
130402351|NCT03013491|469436413|FG013|Main Study|Symptomatic deterioration|0|||
130402352|NCT03013491|469436414|FG014|Main Study|Symptomatic deterioration|0|||
130402353|NCT03013491|469436415|FG015|Main Study|Symptomatic deterioration|0|||
130402354|NCT03013491|469436416|FG016|Main Study|Symptomatic deterioration|0|||
130402355|NCT03013491|469436417|FG017|Main Study|Symptomatic deterioration|0|||
130402356|NCT03013491|469436418|FG018|Main Study|Symptomatic deterioration|0|||
130402357|NCT03013491|469436400|FG000|Main Study|Protocol version 8.0 approval|0|||
130402358|NCT03013491|469436401|FG001|Main Study|Protocol version 8.0 approval|0|||
130402359|NCT03013491|469436402|FG002|Main Study|Protocol version 8.0 approval|0|||
130402360|NCT03013491|469436403|FG003|Main Study|Protocol version 8.0 approval|0|||
130560848|NCT00935272|470022696|FG000|Overall Study|Withdrawal by Subject|8|||
130560849|NCT00935272|470022697|FG001|Overall Study|Withdrawal by Subject|2|||
130560850|NCT00935272|470022696|FG000|Overall Study|Physician Decision|1|||
130560851|NCT00935272|470022697|FG001|Overall Study|Physician Decision|0|||
130560852|NCT00935272|470022696|FG000|Overall Study|Protocol Violation|0|||
130560853|NCT00935272|470022697|FG001|Overall Study|Protocol Violation|1|||
130560854|NCT03492554|470022707|FG000|Overall Study|Protocol Violation|0|||
130560855|NCT03492554|470022708|FG001|Overall Study|Protocol Violation|14|||
130560856|NCT04340557|470022711|FG000|Overall Study|Transferred to ICU and/or death|1|||
130560857|NCT04340557|470022712|FG001|Overall Study|Transferred to ICU and/or death|2|||
130402361|NCT03013491|469436404|FG004|Main Study|Protocol version 8.0 approval|0|||
130402362|NCT03013491|469436405|FG005|Main Study|Protocol version 8.0 approval|0|||
130402363|NCT03013491|469436406|FG006|Main Study|Protocol version 8.0 approval|0|||
130560858|NCT01221727|470022713|FG000|Overall Study|Physician Decision|2|||
130560859|NCT01221727|470022714|FG001|Overall Study|Physician Decision|0|||
130560860|NCT01221727|470022713|FG000|Overall Study|Withdrawal by Subject|1|||
130560861|NCT01221727|470022714|FG001|Overall Study|Withdrawal by Subject|1|||
130560862|NCT00529451|470022742|FG000|Overall Study|Subject withdrew consent|16|||
130560863|NCT00529451|470022743|FG001|Overall Study|Subject withdrew consent|21|||
130560864|NCT00529451|470022744|FG002|Overall Study|Subject withdrew consent|13|||
130402364|NCT03013491|469436407|FG007|Main Study|Protocol version 8.0 approval|0|||
130402365|NCT03013491|469436408|FG008|Main Study|Protocol version 8.0 approval|0|||
130402366|NCT03013491|469436409|FG009|Main Study|Protocol version 8.0 approval|0|||
130560865|NCT00529451|470022745|FG003|Overall Study|Subject withdrew consent|12|||
130560866|NCT00529451|470022742|FG000|Overall Study|Adverse Event|9|||
130402367|NCT03013491|469436410|FG010|Main Study|Protocol version 8.0 approval|1|||
130560867|NCT00529451|470022743|FG001|Overall Study|Adverse Event|16|||
130402368|NCT03013491|469436411|FG011|Main Study|Protocol version 8.0 approval|0|||
130402369|NCT03013491|469436412|FG012|Main Study|Protocol version 8.0 approval|0|||
130560868|NCT00529451|470022744|FG002|Overall Study|Adverse Event|14|||
130560869|NCT00529451|470022745|FG003|Overall Study|Adverse Event|8|||
130560870|NCT00529451|470022742|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
130402370|NCT03013491|469436413|FG013|Main Study|Protocol version 8.0 approval|0|||
130560871|NCT00529451|470022743|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
130560872|NCT00529451|470022744|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
130402371|NCT03013491|469436414|FG014|Main Study|Protocol version 8.0 approval|0|||
130402372|NCT03013491|469436415|FG015|Main Study|Protocol version 8.0 approval|0|||
130402373|NCT03013491|469436416|FG016|Main Study|Protocol version 8.0 approval|0|||
130402374|NCT03013491|469436417|FG017|Main Study|Protocol version 8.0 approval|0|||
130402375|NCT03013491|469436418|FG018|Main Study|Protocol version 8.0 approval|0|||
130723773|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
130723774|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
130723775|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
130402376|NCT03013491|469436400|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
130402377|NCT03013491|469436401|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
130402378|NCT03013491|469436402|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
130402379|NCT03013491|469436403|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
130402380|NCT03013491|469436404|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
130402381|NCT03013491|469436405|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
130402382|NCT03013491|469436406|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
130402383|NCT03013491|469436407|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
130402384|NCT03013491|469436408|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
130402385|NCT03013491|469436409|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
130402386|NCT03013491|469436410|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
130402387|NCT03013491|469436411|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
130402388|NCT03013491|469436412|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
130402389|NCT03013491|469436413|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
130402390|NCT03013491|469436414|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
130402391|NCT03013491|469436415|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
130402392|NCT03013491|469436416|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
130402393|NCT03013491|469436417|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
130402394|NCT03013491|469436418|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
130402395|NCT03013491|469436400|FG000|Main Study|Start of new anticancer therapy|0|||
130402396|NCT03013491|469436401|FG001|Main Study|Start of new anticancer therapy|0|||
130402397|NCT03013491|469436402|FG002|Main Study|Start of new anticancer therapy|0|||
130402398|NCT03013491|469436403|FG003|Main Study|Start of new anticancer therapy|0|||
130402399|NCT03013491|469436404|FG004|Main Study|Start of new anticancer therapy|0|||
130402400|NCT03013491|469436405|FG005|Main Study|Start of new anticancer therapy|0|||
130402401|NCT03013491|469436406|FG006|Main Study|Start of new anticancer therapy|0|||
130402402|NCT03013491|469436407|FG007|Main Study|Start of new anticancer therapy|0|||
130402403|NCT03013491|469436408|FG008|Main Study|Start of new anticancer therapy|0|||
130402404|NCT03013491|469436409|FG009|Main Study|Start of new anticancer therapy|0|||
130402405|NCT03013491|469436410|FG010|Main Study|Start of new anticancer therapy|0|||
130402406|NCT03013491|469436411|FG011|Main Study|Start of new anticancer therapy|0|||
130402407|NCT03013491|469436412|FG012|Main Study|Start of new anticancer therapy|0|||
130402408|NCT03013491|469436413|FG013|Main Study|Start of new anticancer therapy|0|||
130402409|NCT03013491|469436414|FG014|Main Study|Start of new anticancer therapy|0|||
130402410|NCT03013491|469436415|FG015|Main Study|Start of new anticancer therapy|0|||
130402411|NCT03013491|469436416|FG016|Main Study|Start of new anticancer therapy|0|||
130402412|NCT03013491|469436417|FG017|Main Study|Start of new anticancer therapy|0|||
130402413|NCT03013491|469436418|FG018|Main Study|Start of new anticancer therapy|2|||
130402414|NCT03013491|469436400|FG000|Long-term Extension|Disease progression|0|||
130402415|NCT03013491|469436401|FG001|Long-term Extension|Disease progression|0|||
130402416|NCT03013491|469436402|FG002|Long-term Extension|Disease progression|0|||
130402417|NCT03013491|469436403|FG003|Long-term Extension|Disease progression|1|||
130402418|NCT03013491|469436404|FG004|Long-term Extension|Disease progression|0|||
130402419|NCT03013491|469436405|FG005|Long-term Extension|Disease progression|0|||
130402420|NCT03013491|469436406|FG006|Long-term Extension|Disease progression|0|||
130402421|NCT03013491|469436407|FG007|Long-term Extension|Disease progression|0|||
130402422|NCT03013491|469436408|FG008|Long-term Extension|Disease progression|0|||
130402423|NCT03013491|469436409|FG009|Long-term Extension|Disease progression|0|||
130402424|NCT03013491|469436410|FG010|Long-term Extension|Disease progression|0|||
130402425|NCT03013491|469436411|FG011|Long-term Extension|Disease progression|0|||
130402426|NCT03013491|469436412|FG012|Long-term Extension|Disease progression|0|||
130402427|NCT03013491|469436413|FG013|Long-term Extension|Disease progression|0|||
130402428|NCT03013491|469436414|FG014|Long-term Extension|Disease progression|0|||
130402429|NCT03013491|469436415|FG015|Long-term Extension|Disease progression|0|||
130402430|NCT03013491|469436416|FG016|Long-term Extension|Disease progression|0|||
130402431|NCT03013491|469436417|FG017|Long-term Extension|Disease progression|0|||
130402432|NCT03013491|469436418|FG018|Long-term Extension|Disease progression|1|||
130402433|NCT03013491|469436400|FG000|Long-term Extension|Withdrawal by Subject|0|||
130402434|NCT03013491|469436401|FG001|Long-term Extension|Withdrawal by Subject|0|||
130402435|NCT03013491|469436402|FG002|Long-term Extension|Withdrawal by Subject|0|||
130402436|NCT03013491|469436403|FG003|Long-term Extension|Withdrawal by Subject|0|||
130402437|NCT03013491|469436404|FG004|Long-term Extension|Withdrawal by Subject|0|||
130402438|NCT03013491|469436405|FG005|Long-term Extension|Withdrawal by Subject|0|||
130402439|NCT03013491|469436406|FG006|Long-term Extension|Withdrawal by Subject|0|||
130402440|NCT03013491|469436407|FG007|Long-term Extension|Withdrawal by Subject|1|||
130402441|NCT03013491|469436408|FG008|Long-term Extension|Withdrawal by Subject|0|||
130402442|NCT03013491|469436409|FG009|Long-term Extension|Withdrawal by Subject|0|||
130402443|NCT03013491|469436410|FG010|Long-term Extension|Withdrawal by Subject|0|||
130402444|NCT03013491|469436411|FG011|Long-term Extension|Withdrawal by Subject|0|||
130402445|NCT03013491|469436412|FG012|Long-term Extension|Withdrawal by Subject|0|||
130402446|NCT03013491|469436413|FG013|Long-term Extension|Withdrawal by Subject|0|||
130402447|NCT03013491|469436414|FG014|Long-term Extension|Withdrawal by Subject|0|||
130402448|NCT03013491|469436415|FG015|Long-term Extension|Withdrawal by Subject|0|||
130402449|NCT03013491|469436416|FG016|Long-term Extension|Withdrawal by Subject|0|||
130402450|NCT03013491|469436417|FG017|Long-term Extension|Withdrawal by Subject|0|||
130402451|NCT03013491|469436418|FG018|Long-term Extension|Withdrawal by Subject|0|||
130402452|NCT03013491|469436400|FG000|Long-term Extension|Adverse Event|0|||
130402453|NCT03013491|469436401|FG001|Long-term Extension|Adverse Event|0|||
130402454|NCT03013491|469436402|FG002|Long-term Extension|Adverse Event|0|||
130402455|NCT03013491|469436403|FG003|Long-term Extension|Adverse Event|0|||
130402456|NCT03013491|469436404|FG004|Long-term Extension|Adverse Event|0|||
130402457|NCT03013491|469436405|FG005|Long-term Extension|Adverse Event|0|||
130402458|NCT03013491|469436406|FG006|Long-term Extension|Adverse Event|0|||
130402459|NCT03013491|469436407|FG007|Long-term Extension|Adverse Event|0|||
130402460|NCT03013491|469436408|FG008|Long-term Extension|Adverse Event|0|||
130402461|NCT03013491|469436409|FG009|Long-term Extension|Adverse Event|0|||
130402462|NCT03013491|469436410|FG010|Long-term Extension|Adverse Event|0|||
130402463|NCT03013491|469436411|FG011|Long-term Extension|Adverse Event|0|||
130402464|NCT03013491|469436412|FG012|Long-term Extension|Adverse Event|0|||
130402465|NCT03013491|469436413|FG013|Long-term Extension|Adverse Event|0|||
130402466|NCT03013491|469436414|FG014|Long-term Extension|Adverse Event|0|||
130402467|NCT03013491|469436415|FG015|Long-term Extension|Adverse Event|0|||
130402468|NCT03013491|469436416|FG016|Long-term Extension|Adverse Event|0|||
130402469|NCT03013491|469436417|FG017|Long-term Extension|Adverse Event|0|||
130402470|NCT03013491|469436418|FG018|Long-term Extension|Adverse Event|1|||
130402471|NCT03013491|469436400|FG000|Long-term Extension|Death|0|||
130402472|NCT03013491|469436401|FG001|Long-term Extension|Death|0|||
130560873|NCT00529451|470022745|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
130560874|NCT00529451|470022742|FG000|Overall Study|Lost to Follow-up|4|||
130402473|NCT03013491|469436402|FG002|Long-term Extension|Death|0|||
130402474|NCT03013491|469436403|FG003|Long-term Extension|Death|0|||
130402475|NCT03013491|469436404|FG004|Long-term Extension|Death|0|||
130402476|NCT03013491|469436405|FG005|Long-term Extension|Death|0|||
130402477|NCT03013491|469436406|FG006|Long-term Extension|Death|0|||
130402478|NCT03013491|469436407|FG007|Long-term Extension|Death|0|||
130402479|NCT03013491|469436408|FG008|Long-term Extension|Death|0|||
130402480|NCT03013491|469436409|FG009|Long-term Extension|Death|0|||
130402481|NCT03013491|469436410|FG010|Long-term Extension|Death|0|||
130402482|NCT03013491|469436411|FG011|Long-term Extension|Death|0|||
130402483|NCT03013491|469436412|FG012|Long-term Extension|Death|0|||
130402484|NCT03013491|469436413|FG013|Long-term Extension|Death|0|||
130402485|NCT03013491|469436414|FG014|Long-term Extension|Death|0|||
130402486|NCT03013491|469436415|FG015|Long-term Extension|Death|0|||
130402487|NCT03013491|469436416|FG016|Long-term Extension|Death|0|||
130402488|NCT03013491|469436417|FG017|Long-term Extension|Death|0|||
130402489|NCT03013491|469436418|FG018|Long-term Extension|Death|1|||
130402490|NCT04740034|469436424|FG000|Overall Study|Death|0|||
130402491|NCT04740034|469436425|FG001|Overall Study|Death|1|||
130402492|NCT04740034|469436426|FG002|Overall Study|Death|2|||
130402493|NCT04740034|469436427|FG003|Overall Study|Death|3|||
130402494|NCT04740034|469436428|FG004|Overall Study|Death|4|||
130402495|NCT04740034|469436429|FG005|Overall Study|Death|4|||
130402496|NCT04740034|469436430|FG006|Overall Study|Death|2|||
130402497|NCT04740034|469436431|FG007|Overall Study|Death|2|||
130402498|NCT04740034|469436432|FG008|Overall Study|Death|2|||
130402499|NCT04740034|469436433|FG009|Overall Study|Death|4|||
130402500|NCT04740034|469436434|FG010|Overall Study|Death|0|||
130402501|NCT04740034|469436424|FG000|Overall Study|Lost to Follow-up|0|||
130402502|NCT04740034|469436425|FG001|Overall Study|Lost to Follow-up|0|||
130402503|NCT04740034|469436426|FG002|Overall Study|Lost to Follow-up|0|||
130402504|NCT04740034|469436427|FG003|Overall Study|Lost to Follow-up|1|||
130402505|NCT04740034|469436428|FG004|Overall Study|Lost to Follow-up|2|||
130402506|NCT04740034|469436429|FG005|Overall Study|Lost to Follow-up|2|||
130402507|NCT04740034|469436430|FG006|Overall Study|Lost to Follow-up|0|||
130402508|NCT04740034|469436431|FG007|Overall Study|Lost to Follow-up|0|||
130402509|NCT04740034|469436432|FG008|Overall Study|Lost to Follow-up|0|||
130402510|NCT04740034|469436433|FG009|Overall Study|Lost to Follow-up|1|||
130402511|NCT04740034|469436434|FG010|Overall Study|Lost to Follow-up|0|||
130402512|NCT04740034|469436424|FG000|Overall Study|Withdrawal by Subject|1|||
130402513|NCT04740034|469436425|FG001|Overall Study|Withdrawal by Subject|0|||
130402514|NCT04740034|469436426|FG002|Overall Study|Withdrawal by Subject|0|||
130402515|NCT04740034|469436427|FG003|Overall Study|Withdrawal by Subject|0|||
130402516|NCT04740034|469436428|FG004|Overall Study|Withdrawal by Subject|0|||
130402517|NCT04740034|469436429|FG005|Overall Study|Withdrawal by Subject|0|||
130402518|NCT04740034|469436430|FG006|Overall Study|Withdrawal by Subject|0|||
130402519|NCT04740034|469436431|FG007|Overall Study|Withdrawal by Subject|1|||
130402520|NCT04740034|469436432|FG008|Overall Study|Withdrawal by Subject|0|||
130402521|NCT04740034|469436433|FG009|Overall Study|Withdrawal by Subject|1|||
130402522|NCT04740034|469436434|FG010|Overall Study|Withdrawal by Subject|0|||
130402523|NCT04740034|469436424|FG000|Overall Study|Decision by sponsor|0|||
130402524|NCT04740034|469436425|FG001|Overall Study|Decision by sponsor|0|||
130402525|NCT04740034|469436426|FG002|Overall Study|Decision by sponsor|1|||
130402526|NCT04740034|469436427|FG003|Overall Study|Decision by sponsor|0|||
130402527|NCT04740034|469436428|FG004|Overall Study|Decision by sponsor|0|||
130402528|NCT04740034|469436429|FG005|Overall Study|Decision by sponsor|0|||
130402529|NCT04740034|469436430|FG006|Overall Study|Decision by sponsor|1|||
130402530|NCT04740034|469436431|FG007|Overall Study|Decision by sponsor|2|||
130402531|NCT04740034|469436432|FG008|Overall Study|Decision by sponsor|1|||
130402532|NCT04740034|469436433|FG009|Overall Study|Decision by sponsor|1|||
130560875|NCT00529451|470022743|FG001|Overall Study|Lost to Follow-up|7|||
130560876|NCT00529451|470022744|FG002|Overall Study|Lost to Follow-up|4|||
130560877|NCT00529451|470022745|FG003|Overall Study|Lost to Follow-up|4|||
130560878|NCT00529451|470022742|FG000|Overall Study|Protocol deviation|1|||
130560879|NCT00529451|470022743|FG001|Overall Study|Protocol deviation|1|||
130560880|NCT00529451|470022744|FG002|Overall Study|Protocol deviation|4|||
130560881|NCT00529451|470022745|FG003|Overall Study|Protocol deviation|1|||
130560882|NCT00529451|470022742|FG000|Overall Study|Administrative problems|1|||
130560883|NCT00529451|470022743|FG001|Overall Study|Administrative problems|1|||
130560884|NCT00529451|470022744|FG002|Overall Study|Administrative problems|0|||
130560885|NCT00529451|470022745|FG003|Overall Study|Administrative problems|2|||
130560886|NCT00590044|470022748|FG000|Overall Study|Withdrawal by Subject|2|||
130560887|NCT00590044|470022749|FG001|Overall Study|Withdrawal by Subject|2|||
130560888|NCT00590044|470022748|FG000|Overall Study|wrong insulin arm assigned|1|||
130560889|NCT00590044|470022749|FG001|Overall Study|wrong insulin arm assigned|0|||
130560890|NCT00590044|470022748|FG000|Overall Study|Protocol Violation|1|||
130560891|NCT00590044|470022749|FG001|Overall Study|Protocol Violation|0|||
130560892|NCT00773136|470022750|FG000|Overall Study|Physician Decision|2|||
130560893|NCT01010633|470022756|FG000|Overall Study|Adverse Event|1|||
130560894|NCT01010633|470022757|FG001|Overall Study|Adverse Event|1|||
130560895|NCT01010633|470022756|FG000|Overall Study|Protocol Violation|1|||
130560896|NCT01010633|470022757|FG001|Overall Study|Protocol Violation|2|||
130560897|NCT01010633|470022756|FG000|Overall Study|Withdrawal by Subject|2|||
130560898|NCT01010633|470022757|FG001|Overall Study|Withdrawal by Subject|1|||
130560899|NCT01010633|470022756|FG000|Overall Study|Investigator decision|0|||
130560900|NCT01010633|470022757|FG001|Overall Study|Investigator decision|1|||
130560901|NCT02463071|470022759|FG000|Overall Study|Adverse Event|3|||
130560902|NCT02463071|470022760|FG001|Overall Study|Adverse Event|5|||
130560903|NCT02463071|470022761|FG002|Overall Study|Adverse Event|1|||
130723776|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
130402533|NCT04740034|469436434|FG010|Overall Study|Decision by sponsor|2|||
130470816|NCT01017146|469690835|FG000|Overall Study|Took Excluded Medication|2|||
130470817|NCT01017146|469690836|FG001|Overall Study|Took Excluded Medication|0|||
130470818|NCT01017146|469690835|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130470819|NCT01017146|469690836|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130470820|NCT01017146|469690835|FG000|Overall Study|Change in Work Situation|1|||
130470821|NCT01017146|469690836|FG001|Overall Study|Change in Work Situation|0|||
130470822|NCT01084707|469690837|FG000|Overall Study|Withdrawal by Subject|6|||
130470823|NCT00901901|469690841|FG000|Treatment Period|Adverse Event|120|||
130470824|NCT00901901|469690842|FG001|Treatment Period|Adverse Event|128|||
130470825|NCT00901901|469690841|FG000|Treatment Period|Withdrawal by Subject|26|||
130470826|NCT00901901|469690842|FG001|Treatment Period|Withdrawal by Subject|24|||
130470827|NCT00901901|469690841|FG000|Treatment Period|Physician Decision|2|||
130470828|NCT00901901|469690842|FG001|Treatment Period|Physician Decision|2|||
130470829|NCT00901901|469690841|FG000|Treatment Period|Lost to Follow-up|3|||
130470830|NCT00901901|469690842|FG001|Treatment Period|Lost to Follow-up|5|||
130470831|NCT00901901|469690841|FG000|Treatment Period|Noncompliance with study medication|4|||
130470832|NCT00901901|469690842|FG001|Treatment Period|Noncompliance with study medication|1|||
130470833|NCT00901901|469690841|FG000|Treatment Period|Missing|1|||
130470834|NCT00901901|469690842|FG001|Treatment Period|Missing|0|||
130470835|NCT00901901|469690841|FG000|Treatment Period|Never treated|0|||
130470836|NCT00901901|469690842|FG001|Treatment Period|Never treated|3|||
130470837|NCT00901901|469690841|FG000|Treatment Period|Protocol driven decision point|0|||
130470838|NCT00901901|469690842|FG001|Treatment Period|Protocol driven decision point|2|||
130470839|NCT00901901|469690841|FG000|Treatment Period|Study terminated by sponsor|2|||
130470840|NCT00901901|469690842|FG001|Treatment Period|Study terminated by sponsor|0|||
130470841|NCT00901901|469690841|FG000|Treatment Period|Protocol Violation|5|||
130470842|NCT00901901|469690842|FG001|Treatment Period|Protocol Violation|9|||
130470843|NCT00901901|469690841|FG000|Treatment Period|Switch to commercial drug|1|||
130470844|NCT00901901|469690842|FG001|Treatment Period|Switch to commercial drug|1|||
130470845|NCT00901901|469690841|FG000|Treatment Period|Transfer to treatment continuation study|5|||
130470846|NCT00901901|469690842|FG001|Treatment Period|Transfer to treatment continuation study|2|||
130402534|NCT04524403|469437915|FG000|Overall Study|Withdrawal by Subject|10|||
130402535|NCT04524403|469437916|FG001|Overall Study|Withdrawal by Subject|3|||
130402536|NCT04524403|469437917|FG002|Overall Study|Withdrawal by Subject|8|||
130402537|NCT04524403|469437915|FG000|Overall Study|Lost to Follow-up|3|||
130402538|NCT04524403|469437916|FG001|Overall Study|Lost to Follow-up|4|||
130402539|NCT04524403|469437917|FG002|Overall Study|Lost to Follow-up|3|||
130402540|NCT04524403|469437915|FG000|Overall Study|Adverse Event|3|||
130402541|NCT04524403|469437916|FG001|Overall Study|Adverse Event|1|||
130402542|NCT04524403|469437917|FG002|Overall Study|Adverse Event|4|||
130402543|NCT04524403|469437915|FG000|Overall Study|Non-compliant with study drug|1|||
130402544|NCT04524403|469437916|FG001|Overall Study|Non-compliant with study drug|2|||
130402545|NCT04524403|469437917|FG002|Overall Study|Non-compliant with study drug|3|||
130402546|NCT04524403|469437915|FG000|Overall Study|Moved|0|||
130402547|NCT04524403|469437916|FG001|Overall Study|Moved|1|||
130402548|NCT04524403|469437917|FG002|Overall Study|Moved|0|||
130402549|NCT02349711|469437921|FG000|Overall Study|Withdrawal by Subject|2|||
130402550|NCT02349711|469437922|FG001|Overall Study|Withdrawal by Subject|1|||
130402551|NCT02349711|469437921|FG000|Overall Study|Lost to Follow-up|1|||
130402552|NCT02349711|469437922|FG001|Overall Study|Lost to Follow-up|1|||
130402553|NCT02564198|469437923|FG000|Overall Study|Withdrawal by Subject|2|||
130402554|NCT02564198|469437924|FG001|Overall Study|Withdrawal by Subject|4|||
130402555|NCT02564198|469437925|FG002|Overall Study|Withdrawal by Subject|0|||
130402556|NCT02564198|469437923|FG000|Overall Study|Adverse Event|0|||
130402557|NCT02564198|469437924|FG001|Overall Study|Adverse Event|1|||
130402558|NCT02564198|469437925|FG002|Overall Study|Adverse Event|0|||
130402559|NCT02200042|469437926|FG000|Overall Study|Withdrawal by Subject|0|||
130402560|NCT02200042|469437927|FG001|Overall Study|Withdrawal by Subject|1|||
130402561|NCT02097134|469437928|FG000|Overall Study|Physician Decision|4|||
130402562|NCT02097134|469437928|FG000|Overall Study|Non-Protocol Therapy|1|||
130402563|NCT02097134|469437928|FG000|Overall Study|Progressive Disease|3|||
130402564|NCT02097134|469437928|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
130402565|NCT00298896|469437936|FG000|Overall Study|Death|3|||
130402566|NCT00298896|469437936|FG000|Overall Study|Physician Decision|2|||
130402567|NCT00298896|469437936|FG000|Overall Study|Intercurrent Illness|1|||
130402568|NCT00298896|469437936|FG000|Overall Study|Disease Progression|41|||
130402569|NCT00298896|469437936|FG000|Overall Study|Withdrawal by Subject|2|||
130402570|NCT00298896|469437936|FG000|Overall Study|Assigned to treatment in error|1|||
130402571|NCT02649972|469437939|FG000|Overall Study|Not treated|1|||
130402572|NCT03394391|469437942|FG000|Overall Study|Lost to Follow-up|1|||
130402573|NCT03394391|469437943|FG001|Overall Study|Lost to Follow-up|2|||
130402574|NCT02652624|469437944|FG000|Randomized Phase|Pregnancy|3|||
130402575|NCT02652624|469437945|FG001|Randomized Phase|Pregnancy|1|||
130402576|NCT02652624|469437944|FG000|Randomized Phase|Investigator's Discretion|0|||
130402577|NCT02652624|469437945|FG001|Randomized Phase|Investigator's Discretion|2|||
130402578|NCT02652624|469437944|FG000|Randomized Phase|Death|0|||
130402579|NCT02652624|469437945|FG001|Randomized Phase|Death|1|||
130402580|NCT02652624|469437944|FG000|Randomized Phase|Lost to Follow-up|0|||
130402581|NCT02652624|469437945|FG001|Randomized Phase|Lost to Follow-up|1|||
130402582|NCT02652624|469437944|FG000|Extension Phase|Lost to Follow-up|3|||
130402583|NCT02652624|469437945|FG001|Extension Phase|Lost to Follow-up|1|||
130402584|NCT02652624|469437944|FG000|Extension Phase|Pregnancy|1|||
130402585|NCT02652624|469437945|FG001|Extension Phase|Pregnancy|1|||
130402586|NCT02652624|469437944|FG000|Extension Phase|Adverse Event|0|||
130402587|NCT02652624|469437945|FG001|Extension Phase|Adverse Event|1|||
130402588|NCT02652624|469437944|FG000|Extension Phase|Withdrew Consent|0|||
130402589|NCT02652624|469437945|FG001|Extension Phase|Withdrew Consent|1|||
130402590|NCT01023659|469437946|FG000|Overall Study|Lost to Follow-up|73|||
130402591|NCT01023659|469437947|FG001|Overall Study|Lost to Follow-up|228|||
130402592|NCT01023659|469437948|FG002|Overall Study|Lost to Follow-up|99|||
130402593|NCT00912405|469437951|FG000|Overall Study|Lost to Follow-up|5|||
130402594|NCT00501540|469437952|FG000|Overall Study|Death|5|||
130402595|NCT00519649|469437953|FG000|Overall Study|Withdrawal by Subject|1|||
130402596|NCT04879745|469437954|FG000|Overall Study|Lost to Follow-up|4|||
130402597|NCT04879745|469437955|FG001|Overall Study|Lost to Follow-up|1|||
130402598|NCT02984995|469437957|FG000|Overall Study|Required stem cell transplant|13|||
130402599|NCT02984995|469437958|FG001|Overall Study|Required stem cell transplant|2|||
130402600|NCT02984995|469437957|FG000|Overall Study|Progressive disease|11|||
130402601|NCT02984995|469437958|FG001|Overall Study|Progressive disease|1|||
130402602|NCT02984995|469437957|FG000|Overall Study|Adverse Event|1|||
130402603|NCT02984995|469437958|FG001|Overall Study|Adverse Event|0|||
130402604|NCT00482391|469437959|FG000|Overall Study|Withdrawal by Subject|1|||
130402605|NCT00482391|469437959|FG000|Overall Study|Adverse Event|1|||
130402606|NCT00482391|469437959|FG000|Overall Study|Death|1|||
130402607|NCT01448850|469437960|FG000|Overall Study|Death|3|||
130402608|NCT01448850|469437961|FG001|Overall Study|Death|6|||
130402609|NCT01448850|469437960|FG000|Overall Study|Withdrawal by Subject|13|||
130402610|NCT01448850|469437961|FG001|Overall Study|Withdrawal by Subject|21|||
130402611|NCT01448850|469437960|FG000|Overall Study|Lost to Follow-up|3|||
130402612|NCT01448850|469437961|FG001|Overall Study|Lost to Follow-up|1|||
130560904|NCT02463071|470022759|FG000|Overall Study|Death|1|||
130560905|NCT02463071|470022760|FG001|Overall Study|Death|0|||
130560906|NCT02463071|470022761|FG002|Overall Study|Death|0|||
130560907|NCT02463071|470022759|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130560908|NCT02463071|470022760|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130560909|NCT02463071|470022761|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130560910|NCT02463071|470022759|FG000|Overall Study|Reason not specified|7|||
130560911|NCT02463071|470022760|FG001|Overall Study|Reason not specified|9|||
130560912|NCT02463071|470022761|FG002|Overall Study|Reason not specified|4|||
130560913|NCT02463071|470022759|FG000|Overall Study|Protocol Violation|0|||
130560914|NCT02463071|470022760|FG001|Overall Study|Protocol Violation|2|||
130560915|NCT02463071|470022761|FG002|Overall Study|Protocol Violation|0|||
130560916|NCT02463071|470022759|FG000|Overall Study|Lost to Follow-up|0|||
130560917|NCT02463071|470022760|FG001|Overall Study|Lost to Follow-up|0|||
130560918|NCT02463071|470022761|FG002|Overall Study|Lost to Follow-up|1|||
130560919|NCT00888381|470022765|FG000|Overall Study|Lost to Follow-up|0|||
130560920|NCT00888381|470022766|FG001|Overall Study|Lost to Follow-up|1|||
130560921|NCT00097773|470022767|FG000|Overall Study|Lost to Follow-up|2|||
130560922|NCT00097773|470022768|FG001|Overall Study|Lost to Follow-up|2|||
130560923|NCT00097773|470022769|FG002|Overall Study|Lost to Follow-up|0|||
130560924|NCT00097773|470022770|FG003|Overall Study|Lost to Follow-up|1|||
130560925|NCT00097773|470022767|FG000|Overall Study|Physician Decision|2|||
130560926|NCT00097773|470022768|FG001|Overall Study|Physician Decision|2|||
130560927|NCT00097773|470022769|FG002|Overall Study|Physician Decision|3|||
130560928|NCT00097773|470022770|FG003|Overall Study|Physician Decision|1|||
130560929|NCT00097773|470022767|FG000|Overall Study|Withdrawal by Subject|3|||
130560930|NCT00097773|470022768|FG001|Overall Study|Withdrawal by Subject|3|||
130560931|NCT00097773|470022769|FG002|Overall Study|Withdrawal by Subject|3|||
130560932|NCT00097773|470022770|FG003|Overall Study|Withdrawal by Subject|1|||
130560933|NCT00097773|470022767|FG000|Overall Study|Adverse Event|0|||
130560934|NCT00097773|470022768|FG001|Overall Study|Adverse Event|1|||
130560935|NCT00097773|470022769|FG002|Overall Study|Adverse Event|0|||
130560936|NCT00097773|470022770|FG003|Overall Study|Adverse Event|0|||
130560937|NCT00097773|470022767|FG000|Overall Study|Other|1|||
130560938|NCT00097773|470022768|FG001|Overall Study|Other|0|||
130560939|NCT00097773|470022769|FG002|Overall Study|Other|2|||
130560940|NCT00097773|470022770|FG003|Overall Study|Other|0|||
130560941|NCT00003702|470022771|FG000|Overall Study|Ineligible cell types|2|||
130470847|NCT00901901|469690841|FG000|Follow-up Period|Death|181|||
130470848|NCT00901901|469690842|FG001|Follow-up Period|Death|208|||
130470849|NCT00901901|469690841|FG000|Follow-up Period|Protocol driven decision point|47|||
130470850|NCT00901901|469690842|FG001|Follow-up Period|Protocol driven decision point|36|||
130470851|NCT00901901|469690841|FG000|Follow-up Period|Withdrawal by Subject|6|||
130470852|NCT00901901|469690842|FG001|Follow-up Period|Withdrawal by Subject|9|||
130470853|NCT00901901|469690841|FG000|Follow-up Period|Lost to Follow-up|12|||
130470854|NCT00901901|469690842|FG001|Follow-up Period|Lost to Follow-up|8|||
130470855|NCT00901901|469690841|FG000|Follow-up Period|Missing|94|||
130470856|NCT00901901|469690842|FG001|Follow-up Period|Missing|80|||
130470857|NCT02272816|469690845|FG000|Overall Study|Adverse Event|1|||
130470858|NCT05171777|469690846|FG000|Treatment Crossover Period|Adverse Event|9|||
130470859|NCT05171777|469690847|FG001|Treatment Crossover Period|Adverse Event|6|||
130470860|NCT05171777|469690848|FG002|Treatment Crossover Period|Adverse Event|0|||
130470861|NCT05171777|469690849|FG003|Treatment Crossover Period|Adverse Event|0|||
130470862|NCT05171777|469690846|FG000|Treatment Crossover Period|Death|5|||
130470863|NCT05171777|469690847|FG001|Treatment Crossover Period|Death|5|||
130470864|NCT05171777|469690848|FG002|Treatment Crossover Period|Death|0|||
130470865|NCT05171777|469690849|FG003|Treatment Crossover Period|Death|0|||
130470866|NCT05171777|469690846|FG000|Treatment Crossover Period|Disease Relapse|0|||
130470867|NCT05171777|469690847|FG001|Treatment Crossover Period|Disease Relapse|1|||
130560942|NCT00003702|470022772|FG001|Overall Study|Ineligible cell types|2|||
130560943|NCT00003702|470022771|FG000|Overall Study|Did not meet criteria for persistence|8|||
130560944|NCT00003702|470022772|FG001|Overall Study|Did not meet criteria for persistence|5|||
130560945|NCT00003702|470022771|FG000|Overall Study|WHO score > 6|2|||
130470868|NCT05171777|469690848|FG002|Treatment Crossover Period|Disease Relapse|0|||
130470869|NCT05171777|469690849|FG003|Treatment Crossover Period|Disease Relapse|0|||
130560946|NCT00003702|470022772|FG001|Overall Study|WHO score > 6|1|||
130470870|NCT05171777|469690846|FG000|Treatment Crossover Period|Reason not Specified|2|||
130470871|NCT05171777|469690847|FG001|Treatment Crossover Period|Reason not Specified|1|||
130470872|NCT05171777|469690848|FG002|Treatment Crossover Period|Reason not Specified|0|||
130470873|NCT05171777|469690849|FG003|Treatment Crossover Period|Reason not Specified|0|||
130560947|NCT00003702|470022771|FG000|Overall Study|Inadequate documentation of disease|1|||
130560948|NCT00003702|470022772|FG001|Overall Study|Inadequate documentation of disease|3|||
130560949|NCT01009034|470022773|FG000|Overall Study|Lost to Follow-up|2|||
130560950|NCT01009034|470022773|FG000|Overall Study|Withdrawal by Subject|2|||
130560951|NCT01494350|470022774|FG000|Overall Study|Worsening of lesion|1|||
130560952|NCT02054325|470022776|FG000|Overall Study|Lost to Follow-up|8|||
130560953|NCT02054325|470022777|FG001|Overall Study|Lost to Follow-up|5|||
130402613|NCT01448850|469437960|FG000|Overall Study|Other|15|||
130402614|NCT01448850|469437961|FG001|Overall Study|Other|12|||
130402615|NCT02939404|469437962|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
130402616|NCT02939404|469437963|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
130402617|NCT02939404|469437962|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
130402618|NCT02939404|469437963|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
130402619|NCT04304001|469437968|FG000|Overall Study|Lost to Follow-up|13|||
130402620|NCT04304001|469437969|FG001|Overall Study|Lost to Follow-up|9|||
130402621|NCT06640829|469437972|FG000|Overall Study|Withdrawal by Subject|1|||
130402622|NCT06640829|469437972|FG000|Overall Study|Lost to Follow-up|1|||
130402623|NCT01350128|469437982|FG000|Overall Study|Withdrawal by Subject|3|||
130402624|NCT01350128|469437982|FG000|Overall Study|Protocol discontinuation criteria|8|||
130402625|NCT01350128|469437982|FG000|Overall Study|Physician Decision|1|||
130402626|NCT01350128|469437982|FG000|Overall Study|Lost to Follow-up|2|||
130402627|NCT01109316|469437984|FG000|Study Period 1|Adverse Event|0|||
130402628|NCT01109316|469437985|FG001|Study Period 1|Adverse Event|0|||
130402629|NCT01109316|469437986|FG002|Study Period 1|Adverse Event|1|||
130402630|NCT01109316|469437987|FG003|Study Period 1|Adverse Event|0|||
130402631|NCT01109316|469437988|FG004|Study Period 1|Adverse Event|0|||
130402632|NCT01109316|469437989|FG005|Study Period 1|Adverse Event|0|||
130402633|NCT01109316|469437984|FG000|Study Period 1|Lost to Follow-up|0|||
130402634|NCT01109316|469437985|FG001|Study Period 1|Lost to Follow-up|0|||
130402635|NCT01109316|469437986|FG002|Study Period 1|Lost to Follow-up|1|||
130402636|NCT01109316|469437987|FG003|Study Period 1|Lost to Follow-up|1|||
130402637|NCT01109316|469437988|FG004|Study Period 1|Lost to Follow-up|0|||
130402638|NCT01109316|469437989|FG005|Study Period 1|Lost to Follow-up|0|||
130402639|NCT01109316|469437984|FG000|Study Period 1|Withdrawal by Subject|0|||
130402640|NCT01109316|469437985|FG001|Study Period 1|Withdrawal by Subject|0|||
130402641|NCT01109316|469437986|FG002|Study Period 1|Withdrawal by Subject|1|||
130402642|NCT01109316|469437987|FG003|Study Period 1|Withdrawal by Subject|0|||
130402643|NCT01109316|469437988|FG004|Study Period 1|Withdrawal by Subject|2|||
130402644|NCT01109316|469437989|FG005|Study Period 1|Withdrawal by Subject|0|||
130402645|NCT01109316|469437984|FG000|Study Period 1|Sponsor Decision|0|||
130402646|NCT01109316|469437985|FG001|Study Period 1|Sponsor Decision|0|||
130402647|NCT01109316|469437986|FG002|Study Period 1|Sponsor Decision|0|||
130402648|NCT01109316|469437987|FG003|Study Period 1|Sponsor Decision|0|||
130402649|NCT01109316|469437988|FG004|Study Period 1|Sponsor Decision|0|||
130402650|NCT01109316|469437989|FG005|Study Period 1|Sponsor Decision|2|||
130402651|NCT01109316|469437984|FG000|Study Period 2|Entry Criteria Not Met|0|||
130402652|NCT01109316|469437985|FG001|Study Period 2|Entry Criteria Not Met|1|||
130402653|NCT01109316|469437986|FG002|Study Period 2|Entry Criteria Not Met|0|||
130402654|NCT01109316|469437987|FG003|Study Period 2|Entry Criteria Not Met|0|||
130402655|NCT01109316|469437988|FG004|Study Period 2|Entry Criteria Not Met|0|||
130402656|NCT01109316|469437989|FG005|Study Period 2|Entry Criteria Not Met|0|||
130402657|NCT01109316|469437984|FG000|Study Period 2|Physician Decision|0|||
130402658|NCT01109316|469437985|FG001|Study Period 2|Physician Decision|0|||
130402659|NCT01109316|469437986|FG002|Study Period 2|Physician Decision|0|||
130402660|NCT01109316|469437987|FG003|Study Period 2|Physician Decision|1|||
130402661|NCT01109316|469437988|FG004|Study Period 2|Physician Decision|0|||
130402662|NCT01109316|469437989|FG005|Study Period 2|Physician Decision|0|||
130402663|NCT01109316|469437984|FG000|Study Period 2|Protocol Violation|1|||
130402664|NCT01109316|469437985|FG001|Study Period 2|Protocol Violation|0|||
130402665|NCT01109316|469437986|FG002|Study Period 2|Protocol Violation|0|||
130470874|NCT05171777|469690846|FG000|Treatment Crossover Period|Physician Decision|0|||
130470875|NCT05171777|469690847|FG001|Treatment Crossover Period|Physician Decision|1|||
130470876|NCT05171777|469690848|FG002|Treatment Crossover Period|Physician Decision|0|||
130470877|NCT05171777|469690849|FG003|Treatment Crossover Period|Physician Decision|0|||
130470878|NCT05171777|469690846|FG000|Treatment Crossover Period|Progressive Disease|13|||
130402666|NCT01109316|469437987|FG003|Study Period 2|Protocol Violation|0|||
130402667|NCT01109316|469437988|FG004|Study Period 2|Protocol Violation|0|||
130402668|NCT01109316|469437989|FG005|Study Period 2|Protocol Violation|0|||
130402669|NCT01109316|469437984|FG000|Study Period 2|Withdrawal by Subject|0|||
130402670|NCT01109316|469437985|FG001|Study Period 2|Withdrawal by Subject|0|||
130402671|NCT01109316|469437986|FG002|Study Period 2|Withdrawal by Subject|1|||
130470879|NCT05171777|469690847|FG001|Treatment Crossover Period|Progressive Disease|9|||
130402672|NCT01109316|469437987|FG003|Study Period 2|Withdrawal by Subject|0|||
130402673|NCT01109316|469437988|FG004|Study Period 2|Withdrawal by Subject|0|||
130402674|NCT01109316|469437989|FG005|Study Period 2|Withdrawal by Subject|1|||
130402675|NCT01109316|469437984|FG000|Study Period 3|Lost to Follow-up|0|||
130402676|NCT01109316|469437985|FG001|Study Period 3|Lost to Follow-up|0|||
130402677|NCT01109316|469437986|FG002|Study Period 3|Lost to Follow-up|0|||
130470880|NCT05171777|469690848|FG002|Treatment Crossover Period|Progressive Disease|0|||
130402678|NCT01109316|469437987|FG003|Study Period 3|Lost to Follow-up|0|||
130402679|NCT01109316|469437988|FG004|Study Period 3|Lost to Follow-up|1|||
130402680|NCT01109316|469437989|FG005|Study Period 3|Lost to Follow-up|0|||
130402681|NCT01109316|469437984|FG000|Study Period 3|Withdrawal by Subject|1|||
130402682|NCT01109316|469437985|FG001|Study Period 3|Withdrawal by Subject|0|||
130402683|NCT01109316|469437986|FG002|Study Period 3|Withdrawal by Subject|0|||
130402684|NCT01109316|469437987|FG003|Study Period 3|Withdrawal by Subject|0|||
130402685|NCT01109316|469437988|FG004|Study Period 3|Withdrawal by Subject|1|||
130402686|NCT01109316|469437989|FG005|Study Period 3|Withdrawal by Subject|0|||
130402687|NCT00094653|469437999|FG000|Overall Study|Death|306|||
130402688|NCT00094653|469438000|FG001|Overall Study|Death|100|||
130402689|NCT00094653|469438001|FG002|Overall Study|Death|119|||
130402690|NCT00094653|469437999|FG000|Overall Study|Subject Withdrew Consent|10|||
130402691|NCT00094653|469438000|FG001|Overall Study|Subject Withdrew Consent|2|||
130402692|NCT00094653|469438001|FG002|Overall Study|Subject Withdrew Consent|3|||
130402693|NCT00094653|469437999|FG000|Overall Study|Other|2|||
130402694|NCT00094653|469438000|FG001|Overall Study|Other|2|||
130402695|NCT00094653|469438001|FG002|Overall Study|Other|2|||
130402696|NCT00094653|469437999|FG000|Overall Study|Lost to Follow-up|3|||
130402697|NCT00094653|469438000|FG001|Overall Study|Lost to Follow-up|2|||
130402698|NCT00094653|469438001|FG002|Overall Study|Lost to Follow-up|1|||
130402699|NCT00094653|469437999|FG000|Overall Study|Protocol Violation|0|||
130402700|NCT00094653|469438000|FG001|Overall Study|Protocol Violation|0|||
130402701|NCT00094653|469438001|FG002|Overall Study|Protocol Violation|1|||
130402702|NCT03921411|469438002|FG000|Overall Study|Withdrawal by Subject|1|||
130402703|NCT03921411|469438002|FG000|Overall Study|Protocol Deviation|2|||
130402704|NCT03921411|469438002|FG000|Overall Study|Enrolled, but never treated|2|||
130402705|NCT01541826|469438005|FG000|Overall Study|Lost to Follow-up|2|||
130470881|NCT05171777|469690849|FG003|Treatment Crossover Period|Progressive Disease|0|||
130470882|NCT05171777|469690846|FG000|Treatment Crossover Period|Protocol Violation|0|||
130470883|NCT05171777|469690847|FG001|Treatment Crossover Period|Protocol Violation|2|||
130470884|NCT05171777|469690848|FG002|Treatment Crossover Period|Protocol Violation|0|||
130470885|NCT05171777|469690849|FG003|Treatment Crossover Period|Protocol Violation|0|||
130470886|NCT05171777|469690846|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
130470887|NCT05171777|469690847|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
130470888|NCT05171777|469690848|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
130470889|NCT05171777|469690849|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
130470890|NCT05171777|469690846|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
130470891|NCT05171777|469690847|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
130470892|NCT05171777|469690848|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
130470893|NCT05171777|469690849|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
130560954|NCT00617604|470022778|FG000|Overall Study|Death|2|||
130560955|NCT00617604|470022779|FG001|Overall Study|Death|1|||
130560956|NCT00617604|470022778|FG000|Overall Study|Lost to Follow-up|1|||
130560957|NCT00617604|470022779|FG001|Overall Study|Lost to Follow-up|0|||
130560958|NCT00617604|470022778|FG000|Overall Study|Miscellaneous Reasons|8|||
130560959|NCT00617604|470022779|FG001|Overall Study|Miscellaneous Reasons|10|||
130723777|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130723778|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130723779|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
130723780|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
130723781|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130723782|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130723783|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
130723784|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
130723785|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
130402706|NCT01541826|469438006|FG001|Overall Study|Lost to Follow-up|3|||
130402707|NCT01541826|469438007|FG002|Overall Study|Lost to Follow-up|0|||
130402708|NCT01541826|469438005|FG000|Overall Study|Withdrawal by Subject|2|||
130402709|NCT01541826|469438006|FG001|Overall Study|Withdrawal by Subject|0|||
130723786|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130723787|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130723788|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
130723789|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130723790|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
130723791|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130723792|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130723793|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
130723794|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130723795|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130723796|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
130723797|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130723798|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
130723799|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130723800|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130723801|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
130723802|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
130723803|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
130723804|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130723805|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130723806|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
130402710|NCT01541826|469438007|FG002|Overall Study|Withdrawal by Subject|0|||
130402711|NCT01365273|469438010|FG000|Overall Study|Lost to Follow-up|1|||
130402712|NCT01365273|469438011|FG001|Overall Study|Lost to Follow-up|0|||
130402713|NCT01365273|469438010|FG000|Overall Study|Protocol Violation|0|||
130402714|NCT01365273|469438011|FG001|Overall Study|Protocol Violation|1|||
130402715|NCT01365273|469438010|FG000|Overall Study|Physician Decision|1|||
130402716|NCT01365273|469438011|FG001|Overall Study|Physician Decision|0|||
130402717|NCT00854581|469438014|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
130723807|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130723808|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130723809|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
130723810|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130723811|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130723812|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
130723813|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130723814|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130723815|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
130723816|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130723817|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130723818|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
130723819|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
130723820|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
130723821|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
130723822|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130723823|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130723824|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
130723825|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
130402718|NCT00854581|469438014|FG000|Induction (Up to Day 21)|Death|1|||
130470894|NCT05171777|469690846|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
130470895|NCT05171777|469690847|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
130470896|NCT05171777|469690848|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
130470897|NCT05171777|469690849|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
130470898|NCT05171777|469690846|FG000|Treatment Continuation Period|Death|0|||
130470899|NCT05171777|469690847|FG001|Treatment Continuation Period|Death|0|||
130470900|NCT05171777|469690848|FG002|Treatment Continuation Period|Death|1|||
130470901|NCT05171777|469690849|FG003|Treatment Continuation Period|Death|6|||
130470902|NCT05171777|469690846|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
130470903|NCT05171777|469690847|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
130470904|NCT05171777|469690848|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
130470905|NCT05171777|469690849|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
130470906|NCT00632749|469690852|FG000|Overall Study|Progressive disease|3|||
130470907|NCT00632749|469690853|FG001|Overall Study|Progressive disease|2|||
130470908|NCT00632749|469690854|FG002|Overall Study|Progressive disease|2|||
130470909|NCT00632749|469690855|FG003|Overall Study|Progressive disease|2|||
130470910|NCT00632749|469690856|FG004|Overall Study|Progressive disease|4|||
130470911|NCT00632749|469690857|FG005|Overall Study|Progressive disease|4|||
130470912|NCT00632749|469690858|FG006|Overall Study|Progressive disease|3|||
130402719|NCT00854581|469438014|FG000|Induction (Up to Day 21)|Physician Decision|1|||
130402720|NCT00854581|469438014|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
130402721|NCT01339390|469438015|FG000|Overall Study|Death|32|||
130402722|NCT01339390|469438016|FG001|Overall Study|Death|29|||
130402723|NCT01339390|469438015|FG000|Overall Study|Lost to Follow-up|125|||
130402724|NCT01339390|469438016|FG001|Overall Study|Lost to Follow-up|127|||
130402725|NCT04847674|469438017|FG000|Overall Study|Withdrawal by Subject|0|||
130402726|NCT04847674|469438018|FG001|Overall Study|Withdrawal by Subject|1|||
130402727|NCT04847674|469438019|FG002|Overall Study|Withdrawal by Subject|0|||
130402728|NCT04847674|469438017|FG000|Overall Study|Lost to Follow-up|0|||
130402729|NCT04847674|469438018|FG001|Overall Study|Lost to Follow-up|0|||
130402730|NCT04847674|469438019|FG002|Overall Study|Lost to Follow-up|2|||
130402731|NCT04847674|469438017|FG000|Overall Study|Other than specified|21|||
130402732|NCT04847674|469438018|FG001|Overall Study|Other than specified|20|||
130402733|NCT04847674|469438019|FG002|Overall Study|Other than specified|20|||
130402734|NCT03254134|469438021|FG000|Overall Study|Not eligible patients|599|||
130402735|NCT03254134|469438022|FG001|Overall Study|Not eligible patients|3630|||
130402736|NCT02563028|469438023|FG000|Overall Study|Lack of equipment|1|||
130402737|NCT02563028|469438023|FG000|Overall Study|Unable to elicit VEP post induction|1|||
130402738|NCT00378703|469438024|FG000|Overall Study|Disease progression|59|||
130402739|NCT00378703|469438025|FG001|Overall Study|Disease progression|43|||
130402740|NCT00378703|469438026|FG002|Overall Study|Disease progression|48|||
130402741|NCT00378703|469438027|FG003|Overall Study|Disease progression|49|||
130402742|NCT00378703|469438024|FG000|Overall Study|Adverse Event|11|||
130402743|NCT00378703|469438025|FG001|Overall Study|Adverse Event|17|||
130402744|NCT00378703|469438026|FG002|Overall Study|Adverse Event|20|||
130402745|NCT00378703|469438027|FG003|Overall Study|Adverse Event|18|||
130402746|NCT00378703|469438024|FG000|Overall Study|Death|2|||
130402747|NCT00378703|469438025|FG001|Overall Study|Death|2|||
130402748|NCT00378703|469438026|FG002|Overall Study|Death|4|||
130402749|NCT00378703|469438027|FG003|Overall Study|Death|3|||
130402750|NCT00378703|469438024|FG000|Overall Study|Withdrawal by Subject|4|||
130402751|NCT00378703|469438025|FG001|Overall Study|Withdrawal by Subject|8|||
130402752|NCT00378703|469438026|FG002|Overall Study|Withdrawal by Subject|5|||
130402753|NCT00378703|469438027|FG003|Overall Study|Withdrawal by Subject|7|||
130723826|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
130723827|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
130723828|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130723829|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130723830|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
130723831|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130723832|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130723833|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
130723834|NCT00205803|470613540|FG000|Infant Series|Lost to Follow-up|10|||
130723835|NCT00205803|470613541|FG001|Infant Series|Lost to Follow-up|4|||
130723836|NCT00205803|470613540|FG000|Infant Series|Withdrawal by Subject|2|||
130723837|NCT00205803|470613541|FG001|Infant Series|Withdrawal by Subject|5|||
130723838|NCT00205803|470613540|FG000|Infant Series|Physician Decision|3|||
130723839|NCT00205803|470613541|FG001|Infant Series|Physician Decision|1|||
130723840|NCT00205803|470613540|FG000|Infant Series|Protocol Violation|1|||
130723841|NCT00205803|470613541|FG001|Infant Series|Protocol Violation|0|||
130723842|NCT00205803|470613540|FG000|Infant Series|Lost Kaiser coverage|0|||
130723843|NCT00205803|470613541|FG001|Infant Series|Lost Kaiser coverage|1|||
130723844|NCT00205803|470613540|FG000|Infant Series|Non-compliant|1|||
130723845|NCT00205803|470613541|FG001|Infant Series|Non-compliant|0|||
130723846|NCT00205803|470613540|FG000|Infant Series|Sponsor request|1|||
130723847|NCT00205803|470613541|FG001|Infant Series|Sponsor request|0|||
130723848|NCT00205803|470613540|FG000|After Infant Series|Adverse Event|1|||
130723849|NCT00205803|470613541|FG001|After Infant Series|Adverse Event|1|||
130723850|NCT00205803|470613540|FG000|After Infant Series|Protocol Violation|1|||
130723851|NCT00205803|470613541|FG001|After Infant Series|Protocol Violation|1|||
130723852|NCT00205803|470613540|FG000|After Infant Series|Lost to Follow-up|2|||
130723853|NCT00205803|470613541|FG001|After Infant Series|Lost to Follow-up|1|||
130723854|NCT00205803|470613540|FG000|After Infant Series|Physician Decision|3|||
130723855|NCT00205803|470613541|FG001|After Infant Series|Physician Decision|2|||
130723856|NCT00205803|470613540|FG000|After Infant Series|Withdrawal by Subject|1|||
130723857|NCT00205803|470613541|FG001|After Infant Series|Withdrawal by Subject|4|||
130723858|NCT00205803|470613540|FG000|After Infant Series|Other|10|||
130723859|NCT00205803|470613541|FG001|After Infant Series|Other|4|||
130402754|NCT00378703|469438024|FG000|Overall Study|Physician Decision|1|||
130402755|NCT00378703|469438025|FG001|Overall Study|Physician Decision|4|||
130560960|NCT00617604|470022778|FG000|Overall Study|Withdrawal by Subject|4|||
130723860|NCT00205803|470613540|FG000|Toddler Dose|Lost to Follow-up|2|||
130402756|NCT00378703|469438026|FG002|Overall Study|Physician Decision|1|||
130402757|NCT00378703|469438027|FG003|Overall Study|Physician Decision|0|||
130402758|NCT00378703|469438024|FG000|Overall Study|Alternative therapy|4|||
130402759|NCT00378703|469438025|FG001|Overall Study|Alternative therapy|2|||
130402760|NCT00378703|469438026|FG002|Overall Study|Alternative therapy|0|||
130402761|NCT00378703|469438027|FG003|Overall Study|Alternative therapy|0|||
130402762|NCT00378703|469438024|FG000|Overall Study|Other complicated disease|0|||
130402763|NCT00378703|469438025|FG001|Overall Study|Other complicated disease|2|||
130723861|NCT00205803|470613541|FG001|Toddler Dose|Lost to Follow-up|3|||
130723862|NCT02369458|470613548|FG000|Overall Study|Determined to be not eligible|1|||
130723863|NCT02369458|470613549|FG001|Overall Study|Determined to be not eligible|0|||
130723864|NCT04572893|470613550|FG000|Part A|Adverse Event|1|||
130723865|NCT04572893|470613551|FG001|Part A|Adverse Event|0|||
130723866|NCT04572893|470613552|FG002|Part A|Adverse Event|0|||
130723867|NCT04572893|470613553|FG003|Part A|Adverse Event|0|||
130723868|NCT04572893|470613554|FG004|Part A|Adverse Event|0|||
130723869|NCT04572893|470613555|FG005|Part A|Adverse Event|0|||
130723870|NCT04572893|470613556|FG006|Part A|Adverse Event|0|||
130723871|NCT04572893|470613550|FG000|Part B|Withdrawal by Subject|0|||
130723872|NCT04572893|470613551|FG001|Part B|Withdrawal by Subject|0|||
130723873|NCT04572893|470613552|FG002|Part B|Withdrawal by Subject|0|||
130723874|NCT04572893|470613553|FG003|Part B|Withdrawal by Subject|0|||
130723875|NCT04572893|470613554|FG004|Part B|Withdrawal by Subject|0|||
130723876|NCT04572893|470613555|FG005|Part B|Withdrawal by Subject|1|||
130723877|NCT04572893|470613556|FG006|Part B|Withdrawal by Subject|0|||
130723878|NCT04572893|470613550|FG000|Part B|Study terminated by sponsor|0|||
130723879|NCT04572893|470613551|FG001|Part B|Study terminated by sponsor|0|||
130723880|NCT04572893|470613552|FG002|Part B|Study terminated by sponsor|0|||
130723881|NCT04572893|470613553|FG003|Part B|Study terminated by sponsor|0|||
130723882|NCT04572893|470613554|FG004|Part B|Study terminated by sponsor|7|||
130723883|NCT04572893|470613555|FG005|Part B|Study terminated by sponsor|5|||
130723884|NCT04572893|470613556|FG006|Part B|Study terminated by sponsor|3|||
130723885|NCT04572893|470613550|FG000|Part B|Lost to Follow-up|0|||
130723886|NCT04572893|470613551|FG001|Part B|Lost to Follow-up|0|||
130723887|NCT04572893|470613552|FG002|Part B|Lost to Follow-up|0|||
130723888|NCT04572893|470613553|FG003|Part B|Lost to Follow-up|0|||
130723889|NCT04572893|470613554|FG004|Part B|Lost to Follow-up|0|||
130723890|NCT04572893|470613555|FG005|Part B|Lost to Follow-up|0|||
130723891|NCT04572893|470613556|FG006|Part B|Lost to Follow-up|1|||
130723892|NCT04572893|470613550|FG000|Part B|Adverse Event|0|||
130723893|NCT04572893|470613551|FG001|Part B|Adverse Event|0|||
130723894|NCT04572893|470613552|FG002|Part B|Adverse Event|0|||
130723895|NCT04572893|470613553|FG003|Part B|Adverse Event|0|||
130723896|NCT04572893|470613554|FG004|Part B|Adverse Event|1|||
130723897|NCT04572893|470613555|FG005|Part B|Adverse Event|1|||
130723898|NCT04572893|470613556|FG006|Part B|Adverse Event|0|||
130723899|NCT00121134|470613557|FG000|Overall Study|Progression of Disease|5|||
130723900|NCT00121134|470613558|FG001|Overall Study|Progression of Disease|3|||
130723901|NCT00121134|470613559|FG002|Overall Study|Progression of Disease|4|||
130723902|NCT00121134|470613560|FG003|Overall Study|Progression of Disease|2|||
130723903|NCT00121134|470613557|FG000|Overall Study|Toxicity|4|||
130723904|NCT00121134|470613558|FG001|Overall Study|Toxicity|7|||
130723905|NCT00121134|470613559|FG002|Overall Study|Toxicity|13|||
130723906|NCT00121134|470613560|FG003|Overall Study|Toxicity|5|||
130723907|NCT00121134|470613557|FG000|Overall Study|Physician Decision|6|||
130723908|NCT00121134|470613558|FG001|Overall Study|Physician Decision|4|||
130723909|NCT00121134|470613559|FG002|Overall Study|Physician Decision|4|||
130723910|NCT00121134|470613560|FG003|Overall Study|Physician Decision|1|||
130723911|NCT00121134|470613557|FG000|Overall Study|Treatment Delay|1|||
130723912|NCT00121134|470613558|FG001|Overall Study|Treatment Delay|0|||
130723913|NCT00121134|470613559|FG002|Overall Study|Treatment Delay|0|||
130723914|NCT00121134|470613560|FG003|Overall Study|Treatment Delay|0|||
130723915|NCT00121134|470613557|FG000|Overall Study|Intercurrent Illness|0|||
130723916|NCT00121134|470613558|FG001|Overall Study|Intercurrent Illness|0|||
130723917|NCT00121134|470613559|FG002|Overall Study|Intercurrent Illness|0|||
130723918|NCT00121134|470613560|FG003|Overall Study|Intercurrent Illness|1|||
130723919|NCT00121134|470613557|FG000|Overall Study|Patient Personal Reasons|0|||
130723920|NCT00121134|470613558|FG001|Overall Study|Patient Personal Reasons|1|||
130723921|NCT00121134|470613559|FG002|Overall Study|Patient Personal Reasons|0|||
130723922|NCT00121134|470613560|FG003|Overall Study|Patient Personal Reasons|0|||
130723923|NCT01102374|470613574|FG000|Overall Study|Death|9|||
130723924|NCT01102374|470613575|FG001|Overall Study|Death|13|||
130723925|NCT01102374|470613574|FG000|Overall Study|Lost to Follow-up|7|||
130723926|NCT01102374|470613575|FG001|Overall Study|Lost to Follow-up|6|||
130723927|NCT00418821|470613576|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
130723928|NCT02071849|470613577|FG000|6-month Primary Endpoint|Did not receive device|4|||
130723929|NCT02071849|470613577|FG000|6-month Primary Endpoint|Adverse Event|1|||
130402764|NCT00378703|469438026|FG002|Overall Study|Other complicated disease|2|||
130723930|NCT02071849|470613577|FG000|2-year Extended Follow-up|Adverse Event|1|||
130723931|NCT04619992|470613578|FG000|Overall Study|Withdrawal by Subject|1|||
130723932|NCT04619992|470613579|FG001|Overall Study|Withdrawal by Subject|0|||
130723933|NCT00213135|470615422|FG000|Overall Study|Adverse Event|9|||
130723934|NCT00213135|470615423|FG001|Overall Study|Adverse Event|5|||
130723935|NCT00213135|470615424|FG002|Overall Study|Adverse Event|5|||
130723936|NCT00213135|470615422|FG000|Overall Study|Lost to Follow-up|11|||
130723937|NCT00213135|470615423|FG001|Overall Study|Lost to Follow-up|8|||
130723938|NCT00213135|470615424|FG002|Overall Study|Lost to Follow-up|4|||
130723939|NCT00213135|470615422|FG000|Overall Study|Protocol Violation|4|||
130723940|NCT00213135|470615423|FG001|Overall Study|Protocol Violation|4|||
130723941|NCT00213135|470615424|FG002|Overall Study|Protocol Violation|10|||
130723942|NCT00213135|470615422|FG000|Overall Study|Death|1|||
130723943|NCT00213135|470615423|FG001|Overall Study|Death|1|||
130723944|NCT00213135|470615424|FG002|Overall Study|Death|2|||
130723945|NCT00213135|470615422|FG000|Overall Study|Disease progression|4|||
130723946|NCT00213135|470615423|FG001|Overall Study|Disease progression|5|||
130723947|NCT00213135|470615424|FG002|Overall Study|Disease progression|21|||
130723948|NCT00213135|470615422|FG000|Overall Study|Other|21|||
130723949|NCT00213135|470615423|FG001|Overall Study|Other|12|||
130723950|NCT00213135|470615424|FG002|Overall Study|Other|15|||
130723951|NCT00660907|470615428|FG000|Overall Study|Incorrect Enrollment|1|||
130723952|NCT00660907|470615429|FG001|Overall Study|Incorrect Enrollment|1|||
130723953|NCT00660907|470615428|FG000|Overall Study|Adverse Event|33|||
130723954|NCT00660907|470615429|FG001|Overall Study|Adverse Event|19|||
130723955|NCT00660907|470615428|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
130723956|NCT00660907|470615429|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
130723957|NCT00660907|470615428|FG000|Overall Study|Withdrawal by Subject|23|||
130723958|NCT00660907|470615429|FG001|Overall Study|Withdrawal by Subject|32|||
130723959|NCT00660907|470615428|FG000|Overall Study|Lost to Follow-up|3|||
130723960|NCT00660907|470615429|FG001|Overall Study|Lost to Follow-up|3|||
130723961|NCT00660907|470615428|FG000|Overall Study|Poor/Non-Compliance|5|||
130723962|NCT00660907|470615429|FG001|Overall Study|Poor/Non-Compliance|1|||
130723963|NCT00660907|470615428|FG000|Overall Study|Safety|1|||
130723964|NCT00660907|470615429|FG001|Overall Study|Safety|0|||
130723965|NCT00660907|470615428|FG000|Overall Study|Death|1|||
130723966|NCT00660907|470615429|FG001|Overall Study|Death|3|||
130723967|NCT00660907|470615428|FG000|Overall Study|Various|11|||
130723968|NCT00660907|470615429|FG001|Overall Study|Various|8|||
130723969|NCT04975191|470615432|FG000|Overall Study|Protocol Violation|1|||
130723970|NCT04975191|470615433|FG001|Overall Study|Protocol Violation|2|||
130723971|NCT04975191|470615434|FG002|Overall Study|Protocol Violation|2|||
130723972|NCT04975191|470615435|FG003|Overall Study|Protocol Violation|2|||
130723973|NCT04975191|470615432|FG000|Overall Study|Lost to Follow-up|13|||
130723974|NCT04975191|470615433|FG001|Overall Study|Lost to Follow-up|3|||
130723975|NCT04975191|470615434|FG002|Overall Study|Lost to Follow-up|8|||
130723976|NCT04975191|470615435|FG003|Overall Study|Lost to Follow-up|8|||
130723977|NCT02618759|470615462|FG000|Overall Study|Lost to Follow-up|0|||
130723978|NCT02618759|470615463|FG001|Overall Study|Lost to Follow-up|1|||
130723979|NCT02618759|470615462|FG000|Overall Study|Withdrawal by Subject|1|||
130723980|NCT02618759|470615463|FG001|Overall Study|Withdrawal by Subject|0|||
130723981|NCT02618759|470615462|FG000|Overall Study|Other Reasons|1|||
130723982|NCT02618759|470615463|FG001|Overall Study|Other Reasons|4|||
130723983|NCT02500043|470615466|FG000|Overall Study|Randomized, but not Treated|2|||
130723984|NCT02500043|470615467|FG001|Overall Study|Randomized, but not Treated|2|||
130723985|NCT02500043|470615466|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
130723986|NCT02500043|470615467|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
130723987|NCT02500043|470615466|FG000|Overall Study|Adverse Event|33|||
130723988|NCT02500043|470615467|FG001|Overall Study|Adverse Event|11|||
130723989|NCT02500043|470615466|FG000|Overall Study|Clinical Progression|54|||
130723990|NCT02500043|470615467|FG001|Overall Study|Clinical Progression|35|||
130723991|NCT02500043|470615466|FG000|Overall Study|Radiological Progression|192|||
130723992|NCT02500043|470615467|FG001|Overall Study|Radiological Progression|110|||
130723993|NCT02500043|470615466|FG000|Overall Study|Physician's Decision|11|||
130723994|NCT02500043|470615467|FG001|Overall Study|Physician's Decision|3|||
130723995|NCT02500043|470615466|FG000|Overall Study|Withdrawal by Subject|14|||
130723996|NCT02500043|470615467|FG001|Overall Study|Withdrawal by Subject|4|||
130723997|NCT02500043|470615466|FG000|Overall Study|Death|11|||
130723998|NCT02500043|470615467|FG001|Overall Study|Death|2|||
130723999|NCT02500043|470615466|FG000|Overall Study|Protocol Deviation|1|||
130724000|NCT02500043|470615467|FG001|Overall Study|Protocol Deviation|0|||
130724001|NCT02856555|470615468|FG000|Overall Study|Adverse Event|1|||
130724002|NCT02856555|470615469|FG001|Overall Study|Adverse Event|0|||
130724003|NCT02856555|470615470|FG002|Overall Study|Adverse Event|0|||
130724004|NCT02856555|470615468|FG000|Overall Study|Lost to Follow-up|1|||
130724005|NCT02856555|470615469|FG001|Overall Study|Lost to Follow-up|3|||
130724006|NCT02856555|470615470|FG002|Overall Study|Lost to Follow-up|0|||
130724007|NCT02856555|470615468|FG000|Overall Study|Withdrawal by Subject|3|||
130724008|NCT02856555|470615469|FG001|Overall Study|Withdrawal by Subject|0|||
130724009|NCT02856555|470615470|FG002|Overall Study|Withdrawal by Subject|0|||
130724010|NCT02856555|470615468|FG000|Overall Study|Randomized but Never Treated|0|||
130724011|NCT02856555|470615469|FG001|Overall Study|Randomized but Never Treated|1|||
130724012|NCT02856555|470615470|FG002|Overall Study|Randomized but Never Treated|0|||
130724013|NCT03333941|470615471|FG000|Overall Study|Lost to Follow-up|10|||
130724014|NCT03333941|470615471|FG000|Overall Study|Death|2|||
130724015|NCT03333941|470615471|FG000|Overall Study|Adverse Event|1|||
130724016|NCT02932306|470615472|FG000|Overall Study|Withdrawal by Subject|16|||
130724017|NCT02932306|470615473|FG001|Overall Study|Withdrawal by Subject|25|||
130724018|NCT02932306|470615472|FG000|Overall Study|Adverse Event|3|||
130724019|NCT02932306|470615473|FG001|Overall Study|Adverse Event|0|||
130724020|NCT02932306|470615472|FG000|Overall Study|Pregnancy|2|||
130724021|NCT02932306|470615473|FG001|Overall Study|Pregnancy|0|||
130724022|NCT02932306|470615472|FG000|Overall Study|Protocol Violation|1|||
130724023|NCT02932306|470615473|FG001|Overall Study|Protocol Violation|1|||
130724024|NCT02932306|470615472|FG000|Overall Study|Noncompliance with Study Drug|1|||
130724025|NCT02932306|470615473|FG001|Overall Study|Noncompliance with Study Drug|1|||
130560961|NCT00617604|470022779|FG001|Overall Study|Withdrawal by Subject|6|||
130560962|NCT00617604|470022778|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
130560963|NCT00617604|470022779|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
130560964|NCT03250832|470022780|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
130560965|NCT03250832|470022781|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
130560966|NCT03250832|470022782|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
130560967|NCT03250832|470022783|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
130560968|NCT03250832|470022784|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
130560969|NCT03250832|470022785|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
130560970|NCT03250832|470022786|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
130560971|NCT03250832|470022787|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
130560972|NCT03250832|470022788|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
130560973|NCT03250832|470022789|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
130560974|NCT03250832|470022790|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
130560975|NCT03250832|470022791|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
130560976|NCT03250832|470022780|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
130560977|NCT03250832|470022781|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
130560978|NCT03250832|470022782|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
130560979|NCT03250832|470022783|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
130560980|NCT03250832|470022784|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
130560981|NCT03250832|470022785|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
130560982|NCT03250832|470022786|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
130724026|NCT02932306|470615472|FG000|Overall Study|Lost to Follow-up|36|||
130724027|NCT02932306|470615473|FG001|Overall Study|Lost to Follow-up|40|||
130724028|NCT02932306|470615472|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
130724029|NCT02932306|470615473|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
130724030|NCT02932306|470615472|FG000|Overall Study|Lack of Efficacy|0|||
130724031|NCT02932306|470615473|FG001|Overall Study|Lack of Efficacy|2|||
130724032|NCT02932306|470615472|FG000|Overall Study|Worsening condition|2|||
130724033|NCT02932306|470615473|FG001|Overall Study|Worsening condition|0|||
130724034|NCT02932306|470615472|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
130724035|NCT02932306|470615473|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
130724036|NCT05776862|470615474|FG000|Overall Study|Adverse Event|0|||
130724037|NCT05776862|470615475|FG001|Overall Study|Adverse Event|1|||
130724038|NCT05776862|470615474|FG000|Overall Study|non-compliance|1|||
130724039|NCT05776862|470615475|FG001|Overall Study|non-compliance|0|||
130724040|NCT02065700|470615476|FG000|Overall Study|Adverse Event|165|||
130724041|NCT02065700|470615477|FG001|Overall Study|Adverse Event|101|||
130724042|NCT02065700|470615476|FG000|Overall Study|Withdrawal by Subject|90|||
130724043|NCT02065700|470615477|FG001|Overall Study|Withdrawal by Subject|29|||
130724044|NCT02065700|470615476|FG000|Overall Study|Lost to Follow-up|12|||
130724045|NCT02065700|470615477|FG001|Overall Study|Lost to Follow-up|9|||
130724046|NCT02065700|470615476|FG000|Overall Study|Physician Decision|2|||
130724047|NCT02065700|470615477|FG001|Overall Study|Physician Decision|0|||
130724048|NCT02065700|470615476|FG000|Overall Study|Sponsor Request|38|||
130724049|NCT02065700|470615477|FG001|Overall Study|Sponsor Request|15|||
130724050|NCT02065700|470615476|FG000|Overall Study|Treatment Failure|3|||
130724051|NCT02065700|470615477|FG001|Overall Study|Treatment Failure|2|||
130724052|NCT02065700|470615476|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
130724053|NCT02065700|470615477|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
130724054|NCT02065700|470615476|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
130724055|NCT02065700|470615477|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
130724056|NCT02065700|470615476|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130724057|NCT02065700|470615477|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130724058|NCT02065700|470615476|FG000|Overall Study|Not Defined|21|||
130560983|NCT03250832|470022787|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130724059|NCT02065700|470615477|FG001|Overall Study|Not Defined|3|||
130724060|NCT00605540|470615482|FG000|Overall Study|Death|15|||
130724061|NCT00605540|470615482|FG000|Overall Study|Lost to Follow-up|23|||
130560984|NCT03250832|470022788|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130724062|NCT01544179|470615485|FG000|Overall Study|Death|50|||
130724063|NCT01544179|470615486|FG001|Overall Study|Death|37|||
130724064|NCT01544179|470615485|FG000|Overall Study|Lost to Follow-up|0|||
130560985|NCT03250832|470022789|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130724065|NCT01544179|470615486|FG001|Overall Study|Lost to Follow-up|1|||
130724066|NCT01544179|470615485|FG000|Overall Study|Adverse Event|0|||
130470913|NCT00632749|469690859|FG007|Overall Study|Progressive disease|2|||
130470914|NCT00632749|469690860|FG008|Overall Study|Progressive disease|3|||
130470915|NCT00632749|469690861|FG009|Overall Study|Progressive disease|2|||
130470916|NCT00632749|469690862|FG010|Overall Study|Progressive disease|4|||
130470917|NCT00632749|469690863|FG011|Overall Study|Progressive disease|3|||
130470918|NCT00632749|469690864|FG012|Overall Study|Progressive disease|2|||
130470919|NCT00632749|469690865|FG013|Overall Study|Progressive disease|4|||
130470920|NCT00632749|469690852|FG000|Overall Study|Other Adverse event|1|||
130470921|NCT00632749|469690853|FG001|Overall Study|Other Adverse event|1|||
130470922|NCT00632749|469690854|FG002|Overall Study|Other Adverse event|1|||
130402765|NCT00378703|469438027|FG003|Overall Study|Other complicated disease|0|||
130402766|NCT00378703|469438024|FG000|Overall Study|Symptomatic deterioration|0|||
130402767|NCT00378703|469438025|FG001|Overall Study|Symptomatic deterioration|1|||
130470923|NCT00632749|469690855|FG003|Overall Study|Other Adverse event|1|||
130470924|NCT00632749|469690856|FG004|Overall Study|Other Adverse event|2|||
130470925|NCT00632749|469690857|FG005|Overall Study|Other Adverse event|4|||
130560986|NCT03250832|470022790|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130560987|NCT03250832|470022791|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130724067|NCT01544179|470615486|FG001|Overall Study|Adverse Event|1|||
130402768|NCT00378703|469438026|FG002|Overall Study|Symptomatic deterioration|0|||
130402769|NCT00378703|469438027|FG003|Overall Study|Symptomatic deterioration|2|||
130402770|NCT00378703|469438024|FG000|Overall Study|Surgery|1|||
130402771|NCT00378703|469438025|FG001|Overall Study|Surgery|0|||
130402772|NCT00378703|469438026|FG002|Overall Study|Surgery|0|||
130402773|NCT00378703|469438027|FG003|Overall Study|Surgery|1|||
130402774|NCT00378703|469438024|FG000|Overall Study|Joint decision of physician and patient|1|||
130402775|NCT00378703|469438025|FG001|Overall Study|Joint decision of physician and patient|0|||
130402776|NCT00378703|469438026|FG002|Overall Study|Joint decision of physician and patient|0|||
130402777|NCT00378703|469438027|FG003|Overall Study|Joint decision of physician and patient|0|||
130402778|NCT00378703|469438024|FG000|Overall Study|Adverse events and progressive disease|0|||
130402779|NCT00378703|469438025|FG001|Overall Study|Adverse events and progressive disease|0|||
130402780|NCT00378703|469438026|FG002|Overall Study|Adverse events and progressive disease|0|||
130402781|NCT00378703|469438027|FG003|Overall Study|Adverse events and progressive disease|1|||
130402782|NCT00378703|469438024|FG000|Overall Study|Relocation|0|||
130402783|NCT00378703|469438025|FG001|Overall Study|Relocation|0|||
130402784|NCT00378703|469438026|FG002|Overall Study|Relocation|1|||
130402785|NCT00378703|469438027|FG003|Overall Study|Relocation|0|||
130402786|NCT00378703|469438024|FG000|Overall Study|Ineligible|4|||
130402787|NCT00378703|469438025|FG001|Overall Study|Ineligible|7|||
130402788|NCT00378703|469438026|FG002|Overall Study|Ineligible|7|||
130402789|NCT00378703|469438027|FG003|Overall Study|Ineligible|7|||
130402790|NCT00378703|469438024|FG000|Overall Study|Never started treatment|1|||
130402791|NCT00378703|469438025|FG001|Overall Study|Never started treatment|4|||
130402792|NCT00378703|469438026|FG002|Overall Study|Never started treatment|0|||
130470926|NCT00632749|469690858|FG006|Overall Study|Other Adverse event|1|||
130470927|NCT00632749|469690859|FG007|Overall Study|Other Adverse event|2|||
130470928|NCT00632749|469690860|FG008|Overall Study|Other Adverse event|2|||
130724068|NCT01544179|470615485|FG000|Overall Study|Withdrawal by Subject|12|||
130724069|NCT01544179|470615486|FG001|Overall Study|Withdrawal by Subject|7|||
130724070|NCT01544179|470615485|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130724071|NCT01544179|470615486|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130724072|NCT00049530|470615487|FG000|Overall Study|Lack of Efficacy|25|||
130724073|NCT00049530|470615487|FG000|Overall Study|Adverse Event|2|||
130724074|NCT00049530|470615487|FG000|Overall Study|Death|1|||
130724075|NCT00049530|470615487|FG000|Overall Study|symptomatic deterioration|1|||
130724076|NCT00049530|470615487|FG000|Overall Study|ineligible|3|||
130724077|NCT01635283|470615488|FG000|Overall Study|Tumor Progression|3|||
130724078|NCT01635283|470615488|FG000|Overall Study|Lost to Follow-up|1|||
130724079|NCT01433549|470615489|FG000|Phase 2: Second Study Product|Adverse Event|0|||
130724080|NCT01433549|470615490|FG001|Phase 2: Second Study Product|Adverse Event|1|||
130724081|NCT01438996|470615491|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
130724082|NCT01438996|470615492|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
130724083|NCT01438996|470615493|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
130724084|NCT01696058|470615497|FG000|Overall Study|Adverse Event|21|||
130724085|NCT01696058|470615498|FG001|Overall Study|Adverse Event|11|||
130724086|NCT01696058|470615497|FG000|Overall Study|Lack of Efficacy|2|||
130724087|NCT01696058|470615498|FG001|Overall Study|Lack of Efficacy|3|||
130724088|NCT01696058|470615497|FG000|Overall Study|Protocol Violation|9|||
130724089|NCT01696058|470615498|FG001|Overall Study|Protocol Violation|3|||
130724090|NCT01696058|470615497|FG000|Overall Study|Lost to Follow-up|2|||
130724091|NCT01696058|470615498|FG001|Overall Study|Lost to Follow-up|5|||
130724092|NCT01696058|470615497|FG000|Overall Study|Withdrawal by Subject|4|||
130724093|NCT01696058|470615498|FG001|Overall Study|Withdrawal by Subject|6|||
130724094|NCT01696058|470615497|FG000|Overall Study|Other reason prematurely discontinued|5|||
130724095|NCT01696058|470615498|FG001|Overall Study|Other reason prematurely discontinued|3|||
130724096|NCT02278055|470615499|FG000|Overall Study|Adverse Event|1|||
130402793|NCT00378703|469438027|FG003|Overall Study|Never started treatment|0|||
130402794|NCT00378703|469438024|FG000|Overall Study|Other|1|||
130402795|NCT00378703|469438025|FG001|Overall Study|Other|1|||
130402796|NCT00378703|469438026|FG002|Overall Study|Other|2|||
130470929|NCT00632749|469690861|FG009|Overall Study|Other Adverse event|0|||
130470930|NCT00632749|469690862|FG010|Overall Study|Other Adverse event|1|||
130470931|NCT00632749|469690863|FG011|Overall Study|Other Adverse event|0|||
130470932|NCT00632749|469690864|FG012|Overall Study|Other Adverse event|1|||
130470933|NCT00632749|469690865|FG013|Overall Study|Other Adverse event|0|||
130470934|NCT00632749|469690852|FG000|Overall Study|Refuse to continue medication|0|||
130470935|NCT00632749|469690853|FG001|Overall Study|Refuse to continue medication|0|||
130470936|NCT00632749|469690854|FG002|Overall Study|Refuse to continue medication|0|||
130724097|NCT02278055|470615499|FG000|Overall Study|Lost to Follow-up|1|||
130724098|NCT02278055|470615499|FG000|Overall Study|Withdrawal by Subject|2|||
130724099|NCT02278055|470615499|FG000|Overall Study|Progressive Disease|4|||
130724100|NCT01934335|470615500|FG000|Overall Study|Withdrawal by Subject|1|||
130724101|NCT01934335|470615501|FG001|Overall Study|Withdrawal by Subject|1|||
130724102|NCT05384171|470615502|FG000|Overall Study|Lost to Follow-up|9|||
130724103|NCT05384171|470615503|FG001|Overall Study|Lost to Follow-up|9|||
130724104|NCT05384171|470615502|FG000|Overall Study|Withdrawal by Subject|3|||
130724105|NCT05384171|470615503|FG001|Overall Study|Withdrawal by Subject|0|||
130724106|NCT01421511|470615504|FG000|Overall Study|Lost to Follow-up|11|||
130724107|NCT01421511|470615505|FG001|Overall Study|Lost to Follow-up|14|||
130724108|NCT01421511|470615504|FG000|Overall Study|Randomized but didn't receive study drug|1|||
130724109|NCT01421511|470615505|FG001|Overall Study|Randomized but didn't receive study drug|7|||
130724110|NCT01421511|470615504|FG000|Overall Study|Physician Decision|0|||
130724111|NCT01421511|470615505|FG001|Overall Study|Physician Decision|1|||
130724112|NCT01421511|470615504|FG000|Overall Study|Withdrawal by Subject|6|||
130724113|NCT01421511|470615505|FG001|Overall Study|Withdrawal by Subject|5|||
130724114|NCT01421511|470615504|FG000|Overall Study|Death|1|||
130724115|NCT01421511|470615505|FG001|Overall Study|Death|1|||
130724116|NCT00749892|470615506|FG000|Overall Study|Withdrawal by Subject|3|||
130724117|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
130724118|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
130724119|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
130724120|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
130724121|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
130724122|NCT00106964|470615508|FG000|Overall Study|Lost to Follow-up|8|||
130724123|NCT00106964|470615509|FG001|Overall Study|Lost to Follow-up|6|||
130724124|NCT00106964|470615510|FG002|Overall Study|Lost to Follow-up|2|||
130724125|NCT00106964|470615508|FG000|Overall Study|Pregnancy|2|||
130724126|NCT00106964|470615509|FG001|Overall Study|Pregnancy|3|||
130724127|NCT00106964|470615510|FG002|Overall Study|Pregnancy|2|||
130402797|NCT00378703|469438027|FG003|Overall Study|Other|3|||
130402798|NCT04292730|469438034|FG000|Overall Study|Lost to Follow-up|8|||
130402799|NCT04292730|469438035|FG001|Overall Study|Lost to Follow-up|12|||
130402800|NCT04292730|469438036|FG002|Overall Study|Lost to Follow-up|12|||
130402801|NCT04292730|469438037|FG003|Overall Study|Lost to Follow-up|48|||
130402802|NCT04292730|469438034|FG000|Overall Study|Death|2|||
130402803|NCT04292730|469438035|FG001|Overall Study|Death|2|||
130402804|NCT04292730|469438036|FG002|Overall Study|Death|4|||
130402805|NCT04292730|469438037|FG003|Overall Study|Death|12|||
130402806|NCT04292730|469438034|FG000|Overall Study|Withdrew Consent|2|||
130402807|NCT04292730|469438035|FG001|Overall Study|Withdrew Consent|2|||
130402808|NCT04292730|469438036|FG002|Overall Study|Withdrew Consent|5|||
130402809|NCT04292730|469438037|FG003|Overall Study|Withdrew Consent|6|||
130402810|NCT04292730|469438034|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130402811|NCT04292730|469438035|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130402812|NCT04292730|469438036|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130402813|NCT04292730|469438037|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130724128|NCT00106964|470615508|FG000|Overall Study|Death|1|||
130402814|NCT04292730|469438034|FG000|Overall Study|Protocol Violation|0|||
130402815|NCT04292730|469438035|FG001|Overall Study|Protocol Violation|0|||
130402816|NCT04292730|469438036|FG002|Overall Study|Protocol Violation|1|||
130402817|NCT04292730|469438037|FG003|Overall Study|Protocol Violation|0|||
130470937|NCT00632749|469690855|FG003|Overall Study|Refuse to continue medication|1|||
130724129|NCT00106964|470615509|FG001|Overall Study|Death|1|||
130724130|NCT00106964|470615510|FG002|Overall Study|Death|0|||
130724131|NCT00106964|470615508|FG000|Overall Study|Incarceration|0|||
130402818|NCT04292730|469438034|FG000|Overall Study|Randomized but not Treated|8|||
130402819|NCT04292730|469438035|FG001|Overall Study|Randomized but not Treated|4|||
130724132|NCT00106964|470615509|FG001|Overall Study|Incarceration|1|||
130724133|NCT00106964|470615510|FG002|Overall Study|Incarceration|0|||
130560988|NCT03250832|470022780|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560989|NCT03250832|470022781|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560990|NCT03250832|470022782|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
130560991|NCT03250832|470022783|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560992|NCT03250832|470022784|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560993|NCT03250832|470022785|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560994|NCT03250832|470022786|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560995|NCT03250832|470022787|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560996|NCT03250832|470022788|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560997|NCT03250832|470022789|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560998|NCT03250832|470022790|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130560999|NCT03250832|470022791|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130561000|NCT03250832|470022780|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561001|NCT03250832|470022781|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561002|NCT03250832|470022782|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561003|NCT03250832|470022783|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
130402820|NCT04292730|469438036|FG002|Overall Study|Randomized but not Treated|0|||
130402821|NCT04292730|469438037|FG003|Overall Study|Randomized but not Treated|14|||
130402822|NCT01527292|469438038|FG000|Overall Study|Physician Decision|0|||
130402823|NCT01527292|469438039|FG001|Overall Study|Physician Decision|3|||
130402824|NCT00806546|469438040|FG000|Overall Study|Enrolled, not treated|35|||
130402825|NCT00806546|469438040|FG000|Overall Study|Lost to Follow-up|32|||
130402826|NCT00806546|469438040|FG000|Overall Study|Adverse Event|74|||
130402827|NCT00806546|469438040|FG000|Overall Study|Withdrawal by Subject|75|||
130402828|NCT00806546|469438040|FG000|Overall Study|Protocol Violation|49|||
130402829|NCT00806546|469438040|FG000|Overall Study|Various|42|||
130402830|NCT02751983|469438041|FG000|Treatment|Stopped ACT, but Remained in study|2|||
130402831|NCT02751983|469438042|FG001|Treatment|Stopped ACT, but Remained in study|0|||
130402832|NCT02751983|469438041|FG000|Treatment|Discharged prior to beginning ACT|2|||
130402833|NCT02751983|469438042|FG001|Treatment|Discharged prior to beginning ACT|0|||
130402834|NCT02751983|469438041|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
130402835|NCT02751983|469438042|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
130402836|NCT02751983|469438041|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
130402837|NCT02751983|469438042|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
130402838|NCT02751983|469438041|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
130402839|NCT02751983|469438042|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
130402840|NCT00096044|469438043|FG000|Overall Study|Withdrawal by Subject|9|||
130402841|NCT00096044|469438043|FG000|Overall Study|Adverse Event|21|||
130402842|NCT00096044|469438043|FG000|Overall Study|Disease Progression|4|||
130402843|NCT03139916|469438044|FG000|Overall Study|Withdrawal by Subject|2|||
130402844|NCT03139916|469438044|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
130402845|NCT00813358|469438045|FG000|Overall Study|Death|32|||
130402846|NCT00813358|469438045|FG000|Overall Study|Lost to Follow-up|12|||
130402847|NCT00813358|469438045|FG000|Overall Study|other endpoints|5|||
130402848|NCT00813358|469438045|FG000|Overall Study|Withdrawal by Subject|20|||
130402849|NCT00004031|469438046|FG000|Overall Study|Adverse Event|5|||
130402850|NCT00004031|469438047|FG001|Overall Study|Adverse Event|0|||
130402851|NCT00004031|469438046|FG000|Overall Study|Refusal unrelated to adverse events|2|||
130402852|NCT00004031|469438047|FG001|Overall Study|Refusal unrelated to adverse events|11|||
130402853|NCT00004031|469438046|FG000|Overall Study|Progression/relapse|9|||
130402854|NCT00004031|469438047|FG001|Overall Study|Progression/relapse|4|||
130402855|NCT00004031|469438046|FG000|Overall Study|Death|3|||
130402856|NCT00004031|469438047|FG001|Overall Study|Death|1|||
130402857|NCT00004031|469438046|FG000|Overall Study|Other- not protocol specified|3|||
130561004|NCT03250832|470022784|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561005|NCT03250832|470022785|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561006|NCT03250832|470022786|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561007|NCT03250832|470022787|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
130561008|NCT03250832|470022788|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561009|NCT03250832|470022789|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
130402858|NCT00004031|469438047|FG001|Overall Study|Other- not protocol specified|3|||
130402859|NCT00004031|469438046|FG000|Overall Study|Reason under review|3|||
130402860|NCT00004031|469438047|FG001|Overall Study|Reason under review|2|||
130402861|NCT03851016|469438050|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130402862|NCT03851016|469438051|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
130402863|NCT00586469|469438052|FG000|Overall Study|Adverse Event|0|||
130402864|NCT00586469|469438053|FG001|Overall Study|Adverse Event|1|||
130402865|NCT03337724|469438060|FG000|Overall Study|Reason not Specified|12|||
130402866|NCT03337724|469438061|FG001|Overall Study|Reason not Specified|21|||
130402867|NCT03337724|469438062|FG002|Overall Study|Reason not Specified|9|||
130402868|NCT03337724|469438063|FG003|Overall Study|Reason not Specified|9|||
130402869|NCT03337724|469438064|FG004|Overall Study|Reason not Specified|29|||
130470938|NCT00632749|469690856|FG004|Overall Study|Refuse to continue medication|0|||
130470939|NCT00632749|469690857|FG005|Overall Study|Refuse to continue medication|0|||
130470940|NCT00632749|469690858|FG006|Overall Study|Refuse to continue medication|0|||
130470941|NCT00632749|469690859|FG007|Overall Study|Refuse to continue medication|0|||
130470942|NCT00632749|469690860|FG008|Overall Study|Refuse to continue medication|0|||
130470943|NCT00632749|469690861|FG009|Overall Study|Refuse to continue medication|1|||
130470944|NCT00632749|469690862|FG010|Overall Study|Refuse to continue medication|0|||
130470945|NCT00632749|469690863|FG011|Overall Study|Refuse to continue medication|0|||
130470946|NCT00632749|469690864|FG012|Overall Study|Refuse to continue medication|0|||
130470947|NCT00632749|469690865|FG013|Overall Study|Refuse to continue medication|0|||
130470948|NCT00632749|469690852|FG000|Overall Study|Reason other than those specified above|0|||
130470949|NCT00632749|469690853|FG001|Overall Study|Reason other than those specified above|2|||
130561010|NCT03250832|470022790|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
130561011|NCT03250832|470022791|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
130724134|NCT00106964|470615508|FG000|Overall Study|Site Funding Terminated|0|||
130724135|NCT00106964|470615509|FG001|Overall Study|Site Funding Terminated|1|||
130724136|NCT00106964|470615510|FG002|Overall Study|Site Funding Terminated|1|||
130724137|NCT00106964|470615508|FG000|Overall Study|Failure to adhere|2|||
130724138|NCT00106964|470615509|FG001|Overall Study|Failure to adhere|0|||
130724139|NCT00106964|470615510|FG002|Overall Study|Failure to adhere|0|||
130724140|NCT00106964|470615508|FG000|Overall Study|Did not meet eligibility criteria|0|||
130724141|NCT00106964|470615509|FG001|Overall Study|Did not meet eligibility criteria|2|||
130724142|NCT00106964|470615510|FG002|Overall Study|Did not meet eligibility criteria|2|||
130724143|NCT00106964|470615508|FG000|Overall Study|Required disallowed medication|0|||
130724144|NCT00106964|470615509|FG001|Overall Study|Required disallowed medication|1|||
130724145|NCT00106964|470615510|FG002|Overall Study|Required disallowed medication|0|||
130724146|NCT03207243|470615513|FG000|Overall Study|Adverse Event|2|||
130724147|NCT03207243|470615514|FG001|Overall Study|Adverse Event|2|||
130724148|NCT03207243|470615513|FG000|Overall Study|Loss of Asthma Control|47|||
130724149|NCT03207243|470615514|FG001|Overall Study|Loss of Asthma Control|31|||
130724150|NCT03207243|470615513|FG000|Overall Study|Withdrawal by Subject|2|||
130724151|NCT03207243|470615514|FG001|Overall Study|Withdrawal by Subject|4|||
130724152|NCT03207243|470615513|FG000|Overall Study|Physician Decision|1|||
130724153|NCT03207243|470615514|FG001|Overall Study|Physician Decision|1|||
130724154|NCT03207243|470615513|FG000|Overall Study|Lost to Follow-up|0|||
130724155|NCT03207243|470615514|FG001|Overall Study|Lost to Follow-up|1|||
130724156|NCT03207243|470615513|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
130724157|NCT03207243|470615514|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
130724158|NCT03207243|470615513|FG000|Overall Study|Protocol Violation|0|||
130724159|NCT03207243|470615514|FG001|Overall Study|Protocol Violation|3|||
130724160|NCT00168818|470615515|FG000|Overall Study|Adverse Event|23|||
130724161|NCT00168818|470615516|FG001|Overall Study|Adverse Event|29|||
130724162|NCT00168818|470615517|FG002|Overall Study|Adverse Event|31|||
130724163|NCT00168818|470615515|FG000|Overall Study|Protocol Violation|16|||
130724164|NCT00168818|470615516|FG001|Overall Study|Protocol Violation|11|||
130724165|NCT00168818|470615517|FG002|Overall Study|Protocol Violation|11|||
130724166|NCT00168818|470615515|FG000|Overall Study|Lost to Follow-up|13|||
130724167|NCT00168818|470615516|FG001|Overall Study|Lost to Follow-up|4|||
130724168|NCT00168818|470615517|FG002|Overall Study|Lost to Follow-up|15|||
130724169|NCT00168818|470615515|FG000|Overall Study|Withdrawal by Subject|43|||
130724170|NCT00168818|470615516|FG001|Overall Study|Withdrawal by Subject|41|||
130724171|NCT00168818|470615517|FG002|Overall Study|Withdrawal by Subject|37|||
130724172|NCT00168818|470615515|FG000|Overall Study|Other|22|||
130724173|NCT00168818|470615516|FG001|Overall Study|Other|24|||
130724174|NCT00168818|470615517|FG002|Overall Study|Other|30|||
130724175|NCT00168818|470615515|FG000|Treatment|Adverse Event|77|||
130724176|NCT00168818|470615516|FG001|Treatment|Adverse Event|89|||
130724177|NCT00168818|470615517|FG002|Treatment|Adverse Event|68|||
130724178|NCT00168818|470615515|FG000|Treatment|Protocol Violation|8|||
130724179|NCT00168818|470615516|FG001|Treatment|Protocol Violation|11|||
130724180|NCT00168818|470615517|FG002|Treatment|Protocol Violation|11|||
130470950|NCT00632749|469690854|FG002|Overall Study|Reason other than those specified above|0|||
130470951|NCT00632749|469690855|FG003|Overall Study|Reason other than those specified above|0|||
130561012|NCT03250832|470022780|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130724181|NCT00168818|470615515|FG000|Treatment|Lost to Follow-up|0|||
130724182|NCT00168818|470615516|FG001|Treatment|Lost to Follow-up|2|||
130724183|NCT00168818|470615517|FG002|Treatment|Lost to Follow-up|1|||
130724184|NCT00168818|470615515|FG000|Treatment|Withdrawal by Subject|25|||
130724185|NCT00168818|470615516|FG001|Treatment|Withdrawal by Subject|20|||
130724186|NCT00168818|470615517|FG002|Treatment|Withdrawal by Subject|22|||
130724187|NCT00168818|470615515|FG000|Treatment|Other|23|||
130724188|NCT00168818|470615516|FG001|Treatment|Other|29|||
130724189|NCT00168818|470615517|FG002|Treatment|Other|31|||
130724190|NCT00469144|470615518|FG000|Overall Study|Death|0|||
130724191|NCT00469144|470615519|FG001|Overall Study|Death|1|||
130724192|NCT00469144|470615518|FG000|Overall Study|No Response|5|||
130724193|NCT00469144|470615519|FG001|Overall Study|No Response|5|||
130402870|NCT03337724|469438060|FG000|Overall Study|Withdrawal by Subject|13|||
130402871|NCT03337724|469438061|FG001|Overall Study|Withdrawal by Subject|15|||
130402872|NCT03337724|469438062|FG002|Overall Study|Withdrawal by Subject|4|||
130402873|NCT03337724|469438063|FG003|Overall Study|Withdrawal by Subject|15|||
130402874|NCT03337724|469438064|FG004|Overall Study|Withdrawal by Subject|6|||
130402875|NCT03337724|469438060|FG000|Overall Study|Protocol Deviation|0|||
130402876|NCT03337724|469438061|FG001|Overall Study|Protocol Deviation|1|||
130402877|NCT03337724|469438062|FG002|Overall Study|Protocol Deviation|1|||
130402878|NCT03337724|469438063|FG003|Overall Study|Protocol Deviation|1|||
130402879|NCT03337724|469438064|FG004|Overall Study|Protocol Deviation|0|||
130724194|NCT00469144|470615518|FG000|Overall Study|Progressive Disease|1|||
130724195|NCT00469144|470615519|FG001|Overall Study|Progressive Disease|0|||
130724196|NCT02794246|470615520|FG000|Overall Study|Withdrawal by Subject|2|||
130724197|NCT02794246|470615520|FG000|Overall Study|Physician Decision|4|||
130724198|NCT04602546|470615521|FG000|Overall Study|Training|2|||
130724199|NCT04602546|470615522|FG001|Overall Study|Training|2|||
130724200|NCT04602546|470615523|FG002|Overall Study|Training|1|||
130724201|NCT04602546|470615524|FG003|Overall Study|Training|2|||
130724202|NCT04602546|470615525|FG004|Overall Study|Training|0|||
130724203|NCT04602546|470615521|FG000|Overall Study|Randomized with disqualified data|2|||
130724204|NCT04602546|470615522|FG001|Overall Study|Randomized with disqualified data|0|||
130724205|NCT04602546|470615523|FG002|Overall Study|Randomized with disqualified data|2|||
130724206|NCT04602546|470615524|FG003|Overall Study|Randomized with disqualified data|5|||
130724207|NCT04602546|470615525|FG004|Overall Study|Randomized with disqualified data|3|||
130724208|NCT01994291|470615526|FG000|Overall Study|Adverse Event|4|||
130724209|NCT01994291|470615527|FG001|Overall Study|Adverse Event|1|||
130724210|NCT01994291|470615528|FG002|Overall Study|Adverse Event|3|||
130724211|NCT01994291|470615526|FG000|Overall Study|Lost to Follow-up|1|||
130724212|NCT01994291|470615527|FG001|Overall Study|Lost to Follow-up|1|||
130724213|NCT01994291|470615528|FG002|Overall Study|Lost to Follow-up|0|||
130724214|NCT01994291|470615526|FG000|Overall Study|Does not meet entrance criteria|1|||
130724215|NCT01994291|470615527|FG001|Overall Study|Does not meet entrance criteria|0|||
130724216|NCT01994291|470615528|FG002|Overall Study|Does not meet entrance criteria|0|||
130724217|NCT01994291|470615526|FG000|Overall Study|Medication error without associated AE|1|||
130724218|NCT01994291|470615527|FG001|Overall Study|Medication error without associated AE|0|||
130724219|NCT01994291|470615528|FG002|Overall Study|Medication error without associated AE|1|||
130724220|NCT01994291|470615526|FG000|Overall Study|Protocol Violation|1|||
130724221|NCT01994291|470615527|FG001|Overall Study|Protocol Violation|0|||
130724222|NCT01994291|470615528|FG002|Overall Study|Protocol Violation|0|||
130724223|NCT01994291|470615526|FG000|Overall Study|Withdrawal by Subject|6|||
130724224|NCT01994291|470615527|FG001|Overall Study|Withdrawal by Subject|3|||
130724225|NCT01994291|470615528|FG002|Overall Study|Withdrawal by Subject|5|||
130724226|NCT01994291|470615526|FG000|Overall Study|Other|1|||
130724227|NCT01994291|470615527|FG001|Overall Study|Other|2|||
130724228|NCT01994291|470615528|FG002|Overall Study|Other|0|||
130724229|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724230|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130724231|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724232|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724233|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724234|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724235|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724236|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724237|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
130724238|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724239|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724240|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724241|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724242|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724243|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724244|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
130724245|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
130402880|NCT03337724|469438060|FG000|Overall Study|Adverse Event|1|||
130724246|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724247|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724248|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724249|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130402881|NCT03337724|469438061|FG001|Overall Study|Adverse Event|1|||
130402882|NCT03337724|469438062|FG002|Overall Study|Adverse Event|0|||
130402883|NCT03337724|469438063|FG003|Overall Study|Adverse Event|1|||
130402884|NCT03337724|469438064|FG004|Overall Study|Adverse Event|0|||
130402885|NCT03337724|469438060|FG000|Overall Study|Death|40|||
130402886|NCT03337724|469438061|FG001|Overall Study|Death|89|||
130402887|NCT03337724|469438062|FG002|Overall Study|Death|43|||
130402888|NCT03337724|469438063|FG003|Overall Study|Death|76|||
130402889|NCT03337724|469438064|FG004|Overall Study|Death|50|||
130402890|NCT03337724|469438060|FG000|Overall Study|Lost to Follow-up|5|||
130402891|NCT03337724|469438061|FG001|Overall Study|Lost to Follow-up|5|||
130402892|NCT03337724|469438062|FG002|Overall Study|Lost to Follow-up|4|||
130402893|NCT03337724|469438063|FG003|Overall Study|Lost to Follow-up|7|||
130402894|NCT03337724|469438064|FG004|Overall Study|Lost to Follow-up|4|||
130402895|NCT03337724|469438060|FG000|Overall Study|Physician Decision|16|||
130402896|NCT03337724|469438061|FG001|Overall Study|Physician Decision|34|||
130402897|NCT03337724|469438062|FG002|Overall Study|Physician Decision|14|||
130402898|NCT03337724|469438063|FG003|Overall Study|Physician Decision|34|||
130402899|NCT03337724|469438064|FG004|Overall Study|Physician Decision|13|||
130402900|NCT03337724|469438060|FG000|Overall Study|Progressive Disease|0|||
130402901|NCT03337724|469438061|FG001|Overall Study|Progressive Disease|2|||
130470952|NCT00632749|469690856|FG004|Overall Study|Reason other than those specified above|1|||
130470953|NCT00632749|469690857|FG005|Overall Study|Reason other than those specified above|0|||
130402902|NCT03337724|469438062|FG002|Overall Study|Progressive Disease|1|||
130402903|NCT03337724|469438063|FG003|Overall Study|Progressive Disease|2|||
130402904|NCT03337724|469438064|FG004|Overall Study|Progressive Disease|0|||
130402905|NCT03337724|469438060|FG000|Overall Study|Symptomatic Deterioration|0|||
130402906|NCT03337724|469438061|FG001|Overall Study|Symptomatic Deterioration|0|||
130470954|NCT00632749|469690858|FG006|Overall Study|Reason other than those specified above|1|||
130724250|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724251|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724252|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724253|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724254|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724255|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
130724256|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724257|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724258|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724259|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724260|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
130724261|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724262|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724263|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724264|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724265|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724266|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724267|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130724268|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724269|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724270|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130724271|NCT00856375|470615536|FG000|Overall Study|Other|0|||
130724272|NCT00856375|470615537|FG001|Overall Study|Other|1|||
130724273|NCT00856375|470615536|FG000|Overall Study|Death|32|||
130724274|NCT00856375|470615537|FG001|Overall Study|Death|30|||
130724275|NCT00856375|470615536|FG000|Overall Study|Sponsor Terminated Study|7|||
130724276|NCT00856375|470615537|FG001|Overall Study|Sponsor Terminated Study|7|||
130724277|NCT00856375|470615536|FG000|Overall Study|Withdrawal by Subject|2|||
130724278|NCT00856375|470615537|FG001|Overall Study|Withdrawal by Subject|1|||
130724279|NCT00856375|470615536|FG000|Overall Study|Lost to Follow-up|1|||
130724280|NCT00856375|470615537|FG001|Overall Study|Lost to Follow-up|2|||
130724281|NCT02121392|470615540|FG000|Prior to Intervention|Protocol Violation|40|||
130724282|NCT02121392|470615541|FG001|Prior to Intervention|Protocol Violation|35|||
130724283|NCT02121392|470615540|FG000|Prior to Intervention|Withdrawal by Subject|8|||
130724284|NCT02121392|470615541|FG001|Prior to Intervention|Withdrawal by Subject|6|||
130724285|NCT02121392|470615540|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
130724286|NCT02121392|470615541|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
130724287|NCT02121392|470615540|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
130724288|NCT02121392|470615541|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
130724289|NCT01352416|470615542|FG000|Overall Study|Physician Decision|1|||
130724290|NCT01352416|470615543|FG001|Overall Study|Physician Decision|2|||
130724291|NCT01352416|470615544|FG002|Overall Study|Physician Decision|2|||
130724292|NCT01352416|470615545|FG003|Overall Study|Physician Decision|1|||
130470955|NCT00632749|469690859|FG007|Overall Study|Reason other than those specified above|0|||
130470956|NCT00632749|469690860|FG008|Overall Study|Reason other than those specified above|0|||
130470957|NCT00632749|469690861|FG009|Overall Study|Reason other than those specified above|0|||
130470958|NCT00632749|469690862|FG010|Overall Study|Reason other than those specified above|2|||
130470959|NCT00632749|469690863|FG011|Overall Study|Reason other than those specified above|1|||
130470960|NCT00632749|469690864|FG012|Overall Study|Reason other than those specified above|0|||
130470961|NCT00632749|469690865|FG013|Overall Study|Reason other than those specified above|2|||
130470962|NCT02671435|469690866|FG000|Overall Study|Death|1|||
130724293|NCT00811928|470615556|FG000|Overall Study|AEs and SAEs Including Death|7|||
130724294|NCT00811928|470615557|FG001|Overall Study|AEs and SAEs Including Death|11|||
130724295|NCT00811928|470615556|FG000|Overall Study|Withdrawal by Subject|18|||
130724296|NCT00811928|470615557|FG001|Overall Study|Withdrawal by Subject|12|||
130470963|NCT02671435|469690867|FG001|Overall Study|Death|3|||
130470964|NCT02671435|469690868|FG002|Overall Study|Death|0|||
130470965|NCT02671435|469690869|FG003|Overall Study|Death|16|||
130724297|NCT00811928|470615556|FG000|Overall Study|Did Not Take Study Drug|3|||
130402907|NCT03337724|469438062|FG002|Overall Study|Symptomatic Deterioration|0|||
130402908|NCT03337724|469438063|FG003|Overall Study|Symptomatic Deterioration|1|||
130402909|NCT03337724|469438064|FG004|Overall Study|Symptomatic Deterioration|0|||
130402910|NCT03551210|469438066|FG000|Overall Study|Adverse Event|5|||
130402911|NCT03551210|469438067|FG001|Overall Study|Adverse Event|6|||
130402912|NCT03551210|469438066|FG000|Overall Study|Withdrawal by Subject|1|||
130402913|NCT03551210|469438067|FG001|Overall Study|Withdrawal by Subject|7|||
130402914|NCT03551210|469438066|FG000|Overall Study|Needed in other antibiotic treatment|2|||
130402915|NCT03551210|469438067|FG001|Overall Study|Needed in other antibiotic treatment|5|||
130402916|NCT03551210|469438066|FG000|Overall Study|Lost to Follow-up|1|||
130402917|NCT03551210|469438067|FG001|Overall Study|Lost to Follow-up|1|||
130402918|NCT03551210|469438066|FG000|Overall Study|Absence of visit 4 and 5|1|||
130402919|NCT03551210|469438067|FG001|Overall Study|Absence of visit 4 and 5|0|||
130402920|NCT03551210|469438066|FG000|Overall Study|No drug for dispensing|0|||
130402921|NCT03551210|469438067|FG001|Overall Study|No drug for dispensing|1|||
130402922|NCT03265119|469438068|FG000|Overall Study|Adverse Event|2|||
130402923|NCT03265119|469438069|FG001|Overall Study|Adverse Event|1|||
130402924|NCT03265119|469438068|FG000|Overall Study|Lack of Efficacy|3|||
130402925|NCT03265119|469438069|FG001|Overall Study|Lack of Efficacy|0|||
130402926|NCT03265119|469438068|FG000|Overall Study|Protocol Violation|1|||
130402927|NCT03265119|469438069|FG001|Overall Study|Protocol Violation|2|||
130402928|NCT03265119|469438068|FG000|Overall Study|Withdrawal by Subject|2|||
130402929|NCT03265119|469438069|FG001|Overall Study|Withdrawal by Subject|4|||
130402930|NCT03265119|469438068|FG000|Overall Study|Lost to Follow-up|1|||
130402931|NCT03265119|469438069|FG001|Overall Study|Lost to Follow-up|0|||
130402932|NCT03265119|469438068|FG000|Overall Study|Lack of Compliance|1|||
130402933|NCT03265119|469438069|FG001|Overall Study|Lack of Compliance|0|||
130402934|NCT00991302|469439509|FG000|Overall Study|Death|0|||
130402935|NCT00991302|469439510|FG001|Overall Study|Death|1|||
130402936|NCT00991302|469439509|FG000|Overall Study|Lost to Follow-up|14|||
130402937|NCT00991302|469439510|FG001|Overall Study|Lost to Follow-up|12|||
130402938|NCT01709318|469439511|FG000|Overall Study|Adverse Event|3|||
130402939|NCT01709318|469439512|FG001|Overall Study|Adverse Event|4|||
130402940|NCT01709318|469439513|FG002|Overall Study|Adverse Event|2|||
130402941|NCT01709318|469439514|FG003|Overall Study|Adverse Event|2|||
130402942|NCT01709318|469439515|FG004|Overall Study|Adverse Event|0|||
130402943|NCT01709318|469439516|FG005|Overall Study|Adverse Event|1|||
130402944|NCT01709318|469439517|FG006|Overall Study|Adverse Event|2|||
130402945|NCT01709318|469439511|FG000|Overall Study|Lost to Follow-up|2|||
130402946|NCT01709318|469439512|FG001|Overall Study|Lost to Follow-up|0|||
130402947|NCT01709318|469439513|FG002|Overall Study|Lost to Follow-up|0|||
130402948|NCT01709318|469439514|FG003|Overall Study|Lost to Follow-up|0|||
130402949|NCT01709318|469439515|FG004|Overall Study|Lost to Follow-up|1|||
130402950|NCT01709318|469439516|FG005|Overall Study|Lost to Follow-up|1|||
130402951|NCT01709318|469439517|FG006|Overall Study|Lost to Follow-up|1|||
130402952|NCT01709318|469439511|FG000|Overall Study|Non-compliance with Study Drug|0|||
130402953|NCT01709318|469439512|FG001|Overall Study|Non-compliance with Study Drug|2|||
130402954|NCT01709318|469439513|FG002|Overall Study|Non-compliance with Study Drug|1|||
130402955|NCT01709318|469439514|FG003|Overall Study|Non-compliance with Study Drug|1|||
130402956|NCT01709318|469439515|FG004|Overall Study|Non-compliance with Study Drug|0|||
130402957|NCT01709318|469439516|FG005|Overall Study|Non-compliance with Study Drug|0|||
130402958|NCT01709318|469439517|FG006|Overall Study|Non-compliance with Study Drug|2|||
130402959|NCT01709318|469439511|FG000|Overall Study|Physician Decision|0|||
130402960|NCT01709318|469439512|FG001|Overall Study|Physician Decision|0|||
130402961|NCT01709318|469439513|FG002|Overall Study|Physician Decision|0|||
130402962|NCT01709318|469439514|FG003|Overall Study|Physician Decision|0|||
130402963|NCT01709318|469439515|FG004|Overall Study|Physician Decision|0|||
130402964|NCT01709318|469439516|FG005|Overall Study|Physician Decision|0|||
130402965|NCT01709318|469439517|FG006|Overall Study|Physician Decision|1|||
130402966|NCT01709318|469439511|FG000|Overall Study|Pregnancy|0|||
130402967|NCT01709318|469439512|FG001|Overall Study|Pregnancy|0|||
130402968|NCT01709318|469439513|FG002|Overall Study|Pregnancy|0|||
130402969|NCT01709318|469439514|FG003|Overall Study|Pregnancy|0|||
130402970|NCT01709318|469439515|FG004|Overall Study|Pregnancy|1|||
130402971|NCT01709318|469439516|FG005|Overall Study|Pregnancy|0|||
130402972|NCT01709318|469439517|FG006|Overall Study|Pregnancy|0|||
130402973|NCT01709318|469439511|FG000|Overall Study|Protocol Violation|0|||
130402974|NCT01709318|469439512|FG001|Overall Study|Protocol Violation|0|||
130402975|NCT01709318|469439513|FG002|Overall Study|Protocol Violation|0|||
130402976|NCT01709318|469439514|FG003|Overall Study|Protocol Violation|0|||
130402977|NCT01709318|469439515|FG004|Overall Study|Protocol Violation|2|||
130561013|NCT03250832|470022781|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130724298|NCT00811928|470615557|FG001|Overall Study|Did Not Take Study Drug|0|||
130402978|NCT01709318|469439516|FG005|Overall Study|Protocol Violation|0|||
130402979|NCT01709318|469439517|FG006|Overall Study|Protocol Violation|1|||
130402980|NCT01709318|469439511|FG000|Overall Study|Technical Problems|1|||
130402981|NCT01709318|469439512|FG001|Overall Study|Technical Problems|0|||
130402982|NCT01709318|469439513|FG002|Overall Study|Technical Problems|0|||
130402983|NCT01709318|469439514|FG003|Overall Study|Technical Problems|0|||
130402984|NCT01709318|469439515|FG004|Overall Study|Technical Problems|0|||
130402985|NCT01709318|469439516|FG005|Overall Study|Technical Problems|0|||
130402986|NCT01709318|469439517|FG006|Overall Study|Technical Problems|0|||
130402987|NCT01709318|469439511|FG000|Overall Study|Withdrawal by Subject|3|||
130402988|NCT01709318|469439512|FG001|Overall Study|Withdrawal by Subject|0|||
130402989|NCT01709318|469439513|FG002|Overall Study|Withdrawal by Subject|3|||
130402990|NCT01709318|469439514|FG003|Overall Study|Withdrawal by Subject|3|||
130402991|NCT01709318|469439515|FG004|Overall Study|Withdrawal by Subject|0|||
130402992|NCT01709318|469439516|FG005|Overall Study|Withdrawal by Subject|2|||
130402993|NCT01709318|469439517|FG006|Overall Study|Withdrawal by Subject|4|||
130402994|NCT01709318|469439511|FG000|Overall Study|Other Protocol Specified Criteria|0|||
130402995|NCT01709318|469439512|FG001|Overall Study|Other Protocol Specified Criteria|1|||
130402996|NCT01709318|469439513|FG002|Overall Study|Other Protocol Specified Criteria|0|||
130402997|NCT01709318|469439514|FG003|Overall Study|Other Protocol Specified Criteria|0|||
130402998|NCT01709318|469439515|FG004|Overall Study|Other Protocol Specified Criteria|0|||
130402999|NCT01709318|469439516|FG005|Overall Study|Other Protocol Specified Criteria|0|||
130403000|NCT01709318|469439517|FG006|Overall Study|Other Protocol Specified Criteria|0|||
130403001|NCT02383758|469439518|FG000|Overall Study|Withdrawal by Subject|0|||
130403002|NCT02383758|469439519|FG001|Overall Study|Withdrawal by Subject|2|||
130403003|NCT03085927|469439522|FG000|Overall Study|Withdrawal by Subject|1|||
130403004|NCT03085927|469439523|FG001|Overall Study|Withdrawal by Subject|4|||
130403005|NCT03085927|469439522|FG000|Overall Study|Lost to Follow-up|3|||
130403006|NCT03085927|469439523|FG001|Overall Study|Lost to Follow-up|1|||
130403007|NCT03085927|469439522|FG000|Overall Study|Death|1|||
130403008|NCT03085927|469439523|FG001|Overall Study|Death|0|||
130470966|NCT02671435|469690870|FG004|Overall Study|Death|14|||
130470967|NCT02671435|469690871|FG005|Overall Study|Death|29|||
130470968|NCT02671435|469690872|FG006|Overall Study|Death|34|||
130470969|NCT02671435|469690873|FG007|Overall Study|Death|28|||
130470970|NCT02671435|469690874|FG008|Overall Study|Death|19|||
130470971|NCT02671435|469690875|FG009|Overall Study|Death|10|||
130470972|NCT02671435|469690876|FG010|Overall Study|Death|8|||
130470973|NCT02671435|469690877|FG011|Overall Study|Death|29|||
130403009|NCT03085927|469439522|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
130403010|NCT03085927|469439523|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
130403011|NCT03085927|469439522|FG000|Overall Study|Dyad Became Ineligible|0|||
130403012|NCT03085927|469439523|FG001|Overall Study|Dyad Became Ineligible|1|||
130403013|NCT00194012|469439524|FG000|Randomized Phase|Lack of Efficacy|8|||
130403014|NCT00194012|469439525|FG001|Randomized Phase|Lack of Efficacy|18|||
130403015|NCT00194012|469439524|FG000|Randomized Phase|Study nonadherence|2|||
130403016|NCT00194012|469439525|FG001|Randomized Phase|Study nonadherence|1|||
130403017|NCT00194012|469439524|FG000|Randomized Phase|Withdrawal by Subject|3|||
130403018|NCT00194012|469439525|FG001|Randomized Phase|Withdrawal by Subject|3|||
130403019|NCT00194012|469439524|FG000|Randomized Phase|Adverse Event|2|||
130403020|NCT00194012|469439525|FG001|Randomized Phase|Adverse Event|1|||
130403021|NCT00194012|469439524|FG000|Randomized Phase|Participant reported having a rash|1|||
130403022|NCT00194012|469439525|FG001|Randomized Phase|Participant reported having a rash|0|||
130403023|NCT00194012|469439524|FG000|Randomized Phase|Emesis and enuresis|0|||
130403024|NCT00194012|469439525|FG001|Randomized Phase|Emesis and enuresis|1|||
130403025|NCT00194012|469439524|FG000|Randomized Phase|Oral/nasal twitching|0|||
130403026|NCT00194012|469439525|FG001|Randomized Phase|Oral/nasal twitching|1|||
130403027|NCT00194012|469439524|FG000|Open Label Extension (OLE)|Weight Gain|1|||
130403028|NCT00194012|469439525|FG001|Open Label Extension (OLE)|Weight Gain|0|||
130403029|NCT00194012|469439524|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
130403030|NCT00194012|469439525|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
130403031|NCT00194012|469439524|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
130403032|NCT00194012|469439525|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
130403033|NCT00194012|469439524|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
130403034|NCT00194012|469439525|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
130403035|NCT01513317|469439531|FG000|Overall Study|Withdrawal by Subject|15|||
130403036|NCT01513317|469439532|FG001|Overall Study|Withdrawal by Subject|4|||
130403037|NCT01513317|469439531|FG000|Overall Study|Death|1|||
130403038|NCT01513317|469439532|FG001|Overall Study|Death|1|||
130403039|NCT01513317|469439531|FG000|Overall Study|Study terminated by sponsor|18|||
130403040|NCT01513317|469439532|FG001|Overall Study|Study terminated by sponsor|18|||
130403041|NCT01513317|469439531|FG000|Overall Study|Other|0|||
130403042|NCT01513317|469439532|FG001|Overall Study|Other|1|||
130403043|NCT01434823|469439533|FG000|Overall Study|Incomplete data in medical record|4|||
130470974|NCT02671435|469690878|FG012|Overall Study|Death|29|||
130470975|NCT02671435|469690879|FG013|Overall Study|Death|29|||
130724299|NCT00811928|470615556|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
130403044|NCT01434823|469439534|FG001|Overall Study|Incomplete data in medical record|7|||
130403045|NCT01797536|469439535|FG000|Overall Study|Adverse Event|0|||
130470976|NCT02671435|469690880|FG014|Overall Study|Death|27|||
130470977|NCT02671435|469690866|FG000|Overall Study|Lost to Follow-up|0|||
130470978|NCT02671435|469690867|FG001|Overall Study|Lost to Follow-up|0|||
130403046|NCT01797536|469439536|FG001|Overall Study|Adverse Event|1|||
130403047|NCT01797536|469439537|FG002|Overall Study|Adverse Event|0|||
130403048|NCT01797536|469439538|FG003|Overall Study|Adverse Event|0|||
130403049|NCT00120042|469439539|FG000|Overall Study|all completed protocl|0|||
130403050|NCT00120042|469439540|FG001|Overall Study|all completed protocl|0|||
130403051|NCT00120042|469439541|FG002|Overall Study|all completed protocl|0|||
130403052|NCT01263873|469439544|FG000|Overall Study|One provider unable to complete numbers|1|||
130403053|NCT01263873|469439545|FG001|Overall Study|One provider unable to complete numbers|1|||
130403054|NCT00047463|469439546|FG000|Overall Study|Withdrawal by Subject|0|||
130403055|NCT00047463|469439547|FG001|Overall Study|Withdrawal by Subject|3|||
130724300|NCT00811928|470615557|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
130724301|NCT00811928|470615556|FG000|Overall Study|Investigator Decision|2|||
130724302|NCT00811928|470615557|FG001|Overall Study|Investigator Decision|1|||
130724303|NCT00811928|470615556|FG000|Overall Study|Poor Compliance|2|||
130724304|NCT00811928|470615557|FG001|Overall Study|Poor Compliance|5|||
130724305|NCT00171951|470615558|FG000|Overall Study|Adverse Event|1|||
130724306|NCT00171951|470615558|FG000|Overall Study|Abnormal Laboratory Values|2|||
130470979|NCT02671435|469690868|FG002|Overall Study|Lost to Follow-up|1|||
130470980|NCT02671435|469690869|FG003|Overall Study|Lost to Follow-up|0|||
130470981|NCT02671435|469690870|FG004|Overall Study|Lost to Follow-up|1|||
130470982|NCT02671435|469690871|FG005|Overall Study|Lost to Follow-up|1|||
130724307|NCT00171951|470615558|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130724308|NCT00171951|470615558|FG000|Overall Study|Participants Withdrew Consent|3|||
130724309|NCT00171951|470615558|FG000|Overall Study|New Cancer Therapy|5|||
130724310|NCT00171951|470615558|FG000|Overall Study|Reason not Specified|2|||
130724311|NCT00396812|470615559|FG000|Overall Study|Physician Decision|1|||
130724312|NCT00843635|470615568|FG000|Overall Study|Adverse Event|2|||
130724313|NCT00843635|470615569|FG001|Overall Study|Adverse Event|2|||
130724314|NCT00843635|470615570|FG002|Overall Study|Adverse Event|0|||
130724315|NCT03496610|470615571|FG000|Overall Study|Lost to Follow-up|3|||
130724316|NCT03496610|470615572|FG001|Overall Study|Lost to Follow-up|2|||
130724317|NCT03496610|470615571|FG000|Overall Study|Physician Decision|1|||
130724318|NCT03496610|470615572|FG001|Overall Study|Physician Decision|0|||
130724319|NCT03496610|470615571|FG000|Overall Study|Withdrawal by Subject|1|||
130724320|NCT03496610|470615572|FG001|Overall Study|Withdrawal by Subject|0|||
130724321|NCT02714426|470615576|FG000|Overall Study|Withdrawal by Subject|2|||
130724322|NCT02714426|470615577|FG001|Overall Study|Withdrawal by Subject|2|||
130724323|NCT04435184|470615578|FG000|Overall Study|follow-up blood draws missing|3|||
130724324|NCT04435184|470615579|FG001|Overall Study|follow-up blood draws missing|5|||
130724325|NCT00813800|470615583|FG000|Overall Study|Screen Failure after Consent|2|||
130403056|NCT01401530|469439549|FG000|Overall Study|Disease Progression|1|||
130724326|NCT00813800|470615583|FG000|Overall Study|Adverse Event|1|||
130724327|NCT00813800|470615583|FG000|Overall Study|Worsening of depression|2|||
130724328|NCT00813800|470615583|FG000|Overall Study|Physician Decision|1|||
130724329|NCT03456453|470615584|FG000|Overall Study|Withdrawal by Subject|2|||
130724330|NCT03456453|470615585|FG001|Overall Study|Withdrawal by Subject|0|||
130724331|NCT03456453|470615584|FG000|Overall Study|Not released to community|1|||
130724332|NCT03456453|470615585|FG001|Overall Study|Not released to community|5|||
130724333|NCT03456453|470615584|FG000|Overall Study|Lost to Follow-up|0|||
130724334|NCT03456453|470615585|FG001|Overall Study|Lost to Follow-up|2|||
130724335|NCT04762277|470615586|FG000|Overall Study|Withdrawal by Subject|0|||
130724336|NCT04762277|470615587|FG001|Overall Study|Withdrawal by Subject|2|||
130724337|NCT04762277|470615586|FG000|Overall Study|Protocol Violation|0|||
130403057|NCT01401530|469439550|FG001|Overall Study|Disease Progression|2|||
130403058|NCT01401530|469439551|FG002|Overall Study|Disease Progression|1|||
130403059|NCT01401530|469439549|FG000|Overall Study|Adverse Event|1|||
130403060|NCT01401530|469439550|FG001|Overall Study|Adverse Event|1|||
130403061|NCT01401530|469439551|FG002|Overall Study|Adverse Event|1|||
130403062|NCT01401530|469439549|FG000|Overall Study|Participant Choice|1|||
130403063|NCT01401530|469439550|FG001|Overall Study|Participant Choice|2|||
130403064|NCT01401530|469439551|FG002|Overall Study|Participant Choice|1|||
130403065|NCT01401530|469439549|FG000|Overall Study|Physician Decision|0|||
130470983|NCT02671435|469690872|FG006|Overall Study|Lost to Follow-up|2|||
130470984|NCT02671435|469690873|FG007|Overall Study|Lost to Follow-up|2|||
130470985|NCT02671435|469690874|FG008|Overall Study|Lost to Follow-up|0|||
130470986|NCT02671435|469690875|FG009|Overall Study|Lost to Follow-up|2|||
130403066|NCT01401530|469439550|FG001|Overall Study|Physician Decision|1|||
130470987|NCT02671435|469690876|FG010|Overall Study|Lost to Follow-up|0|||
130470988|NCT02671435|469690877|FG011|Overall Study|Lost to Follow-up|3|||
130724338|NCT04762277|470615587|FG001|Overall Study|Protocol Violation|1|||
130724339|NCT04762277|470615586|FG000|Overall Study|Adverse Event|1|||
130724340|NCT04762277|470615587|FG001|Overall Study|Adverse Event|0|||
130724341|NCT01860677|470615588|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
130724342|NCT01860677|470615589|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
130470989|NCT02671435|469690878|FG012|Overall Study|Lost to Follow-up|3|||
130403067|NCT01401530|469439551|FG002|Overall Study|Physician Decision|0|||
130403068|NCT02664038|469439558|FG000|13 Week|Lost to Follow-up|7|||
130403069|NCT02664038|469439559|FG001|13 Week|Lost to Follow-up|14|||
130403070|NCT02664038|469439558|FG000|13 Week|Withdrawal by Subject|1|||
130403071|NCT02664038|469439559|FG001|13 Week|Withdrawal by Subject|0|||
130403072|NCT02664038|469439558|FG000|26 Week|Lost to Follow-up|5|||
130403073|NCT02664038|469439559|FG001|26 Week|Lost to Follow-up|4|||
130403074|NCT02606136|469439564|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
130403075|NCT02606136|469439564|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
130403076|NCT02606136|469439564|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
130403077|NCT02606136|469439564|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
130403078|NCT03296696|469439565|FG000|Overall Study|Started Other Antitumor Therapy|1|||
130403079|NCT03296696|469439566|FG001|Overall Study|Started Other Antitumor Therapy|2|||
130403080|NCT03296696|469439567|FG002|Overall Study|Started Other Antitumor Therapy|1|||
130403081|NCT03296696|469439568|FG003|Overall Study|Started Other Antitumor Therapy|2|||
130403082|NCT03296696|469439569|FG004|Overall Study|Started Other Antitumor Therapy|1|||
130403083|NCT03296696|469439570|FG005|Overall Study|Started Other Antitumor Therapy|1|||
130403084|NCT03296696|469439571|FG006|Overall Study|Started Other Antitumor Therapy|2|||
130403085|NCT03296696|469439572|FG007|Overall Study|Started Other Antitumor Therapy|3|||
130403086|NCT03296696|469439573|FG008|Overall Study|Started Other Antitumor Therapy|1|||
130403087|NCT03296696|469439574|FG009|Overall Study|Started Other Antitumor Therapy|0|||
130403088|NCT03296696|469439565|FG000|Overall Study|Death|0|||
130403089|NCT03296696|469439566|FG001|Overall Study|Death|1|||
130403090|NCT03296696|469439567|FG002|Overall Study|Death|1|||
130403091|NCT03296696|469439568|FG003|Overall Study|Death|2|||
130403092|NCT03296696|469439569|FG004|Overall Study|Death|2|||
130403093|NCT03296696|469439570|FG005|Overall Study|Death|3|||
130403094|NCT03296696|469439571|FG006|Overall Study|Death|1|||
130403095|NCT03296696|469439572|FG007|Overall Study|Death|2|||
130403096|NCT03296696|469439573|FG008|Overall Study|Death|0|||
130403097|NCT03296696|469439574|FG009|Overall Study|Death|0|||
130403098|NCT03296696|469439565|FG000|Overall Study|Withdrawal by Subject|0|||
130403099|NCT03296696|469439566|FG001|Overall Study|Withdrawal by Subject|0|||
130403100|NCT03296696|469439567|FG002|Overall Study|Withdrawal by Subject|1|||
130403101|NCT03296696|469439568|FG003|Overall Study|Withdrawal by Subject|0|||
130403102|NCT03296696|469439569|FG004|Overall Study|Withdrawal by Subject|1|||
130403103|NCT03296696|469439570|FG005|Overall Study|Withdrawal by Subject|0|||
130403104|NCT03296696|469439571|FG006|Overall Study|Withdrawal by Subject|0|||
130403105|NCT03296696|469439572|FG007|Overall Study|Withdrawal by Subject|0|||
130403106|NCT03296696|469439573|FG008|Overall Study|Withdrawal by Subject|0|||
130403107|NCT03296696|469439574|FG009|Overall Study|Withdrawal by Subject|1|||
130403108|NCT04694131|469439575|FG000|Overall Study|Withdrawal by Subject|7|||
130403109|NCT04694131|469439575|FG000|Overall Study|Screen Failure|1|||
130403110|NCT04694131|469439575|FG000|Overall Study|High stimulation threshold|3|||
130403111|NCT01252290|469439579|FG000|Overall Study|Withdrawal by Subject|1|||
130403112|NCT02075437|469439583|FG000|Overall Study|Withdrawal by Subject|5|||
130403113|NCT02075437|469439583|FG000|Overall Study|Lost to Follow-up|1|||
130403114|NCT02047110|469439584|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
130403115|NCT02047110|469439585|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
130403116|NCT02047110|469439586|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
130403117|NCT02047110|469439587|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
130403118|NCT02047110|469439584|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
130403119|NCT02047110|469439585|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130403120|NCT02047110|469439586|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130403121|NCT02047110|469439587|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130403122|NCT02047110|469439584|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
130403123|NCT02047110|469439585|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
130403124|NCT02047110|469439586|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
130403125|NCT02047110|469439587|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
130403126|NCT02047110|469439584|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
130403127|NCT02047110|469439585|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
130403128|NCT02047110|469439586|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
130403129|NCT02047110|469439587|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
130403130|NCT02047110|469439584|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
130403131|NCT02047110|469439585|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
130470990|NCT02671435|469690879|FG013|Overall Study|Lost to Follow-up|2|||
130470991|NCT02671435|469690880|FG014|Overall Study|Lost to Follow-up|0|||
130470992|NCT02671435|469690866|FG000|Overall Study|Withdrawal by Subject|2|||
130403132|NCT02047110|469439586|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
130403133|NCT02047110|469439587|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
130403134|NCT02047110|469439584|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
130403135|NCT02047110|469439585|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
130403136|NCT02047110|469439586|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
130403137|NCT02047110|469439587|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
130403138|NCT02047110|469439584|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
130403139|NCT02047110|469439585|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
130403140|NCT02047110|469439586|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
130403141|NCT02047110|469439587|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
130403142|NCT02047110|469439584|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
130403143|NCT02047110|469439585|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
130403144|NCT02047110|469439586|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
130403145|NCT02047110|469439587|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
130403146|NCT02047110|469439584|FG000|Escape Treatment Period|Adverse Event|1|||
130403147|NCT02047110|469439585|FG001|Escape Treatment Period|Adverse Event|2|||
130403148|NCT02047110|469439586|FG002|Escape Treatment Period|Adverse Event|2|||
130403149|NCT02047110|469439587|FG003|Escape Treatment Period|Adverse Event|0|||
130403150|NCT02047110|469439584|FG000|Escape Treatment Period|Other than specified|1|||
130403151|NCT02047110|469439585|FG001|Escape Treatment Period|Other than specified|2|||
130724343|NCT00896480|470615590|FG000|Overall Study|Disease progression/recurrence|21|||
130724344|NCT00642278|470615591|FG000|Overall Study|Adverse Event|2|||
130724345|NCT00642278|470615592|FG001|Overall Study|Adverse Event|1|||
130724346|NCT00642278|470615593|FG002|Overall Study|Adverse Event|3|||
130724347|NCT00642278|470615594|FG003|Overall Study|Adverse Event|1|||
130724348|NCT00642278|470615595|FG004|Overall Study|Adverse Event|2|||
130724349|NCT00642278|470615596|FG005|Overall Study|Adverse Event|2|||
130724350|NCT00642278|470615597|FG006|Overall Study|Adverse Event|0|||
130724351|NCT00642278|470615591|FG000|Overall Study|Lack of Efficacy|0|||
130724352|NCT00642278|470615592|FG001|Overall Study|Lack of Efficacy|1|||
130724353|NCT00642278|470615593|FG002|Overall Study|Lack of Efficacy|0|||
130724354|NCT00642278|470615594|FG003|Overall Study|Lack of Efficacy|0|||
130724355|NCT00642278|470615595|FG004|Overall Study|Lack of Efficacy|0|||
130724356|NCT00642278|470615596|FG005|Overall Study|Lack of Efficacy|0|||
130724357|NCT00642278|470615597|FG006|Overall Study|Lack of Efficacy|0|||
130724358|NCT00642278|470615591|FG000|Overall Study|Lost to Follow-up|5|||
130724359|NCT00642278|470615592|FG001|Overall Study|Lost to Follow-up|1|||
130724360|NCT00642278|470615593|FG002|Overall Study|Lost to Follow-up|0|||
130724361|NCT00642278|470615594|FG003|Overall Study|Lost to Follow-up|1|||
130724362|NCT00642278|470615595|FG004|Overall Study|Lost to Follow-up|0|||
130724363|NCT00642278|470615596|FG005|Overall Study|Lost to Follow-up|1|||
130724364|NCT00642278|470615597|FG006|Overall Study|Lost to Follow-up|1|||
130724365|NCT00642278|470615591|FG000|Overall Study|Physician Decision|0|||
130724366|NCT00642278|470615592|FG001|Overall Study|Physician Decision|0|||
130724367|NCT00642278|470615593|FG002|Overall Study|Physician Decision|0|||
130724368|NCT00642278|470615594|FG003|Overall Study|Physician Decision|1|||
130724369|NCT00642278|470615595|FG004|Overall Study|Physician Decision|0|||
130724370|NCT00642278|470615596|FG005|Overall Study|Physician Decision|0|||
130724371|NCT00642278|470615597|FG006|Overall Study|Physician Decision|0|||
130724372|NCT00642278|470615591|FG000|Overall Study|Protocol Violation|0|||
130724373|NCT00642278|470615592|FG001|Overall Study|Protocol Violation|0|||
130724374|NCT00642278|470615593|FG002|Overall Study|Protocol Violation|1|||
130724375|NCT00642278|470615594|FG003|Overall Study|Protocol Violation|1|||
130724376|NCT00642278|470615595|FG004|Overall Study|Protocol Violation|0|||
130724377|NCT00642278|470615596|FG005|Overall Study|Protocol Violation|1|||
130724378|NCT00642278|470615597|FG006|Overall Study|Protocol Violation|2|||
130403152|NCT02047110|469439586|FG002|Escape Treatment Period|Other than specified|0|||
130403153|NCT02047110|469439587|FG003|Escape Treatment Period|Other than specified|1|||
130403154|NCT02047110|469439584|FG000|OLE Treatment Period|Other than specified|0|||
130403155|NCT02047110|469439585|FG001|OLE Treatment Period|Other than specified|0|||
130403156|NCT02047110|469439586|FG002|OLE Treatment Period|Other than specified|1|||
130403157|NCT02047110|469439587|FG003|OLE Treatment Period|Other than specified|0|||
130403158|NCT04439240|469439588|FG000|Overall Study|Ineligible|2|||
130403159|NCT04439240|469439588|FG000|Overall Study|Never started treatment|2|||
130403160|NCT04439240|469439588|FG000|Overall Study|Adverse Event|12|||
130403161|NCT04439240|469439588|FG000|Overall Study|Death|2|||
130403162|NCT04439240|469439588|FG000|Overall Study|Disease progression|25|||
130403163|NCT04439240|469439588|FG000|Overall Study|Other diseases|2|||
130403164|NCT04439240|469439588|FG000|Overall Study|Withdrawal by Subject|3|||
130403165|NCT04439240|469439588|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
130403166|NCT04439240|469439588|FG000|Overall Study|Symptomatic decline|1|||
130403167|NCT04439240|469439588|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
130403168|NCT04439240|469439588|FG000|Overall Study|Clinical progression|1|||
130403169|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Adverse Event|41|||
130403170|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Adverse Event|24|||
130403171|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
130403172|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
130403173|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
130403174|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
130403175|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Physician Decision|0|||
130724379|NCT00642278|470615591|FG000|Overall Study|Withdrawal by Subject|1|||
130724380|NCT00642278|470615592|FG001|Overall Study|Withdrawal by Subject|1|||
130724381|NCT00642278|470615593|FG002|Overall Study|Withdrawal by Subject|1|||
130724382|NCT00642278|470615594|FG003|Overall Study|Withdrawal by Subject|3|||
130403176|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Physician Decision|6|||
130724383|NCT00642278|470615595|FG004|Overall Study|Withdrawal by Subject|6|||
130724384|NCT00642278|470615596|FG005|Overall Study|Withdrawal by Subject|2|||
130724385|NCT00642278|470615597|FG006|Overall Study|Withdrawal by Subject|2|||
130724386|NCT00642278|470615591|FG000|Overall Study|Noncompliance with study drug regimen|0|||
130724387|NCT00642278|470615592|FG001|Overall Study|Noncompliance with study drug regimen|0|||
130724388|NCT00642278|470615593|FG002|Overall Study|Noncompliance with study drug regimen|0|||
130403177|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
130403178|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
130403179|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
130724389|NCT00642278|470615594|FG003|Overall Study|Noncompliance with study drug regimen|1|||
130724390|NCT00642278|470615595|FG004|Overall Study|Noncompliance with study drug regimen|0|||
130724391|NCT00642278|470615596|FG005|Overall Study|Noncompliance with study drug regimen|0|||
130724392|NCT00642278|470615597|FG006|Overall Study|Noncompliance with study drug regimen|0|||
130724393|NCT00642278|470615591|FG000|Overall Study|Other|2|||
130724394|NCT00642278|470615592|FG001|Overall Study|Other|1|||
130724395|NCT00642278|470615593|FG002|Overall Study|Other|0|||
130724396|NCT00642278|470615594|FG003|Overall Study|Other|1|||
130724397|NCT00642278|470615595|FG004|Overall Study|Other|0|||
130724398|NCT00642278|470615596|FG005|Overall Study|Other|1|||
130724399|NCT00642278|470615597|FG006|Overall Study|Other|0|||
130724400|NCT00090363|470615598|FG000|Overall Study|Lost to Follow-up|1|||
130724401|NCT00090363|470615599|FG001|Overall Study|Lost to Follow-up|2|||
130724402|NCT00090363|470615600|FG002|Overall Study|Lost to Follow-up|1|||
130724403|NCT00090363|470615598|FG000|Overall Study|Withdrawal by Subject|7|||
130724404|NCT00090363|470615599|FG001|Overall Study|Withdrawal by Subject|7|||
130724405|NCT00090363|470615600|FG002|Overall Study|Withdrawal by Subject|6|||
130724406|NCT00090363|470615598|FG000|Overall Study|Study-specific discontinuation criteria|75|||
130724407|NCT00090363|470615599|FG001|Overall Study|Study-specific discontinuation criteria|74|||
130403180|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
130403181|NCT00673452|469439589|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
130403182|NCT00673452|469439590|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
130403183|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
130403184|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
130403185|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
130403186|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
130403187|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
130403188|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
130403189|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
130403190|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
130403191|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
130403192|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
130403193|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
130403194|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
130403195|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
130403196|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
130403197|NCT00673452|469439589|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
130403198|NCT00673452|469439590|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
130403199|NCT00813124|469439591|FG000|Overall Study|Death|2|||
130403200|NCT00813124|469439591|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
130403201|NCT00813124|469439591|FG000|Overall Study|Withdrawal by Subject|1|||
130403202|NCT00079274|469439596|FG000|Overall Study|Withdrawal by Subject|111|||
130403203|NCT00079274|469439597|FG001|Overall Study|Withdrawal by Subject|10|||
130403204|NCT00079274|469439598|FG002|Overall Study|Withdrawal by Subject|12|||
130403205|NCT00079274|469439599|FG003|Overall Study|Withdrawal by Subject|163|||
130403206|NCT00079274|469439600|FG004|Overall Study|Withdrawal by Subject|7|||
130403207|NCT00079274|469439601|FG005|Overall Study|Withdrawal by Subject|8|||
130403208|NCT00079274|469439602|FG006|Overall Study|Withdrawal by Subject|0|||
130403209|NCT00079274|469439596|FG000|Overall Study|Adverse Event|130|||
130403210|NCT00079274|469439597|FG001|Overall Study|Adverse Event|8|||
130403211|NCT00079274|469439598|FG002|Overall Study|Adverse Event|8|||
130403212|NCT00079274|469439599|FG003|Overall Study|Adverse Event|184|||
130403213|NCT00079274|469439600|FG004|Overall Study|Adverse Event|7|||
130403214|NCT00079274|469439601|FG005|Overall Study|Adverse Event|8|||
130403215|NCT00079274|469439602|FG006|Overall Study|Adverse Event|0|||
130403216|NCT00079274|469439596|FG000|Overall Study|Recurrence|21|||
130403217|NCT00079274|469439597|FG001|Overall Study|Recurrence|0|||
130403218|NCT00079274|469439598|FG002|Overall Study|Recurrence|1|||
130403219|NCT00079274|469439599|FG003|Overall Study|Recurrence|15|||
130403220|NCT00079274|469439600|FG004|Overall Study|Recurrence|0|||
130403221|NCT00079274|469439601|FG005|Overall Study|Recurrence|2|||
130403222|NCT00079274|469439602|FG006|Overall Study|Recurrence|0|||
130403223|NCT00079274|469439596|FG000|Overall Study|Alternate Treatment|6|||
130403224|NCT00079274|469439597|FG001|Overall Study|Alternate Treatment|1|||
130403225|NCT00079274|469439598|FG002|Overall Study|Alternate Treatment|0|||
130403226|NCT00079274|469439599|FG003|Overall Study|Alternate Treatment|3|||
130403227|NCT00079274|469439600|FG004|Overall Study|Alternate Treatment|0|||
130403228|NCT00079274|469439601|FG005|Overall Study|Alternate Treatment|0|||
130403229|NCT00079274|469439602|FG006|Overall Study|Alternate Treatment|0|||
130470993|NCT02671435|469690867|FG001|Overall Study|Withdrawal by Subject|0|||
130470994|NCT02671435|469690868|FG002|Overall Study|Withdrawal by Subject|2|||
130470995|NCT02671435|469690869|FG003|Overall Study|Withdrawal by Subject|2|||
130470996|NCT02671435|469690870|FG004|Overall Study|Withdrawal by Subject|2|||
130470997|NCT02671435|469690871|FG005|Overall Study|Withdrawal by Subject|7|||
130470998|NCT02671435|469690872|FG006|Overall Study|Withdrawal by Subject|2|||
130470999|NCT02671435|469690873|FG007|Overall Study|Withdrawal by Subject|7|||
130724408|NCT00090363|470615600|FG002|Overall Study|Study-specific discontinuation criteria|62|||
130403230|NCT00079274|469439596|FG000|Overall Study|Other Medical Problems|6|||
130403231|NCT00079274|469439597|FG001|Overall Study|Other Medical Problems|1|||
130403232|NCT00079274|469439598|FG002|Overall Study|Other Medical Problems|0|||
130403233|NCT00079274|469439599|FG003|Overall Study|Other Medical Problems|7|||
130403234|NCT00079274|469439600|FG004|Overall Study|Other Medical Problems|0|||
130403235|NCT00079274|469439601|FG005|Overall Study|Other Medical Problems|0|||
130403236|NCT00079274|469439602|FG006|Overall Study|Other Medical Problems|0|||
130403237|NCT00079274|469439596|FG000|Overall Study|Death|4|||
130403238|NCT00079274|469439597|FG001|Overall Study|Death|0|||
130403239|NCT00079274|469439598|FG002|Overall Study|Death|1|||
130403240|NCT00079274|469439599|FG003|Overall Study|Death|15|||
130724409|NCT00090363|470615598|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130724410|NCT00090363|470615599|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130724411|NCT00090363|470615600|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130724412|NCT00090363|470615598|FG000|Overall Study|Consent expired|7|||
130724413|NCT00090363|470615599|FG001|Overall Study|Consent expired|10|||
130724414|NCT00090363|470615600|FG002|Overall Study|Consent expired|9|||
130724415|NCT00090363|470615598|FG000|Overall Study|Reasons not specified|2|||
130724416|NCT00090363|470615599|FG001|Overall Study|Reasons not specified|1|||
130724417|NCT00090363|470615600|FG002|Overall Study|Reasons not specified|1|||
130724418|NCT00090363|470615598|FG000|Overall Study|Continuing on study off treatment|14|||
130724419|NCT00090363|470615599|FG001|Overall Study|Continuing on study off treatment|13|||
130724420|NCT00090363|470615600|FG002|Overall Study|Continuing on study off treatment|16|||
130724421|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130724422|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724423|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130724424|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724425|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724426|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
130724427|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130724428|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130724429|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130724430|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130724431|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724432|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724433|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724434|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130724435|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130724436|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130724437|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724438|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724439|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724440|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724441|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
130724442|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
130724443|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
130724444|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130724445|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130724446|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724447|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724448|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
130724449|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724450|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724451|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130724452|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130724453|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724454|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724455|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724456|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
130724457|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
130724458|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130724459|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130724460|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130724461|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130724462|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130724463|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130724464|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130403241|NCT00079274|469439600|FG004|Overall Study|Death|0|||
130403242|NCT00079274|469439601|FG005|Overall Study|Death|0|||
130403243|NCT00079274|469439602|FG006|Overall Study|Death|0|||
130724465|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130403244|NCT00079274|469439596|FG000|Overall Study|Cytogenetic resistance|0|||
130724466|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
130724467|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
130724468|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130724469|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
130724470|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
130724471|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130724472|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130724473|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
130724474|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130724475|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130724476|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130724477|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130724478|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130724479|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130724480|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130724481|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130724482|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130724483|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130724484|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130724485|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130724486|NCT01908907|470616946|FG000|Overall Study|Physician Decision|1|||
130724487|NCT01908907|470616947|FG001|Overall Study|Physician Decision|0|||
130724488|NCT01908907|470616946|FG000|Overall Study|Protocol Violation|1|||
130724489|NCT01908907|470616947|FG001|Overall Study|Protocol Violation|0|||
130724490|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
130724491|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
130724492|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
130724493|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
130724494|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
130724495|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
130724496|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
130724497|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
130724498|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
130724499|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724500|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724501|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130724502|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130724503|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724504|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724505|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724506|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724507|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724508|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724509|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724510|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
130724511|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
130724512|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724513|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724514|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724515|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724516|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724517|NCT00761657|470616948|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
130724518|NCT00761657|470616949|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
130724519|NCT00761657|470616950|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
130724520|NCT00761657|470616951|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
130724521|NCT00761657|470616952|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
130724522|NCT00761657|470616953|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
130724523|NCT00761657|470616954|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
130724524|NCT00761657|470616955|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
130724525|NCT00761657|470616956|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
130724526|NCT00359801|470616957|FG000|Overall Study|Lost to Follow-up|72|||
130724527|NCT00359801|470616958|FG001|Overall Study|Lost to Follow-up|58|||
130724528|NCT00359801|470616957|FG000|Overall Study|Withdrawal by Subject|143|||
130724529|NCT00359801|470616958|FG001|Overall Study|Withdrawal by Subject|96|||
130724530|NCT00359801|470616957|FG000|Overall Study|Other|66|||
130724531|NCT00359801|470616958|FG001|Overall Study|Other|46|||
130724532|NCT00359801|470616957|FG000|Overall Study|Final Status Unknown: missing data|7|||
130724533|NCT00359801|470616958|FG001|Overall Study|Final Status Unknown: missing data|4|||
130724534|NCT00359801|470616957|FG000|Overall Study|Sponsor Decision|17|||
130724535|NCT00359801|470616958|FG001|Overall Study|Sponsor Decision|16|||
130403245|NCT00079274|469439597|FG001|Overall Study|Cytogenetic resistance|0|||
130724536|NCT03151408|470616963|FG000|Overall Study|Adverse Event|24|||
130724537|NCT03151408|470616964|FG001|Overall Study|Adverse Event|23|||
130724538|NCT03151408|470616963|FG000|Overall Study|Death|46|||
130471000|NCT02671435|469690874|FG008|Overall Study|Withdrawal by Subject|1|||
130471001|NCT02671435|469690875|FG009|Overall Study|Withdrawal by Subject|1|||
130471002|NCT02671435|469690876|FG010|Overall Study|Withdrawal by Subject|2|||
130471003|NCT02671435|469690877|FG011|Overall Study|Withdrawal by Subject|4|||
130471004|NCT02671435|469690878|FG012|Overall Study|Withdrawal by Subject|4|||
130471005|NCT02671435|469690879|FG013|Overall Study|Withdrawal by Subject|4|||
130471006|NCT02671435|469690880|FG014|Overall Study|Withdrawal by Subject|2|||
130471007|NCT02671435|469690866|FG000|Overall Study|Un-specified|0|||
130471008|NCT02671435|469690867|FG001|Overall Study|Un-specified|0|||
130724539|NCT03151408|470616964|FG001|Overall Study|Death|26|||
130724540|NCT03151408|470616963|FG000|Overall Study|Physician Decision|13|||
130724541|NCT03151408|470616964|FG001|Overall Study|Physician Decision|19|||
130724542|NCT03151408|470616963|FG000|Overall Study|Withdrawal by Subject|16|||
130724543|NCT03151408|470616964|FG001|Overall Study|Withdrawal by Subject|20|||
130724544|NCT03151408|470616963|FG000|Overall Study|Progressive disease|45|||
130724545|NCT03151408|470616964|FG001|Overall Study|Progressive disease|61|||
130724546|NCT03151408|470616963|FG000|Overall Study|non-compliance by patient|1|||
130724547|NCT03151408|470616964|FG001|Overall Study|non-compliance by patient|0|||
130724548|NCT03151408|470616963|FG000|Overall Study|other reasons|56|||
130724549|NCT03151408|470616964|FG001|Overall Study|other reasons|52|||
130724550|NCT03151408|470616963|FG000|Overall Study|randomized and not treated|2|||
130724551|NCT03151408|470616964|FG001|Overall Study|randomized and not treated|2|||
130724552|NCT01473524|470616967|FG000|DB Phase|Adverse Event|4|||
130724553|NCT01473524|470616968|FG001|DB Phase|Adverse Event|8|||
130724554|NCT01473524|470616969|FG002|DB Phase|Adverse Event|2|||
130724555|NCT01473524|470616970|FG003|DB Phase|Adverse Event|0|||
130724556|NCT01473524|470616971|FG004|DB Phase|Adverse Event|0|||
130724557|NCT01473524|470616972|FG005|DB Phase|Adverse Event|0|||
130724558|NCT01473524|470616967|FG000|DB Phase|Death|1|||
130724559|NCT01473524|470616968|FG001|DB Phase|Death|0|||
130724560|NCT01473524|470616969|FG002|DB Phase|Death|0|||
130724561|NCT01473524|470616970|FG003|DB Phase|Death|0|||
130724562|NCT01473524|470616971|FG004|DB Phase|Death|0|||
130724563|NCT01473524|470616972|FG005|DB Phase|Death|0|||
130724564|NCT01473524|470616967|FG000|DB Phase|Withdrawal by Subject|2|||
130724565|NCT01473524|470616968|FG001|DB Phase|Withdrawal by Subject|1|||
130724566|NCT01473524|470616969|FG002|DB Phase|Withdrawal by Subject|1|||
130724567|NCT01473524|470616970|FG003|DB Phase|Withdrawal by Subject|0|||
130724568|NCT01473524|470616971|FG004|DB Phase|Withdrawal by Subject|0|||
130724569|NCT01473524|470616972|FG005|DB Phase|Withdrawal by Subject|0|||
130724570|NCT01473524|470616967|FG000|LTSE Phase|Withdrawal by Subject|0|||
130724571|NCT01473524|470616968|FG001|LTSE Phase|Withdrawal by Subject|0|||
130724572|NCT01473524|470616969|FG002|LTSE Phase|Withdrawal by Subject|0|||
130403246|NCT00079274|469439598|FG002|Overall Study|Cytogenetic resistance|0|||
130403247|NCT00079274|469439599|FG003|Overall Study|Cytogenetic resistance|2|||
130403248|NCT00079274|469439600|FG004|Overall Study|Cytogenetic resistance|0|||
130403249|NCT00079274|469439601|FG005|Overall Study|Cytogenetic resistance|0|||
130403250|NCT00079274|469439602|FG006|Overall Study|Cytogenetic resistance|0|||
130403251|NCT00079274|469439596|FG000|Overall Study|Other|43|||
130403252|NCT00079274|469439597|FG001|Overall Study|Other|7|||
130403253|NCT00079274|469439598|FG002|Overall Study|Other|5|||
130403254|NCT00079274|469439599|FG003|Overall Study|Other|55|||
130403255|NCT00079274|469439600|FG004|Overall Study|Other|1|||
130403256|NCT00079274|469439601|FG005|Overall Study|Other|2|||
130403257|NCT00079274|469439602|FG006|Overall Study|Other|0|||
130403258|NCT02075320|469439603|FG000|Overall Study|Withdrawal by Subject|2|||
130403259|NCT03773757|469439605|FG000|Overall Study|Withdrawal by Subject|2|||
130403260|NCT03773757|469439606|FG001|Overall Study|Withdrawal by Subject|4|||
130403261|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
130403262|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
130471009|NCT02671435|469690868|FG002|Overall Study|Un-specified|0|||
130471010|NCT02671435|469690869|FG003|Overall Study|Un-specified|0|||
130471011|NCT02671435|469690870|FG004|Overall Study|Un-specified|1|||
130471012|NCT02671435|469690871|FG005|Overall Study|Un-specified|3|||
130724573|NCT01473524|470616970|FG003|LTSE Phase|Withdrawal by Subject|3|||
130724574|NCT01473524|470616971|FG004|LTSE Phase|Withdrawal by Subject|3|||
130724575|NCT01473524|470616972|FG005|LTSE Phase|Withdrawal by Subject|6|||
130403263|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
130403264|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
130403265|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
130403266|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
130471013|NCT02671435|469690872|FG006|Overall Study|Un-specified|2|||
130724576|NCT01473524|470616967|FG000|LTSE Phase|Death|0|||
130724577|NCT01473524|470616968|FG001|LTSE Phase|Death|0|||
130724578|NCT01473524|470616969|FG002|LTSE Phase|Death|0|||
130724579|NCT01473524|470616970|FG003|LTSE Phase|Death|0|||
130724580|NCT01473524|470616971|FG004|LTSE Phase|Death|1|||
130724581|NCT01473524|470616972|FG005|LTSE Phase|Death|0|||
130724582|NCT01473524|470616967|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
130471014|NCT02671435|469690873|FG007|Overall Study|Un-specified|3|||
130471015|NCT02671435|469690874|FG008|Overall Study|Un-specified|0|||
130471016|NCT02671435|469690875|FG009|Overall Study|Un-specified|5|||
130471017|NCT02671435|469690876|FG010|Overall Study|Un-specified|8|||
130471018|NCT02671435|469690877|FG011|Overall Study|Un-specified|4|||
130471019|NCT02671435|469690878|FG012|Overall Study|Un-specified|5|||
130471020|NCT02671435|469690879|FG013|Overall Study|Un-specified|9|||
130471021|NCT02671435|469690880|FG014|Overall Study|Un-specified|8|||
130724583|NCT01473524|470616968|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
130724584|NCT01473524|470616969|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
130724585|NCT01473524|470616970|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
130724586|NCT01473524|470616971|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
130724587|NCT01473524|470616972|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
130724588|NCT01473524|470616967|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724589|NCT01473524|470616968|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724590|NCT01473524|470616969|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724591|NCT01473524|470616970|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
130724592|NCT01473524|470616971|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
130724593|NCT01473524|470616972|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
130724594|NCT01473524|470616967|FG000|LTSE Phase|Lost to Follow-up|0|||
130724595|NCT01473524|470616968|FG001|LTSE Phase|Lost to Follow-up|0|||
130724596|NCT01473524|470616969|FG002|LTSE Phase|Lost to Follow-up|0|||
130724597|NCT01473524|470616970|FG003|LTSE Phase|Lost to Follow-up|1|||
130724598|NCT01473524|470616971|FG004|LTSE Phase|Lost to Follow-up|3|||
130724599|NCT01473524|470616972|FG005|LTSE Phase|Lost to Follow-up|2|||
130403267|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
130403268|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
130403269|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
130403270|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
130403271|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
130403272|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
130403273|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
130403274|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
130403275|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
130403276|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
130403277|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
130403278|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
130403279|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
130403280|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
130403281|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
130403282|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
130403283|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
130403284|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
130403285|NCT04542070|469439607|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
130403286|NCT04542070|469439608|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
130403287|NCT04542070|469439609|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
130403288|NCT04542070|469439610|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
130403289|NCT04542070|469439607|FG000|Maintenance + Extension Period|Adverse Event|10|||
130403290|NCT04542070|469439608|FG001|Maintenance + Extension Period|Adverse Event|2|||
130403291|NCT04542070|469439609|FG002|Maintenance + Extension Period|Adverse Event|0|||
130403292|NCT04542070|469439610|FG003|Maintenance + Extension Period|Adverse Event|0|||
130403293|NCT04542070|469439607|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
130403294|NCT04542070|469439608|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
130403295|NCT04542070|469439609|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
130403296|NCT04542070|469439610|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
130403297|NCT04542070|469439607|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
130403298|NCT04542070|469439608|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
130403299|NCT04542070|469439609|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
130403300|NCT04542070|469439610|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
130403301|NCT04542070|469439607|FG000|Maintenance + Extension Period|Physician Decision|1|||
130403302|NCT04542070|469439608|FG001|Maintenance + Extension Period|Physician Decision|1|||
130403303|NCT04542070|469439609|FG002|Maintenance + Extension Period|Physician Decision|0|||
130471022|NCT01136876|469690881|FG000|Overall Study|Lost to Follow-up|0|||
130403304|NCT04542070|469439610|FG003|Maintenance + Extension Period|Physician Decision|0|||
130403305|NCT04542070|469439607|FG000|Maintenance + Extension Period|Protocol Violation|2|||
130403306|NCT04542070|469439608|FG001|Maintenance + Extension Period|Protocol Violation|5|||
130471023|NCT01136876|469690882|FG001|Overall Study|Lost to Follow-up|1|||
130724600|NCT01473524|470616967|FG000|LTSE Phase|Principal Investigator Decision|0|||
130724601|NCT01473524|470616968|FG001|LTSE Phase|Principal Investigator Decision|0|||
130403307|NCT04542070|469439609|FG002|Maintenance + Extension Period|Protocol Violation|0|||
130403308|NCT04542070|469439610|FG003|Maintenance + Extension Period|Protocol Violation|0|||
130403309|NCT04542070|469439607|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
130403310|NCT04542070|469439608|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
130403311|NCT04542070|469439609|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
130403312|NCT04542070|469439610|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
130403313|NCT04542070|469439607|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
130403314|NCT04542070|469439608|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
130403315|NCT04542070|469439609|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
130403316|NCT04542070|469439610|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
130403317|NCT04542070|469439607|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130403318|NCT04542070|469439608|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130403319|NCT04542070|469439609|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130403320|NCT04542070|469439610|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
130403321|NCT04542070|469439607|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130403322|NCT04542070|469439608|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130403323|NCT04542070|469439609|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130403324|NCT04542070|469439610|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
130403325|NCT04542070|469439607|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130403326|NCT04542070|469439608|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130403327|NCT04542070|469439609|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130403328|NCT04542070|469439610|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
130403329|NCT04542070|469439607|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130403330|NCT04542070|469439608|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130403331|NCT04542070|469439609|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130403332|NCT04542070|469439610|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
130403333|NCT04542070|469439607|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130403334|NCT04542070|469439608|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130403335|NCT04542070|469439609|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130403336|NCT04542070|469439610|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
130403337|NCT03049813|469439612|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130403338|NCT03049813|469439613|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
130403339|NCT03049813|469439614|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130403340|NCT03049813|469439615|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130403341|NCT03049813|469439612|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
130403342|NCT03049813|469439613|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
130403343|NCT03049813|469439614|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
130724602|NCT01473524|470616969|FG002|LTSE Phase|Principal Investigator Decision|0|||
130724603|NCT01473524|470616970|FG003|LTSE Phase|Principal Investigator Decision|1|||
130724604|NCT01473524|470616971|FG004|LTSE Phase|Principal Investigator Decision|1|||
130724605|NCT01473524|470616972|FG005|LTSE Phase|Principal Investigator Decision|3|||
130724606|NCT01473524|470616967|FG000|LTSE Phase|Liver Transplantation|0|||
130724607|NCT01473524|470616968|FG001|LTSE Phase|Liver Transplantation|0|||
130724608|NCT01473524|470616969|FG002|LTSE Phase|Liver Transplantation|0|||
130724609|NCT01473524|470616970|FG003|LTSE Phase|Liver Transplantation|0|||
130724610|NCT01473524|470616971|FG004|LTSE Phase|Liver Transplantation|0|||
130724611|NCT01473524|470616972|FG005|LTSE Phase|Liver Transplantation|1|||
130724612|NCT01473524|470616967|FG000|LTSE Phase|Pregnancy|0|||
130724613|NCT01473524|470616968|FG001|LTSE Phase|Pregnancy|0|||
130724614|NCT01473524|470616969|FG002|LTSE Phase|Pregnancy|0|||
130724615|NCT01473524|470616970|FG003|LTSE Phase|Pregnancy|1|||
130724616|NCT01473524|470616971|FG004|LTSE Phase|Pregnancy|0|||
130724617|NCT01473524|470616972|FG005|LTSE Phase|Pregnancy|0|||
130724618|NCT01473524|470616967|FG000|LTSE Phase|Protocol Violation|0|||
130724619|NCT01473524|470616968|FG001|LTSE Phase|Protocol Violation|0|||
130724620|NCT01473524|470616969|FG002|LTSE Phase|Protocol Violation|0|||
130724621|NCT01473524|470616970|FG003|LTSE Phase|Protocol Violation|0|||
130724622|NCT01473524|470616971|FG004|LTSE Phase|Protocol Violation|0|||
130724623|NCT01473524|470616972|FG005|LTSE Phase|Protocol Violation|1|||
130724624|NCT02383810|470616973|FG000|Overall Study|Physician Decision|1|||
130724625|NCT02383810|470616974|FG001|Overall Study|Physician Decision|1|||
130724626|NCT02383810|470616975|FG002|Overall Study|Physician Decision|0|||
130724627|NCT02383810|470616976|FG003|Overall Study|Physician Decision|0|||
130724628|NCT02383810|470616977|FG004|Overall Study|Physician Decision|0|||
130403344|NCT03049813|469439615|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
130403345|NCT03049813|469439612|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130403346|NCT03049813|469439613|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
130724629|NCT02383810|470616978|FG005|Overall Study|Physician Decision|0|||
130724630|NCT02383810|470616979|FG006|Overall Study|Physician Decision|0|||
130724631|NCT02383810|470616980|FG007|Overall Study|Physician Decision|0|||
130561014|NCT03250832|470022782|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130561015|NCT03250832|470022783|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130561016|NCT03250832|470022784|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130561017|NCT03250832|470022785|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130403347|NCT03049813|469439614|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130403348|NCT03049813|469439615|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130403349|NCT03049813|469439612|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
130403350|NCT03049813|469439613|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
130403351|NCT03049813|469439614|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
130403352|NCT03049813|469439615|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
130403353|NCT00550836|469439616|FG000|Overall Study|Withdrawal by Subject|3|||
130403354|NCT00550836|469439617|FG001|Overall Study|Withdrawal by Subject|9|||
130403355|NCT03120013|469439618|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130403356|NCT03120013|469439619|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130403357|NCT02705820|469439620|FG000|Overall Study|Death|2|||
130403358|NCT02705820|469439620|FG000|Overall Study|Disease Progression|34|||
130403359|NCT02705820|469439620|FG000|Overall Study|Clinical Deterioration|3|||
130403360|NCT02702401|469439621|FG000|Overall Study|Death|242|||
130403361|NCT02702401|469439622|FG001|Overall Study|Death|125|||
130403362|NCT02702401|469439621|FG000|Overall Study|Withdrawal by Subject|15|||
130403363|NCT02702401|469439622|FG001|Overall Study|Withdrawal by Subject|5|||
130403364|NCT02702401|469439621|FG000|Overall Study|Sponsor Decision|19|||
130403365|NCT02702401|469439622|FG001|Overall Study|Sponsor Decision|3|||
130403366|NCT02702401|469439621|FG000|Overall Study|Physician Decision|1|||
130403367|NCT02702401|469439622|FG001|Overall Study|Physician Decision|2|||
130403368|NCT02702401|469439621|FG000|Overall Study|Lost to Follow-up|1|||
130403369|NCT02702401|469439622|FG001|Overall Study|Lost to Follow-up|0|||
130403370|NCT01856543|469439627|FG000|Overall Study|Treatment discontinued|6|||
130403371|NCT01856543|469439628|FG001|Overall Study|Treatment discontinued|3|||
130403372|NCT01856543|469439627|FG000|Overall Study|Withdrawn before start|7|||
130403373|NCT01856543|469439628|FG001|Overall Study|Withdrawn before start|3|||
130403374|NCT02457325|469439633|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
130403375|NCT02457325|469439634|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
130403376|NCT01541930|469439635|FG000|Overall Study|Withdrawal by Subject|1|||
130403377|NCT04187196|469439636|FG000|Overall Study|Screen Failure|2|||
130403378|NCT04187196|469439637|FG001|Overall Study|Screen Failure|0|||
130403379|NCT01957475|469439640|FG000|Test Period 1|Withdrawal by Subject|1|||
130403380|NCT01957475|469439641|FG001|Test Period 1|Withdrawal by Subject|0|||
130403381|NCT01957475|469439640|FG000|Test Period 1|Other|1|||
130403382|NCT01957475|469439641|FG001|Test Period 1|Other|0|||
130403383|NCT01957475|469439640|FG000|Test Period 1|Lack of Efficacy|0|||
130403384|NCT01957475|469439641|FG001|Test Period 1|Lack of Efficacy|1|||
130403385|NCT01957475|469439640|FG000|Test Period 2|Adverse Event|1|||
130403386|NCT01957475|469439641|FG001|Test Period 2|Adverse Event|0|||
130403387|NCT04587193|469439642|FG000|Overall Study|Screen failure after consent|3|||
130403388|NCT04587193|469439643|FG001|Overall Study|Screen failure after consent|0|||
130403389|NCT04587193|469439642|FG000|Overall Study|Device broke during study|3|||
130403390|NCT04587193|469439643|FG001|Overall Study|Device broke during study|2|||
130403391|NCT01552772|469439644|FG000|Overall Study|Lost to Follow-up|2|||
130403392|NCT01552772|469439644|FG000|Overall Study|Adverse Event|1|||
130403393|NCT01552772|469439644|FG000|Overall Study|Protocol Deviation|1|||
130403394|NCT02920983|469439647|FG000|Dispense 1|Unacceptable Lens Fit|0|||
130403395|NCT02920983|469439648|FG001|Dispense 1|Unacceptable Lens Fit|0|||
130403396|NCT02920983|469439649|FG002|Dispense 1|Unacceptable Lens Fit|0|||
130561018|NCT03250832|470022786|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130403397|NCT02920983|469439650|FG003|Dispense 1|Unacceptable Lens Fit|0|||
130403398|NCT02920983|469439651|FG004|Dispense 1|Unacceptable Lens Fit|1|||
130403399|NCT02920983|469439652|FG005|Dispense 1|Unacceptable Lens Fit|0|||
130403400|NCT02920983|469439647|FG000|Dispense 2|Unscceptable lens fit|1|||
130403401|NCT02920983|469439648|FG001|Dispense 2|Unscceptable lens fit|0|||
130403402|NCT02920983|469439649|FG002|Dispense 2|Unscceptable lens fit|0|||
130403403|NCT02920983|469439650|FG003|Dispense 2|Unscceptable lens fit|0|||
130403404|NCT02920983|469439651|FG004|Dispense 2|Unscceptable lens fit|1|||
130403405|NCT02920983|469439652|FG005|Dispense 2|Unscceptable lens fit|0|||
130403406|NCT02920983|469439647|FG000|Dispense 3|Unacceptable Lens Fit|1|||
130403407|NCT02920983|469439648|FG001|Dispense 3|Unacceptable Lens Fit|1|||
130403408|NCT02920983|469439649|FG002|Dispense 3|Unacceptable Lens Fit|0|||
130403409|NCT02920983|469439650|FG003|Dispense 3|Unacceptable Lens Fit|0|||
130403410|NCT02920983|469439651|FG004|Dispense 3|Unacceptable Lens Fit|1|||
130403411|NCT02920983|469439652|FG005|Dispense 3|Unacceptable Lens Fit|0|||
130724632|NCT02383810|470616973|FG000|Overall Study|Withdrawal by Subject|2|||
130724633|NCT02383810|470616974|FG001|Overall Study|Withdrawal by Subject|3|||
130724634|NCT02383810|470616975|FG002|Overall Study|Withdrawal by Subject|3|||
130724635|NCT02383810|470616976|FG003|Overall Study|Withdrawal by Subject|3|||
130724636|NCT02383810|470616977|FG004|Overall Study|Withdrawal by Subject|0|||
130724637|NCT02383810|470616978|FG005|Overall Study|Withdrawal by Subject|0|||
130724638|NCT02383810|470616979|FG006|Overall Study|Withdrawal by Subject|0|||
130724639|NCT02383810|470616980|FG007|Overall Study|Withdrawal by Subject|0|||
130724640|NCT02383810|470616973|FG000|Overall Study|Adverse Event|0|||
130724641|NCT02383810|470616974|FG001|Overall Study|Adverse Event|2|||
130724642|NCT02383810|470616975|FG002|Overall Study|Adverse Event|4|||
130724643|NCT02383810|470616976|FG003|Overall Study|Adverse Event|5|||
130724644|NCT02383810|470616977|FG004|Overall Study|Adverse Event|0|||
130724645|NCT02383810|470616978|FG005|Overall Study|Adverse Event|1|||
130724646|NCT02383810|470616979|FG006|Overall Study|Adverse Event|1|||
130724647|NCT02383810|470616980|FG007|Overall Study|Adverse Event|0|||
130724648|NCT02383810|470616973|FG000|Overall Study|Lost to Follow-up|0|||
130724649|NCT02383810|470616974|FG001|Overall Study|Lost to Follow-up|1|||
130724650|NCT02383810|470616975|FG002|Overall Study|Lost to Follow-up|0|||
130724651|NCT02383810|470616976|FG003|Overall Study|Lost to Follow-up|1|||
130724652|NCT02383810|470616977|FG004|Overall Study|Lost to Follow-up|0|||
130724653|NCT02383810|470616978|FG005|Overall Study|Lost to Follow-up|0|||
130724654|NCT02383810|470616979|FG006|Overall Study|Lost to Follow-up|0|||
130724655|NCT02383810|470616980|FG007|Overall Study|Lost to Follow-up|0|||
130724656|NCT02383810|470616973|FG000|Overall Study|other|0|||
130724657|NCT02383810|470616974|FG001|Overall Study|other|0|||
130724658|NCT02383810|470616975|FG002|Overall Study|other|0|||
130724659|NCT02383810|470616976|FG003|Overall Study|other|2|||
130724660|NCT02383810|470616977|FG004|Overall Study|other|0|||
130403412|NCT03878134|469439653|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
130403413|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
130403414|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
130403415|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
130403416|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Death|1|||
130403417|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Death|0|||
130403418|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Death|0|||
130403419|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
130403420|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
130403421|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
130403422|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
130403423|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
130403424|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
130403425|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
130403426|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
130403427|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
130403428|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
130403429|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
130403430|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
130403431|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
130403432|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
130403433|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
130403434|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
130403435|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
130403436|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
130403437|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
130403438|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
130403439|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
130403440|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
130403441|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
130403442|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
130403443|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
130403444|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
130403445|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
130403446|NCT03655236|469439656|FG000|Subject Disposition in Part 1 Period|Other|0|||
130403447|NCT03655236|469439657|FG001|Subject Disposition in Part 1 Period|Other|2|||
130403448|NCT03655236|469439658|FG002|Subject Disposition in Part 1 Period|Other|2|||
130403449|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
130724661|NCT02383810|470616978|FG005|Overall Study|other|0|||
130724662|NCT02383810|470616979|FG006|Overall Study|other|0|||
130724663|NCT02383810|470616980|FG007|Overall Study|other|0|||
130724664|NCT02383810|470616973|FG000|Overall Study|subject did not receive study treatment|0|||
130724665|NCT02383810|470616974|FG001|Overall Study|subject did not receive study treatment|1|||
130403450|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
130403451|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
130403452|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
130471024|NCT01136876|469690881|FG000|Overall Study|Physician Decision|3|||
130471025|NCT01136876|469690882|FG001|Overall Study|Physician Decision|5|||
130471026|NCT01136876|469690881|FG000|Overall Study|Missing NGAL measurement|2|||
130471027|NCT01136876|469690882|FG001|Overall Study|Missing NGAL measurement|5|||
130471028|NCT02412748|469690885|FG000|Overall Study|Lost to Follow-up|38|||
130471029|NCT02412748|469690886|FG001|Overall Study|Lost to Follow-up|39|||
130471030|NCT04128319|469690887|FG000|Overall Study|Death|3|||
130471031|NCT00976937|469690890|FG000|Overall Study|Adverse Event|4|||
130471032|NCT00976937|469690891|FG001|Overall Study|Adverse Event|5|||
130471033|NCT00976937|469690890|FG000|Overall Study|Lost to Follow-up|2|||
130471034|NCT00976937|469690891|FG001|Overall Study|Lost to Follow-up|1|||
130471035|NCT00976937|469690890|FG000|Overall Study|Withdrawal by Subject|5|||
130471036|NCT00976937|469690891|FG001|Overall Study|Withdrawal by Subject|3|||
130471037|NCT00976937|469690890|FG000|Overall Study|Poor compliance to protocol|3|||
130471038|NCT00976937|469690891|FG001|Overall Study|Poor compliance to protocol|0|||
130471039|NCT00976937|469690890|FG000|Overall Study|Personal and Familial Reason|2|||
130471040|NCT00976937|469690891|FG001|Overall Study|Personal and Familial Reason|2|||
130471041|NCT03069313|469690892|FG000|Overall Study|Adverse Event|5|||
130471042|NCT01011946|469690894|FG000|Overall Study|Transferred to another hospital|2|||
130471043|NCT01011946|469690894|FG000|Overall Study|No pathological lab value|1|||
130471044|NCT04820686|469690895|FG000|Overall Study|Withdrawal by Subject|5|||
130471045|NCT04820686|469690896|FG001|Overall Study|Withdrawal by Subject|2|||
130471046|NCT04820686|469690897|FG002|Overall Study|Withdrawal by Subject|3|||
130471047|NCT04820686|469690895|FG000|Overall Study|Study Termination|25|||
130471048|NCT04820686|469690896|FG001|Overall Study|Study Termination|13|||
130471049|NCT04820686|469690897|FG002|Overall Study|Study Termination|14|||
130471050|NCT04820686|469690895|FG000|Overall Study|Adverse Event|0|||
130471051|NCT04820686|469690896|FG001|Overall Study|Adverse Event|1|||
130471052|NCT04820686|469690897|FG002|Overall Study|Adverse Event|0|||
130471053|NCT01872078|469690898|FG000|Overall Study|Adverse Event|0|||
130471054|NCT01872078|469690899|FG001|Overall Study|Adverse Event|0|||
130471055|NCT01872078|469690900|FG002|Overall Study|Adverse Event|1|||
130471056|NCT01872078|469690901|FG003|Overall Study|Adverse Event|0|||
130471057|NCT01872078|469690898|FG000|Overall Study|Dose administration non-compliance|0|||
130471058|NCT01872078|469690899|FG001|Overall Study|Dose administration non-compliance|0|||
130471059|NCT01872078|469690900|FG002|Overall Study|Dose administration non-compliance|0|||
130471060|NCT01872078|469690901|FG003|Overall Study|Dose administration non-compliance|1|||
130471061|NCT01872078|469690898|FG000|Overall Study|Protocol Violation|0|||
130471062|NCT01872078|469690899|FG001|Overall Study|Protocol Violation|0|||
130471063|NCT01872078|469690900|FG002|Overall Study|Protocol Violation|1|||
130471064|NCT01872078|469690901|FG003|Overall Study|Protocol Violation|0|||
130471065|NCT01872078|469690898|FG000|Overall Study|Withdrawal by Subject|0|||
130471066|NCT01872078|469690899|FG001|Overall Study|Withdrawal by Subject|0|||
130471067|NCT01872078|469690900|FG002|Overall Study|Withdrawal by Subject|1|||
130471068|NCT01872078|469690901|FG003|Overall Study|Withdrawal by Subject|0|||
130471069|NCT01872078|469690898|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
130471070|NCT01872078|469690899|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
130471071|NCT01872078|469690900|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
130471072|NCT01872078|469690901|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
130471073|NCT01424670|469690902|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
130471074|NCT01424670|469690903|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
130471075|NCT01424670|469690902|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
130471076|NCT01424670|469690903|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
130471077|NCT01424670|469690902|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
130471078|NCT01424670|469690903|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
130471079|NCT01424670|469690902|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
130471080|NCT01424670|469690903|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
130471081|NCT01424670|469690902|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
130471082|NCT01424670|469690903|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
130471083|NCT01424670|469690902|FG000|Continuation Period|Adverse Event|13|||
130471084|NCT01424670|469690903|FG001|Continuation Period|Adverse Event|5|||
130471085|NCT01424670|469690902|FG000|Continuation Period|Lost to Follow-up|2|||
130471086|NCT01424670|469690903|FG001|Continuation Period|Lost to Follow-up|0|||
130471087|NCT01424670|469690902|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
130471088|NCT01424670|469690903|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
130471089|NCT01424670|469690902|FG000|Continuation Period|Physician Decision|5|||
130471090|NCT01424670|469690903|FG001|Continuation Period|Physician Decision|4|||
130724666|NCT02383810|470616975|FG002|Overall Study|subject did not receive study treatment|0|||
130724667|NCT02383810|470616976|FG003|Overall Study|subject did not receive study treatment|0|||
130724668|NCT02383810|470616977|FG004|Overall Study|subject did not receive study treatment|0|||
130724669|NCT02383810|470616978|FG005|Overall Study|subject did not receive study treatment|0|||
130724670|NCT02383810|470616979|FG006|Overall Study|subject did not receive study treatment|0|||
130724671|NCT02383810|470616980|FG007|Overall Study|subject did not receive study treatment|0|||
130724672|NCT00282919|470616981|FG000|Overall Study|Lack of Efficacy|4|||
130724673|NCT00282919|470616981|FG000|Overall Study|Withdrawal by Subject|1|||
130403453|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
130403454|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
130403455|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
130724674|NCT00282919|470616981|FG000|Overall Study|Asymptomatic Parasitemia|2|||
130403456|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
130403457|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
130403458|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
130403459|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
130403460|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
130403461|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
130403462|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
130403463|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
130403464|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
130403465|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
130403466|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
130403467|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
130403468|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
130403469|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
130403470|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
130403471|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
130403472|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
130403473|NCT03655236|469439656|FG000|Subject Disposition in Part 2 Period|Other|1|||
130403474|NCT03655236|469439657|FG001|Subject Disposition in Part 2 Period|Other|0|||
130403475|NCT03655236|469439658|FG002|Subject Disposition in Part 2 Period|Other|0|||
130403476|NCT00600821|469441686|FG000|Overall Study|Death|45|||
130403477|NCT00600821|469441687|FG001|Overall Study|Death|46|||
130403478|NCT00600821|469441686|FG000|Overall Study|Lost to Follow-up|2|||
130403479|NCT00600821|469441687|FG001|Overall Study|Lost to Follow-up|2|||
130403480|NCT00600821|469441686|FG000|Overall Study|Withdrawal by Subject|1|||
130403481|NCT00600821|469441687|FG001|Overall Study|Withdrawal by Subject|1|||
130403482|NCT00600821|469441686|FG000|Overall Study|Terminated by sponsor|8|||
130403483|NCT00600821|469441687|FG001|Overall Study|Terminated by sponsor|6|||
130403484|NCT00600821|469441686|FG000|Overall Study|Objective progression or relapse|0|||
130403485|NCT00600821|469441687|FG001|Overall Study|Objective progression or relapse|1|||
130403486|NCT00600821|469441686|FG000|Overall Study|Randomized but not treated|0|||
130403487|NCT00600821|469441687|FG001|Overall Study|Randomized but not treated|1|||
130403488|NCT00600821|469441686|FG000|Overall Study|Other|2|||
130403489|NCT00600821|469441687|FG001|Overall Study|Other|3|||
130403490|NCT04101526|469441697|FG000|Overall Study|Did not complete all sleep diary entries|0|||
130403491|NCT04101526|469441698|FG001|Overall Study|Did not complete all sleep diary entries|1|||
130403492|NCT00424372|469441699|FG000|Overall Study|Death|1|||
130403493|NCT00424372|469441699|FG000|Overall Study|Adverse Event|18|||
130403494|NCT00424372|469441699|FG000|Overall Study|Lack of Efficacy|6|||
130403495|NCT00424372|469441699|FG000|Overall Study|Withdrawal by Subject|4|||
130403496|NCT00424372|469441699|FG000|Overall Study|Protocol Violation|1|||
130403497|NCT00424372|469441699|FG000|Overall Study|Health deterioration|1|||
130403498|NCT04622254|469441700|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130403499|NCT04622254|469441701|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
130403500|NCT04622254|469441702|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130403501|NCT04622254|469441703|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130403502|NCT04622254|469441704|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130403503|NCT04622254|469441705|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130403504|NCT04622254|469441700|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130403505|NCT04622254|469441701|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
130403506|NCT04622254|469441702|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130403507|NCT04622254|469441703|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130403508|NCT04622254|469441704|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130403509|NCT04622254|469441705|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130403510|NCT04622254|469441700|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
130403511|NCT04622254|469441701|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130403512|NCT04622254|469441702|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130403513|NCT04622254|469441703|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130403514|NCT04622254|469441704|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130403515|NCT04622254|469441705|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130403516|NCT04622254|469441700|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130403517|NCT04622254|469441701|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
130403518|NCT04622254|469441702|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
130403519|NCT04622254|469441703|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130403520|NCT04622254|469441704|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130403521|NCT04622254|469441705|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130403522|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130403523|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130403524|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130403525|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
130471091|NCT01424670|469690902|FG000|Continuation Period|Withdrawal by Subject|13|||
130471092|NCT01424670|469690903|FG001|Continuation Period|Withdrawal by Subject|4|||
130471093|NCT00761189|469690904|FG000|Overall Study|Adverse Event|42|||
130471094|NCT00761189|469690904|FG000|Overall Study|Lack of Efficacy|45|||
130471095|NCT00761189|469690904|FG000|Overall Study|Lost to Follow-up|36|||
130471096|NCT00761189|469690904|FG000|Overall Study|Withdrawal by Subject|49|||
130471097|NCT00761189|469690904|FG000|Overall Study|Other|13|||
130471098|NCT03988842|469690907|FG000|Overall Study|Death|1|||
130471099|NCT00709098|469690911|FG000|Double-blind Period|Withdrawal of consent|3|||
130471100|NCT00709098|469690912|FG001|Double-blind Period|Withdrawal of consent|3|||
130403526|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130403527|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130403528|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130403529|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130403530|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130403531|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
130403532|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130403533|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
130403534|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130403535|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130403536|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130403537|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
130403538|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130403539|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130403540|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130403541|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130403542|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130403543|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
130403544|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130403545|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130403546|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130403547|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130403548|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130403549|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
130403550|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
130403551|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
130403552|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130403553|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130403554|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130403555|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
130403556|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
130403557|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
130403558|NCT04622254|469441700|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
130403559|NCT04622254|469441701|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
130403560|NCT04622254|469441702|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
130403561|NCT04622254|469441703|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
130403562|NCT04622254|469441704|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
130471101|NCT00709098|469690913|FG002|Double-blind Period|Withdrawal of consent|0|||
130471102|NCT00709098|469690911|FG000|Double-blind Period|Administrative reason|1|||
130471103|NCT00709098|469690912|FG001|Double-blind Period|Administrative reason|3|||
130403563|NCT04622254|469441705|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
130403564|NCT00098839|469441708|FG000|Overall Study|Adverse Event|5|||
130403565|NCT00098839|469441709|FG001|Overall Study|Adverse Event|2|||
130403566|NCT00098839|469441708|FG000|Overall Study|Death|1|||
130471104|NCT00709098|469690913|FG002|Double-blind Period|Administrative reason|0|||
130471105|NCT00709098|469690911|FG000|Double-blind Period|Death|1|||
130471106|NCT00709098|469690912|FG001|Double-blind Period|Death|1|||
130403567|NCT00098839|469441709|FG001|Overall Study|Death|2|||
130403568|NCT00098839|469441708|FG000|Overall Study|Physician Decision|4|||
130403569|NCT00098839|469441709|FG001|Overall Study|Physician Decision|14|||
130403570|NCT00098839|469441708|FG000|Overall Study|Withdrawal by Subject|1|||
130403571|NCT00098839|469441709|FG001|Overall Study|Withdrawal by Subject|0|||
130403572|NCT00098839|469441708|FG000|Overall Study|Refusal of further protocol therapy|3|||
130403573|NCT00098839|469441709|FG001|Overall Study|Refusal of further protocol therapy|1|||
130403574|NCT00098839|469441708|FG000|Overall Study|Relapse|6|||
130403575|NCT00098839|469441709|FG001|Overall Study|Relapse|3|||
130403576|NCT00098839|469441708|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
130403577|NCT00098839|469441709|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
130403578|NCT00098839|469441708|FG000|Overall Study|Ineligible|2|||
130403579|NCT00098839|469441709|FG001|Overall Study|Ineligible|0|||
130403580|NCT03228680|469441711|FG000|Overall Study|Adverse Event|13|||
130403581|NCT03228680|469441712|FG001|Overall Study|Adverse Event|18|||
130403582|NCT03228680|469441711|FG000|Overall Study|Randomization failure|0|||
130403583|NCT03228680|469441712|FG001|Overall Study|Randomization failure|1|||
130403584|NCT03228680|469441711|FG000|Overall Study|Withdrawal by Subject|1|||
130403585|NCT03228680|469441712|FG001|Overall Study|Withdrawal by Subject|0|||
130403586|NCT03228680|469441711|FG000|Overall Study|Other|9|||
130403587|NCT03228680|469441712|FG001|Overall Study|Other|16|||
130403588|NCT02167035|469441713|FG000|Overall Study|Adverse Event|2|||
130403589|NCT02167035|469441714|FG001|Overall Study|Adverse Event|2|||
130403590|NCT02167035|469441713|FG000|Overall Study|Lost to Follow-up|3|||
130403591|NCT02167035|469441714|FG001|Overall Study|Lost to Follow-up|3|||
130403592|NCT02167035|469441713|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
130403593|NCT02167035|469441714|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
130403594|NCT02148003|469441715|FG000|Overall Study|Failed inclusion criteria|1|||
130403595|NCT02148003|469441716|FG001|Overall Study|Failed inclusion criteria|0|||
130403596|NCT02148003|469441715|FG000|Overall Study|Met exclusion criteria|0|||
130403597|NCT02148003|469441716|FG001|Overall Study|Met exclusion criteria|1|||
130403598|NCT02148003|469441715|FG000|Overall Study|Withdrawal by Subject|0|||
130403599|NCT02148003|469441716|FG001|Overall Study|Withdrawal by Subject|1|||
130403600|NCT02489981|469441717|FG000|Overall Study|Adverse Event|21|||
130403601|NCT02489981|469441717|FG000|Overall Study|Insufficient effectiveness|16|||
130403602|NCT02489981|469441717|FG000|Overall Study|Improved|31|||
130403603|NCT02489981|469441717|FG000|Overall Study|Lost to Follow-up|31|||
130403604|NCT02489981|469441717|FG000|Overall Study|Other than listed|28|||
130403605|NCT00796861|469441718|FG000|Overall Study|Withdrawal by Subject|2|||
130403606|NCT00796861|469441718|FG000|Overall Study|Death|2|||
130403607|NCT03852316|469441721|FG000|Overall Study|Protocol Violation|1|||
130403608|NCT03852316|469441721|FG000|Overall Study|Withdrawal by Subject|2|||
130403609|NCT03852316|469441721|FG000|Overall Study|Enrolled but Device not Utilized|1|||
130403610|NCT04456699|469441725|FG000|Overall Study|Death|48|||
130403611|NCT04456699|469441726|FG001|Overall Study|Death|50|||
130403612|NCT04456699|469441727|FG002|Overall Study|Death|52|||
130403613|NCT04456699|469441725|FG000|Overall Study|Physician Decision|0|||
130403614|NCT04456699|469441726|FG001|Overall Study|Physician Decision|0|||
130403615|NCT04456699|469441727|FG002|Overall Study|Physician Decision|2|||
130403616|NCT04456699|469441725|FG000|Overall Study|Sponsor Decision|55|||
130403617|NCT04456699|469441726|FG001|Overall Study|Sponsor Decision|61|||
130403618|NCT04456699|469441727|FG002|Overall Study|Sponsor Decision|50|||
130403619|NCT04456699|469441725|FG000|Overall Study|Withdrawal by Subject|8|||
130403620|NCT04456699|469441726|FG001|Overall Study|Withdrawal by Subject|4|||
130403621|NCT04456699|469441727|FG002|Overall Study|Withdrawal by Subject|5|||
130403622|NCT04112810|469441728|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
130403623|NCT01859715|469441733|FG000|Overall Study|No 2nd VAS|16|||
130403624|NCT01859715|469441734|FG001|Overall Study|No 2nd VAS|8|||
130403625|NCT01859715|469441735|FG002|Overall Study|No 2nd VAS|23|||
130403626|NCT00086580|469441736|FG000|Treatment Period|Disease progression|9|||
130403627|NCT00086580|469441737|FG001|Treatment Period|Disease progression|8|||
130403628|NCT00086580|469441736|FG000|Treatment Period|Unable to comply with protocol|3|||
130403629|NCT00086580|469441737|FG001|Treatment Period|Unable to comply with protocol|1|||
130403630|NCT00086580|469441736|FG000|Treatment Period|Withdrawal by Subject|7|||
130403631|NCT00086580|469441737|FG001|Treatment Period|Withdrawal by Subject|8|||
130403632|NCT00086580|469441736|FG000|Treatment Period|Physician Decision|13|||
130403633|NCT00086580|469441737|FG001|Treatment Period|Physician Decision|7|||
130403634|NCT00086580|469441736|FG000|Treatment Period|AE - not treatment related|7|||
130403635|NCT00086580|469441737|FG001|Treatment Period|AE - not treatment related|7|||
130403636|NCT00086580|469441736|FG000|Treatment Period|Toxicity - treatment related|15|||
130403637|NCT00086580|469441737|FG001|Treatment Period|Toxicity - treatment related|15|||
130403638|NCT00086580|469441736|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
130403639|NCT00086580|469441737|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
130403640|NCT00086580|469441736|FG000|Treatment Period|Death|5|||
130403641|NCT00086580|469441737|FG001|Treatment Period|Death|7|||
130403642|NCT00086580|469441736|FG000|Treatment Period|Other|5|||
130403643|NCT00086580|469441737|FG001|Treatment Period|Other|3|||
130403644|NCT00086580|469441736|FG000|Follow-up Period|Disease progression|72|||
130403645|NCT00086580|469441737|FG001|Follow-up Period|Disease progression|99|||
130403646|NCT00086580|469441736|FG000|Follow-up Period|Unable to comply with protocol|5|||
130403647|NCT00086580|469441737|FG001|Follow-up Period|Unable to comply with protocol|0|||
130403648|NCT00086580|469441736|FG000|Follow-up Period|Withdrawal by Subject|6|||
130403649|NCT00086580|469441737|FG001|Follow-up Period|Withdrawal by Subject|6|||
130403650|NCT00086580|469441736|FG000|Follow-up Period|Physician Decision|0|||
130403651|NCT00086580|469441737|FG001|Follow-up Period|Physician Decision|1|||
130403652|NCT00086580|469441736|FG000|Follow-up Period|AE - not related|1|||
130403653|NCT00086580|469441737|FG001|Follow-up Period|AE - not related|0|||
130403654|NCT00086580|469441736|FG000|Follow-up Period|Death|13|||
130403655|NCT00086580|469441737|FG001|Follow-up Period|Death|7|||
130403656|NCT00086580|469441736|FG000|Follow-up Period|Other|7|||
130403657|NCT00086580|469441737|FG001|Follow-up Period|Other|6|||
130403658|NCT00086580|469441736|FG000|Observation Period|Unable to comply with protocol|1|||
130403659|NCT00086580|469441737|FG001|Observation Period|Unable to comply with protocol|1|||
130403660|NCT00086580|469441736|FG000|Observation Period|Withdrawal by Subject|4|||
130403661|NCT00086580|469441737|FG001|Observation Period|Withdrawal by Subject|2|||
130403662|NCT00086580|469441736|FG000|Observation Period|Death|33|||
130403663|NCT00086580|469441737|FG001|Observation Period|Death|55|||
130403664|NCT00086580|469441736|FG000|Observation Period|Other|8|||
130403665|NCT00086580|469441737|FG001|Observation Period|Other|7|||
130403666|NCT01000051|469441739|FG000|Overall Study|Withdrawal by Subject|1|||
130403667|NCT01000051|469441740|FG001|Overall Study|Withdrawal by Subject|1|||
130403668|NCT01000051|469441739|FG000|Overall Study|Disease Progression|1|||
130403669|NCT01000051|469441740|FG001|Overall Study|Disease Progression|0|||
130403670|NCT01000051|469441739|FG000|Overall Study|Serious noncompliance|1|||
130403671|NCT01000051|469441740|FG001|Overall Study|Serious noncompliance|0|||
130403672|NCT02247349|469441741|FG000|Overall Study|Disease Progression|7|||
130403673|NCT02247349|469441742|FG001|Overall Study|Disease Progression|4|||
130403674|NCT02247349|469441743|FG002|Overall Study|Disease Progression|26|||
130403675|NCT02247349|469441744|FG003|Overall Study|Disease Progression|31|||
130403676|NCT02247349|469441745|FG004|Overall Study|Disease Progression|16|||
130403677|NCT02247349|469441746|FG005|Overall Study|Disease Progression|6|||
130403678|NCT02247349|469441741|FG000|Overall Study|Study drug toxicity|0|||
130403679|NCT02247349|469441742|FG001|Overall Study|Study drug toxicity|1|||
130403680|NCT02247349|469441743|FG002|Overall Study|Study drug toxicity|1|||
130403681|NCT02247349|469441744|FG003|Overall Study|Study drug toxicity|1|||
130403682|NCT02247349|469441745|FG004|Overall Study|Study drug toxicity|2|||
130403683|NCT02247349|469441746|FG005|Overall Study|Study drug toxicity|2|||
130403684|NCT02247349|469441741|FG000|Overall Study|Death|0|||
130403685|NCT02247349|469441742|FG001|Overall Study|Death|0|||
130403686|NCT02247349|469441743|FG002|Overall Study|Death|0|||
130403687|NCT02247349|469441744|FG003|Overall Study|Death|1|||
130403688|NCT02247349|469441745|FG004|Overall Study|Death|0|||
130403689|NCT02247349|469441746|FG005|Overall Study|Death|0|||
130403690|NCT02247349|469441741|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130403691|NCT02247349|469441742|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
130403692|NCT02247349|469441743|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
130403693|NCT02247349|469441744|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
130403694|NCT02247349|469441745|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
130403695|NCT02247349|469441746|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
130403696|NCT02247349|469441741|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130403697|NCT02247349|469441742|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130403698|NCT02247349|469441743|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130471107|NCT00709098|469690913|FG002|Double-blind Period|Death|0|||
130471108|NCT00709098|469690911|FG000|Double-blind Period|Lost to Follow-up|1|||
130471109|NCT00709098|469690912|FG001|Double-blind Period|Lost to Follow-up|1|||
130724675|NCT02540850|470616984|FG000|Overall Study|Lost to Follow-up|69|||
130403699|NCT02247349|469441744|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130403700|NCT02247349|469441745|FG004|Overall Study|Participant request to discontinue study treatment|1|||
130403701|NCT02247349|469441746|FG005|Overall Study|Participant request to discontinue study treatment|0|||
130471110|NCT00709098|469690913|FG002|Double-blind Period|Lost to Follow-up|0|||
130471111|NCT00709098|469690911|FG000|Open-label Period|Withdrawal of consent|0|||
130471112|NCT00709098|469690912|FG001|Open-label Period|Withdrawal of consent|0|||
130724676|NCT02540850|470616985|FG001|Overall Study|Lost to Follow-up|66|||
130724677|NCT02540850|470616986|FG002|Overall Study|Lost to Follow-up|34|||
130724678|NCT02861014|470616987|FG000|Primary Analysis|Adverse Event|7|||
130403702|NCT02247349|469441741|FG000|Overall Study|Withdrawal by Subject|0|||
130403703|NCT02247349|469441742|FG001|Overall Study|Withdrawal by Subject|1|||
130403704|NCT02247349|469441743|FG002|Overall Study|Withdrawal by Subject|0|||
130403705|NCT02247349|469441744|FG003|Overall Study|Withdrawal by Subject|0|||
130403706|NCT02247349|469441745|FG004|Overall Study|Withdrawal by Subject|0|||
130403707|NCT02247349|469441746|FG005|Overall Study|Withdrawal by Subject|0|||
130403708|NCT02247349|469441741|FG000|Overall Study|Administrative reason by sponsor|0|||
130403709|NCT02247349|469441742|FG001|Overall Study|Administrative reason by sponsor|0|||
130403710|NCT02247349|469441743|FG002|Overall Study|Administrative reason by sponsor|0|||
130403711|NCT02247349|469441744|FG003|Overall Study|Administrative reason by sponsor|0|||
130403712|NCT02247349|469441745|FG004|Overall Study|Administrative reason by sponsor|1|||
130403713|NCT02247349|469441746|FG005|Overall Study|Administrative reason by sponsor|0|||
130403714|NCT02247349|469441741|FG000|Overall Study|Other reasons|0|||
130403715|NCT02247349|469441742|FG001|Overall Study|Other reasons|0|||
130403716|NCT02247349|469441743|FG002|Overall Study|Other reasons|1|||
130403717|NCT02247349|469441744|FG003|Overall Study|Other reasons|0|||
130403718|NCT02247349|469441745|FG004|Overall Study|Other reasons|0|||
130403719|NCT02247349|469441746|FG005|Overall Study|Other reasons|0|||
130403720|NCT01959581|469441747|FG000|Overall Study|Lost to Follow-up|5|||
130403721|NCT00057746|469441748|FG000|Overall Study|Withdrawal by Subject|0|||
130403722|NCT00057746|469441749|FG001|Overall Study|Withdrawal by Subject|0|||
130403723|NCT00057746|469441750|FG002|Overall Study|Withdrawal by Subject|1|||
130403724|NCT01469065|469441756|FG000|Overall Study|Lack of Efficacy|0|||
130403725|NCT01469065|469441757|FG001|Overall Study|Lack of Efficacy|0|||
130403726|NCT01469065|469441758|FG002|Overall Study|Lack of Efficacy|0|||
130403727|NCT01469065|469441759|FG003|Overall Study|Lack of Efficacy|0|||
130403728|NCT01469065|469441760|FG004|Overall Study|Lack of Efficacy|1|||
130403729|NCT01469065|469441756|FG000|Overall Study|Other|0|||
130403730|NCT01469065|469441757|FG001|Overall Study|Other|1|||
130403731|NCT01469065|469441758|FG002|Overall Study|Other|0|||
130403732|NCT01469065|469441759|FG003|Overall Study|Other|0|||
130403733|NCT01469065|469441760|FG004|Overall Study|Other|0|||
130403734|NCT00179413|469441761|FG000|Overall Study|Adverse Event|38|||
130403735|NCT00179413|469441762|FG001|Overall Study|Adverse Event|20|||
130403736|NCT00179413|469441761|FG000|Overall Study|Withdrawal by Subject|87|||
130403737|NCT00179413|469441762|FG001|Overall Study|Withdrawal by Subject|95|||
130403738|NCT03075644|469441765|FG000|Overall Study|Withdrawal by Subject|1|||
130403739|NCT03075644|469441766|FG001|Overall Study|Withdrawal by Subject|1|||
130403740|NCT01458171|469441767|FG000|Overall Study|Adverse Event|1|||
130403741|NCT01696032|469441768|FG000|Overall Study|Withdrawal by Subject|0|||
130403742|NCT01696032|469441769|FG001|Overall Study|Withdrawal by Subject|0|||
130403743|NCT01696032|469441770|FG002|Overall Study|Withdrawal by Subject|1|||
130403744|NCT01696032|469441771|FG003|Overall Study|Withdrawal by Subject|2|||
130403745|NCT01696032|469441768|FG000|Overall Study|Death|14|||
130403746|NCT01696032|469441769|FG001|Overall Study|Death|4|||
130403747|NCT01696032|469441770|FG002|Overall Study|Death|43|||
130403748|NCT01696032|469441771|FG003|Overall Study|Death|18|||
130403749|NCT01696032|469441768|FG000|Overall Study|Lost to Follow-up|0|||
130403750|NCT01696032|469441769|FG001|Overall Study|Lost to Follow-up|1|||
130403751|NCT01696032|469441770|FG002|Overall Study|Lost to Follow-up|0|||
130403752|NCT01696032|469441771|FG003|Overall Study|Lost to Follow-up|0|||
130471113|NCT00709098|469690913|FG002|Open-label Period|Withdrawal of consent|7|||
130471114|NCT00709098|469690911|FG000|Open-label Period|Administrative reason|0|||
130471115|NCT00709098|469690912|FG001|Open-label Period|Administrative reason|0|||
130471116|NCT00709098|469690913|FG002|Open-label Period|Administrative reason|5|||
130471117|NCT00709098|469690911|FG000|Open-label Period|Death|0|||
130471118|NCT00709098|469690912|FG001|Open-label Period|Death|0|||
130471119|NCT00709098|469690913|FG002|Open-label Period|Death|1|||
130471120|NCT00709098|469690911|FG000|Open-label Period|Lost to Follow-up|0|||
130471121|NCT00709098|469690912|FG001|Open-label Period|Lost to Follow-up|0|||
130471122|NCT00709098|469690913|FG002|Open-label Period|Lost to Follow-up|1|||
130471123|NCT01227265|469690914|FG000|Overall Study|Did Not Receive Treatment|1|||
130471124|NCT01227265|469690915|FG001|Overall Study|Did Not Receive Treatment|2|||
130471125|NCT01227265|469690916|FG002|Overall Study|Did Not Receive Treatment|0|||
130471126|NCT01227265|469690914|FG000|Overall Study|Administrative|1|||
130471127|NCT01227265|469690915|FG001|Overall Study|Administrative|0|||
130471128|NCT01227265|469690916|FG002|Overall Study|Administrative|2|||
130471129|NCT01227265|469690914|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130471130|NCT01227265|469690915|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130471131|NCT01227265|469690916|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
130471132|NCT01227265|469690914|FG000|Overall Study|Protocol Violation|2|||
130471133|NCT01227265|469690915|FG001|Overall Study|Protocol Violation|1|||
130561019|NCT03250832|470022787|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
130724679|NCT02861014|470616987|FG000|Primary Analysis|Death|1|||
130403753|NCT01696032|469441768|FG000|Overall Study|Database lock|0|||
130471134|NCT01227265|469690916|FG002|Overall Study|Protocol Violation|0|||
130471135|NCT01227265|469690914|FG000|Overall Study|Withdrawal by Subject|7|||
130471136|NCT01227265|469690915|FG001|Overall Study|Withdrawal by Subject|7|||
130471137|NCT01227265|469690916|FG002|Overall Study|Withdrawal by Subject|3|||
130471138|NCT01227265|469690914|FG000|Overall Study|Lost to Follow-up|2|||
130471139|NCT01227265|469690915|FG001|Overall Study|Lost to Follow-up|0|||
130403754|NCT01696032|469441769|FG001|Overall Study|Database lock|1|||
130403755|NCT01696032|469441770|FG002|Overall Study|Database lock|7|||
130403756|NCT01696032|469441771|FG003|Overall Study|Database lock|2|||
130403757|NCT00578565|469441774|FG000|Overall Study|Adverse Event|3|||
130403758|NCT01192152|469441775|FG000|Period 1|left prematurely (while on treatment B)|0|||
130403759|NCT01192152|469441776|FG001|Period 1|left prematurely (while on treatment B)|1|||
130471140|NCT01227265|469690916|FG002|Overall Study|Lost to Follow-up|3|||
130403760|NCT01192152|469441775|FG000|Period 3|family emergency|1|||
130403761|NCT01192152|469441776|FG001|Period 3|family emergency|0|||
130403762|NCT02203591|469441778|FG000|Overall Study|Did not meet treatment day baseline|147|||
130403763|NCT02203591|469441779|FG001|Overall Study|Did not meet treatment day baseline|141|||
130403764|NCT02203591|469441780|FG002|Overall Study|Did not meet treatment day baseline|150|||
130403765|NCT02203591|469441781|FG003|Overall Study|Did not meet treatment day baseline|45|||
130403766|NCT02203591|469441782|FG004|Overall Study|Did not meet treatment day baseline|33|||
130403767|NCT02203591|469441783|FG005|Overall Study|Did not meet treatment day baseline|35|||
130403768|NCT02203591|469441784|FG006|Overall Study|Did not meet treatment day baseline|29|||
130403769|NCT02203591|469441785|FG007|Overall Study|Did not meet treatment day baseline|12|||
130561020|NCT03250832|470022788|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130561021|NCT03250832|470022789|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130561022|NCT03250832|470022790|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130724680|NCT02861014|470616987|FG000|Primary Analysis|Lack of Efficacy|3|||
130403770|NCT02203591|469441778|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
130403771|NCT02203591|469441779|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
130403772|NCT02203591|469441780|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
130403773|NCT02203591|469441781|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
130403774|NCT02203591|469441782|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
130403775|NCT02203591|469441783|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
130403776|NCT02203591|469441784|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
130403777|NCT02203591|469441785|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
130403778|NCT05013905|469441786|FG000|Overall Study|Adverse Event|1|||
130403779|NCT05013905|469441786|FG000|Overall Study|Lack of Efficacy|1|||
130403780|NCT04666259|469441790|FG000|Treatment Phase|Physician Decision|9|||
130403781|NCT04666259|469441791|FG001|Treatment Phase|Physician Decision|3|||
130403782|NCT04666259|469441792|FG002|Treatment Phase|Physician Decision|3|||
130403783|NCT04666259|469441790|FG000|Treatment Phase|Adverse Event|3|||
130403784|NCT04666259|469441791|FG001|Treatment Phase|Adverse Event|1|||
130403785|NCT04666259|469441792|FG002|Treatment Phase|Adverse Event|0|||
130403786|NCT04666259|469441790|FG000|Treatment Phase|Subject decision|1|||
130403787|NCT04666259|469441791|FG001|Treatment Phase|Subject decision|2|||
130403788|NCT04666259|469441792|FG002|Treatment Phase|Subject decision|0|||
130403789|NCT04666259|469441790|FG000|Treatment Phase|Progressive disease|0|||
130403790|NCT04666259|469441791|FG001|Treatment Phase|Progressive disease|1|||
130403791|NCT04666259|469441792|FG002|Treatment Phase|Progressive disease|0|||
130403792|NCT04666259|469441790|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
130403793|NCT04666259|469441791|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
130403794|NCT04666259|469441792|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
130403795|NCT04666259|469441790|FG000|Safety Follow-up Phase|Physician Decision|2|||
130403796|NCT04666259|469441791|FG001|Safety Follow-up Phase|Physician Decision|0|||
130403797|NCT04666259|469441792|FG002|Safety Follow-up Phase|Physician Decision|0|||
130403798|NCT04666259|469441790|FG000|Safety Follow-up Phase|Subject decision|1|||
130403799|NCT04666259|469441791|FG001|Safety Follow-up Phase|Subject decision|0|||
130403800|NCT04666259|469441792|FG002|Safety Follow-up Phase|Subject decision|0|||
130403801|NCT04666259|469441790|FG000|Safety Follow-up Phase|Death|0|||
130403802|NCT04666259|469441791|FG001|Safety Follow-up Phase|Death|1|||
130403803|NCT04666259|469441792|FG002|Safety Follow-up Phase|Death|0|||
130403804|NCT01565291|469441793|FG000|Overall Study|Withdrawal by Subject|1|||
130403805|NCT01565291|469441794|FG001|Overall Study|Withdrawal by Subject|0|||
130403806|NCT00515827|469441795|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
130403807|NCT00515827|469441796|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
130403808|NCT00515827|469441795|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
130403809|NCT00515827|469441796|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
130403810|NCT05402995|469441799|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
130403811|NCT05402995|469441800|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130403812|NCT05402995|469441801|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130403813|NCT05402995|469441802|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130403814|NCT01009099|469441803|FG000|Overall Study|Lost to Follow-up|1|||
130403815|NCT01009099|469441804|FG001|Overall Study|Lost to Follow-up|0|||
130403816|NCT01009099|469441803|FG000|Overall Study|Physician Decision|3|||
130403817|NCT01009099|469441804|FG001|Overall Study|Physician Decision|2|||
130403818|NCT01009099|469441803|FG000|Overall Study|Withdrawal by Subject|1|||
130403819|NCT01009099|469441804|FG001|Overall Study|Withdrawal by Subject|1|||
130403820|NCT01009099|469441803|FG000|Overall Study|Death|0|||
130403821|NCT01009099|469441804|FG001|Overall Study|Death|1|||
130403822|NCT02188485|469441819|FG000|Overall Study|Withdrawal by Subject|2|||
130403823|NCT02188485|469441820|FG001|Overall Study|Withdrawal by Subject|1|||
130403824|NCT02188485|469441819|FG000|Overall Study|PI withdrew, lack of capacity|0|||
130403825|NCT02188485|469441820|FG001|Overall Study|PI withdrew, lack of capacity|2|||
130403826|NCT02501096|469441824|FG000|Overall Study|Lost to Follow-up|0|||
130403827|NCT02501096|469441825|FG001|Overall Study|Lost to Follow-up|0|||
130471141|NCT01227265|469690914|FG000|Overall Study|Adverse Event|6|||
130471142|NCT01227265|469690915|FG001|Overall Study|Adverse Event|10|||
130471143|NCT01227265|469690916|FG002|Overall Study|Adverse Event|5|||
130471144|NCT03481816|469690918|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
130471145|NCT03481816|469690919|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
130471146|NCT03481816|469690918|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
130471147|NCT03481816|469690919|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
130471148|NCT03481816|469690918|FG000|Dose Expansion|Withdrawal by Subject|0|||
130471149|NCT03481816|469690919|FG001|Dose Expansion|Withdrawal by Subject|2|||
130471150|NCT03481816|469690918|FG000|Dose Expansion|Physician Decision|0|||
130471151|NCT03481816|469690919|FG001|Dose Expansion|Physician Decision|5|||
130471152|NCT03582722|469690925|FG000|Overall Study|Lost to Follow-up|1|||
130471153|NCT03582722|469690926|FG001|Overall Study|Lost to Follow-up|4|||
130471154|NCT03582722|469690925|FG000|Overall Study|Withdrawal by Subject|3|||
130471155|NCT03582722|469690926|FG001|Overall Study|Withdrawal by Subject|3|||
130471156|NCT03690206|469690927|FG000|Overall Study|Withdrawal by Subject|2|||
130724681|NCT02861014|470616987|FG000|Primary Analysis|Physician Decision|2|||
130724682|NCT02861014|470616987|FG000|Primary Analysis|Pregnancy|4|||
130724683|NCT02861014|470616987|FG000|Primary Analysis|Protocol Violation|2|||
130724684|NCT02861014|470616987|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
130724685|NCT02861014|470616987|FG000|Primary Analysis|Withdrawal by Subject|14|||
130724686|NCT02861014|470616987|FG000|Primary Analysis|Commercial ocrelizumab|3|||
130724687|NCT02861014|470616987|FG000|Safety Follow-up|Adverse Event|1|||
130724688|NCT02861014|470616987|FG000|Safety Follow-up|Pregnancy|1|||
130724689|NCT02861014|470616987|FG000|Safety Follow-up|Withdrawal by Subject|9|||
130724690|NCT02861014|470616987|FG000|Safety Follow-up|Study terminated by sponsor|1|||
130471157|NCT03690206|469690928|FG001|Overall Study|Withdrawal by Subject|0|||
130471158|NCT03690206|469690929|FG002|Overall Study|Withdrawal by Subject|0|||
130471159|NCT03690206|469690927|FG000|Overall Study|ICF withdrawal|2|||
130471160|NCT03690206|469690928|FG001|Overall Study|ICF withdrawal|0|||
130471161|NCT03690206|469690929|FG002|Overall Study|ICF withdrawal|0|||
130471162|NCT06024174|469690930|FG000|Overall Study|Other Reasons|1|||
130471163|NCT06024174|469690930|FG000|Overall Study|Study terminated by Sponsor|4|||
130471164|NCT05028582|469690931|FG000|Overall Study|Lost to Follow-up|11|||
130471165|NCT05028582|469690932|FG001|Overall Study|Lost to Follow-up|9|||
130471166|NCT05028582|469690931|FG000|Overall Study|Withdrawal by Subject|9|||
130471167|NCT05028582|469690932|FG001|Overall Study|Withdrawal by Subject|10|||
130471168|NCT05028582|469690931|FG000|Overall Study|Adverse Event|5|||
130471169|NCT05028582|469690932|FG001|Overall Study|Adverse Event|2|||
130471170|NCT05028582|469690931|FG000|Overall Study|Miscellaneous|3|||
130471171|NCT05028582|469690932|FG001|Overall Study|Miscellaneous|2|||
130471172|NCT05028582|469690931|FG000|Overall Study|Lack of Efficacy|3|||
130471173|NCT05028582|469690932|FG001|Overall Study|Lack of Efficacy|1|||
130471174|NCT05028582|469690931|FG000|Overall Study|Physician Decision|0|||
130471175|NCT05028582|469690932|FG001|Overall Study|Physician Decision|1|||
130471176|NCT01959698|469690933|FG000|Overall Study|Adverse Event|0|||
130471177|NCT01959698|469690934|FG001|Overall Study|Adverse Event|0|||
130471178|NCT01959698|469690935|FG002|Overall Study|Adverse Event|0|||
130471179|NCT01959698|469690936|FG003|Overall Study|Adverse Event|0|||
130471180|NCT01959698|469690937|FG004|Overall Study|Adverse Event|0|||
130724691|NCT02861014|470616987|FG000|Safety Follow-up|Physician Decision|1|||
130403828|NCT02501096|469441826|FG002|Overall Study|Lost to Follow-up|0|||
130403829|NCT02501096|469441827|FG003|Overall Study|Lost to Follow-up|0|||
130403830|NCT02501096|469441828|FG004|Overall Study|Lost to Follow-up|1|||
130403831|NCT02501096|469441829|FG005|Overall Study|Lost to Follow-up|1|||
130403832|NCT02501096|469441830|FG006|Overall Study|Lost to Follow-up|3|||
130403833|NCT02501096|469441831|FG007|Overall Study|Lost to Follow-up|0|||
130403834|NCT02501096|469441832|FG008|Overall Study|Lost to Follow-up|0|||
130403835|NCT02501096|469441824|FG000|Overall Study|Withdrawal by Subject|1|||
130403836|NCT02501096|469441825|FG001|Overall Study|Withdrawal by Subject|0|||
130403837|NCT02501096|469441826|FG002|Overall Study|Withdrawal by Subject|7|||
130403838|NCT02501096|469441827|FG003|Overall Study|Withdrawal by Subject|13|||
130403839|NCT02501096|469441828|FG004|Overall Study|Withdrawal by Subject|2|||
130403840|NCT02501096|469441829|FG005|Overall Study|Withdrawal by Subject|2|||
130403841|NCT02501096|469441830|FG006|Overall Study|Withdrawal by Subject|2|||
130403842|NCT02501096|469441831|FG007|Overall Study|Withdrawal by Subject|3|||
130403843|NCT02501096|469441832|FG008|Overall Study|Withdrawal by Subject|0|||
130403844|NCT02501096|469441824|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
130403845|NCT02501096|469441825|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
130403846|NCT02501096|469441826|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
130403847|NCT02501096|469441827|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
130403848|NCT02501096|469441828|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
130403849|NCT02501096|469441829|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
130403850|NCT02501096|469441830|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
130403851|NCT02501096|469441831|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
130403852|NCT02501096|469441832|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
130403853|NCT02501096|469441824|FG000|Overall Study|Death|1|||
130403854|NCT02501096|469441825|FG001|Overall Study|Death|1|||
130403855|NCT02501096|469441826|FG002|Overall Study|Death|88|||
130403856|NCT02501096|469441827|FG003|Overall Study|Death|74|||
130403857|NCT02501096|469441828|FG004|Overall Study|Death|15|||
130403858|NCT02501096|469441829|FG005|Overall Study|Death|16|||
130403859|NCT02501096|469441830|FG006|Overall Study|Death|15|||
130403860|NCT02501096|469441831|FG007|Overall Study|Death|16|||
130403861|NCT02501096|469441832|FG008|Overall Study|Death|1|||
130403862|NCT03149237|469441833|FG000|Overall Study|Withdrawal by Subject|4|||
130403863|NCT03149237|469441834|FG001|Overall Study|Withdrawal by Subject|5|||
130403864|NCT01466192|469441835|FG000|Overall Study|Physician Decision|1|||
130403865|NCT01466192|469441835|FG000|Overall Study|Withdrawal by Subject|3|||
130403866|NCT01227512|469441836|FG000|Overall Study|Physician Decision|6|||
130403867|NCT01227512|469441837|FG001|Overall Study|Physician Decision|6|||
130403868|NCT01227512|469441836|FG000|Overall Study|Adverse Event|4|||
130403869|NCT01227512|469441837|FG001|Overall Study|Adverse Event|3|||
130403870|NCT01227512|469441836|FG000|Overall Study|Withdrawal by Subject|3|||
130403871|NCT01227512|469441837|FG001|Overall Study|Withdrawal by Subject|0|||
130403872|NCT01227512|469441836|FG000|Overall Study|Participant met withdrawal criteria|0|||
130403873|NCT01227512|469441837|FG001|Overall Study|Participant met withdrawal criteria|1|||
130403874|NCT04055116|469441844|FG000|First Intervention|Physician Decision|2|||
130403875|NCT04055116|469441845|FG001|First Intervention|Physician Decision|7|||
130403876|NCT02774681|469441846|FG000|Treatment on Study|Progressive Disease|7|||
130403877|NCT02774681|469441846|FG000|Follow-Up for 3 Years|Death|11|||
130403878|NCT02774681|469441846|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
130403879|NCT04497987|469441847|FG000|Overall Study|Adverse Event|1|||
130403880|NCT04497987|469441848|FG001|Overall Study|Adverse Event|0|||
130403881|NCT04497987|469441847|FG000|Overall Study|Death|21|||
130471181|NCT01959698|469690938|FG005|Overall Study|Adverse Event|0|||
130471182|NCT01959698|469690939|FG006|Overall Study|Adverse Event|1|||
130471183|NCT01959698|469690933|FG000|Overall Study|Physician Decision|1|||
130471184|NCT01959698|469690934|FG001|Overall Study|Physician Decision|0|||
130471185|NCT01959698|469690935|FG002|Overall Study|Physician Decision|1|||
130471186|NCT01959698|469690936|FG003|Overall Study|Physician Decision|2|||
130471187|NCT01959698|469690937|FG004|Overall Study|Physician Decision|0|||
130471188|NCT01959698|469690938|FG005|Overall Study|Physician Decision|3|||
130471189|NCT01959698|469690939|FG006|Overall Study|Physician Decision|3|||
130471190|NCT03744312|469692592|FG000|Overall Study|Withdrawal by Subject|0|||
130471191|NCT03744312|469692593|FG001|Overall Study|Withdrawal by Subject|1|||
130403882|NCT04497987|469441848|FG001|Overall Study|Death|13|||
130403883|NCT04497987|469441847|FG000|Overall Study|Lost to Follow-up|19|||
130403884|NCT04497987|469441848|FG001|Overall Study|Lost to Follow-up|17|||
130403885|NCT04497987|469441847|FG000|Overall Study|Other - as reported by the investigator|22|||
130403886|NCT04497987|469441848|FG001|Overall Study|Other - as reported by the investigator|16|||
130403887|NCT04497987|469441847|FG000|Overall Study|Physician Decision|1|||
130403888|NCT04497987|469441848|FG001|Overall Study|Physician Decision|0|||
130403889|NCT04497987|469441847|FG000|Overall Study|Withdrawal by Subject|35|||
130403890|NCT04497987|469441848|FG001|Overall Study|Withdrawal by Subject|21|||
130403891|NCT00512096|469441852|FG000|Overall Study|Adverse Event|2|||
130403892|NCT00512096|469441852|FG000|Overall Study|Withdrawal by Subject|2|||
130403893|NCT00512096|469441852|FG000|Overall Study|Lack of Efficacy|3|||
130403894|NCT01069289|469441853|FG000|Overall Study|Withdrawal by Subject|15|||
130403895|NCT01069289|469441854|FG001|Overall Study|Withdrawal by Subject|26|||
130403896|NCT01069289|469441853|FG000|Overall Study|Adverse Event|21|||
130403897|NCT01069289|469441854|FG001|Overall Study|Adverse Event|28|||
130403898|NCT01069289|469441853|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130403899|NCT01069289|469441854|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130403900|NCT01069289|469441853|FG000|Overall Study|Severe non-compliance to protocol|3|||
130403901|NCT01069289|469441854|FG001|Overall Study|Severe non-compliance to protocol|2|||
130403902|NCT01069289|469441853|FG000|Overall Study|Due to deteriorating health condition|1|||
130403903|NCT01069289|469441854|FG001|Overall Study|Due to deteriorating health condition|0|||
130403904|NCT00298038|469441855|FG000|Overall Study|Lost to Follow-up|0|||
130403905|NCT00298038|469441856|FG001|Overall Study|Lost to Follow-up|1|||
130403906|NCT00298038|469441855|FG000|Overall Study|Liver Transplant|0|||
130403907|NCT00298038|469441856|FG001|Overall Study|Liver Transplant|1|||
130403908|NCT00298038|469441855|FG000|Overall Study|Protocol Violation|1|||
130403909|NCT00298038|469441856|FG001|Overall Study|Protocol Violation|3|||
130403910|NCT00298038|469441855|FG000|Overall Study|Death|6|||
130403911|NCT00298038|469441856|FG001|Overall Study|Death|3|||
130403912|NCT00298038|469441855|FG000|Overall Study|Withdrawal by Subject|6|||
130403913|NCT00298038|469441856|FG001|Overall Study|Withdrawal by Subject|9|||
130403914|NCT00298038|469441855|FG000|Overall Study|Adverse Event|8|||
130403915|NCT00298038|469441856|FG001|Overall Study|Adverse Event|7|||
130403916|NCT00298038|469441855|FG000|Overall Study|Breakthrough overt HE episode|28|||
130403917|NCT00298038|469441856|FG001|Overall Study|Breakthrough overt HE episode|69|||
130403918|NCT00298038|469441855|FG000|Overall Study|Noncompliance|1|||
130403919|NCT00298038|469441856|FG001|Overall Study|Noncompliance|0|||
130403920|NCT00298038|469441855|FG000|Overall Study|Cocaine Abuse|1|||
130403921|NCT00298038|469441856|FG001|Overall Study|Cocaine Abuse|0|||
130403922|NCT00298038|469441855|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
130403923|NCT00298038|469441856|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
130403924|NCT02696096|469441857|FG000|Overall Study|ruled out at screening|1|||
130403925|NCT02696096|469441857|FG000|Overall Study|did not attend second fMRI|1|||
130403926|NCT02047604|469441858|FG000|Overall Study|Withdrawal by Subject|0|||
130403927|NCT02047604|469441859|FG001|Overall Study|Withdrawal by Subject|0|||
130403928|NCT02047604|469441860|FG002|Overall Study|Withdrawal by Subject|0|||
130403929|NCT02047604|469441861|FG003|Overall Study|Withdrawal by Subject|0|||
130403930|NCT02047604|469441862|FG004|Overall Study|Withdrawal by Subject|1|||
130403931|NCT02047604|469441863|FG005|Overall Study|Withdrawal by Subject|1|||
130403932|NCT00773097|469441864|FG000|Overall Study|Withdrawal by Subject|1|||
130403933|NCT00773097|469441864|FG000|Overall Study|Physician Decision|6|||
130403934|NCT02707640|469441865|FG000|Overall Study|Adverse Event|4|||
130403935|NCT02707640|469441866|FG001|Overall Study|Adverse Event|2|||
130403936|NCT02707640|469441865|FG000|Overall Study|Death|1|||
130403937|NCT02707640|469441866|FG001|Overall Study|Death|2|||
130403938|NCT02707640|469441865|FG000|Overall Study|Physician Decision|2|||
130403939|NCT02707640|469441866|FG001|Overall Study|Physician Decision|0|||
130403940|NCT02707640|469441865|FG000|Overall Study|Withdrawal by Subject|0|||
130471192|NCT03744312|469692592|FG000|Overall Study|Screen fail|0|||
130471193|NCT03744312|469692593|FG001|Overall Study|Screen fail|1|||
130471194|NCT03012841|469692594|FG000|Overall Study|Protocol Violation|0|||
130471195|NCT03012841|469692595|FG001|Overall Study|Protocol Violation|10|||
130471196|NCT03012841|469692594|FG000|Overall Study|Lost to Follow-up|6|||
130471197|NCT03012841|469692595|FG001|Overall Study|Lost to Follow-up|1|||
130471198|NCT03012841|469692594|FG000|Overall Study|Withdrawal by Subject|6|||
130471199|NCT03012841|469692595|FG001|Overall Study|Withdrawal by Subject|0|||
130471200|NCT03012841|469692594|FG000|Overall Study|Unable to complete 12 month visit|6|||
130403941|NCT02707640|469441866|FG001|Overall Study|Withdrawal by Subject|1|||
130403942|NCT02707640|469441865|FG000|Overall Study|Participant's Personal Decision|1|||
130403943|NCT02707640|469441866|FG001|Overall Study|Participant's Personal Decision|2|||
130403944|NCT02707640|469441865|FG000|Overall Study|Sponsor Discretion|1|||
130403945|NCT02707640|469441866|FG001|Overall Study|Sponsor Discretion|0|||
130403946|NCT01755416|469441868|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
130403947|NCT01755416|469441869|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
130403948|NCT02742103|469443712|FG000|Overall Study|Protocol Violation|1|||
130403949|NCT02742103|469443713|FG001|Overall Study|Protocol Violation|0|||
130403950|NCT02742103|469443712|FG000|Overall Study|Death|2|||
130403951|NCT02742103|469443713|FG001|Overall Study|Death|2|||
130403952|NCT02742103|469443712|FG000|Overall Study|Adverse Event|1|||
130471201|NCT03012841|469692595|FG001|Overall Study|Unable to complete 12 month visit|0|||
130471202|NCT03012841|469692594|FG000|Overall Study|Subject relocation|1|||
130403953|NCT02742103|469443713|FG001|Overall Study|Adverse Event|0|||
130403954|NCT02742103|469443712|FG000|Overall Study|Moved to another town|0|||
130403955|NCT02742103|469443713|FG001|Overall Study|Moved to another town|1|||
130403956|NCT02742103|469443712|FG000|Overall Study|Withdrawal by Subject|5|||
130403957|NCT02742103|469443713|FG001|Overall Study|Withdrawal by Subject|2|||
130403958|NCT03042312|469443714|FG000|Overall Study|Administrative Reason|1|||
130471203|NCT03012841|469692595|FG001|Overall Study|Subject relocation|0|||
130403959|NCT03042312|469443715|FG001|Overall Study|Administrative Reason|1|||
130403960|NCT03042312|469443714|FG000|Overall Study|Adverse Event|0|||
130403961|NCT03042312|469443715|FG001|Overall Study|Adverse Event|1|||
130403962|NCT03042312|469443714|FG000|Overall Study|Lost to Follow-up|1|||
130403963|NCT03042312|469443715|FG001|Overall Study|Lost to Follow-up|3|||
130403964|NCT03042312|469443714|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
130403965|NCT03042312|469443715|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
130403966|NCT03042312|469443714|FG000|Overall Study|Withdrawal by Subject|4|||
130403967|NCT03042312|469443715|FG001|Overall Study|Withdrawal by Subject|5|||
130403968|NCT00646958|469443718|FG000|Overall Study|Lack of Efficacy|1|||
130403969|NCT00646958|469443719|FG001|Overall Study|Lack of Efficacy|0|||
130403970|NCT00646958|469443720|FG002|Overall Study|Lack of Efficacy|0|||
130403971|NCT00646958|469443718|FG000|Overall Study|Adverse Event|4|||
130403972|NCT00646958|469443719|FG001|Overall Study|Adverse Event|0|||
130403973|NCT00646958|469443720|FG002|Overall Study|Adverse Event|0|||
130403974|NCT00646958|469443718|FG000|Overall Study|Lost to Follow-up|1|||
130403975|NCT00646958|469443719|FG001|Overall Study|Lost to Follow-up|5|||
130403976|NCT00646958|469443720|FG002|Overall Study|Lost to Follow-up|7|||
130403977|NCT00646958|469443718|FG000|Overall Study|Protocol Violation|1|||
130403978|NCT00646958|469443719|FG001|Overall Study|Protocol Violation|1|||
130403979|NCT00646958|469443720|FG002|Overall Study|Protocol Violation|0|||
130403980|NCT00646958|469443718|FG000|Overall Study|Abnormal screening lab tests|1|||
130403981|NCT00646958|469443719|FG001|Overall Study|Abnormal screening lab tests|1|||
130403982|NCT00646958|469443720|FG002|Overall Study|Abnormal screening lab tests|0|||
130403983|NCT00646958|469443718|FG000|Overall Study|Withdrawal by Subject|1|||
130403984|NCT00646958|469443719|FG001|Overall Study|Withdrawal by Subject|2|||
130403985|NCT00646958|469443720|FG002|Overall Study|Withdrawal by Subject|0|||
130403986|NCT00646958|469443718|FG000|Overall Study|Did not receive study drug|2|||
130403987|NCT00646958|469443719|FG001|Overall Study|Did not receive study drug|0|||
130403988|NCT00646958|469443720|FG002|Overall Study|Did not receive study drug|2|||
130403989|NCT02573324|469443722|FG000|Overall Study|Withdrawal by Subject|26|||
130403990|NCT02573324|469443723|FG001|Overall Study|Withdrawal by Subject|23|||
130403991|NCT02573324|469443724|FG002|Overall Study|Withdrawal by Subject|3|||
130403992|NCT02573324|469443722|FG000|Overall Study|Lost to Follow-up|4|||
130403993|NCT02573324|469443723|FG001|Overall Study|Lost to Follow-up|5|||
130403994|NCT02573324|469443724|FG002|Overall Study|Lost to Follow-up|0|||
130403995|NCT02573324|469443722|FG000|Overall Study|Study Terminated by Sponsor|107|||
130403996|NCT02573324|469443723|FG001|Overall Study|Study Terminated by Sponsor|89|||
130403997|NCT02573324|469443724|FG002|Overall Study|Study Terminated by Sponsor|2|||
130403998|NCT02573324|469443722|FG000|Overall Study|Death|182|||
130403999|NCT02573324|469443723|FG001|Overall Study|Death|200|||
130404000|NCT02573324|469443724|FG002|Overall Study|Death|1|||
130404001|NCT02573324|469443722|FG000|Overall Study|Other, Not Specified|20|||
130404002|NCT02573324|469443723|FG001|Overall Study|Other, Not Specified|27|||
130404003|NCT02573324|469443724|FG002|Overall Study|Other, Not Specified|0|||
130404004|NCT02573324|469443722|FG000|Overall Study|Unknown Reason|2|||
130404005|NCT02573324|469443723|FG001|Overall Study|Unknown Reason|0|||
130404006|NCT02573324|469443724|FG002|Overall Study|Unknown Reason|0|||
130404007|NCT01607905|469443725|FG000|Overall Study|Withdrawal by participant|7|||
130404008|NCT01607905|469443726|FG001|Overall Study|Withdrawal by participant|2|||
130404009|NCT01607905|469443727|FG002|Overall Study|Withdrawal by participant|4|||
130404010|NCT01607905|469443728|FG003|Overall Study|Withdrawal by participant|6|||
130404011|NCT01607905|469443729|FG004|Overall Study|Withdrawal by participant|0|||
130404012|NCT01607905|469443730|FG005|Overall Study|Withdrawal by participant|4|||
130404013|NCT01607905|469443731|FG006|Overall Study|Withdrawal by participant|12|||
130404014|NCT01607905|469443725|FG000|Overall Study|Incidence or severity of AEs|5|||
130404015|NCT01607905|469443726|FG001|Overall Study|Incidence or severity of AEs|1|||
130404016|NCT01607905|469443727|FG002|Overall Study|Incidence or severity of AEs|1|||
130404017|NCT01607905|469443728|FG003|Overall Study|Incidence or severity of AEs|3|||
130404018|NCT01607905|469443729|FG004|Overall Study|Incidence or severity of AEs|0|||
130404019|NCT01607905|469443730|FG005|Overall Study|Incidence or severity of AEs|2|||
130404020|NCT01607905|469443731|FG006|Overall Study|Incidence or severity of AEs|8|||
130404021|NCT01607905|469443725|FG000|Overall Study|Disease progression|44|||
130404022|NCT01607905|469443726|FG001|Overall Study|Disease progression|16|||
130404023|NCT01607905|469443727|FG002|Overall Study|Disease progression|15|||
130404024|NCT01607905|469443728|FG003|Overall Study|Disease progression|11|||
130404025|NCT01607905|469443729|FG004|Overall Study|Disease progression|6|||
130404026|NCT01607905|469443730|FG005|Overall Study|Disease progression|7|||
130404027|NCT01607905|469443731|FG006|Overall Study|Disease progression|21|||
130404028|NCT01607905|469443725|FG000|Overall Study|Non-compliance with study procedures|0|||
130404029|NCT01607905|469443726|FG001|Overall Study|Non-compliance with study procedures|0|||
130404030|NCT01607905|469443727|FG002|Overall Study|Non-compliance with study procedures|0|||
130471204|NCT03012841|469692594|FG000|Overall Study|Seasonal winter travel|1|||
130471205|NCT03012841|469692595|FG001|Overall Study|Seasonal winter travel|0|||
130471206|NCT03012841|469692594|FG000|Overall Study|Physician Decision|0|||
130724692|NCT02861014|470616987|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
130724693|NCT02861014|470616987|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
130724694|NCT00926783|470616988|FG000|Overall Study|Incomplete CFAE Procedures|3|||
130724695|NCT00926783|470616989|FG001|Overall Study|Incomplete CFAE Procedures|3|||
130724696|NCT04581369|470616991|FG000|Overall Study|Death|7|||
130724697|NCT04581369|470616992|FG001|Overall Study|Death|6|||
130404031|NCT01607905|469443728|FG003|Overall Study|Non-compliance with study procedures|0|||
130404032|NCT01607905|469443729|FG004|Overall Study|Non-compliance with study procedures|0|||
130404033|NCT01607905|469443730|FG005|Overall Study|Non-compliance with study procedures|0|||
130404034|NCT01607905|469443731|FG006|Overall Study|Non-compliance with study procedures|1|||
130404035|NCT01607905|469443725|FG000|Overall Study|Death|1|||
130404036|NCT01607905|469443726|FG001|Overall Study|Death|1|||
130404037|NCT01607905|469443727|FG002|Overall Study|Death|1|||
130404038|NCT01607905|469443728|FG003|Overall Study|Death|1|||
130404039|NCT01607905|469443729|FG004|Overall Study|Death|0|||
130404040|NCT01607905|469443730|FG005|Overall Study|Death|0|||
130404041|NCT01607905|469443731|FG006|Overall Study|Death|3|||
130404042|NCT01607905|469443725|FG000|Overall Study|Other treatments become available|1|||
130404043|NCT01607905|469443726|FG001|Overall Study|Other treatments become available|0|||
130404044|NCT01607905|469443727|FG002|Overall Study|Other treatments become available|0|||
130404045|NCT01607905|469443728|FG003|Overall Study|Other treatments become available|0|||
130404046|NCT01607905|469443729|FG004|Overall Study|Other treatments become available|0|||
130404047|NCT01607905|469443730|FG005|Overall Study|Other treatments become available|0|||
130404048|NCT01607905|469443731|FG006|Overall Study|Other treatments become available|1|||
130404049|NCT01607905|469443725|FG000|Overall Study|Investigator discretion|0|||
130404050|NCT01607905|469443726|FG001|Overall Study|Investigator discretion|0|||
130404051|NCT01607905|469443727|FG002|Overall Study|Investigator discretion|0|||
130404052|NCT01607905|469443728|FG003|Overall Study|Investigator discretion|0|||
130404053|NCT01607905|469443729|FG004|Overall Study|Investigator discretion|0|||
130404054|NCT01607905|469443730|FG005|Overall Study|Investigator discretion|1|||
130404055|NCT01607905|469443731|FG006|Overall Study|Investigator discretion|0|||
130404056|NCT01607905|469443725|FG000|Overall Study|Other|1|||
130404057|NCT01607905|469443726|FG001|Overall Study|Other|0|||
130404058|NCT01607905|469443727|FG002|Overall Study|Other|0|||
130404059|NCT01607905|469443728|FG003|Overall Study|Other|0|||
130404060|NCT01607905|469443729|FG004|Overall Study|Other|0|||
130404061|NCT01607905|469443730|FG005|Overall Study|Other|0|||
130404062|NCT01607905|469443731|FG006|Overall Study|Other|1|||
130404063|NCT01607905|469443725|FG000|Overall Study|Randomized but not treated|1|||
130404064|NCT01607905|469443726|FG001|Overall Study|Randomized but not treated|0|||
130404065|NCT01607905|469443727|FG002|Overall Study|Randomized but not treated|0|||
130404066|NCT01607905|469443728|FG003|Overall Study|Randomized but not treated|0|||
130404067|NCT01607905|469443729|FG004|Overall Study|Randomized but not treated|1|||
130404068|NCT01607905|469443730|FG005|Overall Study|Randomized but not treated|1|||
130404069|NCT01607905|469443731|FG006|Overall Study|Randomized but not treated|0|||
130404070|NCT01105533|469443732|FG000|Overall Study|Death|0|||
130404071|NCT01105533|469443733|FG001|Overall Study|Death|0|||
130404072|NCT01105533|469443734|FG002|Overall Study|Death|0|||
130404073|NCT01105533|469443735|FG003|Overall Study|Death|0|||
130404074|NCT01105533|469443736|FG004|Overall Study|Death|1|||
130404075|NCT01105533|469443737|FG005|Overall Study|Death|0|||
130404076|NCT01105533|469443738|FG006|Overall Study|Death|0|||
130404077|NCT01105533|469443739|FG007|Overall Study|Death|0|||
130404078|NCT01105533|469443740|FG008|Overall Study|Death|0|||
130404079|NCT01105533|469443732|FG000|Overall Study|Lack of Efficacy|1|||
130404080|NCT01105533|469443733|FG001|Overall Study|Lack of Efficacy|1|||
130404081|NCT01105533|469443734|FG002|Overall Study|Lack of Efficacy|3|||
130404082|NCT01105533|469443735|FG003|Overall Study|Lack of Efficacy|3|||
130404083|NCT01105533|469443736|FG004|Overall Study|Lack of Efficacy|4|||
130404084|NCT01105533|469443737|FG005|Overall Study|Lack of Efficacy|5|||
130404085|NCT01105533|469443738|FG006|Overall Study|Lack of Efficacy|3|||
130404086|NCT01105533|469443739|FG007|Overall Study|Lack of Efficacy|2|||
130404087|NCT01105533|469443740|FG008|Overall Study|Lack of Efficacy|9|||
130404088|NCT01105533|469443732|FG000|Overall Study|Adverse Event|0|||
130404089|NCT01105533|469443733|FG001|Overall Study|Adverse Event|0|||
130724698|NCT04581369|470616993|FG002|Overall Study|Death|0|||
130404090|NCT01105533|469443734|FG002|Overall Study|Adverse Event|0|||
130404091|NCT01105533|469443735|FG003|Overall Study|Adverse Event|0|||
130471207|NCT03012841|469692595|FG001|Overall Study|Physician Decision|2|||
130724699|NCT04581369|470616991|FG000|Overall Study|Lost to Follow-up|7|||
130724700|NCT04581369|470616992|FG001|Overall Study|Lost to Follow-up|3|||
130404092|NCT01105533|469443736|FG004|Overall Study|Adverse Event|1|||
130404093|NCT01105533|469443737|FG005|Overall Study|Adverse Event|2|||
130404094|NCT01105533|469443738|FG006|Overall Study|Adverse Event|2|||
130724701|NCT04581369|470616993|FG002|Overall Study|Lost to Follow-up|0|||
130404095|NCT01105533|469443739|FG007|Overall Study|Adverse Event|0|||
130404096|NCT01105533|469443740|FG008|Overall Study|Adverse Event|1|||
130404097|NCT01105533|469443732|FG000|Overall Study|Other|0|||
130404098|NCT01105533|469443733|FG001|Overall Study|Other|0|||
130404099|NCT01105533|469443734|FG002|Overall Study|Other|0|||
130404100|NCT01105533|469443735|FG003|Overall Study|Other|0|||
130404101|NCT01105533|469443736|FG004|Overall Study|Other|1|||
130404102|NCT01105533|469443737|FG005|Overall Study|Other|0|||
130404103|NCT01105533|469443738|FG006|Overall Study|Other|3|||
130404104|NCT01105533|469443739|FG007|Overall Study|Other|1|||
130404105|NCT01105533|469443740|FG008|Overall Study|Other|2|||
130404106|NCT01105533|469443732|FG000|Overall Study|Physician Decision|0|||
130404107|NCT01105533|469443733|FG001|Overall Study|Physician Decision|0|||
130404108|NCT01105533|469443734|FG002|Overall Study|Physician Decision|0|||
130404109|NCT01105533|469443735|FG003|Overall Study|Physician Decision|0|||
130404110|NCT01105533|469443736|FG004|Overall Study|Physician Decision|0|||
130404111|NCT01105533|469443737|FG005|Overall Study|Physician Decision|0|||
130404112|NCT01105533|469443738|FG006|Overall Study|Physician Decision|0|||
130404113|NCT01105533|469443739|FG007|Overall Study|Physician Decision|1|||
130404114|NCT01105533|469443740|FG008|Overall Study|Physician Decision|0|||
130404115|NCT02096835|469443742|FG000|Overall Study|Withdrawal by Subject|1|||
130404116|NCT02096835|469443743|FG001|Overall Study|Withdrawal by Subject|0|||
130404117|NCT02096835|469443744|FG002|Overall Study|Withdrawal by Subject|0|||
130471208|NCT03012841|469692594|FG000|Overall Study|No ablation performed|0|||
130471209|NCT03012841|469692595|FG001|Overall Study|No ablation performed|2|||
130471210|NCT03012841|469692594|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
130471211|NCT03012841|469692595|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
130471212|NCT03012841|469692594|FG000|Overall Study|Insurance change|0|||
130471213|NCT03012841|469692595|FG001|Overall Study|Insurance change|1|||
130471214|NCT03416023|469692606|FG000|Overall Study|Exclusion criteria failure|1|||
130471215|NCT03416023|469692606|FG000|Overall Study|Withdrawal by Subject|6|||
130471216|NCT03416023|469692606|FG000|Overall Study|Explanted|7|||
130471217|NCT03416023|469692606|FG000|Overall Study|Physician Decision|1|||
130471218|NCT03416023|469692606|FG000|Overall Study|Lost to Follow-up|1|||
130471219|NCT03416023|469692606|FG000|Overall Study|Death|1|||
130471220|NCT04878354|469692607|FG000|Overall Study|Adverse Event|4|||
130471221|NCT04878354|469692608|FG001|Overall Study|Adverse Event|13|||
130724702|NCT04581369|470616991|FG000|Overall Study|liver transplant|2|||
130724703|NCT04581369|470616992|FG001|Overall Study|liver transplant|2|||
130724704|NCT04581369|470616993|FG002|Overall Study|liver transplant|0|||
130724705|NCT04581369|470616991|FG000|Overall Study|transitioned to hospice care|0|||
130724706|NCT04581369|470616992|FG001|Overall Study|transitioned to hospice care|5|||
130724707|NCT04581369|470616993|FG002|Overall Study|transitioned to hospice care|0|||
130724708|NCT00780910|470616994|FG000|Overall Study|Adverse Event|2|||
130724709|NCT01111825|470616997|FG000|Overall Study|Withdrawal by Subject|0|||
130724710|NCT01111825|470616998|FG001|Overall Study|Withdrawal by Subject|0|||
130724711|NCT01111825|470616999|FG002|Overall Study|Withdrawal by Subject|1|||
130471222|NCT04878354|469692607|FG000|Overall Study|Withdrawal by Subject|14|||
130471223|NCT04878354|469692608|FG001|Overall Study|Withdrawal by Subject|12|||
130471224|NCT04878354|469692607|FG000|Overall Study|Lost to Follow-up|4|||
130471225|NCT04878354|469692608|FG001|Overall Study|Lost to Follow-up|1|||
130471226|NCT04878354|469692607|FG000|Overall Study|Lack of Efficacy|1|||
130471227|NCT04878354|469692608|FG001|Overall Study|Lack of Efficacy|0|||
130471228|NCT04878354|469692607|FG000|Overall Study|Protocol Violation|0|||
130471229|NCT04878354|469692608|FG001|Overall Study|Protocol Violation|1|||
130471230|NCT04878354|469692607|FG000|Overall Study|"Reason stated as other in CRF"|2|||
130471231|NCT04878354|469692608|FG001|Overall Study|"Reason stated as other in CRF"|3|||
130724712|NCT01111825|470617000|FG003|Overall Study|Withdrawal by Subject|0|||
130404118|NCT02096835|469443742|FG000|Overall Study|converted to open procedures|1|||
130404119|NCT02096835|469443743|FG001|Overall Study|converted to open procedures|0|||
130471232|NCT05510232|469692609|FG000|Overall Study|Withdrawal by Subject|2|||
130471233|NCT05510232|469692610|FG001|Overall Study|Withdrawal by Subject|7|||
130471234|NCT05510232|469692611|FG002|Overall Study|Withdrawal by Subject|6|||
130724713|NCT01111825|470616997|FG000|Overall Study|Lost to Follow-up|0|||
130404120|NCT02096835|469443744|FG002|Overall Study|converted to open procedures|0|||
130471235|NCT04855760|469692613|FG000|Overall Study|Adverse Event|21|||
130471236|NCT04855760|469692613|FG000|Overall Study|Withdrawal by Subject|116|||
130724714|NCT01111825|470616998|FG001|Overall Study|Lost to Follow-up|0|||
130724715|NCT01111825|470616999|FG002|Overall Study|Lost to Follow-up|3|||
130724716|NCT01111825|470617000|FG003|Overall Study|Lost to Follow-up|1|||
130724717|NCT01111825|470616997|FG000|Overall Study|Adverse Event|2|||
130404121|NCT02096835|469443742|FG000|Overall Study|Lost to Follow-up|1|||
130404122|NCT02096835|469443743|FG001|Overall Study|Lost to Follow-up|0|||
130404123|NCT02096835|469443744|FG002|Overall Study|Lost to Follow-up|1|||
130404124|NCT03892889|469443745|FG000|Overall Study|Adverse Event|17|||
130404125|NCT03892889|469443745|FG000|Overall Study|Lack of Efficacy|1|||
130404126|NCT03892889|469443745|FG000|Overall Study|Lost to Follow-up|46|||
130404127|NCT03892889|469443745|FG000|Overall Study|Non-compliance with study drug|22|||
130404128|NCT03892889|469443745|FG000|Overall Study|Pregnancy|1|||
130404129|NCT03892889|469443745|FG000|Overall Study|Protocol Deviation|3|||
130404130|NCT03892889|469443745|FG000|Overall Study|Withdrawal by Subject|50|||
130404131|NCT03892889|469443745|FG000|Overall Study|Withdrawal by Caregiver|1|||
130404132|NCT03892889|469443745|FG000|Overall Study|Study Terminated by Sponsor|50|||
130404133|NCT03892889|469443745|FG000|Overall Study|Physician Decision|8|||
130404134|NCT03892889|469443745|FG000|Overall Study|Reason not Specified|5|||
130404135|NCT04260191|469443746|FG000|Overall Study|Decision by Sponsor|0|||
130404136|NCT04260191|469443747|FG001|Overall Study|Decision by Sponsor|1|||
130404137|NCT04260191|469443748|FG002|Overall Study|Decision by Sponsor|0|||
130404138|NCT04260191|469443746|FG000|Overall Study|Withdrawal by Subject|1|||
130404139|NCT04260191|469443747|FG001|Overall Study|Withdrawal by Subject|0|||
130404140|NCT04260191|469443748|FG002|Overall Study|Withdrawal by Subject|3|||
130404141|NCT04260191|469443746|FG000|Overall Study|Death|4|||
130404142|NCT04260191|469443747|FG001|Overall Study|Death|3|||
130404143|NCT04260191|469443748|FG002|Overall Study|Death|2|||
130404144|NCT00659646|469443753|FG000|Overall Study|Protocol Violation|12|||
130404145|NCT00659646|469443754|FG001|Overall Study|Protocol Violation|8|||
130404146|NCT00659646|469443753|FG000|Overall Study|Adverse Event|1|||
130404147|NCT00659646|469443754|FG001|Overall Study|Adverse Event|0|||
130404148|NCT00659646|469443753|FG000|Overall Study|Lost to Follow-up|1|||
130404149|NCT00659646|469443754|FG001|Overall Study|Lost to Follow-up|0|||
130404150|NCT00659646|469443753|FG000|Overall Study|protocol noncompliance after randomized|1|||
130404151|NCT00659646|469443754|FG001|Overall Study|protocol noncompliance after randomized|0|||
130404152|NCT00023673|469443755|FG000|Overall Study|Ineligible / no protocol treatment|0|||
130404153|NCT00023673|469443756|FG001|Overall Study|Ineligible / no protocol treatment|0|||
130404154|NCT00023673|469443757|FG002|Overall Study|Ineligible / no protocol treatment|0|||
130404155|NCT00023673|469443758|FG003|Overall Study|Ineligible / no protocol treatment|1|||
130404156|NCT00023673|469443755|FG000|Overall Study|Patient withdrew consent|0|||
130404157|NCT00023673|469443756|FG001|Overall Study|Patient withdrew consent|0|||
130404158|NCT00023673|469443757|FG002|Overall Study|Patient withdrew consent|0|||
130404159|NCT00023673|469443758|FG003|Overall Study|Patient withdrew consent|1|||
130404160|NCT02453594|469443759|FG000|Overall Study|Protocol Violation|0|||
130404161|NCT02453594|469443760|FG001|Overall Study|Protocol Violation|0|||
130404162|NCT02453594|469443761|FG002|Overall Study|Protocol Violation|1|||
130404163|NCT02453594|469443759|FG000|Overall Study|Cohort Was Closed|17|||
130404164|NCT02453594|469443760|FG001|Overall Study|Cohort Was Closed|21|||
130404165|NCT02453594|469443761|FG002|Overall Study|Cohort Was Closed|14|||
130404166|NCT02453594|469443759|FG000|Overall Study|Death|20|||
130404167|NCT02453594|469443760|FG001|Overall Study|Death|24|||
130404168|NCT02453594|469443761|FG002|Overall Study|Death|16|||
130404169|NCT02453594|469443759|FG000|Overall Study|Lost to Follow-up|6|||
130404170|NCT02453594|469443760|FG001|Overall Study|Lost to Follow-up|14|||
130404171|NCT02453594|469443761|FG002|Overall Study|Lost to Follow-up|2|||
130404172|NCT02453594|469443759|FG000|Overall Study|Physician Decision|2|||
130404173|NCT02453594|469443760|FG001|Overall Study|Physician Decision|4|||
130404174|NCT02453594|469443761|FG002|Overall Study|Physician Decision|0|||
130404175|NCT02453594|469443759|FG000|Overall Study|Site Terminated by Sponsor|1|||
130404176|NCT02453594|469443760|FG001|Overall Study|Site Terminated by Sponsor|0|||
130404177|NCT02453594|469443761|FG002|Overall Study|Site Terminated by Sponsor|1|||
130404178|NCT02453594|469443759|FG000|Overall Study|Transitioned to Extension Study|16|||
130404179|NCT02453594|469443760|FG001|Overall Study|Transitioned to Extension Study|9|||
130404180|NCT02453594|469443761|FG002|Overall Study|Transitioned to Extension Study|16|||
130404181|NCT02453594|469443759|FG000|Overall Study|Withdrawal by Subject|7|||
130404182|NCT02453594|469443760|FG001|Overall Study|Withdrawal by Subject|9|||
130404183|NCT02453594|469443761|FG002|Overall Study|Withdrawal by Subject|11|||
130404184|NCT02086591|469443762|FG000|Overall Study|Adverse Event|1|||
130404185|NCT02086591|469443762|FG000|Overall Study|Withdrawal by Subject|1|||
130404186|NCT02086591|469443762|FG000|Overall Study|protocol terminated|3|||
130404187|NCT02660359|469443763|FG000|Overall Study|Protocol Deviation|0|||
130404188|NCT02660359|469443764|FG001|Overall Study|Protocol Deviation|0|||
130404189|NCT02660359|469443765|FG002|Overall Study|Protocol Deviation|1|||
130404190|NCT02660359|469443763|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
130404191|NCT02660359|469443764|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
130404192|NCT02660359|469443765|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
130404193|NCT02660359|469443763|FG000|Overall Study|Lack of Efficacy|1|||
130471237|NCT04855760|469692613|FG000|Overall Study|Lack of Efficacy|21|||
130471238|NCT04855760|469692613|FG000|Overall Study|Lost to Follow-up|49|||
130404194|NCT02660359|469443764|FG001|Overall Study|Lack of Efficacy|1|||
130404195|NCT02660359|469443765|FG002|Overall Study|Lack of Efficacy|1|||
130404196|NCT02660359|469443763|FG000|Overall Study|Adverse Event|0|||
130404197|NCT02660359|469443764|FG001|Overall Study|Adverse Event|1|||
130404198|NCT02660359|469443765|FG002|Overall Study|Adverse Event|0|||
130404199|NCT02660359|469443763|FG000|Overall Study|Other|2|||
130404200|NCT02660359|469443764|FG001|Overall Study|Other|1|||
130471239|NCT04855760|469692613|FG000|Overall Study|Protocol Violation|2|||
130404201|NCT02660359|469443765|FG002|Overall Study|Other|3|||
130404202|NCT02660359|469443763|FG000|Overall Study|Withdrawal by Subject|7|||
130404203|NCT02660359|469443764|FG001|Overall Study|Withdrawal by Subject|5|||
130404204|NCT02660359|469443765|FG002|Overall Study|Withdrawal by Subject|8|||
130404205|NCT02660359|469443763|FG000|Overall Study|Lost to Follow-up|3|||
130404206|NCT02660359|469443764|FG001|Overall Study|Lost to Follow-up|3|||
130404207|NCT02660359|469443765|FG002|Overall Study|Lost to Follow-up|0|||
130404208|NCT04086472|469443767|FG000|Overall Study|Lost to Follow-up|1|||
130404209|NCT04086472|469443768|FG001|Overall Study|Lost to Follow-up|0|||
130404210|NCT04086472|469443769|FG002|Overall Study|Lost to Follow-up|0|||
130404211|NCT04086472|469443770|FG003|Overall Study|Lost to Follow-up|0|||
130404212|NCT04086472|469443771|FG004|Overall Study|Lost to Follow-up|1|||
130404213|NCT04086472|469443767|FG000|Overall Study|Physician Decision|0|||
130404214|NCT04086472|469443768|FG001|Overall Study|Physician Decision|1|||
130404215|NCT04086472|469443769|FG002|Overall Study|Physician Decision|1|||
130404216|NCT04086472|469443770|FG003|Overall Study|Physician Decision|0|||
130404217|NCT04086472|469443771|FG004|Overall Study|Physician Decision|0|||
130404218|NCT04086472|469443767|FG000|Overall Study|Withdrawal by Subject|1|||
130404219|NCT04086472|469443768|FG001|Overall Study|Withdrawal by Subject|1|||
130404220|NCT04086472|469443769|FG002|Overall Study|Withdrawal by Subject|1|||
130404221|NCT04086472|469443770|FG003|Overall Study|Withdrawal by Subject|0|||
130404222|NCT04086472|469443771|FG004|Overall Study|Withdrawal by Subject|0|||
130404223|NCT04086472|469443767|FG000|Overall Study|Various reasons|2|||
130404224|NCT04086472|469443768|FG001|Overall Study|Various reasons|0|||
130404225|NCT04086472|469443769|FG002|Overall Study|Various reasons|0|||
130404226|NCT04086472|469443770|FG003|Overall Study|Various reasons|3|||
130404227|NCT04086472|469443771|FG004|Overall Study|Various reasons|1|||
130404228|NCT03348904|469443772|FG000|Overall Study|Administrative reason by the sponsor|0|||
130404229|NCT03348904|469443773|FG001|Overall Study|Administrative reason by the sponsor|1|||
130404230|NCT03348904|469443774|FG002|Overall Study|Administrative reason by the sponsor|0|||
130404231|NCT00048724|469443780|FG000|Overall Study|Adverse Event|53|||
130404232|NCT00048724|469443781|FG001|Overall Study|Adverse Event|12|||
130404233|NCT00048724|469443780|FG000|Overall Study|Withdrawal by Subject|34|||
130404234|NCT00048724|469443781|FG001|Overall Study|Withdrawal by Subject|54|||
130404235|NCT00048724|469443780|FG000|Overall Study|Lost to Follow-up|5|||
130404236|NCT00048724|469443781|FG001|Overall Study|Lost to Follow-up|5|||
130404237|NCT00048724|469443780|FG000|Overall Study|Protocol-defined Clinical Event|17|||
130404238|NCT00048724|469443781|FG001|Overall Study|Protocol-defined Clinical Event|32|||
130404239|NCT00048724|469443780|FG000|Overall Study|Noncompliance With Protocol|4|||
130404240|NCT00048724|469443781|FG001|Overall Study|Noncompliance With Protocol|12|||
130404241|NCT00048724|469443780|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
130404242|NCT00048724|469443781|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
130404243|NCT00048724|469443780|FG000|Overall Study|Administrative|1|||
130404244|NCT00048724|469443781|FG001|Overall Study|Administrative|1|||
130404245|NCT00844545|469443782|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
130404246|NCT00844545|469443782|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
130404247|NCT00844545|469443782|FG000|Extension Treatment Period|Adverse Event|2|||
130404248|NCT00844545|469443782|FG000|Post Treatment Period|Withdrawal by Subject|1|||
130404249|NCT02039427|469443783|FG000|Overall Study|Duration of surgery > 3h|1|||
130404250|NCT02039427|469443784|FG001|Overall Study|Duration of surgery > 3h|1|||
130404251|NCT02039427|469443785|FG002|Overall Study|Duration of surgery > 3h|0|||
130404252|NCT02039427|469443786|FG003|Overall Study|Duration of surgery > 3h|0|||
130404253|NCT02039427|469443783|FG000|Overall Study|Withdrawal on concent|0|||
130404254|NCT02039427|469443784|FG001|Overall Study|Withdrawal on concent|0|||
130404255|NCT02039427|469443785|FG002|Overall Study|Withdrawal on concent|0|||
130404256|NCT02039427|469443786|FG003|Overall Study|Withdrawal on concent|1|||
130404257|NCT02039427|469443783|FG000|Overall Study|Cancellation of surgery|0|||
130404258|NCT02039427|469443784|FG001|Overall Study|Cancellation of surgery|0|||
130404259|NCT02039427|469443785|FG002|Overall Study|Cancellation of surgery|1|||
130404260|NCT02039427|469443786|FG003|Overall Study|Cancellation of surgery|0|||
130404261|NCT02039427|469443783|FG000|Overall Study|Loss of follow - up|1|||
130404262|NCT02039427|469443784|FG001|Overall Study|Loss of follow - up|0|||
130404263|NCT02039427|469443785|FG002|Overall Study|Loss of follow - up|2|||
130404264|NCT02039427|469443786|FG003|Overall Study|Loss of follow - up|4|||
130404265|NCT02039427|469443783|FG000|Overall Study|Steroid Use|1|||
130404266|NCT02039427|469443784|FG001|Overall Study|Steroid Use|0|||
130404267|NCT02039427|469443785|FG002|Overall Study|Steroid Use|0|||
130404268|NCT02039427|469443786|FG003|Overall Study|Steroid Use|0|||
130404269|NCT01743092|469443787|FG000|Overall Study|Lost to Follow-up|14|||
130404270|NCT01743092|469443788|FG001|Overall Study|Lost to Follow-up|15|||
130404271|NCT03586869|469443794|FG000|Overall Study|Progressive Disease|3|||
130404272|NCT00403455|469443797|FG000|Overall Study|Withdrawal by Subject|1|||
130561023|NCT03250832|470022791|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130404273|NCT00087568|469443804|FG000|Overall Study|Adverse Event|4|||
130404274|NCT00087568|469443805|FG001|Overall Study|Adverse Event|0|||
130404275|NCT00087568|469443804|FG000|Overall Study|Withdrawal by Subject|1|||
130404276|NCT00087568|469443805|FG001|Overall Study|Withdrawal by Subject|1|||
130404277|NCT00087568|469443804|FG000|Overall Study|Lost to Follow-up|1|||
130404278|NCT00087568|469443805|FG001|Overall Study|Lost to Follow-up|0|||
130561024|NCT03250832|470022780|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130404279|NCT00087568|469443804|FG000|Overall Study|Lack of Efficacy|24|||
130404280|NCT00087568|469443805|FG001|Overall Study|Lack of Efficacy|1|||
130404281|NCT04394351|469443806|FG000|Part A (16 Weeks)|Adverse Event|1|||
130404282|NCT04394351|469443807|FG001|Part A (16 Weeks)|Adverse Event|0|||
130404283|NCT04394351|469443808|FG002|Part A (16 Weeks)|Adverse Event|0|||
130404284|NCT04394351|469443809|FG003|Part A (16 Weeks)|Adverse Event|0|||
130404285|NCT04394351|469443810|FG004|Part A (16 Weeks)|Adverse Event|0|||
130404286|NCT04394351|469443811|FG005|Part A (16 Weeks)|Adverse Event|0|||
130404287|NCT04394351|469443812|FG006|Part A (16 Weeks)|Adverse Event|0|||
130404288|NCT04394351|469443813|FG007|Part A (16 Weeks)|Adverse Event|0|||
130404289|NCT04394351|469443806|FG000|Part A (16 Weeks)|Physician Decision|0|||
130404290|NCT04394351|469443807|FG001|Part A (16 Weeks)|Physician Decision|1|||
130404291|NCT04394351|469443808|FG002|Part A (16 Weeks)|Physician Decision|0|||
130404292|NCT04394351|469443809|FG003|Part A (16 Weeks)|Physician Decision|0|||
130404293|NCT04394351|469443810|FG004|Part A (16 Weeks)|Physician Decision|0|||
130404294|NCT04394351|469443811|FG005|Part A (16 Weeks)|Physician Decision|0|||
130404295|NCT04394351|469443812|FG006|Part A (16 Weeks)|Physician Decision|0|||
130404296|NCT04394351|469443813|FG007|Part A (16 Weeks)|Physician Decision|0|||
130404297|NCT04394351|469443806|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404298|NCT04394351|469443807|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
130404299|NCT04394351|469443808|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404300|NCT04394351|469443809|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404301|NCT04394351|469443810|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404302|NCT04394351|469443811|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404303|NCT04394351|469443812|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404304|NCT04394351|469443813|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
130404305|NCT04394351|469443806|FG000|Part B (36 Weeks)|Adverse Event|0|||
130404306|NCT04394351|469443807|FG001|Part B (36 Weeks)|Adverse Event|0|||
130404307|NCT04394351|469443808|FG002|Part B (36 Weeks)|Adverse Event|0|||
130404308|NCT04394351|469443809|FG003|Part B (36 Weeks)|Adverse Event|0|||
130404309|NCT04394351|469443810|FG004|Part B (36 Weeks)|Adverse Event|0|||
130404310|NCT04394351|469443811|FG005|Part B (36 Weeks)|Adverse Event|0|||
130404311|NCT04394351|469443812|FG006|Part B (36 Weeks)|Adverse Event|1|||
130404312|NCT04394351|469443813|FG007|Part B (36 Weeks)|Adverse Event|0|||
130404313|NCT04354831|469443818|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
130404314|NCT04354831|469443819|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
130471240|NCT04855760|469692613|FG000|Overall Study|Physician Decision|5|||
130471241|NCT04855760|469692613|FG000|Overall Study|Pregnancy|1|||
130471242|NCT04855760|469692613|FG000|Overall Study|Non-Compliance with Study Drug|11|||
130471243|NCT04855760|469692613|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
130471244|NCT04855760|469692613|FG000|Overall Study|Study Completed by Sponsor|202|||
130724718|NCT01111825|470616998|FG001|Overall Study|Adverse Event|1|||
130724719|NCT01111825|470616999|FG002|Overall Study|Adverse Event|4|||
130724720|NCT01111825|470617000|FG003|Overall Study|Adverse Event|0|||
130724721|NCT01111825|470616997|FG000|Overall Study|Disease Progression|1|||
130724722|NCT01111825|470616998|FG001|Overall Study|Disease Progression|0|||
130724723|NCT01111825|470616999|FG002|Overall Study|Disease Progression|0|||
130724724|NCT01111825|470617000|FG003|Overall Study|Disease Progression|0|||
130404315|NCT02732847|469443820|FG000|Overall Study|some filled early|42|||
130404316|NCT02732847|469443821|FG001|Overall Study|some filled early|42|||
130471245|NCT04855760|469692613|FG000|Overall Study|Other|13|||
130471246|NCT04869982|469692622|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
130471247|NCT04869982|469692623|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
130471248|NCT04869982|469692622|FG000|Overall Study|Migrated / moved from the study area|1|||
130471249|NCT04869982|469692623|FG001|Overall Study|Migrated / moved from the study area|1|||
130471250|NCT04869982|469692622|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
130471251|NCT04869982|469692623|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
130471252|NCT04869982|469692622|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
130471253|NCT04869982|469692623|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
130471254|NCT04869982|469692622|FG000|Overall Study|Solicited adverse event|2|||
130471255|NCT04869982|469692623|FG001|Overall Study|Solicited adverse event|1|||
130404317|NCT01430585|469443826|FG000|Overall Study|Death|1|||
130404318|NCT01430585|469443826|FG000|Overall Study|Objective Progression or Relapse|3|||
130404319|NCT01430585|469443826|FG000|Overall Study|Study Terminated by Sponsor|3|||
130404320|NCT01430585|469443826|FG000|Overall Study|Other|7|||
130404321|NCT01274637|469443829|FG000|Overall Study|Withdrawal by Subject|0|||
130404322|NCT01274637|469443830|FG001|Overall Study|Withdrawal by Subject|1|||
130404323|NCT01274637|469443829|FG000|Overall Study|Lost to Follow-up|0|||
130561025|NCT03250832|470022781|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130404324|NCT01274637|469443830|FG001|Overall Study|Lost to Follow-up|1|||
130561026|NCT03250832|470022782|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130724725|NCT01111825|470616997|FG000|Overall Study|Discontinuation by Sponsor|0|||
130471256|NCT01631214|469692624|FG000|Overall Study|Withdrawal by Subject|276|||
130724726|NCT01111825|470616998|FG001|Overall Study|Discontinuation by Sponsor|0|||
130724727|NCT01111825|470616999|FG002|Overall Study|Discontinuation by Sponsor|0|||
130724728|NCT01111825|470617000|FG003|Overall Study|Discontinuation by Sponsor|20|||
130724729|NCT00741286|470617009|FG000|Overall Study|Lost to Follow-up|15|||
130404325|NCT02357576|469443833|FG000|Treatment Period|Withdrawal by Subject|0|||
130404326|NCT02357576|469443834|FG001|Treatment Period|Withdrawal by Subject|1|||
130404327|NCT02357576|469443833|FG000|Treatment Period|Physician Decision|0|||
130404328|NCT02357576|469443834|FG001|Treatment Period|Physician Decision|1|||
130404329|NCT02357576|469443833|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
130404330|NCT02357576|469443834|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
130404331|NCT02357576|469443833|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
130404332|NCT02357576|469443834|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
130404333|NCT02357576|469443833|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
130404334|NCT02357576|469443834|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
130404335|NCT02357576|469443833|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
130404336|NCT02357576|469443834|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
130404337|NCT00699699|469443837|FG000|Overall Study|Adverse Event|36|||
130404338|NCT00699699|469443837|FG000|Overall Study|Individual different reasons|21|||
130404339|NCT01632800|469443840|FG000|Overall Study|Subject did not fit in apparatus|1|||
130404340|NCT00720876|469443841|FG000|Overall Study|found to be ineligible after starting tx|2|||
130404341|NCT03495908|469443843|FG000|Overall Study|Withdrawal by Subject|3|||
130404342|NCT03495908|469443844|FG001|Overall Study|Withdrawal by Subject|1|||
130404343|NCT03495908|469443843|FG000|Overall Study|Lost to Follow-up|1|||
130404344|NCT03495908|469443844|FG001|Overall Study|Lost to Follow-up|4|||
130404345|NCT03495908|469443843|FG000|Overall Study|Adverse Event|0|||
130404346|NCT03495908|469443844|FG001|Overall Study|Adverse Event|2|||
130404347|NCT03495908|469443843|FG000|Overall Study|Death|1|||
130404348|NCT03495908|469443844|FG001|Overall Study|Death|0|||
130404349|NCT03495908|469443843|FG000|Overall Study|Physician Decision|5|||
130404350|NCT03495908|469443844|FG001|Overall Study|Physician Decision|4|||
130404351|NCT03495908|469443843|FG000|Overall Study|No documented reason|0|||
130404352|NCT03495908|469443844|FG001|Overall Study|No documented reason|2|||
130404353|NCT03511560|469443850|FG000|Overall Study|Death|0|||
130404354|NCT03511560|469443851|FG001|Overall Study|Death|1|||
130404355|NCT03511560|469443850|FG000|Overall Study|Adverse Event|0|||
130404356|NCT03511560|469443851|FG001|Overall Study|Adverse Event|2|||
130404357|NCT03511560|469443850|FG000|Overall Study|Transplant cancelled|0|||
130404358|NCT03511560|469443851|FG001|Overall Study|Transplant cancelled|1|||
130404359|NCT03511560|469443850|FG000|Overall Study|Patient switched to another drug|1|||
130404360|NCT03511560|469443851|FG001|Overall Study|Patient switched to another drug|0|||
130404361|NCT02985736|469443856|FG000|Overall Study|Lost to Follow-up|3|||
130404362|NCT00382733|469443857|FG000|Overall Study|Withdrawal by Subject|0|||
130404363|NCT00382733|469443858|FG001|Overall Study|Withdrawal by Subject|1|||
130404364|NCT00382733|469443859|FG002|Overall Study|Withdrawal by Subject|0|||
130404365|NCT00382733|469443860|FG003|Overall Study|Withdrawal by Subject|0|||
130404366|NCT00382733|469443861|FG004|Overall Study|Withdrawal by Subject|0|||
130404367|NCT00439140|469443862|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130404368|NCT00439140|469443863|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
130404369|NCT00439140|469443864|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
130404370|NCT00439140|469443862|FG000|Treatment Cycle 1|Personal reasons|0|||
130404371|NCT00439140|469443863|FG001|Treatment Cycle 1|Personal reasons|2|||
130404372|NCT00439140|469443864|FG002|Treatment Cycle 1|Personal reasons|0|||
130404373|NCT00439140|469443862|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
130404374|NCT00439140|469443863|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
130404375|NCT00439140|469443864|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
130404376|NCT00439140|469443862|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
130404377|NCT00439140|469443863|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
130404378|NCT00439140|469443864|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
130404379|NCT00439140|469443862|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
130404380|NCT00439140|469443863|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
130404381|NCT00439140|469443864|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
130404382|NCT01193556|469443867|FG000|Overall Study|Study termination|26|||
130404383|NCT01193556|469443868|FG001|Overall Study|Study termination|25|||
130404384|NCT03286140|469443869|FG000|Overall Study|Withdrawal by Subject|10|||
130404385|NCT03286140|469443870|FG001|Overall Study|Withdrawal by Subject|5|||
130404386|NCT03286140|469443869|FG000|Overall Study|Lost to Follow-up|5|||
130724730|NCT00741286|470617010|FG001|Overall Study|Lost to Follow-up|10|||
130724731|NCT00741286|470617009|FG000|Overall Study|Adverse Event|1|||
130404387|NCT03286140|469443870|FG001|Overall Study|Lost to Follow-up|10|||
130404388|NCT03286140|469443869|FG000|Overall Study|Failure to comply|0|||
130404389|NCT03286140|469443870|FG001|Overall Study|Failure to comply|1|||
130404390|NCT02517905|469443873|FG000|Overall Study|Lost to Follow-up|4|||
130404391|NCT02517905|469443874|FG001|Overall Study|Lost to Follow-up|0|||
130404392|NCT02517905|469443873|FG000|Overall Study|Withdrawal by Subject|4|||
130724732|NCT00741286|470617010|FG001|Overall Study|Adverse Event|6|||
130724733|NCT00741286|470617009|FG000|Overall Study|Protocol Violation|3|||
130404393|NCT02517905|469443874|FG001|Overall Study|Withdrawal by Subject|0|||
130471257|NCT01631214|469692625|FG001|Overall Study|Withdrawal by Subject|290|||
130471258|NCT01631214|469692624|FG000|Overall Study|Death|113|||
130471259|NCT01631214|469692625|FG001|Overall Study|Death|106|||
130471260|NCT01631214|469692624|FG000|Overall Study|Lost to Follow-up|54|||
130471261|NCT01631214|469692625|FG001|Overall Study|Lost to Follow-up|40|||
130471262|NCT01631214|469692624|FG000|Overall Study|Adverse Event|45|||
130471263|NCT01631214|469692625|FG001|Overall Study|Adverse Event|45|||
130471264|NCT01631214|469692624|FG000|Overall Study|Other|22|||
130471265|NCT01631214|469692625|FG001|Overall Study|Other|19|||
130471266|NCT01631214|469692624|FG000|Overall Study|Noncompliance|16|||
130471267|NCT01631214|469692625|FG001|Overall Study|Noncompliance|15|||
130471268|NCT01631214|469692624|FG000|Overall Study|Requirement for Alternative Therapy|8|||
130471269|NCT01631214|469692625|FG001|Overall Study|Requirement for Alternative Therapy|3|||
130471270|NCT01631214|469692624|FG000|Overall Study|Protocol Deviation|4|||
130471271|NCT01631214|469692625|FG001|Overall Study|Protocol Deviation|3|||
130471272|NCT01631214|469692624|FG000|Overall Study|Ineligibility determined|5|||
130471273|NCT01631214|469692625|FG001|Overall Study|Ineligibility determined|2|||
130471274|NCT01631214|469692624|FG000|Overall Study|Administrative Decision|1|||
130471275|NCT01631214|469692625|FG001|Overall Study|Administrative Decision|0|||
130471276|NCT04112316|469692631|FG000|First Period (8 Weeks)|Protocol Violation|1|||
130471277|NCT04112316|469692632|FG001|First Period (8 Weeks)|Protocol Violation|0|||
130471278|NCT04112316|469692631|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
130471279|NCT04112316|469692632|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
130471280|NCT03857620|469692633|FG000|Overall Study|Death|4|||
130471281|NCT03857620|469692634|FG001|Overall Study|Death|5|||
130471282|NCT03857620|469692635|FG002|Overall Study|Death|7|||
130471283|NCT03857620|469692633|FG000|Overall Study|Lost to Follow-up|2|||
130471284|NCT03857620|469692634|FG001|Overall Study|Lost to Follow-up|5|||
130404394|NCT02517905|469443873|FG000|Overall Study|Screen failure|2|||
130404395|NCT02517905|469443874|FG001|Overall Study|Screen failure|2|||
130404396|NCT02556710|469445812|FG000|Overall Study|Surgical treatment|3|||
130404397|NCT02556710|469445813|FG001|Overall Study|Surgical treatment|0|||
130404398|NCT02556710|469445812|FG000|Overall Study|Required proscribed pain medication|2|||
130404399|NCT02556710|469445813|FG001|Overall Study|Required proscribed pain medication|1|||
130404400|NCT02556710|469445812|FG000|Overall Study|Lack of Efficacy|1|||
130404401|NCT02556710|469445813|FG001|Overall Study|Lack of Efficacy|0|||
130404402|NCT02556710|469445812|FG000|Overall Study|Worsening osteoarthritis|1|||
130404403|NCT02556710|469445813|FG001|Overall Study|Worsening osteoarthritis|0|||
130404404|NCT02556710|469445812|FG000|Overall Study|Moved out of state|1|||
130404405|NCT02556710|469445813|FG001|Overall Study|Moved out of state|0|||
130404406|NCT02556710|469445812|FG000|Overall Study|Missing reason|3|||
130404407|NCT02556710|469445813|FG001|Overall Study|Missing reason|1|||
130404408|NCT02556710|469445812|FG000|Overall Study|Pain as lack of efficacy|0|||
130404409|NCT02556710|469445813|FG001|Overall Study|Pain as lack of efficacy|4|||
130404410|NCT01312909|469445814|FG000|Overall Study|Randomized but not treated|1|||
130404411|NCT01312909|469445815|FG001|Overall Study|Randomized but not treated|3|||
130404412|NCT01312909|469445816|FG002|Overall Study|Randomized but not treated|1|||
130404413|NCT01312909|469445814|FG000|Overall Study|Adverse Event|1|||
130404414|NCT01312909|469445815|FG001|Overall Study|Adverse Event|0|||
130404415|NCT01312909|469445816|FG002|Overall Study|Adverse Event|3|||
130404416|NCT01312909|469445814|FG000|Overall Study|Protocol Violation|2|||
130404417|NCT01312909|469445815|FG001|Overall Study|Protocol Violation|0|||
130404418|NCT01312909|469445816|FG002|Overall Study|Protocol Violation|2|||
130404419|NCT01312909|469445814|FG000|Overall Study|Other|9|||
130404420|NCT01312909|469445815|FG001|Overall Study|Other|6|||
130404421|NCT01312909|469445816|FG002|Overall Study|Other|11|||
130404422|NCT01312909|469445814|FG000|Overall Study|Withdrawal by Subject|8|||
130404423|NCT01312909|469445815|FG001|Overall Study|Withdrawal by Subject|10|||
130404424|NCT01312909|469445816|FG002|Overall Study|Withdrawal by Subject|7|||
130404425|NCT01312909|469445814|FG000|Overall Study|Lost to Follow-up|21|||
130404426|NCT01312909|469445815|FG001|Overall Study|Lost to Follow-up|17|||
130404427|NCT01312909|469445816|FG002|Overall Study|Lost to Follow-up|20|||
130471285|NCT03857620|469692635|FG002|Overall Study|Lost to Follow-up|3|||
130471286|NCT03857620|469692633|FG000|Overall Study|Disease progression or relapse after study registration|1|||
130404428|NCT01312909|469445814|FG000|Overall Study|Insufficient clinical response|0|||
130404429|NCT01312909|469445815|FG001|Overall Study|Insufficient clinical response|0|||
130471287|NCT03857620|469692634|FG001|Overall Study|Disease progression or relapse after study registration|5|||
130471288|NCT03857620|469692635|FG002|Overall Study|Disease progression or relapse after study registration|1|||
130471289|NCT03857620|469692633|FG000|Overall Study|Ineligible|5|||
130471290|NCT03857620|469692634|FG001|Overall Study|Ineligible|0|||
130404430|NCT01312909|469445816|FG002|Overall Study|Insufficient clinical response|1|||
130471291|NCT03857620|469692635|FG002|Overall Study|Ineligible|2|||
130471292|NCT03857620|469692633|FG000|Overall Study|No malignancy|1|||
130404431|NCT01312909|469445814|FG000|Overall Study|Entrance criteria not met|0|||
130404432|NCT01312909|469445815|FG001|Overall Study|Entrance criteria not met|0|||
130404433|NCT01312909|469445816|FG002|Overall Study|Entrance criteria not met|2|||
130404434|NCT01774903|469445823|FG000|Overall Study|Adverse Event|7|||
130404435|NCT01774903|469445823|FG000|Overall Study|Withdrawal by Subject|2|||
130404436|NCT01774903|469445823|FG000|Overall Study|Lack of Efficacy|1|||
130404437|NCT01774903|469445823|FG000|Overall Study|Ineligible to continue the trial|1|||
130404438|NCT01602315|469445824|FG000|Overall Study|Protocol Violation|0|||
130404439|NCT01602315|469445825|FG001|Overall Study|Protocol Violation|0|||
130404440|NCT01602315|469445826|FG002|Overall Study|Protocol Violation|0|||
130404441|NCT01602315|469445827|FG003|Overall Study|Protocol Violation|0|||
130404442|NCT01602315|469445828|FG004|Overall Study|Protocol Violation|0|||
130404443|NCT01602315|469445829|FG005|Overall Study|Protocol Violation|1|||
130404444|NCT01602315|469445830|FG006|Overall Study|Protocol Violation|0|||
130404445|NCT01602315|469445824|FG000|Overall Study|Physician Decision|2|||
130404446|NCT01602315|469445825|FG001|Overall Study|Physician Decision|0|||
130404447|NCT01602315|469445826|FG002|Overall Study|Physician Decision|0|||
130404448|NCT01602315|469445827|FG003|Overall Study|Physician Decision|0|||
130404449|NCT01602315|469445828|FG004|Overall Study|Physician Decision|2|||
130404450|NCT01602315|469445829|FG005|Overall Study|Physician Decision|1|||
130404451|NCT01602315|469445830|FG006|Overall Study|Physician Decision|1|||
130404452|NCT01602315|469445824|FG000|Overall Study|Disease progression|6|||
130404453|NCT01602315|469445825|FG001|Overall Study|Disease progression|3|||
130404454|NCT01602315|469445826|FG002|Overall Study|Disease progression|10|||
130404455|NCT01602315|469445827|FG003|Overall Study|Disease progression|1|||
130404456|NCT01602315|469445828|FG004|Overall Study|Disease progression|41|||
130404457|NCT01602315|469445829|FG005|Overall Study|Disease progression|12|||
130404458|NCT01602315|469445830|FG006|Overall Study|Disease progression|15|||
130404459|NCT01602315|469445824|FG000|Overall Study|Death|1|||
130404460|NCT01602315|469445825|FG001|Overall Study|Death|1|||
130404461|NCT01602315|469445826|FG002|Overall Study|Death|1|||
130404462|NCT01602315|469445827|FG003|Overall Study|Death|1|||
130404463|NCT01602315|469445828|FG004|Overall Study|Death|7|||
130404464|NCT01602315|469445829|FG005|Overall Study|Death|2|||
130404465|NCT01602315|469445830|FG006|Overall Study|Death|2|||
130404466|NCT01602315|469445824|FG000|Overall Study|Withdrawal by Subject|2|||
130404467|NCT01602315|469445825|FG001|Overall Study|Withdrawal by Subject|0|||
130404468|NCT01602315|469445826|FG002|Overall Study|Withdrawal by Subject|2|||
130404469|NCT01602315|469445827|FG003|Overall Study|Withdrawal by Subject|0|||
130404470|NCT01602315|469445828|FG004|Overall Study|Withdrawal by Subject|6|||
130404471|NCT01602315|469445829|FG005|Overall Study|Withdrawal by Subject|0|||
130404472|NCT01602315|469445830|FG006|Overall Study|Withdrawal by Subject|1|||
130404473|NCT01602315|469445824|FG000|Overall Study|Adverse Event|5|||
130404474|NCT01602315|469445825|FG001|Overall Study|Adverse Event|1|||
130404475|NCT01602315|469445826|FG002|Overall Study|Adverse Event|5|||
130404476|NCT01602315|469445827|FG003|Overall Study|Adverse Event|4|||
130404477|NCT01602315|469445828|FG004|Overall Study|Adverse Event|15|||
130404478|NCT01602315|469445829|FG005|Overall Study|Adverse Event|3|||
130404479|NCT01602315|469445830|FG006|Overall Study|Adverse Event|9|||
130404480|NCT01602315|469445824|FG000|Overall Study|Subject/guardian decision|0|||
130404481|NCT01602315|469445825|FG001|Overall Study|Subject/guardian decision|0|||
130404482|NCT01602315|469445826|FG002|Overall Study|Subject/guardian decision|0|||
130404483|NCT01602315|469445827|FG003|Overall Study|Subject/guardian decision|0|||
130404484|NCT01602315|469445828|FG004|Overall Study|Subject/guardian decision|0|||
130404485|NCT01602315|469445829|FG005|Overall Study|Subject/guardian decision|0|||
130404486|NCT01602315|469445830|FG006|Overall Study|Subject/guardian decision|1|||
130404487|NCT01602315|469445824|FG000|Overall Study|Cross-over patients to combo treatment|0|||
130404488|NCT01602315|469445825|FG001|Overall Study|Cross-over patients to combo treatment|0|||
130404489|NCT01602315|469445826|FG002|Overall Study|Cross-over patients to combo treatment|0|||
130404490|NCT01602315|469445827|FG003|Overall Study|Cross-over patients to combo treatment|0|||
130404491|NCT01602315|469445828|FG004|Overall Study|Cross-over patients to combo treatment|0|||
130404492|NCT01602315|469445829|FG005|Overall Study|Cross-over patients to combo treatment|16|||
130404493|NCT01602315|469445830|FG006|Overall Study|Cross-over patients to combo treatment|0|||
130404494|NCT02212730|469445833|FG000|Overall Study|Tumor not of the required cell histology|1|||
130404495|NCT02212730|469445834|FG001|Overall Study|Tumor not of the required cell histology|0|||
130404496|NCT02212730|469445833|FG000|Overall Study|Withdrawal by Subject|1|||
130471293|NCT03857620|469692634|FG001|Overall Study|No malignancy|0|||
130471294|NCT03857620|469692635|FG002|Overall Study|No malignancy|1|||
130404497|NCT02212730|469445834|FG001|Overall Study|Withdrawal by Subject|0|||
130404498|NCT02212730|469445833|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
130404499|NCT02212730|469445834|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
130404500|NCT02880371|469445835|FG000|Phase 1b|Lost to Follow-up|1|||
130471295|NCT03857620|469692633|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
130404501|NCT02880371|469445836|FG001|Phase 1b|Lost to Follow-up|0|||
130404502|NCT02880371|469445837|FG002|Phase 1b|Lost to Follow-up|0|||
130404503|NCT02880371|469445838|FG003|Phase 1b|Lost to Follow-up|0|||
130404504|NCT02880371|469445839|FG004|Phase 1b|Lost to Follow-up|0|||
130724734|NCT00741286|470617010|FG001|Overall Study|Protocol Violation|2|||
130724735|NCT00741286|470617009|FG000|Overall Study|Primary Outcome|1|||
130724736|NCT00741286|470617010|FG001|Overall Study|Primary Outcome|1|||
130724737|NCT01831258|470617011|FG000|Overall Study|Withdrawal by Subject|2|||
130724738|NCT01831258|470617012|FG001|Overall Study|Withdrawal by Subject|1|||
130724739|NCT01831258|470617011|FG000|Overall Study|Lost to Follow-up|3|||
130404505|NCT02880371|469445840|FG005|Phase 1b|Lost to Follow-up|0|||
130404506|NCT02880371|469445841|FG006|Phase 1b|Lost to Follow-up|0|||
130404507|NCT02880371|469445842|FG007|Phase 1b|Lost to Follow-up|0|||
130404508|NCT02880371|469445835|FG000|Phase 1b|Participants terminated by Sponsor|1|||
130404509|NCT02880371|469445836|FG001|Phase 1b|Participants terminated by Sponsor|0|||
130404510|NCT02880371|469445837|FG002|Phase 1b|Participants terminated by Sponsor|0|||
130404511|NCT02880371|469445838|FG003|Phase 1b|Participants terminated by Sponsor|0|||
130404512|NCT02880371|469445839|FG004|Phase 1b|Participants terminated by Sponsor|0|||
130404513|NCT02880371|469445840|FG005|Phase 1b|Participants terminated by Sponsor|0|||
130404514|NCT02880371|469445841|FG006|Phase 1b|Participants terminated by Sponsor|0|||
130404515|NCT02880371|469445842|FG007|Phase 1b|Participants terminated by Sponsor|0|||
130404516|NCT02880371|469445835|FG000|Phase 1b|Withdrawal by Subject|0|||
130404517|NCT02880371|469445836|FG001|Phase 1b|Withdrawal by Subject|0|||
130404518|NCT02880371|469445837|FG002|Phase 1b|Withdrawal by Subject|1|||
130404519|NCT02880371|469445838|FG003|Phase 1b|Withdrawal by Subject|0|||
130404520|NCT02880371|469445839|FG004|Phase 1b|Withdrawal by Subject|0|||
130404521|NCT02880371|469445840|FG005|Phase 1b|Withdrawal by Subject|0|||
130404522|NCT02880371|469445841|FG006|Phase 1b|Withdrawal by Subject|0|||
130404523|NCT02880371|469445842|FG007|Phase 1b|Withdrawal by Subject|0|||
130404524|NCT02880371|469445835|FG000|Phase 1b|Death|4|||
130404525|NCT02880371|469445836|FG001|Phase 1b|Death|6|||
130404526|NCT02880371|469445837|FG002|Phase 1b|Death|5|||
130404527|NCT02880371|469445838|FG003|Phase 1b|Death|1|||
130404528|NCT02880371|469445839|FG004|Phase 1b|Death|0|||
130404529|NCT02880371|469445840|FG005|Phase 1b|Death|0|||
130404530|NCT02880371|469445841|FG006|Phase 1b|Death|0|||
130404531|NCT02880371|469445842|FG007|Phase 1b|Death|0|||
130404532|NCT02880371|469445835|FG000|Phase 1b|Enrolled but not Treated|0|||
130404533|NCT02880371|469445836|FG001|Phase 1b|Enrolled but not Treated|1|||
130404534|NCT02880371|469445837|FG002|Phase 1b|Enrolled but not Treated|0|||
130404535|NCT02880371|469445838|FG003|Phase 1b|Enrolled but not Treated|0|||
130404536|NCT02880371|469445839|FG004|Phase 1b|Enrolled but not Treated|0|||
130404537|NCT02880371|469445840|FG005|Phase 1b|Enrolled but not Treated|0|||
130404538|NCT02880371|469445841|FG006|Phase 1b|Enrolled but not Treated|0|||
130404539|NCT02880371|469445842|FG007|Phase 1b|Enrolled but not Treated|0|||
130404540|NCT02880371|469445835|FG000|Phase 2|Enrolled but not Treated|0|||
130404541|NCT02880371|469445836|FG001|Phase 2|Enrolled but not Treated|0|||
130404542|NCT02880371|469445837|FG002|Phase 2|Enrolled but not Treated|0|||
130404543|NCT02880371|469445838|FG003|Phase 2|Enrolled but not Treated|0|||
130404544|NCT02880371|469445839|FG004|Phase 2|Enrolled but not Treated|0|||
130404545|NCT02880371|469445840|FG005|Phase 2|Enrolled but not Treated|1|||
130404546|NCT02880371|469445841|FG006|Phase 2|Enrolled but not Treated|1|||
130404547|NCT02880371|469445842|FG007|Phase 2|Enrolled but not Treated|0|||
130404548|NCT02880371|469445835|FG000|Phase 2|Other|0|||
130404549|NCT02880371|469445836|FG001|Phase 2|Other|0|||
130404550|NCT02880371|469445837|FG002|Phase 2|Other|0|||
130404551|NCT02880371|469445838|FG003|Phase 2|Other|0|||
130404552|NCT02880371|469445839|FG004|Phase 2|Other|0|||
130404553|NCT02880371|469445840|FG005|Phase 2|Other|1|||
130404554|NCT02880371|469445841|FG006|Phase 2|Other|2|||
130404555|NCT02880371|469445842|FG007|Phase 2|Other|1|||
130404556|NCT02880371|469445835|FG000|Phase 2|Participants terminated by Sponsor|0|||
130404557|NCT02880371|469445836|FG001|Phase 2|Participants terminated by Sponsor|0|||
130404558|NCT02880371|469445837|FG002|Phase 2|Participants terminated by Sponsor|0|||
130404559|NCT02880371|469445838|FG003|Phase 2|Participants terminated by Sponsor|0|||
130404560|NCT02880371|469445839|FG004|Phase 2|Participants terminated by Sponsor|1|||
130404561|NCT02880371|469445840|FG005|Phase 2|Participants terminated by Sponsor|6|||
130404562|NCT02880371|469445841|FG006|Phase 2|Participants terminated by Sponsor|1|||
130404563|NCT02880371|469445842|FG007|Phase 2|Participants terminated by Sponsor|5|||
130724740|NCT01831258|470617012|FG001|Overall Study|Lost to Follow-up|2|||
130724741|NCT02564887|470617013|FG000|Overall Study|Lost to Follow-up|6|||
130404564|NCT02880371|469445835|FG000|Phase 2|Death|0|||
130404565|NCT02880371|469445836|FG001|Phase 2|Death|0|||
130404566|NCT02880371|469445837|FG002|Phase 2|Death|0|||
130404567|NCT02880371|469445838|FG003|Phase 2|Death|0|||
130404568|NCT02880371|469445839|FG004|Phase 2|Death|1|||
130404569|NCT02880371|469445840|FG005|Phase 2|Death|10|||
130404570|NCT02880371|469445841|FG006|Phase 2|Death|20|||
130404571|NCT02880371|469445842|FG007|Phase 2|Death|5|||
130404572|NCT02880371|469445835|FG000|Phase 2|Lost to Follow-up|0|||
130724742|NCT02564887|470617014|FG001|Overall Study|Lost to Follow-up|0|||
130404573|NCT02880371|469445836|FG001|Phase 2|Lost to Follow-up|0|||
130404574|NCT02880371|469445837|FG002|Phase 2|Lost to Follow-up|0|||
130404575|NCT02880371|469445838|FG003|Phase 2|Lost to Follow-up|0|||
130404576|NCT02880371|469445839|FG004|Phase 2|Lost to Follow-up|0|||
130404577|NCT02880371|469445840|FG005|Phase 2|Lost to Follow-up|0|||
130404578|NCT02880371|469445841|FG006|Phase 2|Lost to Follow-up|3|||
130404579|NCT02880371|469445842|FG007|Phase 2|Lost to Follow-up|0|||
130404580|NCT02880371|469445835|FG000|Phase 2|Withdrawal by Subject|0|||
130404581|NCT02880371|469445836|FG001|Phase 2|Withdrawal by Subject|0|||
130404582|NCT02880371|469445837|FG002|Phase 2|Withdrawal by Subject|0|||
130404583|NCT02880371|469445838|FG003|Phase 2|Withdrawal by Subject|0|||
130404584|NCT02880371|469445839|FG004|Phase 2|Withdrawal by Subject|0|||
130404585|NCT02880371|469445840|FG005|Phase 2|Withdrawal by Subject|1|||
130404586|NCT02880371|469445841|FG006|Phase 2|Withdrawal by Subject|1|||
130404587|NCT02880371|469445842|FG007|Phase 2|Withdrawal by Subject|0|||
130404588|NCT02880371|469445835|FG000|Phase 2|End of Study page not completed by error|0|||
130404589|NCT02880371|469445836|FG001|Phase 2|End of Study page not completed by error|0|||
130404590|NCT02880371|469445837|FG002|Phase 2|End of Study page not completed by error|0|||
130404591|NCT02880371|469445838|FG003|Phase 2|End of Study page not completed by error|0|||
130404592|NCT02880371|469445839|FG004|Phase 2|End of Study page not completed by error|0|||
130404593|NCT02880371|469445840|FG005|Phase 2|End of Study page not completed by error|1|||
130404594|NCT02880371|469445841|FG006|Phase 2|End of Study page not completed by error|0|||
130404595|NCT02880371|469445842|FG007|Phase 2|End of Study page not completed by error|0|||
130404596|NCT01777997|469445845|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
130404597|NCT01777997|469445845|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
130404598|NCT01777997|469445845|FG000|Weeks 48 to 72/96 on ART|Death|1|||
130404599|NCT01777997|469445845|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
130404600|NCT02932891|469445846|FG000|Overall Study|Lost to Follow-up|2|||
130404601|NCT02932891|469445846|FG000|Overall Study|HPA Suppress|2|||
130404602|NCT00451282|469445847|FG000|Overall Study|Lost to Follow-up|6|||
130404603|NCT00451282|469445848|FG001|Overall Study|Lost to Follow-up|5|||
130404604|NCT00577122|469445849|FG000|Overall Study|Adverse Event|0|||
130404605|NCT00577122|469445850|FG001|Overall Study|Adverse Event|2|||
130404606|NCT00577122|469445849|FG000|Overall Study|Progression, relapse during active trt|6|||
130404607|NCT00577122|469445850|FG001|Overall Study|Progression, relapse during active trt|8|||
130404608|NCT00577122|469445849|FG000|Overall Study|Prog, refract disease during active trt|8|||
130404609|NCT00577122|469445850|FG001|Overall Study|Prog, refract disease during active trt|5|||
130404610|NCT00577122|469445849|FG000|Overall Study|Alternative Therapy|0|||
130404611|NCT00577122|469445850|FG001|Overall Study|Alternative Therapy|1|||
130404612|NCT00529386|469445859|FG000|Overall Study|Lost to Follow-up|1|||
130404613|NCT04532112|469445860|FG000|Overall Study|Adverse Event|3|||
130404614|NCT04532112|469445861|FG001|Overall Study|Adverse Event|0|||
130404615|NCT02992899|469445862|FG000|Overall Study|Withdrawal by Subject|1|||
130404616|NCT02992899|469445863|FG001|Overall Study|Withdrawal by Subject|0|||
130404617|NCT02992899|469445862|FG000|Overall Study|Lost to Follow-up|1|||
130404618|NCT02992899|469445863|FG001|Overall Study|Lost to Follow-up|3|||
130404619|NCT02738775|469445864|FG000|Overall Study|Withdrawal by Subject|0|||
130404620|NCT02738775|469445865|FG001|Overall Study|Withdrawal by Subject|1|||
130404621|NCT02738775|469445866|FG002|Overall Study|Withdrawal by Subject|0|||
130404622|NCT02738775|469445867|FG003|Overall Study|Withdrawal by Subject|0|||
130404623|NCT02738775|469445868|FG004|Overall Study|Withdrawal by Subject|0|||
130404624|NCT02738775|469445869|FG005|Overall Study|Withdrawal by Subject|0|||
130404625|NCT02738775|469445864|FG000|Overall Study|Adverse Event|0|||
130404626|NCT02738775|469445865|FG001|Overall Study|Adverse Event|0|||
130404627|NCT02738775|469445866|FG002|Overall Study|Adverse Event|0|||
130404628|NCT02738775|469445867|FG003|Overall Study|Adverse Event|1|||
130404629|NCT02738775|469445868|FG004|Overall Study|Adverse Event|0|||
130404630|NCT02738775|469445869|FG005|Overall Study|Adverse Event|0|||
130404631|NCT02738775|469445864|FG000|Overall Study|Pregnancy|0|||
130404632|NCT02738775|469445865|FG001|Overall Study|Pregnancy|1|||
130404633|NCT02738775|469445866|FG002|Overall Study|Pregnancy|0|||
130404634|NCT02738775|469445867|FG003|Overall Study|Pregnancy|0|||
130404635|NCT02738775|469445868|FG004|Overall Study|Pregnancy|0|||
130404636|NCT02738775|469445869|FG005|Overall Study|Pregnancy|0|||
130404637|NCT02738775|469445864|FG000|Overall Study|Missing|0|||
130404638|NCT02738775|469445865|FG001|Overall Study|Missing|0|||
130404639|NCT02738775|469445866|FG002|Overall Study|Missing|0|||
130471296|NCT03857620|469692634|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
130471297|NCT03857620|469692635|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
130724743|NCT01851330|470617015|FG000|Overall Study|Lack of Efficacy|10|||
130404640|NCT02738775|469445867|FG003|Overall Study|Missing|0|||
130404641|NCT02738775|469445868|FG004|Overall Study|Missing|0|||
130404642|NCT02738775|469445869|FG005|Overall Study|Missing|1|||
130404643|NCT02370888|469445870|FG000|Overall Study|disease progression|2|||
130471298|NCT03857620|469692633|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
130404644|NCT02370888|469445870|FG000|Overall Study|did not meet chimerism criteria|6|||
130404645|NCT04574362|469445871|FG000|Overall Study|Other|0|||
130404646|NCT04574362|469445872|FG001|Overall Study|Other|5|||
130404647|NCT04574362|469445871|FG000|Overall Study|COVID-19|0|||
130404648|NCT04574362|469445872|FG001|Overall Study|COVID-19|1|||
130404649|NCT04574362|469445871|FG000|Overall Study|Adverse Event|1|||
130404650|NCT04574362|469445872|FG001|Overall Study|Adverse Event|1|||
130404651|NCT04574362|469445871|FG000|Overall Study|Withdrawal by Subject|2|||
130404652|NCT04574362|469445872|FG001|Overall Study|Withdrawal by Subject|4|||
130404653|NCT04574362|469445871|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
130404654|NCT04574362|469445872|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
130404655|NCT04574362|469445871|FG000|Overall Study|Participant refused to come to the hospital|1|||
130404656|NCT04574362|469445872|FG001|Overall Study|Participant refused to come to the hospital|0|||
130404657|NCT04574362|469445871|FG000|Overall Study|Participant refused the visit|1|||
130404658|NCT04574362|469445872|FG001|Overall Study|Participant refused the visit|0|||
130404659|NCT04574362|469445871|FG000|Overall Study|Participant quit early because of business trip|1|||
130404660|NCT04574362|469445872|FG001|Overall Study|Participant quit early because of business trip|0|||
130404661|NCT01060384|469445873|FG000|Overall Study|Withdrawal by Subject|0|||
130404662|NCT01060384|469445874|FG001|Overall Study|Withdrawal by Subject|1|||
130404663|NCT01060384|469445875|FG002|Overall Study|Withdrawal by Subject|0|||
130404664|NCT01060384|469445876|FG003|Overall Study|Withdrawal by Subject|0|||
130404665|NCT01060384|469445877|FG004|Overall Study|Withdrawal by Subject|0|||
130404666|NCT01060384|469445873|FG000|Overall Study|Death|0|||
130404667|NCT01060384|469445874|FG001|Overall Study|Death|0|||
130404668|NCT01060384|469445875|FG002|Overall Study|Death|0|||
130404669|NCT01060384|469445876|FG003|Overall Study|Death|0|||
130404670|NCT01060384|469445877|FG004|Overall Study|Death|1|||
130404671|NCT01060384|469445873|FG000|Overall Study|Intercurrent illness|0|||
130404672|NCT01060384|469445874|FG001|Overall Study|Intercurrent illness|0|||
130404673|NCT01060384|469445875|FG002|Overall Study|Intercurrent illness|0|||
130404674|NCT01060384|469445876|FG003|Overall Study|Intercurrent illness|0|||
130404675|NCT01060384|469445877|FG004|Overall Study|Intercurrent illness|1|||
130404676|NCT00812929|469445881|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
130404677|NCT00812929|469445882|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
130404678|NCT00812929|469445883|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
130404679|NCT00812929|469445884|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
130404680|NCT00812929|469445885|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
130404681|NCT00812929|469445886|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
130404682|NCT00812929|469445887|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
130404683|NCT00812929|469445888|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
130404684|NCT00812929|469445889|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
130404685|NCT00812929|469445890|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
130404686|NCT00812929|469445881|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
130404687|NCT00812929|469445882|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
130404688|NCT00812929|469445883|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
130404689|NCT00812929|469445884|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
130404690|NCT00812929|469445885|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
130404691|NCT00812929|469445886|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
130404692|NCT00812929|469445887|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
130404693|NCT00812929|469445888|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
130404694|NCT00812929|469445889|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
130404695|NCT00812929|469445890|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
130404696|NCT00812929|469445881|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
130404697|NCT00812929|469445882|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
130404698|NCT00812929|469445883|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
130404699|NCT00812929|469445884|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
130404700|NCT00812929|469445885|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
130404701|NCT00812929|469445886|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
130404702|NCT00812929|469445887|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
130404703|NCT00812929|469445888|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
130724744|NCT01851330|470617016|FG001|Overall Study|Lack of Efficacy|9|||
130724745|NCT01851330|470617017|FG002|Overall Study|Lack of Efficacy|2|||
130404704|NCT00812929|469445889|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
130404705|NCT00812929|469445890|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
130404706|NCT00211081|469445891|FG000|Overall Study|Withdrawal by Subject|2|||
130404707|NCT01332305|469445892|FG000|Overall Study|Adverse Event|1|||
130404708|NCT01332305|469445893|FG001|Overall Study|Adverse Event|4|||
130404709|NCT01332305|469445894|FG002|Overall Study|Adverse Event|6|||
130404710|NCT01332305|469445895|FG003|Overall Study|Adverse Event|3|||
130404711|NCT01332305|469445896|FG004|Overall Study|Adverse Event|5|||
130724746|NCT01851330|470617015|FG000|Overall Study|Lost to Follow-up|1|||
130404712|NCT01332305|469445892|FG000|Overall Study|Withdrawal by Subject|6|||
130404713|NCT01332305|469445893|FG001|Overall Study|Withdrawal by Subject|5|||
130404714|NCT01332305|469445894|FG002|Overall Study|Withdrawal by Subject|4|||
130404715|NCT01332305|469445895|FG003|Overall Study|Withdrawal by Subject|1|||
130404716|NCT01332305|469445896|FG004|Overall Study|Withdrawal by Subject|0|||
130404717|NCT01332305|469445892|FG000|Overall Study|Lost to Follow-up|0|||
130471299|NCT03857620|469692634|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
130471300|NCT03857620|469692635|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
130471301|NCT03857620|469692633|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
130404718|NCT01332305|469445893|FG001|Overall Study|Lost to Follow-up|2|||
130404719|NCT01332305|469445894|FG002|Overall Study|Lost to Follow-up|3|||
130404720|NCT01332305|469445895|FG003|Overall Study|Lost to Follow-up|2|||
130404721|NCT01332305|469445896|FG004|Overall Study|Lost to Follow-up|3|||
130404722|NCT01332305|469445892|FG000|Overall Study|Protocol Violation|1|||
130404723|NCT01332305|469445893|FG001|Overall Study|Protocol Violation|2|||
130404724|NCT01332305|469445894|FG002|Overall Study|Protocol Violation|1|||
130404725|NCT01332305|469445895|FG003|Overall Study|Protocol Violation|0|||
130404726|NCT01332305|469445896|FG004|Overall Study|Protocol Violation|3|||
130404727|NCT01332305|469445892|FG000|Overall Study|Withdrawal by Sponsor|1|||
130404728|NCT01332305|469445893|FG001|Overall Study|Withdrawal by Sponsor|0|||
130404729|NCT01332305|469445894|FG002|Overall Study|Withdrawal by Sponsor|0|||
130404730|NCT01332305|469445895|FG003|Overall Study|Withdrawal by Sponsor|1|||
130404731|NCT01332305|469445896|FG004|Overall Study|Withdrawal by Sponsor|1|||
130404732|NCT01332305|469445892|FG000|Overall Study|Treatment Failure|1|||
130404733|NCT01332305|469445893|FG001|Overall Study|Treatment Failure|1|||
130404734|NCT01332305|469445894|FG002|Overall Study|Treatment Failure|0|||
130404735|NCT01332305|469445895|FG003|Overall Study|Treatment Failure|0|||
130404736|NCT01332305|469445896|FG004|Overall Study|Treatment Failure|0|||
130404737|NCT01332305|469445892|FG000|Overall Study|Physician Decision|0|||
130404738|NCT01332305|469445893|FG001|Overall Study|Physician Decision|0|||
130404739|NCT01332305|469445894|FG002|Overall Study|Physician Decision|0|||
130404740|NCT01332305|469445895|FG003|Overall Study|Physician Decision|1|||
130404741|NCT01332305|469445896|FG004|Overall Study|Physician Decision|0|||
130404742|NCT01600040|469445897|FG000|Overall Study|Withdrawal by Subject|1|||
130404743|NCT04027686|469445898|FG000|Overall Study|Lost to Follow-up|2|||
130404744|NCT04027686|469445899|FG001|Overall Study|Lost to Follow-up|0|||
130404745|NCT04027686|469445898|FG000|Overall Study|Withdrawal by Subject|0|||
130404746|NCT04027686|469445899|FG001|Overall Study|Withdrawal by Subject|1|||
130404747|NCT03755765|469445905|FG000|Overall Study|Withdrawal by Subject|2|||
130404748|NCT03755765|469445906|FG001|Overall Study|Withdrawal by Subject|4|||
130404749|NCT03755765|469445907|FG002|Overall Study|Withdrawal by Subject|4|||
130404750|NCT02104557|469445908|FG000|Overall Study|Adverse Event|24|||
130404751|NCT02104557|469445908|FG000|Overall Study|Lost to Follow-up|34|||
130404752|NCT02104557|469445908|FG000|Overall Study|Violated the usage and dosage|14|||
130404753|NCT02104557|469445908|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
130404754|NCT02104557|469445908|FG000|Overall Study|Administered Sayana prior to the contract|1|||
130404755|NCT02104557|469445908|FG000|Overall Study|Other|17|||
130404756|NCT02104557|469445908|FG000|Overall Study|Change to other contraception methods|5|||
130404757|NCT02104557|469445908|FG000|Overall Study|Discontinuation due to no pain|1|||
130404758|NCT02104557|469445908|FG000|Overall Study|Withdrawal consent|2|||
130404759|NCT02104557|469445908|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
130404760|NCT02104557|469445908|FG000|Overall Study|Discontinuation of contraception|9|||
130404761|NCT00111228|469445912|FG000|Overall Study|Withdrawal by Subject|5|||
130404762|NCT00111228|469445913|FG001|Overall Study|Withdrawal by Subject|1|||
130404763|NCT00111228|469445914|FG002|Overall Study|Withdrawal by Subject|0|||
130404764|NCT00678691|469445915|FG000|Overall Study|Adverse Event|6|||
130404765|NCT00678691|469445916|FG001|Overall Study|Adverse Event|4|||
130404766|NCT02178475|469445923|FG000|Overall Study|Withdrawal by Subject|7|||
130404767|NCT02178475|469445923|FG000|Overall Study|Lost to Follow-up|10|||
130404768|NCT02178475|469445923|FG000|Overall Study|Death|13|||
130404769|NCT02178475|469445923|FG000|Overall Study|Protocol-specified Criteria|99|||
130404770|NCT00779766|469445924|FG000|Month 24|Serious Adverse Event|2|||
130404771|NCT00779766|469445925|FG001|Month 24|Serious Adverse Event|3|||
130404772|NCT00779766|469445924|FG000|Month 24|Adverse Event|3|||
130404773|NCT00779766|469445925|FG001|Month 24|Adverse Event|3|||
130404774|NCT00779766|469445924|FG000|Month 24|Protocol Violation|3|||
130404775|NCT00779766|469445925|FG001|Month 24|Protocol Violation|1|||
130404776|NCT00779766|469445924|FG000|Month 24|Withdrawal by Subject|159|||
130404777|NCT00779766|469445925|FG001|Month 24|Withdrawal by Subject|127|||
130404778|NCT00779766|469445924|FG000|Month 24|Migrated/moved from study area|138|||
130404779|NCT00779766|469445925|FG001|Month 24|Migrated/moved from study area|162|||
130404780|NCT00779766|469445924|FG000|Month 24|Lost to Follow-up|9|||
130404781|NCT00779766|469445925|FG001|Month 24|Lost to Follow-up|9|||
130404782|NCT00779766|469445924|FG000|Month 24|Other|18|||
130404783|NCT00779766|469445925|FG001|Month 24|Other|27|||
130404784|NCT00779766|469445924|FG000|Month 48|Withdrawal by Subject|68|||
130561027|NCT03250832|470022783|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130404785|NCT00779766|469445925|FG001|Month 48|Withdrawal by Subject|63|||
130404786|NCT00779766|469445924|FG000|Month 48|Migrated/moved from study area|76|||
130404787|NCT00779766|469445925|FG001|Month 48|Migrated/moved from study area|75|||
130404788|NCT00779766|469445924|FG000|Month 48|Lost to Follow-up|29|||
130404789|NCT00779766|469445925|FG001|Month 48|Lost to Follow-up|30|||
130404790|NCT00779766|469445924|FG000|Month 48|Other|1|||
130404791|NCT00779766|469445925|FG001|Month 48|Other|0|||
130404792|NCT00779766|469445924|FG000|Month 72|Withdrawal by Subject|55|||
130404793|NCT00779766|469445925|FG001|Month 72|Withdrawal by Subject|71|||
130404794|NCT00779766|469445924|FG000|Month 72|Migrated/moved from study area|124|||
130404795|NCT00779766|469445925|FG001|Month 72|Migrated/moved from study area|109|||
130404796|NCT00779766|469445924|FG000|Month 72|Lost to Follow-up|6|||
130404797|NCT00779766|469445925|FG001|Month 72|Lost to Follow-up|8|||
130561028|NCT03250832|470022784|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561029|NCT03250832|470022785|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561030|NCT03250832|470022786|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561031|NCT03250832|470022787|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
130561032|NCT03250832|470022788|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561033|NCT03250832|470022789|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561034|NCT03250832|470022790|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561035|NCT03250832|470022791|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130561036|NCT03250832|470022780|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561037|NCT03250832|470022781|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561038|NCT03250832|470022782|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561039|NCT03250832|470022783|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561040|NCT03250832|470022784|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561041|NCT03250832|470022785|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561042|NCT03250832|470022786|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561043|NCT03250832|470022787|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
130561044|NCT03250832|470022788|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561045|NCT03250832|470022789|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561046|NCT03250832|470022790|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561047|NCT03250832|470022791|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130561048|NCT03250832|470022780|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561049|NCT03250832|470022781|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561050|NCT03250832|470022782|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561051|NCT03250832|470022783|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561052|NCT03250832|470022784|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561053|NCT03250832|470022785|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561054|NCT03250832|470022786|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561055|NCT03250832|470022787|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
130404798|NCT00779766|469445924|FG000|Month 72|Other|0|||
130404799|NCT00779766|469445925|FG001|Month 72|Other|1|||
130404800|NCT01412424|469445926|FG000|Core Treatment Period|Treatment Failure|24|||
130404801|NCT01412424|469445926|FG000|Core Treatment Period|Adverse Event|21|||
130404802|NCT01412424|469445926|FG000|Core Treatment Period|Patient Request|5|||
130404803|NCT01412424|469445926|FG000|Core Treatment Period|Lost to Follow-up|2|||
130404804|NCT01412424|469445926|FG000|Core Treatment Period|Sponsor Request|1|||
130404805|NCT01412424|469445926|FG000|Extension Treatment Period|Adverse Event|2|||
130404806|NCT01412424|469445926|FG000|Extension Treatment Period|Treatment Failure|2|||
130404807|NCT01412424|469445926|FG000|Extension Treatment Period|Patient Request|2|||
130404808|NCT03235024|469445932|FG000|Overall Study|Adverse Event|2|||
130404809|NCT03235024|469445933|FG001|Overall Study|Adverse Event|2|||
130404810|NCT03235024|469445932|FG000|Overall Study|Death|1|||
130404811|NCT03235024|469445933|FG001|Overall Study|Death|0|||
130404812|NCT03235024|469445932|FG000|Overall Study|Lost to Follow-up|2|||
130404813|NCT03235024|469445933|FG001|Overall Study|Lost to Follow-up|5|||
130404814|NCT03235024|469445932|FG000|Overall Study|Protocol Violation|1|||
130404815|NCT03235024|469445933|FG001|Overall Study|Protocol Violation|0|||
130404816|NCT03235024|469445932|FG000|Overall Study|Withdrawal by Subject|0|||
130404817|NCT03235024|469445933|FG001|Overall Study|Withdrawal by Subject|3|||
130404818|NCT00414050|469445934|FG000|Overall Study|Adverse Event|1|||
130404819|NCT00414050|469445935|FG001|Overall Study|Adverse Event|1|||
130404820|NCT00414050|469445936|FG002|Overall Study|Adverse Event|1|||
130404821|NCT00414050|469445937|FG003|Overall Study|Adverse Event|1|||
130404822|NCT00414050|469445934|FG000|Overall Study|Lost to Follow-up|2|||
130404823|NCT00414050|469445935|FG001|Overall Study|Lost to Follow-up|2|||
130404824|NCT00414050|469445936|FG002|Overall Study|Lost to Follow-up|1|||
130404825|NCT00414050|469445937|FG003|Overall Study|Lost to Follow-up|1|||
130404826|NCT00414050|469445934|FG000|Overall Study|Withdrawal by Subject|5|||
130404827|NCT00414050|469445935|FG001|Overall Study|Withdrawal by Subject|3|||
130404828|NCT00414050|469445936|FG002|Overall Study|Withdrawal by Subject|2|||
130404829|NCT00414050|469445937|FG003|Overall Study|Withdrawal by Subject|4|||
130404830|NCT00414050|469445934|FG000|Overall Study|Subject discontinued for other reason|1|||
130724747|NCT01851330|470617016|FG001|Overall Study|Lost to Follow-up|6|||
130724748|NCT01851330|470617017|FG002|Overall Study|Lost to Follow-up|9|||
130724749|NCT01851330|470617015|FG000|Overall Study|Withdrew Consent|2|||
130724750|NCT01851330|470617016|FG001|Overall Study|Withdrew Consent|1|||
130404831|NCT00414050|469445935|FG001|Overall Study|Subject discontinued for other reason|2|||
130404832|NCT00414050|469445936|FG002|Overall Study|Subject discontinued for other reason|2|||
130724751|NCT01851330|470617017|FG002|Overall Study|Withdrew Consent|0|||
130404833|NCT00414050|469445937|FG003|Overall Study|Subject discontinued for other reason|1|||
130404834|NCT00414050|469445934|FG000|Overall Study|Subject Moved|0|||
130404835|NCT00414050|469445935|FG001|Overall Study|Subject Moved|0|||
130404836|NCT00414050|469445936|FG002|Overall Study|Subject Moved|0|||
130404837|NCT00414050|469445937|FG003|Overall Study|Subject Moved|1|||
130471302|NCT03857620|469692634|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
130471303|NCT03857620|469692635|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
130471304|NCT03857620|469692633|FG000|Overall Study|Surgery not performed, patient decision|0|||
130471305|NCT03857620|469692634|FG001|Overall Study|Surgery not performed, patient decision|3|||
130471306|NCT03857620|469692635|FG002|Overall Study|Surgery not performed, patient decision|1|||
130471307|NCT03857620|469692633|FG000|Overall Study|Surgery not performed, other reason|3|||
130471308|NCT03857620|469692634|FG001|Overall Study|Surgery not performed, other reason|1|||
130471309|NCT03857620|469692635|FG002|Overall Study|Surgery not performed, other reason|4|||
130471310|NCT03857620|469692633|FG000|Overall Study|Worsening performance status after surgery performed|0|||
130471311|NCT03857620|469692634|FG001|Overall Study|Worsening performance status after surgery performed|1|||
130471312|NCT03857620|469692635|FG002|Overall Study|Worsening performance status after surgery performed|1|||
130471313|NCT02473250|469692636|FG000|Overall Study|Lost to Follow-up|10|||
130471314|NCT02473250|469692636|FG000|Overall Study|Physician Decision|5|||
130404838|NCT03304379|469445942|FG000|Overall Study|Protocol Violation|8|||
130404839|NCT03304379|469445943|FG001|Overall Study|Protocol Violation|10|||
130404840|NCT03304379|469445944|FG002|Overall Study|Protocol Violation|5|||
130404841|NCT03304379|469445945|FG003|Overall Study|Protocol Violation|0|||
130404842|NCT03304379|469445946|FG004|Overall Study|Protocol Violation|2|||
130404843|NCT03304379|469445942|FG000|Overall Study|Adverse Event|4|||
130404844|NCT03304379|469445943|FG001|Overall Study|Adverse Event|20|||
130404845|NCT03304379|469445944|FG002|Overall Study|Adverse Event|17|||
130404846|NCT03304379|469445945|FG003|Overall Study|Adverse Event|1|||
130404847|NCT03304379|469445946|FG004|Overall Study|Adverse Event|0|||
130404848|NCT03304379|469445942|FG000|Overall Study|Lack of Efficacy|17|||
130404849|NCT03304379|469445943|FG001|Overall Study|Lack of Efficacy|16|||
130404850|NCT03304379|469445944|FG002|Overall Study|Lack of Efficacy|20|||
130404851|NCT03304379|469445945|FG003|Overall Study|Lack of Efficacy|0|||
130404852|NCT03304379|469445946|FG004|Overall Study|Lack of Efficacy|0|||
130404853|NCT03304379|469445942|FG000|Overall Study|Physician Decision|6|||
130404854|NCT03304379|469445943|FG001|Overall Study|Physician Decision|10|||
130404855|NCT03304379|469445944|FG002|Overall Study|Physician Decision|6|||
130404856|NCT03304379|469445945|FG003|Overall Study|Physician Decision|9|||
130404857|NCT03304379|469445946|FG004|Overall Study|Physician Decision|10|||
130404858|NCT03304379|469445942|FG000|Overall Study|Withdrawal by Subject|26|||
130404859|NCT03304379|469445943|FG001|Overall Study|Withdrawal by Subject|58|||
130404860|NCT03304379|469445944|FG002|Overall Study|Withdrawal by Subject|66|||
130404861|NCT03304379|469445945|FG003|Overall Study|Withdrawal by Subject|3|||
130404862|NCT03304379|469445946|FG004|Overall Study|Withdrawal by Subject|5|||
130404863|NCT03304379|469445942|FG000|Overall Study|Lost to Follow-up|8|||
130404864|NCT03304379|469445943|FG001|Overall Study|Lost to Follow-up|24|||
130404865|NCT03304379|469445944|FG002|Overall Study|Lost to Follow-up|35|||
130404866|NCT03304379|469445945|FG003|Overall Study|Lost to Follow-up|4|||
130404867|NCT03304379|469445946|FG004|Overall Study|Lost to Follow-up|0|||
130404868|NCT03304379|469445942|FG000|Overall Study|Death|1|||
130404869|NCT03304379|469445943|FG001|Overall Study|Death|2|||
130404870|NCT03304379|469445944|FG002|Overall Study|Death|0|||
130404871|NCT03304379|469445945|FG003|Overall Study|Death|0|||
130404872|NCT03304379|469445946|FG004|Overall Study|Death|0|||
130404873|NCT03304379|469445942|FG000|Overall Study|Other|0|||
130404874|NCT03304379|469445943|FG001|Overall Study|Other|1|||
130404875|NCT03304379|469445944|FG002|Overall Study|Other|0|||
130404876|NCT03304379|469445945|FG003|Overall Study|Other|0|||
130404877|NCT03304379|469445946|FG004|Overall Study|Other|0|||
130471315|NCT02473250|469692636|FG000|Overall Study|Did not tolerate medication washout|3|||
130471316|NCT02473250|469692636|FG000|Overall Study|Antidepressant effect of divalproex|2|||
130471317|NCT00567398|469692637|FG000|Overall Study|Adverse Event|6|||
130471318|NCT00567398|469692638|FG001|Overall Study|Adverse Event|14|||
130471319|NCT00567398|469692637|FG000|Overall Study|Physician Decision|0|||
130471320|NCT00567398|469692638|FG001|Overall Study|Physician Decision|4|||
130404878|NCT00684424|469445952|FG000|Overall Study|Adverse Event|1|||
130404879|NCT00684424|469445952|FG000|Overall Study|Lost to Follow-up|2|||
130404880|NCT00684424|469445952|FG000|Overall Study|Other|2|||
130404881|NCT01752933|469445956|FG000|Treatment|Disease Progression|3|||
130404882|NCT01752933|469445957|FG001|Treatment|Disease Progression|29|||
130404883|NCT01752933|469445956|FG000|Treatment|Withdrawal by Subject|0|||
130404884|NCT01752933|469445957|FG001|Treatment|Withdrawal by Subject|5|||
130471321|NCT00567398|469692637|FG000|Overall Study|Withdrawal by Subject|0|||
130404885|NCT01752933|469445956|FG000|Treatment|Adverse Event|1|||
130404886|NCT01752933|469445957|FG001|Treatment|Adverse Event|4|||
130404887|NCT01752933|469445956|FG000|Treatment|Physician Decision|0|||
130404888|NCT01752933|469445957|FG001|Treatment|Physician Decision|3|||
130404889|NCT01752933|469445956|FG000|Treatment|Death|0|||
130404890|NCT01752933|469445957|FG001|Treatment|Death|2|||
130404891|NCT01752933|469445956|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
130404892|NCT01752933|469445957|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
130404893|NCT01752933|469445956|FG000|Treatment|Patient noncompliant|0|||
130404894|NCT01752933|469445957|FG001|Treatment|Patient noncompliant|1|||
130404895|NCT01752933|469445956|FG000|Treatment|Patient unable to travel to appointments|0|||
130404896|NCT01752933|469445957|FG001|Treatment|Patient unable to travel to appointments|1|||
130404897|NCT01752933|469445956|FG000|Overall Study and Follow-up|Death|4|||
130404898|NCT01752933|469445957|FG001|Overall Study and Follow-up|Death|34|||
130404899|NCT01752933|469445956|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
130404900|NCT01752933|469445957|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
130404901|NCT01752933|469445956|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
130404902|NCT01752933|469445957|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
130404903|NCT01752933|469445956|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
130404904|NCT01752933|469445957|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
130404905|NCT00835406|469445958|FG000|Period: First Intervention|Adverse Event|0|||
130404906|NCT00835406|469445959|FG001|Period: First Intervention|Adverse Event|1|||
130404907|NCT00835406|469445958|FG000|Period: First Intervention|Withdrawal by Subject|2|||
130404908|NCT00835406|469445959|FG001|Period: First Intervention|Withdrawal by Subject|0|||
130404909|NCT00835406|469445958|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
130404910|NCT00835406|469445959|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
130404911|NCT02550652|469445960|FG000|Overall Study|Death|1|||
130404912|NCT02550652|469445961|FG001|Overall Study|Death|4|||
130404913|NCT02550652|469445960|FG000|Overall Study|Lack of Efficacy|1|||
130724752|NCT01851330|470617015|FG000|Overall Study|Investigator's Discretion|0|||
130724753|NCT01851330|470617016|FG001|Overall Study|Investigator's Discretion|0|||
130724754|NCT01851330|470617017|FG002|Overall Study|Investigator's Discretion|1|||
130404914|NCT02550652|469445961|FG001|Overall Study|Lack of Efficacy|0|||
130404915|NCT02550652|469445960|FG000|Overall Study|Withdrawal by Subject|4|||
130404916|NCT02550652|469445961|FG001|Overall Study|Withdrawal by Subject|7|||
130404917|NCT02550652|469445960|FG000|Overall Study|Post Trial Access|1|||
130404918|NCT02550652|469445961|FG001|Overall Study|Post Trial Access|0|||
130404919|NCT02550652|469445960|FG000|Overall Study|Lost to Follow-up|1|||
130404920|NCT02550652|469445961|FG001|Overall Study|Lost to Follow-up|3|||
130404921|NCT02550652|469445960|FG000|Overall Study|Physician Decision|0|||
130404922|NCT02550652|469445961|FG001|Overall Study|Physician Decision|2|||
130404923|NCT02550652|469445960|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
130404924|NCT02550652|469445961|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
130404925|NCT01706250|469445962|FG000|Overall Study|Lost to Follow-up|2|||
130404926|NCT02486406|469445963|FG000|Overall Study|Withdrew consent|1|||
130404927|NCT02486406|469445964|FG001|Overall Study|Withdrew consent|0|||
130404928|NCT02486406|469445965|FG002|Overall Study|Withdrew consent|0|||
130471322|NCT00567398|469692638|FG001|Overall Study|Withdrawal by Subject|2|||
130471323|NCT00567398|469692637|FG000|Overall Study|Renal Transplantation|0|||
130471324|NCT00567398|469692638|FG001|Overall Study|Renal Transplantation|3|||
130471325|NCT00567398|469692637|FG000|Overall Study|Other|1|||
130471326|NCT00567398|469692638|FG001|Overall Study|Other|0|||
130471327|NCT03517553|469692639|FG000|Overall Study|Withdrawal by Subject|2|||
130471328|NCT03271151|469692640|FG000|Overall Study|Lost to Follow-up|1|||
130471329|NCT03271151|469692641|FG001|Overall Study|Lost to Follow-up|3|||
130471330|NCT03271151|469692640|FG000|Overall Study|Withdrawal by Subject|1|||
130471331|NCT03271151|469692641|FG001|Overall Study|Withdrawal by Subject|0|||
130471332|NCT04093362|469692644|FG000|Overall Study|Study Termination|1|||
130471333|NCT04093362|469692645|FG001|Overall Study|Study Termination|1|||
130471334|NCT04093362|469692644|FG000|Overall Study|Withdrawal of Consent|1|||
130471335|NCT04093362|469692645|FG001|Overall Study|Withdrawal of Consent|0|||
130471336|NCT04093362|469692644|FG000|Overall Study|Death|1|||
130471337|NCT04093362|469692645|FG001|Overall Study|Death|3|||
130471338|NCT04093362|469692644|FG000|Overall Study|Reason not Specified|1|||
130471339|NCT04093362|469692645|FG001|Overall Study|Reason not Specified|2|||
130471340|NCT02201108|469692648|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
130471341|NCT02201108|469692649|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
130471342|NCT02201108|469692650|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
130471343|NCT02201108|469692648|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
130471344|NCT02201108|469692649|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
130471345|NCT02201108|469692650|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
130471346|NCT02201108|469692648|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
130471347|NCT02201108|469692649|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
130471348|NCT02201108|469692650|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
130471349|NCT02201108|469692648|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
130471350|NCT02201108|469692649|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
130404929|NCT02486406|469445966|FG003|Overall Study|Withdrew consent|1|||
130471351|NCT02201108|469692650|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
130471352|NCT02201108|469692648|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
130471353|NCT02201108|469692649|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
130471354|NCT02201108|469692650|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
130404930|NCT02486406|469445963|FG000|Overall Study|Lost to Follow-up|1|||
130404931|NCT02486406|469445964|FG001|Overall Study|Lost to Follow-up|3|||
130404932|NCT02486406|469445965|FG002|Overall Study|Lost to Follow-up|1|||
130404933|NCT02486406|469445966|FG003|Overall Study|Lost to Follow-up|3|||
130404934|NCT02486406|469445963|FG000|Overall Study|Other, not specified|0|||
130404935|NCT02486406|469445964|FG001|Overall Study|Other, not specified|0|||
130404936|NCT02486406|469445965|FG002|Overall Study|Other, not specified|1|||
130404937|NCT02486406|469445966|FG003|Overall Study|Other, not specified|0|||
130404938|NCT01826825|469445967|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
130404939|NCT01826825|469445968|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
130404940|NCT01858194|469445969|FG000|Overall Study|Total Artificial Heart Implant|0|||
130404941|NCT01858194|469445970|FG001|Overall Study|Total Artificial Heart Implant|1|||
130404942|NCT01858194|469445969|FG000|Overall Study|Lost to Follow-up|0|||
130404943|NCT01858194|469445970|FG001|Overall Study|Lost to Follow-up|1|||
130404944|NCT00799617|469445974|FG000|Main Testosterone Trial|Randomized in error|1|||
130404945|NCT00799617|469445975|FG001|Main Testosterone Trial|Randomized in error|1|||
130404946|NCT00799617|469445974|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
130404947|NCT00799617|469445975|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
130404948|NCT00799617|469445974|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
130561056|NCT03250832|470022788|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561057|NCT03250832|470022789|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561058|NCT03250832|470022790|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
130404949|NCT00799617|469445975|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
130404950|NCT00799617|469445974|FG000|Sexual Funtion Trial|No Baseline Data|4|||
130404951|NCT00799617|469445975|FG001|Sexual Funtion Trial|No Baseline Data|7|||
130404952|NCT00799617|469445974|FG000|Physical Function Trial|Lost to Follow-up|6|||
130404953|NCT00799617|469445975|FG001|Physical Function Trial|Lost to Follow-up|11|||
130404954|NCT00799617|469445974|FG000|Vitality Trial|Lost to Follow-up|7|||
130404955|NCT00799617|469445975|FG001|Vitality Trial|Lost to Follow-up|22|||
130404956|NCT00799617|469445974|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
130404957|NCT00799617|469445975|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
130404958|NCT00799617|469445974|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
130404959|NCT00799617|469445975|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
130404960|NCT00799617|469445974|FG000|Bone Trial|Month 12 scan not available|6|||
130404961|NCT00799617|469445975|FG001|Bone Trial|Month 12 scan not available|16|||
130404962|NCT00799617|469445974|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
130404963|NCT00799617|469445975|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
130404964|NCT00799617|469445974|FG000|Anemia Trial|Withdrawal by Subject|3|||
130404965|NCT00799617|469445975|FG001|Anemia Trial|Withdrawal by Subject|3|||
130404966|NCT04545515|469445976|FG000|Overall Study|Adverse Event|1|||
130404967|NCT04545515|469445976|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
130404968|NCT04545515|469445976|FG000|Overall Study|Commercial drug is available for participant|7|||
130404969|NCT01848990|469445977|FG000|Overall Study|Adverse Event|6|||
130404970|NCT01848990|469445978|FG001|Overall Study|Adverse Event|2|||
130404971|NCT01848990|469445979|FG002|Overall Study|Adverse Event|0|||
130404972|NCT01848990|469445977|FG000|Overall Study|Lost to Follow-up|6|||
130404973|NCT01848990|469445978|FG001|Overall Study|Lost to Follow-up|2|||
130404974|NCT01848990|469445979|FG002|Overall Study|Lost to Follow-up|2|||
130404975|NCT01848990|469445977|FG000|Overall Study|Protocol Violation|1|||
130404976|NCT01848990|469445978|FG001|Overall Study|Protocol Violation|1|||
130404977|NCT01848990|469445979|FG002|Overall Study|Protocol Violation|0|||
130404978|NCT01848990|469445977|FG000|Overall Study|Withdrawal by Subject|29|||
130404979|NCT01848990|469445978|FG001|Overall Study|Withdrawal by Subject|10|||
130404980|NCT01848990|469445979|FG002|Overall Study|Withdrawal by Subject|11|||
130404981|NCT01848990|469445977|FG000|Overall Study|Physician Decision|1|||
130404982|NCT01848990|469445978|FG001|Overall Study|Physician Decision|1|||
130404983|NCT01848990|469445979|FG002|Overall Study|Physician Decision|0|||
130404984|NCT01848990|469445977|FG000|Overall Study|Non Compliance|1|||
130404985|NCT01848990|469445978|FG001|Overall Study|Non Compliance|0|||
130404986|NCT01848990|469445979|FG002|Overall Study|Non Compliance|0|||
130404987|NCT01848990|469445977|FG000|Overall Study|Death|1|||
130404988|NCT01848990|469445978|FG001|Overall Study|Death|0|||
130404989|NCT01848990|469445979|FG002|Overall Study|Death|1|||
130404990|NCT01848990|469445977|FG000|Overall Study|Other|1|||
130404991|NCT01848990|469445978|FG001|Overall Study|Other|4|||
130404992|NCT01848990|469445979|FG002|Overall Study|Other|2|||
130404993|NCT00958880|469445980|FG000|Overall Study|Lost to Follow-up|2|||
130404994|NCT00958880|469445981|FG001|Overall Study|Lost to Follow-up|2|||
130404995|NCT01712984|469445984|FG000|Overall Study|Adverse Event|0|||
130404996|NCT01712984|469445985|FG001|Overall Study|Adverse Event|0|||
130404997|NCT01712984|469445986|FG002|Overall Study|Adverse Event|1|||
130404998|NCT01712984|469445984|FG000|Overall Study|Protocol Violation|2|||
130404999|NCT01712984|469445985|FG001|Overall Study|Protocol Violation|0|||
130405000|NCT01712984|469445986|FG002|Overall Study|Protocol Violation|1|||
130405001|NCT01712984|469445984|FG000|Overall Study|Lost to Follow-up|8|||
130405002|NCT01712984|469445985|FG001|Overall Study|Lost to Follow-up|10|||
130405003|NCT01712984|469445986|FG002|Overall Study|Lost to Follow-up|1|||
130405004|NCT01712984|469445984|FG000|Overall Study|Withdrawal by Subject|6|||
130405005|NCT01712984|469445985|FG001|Overall Study|Withdrawal by Subject|6|||
130405006|NCT01712984|469445986|FG002|Overall Study|Withdrawal by Subject|7|||
130405007|NCT00678561|469445991|FG000|Overall Study|Adverse Event|0|||
130405008|NCT00678561|469445992|FG001|Overall Study|Adverse Event|1|||
130405009|NCT00678561|469445993|FG002|Overall Study|Adverse Event|1|||
130405010|NCT00678561|469445994|FG003|Overall Study|Adverse Event|0|||
130405011|NCT00678561|469445995|FG004|Overall Study|Adverse Event|1|||
130405012|NCT00678561|469445996|FG005|Overall Study|Adverse Event|0|||
130405013|NCT00678561|469445997|FG006|Overall Study|Adverse Event|0|||
130405014|NCT00678561|469445998|FG007|Overall Study|Adverse Event|0|||
130405015|NCT00678561|469445991|FG000|Overall Study|Protocol Violation|0|||
130405016|NCT00678561|469445992|FG001|Overall Study|Protocol Violation|0|||
130405017|NCT00678561|469445993|FG002|Overall Study|Protocol Violation|0|||
130405018|NCT00678561|469445994|FG003|Overall Study|Protocol Violation|0|||
130405019|NCT00678561|469445995|FG004|Overall Study|Protocol Violation|1|||
130405020|NCT00678561|469445996|FG005|Overall Study|Protocol Violation|1|||
130405021|NCT00678561|469445997|FG006|Overall Study|Protocol Violation|0|||
130405022|NCT00678561|469445998|FG007|Overall Study|Protocol Violation|0|||
130405023|NCT00678561|469445991|FG000|Overall Study|Withdrawal by Subject|0|||
130405024|NCT00678561|469445992|FG001|Overall Study|Withdrawal by Subject|0|||
130405025|NCT00678561|469445993|FG002|Overall Study|Withdrawal by Subject|0|||
130405026|NCT00678561|469445994|FG003|Overall Study|Withdrawal by Subject|0|||
130405027|NCT00678561|469445995|FG004|Overall Study|Withdrawal by Subject|0|||
130405028|NCT00678561|469445996|FG005|Overall Study|Withdrawal by Subject|0|||
130405029|NCT00678561|469445997|FG006|Overall Study|Withdrawal by Subject|0|||
130405030|NCT00678561|469445998|FG007|Overall Study|Withdrawal by Subject|1|||
130405031|NCT00437034|469445999|FG000|Overall Study|Adverse Event|1|||
130405032|NCT00437034|469445999|FG000|Overall Study|Disease progression during treatment|5|||
130405033|NCT04258839|469448082|FG000|Overall Study|Adverse Event|2|||
130405034|NCT04258839|469448083|FG001|Overall Study|Adverse Event|4|||
130405035|NCT04258839|469448082|FG000|Overall Study|Lack of Efficacy|0|||
130405036|NCT04258839|469448083|FG001|Overall Study|Lack of Efficacy|2|||
130405037|NCT04258839|469448082|FG000|Overall Study|Lost to Follow-up|2|||
130405038|NCT04258839|469448083|FG001|Overall Study|Lost to Follow-up|0|||
130405039|NCT04258839|469448082|FG000|Overall Study|Withdrawal by Subject|1|||
130405040|NCT04258839|469448083|FG001|Overall Study|Withdrawal by Subject|2|||
130405041|NCT04258839|469448082|FG000|Overall Study|Withdrawal by Caregiver|5|||
130405042|NCT04258839|469448083|FG001|Overall Study|Withdrawal by Caregiver|6|||
130405043|NCT04258839|469448082|FG000|Overall Study|Reason not Specified|0|||
130405044|NCT04258839|469448083|FG001|Overall Study|Reason not Specified|1|||
130405045|NCT02602288|469448088|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
130405046|NCT02602288|469448089|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
130405047|NCT02602288|469448088|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
130405048|NCT02602288|469448089|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
130405049|NCT02602288|469448088|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
130405050|NCT02602288|469448089|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
130405051|NCT02602288|469448088|FG000|12 Month Follow-up|Lost to Follow-up|0|||
130471355|NCT02201108|469692648|FG000|Open Label Period (up to Week 192)|Other reason|4|||
130471356|NCT02201108|469692649|FG001|Open Label Period (up to Week 192)|Other reason|7|||
130471357|NCT02201108|469692650|FG002|Open Label Period (up to Week 192)|Other reason|0|||
130471358|NCT02201108|469692648|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
130471359|NCT02201108|469692649|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
130471360|NCT02201108|469692650|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
130471361|NCT02201108|469692648|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
130471362|NCT02201108|469692649|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
130471363|NCT02201108|469692650|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
130471364|NCT02201108|469692648|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
130471365|NCT02201108|469692649|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
130405052|NCT02602288|469448089|FG001|12 Month Follow-up|Lost to Follow-up|4|||
130471366|NCT02201108|469692650|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
130471367|NCT03055377|469692660|FG000|Treatment Phase|Lost to Follow-up|28|||
130471368|NCT03055377|469692661|FG001|Treatment Phase|Lost to Follow-up|24|||
130471369|NCT03055377|469692660|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
130471370|NCT03055377|469692661|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
130471371|NCT01718743|469692663|FG000|Overall Study|Physician Decision|7|||
130471372|NCT01718743|469692663|FG000|Overall Study|Withdrawal by Subject|14|||
130471373|NCT01718743|469692663|FG000|Overall Study|Progressive Disease|22|||
130471374|NCT01718743|469692663|FG000|Overall Study|Toxicity|1|||
130471375|NCT01718743|469692663|FG000|Overall Study|Malignancy|1|||
130471376|NCT03263026|469692665|FG000|Overall Study|Withdrawal by Subject|1|||
130471377|NCT03263026|469692666|FG001|Overall Study|Withdrawal by Subject|0|||
130471378|NCT03263026|469692665|FG000|Overall Study|Death|1|||
130405053|NCT02602288|469448088|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
130405054|NCT02602288|469448089|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
130405055|NCT01310413|469448090|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
130405056|NCT01310413|469448091|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
130405057|NCT01310413|469448092|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
130405058|NCT01310413|469448093|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
130405059|NCT01310413|469448094|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
130405060|NCT01310413|469448095|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
130405061|NCT01310413|469448096|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
130405062|NCT01310413|469448090|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
130405063|NCT01310413|469448091|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
130405064|NCT01310413|469448092|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
130405065|NCT01310413|469448093|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
130405066|NCT01310413|469448094|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
130405067|NCT01310413|469448095|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
130405068|NCT01310413|469448096|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
130405069|NCT01310413|469448090|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
130405070|NCT01310413|469448091|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
130405071|NCT01310413|469448092|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
130405072|NCT01310413|469448093|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
130405073|NCT01310413|469448094|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
130405074|NCT01310413|469448095|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
130405075|NCT01310413|469448096|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
130405076|NCT01310413|469448090|FG000|Day 0 to Day 385|Other|1|||
130405077|NCT01310413|469448091|FG001|Day 0 to Day 385|Other|0|||
130405078|NCT01310413|469448092|FG002|Day 0 to Day 385|Other|3|||
130405079|NCT01310413|469448093|FG003|Day 0 to Day 385|Other|0|||
130405080|NCT01310413|469448094|FG004|Day 0 to Day 385|Other|0|||
130405081|NCT01310413|469448095|FG005|Day 0 to Day 385|Other|0|||
130405082|NCT01310413|469448096|FG006|Day 0 to Day 385|Other|0|||
130405083|NCT01310413|469448090|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405084|NCT01310413|469448091|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405085|NCT01310413|469448092|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405086|NCT01310413|469448093|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405087|NCT01310413|469448094|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405088|NCT01310413|469448095|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
130405089|NCT01310413|469448096|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
130405090|NCT01310413|469448090|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
130405091|NCT01310413|469448091|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
130405092|NCT01310413|469448092|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
130405093|NCT01310413|469448093|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
130405094|NCT01310413|469448094|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
130405095|NCT01310413|469448095|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
130405096|NCT01310413|469448096|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
130405097|NCT00612066|469448097|FG000|Overall Study|Adverse Event|1|||
130405098|NCT00630877|469448098|FG000|Overall Study|Adverse Event|11|||
130405099|NCT00630877|469448099|FG001|Overall Study|Adverse Event|8|||
130405100|NCT00630877|469448100|FG002|Overall Study|Adverse Event|7|||
130405101|NCT00630877|469448098|FG000|Overall Study|Withdrawal by Subject|3|||
130405102|NCT00630877|469448099|FG001|Overall Study|Withdrawal by Subject|4|||
130405103|NCT00630877|469448100|FG002|Overall Study|Withdrawal by Subject|0|||
130405104|NCT00630877|469448098|FG000|Overall Study|Lost to Follow-up|2|||
130405105|NCT00630877|469448099|FG001|Overall Study|Lost to Follow-up|0|||
130405106|NCT00630877|469448100|FG002|Overall Study|Lost to Follow-up|0|||
130405107|NCT00630877|469448098|FG000|Overall Study|Noncompliance|2|||
130405108|NCT00630877|469448099|FG001|Overall Study|Noncompliance|3|||
130405109|NCT00630877|469448100|FG002|Overall Study|Noncompliance|1|||
130405110|NCT00630877|469448098|FG000|Overall Study|Protocol violation|1|||
130405111|NCT00630877|469448099|FG001|Overall Study|Protocol violation|0|||
130405112|NCT00630877|469448100|FG002|Overall Study|Protocol violation|1|||
130405113|NCT00630877|469448098|FG000|Overall Study|Personal reasons|0|||
130405114|NCT00630877|469448099|FG001|Overall Study|Personal reasons|0|||
130405115|NCT00630877|469448100|FG002|Overall Study|Personal reasons|1|||
130405116|NCT01519518|469448101|FG000|Overall Study|Consent not available|7|||
130405117|NCT01519518|469448102|FG001|Overall Study|Consent not available|10|||
130405118|NCT02033889|469448103|FG000|Overall Study|Adverse Event|3|||
130405119|NCT02033889|469448104|FG001|Overall Study|Adverse Event|1|||
130724755|NCT00314951|470617020|FG000|Treatment|Didn't meet criteria for mITT population|16|||
130405120|NCT02033889|469448105|FG002|Overall Study|Adverse Event|3|||
130405121|NCT02033889|469448103|FG000|Overall Study|Death|3|||
130405122|NCT02033889|469448104|FG001|Overall Study|Death|1|||
130405123|NCT02033889|469448105|FG002|Overall Study|Death|2|||
130405124|NCT02033889|469448103|FG000|Overall Study|Excluded Medication|1|||
130405125|NCT02033889|469448104|FG001|Overall Study|Excluded Medication|1|||
130471379|NCT03263026|469692666|FG001|Overall Study|Death|0|||
130405126|NCT02033889|469448105|FG002|Overall Study|Excluded Medication|0|||
130405127|NCT02033889|469448103|FG000|Overall Study|Lost to Follow-up|8|||
130405128|NCT02033889|469448104|FG001|Overall Study|Lost to Follow-up|5|||
130405129|NCT02033889|469448105|FG002|Overall Study|Lost to Follow-up|6|||
130405130|NCT02033889|469448103|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130405131|NCT02033889|469448104|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130405132|NCT02033889|469448105|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130405133|NCT02033889|469448103|FG000|Overall Study|Physician Decision|0|||
130405134|NCT02033889|469448104|FG001|Overall Study|Physician Decision|1|||
130405135|NCT02033889|469448105|FG002|Overall Study|Physician Decision|1|||
130405136|NCT02033889|469448103|FG000|Overall Study|Participant moved|0|||
130405137|NCT02033889|469448104|FG001|Overall Study|Participant moved|1|||
130405138|NCT02033889|469448105|FG002|Overall Study|Participant moved|0|||
130405139|NCT02033889|469448103|FG000|Overall Study|Withdrawal by Subject|18|||
130405140|NCT02033889|469448104|FG001|Overall Study|Withdrawal by Subject|10|||
130405141|NCT02033889|469448105|FG002|Overall Study|Withdrawal by Subject|13|||
130405142|NCT01913041|469448107|FG000|Overall Study|Protocol Violation|35|||
130405143|NCT01913041|469448107|FG000|Overall Study|Withdrawal by Subject|3|||
130405144|NCT01913041|469448107|FG000|Overall Study|Physician Decision|1|||
130405145|NCT01610700|469448109|FG000|Overall Study|Adverse Event|3|||
130405146|NCT01610700|469448110|FG001|Overall Study|Adverse Event|1|||
130405147|NCT01610700|469448109|FG000|Overall Study|Withdrawal by Subject|0|||
130405148|NCT01610700|469448110|FG001|Overall Study|Withdrawal by Subject|1|||
130405149|NCT01610700|469448109|FG000|Overall Study|subject took one dose of street cannabis|0|||
130405150|NCT01610700|469448110|FG001|Overall Study|subject took one dose of street cannabis|1|||
130405151|NCT00938431|469448111|FG000|Overall Study|Adverse Event|5|||
130405152|NCT00938431|469448112|FG001|Overall Study|Adverse Event|8|||
130405153|NCT00938431|469448113|FG002|Overall Study|Adverse Event|6|||
130405154|NCT00938431|469448111|FG000|Overall Study|Lack of Efficacy|0|||
130405155|NCT00938431|469448112|FG001|Overall Study|Lack of Efficacy|1|||
130405156|NCT00938431|469448113|FG002|Overall Study|Lack of Efficacy|0|||
130405157|NCT00938431|469448111|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
130405158|NCT00938431|469448112|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
130405159|NCT00938431|469448113|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
130405160|NCT00938431|469448111|FG000|Overall Study|Dosing compliance issue|0|||
130405161|NCT00938431|469448112|FG001|Overall Study|Dosing compliance issue|0|||
130405162|NCT00938431|469448113|FG002|Overall Study|Dosing compliance issue|1|||
130471380|NCT03263026|469692665|FG000|Overall Study|Other/ Various|41|||
130471381|NCT03263026|469692666|FG001|Overall Study|Other/ Various|29|||
130471382|NCT03739996|469692669|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
130471383|NCT03739996|469692669|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
130471384|NCT03739996|469692669|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
130471385|NCT03739996|469692669|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
130471386|NCT03739996|469692669|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
130471387|NCT03739996|469692669|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
130471388|NCT03739996|469692669|FG000|Step 3 (SOC ART)|Death|1|||
130471389|NCT03739996|469692669|FG000|Step 3 (SOC ART)|Participant moved|1|||
130471390|NCT02553642|469692670|FG000|Overall Study|Withdrawal by Subject|0|||
130471391|NCT02553642|469692671|FG001|Overall Study|Withdrawal by Subject|3|||
130471392|NCT02553642|469692670|FG000|Overall Study|Physician Decision|0|||
130471393|NCT02553642|469692671|FG001|Overall Study|Physician Decision|1|||
130471394|NCT02553642|469692670|FG000|Overall Study|Additional cancer dx|0|||
130471395|NCT02553642|469692671|FG001|Overall Study|Additional cancer dx|1|||
130471396|NCT02553642|469692670|FG000|Overall Study|Never started treatment|0|||
130471397|NCT02553642|469692671|FG001|Overall Study|Never started treatment|1|||
130471398|NCT05444192|469692672|FG000|Overall Study|Lost to Follow-up|1|||
130471399|NCT05444192|469692673|FG001|Overall Study|Lost to Follow-up|0|||
130471400|NCT00894543|469692677|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
130471401|NCT00894543|469692678|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
130405163|NCT00938431|469448111|FG000|Overall Study|Reached maximum dose early|0|||
130405164|NCT00938431|469448112|FG001|Overall Study|Reached maximum dose early|0|||
130471402|NCT00894543|469692677|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
130471403|NCT00894543|469692678|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
130471404|NCT01532388|469692679|FG000|3-month Follow-up|Lost to Follow-up|68|||
130471405|NCT01532388|469692680|FG001|3-month Follow-up|Lost to Follow-up|68|||
130471406|NCT01532388|469692679|FG000|6-month Follow-up|Lost to Follow-up|74|||
130471407|NCT01532388|469692680|FG001|6-month Follow-up|Lost to Follow-up|66|||
130471408|NCT01532388|469692679|FG000|12-month Follow-up|Lost to Follow-up|69|||
130471409|NCT01532388|469692680|FG001|12-month Follow-up|Lost to Follow-up|67|||
130471410|NCT02919449|469692681|FG000|Overall Study|Withdrawal by Subject|1|||
130724756|NCT00314951|470617021|FG001|Treatment|Didn't meet criteria for mITT population|11|||
130405165|NCT00938431|469448113|FG002|Overall Study|Reached maximum dose early|1|||
130405166|NCT01529645|469448114|FG000|Overall Study|Lost to Follow-up|0|||
130405167|NCT01529645|469448115|FG001|Overall Study|Lost to Follow-up|1|||
130405168|NCT01529645|469448116|FG002|Overall Study|Lost to Follow-up|1|||
130405169|NCT01529645|469448117|FG003|Overall Study|Lost to Follow-up|1|||
130471411|NCT02919449|469692681|FG000|Overall Study|Investigator decision|1|||
130471412|NCT05623345|469692682|FG000|Overall Study|Withdrawal by Subject|14|||
130471413|NCT05623345|469692683|FG001|Overall Study|Withdrawal by Subject|0|||
130405170|NCT01529645|469448118|FG004|Overall Study|Lost to Follow-up|1|||
130405171|NCT01529645|469448119|FG005|Overall Study|Lost to Follow-up|0|||
130405172|NCT01529645|469448120|FG006|Overall Study|Lost to Follow-up|2|||
130405173|NCT01529645|469448121|FG007|Overall Study|Lost to Follow-up|0|||
130405174|NCT01529645|469448122|FG008|Overall Study|Lost to Follow-up|1|||
130405175|NCT01529645|469448123|FG009|Overall Study|Lost to Follow-up|0|||
130405176|NCT01529645|469448114|FG000|Overall Study|SAE - Premature contractions|0|||
130405177|NCT01529645|469448115|FG001|Overall Study|SAE - Premature contractions|0|||
130405178|NCT01529645|469448116|FG002|Overall Study|SAE - Premature contractions|1|||
130405179|NCT01529645|469448117|FG003|Overall Study|SAE - Premature contractions|0|||
130405180|NCT01529645|469448118|FG004|Overall Study|SAE - Premature contractions|0|||
130405181|NCT01529645|469448119|FG005|Overall Study|SAE - Premature contractions|0|||
130405182|NCT01529645|469448120|FG006|Overall Study|SAE - Premature contractions|0|||
130405183|NCT01529645|469448121|FG007|Overall Study|SAE - Premature contractions|0|||
130405184|NCT01529645|469448122|FG008|Overall Study|SAE - Premature contractions|0|||
130405185|NCT01529645|469448123|FG009|Overall Study|SAE - Premature contractions|0|||
130405186|NCT01529645|469448114|FG000|Overall Study|Withdrawal by Subject|2|||
130405187|NCT01529645|469448115|FG001|Overall Study|Withdrawal by Subject|0|||
130405188|NCT01529645|469448116|FG002|Overall Study|Withdrawal by Subject|0|||
130405189|NCT01529645|469448117|FG003|Overall Study|Withdrawal by Subject|1|||
130405190|NCT01529645|469448118|FG004|Overall Study|Withdrawal by Subject|1|||
130405191|NCT01529645|469448119|FG005|Overall Study|Withdrawal by Subject|1|||
130405192|NCT01529645|469448120|FG006|Overall Study|Withdrawal by Subject|0|||
130405193|NCT01529645|469448121|FG007|Overall Study|Withdrawal by Subject|0|||
130405194|NCT01529645|469448122|FG008|Overall Study|Withdrawal by Subject|0|||
130405195|NCT01529645|469448123|FG009|Overall Study|Withdrawal by Subject|0|||
130405196|NCT00440271|469448132|FG000|Overall Study|Protocol Violation|1|||
130405197|NCT00440271|469448133|FG001|Overall Study|Protocol Violation|1|||
130405198|NCT00440271|469448132|FG000|Overall Study|Adverse Event|0|||
130405199|NCT00440271|469448133|FG001|Overall Study|Adverse Event|1|||
130405200|NCT00440271|469448132|FG000|Overall Study|Lost to Follow-up|1|||
130405201|NCT00440271|469448133|FG001|Overall Study|Lost to Follow-up|0|||
130405202|NCT00440271|469448132|FG000|Overall Study|Withdrawal by Subject|0|||
130405203|NCT00440271|469448133|FG001|Overall Study|Withdrawal by Subject|2|||
130405204|NCT00440271|469448132|FG000|Overall Study|Lack of Efficacy|0|||
130471414|NCT05623345|469692684|FG002|Overall Study|Withdrawal by Subject|9|||
130471415|NCT05623345|469692685|FG003|Overall Study|Withdrawal by Subject|20|||
130471416|NCT05623345|469692682|FG000|Overall Study|Lost to Follow-up|3|||
130471417|NCT05623345|469692683|FG001|Overall Study|Lost to Follow-up|0|||
130471418|NCT05623345|469692684|FG002|Overall Study|Lost to Follow-up|7|||
130471419|NCT05623345|469692685|FG003|Overall Study|Lost to Follow-up|2|||
130471420|NCT05623345|469692682|FG000|Overall Study|Termination of Study By Sponsor|37|||
130471421|NCT05623345|469692683|FG001|Overall Study|Termination of Study By Sponsor|4|||
130471422|NCT05623345|469692684|FG002|Overall Study|Termination of Study By Sponsor|40|||
130471423|NCT05623345|469692685|FG003|Overall Study|Termination of Study By Sponsor|38|||
130471424|NCT01772472|469692687|FG000|Overall Study|Death|126|||
130471425|NCT01772472|469692688|FG001|Overall Study|Death|94|||
130471426|NCT01772472|469692687|FG000|Overall Study|Lost to Follow-up|51|||
130471427|NCT01772472|469692688|FG001|Overall Study|Lost to Follow-up|50|||
130471428|NCT01772472|469692687|FG000|Overall Study|Other|9|||
130471429|NCT01772472|469692688|FG001|Overall Study|Other|7|||
130471430|NCT01772472|469692687|FG000|Overall Study|Physician Decision|1|||
130471431|NCT01772472|469692688|FG001|Overall Study|Physician Decision|7|||
130471432|NCT01772472|469692687|FG000|Overall Study|Withdrawal by Subject|115|||
130471433|NCT01772472|469692688|FG001|Overall Study|Withdrawal by Subject|90|||
130471434|NCT01772472|469692687|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
130471435|NCT01772472|469692688|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
130471436|NCT02697136|469692689|FG000|Overall Study|Adverse Event|3|||
130471437|NCT02697136|469692690|FG001|Overall Study|Adverse Event|0|||
130471438|NCT03578536|469692693|FG000|Overall Study|Lost to Follow-up|1|||
130471439|NCT02538900|469692694|FG000|Overall Study|Death|2|||
130471440|NCT02538900|469692695|FG001|Overall Study|Death|2|||
130405205|NCT00440271|469448133|FG001|Overall Study|Lack of Efficacy|1|||
130405206|NCT00440271|469448132|FG000|Overall Study|Due to closure of trial|8|||
130405207|NCT00440271|469448133|FG001|Overall Study|Due to closure of trial|10|||
130405208|NCT00440271|469448132|FG000|Overall Study|Other|2|||
130405209|NCT00440271|469448133|FG001|Overall Study|Other|0|||
130405210|NCT00723801|469448134|FG000|Overall Study|Lost to Follow-up|1|||
130471441|NCT02538900|469692696|FG002|Overall Study|Death|2|||
130471442|NCT02538900|469692694|FG000|Overall Study|Withdrawal by Subject|18|||
130471443|NCT02538900|469692695|FG001|Overall Study|Withdrawal by Subject|16|||
130471444|NCT02538900|469692696|FG002|Overall Study|Withdrawal by Subject|15|||
130471445|NCT02874534|469692697|FG000|Overall Study|Withdrawal by Subject|5|||
130471446|NCT02874534|469692698|FG001|Overall Study|Withdrawal by Subject|8|||
130471447|NCT02874534|469692697|FG000|Overall Study|Lost to Follow-up|2|||
130471448|NCT02874534|469692698|FG001|Overall Study|Lost to Follow-up|2|||
130471449|NCT02874534|469692697|FG000|Overall Study|Ongoing in study|1|||
130405211|NCT00723801|469448135|FG001|Overall Study|Lost to Follow-up|2|||
130405212|NCT00723801|469448134|FG000|Overall Study|Protocol Violation|2|||
130405213|NCT00723801|469448135|FG001|Overall Study|Protocol Violation|1|||
130405214|NCT01565993|469448143|FG000|Overall Study|Physician Decision|0|||
130405215|NCT01565993|469448144|FG001|Overall Study|Physician Decision|3|||
130405216|NCT01824303|469448145|FG000|Randomized Study|Withdrawal by Subject|1|||
130405217|NCT01824303|469448146|FG001|Randomized Study|Withdrawal by Subject|1|||
130405218|NCT01824303|469448145|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
130405219|NCT01824303|469448146|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
130405220|NCT02809976|469448147|FG000|Overall Study|Lost to Follow-up|1|||
130405221|NCT02809976|469448147|FG000|Overall Study|Withdrawal by Subject|1|||
130405222|NCT00113516|469448148|FG000|Part 1|Adverse Event|6|||
130405223|NCT00113516|469448149|FG001|Part 1|Adverse Event|0|||
130405224|NCT00113516|469448148|FG000|Part 1|Death|3|||
130724757|NCT00314951|470617020|FG000|Follow-up|mITT failure|44|||
130405225|NCT00113516|469448149|FG001|Part 1|Death|0|||
130405226|NCT00113516|469448148|FG000|Part 1|Other|3|||
130405227|NCT00113516|469448149|FG001|Part 1|Other|0|||
130405228|NCT00113516|469448148|FG000|Part 1|Withdrawal by Subject|2|||
130405229|NCT00113516|469448149|FG001|Part 1|Withdrawal by Subject|0|||
130405230|NCT00113516|469448148|FG000|Part 1|Lack of Efficacy|2|||
130405231|NCT00113516|469448149|FG001|Part 1|Lack of Efficacy|0|||
130405232|NCT00113516|469448148|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
130405233|NCT00113516|469448149|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
130405234|NCT00113516|469448148|FG000|Part 1|Laboratory Abnormality|1|||
130405235|NCT00113516|469448149|FG001|Part 1|Laboratory Abnormality|0|||
130405236|NCT00113516|469448148|FG000|Part 1|Ongoing|1|||
130405237|NCT00113516|469448149|FG001|Part 1|Ongoing|0|||
130405238|NCT00113516|469448148|FG000|Part 1|Missing|65|||
130405239|NCT00113516|469448149|FG001|Part 1|Missing|0|||
130405240|NCT00113516|469448148|FG000|Part 2|Adverse Event|0|||
130405241|NCT00113516|469448149|FG001|Part 2|Adverse Event|16|||
130405242|NCT00113516|469448148|FG000|Part 2|Death|0|||
130405243|NCT00113516|469448149|FG001|Part 2|Death|5|||
130405244|NCT00113516|469448148|FG000|Part 2|Lack of Efficacy|0|||
130405245|NCT00113516|469448149|FG001|Part 2|Lack of Efficacy|37|||
130405246|NCT00113516|469448148|FG000|Part 2|Withdrawal by Subject|0|||
130405247|NCT00113516|469448149|FG001|Part 2|Withdrawal by Subject|3|||
130405248|NCT00113516|469448148|FG000|Part 2|Other|0|||
130405249|NCT00113516|469448149|FG001|Part 2|Other|3|||
130471450|NCT02874534|469692698|FG001|Overall Study|Ongoing in study|1|||
130471451|NCT04431726|469692699|FG000|Overall Study|Ongoing in the Study|55|||
130471452|NCT02923180|469692700|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
130471453|NCT02923180|469692700|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
130471454|NCT05198310|469692701|FG000|Overall Study|Lost to Follow-up|0|||
130471455|NCT05198310|469692702|FG001|Overall Study|Lost to Follow-up|1|||
130471456|NCT05198310|469692703|FG002|Overall Study|Lost to Follow-up|0|||
130471457|NCT05198310|469692704|FG003|Overall Study|Lost to Follow-up|0|||
130471458|NCT05198310|469692705|FG004|Overall Study|Lost to Follow-up|0|||
130471459|NCT05198310|469692706|FG005|Overall Study|Lost to Follow-up|0|||
130471460|NCT05198310|469692707|FG006|Overall Study|Lost to Follow-up|0|||
130471461|NCT05198310|469692708|FG007|Overall Study|Lost to Follow-up|0|||
130471462|NCT05198310|469692701|FG000|Overall Study|Withdrawal by Subject|0|||
130471463|NCT05198310|469692702|FG001|Overall Study|Withdrawal by Subject|0|||
130471464|NCT05198310|469692703|FG002|Overall Study|Withdrawal by Subject|0|||
130471465|NCT05198310|469692704|FG003|Overall Study|Withdrawal by Subject|2|||
130471466|NCT05198310|469692705|FG004|Overall Study|Withdrawal by Subject|0|||
130471467|NCT05198310|469692706|FG005|Overall Study|Withdrawal by Subject|2|||
130471468|NCT05198310|469692707|FG006|Overall Study|Withdrawal by Subject|1|||
130471469|NCT05198310|469692708|FG007|Overall Study|Withdrawal by Subject|3|||
130471470|NCT04436107|469692709|FG000|Overall Study|Sponsor Ended Study|2|||
130471471|NCT04436107|469692710|FG001|Overall Study|Sponsor Ended Study|4|||
130471472|NCT04436107|469692711|FG002|Overall Study|Sponsor Ended Study|8|||
130724758|NCT00314951|470617021|FG001|Follow-up|mITT failure|34|||
130724759|NCT00233402|470617022|FG000|Overall Study|No pathology data|12|||
130724760|NCT00233402|470617023|FG001|Overall Study|No pathology data|9|||
130405250|NCT00113516|469448148|FG000|Part 2|Laboratory Abnormality|0|||
130471473|NCT04436107|469692712|FG003|Overall Study|Sponsor Ended Study|20|||
130471474|NCT04436107|469692709|FG000|Overall Study|Death|3|||
130471475|NCT04436107|469692710|FG001|Overall Study|Death|5|||
130471476|NCT04436107|469692711|FG002|Overall Study|Death|3|||
130471477|NCT04436107|469692712|FG003|Overall Study|Death|18|||
130405251|NCT00113516|469448149|FG001|Part 2|Laboratory Abnormality|1|||
130405252|NCT00113516|469448148|FG000|Part 2|Ongoing|0|||
130405253|NCT00113516|469448149|FG001|Part 2|Ongoing|1|||
130405254|NCT00642304|469448150|FG000|Overall Study|Adverse Event|1|||
130405255|NCT00642304|469448150|FG000|Overall Study|Death|1|||
130405256|NCT00642304|469448150|FG000|Overall Study|Blood transfusion|2|||
130405257|NCT00642304|469448150|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
130405258|NCT00642304|469448150|FG000|Overall Study|Transplantation|1|||
130405259|NCT00812812|469448151|FG000|Overall Study|Adverse Event|2|||
130471478|NCT04436107|469692709|FG000|Overall Study|Withdrawal by Subject|1|||
130724761|NCT00233402|470617022|FG000|Overall Study|No Ta/T1|89|||
130405260|NCT00812812|469448152|FG001|Overall Study|Adverse Event|1|||
130405261|NCT00812812|469448151|FG000|Overall Study|Lack of Efficacy|1|||
130405262|NCT00812812|469448152|FG001|Overall Study|Lack of Efficacy|0|||
130405263|NCT00812812|469448151|FG000|Overall Study|Lost to Follow-up|0|||
130405264|NCT00812812|469448152|FG001|Overall Study|Lost to Follow-up|1|||
130405265|NCT00812812|469448151|FG000|Overall Study|Withdrawal by Subject|0|||
130405266|NCT00812812|469448152|FG001|Overall Study|Withdrawal by Subject|2|||
130405267|NCT02863354|469448156|FG000|Year 1|Lost to Follow-up|1|||
130405268|NCT02863354|469448157|FG001|Year 1|Lost to Follow-up|1|||
130405269|NCT02863354|469448156|FG000|Year 1|Withdrawal by Subject|3|||
130405270|NCT02863354|469448157|FG001|Year 1|Withdrawal by Subject|0|||
130405271|NCT02863354|469448156|FG000|Year 1|Death|0|||
130405272|NCT02863354|469448157|FG001|Year 1|Death|1|||
130405273|NCT02863354|469448156|FG000|Year 2|Lost to Follow-up|2|||
130405274|NCT02863354|469448157|FG001|Year 2|Lost to Follow-up|2|||
130405275|NCT00705575|469448158|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130405276|NCT00705575|469448159|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130405277|NCT00705575|469448158|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130405278|NCT00705575|469448159|FG001|Overall Study|Abnormal test procedure result(s)|12|||
130405279|NCT00705575|469448158|FG000|Overall Study|Adverse Event|11|||
130405280|NCT00705575|469448159|FG001|Overall Study|Adverse Event|15|||
130405281|NCT00705575|469448158|FG000|Overall Study|Lost to Follow-up|3|||
130405282|NCT00705575|469448159|FG001|Overall Study|Lost to Follow-up|4|||
130405283|NCT00705575|469448158|FG000|Overall Study|Protocol Violation|2|||
130405284|NCT00705575|469448159|FG001|Overall Study|Protocol Violation|2|||
130405285|NCT00705575|469448158|FG000|Overall Study|Withdrawal by Subject|5|||
130405286|NCT00705575|469448159|FG001|Overall Study|Withdrawal by Subject|10|||
130405287|NCT02410811|469448166|FG000|Overall Study|Withdrawal by Subject|0|||
130405288|NCT02410811|469448167|FG001|Overall Study|Withdrawal by Subject|0|||
130405289|NCT02410811|469448168|FG002|Overall Study|Withdrawal by Subject|1|||
130405290|NCT02410811|469448169|FG003|Overall Study|Withdrawal by Subject|0|||
130405291|NCT03181542|469448172|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
130405292|NCT03181542|469448173|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
130405293|NCT01071512|469448174|FG000|Overall Study|Adverse Event|1|||
130405294|NCT01071512|469448174|FG000|Overall Study|Development of antibodies to drug|2|||
130405295|NCT01071512|469448174|FG000|Overall Study|positive anti-JC virus antibody test|2|||
130405296|NCT00853658|469448185|FG000|Overall Study|Death|713|||
130405297|NCT00853658|469448186|FG001|Overall Study|Death|768|||
130724762|NCT00233402|470617023|FG001|Overall Study|No Ta/T1|94|||
130724763|NCT00233402|470617022|FG000|Overall Study|Lost to follow up etc|3|||
130724764|NCT00233402|470617023|FG001|Overall Study|Lost to follow up etc|21|||
130724765|NCT02087189|470617026|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
130724766|NCT01189487|470617027|FG000|Overall Study|Lack of Efficacy|2|||
130724767|NCT01189487|470617027|FG000|Overall Study|Adverse Event|1|||
130724768|NCT04630158|470617028|FG000|Overall Study|Adverse Event|1|||
130724769|NCT04630158|470617029|FG001|Overall Study|Adverse Event|1|||
130724770|NCT04630158|470617030|FG002|Overall Study|Adverse Event|1|||
130724771|NCT04630158|470617028|FG000|Overall Study|Physician Decision|0|||
130724772|NCT04630158|470617029|FG001|Overall Study|Physician Decision|2|||
130724773|NCT04630158|470617030|FG002|Overall Study|Physician Decision|0|||
130724774|NCT04630158|470617028|FG000|Overall Study|Protocol Violation|1|||
130724775|NCT04630158|470617029|FG001|Overall Study|Protocol Violation|0|||
130724776|NCT04630158|470617030|FG002|Overall Study|Protocol Violation|1|||
130724777|NCT04630158|470617028|FG000|Overall Study|Withdrawal by Subject|2|||
130724778|NCT04630158|470617029|FG001|Overall Study|Withdrawal by Subject|1|||
130724779|NCT04630158|470617030|FG002|Overall Study|Withdrawal by Subject|2|||
130724780|NCT03136965|470617033|FG000|Overall Study|Lost to Follow-up|0|||
130405298|NCT00853658|469448187|FG002|Overall Study|Death|753|||
130405299|NCT00853658|469448185|FG000|Overall Study|Lost to Follow-up|11|||
130405300|NCT00853658|469448186|FG001|Overall Study|Lost to Follow-up|6|||
130405301|NCT00853658|469448187|FG002|Overall Study|Lost to Follow-up|11|||
130405302|NCT00853658|469448185|FG000|Overall Study|H.A. Request|26|||
130405303|NCT00853658|469448186|FG001|Overall Study|H.A. Request|23|||
130405304|NCT00853658|469448187|FG002|Overall Study|H.A. Request|19|||
130405305|NCT00853658|469448185|FG000|Overall Study|IRB request|0|||
130405306|NCT00853658|469448186|FG001|Overall Study|IRB request|0|||
130405307|NCT00853658|469448187|FG002|Overall Study|IRB request|2|||
130405308|NCT00853658|469448185|FG000|Overall Study|Vital Status known (alive) at study end|2|||
130724781|NCT03136965|470617034|FG001|Overall Study|Lost to Follow-up|1|||
130724782|NCT03136965|470617035|FG002|Overall Study|Lost to Follow-up|0|||
130405309|NCT00853658|469448186|FG001|Overall Study|Vital Status known (alive) at study end|3|||
130405310|NCT00853658|469448187|FG002|Overall Study|Vital Status known (alive) at study end|3|||
130405311|NCT00853658|469448185|FG000|Overall Study|Vital Status unknown at study end|1|||
130405312|NCT00853658|469448186|FG001|Overall Study|Vital Status unknown at study end|1|||
130405313|NCT00853658|469448187|FG002|Overall Study|Vital Status unknown at study end|0|||
130724783|NCT04868968|470617037|FG000|Overall Study|Lost to Follow-up|1|||
130724784|NCT05038800|470617043|FG000|Overall Study|Death|1|||
130724785|NCT05038800|470617044|FG001|Overall Study|Death|1|||
130724786|NCT05038800|470617045|FG002|Overall Study|Death|5|||
130724787|NCT05038800|470617046|FG003|Overall Study|Death|3|||
130724788|NCT05038800|470617047|FG004|Overall Study|Death|1|||
130724789|NCT05038800|470617043|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724790|NCT05038800|470617044|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724791|NCT05038800|470617045|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724792|NCT05038800|470617046|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724793|NCT05038800|470617047|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130724794|NCT05038800|470617043|FG000|Overall Study|Lack of Efficacy|0|||
130724795|NCT05038800|470617044|FG001|Overall Study|Lack of Efficacy|0|||
130724796|NCT05038800|470617045|FG002|Overall Study|Lack of Efficacy|0|||
130724797|NCT05038800|470617046|FG003|Overall Study|Lack of Efficacy|0|||
130724798|NCT05038800|470617047|FG004|Overall Study|Lack of Efficacy|1|||
130724799|NCT00197496|470617048|FG000|Baseline to Discharge|not interested|1|||
130724800|NCT00197496|470617049|FG001|Baseline to Discharge|not interested|0|||
130724801|NCT00197496|470617048|FG000|Baseline to Discharge|MRSA|1|||
130724802|NCT00197496|470617049|FG001|Baseline to Discharge|MRSA|0|||
130724803|NCT00197496|470617048|FG000|Baseline to Discharge|Physician Decision|0|||
130724804|NCT00197496|470617049|FG001|Baseline to Discharge|Physician Decision|1|||
130724805|NCT00197496|470617048|FG000|Baseline to Discharge|Protocol Violation|0|||
130724806|NCT00197496|470617049|FG001|Baseline to Discharge|Protocol Violation|1|||
130724807|NCT00197496|470617048|FG000|Follow-up|Lost to Follow-up|2|||
130724808|NCT00197496|470617049|FG001|Follow-up|Lost to Follow-up|1|||
130724809|NCT00857584|470617050|FG000|Overall Study|Lack of Efficacy|1|||
130724810|NCT00857584|470617051|FG001|Overall Study|Lack of Efficacy|2|||
130724811|NCT00857584|470617050|FG000|Overall Study|Adverse Event|2|||
130724812|NCT00857584|470617051|FG001|Overall Study|Adverse Event|2|||
130724813|NCT00857584|470617050|FG000|Overall Study|Physician Decision|1|||
130724814|NCT00857584|470617051|FG001|Overall Study|Physician Decision|1|||
130724815|NCT00259272|470617053|FG000|Overall Study|Adverse Event|2|||
130724816|NCT00259272|470617054|FG001|Overall Study|Adverse Event|1|||
130724817|NCT00259272|470617055|FG002|Overall Study|Adverse Event|0|||
130724818|NCT00259272|470617056|FG003|Overall Study|Adverse Event|3|||
130724819|NCT00259272|470617053|FG000|Overall Study|Lack of Efficacy|5|||
130724820|NCT00259272|470617054|FG001|Overall Study|Lack of Efficacy|1|||
130724821|NCT00259272|470617055|FG002|Overall Study|Lack of Efficacy|2|||
130724822|NCT00259272|470617056|FG003|Overall Study|Lack of Efficacy|6|||
130724823|NCT00259272|470617053|FG000|Overall Study|Physician Decision|1|||
130724824|NCT00259272|470617054|FG001|Overall Study|Physician Decision|2|||
130724825|NCT00259272|470617055|FG002|Overall Study|Physician Decision|1|||
130724826|NCT00259272|470617056|FG003|Overall Study|Physician Decision|3|||
130405314|NCT00853658|469448185|FG000|Overall Study|Vital Status at study end N/A|8|||
130405315|NCT00853658|469448186|FG001|Overall Study|Vital Status at study end N/A|10|||
130405316|NCT00853658|469448187|FG002|Overall Study|Vital Status at study end N/A|10|||
130405317|NCT00853658|469448185|FG000|Overall Study|Patient's request|21|||
130405318|NCT00853658|469448186|FG001|Overall Study|Patient's request|17|||
130405319|NCT00853658|469448187|FG002|Overall Study|Patient's request|11|||
130405320|NCT00853658|469448185|FG000|Overall Study|Missing study completion information|5|||
130405321|NCT00853658|469448186|FG001|Overall Study|Missing study completion information|4|||
130405322|NCT00853658|469448187|FG002|Overall Study|Missing study completion information|6|||
130405323|NCT02460224|469448188|FG000|Overall Study|Adverse Event|0|||
130405324|NCT02460224|469448189|FG001|Overall Study|Adverse Event|0|||
130405325|NCT02460224|469448190|FG002|Overall Study|Adverse Event|0|||
130405326|NCT02460224|469448191|FG003|Overall Study|Adverse Event|0|||
130405327|NCT02460224|469448192|FG004|Overall Study|Adverse Event|0|||
130405328|NCT02460224|469448193|FG005|Overall Study|Adverse Event|0|||
130405329|NCT02460224|469448194|FG006|Overall Study|Adverse Event|1|||
130724827|NCT00259272|470617053|FG000|Overall Study|Protocol Violation|2|||
130724828|NCT00259272|470617054|FG001|Overall Study|Protocol Violation|0|||
130724829|NCT00259272|470617055|FG002|Overall Study|Protocol Violation|0|||
130724830|NCT00259272|470617056|FG003|Overall Study|Protocol Violation|1|||
130405330|NCT02460224|469448195|FG007|Overall Study|Adverse Event|0|||
130405331|NCT02460224|469448196|FG008|Overall Study|Adverse Event|0|||
130724831|NCT00259272|470617053|FG000|Overall Study|Sponsor Decision|0|||
130724832|NCT00259272|470617054|FG001|Overall Study|Sponsor Decision|1|||
130724833|NCT00259272|470617055|FG002|Overall Study|Sponsor Decision|0|||
130724834|NCT00259272|470617056|FG003|Overall Study|Sponsor Decision|0|||
130405332|NCT02460224|469448197|FG009|Overall Study|Adverse Event|0|||
130405333|NCT02460224|469448198|FG010|Overall Study|Adverse Event|0|||
130724835|NCT00259272|470617053|FG000|Overall Study|Withdrawal by Subject|4|||
130724836|NCT00259272|470617054|FG001|Overall Study|Withdrawal by Subject|2|||
130724837|NCT00259272|470617055|FG002|Overall Study|Withdrawal by Subject|2|||
130724838|NCT00259272|470617056|FG003|Overall Study|Withdrawal by Subject|7|||
130724839|NCT00259272|470617053|FG000|Overall Study|Lost to Follow-up|1|||
130724840|NCT00259272|470617054|FG001|Overall Study|Lost to Follow-up|0|||
130724841|NCT00259272|470617055|FG002|Overall Study|Lost to Follow-up|0|||
130405334|NCT02460224|469448199|FG011|Overall Study|Adverse Event|0|||
130405335|NCT02460224|469448200|FG012|Overall Study|Adverse Event|1|||
130724842|NCT00259272|470617056|FG003|Overall Study|Lost to Follow-up|1|||
130724843|NCT00658021|470617057|FG000|28-Week Treatment Period|Adverse Event|3|||
130724844|NCT00658021|470617058|FG001|28-Week Treatment Period|Adverse Event|1|||
130405336|NCT02460224|469448201|FG013|Overall Study|Adverse Event|0|||
130405337|NCT02460224|469448202|FG014|Overall Study|Adverse Event|0|||
130405338|NCT02460224|469448203|FG015|Overall Study|Adverse Event|0|||
130405339|NCT02460224|469448204|FG016|Overall Study|Adverse Event|1|||
130405340|NCT02460224|469448205|FG017|Overall Study|Adverse Event|0|||
130405341|NCT02460224|469448206|FG018|Overall Study|Adverse Event|1|||
130405342|NCT02460224|469448207|FG019|Overall Study|Adverse Event|0|||
130405343|NCT02460224|469448208|FG020|Overall Study|Adverse Event|1|||
130405344|NCT02460224|469448209|FG021|Overall Study|Adverse Event|1|||
130405345|NCT02460224|469448210|FG022|Overall Study|Adverse Event|1|||
130405346|NCT02460224|469448211|FG023|Overall Study|Adverse Event|0|||
130405347|NCT02460224|469448212|FG024|Overall Study|Adverse Event|0|||
130405348|NCT02460224|469448213|FG025|Overall Study|Adverse Event|0|||
130405349|NCT02460224|469448214|FG026|Overall Study|Adverse Event|11|||
130405350|NCT02460224|469448215|FG027|Overall Study|Adverse Event|1|||
130405351|NCT02460224|469448216|FG028|Overall Study|Adverse Event|6|||
130405352|NCT02460224|469448188|FG000|Overall Study|Death|0|||
130405353|NCT02460224|469448189|FG001|Overall Study|Death|0|||
130405354|NCT02460224|469448190|FG002|Overall Study|Death|0|||
130405355|NCT02460224|469448191|FG003|Overall Study|Death|0|||
130405356|NCT02460224|469448192|FG004|Overall Study|Death|0|||
130405357|NCT02460224|469448193|FG005|Overall Study|Death|2|||
130405358|NCT02460224|469448194|FG006|Overall Study|Death|1|||
130405359|NCT02460224|469448195|FG007|Overall Study|Death|0|||
130724845|NCT00658021|470617059|FG002|28-Week Treatment Period|Adverse Event|0|||
130724846|NCT00658021|470617057|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130724847|NCT00658021|470617058|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
130724848|NCT00658021|470617059|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130724849|NCT00658021|470617057|FG000|28-Week Treatment Period|Protocol Violation|0|||
130405360|NCT02460224|469448196|FG008|Overall Study|Death|0|||
130405361|NCT02460224|469448197|FG009|Overall Study|Death|1|||
130405362|NCT02460224|469448198|FG010|Overall Study|Death|0|||
130405363|NCT02460224|469448199|FG011|Overall Study|Death|0|||
130405364|NCT02460224|469448200|FG012|Overall Study|Death|0|||
130405365|NCT02460224|469448201|FG013|Overall Study|Death|1|||
130405366|NCT02460224|469448202|FG014|Overall Study|Death|0|||
130405367|NCT02460224|469448203|FG015|Overall Study|Death|0|||
130405368|NCT02460224|469448204|FG016|Overall Study|Death|2|||
130405369|NCT02460224|469448205|FG017|Overall Study|Death|1|||
130405370|NCT02460224|469448206|FG018|Overall Study|Death|0|||
130405371|NCT02460224|469448207|FG019|Overall Study|Death|2|||
130405372|NCT02460224|469448208|FG020|Overall Study|Death|0|||
130405373|NCT02460224|469448209|FG021|Overall Study|Death|0|||
130405374|NCT02460224|469448210|FG022|Overall Study|Death|0|||
130405375|NCT02460224|469448211|FG023|Overall Study|Death|0|||
130405376|NCT02460224|469448212|FG024|Overall Study|Death|1|||
130405377|NCT02460224|469448213|FG025|Overall Study|Death|1|||
130405378|NCT02460224|469448214|FG026|Overall Study|Death|5|||
130405379|NCT02460224|469448215|FG027|Overall Study|Death|0|||
130724850|NCT00658021|470617058|FG001|28-Week Treatment Period|Protocol Violation|2|||
130405380|NCT02460224|469448216|FG028|Overall Study|Death|1|||
130405381|NCT02460224|469448188|FG000|Overall Study|Lost to Follow-up|0|||
130405382|NCT02460224|469448189|FG001|Overall Study|Lost to Follow-up|0|||
130405383|NCT02460224|469448190|FG002|Overall Study|Lost to Follow-up|0|||
130405384|NCT02460224|469448191|FG003|Overall Study|Lost to Follow-up|0|||
130405385|NCT02460224|469448192|FG004|Overall Study|Lost to Follow-up|0|||
130405386|NCT02460224|469448193|FG005|Overall Study|Lost to Follow-up|0|||
130405387|NCT02460224|469448194|FG006|Overall Study|Lost to Follow-up|0|||
130405388|NCT02460224|469448195|FG007|Overall Study|Lost to Follow-up|0|||
130405389|NCT02460224|469448196|FG008|Overall Study|Lost to Follow-up|0|||
130405390|NCT02460224|469448197|FG009|Overall Study|Lost to Follow-up|0|||
130405391|NCT02460224|469448198|FG010|Overall Study|Lost to Follow-up|0|||
130405392|NCT02460224|469448199|FG011|Overall Study|Lost to Follow-up|0|||
130724851|NCT00658021|470617059|FG002|28-Week Treatment Period|Protocol Violation|1|||
130724852|NCT00658021|470617057|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
130405393|NCT02460224|469448200|FG012|Overall Study|Lost to Follow-up|0|||
130405394|NCT02460224|469448201|FG013|Overall Study|Lost to Follow-up|0|||
130405395|NCT02460224|469448202|FG014|Overall Study|Lost to Follow-up|0|||
130405396|NCT02460224|469448203|FG015|Overall Study|Lost to Follow-up|0|||
130405397|NCT02460224|469448204|FG016|Overall Study|Lost to Follow-up|0|||
130405398|NCT02460224|469448205|FG017|Overall Study|Lost to Follow-up|0|||
130405399|NCT02460224|469448206|FG018|Overall Study|Lost to Follow-up|0|||
130405400|NCT02460224|469448207|FG019|Overall Study|Lost to Follow-up|0|||
130405401|NCT02460224|469448208|FG020|Overall Study|Lost to Follow-up|0|||
130405402|NCT02460224|469448209|FG021|Overall Study|Lost to Follow-up|0|||
130405403|NCT02460224|469448210|FG022|Overall Study|Lost to Follow-up|1|||
130405404|NCT02460224|469448211|FG023|Overall Study|Lost to Follow-up|0|||
130724853|NCT00658021|470617058|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
130724854|NCT00658021|470617059|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
130724855|NCT00658021|470617057|FG000|28-Week Treatment Period|Physician Decision|1|||
130724856|NCT00658021|470617058|FG001|28-Week Treatment Period|Physician Decision|2|||
130405405|NCT02460224|469448212|FG024|Overall Study|Lost to Follow-up|0|||
130405406|NCT02460224|469448213|FG025|Overall Study|Lost to Follow-up|0|||
130405407|NCT02460224|469448214|FG026|Overall Study|Lost to Follow-up|0|||
130405408|NCT02460224|469448215|FG027|Overall Study|Lost to Follow-up|0|||
130405409|NCT02460224|469448216|FG028|Overall Study|Lost to Follow-up|0|||
130405410|NCT02460224|469448188|FG000|Overall Study|Physician Decision|0|||
130405411|NCT02460224|469448189|FG001|Overall Study|Physician Decision|1|||
130405412|NCT02460224|469448190|FG002|Overall Study|Physician Decision|0|||
130405413|NCT02460224|469448191|FG003|Overall Study|Physician Decision|0|||
130405414|NCT02460224|469448192|FG004|Overall Study|Physician Decision|1|||
130405415|NCT02460224|469448193|FG005|Overall Study|Physician Decision|0|||
130405416|NCT02460224|469448194|FG006|Overall Study|Physician Decision|0|||
130405417|NCT02460224|469448195|FG007|Overall Study|Physician Decision|1|||
130405418|NCT02460224|469448196|FG008|Overall Study|Physician Decision|0|||
130405419|NCT02460224|469448197|FG009|Overall Study|Physician Decision|0|||
130405420|NCT02460224|469448198|FG010|Overall Study|Physician Decision|0|||
130405421|NCT02460224|469448199|FG011|Overall Study|Physician Decision|1|||
130405422|NCT02460224|469448200|FG012|Overall Study|Physician Decision|0|||
130405423|NCT02460224|469448201|FG013|Overall Study|Physician Decision|1|||
130405424|NCT02460224|469448202|FG014|Overall Study|Physician Decision|0|||
130405425|NCT02460224|469448203|FG015|Overall Study|Physician Decision|0|||
130405426|NCT02460224|469448204|FG016|Overall Study|Physician Decision|2|||
130405427|NCT02460224|469448205|FG017|Overall Study|Physician Decision|1|||
130405428|NCT02460224|469448206|FG018|Overall Study|Physician Decision|1|||
130405429|NCT02460224|469448207|FG019|Overall Study|Physician Decision|2|||
130405430|NCT02460224|469448208|FG020|Overall Study|Physician Decision|1|||
130405431|NCT02460224|469448209|FG021|Overall Study|Physician Decision|1|||
130405432|NCT02460224|469448210|FG022|Overall Study|Physician Decision|0|||
130405433|NCT02460224|469448211|FG023|Overall Study|Physician Decision|0|||
130405434|NCT02460224|469448212|FG024|Overall Study|Physician Decision|1|||
130405435|NCT02460224|469448213|FG025|Overall Study|Physician Decision|0|||
130405436|NCT02460224|469448214|FG026|Overall Study|Physician Decision|14|||
130405437|NCT02460224|469448215|FG027|Overall Study|Physician Decision|1|||
130405438|NCT02460224|469448216|FG028|Overall Study|Physician Decision|6|||
130405439|NCT02460224|469448188|FG000|Overall Study|Progressive disease|15|||
130405440|NCT02460224|469448189|FG001|Overall Study|Progressive disease|11|||
130405441|NCT02460224|469448190|FG002|Overall Study|Progressive disease|5|||
130405442|NCT02460224|469448191|FG003|Overall Study|Progressive disease|6|||
130405443|NCT02460224|469448192|FG004|Overall Study|Progressive disease|3|||
130405444|NCT02460224|469448193|FG005|Overall Study|Progressive disease|26|||
130405445|NCT02460224|469448194|FG006|Overall Study|Progressive disease|28|||
130405446|NCT02460224|469448195|FG007|Overall Study|Progressive disease|4|||
130405447|NCT02460224|469448196|FG008|Overall Study|Progressive disease|5|||
130405448|NCT02460224|469448197|FG009|Overall Study|Progressive disease|9|||
130405449|NCT02460224|469448198|FG010|Overall Study|Progressive disease|5|||
130405450|NCT02460224|469448199|FG011|Overall Study|Progressive disease|4|||
130405451|NCT02460224|469448200|FG012|Overall Study|Progressive disease|5|||
130405452|NCT02460224|469448201|FG013|Overall Study|Progressive disease|4|||
130405453|NCT02460224|469448202|FG014|Overall Study|Progressive disease|5|||
130405454|NCT02460224|469448203|FG015|Overall Study|Progressive disease|5|||
130405455|NCT02460224|469448204|FG016|Overall Study|Progressive disease|15|||
130405456|NCT02460224|469448205|FG017|Overall Study|Progressive disease|3|||
130405457|NCT02460224|469448206|FG018|Overall Study|Progressive disease|8|||
130405458|NCT02460224|469448207|FG019|Overall Study|Progressive disease|3|||
130405459|NCT02460224|469448208|FG020|Overall Study|Progressive disease|4|||
130405460|NCT02460224|469448209|FG021|Overall Study|Progressive disease|9|||
130405461|NCT02460224|469448210|FG022|Overall Study|Progressive disease|4|||
130471479|NCT04436107|469692710|FG001|Overall Study|Withdrawal by Subject|1|||
130471480|NCT04436107|469692711|FG002|Overall Study|Withdrawal by Subject|0|||
130724857|NCT00658021|470617059|FG002|28-Week Treatment Period|Physician Decision|1|||
130724858|NCT00658021|470617057|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130405462|NCT02460224|469448211|FG023|Overall Study|Progressive disease|11|||
130405463|NCT02460224|469448212|FG024|Overall Study|Progressive disease|4|||
130405464|NCT02460224|469448213|FG025|Overall Study|Progressive disease|5|||
130405465|NCT02460224|469448214|FG026|Overall Study|Progressive disease|85|||
130405466|NCT02460224|469448215|FG027|Overall Study|Progressive disease|17|||
130405467|NCT02460224|469448216|FG028|Overall Study|Progressive disease|77|||
130405468|NCT02460224|469448188|FG000|Overall Study|Subject/guardian decision|2|||
130405469|NCT02460224|469448189|FG001|Overall Study|Subject/guardian decision|0|||
130405470|NCT02460224|469448190|FG002|Overall Study|Subject/guardian decision|1|||
130405471|NCT02460224|469448191|FG003|Overall Study|Subject/guardian decision|0|||
130405472|NCT02460224|469448192|FG004|Overall Study|Subject/guardian decision|2|||
130724859|NCT00658021|470617058|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130405473|NCT02460224|469448193|FG005|Overall Study|Subject/guardian decision|2|||
130405474|NCT02460224|469448194|FG006|Overall Study|Subject/guardian decision|0|||
130405475|NCT02460224|469448195|FG007|Overall Study|Subject/guardian decision|0|||
130405476|NCT02460224|469448196|FG008|Overall Study|Subject/guardian decision|1|||
130405477|NCT02460224|469448197|FG009|Overall Study|Subject/guardian decision|1|||
130405478|NCT02460224|469448198|FG010|Overall Study|Subject/guardian decision|0|||
130405479|NCT02460224|469448199|FG011|Overall Study|Subject/guardian decision|1|||
130405480|NCT02460224|469448200|FG012|Overall Study|Subject/guardian decision|0|||
130405481|NCT02460224|469448201|FG013|Overall Study|Subject/guardian decision|0|||
130405482|NCT02460224|469448202|FG014|Overall Study|Subject/guardian decision|0|||
130405483|NCT02460224|469448203|FG015|Overall Study|Subject/guardian decision|1|||
130405484|NCT02460224|469448204|FG016|Overall Study|Subject/guardian decision|0|||
130405485|NCT02460224|469448205|FG017|Overall Study|Subject/guardian decision|1|||
130405486|NCT02460224|469448206|FG018|Overall Study|Subject/guardian decision|2|||
130405487|NCT02460224|469448207|FG019|Overall Study|Subject/guardian decision|0|||
130405488|NCT02460224|469448208|FG020|Overall Study|Subject/guardian decision|0|||
130405489|NCT02460224|469448209|FG021|Overall Study|Subject/guardian decision|1|||
130405490|NCT02460224|469448210|FG022|Overall Study|Subject/guardian decision|0|||
130405491|NCT02460224|469448211|FG023|Overall Study|Subject/guardian decision|0|||
130405492|NCT02460224|469448212|FG024|Overall Study|Subject/guardian decision|0|||
130405493|NCT02460224|469448213|FG025|Overall Study|Subject/guardian decision|0|||
130405494|NCT02460224|469448214|FG026|Overall Study|Subject/guardian decision|6|||
130405495|NCT02460224|469448215|FG027|Overall Study|Subject/guardian decision|2|||
130405496|NCT02460224|469448216|FG028|Overall Study|Subject/guardian decision|3|||
130405497|NCT02797262|469448217|FG000|Overall Study|Withdrawal by Subject|5|||
130405498|NCT02797262|469448218|FG001|Overall Study|Withdrawal by Subject|1|||
130405499|NCT02797262|469448217|FG000|Overall Study|Lost to Follow-up|10|||
130405500|NCT02797262|469448218|FG001|Overall Study|Lost to Follow-up|7|||
130405501|NCT02797262|469448217|FG000|Overall Study|Death|1|||
130405502|NCT02797262|469448218|FG001|Overall Study|Death|2|||
130405503|NCT02797262|469448217|FG000|Overall Study|Adverse Event|1|||
130405504|NCT02797262|469448218|FG001|Overall Study|Adverse Event|0|||
130405505|NCT02797262|469448217|FG000|Overall Study|COVID-19|2|||
130405506|NCT02797262|469448218|FG001|Overall Study|COVID-19|1|||
130405507|NCT02797262|469448217|FG000|Overall Study|Out-of-country|1|||
130405508|NCT02797262|469448218|FG001|Overall Study|Out-of-country|0|||
130405509|NCT03146650|469448220|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
130405510|NCT03146650|469448220|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
130405511|NCT03146650|469448220|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
130405512|NCT03146650|469448220|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
130405513|NCT03146650|469448220|FG000|2 Year Follow-up|Death|11|||
130405514|NCT03146650|469448220|FG000|2 Year Follow-up|Still in follow-up|7|||
130405515|NCT03146650|469448220|FG000|2 Year Follow-up|Lost to Follow-up|1|||
130405516|NCT00983814|469448223|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
130405517|NCT00983814|469448224|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
130405518|NCT00983814|469448225|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
130405519|NCT00983814|469448223|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
130405520|NCT00983814|469448224|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
130405521|NCT00983814|469448225|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
130405522|NCT00983814|469448223|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
130405523|NCT00983814|469448224|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
130405524|NCT00983814|469448225|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
130471481|NCT04436107|469692712|FG003|Overall Study|Withdrawal by Subject|1|||
130471482|NCT01095796|469692713|FG000|Overall Study|Randomized but Not Treated|5|||
130471483|NCT01095796|469692714|FG001|Overall Study|Randomized but Not Treated|2|||
130471484|NCT01095796|469692713|FG000|Overall Study|Adverse Event|9|||
130471485|NCT01095796|469692714|FG001|Overall Study|Adverse Event|19|||
130471486|NCT01095796|469692713|FG000|Overall Study|Death|3|||
130471487|NCT01095796|469692714|FG001|Overall Study|Death|2|||
130471488|NCT01095796|469692713|FG000|Overall Study|Pregnancy|2|||
130471489|NCT01095796|469692714|FG001|Overall Study|Pregnancy|0|||
130471490|NCT01095796|469692713|FG000|Overall Study|Lack of Efficacy|5|||
130471491|NCT01095796|469692714|FG001|Overall Study|Lack of Efficacy|3|||
130405525|NCT00983814|469448223|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
130405526|NCT00983814|469448224|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
130405527|NCT00983814|469448225|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
130471492|NCT01095796|469692713|FG000|Overall Study|Investigator's Discretion|7|||
130405528|NCT00983814|469448223|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
130405529|NCT00983814|469448224|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
130405530|NCT00983814|469448225|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
130405531|NCT03333486|469448226|FG000|Overall Study|Withdrawal by Subject|1|||
130405532|NCT03333486|469448226|FG000|Overall Study|Lost to Follow-up|1|||
130405533|NCT01976845|469448229|FG000|Overall Study|Physician Decision|8|||
130405534|NCT01976845|469448230|FG001|Overall Study|Physician Decision|8|||
130471493|NCT01095796|469692714|FG001|Overall Study|Investigator's Discretion|2|||
130471494|NCT01095796|469692713|FG000|Overall Study|Withdrew Consent|16|||
130471495|NCT01095796|469692714|FG001|Overall Study|Withdrew Consent|22|||
130471496|NCT01095796|469692713|FG000|Overall Study|Lost to Follow-up|27|||
130405535|NCT01976845|469448231|FG002|Overall Study|Physician Decision|3|||
130405536|NCT03246529|469448233|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
130405537|NCT03246529|469448234|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
130405538|NCT03246529|469448235|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
130405539|NCT03246529|469448233|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
130405540|NCT03246529|469448234|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
130405541|NCT03246529|469448235|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
130405542|NCT03246529|469448233|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
130405543|NCT03246529|469448234|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
130405544|NCT03246529|469448235|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
130405545|NCT03246529|469448233|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
130405546|NCT03246529|469448234|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
130405547|NCT03246529|469448235|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
130405548|NCT03246529|469448233|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
130405549|NCT03246529|469448234|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
130405550|NCT03246529|469448235|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
130405551|NCT03246529|469448233|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
130405552|NCT03246529|469448234|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
130405553|NCT03246529|469448235|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
130405554|NCT03246529|469448233|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
130405555|NCT03246529|469448234|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
130405556|NCT03246529|469448235|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
130405557|NCT03246529|469448233|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
130405558|NCT03246529|469448234|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
130405559|NCT03246529|469448235|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
130405560|NCT03246529|469448233|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
130405561|NCT03246529|469448234|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
130405562|NCT03246529|469448235|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
130405563|NCT01209624|469448236|FG000|Overall Study|Death|2|||
130405564|NCT01209624|469448236|FG000|Overall Study|Adverse Event|13|||
130405565|NCT01209624|469448236|FG000|Overall Study|Lack of Efficacy|17|||
130405566|NCT01209624|469448236|FG000|Overall Study|Lost to Follow-up|290|||
130405567|NCT01209624|469448236|FG000|Overall Study|Other|4|||
130405568|NCT01818336|469449959|FG000|Overall Study|Declined retest visit|0|||
130405569|NCT01818336|469449960|FG001|Overall Study|Declined retest visit|11|||
130405570|NCT01818336|469449959|FG000|Overall Study|Lost to Follow-up|0|||
130405571|NCT01818336|469449960|FG001|Overall Study|Lost to Follow-up|1|||
130405572|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
130405573|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130405574|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130405575|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130405576|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130405577|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130405578|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
130405579|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130405580|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130405581|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130405582|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130405583|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130405584|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
130405585|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130405586|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130405587|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130405588|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130405589|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130405590|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
130405591|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130405592|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130405593|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130405594|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130405595|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130471497|NCT01095796|469692714|FG001|Overall Study|Lost to Follow-up|29|||
130724860|NCT00658021|470617059|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130724861|NCT00658021|470617057|FG000|28-Week Treatment Period|Loss of glucose control|1|||
130724862|NCT00658021|470617058|FG001|28-Week Treatment Period|Loss of glucose control|1|||
130724863|NCT00658021|470617059|FG002|28-Week Treatment Period|Loss of glucose control|10|||
130724864|NCT00658021|470617057|FG000|28-Week Treatment Period|Other|2|||
130405596|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
130405597|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130405598|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130405599|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130405600|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130405601|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130405602|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
130405603|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130405604|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130405605|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
130405606|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130405607|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
130405608|NCT02139644|469449963|FG000|Run-In Period (Pre-assignment)|Other|6|||
130405609|NCT02139644|469449964|FG001|Run-In Period (Pre-assignment)|Other|0|||
130405610|NCT02139644|469449965|FG002|Run-In Period (Pre-assignment)|Other|0|||
130405611|NCT02139644|469449966|FG003|Run-In Period (Pre-assignment)|Other|0|||
130405612|NCT02139644|469449967|FG004|Run-In Period (Pre-assignment)|Other|0|||
130405613|NCT02139644|469449968|FG005|Run-In Period (Pre-assignment)|Other|0|||
130405614|NCT02139644|469449963|FG000|Treatment Period|Adverse Event|0|||
130405615|NCT02139644|469449964|FG001|Treatment Period|Adverse Event|0|||
130405616|NCT02139644|469449965|FG002|Treatment Period|Adverse Event|3|||
130405617|NCT02139644|469449966|FG003|Treatment Period|Adverse Event|2|||
130405618|NCT02139644|469449967|FG004|Treatment Period|Adverse Event|1|||
130405619|NCT02139644|469449968|FG005|Treatment Period|Adverse Event|6|||
130405620|NCT02139644|469449963|FG000|Treatment Period|Withdrawal by Subject|0|||
130405621|NCT02139644|469449964|FG001|Treatment Period|Withdrawal by Subject|0|||
130405622|NCT02139644|469449965|FG002|Treatment Period|Withdrawal by Subject|2|||
130405623|NCT02139644|469449966|FG003|Treatment Period|Withdrawal by Subject|2|||
130405624|NCT02139644|469449967|FG004|Treatment Period|Withdrawal by Subject|3|||
130405625|NCT02139644|469449968|FG005|Treatment Period|Withdrawal by Subject|2|||
130405626|NCT02139644|469449963|FG000|Treatment Period|Non-compliance|0|||
130405627|NCT02139644|469449964|FG001|Treatment Period|Non-compliance|0|||
130405628|NCT02139644|469449965|FG002|Treatment Period|Non-compliance|0|||
130405629|NCT02139644|469449966|FG003|Treatment Period|Non-compliance|1|||
130405630|NCT02139644|469449967|FG004|Treatment Period|Non-compliance|0|||
130405631|NCT02139644|469449968|FG005|Treatment Period|Non-compliance|0|||
130405632|NCT02139644|469449963|FG000|Treatment Period|Protocol Violation|0|||
130405633|NCT02139644|469449964|FG001|Treatment Period|Protocol Violation|0|||
130405634|NCT02139644|469449965|FG002|Treatment Period|Protocol Violation|0|||
130405635|NCT02139644|469449966|FG003|Treatment Period|Protocol Violation|1|||
130405636|NCT02139644|469449967|FG004|Treatment Period|Protocol Violation|1|||
130405637|NCT02139644|469449968|FG005|Treatment Period|Protocol Violation|1|||
130405638|NCT02139644|469449963|FG000|Treatment Period|Disease progression|0|||
130405639|NCT02139644|469449964|FG001|Treatment Period|Disease progression|0|||
130405640|NCT02139644|469449965|FG002|Treatment Period|Disease progression|0|||
130405641|NCT02139644|469449966|FG003|Treatment Period|Disease progression|1|||
130405642|NCT02139644|469449967|FG004|Treatment Period|Disease progression|1|||
130405643|NCT02139644|469449968|FG005|Treatment Period|Disease progression|2|||
130405644|NCT02139644|469449963|FG000|Treatment Period|Lost to Follow-up|0|||
130405645|NCT02139644|469449964|FG001|Treatment Period|Lost to Follow-up|0|||
130405646|NCT02139644|469449965|FG002|Treatment Period|Lost to Follow-up|1|||
130405647|NCT02139644|469449966|FG003|Treatment Period|Lost to Follow-up|1|||
130405648|NCT02139644|469449967|FG004|Treatment Period|Lost to Follow-up|1|||
130405649|NCT02139644|469449968|FG005|Treatment Period|Lost to Follow-up|1|||
130405650|NCT02139644|469449963|FG000|Treatment Period|Lack of Efficacy|0|||
130405651|NCT02139644|469449964|FG001|Treatment Period|Lack of Efficacy|0|||
130405652|NCT02139644|469449965|FG002|Treatment Period|Lack of Efficacy|1|||
130405653|NCT02139644|469449966|FG003|Treatment Period|Lack of Efficacy|0|||
130405654|NCT02139644|469449967|FG004|Treatment Period|Lack of Efficacy|1|||
130405655|NCT02139644|469449968|FG005|Treatment Period|Lack of Efficacy|4|||
130405656|NCT02139644|469449963|FG000|Treatment Period|Other|0|||
130405657|NCT02139644|469449964|FG001|Treatment Period|Other|3|||
130405658|NCT02139644|469449965|FG002|Treatment Period|Other|1|||
130405659|NCT02139644|469449966|FG003|Treatment Period|Other|1|||
130405660|NCT02139644|469449967|FG004|Treatment Period|Other|0|||
130405661|NCT02139644|469449968|FG005|Treatment Period|Other|1|||
130405662|NCT03328897|469449969|FG000|Randomized-treatment Epoch|Adverse Event|4|||
130405663|NCT03328897|469449970|FG001|Randomized-treatment Epoch|Adverse Event|1|||
130405664|NCT03328897|469449971|FG002|Randomized-treatment Epoch|Adverse Event|1|||
130405665|NCT03328897|469449969|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
130405666|NCT03328897|469449970|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
130405667|NCT03328897|469449971|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
130405668|NCT03328897|469449969|FG000|Randomized-treatment Epoch|Pregnancy|3|||
130405669|NCT03328897|469449970|FG001|Randomized-treatment Epoch|Pregnancy|0|||
130405670|NCT03328897|469449971|FG002|Randomized-treatment Epoch|Pregnancy|0|||
130405671|NCT03328897|469449969|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
130405672|NCT03328897|469449970|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
130405673|NCT03328897|469449971|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
130405674|NCT03328897|469449969|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
130405675|NCT03328897|469449970|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
130405676|NCT03328897|469449971|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
130405677|NCT03328897|469449969|FG000|Follow-up Epoch|Adverse Event|4|||
130405678|NCT03328897|469449970|FG001|Follow-up Epoch|Adverse Event|0|||
130405679|NCT03328897|469449971|FG002|Follow-up Epoch|Adverse Event|1|||
130405680|NCT03328897|469449969|FG000|Follow-up Epoch|Lack of Efficacy|1|||
130405681|NCT03328897|469449970|FG001|Follow-up Epoch|Lack of Efficacy|1|||
130405682|NCT03328897|469449971|FG002|Follow-up Epoch|Lack of Efficacy|1|||
130405683|NCT03328897|469449969|FG000|Follow-up Epoch|Lost to Follow-up|0|||
130405684|NCT03328897|469449970|FG001|Follow-up Epoch|Lost to Follow-up|1|||
130405685|NCT03328897|469449971|FG002|Follow-up Epoch|Lost to Follow-up|0|||
130405686|NCT03328897|469449969|FG000|Follow-up Epoch|Pregnancy|1|||
130405687|NCT03328897|469449970|FG001|Follow-up Epoch|Pregnancy|0|||
130405688|NCT03328897|469449971|FG002|Follow-up Epoch|Pregnancy|0|||
130405689|NCT03328897|469449969|FG000|Follow-up Epoch|Patient/guardian decision|2|||
130405690|NCT03328897|469449970|FG001|Follow-up Epoch|Patient/guardian decision|1|||
130405691|NCT03328897|469449971|FG002|Follow-up Epoch|Patient/guardian decision|0|||
130405692|NCT00941733|469449972|FG000|Overall Study|Death|24|||
130405693|NCT00941733|469449973|FG001|Overall Study|Death|10|||
130405694|NCT00941733|469449972|FG000|Overall Study|Withdrawal by Subject|14|||
130405695|NCT00941733|469449973|FG001|Overall Study|Withdrawal by Subject|6|||
130405696|NCT00941733|469449972|FG000|Overall Study|Adverse Event|20|||
130405697|NCT00941733|469449973|FG001|Overall Study|Adverse Event|4|||
130405698|NCT00941733|469449972|FG000|Overall Study|Lost to Follow-up|1|||
130405699|NCT00941733|469449973|FG001|Overall Study|Lost to Follow-up|2|||
130405700|NCT00941733|469449972|FG000|Overall Study|Protocol Violation|15|||
130405701|NCT00941733|469449973|FG001|Overall Study|Protocol Violation|6|||
130405702|NCT01643473|469449976|FG000|Overall Study|Lost to Follow-up|1|||
130405703|NCT01643473|469449977|FG001|Overall Study|Lost to Follow-up|0|||
130405704|NCT02343458|469449981|FG000|Overall Study|Adverse Event|15|||
130405705|NCT02343458|469449982|FG001|Overall Study|Adverse Event|14|||
130405706|NCT02343458|469449983|FG002|Overall Study|Adverse Event|15|||
130405707|NCT02343458|469449984|FG003|Overall Study|Adverse Event|3|||
130405708|NCT02343458|469449981|FG000|Overall Study|Lack of Efficacy|3|||
130405709|NCT02343458|469449982|FG001|Overall Study|Lack of Efficacy|8|||
130405710|NCT02343458|469449983|FG002|Overall Study|Lack of Efficacy|4|||
130405711|NCT02343458|469449984|FG003|Overall Study|Lack of Efficacy|8|||
130405712|NCT02343458|469449981|FG000|Overall Study|Withdrawal by Subject|18|||
130405713|NCT02343458|469449982|FG001|Overall Study|Withdrawal by Subject|17|||
130405714|NCT02343458|469449983|FG002|Overall Study|Withdrawal by Subject|23|||
130405715|NCT02343458|469449984|FG003|Overall Study|Withdrawal by Subject|14|||
130405716|NCT02343458|469449981|FG000|Overall Study|Physician Decision|1|||
130405717|NCT02343458|469449982|FG001|Overall Study|Physician Decision|4|||
130405718|NCT02343458|469449983|FG002|Overall Study|Physician Decision|2|||
130405719|NCT02343458|469449984|FG003|Overall Study|Physician Decision|2|||
130405720|NCT02343458|469449981|FG000|Overall Study|Lost to Follow-up|5|||
130405721|NCT02343458|469449982|FG001|Overall Study|Lost to Follow-up|5|||
130405722|NCT02343458|469449983|FG002|Overall Study|Lost to Follow-up|3|||
130405723|NCT02343458|469449984|FG003|Overall Study|Lost to Follow-up|1|||
130405724|NCT02343458|469449981|FG000|Overall Study|Protocol Violation|2|||
130405725|NCT02343458|469449982|FG001|Overall Study|Protocol Violation|5|||
130405726|NCT02343458|469449983|FG002|Overall Study|Protocol Violation|2|||
130405727|NCT02343458|469449984|FG003|Overall Study|Protocol Violation|2|||
130405728|NCT02343458|469449981|FG000|Overall Study|Protocol Specified Criteria|17|||
130471498|NCT01095796|469692713|FG000|Overall Study|Participant Noncompliance|5|||
130724865|NCT00658021|470617058|FG001|28-Week Treatment Period|Other|3|||
130724866|NCT00658021|470617059|FG002|28-Week Treatment Period|Other|1|||
130471499|NCT01095796|469692714|FG001|Overall Study|Participant Noncompliance|10|||
130724867|NCT00658021|470617057|FG000|28-Week Treatment Period|Did not receive treatment|2|||
130724868|NCT00658021|470617058|FG001|28-Week Treatment Period|Did not receive treatment|0|||
130471500|NCT01095796|469692713|FG000|Overall Study|Protocol Violation|1|||
130405729|NCT02343458|469449982|FG001|Overall Study|Protocol Specified Criteria|13|||
130405730|NCT02343458|469449983|FG002|Overall Study|Protocol Specified Criteria|14|||
130405731|NCT02343458|469449984|FG003|Overall Study|Protocol Specified Criteria|8|||
130405732|NCT01265953|469449985|FG000|Overall Study|Non compliance|5|||
130405733|NCT01265953|469449986|FG001|Overall Study|Non compliance|3|||
130405734|NCT02648698|469449988|FG000|Overall Study|Protocol Violation|1|||
130405735|NCT02648698|469449989|FG001|Overall Study|Protocol Violation|5|||
130405736|NCT01640301|469449990|FG000|Overall Study|Death|0|||
130405737|NCT01640301|469449991|FG001|Overall Study|Death|8|||
130405738|NCT02391948|469449996|FG000|6-month Assessment|Death|0|||
130405739|NCT02391948|469449997|FG001|6-month Assessment|Death|0|||
130405740|NCT02391948|469449998|FG002|6-month Assessment|Death|0|||
130405741|NCT02391948|469449999|FG003|6-month Assessment|Death|0|||
130471501|NCT01095796|469692714|FG001|Overall Study|Protocol Violation|0|||
130471502|NCT01095796|469692713|FG000|Overall Study|Participant Transferred to Another Study|215|||
130405742|NCT02391948|469450000|FG004|6-month Assessment|Death|1|||
130405743|NCT02391948|469449996|FG000|6-month Assessment|Withdrawal by Subject|0|||
130405744|NCT02391948|469449997|FG001|6-month Assessment|Withdrawal by Subject|0|||
130405745|NCT02391948|469449998|FG002|6-month Assessment|Withdrawal by Subject|1|||
130405746|NCT02391948|469449999|FG003|6-month Assessment|Withdrawal by Subject|2|||
130405747|NCT02391948|469450000|FG004|6-month Assessment|Withdrawal by Subject|0|||
130405748|NCT02391948|469449996|FG000|6-month Assessment|Lost to Follow-up|4|||
130405749|NCT02391948|469449997|FG001|6-month Assessment|Lost to Follow-up|5|||
130405750|NCT02391948|469449998|FG002|6-month Assessment|Lost to Follow-up|2|||
130405751|NCT02391948|469449999|FG003|6-month Assessment|Lost to Follow-up|3|||
130405752|NCT02391948|469450000|FG004|6-month Assessment|Lost to Follow-up|1|||
130405753|NCT02391948|469449996|FG000|6-month Assessment|Medical issue/illness|1|||
130405754|NCT02391948|469449997|FG001|6-month Assessment|Medical issue/illness|1|||
130405755|NCT02391948|469449998|FG002|6-month Assessment|Medical issue/illness|0|||
130405756|NCT02391948|469449999|FG003|6-month Assessment|Medical issue/illness|0|||
130405757|NCT02391948|469450000|FG004|6-month Assessment|Medical issue/illness|0|||
130405758|NCT02391948|469449996|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
130405759|NCT02391948|469449997|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
130405760|NCT02391948|469449998|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
130405761|NCT02391948|469449999|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
130405762|NCT02391948|469450000|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
130405763|NCT02391948|469449996|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
130405764|NCT02391948|469449997|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
130405765|NCT02391948|469449998|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
130405766|NCT02391948|469449999|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
130405767|NCT02391948|469450000|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
130405768|NCT02391948|469449996|FG000|12-month Assessment|Death|0|||
130405769|NCT02391948|469449997|FG001|12-month Assessment|Death|0|||
130405770|NCT02391948|469449998|FG002|12-month Assessment|Death|0|||
130405771|NCT02391948|469449999|FG003|12-month Assessment|Death|1|||
130405772|NCT02391948|469450000|FG004|12-month Assessment|Death|0|||
130405773|NCT02391948|469449996|FG000|12-month Assessment|Withdrawal by Subject|1|||
130405774|NCT02391948|469449997|FG001|12-month Assessment|Withdrawal by Subject|0|||
130405775|NCT02391948|469449998|FG002|12-month Assessment|Withdrawal by Subject|0|||
130405776|NCT02391948|469449999|FG003|12-month Assessment|Withdrawal by Subject|1|||
130405777|NCT02391948|469450000|FG004|12-month Assessment|Withdrawal by Subject|0|||
130405778|NCT02391948|469449996|FG000|12-month Assessment|Lost to Follow-up|5|||
130405779|NCT02391948|469449997|FG001|12-month Assessment|Lost to Follow-up|4|||
130405780|NCT02391948|469449998|FG002|12-month Assessment|Lost to Follow-up|4|||
130405781|NCT02391948|469449999|FG003|12-month Assessment|Lost to Follow-up|4|||
130405782|NCT02391948|469450000|FG004|12-month Assessment|Lost to Follow-up|5|||
130405783|NCT02391948|469449996|FG000|12-month Assessment|Medical issue/illness|0|||
130405784|NCT02391948|469449997|FG001|12-month Assessment|Medical issue/illness|1|||
130724869|NCT00658021|470617059|FG002|28-Week Treatment Period|Did not receive treatment|0|||
130724870|NCT00658021|470617057|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
130405785|NCT02391948|469449998|FG002|12-month Assessment|Medical issue/illness|0|||
130405786|NCT02391948|469449999|FG003|12-month Assessment|Medical issue/illness|1|||
130405787|NCT02391948|469450000|FG004|12-month Assessment|Medical issue/illness|0|||
130405788|NCT02391948|469449996|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
130405789|NCT02391948|469449997|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
130405790|NCT02391948|469449998|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
130405791|NCT02391948|469449999|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
130405792|NCT02391948|469450000|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
130405793|NCT02391948|469449996|FG000|18-month Assessment|Death|0|||
130405794|NCT02391948|469449997|FG001|18-month Assessment|Death|0|||
130405795|NCT02391948|469449998|FG002|18-month Assessment|Death|0|||
130405796|NCT02391948|469449999|FG003|18-month Assessment|Death|1|||
130405797|NCT02391948|469450000|FG004|18-month Assessment|Death|1|||
130405798|NCT02391948|469449996|FG000|18-month Assessment|Withdrawal by Subject|1|||
130405799|NCT02391948|469449997|FG001|18-month Assessment|Withdrawal by Subject|0|||
130405800|NCT02391948|469449998|FG002|18-month Assessment|Withdrawal by Subject|0|||
130405801|NCT02391948|469449999|FG003|18-month Assessment|Withdrawal by Subject|1|||
130405802|NCT02391948|469450000|FG004|18-month Assessment|Withdrawal by Subject|0|||
130405803|NCT02391948|469449996|FG000|18-month Assessment|Lost to Follow-up|2|||
130405804|NCT02391948|469449997|FG001|18-month Assessment|Lost to Follow-up|6|||
130405805|NCT02391948|469449998|FG002|18-month Assessment|Lost to Follow-up|2|||
130405806|NCT02391948|469449999|FG003|18-month Assessment|Lost to Follow-up|2|||
130405807|NCT02391948|469450000|FG004|18-month Assessment|Lost to Follow-up|3|||
130405808|NCT02391948|469449996|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
130405809|NCT02391948|469449997|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
130405810|NCT02391948|469449998|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
130561059|NCT03250832|470022791|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
130561060|NCT03250832|470022780|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
130405811|NCT02391948|469449999|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
130405812|NCT02391948|469450000|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
130405813|NCT02391948|469449996|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
130405814|NCT02391948|469449997|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
130405815|NCT02391948|469449998|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
130405816|NCT02391948|469449999|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
130405817|NCT02391948|469450000|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
130405818|NCT02391948|469449996|FG000|24-month Assessment|Death|0|||
130405819|NCT02391948|469449997|FG001|24-month Assessment|Death|0|||
130405820|NCT02391948|469449998|FG002|24-month Assessment|Death|0|||
130405821|NCT02391948|469449999|FG003|24-month Assessment|Death|0|||
130405822|NCT02391948|469450000|FG004|24-month Assessment|Death|1|||
130405823|NCT02391948|469449996|FG000|24-month Assessment|Withdrawal by Subject|1|||
130405824|NCT02391948|469449997|FG001|24-month Assessment|Withdrawal by Subject|1|||
130405825|NCT02391948|469449998|FG002|24-month Assessment|Withdrawal by Subject|0|||
130405826|NCT02391948|469449999|FG003|24-month Assessment|Withdrawal by Subject|0|||
130405827|NCT02391948|469450000|FG004|24-month Assessment|Withdrawal by Subject|1|||
130405828|NCT02391948|469449996|FG000|24-month Assessment|Lost to Follow-up|5|||
130405829|NCT02391948|469449997|FG001|24-month Assessment|Lost to Follow-up|4|||
130405830|NCT02391948|469449998|FG002|24-month Assessment|Lost to Follow-up|0|||
130405831|NCT02391948|469449999|FG003|24-month Assessment|Lost to Follow-up|0|||
130405832|NCT02391948|469450000|FG004|24-month Assessment|Lost to Follow-up|0|||
130405833|NCT02391948|469449996|FG000|24-month Assessment|Medical issue/illness|0|||
130405834|NCT02391948|469449997|FG001|24-month Assessment|Medical issue/illness|0|||
130405835|NCT02391948|469449998|FG002|24-month Assessment|Medical issue/illness|1|||
130405836|NCT02391948|469449999|FG003|24-month Assessment|Medical issue/illness|0|||
130405837|NCT02391948|469450000|FG004|24-month Assessment|Medical issue/illness|0|||
130405838|NCT02391948|469449996|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
130405839|NCT02391948|469449997|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
130405840|NCT02391948|469449998|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
130405841|NCT02391948|469449999|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
130405842|NCT02391948|469450000|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
130405843|NCT01639001|469450001|FG000|Overall Study|Refused further follow-up|9|||
130405844|NCT01639001|469450002|FG001|Overall Study|Refused further follow-up|12|||
130405845|NCT01639001|469450001|FG000|Overall Study|Lost to Follow-up|3|||
130405846|NCT01639001|469450002|FG001|Overall Study|Lost to Follow-up|0|||
130405847|NCT01639001|469450001|FG000|Overall Study|Death|62|||
130405848|NCT01639001|469450002|FG001|Overall Study|Death|61|||
130405849|NCT01639001|469450001|FG000|Overall Study|Randomized but not treated|0|||
130405850|NCT01639001|469450002|FG001|Overall Study|Randomized but not treated|2|||
130405851|NCT01639001|469450001|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
130405852|NCT01639001|469450002|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
130405853|NCT01969838|469450003|FG000|Double-blind Phase|Adverse Event|10|||
130471503|NCT01095796|469692714|FG001|Overall Study|Participant Transferred to Another Study|200|||
130471504|NCT01989455|469692719|FG000|Overall Study|Adverse Event|0|||
130471505|NCT01989455|469692720|FG001|Overall Study|Adverse Event|1|||
130405854|NCT01969838|469450004|FG001|Double-blind Phase|Adverse Event|4|||
130405855|NCT01969838|469450005|FG002|Double-blind Phase|Adverse Event|0|||
130405856|NCT01969838|469450006|FG003|Double-blind Phase|Adverse Event|0|||
130405857|NCT01969838|469450003|FG000|Double-blind Phase|Death|5|||
130405858|NCT01969838|469450004|FG001|Double-blind Phase|Death|2|||
130405859|NCT01969838|469450005|FG002|Double-blind Phase|Death|0|||
130405860|NCT01969838|469450006|FG003|Double-blind Phase|Death|0|||
130405861|NCT01969838|469450003|FG000|Double-blind Phase|Physician Decision|5|||
130405862|NCT01969838|469450004|FG001|Double-blind Phase|Physician Decision|1|||
130405863|NCT01969838|469450005|FG002|Double-blind Phase|Physician Decision|0|||
130405864|NCT01969838|469450006|FG003|Double-blind Phase|Physician Decision|0|||
130405865|NCT01969838|469450003|FG000|Double-blind Phase|Subject Decision|4|||
130405866|NCT01969838|469450004|FG001|Double-blind Phase|Subject Decision|2|||
130405867|NCT01969838|469450005|FG002|Double-blind Phase|Subject Decision|0|||
130405868|NCT01969838|469450006|FG003|Double-blind Phase|Subject Decision|0|||
130405869|NCT01969838|469450003|FG000|Double-blind Phase|Disease Progression|2|||
130405870|NCT01969838|469450004|FG001|Double-blind Phase|Disease Progression|0|||
130405871|NCT01969838|469450005|FG002|Double-blind Phase|Disease Progression|0|||
130405872|NCT01969838|469450006|FG003|Double-blind Phase|Disease Progression|0|||
130405873|NCT01969838|469450003|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
130405874|NCT01969838|469450004|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
130405875|NCT01969838|469450005|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
130405876|NCT01969838|469450006|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
130471506|NCT01989455|469692721|FG002|Overall Study|Adverse Event|0|||
130471507|NCT01989455|469692722|FG003|Overall Study|Adverse Event|0|||
130471508|NCT01989455|469692723|FG004|Overall Study|Adverse Event|0|||
130471509|NCT01989455|469692719|FG000|Overall Study|Withdrawal by Subject|0|||
130405877|NCT01969838|469450003|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
130405878|NCT01969838|469450004|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
130405879|NCT01969838|469450005|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
130405880|NCT01969838|469450006|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
130405881|NCT01969838|469450003|FG000|Open-label Phase|Adverse Event|0|||
130405882|NCT01969838|469450004|FG001|Open-label Phase|Adverse Event|0|||
130405883|NCT01969838|469450005|FG002|Open-label Phase|Adverse Event|37|||
130405884|NCT01969838|469450006|FG003|Open-label Phase|Adverse Event|49|||
130405885|NCT01969838|469450003|FG000|Open-label Phase|Disease Progression|0|||
130405886|NCT01969838|469450004|FG001|Open-label Phase|Disease Progression|0|||
130405887|NCT01969838|469450005|FG002|Open-label Phase|Disease Progression|26|||
130405888|NCT01969838|469450006|FG003|Open-label Phase|Disease Progression|27|||
130405889|NCT01969838|469450003|FG000|Open-label Phase|Lack of Efficacy|0|||
130405890|NCT01969838|469450004|FG001|Open-label Phase|Lack of Efficacy|0|||
130405891|NCT01969838|469450005|FG002|Open-label Phase|Lack of Efficacy|17|||
130405892|NCT01969838|469450006|FG003|Open-label Phase|Lack of Efficacy|19|||
130405893|NCT01969838|469450003|FG000|Open-label Phase|Subject Decision|0|||
130405894|NCT01969838|469450004|FG001|Open-label Phase|Subject Decision|0|||
130405895|NCT01969838|469450005|FG002|Open-label Phase|Subject Decision|14|||
130405896|NCT01969838|469450006|FG003|Open-label Phase|Subject Decision|15|||
130405897|NCT01969838|469450003|FG000|Open-label Phase|Death|0|||
130405898|NCT01969838|469450004|FG001|Open-label Phase|Death|0|||
130405899|NCT01969838|469450005|FG002|Open-label Phase|Death|13|||
130405900|NCT01969838|469450006|FG003|Open-label Phase|Death|11|||
130405901|NCT01969838|469450003|FG000|Open-label Phase|Physician Decision|0|||
130405902|NCT01969838|469450004|FG001|Open-label Phase|Physician Decision|0|||
130405903|NCT01969838|469450005|FG002|Open-label Phase|Physician Decision|9|||
130405904|NCT01969838|469450006|FG003|Open-label Phase|Physician Decision|14|||
130724871|NCT00658021|470617058|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
130724872|NCT00658021|470617059|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
130724873|NCT00658021|470617057|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
130724874|NCT00658021|470617058|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
130405905|NCT01969838|469450003|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
130405906|NCT01969838|469450004|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
130405907|NCT01969838|469450005|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
130405908|NCT01969838|469450006|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
130405909|NCT02944578|469450009|FG000|Overall Study|Physician Decision|1|||
130405910|NCT02944578|469450010|FG001|Overall Study|Physician Decision|0|||
130405911|NCT00807092|469450011|FG000|Overall Study|Adverse Event|0|||
130405912|NCT00807092|469450012|FG001|Overall Study|Adverse Event|1|||
130405913|NCT00807092|469450011|FG000|Overall Study|Protocol Violation|0|||
130405914|NCT00807092|469450012|FG001|Overall Study|Protocol Violation|2|||
130405915|NCT00807092|469450011|FG000|Overall Study|Withdrawal by Subject|1|||
130405916|NCT00807092|469450012|FG001|Overall Study|Withdrawal by Subject|0|||
130405917|NCT00807092|469450011|FG000|Overall Study|CGMS data collection failed|0|||
130405918|NCT00807092|469450012|FG001|Overall Study|CGMS data collection failed|1|||
130405919|NCT04116229|469450013|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
130405920|NCT04116229|469450014|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
130405921|NCT04116229|469450013|FG000|Overall Study|Scheduling not possible.|0|||
130405922|NCT04116229|469450014|FG001|Overall Study|Scheduling not possible.|1|||
130405923|NCT02170727|469450023|FG000|Overall Study|Lost to Follow-up|1|||
130405924|NCT02170727|469450024|FG001|Overall Study|Lost to Follow-up|0|||
130405925|NCT02170727|469450023|FG000|Overall Study|Withdrawal by Subject|2|||
130405926|NCT02170727|469450024|FG001|Overall Study|Withdrawal by Subject|0|||
130405927|NCT01599650|469450025|FG000|Overall Study|Administrative issue|1|||
130405928|NCT01599650|469450026|FG001|Overall Study|Administrative issue|0|||
130405929|NCT01599650|469450027|FG002|Overall Study|Administrative issue|1|||
130405930|NCT01599650|469450025|FG000|Overall Study|Physician Decision|2|||
130405931|NCT01599650|469450026|FG001|Overall Study|Physician Decision|0|||
130405932|NCT01599650|469450027|FG002|Overall Study|Physician Decision|7|||
130405933|NCT01599650|469450025|FG000|Overall Study|Protocol Violation|0|||
130405934|NCT01599650|469450026|FG001|Overall Study|Protocol Violation|3|||
130405935|NCT01599650|469450027|FG002|Overall Study|Protocol Violation|0|||
130405936|NCT01599650|469450025|FG000|Overall Study|Death|2|||
130405937|NCT01599650|469450026|FG001|Overall Study|Death|1|||
130405938|NCT01599650|469450027|FG002|Overall Study|Death|2|||
130405939|NCT01599650|469450025|FG000|Overall Study|Lost to Follow-up|3|||
130405940|NCT01599650|469450026|FG001|Overall Study|Lost to Follow-up|3|||
130405941|NCT01599650|469450027|FG002|Overall Study|Lost to Follow-up|3|||
130405942|NCT01599650|469450025|FG000|Overall Study|Withdrawal by Subject|11|||
130405943|NCT01599650|469450026|FG001|Overall Study|Withdrawal by Subject|11|||
130405944|NCT01599650|469450027|FG002|Overall Study|Withdrawal by Subject|10|||
130405945|NCT01599650|469450025|FG000|Overall Study|Adverse Event|3|||
130405946|NCT01599650|469450026|FG001|Overall Study|Adverse Event|8|||
130405947|NCT01599650|469450027|FG002|Overall Study|Adverse Event|4|||
130405948|NCT00179647|469450035|FG000|Overall Study|Adverse Event|294|||
130471510|NCT01989455|469692720|FG001|Overall Study|Withdrawal by Subject|1|||
130724875|NCT00658021|470617059|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
130724876|NCT02952898|470617065|FG000|Overall Study|Withdrawal by Subject|10|||
130724877|NCT02952898|470617066|FG001|Overall Study|Withdrawal by Subject|8|||
130724878|NCT02952898|470617067|FG002|Overall Study|Withdrawal by Subject|8|||
130724879|NCT02952898|470617065|FG000|Overall Study|Adverse Event|8|||
130724880|NCT02952898|470617066|FG001|Overall Study|Adverse Event|8|||
130724881|NCT02952898|470617067|FG002|Overall Study|Adverse Event|3|||
130724882|NCT02952898|470617065|FG000|Overall Study|Lost to Follow-up|3|||
130724883|NCT02952898|470617066|FG001|Overall Study|Lost to Follow-up|2|||
130405949|NCT00179647|469450035|FG000|Overall Study|Lack of Efficacy|478|||
130405950|NCT00179647|469450035|FG000|Overall Study|Withdrawal by Subject|83|||
130405951|NCT00179647|469450035|FG000|Overall Study|Lost to Follow-up|4|||
130405952|NCT00179647|469450035|FG000|Overall Study|Death|94|||
130405953|NCT00179647|469450035|FG000|Overall Study|Other|960|||
130405954|NCT04154631|469450036|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
130405955|NCT04154631|469450037|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
130405956|NCT02138214|469450040|FG000|Overall Study|Withdrawal by Subject|0|||
130405957|NCT02138214|469450041|FG001|Overall Study|Withdrawal by Subject|1|||
130405958|NCT02138214|469450042|FG002|Overall Study|Withdrawal by Subject|0|||
130405959|NCT02138214|469450040|FG000|Overall Study|Lost to Follow-up|0|||
130405960|NCT02138214|469450041|FG001|Overall Study|Lost to Follow-up|2|||
130405961|NCT02138214|469450042|FG002|Overall Study|Lost to Follow-up|4|||
130405962|NCT02138214|469450040|FG000|Overall Study|Screen Failure|0|||
130405963|NCT02138214|469450041|FG001|Overall Study|Screen Failure|1|||
130405964|NCT02138214|469450042|FG002|Overall Study|Screen Failure|0|||
130405965|NCT02185768|469450043|FG000|Overall Study|Patients were not treated|2|||
130405966|NCT02158039|469450054|FG000|Overall Study|Withdrawal by Subject|1|||
130405967|NCT02158039|469450054|FG000|Overall Study|Screen Failure|9|||
130405968|NCT03062891|469450066|FG000|Overall Study|Withdrawal by Subject|2|||
130405969|NCT03062891|469450067|FG001|Overall Study|Withdrawal by Subject|0|||
130405970|NCT03062891|469450066|FG000|Overall Study|Lost to Follow-up|50|||
130405971|NCT03062891|469450067|FG001|Overall Study|Lost to Follow-up|38|||
130405972|NCT02127307|469450068|FG000|Overall Study|Protocol Violation|36|||
130405973|NCT02127307|469450068|FG000|Overall Study|Lost to Follow-up|2|||
130405974|NCT02127307|469450068|FG000|Overall Study|Death|101|||
130405975|NCT02127307|469450068|FG000|Overall Study|Other than specified above|169|||
130405976|NCT03509948|469450069|FG000|Overall Study|Protocol Violation|0|||
130405977|NCT03509948|469450070|FG001|Overall Study|Protocol Violation|1|||
130405978|NCT03221257|469450071|FG000|Overall Study|Lost to Follow-up|0|||
130405979|NCT03221257|469450072|FG001|Overall Study|Lost to Follow-up|1|||
130405980|NCT03221257|469450071|FG000|Overall Study|Withdrawal by Subject|1|||
130405981|NCT03221257|469450072|FG001|Overall Study|Withdrawal by Subject|1|||
130405982|NCT01334866|469450076|FG000|Overall Study|Withdrawal by Subject|10|||
130405983|NCT01334866|469450076|FG000|Overall Study|Lost to Follow-up|3|||
130405984|NCT01334866|469450076|FG000|Overall Study|Physician Decision|3|||
130405985|NCT01334866|469450076|FG000|Overall Study|medically necessary prior to procedure|2|||
130405986|NCT01334866|469450076|FG000|Overall Study|medically necessary post-procedure|1|||
130405987|NCT01687166|469450085|FG000|Overall Study|Attempt subject|2|||
130405988|NCT01687166|469450086|FG001|Overall Study|Attempt subject|3|||
130405989|NCT01687166|469450087|FG002|Overall Study|Attempt subject|2|||
130405990|NCT01687166|469450088|FG003|Overall Study|Attempt subject|0|||
130405991|NCT01687166|469450085|FG000|Overall Study|Did not meet eligibility criteria|4|||
130405992|NCT01687166|469450086|FG001|Overall Study|Did not meet eligibility criteria|6|||
130405993|NCT01687166|469450087|FG002|Overall Study|Did not meet eligibility criteria|1|||
130405994|NCT01687166|469450088|FG003|Overall Study|Did not meet eligibility criteria|1|||
130405995|NCT01687166|469450085|FG000|Overall Study|Adverse Event|2|||
130405996|NCT01687166|469450086|FG001|Overall Study|Adverse Event|1|||
130405997|NCT01687166|469450087|FG002|Overall Study|Adverse Event|0|||
130724884|NCT02952898|470617067|FG002|Overall Study|Lost to Follow-up|2|||
130724885|NCT02952898|470617065|FG000|Overall Study|Non-compliance with study drug|1|||
130405998|NCT01687166|469450088|FG003|Overall Study|Adverse Event|0|||
130405999|NCT01687166|469450085|FG000|Overall Study|Physician Decision|3|||
130406000|NCT01687166|469450086|FG001|Overall Study|Physician Decision|2|||
130471511|NCT01989455|469692721|FG002|Overall Study|Withdrawal by Subject|0|||
130471512|NCT01989455|469692722|FG003|Overall Study|Withdrawal by Subject|0|||
130471513|NCT01989455|469692723|FG004|Overall Study|Withdrawal by Subject|0|||
130471514|NCT01989455|469692719|FG000|Overall Study|Technical problems with infusion|0|||
130724886|NCT02952898|470617066|FG001|Overall Study|Non-compliance with study drug|1|||
130724887|NCT02952898|470617067|FG002|Overall Study|Non-compliance with study drug|2|||
130724888|NCT04123561|470617076|FG000|Overall Study|Lost to Follow-up|20|||
130406001|NCT01687166|469450087|FG002|Overall Study|Physician Decision|1|||
130406002|NCT01687166|469450088|FG003|Overall Study|Physician Decision|0|||
130406003|NCT01687166|469450085|FG000|Overall Study|Withdrawal by Subject|11|||
130406004|NCT01687166|469450086|FG001|Overall Study|Withdrawal by Subject|4|||
130406005|NCT01687166|469450087|FG002|Overall Study|Withdrawal by Subject|3|||
130406006|NCT01687166|469450088|FG003|Overall Study|Withdrawal by Subject|0|||
130724889|NCT04123561|470617077|FG001|Overall Study|Lost to Follow-up|12|||
130724890|NCT04123561|470617078|FG002|Overall Study|Lost to Follow-up|5|||
130724891|NCT04123561|470617076|FG000|Overall Study|Withdrawal by Subject|9|||
130724892|NCT04123561|470617077|FG001|Overall Study|Withdrawal by Subject|7|||
130724893|NCT04123561|470617078|FG002|Overall Study|Withdrawal by Subject|9|||
130724894|NCT04123561|470617076|FG000|Overall Study|Lack of Efficacy|7|||
130724895|NCT04123561|470617077|FG001|Overall Study|Lack of Efficacy|8|||
130724896|NCT04123561|470617078|FG002|Overall Study|Lack of Efficacy|6|||
130724897|NCT04123561|470617076|FG000|Overall Study|Adverse Event|5|||
130724898|NCT04123561|470617077|FG001|Overall Study|Adverse Event|2|||
130724899|NCT04123561|470617078|FG002|Overall Study|Adverse Event|3|||
130724900|NCT04123561|470617076|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
130724901|NCT04123561|470617077|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
130724902|NCT04123561|470617078|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
130724903|NCT04123561|470617076|FG000|Overall Study|Death|0|||
130724904|NCT04123561|470617077|FG001|Overall Study|Death|0|||
130724905|NCT04123561|470617078|FG002|Overall Study|Death|1|||
130724906|NCT04123561|470617076|FG000|Overall Study|Protocol Violation|0|||
130724907|NCT04123561|470617077|FG001|Overall Study|Protocol Violation|1|||
130724908|NCT04123561|470617078|FG002|Overall Study|Protocol Violation|0|||
130724909|NCT03462459|470617086|FG000|Overall Study|Death|1|||
130724910|NCT03462459|470617087|FG001|Overall Study|Death|0|||
130724911|NCT03462459|470617086|FG000|Overall Study|Lack of Efficacy|2|||
130724912|NCT03462459|470617087|FG001|Overall Study|Lack of Efficacy|4|||
130724913|NCT03462459|470617086|FG000|Overall Study|Lost to Follow-up|1|||
130724914|NCT03462459|470617087|FG001|Overall Study|Lost to Follow-up|3|||
130724915|NCT03462459|470617086|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
130724916|NCT03462459|470617087|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
130724917|NCT03462459|470617086|FG000|Overall Study|Withdrawal by Subject|3|||
130724918|NCT03462459|470617087|FG001|Overall Study|Withdrawal by Subject|2|||
130724919|NCT03462459|470617086|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
130724920|NCT03462459|470617087|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
130724921|NCT03132155|470619135|FG000|Overall Study|Lack of Efficacy|6|||
130724922|NCT03132155|470619135|FG000|Overall Study|Lost to Follow-up|1|||
130724923|NCT03132155|470619135|FG000|Overall Study|Withdrawal by Subject|1|||
130724924|NCT00270855|470619137|FG000|Overall Study|Withdrawal by Subject|8|||
130724925|NCT00270855|470619138|FG001|Overall Study|Withdrawal by Subject|8|||
130724926|NCT01396512|470619143|FG000|Overall Study|Withdrawal by Subject|0|||
130724927|NCT01396512|470619144|FG001|Overall Study|Withdrawal by Subject|1|||
130724928|NCT02755649|470619145|FG000|Overall Study|Transitioned into OLE study|99|||
130724929|NCT02755649|470619146|FG001|Overall Study|Transitioned into OLE study|98|||
130724930|NCT02755649|470619147|FG002|Overall Study|Transitioned into OLE study|100|||
130724931|NCT02755649|470619145|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
130724932|NCT02755649|470619146|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
130724933|NCT02755649|470619147|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
130724934|NCT02755649|470619145|FG000|Overall Study|Physician Decision|0|||
130724935|NCT02755649|470619146|FG001|Overall Study|Physician Decision|0|||
130724936|NCT02755649|470619147|FG002|Overall Study|Physician Decision|2|||
130724937|NCT02755649|470619145|FG000|Overall Study|Withdrawal by Subject|0|||
130724938|NCT02755649|470619146|FG001|Overall Study|Withdrawal by Subject|1|||
130724939|NCT02755649|470619147|FG002|Overall Study|Withdrawal by Subject|0|||
130724940|NCT02755649|470619145|FG000|Overall Study|Undecided|1|||
130724941|NCT02755649|470619146|FG001|Overall Study|Undecided|0|||
130724942|NCT02755649|470619147|FG002|Overall Study|Undecided|0|||
130724943|NCT02152605|470619148|FG000|Overall Study|Adverse Event|6|||
130724944|NCT02152605|470619149|FG001|Overall Study|Adverse Event|8|||
130724945|NCT02152605|470619148|FG000|Overall Study|Lack of Efficacy|7|||
130724946|NCT02152605|470619149|FG001|Overall Study|Lack of Efficacy|4|||
130724947|NCT02152605|470619148|FG000|Overall Study|Protocol deviation|1|||
130724948|NCT02152605|470619149|FG001|Overall Study|Protocol deviation|4|||
130724949|NCT02152605|470619148|FG000|Overall Study|Lost to Follow-up|1|||
130724950|NCT02152605|470619149|FG001|Overall Study|Lost to Follow-up|0|||
130724951|NCT02152605|470619148|FG000|Overall Study|Withdrew consent|4|||
130724952|NCT02152605|470619149|FG001|Overall Study|Withdrew consent|2|||
130724953|NCT03301649|470619150|FG000|Overall Study|Need alternate therapy due to live lice|17|||
130724954|NCT03301649|470619151|FG001|Overall Study|Need alternate therapy due to live lice|25|||
130724955|NCT03301649|470619152|FG002|Overall Study|Need alternate therapy due to live lice|81|||
130724956|NCT03301649|470619150|FG000|Overall Study|Lost to Follow-up|11|||
130724957|NCT03301649|470619151|FG001|Overall Study|Lost to Follow-up|11|||
130724958|NCT03301649|470619152|FG002|Overall Study|Lost to Follow-up|3|||
130724959|NCT03301649|470619150|FG000|Overall Study|Protocol Violation|0|||
130724960|NCT03301649|470619151|FG001|Overall Study|Protocol Violation|1|||
130724961|NCT03301649|470619152|FG002|Overall Study|Protocol Violation|1|||
130724962|NCT03301649|470619150|FG000|Overall Study|Withdrawal by Subject|10|||
130724963|NCT03301649|470619151|FG001|Overall Study|Withdrawal by Subject|4|||
130724964|NCT03301649|470619152|FG002|Overall Study|Withdrawal by Subject|0|||
130561061|NCT03250832|470022781|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561062|NCT03250832|470022782|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561063|NCT03250832|470022783|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561064|NCT03250832|470022784|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561065|NCT03250832|470022785|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561066|NCT03250832|470022786|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561067|NCT03250832|470022787|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561068|NCT03250832|470022788|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
130561069|NCT03250832|470022789|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
130561070|NCT03250832|470022790|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561071|NCT03250832|470022791|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
130561072|NCT03250832|470022780|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561073|NCT03250832|470022781|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561074|NCT03250832|470022782|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561075|NCT03250832|470022783|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561076|NCT03250832|470022784|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561077|NCT03250832|470022785|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561078|NCT03250832|470022786|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561079|NCT03250832|470022787|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561080|NCT03250832|470022788|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
130561081|NCT03250832|470022789|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
130561082|NCT03250832|470022790|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561083|NCT03250832|470022791|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130561084|NCT03250832|470022780|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130406007|NCT01687166|469450085|FG000|Overall Study|Lost to Follow-up|2|||
130406008|NCT01687166|469450086|FG001|Overall Study|Lost to Follow-up|5|||
130406009|NCT01687166|469450087|FG002|Overall Study|Lost to Follow-up|1|||
130406010|NCT01687166|469450088|FG003|Overall Study|Lost to Follow-up|0|||
130406011|NCT01687166|469450085|FG000|Overall Study|Equipment/Device Availability|0|||
130406012|NCT01687166|469450086|FG001|Overall Study|Equipment/Device Availability|1|||
130406013|NCT01687166|469450087|FG002|Overall Study|Equipment/Device Availability|0|||
130406014|NCT01687166|469450088|FG003|Overall Study|Equipment/Device Availability|0|||
130406015|NCT01687166|469450085|FG000|Overall Study|Death|1|||
130406016|NCT01687166|469450086|FG001|Overall Study|Death|1|||
130406017|NCT01687166|469450087|FG002|Overall Study|Death|0|||
130406018|NCT01687166|469450088|FG003|Overall Study|Death|0|||
130406019|NCT01687166|469450085|FG000|Overall Study|Protocol Violation|1|||
130406020|NCT01687166|469450086|FG001|Overall Study|Protocol Violation|1|||
130406021|NCT01687166|469450087|FG002|Overall Study|Protocol Violation|1|||
130406022|NCT01687166|469450088|FG003|Overall Study|Protocol Violation|0|||
130406023|NCT01687166|469450085|FG000|Overall Study|Subject moved out of state|0|||
130406024|NCT01687166|469450086|FG001|Overall Study|Subject moved out of state|1|||
130406025|NCT01687166|469450087|FG002|Overall Study|Subject moved out of state|0|||
130406026|NCT01687166|469450088|FG003|Overall Study|Subject moved out of state|0|||
130406027|NCT01687166|469450085|FG000|Overall Study|Patient unable to be compliant|1|||
130406028|NCT01687166|469450086|FG001|Overall Study|Patient unable to be compliant|0|||
130406029|NCT01687166|469450087|FG002|Overall Study|Patient unable to be compliant|0|||
130406030|NCT01687166|469450088|FG003|Overall Study|Patient unable to be compliant|0|||
130406031|NCT01687166|469450085|FG000|Overall Study|Physician choice to use different device|1|||
130406032|NCT01687166|469450086|FG001|Overall Study|Physician choice to use different device|2|||
130406033|NCT01687166|469450087|FG002|Overall Study|Physician choice to use different device|4|||
130406034|NCT01687166|469450088|FG003|Overall Study|Physician choice to use different device|0|||
130406035|NCT01687166|469450085|FG000|Overall Study|Insurance|0|||
130406036|NCT01687166|469450086|FG001|Overall Study|Insurance|0|||
130406037|NCT01687166|469450087|FG002|Overall Study|Insurance|1|||
130406038|NCT01687166|469450088|FG003|Overall Study|Insurance|1|||
130406039|NCT02755831|469450089|FG000|Overall Study|Lost to Follow-up|3|||
130406040|NCT02755831|469450090|FG001|Overall Study|Lost to Follow-up|3|||
130406041|NCT02296112|469450091|FG000|Overall Study|Disease progression|7|||
130406042|NCT02296112|469450091|FG000|Overall Study|Toxicity|1|||
130406043|NCT02296112|469450091|FG000|Overall Study|Began an alternate therapy|1|||
130471515|NCT01989455|469692720|FG001|Overall Study|Technical problems with infusion|0|||
130406044|NCT02442830|469450092|FG000|Overall Study|Technical Failure|0|||
130471516|NCT01989455|469692721|FG002|Overall Study|Technical problems with infusion|1|||
130471517|NCT01989455|469692722|FG003|Overall Study|Technical problems with infusion|0|||
130471518|NCT01989455|469692723|FG004|Overall Study|Technical problems with infusion|1|||
130471519|NCT02638337|469692724|FG000|Overall Study|Adverse Event|6|||
130471520|NCT02638337|469692725|FG001|Overall Study|Adverse Event|10|||
130471521|NCT02638337|469692724|FG000|Overall Study|Protocol Violation|3|||
130471522|NCT02638337|469692725|FG001|Overall Study|Protocol Violation|0|||
130471523|NCT02638337|469692724|FG000|Overall Study|Withdrawal by Subject|13|||
130471524|NCT02638337|469692725|FG001|Overall Study|Withdrawal by Subject|16|||
130406045|NCT02442830|469450093|FG001|Overall Study|Technical Failure|1|||
130406046|NCT01516879|469450094|FG000|Overall Study|Withdrawal by Subject|9|||
130406047|NCT01516879|469450095|FG001|Overall Study|Withdrawal by Subject|11|||
130406048|NCT01516879|469450094|FG000|Overall Study|Death|0|||
130406049|NCT01516879|469450095|FG001|Overall Study|Death|2|||
130406050|NCT01516879|469450094|FG000|Overall Study|Lost to Follow-up|2|||
130406051|NCT01516879|469450095|FG001|Overall Study|Lost to Follow-up|11|||
130471525|NCT02638337|469692724|FG000|Overall Study|Lost to Follow-up|7|||
130471526|NCT02638337|469692725|FG001|Overall Study|Lost to Follow-up|7|||
130471527|NCT02638337|469692724|FG000|Overall Study|Other - Miscellaneous|4|||
130471528|NCT02638337|469692725|FG001|Overall Study|Other - Miscellaneous|3|||
130471529|NCT04116736|469692726|FG000|Overall Study|Withdrew consent during study|3|||
130471530|NCT04116736|469692727|FG001|Overall Study|Withdrew consent during study|1|||
130471531|NCT04116736|469692726|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
130471532|NCT04116736|469692727|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
130471533|NCT04116736|469692726|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
130471534|NCT04116736|469692727|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
130471535|NCT04116736|469692726|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
130471536|NCT04116736|469692727|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
130471537|NCT04116736|469692726|FG000|Overall Study|Subject was enrolled in error|2|||
130471538|NCT04116736|469692727|FG001|Overall Study|Subject was enrolled in error|0|||
130471539|NCT04116736|469692726|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
130471540|NCT04116736|469692727|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
130471541|NCT04116736|469692726|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
130471542|NCT04116736|469692727|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
130471543|NCT04116736|469692726|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
130471544|NCT04116736|469692727|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
130471545|NCT03380390|469692731|FG000|Overall Study|Adverse Event|3|||
130471546|NCT01426412|469692732|FG000|Overall Study|Withdrawal by Subject|1|||
130471547|NCT01426412|469692733|FG001|Overall Study|Withdrawal by Subject|0|||
130471548|NCT01426412|469692734|FG002|Overall Study|Withdrawal by Subject|0|||
130471549|NCT01426412|469692735|FG003|Overall Study|Withdrawal by Subject|0|||
130471550|NCT01426412|469692736|FG004|Overall Study|Withdrawal by Subject|1|||
130471551|NCT01426412|469692737|FG005|Overall Study|Withdrawal by Subject|0|||
130471552|NCT01426412|469692738|FG006|Overall Study|Withdrawal by Subject|0|||
130471553|NCT01426412|469692739|FG007|Overall Study|Withdrawal by Subject|3|||
130561085|NCT03250832|470022781|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561086|NCT03250832|470022782|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561087|NCT03250832|470022783|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561088|NCT03250832|470022784|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130406052|NCT01516879|469450094|FG000|Overall Study|Other|5|||
130406053|NCT01516879|469450095|FG001|Overall Study|Other|10|||
130406054|NCT00183872|469450096|FG000|Overall Study|Death|3|||
130406055|NCT00183872|469450096|FG000|Overall Study|Adverse Event|9|||
130471554|NCT01426412|469692740|FG008|Overall Study|Withdrawal by Subject|1|||
130471555|NCT04157348|469692742|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
130561089|NCT03250832|470022785|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561090|NCT03250832|470022786|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561091|NCT03250832|470022787|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561092|NCT03250832|470022788|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
130561093|NCT03250832|470022789|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
130561094|NCT03250832|470022790|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561095|NCT03250832|470022791|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130561096|NCT03250832|470022780|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561097|NCT03250832|470022781|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561098|NCT03250832|470022782|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561099|NCT03250832|470022783|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561100|NCT03250832|470022784|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561101|NCT03250832|470022785|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561102|NCT03250832|470022786|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130471556|NCT04157348|469692743|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
130471557|NCT04157348|469692742|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130406056|NCT00183872|469450096|FG000|Overall Study|Withdrawal by Subject|2|||
130406057|NCT00183872|469450096|FG000|Overall Study|Drug delayed more than 28 days|2|||
130406058|NCT01720069|469450097|FG000|Overall Study|Could not use e-diary correctly|0|||
130406059|NCT01720069|469450098|FG001|Overall Study|Could not use e-diary correctly|1|||
130406060|NCT01720069|469450099|FG002|Overall Study|Could not use e-diary correctly|1|||
130406061|NCT01720069|469450097|FG000|Overall Study|Randomised without baseline values|0|||
130406062|NCT01720069|469450098|FG001|Overall Study|Randomised without baseline values|0|||
130406063|NCT01720069|469450099|FG002|Overall Study|Randomised without baseline values|1|||
130406064|NCT01720069|469450097|FG000|Overall Study|Adverse Event|0|||
130406065|NCT01720069|469450098|FG001|Overall Study|Adverse Event|0|||
130406066|NCT01720069|469450099|FG002|Overall Study|Adverse Event|1|||
130406067|NCT01720069|469450097|FG000|Overall Study|Lack of Efficacy|0|||
130406068|NCT01720069|469450098|FG001|Overall Study|Lack of Efficacy|4|||
130406069|NCT01720069|469450099|FG002|Overall Study|Lack of Efficacy|0|||
130406070|NCT01720069|469450097|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
130406071|NCT01720069|469450098|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
130406072|NCT01720069|469450099|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
130406073|NCT01720069|469450097|FG000|Overall Study|Withdrawal by Subject|0|||
130406074|NCT01720069|469450098|FG001|Overall Study|Withdrawal by Subject|2|||
130406075|NCT01720069|469450099|FG002|Overall Study|Withdrawal by Subject|1|||
130406076|NCT01720069|469450097|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
130406077|NCT01720069|469450098|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
130406078|NCT01720069|469450099|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
130406079|NCT01720069|469450097|FG000|Overall Study|Non-compliance on using e-diary|0|||
130406080|NCT01720069|469450098|FG001|Overall Study|Non-compliance on using e-diary|0|||
130406081|NCT01720069|469450099|FG002|Overall Study|Non-compliance on using e-diary|1|||
130406082|NCT01720069|469450097|FG000|Overall Study|Lost to Follow-up|0|||
130406083|NCT01720069|469450098|FG001|Overall Study|Lost to Follow-up|0|||
130406084|NCT01720069|469450099|FG002|Overall Study|Lost to Follow-up|1|||
130406085|NCT00508742|469450100|FG000|Period 1: Infant Series|Adverse Event|5|||
130406086|NCT00508742|469450101|FG001|Period 1: Infant Series|Adverse Event|4|||
130724965|NCT03301649|470619150|FG000|Overall Study|Other than specified|5|||
130406087|NCT00508742|469450100|FG000|Period 1: Infant Series|Protocol Violation|1|||
130406088|NCT00508742|469450101|FG001|Period 1: Infant Series|Protocol Violation|0|||
130406089|NCT00508742|469450100|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
130406090|NCT00508742|469450101|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
130724966|NCT03301649|470619151|FG001|Overall Study|Other than specified|3|||
130724967|NCT03301649|470619152|FG002|Overall Study|Other than specified|0|||
130724968|NCT01564537|470619153|FG000|Overall Study|Site Terminated by Sponsor|1|||
130724969|NCT01564537|470619154|FG001|Overall Study|Site Terminated by Sponsor|0|||
130724970|NCT01564537|470619153|FG000|Overall Study|Withdrawal by Subject|12|||
130724971|NCT01564537|470619154|FG001|Overall Study|Withdrawal by Subject|14|||
130724972|NCT01564537|470619153|FG000|Overall Study|Lost to Follow-up|7|||
130724973|NCT01564537|470619154|FG001|Overall Study|Lost to Follow-up|3|||
130724974|NCT01564537|470619153|FG000|Overall Study|Reason not specified|81|||
130724975|NCT01564537|470619154|FG001|Overall Study|Reason not specified|82|||
130724976|NCT00837473|470619155|FG000|Overall Study|Lost to Follow-up|1|||
130724977|NCT00837473|470619155|FG000|Overall Study|Withdrawal by Subject|2|||
130724978|NCT01635218|470619156|FG000|Overall Study|Lost to Follow-up|3|||
130724979|NCT01635218|470619157|FG001|Overall Study|Lost to Follow-up|7|||
130724980|NCT01635218|470619158|FG002|Overall Study|Lost to Follow-up|6|||
130724981|NCT03559400|470619159|FG000|Overall Study|Lost to Follow-up|9|||
130724982|NCT03559400|470619160|FG001|Overall Study|Lost to Follow-up|7|||
130724983|NCT03559400|470619159|FG000|Overall Study|Death|0|||
130724984|NCT03559400|470619160|FG001|Overall Study|Death|2|||
130724985|NCT03262038|470619161|FG000|Overall Study|Withdrawal by Subject|0|||
130724986|NCT03262038|470619162|FG001|Overall Study|Withdrawal by Subject|1|||
130724987|NCT04933968|470619163|FG000|Overall Study|Adverse Event|0|||
130724988|NCT04933968|470619164|FG001|Overall Study|Adverse Event|0|||
130724989|NCT04933968|470619165|FG002|Overall Study|Adverse Event|1|||
130724990|NCT04933968|470619166|FG003|Overall Study|Adverse Event|1|||
130724991|NCT04933968|470619167|FG004|Overall Study|Adverse Event|0|||
130724992|NCT04933968|470619168|FG005|Overall Study|Adverse Event|0|||
130724993|NCT04933968|470619163|FG000|Overall Study|Lost to Follow-up|1|||
130724994|NCT04933968|470619164|FG001|Overall Study|Lost to Follow-up|0|||
130724995|NCT04933968|470619165|FG002|Overall Study|Lost to Follow-up|1|||
130724996|NCT04933968|470619166|FG003|Overall Study|Lost to Follow-up|0|||
130724997|NCT04933968|470619167|FG004|Overall Study|Lost to Follow-up|0|||
130406091|NCT00508742|469450100|FG000|Period 1: Infant Series|Physician Decision|1|||
130406092|NCT00508742|469450101|FG001|Period 1: Infant Series|Physician Decision|0|||
130724998|NCT04933968|470619168|FG005|Overall Study|Lost to Follow-up|0|||
130724999|NCT04933968|470619163|FG000|Overall Study|Randomized not treated|1|||
130725000|NCT04933968|470619164|FG001|Overall Study|Randomized not treated|0|||
130725001|NCT04933968|470619165|FG002|Overall Study|Randomized not treated|0|||
130725002|NCT04933968|470619166|FG003|Overall Study|Randomized not treated|0|||
130725003|NCT04933968|470619167|FG004|Overall Study|Randomized not treated|0|||
130725004|NCT04933968|470619168|FG005|Overall Study|Randomized not treated|0|||
130725005|NCT04933968|470619163|FG000|Overall Study|Sponsor terminated study|0|||
130406093|NCT00508742|469450100|FG000|Period 1: Infant Series|Other|4|||
130406094|NCT00508742|469450101|FG001|Period 1: Infant Series|Other|1|||
130406095|NCT00508742|469450100|FG000|Period 2: After Infant Series|Adverse Event|2|||
130406096|NCT00508742|469450101|FG001|Period 2: After Infant Series|Adverse Event|6|||
130406097|NCT00508742|469450100|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
130406098|NCT00508742|469450101|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
130406099|NCT00508742|469450100|FG000|Period 2: After Infant Series|Protocol Violation|1|||
130406100|NCT00508742|469450101|FG001|Period 2: After Infant Series|Protocol Violation|0|||
130406101|NCT00508742|469450100|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
130406102|NCT00508742|469450101|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
130406103|NCT00508742|469450100|FG000|Period 2: After Infant Series|Failed to Return|1|||
130406104|NCT00508742|469450101|FG001|Period 2: After Infant Series|Failed to Return|0|||
130406105|NCT00508742|469450100|FG000|Period 2: After Infant Series|Other|2|||
130406106|NCT00508742|469450101|FG001|Period 2: After Infant Series|Other|1|||
130406107|NCT00508742|469450100|FG000|Period 3: Toddler Dose|Adverse Event|1|||
130406108|NCT00508742|469450101|FG001|Period 3: Toddler Dose|Adverse Event|0|||
130406109|NCT00508742|469450100|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
130406110|NCT00508742|469450101|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
130406111|NCT00508742|469450100|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
130406112|NCT00508742|469450101|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
130406113|NCT00508742|469450100|FG000|Period 3: Toddler Dose|Other|5|||
130406114|NCT00508742|469450101|FG001|Period 3: Toddler Dose|Other|4|||
130406115|NCT04568122|469450102|FG000|Overall Study|Lost to Follow-up|48|||
130406116|NCT04568122|469450103|FG001|Overall Study|Lost to Follow-up|44|||
130406117|NCT04568122|469450104|FG002|Overall Study|Lost to Follow-up|4|||
130406118|NCT04568122|469450105|FG003|Overall Study|Lost to Follow-up|0|||
130406119|NCT04568122|469450106|FG004|Overall Study|Lost to Follow-up|0|||
130406120|NCT00700011|469450112|FG000|Overall Study|Death|0|||
130406121|NCT00700011|469450113|FG001|Overall Study|Death|1|||
130406122|NCT01600586|469450114|FG000|Overall Study|Physician Decision|3|||
130406123|NCT01600586|469450115|FG001|Overall Study|Physician Decision|3|||
130406124|NCT00931307|469450116|FG000|Overall Study|Lack of Efficacy|12|||
130406125|NCT00931307|469450116|FG000|Overall Study|Biomicroscopy|1|||
130406126|NCT02447991|469450117|FG000|Overall Study|Withdrawn by subject - no data|0|||
130406127|NCT02447991|469450118|FG001|Overall Study|Withdrawn by subject - no data|2|||
130406128|NCT02447991|469450117|FG000|Overall Study|Withdrawn by Subject - with data|4|||
130406129|NCT02447991|469450118|FG001|Overall Study|Withdrawn by Subject - with data|4|||
130406130|NCT02447991|469450117|FG000|Overall Study|Lost to Follow-up - no data|3|||
130406131|NCT02447991|469450118|FG001|Overall Study|Lost to Follow-up - no data|6|||
130406132|NCT02447991|469450117|FG000|Overall Study|Lost to follow-up - with data|0|||
130406133|NCT02447991|469450118|FG001|Overall Study|Lost to follow-up - with data|3|||
130406134|NCT02447991|469450117|FG000|Overall Study|End of study - no treatment results|3|||
130406135|NCT02447991|469450118|FG001|Overall Study|End of study - no treatment results|6|||
130406136|NCT02447991|469450117|FG000|Overall Study|End of study - partial treatment results|0|||
130406137|NCT02447991|469450118|FG001|Overall Study|End of study - partial treatment results|9|||
130406138|NCT00459134|469450119|FG000|Overall Study|Physician Decision|1|||
130406139|NCT00459134|469450120|FG001|Overall Study|Physician Decision|1|||
130406140|NCT00459134|469450119|FG000|Overall Study|Withdrawal by Subject|8|||
130406141|NCT00459134|469450120|FG001|Overall Study|Withdrawal by Subject|7|||
130406142|NCT00459134|469450119|FG000|Overall Study|Lost to Follow-up|6|||
130406143|NCT00459134|469450120|FG001|Overall Study|Lost to Follow-up|7|||
130406144|NCT00459134|469450119|FG000|Overall Study|Surgery|1|||
130406145|NCT00459134|469450120|FG001|Overall Study|Surgery|2|||
130406146|NCT00459134|469450119|FG000|Overall Study|Toxicity|4|||
130406147|NCT00459134|469450120|FG001|Overall Study|Toxicity|5|||
130406148|NCT00459134|469450119|FG000|Overall Study|Progression|1|||
130406149|NCT00459134|469450120|FG001|Overall Study|Progression|0|||
130406150|NCT00459134|469450119|FG000|Overall Study|Multiple Reasons|2|||
130406151|NCT00459134|469450120|FG001|Overall Study|Multiple Reasons|3|||
130406152|NCT00829621|469450121|FG000|Overall Study|Death|1|||
130406153|NCT00829621|469450122|FG001|Overall Study|Death|0|||
130406154|NCT00829621|469450121|FG000|Overall Study|Lost to Follow-up|3|||
130406155|NCT00829621|469450122|FG001|Overall Study|Lost to Follow-up|4|||
130406156|NCT00774995|469450123|FG000|Overall Study|Protocol Violation|0|||
130471558|NCT04157348|469692743|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130471559|NCT04157348|469692742|FG000|Double-blind Treatment Period|Adverse Event|0|||
130471560|NCT04157348|469692743|FG001|Double-blind Treatment Period|Adverse Event|1|||
130471561|NCT04157348|469692742|FG000|Open-label Extension Period|Adverse Event|1|||
130471562|NCT04157348|469692743|FG001|Open-label Extension Period|Adverse Event|1|||
130471563|NCT04157348|469692742|FG000|Open-label Extension Period|Death|0|||
130471564|NCT04157348|469692743|FG001|Open-label Extension Period|Death|1|||
130406157|NCT00774995|469450124|FG001|Overall Study|Protocol Violation|0|||
130406158|NCT00774995|469450125|FG002|Overall Study|Protocol Violation|1|||
130406159|NCT00774995|469450126|FG003|Overall Study|Protocol Violation|0|||
130406160|NCT00441337|469450130|FG000|Overall Study|Disease Progression|6|||
130406161|NCT00441337|469450131|FG001|Overall Study|Disease Progression|6|||
130406162|NCT00441337|469450132|FG002|Overall Study|Disease Progression|4|||
130406163|NCT00441337|469450133|FG003|Overall Study|Disease Progression|18|||
130406164|NCT00441337|469450130|FG000|Overall Study|Lost to Follow-up|0|||
130561103|NCT03250832|470022787|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561104|NCT03250832|470022788|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561105|NCT03250832|470022789|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561106|NCT03250832|470022790|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130561107|NCT03250832|470022791|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
130561108|NCT02303704|470022792|FG000|Overall Study|Protocol Violation|5|||
130561109|NCT02303704|470022793|FG001|Overall Study|Protocol Violation|9|||
130406165|NCT00441337|469450131|FG001|Overall Study|Lost to Follow-up|0|||
130561110|NCT00397033|470022798|FG000|Overall Study|Adverse Event|7|||
130561111|NCT00397033|470022799|FG001|Overall Study|Adverse Event|10|||
130561112|NCT00397033|470022800|FG002|Overall Study|Adverse Event|4|||
130561113|NCT00397033|470022798|FG000|Overall Study|Lack of Efficacy|22|||
130561114|NCT00397033|470022799|FG001|Overall Study|Lack of Efficacy|12|||
130406166|NCT00441337|469450132|FG002|Overall Study|Lost to Follow-up|0|||
130406167|NCT00441337|469450133|FG003|Overall Study|Lost to Follow-up|1|||
130406168|NCT00441337|469450130|FG000|Overall Study|Sponsor Decision|0|||
130406169|NCT00441337|469450131|FG001|Overall Study|Sponsor Decision|0|||
130406170|NCT00441337|469450132|FG002|Overall Study|Sponsor Decision|1|||
130406171|NCT00441337|469450133|FG003|Overall Study|Sponsor Decision|2|||
130406172|NCT00441337|469450130|FG000|Overall Study|Did not meet inclusion criteria|0|||
130406173|NCT00441337|469450131|FG001|Overall Study|Did not meet inclusion criteria|0|||
130406174|NCT00441337|469450132|FG002|Overall Study|Did not meet inclusion criteria|1|||
130406175|NCT00441337|469450133|FG003|Overall Study|Did not meet inclusion criteria|0|||
130406176|NCT06748040|469450137|FG000|Overall Study|Death|3|||
130406177|NCT06748040|469450138|FG001|Overall Study|Death|4|||
130406178|NCT06748040|469450137|FG000|Overall Study|Lost to Follow-up|134|||
130406179|NCT06748040|469450138|FG001|Overall Study|Lost to Follow-up|132|||
130406180|NCT06748040|469450137|FG000|Overall Study|Withdrawal by Subject|3|||
130561115|NCT00397033|470022800|FG002|Overall Study|Lack of Efficacy|9|||
130561116|NCT00397033|470022798|FG000|Overall Study|Lost to Follow-up|3|||
130561117|NCT00397033|470022799|FG001|Overall Study|Lost to Follow-up|3|||
130561118|NCT00397033|470022800|FG002|Overall Study|Lost to Follow-up|3|||
130561119|NCT00397033|470022798|FG000|Overall Study|Withdrawal by Subject|12|||
130561120|NCT00397033|470022799|FG001|Overall Study|Withdrawal by Subject|7|||
130561121|NCT00397033|470022800|FG002|Overall Study|Withdrawal by Subject|5|||
130561122|NCT00397033|470022798|FG000|Overall Study|Other|0|||
130561123|NCT00397033|470022799|FG001|Overall Study|Other|5|||
130561124|NCT00397033|470022800|FG002|Overall Study|Other|2|||
130561125|NCT01984164|470022801|FG000|Overall Study|Withdrawal by Subject|4|||
130561126|NCT01984164|470022802|FG001|Overall Study|Withdrawal by Subject|3|||
130561127|NCT01984164|470022801|FG000|Overall Study|Adverse Event|5|||
130561128|NCT01984164|470022802|FG001|Overall Study|Adverse Event|19|||
130561129|NCT01984164|470022801|FG000|Overall Study|Lost to Follow-up|1|||
130561130|NCT01984164|470022802|FG001|Overall Study|Lost to Follow-up|3|||
130561131|NCT05293743|470022803|FG000|Overall Study|Withdrawal by Subject|1|||
130561132|NCT05293743|470022804|FG001|Overall Study|Withdrawal by Subject|0|||
130561133|NCT00667823|470022805|FG000|Overall Study|Lost to Follow-up|5|||
130561134|NCT00667823|470022805|FG000|Overall Study|Adverse Event|7|||
130561135|NCT00667823|470022805|FG000|Overall Study|Death|182|||
130406181|NCT06748040|469450138|FG001|Overall Study|Withdrawal by Subject|5|||
130406182|NCT00827372|469451681|FG000|Overall Study|Adverse Event|5|||
130406183|NCT00827372|469451681|FG000|Overall Study|Lack of Efficacy|3|||
130406184|NCT02293005|469451682|FG000|Overall Study|Adverse Event|2|||
130406185|NCT02293005|469451682|FG000|Overall Study|Death|4|||
130406186|NCT02293005|469451682|FG000|Overall Study|Lost to Follow-up|1|||
130406187|NCT02293005|469451682|FG000|Overall Study|Withdrawal by Subject|2|||
130406188|NCT02293005|469451682|FG000|Overall Study|Progression|17|||
130406189|NCT00608829|469451684|FG000|Overall Study|Death|6|||
130406190|NCT00608829|469451684|FG000|Overall Study|Withdrawal by Subject|4|||
130406191|NCT00608829|469451684|FG000|Overall Study|Subject refuses to follow up or return.|5|||
130406192|NCT02564471|469451687|FG000|Overall Study|Adverse Event|1|||
130406193|NCT02564471|469451688|FG001|Overall Study|Adverse Event|0|||
130406194|NCT02564471|469451689|FG002|Overall Study|Adverse Event|0|||
130406195|NCT02564471|469451690|FG003|Overall Study|Adverse Event|0|||
130561136|NCT00667823|470022805|FG000|Overall Study|Withdrawal by Subject|12|||
130561137|NCT00667823|470022805|FG000|Overall Study|Other|8|||
130561138|NCT00667823|470022805|FG000|Overall Study|Missing (completion page missing)|2|||
130561139|NCT00583024|470022806|FG000|Overall Study|Lost to Follow-up|4|||
130725006|NCT04933968|470619164|FG001|Overall Study|Sponsor terminated study|0|||
130725007|NCT04933968|470619165|FG002|Overall Study|Sponsor terminated study|0|||
130725008|NCT04933968|470619166|FG003|Overall Study|Sponsor terminated study|1|||
130406196|NCT02564471|469451687|FG000|Overall Study|Withdrawal by Subject|2|||
130561140|NCT02553265|470024739|FG000|Enrollment|Death|0|||
130561141|NCT02553265|470024740|FG001|Enrollment|Death|0|||
130561142|NCT02553265|470024741|FG002|Enrollment|Death|1|||
130406197|NCT02564471|469451688|FG001|Overall Study|Withdrawal by Subject|1|||
130406198|NCT02564471|469451689|FG002|Overall Study|Withdrawal by Subject|3|||
130406199|NCT02564471|469451690|FG003|Overall Study|Withdrawal by Subject|0|||
130406200|NCT02564471|469451687|FG000|Overall Study|Lost to Follow-up|0|||
130406201|NCT02564471|469451688|FG001|Overall Study|Lost to Follow-up|2|||
130406202|NCT02564471|469451689|FG002|Overall Study|Lost to Follow-up|0|||
130406203|NCT02564471|469451690|FG003|Overall Study|Lost to Follow-up|0|||
130406204|NCT02805257|469451691|FG000|Overall Study|Lost to Follow-up|7|||
130406205|NCT02805257|469451692|FG001|Overall Study|Lost to Follow-up|6|||
130406206|NCT02805257|469451691|FG000|Overall Study|Death|0|||
130406207|NCT02805257|469451692|FG001|Overall Study|Death|1|||
130406208|NCT02766608|469451696|FG000|Overall Study|Adverse Event|27|||
130406209|NCT02766608|469451697|FG001|Overall Study|Adverse Event|22|||
130406210|NCT02766608|469451698|FG002|Overall Study|Adverse Event|17|||
130406211|NCT02766608|469451699|FG003|Overall Study|Adverse Event|13|||
130406212|NCT02766608|469451700|FG004|Overall Study|Adverse Event|12|||
130406213|NCT02766608|469451696|FG000|Overall Study|Withdrawal by Subject|21|||
130406214|NCT02766608|469451697|FG001|Overall Study|Withdrawal by Subject|20|||
130406215|NCT02766608|469451698|FG002|Overall Study|Withdrawal by Subject|24|||
130406216|NCT02766608|469451699|FG003|Overall Study|Withdrawal by Subject|13|||
130406217|NCT02766608|469451700|FG004|Overall Study|Withdrawal by Subject|10|||
130406218|NCT02766608|469451696|FG000|Overall Study|Lack of Efficacy|16|||
130406219|NCT02766608|469451697|FG001|Overall Study|Lack of Efficacy|15|||
130406220|NCT02766608|469451698|FG002|Overall Study|Lack of Efficacy|32|||
130406221|NCT02766608|469451699|FG003|Overall Study|Lack of Efficacy|8|||
130406222|NCT02766608|469451700|FG004|Overall Study|Lack of Efficacy|2|||
130406223|NCT02766608|469451696|FG000|Overall Study|Lost to Follow-up|6|||
130406224|NCT02766608|469451697|FG001|Overall Study|Lost to Follow-up|3|||
130406225|NCT02766608|469451698|FG002|Overall Study|Lost to Follow-up|5|||
130406226|NCT02766608|469451699|FG003|Overall Study|Lost to Follow-up|2|||
130406227|NCT02766608|469451700|FG004|Overall Study|Lost to Follow-up|2|||
130406228|NCT02766608|469451696|FG000|Overall Study|Physician Decision|3|||
130406229|NCT02766608|469451697|FG001|Overall Study|Physician Decision|2|||
130406230|NCT02766608|469451698|FG002|Overall Study|Physician Decision|3|||
130406231|NCT02766608|469451699|FG003|Overall Study|Physician Decision|1|||
130406232|NCT02766608|469451700|FG004|Overall Study|Physician Decision|2|||
130406233|NCT02766608|469451696|FG000|Overall Study|Protocol disc criteria|3|||
130406234|NCT02766608|469451697|FG001|Overall Study|Protocol disc criteria|3|||
130406235|NCT02766608|469451698|FG002|Overall Study|Protocol disc criteria|4|||
130406236|NCT02766608|469451699|FG003|Overall Study|Protocol disc criteria|0|||
130406237|NCT02766608|469451700|FG004|Overall Study|Protocol disc criteria|0|||
130406238|NCT02766608|469451696|FG000|Overall Study|Protocol Violation|0|||
130406239|NCT02766608|469451697|FG001|Overall Study|Protocol Violation|4|||
130406240|NCT02766608|469451698|FG002|Overall Study|Protocol Violation|4|||
130406241|NCT02766608|469451699|FG003|Overall Study|Protocol Violation|0|||
130406242|NCT02766608|469451700|FG004|Overall Study|Protocol Violation|1|||
130406243|NCT02766608|469451696|FG000|Overall Study|Administrative Reasons|3|||
130406244|NCT02766608|469451697|FG001|Overall Study|Administrative Reasons|1|||
130406245|NCT02766608|469451698|FG002|Overall Study|Administrative Reasons|1|||
130406246|NCT02766608|469451699|FG003|Overall Study|Administrative Reasons|0|||
130406247|NCT02766608|469451700|FG004|Overall Study|Administrative Reasons|0|||
130406248|NCT02080091|469451702|FG000|Overall Study|Study Terminated|22|||
130406249|NCT02080091|469451702|FG000|Overall Study|Death|1|||
130406250|NCT02080091|469451702|FG000|Overall Study|Withdrawal by Subject|1|||
130406251|NCT02080091|469451702|FG000|Overall Study|Other|1|||
130406252|NCT03143829|469451703|FG000|Overall Study|Withdrawal by Subject|2|||
130406253|NCT03143829|469451704|FG001|Overall Study|Withdrawal by Subject|5|||
130406254|NCT03143829|469451703|FG000|Overall Study|Lost to Follow-up|0|||
130471565|NCT04157348|469692742|FG000|Open-label Extension Period|Lack of Efficacy|2|||
130471566|NCT04157348|469692743|FG001|Open-label Extension Period|Lack of Efficacy|2|||
130471567|NCT04157348|469692742|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
130471568|NCT04157348|469692743|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130406255|NCT03143829|469451704|FG001|Overall Study|Lost to Follow-up|2|||
130406256|NCT03143829|469451703|FG000|Overall Study|Death|1|||
130406257|NCT03143829|469451704|FG001|Overall Study|Death|1|||
130406258|NCT03143829|469451703|FG000|Overall Study|changed treatment, no longer eligible|2|||
130406259|NCT03143829|469451704|FG001|Overall Study|changed treatment, no longer eligible|2|||
130406260|NCT00672477|469451706|FG000|Overall Study|Adverse Event|10|||
130406261|NCT00672477|469451707|FG001|Overall Study|Adverse Event|7|||
130471569|NCT04157348|469692742|FG000|Open-label Extension Period|Ongoing|60|||
130471570|NCT04157348|469692743|FG001|Open-label Extension Period|Ongoing|57|||
130471571|NCT04157348|469692742|FG000|Open-label Extension Period|other reasons|1|||
130406262|NCT00672477|469451706|FG000|Overall Study|Death|7|||
130406263|NCT00672477|469451707|FG001|Overall Study|Death|11|||
130406264|NCT00672477|469451706|FG000|Overall Study|Physician Decision|2|||
130406265|NCT00672477|469451707|FG001|Overall Study|Physician Decision|0|||
130406266|NCT00672477|469451706|FG000|Overall Study|Protocol Violation|1|||
130406267|NCT00672477|469451707|FG001|Overall Study|Protocol Violation|1|||
130406268|NCT00672477|469451706|FG000|Overall Study|Withdrawal by Subject|5|||
130406269|NCT00672477|469451707|FG001|Overall Study|Withdrawal by Subject|3|||
130471572|NCT04157348|469692743|FG001|Open-label Extension Period|other reasons|1|||
130406270|NCT00672477|469451706|FG000|Overall Study|Lack of Efficacy|1|||
130561143|NCT02553265|470024739|FG000|First Intervention (28 Days)|Adverse Event|1|||
130561144|NCT02553265|470024740|FG001|First Intervention (28 Days)|Adverse Event|0|||
130561145|NCT02553265|470024741|FG002|First Intervention (28 Days)|Adverse Event|0|||
130561146|NCT02553265|470024739|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
130406271|NCT00672477|469451707|FG001|Overall Study|Lack of Efficacy|1|||
130406272|NCT00672477|469451706|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
130406273|NCT00672477|469451707|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
130406274|NCT02348489|469451710|FG000|Overall Study|Death|336|||
130406275|NCT02348489|469451711|FG001|Overall Study|Death|335|||
130406276|NCT02348489|469451710|FG000|Overall Study|Withdrawal by Subject|14|||
130406277|NCT02348489|469451711|FG001|Overall Study|Withdrawal by Subject|27|||
130406278|NCT02348489|469451710|FG000|Overall Study|Lost to Follow-up|3|||
130406279|NCT02348489|469451711|FG001|Overall Study|Lost to Follow-up|5|||
130406280|NCT02886572|469451713|FG000|Overall Study|Death|8|||
130406281|NCT00408993|469451716|FG000|Overall Study|Adverse Event|15|||
130406282|NCT00408993|469451717|FG001|Overall Study|Adverse Event|4|||
130406283|NCT00408993|469451716|FG000|Overall Study|Protocol Violation|1|||
130406284|NCT00408993|469451717|FG001|Overall Study|Protocol Violation|6|||
130406285|NCT00408993|469451716|FG000|Overall Study|Lack of Efficacy|1|||
130406286|NCT00408993|469451717|FG001|Overall Study|Lack of Efficacy|4|||
130406287|NCT00408993|469451716|FG000|Overall Study|Withdrawal by Subject|2|||
130406288|NCT00408993|469451717|FG001|Overall Study|Withdrawal by Subject|3|||
130406289|NCT03738865|469451718|FG000|Overall Study|Withdrawal by Subject|3|||
130406290|NCT03738865|469451719|FG001|Overall Study|Withdrawal by Subject|3|||
130406291|NCT03738865|469451718|FG000|Overall Study|Adverse Event|2|||
130406292|NCT03738865|469451719|FG001|Overall Study|Adverse Event|0|||
130406293|NCT03738865|469451718|FG000|Overall Study|Physician Decision|0|||
130406294|NCT03738865|469451719|FG001|Overall Study|Physician Decision|1|||
130406295|NCT00961259|469451720|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
130406296|NCT00961259|469451721|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
130406297|NCT00961259|469451722|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
130406298|NCT01324024|469451723|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
130406299|NCT01324024|469451724|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130406300|NCT01923181|469451725|FG000|Overall Study|Protocol Violation|2|||
130406301|NCT01923181|469451726|FG001|Overall Study|Protocol Violation|2|||
130406302|NCT01923181|469451727|FG002|Overall Study|Protocol Violation|0|||
130406303|NCT01923181|469451728|FG003|Overall Study|Protocol Violation|2|||
130406304|NCT01923181|469451729|FG004|Overall Study|Protocol Violation|2|||
130406305|NCT01923181|469451730|FG005|Overall Study|Protocol Violation|1|||
130406306|NCT01923181|469451731|FG006|Overall Study|Protocol Violation|1|||
130406307|NCT01923181|469451732|FG007|Overall Study|Protocol Violation|2|||
130406308|NCT01923181|469451733|FG008|Overall Study|Protocol Violation|1|||
130406309|NCT01923181|469451725|FG000|Overall Study|Withdrawal by Subject|0|||
130406310|NCT01923181|469451726|FG001|Overall Study|Withdrawal by Subject|1|||
130406311|NCT01923181|469451727|FG002|Overall Study|Withdrawal by Subject|0|||
130406312|NCT01923181|469451728|FG003|Overall Study|Withdrawal by Subject|1|||
130406313|NCT01923181|469451729|FG004|Overall Study|Withdrawal by Subject|4|||
130406314|NCT01923181|469451730|FG005|Overall Study|Withdrawal by Subject|2|||
130406315|NCT01923181|469451731|FG006|Overall Study|Withdrawal by Subject|4|||
130406316|NCT01923181|469451732|FG007|Overall Study|Withdrawal by Subject|3|||
130406317|NCT01923181|469451733|FG008|Overall Study|Withdrawal by Subject|1|||
130406318|NCT01923181|469451725|FG000|Overall Study|Other|1|||
130406319|NCT01923181|469451726|FG001|Overall Study|Other|0|||
130406320|NCT01923181|469451727|FG002|Overall Study|Other|0|||
130406321|NCT01923181|469451728|FG003|Overall Study|Other|1|||
130406322|NCT01923181|469451729|FG004|Overall Study|Other|0|||
130406323|NCT01923181|469451730|FG005|Overall Study|Other|0|||
130406324|NCT01923181|469451731|FG006|Overall Study|Other|0|||
130406325|NCT01923181|469451732|FG007|Overall Study|Other|0|||
130406326|NCT01923181|469451733|FG008|Overall Study|Other|0|||
130406327|NCT01923181|469451725|FG000|Overall Study|Lost to Follow-up|0|||
130406328|NCT01923181|469451726|FG001|Overall Study|Lost to Follow-up|3|||
130406329|NCT01923181|469451727|FG002|Overall Study|Lost to Follow-up|2|||
130406330|NCT01923181|469451728|FG003|Overall Study|Lost to Follow-up|1|||
130406331|NCT01923181|469451729|FG004|Overall Study|Lost to Follow-up|2|||
130406332|NCT01923181|469451730|FG005|Overall Study|Lost to Follow-up|1|||
130406333|NCT01923181|469451731|FG006|Overall Study|Lost to Follow-up|3|||
130406334|NCT01923181|469451732|FG007|Overall Study|Lost to Follow-up|3|||
130406335|NCT01923181|469451733|FG008|Overall Study|Lost to Follow-up|1|||
130406336|NCT02691455|469451734|FG000|Overall Study|Withdrawal by Subject|1|||
130406337|NCT02691455|469451735|FG001|Overall Study|Withdrawal by Subject|2|||
130406338|NCT02691455|469451734|FG000|Overall Study|Lost to Follow-up|15|||
130406339|NCT02691455|469451735|FG001|Overall Study|Lost to Follow-up|15|||
130406340|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130406341|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
130406342|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
130406343|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
130406344|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
130406345|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
130406346|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130406347|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
130406348|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130406349|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130406350|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
130406351|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130406352|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
130406353|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
130406354|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
130406355|NCT01257204|469451736|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
130406356|NCT01257204|469451737|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
130406357|NCT01257204|469451738|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
130406358|NCT01257204|469451736|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
130406359|NCT01257204|469451737|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
130406360|NCT01257204|469451738|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
130406361|NCT01257204|469451736|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
130406362|NCT01257204|469451737|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
130406363|NCT01257204|469451738|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
130406364|NCT01257204|469451736|FG000|Follow-up Period (up to Week 48)|Other|0|||
130406365|NCT01257204|469451737|FG001|Follow-up Period (up to Week 48)|Other|0|||
130406366|NCT01257204|469451738|FG002|Follow-up Period (up to Week 48)|Other|5|||
130406367|NCT01863446|469451740|FG000|Overall Study|Withdrawal by Subject|1|||
130406368|NCT01863446|469451741|FG001|Overall Study|Withdrawal by Subject|0|||
130406369|NCT01863446|469451742|FG002|Overall Study|Withdrawal by Subject|1|||
130406370|NCT01863446|469451743|FG003|Overall Study|Withdrawal by Subject|2|||
130406371|NCT01863446|469451740|FG000|Overall Study|Physician Decision|0|||
130406372|NCT01863446|469451741|FG001|Overall Study|Physician Decision|0|||
130406373|NCT01863446|469451742|FG002|Overall Study|Physician Decision|1|||
130406374|NCT01863446|469451743|FG003|Overall Study|Physician Decision|0|||
130406375|NCT02252081|469451744|FG000|Overall Study|Withdrawal by Subject|2|||
130406376|NCT02252081|469451745|FG001|Overall Study|Withdrawal by Subject|1|||
130406377|NCT02252081|469451744|FG000|Overall Study|Adverse Event|4|||
130406378|NCT02252081|469451745|FG001|Overall Study|Adverse Event|1|||
130406379|NCT02252081|469451744|FG000|Overall Study|non compliance & others|0|||
130406380|NCT02252081|469451745|FG001|Overall Study|non compliance & others|2|||
130406381|NCT01276327|469451752|FG000|Overall Study|Adverse Event|1|||
130406382|NCT01276327|469451753|FG001|Overall Study|Adverse Event|3|||
130406383|NCT01276327|469451752|FG000|Overall Study|Withdrawal by Subject|1|||
130406384|NCT01276327|469451753|FG001|Overall Study|Withdrawal by Subject|0|||
130406385|NCT01794949|469451754|FG000|Overall Study|Lost to Follow-up|1|||
130406386|NCT01794949|469451755|FG001|Overall Study|Lost to Follow-up|0|||
130406387|NCT03766646|469451757|FG000|Overall Study|Withdrawal by Subject|1|||
130406388|NCT03766646|469451758|FG001|Overall Study|Withdrawal by Subject|0|||
130725009|NCT04933968|470619167|FG004|Overall Study|Sponsor terminated study|2|||
130406389|NCT03766646|469451757|FG000|Overall Study|Protocol Violation|0|||
130406390|NCT03766646|469451758|FG001|Overall Study|Protocol Violation|3|||
130406391|NCT04713748|469451768|FG000|Overall Study|Not enough kits allocated|35|||
130406392|NCT01410110|469451775|FG000|Overall Study|Withdrawal by Subject|4|||
130406393|NCT01410110|469451776|FG001|Overall Study|Withdrawal by Subject|2|||
130406394|NCT02802345|469451780|FG000|Overall Study|Not Treated|0|||
130406395|NCT02802345|469451781|FG001|Overall Study|Not Treated|1|||
130406396|NCT02802345|469451780|FG000|Overall Study|Adverse Event|28|||
130406397|NCT02802345|469451781|FG001|Overall Study|Adverse Event|20|||
130406398|NCT02802345|469451780|FG000|Overall Study|Withdrawal by Subject|3|||
130406399|NCT02802345|469451781|FG001|Overall Study|Withdrawal by Subject|3|||
130406400|NCT02802345|469451780|FG000|Overall Study|Protocol Violation|0|||
130406401|NCT02802345|469451781|FG001|Overall Study|Protocol Violation|1|||
130406402|NCT02802345|469451780|FG000|Overall Study|Other than listed|1|||
130406403|NCT02802345|469451781|FG001|Overall Study|Other than listed|5|||
130406404|NCT04632940|469451782|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
130406405|NCT04632940|469451783|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
130406406|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
130471573|NCT04757610|469692744|FG000|Overall Study|Adverse Event|13|||
130471574|NCT04757610|469692745|FG001|Overall Study|Adverse Event|10|||
130471575|NCT04757610|469692746|FG002|Overall Study|Adverse Event|5|||
130725010|NCT04933968|470619168|FG005|Overall Study|Sponsor terminated study|0|||
130406407|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
130406408|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
130406409|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
130406410|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
130471576|NCT04757610|469692744|FG000|Overall Study|Death|5|||
130725011|NCT04933968|470619163|FG000|Overall Study|Other|0|||
130406411|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
130406412|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
130406413|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
130406414|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
130406415|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
130406416|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Other than specified|0|||
130406417|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Other than specified|1|||
130471577|NCT04757610|469692745|FG001|Overall Study|Death|13|||
130406418|NCT04632940|469451782|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
130406419|NCT04632940|469451783|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
130406420|NCT05857527|469451786|FG000|Overall Study|Withdrawal by Subject|0|||
130406421|NCT05857527|469451787|FG001|Overall Study|Withdrawal by Subject|1|||
130406422|NCT02799082|469451790|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
130406423|NCT02799082|469451791|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
130406424|NCT02799082|469451790|FG000|Overall Study|Protocol Violation|0|||
130406425|NCT02799082|469451791|FG001|Overall Study|Protocol Violation|1|||
130406426|NCT01748994|469451796|FG000|Overall Study|Lost to Follow-up|8|||
130406427|NCT01748994|469451797|FG001|Overall Study|Lost to Follow-up|6|||
130406428|NCT02520531|469451800|FG000|Overall Study|Revision of study device components|2|||
130471578|NCT04757610|469692746|FG002|Overall Study|Death|8|||
130471579|NCT04757610|469692744|FG000|Overall Study|Lack of Efficacy|1|||
130471580|NCT04757610|469692745|FG001|Overall Study|Lack of Efficacy|2|||
130471581|NCT04757610|469692746|FG002|Overall Study|Lack of Efficacy|3|||
130471582|NCT04757610|469692744|FG000|Overall Study|Lost to Follow-up|7|||
130471583|NCT04757610|469692745|FG001|Overall Study|Lost to Follow-up|2|||
130471584|NCT04757610|469692746|FG002|Overall Study|Lost to Follow-up|7|||
130471585|NCT04757610|469692744|FG000|Overall Study|Physician Decision|4|||
130471586|NCT04757610|469692745|FG001|Overall Study|Physician Decision|1|||
130471587|NCT04757610|469692746|FG002|Overall Study|Physician Decision|2|||
130471588|NCT04757610|469692744|FG000|Overall Study|Withdrawal by Subject|26|||
130471589|NCT04757610|469692745|FG001|Overall Study|Withdrawal by Subject|25|||
130471590|NCT04757610|469692746|FG002|Overall Study|Withdrawal by Subject|25|||
130471591|NCT04757610|469692744|FG000|Overall Study|Study Terminated by Sponsor|105|||
130471592|NCT04757610|469692745|FG001|Overall Study|Study Terminated by Sponsor|105|||
130471593|NCT04757610|469692746|FG002|Overall Study|Study Terminated by Sponsor|110|||
130471594|NCT04757610|469692744|FG000|Overall Study|Randomized in Error|1|||
130471595|NCT04757610|469692745|FG001|Overall Study|Randomized in Error|0|||
130471596|NCT04757610|469692746|FG002|Overall Study|Randomized in Error|0|||
130471597|NCT02965846|469692747|FG000|Overall Study|Lost to Follow-up|1|||
130471598|NCT02965846|469692748|FG001|Overall Study|Lost to Follow-up|0|||
130471599|NCT02965846|469692749|FG002|Overall Study|Lost to Follow-up|0|||
130471600|NCT02965846|469692747|FG000|Overall Study|Withdrawal by Subject|0|||
130471601|NCT02965846|469692748|FG001|Overall Study|Withdrawal by Subject|1|||
130471602|NCT02965846|469692749|FG002|Overall Study|Withdrawal by Subject|0|||
130471603|NCT02965846|469692747|FG000|Overall Study|Study Terminated By Sponsor|4|||
130471604|NCT02965846|469692748|FG001|Overall Study|Study Terminated By Sponsor|4|||
130471605|NCT02965846|469692749|FG002|Overall Study|Study Terminated By Sponsor|0|||
130471606|NCT02965846|469692747|FG000|Overall Study|Participants not randomized|0|||
130471607|NCT02965846|469692748|FG001|Overall Study|Participants not randomized|0|||
130471608|NCT02965846|469692749|FG002|Overall Study|Participants not randomized|33|||
130471609|NCT04924062|469693896|FG000|Overall Study|Death|49|||
130471610|NCT04924062|469693897|FG001|Overall Study|Death|63|||
130471611|NCT04924062|469693896|FG000|Overall Study|Participant On-going|26|||
130471612|NCT04924062|469693897|FG001|Overall Study|Participant On-going|20|||
130471613|NCT04607044|469693900|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
130471614|NCT04607044|469693900|FG000|Overall Study|Adverse Event|1|||
130471615|NCT04607044|469693900|FG000|Overall Study|Did not receive study device|3|||
130471616|NCT04607044|469693900|FG000|Overall Study|Death|1|||
130471617|NCT03651895|469693901|FG000|First Drug Assignment|Adverse Event|4|||
130471618|NCT03651895|469693902|FG001|First Drug Assignment|Adverse Event|5|||
130471619|NCT03651895|469693901|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
130471620|NCT03651895|469693902|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
130471621|NCT02525692|469693903|FG000|Overall Study|Withdrawal by Subject|1|||
130471622|NCT02525692|469693904|FG001|Overall Study|Withdrawal by Subject|1|||
130471623|NCT02525692|469693905|FG002|Overall Study|Withdrawal by Subject|0|||
130471624|NCT02525692|469693906|FG003|Overall Study|Withdrawal by Subject|5|||
130471625|NCT02525692|469693907|FG004|Overall Study|Withdrawal by Subject|0|||
130471626|NCT02525692|469693908|FG005|Overall Study|Withdrawal by Subject|1|||
130471627|NCT02525692|469693903|FG000|Overall Study|Death|16|||
130471628|NCT02525692|469693904|FG001|Overall Study|Death|18|||
130471629|NCT02525692|469693905|FG002|Overall Study|Death|7|||
130471630|NCT02525692|469693906|FG003|Overall Study|Death|20|||
130471631|NCT02525692|469693907|FG004|Overall Study|Death|3|||
130471632|NCT02525692|469693908|FG005|Overall Study|Death|6|||
130471633|NCT02525692|469693903|FG000|Overall Study|Lost to Follow-up|0|||
130406429|NCT02520531|469451801|FG001|Overall Study|Revision of study device components|2|||
130406430|NCT02520531|469451800|FG000|Overall Study|Death|1|||
130561147|NCT02553265|470024740|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
130406431|NCT02520531|469451801|FG001|Overall Study|Death|2|||
130406432|NCT02520531|469451800|FG000|Overall Study|Lost to Follow-up|1|||
130406433|NCT02520531|469451801|FG001|Overall Study|Lost to Follow-up|1|||
130406434|NCT02520531|469451800|FG000|Overall Study|Meet exclusion criterion|0|||
130406435|NCT02520531|469451801|FG001|Overall Study|Meet exclusion criterion|1|||
130406436|NCT02520531|469451800|FG000|Overall Study|Withdrawal by Subject|1|||
130406437|NCT02520531|469451801|FG001|Overall Study|Withdrawal by Subject|0|||
130406438|NCT02520531|469451800|FG000|Overall Study|Not study device|1|||
130406439|NCT02520531|469451801|FG001|Overall Study|Not study device|0|||
130406440|NCT01723904|469451805|FG000|Overall Study|Noncompliant|3|||
130406441|NCT01723904|469451805|FG000|Overall Study|Adverse Event|5|||
130406442|NCT01723904|469451805|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
130406443|NCT03251924|469451806|FG000|Overall Study|Disease Progression|6|||
130406444|NCT03251924|469451807|FG001|Overall Study|Disease Progression|6|||
130406445|NCT03251924|469451808|FG002|Overall Study|Disease Progression|7|||
130406446|NCT03251924|469451809|FG003|Overall Study|Disease Progression|8|||
130406447|NCT03251924|469451810|FG004|Overall Study|Disease Progression|8|||
130406448|NCT03251924|469451811|FG005|Overall Study|Disease Progression|7|||
130406449|NCT03251924|469451812|FG006|Overall Study|Disease Progression|6|||
130406450|NCT03251924|469451813|FG007|Overall Study|Disease Progression|10|||
130406451|NCT03251924|469451814|FG008|Overall Study|Disease Progression|6|||
130406452|NCT03251924|469451806|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130406453|NCT03251924|469451807|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
130471634|NCT02525692|469693904|FG001|Overall Study|Lost to Follow-up|0|||
130471635|NCT02525692|469693905|FG002|Overall Study|Lost to Follow-up|1|||
130471636|NCT02525692|469693906|FG003|Overall Study|Lost to Follow-up|5|||
130471637|NCT02525692|469693907|FG004|Overall Study|Lost to Follow-up|0|||
130471638|NCT02525692|469693908|FG005|Overall Study|Lost to Follow-up|0|||
130471639|NCT02396199|469693909|FG000|Overall Study|Lost to Follow-up|1|||
130471640|NCT02396199|469693909|FG000|Overall Study|Death|4|||
130471641|NCT02349412|469693919|FG000|Overall Study|Withdrawal by Subject|7|||
130471642|NCT02349412|469693920|FG001|Overall Study|Withdrawal by Subject|7|||
130471643|NCT04337372|469693921|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
130471644|NCT04337372|469693922|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
130471645|NCT04337372|469693923|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
130471646|NCT04337372|469693924|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
130471647|NCT04337372|469693921|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
130471648|NCT04337372|469693922|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
130471649|NCT04337372|469693923|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
130471650|NCT04337372|469693924|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
130471651|NCT04337372|469693921|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
130471652|NCT04337372|469693922|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
130471653|NCT04337372|469693923|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
130471654|NCT04337372|469693924|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
130471655|NCT04337372|469693921|FG000|Day 2: EEG Measures|Protocol Violation|6|||
130471656|NCT04337372|469693922|FG001|Day 2: EEG Measures|Protocol Violation|6|||
130471657|NCT04337372|469693923|FG002|Day 2: EEG Measures|Protocol Violation|5|||
130471658|NCT04337372|469693924|FG003|Day 2: EEG Measures|Protocol Violation|17|||
130471659|NCT05307783|469693925|FG000|Overall Study|Death|7|||
130471660|NCT05307783|469693925|FG000|Overall Study|Lost to Follow-up|4|||
130471661|NCT04883645|469693926|FG000|Overall Study|Death|1|||
130471662|NCT03460236|469693927|FG000|Overall Study|failed radiographic screening|16|||
130471663|NCT03460236|469693927|FG000|Overall Study|Withdrawal by Subject|11|||
130471664|NCT00979576|469693930|FG000|Combination Treatment Phase|Progressive disease|3|||
130471665|NCT00979576|469693931|FG001|Combination Treatment Phase|Progressive disease|1|||
130471666|NCT00979576|469693932|FG002|Combination Treatment Phase|Progressive disease|5|||
130471667|NCT00979576|469693930|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
130471668|NCT00979576|469693931|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
130471669|NCT00979576|469693932|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
130471670|NCT00979576|469693930|FG000|Combination Treatment Phase|Adverse Event|0|||
130471671|NCT00979576|469693931|FG001|Combination Treatment Phase|Adverse Event|2|||
130471672|NCT00979576|469693932|FG002|Combination Treatment Phase|Adverse Event|2|||
130471673|NCT00979576|469693930|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
130471674|NCT00979576|469693931|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
130471675|NCT00979576|469693932|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
130471676|NCT04840199|469693933|FG000|Overall Study|Study Terminated by Sponsor|8|||
130471677|NCT04840199|469693934|FG001|Overall Study|Study Terminated by Sponsor|9|||
130471678|NCT04840199|469693933|FG000|Overall Study|Lost to Follow-up|0|||
130471679|NCT04840199|469693934|FG001|Overall Study|Lost to Follow-up|2|||
130471680|NCT04840199|469693933|FG000|Overall Study|Withdrawal by Subject|2|||
130471681|NCT04840199|469693934|FG001|Overall Study|Withdrawal by Subject|0|||
130471682|NCT04840199|469693933|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
130725012|NCT04933968|470619164|FG001|Overall Study|Other|0|||
130725013|NCT04933968|470619165|FG002|Overall Study|Other|0|||
130725014|NCT04933968|470619166|FG003|Overall Study|Other|1|||
130406454|NCT03251924|469451808|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
130406455|NCT03251924|469451809|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
130406456|NCT03251924|469451810|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
130406457|NCT03251924|469451811|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
130406458|NCT03251924|469451812|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
130406459|NCT03251924|469451813|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
130406460|NCT03251924|469451814|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
130406461|NCT03251924|469451806|FG000|Overall Study|Death|0|||
130406462|NCT03251924|469451807|FG001|Overall Study|Death|1|||
130406463|NCT03251924|469451808|FG002|Overall Study|Death|0|||
130406464|NCT03251924|469451809|FG003|Overall Study|Death|1|||
130406465|NCT03251924|469451810|FG004|Overall Study|Death|1|||
130406466|NCT03251924|469451811|FG005|Overall Study|Death|1|||
130406467|NCT03251924|469451812|FG006|Overall Study|Death|0|||
130406468|NCT03251924|469451813|FG007|Overall Study|Death|0|||
130406469|NCT03251924|469451814|FG008|Overall Study|Death|0|||
130406470|NCT03251924|469451806|FG000|Overall Study|Study Drug Toxicity|0|||
130406471|NCT03251924|469451807|FG001|Overall Study|Study Drug Toxicity|0|||
130406472|NCT03251924|469451808|FG002|Overall Study|Study Drug Toxicity|0|||
130406473|NCT03251924|469451809|FG003|Overall Study|Study Drug Toxicity|1|||
130406474|NCT03251924|469451810|FG004|Overall Study|Study Drug Toxicity|0|||
130406475|NCT03251924|469451811|FG005|Overall Study|Study Drug Toxicity|0|||
130406476|NCT03251924|469451812|FG006|Overall Study|Study Drug Toxicity|0|||
130406477|NCT03251924|469451813|FG007|Overall Study|Study Drug Toxicity|0|||
130406478|NCT03251924|469451814|FG008|Overall Study|Study Drug Toxicity|1|||
130406479|NCT03251924|469451806|FG000|Overall Study|Other Reasons|0|||
130406480|NCT03251924|469451807|FG001|Overall Study|Other Reasons|0|||
130406481|NCT03251924|469451808|FG002|Overall Study|Other Reasons|0|||
130406482|NCT03251924|469451809|FG003|Overall Study|Other Reasons|0|||
130406483|NCT03251924|469451810|FG004|Overall Study|Other Reasons|0|||
130406484|NCT03251924|469451811|FG005|Overall Study|Other Reasons|0|||
130406485|NCT03251924|469451812|FG006|Overall Study|Other Reasons|0|||
130406486|NCT03251924|469451813|FG007|Overall Study|Other Reasons|0|||
130406487|NCT03251924|469451814|FG008|Overall Study|Other Reasons|1|||
130406488|NCT03251924|469451806|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130406489|NCT03251924|469451807|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130406490|NCT03251924|469451808|FG002|Overall Study|Participant request to discontinue study treatment|0|||
130406491|NCT03251924|469451809|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130406492|NCT03251924|469451810|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130406493|NCT03251924|469451811|FG005|Overall Study|Participant request to discontinue study treatment|0|||
130406494|NCT03251924|469451812|FG006|Overall Study|Participant request to discontinue study treatment|0|||
130406495|NCT03251924|469451813|FG007|Overall Study|Participant request to discontinue study treatment|1|||
130406496|NCT03251924|469451814|FG008|Overall Study|Participant request to discontinue study treatment|0|||
130406497|NCT02617589|469451825|FG000|Randomization|Request to Discontinue Study Treatment|1|||
130406498|NCT02617589|469451826|FG001|Randomization|Request to Discontinue Study Treatment|3|||
130406499|NCT02617589|469451825|FG000|Randomization|Participant Withdrew Consent|1|||
130406500|NCT02617589|469451826|FG001|Randomization|Participant Withdrew Consent|2|||
130406501|NCT02617589|469451825|FG000|Treatment|Other Reasons|3|||
130406502|NCT02617589|469451826|FG001|Treatment|Other Reasons|3|||
130406503|NCT02617589|469451825|FG000|Treatment|Poor/Non Compliance|1|||
130406504|NCT02617589|469451826|FG001|Treatment|Poor/Non Compliance|1|||
130406505|NCT02617589|469451825|FG000|Treatment|Maximum Clinical Benefit|0|||
130406506|NCT02617589|469451826|FG001|Treatment|Maximum Clinical Benefit|2|||
130406507|NCT02617589|469451825|FG000|Treatment|Participant Withdrew Consent|2|||
130406508|NCT02617589|469451826|FG001|Treatment|Participant Withdrew Consent|6|||
130406509|NCT02617589|469451825|FG000|Treatment|Participant Request to Discontinue|12|||
130406510|NCT02617589|469451826|FG001|Treatment|Participant Request to Discontinue|21|||
130406511|NCT02617589|469451825|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
130406512|NCT02617589|469451826|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
130406513|NCT02617589|469451825|FG000|Treatment|Death|1|||
130406514|NCT02617589|469451826|FG001|Treatment|Death|1|||
130406515|NCT02617589|469451825|FG000|Treatment|Study Drug Toxicity|27|||
130406516|NCT02617589|469451826|FG001|Treatment|Study Drug Toxicity|20|||
130406517|NCT02617589|469451825|FG000|Treatment|Disease Progression|216|||
130406518|NCT02617589|469451826|FG001|Treatment|Disease Progression|136|||
130406519|NCT01649856|469451827|FG000|Overall Study|Withdrawal by Subject|14|||
130406520|NCT01649856|469451828|FG001|Overall Study|Withdrawal by Subject|14|||
130406521|NCT01649856|469451827|FG000|Overall Study|Protocol Violation|4|||
130406522|NCT01649856|469451828|FG001|Overall Study|Protocol Violation|4|||
130406523|NCT01649856|469451827|FG000|Overall Study|Treatment Failure|1|||
130406524|NCT01649856|469451828|FG001|Overall Study|Treatment Failure|1|||
130406525|NCT01649856|469451827|FG000|Overall Study|Death|69|||
130406526|NCT01649856|469451828|FG001|Overall Study|Death|34|||
130406527|NCT01649856|469451827|FG000|Overall Study|Stable or Progressed Disease|5|||
130406528|NCT01649856|469451828|FG001|Overall Study|Stable or Progressed Disease|3|||
130471683|NCT04840199|469693934|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
130471684|NCT04143061|469693935|FG000|Overall Study|Protocol Deviation|0|||
130471685|NCT04143061|469693936|FG001|Overall Study|Protocol Deviation|0|||
130471686|NCT04143061|469693937|FG002|Overall Study|Protocol Deviation|0|||
130471687|NCT04143061|469693938|FG003|Overall Study|Protocol Deviation|0|||
130471688|NCT04143061|469693939|FG004|Overall Study|Protocol Deviation|0|||
130471689|NCT04143061|469693940|FG005|Overall Study|Protocol Deviation|0|||
130471690|NCT04143061|469693941|FG006|Overall Study|Protocol Deviation|5|||
130471691|NCT04143061|469693942|FG007|Overall Study|Protocol Deviation|5|||
130471692|NCT04143061|469693935|FG000|Overall Study|Withdrawal by Subject|2|||
130471693|NCT04143061|469693936|FG001|Overall Study|Withdrawal by Subject|0|||
130471694|NCT04143061|469693937|FG002|Overall Study|Withdrawal by Subject|0|||
130471695|NCT04143061|469693938|FG003|Overall Study|Withdrawal by Subject|0|||
130561148|NCT02553265|470024741|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
130561149|NCT02553265|470024739|FG000|Second Intervention (28 Days)|Adverse Event|1|||
130561150|NCT02553265|470024740|FG001|Second Intervention (28 Days)|Adverse Event|0|||
130561151|NCT02553265|470024741|FG002|Second Intervention (28 Days)|Adverse Event|0|||
130561152|NCT02553265|470024739|FG000|Third Intervention (28 Days)|Adverse Event|1|||
130561153|NCT02553265|470024740|FG001|Third Intervention (28 Days)|Adverse Event|0|||
130561154|NCT02553265|470024741|FG002|Third Intervention (28 Days)|Adverse Event|0|||
130561155|NCT02553265|470024739|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
130561156|NCT02553265|470024740|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
130561157|NCT02553265|470024741|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
130406529|NCT01649856|469451827|FG000|Overall Study|Lost to Follow-up|20|||
130406530|NCT01649856|469451828|FG001|Overall Study|Lost to Follow-up|16|||
130406531|NCT01649856|469451827|FG000|Overall Study|Lack of Compliance|6|||
130406532|NCT01649856|469451828|FG001|Overall Study|Lack of Compliance|1|||
130406533|NCT01649856|469451827|FG000|Overall Study|Other|20|||
130406534|NCT01649856|469451828|FG001|Overall Study|Other|5|||
130406535|NCT00622635|469451829|FG000|Treatment Period 1|Adverse Event|0|||
130406536|NCT00622635|469451830|FG001|Treatment Period 1|Adverse Event|0|||
130406537|NCT00622635|469451831|FG002|Treatment Period 1|Adverse Event|1|||
130561158|NCT02667275|470024742|FG000|Overall Study|Protocol Violation|11|||
130561159|NCT02667275|470024743|FG001|Overall Study|Protocol Violation|7|||
130561160|NCT02667275|470024742|FG000|Overall Study|Lost to Follow-up|0|||
130561161|NCT02667275|470024743|FG001|Overall Study|Lost to Follow-up|2|||
130561162|NCT02667275|470024742|FG000|Overall Study|Withdrawal by Subject|0|||
130561163|NCT02667275|470024743|FG001|Overall Study|Withdrawal by Subject|5|||
130561164|NCT02667275|470024742|FG000|Overall Study|Discontinued early without completing|0|||
130561165|NCT02667275|470024743|FG001|Overall Study|Discontinued early without completing|1|||
130561166|NCT02357134|470024744|FG000|Overall Study|Lost to Follow-up|1|||
130561167|NCT02357134|470024745|FG001|Overall Study|Lost to Follow-up|0|||
130561168|NCT02357134|470024746|FG002|Overall Study|Lost to Follow-up|0|||
130561169|NCT02357134|470024747|FG003|Overall Study|Lost to Follow-up|0|||
130561170|NCT03583450|470024748|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
130561171|NCT03583450|470024749|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
130561172|NCT03374995|470024750|FG000|Overall Study|Withdrawal by Subject|0|||
130561173|NCT03374995|470024751|FG001|Overall Study|Withdrawal by Subject|1|||
130561174|NCT01380730|470024754|FG000|Overall Study|Death|0|||
130725015|NCT04933968|470619167|FG004|Overall Study|Other|0|||
130725016|NCT04933968|470619168|FG005|Overall Study|Other|0|||
130725017|NCT04933968|470619163|FG000|Overall Study|Missing|1|||
130725018|NCT04933968|470619164|FG001|Overall Study|Missing|3|||
130725019|NCT04933968|470619165|FG002|Overall Study|Missing|2|||
130725020|NCT04933968|470619166|FG003|Overall Study|Missing|1|||
130406538|NCT00622635|469451832|FG003|Treatment Period 1|Adverse Event|0|||
130406539|NCT00622635|469451833|FG004|Treatment Period 1|Adverse Event|0|||
130406540|NCT00622635|469451834|FG005|Treatment Period 1|Adverse Event|0|||
130471696|NCT04143061|469693939|FG004|Overall Study|Withdrawal by Subject|0|||
130471697|NCT04143061|469693940|FG005|Overall Study|Withdrawal by Subject|1|||
130471698|NCT04143061|469693941|FG006|Overall Study|Withdrawal by Subject|0|||
130561175|NCT01380730|470024755|FG001|Overall Study|Death|0|||
130561176|NCT01380730|470024756|FG002|Overall Study|Death|0|||
130725021|NCT04933968|470619167|FG004|Overall Study|Missing|1|||
130725022|NCT04933968|470619168|FG005|Overall Study|Missing|0|||
130406541|NCT00622635|469451829|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130471699|NCT04143061|469693942|FG007|Overall Study|Withdrawal by Subject|0|||
130406542|NCT00622635|469451830|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130471700|NCT04143061|469693935|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130561177|NCT01380730|470024757|FG003|Overall Study|Death|0|||
130561178|NCT01380730|470024758|FG004|Overall Study|Death|1|||
130725023|NCT01724489|470619169|FG000|Overall Study|Adverse Event|8|||
130406543|NCT00622635|469451831|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130406544|NCT00622635|469451832|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130471701|NCT04143061|469693936|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130471702|NCT04143061|469693937|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130725024|NCT01724489|470619170|FG001|Overall Study|Adverse Event|3|||
130725025|NCT01724489|470619169|FG000|Overall Study|Surgery, medication|1|||
130725026|NCT01724489|470619170|FG001|Overall Study|Surgery, medication|1|||
130406545|NCT00622635|469451833|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130406546|NCT00622635|469451834|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130406547|NCT00622635|469451829|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
130406548|NCT00622635|469451830|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
130406549|NCT00622635|469451831|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
130406550|NCT00622635|469451832|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
130406551|NCT00622635|469451833|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
130406552|NCT00622635|469451834|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
130406553|NCT00622635|469451829|FG000|Treatment Period 2|Adverse Event|1|||
130406554|NCT00622635|469451830|FG001|Treatment Period 2|Adverse Event|0|||
130406555|NCT00622635|469451831|FG002|Treatment Period 2|Adverse Event|0|||
130406556|NCT00622635|469451832|FG003|Treatment Period 2|Adverse Event|0|||
130406557|NCT00622635|469451833|FG004|Treatment Period 2|Adverse Event|0|||
130406558|NCT00622635|469451834|FG005|Treatment Period 2|Adverse Event|0|||
130406559|NCT00622635|469451829|FG000|Treatment Period 3|Adverse Event|0|||
130406560|NCT00622635|469451830|FG001|Treatment Period 3|Adverse Event|0|||
130406561|NCT00622635|469451831|FG002|Treatment Period 3|Adverse Event|0|||
130406562|NCT00622635|469451832|FG003|Treatment Period 3|Adverse Event|2|||
130406563|NCT00622635|469451833|FG004|Treatment Period 3|Adverse Event|0|||
130406564|NCT00622635|469451834|FG005|Treatment Period 3|Adverse Event|0|||
130406565|NCT00622635|469451829|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130406566|NCT00622635|469451830|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130406567|NCT00622635|469451831|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130406568|NCT00622635|469451832|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130406569|NCT00622635|469451833|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130406570|NCT00622635|469451834|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130406571|NCT03027466|469451835|FG000|Overall Study|Opting out of the app|1869|||
130406572|NCT03027466|469451836|FG001|Overall Study|Opting out of the app|1819|||
130406573|NCT03027466|469451837|FG002|Overall Study|Opting out of the app|1743|||
130406574|NCT03027466|469451838|FG003|Overall Study|Opting out of the app|1821|||
130406575|NCT01898793|469451843|FG000|Overall Study|Death|2|||
130406576|NCT01898793|469451844|FG001|Overall Study|Death|1|||
130406577|NCT01898793|469451845|FG002|Overall Study|Death|4|||
130406578|NCT01898793|469451846|FG003|Overall Study|Death|0|||
130406579|NCT01898793|469451847|FG004|Overall Study|Death|0|||
130406580|NCT01898793|469451848|FG005|Overall Study|Death|0|||
130406581|NCT01898793|469451849|FG006|Overall Study|Death|0|||
130406582|NCT02066298|469453627|FG000|Overall Study|Lost to Follow-up|3|||
130406583|NCT02066298|469453628|FG001|Overall Study|Lost to Follow-up|2|||
130406584|NCT02066298|469453629|FG002|Overall Study|Lost to Follow-up|3|||
130406585|NCT02066298|469453630|FG003|Overall Study|Lost to Follow-up|2|||
130406586|NCT02066298|469453631|FG004|Overall Study|Lost to Follow-up|3|||
130406587|NCT02066298|469453632|FG005|Overall Study|Lost to Follow-up|4|||
130406588|NCT02066298|469453627|FG000|Overall Study|Withdrawal by Subject|6|||
130406589|NCT02066298|469453628|FG001|Overall Study|Withdrawal by Subject|6|||
130406590|NCT02066298|469453629|FG002|Overall Study|Withdrawal by Subject|6|||
130406591|NCT02066298|469453630|FG003|Overall Study|Withdrawal by Subject|4|||
130406592|NCT02066298|469453631|FG004|Overall Study|Withdrawal by Subject|5|||
130406593|NCT02066298|469453632|FG005|Overall Study|Withdrawal by Subject|8|||
130406594|NCT02066298|469453627|FG000|Overall Study|Physician Decision|0|||
130406595|NCT02066298|469453628|FG001|Overall Study|Physician Decision|0|||
130406596|NCT02066298|469453629|FG002|Overall Study|Physician Decision|1|||
130406597|NCT02066298|469453630|FG003|Overall Study|Physician Decision|0|||
130406598|NCT02066298|469453631|FG004|Overall Study|Physician Decision|1|||
130406599|NCT02066298|469453632|FG005|Overall Study|Physician Decision|0|||
130406600|NCT02866682|469453633|FG000|Overall Study|Death|0|||
130406601|NCT02866682|469453634|FG001|Overall Study|Death|1|||
130406602|NCT02866682|469453633|FG000|Overall Study|Lost to Follow-up|0|||
130406603|NCT02866682|469453634|FG001|Overall Study|Lost to Follow-up|4|||
130406604|NCT02866682|469453633|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
130406605|NCT02866682|469453634|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
130406606|NCT02866682|469453633|FG000|Overall Study|Other|0|||
130406607|NCT02866682|469453634|FG001|Overall Study|Other|1|||
130406608|NCT01750268|469453635|FG000|Overall Study|Lost to Follow-up|0|||
130725027|NCT01724489|470619169|FG000|Overall Study|Lost to Follow-up|1|||
130725028|NCT01724489|470619170|FG001|Overall Study|Lost to Follow-up|2|||
130725029|NCT01724489|470619169|FG000|Overall Study|Withdrawal by Subject|6|||
130406609|NCT01750268|469453636|FG001|Overall Study|Lost to Follow-up|2|||
130406610|NCT01750268|469453635|FG000|Overall Study|Physician Decision|0|||
130406611|NCT01750268|469453636|FG001|Overall Study|Physician Decision|3|||
130725030|NCT01724489|470619170|FG001|Overall Study|Withdrawal by Subject|6|||
130406612|NCT01750268|469453635|FG000|Overall Study|Withdrawal by Subject|2|||
130406613|NCT01750268|469453636|FG001|Overall Study|Withdrawal by Subject|0|||
130406614|NCT03087591|469453639|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
130725031|NCT04576923|470619171|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
130561179|NCT01380730|470024759|FG005|Overall Study|Death|0|||
130561180|NCT01380730|470024760|FG006|Overall Study|Death|0|||
130561181|NCT01380730|470024761|FG007|Overall Study|Death|0|||
130561182|NCT00467779|470024766|FG000|Stage 1|Adverse Event|1|||
130561183|NCT00467779|470024767|FG001|Stage 1|Adverse Event|0|||
130561184|NCT00467779|470024768|FG002|Stage 1|Adverse Event|0|||
130561185|NCT00467779|470024769|FG003|Stage 1|Adverse Event|0|||
130561186|NCT00467779|470024770|FG004|Stage 1|Adverse Event|0|||
130561187|NCT00467779|470024771|FG005|Stage 1|Adverse Event|1|||
130561188|NCT00467779|470024772|FG006|Stage 1|Adverse Event|2|||
130561189|NCT00467779|470024773|FG007|Stage 1|Adverse Event|1|||
130406615|NCT03087591|469453639|FG000|Overall Study|Withdrawal by Subject|1|||
130406616|NCT02621606|469453640|FG000|Overall Study|Withdrawal by Subject|0|||
130406617|NCT02621606|469453641|FG001|Overall Study|Withdrawal by Subject|1|||
130406618|NCT02621606|469453642|FG002|Overall Study|Withdrawal by Subject|0|||
130406619|NCT00274716|469453643|FG000|Phase A|Other non-reported reason|4|||
130406620|NCT00274716|469453644|FG001|Phase A|Other non-reported reason|2|||
130406621|NCT00274716|469453645|FG002|Phase A|Other non-reported reason|1|||
130406622|NCT00274716|469453646|FG003|Phase A|Other non-reported reason|2|||
130406623|NCT00274716|469453647|FG004|Phase A|Other non-reported reason|0|||
130406624|NCT00274716|469453648|FG005|Phase A|Other non-reported reason|1|||
130406625|NCT00274716|469453643|FG000|Phase A|Participant moved|0|||
130406626|NCT00274716|469453644|FG001|Phase A|Participant moved|0|||
130406627|NCT00274716|469453645|FG002|Phase A|Participant moved|1|||
130406628|NCT00274716|469453646|FG003|Phase A|Participant moved|0|||
130406629|NCT00274716|469453647|FG004|Phase A|Participant moved|0|||
130406630|NCT00274716|469453648|FG005|Phase A|Participant moved|1|||
130406631|NCT00274716|469453643|FG000|Phase A|Site Terminated|0|||
130406632|NCT00274716|469453644|FG001|Phase A|Site Terminated|0|||
130406633|NCT00274716|469453645|FG002|Phase A|Site Terminated|0|||
130406634|NCT00274716|469453646|FG003|Phase A|Site Terminated|1|||
130406635|NCT00274716|469453647|FG004|Phase A|Site Terminated|0|||
130406636|NCT00274716|469453648|FG005|Phase A|Site Terminated|0|||
130406637|NCT00274716|469453643|FG000|Phase A|Protocol Violation|1|||
130406638|NCT00274716|469453644|FG001|Phase A|Protocol Violation|0|||
130406639|NCT00274716|469453645|FG002|Phase A|Protocol Violation|0|||
130406640|NCT00274716|469453646|FG003|Phase A|Protocol Violation|1|||
130406641|NCT00274716|469453647|FG004|Phase A|Protocol Violation|0|||
130406642|NCT00274716|469453648|FG005|Phase A|Protocol Violation|0|||
130406643|NCT00274716|469453643|FG000|Phase A|Met criteria for discontinuation|1|||
130406644|NCT00274716|469453644|FG001|Phase A|Met criteria for discontinuation|1|||
130406645|NCT00274716|469453645|FG002|Phase A|Met criteria for discontinuation|0|||
130406646|NCT00274716|469453646|FG003|Phase A|Met criteria for discontinuation|0|||
130406647|NCT00274716|469453647|FG004|Phase A|Met criteria for discontinuation|0|||
130406648|NCT00274716|469453648|FG005|Phase A|Met criteria for discontinuation|0|||
130406649|NCT00274716|469453643|FG000|Phase A|Withdrawal by Subject|2|||
130406650|NCT00274716|469453644|FG001|Phase A|Withdrawal by Subject|2|||
130406651|NCT00274716|469453645|FG002|Phase A|Withdrawal by Subject|1|||
130406652|NCT00274716|469453646|FG003|Phase A|Withdrawal by Subject|3|||
130406653|NCT00274716|469453647|FG004|Phase A|Withdrawal by Subject|0|||
130406654|NCT00274716|469453648|FG005|Phase A|Withdrawal by Subject|1|||
130471703|NCT04143061|469693938|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130471704|NCT04143061|469693939|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
130471705|NCT04143061|469693940|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
130471706|NCT04143061|469693941|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
130471707|NCT04143061|469693942|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
130471708|NCT03602014|469693943|FG000|Overall Study|Lost to Follow-up|2|||
130471709|NCT03602014|469693944|FG001|Overall Study|Lost to Follow-up|0|||
130471710|NCT03602014|469693945|FG002|Overall Study|Lost to Follow-up|0|||
130471711|NCT04905407|469693949|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
130471712|NCT04905407|469693950|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
130471713|NCT04905407|469693951|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
130471714|NCT04905407|469693952|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
130471715|NCT04905407|469693949|FG000|Part 1 and Part 2|Death|7|||
130471716|NCT04905407|469693950|FG001|Part 1 and Part 2|Death|7|||
130471717|NCT04905407|469693951|FG002|Part 1 and Part 2|Death|7|||
130471718|NCT04905407|469693952|FG003|Part 1 and Part 2|Death|0|||
130471719|NCT04905407|469693949|FG000|Part 1 and Part 2|Other than specified|0|||
130471720|NCT04905407|469693950|FG001|Part 1 and Part 2|Other than specified|0|||
130471721|NCT04905407|469693951|FG002|Part 1 and Part 2|Other than specified|1|||
130471722|NCT04905407|469693952|FG003|Part 1 and Part 2|Other than specified|0|||
130406655|NCT00274716|469453643|FG000|Phase A|Adverse Event|2|||
130406656|NCT00274716|469453644|FG001|Phase A|Adverse Event|3|||
130406657|NCT00274716|469453645|FG002|Phase A|Adverse Event|3|||
130406658|NCT00274716|469453646|FG003|Phase A|Adverse Event|0|||
130406659|NCT00274716|469453647|FG004|Phase A|Adverse Event|2|||
130471723|NCT04905407|469693949|FG000|Part 3|Death|0|||
130471724|NCT04905407|469693950|FG001|Part 3|Death|0|||
130471725|NCT04905407|469693951|FG002|Part 3|Death|0|||
130471726|NCT04905407|469693952|FG003|Part 3|Death|2|||
130561190|NCT00467779|470024774|FG008|Stage 1|Adverse Event|0|||
130561191|NCT00467779|470024775|FG009|Stage 1|Adverse Event|0|||
130561192|NCT00467779|470024776|FG010|Stage 1|Adverse Event|0|||
130561193|NCT00467779|470024777|FG011|Stage 1|Adverse Event|0|||
130561194|NCT00467779|470024778|FG012|Stage 1|Adverse Event|0|||
130561195|NCT00467779|470024779|FG013|Stage 1|Adverse Event|0|||
130561196|NCT00467779|470024780|FG014|Stage 1|Adverse Event|0|||
130561197|NCT00467779|470024766|FG000|Stage 1|Disease Progression|2|||
130561198|NCT00467779|470024767|FG001|Stage 1|Disease Progression|2|||
130561199|NCT00467779|470024768|FG002|Stage 1|Disease Progression|2|||
130561200|NCT00467779|470024769|FG003|Stage 1|Disease Progression|3|||
130561201|NCT00467779|470024770|FG004|Stage 1|Disease Progression|2|||
130561202|NCT00467779|470024771|FG005|Stage 1|Disease Progression|2|||
130561203|NCT00467779|470024772|FG006|Stage 1|Disease Progression|4|||
130561204|NCT00467779|470024773|FG007|Stage 1|Disease Progression|5|||
130561205|NCT00467779|470024774|FG008|Stage 1|Disease Progression|0|||
130561206|NCT00467779|470024775|FG009|Stage 1|Disease Progression|0|||
130561207|NCT00467779|470024776|FG010|Stage 1|Disease Progression|0|||
130561208|NCT00467779|470024777|FG011|Stage 1|Disease Progression|0|||
130561209|NCT00467779|470024778|FG012|Stage 1|Disease Progression|0|||
130561210|NCT00467779|470024779|FG013|Stage 1|Disease Progression|0|||
130561211|NCT00467779|470024780|FG014|Stage 1|Disease Progression|0|||
130561212|NCT00467779|470024766|FG000|Stage 1|Unspecified Reason|1|||
130561213|NCT00467779|470024767|FG001|Stage 1|Unspecified Reason|0|||
130561214|NCT00467779|470024768|FG002|Stage 1|Unspecified Reason|1|||
130561215|NCT00467779|470024769|FG003|Stage 1|Unspecified Reason|0|||
130561216|NCT00467779|470024770|FG004|Stage 1|Unspecified Reason|1|||
130561217|NCT00467779|470024771|FG005|Stage 1|Unspecified Reason|2|||
130561218|NCT00467779|470024772|FG006|Stage 1|Unspecified Reason|0|||
130561219|NCT00467779|470024773|FG007|Stage 1|Unspecified Reason|0|||
130561220|NCT00467779|470024774|FG008|Stage 1|Unspecified Reason|0|||
130561221|NCT00467779|470024775|FG009|Stage 1|Unspecified Reason|0|||
130561222|NCT00467779|470024776|FG010|Stage 1|Unspecified Reason|0|||
130561223|NCT00467779|470024777|FG011|Stage 1|Unspecified Reason|0|||
130561224|NCT00467779|470024778|FG012|Stage 1|Unspecified Reason|0|||
130561225|NCT00467779|470024779|FG013|Stage 1|Unspecified Reason|0|||
130561226|NCT00467779|470024780|FG014|Stage 1|Unspecified Reason|0|||
130561227|NCT00467779|470024766|FG000|Stage 1|Physician Decision|0|||
130561228|NCT00467779|470024767|FG001|Stage 1|Physician Decision|1|||
130561229|NCT00467779|470024768|FG002|Stage 1|Physician Decision|0|||
130561230|NCT00467779|470024769|FG003|Stage 1|Physician Decision|0|||
130561231|NCT00467779|470024770|FG004|Stage 1|Physician Decision|0|||
130561232|NCT00467779|470024771|FG005|Stage 1|Physician Decision|0|||
130561233|NCT00467779|470024772|FG006|Stage 1|Physician Decision|0|||
130561234|NCT00467779|470024773|FG007|Stage 1|Physician Decision|0|||
130561235|NCT00467779|470024774|FG008|Stage 1|Physician Decision|0|||
130561236|NCT00467779|470024775|FG009|Stage 1|Physician Decision|0|||
130561237|NCT00467779|470024776|FG010|Stage 1|Physician Decision|0|||
130561238|NCT00467779|470024777|FG011|Stage 1|Physician Decision|0|||
130561239|NCT00467779|470024778|FG012|Stage 1|Physician Decision|0|||
130561240|NCT00467779|470024779|FG013|Stage 1|Physician Decision|0|||
130561241|NCT00467779|470024780|FG014|Stage 1|Physician Decision|0|||
130561242|NCT00467779|470024766|FG000|Stage 1|Withdrawal by Subject|0|||
130561243|NCT00467779|470024767|FG001|Stage 1|Withdrawal by Subject|0|||
130561244|NCT00467779|470024768|FG002|Stage 1|Withdrawal by Subject|0|||
130561245|NCT00467779|470024769|FG003|Stage 1|Withdrawal by Subject|0|||
130561246|NCT00467779|470024770|FG004|Stage 1|Withdrawal by Subject|0|||
130561247|NCT00467779|470024771|FG005|Stage 1|Withdrawal by Subject|0|||
130561248|NCT00467779|470024772|FG006|Stage 1|Withdrawal by Subject|1|||
130561249|NCT00467779|470024773|FG007|Stage 1|Withdrawal by Subject|1|||
130561250|NCT00467779|470024774|FG008|Stage 1|Withdrawal by Subject|0|||
130561251|NCT00467779|470024775|FG009|Stage 1|Withdrawal by Subject|0|||
130561252|NCT00467779|470024776|FG010|Stage 1|Withdrawal by Subject|0|||
130561253|NCT00467779|470024777|FG011|Stage 1|Withdrawal by Subject|0|||
130561254|NCT00467779|470024778|FG012|Stage 1|Withdrawal by Subject|0|||
130561255|NCT00467779|470024779|FG013|Stage 1|Withdrawal by Subject|0|||
130561256|NCT00467779|470024780|FG014|Stage 1|Withdrawal by Subject|0|||
130406660|NCT00274716|469453648|FG005|Phase A|Adverse Event|0|||
130561257|NCT00467779|470024766|FG000|Stage 1A|Adverse Event|0|||
130561258|NCT00467779|470024767|FG001|Stage 1A|Adverse Event|0|||
130561259|NCT00467779|470024768|FG002|Stage 1A|Adverse Event|0|||
130561260|NCT00467779|470024769|FG003|Stage 1A|Adverse Event|0|||
130561261|NCT00467779|470024770|FG004|Stage 1A|Adverse Event|0|||
130561262|NCT00467779|470024771|FG005|Stage 1A|Adverse Event|0|||
130561263|NCT00467779|470024772|FG006|Stage 1A|Adverse Event|0|||
130561264|NCT00467779|470024773|FG007|Stage 1A|Adverse Event|0|||
130561265|NCT00467779|470024774|FG008|Stage 1A|Adverse Event|0|||
130561266|NCT00467779|470024775|FG009|Stage 1A|Adverse Event|0|||
130561267|NCT00467779|470024776|FG010|Stage 1A|Adverse Event|0|||
130561268|NCT00467779|470024777|FG011|Stage 1A|Adverse Event|0|||
130471727|NCT06023082|469693955|FG000|Overall Study|Withdrawal by Subject|2|||
130471728|NCT06023082|469693955|FG000|Overall Study|Lost to Follow-up|15|||
130471729|NCT06023082|469693955|FG000|Overall Study|Side effects|5|||
130471730|NCT03584516|469693956|FG000|Part 1|Death|2|||
130471731|NCT03584516|469693957|FG001|Part 1|Death|3|||
130471732|NCT03584516|469693958|FG002|Part 1|Death|0|||
130471733|NCT03584516|469693959|FG003|Part 1|Death|0|||
130471734|NCT03584516|469693960|FG004|Part 1|Death|0|||
130725032|NCT02679235|470619174|FG000|Overall Study|Withdrawal by Subject|3|||
130725033|NCT02679235|470619174|FG000|Overall Study|Adverse Event|1|||
130725034|NCT00094861|470619175|FG000|Overall Study|Adverse Event|5|||
130725035|NCT00094861|470619176|FG001|Overall Study|Adverse Event|2|||
130406661|NCT00274716|469453643|FG000|Phase A|Completed but did not enter Phase B|1|||
130406662|NCT00274716|469453644|FG001|Phase A|Completed but did not enter Phase B|2|||
130406663|NCT00274716|469453645|FG002|Phase A|Completed but did not enter Phase B|2|||
130406664|NCT00274716|469453646|FG003|Phase A|Completed but did not enter Phase B|2|||
130406665|NCT00274716|469453647|FG004|Phase A|Completed but did not enter Phase B|1|||
130406666|NCT00274716|469453648|FG005|Phase A|Completed but did not enter Phase B|1|||
130406667|NCT00274716|469453643|FG000|Phase B|Adverse Event|0|||
130406668|NCT00274716|469453644|FG001|Phase B|Adverse Event|0|||
130406669|NCT00274716|469453645|FG002|Phase B|Adverse Event|2|||
130406670|NCT00274716|469453646|FG003|Phase B|Adverse Event|0|||
130406671|NCT00274716|469453647|FG004|Phase B|Adverse Event|0|||
130406672|NCT00274716|469453648|FG005|Phase B|Adverse Event|1|||
130406673|NCT00274716|469453643|FG000|Phase B|Protocol Violation|0|||
130406674|NCT00274716|469453644|FG001|Phase B|Protocol Violation|2|||
130406675|NCT00274716|469453645|FG002|Phase B|Protocol Violation|0|||
130406676|NCT00274716|469453646|FG003|Phase B|Protocol Violation|0|||
130406677|NCT00274716|469453647|FG004|Phase B|Protocol Violation|0|||
130406678|NCT00274716|469453648|FG005|Phase B|Protocol Violation|0|||
130406679|NCT00274716|469453643|FG000|Phase B|Withdrawal by Subject|0|||
130406680|NCT00274716|469453644|FG001|Phase B|Withdrawal by Subject|1|||
130406681|NCT00274716|469453645|FG002|Phase B|Withdrawal by Subject|0|||
130406682|NCT00274716|469453646|FG003|Phase B|Withdrawal by Subject|0|||
130406683|NCT00274716|469453647|FG004|Phase B|Withdrawal by Subject|0|||
130406684|NCT00274716|469453648|FG005|Phase B|Withdrawal by Subject|0|||
130406685|NCT00274716|469453643|FG000|Phase B|Participant moved|1|||
130406686|NCT00274716|469453644|FG001|Phase B|Participant moved|0|||
130406687|NCT00274716|469453645|FG002|Phase B|Participant moved|0|||
130406688|NCT00274716|469453646|FG003|Phase B|Participant moved|0|||
130406689|NCT00274716|469453647|FG004|Phase B|Participant moved|0|||
130406690|NCT00274716|469453648|FG005|Phase B|Participant moved|0|||
130406691|NCT00274716|469453643|FG000|Phase B|Other non-reported reason|0|||
130406692|NCT00274716|469453644|FG001|Phase B|Other non-reported reason|0|||
130406693|NCT00274716|469453645|FG002|Phase B|Other non-reported reason|1|||
130406694|NCT00274716|469453646|FG003|Phase B|Other non-reported reason|1|||
130406695|NCT00274716|469453647|FG004|Phase B|Other non-reported reason|0|||
130406696|NCT00274716|469453648|FG005|Phase B|Other non-reported reason|0|||
130406697|NCT00274716|469453643|FG000|Phase B|Lost to Follow-up|0|||
130406698|NCT00274716|469453644|FG001|Phase B|Lost to Follow-up|1|||
130406699|NCT00274716|469453645|FG002|Phase B|Lost to Follow-up|0|||
130406700|NCT00274716|469453646|FG003|Phase B|Lost to Follow-up|0|||
130406701|NCT00274716|469453647|FG004|Phase B|Lost to Follow-up|0|||
130406702|NCT00274716|469453648|FG005|Phase B|Lost to Follow-up|0|||
130406703|NCT00982319|469453651|FG000|Overall Study|Surgery date change|1|||
130471735|NCT03584516|469693961|FG005|Part 1|Death|0|||
130471736|NCT03584516|469693956|FG000|Part 1|Withdrawal by Subject|2|||
130406704|NCT00982319|469453652|FG001|Overall Study|Surgery date change|0|||
130406705|NCT00982319|469453651|FG000|Overall Study|Preop values out of acceptable range|1|||
130406706|NCT00982319|469453652|FG001|Overall Study|Preop values out of acceptable range|1|||
130406707|NCT00982319|469453651|FG000|Overall Study|Pregnancy|0|||
130725036|NCT00094861|470619175|FG000|Overall Study|Withdrawal by Subject|5|||
130406708|NCT00982319|469453652|FG001|Overall Study|Pregnancy|1|||
130725037|NCT00094861|470619176|FG001|Overall Study|Withdrawal by Subject|3|||
130725038|NCT00094861|470619175|FG000|Overall Study|Physician Decision|1|||
130725039|NCT00094861|470619176|FG001|Overall Study|Physician Decision|1|||
130406709|NCT01694706|469453653|FG000|Overall Study|Adverse Event|0|||
130406710|NCT01694706|469453654|FG001|Overall Study|Adverse Event|1|||
130406711|NCT01694706|469453655|FG002|Overall Study|Adverse Event|0|||
130406712|NCT01694706|469453653|FG000|Overall Study|other reason not defined above|1|||
130406713|NCT01694706|469453654|FG001|Overall Study|other reason not defined above|0|||
130406714|NCT01694706|469453655|FG002|Overall Study|other reason not defined above|0|||
130406715|NCT00975975|469453656|FG000|Overall Study|Death|6|||
130406716|NCT01252251|469453657|FG000|Overall Study|Withdrawal by Subject|1|||
130406717|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
130406718|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
130406719|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
130471737|NCT03584516|469693957|FG001|Part 1|Withdrawal by Subject|0|||
130471738|NCT03584516|469693958|FG002|Part 1|Withdrawal by Subject|0|||
130471739|NCT03584516|469693959|FG003|Part 1|Withdrawal by Subject|0|||
130725040|NCT00094861|470619175|FG000|Overall Study|Lost to Follow-up|0|||
130406720|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Death|1|||
130406721|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
130406722|NCT02840877|469453658|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
130406723|NCT02840877|469453658|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
130406724|NCT02840877|469453658|FG000|12 Weeks to 6 Months|Treatment failure|1|||
130406725|NCT02840877|469453658|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
130406726|NCT02840877|469453658|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
130406727|NCT02840877|469453658|FG000|12 Weeks to 6 Months|Death|1|||
130406728|NCT02840877|469453658|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
130406729|NCT02840877|469453658|FG000|6 Months to 18 Months|Treatment failure|7|||
130406730|NCT02840877|469453658|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
130406731|NCT02840877|469453658|FG000|6 Months to 18 Months|Moved/transferred out|6|||
130406732|NCT02840877|469453658|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
130406733|NCT02840877|469453658|FG000|6 Months to 18 Months|Death|4|||
130406734|NCT02840877|469453658|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
130406735|NCT02840877|469453658|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
130406736|NCT02840877|469453658|FG000|6 Months to 18 Months|Still in study.|14|||
130406737|NCT03003676|469453661|FG000|Overall Study|Lack of Efficacy|5|||
130406738|NCT03003676|469453662|FG001|Overall Study|Lack of Efficacy|7|||
130406739|NCT03003676|469453661|FG000|Overall Study|Withdrawal by Subject|0|||
130406740|NCT03003676|469453662|FG001|Overall Study|Withdrawal by Subject|1|||
130406741|NCT03003676|469453661|FG000|Overall Study|Hepatitis B infection|1|||
130406742|NCT03003676|469453662|FG001|Overall Study|Hepatitis B infection|0|||
130406743|NCT00530023|469453673|FG000|Overall Study|Withdrawal by Subject|0|||
130406744|NCT00530023|469453674|FG001|Overall Study|Withdrawal by Subject|1|||
130406745|NCT03224468|469453684|FG000|Overall Study|Did not obtain MM card|53|||
130406746|NCT03224468|469453685|FG001|Overall Study|Did not obtain MM card|0|||
130406747|NCT03224468|469453684|FG000|Overall Study|Lost to Follow-up|4|||
130406748|NCT03224468|469453685|FG001|Overall Study|Lost to Follow-up|11|||
130406749|NCT03224468|469453684|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
130406750|NCT03224468|469453685|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
130406751|NCT02461589|469453686|FG000|Overall Study|Withdrawal by Subject|5|||
130406752|NCT02461589|469453687|FG001|Overall Study|Withdrawal by Subject|1|||
130406753|NCT02461589|469453688|FG002|Overall Study|Withdrawal by Subject|3|||
130406754|NCT02461589|469453689|FG003|Overall Study|Withdrawal by Subject|2|||
130406755|NCT02461589|469453690|FG004|Overall Study|Withdrawal by Subject|1|||
130406756|NCT02461589|469453691|FG005|Overall Study|Withdrawal by Subject|2|||
130406757|NCT02461589|469453692|FG006|Overall Study|Withdrawal by Subject|1|||
130406758|NCT02461589|469453693|FG007|Overall Study|Withdrawal by Subject|3|||
130406759|NCT02461589|469453694|FG008|Overall Study|Withdrawal by Subject|3|||
130406760|NCT02461589|469453695|FG009|Overall Study|Withdrawal by Subject|1|||
130406761|NCT02461589|469453686|FG000|Overall Study|Lost to Follow-up|0|||
130406762|NCT02461589|469453687|FG001|Overall Study|Lost to Follow-up|0|||
130406763|NCT02461589|469453688|FG002|Overall Study|Lost to Follow-up|2|||
130406764|NCT02461589|469453689|FG003|Overall Study|Lost to Follow-up|3|||
130406765|NCT02461589|469453690|FG004|Overall Study|Lost to Follow-up|1|||
130406766|NCT02461589|469453691|FG005|Overall Study|Lost to Follow-up|1|||
130406767|NCT02461589|469453692|FG006|Overall Study|Lost to Follow-up|3|||
130406768|NCT02461589|469453693|FG007|Overall Study|Lost to Follow-up|1|||
130406769|NCT02461589|469453694|FG008|Overall Study|Lost to Follow-up|3|||
130406770|NCT02461589|469453695|FG009|Overall Study|Lost to Follow-up|1|||
130406771|NCT02461589|469453686|FG000|Overall Study|Death|0|||
130406772|NCT02461589|469453687|FG001|Overall Study|Death|0|||
130406773|NCT02461589|469453688|FG002|Overall Study|Death|0|||
130406774|NCT02461589|469453689|FG003|Overall Study|Death|0|||
130406775|NCT02461589|469453690|FG004|Overall Study|Death|0|||
130406776|NCT02461589|469453691|FG005|Overall Study|Death|0|||
130406777|NCT02461589|469453692|FG006|Overall Study|Death|0|||
130406778|NCT02461589|469453693|FG007|Overall Study|Death|1|||
130406779|NCT02461589|469453694|FG008|Overall Study|Death|0|||
130406780|NCT02461589|469453695|FG009|Overall Study|Death|0|||
130406781|NCT02461589|469453686|FG000|Overall Study|Unclassified|0|||
130406782|NCT02461589|469453687|FG001|Overall Study|Unclassified|0|||
130406783|NCT02461589|469453688|FG002|Overall Study|Unclassified|0|||
130406784|NCT02461589|469453689|FG003|Overall Study|Unclassified|0|||
130406785|NCT02461589|469453690|FG004|Overall Study|Unclassified|0|||
130406786|NCT02461589|469453691|FG005|Overall Study|Unclassified|0|||
130406787|NCT02461589|469453692|FG006|Overall Study|Unclassified|1|||
130406788|NCT02461589|469453693|FG007|Overall Study|Unclassified|0|||
130406789|NCT02461589|469453694|FG008|Overall Study|Unclassified|0|||
130406790|NCT02461589|469453695|FG009|Overall Study|Unclassified|2|||
130406791|NCT02461589|469453686|FG000|Overall Study|Missing follow-up information|1|||
130406792|NCT02461589|469453687|FG001|Overall Study|Missing follow-up information|1|||
130406793|NCT02461589|469453688|FG002|Overall Study|Missing follow-up information|0|||
130406794|NCT02461589|469453689|FG003|Overall Study|Missing follow-up information|0|||
130406795|NCT02461589|469453690|FG004|Overall Study|Missing follow-up information|0|||
130471740|NCT03584516|469693960|FG004|Part 1|Withdrawal by Subject|0|||
130725041|NCT00094861|470619176|FG001|Overall Study|Lost to Follow-up|1|||
130725042|NCT00094861|470619175|FG000|Overall Study|Death|4|||
130725043|NCT00094861|470619176|FG001|Overall Study|Death|2|||
130725044|NCT00094861|470619175|FG000|Overall Study|Other|3|||
130725045|NCT00094861|470619176|FG001|Overall Study|Other|0|||
130725046|NCT02549027|470619178|FG000|Washout After Period 4|Withdrawal by Subject|0|||
130725047|NCT02549027|470619179|FG001|Washout After Period 4|Withdrawal by Subject|1|||
130725048|NCT02549027|470619180|FG002|Washout After Period 4|Withdrawal by Subject|1|||
130725049|NCT02549027|470619181|FG003|Washout After Period 4|Withdrawal by Subject|1|||
130725050|NCT02549027|470619182|FG004|Washout After Period 4|Withdrawal by Subject|0|||
130725051|NCT02549027|470619183|FG005|Washout After Period 4|Withdrawal by Subject|0|||
130725052|NCT02549027|470619178|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130406796|NCT02461589|469453691|FG005|Overall Study|Missing follow-up information|0|||
130406797|NCT02461589|469453692|FG006|Overall Study|Missing follow-up information|1|||
130406798|NCT02461589|469453693|FG007|Overall Study|Missing follow-up information|0|||
130406799|NCT02461589|469453694|FG008|Overall Study|Missing follow-up information|0|||
130406800|NCT02461589|469453695|FG009|Overall Study|Missing follow-up information|0|||
130406801|NCT02461589|469453686|FG000|Overall Study|Withdrawal from trial before exposure|0|||
130406802|NCT02461589|469453687|FG001|Overall Study|Withdrawal from trial before exposure|0|||
130406803|NCT02461589|469453688|FG002|Overall Study|Withdrawal from trial before exposure|0|||
130406804|NCT02461589|469453689|FG003|Overall Study|Withdrawal from trial before exposure|0|||
130406805|NCT02461589|469453690|FG004|Overall Study|Withdrawal from trial before exposure|0|||
130406806|NCT02461589|469453691|FG005|Overall Study|Withdrawal from trial before exposure|0|||
130406807|NCT02461589|469453692|FG006|Overall Study|Withdrawal from trial before exposure|0|||
130406808|NCT02461589|469453693|FG007|Overall Study|Withdrawal from trial before exposure|0|||
130406809|NCT02461589|469453694|FG008|Overall Study|Withdrawal from trial before exposure|0|||
130406810|NCT02461589|469453695|FG009|Overall Study|Withdrawal from trial before exposure|1|||
130406811|NCT04067141|469453696|FG000|First Intervention|Withdrawal by Subject|0|||
130406812|NCT04067141|469453697|FG001|First Intervention|Withdrawal by Subject|1|||
130406813|NCT04067141|469453696|FG000|Second Intervention|Adverse Event|0|||
130406814|NCT04067141|469453697|FG001|Second Intervention|Adverse Event|2|||
130406815|NCT01038921|469453698|FG000|Overall Study|Withdrawal by Subject|1|||
130406816|NCT01038921|469453699|FG001|Overall Study|Withdrawal by Subject|0|||
130406817|NCT01038921|469453698|FG000|Overall Study|Physician Decision|1|||
130406818|NCT01038921|469453699|FG001|Overall Study|Physician Decision|0|||
130406819|NCT01978119|469453700|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
130406820|NCT01978119|469453701|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
130406821|NCT01978119|469453700|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130406822|NCT01978119|469453701|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130406823|NCT01978119|469453700|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130406824|NCT01978119|469453701|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
130406825|NCT03295201|469453702|FG000|Overall Study|Lost to Follow-up|1|||
130406826|NCT03295201|469453703|FG001|Overall Study|Lost to Follow-up|1|||
130406827|NCT03295201|469453702|FG000|Overall Study|Hospital admission|0|||
130406828|NCT03295201|469453703|FG001|Overall Study|Hospital admission|1|||
130406829|NCT00733824|469453704|FG000|Phase I|Withdrawal by Subject|1|||
130406830|NCT00733824|469453705|FG001|Phase I|Withdrawal by Subject|0|||
130406831|NCT00733824|469453706|FG002|Phase I|Withdrawal by Subject|0|||
130406832|NCT00733824|469453707|FG003|Phase I|Withdrawal by Subject|0|||
130406833|NCT00733824|469453708|FG004|Phase I|Withdrawal by Subject|0|||
130406834|NCT01243944|469453709|FG000|Overall Study|Adverse Event|15|||
130406835|NCT01243944|469453710|FG001|Overall Study|Adverse Event|13|||
130406836|NCT01243944|469453709|FG000|Overall Study|Lost to Follow-up|2|||
130406837|NCT01243944|469453710|FG001|Overall Study|Lost to Follow-up|1|||
130406838|NCT01243944|469453709|FG000|Overall Study|Physician Decision|2|||
130406839|NCT01243944|469453710|FG001|Overall Study|Physician Decision|7|||
130406840|NCT01243944|469453709|FG000|Overall Study|Disease progression|12|||
130406841|NCT01243944|469453710|FG001|Overall Study|Disease progression|11|||
130406842|NCT01243944|469453709|FG000|Overall Study|Protocol deviation|1|||
130406843|NCT01243944|469453710|FG001|Overall Study|Protocol deviation|1|||
130406844|NCT01243944|469453709|FG000|Overall Study|Participant decision|10|||
130471741|NCT03584516|469693961|FG005|Part 1|Withdrawal by Subject|0|||
130471742|NCT03584516|469693956|FG000|Part 1|Lost to Follow-up|1|||
130471743|NCT03584516|469693957|FG001|Part 1|Lost to Follow-up|0|||
130471744|NCT03584516|469693958|FG002|Part 1|Lost to Follow-up|0|||
130471745|NCT03584516|469693959|FG003|Part 1|Lost to Follow-up|0|||
130471746|NCT03584516|469693960|FG004|Part 1|Lost to Follow-up|0|||
130471747|NCT03584516|469693961|FG005|Part 1|Lost to Follow-up|0|||
130471748|NCT03584516|469693956|FG000|Part 1|Study Terminated by Sponsor|0|||
130471749|NCT03584516|469693957|FG001|Part 1|Study Terminated by Sponsor|2|||
130471750|NCT03584516|469693958|FG002|Part 1|Study Terminated by Sponsor|0|||
130471751|NCT03584516|469693959|FG003|Part 1|Study Terminated by Sponsor|0|||
130471752|NCT03584516|469693960|FG004|Part 1|Study Terminated by Sponsor|0|||
130471753|NCT03584516|469693961|FG005|Part 1|Study Terminated by Sponsor|0|||
130471754|NCT03584516|469693956|FG000|Part 1 Expansion|Death|0|||
130561269|NCT00467779|470024778|FG012|Stage 1A|Adverse Event|1|||
130561270|NCT00467779|470024779|FG013|Stage 1A|Adverse Event|0|||
130561271|NCT00467779|470024780|FG014|Stage 1A|Adverse Event|0|||
130561272|NCT00467779|470024766|FG000|Stage 1A|Death|0|||
130561273|NCT00467779|470024767|FG001|Stage 1A|Death|0|||
130561274|NCT00467779|470024768|FG002|Stage 1A|Death|0|||
130561275|NCT00467779|470024769|FG003|Stage 1A|Death|0|||
130406845|NCT01243944|469453710|FG001|Overall Study|Participant decision|15|||
130406846|NCT01243944|469453709|FG000|Overall Study|Death|2|||
130406847|NCT01243944|469453710|FG001|Overall Study|Death|3|||
130406848|NCT01243944|469453709|FG000|Overall Study|Non-compliance with study treatment|1|||
130406849|NCT01243944|469453710|FG001|Overall Study|Non-compliance with study treatment|0|||
130406850|NCT01416805|469453711|FG000|Overall Study|Lost to Follow-up|4|||
130406851|NCT01416805|469453712|FG001|Overall Study|Lost to Follow-up|4|||
130406852|NCT00153101|469453713|FG000|Overall Study|Lost to Follow-up|14|||
130406853|NCT00153101|469453714|FG001|Overall Study|Lost to Follow-up|14|||
130406854|NCT00153101|469453715|FG002|Overall Study|Lost to Follow-up|12|||
130406855|NCT00153101|469453716|FG003|Overall Study|Lost to Follow-up|5|||
130406856|NCT00153101|469453717|FG004|Overall Study|Lost to Follow-up|5|||
130406857|NCT00153101|469453713|FG000|Overall Study|Withdrawal by Subject|3|||
130406858|NCT00153101|469453714|FG001|Overall Study|Withdrawal by Subject|4|||
130406859|NCT00153101|469453715|FG002|Overall Study|Withdrawal by Subject|3|||
130406860|NCT00153101|469453716|FG003|Overall Study|Withdrawal by Subject|3|||
130406861|NCT00153101|469453717|FG004|Overall Study|Withdrawal by Subject|5|||
130406862|NCT02610140|469453718|FG000|Randomization and Treatment Period|Radiological progression|23|||
130406863|NCT02610140|469453719|FG001|Randomization and Treatment Period|Radiological progression|15|||
130406864|NCT02610140|469453718|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
130406865|NCT02610140|469453719|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
130406866|NCT02610140|469453718|FG000|Randomization and Treatment Period|Protocol Violation|1|||
130406867|NCT02610140|469453719|FG001|Randomization and Treatment Period|Protocol Violation|0|||
130406868|NCT02610140|469453718|FG000|Randomization and Treatment Period|Physician Decision|0|||
130406869|NCT02610140|469453719|FG001|Randomization and Treatment Period|Physician Decision|1|||
130406870|NCT02610140|469453718|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
130406871|NCT02610140|469453719|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
130406872|NCT02610140|469453718|FG000|Randomization and Treatment Period|Death|7|||
130406873|NCT02610140|469453719|FG001|Randomization and Treatment Period|Death|1|||
130406874|NCT02610140|469453718|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
130406875|NCT02610140|469453719|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
130406876|NCT02610140|469453718|FG000|Randomization and Treatment Period|Adverse Event|44|||
130406877|NCT02610140|469453719|FG001|Randomization and Treatment Period|Adverse Event|13|||
130406878|NCT02610140|469453718|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
130406879|NCT02610140|469453719|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
130406880|NCT02610140|469453718|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
130406881|NCT02610140|469453719|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
130406882|NCT02610140|469453718|FG000|Randomization and Treatment Period|Not treated|3|||
130406883|NCT02610140|469453719|FG001|Randomization and Treatment Period|Not treated|10|||
130406884|NCT02610140|469453718|FG000|Safety Follow-up|Other|0|||
130406885|NCT02610140|469453719|FG001|Safety Follow-up|Other|2|||
130406886|NCT02610140|469453718|FG000|Safety Follow-up|Lost to Follow-up|1|||
130406887|NCT02610140|469453719|FG001|Safety Follow-up|Lost to Follow-up|0|||
130406888|NCT02610140|469453718|FG000|Safety Follow-up|No follow-up|5|||
130406889|NCT02610140|469453719|FG001|Safety Follow-up|No follow-up|3|||
130406890|NCT02610140|469453718|FG000|Safety Follow-up|Death|12|||
130406891|NCT02610140|469453719|FG001|Safety Follow-up|Death|2|||
130406892|NCT02610140|469453718|FG000|Safety Follow-up|Deterioration of general conditions|15|||
130406893|NCT02610140|469453719|FG001|Safety Follow-up|Deterioration of general conditions|5|||
130406894|NCT02610140|469453718|FG000|Safety Follow-up|Withdrawal by Subject|12|||
130406895|NCT02610140|469453719|FG001|Safety Follow-up|Withdrawal by Subject|12|||
130406896|NCT02610140|469453718|FG000|Active Follow-up|Progressive disease - radiological|30|||
130406897|NCT02610140|469453719|FG001|Active Follow-up|Progressive disease - radiological|22|||
130406898|NCT02610140|469453718|FG000|Active Follow-up|Death|8|||
130406899|NCT02610140|469453719|FG001|Active Follow-up|Death|1|||
130406900|NCT02610140|469453718|FG000|Active Follow-up|Withdrawal by Subject|4|||
130406901|NCT02610140|469453719|FG001|Active Follow-up|Withdrawal by Subject|0|||
130406902|NCT02610140|469453718|FG000|Active Follow-up|Progressive disease - clinical|1|||
130406903|NCT02610140|469453719|FG001|Active Follow-up|Progressive disease - clinical|2|||
130406904|NCT02610140|469453718|FG000|Active Follow-up|Deterioration of general conditions|1|||
130406905|NCT02610140|469453719|FG001|Active Follow-up|Deterioration of general conditions|0|||
130561276|NCT00467779|470024770|FG004|Stage 1A|Death|0|||
130406906|NCT02610140|469453718|FG000|Active Follow-up|Ongoing but not completed|4|||
130406907|NCT02610140|469453719|FG001|Active Follow-up|Ongoing but not completed|1|||
130406908|NCT02610140|469453718|FG000|Long-term Follow-up|Death|86|||
130406909|NCT02610140|469453719|FG001|Long-term Follow-up|Death|44|||
130561277|NCT00467779|470024771|FG005|Stage 1A|Death|0|||
130561278|NCT00467779|470024772|FG006|Stage 1A|Death|0|||
130725053|NCT02549027|470619179|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725054|NCT02549027|470619180|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725055|NCT02549027|470619181|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725056|NCT02549027|470619182|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
130725057|NCT02549027|470619183|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725058|NCT02186834|470619184|FG000|Dose Escalation|Death|0|||
130725059|NCT02186834|470619185|FG001|Dose Escalation|Death|0|||
130725060|NCT02186834|470619186|FG002|Dose Escalation|Death|0|||
130725061|NCT02186834|470619187|FG003|Dose Escalation|Death|1|||
130725062|NCT02186834|470619188|FG004|Dose Escalation|Death|0|||
130725063|NCT02186834|470619189|FG005|Dose Escalation|Death|0|||
130725064|NCT02186834|470619184|FG000|Treatment at RP2D|Died prior to treatment|0|||
130725065|NCT02186834|470619185|FG001|Treatment at RP2D|Died prior to treatment|0|||
130725066|NCT02186834|470619186|FG002|Treatment at RP2D|Died prior to treatment|0|||
130725067|NCT02186834|470619187|FG003|Treatment at RP2D|Died prior to treatment|0|||
130725068|NCT02186834|470619188|FG004|Treatment at RP2D|Died prior to treatment|0|||
130725069|NCT02186834|470619189|FG005|Treatment at RP2D|Died prior to treatment|1|||
130725070|NCT01199016|470619202|FG000|Overall Study|No longer meets eligibility criteria|4|||
130725071|NCT01199016|470619202|FG000|Overall Study|Entrance criteria|5|||
130725072|NCT01199016|470619202|FG000|Overall Study|Protocol Violation|9|||
130725073|NCT01199016|470619202|FG000|Overall Study|Other|13|||
130725074|NCT01199016|470619202|FG000|Overall Study|Withdrawal by Subject|21|||
130725075|NCT01199016|470619202|FG000|Overall Study|Lost to Follow-up|25|||
130725076|NCT02368314|470619210|FG000|Overall Study|Withdrawal by Subject|2|||
130725077|NCT02368314|470619211|FG001|Overall Study|Withdrawal by Subject|1|||
130725078|NCT02368314|470619210|FG000|Overall Study|Adverse Event|1|||
130725079|NCT02368314|470619211|FG001|Overall Study|Adverse Event|2|||
130725080|NCT02842073|470619216|FG000|Overall Study|Withdrawal by Subject|1|||
130725081|NCT00195338|470619217|FG000|Overall Study|Lost to Follow-up|2|||
130725082|NCT00195338|470619217|FG000|Overall Study|Adverse Event|5|||
130725083|NCT00195338|470619217|FG000|Overall Study|Lack of Efficacy|1|||
130725084|NCT00195338|470619217|FG000|Overall Study|Early closure of the site|4|||
130725085|NCT05320887|470619221|FG000|Overall Study|Lost to Follow-up|0|||
130725086|NCT05320887|470619222|FG001|Overall Study|Lost to Follow-up|3|||
130725087|NCT05320887|470619223|FG002|Overall Study|Lost to Follow-up|0|||
130725088|NCT05320887|470619224|FG003|Overall Study|Lost to Follow-up|0|||
130725089|NCT02289456|470619225|FG000|Induction Period|Death|2|||
130725090|NCT02289456|470619225|FG000|Induction Period|Adverse Event|11|||
130725091|NCT02289456|470619225|FG000|Induction Period|Progressive Disease (PD)|4|||
130725092|NCT02289456|470619225|FG000|Induction Period|Symptomatic Deterioration|4|||
130725093|NCT02289456|470619225|FG000|Induction Period|Withdrawal by Subject|2|||
130725094|NCT02289456|470619225|FG000|Induction Period|Miscellaneous|1|||
130725095|NCT02289456|470619225|FG000|Monotherapy Period|Death|1|||
130725096|NCT02289456|470619225|FG000|Monotherapy Period|Adverse Event|1|||
130725097|NCT02289456|470619225|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
130725098|NCT02289456|470619225|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
130725099|NCT02289456|470619225|FG000|Monotherapy Period|Withdrawal by Subject|2|||
130725100|NCT02289456|470619225|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
130725101|NCT02289456|470619225|FG000|Monotherapy Period|Miscellaneous|1|||
130725102|NCT01661062|470619228|FG000|Overall Study|Completed Treatment Off Study|3|||
130725103|NCT01661062|470619228|FG000|Overall Study|Withdrawal by Subject|2|||
130725104|NCT02015065|470619233|FG000|Overall Study|Death on study|1|||
130725105|NCT02015065|470619234|FG001|Overall Study|Death on study|2|||
130725106|NCT02015065|470619235|FG002|Overall Study|Death on study|1|||
130725107|NCT03485365|470619270|FG000|Overall Study|Protocol Violation|0|||
130725108|NCT03485365|470619271|FG001|Overall Study|Protocol Violation|0|||
130725109|NCT03485365|470619272|FG002|Overall Study|Protocol Violation|0|||
130725110|NCT03485365|470619273|FG003|Overall Study|Protocol Violation|1|||
130725111|NCT03485365|470619274|FG004|Overall Study|Protocol Violation|0|||
130725112|NCT03485365|470619275|FG005|Overall Study|Protocol Violation|0|||
130725113|NCT03485365|470619276|FG006|Overall Study|Protocol Violation|1|||
130725114|NCT03485365|470619277|FG007|Overall Study|Protocol Violation|0|||
130725115|NCT03485365|470619278|FG008|Overall Study|Protocol Violation|0|||
130725116|NCT01547130|470619281|FG000|Overall Study|Lost to Follow-up|9|||
130725117|NCT01547130|470619282|FG001|Overall Study|Lost to Follow-up|5|||
130725118|NCT03553576|470619283|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130725119|NCT03553576|470619284|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130725120|NCT03553576|470619283|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
130725121|NCT03553576|470619284|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
130725122|NCT03553576|470619283|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
130725123|NCT03553576|470619284|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
130725124|NCT03553576|470619283|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
130725125|NCT03553576|470619284|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
130725126|NCT03553576|470619283|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
130406910|NCT02610140|469453718|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
130406911|NCT02610140|469453719|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
130406912|NCT02610140|469453718|FG000|Long-term Follow-up|Lost to Follow-up|1|||
130406913|NCT02610140|469453719|FG001|Long-term Follow-up|Lost to Follow-up|2|||
130406914|NCT02610140|469453718|FG000|Long-term Follow-up|Ongoing but not completed|30|||
130406915|NCT02610140|469453719|FG001|Long-term Follow-up|Ongoing but not completed|17|||
130406916|NCT03169153|469453720|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130406917|NCT03169153|469453721|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130406918|NCT03169153|469453720|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
130406919|NCT03169153|469453721|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
130406920|NCT03169153|469453720|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
130406921|NCT03169153|469453721|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
130406922|NCT03169153|469453720|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
130406923|NCT03169153|469453721|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
130406924|NCT00887341|469453722|FG000|Overall Study|Refused treatment|1|||
130406925|NCT00887341|469453723|FG001|Overall Study|Refused treatment|0|||
130406926|NCT00887341|469453722|FG000|Overall Study|Withdrawal by Subject|1|||
130406927|NCT00887341|469453723|FG001|Overall Study|Withdrawal by Subject|1|||
130406928|NCT00887341|469453722|FG000|Overall Study|Adverse Event|0|||
130406929|NCT00887341|469453723|FG001|Overall Study|Adverse Event|1|||
130406930|NCT00887341|469453722|FG000|Overall Study|Lost to Follow-up|0|||
130406931|NCT00887341|469453723|FG001|Overall Study|Lost to Follow-up|1|||
130406932|NCT01591681|469453726|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
130406933|NCT01591681|469453726|FG000|Overall Study|Failed to use system during run-in|1|||
130406934|NCT00281840|469453729|FG000|Overall Study|Adverse Event|12|||
130406935|NCT00281840|469453729|FG000|Overall Study|Physician Decision|6|||
130406936|NCT00281840|469453729|FG000|Overall Study|Withdrawal by Subject|3|||
130406937|NCT00281840|469453729|FG000|Overall Study|Disease Progression|2|||
130406938|NCT00281840|469453729|FG000|Overall Study|exceed maximum delay in treatment|1|||
130406939|NCT00281840|469453729|FG000|Overall Study|Complicating Disease|1|||
130406940|NCT01079234|469453732|FG000|Main: Week 0 to 26|Adverse Event|5|||
130406941|NCT01079234|469453733|FG001|Main: Week 0 to 26|Adverse Event|4|||
130406942|NCT01079234|469453734|FG002|Main: Week 0 to 26|Adverse Event|1|||
130406943|NCT01079234|469453735|FG003|Main: Week 0 to 26|Adverse Event|0|||
130406944|NCT01079234|469453732|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
130406945|NCT01079234|469453733|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
130406946|NCT01079234|469453734|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
130406947|NCT01079234|469453735|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
130406948|NCT01079234|469453732|FG000|Main: Week 0 to 26|Protocol Violation|6|||
130406949|NCT01079234|469453733|FG001|Main: Week 0 to 26|Protocol Violation|2|||
130406950|NCT01079234|469453734|FG002|Main: Week 0 to 26|Protocol Violation|4|||
130406951|NCT01079234|469453735|FG003|Main: Week 0 to 26|Protocol Violation|0|||
130406952|NCT01079234|469453732|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
130406953|NCT01079234|469453733|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
130406954|NCT01079234|469453734|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
130406955|NCT01079234|469453735|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
130406956|NCT01079234|469453732|FG000|Main: Week 0 to 26|Unclassified|7|||
130406957|NCT01079234|469453733|FG001|Main: Week 0 to 26|Unclassified|13|||
130471755|NCT03584516|469693957|FG001|Part 1 Expansion|Death|0|||
130471756|NCT03584516|469693958|FG002|Part 1 Expansion|Death|9|||
130471757|NCT03584516|469693959|FG003|Part 1 Expansion|Death|8|||
130406958|NCT01079234|469453734|FG002|Main: Week 0 to 26|Unclassified|4|||
130406959|NCT01079234|469453735|FG003|Main: Week 0 to 26|Unclassified|0|||
130406960|NCT01079234|469453732|FG000|Extension: Week 27 to 52|Adverse Event|0|||
130406961|NCT01079234|469453733|FG001|Extension: Week 27 to 52|Adverse Event|0|||
130471758|NCT03584516|469693960|FG004|Part 1 Expansion|Death|4|||
130471759|NCT03584516|469693961|FG005|Part 1 Expansion|Death|5|||
130471760|NCT03584516|469693956|FG000|Part 1 Expansion|Lost to Follow-up|0|||
130471761|NCT03584516|469693957|FG001|Part 1 Expansion|Lost to Follow-up|0|||
130471762|NCT03584516|469693958|FG002|Part 1 Expansion|Lost to Follow-up|0|||
130471763|NCT03584516|469693959|FG003|Part 1 Expansion|Lost to Follow-up|1|||
130471764|NCT03584516|469693960|FG004|Part 1 Expansion|Lost to Follow-up|0|||
130471765|NCT03584516|469693961|FG005|Part 1 Expansion|Lost to Follow-up|0|||
130471766|NCT03584516|469693956|FG000|Part 1 Expansion|Physician Decision|0|||
130471767|NCT03584516|469693957|FG001|Part 1 Expansion|Physician Decision|0|||
130471768|NCT03584516|469693958|FG002|Part 1 Expansion|Physician Decision|4|||
130471769|NCT03584516|469693959|FG003|Part 1 Expansion|Physician Decision|3|||
130471770|NCT03584516|469693960|FG004|Part 1 Expansion|Physician Decision|2|||
130471771|NCT03584516|469693961|FG005|Part 1 Expansion|Physician Decision|3|||
130471772|NCT03584516|469693956|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
130471773|NCT03584516|469693957|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
130471774|NCT03584516|469693958|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
130471775|NCT03584516|469693959|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
130471776|NCT03584516|469693960|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
130471777|NCT03584516|469693961|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
130471778|NCT03584516|469693956|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
130471779|NCT03584516|469693957|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
130471780|NCT03584516|469693958|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
130471781|NCT03584516|469693959|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
130471782|NCT03584516|469693960|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
130471783|NCT03584516|469693961|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
130471784|NCT03584516|469693956|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130471785|NCT03584516|469693957|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130471786|NCT03584516|469693958|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130471787|NCT03584516|469693959|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
130471788|NCT03584516|469693960|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130471789|NCT03584516|469693961|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130471790|NCT03584516|469693956|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130471791|NCT03584516|469693957|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130471792|NCT03584516|469693958|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130471793|NCT03584516|469693959|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130471794|NCT03584516|469693960|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130471795|NCT03584516|469693961|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
130471796|NCT04868110|469693964|FG000|Overall Study|Withdrawal by Subject|3|||
130471797|NCT04868110|469693965|FG001|Overall Study|Withdrawal by Subject|4|||
130471798|NCT04823611|469693966|FG000|Overall Study|Adverse Event|2|||
130471799|NCT04823611|469693967|FG001|Overall Study|Adverse Event|0|||
130471800|NCT04823611|469693968|FG002|Overall Study|Adverse Event|1|||
130471801|NCT04823611|469693969|FG003|Overall Study|Adverse Event|0|||
130471802|NCT04823611|469693970|FG004|Overall Study|Adverse Event|0|||
130471803|NCT04823611|469693971|FG005|Overall Study|Adverse Event|0|||
130471804|NCT04823611|469693972|FG006|Overall Study|Adverse Event|0|||
130471805|NCT01894061|469693974|FG000|Overall Study|Screen failure|1|||
130471806|NCT01894061|469693974|FG000|Overall Study|Withdrawal by Subject|1|||
130471807|NCT01673984|469693975|FG000|Overall Study|Adverse Event|1|||
130471808|NCT01673984|469693976|FG001|Overall Study|Adverse Event|0|||
130471809|NCT01673984|469693975|FG000|Overall Study|Study termination|9|||
130471810|NCT01673984|469693976|FG001|Overall Study|Study termination|6|||
130471811|NCT04437433|469693977|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
130471812|NCT04437433|469693978|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
130725127|NCT03553576|470619284|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
130725128|NCT03553576|470619283|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
130725129|NCT03553576|470619284|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
130725130|NCT03553576|470619283|FG000|Overall Study|Physician Decision|2|||
130471813|NCT04437433|469693977|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
130471814|NCT04437433|469693978|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
130471815|NCT04437433|469693977|FG000|Overall Study|Adverse Event|9|||
130471816|NCT04437433|469693978|FG001|Overall Study|Adverse Event|0|||
130725131|NCT03553576|470619284|FG001|Overall Study|Physician Decision|5|||
130471817|NCT04437433|469693977|FG000|Overall Study|Lack of Efficacy|4|||
130471818|NCT04437433|469693978|FG001|Overall Study|Lack of Efficacy|0|||
130725132|NCT01104792|470619285|FG000|Overall Study|Adverse Event|77|||
130471819|NCT04437433|469693977|FG000|Overall Study|Withdrawal by Subject|4|||
130471820|NCT04437433|469693978|FG001|Overall Study|Withdrawal by Subject|1|||
130471821|NCT04437433|469693977|FG000|Overall Study|Protocol Deviation|0|||
130471822|NCT04437433|469693978|FG001|Overall Study|Protocol Deviation|1|||
130471823|NCT04437433|469693977|FG000|Overall Study|Other, not specified|0|||
130561279|NCT00467779|470024773|FG007|Stage 1A|Death|0|||
130561280|NCT00467779|470024774|FG008|Stage 1A|Death|0|||
130561281|NCT00467779|470024775|FG009|Stage 1A|Death|0|||
130561282|NCT00467779|470024776|FG010|Stage 1A|Death|0|||
130561283|NCT00467779|470024777|FG011|Stage 1A|Death|1|||
130561284|NCT00467779|470024778|FG012|Stage 1A|Death|1|||
130561285|NCT00467779|470024779|FG013|Stage 1A|Death|0|||
130561286|NCT00467779|470024780|FG014|Stage 1A|Death|0|||
130561287|NCT00467779|470024766|FG000|Stage 1A|Disease Progression|0|||
130561288|NCT00467779|470024767|FG001|Stage 1A|Disease Progression|0|||
130561289|NCT00467779|470024768|FG002|Stage 1A|Disease Progression|0|||
130561290|NCT00467779|470024769|FG003|Stage 1A|Disease Progression|0|||
130725133|NCT01104792|470619285|FG000|Overall Study|Insufficient Therapeutic Response|22|||
130725134|NCT01104792|470619285|FG000|Overall Study|Protocol Violation|45|||
130725135|NCT01104792|470619285|FG000|Overall Study|Withdrawal of Consent|179|||
130725136|NCT01104792|470619285|FG000|Overall Study|Lost to Follow-up|43|||
130725137|NCT01104792|470619285|FG000|Overall Study|Reasons Not Specified|27|||
130725138|NCT01104792|470619285|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
130725139|NCT00103610|470619289|FG000|Overall Study|Entered Rescue Procedure|10|||
130725140|NCT00103610|470619290|FG001|Overall Study|Entered Rescue Procedure|52|||
130725141|NCT00103610|470619289|FG000|Overall Study|Death|16|||
130725142|NCT00103610|470619290|FG001|Overall Study|Death|12|||
130725143|NCT00103610|470619289|FG000|Overall Study|Elective Withdrawal|4|||
130725144|NCT00103610|470619290|FG001|Overall Study|Elective Withdrawal|0|||
130725145|NCT00103610|470619289|FG000|Overall Study|Lost to Follow-up|3|||
130725146|NCT00103610|470619290|FG001|Overall Study|Lost to Follow-up|1|||
130725147|NCT00103610|470619289|FG000|Overall Study|Adverse Event|2|||
130725148|NCT00103610|470619290|FG001|Overall Study|Adverse Event|2|||
130725149|NCT00103610|470619289|FG000|Overall Study|Other|2|||
130725150|NCT00103610|470619290|FG001|Overall Study|Other|7|||
130725151|NCT00103610|470619289|FG000|Overall Study|Failed mobilization|1|||
130725152|NCT00103610|470619290|FG001|Overall Study|Failed mobilization|5|||
130725153|NCT00103610|470619289|FG000|Overall Study|Noncompliance|0|||
130725154|NCT00103610|470619290|FG001|Overall Study|Noncompliance|1|||
130725155|NCT03301623|470619291|FG000|Overall Study|Death|3|||
130725156|NCT03301623|470619292|FG001|Overall Study|Death|1|||
130725157|NCT03301623|470619291|FG000|Overall Study|Withdrawal by Subject|11|||
130725158|NCT03301623|470619292|FG001|Overall Study|Withdrawal by Subject|13|||
130725159|NCT03301623|470619291|FG000|Overall Study|Lost to Follow-up|3|||
130725160|NCT03301623|470619292|FG001|Overall Study|Lost to Follow-up|1|||
130725161|NCT02092467|470619293|FG000|Overall Study|Death|49|||
130725162|NCT02092467|470619294|FG001|Overall Study|Death|66|||
130725163|NCT02092467|470619295|FG002|Overall Study|Death|38|||
130725164|NCT02092467|470619293|FG000|Overall Study|Lost to Follow-up|38|||
130725165|NCT02092467|470619294|FG001|Overall Study|Lost to Follow-up|35|||
130725166|NCT02092467|470619295|FG002|Overall Study|Lost to Follow-up|40|||
130725167|NCT02092467|470619293|FG000|Overall Study|Global Deterioration of Health Status|1|||
130725168|NCT02092467|470619294|FG001|Overall Study|Global Deterioration of Health Status|0|||
130725169|NCT02092467|470619295|FG002|Overall Study|Global Deterioration of Health Status|0|||
130725170|NCT02092467|470619293|FG000|Overall Study|Other|32|||
130725171|NCT02092467|470619294|FG001|Overall Study|Other|30|||
130725172|NCT02092467|470619295|FG002|Overall Study|Other|24|||
130725173|NCT02092467|470619293|FG000|Overall Study|Withdrawal by Subject|282|||
130725174|NCT02092467|470619294|FG001|Overall Study|Withdrawal by Subject|327|||
130725175|NCT02092467|470619295|FG002|Overall Study|Withdrawal by Subject|289|||
130725176|NCT02092467|470619293|FG000|Overall Study|Randomized but not treated|2|||
130725177|NCT02092467|470619294|FG001|Overall Study|Randomized but not treated|1|||
130725178|NCT02092467|470619295|FG002|Overall Study|Randomized but not treated|7|||
130725179|NCT04844762|470619300|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725180|NCT04844762|470619301|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725181|NCT04844762|470619302|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130725182|NCT04844762|470619303|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725183|NCT04844762|470619304|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725184|NCT04844762|470619305|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725185|NCT04844762|470619300|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725186|NCT04844762|470619301|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725187|NCT04844762|470619302|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725188|NCT04844762|470619303|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725189|NCT04844762|470619304|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725190|NCT04844762|470619305|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725191|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725192|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725193|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725194|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
130561291|NCT00467779|470024770|FG004|Stage 1A|Disease Progression|0|||
130561292|NCT00467779|470024771|FG005|Stage 1A|Disease Progression|0|||
130561293|NCT00467779|470024772|FG006|Stage 1A|Disease Progression|0|||
130406962|NCT01079234|469453734|FG002|Extension: Week 27 to 52|Adverse Event|1|||
130406963|NCT01079234|469453735|FG003|Extension: Week 27 to 52|Adverse Event|0|||
130406964|NCT01079234|469453732|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
130406965|NCT01079234|469453733|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
130406966|NCT01079234|469453734|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
130406967|NCT01079234|469453735|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
130406968|NCT01079234|469453732|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
130406969|NCT01079234|469453733|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
130406970|NCT01079234|469453734|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
130406971|NCT01079234|469453735|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
130406972|NCT01079234|469453732|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
130406973|NCT01079234|469453733|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
130406974|NCT01079234|469453734|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
130561294|NCT00467779|470024773|FG007|Stage 1A|Disease Progression|0|||
130561295|NCT00467779|470024774|FG008|Stage 1A|Disease Progression|0|||
130561296|NCT00467779|470024775|FG009|Stage 1A|Disease Progression|2|||
130561297|NCT00467779|470024776|FG010|Stage 1A|Disease Progression|2|||
130561298|NCT00467779|470024777|FG011|Stage 1A|Disease Progression|5|||
130561299|NCT00467779|470024778|FG012|Stage 1A|Disease Progression|2|||
130561300|NCT00467779|470024779|FG013|Stage 1A|Disease Progression|0|||
130561301|NCT00467779|470024780|FG014|Stage 1A|Disease Progression|0|||
130561302|NCT00467779|470024766|FG000|Stage 1A|Physician Decision|0|||
130561303|NCT00467779|470024767|FG001|Stage 1A|Physician Decision|0|||
130561304|NCT00467779|470024768|FG002|Stage 1A|Physician Decision|0|||
130561305|NCT00467779|470024769|FG003|Stage 1A|Physician Decision|0|||
130561306|NCT00467779|470024770|FG004|Stage 1A|Physician Decision|0|||
130561307|NCT00467779|470024771|FG005|Stage 1A|Physician Decision|0|||
130561308|NCT00467779|470024772|FG006|Stage 1A|Physician Decision|0|||
130561309|NCT00467779|470024773|FG007|Stage 1A|Physician Decision|0|||
130561310|NCT00467779|470024774|FG008|Stage 1A|Physician Decision|0|||
130561311|NCT00467779|470024775|FG009|Stage 1A|Physician Decision|1|||
130561312|NCT00467779|470024776|FG010|Stage 1A|Physician Decision|0|||
130561313|NCT00467779|470024777|FG011|Stage 1A|Physician Decision|0|||
130561314|NCT00467779|470024778|FG012|Stage 1A|Physician Decision|0|||
130561315|NCT00467779|470024779|FG013|Stage 1A|Physician Decision|0|||
130561316|NCT00467779|470024780|FG014|Stage 1A|Physician Decision|0|||
130561317|NCT00467779|470024766|FG000|Stage 1A|Withdrawal by Subject|0|||
130561318|NCT00467779|470024767|FG001|Stage 1A|Withdrawal by Subject|0|||
130561319|NCT00467779|470024768|FG002|Stage 1A|Withdrawal by Subject|0|||
130561320|NCT00467779|470024769|FG003|Stage 1A|Withdrawal by Subject|0|||
130561321|NCT00467779|470024770|FG004|Stage 1A|Withdrawal by Subject|0|||
130561322|NCT00467779|470024771|FG005|Stage 1A|Withdrawal by Subject|0|||
130561323|NCT00467779|470024772|FG006|Stage 1A|Withdrawal by Subject|0|||
130561324|NCT00467779|470024773|FG007|Stage 1A|Withdrawal by Subject|0|||
130561325|NCT00467779|470024774|FG008|Stage 1A|Withdrawal by Subject|0|||
130561326|NCT00467779|470024775|FG009|Stage 1A|Withdrawal by Subject|0|||
130561327|NCT00467779|470024776|FG010|Stage 1A|Withdrawal by Subject|1|||
130561328|NCT00467779|470024777|FG011|Stage 1A|Withdrawal by Subject|1|||
130561329|NCT00467779|470024778|FG012|Stage 1A|Withdrawal by Subject|1|||
130561330|NCT00467779|470024779|FG013|Stage 1A|Withdrawal by Subject|0|||
130561331|NCT00467779|470024780|FG014|Stage 1A|Withdrawal by Subject|0|||
130561332|NCT00467779|470024766|FG000|Stage 1A|Unspecified Reason|0|||
130561333|NCT00467779|470024767|FG001|Stage 1A|Unspecified Reason|0|||
130561334|NCT00467779|470024768|FG002|Stage 1A|Unspecified Reason|0|||
130561335|NCT00467779|470024769|FG003|Stage 1A|Unspecified Reason|0|||
130561336|NCT00467779|470024770|FG004|Stage 1A|Unspecified Reason|0|||
130561337|NCT00467779|470024771|FG005|Stage 1A|Unspecified Reason|0|||
130561338|NCT00467779|470024772|FG006|Stage 1A|Unspecified Reason|0|||
130561339|NCT00467779|470024773|FG007|Stage 1A|Unspecified Reason|0|||
130561340|NCT00467779|470024774|FG008|Stage 1A|Unspecified Reason|0|||
130561341|NCT00467779|470024775|FG009|Stage 1A|Unspecified Reason|0|||
130561342|NCT00467779|470024776|FG010|Stage 1A|Unspecified Reason|0|||
130561343|NCT00467779|470024777|FG011|Stage 1A|Unspecified Reason|1|||
130561344|NCT00467779|470024778|FG012|Stage 1A|Unspecified Reason|1|||
130561345|NCT00467779|470024779|FG013|Stage 1A|Unspecified Reason|0|||
130561346|NCT00467779|470024780|FG014|Stage 1A|Unspecified Reason|0|||
130561347|NCT00467779|470024766|FG000|Stage 2|Adverse Event|0|||
130561348|NCT00467779|470024767|FG001|Stage 2|Adverse Event|0|||
130561349|NCT00467779|470024768|FG002|Stage 2|Adverse Event|0|||
130561350|NCT00467779|470024769|FG003|Stage 2|Adverse Event|0|||
130561351|NCT00467779|470024770|FG004|Stage 2|Adverse Event|0|||
130406975|NCT01079234|469453735|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
130406976|NCT01079234|469453732|FG000|Extension: Week 27 to 52|Unclassified|0|||
130406977|NCT01079234|469453733|FG001|Extension: Week 27 to 52|Unclassified|0|||
130561352|NCT00467779|470024771|FG005|Stage 2|Adverse Event|0|||
130561353|NCT00467779|470024772|FG006|Stage 2|Adverse Event|0|||
130561354|NCT00467779|470024773|FG007|Stage 2|Adverse Event|0|||
130561355|NCT00467779|470024774|FG008|Stage 2|Adverse Event|1|||
130561356|NCT00467779|470024775|FG009|Stage 2|Adverse Event|0|||
130561357|NCT00467779|470024776|FG010|Stage 2|Adverse Event|0|||
130561358|NCT00467779|470024777|FG011|Stage 2|Adverse Event|0|||
130561359|NCT00467779|470024778|FG012|Stage 2|Adverse Event|0|||
130406978|NCT01079234|469453734|FG002|Extension: Week 27 to 52|Unclassified|4|||
130406979|NCT01079234|469453735|FG003|Extension: Week 27 to 52|Unclassified|7|||
130406980|NCT01312961|469453741|FG000|Overall Study|Adverse Event|3|||
130406981|NCT01312961|469453742|FG001|Overall Study|Adverse Event|3|||
130406982|NCT01312961|469453741|FG000|Overall Study|Lack of Efficacy|11|||
130406983|NCT01312961|469453742|FG001|Overall Study|Lack of Efficacy|1|||
130406984|NCT01312961|469453741|FG000|Overall Study|Poor compliance to protocol|1|||
130406985|NCT01312961|469453742|FG001|Overall Study|Poor compliance to protocol|0|||
130406986|NCT01312961|469453741|FG000|Overall Study|Other than specified above|2|||
130406987|NCT01312961|469453742|FG001|Overall Study|Other than specified above|3|||
130406988|NCT04278417|469453744|FG000|Overall Study|Withdrawal by Subject|20|||
130561360|NCT00467779|470024779|FG013|Stage 2|Adverse Event|0|||
130561361|NCT00467779|470024780|FG014|Stage 2|Adverse Event|0|||
130561362|NCT00467779|470024766|FG000|Stage 2|Death|0|||
130561363|NCT00467779|470024767|FG001|Stage 2|Death|0|||
130561364|NCT00467779|470024768|FG002|Stage 2|Death|0|||
130561365|NCT00467779|470024769|FG003|Stage 2|Death|0|||
130561366|NCT00467779|470024770|FG004|Stage 2|Death|0|||
130561367|NCT00467779|470024771|FG005|Stage 2|Death|0|||
130725195|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725196|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725197|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725198|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725199|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725200|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725201|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130725202|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725203|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130725204|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
130725205|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725206|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725207|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725208|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725209|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725210|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725211|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725212|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725213|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725214|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725215|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725216|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725217|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725218|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725219|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725220|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725221|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130725222|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725223|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725224|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725225|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725226|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725227|NCT04844762|470619300|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725228|NCT04844762|470619301|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725229|NCT04844762|470619302|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725230|NCT04844762|470619303|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725231|NCT04844762|470619304|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725232|NCT04844762|470619305|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725233|NCT04844762|470619300|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725234|NCT04844762|470619301|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
130725235|NCT04844762|470619302|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130406989|NCT04278417|469453745|FG001|Overall Study|Withdrawal by Subject|20|||
130406990|NCT04278417|469453744|FG000|Overall Study|Progressive disease|0|||
130406991|NCT04278417|469453745|FG001|Overall Study|Progressive disease|2|||
130561368|NCT00467779|470024772|FG006|Stage 2|Death|0|||
130561369|NCT00467779|470024773|FG007|Stage 2|Death|0|||
130561370|NCT00467779|470024774|FG008|Stage 2|Death|1|||
130561371|NCT00467779|470024775|FG009|Stage 2|Death|0|||
130561372|NCT00467779|470024776|FG010|Stage 2|Death|0|||
130406992|NCT04278417|469453744|FG000|Overall Study|Physician Decision|4|||
130725236|NCT04844762|470619303|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725237|NCT04844762|470619304|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725238|NCT04844762|470619305|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130406993|NCT04278417|469453745|FG001|Overall Study|Physician Decision|6|||
130406994|NCT04278417|469453744|FG000|Overall Study|Lost to Follow-up|11|||
130406995|NCT04278417|469453745|FG001|Overall Study|Lost to Follow-up|13|||
130406996|NCT04278417|469453744|FG000|Overall Study|Death|8|||
130406997|NCT04278417|469453745|FG001|Overall Study|Death|9|||
130406998|NCT04278417|469453744|FG000|Overall Study|Adverse Event|3|||
130406999|NCT04278417|469453745|FG001|Overall Study|Adverse Event|5|||
130407000|NCT00205712|469453747|FG000|Overall Study|Lost to Follow-up|0|||
130407001|NCT00205712|469453748|FG001|Overall Study|Lost to Follow-up|1|||
130407002|NCT01652716|469453758|FG000|Overall Study|Loss of glucose control|1|||
130407003|NCT01652716|469453759|FG001|Overall Study|Loss of glucose control|0|||
130407004|NCT01652716|469453758|FG000|Overall Study|Administrative|0|||
130407005|NCT01652716|469453759|FG001|Overall Study|Administrative|2|||
130407006|NCT01652716|469453758|FG000|Overall Study|Investigator decision|1|||
130407007|NCT01652716|469453759|FG001|Overall Study|Investigator decision|4|||
130407008|NCT01652716|469453758|FG000|Overall Study|Lost to Follow-up|12|||
130407009|NCT01652716|469453759|FG001|Overall Study|Lost to Follow-up|11|||
130471824|NCT04437433|469693978|FG001|Overall Study|Other, not specified|1|||
130471825|NCT04048681|469693979|FG000|Overall Study|family emergency|0|||
130471826|NCT04048681|469693980|FG001|Overall Study|family emergency|0|||
130471827|NCT04048681|469693981|FG002|Overall Study|family emergency|0|||
130471828|NCT04048681|469693982|FG003|Overall Study|family emergency|1|||
130471829|NCT04048681|469693983|FG004|Overall Study|family emergency|0|||
130471830|NCT05384730|469693986|FG000|Overall Study|Adverse Event|1|||
130471831|NCT05384730|469693987|FG001|Overall Study|Adverse Event|0|||
130471832|NCT05384730|469693986|FG000|Overall Study|Lack of social support|2|||
130471833|NCT05384730|469693987|FG001|Overall Study|Lack of social support|0|||
130471834|NCT05384730|469693986|FG000|Overall Study|Hospital readmission|2|||
130471835|NCT05384730|469693987|FG001|Overall Study|Hospital readmission|0|||
130471836|NCT05384730|469693986|FG000|Overall Study|Disease progression|5|||
130471837|NCT05384730|469693987|FG001|Overall Study|Disease progression|0|||
130471838|NCT05384730|469693986|FG000|Overall Study|Overwhelmed with College commitments|0|||
130471839|NCT05384730|469693987|FG001|Overall Study|Overwhelmed with College commitments|2|||
130471840|NCT04854096|469693992|FG000|Overall Study|Adverse Event|1|||
130471841|NCT04854096|469693993|FG001|Overall Study|Adverse Event|0|||
130471842|NCT04854096|469693992|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
130471843|NCT04854096|469693993|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
130471844|NCT04854096|469693992|FG000|Overall Study|Withdrawal by Subject|1|||
130471845|NCT04854096|469693993|FG001|Overall Study|Withdrawal by Subject|0|||
130471846|NCT04854096|469693992|FG000|Overall Study|Other reasons|1|||
130471847|NCT04854096|469693993|FG001|Overall Study|Other reasons|0|||
130471848|NCT00879333|469693994|FG000|Overall Study|Adverse Event|94|||
130471849|NCT00879333|469693995|FG001|Overall Study|Adverse Event|34|||
130471850|NCT00879333|469693994|FG000|Overall Study|Abnormal Laboratory Value|1|||
130471851|NCT00879333|469693995|FG001|Overall Study|Abnormal Laboratory Value|0|||
130471852|NCT00879333|469693994|FG000|Overall Study|Withdrawal by Subject|20|||
130471853|NCT00879333|469693995|FG001|Overall Study|Withdrawal by Subject|7|||
130471854|NCT00879333|469693994|FG000|Overall Study|Lost to Follow-up|2|||
130471855|NCT00879333|469693995|FG001|Overall Study|Lost to Follow-up|1|||
130471856|NCT00879333|469693994|FG000|Overall Study|Administrative Problems|2|||
130471857|NCT00879333|469693995|FG001|Overall Study|Administrative Problems|0|||
130471858|NCT00879333|469693994|FG000|Overall Study|Death|16|||
130471859|NCT00879333|469693995|FG001|Overall Study|Death|5|||
130561373|NCT00467779|470024777|FG011|Stage 2|Death|0|||
130561374|NCT00467779|470024778|FG012|Stage 2|Death|0|||
130725239|NCT04844762|470619300|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725240|NCT04844762|470619301|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725241|NCT04844762|470619302|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130407010|NCT01652716|469453758|FG000|Overall Study|Protocol Violation|2|||
130407011|NCT01652716|469453759|FG001|Overall Study|Protocol Violation|1|||
130407012|NCT01652716|469453758|FG000|Overall Study|Adverse Event|7|||
130407013|NCT01652716|469453759|FG001|Overall Study|Adverse Event|10|||
130407014|NCT01652716|469453758|FG000|Overall Study|Withdrawal by Subject|33|||
130471860|NCT00879333|469693994|FG000|Overall Study|Disease Progression|292|||
130471861|NCT00879333|469693995|FG001|Overall Study|Disease Progression|169|||
130471862|NCT00879333|469693994|FG000|Overall Study|Protocol Violation|1|||
130471863|NCT00879333|469693995|FG001|Overall Study|Protocol Violation|1|||
130471864|NCT04154384|469693996|FG000|Overall Study|Lost to Follow-up|24|||
130471865|NCT04154384|469693997|FG001|Overall Study|Lost to Follow-up|33|||
130471866|NCT04154384|469693998|FG002|Overall Study|Lost to Follow-up|0|||
130471867|NCT04154384|469693996|FG000|Overall Study|Withdrawal by Subject|7|||
130471868|NCT04154384|469693997|FG001|Overall Study|Withdrawal by Subject|18|||
130471869|NCT04154384|469693998|FG002|Overall Study|Withdrawal by Subject|0|||
130561375|NCT00467779|470024779|FG013|Stage 2|Death|0|||
130725242|NCT04844762|470619303|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
130725243|NCT04844762|470619304|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725244|NCT04844762|470619305|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725245|NCT04400682|470619308|FG000|Period 1|Withdrawal by Subject|1|||
130407015|NCT01652716|469453759|FG001|Overall Study|Withdrawal by Subject|18|||
130407016|NCT01337297|469453760|FG000|Overall Study|They entered to single anodal tDCS|4|||
130407017|NCT01337297|469453761|FG001|Overall Study|They entered to single anodal tDCS|3|||
130407018|NCT01337297|469453760|FG000|Overall Study|Lost to Follow-up|1|||
130407019|NCT01337297|469453761|FG001|Overall Study|Lost to Follow-up|3|||
130407020|NCT02778204|469453762|FG000|Overall Study|Adverse Event|1|||
130407021|NCT02778204|469453763|FG001|Overall Study|Adverse Event|0|||
130407022|NCT02778204|469453764|FG002|Overall Study|Adverse Event|0|||
130407023|NCT02778204|469453765|FG003|Overall Study|Adverse Event|0|||
130407024|NCT02778204|469453762|FG000|Overall Study|Withdrawal by Subject|0|||
130407025|NCT02778204|469453763|FG001|Overall Study|Withdrawal by Subject|0|||
130407026|NCT02778204|469453764|FG002|Overall Study|Withdrawal by Subject|1|||
130407027|NCT02778204|469453765|FG003|Overall Study|Withdrawal by Subject|2|||
130407028|NCT02778204|469453762|FG000|Overall Study|Lost to Follow-up|1|||
130407029|NCT02778204|469453763|FG001|Overall Study|Lost to Follow-up|0|||
130407030|NCT02778204|469453764|FG002|Overall Study|Lost to Follow-up|2|||
130407031|NCT02778204|469453765|FG003|Overall Study|Lost to Follow-up|1|||
130407032|NCT02778204|469453762|FG000|Overall Study|Protocol Violation|0|||
130407033|NCT02778204|469453763|FG001|Overall Study|Protocol Violation|0|||
130407034|NCT02778204|469453764|FG002|Overall Study|Protocol Violation|1|||
130407035|NCT02778204|469453765|FG003|Overall Study|Protocol Violation|0|||
130407036|NCT02778204|469453762|FG000|Overall Study|Eligibility Violation|0|||
130407037|NCT02778204|469453763|FG001|Overall Study|Eligibility Violation|0|||
130407038|NCT02778204|469453764|FG002|Overall Study|Eligibility Violation|0|||
130407039|NCT02778204|469453765|FG003|Overall Study|Eligibility Violation|1|||
130407040|NCT00965848|469453774|FG000|Overall Study|Protocol Violation|3|||
130407041|NCT00965848|469453775|FG001|Overall Study|Protocol Violation|0|||
130407042|NCT00965848|469453776|FG002|Overall Study|Protocol Violation|1|||
130407043|NCT00965848|469453774|FG000|Overall Study|Death|11|||
130407044|NCT00965848|469453775|FG001|Overall Study|Death|1|||
130407045|NCT00965848|469453776|FG002|Overall Study|Death|5|||
130407046|NCT00965848|469453774|FG000|Overall Study|Lost to Follow-up|0|||
130407047|NCT00965848|469453775|FG001|Overall Study|Lost to Follow-up|0|||
130407048|NCT00965848|469453776|FG002|Overall Study|Lost to Follow-up|1|||
130407049|NCT00965848|469453774|FG000|Overall Study|Withdrawal by Subject|1|||
130407050|NCT00965848|469453775|FG001|Overall Study|Withdrawal by Subject|0|||
130407051|NCT00965848|469453776|FG002|Overall Study|Withdrawal by Subject|0|||
130407052|NCT00965848|469453774|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
130407053|NCT00965848|469453775|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
130407054|NCT00965848|469453776|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
130407055|NCT00965848|469453774|FG000|Overall Study|Not Clinically Evaluable|7|||
130407056|NCT00965848|469453775|FG001|Overall Study|Not Clinically Evaluable|1|||
130407057|NCT00965848|469453776|FG002|Overall Study|Not Clinically Evaluable|1|||
130407058|NCT00965848|469453774|FG000|Overall Study|Other|5|||
130407059|NCT00965848|469453775|FG001|Overall Study|Other|0|||
130725246|NCT04400682|470619309|FG001|Period 1|Withdrawal by Subject|4|||
130725247|NCT02293863|470619310|FG000|Overall Study|Death|4|||
130407060|NCT00965848|469453776|FG002|Overall Study|Other|1|||
130407061|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
130407062|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130407063|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130407064|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130407065|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
130407066|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
130407067|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
130407068|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
130407069|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130407070|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130407071|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130407072|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
130407073|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130407074|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130407075|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
130407076|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130407077|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130407078|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130407079|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
130407080|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130407081|NCT00813761|469453778|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130407082|NCT00813761|469453779|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
130407083|NCT00813761|469453780|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130725248|NCT02293863|470619311|FG001|Overall Study|Death|6|||
130561376|NCT00467779|470024780|FG014|Stage 2|Death|0|||
130561377|NCT00467779|470024766|FG000|Stage 2|Disease Progression|0|||
130561378|NCT00467779|470024767|FG001|Stage 2|Disease Progression|0|||
130561379|NCT00467779|470024768|FG002|Stage 2|Disease Progression|0|||
130561380|NCT00467779|470024769|FG003|Stage 2|Disease Progression|0|||
130561381|NCT00467779|470024770|FG004|Stage 2|Disease Progression|0|||
130561382|NCT00467779|470024771|FG005|Stage 2|Disease Progression|0|||
130407084|NCT00813761|469453781|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130407085|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
130407086|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
130407087|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
130407088|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
130407089|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
130407090|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
130407091|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
130407092|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
130407093|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
130407094|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
130407095|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
130407096|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
130407097|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130407098|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130407099|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130407100|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
130407101|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
130407102|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
130407103|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
130407104|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
130407105|NCT00813761|469453778|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
130407106|NCT00813761|469453779|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
130407107|NCT00813761|469453780|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
130407108|NCT00813761|469453781|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
130407109|NCT01328002|469453782|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
130407110|NCT01328002|469453783|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
130407111|NCT01328002|469453782|FG000|Open-Label Period|Adverse Event|8|||
130407112|NCT01328002|469453783|FG001|Open-Label Period|Adverse Event|0|||
130407113|NCT01328002|469453782|FG000|Open-Label Period|Lack of Efficacy|3|||
130407114|NCT01328002|469453783|FG001|Open-Label Period|Lack of Efficacy|0|||
130407115|NCT01328002|469453782|FG000|Open-Label Period|Protocol Violation|2|||
130407116|NCT01328002|469453783|FG001|Open-Label Period|Protocol Violation|0|||
130407117|NCT01328002|469453782|FG000|Open-Label Period|Withdrawal by Subject|9|||
130407118|NCT01328002|469453783|FG001|Open-Label Period|Withdrawal by Subject|0|||
130407119|NCT01328002|469453782|FG000|Open-Label Period|Lost to Follow-up|6|||
130407120|NCT01328002|469453783|FG001|Open-Label Period|Lost to Follow-up|0|||
130407121|NCT01328002|469453782|FG000|Open-Label Period|Other Reason|2|||
130407122|NCT01328002|469453783|FG001|Open-Label Period|Other Reason|0|||
130407123|NCT01328002|469453782|FG000|Double-Blind Period|Adverse Event|1|||
130407124|NCT01328002|469453783|FG001|Double-Blind Period|Adverse Event|0|||
130407125|NCT01328002|469453782|FG000|Double-Blind Period|Lack of Efficacy|1|||
130407126|NCT01328002|469453783|FG001|Double-Blind Period|Lack of Efficacy|0|||
130407127|NCT01208233|469453785|FG000|Overall Study|Adverse Event|0|||
130407128|NCT01208233|469453786|FG001|Overall Study|Adverse Event|1|||
130407129|NCT01208233|469453787|FG002|Overall Study|Adverse Event|2|||
130407130|NCT01208233|469453788|FG003|Overall Study|Adverse Event|0|||
130407131|NCT01208233|469453789|FG004|Overall Study|Adverse Event|3|||
130407132|NCT01208233|469453790|FG005|Overall Study|Adverse Event|5|||
130407133|NCT01208233|469453785|FG000|Overall Study|Death|0|||
130407134|NCT01208233|469453786|FG001|Overall Study|Death|0|||
130407135|NCT01208233|469453787|FG002|Overall Study|Death|0|||
130407136|NCT01208233|469453788|FG003|Overall Study|Death|0|||
130407137|NCT01208233|469453789|FG004|Overall Study|Death|3|||
130407138|NCT01208233|469453790|FG005|Overall Study|Death|5|||
130407139|NCT01208233|469453785|FG000|Overall Study|Did not meet entrance criteria|2|||
130407140|NCT01208233|469453786|FG001|Overall Study|Did not meet entrance criteria|1|||
130407141|NCT01208233|469453787|FG002|Overall Study|Did not meet entrance criteria|1|||
130407142|NCT01208233|469453788|FG003|Overall Study|Did not meet entrance criteria|0|||
130407143|NCT01208233|469453789|FG004|Overall Study|Did not meet entrance criteria|1|||
130407144|NCT01208233|469453790|FG005|Overall Study|Did not meet entrance criteria|0|||
130407145|NCT01208233|469453785|FG000|Overall Study|Medication error without adverse event|0|||
130407146|NCT01208233|469453786|FG001|Overall Study|Medication error without adverse event|0|||
130407147|NCT01208233|469453787|FG002|Overall Study|Medication error without adverse event|0|||
130561383|NCT00467779|470024772|FG006|Stage 2|Disease Progression|0|||
130561384|NCT00467779|470024773|FG007|Stage 2|Disease Progression|0|||
130561385|NCT00467779|470024774|FG008|Stage 2|Disease Progression|16|||
130561386|NCT00467779|470024775|FG009|Stage 2|Disease Progression|0|||
130725249|NCT02293863|470619312|FG002|Overall Study|Death|4|||
130725250|NCT02293863|470619310|FG000|Overall Study|Lost to Follow-up|2|||
130725251|NCT02293863|470619311|FG001|Overall Study|Lost to Follow-up|2|||
130725252|NCT02293863|470619312|FG002|Overall Study|Lost to Follow-up|2|||
130725253|NCT02293863|470619310|FG000|Overall Study|Withdrawal by Subject|3|||
130725254|NCT02293863|470619311|FG001|Overall Study|Withdrawal by Subject|3|||
130725255|NCT02293863|470619312|FG002|Overall Study|Withdrawal by Subject|1|||
130725256|NCT02293863|470619310|FG000|Overall Study|Reason Not Specified|0|||
130725257|NCT02293863|470619311|FG001|Overall Study|Reason Not Specified|2|||
130725258|NCT02293863|470619312|FG002|Overall Study|Reason Not Specified|2|||
130407148|NCT01208233|469453788|FG003|Overall Study|Medication error without adverse event|0|||
130725259|NCT00477633|470619313|FG000|Overall Study|Did not receive treatment|23|||
130725260|NCT00477633|470619313|FG000|Overall Study|Adverse Event|143|||
130725261|NCT00477633|470619313|FG000|Overall Study|Pregnancy|23|||
130725262|NCT00477633|470619313|FG000|Overall Study|Lost to Follow-up|271|||
130725263|NCT00477633|470619313|FG000|Overall Study|Withdrawal by Subject|149|||
130725264|NCT00477633|470619313|FG000|Overall Study|Protocol Violation|25|||
130725265|NCT00477633|470619313|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
130725266|NCT01374269|470619322|FG000|Overall Study|Withdrawal by Subject|4|||
130725267|NCT01374269|470619323|FG001|Overall Study|Withdrawal by Subject|0|||
130725268|NCT01374269|470619322|FG000|Overall Study|Lost to Follow-up|1|||
130725269|NCT01374269|470619323|FG001|Overall Study|Lost to Follow-up|3|||
130725270|NCT01374269|470619322|FG000|Overall Study|closed research|1|||
130725271|NCT01374269|470619323|FG001|Overall Study|closed research|2|||
130725272|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
130725273|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
130725274|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
130725275|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
130725276|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
130725277|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
130725278|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
130725279|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
130725280|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
130725281|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
130725282|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
130725283|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
130725284|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
130725285|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
130725286|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
130725287|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
130725288|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
130725289|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
130725290|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
130725291|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
130725292|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Death|1|||
130725293|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Death|0|||
130725294|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Death|0|||
130725295|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Death|0|||
130561387|NCT00467779|470024776|FG010|Stage 2|Disease Progression|0|||
130561388|NCT00467779|470024777|FG011|Stage 2|Disease Progression|0|||
130561389|NCT00467779|470024778|FG012|Stage 2|Disease Progression|0|||
130561390|NCT00467779|470024779|FG013|Stage 2|Disease Progression|0|||
130561391|NCT00467779|470024780|FG014|Stage 2|Disease Progression|0|||
130561392|NCT00467779|470024766|FG000|Stage 2|Unspecified Reason|0|||
130561393|NCT00467779|470024767|FG001|Stage 2|Unspecified Reason|0|||
130407149|NCT01208233|469453789|FG004|Overall Study|Medication error without adverse event|0|||
130407150|NCT01208233|469453790|FG005|Overall Study|Medication error without adverse event|1|||
130407151|NCT01208233|469453785|FG000|Overall Study|Study terminated by sponsor|0|||
130407152|NCT01208233|469453786|FG001|Overall Study|Study terminated by sponsor|0|||
130407153|NCT01208233|469453787|FG002|Overall Study|Study terminated by sponsor|0|||
130407154|NCT01208233|469453788|FG003|Overall Study|Study terminated by sponsor|0|||
130407155|NCT01208233|469453789|FG004|Overall Study|Study terminated by sponsor|10|||
130407156|NCT01208233|469453790|FG005|Overall Study|Study terminated by sponsor|7|||
130407157|NCT01208233|469453785|FG000|Overall Study|Protocol Violation|0|||
130407158|NCT01208233|469453786|FG001|Overall Study|Protocol Violation|0|||
130725296|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Death|0|||
130407159|NCT01208233|469453787|FG002|Overall Study|Protocol Violation|0|||
130725297|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Death|1|||
130725298|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Death|0|||
130725299|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Death|0|||
130407160|NCT01208233|469453788|FG003|Overall Study|Protocol Violation|0|||
130561394|NCT00467779|470024768|FG002|Stage 2|Unspecified Reason|0|||
130725300|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Death|0|||
130725301|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Death|0|||
130725302|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Death|0|||
130725303|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Death|0|||
130725304|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Death|0|||
130725305|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Death|0|||
130407161|NCT01208233|469453789|FG004|Overall Study|Protocol Violation|3|||
130407162|NCT01208233|469453790|FG005|Overall Study|Protocol Violation|0|||
130407163|NCT01208233|469453785|FG000|Overall Study|Other|2|||
130407164|NCT01208233|469453786|FG001|Overall Study|Other|1|||
130407165|NCT01208233|469453787|FG002|Overall Study|Other|0|||
130407166|NCT01208233|469453788|FG003|Overall Study|Other|0|||
130407167|NCT01208233|469453789|FG004|Overall Study|Other|0|||
130407168|NCT01208233|469453790|FG005|Overall Study|Other|1|||
130407169|NCT01208233|469453785|FG000|Overall Study|Withdrawal by Subject|1|||
130407170|NCT01208233|469453786|FG001|Overall Study|Withdrawal by Subject|0|||
130407171|NCT01208233|469453787|FG002|Overall Study|Withdrawal by Subject|1|||
130407172|NCT01208233|469453788|FG003|Overall Study|Withdrawal by Subject|1|||
130407173|NCT01208233|469453789|FG004|Overall Study|Withdrawal by Subject|4|||
130407174|NCT01208233|469453790|FG005|Overall Study|Withdrawal by Subject|2|||
130407175|NCT01181895|469453793|FG000|Overall Study|Adverse Event|3|||
130407176|NCT01181895|469453794|FG001|Overall Study|Adverse Event|1|||
130407177|NCT01181895|469453795|FG002|Overall Study|Adverse Event|1|||
130471870|NCT04154384|469693996|FG000|Overall Study|Missing outcome data|1|||
130471871|NCT04154384|469693997|FG001|Overall Study|Missing outcome data|0|||
130471872|NCT04154384|469693998|FG002|Overall Study|Missing outcome data|0|||
130471873|NCT05048186|469693999|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
130471874|NCT05048186|469694000|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
130471875|NCT05048186|469693999|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
130471876|NCT05048186|469694000|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
130471877|NCT00951379|469694001|FG000|Overall Study|Adverse Event|4|||
130471878|NCT00951379|469694002|FG001|Overall Study|Adverse Event|1|||
130471879|NCT00951379|469694001|FG000|Overall Study|Withdrawal by Subject|1|||
130471880|NCT00951379|469694002|FG001|Overall Study|Withdrawal by Subject|0|||
130725306|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Death|0|||
130725307|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Death|0|||
130725308|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Death|0|||
130725309|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Death|0|||
130725310|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Death|0|||
130725311|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Death|0|||
130725312|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
130725313|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
130725314|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
130725315|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
130725316|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
130725317|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
130725318|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
130725319|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
130725320|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
130725321|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
130725322|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
130725323|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
130725324|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
130725325|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
130725326|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
130725327|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
130725328|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
130725329|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
130725330|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
130725331|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
130725332|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725333|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725334|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725335|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
130725336|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725337|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725338|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725339|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725340|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725341|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725342|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725343|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725344|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130407178|NCT01181895|469453793|FG000|Overall Study|Lack of Efficacy|8|||
130407179|NCT01181895|469453794|FG001|Overall Study|Lack of Efficacy|9|||
130407180|NCT01181895|469453795|FG002|Overall Study|Lack of Efficacy|9|||
130407181|NCT01181895|469453793|FG000|Overall Study|Protocol Violation|2|||
130407182|NCT01181895|469453794|FG001|Overall Study|Protocol Violation|1|||
130725345|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130561395|NCT00467779|470024769|FG003|Stage 2|Unspecified Reason|0|||
130561396|NCT00467779|470024770|FG004|Stage 2|Unspecified Reason|0|||
130561397|NCT00467779|470024771|FG005|Stage 2|Unspecified Reason|0|||
130561398|NCT00467779|470024772|FG006|Stage 2|Unspecified Reason|0|||
130561399|NCT00467779|470024773|FG007|Stage 2|Unspecified Reason|0|||
130561400|NCT00467779|470024774|FG008|Stage 2|Unspecified Reason|3|||
130561401|NCT00467779|470024775|FG009|Stage 2|Unspecified Reason|0|||
130561402|NCT00467779|470024776|FG010|Stage 2|Unspecified Reason|0|||
130561403|NCT00467779|470024777|FG011|Stage 2|Unspecified Reason|0|||
130561404|NCT00467779|470024778|FG012|Stage 2|Unspecified Reason|0|||
130561405|NCT00467779|470024779|FG013|Stage 2|Unspecified Reason|0|||
130561406|NCT00467779|470024780|FG014|Stage 2|Unspecified Reason|0|||
130561407|NCT00467779|470024766|FG000|Stage 2A|Adverse Event|0|||
130561408|NCT00467779|470024767|FG001|Stage 2A|Adverse Event|0|||
130561409|NCT00467779|470024768|FG002|Stage 2A|Adverse Event|0|||
130561410|NCT00467779|470024769|FG003|Stage 2A|Adverse Event|0|||
130561411|NCT00467779|470024770|FG004|Stage 2A|Adverse Event|0|||
130561412|NCT00467779|470024771|FG005|Stage 2A|Adverse Event|0|||
130725346|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725347|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725348|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725349|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725350|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725351|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725352|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
130725353|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
130725354|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
130725355|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
130725356|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
130725357|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
130561413|NCT00467779|470024772|FG006|Stage 2A|Adverse Event|0|||
130561414|NCT00467779|470024773|FG007|Stage 2A|Adverse Event|0|||
130725358|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
130725359|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
130725360|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
130725361|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
130725362|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
130725363|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
130725364|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
130725365|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
130407183|NCT01181895|469453795|FG002|Overall Study|Protocol Violation|0|||
130407184|NCT01181895|469453793|FG000|Overall Study|Lost to Follow-up|0|||
130407185|NCT01181895|469453794|FG001|Overall Study|Lost to Follow-up|1|||
130407186|NCT01181895|469453795|FG002|Overall Study|Lost to Follow-up|2|||
130407187|NCT01181895|469453793|FG000|Overall Study|Investigator Discretion|1|||
130407188|NCT01181895|469453794|FG001|Overall Study|Investigator Discretion|2|||
130407189|NCT01181895|469453795|FG002|Overall Study|Investigator Discretion|1|||
130407190|NCT01181895|469453793|FG000|Overall Study|Withdrawal by Subject|3|||
130407191|NCT01181895|469453794|FG001|Overall Study|Withdrawal by Subject|0|||
130407192|NCT01181895|469453795|FG002|Overall Study|Withdrawal by Subject|5|||
130407193|NCT00061048|469453799|FG000|Overall Study|Adverse Event|2|||
130407194|NCT00061048|469453799|FG000|Overall Study|disease progression|20|||
130407195|NCT01114516|469453800|FG000|Overall Study|Lost to Follow-up|2|||
130407196|NCT01114516|469453801|FG001|Overall Study|Lost to Follow-up|1|||
130407197|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407198|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407199|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407200|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407201|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130407202|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407203|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407204|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130407205|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130561415|NCT00467779|470024774|FG008|Stage 2A|Adverse Event|0|||
130561416|NCT00467779|470024775|FG009|Stage 2A|Adverse Event|0|||
130561417|NCT00467779|470024776|FG010|Stage 2A|Adverse Event|0|||
130561418|NCT00467779|470024777|FG011|Stage 2A|Adverse Event|0|||
130561419|NCT00467779|470024778|FG012|Stage 2A|Adverse Event|0|||
130561420|NCT00467779|470024779|FG013|Stage 2A|Adverse Event|2|||
130561421|NCT00467779|470024780|FG014|Stage 2A|Adverse Event|0|||
130561422|NCT00467779|470024766|FG000|Stage 2A|Death|0|||
130561423|NCT00467779|470024767|FG001|Stage 2A|Death|0|||
130561424|NCT00467779|470024768|FG002|Stage 2A|Death|0|||
130725366|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
130725367|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
130725368|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
130407206|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407207|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130407208|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130407209|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407210|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407211|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407212|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130407213|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130407214|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130407215|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130407216|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130407217|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
130471881|NCT00951379|469694001|FG000|Overall Study|Noncompliance|1|||
130471882|NCT00951379|469694002|FG001|Overall Study|Noncompliance|0|||
130471883|NCT00951379|469694001|FG000|Overall Study|Disease Progression|0|||
130471884|NCT00951379|469694002|FG001|Overall Study|Disease Progression|1|||
130471885|NCT04218266|469694004|FG000|Overall Study|Death|1|||
130471886|NCT04218266|469694005|FG001|Overall Study|Death|2|||
130471887|NCT04218266|469694006|FG002|Overall Study|Death|3|||
130471888|NCT04218266|469694004|FG000|Overall Study|Adverse Event|13|||
130471889|NCT04218266|469694005|FG001|Overall Study|Adverse Event|14|||
130471890|NCT04218266|469694006|FG002|Overall Study|Adverse Event|11|||
130471891|NCT04218266|469694004|FG000|Overall Study|Other|7|||
130471892|NCT04218266|469694005|FG001|Overall Study|Other|5|||
130471893|NCT04218266|469694006|FG002|Overall Study|Other|14|||
130471894|NCT04218266|469694004|FG000|Overall Study|Physician Decision|1|||
130471895|NCT04218266|469694005|FG001|Overall Study|Physician Decision|3|||
130471896|NCT04218266|469694006|FG002|Overall Study|Physician Decision|2|||
130471897|NCT04218266|469694004|FG000|Overall Study|Non-compliance with study drug|0|||
130471898|NCT04218266|469694005|FG001|Overall Study|Non-compliance with study drug|0|||
130471899|NCT04218266|469694006|FG002|Overall Study|Non-compliance with study drug|1|||
130471900|NCT04218266|469694004|FG000|Overall Study|Withdrawal by Subject|1|||
130471901|NCT04218266|469694005|FG001|Overall Study|Withdrawal by Subject|3|||
130471902|NCT04218266|469694006|FG002|Overall Study|Withdrawal by Subject|1|||
130471903|NCT04218266|469694004|FG000|Overall Study|Study drug never administered|2|||
130471904|NCT04218266|469694005|FG001|Overall Study|Study drug never administered|0|||
130471905|NCT04218266|469694006|FG002|Overall Study|Study drug never administered|0|||
130471906|NCT01494922|469694007|FG000|Overall Study|Adverse Event|1|||
130471907|NCT02891915|469694008|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
130471908|NCT02891915|469694009|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
130471909|NCT02891915|469694008|FG000|Overall Study|Withdrawal by Subject|3|||
130471910|NCT02891915|469694009|FG001|Overall Study|Withdrawal by Subject|3|||
130725369|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
130725370|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
130725371|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
130725372|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
130725373|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
130407218|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
130407219|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
130407220|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
130407221|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
130407222|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
130407223|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
130725374|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
130407224|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
130407225|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130407226|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130407227|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130407228|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130471911|NCT02891915|469694008|FG000|Overall Study|Became Ineligible After Enrollment|2|||
130471912|NCT02891915|469694009|FG001|Overall Study|Became Ineligible After Enrollment|1|||
130471913|NCT02891915|469694008|FG000|Overall Study|Lost to Follow-up|1|||
130471914|NCT02891915|469694009|FG001|Overall Study|Lost to Follow-up|4|||
130471915|NCT02891915|469694008|FG000|Overall Study|Physician Decision|1|||
130471916|NCT02891915|469694009|FG001|Overall Study|Physician Decision|0|||
130471917|NCT01091168|469694010|FG000|Overall Study|Progressive disease|250|||
130471918|NCT01091168|469694011|FG001|Overall Study|Progressive disease|234|||
130471919|NCT01091168|469694010|FG000|Overall Study|Adverse Event|21|||
130471920|NCT01091168|469694011|FG001|Overall Study|Adverse Event|24|||
130471921|NCT01091168|469694010|FG000|Overall Study|Lost to Follow-up|0|||
130471922|NCT01091168|469694011|FG001|Overall Study|Lost to Follow-up|1|||
130561425|NCT00467779|470024769|FG003|Stage 2A|Death|0|||
130725375|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
130725376|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
130725377|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
130725378|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
130725379|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
130725380|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
130725381|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
130725382|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
130725383|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
130725384|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
130725385|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
130725386|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
130725387|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
130725388|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
130725389|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
130725390|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
130725391|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
130725392|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Death|0|||
130725393|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Death|0|||
130725394|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Death|0|||
130725395|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Death|0|||
130725396|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Death|0|||
130725397|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Death|0|||
130725398|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Death|0|||
130725399|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Death|0|||
130725400|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Death|0|||
130725401|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Death|2|||
130725402|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Death|0|||
130725403|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Death|1|||
130725404|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Death|1|||
130725405|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Death|0|||
130725406|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Death|0|||
130725407|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Death|0|||
130725408|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Death|0|||
130725409|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Death|0|||
130725410|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Death|0|||
130725411|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Death|0|||
130725412|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
130725413|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
130725414|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
130725415|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
130725416|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
130725417|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
130725418|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
130725419|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
130725420|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
130725421|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
130725422|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
130725423|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
130725424|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
130725425|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
130725426|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
130725427|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
130725428|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
130725429|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
130725430|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
130725431|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
130407229|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407230|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130725432|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725433|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725434|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725435|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725436|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130407231|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407232|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130725437|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725438|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725439|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725440|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725441|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725442|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725443|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725444|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725445|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130471923|NCT01091168|469694010|FG000|Overall Study|Physician, patient's decision, other|27|||
130471924|NCT01091168|469694011|FG001|Overall Study|Physician, patient's decision, other|37|||
130471925|NCT04567615|469694016|FG000|Randomization|Participant withdrew consent|1|||
130471926|NCT04567615|469694017|FG001|Randomization|Participant withdrew consent|0|||
130471927|NCT04567615|469694018|FG002|Randomization|Participant withdrew consent|0|||
130471928|NCT04567615|469694016|FG000|Randomization|Adverse event unrelated to study drug|0|||
130471929|NCT04567615|469694017|FG001|Randomization|Adverse event unrelated to study drug|1|||
130471930|NCT04567615|469694018|FG002|Randomization|Adverse event unrelated to study drug|0|||
130471931|NCT04567615|469694016|FG000|Treatment Period|Participant Withdrew Consent|2|||
130471932|NCT04567615|469694017|FG001|Treatment Period|Participant Withdrew Consent|5|||
130471933|NCT04567615|469694018|FG002|Treatment Period|Participant Withdrew Consent|1|||
130471934|NCT04567615|469694016|FG000|Treatment Period|Death|1|||
130471935|NCT04567615|469694017|FG001|Treatment Period|Death|2|||
130471936|NCT04567615|469694018|FG002|Treatment Period|Death|0|||
130471937|NCT04567615|469694016|FG000|Treatment Period|Lost to Follow-up|0|||
130471938|NCT04567615|469694017|FG001|Treatment Period|Lost to Follow-up|1|||
130471939|NCT04567615|469694018|FG002|Treatment Period|Lost to Follow-up|0|||
130471940|NCT04567615|469694016|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
130471941|NCT04567615|469694017|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
130471942|NCT04567615|469694018|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
130471943|NCT04567615|469694016|FG000|Treatment Period|Disease Progression|85|||
130471944|NCT04567615|469694017|FG001|Treatment Period|Disease Progression|63|||
130471945|NCT04567615|469694018|FG002|Treatment Period|Disease Progression|16|||
130471946|NCT04567615|469694016|FG000|Treatment Period|Study Drug Toxicity|3|||
130471947|NCT04567615|469694017|FG001|Treatment Period|Study Drug Toxicity|10|||
130471948|NCT04567615|469694018|FG002|Treatment Period|Study Drug Toxicity|4|||
130471949|NCT04567615|469694016|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
130471950|NCT04567615|469694017|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
130471951|NCT04567615|469694018|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
130471952|NCT04567615|469694016|FG000|Treatment Period|Other Reasons|1|||
130471953|NCT04567615|469694017|FG001|Treatment Period|Other Reasons|2|||
130471954|NCT04567615|469694018|FG002|Treatment Period|Other Reasons|0|||
130471955|NCT04567615|469694016|FG000|Treatment Period|Still On-going Treatment|21|||
130407233|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130471956|NCT04567615|469694017|FG001|Treatment Period|Still On-going Treatment|22|||
130471957|NCT04567615|469694018|FG002|Treatment Period|Still On-going Treatment|2|||
130471958|NCT05134337|469695527|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
130471959|NCT05134337|469695528|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
130407234|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130407235|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130407236|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407237|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407238|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
130407239|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
130407240|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130407241|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407242|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407243|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407244|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130407245|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407246|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130471960|NCT04059354|469695533|FG000|Overall Study|COVID-19 pandemic|3|||
130471961|NCT05403801|469695534|FG000|Overall Study|Withdrawal by Subject|2|||
130471962|NCT05215847|469695536|FG000|Overall Study|Lost to Follow-up|1|||
130471963|NCT02819843|469695543|FG000|Overall Study|Disease progression before RT|0|||
130471964|NCT02819843|469695544|FG001|Overall Study|Disease progression before RT|1|||
130471965|NCT03055858|469695546|FG000|Overall Study|Death|9|||
130471966|NCT03055858|469695546|FG000|Overall Study|Withdrawal by Subject|11|||
130471967|NCT03055858|469695546|FG000|Overall Study|Lost to Follow-up|6|||
130471968|NCT03055858|469695546|FG000|Overall Study|Missed Follow-Up Visits|18|||
130471969|NCT04586920|469695547|FG000|Overall Study|Lost to Follow-up|0|||
130471970|NCT04586920|469695548|FG001|Overall Study|Lost to Follow-up|0|||
130471971|NCT04586920|469695549|FG002|Overall Study|Lost to Follow-up|0|||
130471972|NCT04586920|469695550|FG003|Overall Study|Lost to Follow-up|0|||
130471973|NCT04586920|469695551|FG004|Overall Study|Lost to Follow-up|0|||
130471974|NCT04586920|469695552|FG005|Overall Study|Lost to Follow-up|0|||
130471975|NCT04586920|469695553|FG006|Overall Study|Lost to Follow-up|1|||
130471976|NCT04586920|469695554|FG007|Overall Study|Lost to Follow-up|1|||
130471977|NCT04586920|469695555|FG008|Overall Study|Lost to Follow-up|0|||
130471978|NCT04586920|469695556|FG009|Overall Study|Lost to Follow-up|1|||
130471979|NCT04586920|469695557|FG010|Overall Study|Lost to Follow-up|0|||
130725446|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725447|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725448|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725449|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725450|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725451|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725452|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
130725453|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
130725454|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
130725455|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
130725456|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
130725457|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
130725458|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
130725459|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
130725460|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
130725461|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
130725462|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
130725463|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
130725464|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
130725465|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
130725466|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
130725467|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
130725468|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
130725469|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
130725470|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
130725471|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
130725472|NCT00996892|470619324|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
130725473|NCT00996892|470619325|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
130725474|NCT00996892|470619326|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
130725475|NCT00996892|470619327|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
130725476|NCT00996892|470619328|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
130725477|NCT00996892|470619329|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
130725478|NCT00996892|470619330|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
130725479|NCT00996892|470619331|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
130725480|NCT00996892|470619332|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
130725481|NCT00996892|470619333|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
130725482|NCT00996892|470619334|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
130725483|NCT00996892|470619335|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
130725484|NCT00996892|470619336|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
130407247|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407248|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407249|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407250|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
130407251|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407252|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407253|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407254|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407255|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407256|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
130407257|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407258|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407259|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407260|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130407261|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130471980|NCT04586920|469695558|FG011|Overall Study|Lost to Follow-up|0|||
130471981|NCT04586920|469695559|FG012|Overall Study|Lost to Follow-up|0|||
130407262|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407263|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130725485|NCT00996892|470619337|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
130725486|NCT00996892|470619338|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
130725487|NCT00996892|470619339|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
130725488|NCT00996892|470619340|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
130725489|NCT00996892|470619341|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
130725490|NCT00996892|470619342|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
130725491|NCT00996892|470619343|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
130725492|NCT00996892|470619324|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
130725493|NCT00996892|470619325|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
130725494|NCT00996892|470619326|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
130725495|NCT00996892|470619327|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
130725496|NCT00996892|470619328|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
130725497|NCT00996892|470619329|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
130725498|NCT00996892|470619330|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
130725499|NCT00996892|470619331|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
130725500|NCT00996892|470619332|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
130725501|NCT00996892|470619333|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
130725502|NCT00996892|470619334|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
130725503|NCT00996892|470619335|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
130725504|NCT00996892|470619336|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
130725505|NCT00996892|470619337|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
130407264|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407265|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407266|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
130407267|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407268|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407269|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407270|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407271|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407272|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407273|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407274|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407275|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407276|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130407277|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407278|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407279|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407280|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407281|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407282|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407283|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407284|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407285|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
130407286|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407287|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407288|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407289|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407290|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407291|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407292|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130407293|NCT01609556|469453806|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
130407294|NCT01609556|469453807|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407295|NCT01609556|469453808|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407296|NCT01609556|469453809|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407297|NCT01609556|469453810|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407298|NCT01609556|469453811|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
130407299|NCT01609556|469453812|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407300|NCT01609556|469453813|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407301|NCT01609556|469453814|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407302|NCT01609556|469453815|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407303|NCT01609556|469453816|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
130407304|NCT01609556|469453817|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130471982|NCT04586920|469695560|FG013|Overall Study|Lost to Follow-up|1|||
130471983|NCT04586920|469695561|FG014|Overall Study|Lost to Follow-up|0|||
130471984|NCT04586920|469695562|FG015|Overall Study|Lost to Follow-up|0|||
130471985|NCT04586920|469695563|FG016|Overall Study|Lost to Follow-up|0|||
130471986|NCT04586920|469695564|FG017|Overall Study|Lost to Follow-up|0|||
130471987|NCT04586920|469695547|FG000|Overall Study|Withdrawal by Subject|0|||
130471988|NCT04586920|469695548|FG001|Overall Study|Withdrawal by Subject|0|||
130725506|NCT00996892|470619338|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
130725507|NCT00996892|470619339|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
130471989|NCT04586920|469695549|FG002|Overall Study|Withdrawal by Subject|0|||
130471990|NCT04586920|469695550|FG003|Overall Study|Withdrawal by Subject|0|||
130471991|NCT04586920|469695551|FG004|Overall Study|Withdrawal by Subject|0|||
130471992|NCT04586920|469695552|FG005|Overall Study|Withdrawal by Subject|0|||
130471993|NCT04586920|469695553|FG006|Overall Study|Withdrawal by Subject|0|||
130471994|NCT04586920|469695554|FG007|Overall Study|Withdrawal by Subject|1|||
130471995|NCT04586920|469695555|FG008|Overall Study|Withdrawal by Subject|0|||
130471996|NCT04586920|469695556|FG009|Overall Study|Withdrawal by Subject|1|||
130471997|NCT04586920|469695557|FG010|Overall Study|Withdrawal by Subject|0|||
130471998|NCT04586920|469695558|FG011|Overall Study|Withdrawal by Subject|1|||
130471999|NCT04586920|469695559|FG012|Overall Study|Withdrawal by Subject|0|||
130472000|NCT04586920|469695560|FG013|Overall Study|Withdrawal by Subject|0|||
130472001|NCT04586920|469695561|FG014|Overall Study|Withdrawal by Subject|0|||
130472002|NCT04586920|469695562|FG015|Overall Study|Withdrawal by Subject|0|||
130472003|NCT04586920|469695563|FG016|Overall Study|Withdrawal by Subject|0|||
130472004|NCT04586920|469695564|FG017|Overall Study|Withdrawal by Subject|0|||
130472005|NCT02728557|469695569|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
130472006|NCT02728557|469695570|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
130472007|NCT02728557|469695569|FG000|Overall Study|Dissatisfaction with research tasks|0|||
130472008|NCT02728557|469695570|FG001|Overall Study|Dissatisfaction with research tasks|1|||
130472009|NCT02728557|469695569|FG000|Overall Study|Scheduling or change in availability|1|||
130472010|NCT02728557|469695570|FG001|Overall Study|Scheduling or change in availability|1|||
130472011|NCT03897686|469695571|FG000|Overall Study|Protocol Violation|1|||
130472012|NCT03897686|469695572|FG001|Overall Study|Protocol Violation|1|||
130472013|NCT03897686|469695571|FG000|Overall Study|Withdrawal by Subject|1|||
130472014|NCT03897686|469695572|FG001|Overall Study|Withdrawal by Subject|1|||
130472015|NCT03416010|469695573|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
130472016|NCT03416010|469695574|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
130472017|NCT03416010|469695573|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
130472018|NCT03416010|469695574|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
130472019|NCT03416010|469695573|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
130472020|NCT03416010|469695574|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
130472021|NCT03416010|469695573|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
130472022|NCT03416010|469695574|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
130407305|NCT01609556|469453818|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407306|NCT01609556|469453819|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407307|NCT01609556|469453820|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407308|NCT01609556|469453821|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130407309|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407310|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407311|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407312|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407313|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407314|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407315|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130472023|NCT03416010|469695573|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
130407316|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407317|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130472024|NCT03416010|469695574|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
130561426|NCT00467779|470024770|FG004|Stage 2A|Death|0|||
130472025|NCT03416010|469695573|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
130472026|NCT03416010|469695574|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
130472027|NCT03416010|469695573|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
130472028|NCT03416010|469695574|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
130472029|NCT05415436|469695575|FG000|Overall Study|Surgeon cancelled procedure|1|||
130472030|NCT05415436|469695576|FG001|Overall Study|Surgeon cancelled procedure|0|||
130472031|NCT05415436|469695575|FG000|Overall Study|Death|1|||
130472032|NCT05415436|469695576|FG001|Overall Study|Death|0|||
130472033|NCT03819686|469695586|FG000|Overall Study|Lost to Follow-up|2|||
130472034|NCT03819686|469695587|FG001|Overall Study|Lost to Follow-up|3|||
130472035|NCT03157167|469695598|FG000|Overall Study|Withdrawal by Subject|1|||
130472036|NCT03157167|469695599|FG001|Overall Study|Withdrawal by Subject|0|||
130561427|NCT00467779|470024771|FG005|Stage 2A|Death|0|||
130472037|NCT03157167|469695600|FG002|Overall Study|Withdrawal by Subject|0|||
130472038|NCT02840474|469695606|FG000|Overall Study|Lost to Follow-up|1|||
130472039|NCT02840474|469695607|FG001|Overall Study|Lost to Follow-up|0|||
130472040|NCT03655132|469695608|FG000|Overall Study|Lost to Follow-up|2|||
130472041|NCT03655132|469695609|FG001|Overall Study|Lost to Follow-up|1|||
130472042|NCT03655132|469695608|FG000|Overall Study|Withdrawal by Subject|0|||
130472043|NCT03655132|469695609|FG001|Overall Study|Withdrawal by Subject|1|||
130472044|NCT03655132|469695608|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
130472045|NCT03655132|469695609|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
130472046|NCT00650104|469695616|FG000|Overall Study|Adverse Event|17|||
130472047|NCT00650104|469695616|FG000|Overall Study|Death|2|||
130472048|NCT00650104|469695616|FG000|Overall Study|Withdrawal by Subject|11|||
130472049|NCT00650104|469695616|FG000|Overall Study|Physician Decision|7|||
130472050|NCT00650104|469695616|FG000|Overall Study|Lost to Follow-up|1|||
130472051|NCT00650104|469695616|FG000|Overall Study|Non-compliance|2|||
130472052|NCT00650104|469695616|FG000|Overall Study|Sponsor Terminated Dosing|1|||
130472053|NCT01376700|469695617|FG000|Overall Study|Sponsor terminated study early|8|||
130472054|NCT01376700|469695617|FG000|Overall Study|Low or high titer inhibitor|8|||
130472055|NCT00601900|469695629|FG000|Overall Study|Withdrawal by Subject|0|||
130472056|NCT00601900|469695630|FG001|Overall Study|Withdrawal by Subject|3|||
130472057|NCT02500758|469695639|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
130472058|NCT02500758|469695640|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
130472059|NCT02500758|469695639|FG000|Washout (1 Week)|Lost to Follow-up|2|||
130472060|NCT02500758|469695640|FG001|Washout (1 Week)|Lost to Follow-up|2|||
130472061|NCT02500758|469695639|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
130472062|NCT02500758|469695640|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
130472063|NCT02500758|469695639|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
130472064|NCT02500758|469695640|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
130472065|NCT02500758|469695639|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
130472066|NCT02500758|469695640|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
130472067|NCT00274469|469695641|FG000|Overall Study|Death|63|||
130472068|NCT00274469|469695642|FG001|Overall Study|Death|74|||
130472069|NCT00274469|469695641|FG000|Overall Study|Did not consent to OS follow-up|16|||
130472070|NCT00274469|469695642|FG001|Overall Study|Did not consent to OS follow-up|19|||
130472071|NCT04093752|469695646|FG000|Overall Study|Adverse Event|7|||
130472072|NCT04093752|469695647|FG001|Overall Study|Adverse Event|19|||
130472073|NCT04093752|469695648|FG002|Overall Study|Adverse Event|18|||
130472074|NCT04093752|469695649|FG003|Overall Study|Adverse Event|4|||
130472075|NCT04093752|469695646|FG000|Overall Study|Withdrawal by Subject|6|||
130472076|NCT04093752|469695647|FG001|Overall Study|Withdrawal by Subject|6|||
130472077|NCT04093752|469695648|FG002|Overall Study|Withdrawal by Subject|8|||
130472078|NCT04093752|469695649|FG003|Overall Study|Withdrawal by Subject|20|||
130472079|NCT04093752|469695646|FG000|Overall Study|Lost to Follow-up|2|||
130472080|NCT04093752|469695647|FG001|Overall Study|Lost to Follow-up|1|||
130472081|NCT04093752|469695648|FG002|Overall Study|Lost to Follow-up|1|||
130472082|NCT04093752|469695649|FG003|Overall Study|Lost to Follow-up|1|||
130472083|NCT04093752|469695646|FG000|Overall Study|Death|0|||
130472084|NCT04093752|469695647|FG001|Overall Study|Death|0|||
130472085|NCT04093752|469695648|FG002|Overall Study|Death|1|||
130472086|NCT04093752|469695649|FG003|Overall Study|Death|2|||
130472087|NCT04093752|469695646|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
130472088|NCT04093752|469695647|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
130472089|NCT04093752|469695648|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
130472090|NCT04093752|469695649|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
130472091|NCT04093752|469695646|FG000|Overall Study|Covid 19|0|||
130472092|NCT04093752|469695647|FG001|Overall Study|Covid 19|0|||
130561428|NCT00467779|470024772|FG006|Stage 2A|Death|0|||
130472093|NCT04093752|469695648|FG002|Overall Study|Covid 19|0|||
130472094|NCT04093752|469695649|FG003|Overall Study|Covid 19|1|||
130472095|NCT04093752|469695646|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
130472096|NCT04093752|469695647|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
130561429|NCT00467779|470024773|FG007|Stage 2A|Death|0|||
130561430|NCT00467779|470024774|FG008|Stage 2A|Death|0|||
130561431|NCT00467779|470024775|FG009|Stage 2A|Death|0|||
130561432|NCT00467779|470024776|FG010|Stage 2A|Death|0|||
130561433|NCT00467779|470024777|FG011|Stage 2A|Death|0|||
130561434|NCT00467779|470024778|FG012|Stage 2A|Death|0|||
130561435|NCT00467779|470024779|FG013|Stage 2A|Death|1|||
130561436|NCT00467779|470024780|FG014|Stage 2A|Death|0|||
130561437|NCT00467779|470024766|FG000|Stage 2A|Disease Progression|0|||
130561438|NCT00467779|470024767|FG001|Stage 2A|Disease Progression|0|||
130561439|NCT00467779|470024768|FG002|Stage 2A|Disease Progression|0|||
130407318|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407319|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407320|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130407321|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
130407322|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130407323|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130407324|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130407325|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407326|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407327|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407328|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407329|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407330|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407331|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407332|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407333|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407334|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407335|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407336|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130407337|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
130407338|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
130407339|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
130407340|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
130407341|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407342|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407343|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130561440|NCT00467779|470024769|FG003|Stage 2A|Disease Progression|0|||
130561441|NCT00467779|470024770|FG004|Stage 2A|Disease Progression|0|||
130725508|NCT00996892|470619340|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
130407344|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407345|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407346|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407347|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407348|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407349|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407350|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407351|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407352|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130407353|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130407354|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130407355|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130407356|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
130407357|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407358|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407359|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407360|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407361|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407362|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407363|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407364|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407365|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407366|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407367|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407368|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407369|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
130407370|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130561442|NCT00467779|470024771|FG005|Stage 2A|Disease Progression|0|||
130561443|NCT00467779|470024772|FG006|Stage 2A|Disease Progression|0|||
130407371|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407372|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130407373|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407374|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407375|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407376|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407377|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407378|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407379|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407380|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407381|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407382|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407383|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407384|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130407385|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
130407386|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
130407387|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
130407388|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
130407389|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407390|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407391|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407392|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407393|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407394|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407395|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407396|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407397|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407398|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407399|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407400|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407401|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407402|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407403|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130407404|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
130407405|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407406|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407407|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407408|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407409|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407410|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407411|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407412|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407413|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407414|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407415|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407416|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407417|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
130407418|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
130407419|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
130407420|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
130407421|NCT01609556|469453806|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130472097|NCT04093752|469695648|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
130472098|NCT04093752|469695649|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
130472099|NCT04093752|469695646|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
130472100|NCT04093752|469695647|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
130472101|NCT04093752|469695648|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
130472102|NCT04093752|469695649|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
130472103|NCT04093752|469695646|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
130472104|NCT04093752|469695647|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
130472105|NCT04093752|469695648|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
130472106|NCT04093752|469695649|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
130472107|NCT00593489|469695652|FG000|Allocation|did not attend workshop; allocation not|2|||
130472108|NCT00593489|469695653|FG001|Allocation|did not attend workshop; allocation not|1|||
130472109|NCT02742519|469695654|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
130472110|NCT02742519|469695655|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
130472111|NCT02742519|469695656|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
130407422|NCT01609556|469453807|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407423|NCT01609556|469453808|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407424|NCT01609556|469453809|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407425|NCT01609556|469453810|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407426|NCT01609556|469453811|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407427|NCT01609556|469453812|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407428|NCT01609556|469453813|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407429|NCT01609556|469453814|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407430|NCT01609556|469453815|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407431|NCT01609556|469453816|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407432|NCT01609556|469453817|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407433|NCT01609556|469453818|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
130407434|NCT01609556|469453819|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407435|NCT01609556|469453820|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407436|NCT01609556|469453821|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130407437|NCT03964454|469453825|FG000|Overall Study|Lost to Follow-up|13|||
130561444|NCT00467779|470024773|FG007|Stage 2A|Disease Progression|0|||
130561445|NCT00467779|470024774|FG008|Stage 2A|Disease Progression|0|||
130561446|NCT00467779|470024775|FG009|Stage 2A|Disease Progression|0|||
130725509|NCT00996892|470619341|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
130725510|NCT00996892|470619342|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
130725511|NCT00996892|470619343|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
130725512|NCT00996892|470619324|FG000|Expansion Stage 2|Adverse Event|0|||
130725513|NCT00996892|470619325|FG001|Expansion Stage 2|Adverse Event|0|||
130725514|NCT00996892|470619326|FG002|Expansion Stage 2|Adverse Event|0|||
130725515|NCT00996892|470619327|FG003|Expansion Stage 2|Adverse Event|0|||
130725516|NCT00996892|470619328|FG004|Expansion Stage 2|Adverse Event|0|||
130725517|NCT00996892|470619329|FG005|Expansion Stage 2|Adverse Event|0|||
130725518|NCT00996892|470619330|FG006|Expansion Stage 2|Adverse Event|0|||
130725519|NCT00996892|470619331|FG007|Expansion Stage 2|Adverse Event|0|||
130725520|NCT00996892|470619332|FG008|Expansion Stage 2|Adverse Event|0|||
130725521|NCT00996892|470619333|FG009|Expansion Stage 2|Adverse Event|0|||
130725522|NCT00996892|470619334|FG010|Expansion Stage 2|Adverse Event|0|||
130725523|NCT00996892|470619335|FG011|Expansion Stage 2|Adverse Event|0|||
130725524|NCT00996892|470619336|FG012|Expansion Stage 2|Adverse Event|0|||
130725525|NCT00996892|470619337|FG013|Expansion Stage 2|Adverse Event|0|||
130725526|NCT00996892|470619338|FG014|Expansion Stage 2|Adverse Event|0|||
130725527|NCT00996892|470619339|FG015|Expansion Stage 2|Adverse Event|0|||
130725528|NCT00996892|470619340|FG016|Expansion Stage 2|Adverse Event|0|||
130725529|NCT00996892|470619341|FG017|Expansion Stage 2|Adverse Event|0|||
130725530|NCT00996892|470619342|FG018|Expansion Stage 2|Adverse Event|3|||
130725531|NCT00996892|470619343|FG019|Expansion Stage 2|Adverse Event|0|||
130725532|NCT00996892|470619324|FG000|Expansion Stage 2|Death|0|||
130725533|NCT00996892|470619325|FG001|Expansion Stage 2|Death|0|||
130725534|NCT00996892|470619326|FG002|Expansion Stage 2|Death|0|||
130725535|NCT00996892|470619327|FG003|Expansion Stage 2|Death|0|||
130725536|NCT00996892|470619328|FG004|Expansion Stage 2|Death|0|||
130725537|NCT00996892|470619329|FG005|Expansion Stage 2|Death|0|||
130725538|NCT00996892|470619330|FG006|Expansion Stage 2|Death|0|||
130725539|NCT00996892|470619331|FG007|Expansion Stage 2|Death|0|||
130725540|NCT00996892|470619332|FG008|Expansion Stage 2|Death|0|||
130725541|NCT00996892|470619333|FG009|Expansion Stage 2|Death|0|||
130725542|NCT00996892|470619334|FG010|Expansion Stage 2|Death|0|||
130725543|NCT00996892|470619335|FG011|Expansion Stage 2|Death|0|||
130725544|NCT00996892|470619336|FG012|Expansion Stage 2|Death|0|||
130725545|NCT00996892|470619337|FG013|Expansion Stage 2|Death|0|||
130725546|NCT00996892|470619338|FG014|Expansion Stage 2|Death|0|||
130725547|NCT00996892|470619339|FG015|Expansion Stage 2|Death|0|||
130725548|NCT00996892|470619340|FG016|Expansion Stage 2|Death|0|||
130725549|NCT00996892|470619341|FG017|Expansion Stage 2|Death|0|||
130725550|NCT00996892|470619342|FG018|Expansion Stage 2|Death|2|||
130472112|NCT02742519|469695654|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
130472113|NCT02742519|469695655|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
130472114|NCT02742519|469695656|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
130472115|NCT02742519|469695654|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
130472116|NCT02742519|469695655|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
130472117|NCT02742519|469695656|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
130472118|NCT02759016|469695658|FG000|Overall Study|Not treated with BI 836826|1|||
130725551|NCT00996892|470619343|FG019|Expansion Stage 2|Death|0|||
130725552|NCT00996892|470619324|FG000|Expansion Stage 2|Physician Decision|0|||
130725553|NCT00996892|470619325|FG001|Expansion Stage 2|Physician Decision|0|||
130725554|NCT00996892|470619326|FG002|Expansion Stage 2|Physician Decision|0|||
130725555|NCT00996892|470619327|FG003|Expansion Stage 2|Physician Decision|0|||
130725556|NCT00996892|470619328|FG004|Expansion Stage 2|Physician Decision|0|||
130725557|NCT00996892|470619329|FG005|Expansion Stage 2|Physician Decision|0|||
130725558|NCT00996892|470619330|FG006|Expansion Stage 2|Physician Decision|0|||
130725559|NCT00996892|470619331|FG007|Expansion Stage 2|Physician Decision|0|||
130725560|NCT00996892|470619332|FG008|Expansion Stage 2|Physician Decision|0|||
130725561|NCT00996892|470619333|FG009|Expansion Stage 2|Physician Decision|0|||
130725562|NCT00996892|470619334|FG010|Expansion Stage 2|Physician Decision|0|||
130725563|NCT00996892|470619335|FG011|Expansion Stage 2|Physician Decision|0|||
130725564|NCT00996892|470619336|FG012|Expansion Stage 2|Physician Decision|0|||
130725565|NCT00996892|470619337|FG013|Expansion Stage 2|Physician Decision|0|||
130725566|NCT00996892|470619338|FG014|Expansion Stage 2|Physician Decision|0|||
130725567|NCT00996892|470619339|FG015|Expansion Stage 2|Physician Decision|0|||
130725568|NCT00996892|470619340|FG016|Expansion Stage 2|Physician Decision|0|||
130725569|NCT00996892|470619341|FG017|Expansion Stage 2|Physician Decision|0|||
130725570|NCT00996892|470619342|FG018|Expansion Stage 2|Physician Decision|1|||
130725571|NCT00996892|470619343|FG019|Expansion Stage 2|Physician Decision|0|||
130725572|NCT00996892|470619324|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
130725573|NCT00996892|470619325|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
130725574|NCT00996892|470619326|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
130725575|NCT00996892|470619327|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
130725576|NCT00996892|470619328|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
130725577|NCT00996892|470619329|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
130725578|NCT00996892|470619330|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
130725579|NCT00996892|470619331|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
130407438|NCT03964454|469453826|FG001|Overall Study|Lost to Follow-up|7|||
130407439|NCT03964454|469453825|FG000|Overall Study|Withdrawal by Subject|4|||
130407440|NCT03964454|469453826|FG001|Overall Study|Withdrawal by Subject|11|||
130407441|NCT01076400|469455714|FG000|Overall Study|Adverse Event|2|||
130407442|NCT01076400|469455715|FG001|Overall Study|Adverse Event|0|||
130407443|NCT01076400|469455716|FG002|Overall Study|Adverse Event|0|||
130407444|NCT01076400|469455714|FG000|Overall Study|Progressive Disease|5|||
130407445|NCT01076400|469455715|FG001|Overall Study|Progressive Disease|0|||
130407446|NCT01076400|469455716|FG002|Overall Study|Progressive Disease|0|||
130407447|NCT03019536|469455718|FG000|Overall Study|Withdrawal by Subject|1|||
130407448|NCT03019536|469455719|FG001|Overall Study|Withdrawal by Subject|1|||
130407449|NCT03019536|469455720|FG002|Overall Study|Withdrawal by Subject|0|||
130407450|NCT03019536|469455718|FG000|Overall Study|Adverse Event|0|||
130472119|NCT02759016|469695659|FG001|Overall Study|Not treated with BI 836826|0|||
130472120|NCT02759016|469695658|FG000|Overall Study|Progressive disease|1|||
130472121|NCT02759016|469695659|FG001|Overall Study|Progressive disease|0|||
130472122|NCT02759016|469695658|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
130472123|NCT02759016|469695659|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
130472124|NCT02759016|469695658|FG000|Overall Study|Other not defined above|2|||
130472125|NCT02759016|469695659|FG001|Overall Study|Other not defined above|1|||
130472126|NCT04377308|469695660|FG000|Overall Study|Withdrawal by Subject|0|||
130472127|NCT04377308|469695661|FG001|Overall Study|Withdrawal by Subject|1|||
130472128|NCT03580369|469695662|FG000|Overall Study|No treatment due to mis-randomization|1|||
130472129|NCT03580369|469695663|FG001|Overall Study|No treatment due to mis-randomization|0|||
130472130|NCT03580369|469695664|FG002|Overall Study|No treatment due to mis-randomization|0|||
130472131|NCT03580369|469695665|FG003|Overall Study|No treatment due to mis-randomization|0|||
130472132|NCT03580369|469695666|FG004|Overall Study|No treatment due to mis-randomization|3|||
130472133|NCT03580369|469695667|FG005|Overall Study|No treatment due to mis-randomization|0|||
130472134|NCT03580369|469695668|FG006|Overall Study|No treatment due to mis-randomization|0|||
130472135|NCT03580369|469695669|FG007|Overall Study|No treatment due to mis-randomization|0|||
130472136|NCT03580369|469695662|FG000|Overall Study|Reason unknown|0|||
130472137|NCT03580369|469695663|FG001|Overall Study|Reason unknown|0|||
130472138|NCT03580369|469695664|FG002|Overall Study|Reason unknown|1|||
130472139|NCT03580369|469695665|FG003|Overall Study|Reason unknown|0|||
130472140|NCT03580369|469695666|FG004|Overall Study|Reason unknown|0|||
130472141|NCT03580369|469695667|FG005|Overall Study|Reason unknown|0|||
130472142|NCT03580369|469695668|FG006|Overall Study|Reason unknown|0|||
130472143|NCT03580369|469695669|FG007|Overall Study|Reason unknown|0|||
130472144|NCT03580369|469695662|FG000|Overall Study|Technical problems|0|||
130472145|NCT03580369|469695663|FG001|Overall Study|Technical problems|0|||
130472146|NCT03580369|469695664|FG002|Overall Study|Technical problems|0|||
130472147|NCT03580369|469695665|FG003|Overall Study|Technical problems|0|||
130472148|NCT03580369|469695666|FG004|Overall Study|Technical problems|1|||
130472149|NCT03580369|469695667|FG005|Overall Study|Technical problems|0|||
130472150|NCT03580369|469695668|FG006|Overall Study|Technical problems|2|||
130472151|NCT03580369|469695669|FG007|Overall Study|Technical problems|0|||
130472152|NCT03580369|469695662|FG000|Overall Study|Pregnancy|2|||
130472153|NCT03580369|469695663|FG001|Overall Study|Pregnancy|0|||
130472154|NCT03580369|469695664|FG002|Overall Study|Pregnancy|3|||
130472155|NCT03580369|469695665|FG003|Overall Study|Pregnancy|0|||
130472156|NCT03580369|469695666|FG004|Overall Study|Pregnancy|2|||
130472157|NCT03580369|469695667|FG005|Overall Study|Pregnancy|0|||
130472158|NCT03580369|469695668|FG006|Overall Study|Pregnancy|0|||
130472159|NCT03580369|469695669|FG007|Overall Study|Pregnancy|0|||
130472160|NCT03580369|469695662|FG000|Overall Study|Lost to Follow-up|2|||
130472161|NCT03580369|469695663|FG001|Overall Study|Lost to Follow-up|0|||
130472162|NCT03580369|469695664|FG002|Overall Study|Lost to Follow-up|2|||
130725580|NCT00996892|470619332|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
130725581|NCT00996892|470619333|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
130725582|NCT00996892|470619334|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
130725583|NCT00996892|470619335|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
130725584|NCT00996892|470619336|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
130407451|NCT03019536|469455719|FG001|Overall Study|Adverse Event|0|||
130407452|NCT03019536|469455720|FG002|Overall Study|Adverse Event|2|||
130407453|NCT00182689|469455728|FG000|Overall Study|Adverse Event|8|||
130472163|NCT03580369|469695665|FG003|Overall Study|Lost to Follow-up|0|||
130472164|NCT03580369|469695666|FG004|Overall Study|Lost to Follow-up|3|||
130472165|NCT03580369|469695667|FG005|Overall Study|Lost to Follow-up|0|||
130472166|NCT03580369|469695668|FG006|Overall Study|Lost to Follow-up|1|||
130472167|NCT03580369|469695669|FG007|Overall Study|Lost to Follow-up|0|||
130407454|NCT00182689|469455729|FG001|Overall Study|Adverse Event|11|||
130472168|NCT03580369|469695662|FG000|Overall Study|Physician Decision|4|||
130472169|NCT03580369|469695663|FG001|Overall Study|Physician Decision|0|||
130472170|NCT03580369|469695664|FG002|Overall Study|Physician Decision|4|||
130472171|NCT03580369|469695665|FG003|Overall Study|Physician Decision|1|||
130472172|NCT03580369|469695666|FG004|Overall Study|Physician Decision|1|||
130472173|NCT03580369|469695667|FG005|Overall Study|Physician Decision|0|||
130725585|NCT00996892|470619337|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
130725586|NCT00996892|470619338|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
130725587|NCT00996892|470619339|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
130725588|NCT00996892|470619340|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
130725589|NCT00996892|470619341|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
130725590|NCT00996892|470619342|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
130725591|NCT00996892|470619343|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
130725592|NCT00996892|470619324|FG000|Expansion Stage 2|Disease Progression|0|||
130725593|NCT00996892|470619325|FG001|Expansion Stage 2|Disease Progression|0|||
130725594|NCT00996892|470619326|FG002|Expansion Stage 2|Disease Progression|0|||
130725595|NCT00996892|470619327|FG003|Expansion Stage 2|Disease Progression|0|||
130725596|NCT00996892|470619328|FG004|Expansion Stage 2|Disease Progression|0|||
130725597|NCT00996892|470619329|FG005|Expansion Stage 2|Disease Progression|0|||
130725598|NCT00996892|470619330|FG006|Expansion Stage 2|Disease Progression|0|||
130725599|NCT00996892|470619331|FG007|Expansion Stage 2|Disease Progression|0|||
130725600|NCT00996892|470619332|FG008|Expansion Stage 2|Disease Progression|0|||
130725601|NCT00996892|470619333|FG009|Expansion Stage 2|Disease Progression|0|||
130725602|NCT00996892|470619334|FG010|Expansion Stage 2|Disease Progression|0|||
130725603|NCT00996892|470619335|FG011|Expansion Stage 2|Disease Progression|0|||
130725604|NCT00996892|470619336|FG012|Expansion Stage 2|Disease Progression|0|||
130725605|NCT00996892|470619337|FG013|Expansion Stage 2|Disease Progression|0|||
130725606|NCT00996892|470619338|FG014|Expansion Stage 2|Disease Progression|0|||
130725607|NCT00996892|470619339|FG015|Expansion Stage 2|Disease Progression|0|||
130725608|NCT00996892|470619340|FG016|Expansion Stage 2|Disease Progression|0|||
130725609|NCT00996892|470619341|FG017|Expansion Stage 2|Disease Progression|0|||
130725610|NCT00996892|470619342|FG018|Expansion Stage 2|Disease Progression|28|||
130725611|NCT00996892|470619343|FG019|Expansion Stage 2|Disease Progression|0|||
130407455|NCT00182689|469455728|FG000|Overall Study|Withdrawal by Subject|2|||
130407456|NCT00182689|469455729|FG001|Overall Study|Withdrawal by Subject|2|||
130407457|NCT00182689|469455728|FG000|Overall Study|Progression|27|||
130407458|NCT00182689|469455729|FG001|Overall Study|Progression|29|||
130407459|NCT00182689|469455728|FG000|Overall Study|Death|1|||
130407460|NCT00182689|469455729|FG001|Overall Study|Death|0|||
130407461|NCT00182689|469455728|FG000|Overall Study|not protocol specified|0|||
130407462|NCT00182689|469455729|FG001|Overall Study|not protocol specified|3|||
130407463|NCT00182689|469455728|FG000|Overall Study|Ineligible|1|||
130407464|NCT00182689|469455729|FG001|Overall Study|Ineligible|4|||
130407465|NCT00182689|469455728|FG000|Overall Study|Never received treatment|1|||
130407466|NCT00182689|469455729|FG001|Overall Study|Never received treatment|0|||
130407467|NCT00201006|469455730|FG000|Overall Study|Withdrawal by Subject|7|||
130407468|NCT00201006|469455731|FG001|Overall Study|Withdrawal by Subject|2|||
130407469|NCT00201006|469455732|FG002|Overall Study|Withdrawal by Subject|3|||
130407470|NCT00201006|469455730|FG000|Overall Study|Adverse Event|1|||
130407471|NCT00201006|469455731|FG001|Overall Study|Adverse Event|0|||
130407472|NCT00201006|469455732|FG002|Overall Study|Adverse Event|1|||
130407473|NCT01040871|469455733|FG000|Overall Study|Adverse Event|6|||
130407474|NCT01040871|469455734|FG001|Overall Study|Adverse Event|2|||
130407475|NCT01040871|469455733|FG000|Overall Study|Withdrawal by Subject|2|||
130407476|NCT01040871|469455734|FG001|Overall Study|Withdrawal by Subject|0|||
130407477|NCT01040871|469455733|FG000|Overall Study|Death|1|||
130561447|NCT00467779|470024776|FG010|Stage 2A|Disease Progression|0|||
130561448|NCT00467779|470024777|FG011|Stage 2A|Disease Progression|0|||
130561449|NCT00467779|470024778|FG012|Stage 2A|Disease Progression|0|||
130561450|NCT00467779|470024779|FG013|Stage 2A|Disease Progression|10|||
130561451|NCT00467779|470024780|FG014|Stage 2A|Disease Progression|0|||
130561452|NCT00467779|470024766|FG000|Stage 2A|Unspecified Reason|0|||
130561453|NCT00467779|470024767|FG001|Stage 2A|Unspecified Reason|0|||
130561454|NCT00467779|470024768|FG002|Stage 2A|Unspecified Reason|0|||
130561455|NCT00467779|470024769|FG003|Stage 2A|Unspecified Reason|0|||
130561456|NCT00467779|470024770|FG004|Stage 2A|Unspecified Reason|0|||
130561457|NCT00467779|470024771|FG005|Stage 2A|Unspecified Reason|0|||
130561458|NCT00467779|470024772|FG006|Stage 2A|Unspecified Reason|0|||
130725612|NCT00996892|470619324|FG000|Expansion Stage 2A|Adverse Event|0|||
130725613|NCT00996892|470619325|FG001|Expansion Stage 2A|Adverse Event|0|||
130725614|NCT00996892|470619326|FG002|Expansion Stage 2A|Adverse Event|0|||
130725615|NCT00996892|470619327|FG003|Expansion Stage 2A|Adverse Event|0|||
130407478|NCT01040871|469455734|FG001|Overall Study|Death|3|||
130407479|NCT01040871|469455733|FG000|Overall Study|Lack of Efficacy|1|||
130407480|NCT01040871|469455734|FG001|Overall Study|Lack of Efficacy|1|||
130407481|NCT01040871|469455733|FG000|Overall Study|drug supply issue|1|||
130407482|NCT01040871|469455734|FG001|Overall Study|drug supply issue|0|||
130561459|NCT00467779|470024773|FG007|Stage 2A|Unspecified Reason|0|||
130725616|NCT00996892|470619328|FG004|Expansion Stage 2A|Adverse Event|0|||
130725617|NCT00996892|470619329|FG005|Expansion Stage 2A|Adverse Event|0|||
130725618|NCT00996892|470619330|FG006|Expansion Stage 2A|Adverse Event|0|||
130725619|NCT00996892|470619331|FG007|Expansion Stage 2A|Adverse Event|0|||
130725620|NCT00996892|470619332|FG008|Expansion Stage 2A|Adverse Event|0|||
130725621|NCT00996892|470619333|FG009|Expansion Stage 2A|Adverse Event|0|||
130725622|NCT00996892|470619334|FG010|Expansion Stage 2A|Adverse Event|0|||
130725623|NCT00996892|470619335|FG011|Expansion Stage 2A|Adverse Event|0|||
130472174|NCT03580369|469695668|FG006|Overall Study|Physician Decision|0|||
130407483|NCT01040871|469455733|FG000|Overall Study|Randomized and Not Treated|2|||
130407484|NCT01040871|469455734|FG001|Overall Study|Randomized and Not Treated|1|||
130407485|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
130407486|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
130407487|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
130407488|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
130407489|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Death|235|||
130407490|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Death|167|||
130407491|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Death|1|||
130407492|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Death|0|||
130407493|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
130407494|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
130407495|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
130407496|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
130407497|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
130407498|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
130407499|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
130407500|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
130407501|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Other|1|||
130407502|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Other|2|||
130407503|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Other|0|||
130407504|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Other|0|||
130407505|NCT00673049|469455738|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
130407506|NCT00673049|469455739|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
130407507|NCT00673049|469455740|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
130407508|NCT00673049|469455741|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
130407509|NCT00673049|469455738|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
130407510|NCT00673049|469455739|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
130407511|NCT00673049|469455740|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
130407512|NCT00673049|469455741|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
130407513|NCT00673049|469455738|FG000|After Progression on Erlotinib|Death|0|||
130407514|NCT00673049|469455739|FG001|After Progression on Erlotinib|Death|0|||
130407515|NCT00673049|469455740|FG002|After Progression on Erlotinib|Death|0|||
130407516|NCT00673049|469455741|FG003|After Progression on Erlotinib|Death|71|||
130407517|NCT00673049|469455738|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
130407518|NCT00673049|469455739|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
130407519|NCT00673049|469455740|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
130407520|NCT00673049|469455741|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
130407521|NCT00673049|469455738|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
130407522|NCT00673049|469455739|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
130407523|NCT00673049|469455740|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
130407524|NCT00673049|469455741|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
130407525|NCT00673049|469455738|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
130407526|NCT00673049|469455739|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
130407527|NCT00673049|469455740|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
130472175|NCT03580369|469695669|FG007|Overall Study|Physician Decision|0|||
130472176|NCT03580369|469695662|FG000|Overall Study|Lack of Efficacy|3|||
130472177|NCT03580369|469695663|FG001|Overall Study|Lack of Efficacy|0|||
130472178|NCT03580369|469695664|FG002|Overall Study|Lack of Efficacy|7|||
130472179|NCT03580369|469695665|FG003|Overall Study|Lack of Efficacy|0|||
130472180|NCT03580369|469695666|FG004|Overall Study|Lack of Efficacy|2|||
130472181|NCT03580369|469695667|FG005|Overall Study|Lack of Efficacy|0|||
130472182|NCT03580369|469695668|FG006|Overall Study|Lack of Efficacy|3|||
130472183|NCT03580369|469695669|FG007|Overall Study|Lack of Efficacy|0|||
130472184|NCT03580369|469695662|FG000|Overall Study|Protocol Violation|6|||
130472185|NCT03580369|469695663|FG001|Overall Study|Protocol Violation|0|||
130725624|NCT00996892|470619336|FG012|Expansion Stage 2A|Adverse Event|0|||
130725625|NCT00996892|470619337|FG013|Expansion Stage 2A|Adverse Event|0|||
130407528|NCT00673049|469455741|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
130407529|NCT00924950|469455742|FG000|Overall Study|Lost to Follow-up|2|||
130407530|NCT04193202|469455743|FG000|Overall Study|Adverse Event|2|||
130407531|NCT04193202|469455744|FG001|Overall Study|Adverse Event|1|||
130407532|NCT04193202|469455743|FG000|Overall Study|Death|0|||
130472186|NCT03580369|469695664|FG002|Overall Study|Protocol Violation|6|||
130472187|NCT03580369|469695665|FG003|Overall Study|Protocol Violation|1|||
130407533|NCT04193202|469455744|FG001|Overall Study|Death|1|||
130407534|NCT04193202|469455743|FG000|Overall Study|Physician Decision|1|||
130472188|NCT03580369|469695666|FG004|Overall Study|Protocol Violation|8|||
130472189|NCT03580369|469695667|FG005|Overall Study|Protocol Violation|2|||
130472190|NCT03580369|469695668|FG006|Overall Study|Protocol Violation|1|||
130472191|NCT03580369|469695669|FG007|Overall Study|Protocol Violation|0|||
130725626|NCT00996892|470619338|FG014|Expansion Stage 2A|Adverse Event|0|||
130407535|NCT04193202|469455744|FG001|Overall Study|Physician Decision|1|||
130407536|NCT04193202|469455743|FG000|Overall Study|Protocol Violation|2|||
130407537|NCT04193202|469455744|FG001|Overall Study|Protocol Violation|2|||
130407538|NCT04193202|469455743|FG000|Overall Study|Withdrawal by Subject|11|||
130407539|NCT04193202|469455744|FG001|Overall Study|Withdrawal by Subject|5|||
130407540|NCT02979535|469455745|FG000|Overall Study|Non compliance with the protocol|78|||
130407541|NCT02979535|469455746|FG001|Overall Study|Non compliance with the protocol|82|||
130407542|NCT02979535|469455745|FG000|Overall Study|Consent withdrawn by participant|11|||
130407543|NCT02979535|469455746|FG001|Overall Study|Consent withdrawn by participant|18|||
130407544|NCT02979535|469455745|FG000|Overall Study|Lost to Follow-up|6|||
130407545|NCT02979535|469455746|FG001|Overall Study|Lost to Follow-up|1|||
130407546|NCT02057757|469455753|FG000|Overall Study|Withdrawal by Subject|3|||
130407547|NCT02057757|469455754|FG001|Overall Study|Withdrawal by Subject|5|||
130407548|NCT02057757|469455753|FG000|Overall Study|Death|2|||
130407549|NCT02057757|469455754|FG001|Overall Study|Death|0|||
130407550|NCT02057757|469455753|FG000|Overall Study|Lost to Follow-up|8|||
130407551|NCT02057757|469455754|FG001|Overall Study|Lost to Follow-up|3|||
130407552|NCT02057757|469455753|FG000|Overall Study|Non-compliance|1|||
130407553|NCT02057757|469455754|FG001|Overall Study|Non-compliance|0|||
130407554|NCT03614793|469455755|FG000|Overall Study|Lost to Follow-up|1|||
130407555|NCT03614793|469455756|FG001|Overall Study|Lost to Follow-up|2|||
130407556|NCT03614793|469455755|FG000|Overall Study|Lack of Efficacy|0|||
130407557|NCT03614793|469455756|FG001|Overall Study|Lack of Efficacy|5|||
130407558|NCT03614793|469455755|FG000|Overall Study|Withdrawal by Subject|0|||
130407559|NCT03614793|469455756|FG001|Overall Study|Withdrawal by Subject|1|||
130407560|NCT03614793|469455755|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
130407561|NCT03614793|469455756|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
130407562|NCT02082522|469455757|FG000|Overall Study|Sponsor termination|5|||
130407563|NCT02082522|469455758|FG001|Overall Study|Sponsor termination|3|||
130407564|NCT02082522|469455757|FG000|Overall Study|Withdrawal by Subject|2|||
130407565|NCT02082522|469455758|FG001|Overall Study|Withdrawal by Subject|4|||
130407566|NCT02082522|469455757|FG000|Overall Study|Death|1|||
130407567|NCT02082522|469455758|FG001|Overall Study|Death|0|||
130407568|NCT02082522|469455757|FG000|Overall Study|Lost to Follow-up|1|||
130407569|NCT02082522|469455758|FG001|Overall Study|Lost to Follow-up|0|||
130407570|NCT02082522|469455757|FG000|Overall Study|Physician Decision|3|||
130407571|NCT02082522|469455758|FG001|Overall Study|Physician Decision|1|||
130407572|NCT02082522|469455757|FG000|Overall Study|Disease progression|2|||
130407573|NCT02082522|469455758|FG001|Overall Study|Disease progression|2|||
130407574|NCT02082522|469455757|FG000|Overall Study|Chemotherapy change|1|||
130407575|NCT02082522|469455758|FG001|Overall Study|Chemotherapy change|3|||
130407576|NCT00456092|469455759|FG000|Extension Phase|Grade 2 or Greater AE|2|||
130407577|NCT00456092|469455760|FG001|Extension Phase|Grade 2 or Greater AE|2|||
130407578|NCT00456092|469455761|FG002|Extension Phase|Grade 2 or Greater AE|0|||
130407579|NCT00456092|469455762|FG003|Extension Phase|Grade 2 or Greater AE|0|||
130407580|NCT00456092|469455763|FG004|Extension Phase|Grade 2 or Greater AE|2|||
130407581|NCT00456092|469455759|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
130407582|NCT00456092|469455760|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
130407583|NCT00456092|469455761|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
130407584|NCT00456092|469455762|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
130407585|NCT00456092|469455763|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
130407586|NCT00456092|469455759|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
130407587|NCT00456092|469455760|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
130407588|NCT00456092|469455761|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
130407589|NCT00456092|469455762|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
130407590|NCT00456092|469455763|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
130407591|NCT00456092|469455759|FG000|Extension Phase|Withdrew Consent|2|||
130407592|NCT00456092|469455760|FG001|Extension Phase|Withdrew Consent|0|||
130407593|NCT00456092|469455761|FG002|Extension Phase|Withdrew Consent|0|||
130407594|NCT00456092|469455762|FG003|Extension Phase|Withdrew Consent|0|||
130407595|NCT00456092|469455763|FG004|Extension Phase|Withdrew Consent|0|||
130407596|NCT00456092|469455759|FG000|Extension Phase|Lost to Follow-up|1|||
130407597|NCT00456092|469455760|FG001|Extension Phase|Lost to Follow-up|1|||
130407598|NCT00456092|469455761|FG002|Extension Phase|Lost to Follow-up|0|||
130725627|NCT00996892|470619339|FG015|Expansion Stage 2A|Adverse Event|0|||
130407599|NCT00456092|469455762|FG003|Extension Phase|Lost to Follow-up|0|||
130407600|NCT00456092|469455763|FG004|Extension Phase|Lost to Follow-up|1|||
130407601|NCT00456092|469455759|FG000|Extension Phase|Other|2|||
130407602|NCT00456092|469455760|FG001|Extension Phase|Other|0|||
130407603|NCT00456092|469455761|FG002|Extension Phase|Other|0|||
130407604|NCT00456092|469455762|FG003|Extension Phase|Other|1|||
130407605|NCT00456092|469455763|FG004|Extension Phase|Other|1|||
130407606|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
130407607|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
130407608|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
130725628|NCT00996892|470619340|FG016|Expansion Stage 2A|Adverse Event|0|||
130407609|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
130407610|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
130407611|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
130407612|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
130407613|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130407614|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130407615|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130407616|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
130407617|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130407618|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130407619|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130407620|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130407621|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130407622|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
130407623|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
130407624|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130407625|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130407626|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130407627|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
130407628|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
130407629|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130407630|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130407631|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
130407632|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
130407633|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
130407634|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
130407635|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
130407636|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130407637|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
130407638|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
130407639|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130407640|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130407641|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130407642|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130407643|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130407644|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130472192|NCT03580369|469695662|FG000|Overall Study|Adverse Event|7|||
130472193|NCT03580369|469695663|FG001|Overall Study|Adverse Event|0|||
130472194|NCT03580369|469695664|FG002|Overall Study|Adverse Event|14|||
130472195|NCT03580369|469695665|FG003|Overall Study|Adverse Event|1|||
130472196|NCT03580369|469695666|FG004|Overall Study|Adverse Event|6|||
130472197|NCT03580369|469695667|FG005|Overall Study|Adverse Event|0|||
130472198|NCT03580369|469695668|FG006|Overall Study|Adverse Event|1|||
130472199|NCT03580369|469695669|FG007|Overall Study|Adverse Event|0|||
130472200|NCT03580369|469695662|FG000|Overall Study|Withdrawal by Subject|19|||
130472201|NCT03580369|469695663|FG001|Overall Study|Withdrawal by Subject|0|||
130472202|NCT03580369|469695664|FG002|Overall Study|Withdrawal by Subject|17|||
130472203|NCT03580369|469695665|FG003|Overall Study|Withdrawal by Subject|0|||
130725629|NCT00996892|470619341|FG017|Expansion Stage 2A|Adverse Event|0|||
130725630|NCT00996892|470619342|FG018|Expansion Stage 2A|Adverse Event|0|||
130725631|NCT00996892|470619343|FG019|Expansion Stage 2A|Adverse Event|8|||
130725632|NCT00996892|470619324|FG000|Expansion Stage 2A|Physician Decision|0|||
130725633|NCT00996892|470619325|FG001|Expansion Stage 2A|Physician Decision|0|||
130725634|NCT00996892|470619326|FG002|Expansion Stage 2A|Physician Decision|0|||
130725635|NCT00996892|470619327|FG003|Expansion Stage 2A|Physician Decision|0|||
130725636|NCT00996892|470619328|FG004|Expansion Stage 2A|Physician Decision|0|||
130725637|NCT00996892|470619329|FG005|Expansion Stage 2A|Physician Decision|0|||
130725638|NCT00996892|470619330|FG006|Expansion Stage 2A|Physician Decision|0|||
130725639|NCT00996892|470619331|FG007|Expansion Stage 2A|Physician Decision|0|||
130725640|NCT00996892|470619332|FG008|Expansion Stage 2A|Physician Decision|0|||
130725641|NCT00996892|470619333|FG009|Expansion Stage 2A|Physician Decision|0|||
130725642|NCT00996892|470619334|FG010|Expansion Stage 2A|Physician Decision|0|||
130407645|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130725643|NCT00996892|470619335|FG011|Expansion Stage 2A|Physician Decision|0|||
130472204|NCT03580369|469695666|FG004|Overall Study|Withdrawal by Subject|16|||
130472205|NCT03580369|469695667|FG005|Overall Study|Withdrawal by Subject|1|||
130561460|NCT00467779|470024774|FG008|Stage 2A|Unspecified Reason|0|||
130725644|NCT00996892|470619336|FG012|Expansion Stage 2A|Physician Decision|0|||
130725645|NCT00996892|470619337|FG013|Expansion Stage 2A|Physician Decision|0|||
130725646|NCT00996892|470619338|FG014|Expansion Stage 2A|Physician Decision|0|||
130407646|NCT00456092|469455759|FG000|Treatment Phase (12 Weeks)|Other|1|||
130407647|NCT00456092|469455760|FG001|Treatment Phase (12 Weeks)|Other|0|||
130407648|NCT00456092|469455761|FG002|Treatment Phase (12 Weeks)|Other|1|||
130407649|NCT00456092|469455762|FG003|Treatment Phase (12 Weeks)|Other|0|||
130407650|NCT00456092|469455763|FG004|Treatment Phase (12 Weeks)|Other|0|||
130561461|NCT00467779|470024775|FG009|Stage 2A|Unspecified Reason|0|||
130561462|NCT00467779|470024776|FG010|Stage 2A|Unspecified Reason|0|||
130561463|NCT00467779|470024777|FG011|Stage 2A|Unspecified Reason|0|||
130561464|NCT00467779|470024778|FG012|Stage 2A|Unspecified Reason|0|||
130561465|NCT00467779|470024779|FG013|Stage 2A|Unspecified Reason|7|||
130561466|NCT00467779|470024780|FG014|Stage 2A|Unspecified Reason|0|||
130561467|NCT00467779|470024766|FG000|Stage 2A|Withdrawal by Subject|0|||
130561468|NCT00467779|470024767|FG001|Stage 2A|Withdrawal by Subject|0|||
130561469|NCT00467779|470024768|FG002|Stage 2A|Withdrawal by Subject|0|||
130561470|NCT00467779|470024769|FG003|Stage 2A|Withdrawal by Subject|0|||
130561471|NCT00467779|470024770|FG004|Stage 2A|Withdrawal by Subject|0|||
130561472|NCT00467779|470024771|FG005|Stage 2A|Withdrawal by Subject|0|||
130561473|NCT00467779|470024772|FG006|Stage 2A|Withdrawal by Subject|0|||
130561474|NCT00467779|470024773|FG007|Stage 2A|Withdrawal by Subject|0|||
130561475|NCT00467779|470024774|FG008|Stage 2A|Withdrawal by Subject|0|||
130561476|NCT00467779|470024775|FG009|Stage 2A|Withdrawal by Subject|0|||
130561477|NCT00467779|470024776|FG010|Stage 2A|Withdrawal by Subject|0|||
130561478|NCT00467779|470024777|FG011|Stage 2A|Withdrawal by Subject|0|||
130561479|NCT00467779|470024778|FG012|Stage 2A|Withdrawal by Subject|0|||
130561480|NCT00467779|470024779|FG013|Stage 2A|Withdrawal by Subject|1|||
130561481|NCT00467779|470024780|FG014|Stage 2A|Withdrawal by Subject|0|||
130561482|NCT00467779|470024766|FG000|Stage 3|Adverse Event|0|||
130561483|NCT00467779|470024767|FG001|Stage 3|Adverse Event|0|||
130561484|NCT00467779|470024768|FG002|Stage 3|Adverse Event|0|||
130561485|NCT00467779|470024769|FG003|Stage 3|Adverse Event|0|||
130561486|NCT00467779|470024770|FG004|Stage 3|Adverse Event|0|||
130561487|NCT00467779|470024771|FG005|Stage 3|Adverse Event|0|||
130561488|NCT00467779|470024772|FG006|Stage 3|Adverse Event|0|||
130561489|NCT00467779|470024773|FG007|Stage 3|Adverse Event|0|||
130561490|NCT00467779|470024774|FG008|Stage 3|Adverse Event|0|||
130561491|NCT00467779|470024775|FG009|Stage 3|Adverse Event|0|||
130561492|NCT00467779|470024776|FG010|Stage 3|Adverse Event|0|||
130561493|NCT00467779|470024777|FG011|Stage 3|Adverse Event|0|||
130561494|NCT00467779|470024778|FG012|Stage 3|Adverse Event|0|||
130561495|NCT00467779|470024779|FG013|Stage 3|Adverse Event|0|||
130561496|NCT00467779|470024780|FG014|Stage 3|Adverse Event|2|||
130561497|NCT00467779|470024766|FG000|Stage 3|Death|0|||
130561498|NCT00467779|470024767|FG001|Stage 3|Death|0|||
130561499|NCT00467779|470024768|FG002|Stage 3|Death|0|||
130561500|NCT00467779|470024769|FG003|Stage 3|Death|0|||
130561501|NCT00467779|470024770|FG004|Stage 3|Death|0|||
130561502|NCT00467779|470024771|FG005|Stage 3|Death|0|||
130725647|NCT00996892|470619339|FG015|Expansion Stage 2A|Physician Decision|0|||
130725648|NCT00996892|470619340|FG016|Expansion Stage 2A|Physician Decision|0|||
130725649|NCT00996892|470619341|FG017|Expansion Stage 2A|Physician Decision|0|||
130725650|NCT00996892|470619342|FG018|Expansion Stage 2A|Physician Decision|0|||
130725651|NCT00996892|470619343|FG019|Expansion Stage 2A|Physician Decision|2|||
130725652|NCT00996892|470619324|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
130725653|NCT00996892|470619325|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
130725654|NCT00996892|470619326|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
130725655|NCT00996892|470619327|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
130725656|NCT00996892|470619328|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
130725657|NCT00996892|470619329|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
130725658|NCT00996892|470619330|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
130725659|NCT00996892|470619331|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
130725660|NCT00996892|470619332|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
130725661|NCT00996892|470619333|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
130725662|NCT00996892|470619334|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
130725663|NCT00996892|470619335|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
130725664|NCT00996892|470619336|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
130561503|NCT00467779|470024772|FG006|Stage 3|Death|0|||
130561504|NCT00467779|470024773|FG007|Stage 3|Death|0|||
130561505|NCT00467779|470024774|FG008|Stage 3|Death|0|||
130725665|NCT00996892|470619337|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
130725666|NCT00996892|470619338|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
130725667|NCT00996892|470619339|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
130407651|NCT01168999|469455764|FG000|Overall Study|Lost to Follow-up|2|||
130407652|NCT01168999|469455765|FG001|Overall Study|Lost to Follow-up|1|||
130561506|NCT00467779|470024775|FG009|Stage 3|Death|0|||
130561507|NCT00467779|470024776|FG010|Stage 3|Death|0|||
130561508|NCT00467779|470024777|FG011|Stage 3|Death|0|||
130561509|NCT00467779|470024778|FG012|Stage 3|Death|0|||
130561510|NCT00467779|470024779|FG013|Stage 3|Death|0|||
130561511|NCT00467779|470024780|FG014|Stage 3|Death|1|||
130561512|NCT00467779|470024766|FG000|Stage 3|Disease Progression|0|||
130561513|NCT00467779|470024767|FG001|Stage 3|Disease Progression|0|||
130725668|NCT00996892|470619340|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
130725669|NCT00996892|470619341|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
130561514|NCT00467779|470024768|FG002|Stage 3|Disease Progression|0|||
130561515|NCT00467779|470024769|FG003|Stage 3|Disease Progression|0|||
130561516|NCT00467779|470024770|FG004|Stage 3|Disease Progression|0|||
130561517|NCT00467779|470024771|FG005|Stage 3|Disease Progression|0|||
130561518|NCT00467779|470024772|FG006|Stage 3|Disease Progression|0|||
130561519|NCT00467779|470024773|FG007|Stage 3|Disease Progression|0|||
130561520|NCT00467779|470024774|FG008|Stage 3|Disease Progression|0|||
130561521|NCT00467779|470024775|FG009|Stage 3|Disease Progression|0|||
130561522|NCT00467779|470024776|FG010|Stage 3|Disease Progression|0|||
130561523|NCT00467779|470024777|FG011|Stage 3|Disease Progression|0|||
130561524|NCT00467779|470024778|FG012|Stage 3|Disease Progression|0|||
130561525|NCT00467779|470024779|FG013|Stage 3|Disease Progression|0|||
130561526|NCT00467779|470024780|FG014|Stage 3|Disease Progression|9|||
130561527|NCT00467779|470024766|FG000|Stage 3|Unspecified Reason|0|||
130561528|NCT00467779|470024767|FG001|Stage 3|Unspecified Reason|0|||
130561529|NCT00467779|470024768|FG002|Stage 3|Unspecified Reason|0|||
130561530|NCT00467779|470024769|FG003|Stage 3|Unspecified Reason|0|||
130561531|NCT00467779|470024770|FG004|Stage 3|Unspecified Reason|0|||
130561532|NCT00467779|470024771|FG005|Stage 3|Unspecified Reason|0|||
130561533|NCT00467779|470024772|FG006|Stage 3|Unspecified Reason|0|||
130561534|NCT00467779|470024773|FG007|Stage 3|Unspecified Reason|0|||
130561535|NCT00467779|470024774|FG008|Stage 3|Unspecified Reason|0|||
130561536|NCT00467779|470024775|FG009|Stage 3|Unspecified Reason|0|||
130561537|NCT00467779|470024776|FG010|Stage 3|Unspecified Reason|0|||
130561538|NCT00467779|470024777|FG011|Stage 3|Unspecified Reason|0|||
130561539|NCT00467779|470024778|FG012|Stage 3|Unspecified Reason|0|||
130561540|NCT00467779|470024779|FG013|Stage 3|Unspecified Reason|0|||
130725670|NCT00996892|470619342|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
130725671|NCT00996892|470619343|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
130725672|NCT00996892|470619324|FG000|Expansion Stage 2A|Disease Progression|0|||
130725673|NCT00996892|470619325|FG001|Expansion Stage 2A|Disease Progression|0|||
130725674|NCT00996892|470619326|FG002|Expansion Stage 2A|Disease Progression|0|||
130725675|NCT00996892|470619327|FG003|Expansion Stage 2A|Disease Progression|0|||
130725676|NCT00996892|470619328|FG004|Expansion Stage 2A|Disease Progression|0|||
130725677|NCT00996892|470619329|FG005|Expansion Stage 2A|Disease Progression|0|||
130725678|NCT00996892|470619330|FG006|Expansion Stage 2A|Disease Progression|0|||
130725679|NCT00996892|470619331|FG007|Expansion Stage 2A|Disease Progression|0|||
130725680|NCT00996892|470619332|FG008|Expansion Stage 2A|Disease Progression|0|||
130725681|NCT00996892|470619333|FG009|Expansion Stage 2A|Disease Progression|0|||
130725682|NCT00996892|470619334|FG010|Expansion Stage 2A|Disease Progression|0|||
130725683|NCT00996892|470619335|FG011|Expansion Stage 2A|Disease Progression|0|||
130725684|NCT00996892|470619336|FG012|Expansion Stage 2A|Disease Progression|0|||
130725685|NCT00996892|470619337|FG013|Expansion Stage 2A|Disease Progression|0|||
130725686|NCT00996892|470619338|FG014|Expansion Stage 2A|Disease Progression|0|||
130725687|NCT00996892|470619339|FG015|Expansion Stage 2A|Disease Progression|0|||
130725688|NCT00996892|470619340|FG016|Expansion Stage 2A|Disease Progression|0|||
130725689|NCT00996892|470619341|FG017|Expansion Stage 2A|Disease Progression|0|||
130725690|NCT00996892|470619342|FG018|Expansion Stage 2A|Disease Progression|0|||
130725691|NCT00996892|470619343|FG019|Expansion Stage 2A|Disease Progression|31|||
130725692|NCT01987479|470619344|FG000|Overall Study|Protocol Violation|1|||
130725693|NCT01987479|470619344|FG000|Overall Study|Physician Decision|2|||
130725694|NCT01987479|470619344|FG000|Overall Study|Participant/legal guardian decision|1|||
130725695|NCT01987479|470619344|FG000|Overall Study|Other|5|||
130725696|NCT01987479|470619344|FG000|Overall Study|Lost to Follow-up|1|||
130725697|NCT01987479|470619344|FG000|Overall Study|Adverse Event|7|||
130725698|NCT00278889|470619345|FG000|Overall Study|Withdrawal by Subject|0|||
130725699|NCT00278889|470619346|FG001|Overall Study|Withdrawal by Subject|5|||
130725700|NCT00278889|470619347|FG002|Overall Study|Withdrawal by Subject|3|||
130725701|NCT00278889|470619345|FG000|Overall Study|Lost to Follow-up|1|||
130725702|NCT00278889|470619346|FG001|Overall Study|Lost to Follow-up|1|||
130725703|NCT00278889|470619347|FG002|Overall Study|Lost to Follow-up|0|||
130725704|NCT00278889|470619345|FG000|Overall Study|Death|24|||
130725705|NCT00278889|470619346|FG001|Overall Study|Death|21|||
130725706|NCT00278889|470619347|FG002|Overall Study|Death|17|||
130725707|NCT04042376|470619348|FG000|Overall Study|Withdrawal by Subject|1|||
130725708|NCT04042376|470619348|FG000|Overall Study|Death|3|||
130725709|NCT00602641|470621072|FG000|Overall Study|Never started protocol therapy|6|||
130561541|NCT00467779|470024780|FG014|Stage 3|Unspecified Reason|5|||
130561542|NCT01195090|470024783|FG000|Overall Study|Adverse Event|1|||
130725710|NCT00602641|470621073|FG001|Overall Study|Never started protocol therapy|2|||
130725711|NCT00602641|470621072|FG000|Overall Study|Still on treatment at time of analysis|8|||
130561543|NCT01195090|470024784|FG001|Overall Study|Adverse Event|2|||
130561544|NCT01195090|470024783|FG000|Overall Study|Lost to Follow-up|2|||
130725712|NCT00602641|470621073|FG001|Overall Study|Still on treatment at time of analysis|15|||
130725713|NCT00602641|470621072|FG000|Overall Study|Adverse Event|62|||
130725714|NCT00602641|470621073|FG001|Overall Study|Adverse Event|53|||
130725715|NCT00602641|470621072|FG000|Overall Study|Disease progression|38|||
130725716|NCT00602641|470621073|FG001|Overall Study|Disease progression|55|||
130725717|NCT00602641|470621072|FG000|Overall Study|Death|6|||
130472206|NCT03580369|469695668|FG006|Overall Study|Withdrawal by Subject|7|||
130472207|NCT03580369|469695669|FG007|Overall Study|Withdrawal by Subject|0|||
130472208|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
130472209|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
130472210|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
130472211|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
130472212|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
130472213|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
130472214|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
130472215|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
130472216|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
130472217|NCT03939312|469695672|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
130472218|NCT03939312|469695672|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
130472219|NCT03939312|469695672|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
130472220|NCT02119650|469695673|FG000|Overall Study|Adverse Event|3|||
130472221|NCT02119650|469695674|FG001|Overall Study|Adverse Event|4|||
130472222|NCT02119650|469695673|FG000|Overall Study|Subject decision|2|||
130472223|NCT02119650|469695674|FG001|Overall Study|Subject decision|3|||
130472224|NCT02119650|469695673|FG000|Overall Study|Disease progression|11|||
130472225|NCT02119650|469695674|FG001|Overall Study|Disease progression|14|||
130472226|NCT02119650|469695673|FG000|Overall Study|Death|5|||
130472227|NCT02119650|469695674|FG001|Overall Study|Death|1|||
130472228|NCT02119650|469695673|FG000|Overall Study|Noncompliance with study treatment|1|||
130472229|NCT02119650|469695674|FG001|Overall Study|Noncompliance with study treatment|1|||
130472230|NCT02119650|469695673|FG000|Overall Study|Study terminated by the sponsor|1|||
130472231|NCT02119650|469695674|FG001|Overall Study|Study terminated by the sponsor|0|||
130472232|NCT02119650|469695673|FG000|Overall Study|Physician Decision|0|||
130472233|NCT02119650|469695674|FG001|Overall Study|Physician Decision|2|||
130472234|NCT02119650|469695673|FG000|Overall Study|Multiple reasons for termination|2|||
130472235|NCT02119650|469695674|FG001|Overall Study|Multiple reasons for termination|1|||
130472236|NCT01721291|469695677|FG000|Overall Study|Withdrawal by Subject|1|||
130472237|NCT01721291|469695678|FG001|Overall Study|Withdrawal by Subject|0|||
130472238|NCT01721291|469695677|FG000|Overall Study|did not like the treatment|1|||
130472239|NCT01721291|469695678|FG001|Overall Study|did not like the treatment|0|||
130472240|NCT04442126|469695689|FG000|Overall Study|Withdrawal by Subject|0|||
130472241|NCT04442126|469695690|FG001|Overall Study|Withdrawal by Subject|0|||
130472242|NCT04442126|469695691|FG002|Overall Study|Withdrawal by Subject|0|||
130472243|NCT04442126|469695692|FG003|Overall Study|Withdrawal by Subject|2|||
130472244|NCT04442126|469695693|FG004|Overall Study|Withdrawal by Subject|1|||
130472245|NCT04442126|469695694|FG005|Overall Study|Withdrawal by Subject|0|||
130472246|NCT04442126|469695695|FG006|Overall Study|Withdrawal by Subject|1|||
130472247|NCT04442126|469695696|FG007|Overall Study|Withdrawal by Subject|1|||
130725718|NCT00602641|470621073|FG001|Overall Study|Death|5|||
130725719|NCT00602641|470621072|FG000|Overall Study|Withdrawal by Subject|15|||
130725720|NCT00602641|470621073|FG001|Overall Study|Withdrawal by Subject|12|||
130725721|NCT00602641|470621072|FG000|Overall Study|Alternative therapy|5|||
130725722|NCT00602641|470621073|FG001|Overall Study|Alternative therapy|2|||
130725723|NCT00602641|470621072|FG000|Overall Study|Other Complicating Disease|5|||
130725724|NCT00602641|470621073|FG001|Overall Study|Other Complicating Disease|2|||
130725725|NCT00602641|470621072|FG000|Overall Study|Physician Decision|5|||
130725726|NCT00602641|470621073|FG001|Overall Study|Physician Decision|4|||
130725727|NCT00602641|470621072|FG000|Overall Study|Administrative Closure|1|||
130725728|NCT00602641|470621073|FG001|Overall Study|Administrative Closure|1|||
130725729|NCT00602641|470621072|FG000|Overall Study|Other|3|||
130725730|NCT00602641|470621073|FG001|Overall Study|Other|1|||
130725731|NCT00478244|470621076|FG000|Overall Study|Did not receive transplant|1|||
130725732|NCT02929056|470621079|FG000|Overall Study|Lost to Follow-up|0|||
130725733|NCT02929056|470621080|FG001|Overall Study|Lost to Follow-up|1|||
130725734|NCT02925403|470621086|FG000|Overall Study|Lost to Follow-up|0|||
130725735|NCT02925403|470621087|FG001|Overall Study|Lost to Follow-up|1|||
130725736|NCT00459043|470621088|FG000|Overall Study|Withdrawal by Subject|1|||
130725737|NCT00459043|470621089|FG001|Overall Study|Withdrawal by Subject|0|||
130725738|NCT02899195|470621092|FG000|Concurrent Durvalumab|Adverse Event|4|||
130725739|NCT02899195|470621092|FG000|Concurrent Durvalumab|Physician Decision|1|||
130725740|NCT02899195|470621092|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
130472248|NCT04442126|469695697|FG008|Overall Study|Withdrawal by Subject|3|||
130472249|NCT04442126|469695689|FG000|Overall Study|Death|1|||
130472250|NCT04442126|469695690|FG001|Overall Study|Death|0|||
130472251|NCT04442126|469695691|FG002|Overall Study|Death|0|||
130472252|NCT04442126|469695692|FG003|Overall Study|Death|1|||
130472253|NCT04442126|469695693|FG004|Overall Study|Death|2|||
130725741|NCT02899195|470621092|FG000|Concurrent Durvalumab|Progressive Disease|5|||
130725742|NCT02899195|470621092|FG000|Maintenance Durvalumab|Adverse Event|1|||
130725743|NCT02899195|470621092|FG000|Maintenance Durvalumab|Physician Decision|1|||
130725744|NCT02899195|470621092|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
130725745|NCT02899195|470621092|FG000|Maintenance Durvalumab|Progressive Disease|31|||
130472254|NCT04442126|469695694|FG005|Overall Study|Death|2|||
130472255|NCT04442126|469695695|FG006|Overall Study|Death|4|||
130472256|NCT04442126|469695696|FG007|Overall Study|Death|1|||
130472257|NCT04442126|469695697|FG008|Overall Study|Death|5|||
130472258|NCT04442126|469695689|FG000|Overall Study|Study Terminated by Sponsor|0|||
130407653|NCT01168999|469455766|FG002|Overall Study|Lost to Follow-up|0|||
130407654|NCT01168999|469455767|FG003|Overall Study|Lost to Follow-up|0|||
130407655|NCT03603964|469455768|FG000|Overall Study|Death|9|||
130407656|NCT03603964|469455768|FG000|Overall Study|Withdrawal by participant|7|||
130407657|NCT03603964|469455768|FG000|Overall Study|Study terminated by Sponsor|19|||
130407658|NCT04317586|469455769|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
130407659|NCT04317586|469455769|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
130407660|NCT00563797|469455770|FG000|Overall Study|Lost to Follow-up|7|||
130472259|NCT04442126|469695690|FG001|Overall Study|Study Terminated by Sponsor|0|||
130472260|NCT04442126|469695691|FG002|Overall Study|Study Terminated by Sponsor|0|||
130472261|NCT04442126|469695692|FG003|Overall Study|Study Terminated by Sponsor|0|||
130407661|NCT00563797|469455771|FG001|Overall Study|Lost to Follow-up|2|||
130472262|NCT04442126|469695693|FG004|Overall Study|Study Terminated by Sponsor|0|||
130472263|NCT04442126|469695694|FG005|Overall Study|Study Terminated by Sponsor|1|||
130407662|NCT04327934|469455772|FG000|Overall Study|Did not qualify|7|||
130472264|NCT04442126|469695695|FG006|Overall Study|Study Terminated by Sponsor|4|||
130407663|NCT04327934|469455773|FG001|Overall Study|Did not qualify|4|||
130407664|NCT04327934|469455772|FG000|Overall Study|Physician Decision|0|||
130407665|NCT04327934|469455773|FG001|Overall Study|Physician Decision|1|||
130407666|NCT03095417|469455778|FG000|Overall Study|missed|1|||
130407667|NCT03095417|469455779|FG001|Overall Study|missed|2|||
130407668|NCT03095417|469455780|FG002|Overall Study|missed|0|||
130407669|NCT03095417|469455781|FG003|Overall Study|missed|1|||
130407670|NCT03095417|469455778|FG000|Overall Study|Lost to Follow-up|2|||
130407671|NCT03095417|469455779|FG001|Overall Study|Lost to Follow-up|2|||
130407672|NCT03095417|469455780|FG002|Overall Study|Lost to Follow-up|1|||
130407673|NCT03095417|469455781|FG003|Overall Study|Lost to Follow-up|0|||
130407674|NCT03095417|469455778|FG000|Overall Study|refusal|0|||
130407675|NCT03095417|469455779|FG001|Overall Study|refusal|1|||
130407676|NCT03095417|469455780|FG002|Overall Study|refusal|0|||
130407677|NCT03095417|469455781|FG003|Overall Study|refusal|1|||
130407678|NCT03095417|469455778|FG000|Overall Study|Withdrawal by Subject|8|||
130407679|NCT03095417|469455779|FG001|Overall Study|Withdrawal by Subject|2|||
130407680|NCT03095417|469455780|FG002|Overall Study|Withdrawal by Subject|5|||
130407681|NCT03095417|469455781|FG003|Overall Study|Withdrawal by Subject|4|||
130407682|NCT03095417|469455778|FG000|Overall Study|Physician Decision|1|||
130407683|NCT03095417|469455779|FG001|Overall Study|Physician Decision|2|||
130407684|NCT03095417|469455780|FG002|Overall Study|Physician Decision|2|||
130407685|NCT03095417|469455781|FG003|Overall Study|Physician Decision|2|||
130407686|NCT03095417|469455778|FG000|Overall Study|Death|1|||
130407687|NCT03095417|469455779|FG001|Overall Study|Death|2|||
130407688|NCT03095417|469455780|FG002|Overall Study|Death|1|||
130407689|NCT03095417|469455781|FG003|Overall Study|Death|3|||
130407690|NCT01490060|469455782|FG000|Cycle 1|Change of Treatment|0|||
130407691|NCT01490060|469455783|FG001|Cycle 1|Change of Treatment|1|||
130407692|NCT01490060|469455784|FG002|Cycle 1|Change of Treatment|1|||
130407693|NCT01490060|469455785|FG003|Cycle 1|Change of Treatment|1|||
130407694|NCT01490060|469455782|FG000|Cycle 1|Insurance Denied|0|||
130407695|NCT01490060|469455783|FG001|Cycle 1|Insurance Denied|0|||
130407696|NCT01490060|469455784|FG002|Cycle 1|Insurance Denied|2|||
130407697|NCT01490060|469455785|FG003|Cycle 1|Insurance Denied|0|||
130407698|NCT01490060|469455782|FG000|Cycle 1|Withdrawal by Subject|0|||
130407699|NCT01490060|469455783|FG001|Cycle 1|Withdrawal by Subject|0|||
130407700|NCT01490060|469455784|FG002|Cycle 1|Withdrawal by Subject|0|||
130407701|NCT01490060|469455785|FG003|Cycle 1|Withdrawal by Subject|1|||
130407702|NCT01490060|469455782|FG000|Cycle 1|Treatment at Another Facility|0|||
130407703|NCT01490060|469455783|FG001|Cycle 1|Treatment at Another Facility|0|||
130407704|NCT01490060|469455784|FG002|Cycle 1|Treatment at Another Facility|0|||
130407705|NCT01490060|469455785|FG003|Cycle 1|Treatment at Another Facility|1|||
130407706|NCT01490060|469455782|FG000|Cycle 2|Change of Treatment|1|||
130407707|NCT01490060|469455783|FG001|Cycle 2|Change of Treatment|1|||
130407708|NCT01490060|469455784|FG002|Cycle 2|Change of Treatment|0|||
130407709|NCT01490060|469455785|FG003|Cycle 2|Change of Treatment|0|||
130407710|NCT01490060|469455782|FG000|Cycle 2|Non-Compliance|0|||
130407711|NCT01490060|469455783|FG001|Cycle 2|Non-Compliance|0|||
130407712|NCT01490060|469455784|FG002|Cycle 2|Non-Compliance|1|||
130407713|NCT01490060|469455785|FG003|Cycle 2|Non-Compliance|0|||
130407714|NCT01490060|469455782|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
130407715|NCT01490060|469455783|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130407716|NCT01490060|469455784|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130407717|NCT01490060|469455785|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130407718|NCT01877421|469455786|FG000|Phase 2|Lost to Follow-up|0|||
130472265|NCT04442126|469695696|FG007|Overall Study|Study Terminated by Sponsor|2|||
130472266|NCT04442126|469695697|FG008|Overall Study|Study Terminated by Sponsor|10|||
130472267|NCT04442126|469695689|FG000|Overall Study|Lost to Follow-up|0|||
130472268|NCT04442126|469695690|FG001|Overall Study|Lost to Follow-up|0|||
130472269|NCT04442126|469695691|FG002|Overall Study|Lost to Follow-up|0|||
130472270|NCT04442126|469695692|FG003|Overall Study|Lost to Follow-up|0|||
130472271|NCT04442126|469695693|FG004|Overall Study|Lost to Follow-up|0|||
130472272|NCT04442126|469695694|FG005|Overall Study|Lost to Follow-up|0|||
130472273|NCT04442126|469695695|FG006|Overall Study|Lost to Follow-up|0|||
130472274|NCT04442126|469695696|FG007|Overall Study|Lost to Follow-up|1|||
130407719|NCT01877421|469455787|FG001|Phase 2|Lost to Follow-up|0|||
130407720|NCT01877421|469455788|FG002|Phase 2|Lost to Follow-up|0|||
130407721|NCT01877421|469455789|FG003|Phase 2|Lost to Follow-up|0|||
130407722|NCT01877421|469455790|FG004|Phase 2|Lost to Follow-up|0|||
130407723|NCT01877421|469455791|FG005|Phase 2|Lost to Follow-up|0|||
130407724|NCT01877421|469455792|FG006|Phase 2|Lost to Follow-up|1|||
130407725|NCT01877421|469455793|FG007|Phase 2|Lost to Follow-up|0|||
130472275|NCT04442126|469695697|FG008|Overall Study|Lost to Follow-up|2|||
130472276|NCT04442126|469695689|FG000|Overall Study|Progressive Disease|0|||
130407726|NCT01877421|469455794|FG008|Phase 2|Lost to Follow-up|0|||
130407727|NCT01877421|469455795|FG009|Phase 2|Lost to Follow-up|0|||
130407728|NCT01877421|469455796|FG010|Phase 2|Lost to Follow-up|0|||
130407729|NCT01877421|469455797|FG011|Phase 2|Lost to Follow-up|0|||
130472277|NCT04442126|469695690|FG001|Overall Study|Progressive Disease|1|||
130472278|NCT04442126|469695691|FG002|Overall Study|Progressive Disease|3|||
130472279|NCT04442126|469695692|FG003|Overall Study|Progressive Disease|0|||
130472280|NCT04442126|469695693|FG004|Overall Study|Progressive Disease|3|||
130472281|NCT04442126|469695694|FG005|Overall Study|Progressive Disease|0|||
130472282|NCT04442126|469695695|FG006|Overall Study|Progressive Disease|0|||
130472283|NCT04442126|469695696|FG007|Overall Study|Progressive Disease|0|||
130472284|NCT04442126|469695697|FG008|Overall Study|Progressive Disease|0|||
130472285|NCT04442126|469695689|FG000|Overall Study|Other|0|||
130472286|NCT04442126|469695690|FG001|Overall Study|Other|0|||
130472287|NCT04442126|469695691|FG002|Overall Study|Other|0|||
130472288|NCT04442126|469695692|FG003|Overall Study|Other|0|||
130472289|NCT04442126|469695693|FG004|Overall Study|Other|0|||
130472290|NCT04442126|469695694|FG005|Overall Study|Other|0|||
130407730|NCT01877421|469455798|FG012|Phase 2|Lost to Follow-up|0|||
130407731|NCT01877421|469455799|FG013|Phase 2|Lost to Follow-up|0|||
130407732|NCT01877421|469455800|FG014|Phase 2|Lost to Follow-up|0|||
130407733|NCT01877421|469455801|FG015|Phase 2|Lost to Follow-up|0|||
130407734|NCT01877421|469455802|FG016|Phase 2|Lost to Follow-up|0|||
130407735|NCT01877421|469455803|FG017|Phase 2|Lost to Follow-up|0|||
130407736|NCT01877421|469455786|FG000|Phase 2|Withdrawal by Subject|0|||
130407737|NCT01877421|469455787|FG001|Phase 2|Withdrawal by Subject|0|||
130407738|NCT01877421|469455788|FG002|Phase 2|Withdrawal by Subject|0|||
130407739|NCT01877421|469455789|FG003|Phase 2|Withdrawal by Subject|0|||
130407740|NCT01877421|469455790|FG004|Phase 2|Withdrawal by Subject|0|||
130407741|NCT01877421|469455791|FG005|Phase 2|Withdrawal by Subject|0|||
130407742|NCT01877421|469455792|FG006|Phase 2|Withdrawal by Subject|0|||
130407743|NCT01877421|469455793|FG007|Phase 2|Withdrawal by Subject|0|||
130407744|NCT01877421|469455794|FG008|Phase 2|Withdrawal by Subject|1|||
130407745|NCT01877421|469455795|FG009|Phase 2|Withdrawal by Subject|0|||
130407746|NCT01877421|469455796|FG010|Phase 2|Withdrawal by Subject|1|||
130407747|NCT01877421|469455797|FG011|Phase 2|Withdrawal by Subject|0|||
130407748|NCT01877421|469455798|FG012|Phase 2|Withdrawal by Subject|1|||
130407749|NCT01877421|469455799|FG013|Phase 2|Withdrawal by Subject|0|||
130407750|NCT01877421|469455800|FG014|Phase 2|Withdrawal by Subject|0|||
130407751|NCT01877421|469455801|FG015|Phase 2|Withdrawal by Subject|1|||
130725746|NCT03156504|470621094|FG000|Overall Study|Withdrawal by Subject|1|||
130407752|NCT01877421|469455802|FG016|Phase 2|Withdrawal by Subject|0|||
130407753|NCT01877421|469455803|FG017|Phase 2|Withdrawal by Subject|0|||
130407754|NCT01877421|469455786|FG000|Phase 2|Protocol Violation|0|||
130407755|NCT01877421|469455787|FG001|Phase 2|Protocol Violation|0|||
130407756|NCT01877421|469455788|FG002|Phase 2|Protocol Violation|0|||
130407757|NCT01877421|469455789|FG003|Phase 2|Protocol Violation|0|||
130407758|NCT01877421|469455790|FG004|Phase 2|Protocol Violation|0|||
130407759|NCT01877421|469455791|FG005|Phase 2|Protocol Violation|0|||
130725747|NCT00450801|470621095|FG000|Overall Study|Death|1|||
130407760|NCT01877421|469455792|FG006|Phase 2|Protocol Violation|0|||
130407761|NCT01877421|469455793|FG007|Phase 2|Protocol Violation|0|||
130407762|NCT01877421|469455794|FG008|Phase 2|Protocol Violation|0|||
130407763|NCT01877421|469455795|FG009|Phase 2|Protocol Violation|0|||
130407764|NCT01877421|469455796|FG010|Phase 2|Protocol Violation|1|||
130407765|NCT01877421|469455797|FG011|Phase 2|Protocol Violation|0|||
130407766|NCT01877421|469455798|FG012|Phase 2|Protocol Violation|0|||
130725748|NCT00587860|470621096|FG000|Overall Study|Lost to Follow-up|2|||
130725749|NCT00587860|470621097|FG001|Overall Study|Lost to Follow-up|2|||
130725750|NCT00587860|470621096|FG000|Overall Study|Withdrawal by Subject|3|||
130725751|NCT00587860|470621097|FG001|Overall Study|Withdrawal by Subject|3|||
130725752|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
130725753|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130725754|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130725755|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
130725756|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130725757|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130725758|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
130725759|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130725760|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130725761|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
130725762|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130725763|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130725764|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
130725765|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130725766|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130725767|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
130725768|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130407767|NCT01877421|469455799|FG013|Phase 2|Protocol Violation|0|||
130407768|NCT01877421|469455800|FG014|Phase 2|Protocol Violation|0|||
130407769|NCT01877421|469455801|FG015|Phase 2|Protocol Violation|0|||
130407770|NCT01877421|469455802|FG016|Phase 2|Protocol Violation|0|||
130407771|NCT01877421|469455803|FG017|Phase 2|Protocol Violation|0|||
130407772|NCT01047683|469455804|FG000|Overall Study|Adverse Event|3|||
130407773|NCT01047683|469455805|FG001|Overall Study|Adverse Event|1|||
130407774|NCT01047683|469455806|FG002|Overall Study|Adverse Event|0|||
130407775|NCT01047683|469455804|FG000|Overall Study|Withdrew Consent|1|||
130407776|NCT01047683|469455805|FG001|Overall Study|Withdrew Consent|4|||
130407777|NCT01047683|469455806|FG002|Overall Study|Withdrew Consent|2|||
130407778|NCT01047683|469455804|FG000|Overall Study|Lost to Follow-up|0|||
130407779|NCT01047683|469455805|FG001|Overall Study|Lost to Follow-up|1|||
130725769|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130725770|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
130407780|NCT01047683|469455806|FG002|Overall Study|Lost to Follow-up|0|||
130407781|NCT01047683|469455804|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
130407782|NCT01047683|469455805|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
130407783|NCT01047683|469455806|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
130407784|NCT03698773|469455808|FG000|Overall Study|Lost to Follow-up|2|||
130407785|NCT03698773|469455809|FG001|Overall Study|Lost to Follow-up|1|||
130407786|NCT00908960|469455810|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
130407787|NCT00908960|469455811|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
130407788|NCT00908960|469455812|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
130407789|NCT05074433|469455813|FG000|Overall Study|Adverse Event|0|||
130407790|NCT05074433|469455814|FG001|Overall Study|Adverse Event|2|||
130407791|NCT05074433|469455815|FG002|Overall Study|Adverse Event|0|||
130407792|NCT05074433|469455816|FG003|Overall Study|Adverse Event|1|||
130407793|NCT05074433|469455813|FG000|Overall Study|Sponsor Request|0|||
130407794|NCT05074433|469455814|FG001|Overall Study|Sponsor Request|1|||
130407795|NCT05074433|469455815|FG002|Overall Study|Sponsor Request|1|||
130407796|NCT05074433|469455816|FG003|Overall Study|Sponsor Request|0|||
130407797|NCT05074433|469455813|FG000|Overall Study|Death|1|||
130407798|NCT05074433|469455814|FG001|Overall Study|Death|0|||
130407799|NCT05074433|469455815|FG002|Overall Study|Death|0|||
130407800|NCT05074433|469455816|FG003|Overall Study|Death|0|||
130407801|NCT05074433|469455813|FG000|Overall Study|Lost to Follow-up|0|||
130407802|NCT05074433|469455814|FG001|Overall Study|Lost to Follow-up|0|||
130407803|NCT05074433|469455815|FG002|Overall Study|Lost to Follow-up|2|||
130407804|NCT05074433|469455816|FG003|Overall Study|Lost to Follow-up|0|||
130407805|NCT05074433|469455813|FG000|Overall Study|Subject Decision|8|||
130472291|NCT04442126|469695695|FG006|Overall Study|Other|0|||
130472292|NCT04442126|469695696|FG007|Overall Study|Other|0|||
130472293|NCT04442126|469695697|FG008|Overall Study|Other|1|||
130472294|NCT06450405|469695698|FG000|Overall Study|Study funding terminated.|0|||
130472295|NCT06450405|469695699|FG001|Overall Study|Study funding terminated.|2|||
130472296|NCT04923347|469696670|FG000|Overall Study|Withdrawal by Subject|14|||
130725771|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130725772|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130725773|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
130725774|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130725775|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130725776|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
130725777|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
130725778|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
130725779|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
130725780|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130725781|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130725782|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
130725783|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130725784|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130725785|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
130725786|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130725787|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130725788|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
130725789|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
130725790|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
130725791|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
130725792|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130725793|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130725794|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
130725795|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130725796|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130725797|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
130725798|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
130725799|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
130725800|NCT00261443|470621098|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
130407806|NCT05074433|469455814|FG001|Overall Study|Subject Decision|6|||
130407807|NCT05074433|469455815|FG002|Overall Study|Subject Decision|4|||
130407808|NCT05074433|469455816|FG003|Overall Study|Subject Decision|5|||
130407809|NCT01158924|469455818|FG000|Overall Study|Withdrawal by Subject|1|||
130407810|NCT01158924|469455819|FG001|Overall Study|Withdrawal by Subject|2|||
130407811|NCT01158924|469455818|FG000|Overall Study|Lost to Follow-up|0|||
130407812|NCT01158924|469455819|FG001|Overall Study|Lost to Follow-up|1|||
130407813|NCT03795922|469455820|FG000|Overall Study|Adverse Event|2|||
130472297|NCT03424811|469696671|FG000|Overall Study|Lost to Follow-up|9|||
130472298|NCT03424811|469696672|FG001|Overall Study|Lost to Follow-up|0|||
130725801|NCT00261443|470621099|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
130725802|NCT00261443|470621100|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
130725803|NCT00261443|470621098|FG000|3: Assessment of Relapse|Adverse Event|0|||
130725804|NCT00261443|470621099|FG001|3: Assessment of Relapse|Adverse Event|15|||
130725805|NCT00261443|470621100|FG002|3: Assessment of Relapse|Adverse Event|19|||
130725806|NCT00261443|470621098|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
130725807|NCT00261443|470621099|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
130725808|NCT00261443|470621100|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
130725809|NCT00261443|470621098|FG000|3: Assessment of Relapse|Death|0|||
130725810|NCT00261443|470621099|FG001|3: Assessment of Relapse|Death|0|||
130725811|NCT00261443|470621100|FG002|3: Assessment of Relapse|Death|1|||
130725812|NCT00261443|470621098|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
130725813|NCT00261443|470621099|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
130725814|NCT00261443|470621100|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
130725815|NCT00261443|470621098|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
130725816|NCT00261443|470621099|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
130725817|NCT00261443|470621100|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
130725818|NCT00261443|470621098|FG000|3: Assessment of Relapse|Pregnancy|0|||
130725819|NCT00261443|470621099|FG001|3: Assessment of Relapse|Pregnancy|2|||
130725820|NCT00261443|470621100|FG002|3: Assessment of Relapse|Pregnancy|1|||
130725821|NCT00261443|470621098|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
130725822|NCT00261443|470621099|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
130725823|NCT00261443|470621100|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
130725824|NCT00261443|470621098|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130725825|NCT00261443|470621099|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130725826|NCT00261443|470621100|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
130725827|NCT00261443|470621098|FG000|3: Assessment of Relapse|Other Reasons|0|||
130725828|NCT00261443|470621099|FG001|3: Assessment of Relapse|Other Reasons|4|||
130725829|NCT00261443|470621100|FG002|3: Assessment of Relapse|Other Reasons|3|||
130725830|NCT00261443|470621098|FG000|4: Extension Phase|Adverse Event|0|||
130725831|NCT00261443|470621099|FG001|4: Extension Phase|Adverse Event|1|||
130725832|NCT00261443|470621100|FG002|4: Extension Phase|Adverse Event|0|||
130725833|NCT00261443|470621098|FG000|4: Extension Phase|Withdrawal by Subject|0|||
130725834|NCT00261443|470621099|FG001|4: Extension Phase|Withdrawal by Subject|1|||
130725835|NCT00261443|470621100|FG002|4: Extension Phase|Withdrawal by Subject|2|||
130725836|NCT00261443|470621098|FG000|4: Extension Phase|Lost to Follow-up|0|||
130725837|NCT00261443|470621099|FG001|4: Extension Phase|Lost to Follow-up|1|||
130725838|NCT00261443|470621100|FG002|4: Extension Phase|Lost to Follow-up|0|||
130725839|NCT01286753|470621103|FG000|Overall Study|Adverse Event|7|||
130725840|NCT01286753|470621104|FG001|Overall Study|Adverse Event|6|||
130725841|NCT01286753|470621103|FG000|Overall Study|Progression|11|||
130725842|NCT01286753|470621104|FG001|Overall Study|Progression|13|||
130725843|NCT01286753|470621103|FG000|Overall Study|Refused Treatment|1|||
130725844|NCT01286753|470621104|FG001|Overall Study|Refused Treatment|0|||
130725845|NCT01286753|470621103|FG000|Overall Study|Withdrawal of Consent|0|||
130725846|NCT01286753|470621104|FG001|Overall Study|Withdrawal of Consent|2|||
130725847|NCT01286753|470621103|FG000|Overall Study|Discontinued to Join Extension Study|6|||
130725848|NCT01286753|470621104|FG001|Overall Study|Discontinued to Join Extension Study|4|||
130725849|NCT01286753|470621103|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
130725850|NCT01286753|470621104|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
130725851|NCT00923273|470621114|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725852|NCT00923273|470621115|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725853|NCT00923273|470621116|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725854|NCT00923273|470621117|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
130725855|NCT00923273|470621118|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725856|NCT00923273|470621114|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725857|NCT00923273|470621115|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725858|NCT00923273|470621116|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725859|NCT00923273|470621117|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
130725860|NCT00923273|470621118|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725861|NCT00509366|470621119|FG000|Overall Study|Not Treated (Screen Failure)|1|||
130725862|NCT00509366|470621120|FG001|Overall Study|Not Treated (Screen Failure)|1|||
130725863|NCT00509366|470621121|FG002|Overall Study|Not Treated (Screen Failure)|1|||
130725864|NCT00509366|470621122|FG003|Overall Study|Not Treated (Screen Failure)|0|||
130725865|NCT00509366|470621123|FG004|Overall Study|Not Treated (Screen Failure)|0|||
130725866|NCT00264550|470621124|FG000|Overall Study|Death|0|||
130725867|NCT00264550|470621125|FG001|Overall Study|Death|3|||
130725868|NCT00264550|470621126|FG002|Overall Study|Death|0|||
130725869|NCT00264550|470621127|FG003|Overall Study|Death|0|||
130725870|NCT00264550|470621124|FG000|Overall Study|Lost to Follow-up|3|||
130725871|NCT00264550|470621125|FG001|Overall Study|Lost to Follow-up|1|||
130472299|NCT03948763|469696673|FG000|Overall Study|Sponsor's decision|0|||
130472300|NCT03948763|469696674|FG001|Overall Study|Sponsor's decision|2|||
130472301|NCT03948763|469696675|FG002|Overall Study|Sponsor's decision|6|||
130472302|NCT03948763|469696676|FG003|Overall Study|Sponsor's decision|4|||
130472303|NCT03948763|469696677|FG004|Overall Study|Sponsor's decision|0|||
130472304|NCT03948763|469696673|FG000|Overall Study|Physician Decision|0|||
130472305|NCT03948763|469696674|FG001|Overall Study|Physician Decision|0|||
130472306|NCT03948763|469696675|FG002|Overall Study|Physician Decision|1|||
130472307|NCT03948763|469696676|FG003|Overall Study|Physician Decision|0|||
130472308|NCT03948763|469696677|FG004|Overall Study|Physician Decision|0|||
130472309|NCT03948763|469696673|FG000|Overall Study|Lost to Follow-up|0|||
130472310|NCT03948763|469696674|FG001|Overall Study|Lost to Follow-up|0|||
130472311|NCT03948763|469696675|FG002|Overall Study|Lost to Follow-up|0|||
130472312|NCT03948763|469696676|FG003|Overall Study|Lost to Follow-up|0|||
130472313|NCT03948763|469696677|FG004|Overall Study|Lost to Follow-up|1|||
130472314|NCT03948763|469696673|FG000|Overall Study|Death|2|||
130472315|NCT03948763|469696674|FG001|Overall Study|Death|12|||
130472316|NCT03948763|469696675|FG002|Overall Study|Death|13|||
130472317|NCT03948763|469696676|FG003|Overall Study|Death|10|||
130472318|NCT03948763|469696677|FG004|Overall Study|Death|11|||
130472319|NCT03948763|469696673|FG000|Overall Study|Withdrawal by Subject|1|||
130472320|NCT03948763|469696674|FG001|Overall Study|Withdrawal by Subject|1|||
130472321|NCT03948763|469696675|FG002|Overall Study|Withdrawal by Subject|0|||
130472322|NCT03948763|469696676|FG003|Overall Study|Withdrawal by Subject|2|||
130472323|NCT03948763|469696677|FG004|Overall Study|Withdrawal by Subject|4|||
130472324|NCT05038566|469696679|FG000|Overall Study|Technical Difficulties with the Device|0|||
130472325|NCT05038566|469696680|FG001|Overall Study|Technical Difficulties with the Device|1|||
130472326|NCT04511702|469696681|FG000|Overall Study|Lost to Follow-up|3|||
130472327|NCT04511702|469696682|FG001|Overall Study|Lost to Follow-up|0|||
130472328|NCT04511702|469696683|FG002|Overall Study|Lost to Follow-up|4|||
130472329|NCT04511702|469696681|FG000|Overall Study|Withdrawal by Subject|17|||
130472330|NCT04511702|469696682|FG001|Overall Study|Withdrawal by Subject|1|||
130472331|NCT04511702|469696683|FG002|Overall Study|Withdrawal by Subject|8|||
130472332|NCT03192891|469696686|FG000|Overall Study|Lost to Follow-up|55|||
130472333|NCT05141903|469696688|FG000|Overall Study|Withdrawal by Subject|0|||
130472334|NCT05141903|469696689|FG001|Overall Study|Withdrawal by Subject|1|||
130472335|NCT05141903|469696690|FG002|Overall Study|Withdrawal by Subject|1|||
130472336|NCT05141903|469696691|FG003|Overall Study|Withdrawal by Subject|0|||
130472337|NCT05141903|469696692|FG004|Overall Study|Withdrawal by Subject|0|||
130472338|NCT05141903|469696688|FG000|Overall Study|Other|1|||
130472339|NCT05141903|469696689|FG001|Overall Study|Other|1|||
130472340|NCT05141903|469696690|FG002|Overall Study|Other|0|||
130472341|NCT05141903|469696691|FG003|Overall Study|Other|0|||
130472342|NCT05141903|469696692|FG004|Overall Study|Other|0|||
130472343|NCT04716634|469696693|FG000|Overall Study|Death|24|||
130472344|NCT04716634|469696694|FG001|Overall Study|Death|24|||
130472345|NCT04716634|469696695|FG002|Overall Study|Death|8|||
130472346|NCT04716634|469696693|FG000|Overall Study|Closed by Sponsor|4|||
130472347|NCT04716634|469696694|FG001|Overall Study|Closed by Sponsor|4|||
130472348|NCT04716634|469696695|FG002|Overall Study|Closed by Sponsor|5|||
130472349|NCT04716634|469696693|FG000|Overall Study|Lost to Follow-up|1|||
130472350|NCT04716634|469696694|FG001|Overall Study|Lost to Follow-up|0|||
130472351|NCT04716634|469696695|FG002|Overall Study|Lost to Follow-up|1|||
130472352|NCT04716634|469696693|FG000|Overall Study|Withdrawal by Subject|0|||
130472353|NCT04716634|469696694|FG001|Overall Study|Withdrawal by Subject|0|||
130472354|NCT04716634|469696695|FG002|Overall Study|Withdrawal by Subject|1|||
130472355|NCT02630823|469696704|FG000|Overall Study|Withdrawal by Subject|1|||
130472356|NCT02630823|469696704|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
130472357|NCT05387447|469696705|FG000|Overall Study|Participants changed their minds about study participation.|3|||
130472358|NCT05387447|469696706|FG001|Overall Study|Participants changed their minds about study participation.|5|||
130472359|NCT03391466|469696709|FG000|Overall Study|Death|82|||
130472360|NCT03391466|469696710|FG001|Overall Study|Death|85|||
130472361|NCT03391466|469696709|FG000|Overall Study|Still on study|93|||
130472362|NCT03391466|469696710|FG001|Overall Study|Still on study|74|||
130472363|NCT03391466|469696709|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
130472364|NCT03391466|469696710|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
130472365|NCT03391466|469696709|FG000|Overall Study|Lost to Follow-up|5|||
130472366|NCT03391466|469696710|FG001|Overall Study|Lost to Follow-up|5|||
130472367|NCT03391466|469696709|FG000|Overall Study|Investigator decision|0|||
130472368|NCT03391466|469696710|FG001|Overall Study|Investigator decision|1|||
130472369|NCT03391466|469696709|FG000|Overall Study|Other|0|||
130472370|NCT03391466|469696710|FG001|Overall Study|Other|1|||
130472371|NCT05919082|469696713|FG000|Overall Study|Adverse Event|3|||
130472372|NCT05919082|469696714|FG001|Overall Study|Adverse Event|0|||
130472373|NCT05919082|469696713|FG000|Overall Study|Lost to Follow-up|0|||
130472374|NCT05919082|469696714|FG001|Overall Study|Lost to Follow-up|1|||
130472375|NCT05919082|469696713|FG000|Overall Study|Withdrawal by Subject|8|||
130472376|NCT05919082|469696714|FG001|Overall Study|Withdrawal by Subject|9|||
130407814|NCT03795922|469455821|FG001|Overall Study|Adverse Event|1|||
130561545|NCT01195090|470024784|FG001|Overall Study|Lost to Follow-up|2|||
130407815|NCT03795922|469455820|FG000|Overall Study|Withdrawal by Subject|5|||
130407816|NCT03795922|469455821|FG001|Overall Study|Withdrawal by Subject|13|||
130407817|NCT03795922|469455820|FG000|Overall Study|Lost to Follow-up|2|||
130407818|NCT03795922|469455821|FG001|Overall Study|Lost to Follow-up|3|||
130407819|NCT03795922|469455820|FG000|Overall Study|Pregnancy|0|||
130407820|NCT03795922|469455821|FG001|Overall Study|Pregnancy|1|||
130407821|NCT03795922|469455820|FG000|Overall Study|Physician Decision|1|||
130407822|NCT03795922|469455821|FG001|Overall Study|Physician Decision|2|||
130407823|NCT03795922|469455820|FG000|Overall Study|Protocol Violation|0|||
130407824|NCT03795922|469455821|FG001|Overall Study|Protocol Violation|1|||
130407825|NCT03795922|469455820|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
130407826|NCT03795922|469455821|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
130407827|NCT00724451|469455825|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
130407828|NCT00724451|469455825|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
130407829|NCT00724451|469455825|FG000|Overall Study|Not Eligible for Treatment|431|||
130407830|NCT00724451|469455825|FG000|Overall Study|Participant Refused Treatment|89|||
130407831|NCT00724451|469455825|FG000|Overall Study|Never Started Treatment|89|||
130407832|NCT00724451|469455825|FG000|Overall Study|Unknown; No Data Sources Available|9|||
130407833|NCT00724451|469455825|FG000|Overall Study|Physician Decision|116|||
130472377|NCT05919082|469696713|FG000|Overall Study|Lack of Efficacy|0|||
130472378|NCT05919082|469696714|FG001|Overall Study|Lack of Efficacy|1|||
130472379|NCT05919082|469696713|FG000|Overall Study|Investigator Decision|1|||
130472380|NCT05919082|469696714|FG001|Overall Study|Investigator Decision|0|||
130472381|NCT01707030|469696719|FG000|Overall Study|Death|1|||
130472382|NCT01707030|469696720|FG001|Overall Study|Death|1|||
130472383|NCT01707030|469696719|FG000|Overall Study|Withdrawal by Subject|2|||
130472384|NCT01707030|469696720|FG001|Overall Study|Withdrawal by Subject|3|||
130472385|NCT01707030|469696719|FG000|Overall Study|Lost to Follow-up|8|||
130472386|NCT01707030|469696720|FG001|Overall Study|Lost to Follow-up|13|||
130472387|NCT04820855|469696721|FG000|Overall Study|Lost to Follow-up|6|||
130472388|NCT04820855|469696722|FG001|Overall Study|Lost to Follow-up|9|||
130472389|NCT02140645|469696726|FG000|Overall Study|Not linked|5489|||
130472390|NCT02140645|469696727|FG001|Overall Study|Not linked|61654|||
130472391|NCT02140645|469696728|FG002|Overall Study|Not linked|4236|||
130472392|NCT02140645|469696729|FG003|Overall Study|Not linked|13833|||
130725872|NCT00264550|470621126|FG002|Overall Study|Lost to Follow-up|1|||
130725873|NCT00264550|470621127|FG003|Overall Study|Lost to Follow-up|1|||
130725874|NCT00264550|470621124|FG000|Overall Study|Adverse Event|23|||
130725875|NCT00264550|470621125|FG001|Overall Study|Adverse Event|18|||
130725876|NCT00264550|470621126|FG002|Overall Study|Adverse Event|9|||
130725877|NCT00264550|470621127|FG003|Overall Study|Adverse Event|14|||
130725878|NCT00264550|470621124|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130725879|NCT00264550|470621125|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130725880|NCT00264550|470621126|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130725881|NCT00264550|470621127|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
130725882|NCT00264550|470621124|FG000|Overall Study|Discontinued oral study agent|0|||
130725883|NCT00264550|470621125|FG001|Overall Study|Discontinued oral study agent|1|||
130725884|NCT00264550|470621126|FG002|Overall Study|Discontinued oral study agent|0|||
130725885|NCT00264550|470621127|FG003|Overall Study|Discontinued oral study agent|0|||
130725886|NCT00264550|470621124|FG000|Overall Study|Other|13|||
130725887|NCT00264550|470621125|FG001|Overall Study|Other|7|||
130725888|NCT00264550|470621126|FG002|Overall Study|Other|3|||
130725889|NCT00264550|470621127|FG003|Overall Study|Other|9|||
130725890|NCT01439009|470621132|FG000|Overall Study|Physician Decision|5|||
130725891|NCT01439009|470621133|FG001|Overall Study|Physician Decision|3|||
130725892|NCT01439009|470621132|FG000|Overall Study|Protocol Violation|2|||
130725893|NCT01439009|470621133|FG001|Overall Study|Protocol Violation|0|||
130725894|NCT01439009|470621132|FG000|Overall Study|Deviation of exclusion criteria|1|||
130725895|NCT01439009|470621133|FG001|Overall Study|Deviation of exclusion criteria|0|||
130725896|NCT00696787|470621135|FG000|Overall Study|Adverse Event|1|||
130725897|NCT00696787|470621136|FG001|Overall Study|Adverse Event|0|||
130725898|NCT00696787|470621137|FG002|Overall Study|Adverse Event|6|||
130725899|NCT00696787|470621135|FG000|Overall Study|Discontinuation by Sponsor|9|||
130725900|NCT00696787|470621136|FG001|Overall Study|Discontinuation by Sponsor|13|||
130725901|NCT00696787|470621137|FG002|Overall Study|Discontinuation by Sponsor|14|||
130725902|NCT00696787|470621135|FG000|Overall Study|Lack of Efficacy|0|||
130725903|NCT00696787|470621136|FG001|Overall Study|Lack of Efficacy|1|||
130725904|NCT00696787|470621137|FG002|Overall Study|Lack of Efficacy|0|||
130725905|NCT00696787|470621135|FG000|Overall Study|Lost to Follow-up|4|||
130725906|NCT00696787|470621136|FG001|Overall Study|Lost to Follow-up|0|||
130725907|NCT00696787|470621137|FG002|Overall Study|Lost to Follow-up|3|||
130725908|NCT00696787|470621135|FG000|Overall Study|Withdrawal by Subject|0|||
130725909|NCT00696787|470621136|FG001|Overall Study|Withdrawal by Subject|3|||
130725910|NCT00696787|470621137|FG002|Overall Study|Withdrawal by Subject|2|||
130725911|NCT00696787|470621135|FG000|Overall Study|Failed to return|1|||
130725912|NCT00696787|470621136|FG001|Overall Study|Failed to return|3|||
130725913|NCT00696787|470621137|FG002|Overall Study|Failed to return|1|||
130725914|NCT02552303|470621143|FG000|Allocation|Withdrawal by Subject|2|||
130725915|NCT02552303|470621144|FG001|Allocation|Withdrawal by Subject|1|||
130725916|NCT02552303|470621145|FG002|Allocation|Withdrawal by Subject|1|||
130472393|NCT02140645|469696730|FG004|Overall Study|Not linked|3286|||
130472394|NCT02140645|469696731|FG005|Overall Study|Not linked|70896|||
130472395|NCT01101451|469696732|FG000|Overall Study|Eligible and never treated|0|||
130472396|NCT01101451|469696733|FG001|Overall Study|Eligible and never treated|5|||
130472397|NCT01101451|469696732|FG000|Overall Study|Ineligible and treated|12|||
130472398|NCT01101451|469696733|FG001|Overall Study|Ineligible and treated|8|||
130472399|NCT01101451|469696732|FG000|Overall Study|Ineligible and never treated|2|||
130472400|NCT01101451|469696733|FG001|Overall Study|Ineligible and never treated|2|||
130725917|NCT02552303|470621146|FG003|Allocation|Withdrawal by Subject|1|||
130725918|NCT02552303|470621143|FG000|Allocation|ineligible|1|||
130725919|NCT02552303|470621144|FG001|Allocation|ineligible|1|||
130725920|NCT02552303|470621145|FG002|Allocation|ineligible|0|||
130725921|NCT02552303|470621146|FG003|Allocation|ineligible|0|||
130725922|NCT02552303|470621143|FG000|Follow-Up|Lost to Follow-up|0|||
130725923|NCT02552303|470621144|FG001|Follow-Up|Lost to Follow-up|0|||
130725924|NCT02552303|470621145|FG002|Follow-Up|Lost to Follow-up|1|||
130725925|NCT02552303|470621146|FG003|Follow-Up|Lost to Follow-up|0|||
130725926|NCT02552303|470621143|FG000|Follow-Up|ineligible|0|||
130472401|NCT00073749|469696741|FG000|Overall Study|Disease Progression|2|||
130472402|NCT00073749|469696742|FG001|Overall Study|Disease Progression|0|||
130472403|NCT00073749|469696743|FG002|Overall Study|Disease Progression|3|||
130472404|NCT00073749|469696744|FG003|Overall Study|Disease Progression|2|||
130472405|NCT00073749|469696745|FG004|Overall Study|Disease Progression|3|||
130472406|NCT00073749|469696746|FG005|Overall Study|Disease Progression|1|||
130472407|NCT00073749|469696747|FG006|Overall Study|Disease Progression|3|||
130472408|NCT00073749|469696741|FG000|Overall Study|Death|0|||
130472409|NCT00073749|469696742|FG001|Overall Study|Death|1|||
130472410|NCT00073749|469696743|FG002|Overall Study|Death|1|||
130472411|NCT00073749|469696744|FG003|Overall Study|Death|0|||
130472412|NCT00073749|469696745|FG004|Overall Study|Death|0|||
130472413|NCT00073749|469696746|FG005|Overall Study|Death|0|||
130472414|NCT00073749|469696747|FG006|Overall Study|Death|29|||
130472415|NCT00073749|469696741|FG000|Overall Study|Adverse Event|0|||
130472416|NCT00073749|469696742|FG001|Overall Study|Adverse Event|3|||
130472417|NCT00073749|469696743|FG002|Overall Study|Adverse Event|6|||
130472418|NCT00073749|469696744|FG003|Overall Study|Adverse Event|4|||
130472419|NCT00073749|469696745|FG004|Overall Study|Adverse Event|2|||
130472420|NCT00073749|469696746|FG005|Overall Study|Adverse Event|1|||
130472421|NCT00073749|469696747|FG006|Overall Study|Adverse Event|0|||
130472422|NCT00073749|469696741|FG000|Overall Study|Physician Decision|0|||
130472423|NCT00073749|469696742|FG001|Overall Study|Physician Decision|0|||
130472424|NCT00073749|469696743|FG002|Overall Study|Physician Decision|1|||
130472425|NCT00073749|469696744|FG003|Overall Study|Physician Decision|0|||
130472426|NCT00073749|469696745|FG004|Overall Study|Physician Decision|0|||
130472427|NCT00073749|469696746|FG005|Overall Study|Physician Decision|2|||
130472428|NCT00073749|469696747|FG006|Overall Study|Physician Decision|0|||
130472429|NCT00073749|469696741|FG000|Overall Study|Withdrawal by Subject|0|||
130472430|NCT00073749|469696742|FG001|Overall Study|Withdrawal by Subject|1|||
130472431|NCT00073749|469696743|FG002|Overall Study|Withdrawal by Subject|0|||
130472432|NCT00073749|469696744|FG003|Overall Study|Withdrawal by Subject|0|||
130472433|NCT00073749|469696745|FG004|Overall Study|Withdrawal by Subject|1|||
130472434|NCT00073749|469696746|FG005|Overall Study|Withdrawal by Subject|0|||
130472435|NCT00073749|469696747|FG006|Overall Study|Withdrawal by Subject|2|||
130472436|NCT00073749|469696741|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
130472437|NCT00073749|469696742|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130472438|NCT00073749|469696743|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
130472439|NCT00073749|469696744|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130472440|NCT00073749|469696745|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
130472441|NCT00073749|469696746|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
130472442|NCT00073749|469696747|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
130472443|NCT00073749|469696741|FG000|Overall Study|Lost to Follow-up|0|||
130472444|NCT00073749|469696742|FG001|Overall Study|Lost to Follow-up|0|||
130472445|NCT00073749|469696743|FG002|Overall Study|Lost to Follow-up|0|||
130472446|NCT00073749|469696744|FG003|Overall Study|Lost to Follow-up|0|||
130472447|NCT00073749|469696745|FG004|Overall Study|Lost to Follow-up|0|||
130472448|NCT00073749|469696746|FG005|Overall Study|Lost to Follow-up|0|||
130472449|NCT00073749|469696747|FG006|Overall Study|Lost to Follow-up|2|||
130472450|NCT00073749|469696741|FG000|Overall Study|Other|0|||
130472451|NCT00073749|469696742|FG001|Overall Study|Other|0|||
130472452|NCT00073749|469696743|FG002|Overall Study|Other|0|||
130472453|NCT00073749|469696744|FG003|Overall Study|Other|0|||
130472454|NCT00073749|469696745|FG004|Overall Study|Other|0|||
130472455|NCT00073749|469696746|FG005|Overall Study|Other|2|||
130472456|NCT00073749|469696747|FG006|Overall Study|Other|0|||
130472457|NCT00611559|469696748|FG000|Overall Study|Lost to Follow-up|0|||
130472458|NCT00611559|469696749|FG001|Overall Study|Lost to Follow-up|1|||
130472459|NCT00611559|469696750|FG002|Overall Study|Lost to Follow-up|0|||
130472460|NCT00611559|469696748|FG000|Overall Study|Protocol Violation|1|||
130472461|NCT00611559|469696749|FG001|Overall Study|Protocol Violation|0|||
130472462|NCT00611559|469696750|FG002|Overall Study|Protocol Violation|1|||
130561546|NCT01195090|470024783|FG000|Overall Study|Protocol Violation|3|||
130472463|NCT04999592|469696751|FG000|Overall Study|Withdrawal by Subject|1|||
130472464|NCT04999592|469696752|FG001|Overall Study|Withdrawal by Subject|0|||
130472465|NCT04095104|469696753|FG000|Overall Study|Withdrawal by Subject|0|||
130725927|NCT02552303|470621144|FG001|Follow-Up|ineligible|2|||
130725928|NCT02552303|470621145|FG002|Follow-Up|ineligible|0|||
130725929|NCT02552303|470621146|FG003|Follow-Up|ineligible|0|||
130725930|NCT01377987|470621149|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
130725931|NCT01377987|470621150|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130725932|NCT00253448|470621151|FG000|Overall Study|Withdrawal by Subject|1|||
130725933|NCT02052011|470621152|FG000|Overall Study|Lost to Follow-up|3|||
130725934|NCT02052011|470621153|FG001|Overall Study|Lost to Follow-up|0|||
130725935|NCT02052011|470621152|FG000|Overall Study|Withdrawal by Subject|1|||
130725936|NCT02052011|470621153|FG001|Overall Study|Withdrawal by Subject|2|||
130725937|NCT00000620|470621154|FG000|Overall Study|Death|86|||
130725938|NCT00000620|470621155|FG001|Overall Study|Death|67|||
130725939|NCT00000620|470621156|FG002|Overall Study|Death|112|||
130725940|NCT00000620|470621157|FG003|Overall Study|Death|126|||
130725941|NCT00000620|470621158|FG004|Overall Study|Death|64|||
130725942|NCT00000620|470621159|FG005|Overall Study|Death|77|||
130725943|NCT00000620|470621160|FG006|Overall Study|Death|91|||
130725944|NCT00000620|470621161|FG007|Overall Study|Death|95|||
130725945|NCT00000620|470621154|FG000|Overall Study|Lost to Follow-up|14|||
130725946|NCT00000620|470621155|FG001|Overall Study|Lost to Follow-up|14|||
130725947|NCT00000620|470621156|FG002|Overall Study|Lost to Follow-up|14|||
130725948|NCT00000620|470621157|FG003|Overall Study|Lost to Follow-up|14|||
130725949|NCT00000620|470621158|FG004|Overall Study|Lost to Follow-up|15|||
130725950|NCT00000620|470621159|FG005|Overall Study|Lost to Follow-up|15|||
130725951|NCT00000620|470621160|FG006|Overall Study|Lost to Follow-up|13|||
130725952|NCT00000620|470621161|FG007|Overall Study|Lost to Follow-up|14|||
130725953|NCT00000620|470621154|FG000|Overall Study|Withdrawal by Subject|40|||
130725954|NCT00000620|470621155|FG001|Overall Study|Withdrawal by Subject|27|||
130725955|NCT00000620|470621156|FG002|Overall Study|Withdrawal by Subject|28|||
130725956|NCT00000620|470621157|FG003|Overall Study|Withdrawal by Subject|27|||
130725957|NCT00000620|470621158|FG004|Overall Study|Withdrawal by Subject|30|||
130725958|NCT00000620|470621159|FG005|Overall Study|Withdrawal by Subject|32|||
130725959|NCT00000620|470621160|FG006|Overall Study|Withdrawal by Subject|32|||
130725960|NCT00000620|470621161|FG007|Overall Study|Withdrawal by Subject|21|||
130725961|NCT00000620|470621154|FG000|Overall Study|missed closeout visit|22|||
130725962|NCT00000620|470621155|FG001|Overall Study|missed closeout visit|28|||
130725963|NCT00000620|470621156|FG002|Overall Study|missed closeout visit|16|||
130725964|NCT00000620|470621157|FG003|Overall Study|missed closeout visit|11|||
130725965|NCT00000620|470621158|FG004|Overall Study|missed closeout visit|26|||
130725966|NCT00000620|470621159|FG005|Overall Study|missed closeout visit|28|||
130725967|NCT00000620|470621160|FG006|Overall Study|missed closeout visit|13|||
130725968|NCT00000620|470621161|FG007|Overall Study|missed closeout visit|16|||
130725969|NCT02648932|470621162|FG000|Overall Study|No transplant|3|||
130725970|NCT02648932|470621163|FG001|Overall Study|No transplant|1|||
130725971|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
130725972|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
130725973|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725974|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725975|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725976|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725977|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725978|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725979|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725980|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725981|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725982|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
130725983|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725984|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725985|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725986|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725987|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725988|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725989|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725990|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130472466|NCT04095104|469696754|FG001|Overall Study|Withdrawal by Subject|1|||
130725991|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
130725992|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
130725993|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725994|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725995|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725996|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130472467|NCT03912831|469696756|FG000|Overall Study|Death|1|||
130725997|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130472468|NCT03912831|469696757|FG001|Overall Study|Death|1|||
130472469|NCT03912831|469696758|FG002|Overall Study|Death|1|||
130472470|NCT03912831|469696759|FG003|Overall Study|Death|1|||
130472471|NCT03912831|469696760|FG004|Overall Study|Death|1|||
130472472|NCT03912831|469696761|FG005|Overall Study|Death|1|||
130472473|NCT03912831|469696756|FG000|Overall Study|Reason not Specified|0|||
130472474|NCT03912831|469696757|FG001|Overall Study|Reason not Specified|0|||
130472475|NCT03912831|469696758|FG002|Overall Study|Reason not Specified|0|||
130472476|NCT03912831|469696759|FG003|Overall Study|Reason not Specified|0|||
130472477|NCT03912831|469696760|FG004|Overall Study|Reason not Specified|1|||
130725998|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725999|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130726000|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130726001|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130726002|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130726003|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726004|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726005|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726006|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726007|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726008|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726009|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726010|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726011|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726012|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726013|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130726014|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130726015|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726016|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
130726017|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726018|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726019|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726020|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726021|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726022|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726023|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130726024|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726025|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130726026|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726027|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726028|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726029|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726030|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726031|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
130726032|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
130726033|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
130726034|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
130726035|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
130726036|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
130726037|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
130726038|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
130726039|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
130726040|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
130726041|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726042|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726043|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726044|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726045|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726046|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726047|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
130726048|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
130472478|NCT03912831|469696761|FG005|Overall Study|Reason not Specified|0|||
130726049|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
130726050|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726051|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130472479|NCT03912831|469696756|FG000|Overall Study|Withdrawal by Participant|0|||
130561547|NCT01195090|470024784|FG001|Overall Study|Protocol Violation|4|||
130561548|NCT05111041|470024785|FG000|Overall Study|Lost to Follow-up|6|||
130561549|NCT05111041|470024786|FG001|Overall Study|Lost to Follow-up|7|||
130561550|NCT05111041|470024785|FG000|Overall Study|Withdrawal by Subject|1|||
130561551|NCT05111041|470024786|FG001|Overall Study|Withdrawal by Subject|0|||
130407834|NCT00724451|469455825|FG000|Overall Study|Withdrawal by Subject|45|||
130407835|NCT00724451|469455825|FG000|Overall Study|Investigator + Participant Decision|13|||
130407836|NCT01260922|469455827|FG000|First Intervention|Withdrawal by Subject|0|||
130407837|NCT01260922|469455828|FG001|First Intervention|Withdrawal by Subject|1|||
130407838|NCT01260922|469455827|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
130407839|NCT01260922|469455828|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
130407840|NCT01260922|469455827|FG000|Second Intervention|Emesis|0|||
130407841|NCT01260922|469455828|FG001|Second Intervention|Emesis|2|||
130407842|NCT02822794|469455833|FG000|Overall Study|Withdrew Consent|1|||
130407843|NCT02822794|469455834|FG001|Overall Study|Withdrew Consent|0|||
130407844|NCT03732248|469455835|FG000|Overall Study|Withdrawal by Subject|1|||
130407845|NCT03732248|469455836|FG001|Overall Study|Withdrawal by Subject|0|||
130407846|NCT01525082|469455841|FG000|Overall Study|Death|1|||
130407847|NCT02480621|469455842|FG000|Randomization|Withdrawal by Subject|1|||
130407848|NCT02480621|469455843|FG001|Randomization|Withdrawal by Subject|0|||
130407849|NCT02480621|469455842|FG000|Randomization|Surgeon did not give intervention|0|||
130407850|NCT02480621|469455843|FG001|Randomization|Surgeon did not give intervention|1|||
130407851|NCT02480621|469455842|FG000|Follow Up|Lost to Follow-up|4|||
130407852|NCT02480621|469455843|FG001|Follow Up|Lost to Follow-up|2|||
130407853|NCT03056690|469455844|FG000|Overall Study|Adverse Event|3|||
130407854|NCT03056690|469455845|FG001|Overall Study|Adverse Event|2|||
130407855|NCT03056690|469455844|FG000|Overall Study|Lack of Efficacy|1|||
130407856|NCT03056690|469455845|FG001|Overall Study|Lack of Efficacy|2|||
130407857|NCT03056690|469455844|FG000|Overall Study|Lost to Follow-up|3|||
130407858|NCT03056690|469455845|FG001|Overall Study|Lost to Follow-up|2|||
130407859|NCT03056690|469455844|FG000|Overall Study|Protocol Violation|2|||
130407860|NCT03056690|469455845|FG001|Overall Study|Protocol Violation|2|||
130407861|NCT03056690|469455844|FG000|Overall Study|Withdrawal by Subject|3|||
130407862|NCT03056690|469455845|FG001|Overall Study|Withdrawal by Subject|6|||
130407863|NCT03056690|469455844|FG000|Overall Study|Non-compliance with Study Drug|1|||
130407864|NCT03056690|469455845|FG001|Overall Study|Non-compliance with Study Drug|0|||
130407865|NCT03056690|469455844|FG000|Overall Study|Miscellaneous|1|||
130407866|NCT03056690|469455845|FG001|Overall Study|Miscellaneous|2|||
130407867|NCT02141516|469455852|FG000|Overall Study|Adverse Event|0|||
130407868|NCT02141516|469455853|FG001|Overall Study|Adverse Event|1|||
130407869|NCT02141516|469455854|FG002|Overall Study|Adverse Event|0|||
130407870|NCT02141516|469455852|FG000|Overall Study|Lost to Follow-up|0|||
130407871|NCT02141516|469455853|FG001|Overall Study|Lost to Follow-up|1|||
130561552|NCT01205230|470024787|FG000|Overall Study|Adverse Event|4|||
130407872|NCT02141516|469455854|FG002|Overall Study|Lost to Follow-up|0|||
130407873|NCT02141516|469455852|FG000|Overall Study|Other|0|||
130407874|NCT02141516|469455853|FG001|Overall Study|Other|3|||
130407875|NCT02141516|469455854|FG002|Overall Study|Other|0|||
130407876|NCT01440946|469455855|FG000|Overall Study|Lost to Follow-up|1|||
130407877|NCT01440946|469455856|FG001|Overall Study|Lost to Follow-up|1|||
130407878|NCT01440946|469455855|FG000|Overall Study|Physician Decision|1|||
130407879|NCT01440946|469455856|FG001|Overall Study|Physician Decision|0|||
130407880|NCT00235989|469455863|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
130407881|NCT00235989|469455864|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
130407882|NCT00235989|469455865|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
130407883|NCT00235989|469455866|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
130407884|NCT00235989|469455867|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
130407885|NCT00235989|469455868|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
130407886|NCT00235989|469455863|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
130561553|NCT01205230|470024788|FG001|Overall Study|Adverse Event|0|||
130561554|NCT01205230|470024787|FG000|Overall Study|Physician Decision|1|||
130561555|NCT01205230|470024788|FG001|Overall Study|Physician Decision|0|||
130561556|NCT00041080|470024789|FG000|Overall Study|Adverse Event|21|||
130561557|NCT00041080|470024790|FG001|Overall Study|Adverse Event|1|||
130561558|NCT00041080|470024789|FG000|Overall Study|Withdrawal by Subject|6|||
130561559|NCT00041080|470024790|FG001|Overall Study|Withdrawal by Subject|6|||
130561560|NCT00041080|470024789|FG000|Overall Study|Concommitant Illness/Other|1|||
130561561|NCT00041080|470024790|FG001|Overall Study|Concommitant Illness/Other|2|||
130407887|NCT00235989|469455864|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
130407888|NCT00235989|469455865|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
130407889|NCT00235989|469455866|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
130407890|NCT00235989|469455867|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
130407891|NCT00235989|469455868|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
130407892|NCT00235989|469455863|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
130407893|NCT00235989|469455864|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130407894|NCT00235989|469455865|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
130407895|NCT00235989|469455866|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130407896|NCT00235989|469455867|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130407897|NCT00235989|469455868|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130407898|NCT00235989|469455863|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130407899|NCT00235989|469455864|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130472480|NCT03912831|469696757|FG001|Overall Study|Withdrawal by Participant|0|||
130472481|NCT03912831|469696758|FG002|Overall Study|Withdrawal by Participant|0|||
130472482|NCT03912831|469696759|FG003|Overall Study|Withdrawal by Participant|0|||
130561562|NCT00041080|470024789|FG000|Overall Study|Did not start therapy|1|||
130561563|NCT00041080|470024790|FG001|Overall Study|Did not start therapy|1|||
130561564|NCT00041080|470024789|FG000|Overall Study|Ineligible|1|||
130561565|NCT00041080|470024790|FG001|Overall Study|Ineligible|0|||
130561566|NCT00922480|470024791|FG000|Main Study|Protocol Violation|3|||
130561567|NCT00922480|470024792|FG001|Main Study|Protocol Violation|6|||
130561568|NCT00922480|470024791|FG000|Main Study|Adverse Event|6|||
130561569|NCT00922480|470024792|FG001|Main Study|Adverse Event|7|||
130561570|NCT00922480|470024791|FG000|Main Study|Lack of Efficacy|3|||
130561571|NCT00922480|470024792|FG001|Main Study|Lack of Efficacy|0|||
130561572|NCT00922480|470024791|FG000|Main Study|Withdrawal by Subject|20|||
130561573|NCT00922480|470024792|FG001|Main Study|Withdrawal by Subject|15|||
130472483|NCT03912831|469696760|FG004|Overall Study|Withdrawal by Participant|1|||
130472484|NCT03912831|469696761|FG005|Overall Study|Withdrawal by Participant|0|||
130472485|NCT03527160|469696762|FG000|Overall Study|No urine collected|13|||
130472486|NCT03527160|469696762|FG000|Overall Study|No clinical serum creatinine collected|6|||
130472487|NCT03527160|469696762|FG000|Overall Study|Did not meet inclusion|2|||
130472488|NCT03767517|469696764|FG000|Overall Study|Lost to Follow-up|16|||
130472489|NCT03767517|469696765|FG001|Overall Study|Lost to Follow-up|10|||
130472490|NCT03767517|469696764|FG000|Overall Study|Death|2|||
130472491|NCT03767517|469696765|FG001|Overall Study|Death|3|||
130472492|NCT04774237|469696766|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
130472493|NCT04774237|469696767|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
130472494|NCT04774237|469696768|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
130472495|NCT04774237|469696769|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
130472496|NCT04774237|469696770|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
130472497|NCT04774237|469696771|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
130472498|NCT03152786|469698342|FG000|Overall Study|Withdrawal by Subject|2|||
130472499|NCT03152786|469698343|FG001|Overall Study|Withdrawal by Subject|1|||
130472500|NCT00753090|469698355|FG000|Overall Study|Withdrawal by Subject|10|||
130472501|NCT00753090|469698356|FG001|Overall Study|Withdrawal by Subject|10|||
130472502|NCT00753090|469698355|FG000|Overall Study|Death|17|||
130472503|NCT00753090|469698356|FG001|Overall Study|Death|6|||
130472504|NCT00753090|469698355|FG000|Overall Study|Study Prosthesis Removed|12|||
130472505|NCT00753090|469698356|FG001|Overall Study|Study Prosthesis Removed|3|||
130472506|NCT00753090|469698355|FG000|Overall Study|Lost to Follow-up|2|||
130472507|NCT00753090|469698356|FG001|Overall Study|Lost to Follow-up|2|||
130561574|NCT00922480|470024791|FG000|Main Study|Lost to Follow-up|5|||
130561575|NCT00922480|470024792|FG001|Main Study|Lost to Follow-up|0|||
130561576|NCT00922480|470024791|FG000|Main Study|Physician Decision|0|||
130561577|NCT00922480|470024792|FG001|Main Study|Physician Decision|1|||
130407900|NCT00235989|469455865|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130407901|NCT00235989|469455866|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
130472508|NCT00753090|469698355|FG000|Overall Study|Other|127|||
130472509|NCT00753090|469698356|FG001|Overall Study|Other|75|||
130561578|NCT00922480|470024791|FG000|Extension Study|Protocol Violation|3|||
130561579|NCT00922480|470024792|FG001|Extension Study|Protocol Violation|0|||
130472510|NCT06066541|469698357|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
130472511|NCT06066541|469698358|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
130472512|NCT06066541|469698359|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
130561580|NCT00922480|470024791|FG000|Extension Study|Adverse Event|1|||
130561581|NCT00922480|470024792|FG001|Extension Study|Adverse Event|1|||
130726052|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726053|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726054|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726055|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726056|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726057|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726058|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
130726059|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726060|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726061|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726062|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726063|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726064|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726065|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726066|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726067|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
130726068|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130726069|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130726070|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
130726071|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726072|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726073|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726074|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726075|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726076|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726077|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
130726078|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726079|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726080|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726081|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
130407902|NCT00235989|469455867|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
130407903|NCT00235989|469455868|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
130407904|NCT00235989|469455863|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
130407905|NCT00235989|469455864|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
130407906|NCT00235989|469455865|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
130407907|NCT00235989|469455866|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
130407908|NCT00235989|469455867|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
130407909|NCT00235989|469455868|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
130407910|NCT00983580|469455869|FG000|Overall Study|Cancel Prior to treatment|1|||
130407911|NCT00983580|469455870|FG001|Overall Study|Cancel Prior to treatment|3|||
130407912|NCT00983580|469455869|FG000|Overall Study|Protocol Violation|1|||
130407913|NCT00983580|469455870|FG001|Overall Study|Protocol Violation|1|||
130407914|NCT00983580|469455869|FG000|Overall Study|Ineligible|3|||
130407915|NCT00983580|469455870|FG001|Overall Study|Ineligible|0|||
130407916|NCT02316717|469455873|FG000|Overall Study|Adverse Event|2|||
130407917|NCT02316717|469455874|FG001|Overall Study|Adverse Event|2|||
130407918|NCT02316717|469455875|FG002|Overall Study|Adverse Event|0|||
130407919|NCT02316717|469455873|FG000|Overall Study|Lost to Follow-up|1|||
130407920|NCT02316717|469455874|FG001|Overall Study|Lost to Follow-up|2|||
130407921|NCT02316717|469455875|FG002|Overall Study|Lost to Follow-up|1|||
130407922|NCT02316717|469455873|FG000|Overall Study|Non compliance|3|||
130407923|NCT02316717|469455874|FG001|Overall Study|Non compliance|1|||
130407924|NCT02316717|469455875|FG002|Overall Study|Non compliance|0|||
130407925|NCT02316717|469455873|FG000|Overall Study|Protocol Violation|2|||
130407926|NCT02316717|469455874|FG001|Overall Study|Protocol Violation|0|||
130407927|NCT02316717|469455875|FG002|Overall Study|Protocol Violation|0|||
130407928|NCT02316717|469455873|FG000|Overall Study|Withdrawal by Subject|2|||
130561582|NCT00922480|470024791|FG000|Extension Study|Withdrawal by Subject|1|||
130407929|NCT02316717|469455874|FG001|Overall Study|Withdrawal by Subject|1|||
130407930|NCT02316717|469455875|FG002|Overall Study|Withdrawal by Subject|1|||
130407931|NCT02316717|469455873|FG000|Overall Study|Death|0|||
130407932|NCT02316717|469455874|FG001|Overall Study|Death|0|||
130407933|NCT02316717|469455875|FG002|Overall Study|Death|1|||
130407934|NCT02316717|469455873|FG000|Overall Study|Physician Decision|0|||
130407935|NCT02316717|469455874|FG001|Overall Study|Physician Decision|1|||
130407936|NCT02316717|469455875|FG002|Overall Study|Physician Decision|0|||
130407937|NCT02316717|469455873|FG000|Overall Study|TBC|1|||
130407938|NCT02316717|469455874|FG001|Overall Study|TBC|0|||
130407939|NCT02316717|469455875|FG002|Overall Study|TBC|0|||
130472513|NCT06066541|469698360|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
130472514|NCT06066541|469698361|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
130472515|NCT06066541|469698362|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
130472516|NCT06066541|469698363|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
130472517|NCT06066541|469698357|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
130472518|NCT06066541|469698358|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
130472519|NCT06066541|469698359|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
130472520|NCT06066541|469698360|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
130472521|NCT06066541|469698361|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
130472522|NCT06066541|469698362|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
130472523|NCT06066541|469698363|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
130472524|NCT04533022|469698364|FG000|Overall Study|Withdrawal by Subject|15|||
130472525|NCT04533022|469698364|FG000|Overall Study|Adverse Event|6|||
130472526|NCT04533022|469698364|FG000|Overall Study|Death|1|||
130472527|NCT04533022|469698364|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
130472528|NCT04533022|469698364|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
130472529|NCT02163447|469698365|FG000|Overall Study|Withdrawal by Subject|2|||
130472530|NCT02163447|469698366|FG001|Overall Study|Withdrawal by Subject|0|||
130472531|NCT02163447|469698367|FG002|Overall Study|Withdrawal by Subject|1|||
130472532|NCT02163447|469698365|FG000|Overall Study|Lost to Follow-up|1|||
130472533|NCT02163447|469698366|FG001|Overall Study|Lost to Follow-up|3|||
130472534|NCT02163447|469698367|FG002|Overall Study|Lost to Follow-up|0|||
130472535|NCT02163447|469698365|FG000|Overall Study|Moved out of study area|2|||
130472536|NCT02163447|469698366|FG001|Overall Study|Moved out of study area|3|||
130472537|NCT02163447|469698367|FG002|Overall Study|Moved out of study area|2|||
130472538|NCT02163447|469698365|FG000|Overall Study|Became HIV infected at time of delivery|1|||
130472539|NCT02163447|469698366|FG001|Overall Study|Became HIV infected at time of delivery|0|||
130472540|NCT02163447|469698367|FG002|Overall Study|Became HIV infected at time of delivery|0|||
130472541|NCT04052516|469698369|FG000|Overall Study|Withdrawal by Subject|4|||
130472542|NCT04052516|469698370|FG001|Overall Study|Withdrawal by Subject|5|||
130472543|NCT04052516|469698371|FG002|Overall Study|Withdrawal by Subject|6|||
130472544|NCT04052516|469698369|FG000|Overall Study|Adverse Event|3|||
130472545|NCT04052516|469698370|FG001|Overall Study|Adverse Event|2|||
130472546|NCT04052516|469698371|FG002|Overall Study|Adverse Event|8|||
130472547|NCT04052516|469698369|FG000|Overall Study|Lost to Follow-up|2|||
130472548|NCT04052516|469698370|FG001|Overall Study|Lost to Follow-up|5|||
130472549|NCT04052516|469698371|FG002|Overall Study|Lost to Follow-up|3|||
130472550|NCT04052516|469698369|FG000|Overall Study|Protocol Violation|1|||
130472551|NCT04052516|469698370|FG001|Overall Study|Protocol Violation|1|||
130472552|NCT04052516|469698371|FG002|Overall Study|Protocol Violation|0|||
130472553|NCT04052516|469698369|FG000|Overall Study|Death|1|||
130472554|NCT04052516|469698370|FG001|Overall Study|Death|0|||
130472555|NCT04052516|469698371|FG002|Overall Study|Death|0|||
130472556|NCT04052516|469698369|FG000|Overall Study|Physician Decision|0|||
130472557|NCT04052516|469698370|FG001|Overall Study|Physician Decision|1|||
130472558|NCT04052516|469698371|FG002|Overall Study|Physician Decision|0|||
130472559|NCT04052516|469698369|FG000|Overall Study|Pregnancy|1|||
130472560|NCT04052516|469698370|FG001|Overall Study|Pregnancy|0|||
130472561|NCT04052516|469698371|FG002|Overall Study|Pregnancy|0|||
130472562|NCT04052516|469698369|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
130472563|NCT04052516|469698370|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
130472564|NCT04052516|469698371|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
130472565|NCT04052516|469698369|FG000|Overall Study|Reason not recorded|0|||
130472566|NCT04052516|469698370|FG001|Overall Study|Reason not recorded|1|||
130472567|NCT04052516|469698371|FG002|Overall Study|Reason not recorded|0|||
130472568|NCT05113966|469698372|FG000|Overall Study|Death|21|||
130472569|NCT05113966|469698372|FG000|Overall Study|Study Terminated by Sponsor|9|||
130472570|NCT05386355|469698373|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
130472571|NCT05386355|469698374|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
130472572|NCT05386355|469698375|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
130472573|NCT05386355|469698376|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
130472574|NCT06143670|469698377|FG000|Overall Study|Lost to Follow-up|0|||
130472575|NCT06143670|469698378|FG001|Overall Study|Lost to Follow-up|1|||
130472576|NCT06143670|469698377|FG000|Overall Study|Withdrawal by Subject|3|||
130472577|NCT06143670|469698378|FG001|Overall Study|Withdrawal by Subject|0|||
130472578|NCT03747484|469698379|FG000|Overall Study|Lack of Efficacy|0|||
130472579|NCT03747484|469698380|FG001|Overall Study|Lack of Efficacy|1|||
130472580|NCT03747484|469698381|FG002|Overall Study|Lack of Efficacy|1|||
130472581|NCT03747484|469698382|FG003|Overall Study|Lack of Efficacy|2|||
130472582|NCT03747484|469698383|FG004|Overall Study|Lack of Efficacy|2|||
130472583|NCT02597946|469698387|FG000|Overall Study|Withdrawal by Subject|1|||
130407940|NCT01072201|469455876|FG000|Overall Study|Lost to Follow-up|0|||
130407941|NCT01072201|469455877|FG001|Overall Study|Lost to Follow-up|1|||
130407942|NCT02052466|469455878|FG000|Overall Study|Withdrawal by Subject|1|||
130407943|NCT02052466|469455878|FG000|Overall Study|Acromial fracture|1|||
130407944|NCT00360334|469455879|FG000|Overall Study|Adverse Event|7|||
130407945|NCT00360334|469455880|FG001|Overall Study|Adverse Event|4|||
130407946|NCT00360334|469455879|FG000|Overall Study|Protocol Violation|1|||
130407947|NCT00360334|469455880|FG001|Overall Study|Protocol Violation|1|||
130407948|NCT00360334|469455879|FG000|Overall Study|Physician Decision|2|||
130407949|NCT00360334|469455880|FG001|Overall Study|Physician Decision|3|||
130407950|NCT00360334|469455879|FG000|Overall Study|Lack of Efficacy|0|||
130407951|NCT00360334|469455880|FG001|Overall Study|Lack of Efficacy|1|||
130407952|NCT00360334|469455879|FG000|Overall Study|Entry criterion not met|1|||
130407953|NCT00360334|469455880|FG001|Overall Study|Entry criterion not met|2|||
130407954|NCT00360334|469455879|FG000|Overall Study|Subject decision|8|||
130726082|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726083|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726084|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726085|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726086|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726087|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726088|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
130726089|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726090|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726091|NCT01307111|470621179|FG000|IUD Insertion|Lost to Follow-up|2|||
130726092|NCT01307111|470621180|FG001|IUD Insertion|Lost to Follow-up|0|||
130726093|NCT01307111|470621179|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130726094|NCT01307111|470621180|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130726095|NCT01333397|470621181|FG000|Overall Study|Lost to Follow-up|1|||
130726096|NCT01333397|470621182|FG001|Overall Study|Lost to Follow-up|0|||
130726097|NCT01333397|470621183|FG002|Overall Study|Lost to Follow-up|0|||
130726098|NCT01333397|470621184|FG003|Overall Study|Lost to Follow-up|1|||
130726099|NCT01333397|470621185|FG004|Overall Study|Lost to Follow-up|0|||
130726100|NCT01085357|470621186|FG000|Overall Study|Adverse Event|1|||
130726101|NCT01085357|470621187|FG001|Overall Study|Adverse Event|1|||
130726102|NCT01085357|470621186|FG000|Overall Study|Subject Decision|4|||
130726103|NCT01085357|470621187|FG001|Overall Study|Subject Decision|3|||
130726104|NCT01085357|470621186|FG000|Overall Study|Investigator Decision|1|||
130726105|NCT01085357|470621187|FG001|Overall Study|Investigator Decision|1|||
130726106|NCT01085357|470621186|FG000|Overall Study|Death|11|||
130726107|NCT01085357|470621187|FG001|Overall Study|Death|1|||
130726108|NCT01085357|470621186|FG000|Overall Study|Lost to Follow-up|2|||
130726109|NCT01085357|470621187|FG001|Overall Study|Lost to Follow-up|0|||
130726110|NCT00920790|470621195|FG000|Overall Study|aggravation of general condition|14|||
130726111|NCT02892149|470621196|FG000|Overall Study|Death|262|||
130726112|NCT02892149|470621197|FG001|Overall Study|Death|278|||
130726113|NCT02892149|470621196|FG000|Overall Study|Withdrawal by Subject|53|||
130726114|NCT02892149|470621197|FG001|Overall Study|Withdrawal by Subject|47|||
130726115|NCT02892149|470621196|FG000|Overall Study|Lost to Follow-up|37|||
130726116|NCT02892149|470621197|FG001|Overall Study|Lost to Follow-up|31|||
130726117|NCT00478426|470621202|FG000|Overall Study|Withdrawal by Subject|1|||
130726118|NCT00384930|470621203|FG000|Overall Study|Adverse Event|5|||
130726119|NCT00384930|470621204|FG001|Overall Study|Adverse Event|4|||
130726120|NCT00384930|470621205|FG002|Overall Study|Adverse Event|12|||
130726121|NCT00384930|470621206|FG003|Overall Study|Adverse Event|11|||
130726122|NCT00384930|470621207|FG004|Overall Study|Adverse Event|14|||
130726123|NCT00384930|470621203|FG000|Overall Study|Entry Criteria Not Met|2|||
130726124|NCT00384930|470621204|FG001|Overall Study|Entry Criteria Not Met|6|||
130726125|NCT00384930|470621205|FG002|Overall Study|Entry Criteria Not Met|7|||
130726126|NCT00384930|470621206|FG003|Overall Study|Entry Criteria Not Met|8|||
130726127|NCT00384930|470621207|FG004|Overall Study|Entry Criteria Not Met|4|||
130726128|NCT00384930|470621203|FG000|Overall Study|Lack of Efficacy|1|||
130726129|NCT00384930|470621204|FG001|Overall Study|Lack of Efficacy|1|||
130726130|NCT00384930|470621205|FG002|Overall Study|Lack of Efficacy|2|||
130726131|NCT00384930|470621206|FG003|Overall Study|Lack of Efficacy|1|||
130726132|NCT00384930|470621207|FG004|Overall Study|Lack of Efficacy|2|||
130726133|NCT00384930|470621203|FG000|Overall Study|Lost to Follow-up|5|||
130726134|NCT00384930|470621204|FG001|Overall Study|Lost to Follow-up|3|||
130726135|NCT00384930|470621205|FG002|Overall Study|Lost to Follow-up|0|||
130407955|NCT00360334|469455880|FG001|Overall Study|Subject decision|2|||
130407956|NCT00595582|469455881|FG000|Overall Study|Pilot study that PI terminated|2|||
130407957|NCT00595582|469455881|FG000|Overall Study|Lost to Follow-up|1|||
130407958|NCT00595582|469455881|FG000|Overall Study|Adverse Event|2|||
130407959|NCT00595582|469455881|FG000|Overall Study|Physician Decision|5|||
130407960|NCT01978184|469455883|FG000|Overall Study|Progressive disease|5|||
130726136|NCT00384930|470621206|FG003|Overall Study|Lost to Follow-up|4|||
130726137|NCT00384930|470621207|FG004|Overall Study|Lost to Follow-up|6|||
130726138|NCT00384930|470621203|FG000|Overall Study|Physician Decision|0|||
130472584|NCT02597946|469698387|FG000|Overall Study|Progressive disease|16|||
130472585|NCT02597946|469698387|FG000|Overall Study|Other than above|1|||
130472586|NCT03625882|469698391|FG000|Overall Study|Protocol Violation|3|||
130472587|NCT05058391|469698399|FG000|Overall Study|Adverse Event|1|||
130472588|NCT03833245|469698402|FG000|Overall Study|Death|0|||
130472589|NCT03833245|469698403|FG001|Overall Study|Death|1|||
130472590|NCT00739648|469698404|FG000|Overall Study|Adverse Event|3|||
130472591|NCT00739648|469698405|FG001|Overall Study|Adverse Event|15|||
130472592|NCT00739648|469698404|FG000|Overall Study|Withdrawal by Subject|13|||
130472593|NCT00739648|469698405|FG001|Overall Study|Withdrawal by Subject|25|||
130472594|NCT00739648|469698404|FG000|Overall Study|Lost to Follow-up|4|||
130472595|NCT00739648|469698405|FG001|Overall Study|Lost to Follow-up|7|||
130472596|NCT00739648|469698404|FG000|Overall Study|Death|2|||
130472597|NCT00739648|469698405|FG001|Overall Study|Death|0|||
130472598|NCT00739648|469698404|FG000|Overall Study|Do not know|4|||
130472599|NCT00739648|469698405|FG001|Overall Study|Do not know|6|||
130472600|NCT05110495|469698406|FG000|Overall Study|Lost to Follow-up|1|||
130472601|NCT05110495|469698406|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
130472602|NCT04173663|469698407|FG000|Overall Study|Withdrawal by Subject|1|||
130472603|NCT04173663|469698408|FG001|Overall Study|Withdrawal by Subject|6|||
130472604|NCT04173663|469698407|FG000|Overall Study|Lost to Follow-up|17|||
130472605|NCT04173663|469698408|FG001|Overall Study|Lost to Follow-up|24|||
130472606|NCT01757665|469698410|FG000|Overall Study|Still on Study - Visit Completed|240|||
130472607|NCT01757665|469698411|FG001|Overall Study|Still on Study - Visit Completed|30|||
130472608|NCT01757665|469698410|FG000|Overall Study|Still on Study - Visit Pending|398|||
130472609|NCT01757665|469698411|FG001|Overall Study|Still on Study - Visit Pending|40|||
130472610|NCT01757665|469698410|FG000|Overall Study|Still on Study - Missed Visit|14|||
130472611|NCT01757665|469698411|FG001|Overall Study|Still on Study - Missed Visit|1|||
130472612|NCT01757665|469698410|FG000|Overall Study|Death|25|||
130472613|NCT01757665|469698411|FG001|Overall Study|Death|8|||
130472614|NCT01757665|469698410|FG000|Overall Study|Explant|1|||
130472615|NCT01757665|469698411|FG001|Overall Study|Explant|2|||
130472616|NCT01757665|469698410|FG000|Overall Study|Withdrawal by Subject|10|||
130472617|NCT01757665|469698411|FG001|Overall Study|Withdrawal by Subject|0|||
130472618|NCT01757665|469698410|FG000|Overall Study|Lost to Follow-up|1|||
130472619|NCT01757665|469698411|FG001|Overall Study|Lost to Follow-up|1|||
130472620|NCT01757665|469698410|FG000|Overall Study|Not Implanted with Device|5|||
130472621|NCT01757665|469698411|FG001|Overall Study|Not Implanted with Device|1|||
130472622|NCT03089398|469698419|FG000|Overall Study|Death|4|||
130472623|NCT03089398|469698420|FG001|Overall Study|Death|9|||
130472624|NCT03089398|469698419|FG000|Overall Study|Lost to Follow-up|21|||
130472625|NCT03089398|469698420|FG001|Overall Study|Lost to Follow-up|30|||
130472626|NCT03089398|469698419|FG000|Overall Study|Withdrawal by Subject|2|||
130472627|NCT03089398|469698420|FG001|Overall Study|Withdrawal by Subject|2|||
130726139|NCT00384930|470621204|FG001|Overall Study|Physician Decision|1|||
130726140|NCT00384930|470621205|FG002|Overall Study|Physician Decision|1|||
130726141|NCT00384930|470621206|FG003|Overall Study|Physician Decision|0|||
130407961|NCT01978184|469455884|FG001|Overall Study|Progressive disease|5|||
130407962|NCT01978184|469455883|FG000|Overall Study|Other than PDA|2|||
130407963|NCT01978184|469455884|FG001|Overall Study|Other than PDA|2|||
130407964|NCT01978184|469455883|FG000|Overall Study|Physician Decision|0|||
130407965|NCT01978184|469455884|FG001|Overall Study|Physician Decision|3|||
130407966|NCT01978184|469455883|FG000|Overall Study|Noncompliance|1|||
130407967|NCT01978184|469455884|FG001|Overall Study|Noncompliance|2|||
130407968|NCT01978184|469455883|FG000|Overall Study|Death|1|||
130407969|NCT01978184|469455884|FG001|Overall Study|Death|0|||
130407970|NCT01978184|469455883|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
130407971|NCT01978184|469455884|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
130407972|NCT00555438|469455889|FG000|10 Days Post-operative|Death|4|||
130407973|NCT00555438|469455889|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
130472628|NCT05062265|469698421|FG000|Overall Study|Withdrawal by Subject|1|||
130472629|NCT05062265|469698422|FG001|Overall Study|Withdrawal by Subject|0|||
130472630|NCT05439603|469698423|FG000|Overall Study|met withdrawal criteria|2|||
130472631|NCT05461131|469698424|FG000|Overall Study|Lost to Follow-up|0|||
130472632|NCT05461131|469698425|FG001|Overall Study|Lost to Follow-up|2|||
130472633|NCT03101904|469698431|FG000|Wash Out (10 Days)|Adverse Event|1|||
130472634|NCT03101904|469698432|FG001|Wash Out (10 Days)|Adverse Event|0|||
130472635|NCT03101904|469698431|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
130407974|NCT01431508|469455890|FG000|Overall Study|Lack of Efficacy|1|||
130472636|NCT03101904|469698432|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
130472637|NCT02682316|469698433|FG000|Overall Study|Benign Final Pathology|27|||
130472638|NCT02682316|469698434|FG001|Overall Study|Benign Final Pathology|26|||
130472639|NCT02682316|469698433|FG000|Overall Study|Reoperation before 30 days|7|||
130472640|NCT02682316|469698434|FG001|Overall Study|Reoperation before 30 days|6|||
130407975|NCT01431508|469455890|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
130407976|NCT00129259|469455891|FG000|Overall Study|Lost to Follow-up|1|||
130472641|NCT02682316|469698433|FG000|Overall Study|Ineligible|1|||
130472642|NCT02682316|469698434|FG001|Overall Study|Ineligible|0|||
130726142|NCT00384930|470621207|FG004|Overall Study|Physician Decision|1|||
130407977|NCT00129259|469455892|FG001|Overall Study|Lost to Follow-up|1|||
130407978|NCT00129259|469455891|FG000|Overall Study|Withdrawal by Subject|2|||
130407979|NCT00129259|469455892|FG001|Overall Study|Withdrawal by Subject|1|||
130407980|NCT00129259|469455891|FG000|Overall Study|Only available minimal phone assessments|0|||
130407981|NCT00129259|469455892|FG001|Overall Study|Only available minimal phone assessments|1|||
130407982|NCT00023452|469455893|FG000|Overall Study|Ineligible for Study|163|||
130407983|NCT00023452|469455894|FG001|Overall Study|Ineligible for Study|159|||
130407984|NCT00023452|469455893|FG000|Overall Study|Out of Window|129|||
130407985|NCT00023452|469455894|FG001|Overall Study|Out of Window|69|||
130407986|NCT00023452|469455893|FG000|Overall Study|Death|2|||
130407987|NCT00023452|469455894|FG001|Overall Study|Death|0|||
130407988|NCT00023452|469455893|FG000|Overall Study|Withdrawal by Subject|66|||
130407989|NCT00023452|469455894|FG001|Overall Study|Withdrawal by Subject|54|||
130407990|NCT00023452|469455893|FG000|Overall Study|Adverse Event|139|||
130407991|NCT00023452|469455894|FG001|Overall Study|Adverse Event|196|||
130407992|NCT00023452|469455893|FG000|Overall Study|Lost to Follow-up|293|||
130407993|NCT00023452|469455894|FG001|Overall Study|Lost to Follow-up|60|||
130407994|NCT00023452|469455893|FG000|Overall Study|Physician Decision|49|||
130407995|NCT00023452|469455894|FG001|Overall Study|Physician Decision|21|||
130407996|NCT00023452|469455893|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
130407997|NCT00023452|469455894|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
130407998|NCT00023452|469455893|FG000|Overall Study|Pregnant|53|||
130407999|NCT00023452|469455894|FG001|Overall Study|Pregnant|20|||
130408000|NCT00023452|469455893|FG000|Overall Study|Other|204|||
130408001|NCT00023452|469455894|FG001|Overall Study|Other|69|||
130408002|NCT05789875|469455895|FG000|Overall Study|Lost to Follow-up|6|||
130408003|NCT01043874|469457671|FG000|Overall Study|Adverse Event|3|||
130408004|NCT01043874|469457671|FG000|Overall Study|Withdrawal by Subject|1|||
130408005|NCT01043874|469457671|FG000|Overall Study|Lack of Efficacy|1|||
130408006|NCT01043874|469457671|FG000|Overall Study|Administrative Problems|1|||
130408007|NCT03422003|469457672|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
130408008|NCT03422003|469457673|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
130408009|NCT03422003|469457672|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
130408010|NCT03422003|469457673|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
130408011|NCT00966940|469457678|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
130408012|NCT00966940|469457679|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
130408013|NCT00966940|469457678|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
130408014|NCT00966940|469457679|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
130408015|NCT02696850|469457684|FG000|Overall Study|Withdrawal by Subject|3|||
130408016|NCT02696850|469457685|FG001|Overall Study|Withdrawal by Subject|3|||
130408017|NCT02696850|469457684|FG000|Overall Study|Lost to Follow-up|8|||
130408018|NCT02696850|469457685|FG001|Overall Study|Lost to Follow-up|5|||
130408019|NCT01175824|469457686|FG000|Overall Study|Adverse Event|2|||
130408020|NCT01175824|469457687|FG001|Overall Study|Adverse Event|1|||
130408021|NCT01175824|469457686|FG000|Overall Study|Lack of Efficacy|2|||
130408022|NCT01175824|469457687|FG001|Overall Study|Lack of Efficacy|0|||
130408023|NCT01175824|469457686|FG000|Overall Study|Lost to Follow-up|0|||
130408024|NCT01175824|469457687|FG001|Overall Study|Lost to Follow-up|1|||
130408025|NCT01175824|469457686|FG000|Overall Study|Physician Decision|0|||
130408026|NCT01175824|469457687|FG001|Overall Study|Physician Decision|4|||
130408027|NCT01175824|469457686|FG000|Overall Study|Protocol Violation|2|||
130408028|NCT01175824|469457687|FG001|Overall Study|Protocol Violation|5|||
130408029|NCT01175824|469457686|FG000|Overall Study|Withdrawal by Subject|3|||
130408030|NCT01175824|469457687|FG001|Overall Study|Withdrawal by Subject|7|||
130408031|NCT01175824|469457686|FG000|Overall Study|Sponsor Decision|1|||
130408032|NCT01175824|469457687|FG001|Overall Study|Sponsor Decision|0|||
130408033|NCT01175824|469457686|FG000|Overall Study|Entry Criteria Not Met|6|||
130408034|NCT01175824|469457687|FG001|Overall Study|Entry Criteria Not Met|4|||
130408035|NCT03455855|469457688|FG000|Overall Study|Lost to Follow-up|4|||
130408036|NCT03455855|469457689|FG001|Overall Study|Lost to Follow-up|2|||
130408037|NCT04820673|469457693|FG000|Overall Study|Adverse Event|6|||
130408038|NCT04820673|469457693|FG000|Overall Study|Due to Lack of Effectiveness|1|||
130408039|NCT04820673|469457693|FG000|Overall Study|Pregnancy|1|||
130408040|NCT04820673|469457693|FG000|Overall Study|Voluntary Withdrawal|20|||
130408041|NCT04820673|469457693|FG000|Overall Study|Lost to Follow-up|10|||
130408042|NCT00767000|469457697|FG000|54-week Study|Adverse Event|4|||
130408043|NCT00767000|469457698|FG001|54-week Study|Adverse Event|6|||
130408044|NCT00767000|469457699|FG002|54-week Study|Adverse Event|6|||
130408045|NCT00767000|469457700|FG003|54-week Study|Adverse Event|8|||
130408046|NCT00767000|469457701|FG004|54-week Study|Adverse Event|4|||
130408047|NCT00767000|469457697|FG000|54-week Study|Creaninine/creatinine clearance|2|||
130472643|NCT02682316|469698433|FG000|Overall Study|Death|1|||
130472644|NCT02682316|469698434|FG001|Overall Study|Death|0|||
130472645|NCT02682316|469698433|FG000|Overall Study|Lost to Follow-up|7|||
130472646|NCT02682316|469698434|FG001|Overall Study|Lost to Follow-up|3|||
130472647|NCT04538417|469698435|FG000|Overall Study|Withdrawal by Subject|2|||
130408048|NCT00767000|469457698|FG001|54-week Study|Creaninine/creatinine clearance|1|||
130408049|NCT00767000|469457699|FG002|54-week Study|Creaninine/creatinine clearance|2|||
130408050|NCT00767000|469457700|FG003|54-week Study|Creaninine/creatinine clearance|2|||
130408051|NCT00767000|469457701|FG004|54-week Study|Creaninine/creatinine clearance|4|||
130408052|NCT00767000|469457697|FG000|54-week Study|Hyperglycemia|0|||
130408053|NCT00767000|469457698|FG001|54-week Study|Hyperglycemia|0|||
130408054|NCT00767000|469457699|FG002|54-week Study|Hyperglycemia|1|||
130408055|NCT00767000|469457700|FG003|54-week Study|Hyperglycemia|0|||
130408056|NCT00767000|469457701|FG004|54-week Study|Hyperglycemia|1|||
130408057|NCT00767000|469457697|FG000|54-week Study|Hypoglycemia|0|||
130408058|NCT00767000|469457698|FG001|54-week Study|Hypoglycemia|1|||
130408059|NCT00767000|469457699|FG002|54-week Study|Hypoglycemia|0|||
130408060|NCT00767000|469457700|FG003|54-week Study|Hypoglycemia|0|||
130408061|NCT00767000|469457701|FG004|54-week Study|Hypoglycemia|0|||
130408062|NCT00767000|469457697|FG000|54-week Study|Interruption of study medication|0|||
130408063|NCT00767000|469457698|FG001|54-week Study|Interruption of study medication|0|||
130408064|NCT00767000|469457699|FG002|54-week Study|Interruption of study medication|1|||
130408065|NCT00767000|469457700|FG003|54-week Study|Interruption of study medication|0|||
130408066|NCT00767000|469457701|FG004|54-week Study|Interruption of study medication|0|||
130408067|NCT00767000|469457697|FG000|54-week Study|Lack of Efficacy|2|||
130408068|NCT00767000|469457698|FG001|54-week Study|Lack of Efficacy|0|||
130408069|NCT00767000|469457699|FG002|54-week Study|Lack of Efficacy|1|||
130408070|NCT00767000|469457700|FG003|54-week Study|Lack of Efficacy|0|||
130408071|NCT00767000|469457701|FG004|54-week Study|Lack of Efficacy|5|||
130408072|NCT00767000|469457697|FG000|54-week Study|Lost to Follow-up|4|||
130408073|NCT00767000|469457698|FG001|54-week Study|Lost to Follow-up|0|||
130408074|NCT00767000|469457699|FG002|54-week Study|Lost to Follow-up|1|||
130408075|NCT00767000|469457700|FG003|54-week Study|Lost to Follow-up|4|||
130408076|NCT00767000|469457701|FG004|54-week Study|Lost to Follow-up|2|||
130408077|NCT00767000|469457697|FG000|54-week Study|Physician Decision|4|||
130408078|NCT00767000|469457698|FG001|54-week Study|Physician Decision|0|||
130408079|NCT00767000|469457699|FG002|54-week Study|Physician Decision|1|||
130408080|NCT00767000|469457700|FG003|54-week Study|Physician Decision|1|||
130408081|NCT00767000|469457701|FG004|54-week Study|Physician Decision|1|||
130408082|NCT00767000|469457697|FG000|54-week Study|Progressive disease|0|||
130408083|NCT00767000|469457698|FG001|54-week Study|Progressive disease|0|||
130408084|NCT00767000|469457699|FG002|54-week Study|Progressive disease|1|||
130408085|NCT00767000|469457700|FG003|54-week Study|Progressive disease|0|||
130408086|NCT00767000|469457701|FG004|54-week Study|Progressive disease|0|||
130408087|NCT00767000|469457697|FG000|54-week Study|Protocol Violation|0|||
130408088|NCT00767000|469457698|FG001|54-week Study|Protocol Violation|0|||
130472648|NCT00150813|469698437|FG000|Overall Study|Adverse Event|1|||
130472649|NCT00150813|469698437|FG000|Overall Study|Lack of Efficacy|1|||
130472650|NCT00150813|469698437|FG000|Overall Study|Lost to Follow-up|5|||
130472651|NCT00150813|469698437|FG000|Overall Study|Withdrawal by Subject|5|||
130472652|NCT00150813|469698437|FG000|Overall Study|Remission|3|||
130472653|NCT00150813|469698437|FG000|Overall Study|Planned pregancy|1|||
130472654|NCT00150813|469698437|FG000|Overall Study|Switch to commercially available LEV|2|||
130472655|NCT03052608|469698439|FG000|Treatment Phase|Adverse Event|10|||
130472656|NCT03052608|469698440|FG001|Treatment Phase|Adverse Event|12|||
130472657|NCT03052608|469698439|FG000|Treatment Phase|Death|6|||
130472658|NCT03052608|469698440|FG001|Treatment Phase|Death|4|||
130472659|NCT03052608|469698439|FG000|Treatment Phase|Withdrawal by Subject|4|||
130472660|NCT03052608|469698440|FG001|Treatment Phase|Withdrawal by Subject|12|||
130472661|NCT03052608|469698439|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
130726143|NCT00384930|470621203|FG000|Overall Study|Protocol Violation|1|||
130726144|NCT00384930|470621204|FG001|Overall Study|Protocol Violation|0|||
130726145|NCT00384930|470621205|FG002|Overall Study|Protocol Violation|1|||
130726146|NCT00384930|470621206|FG003|Overall Study|Protocol Violation|6|||
130726147|NCT00384930|470621207|FG004|Overall Study|Protocol Violation|4|||
130726148|NCT00384930|470621203|FG000|Overall Study|Sponsor Decision|3|||
130726149|NCT00384930|470621204|FG001|Overall Study|Sponsor Decision|4|||
130726150|NCT00384930|470621205|FG002|Overall Study|Sponsor Decision|0|||
130726151|NCT00384930|470621206|FG003|Overall Study|Sponsor Decision|5|||
130726152|NCT00384930|470621207|FG004|Overall Study|Sponsor Decision|0|||
130726153|NCT00384930|470621203|FG000|Overall Study|Withdrawal by Subject|9|||
130726154|NCT00384930|470621204|FG001|Overall Study|Withdrawal by Subject|7|||
130726155|NCT00384930|470621205|FG002|Overall Study|Withdrawal by Subject|7|||
130726156|NCT00384930|470621206|FG003|Overall Study|Withdrawal by Subject|6|||
130726157|NCT00384930|470621207|FG004|Overall Study|Withdrawal by Subject|16|||
130726158|NCT00384930|470621203|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
130726159|NCT00384930|470621204|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
130408089|NCT00767000|469457699|FG002|54-week Study|Protocol Violation|1|||
130408090|NCT00767000|469457700|FG003|54-week Study|Protocol Violation|2|||
130408091|NCT00767000|469457701|FG004|54-week Study|Protocol Violation|0|||
130408092|NCT00767000|469457697|FG000|54-week Study|Withdrawal by Subject|2|||
130408093|NCT00767000|469457698|FG001|54-week Study|Withdrawal by Subject|3|||
130726160|NCT00384930|470621205|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130408094|NCT00767000|469457699|FG002|54-week Study|Withdrawal by Subject|5|||
130408095|NCT00767000|469457700|FG003|54-week Study|Withdrawal by Subject|11|||
130408096|NCT00767000|469457701|FG004|54-week Study|Withdrawal by Subject|13|||
130408097|NCT00767000|469457697|FG000|54-week Study|Study terminated by sponsor|90|||
130408098|NCT00767000|469457698|FG001|54-week Study|Study terminated by sponsor|102|||
130408099|NCT00767000|469457699|FG002|54-week Study|Study terminated by sponsor|89|||
130408100|NCT00767000|469457700|FG003|54-week Study|Study terminated by sponsor|196|||
130408101|NCT00767000|469457701|FG004|54-week Study|Study terminated by sponsor|194|||
130408102|NCT00767000|469457697|FG000|54-week Study|Reason not reported|0|||
130408103|NCT00767000|469457698|FG001|54-week Study|Reason not reported|0|||
130408104|NCT00767000|469457699|FG002|54-week Study|Reason not reported|0|||
130408105|NCT00767000|469457700|FG003|54-week Study|Reason not reported|1|||
130408106|NCT00767000|469457701|FG004|54-week Study|Reason not reported|0|||
130408107|NCT00767000|469457697|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
130408108|NCT00767000|469457698|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
130408109|NCT00767000|469457699|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
130408110|NCT00767000|469457700|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
130408111|NCT00767000|469457701|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
130408112|NCT02530619|469457702|FG000|Registered for Study|Withdrawal by Subject|2|||
130408113|NCT02530619|469457702|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
130408114|NCT02530619|469457702|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
130408115|NCT02530619|469457702|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
130408116|NCT02530619|469457702|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
130408117|NCT02530619|469457702|FG000|Follow-up Period (6 Months)|Death|4|||
130408118|NCT02530619|469457702|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
130408119|NCT02530619|469457702|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
130408120|NCT01163682|469457703|FG000|Overall Study|Lost to Follow-up|6|||
130408121|NCT01163682|469457704|FG001|Overall Study|Lost to Follow-up|9|||
130408122|NCT00359762|469457705|FG000|Period II|Adverse Event|17|||
130408123|NCT00359762|469457706|FG001|Period II|Adverse Event|0|||
130408124|NCT00359762|469457707|FG002|Period II|Adverse Event|0|||
130408125|NCT00359762|469457708|FG003|Period II|Adverse Event|0|||
130408126|NCT00359762|469457709|FG004|Period II|Adverse Event|49|||
130408127|NCT00359762|469457705|FG000|Period II|Protocol Violation|18|||
130408128|NCT00359762|469457706|FG001|Period II|Protocol Violation|0|||
130726161|NCT00384930|470621206|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130726162|NCT00384930|470621207|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130726163|NCT02752087|470621208|FG000|Washout|Physician Decision|1|||
130726164|NCT02752087|470621209|FG001|Washout|Physician Decision|0|||
130726165|NCT00863772|470621210|FG000|Overall Study|Adverse Event|1|||
130726166|NCT00863772|470621211|FG001|Overall Study|Adverse Event|4|||
130726167|NCT00863772|470621212|FG002|Overall Study|Adverse Event|0|||
130726168|NCT00863772|470621210|FG000|Overall Study|Lack of Efficacy|4|||
130726169|NCT00863772|470621211|FG001|Overall Study|Lack of Efficacy|2|||
130726170|NCT00863772|470621212|FG002|Overall Study|Lack of Efficacy|4|||
130726171|NCT00863772|470621210|FG000|Overall Study|Lost to Follow-up|5|||
130726172|NCT00863772|470621211|FG001|Overall Study|Lost to Follow-up|1|||
130726173|NCT00863772|470621212|FG002|Overall Study|Lost to Follow-up|1|||
130726174|NCT00863772|470621210|FG000|Overall Study|Protocol Violation|2|||
130726175|NCT00863772|470621211|FG001|Overall Study|Protocol Violation|0|||
130726176|NCT00863772|470621212|FG002|Overall Study|Protocol Violation|2|||
130726177|NCT00863772|470621210|FG000|Overall Study|Withdrawal by Subject|4|||
130726178|NCT00863772|470621211|FG001|Overall Study|Withdrawal by Subject|7|||
130726179|NCT00863772|470621212|FG002|Overall Study|Withdrawal by Subject|5|||
130726180|NCT00863772|470621210|FG000|Overall Study|Study terminated by sponsor|44|||
130726181|NCT00863772|470621211|FG001|Overall Study|Study terminated by sponsor|45|||
130726182|NCT00863772|470621212|FG002|Overall Study|Study terminated by sponsor|36|||
130726183|NCT00863772|470621210|FG000|Overall Study|Entered extension study|6|||
130726184|NCT00863772|470621211|FG001|Overall Study|Entered extension study|4|||
130726185|NCT00863772|470621212|FG002|Overall Study|Entered extension study|9|||
130726186|NCT00863772|470621210|FG000|Overall Study|Other|1|||
130726187|NCT00863772|470621211|FG001|Overall Study|Other|2|||
130726188|NCT00863772|470621212|FG002|Overall Study|Other|4|||
130726189|NCT00863772|470621210|FG000|Overall Study|Randomized but not Treated|1|||
130726190|NCT00863772|470621211|FG001|Overall Study|Randomized but not Treated|0|||
130726191|NCT00863772|470621212|FG002|Overall Study|Randomized but not Treated|0|||
130408129|NCT00359762|469457707|FG002|Period II|Protocol Violation|0|||
130726192|NCT02728843|470621213|FG000|Overall Study|Adverse Event|0|||
130726193|NCT02728843|470621214|FG001|Overall Study|Adverse Event|2|||
130726194|NCT02728843|470621215|FG002|Overall Study|Adverse Event|3|||
130408130|NCT00359762|469457708|FG003|Period II|Protocol Violation|0|||
130408131|NCT00359762|469457709|FG004|Period II|Protocol Violation|11|||
130408132|NCT00359762|469457705|FG000|Period II|Physician Decision|17|||
130408133|NCT00359762|469457706|FG001|Period II|Physician Decision|0|||
130408134|NCT00359762|469457707|FG002|Period II|Physician Decision|0|||
130408135|NCT00359762|469457708|FG003|Period II|Physician Decision|0|||
130408136|NCT00359762|469457709|FG004|Period II|Physician Decision|23|||
130408137|NCT00359762|469457705|FG000|Period II|Death|2|||
130408138|NCT00359762|469457706|FG001|Period II|Death|0|||
130408139|NCT00359762|469457707|FG002|Period II|Death|0|||
130408140|NCT00359762|469457708|FG003|Period II|Death|0|||
130408141|NCT00359762|469457709|FG004|Period II|Death|4|||
130408142|NCT00359762|469457705|FG000|Period II|Lack of Efficacy|11|||
130408143|NCT00359762|469457706|FG001|Period II|Lack of Efficacy|0|||
130408144|NCT00359762|469457707|FG002|Period II|Lack of Efficacy|0|||
130408145|NCT00359762|469457708|FG003|Period II|Lack of Efficacy|0|||
130408146|NCT00359762|469457709|FG004|Period II|Lack of Efficacy|8|||
130408147|NCT00359762|469457705|FG000|Period II|Lost to follow up|5|||
130408148|NCT00359762|469457706|FG001|Period II|Lost to follow up|0|||
130408149|NCT00359762|469457707|FG002|Period II|Lost to follow up|0|||
130408150|NCT00359762|469457708|FG003|Period II|Lost to follow up|0|||
130408151|NCT00359762|469457709|FG004|Period II|Lost to follow up|5|||
130408152|NCT00359762|469457705|FG000|Period II|Entry Criteria Not Met|8|||
130408153|NCT00359762|469457706|FG001|Period II|Entry Criteria Not Met|0|||
130408154|NCT00359762|469457707|FG002|Period II|Entry Criteria Not Met|0|||
130408155|NCT00359762|469457708|FG003|Period II|Entry Criteria Not Met|0|||
130408156|NCT00359762|469457709|FG004|Period II|Entry Criteria Not Met|4|||
130408157|NCT00359762|469457705|FG000|Period II|Subject Decision|50|||
130408158|NCT00359762|469457706|FG001|Period II|Subject Decision|0|||
130408159|NCT00359762|469457707|FG002|Period II|Subject Decision|0|||
130408160|NCT00359762|469457708|FG003|Period II|Subject Decision|0|||
130408161|NCT00359762|469457709|FG004|Period II|Subject Decision|70|||
130408162|NCT00359762|469457705|FG000|Period III|Protocol Violation|0|||
130561583|NCT00922480|470024792|FG001|Extension Study|Withdrawal by Subject|1|||
130561584|NCT00922480|470024791|FG000|Extension Study|Others|0|||
130561585|NCT00922480|470024792|FG001|Extension Study|Others|1|||
130561586|NCT04784897|470024793|FG000|Overall Study|Death|4|||
130561587|NCT04784897|470024794|FG001|Overall Study|Death|2|||
130561588|NCT04784897|470024795|FG002|Overall Study|Death|1|||
130561589|NCT04784897|470024793|FG000|Overall Study|Withdrawal by Subject|0|||
130561590|NCT04784897|470024794|FG001|Overall Study|Withdrawal by Subject|0|||
130561591|NCT04784897|470024795|FG002|Overall Study|Withdrawal by Subject|1|||
130561592|NCT01994382|470024796|FG000|Overall Study|Informed consent withdrawn|0|||
130561593|NCT01994382|470024797|FG001|Overall Study|Informed consent withdrawn|0|||
130561594|NCT01994382|470024798|FG002|Overall Study|Informed consent withdrawn|0|||
130408163|NCT00359762|469457706|FG001|Period III|Protocol Violation|5|||
130561595|NCT01994382|470024799|FG003|Overall Study|Informed consent withdrawn|0|||
130561596|NCT01994382|470024800|FG004|Overall Study|Informed consent withdrawn|0|||
130561597|NCT01994382|470024801|FG005|Overall Study|Informed consent withdrawn|0|||
130561598|NCT01994382|470024802|FG006|Overall Study|Informed consent withdrawn|1|||
130561599|NCT01994382|470024803|FG007|Overall Study|Informed consent withdrawn|0|||
130561600|NCT01994382|470024804|FG008|Overall Study|Informed consent withdrawn|0|||
130561601|NCT01994382|470024805|FG009|Overall Study|Informed consent withdrawn|0|||
130561602|NCT01994382|470024806|FG010|Overall Study|Informed consent withdrawn|0|||
130561603|NCT01994382|470024807|FG011|Overall Study|Informed consent withdrawn|0|||
130561604|NCT01994382|470024808|FG012|Overall Study|Informed consent withdrawn|0|||
130561605|NCT01994382|470024809|FG013|Overall Study|Informed consent withdrawn|0|||
130561606|NCT01994382|470024810|FG014|Overall Study|Informed consent withdrawn|0|||
130561607|NCT01994382|470024811|FG015|Overall Study|Informed consent withdrawn|0|||
130561608|NCT01994382|470024812|FG016|Overall Study|Informed consent withdrawn|0|||
130561609|NCT01994382|470024796|FG000|Overall Study|Progressive disease|3|||
130561610|NCT01994382|470024797|FG001|Overall Study|Progressive disease|4|||
130561611|NCT01994382|470024798|FG002|Overall Study|Progressive disease|4|||
130561612|NCT01994382|470024799|FG003|Overall Study|Progressive disease|3|||
130561613|NCT01994382|470024800|FG004|Overall Study|Progressive disease|2|||
130561614|NCT01994382|470024801|FG005|Overall Study|Progressive disease|3|||
130561615|NCT01994382|470024802|FG006|Overall Study|Progressive disease|3|||
130561616|NCT01994382|470024803|FG007|Overall Study|Progressive disease|6|||
130561617|NCT01994382|470024804|FG008|Overall Study|Progressive disease|2|||
130561618|NCT01994382|470024805|FG009|Overall Study|Progressive disease|2|||
130561619|NCT01994382|470024806|FG010|Overall Study|Progressive disease|13|||
130561620|NCT01994382|470024807|FG011|Overall Study|Progressive disease|8|||
130561621|NCT01994382|470024808|FG012|Overall Study|Progressive disease|7|||
130561622|NCT01994382|470024809|FG013|Overall Study|Progressive disease|3|||
130561623|NCT01994382|470024810|FG014|Overall Study|Progressive disease|6|||
130561624|NCT01994382|470024811|FG015|Overall Study|Progressive disease|44|||
130726195|NCT02728843|470621216|FG003|Overall Study|Adverse Event|1|||
130408164|NCT00359762|469457707|FG002|Period III|Protocol Violation|3|||
130408165|NCT00359762|469457708|FG003|Period III|Protocol Violation|8|||
130408166|NCT00359762|469457709|FG004|Period III|Protocol Violation|0|||
130408167|NCT00359762|469457705|FG000|Period III|Adverse Event|0|||
130408168|NCT00359762|469457706|FG001|Period III|Adverse Event|3|||
130408169|NCT00359762|469457707|FG002|Period III|Adverse Event|4|||
130408170|NCT00359762|469457708|FG003|Period III|Adverse Event|10|||
130408171|NCT00359762|469457709|FG004|Period III|Adverse Event|0|||
130408172|NCT00359762|469457705|FG000|Period III|Physician Decision|0|||
130408173|NCT00359762|469457706|FG001|Period III|Physician Decision|5|||
130408174|NCT00359762|469457707|FG002|Period III|Physician Decision|9|||
130726196|NCT02728843|470621217|FG004|Overall Study|Adverse Event|2|||
130726197|NCT02728843|470621213|FG000|Overall Study|Lack of Efficacy|0|||
130726198|NCT02728843|470621214|FG001|Overall Study|Lack of Efficacy|1|||
130726199|NCT02728843|470621215|FG002|Overall Study|Lack of Efficacy|1|||
130726200|NCT02728843|470621216|FG003|Overall Study|Lack of Efficacy|0|||
130726201|NCT02728843|470621217|FG004|Overall Study|Lack of Efficacy|0|||
130726202|NCT02728843|470621213|FG000|Overall Study|Protocol Violation|2|||
130726203|NCT02728843|470621214|FG001|Overall Study|Protocol Violation|0|||
130726204|NCT02728843|470621215|FG002|Overall Study|Protocol Violation|4|||
130726205|NCT02728843|470621216|FG003|Overall Study|Protocol Violation|2|||
130726206|NCT02728843|470621217|FG004|Overall Study|Protocol Violation|2|||
130726207|NCT02728843|470621213|FG000|Overall Study|Withdrawal by Subject|1|||
130726208|NCT02728843|470621214|FG001|Overall Study|Withdrawal by Subject|0|||
130726209|NCT02728843|470621215|FG002|Overall Study|Withdrawal by Subject|0|||
130726210|NCT02728843|470621216|FG003|Overall Study|Withdrawal by Subject|1|||
130726211|NCT02728843|470621217|FG004|Overall Study|Withdrawal by Subject|0|||
130726212|NCT02728843|470621213|FG000|Overall Study|Use of rescue medication|0|||
130726213|NCT02728843|470621214|FG001|Overall Study|Use of rescue medication|2|||
130726214|NCT02728843|470621215|FG002|Overall Study|Use of rescue medication|0|||
130726215|NCT02728843|470621216|FG003|Overall Study|Use of rescue medication|2|||
130726216|NCT02728843|470621217|FG004|Overall Study|Use of rescue medication|1|||
130726217|NCT01671332|470621218|FG000|Overall Study|Withdrawal by Subject|1|||
130726218|NCT01671332|470621219|FG001|Overall Study|Withdrawal by Subject|1|||
130726219|NCT00351533|470621220|FG000|Overall Study|Extubated before first BAL|1|||
130726220|NCT00351533|470621221|FG001|Overall Study|Extubated before first BAL|0|||
130726221|NCT00351533|470621220|FG000|Overall Study|Lost to Follow-up|1|||
130726222|NCT00351533|470621221|FG001|Overall Study|Lost to Follow-up|3|||
130726223|NCT00351533|470621220|FG000|Overall Study|Physician Decision|0|||
130726224|NCT00351533|470621221|FG001|Overall Study|Physician Decision|1|||
130726225|NCT00351533|470621220|FG000|Overall Study|Withdrawal by Subject|0|||
130726226|NCT00351533|470621221|FG001|Overall Study|Withdrawal by Subject|1|||
130726227|NCT01653912|470621226|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726228|NCT01653912|470621227|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
130726229|NCT01653912|470621228|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726230|NCT01653912|470621229|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726231|NCT01653912|470621230|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726232|NCT01653912|470621231|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726233|NCT01653912|470621226|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726234|NCT01653912|470621227|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726235|NCT01653912|470621228|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
130726236|NCT01653912|470621229|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726237|NCT01653912|470621230|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726238|NCT01653912|470621231|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726239|NCT01653912|470621226|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130408175|NCT00359762|469457708|FG003|Period III|Physician Decision|15|||
130408176|NCT00359762|469457709|FG004|Period III|Physician Decision|0|||
130408177|NCT00359762|469457705|FG000|Period III|Lack of Efficacy|0|||
130408178|NCT00359762|469457706|FG001|Period III|Lack of Efficacy|7|||
130408179|NCT00359762|469457707|FG002|Period III|Lack of Efficacy|5|||
130408180|NCT00359762|469457708|FG003|Period III|Lack of Efficacy|9|||
130408181|NCT00359762|469457709|FG004|Period III|Lack of Efficacy|0|||
130408182|NCT00359762|469457705|FG000|Period III|Lost to follow up|0|||
130408183|NCT00359762|469457706|FG001|Period III|Lost to follow up|1|||
130408184|NCT00359762|469457707|FG002|Period III|Lost to follow up|1|||
130408185|NCT00359762|469457708|FG003|Period III|Lost to follow up|2|||
130408186|NCT00359762|469457709|FG004|Period III|Lost to follow up|0|||
130408187|NCT00359762|469457705|FG000|Period III|Entry Criteria Not Met|0|||
130408188|NCT00359762|469457706|FG001|Period III|Entry Criteria Not Met|1|||
130408189|NCT00359762|469457707|FG002|Period III|Entry Criteria Not Met|0|||
130408190|NCT00359762|469457708|FG003|Period III|Entry Criteria Not Met|1|||
130408191|NCT00359762|469457709|FG004|Period III|Entry Criteria Not Met|0|||
130408192|NCT00359762|469457705|FG000|Period III|Subject Decision|0|||
130408193|NCT00359762|469457706|FG001|Period III|Subject Decision|7|||
130408194|NCT00359762|469457707|FG002|Period III|Subject Decision|8|||
130408195|NCT00359762|469457708|FG003|Period III|Subject Decision|20|||
130408196|NCT00359762|469457709|FG004|Period III|Subject Decision|0|||
130408197|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
130408198|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
130408199|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
130408200|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130408201|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130408202|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130408203|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130408204|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130408205|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130472662|NCT03052608|469698440|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
130472663|NCT03052608|469698439|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
130472664|NCT03052608|469698440|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
130472665|NCT03052608|469698439|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
130472666|NCT03052608|469698440|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
130472667|NCT03052608|469698439|FG000|Treatment Phase|Ongoing|103|||
130472668|NCT03052608|469698440|FG001|Treatment Phase|Ongoing|31|||
130472669|NCT03052608|469698439|FG000|Long-Term Follow-up Phase|Death|23|||
130472670|NCT03052608|469698440|FG001|Long-Term Follow-up Phase|Death|28|||
130472671|NCT03052608|469698439|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
130472672|NCT03052608|469698440|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
130472673|NCT03052608|469698439|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
130472674|NCT03052608|469698440|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
130472675|NCT03052608|469698439|FG000|Long-Term Follow-up Phase|Ongoing|122|||
130472676|NCT03052608|469698440|FG001|Long-Term Follow-up Phase|Ongoing|99|||
130472677|NCT03113500|469698441|FG000|Overall Study|Withdrawal by Subject|1|||
130472678|NCT05249439|469698443|FG000|Overall Study|Withdrawal by Subject|2|||
130472679|NCT05249439|469698444|FG001|Overall Study|Withdrawal by Subject|5|||
130472680|NCT05249439|469698443|FG000|Overall Study|Physician Decision|3|||
130472681|NCT05249439|469698444|FG001|Overall Study|Physician Decision|1|||
130472682|NCT03526861|469698447|FG000|Initial Treatment Period|Not dosed|1|||
130472683|NCT03526861|469698448|FG001|Initial Treatment Period|Not dosed|1|||
130472684|NCT03526861|469698449|FG002|Initial Treatment Period|Not dosed|1|||
130472685|NCT03526861|469698450|FG003|Initial Treatment Period|Not dosed|0|||
130472686|NCT03526861|469698451|FG004|Initial Treatment Period|Not dosed|0|||
130472687|NCT03526861|469698452|FG005|Initial Treatment Period|Not dosed|0|||
130472688|NCT03526861|469698453|FG006|Initial Treatment Period|Not dosed|0|||
130472689|NCT03526861|469698454|FG007|Initial Treatment Period|Not dosed|0|||
130472690|NCT03526861|469698455|FG008|Initial Treatment Period|Not dosed|0|||
130472691|NCT03526861|469698447|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
130472692|NCT03526861|469698448|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
130472693|NCT03526861|469698449|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
130472694|NCT03526861|469698450|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472695|NCT03526861|469698451|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472696|NCT03526861|469698452|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472697|NCT03526861|469698453|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472698|NCT03526861|469698454|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472699|NCT03526861|469698455|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472700|NCT03526861|469698447|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
130726240|NCT01653912|470621227|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726241|NCT01653912|470621228|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726242|NCT01653912|470621229|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
130726243|NCT01653912|470621230|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726244|NCT01653912|470621231|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726245|NCT01653912|470621226|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726246|NCT01653912|470621227|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726247|NCT01653912|470621228|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726248|NCT01653912|470621229|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
130726249|NCT01653912|470621230|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726250|NCT01653912|470621231|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726251|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726252|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726253|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726254|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726255|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726256|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
130726257|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726258|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726259|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726260|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726261|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726262|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
130726263|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726264|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726265|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726266|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726267|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726268|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
130726269|NCT03408639|470623044|FG000|Overall Study|Death|5|||
130726270|NCT03408639|470623045|FG001|Overall Study|Death|5|||
130726271|NCT03408639|470623044|FG000|Overall Study|Lost to Follow-up|1|||
130726272|NCT03408639|470623045|FG001|Overall Study|Lost to Follow-up|4|||
130726273|NCT03408639|470623044|FG000|Overall Study|Withdrawal by Subject|2|||
130726274|NCT03408639|470623045|FG001|Overall Study|Withdrawal by Subject|7|||
130726275|NCT03408639|470623044|FG000|Overall Study|Physician Decision|3|||
130726276|NCT03408639|470623045|FG001|Overall Study|Physician Decision|6|||
130726277|NCT02245412|470623046|FG000|Treatment Period|Death|1|||
130726278|NCT02245412|470623047|FG001|Treatment Period|Death|1|||
130726279|NCT02245412|470623048|FG002|Treatment Period|Death|0|||
130726280|NCT02245412|470623046|FG000|Treatment Period|Physician Decision|1|||
130726281|NCT02245412|470623047|FG001|Treatment Period|Physician Decision|1|||
130726282|NCT02245412|470623048|FG002|Treatment Period|Physician Decision|0|||
130726283|NCT02245412|470623046|FG000|Treatment Period|Withdrawal by Subject|2|||
130726284|NCT02245412|470623047|FG001|Treatment Period|Withdrawal by Subject|1|||
130726285|NCT02245412|470623048|FG002|Treatment Period|Withdrawal by Subject|0|||
130726286|NCT02245412|470623046|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
130726287|NCT02245412|470623047|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130726288|NCT02245412|470623048|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130726289|NCT02245412|470623046|FG000|Follow-Up Period|Death|4|||
130726290|NCT02245412|470623047|FG001|Follow-Up Period|Death|2|||
130726291|NCT02245412|470623048|FG002|Follow-Up Period|Death|1|||
130726292|NCT02245412|470623046|FG000|Follow-Up Period|Physician Decision|1|||
130726293|NCT02245412|470623047|FG001|Follow-Up Period|Physician Decision|0|||
130726294|NCT02245412|470623048|FG002|Follow-Up Period|Physician Decision|0|||
130726295|NCT02245412|470623046|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
130726296|NCT02245412|470623047|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
130726297|NCT02245412|470623048|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
130726298|NCT03452137|470623049|FG000|Overall Study|Death|67|||
130726299|NCT03452137|470623050|FG001|Overall Study|Death|70|||
130726300|NCT03452137|470623049|FG000|Overall Study|Lost to Follow-up|4|||
130726301|NCT03452137|470623050|FG001|Overall Study|Lost to Follow-up|2|||
130726302|NCT03452137|470623049|FG000|Overall Study|Physician Decision|0|||
130726303|NCT03452137|470623050|FG001|Overall Study|Physician Decision|1|||
130726304|NCT03452137|470623049|FG000|Overall Study|Study Terminated by Sponsor|120|||
130726305|NCT03452137|470623050|FG001|Overall Study|Study Terminated by Sponsor|121|||
130726306|NCT03452137|470623049|FG000|Overall Study|Withdrawal by Subject|12|||
130726307|NCT03452137|470623050|FG001|Overall Study|Withdrawal by Subject|9|||
130726308|NCT01371747|470623051|FG000|Overall Study|Adverse Event|4|||
130726309|NCT01371747|470623052|FG001|Overall Study|Adverse Event|2|||
130726310|NCT01371747|470623053|FG002|Overall Study|Adverse Event|7|||
130726311|NCT01371747|470623054|FG003|Overall Study|Adverse Event|2|||
130726312|NCT01371747|470623055|FG004|Overall Study|Adverse Event|2|||
130726313|NCT01371747|470623056|FG005|Overall Study|Adverse Event|2|||
130726314|NCT01371747|470623051|FG000|Overall Study|Death|1|||
130726315|NCT01371747|470623052|FG001|Overall Study|Death|0|||
130726316|NCT01371747|470623053|FG002|Overall Study|Death|4|||
130726317|NCT01371747|470623054|FG003|Overall Study|Death|1|||
130726318|NCT01371747|470623055|FG004|Overall Study|Death|2|||
130726319|NCT01371747|470623056|FG005|Overall Study|Death|0|||
130726320|NCT01371747|470623051|FG000|Overall Study|Abnormal Renal Function|0|||
130726321|NCT01371747|470623052|FG001|Overall Study|Abnormal Renal Function|2|||
130408206|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
130408207|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
130408208|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
130408209|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130408210|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130408211|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130408212|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130561625|NCT01994382|470024812|FG016|Overall Study|Progressive disease|28|||
130726322|NCT01371747|470623053|FG002|Overall Study|Abnormal Renal Function|0|||
130726323|NCT01371747|470623054|FG003|Overall Study|Abnormal Renal Function|1|||
130726324|NCT01371747|470623055|FG004|Overall Study|Abnormal Renal Function|0|||
130726325|NCT01371747|470623056|FG005|Overall Study|Abnormal Renal Function|1|||
130726326|NCT01371747|470623051|FG000|Overall Study|High Serum Potassium Results|1|||
130726327|NCT01371747|470623052|FG001|Overall Study|High Serum Potassium Results|1|||
130726328|NCT01371747|470623053|FG002|Overall Study|High Serum Potassium Results|1|||
130726329|NCT01371747|470623054|FG003|Overall Study|High Serum Potassium Results|2|||
130726330|NCT01371747|470623055|FG004|Overall Study|High Serum Potassium Results|0|||
130726331|NCT01371747|470623056|FG005|Overall Study|High Serum Potassium Results|2|||
130726332|NCT01371747|470623051|FG000|Overall Study|Low Serum Potassium Results|1|||
130726333|NCT01371747|470623052|FG001|Overall Study|Low Serum Potassium Results|1|||
130726334|NCT01371747|470623053|FG002|Overall Study|Low Serum Potassium Results|1|||
130726335|NCT01371747|470623054|FG003|Overall Study|Low Serum Potassium Results|1|||
130726336|NCT01371747|470623055|FG004|Overall Study|Low Serum Potassium Results|0|||
130726337|NCT01371747|470623056|FG005|Overall Study|Low Serum Potassium Results|3|||
130726338|NCT01371747|470623051|FG000|Overall Study|Protocol Violation|0|||
130726339|NCT01371747|470623052|FG001|Overall Study|Protocol Violation|0|||
130726340|NCT01371747|470623053|FG002|Overall Study|Protocol Violation|1|||
130726341|NCT01371747|470623054|FG003|Overall Study|Protocol Violation|0|||
130726342|NCT01371747|470623055|FG004|Overall Study|Protocol Violation|0|||
130726343|NCT01371747|470623056|FG005|Overall Study|Protocol Violation|0|||
130726344|NCT01371747|470623051|FG000|Overall Study|Non-Compliance|3|||
130726345|NCT01371747|470623052|FG001|Overall Study|Non-Compliance|4|||
130726346|NCT01371747|470623053|FG002|Overall Study|Non-Compliance|3|||
130726347|NCT01371747|470623054|FG003|Overall Study|Non-Compliance|0|||
130726348|NCT01371747|470623055|FG004|Overall Study|Non-Compliance|0|||
130726349|NCT01371747|470623056|FG005|Overall Study|Non-Compliance|1|||
130726350|NCT01371747|470623051|FG000|Overall Study|Physician Decision|0|||
130726351|NCT01371747|470623052|FG001|Overall Study|Physician Decision|0|||
130726352|NCT01371747|470623053|FG002|Overall Study|Physician Decision|0|||
130726353|NCT01371747|470623054|FG003|Overall Study|Physician Decision|0|||
130726354|NCT01371747|470623055|FG004|Overall Study|Physician Decision|1|||
130726355|NCT01371747|470623056|FG005|Overall Study|Physician Decision|0|||
130726356|NCT01371747|470623051|FG000|Overall Study|Withdrawal by Subject|6|||
130726357|NCT01371747|470623052|FG001|Overall Study|Withdrawal by Subject|12|||
130726358|NCT01371747|470623053|FG002|Overall Study|Withdrawal by Subject|5|||
130726359|NCT01371747|470623054|FG003|Overall Study|Withdrawal by Subject|2|||
130726360|NCT01371747|470623055|FG004|Overall Study|Withdrawal by Subject|2|||
130726361|NCT01371747|470623056|FG005|Overall Study|Withdrawal by Subject|4|||
130726362|NCT01371747|470623051|FG000|Overall Study|Other Reasons|2|||
130726363|NCT01371747|470623052|FG001|Overall Study|Other Reasons|1|||
130726364|NCT01371747|470623053|FG002|Overall Study|Other Reasons|2|||
130726365|NCT01371747|470623054|FG003|Overall Study|Other Reasons|0|||
130726366|NCT01371747|470623055|FG004|Overall Study|Other Reasons|0|||
130726367|NCT01371747|470623056|FG005|Overall Study|Other Reasons|1|||
130726368|NCT02094417|470623060|FG000|Overall Study|Adverse Event|0|||
130726369|NCT02094417|470623061|FG001|Overall Study|Adverse Event|0|||
130726370|NCT02094417|470623062|FG002|Overall Study|Adverse Event|0|||
130726371|NCT02094417|470623063|FG003|Overall Study|Adverse Event|1|||
130726372|NCT02094417|470623060|FG000|Overall Study|Eligibility criteria|0|||
130726373|NCT02094417|470623061|FG001|Overall Study|Eligibility criteria|1|||
130726374|NCT02094417|470623062|FG002|Overall Study|Eligibility criteria|0|||
130726375|NCT02094417|470623063|FG003|Overall Study|Eligibility criteria|0|||
130726376|NCT02094417|470623060|FG000|Overall Study|No responder|4|||
130726377|NCT02094417|470623061|FG001|Overall Study|No responder|4|||
130726378|NCT02094417|470623062|FG002|Overall Study|No responder|4|||
130726379|NCT02094417|470623063|FG003|Overall Study|No responder|3|||
130726380|NCT02094417|470623060|FG000|Overall Study|Unable to conduct observations or assess|0|||
130726381|NCT02094417|470623061|FG001|Overall Study|Unable to conduct observations or assess|1|||
130726382|NCT02094417|470623062|FG002|Overall Study|Unable to conduct observations or assess|0|||
130408213|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130408214|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130408215|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408216|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130408217|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
130408218|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408219|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408220|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408221|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408222|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130472701|NCT03526861|469698448|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
130726383|NCT02094417|470623063|FG003|Overall Study|Unable to conduct observations or assess|0|||
130726384|NCT02094417|470623060|FG000|Overall Study|Withdrawal by Subject|1|||
130726385|NCT02094417|470623061|FG001|Overall Study|Withdrawal by Subject|2|||
130726386|NCT02094417|470623062|FG002|Overall Study|Withdrawal by Subject|1|||
130726387|NCT02094417|470623063|FG003|Overall Study|Withdrawal by Subject|3|||
130726388|NCT00580788|470623064|FG000|Overall Study|Adverse Event|0|||
130726389|NCT00580788|470623065|FG001|Overall Study|Adverse Event|0|||
130726390|NCT00580788|470623066|FG002|Overall Study|Adverse Event|0|||
130726391|NCT00580788|470623067|FG003|Overall Study|Adverse Event|1|||
130726392|NCT01443728|470623068|FG000|Overall Study|Lost to Follow-up|2|||
130726393|NCT01443728|470623069|FG001|Overall Study|Lost to Follow-up|0|||
130726394|NCT01443728|470623068|FG000|Overall Study|Withdrawal by Subject|1|||
130726395|NCT01443728|470623069|FG001|Overall Study|Withdrawal by Subject|1|||
130726396|NCT01443728|470623068|FG000|Overall Study|Adverse Event|0|||
130726397|NCT01443728|470623069|FG001|Overall Study|Adverse Event|2|||
130726398|NCT04971187|470623070|FG000|Overall Study|Screen failures|2|||
130726399|NCT01403051|470623071|FG000|Overall Study|Protocol Violation|2|||
130726400|NCT01403051|470623072|FG001|Overall Study|Protocol Violation|0|||
130726401|NCT01403051|470623071|FG000|Overall Study|Death|1|||
130726402|NCT01403051|470623072|FG001|Overall Study|Death|0|||
130726403|NCT01403051|470623071|FG000|Overall Study|Withdrawal by Subject|2|||
130726404|NCT01403051|470623072|FG001|Overall Study|Withdrawal by Subject|1|||
130726405|NCT01403051|470623071|FG000|Overall Study|Lost to Follow-up|5|||
130726406|NCT01403051|470623072|FG001|Overall Study|Lost to Follow-up|5|||
130726407|NCT02135614|470623078|FG000|Overall Study|Randomized but Not Treated|2|||
130726408|NCT02135614|470623079|FG001|Overall Study|Randomized but Not Treated|1|||
130726409|NCT02135614|470623078|FG000|Overall Study|Adverse Event|0|||
130726410|NCT02135614|470623079|FG001|Overall Study|Adverse Event|1|||
130726411|NCT02135614|470623078|FG000|Overall Study|Death|1|||
130726412|NCT02135614|470623079|FG001|Overall Study|Death|0|||
130726413|NCT02135614|470623078|FG000|Overall Study|Investigator's Discretion|0|||
130726414|NCT02135614|470623079|FG001|Overall Study|Investigator's Discretion|1|||
130726415|NCT02135614|470623078|FG000|Overall Study|Withdrew Consent|2|||
130726416|NCT02135614|470623079|FG001|Overall Study|Withdrew Consent|2|||
130726417|NCT02135614|470623078|FG000|Overall Study|Lost to Follow-up|3|||
130726418|NCT02135614|470623079|FG001|Overall Study|Lost to Follow-up|0|||
130726419|NCT02906358|470623083|FG000|Overall Study|Withdrawal by Subject|10|||
130726420|NCT02906358|470623084|FG001|Overall Study|Withdrawal by Subject|7|||
130726421|NCT02906358|470623083|FG000|Overall Study|Lost to Follow-up|12|||
130726422|NCT02906358|470623084|FG001|Overall Study|Lost to Follow-up|15|||
130726423|NCT02119819|470623086|FG000|Overall Study|Adverse Event|3|||
130726424|NCT02119819|470623087|FG001|Overall Study|Adverse Event|1|||
130726425|NCT02119819|470623088|FG002|Overall Study|Adverse Event|2|||
130726426|NCT02119819|470623089|FG003|Overall Study|Adverse Event|3|||
130726427|NCT02119819|470623090|FG004|Overall Study|Adverse Event|0|||
130726428|NCT02119819|470623091|FG005|Overall Study|Adverse Event|1|||
130726429|NCT02119819|470623086|FG000|Overall Study|Lack of Efficacy|0|||
130726430|NCT02119819|470623087|FG001|Overall Study|Lack of Efficacy|0|||
130726431|NCT02119819|470623088|FG002|Overall Study|Lack of Efficacy|0|||
130726432|NCT02119819|470623089|FG003|Overall Study|Lack of Efficacy|0|||
130726433|NCT02119819|470623090|FG004|Overall Study|Lack of Efficacy|0|||
130726434|NCT02119819|470623091|FG005|Overall Study|Lack of Efficacy|1|||
130726435|NCT02119819|470623086|FG000|Overall Study|Lost to Follow-up|0|||
130726436|NCT02119819|470623087|FG001|Overall Study|Lost to Follow-up|0|||
130726437|NCT02119819|470623088|FG002|Overall Study|Lost to Follow-up|1|||
130726438|NCT02119819|470623089|FG003|Overall Study|Lost to Follow-up|2|||
130726439|NCT02119819|470623090|FG004|Overall Study|Lost to Follow-up|1|||
130726440|NCT02119819|470623091|FG005|Overall Study|Lost to Follow-up|2|||
130726441|NCT02119819|470623086|FG000|Overall Study|Physician Decision|1|||
130726442|NCT02119819|470623087|FG001|Overall Study|Physician Decision|1|||
130726443|NCT02119819|470623088|FG002|Overall Study|Physician Decision|0|||
130726444|NCT02119819|470623089|FG003|Overall Study|Physician Decision|0|||
130726445|NCT02119819|470623090|FG004|Overall Study|Physician Decision|0|||
130561626|NCT01994382|470024796|FG000|Overall Study|Physician Decision|0|||
130561627|NCT01994382|470024797|FG001|Overall Study|Physician Decision|1|||
130408223|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130408224|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
130408225|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
130408226|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
130408227|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130408228|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130408229|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130561628|NCT01994382|470024798|FG002|Overall Study|Physician Decision|0|||
130561629|NCT01994382|470024799|FG003|Overall Study|Physician Decision|0|||
130408230|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130408231|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130408232|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130408233|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408234|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
130408235|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408236|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408237|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408238|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408239|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408240|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408241|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
130408242|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
130408243|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408244|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408245|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408246|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408247|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408248|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130472702|NCT03526861|469698449|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
130472703|NCT03526861|469698450|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130472704|NCT03526861|469698451|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130472705|NCT03526861|469698452|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130472706|NCT03526861|469698453|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130472707|NCT03526861|469698454|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130726446|NCT02119819|470623091|FG005|Overall Study|Physician Decision|1|||
130726447|NCT02119819|470623086|FG000|Overall Study|Withdrawal by Subject|5|||
130726448|NCT02119819|470623087|FG001|Overall Study|Withdrawal by Subject|3|||
130726449|NCT02119819|470623088|FG002|Overall Study|Withdrawal by Subject|0|||
130726450|NCT02119819|470623089|FG003|Overall Study|Withdrawal by Subject|0|||
130726451|NCT02119819|470623090|FG004|Overall Study|Withdrawal by Subject|6|||
130726452|NCT02119819|470623091|FG005|Overall Study|Withdrawal by Subject|10|||
130726453|NCT02119819|470623086|FG000|Overall Study|Jury Duty|0|||
130726454|NCT02119819|470623087|FG001|Overall Study|Jury Duty|0|||
130726455|NCT02119819|470623088|FG002|Overall Study|Jury Duty|1|||
130726456|NCT02119819|470623089|FG003|Overall Study|Jury Duty|0|||
130726457|NCT02119819|470623090|FG004|Overall Study|Jury Duty|0|||
130726458|NCT02119819|470623091|FG005|Overall Study|Jury Duty|0|||
130726459|NCT02119819|470623086|FG000|Overall Study|Protocol Violation|0|||
130726460|NCT02119819|470623087|FG001|Overall Study|Protocol Violation|0|||
130726461|NCT02119819|470623088|FG002|Overall Study|Protocol Violation|0|||
130726462|NCT02119819|470623089|FG003|Overall Study|Protocol Violation|1|||
130726463|NCT02119819|470623090|FG004|Overall Study|Protocol Violation|0|||
130726464|NCT02119819|470623091|FG005|Overall Study|Protocol Violation|0|||
130726465|NCT02119819|470623086|FG000|Overall Study|Left the city to get a job|0|||
130726466|NCT02119819|470623087|FG001|Overall Study|Left the city to get a job|0|||
130726467|NCT02119819|470623088|FG002|Overall Study|Left the city to get a job|0|||
130726468|NCT02119819|470623089|FG003|Overall Study|Left the city to get a job|1|||
130726469|NCT02119819|470623090|FG004|Overall Study|Left the city to get a job|0|||
130726470|NCT02119819|470623091|FG005|Overall Study|Left the city to get a job|0|||
130726471|NCT02699684|470623092|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
130726472|NCT02699684|470623093|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
130726473|NCT01145508|470623094|FG000|Overall Study|Adverse Event|1|||
130726474|NCT01145508|470623095|FG001|Overall Study|Adverse Event|0|||
130726475|NCT01145508|470623094|FG000|Overall Study|Death|1|||
130726476|NCT01145508|470623095|FG001|Overall Study|Death|0|||
130726477|NCT01145508|470623094|FG000|Overall Study|Physician Decision|2|||
130726478|NCT01145508|470623095|FG001|Overall Study|Physician Decision|1|||
130726479|NCT01145508|470623094|FG000|Overall Study|Never started treatment|1|||
130726480|NCT01145508|470623095|FG001|Overall Study|Never started treatment|1|||
130726481|NCT02045147|470623096|FG000|Overall Study|Withdrawal by Subject|2|||
130726482|NCT02045147|470623097|FG001|Overall Study|Withdrawal by Subject|0|||
130726483|NCT02045147|470623098|FG002|Overall Study|Withdrawal by Subject|0|||
130726484|NCT02045147|470623099|FG003|Overall Study|Withdrawal by Subject|0|||
130726485|NCT02045147|470623100|FG004|Overall Study|Withdrawal by Subject|0|||
130726486|NCT02045147|470623101|FG005|Overall Study|Withdrawal by Subject|0|||
130726487|NCT02045147|470623102|FG006|Overall Study|Withdrawal by Subject|0|||
130726488|NCT02045147|470623103|FG007|Overall Study|Withdrawal by Subject|1|||
130726489|NCT02045147|470623096|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
130726490|NCT02045147|470623097|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
130726491|NCT02045147|470623098|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130726492|NCT02045147|470623099|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130726493|NCT02045147|470623100|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
130726494|NCT02045147|470623101|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
130726495|NCT02045147|470623102|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130726496|NCT02045147|470623103|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130726497|NCT04839692|470623104|FG000|Overall Study|Withdrawal by Subject|0|||
130726498|NCT04839692|470623105|FG001|Overall Study|Withdrawal by Subject|3|||
130408249|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130408250|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130726499|NCT04839692|470623104|FG000|Overall Study|Physician Decision|1|||
130726500|NCT04839692|470623105|FG001|Overall Study|Physician Decision|0|||
130408251|NCT01172938|469457713|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408252|NCT01172938|469457714|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
130408253|NCT01172938|469457715|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
130408254|NCT01172938|469457716|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408255|NCT01172938|469457717|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408256|NCT01172938|469457718|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408257|NCT01172938|469457719|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408258|NCT01172938|469457720|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408259|NCT01172938|469457721|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
130408260|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130408261|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
130408262|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
130408263|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
130408264|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
130408265|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
130408266|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130408267|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130408268|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130408269|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130408270|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
130408271|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
130408272|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
130408273|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
130408274|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
130408275|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130408276|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130408277|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130408278|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408279|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408280|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
130408281|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408282|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408283|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408284|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408285|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408286|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130408287|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130408288|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
130408289|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
130408290|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
130726501|NCT03146962|470623106|FG000|Overall Study|Lost to Follow-up|1|||
130726502|NCT03146962|470623107|FG001|Overall Study|Lost to Follow-up|1|||
130726503|NCT03146962|470623108|FG002|Overall Study|Lost to Follow-up|0|||
130726504|NCT03146962|470623109|FG003|Overall Study|Lost to Follow-up|0|||
130726505|NCT03146962|470623110|FG004|Overall Study|Lost to Follow-up|0|||
130726506|NCT03146962|470623111|FG005|Overall Study|Lost to Follow-up|0|||
130726507|NCT03146962|470623112|FG006|Overall Study|Lost to Follow-up|0|||
130726508|NCT03146962|470623113|FG007|Overall Study|Lost to Follow-up|0|||
130726509|NCT03146962|470623114|FG008|Overall Study|Lost to Follow-up|0|||
130726510|NCT03146962|470623115|FG009|Overall Study|Lost to Follow-up|0|||
130726511|NCT03146962|470623106|FG000|Overall Study|Adverse Event|0|||
130726512|NCT03146962|470623107|FG001|Overall Study|Adverse Event|3|||
130726513|NCT03146962|470623108|FG002|Overall Study|Adverse Event|0|||
130726514|NCT03146962|470623109|FG003|Overall Study|Adverse Event|0|||
130726515|NCT03146962|470623110|FG004|Overall Study|Adverse Event|0|||
130726516|NCT03146962|470623111|FG005|Overall Study|Adverse Event|0|||
130726517|NCT03146962|470623112|FG006|Overall Study|Adverse Event|0|||
130726518|NCT03146962|470623113|FG007|Overall Study|Adverse Event|1|||
130726519|NCT03146962|470623114|FG008|Overall Study|Adverse Event|0|||
130726520|NCT03146962|470623115|FG009|Overall Study|Adverse Event|0|||
130408291|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
130408292|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
130408293|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
130408294|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130408295|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130408296|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408297|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130408298|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130408299|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130408300|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408301|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408302|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408303|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408304|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130408305|NCT01172938|469457713|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408306|NCT01172938|469457714|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408307|NCT01172938|469457715|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408308|NCT01172938|469457716|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408309|NCT01172938|469457717|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408310|NCT01172938|469457718|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
130408311|NCT01172938|469457719|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
130408312|NCT01172938|469457720|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408313|NCT01172938|469457721|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
130408314|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130408315|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
130408316|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
130408317|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130408318|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130408319|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130408320|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130408321|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
130408322|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
130408323|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408324|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
130408325|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
130408326|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408327|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408328|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408329|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408330|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
130408331|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130408332|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408333|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408334|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
130408335|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408336|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130726521|NCT03146962|470623106|FG000|Overall Study|Withdrawal by Subject|0|||
130726522|NCT03146962|470623107|FG001|Overall Study|Withdrawal by Subject|0|||
130726523|NCT03146962|470623108|FG002|Overall Study|Withdrawal by Subject|0|||
130726524|NCT03146962|470623109|FG003|Overall Study|Withdrawal by Subject|0|||
130726525|NCT03146962|470623110|FG004|Overall Study|Withdrawal by Subject|1|||
130726526|NCT03146962|470623111|FG005|Overall Study|Withdrawal by Subject|0|||
130726527|NCT03146962|470623112|FG006|Overall Study|Withdrawal by Subject|0|||
130726528|NCT03146962|470623113|FG007|Overall Study|Withdrawal by Subject|0|||
130726529|NCT03146962|470623114|FG008|Overall Study|Withdrawal by Subject|0|||
130726530|NCT03146962|470623115|FG009|Overall Study|Withdrawal by Subject|0|||
130726531|NCT03146962|470623106|FG000|Overall Study|Death|0|||
130726532|NCT03146962|470623107|FG001|Overall Study|Death|1|||
130726533|NCT03146962|470623108|FG002|Overall Study|Death|0|||
130726534|NCT03146962|470623109|FG003|Overall Study|Death|0|||
130726535|NCT03146962|470623110|FG004|Overall Study|Death|0|||
130726536|NCT03146962|470623111|FG005|Overall Study|Death|0|||
130408337|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408338|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408339|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408340|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130408341|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130408342|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
130408343|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
130408344|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130408345|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130408346|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130408347|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130408348|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
130408349|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
130408350|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408351|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408352|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
130408353|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408354|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408355|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408356|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408357|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408358|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130408359|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408360|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
130408361|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
130408362|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408363|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408364|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408365|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408366|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
130408367|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130408368|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408369|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
130408370|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408371|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408372|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408373|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408374|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408375|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130408376|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
130408377|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408378|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
130408379|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408380|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408381|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408382|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408383|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408384|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408385|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130408386|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130726537|NCT03146962|470623112|FG006|Overall Study|Death|0|||
130726538|NCT03146962|470623113|FG007|Overall Study|Death|0|||
130726539|NCT03146962|470623114|FG008|Overall Study|Death|0|||
130726540|NCT03146962|470623115|FG009|Overall Study|Death|0|||
130726541|NCT03146962|470623106|FG000|Overall Study|COVID Precautions|1|||
130408387|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408388|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130726542|NCT03146962|470623107|FG001|Overall Study|COVID Precautions|0|||
130726543|NCT03146962|470623108|FG002|Overall Study|COVID Precautions|0|||
130726544|NCT03146962|470623109|FG003|Overall Study|COVID Precautions|0|||
130726545|NCT03146962|470623110|FG004|Overall Study|COVID Precautions|0|||
130726546|NCT03146962|470623111|FG005|Overall Study|COVID Precautions|0|||
130726547|NCT03146962|470623112|FG006|Overall Study|COVID Precautions|0|||
130726548|NCT03146962|470623113|FG007|Overall Study|COVID Precautions|0|||
130726549|NCT03146962|470623114|FG008|Overall Study|COVID Precautions|0|||
130726550|NCT03146962|470623115|FG009|Overall Study|COVID Precautions|0|||
130726551|NCT03146962|470623106|FG000|Overall Study|Physician Decision|0|||
130726552|NCT03146962|470623107|FG001|Overall Study|Physician Decision|0|||
130726553|NCT03146962|470623108|FG002|Overall Study|Physician Decision|0|||
130726554|NCT03146962|470623109|FG003|Overall Study|Physician Decision|0|||
130726555|NCT03146962|470623110|FG004|Overall Study|Physician Decision|0|||
130726556|NCT03146962|470623111|FG005|Overall Study|Physician Decision|0|||
130726557|NCT03146962|470623112|FG006|Overall Study|Physician Decision|0|||
130726558|NCT03146962|470623113|FG007|Overall Study|Physician Decision|0|||
130726559|NCT03146962|470623114|FG008|Overall Study|Physician Decision|0|||
130726560|NCT03146962|470623115|FG009|Overall Study|Physician Decision|1|||
130726561|NCT03146962|470623106|FG000|Overall Study|Started New Treatment|0|||
130726562|NCT03146962|470623107|FG001|Overall Study|Started New Treatment|1|||
130726563|NCT03146962|470623108|FG002|Overall Study|Started New Treatment|0|||
130726564|NCT03146962|470623109|FG003|Overall Study|Started New Treatment|0|||
130726565|NCT03146962|470623110|FG004|Overall Study|Started New Treatment|0|||
130726566|NCT03146962|470623111|FG005|Overall Study|Started New Treatment|0|||
130726567|NCT03146962|470623112|FG006|Overall Study|Started New Treatment|0|||
130726568|NCT03146962|470623113|FG007|Overall Study|Started New Treatment|0|||
130726569|NCT03146962|470623114|FG008|Overall Study|Started New Treatment|0|||
130726570|NCT03146962|470623115|FG009|Overall Study|Started New Treatment|0|||
130726571|NCT04497948|470623118|FG000|Overall Study|Death|2|||
130726572|NCT02246114|470623121|FG000|Overall Study|miscarriage|1|||
130726573|NCT02246114|470623122|FG001|Overall Study|miscarriage|0|||
130408389|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408390|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408391|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408392|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408393|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130408394|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
130408395|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130408396|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
130408397|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130408398|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130408399|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130408400|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130408401|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130408402|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130408403|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130408404|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130408405|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
130408406|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
130408407|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130408408|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130408409|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130408410|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130472708|NCT03526861|469698455|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
130472709|NCT03526861|469698447|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472710|NCT03526861|469698448|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472711|NCT03526861|469698449|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130561630|NCT01994382|470024800|FG004|Overall Study|Physician Decision|0|||
130408411|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
130408412|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
130726574|NCT00129389|470623123|FG000|Overall Study|Adverse Event|19|||
130726575|NCT00129389|470623124|FG001|Overall Study|Adverse Event|87|||
130726576|NCT00129389|470623123|FG000|Overall Study|Death|0|||
130726577|NCT00129389|470623124|FG001|Overall Study|Death|1|||
130726578|NCT00129389|470623123|FG000|Overall Study|Lost to Follow-up|2|||
130726579|NCT00129389|470623124|FG001|Overall Study|Lost to Follow-up|1|||
130726580|NCT00129389|470623123|FG000|Overall Study|Physician Decision|0|||
130726581|NCT00129389|470623124|FG001|Overall Study|Physician Decision|4|||
130726582|NCT00129389|470623123|FG000|Overall Study|Protocol Violation|0|||
130726583|NCT00129389|470623124|FG001|Overall Study|Protocol Violation|6|||
130726584|NCT00129389|470623123|FG000|Overall Study|Withdrawal by Subject|9|||
130726585|NCT00129389|470623124|FG001|Overall Study|Withdrawal by Subject|23|||
130726586|NCT00129389|470623123|FG000|Overall Study|Relapse|1|||
130726587|NCT00129389|470623124|FG001|Overall Study|Relapse|0|||
130726588|NCT00129389|470623123|FG000|Overall Study|Not eligible|1|||
130726589|NCT00129389|470623124|FG001|Overall Study|Not eligible|2|||
130726590|NCT00129389|470623123|FG000|Overall Study|Crossed to the other arm|1|||
130726591|NCT00129389|470623124|FG001|Overall Study|Crossed to the other arm|16|||
130726592|NCT03760185|470623125|FG000|Overall Study|Lost to Follow-up|1|||
130726593|NCT03760185|470623126|FG001|Overall Study|Lost to Follow-up|1|||
130726594|NCT01191944|470623127|FG000|Overall Study|Adverse Event|11|||
130726595|NCT01191944|470623128|FG001|Overall Study|Adverse Event|12|||
130726596|NCT01191944|470623127|FG000|Overall Study|Protocol Violation|1|||
130726597|NCT01191944|470623128|FG001|Overall Study|Protocol Violation|2|||
130726598|NCT01191944|470623127|FG000|Overall Study|Withdrawal by Subject|4|||
130726599|NCT01191944|470623128|FG001|Overall Study|Withdrawal by Subject|2|||
130726600|NCT01191944|470623127|FG000|Overall Study|Other|1|||
130726601|NCT01191944|470623128|FG001|Overall Study|Other|3|||
130726602|NCT00603837|470623131|FG000|Overall Study|Physician Decision|3|||
130726603|NCT00603837|470623132|FG001|Overall Study|Physician Decision|0|||
130726604|NCT04611529|470623133|FG000|2-day Follow up|Lost to Follow-up|5|||
130726605|NCT04611529|470623134|FG001|2-day Follow up|Lost to Follow-up|6|||
130726606|NCT04611529|470623135|FG002|2-day Follow up|Lost to Follow-up|3|||
130726607|NCT01275729|470623203|FG000|Overall Study|Death|3|||
130726608|NCT01275729|470623203|FG000|Overall Study|Withdrawal by Subject|1|||
130726609|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
130726610|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
130726611|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
130726612|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
130726613|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
130726614|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
130726615|NCT02252406|470623204|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130726616|NCT02252406|470623205|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130726617|NCT02252406|470623204|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
130726618|NCT02252406|470623205|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
130726619|NCT03717012|470623210|FG000|Overall Study|Due to trial termination|1|||
130726620|NCT03717012|470623211|FG001|Overall Study|Due to trial termination|2|||
130726621|NCT03717012|470623210|FG000|Overall Study|Protocol Violation|0|||
130726622|NCT03717012|470623211|FG001|Overall Study|Protocol Violation|2|||
130726623|NCT03717012|470623210|FG000|Overall Study|Adverse Event|0|||
130726624|NCT03717012|470623211|FG001|Overall Study|Adverse Event|1|||
130726625|NCT03717012|470623210|FG000|Overall Study|Lung transplant|0|||
130726626|NCT03717012|470623211|FG001|Overall Study|Lung transplant|1|||
130726627|NCT00789035|470623212|FG000|Overall Study|Adverse Event|0|||
130726628|NCT00789035|470623213|FG001|Overall Study|Adverse Event|2|||
130726629|NCT00789035|470623214|FG002|Overall Study|Adverse Event|0|||
130726630|NCT00789035|470623215|FG003|Overall Study|Adverse Event|1|||
130726631|NCT00789035|470623216|FG004|Overall Study|Adverse Event|3|||
130726632|NCT00789035|470623212|FG000|Overall Study|Lack of Efficacy|3|||
130726633|NCT00789035|470623213|FG001|Overall Study|Lack of Efficacy|0|||
130726634|NCT00789035|470623214|FG002|Overall Study|Lack of Efficacy|0|||
130726635|NCT00789035|470623215|FG003|Overall Study|Lack of Efficacy|0|||
130726636|NCT00789035|470623216|FG004|Overall Study|Lack of Efficacy|2|||
130726637|NCT00789035|470623212|FG000|Overall Study|Protocol Violation|1|||
130726638|NCT00789035|470623213|FG001|Overall Study|Protocol Violation|0|||
130726639|NCT00789035|470623214|FG002|Overall Study|Protocol Violation|0|||
130726640|NCT00789035|470623215|FG003|Overall Study|Protocol Violation|0|||
130726641|NCT00789035|470623216|FG004|Overall Study|Protocol Violation|0|||
130726642|NCT00789035|470623212|FG000|Overall Study|Withdrawal by Subject|0|||
130726643|NCT00789035|470623213|FG001|Overall Study|Withdrawal by Subject|2|||
130726644|NCT00789035|470623214|FG002|Overall Study|Withdrawal by Subject|0|||
130726645|NCT00789035|470623215|FG003|Overall Study|Withdrawal by Subject|0|||
130408413|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
130726646|NCT00789035|470623216|FG004|Overall Study|Withdrawal by Subject|0|||
130408414|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
130726647|NCT00789035|470623212|FG000|Overall Study|Other reason not defined above|2|||
130726648|NCT00789035|470623213|FG001|Overall Study|Other reason not defined above|3|||
130726649|NCT00789035|470623214|FG002|Overall Study|Other reason not defined above|1|||
130726650|NCT00789035|470623215|FG003|Overall Study|Other reason not defined above|0|||
130726651|NCT00789035|470623216|FG004|Overall Study|Other reason not defined above|1|||
130726652|NCT02640690|470623217|FG000|Overall Study|Lost to Follow-up|7|||
130726653|NCT02640690|470623218|FG001|Overall Study|Lost to Follow-up|7|||
130726654|NCT02640690|470623217|FG000|Overall Study|Withdrawal by Subject|16|||
130726655|NCT02640690|470623218|FG001|Overall Study|Withdrawal by Subject|20|||
130408415|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408416|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408417|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408418|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408419|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408420|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
130408421|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
130408422|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408423|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
130408424|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408425|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408426|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408427|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408428|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408429|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408430|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130408431|NCT01172938|469457713|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408432|NCT01172938|469457714|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408433|NCT01172938|469457715|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
130408434|NCT01172938|469457716|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408435|NCT01172938|469457717|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408436|NCT01172938|469457718|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408437|NCT01172938|469457719|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408438|NCT01172938|469457720|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408439|NCT01172938|469457721|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130408440|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408441|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
130408442|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
130408443|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408444|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408445|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408446|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408447|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
130408448|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130408449|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130408450|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
130408451|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
130408452|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130408453|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130408454|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130408455|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130408456|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
130408457|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
130408458|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130408459|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
130408460|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
130408461|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130561631|NCT01994382|470024801|FG005|Overall Study|Physician Decision|0|||
130408462|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130408463|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130408464|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130408465|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
130408466|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
130408467|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408468|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408469|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
130408470|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408471|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408472|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408473|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408474|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130408475|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
130408476|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408477|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408478|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408479|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408480|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408481|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408482|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408483|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
130408484|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130408485|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408486|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408487|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130408488|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408489|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408490|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408491|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130408492|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130408493|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130408494|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408495|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408496|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
130408497|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408498|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408499|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408500|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408501|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408502|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130408503|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408504|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
130408505|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408506|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408507|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408508|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408509|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408510|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
130408511|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130408512|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130472712|NCT03526861|469698450|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
130472713|NCT03526861|469698451|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
130472714|NCT03526861|469698452|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472715|NCT03526861|469698453|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
130472716|NCT03526861|469698454|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472717|NCT03526861|469698455|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472718|NCT03526861|469698447|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
130472719|NCT03526861|469698448|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
130561632|NCT01994382|470024802|FG006|Overall Study|Physician Decision|0|||
130726656|NCT02640690|470623217|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
130726657|NCT02640690|470623218|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
130726658|NCT01118975|470623219|FG000|Overall Study|Adverse Event|0|||
130726659|NCT01118975|470623220|FG001|Overall Study|Adverse Event|1|||
130726660|NCT01520870|470623221|FG000|Overall Study|Withdrawal by Subject|2|||
130726661|NCT02463357|470623222|FG000|Overall Study|Withdrawal by Subject|1|||
130726662|NCT02463357|470623223|FG001|Overall Study|Withdrawal by Subject|0|||
130726663|NCT02463357|470623224|FG002|Overall Study|Withdrawal by Subject|0|||
130726664|NCT02463357|470623225|FG003|Overall Study|Withdrawal by Subject|0|||
130726665|NCT02463357|470623226|FG004|Overall Study|Withdrawal by Subject|0|||
130726666|NCT02463357|470623222|FG000|Overall Study|Withdrawal by Subject|0|||
130726667|NCT02463357|470623223|FG001|Overall Study|Withdrawal by Subject|0|||
130726668|NCT02463357|470623224|FG002|Overall Study|Withdrawal by Subject|0|||
130726669|NCT02463357|470623225|FG003|Overall Study|Withdrawal by Subject|0|||
130726670|NCT02463357|470623226|FG004|Overall Study|Withdrawal by Subject|1|||
130408513|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
130408514|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
130408515|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130408516|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130408517|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130408518|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130408519|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
130408520|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130408521|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408522|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408523|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
130408524|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408525|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408526|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408527|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408528|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408529|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130408530|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408531|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408532|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
130408533|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408534|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408535|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408536|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408537|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408538|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130408539|NCT01172938|469457713|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408540|NCT01172938|469457714|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408541|NCT01172938|469457715|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130726671|NCT01399658|470623227|FG000|Overall Study|Ineligible|1|||
130726672|NCT01399658|470623227|FG000|Overall Study|Machine Technical Issue|3|||
130726673|NCT01399658|470623227|FG000|Overall Study|Alternative therapy|1|||
130726674|NCT01399658|470623227|FG000|Overall Study|No reason given|1|||
130726675|NCT02460679|470623228|FG000|Overall Study|Investigator Decision|1|||
130726676|NCT02460679|470623228|FG000|Overall Study|Withdrawal by Subject|4|||
130726677|NCT02620579|470623234|FG000|Overall Study|Physician Decision|0|||
130726678|NCT02620579|470623235|FG001|Overall Study|Physician Decision|0|||
130726679|NCT02620579|470623236|FG002|Overall Study|Physician Decision|0|||
130726680|NCT02620579|470623237|FG003|Overall Study|Physician Decision|1|||
130726681|NCT02620579|470623234|FG000|Overall Study|Withdrawal by Subject|0|||
130726682|NCT02620579|470623235|FG001|Overall Study|Withdrawal by Subject|1|||
130726683|NCT02620579|470623236|FG002|Overall Study|Withdrawal by Subject|1|||
130408542|NCT01172938|469457716|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408543|NCT01172938|469457717|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408544|NCT01172938|469457718|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408545|NCT01172938|469457719|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408546|NCT01172938|469457720|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130408547|NCT01172938|469457721|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
130408548|NCT00003498|469457722|FG000|Overall Study|Not evaluable.|4|||
130408549|NCT05282004|469457726|FG000|Overall Study|Adverse Event|2|||
130408550|NCT00889421|469457727|FG000|Overall Study|Lack of Efficacy|3|||
130408551|NCT01958918|469457728|FG000|Overall Study|Death|1|||
130408552|NCT01958918|469457729|FG001|Overall Study|Death|3|||
130726684|NCT02620579|470623237|FG003|Overall Study|Withdrawal by Subject|0|||
130408553|NCT01958918|469457728|FG000|Overall Study|Lost to Follow-up|4|||
130726685|NCT00796107|470623238|FG000|Overall Study|Lack of Efficacy|1|||
130726686|NCT00796107|470623238|FG000|Overall Study|Progressive Disease|5|||
130726687|NCT04411914|470623239|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
130726688|NCT04411914|470623240|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
130726689|NCT01721317|470623242|FG000|Overall Study|Study Closed / Terminated|2|||
130726690|NCT01721317|470623243|FG001|Overall Study|Study Closed / Terminated|2|||
130726691|NCT01721317|470623242|FG000|Overall Study|Physician Decision|0|||
130726692|NCT01721317|470623243|FG001|Overall Study|Physician Decision|1|||
130408554|NCT01958918|469457729|FG001|Overall Study|Lost to Follow-up|7|||
130408555|NCT01958918|469457728|FG000|Overall Study|Withdrawal by Subject|13|||
130408556|NCT01958918|469457729|FG001|Overall Study|Withdrawal by Subject|8|||
130408557|NCT01958918|469457728|FG000|Overall Study|Lack of Efficacy|13|||
130408558|NCT01958918|469457729|FG001|Overall Study|Lack of Efficacy|10|||
130408559|NCT01958918|469457728|FG000|Overall Study|Adverse Event|12|||
130408560|NCT01958918|469457729|FG001|Overall Study|Adverse Event|12|||
130408561|NCT01958918|469457728|FG000|Overall Study|administrative problems|0|||
130408562|NCT01958918|469457729|FG001|Overall Study|administrative problems|2|||
130408563|NCT02013765|469457733|FG000|Overall Study|Trial was terminated by sponsor|1|||
130408564|NCT00659269|469457734|FG000|Overall Study|Physician Decision|1|||
130408565|NCT00659269|469457735|FG001|Overall Study|Physician Decision|1|||
130408566|NCT01158222|469457736|FG000|Overall Study|Not eligible for intermediate phase|17|||
130408567|NCT00718042|469457737|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130408568|NCT00718042|469457738|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130408569|NCT00718042|469457739|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130408570|NCT00718042|469457740|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130408571|NCT00718042|469457741|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
130408572|NCT00718042|469457742|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130408573|NCT00718042|469457737|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
130408574|NCT00718042|469457738|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130408575|NCT00718042|469457739|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130408576|NCT00718042|469457740|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130408577|NCT00718042|469457741|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
130408578|NCT00718042|469457742|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130408579|NCT00718042|469457737|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130408580|NCT00718042|469457738|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
130408581|NCT00718042|469457739|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
130408582|NCT00718042|469457740|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130408583|NCT00718042|469457741|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130408584|NCT00718042|469457742|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130408585|NCT00718042|469457737|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130408586|NCT00718042|469457738|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
130408587|NCT00718042|469457739|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130408588|NCT00718042|469457740|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130408589|NCT00718042|469457741|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130408590|NCT00718042|469457742|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130408591|NCT00718042|469457737|FG000|Donor Follow-up|Lost to Follow-up|13|||
130408592|NCT00718042|469457738|FG001|Donor Follow-up|Lost to Follow-up|0|||
130408593|NCT00718042|469457739|FG002|Donor Follow-up|Lost to Follow-up|0|||
130408594|NCT00718042|469457740|FG003|Donor Follow-up|Lost to Follow-up|0|||
130408595|NCT00718042|469457741|FG004|Donor Follow-up|Lost to Follow-up|19|||
130408596|NCT00718042|469457742|FG005|Donor Follow-up|Lost to Follow-up|0|||
130408597|NCT02443298|469457743|FG000|Overall Study|Adverse Event|3|||
130408598|NCT02443298|469457744|FG001|Overall Study|Adverse Event|3|||
130408599|NCT02443298|469457743|FG000|Overall Study|Withdrawal by Subject|1|||
130408600|NCT02443298|469457744|FG001|Overall Study|Withdrawal by Subject|2|||
130408601|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
130408602|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
130408603|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
130408604|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
130408605|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
130408606|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
130408607|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
130408608|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
130408609|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
130408610|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
130726693|NCT01721317|470623242|FG000|Overall Study|Withdrawal by Subject|0|||
130408611|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
130408612|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
130408613|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
130408614|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
130408615|NCT02464969|469457745|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
130408616|NCT02464969|469457746|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
130561633|NCT01994382|470024803|FG007|Overall Study|Physician Decision|0|||
130561634|NCT01994382|470024804|FG008|Overall Study|Physician Decision|0|||
130726694|NCT01721317|470623243|FG001|Overall Study|Withdrawal by Subject|1|||
130472720|NCT03526861|469698449|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
130472721|NCT03526861|469698450|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
130472722|NCT03526861|469698451|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
130472723|NCT03526861|469698452|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
130472724|NCT03526861|469698453|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
130472725|NCT03526861|469698454|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
130408617|NCT02464969|469457745|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
130408618|NCT02464969|469457746|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
130408619|NCT02464969|469457745|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
130408620|NCT02464969|469457746|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
130408621|NCT02464969|469457745|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
130408622|NCT02464969|469457746|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
130408623|NCT02399085|469457751|FG000|Overall Study|Adverse Event|16|||
130408624|NCT02399085|469457751|FG000|Overall Study|Death|2|||
130408625|NCT02399085|469457751|FG000|Overall Study|Withdrawal by Subject|8|||
130408626|NCT02399085|469457751|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
130408627|NCT02399085|469457751|FG000|Overall Study|Physician Decision|5|||
130408628|NCT00833924|469457752|FG000|Overall Study|Death|21|||
130408629|NCT00833924|469457752|FG000|Overall Study|Conversion|2|||
130408630|NCT00833924|469457752|FG000|Overall Study|Lost to Follow-up|2|||
130408631|NCT00833924|469457752|FG000|Overall Study|Withdrawal by Subject|13|||
130408632|NCT00833924|469457752|FG000|Overall Study|In study follow-up|71|||
130408633|NCT02543346|469457755|FG000|Second Priming Visit|Withdrawal by Subject|0|||
130408634|NCT02543346|469457756|FG001|Second Priming Visit|Withdrawal by Subject|2|||
130408635|NCT02543346|469457757|FG002|Second Priming Visit|Withdrawal by Subject|2|||
130408636|NCT02543346|469457758|FG003|Second Priming Visit|Withdrawal by Subject|2|||
130408637|NCT02543346|469457755|FG000|Second Priming Visit|Adverse Event|1|||
130408638|NCT02543346|469457756|FG001|Second Priming Visit|Adverse Event|0|||
130408639|NCT02543346|469457757|FG002|Second Priming Visit|Adverse Event|0|||
130408640|NCT02543346|469457758|FG003|Second Priming Visit|Adverse Event|0|||
130408641|NCT01767116|469457759|FG000|Overall Study|Lost to Follow-up|2|||
130408642|NCT01767116|469457760|FG001|Overall Study|Lost to Follow-up|2|||
130408643|NCT01975389|469457761|FG000|Overall Study|Adverse Event|10|||
130408644|NCT01975389|469457762|FG001|Overall Study|Adverse Event|6|||
130408645|NCT01975389|469457761|FG000|Overall Study|Death|61|||
130408646|NCT01975389|469457762|FG001|Overall Study|Death|54|||
130408647|NCT01975389|469457761|FG000|Overall Study|Lost to Follow-up|81|||
130408648|NCT01975389|469457762|FG001|Overall Study|Lost to Follow-up|86|||
130408649|NCT01975389|469457761|FG000|Overall Study|Withdrawal by Subject|90|||
130408650|NCT01975389|469457762|FG001|Overall Study|Withdrawal by Subject|76|||
130408651|NCT01975389|469457761|FG000|Overall Study|Other|6|||
130408652|NCT01975389|469457762|FG001|Overall Study|Other|9|||
130408653|NCT01975389|469457761|FG000|Overall Study|Randomized, not treated|4|||
130408654|NCT01975389|469457762|FG001|Overall Study|Randomized, not treated|5|||
130408655|NCT03299192|469457763|FG000|Overall Study|Fell before classes started|1|||
130408656|NCT03299192|469457764|FG001|Overall Study|Fell before classes started|0|||
130408657|NCT03299192|469457765|FG002|Overall Study|Fell before classes started|0|||
130408658|NCT03299192|469457763|FG000|Overall Study|Other|0|||
130408659|NCT03299192|469457764|FG001|Overall Study|Other|2|||
130408660|NCT03299192|469457765|FG002|Overall Study|Other|1|||
130408661|NCT00298831|469457774|FG000|Overall Study|Adverse Event|1|||
130408662|NCT00298831|469457774|FG000|Overall Study|Lost to Follow-up|3|||
130408663|NCT00298831|469457774|FG000|Overall Study|Withdrawal by Subject|1|||
130408664|NCT00298831|469457774|FG000|Overall Study|Participants did not receive treatment|27|||
130408665|NCT04122443|469457775|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
130408666|NCT04122443|469457776|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
130408667|NCT04122443|469457777|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
130408668|NCT04122443|469457775|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
130408669|NCT04122443|469457776|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
130408670|NCT04122443|469457777|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
130408671|NCT00691210|469457779|FG000|Overall Study|Progression of Disease|0|||
130408672|NCT00691210|469457780|FG001|Overall Study|Progression of Disease|0|||
130408673|NCT00691210|469457781|FG002|Overall Study|Progression of Disease|0|||
130408674|NCT00691210|469457782|FG003|Overall Study|Progression of Disease|2|||
130472726|NCT03526861|469698455|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
130472727|NCT03526861|469698447|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472728|NCT03526861|469698448|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130408675|NCT00691210|469457783|FG004|Overall Study|Progression of Disease|0|||
130408676|NCT00691210|469457784|FG005|Overall Study|Progression of Disease|0|||
130408677|NCT00691210|469457785|FG006|Overall Study|Progression of Disease|0|||
130408678|NCT00691210|469457786|FG007|Overall Study|Progression of Disease|0|||
130408679|NCT00691210|469457779|FG000|Overall Study|Lack of Efficacy|0|||
130408680|NCT00691210|469457780|FG001|Overall Study|Lack of Efficacy|0|||
130408681|NCT00691210|469457781|FG002|Overall Study|Lack of Efficacy|0|||
130408682|NCT00691210|469457782|FG003|Overall Study|Lack of Efficacy|1|||
130408683|NCT00691210|469457783|FG004|Overall Study|Lack of Efficacy|0|||
130408684|NCT00691210|469457784|FG005|Overall Study|Lack of Efficacy|1|||
130408685|NCT00691210|469457785|FG006|Overall Study|Lack of Efficacy|0|||
130472729|NCT03526861|469698449|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472730|NCT03526861|469698450|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
130472731|NCT03526861|469698451|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472732|NCT03526861|469698452|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472733|NCT03526861|469698453|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472734|NCT03526861|469698454|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472735|NCT03526861|469698455|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472736|NCT03526861|469698447|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472737|NCT03526861|469698448|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472738|NCT03526861|469698449|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472739|NCT03526861|469698450|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472740|NCT03526861|469698451|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472741|NCT03526861|469698452|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472742|NCT03526861|469698453|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472743|NCT03526861|469698454|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
130472744|NCT03526861|469698455|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
130472745|NCT03526861|469698447|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472746|NCT03526861|469698448|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472747|NCT03526861|469698449|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472748|NCT03526861|469698450|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472749|NCT03526861|469698451|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472750|NCT03526861|469698452|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472751|NCT03526861|469698453|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472752|NCT03526861|469698454|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
130472753|NCT03526861|469698455|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
130472754|NCT03526861|469698447|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472755|NCT03526861|469698448|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472756|NCT03526861|469698449|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472757|NCT03526861|469698450|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472758|NCT03526861|469698451|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472759|NCT03526861|469698452|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472760|NCT03526861|469698453|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472761|NCT03526861|469698454|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130472762|NCT03526861|469698455|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
130472763|NCT03385629|469698457|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
130472764|NCT03385629|469698458|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
130472765|NCT03385629|469698457|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
130472766|NCT03385629|469698458|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
130472767|NCT03385629|469698457|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
130472768|NCT03385629|469698458|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
130472769|NCT05633407|469698462|FG000|Overall Study|Physician Decision|2|||
130408686|NCT00691210|469457786|FG007|Overall Study|Lack of Efficacy|0|||
130408687|NCT01306617|469457788|FG000|Overall Study|Adverse Event|1|||
130408688|NCT01306617|469457789|FG001|Overall Study|Adverse Event|0|||
130408689|NCT01306617|469457790|FG002|Overall Study|Adverse Event|0|||
130472770|NCT05633407|469698463|FG001|Overall Study|Physician Decision|0|||
130472771|NCT05633407|469698462|FG000|Overall Study|Adverse Event|1|||
130472772|NCT05633407|469698463|FG001|Overall Study|Adverse Event|0|||
130472773|NCT05633407|469698462|FG000|Overall Study|Withdrawal by Subject|1|||
130472774|NCT05633407|469698463|FG001|Overall Study|Withdrawal by Subject|0|||
130472775|NCT05633407|469698462|FG000|Overall Study|Other|1|||
130472776|NCT05633407|469698463|FG001|Overall Study|Other|1|||
130472777|NCT02814838|469698468|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
130472778|NCT02814838|469698469|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
130472779|NCT02814838|469698468|FG000|Overall Study|Consent withdrawal|1|||
130472780|NCT02814838|469698469|FG001|Overall Study|Consent withdrawal|1|||
130472781|NCT02910713|469698471|FG000|Overall Study|Protocol Violation|2|||
130472782|NCT02910713|469698471|FG000|Overall Study|Subject Choice|4|||
130472783|NCT02910713|469698471|FG000|Overall Study|Received One Application|10|||
130472784|NCT02910713|469698471|FG000|Overall Study|Received Neither Application|18|||
130472785|NCT02910713|469698471|FG000|Overall Study|Enrollment cap|7|||
130472786|NCT02910713|469698471|FG000|Overall Study|Investigator Discretion|1|||
130472787|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
130472788|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
130472789|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
130472790|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
130472791|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
130472792|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
130472793|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
130472794|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
130472795|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
130472796|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
130472797|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
130472798|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
130472799|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
130472800|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
130472801|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
130472802|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
130472803|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
130472804|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
130472805|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
130472806|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
130472807|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
130472808|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
130472809|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
130472810|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
130472811|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
130472812|NCT05338086|469699568|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
130472813|NCT05338086|469699569|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
130561635|NCT01994382|470024805|FG009|Overall Study|Physician Decision|0|||
130561636|NCT01994382|470024806|FG010|Overall Study|Physician Decision|3|||
130408690|NCT01306617|469457788|FG000|Overall Study|Virologic Failure|0|||
130408691|NCT01306617|469457789|FG001|Overall Study|Virologic Failure|0|||
130408692|NCT01306617|469457790|FG002|Overall Study|Virologic Failure|5|||
130408693|NCT01306617|469457788|FG000|Overall Study|Non-compliance|0|||
130408694|NCT01306617|469457789|FG001|Overall Study|Non-compliance|1|||
130408695|NCT01306617|469457790|FG002|Overall Study|Non-compliance|0|||
130408696|NCT04028388|469457800|FG000|Overall Study|Evaluations missing|3|||
130408697|NCT04028388|469457801|FG001|Overall Study|Evaluations missing|6|||
130408698|NCT04028388|469457800|FG000|Overall Study|Not started|2|||
130408699|NCT04028388|469457801|FG001|Overall Study|Not started|0|||
130408700|NCT01994395|469457802|FG000|Overall Study|Withdrawal by Subject|1|||
130408701|NCT01994395|469457803|FG001|Overall Study|Withdrawal by Subject|2|||
130408702|NCT01940705|469457805|FG000|Overall Study|Lost to Follow-up|1|||
130408703|NCT01940705|469457806|FG001|Overall Study|Lost to Follow-up|3|||
130408704|NCT01940705|469457807|FG002|Overall Study|Lost to Follow-up|2|||
130408705|NCT01940705|469457808|FG003|Overall Study|Lost to Follow-up|2|||
130472814|NCT05338086|469699570|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
130561637|NCT01994382|470024807|FG011|Overall Study|Physician Decision|1|||
130561638|NCT01994382|470024808|FG012|Overall Study|Physician Decision|1|||
130408706|NCT01940705|469457805|FG000|Overall Study|Withdrawal by Subject|2|||
130408707|NCT01940705|469457806|FG001|Overall Study|Withdrawal by Subject|2|||
130408708|NCT01940705|469457807|FG002|Overall Study|Withdrawal by Subject|3|||
130408709|NCT01940705|469457808|FG003|Overall Study|Withdrawal by Subject|2|||
130726695|NCT02806024|470623262|FG000|Overall Study|Night Delivery|1|||
130726696|NCT02806024|470623263|FG001|Overall Study|Night Delivery|1|||
130726697|NCT02806024|470623262|FG000|Overall Study|DVT during antepartum admission|0|||
130726698|NCT02806024|470623263|FG001|Overall Study|DVT during antepartum admission|1|||
130726699|NCT01994850|470623264|FG000|Overall Study|Physician Decision|1|||
130726700|NCT01994850|470623264|FG000|Overall Study|Withdrawal by Subject|1|||
130726701|NCT00895414|470623267|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
130726702|NCT00895414|470623268|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
130726703|NCT00895414|470623267|FG000|First Intervention (14 Days)|Physician Decision|0|||
130726704|NCT00895414|470623268|FG001|First Intervention (14 Days)|Physician Decision|1|||
130726705|NCT00252239|470623269|FG000|Overall Study|Withdrawal by Subject|1|||
130726706|NCT00252239|470623270|FG001|Overall Study|Withdrawal by Subject|0|||
130726707|NCT00252239|470623271|FG002|Overall Study|Withdrawal by Subject|0|||
130726708|NCT00252239|470623272|FG003|Overall Study|Withdrawal by Subject|1|||
130726709|NCT00252239|470623269|FG000|Overall Study|Lost to Follow-up|0|||
130726710|NCT00252239|470623270|FG001|Overall Study|Lost to Follow-up|0|||
130726711|NCT00252239|470623271|FG002|Overall Study|Lost to Follow-up|2|||
130726712|NCT00252239|470623272|FG003|Overall Study|Lost to Follow-up|0|||
130726713|NCT00789737|470623273|FG000|Overall Study|Withdrawal by Subject|13|||
130726714|NCT00789737|470623274|FG001|Overall Study|Withdrawal by Subject|22|||
130726715|NCT00789737|470623273|FG000|Overall Study|Lost to Follow-up|10|||
130726716|NCT00789737|470623274|FG001|Overall Study|Lost to Follow-up|14|||
130726717|NCT00789737|470623273|FG000|Overall Study|Adverse Event|8|||
130726718|NCT00789737|470623274|FG001|Overall Study|Adverse Event|8|||
130726719|NCT00789737|470623273|FG000|Overall Study|Protocol Violation|3|||
130726720|NCT00789737|470623274|FG001|Overall Study|Protocol Violation|0|||
130726721|NCT00789737|470623273|FG000|Overall Study|Lack of Efficacy|3|||
130726722|NCT00789737|470623274|FG001|Overall Study|Lack of Efficacy|0|||
130726723|NCT00789737|470623273|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
130726724|NCT00789737|470623274|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
130726725|NCT00789737|470623273|FG000|Overall Study|Other|11|||
130726726|NCT00789737|470623274|FG001|Overall Study|Other|7|||
130726727|NCT03489109|470623281|FG000|Overall Study|Lost to Follow-up|1|||
130726728|NCT03489109|470623282|FG001|Overall Study|Lost to Follow-up|2|||
130726729|NCT02181790|470623283|FG000|Overall Study|study terminated|2|||
130726730|NCT02181790|470623284|FG001|Overall Study|study terminated|0|||
130726731|NCT02458287|470623285|FG000|Overall Study|Adverse Event|0|||
130726732|NCT02458287|470623286|FG001|Overall Study|Adverse Event|0|||
130726733|NCT02458287|470623287|FG002|Overall Study|Adverse Event|0|||
130726734|NCT02458287|470623288|FG003|Overall Study|Adverse Event|1|||
130726735|NCT02458287|470623285|FG000|Overall Study|Lost to Follow-up|0|||
130726736|NCT02458287|470623286|FG001|Overall Study|Lost to Follow-up|1|||
130726737|NCT02458287|470623287|FG002|Overall Study|Lost to Follow-up|1|||
130726738|NCT02458287|470623288|FG003|Overall Study|Lost to Follow-up|0|||
130726739|NCT02458287|470623285|FG000|Overall Study|Protocol Violation|0|||
130726740|NCT02458287|470623286|FG001|Overall Study|Protocol Violation|1|||
130408710|NCT01940705|469457805|FG000|Overall Study|Intervention not given|0|||
130408711|NCT01940705|469457806|FG001|Overall Study|Intervention not given|3|||
130408712|NCT01940705|469457807|FG002|Overall Study|Intervention not given|3|||
130408713|NCT01940705|469457808|FG003|Overall Study|Intervention not given|0|||
130408714|NCT01940705|469457805|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
130408715|NCT01940705|469457806|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
130408716|NCT01940705|469457807|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
130408717|NCT01940705|469457808|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
130408718|NCT01632579|469457811|FG000|Washout Period|Adverse Event|1|||
130408719|NCT01632579|469457812|FG001|Washout Period|Adverse Event|0|||
130408720|NCT01632579|469457813|FG002|Washout Period|Adverse Event|0|||
130408721|NCT01632579|469457814|FG003|Washout Period|Adverse Event|0|||
130408722|NCT01632579|469457815|FG004|Washout Period|Adverse Event|0|||
130408723|NCT01632579|469457816|FG005|Washout Period|Adverse Event|0|||
130726741|NCT02458287|470623287|FG002|Overall Study|Protocol Violation|0|||
130726742|NCT02458287|470623288|FG003|Overall Study|Protocol Violation|0|||
130726743|NCT02458287|470623285|FG000|Overall Study|Withdrawal by Subject|0|||
130726744|NCT02458287|470623286|FG001|Overall Study|Withdrawal by Subject|2|||
130726745|NCT02458287|470623287|FG002|Overall Study|Withdrawal by Subject|2|||
130726746|NCT02458287|470623288|FG003|Overall Study|Withdrawal by Subject|1|||
130726747|NCT02458287|470623285|FG000|Overall Study|Relocated Out of State|0|||
130726748|NCT02458287|470623286|FG001|Overall Study|Relocated Out of State|0|||
130726749|NCT02458287|470623287|FG002|Overall Study|Relocated Out of State|0|||
130726750|NCT02458287|470623288|FG003|Overall Study|Relocated Out of State|1|||
130726751|NCT02613182|470623289|FG000|Overall Study|Death|6|||
130726752|NCT02613182|470623289|FG000|Overall Study|Physician Decision|1|||
130726753|NCT02613182|470623289|FG000|Overall Study|Study Terminated by Sponsor|21|||
130408724|NCT01632579|469457817|FG006|Washout Period|Adverse Event|0|||
130408725|NCT01632579|469457818|FG007|Washout Period|Adverse Event|0|||
130408726|NCT01632579|469457819|FG008|Washout Period|Adverse Event|0|||
130726754|NCT02613182|470623289|FG000|Overall Study|Withdrawal by Subject|6|||
130408727|NCT01632579|469457811|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
130408728|NCT01632579|469457812|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
130408729|NCT01632579|469457813|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
130408730|NCT01632579|469457814|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
130408731|NCT01632579|469457815|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
130408732|NCT01632579|469457816|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
130408733|NCT01632579|469457817|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
130408734|NCT01632579|469457818|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
130408735|NCT01632579|469457819|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
130408736|NCT03779841|469457820|FG000|Randomized Population|Did Not Receive Treatment|3|||
130408737|NCT03779841|469457821|FG001|Randomized Population|Did Not Receive Treatment|1|||
130408738|NCT03779841|469457822|FG002|Randomized Population|Did Not Receive Treatment|0|||
130408739|NCT03779841|469457820|FG000|Treated (Safety) Population|Adverse Event|1|||
130408740|NCT03779841|469457821|FG001|Treated (Safety) Population|Adverse Event|1|||
130408741|NCT03779841|469457822|FG002|Treated (Safety) Population|Adverse Event|0|||
130408742|NCT03779841|469457820|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
130408743|NCT03779841|469457821|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
130408744|NCT03779841|469457822|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
130408745|NCT03779841|469457820|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
130408746|NCT03779841|469457821|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
130408747|NCT03779841|469457822|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
130408748|NCT03779841|469457820|FG000|Treated (Safety) Population|Death|1|||
130408749|NCT03779841|469457821|FG001|Treated (Safety) Population|Death|0|||
130408750|NCT03779841|469457822|FG002|Treated (Safety) Population|Death|2|||
130408751|NCT02788175|469457823|FG000|Overall Study|Protocol Violation|3|||
130408752|NCT02788175|469457823|FG000|Overall Study|Withdrawal by Subject|4|||
130408753|NCT02788175|469457823|FG000|Overall Study|Ineligible prior to study agent|6|||
130408754|NCT00162136|469457824|FG000|Overall Study|Adverse Event|1|||
130408755|NCT00162136|469457824|FG000|Overall Study|Death|1|||
130408756|NCT00162136|469457824|FG000|Overall Study|Disease Progression/Relapse|23|||
130408757|NCT00162136|469457824|FG000|Overall Study|Investigator Request|5|||
130408758|NCT00162136|469457824|FG000|Overall Study|Study Drug Toxicity|4|||
130408759|NCT00162136|469457824|FG000|Overall Study|Withdrawal by Subject|1|||
130408760|NCT03930745|469457825|FG000|Overall Study|Lost to Follow-up|10|||
130408761|NCT03930745|469457826|FG001|Overall Study|Lost to Follow-up|5|||
130408762|NCT03930745|469457825|FG000|Overall Study|Withdrawal by Subject|1|||
130408763|NCT03930745|469457826|FG001|Overall Study|Withdrawal by Subject|2|||
130408764|NCT03930745|469457825|FG000|Overall Study|Protocol Violation|2|||
130408765|NCT03930745|469457826|FG001|Overall Study|Protocol Violation|2|||
130408766|NCT03930745|469457825|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
130408767|NCT03930745|469457826|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
130408768|NCT03930745|469457825|FG000|Overall Study|Adverse Event|0|||
130408769|NCT03930745|469457826|FG001|Overall Study|Adverse Event|1|||
130408770|NCT03930745|469457825|FG000|Overall Study|Pregnancy|0|||
130408771|NCT03930745|469457826|FG001|Overall Study|Pregnancy|1|||
130408772|NCT03483623|469457843|FG000|Overall Study|43 complete sets achieved|1|||
130408773|NCT02770391|469457844|FG000|Overall Study|Lost to Follow-up|2|||
130408774|NCT02770391|469457844|FG000|Overall Study|Withdrawal by Subject|1|||
130408775|NCT02770391|469457844|FG000|Overall Study|Surgery delayed unevaluable|2|||
130408776|NCT02770391|469457844|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
130408777|NCT00612313|469457850|FG000|Overall Study|Withdrawal by Subject|6|||
130408778|NCT00612313|469457851|FG001|Overall Study|Withdrawal by Subject|9|||
130408779|NCT00612313|469457850|FG000|Overall Study|Lost to Follow-up|11|||
130408780|NCT00612313|469457851|FG001|Overall Study|Lost to Follow-up|4|||
130726755|NCT03968978|470623290|FG000|Overall Study|Adverse Event|1|||
130726756|NCT03968978|470623291|FG001|Overall Study|Adverse Event|0|||
130726757|NCT00908310|470623295|FG000|Overall Study|Death|37|||
130726758|NCT00908310|470623295|FG000|Overall Study|Withdrawal by Subject|7|||
130726759|NCT00908310|470623295|FG000|Overall Study|Lost to Follow-up|7|||
130726760|NCT00908310|470623295|FG000|Overall Study|Screening failure|5|||
130726761|NCT00908310|470623295|FG000|Overall Study|Other reasons|4|||
130726762|NCT02785952|470623298|FG000|Overall Study|Adverse Event|31|||
130726763|NCT02785952|470623299|FG001|Overall Study|Adverse Event|19|||
130408781|NCT03403634|469457860|FG000|Overall Study|Disease progression|3|||
130408782|NCT03403634|469457860|FG000|Overall Study|Did not meet eligibility criteria|4|||
130408783|NCT01337089|469459853|FG000|Overall Study|Adverse Event|237|||
130408784|NCT01337089|469459853|FG000|Overall Study|Withdrawal by Subject|129|||
130726764|NCT02785952|470623298|FG000|Overall Study|Refusal unrelated to adverse events|10|||
130726765|NCT02785952|470623299|FG001|Overall Study|Refusal unrelated to adverse events|5|||
130726766|NCT02785952|470623298|FG000|Overall Study|Disease progression/relapse|61|||
130726767|NCT02785952|470623299|FG001|Overall Study|Disease progression/relapse|89|||
130726768|NCT02785952|470623298|FG000|Overall Study|Death|11|||
130408785|NCT01337089|469459853|FG000|Overall Study|Withdrawal by Investigator|33|||
130408786|NCT01337089|469459853|FG000|Overall Study|Met Withdrawal Criteria|3|||
130408787|NCT01337089|469459853|FG000|Overall Study|Lost to Follow-up|2|||
130408788|NCT01627249|469459854|FG000|Overall Study|Death|3|||
130726769|NCT02785952|470623299|FG001|Overall Study|Death|7|||
130726770|NCT02785952|470623298|FG000|Overall Study|Other- not protocol specified|6|||
130726771|NCT02785952|470623299|FG001|Overall Study|Other- not protocol specified|4|||
130726772|NCT02785952|470623298|FG000|Overall Study|On protocol treatment|6|||
130726773|NCT02785952|470623299|FG001|Overall Study|On protocol treatment|3|||
130726774|NCT01806506|470623300|FG000|Overall Study|Lost to Follow-up|2|||
130726775|NCT01806506|470623301|FG001|Overall Study|Lost to Follow-up|1|||
130726776|NCT04614246|470623302|FG000|Overall Study|Adverse Event|0|||
130726777|NCT04614246|470623303|FG001|Overall Study|Adverse Event|1|||
130726778|NCT04614246|470623304|FG002|Overall Study|Adverse Event|1|||
130726779|NCT04614246|470623305|FG003|Overall Study|Adverse Event|2|||
130726780|NCT04614246|470623306|FG004|Overall Study|Adverse Event|1|||
130726781|NCT04614246|470623302|FG000|Overall Study|Lost to Follow-up|0|||
130726782|NCT04614246|470623303|FG001|Overall Study|Lost to Follow-up|1|||
130726783|NCT04614246|470623304|FG002|Overall Study|Lost to Follow-up|0|||
130726784|NCT04614246|470623305|FG003|Overall Study|Lost to Follow-up|1|||
130726785|NCT04614246|470623306|FG004|Overall Study|Lost to Follow-up|3|||
130726786|NCT04614246|470623302|FG000|Overall Study|Other reason|0|||
130726787|NCT04614246|470623303|FG001|Overall Study|Other reason|1|||
130726788|NCT04614246|470623304|FG002|Overall Study|Other reason|2|||
130726789|NCT04614246|470623305|FG003|Overall Study|Other reason|0|||
130726790|NCT04614246|470623306|FG004|Overall Study|Other reason|0|||
130726791|NCT04614246|470623302|FG000|Overall Study|Withdrawal by Subject|4|||
130726792|NCT04614246|470623303|FG001|Overall Study|Withdrawal by Subject|2|||
130726793|NCT04614246|470623304|FG002|Overall Study|Withdrawal by Subject|4|||
130726794|NCT04614246|470623305|FG003|Overall Study|Withdrawal by Subject|3|||
130726795|NCT04614246|470623306|FG004|Overall Study|Withdrawal by Subject|4|||
130726796|NCT04614246|470623302|FG000|Overall Study|Physician Decision|0|||
130726797|NCT04614246|470623303|FG001|Overall Study|Physician Decision|2|||
130726798|NCT04614246|470623304|FG002|Overall Study|Physician Decision|1|||
130408789|NCT01627249|469459855|FG001|Overall Study|Death|5|||
130408790|NCT01627249|469459856|FG002|Overall Study|Death|3|||
130408791|NCT01627249|469459854|FG000|Overall Study|Withdrawal by Subject|12|||
130408792|NCT01627249|469459855|FG001|Overall Study|Withdrawal by Subject|6|||
130408793|NCT01627249|469459856|FG002|Overall Study|Withdrawal by Subject|9|||
130408794|NCT01627249|469459854|FG000|Overall Study|Missed Visit|1|||
130408795|NCT01627249|469459855|FG001|Overall Study|Missed Visit|1|||
130408796|NCT01627249|469459856|FG002|Overall Study|Missed Visit|0|||
130408797|NCT02039505|469459859|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
130408798|NCT02039505|469459860|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
130408799|NCT02039505|469459861|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
130408800|NCT02039505|469459862|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130408801|NCT02039505|469459863|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130408802|NCT02039505|469459864|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130408803|NCT02039505|469459865|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130408804|NCT02039505|469459859|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
130408805|NCT02039505|469459860|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
130408806|NCT02039505|469459861|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
130408807|NCT02039505|469459862|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130408808|NCT02039505|469459863|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130408809|NCT02039505|469459864|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130472815|NCT05338086|469699571|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
130726799|NCT04614246|470623305|FG003|Overall Study|Physician Decision|0|||
130726800|NCT04614246|470623306|FG004|Overall Study|Physician Decision|0|||
130726801|NCT04614246|470623302|FG000|Overall Study|Study terminated by sponsor|10|||
130726802|NCT04614246|470623303|FG001|Overall Study|Study terminated by sponsor|15|||
130726803|NCT04614246|470623304|FG002|Overall Study|Study terminated by sponsor|12|||
130726804|NCT04614246|470623305|FG003|Overall Study|Study terminated by sponsor|13|||
130726805|NCT04614246|470623306|FG004|Overall Study|Study terminated by sponsor|9|||
130726806|NCT04614246|470623302|FG000|Overall Study|Pregnancy|2|||
130726807|NCT04614246|470623303|FG001|Overall Study|Pregnancy|0|||
130726808|NCT04614246|470623304|FG002|Overall Study|Pregnancy|1|||
130726809|NCT04614246|470623305|FG003|Overall Study|Pregnancy|0|||
130472816|NCT05338086|469699572|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
130472817|NCT05338086|469699568|FG000|Transition Period (M12 to M18)|Death|0|||
130472818|NCT05338086|469699569|FG001|Transition Period (M12 to M18)|Death|0|||
130726810|NCT04614246|470623306|FG004|Overall Study|Pregnancy|0|||
130726811|NCT01680497|470623307|FG000|Overall Study|Lost to Follow-up|2|||
130726812|NCT00725205|470623308|FG000|Overall Study|Adverse Event|22|||
130726813|NCT00725205|470623308|FG000|Overall Study|Investigator Discontinued|1|||
130726814|NCT00725205|470623308|FG000|Overall Study|Non-compliance With Protocol|14|||
130726815|NCT00725205|470623308|FG000|Overall Study|Other|8|||
130408810|NCT02039505|469459865|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130472819|NCT05338086|469699570|FG002|Transition Period (M12 to M18)|Death|1|||
130408811|NCT02039505|469459859|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
130408812|NCT02039505|469459860|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408813|NCT02039505|469459861|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408814|NCT02039505|469459862|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408815|NCT02039505|469459863|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408816|NCT02039505|469459864|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408817|NCT02039505|469459865|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130408818|NCT02039505|469459859|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130408819|NCT02039505|469459860|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130408820|NCT02039505|469459861|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130408821|NCT02039505|469459862|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
130408822|NCT02039505|469459863|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
130408823|NCT02039505|469459864|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
130408824|NCT02039505|469459865|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130408825|NCT02039505|469459859|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130408826|NCT02039505|469459860|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130408827|NCT02039505|469459861|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130408828|NCT02039505|469459862|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
130408829|NCT02039505|469459863|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
130408830|NCT02039505|469459864|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
130408831|NCT02039505|469459865|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130408832|NCT02039505|469459859|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130408833|NCT02039505|469459860|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130408834|NCT02039505|469459861|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130408835|NCT02039505|469459862|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
130408836|NCT02039505|469459863|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
130408837|NCT02039505|469459864|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
130408838|NCT02039505|469459865|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130408839|NCT02039505|469459859|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408840|NCT02039505|469459860|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408841|NCT02039505|469459861|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408842|NCT02039505|469459862|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
130408843|NCT02039505|469459863|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408844|NCT02039505|469459864|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408845|NCT02039505|469459865|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130408846|NCT02039505|469459859|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408847|NCT02039505|469459860|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408848|NCT02039505|469459861|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408849|NCT02039505|469459862|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408850|NCT02039505|469459863|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408851|NCT02039505|469459864|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130408852|NCT02039505|469459865|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
130408853|NCT02039505|469459859|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408854|NCT02039505|469459860|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408855|NCT02039505|469459861|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408856|NCT02039505|469459862|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408857|NCT02039505|469459863|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408858|NCT02039505|469459864|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130408859|NCT02039505|469459865|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
130408860|NCT02039505|469459859|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130408861|NCT02039505|469459860|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130726816|NCT00725205|470623308|FG000|Overall Study|Protocol Defined Clinical Event|1|||
130726817|NCT00725205|470623308|FG000|Overall Study|Treatment Failure|41|||
130726818|NCT01200069|470625416|FG000|Overall Study|Withdrawal by Subject|0|||
130726819|NCT01200069|470625417|FG001|Overall Study|Withdrawal by Subject|1|||
130408862|NCT02039505|469459861|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130408863|NCT02039505|469459862|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130408864|NCT02039505|469459863|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130408865|NCT02039505|469459864|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130472820|NCT05338086|469699571|FG003|Transition Period (M12 to M18)|Death|0|||
130472821|NCT05338086|469699572|FG004|Transition Period (M12 to M18)|Death|0|||
130472822|NCT05338086|469699568|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
130472823|NCT05338086|469699569|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
130726820|NCT04998851|470625418|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
130408866|NCT02039505|469459865|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
130408867|NCT02039505|469459859|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408868|NCT02039505|469459860|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408869|NCT02039505|469459861|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408870|NCT02039505|469459862|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408871|NCT02039505|469459863|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408872|NCT02039505|469459864|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130408873|NCT02039505|469459865|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
130408874|NCT00633984|469459866|FG000|Overall Study|Lost to Follow-up|0|||
130408875|NCT00633984|469459867|FG001|Overall Study|Lost to Follow-up|6|||
130408876|NCT00633984|469459866|FG000|Overall Study|Withdrawal by Subject|8|||
130408877|NCT00633984|469459867|FG001|Overall Study|Withdrawal by Subject|7|||
130408878|NCT00633984|469459866|FG000|Overall Study|Hospitalized|1|||
130408879|NCT00633984|469459867|FG001|Overall Study|Hospitalized|0|||
130408880|NCT02496884|469459868|FG000|Overall Study|Counted twice as enrolled|2|||
130408881|NCT02496884|469459869|FG001|Overall Study|Counted twice as enrolled|0|||
130408882|NCT02496884|469459870|FG002|Overall Study|Counted twice as enrolled|0|||
130408883|NCT02496884|469459871|FG003|Overall Study|Counted twice as enrolled|0|||
130408884|NCT02496884|469459868|FG000|Overall Study|Withdrawal by Subject|0|||
130408885|NCT02496884|469459869|FG001|Overall Study|Withdrawal by Subject|3|||
130408886|NCT02496884|469459870|FG002|Overall Study|Withdrawal by Subject|0|||
130408887|NCT02496884|469459871|FG003|Overall Study|Withdrawal by Subject|0|||
130408888|NCT00097591|469459872|FG000|Overall Study|Withdrawal of consent|342|||
130408889|NCT00097591|469459873|FG001|Overall Study|Withdrawal of consent|323|||
130408890|NCT00097591|469459872|FG000|Overall Study|Less than 6 months on study drug|9|||
130408891|NCT00097591|469459873|FG001|Overall Study|Less than 6 months on study drug|7|||
130408892|NCT00097591|469459872|FG000|Overall Study|Unable to attend termination visit|53|||
130408893|NCT00097591|469459873|FG001|Overall Study|Unable to attend termination visit|51|||
130408894|NCT00097591|469459872|FG000|Overall Study|Lost to follow up|6|||
130408895|NCT00097591|469459873|FG001|Overall Study|Lost to follow up|10|||
130408896|NCT00097591|469459872|FG000|Overall Study|Other|0|||
130408897|NCT00097591|469459873|FG001|Overall Study|Other|3|||
130408898|NCT00009737|469459875|FG000|Overall Study|Adverse Event|112|||
130408899|NCT00009737|469459876|FG001|Overall Study|Adverse Event|75|||
130408900|NCT00009737|469459875|FG000|Overall Study|Death|4|||
130408901|NCT00009737|469459876|FG001|Overall Study|Death|6|||
130408902|NCT00009737|469459875|FG000|Overall Study|Lack of Efficacy|17|||
130408903|NCT00009737|469459876|FG001|Overall Study|Lack of Efficacy|15|||
130408904|NCT00009737|469459875|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
130408905|NCT00009737|469459876|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
130408906|NCT00009737|469459875|FG000|Overall Study|Other Protocol Violation|1|||
130408907|NCT00009737|469459876|FG001|Overall Study|Other Protocol Violation|0|||
130408908|NCT00009737|469459875|FG000|Overall Study|Refused Treatment|15|||
130408909|NCT00009737|469459876|FG001|Overall Study|Refused Treatment|16|||
130408910|NCT00009737|469459875|FG000|Overall Study|Lost to Follow-up|1|||
130408911|NCT00009737|469459876|FG001|Overall Study|Lost to Follow-up|1|||
130408912|NCT00009737|469459875|FG000|Overall Study|Administrative/Other Reasons|7|||
130408913|NCT00009737|469459876|FG001|Overall Study|Administrative/Other Reasons|1|||
130408914|NCT01033747|469459885|FG000|Overall Study|Adverse Event|9|||
130408915|NCT01033747|469459886|FG001|Overall Study|Adverse Event|4|||
130408916|NCT01033747|469459885|FG000|Overall Study|Abnormal Laboratory Value|1|||
130408917|NCT01033747|469459886|FG001|Overall Study|Abnormal Laboratory Value|0|||
130408918|NCT01033747|469459885|FG000|Overall Study|Abnormal test procedure|0|||
130408919|NCT01033747|469459886|FG001|Overall Study|Abnormal test procedure|1|||
130408920|NCT01033747|469459885|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
130408921|NCT01033747|469459886|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130408922|NCT01033747|469459885|FG000|Overall Study|Protocol Violation|1|||
130408923|NCT01033747|469459886|FG001|Overall Study|Protocol Violation|0|||
130408924|NCT01033747|469459885|FG000|Overall Study|Withdrawal by Subject|9|||
130408925|NCT01033747|469459886|FG001|Overall Study|Withdrawal by Subject|6|||
130408926|NCT01033747|469459885|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
130408927|NCT01033747|469459886|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
130561639|NCT01994382|470024809|FG013|Overall Study|Physician Decision|0|||
130561640|NCT01994382|470024810|FG014|Overall Study|Physician Decision|1|||
130408928|NCT01033747|469459885|FG000|Overall Study|Stopped at end of Extension 1|2|||
130408929|NCT01033747|469459886|FG001|Overall Study|Stopped at end of Extension 1|0|||
130408930|NCT02956629|469459887|FG000|Overall Study|Adverse Event|0|||
130408931|NCT02956629|469459888|FG001|Overall Study|Adverse Event|0|||
130408932|NCT02956629|469459889|FG002|Overall Study|Adverse Event|1|||
130408933|NCT02956629|469459890|FG003|Overall Study|Adverse Event|0|||
130408934|NCT02956629|469459891|FG004|Overall Study|Adverse Event|0|||
130408935|NCT02956629|469459892|FG005|Overall Study|Adverse Event|0|||
130408936|NCT02956629|469459887|FG000|Overall Study|Lost to Follow-up|2|||
130408937|NCT02956629|469459888|FG001|Overall Study|Lost to Follow-up|5|||
130408938|NCT02956629|469459889|FG002|Overall Study|Lost to Follow-up|3|||
130408939|NCT02956629|469459890|FG003|Overall Study|Lost to Follow-up|1|||
130408940|NCT02956629|469459891|FG004|Overall Study|Lost to Follow-up|0|||
130408941|NCT02956629|469459892|FG005|Overall Study|Lost to Follow-up|1|||
130408942|NCT02956629|469459887|FG000|Overall Study|Withdrawal by Subject|3|||
130408943|NCT02956629|469459888|FG001|Overall Study|Withdrawal by Subject|1|||
130408944|NCT02956629|469459889|FG002|Overall Study|Withdrawal by Subject|0|||
130408945|NCT02956629|469459890|FG003|Overall Study|Withdrawal by Subject|0|||
130408946|NCT02956629|469459891|FG004|Overall Study|Withdrawal by Subject|0|||
130408947|NCT02956629|469459892|FG005|Overall Study|Withdrawal by Subject|0|||
130408948|NCT04808609|469459897|FG000|Overall Study|Lost to Follow-up|0|||
130408949|NCT04808609|469459898|FG001|Overall Study|Lost to Follow-up|2|||
130408950|NCT04808609|469459897|FG000|Overall Study|Administrative Withdrawal|0|||
130408951|NCT04808609|469459898|FG001|Overall Study|Administrative Withdrawal|1|||
130408952|NCT01993719|469459900|FG000|First Drug Administration|Not treated|1|||
130408953|NCT01993719|469459901|FG001|First Drug Administration|Not treated|0|||
130408954|NCT01993719|469459902|FG002|First Drug Administration|Not treated|0|||
130408955|NCT01993719|469459903|FG003|First Drug Administration|Not treated|0|||
130408956|NCT01993719|469459904|FG004|First Drug Administration|Not treated|0|||
130408957|NCT01931839|469459910|FG000|Overall Study|Death|0|||
130408958|NCT01931839|469459911|FG001|Overall Study|Death|1|||
130408959|NCT01931839|469459912|FG002|Overall Study|Death|2|||
130408960|NCT01931839|469459913|FG003|Overall Study|Death|0|||
130408961|NCT01931839|469459914|FG004|Overall Study|Death|0|||
130408962|NCT01931839|469459915|FG005|Overall Study|Death|0|||
130408963|NCT01931839|469459916|FG006|Overall Study|Death|0|||
130408964|NCT01931839|469459910|FG000|Overall Study|Physician Decision|1|||
130408965|NCT01931839|469459911|FG001|Overall Study|Physician Decision|0|||
130408966|NCT01931839|469459912|FG002|Overall Study|Physician Decision|1|||
130408967|NCT01931839|469459913|FG003|Overall Study|Physician Decision|0|||
130408968|NCT01931839|469459914|FG004|Overall Study|Physician Decision|0|||
130408969|NCT01931839|469459915|FG005|Overall Study|Physician Decision|0|||
130408970|NCT01931839|469459916|FG006|Overall Study|Physician Decision|1|||
130408971|NCT01931839|469459910|FG000|Overall Study|Withdrawal of consent|0|||
130408972|NCT01931839|469459911|FG001|Overall Study|Withdrawal of consent|0|||
130408973|NCT01931839|469459912|FG002|Overall Study|Withdrawal of consent|0|||
130408974|NCT01931839|469459913|FG003|Overall Study|Withdrawal of consent|0|||
130408975|NCT01931839|469459914|FG004|Overall Study|Withdrawal of consent|1|||
130408976|NCT01931839|469459915|FG005|Overall Study|Withdrawal of consent|0|||
130408977|NCT01931839|469459916|FG006|Overall Study|Withdrawal of consent|0|||
130408978|NCT01931839|469459910|FG000|Overall Study|Adverse Event|9|||
130408979|NCT01931839|469459911|FG001|Overall Study|Adverse Event|4|||
130408980|NCT01931839|469459912|FG002|Overall Study|Adverse Event|1|||
130408981|NCT01931839|469459913|FG003|Overall Study|Adverse Event|3|||
130408982|NCT01931839|469459914|FG004|Overall Study|Adverse Event|0|||
130408983|NCT01931839|469459915|FG005|Overall Study|Adverse Event|0|||
130408984|NCT01931839|469459916|FG006|Overall Study|Adverse Event|1|||
130408985|NCT01931839|469459910|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
130408986|NCT01931839|469459911|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
130408987|NCT01931839|469459912|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
130408988|NCT01931839|469459913|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
130408989|NCT01931839|469459914|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
130408990|NCT01931839|469459915|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
130408991|NCT01931839|469459916|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
130408992|NCT01931839|469459910|FG000|Overall Study|Other non-compliance|15|||
130408993|NCT01931839|469459911|FG001|Overall Study|Other non-compliance|9|||
130726821|NCT04998851|470625419|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
130726822|NCT04998851|470625418|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130726823|NCT04998851|470625419|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130726824|NCT00070499|470625420|FG000|Overall Study|Adverse Event|6|||
130408994|NCT01931839|469459912|FG002|Overall Study|Other non-compliance|12|||
130408995|NCT01931839|469459913|FG003|Overall Study|Other non-compliance|3|||
130408996|NCT01931839|469459914|FG004|Overall Study|Other non-compliance|0|||
130408997|NCT01931839|469459915|FG005|Overall Study|Other non-compliance|3|||
130408998|NCT01931839|469459916|FG006|Overall Study|Other non-compliance|0|||
130408999|NCT01931839|469459910|FG000|Overall Study|Lost to Follow-up|1|||
130409000|NCT01931839|469459911|FG001|Overall Study|Lost to Follow-up|2|||
130409001|NCT01931839|469459912|FG002|Overall Study|Lost to Follow-up|4|||
130409002|NCT01931839|469459913|FG003|Overall Study|Lost to Follow-up|5|||
130409003|NCT01931839|469459914|FG004|Overall Study|Lost to Follow-up|0|||
130726825|NCT00070499|470625421|FG001|Overall Study|Adverse Event|6|||
130409004|NCT01931839|469459915|FG005|Overall Study|Lost to Follow-up|0|||
130409005|NCT01931839|469459916|FG006|Overall Study|Lost to Follow-up|0|||
130409006|NCT01931839|469459910|FG000|Overall Study|Other|4|||
130409007|NCT01931839|469459911|FG001|Overall Study|Other|2|||
130409008|NCT01931839|469459912|FG002|Overall Study|Other|6|||
130409009|NCT01931839|469459913|FG003|Overall Study|Other|0|||
130409010|NCT01931839|469459914|FG004|Overall Study|Other|0|||
130409011|NCT01931839|469459915|FG005|Overall Study|Other|0|||
130409012|NCT01931839|469459916|FG006|Overall Study|Other|0|||
130409013|NCT04382326|469459917|FG000|Overall Study|Adverse Event, not serious|1|||
130409014|NCT04382326|469459918|FG001|Overall Study|Adverse Event, not serious|2|||
130409015|NCT04382326|469459917|FG000|Overall Study|Other|1|||
130409016|NCT04382326|469459918|FG001|Overall Study|Other|0|||
130409017|NCT04382326|469459917|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
130409018|NCT04382326|469459918|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
130409019|NCT04382326|469459917|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
130409020|NCT04382326|469459918|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
130409021|NCT04382326|469459917|FG000|Overall Study|Protocol Violation|29|||
130409022|NCT04382326|469459918|FG001|Overall Study|Protocol Violation|23|||
130409023|NCT04382326|469459917|FG000|Overall Study|Physician Decision|0|||
130409024|NCT04382326|469459918|FG001|Overall Study|Physician Decision|1|||
130409025|NCT04382326|469459917|FG000|Overall Study|Lost to Follow-up|48|||
130409026|NCT04382326|469459918|FG001|Overall Study|Lost to Follow-up|63|||
130409027|NCT04382326|469459917|FG000|Overall Study|Adverse Event, non-fatal|1|||
130409028|NCT04382326|469459918|FG001|Overall Study|Adverse Event, non-fatal|1|||
130409029|NCT01762761|469459919|FG000|Overall Study|Adverse Event|15|||
130409030|NCT01762761|469459920|FG001|Overall Study|Adverse Event|17|||
130409031|NCT01762761|469459919|FG000|Overall Study|Lack of Efficacy|9|||
130409032|NCT01762761|469459920|FG001|Overall Study|Lack of Efficacy|25|||
130409033|NCT01762761|469459919|FG000|Overall Study|Protocol Violation|1|||
130409034|NCT01762761|469459920|FG001|Overall Study|Protocol Violation|1|||
130409035|NCT01762761|469459919|FG000|Overall Study|Study closed/terminated|0|||
130409036|NCT01762761|469459920|FG001|Overall Study|Study closed/terminated|2|||
130409037|NCT01762761|469459919|FG000|Overall Study|Lost to Follow-up|3|||
130409038|NCT01762761|469459920|FG001|Overall Study|Lost to Follow-up|6|||
130409039|NCT01762761|469459919|FG000|Overall Study|Physician Decision|4|||
130409040|NCT01762761|469459920|FG001|Overall Study|Physician Decision|6|||
130409041|NCT01762761|469459919|FG000|Overall Study|Withdrawal by Subject|7|||
130409042|NCT01762761|469459920|FG001|Overall Study|Withdrawal by Subject|8|||
130409043|NCT01557946|469459923|FG000|Overall Study|Adverse Event|3|||
130409044|NCT01557946|469459924|FG001|Overall Study|Adverse Event|0|||
130409045|NCT02352493|469459926|FG000|Overall Study|Pregnancy|0|||
130409046|NCT02352493|469459927|FG001|Overall Study|Pregnancy|0|||
130409047|NCT02352493|469459928|FG002|Overall Study|Pregnancy|0|||
130409048|NCT02352493|469459929|FG003|Overall Study|Pregnancy|0|||
130409049|NCT02352493|469459930|FG004|Overall Study|Pregnancy|0|||
130409050|NCT02352493|469459931|FG005|Overall Study|Pregnancy|0|||
130409051|NCT02352493|469459932|FG006|Overall Study|Pregnancy|1|||
130409052|NCT02352493|469459933|FG007|Overall Study|Pregnancy|0|||
130409053|NCT02352493|469459934|FG008|Overall Study|Pregnancy|1|||
130409054|NCT02352493|469459935|FG009|Overall Study|Pregnancy|0|||
130409055|NCT02352493|469459936|FG010|Overall Study|Pregnancy|0|||
130726826|NCT00070499|470625422|FG002|Overall Study|Adverse Event|19|||
130726827|NCT00070499|470625423|FG003|Overall Study|Adverse Event|15|||
130409056|NCT02352493|469459937|FG011|Overall Study|Pregnancy|0|||
130409057|NCT02352493|469459938|FG012|Overall Study|Pregnancy|0|||
130409058|NCT02352493|469459939|FG013|Overall Study|Pregnancy|0|||
130409059|NCT02352493|469459940|FG014|Overall Study|Pregnancy|0|||
130409060|NCT02352493|469459941|FG015|Overall Study|Pregnancy|0|||
130409061|NCT02352493|469459942|FG016|Overall Study|Pregnancy|0|||
130409062|NCT02352493|469459943|FG017|Overall Study|Pregnancy|0|||
130409063|NCT02352493|469459926|FG000|Overall Study|Withdrawal by Subject|0|||
130409064|NCT02352493|469459927|FG001|Overall Study|Withdrawal by Subject|0|||
130409065|NCT02352493|469459928|FG002|Overall Study|Withdrawal by Subject|0|||
130409066|NCT02352493|469459929|FG003|Overall Study|Withdrawal by Subject|0|||
130409067|NCT02352493|469459930|FG004|Overall Study|Withdrawal by Subject|0|||
130409068|NCT02352493|469459931|FG005|Overall Study|Withdrawal by Subject|0|||
130409069|NCT02352493|469459932|FG006|Overall Study|Withdrawal by Subject|0|||
130409070|NCT02352493|469459933|FG007|Overall Study|Withdrawal by Subject|0|||
130409071|NCT02352493|469459934|FG008|Overall Study|Withdrawal by Subject|1|||
130409072|NCT02352493|469459935|FG009|Overall Study|Withdrawal by Subject|0|||
130409073|NCT02352493|469459936|FG010|Overall Study|Withdrawal by Subject|0|||
130409074|NCT02352493|469459937|FG011|Overall Study|Withdrawal by Subject|0|||
130726828|NCT00070499|470625420|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
130726829|NCT00070499|470625421|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
130409075|NCT02352493|469459938|FG012|Overall Study|Withdrawal by Subject|0|||
130409076|NCT02352493|469459939|FG013|Overall Study|Withdrawal by Subject|0|||
130409077|NCT02352493|469459940|FG014|Overall Study|Withdrawal by Subject|1|||
130409078|NCT02352493|469459941|FG015|Overall Study|Withdrawal by Subject|0|||
130409079|NCT02352493|469459942|FG016|Overall Study|Withdrawal by Subject|0|||
130409080|NCT02352493|469459943|FG017|Overall Study|Withdrawal by Subject|0|||
130409081|NCT02352493|469459926|FG000|Overall Study|Lost to Follow-up|0|||
130409082|NCT02352493|469459927|FG001|Overall Study|Lost to Follow-up|0|||
130409083|NCT02352493|469459928|FG002|Overall Study|Lost to Follow-up|0|||
130409084|NCT02352493|469459929|FG003|Overall Study|Lost to Follow-up|0|||
130409085|NCT02352493|469459930|FG004|Overall Study|Lost to Follow-up|0|||
130409086|NCT02352493|469459931|FG005|Overall Study|Lost to Follow-up|0|||
130409087|NCT02352493|469459932|FG006|Overall Study|Lost to Follow-up|0|||
130409088|NCT02352493|469459933|FG007|Overall Study|Lost to Follow-up|0|||
130409089|NCT02352493|469459934|FG008|Overall Study|Lost to Follow-up|0|||
130409090|NCT02352493|469459935|FG009|Overall Study|Lost to Follow-up|1|||
130409091|NCT02352493|469459936|FG010|Overall Study|Lost to Follow-up|0|||
130409092|NCT02352493|469459937|FG011|Overall Study|Lost to Follow-up|0|||
130409093|NCT02352493|469459938|FG012|Overall Study|Lost to Follow-up|1|||
130409094|NCT02352493|469459939|FG013|Overall Study|Lost to Follow-up|2|||
130409095|NCT02352493|469459940|FG014|Overall Study|Lost to Follow-up|0|||
130409096|NCT02352493|469459941|FG015|Overall Study|Lost to Follow-up|0|||
130409097|NCT02352493|469459942|FG016|Overall Study|Lost to Follow-up|0|||
130409098|NCT02352493|469459943|FG017|Overall Study|Lost to Follow-up|0|||
130409099|NCT01465334|469459944|FG000|Overall Study|Disease Progression|1|||
130409100|NCT01465334|469459945|FG001|Overall Study|Disease Progression|0|||
130409101|NCT01465334|469459944|FG000|Overall Study|Adverse Event|1|||
130409102|NCT01465334|469459945|FG001|Overall Study|Adverse Event|0|||
130409103|NCT01465334|469459944|FG000|Overall Study|Richter's transformation|0|||
130409104|NCT01465334|469459945|FG001|Overall Study|Richter's transformation|3|||
130409105|NCT01465334|469459944|FG000|Overall Study|Refractory Disease|0|||
130409106|NCT01465334|469459945|FG001|Overall Study|Refractory Disease|3|||
130409107|NCT00572572|469459946|FG000|Overall Study|Withdrawal by Subject|3|||
130409108|NCT00572572|469459947|FG001|Overall Study|Withdrawal by Subject|6|||
130409109|NCT01831089|469459948|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
130409110|NCT01831089|469459949|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
130409111|NCT01831089|469459950|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
130409112|NCT01831089|469459951|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
130409113|NCT01831089|469459952|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
130409114|NCT01831089|469459953|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
130409115|NCT01831089|469459948|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
130409116|NCT01831089|469459949|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
130409117|NCT01831089|469459950|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
130409118|NCT01831089|469459951|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
130409119|NCT01831089|469459952|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
130409120|NCT01831089|469459953|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
130409121|NCT01831089|469459948|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130409122|NCT01831089|469459949|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
130409123|NCT01831089|469459950|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130409124|NCT01831089|469459951|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130409125|NCT01831089|469459952|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130409126|NCT01831089|469459953|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130409127|NCT01831089|469459948|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
130409128|NCT01831089|469459949|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
130409129|NCT01831089|469459950|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
130409130|NCT01831089|469459951|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
130409131|NCT01831089|469459952|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
130409132|NCT01831089|469459953|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
130409133|NCT01831089|469459948|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130409134|NCT01831089|469459949|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130409135|NCT01831089|469459950|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
130409136|NCT01831089|469459951|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130409137|NCT01831089|469459952|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130472824|NCT05338086|469699570|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
130472825|NCT05338086|469699571|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
130472826|NCT05338086|469699572|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
130409138|NCT01831089|469459953|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130409139|NCT01831089|469459948|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
130409140|NCT01831089|469459949|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
130409141|NCT01831089|469459950|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
130409142|NCT01831089|469459951|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
130409143|NCT01831089|469459952|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
130472827|NCT05338086|469699568|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
130726830|NCT00070499|470625422|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
130726831|NCT00070499|470625423|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
130409144|NCT01831089|469459953|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
130409145|NCT01831089|469459948|FG000|Cohort III: Dose Level 3|Global end of study|0|||
130409146|NCT01831089|469459949|FG001|Cohort III: Dose Level 3|Global end of study|0|||
130409147|NCT01831089|469459950|FG002|Cohort III: Dose Level 3|Global end of study|1|||
130409148|NCT01831089|469459951|FG003|Cohort III: Dose Level 3|Global end of study|0|||
130472828|NCT05338086|469699569|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
130472829|NCT05338086|469699570|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
130726832|NCT00070499|470625420|FG000|Overall Study|Progression/relapse|4|||
130726833|NCT00070499|470625421|FG001|Overall Study|Progression/relapse|2|||
130561641|NCT01994382|470024811|FG015|Overall Study|Physician Decision|4|||
130561642|NCT01994382|470024812|FG016|Overall Study|Physician Decision|2|||
130561643|NCT01994382|470024796|FG000|Overall Study|Death|0|||
130561644|NCT01994382|470024797|FG001|Overall Study|Death|0|||
130726834|NCT00070499|470625422|FG002|Overall Study|Progression/relapse|1|||
130409149|NCT01831089|469459952|FG004|Cohort III: Dose Level 3|Global end of study|0|||
130409150|NCT01831089|469459953|FG005|Cohort III: Dose Level 3|Global end of study|0|||
130409151|NCT01831089|469459948|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
130409152|NCT01831089|469459949|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
130409153|NCT01831089|469459950|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
130409154|NCT01831089|469459951|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
130409155|NCT01831089|469459952|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
130409156|NCT01831089|469459953|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
130409157|NCT01831089|469459948|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
130409158|NCT01831089|469459949|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
130409159|NCT01831089|469459950|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
130409160|NCT01831089|469459951|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
130409161|NCT01831089|469459952|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
130409162|NCT01831089|469459953|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
130409163|NCT01831089|469459948|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130409164|NCT01831089|469459949|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130409165|NCT01831089|469459950|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130409166|NCT01831089|469459951|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130409167|NCT01831089|469459952|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
130409168|NCT01831089|469459953|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130409169|NCT01831089|469459948|FG000|Cohort V: Dose Level 5|Death|0|||
130409170|NCT01831089|469459949|FG001|Cohort V: Dose Level 5|Death|0|||
130409171|NCT01831089|469459950|FG002|Cohort V: Dose Level 5|Death|0|||
130409172|NCT01831089|469459951|FG003|Cohort V: Dose Level 5|Death|0|||
130409173|NCT01831089|469459952|FG004|Cohort V: Dose Level 5|Death|1|||
130409174|NCT01831089|469459953|FG005|Cohort V: Dose Level 5|Death|0|||
130409175|NCT01831089|469459948|FG000|Cohort V: Dose Level 5|Global end of study|0|||
130409176|NCT01831089|469459949|FG001|Cohort V: Dose Level 5|Global end of study|0|||
130409177|NCT01831089|469459950|FG002|Cohort V: Dose Level 5|Global end of study|0|||
130409178|NCT01831089|469459951|FG003|Cohort V: Dose Level 5|Global end of study|0|||
130409179|NCT01831089|469459952|FG004|Cohort V: Dose Level 5|Global end of study|2|||
130409180|NCT01831089|469459953|FG005|Cohort V: Dose Level 5|Global end of study|0|||
130409181|NCT01831089|469459948|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130409182|NCT01831089|469459949|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130409183|NCT01831089|469459950|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130409184|NCT01831089|469459951|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130409185|NCT01831089|469459952|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
130409186|NCT01831089|469459953|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130409187|NCT01831089|469459948|FG000|Cohort B: Arm B|Progressive disease|0|||
130409188|NCT01831089|469459949|FG001|Cohort B: Arm B|Progressive disease|0|||
130409189|NCT01831089|469459950|FG002|Cohort B: Arm B|Progressive disease|0|||
130409190|NCT01831089|469459951|FG003|Cohort B: Arm B|Progressive disease|0|||
130409191|NCT01831089|469459952|FG004|Cohort B: Arm B|Progressive disease|0|||
130409192|NCT01831089|469459953|FG005|Cohort B: Arm B|Progressive disease|8|||
130409193|NCT01831089|469459948|FG000|Cohort B: Arm B|Physician Decision|0|||
130409194|NCT01831089|469459949|FG001|Cohort B: Arm B|Physician Decision|0|||
130409195|NCT01831089|469459950|FG002|Cohort B: Arm B|Physician Decision|0|||
130409196|NCT01831089|469459951|FG003|Cohort B: Arm B|Physician Decision|0|||
130409197|NCT01831089|469459952|FG004|Cohort B: Arm B|Physician Decision|0|||
130409198|NCT01831089|469459953|FG005|Cohort B: Arm B|Physician Decision|2|||
130409199|NCT01831089|469459948|FG000|Cohort B: Arm B|Never treated|0|||
130409200|NCT01831089|469459949|FG001|Cohort B: Arm B|Never treated|0|||
130409201|NCT01831089|469459950|FG002|Cohort B: Arm B|Never treated|0|||
130409202|NCT01831089|469459951|FG003|Cohort B: Arm B|Never treated|0|||
130409203|NCT01831089|469459952|FG004|Cohort B: Arm B|Never treated|0|||
130409204|NCT01831089|469459953|FG005|Cohort B: Arm B|Never treated|2|||
130409205|NCT01831089|469459948|FG000|Cohort B: Arm B|Adverse Event|0|||
130409206|NCT01831089|469459949|FG001|Cohort B: Arm B|Adverse Event|0|||
130409207|NCT01831089|469459950|FG002|Cohort B: Arm B|Adverse Event|0|||
130409208|NCT01831089|469459951|FG003|Cohort B: Arm B|Adverse Event|0|||
130409209|NCT01831089|469459952|FG004|Cohort B: Arm B|Adverse Event|0|||
130409210|NCT01831089|469459953|FG005|Cohort B: Arm B|Adverse Event|1|||
130409211|NCT01831089|469459948|FG000|Cohort B: Arm B|Global end of study|0|||
130409212|NCT01831089|469459949|FG001|Cohort B: Arm B|Global end of study|0|||
130409213|NCT01831089|469459950|FG002|Cohort B: Arm B|Global end of study|0|||
130409214|NCT01831089|469459951|FG003|Cohort B: Arm B|Global end of study|0|||
130409215|NCT01831089|469459952|FG004|Cohort B: Arm B|Global end of study|0|||
130409216|NCT01831089|469459953|FG005|Cohort B: Arm B|Global end of study|1|||
130726835|NCT00070499|470625423|FG003|Overall Study|Progression/relapse|4|||
130409217|NCT02114892|469459959|FG000|Overall Study|Lost to Follow-up|1|||
130726836|NCT00070499|470625420|FG000|Overall Study|Death|1|||
130726837|NCT00070499|470625421|FG001|Overall Study|Death|1|||
130409218|NCT02114892|469459960|FG001|Overall Study|Lost to Follow-up|2|||
130409219|NCT03525834|469459963|FG000|Overall Study|Progressive disease|1|||
130409220|NCT01751568|469459976|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
130409221|NCT01751568|469459977|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
130409222|NCT01751568|469459978|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
130409223|NCT02660944|469459979|FG000|Overall Study|Adverse Event|3|||
130409224|NCT02660944|469459980|FG001|Overall Study|Adverse Event|4|||
130409225|NCT02660944|469459979|FG000|Overall Study|Physician Decision|3|||
130409226|NCT02660944|469459980|FG001|Overall Study|Physician Decision|1|||
130409227|NCT02660944|469459979|FG000|Overall Study|Withdrawal by Subject|5|||
130409228|NCT02660944|469459980|FG001|Overall Study|Withdrawal by Subject|3|||
130409229|NCT02660944|469459979|FG000|Overall Study|Lost to Follow-up|4|||
130409230|NCT02660944|469459980|FG001|Overall Study|Lost to Follow-up|1|||
130409231|NCT02660944|469459979|FG000|Overall Study|Subject schedule|0|||
130409232|NCT02660944|469459980|FG001|Overall Study|Subject schedule|1|||
130409233|NCT02660944|469459979|FG000|Overall Study|Exclusion criteria met|2|||
130409234|NCT02660944|469459980|FG001|Overall Study|Exclusion criteria met|0|||
130409235|NCT03586999|469459981|FG000|Overall Study|Lack of Efficacy|2|||
130409236|NCT04096560|469459982|FG000|Overall Study|Reason not Specified|1|||
130409237|NCT04096560|469459983|FG001|Overall Study|Reason not Specified|0|||
130409238|NCT04096560|469459984|FG002|Overall Study|Reason not Specified|0|||
130409239|NCT04096560|469459985|FG003|Overall Study|Reason not Specified|0|||
130409240|NCT04096560|469459986|FG004|Overall Study|Reason not Specified|1|||
130409241|NCT04096560|469459987|FG005|Overall Study|Reason not Specified|1|||
130409242|NCT04096560|469459988|FG006|Overall Study|Reason not Specified|1|||
130409243|NCT04096560|469459989|FG007|Overall Study|Reason not Specified|0|||
130409244|NCT04096560|469459982|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130409245|NCT04096560|469459983|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130409246|NCT04096560|469459984|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130409247|NCT04096560|469459985|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130409248|NCT04096560|469459986|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130409249|NCT04096560|469459987|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
130409250|NCT04096560|469459988|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
130409251|NCT04096560|469459989|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130472830|NCT05338086|469699571|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
130472831|NCT05338086|469699572|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
130472832|NCT05338086|469699568|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
130472833|NCT05338086|469699569|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
130472834|NCT05338086|469699570|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
130472835|NCT05338086|469699571|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
130472836|NCT05338086|469699572|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
130472837|NCT03940703|469699573|FG000|Overall Study|Still under treatment|31|||
130472838|NCT03940703|469699574|FG001|Overall Study|Still under treatment|0|||
130472839|NCT04521478|469699575|FG000|Overall Study|Protocol Violation|2|||
130472840|NCT04521478|469699576|FG001|Overall Study|Protocol Violation|0|||
130472841|NCT04521478|469699577|FG002|Overall Study|Protocol Violation|1|||
130472842|NCT04521478|469699578|FG003|Overall Study|Protocol Violation|0|||
130472843|NCT04521478|469699579|FG004|Overall Study|Protocol Violation|0|||
130472844|NCT04521478|469699580|FG005|Overall Study|Protocol Violation|0|||
130472845|NCT04521478|469699575|FG000|Overall Study|Technical Problems|0|||
130472846|NCT04521478|469699576|FG001|Overall Study|Technical Problems|0|||
130472847|NCT04521478|469699577|FG002|Overall Study|Technical Problems|0|||
130472848|NCT04521478|469699578|FG003|Overall Study|Technical Problems|1|||
130472849|NCT04521478|469699579|FG004|Overall Study|Technical Problems|0|||
130472850|NCT04521478|469699580|FG005|Overall Study|Technical Problems|0|||
130472851|NCT04521478|469699575|FG000|Overall Study|Burden of Study Procedures|1|||
130472852|NCT04521478|469699576|FG001|Overall Study|Burden of Study Procedures|0|||
130472853|NCT04521478|469699577|FG002|Overall Study|Burden of Study Procedures|0|||
130472854|NCT04521478|469699578|FG003|Overall Study|Burden of Study Procedures|1|||
130472855|NCT04521478|469699579|FG004|Overall Study|Burden of Study Procedures|0|||
130726838|NCT00070499|470625422|FG002|Overall Study|Death|1|||
130726839|NCT00070499|470625423|FG003|Overall Study|Death|2|||
130726840|NCT00070499|470625420|FG000|Overall Study|Other - not protocol specified|7|||
130409252|NCT04096560|469459982|FG000|Overall Study|Study Terminated by Sponsor|0|||
130472856|NCT04521478|469699580|FG005|Overall Study|Burden of Study Procedures|1|||
130472857|NCT04521478|469699575|FG000|Overall Study|Lack of Efficacy|0|||
130472858|NCT04521478|469699576|FG001|Overall Study|Lack of Efficacy|0|||
130472859|NCT04521478|469699577|FG002|Overall Study|Lack of Efficacy|0|||
130726841|NCT00070499|470625421|FG001|Overall Study|Other - not protocol specified|3|||
130561645|NCT01994382|470024798|FG002|Overall Study|Death|0|||
130726842|NCT00070499|470625422|FG002|Overall Study|Other - not protocol specified|12|||
130472860|NCT04521478|469699578|FG003|Overall Study|Lack of Efficacy|0|||
130472861|NCT04521478|469699579|FG004|Overall Study|Lack of Efficacy|1|||
130472862|NCT04521478|469699580|FG005|Overall Study|Lack of Efficacy|1|||
130472863|NCT04521478|469699575|FG000|Overall Study|Adverse Event|7|||
130472864|NCT04521478|469699576|FG001|Overall Study|Adverse Event|0|||
130472865|NCT04521478|469699577|FG002|Overall Study|Adverse Event|2|||
130472866|NCT04521478|469699578|FG003|Overall Study|Adverse Event|1|||
130472867|NCT04521478|469699579|FG004|Overall Study|Adverse Event|2|||
130472868|NCT04521478|469699580|FG005|Overall Study|Adverse Event|7|||
130472869|NCT04521478|469699575|FG000|Overall Study|No Reason Available|0|||
130472870|NCT04521478|469699576|FG001|Overall Study|No Reason Available|2|||
130472871|NCT04521478|469699577|FG002|Overall Study|No Reason Available|0|||
130472872|NCT04521478|469699578|FG003|Overall Study|No Reason Available|0|||
130472873|NCT04521478|469699579|FG004|Overall Study|No Reason Available|1|||
130472874|NCT04521478|469699580|FG005|Overall Study|No Reason Available|0|||
130472875|NCT04521478|469699575|FG000|Overall Study|Other than listed|3|||
130472876|NCT04521478|469699576|FG001|Overall Study|Other than listed|3|||
130472877|NCT04521478|469699577|FG002|Overall Study|Other than listed|3|||
130472878|NCT04521478|469699578|FG003|Overall Study|Other than listed|2|||
130472879|NCT04521478|469699579|FG004|Overall Study|Other than listed|3|||
130472880|NCT04521478|469699580|FG005|Overall Study|Other than listed|3|||
130472881|NCT04521478|469699575|FG000|Overall Study|Not treated|0|||
130472882|NCT04521478|469699576|FG001|Overall Study|Not treated|0|||
130472883|NCT04521478|469699577|FG002|Overall Study|Not treated|0|||
130472884|NCT04521478|469699578|FG003|Overall Study|Not treated|0|||
130472885|NCT04521478|469699579|FG004|Overall Study|Not treated|0|||
130472886|NCT04521478|469699580|FG005|Overall Study|Not treated|1|||
130472887|NCT03775109|469699582|FG000|Overall Study|Adverse Event|1|||
130472888|NCT03775109|469699583|FG001|Overall Study|Adverse Event|0|||
130472889|NCT03775109|469699582|FG000|Overall Study|COVID-19 outbreak|2|||
130472890|NCT03775109|469699583|FG001|Overall Study|COVID-19 outbreak|0|||
130472891|NCT03775109|469699582|FG000|Overall Study|Lost to Follow-up|0|||
130472892|NCT03775109|469699583|FG001|Overall Study|Lost to Follow-up|2|||
130472893|NCT03775109|469699582|FG000|Overall Study|Withdrawal by Subject|1|||
130472894|NCT03775109|469699583|FG001|Overall Study|Withdrawal by Subject|1|||
130472895|NCT03775109|469699582|FG000|Overall Study|Death|0|||
130472896|NCT03775109|469699583|FG001|Overall Study|Death|1|||
130472897|NCT03775109|469699582|FG000|Overall Study|Lack of Efficacy|1|||
130472898|NCT03775109|469699583|FG001|Overall Study|Lack of Efficacy|0|||
130472899|NCT03347383|469699584|FG000|Overall Study|Death|39|||
130472900|NCT03347383|469699584|FG000|Overall Study|Withdrawal by Subject|3|||
130472901|NCT03347383|469699584|FG000|Overall Study|Lost to Follow-up|9|||
130472902|NCT05691452|469699592|FG000|Overall Study|Withdrawal by Subject|1|||
130472903|NCT05691452|469699593|FG001|Overall Study|Withdrawal by Subject|1|||
130472904|NCT05691452|469699594|FG002|Overall Study|Withdrawal by Subject|0|||
130472905|NCT05691452|469699592|FG000|Overall Study|Physician Decision|1|||
130472906|NCT05691452|469699593|FG001|Overall Study|Physician Decision|0|||
130472907|NCT05691452|469699594|FG002|Overall Study|Physician Decision|0|||
130472908|NCT05691452|469699592|FG000|Overall Study|Lost to Follow-up|0|||
130472909|NCT05691452|469699593|FG001|Overall Study|Lost to Follow-up|0|||
130472910|NCT05691452|469699594|FG002|Overall Study|Lost to Follow-up|1|||
130472911|NCT05691452|469699592|FG000|Overall Study|Adverse Event|0|||
130472912|NCT05691452|469699593|FG001|Overall Study|Adverse Event|0|||
130472913|NCT05691452|469699594|FG002|Overall Study|Adverse Event|1|||
130472914|NCT01938547|469699597|FG000|Overall Study|Physician Decision|1|||
130472915|NCT05320432|469699600|FG000|Overall Study|Withdrawal by Subject|0|||
130472916|NCT05320432|469699601|FG001|Overall Study|Withdrawal by Subject|2|||
130472917|NCT04842643|469699604|FG000|Overall Study|Physician Decision|1|||
130472918|NCT04842643|469699604|FG000|Overall Study|Other|1|||
130472919|NCT03484702|469699605|FG000|Treatment Period|Death|3|||
130472920|NCT03484702|469699606|FG001|Treatment Period|Death|1|||
130472921|NCT03484702|469699607|FG002|Treatment Period|Death|0|||
130472922|NCT03484702|469699608|FG003|Treatment Period|Death|0|||
130472923|NCT03484702|469699609|FG004|Treatment Period|Death|0|||
130726843|NCT00070499|470625423|FG003|Overall Study|Other - not protocol specified|20|||
130472924|NCT03484702|469699610|FG005|Treatment Period|Death|0|||
130472925|NCT03484702|469699605|FG000|Treatment Period|Adverse Event|1|||
130472926|NCT03484702|469699606|FG001|Treatment Period|Adverse Event|0|||
130472927|NCT03484702|469699607|FG002|Treatment Period|Adverse Event|0|||
130472928|NCT03484702|469699608|FG003|Treatment Period|Adverse Event|0|||
130472929|NCT03484702|469699609|FG004|Treatment Period|Adverse Event|0|||
130472930|NCT03484702|469699610|FG005|Treatment Period|Adverse Event|0|||
130472931|NCT03484702|469699605|FG000|Treatment Period|Participant Withdrew from Study|0|||
130472932|NCT03484702|469699606|FG001|Treatment Period|Participant Withdrew from Study|1|||
130472933|NCT03484702|469699607|FG002|Treatment Period|Participant Withdrew from Study|0|||
130472934|NCT03484702|469699608|FG003|Treatment Period|Participant Withdrew from Study|0|||
130472935|NCT03484702|469699609|FG004|Treatment Period|Participant Withdrew from Study|0|||
130472936|NCT03484702|469699610|FG005|Treatment Period|Participant Withdrew from Study|0|||
130472937|NCT03484702|469699605|FG000|Treatment Period|Physician Decision|0|||
130472938|NCT03484702|469699606|FG001|Treatment Period|Physician Decision|1|||
130409253|NCT04096560|469459983|FG001|Overall Study|Study Terminated by Sponsor|0|||
130409254|NCT04096560|469459984|FG002|Overall Study|Study Terminated by Sponsor|0|||
130409255|NCT04096560|469459985|FG003|Overall Study|Study Terminated by Sponsor|5|||
130409256|NCT04096560|469459986|FG004|Overall Study|Study Terminated by Sponsor|6|||
130409257|NCT04096560|469459987|FG005|Overall Study|Study Terminated by Sponsor|4|||
130409258|NCT04096560|469459988|FG006|Overall Study|Study Terminated by Sponsor|6|||
130409259|NCT04096560|469459989|FG007|Overall Study|Study Terminated by Sponsor|1|||
130409260|NCT04096560|469459982|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409261|NCT04096560|469459983|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409262|NCT04096560|469459984|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409263|NCT04096560|469459985|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409264|NCT04096560|469459986|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409265|NCT04096560|469459987|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409266|NCT04096560|469459988|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130409267|NCT04096560|469459989|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
130409268|NCT01485861|469459990|FG000|Phase Ib|Death|1|||
130726844|NCT00070499|470625420|FG000|Overall Study|Still on protocol treatment|10|||
130726845|NCT00070499|470625421|FG001|Overall Study|Still on protocol treatment|4|||
130726846|NCT00070499|470625422|FG002|Overall Study|Still on protocol treatment|79|||
130726847|NCT00070499|470625423|FG003|Overall Study|Still on protocol treatment|57|||
130409269|NCT01485861|469459991|FG001|Phase Ib|Death|0|||
130409270|NCT01485861|469459992|FG002|Phase Ib|Death|0|||
130409271|NCT01485861|469459993|FG003|Phase Ib|Death|0|||
130409272|NCT01485861|469459994|FG004|Phase Ib|Death|0|||
130726848|NCT00070499|470625420|FG000|Overall Study|Did not start treatment|1|||
130726849|NCT00070499|470625421|FG001|Overall Study|Did not start treatment|0|||
130726850|NCT00070499|470625422|FG002|Overall Study|Did not start treatment|0|||
130726851|NCT00070499|470625423|FG003|Overall Study|Did not start treatment|2|||
130726852|NCT00070499|470625420|FG000|Overall Study|Not eligible|2|||
130726853|NCT00070499|470625421|FG001|Overall Study|Not eligible|5|||
130726854|NCT00070499|470625422|FG002|Overall Study|Not eligible|3|||
130726855|NCT00070499|470625423|FG003|Overall Study|Not eligible|2|||
130726856|NCT02883049|470625424|FG000|Induction|Adverse Event|52|||
130726857|NCT02883049|470625425|FG001|Induction|Adverse Event|2|||
130726858|NCT02883049|470625426|FG002|Induction|Adverse Event|0|||
130726859|NCT02883049|470625427|FG003|Induction|Adverse Event|0|||
130409273|NCT01485861|469459995|FG005|Phase Ib|Death|0|||
130409274|NCT01485861|469459990|FG000|Phase Ib|Physician Decision|1|||
130409275|NCT01485861|469459991|FG001|Phase Ib|Physician Decision|1|||
130409276|NCT01485861|469459992|FG002|Phase Ib|Physician Decision|0|||
130409277|NCT01485861|469459993|FG003|Phase Ib|Physician Decision|0|||
130409278|NCT01485861|469459994|FG004|Phase Ib|Physician Decision|0|||
130409279|NCT01485861|469459995|FG005|Phase Ib|Physician Decision|0|||
130409280|NCT01485861|469459990|FG000|Phase Ib|Adverse Event|0|||
130409281|NCT01485861|469459991|FG001|Phase Ib|Adverse Event|4|||
130409282|NCT01485861|469459992|FG002|Phase Ib|Adverse Event|0|||
130409283|NCT01485861|469459993|FG003|Phase Ib|Adverse Event|0|||
130409284|NCT01485861|469459994|FG004|Phase Ib|Adverse Event|0|||
130409285|NCT01485861|469459995|FG005|Phase Ib|Adverse Event|0|||
130409286|NCT01485861|469459990|FG000|Phase Ib|Progression of disease|5|||
130409287|NCT01485861|469459991|FG001|Phase Ib|Progression of disease|0|||
130409288|NCT01485861|469459992|FG002|Phase Ib|Progression of disease|0|||
130409289|NCT01485861|469459993|FG003|Phase Ib|Progression of disease|0|||
130409290|NCT01485861|469459994|FG004|Phase Ib|Progression of disease|0|||
130409291|NCT01485861|469459995|FG005|Phase Ib|Progression of disease|0|||
130409292|NCT01485861|469459990|FG000|Phase Ib|Other|3|||
130472939|NCT03484702|469699607|FG002|Treatment Period|Physician Decision|0|||
130472940|NCT03484702|469699608|FG003|Treatment Period|Physician Decision|0|||
130472941|NCT03484702|469699609|FG004|Treatment Period|Physician Decision|0|||
130472942|NCT03484702|469699610|FG005|Treatment Period|Physician Decision|1|||
130472943|NCT05816551|469699623|FG000|Overall Study|Withdrawal by Subject|0|||
130472944|NCT05816551|469699624|FG001|Overall Study|Withdrawal by Subject|1|||
130472945|NCT05816551|469699623|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
130472946|NCT05816551|469699624|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
130472947|NCT02651324|469699633|FG000|Overall Study|drug not administered, due dispensing issue|1|||
130472948|NCT02651324|469699634|FG001|Overall Study|drug not administered, due dispensing issue|0|||
130472949|NCT04549168|469699635|FG000|Randomization Phase|Adverse Event|0|||
130472950|NCT04549168|469699636|FG001|Randomization Phase|Adverse Event|0|||
130472951|NCT04549168|469699637|FG002|Randomization Phase|Adverse Event|1|||
130472952|NCT04549168|469699635|FG000|Randomization Phase|Other|0|||
130472953|NCT04549168|469699636|FG001|Randomization Phase|Other|2|||
130472954|NCT04549168|469699637|FG002|Randomization Phase|Other|0|||
130472955|NCT04549168|469699635|FG000|Randomization Phase|Withdrawal by Subject|0|||
130472956|NCT04549168|469699636|FG001|Randomization Phase|Withdrawal by Subject|2|||
130472957|NCT04549168|469699637|FG002|Randomization Phase|Withdrawal by Subject|1|||
130472958|NCT02662062|469699641|FG000|Overall Study|Withdrawal by Subject|1|||
130472959|NCT06311084|469699642|FG000|Overall Study|Lost to Follow-up|14|||
130472960|NCT03988634|469699643|FG000|Double-Blind|Adverse Event|4|||
130561646|NCT01994382|470024799|FG003|Overall Study|Death|0|||
130561647|NCT01994382|470024800|FG004|Overall Study|Death|1|||
130561648|NCT01994382|470024801|FG005|Overall Study|Death|0|||
130561649|NCT01994382|470024802|FG006|Overall Study|Death|0|||
130561650|NCT01994382|470024803|FG007|Overall Study|Death|0|||
130561651|NCT01994382|470024804|FG008|Overall Study|Death|1|||
130561652|NCT01994382|470024805|FG009|Overall Study|Death|1|||
130561653|NCT01994382|470024806|FG010|Overall Study|Death|0|||
130561654|NCT01994382|470024807|FG011|Overall Study|Death|0|||
130561655|NCT01994382|470024808|FG012|Overall Study|Death|0|||
130561656|NCT01994382|470024809|FG013|Overall Study|Death|0|||
130561657|NCT01994382|470024810|FG014|Overall Study|Death|0|||
130561658|NCT01994382|470024811|FG015|Overall Study|Death|1|||
130561659|NCT01994382|470024812|FG016|Overall Study|Death|0|||
130561660|NCT01994382|470024796|FG000|Overall Study|Adverse Event|0|||
130561661|NCT01994382|470024797|FG001|Overall Study|Adverse Event|1|||
130561662|NCT01994382|470024798|FG002|Overall Study|Adverse Event|2|||
130561663|NCT01994382|470024799|FG003|Overall Study|Adverse Event|0|||
130561664|NCT01994382|470024800|FG004|Overall Study|Adverse Event|0|||
130561665|NCT01994382|470024801|FG005|Overall Study|Adverse Event|0|||
130561666|NCT01994382|470024802|FG006|Overall Study|Adverse Event|0|||
130561667|NCT01994382|470024803|FG007|Overall Study|Adverse Event|0|||
130561668|NCT01994382|470024804|FG008|Overall Study|Adverse Event|0|||
130561669|NCT01994382|470024805|FG009|Overall Study|Adverse Event|0|||
130561670|NCT01994382|470024806|FG010|Overall Study|Adverse Event|15|||
130561671|NCT01994382|470024807|FG011|Overall Study|Adverse Event|2|||
130561672|NCT01994382|470024808|FG012|Overall Study|Adverse Event|7|||
130472961|NCT03988634|469699644|FG001|Double-Blind|Adverse Event|0|||
130472962|NCT03988634|469699645|FG002|Double-Blind|Adverse Event|0|||
130472963|NCT03988634|469699643|FG000|Double-Blind|Death|18|||
130472964|NCT03988634|469699644|FG001|Double-Blind|Death|26|||
130472965|NCT03988634|469699645|FG002|Double-Blind|Death|0|||
130472966|NCT03988634|469699643|FG000|Double-Blind|Lost to Follow-up|6|||
130472967|NCT03988634|469699644|FG001|Double-Blind|Lost to Follow-up|7|||
130472968|NCT03988634|469699645|FG002|Double-Blind|Lost to Follow-up|0|||
130472969|NCT03988634|469699643|FG000|Double-Blind|Physician Decision|9|||
130472970|NCT03988634|469699644|FG001|Double-Blind|Physician Decision|5|||
130472971|NCT03988634|469699645|FG002|Double-Blind|Physician Decision|0|||
130472972|NCT03988634|469699643|FG000|Double-Blind|Subject decision|24|||
130472973|NCT03988634|469699644|FG001|Double-Blind|Subject decision|13|||
130472974|NCT03988634|469699645|FG002|Double-Blind|Subject decision|0|||
130472975|NCT03988634|469699643|FG000|Open-Label|Adverse Event|0|||
130472976|NCT03988634|469699644|FG001|Open-Label|Adverse Event|0|||
130561673|NCT01994382|470024809|FG013|Overall Study|Adverse Event|3|||
130561674|NCT01994382|470024810|FG014|Overall Study|Adverse Event|17|||
130561675|NCT01994382|470024811|FG015|Overall Study|Adverse Event|6|||
130561676|NCT01994382|470024812|FG016|Overall Study|Adverse Event|3|||
130561677|NCT01994382|470024796|FG000|Overall Study|Other than specified|0|||
130561678|NCT01994382|470024797|FG001|Overall Study|Other than specified|0|||
130561679|NCT01994382|470024798|FG002|Overall Study|Other than specified|0|||
130561680|NCT01994382|470024799|FG003|Overall Study|Other than specified|0|||
130561681|NCT01994382|470024800|FG004|Overall Study|Other than specified|0|||
130561682|NCT01994382|470024801|FG005|Overall Study|Other than specified|0|||
130561683|NCT01994382|470024802|FG006|Overall Study|Other than specified|0|||
130561684|NCT01994382|470024803|FG007|Overall Study|Other than specified|0|||
130561685|NCT01994382|470024804|FG008|Overall Study|Other than specified|0|||
130561686|NCT01994382|470024805|FG009|Overall Study|Other than specified|0|||
130561687|NCT01994382|470024806|FG010|Overall Study|Other than specified|2|||
130561688|NCT01994382|470024807|FG011|Overall Study|Other than specified|0|||
130561689|NCT01994382|470024808|FG012|Overall Study|Other than specified|2|||
130561690|NCT01994382|470024809|FG013|Overall Study|Other than specified|0|||
130561691|NCT01994382|470024810|FG014|Overall Study|Other than specified|0|||
130561692|NCT01994382|470024811|FG015|Overall Study|Other than specified|4|||
130561693|NCT01994382|470024812|FG016|Overall Study|Other than specified|4|||
130561694|NCT01994382|470024796|FG000|Overall Study|Withdrawal by Subject|0|||
130472977|NCT03988634|469699645|FG002|Open-Label|Adverse Event|7|||
130472978|NCT03988634|469699643|FG000|Open-Label|Physician Decision|0|||
130561695|NCT01994382|470024797|FG001|Overall Study|Withdrawal by Subject|0|||
130561696|NCT01994382|470024798|FG002|Overall Study|Withdrawal by Subject|0|||
130561697|NCT01994382|470024799|FG003|Overall Study|Withdrawal by Subject|0|||
130561698|NCT01994382|470024800|FG004|Overall Study|Withdrawal by Subject|0|||
130472979|NCT03988634|469699644|FG001|Open-Label|Physician Decision|0|||
130472980|NCT03988634|469699645|FG002|Open-Label|Physician Decision|1|||
130472981|NCT03988634|469699643|FG000|Open-Label|Technical problems|0|||
130472982|NCT03988634|469699644|FG001|Open-Label|Technical problems|0|||
130472983|NCT03988634|469699645|FG002|Open-Label|Technical problems|1|||
130472984|NCT04725240|469699646|FG000|Overall Study|Adverse Event|2|||
130472985|NCT05458011|469699653|FG000|DB Period (12 Weeks)|Adverse Event|2|||
130561699|NCT01994382|470024801|FG005|Overall Study|Withdrawal by Subject|0|||
130561700|NCT01994382|470024802|FG006|Overall Study|Withdrawal by Subject|0|||
130561701|NCT01994382|470024803|FG007|Overall Study|Withdrawal by Subject|0|||
130726860|NCT02883049|470625428|FG004|Induction|Adverse Event|0|||
130726861|NCT02883049|470625429|FG005|Induction|Adverse Event|0|||
130726862|NCT02883049|470625430|FG006|Induction|Adverse Event|0|||
130726863|NCT02883049|470625431|FG007|Induction|Adverse Event|0|||
130726864|NCT02883049|470625432|FG008|Induction|Adverse Event|0|||
130726865|NCT02883049|470625433|FG009|Induction|Adverse Event|0|||
130726866|NCT02883049|470625434|FG010|Induction|Adverse Event|0|||
130726867|NCT02883049|470625435|FG011|Induction|Adverse Event|0|||
130726868|NCT02883049|470625436|FG012|Induction|Adverse Event|0|||
130726869|NCT02883049|470625437|FG013|Induction|Adverse Event|0|||
130726870|NCT02883049|470625438|FG014|Induction|Adverse Event|0|||
130726871|NCT02883049|470625439|FG015|Induction|Adverse Event|0|||
130726872|NCT02883049|470625424|FG000|Induction|Death|76|||
130726873|NCT02883049|470625425|FG001|Induction|Death|8|||
130726874|NCT02883049|470625426|FG002|Induction|Death|0|||
130726875|NCT02883049|470625427|FG003|Induction|Death|0|||
130726876|NCT02883049|470625428|FG004|Induction|Death|0|||
130726877|NCT02883049|470625429|FG005|Induction|Death|0|||
130726878|NCT02883049|470625430|FG006|Induction|Death|0|||
130726879|NCT02883049|470625431|FG007|Induction|Death|0|||
130726880|NCT02883049|470625432|FG008|Induction|Death|0|||
130726881|NCT02883049|470625433|FG009|Induction|Death|0|||
130726882|NCT02883049|470625434|FG010|Induction|Death|0|||
130726883|NCT02883049|470625435|FG011|Induction|Death|0|||
130726884|NCT02883049|470625436|FG012|Induction|Death|0|||
130726885|NCT02883049|470625437|FG013|Induction|Death|0|||
130726886|NCT02883049|470625438|FG014|Induction|Death|0|||
130726887|NCT02883049|470625439|FG015|Induction|Death|0|||
130726888|NCT02883049|470625424|FG000|Induction|Lost to Follow-up|2|||
130726889|NCT02883049|470625425|FG001|Induction|Lost to Follow-up|0|||
130726890|NCT02883049|470625426|FG002|Induction|Lost to Follow-up|0|||
130726891|NCT02883049|470625427|FG003|Induction|Lost to Follow-up|0|||
130726892|NCT02883049|470625428|FG004|Induction|Lost to Follow-up|0|||
130726893|NCT02883049|470625429|FG005|Induction|Lost to Follow-up|0|||
130726894|NCT02883049|470625430|FG006|Induction|Lost to Follow-up|0|||
130726895|NCT02883049|470625431|FG007|Induction|Lost to Follow-up|0|||
130726896|NCT02883049|470625432|FG008|Induction|Lost to Follow-up|0|||
130726897|NCT02883049|470625433|FG009|Induction|Lost to Follow-up|0|||
130726898|NCT02883049|470625434|FG010|Induction|Lost to Follow-up|0|||
130726899|NCT02883049|470625435|FG011|Induction|Lost to Follow-up|0|||
130726900|NCT02883049|470625436|FG012|Induction|Lost to Follow-up|0|||
130726901|NCT02883049|470625437|FG013|Induction|Lost to Follow-up|0|||
130726902|NCT02883049|470625438|FG014|Induction|Lost to Follow-up|0|||
130726903|NCT02883049|470625439|FG015|Induction|Lost to Follow-up|0|||
130726904|NCT02883049|470625424|FG000|Induction|Physician Decision|1407|||
130726905|NCT02883049|470625425|FG001|Induction|Physician Decision|8|||
130726906|NCT02883049|470625426|FG002|Induction|Physician Decision|0|||
130726907|NCT02883049|470625427|FG003|Induction|Physician Decision|0|||
130726908|NCT02883049|470625428|FG004|Induction|Physician Decision|0|||
130726909|NCT02883049|470625429|FG005|Induction|Physician Decision|0|||
130726910|NCT02883049|470625430|FG006|Induction|Physician Decision|0|||
130726911|NCT02883049|470625431|FG007|Induction|Physician Decision|0|||
130726912|NCT02883049|470625432|FG008|Induction|Physician Decision|0|||
130726913|NCT02883049|470625433|FG009|Induction|Physician Decision|0|||
130726914|NCT02883049|470625434|FG010|Induction|Physician Decision|0|||
130726915|NCT02883049|470625435|FG011|Induction|Physician Decision|0|||
130726916|NCT02883049|470625436|FG012|Induction|Physician Decision|0|||
130726917|NCT02883049|470625437|FG013|Induction|Physician Decision|0|||
130726918|NCT02883049|470625438|FG014|Induction|Physician Decision|0|||
130726919|NCT02883049|470625439|FG015|Induction|Physician Decision|0|||
130726920|NCT02883049|470625424|FG000|Induction|Protocol Violation|6|||
130726921|NCT02883049|470625425|FG001|Induction|Protocol Violation|0|||
130726922|NCT02883049|470625426|FG002|Induction|Protocol Violation|0|||
130726923|NCT02883049|470625427|FG003|Induction|Protocol Violation|0|||
130726924|NCT02883049|470625428|FG004|Induction|Protocol Violation|0|||
130726925|NCT02883049|470625429|FG005|Induction|Protocol Violation|0|||
130726926|NCT02883049|470625430|FG006|Induction|Protocol Violation|0|||
130726927|NCT02883049|470625431|FG007|Induction|Protocol Violation|0|||
130726928|NCT02883049|470625432|FG008|Induction|Protocol Violation|0|||
130726929|NCT02883049|470625433|FG009|Induction|Protocol Violation|0|||
130726930|NCT02883049|470625434|FG010|Induction|Protocol Violation|0|||
130726931|NCT02883049|470625435|FG011|Induction|Protocol Violation|0|||
130726932|NCT02883049|470625436|FG012|Induction|Protocol Violation|0|||
130726933|NCT02883049|470625437|FG013|Induction|Protocol Violation|0|||
130726934|NCT02883049|470625438|FG014|Induction|Protocol Violation|0|||
130726935|NCT02883049|470625439|FG015|Induction|Protocol Violation|0|||
130726936|NCT02883049|470625424|FG000|Induction|Withdrawal by Subject|6|||
130726937|NCT02883049|470625425|FG001|Induction|Withdrawal by Subject|0|||
130726938|NCT02883049|470625426|FG002|Induction|Withdrawal by Subject|0|||
130726939|NCT02883049|470625427|FG003|Induction|Withdrawal by Subject|0|||
130726940|NCT02883049|470625428|FG004|Induction|Withdrawal by Subject|0|||
130726941|NCT02883049|470625429|FG005|Induction|Withdrawal by Subject|0|||
130726942|NCT02883049|470625430|FG006|Induction|Withdrawal by Subject|0|||
130726943|NCT02883049|470625431|FG007|Induction|Withdrawal by Subject|0|||
130726944|NCT02883049|470625432|FG008|Induction|Withdrawal by Subject|0|||
130726945|NCT02883049|470625433|FG009|Induction|Withdrawal by Subject|0|||
130726946|NCT02883049|470625434|FG010|Induction|Withdrawal by Subject|0|||
130726947|NCT02883049|470625435|FG011|Induction|Withdrawal by Subject|0|||
130726948|NCT02883049|470625436|FG012|Induction|Withdrawal by Subject|0|||
130726949|NCT02883049|470625437|FG013|Induction|Withdrawal by Subject|0|||
130726950|NCT02883049|470625438|FG014|Induction|Withdrawal by Subject|0|||
130726951|NCT02883049|470625439|FG015|Induction|Withdrawal by Subject|0|||
130726952|NCT02883049|470625424|FG000|Induction|Ineligible|35|||
130409293|NCT01485861|469459991|FG001|Phase Ib|Other|0|||
130409294|NCT01485861|469459992|FG002|Phase Ib|Other|0|||
130409295|NCT01485861|469459993|FG003|Phase Ib|Other|0|||
130409296|NCT01485861|469459994|FG004|Phase Ib|Other|0|||
130409297|NCT01485861|469459995|FG005|Phase Ib|Other|0|||
130409298|NCT01485861|469459990|FG000|Phase Ib|Withdrawal by Subject|4|||
130409299|NCT01485861|469459991|FG001|Phase Ib|Withdrawal by Subject|1|||
130409300|NCT01485861|469459992|FG002|Phase Ib|Withdrawal by Subject|0|||
130409301|NCT01485861|469459993|FG003|Phase Ib|Withdrawal by Subject|0|||
130726953|NCT02883049|470625425|FG001|Induction|Ineligible|1|||
130726954|NCT02883049|470625426|FG002|Induction|Ineligible|0|||
130726955|NCT02883049|470625427|FG003|Induction|Ineligible|0|||
130726956|NCT02883049|470625428|FG004|Induction|Ineligible|0|||
130726957|NCT02883049|470625429|FG005|Induction|Ineligible|0|||
130726958|NCT02883049|470625430|FG006|Induction|Ineligible|0|||
130726959|NCT02883049|470625431|FG007|Induction|Ineligible|0|||
130726960|NCT02883049|470625432|FG008|Induction|Ineligible|0|||
130726961|NCT02883049|470625433|FG009|Induction|Ineligible|0|||
130726962|NCT02883049|470625434|FG010|Induction|Ineligible|0|||
130726963|NCT02883049|470625435|FG011|Induction|Ineligible|0|||
130726964|NCT02883049|470625436|FG012|Induction|Ineligible|0|||
130409302|NCT01485861|469459994|FG004|Phase Ib|Withdrawal by Subject|0|||
130409303|NCT01485861|469459995|FG005|Phase Ib|Withdrawal by Subject|0|||
130409304|NCT01485861|469459990|FG000|Phase II|Death|0|||
130409305|NCT01485861|469459991|FG001|Phase II|Death|0|||
130409306|NCT01485861|469459992|FG002|Phase II|Death|67|||
130409307|NCT01485861|469459993|FG003|Phase II|Death|71|||
130409308|NCT01485861|469459994|FG004|Phase II|Death|68|||
130409309|NCT01485861|469459995|FG005|Phase II|Death|0|||
130409310|NCT01485861|469459990|FG000|Phase II|Progression of Disease|0|||
130409311|NCT01485861|469459991|FG001|Phase II|Progression of Disease|0|||
130409312|NCT01485861|469459992|FG002|Phase II|Progression of Disease|1|||
130409313|NCT01485861|469459993|FG003|Phase II|Progression of Disease|0|||
130726965|NCT02883049|470625437|FG013|Induction|Ineligible|0|||
130726966|NCT02883049|470625438|FG014|Induction|Ineligible|0|||
130726967|NCT02883049|470625439|FG015|Induction|Ineligible|0|||
130726968|NCT02883049|470625424|FG000|Induction|Refusal of further protocol therapy|466|||
130726969|NCT02883049|470625425|FG001|Induction|Refusal of further protocol therapy|2|||
130726970|NCT02883049|470625426|FG002|Induction|Refusal of further protocol therapy|0|||
130726971|NCT02883049|470625427|FG003|Induction|Refusal of further protocol therapy|0|||
130726972|NCT02883049|470625428|FG004|Induction|Refusal of further protocol therapy|0|||
130726973|NCT02883049|470625429|FG005|Induction|Refusal of further protocol therapy|0|||
130726974|NCT02883049|470625430|FG006|Induction|Refusal of further protocol therapy|0|||
130726975|NCT02883049|470625431|FG007|Induction|Refusal of further protocol therapy|0|||
130726976|NCT02883049|470625432|FG008|Induction|Refusal of further protocol therapy|0|||
130726977|NCT02883049|470625433|FG009|Induction|Refusal of further protocol therapy|0|||
130726978|NCT02883049|470625434|FG010|Induction|Refusal of further protocol therapy|0|||
130726979|NCT02883049|470625435|FG011|Induction|Refusal of further protocol therapy|0|||
130726980|NCT02883049|470625436|FG012|Induction|Refusal of further protocol therapy|0|||
130726981|NCT02883049|470625437|FG013|Induction|Refusal of further protocol therapy|0|||
130726982|NCT02883049|470625438|FG014|Induction|Refusal of further protocol therapy|0|||
130726983|NCT02883049|470625439|FG015|Induction|Refusal of further protocol therapy|0|||
130726984|NCT02883049|470625424|FG000|Induction|Identified as Ph+ patients|279|||
130726985|NCT02883049|470625425|FG001|Induction|Identified as Ph+ patients|1|||
130409314|NCT01485861|469459994|FG004|Phase II|Progression of Disease|0|||
130409315|NCT01485861|469459995|FG005|Phase II|Progression of Disease|0|||
130409316|NCT01485861|469459990|FG000|Phase II|Other|0|||
130409317|NCT01485861|469459991|FG001|Phase II|Other|0|||
130409318|NCT01485861|469459992|FG002|Phase II|Other|0|||
130726986|NCT02883049|470625426|FG002|Induction|Identified as Ph+ patients|0|||
130726987|NCT02883049|470625427|FG003|Induction|Identified as Ph+ patients|0|||
130409319|NCT01485861|469459993|FG003|Phase II|Other|1|||
130726988|NCT02883049|470625428|FG004|Induction|Identified as Ph+ patients|0|||
130726989|NCT02883049|470625429|FG005|Induction|Identified as Ph+ patients|0|||
130409320|NCT01485861|469459994|FG004|Phase II|Other|0|||
130409321|NCT01485861|469459995|FG005|Phase II|Other|0|||
130409322|NCT01485861|469459990|FG000|Phase II|Withdrawal by Subject|0|||
130409323|NCT01485861|469459991|FG001|Phase II|Withdrawal by Subject|0|||
130409324|NCT01485861|469459992|FG002|Phase II|Withdrawal by Subject|6|||
130409325|NCT01485861|469459993|FG003|Phase II|Withdrawal by Subject|3|||
130409326|NCT01485861|469459994|FG004|Phase II|Withdrawal by Subject|4|||
130409327|NCT01485861|469459995|FG005|Phase II|Withdrawal by Subject|0|||
130409328|NCT01485861|469459990|FG000|Phase II|Lost to Follow-up|0|||
130726990|NCT02883049|470625430|FG006|Induction|Identified as Ph+ patients|0|||
130409329|NCT01485861|469459991|FG001|Phase II|Lost to Follow-up|0|||
130409330|NCT01485861|469459992|FG002|Phase II|Lost to Follow-up|2|||
130409331|NCT01485861|469459993|FG003|Phase II|Lost to Follow-up|3|||
130409332|NCT01485861|469459994|FG004|Phase II|Lost to Follow-up|5|||
130409333|NCT01485861|469459995|FG005|Phase II|Lost to Follow-up|0|||
130409334|NCT01485861|469459990|FG000|Phase II|Study Ended|0|||
130409335|NCT01485861|469459991|FG001|Phase II|Study Ended|0|||
130409336|NCT01485861|469459992|FG002|Phase II|Study Ended|7|||
130409337|NCT01485861|469459993|FG003|Phase II|Study Ended|8|||
130409338|NCT01485861|469459994|FG004|Phase II|Study Ended|6|||
130409339|NCT01485861|469459995|FG005|Phase II|Study Ended|0|||
130409340|NCT01485861|469459990|FG000|Safety Phase|Death|0|||
130409341|NCT01485861|469459991|FG001|Safety Phase|Death|0|||
130409342|NCT01485861|469459992|FG002|Safety Phase|Death|0|||
130409343|NCT01485861|469459993|FG003|Safety Phase|Death|0|||
130409344|NCT01485861|469459994|FG004|Safety Phase|Death|0|||
130409345|NCT01485861|469459995|FG005|Safety Phase|Death|2|||
130409346|NCT01485861|469459990|FG000|Safety Phase|Adverse Event|0|||
130409347|NCT01485861|469459991|FG001|Safety Phase|Adverse Event|0|||
130409348|NCT01485861|469459992|FG002|Safety Phase|Adverse Event|0|||
130409349|NCT01485861|469459993|FG003|Safety Phase|Adverse Event|0|||
130409350|NCT01485861|469459994|FG004|Safety Phase|Adverse Event|0|||
130409351|NCT01485861|469459995|FG005|Safety Phase|Adverse Event|1|||
130409352|NCT01485861|469459990|FG000|Safety Phase|Other|0|||
130409353|NCT01485861|469459991|FG001|Safety Phase|Other|0|||
130409354|NCT01485861|469459992|FG002|Safety Phase|Other|0|||
130409355|NCT01485861|469459993|FG003|Safety Phase|Other|0|||
130409356|NCT01485861|469459994|FG004|Safety Phase|Other|0|||
130409357|NCT01485861|469459995|FG005|Safety Phase|Other|5|||
130409358|NCT01485861|469459990|FG000|Safety Phase|Progression of Disease|0|||
130409359|NCT01485861|469459991|FG001|Safety Phase|Progression of Disease|0|||
130409360|NCT01485861|469459992|FG002|Safety Phase|Progression of Disease|0|||
130409361|NCT01485861|469459993|FG003|Safety Phase|Progression of Disease|0|||
130409362|NCT01485861|469459994|FG004|Safety Phase|Progression of Disease|0|||
130409363|NCT01485861|469459995|FG005|Safety Phase|Progression of Disease|9|||
130409364|NCT01485861|469459990|FG000|Safety Phase|Withdrawal by Subject|0|||
130409365|NCT01485861|469459991|FG001|Safety Phase|Withdrawal by Subject|0|||
130409366|NCT01485861|469459992|FG002|Safety Phase|Withdrawal by Subject|0|||
130409367|NCT01485861|469459993|FG003|Safety Phase|Withdrawal by Subject|0|||
130409368|NCT01485861|469459994|FG004|Safety Phase|Withdrawal by Subject|0|||
130409369|NCT01485861|469459995|FG005|Safety Phase|Withdrawal by Subject|6|||
130409370|NCT01485861|469459990|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
130409371|NCT01485861|469459991|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
130409372|NCT01485861|469459992|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
130409373|NCT01485861|469459993|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
130409374|NCT01485861|469459994|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
130409375|NCT01485861|469459995|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
130409376|NCT01229436|469459996|FG000|Overall Study|Withdrawal by Subject|2|||
130409377|NCT01229436|469459996|FG000|Overall Study|Lost to Follow-up|3|||
130409378|NCT02266381|469459999|FG000|Overall Study|Physician Decision|3|||
130409379|NCT02266381|469460000|FG001|Overall Study|Physician Decision|5|||
130409380|NCT02266381|469460001|FG002|Overall Study|Physician Decision|4|||
130409381|NCT01731171|469460019|FG000|Overall Study|Withdrawal by Subject|4|||
130409382|NCT01731171|469460020|FG001|Overall Study|Withdrawal by Subject|1|||
130409383|NCT01731171|469460019|FG000|Overall Study|Lost to Follow-up|3|||
130409384|NCT01731171|469460020|FG001|Overall Study|Lost to Follow-up|2|||
130409385|NCT01731171|469460019|FG000|Overall Study|Moved out of Area|0|||
130409386|NCT01731171|469460020|FG001|Overall Study|Moved out of Area|2|||
130409387|NCT01731171|469460019|FG000|Overall Study|Terminated for Lack of Adherence|0|||
130409388|NCT01731171|469460020|FG001|Overall Study|Terminated for Lack of Adherence|1|||
130409389|NCT01731171|469460019|FG000|Overall Study|Terminated for Safety Reasons|0|||
130409390|NCT01731171|469460020|FG001|Overall Study|Terminated for Safety Reasons|1|||
130409391|NCT03653429|469460023|FG000|Overall Study|Physician Decision|4|||
130409392|NCT03653429|469460024|FG001|Overall Study|Physician Decision|10|||
130409393|NCT00403546|469460025|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
130409394|NCT00403546|469460026|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
130472986|NCT05458011|469699654|FG001|DB Period (12 Weeks)|Adverse Event|1|||
130472987|NCT05458011|469699655|FG002|DB Period (12 Weeks)|Adverse Event|1|||
130472988|NCT05458011|469699653|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
130472989|NCT05458011|469699654|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
130472990|NCT05458011|469699655|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
130472991|NCT05458011|469699653|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
130472992|NCT05458011|469699654|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
130472993|NCT05458011|469699655|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
130472994|NCT05458011|469699653|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
130472995|NCT05458011|469699654|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
130472996|NCT05458011|469699655|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
130472997|NCT05458011|469699653|FG000|OL Period (12 Weeks)|Adverse Event|1|||
130472998|NCT05458011|469699654|FG001|OL Period (12 Weeks)|Adverse Event|2|||
130472999|NCT05458011|469699655|FG002|OL Period (12 Weeks)|Adverse Event|1|||
130473000|NCT05458011|469699653|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
130473001|NCT05458011|469699654|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
130473002|NCT05458011|469699655|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
130473003|NCT04850807|469700973|FG000|Overall Study|Death|50|||
130473004|NCT04850807|469700974|FG001|Overall Study|Death|55|||
130473005|NCT04850807|469700973|FG000|Overall Study|Discharged|17|||
130473006|NCT04850807|469700974|FG001|Overall Study|Discharged|13|||
130473007|NCT04850807|469700973|FG000|Overall Study|Incomplete baseline data|3|||
130473008|NCT04850807|469700974|FG001|Overall Study|Incomplete baseline data|2|||
130473009|NCT02187003|469700975|FG000|Overall Study|Adverse Event|2|||
130473010|NCT02187003|469700976|FG001|Overall Study|Adverse Event|0|||
130473011|NCT02187003|469700975|FG000|Overall Study|Lost to Follow-up|14|||
130473012|NCT02187003|469700976|FG001|Overall Study|Lost to Follow-up|10|||
130473013|NCT02187003|469700975|FG000|Overall Study|Withdrawal by Subject|3|||
130473014|NCT02187003|469700976|FG001|Overall Study|Withdrawal by Subject|7|||
130473015|NCT02187003|469700975|FG000|Overall Study|Protocol Violation|2|||
130473016|NCT02187003|469700976|FG001|Overall Study|Protocol Violation|4|||
130473017|NCT02187003|469700975|FG000|Overall Study|Other|5|||
130473018|NCT02187003|469700976|FG001|Overall Study|Other|5|||
130473019|NCT02187003|469700975|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130473020|NCT02187003|469700976|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
130473021|NCT04593472|469700977|FG000|Overall Study|Death|31|||
130473022|NCT04593472|469700978|FG001|Overall Study|Death|27|||
130473023|NCT04593472|469700977|FG000|Overall Study|Withdrawal by Subject|12|||
130473024|NCT04593472|469700978|FG001|Overall Study|Withdrawal by Subject|12|||
130473025|NCT04593472|469700977|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
130726991|NCT02883049|470625431|FG007|Induction|Identified as Ph+ patients|0|||
130726992|NCT02883049|470625432|FG008|Induction|Identified as Ph+ patients|0|||
130726993|NCT02883049|470625433|FG009|Induction|Identified as Ph+ patients|0|||
130726994|NCT02883049|470625434|FG010|Induction|Identified as Ph+ patients|0|||
130726995|NCT02883049|470625435|FG011|Induction|Identified as Ph+ patients|0|||
130726996|NCT02883049|470625436|FG012|Induction|Identified as Ph+ patients|0|||
130726997|NCT02883049|470625437|FG013|Induction|Identified as Ph+ patients|0|||
130726998|NCT02883049|470625438|FG014|Induction|Identified as Ph+ patients|0|||
130726999|NCT02883049|470625439|FG015|Induction|Identified as Ph+ patients|0|||
130727000|NCT02883049|470625424|FG000|Induction|M3 Marrow at Day29|8|||
130727001|NCT02883049|470625425|FG001|Induction|M3 Marrow at Day29|1|||
130727002|NCT02883049|470625426|FG002|Induction|M3 Marrow at Day29|0|||
130727003|NCT02883049|470625427|FG003|Induction|M3 Marrow at Day29|0|||
130727004|NCT02883049|470625428|FG004|Induction|M3 Marrow at Day29|0|||
130727005|NCT02883049|470625429|FG005|Induction|M3 Marrow at Day29|0|||
130727006|NCT02883049|470625430|FG006|Induction|M3 Marrow at Day29|0|||
130727007|NCT02883049|470625431|FG007|Induction|M3 Marrow at Day29|0|||
130727008|NCT02883049|470625432|FG008|Induction|M3 Marrow at Day29|0|||
130727009|NCT02883049|470625433|FG009|Induction|M3 Marrow at Day29|0|||
130727010|NCT02883049|470625434|FG010|Induction|M3 Marrow at Day29|0|||
130727011|NCT02883049|470625435|FG011|Induction|M3 Marrow at Day29|0|||
130727012|NCT02883049|470625436|FG012|Induction|M3 Marrow at Day29|0|||
130727013|NCT02883049|470625437|FG013|Induction|M3 Marrow at Day29|0|||
130727014|NCT02883049|470625438|FG014|Induction|M3 Marrow at Day29|0|||
130727015|NCT02883049|470625439|FG015|Induction|M3 Marrow at Day29|0|||
130727016|NCT02883049|470625424|FG000|Induction|Inevaluable|33|||
130727017|NCT02883049|470625425|FG001|Induction|Inevaluable|1|||
130727018|NCT02883049|470625426|FG002|Induction|Inevaluable|0|||
130727019|NCT02883049|470625427|FG003|Induction|Inevaluable|0|||
130727020|NCT02883049|470625428|FG004|Induction|Inevaluable|0|||
130727021|NCT02883049|470625429|FG005|Induction|Inevaluable|0|||
130727022|NCT02883049|470625430|FG006|Induction|Inevaluable|0|||
130727023|NCT02883049|470625431|FG007|Induction|Inevaluable|0|||
130727024|NCT02883049|470625432|FG008|Induction|Inevaluable|0|||
130727025|NCT02883049|470625433|FG009|Induction|Inevaluable|0|||
130727026|NCT02883049|470625434|FG010|Induction|Inevaluable|0|||
130727027|NCT02883049|470625435|FG011|Induction|Inevaluable|0|||
130727028|NCT02883049|470625436|FG012|Induction|Inevaluable|0|||
130473026|NCT04593472|469700978|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
130473027|NCT04593472|469700977|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
130409395|NCT00403546|469460027|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
130409396|NCT00403546|469460025|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
130409397|NCT00403546|469460026|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
130409398|NCT00403546|469460027|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
130409399|NCT00403546|469460025|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
130409400|NCT00403546|469460026|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
130409401|NCT00403546|469460027|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
130409402|NCT00403546|469460025|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
130409403|NCT00403546|469460026|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
130409404|NCT00403546|469460027|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
130409405|NCT00403546|469460025|FG000|Screening Phase|Screening Failure|22|||
130409406|NCT00403546|469460026|FG001|Screening Phase|Screening Failure|0|||
130409407|NCT00403546|469460027|FG002|Screening Phase|Screening Failure|0|||
130409408|NCT00403546|469460025|FG000|Screening Phase|Adverse Event|1|||
130409409|NCT00403546|469460026|FG001|Screening Phase|Adverse Event|0|||
130409410|NCT00403546|469460027|FG002|Screening Phase|Adverse Event|0|||
130473028|NCT04593472|469700978|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
130473029|NCT04593472|469700977|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
130473030|NCT04593472|469700978|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
130473031|NCT04593472|469700977|FG000|Overall Study|Lost to Follow-up|0|||
130473032|NCT04593472|469700978|FG001|Overall Study|Lost to Follow-up|2|||
130473033|NCT04593472|469700977|FG000|Overall Study|Still collecting 24-month assessment|17|||
130473034|NCT04593472|469700978|FG001|Overall Study|Still collecting 24-month assessment|10|||
130473035|NCT03896516|469700979|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
130473036|NCT03896516|469700980|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
130473037|NCT03896516|469700979|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
130473038|NCT03896516|469700980|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
130473039|NCT03896516|469700979|FG000|Washout Period|Physician Decision|3|||
130473040|NCT03896516|469700980|FG001|Washout Period|Physician Decision|1|||
130473041|NCT03896516|469700979|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
130473042|NCT03896516|469700980|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
130473043|NCT00676715|469700983|FG000|Treatment Period (TP)|Adverse Event|0|||
130473044|NCT00676715|469700984|FG001|Treatment Period (TP)|Adverse Event|3|||
130473045|NCT00676715|469700985|FG002|Treatment Period (TP)|Adverse Event|2|||
130473046|NCT00676715|469700986|FG003|Treatment Period (TP)|Adverse Event|2|||
130473047|NCT00676715|469700983|FG000|Treatment Period (TP)|Death|0|||
130473048|NCT00676715|469700984|FG001|Treatment Period (TP)|Death|0|||
130473049|NCT00676715|469700985|FG002|Treatment Period (TP)|Death|1|||
130473050|NCT00676715|469700986|FG003|Treatment Period (TP)|Death|0|||
130473051|NCT00676715|469700983|FG000|Treatment Period (TP)|Failure to return|1|||
130473052|NCT00676715|469700984|FG001|Treatment Period (TP)|Failure to return|0|||
130473053|NCT00676715|469700985|FG002|Treatment Period (TP)|Failure to return|0|||
130473054|NCT00676715|469700986|FG003|Treatment Period (TP)|Failure to return|0|||
130473055|NCT00676715|469700983|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
130473056|NCT00676715|469700984|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
130473057|NCT00676715|469700985|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
130473058|NCT00676715|469700986|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
130473059|NCT00676715|469700983|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
130473060|NCT00676715|469700984|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
130473061|NCT00676715|469700985|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
130473062|NCT00676715|469700986|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
130409411|NCT00403546|469460025|FG000|Screening Phase|Terminated Prior to Randomization|5|||
130409412|NCT00403546|469460026|FG001|Screening Phase|Terminated Prior to Randomization|0|||
130409413|NCT00403546|469460027|FG002|Screening Phase|Terminated Prior to Randomization|0|||
130409414|NCT00403546|469460025|FG000|Randomized Trial|Early Terminations|0|||
130409415|NCT00403546|469460026|FG001|Randomized Trial|Early Terminations|17|||
130409416|NCT00403546|469460027|FG002|Randomized Trial|Early Terminations|16|||
130473063|NCT00676715|469700983|FG000|Treatment Period (TP)|Withdrew consent|3|||
130473064|NCT00676715|469700984|FG001|Treatment Period (TP)|Withdrew consent|3|||
130473065|NCT00676715|469700985|FG002|Treatment Period (TP)|Withdrew consent|3|||
130473066|NCT00676715|469700986|FG003|Treatment Period (TP)|Withdrew consent|3|||
130473067|NCT00676715|469700983|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
130473068|NCT00676715|469700984|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
130473069|NCT00676715|469700985|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
130473070|NCT00676715|469700986|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
130473071|NCT00676715|469700983|FG000|Treatment Period (TP)|Administrative|0|||
130473072|NCT00676715|469700984|FG001|Treatment Period (TP)|Administrative|0|||
130473073|NCT00676715|469700985|FG002|Treatment Period (TP)|Administrative|0|||
130473074|NCT00676715|469700986|FG003|Treatment Period (TP)|Administrative|1|||
130473075|NCT00676715|469700983|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
130473076|NCT00676715|469700984|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
130473077|NCT00676715|469700985|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
130473078|NCT00676715|469700986|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
130473079|NCT00676715|469700983|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
130473080|NCT00676715|469700984|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
130473081|NCT00676715|469700985|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
130473082|NCT00676715|469700986|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
130473083|NCT00676715|469700983|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
130473084|NCT00676715|469700984|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
130473085|NCT00676715|469700985|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
130473086|NCT00676715|469700986|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
130473087|NCT00676715|469700983|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
130473088|NCT00676715|469700984|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
130473089|NCT00676715|469700985|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
130473090|NCT00676715|469700986|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
130473091|NCT00676715|469700983|FG000|Treatment-free Period (TFP)|Death|1|||
130473092|NCT00676715|469700984|FG001|Treatment-free Period (TFP)|Death|1|||
130473093|NCT00676715|469700985|FG002|Treatment-free Period (TFP)|Death|1|||
130473094|NCT00676715|469700986|FG003|Treatment-free Period (TFP)|Death|0|||
130473095|NCT00676715|469700983|FG000|Open Label Extension (OLE)|Reason not provided|3|||
130473096|NCT00676715|469700984|FG001|Open Label Extension (OLE)|Reason not provided|4|||
130473097|NCT00676715|469700985|FG002|Open Label Extension (OLE)|Reason not provided|1|||
130473098|NCT00676715|469700986|FG003|Open Label Extension (OLE)|Reason not provided|4|||
130473099|NCT00676715|469700983|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
130473100|NCT00676715|469700984|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
130473101|NCT00676715|469700985|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
130473102|NCT00676715|469700986|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
130473103|NCT00676715|469700983|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
130473104|NCT00676715|469700984|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
130473105|NCT00676715|469700985|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
130473106|NCT00676715|469700986|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
130473107|NCT00676715|469700983|FG000|Open Label Extension (OLE)|Adverse Event|0|||
130473108|NCT00676715|469700984|FG001|Open Label Extension (OLE)|Adverse Event|3|||
130473109|NCT00676715|469700985|FG002|Open Label Extension (OLE)|Adverse Event|1|||
130473110|NCT00676715|469700986|FG003|Open Label Extension (OLE)|Adverse Event|0|||
130473111|NCT00676715|469700983|FG000|Open Label Extension (OLE)|Death|2|||
130473112|NCT00676715|469700984|FG001|Open Label Extension (OLE)|Death|0|||
130473113|NCT00676715|469700985|FG002|Open Label Extension (OLE)|Death|2|||
130473114|NCT00676715|469700986|FG003|Open Label Extension (OLE)|Death|2|||
130473115|NCT01820260|469700987|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473116|NCT01820260|469700988|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473117|NCT01820260|469700989|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473118|NCT01820260|469700990|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473119|NCT01820260|469700991|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473120|NCT01820260|469700992|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473121|NCT01820260|469700993|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
130473122|NCT01820260|469700994|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473123|NCT01820260|469700995|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473124|NCT01820260|469700996|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473125|NCT01820260|469700997|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473126|NCT01820260|469700998|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473127|NCT01820260|469700999|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130473128|NCT01820260|469701000|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130561702|NCT01994382|470024804|FG008|Overall Study|Withdrawal by Subject|0|||
130561703|NCT01994382|470024805|FG009|Overall Study|Withdrawal by Subject|0|||
130561704|NCT01994382|470024806|FG010|Overall Study|Withdrawal by Subject|6|||
130561705|NCT01994382|470024807|FG011|Overall Study|Withdrawal by Subject|0|||
130561706|NCT01994382|470024808|FG012|Overall Study|Withdrawal by Subject|2|||
130561707|NCT01994382|470024809|FG013|Overall Study|Withdrawal by Subject|0|||
130561708|NCT01994382|470024810|FG014|Overall Study|Withdrawal by Subject|4|||
130561709|NCT01994382|470024811|FG015|Overall Study|Withdrawal by Subject|3|||
130561710|NCT01994382|470024812|FG016|Overall Study|Withdrawal by Subject|0|||
130561711|NCT01994382|470024796|FG000|Overall Study|Lost to Follow-up|0|||
130561712|NCT01994382|470024797|FG001|Overall Study|Lost to Follow-up|0|||
130561713|NCT01994382|470024798|FG002|Overall Study|Lost to Follow-up|0|||
130561714|NCT01994382|470024799|FG003|Overall Study|Lost to Follow-up|0|||
130561715|NCT01994382|470024800|FG004|Overall Study|Lost to Follow-up|0|||
130561716|NCT01994382|470024801|FG005|Overall Study|Lost to Follow-up|0|||
130561717|NCT01994382|470024802|FG006|Overall Study|Lost to Follow-up|0|||
130561718|NCT01994382|470024803|FG007|Overall Study|Lost to Follow-up|0|||
130561719|NCT01994382|470024804|FG008|Overall Study|Lost to Follow-up|0|||
130561720|NCT01994382|470024805|FG009|Overall Study|Lost to Follow-up|0|||
130561721|NCT01994382|470024806|FG010|Overall Study|Lost to Follow-up|1|||
130561722|NCT01994382|470024807|FG011|Overall Study|Lost to Follow-up|0|||
130561723|NCT01994382|470024808|FG012|Overall Study|Lost to Follow-up|0|||
130561724|NCT01994382|470024809|FG013|Overall Study|Lost to Follow-up|0|||
130561725|NCT01994382|470024810|FG014|Overall Study|Lost to Follow-up|0|||
130561726|NCT01994382|470024811|FG015|Overall Study|Lost to Follow-up|0|||
130561727|NCT01994382|470024812|FG016|Overall Study|Lost to Follow-up|0|||
130561728|NCT01994382|470024796|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561729|NCT01994382|470024797|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561730|NCT01994382|470024798|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561731|NCT01994382|470024799|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561732|NCT01994382|470024800|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561733|NCT01994382|470024801|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561734|NCT01994382|470024802|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561735|NCT01994382|470024803|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561736|NCT01994382|470024804|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561737|NCT01994382|470024805|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561738|NCT01994382|470024806|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
130561739|NCT01994382|470024807|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561740|NCT01994382|470024808|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
130561741|NCT01994382|470024809|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561742|NCT01994382|470024810|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130561743|NCT01994382|470024811|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
130561744|NCT01994382|470024812|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
130561745|NCT01994382|470024796|FG000|Overall Study|Protocol violation/noncompliance|0|||
130561746|NCT01994382|470024797|FG001|Overall Study|Protocol violation/noncompliance|0|||
130561747|NCT01994382|470024798|FG002|Overall Study|Protocol violation/noncompliance|0|||
130561748|NCT01994382|470024799|FG003|Overall Study|Protocol violation/noncompliance|0|||
130561749|NCT01994382|470024800|FG004|Overall Study|Protocol violation/noncompliance|0|||
130561750|NCT01994382|470024801|FG005|Overall Study|Protocol violation/noncompliance|0|||
130561751|NCT01994382|470024802|FG006|Overall Study|Protocol violation/noncompliance|0|||
130561752|NCT01994382|470024803|FG007|Overall Study|Protocol violation/noncompliance|0|||
130561753|NCT01994382|470024804|FG008|Overall Study|Protocol violation/noncompliance|0|||
130561754|NCT01994382|470024805|FG009|Overall Study|Protocol violation/noncompliance|0|||
130561755|NCT01994382|470024806|FG010|Overall Study|Protocol violation/noncompliance|0|||
130561756|NCT01994382|470024807|FG011|Overall Study|Protocol violation/noncompliance|1|||
130561757|NCT01994382|470024808|FG012|Overall Study|Protocol violation/noncompliance|0|||
130561758|NCT01994382|470024809|FG013|Overall Study|Protocol violation/noncompliance|0|||
130561759|NCT01994382|470024810|FG014|Overall Study|Protocol violation/noncompliance|0|||
130561760|NCT01994382|470024811|FG015|Overall Study|Protocol violation/noncompliance|0|||
130561761|NCT01994382|470024812|FG016|Overall Study|Protocol violation/noncompliance|2|||
130561762|NCT01994382|470024796|FG000|Overall Study|Rolled over to Phase 2a|0|||
130561763|NCT01994382|470024797|FG001|Overall Study|Rolled over to Phase 2a|0|||
130561764|NCT01994382|470024798|FG002|Overall Study|Rolled over to Phase 2a|1|||
130561765|NCT01994382|470024799|FG003|Overall Study|Rolled over to Phase 2a|0|||
130561766|NCT01994382|470024800|FG004|Overall Study|Rolled over to Phase 2a|0|||
130561767|NCT01994382|470024801|FG005|Overall Study|Rolled over to Phase 2a|0|||
130561768|NCT01994382|470024802|FG006|Overall Study|Rolled over to Phase 2a|0|||
130727029|NCT02883049|470625437|FG013|Induction|Inevaluable|0|||
130727030|NCT02883049|470625438|FG014|Induction|Inevaluable|0|||
130473129|NCT01820260|469700987|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473130|NCT01820260|469700988|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473131|NCT01820260|469700989|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473132|NCT01820260|469700990|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473133|NCT01820260|469700991|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473134|NCT01820260|469700992|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473135|NCT01820260|469700993|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473136|NCT01820260|469700994|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473137|NCT01820260|469700995|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473138|NCT01820260|469700996|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
130473139|NCT01820260|469700997|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473140|NCT01820260|469700998|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473141|NCT01820260|469700999|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473142|NCT01820260|469701000|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130473143|NCT04831281|469701002|FG000|Overall Study|Adverse Event|1|||
130473144|NCT04831281|469701003|FG001|Overall Study|Adverse Event|0|||
130473145|NCT04831281|469701004|FG002|Overall Study|Adverse Event|3|||
130473146|NCT04831281|469701002|FG000|Overall Study|Withdrawal by Subject|0|||
130473147|NCT04831281|469701003|FG001|Overall Study|Withdrawal by Subject|1|||
130473148|NCT04831281|469701004|FG002|Overall Study|Withdrawal by Subject|2|||
130473149|NCT04831281|469701002|FG000|Overall Study|Undetermined|1|||
130473150|NCT04831281|469701003|FG001|Overall Study|Undetermined|1|||
130473151|NCT04831281|469701004|FG002|Overall Study|Undetermined|0|||
130473152|NCT02249949|469701005|FG000|Overall Study|Cancelled prior to treatment|2|||
130473153|NCT02097420|469701006|FG000|Overall Study|Death|6|||
130473154|NCT02097420|469701006|FG000|Overall Study|Valve explanted|13|||
130473155|NCT02097420|469701006|FG000|Overall Study|Other Reason|1|||
130473156|NCT03161379|469701014|FG000|Overall Study|Withdrawal by Subject|4|||
130473157|NCT03161379|469701014|FG000|Overall Study|disease progression during chemotherapy|5|||
130473158|NCT03161379|469701014|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
130473159|NCT03161379|469701014|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
130473160|NCT02312960|469701019|FG000|Overall Study|Death|24|||
130473161|NCT02312960|469701020|FG001|Overall Study|Death|32|||
130473162|NCT02312960|469701021|FG002|Overall Study|Death|25|||
130473163|NCT02312960|469701022|FG003|Overall Study|Death|11|||
130473164|NCT02312960|469701023|FG004|Overall Study|Death|5|||
130473165|NCT02312960|469701024|FG005|Overall Study|Death|5|||
130473166|NCT02312960|469701025|FG006|Overall Study|Death|8|||
130473167|NCT02312960|469701026|FG007|Overall Study|Death|5|||
130473168|NCT02312960|469701027|FG008|Overall Study|Death|7|||
130473169|NCT02312960|469701028|FG009|Overall Study|Death|3|||
130473170|NCT02312960|469701029|FG010|Overall Study|Death|3|||
130473171|NCT02312960|469701030|FG011|Overall Study|Death|1|||
130473172|NCT02312960|469701031|FG012|Overall Study|Death|25|||
130473173|NCT02312960|469701032|FG013|Overall Study|Death|19|||
130473174|NCT02312960|469701019|FG000|Overall Study|Missing|0|||
130473175|NCT02312960|469701020|FG001|Overall Study|Missing|0|||
130473176|NCT02312960|469701021|FG002|Overall Study|Missing|2|||
130473177|NCT02312960|469701022|FG003|Overall Study|Missing|0|||
130473178|NCT02312960|469701023|FG004|Overall Study|Missing|0|||
130473179|NCT02312960|469701024|FG005|Overall Study|Missing|0|||
130473180|NCT02312960|469701025|FG006|Overall Study|Missing|0|||
130473181|NCT02312960|469701026|FG007|Overall Study|Missing|0|||
130473182|NCT02312960|469701027|FG008|Overall Study|Missing|0|||
130473183|NCT02312960|469701028|FG009|Overall Study|Missing|0|||
130473184|NCT02312960|469701029|FG010|Overall Study|Missing|0|||
130473185|NCT02312960|469701030|FG011|Overall Study|Missing|0|||
130473186|NCT02312960|469701031|FG012|Overall Study|Missing|0|||
130473187|NCT02312960|469701032|FG013|Overall Study|Missing|0|||
130473188|NCT02312960|469701019|FG000|Overall Study|Lost to Follow-up|0|||
130473189|NCT02312960|469701020|FG001|Overall Study|Lost to Follow-up|0|||
130473190|NCT02312960|469701021|FG002|Overall Study|Lost to Follow-up|1|||
130473191|NCT02312960|469701022|FG003|Overall Study|Lost to Follow-up|0|||
130473192|NCT02312960|469701023|FG004|Overall Study|Lost to Follow-up|0|||
130473193|NCT02312960|469701024|FG005|Overall Study|Lost to Follow-up|0|||
130473194|NCT02312960|469701025|FG006|Overall Study|Lost to Follow-up|1|||
130473195|NCT02312960|469701026|FG007|Overall Study|Lost to Follow-up|1|||
130473196|NCT02312960|469701027|FG008|Overall Study|Lost to Follow-up|0|||
130473197|NCT02312960|469701028|FG009|Overall Study|Lost to Follow-up|1|||
130473198|NCT02312960|469701029|FG010|Overall Study|Lost to Follow-up|0|||
130473199|NCT02312960|469701030|FG011|Overall Study|Lost to Follow-up|0|||
130473200|NCT02312960|469701031|FG012|Overall Study|Lost to Follow-up|1|||
130473201|NCT02312960|469701032|FG013|Overall Study|Lost to Follow-up|0|||
130473202|NCT02312960|469701019|FG000|Overall Study|Withdrawal by Subject|1|||
130473203|NCT02312960|469701020|FG001|Overall Study|Withdrawal by Subject|2|||
130473204|NCT02312960|469701021|FG002|Overall Study|Withdrawal by Subject|0|||
130473205|NCT02312960|469701022|FG003|Overall Study|Withdrawal by Subject|0|||
130473206|NCT02312960|469701023|FG004|Overall Study|Withdrawal by Subject|1|||
130473207|NCT02312960|469701024|FG005|Overall Study|Withdrawal by Subject|0|||
130473208|NCT02312960|469701025|FG006|Overall Study|Withdrawal by Subject|1|||
130473209|NCT02312960|469701026|FG007|Overall Study|Withdrawal by Subject|2|||
130473210|NCT02312960|469701027|FG008|Overall Study|Withdrawal by Subject|2|||
130473211|NCT02312960|469701028|FG009|Overall Study|Withdrawal by Subject|3|||
130473212|NCT02312960|469701029|FG010|Overall Study|Withdrawal by Subject|0|||
130473213|NCT02312960|469701030|FG011|Overall Study|Withdrawal by Subject|0|||
130473214|NCT02312960|469701031|FG012|Overall Study|Withdrawal by Subject|2|||
130473215|NCT02312960|469701032|FG013|Overall Study|Withdrawal by Subject|0|||
130473216|NCT02728076|469701033|FG000|Overall Study|Physician Decision|4|||
130473217|NCT04089371|469701034|FG000|Overall Study|Withdrawal by Subject|0|||
130473218|NCT04089371|469701035|FG001|Overall Study|Withdrawal by Subject|1|||
130473219|NCT04089371|469701034|FG000|Overall Study|Study terminated early|0|||
130473220|NCT04089371|469701035|FG001|Overall Study|Study terminated early|9|||
130473221|NCT03453619|469701036|FG000|Core Study (Part A)|Physician Decision|0|||
130473222|NCT03453619|469701037|FG001|Core Study (Part A)|Physician Decision|0|||
130473223|NCT03453619|469701038|FG002|Core Study (Part A)|Physician Decision|2|||
130473224|NCT03453619|469701039|FG003|Core Study (Part A)|Physician Decision|0|||
130473225|NCT03453619|469701036|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
130473226|NCT03453619|469701037|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
130473227|NCT03453619|469701038|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
130473228|NCT03453619|469701039|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
130473229|NCT03453619|469701036|FG000|Core Study (Part A)|Other|0|||
130473230|NCT03453619|469701037|FG001|Core Study (Part A)|Other|1|||
130473231|NCT03453619|469701038|FG002|Core Study (Part A)|Other|0|||
130473232|NCT03453619|469701039|FG003|Core Study (Part A)|Other|0|||
130473233|NCT03453619|469701036|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
130473234|NCT03453619|469701037|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
130473235|NCT03453619|469701038|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
130473236|NCT03453619|469701039|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
130473237|NCT03453619|469701036|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
130473238|NCT03453619|469701037|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
130473239|NCT03453619|469701038|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
130473240|NCT03453619|469701039|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
130473241|NCT03453619|469701036|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
130473242|NCT03453619|469701037|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
130473243|NCT03453619|469701038|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
130473244|NCT03453619|469701039|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
130473245|NCT03453619|469701036|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
130473246|NCT03453619|469701037|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
130473247|NCT03453619|469701038|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
130473248|NCT03453619|469701039|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
130473249|NCT05229120|469701040|FG000|Overall Study|Withdrawal by Subject|8|||
130473250|NCT05862870|469701043|FG000|Overall Study|Lost to Follow-up|3|||
130473251|NCT02900924|469701044|FG000|Overall Study|Death|52|||
130473252|NCT02900924|469701044|FG000|Overall Study|Lost to Follow-up|4|||
130473253|NCT02900924|469701044|FG000|Overall Study|Withdrawal by Subject|20|||
130473254|NCT02900924|469701044|FG000|Overall Study|Missed Visit|33|||
130473255|NCT02365766|469701064|FG000|Overall Study|Withdrawal by Subject|0|||
130473256|NCT02365766|469701065|FG001|Overall Study|Withdrawal by Subject|0|||
130473257|NCT02365766|469701066|FG002|Overall Study|Withdrawal by Subject|1|||
130473258|NCT02365766|469701064|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130561769|NCT01994382|470024803|FG007|Overall Study|Rolled over to Phase 2a|0|||
130561770|NCT01994382|470024804|FG008|Overall Study|Rolled over to Phase 2a|0|||
130561771|NCT01994382|470024805|FG009|Overall Study|Rolled over to Phase 2a|2|||
130727031|NCT02883049|470625439|FG015|Induction|Inevaluable|0|||
130561772|NCT01994382|470024806|FG010|Overall Study|Rolled over to Phase 2a|0|||
130561773|NCT01994382|470024807|FG011|Overall Study|Rolled over to Phase 2a|0|||
130561774|NCT01994382|470024808|FG012|Overall Study|Rolled over to Phase 2a|0|||
130473259|NCT02365766|469701065|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130473260|NCT02365766|469701066|FG002|Overall Study|Eligibility Criteria Not Met|1|||
130473261|NCT03763708|469701070|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
130473262|NCT03763708|469701071|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473263|NCT03763708|469701072|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473264|NCT03763708|469701073|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473265|NCT03763708|469701074|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473266|NCT03763708|469701075|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473267|NCT03763708|469701076|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473268|NCT03763708|469701077|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473269|NCT03763708|469701078|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130473270|NCT03763708|469701070|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473271|NCT03763708|469701071|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130561775|NCT01994382|470024809|FG013|Overall Study|Rolled over to Phase 2a|0|||
130727032|NCT02883049|470625424|FG000|Induction|Identified as VHR at end of Induction|244|||
130727033|NCT02883049|470625425|FG001|Induction|Identified as VHR at end of Induction|0|||
130561776|NCT01994382|470024810|FG014|Overall Study|Rolled over to Phase 2a|0|||
130561777|NCT01994382|470024811|FG015|Overall Study|Rolled over to Phase 2a|0|||
130561778|NCT01994382|470024812|FG016|Overall Study|Rolled over to Phase 2a|0|||
130561779|NCT04667377|470024813|FG000|Dose Escalation Period|Other not specified below|3|||
130561780|NCT04667377|470024814|FG001|Dose Escalation Period|Other not specified below|3|||
130561781|NCT04667377|470024815|FG002|Dose Escalation Period|Other not specified below|2|||
130561782|NCT04667377|470024816|FG003|Dose Escalation Period|Other not specified below|1|||
130561783|NCT04667377|470024817|FG004|Dose Escalation Period|Other not specified below|3|||
130561784|NCT04667377|470024813|FG000|Dose Escalation Period|Protocol Violation|2|||
130561785|NCT04667377|470024814|FG001|Dose Escalation Period|Protocol Violation|2|||
130561786|NCT04667377|470024815|FG002|Dose Escalation Period|Protocol Violation|0|||
130561787|NCT04667377|470024816|FG003|Dose Escalation Period|Protocol Violation|2|||
130561788|NCT04667377|470024817|FG004|Dose Escalation Period|Protocol Violation|1|||
130561789|NCT04667377|470024813|FG000|Dose Escalation Period|Burden of study procedures|2|||
130561790|NCT04667377|470024814|FG001|Dose Escalation Period|Burden of study procedures|1|||
130561791|NCT04667377|470024815|FG002|Dose Escalation Period|Burden of study procedures|1|||
130561792|NCT04667377|470024816|FG003|Dose Escalation Period|Burden of study procedures|1|||
130561793|NCT04667377|470024817|FG004|Dose Escalation Period|Burden of study procedures|5|||
130561794|NCT04667377|470024813|FG000|Dose Escalation Period|Change of residence|0|||
130561795|NCT04667377|470024814|FG001|Dose Escalation Period|Change of residence|0|||
130409417|NCT02604589|469460033|FG000|Overall Study|catheter dislodgement|0|||
130409418|NCT02604589|469460034|FG001|Overall Study|catheter dislodgement|0|||
130409419|NCT02604589|469460035|FG002|Overall Study|catheter dislodgement|1|||
130409420|NCT00793910|469460036|FG000|Overall Study|discarded study pills|0|||
130409421|NCT00793910|469460037|FG001|Overall Study|discarded study pills|1|||
130561796|NCT04667377|470024815|FG002|Dose Escalation Period|Change of residence|1|||
130561797|NCT04667377|470024816|FG003|Dose Escalation Period|Change of residence|0|||
130561798|NCT04667377|470024817|FG004|Dose Escalation Period|Change of residence|0|||
130561799|NCT04667377|470024813|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
130561800|NCT04667377|470024814|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
130561801|NCT04667377|470024815|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
130561802|NCT04667377|470024816|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
130561803|NCT04667377|470024817|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
130561804|NCT04667377|470024813|FG000|Dose Escalation Period|Adverse Event|9|||
130561805|NCT04667377|470024814|FG001|Dose Escalation Period|Adverse Event|10|||
130561806|NCT04667377|470024815|FG002|Dose Escalation Period|Adverse Event|12|||
130561807|NCT04667377|470024816|FG003|Dose Escalation Period|Adverse Event|17|||
130561808|NCT04667377|470024817|FG004|Dose Escalation Period|Adverse Event|3|||
130561809|NCT04667377|470024813|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
130561810|NCT04667377|470024814|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
130561811|NCT04667377|470024815|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
130561812|NCT04667377|470024816|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
130561813|NCT04667377|470024817|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
130561814|NCT04667377|470024813|FG000|Dose Escalation Period|Not treated|1|||
130561815|NCT04667377|470024814|FG001|Dose Escalation Period|Not treated|0|||
130561816|NCT04667377|470024815|FG002|Dose Escalation Period|Not treated|0|||
130561817|NCT04667377|470024816|FG003|Dose Escalation Period|Not treated|0|||
130561818|NCT04667377|470024817|FG004|Dose Escalation Period|Not treated|0|||
130561819|NCT04667377|470024813|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
130561820|NCT04667377|470024814|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
130561821|NCT04667377|470024815|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130561822|NCT04667377|470024816|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
130561823|NCT04667377|470024817|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
130561824|NCT04667377|470024813|FG000|Dose Escalation Period|Lost to Follow-up|0|||
130561825|NCT04667377|470024814|FG001|Dose Escalation Period|Lost to Follow-up|1|||
130561826|NCT04667377|470024815|FG002|Dose Escalation Period|Lost to Follow-up|0|||
130561827|NCT04667377|470024816|FG003|Dose Escalation Period|Lost to Follow-up|0|||
130561828|NCT04667377|470024817|FG004|Dose Escalation Period|Lost to Follow-up|0|||
130561829|NCT04667377|470024813|FG000|Maintenance Period|Perceived lack of efficacy|0|||
130561830|NCT04667377|470024814|FG001|Maintenance Period|Perceived lack of efficacy|2|||
130561831|NCT04667377|470024815|FG002|Maintenance Period|Perceived lack of efficacy|1|||
130561832|NCT04667377|470024816|FG003|Maintenance Period|Perceived lack of efficacy|0|||
130561833|NCT04667377|470024817|FG004|Maintenance Period|Perceived lack of efficacy|1|||
130561834|NCT04667377|470024813|FG000|Maintenance Period|Adverse Event|2|||
130561835|NCT04667377|470024814|FG001|Maintenance Period|Adverse Event|8|||
130561836|NCT04667377|470024815|FG002|Maintenance Period|Adverse Event|5|||
130561837|NCT04667377|470024816|FG003|Maintenance Period|Adverse Event|4|||
130561838|NCT04667377|470024817|FG004|Maintenance Period|Adverse Event|1|||
130561839|NCT04667377|470024813|FG000|Maintenance Period|Adverse event: COVID infection|0|||
130409422|NCT00793910|469460036|FG000|Overall Study|did not pick up medications|1|||
130409423|NCT00793910|469460037|FG001|Overall Study|did not pick up medications|1|||
130409424|NCT00793910|469460036|FG000|Overall Study|ineligible based on entry criteria|2|||
130561840|NCT04667377|470024814|FG001|Maintenance Period|Adverse event: COVID infection|1|||
130561841|NCT04667377|470024815|FG002|Maintenance Period|Adverse event: COVID infection|0|||
130561842|NCT04667377|470024816|FG003|Maintenance Period|Adverse event: COVID infection|0|||
130561843|NCT04667377|470024817|FG004|Maintenance Period|Adverse event: COVID infection|0|||
130561844|NCT04667377|470024813|FG000|Maintenance Period|COVID-related|0|||
130561845|NCT04667377|470024814|FG001|Maintenance Period|COVID-related|0|||
130561846|NCT04667377|470024815|FG002|Maintenance Period|COVID-related|1|||
130561847|NCT04667377|470024816|FG003|Maintenance Period|COVID-related|1|||
130561848|NCT04667377|470024817|FG004|Maintenance Period|COVID-related|0|||
130561849|NCT04667377|470024813|FG000|Maintenance Period|Protocol Violation|1|||
130561850|NCT04667377|470024814|FG001|Maintenance Period|Protocol Violation|0|||
130561851|NCT04667377|470024815|FG002|Maintenance Period|Protocol Violation|0|||
130561852|NCT04667377|470024816|FG003|Maintenance Period|Protocol Violation|0|||
130561853|NCT04667377|470024817|FG004|Maintenance Period|Protocol Violation|1|||
130561854|NCT04667377|470024813|FG000|Maintenance Period|Burden of study procedures|1|||
130561855|NCT04667377|470024814|FG001|Maintenance Period|Burden of study procedures|2|||
130561856|NCT04667377|470024815|FG002|Maintenance Period|Burden of study procedures|0|||
130561857|NCT04667377|470024816|FG003|Maintenance Period|Burden of study procedures|1|||
130561858|NCT04667377|470024817|FG004|Maintenance Period|Burden of study procedures|0|||
130561859|NCT04667377|470024813|FG000|Maintenance Period|Change of residence|0|||
130561860|NCT04667377|470024814|FG001|Maintenance Period|Change of residence|1|||
130561861|NCT04667377|470024815|FG002|Maintenance Period|Change of residence|0|||
130561862|NCT04667377|470024816|FG003|Maintenance Period|Change of residence|0|||
130561863|NCT04667377|470024817|FG004|Maintenance Period|Change of residence|1|||
130561864|NCT04667377|470024813|FG000|Maintenance Period|Missing|1|||
130561865|NCT04667377|470024814|FG001|Maintenance Period|Missing|0|||
130561866|NCT04667377|470024815|FG002|Maintenance Period|Missing|0|||
130561867|NCT04667377|470024816|FG003|Maintenance Period|Missing|0|||
130561868|NCT04667377|470024817|FG004|Maintenance Period|Missing|0|||
130561869|NCT04667377|470024813|FG000|Maintenance Period|Other than listed above|2|||
130561870|NCT04667377|470024814|FG001|Maintenance Period|Other than listed above|0|||
130561871|NCT04667377|470024815|FG002|Maintenance Period|Other than listed above|3|||
130561872|NCT04667377|470024816|FG003|Maintenance Period|Other than listed above|2|||
130561873|NCT04667377|470024817|FG004|Maintenance Period|Other than listed above|6|||
130561874|NCT04667377|470024813|FG000|Maintenance Period|Withdrawal by Subject|0|||
130561875|NCT04667377|470024814|FG001|Maintenance Period|Withdrawal by Subject|1|||
130561876|NCT04667377|470024815|FG002|Maintenance Period|Withdrawal by Subject|0|||
130561877|NCT04667377|470024816|FG003|Maintenance Period|Withdrawal by Subject|0|||
130561878|NCT04667377|470024817|FG004|Maintenance Period|Withdrawal by Subject|0|||
130561879|NCT04667377|470024813|FG000|Maintenance Period|Lost to Follow-up|1|||
130561880|NCT04667377|470024814|FG001|Maintenance Period|Lost to Follow-up|0|||
130561881|NCT04667377|470024815|FG002|Maintenance Period|Lost to Follow-up|1|||
130561882|NCT04667377|470024816|FG003|Maintenance Period|Lost to Follow-up|0|||
130561883|NCT04667377|470024817|FG004|Maintenance Period|Lost to Follow-up|1|||
130561884|NCT01011439|470024818|FG000|Overall Study|Death|37|||
130561885|NCT01011439|470024818|FG000|Overall Study|Lost to Follow-up|4|||
130561886|NCT01011439|470024818|FG000|Overall Study|Withdrawal by Subject|1|||
130561887|NCT01011439|470024818|FG000|Overall Study|Sponsor's decision|15|||
130561888|NCT02428855|470024819|FG000|Overall Study|Withdrawal by Subject|2|||
130561889|NCT02066311|470024820|FG000|Overall Study|Adverse Event|4|||
130561890|NCT02066311|470024820|FG000|Overall Study|Withdrawal by Subject|1|||
130561891|NCT03198520|470024827|FG000|Overall Study|Physician Decision|2|||
130561892|NCT03198520|470024827|FG000|Overall Study|Protocol Violation|2|||
130561893|NCT03198520|470024827|FG000|Overall Study|Withdrawal by Subject|1|||
130561894|NCT03198520|470024827|FG000|Overall Study|Study Ended|1|||
130561895|NCT01670539|470024828|FG000|Overall Study|Death|3|||
130561896|NCT01670539|470024829|FG001|Overall Study|Death|5|||
130561897|NCT01670539|470024828|FG000|Overall Study|Withdrawal by Subject|3|||
130409425|NCT00793910|469460037|FG001|Overall Study|ineligible based on entry criteria|3|||
130409426|NCT00793910|469460036|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
130409427|NCT00793910|469460037|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
130409428|NCT00793910|469460036|FG000|Overall Study|Withdrawal by Subject|0|||
130409429|NCT00793910|469460037|FG001|Overall Study|Withdrawal by Subject|1|||
130409430|NCT01700946|469460038|FG000|Overall Study|Lost to Follow-up|1|||
130409431|NCT01700946|469460039|FG001|Overall Study|Lost to Follow-up|0|||
130409432|NCT01700946|469460038|FG000|Overall Study|Physician Decision|7|||
130409433|NCT01700946|469460039|FG001|Overall Study|Physician Decision|12|||
130561898|NCT01670539|470024829|FG001|Overall Study|Withdrawal by Subject|0|||
130561899|NCT04353596|470024830|FG000|Overall Study|Protocol Violation|4|||
130561900|NCT04353596|470024831|FG001|Overall Study|Protocol Violation|4|||
130561901|NCT04353596|470024830|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
130561902|NCT04353596|470024831|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
130561903|NCT05418673|470024832|FG000|Overall Study|Study Terminated by Sponsor|2|||
130409434|NCT01700946|469460038|FG000|Overall Study|Withdrawal by Subject|0|||
130561904|NCT05418673|470024833|FG001|Overall Study|Study Terminated by Sponsor|4|||
130473272|NCT03763708|469701072|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
130473273|NCT03763708|469701073|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473274|NCT03763708|469701074|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473275|NCT03763708|469701075|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473276|NCT03763708|469701076|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473277|NCT03763708|469701077|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473278|NCT03763708|469701078|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130473279|NCT03763708|469701070|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473280|NCT03763708|469701071|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473281|NCT03763708|469701072|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473282|NCT03763708|469701073|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
130473283|NCT03763708|469701074|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473284|NCT03763708|469701075|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473285|NCT03763708|469701076|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473286|NCT03763708|469701077|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473287|NCT03763708|469701078|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130473288|NCT03763708|469701070|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473289|NCT03763708|469701071|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473290|NCT03763708|469701072|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473291|NCT03763708|469701073|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473292|NCT03763708|469701074|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
130473293|NCT03763708|469701075|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473294|NCT03763708|469701076|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473295|NCT03763708|469701077|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473296|NCT03763708|469701078|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
130473297|NCT03763708|469701070|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473298|NCT03763708|469701071|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473299|NCT03763708|469701072|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473300|NCT03763708|469701073|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473301|NCT03763708|469701074|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473302|NCT03763708|469701075|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
130473303|NCT03763708|469701076|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473304|NCT03763708|469701077|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473305|NCT03763708|469701078|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
130473306|NCT03763708|469701070|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473307|NCT03763708|469701071|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473308|NCT03763708|469701072|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473309|NCT03763708|469701073|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473310|NCT03763708|469701074|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473311|NCT03763708|469701075|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473312|NCT03763708|469701076|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
130473313|NCT03763708|469701077|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473314|NCT03763708|469701078|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
130473315|NCT03763708|469701070|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
130473316|NCT03763708|469701071|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
130473317|NCT03763708|469701072|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
130473318|NCT03763708|469701073|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
130473319|NCT03763708|469701074|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
130473320|NCT03763708|469701075|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
130473321|NCT03763708|469701076|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
130473322|NCT03763708|469701077|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
130473323|NCT03763708|469701078|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
130473324|NCT03763708|469701070|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
130473325|NCT03763708|469701071|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
130473326|NCT03763708|469701072|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
130409435|NCT01700946|469460039|FG001|Overall Study|Withdrawal by Subject|2|||
130409436|NCT01700946|469460038|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
130409437|NCT01700946|469460039|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
130409438|NCT01700946|469460038|FG000|Overall Study|Relapse|2|||
130409439|NCT01700946|469460039|FG001|Overall Study|Relapse|1|||
130409440|NCT01700946|469460038|FG000|Overall Study|Unacceptable toxicity|1|||
130409441|NCT01700946|469460039|FG001|Overall Study|Unacceptable toxicity|0|||
130409442|NCT03321981|469460049|FG000|Overall Study|Progressive Disease (PD)|15|||
130409443|NCT03321981|469460050|FG001|Overall Study|Progressive Disease (PD)|30|||
130409444|NCT03321981|469460051|FG002|Overall Study|Progressive Disease (PD)|47|||
130409445|NCT03321981|469460049|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
130409446|NCT03321981|469460050|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
130409447|NCT03321981|469460051|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
130409448|NCT03321981|469460049|FG000|Overall Study|Adverse Event|0|||
130409449|NCT03321981|469460050|FG001|Overall Study|Adverse Event|0|||
130409450|NCT03321981|469460051|FG002|Overall Study|Adverse Event|2|||
130409451|NCT03321981|469460049|FG000|Overall Study|symptomatic deterioration|0|||
130409452|NCT03321981|469460050|FG001|Overall Study|symptomatic deterioration|1|||
130409453|NCT03321981|469460051|FG002|Overall Study|symptomatic deterioration|1|||
130409454|NCT03321981|469460049|FG000|Overall Study|Lack of compliance|0|||
130409455|NCT03321981|469460050|FG001|Overall Study|Lack of compliance|1|||
130409456|NCT03321981|469460051|FG002|Overall Study|Lack of compliance|0|||
130473327|NCT03763708|469701073|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
130473328|NCT03763708|469701074|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
130473329|NCT03763708|469701075|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
130473330|NCT03763708|469701076|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
130473331|NCT03763708|469701077|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
130473332|NCT03763708|469701078|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
130473333|NCT03763708|469701070|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
130473334|NCT03763708|469701071|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
130473335|NCT03763708|469701072|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
130473336|NCT03763708|469701073|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
130473337|NCT03763708|469701074|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
130473338|NCT03763708|469701075|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
130473339|NCT03763708|469701076|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
130473340|NCT03763708|469701077|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
130473341|NCT03763708|469701078|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
130473342|NCT00931710|469701081|FG000|Overall Study|Adverse Event|16|||
130473343|NCT00931710|469701082|FG001|Overall Study|Adverse Event|10|||
130473344|NCT00931710|469701081|FG000|Overall Study|Abnormal test procedure results|2|||
130473345|NCT00931710|469701082|FG001|Overall Study|Abnormal test procedure results|0|||
130473346|NCT00931710|469701081|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
130473347|NCT00931710|469701082|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
130473348|NCT00931710|469701081|FG000|Overall Study|Patient withdrew consent|4|||
130473349|NCT00931710|469701082|FG001|Overall Study|Patient withdrew consent|9|||
130473350|NCT00931710|469701081|FG000|Overall Study|Lost to Follow-up|6|||
130473351|NCT00931710|469701082|FG001|Overall Study|Lost to Follow-up|5|||
130473352|NCT00931710|469701081|FG000|Overall Study|Protocol deviation|1|||
130473353|NCT00931710|469701082|FG001|Overall Study|Protocol deviation|2|||
130473354|NCT02913872|469701083|FG000|Overall Study|Withdrawal by Subject|1|||
130473355|NCT02323321|469701084|FG000|Overall Study|Re-Transplant|1|||
130473356|NCT02323321|469701084|FG000|Overall Study|Death|12|||
130473357|NCT00446225|469701085|FG000|Overall Study|Protocol Violation|1|||
130473358|NCT00446225|469701086|FG001|Overall Study|Protocol Violation|0|||
130473359|NCT04450342|469701087|FG000|Overall Study|Adverse Event|1|||
130473360|NCT04450342|469701088|FG001|Overall Study|Adverse Event|1|||
130473361|NCT04450342|469701089|FG002|Overall Study|Adverse Event|0|||
130473362|NCT04450342|469701087|FG000|Overall Study|Device not used|1|||
130473363|NCT04450342|469701088|FG001|Overall Study|Device not used|0|||
130473364|NCT04450342|469701089|FG002|Overall Study|Device not used|0|||
130473365|NCT04450342|469701087|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
130473366|NCT04450342|469701088|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
130473367|NCT04450342|469701089|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
130473368|NCT04450342|469701087|FG000|Overall Study|Physician Decision|1|||
130473369|NCT04450342|469701088|FG001|Overall Study|Physician Decision|0|||
130473370|NCT04450342|469701089|FG002|Overall Study|Physician Decision|1|||
130473371|NCT04450342|469701087|FG000|Overall Study|Protocol Deviation|0|||
130473372|NCT04450342|469701088|FG001|Overall Study|Protocol Deviation|1|||
130473373|NCT04450342|469701089|FG002|Overall Study|Protocol Deviation|0|||
130473374|NCT04450342|469701087|FG000|Overall Study|Reoperation|1|||
130473375|NCT04450342|469701088|FG001|Overall Study|Reoperation|1|||
130473376|NCT04450342|469701089|FG002|Overall Study|Reoperation|0|||
130473377|NCT04450342|469701087|FG000|Overall Study|Screen Failures|0|||
130473378|NCT04450342|469701088|FG001|Overall Study|Screen Failures|0|||
130473379|NCT04450342|469701089|FG002|Overall Study|Screen Failures|2|||
130473380|NCT04450342|469701087|FG000|Overall Study|Site Terminated by Sponsor|1|||
130473381|NCT04450342|469701088|FG001|Overall Study|Site Terminated by Sponsor|1|||
130473382|NCT04450342|469701089|FG002|Overall Study|Site Terminated by Sponsor|1|||
130473383|NCT04450342|469701087|FG000|Overall Study|Study Terminated by Sponsor|31|||
130473384|NCT04450342|469701088|FG001|Overall Study|Study Terminated by Sponsor|29|||
130561905|NCT05418673|470024832|FG000|Overall Study|Lost to Follow-up|1|||
130473385|NCT04450342|469701089|FG002|Overall Study|Study Terminated by Sponsor|6|||
130473386|NCT04450342|469701087|FG000|Overall Study|Withdrawal by Subject|0|||
130473387|NCT04450342|469701088|FG001|Overall Study|Withdrawal by Subject|1|||
130473388|NCT04450342|469701089|FG002|Overall Study|Withdrawal by Subject|2|||
130473389|NCT03361748|469701097|FG000|Overall Study|Death|77|||
130473390|NCT03361748|469701097|FG000|Overall Study|Lost to Follow-up|4|||
130473391|NCT03361748|469701097|FG000|Overall Study|Withdrawal by Subject|20|||
130473392|NCT01361711|469701098|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
130409457|NCT03321981|469460049|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
130473393|NCT01361711|469701098|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
130561906|NCT05418673|470024833|FG001|Overall Study|Lost to Follow-up|0|||
130561907|NCT02665052|470024836|FG000|Overall Study|Lost to Follow-up|1|||
130561908|NCT02665052|470024837|FG001|Overall Study|Lost to Follow-up|0|||
130561909|NCT02665052|470024838|FG002|Overall Study|Lost to Follow-up|0|||
130561910|NCT02665052|470024839|FG003|Overall Study|Lost to Follow-up|0|||
130561911|NCT02665052|470024836|FG000|Overall Study|Withdrawal by Subject|1|||
130561912|NCT02665052|470024837|FG001|Overall Study|Withdrawal by Subject|1|||
130561913|NCT02665052|470024838|FG002|Overall Study|Withdrawal by Subject|0|||
130561914|NCT02665052|470024839|FG003|Overall Study|Withdrawal by Subject|5|||
130561915|NCT02665052|470024836|FG000|Overall Study|Adverse Event|1|||
130561916|NCT02665052|470024837|FG001|Overall Study|Adverse Event|1|||
130561917|NCT02665052|470024838|FG002|Overall Study|Adverse Event|0|||
130561918|NCT02665052|470024839|FG003|Overall Study|Adverse Event|0|||
130561919|NCT00823823|470024840|FG000|Overall Study|Lost to Follow-up|3|||
130561920|NCT00823823|470024841|FG001|Overall Study|Lost to Follow-up|1|||
130561921|NCT00823823|470024840|FG000|Overall Study|Protocol Violation|5|||
130561922|NCT00823823|470024841|FG001|Overall Study|Protocol Violation|5|||
130561923|NCT02234284|470024842|FG000|Overall Study|Death|4|||
130561924|NCT02234284|470024843|FG001|Overall Study|Death|2|||
130561925|NCT02234284|470024842|FG000|Overall Study|Withdrawal by Subject|1|||
130561926|NCT02234284|470024843|FG001|Overall Study|Withdrawal by Subject|0|||
130561927|NCT02234284|470024842|FG000|Overall Study|Lost to Follow-up|20|||
130561928|NCT02234284|470024843|FG001|Overall Study|Lost to Follow-up|7|||
130561929|NCT01835015|470024844|FG000|Overall Study|Adverse Event|0|||
130561930|NCT01835015|470024845|FG001|Overall Study|Adverse Event|0|||
130561931|NCT01835015|470024846|FG002|Overall Study|Adverse Event|1|||
130561932|NCT01835015|470024847|FG003|Overall Study|Adverse Event|0|||
130561933|NCT01835015|470024848|FG004|Overall Study|Adverse Event|0|||
130561934|NCT00536809|470024852|FG000|Phase II|Adverse Event|1|||
130561935|NCT00536809|470024852|FG000|Phase II|Referred for surgical resection|1|||
130561936|NCT00233363|470024856|FG000|Overall Study|Adverse Event|1|||
130561937|NCT00233363|470024857|FG001|Overall Study|Adverse Event|2|||
130561938|NCT00233363|470024856|FG000|Overall Study|Lack of Efficacy|0|||
130561939|NCT00233363|470024857|FG001|Overall Study|Lack of Efficacy|2|||
130561940|NCT00233363|470024856|FG000|Overall Study|Withdrawal by Subject|1|||
130561941|NCT00233363|470024857|FG001|Overall Study|Withdrawal by Subject|1|||
130561942|NCT00233363|470024856|FG000|Overall Study|Aggravation of complication|1|||
130561943|NCT00233363|470024857|FG001|Overall Study|Aggravation of complication|0|||
130561944|NCT01576172|470024858|FG000|Overall Study|Ineligible|2|||
130561945|NCT01576172|470024859|FG001|Overall Study|Ineligible|1|||
130561946|NCT01576172|470024858|FG000|Overall Study|Withdrawal by Subject|2|||
130561947|NCT01576172|470024859|FG001|Overall Study|Withdrawal by Subject|0|||
130561948|NCT01576172|470024858|FG000|Overall Study|Insurance issue|1|||
130561949|NCT01576172|470024859|FG001|Overall Study|Insurance issue|0|||
130561950|NCT01303965|470024861|FG000|Overall Study|Adverse Event|1|||
130561951|NCT01303965|470024862|FG001|Overall Study|Adverse Event|1|||
130561952|NCT01303965|470024861|FG000|Overall Study|Death|0|||
130561953|NCT01303965|470024862|FG001|Overall Study|Death|3|||
130561954|NCT01303965|470024861|FG000|Overall Study|Withdrawal by Subject|1|||
130561955|NCT01303965|470024862|FG001|Overall Study|Withdrawal by Subject|0|||
130561956|NCT01303965|470024861|FG000|Overall Study|Disease Progression|1|||
130561957|NCT01303965|470024862|FG001|Overall Study|Disease Progression|6|||
130561958|NCT01490814|470024867|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
130561959|NCT01490814|470024868|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
130561960|NCT01490814|470024867|FG000|Overall Study|Physician Decision|1|||
130561961|NCT01490814|470024868|FG001|Overall Study|Physician Decision|0|||
130561962|NCT01490814|470024867|FG000|Overall Study|Withdrawal by Subject|0|||
130561963|NCT01490814|470024868|FG001|Overall Study|Withdrawal by Subject|5|||
130561964|NCT03024970|470024872|FG000|First Intervention|Adverse Event|1|||
130561965|NCT03024970|470024873|FG001|First Intervention|Adverse Event|0|||
130561966|NCT03024970|470024872|FG000|Second Intervention|Lost to Follow-up|1|||
130561967|NCT03024970|470024873|FG001|Second Intervention|Lost to Follow-up|0|||
130561968|NCT02790138|470024876|FG000|Overall Study|Adverse Event|5|||
130561969|NCT02790138|470024877|FG001|Overall Study|Adverse Event|2|||
130561970|NCT02790138|470024876|FG000|Overall Study|Significant Protocol Deviation|0|||
130561971|NCT02790138|470024877|FG001|Overall Study|Significant Protocol Deviation|1|||
130561972|NCT02790138|470024876|FG000|Overall Study|Lost to Follow-up|1|||
130561973|NCT02790138|470024877|FG001|Overall Study|Lost to Follow-up|0|||
130561974|NCT02790138|470024876|FG000|Overall Study|Voluntary Withdrawal|8|||
130561975|NCT02790138|470024877|FG001|Overall Study|Voluntary Withdrawal|9|||
130561976|NCT02790138|470024876|FG000|Overall Study|Lack of Efficacy|6|||
130561977|NCT02790138|470024877|FG001|Overall Study|Lack of Efficacy|7|||
130561978|NCT02790138|470024876|FG000|Overall Study|Reason not Specified|1|||
130561979|NCT02790138|470024877|FG001|Overall Study|Reason not Specified|0|||
130561980|NCT01786603|470024878|FG000|Overall Study|Death|5|||
130561981|NCT01786603|470024879|FG001|Overall Study|Death|1|||
130561982|NCT01786603|470024878|FG000|Overall Study|Adverse Event|6|||
130561983|NCT01786603|470024879|FG001|Overall Study|Adverse Event|2|||
130561984|NCT01786603|470024878|FG000|Overall Study|Physician decision to withdraw|6|||
130561985|NCT01786603|470024879|FG001|Overall Study|Physician decision to withdraw|7|||
130561986|NCT01786603|470024878|FG000|Overall Study|Lost to Follow-up|1|||
130561987|NCT01786603|470024879|FG001|Overall Study|Lost to Follow-up|2|||
130561988|NCT01226459|470024880|FG000|Overall Study|Adverse Event|2|||
130561989|NCT01226459|470024881|FG001|Overall Study|Adverse Event|8|||
130561990|NCT01226459|470024880|FG000|Overall Study|Protocol Violation|4|||
130561991|NCT01226459|470024881|FG001|Overall Study|Protocol Violation|3|||
130561992|NCT01226459|470024880|FG000|Overall Study|Withdrawal by Subject|10|||
130561993|NCT01226459|470024881|FG001|Overall Study|Withdrawal by Subject|13|||
130561994|NCT01226459|470024880|FG000|Overall Study|Lost to Follow-up|4|||
130561995|NCT01226459|470024881|FG001|Overall Study|Lost to Follow-up|8|||
130561996|NCT01226459|470024880|FG000|Overall Study|Pregnancy|1|||
130561997|NCT01226459|470024881|FG001|Overall Study|Pregnancy|0|||
130561998|NCT00474708|470024882|FG000|Overall Study|Lack of Efficacy|11|||
130409458|NCT03321981|469460050|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
130409459|NCT03321981|469460051|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
130409460|NCT03321981|469460049|FG000|Overall Study|Death|0|||
130409461|NCT03321981|469460050|FG001|Overall Study|Death|1|||
130409462|NCT03321981|469460051|FG002|Overall Study|Death|0|||
130409463|NCT03321981|469460049|FG000|Overall Study|Subject withdrawal of investigational product|0|||
130409464|NCT03321981|469460050|FG001|Overall Study|Subject withdrawal of investigational product|1|||
130409465|NCT03321981|469460051|FG002|Overall Study|Subject withdrawal of investigational product|0|||
130409466|NCT03321981|469460049|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
130409467|NCT03321981|469460050|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
130409468|NCT03321981|469460051|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
130409469|NCT03321981|469460049|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
130409470|NCT03321981|469460050|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
130409471|NCT03321981|469460051|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
130409472|NCT05061446|469460053|FG000|Overall Study|Adverse Event|2|||
130561999|NCT00474708|470024883|FG001|Overall Study|Lack of Efficacy|5|||
130562000|NCT00474708|470024882|FG000|Overall Study|Suicide ideation/behavior|0|||
130562001|NCT00474708|470024883|FG001|Overall Study|Suicide ideation/behavior|1|||
130562002|NCT00474708|470024882|FG000|Overall Study|Withdrawal by Subject|7|||
130562003|NCT00474708|470024883|FG001|Overall Study|Withdrawal by Subject|0|||
130562004|NCT00474708|470024882|FG000|Overall Study|Lack of compliance|12|||
130562005|NCT00474708|470024883|FG001|Overall Study|Lack of compliance|4|||
130562006|NCT00474708|470024882|FG000|Overall Study|Lost to Follow-up|18|||
130562007|NCT00474708|470024883|FG001|Overall Study|Lost to Follow-up|9|||
130562008|NCT00474708|470024882|FG000|Overall Study|Physician Decision|9|||
130562009|NCT00474708|470024883|FG001|Overall Study|Physician Decision|6|||
130562010|NCT03700320|470024887|FG000|Overall Study|Adverse Event|5|||
130562011|NCT03700320|470024888|FG001|Overall Study|Adverse Event|31|||
130562012|NCT03700320|470024887|FG000|Overall Study|Lack of Efficacy|2|||
130562013|NCT03700320|470024888|FG001|Overall Study|Lack of Efficacy|5|||
130562014|NCT03700320|470024887|FG000|Overall Study|Withdrawal by Subject|29|||
130562015|NCT03700320|470024888|FG001|Overall Study|Withdrawal by Subject|75|||
130562016|NCT03700320|470024887|FG000|Overall Study|Lost to Follow-up|16|||
130562017|NCT03700320|470024888|FG001|Overall Study|Lost to Follow-up|23|||
130562018|NCT03700320|470024887|FG000|Overall Study|Pregnancy|2|||
130562019|NCT03700320|470024888|FG001|Overall Study|Pregnancy|4|||
130562020|NCT03700320|470024887|FG000|Overall Study|Protocol Deviation|7|||
130562021|NCT03700320|470024888|FG001|Overall Study|Protocol Deviation|31|||
130562022|NCT03700320|470024887|FG000|Overall Study|Non-compliance with Study Drug|1|||
130562023|NCT03700320|470024888|FG001|Overall Study|Non-compliance with Study Drug|3|||
130562024|NCT03700320|470024887|FG000|Overall Study|Reason not Specified|0|||
130562025|NCT03700320|470024888|FG001|Overall Study|Reason not Specified|1|||
130562026|NCT00175877|470024889|FG000|Overall Study|Adverse Event|136|||
130562027|NCT00175877|470024889|FG000|Overall Study|Withdrawal by Subject|141|||
130562028|NCT00175877|470024889|FG000|Overall Study|Lost to Follow-up|9|||
130562029|NCT00175877|470024889|FG000|Overall Study|Lack of Efficacy|26|||
130562030|NCT00175877|470024889|FG000|Overall Study|Protocol Violation|15|||
130562031|NCT00175877|470024889|FG000|Overall Study|Other Reason|20|||
130562032|NCT00175877|470024889|FG000|Overall Study|AE & Other|1|||
130562033|NCT00175877|470024889|FG000|Overall Study|Withdrawal by subject & Other|1|||
130562034|NCT01092143|470024892|FG000|Overall Study|Adverse Event|10|||
130562035|NCT01092143|470024893|FG001|Overall Study|Adverse Event|5|||
130562036|NCT01092143|470024894|FG002|Overall Study|Adverse Event|1|||
130562037|NCT01092143|470024895|FG003|Overall Study|Adverse Event|4|||
130562038|NCT01092143|470024896|FG004|Overall Study|Adverse Event|3|||
130562039|NCT01092143|470024892|FG000|Overall Study|Lost to Follow-up|1|||
130562040|NCT01092143|470024893|FG001|Overall Study|Lost to Follow-up|0|||
130562041|NCT01092143|470024894|FG002|Overall Study|Lost to Follow-up|1|||
130562042|NCT01092143|470024895|FG003|Overall Study|Lost to Follow-up|0|||
130473394|NCT01361711|469701098|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
130562043|NCT01092143|470024896|FG004|Overall Study|Lost to Follow-up|0|||
130473395|NCT01361711|469701098|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
130473396|NCT01361711|469701098|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
130473397|NCT01361711|469701098|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
130562044|NCT01092143|470024892|FG000|Overall Study|Consent withdrawn|2|||
130562045|NCT01092143|470024893|FG001|Overall Study|Consent withdrawn|1|||
130562046|NCT01092143|470024894|FG002|Overall Study|Consent withdrawn|0|||
130562047|NCT01092143|470024895|FG003|Overall Study|Consent withdrawn|1|||
130562048|NCT01092143|470024896|FG004|Overall Study|Consent withdrawn|3|||
130562049|NCT01092143|470024892|FG000|Overall Study|Not treated|0|||
130562050|NCT01092143|470024893|FG001|Overall Study|Not treated|0|||
130562051|NCT01092143|470024894|FG002|Overall Study|Not treated|1|||
130562052|NCT01092143|470024895|FG003|Overall Study|Not treated|0|||
130562053|NCT01092143|470024896|FG004|Overall Study|Not treated|0|||
130562054|NCT01092143|470024892|FG000|Overall Study|did not reversibility criteria|0|||
130562055|NCT01092143|470024893|FG001|Overall Study|did not reversibility criteria|0|||
130562056|NCT01092143|470024894|FG002|Overall Study|did not reversibility criteria|1|||
130562057|NCT01092143|470024895|FG003|Overall Study|did not reversibility criteria|0|||
130562058|NCT01092143|470024896|FG004|Overall Study|did not reversibility criteria|0|||
130562059|NCT01092143|470024892|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
130562060|NCT01092143|470024893|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
130562061|NCT01092143|470024894|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
130562062|NCT01092143|470024895|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
130562063|NCT01092143|470024896|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
130562064|NCT01092143|470024892|FG000|Overall Study|Ineligible patient|1|||
130562065|NCT01092143|470024893|FG001|Overall Study|Ineligible patient|0|||
130562066|NCT01092143|470024894|FG002|Overall Study|Ineligible patient|0|||
130562067|NCT01092143|470024895|FG003|Overall Study|Ineligible patient|0|||
130562068|NCT01092143|470024896|FG004|Overall Study|Ineligible patient|0|||
130409473|NCT05061446|469460054|FG001|Overall Study|Adverse Event|0|||
130409474|NCT05061446|469460055|FG002|Overall Study|Adverse Event|0|||
130409475|NCT05061446|469460053|FG000|Overall Study|Participant no longer available due to personal reason|0|||
130409476|NCT05061446|469460054|FG001|Overall Study|Participant no longer available due to personal reason|1|||
130409477|NCT05061446|469460055|FG002|Overall Study|Participant no longer available due to personal reason|0|||
130409478|NCT03880578|469460056|FG000|Overall Study|Withdrawal by Subject|0|||
130409479|NCT03880578|469460057|FG001|Overall Study|Withdrawal by Subject|3|||
130409480|NCT03880578|469460058|FG002|Overall Study|Withdrawal by Subject|1|||
130409481|NCT03880578|469460056|FG000|Overall Study|Death|0|||
130409482|NCT03880578|469460057|FG001|Overall Study|Death|1|||
130409483|NCT03880578|469460058|FG002|Overall Study|Death|0|||
130409484|NCT04934670|469460059|FG000|Overall Study|Death|4|||
130409485|NCT04934670|469460060|FG001|Overall Study|Death|0|||
130409486|NCT04934670|469460059|FG000|Overall Study|Lost to Follow-up|1|||
130409487|NCT04934670|469460060|FG001|Overall Study|Lost to Follow-up|4|||
130409488|NCT00861341|469460061|FG000|Overall Study|Withdrawal by Subject|2|||
130409489|NCT01916304|469460062|FG000|Overall Study|Screening failure|17|||
130409490|NCT03149328|469460063|FG000|Overall Study|Withdrawal by Subject|30|||
130409491|NCT03149328|469460064|FG001|Overall Study|Withdrawal by Subject|26|||
130409492|NCT03149328|469460063|FG000|Overall Study|Changed Dialysis Modality|18|||
130409493|NCT03149328|469460064|FG001|Overall Study|Changed Dialysis Modality|1|||
130473398|NCT01361711|469701098|FG000|Completed Week 18 of Treatment|Other|9|||
130473399|NCT01361711|469701098|FG000|10 Year Follow-up|Still in follow-up|22|||
130473400|NCT01361711|469701098|FG000|10 Year Follow-up|Death|7|||
130473401|NCT01361711|469701098|FG000|10 Year Follow-up|Developed new cancer|1|||
130473402|NCT01361711|469701098|FG000|10 Year Follow-up|Lost to Follow-up|2|||
130473403|NCT01361711|469701098|FG000|10 Year Follow-up|New treatment started|6|||
130473404|NCT01361711|469701098|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
130473405|NCT01361711|469701098|FG000|10 Year Follow-up|Progressive Disease|1|||
130473406|NCT02596126|469701099|FG000|Overall Study|Lost to Follow-up|12|||
130473407|NCT02596126|469701100|FG001|Overall Study|Lost to Follow-up|21|||
130473408|NCT02596126|469701099|FG000|Overall Study|Protocol Violation|7|||
130409494|NCT03149328|469460063|FG000|Overall Study|Transplant|9|||
130562069|NCT01092143|470024892|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
130562070|NCT01092143|470024893|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
130562071|NCT01092143|470024894|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
130562072|NCT01092143|470024895|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
130562073|NCT01092143|470024896|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
130562074|NCT01092143|470024892|FG000|Overall Study|Patient travel|0|||
130409495|NCT03149328|469460064|FG001|Overall Study|Transplant|1|||
130409496|NCT03149328|469460063|FG000|Overall Study|Lost to Follow-up|25|||
130409497|NCT03149328|469460064|FG001|Overall Study|Lost to Follow-up|16|||
130409498|NCT03149328|469460063|FG000|Overall Study|Left Study Site|1|||
130562075|NCT01092143|470024893|FG001|Overall Study|Patient travel|0|||
130562076|NCT01092143|470024894|FG002|Overall Study|Patient travel|0|||
130562077|NCT01092143|470024895|FG003|Overall Study|Patient travel|0|||
130562078|NCT01092143|470024896|FG004|Overall Study|Patient travel|1|||
130562079|NCT01092143|470024892|FG000|Overall Study|Non compliance with study medication|0|||
130409499|NCT03149328|469460064|FG001|Overall Study|Left Study Site|2|||
130409500|NCT03149328|469460063|FG000|Overall Study|Language Barrier|1|||
130409501|NCT03149328|469460064|FG001|Overall Study|Language Barrier|0|||
130409502|NCT02758236|469460065|FG000|Overall Study|Investigator discretion|43|||
130409503|NCT00818441|469460066|FG000|Overall Study|Death|69|||
130562080|NCT01092143|470024893|FG001|Overall Study|Non compliance with study medication|0|||
130562081|NCT01092143|470024894|FG002|Overall Study|Non compliance with study medication|0|||
130562082|NCT01092143|470024895|FG003|Overall Study|Non compliance with study medication|0|||
130562083|NCT01092143|470024896|FG004|Overall Study|Non compliance with study medication|1|||
130562084|NCT01092143|470024892|FG000|Overall Study|Randomized by mistake|0|||
130562085|NCT01092143|470024893|FG001|Overall Study|Randomized by mistake|0|||
130562086|NCT01092143|470024894|FG002|Overall Study|Randomized by mistake|0|||
130562087|NCT01092143|470024895|FG003|Overall Study|Randomized by mistake|1|||
130562088|NCT01092143|470024896|FG004|Overall Study|Randomized by mistake|0|||
130562089|NCT01092143|470024892|FG000|Overall Study|Pregnancy|0|||
130562090|NCT01092143|470024893|FG001|Overall Study|Pregnancy|0|||
130562091|NCT01092143|470024894|FG002|Overall Study|Pregnancy|0|||
130562092|NCT01092143|470024895|FG003|Overall Study|Pregnancy|1|||
130562093|NCT01092143|470024896|FG004|Overall Study|Pregnancy|0|||
130562094|NCT03986866|470024897|FG000|Overall Study|Withdrawal by Subject|0|||
130562095|NCT03986866|470024898|FG001|Overall Study|Withdrawal by Subject|3|||
130562096|NCT03986866|470024897|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
130562097|NCT03986866|470024898|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
130562098|NCT05093322|470024901|FG000|Overall Study|Death|6|||
130562099|NCT05093322|470024902|FG001|Overall Study|Death|2|||
130562100|NCT05093322|470024901|FG000|Overall Study|Other|4|||
130562101|NCT05093322|470024902|FG001|Overall Study|Other|1|||
130562102|NCT00545402|470024905|FG000|Overall Study|Discontinuation of treatment|17|||
130562103|NCT00545402|470024906|FG001|Overall Study|Discontinuation of treatment|9|||
130562104|NCT00545402|470024905|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
130562105|NCT00545402|470024906|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
130562106|NCT00545402|470024905|FG000|Overall Study|Death|5|||
130562107|NCT00545402|470024906|FG001|Overall Study|Death|7|||
130562108|NCT00545402|470024905|FG000|Overall Study|Graft loss|2|||
130562109|NCT00545402|470024906|FG001|Overall Study|Graft loss|4|||
130562110|NCT00545402|470024905|FG000|Overall Study|Withdrawal by Subject|0|||
130562111|NCT00545402|470024906|FG001|Overall Study|Withdrawal by Subject|1|||
130562112|NCT00545402|470024905|FG000|Overall Study|Protocol Violation|1|||
130562113|NCT00545402|470024906|FG001|Overall Study|Protocol Violation|0|||
130562114|NCT00545402|470024905|FG000|Overall Study|Reason not specified|1|||
130562115|NCT00545402|470024906|FG001|Overall Study|Reason not specified|1|||
130562116|NCT00555477|470024907|FG000|Overall Study|Adverse Event|0|||
130562117|NCT00555477|470024908|FG001|Overall Study|Adverse Event|9|||
130562118|NCT00555477|470024907|FG000|Overall Study|Withdrawal by Subject|1|||
130562119|NCT00555477|470024908|FG001|Overall Study|Withdrawal by Subject|2|||
130562120|NCT00555477|470024907|FG000|Overall Study|Physician Decision|1|||
130562121|NCT00555477|470024908|FG001|Overall Study|Physician Decision|2|||
130562122|NCT01721876|470024909|FG000|Overall Study|Not treated|1|||
130562123|NCT01721876|470024910|FG001|Overall Study|Not treated|4|||
130562124|NCT01721876|470024909|FG000|Overall Study|Disease progression / relapse|123|||
130562125|NCT01721876|470024910|FG001|Overall Study|Disease progression / relapse|156|||
130562126|NCT01721876|470024909|FG000|Overall Study|Death|6|||
130562127|NCT01721876|470024910|FG001|Overall Study|Death|13|||
130562128|NCT01721876|470024909|FG000|Overall Study|Adverse Event|41|||
130562129|NCT01721876|470024910|FG001|Overall Study|Adverse Event|165|||
130562130|NCT01721876|470024909|FG000|Overall Study|Protocol Violation|2|||
130562131|NCT01721876|470024910|FG001|Overall Study|Protocol Violation|1|||
130562132|NCT01721876|470024909|FG000|Overall Study|Withdrawal by Subject|15|||
130562133|NCT01721876|470024910|FG001|Overall Study|Withdrawal by Subject|38|||
130562134|NCT01721876|470024909|FG000|Overall Study|Reason not listed|34|||
130562135|NCT01721876|470024910|FG001|Overall Study|Reason not listed|63|||
130562136|NCT01721876|470024909|FG000|Overall Study|Sponsor terminated trial|0|||
130562137|NCT01721876|470024910|FG001|Overall Study|Sponsor terminated trial|4|||
130562138|NCT01721057|470024913|FG000|Treatment Period|Withdrawal by Subject|11|||
130409504|NCT00818441|469460067|FG001|Overall Study|Death|26|||
130562139|NCT01721057|470024914|FG001|Treatment Period|Withdrawal by Subject|5|||
130562140|NCT01721057|470024915|FG002|Treatment Period|Withdrawal by Subject|8|||
130562141|NCT01721057|470024916|FG003|Treatment Period|Withdrawal by Subject|0|||
130562142|NCT01721057|470024917|FG004|Treatment Period|Withdrawal by Subject|0|||
130562143|NCT01721057|470024918|FG005|Treatment Period|Withdrawal by Subject|0|||
130562144|NCT01721057|470024919|FG006|Treatment Period|Withdrawal by Subject|0|||
130409505|NCT00818441|469460066|FG000|Overall Study|Other|5|||
130562145|NCT01721057|470024913|FG000|Treatment Period|Adverse Event|7|||
130409506|NCT00818441|469460067|FG001|Overall Study|Other|0|||
130409507|NCT00818441|469460066|FG000|Overall Study|Lost to Follow-up|2|||
130409508|NCT00818441|469460067|FG001|Overall Study|Lost to Follow-up|1|||
130562146|NCT01721057|470024914|FG001|Treatment Period|Adverse Event|10|||
130562147|NCT01721057|470024915|FG002|Treatment Period|Adverse Event|12|||
130562148|NCT01721057|470024916|FG003|Treatment Period|Adverse Event|0|||
130409509|NCT00818441|469460066|FG000|Overall Study|Withdrawal by Subject|2|||
130409510|NCT00818441|469460067|FG001|Overall Study|Withdrawal by Subject|0|||
130409511|NCT00818441|469460066|FG000|Overall Study|Adverse Event|0|||
130409512|NCT00818441|469460067|FG001|Overall Study|Adverse Event|1|||
130409513|NCT00818441|469460066|FG000|Overall Study|Study terminated by sponsor|11|||
130409514|NCT00818441|469460067|FG001|Overall Study|Study terminated by sponsor|2|||
130409515|NCT03136068|469461520|FG000|Overall Study|Lost to Follow-up|1|||
130409516|NCT03136068|469461521|FG001|Overall Study|Lost to Follow-up|1|||
130409517|NCT03136068|469461520|FG000|Overall Study|Protocol Violation|1|||
130409518|NCT03136068|469461521|FG001|Overall Study|Protocol Violation|0|||
130409519|NCT00432380|469461527|FG000|Overall Study|Migrated/moved from study area|3|||
130409520|NCT00432380|469461528|FG001|Overall Study|Migrated/moved from study area|4|||
130409521|NCT00432380|469461529|FG002|Overall Study|Migrated/moved from study area|1|||
130562149|NCT01721057|470024917|FG004|Treatment Period|Adverse Event|0|||
130562150|NCT01721057|470024918|FG005|Treatment Period|Adverse Event|0|||
130562151|NCT01721057|470024919|FG006|Treatment Period|Adverse Event|0|||
130562152|NCT01721057|470024913|FG000|Treatment Period|Lack of Efficacy|7|||
130562153|NCT01721057|470024914|FG001|Treatment Period|Lack of Efficacy|3|||
130562154|NCT01721057|470024915|FG002|Treatment Period|Lack of Efficacy|0|||
130562155|NCT01721057|470024916|FG003|Treatment Period|Lack of Efficacy|0|||
130562156|NCT01721057|470024917|FG004|Treatment Period|Lack of Efficacy|0|||
130562157|NCT01721057|470024918|FG005|Treatment Period|Lack of Efficacy|0|||
130562158|NCT01721057|470024919|FG006|Treatment Period|Lack of Efficacy|0|||
130562159|NCT01721057|470024913|FG000|Treatment Period|Lost to Follow-up|1|||
130562160|NCT01721057|470024914|FG001|Treatment Period|Lost to Follow-up|0|||
130562161|NCT01721057|470024915|FG002|Treatment Period|Lost to Follow-up|0|||
130562162|NCT01721057|470024916|FG003|Treatment Period|Lost to Follow-up|0|||
130562163|NCT01721057|470024917|FG004|Treatment Period|Lost to Follow-up|0|||
130562164|NCT01721057|470024918|FG005|Treatment Period|Lost to Follow-up|0|||
130562165|NCT01721057|470024919|FG006|Treatment Period|Lost to Follow-up|0|||
130562166|NCT01721057|470024913|FG000|Treatment Period|Physician Decision|0|||
130562167|NCT01721057|470024914|FG001|Treatment Period|Physician Decision|1|||
130562168|NCT01721057|470024915|FG002|Treatment Period|Physician Decision|3|||
130562169|NCT01721057|470024916|FG003|Treatment Period|Physician Decision|0|||
130562170|NCT01721057|470024917|FG004|Treatment Period|Physician Decision|0|||
130562171|NCT01721057|470024918|FG005|Treatment Period|Physician Decision|0|||
130562172|NCT01721057|470024919|FG006|Treatment Period|Physician Decision|0|||
130727034|NCT02883049|470625426|FG002|Induction|Identified as VHR at end of Induction|0|||
130727035|NCT02883049|470625427|FG003|Induction|Identified as VHR at end of Induction|0|||
130727036|NCT02883049|470625428|FG004|Induction|Identified as VHR at end of Induction|0|||
130727037|NCT02883049|470625429|FG005|Induction|Identified as VHR at end of Induction|0|||
130727038|NCT02883049|470625430|FG006|Induction|Identified as VHR at end of Induction|0|||
130727039|NCT02883049|470625431|FG007|Induction|Identified as VHR at end of Induction|0|||
130727040|NCT02883049|470625432|FG008|Induction|Identified as VHR at end of Induction|0|||
130727041|NCT02883049|470625433|FG009|Induction|Identified as VHR at end of Induction|0|||
130727042|NCT02883049|470625434|FG010|Induction|Identified as VHR at end of Induction|0|||
130727043|NCT02883049|470625435|FG011|Induction|Identified as VHR at end of Induction|0|||
130727044|NCT02883049|470625436|FG012|Induction|Identified as VHR at end of Induction|0|||
130727045|NCT02883049|470625437|FG013|Induction|Identified as VHR at end of Induction|0|||
130727046|NCT02883049|470625438|FG014|Induction|Identified as VHR at end of Induction|0|||
130727047|NCT02883049|470625439|FG015|Induction|Identified as VHR at end of Induction|0|||
130727048|NCT02883049|470625424|FG000|Induction|Moved to another non-COG institution|3|||
130562173|NCT01721057|470024913|FG000|Treatment Period|Death|2|||
130562174|NCT01721057|470024914|FG001|Treatment Period|Death|0|||
130727049|NCT02883049|470625425|FG001|Induction|Moved to another non-COG institution|0|||
130727050|NCT02883049|470625426|FG002|Induction|Moved to another non-COG institution|0|||
130727051|NCT02883049|470625427|FG003|Induction|Moved to another non-COG institution|0|||
130727052|NCT02883049|470625428|FG004|Induction|Moved to another non-COG institution|0|||
130562175|NCT01721057|470024915|FG002|Treatment Period|Death|0|||
130562176|NCT01721057|470024916|FG003|Treatment Period|Death|0|||
130409522|NCT00432380|469461527|FG000|Overall Study|Adverse Event|1|||
130409523|NCT00432380|469461528|FG001|Overall Study|Adverse Event|0|||
130409524|NCT00432380|469461529|FG002|Overall Study|Adverse Event|0|||
130562177|NCT01721057|470024917|FG004|Treatment Period|Death|0|||
130562178|NCT01721057|470024918|FG005|Treatment Period|Death|0|||
130562179|NCT01721057|470024919|FG006|Treatment Period|Death|0|||
130562180|NCT01721057|470024913|FG000|Rescue Period|Adverse Event|0|||
130562181|NCT01721057|470024914|FG001|Rescue Period|Adverse Event|0|||
130562182|NCT01721057|470024915|FG002|Rescue Period|Adverse Event|0|||
130409525|NCT02627677|469461530|FG000|Overall Study|Adverse event (not progressive disease)|1|||
130409526|NCT02627677|469461531|FG001|Overall Study|Adverse event (not progressive disease)|4|||
130409527|NCT02627677|469461532|FG002|Overall Study|Adverse event (not progressive disease)|1|||
130409528|NCT02627677|469461530|FG000|Overall Study|Progressive disease|1|||
130409529|NCT02627677|469461531|FG001|Overall Study|Progressive disease|3|||
130409530|NCT02627677|469461532|FG002|Overall Study|Progressive disease|0|||
130409531|NCT02627677|469461530|FG000|Overall Study|Lack of Efficacy|1|||
130409532|NCT02627677|469461531|FG001|Overall Study|Lack of Efficacy|2|||
130409533|NCT02627677|469461532|FG002|Overall Study|Lack of Efficacy|0|||
130409534|NCT02627677|469461530|FG000|Overall Study|Lost to Follow-up|0|||
130409535|NCT02627677|469461531|FG001|Overall Study|Lost to Follow-up|0|||
130409536|NCT02627677|469461532|FG002|Overall Study|Lost to Follow-up|1|||
130409537|NCT02627677|469461530|FG000|Overall Study|Pregnancy|0|||
130409538|NCT02627677|469461531|FG001|Overall Study|Pregnancy|1|||
130409539|NCT02627677|469461532|FG002|Overall Study|Pregnancy|0|||
130409540|NCT02627677|469461530|FG000|Overall Study|Study Terminated by Sponsor|5|||
130409541|NCT02627677|469461531|FG001|Overall Study|Study Terminated by Sponsor|10|||
130409542|NCT02627677|469461532|FG002|Overall Study|Study Terminated by Sponsor|6|||
130409543|NCT02627677|469461530|FG000|Overall Study|Physician Decision|0|||
130409544|NCT02627677|469461531|FG001|Overall Study|Physician Decision|0|||
130409545|NCT02627677|469461532|FG002|Overall Study|Physician Decision|2|||
130409546|NCT02627677|469461530|FG000|Overall Study|Withdrawal by Subject|2|||
130409547|NCT02627677|469461531|FG001|Overall Study|Withdrawal by Subject|1|||
130409548|NCT02627677|469461532|FG002|Overall Study|Withdrawal by Subject|1|||
130409549|NCT02627677|469461530|FG000|Overall Study|Reason not Specified|0|||
130409550|NCT02627677|469461531|FG001|Overall Study|Reason not Specified|0|||
130409551|NCT02627677|469461532|FG002|Overall Study|Reason not Specified|1|||
130409552|NCT02627677|469461530|FG000|Overall Study|Randomized but not Treated|1|||
130409553|NCT02627677|469461531|FG001|Overall Study|Randomized but not Treated|0|||
130409554|NCT02627677|469461532|FG002|Overall Study|Randomized but not Treated|0|||
130409555|NCT02044510|469461533|FG000|Overall Study|Adverse Event|1|||
130409556|NCT02044510|469461534|FG001|Overall Study|Adverse Event|2|||
130409557|NCT00581945|469461537|FG000|Overall Study|Adverse Event|4|||
130409558|NCT00581945|469461538|FG001|Overall Study|Adverse Event|4|||
130409559|NCT00581945|469461537|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130409560|NCT00581945|469461538|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130409561|NCT00581945|469461537|FG000|Overall Study|Withdrawal by Subject|2|||
130409562|NCT00581945|469461538|FG001|Overall Study|Withdrawal by Subject|6|||
130409563|NCT00581945|469461537|FG000|Overall Study|Death|1|||
130409564|NCT00581945|469461538|FG001|Overall Study|Death|0|||
130409565|NCT00587587|469461541|FG000|Overall Study|Lost to Follow-up|6|||
130409566|NCT00587587|469461542|FG001|Overall Study|Lost to Follow-up|1|||
130409567|NCT01933334|469461546|FG000|Overall Study|Adverse Event|5|||
130409568|NCT01933334|469461547|FG001|Overall Study|Adverse Event|1|||
130409569|NCT01933334|469461546|FG000|Overall Study|Withdrawal by Subject|0|||
130409570|NCT01933334|469461547|FG001|Overall Study|Withdrawal by Subject|1|||
130409571|NCT02032901|469461548|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
130409572|NCT02032901|469461549|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
130409573|NCT02032901|469461548|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
130409574|NCT02032901|469461549|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
130409575|NCT01722331|469461550|FG000|Part 1|Adverse Event|5|||
130409576|NCT01722331|469461551|FG001|Part 1|Adverse Event|0|||
130409577|NCT01722331|469461552|FG002|Part 1|Adverse Event|0|||
130409578|NCT01722331|469461553|FG003|Part 1|Adverse Event|0|||
130409579|NCT01722331|469461554|FG004|Part 1|Adverse Event|0|||
130409580|NCT01722331|469461555|FG005|Part 1|Adverse Event|0|||
130409581|NCT01722331|469461556|FG006|Part 1|Adverse Event|0|||
130409582|NCT01722331|469461550|FG000|Part 1|Lack of Efficacy|0|||
130409583|NCT01722331|469461551|FG001|Part 1|Lack of Efficacy|0|||
130409584|NCT01722331|469461552|FG002|Part 1|Lack of Efficacy|1|||
130409585|NCT01722331|469461553|FG003|Part 1|Lack of Efficacy|0|||
130409586|NCT01722331|469461554|FG004|Part 1|Lack of Efficacy|2|||
130409587|NCT01722331|469461555|FG005|Part 1|Lack of Efficacy|0|||
130409588|NCT01722331|469461556|FG006|Part 1|Lack of Efficacy|0|||
130409589|NCT01722331|469461550|FG000|Part 1|Lost to Follow-up|1|||
130409590|NCT01722331|469461551|FG001|Part 1|Lost to Follow-up|0|||
130409591|NCT01722331|469461552|FG002|Part 1|Lost to Follow-up|2|||
130409592|NCT01722331|469461553|FG003|Part 1|Lost to Follow-up|0|||
130409593|NCT01722331|469461554|FG004|Part 1|Lost to Follow-up|1|||
130409594|NCT01722331|469461555|FG005|Part 1|Lost to Follow-up|0|||
130409595|NCT01722331|469461556|FG006|Part 1|Lost to Follow-up|0|||
130409596|NCT01722331|469461550|FG000|Part 1|Physician Decision|0|||
130409597|NCT01722331|469461551|FG001|Part 1|Physician Decision|0|||
130409598|NCT01722331|469461552|FG002|Part 1|Physician Decision|3|||
130409599|NCT01722331|469461553|FG003|Part 1|Physician Decision|0|||
130409600|NCT01722331|469461554|FG004|Part 1|Physician Decision|1|||
130409601|NCT01722331|469461555|FG005|Part 1|Physician Decision|0|||
130409602|NCT01722331|469461556|FG006|Part 1|Physician Decision|0|||
130409603|NCT01722331|469461550|FG000|Part 1|Pregnancy|1|||
130409604|NCT01722331|469461551|FG001|Part 1|Pregnancy|0|||
130409605|NCT01722331|469461552|FG002|Part 1|Pregnancy|0|||
130727053|NCT02883049|470625429|FG005|Induction|Moved to another non-COG institution|0|||
130727054|NCT02883049|470625430|FG006|Induction|Moved to another non-COG institution|0|||
130727055|NCT02883049|470625431|FG007|Induction|Moved to another non-COG institution|0|||
130727056|NCT02883049|470625432|FG008|Induction|Moved to another non-COG institution|0|||
130727057|NCT02883049|470625433|FG009|Induction|Moved to another non-COG institution|0|||
130562183|NCT01721057|470024916|FG003|Rescue Period|Adverse Event|1|||
130562184|NCT01721057|470024917|FG004|Rescue Period|Adverse Event|0|||
130727058|NCT02883049|470625434|FG010|Induction|Moved to another non-COG institution|0|||
130727059|NCT02883049|470625435|FG011|Induction|Moved to another non-COG institution|0|||
130727060|NCT02883049|470625436|FG012|Induction|Moved to another non-COG institution|0|||
130727061|NCT02883049|470625437|FG013|Induction|Moved to another non-COG institution|0|||
130727062|NCT02883049|470625438|FG014|Induction|Moved to another non-COG institution|0|||
130727063|NCT02883049|470625439|FG015|Induction|Moved to another non-COG institution|0|||
130727064|NCT02883049|470625424|FG000|Induction|Randomization closed|41|||
130727065|NCT02883049|470625425|FG001|Induction|Randomization closed|0|||
130727066|NCT02883049|470625426|FG002|Induction|Randomization closed|0|||
130727067|NCT02883049|470625427|FG003|Induction|Randomization closed|0|||
130727068|NCT02883049|470625428|FG004|Induction|Randomization closed|0|||
130727069|NCT02883049|470625429|FG005|Induction|Randomization closed|0|||
130727070|NCT02883049|470625430|FG006|Induction|Randomization closed|0|||
130727071|NCT02883049|470625431|FG007|Induction|Randomization closed|0|||
130727072|NCT02883049|470625432|FG008|Induction|Randomization closed|0|||
130727073|NCT02883049|470625433|FG009|Induction|Randomization closed|0|||
130727074|NCT02883049|470625434|FG010|Induction|Randomization closed|0|||
130727075|NCT02883049|470625435|FG011|Induction|Randomization closed|0|||
130727076|NCT02883049|470625436|FG012|Induction|Randomization closed|0|||
130727077|NCT02883049|470625437|FG013|Induction|Randomization closed|0|||
130727078|NCT02883049|470625438|FG014|Induction|Randomization closed|0|||
130727079|NCT02883049|470625439|FG015|Induction|Randomization closed|0|||
130727080|NCT02883049|470625424|FG000|Induction|MRD negative|36|||
130727081|NCT02883049|470625425|FG001|Induction|MRD negative|0|||
130727082|NCT02883049|470625426|FG002|Induction|MRD negative|0|||
130727083|NCT02883049|470625427|FG003|Induction|MRD negative|0|||
130727084|NCT02883049|470625428|FG004|Induction|MRD negative|0|||
130727085|NCT02883049|470625429|FG005|Induction|MRD negative|0|||
130727086|NCT02883049|470625430|FG006|Induction|MRD negative|0|||
130727087|NCT02883049|470625431|FG007|Induction|MRD negative|0|||
130727088|NCT02883049|470625432|FG008|Induction|MRD negative|0|||
130727089|NCT02883049|470625433|FG009|Induction|MRD negative|0|||
130727090|NCT02883049|470625434|FG010|Induction|MRD negative|0|||
130727091|NCT02883049|470625435|FG011|Induction|MRD negative|0|||
130727092|NCT02883049|470625436|FG012|Induction|MRD negative|0|||
130727093|NCT02883049|470625437|FG013|Induction|MRD negative|0|||
130727094|NCT02883049|470625438|FG014|Induction|MRD negative|0|||
130727095|NCT02883049|470625439|FG015|Induction|MRD negative|0|||
130727096|NCT02883049|470625424|FG000|Induction|Identified as HR patients|165|||
130727097|NCT02883049|470625425|FG001|Induction|Identified as HR patients|0|||
130727098|NCT02883049|470625426|FG002|Induction|Identified as HR patients|0|||
130727099|NCT02883049|470625427|FG003|Induction|Identified as HR patients|0|||
130727100|NCT02883049|470625428|FG004|Induction|Identified as HR patients|0|||
130727101|NCT02883049|470625429|FG005|Induction|Identified as HR patients|0|||
130727102|NCT02883049|470625430|FG006|Induction|Identified as HR patients|0|||
130727103|NCT02883049|470625431|FG007|Induction|Identified as HR patients|0|||
130727104|NCT02883049|470625432|FG008|Induction|Identified as HR patients|0|||
130727105|NCT02883049|470625433|FG009|Induction|Identified as HR patients|0|||
130727106|NCT02883049|470625434|FG010|Induction|Identified as HR patients|0|||
130727107|NCT02883049|470625435|FG011|Induction|Identified as HR patients|0|||
130727108|NCT02883049|470625436|FG012|Induction|Identified as HR patients|0|||
130727109|NCT02883049|470625437|FG013|Induction|Identified as HR patients|0|||
130727110|NCT02883049|470625438|FG014|Induction|Identified as HR patients|0|||
130727111|NCT02883049|470625439|FG015|Induction|Identified as HR patients|0|||
130727112|NCT02883049|470625424|FG000|Induction|Developed SMN|0|||
130562185|NCT01721057|470024918|FG005|Rescue Period|Adverse Event|0|||
130562186|NCT01721057|470024919|FG006|Rescue Period|Adverse Event|0|||
130562187|NCT01721057|470024913|FG000|Rescue Period|Lack of Efficacy|0|||
130562188|NCT01721057|470024914|FG001|Rescue Period|Lack of Efficacy|0|||
130562189|NCT01721057|470024915|FG002|Rescue Period|Lack of Efficacy|0|||
130562190|NCT01721057|470024916|FG003|Rescue Period|Lack of Efficacy|2|||
130562191|NCT01721057|470024917|FG004|Rescue Period|Lack of Efficacy|0|||
130562192|NCT01721057|470024918|FG005|Rescue Period|Lack of Efficacy|0|||
130562193|NCT01721057|470024919|FG006|Rescue Period|Lack of Efficacy|0|||
130562194|NCT01202279|470024920|FG000|Overall Study|Adverse Event|8|||
130562195|NCT01202279|470024921|FG001|Overall Study|Adverse Event|6|||
130562196|NCT01202279|470024920|FG000|Overall Study|Withdrawal by Subject|13|||
130562197|NCT01202279|470024921|FG001|Overall Study|Withdrawal by Subject|10|||
130727113|NCT02883049|470625425|FG001|Induction|Developed SMN|1|||
130727114|NCT02883049|470625426|FG002|Induction|Developed SMN|0|||
130727115|NCT02883049|470625427|FG003|Induction|Developed SMN|0|||
130727116|NCT02883049|470625428|FG004|Induction|Developed SMN|0|||
130727117|NCT02883049|470625429|FG005|Induction|Developed SMN|0|||
130562198|NCT01202279|470024920|FG000|Overall Study|Physician Decision|0|||
130562199|NCT01202279|470024921|FG001|Overall Study|Physician Decision|1|||
130562200|NCT01202279|470024920|FG000|Overall Study|Lost to Follow-up|10|||
130562201|NCT01202279|470024921|FG001|Overall Study|Lost to Follow-up|7|||
130562202|NCT01202279|470024920|FG000|Overall Study|Protocol Violation|1|||
130562203|NCT01202279|470024921|FG001|Overall Study|Protocol Violation|1|||
130562204|NCT01202279|470024920|FG000|Overall Study|study compliance|5|||
130562205|NCT01202279|470024921|FG001|Overall Study|study compliance|2|||
130562206|NCT01177683|470024922|FG000|Study Treatment|Disease Progressions during treatment|2|||
130562207|NCT01177683|470024923|FG001|Study Treatment|Disease Progressions during treatment|0|||
130562208|NCT01177683|470024924|FG002|Study Treatment|Disease Progressions during treatment|3|||
130562209|NCT01177683|470024922|FG000|Study Treatment|Adverse Event|0|||
130562210|NCT01177683|470024923|FG001|Study Treatment|Adverse Event|1|||
130562211|NCT01177683|470024924|FG002|Study Treatment|Adverse Event|12|||
130562212|NCT01177683|470024922|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130562213|NCT01177683|470024923|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
130562214|NCT01177683|470024924|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130562215|NCT01177683|470024922|FG000|Study Treatment|Alternative therapy|0|||
130562216|NCT01177683|470024923|FG001|Study Treatment|Alternative therapy|0|||
130562217|NCT01177683|470024924|FG002|Study Treatment|Alternative therapy|4|||
130562218|NCT01177683|470024922|FG000|Study Treatment|Physician Decision|1|||
130562219|NCT01177683|470024923|FG001|Study Treatment|Physician Decision|0|||
130562220|NCT01177683|470024924|FG002|Study Treatment|Physician Decision|1|||
130562221|NCT01177683|470024922|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
130562222|NCT01177683|470024923|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
130562223|NCT01177683|470024924|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
130562224|NCT01177683|470024922|FG000|Study Treatment|Symptomatic Deterioration|0|||
130562225|NCT01177683|470024923|FG001|Study Treatment|Symptomatic Deterioration|0|||
130562226|NCT01177683|470024924|FG002|Study Treatment|Symptomatic Deterioration|1|||
130562227|NCT01177683|470024922|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
130562228|NCT01177683|470024923|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
130562229|NCT01177683|470024924|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
130727118|NCT02883049|470625430|FG006|Induction|Developed SMN|0|||
130727119|NCT02883049|470625431|FG007|Induction|Developed SMN|0|||
130727120|NCT02883049|470625432|FG008|Induction|Developed SMN|0|||
130727121|NCT02883049|470625433|FG009|Induction|Developed SMN|0|||
130727122|NCT02883049|470625434|FG010|Induction|Developed SMN|0|||
130727123|NCT02883049|470625435|FG011|Induction|Developed SMN|0|||
130409606|NCT01722331|469461553|FG003|Part 1|Pregnancy|0|||
130409607|NCT01722331|469461554|FG004|Part 1|Pregnancy|0|||
130409608|NCT01722331|469461555|FG005|Part 1|Pregnancy|0|||
130409609|NCT01722331|469461556|FG006|Part 1|Pregnancy|0|||
130409610|NCT01722331|469461550|FG000|Part 1|Progressive Disease|0|||
130409611|NCT01722331|469461551|FG001|Part 1|Progressive Disease|0|||
130409612|NCT01722331|469461552|FG002|Part 1|Progressive Disease|0|||
130409613|NCT01722331|469461553|FG003|Part 1|Progressive Disease|0|||
130409614|NCT01722331|469461554|FG004|Part 1|Progressive Disease|1|||
130409615|NCT01722331|469461555|FG005|Part 1|Progressive Disease|0|||
130409616|NCT01722331|469461556|FG006|Part 1|Progressive Disease|0|||
130409617|NCT01722331|469461550|FG000|Part 1|Protocol Violation|1|||
130409618|NCT01722331|469461551|FG001|Part 1|Protocol Violation|0|||
130409619|NCT01722331|469461552|FG002|Part 1|Protocol Violation|0|||
130409620|NCT01722331|469461553|FG003|Part 1|Protocol Violation|0|||
130409621|NCT01722331|469461554|FG004|Part 1|Protocol Violation|1|||
130409622|NCT01722331|469461555|FG005|Part 1|Protocol Violation|0|||
130409623|NCT01722331|469461556|FG006|Part 1|Protocol Violation|0|||
130409624|NCT01722331|469461550|FG000|Part 1|Withdrawal by Subject|2|||
130409625|NCT01722331|469461551|FG001|Part 1|Withdrawal by Subject|0|||
130409626|NCT01722331|469461552|FG002|Part 1|Withdrawal by Subject|3|||
130409627|NCT01722331|469461553|FG003|Part 1|Withdrawal by Subject|0|||
130409628|NCT01722331|469461554|FG004|Part 1|Withdrawal by Subject|3|||
130409629|NCT01722331|469461555|FG005|Part 1|Withdrawal by Subject|0|||
130409630|NCT01722331|469461556|FG006|Part 1|Withdrawal by Subject|0|||
130409631|NCT01722331|469461550|FG000|Part 2|Adverse Event|3|||
130409632|NCT01722331|469461551|FG001|Part 2|Adverse Event|0|||
130409633|NCT01722331|469461552|FG002|Part 2|Adverse Event|0|||
130409634|NCT01722331|469461553|FG003|Part 2|Adverse Event|0|||
130409635|NCT01722331|469461554|FG004|Part 2|Adverse Event|0|||
130409636|NCT01722331|469461555|FG005|Part 2|Adverse Event|1|||
130409637|NCT01722331|469461556|FG006|Part 2|Adverse Event|0|||
130409638|NCT01722331|469461550|FG000|Part 2|Lack of Efficacy|3|||
130409639|NCT01722331|469461551|FG001|Part 2|Lack of Efficacy|0|||
130409640|NCT01722331|469461552|FG002|Part 2|Lack of Efficacy|11|||
130409641|NCT01722331|469461553|FG003|Part 2|Lack of Efficacy|0|||
130409642|NCT01722331|469461554|FG004|Part 2|Lack of Efficacy|0|||
130409643|NCT01722331|469461555|FG005|Part 2|Lack of Efficacy|3|||
130409644|NCT01722331|469461556|FG006|Part 2|Lack of Efficacy|3|||
130409645|NCT01722331|469461550|FG000|Part 2|Lost to Follow-up|0|||
130409646|NCT01722331|469461551|FG001|Part 2|Lost to Follow-up|0|||
130409647|NCT01722331|469461552|FG002|Part 2|Lost to Follow-up|3|||
130562230|NCT01177683|470024922|FG000|Follow up|Patient lost to follow up|0|||
130562231|NCT01177683|470024923|FG001|Follow up|Patient lost to follow up|0|||
130562232|NCT01177683|470024924|FG002|Follow up|Patient lost to follow up|2|||
130562233|NCT01177683|470024922|FG000|Follow up|Death|2|||
130562234|NCT01177683|470024923|FG001|Follow up|Death|1|||
130562235|NCT01177683|470024924|FG002|Follow up|Death|7|||
130562236|NCT01177683|470024922|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
130562237|NCT01177683|470024923|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
130562238|NCT01177683|470024924|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
130562239|NCT00682448|470026298|FG000|Overall Study|Adverse Event|1|||
130562240|NCT00682448|470026299|FG001|Overall Study|Adverse Event|2|||
130562241|NCT00682448|470026298|FG000|Overall Study|Lack of Efficacy|1|||
130562242|NCT00682448|470026299|FG001|Overall Study|Lack of Efficacy|0|||
130562243|NCT00682448|470026298|FG000|Overall Study|Lost to Follow-up|1|||
130562244|NCT00682448|470026299|FG001|Overall Study|Lost to Follow-up|3|||
130562245|NCT00682448|470026298|FG000|Overall Study|Pregnancy|0|||
130562246|NCT00682448|470026299|FG001|Overall Study|Pregnancy|1|||
130562247|NCT00682448|470026298|FG000|Overall Study|Withdrawal by Subject|2|||
130562248|NCT00682448|470026299|FG001|Overall Study|Withdrawal by Subject|0|||
130562249|NCT00257166|470026303|FG000|Overall Study|Adverse Event|18|||
130562250|NCT00257166|470026304|FG001|Overall Study|Adverse Event|13|||
130562251|NCT00257166|470026303|FG000|Overall Study|Laboratory abnormality|1|||
130562252|NCT00257166|470026304|FG001|Overall Study|Laboratory abnormality|0|||
130562253|NCT00257166|470026303|FG000|Overall Study|Lost to Follow-up|8|||
130562254|NCT00257166|470026304|FG001|Overall Study|Lost to Follow-up|1|||
130562255|NCT00257166|470026303|FG000|Overall Study|Withdrawal by Subject|9|||
130562256|NCT00257166|470026304|FG001|Overall Study|Withdrawal by Subject|2|||
130562257|NCT00257166|470026303|FG000|Overall Study|Other|16|||
130562258|NCT00257166|470026304|FG001|Overall Study|Other|21|||
130562259|NCT00257166|470026303|FG000|Overall Study|Randomized, but not treated|1|||
130562260|NCT00257166|470026304|FG001|Overall Study|Randomized, but not treated|0|||
130562261|NCT02737852|470026307|FG000|Overall Study|Withdrawal by Subject|2|||
130562262|NCT00525044|470026308|FG000|Overall Study|Lost to Follow-up|0|||
130562263|NCT00525044|470026309|FG001|Overall Study|Lost to Follow-up|1|||
130562264|NCT04042740|470026311|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
130562265|NCT04042740|470026311|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
130562266|NCT02713542|470026315|FG000|Overall Study|Use of prohibited medication|14|||
130562267|NCT02713542|470026316|FG001|Overall Study|Use of prohibited medication|5|||
130562268|NCT02713542|470026315|FG000|Overall Study|Withdrawal by Subject|4|||
130562269|NCT02713542|470026316|FG001|Overall Study|Withdrawal by Subject|1|||
130562270|NCT00066742|470026317|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
130562271|NCT00066742|470026317|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
130562272|NCT00066742|470026317|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
130562273|NCT00066742|470026317|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
130562274|NCT00066742|470026317|FG000|Induction Chemoradiotherapy|Ineligible|3|||
130562275|NCT00066742|470026317|FG000|Consolidation Chemotherapy|not protocol specified|1|||
130562276|NCT00066742|470026317|FG000|Consolidation Chemotherapy|Ineligible|2|||
130562277|NCT00359021|470026318|FG000|Overall Study|Adverse Event|26|||
130562278|NCT00359021|470026319|FG001|Overall Study|Adverse Event|8|||
130562279|NCT00359021|470026318|FG000|Overall Study|Subject Non-Compliant|1|||
130562280|NCT00359021|470026319|FG001|Overall Study|Subject Non-Compliant|2|||
130562281|NCT00359021|470026318|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
130562282|NCT00359021|470026319|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
130562283|NCT00359021|470026318|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
130562284|NCT00359021|470026319|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
130562285|NCT00359021|470026318|FG000|Overall Study|Withdrawal by Subject|2|||
130562286|NCT00359021|470026319|FG001|Overall Study|Withdrawal by Subject|9|||
130562287|NCT00359021|470026318|FG000|Overall Study|Lost to Follow-up|1|||
130562288|NCT00359021|470026319|FG001|Overall Study|Lost to Follow-up|0|||
130562289|NCT00359021|470026318|FG000|Overall Study|Other|4|||
130562290|NCT00359021|470026319|FG001|Overall Study|Other|1|||
130562291|NCT00359021|470026318|FG000|Overall Study|Pregnancy|1|||
130562292|NCT00359021|470026319|FG001|Overall Study|Pregnancy|0|||
130562293|NCT02161575|470026320|FG000|Overall Study|Protocol Violation|8|||
130562294|NCT02161575|470026320|FG000|Overall Study|Lack of Efficacy|1|||
130562295|NCT02161575|470026320|FG000|Overall Study|Adverse Event|2|||
130562296|NCT00702325|470026324|FG000|Overall Study|Adverse Event|1|||
130562297|NCT00702325|470026325|FG001|Overall Study|Adverse Event|0|||
130562298|NCT00702325|470026324|FG000|Overall Study|Withdrawal by Subject|7|||
130562299|NCT00702325|470026325|FG001|Overall Study|Withdrawal by Subject|7|||
130562300|NCT00702325|470026324|FG000|Overall Study|Lost to Follow-up|3|||
130562301|NCT00702325|470026325|FG001|Overall Study|Lost to Follow-up|4|||
130562302|NCT00702325|470026324|FG000|Overall Study|Incorrect enrollment|5|||
130562303|NCT00702325|470026325|FG001|Overall Study|Incorrect enrollment|7|||
130562304|NCT00702325|470026324|FG000|Overall Study|Developed study discontinuation criteria|18|||
130562305|NCT00702325|470026325|FG001|Overall Study|Developed study discontinuation criteria|28|||
130562306|NCT00702325|470026324|FG000|Overall Study|Severe noncompliance to protocol|3|||
130562307|NCT00702325|470026325|FG001|Overall Study|Severe noncompliance to protocol|3|||
130562308|NCT00702325|470026324|FG000|Overall Study|Termination due to lab results|1|||
130562309|NCT00702325|470026325|FG001|Overall Study|Termination due to lab results|0|||
130562310|NCT00702325|470026324|FG000|Overall Study|Didn't follow study medication dosage|0|||
130562311|NCT00702325|470026325|FG001|Overall Study|Didn't follow study medication dosage|2|||
130562312|NCT00702325|470026324|FG000|Overall Study|Withdrew consent|0|||
130562313|NCT00702325|470026325|FG001|Overall Study|Withdrew consent|1|||
130562314|NCT00702325|470026324|FG000|Overall Study|Incorrectly Discontinued|0|||
130562315|NCT00702325|470026325|FG001|Overall Study|Incorrectly Discontinued|1|||
130562316|NCT01022502|470026329|FG000|Overall Study|Adverse Event|1|||
130562317|NCT01022502|470026329|FG000|Overall Study|employment related reasons|1|||
130562318|NCT01022502|470026329|FG000|Overall Study|Withdrawal by Subject|1|||
130562319|NCT03716050|470026330|FG000|Overall Study|Lost to Follow-up|0|||
130562320|NCT03716050|470026331|FG001|Overall Study|Lost to Follow-up|0|||
130562321|NCT03716050|470026332|FG002|Overall Study|Lost to Follow-up|1|||
130562322|NCT03716050|470026333|FG003|Overall Study|Lost to Follow-up|0|||
130562323|NCT03716050|470026334|FG004|Overall Study|Lost to Follow-up|0|||
130562324|NCT03716050|470026335|FG005|Overall Study|Lost to Follow-up|0|||
130562325|NCT03716050|470026336|FG006|Overall Study|Lost to Follow-up|0|||
130562326|NCT03716050|470026337|FG007|Overall Study|Lost to Follow-up|0|||
130562327|NCT03716050|470026330|FG000|Overall Study|Physician Decision|0|||
130562328|NCT03716050|470026331|FG001|Overall Study|Physician Decision|0|||
130562329|NCT03716050|470026332|FG002|Overall Study|Physician Decision|0|||
130562330|NCT03716050|470026333|FG003|Overall Study|Physician Decision|1|||
130562331|NCT03716050|470026334|FG004|Overall Study|Physician Decision|0|||
130562332|NCT03716050|470026335|FG005|Overall Study|Physician Decision|0|||
130562333|NCT03716050|470026336|FG006|Overall Study|Physician Decision|0|||
130562334|NCT03716050|470026337|FG007|Overall Study|Physician Decision|0|||
130562335|NCT03716050|470026330|FG000|Overall Study|Protocol Violation|0|||
130562336|NCT03716050|470026331|FG001|Overall Study|Protocol Violation|0|||
130562337|NCT03716050|470026332|FG002|Overall Study|Protocol Violation|0|||
130562338|NCT03716050|470026333|FG003|Overall Study|Protocol Violation|1|||
130562339|NCT03716050|470026334|FG004|Overall Study|Protocol Violation|0|||
130562340|NCT03716050|470026335|FG005|Overall Study|Protocol Violation|0|||
130562341|NCT03716050|470026336|FG006|Overall Study|Protocol Violation|0|||
130562342|NCT03716050|470026337|FG007|Overall Study|Protocol Violation|2|||
130562343|NCT03123250|470026338|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
130562344|NCT01390272|470026339|FG000|Overall Study|Death|3|||
130562345|NCT01390272|470026340|FG001|Overall Study|Death|2|||
130562346|NCT01390272|470026339|FG000|Overall Study|Withdrawal by Subject|9|||
130562347|NCT01390272|470026340|FG001|Overall Study|Withdrawal by Subject|5|||
130562348|NCT01390272|470026339|FG000|Overall Study|Patient moved, no longer eligible|5|||
130562349|NCT01390272|470026340|FG001|Overall Study|Patient moved, no longer eligible|8|||
130562350|NCT03199040|470026341|FG000|Overall Study|Lack of Efficacy|2|||
130562351|NCT03199040|470026342|FG001|Overall Study|Lack of Efficacy|0|||
130562352|NCT03199040|470026341|FG000|Overall Study|Withdrawal by Subject|2|||
130562353|NCT03199040|470026342|FG001|Overall Study|Withdrawal by Subject|0|||
130562354|NCT03199040|470026341|FG000|Overall Study|Adverse Event|0|||
130562355|NCT03199040|470026342|FG001|Overall Study|Adverse Event|1|||
130562356|NCT03199040|470026341|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
130562357|NCT03199040|470026342|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
130562358|NCT00199836|470026343|FG000|Overall Study|Progressive Disease|5|||
130562359|NCT00199836|470026343|FG000|Overall Study|Death|1|||
130562360|NCT01854645|470026349|FG000|Overall Study|Protocol-Specified Criteria|13|||
130562361|NCT01854645|470026350|FG001|Overall Study|Protocol-Specified Criteria|10|||
130562362|NCT01854645|470026351|FG002|Overall Study|Protocol-Specified Criteria|8|||
130562363|NCT01854645|470026352|FG003|Overall Study|Protocol-Specified Criteria|5|||
130562364|NCT01854645|470026353|FG004|Overall Study|Protocol-Specified Criteria|7|||
130562365|NCT01854645|470026349|FG000|Overall Study|Administrative Reasons / Missing|0|||
130562366|NCT01854645|470026350|FG001|Overall Study|Administrative Reasons / Missing|0|||
130562367|NCT01854645|470026351|FG002|Overall Study|Administrative Reasons / Missing|0|||
130562368|NCT01854645|470026352|FG003|Overall Study|Administrative Reasons / Missing|1|||
130562369|NCT01854645|470026353|FG004|Overall Study|Administrative Reasons / Missing|1|||
130562370|NCT01854645|470026349|FG000|Overall Study|Protocol Violation|3|||
130562371|NCT01854645|470026350|FG001|Overall Study|Protocol Violation|0|||
130562372|NCT01854645|470026351|FG002|Overall Study|Protocol Violation|5|||
130562373|NCT01854645|470026352|FG003|Overall Study|Protocol Violation|4|||
130562374|NCT01854645|470026353|FG004|Overall Study|Protocol Violation|1|||
130562375|NCT01854645|470026349|FG000|Overall Study|Lost to Follow-up|10|||
130562376|NCT01854645|470026350|FG001|Overall Study|Lost to Follow-up|7|||
130562377|NCT01854645|470026351|FG002|Overall Study|Lost to Follow-up|8|||
130562378|NCT01854645|470026352|FG003|Overall Study|Lost to Follow-up|5|||
130562379|NCT01854645|470026353|FG004|Overall Study|Lost to Follow-up|0|||
130562380|NCT01854645|470026349|FG000|Overall Study|Physician Decision|1|||
130562381|NCT01854645|470026350|FG001|Overall Study|Physician Decision|5|||
130562382|NCT01854645|470026351|FG002|Overall Study|Physician Decision|3|||
130562383|NCT01854645|470026352|FG003|Overall Study|Physician Decision|3|||
130409648|NCT01722331|469461553|FG003|Part 2|Lost to Follow-up|0|||
130409649|NCT01722331|469461554|FG004|Part 2|Lost to Follow-up|0|||
130409650|NCT01722331|469461555|FG005|Part 2|Lost to Follow-up|1|||
130409651|NCT01722331|469461556|FG006|Part 2|Lost to Follow-up|1|||
130409652|NCT01722331|469461550|FG000|Part 2|Non-Compliance with Study Drug|1|||
130409653|NCT01722331|469461551|FG001|Part 2|Non-Compliance with Study Drug|0|||
130409654|NCT01722331|469461552|FG002|Part 2|Non-Compliance with Study Drug|1|||
130409655|NCT01722331|469461553|FG003|Part 2|Non-Compliance with Study Drug|0|||
130409656|NCT01722331|469461554|FG004|Part 2|Non-Compliance with Study Drug|0|||
130409657|NCT01722331|469461555|FG005|Part 2|Non-Compliance with Study Drug|0|||
130409658|NCT01722331|469461556|FG006|Part 2|Non-Compliance with Study Drug|0|||
130409659|NCT01722331|469461550|FG000|Part 2|Physician Decision|0|||
130409660|NCT01722331|469461551|FG001|Part 2|Physician Decision|0|||
130409661|NCT01722331|469461552|FG002|Part 2|Physician Decision|2|||
130409662|NCT01722331|469461553|FG003|Part 2|Physician Decision|0|||
130409663|NCT01722331|469461554|FG004|Part 2|Physician Decision|0|||
130409664|NCT01722331|469461555|FG005|Part 2|Physician Decision|0|||
130409665|NCT01722331|469461556|FG006|Part 2|Physician Decision|0|||
130409666|NCT01722331|469461550|FG000|Part 2|Pregnancy|0|||
130409667|NCT01722331|469461551|FG001|Part 2|Pregnancy|0|||
130409668|NCT01722331|469461552|FG002|Part 2|Pregnancy|0|||
130409669|NCT01722331|469461553|FG003|Part 2|Pregnancy|0|||
130409670|NCT01722331|469461554|FG004|Part 2|Pregnancy|0|||
130473409|NCT02596126|469701100|FG001|Overall Study|Protocol Violation|9|||
130473410|NCT03396588|469701101|FG000|Overall Study|Physician Decision|2|||
130473411|NCT03396588|469701102|FG001|Overall Study|Physician Decision|3|||
130473412|NCT05179395|469701103|FG000|Overall Study|Lack of Efficacy|1|||
130473413|NCT00812461|469701104|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
130473414|NCT00812461|469701105|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
130473415|NCT00812461|469701104|FG000|All Treated Patients|Adverse Event|8|||
130473416|NCT00812461|469701105|FG001|All Treated Patients|Adverse Event|15|||
130473417|NCT00812461|469701104|FG000|All Treated Patients|Lack of Efficacy|13|||
130473418|NCT00812461|469701105|FG001|All Treated Patients|Lack of Efficacy|7|||
130473419|NCT00812461|469701104|FG000|All Treated Patients|Non-compliance|6|||
130473420|NCT00812461|469701105|FG001|All Treated Patients|Non-compliance|9|||
130473421|NCT00812461|469701104|FG000|All Treated Patients|Protocol Violation|36|||
130473422|NCT00812461|469701105|FG001|All Treated Patients|Protocol Violation|27|||
130473423|NCT00812461|469701104|FG000|All Treated Patients|Withdrawal by Subject|45|||
130473424|NCT00812461|469701105|FG001|All Treated Patients|Withdrawal by Subject|54|||
130473425|NCT00812461|469701104|FG000|All Treated Patients|Lost to Follow-up|11|||
130473426|NCT00812461|469701105|FG001|All Treated Patients|Lost to Follow-up|14|||
130473427|NCT00812461|469701104|FG000|All Treated Patients|Other Reason|13|||
130473428|NCT00812461|469701105|FG001|All Treated Patients|Other Reason|21|||
130473429|NCT05792423|469701110|FG000|Overall Study|Withdrawal by Subject|2|||
130473430|NCT02471638|469701111|FG000|Overall Study|Early Term Withdrawal|10|||
130473431|NCT04178733|469702423|FG000|Overall Study|Investigator Decision|0|||
130473432|NCT04178733|469702424|FG001|Overall Study|Investigator Decision|0|||
130473433|NCT04178733|469702425|FG002|Overall Study|Investigator Decision|0|||
130473434|NCT04178733|469702426|FG003|Overall Study|Investigator Decision|1|||
130473435|NCT04178733|469702427|FG004|Overall Study|Investigator Decision|2|||
130473436|NCT02287311|469702431|FG000|Cohort 1: Dose Level 1|Death|2|||
130473437|NCT02287311|469702432|FG001|Cohort 1: Dose Level 1|Death|0|||
130473438|NCT02287311|469702433|FG002|Cohort 1: Dose Level 1|Death|0|||
130473439|NCT02287311|469702434|FG003|Cohort 1: Dose Level 1|Death|3|||
130473440|NCT02287311|469702435|FG004|Cohort 1: Dose Level 1|Death|0|||
130473441|NCT02287311|469702436|FG005|Cohort 1: Dose Level 1|Death|0|||
130473442|NCT02287311|469702437|FG006|Cohort 1: Dose Level 1|Death|1|||
130473443|NCT02287311|469702438|FG007|Cohort 1: Dose Level 1|Death|0|||
130473444|NCT02287311|469702439|FG008|Cohort 1: Dose Level 1|Death|0|||
130473445|NCT02287311|469702431|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473446|NCT02287311|469702432|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473447|NCT02287311|469702433|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473448|NCT02287311|469702434|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
130473449|NCT02287311|469702435|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473450|NCT02287311|469702436|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473451|NCT02287311|469702437|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
130473452|NCT02287311|469702438|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473453|NCT02287311|469702439|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
130473454|NCT02287311|469702431|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
130562384|NCT01854645|470026353|FG004|Overall Study|Physician Decision|7|||
130562385|NCT01854645|470026349|FG000|Overall Study|Withdrawal by Subject|31|||
130473455|NCT02287311|469702432|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
130473456|NCT02287311|469702433|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
130473457|NCT02287311|469702434|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
130473458|NCT02287311|469702435|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
130473459|NCT02287311|469702436|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
130473460|NCT02287311|469702437|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
130473461|NCT02287311|469702438|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
130473462|NCT02287311|469702439|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
130562386|NCT01854645|470026350|FG001|Overall Study|Withdrawal by Subject|41|||
130562387|NCT01854645|470026351|FG002|Overall Study|Withdrawal by Subject|30|||
130562388|NCT01854645|470026352|FG003|Overall Study|Withdrawal by Subject|21|||
130562389|NCT01854645|470026353|FG004|Overall Study|Withdrawal by Subject|24|||
130562390|NCT01854645|470026349|FG000|Overall Study|Lack of Efficacy|7|||
130562391|NCT01854645|470026350|FG001|Overall Study|Lack of Efficacy|12|||
130562392|NCT01854645|470026351|FG002|Overall Study|Lack of Efficacy|9|||
130562393|NCT01854645|470026352|FG003|Overall Study|Lack of Efficacy|3|||
130562394|NCT01854645|470026353|FG004|Overall Study|Lack of Efficacy|9|||
130562395|NCT01854645|470026349|FG000|Overall Study|Adverse Event|33|||
130562396|NCT01854645|470026350|FG001|Overall Study|Adverse Event|31|||
130562397|NCT01854645|470026351|FG002|Overall Study|Adverse Event|19|||
130562398|NCT01854645|470026352|FG003|Overall Study|Adverse Event|20|||
130562399|NCT01854645|470026353|FG004|Overall Study|Adverse Event|11|||
130562400|NCT00430482|470026354|FG000|Completed Treatment|Insufficient Treatment|7|||
130562401|NCT00430482|470026355|FG001|Completed Treatment|Insufficient Treatment|11|||
130562402|NCT02546765|470026359|FG000|Overall Study|Withdrawal by Subject|0|||
130562403|NCT02546765|470026360|FG001|Overall Study|Withdrawal by Subject|1|||
130562404|NCT02546765|470026361|FG002|Overall Study|Withdrawal by Subject|0|||
130562405|NCT02546765|470026362|FG003|Overall Study|Withdrawal by Subject|0|||
130562406|NCT00475722|470026363|FG000|Overall Study|Withdrawal by Subject|12|||
130562407|NCT00475722|470026364|FG001|Overall Study|Withdrawal by Subject|12|||
130562408|NCT00475722|470026363|FG000|Overall Study|Protocol Violation|3|||
130562409|NCT00475722|470026364|FG001|Overall Study|Protocol Violation|0|||
130562410|NCT00916279|470026365|FG000|Overall Study|Death|2|||
130562411|NCT00916279|470026365|FG000|Overall Study|Lost to Follow-up|2|||
130562412|NCT02064920|470026366|FG000|Overall Study|Adverse Event|0|||
130562413|NCT02064920|470026367|FG001|Overall Study|Adverse Event|4|||
130562414|NCT02064920|470026366|FG000|Overall Study|Physician Decision|0|||
130562415|NCT02064920|470026367|FG001|Overall Study|Physician Decision|1|||
130562416|NCT02064920|470026366|FG000|Overall Study|Technical Problems|0|||
130562417|NCT02064920|470026367|FG001|Overall Study|Technical Problems|1|||
130562418|NCT02064920|470026366|FG000|Overall Study|Withdrawal by Subject|1|||
130562419|NCT02064920|470026367|FG001|Overall Study|Withdrawal by Subject|3|||
130562420|NCT00310804|470026368|FG000|Overall Study|Lost to Follow-up|2|||
130562421|NCT00310804|470026369|FG001|Overall Study|Lost to Follow-up|0|||
130562422|NCT00310804|470026368|FG000|Overall Study|Withdrawal by Subject|3|||
130562423|NCT00310804|470026369|FG001|Overall Study|Withdrawal by Subject|0|||
130562424|NCT02109562|470026370|FG000|Overall Study|Insufficient clinical response|2|||
130562425|NCT02109562|470026371|FG001|Overall Study|Insufficient clinical response|0|||
130562426|NCT02109562|470026372|FG002|Overall Study|Insufficient clinical response|4|||
130562427|NCT02109562|470026370|FG000|Overall Study|Adverse Event|0|||
130562428|NCT02109562|470026371|FG001|Overall Study|Adverse Event|2|||
130562429|NCT02109562|470026372|FG002|Overall Study|Adverse Event|3|||
130409671|NCT01722331|469461555|FG005|Part 2|Pregnancy|1|||
130409672|NCT01722331|469461556|FG006|Part 2|Pregnancy|0|||
130409673|NCT01722331|469461550|FG000|Part 2|Progressive Disease|0|||
130409674|NCT01722331|469461551|FG001|Part 2|Progressive Disease|0|||
130409675|NCT01722331|469461552|FG002|Part 2|Progressive Disease|1|||
130409676|NCT01722331|469461553|FG003|Part 2|Progressive Disease|0|||
130409677|NCT01722331|469461554|FG004|Part 2|Progressive Disease|0|||
130409678|NCT01722331|469461555|FG005|Part 2|Progressive Disease|0|||
130409679|NCT01722331|469461556|FG006|Part 2|Progressive Disease|0|||
130409680|NCT01722331|469461550|FG000|Part 2|Protocol Violation|1|||
130409681|NCT01722331|469461551|FG001|Part 2|Protocol Violation|0|||
130409682|NCT01722331|469461552|FG002|Part 2|Protocol Violation|0|||
130409683|NCT01722331|469461553|FG003|Part 2|Protocol Violation|0|||
130409684|NCT01722331|469461554|FG004|Part 2|Protocol Violation|0|||
130409685|NCT01722331|469461555|FG005|Part 2|Protocol Violation|0|||
130562430|NCT02109562|470026370|FG000|Overall Study|Lost to Follow-up|1|||
130562431|NCT02109562|470026371|FG001|Overall Study|Lost to Follow-up|0|||
130562432|NCT02109562|470026372|FG002|Overall Study|Lost to Follow-up|1|||
130562433|NCT02109562|470026370|FG000|Overall Study|Protocol Violation|0|||
130562434|NCT02109562|470026371|FG001|Overall Study|Protocol Violation|3|||
130562435|NCT02109562|470026372|FG002|Overall Study|Protocol Violation|1|||
130562436|NCT02109562|470026370|FG000|Overall Study|Withdrawal by Subject|20|||
130562437|NCT02109562|470026371|FG001|Overall Study|Withdrawal by Subject|25|||
130562438|NCT02109562|470026372|FG002|Overall Study|Withdrawal by Subject|21|||
130562439|NCT02109562|470026370|FG000|Overall Study|Physician Decision|3|||
130562440|NCT02109562|470026371|FG001|Overall Study|Physician Decision|4|||
130562441|NCT02109562|470026372|FG002|Overall Study|Physician Decision|5|||
130409686|NCT01722331|469461556|FG006|Part 2|Protocol Violation|0|||
130409687|NCT01722331|469461550|FG000|Part 2|Withdrawal by Subject|5|||
130562442|NCT00688155|470026377|FG000|Overall Study|Withdrawal by Subject|2|||
130562443|NCT00688155|470026378|FG001|Overall Study|Withdrawal by Subject|2|||
130562444|NCT00688155|470026379|FG002|Overall Study|Withdrawal by Subject|1|||
130562445|NCT00688155|470026380|FG003|Overall Study|Withdrawal by Subject|1|||
130562446|NCT01889238|470026384|FG000|Overall Study|Death|1|||
130562447|NCT01889238|470026384|FG000|Overall Study|Withdrawal by Subject|1|||
130562448|NCT01889238|470026384|FG000|Overall Study|Adverse Event|6|||
130562449|NCT01889238|470026384|FG000|Overall Study|Disease Progression|104|||
130562450|NCT01889238|470026384|FG000|Overall Study|Other|6|||
130562451|NCT04136184|470026385|FG000|Overall Study|Lost to Follow-up|0|||
130562452|NCT04136184|470026386|FG001|Overall Study|Lost to Follow-up|3|||
130562453|NCT04136184|470026385|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
130562454|NCT04136184|470026386|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
130562455|NCT03318978|470026390|FG000|Overall Study|Withdrawal by Subject|1|||
130562456|NCT02844816|470026391|FG000|Overall Study|No protocol treatment received|5|||
130562457|NCT02844816|470026392|FG001|Overall Study|No protocol treatment received|1|||
130562458|NCT02844816|470026391|FG000|Overall Study|Ineligible|22|||
130562459|NCT02844816|470026392|FG001|Overall Study|Ineligible|15|||
130562460|NCT02844816|470026391|FG000|Overall Study|Participant refusal|5|||
130562461|NCT02844816|470026392|FG001|Overall Study|Participant refusal|5|||
130562462|NCT02844816|470026391|FG000|Overall Study|Adverse Event|5|||
130562463|NCT02844816|470026392|FG001|Overall Study|Adverse Event|4|||
130562464|NCT02844816|470026391|FG000|Overall Study|Death|0|||
130562465|NCT02844816|470026392|FG001|Overall Study|Death|1|||
130562466|NCT02844816|470026391|FG000|Overall Study|Disease progression/recurrence|50|||
130562467|NCT02844816|470026392|FG001|Overall Study|Disease progression/recurrence|24|||
130562468|NCT02844816|470026391|FG000|Overall Study|Physician Decision|1|||
130562469|NCT02844816|470026392|FG001|Overall Study|Physician Decision|1|||
130562470|NCT01200238|470026394|FG000|Overall Study|Adverse Event|2|||
130562471|NCT01200238|470026395|FG001|Overall Study|Adverse Event|1|||
130562472|NCT01200238|470026394|FG000|Overall Study|Progressive Disease|5|||
130562473|NCT01200238|470026395|FG001|Overall Study|Progressive Disease|8|||
130562474|NCT01200238|470026394|FG000|Overall Study|Withdrawal by Subject|0|||
130409688|NCT01722331|469461551|FG001|Part 2|Withdrawal by Subject|0|||
130409689|NCT01722331|469461552|FG002|Part 2|Withdrawal by Subject|3|||
130409690|NCT01722331|469461553|FG003|Part 2|Withdrawal by Subject|0|||
130409691|NCT01722331|469461554|FG004|Part 2|Withdrawal by Subject|0|||
130409692|NCT01722331|469461555|FG005|Part 2|Withdrawal by Subject|2|||
130409693|NCT01722331|469461556|FG006|Part 2|Withdrawal by Subject|2|||
130409694|NCT01722331|469461550|FG000|Part 2|Other Protocol Specified Criteria|6|||
130409695|NCT01722331|469461551|FG001|Part 2|Other Protocol Specified Criteria|0|||
130409696|NCT01722331|469461552|FG002|Part 2|Other Protocol Specified Criteria|10|||
130409697|NCT01722331|469461553|FG003|Part 2|Other Protocol Specified Criteria|0|||
130409698|NCT01722331|469461554|FG004|Part 2|Other Protocol Specified Criteria|0|||
130409699|NCT01722331|469461555|FG005|Part 2|Other Protocol Specified Criteria|2|||
130409700|NCT01722331|469461556|FG006|Part 2|Other Protocol Specified Criteria|1|||
130409701|NCT01722331|469461550|FG000|Part 3|Adverse Event|2|||
130409702|NCT01722331|469461551|FG001|Part 3|Adverse Event|2|||
130409703|NCT01722331|469461552|FG002|Part 3|Adverse Event|0|||
130409704|NCT01722331|469461553|FG003|Part 3|Adverse Event|1|||
130409705|NCT01722331|469461554|FG004|Part 3|Adverse Event|0|||
130409706|NCT01722331|469461555|FG005|Part 3|Adverse Event|0|||
130409707|NCT01722331|469461556|FG006|Part 3|Adverse Event|0|||
130409708|NCT01722331|469461550|FG000|Part 3|Death|1|||
130409709|NCT01722331|469461551|FG001|Part 3|Death|0|||
130409710|NCT01722331|469461552|FG002|Part 3|Death|0|||
130409711|NCT01722331|469461553|FG003|Part 3|Death|0|||
130409712|NCT01722331|469461554|FG004|Part 3|Death|0|||
130409713|NCT01722331|469461555|FG005|Part 3|Death|0|||
130409714|NCT01722331|469461556|FG006|Part 3|Death|0|||
130409715|NCT01722331|469461550|FG000|Part 3|Lack of Efficacy|1|||
130409716|NCT01722331|469461551|FG001|Part 3|Lack of Efficacy|0|||
130409717|NCT01722331|469461552|FG002|Part 3|Lack of Efficacy|0|||
130409718|NCT01722331|469461553|FG003|Part 3|Lack of Efficacy|0|||
130409719|NCT01722331|469461554|FG004|Part 3|Lack of Efficacy|0|||
130409720|NCT01722331|469461555|FG005|Part 3|Lack of Efficacy|0|||
130409721|NCT01722331|469461556|FG006|Part 3|Lack of Efficacy|0|||
130409722|NCT01722331|469461550|FG000|Part 3|Lost to Follow-up|3|||
130409723|NCT01722331|469461551|FG001|Part 3|Lost to Follow-up|4|||
130409724|NCT01722331|469461552|FG002|Part 3|Lost to Follow-up|0|||
130409725|NCT01722331|469461553|FG003|Part 3|Lost to Follow-up|0|||
130409726|NCT01722331|469461554|FG004|Part 3|Lost to Follow-up|0|||
130409727|NCT01722331|469461555|FG005|Part 3|Lost to Follow-up|1|||
130409728|NCT01722331|469461556|FG006|Part 3|Lost to Follow-up|0|||
130409729|NCT01722331|469461550|FG000|Part 3|Non-Compliance with Study Drug|0|||
130409730|NCT01722331|469461551|FG001|Part 3|Non-Compliance with Study Drug|1|||
130562475|NCT01200238|470026395|FG001|Overall Study|Withdrawal by Subject|1|||
130727124|NCT02883049|470625436|FG012|Induction|Developed SMN|0|||
130409731|NCT01722331|469461552|FG002|Part 3|Non-Compliance with Study Drug|0|||
130409732|NCT01722331|469461553|FG003|Part 3|Non-Compliance with Study Drug|0|||
130409733|NCT01722331|469461554|FG004|Part 3|Non-Compliance with Study Drug|0|||
130409734|NCT01722331|469461555|FG005|Part 3|Non-Compliance with Study Drug|0|||
130409735|NCT01722331|469461556|FG006|Part 3|Non-Compliance with Study Drug|0|||
130409736|NCT01722331|469461550|FG000|Part 3|Physician Decision|1|||
130409737|NCT01722331|469461551|FG001|Part 3|Physician Decision|1|||
130562476|NCT02717754|470026396|FG000|Overall Study|Incorrect Infusion Duration|0|||
130562477|NCT02717754|470026397|FG001|Overall Study|Incorrect Infusion Duration|0|||
130562478|NCT02717754|470026398|FG002|Overall Study|Incorrect Infusion Duration|0|||
130562479|NCT02717754|470026399|FG003|Overall Study|Incorrect Infusion Duration|10|||
130562480|NCT02717754|470026400|FG004|Overall Study|Incorrect Infusion Duration|20|||
130562481|NCT02717754|470026401|FG005|Overall Study|Incorrect Infusion Duration|20|||
130562482|NCT03734016|470026405|FG000|Overall Study|Sponsor Ended Study|225|||
130562483|NCT03734016|470026406|FG001|Overall Study|Sponsor Ended Study|200|||
130562484|NCT03734016|470026405|FG000|Overall Study|Death|69|||
130562485|NCT03734016|470026406|FG001|Overall Study|Death|83|||
130562486|NCT03734016|470026405|FG000|Overall Study|Withdrawal by Subject|21|||
130727125|NCT02883049|470625437|FG013|Induction|Developed SMN|0|||
130727126|NCT02883049|470625438|FG014|Induction|Developed SMN|0|||
130727127|NCT02883049|470625439|FG015|Induction|Developed SMN|0|||
130409738|NCT01722331|469461552|FG002|Part 3|Physician Decision|0|||
130409739|NCT01722331|469461553|FG003|Part 3|Physician Decision|0|||
130409740|NCT01722331|469461554|FG004|Part 3|Physician Decision|0|||
130409741|NCT01722331|469461555|FG005|Part 3|Physician Decision|0|||
130409742|NCT01722331|469461556|FG006|Part 3|Physician Decision|1|||
130409743|NCT01722331|469461550|FG000|Part 3|Protocol Violation|2|||
130409744|NCT01722331|469461551|FG001|Part 3|Protocol Violation|1|||
130409745|NCT01722331|469461552|FG002|Part 3|Protocol Violation|0|||
130409746|NCT01722331|469461553|FG003|Part 3|Protocol Violation|0|||
130409747|NCT01722331|469461554|FG004|Part 3|Protocol Violation|0|||
130409748|NCT01722331|469461555|FG005|Part 3|Protocol Violation|0|||
130409749|NCT01722331|469461556|FG006|Part 3|Protocol Violation|0|||
130409750|NCT01722331|469461550|FG000|Part 3|Withdrawal by Subject|4|||
130409751|NCT01722331|469461551|FG001|Part 3|Withdrawal by Subject|7|||
130409752|NCT01722331|469461552|FG002|Part 3|Withdrawal by Subject|0|||
130409753|NCT01722331|469461553|FG003|Part 3|Withdrawal by Subject|0|||
130409754|NCT01722331|469461554|FG004|Part 3|Withdrawal by Subject|0|||
130409755|NCT01722331|469461555|FG005|Part 3|Withdrawal by Subject|2|||
130409756|NCT01722331|469461556|FG006|Part 3|Withdrawal by Subject|1|||
130409757|NCT01722331|469461550|FG000|Part 3|Other Protocol Specified Criteria|1|||
130409758|NCT01722331|469461551|FG001|Part 3|Other Protocol Specified Criteria|1|||
130409759|NCT01722331|469461552|FG002|Part 3|Other Protocol Specified Criteria|0|||
130409760|NCT01722331|469461553|FG003|Part 3|Other Protocol Specified Criteria|0|||
130409761|NCT01722331|469461554|FG004|Part 3|Other Protocol Specified Criteria|0|||
130409762|NCT01722331|469461555|FG005|Part 3|Other Protocol Specified Criteria|0|||
130409763|NCT01722331|469461556|FG006|Part 3|Other Protocol Specified Criteria|0|||
130409764|NCT01054729|469461562|FG000|Overall Study|Randomized but Not Treated|0|||
130409765|NCT01054729|469461563|FG001|Overall Study|Randomized but Not Treated|1|||
130409766|NCT01054729|469461564|FG002|Overall Study|Randomized but Not Treated|0|||
130409767|NCT01054729|469461565|FG003|Overall Study|Randomized but Not Treated|0|||
130409768|NCT01054729|469461562|FG000|Overall Study|Adverse Event|1|||
130409769|NCT01054729|469461563|FG001|Overall Study|Adverse Event|1|||
130409770|NCT01054729|469461564|FG002|Overall Study|Adverse Event|2|||
130409771|NCT01054729|469461565|FG003|Overall Study|Adverse Event|1|||
130409772|NCT01054729|469461562|FG000|Overall Study|Withdrawal by Subject|1|||
130409773|NCT01054729|469461563|FG001|Overall Study|Withdrawal by Subject|0|||
130409774|NCT01054729|469461564|FG002|Overall Study|Withdrawal by Subject|1|||
130409775|NCT01054729|469461565|FG003|Overall Study|Withdrawal by Subject|0|||
130473463|NCT02287311|469702431|FG000|Cohort 2: Dose Level 2|Death|0|||
130473464|NCT02287311|469702432|FG001|Cohort 2: Dose Level 2|Death|2|||
130473465|NCT02287311|469702433|FG002|Cohort 2: Dose Level 2|Death|0|||
130473466|NCT02287311|469702434|FG003|Cohort 2: Dose Level 2|Death|0|||
130473467|NCT02287311|469702435|FG004|Cohort 2: Dose Level 2|Death|2|||
130473468|NCT02287311|469702436|FG005|Cohort 2: Dose Level 2|Death|0|||
130473469|NCT02287311|469702437|FG006|Cohort 2: Dose Level 2|Death|0|||
130473470|NCT02287311|469702438|FG007|Cohort 2: Dose Level 2|Death|2|||
130473471|NCT02287311|469702439|FG008|Cohort 2: Dose Level 2|Death|0|||
130473472|NCT02287311|469702431|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473473|NCT02287311|469702432|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473474|NCT02287311|469702433|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473475|NCT02287311|469702434|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473476|NCT02287311|469702435|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
130473477|NCT02287311|469702436|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130409776|NCT01054729|469461562|FG000|Overall Study|Lost to Follow-up|0|||
130409777|NCT01054729|469461563|FG001|Overall Study|Lost to Follow-up|1|||
130409778|NCT01054729|469461564|FG002|Overall Study|Lost to Follow-up|0|||
130409779|NCT01054729|469461565|FG003|Overall Study|Lost to Follow-up|0|||
130409780|NCT01054729|469461562|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130409781|NCT01054729|469461563|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
130409782|NCT01054729|469461564|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130409783|NCT01054729|469461565|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130409784|NCT01054729|469461562|FG000|Overall Study|Non-responder|1|||
130473478|NCT02287311|469702437|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473479|NCT02287311|469702438|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130562487|NCT03734016|470026406|FG001|Overall Study|Withdrawal by Subject|27|||
130562488|NCT03734016|470026405|FG000|Overall Study|Physician Decision|1|||
130727128|NCT02883049|470625424|FG000|Induction|Enrolled onto another COG study|72|||
130727129|NCT02883049|470625425|FG001|Induction|Enrolled onto another COG study|0|||
130727130|NCT02883049|470625426|FG002|Induction|Enrolled onto another COG study|0|||
130727131|NCT02883049|470625427|FG003|Induction|Enrolled onto another COG study|0|||
130727132|NCT02883049|470625428|FG004|Induction|Enrolled onto another COG study|0|||
130727133|NCT02883049|470625429|FG005|Induction|Enrolled onto another COG study|0|||
130727134|NCT02883049|470625430|FG006|Induction|Enrolled onto another COG study|0|||
130727135|NCT02883049|470625431|FG007|Induction|Enrolled onto another COG study|0|||
130727136|NCT02883049|470625432|FG008|Induction|Enrolled onto another COG study|0|||
130727137|NCT02883049|470625433|FG009|Induction|Enrolled onto another COG study|0|||
130727138|NCT02883049|470625434|FG010|Induction|Enrolled onto another COG study|0|||
130727139|NCT02883049|470625435|FG011|Induction|Enrolled onto another COG study|0|||
130409785|NCT01054729|469461563|FG001|Overall Study|Non-responder|0|||
130409786|NCT01054729|469461564|FG002|Overall Study|Non-responder|1|||
130409787|NCT01054729|469461565|FG003|Overall Study|Non-responder|1|||
130409788|NCT01054729|469461562|FG000|Overall Study|PEG/RBV Non-responder|1|||
130409789|NCT01054729|469461563|FG001|Overall Study|PEG/RBV Non-responder|0|||
130409790|NCT01054729|469461564|FG002|Overall Study|PEG/RBV Non-responder|1|||
130409791|NCT01054729|469461565|FG003|Overall Study|PEG/RBV Non-responder|0|||
130409792|NCT01054729|469461562|FG000|Overall Study|Personal/Obligations|0|||
130409793|NCT01054729|469461563|FG001|Overall Study|Personal/Obligations|1|||
130409794|NCT01054729|469461564|FG002|Overall Study|Personal/Obligations|0|||
130409795|NCT01054729|469461565|FG003|Overall Study|Personal/Obligations|0|||
130409796|NCT01054729|469461562|FG000|Overall Study|Subject moved|0|||
130409797|NCT01054729|469461563|FG001|Overall Study|Subject moved|0|||
130409798|NCT01054729|469461564|FG002|Overall Study|Subject moved|1|||
130409799|NCT01054729|469461565|FG003|Overall Study|Subject moved|0|||
130409800|NCT01054729|469461562|FG000|Overall Study|Lack of Efficacy|0|||
130409801|NCT01054729|469461563|FG001|Overall Study|Lack of Efficacy|0|||
130409802|NCT01054729|469461564|FG002|Overall Study|Lack of Efficacy|0|||
130409803|NCT01054729|469461565|FG003|Overall Study|Lack of Efficacy|1|||
130409804|NCT01925183|469461566|FG000|Overall Study|Adverse Event|1|||
130409805|NCT01925183|469461567|FG001|Overall Study|Adverse Event|0|||
130409806|NCT01046110|469461568|FG000|Overall Study|Adverse Event|9|||
130409807|NCT01046110|469461569|FG001|Overall Study|Adverse Event|2|||
130409808|NCT01046110|469461568|FG000|Overall Study|Lack of Efficacy|0|||
130409809|NCT01046110|469461569|FG001|Overall Study|Lack of Efficacy|1|||
130409810|NCT01046110|469461568|FG000|Overall Study|Protocol Violation|7|||
130409811|NCT01046110|469461569|FG001|Overall Study|Protocol Violation|12|||
130409812|NCT01046110|469461568|FG000|Overall Study|Withdrawal Criteria|3|||
130409813|NCT01046110|469461569|FG001|Overall Study|Withdrawal Criteria|5|||
130409814|NCT01046110|469461568|FG000|Overall Study|Unclassified|36|||
130409815|NCT01046110|469461569|FG001|Overall Study|Unclassified|35|||
130409816|NCT00575588|469461576|FG000|Overall Study|Adverse Event|11|||
130409817|NCT00575588|469461577|FG001|Overall Study|Adverse Event|13|||
130473480|NCT02287311|469702439|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
130473481|NCT02287311|469702431|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473482|NCT02287311|469702432|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
130473483|NCT02287311|469702433|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473484|NCT02287311|469702434|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473485|NCT02287311|469702435|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473486|NCT02287311|469702436|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473487|NCT02287311|469702437|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473488|NCT02287311|469702438|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473489|NCT02287311|469702439|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
130473490|NCT02287311|469702431|FG000|Cohort 3: Dose Level 3|Death|0|||
130473491|NCT02287311|469702432|FG001|Cohort 3: Dose Level 3|Death|0|||
130473492|NCT02287311|469702433|FG002|Cohort 3: Dose Level 3|Death|4|||
130473493|NCT02287311|469702434|FG003|Cohort 3: Dose Level 3|Death|0|||
130473494|NCT02287311|469702435|FG004|Cohort 3: Dose Level 3|Death|0|||
130473495|NCT02287311|469702436|FG005|Cohort 3: Dose Level 3|Death|4|||
130473496|NCT02287311|469702437|FG006|Cohort 3: Dose Level 3|Death|0|||
130473497|NCT02287311|469702438|FG007|Cohort 3: Dose Level 3|Death|0|||
130473498|NCT02287311|469702439|FG008|Cohort 3: Dose Level 3|Death|2|||
130473499|NCT02287311|469702431|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130473500|NCT02287311|469702432|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130473501|NCT02287311|469702433|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
130473502|NCT02287311|469702434|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130473503|NCT02287311|469702435|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130473504|NCT02287311|469702436|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
130473505|NCT02287311|469702437|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130409818|NCT00575588|469461576|FG000|Overall Study|Withdrawal by Subject|27|||
130409819|NCT00575588|469461577|FG001|Overall Study|Withdrawal by Subject|31|||
130409820|NCT00575588|469461576|FG000|Overall Study|Lost to Follow-up|1|||
130409821|NCT00575588|469461577|FG001|Overall Study|Lost to Follow-up|3|||
130409822|NCT00575588|469461576|FG000|Overall Study|Death|4|||
130473506|NCT02287311|469702438|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130473507|NCT02287311|469702439|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130562489|NCT03734016|470026406|FG001|Overall Study|Physician Decision|12|||
130562490|NCT03734016|470026405|FG000|Overall Study|Lost to Follow-up|6|||
130562491|NCT03734016|470026406|FG001|Overall Study|Lost to Follow-up|2|||
130562492|NCT03734016|470026405|FG000|Overall Study|Miscellaneous|5|||
130562493|NCT03734016|470026406|FG001|Overall Study|Miscellaneous|1|||
130562494|NCT01979835|470026407|FG000|Primary Outcome SA Measurment|failed insertion|18|||
130562495|NCT01979835|470026407|FG000|Follow-up|Lost to Follow-up|32|||
130562496|NCT02592018|470026410|FG000|Overall Study|Adverse Event|1|||
130562497|NCT02592018|470026410|FG000|Overall Study|Lost to Follow-up|1|||
130562498|NCT02710136|470026413|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
130562499|NCT02710136|470026414|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
130562500|NCT00418665|470026415|FG000|Treatment Period|Ineligibility determined|1|||
130562501|NCT00418665|470026416|FG001|Treatment Period|Ineligibility determined|1|||
130562502|NCT00418665|470026417|FG002|Treatment Period|Ineligibility determined|0|||
130727140|NCT02883049|470625436|FG012|Induction|Enrolled onto another COG study|0|||
130409823|NCT00575588|469461577|FG001|Overall Study|Death|2|||
130409824|NCT00575588|469461576|FG000|Overall Study|Incorrect enrollment|8|||
130409825|NCT00575588|469461577|FG001|Overall Study|Incorrect enrollment|4|||
130409826|NCT00575588|469461576|FG000|Overall Study|Study specific discontinuation criteria|203|||
130409827|NCT00575588|469461577|FG001|Overall Study|Study specific discontinuation criteria|218|||
130409828|NCT00575588|469461576|FG000|Overall Study|Severe non-compliance to protocol|5|||
130409829|NCT00575588|469461577|FG001|Overall Study|Severe non-compliance to protocol|7|||
130409830|NCT00575588|469461576|FG000|Overall Study|Safety reasons|2|||
130409831|NCT00575588|469461577|FG001|Overall Study|Safety reasons|1|||
130409832|NCT00575588|469461576|FG000|Overall Study|Elevated triglyceride|1|||
130409833|NCT00575588|469461577|FG001|Overall Study|Elevated triglyceride|0|||
130409834|NCT00575588|469461576|FG000|Overall Study|Patient moved|1|||
130409835|NCT00575588|469461577|FG001|Overall Study|Patient moved|3|||
130409836|NCT00575588|469461576|FG000|Overall Study|Impossible to determine HbA1c|0|||
130409837|NCT00575588|469461577|FG001|Overall Study|Impossible to determine HbA1c|1|||
130409838|NCT00614939|469461578|FG000|Overall Study|Withdrawal by Subject|10|||
130409839|NCT00614939|469461579|FG001|Overall Study|Withdrawal by Subject|17|||
130409840|NCT00614939|469461578|FG000|Overall Study|Study specific discontinuation criteris|13|||
130409841|NCT00614939|469461579|FG001|Overall Study|Study specific discontinuation criteris|16|||
130409842|NCT00614939|469461578|FG000|Overall Study|Adverse Event|2|||
130409843|NCT00614939|469461579|FG001|Overall Study|Adverse Event|5|||
130409844|NCT00614939|469461578|FG000|Overall Study|Incorrect enrollment|1|||
130409845|NCT00614939|469461579|FG001|Overall Study|Incorrect enrollment|2|||
130409846|NCT00614939|469461578|FG000|Overall Study|Death|4|||
130409847|NCT00614939|469461579|FG001|Overall Study|Death|3|||
130409848|NCT00614939|469461578|FG000|Overall Study|Poor/non-compliance|4|||
130409849|NCT00614939|469461579|FG001|Overall Study|Poor/non-compliance|0|||
130409850|NCT00614939|469461578|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
130409851|NCT00614939|469461579|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
130409852|NCT00840970|469461580|FG000|Overall Study|Adverse Event|0|||
130409853|NCT00840970|469461581|FG001|Overall Study|Adverse Event|0|||
130409854|NCT00840970|469461582|FG002|Overall Study|Adverse Event|1|||
130409855|NCT00504829|469461583|FG000|Overall Study|Protocol Violation|6|||
130409856|NCT00504829|469461584|FG001|Overall Study|Protocol Violation|4|||
130409857|NCT00504829|469461585|FG002|Overall Study|Protocol Violation|10|||
130409858|NCT01854827|469461586|FG000|Overall Study|Death|1|||
130409859|NCT02571452|469461587|FG000|Overall Study Treatment|Protocol Violation|0|||
130409860|NCT02571452|469461588|FG001|Overall Study Treatment|Protocol Violation|1|||
130409861|NCT02571452|469461587|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
130409862|NCT02571452|469461588|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
130409863|NCT02571452|469461587|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
130409864|NCT02571452|469461588|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
130409865|NCT00534352|469461589|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
130409866|NCT00534352|469461589|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
130409867|NCT00534352|469461589|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
130409868|NCT00534352|469461589|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
130727141|NCT02883049|470625437|FG013|Induction|Enrolled onto another COG study|0|||
130727142|NCT02883049|470625438|FG014|Induction|Enrolled onto another COG study|0|||
130409869|NCT00534352|469461589|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
130409870|NCT00534352|469461589|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
130409871|NCT04788147|469461590|FG000|Overall Study|Screen Failure|3|||
130409872|NCT04788147|469461591|FG001|Overall Study|Screen Failure|10|||
130409873|NCT04788147|469461590|FG000|Overall Study|Incomplete RMRS image session|2|||
130409874|NCT04788147|469461591|FG001|Overall Study|Incomplete RMRS image session|0|||
130409875|NCT05101252|469461592|FG000|Overall Study|Unsatisfactory Test Article|1|||
130409876|NCT05101252|469461593|FG001|Overall Study|Unsatisfactory Test Article|0|||
130409877|NCT05101252|469461592|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130409878|NCT05101252|469461593|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130562503|NCT00418665|470026415|FG000|Treatment Period|Adverse Event|2|||
130473508|NCT02287311|469702431|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473509|NCT02287311|469702432|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473510|NCT02287311|469702433|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473511|NCT02287311|469702434|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473512|NCT02287311|469702435|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473513|NCT02287311|469702436|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
130473514|NCT02287311|469702437|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473515|NCT02287311|469702438|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130473516|NCT02287311|469702439|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
130473517|NCT05418296|469702444|FG000|Overall Study|Withdrawal by Subject|4|||
130473518|NCT05418296|469702445|FG001|Overall Study|Withdrawal by Subject|1|||
130473519|NCT01195831|469702450|FG000|Overall Study|Lost to Follow-up|2|||
130473520|NCT01195831|469702451|FG001|Overall Study|Lost to Follow-up|4|||
130473521|NCT01195831|469702450|FG000|Overall Study|Withdrawal by Subject|2|||
130473522|NCT01195831|469702451|FG001|Overall Study|Withdrawal by Subject|2|||
130473523|NCT01195831|469702450|FG000|Overall Study|Adverse Event|4|||
130473524|NCT01195831|469702451|FG001|Overall Study|Adverse Event|2|||
130473525|NCT01195831|469702450|FG000|Overall Study|Protocol Violation|0|||
130473526|NCT01195831|469702451|FG001|Overall Study|Protocol Violation|2|||
130473527|NCT04703322|469702453|FG000|Overall Study|Ongoing|8|||
130473528|NCT04703322|469702453|FG000|Overall Study|Withdrawal by Subject|1|||
130473529|NCT03692611|469702455|FG000|Overall Study|Found to be ineligible postrandomization|3|||
130473530|NCT03692611|469702456|FG001|Overall Study|Found to be ineligible postrandomization|0|||
130473531|NCT03713086|469702459|FG000|Overall Study|Withdrawal by Subject|0|||
130473532|NCT03713086|469702460|FG001|Overall Study|Withdrawal by Subject|2|||
130473533|NCT03713086|469702461|FG002|Overall Study|Withdrawal by Subject|1|||
130473534|NCT03713086|469702462|FG003|Overall Study|Withdrawal by Subject|0|||
130473535|NCT03713086|469702459|FG000|Overall Study|Lost to Follow-up|0|||
130473536|NCT03713086|469702460|FG001|Overall Study|Lost to Follow-up|1|||
130473537|NCT03713086|469702461|FG002|Overall Study|Lost to Follow-up|0|||
130473538|NCT03713086|469702462|FG003|Overall Study|Lost to Follow-up|1|||
130473539|NCT05374837|469702467|FG000|Overall Study|Lost to Follow-up|17|||
130473540|NCT05374837|469702468|FG001|Overall Study|Lost to Follow-up|18|||
130473541|NCT02549339|469702471|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
130473542|NCT02549339|469702472|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
130473543|NCT02549339|469702471|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
130473544|NCT02549339|469702472|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
130473545|NCT02549339|469702471|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
130473546|NCT02549339|469702472|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
130473547|NCT02549339|469702471|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
130473548|NCT02549339|469702472|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
130473549|NCT02549339|469702471|FG000|12-month Follow-up|Lack of Efficacy|0|||
130473550|NCT02549339|469702472|FG001|12-month Follow-up|Lack of Efficacy|2|||
130473551|NCT02549339|469702471|FG000|12-month Follow-up|Withdrawal by Subject|8|||
130473552|NCT02549339|469702472|FG001|12-month Follow-up|Withdrawal by Subject|3|||
130473553|NCT02549339|469702471|FG000|12-month Follow-up|Lost to Follow-up|1|||
130473554|NCT02549339|469702472|FG001|12-month Follow-up|Lost to Follow-up|3|||
130473555|NCT02549339|469702471|FG000|12-month Follow-up|Other|0|||
130473556|NCT02549339|469702472|FG001|12-month Follow-up|Other|3|||
130473557|NCT05054374|469702489|FG000|Overall Study|Withdrawal by Subject|1|||
130473558|NCT05054374|469702490|FG001|Overall Study|Withdrawal by Subject|0|||
130473559|NCT05054374|469702491|FG002|Overall Study|Withdrawal by Subject|0|||
130473560|NCT05054374|469702492|FG003|Overall Study|Withdrawal by Subject|0|||
130473561|NCT05054374|469702489|FG000|Overall Study|Progressive Disease|5|||
130473562|NCT05054374|469702490|FG001|Overall Study|Progressive Disease|0|||
130473563|NCT05054374|469702491|FG002|Overall Study|Progressive Disease|0|||
130473564|NCT05054374|469702492|FG003|Overall Study|Progressive Disease|0|||
130473565|NCT03958955|469702494|FG000|Overall Study|Adverse Event|1|||
130473566|NCT04838262|469702495|FG000|Overall Study|Withdrawal by Subject|9|||
130562504|NCT00418665|470026416|FG001|Treatment Period|Adverse Event|2|||
130562505|NCT00418665|470026417|FG002|Treatment Period|Adverse Event|0|||
130473567|NCT04838262|469702496|FG001|Overall Study|Withdrawal by Subject|4|||
130473568|NCT04382898|469702505|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
130473569|NCT04382898|469702506|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
130473570|NCT04382898|469702507|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
130473571|NCT04382898|469702508|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
130473572|NCT04382898|469702509|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
130473573|NCT04382898|469702505|FG000|Part 1: Dose Titration|Death|6|||
130473574|NCT04382898|469702506|FG001|Part 1: Dose Titration|Death|0|||
130473575|NCT04382898|469702507|FG002|Part 1: Dose Titration|Death|0|||
130473576|NCT04382898|469702508|FG003|Part 1: Dose Titration|Death|0|||
130473577|NCT04382898|469702509|FG004|Part 1: Dose Titration|Death|0|||
130473578|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130473579|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130473580|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
130473581|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130473582|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130473583|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
130473584|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
130473585|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
130473586|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
130473587|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
130473588|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Death|0|||
130473589|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Death|17|||
130473590|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Death|13|||
130473591|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Death|1|||
130473592|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Death|0|||
130473593|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
130473594|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
130473595|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
130473596|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
130473597|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
130473598|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
130473599|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
130473600|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
130473601|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
130473602|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
130473603|NCT04382898|469702505|FG000|Part 2: Dose Expansion|Other|0|||
130473604|NCT04382898|469702506|FG001|Part 2: Dose Expansion|Other|0|||
130473605|NCT04382898|469702507|FG002|Part 2: Dose Expansion|Other|1|||
130473606|NCT04382898|469702508|FG003|Part 2: Dose Expansion|Other|0|||
130473607|NCT04382898|469702509|FG004|Part 2: Dose Expansion|Other|0|||
130473608|NCT03932682|469702510|FG000|Overall Study|Death|1|||
130473609|NCT03932682|469702511|FG001|Overall Study|Death|2|||
130473610|NCT03932682|469702510|FG000|Overall Study|Withdrawal by Subject|37|||
130473611|NCT03932682|469702511|FG001|Overall Study|Withdrawal by Subject|45|||
130473612|NCT03932682|469702510|FG000|Overall Study|Lost to Follow-up|19|||
130473613|NCT03932682|469702511|FG001|Overall Study|Lost to Follow-up|25|||
130473614|NCT03932682|469702510|FG000|Overall Study|Protocol Violation|0|||
130473615|NCT03932682|469702511|FG001|Overall Study|Protocol Violation|2|||
130473616|NCT03932682|469702510|FG000|Overall Study|Other|9|||
130473617|NCT03932682|469702511|FG001|Overall Study|Other|23|||
130473618|NCT02307565|469702513|FG000|Overall Study|Adverse Event|3|||
130473619|NCT02307565|469702514|FG001|Overall Study|Adverse Event|2|||
130473620|NCT02307565|469702513|FG000|Overall Study|Withdrawal by Subject|2|||
130473621|NCT02307565|469702514|FG001|Overall Study|Withdrawal by Subject|2|||
130473622|NCT04936035|469702521|FG000|Overall Study|Adverse Event|0|||
130473623|NCT04936035|469702522|FG001|Overall Study|Adverse Event|1|||
130473624|NCT04936035|469702523|FG002|Overall Study|Adverse Event|0|||
130473625|NCT04936035|469702524|FG003|Overall Study|Adverse Event|0|||
130473626|NCT04936035|469702525|FG004|Overall Study|Adverse Event|0|||
130473627|NCT04936035|469702521|FG000|Overall Study|Death|0|||
130473628|NCT04936035|469702522|FG001|Overall Study|Death|0|||
130473629|NCT04936035|469702523|FG002|Overall Study|Death|0|||
130473630|NCT04936035|469702524|FG003|Overall Study|Death|1|||
130473631|NCT04936035|469702525|FG004|Overall Study|Death|0|||
130473632|NCT04936035|469702521|FG000|Overall Study|Lost to Follow-up|0|||
130473633|NCT04936035|469702522|FG001|Overall Study|Lost to Follow-up|1|||
130473634|NCT04936035|469702523|FG002|Overall Study|Lost to Follow-up|1|||
130473635|NCT04936035|469702524|FG003|Overall Study|Lost to Follow-up|2|||
130473636|NCT04936035|469702525|FG004|Overall Study|Lost to Follow-up|1|||
130562506|NCT00418665|470026415|FG000|Treatment Period|Withdrawal by Subject|0|||
130562507|NCT00418665|470026416|FG001|Treatment Period|Withdrawal by Subject|3|||
130562508|NCT00418665|470026417|FG002|Treatment Period|Withdrawal by Subject|1|||
130473637|NCT04936035|469702521|FG000|Overall Study|Physician Decision|0|||
130473638|NCT04936035|469702522|FG001|Overall Study|Physician Decision|1|||
130473639|NCT04936035|469702523|FG002|Overall Study|Physician Decision|0|||
130473640|NCT04936035|469702524|FG003|Overall Study|Physician Decision|0|||
130473641|NCT04936035|469702525|FG004|Overall Study|Physician Decision|0|||
130473642|NCT04936035|469702521|FG000|Overall Study|Protocol Deviation|0|||
130473643|NCT04936035|469702522|FG001|Overall Study|Protocol Deviation|0|||
130473644|NCT04936035|469702523|FG002|Overall Study|Protocol Deviation|1|||
130473645|NCT04936035|469702524|FG003|Overall Study|Protocol Deviation|0|||
130473646|NCT04936035|469702525|FG004|Overall Study|Protocol Deviation|0|||
130473647|NCT04936035|469702521|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
130473648|NCT04936035|469702522|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
130473649|NCT04936035|469702523|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
130473650|NCT04936035|469702524|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
130473651|NCT04936035|469702525|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
130473652|NCT04936035|469702521|FG000|Overall Study|Reason Unknown|0|||
130473653|NCT04936035|469702522|FG001|Overall Study|Reason Unknown|0|||
130473654|NCT04936035|469702523|FG002|Overall Study|Reason Unknown|0|||
130409879|NCT05101252|469461592|FG000|Overall Study|Withdrew Consent during study|0|||
130409880|NCT05101252|469461593|FG001|Overall Study|Withdrew Consent during study|1|||
130409881|NCT05101252|469461592|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
130409882|NCT05101252|469461593|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
130409883|NCT04796610|469461596|FG000|Overall Study|Withdrawal by Subject|1|||
130409884|NCT04796610|469461597|FG001|Overall Study|Withdrawal by Subject|0|||
130409885|NCT04796610|469461598|FG002|Overall Study|Withdrawal by Subject|0|||
130409886|NCT04796610|469461599|FG003|Overall Study|Withdrawal by Subject|0|||
130409887|NCT04796610|469461596|FG000|Overall Study|Lost to Follow-up|2|||
130409888|NCT04796610|469461597|FG001|Overall Study|Lost to Follow-up|0|||
130409889|NCT04796610|469461598|FG002|Overall Study|Lost to Follow-up|1|||
130409890|NCT04796610|469461599|FG003|Overall Study|Lost to Follow-up|1|||
130409891|NCT02401672|469461600|FG000|Overall Study|Withdrawal by Subject|1|||
130409892|NCT02401672|469461601|FG001|Overall Study|Withdrawal by Subject|3|||
130409893|NCT00701051|469461602|FG000|Screening|Failed Screening|40|||
130409894|NCT00701051|469461603|FG001|Screening|Failed Screening|0|||
130409895|NCT00701051|469461604|FG002|Screening|Failed Screening|0|||
130409896|NCT00701051|469461602|FG000|Screening|Time conflicts|19|||
130409897|NCT00701051|469461603|FG001|Screening|Time conflicts|0|||
130409898|NCT00701051|469461604|FG002|Screening|Time conflicts|0|||
130409899|NCT00701051|469461602|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
130409900|NCT00701051|469461603|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
130409901|NCT00701051|469461604|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
130409902|NCT02059148|469461605|FG000|Treatment 1|Protocol Violation|0|||
130409903|NCT02059148|469461606|FG001|Treatment 1|Protocol Violation|0|||
130409904|NCT02059148|469461607|FG002|Treatment 1|Protocol Violation|0|||
130409905|NCT02059148|469461608|FG003|Treatment 1|Protocol Violation|0|||
130409906|NCT02059148|469461609|FG004|Treatment 1|Protocol Violation|0|||
130409907|NCT02059148|469461610|FG005|Treatment 1|Protocol Violation|1|||
130409908|NCT00345579|469461612|FG000|Overall Study|Adverse Event|9|||
130409909|NCT00345579|469461613|FG001|Overall Study|Adverse Event|6|||
130409910|NCT00345579|469461612|FG000|Overall Study|Protocol Violation|14|||
130409911|NCT00345579|469461613|FG001|Overall Study|Protocol Violation|5|||
130409912|NCT00345579|469461612|FG000|Overall Study|Withdrawal by Subject|50|||
130409913|NCT00345579|469461613|FG001|Overall Study|Withdrawal by Subject|17|||
130409914|NCT00345579|469461612|FG000|Overall Study|Lost to Follow-up|82|||
130409915|NCT00345579|469461613|FG001|Overall Study|Lost to Follow-up|36|||
130409916|NCT00345579|469461612|FG000|Overall Study|Other|9|||
130409917|NCT00345579|469461613|FG001|Overall Study|Other|1|||
130409918|NCT02673697|469461616|FG000|Overall Study|Adverse Event|2|||
130409919|NCT02673697|469461617|FG001|Overall Study|Adverse Event|0|||
130409920|NCT02673697|469461616|FG000|Overall Study|Death|32|||
130409921|NCT02673697|469461617|FG001|Overall Study|Death|24|||
130409922|NCT02673697|469461616|FG000|Overall Study|Lost to Follow-up|5|||
130409923|NCT02673697|469461617|FG001|Overall Study|Lost to Follow-up|2|||
130409924|NCT02673697|469461616|FG000|Overall Study|Physician Decision|2|||
130473655|NCT04936035|469702524|FG003|Overall Study|Reason Unknown|0|||
130473656|NCT04936035|469702525|FG004|Overall Study|Reason Unknown|1|||
130473657|NCT04936035|469702521|FG000|Overall Study|Withdrawal by Subject|1|||
130473658|NCT04936035|469702522|FG001|Overall Study|Withdrawal by Subject|0|||
130473659|NCT04936035|469702523|FG002|Overall Study|Withdrawal by Subject|0|||
130473660|NCT04936035|469702524|FG003|Overall Study|Withdrawal by Subject|0|||
130473661|NCT04936035|469702525|FG004|Overall Study|Withdrawal by Subject|0|||
130473662|NCT04936035|469702521|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
130473663|NCT04936035|469702522|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
130473664|NCT04936035|469702523|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
130473665|NCT04936035|469702524|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
130473666|NCT04936035|469702525|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
130473667|NCT04936035|469702521|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
130473668|NCT04936035|469702522|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
130473669|NCT04936035|469702523|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
130473670|NCT04936035|469702524|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
130473671|NCT04936035|469702525|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
130473672|NCT04936035|469702521|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
130473673|NCT04936035|469702522|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
130409925|NCT02673697|469461617|FG001|Overall Study|Physician Decision|1|||
130409926|NCT02673697|469461616|FG000|Overall Study|Withdrawal by Subject|10|||
130409927|NCT02673697|469461617|FG001|Overall Study|Withdrawal by Subject|7|||
130409928|NCT02673697|469461616|FG000|Overall Study|Change subj medical status|1|||
130409929|NCT02673697|469461617|FG001|Overall Study|Change subj medical status|2|||
130562509|NCT00418665|470026415|FG000|Treatment Period|Requirement for alternative therapy|1|||
130562510|NCT00418665|470026416|FG001|Treatment Period|Requirement for alternative therapy|0|||
130562511|NCT00418665|470026417|FG002|Treatment Period|Requirement for alternative therapy|0|||
130562512|NCT00418665|470026415|FG000|Treatment Period|Physician Decision|1|||
130562513|NCT00418665|470026416|FG001|Treatment Period|Physician Decision|0|||
130562514|NCT00418665|470026417|FG002|Treatment Period|Physician Decision|3|||
130562515|NCT00418665|470026415|FG000|Treatment Extension|Adverse Event|1|||
130562516|NCT00418665|470026416|FG001|Treatment Extension|Adverse Event|0|||
130562517|NCT00418665|470026417|FG002|Treatment Extension|Adverse Event|0|||
130562518|NCT00418665|470026415|FG000|Treatment Extension|Withdrawal by Subject|1|||
130562519|NCT00418665|470026416|FG001|Treatment Extension|Withdrawal by Subject|0|||
130562520|NCT00418665|470026417|FG002|Treatment Extension|Withdrawal by Subject|0|||
130562521|NCT00418665|470026415|FG000|Treatment Extension|Requirement for alternative therapy|2|||
130562522|NCT00418665|470026416|FG001|Treatment Extension|Requirement for alternative therapy|2|||
130562523|NCT00418665|470026417|FG002|Treatment Extension|Requirement for alternative therapy|0|||
130473674|NCT04936035|469702523|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
130473675|NCT04936035|469702524|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
130473676|NCT04936035|469702525|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
130473677|NCT03978871|469702536|FG000|Overall Study|Lost to Follow-up|11|||
130473678|NCT03978871|469702537|FG001|Overall Study|Lost to Follow-up|12|||
130473679|NCT04072822|469702538|FG000|Treatment|Adverse Event|9|||
130409930|NCT02673697|469461616|FG000|Overall Study|Explant|10|||
130473680|NCT04072822|469702539|FG001|Treatment|Adverse Event|5|||
130473681|NCT04072822|469702538|FG000|Treatment|Met Stopping Criteria|13|||
130473682|NCT04072822|469702539|FG001|Treatment|Met Stopping Criteria|24|||
130473683|NCT04072822|469702538|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
130473684|NCT04072822|469702539|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
130473685|NCT04072822|469702538|FG000|Treatment|Withdrawal by Subject|0|||
130473686|NCT04072822|469702539|FG001|Treatment|Withdrawal by Subject|2|||
130473687|NCT04072822|469702538|FG000|Treatment|Death|0|||
130473688|NCT04072822|469702539|FG001|Treatment|Death|2|||
130473689|NCT04072822|469702538|FG000|Treatment|Lost to Follow-up|11|||
130473690|NCT04072822|469702539|FG001|Treatment|Lost to Follow-up|3|||
130473691|NCT04072822|469702538|FG000|Treatment|Physician Decision|1|||
130473692|NCT04072822|469702539|FG001|Treatment|Physician Decision|0|||
130473693|NCT04072822|469702538|FG000|Treatment|Other|7|||
130473694|NCT04072822|469702539|FG001|Treatment|Other|9|||
130473695|NCT04072822|469702538|FG000|Follow-up|Withdrawal by Subject|1|||
130473696|NCT04072822|469702539|FG001|Follow-up|Withdrawal by Subject|0|||
130473697|NCT04072822|469702538|FG000|Follow-up|Lost to Follow-up|5|||
130473698|NCT04072822|469702539|FG001|Follow-up|Lost to Follow-up|4|||
130473699|NCT04391894|469702541|FG000|Overall Study|Adverse Event|1|||
130473700|NCT04391894|469702542|FG001|Overall Study|Adverse Event|1|||
130473701|NCT04391894|469702543|FG002|Overall Study|Adverse Event|1|||
130473702|NCT04391894|469702544|FG003|Overall Study|Adverse Event|1|||
130473703|NCT04391894|469702545|FG004|Overall Study|Adverse Event|1|||
130562524|NCT00418665|470026415|FG000|Treatment Extension|Physician Decision|2|||
130562525|NCT00418665|470026416|FG001|Treatment Extension|Physician Decision|2|||
130562526|NCT00418665|470026417|FG002|Treatment Extension|Physician Decision|1|||
130562527|NCT00418665|470026415|FG000|Treatment Extension|Death|0|||
130409931|NCT02673697|469461617|FG001|Overall Study|Explant|5|||
130409932|NCT02673697|469461616|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
130409933|NCT02673697|469461617|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
130409934|NCT00437489|469461618|FG000|Overall Study|Study terminated by sponsor|23|||
130409935|NCT00437489|469461619|FG001|Overall Study|Study terminated by sponsor|21|||
130409936|NCT00437489|469461618|FG000|Overall Study|Lost to Follow-up|0|||
130409937|NCT00437489|469461619|FG001|Overall Study|Lost to Follow-up|1|||
130409938|NCT03893448|469461624|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
130409939|NCT03893448|469461625|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
130409940|NCT03893448|469461624|FG000|Overall Study|Physician Decision|8|||
130409941|NCT03893448|469461625|FG001|Overall Study|Physician Decision|14|||
130473704|NCT04391894|469702541|FG000|Overall Study|Lost to Follow-up|1|||
130473705|NCT04391894|469702542|FG001|Overall Study|Lost to Follow-up|0|||
130473706|NCT04391894|469702543|FG002|Overall Study|Lost to Follow-up|0|||
130473707|NCT04391894|469702544|FG003|Overall Study|Lost to Follow-up|0|||
130473708|NCT04391894|469702545|FG004|Overall Study|Lost to Follow-up|0|||
130473709|NCT04391894|469702541|FG000|Overall Study|Protocol Violation|0|||
130562528|NCT00418665|470026416|FG001|Treatment Extension|Death|0|||
130562529|NCT00418665|470026417|FG002|Treatment Extension|Death|1|||
130562530|NCT01133379|470026420|FG000|Overall Study|Withdrawal by Subject|0|||
130562531|NCT01133379|470026421|FG001|Overall Study|Withdrawal by Subject|1|||
130473710|NCT04391894|469702542|FG001|Overall Study|Protocol Violation|0|||
130562532|NCT01133379|470026422|FG002|Overall Study|Withdrawal by Subject|1|||
130473711|NCT04391894|469702543|FG002|Overall Study|Protocol Violation|0|||
130473712|NCT04391894|469702544|FG003|Overall Study|Protocol Violation|1|||
130409942|NCT03893448|469461624|FG000|Overall Study|Lost to Follow-up|34|||
130409943|NCT03893448|469461625|FG001|Overall Study|Lost to Follow-up|27|||
130562533|NCT01133379|470026420|FG000|Overall Study|Lost to Follow-up|1|||
130562534|NCT01133379|470026421|FG001|Overall Study|Lost to Follow-up|1|||
130562535|NCT01133379|470026422|FG002|Overall Study|Lost to Follow-up|1|||
130562536|NCT01134614|470027317|FG000|Overall Study|Still on treatment as of March 2013|21|||
130562537|NCT01134614|470027318|FG001|Overall Study|Still on treatment as of March 2013|13|||
130562538|NCT01134614|470027317|FG000|Overall Study|Progressive disease|60|||
130562539|NCT01134614|470027318|FG001|Overall Study|Progressive disease|54|||
130562540|NCT01134614|470027317|FG000|Overall Study|Adverse Event|26|||
130562541|NCT01134614|470027318|FG001|Overall Study|Adverse Event|39|||
130562542|NCT01134614|470027317|FG000|Overall Study|Death|5|||
130562543|NCT01134614|470027318|FG001|Overall Study|Death|8|||
130562544|NCT01134614|470027317|FG000|Overall Study|Withdrawal by Subject|3|||
130562545|NCT01134614|470027318|FG001|Overall Study|Withdrawal by Subject|2|||
130562546|NCT01134614|470027317|FG000|Overall Study|Alternative therapy|2|||
130562547|NCT01134614|470027318|FG001|Overall Study|Alternative therapy|0|||
130562548|NCT01134614|470027317|FG000|Overall Study|Complicating disease|2|||
130562549|NCT01134614|470027318|FG001|Overall Study|Complicating disease|1|||
130562550|NCT01134614|470027317|FG000|Overall Study|Physician's decision|0|||
130562551|NCT01134614|470027318|FG001|Overall Study|Physician's decision|1|||
130562552|NCT01134614|470027317|FG000|Overall Study|Never started treatment|4|||
130562553|NCT01134614|470027318|FG001|Overall Study|Never started treatment|1|||
130562554|NCT01134614|470027317|FG000|Overall Study|Pt received tx not allowed on study|0|||
130562555|NCT01134614|470027318|FG001|Overall Study|Pt received tx not allowed on study|1|||
130562556|NCT01134614|470027317|FG000|Overall Study|Symptomatic deterioration|0|||
130562557|NCT01134614|470027318|FG001|Overall Study|Symptomatic deterioration|1|||
130562558|NCT01134614|470027317|FG000|Overall Study|Patient in hospice care|0|||
130562559|NCT01134614|470027318|FG001|Overall Study|Patient in hospice care|1|||
130562560|NCT01519934|470027319|FG000|Overall Study|Lost to Follow-up|3|||
130409944|NCT03893448|469461624|FG000|Overall Study|Death|1|||
130409945|NCT03893448|469461625|FG001|Overall Study|Death|0|||
130409946|NCT04111497|469461629|FG000|Overall Study|relapse of primary disease|1|||
130409947|NCT04111497|469461629|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
130409948|NCT00817089|469461630|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
130409949|NCT00817089|469461631|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
130409950|NCT00817089|469461632|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
130409951|NCT00817089|469461633|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
130409952|NCT00817089|469461630|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
130409953|NCT00817089|469461631|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
130409954|NCT00817089|469461632|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
130409955|NCT00817089|469461633|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
130409956|NCT03783923|469461634|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
130409957|NCT03783923|469461635|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
130409958|NCT03783923|469461634|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
130409959|NCT03783923|469461635|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
130409960|NCT03783923|469461634|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130562561|NCT03861936|470027320|FG000|Overall Study|Withdrawal by Subject|4|||
130562562|NCT03861936|470027321|FG001|Overall Study|Withdrawal by Subject|1|||
130562563|NCT03861936|470027322|FG002|Overall Study|Withdrawal by Subject|3|||
130562564|NCT03861936|470027320|FG000|Overall Study|Lost to Follow-up|5|||
130562565|NCT03861936|470027321|FG001|Overall Study|Lost to Follow-up|3|||
130562566|NCT03861936|470027322|FG002|Overall Study|Lost to Follow-up|3|||
130562567|NCT03861936|470027320|FG000|Overall Study|Physician Decision|0|||
130562568|NCT03861936|470027321|FG001|Overall Study|Physician Decision|1|||
130562569|NCT03861936|470027322|FG002|Overall Study|Physician Decision|0|||
130562570|NCT03861936|470027320|FG000|Overall Study|Protocol Deviation|0|||
130562571|NCT03861936|470027321|FG001|Overall Study|Protocol Deviation|0|||
130562572|NCT03861936|470027322|FG002|Overall Study|Protocol Deviation|1|||
130562573|NCT03861936|470027320|FG000|Overall Study|Reason not Specified|5|||
130562574|NCT03861936|470027321|FG001|Overall Study|Reason not Specified|5|||
130562575|NCT03861936|470027322|FG002|Overall Study|Reason not Specified|3|||
130562576|NCT01236573|470027323|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562577|NCT01236573|470027324|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562578|NCT01236573|470027325|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562579|NCT01236573|470027326|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562580|NCT01236573|470027327|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562581|NCT01236573|470027328|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562582|NCT01236573|470027329|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130562583|NCT01236573|470027330|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130562584|NCT01236573|470027331|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130562585|NCT01236573|470027332|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130562586|NCT01236573|470027333|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130409961|NCT03783923|469461635|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
130409962|NCT03783923|469461634|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
130409963|NCT03783923|469461635|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
130409964|NCT03783923|469461634|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
130409965|NCT03783923|469461635|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
130409966|NCT01592708|469461636|FG000|Overall Study|Protocol Violation|3|||
130409967|NCT01592708|469461637|FG001|Overall Study|Protocol Violation|0|||
130409968|NCT01785602|469461641|FG000|Overall Study|Withdrawal by Subject|2|||
130409969|NCT01785602|469461642|FG001|Overall Study|Withdrawal by Subject|0|||
130409970|NCT01785602|469461641|FG000|Overall Study|Lost to Follow-up|1|||
130409971|NCT01785602|469461642|FG001|Overall Study|Lost to Follow-up|1|||
130409972|NCT01785602|469461641|FG000|Overall Study|Adverse Event|3|||
130409973|NCT01785602|469461642|FG001|Overall Study|Adverse Event|5|||
130409974|NCT01785602|469461641|FG000|Overall Study|Administrative problems|7|||
130409975|NCT01785602|469461642|FG001|Overall Study|Administrative problems|3|||
130409976|NCT02041429|469461644|FG000|Overall Study|Progressive Disease|2|||
130409977|NCT02041429|469461645|FG001|Overall Study|Progressive Disease|2|||
130409978|NCT02041429|469461646|FG002|Overall Study|Progressive Disease|3|||
130409979|NCT02041429|469461647|FG003|Overall Study|Progressive Disease|2|||
130409980|NCT02041429|469461644|FG000|Overall Study|Toxicity|0|||
130409981|NCT02041429|469461645|FG001|Overall Study|Toxicity|1|||
130409982|NCT02041429|469461646|FG002|Overall Study|Toxicity|4|||
130409983|NCT02041429|469461647|FG003|Overall Study|Toxicity|2|||
130409984|NCT02041429|469461644|FG000|Overall Study|Withdrawal by Subject|0|||
130409985|NCT02041429|469461645|FG001|Overall Study|Withdrawal by Subject|1|||
130409986|NCT02041429|469461646|FG002|Overall Study|Withdrawal by Subject|0|||
130409987|NCT02041429|469461647|FG003|Overall Study|Withdrawal by Subject|0|||
130409988|NCT02041429|469461644|FG000|Overall Study|On Maintenance Therapy|1|||
130409989|NCT02041429|469461645|FG001|Overall Study|On Maintenance Therapy|0|||
130409990|NCT02041429|469461646|FG002|Overall Study|On Maintenance Therapy|0|||
130409991|NCT02041429|469461647|FG003|Overall Study|On Maintenance Therapy|2|||
130409992|NCT01418209|469461648|FG000|Overall Study|Withdrawal by Subject|1|||
130409993|NCT01418209|469461649|FG001|Overall Study|Withdrawal by Subject|0|||
130409994|NCT01418209|469461650|FG002|Overall Study|Withdrawal by Subject|1|||
130409995|NCT01418209|469461648|FG000|Overall Study|Did not provide hot flash diary data|1|||
130409996|NCT01418209|469461649|FG001|Overall Study|Did not provide hot flash diary data|3|||
130409997|NCT01418209|469461650|FG002|Overall Study|Did not provide hot flash diary data|3|||
130409998|NCT00101101|469461651|FG000|Overall Study|never received vaccine|20|||
130409999|NCT01603875|469461653|FG000|Overall Study|Preexisting rabies antibody|3|||
130410000|NCT01603875|469461654|FG001|Overall Study|Preexisting rabies antibody|4|||
130410001|NCT01603875|469461655|FG002|Overall Study|Preexisting rabies antibody|3|||
130410002|NCT01603875|469461653|FG000|Overall Study|Lost to Follow-up|4|||
130410003|NCT01603875|469461654|FG001|Overall Study|Lost to Follow-up|3|||
130410004|NCT01603875|469461655|FG002|Overall Study|Lost to Follow-up|6|||
130410005|NCT01603875|469461653|FG000|Overall Study|Protocol Violation|0|||
130410006|NCT01603875|469461654|FG001|Overall Study|Protocol Violation|1|||
130410007|NCT01603875|469461655|FG002|Overall Study|Protocol Violation|0|||
130410008|NCT01971346|469461656|FG000|Overall Study|Protocol Violation|3|||
130410009|NCT01971346|469461656|FG000|Overall Study|Lost to Follow-up|2|||
130410010|NCT01971346|469461656|FG000|Overall Study|Withdrawal by Subject|2|||
130410011|NCT01971346|469461656|FG000|Overall Study|Physician Decision|1|||
130410012|NCT02460198|469461660|FG000|Overall Study|Adverse Event|1|||
130410013|NCT02460198|469461661|FG001|Overall Study|Adverse Event|3|||
130410014|NCT02460198|469461660|FG000|Overall Study|Death|36|||
130410015|NCT02460198|469461661|FG001|Overall Study|Death|28|||
130410016|NCT02460198|469461660|FG000|Overall Study|Lost to Follow-up|1|||
130410017|NCT02460198|469461661|FG001|Overall Study|Lost to Follow-up|1|||
130410018|NCT02460198|469461660|FG000|Overall Study|Transferred to Extension Study|15|||
130410019|NCT02460198|469461661|FG001|Overall Study|Transferred to Extension Study|15|||
130410020|NCT02460198|469461660|FG000|Overall Study|Withdrawal by Subject|2|||
130410021|NCT02460198|469461661|FG001|Overall Study|Withdrawal by Subject|4|||
130410022|NCT02460198|469461660|FG000|Overall Study|Site Terminated By Sponsor|0|||
130410023|NCT02460198|469461661|FG001|Overall Study|Site Terminated By Sponsor|1|||
130410024|NCT02460198|469461660|FG000|Overall Study|Did Not Continue on Extension Study|6|||
130410025|NCT02460198|469461661|FG001|Overall Study|Did Not Continue on Extension Study|11|||
130410026|NCT04382612|469461662|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
130410027|NCT04666441|469461663|FG000|Overall Study|Lost to Follow-up|1|||
130410028|NCT04666441|469461664|FG001|Overall Study|Lost to Follow-up|4|||
130410029|NCT04666441|469461665|FG002|Overall Study|Lost to Follow-up|1|||
130410030|NCT04666441|469461666|FG003|Overall Study|Lost to Follow-up|3|||
130410031|NCT04666441|469461667|FG004|Overall Study|Lost to Follow-up|0|||
130410032|NCT04666441|469461668|FG005|Overall Study|Lost to Follow-up|2|||
130410033|NCT04666441|469461669|FG006|Overall Study|Lost to Follow-up|2|||
130410034|NCT04666441|469461670|FG007|Overall Study|Lost to Follow-up|2|||
130410035|NCT04666441|469461663|FG000|Overall Study|Subject Decision|1|||
130410036|NCT04666441|469461664|FG001|Overall Study|Subject Decision|1|||
130410037|NCT04666441|469461665|FG002|Overall Study|Subject Decision|3|||
130410038|NCT04666441|469461666|FG003|Overall Study|Subject Decision|1|||
130410039|NCT04666441|469461667|FG004|Overall Study|Subject Decision|0|||
130410040|NCT04666441|469461668|FG005|Overall Study|Subject Decision|1|||
130473713|NCT04391894|469702545|FG004|Overall Study|Protocol Violation|0|||
130473714|NCT04391894|469702541|FG000|Overall Study|Withdrawal by Subject|2|||
130473715|NCT04391894|469702542|FG001|Overall Study|Withdrawal by Subject|0|||
130473716|NCT04391894|469702543|FG002|Overall Study|Withdrawal by Subject|3|||
130473717|NCT04391894|469702544|FG003|Overall Study|Withdrawal by Subject|0|||
130410041|NCT04666441|469461669|FG006|Overall Study|Subject Decision|3|||
130410042|NCT04666441|469461670|FG007|Overall Study|Subject Decision|2|||
130473718|NCT04391894|469702545|FG004|Overall Study|Withdrawal by Subject|1|||
130473719|NCT04391894|469702541|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
130473720|NCT04391894|469702542|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
130473721|NCT04391894|469702543|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
130473722|NCT04391894|469702544|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
130473723|NCT04391894|469702545|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
130410043|NCT03285477|469461671|FG000|Treatment and Response Assessment Period|Death|1|||
130410044|NCT03285477|469461672|FG001|Treatment and Response Assessment Period|Death|0|||
130410045|NCT03285477|469461671|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
130410046|NCT03285477|469461672|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
130410047|NCT03285477|469461671|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
130410048|NCT03285477|469461672|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
130410049|NCT03285477|469461671|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
130410050|NCT03285477|469461672|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
130410051|NCT03285477|469461671|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
130410052|NCT03285477|469461672|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
130410053|NCT00836875|469461675|FG000|Overall Study|Death|3|||
130410054|NCT00836875|469461676|FG001|Overall Study|Death|2|||
130410055|NCT00836875|469461675|FG000|Overall Study|Withdrawal by Subject|0|||
130410056|NCT00836875|469461676|FG001|Overall Study|Withdrawal by Subject|1|||
130410057|NCT01071395|469463757|FG000|Overall Study|Withdrawal by Subject|2|||
130410058|NCT01071395|469463758|FG001|Overall Study|Withdrawal by Subject|1|||
130410059|NCT01071395|469463757|FG000|Overall Study|Adverse Event|3|||
130410060|NCT01071395|469463758|FG001|Overall Study|Adverse Event|1|||
130410061|NCT01539291|469463759|FG000|Study GS-US-312-0116|Adverse Event|9|||
130410062|NCT01539291|469463760|FG001|Study GS-US-312-0116|Adverse Event|0|||
130410063|NCT01539291|469463761|FG002|Study GS-US-312-0116|Adverse Event|0|||
130410064|NCT01539291|469463762|FG003|Study GS-US-312-0116|Adverse Event|0|||
130410065|NCT01539291|469463759|FG000|Study GS-US-312-0116|Physician Decision|1|||
130410066|NCT01539291|469463760|FG001|Study GS-US-312-0116|Physician Decision|0|||
130410067|NCT01539291|469463761|FG002|Study GS-US-312-0116|Physician Decision|0|||
130410068|NCT01539291|469463762|FG003|Study GS-US-312-0116|Physician Decision|0|||
130410069|NCT01539291|469463759|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
130410070|NCT01539291|469463760|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
130410071|NCT01539291|469463761|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
130410072|NCT01539291|469463762|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
130410073|NCT01539291|469463759|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
130410074|NCT01539291|469463760|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130410075|NCT01539291|469463761|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130410076|NCT01539291|469463762|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130410077|NCT01539291|469463759|FG000|Study GS-US-312-0116|Other|1|||
130410078|NCT01539291|469463760|FG001|Study GS-US-312-0116|Other|0|||
130410079|NCT01539291|469463761|FG002|Study GS-US-312-0116|Other|0|||
130410080|NCT01539291|469463762|FG003|Study GS-US-312-0116|Other|0|||
130410081|NCT01539291|469463759|FG000|Study GS-US-312-0117|Adverse Event|22|||
130410082|NCT01539291|469463760|FG001|Study GS-US-312-0117|Adverse Event|1|||
130410083|NCT01539291|469463761|FG002|Study GS-US-312-0117|Adverse Event|9|||
130410084|NCT01539291|469463762|FG003|Study GS-US-312-0117|Adverse Event|12|||
130410085|NCT01539291|469463759|FG000|Study GS-US-312-0117|Physician Decision|9|||
130410086|NCT01539291|469463760|FG001|Study GS-US-312-0117|Physician Decision|0|||
130410087|NCT01539291|469463761|FG002|Study GS-US-312-0117|Physician Decision|6|||
130410088|NCT01539291|469463762|FG003|Study GS-US-312-0117|Physician Decision|4|||
130410089|NCT01539291|469463759|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
130410090|NCT01539291|469463760|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
130473724|NCT00220740|469702551|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
130473725|NCT00220740|469702552|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
130473726|NCT00220740|469702551|FG000|Efficacy Period|Adverse Event|1|||
130473727|NCT00220740|469702552|FG001|Efficacy Period|Adverse Event|1|||
130473728|NCT00220740|469702551|FG000|Efficacy Period|Withdrawal by Subject|1|||
130473729|NCT00220740|469702552|FG001|Efficacy Period|Withdrawal by Subject|0|||
130473730|NCT00220740|469702551|FG000|Efficacy Period|Protocol Violation|1|||
130473731|NCT00220740|469702552|FG001|Efficacy Period|Protocol Violation|0|||
130473732|NCT00220740|469702551|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
130410091|NCT01539291|469463761|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
130410092|NCT01539291|469463762|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
130410093|NCT01539291|469463759|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
130410094|NCT01539291|469463760|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
130410095|NCT01539291|469463761|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
130410096|NCT01539291|469463762|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
130410097|NCT01539291|469463759|FG000|Study GS-US-312-0117|Other|2|||
130410098|NCT01539291|469463760|FG001|Study GS-US-312-0117|Other|1|||
130410099|NCT01539291|469463761|FG002|Study GS-US-312-0117|Other|1|||
130410100|NCT01539291|469463762|FG003|Study GS-US-312-0117|Other|1|||
130410101|NCT02239510|469463765|FG000|Overall Study|Lost to Follow-up|2|||
130410102|NCT02239510|469463766|FG001|Overall Study|Lost to Follow-up|1|||
130410103|NCT03859323|469463769|FG000|Overall Study|Lost to Follow-up|0|||
130410104|NCT03859323|469463770|FG001|Overall Study|Lost to Follow-up|0|||
130410105|NCT03859323|469463771|FG002|Overall Study|Lost to Follow-up|0|||
130410106|NCT03859323|469463772|FG003|Overall Study|Lost to Follow-up|0|||
130410107|NCT03859323|469463773|FG004|Overall Study|Lost to Follow-up|0|||
130410108|NCT03859323|469463774|FG005|Overall Study|Lost to Follow-up|0|||
130410109|NCT03859323|469463775|FG006|Overall Study|Lost to Follow-up|1|||
130410110|NCT03859323|469463776|FG007|Overall Study|Lost to Follow-up|0|||
130410111|NCT03859323|469463777|FG008|Overall Study|Lost to Follow-up|0|||
130410112|NCT03859323|469463778|FG009|Overall Study|Lost to Follow-up|0|||
130410113|NCT03859323|469463779|FG010|Overall Study|Lost to Follow-up|0|||
130410114|NCT03859323|469463780|FG011|Overall Study|Lost to Follow-up|0|||
130410115|NCT03859323|469463781|FG012|Overall Study|Lost to Follow-up|0|||
130410116|NCT03859323|469463769|FG000|Overall Study|Withdrawal by Subject|0|||
130410117|NCT03859323|469463770|FG001|Overall Study|Withdrawal by Subject|0|||
130410118|NCT03859323|469463771|FG002|Overall Study|Withdrawal by Subject|1|||
130410119|NCT03859323|469463772|FG003|Overall Study|Withdrawal by Subject|0|||
130410120|NCT03859323|469463773|FG004|Overall Study|Withdrawal by Subject|0|||
130410121|NCT03859323|469463774|FG005|Overall Study|Withdrawal by Subject|1|||
130410122|NCT03859323|469463775|FG006|Overall Study|Withdrawal by Subject|0|||
130410123|NCT03859323|469463776|FG007|Overall Study|Withdrawal by Subject|0|||
130410124|NCT03859323|469463777|FG008|Overall Study|Withdrawal by Subject|0|||
130410125|NCT03859323|469463778|FG009|Overall Study|Withdrawal by Subject|1|||
130410126|NCT03859323|469463779|FG010|Overall Study|Withdrawal by Subject|1|||
130410127|NCT03859323|469463780|FG011|Overall Study|Withdrawal by Subject|2|||
130410128|NCT03859323|469463781|FG012|Overall Study|Withdrawal by Subject|1|||
130410129|NCT03859323|469463769|FG000|Overall Study|Pregnancy|0|||
130410130|NCT03859323|469463770|FG001|Overall Study|Pregnancy|0|||
130410131|NCT03859323|469463771|FG002|Overall Study|Pregnancy|0|||
130410132|NCT03859323|469463772|FG003|Overall Study|Pregnancy|0|||
130410133|NCT03859323|469463773|FG004|Overall Study|Pregnancy|0|||
130410134|NCT03859323|469463774|FG005|Overall Study|Pregnancy|0|||
130410135|NCT03859323|469463775|FG006|Overall Study|Pregnancy|0|||
130410136|NCT03859323|469463776|FG007|Overall Study|Pregnancy|0|||
130410137|NCT03859323|469463777|FG008|Overall Study|Pregnancy|0|||
130410138|NCT03859323|469463778|FG009|Overall Study|Pregnancy|1|||
130410139|NCT03859323|469463779|FG010|Overall Study|Pregnancy|0|||
130410140|NCT03859323|469463780|FG011|Overall Study|Pregnancy|0|||
130410141|NCT03859323|469463781|FG012|Overall Study|Pregnancy|0|||
130410142|NCT03794089|469463784|FG000|Overall Study|Lost to Follow-up|4|||
130410143|NCT03794089|469463785|FG001|Overall Study|Lost to Follow-up|1|||
130410144|NCT03794089|469463784|FG000|Overall Study|Withdrawal by Subject|2|||
130410145|NCT03794089|469463785|FG001|Overall Study|Withdrawal by Subject|0|||
130410146|NCT03985423|469463786|FG000|Overall Study|Adverse Event|1|||
130473733|NCT00220740|469702552|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
130473734|NCT01057433|469702553|FG000|Overall Study|Adverse Event|1|||
130473735|NCT05268302|469702554|FG000|Overall Study|Death|0|||
130473736|NCT05268302|469702555|FG001|Overall Study|Death|1|||
130473737|NCT02811679|469702556|FG000|Overall Study|Adverse Event|1|||
130473738|NCT02811679|469702556|FG000|Overall Study|Lack of Efficacy|6|||
130473739|NCT02811679|469702556|FG000|Overall Study|Early study closure due to slow accrual|3|||
130473740|NCT05319860|469702558|FG000|Overall Study|Death|1|||
130473741|NCT05319860|469702559|FG001|Overall Study|Death|1|||
130473742|NCT05319860|469702558|FG000|Overall Study|Lost to Follow-up|3|||
130473743|NCT05319860|469702559|FG001|Overall Study|Lost to Follow-up|1|||
130473744|NCT05319860|469702558|FG000|Overall Study|Withdrawal by Subject|1|||
130473745|NCT05319860|469702559|FG001|Overall Study|Withdrawal by Subject|7|||
130410147|NCT03985423|469463786|FG000|Overall Study|Death|2|||
130410148|NCT03985423|469463786|FG000|Overall Study|Physician Decision|1|||
130410149|NCT03985423|469463786|FG000|Overall Study|Withdrawal by Subject|2|||
130410150|NCT03985423|469463786|FG000|Overall Study|Lack of insurance and citizenship|1|||
130410151|NCT01045447|469463795|FG000|Overall Study|Adverse Event|0|||
130410152|NCT01045447|469463796|FG001|Overall Study|Adverse Event|1|||
130410153|NCT01045447|469463795|FG000|Overall Study|Lack of Efficacy|3|||
130410154|NCT01045447|469463796|FG001|Overall Study|Lack of Efficacy|1|||
130410155|NCT01045447|469463795|FG000|Overall Study|Protocol Violation|6|||
130410156|NCT01045447|469463796|FG001|Overall Study|Protocol Violation|3|||
130410157|NCT01045447|469463795|FG000|Overall Study|Withdrawal Criteria|10|||
130410158|NCT01045447|469463796|FG001|Overall Study|Withdrawal Criteria|10|||
130410159|NCT01045447|469463795|FG000|Overall Study|Unclassified|17|||
130410160|NCT01045447|469463796|FG001|Overall Study|Unclassified|13|||
130562587|NCT01236573|470027323|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562588|NCT01236573|470027324|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562589|NCT01236573|470027325|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562590|NCT01236573|470027326|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562591|NCT01236573|470027327|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562592|NCT01236573|470027328|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562593|NCT01236573|470027329|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562594|NCT01236573|470027330|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562595|NCT01236573|470027331|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
130562596|NCT01236573|470027332|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562597|NCT01236573|470027333|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130562598|NCT01236573|470027323|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562599|NCT01236573|470027324|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562600|NCT01236573|470027325|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562601|NCT01236573|470027326|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562602|NCT01236573|470027327|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562603|NCT01236573|470027328|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562604|NCT01236573|470027329|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562605|NCT01236573|470027330|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562606|NCT01236573|470027331|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562607|NCT01236573|470027332|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130562608|NCT01236573|470027333|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
130410161|NCT00129987|469463798|FG000|1st Educational Session|Withdrawal by Subject|141|||
130410162|NCT00129987|469463799|FG001|1st Educational Session|Withdrawal by Subject|109|||
130410163|NCT00129987|469463798|FG000|1 Year|Withdrawal by Subject|32|||
130410164|NCT00129987|469463799|FG001|1 Year|Withdrawal by Subject|21|||
130410165|NCT00116805|469463803|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
130410166|NCT00116805|469463804|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
130410167|NCT00116805|469463803|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
130410168|NCT00116805|469463804|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
130410169|NCT00116805|469463803|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
130410170|NCT00116805|469463804|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
130410171|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
130410172|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
130410173|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
130410174|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
130410175|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
130410176|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
130410177|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
130410178|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
130410179|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
130410180|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
130410181|NCT00116805|469463803|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
130410182|NCT00116805|469463804|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
130410183|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
130410184|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
130410185|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
130410186|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
130410187|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
130410188|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
130410189|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
130410190|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
130410191|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
130410192|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
130410193|NCT00116805|469463803|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
130410194|NCT00116805|469463804|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
130410195|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
130410196|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
130410197|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
130410198|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
130410199|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
130410200|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
130410201|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
130410202|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
130410203|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
130410204|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
130562609|NCT04109222|470027344|FG000|Overall Study|Adverse Event|1|||
130562610|NCT04109222|470027345|FG001|Overall Study|Adverse Event|0|||
130562611|NCT04109222|470027346|FG002|Overall Study|Adverse Event|0|||
130562612|NCT04569032|470027347|FG000|Overall Study|Death|10|||
130562613|NCT04569032|470027348|FG001|Overall Study|Death|13|||
130562614|NCT04569032|470027347|FG000|Overall Study|Withdrawal by Subject|2|||
130562615|NCT04569032|470027348|FG001|Overall Study|Withdrawal by Subject|0|||
130562616|NCT04569032|470027347|FG000|Overall Study|Lost to Follow-up|0|||
130562617|NCT04569032|470027348|FG001|Overall Study|Lost to Follow-up|1|||
130562618|NCT04569032|470027347|FG000|Overall Study|In long term follow up|22|||
130562619|NCT04569032|470027348|FG001|Overall Study|In long term follow up|34|||
130562620|NCT00701090|470027350|FG000|Overall Study|Adverse Event|11|||
130562621|NCT00701090|470027351|FG001|Overall Study|Adverse Event|2|||
130562622|NCT00701090|470027350|FG000|Overall Study|Death|0|||
130562623|NCT00701090|470027351|FG001|Overall Study|Death|1|||
130562624|NCT00701090|470027350|FG000|Overall Study|Lack of Efficacy|5|||
130562625|NCT00701090|470027351|FG001|Overall Study|Lack of Efficacy|4|||
130562626|NCT00701090|470027350|FG000|Overall Study|Lost to Follow-up|9|||
130562627|NCT00701090|470027351|FG001|Overall Study|Lost to Follow-up|9|||
130562628|NCT00701090|470027350|FG000|Overall Study|Physician Decision|3|||
130562629|NCT00701090|470027351|FG001|Overall Study|Physician Decision|4|||
130562630|NCT00701090|470027350|FG000|Overall Study|Protocol Violation|2|||
130562631|NCT00701090|470027351|FG001|Overall Study|Protocol Violation|3|||
130562632|NCT00701090|470027350|FG000|Overall Study|Withdrawal by Subject|11|||
130562633|NCT00701090|470027351|FG001|Overall Study|Withdrawal by Subject|16|||
130562634|NCT00701090|470027350|FG000|Overall Study|Other|7|||
130562635|NCT00701090|470027351|FG001|Overall Study|Other|12|||
130562636|NCT00873366|470027352|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
130562637|NCT00873366|470027352|FG000|Overall Study|Off tamoxifen due to side effects|2|||
130562638|NCT00873366|470027352|FG000|Overall Study|Refused to continue DM-BT testing|3|||
130562639|NCT01537198|470027364|FG000|Overall Study|RSV infection|2|||
130562640|NCT01537198|470027364|FG000|Overall Study|Adverse Event|4|||
130562641|NCT01537198|470027364|FG000|Overall Study|No Further Visits to the Clinic|37|||
130562642|NCT01537198|470027364|FG000|Overall Study|Other|111|||
130562643|NCT01231659|470027365|FG000|Overall Study|Adverse Event|9|||
130562644|NCT01231659|470027365|FG000|Overall Study|Disease Progression|48|||
130562645|NCT01231659|470027365|FG000|Overall Study|Death|2|||
130562646|NCT01231659|470027365|FG000|Overall Study|Patient refused to complete study visit|1|||
130562647|NCT01231659|470027365|FG000|Overall Study|Other protocol defined criteria|12|||
130562648|NCT04534491|470027366|FG000|Overall Study|Not completed end-of-study interview|24|||
130562649|NCT04534491|470027366|FG000|Overall Study|Non-users|70|||
130562650|NCT04534491|470027366|FG000|Overall Study|Non-verifiable users|58|||
130562651|NCT00131469|470027368|FG000|Overall Study|Withdrawal by Subject|3|||
130562652|NCT00131469|470027369|FG001|Overall Study|Withdrawal by Subject|4|||
130562653|NCT00131469|470027368|FG000|Overall Study|Protocol Violation|3|||
130562654|NCT00131469|470027369|FG001|Overall Study|Protocol Violation|1|||
130562655|NCT00131469|470027368|FG000|Overall Study|Death|0|||
130562656|NCT00131469|470027369|FG001|Overall Study|Death|1|||
130562657|NCT00131469|470027368|FG000|Overall Study|Lost to Follow-up|0|||
130562658|NCT00131469|470027369|FG001|Overall Study|Lost to Follow-up|1|||
130562659|NCT00131469|470027368|FG000|Overall Study|scan not analyzable|3|||
130562660|NCT00131469|470027369|FG001|Overall Study|scan not analyzable|6|||
130562661|NCT02247960|470027370|FG000|Patient Consent and Randomization|Physician Decision|2|||
130562662|NCT02247960|470027371|FG001|Patient Consent and Randomization|Physician Decision|2|||
130562663|NCT02247960|470027370|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
130562664|NCT02247960|470027371|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
130562665|NCT02247960|470027370|FG000|Catheter Removed|Lost to Follow-up|7|||
130562666|NCT02247960|470027371|FG001|Catheter Removed|Lost to Follow-up|10|||
130562667|NCT00356889|470027372|FG000|Overall Study|Protocol Violation|2|||
130562668|NCT00356889|470027372|FG000|Overall Study|Adverse Event|1|||
130562669|NCT00736034|470027373|FG000|Overall Study|Adverse Event|2|||
130562670|NCT02566577|470027375|FG000|Overall Study|Withdrawal by Subject|1|||
130562671|NCT02566577|470027376|FG001|Overall Study|Withdrawal by Subject|1|||
130562672|NCT02566577|470027375|FG000|Overall Study|Equipment failure|1|||
130410205|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
130410206|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
130410207|NCT00116805|469463803|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
130562673|NCT02566577|470027376|FG001|Overall Study|Equipment failure|1|||
130562674|NCT02566577|470027375|FG000|Overall Study|Physical limitation|1|||
130562675|NCT02566577|470027376|FG001|Overall Study|Physical limitation|0|||
130562676|NCT03086057|470027382|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
130562677|NCT03086057|470027383|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
130562678|NCT03086057|470027384|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
130562679|NCT03086057|470027385|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
130562680|NCT03086057|470027382|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
130562681|NCT03086057|470027383|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
130562682|NCT03086057|470027384|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
130562683|NCT03086057|470027385|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
130562684|NCT03086057|470027382|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
130562685|NCT03086057|470027383|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
130562686|NCT03086057|470027384|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
130562687|NCT03086057|470027385|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
130562688|NCT03086057|470027382|FG000|Stage 1: PrEP Uptake|Death|1|||
130562689|NCT03086057|470027383|FG001|Stage 1: PrEP Uptake|Death|0|||
130562690|NCT03086057|470027384|FG002|Stage 1: PrEP Uptake|Death|0|||
130562691|NCT03086057|470027385|FG003|Stage 1: PrEP Uptake|Death|0|||
130562692|NCT03086057|470027382|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
130562693|NCT03086057|470027383|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
130562694|NCT03086057|470027384|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
130562695|NCT03086057|470027385|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
130562696|NCT03086057|470027382|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130562697|NCT03086057|470027383|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130562698|NCT03086057|470027384|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
130562699|NCT03086057|470027385|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130562700|NCT03086057|470027382|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
130562701|NCT03086057|470027383|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
130562702|NCT03086057|470027384|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
130562703|NCT03086057|470027385|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
130562704|NCT04305275|470027386|FG000|Overall Study|Adverse Event|4|||
130562705|NCT04305275|470027387|FG001|Overall Study|Adverse Event|0|||
130562706|NCT04305275|470027386|FG000|Overall Study|Lost to Follow-up|1|||
130562707|NCT04305275|470027387|FG001|Overall Study|Lost to Follow-up|1|||
130562708|NCT04305275|470027386|FG000|Overall Study|Withdrawal by Participant|8|||
130562709|NCT04305275|470027387|FG001|Overall Study|Withdrawal by Participant|1|||
130562710|NCT01708291|470027398|FG000|Overall Study|fighting|2|||
130562711|NCT01708291|470027399|FG001|Overall Study|fighting|1|||
130562712|NCT01536951|470027400|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562713|NCT01536951|470027401|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562714|NCT01536951|470027402|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
130562715|NCT01536951|470027403|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562716|NCT01536951|470027404|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562717|NCT01536951|470027405|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562718|NCT01536951|470027406|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562719|NCT01536951|470027407|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562720|NCT01536951|470027408|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130562721|NCT01536951|470027400|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
130562722|NCT01536951|470027401|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
130562723|NCT01536951|470027402|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
130562724|NCT01536951|470027403|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
130562725|NCT01536951|470027404|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
130562726|NCT01536951|470027405|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
130562727|NCT01536951|470027406|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
130562728|NCT01536951|470027407|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
130562729|NCT01536951|470027408|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
130562730|NCT01843972|470027409|FG000|Overall Study|Withdrawal by Subject|0|||
130562731|NCT01843972|470027410|FG001|Overall Study|Withdrawal by Subject|0|||
130562732|NCT01843972|470027411|FG002|Overall Study|Withdrawal by Subject|0|||
130562733|NCT01843972|470027412|FG003|Overall Study|Withdrawal by Subject|0|||
130562734|NCT01843972|470027413|FG004|Overall Study|Withdrawal by Subject|1|||
130562735|NCT01843972|470027414|FG005|Overall Study|Withdrawal by Subject|0|||
130562736|NCT01843972|470027415|FG006|Overall Study|Withdrawal by Subject|0|||
130562737|NCT01843972|470027416|FG007|Overall Study|Withdrawal by Subject|0|||
130562738|NCT01843972|470027417|FG008|Overall Study|Withdrawal by Subject|0|||
130562739|NCT01843972|470027418|FG009|Overall Study|Withdrawal by Subject|0|||
130562740|NCT00932425|470027419|FG000|Overall Study|Lost to Follow-up|0|||
130562741|NCT00932425|470027420|FG001|Overall Study|Lost to Follow-up|1|||
130562742|NCT00932425|470027419|FG000|Overall Study|Withdrawal by Subject|0|||
130562743|NCT00932425|470027420|FG001|Overall Study|Withdrawal by Subject|1|||
130562744|NCT00382018|470027421|FG000|Overall Study|Progression|0|||
130562745|NCT00382018|470027422|FG001|Overall Study|Progression|136|||
130562746|NCT00382018|470027423|FG002|Overall Study|Progression|51|||
130562747|NCT00382018|470027424|FG003|Overall Study|Progression|43|||
130562748|NCT00382018|470027421|FG000|Overall Study|Death|0|||
130562749|NCT00382018|470027422|FG001|Overall Study|Death|9|||
130562750|NCT00382018|470027423|FG002|Overall Study|Death|7|||
130562751|NCT00382018|470027424|FG003|Overall Study|Death|11|||
130562752|NCT00382018|470027421|FG000|Overall Study|Withdrawal by Subject|0|||
130562753|NCT00382018|470027422|FG001|Overall Study|Withdrawal by Subject|4|||
130562754|NCT00382018|470027423|FG002|Overall Study|Withdrawal by Subject|3|||
130562755|NCT00382018|470027424|FG003|Overall Study|Withdrawal by Subject|4|||
130562756|NCT00382018|470027421|FG000|Overall Study|Other, not protocol specified|0|||
130562757|NCT00382018|470027422|FG001|Overall Study|Other, not protocol specified|16|||
130727143|NCT02883049|470625439|FG015|Induction|Enrolled onto another COG study|0|||
130410208|NCT00116805|469463804|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
130410209|NCT00116805|469463803|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
130410210|NCT00116805|469463804|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
130410211|NCT00116805|469463803|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
130410212|NCT00116805|469463804|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
130410213|NCT00116805|469463803|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
130410214|NCT00116805|469463804|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
130410215|NCT00116805|469463803|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
130410216|NCT00116805|469463804|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
130410217|NCT00116805|469463803|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
130410218|NCT00116805|469463804|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
130410219|NCT00116805|469463803|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
130410220|NCT00116805|469463804|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
130410221|NCT00116805|469463803|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
130410222|NCT00116805|469463804|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
130410223|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
130410224|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
130410225|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
130410226|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
130410227|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
130410228|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
130410229|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
130410230|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
130410231|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
130473746|NCT04314895|469702560|FG000|Overall Study|Lost to Follow-up|1|||
130473747|NCT04314895|469702560|FG000|Overall Study|Death|10|||
130473748|NCT04314895|469702560|FG000|Overall Study|Physician Decision|2|||
130473749|NCT03941860|469702561|FG000|Overall Study|Withdrawal by Subject|0|||
130473750|NCT03941860|469702562|FG001|Overall Study|Withdrawal by Subject|1|||
130473751|NCT04402489|469704649|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
130473752|NCT04402489|469704650|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
130473753|NCT04402489|469704651|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
130473754|NCT04402489|469704652|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
130473755|NCT04402489|469704653|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
130473756|NCT04402489|469704649|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
130473757|NCT04402489|469704650|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
130473758|NCT04402489|469704651|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
130473759|NCT04402489|469704652|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
130473760|NCT04402489|469704653|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
130473761|NCT04402489|469704649|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
130473762|NCT04402489|469704650|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
130473763|NCT04402489|469704651|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
130473764|NCT04402489|469704652|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
130473765|NCT04402489|469704653|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
130473766|NCT04402489|469704649|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
130473767|NCT04402489|469704650|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
130473768|NCT04402489|469704651|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
130473769|NCT04402489|469704652|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
130473770|NCT04402489|469704653|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
130473771|NCT04402489|469704649|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
130473772|NCT04402489|469704650|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
130473773|NCT04402489|469704651|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
130473774|NCT04402489|469704652|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
130473775|NCT04402489|469704653|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
130473776|NCT04402489|469704649|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
130473777|NCT04402489|469704650|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
130473778|NCT04402489|469704651|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
130473779|NCT04402489|469704652|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
130473780|NCT04402489|469704653|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
130473781|NCT04833777|469704659|FG000|Overall Study|Lost to Follow-up|1|||
130473782|NCT04833777|469704660|FG001|Overall Study|Lost to Follow-up|0|||
130473783|NCT03648840|469704669|FG000|First IV Infusion Session|Adverse Event|0|||
130473784|NCT03648840|469704670|FG001|First IV Infusion Session|Adverse Event|2|||
130562758|NCT00382018|470027423|FG002|Overall Study|Other, not protocol specified|3|||
130562759|NCT00382018|470027424|FG003|Overall Study|Other, not protocol specified|1|||
130562760|NCT03805750|470027425|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
130562761|NCT03805750|470027426|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
130562762|NCT00789880|470027427|FG000|Overall Study|Adverse Event|0|||
130562763|NCT00789880|470027428|FG001|Overall Study|Adverse Event|0|||
130562764|NCT00789880|470027429|FG002|Overall Study|Adverse Event|0|||
130562765|NCT00789880|470027430|FG003|Overall Study|Adverse Event|0|||
130562766|NCT00789880|470027431|FG004|Overall Study|Adverse Event|1|||
130562767|NCT00789880|470027432|FG005|Overall Study|Adverse Event|0|||
130562768|NCT00789880|470027427|FG000|Overall Study|Protocol Violation|0|||
130562769|NCT00789880|470027428|FG001|Overall Study|Protocol Violation|1|||
130562770|NCT00789880|470027429|FG002|Overall Study|Protocol Violation|0|||
130562771|NCT00789880|470027430|FG003|Overall Study|Protocol Violation|1|||
130562772|NCT00789880|470027431|FG004|Overall Study|Protocol Violation|0|||
130562773|NCT00789880|470027432|FG005|Overall Study|Protocol Violation|0|||
130562774|NCT00789880|470027427|FG000|Overall Study|Withdrawal by Subject|1|||
130562775|NCT00789880|470027428|FG001|Overall Study|Withdrawal by Subject|0|||
130562776|NCT00789880|470027429|FG002|Overall Study|Withdrawal by Subject|0|||
130562777|NCT00789880|470027430|FG003|Overall Study|Withdrawal by Subject|0|||
130562778|NCT00789880|470027431|FG004|Overall Study|Withdrawal by Subject|2|||
130562779|NCT00789880|470027432|FG005|Overall Study|Withdrawal by Subject|0|||
130562780|NCT01977820|470027437|FG000|Overall Study|Sponsor terminated the study|1|||
130562781|NCT01977820|470027438|FG001|Overall Study|Sponsor terminated the study|1|||
130562782|NCT02568475|470027439|FG000|Overall Study|Lost to Follow-up|40|||
130562783|NCT02568475|470027440|FG001|Overall Study|Lost to Follow-up|39|||
130562784|NCT02568475|470027439|FG000|Overall Study|Withdrawal by Subject|2|||
130562785|NCT02568475|470027440|FG001|Overall Study|Withdrawal by Subject|0|||
130562786|NCT02568475|470027439|FG000|Overall Study|Discharged home|4|||
130562787|NCT02568475|470027440|FG001|Overall Study|Discharged home|4|||
130562788|NCT02568475|470027439|FG000|Overall Study|Short-term: Discharge location unknown|4|||
130562789|NCT02568475|470027440|FG001|Overall Study|Short-term: Discharge location unknown|0|||
130562790|NCT02568475|470027439|FG000|Overall Study|Transferred to another facility|1|||
130562791|NCT02568475|470027440|FG001|Overall Study|Transferred to another facility|0|||
130562792|NCT00493220|470027441|FG000|Third Intervention|Withdrawal by Subject|1|||
130562793|NCT00493220|470027442|FG001|Third Intervention|Withdrawal by Subject|0|||
130562794|NCT00493220|470027443|FG002|Third Intervention|Withdrawal by Subject|0|||
130562795|NCT00493220|470027444|FG003|Third Intervention|Withdrawal by Subject|0|||
130562796|NCT00493220|470027445|FG004|Third Intervention|Withdrawal by Subject|0|||
130562797|NCT00493220|470027446|FG005|Third Intervention|Withdrawal by Subject|0|||
130562798|NCT02625233|470027447|FG000|Overall Study|Adverse Event|2|||
130562799|NCT02625233|470027448|FG001|Overall Study|Adverse Event|0|||
130562800|NCT00445224|470027456|FG000|Specific Exercises|Withdrawal by Subject|3|||
130562801|NCT00445224|470027457|FG001|Specific Exercises|Withdrawal by Subject|3|||
130562802|NCT00445224|470027456|FG000|Specific Exercises|Withdrawal by Subject|1|||
130562803|NCT00445224|470027457|FG001|Specific Exercises|Withdrawal by Subject|0|||
130562804|NCT00591214|470027460|FG000|Overall Study|Physician Decision|7|||
130562805|NCT00591214|470027460|FG000|Overall Study|Withdrawal by Subject|1|||
130562806|NCT01129921|470027461|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
130562807|NCT01129921|470027462|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
130562808|NCT01129921|470027461|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
130562809|NCT01129921|470027462|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
130562810|NCT01129921|470027461|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
130562811|NCT01129921|470027462|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
130562812|NCT01129921|470027461|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
130562813|NCT01129921|470027462|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
130562814|NCT05050318|470028729|FG000|Overall Study|Protocol Deviation|1|||
130562815|NCT05050318|470028730|FG001|Overall Study|Protocol Deviation|0|||
130562816|NCT05050318|470028731|FG002|Overall Study|Protocol Deviation|0|||
130562817|NCT00574145|470028739|FG000|Overall Study|Withdrawal by Subject|2|||
130562818|NCT00574145|470028740|FG001|Overall Study|Withdrawal by Subject|1|||
130562819|NCT03227471|470028744|FG000|Overall Study|Withdrawal by Subject|0|||
130562820|NCT03227471|470028745|FG001|Overall Study|Withdrawal by Subject|0|||
130562821|NCT03227471|470028746|FG002|Overall Study|Withdrawal by Subject|0|||
130562822|NCT03227471|470028747|FG003|Overall Study|Withdrawal by Subject|0|||
130562823|NCT03227471|470028748|FG004|Overall Study|Withdrawal by Subject|1|||
130562824|NCT03227471|470028749|FG005|Overall Study|Withdrawal by Subject|0|||
130562825|NCT03227471|470028750|FG006|Overall Study|Withdrawal by Subject|0|||
130562826|NCT03227471|470028751|FG007|Overall Study|Withdrawal by Subject|0|||
130562827|NCT03227471|470028752|FG008|Overall Study|Withdrawal by Subject|0|||
130562828|NCT03227471|470028753|FG009|Overall Study|Withdrawal by Subject|0|||
130562829|NCT03227471|470028754|FG010|Overall Study|Withdrawal by Subject|0|||
130562830|NCT03227471|470028755|FG011|Overall Study|Withdrawal by Subject|0|||
130562831|NCT03227471|470028756|FG012|Overall Study|Withdrawal by Subject|1|||
130562832|NCT03227471|470028757|FG013|Overall Study|Withdrawal by Subject|0|||
130562833|NCT03227471|470028758|FG014|Overall Study|Withdrawal by Subject|0|||
130562834|NCT03227471|470028744|FG000|Overall Study|Randomized, Never Dosed|0|||
130562835|NCT03227471|470028745|FG001|Overall Study|Randomized, Never Dosed|0|||
130562836|NCT03227471|470028746|FG002|Overall Study|Randomized, Never Dosed|0|||
130562837|NCT03227471|470028747|FG003|Overall Study|Randomized, Never Dosed|0|||
130562838|NCT03227471|470028748|FG004|Overall Study|Randomized, Never Dosed|0|||
130562839|NCT03227471|470028749|FG005|Overall Study|Randomized, Never Dosed|0|||
130562840|NCT03227471|470028750|FG006|Overall Study|Randomized, Never Dosed|0|||
130562841|NCT03227471|470028751|FG007|Overall Study|Randomized, Never Dosed|0|||
130562842|NCT03227471|470028752|FG008|Overall Study|Randomized, Never Dosed|0|||
130562843|NCT03227471|470028753|FG009|Overall Study|Randomized, Never Dosed|0|||
130562844|NCT03227471|470028754|FG010|Overall Study|Randomized, Never Dosed|0|||
130562845|NCT03227471|470028755|FG011|Overall Study|Randomized, Never Dosed|0|||
130562846|NCT03227471|470028756|FG012|Overall Study|Randomized, Never Dosed|0|||
130562847|NCT03227471|470028757|FG013|Overall Study|Randomized, Never Dosed|0|||
130562848|NCT03227471|470028758|FG014|Overall Study|Randomized, Never Dosed|1|||
130562849|NCT00382720|470028759|FG000|Overall Study|Adverse Event|21|||
130562850|NCT00382720|470028760|FG001|Overall Study|Adverse Event|23|||
130562851|NCT00382720|470028761|FG002|Overall Study|Adverse Event|15|||
130562852|NCT00382720|470028759|FG000|Overall Study|Protocol Violation|2|||
130562853|NCT00382720|470028760|FG001|Overall Study|Protocol Violation|5|||
130562854|NCT00382720|470028761|FG002|Overall Study|Protocol Violation|1|||
130562855|NCT00382720|470028759|FG000|Overall Study|Death|0|||
130562856|NCT00382720|470028760|FG001|Overall Study|Death|1|||
130562857|NCT00382720|470028761|FG002|Overall Study|Death|2|||
130562858|NCT00382720|470028759|FG000|Overall Study|Progressive disease|37|||
130562859|NCT00382720|470028760|FG001|Overall Study|Progressive disease|28|||
130562860|NCT00382720|470028761|FG002|Overall Study|Progressive disease|38|||
130562861|NCT00382720|470028759|FG000|Overall Study|Withdrew consent|1|||
130562862|NCT00382720|470028760|FG001|Overall Study|Withdrew consent|1|||
130562863|NCT00382720|470028761|FG002|Overall Study|Withdrew consent|2|||
130562864|NCT00382720|470028759|FG000|Overall Study|Withdrawal by Subject|11|||
130562865|NCT00382720|470028760|FG001|Overall Study|Withdrawal by Subject|20|||
130562866|NCT00382720|470028761|FG002|Overall Study|Withdrawal by Subject|12|||
130562867|NCT00382720|470028759|FG000|Overall Study|Surgery|1|||
130562868|NCT00382720|470028760|FG001|Overall Study|Surgery|1|||
130562869|NCT00382720|470028761|FG002|Overall Study|Surgery|4|||
130562870|NCT00382720|470028759|FG000|Overall Study|Patient did not receive study medication|1|||
130562871|NCT00382720|470028760|FG001|Overall Study|Patient did not receive study medication|1|||
130562872|NCT00382720|470028761|FG002|Overall Study|Patient did not receive study medication|4|||
130562873|NCT00382720|470028759|FG000|Overall Study|Clinically progressive disease|0|||
130562874|NCT00382720|470028760|FG001|Overall Study|Clinically progressive disease|1|||
130562875|NCT00382720|470028761|FG002|Overall Study|Clinically progressive disease|0|||
130562876|NCT00382720|470028759|FG000|Overall Study|Good prognosis|0|||
130562877|NCT00382720|470028760|FG001|Overall Study|Good prognosis|1|||
130562878|NCT00382720|470028761|FG002|Overall Study|Good prognosis|0|||
130562879|NCT00382720|470028759|FG000|Overall Study|Investigator/Clinical decision|5|||
130562880|NCT00382720|470028760|FG001|Overall Study|Investigator/Clinical decision|6|||
130562881|NCT00382720|470028761|FG002|Overall Study|Investigator/Clinical decision|6|||
130562882|NCT00382720|470028759|FG000|Overall Study|Discontinued at end of study|0|||
130562883|NCT00382720|470028760|FG001|Overall Study|Discontinued at end of study|1|||
130562884|NCT00382720|470028761|FG002|Overall Study|Discontinued at end of study|2|||
130562885|NCT02142738|470028764|FG000|Overall Study|Adverse Event|13|||
130562886|NCT02142738|470028765|FG001|Overall Study|Adverse Event|9|||
130562887|NCT02142738|470028764|FG000|Overall Study|Death|92|||
130562888|NCT02142738|470028765|FG001|Overall Study|Death|112|||
130562889|NCT02142738|470028764|FG000|Overall Study|Lost to Follow-up|0|||
130562890|NCT02142738|470028765|FG001|Overall Study|Lost to Follow-up|3|||
130562891|NCT02142738|470028764|FG000|Overall Study|Withdrawal by Subject|6|||
130562892|NCT02142738|470028765|FG001|Overall Study|Withdrawal by Subject|7|||
130562893|NCT02142738|470028764|FG000|Overall Study|Follow up ended by sponsor|43|||
130562894|NCT02142738|470028765|FG001|Overall Study|Follow up ended by sponsor|20|||
130562895|NCT03688880|470028766|FG000|Overall Study|Withdrawal by Subject|0|||
130562896|NCT03688880|470028767|FG001|Overall Study|Withdrawal by Subject|2|||
130562897|NCT03688880|470028766|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
130562898|NCT03688880|470028767|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
130562899|NCT03688880|470028766|FG000|Overall Study|Lost to Follow-up|4|||
130562900|NCT03688880|470028767|FG001|Overall Study|Lost to Follow-up|7|||
130562901|NCT03688880|470028766|FG000|Overall Study|Adverse Event|0|||
130562902|NCT03688880|470028767|FG001|Overall Study|Adverse Event|2|||
130562903|NCT03688880|470028766|FG000|Overall Study|Device deficiencies|0|||
130562904|NCT03688880|470028767|FG001|Overall Study|Device deficiencies|2|||
130562905|NCT03688880|470028766|FG000|Overall Study|Other|10|||
130562906|NCT03688880|470028767|FG001|Overall Study|Other|16|||
130562907|NCT01704287|470028769|FG000|Initial Treatment Period|Death|139|||
130562908|NCT01704287|470028770|FG001|Initial Treatment Period|Death|129|||
130562909|NCT01704287|470028771|FG002|Initial Treatment Period|Death|71|||
130562910|NCT01704287|470028772|FG003|Initial Treatment Period|Death|0|||
130562911|NCT01704287|470028773|FG004|Initial Treatment Period|Death|0|||
130562912|NCT01704287|470028769|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
130562913|NCT01704287|470028770|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
130562914|NCT01704287|470028771|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
130562915|NCT01704287|470028772|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
130562916|NCT01704287|470028773|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
130562917|NCT01704287|470028769|FG000|Initial Treatment Period|Lost to Follow-up|5|||
130562918|NCT01704287|470028770|FG001|Initial Treatment Period|Lost to Follow-up|3|||
130562919|NCT01704287|470028771|FG002|Initial Treatment Period|Lost to Follow-up|0|||
130562920|NCT01704287|470028772|FG003|Initial Treatment Period|Lost to Follow-up|0|||
130562921|NCT01704287|470028773|FG004|Initial Treatment Period|Lost to Follow-up|0|||
130562922|NCT01704287|470028769|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
130562923|NCT01704287|470028770|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
130562924|NCT01704287|470028771|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
130562925|NCT01704287|470028772|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
130562926|NCT01704287|470028773|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
130562927|NCT01704287|470028769|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130562928|NCT01704287|470028770|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130562929|NCT01704287|470028771|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130562930|NCT01704287|470028772|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
130562931|NCT01704287|470028773|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
130562932|NCT01704287|470028769|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
130562933|NCT01704287|470028770|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
130562934|NCT01704287|470028771|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
130562935|NCT01704287|470028772|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
130562936|NCT01704287|470028773|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
130562937|NCT01704287|470028769|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130562938|NCT01704287|470028770|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130562939|NCT01704287|470028771|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130562940|NCT01704287|470028772|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
130562941|NCT01704287|470028773|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130562942|NCT04024228|470028774|FG000|Overall Study|Adverse Event|1|||
130562943|NCT04024228|470028775|FG001|Overall Study|Adverse Event|0|||
130562944|NCT04024228|470028774|FG000|Overall Study|Protocol Deviation|0|||
130562945|NCT04024228|470028775|FG001|Overall Study|Protocol Deviation|2|||
130562946|NCT04024228|470028774|FG000|Overall Study|Withdrawal by Subject|3|||
130562947|NCT04024228|470028775|FG001|Overall Study|Withdrawal by Subject|4|||
130562948|NCT04490395|470028776|FG000|Overall Study|Lost to Follow-up|0|||
130562949|NCT04490395|470028777|FG001|Overall Study|Lost to Follow-up|1|||
130562950|NCT00938717|470028778|FG000|Overall Study|Adverse Event|10|||
130562951|NCT00938717|470028779|FG001|Overall Study|Adverse Event|41|||
130562952|NCT00938717|470028778|FG000|Overall Study|Protocol Violation|11|||
130562953|NCT00938717|470028779|FG001|Overall Study|Protocol Violation|8|||
130562954|NCT00938717|470028778|FG000|Overall Study|Withdrawal by Subject|26|||
130562955|NCT00938717|470028779|FG001|Overall Study|Withdrawal by Subject|24|||
130562956|NCT00938717|470028778|FG000|Overall Study|Lost to Follow-up|13|||
130562957|NCT00938717|470028779|FG001|Overall Study|Lost to Follow-up|18|||
130562958|NCT00938717|470028778|FG000|Overall Study|Lack of Efficacy|33|||
130562959|NCT00938717|470028779|FG001|Overall Study|Lack of Efficacy|15|||
130562960|NCT00938717|470028778|FG000|Overall Study|Other reason|5|||
130562961|NCT00938717|470028779|FG001|Overall Study|Other reason|2|||
130562962|NCT01462435|470028782|FG000|Overall Study|Lack of Efficacy|1|||
130562963|NCT01462435|470028783|FG001|Overall Study|Lack of Efficacy|0|||
130562964|NCT01462435|470028784|FG002|Overall Study|Lack of Efficacy|0|||
130562965|NCT01462435|470028785|FG003|Overall Study|Lack of Efficacy|3|||
130562966|NCT01462435|470028782|FG000|Overall Study|Physician Decision|0|||
130562967|NCT01462435|470028783|FG001|Overall Study|Physician Decision|0|||
130562968|NCT01462435|470028784|FG002|Overall Study|Physician Decision|1|||
130562969|NCT01462435|470028785|FG003|Overall Study|Physician Decision|0|||
130562970|NCT01462435|470028782|FG000|Overall Study|Withdrawal by Subject|0|||
130562971|NCT01462435|470028783|FG001|Overall Study|Withdrawal by Subject|0|||
130727144|NCT02883049|470625424|FG000|Induction|Incomplete induction data|17|||
130727145|NCT02883049|470625425|FG001|Induction|Incomplete induction data|0|||
130727146|NCT02883049|470625426|FG002|Induction|Incomplete induction data|0|||
130727147|NCT02883049|470625427|FG003|Induction|Incomplete induction data|0|||
130727148|NCT02883049|470625428|FG004|Induction|Incomplete induction data|0|||
130727149|NCT02883049|470625429|FG005|Induction|Incomplete induction data|0|||
130727150|NCT02883049|470625430|FG006|Induction|Incomplete induction data|0|||
130727151|NCT02883049|470625431|FG007|Induction|Incomplete induction data|0|||
130562972|NCT01462435|470028784|FG002|Overall Study|Withdrawal by Subject|0|||
130562973|NCT01462435|470028785|FG003|Overall Study|Withdrawal by Subject|1|||
130562974|NCT01462435|470028782|FG000|Overall Study|Lost to Follow-up|0|||
130562975|NCT01462435|470028783|FG001|Overall Study|Lost to Follow-up|0|||
130562976|NCT01462435|470028784|FG002|Overall Study|Lost to Follow-up|0|||
130562977|NCT01462435|470028785|FG003|Overall Study|Lost to Follow-up|1|||
130562978|NCT05092919|470028786|FG000|Overall Study|Lost to Follow-up|7|||
130562979|NCT05092919|470028786|FG000|Overall Study|Withdrawal by Subject|2|||
130562980|NCT01942148|470028788|FG000|Overall Study|Adverse Event|4|||
130562981|NCT01942148|470028788|FG000|Overall Study|Lack of Efficacy|2|||
130562982|NCT01942148|470028788|FG000|Overall Study|Physician Decision|11|||
130562983|NCT01942148|470028788|FG000|Overall Study|Protocol Violation|1|||
130562984|NCT01942148|470028788|FG000|Overall Study|Withdrawal by Subject|8|||
130562985|NCT01942148|470028788|FG000|Overall Study|Use of the prohibition medicine|1|||
130562986|NCT02163187|470028789|FG000|Overall Study|Device removed|1|||
130562987|NCT02163187|470028790|FG001|Overall Study|Device removed|0|||
130562988|NCT02163187|470028789|FG000|Overall Study|Progressive disease|1|||
130562989|NCT02163187|470028790|FG001|Overall Study|Progressive disease|0|||
130562990|NCT00257725|470028792|FG000|Overall Study|Adverse Event|3|||
130562991|NCT01858532|470028793|FG000|Overall Study|Adverse Event|58|||
130562992|NCT01858532|470028794|FG001|Overall Study|Adverse Event|50|||
130562993|NCT01858532|470028795|FG002|Overall Study|Adverse Event|23|||
130562994|NCT01858532|470028796|FG003|Overall Study|Adverse Event|28|||
130562995|NCT01858532|470028793|FG000|Overall Study|Withdrew consent|71|||
130562996|NCT01858532|470028794|FG001|Overall Study|Withdrew consent|93|||
130562997|NCT01858532|470028795|FG002|Overall Study|Withdrew consent|46|||
130727152|NCT02883049|470625432|FG008|Induction|Incomplete induction data|0|||
130727153|NCT02883049|470625433|FG009|Induction|Incomplete induction data|0|||
130727154|NCT02883049|470625434|FG010|Induction|Incomplete induction data|0|||
130727155|NCT02883049|470625435|FG011|Induction|Incomplete induction data|0|||
130727156|NCT02883049|470625436|FG012|Induction|Incomplete induction data|0|||
130727157|NCT02883049|470625437|FG013|Induction|Incomplete induction data|0|||
130727158|NCT02883049|470625438|FG014|Induction|Incomplete induction data|0|||
130727159|NCT02883049|470625439|FG015|Induction|Incomplete induction data|0|||
130562998|NCT01858532|470028796|FG003|Overall Study|Withdrew consent|27|||
130562999|NCT01858532|470028793|FG000|Overall Study|Lost to Follow-up|17|||
130563000|NCT01858532|470028794|FG001|Overall Study|Lost to Follow-up|26|||
130563001|NCT01858532|470028795|FG002|Overall Study|Lost to Follow-up|11|||
130563002|NCT01858532|470028796|FG003|Overall Study|Lost to Follow-up|14|||
130563003|NCT01858532|470028793|FG000|Overall Study|Deterioration of medical status|3|||
130563004|NCT01858532|470028794|FG001|Overall Study|Deterioration of medical status|4|||
130563005|NCT01858532|470028795|FG002|Overall Study|Deterioration of medical status|3|||
130563006|NCT01858532|470028796|FG003|Overall Study|Deterioration of medical status|7|||
130563007|NCT01858532|470028793|FG000|Overall Study|Investigator request|3|||
130563008|NCT01858532|470028794|FG001|Overall Study|Investigator request|4|||
130563009|NCT01858532|470028795|FG002|Overall Study|Investigator request|2|||
130563010|NCT01858532|470028796|FG003|Overall Study|Investigator request|6|||
130563011|NCT01858532|470028793|FG000|Overall Study|Other, not specified|29|||
130563012|NCT01858532|470028794|FG001|Overall Study|Other, not specified|15|||
130563013|NCT01858532|470028795|FG002|Overall Study|Other, not specified|13|||
130563014|NCT01858532|470028796|FG003|Overall Study|Other, not specified|11|||
130563015|NCT00514514|470028797|FG000|Pre-phase|Death|10|||
130563016|NCT00514514|470028798|FG001|Pre-phase|Death|0|||
130563017|NCT00514514|470028799|FG002|Pre-phase|Death|0|||
130563018|NCT00514514|470028797|FG000|Pre-phase|administrative problems|2|||
130563019|NCT00514514|470028798|FG001|Pre-phase|administrative problems|0|||
130563020|NCT00514514|470028799|FG002|Pre-phase|administrative problems|0|||
130563021|NCT00514514|470028797|FG000|Pre-phase|Protocol Violation|6|||
130563022|NCT00514514|470028798|FG001|Pre-phase|Protocol Violation|0|||
130563023|NCT00514514|470028799|FG002|Pre-phase|Protocol Violation|0|||
130563024|NCT00514514|470028797|FG000|Pre-phase|condition no longer requires study drug|7|||
130563025|NCT00514514|470028798|FG001|Pre-phase|condition no longer requires study drug|0|||
130563026|NCT00514514|470028799|FG002|Pre-phase|condition no longer requires study drug|0|||
130563027|NCT00514514|470028797|FG000|Pre-phase|abnormal test procedure results|15|||
130727160|NCT02883049|470625424|FG000|Post Induction|Adverse Event|0|||
130727161|NCT02883049|470625425|FG001|Post Induction|Adverse Event|0|||
130727162|NCT02883049|470625426|FG002|Post Induction|Adverse Event|0|||
130727163|NCT02883049|470625427|FG003|Post Induction|Adverse Event|7|||
130727164|NCT02883049|470625428|FG004|Post Induction|Adverse Event|8|||
130727165|NCT02883049|470625429|FG005|Post Induction|Adverse Event|3|||
130727166|NCT02883049|470625430|FG006|Post Induction|Adverse Event|4|||
130563028|NCT00514514|470028798|FG001|Pre-phase|abnormal test procedure results|0|||
130563029|NCT00514514|470028799|FG002|Pre-phase|abnormal test procedure results|0|||
130563030|NCT00514514|470028797|FG000|Pre-phase|Lost to Follow-up|2|||
130563031|NCT00514514|470028798|FG001|Pre-phase|Lost to Follow-up|0|||
130563032|NCT00514514|470028799|FG002|Pre-phase|Lost to Follow-up|0|||
130563033|NCT00514514|470028797|FG000|Pre-phase|abnormal lab values|23|||
130727167|NCT02883049|470625431|FG007|Post Induction|Adverse Event|5|||
130563034|NCT00514514|470028798|FG001|Pre-phase|abnormal lab values|0|||
130563035|NCT00514514|470028799|FG002|Pre-phase|abnormal lab values|0|||
130563036|NCT00514514|470028797|FG000|Pre-phase|Lack of Efficacy|35|||
130563037|NCT00514514|470028798|FG001|Pre-phase|Lack of Efficacy|0|||
130563038|NCT00514514|470028799|FG002|Pre-phase|Lack of Efficacy|0|||
130563039|NCT00514514|470028797|FG000|Pre-phase|Adverse Event|137|||
130563040|NCT00514514|470028798|FG001|Pre-phase|Adverse Event|0|||
130563041|NCT00514514|470028799|FG002|Pre-phase|Adverse Event|0|||
130563042|NCT00514514|470028797|FG000|Pre-phase|Withdrawal by Subject|66|||
130563043|NCT00514514|470028798|FG001|Pre-phase|Withdrawal by Subject|0|||
130563044|NCT00514514|470028799|FG002|Pre-phase|Withdrawal by Subject|0|||
130563045|NCT00514514|470028797|FG000|Randomized - 9 Month|Death|3|||
130563046|NCT00514514|470028798|FG001|Randomized - 9 Month|Death|2|||
130563047|NCT00514514|470028799|FG002|Randomized - 9 Month|Death|2|||
130563048|NCT00514514|470028797|FG000|Randomized - 9 Month|Administrative problems|1|||
130563049|NCT00514514|470028798|FG001|Randomized - 9 Month|Administrative problems|1|||
130563050|NCT00514514|470028799|FG002|Randomized - 9 Month|Administrative problems|2|||
130563051|NCT00514514|470028797|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
130563052|NCT00514514|470028798|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
130563053|NCT00514514|470028799|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
130563054|NCT00514514|470028797|FG000|Randomized - 9 Month|Protocol Violation|1|||
130563055|NCT00514514|470028798|FG001|Randomized - 9 Month|Protocol Violation|1|||
130563056|NCT00514514|470028799|FG002|Randomized - 9 Month|Protocol Violation|0|||
130563057|NCT00514514|470028797|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
130563058|NCT00514514|470028798|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
130563059|NCT00514514|470028799|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
130563060|NCT00514514|470028797|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
130563061|NCT00514514|470028798|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
130563062|NCT00514514|470028799|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
130563063|NCT00514514|470028797|FG000|Randomized - 9 Month|Adverse Event|25|||
130563064|NCT00514514|470028798|FG001|Randomized - 9 Month|Adverse Event|44|||
130563065|NCT00514514|470028799|FG002|Randomized - 9 Month|Adverse Event|27|||
130563066|NCT00514514|470028797|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
130563067|NCT00514514|470028798|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
130563068|NCT00514514|470028799|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
130563069|NCT00514514|470028797|FG000|Extension - 4 Years|Lost to Follow-up|12|||
130563070|NCT00514514|470028798|FG001|Extension - 4 Years|Lost to Follow-up|10|||
130563071|NCT00514514|470028799|FG002|Extension - 4 Years|Lost to Follow-up|9|||
130563072|NCT00514514|470028797|FG000|Extension - 4 Years|Administrative problems|3|||
130410232|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
130410233|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
130563073|NCT00514514|470028798|FG001|Extension - 4 Years|Administrative problems|1|||
130563074|NCT00514514|470028799|FG002|Extension - 4 Years|Administrative problems|1|||
130563075|NCT00514514|470028797|FG000|Extension - 4 Years|Death|8|||
130563076|NCT00514514|470028798|FG001|Extension - 4 Years|Death|3|||
130563077|NCT00514514|470028799|FG002|Extension - 4 Years|Death|6|||
130563078|NCT00514514|470028797|FG000|Extension - 4 Years|Adverse Event|9|||
130563079|NCT00514514|470028798|FG001|Extension - 4 Years|Adverse Event|6|||
130563080|NCT00514514|470028799|FG002|Extension - 4 Years|Adverse Event|3|||
130563081|NCT03785925|470028801|FG000|Overall Study|Withdrawal by Subject|15|||
130563082|NCT03785925|470028801|FG000|Overall Study|Lost to Follow-up|1|||
130563083|NCT01848288|470028804|FG000|Overall Study|Death|1|||
130563084|NCT01848288|470028804|FG000|Overall Study|Protocol Violation|1|||
130563085|NCT01848288|470028804|FG000|Overall Study|Withdrawal by Subject|1|||
130563086|NCT03794583|470028809|FG000|Overall Study|Death|8|||
130563087|NCT03794583|470028809|FG000|Overall Study|Study Terminated by Sponsor|24|||
130727168|NCT02883049|470625432|FG008|Post Induction|Adverse Event|6|||
130727169|NCT02883049|470625433|FG009|Post Induction|Adverse Event|7|||
130727170|NCT02883049|470625434|FG010|Post Induction|Adverse Event|2|||
130727171|NCT02883049|470625435|FG011|Post Induction|Adverse Event|2|||
130727172|NCT02883049|470625436|FG012|Post Induction|Adverse Event|0|||
130727173|NCT02883049|470625437|FG013|Post Induction|Adverse Event|0|||
130727174|NCT02883049|470625438|FG014|Post Induction|Adverse Event|5|||
130727175|NCT02883049|470625439|FG015|Post Induction|Adverse Event|2|||
130563088|NCT03794583|470028809|FG000|Overall Study|Withdrawal by Subject|9|||
130727176|NCT02883049|470625424|FG000|Post Induction|Death|0|||
130727177|NCT02883049|470625425|FG001|Post Induction|Death|0|||
130563089|NCT00003895|470028810|FG000|Overall Study|Adverse Event|4|||
130563090|NCT00003895|470028811|FG001|Overall Study|Adverse Event|0|||
130727178|NCT02883049|470625426|FG002|Post Induction|Death|0|||
130410234|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
130563091|NCT00003895|470028810|FG000|Overall Study|Lack of Efficacy|1|||
130563092|NCT00003895|470028811|FG001|Overall Study|Lack of Efficacy|1|||
130563093|NCT00003895|470028810|FG000|Overall Study|Patient Vacation|2|||
130563094|NCT00003895|470028811|FG001|Overall Study|Patient Vacation|0|||
130563095|NCT00003895|470028810|FG000|Overall Study|Withdrawal by Subject|0|||
130727179|NCT02883049|470625427|FG003|Post Induction|Death|9|||
130563096|NCT00003895|470028811|FG001|Overall Study|Withdrawal by Subject|3|||
130727180|NCT02883049|470625428|FG004|Post Induction|Death|9|||
130727181|NCT02883049|470625429|FG005|Post Induction|Death|0|||
130410235|NCT00116805|469463803|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
130410236|NCT00116805|469463804|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
130410237|NCT00116805|469463803|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
130410238|NCT00116805|469463804|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
130410239|NCT00116805|469463803|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
130410240|NCT00116805|469463804|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
130410241|NCT00116805|469463803|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
130410242|NCT00116805|469463804|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
130410243|NCT00116805|469463803|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
130410244|NCT00116805|469463804|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
130563097|NCT00806195|470028814|FG000|Overall Study|Death|6|||
130563098|NCT00806195|470028815|FG001|Overall Study|Death|0|||
130563099|NCT00806195|470028816|FG002|Overall Study|Death|1|||
130563100|NCT00806195|470028817|FG003|Overall Study|Death|0|||
130563101|NCT00806195|470028814|FG000|Overall Study|Adverse Event|25|||
130563102|NCT00806195|470028815|FG001|Overall Study|Adverse Event|5|||
130563103|NCT00806195|470028816|FG002|Overall Study|Adverse Event|11|||
130563104|NCT00806195|470028817|FG003|Overall Study|Adverse Event|2|||
130563105|NCT00806195|470028814|FG000|Overall Study|Withdrawal by Subject|119|||
130563106|NCT00806195|470028815|FG001|Overall Study|Withdrawal by Subject|31|||
130563107|NCT00806195|470028816|FG002|Overall Study|Withdrawal by Subject|76|||
130563108|NCT00806195|470028817|FG003|Overall Study|Withdrawal by Subject|35|||
130563109|NCT00806195|470028814|FG000|Overall Study|Lost to Follow-up|217|||
130563110|NCT00806195|470028815|FG001|Overall Study|Lost to Follow-up|66|||
130563111|NCT00806195|470028816|FG002|Overall Study|Lost to Follow-up|90|||
130563112|NCT00806195|470028817|FG003|Overall Study|Lost to Follow-up|34|||
130563113|NCT00806195|470028814|FG000|Overall Study|Inappropriate Enrollment|0|||
130563114|NCT00806195|470028815|FG001|Overall Study|Inappropriate Enrollment|1|||
130563115|NCT00806195|470028816|FG002|Overall Study|Inappropriate Enrollment|0|||
130563116|NCT00806195|470028817|FG003|Overall Study|Inappropriate Enrollment|0|||
130563117|NCT00806195|470028814|FG000|Overall Study|Administrative Reason|113|||
130563118|NCT00806195|470028815|FG001|Overall Study|Administrative Reason|35|||
130563119|NCT00806195|470028816|FG002|Overall Study|Administrative Reason|66|||
130563120|NCT00806195|470028817|FG003|Overall Study|Administrative Reason|26|||
130563121|NCT00806195|470028814|FG000|Overall Study|Protocol Violation|34|||
130563122|NCT00806195|470028815|FG001|Overall Study|Protocol Violation|24|||
130563123|NCT00806195|470028816|FG002|Overall Study|Protocol Violation|26|||
130563124|NCT00806195|470028817|FG003|Overall Study|Protocol Violation|9|||
130410245|NCT00116805|469463803|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
130563125|NCT02490475|470028818|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
130563126|NCT02490475|470028819|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
130410246|NCT00116805|469463804|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
130410247|NCT00116805|469463803|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
130410248|NCT00116805|469463804|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
130410249|NCT00116805|469463803|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
130410250|NCT00116805|469463804|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
130410251|NCT00116805|469463803|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
130410252|NCT00116805|469463804|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
130410253|NCT00116805|469463803|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
130410254|NCT00116805|469463804|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
130410255|NCT01782131|469463805|FG000|Overall Study|Death|93|||
130410256|NCT01782131|469463806|FG001|Overall Study|Death|96|||
130410257|NCT01782131|469463805|FG000|Overall Study|Lost to Follow-up|1|||
130410258|NCT01782131|469463806|FG001|Overall Study|Lost to Follow-up|3|||
130410259|NCT01782131|469463805|FG000|Overall Study|Withdrawal by Subject|10|||
130410260|NCT01782131|469463806|FG001|Overall Study|Withdrawal by Subject|10|||
130410261|NCT01782131|469463805|FG000|Overall Study|Randomized but not treated|5|||
130410262|NCT01782131|469463806|FG001|Overall Study|Randomized but not treated|5|||
130410263|NCT01782131|469463805|FG000|Overall Study|Reason not provided|0|||
130563127|NCT02490475|470028820|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
130410264|NCT01782131|469463806|FG001|Overall Study|Reason not provided|1|||
130410265|NCT00796718|469463807|FG000|Overall Study|Adverse Event|2|||
130410266|NCT00796718|469463807|FG000|Overall Study|Exclusion Criteria|1|||
130410267|NCT00796718|469463807|FG000|Overall Study|Lost to Follow-up|5|||
130410268|NCT00796718|469463807|FG000|Overall Study|Withdrawal by Informed Consent|1|||
130410269|NCT03266588|469463808|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
130410270|NCT03266588|469463809|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
130563128|NCT02490475|470028821|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
130563129|NCT02490475|470028818|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130563130|NCT02490475|470028819|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
130410271|NCT03266588|469463810|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
130410272|NCT03266588|469463808|FG000|Observational Period|Withdrawal by Subject|44|||
130563131|NCT02490475|470028820|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130473785|NCT03648840|469704669|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
130473786|NCT03648840|469704670|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
130473787|NCT03648840|469704669|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
130473788|NCT03648840|469704670|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
130473789|NCT03648840|469704669|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
130473790|NCT03648840|469704670|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
130473791|NCT05382936|469704674|FG000|Overall Study|Progressive Disease|3|||
130473792|NCT05382936|469704675|FG001|Overall Study|Progressive Disease|5|||
130473793|NCT05382936|469704676|FG002|Overall Study|Progressive Disease|2|||
130473794|NCT05382936|469704677|FG003|Overall Study|Progressive Disease|5|||
130473795|NCT05382936|469704674|FG000|Overall Study|Adverse Event|0|||
130473796|NCT05382936|469704675|FG001|Overall Study|Adverse Event|1|||
130473797|NCT05382936|469704676|FG002|Overall Study|Adverse Event|1|||
130410273|NCT03266588|469463809|FG001|Observational Period|Withdrawal by Subject|22|||
130410274|NCT03266588|469463810|FG002|Observational Period|Withdrawal by Subject|13|||
130410275|NCT03266588|469463808|FG000|Observational Period|Non-compliance|18|||
130410276|NCT03266588|469463809|FG001|Observational Period|Non-compliance|12|||
130410277|NCT03266588|469463810|FG002|Observational Period|Non-compliance|10|||
130410278|NCT03266588|469463808|FG000|Observational Period|Lost to Follow-up|8|||
130410279|NCT03266588|469463809|FG001|Observational Period|Lost to Follow-up|12|||
130410280|NCT03266588|469463810|FG002|Observational Period|Lost to Follow-up|4|||
130410281|NCT03266588|469463808|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
130410282|NCT03266588|469463809|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
130410283|NCT03266588|469463810|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
130410284|NCT03266588|469463808|FG000|Observational Period|Protocol Deviation|1|||
130410285|NCT03266588|469463809|FG001|Observational Period|Protocol Deviation|0|||
130410286|NCT03266588|469463810|FG002|Observational Period|Protocol Deviation|0|||
130473798|NCT05382936|469704677|FG003|Overall Study|Adverse Event|0|||
130473799|NCT05382936|469704674|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
130473800|NCT05382936|469704675|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
130473801|NCT05382936|469704676|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
130473802|NCT05382936|469704677|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
130473803|NCT05382936|469704674|FG000|Overall Study|Withdrawal by Subject|0|||
130473804|NCT05382936|469704675|FG001|Overall Study|Withdrawal by Subject|0|||
130473805|NCT05382936|469704676|FG002|Overall Study|Withdrawal by Subject|1|||
130473806|NCT05382936|469704677|FG003|Overall Study|Withdrawal by Subject|1|||
130473807|NCT05063994|469704678|FG000|Cortef Run-In|Withdrawal of Consent|1|||
130473808|NCT05063994|469704679|FG001|Cortef Run-In|Withdrawal of Consent|0|||
130473809|NCT05063994|469704680|FG002|Cortef Run-In|Withdrawal of Consent|0|||
130473810|NCT05063994|469704678|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
130473811|NCT05063994|469704679|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
130473812|NCT05063994|469704680|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
130473813|NCT05063994|469704678|FG000|Treatment|Physician Decision|0|||
130473814|NCT05063994|469704679|FG001|Treatment|Physician Decision|0|||
130473815|NCT05063994|469704680|FG002|Treatment|Physician Decision|1|||
130473816|NCT05063994|469704678|FG000|Treatment|Withdrawal by Subject|0|||
130473817|NCT05063994|469704679|FG001|Treatment|Withdrawal by Subject|0|||
130473818|NCT05063994|469704680|FG002|Treatment|Withdrawal by Subject|1|||
130473819|NCT05063994|469704678|FG000|Treatment|Withdrawal of Consent|0|||
130473820|NCT05063994|469704679|FG001|Treatment|Withdrawal of Consent|0|||
130473821|NCT05063994|469704680|FG002|Treatment|Withdrawal of Consent|1|||
130473822|NCT04630262|469704684|FG000|Overall Study|Intraoperative Screen Failure|5|||
130473823|NCT04630262|469704684|FG000|Overall Study|Study terminated prematurely|71|||
130473824|NCT04630262|469704684|FG000|Overall Study|Withdrawal by Subject|2|||
130473825|NCT04630262|469704684|FG000|Overall Study|Physician Decision|2|||
130473826|NCT01857934|469704686|FG000|Overall Study|Relapse or progression|2|||
130473827|NCT01857934|469704686|FG000|Overall Study|Unacceptable toxicity|3|||
130473828|NCT01857934|469704686|FG000|Overall Study|Unwillingness or inability to comply|2|||
130473829|NCT01857934|469704686|FG000|Overall Study|Physician Decision|3|||
130473830|NCT04638998|469704690|FG000|Overall Study|Withdrawal by Subject|1|||
130473831|NCT04638998|469704691|FG001|Overall Study|Withdrawal by Subject|3|||
130473832|NCT03692676|469704692|FG000|Overall Study|exclude patients with prior use|4424|||
130473833|NCT03692676|469704693|FG001|Overall Study|exclude patients with prior use|24726|||
130563132|NCT02490475|470028821|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130410287|NCT03266588|469463808|FG000|Observational Period|Other Reasons|3|||
130410288|NCT03266588|469463809|FG001|Observational Period|Other Reasons|0|||
130410289|NCT03266588|469463810|FG002|Observational Period|Other Reasons|1|||
130410290|NCT03266588|469463808|FG000|Long-term Treatment Period|Adverse Event|33|||
130410291|NCT03266588|469463809|FG001|Long-term Treatment Period|Adverse Event|17|||
130410292|NCT03266588|469463810|FG002|Long-term Treatment Period|Adverse Event|8|||
130410293|NCT03266588|469463808|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
130473834|NCT03692676|469704694|FG002|Overall Study|exclude patients with prior use|0|||
130473835|NCT03692676|469704695|FG003|Overall Study|exclude patients with prior use|0|||
130473836|NCT03692676|469704692|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
130473837|NCT03692676|469704693|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
130473838|NCT03692676|469704694|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
130473839|NCT03692676|469704695|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
130473840|NCT03692676|469704692|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
130473841|NCT03692676|469704693|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
130473842|NCT03692676|469704694|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
130473843|NCT03692676|469704695|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
130473844|NCT03692676|469704692|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
130473845|NCT03692676|469704693|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
130473846|NCT03692676|469704694|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
130473847|NCT03692676|469704695|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
130473848|NCT03692676|469704692|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
130473849|NCT03692676|469704693|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
130473850|NCT03692676|469704694|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
130473851|NCT03692676|469704695|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
130473852|NCT03692676|469704692|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
130473853|NCT03692676|469704693|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
130473854|NCT03692676|469704694|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
130473855|NCT03692676|469704695|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
130473856|NCT03692676|469704692|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
130473857|NCT03692676|469704693|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
130473858|NCT03692676|469704694|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
130473859|NCT03692676|469704695|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
130473860|NCT03692676|469704692|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
130473861|NCT03692676|469704693|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
130473862|NCT03692676|469704694|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
130473863|NCT03692676|469704695|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
130473864|NCT03692676|469704692|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
130473865|NCT03692676|469704693|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
130473866|NCT03692676|469704694|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
130473867|NCT03692676|469704695|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
130473868|NCT03692676|469704692|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
130473869|NCT03692676|469704693|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
130473870|NCT03692676|469704694|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
130473871|NCT03692676|469704695|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
130473872|NCT03692676|469704692|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
130473873|NCT03692676|469704693|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
130473874|NCT03692676|469704694|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
130473875|NCT03692676|469704695|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
130473876|NCT03692676|469704692|FG000|Overall Study|Other|0|||
130473877|NCT03692676|469704693|FG001|Overall Study|Other|805|||
130473878|NCT03692676|469704694|FG002|Overall Study|Other|758|||
130473879|NCT03692676|469704695|FG003|Overall Study|Other|277|||
130473880|NCT03692676|469704692|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
130473881|NCT03692676|469704693|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
130473882|NCT03692676|469704694|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
130473883|NCT03692676|469704695|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
130473884|NCT04490915|469704696|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130473885|NCT04490915|469704697|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130473886|NCT04490915|469704696|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130473887|NCT04490915|469704697|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130473888|NCT04490915|469704696|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130473889|NCT04490915|469704697|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
130473890|NCT04490915|469704696|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
130473891|NCT04490915|469704697|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
130473892|NCT04490915|469704696|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
130563133|NCT02490475|470028818|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
130563134|NCT02490475|470028819|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
130563135|NCT02490475|470028820|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
130563136|NCT02490475|470028821|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
130563137|NCT02490475|470028818|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
130563138|NCT02490475|470028819|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
130563139|NCT02490475|470028820|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
130563140|NCT02490475|470028821|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
130563141|NCT02490475|470028818|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
130563142|NCT02490475|470028819|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
130563143|NCT02490475|470028820|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
130563144|NCT02490475|470028821|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
130563145|NCT02490475|470028818|FG000|Period 2: Extension Phase|Refused Treatment|0|||
130563146|NCT02490475|470028819|FG001|Period 2: Extension Phase|Refused Treatment|0|||
130563147|NCT02490475|470028820|FG002|Period 2: Extension Phase|Refused Treatment|0|||
130563148|NCT02490475|470028821|FG003|Period 2: Extension Phase|Refused Treatment|1|||
130563149|NCT02490475|470028818|FG000|Period 2: Extension Phase|Adverse Event|0|||
130563150|NCT02490475|470028819|FG001|Period 2: Extension Phase|Adverse Event|0|||
130563151|NCT02490475|470028820|FG002|Period 2: Extension Phase|Adverse Event|1|||
130563152|NCT02490475|470028821|FG003|Period 2: Extension Phase|Adverse Event|0|||
130563153|NCT00139776|470028822|FG000|Period I|Did not enter Period II|575|||
130563154|NCT00139776|470028823|FG001|Period I|Did not enter Period II|0|||
130563155|NCT00139776|470028824|FG002|Period I|Did not enter Period II|0|||
130563156|NCT00139776|470028825|FG003|Period I|Did not enter Period II|0|||
130563157|NCT00139776|470028822|FG000|Period II|Not Randomized into Period III|0|||
130563158|NCT00139776|470028823|FG001|Period II|Not Randomized into Period III|322|||
130563159|NCT00139776|470028824|FG002|Period II|Not Randomized into Period III|0|||
130563160|NCT00139776|470028825|FG003|Period II|Not Randomized into Period III|0|||
130563161|NCT00139776|470028822|FG000|Period III|Adverse Event|0|||
130563162|NCT00139776|470028823|FG001|Period III|Adverse Event|0|||
130563163|NCT00139776|470028824|FG002|Period III|Adverse Event|22|||
130563164|NCT00139776|470028825|FG003|Period III|Adverse Event|23|||
130563165|NCT00139776|470028822|FG000|Period III|Other|0|||
130563166|NCT00139776|470028823|FG001|Period III|Other|0|||
130410294|NCT03266588|469463809|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
130410295|NCT03266588|469463810|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
130410296|NCT03266588|469463808|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
130563167|NCT00139776|470028824|FG002|Period III|Other|23|||
130563168|NCT00139776|470028825|FG003|Period III|Other|34|||
130563169|NCT00139776|470028822|FG000|Period III|Lack of Efficacy|0|||
130563170|NCT00139776|470028823|FG001|Period III|Lack of Efficacy|0|||
130563171|NCT00139776|470028824|FG002|Period III|Lack of Efficacy|10|||
130563172|NCT00139776|470028825|FG003|Period III|Lack of Efficacy|24|||
130563173|NCT00139776|470028822|FG000|Period III|Lost to Follow-up|0|||
130563174|NCT00139776|470028823|FG001|Period III|Lost to Follow-up|0|||
130563175|NCT00139776|470028824|FG002|Period III|Lost to Follow-up|5|||
130563176|NCT00139776|470028825|FG003|Period III|Lost to Follow-up|4|||
130563177|NCT00139776|470028822|FG000|Period III|Withdrawal by Subject|0|||
130563178|NCT00139776|470028823|FG001|Period III|Withdrawal by Subject|0|||
130563179|NCT00139776|470028824|FG002|Period III|Withdrawal by Subject|16|||
130563180|NCT00139776|470028825|FG003|Period III|Withdrawal by Subject|21|||
130563181|NCT04912245|470028828|FG000|Overall Study|Withdrawal by Subject|21|||
130563182|NCT04912245|470028829|FG001|Overall Study|Withdrawal by Subject|4|||
130563183|NCT04912245|470028828|FG000|Overall Study|Lost to Follow-up|5|||
130563184|NCT04912245|470028829|FG001|Overall Study|Lost to Follow-up|11|||
130563185|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
130563186|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130563187|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130563188|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130563189|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
130563190|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130563191|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130563192|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130563193|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
130563194|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130563195|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130563196|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130727182|NCT02883049|470625430|FG006|Post Induction|Death|1|||
130727183|NCT02883049|470625431|FG007|Post Induction|Death|6|||
130727184|NCT02883049|470625432|FG008|Post Induction|Death|5|||
130410297|NCT03266588|469463809|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
130410298|NCT03266588|469463810|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
130563197|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
130727185|NCT02883049|470625433|FG009|Post Induction|Death|3|||
130727186|NCT02883049|470625434|FG010|Post Induction|Death|1|||
130727187|NCT02883049|470625435|FG011|Post Induction|Death|0|||
130410299|NCT03266588|469463808|FG000|Long-term Treatment Period|Non-Compliance|126|||
130410300|NCT03266588|469463809|FG001|Long-term Treatment Period|Non-Compliance|57|||
130410301|NCT03266588|469463810|FG002|Long-term Treatment Period|Non-Compliance|7|||
130410302|NCT03266588|469463808|FG000|Long-term Treatment Period|Pregnancy|11|||
130410303|NCT03266588|469463809|FG001|Long-term Treatment Period|Pregnancy|5|||
130410304|NCT03266588|469463810|FG002|Long-term Treatment Period|Pregnancy|0|||
130410305|NCT03266588|469463808|FG000|Long-term Treatment Period|Protocol Deviation|17|||
130410306|NCT03266588|469463809|FG001|Long-term Treatment Period|Protocol Deviation|10|||
130410307|NCT03266588|469463810|FG002|Long-term Treatment Period|Protocol Deviation|4|||
130410308|NCT03266588|469463808|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
130410309|NCT03266588|469463809|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
130410310|NCT03266588|469463810|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
130410311|NCT03266588|469463808|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
130410312|NCT03266588|469463809|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
130410313|NCT03266588|469463810|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
130410314|NCT03266588|469463808|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
130410315|NCT03266588|469463809|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
130410316|NCT03266588|469463810|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
130410317|NCT03266588|469463808|FG000|Long-term Treatment Period|Other Reasons|5|||
130410318|NCT03266588|469463809|FG001|Long-term Treatment Period|Other Reasons|0|||
130410319|NCT03266588|469463810|FG002|Long-term Treatment Period|Other Reasons|0|||
130410320|NCT03266588|469463808|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
130410321|NCT03266588|469463809|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
130410322|NCT03266588|469463810|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
130410323|NCT00317772|469463811|FG000|Overall Study|Adverse Event|0|||
130410324|NCT00317772|469463812|FG001|Overall Study|Adverse Event|0|||
130410325|NCT00317772|469463813|FG002|Overall Study|Adverse Event|0|||
130410326|NCT00317772|469463814|FG003|Overall Study|Adverse Event|2|||
130410327|NCT00317772|469463811|FG000|Overall Study|Disease Progression|2|||
130410328|NCT00317772|469463812|FG001|Overall Study|Disease Progression|2|||
130410329|NCT00317772|469463813|FG002|Overall Study|Disease Progression|1|||
130410330|NCT00317772|469463814|FG003|Overall Study|Disease Progression|7|||
130410331|NCT01075321|469463821|FG000|Overall Study|Withdrawal by Subject|0|||
130410332|NCT01075321|469463822|FG001|Overall Study|Withdrawal by Subject|0|||
130410333|NCT01075321|469463823|FG002|Overall Study|Withdrawal by Subject|1|||
130410334|NCT01075321|469463824|FG003|Overall Study|Withdrawal by Subject|1|||
130410335|NCT01075321|469463821|FG000|Overall Study|Protocol Violation|0|||
130473893|NCT04490915|469704697|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
130473894|NCT04490915|469704696|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
130473895|NCT04490915|469704697|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
130473896|NCT04490915|469704696|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
130473897|NCT04490915|469704697|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
130473898|NCT05406921|469704701|FG000|Overall Study|Withdrawal by Subject|25|||
130473899|NCT05406921|469704702|FG001|Overall Study|Withdrawal by Subject|0|||
130473900|NCT05406921|469704703|FG002|Overall Study|Withdrawal by Subject|25|||
130473901|NCT05406921|469704701|FG000|Overall Study|Protocol Violation|0|||
130473902|NCT05406921|469704702|FG001|Overall Study|Protocol Violation|12|||
130473903|NCT05406921|469704703|FG002|Overall Study|Protocol Violation|0|||
130473904|NCT03016169|469704711|FG000|Overall Study|Lost to Follow-up|4|||
130727188|NCT02883049|470625436|FG012|Post Induction|Death|1|||
130727189|NCT02883049|470625437|FG013|Post Induction|Death|1|||
130727190|NCT02883049|470625438|FG014|Post Induction|Death|10|||
130727191|NCT02883049|470625439|FG015|Post Induction|Death|2|||
130410336|NCT01075321|469463822|FG001|Overall Study|Protocol Violation|0|||
130410337|NCT01075321|469463823|FG002|Overall Study|Protocol Violation|1|||
130410338|NCT01075321|469463824|FG003|Overall Study|Protocol Violation|0|||
130410339|NCT01075321|469463821|FG000|Overall Study|Treatment Incomplete due to progression|1|||
130410340|NCT01075321|469463822|FG001|Overall Study|Treatment Incomplete due to progression|0|||
130410341|NCT01075321|469463823|FG002|Overall Study|Treatment Incomplete due to progression|0|||
130410342|NCT01075321|469463824|FG003|Overall Study|Treatment Incomplete due to progression|0|||
130410343|NCT01075321|469463821|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
130473905|NCT03016169|469704711|FG000|Overall Study|Death|54|||
130473906|NCT03016169|469704711|FG000|Overall Study|Device Explant|11|||
130727192|NCT02883049|470625424|FG000|Post Induction|Lost to Follow-up|0|||
130410344|NCT01075321|469463822|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
130410345|NCT01075321|469463823|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
130410346|NCT01075321|469463824|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
130410347|NCT00262834|469463825|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
130410348|NCT00262834|469463826|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
130473907|NCT03016169|469704711|FG000|Overall Study|Withdrawal by Subject|19|||
130473908|NCT03016169|469704711|FG000|Overall Study|Other Reasons|1|||
130563198|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130563199|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130563200|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130563201|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
130563202|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
130563203|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
130563204|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
130727193|NCT02883049|470625425|FG001|Post Induction|Lost to Follow-up|0|||
130727194|NCT02883049|470625426|FG002|Post Induction|Lost to Follow-up|0|||
130727195|NCT02883049|470625427|FG003|Post Induction|Lost to Follow-up|0|||
130727196|NCT02883049|470625428|FG004|Post Induction|Lost to Follow-up|1|||
130563205|NCT02752035|470028830|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
130563206|NCT02752035|470028831|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130563207|NCT02752035|470028832|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130563208|NCT02752035|470028833|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130563209|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
130563210|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
130563211|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
130563212|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
130563213|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
130563214|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
130563215|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
130563216|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
130563217|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
130563218|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
130563219|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
130563220|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
130563221|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
130563222|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
130563223|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
130563224|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
130563225|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
130563226|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
130563227|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
130563228|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
130563229|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Death|0|||
130563230|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Death|25|||
130563231|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Death|13|||
130563232|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Death|4|||
130563233|NCT02752035|470028830|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
130563234|NCT02752035|470028831|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
130563235|NCT02752035|470028832|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
130563236|NCT02752035|470028833|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
130563237|NCT02752035|470028830|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
130563238|NCT02752035|470028831|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
130563239|NCT02752035|470028832|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
130563240|NCT02752035|470028833|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
130563241|NCT02752035|470028830|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
130563242|NCT02752035|470028831|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
130563243|NCT02752035|470028832|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
130563244|NCT02752035|470028833|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
130563245|NCT02752035|470028830|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
130563246|NCT02752035|470028831|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
130563247|NCT02752035|470028832|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
130563248|NCT02752035|470028833|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
130563249|NCT02752035|470028830|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130563250|NCT02752035|470028831|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
130563251|NCT02752035|470028832|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130727197|NCT02883049|470625429|FG005|Post Induction|Lost to Follow-up|1|||
130410349|NCT00003457|469463829|FG000|Overall Study|Not evaluable|9|||
130410350|NCT02525133|469463830|FG000|Overall Study|Adverse Event|0|||
130410351|NCT02525133|469463831|FG001|Overall Study|Adverse Event|1|||
130410352|NCT02525133|469463830|FG000|Overall Study|Death|0|||
130410353|NCT02525133|469463831|FG001|Overall Study|Death|1|||
130410354|NCT02525133|469463830|FG000|Overall Study|did not meet randomization criteria|1|||
130410355|NCT02525133|469463831|FG001|Overall Study|did not meet randomization criteria|0|||
130410356|NCT02525133|469463830|FG000|Overall Study|Lost to Follow-up|5|||
130410357|NCT02525133|469463831|FG001|Overall Study|Lost to Follow-up|1|||
130410358|NCT02525133|469463830|FG000|Overall Study|randomized not enrolled|3|||
130410359|NCT02525133|469463831|FG001|Overall Study|randomized not enrolled|0|||
130410360|NCT02525133|469463830|FG000|Overall Study|Withdrawal by Subject|1|||
130410361|NCT02525133|469463831|FG001|Overall Study|Withdrawal by Subject|0|||
130410362|NCT01075074|469463832|FG000|Overall Study|Surgeon changed to open incisional case|1|||
130410363|NCT01075074|469463833|FG001|Overall Study|Surgeon changed to open incisional case|2|||
130410364|NCT01075074|469463834|FG002|Overall Study|Surgeon changed to open incisional case|2|||
130410365|NCT04265755|469463835|FG000|Overall Study|Withdrawal by Subject|39|||
130410366|NCT04265755|469463835|FG000|Overall Study|Decision by sponsor|2|||
130410367|NCT04265755|469463835|FG000|Overall Study|Lost to Follow-up|11|||
130410368|NCT04265755|469463835|FG000|Overall Study|Death|1|||
130410369|NCT01575561|469463836|FG000|Overall Study|Adverse Event|9|||
130410370|NCT01575561|469463836|FG000|Overall Study|Lack of Efficacy|8|||
130410371|NCT01575561|469463836|FG000|Overall Study|Lost to Follow-up|6|||
130410372|NCT01575561|469463836|FG000|Overall Study|Protocol Violation|4|||
130410373|NCT01575561|469463836|FG000|Overall Study|Withdrawal by Subject|11|||
130410374|NCT01575561|469463836|FG000|Overall Study|administration|1|||
130410375|NCT01992536|469463837|FG000|Overall Study|Administrative Reason|0|||
130410376|NCT01992536|469463838|FG001|Overall Study|Administrative Reason|0|||
130410377|NCT01992536|469463839|FG002|Overall Study|Administrative Reason|0|||
130410378|NCT01992536|469463840|FG003|Overall Study|Administrative Reason|0|||
130410379|NCT01992536|469463841|FG004|Overall Study|Administrative Reason|0|||
130410380|NCT01992536|469463842|FG005|Overall Study|Administrative Reason|0|||
130410381|NCT01992536|469463843|FG006|Overall Study|Administrative Reason|7|||
130410382|NCT01992536|469463844|FG007|Overall Study|Administrative Reason|0|||
130410383|NCT01992536|469463845|FG008|Overall Study|Administrative Reason|0|||
130410384|NCT01992536|469463846|FG009|Overall Study|Administrative Reason|0|||
130410385|NCT01992536|469463837|FG000|Overall Study|Lost to Follow-up|4|||
130410386|NCT01992536|469463838|FG001|Overall Study|Lost to Follow-up|2|||
130410387|NCT01992536|469463839|FG002|Overall Study|Lost to Follow-up|1|||
130410388|NCT01992536|469463840|FG003|Overall Study|Lost to Follow-up|0|||
130410389|NCT01992536|469463841|FG004|Overall Study|Lost to Follow-up|0|||
130410390|NCT01992536|469463842|FG005|Overall Study|Lost to Follow-up|1|||
130410391|NCT01992536|469463843|FG006|Overall Study|Lost to Follow-up|0|||
130410392|NCT01992536|469463844|FG007|Overall Study|Lost to Follow-up|0|||
130410393|NCT01992536|469463845|FG008|Overall Study|Lost to Follow-up|1|||
130410394|NCT01992536|469463846|FG009|Overall Study|Lost to Follow-up|1|||
130410395|NCT01992536|469463837|FG000|Overall Study|Withdrawal by Subject|0|||
130410396|NCT01992536|469463838|FG001|Overall Study|Withdrawal by Subject|1|||
130410397|NCT01992536|469463839|FG002|Overall Study|Withdrawal by Subject|0|||
130410398|NCT01992536|469463840|FG003|Overall Study|Withdrawal by Subject|2|||
130410399|NCT01992536|469463841|FG004|Overall Study|Withdrawal by Subject|0|||
130410400|NCT01992536|469463842|FG005|Overall Study|Withdrawal by Subject|0|||
130410401|NCT01992536|469463843|FG006|Overall Study|Withdrawal by Subject|0|||
130410402|NCT01992536|469463844|FG007|Overall Study|Withdrawal by Subject|0|||
130410403|NCT01992536|469463845|FG008|Overall Study|Withdrawal by Subject|0|||
130410404|NCT01992536|469463846|FG009|Overall Study|Withdrawal by Subject|0|||
130410405|NCT00406029|469463854|FG000|Overall Study|Adverse Event|12|||
130410406|NCT00406029|469463855|FG001|Overall Study|Adverse Event|2|||
130410407|NCT00406029|469463856|FG002|Overall Study|Adverse Event|5|||
130410408|NCT00406029|469463857|FG003|Overall Study|Adverse Event|10|||
130410409|NCT00406029|469463858|FG004|Overall Study|Adverse Event|7|||
130410410|NCT00406029|469463854|FG000|Overall Study|Withdrawal by Subject|3|||
130410411|NCT00406029|469463855|FG001|Overall Study|Withdrawal by Subject|4|||
130410412|NCT00406029|469463856|FG002|Overall Study|Withdrawal by Subject|2|||
130410413|NCT00406029|469463857|FG003|Overall Study|Withdrawal by Subject|2|||
130410414|NCT00406029|469463858|FG004|Overall Study|Withdrawal by Subject|0|||
130410415|NCT00406029|469463854|FG000|Overall Study|Protocol Violation|1|||
130410416|NCT00406029|469463855|FG001|Overall Study|Protocol Violation|2|||
130410417|NCT00406029|469463856|FG002|Overall Study|Protocol Violation|0|||
130410418|NCT00406029|469463857|FG003|Overall Study|Protocol Violation|2|||
130410419|NCT00406029|469463858|FG004|Overall Study|Protocol Violation|0|||
130410420|NCT00406029|469463854|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130410421|NCT00406029|469463855|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130410422|NCT00406029|469463856|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
130473909|NCT02724878|469704712|FG000|Overall Study|Still on Active Therapy|15|||
130473910|NCT02724878|469704712|FG000|Overall Study|Disease Progression|31|||
130473911|NCT02724878|469704712|FG000|Overall Study|Toxicity|5|||
130410423|NCT00406029|469463857|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
130410424|NCT00406029|469463858|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
130410425|NCT00406029|469463854|FG000|Overall Study|Randomized in Error|0|||
130410426|NCT00406029|469463855|FG001|Overall Study|Randomized in Error|0|||
130410427|NCT00406029|469463856|FG002|Overall Study|Randomized in Error|2|||
130410428|NCT00406029|469463857|FG003|Overall Study|Randomized in Error|3|||
130410429|NCT00406029|469463858|FG004|Overall Study|Randomized in Error|1|||
130410430|NCT01709227|469463862|FG000|Overall Study|Physician Decision|1|||
130410431|NCT01709227|469463863|FG001|Overall Study|Physician Decision|0|||
130473912|NCT02724878|469704712|FG000|Overall Study|Death|1|||
130410432|NCT01709227|469463862|FG000|Overall Study|Pleural Peritoneal communication|0|||
130410433|NCT01709227|469463863|FG001|Overall Study|Pleural Peritoneal communication|9|||
130410434|NCT03669081|469463866|FG000|Overall Study|Data could not be validated|1|||
130410435|NCT03669081|469463867|FG001|Overall Study|Data could not be validated|1|||
130410436|NCT00389324|469463868|FG000|Run-In Phase|Adverse Event|1|||
130410437|NCT00389324|469463868|FG000|Run-In Phase|Lost to Follow-up|1|||
130410438|NCT00389324|469463868|FG000|Run-In Phase|Withdrawal by Subject|1|||
130410439|NCT00389324|469463868|FG000|Subcutaneous Phase|Adverse Event|2|||
130563252|NCT02752035|470028833|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130563253|NCT03023059|470028840|FG000|Overall Study|Withdrawal by Subject|5|||
130563254|NCT04754802|470028841|FG000|Overall Study|Lost to Follow-up|0|||
130563255|NCT04754802|470028842|FG001|Overall Study|Lost to Follow-up|2|||
130563256|NCT04754802|470028841|FG000|Overall Study|Withdrawal by Subject|2|||
130563257|NCT04754802|470028842|FG001|Overall Study|Withdrawal by Subject|0|||
130563258|NCT04451161|470028843|FG000|Overall Study|Lost to Follow-up|28|||
130563259|NCT04451161|470028844|FG001|Overall Study|Lost to Follow-up|37|||
130563260|NCT04451161|470028845|FG002|Overall Study|Lost to Follow-up|22|||
130563261|NCT04451161|470028846|FG003|Overall Study|Lost to Follow-up|13|||
130563262|NCT04451161|470028847|FG004|Overall Study|Lost to Follow-up|11|||
130563263|NCT04451161|470028848|FG005|Overall Study|Lost to Follow-up|14|||
130563264|NCT04451161|470028843|FG000|Overall Study|Withdrawal by Subject|3|||
130563265|NCT04451161|470028844|FG001|Overall Study|Withdrawal by Subject|0|||
130563266|NCT04451161|470028845|FG002|Overall Study|Withdrawal by Subject|0|||
130563267|NCT04451161|470028846|FG003|Overall Study|Withdrawal by Subject|0|||
130563268|NCT04451161|470028847|FG004|Overall Study|Withdrawal by Subject|2|||
130563269|NCT04451161|470028848|FG005|Overall Study|Withdrawal by Subject|4|||
130563270|NCT00073528|470028853|FG000|Overall Study|Death|488|||
130563271|NCT00073528|470028854|FG001|Overall Study|Death|473|||
130563272|NCT00073528|470028853|FG000|Overall Study|Lost to Follow-up|52|||
130563273|NCT00073528|470028854|FG001|Overall Study|Lost to Follow-up|45|||
130563274|NCT00073528|470028853|FG000|Overall Study|Withdrawal by Subject|50|||
130563275|NCT00073528|470028854|FG001|Overall Study|Withdrawal by Subject|45|||
130563276|NCT00073528|470028853|FG000|Overall Study|Study terminated by Sponsor|10|||
130563277|NCT00073528|470028854|FG001|Overall Study|Study terminated by Sponsor|29|||
130563278|NCT00073528|470028853|FG000|Overall Study|Other|18|||
130563279|NCT00073528|470028854|FG001|Overall Study|Other|19|||
130563280|NCT00073528|470028853|FG000|Overall Study|Other|9|||
130563281|NCT00073528|470028854|FG001|Overall Study|Other|12|||
130563282|NCT00073528|470028853|FG000|Overall Study|Protocol Violation|3|||
130563283|NCT00073528|470028854|FG001|Overall Study|Protocol Violation|5|||
130563284|NCT00117598|470028857|FG000|Prior to Treatment Cross Over|Death|40|||
130563285|NCT00117598|470028858|FG001|Prior to Treatment Cross Over|Death|41|||
130563286|NCT00117598|470028859|FG002|Prior to Treatment Cross Over|Death|37|||
130563287|NCT00117598|470028860|FG003|Prior to Treatment Cross Over|Death|0|||
130563288|NCT00117598|470028861|FG004|Prior to Treatment Cross Over|Death|0|||
130563289|NCT00117598|470028857|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130563290|NCT00117598|470028858|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
130563291|NCT00117598|470028859|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
130563292|NCT00117598|470028860|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130563293|NCT00117598|470028861|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130563294|NCT00117598|470028857|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
130563295|NCT00117598|470028858|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
130563296|NCT00117598|470028859|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
130563297|NCT00117598|470028860|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
130563298|NCT00117598|470028861|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
130563299|NCT00117598|470028857|FG000|Prior to Treatment Cross Over|Other|15|||
130563300|NCT00117598|470028858|FG001|Prior to Treatment Cross Over|Other|9|||
130563301|NCT00117598|470028859|FG002|Prior to Treatment Cross Over|Other|9|||
130563302|NCT00117598|470028860|FG003|Prior to Treatment Cross Over|Other|0|||
130563303|NCT00117598|470028861|FG004|Prior to Treatment Cross Over|Other|0|||
130563304|NCT00117598|470028857|FG000|After Treament Cross Over|Death|0|||
130563305|NCT00117598|470028858|FG001|After Treament Cross Over|Death|0|||
130563306|NCT00117598|470028859|FG002|After Treament Cross Over|Death|0|||
130563307|NCT00117598|470028860|FG003|After Treament Cross Over|Death|1|||
130563308|NCT00117598|470028861|FG004|After Treament Cross Over|Death|2|||
130563309|NCT00117598|470028857|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
130563310|NCT00117598|470028858|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
130410440|NCT00389324|469463868|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
130563311|NCT00117598|470028859|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
130563312|NCT00117598|470028860|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
130563313|NCT00117598|470028861|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
130563314|NCT00117598|470028857|FG000|After Treament Cross Over|Other|0|||
130563315|NCT00117598|470028858|FG001|After Treament Cross Over|Other|0|||
130563316|NCT00117598|470028859|FG002|After Treament Cross Over|Other|0|||
130563317|NCT00117598|470028860|FG003|After Treament Cross Over|Other|1|||
130563318|NCT00117598|470028861|FG004|After Treament Cross Over|Other|2|||
130473913|NCT02724878|469704712|FG000|Overall Study|Withdrawal by Subject|4|||
130473914|NCT02724878|469704712|FG000|Overall Study|Lost to Follow-up|2|||
130473915|NCT02724878|469704712|FG000|Overall Study|Protocol Violation|1|||
130473916|NCT02724878|469704712|FG000|Overall Study|Ineligible for Study Drug|5|||
130473917|NCT02724878|469704712|FG000|Overall Study|not started|1|||
130473918|NCT03175029|469704713|FG000|Overall Study|Withdrawal by Subject|2|||
130473919|NCT03175029|469704714|FG001|Overall Study|Withdrawal by Subject|1|||
130473920|NCT03175029|469704713|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
130473921|NCT03175029|469704714|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
130473922|NCT01426425|469704715|FG000|Overall Study|Exited prior to EP study|22|||
130473923|NCT01426425|469704715|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
130473924|NCT01426425|469704715|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
130473925|NCT03281291|469704721|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
130473926|NCT03281291|469704722|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
130473927|NCT03281291|469704723|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
130473928|NCT03281291|469704724|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
130473929|NCT03281291|469704725|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
130473930|NCT03281291|469704721|FG000|Overall Study|Protocol Deviation|2|||
130473931|NCT03281291|469704722|FG001|Overall Study|Protocol Deviation|0|||
130473932|NCT03281291|469704723|FG002|Overall Study|Protocol Deviation|1|||
130473933|NCT03281291|469704724|FG003|Overall Study|Protocol Deviation|2|||
130473934|NCT03281291|469704725|FG004|Overall Study|Protocol Deviation|1|||
130473935|NCT03281291|469704721|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
130473936|NCT03281291|469704722|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130473937|NCT03281291|469704723|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
130473938|NCT03281291|469704724|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130473939|NCT03281291|469704725|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
130563319|NCT04688775|470028864|FG000|Placebo-controlled Period|Randomized, not treated|1|||
130563320|NCT04688775|470028865|FG001|Placebo-controlled Period|Randomized, not treated|1|||
130563321|NCT04688775|470028866|FG002|Placebo-controlled Period|Randomized, not treated|0|||
130473940|NCT03281291|469704721|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
130473941|NCT03281291|469704722|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
130473942|NCT03281291|469704723|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
130473943|NCT03281291|469704724|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
130473944|NCT03281291|469704725|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
130473945|NCT03281291|469704721|FG000|Overall Study|Lost to Follow-up|10|||
130473946|NCT03281291|469704722|FG001|Overall Study|Lost to Follow-up|10|||
130473947|NCT03281291|469704723|FG002|Overall Study|Lost to Follow-up|4|||
130473948|NCT03281291|469704724|FG003|Overall Study|Lost to Follow-up|6|||
130473949|NCT03281291|469704725|FG004|Overall Study|Lost to Follow-up|10|||
130473950|NCT03281291|469704721|FG000|Overall Study|Other|0|||
130473951|NCT03281291|469704722|FG001|Overall Study|Other|2|||
130473952|NCT03281291|469704723|FG002|Overall Study|Other|0|||
130473953|NCT03281291|469704724|FG003|Overall Study|Other|2|||
130473954|NCT03281291|469704725|FG004|Overall Study|Other|1|||
130473955|NCT00512070|469704728|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
130473956|NCT00512070|469704729|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
130563322|NCT04688775|470028867|FG003|Placebo-controlled Period|Randomized, not treated|0|||
130563323|NCT04688775|470028864|FG000|Placebo-controlled Period|Adverse Event|2|||
130563324|NCT04688775|470028865|FG001|Placebo-controlled Period|Adverse Event|0|||
130563325|NCT04688775|470028866|FG002|Placebo-controlled Period|Adverse Event|0|||
130563326|NCT04688775|470028867|FG003|Placebo-controlled Period|Adverse Event|0|||
130563327|NCT04688775|470028864|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
130563328|NCT04688775|470028865|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
130563329|NCT04688775|470028866|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
130563330|NCT04688775|470028867|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
130563331|NCT04688775|470028864|FG000|Placebo-controlled Period|Protocol Violation|0|||
130563332|NCT04688775|470028865|FG001|Placebo-controlled Period|Protocol Violation|1|||
130563333|NCT04688775|470028866|FG002|Placebo-controlled Period|Protocol Violation|0|||
130563334|NCT04688775|470028867|FG003|Placebo-controlled Period|Protocol Violation|0|||
130473957|NCT00512070|469704730|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
130473958|NCT00512070|469704728|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
130473959|NCT00512070|469704729|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
130563335|NCT04688775|470028864|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
130563336|NCT04688775|470028865|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
130563337|NCT04688775|470028866|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
130473960|NCT00512070|469704730|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
130473961|NCT00961571|469704731|FG000|Overall Study|Physician Decision|39|||
130473962|NCT05524233|469704732|FG000|Overall Study|Lost to Follow-up|2|||
130473963|NCT05524233|469704732|FG000|Overall Study|Adverse Event|2|||
130727198|NCT02883049|470625430|FG006|Post Induction|Lost to Follow-up|0|||
130727199|NCT02883049|470625431|FG007|Post Induction|Lost to Follow-up|0|||
130727200|NCT02883049|470625432|FG008|Post Induction|Lost to Follow-up|3|||
130727201|NCT02883049|470625433|FG009|Post Induction|Lost to Follow-up|0|||
130727202|NCT02883049|470625434|FG010|Post Induction|Lost to Follow-up|1|||
130410441|NCT00389324|469463868|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
130410442|NCT00389324|469463868|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
130410443|NCT02317575|469463869|FG000|Period 1|Difficulty with venous cannulation|0|||
130410444|NCT02317575|469463870|FG001|Period 1|Difficulty with venous cannulation|1|||
130410445|NCT02317575|469463871|FG002|Period 1|Difficulty with venous cannulation|0|||
130410446|NCT02317575|469463872|FG003|Period 1|Difficulty with venous cannulation|0|||
130410447|NCT02317575|469463873|FG004|Period 1|Difficulty with venous cannulation|0|||
130410448|NCT02317575|469463869|FG000|Period 1|Withdrawal by Subject|1|||
130410449|NCT02317575|469463870|FG001|Period 1|Withdrawal by Subject|0|||
130410450|NCT02317575|469463871|FG002|Period 1|Withdrawal by Subject|0|||
130410451|NCT02317575|469463872|FG003|Period 1|Withdrawal by Subject|0|||
130410452|NCT02317575|469463873|FG004|Period 1|Withdrawal by Subject|0|||
130410453|NCT02843568|469463874|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
130410454|NCT02843568|469463875|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
130410455|NCT02843568|469463874|FG000|Overall Study|Death|3|||
130410456|NCT02843568|469463875|FG001|Overall Study|Death|3|||
130410457|NCT02843568|469463874|FG000|Overall Study|Withdrawal by Subject|1|||
130410458|NCT02843568|469463875|FG001|Overall Study|Withdrawal by Subject|1|||
130410459|NCT02843568|469463874|FG000|Overall Study|Lost to Follow-up|2|||
130410460|NCT02843568|469463875|FG001|Overall Study|Lost to Follow-up|0|||
130473964|NCT05524233|469704732|FG000|Overall Study|Withdrawal by Subject|1|||
130473965|NCT02506959|469704734|FG000|Overall Study|Physician Decision|2|||
130473966|NCT02506959|469704735|FG001|Overall Study|Physician Decision|1|||
130473967|NCT04390048|469704741|FG000|Overall Study|Withdrawal by Subject|1|||
130473968|NCT04390048|469704742|FG001|Overall Study|Withdrawal by Subject|3|||
130473969|NCT03126019|469704743|FG000|Overall Study|Death|5|||
130473970|NCT03126019|469704744|FG001|Overall Study|Death|27|||
130473971|NCT03126019|469704743|FG000|Overall Study|Lost to Follow-up|2|||
130410461|NCT04079933|469463878|FG000|Overall Study|Withdrawal by Subject|3|||
130410462|NCT04079933|469463879|FG001|Overall Study|Withdrawal by Subject|4|||
130410463|NCT04079933|469463878|FG000|Overall Study|Lost to Follow-up|0|||
130410464|NCT04079933|469463879|FG001|Overall Study|Lost to Follow-up|1|||
130410465|NCT01459796|469463880|FG000|Overall Study|Non compliance with protocol|2|||
130473972|NCT03126019|469704744|FG001|Overall Study|Lost to Follow-up|4|||
130473973|NCT03126019|469704743|FG000|Overall Study|Withdrawal by Subject|1|||
130473974|NCT03126019|469704744|FG001|Overall Study|Withdrawal by Subject|9|||
130473975|NCT03126019|469704743|FG000|Overall Study|Physician Decision|1|||
130473976|NCT03126019|469704744|FG001|Overall Study|Physician Decision|0|||
130473977|NCT03126019|469704743|FG000|Overall Study|Transitioned to Rollover Study|0|||
130473978|NCT03126019|469704744|FG001|Overall Study|Transitioned to Rollover Study|11|||
130473979|NCT03126019|469704743|FG000|Overall Study|Did Not Return to Site for Care|0|||
130473980|NCT03126019|469704744|FG001|Overall Study|Did Not Return to Site for Care|1|||
130473981|NCT03126019|469704743|FG000|Overall Study|Site Closed|0|||
130473982|NCT03126019|469704744|FG001|Overall Study|Site Closed|1|||
130473983|NCT04556656|469704746|FG000|Overall Study|Withdrawal by Subject|14|||
130473984|NCT04556656|469704747|FG001|Overall Study|Withdrawal by Subject|12|||
130473985|NCT04556656|469704746|FG000|Overall Study|Physician Decision|1|||
130473986|NCT04556656|469704747|FG001|Overall Study|Physician Decision|0|||
130473987|NCT04556656|469704746|FG000|Overall Study|Adverse Event|4|||
130473988|NCT04556656|469704747|FG001|Overall Study|Adverse Event|7|||
130473989|NCT04556656|469704746|FG000|Overall Study|Death|4|||
130473990|NCT04556656|469704747|FG001|Overall Study|Death|0|||
130473991|NCT04556656|469704746|FG000|Overall Study|Lost to Follow-up|3|||
130473992|NCT04556656|469704747|FG001|Overall Study|Lost to Follow-up|2|||
130473993|NCT04556656|469704746|FG000|Overall Study|Not further specified|2|||
130473994|NCT04556656|469704747|FG001|Overall Study|Not further specified|1|||
130473995|NCT01566695|469704755|FG000|Overall Study|Lack of Efficacy|1|||
130473996|NCT01566695|469704756|FG001|Overall Study|Lack of Efficacy|0|||
130473997|NCT01566695|469704755|FG000|Overall Study|Adverse Event|3|||
130473998|NCT01566695|469704756|FG001|Overall Study|Adverse Event|0|||
130473999|NCT01566695|469704755|FG000|Overall Study|Death|79|||
130474000|NCT01566695|469704756|FG001|Overall Study|Death|86|||
130474001|NCT01566695|469704755|FG000|Overall Study|Withdrawal by Subject|13|||
130727203|NCT02883049|470625435|FG011|Post Induction|Lost to Follow-up|0|||
130410466|NCT01459796|469463881|FG001|Overall Study|Non compliance with protocol|4|||
130474002|NCT01566695|469704756|FG001|Overall Study|Withdrawal by Subject|12|||
130474003|NCT01566695|469704755|FG000|Overall Study|Lost to Follow-up|0|||
130474004|NCT01566695|469704756|FG001|Overall Study|Lost to Follow-up|3|||
130474005|NCT01566695|469704755|FG000|Overall Study|Other reasons|11|||
130474006|NCT01566695|469704756|FG001|Overall Study|Other reasons|8|||
130474007|NCT05956002|469704757|FG000|Treatment Period 3|Adverse Event|0|||
130474008|NCT05956002|469704758|FG001|Treatment Period 3|Adverse Event|0|||
130727204|NCT02883049|470625436|FG012|Post Induction|Lost to Follow-up|0|||
130563338|NCT04688775|470028867|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
130563339|NCT04688775|470028864|FG000|Placebo-controlled Period|Other reasons|0|||
130563340|NCT04688775|470028865|FG001|Placebo-controlled Period|Other reasons|1|||
130563341|NCT04688775|470028866|FG002|Placebo-controlled Period|Other reasons|0|||
130563342|NCT04688775|470028867|FG003|Placebo-controlled Period|Other reasons|0|||
130563343|NCT04688775|470028864|FG000|Delayed Start Period|Adverse Event|0|||
130563344|NCT04688775|470028865|FG001|Delayed Start Period|Adverse Event|0|||
130563345|NCT04688775|470028866|FG002|Delayed Start Period|Adverse Event|1|||
130563346|NCT04688775|470028867|FG003|Delayed Start Period|Adverse Event|0|||
130563347|NCT04688775|470028864|FG000|Delayed Start Period|Lack of Efficacy|0|||
130563348|NCT04688775|470028865|FG001|Delayed Start Period|Lack of Efficacy|0|||
130563349|NCT04688775|470028866|FG002|Delayed Start Period|Lack of Efficacy|0|||
130563350|NCT04688775|470028867|FG003|Delayed Start Period|Lack of Efficacy|3|||
130563351|NCT04688775|470028864|FG000|Delayed Start Period|Withdrawal by Subject|0|||
130563352|NCT04688775|470028865|FG001|Delayed Start Period|Withdrawal by Subject|0|||
130563353|NCT04688775|470028866|FG002|Delayed Start Period|Withdrawal by Subject|2|||
130563354|NCT04688775|470028867|FG003|Delayed Start Period|Withdrawal by Subject|4|||
130563355|NCT04688775|470028864|FG000|Delayed Start Period|Lost to Follow-up|0|||
130410467|NCT01459796|469463880|FG000|Overall Study|Adverse Event|5|||
130410468|NCT01459796|469463881|FG001|Overall Study|Adverse Event|5|||
130410469|NCT01459796|469463880|FG000|Overall Study|Withdrawal by Subject|6|||
130410470|NCT01459796|469463881|FG001|Overall Study|Withdrawal by Subject|3|||
130410471|NCT01459796|469463880|FG000|Overall Study|Lost to Follow-up|5|||
130410472|NCT01459796|469463881|FG001|Overall Study|Lost to Follow-up|4|||
130410473|NCT01459796|469463880|FG000|Overall Study|Reason unspecified|1|||
130410474|NCT01459796|469463881|FG001|Overall Study|Reason unspecified|2|||
130410475|NCT01459796|469463880|FG000|Overall Study|Decision by the sponsor|75|||
130410476|NCT01459796|469463881|FG001|Overall Study|Decision by the sponsor|108|||
130410477|NCT00413413|469463882|FG000|Single-Blind|Adverse Event|0|||
130410478|NCT00413413|469463883|FG001|Single-Blind|Adverse Event|9|||
130410479|NCT00413413|469463884|FG002|Single-Blind|Adverse Event|0|||
130410480|NCT00413413|469463882|FG000|Single-Blind|Lack of Efficacy|0|||
130410481|NCT00413413|469463883|FG001|Single-Blind|Lack of Efficacy|5|||
130410482|NCT00413413|469463884|FG002|Single-Blind|Lack of Efficacy|0|||
130410483|NCT00413413|469463882|FG000|Single-Blind|Subject no longer requires study drug|0|||
130410484|NCT00413413|469463883|FG001|Single-Blind|Subject no longer requires study drug|151|||
130410485|NCT00413413|469463884|FG002|Single-Blind|Subject no longer requires study drug|0|||
130410486|NCT00413413|469463882|FG000|Single-Blind|Protocol Violation|0|||
130410487|NCT00413413|469463883|FG001|Single-Blind|Protocol Violation|16|||
130410488|NCT00413413|469463884|FG002|Single-Blind|Protocol Violation|0|||
130410489|NCT00413413|469463882|FG000|Single-Blind|Withdrawal by Subject|0|||
130410490|NCT00413413|469463883|FG001|Single-Blind|Withdrawal by Subject|27|||
130410491|NCT00413413|469463884|FG002|Single-Blind|Withdrawal by Subject|0|||
130410492|NCT00413413|469463882|FG000|Single-Blind|Lost to Follow-up|0|||
130410493|NCT00413413|469463883|FG001|Single-Blind|Lost to Follow-up|8|||
130410494|NCT00413413|469463884|FG002|Single-Blind|Lost to Follow-up|0|||
130410495|NCT00413413|469463882|FG000|Double-Blind|Adverse Event|6|||
130410496|NCT00413413|469463883|FG001|Double-Blind|Adverse Event|0|||
130410497|NCT00413413|469463884|FG002|Double-Blind|Adverse Event|5|||
130410498|NCT00413413|469463882|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
130410499|NCT00413413|469463883|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
130410500|NCT00413413|469463884|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
130410501|NCT00413413|469463882|FG000|Double-Blind|Protocol deviation|1|||
130410502|NCT00413413|469463883|FG001|Double-Blind|Protocol deviation|2|||
130410503|NCT00413413|469463884|FG002|Double-Blind|Protocol deviation|1|||
130410504|NCT00413413|469463882|FG000|Double-Blind|Subject withdrew consent|4|||
130410505|NCT00413413|469463883|FG001|Double-Blind|Subject withdrew consent|6|||
130410506|NCT00413413|469463884|FG002|Double-Blind|Subject withdrew consent|9|||
130410507|NCT00413413|469463882|FG000|Double-Blind|Lost to Follow-up|3|||
130410508|NCT00413413|469463883|FG001|Double-Blind|Lost to Follow-up|4|||
130410509|NCT00413413|469463884|FG002|Double-Blind|Lost to Follow-up|2|||
130410510|NCT03207750|469463885|FG000|Overall Study|Adverse Event|3|||
130410511|NCT03207750|469463886|FG001|Overall Study|Adverse Event|2|||
130410512|NCT03207750|469463885|FG000|Overall Study|Lost to Follow-up|21|||
130410513|NCT03207750|469463886|FG001|Overall Study|Lost to Follow-up|29|||
130563356|NCT04688775|470028865|FG001|Delayed Start Period|Lost to Follow-up|0|||
130563357|NCT04688775|470028866|FG002|Delayed Start Period|Lost to Follow-up|2|||
130563358|NCT04688775|470028867|FG003|Delayed Start Period|Lost to Follow-up|1|||
130410514|NCT03207750|469463885|FG000|Overall Study|Protocol Violation|0|||
130410515|NCT03207750|469463886|FG001|Overall Study|Protocol Violation|1|||
130410516|NCT03207750|469463885|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
130410517|NCT03207750|469463886|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
130410518|NCT03207750|469463885|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
130410519|NCT03207750|469463886|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
130410520|NCT03207750|469463885|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
130410521|NCT03207750|469463886|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
130563359|NCT04688775|470028864|FG000|Delayed Start Period|other reasons|0|||
130563360|NCT04688775|470028865|FG001|Delayed Start Period|other reasons|0|||
130563361|NCT04688775|470028866|FG002|Delayed Start Period|other reasons|1|||
130563362|NCT04688775|470028867|FG003|Delayed Start Period|other reasons|0|||
130563363|NCT00898443|470028868|FG000|Overall Study|Withdrawal by Subject|1|||
130563364|NCT00898443|470028869|FG001|Overall Study|Withdrawal by Subject|0|||
130563365|NCT04695392|470028870|FG000|Overall Study|Withdrawn by parent/guardian|0|||
130563366|NCT04695392|470028871|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130563367|NCT04695392|470028870|FG000|Overall Study|Withdrawn by physician|0|||
130563368|NCT04695392|470028871|FG001|Overall Study|Withdrawn by physician|1|||
130563369|NCT02811549|470028874|FG000|Overall Study|Lost to Follow-up|1|||
130563370|NCT02811549|470028874|FG000|Overall Study|Withdrawal by Subject|3|||
130563371|NCT02811549|470028874|FG000|Overall Study|Subject screen failed|4|||
130563372|NCT02811549|470028874|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
130563373|NCT02573870|470030441|FG000|Overall Study|Adverse Event|0|||
130563374|NCT02573870|470030442|FG001|Overall Study|Adverse Event|2|||
130563375|NCT02573870|470030441|FG000|Overall Study|Lack of Efficacy|0|||
130563376|NCT02573870|470030442|FG001|Overall Study|Lack of Efficacy|1|||
130563377|NCT02573870|470030441|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
130563378|NCT02573870|470030442|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
130563379|NCT02573870|470030441|FG000|Overall Study|Lost to Follow-up|0|||
130563380|NCT02573870|470030442|FG001|Overall Study|Lost to Follow-up|1|||
130563381|NCT02573870|470030441|FG000|Overall Study|Other: Fail to Meet Visit|0|||
130563382|NCT02573870|470030442|FG001|Overall Study|Other: Fail to Meet Visit|2|||
130563383|NCT00762892|470030450|FG000|Overall Study|Lost to Follow-up|2|||
130563384|NCT00762892|470030451|FG001|Overall Study|Lost to Follow-up|5|||
130563385|NCT00762892|470030450|FG000|Overall Study|Withdrawal by Subject|0|||
130563386|NCT00762892|470030451|FG001|Overall Study|Withdrawal by Subject|1|||
130563387|NCT00762892|470030450|FG000|Overall Study|Death|1|||
130563388|NCT00762892|470030451|FG001|Overall Study|Death|0|||
130563389|NCT00762892|470030450|FG000|Overall Study|Pregnancy|1|||
130563390|NCT00762892|470030451|FG001|Overall Study|Pregnancy|0|||
130563391|NCT00762892|470030450|FG000|Overall Study|Incarceration|1|||
130563392|NCT00762892|470030451|FG001|Overall Study|Incarceration|0|||
130563393|NCT01007032|470030454|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
130563394|NCT01007032|470030455|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
130563395|NCT01007032|470030456|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
130563396|NCT01007032|470030457|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
130563397|NCT01007032|470030454|FG000|Overall Study|Withdrawal by Subject|0|||
130563398|NCT01007032|470030455|FG001|Overall Study|Withdrawal by Subject|0|||
130563399|NCT01007032|470030456|FG002|Overall Study|Withdrawal by Subject|0|||
130563400|NCT01007032|470030457|FG003|Overall Study|Withdrawal by Subject|1|||
130563401|NCT01841749|470030458|FG000|Overall Study|Protocol Violation|1|||
130563402|NCT00677820|470030459|FG000|Overall Study|Lost to Follow-up|1|||
130563403|NCT00677820|470030460|FG001|Overall Study|Lost to Follow-up|0|||
130563404|NCT01101438|470030464|FG000|Overall Study|Withdrawal by Subject|8|||
130563405|NCT01101438|470030465|FG001|Overall Study|Withdrawal by Subject|9|||
130563406|NCT00290290|470030482|FG000|Overall Study|Death|3|||
130563407|NCT00290290|470030483|FG001|Overall Study|Death|4|||
130563408|NCT00290290|470030482|FG000|Overall Study|Withdrawal by Subject|2|||
130563409|NCT00290290|470030483|FG001|Overall Study|Withdrawal by Subject|2|||
130563410|NCT00290290|470030482|FG000|Overall Study|Underwent clean surgical procedure|13|||
130563411|NCT00290290|470030483|FG001|Overall Study|Underwent clean surgical procedure|12|||
130410522|NCT03207750|469463885|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
130410523|NCT03207750|469463886|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
130410524|NCT03207750|469463885|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
130410525|NCT03207750|469463886|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
130410526|NCT03634579|469463887|FG000|Overall Study|study termination|9|||
130410527|NCT03321019|469463895|FG000|Overall Study|Withdrawal by Subject|0|||
130410528|NCT03321019|469463896|FG001|Overall Study|Withdrawal by Subject|6|||
130410529|NCT03321019|469463895|FG000|Overall Study|Lost to Follow-up|0|||
130410530|NCT03321019|469463896|FG001|Overall Study|Lost to Follow-up|22|||
130410531|NCT01578551|469463899|FG000|Overall Study|Adverse Event|1|||
130563412|NCT00549939|470030489|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
130563413|NCT00549939|470030490|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
130563414|NCT00549939|470030491|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
130563415|NCT00549939|470030489|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
130563416|NCT00549939|470030490|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
130563417|NCT00549939|470030491|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
130563418|NCT00549939|470030489|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
130563419|NCT00549939|470030490|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
130563420|NCT00549939|470030491|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
130727205|NCT02883049|470625437|FG013|Post Induction|Lost to Follow-up|0|||
130410532|NCT01578551|469463900|FG001|Overall Study|Adverse Event|0|||
130410533|NCT00766415|469463901|FG000|Overall Study|Withdrawal by Subject|0|||
130410534|NCT00766415|469463902|FG001|Overall Study|Withdrawal by Subject|1|||
130410535|NCT02752048|469463905|FG000|Overall Study|Withdrawal by Subject|0|||
130410536|NCT02752048|469463906|FG001|Overall Study|Withdrawal by Subject|0|||
130410537|NCT02752048|469463907|FG002|Overall Study|Withdrawal by Subject|3|||
130410538|NCT01312467|469463908|FG000|Overall Study|Adverse Event|4|||
130410539|NCT01312467|469463908|FG000|Overall Study|Lost to Follow-up|1|||
130410540|NCT01312467|469463908|FG000|Overall Study|Withdrawal by Subject|2|||
130410541|NCT01312467|469463908|FG000|Overall Study|Deported to country of origin|1|||
130410542|NCT01312467|469463908|FG000|Overall Study|Another medical condition|1|||
130410543|NCT01312467|469463908|FG000|Overall Study|Ineligible|4|||
130410544|NCT00132769|469463909|FG000|Overall Study|Withdrawal by Subject|1|||
130410545|NCT00132769|469463910|FG001|Overall Study|Withdrawal by Subject|3|||
130410546|NCT00132769|469463909|FG000|Overall Study|Lack of Efficacy|7|||
130410547|NCT00132769|469463910|FG001|Overall Study|Lack of Efficacy|6|||
130410548|NCT00132769|469463909|FG000|Overall Study|Adverse Event|2|||
130410549|NCT00132769|469463910|FG001|Overall Study|Adverse Event|1|||
130410550|NCT00132769|469463909|FG000|Overall Study|Protocol Violation|1|||
130410551|NCT00132769|469463910|FG001|Overall Study|Protocol Violation|1|||
130410552|NCT04452344|469463911|FG000|Overall Study|Withdrawal by Subject|3|||
130410553|NCT04452344|469463912|FG001|Overall Study|Withdrawal by Subject|6|||
130410554|NCT04452344|469463911|FG000|Overall Study|Adverse Event|1|||
130410555|NCT04452344|469463912|FG001|Overall Study|Adverse Event|2|||
130474009|NCT05956002|469704759|FG002|Treatment Period 3|Adverse Event|1|||
130474010|NCT05956002|469704760|FG003|Treatment Period 3|Adverse Event|0|||
130474011|NCT02281955|469704766|FG000|Overall Study|Death|1|||
130474012|NCT02783300|469704767|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474013|NCT02783300|469704768|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474014|NCT02783300|469704769|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474015|NCT02783300|469704770|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474016|NCT02783300|469704771|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474017|NCT02783300|469704772|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474018|NCT02783300|469704773|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
130474019|NCT02783300|469704774|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474020|NCT02783300|469704775|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474021|NCT02783300|469704776|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474022|NCT02783300|469704777|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474023|NCT02783300|469704778|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474024|NCT02783300|469704779|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474025|NCT02783300|469704780|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474026|NCT02783300|469704781|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474027|NCT02783300|469704782|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474028|NCT02783300|469704783|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474029|NCT02783300|469704784|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474030|NCT02783300|469704785|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474031|NCT02783300|469704786|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474032|NCT02783300|469704787|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474033|NCT02783300|469704788|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474034|NCT02783300|469704789|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474035|NCT02783300|469704790|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474036|NCT02783300|469704791|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474037|NCT02783300|469704792|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474038|NCT02783300|469704793|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130474039|NCT02783300|469704767|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474040|NCT02783300|469704768|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130410556|NCT04452344|469463911|FG000|Overall Study|Lost to Follow-up|2|||
130410557|NCT04452344|469463912|FG001|Overall Study|Lost to Follow-up|2|||
130410558|NCT04452344|469463911|FG000|Overall Study|No Post-Op Visit|6|||
130410559|NCT04452344|469463912|FG001|Overall Study|No Post-Op Visit|7|||
130410560|NCT04095858|469463918|FG000|Overall Study|Death|1|||
130474041|NCT02783300|469704769|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474042|NCT02783300|469704770|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
130474043|NCT02783300|469704771|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474044|NCT02783300|469704772|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474045|NCT02783300|469704773|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474046|NCT02783300|469704774|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130410561|NCT04095858|469463919|FG001|Overall Study|Death|0|||
130410562|NCT04095858|469463918|FG000|Overall Study|Study terminated by Sponsor|2|||
130410563|NCT04095858|469463919|FG001|Overall Study|Study terminated by Sponsor|4|||
130410564|NCT01344460|469463920|FG000|Overall Study|Withdrawal by Subject|1|||
130410565|NCT01344460|469463920|FG000|Overall Study|Lost to Follow-up|2|||
130410566|NCT00560833|469463921|FG000|Overall Study|Adverse Event|16|||
130410567|NCT00560833|469463922|FG001|Overall Study|Adverse Event|10|||
130410568|NCT00560833|469463923|FG002|Overall Study|Adverse Event|25|||
130410569|NCT00560833|469463924|FG003|Overall Study|Adverse Event|23|||
130410570|NCT00560833|469463925|FG004|Overall Study|Adverse Event|35|||
130410571|NCT00560833|469463921|FG000|Overall Study|Lost to Follow-up|0|||
130410572|NCT00560833|469463922|FG001|Overall Study|Lost to Follow-up|0|||
130410573|NCT00560833|469463923|FG002|Overall Study|Lost to Follow-up|1|||
130410574|NCT00560833|469463924|FG003|Overall Study|Lost to Follow-up|0|||
130410575|NCT00560833|469463925|FG004|Overall Study|Lost to Follow-up|0|||
130410576|NCT00560833|469463921|FG000|Overall Study|Lack of Efficacy|22|||
130410577|NCT00560833|469463922|FG001|Overall Study|Lack of Efficacy|9|||
130410578|NCT00560833|469463923|FG002|Overall Study|Lack of Efficacy|6|||
130410579|NCT00560833|469463924|FG003|Overall Study|Lack of Efficacy|4|||
130410580|NCT00560833|469463925|FG004|Overall Study|Lack of Efficacy|4|||
130410581|NCT00560833|469463921|FG000|Overall Study|Participant uncooperative|5|||
130410582|NCT00560833|469463922|FG001|Overall Study|Participant uncooperative|5|||
130410583|NCT00560833|469463923|FG002|Overall Study|Participant uncooperative|4|||
130410584|NCT00560833|469463924|FG003|Overall Study|Participant uncooperative|4|||
130410585|NCT00560833|469463925|FG004|Overall Study|Participant uncooperative|2|||
130410586|NCT00560833|469463921|FG000|Overall Study|Other|1|||
130410587|NCT00560833|469463922|FG001|Overall Study|Other|1|||
130410588|NCT00560833|469463923|FG002|Overall Study|Other|3|||
130410589|NCT00560833|469463924|FG003|Overall Study|Other|0|||
130410590|NCT00560833|469463925|FG004|Overall Study|Other|0|||
130410591|NCT00560833|469463921|FG000|Overall Study|Never received drug|0|||
130410592|NCT00560833|469463922|FG001|Overall Study|Never received drug|1|||
130410593|NCT00560833|469463923|FG002|Overall Study|Never received drug|0|||
130410594|NCT00560833|469463924|FG003|Overall Study|Never received drug|0|||
130410595|NCT00560833|469463925|FG004|Overall Study|Never received drug|1|||
130410596|NCT00898677|469463928|FG000|Overall Study|Adverse Event|0|||
130410597|NCT00898677|469463929|FG001|Overall Study|Adverse Event|0|||
130410598|NCT00898677|469463930|FG002|Overall Study|Adverse Event|1|||
130410599|NCT00898677|469463931|FG003|Overall Study|Adverse Event|0|||
130410600|NCT00898677|469463928|FG000|Overall Study|Lost to Follow-up|0|||
130410601|NCT00898677|469463929|FG001|Overall Study|Lost to Follow-up|0|||
130410602|NCT00898677|469463930|FG002|Overall Study|Lost to Follow-up|2|||
130410603|NCT00898677|469463931|FG003|Overall Study|Lost to Follow-up|0|||
130410604|NCT00898677|469463928|FG000|Overall Study|Protocol Violation|1|||
130410605|NCT00898677|469463929|FG001|Overall Study|Protocol Violation|1|||
130410606|NCT00898677|469463930|FG002|Overall Study|Protocol Violation|2|||
130410607|NCT00898677|469463931|FG003|Overall Study|Protocol Violation|0|||
130410608|NCT00898677|469463928|FG000|Overall Study|Withdrawal by Subject|0|||
130410609|NCT00898677|469463929|FG001|Overall Study|Withdrawal by Subject|0|||
130410610|NCT00898677|469463930|FG002|Overall Study|Withdrawal by Subject|0|||
130410611|NCT00898677|469463931|FG003|Overall Study|Withdrawal by Subject|1|||
130410612|NCT00898677|469463928|FG000|Overall Study|Not Treated: Adverse Event|0|||
130410613|NCT00898677|469463929|FG001|Overall Study|Not Treated: Adverse Event|2|||
130410614|NCT00898677|469463930|FG002|Overall Study|Not Treated: Adverse Event|1|||
130410615|NCT00898677|469463931|FG003|Overall Study|Not Treated: Adverse Event|0|||
130410616|NCT00898677|469463928|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
130410617|NCT00898677|469463929|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
130474047|NCT02783300|469704775|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474048|NCT02783300|469704776|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474049|NCT02783300|469704777|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474050|NCT02783300|469704778|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474051|NCT02783300|469704779|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130410618|NCT00898677|469463930|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
130410619|NCT00898677|469463931|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
130410620|NCT00898677|469463928|FG000|Overall Study|Not Treated: Pregnancy|0|||
130410621|NCT00898677|469463929|FG001|Overall Study|Not Treated: Pregnancy|0|||
130410622|NCT00898677|469463930|FG002|Overall Study|Not Treated: Pregnancy|1|||
130410623|NCT00898677|469463931|FG003|Overall Study|Not Treated: Pregnancy|0|||
130410624|NCT00898677|469463928|FG000|Overall Study|Not Treated: Protocol Violation|2|||
130410625|NCT00898677|469463929|FG001|Overall Study|Not Treated: Protocol Violation|0|||
130474052|NCT02783300|469704780|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130410626|NCT00898677|469463930|FG002|Overall Study|Not Treated: Protocol Violation|2|||
130410627|NCT00898677|469463931|FG003|Overall Study|Not Treated: Protocol Violation|0|||
130410628|NCT00898677|469463928|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
130410629|NCT00898677|469463929|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
130410630|NCT00898677|469463930|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
130410631|NCT00898677|469463931|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
130410632|NCT00898677|469463928|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
130410633|NCT00898677|469463929|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
130410634|NCT00898677|469463930|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
130410635|NCT00898677|469463931|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
130410636|NCT00898677|469463928|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
130410637|NCT00898677|469463929|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
130410638|NCT00898677|469463930|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
130410639|NCT00898677|469463931|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
130410640|NCT00898677|469463928|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
130410641|NCT00898677|469463929|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130410642|NCT00898677|469463930|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130410643|NCT00898677|469463931|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130410644|NCT00898677|469463928|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
130410645|NCT00898677|469463929|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
130410646|NCT00898677|469463930|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
130410647|NCT00898677|469463931|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
130410648|NCT00898677|469463928|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
130410649|NCT00898677|469463929|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
130410650|NCT00898677|469463930|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
130410651|NCT00898677|469463931|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
130410652|NCT00898677|469463928|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
130410653|NCT00898677|469463929|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
130410654|NCT00898677|469463930|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
130410655|NCT00898677|469463931|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
130410656|NCT02199691|469463932|FG000|Overall Study|Protocol Violation|3|||
130410657|NCT02199691|469463933|FG001|Overall Study|Protocol Violation|3|||
130410658|NCT02199691|469463934|FG002|Overall Study|Protocol Violation|6|||
130410659|NCT02199691|469463935|FG003|Overall Study|Protocol Violation|7|||
130410660|NCT02199691|469463932|FG000|Overall Study|Withdrawal by Subject|5|||
130410661|NCT02199691|469463933|FG001|Overall Study|Withdrawal by Subject|3|||
130410662|NCT02199691|469463934|FG002|Overall Study|Withdrawal by Subject|12|||
130410663|NCT02199691|469463935|FG003|Overall Study|Withdrawal by Subject|13|||
130410664|NCT02199691|469463932|FG000|Overall Study|Lost to Follow-up|2|||
130410665|NCT02199691|469463933|FG001|Overall Study|Lost to Follow-up|1|||
130410666|NCT02199691|469463934|FG002|Overall Study|Lost to Follow-up|9|||
130410667|NCT02199691|469463935|FG003|Overall Study|Lost to Follow-up|10|||
130410668|NCT03823651|469463936|FG000|Overall Study|Death|5|||
130410669|NCT03823651|469463937|FG001|Overall Study|Death|0|||
130410670|NCT03823651|469463936|FG000|Overall Study|Physician Decision|1|||
130410671|NCT03823651|469463937|FG001|Overall Study|Physician Decision|0|||
130410672|NCT03823651|469463936|FG000|Overall Study|Caregiver to patient who died|0|||
130410673|NCT03823651|469463937|FG001|Overall Study|Caregiver to patient who died|5|||
130410674|NCT03823651|469463936|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
130410675|NCT03823651|469463937|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
130410676|NCT00428610|469463938|FG000|Overall Study|Death Due to Adverse Event|3|||
130410677|NCT00428610|469463939|FG001|Overall Study|Death Due to Adverse Event|0|||
130410678|NCT00428610|469463940|FG002|Overall Study|Death Due to Adverse Event|5|||
130410679|NCT00428610|469463938|FG000|Overall Study|Death Due to Progressive Disease|0|||
130410680|NCT00428610|469463939|FG001|Overall Study|Death Due to Progressive Disease|0|||
130410681|NCT00428610|469463940|FG002|Overall Study|Death Due to Progressive Disease|2|||
130410682|NCT00428610|469463938|FG000|Overall Study|Adverse Event|2|||
130410683|NCT00428610|469463939|FG001|Overall Study|Adverse Event|3|||
130410684|NCT00428610|469463940|FG002|Overall Study|Adverse Event|2|||
130410685|NCT00428610|469463938|FG000|Overall Study|Investigator Decision|2|||
130410686|NCT00428610|469463939|FG001|Overall Study|Investigator Decision|1|||
130410687|NCT00428610|469463940|FG002|Overall Study|Investigator Decision|1|||
130410688|NCT00428610|469463938|FG000|Overall Study|Progressive Disease|42|||
130410689|NCT00428610|469463939|FG001|Overall Study|Progressive Disease|14|||
130410690|NCT00428610|469463940|FG002|Overall Study|Progressive Disease|22|||
130410691|NCT00428610|469463938|FG000|Overall Study|Withdrawal by Subject|4|||
130410692|NCT00428610|469463939|FG001|Overall Study|Withdrawal by Subject|0|||
130410693|NCT00428610|469463940|FG002|Overall Study|Withdrawal by Subject|0|||
130410694|NCT05350449|469463941|FG000|Overall Study|Withdrawal by Subject|4|||
130410695|NCT05350449|469463942|FG001|Overall Study|Withdrawal by Subject|8|||
130410696|NCT01404312|469465928|FG000|Overall Study|Death|21|||
130410697|NCT01404312|469465929|FG001|Overall Study|Death|27|||
130410698|NCT01404312|469465928|FG000|Overall Study|Withdrawal by Subject|15|||
130410699|NCT01404312|469465929|FG001|Overall Study|Withdrawal by Subject|18|||
130410700|NCT01404312|469465928|FG000|Overall Study|Participant Unable to get to clinic|93|||
130410701|NCT01404312|469465929|FG001|Overall Study|Participant Unable to get to clinic|103|||
130410702|NCT01404312|469465928|FG000|Overall Study|Lost to Follow-up|115|||
130410703|NCT01404312|469465929|FG001|Overall Study|Lost to Follow-up|111|||
130410704|NCT01404312|469465928|FG000|Overall Study|Site closed|22|||
130410705|NCT01404312|469465929|FG001|Overall Study|Site closed|21|||
130410706|NCT01404312|469465928|FG000|Overall Study|Participant not willing to adhere to req|31|||
130410707|NCT01404312|469465929|FG001|Overall Study|Participant not willing to adhere to req|29|||
130410708|NCT01404312|469465928|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130563421|NCT00549939|470030489|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
130563422|NCT00549939|470030490|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
130410709|NCT01404312|469465929|FG001|Overall Study|Severe debilitation, unable to continue|2|||
130410710|NCT04419493|469465930|FG000|Wash-out After Period 1|Adverse Event|1|||
130410711|NCT04419493|469465931|FG001|Wash-out After Period 1|Adverse Event|2|||
130410712|NCT04419493|469465932|FG002|Wash-out After Period 1|Adverse Event|1|||
130410713|NCT04419493|469465933|FG003|Wash-out After Period 1|Adverse Event|0|||
130410714|NCT00524134|469465934|FG000|Overall Study|Withdrawal by Subject|1|||
130410715|NCT00524134|469465934|FG000|Overall Study|Physician Decision|1|||
130410716|NCT01073618|469465937|FG000|Overall Study|Death|208|||
130410717|NCT01073618|469465937|FG000|Overall Study|Adverse Event|19|||
130410718|NCT01073618|469465937|FG000|Overall Study|Other|80|||
130410719|NCT00982020|469465938|FG000|Overall Study|Adverse Event|19|||
130410720|NCT00982020|469465939|FG001|Overall Study|Adverse Event|15|||
130410721|NCT00982020|469465938|FG000|Overall Study|Withdrawal by Subject|11|||
130410722|NCT00982020|469465939|FG001|Overall Study|Withdrawal by Subject|14|||
130410723|NCT00982020|469465938|FG000|Overall Study|Lost to Follow-up|5|||
130410724|NCT00982020|469465939|FG001|Overall Study|Lost to Follow-up|11|||
130410725|NCT00982020|469465938|FG000|Overall Study|Lack of Efficacy|10|||
130410726|NCT00982020|469465939|FG001|Overall Study|Lack of Efficacy|4|||
130410727|NCT00982020|469465938|FG000|Overall Study|Parent/Caregiver Decision|5|||
130410728|NCT00982020|469465939|FG001|Overall Study|Parent/Caregiver Decision|5|||
130410729|NCT00982020|469465938|FG000|Overall Study|Treatment Non-compliance|3|||
130410730|NCT00982020|469465939|FG001|Overall Study|Treatment Non-compliance|6|||
130410731|NCT00982020|469465938|FG000|Overall Study|Physician Decision|2|||
130410732|NCT00982020|469465939|FG001|Overall Study|Physician Decision|5|||
130410733|NCT00982020|469465938|FG000|Overall Study|Entry Criteria Not Met|2|||
130410734|NCT00982020|469465939|FG001|Overall Study|Entry Criteria Not Met|1|||
130410735|NCT00982020|469465938|FG000|Overall Study|Protocol Violation|0|||
130410736|NCT00982020|469465939|FG001|Overall Study|Protocol Violation|2|||
130410737|NCT00982020|469465938|FG000|Overall Study|Clinical Relapse|0|||
130410738|NCT00982020|469465939|FG001|Overall Study|Clinical Relapse|1|||
130410739|NCT00466193|469465940|FG000|Overall Study|Adverse Event|0|||
130410740|NCT00466193|469465941|FG001|Overall Study|Adverse Event|1|||
130410741|NCT00466193|469465940|FG000|Overall Study|Lost to Follow-up|2|||
130410742|NCT00466193|469465941|FG001|Overall Study|Lost to Follow-up|4|||
130410743|NCT00466193|469465940|FG000|Overall Study|Physician Decision|1|||
130410744|NCT00466193|469465941|FG001|Overall Study|Physician Decision|0|||
130410745|NCT00466193|469465940|FG000|Overall Study|Protocol Violation|1|||
130410746|NCT00466193|469465941|FG001|Overall Study|Protocol Violation|1|||
130410747|NCT00466193|469465940|FG000|Overall Study|Withdrawal by Subject|7|||
130410748|NCT00466193|469465941|FG001|Overall Study|Withdrawal by Subject|2|||
130410749|NCT00466193|469465940|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
130410750|NCT00466193|469465941|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
130410751|NCT02246998|469465942|FG000|Overall Study|Adverse Event|0|||
130410752|NCT02246998|469465943|FG001|Overall Study|Adverse Event|1|||
130410753|NCT02246998|469465944|FG002|Overall Study|Adverse Event|1|||
130410754|NCT02246998|469465945|FG003|Overall Study|Adverse Event|0|||
130410755|NCT02246998|469465942|FG000|Overall Study|Lost to Follow-up|1|||
130410756|NCT02246998|469465943|FG001|Overall Study|Lost to Follow-up|0|||
130410757|NCT02246998|469465944|FG002|Overall Study|Lost to Follow-up|0|||
130410758|NCT02246998|469465945|FG003|Overall Study|Lost to Follow-up|1|||
130410759|NCT02246998|469465942|FG000|Overall Study|Randomized but Never Dosed|1|||
130410760|NCT02246998|469465943|FG001|Overall Study|Randomized but Never Dosed|2|||
130410761|NCT02246998|469465944|FG002|Overall Study|Randomized but Never Dosed|2|||
130410762|NCT02246998|469465945|FG003|Overall Study|Randomized but Never Dosed|1|||
130410763|NCT01343082|469465948|FG000|The run-in Period|Not meeting criteria|3|||
130410764|NCT01343082|469465949|FG001|The run-in Period|Not meeting criteria|4|||
130410765|NCT01343082|469465950|FG002|The run-in Period|Not meeting criteria|5|||
130410766|NCT01343082|469465948|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
130410767|NCT01343082|469465949|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
130410768|NCT01343082|469465950|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
130410769|NCT01343082|469465948|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
130410770|NCT01343082|469465949|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
130410771|NCT01343082|469465950|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
130410772|NCT01343082|469465948|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
130410773|NCT01343082|469465949|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
130410774|NCT01343082|469465950|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
130410775|NCT01343082|469465948|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
130410776|NCT01343082|469465949|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
130410777|NCT01343082|469465950|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
130410778|NCT02554773|469465951|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
130410779|NCT02554773|469465952|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
130410780|NCT02554773|469465951|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
130410781|NCT02554773|469465952|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
130410782|NCT02554773|469465951|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
130410783|NCT02554773|469465952|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
130474053|NCT02783300|469704781|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474054|NCT02783300|469704782|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474055|NCT02783300|469704783|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474056|NCT02783300|469704784|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474057|NCT02783300|469704785|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474058|NCT02783300|469704786|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474059|NCT02783300|469704787|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474060|NCT02783300|469704788|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474061|NCT02783300|469704789|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474062|NCT02783300|469704790|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474063|NCT02783300|469704791|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130563423|NCT00549939|470030491|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
130410784|NCT02554773|469465951|FG000|Original Dose Regimen (SAS 1)|Death|1|||
130410785|NCT02554773|469465952|FG001|Original Dose Regimen (SAS 1)|Death|0|||
130410786|NCT02554773|469465951|FG000|Original Dose Regimen (SAS 1)|Other|4|||
130410787|NCT02554773|469465952|FG001|Original Dose Regimen (SAS 1)|Other|0|||
130410788|NCT02554773|469465951|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
130410789|NCT02554773|469465952|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
130410790|NCT02554773|469465951|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
130410791|NCT02554773|469465952|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
130410792|NCT02554773|469465951|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
130410793|NCT02554773|469465952|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
130410794|NCT02554773|469465951|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
130410795|NCT02554773|469465952|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
130410796|NCT01854554|469465953|FG000|Overall Study|Denial of Insurance Coverage|12|||
130410797|NCT01854554|469465954|FG001|Overall Study|Denial of Insurance Coverage|0|||
130410798|NCT01854554|469465953|FG000|Overall Study|Decided to get treatment locally|1|||
130410799|NCT01854554|469465954|FG001|Overall Study|Decided to get treatment locally|5|||
130410800|NCT01854554|469465953|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
130410801|NCT01854554|469465954|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
130410802|NCT01854554|469465953|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130410803|NCT01854554|469465954|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130410804|NCT01854554|469465953|FG000|Overall Study|Progression|0|||
130410805|NCT01854554|469465954|FG001|Overall Study|Progression|1|||
130410806|NCT01854554|469465953|FG000|Overall Study|Lost to Follow-up|0|||
130410807|NCT01854554|469465954|FG001|Overall Study|Lost to Follow-up|1|||
130410808|NCT02819726|469465955|FG000|Part A (All Participants)|Lost to Follow-up|0|||
130410809|NCT02819726|469465956|FG001|Part A (All Participants)|Lost to Follow-up|1|||
130410810|NCT02819726|469465957|FG002|Part A (All Participants)|Lost to Follow-up|0|||
130410811|NCT02819726|469465958|FG003|Part A (All Participants)|Lost to Follow-up|0|||
130410812|NCT02819726|469465955|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
130410813|NCT02819726|469465956|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
130410814|NCT02819726|469465957|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
130410815|NCT02819726|469465958|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
130410816|NCT02819726|469465955|FG000|Part A (All Participants)|Protocol non-compliance|3|||
130410817|NCT02819726|469465956|FG001|Part A (All Participants)|Protocol non-compliance|4|||
130410818|NCT02819726|469465957|FG002|Part A (All Participants)|Protocol non-compliance|5|||
130563424|NCT00549939|470030489|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
130563425|NCT00549939|470030490|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
130563426|NCT00549939|470030491|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
130563427|NCT00549939|470030489|FG000|40-week Open Label Treatment Period|Other|0|||
130563428|NCT00549939|470030490|FG001|40-week Open Label Treatment Period|Other|1|||
130563429|NCT00549939|470030491|FG002|40-week Open Label Treatment Period|Other|4|||
130563430|NCT03677596|470030492|FG000|Overall Study|Adverse Event|0|||
130563431|NCT03677596|470030493|FG001|Overall Study|Adverse Event|1|||
130563432|NCT03677596|470030492|FG000|Overall Study|Death|10|||
130563433|NCT03677596|470030493|FG001|Overall Study|Death|6|||
130563434|NCT03677596|470030492|FG000|Overall Study|Lost to Follow-up|0|||
130563435|NCT03677596|470030493|FG001|Overall Study|Lost to Follow-up|1|||
130563436|NCT03677596|470030492|FG000|Overall Study|Progressive Disease|8|||
130563437|NCT03677596|470030493|FG001|Overall Study|Progressive Disease|8|||
130563438|NCT03677596|470030492|FG000|Overall Study|Withdrawal by Subject|3|||
130563439|NCT03677596|470030493|FG001|Overall Study|Withdrawal by Subject|0|||
130563440|NCT03677596|470030492|FG000|Overall Study|Disease Relapse|2|||
130727206|NCT02883049|470625438|FG014|Post Induction|Lost to Follow-up|0|||
130727207|NCT02883049|470625439|FG015|Post Induction|Lost to Follow-up|0|||
130727208|NCT02883049|470625424|FG000|Post Induction|Physician Decision|0|||
130410819|NCT02819726|469465958|FG003|Part A (All Participants)|Protocol non-compliance|0|||
130563441|NCT03677596|470030493|FG001|Overall Study|Disease Relapse|2|||
130563442|NCT03677596|470030492|FG000|Overall Study|Other|0|||
130727209|NCT02883049|470625425|FG001|Post Induction|Physician Decision|0|||
130474064|NCT02783300|469704792|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130474065|NCT02783300|469704793|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130410820|NCT02819726|469465955|FG000|Part B (All Participants)|Lost to Follow-up|1|||
130410821|NCT02819726|469465956|FG001|Part B (All Participants)|Lost to Follow-up|1|||
130410822|NCT02819726|469465957|FG002|Part B (All Participants)|Lost to Follow-up|2|||
130410823|NCT02819726|469465958|FG003|Part B (All Participants)|Lost to Follow-up|2|||
130410824|NCT02819726|469465955|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
130410825|NCT02819726|469465956|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
130410826|NCT02819726|469465957|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
130410827|NCT02819726|469465958|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
130410828|NCT02819726|469465955|FG000|Part B (All Participants)|Protocol non-compliance|0|||
130410829|NCT02819726|469465956|FG001|Part B (All Participants)|Protocol non-compliance|0|||
130410830|NCT02819726|469465957|FG002|Part B (All Participants)|Protocol non-compliance|1|||
130410831|NCT02819726|469465958|FG003|Part B (All Participants)|Protocol non-compliance|0|||
130410832|NCT02613481|469465959|FG000|Overall Study|Lost to Follow-up|7|||
130410833|NCT02613481|469465959|FG000|Overall Study|Withdrawal by Subject|2|||
130410834|NCT00844194|469465960|FG000|Overall Study|Adverse Event|17|||
130410835|NCT00844194|469465961|FG001|Overall Study|Adverse Event|5|||
130410836|NCT00844194|469465960|FG000|Overall Study|Protocol Violation|1|||
130410837|NCT00844194|469465961|FG001|Overall Study|Protocol Violation|1|||
130410838|NCT00844194|469465960|FG000|Overall Study|Lost to Follow-up|1|||
130410839|NCT00844194|469465961|FG001|Overall Study|Lost to Follow-up|1|||
130410840|NCT00844194|469465960|FG000|Overall Study|Withdrawal by Subject|2|||
130410841|NCT00844194|469465961|FG001|Overall Study|Withdrawal by Subject|1|||
130410842|NCT00844194|469465960|FG000|Overall Study|Lack of Efficacy|3|||
130410843|NCT00844194|469465961|FG001|Overall Study|Lack of Efficacy|0|||
130410844|NCT00844194|469465960|FG000|Overall Study|Other reason (not specified)|1|||
130410845|NCT00844194|469465961|FG001|Overall Study|Other reason (not specified)|0|||
130410846|NCT00803023|469465962|FG000|Overall Study|Adverse Event|5|||
130410847|NCT00803023|469465963|FG001|Overall Study|Adverse Event|4|||
130410848|NCT00803023|469465964|FG002|Overall Study|Adverse Event|8|||
130410849|NCT00803023|469465965|FG003|Overall Study|Adverse Event|6|||
130410850|NCT00803023|469465962|FG000|Overall Study|Withdrawal by Subject|0|||
130410851|NCT00803023|469465963|FG001|Overall Study|Withdrawal by Subject|2|||
130410852|NCT00803023|469465964|FG002|Overall Study|Withdrawal by Subject|0|||
130410853|NCT00803023|469465965|FG003|Overall Study|Withdrawal by Subject|0|||
130410854|NCT00803023|469465962|FG000|Overall Study|Lost to Follow-up|0|||
130474066|NCT02783300|469704767|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
130474067|NCT02783300|469704768|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
130474068|NCT02783300|469704769|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
130474069|NCT02783300|469704770|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
130474070|NCT02783300|469704771|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
130474071|NCT02783300|469704772|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
130474072|NCT02783300|469704773|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
130474073|NCT02783300|469704774|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
130474074|NCT02783300|469704775|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
130474075|NCT02783300|469704776|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
130474076|NCT02783300|469704777|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
130474077|NCT02783300|469704778|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
130474078|NCT02783300|469704779|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
130474079|NCT02783300|469704780|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
130474080|NCT02783300|469704781|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
130474081|NCT02783300|469704782|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
130563443|NCT03677596|470030493|FG001|Overall Study|Other|1|||
130563444|NCT05197049|470030496|FG000|Overall Study|Death|0|||
130563445|NCT05197049|470030497|FG001|Overall Study|Death|1|||
130563446|NCT05197049|470030498|FG002|Overall Study|Death|0|||
130474082|NCT02783300|469704783|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
130474083|NCT02783300|469704784|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
130474084|NCT02783300|469704785|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
130474085|NCT02783300|469704786|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
130474086|NCT02783300|469704787|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
130563447|NCT05197049|470030496|FG000|Overall Study|Lost to Follow-up|3|||
130474087|NCT02783300|469704788|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
130563448|NCT05197049|470030497|FG001|Overall Study|Lost to Follow-up|1|||
130563449|NCT05197049|470030498|FG002|Overall Study|Lost to Follow-up|0|||
130563450|NCT05197049|470030496|FG000|Overall Study|Withdrawal by Subject|15|||
130563451|NCT05197049|470030497|FG001|Overall Study|Withdrawal by Subject|3|||
130563452|NCT05197049|470030498|FG002|Overall Study|Withdrawal by Subject|1|||
130410855|NCT00803023|469465963|FG001|Overall Study|Lost to Follow-up|1|||
130563453|NCT05197049|470030496|FG000|Overall Study|GCP non-compliance|1|||
130410856|NCT00803023|469465964|FG002|Overall Study|Lost to Follow-up|2|||
130410857|NCT00803023|469465965|FG003|Overall Study|Lost to Follow-up|1|||
130410858|NCT00803023|469465962|FG000|Overall Study|Lack of Efficacy|0|||
130410859|NCT00803023|469465963|FG001|Overall Study|Lack of Efficacy|1|||
130410860|NCT00803023|469465964|FG002|Overall Study|Lack of Efficacy|1|||
130474088|NCT02783300|469704789|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
130563454|NCT05197049|470030497|FG001|Overall Study|GCP non-compliance|2|||
130563455|NCT05197049|470030498|FG002|Overall Study|GCP non-compliance|0|||
130563456|NCT01368536|470030499|FG000|Overall Study|Adverse Event|5|||
130563457|NCT01368536|470030500|FG001|Overall Study|Adverse Event|6|||
130563458|NCT01368536|470030501|FG002|Overall Study|Adverse Event|8|||
130563459|NCT01368536|470030499|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130563460|NCT01368536|470030500|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130563461|NCT01368536|470030501|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130563462|NCT01368536|470030499|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130563463|NCT01368536|470030500|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130563464|NCT01368536|470030501|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130563465|NCT01368536|470030499|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
130563466|NCT01368536|470030500|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130563467|NCT01368536|470030501|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130563468|NCT01368536|470030499|FG000|Overall Study|No longer required study medication|0|||
130563469|NCT01368536|470030500|FG001|Overall Study|No longer required study medication|0|||
130563470|NCT01368536|470030501|FG002|Overall Study|No longer required study medication|1|||
130563471|NCT01368536|470030499|FG000|Overall Study|Withdrawal by Subject|2|||
130563472|NCT01368536|470030500|FG001|Overall Study|Withdrawal by Subject|5|||
130563473|NCT01368536|470030501|FG002|Overall Study|Withdrawal by Subject|4|||
130563474|NCT01368536|470030499|FG000|Overall Study|Lost to Follow-up|3|||
130563475|NCT01368536|470030500|FG001|Overall Study|Lost to Follow-up|3|||
130563476|NCT01368536|470030501|FG002|Overall Study|Lost to Follow-up|5|||
130563477|NCT01368536|470030499|FG000|Overall Study|Administrative problems|34|||
130563478|NCT01368536|470030500|FG001|Overall Study|Administrative problems|39|||
130563479|NCT01368536|470030501|FG002|Overall Study|Administrative problems|35|||
130563480|NCT01368536|470030499|FG000|Overall Study|Protocol deviation|0|||
130410861|NCT00803023|469465965|FG003|Overall Study|Lack of Efficacy|1|||
130410862|NCT02647658|469465966|FG000|Overall Study|Consent refusal|15|||
130410863|NCT02647658|469465967|FG001|Overall Study|Consent refusal|24|||
130410864|NCT01542528|469465968|FG000|Overall Study|Lost to Follow-up|2|||
130410865|NCT01542528|469465969|FG001|Overall Study|Lost to Follow-up|1|||
130410866|NCT01542528|469465968|FG000|Overall Study|Physician Decision|1|||
130410867|NCT01542528|469465969|FG001|Overall Study|Physician Decision|0|||
130410868|NCT01542528|469465968|FG000|Overall Study|Withdrawal by Subject|9|||
130410869|NCT01542528|469465969|FG001|Overall Study|Withdrawal by Subject|6|||
130410870|NCT01921348|469465975|FG000|Overall Study|Withdrawal by Subject|1|||
130410871|NCT01921348|469465976|FG001|Overall Study|Withdrawal by Subject|0|||
130410872|NCT01921348|469465975|FG000|Overall Study|Lost to Follow-up|0|||
130410873|NCT01921348|469465976|FG001|Overall Study|Lost to Follow-up|2|||
130410874|NCT04831736|469465982|FG000|Overall Study|Withdrawal by Subject|0|||
130410875|NCT04831736|469465983|FG001|Overall Study|Withdrawal by Subject|1|||
130410876|NCT00795600|469465984|FG000|Overall Study|Adverse Event|1|||
130410877|NCT00795600|469465985|FG001|Overall Study|Adverse Event|1|||
130410878|NCT00795600|469465984|FG000|Overall Study|Protocol Violation|1|||
130410879|NCT00795600|469465985|FG001|Overall Study|Protocol Violation|2|||
130410880|NCT00795600|469465984|FG000|Overall Study|Withdrawal by Subject|1|||
130410881|NCT00795600|469465985|FG001|Overall Study|Withdrawal by Subject|0|||
130410882|NCT00795600|469465984|FG000|Overall Study|Unclassified|1|||
130410883|NCT00795600|469465985|FG001|Overall Study|Unclassified|1|||
130410884|NCT03936244|469465986|FG000|Overall Study|Lost to Follow-up|5|||
130410885|NCT03936244|469465987|FG001|Overall Study|Lost to Follow-up|1|||
130410886|NCT03936244|469465986|FG000|Overall Study|Physician Decision|7|||
130410887|NCT03936244|469465987|FG001|Overall Study|Physician Decision|3|||
130410888|NCT01114646|469465988|FG000|Overall Study|Withdrawal by Subject|3|||
130410889|NCT01114646|469465989|FG001|Overall Study|Withdrawal by Subject|2|||
130410890|NCT01666002|469465994|FG000|Overall Study|Lost to Follow-up|5|||
130410891|NCT01666002|469465995|FG001|Overall Study|Lost to Follow-up|0|||
130410892|NCT02159482|469465998|FG000|Overall Study|Withdrawal by Subject|2|||
130410893|NCT02159482|469465998|FG000|Overall Study|Physician Decision|3|||
130410894|NCT01233817|469465999|FG000|Overall Study|Lost to Follow-up|1|||
130563481|NCT01368536|470030500|FG001|Overall Study|Protocol deviation|3|||
130563482|NCT01368536|470030501|FG002|Overall Study|Protocol deviation|1|||
130727210|NCT02883049|470625426|FG002|Post Induction|Physician Decision|0|||
130727211|NCT02883049|470625427|FG003|Post Induction|Physician Decision|27|||
130410895|NCT01233817|469465999|FG000|Overall Study|Withdrawal by Subject|2|||
130410896|NCT01248884|469466000|FG000|Overall Study|Withdrawal by Subject|1|||
130410897|NCT01248884|469466001|FG001|Overall Study|Withdrawal by Subject|3|||
130410898|NCT01248884|469466002|FG002|Overall Study|Withdrawal by Subject|1|||
130410899|NCT01248884|469466000|FG000|Overall Study|Adverse Event|1|||
130410900|NCT01248884|469466001|FG001|Overall Study|Adverse Event|0|||
130563483|NCT01161043|470030504|FG000|Overall Study|Withdrawal by Subject|3|||
130563484|NCT02164929|470030511|FG000|Overall Study|Converted to open procedure|1|||
130727212|NCT02883049|470625428|FG004|Post Induction|Physician Decision|27|||
130563485|NCT02164929|470030512|FG001|Overall Study|Converted to open procedure|0|||
130563486|NCT02164929|470030513|FG002|Overall Study|Converted to open procedure|0|||
130563487|NCT02164929|470030514|FG003|Overall Study|Converted to open procedure|2|||
130410901|NCT01248884|469466002|FG002|Overall Study|Adverse Event|0|||
130410902|NCT02511431|469466003|FG000|Treatment|Lost to Follow-up|0|||
130410903|NCT02511431|469466004|FG001|Treatment|Lost to Follow-up|0|||
130410904|NCT02511431|469466005|FG002|Treatment|Lost to Follow-up|1|||
130410905|NCT02511431|469466006|FG003|Treatment|Lost to Follow-up|0|||
130410906|NCT02511431|469466007|FG004|Treatment|Lost to Follow-up|0|||
130410907|NCT02511431|469466008|FG005|Treatment|Lost to Follow-up|1|||
130410908|NCT04479618|469466009|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
130410909|NCT04479618|469466010|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
130410910|NCT04479618|469466011|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
130410911|NCT04479618|469466009|FG000|Overall Study|Lack of Efficacy|1|||
130410912|NCT04479618|469466010|FG001|Overall Study|Lack of Efficacy|0|||
130410913|NCT04479618|469466011|FG002|Overall Study|Lack of Efficacy|0|||
130410914|NCT04479618|469466009|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
130410915|NCT04479618|469466010|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
130410916|NCT04479618|469466011|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
130410917|NCT04479618|469466009|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
130410918|NCT04479618|469466010|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
130410919|NCT04479618|469466011|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
130410920|NCT04479618|469466009|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
130410921|NCT04479618|469466010|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
130410922|NCT04479618|469466011|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
130410923|NCT04479618|469466009|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
130410924|NCT04479618|469466010|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
130563488|NCT02164929|470030511|FG000|Overall Study|Failed regional block|0|||
130563489|NCT02164929|470030512|FG001|Overall Study|Failed regional block|0|||
130410925|NCT04479618|469466011|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
130410926|NCT01202773|469466012|FG000|Overall Study|Adverse Event|4|||
130410927|NCT01202773|469466013|FG001|Overall Study|Adverse Event|5|||
130410928|NCT01202773|469466014|FG002|Overall Study|Adverse Event|5|||
130410929|NCT01202773|469466012|FG000|Overall Study|Lack of Efficacy|5|||
130410930|NCT01202773|469466013|FG001|Overall Study|Lack of Efficacy|4|||
130410931|NCT01202773|469466014|FG002|Overall Study|Lack of Efficacy|9|||
130410932|NCT01202773|469466012|FG000|Overall Study|Entry Criteria Not Met|2|||
130410933|NCT01202773|469466013|FG001|Overall Study|Entry Criteria Not Met|0|||
130410934|NCT01202773|469466014|FG002|Overall Study|Entry Criteria Not Met|1|||
130410935|NCT01202773|469466012|FG000|Overall Study|Lost to Follow-up|1|||
130410936|NCT01202773|469466013|FG001|Overall Study|Lost to Follow-up|2|||
130410937|NCT01202773|469466014|FG002|Overall Study|Lost to Follow-up|2|||
130410938|NCT01202773|469466012|FG000|Overall Study|Withdrawal by Subject|13|||
130410939|NCT01202773|469466013|FG001|Overall Study|Withdrawal by Subject|6|||
130410940|NCT01202773|469466014|FG002|Overall Study|Withdrawal by Subject|5|||
130410941|NCT01202773|469466012|FG000|Overall Study|Physician Decision|2|||
130410942|NCT01202773|469466013|FG001|Overall Study|Physician Decision|0|||
130410943|NCT01202773|469466014|FG002|Overall Study|Physician Decision|0|||
130410944|NCT01202773|469466012|FG000|Overall Study|Protocol Violation|11|||
130410945|NCT01202773|469466013|FG001|Overall Study|Protocol Violation|6|||
130410946|NCT01202773|469466014|FG002|Overall Study|Protocol Violation|10|||
130410947|NCT01202773|469466012|FG000|Overall Study|Sponsor Decision|19|||
130563490|NCT02164929|470030513|FG002|Overall Study|Failed regional block|1|||
130563491|NCT02164929|470030514|FG003|Overall Study|Failed regional block|0|||
130563492|NCT00971178|470030515|FG000|Overall Study|Lost to Follow-up|2|||
130563493|NCT00971178|470030516|FG001|Overall Study|Lost to Follow-up|2|||
130563494|NCT00971178|470030517|FG002|Overall Study|Lost to Follow-up|2|||
130563495|NCT00424749|470030519|FG000|Overall Study|Withdrawal by Subject|1|||
130563496|NCT02577406|470030520|FG000|Randomized Period|Death|1|||
130563497|NCT02577406|470030521|FG001|Randomized Period|Death|0|||
130563498|NCT02577406|470030520|FG000|Randomized Period|Other reasons|0|||
130563499|NCT02577406|470030521|FG001|Randomized Period|Other reasons|20|||
130563500|NCT02577406|470030520|FG000|Treatment Period|Death|38|||
130563501|NCT02577406|470030521|FG001|Treatment Period|Death|23|||
130563502|NCT02577406|470030520|FG000|Treatment Period|Adverse Event|17|||
130563503|NCT02577406|470030521|FG001|Treatment Period|Adverse Event|12|||
130563504|NCT02577406|470030520|FG000|Treatment Period|Progressive Disease|53|||
130563505|NCT02577406|470030521|FG001|Treatment Period|Progressive Disease|37|||
130563506|NCT02577406|470030520|FG000|Treatment Period|Withdrawal by Subject|10|||
130563507|NCT02577406|470030521|FG001|Treatment Period|Withdrawal by Subject|24|||
130563508|NCT02577406|470030520|FG000|Treatment Period|Lost to Follow-up|0|||
130563509|NCT02577406|470030521|FG001|Treatment Period|Lost to Follow-up|1|||
130563510|NCT02577406|470030520|FG000|Treatment Period|Transition to commercially available treatment|1|||
130410948|NCT01202773|469466013|FG001|Overall Study|Sponsor Decision|20|||
130410949|NCT01202773|469466014|FG002|Overall Study|Sponsor Decision|23|||
130410950|NCT01430130|469466019|FG000|Overall Study|Lost to Follow-up|1|||
130410951|NCT01430130|469466019|FG000|Overall Study|Infection on Control Side of Incision|1|||
130410952|NCT02828111|469466023|FG000|Overall Study|Withdrawal by Subject|0|||
130410953|NCT02828111|469466024|FG001|Overall Study|Withdrawal by Subject|0|||
130410954|NCT02828111|469466025|FG002|Overall Study|Withdrawal by Subject|2|||
130410955|NCT02828111|469466026|FG003|Overall Study|Withdrawal by Subject|0|||
130410956|NCT02828111|469466027|FG004|Overall Study|Withdrawal by Subject|0|||
130410957|NCT02828111|469466023|FG000|Overall Study|Lost to Follow-up|0|||
130410958|NCT02828111|469466024|FG001|Overall Study|Lost to Follow-up|0|||
130410959|NCT02828111|469466025|FG002|Overall Study|Lost to Follow-up|0|||
130410960|NCT02828111|469466026|FG003|Overall Study|Lost to Follow-up|1|||
130410961|NCT02828111|469466027|FG004|Overall Study|Lost to Follow-up|1|||
130410962|NCT02667912|469466030|FG000|Overall Study|Death|3|||
130410963|NCT02667912|469466031|FG001|Overall Study|Death|1|||
130410964|NCT02667912|469466030|FG000|Overall Study|Withdrawal by Subject|1|||
130410965|NCT02667912|469466031|FG001|Overall Study|Withdrawal by Subject|2|||
130410966|NCT02667912|469466030|FG000|Overall Study|Withdrawal by Subject|1|||
130410967|NCT02667912|469466031|FG001|Overall Study|Withdrawal by Subject|0|||
130410968|NCT04443218|469466032|FG000|Overall Study|Exited study for other reasons|9|||
130410969|NCT04443218|469466032|FG000|Overall Study|Withdrawal by Subject|1|||
130410970|NCT04443218|469466032|FG000|Overall Study|Lost to Follow-up|4|||
130410971|NCT04443218|469466032|FG000|Overall Study|Death|19|||
130410972|NCT00022516|469466049|FG000|Overall Study|Adverse Event|0|||
130410973|NCT00022516|469466050|FG001|Overall Study|Adverse Event|59|||
130410974|NCT00022516|469466049|FG000|Overall Study|Lack of Efficacy|0|||
130410975|NCT00022516|469466050|FG001|Overall Study|Lack of Efficacy|27|||
130410976|NCT00022516|469466049|FG000|Overall Study|Physician Decision|0|||
130410977|NCT00022516|469466050|FG001|Overall Study|Physician Decision|1|||
130410978|NCT00022516|469466049|FG000|Overall Study|Protocol Violation|1|||
130410979|NCT00022516|469466050|FG001|Overall Study|Protocol Violation|3|||
130410980|NCT00022516|469466049|FG000|Overall Study|Withdrawal by Subject|2|||
130410981|NCT00022516|469466050|FG001|Overall Study|Withdrawal by Subject|113|||
130410982|NCT00022516|469466049|FG000|Overall Study|Incomplete documentation|0|||
130410983|NCT00022516|469466050|FG001|Overall Study|Incomplete documentation|27|||
130410984|NCT00766376|469466056|FG000|Overall Study|Withdrawal by Subject|27|||
130410985|NCT02207829|469466057|FG000|Overall Study|Adverse Event|10|||
130410986|NCT02207829|469466058|FG001|Overall Study|Adverse Event|9|||
130410987|NCT02207829|469466057|FG000|Overall Study|Lack of Efficacy|7|||
130410988|NCT02207829|469466058|FG001|Overall Study|Lack of Efficacy|5|||
130410989|NCT02207829|469466057|FG000|Overall Study|Lost to Follow-up|2|||
130410990|NCT02207829|469466058|FG001|Overall Study|Lost to Follow-up|2|||
130410991|NCT02207829|469466057|FG000|Overall Study|Protocol deviation|5|||
130410992|NCT02207829|469466058|FG001|Overall Study|Protocol deviation|4|||
130410993|NCT02207829|469466057|FG000|Overall Study|Withdrew consent|18|||
130410994|NCT02207829|469466058|FG001|Overall Study|Withdrew consent|14|||
130410995|NCT01800903|469466059|FG000|Second Test Period|unable to catheterise|1|||
130410996|NCT01800903|469466060|FG001|Second Test Period|unable to catheterise|0|||
130410997|NCT01800903|469466061|FG002|Second Test Period|unable to catheterise|0|||
130410998|NCT01800903|469466062|FG003|Second Test Period|unable to catheterise|0|||
130410999|NCT01800903|469466063|FG004|Second Test Period|unable to catheterise|0|||
130411000|NCT01800903|469466064|FG005|Second Test Period|unable to catheterise|0|||
130411001|NCT03283670|469466071|FG000|Placebo Gas|Withdrawal by Subject|2|||
130411002|NCT03283670|469466071|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
130411003|NCT03283670|469466071|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
130411004|NCT00852397|469466072|FG000|Overall Study|Adverse Event|4|||
130411005|NCT00852397|469466073|FG001|Overall Study|Adverse Event|6|||
130411006|NCT00852397|469466074|FG002|Overall Study|Adverse Event|4|||
130411007|NCT00852397|469466072|FG000|Overall Study|Death|0|||
130411008|NCT00852397|469466073|FG001|Overall Study|Death|0|||
130411009|NCT00852397|469466074|FG002|Overall Study|Death|1|||
130411010|NCT00852397|469466072|FG000|Overall Study|Withdrawal by Subject|4|||
130411011|NCT00852397|469466073|FG001|Overall Study|Withdrawal by Subject|1|||
130411012|NCT00852397|469466074|FG002|Overall Study|Withdrawal by Subject|2|||
130411013|NCT00852397|469466072|FG000|Overall Study|Study terminated by sponsor|2|||
130411014|NCT00852397|469466073|FG001|Overall Study|Study terminated by sponsor|1|||
130411015|NCT00852397|469466074|FG002|Overall Study|Study terminated by sponsor|6|||
130411016|NCT00852397|469466072|FG000|Overall Study|Difficulty in study site visit|1|||
130411017|NCT00852397|469466073|FG001|Overall Study|Difficulty in study site visit|0|||
130563511|NCT02577406|470030521|FG001|Treatment Period|Transition to commercially available treatment|1|||
130411018|NCT00852397|469466074|FG002|Overall Study|Difficulty in study site visit|0|||
130411019|NCT00852397|469466072|FG000|Overall Study|Protocol Violation|0|||
130411020|NCT00852397|469466073|FG001|Overall Study|Protocol Violation|0|||
130411021|NCT00852397|469466074|FG002|Overall Study|Protocol Violation|1|||
130411022|NCT01850004|469466078|FG000|Overall Study|Poor/Non-compliance|1|||
130411023|NCT01850004|469466078|FG000|Overall Study|Participant Withdrew Consent|9|||
130411024|NCT01850004|469466078|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
130411025|NCT01850004|469466078|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130411026|NCT01850004|469466078|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
130411027|NCT01850004|469466078|FG000|Overall Study|Other Reasons|2|||
130411028|NCT01850004|469466078|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
130411029|NCT01850004|469466078|FG000|Overall Study|Maximum Clinical Benefit|4|||
130411030|NCT00462384|469467889|FG000|Overall Study|Adverse Event|2|||
130411031|NCT00462384|469467889|FG000|Overall Study|Death|2|||
130411032|NCT00462384|469467889|FG000|Overall Study|Withdrawal by Subject|1|||
130411033|NCT00462384|469467889|FG000|Overall Study|Other|4|||
130411034|NCT00346034|469467890|FG000|Overall Study|Adverse Event|34|||
130411035|NCT00346034|469467890|FG000|Overall Study|Lack of Efficacy|8|||
130411036|NCT00346034|469467890|FG000|Overall Study|Withdrawal by Subject|13|||
130411037|NCT00346034|469467890|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
130411038|NCT00346034|469467890|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
130411039|NCT01255358|469467891|FG000|Overall Study|Adverse Event|2|||
130411040|NCT01255358|469467891|FG000|Overall Study|Protocol Violation|2|||
130411041|NCT00797667|469467892|FG000|Overall Study|Lack of Efficacy|0|||
130411042|NCT00797667|469467893|FG001|Overall Study|Lack of Efficacy|1|||
130411043|NCT00797667|469467894|FG002|Overall Study|Lack of Efficacy|0|||
130411044|NCT00797667|469467892|FG000|Overall Study|Lost to Follow-up|8|||
130411045|NCT00797667|469467893|FG001|Overall Study|Lost to Follow-up|12|||
130411046|NCT00797667|469467894|FG002|Overall Study|Lost to Follow-up|2|||
130411047|NCT00797667|469467892|FG000|Overall Study|Physician Decision|3|||
130411048|NCT00797667|469467893|FG001|Overall Study|Physician Decision|1|||
130411049|NCT00797667|469467894|FG002|Overall Study|Physician Decision|0|||
130411050|NCT00797667|469467892|FG000|Overall Study|Pregnancy|2|||
130411051|NCT00797667|469467893|FG001|Overall Study|Pregnancy|0|||
130411052|NCT00797667|469467894|FG002|Overall Study|Pregnancy|0|||
130411053|NCT00797667|469467892|FG000|Overall Study|Protocol Violation|2|||
130411054|NCT00797667|469467893|FG001|Overall Study|Protocol Violation|7|||
130411055|NCT00797667|469467894|FG002|Overall Study|Protocol Violation|0|||
130411056|NCT00797667|469467892|FG000|Overall Study|Study Terminated by Sponsor|217|||
130411057|NCT00797667|469467893|FG001|Overall Study|Study Terminated by Sponsor|216|||
130411058|NCT00797667|469467894|FG002|Overall Study|Study Terminated by Sponsor|115|||
130411059|NCT00797667|469467892|FG000|Overall Study|Withdrawal by Subject|9|||
130411060|NCT00797667|469467893|FG001|Overall Study|Withdrawal by Subject|14|||
130411061|NCT00797667|469467894|FG002|Overall Study|Withdrawal by Subject|2|||
130411062|NCT00797667|469467892|FG000|Overall Study|Adverse Event|19|||
130411063|NCT00797667|469467893|FG001|Overall Study|Adverse Event|8|||
130411064|NCT00797667|469467894|FG002|Overall Study|Adverse Event|8|||
130411065|NCT01986829|469467895|FG000|Overall Study|Death|1|||
130411066|NCT02504866|469467896|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
130411067|NCT02504866|469467897|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
130411068|NCT02504866|469467898|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
130411069|NCT00781326|469467901|FG000|Phase I|Adverse Event|1|||
130411070|NCT00781326|469467901|FG000|Phase I|Withdrawal by Subject|1|||
130411071|NCT00781326|469467901|FG000|Phase I|Physician Decision|2|||
130411072|NCT00096941|469467902|FG000|Overall Study|disease progression|3|||
130411073|NCT01343056|469467903|FG000|Overall Study|Lost to Follow-up|7|||
130411074|NCT01343056|469467904|FG001|Overall Study|Lost to Follow-up|5|||
130411075|NCT01343056|469467905|FG002|Overall Study|Lost to Follow-up|3|||
130411076|NCT01343056|469467906|FG003|Overall Study|Lost to Follow-up|9|||
130411077|NCT03231371|469467907|FG000|Overall Study|Withdrawal by Subject|1|||
130411078|NCT03231371|469467907|FG000|Overall Study|chose or were ineligible to have MRI|12|||
130411079|NCT03029208|469467908|FG000|Overall Study|Withdrawal by Subject|2|||
130411080|NCT03029208|469467909|FG001|Overall Study|Withdrawal by Subject|3|||
130411081|NCT03029208|469467908|FG000|Overall Study|Lost to Follow-up|0|||
130411082|NCT03029208|469467909|FG001|Overall Study|Lost to Follow-up|1|||
130411083|NCT01732835|469467912|FG000|6-month Primary Endpoint|Did not receive device|19|||
130411084|NCT01732835|469467912|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
130411085|NCT01732835|469467912|FG000|6-month Primary Endpoint|Adverse Event|3|||
130411086|NCT01732835|469467912|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
130411087|NCT01732835|469467912|FG000|2-year Extended Follow-up|Adverse Event|3|||
130411088|NCT01732835|469467912|FG000|2-year Extended Follow-up|Death|1|||
130411089|NCT02334748|469467913|FG000|Overall Study|Adverse Event|1|||
130411090|NCT02334748|469467913|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
130411091|NCT02334748|469467913|FG000|Overall Study|Patient no longer required study drug|2|||
130411092|NCT02334748|469467913|FG000|Overall Study|Lack of Efficacy|4|||
130411093|NCT02493361|469467914|FG000|Overall Study|Withdrawal by Subject|3|||
130411094|NCT01046643|469467915|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130411095|NCT01046643|469467916|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
130411096|NCT01046643|469467917|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130411097|NCT01046643|469467918|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130411098|NCT03067441|469467919|FG000|Overall Study|Withdrawal by Subject|16|||
130411099|NCT03067441|469467920|FG001|Overall Study|Withdrawal by Subject|34|||
130727213|NCT02883049|470625429|FG005|Post Induction|Physician Decision|23|||
130411100|NCT03067441|469467919|FG000|Overall Study|Lost to Follow-up|7|||
130411101|NCT03067441|469467920|FG001|Overall Study|Lost to Follow-up|5|||
130411102|NCT03067441|469467919|FG000|Overall Study|Adverse Event|7|||
130411103|NCT03067441|469467920|FG001|Overall Study|Adverse Event|14|||
130411104|NCT03067441|469467919|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
130411105|NCT03067441|469467920|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
130411106|NCT03067441|469467919|FG000|Overall Study|Physician Decision|1|||
130411107|NCT03067441|469467920|FG001|Overall Study|Physician Decision|3|||
130411108|NCT03067441|469467919|FG000|Overall Study|Other|1|||
130411109|NCT03067441|469467920|FG001|Overall Study|Other|1|||
130411110|NCT02056301|469467924|FG000|Overall Study|Protocol Violation|1|||
130411111|NCT02056301|469467925|FG001|Overall Study|Protocol Violation|2|||
130411112|NCT02056301|469467924|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
130411113|NCT02056301|469467925|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
130411114|NCT02056301|469467924|FG000|Overall Study|Withdrawal by Subject|0|||
130411115|NCT02056301|469467925|FG001|Overall Study|Withdrawal by Subject|1|||
130411116|NCT02056301|469467924|FG000|Overall Study|Issues with epidural|0|||
130411117|NCT02056301|469467925|FG001|Overall Study|Issues with epidural|3|||
130411118|NCT02209324|469467929|FG000|Overall Study|Adverse Event|2|||
130411119|NCT02209324|469467929|FG000|Overall Study|Lack of Efficacy|1|||
130411120|NCT02209324|469467929|FG000|Overall Study|Lost to Follow-up|1|||
130411121|NCT02209324|469467929|FG000|Overall Study|Physician Decision|3|||
130411122|NCT02209324|469467929|FG000|Overall Study|Protocol Violation|14|||
130411123|NCT02209324|469467929|FG000|Overall Study|Withdrawal by Subject|8|||
130411124|NCT02209324|469467929|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
130411125|NCT02209324|469467929|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
130411126|NCT02209324|469467929|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
130411127|NCT03433456|469467930|FG000|Overall Study|Death|1|||
130411128|NCT03433456|469467931|FG001|Overall Study|Death|1|||
130411129|NCT03433456|469467930|FG000|Overall Study|Lost to Follow-up|14|||
130411130|NCT03433456|469467931|FG001|Overall Study|Lost to Follow-up|11|||
130411131|NCT03433456|469467930|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
130411132|NCT03433456|469467931|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
130411133|NCT05799495|469467932|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
130411134|NCT05799495|469467933|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
130411135|NCT05799495|469467934|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
130411136|NCT05799495|469467935|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
130411137|NCT05799495|469467932|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
130411138|NCT05799495|469467933|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
130411139|NCT05799495|469467934|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
130411140|NCT05799495|469467935|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
130411141|NCT05799495|469467932|FG000|Treatment (Up to 5 Days)|Other|0|||
130411142|NCT05799495|469467933|FG001|Treatment (Up to 5 Days)|Other|1|||
130411143|NCT05799495|469467934|FG002|Treatment (Up to 5 Days)|Other|0|||
130411144|NCT05799495|469467935|FG003|Treatment (Up to 5 Days)|Other|0|||
130411145|NCT05799495|469467932|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130411146|NCT05799495|469467933|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130411147|NCT05799495|469467934|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130411148|NCT05799495|469467935|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
130411149|NCT05799495|469467932|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
130411150|NCT05799495|469467933|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
130411151|NCT05799495|469467934|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
130411152|NCT05799495|469467935|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
130411153|NCT05799495|469467932|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130411154|NCT05799495|469467933|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130474089|NCT02783300|469704790|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
130474090|NCT02783300|469704791|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
130474091|NCT02783300|469704792|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
130474092|NCT02783300|469704793|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
130474093|NCT02783300|469704767|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474094|NCT02783300|469704768|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474095|NCT02783300|469704769|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130563512|NCT02577406|470030520|FG000|Treatment Period|Physician Decision|1|||
130563513|NCT02577406|470030521|FG001|Treatment Period|Physician Decision|0|||
130474096|NCT02783300|469704770|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474097|NCT02783300|469704771|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474098|NCT02783300|469704772|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474099|NCT02783300|469704773|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
130563514|NCT02577406|470030520|FG000|Treatment Period|Disease Relapse|28|||
130411155|NCT05799495|469467934|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
130411156|NCT05799495|469467935|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130411157|NCT03105362|469467936|FG000|Overall Study|Withdrawal by Subject|1|||
130411158|NCT03105362|469467936|FG000|Overall Study|Lost to Follow-up|1|||
130411159|NCT01198600|469467937|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
130411160|NCT01198600|469467938|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130411161|NCT01198600|469467939|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130411162|NCT01198600|469467940|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130411163|NCT01198600|469467937|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
130411164|NCT01198600|469467938|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130411165|NCT01198600|469467939|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130411166|NCT01198600|469467940|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130411167|NCT01198600|469467937|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130411168|NCT01198600|469467938|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
130411169|NCT01198600|469467939|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130411170|NCT01198600|469467940|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130411171|NCT01198600|469467937|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130411172|NCT01198600|469467938|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
130411173|NCT01198600|469467939|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130411174|NCT01198600|469467940|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130411175|NCT01198600|469467937|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
130411176|NCT01198600|469467938|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
130411177|NCT01198600|469467939|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
130411178|NCT01198600|469467940|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
130411179|NCT01198600|469467937|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
130411180|NCT01198600|469467938|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
130411181|NCT01198600|469467939|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
130411182|NCT01198600|469467940|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
130411183|NCT01198600|469467937|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130411184|NCT01198600|469467938|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130411185|NCT01198600|469467939|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
130411186|NCT01198600|469467940|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130411187|NCT03694548|469467941|FG000|Part A Survey|Protocol Violation|3|||
130411188|NCT03694548|469467942|FG001|Part A Survey|Protocol Violation|3|||
130411189|NCT03694548|469467943|FG002|Part A Survey|Protocol Violation|0|||
130411190|NCT03694548|469467941|FG000|Part B Yoga Program|Protocol Violation|0|||
130411191|NCT03694548|469467942|FG001|Part B Yoga Program|Protocol Violation|0|||
130411192|NCT03694548|469467943|FG002|Part B Yoga Program|Protocol Violation|3|||
130411193|NCT03694548|469467941|FG000|Part B Yoga Program|Did not attend intervention|0|||
130411194|NCT03694548|469467942|FG001|Part B Yoga Program|Did not attend intervention|0|||
130411195|NCT03694548|469467943|FG002|Part B Yoga Program|Did not attend intervention|8|||
130411196|NCT04177108|469467944|FG000|Overall Study|Withdrawal by Subject|4|||
130411197|NCT04177108|469467945|FG001|Overall Study|Withdrawal by Subject|8|||
130411198|NCT04177108|469467946|FG002|Overall Study|Withdrawal by Subject|9|||
130411199|NCT04177108|469467947|FG003|Overall Study|Withdrawal by Subject|11|||
130411200|NCT04177108|469467948|FG004|Overall Study|Withdrawal by Subject|13|||
130411201|NCT04177108|469467944|FG000|Overall Study|Physician Decision|23|||
130411202|NCT04177108|469467945|FG001|Overall Study|Physician Decision|15|||
130411203|NCT04177108|469467946|FG002|Overall Study|Physician Decision|18|||
130411204|NCT04177108|469467947|FG003|Overall Study|Physician Decision|29|||
130411205|NCT04177108|469467948|FG004|Overall Study|Physician Decision|23|||
130411206|NCT04177108|469467944|FG000|Overall Study|Reason Not Specified|0|||
130411207|NCT04177108|469467945|FG001|Overall Study|Reason Not Specified|1|||
130411208|NCT04177108|469467946|FG002|Overall Study|Reason Not Specified|0|||
130411209|NCT04177108|469467947|FG003|Overall Study|Reason Not Specified|0|||
130411210|NCT04177108|469467948|FG004|Overall Study|Reason Not Specified|2|||
130411211|NCT04177108|469467944|FG000|Overall Study|Lost to Follow-up|0|||
130411212|NCT04177108|469467945|FG001|Overall Study|Lost to Follow-up|0|||
130411213|NCT04177108|469467946|FG002|Overall Study|Lost to Follow-up|1|||
130411214|NCT04177108|469467947|FG003|Overall Study|Lost to Follow-up|1|||
130411215|NCT04177108|469467948|FG004|Overall Study|Lost to Follow-up|1|||
130411216|NCT04177108|469467944|FG000|Overall Study|Death|16|||
130474100|NCT02783300|469704774|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474101|NCT02783300|469704775|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474102|NCT02783300|469704776|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474103|NCT02783300|469704777|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474104|NCT02783300|469704778|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130411217|NCT04177108|469467945|FG001|Overall Study|Death|19|||
130411218|NCT04177108|469467946|FG002|Overall Study|Death|13|||
130411219|NCT04177108|469467947|FG003|Overall Study|Death|17|||
130411220|NCT04177108|469467948|FG004|Overall Study|Death|18|||
130411221|NCT04496258|469467952|FG000|Overall Study|Withdrawal by Subject|2|||
130474105|NCT02783300|469704779|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
130474106|NCT02783300|469704780|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474107|NCT02783300|469704781|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130563515|NCT02577406|470030521|FG001|Treatment Period|Disease Relapse|1|||
130563516|NCT02577406|470030520|FG000|Treatment Period|Protocol Violation|0|||
130411222|NCT04496258|469467953|FG001|Overall Study|Withdrawal by Subject|1|||
130411223|NCT01427712|469467954|FG000|Overall Study|Transfer to a different hospital|2|||
130411224|NCT01427712|469467954|FG000|Overall Study|Lost to Follow-up|1|||
130411225|NCT01427712|469467954|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
130411226|NCT01427712|469467954|FG000|Overall Study|Failure to visit|1|||
130563517|NCT02577406|470030521|FG001|Treatment Period|Protocol Violation|1|||
130411227|NCT01669343|469467956|FG000|Part A: All Patients|Withdrawal by Subject|7|||
130411228|NCT01669343|469467956|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
130411229|NCT01669343|469467956|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
130411230|NCT01669343|469467956|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
130411231|NCT01669343|469467956|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
130411232|NCT04798586|469467958|FG000|Overall Study|Death|2|||
130411233|NCT04433767|469467959|FG000|Overall Study|Adverse Event|1|||
130411234|NCT02371369|469467964|FG000|Part 1|Physician Decision|0|||
130411235|NCT02371369|469467965|FG001|Part 1|Physician Decision|3|||
130411236|NCT02371369|469467964|FG000|Part 1|Adverse Event|8|||
130411237|NCT02371369|469467965|FG001|Part 1|Adverse Event|0|||
130411238|NCT02371369|469467964|FG000|Part 1|Withdrawal by Subject|1|||
130411239|NCT02371369|469467965|FG001|Part 1|Withdrawal by Subject|6|||
130411240|NCT02371369|469467964|FG000|Part 1|Disease progression|0|||
130411241|NCT02371369|469467965|FG001|Part 1|Disease progression|1|||
130411242|NCT02371369|469467964|FG000|Part 1|Protocol Violation|0|||
130411243|NCT02371369|469467965|FG001|Part 1|Protocol Violation|1|||
130411244|NCT02371369|469467964|FG000|Part 2|Adverse Event|6|||
130411245|NCT02371369|469467965|FG001|Part 2|Adverse Event|5|||
130411246|NCT02371369|469467964|FG000|Part 2|Withdrawal by Subject|16|||
130411247|NCT02371369|469467965|FG001|Part 2|Withdrawal by Subject|6|||
130411248|NCT02371369|469467964|FG000|Part 2|Investigator decision|1|||
130411249|NCT02371369|469467965|FG001|Part 2|Investigator decision|2|||
130411250|NCT02371369|469467964|FG000|Part 2|Death|0|||
130411251|NCT02371369|469467965|FG001|Part 2|Death|1|||
130411252|NCT02371369|469467964|FG000|Part 2|Disease progression|1|||
130411253|NCT02371369|469467965|FG001|Part 2|Disease progression|0|||
130411254|NCT02371369|469467964|FG000|Part 2|Subject Noncompliance|1|||
130411255|NCT02371369|469467965|FG001|Part 2|Subject Noncompliance|0|||
130411256|NCT02371369|469467964|FG000|Part 2|Lost to Follow-up|1|||
130474108|NCT02783300|469704782|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474109|NCT02783300|469704783|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474110|NCT02783300|469704784|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474111|NCT02783300|469704785|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474112|NCT02783300|469704786|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474113|NCT02783300|469704787|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474114|NCT02783300|469704788|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474115|NCT02783300|469704789|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474116|NCT02783300|469704790|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474117|NCT02783300|469704791|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474118|NCT02783300|469704792|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474119|NCT02783300|469704793|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130474120|NCT02783300|469704767|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474121|NCT02783300|469704768|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474122|NCT02783300|469704769|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474123|NCT02783300|469704770|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474124|NCT02783300|469704771|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
130474125|NCT02783300|469704772|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474126|NCT02783300|469704773|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
130474127|NCT02783300|469704774|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474128|NCT02783300|469704775|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130563518|NCT02577406|470030520|FG000|Treatment Period|Other Reasons|3|||
130563519|NCT02577406|470030521|FG001|Treatment Period|Other Reasons|39|||
130563520|NCT02577406|470030520|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
130563521|NCT02577406|470030521|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
130563522|NCT02138617|470030522|FG000|Overall Study|Death|1|||
130563523|NCT02138617|470030523|FG001|Overall Study|Death|2|||
130563524|NCT02138617|470030524|FG002|Overall Study|Death|2|||
130563525|NCT02138617|470030522|FG000|Overall Study|Adverse Event|8|||
130727214|NCT02883049|470625430|FG006|Post Induction|Physician Decision|30|||
130411257|NCT02371369|469467965|FG001|Part 2|Lost to Follow-up|1|||
130563526|NCT02138617|470030523|FG001|Overall Study|Adverse Event|5|||
130411258|NCT02371369|469467964|FG000|Part 2|Subject transitioned to commercial supply|6|||
130411259|NCT02371369|469467965|FG001|Part 2|Subject transitioned to commercial supply|4|||
130411260|NCT02371369|469467964|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
130411261|NCT02371369|469467965|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
130474129|NCT02783300|469704776|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
130474130|NCT02783300|469704777|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474131|NCT02783300|469704778|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474132|NCT02783300|469704779|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
130474133|NCT02783300|469704780|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474134|NCT02783300|469704781|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474135|NCT02783300|469704782|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474136|NCT02783300|469704783|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474137|NCT02783300|469704784|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474138|NCT02783300|469704785|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474139|NCT02783300|469704786|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130411262|NCT02371369|469467964|FG000|Part 2|Surgical resection of tumor|1|||
130411263|NCT02371369|469467965|FG001|Part 2|Surgical resection of tumor|1|||
130411264|NCT02371369|469467964|FG000|Part 2|Other|0|||
130411265|NCT02371369|469467965|FG001|Part 2|Other|1|||
130411266|NCT00439777|469467966|FG000|Treatment Period|Death|29|||
130411267|NCT00439777|469467967|FG001|Treatment Period|Death|21|||
130411268|NCT00439777|469467966|FG000|Treatment Period|Study terminated by sponsor|125|||
130411269|NCT00439777|469467967|FG001|Treatment Period|Study terminated by sponsor|132|||
130411270|NCT00439777|469467966|FG000|Treatment Period|Site closed by investigator|0|||
130411271|NCT00439777|469467967|FG001|Treatment Period|Site closed by investigator|1|||
130411272|NCT00439777|469467966|FG000|Treatment Period|Did not take study treatment|7|||
130411273|NCT00439777|469467967|FG001|Treatment Period|Did not take study treatment|8|||
130411274|NCT00439777|469467966|FG000|Treatment Period|Adverse Event|111|||
130411275|NCT00439777|469467967|FG001|Treatment Period|Adverse Event|92|||
130411276|NCT00439777|469467966|FG000|Treatment Period|Protocol Violation|23|||
130411277|NCT00439777|469467967|FG001|Treatment Period|Protocol Violation|30|||
130411278|NCT00439777|469467966|FG000|Treatment Period|Withdrawal by Subject|66|||
130411279|NCT00439777|469467967|FG001|Treatment Period|Withdrawal by Subject|118|||
130411280|NCT00439777|469467966|FG000|Treatment Period|Lack of Efficacy|1|||
130411281|NCT00439777|469467967|FG001|Treatment Period|Lack of Efficacy|4|||
130411282|NCT00439777|469467966|FG000|Treatment Period|Lost to Follow-up|8|||
130411283|NCT00439777|469467967|FG001|Treatment Period|Lost to Follow-up|10|||
130411284|NCT00439777|469467966|FG000|Treatment Period|Protocol driven decision point|1|||
130411285|NCT00439777|469467967|FG001|Treatment Period|Protocol driven decision point|3|||
130411286|NCT00439777|469467966|FG000|Treatment Period|Physician Decision|7|||
130411287|NCT00439777|469467967|FG001|Treatment Period|Physician Decision|18|||
130411288|NCT00439777|469467966|FG000|Treatment Period|Clinical endpoint reached|26|||
130411289|NCT00439777|469467967|FG001|Treatment Period|Clinical endpoint reached|13|||
130411290|NCT00439777|469467966|FG000|Treatment Period|Technical problems|3|||
130411291|NCT00439777|469467967|FG001|Treatment Period|Technical problems|1|||
130411292|NCT00439777|469467966|FG000|Treatment Period|Participant convenience|12|||
130411293|NCT00439777|469467967|FG001|Treatment Period|Participant convenience|8|||
130411294|NCT00439777|469467966|FG000|Observational Period|Protocol Violation|0|||
130411295|NCT00439777|469467967|FG001|Observational Period|Protocol Violation|2|||
130411296|NCT00439777|469467966|FG000|Observational Period|Withdrawal by Subject|9|||
130411297|NCT00439777|469467967|FG001|Observational Period|Withdrawal by Subject|5|||
130411298|NCT00439777|469467966|FG000|Observational Period|Lost to Follow-up|1|||
130411299|NCT00439777|469467967|FG001|Observational Period|Lost to Follow-up|11|||
130411300|NCT00439777|469467966|FG000|Observational Period|Death|27|||
130411301|NCT00439777|469467967|FG001|Observational Period|Death|20|||
130411302|NCT00439777|469467966|FG000|Observational Period|Study terminated by sponsor|3|||
130411303|NCT00439777|469467967|FG001|Observational Period|Study terminated by sponsor|1|||
130411304|NCT00439777|469467966|FG000|Observational Period|Protocol driven decision point|0|||
130411305|NCT00439777|469467967|FG001|Observational Period|Protocol driven decision point|1|||
130411306|NCT00439777|469467966|FG000|Observational Period|Lack of Efficacy|1|||
130411307|NCT00439777|469467967|FG001|Observational Period|Lack of Efficacy|0|||
130411308|NCT00439777|469467966|FG000|Observational Period|Technical problems|0|||
130411309|NCT00439777|469467967|FG001|Observational Period|Technical problems|1|||
130411310|NCT00661492|469467968|FG000|Overall Study|Adverse Event|16|||
130411311|NCT00661492|469467969|FG001|Overall Study|Adverse Event|13|||
130411312|NCT00661492|469467968|FG000|Overall Study|Disease Progression|44|||
130411313|NCT00661492|469467969|FG001|Overall Study|Disease Progression|14|||
130411314|NCT00661492|469467968|FG000|Overall Study|Patient Request|6|||
130411315|NCT00661492|469467969|FG001|Overall Study|Patient Request|1|||
130411316|NCT00661492|469467968|FG000|Overall Study|Investigator Request|1|||
130411317|NCT00661492|469467969|FG001|Overall Study|Investigator Request|0|||
130411318|NCT00661492|469467968|FG000|Overall Study|Lost to Follow-up|0|||
130411319|NCT00661492|469467969|FG001|Overall Study|Lost to Follow-up|1|||
130411320|NCT00661492|469467968|FG000|Overall Study|Other|1|||
130563527|NCT02138617|470030524|FG002|Overall Study|Adverse Event|2|||
130411321|NCT00661492|469467969|FG001|Overall Study|Other|0|||
130411322|NCT01024387|469467970|FG000|Overall Study|Radiographic Progression|29|||
130411323|NCT01024387|469467970|FG000|Overall Study|Symptomatic Progression|10|||
130411324|NCT01024387|469467970|FG000|Overall Study|Physician Decision|5|||
130474140|NCT02783300|469704787|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474141|NCT02783300|469704788|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474142|NCT02783300|469704789|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474143|NCT02783300|469704790|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474144|NCT02783300|469704791|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474145|NCT02783300|469704792|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474146|NCT02783300|469704793|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
130474147|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474148|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474149|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474150|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474151|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130411325|NCT01024387|469467970|FG000|Overall Study|Withdrawal by Subject|5|||
130411326|NCT01024387|469467970|FG000|Overall Study|Death|2|||
130411327|NCT01024387|469467970|FG000|Overall Study|Prolonged Treatment Delay|1|||
130411328|NCT01024387|469467970|FG000|Overall Study|Adverse Event|3|||
130411329|NCT01024387|469467970|FG000|Overall Study|Other|5|||
130411330|NCT03855189|469467971|FG000|Overall Study|Adverse Event|5|||
130411331|NCT03855189|469467972|FG001|Overall Study|Adverse Event|2|||
130411332|NCT03855189|469467973|FG002|Overall Study|Adverse Event|4|||
130411333|NCT03855189|469467971|FG000|Overall Study|Treatment Failure|1|||
130411334|NCT03855189|469467972|FG001|Overall Study|Treatment Failure|1|||
130411335|NCT03855189|469467973|FG002|Overall Study|Treatment Failure|2|||
130411336|NCT03855189|469467971|FG000|Overall Study|Noncompliance with Protocol|0|||
130411337|NCT03855189|469467972|FG001|Overall Study|Noncompliance with Protocol|1|||
130411338|NCT03855189|469467973|FG002|Overall Study|Noncompliance with Protocol|0|||
130411339|NCT03855189|469467971|FG000|Overall Study|Did Not Return|4|||
130411340|NCT03855189|469467972|FG001|Overall Study|Did Not Return|3|||
130411341|NCT03855189|469467973|FG002|Overall Study|Did Not Return|0|||
130411342|NCT01143259|469467974|FG000|Overall Study|Withdrawal by Subject|3|||
130411343|NCT01143259|469467975|FG001|Overall Study|Withdrawal by Subject|2|||
130411344|NCT01143259|469467974|FG000|Overall Study|Protocol Violation|13|||
130411345|NCT01143259|469467975|FG001|Overall Study|Protocol Violation|9|||
130411346|NCT01143259|469467974|FG000|Overall Study|Screen Failure|7|||
130411347|NCT01143259|469467975|FG001|Overall Study|Screen Failure|9|||
130411348|NCT00099983|469467976|FG000|Overall Study|Lost to Follow-up|2|||
130411349|NCT00099983|469467977|FG001|Overall Study|Lost to Follow-up|3|||
130411350|NCT00099983|469467976|FG000|Overall Study|Missing Source Documents|14|||
130411351|NCT00099983|469467977|FG001|Overall Study|Missing Source Documents|15|||
130411352|NCT00099983|469467976|FG000|Overall Study|Withdrawal by Subject|3|||
130411353|NCT00099983|469467977|FG001|Overall Study|Withdrawal by Subject|2|||
130411354|NCT00099983|469467976|FG000|Overall Study|Adverse Event|1|||
130411355|NCT00099983|469467977|FG001|Overall Study|Adverse Event|1|||
130411356|NCT00099983|469467976|FG000|Overall Study|Lack of Efficacy|0|||
130411357|NCT00099983|469467977|FG001|Overall Study|Lack of Efficacy|1|||
130411358|NCT00099983|469467976|FG000|Overall Study|Unable to return for appointments|1|||
130411359|NCT00099983|469467977|FG001|Overall Study|Unable to return for appointments|1|||
130411360|NCT00099983|469467976|FG000|Overall Study|Moved|1|||
130411361|NCT00099983|469467977|FG001|Overall Study|Moved|0|||
130411362|NCT00099983|469467976|FG000|Overall Study|Other psychiatric problem|1|||
130411363|NCT00099983|469467977|FG001|Overall Study|Other psychiatric problem|0|||
130411364|NCT00099983|469467976|FG000|Overall Study|Incarcerated|0|||
130411365|NCT00099983|469467977|FG001|Overall Study|Incarcerated|1|||
130411366|NCT00099983|469467976|FG000|Overall Study|Intolerant of burden of visits|0|||
130411367|NCT00099983|469467977|FG001|Overall Study|Intolerant of burden of visits|1|||
130411368|NCT00099983|469467976|FG000|Overall Study|Other issue|1|||
130411369|NCT00099983|469467977|FG001|Overall Study|Other issue|0|||
130411370|NCT02641080|469467978|FG000|Overall Study|Physician Decision|2|||
130411371|NCT02641080|469467979|FG001|Overall Study|Physician Decision|0|||
130411372|NCT02641080|469467978|FG000|Overall Study|Withdrawal by Subject|0|||
130474152|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474153|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474154|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474155|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474156|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130563528|NCT02138617|470030522|FG000|Overall Study|Disease Progression|20|||
130411373|NCT02641080|469467979|FG001|Overall Study|Withdrawal by Subject|1|||
130411374|NCT02641080|469467978|FG000|Overall Study|Rehab Center denied use of pumps|0|||
130411375|NCT02641080|469467979|FG001|Overall Study|Rehab Center denied use of pumps|3|||
130411376|NCT02641080|469467978|FG000|Overall Study|Lost to Follow-up|0|||
130411377|NCT02641080|469467979|FG001|Overall Study|Lost to Follow-up|3|||
130411378|NCT00803634|469467980|FG000|Overall Study|Withdrew Consent|1|||
130411379|NCT00803634|469467981|FG001|Overall Study|Withdrew Consent|0|||
130411380|NCT00803634|469467980|FG000|Overall Study|Lost to Follow-up|2|||
130411381|NCT00803634|469467981|FG001|Overall Study|Lost to Follow-up|3|||
130411382|NCT00803634|469467980|FG000|Overall Study|Death|3|||
130411383|NCT00803634|469467981|FG001|Overall Study|Death|2|||
130411384|NCT04307186|469467984|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
130411385|NCT04307186|469467984|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
130411386|NCT04307186|469467984|FG000|Washout 3-14 Days|Progressive disease|1|||
130411387|NCT04307186|469467984|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
130411388|NCT04307186|469467984|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
130411389|NCT03864900|469467993|FG000|Overall Study|Withdrawal by Subject|1|||
130411390|NCT03864900|469467994|FG001|Overall Study|Withdrawal by Subject|1|||
130411391|NCT03864900|469467993|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
130411392|NCT03864900|469467994|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
130411393|NCT03238001|469467995|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
130411394|NCT03238001|469467995|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
130411395|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
130411396|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
130411397|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
130411398|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
130411399|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
130411400|NCT03238001|469467995|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
130411401|NCT00759109|469467996|FG000|Overall Study|Adverse Event|17|||
130411402|NCT00759109|469467997|FG001|Overall Study|Adverse Event|12|||
130411403|NCT00759109|469467996|FG000|Overall Study|Inability to comply|1|||
130411404|NCT00759109|469467997|FG001|Overall Study|Inability to comply|1|||
130411405|NCT00759109|469467996|FG000|Overall Study|Withdrawal by Subject|9|||
130411406|NCT00759109|469467997|FG001|Overall Study|Withdrawal by Subject|5|||
130411407|NCT00759109|469467996|FG000|Overall Study|Death|4|||
130411408|NCT00759109|469467997|FG001|Overall Study|Death|3|||
130411409|NCT00759109|469467996|FG000|Overall Study|Lost to Follow-up|4|||
130411410|NCT00759109|469467997|FG001|Overall Study|Lost to Follow-up|6|||
130411411|NCT00759109|469467996|FG000|Overall Study|Started new therapy|2|||
130411412|NCT00759109|469467997|FG001|Overall Study|Started new therapy|6|||
130411413|NCT00759109|469467996|FG000|Overall Study|HCV RNA negative|1|||
130411414|NCT00759109|469467997|FG001|Overall Study|HCV RNA negative|0|||
130411415|NCT00759109|469467996|FG000|Overall Study|Participant moved to a different city|0|||
130411416|NCT00759109|469467997|FG001|Overall Study|Participant moved to a different city|1|||
130411417|NCT00759109|469467996|FG000|Overall Study|Participant had a liver transplant|0|||
130411418|NCT00759109|469467997|FG001|Overall Study|Participant had a liver transplant|1|||
130411419|NCT00759109|469467996|FG000|Overall Study|Lost during study|1|||
130411420|NCT00759109|469467997|FG001|Overall Study|Lost during study|0|||
130411421|NCT03165045|469467998|FG000|Visit 1|No registration after visit 1|9|||
130411422|NCT03165045|469467998|FG000|Visit 1|No treatment documented|10|||
130411423|NCT03165045|469467998|FG000|Visit 1|No visit 1|10|||
130411424|NCT03165045|469467998|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
130411425|NCT03165045|469467998|FG000|Visit 2|No available total CCQ score at all|29|||
130411426|NCT03165045|469467998|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
130411427|NCT01827904|469467999|FG000|Main Study|Withdrawal by Subject|1|||
130411428|NCT01827904|469468000|FG001|Main Study|Withdrawal by Subject|0|||
130411429|NCT01827904|469468001|FG002|Main Study|Withdrawal by Subject|0|||
130411430|NCT01827904|469467999|FG000|Main Study|Adverse Event|1|||
130411431|NCT01827904|469468000|FG001|Main Study|Adverse Event|0|||
130411432|NCT01827904|469468001|FG002|Main Study|Adverse Event|0|||
130411433|NCT01827904|469467999|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
130411434|NCT01827904|469468000|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
130411435|NCT01827904|469468001|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
130411436|NCT01827904|469467999|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
130411437|NCT01827904|469468000|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
130411438|NCT01827904|469468001|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
130411439|NCT01827904|469467999|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
130411440|NCT01827904|469468000|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
130411441|NCT01827904|469468001|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
130411442|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
130411443|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
130411444|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
130411445|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
130411446|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
130411447|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
130411448|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
130411449|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
130411450|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
130411451|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
130411452|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
130411453|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
130411454|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Physician Decision|1|||
130411455|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Physician Decision|0|||
130411456|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Physician Decision|0|||
130411457|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
130411458|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
130411459|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
130411460|NCT01827904|469467999|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
130411461|NCT01827904|469468000|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
130411462|NCT01827904|469468001|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
130411463|NCT01866709|469468008|FG000|Overall Study|Adverse Event|1|||
130411464|NCT01866709|469468009|FG001|Overall Study|Adverse Event|0|||
130411465|NCT03791398|469468010|FG000|Overall Study|Progression of Disease Under Study|2|||
130411466|NCT03791398|469468011|FG001|Overall Study|Progression of Disease Under Study|0|||
130411467|NCT03791398|469468012|FG002|Overall Study|Progression of Disease Under Study|0|||
130411468|NCT03191903|469468013|FG000|Overall Study|Withdrawal by Subject|6|||
130411469|NCT03191903|469468014|FG001|Overall Study|Withdrawal by Subject|5|||
130411470|NCT03191903|469468015|FG002|Overall Study|Withdrawal by Subject|4|||
130411471|NCT03191903|469468013|FG000|Overall Study|Adverse Event|1|||
130411472|NCT03191903|469468014|FG001|Overall Study|Adverse Event|0|||
130411473|NCT03191903|469468015|FG002|Overall Study|Adverse Event|0|||
130411474|NCT00503685|469468019|FG000|Overall Study|Adverse Event|0|||
130411475|NCT00503685|469468020|FG001|Overall Study|Adverse Event|0|||
130411476|NCT00503685|469468021|FG002|Overall Study|Adverse Event|2|||
130411477|NCT00503685|469468019|FG000|Overall Study|Withdrawal by Subject|0|||
130411478|NCT00503685|469468020|FG001|Overall Study|Withdrawal by Subject|1|||
130411479|NCT00503685|469468021|FG002|Overall Study|Withdrawal by Subject|0|||
130411480|NCT00503685|469468019|FG000|Overall Study|Protocol Violation|0|||
130411481|NCT00503685|469468020|FG001|Overall Study|Protocol Violation|1|||
130411482|NCT00503685|469468021|FG002|Overall Study|Protocol Violation|0|||
130411483|NCT00503685|469468019|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130411484|NCT00503685|469468020|FG001|Overall Study|Eligibility Criteria Not Met|1|||
130411485|NCT00503685|469468021|FG002|Overall Study|Eligibility Criteria Not Met|0|||
130411486|NCT00927927|469468024|FG000|Overall Study|Withdrawal by Subject|0|||
130411487|NCT00927927|469468025|FG001|Overall Study|Withdrawal by Subject|0|||
130411488|NCT00927927|469468026|FG002|Overall Study|Withdrawal by Subject|0|||
130411489|NCT00927927|469468027|FG003|Overall Study|Withdrawal by Subject|0|||
130411490|NCT00927927|469468028|FG004|Overall Study|Withdrawal by Subject|0|||
130411491|NCT00927927|469468029|FG005|Overall Study|Withdrawal by Subject|0|||
130411492|NCT00927927|469468030|FG006|Overall Study|Withdrawal by Subject|0|||
130411493|NCT00927927|469468031|FG007|Overall Study|Withdrawal by Subject|2|||
130411494|NCT00927927|469468032|FG008|Overall Study|Withdrawal by Subject|0|||
130411495|NCT00927927|469468033|FG009|Overall Study|Withdrawal by Subject|0|||
130411496|NCT00927927|469468034|FG010|Overall Study|Withdrawal by Subject|0|||
130411497|NCT00927927|469468035|FG011|Overall Study|Withdrawal by Subject|2|||
130411498|NCT00927927|469468036|FG012|Overall Study|Withdrawal by Subject|0|||
130411499|NCT00927927|469468037|FG013|Overall Study|Withdrawal by Subject|0|||
130411500|NCT00927927|469468038|FG014|Overall Study|Withdrawal by Subject|0|||
130411501|NCT01110239|469468041|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
130411502|NCT01110239|469468042|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
130411503|NCT01110239|469468043|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
130411504|NCT01110239|469468044|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
130411505|NCT01110239|469468041|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
130411506|NCT01110239|469468042|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
130411507|NCT01110239|469468043|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
130411508|NCT01110239|469468044|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
130411509|NCT00080223|469468047|FG000|Overall Study|Adverse Event|23|||
130411510|NCT00080223|469468047|FG000|Overall Study|Death|21|||
130411511|NCT00080223|469468047|FG000|Overall Study|Withdrawal by Subject|13|||
130411512|NCT00080223|469468047|FG000|Overall Study|Lung Transplantation|9|||
130411513|NCT00080223|469468047|FG000|Overall Study|Non-compliance With Study Treatment|7|||
130411514|NCT00080223|469468047|FG000|Overall Study|Participant unwilling to continue|2|||
130411515|NCT00080223|469468047|FG000|Overall Study|Physician Decision|1|||
130411516|NCT04369469|469468050|FG000|Overall Study|Lost to Follow-up|2|||
130411517|NCT04369469|469468051|FG001|Overall Study|Lost to Follow-up|4|||
130411518|NCT04369469|469468050|FG000|Overall Study|Physician Decision|2|||
130411519|NCT04369469|469468051|FG001|Overall Study|Physician Decision|1|||
130411520|NCT04369469|469468050|FG000|Overall Study|Withdrawal by Subject|2|||
130411521|NCT04369469|469468051|FG001|Overall Study|Withdrawal by Subject|3|||
130474157|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130563529|NCT02138617|470030523|FG001|Overall Study|Disease Progression|13|||
130411522|NCT04369469|469468050|FG000|Overall Study|Adverse Event|1|||
130411523|NCT04369469|469468051|FG001|Overall Study|Adverse Event|0|||
130411524|NCT04369469|469468050|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
130411525|NCT04369469|469468051|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
130411526|NCT04369469|469468050|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
130411527|NCT04369469|469468051|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
130411528|NCT04369469|469468050|FG000|Overall Study|Unable to Provide Consent|0|||
130411529|NCT04369469|469468051|FG001|Overall Study|Unable to Provide Consent|1|||
130411530|NCT05204134|469468052|FG000|Overall Study|Withdrawal by Subject|3|||
130411531|NCT05204134|469468052|FG000|Overall Study|Physician Decision|1|||
130411532|NCT03099382|469468056|FG000|Overall Study|Protocol Violation|2|||
130411533|NCT03099382|469468057|FG001|Overall Study|Protocol Violation|3|||
130411534|NCT00499369|469468058|FG000|Overall Study|Adverse Event|2|||
130411535|NCT00499369|469468059|FG001|Overall Study|Adverse Event|2|||
130411536|NCT00499369|469468060|FG002|Overall Study|Adverse Event|3|||
130411537|NCT00499369|469468061|FG003|Overall Study|Adverse Event|1|||
130411538|NCT00499369|469468062|FG004|Overall Study|Adverse Event|2|||
130411539|NCT00499369|469468058|FG000|Overall Study|Withdrawal by Subject|0|||
130411540|NCT00499369|469468059|FG001|Overall Study|Withdrawal by Subject|1|||
130411541|NCT00499369|469468060|FG002|Overall Study|Withdrawal by Subject|1|||
130411542|NCT00499369|469468061|FG003|Overall Study|Withdrawal by Subject|0|||
130411543|NCT00499369|469468062|FG004|Overall Study|Withdrawal by Subject|0|||
130411544|NCT00499369|469468058|FG000|Overall Study|Progression|10|||
130411545|NCT00499369|469468059|FG001|Overall Study|Progression|12|||
130411546|NCT00499369|469468060|FG002|Overall Study|Progression|9|||
130411547|NCT00499369|469468061|FG003|Overall Study|Progression|6|||
130411548|NCT00499369|469468062|FG004|Overall Study|Progression|10|||
130411549|NCT00499369|469468058|FG000|Overall Study|Death|0|||
130411550|NCT00499369|469468059|FG001|Overall Study|Death|1|||
130411551|NCT00499369|469468060|FG002|Overall Study|Death|0|||
130411552|NCT00499369|469468061|FG003|Overall Study|Death|0|||
130411553|NCT00499369|469468062|FG004|Overall Study|Death|0|||
130411554|NCT00499369|469468058|FG000|Overall Study|Not protocol specified|2|||
130411555|NCT00499369|469468059|FG001|Overall Study|Not protocol specified|0|||
130411556|NCT00499369|469468060|FG002|Overall Study|Not protocol specified|3|||
130411557|NCT00499369|469468061|FG003|Overall Study|Not protocol specified|1|||
130411558|NCT00499369|469468062|FG004|Overall Study|Not protocol specified|0|||
130411559|NCT00499369|469468058|FG000|Overall Study|Ineligible|2|||
130411560|NCT00499369|469468059|FG001|Overall Study|Ineligible|2|||
130411561|NCT00499369|469468060|FG002|Overall Study|Ineligible|1|||
130411562|NCT00499369|469468061|FG003|Overall Study|Ineligible|1|||
130411563|NCT00499369|469468062|FG004|Overall Study|Ineligible|0|||
130411564|NCT01802411|469468063|FG000|Overall Study|Death|2|||
130411565|NCT01802411|469468064|FG001|Overall Study|Death|1|||
130411566|NCT01802411|469468063|FG000|Overall Study|Adverse Event|2|||
130411567|NCT01802411|469468064|FG001|Overall Study|Adverse Event|7|||
130411568|NCT01802411|469468063|FG000|Overall Study|Lack of Efficacy|8|||
130411569|NCT01802411|469468064|FG001|Overall Study|Lack of Efficacy|10|||
130411570|NCT01802411|469468063|FG000|Overall Study|Withdrawal by Subject|0|||
130411571|NCT01802411|469468064|FG001|Overall Study|Withdrawal by Subject|2|||
130411572|NCT01802411|469468063|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
130411573|NCT01802411|469468064|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
130411574|NCT01802411|469468063|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
130411575|NCT01802411|469468064|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
130411576|NCT01802411|469468063|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
130411577|NCT01802411|469468064|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
130411578|NCT01059617|469468067|FG000|Overall Study|Other|7|||
130411579|NCT01059617|469468068|FG001|Overall Study|Other|1|||
130411580|NCT01059617|469468069|FG002|Overall Study|Other|8|||
130474158|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474159|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474160|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130563530|NCT02138617|470030524|FG002|Overall Study|Disease Progression|4|||
130411581|NCT01059617|469468070|FG003|Overall Study|Other|6|||
130411582|NCT03864614|469468075|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
130411583|NCT03864614|469468076|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
130411584|NCT03864614|469468077|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
130411585|NCT03864614|469468078|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
130411586|NCT03864614|469468075|FG000|Overall Study|Withdrawal by Subject|72|||
130411587|NCT03864614|469468076|FG001|Overall Study|Withdrawal by Subject|100|||
130411588|NCT03864614|469468077|FG002|Overall Study|Withdrawal by Subject|1|||
130411589|NCT03864614|469468078|FG003|Overall Study|Withdrawal by Subject|21|||
130411590|NCT03864614|469468075|FG000|Overall Study|Lost to Follow-up|45|||
130411591|NCT03864614|469468076|FG001|Overall Study|Lost to Follow-up|54|||
130411592|NCT03864614|469468077|FG002|Overall Study|Lost to Follow-up|0|||
130411593|NCT03864614|469468078|FG003|Overall Study|Lost to Follow-up|9|||
130411594|NCT03864614|469468075|FG000|Overall Study|Adverse Event|42|||
130411595|NCT03864614|469468076|FG001|Overall Study|Adverse Event|30|||
130411596|NCT03864614|469468077|FG002|Overall Study|Adverse Event|1|||
130411597|NCT03864614|469468078|FG003|Overall Study|Adverse Event|9|||
130411598|NCT03864614|469468075|FG000|Overall Study|Protocol Deviation|6|||
130411599|NCT03864614|469468076|FG001|Overall Study|Protocol Deviation|26|||
130411600|NCT03864614|469468077|FG002|Overall Study|Protocol Deviation|0|||
130411601|NCT03864614|469468078|FG003|Overall Study|Protocol Deviation|1|||
130411602|NCT03864614|469468075|FG000|Overall Study|Physician Decision|7|||
130411603|NCT03864614|469468076|FG001|Overall Study|Physician Decision|10|||
130411604|NCT03864614|469468077|FG002|Overall Study|Physician Decision|1|||
130411605|NCT03864614|469468078|FG003|Overall Study|Physician Decision|5|||
130411606|NCT03864614|469468075|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
130411607|NCT03864614|469468076|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
130411608|NCT03864614|469468077|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
130411609|NCT03864614|469468078|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
130411610|NCT03864614|469468075|FG000|Overall Study|Sponsor Decision|1|||
130411611|NCT03864614|469468076|FG001|Overall Study|Sponsor Decision|2|||
130411612|NCT03864614|469468077|FG002|Overall Study|Sponsor Decision|0|||
130411613|NCT03864614|469468078|FG003|Overall Study|Sponsor Decision|0|||
130411614|NCT03864614|469468075|FG000|Overall Study|Pregnancy|0|||
130411615|NCT03864614|469468076|FG001|Overall Study|Pregnancy|1|||
130411616|NCT03864614|469468077|FG002|Overall Study|Pregnancy|0|||
130411617|NCT03864614|469468078|FG003|Overall Study|Pregnancy|0|||
130411618|NCT03864614|469468075|FG000|Overall Study|Other|7|||
130411619|NCT03864614|469468076|FG001|Overall Study|Other|9|||
130411620|NCT03864614|469468077|FG002|Overall Study|Other|1|||
130411621|NCT03864614|469468078|FG003|Overall Study|Other|4|||
130411622|NCT03864614|469468075|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
130411623|NCT03864614|469468076|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
130411624|NCT03864614|469468077|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
130411625|NCT03864614|469468078|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
130411626|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
130411627|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
130411628|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
130411629|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
130411630|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Adverse Event|5|||
130411631|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Adverse Event|3|||
130411632|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Adverse Event|4|||
130411633|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Adverse Event|10|||
130411634|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
130411635|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
130411636|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
130411637|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
130411638|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130411639|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130411640|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130474161|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474162|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
130474163|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474164|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
130474165|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
130474166|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
130474167|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474168|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474169|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474170|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474171|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
130474172|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474173|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
130474174|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474175|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474176|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474177|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474178|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474179|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474180|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474181|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130411641|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
130411642|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Pregnancy|5|||
130411643|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Pregnancy|0|||
130411644|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Pregnancy|3|||
130411645|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Pregnancy|2|||
130411646|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Non-compliance|1|||
130411647|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Non-compliance|4|||
130411648|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Non-compliance|0|||
130474182|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474183|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474184|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474185|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474186|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474187|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474188|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474189|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474190|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
130474191|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474192|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
130474193|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
130474194|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474195|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474196|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474197|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474198|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474199|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474200|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130474201|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474202|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474203|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474204|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474205|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474206|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474207|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474208|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474209|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474210|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474211|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474212|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474213|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474214|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474215|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474216|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130411649|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Non-compliance|3|||
130411650|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Other|0|||
130411651|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Other|3|||
130411652|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Other|3|||
130411653|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Other|1|||
130411654|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
130411655|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
130411656|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
130411657|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
130411658|NCT01760954|469469945|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
130411659|NCT01760954|469469946|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
130411660|NCT01760954|469469947|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
130411661|NCT01760954|469469948|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
130411662|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
130411663|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
130411664|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
130411665|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
130474217|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
130474218|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474219|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
130474220|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
130474221|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
130474222|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474223|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130411666|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
130411667|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
130411668|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
130411669|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
130411670|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
130411671|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
130411672|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
130411673|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
130411674|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
130411675|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
130411676|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
130411677|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
130411678|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130411679|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130411680|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
130411681|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130411682|NCT01760954|469469945|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
130411683|NCT01760954|469469946|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
130411684|NCT01760954|469469947|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
130411685|NCT01760954|469469948|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
130411686|NCT03320070|469469949|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
130411687|NCT03320070|469469950|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
130411688|NCT03320070|469469949|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
130411689|NCT03320070|469469950|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
130411690|NCT03320070|469469949|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
130411691|NCT03320070|469469950|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
130411692|NCT03320070|469469949|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
130411693|NCT03320070|469469950|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
130411694|NCT03320070|469469949|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
130411695|NCT03320070|469469950|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
130411696|NCT03320070|469469949|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
130411697|NCT03320070|469469950|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
130411698|NCT00353704|469469967|FG000|Overall Study|Protocol Violation|3|||
130411699|NCT00353704|469469968|FG001|Overall Study|Protocol Violation|1|||
130411700|NCT02473614|469469969|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
130411701|NCT02473614|469469970|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
130411702|NCT01154166|469469971|FG000|Overall Study|Adverse Event|14|||
130411703|NCT01154166|469469972|FG001|Overall Study|Adverse Event|9|||
130411704|NCT01154166|469469971|FG000|Overall Study|Lost to Follow-up|1|||
130411705|NCT01154166|469469972|FG001|Overall Study|Lost to Follow-up|1|||
130411706|NCT01154166|469469971|FG000|Overall Study|Protocol Violation|4|||
130411707|NCT01154166|469469972|FG001|Overall Study|Protocol Violation|1|||
130411708|NCT01154166|469469971|FG000|Overall Study|Withdrawal by Subject|10|||
130411709|NCT01154166|469469972|FG001|Overall Study|Withdrawal by Subject|1|||
130411710|NCT01154166|469469971|FG000|Overall Study|Lack of Efficacy|3|||
130411711|NCT01154166|469469972|FG001|Overall Study|Lack of Efficacy|0|||
130411712|NCT01154166|469469971|FG000|Overall Study|Disease Progression|1|||
130411713|NCT01154166|469469972|FG001|Overall Study|Disease Progression|0|||
130411714|NCT01154166|469469971|FG000|Overall Study|Poor Compliance|1|||
130411715|NCT01154166|469469972|FG001|Overall Study|Poor Compliance|0|||
130411716|NCT01375049|469469973|FG000|Overall Study|Adverse Event|2|||
130411717|NCT01375049|469469973|FG000|Overall Study|Lost to Follow-up|1|||
130411718|NCT01375049|469469973|FG000|Overall Study|Withdrawal by Subject|2|||
130411719|NCT01375049|469469973|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
130411720|NCT04121962|469469976|FG000|Overall Study|Lost to Follow-up|42|||
130411721|NCT04121962|469469977|FG001|Overall Study|Lost to Follow-up|39|||
130411722|NCT01175382|469469978|FG000|Overall Study|Lost to Follow-up|4|||
130727215|NCT02883049|470625431|FG007|Post Induction|Physician Decision|56|||
130727216|NCT02883049|470625432|FG008|Post Induction|Physician Decision|85|||
130411723|NCT01175382|469469979|FG001|Overall Study|Lost to Follow-up|3|||
130411724|NCT01175382|469469980|FG002|Overall Study|Lost to Follow-up|1|||
130411725|NCT01175382|469469978|FG000|Overall Study|Physician Decision|0|||
130411726|NCT01175382|469469979|FG001|Overall Study|Physician Decision|1|||
130411727|NCT01175382|469469980|FG002|Overall Study|Physician Decision|0|||
130411728|NCT01175382|469469978|FG000|Overall Study|Withdrawal by Subject|0|||
130411729|NCT01175382|469469979|FG001|Overall Study|Withdrawal by Subject|0|||
130411730|NCT01175382|469469980|FG002|Overall Study|Withdrawal by Subject|1|||
130411731|NCT01175382|469469978|FG000|Overall Study|No longer having problem|1|||
130411732|NCT01175382|469469979|FG001|Overall Study|No longer having problem|0|||
130411733|NCT01175382|469469980|FG002|Overall Study|No longer having problem|1|||
130411734|NCT01175382|469469978|FG000|Overall Study|Unable/unwilling to attend visits|3|||
130411735|NCT01175382|469469979|FG001|Overall Study|Unable/unwilling to attend visits|1|||
130411736|NCT01175382|469469980|FG002|Overall Study|Unable/unwilling to attend visits|2|||
130411737|NCT01175382|469469978|FG000|Overall Study|Unwilling to follow protocol|0|||
130411738|NCT01175382|469469979|FG001|Overall Study|Unwilling to follow protocol|1|||
130563531|NCT02138617|470030522|FG000|Overall Study|Withdrawal by Subject|7|||
130411739|NCT01175382|469469980|FG002|Overall Study|Unwilling to follow protocol|0|||
130411740|NCT01175382|469469978|FG000|Overall Study|Unable to tolerate study meds|0|||
130411741|NCT01175382|469469979|FG001|Overall Study|Unable to tolerate study meds|1|||
130411742|NCT01175382|469469980|FG002|Overall Study|Unable to tolerate study meds|1|||
130411743|NCT00774787|469469981|FG000|Overall Study|Lost to Follow-up|1|||
130411744|NCT02019719|469469982|FG000|Overall Study|Adverse Event|1|||
130411745|NCT02019719|469469983|FG001|Overall Study|Adverse Event|0|||
130411746|NCT02019719|469469984|FG002|Overall Study|Adverse Event|0|||
130411747|NCT02019719|469469985|FG003|Overall Study|Adverse Event|1|||
130411748|NCT02019719|469469986|FG004|Overall Study|Adverse Event|1|||
130411749|NCT02019719|469469982|FG000|Overall Study|Protocol Violation|1|||
130411750|NCT02019719|469469983|FG001|Overall Study|Protocol Violation|1|||
130411751|NCT02019719|469469984|FG002|Overall Study|Protocol Violation|0|||
130411752|NCT02019719|469469985|FG003|Overall Study|Protocol Violation|0|||
130411753|NCT02019719|469469986|FG004|Overall Study|Protocol Violation|0|||
130411754|NCT02019719|469469982|FG000|Overall Study|Protocol defined stopping criteria|2|||
130411755|NCT02019719|469469983|FG001|Overall Study|Protocol defined stopping criteria|0|||
130411756|NCT02019719|469469984|FG002|Overall Study|Protocol defined stopping criteria|0|||
130411757|NCT02019719|469469985|FG003|Overall Study|Protocol defined stopping criteria|1|||
130411758|NCT02019719|469469986|FG004|Overall Study|Protocol defined stopping criteria|1|||
130411759|NCT02019719|469469982|FG000|Overall Study|Physician Decision|2|||
130411760|NCT02019719|469469983|FG001|Overall Study|Physician Decision|0|||
130411761|NCT02019719|469469984|FG002|Overall Study|Physician Decision|0|||
130411762|NCT02019719|469469985|FG003|Overall Study|Physician Decision|0|||
130411763|NCT02019719|469469986|FG004|Overall Study|Physician Decision|0|||
130411764|NCT02731131|469469990|FG000|Overall Study|Psychiatric Disorder|0|||
130411765|NCT02731131|469469991|FG001|Overall Study|Psychiatric Disorder|1|||
130411766|NCT02731131|469469990|FG000|Overall Study|Refused Therapy|0|||
130411767|NCT02731131|469469991|FG001|Overall Study|Refused Therapy|1|||
130411768|NCT02348216|469469996|FG000|Overall Study|Death|5|||
130411769|NCT02348216|469469997|FG001|Overall Study|Death|53|||
130411770|NCT02348216|469469998|FG002|Overall Study|Death|11|||
130411771|NCT02348216|469469999|FG003|Overall Study|Death|20|||
130411772|NCT02348216|469470000|FG004|Overall Study|Death|16|||
130411773|NCT02348216|469470001|FG005|Overall Study|Death|32|||
130411774|NCT02348216|469470002|FG006|Overall Study|Death|17|||
130411775|NCT02348216|469469996|FG000|Overall Study|Full consent withdrawal|0|||
130411776|NCT02348216|469469997|FG001|Overall Study|Full consent withdrawal|0|||
130411777|NCT02348216|469469998|FG002|Overall Study|Full consent withdrawal|0|||
130563532|NCT02138617|470030523|FG001|Overall Study|Withdrawal by Subject|10|||
130563533|NCT02138617|470030524|FG002|Overall Study|Withdrawal by Subject|2|||
130563534|NCT02138617|470030522|FG000|Overall Study|other complicating disease|0|||
130563535|NCT02138617|470030523|FG001|Overall Study|other complicating disease|2|||
130563536|NCT02138617|470030524|FG002|Overall Study|other complicating disease|0|||
130727217|NCT02883049|470625433|FG009|Post Induction|Physician Decision|12|||
130727218|NCT02883049|470625434|FG010|Post Induction|Physician Decision|5|||
130563537|NCT02138617|470030522|FG000|Overall Study|Protocol Violation|1|||
130411778|NCT02348216|469469999|FG003|Overall Study|Full consent withdrawal|1|||
130411779|NCT02348216|469470000|FG004|Overall Study|Full consent withdrawal|3|||
130411780|NCT02348216|469470001|FG005|Overall Study|Full consent withdrawal|0|||
130411781|NCT02348216|469470002|FG006|Overall Study|Full consent withdrawal|3|||
130411782|NCT02348216|469469996|FG000|Overall Study|Lost to Follow-up|0|||
130411783|NCT02348216|469469997|FG001|Overall Study|Lost to Follow-up|5|||
130411784|NCT02348216|469469998|FG002|Overall Study|Lost to Follow-up|2|||
130411785|NCT02348216|469469999|FG003|Overall Study|Lost to Follow-up|0|||
130411786|NCT02348216|469470000|FG004|Overall Study|Lost to Follow-up|1|||
130411787|NCT02348216|469470001|FG005|Overall Study|Lost to Follow-up|1|||
130563538|NCT02138617|470030523|FG001|Overall Study|Protocol Violation|0|||
130563539|NCT02138617|470030524|FG002|Overall Study|Protocol Violation|0|||
130563540|NCT02138617|470030522|FG000|Overall Study|Physician Decision|7|||
130563541|NCT02138617|470030523|FG001|Overall Study|Physician Decision|6|||
130411788|NCT02348216|469470002|FG006|Overall Study|Lost to Follow-up|1|||
130411789|NCT02348216|469469996|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
130411790|NCT02348216|469469997|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
130411791|NCT02348216|469469998|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
130563542|NCT02138617|470030524|FG002|Overall Study|Physician Decision|0|||
130411792|NCT02348216|469469999|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
130411793|NCT02348216|469470000|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
130411794|NCT02348216|469470001|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
130563543|NCT02138617|470030522|FG000|Overall Study|financial reason|0|||
130411795|NCT02348216|469470002|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
130411796|NCT02348216|469469996|FG000|Overall Study|Reason not specified|2|||
130411797|NCT02348216|469469997|FG001|Overall Study|Reason not specified|19|||
130563544|NCT02138617|470030523|FG001|Overall Study|financial reason|1|||
130411798|NCT02348216|469469998|FG002|Overall Study|Reason not specified|11|||
130411799|NCT02348216|469469999|FG003|Overall Study|Reason not specified|17|||
130411800|NCT02348216|469470000|FG004|Overall Study|Reason not specified|21|||
130411801|NCT02348216|469470001|FG005|Overall Study|Reason not specified|17|||
130411802|NCT02348216|469470002|FG006|Overall Study|Reason not specified|19|||
130411803|NCT01055639|469470003|FG000|Overall Study|Adverse Event|0|||
130411804|NCT01055639|469470004|FG001|Overall Study|Adverse Event|1|||
130411805|NCT01055639|469470003|FG000|Overall Study|Lack of Efficacy|0|||
130411806|NCT01055639|469470004|FG001|Overall Study|Lack of Efficacy|1|||
130411807|NCT01055639|469470003|FG000|Overall Study|Lost to Follow-up|8|||
130411808|NCT01055639|469470004|FG001|Overall Study|Lost to Follow-up|11|||
130411809|NCT01055639|469470003|FG000|Overall Study|Protocol Violation|5|||
130411810|NCT01055639|469470004|FG001|Overall Study|Protocol Violation|5|||
130411811|NCT01055639|469470003|FG000|Overall Study|Withdrawal by Subject|8|||
130411812|NCT01055639|469470004|FG001|Overall Study|Withdrawal by Subject|11|||
130411813|NCT00562159|469470005|FG000|Overall Study|Adverse Event|11|||
130411814|NCT00562159|469470006|FG001|Overall Study|Adverse Event|8|||
130411815|NCT00562159|469470005|FG000|Overall Study|Lost to Follow-up|5|||
130411816|NCT00562159|469470006|FG001|Overall Study|Lost to Follow-up|4|||
130411817|NCT00562159|469470005|FG000|Overall Study|Withdrawal by Subject|9|||
130411818|NCT00562159|469470006|FG001|Overall Study|Withdrawal by Subject|8|||
130411819|NCT00562159|469470005|FG000|Overall Study|Protocol Violation|12|||
130411820|NCT00562159|469470006|FG001|Overall Study|Protocol Violation|12|||
130411821|NCT00562159|469470005|FG000|Overall Study|Did not meet protocol eligibility|1|||
130411822|NCT00562159|469470006|FG001|Overall Study|Did not meet protocol eligibility|1|||
130411823|NCT00765245|469470007|FG000|Overall Study|disease progression|3|||
130411824|NCT00765245|469470008|FG001|Overall Study|disease progression|2|||
130411825|NCT00765245|469470007|FG000|Overall Study|Withdrawal by Subject|3|||
130411826|NCT00765245|469470008|FG001|Overall Study|Withdrawal by Subject|0|||
130411827|NCT00765245|469470007|FG000|Overall Study|Adverse Event|5|||
130411828|NCT00765245|469470008|FG001|Overall Study|Adverse Event|0|||
130411829|NCT00765245|469470007|FG000|Overall Study|Physician Decision|1|||
130411830|NCT00765245|469470008|FG001|Overall Study|Physician Decision|0|||
130411831|NCT00765245|469470007|FG000|Overall Study|Death|1|||
130411832|NCT00765245|469470008|FG001|Overall Study|Death|0|||
130411833|NCT01181921|469470012|FG000|Overall Study|Lost to Follow-up|1|||
130411834|NCT02162810|469470013|FG000|Overall Study|Protocol Violation|1|||
130411835|NCT02162810|469470014|FG001|Overall Study|Protocol Violation|0|||
130411836|NCT02162810|469470013|FG000|Overall Study|patients did not report compliance|4|||
130411837|NCT02162810|469470014|FG001|Overall Study|patients did not report compliance|1|||
130411838|NCT02519504|469470019|FG000|Overall Study|Protocol Violation|6|||
130411839|NCT02519504|469470020|FG001|Overall Study|Protocol Violation|5|||
130411840|NCT02519504|469470019|FG000|Overall Study|Ineligible for direct testing|12|||
130411841|NCT02519504|469470020|FG001|Overall Study|Ineligible for direct testing|12|||
130411842|NCT02519504|469470019|FG000|Overall Study|Did not participate in direct testing|95|||
130411843|NCT02519504|469470020|FG001|Overall Study|Did not participate in direct testing|86|||
130411844|NCT02546544|469470021|FG000|Overall Study|Disease Progression|14|||
130411845|NCT02546544|469470021|FG000|Overall Study|Adverse Event|1|||
130411846|NCT02546544|469470021|FG000|Overall Study|Withdrawal by Subject|1|||
130411847|NCT02223390|469470022|FG000|Overall Study|Lost to Follow-up|9|||
130411848|NCT02223390|469470023|FG001|Overall Study|Lost to Follow-up|4|||
130411849|NCT02548962|469470025|FG000|Overall Study|Withdrawal by Subject|1|||
130411850|NCT02548962|469470026|FG001|Overall Study|Withdrawal by Subject|0|||
130411851|NCT01197950|469470027|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
130411852|NCT01197950|469470028|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
130411853|NCT01197950|469470029|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
130411854|NCT02553330|469470030|FG000|Overall Study|Study Terminated by Sponsor|2|||
130411855|NCT02553330|469470031|FG001|Overall Study|Study Terminated by Sponsor|13|||
130411856|NCT02553330|469470032|FG002|Overall Study|Study Terminated by Sponsor|12|||
130411857|NCT02553330|469470030|FG000|Overall Study|Withdrawal by Subject|3|||
130411858|NCT02553330|469470031|FG001|Overall Study|Withdrawal by Subject|19|||
130411859|NCT02553330|469470032|FG002|Overall Study|Withdrawal by Subject|21|||
130411860|NCT02553330|469470030|FG000|Overall Study|Other|0|||
130411861|NCT02553330|469470031|FG001|Overall Study|Other|1|||
130411862|NCT02553330|469470032|FG002|Overall Study|Other|0|||
130411863|NCT02553330|469470030|FG000|Overall Study|Non compliance to study treatment|0|||
130411864|NCT02553330|469470031|FG001|Overall Study|Non compliance to study treatment|1|||
130411865|NCT02553330|469470032|FG002|Overall Study|Non compliance to study treatment|0|||
130411866|NCT02553330|469470030|FG000|Overall Study|Adverse Event|0|||
130411867|NCT02553330|469470031|FG001|Overall Study|Adverse Event|1|||
130411868|NCT02553330|469470032|FG002|Overall Study|Adverse Event|0|||
130411869|NCT02553330|469470030|FG000|Overall Study|Lost to Follow-up|0|||
130411870|NCT02553330|469470031|FG001|Overall Study|Lost to Follow-up|4|||
130411871|NCT02553330|469470032|FG002|Overall Study|Lost to Follow-up|4|||
130411872|NCT03551938|469470036|FG000|3-Month Follow Up|Lost to Follow-up|39|||
130411873|NCT03551938|469470037|FG001|3-Month Follow Up|Lost to Follow-up|38|||
130411874|NCT03551938|469470036|FG000|6-Month Follow Up|Lost to Follow-up|46|||
130411875|NCT03551938|469470037|FG001|6-Month Follow Up|Lost to Follow-up|42|||
130411876|NCT03551938|469470036|FG000|9-Month Follow Up|Lost to Follow-up|44|||
130411877|NCT03551938|469470037|FG001|9-Month Follow Up|Lost to Follow-up|43|||
130411878|NCT04137380|469470043|FG000|Overall Study|Physician Decision|0|||
130411879|NCT04137380|469470044|FG001|Overall Study|Physician Decision|0|||
130411880|NCT04137380|469470045|FG002|Overall Study|Physician Decision|0|||
130411881|NCT04137380|469470046|FG003|Overall Study|Physician Decision|1|||
130411882|NCT04137380|469470047|FG004|Overall Study|Physician Decision|0|||
130411883|NCT04137380|469470048|FG005|Overall Study|Physician Decision|0|||
130411884|NCT04137380|469470049|FG006|Overall Study|Physician Decision|0|||
130411885|NCT02265705|469470055|FG000|Treatment Period Week 0-24|Adverse Event|3|||
130411886|NCT02265705|469470056|FG001|Treatment Period Week 0-24|Adverse Event|2|||
130411887|NCT02265705|469470057|FG002|Treatment Period Week 0-24|Adverse Event|0|||
130411888|NCT02265705|469470058|FG003|Treatment Period Week 0-24|Adverse Event|0|||
130411889|NCT02265705|469470059|FG004|Treatment Period Week 0-24|Adverse Event|0|||
130411890|NCT02265705|469470060|FG005|Treatment Period Week 0-24|Adverse Event|0|||
130411891|NCT02265705|469470061|FG006|Treatment Period Week 0-24|Adverse Event|0|||
130411892|NCT02265705|469470055|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
130411893|NCT02265705|469470056|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
130411894|NCT02265705|469470057|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130411895|NCT02265705|469470058|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130411896|NCT02265705|469470059|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130411897|NCT02265705|469470060|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130411898|NCT02265705|469470061|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130411899|NCT02265705|469470055|FG000|Treatment Period Week 0-24|Physician Decision|1|||
130411900|NCT02265705|469470056|FG001|Treatment Period Week 0-24|Physician Decision|0|||
130411901|NCT02265705|469470057|FG002|Treatment Period Week 0-24|Physician Decision|0|||
130411902|NCT02265705|469470058|FG003|Treatment Period Week 0-24|Physician Decision|0|||
130411903|NCT02265705|469470059|FG004|Treatment Period Week 0-24|Physician Decision|0|||
130411904|NCT02265705|469470060|FG005|Treatment Period Week 0-24|Physician Decision|0|||
130411905|NCT02265705|469470061|FG006|Treatment Period Week 0-24|Physician Decision|0|||
130411906|NCT02265705|469470055|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
130411907|NCT02265705|469470056|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
130411908|NCT02265705|469470057|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130411909|NCT02265705|469470058|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130411910|NCT02265705|469470059|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130411911|NCT02265705|469470060|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130411912|NCT02265705|469470061|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130411913|NCT02265705|469470055|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411914|NCT02265705|469470056|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
130411915|NCT02265705|469470057|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411916|NCT02265705|469470058|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411917|NCT02265705|469470059|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411918|NCT02265705|469470060|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411919|NCT02265705|469470061|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
130411920|NCT02265705|469470055|FG000|Rescue Period|Withdrawal by Subject|0|||
130411921|NCT02265705|469470056|FG001|Rescue Period|Withdrawal by Subject|0|||
130411922|NCT02265705|469470057|FG002|Rescue Period|Withdrawal by Subject|1|||
130411923|NCT02265705|469470058|FG003|Rescue Period|Withdrawal by Subject|0|||
130411924|NCT02265705|469470059|FG004|Rescue Period|Withdrawal by Subject|0|||
130411925|NCT02265705|469470060|FG005|Rescue Period|Withdrawal by Subject|0|||
130411926|NCT02265705|469470061|FG006|Rescue Period|Withdrawal by Subject|0|||
130411927|NCT02265705|469470055|FG000|Rescue Period|Death|0|||
130411928|NCT02265705|469470056|FG001|Rescue Period|Death|0|||
130411929|NCT02265705|469470057|FG002|Rescue Period|Death|1|||
130411930|NCT02265705|469470058|FG003|Rescue Period|Death|0|||
130411931|NCT02265705|469470059|FG004|Rescue Period|Death|0|||
130411932|NCT02265705|469470060|FG005|Rescue Period|Death|0|||
130411933|NCT02265705|469470061|FG006|Rescue Period|Death|0|||
130411934|NCT02265705|469470055|FG000|Rescue Period|Lack of Efficacy|0|||
130411935|NCT02265705|469470056|FG001|Rescue Period|Lack of Efficacy|0|||
130411936|NCT02265705|469470057|FG002|Rescue Period|Lack of Efficacy|1|||
130411937|NCT02265705|469470058|FG003|Rescue Period|Lack of Efficacy|0|||
130411938|NCT02265705|469470059|FG004|Rescue Period|Lack of Efficacy|0|||
130411939|NCT02265705|469470060|FG005|Rescue Period|Lack of Efficacy|0|||
130411940|NCT02265705|469470061|FG006|Rescue Period|Lack of Efficacy|0|||
130411941|NCT02265705|469470055|FG000|Open Label Period|Adverse Event|0|||
130411942|NCT02265705|469470056|FG001|Open Label Period|Adverse Event|0|||
130411943|NCT02265705|469470057|FG002|Open Label Period|Adverse Event|0|||
130411944|NCT02265705|469470058|FG003|Open Label Period|Adverse Event|2|||
130411945|NCT02265705|469470059|FG004|Open Label Period|Adverse Event|2|||
130411946|NCT02265705|469470060|FG005|Open Label Period|Adverse Event|0|||
130411947|NCT02265705|469470061|FG006|Open Label Period|Adverse Event|0|||
130411948|NCT02265705|469470055|FG000|Open Label Period|Physician Decision|0|||
130411949|NCT02265705|469470056|FG001|Open Label Period|Physician Decision|0|||
130727219|NCT02883049|470625435|FG011|Post Induction|Physician Decision|14|||
130411950|NCT02265705|469470057|FG002|Open Label Period|Physician Decision|0|||
130411951|NCT02265705|469470058|FG003|Open Label Period|Physician Decision|0|||
130411952|NCT02265705|469470059|FG004|Open Label Period|Physician Decision|1|||
130411953|NCT02265705|469470060|FG005|Open Label Period|Physician Decision|0|||
130411954|NCT02265705|469470061|FG006|Open Label Period|Physician Decision|0|||
130411955|NCT02265705|469470055|FG000|Open Label Period|Withdrawal by Subject|0|||
130411956|NCT02265705|469470056|FG001|Open Label Period|Withdrawal by Subject|0|||
130411957|NCT02265705|469470057|FG002|Open Label Period|Withdrawal by Subject|0|||
130411958|NCT02265705|469470058|FG003|Open Label Period|Withdrawal by Subject|0|||
130411959|NCT02265705|469470059|FG004|Open Label Period|Withdrawal by Subject|2|||
130411960|NCT02265705|469470060|FG005|Open Label Period|Withdrawal by Subject|0|||
130411961|NCT02265705|469470061|FG006|Open Label Period|Withdrawal by Subject|0|||
130411962|NCT02265705|469470055|FG000|Follow-up Period|Sponsor Decision|0|||
130411963|NCT02265705|469470056|FG001|Follow-up Period|Sponsor Decision|0|||
130411964|NCT02265705|469470057|FG002|Follow-up Period|Sponsor Decision|0|||
130411965|NCT02265705|469470058|FG003|Follow-up Period|Sponsor Decision|0|||
130411966|NCT02265705|469470059|FG004|Follow-up Period|Sponsor Decision|0|||
130411967|NCT02265705|469470060|FG005|Follow-up Period|Sponsor Decision|1|||
130411968|NCT02265705|469470061|FG006|Follow-up Period|Sponsor Decision|6|||
130411969|NCT02265705|469470055|FG000|Follow-up Period|Adverse Event|0|||
130411970|NCT02265705|469470056|FG001|Follow-up Period|Adverse Event|0|||
130411971|NCT02265705|469470057|FG002|Follow-up Period|Adverse Event|0|||
130411972|NCT02265705|469470058|FG003|Follow-up Period|Adverse Event|0|||
130411973|NCT02265705|469470059|FG004|Follow-up Period|Adverse Event|0|||
130411974|NCT02265705|469470060|FG005|Follow-up Period|Adverse Event|0|||
130411975|NCT02265705|469470061|FG006|Follow-up Period|Adverse Event|3|||
130411976|NCT02265705|469470055|FG000|Follow-up Period|Physician Decision|0|||
130411977|NCT02265705|469470056|FG001|Follow-up Period|Physician Decision|0|||
130411978|NCT02265705|469470057|FG002|Follow-up Period|Physician Decision|0|||
130411979|NCT02265705|469470058|FG003|Follow-up Period|Physician Decision|0|||
130411980|NCT02265705|469470059|FG004|Follow-up Period|Physician Decision|0|||
130411981|NCT02265705|469470060|FG005|Follow-up Period|Physician Decision|0|||
130411982|NCT02265705|469470061|FG006|Follow-up Period|Physician Decision|1|||
130411983|NCT02265705|469470055|FG000|Follow-up Period|Withdrawal by Subject|0|||
130411984|NCT02265705|469470056|FG001|Follow-up Period|Withdrawal by Subject|0|||
130411985|NCT02265705|469470057|FG002|Follow-up Period|Withdrawal by Subject|0|||
130411986|NCT02265705|469470058|FG003|Follow-up Period|Withdrawal by Subject|0|||
130411987|NCT02265705|469470059|FG004|Follow-up Period|Withdrawal by Subject|0|||
130411988|NCT02265705|469470060|FG005|Follow-up Period|Withdrawal by Subject|0|||
130411989|NCT02265705|469470061|FG006|Follow-up Period|Withdrawal by Subject|1|||
130411990|NCT00779246|469470062|FG000|Overall Study|Missing sufficient data for analysis|33|||
130411991|NCT00779246|469470063|FG001|Overall Study|Missing sufficient data for analysis|53|||
130411992|NCT03465540|469470064|FG000|Overall Study|Withdrawal by Subject|0|||
130411993|NCT03465540|469470065|FG001|Overall Study|Withdrawal by Subject|0|||
130411994|NCT03465540|469470066|FG002|Overall Study|Withdrawal by Subject|1|||
130411995|NCT03465540|469470067|FG003|Overall Study|Withdrawal by Subject|1|||
130411996|NCT03465540|469470068|FG004|Overall Study|Withdrawal by Subject|1|||
130411997|NCT03465540|469470069|FG005|Overall Study|Withdrawal by Subject|0|||
130411998|NCT03465540|469470064|FG000|Overall Study|Lost to Follow-up|0|||
130411999|NCT03465540|469470065|FG001|Overall Study|Lost to Follow-up|1|||
130474224|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474225|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474226|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474227|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130474228|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474229|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474230|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474231|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474232|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474233|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474234|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474235|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474236|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474237|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474238|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130412000|NCT03465540|469470066|FG002|Overall Study|Lost to Follow-up|0|||
130412001|NCT03465540|469470067|FG003|Overall Study|Lost to Follow-up|0|||
130412002|NCT03465540|469470068|FG004|Overall Study|Lost to Follow-up|1|||
130412003|NCT03465540|469470069|FG005|Overall Study|Lost to Follow-up|0|||
130412004|NCT03465540|469470064|FG000|Overall Study|Death|1|||
130412005|NCT03465540|469470065|FG001|Overall Study|Death|1|||
130412006|NCT03465540|469470066|FG002|Overall Study|Death|0|||
130412007|NCT03465540|469470067|FG003|Overall Study|Death|2|||
130412008|NCT03465540|469470068|FG004|Overall Study|Death|0|||
130412009|NCT03465540|469470069|FG005|Overall Study|Death|2|||
130412010|NCT03465540|469470064|FG000|Overall Study|Protocol specified criteria|0|||
130412011|NCT03465540|469470065|FG001|Overall Study|Protocol specified criteria|2|||
130412012|NCT03465540|469470066|FG002|Overall Study|Protocol specified criteria|2|||
130412013|NCT03465540|469470067|FG003|Overall Study|Protocol specified criteria|0|||
130412014|NCT03465540|469470068|FG004|Overall Study|Protocol specified criteria|2|||
130412015|NCT03465540|469470069|FG005|Overall Study|Protocol specified criteria|0|||
130412016|NCT00736996|469470070|FG000|Overall Study|Lost to Follow-up|1|||
130412017|NCT00736996|469470071|FG001|Overall Study|Lost to Follow-up|9|||
130412018|NCT00736996|469470072|FG002|Overall Study|Lost to Follow-up|2|||
130412019|NCT02844946|469470073|FG000|Overall Study|Lost to Follow-up|7|||
130412020|NCT02844946|469470074|FG001|Overall Study|Lost to Follow-up|0|||
130412021|NCT02806986|469470075|FG000|Treatment Stage 1|Adverse Event|1|||
130412022|NCT02806986|469470075|FG000|Treatment Stage 2|Adverse Event|3|||
130412023|NCT02806986|469470075|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
130412024|NCT04000165|469470076|FG000|Overall Study|Physician Decision|1|||
130412025|NCT04000165|469470076|FG000|Overall Study|Withdrawal by Subject|1|||
130412026|NCT01753193|469470077|FG000|Overall Study|Withdrawal by Subject|23|||
130412027|NCT01753193|469470077|FG000|Overall Study|Lost to Follow-up|6|||
130412028|NCT01753193|469470077|FG000|Overall Study|Death|1|||
130412029|NCT01753193|469470077|FG000|Overall Study|Other|16|||
130412030|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
130412031|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
130412032|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
130412033|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
130412034|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
130412035|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130412036|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
130412037|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130412038|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
130412039|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
130412040|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
130412041|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
130412042|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
130412043|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130412044|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130412045|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
130412046|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
130412047|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
130412048|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
130412049|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
130412050|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
130412051|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130412052|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
130412053|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130412054|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
130412055|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
130412056|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130412057|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
130412058|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130412059|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
130412060|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
130412061|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
130412062|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
130412063|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130412064|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
130412065|NCT00383435|469470078|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
130412066|NCT00383435|469470079|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
130412067|NCT00383435|469470080|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
130412068|NCT00383435|469470081|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
130412069|NCT00383435|469470082|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
130412070|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
130412071|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
130412072|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
130412073|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
130412074|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
130412075|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130412076|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130412077|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130412078|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130412079|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130412080|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130412081|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
130412082|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130412083|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130412084|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130412085|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130412086|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130412087|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130412088|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130412089|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
130412090|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130412091|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130412092|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
130412093|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130412094|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130412095|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
130412096|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130412097|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130412098|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130412099|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
130412100|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130412101|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130412102|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130412103|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130412104|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130412105|NCT00383435|469470078|FG000|26-Week Treatment Safety Extension|Administrative|1|||
130412106|NCT00383435|469470079|FG001|26-Week Treatment Safety Extension|Administrative|1|||
130412107|NCT00383435|469470080|FG002|26-Week Treatment Safety Extension|Administrative|0|||
130412108|NCT00383435|469470081|FG003|26-Week Treatment Safety Extension|Administrative|1|||
130412109|NCT00383435|469470082|FG004|26-Week Treatment Safety Extension|Administrative|0|||
130412110|NCT02682264|469470083|FG000|Overall Study|Withdrawal by Subject|56|||
130412111|NCT02682264|469470084|FG001|Overall Study|Withdrawal by Subject|45|||
130412112|NCT02682264|469470083|FG000|Overall Study|Lost to Follow-up|49|||
130412113|NCT02682264|469470084|FG001|Overall Study|Lost to Follow-up|41|||
130412114|NCT02682264|469470083|FG000|Overall Study|Lack of Efficacy|14|||
130412115|NCT02682264|469470084|FG001|Overall Study|Lack of Efficacy|16|||
130412116|NCT02682264|469470083|FG000|Overall Study|Withdrawal by Parent|6|||
130412117|NCT02682264|469470084|FG001|Overall Study|Withdrawal by Parent|7|||
130412118|NCT02682264|469470083|FG000|Overall Study|Adverse Event|9|||
130412119|NCT02682264|469470084|FG001|Overall Study|Adverse Event|0|||
130412120|NCT02682264|469470083|FG000|Overall Study|Noncompliance with study drug|1|||
130412121|NCT02682264|469470084|FG001|Overall Study|Noncompliance with study drug|4|||
130412122|NCT02682264|469470083|FG000|Overall Study|Pregnancy|1|||
130412123|NCT02682264|469470084|FG001|Overall Study|Pregnancy|2|||
130412124|NCT02682264|469470083|FG000|Overall Study|Recovery|1|||
130412125|NCT02682264|469470084|FG001|Overall Study|Recovery|2|||
130412126|NCT02682264|469470083|FG000|Overall Study|Progressive Disease|1|||
130412127|NCT02682264|469470084|FG001|Overall Study|Progressive Disease|0|||
130412128|NCT02682264|469470083|FG000|Overall Study|Technical Problems|0|||
130412129|NCT02682264|469470084|FG001|Overall Study|Technical Problems|1|||
130412130|NCT02682264|469470083|FG000|Overall Study|Moved abroad and unable to continue|0|||
130412131|NCT02682264|469470084|FG001|Overall Study|Moved abroad and unable to continue|3|||
130412132|NCT02682264|469470083|FG000|Overall Study|Stopped test article application|0|||
130474239|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474240|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474241|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474242|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474243|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
130474244|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474245|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474246|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474247|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130412133|NCT02682264|469470084|FG001|Overall Study|Stopped test article application|1|||
130412134|NCT01131312|469470085|FG000|Overall Study|Lost to Follow-up|425|||
130412135|NCT01131312|469470086|FG001|Overall Study|Lost to Follow-up|229|||
130412136|NCT01131312|469470087|FG002|Overall Study|Lost to Follow-up|351|||
130412137|NCT03447769|469470089|FG000|Overall Study|Progressive disease|138|||
130412138|NCT03447769|469470090|FG001|Overall Study|Progressive disease|148|||
130412139|NCT03447769|469470089|FG000|Overall Study|Study terminated by Sponsor|60|||
130412140|NCT03447769|469470090|FG001|Overall Study|Study terminated by Sponsor|44|||
130412141|NCT03447769|469470089|FG000|Overall Study|Adverse Event|34|||
130412142|NCT03447769|469470090|FG001|Overall Study|Adverse Event|31|||
130412143|NCT03447769|469470089|FG000|Overall Study|Patient decision|27|||
130412144|NCT03447769|469470090|FG001|Overall Study|Patient decision|27|||
130412145|NCT03447769|469470089|FG000|Overall Study|Protocol deviation|4|||
130412146|NCT03447769|469470090|FG001|Overall Study|Protocol deviation|6|||
130412147|NCT03447769|469470089|FG000|Overall Study|Death|2|||
130412148|NCT03447769|469470090|FG001|Overall Study|Death|7|||
130412149|NCT03447769|469470089|FG000|Overall Study|Technical problems|1|||
130412150|NCT03447769|469470090|FG001|Overall Study|Technical problems|0|||
130412151|NCT03447769|469470089|FG000|Overall Study|Lost to Follow-up|0|||
130412152|NCT03447769|469470090|FG001|Overall Study|Lost to Follow-up|1|||
130412153|NCT03447769|469470089|FG000|Overall Study|Physician Decision|13|||
130412154|NCT03447769|469470090|FG001|Overall Study|Physician Decision|5|||
130412155|NCT01343407|469470092|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
130412156|NCT01343407|469470093|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
130412157|NCT01343407|469470094|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
130412158|NCT01343407|469470095|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
130412159|NCT01343407|469470096|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
130412160|NCT01343407|469470097|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
130412161|NCT01343407|469470092|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
130412162|NCT01343407|469470093|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
130412163|NCT01343407|469470094|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
130412164|NCT01343407|469470095|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
130412165|NCT01343407|469470096|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
130412166|NCT01343407|469470097|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
130412167|NCT03950739|469470098|FG000|Treatment Phase|Adverse Event|2|||
130412168|NCT03950739|469470098|FG000|Optional Extension Phase|Death|1|||
130412169|NCT03950739|469470098|FG000|Optional Extension Phase|Progressive Disease|5|||
130412170|NCT03950739|469470098|FG000|Optional Extension Phase|Adverse Event|7|||
130412171|NCT03950739|469470098|FG000|Optional Extension Phase|Lost to Follow-up|2|||
130412172|NCT03950739|469470098|FG000|Optional Extension Phase|Site Closure|2|||
130412173|NCT03950739|469470098|FG000|Optional Extension Phase|Pregnancy|1|||
130412174|NCT03264989|469470102|FG000|Overall Study|Lost to Follow-up|1|||
130412175|NCT03264989|469470103|FG001|Overall Study|Lost to Follow-up|0|||
130412176|NCT03264989|469470102|FG000|Overall Study|New Therapy for study Indication|1|||
130412177|NCT03264989|469470103|FG001|Overall Study|New Therapy for study Indication|0|||
130412178|NCT03264989|469470102|FG000|Overall Study|Protocol Violation|0|||
130412179|NCT03264989|469470103|FG001|Overall Study|Protocol Violation|1|||
130412180|NCT03264989|469470102|FG000|Overall Study|Patient decision|13|||
130412181|NCT03264989|469470103|FG001|Overall Study|Patient decision|0|||
130412182|NCT03264989|469470102|FG000|Overall Study|Physician Decision|6|||
130412183|NCT03264989|469470103|FG001|Overall Study|Physician Decision|4|||
130412184|NCT03264989|469470102|FG000|Overall Study|Adverse Event|2|||
130412185|NCT03264989|469470103|FG001|Overall Study|Adverse Event|1|||
130412186|NCT03264989|469470102|FG000|Overall Study|Death|1|||
130412187|NCT03264989|469470103|FG001|Overall Study|Death|1|||
130474248|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474249|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474250|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
130412188|NCT03264989|469470102|FG000|Overall Study|Pregnancy|2|||
130412189|NCT03264989|469470103|FG001|Overall Study|Pregnancy|0|||
130563545|NCT02138617|470030524|FG002|Overall Study|financial reason|0|||
130412190|NCT03264989|469470102|FG000|Overall Study|End of Study|19|||
130412191|NCT03264989|469470103|FG001|Overall Study|End of Study|5|||
130412192|NCT00305058|469470109|FG000|Overall Study|Participant too young|1|||
130412193|NCT00305058|469470110|FG001|Overall Study|Participant too young|0|||
130412194|NCT00305058|469470109|FG000|Overall Study|Missing data collection instrument|3|||
130412195|NCT00305058|469470110|FG001|Overall Study|Missing data collection instrument|2|||
130412196|NCT00305058|469470109|FG000|Overall Study|Missing outcome data|3|||
130412197|NCT00305058|469470110|FG001|Overall Study|Missing outcome data|2|||
130412198|NCT04102501|469470111|FG000|Overall Study|Withdrawal by Subject|7|||
130412199|NCT04102501|469470112|FG001|Overall Study|Withdrawal by Subject|9|||
130412200|NCT04102501|469470111|FG000|Overall Study|Adverse Event|1|||
130412201|NCT04102501|469470112|FG001|Overall Study|Adverse Event|3|||
130412202|NCT00968617|469470113|FG000|Overall Study|Study terminated by sponsor|6|||
130412203|NCT03135522|469470121|FG000|Overall Study|Adverse Event|1|||
130412204|NCT03135522|469470122|FG001|Overall Study|Adverse Event|0|||
130412205|NCT02838017|469470123|FG000|Overall Study|Lost to Follow-up|14|||
130412206|NCT02838017|469470124|FG001|Overall Study|Lost to Follow-up|11|||
130412207|NCT02120924|469470125|FG000|Overall Study|Lack of Efficacy|1|||
130412208|NCT02120924|469470126|FG001|Overall Study|Lack of Efficacy|2|||
130412209|NCT02120924|469470127|FG002|Overall Study|Lack of Efficacy|3|||
130412210|NCT02120924|469470125|FG000|Overall Study|Adverse Event|0|||
130412211|NCT02120924|469470126|FG001|Overall Study|Adverse Event|1|||
130412212|NCT02120924|469470127|FG002|Overall Study|Adverse Event|3|||
130412213|NCT02120924|469470125|FG000|Overall Study|Withdrawal by Subject|16|||
130412214|NCT02120924|469470126|FG001|Overall Study|Withdrawal by Subject|20|||
130412215|NCT02120924|469470127|FG002|Overall Study|Withdrawal by Subject|8|||
130412216|NCT02120924|469470125|FG000|Overall Study|Lost to Follow-up|14|||
130412217|NCT02120924|469470126|FG001|Overall Study|Lost to Follow-up|14|||
130412218|NCT02120924|469470127|FG002|Overall Study|Lost to Follow-up|11|||
130412219|NCT02120924|469470125|FG000|Overall Study|Pregnancy|2|||
130412220|NCT02120924|469470126|FG001|Overall Study|Pregnancy|0|||
130412221|NCT02120924|469470127|FG002|Overall Study|Pregnancy|0|||
130412222|NCT02120924|469470125|FG000|Overall Study|Protocol Violation|3|||
130412223|NCT02120924|469470126|FG001|Overall Study|Protocol Violation|7|||
130412224|NCT02120924|469470127|FG002|Overall Study|Protocol Violation|2|||
130412225|NCT02120924|469470125|FG000|Overall Study|Physician Decision|0|||
130412226|NCT02120924|469470126|FG001|Overall Study|Physician Decision|1|||
130412227|NCT02120924|469470127|FG002|Overall Study|Physician Decision|1|||
130412228|NCT02120924|469470125|FG000|Overall Study|Death|1|||
130412229|NCT02120924|469470126|FG001|Overall Study|Death|0|||
130412230|NCT02120924|469470127|FG002|Overall Study|Death|0|||
130412231|NCT02120924|469470125|FG000|Overall Study|Compliance with IP|5|||
130412232|NCT02120924|469470126|FG001|Overall Study|Compliance with IP|1|||
130412233|NCT02120924|469470127|FG002|Overall Study|Compliance with IP|1|||
130412234|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
130412235|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
130412236|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
130412237|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
130412238|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
130412239|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
130412240|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
130412241|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
130412242|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
130412243|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
130412244|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
130412245|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
130412246|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
130412247|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
130412248|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
130412249|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130412250|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
130412251|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130412252|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
130412253|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
130412254|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
130412255|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
130412256|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
130412257|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
130412258|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
130412259|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
130412260|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
130412261|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
130412262|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
130412263|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
130412264|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
130412265|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
130412266|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
130412267|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
130563546|NCT02138617|470030522|FG000|Overall Study|other therapy|3|||
130412268|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
130412269|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
130412270|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
130412271|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
130412272|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
130563547|NCT02138617|470030523|FG001|Overall Study|other therapy|4|||
130412273|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
130412274|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
130412275|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
130412276|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
130412277|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
130412278|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
130412279|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
130412280|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
130412281|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
130412282|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
130412283|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130412284|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
130412285|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
130412286|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
130412287|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
130412288|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
130412289|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
130412290|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
130412291|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
130412292|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
130412293|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
130412294|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
130412295|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
130412296|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
130412297|NCT01884350|469470128|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
130412298|NCT01884350|469470129|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
130412299|NCT01884350|469470130|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
130412300|NCT02345512|469470131|FG000|Overall Study|Adverse Event|1|||
130412301|NCT02345512|469470131|FG000|Overall Study|Withdrawal by Subject|1|||
130412302|NCT01968434|469470134|FG000|Overall Study|Lost to Follow-up|3|||
130412303|NCT01968434|469470135|FG001|Overall Study|Lost to Follow-up|6|||
130412304|NCT00074282|469471781|FG000|Step 1|Adverse Event|32|||
130412305|NCT00074282|469471782|FG001|Step 1|Adverse Event|0|||
130412306|NCT00074282|469471783|FG002|Step 1|Adverse Event|0|||
130412307|NCT00074282|469471781|FG000|Step 1|Death|6|||
130412308|NCT00074282|469471782|FG001|Step 1|Death|0|||
130412309|NCT00074282|469471783|FG002|Step 1|Death|0|||
130412310|NCT00074282|469471781|FG000|Step 1|Withdrawal by Subject|7|||
130412311|NCT00074282|469471782|FG001|Step 1|Withdrawal by Subject|0|||
130412312|NCT00074282|469471783|FG002|Step 1|Withdrawal by Subject|0|||
130412313|NCT00074282|469471781|FG000|Step 1|Disease progression|2|||
130412314|NCT00074282|469471782|FG001|Step 1|Disease progression|0|||
130412315|NCT00074282|469471783|FG002|Step 1|Disease progression|0|||
130412316|NCT00074282|469471781|FG000|Step 1|Alternative therapy|2|||
130412317|NCT00074282|469471782|FG001|Step 1|Alternative therapy|0|||
130412318|NCT00074282|469471783|FG002|Step 1|Alternative therapy|0|||
130412319|NCT00074282|469471781|FG000|Step 1|Other complicating disease|2|||
130412320|NCT00074282|469471782|FG001|Step 1|Other complicating disease|0|||
130412321|NCT00074282|469471783|FG002|Step 1|Other complicating disease|0|||
130412322|NCT00074282|469471781|FG000|Step 1|Physician Decision|1|||
130412323|NCT00074282|469471782|FG001|Step 1|Physician Decision|0|||
130412324|NCT00074282|469471783|FG002|Step 1|Physician Decision|0|||
130412325|NCT00074282|469471781|FG000|Step 1|Ineligible|4|||
130412326|NCT00074282|469471782|FG001|Step 1|Ineligible|0|||
130412327|NCT00074282|469471783|FG002|Step 1|Ineligible|0|||
130412328|NCT00074282|469471781|FG000|Step 1|Never started treatment|2|||
130412329|NCT00074282|469471782|FG001|Step 1|Never started treatment|0|||
130412330|NCT00074282|469471783|FG002|Step 1|Never started treatment|0|||
130412331|NCT00074282|469471781|FG000|Step 2|Adverse Event|0|||
130412332|NCT00074282|469471782|FG001|Step 2|Adverse Event|2|||
130412333|NCT00074282|469471783|FG002|Step 2|Adverse Event|12|||
130412334|NCT00074282|469471781|FG000|Step 2|Disease progression|0|||
130412335|NCT00074282|469471782|FG001|Step 2|Disease progression|0|||
130412336|NCT00074282|469471783|FG002|Step 2|Disease progression|5|||
130412337|NCT00074282|469471781|FG000|Step 2|Death|0|||
130412338|NCT00074282|469471782|FG001|Step 2|Death|0|||
130412339|NCT00074282|469471783|FG002|Step 2|Death|3|||
130412340|NCT00074282|469471781|FG000|Step 2|Withdrawal by Subject|0|||
130412341|NCT00074282|469471782|FG001|Step 2|Withdrawal by Subject|0|||
130412342|NCT00074282|469471783|FG002|Step 2|Withdrawal by Subject|2|||
130412343|NCT00074282|469471781|FG000|Step 2|Physician Decision|0|||
130412344|NCT00074282|469471782|FG001|Step 2|Physician Decision|0|||
130412345|NCT00074282|469471783|FG002|Step 2|Physician Decision|1|||
130412346|NCT00074282|469471781|FG000|Step 2|Ineligible|0|||
130412347|NCT00074282|469471782|FG001|Step 2|Ineligible|0|||
130412348|NCT00074282|469471783|FG002|Step 2|Ineligible|1|||
130412349|NCT00464542|469471784|FG000|Pre-treatment|Withdrawal by Subject|2|||
130412350|NCT01773226|469471786|FG000|Overall Study|Withdrawal by Subject|1|||
130412351|NCT02055352|469471791|FG000|Overall Study|Adverse Event|0|||
130412352|NCT02055352|469471792|FG001|Overall Study|Adverse Event|1|||
130412353|NCT02055352|469471791|FG000|Overall Study|Non-eligible|0|||
130412354|NCT02055352|469471792|FG001|Overall Study|Non-eligible|1|||
130412355|NCT02055352|469471791|FG000|Overall Study|Poor compliance|1|||
130412356|NCT02055352|469471792|FG001|Overall Study|Poor compliance|1|||
130412357|NCT02055352|469471791|FG000|Overall Study|Death|1|||
130412358|NCT02055352|469471792|FG001|Overall Study|Death|2|||
130412359|NCT02055352|469471791|FG000|Overall Study|Patient decision|1|||
130412360|NCT02055352|469471792|FG001|Overall Study|Patient decision|1|||
130412361|NCT02055352|469471791|FG000|Overall Study|Use of prohibited treatment|0|||
130412362|NCT02055352|469471792|FG001|Overall Study|Use of prohibited treatment|3|||
130412363|NCT02055352|469471791|FG000|Overall Study|AE, study drug would be detrimental|1|||
130412364|NCT02055352|469471792|FG001|Overall Study|AE, study drug would be detrimental|3|||
130412365|NCT02055352|469471791|FG000|Overall Study|Withdrawal of informed consent|1|||
130412366|NCT02055352|469471792|FG001|Overall Study|Withdrawal of informed consent|0|||
130412367|NCT02055352|469471791|FG000|Overall Study|Reason unknown|1|||
130412368|NCT02055352|469471792|FG001|Overall Study|Reason unknown|5|||
130412369|NCT00489970|469471799|FG000|Persistence Year 9|Lost to Follow-up|2|||
130412370|NCT00489970|469471800|FG001|Persistence Year 9|Lost to Follow-up|2|||
130412371|NCT00489970|469471801|FG002|Persistence Year 9|Lost to Follow-up|3|||
130412372|NCT00489970|469471799|FG000|Persistence Year 9|Other|1|||
130412373|NCT00489970|469471800|FG001|Persistence Year 9|Other|0|||
130412374|NCT00489970|469471801|FG002|Persistence Year 9|Other|2|||
130412375|NCT02707055|469471808|FG000|Phase 1|Withdrawal by Subject|1|||
130412376|NCT02707055|469471809|FG001|Phase 1|Withdrawal by Subject|2|||
130412377|NCT02707055|469471808|FG000|Phase 1|Physician Decision|0|||
130412378|NCT02707055|469471809|FG001|Phase 1|Physician Decision|1|||
130412379|NCT02707055|469471808|FG000|Phase 2|Adverse Event|1|||
130412380|NCT02707055|469471809|FG001|Phase 2|Adverse Event|2|||
130412381|NCT03564496|469471810|FG000|Overall Study|Withdrawal by Subject|1|||
130412382|NCT03564496|469471811|FG001|Overall Study|Withdrawal by Subject|1|||
130412383|NCT03564496|469471812|FG002|Overall Study|Withdrawal by Subject|0|||
130412384|NCT03564496|469471810|FG000|Overall Study|Screen failure|0|||
130412385|NCT03564496|469471811|FG001|Overall Study|Screen failure|3|||
130412386|NCT03564496|469471812|FG002|Overall Study|Screen failure|0|||
130412387|NCT01159938|469471813|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130412388|NCT01159938|469471814|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130412389|NCT01159938|469471815|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
130412390|NCT01159938|469471816|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130412391|NCT01159938|469471817|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130412392|NCT02318329|469471818|FG000|Overall Study|Progressive Disease|2|||
130412393|NCT02318329|469471819|FG001|Overall Study|Progressive Disease|3|||
130412394|NCT02318329|469471820|FG002|Overall Study|Progressive Disease|2|||
130412395|NCT02318329|469471821|FG003|Overall Study|Progressive Disease|3|||
130412396|NCT02318329|469471822|FG004|Overall Study|Progressive Disease|3|||
130412397|NCT02318329|469471823|FG005|Overall Study|Progressive Disease|3|||
130412398|NCT02318329|469471824|FG006|Overall Study|Progressive Disease|1|||
130412399|NCT02318329|469471825|FG007|Overall Study|Progressive Disease|1|||
130412400|NCT02318329|469471826|FG008|Overall Study|Progressive Disease|5|||
130412401|NCT02318329|469471827|FG009|Overall Study|Progressive Disease|39|||
130412402|NCT02318329|469471818|FG000|Overall Study|Death|0|||
130412403|NCT02318329|469471819|FG001|Overall Study|Death|0|||
130412404|NCT02318329|469471820|FG002|Overall Study|Death|0|||
130412405|NCT02318329|469471821|FG003|Overall Study|Death|0|||
130412406|NCT02318329|469471822|FG004|Overall Study|Death|0|||
130412407|NCT02318329|469471823|FG005|Overall Study|Death|0|||
130412408|NCT02318329|469471824|FG006|Overall Study|Death|0|||
130412409|NCT02318329|469471825|FG007|Overall Study|Death|0|||
130412410|NCT02318329|469471826|FG008|Overall Study|Death|0|||
130412411|NCT02318329|469471827|FG009|Overall Study|Death|5|||
130412412|NCT02318329|469471818|FG000|Overall Study|Lost to Follow-up|0|||
130412413|NCT02318329|469471819|FG001|Overall Study|Lost to Follow-up|0|||
130412414|NCT02318329|469471820|FG002|Overall Study|Lost to Follow-up|0|||
130412415|NCT02318329|469471821|FG003|Overall Study|Lost to Follow-up|0|||
130412416|NCT02318329|469471822|FG004|Overall Study|Lost to Follow-up|0|||
130412417|NCT02318329|469471823|FG005|Overall Study|Lost to Follow-up|0|||
130412418|NCT02318329|469471824|FG006|Overall Study|Lost to Follow-up|0|||
130412419|NCT02318329|469471825|FG007|Overall Study|Lost to Follow-up|0|||
130412420|NCT02318329|469471826|FG008|Overall Study|Lost to Follow-up|0|||
130412421|NCT02318329|469471827|FG009|Overall Study|Lost to Follow-up|1|||
130412422|NCT02318329|469471818|FG000|Overall Study|Withdrawal by Subject|0|||
130412423|NCT02318329|469471819|FG001|Overall Study|Withdrawal by Subject|0|||
130412424|NCT02318329|469471820|FG002|Overall Study|Withdrawal by Subject|0|||
130412425|NCT02318329|469471821|FG003|Overall Study|Withdrawal by Subject|0|||
130412426|NCT02318329|469471822|FG004|Overall Study|Withdrawal by Subject|0|||
130412427|NCT02318329|469471823|FG005|Overall Study|Withdrawal by Subject|0|||
130412428|NCT02318329|469471824|FG006|Overall Study|Withdrawal by Subject|0|||
130412429|NCT02318329|469471825|FG007|Overall Study|Withdrawal by Subject|0|||
130412430|NCT02318329|469471826|FG008|Overall Study|Withdrawal by Subject|0|||
130412431|NCT02318329|469471827|FG009|Overall Study|Withdrawal by Subject|6|||
130412432|NCT02318329|469471818|FG000|Overall Study|Other|1|||
130412433|NCT02318329|469471819|FG001|Overall Study|Other|1|||
130412434|NCT02318329|469471820|FG002|Overall Study|Other|1|||
130412435|NCT02318329|469471821|FG003|Overall Study|Other|0|||
130412436|NCT02318329|469471822|FG004|Overall Study|Other|0|||
130412437|NCT02318329|469471823|FG005|Overall Study|Other|0|||
130412438|NCT02318329|469471824|FG006|Overall Study|Other|0|||
130412439|NCT02318329|469471825|FG007|Overall Study|Other|0|||
130412440|NCT02318329|469471826|FG008|Overall Study|Other|1|||
130412441|NCT02318329|469471827|FG009|Overall Study|Other|1|||
130412442|NCT00086346|469471828|FG000|Randomization|Did not receive test article|4|||
130412443|NCT00086346|469471829|FG001|Randomization|Did not receive test article|4|||
130412444|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Adverse Event|94|||
130412445|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Adverse Event|11|||
130412446|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
130412447|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
130412448|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
130412449|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
130412450|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
130412451|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
130412452|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
130412453|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
130412454|NCT00086346|469471828|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
130412455|NCT00086346|469471829|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
130412456|NCT04495374|469471830|FG000|Overall Study|Protocol Violation|2|||
130412457|NCT04495374|469471831|FG001|Overall Study|Protocol Violation|1|||
130412458|NCT01303627|469471832|FG000|Overall Study|the failure while performing URS|0|||
130412459|NCT01303627|469471833|FG001|Overall Study|the failure while performing URS|1|||
130412460|NCT02416791|469471835|FG000|6 Months|Lost to Follow-up|0|||
130412461|NCT02416791|469471836|FG001|6 Months|Lost to Follow-up|0|||
130412462|NCT02416791|469471837|FG002|6 Months|Lost to Follow-up|1|||
130412463|NCT01054820|469471838|FG000|Overall Study|Withdrawal by Subject|2|||
130412464|NCT00996996|469471840|FG000|Overall Study|Progressive Disease|10|||
130412465|NCT00996996|469471840|FG000|Overall Study|Non-compliance|8|||
130412466|NCT00996996|469471840|FG000|Overall Study|Lost to Follow-up|9|||
130412467|NCT00996996|469471840|FG000|Overall Study|Death|5|||
130412468|NCT00996996|469471840|FG000|Overall Study|Did Not Receive Study Medications|1|||
130412469|NCT04535037|469471843|FG000|Overall Study|Protocol Violation|1|||
130412470|NCT04535037|469471844|FG001|Overall Study|Protocol Violation|0|||
130412471|NCT04535037|469471843|FG000|Overall Study|Withdrawal by Subject|8|||
130412472|NCT04535037|469471844|FG001|Overall Study|Withdrawal by Subject|9|||
130412473|NCT04535037|469471843|FG000|Overall Study|Migrated / moved from the study area|1|||
130412474|NCT04535037|469471844|FG001|Overall Study|Migrated / moved from the study area|4|||
130412475|NCT04535037|469471843|FG000|Overall Study|Other|2|||
130412476|NCT04535037|469471844|FG001|Overall Study|Other|5|||
130412477|NCT02031276|469471845|FG000|Period 1 Double-blind IV|Adverse Event|6|||
130412478|NCT02031276|469471846|FG001|Period 1 Double-blind IV|Adverse Event|5|||
130412479|NCT02031276|469471847|FG002|Period 1 Double-blind IV|Adverse Event|1|||
130412480|NCT02031276|469471845|FG000|Period 1 Double-blind IV|Other|0|||
130412481|NCT02031276|469471846|FG001|Period 1 Double-blind IV|Other|1|||
130412482|NCT02031276|469471847|FG002|Period 1 Double-blind IV|Other|0|||
130563548|NCT02138617|470030524|FG002|Overall Study|other therapy|0|||
130563549|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
130563550|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
130563551|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563552|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130412483|NCT02031276|469471845|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
130412484|NCT02031276|469471846|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
130412485|NCT02031276|469471847|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
130412486|NCT02031276|469471845|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
130563553|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130412487|NCT02031276|469471846|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
130412488|NCT02031276|469471847|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
130412489|NCT02031276|469471845|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
130412490|NCT02031276|469471846|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
130412491|NCT02031276|469471847|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
130412492|NCT02031276|469471845|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
130412493|NCT02031276|469471846|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
130412494|NCT02031276|469471847|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
130412495|NCT02031276|469471845|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
130474251|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130412496|NCT02031276|469471846|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
130412497|NCT02031276|469471847|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
130412498|NCT02031276|469471845|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130412499|NCT02031276|469471846|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130412500|NCT02031276|469471847|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130412501|NCT02031276|469471845|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
130412502|NCT02031276|469471846|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
130412503|NCT02031276|469471847|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
130412504|NCT01148810|469471848|FG000|Overall Study|Adverse Event|0|||
130412505|NCT01148810|469471849|FG001|Overall Study|Adverse Event|2|||
130412506|NCT01148810|469471848|FG000|Overall Study|Lack of Efficacy|0|||
130412507|NCT01148810|469471849|FG001|Overall Study|Lack of Efficacy|1|||
130412508|NCT01148810|469471848|FG000|Overall Study|Withdrawal by Subject|0|||
130412509|NCT01148810|469471849|FG001|Overall Study|Withdrawal by Subject|2|||
130412510|NCT01148810|469471848|FG000|Overall Study|Protocol Violation|1|||
130412511|NCT01148810|469471849|FG001|Overall Study|Protocol Violation|0|||
130412512|NCT02417246|469471856|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
130412513|NCT02417246|469471857|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
130412514|NCT02417246|469471856|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
130412515|NCT02417246|469471857|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
130412516|NCT02417246|469471856|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
130412517|NCT02417246|469471857|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
130412518|NCT02417246|469471856|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
130412519|NCT02417246|469471857|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
130412520|NCT04408469|469471858|FG000|Overall Study|Lost to Follow-up|6|||
130474252|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474253|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474254|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130474255|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474256|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474257|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474258|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474259|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474260|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474261|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474262|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130563554|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
130563555|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
130412521|NCT04408469|469471859|FG001|Overall Study|Lost to Follow-up|9|||
130412522|NCT04408469|469471858|FG000|Overall Study|Withdrawal by Subject|6|||
130412523|NCT04408469|469471859|FG001|Overall Study|Withdrawal by Subject|1|||
130412524|NCT04408469|469471858|FG000|Overall Study|Dismissal due to ineligibility|0|||
130412525|NCT04408469|469471859|FG001|Overall Study|Dismissal due to ineligibility|1|||
130412526|NCT04321460|469471860|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
130412527|NCT04321460|469471861|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
130412528|NCT01308749|469471864|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
130412529|NCT01308749|469471865|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
130412530|NCT01308749|469471864|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
130412531|NCT01308749|469471865|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
130412532|NCT01308749|469471864|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
130412533|NCT01308749|469471865|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
130412534|NCT04726709|469471866|FG000|Overall Study|Withdrawal by Subject|2|||
130412535|NCT04726709|469471867|FG001|Overall Study|Withdrawal by Subject|2|||
130412536|NCT02079805|469471868|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130412537|NCT02079805|469471869|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130412538|NCT02079805|469471868|FG000|Overall Study|Voluntary Withdrawal|0|||
130412539|NCT02079805|469471869|FG001|Overall Study|Voluntary Withdrawal|1|||
130412540|NCT01775137|469471875|FG000|Overall Study|Death|1|||
130412541|NCT01775137|469471875|FG000|Overall Study|Protocol deviation|2|||
130563556|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563557|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130412542|NCT01775137|469471875|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130412543|NCT01775137|469471875|FG000|Overall Study|Adverse Event|1|||
130412544|NCT01775137|469471875|FG000|Overall Study|Withdrawal by participants|5|||
130412545|NCT00096135|469471882|FG000|Overall Study|Physician Decision|20|||
130412546|NCT00096135|469471883|FG001|Overall Study|Physician Decision|4|||
130412547|NCT00096135|469471882|FG000|Overall Study|Refusal of further protocol therapy|4|||
130412548|NCT00096135|469471883|FG001|Overall Study|Refusal of further protocol therapy|1|||
130412549|NCT00096135|469471882|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
130412550|NCT00096135|469471883|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
130412551|NCT00096135|469471882|FG000|Overall Study|Other, specify|15|||
130412552|NCT00096135|469471883|FG001|Overall Study|Other, specify|3|||
130412553|NCT00096135|469471882|FG000|Overall Study|Ineligible|2|||
130412554|NCT00096135|469471883|FG001|Overall Study|Ineligible|0|||
130412555|NCT00874029|469471885|FG000|Overall Study|Withdrawal by Subject|10|||
130412556|NCT00874029|469471885|FG000|Overall Study|Pregnancy|4|||
130412557|NCT00874029|469471885|FG000|Overall Study|Physician Decision|1|||
130412558|NCT00874029|469471885|FG000|Overall Study|Adverse Event|1|||
130412559|NCT00874029|469471885|FG000|Overall Study|Lost to Follow-up|5|||
130412560|NCT00856583|469471886|FG000|Overall Study|Lack of Efficacy|389|||
130412561|NCT00856583|469471887|FG001|Overall Study|Lack of Efficacy|377|||
130412562|NCT00856583|469471886|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
130412563|NCT00856583|469471887|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
130412564|NCT00856583|469471886|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
130412565|NCT00856583|469471887|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
130412566|NCT00856583|469471886|FG000|Overall Study|Non-compliance|305|||
130412567|NCT00856583|469471887|FG001|Overall Study|Non-compliance|262|||
130412568|NCT00856583|469471886|FG000|Overall Study|Withdrawal by Subject|1092|||
130412569|NCT00856583|469471887|FG001|Overall Study|Withdrawal by Subject|919|||
130412570|NCT00856583|469471886|FG000|Overall Study|Physician Decision|59|||
130412571|NCT00856583|469471887|FG001|Overall Study|Physician Decision|82|||
130412572|NCT00856583|469471886|FG000|Overall Study|Pregnancy|14|||
130412573|NCT00856583|469471887|FG001|Overall Study|Pregnancy|5|||
130412574|NCT00856583|469471886|FG000|Overall Study|Other|92|||
130412575|NCT00856583|469471887|FG001|Overall Study|Other|104|||
130412576|NCT00856583|469471886|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
130412577|NCT00856583|469471887|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
130412578|NCT02328326|469471892|FG000|Overall Study|Withdrawal by Subject|10|||
130412579|NCT02328326|469471893|FG001|Overall Study|Withdrawal by Subject|3|||
130412580|NCT02328326|469471892|FG000|Overall Study|Death|2|||
130412581|NCT02328326|469471893|FG001|Overall Study|Death|1|||
130412582|NCT02328326|469471892|FG000|Overall Study|Lost to Follow-up|10|||
130412583|NCT02328326|469471893|FG001|Overall Study|Lost to Follow-up|4|||
130412584|NCT00784043|469471907|FG000|Overall Study|Withdrawal by Subject|8|||
130412585|NCT00784043|469471908|FG001|Overall Study|Withdrawal by Subject|5|||
130412586|NCT00784043|469471907|FG000|Overall Study|Protocol Terminated|23|||
130412587|NCT00784043|469471908|FG001|Overall Study|Protocol Terminated|1|||
130412588|NCT03965052|469471910|FG000|Overall Study|Protocol Violation|1|||
130412589|NCT03965052|469471911|FG001|Overall Study|Protocol Violation|0|||
130412590|NCT00499889|469471917|FG000|Overall Study|Infection prior to treatment|1|||
130412591|NCT00142909|469471921|FG000|Randomization|Various Reasons|7|||
130412592|NCT00142909|469471922|FG001|Randomization|Various Reasons|10|||
130412593|NCT00142909|469471921|FG000|Medications Begin|Protocol Violation|2|||
130412594|NCT00142909|469471922|FG001|Medications Begin|Protocol Violation|0|||
130412595|NCT00142909|469471921|FG000|Medications Begin|Withdrawal by Subject|5|||
130474263|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474264|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474265|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474266|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474267|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130412596|NCT00142909|469471922|FG001|Medications Begin|Withdrawal by Subject|3|||
130474268|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
130474269|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
130474270|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
130474271|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
130474272|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474273|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
130412597|NCT00142909|469471921|FG000|Medications Begin|Withdrawal by Subject|2|||
130412598|NCT00142909|469471922|FG001|Medications Begin|Withdrawal by Subject|0|||
130412599|NCT01898195|469471923|FG000|Smoking Abstinence|Did not have good measurements|35|||
130412600|NCT01898195|469471924|FG001|Smoking Abstinence|Did not have good measurements|38|||
130412601|NCT01898195|469471925|FG002|Smoking Abstinence|Did not have good measurements|36|||
130412602|NCT00136955|469474049|FG000|Overall Study|Adverse Event|8|||
130412603|NCT00136955|469474049|FG000|Overall Study|Lost to Follow-up|1|||
130412604|NCT00136955|469474049|FG000|Overall Study|Withdrawal by Subject|2|||
130412605|NCT00136955|469474049|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
130412606|NCT04450264|469474050|FG000|Overall Study|Incomplete survey|13|||
130474274|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
130727220|NCT02883049|470625436|FG012|Post Induction|Physician Decision|1|||
130412607|NCT04450264|469474051|FG001|Overall Study|Incomplete survey|19|||
130412608|NCT04401579|469474053|FG000|Overall Study|Death|23|||
130412609|NCT04401579|469474054|FG001|Overall Study|Death|36|||
130412610|NCT04401579|469474053|FG000|Overall Study|Lost to Follow-up|40|||
130412611|NCT04401579|469474054|FG001|Overall Study|Lost to Follow-up|41|||
130412612|NCT04401579|469474053|FG000|Overall Study|Withdrawal by Subject|8|||
130412613|NCT04401579|469474054|FG001|Overall Study|Withdrawal by Subject|16|||
130412614|NCT04401579|469474053|FG000|Overall Study|Physician Decision|1|||
130412615|NCT04401579|469474054|FG001|Overall Study|Physician Decision|2|||
130412616|NCT04401579|469474053|FG000|Overall Study|Became ineligible after enrollment|1|||
130412617|NCT04401579|469474054|FG001|Overall Study|Became ineligible after enrollment|1|||
130412618|NCT04401579|469474053|FG000|Overall Study|Enrolled but treatment not administered|7|||
130412619|NCT04401579|469474054|FG001|Overall Study|Enrolled but treatment not administered|9|||
130412620|NCT04401579|469474053|FG000|Overall Study|Adverse Event|2|||
130412621|NCT04401579|469474054|FG001|Overall Study|Adverse Event|1|||
130412622|NCT04401579|469474053|FG000|Overall Study|Scheduling error|1|||
130412623|NCT04401579|469474054|FG001|Overall Study|Scheduling error|2|||
130412624|NCT04401579|469474053|FG000|Overall Study|Transferred to another hospital|1|||
130412625|NCT04401579|469474054|FG001|Overall Study|Transferred to another hospital|2|||
130412626|NCT03521635|469474055|FG000|Overall Study|Adverse Event|1|||
130412627|NCT03521635|469474056|FG001|Overall Study|Adverse Event|1|||
130412628|NCT03521635|469474055|FG000|Overall Study|Refused to complete study visit|1|||
130412629|NCT03521635|469474056|FG001|Overall Study|Refused to complete study visit|0|||
130412630|NCT03521635|469474055|FG000|Overall Study|Refused to continue trial medication|2|||
130412631|NCT03521635|469474056|FG001|Overall Study|Refused to continue trial medication|2|||
130412632|NCT03521635|469474055|FG000|Overall Study|Lost to Follow-up|0|||
130412633|NCT03521635|469474056|FG001|Overall Study|Lost to Follow-up|1|||
130412634|NCT03521635|469474055|FG000|Overall Study|Meet exclusion criteria|0|||
130412635|NCT03521635|469474056|FG001|Overall Study|Meet exclusion criteria|1|||
130412636|NCT03521635|469474055|FG000|Overall Study|Patient not taken study medicine|0|||
130412637|NCT03521635|469474056|FG001|Overall Study|Patient not taken study medicine|1|||
130412638|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Adverse Event|5|||
130412639|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Adverse Event|8|||
130412640|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Adverse Event|4|||
130412641|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Adverse Event|8|||
130412642|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
130412643|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
130412644|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
130412645|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
130412646|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130412647|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
130412648|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130412649|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130412650|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Physician Decision|1|||
130412651|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Physician Decision|0|||
130412652|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Physician Decision|0|||
130412653|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Physician Decision|0|||
130412654|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
130412655|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
130412656|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
130412657|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
130412658|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Pregnancy|0|||
130412659|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Pregnancy|1|||
130412660|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Pregnancy|0|||
130412661|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Pregnancy|0|||
130412662|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
130412663|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
130412664|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
130412665|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
130412666|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Death|0|||
130412667|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Death|1|||
130412668|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Death|0|||
130412669|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Death|0|||
130412670|NCT00071487|469474060|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
130412671|NCT00071487|469474061|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
130412672|NCT00071487|469474062|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
130412673|NCT00071487|469474063|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
130412674|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
130412675|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
130412676|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
130412677|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
130412678|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130412679|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130412680|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130412681|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
130474275|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130412682|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130412683|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130412684|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130412685|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
130412686|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
130412687|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
130412688|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
130412689|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
130412690|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130412691|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130474276|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474277|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474278|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474279|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474280|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474281|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130474282|NCT02783300|469704767|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474283|NCT02783300|469704768|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474284|NCT02783300|469704769|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474285|NCT02783300|469704770|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130412692|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130412693|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
130412694|NCT00071487|469474060|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130412695|NCT00071487|469474061|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130412696|NCT00071487|469474062|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130412697|NCT00071487|469474063|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
130412698|NCT01227889|469474064|FG000|Randomized Phase (RP)|Adverse Event|13|||
130412699|NCT01227889|469474065|FG001|Randomized Phase (RP)|Adverse Event|0|||
130412700|NCT01227889|469474064|FG000|Randomized Phase (RP)|Physician Decision|13|||
130412701|NCT01227889|469474065|FG001|Randomized Phase (RP)|Physician Decision|5|||
130412702|NCT01227889|469474064|FG000|Randomized Phase (RP)|Progressive Disease|135|||
130412703|NCT01227889|469474065|FG001|Randomized Phase (RP)|Progressive Disease|52|||
130412704|NCT01227889|469474064|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
130412705|NCT01227889|469474065|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
130412706|NCT01227889|469474064|FG000|Randomized Phase (RP)|Missing|1|||
130412707|NCT01227889|469474065|FG001|Randomized Phase (RP)|Missing|3|||
130412708|NCT01227889|469474064|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
130412709|NCT01227889|469474065|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
130412710|NCT01227889|469474064|FG000|Crossover Phase|Adverse Event|0|||
130412711|NCT01227889|469474065|FG001|Crossover Phase|Adverse Event|1|||
130412712|NCT01227889|469474064|FG000|Crossover Phase|Physician Decision|0|||
130412713|NCT01227889|469474065|FG001|Crossover Phase|Physician Decision|3|||
130412714|NCT01227889|469474064|FG000|Crossover Phase|Progressive Disease|0|||
130412715|NCT01227889|469474065|FG001|Crossover Phase|Progressive Disease|31|||
130412716|NCT01227889|469474064|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
130412717|NCT01227889|469474065|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
130412718|NCT01227889|469474064|FG000|Crossover Phase|Withdrawal by Subject|0|||
130412719|NCT01227889|469474065|FG001|Crossover Phase|Withdrawal by Subject|1|||
130412720|NCT03268811|469474066|FG000|Overall Study|Adverse Event|0|||
130412721|NCT03268811|469474067|FG001|Overall Study|Adverse Event|1|||
130412722|NCT04827212|469474072|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
130412723|NCT04827212|469474073|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
130412724|NCT04827212|469474072|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
130412725|NCT04827212|469474073|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
130412726|NCT03434119|469474080|FG000|Overall Study|Randomized but not treated|1|||
130412727|NCT03434119|469474081|FG001|Overall Study|Randomized but not treated|0|||
130412728|NCT03434119|469474080|FG000|Overall Study|Adverse Event|1|||
130412729|NCT03434119|469474081|FG001|Overall Study|Adverse Event|0|||
130412730|NCT03434119|469474080|FG000|Overall Study|Poor Compliance to Protocol|0|||
130412731|NCT03434119|469474081|FG001|Overall Study|Poor Compliance to Protocol|1|||
130412732|NCT03434119|469474080|FG000|Overall Study|Study Terminated by Sponsor|91|||
130474286|NCT02783300|469704771|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474287|NCT02783300|469704772|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474288|NCT02783300|469704773|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474289|NCT02783300|469704774|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130412733|NCT03434119|469474081|FG001|Overall Study|Study Terminated by Sponsor|102|||
130412734|NCT03434119|469474080|FG000|Overall Study|Withdrawal by Subject|7|||
130412735|NCT03434119|469474081|FG001|Overall Study|Withdrawal by Subject|5|||
130412736|NCT03434119|469474080|FG000|Overall Study|Other than specified|7|||
130412737|NCT03434119|469474081|FG001|Overall Study|Other than specified|5|||
130412738|NCT00148343|469474083|FG000|Overall Study|Withdrawal by Subject|12|||
130412739|NCT00148343|469474084|FG001|Overall Study|Withdrawal by Subject|7|||
130412740|NCT00148343|469474083|FG000|Overall Study|Physician Decision|3|||
130412741|NCT00148343|469474084|FG001|Overall Study|Physician Decision|4|||
130412742|NCT03579459|469474085|FG000|Overall Study|Adverse Event|7|||
130412743|NCT03579459|469474086|FG001|Overall Study|Adverse Event|6|||
130412744|NCT03579459|469474087|FG002|Overall Study|Adverse Event|2|||
130412745|NCT03579459|469474088|FG003|Overall Study|Adverse Event|6|||
130412746|NCT03579459|469474085|FG000|Overall Study|Death|1|||
130412747|NCT03579459|469474086|FG001|Overall Study|Death|0|||
130412748|NCT03579459|469474087|FG002|Overall Study|Death|1|||
130412749|NCT03579459|469474088|FG003|Overall Study|Death|2|||
130412750|NCT03579459|469474085|FG000|Overall Study|Lost to Follow-up|6|||
130412751|NCT03579459|469474086|FG001|Overall Study|Lost to Follow-up|2|||
130412752|NCT03579459|469474087|FG002|Overall Study|Lost to Follow-up|4|||
130412753|NCT03579459|469474088|FG003|Overall Study|Lost to Follow-up|1|||
130412754|NCT03579459|469474085|FG000|Overall Study|Physician Decision|0|||
130412755|NCT03579459|469474086|FG001|Overall Study|Physician Decision|1|||
130412756|NCT03579459|469474087|FG002|Overall Study|Physician Decision|0|||
130412757|NCT03579459|469474088|FG003|Overall Study|Physician Decision|1|||
130412758|NCT03579459|469474085|FG000|Overall Study|Protocol Violation|1|||
130412759|NCT03579459|469474086|FG001|Overall Study|Protocol Violation|2|||
130412760|NCT03579459|469474087|FG002|Overall Study|Protocol Violation|3|||
130412761|NCT03579459|469474088|FG003|Overall Study|Protocol Violation|5|||
130412762|NCT03579459|469474085|FG000|Overall Study|Withdrawal by Subject|12|||
130412763|NCT03579459|469474086|FG001|Overall Study|Withdrawal by Subject|8|||
130412764|NCT03579459|469474087|FG002|Overall Study|Withdrawal by Subject|11|||
130412765|NCT03579459|469474088|FG003|Overall Study|Withdrawal by Subject|8|||
130412766|NCT03579459|469474085|FG000|Overall Study|Medication error without associated adverse event|2|||
130412767|NCT03579459|469474086|FG001|Overall Study|Medication error without associated adverse event|1|||
130412768|NCT03579459|469474087|FG002|Overall Study|Medication error without associated adverse event|1|||
130563558|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563559|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563560|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130412769|NCT03579459|469474088|FG003|Overall Study|Medication error without associated adverse event|0|||
130412770|NCT03579459|469474085|FG000|Overall Study|Other|0|||
130412771|NCT03579459|469474086|FG001|Overall Study|Other|1|||
130412772|NCT03579459|469474087|FG002|Overall Study|Other|1|||
130412773|NCT03579459|469474088|FG003|Overall Study|Other|0|||
130412774|NCT03579459|469474085|FG000|Overall Study|Randomized not vaccinated|0|||
130412775|NCT03579459|469474086|FG001|Overall Study|Randomized not vaccinated|2|||
130412776|NCT03579459|469474087|FG002|Overall Study|Randomized not vaccinated|0|||
130412777|NCT03579459|469474088|FG003|Overall Study|Randomized not vaccinated|1|||
130412778|NCT02528214|469474099|FG000|Overall Study|Protocol Violation|0|||
130412779|NCT02528214|469474100|FG001|Overall Study|Protocol Violation|1|||
130412780|NCT02528214|469474099|FG000|Overall Study|Adverse Event|0|||
130412781|NCT02528214|469474100|FG001|Overall Study|Adverse Event|1|||
130412782|NCT02528214|469474099|FG000|Overall Study|Other than specified above|0|||
130412783|NCT02528214|469474100|FG001|Overall Study|Other than specified above|1|||
130412784|NCT00941603|469474104|FG000|Overall Study|Adverse Event|10|||
130412785|NCT00941603|469474105|FG001|Overall Study|Adverse Event|15|||
130412786|NCT00941603|469474106|FG002|Overall Study|Adverse Event|5|||
130563561|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563562|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130563563|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563564|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130727221|NCT02883049|470625437|FG013|Post Induction|Physician Decision|11|||
130412787|NCT00941603|469474107|FG003|Overall Study|Adverse Event|1|||
130412788|NCT00941603|469474108|FG004|Overall Study|Adverse Event|4|||
130412789|NCT00941603|469474109|FG005|Overall Study|Adverse Event|0|||
130412790|NCT00941603|469474104|FG000|Overall Study|Lost to Follow-up|0|||
130412791|NCT00941603|469474105|FG001|Overall Study|Lost to Follow-up|0|||
130412792|NCT00941603|469474106|FG002|Overall Study|Lost to Follow-up|0|||
130412793|NCT00941603|469474107|FG003|Overall Study|Lost to Follow-up|1|||
130412794|NCT00941603|469474108|FG004|Overall Study|Lost to Follow-up|0|||
130412795|NCT00941603|469474109|FG005|Overall Study|Lost to Follow-up|2|||
130412796|NCT00941603|469474104|FG000|Overall Study|Withdrawal by Subject|0|||
130412797|NCT00941603|469474105|FG001|Overall Study|Withdrawal by Subject|0|||
130412798|NCT00941603|469474106|FG002|Overall Study|Withdrawal by Subject|0|||
130412799|NCT00941603|469474107|FG003|Overall Study|Withdrawal by Subject|2|||
130412800|NCT00941603|469474108|FG004|Overall Study|Withdrawal by Subject|0|||
130412801|NCT00941603|469474109|FG005|Overall Study|Withdrawal by Subject|1|||
130412802|NCT00941603|469474104|FG000|Overall Study|Protocol Violation|0|||
130412803|NCT00941603|469474105|FG001|Overall Study|Protocol Violation|1|||
130412804|NCT00941603|469474106|FG002|Overall Study|Protocol Violation|0|||
130412805|NCT00941603|469474107|FG003|Overall Study|Protocol Violation|0|||
130412806|NCT00941603|469474108|FG004|Overall Study|Protocol Violation|0|||
130412807|NCT00941603|469474109|FG005|Overall Study|Protocol Violation|0|||
130412808|NCT00941603|469474104|FG000|Overall Study|Did not meet protocol eligibility|1|||
130412809|NCT00941603|469474105|FG001|Overall Study|Did not meet protocol eligibility|0|||
130412810|NCT00941603|469474106|FG002|Overall Study|Did not meet protocol eligibility|0|||
130412811|NCT00941603|469474107|FG003|Overall Study|Did not meet protocol eligibility|0|||
130412812|NCT00941603|469474108|FG004|Overall Study|Did not meet protocol eligibility|0|||
130412813|NCT00941603|469474109|FG005|Overall Study|Did not meet protocol eligibility|0|||
130412814|NCT00407537|469474110|FG000|Overall Study|Death|5|||
130412815|NCT00407537|469474111|FG001|Overall Study|Death|2|||
130412816|NCT00407537|469474110|FG000|Overall Study|Adverse Event|36|||
130412817|NCT00407537|469474111|FG001|Overall Study|Adverse Event|0|||
130412818|NCT00407537|469474110|FG000|Overall Study|Lost to Follow-up|12|||
130412819|NCT00407537|469474111|FG001|Overall Study|Lost to Follow-up|19|||
130412820|NCT00407537|469474110|FG000|Overall Study|Other|6|||
130412821|NCT00407537|469474111|FG001|Overall Study|Other|7|||
130412822|NCT00407537|469474110|FG000|Overall Study|Withdrawal by Subject|34|||
130412823|NCT00407537|469474111|FG001|Overall Study|Withdrawal by Subject|16|||
130412824|NCT02014116|469474113|FG000|Overall Study|Progressive Disease|3|||
130412825|NCT02014116|469474114|FG001|Overall Study|Progressive Disease|4|||
130412826|NCT02014116|469474115|FG002|Overall Study|Progressive Disease|2|||
130412827|NCT02014116|469474116|FG003|Overall Study|Progressive Disease|6|||
130412828|NCT02014116|469474117|FG004|Overall Study|Progressive Disease|1|||
130412829|NCT02014116|469474118|FG005|Overall Study|Progressive Disease|13|||
130412830|NCT02014116|469474119|FG006|Overall Study|Progressive Disease|1|||
130412831|NCT02014116|469474120|FG007|Overall Study|Progressive Disease|3|||
130412832|NCT02014116|469474121|FG008|Overall Study|Progressive Disease|7|||
130412833|NCT02014116|469474113|FG000|Overall Study|Adverse Event|0|||
130412834|NCT02014116|469474114|FG001|Overall Study|Adverse Event|0|||
130412835|NCT02014116|469474115|FG002|Overall Study|Adverse Event|0|||
130412836|NCT02014116|469474116|FG003|Overall Study|Adverse Event|0|||
130412837|NCT02014116|469474117|FG004|Overall Study|Adverse Event|1|||
130412838|NCT02014116|469474118|FG005|Overall Study|Adverse Event|0|||
130412839|NCT02014116|469474119|FG006|Overall Study|Adverse Event|0|||
130412840|NCT02014116|469474120|FG007|Overall Study|Adverse Event|1|||
130412841|NCT02014116|469474121|FG008|Overall Study|Adverse Event|0|||
130412842|NCT02014116|469474113|FG000|Overall Study|Lost to Follow-up|0|||
130412843|NCT02014116|469474114|FG001|Overall Study|Lost to Follow-up|0|||
130412844|NCT02014116|469474115|FG002|Overall Study|Lost to Follow-up|0|||
130412845|NCT02014116|469474116|FG003|Overall Study|Lost to Follow-up|0|||
130412846|NCT02014116|469474117|FG004|Overall Study|Lost to Follow-up|0|||
130412847|NCT02014116|469474118|FG005|Overall Study|Lost to Follow-up|1|||
130412848|NCT02014116|469474119|FG006|Overall Study|Lost to Follow-up|0|||
130412849|NCT02014116|469474120|FG007|Overall Study|Lost to Follow-up|0|||
130412850|NCT02014116|469474121|FG008|Overall Study|Lost to Follow-up|1|||
130412851|NCT02014116|469474113|FG000|Overall Study|Death|0|||
130412852|NCT02014116|469474114|FG001|Overall Study|Death|0|||
130412853|NCT02014116|469474115|FG002|Overall Study|Death|0|||
130412854|NCT02014116|469474116|FG003|Overall Study|Death|0|||
130412855|NCT02014116|469474117|FG004|Overall Study|Death|0|||
130412856|NCT02014116|469474118|FG005|Overall Study|Death|0|||
130412857|NCT02014116|469474119|FG006|Overall Study|Death|0|||
130412858|NCT02014116|469474120|FG007|Overall Study|Death|1|||
130412859|NCT02014116|469474121|FG008|Overall Study|Death|1|||
130412860|NCT02014116|469474113|FG000|Overall Study|Withdrawal by Subject|0|||
130412861|NCT02014116|469474114|FG001|Overall Study|Withdrawal by Subject|0|||
130412862|NCT02014116|469474115|FG002|Overall Study|Withdrawal by Subject|1|||
130412863|NCT02014116|469474116|FG003|Overall Study|Withdrawal by Subject|1|||
130474290|NCT02783300|469704775|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474291|NCT02783300|469704776|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474292|NCT02783300|469704777|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474293|NCT02783300|469704778|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474294|NCT02783300|469704779|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474295|NCT02783300|469704780|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
130474296|NCT02783300|469704781|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
130474297|NCT02783300|469704782|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
130474298|NCT02783300|469704783|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
130727222|NCT02883049|470625438|FG014|Post Induction|Physician Decision|19|||
130412864|NCT02014116|469474117|FG004|Overall Study|Withdrawal by Subject|0|||
130412865|NCT02014116|469474118|FG005|Overall Study|Withdrawal by Subject|1|||
130412866|NCT02014116|469474119|FG006|Overall Study|Withdrawal by Subject|0|||
130412867|NCT02014116|469474120|FG007|Overall Study|Withdrawal by Subject|0|||
130412868|NCT02014116|469474121|FG008|Overall Study|Withdrawal by Subject|0|||
130412869|NCT02014116|469474113|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
130412870|NCT02014116|469474114|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
130412871|NCT02014116|469474115|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
130412872|NCT02014116|469474116|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
130412873|NCT02014116|469474117|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
130412874|NCT02014116|469474118|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
130412875|NCT02014116|469474119|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
130412876|NCT02014116|469474120|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
130412877|NCT02014116|469474121|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
130412878|NCT02014116|469474113|FG000|Overall Study|Physician Decision|0|||
130412879|NCT02014116|469474114|FG001|Overall Study|Physician Decision|0|||
130412880|NCT02014116|469474115|FG002|Overall Study|Physician Decision|0|||
130412881|NCT02014116|469474116|FG003|Overall Study|Physician Decision|0|||
130412882|NCT02014116|469474117|FG004|Overall Study|Physician Decision|0|||
130412883|NCT02014116|469474118|FG005|Overall Study|Physician Decision|0|||
130412884|NCT02014116|469474119|FG006|Overall Study|Physician Decision|0|||
130412885|NCT02014116|469474120|FG007|Overall Study|Physician Decision|0|||
130412886|NCT02014116|469474121|FG008|Overall Study|Physician Decision|1|||
130412887|NCT00583557|469474122|FG000|Overall Study|Withdrawal by Subject|18|||
130412888|NCT00583557|469474122|FG000|Overall Study|Adverse Event|9|||
130412889|NCT00583557|469474122|FG000|Overall Study|Lack of Efficacy|31|||
130412890|NCT00583557|469474122|FG000|Overall Study|Lack of Compliance|5|||
130412891|NCT00583557|469474122|FG000|Overall Study|Other|5|||
130412892|NCT00583557|469474122|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
130412893|NCT02347761|469474123|FG000|All Collected|Death|1|||
130412894|NCT02347761|469474124|FG001|All Collected|Death|0|||
130412895|NCT02347761|469474125|FG002|All Collected|Death|0|||
130412896|NCT02347761|469474123|FG000|All Collected|Lost to Follow-up|3|||
130412897|NCT02347761|469474124|FG001|All Collected|Lost to Follow-up|2|||
130412898|NCT02347761|469474125|FG002|All Collected|Lost to Follow-up|3|||
130412899|NCT02347761|469474123|FG000|All Collected|Withdrawal by Subject|11|||
130412900|NCT02347761|469474124|FG001|All Collected|Withdrawal by Subject|11|||
130412901|NCT02347761|469474125|FG002|All Collected|Withdrawal by Subject|22|||
130412902|NCT02347761|469474123|FG000|All Collected|invetigator disretion|2|||
130412903|NCT02347761|469474124|FG001|All Collected|invetigator disretion|0|||
130412904|NCT02347761|469474125|FG002|All Collected|invetigator disretion|0|||
130412905|NCT02347761|469474123|FG000|All Collected|instillation site pain|0|||
130412906|NCT02347761|469474124|FG001|All Collected|instillation site pain|0|||
130412907|NCT02347761|469474125|FG002|All Collected|instillation site pain|1|||
130412908|NCT02347761|469474123|FG000|All Collected|exacerbation of COPD|0|||
130412909|NCT02347761|469474124|FG001|All Collected|exacerbation of COPD|0|||
130412910|NCT02347761|469474125|FG002|All Collected|exacerbation of COPD|1|||
130412911|NCT02347761|469474123|FG000|All Collected|moved/travel|0|||
130412912|NCT02347761|469474124|FG001|All Collected|moved/travel|1|||
130412913|NCT02347761|469474125|FG002|All Collected|moved/travel|0|||
130412914|NCT02347761|469474123|FG000|On Study Treatment|Lack of Efficacy|2|||
130412915|NCT02347761|469474124|FG001|On Study Treatment|Lack of Efficacy|3|||
130412916|NCT02347761|469474125|FG002|On Study Treatment|Lack of Efficacy|4|||
130412917|NCT02347761|469474123|FG000|On Study Treatment|non-compliance with study medication|0|||
130412918|NCT02347761|469474124|FG001|On Study Treatment|non-compliance with study medication|0|||
130412919|NCT02347761|469474125|FG002|On Study Treatment|non-compliance with study medication|2|||
130412920|NCT02347761|469474123|FG000|On Study Treatment|Withdrawal by Subject|7|||
130412921|NCT02347761|469474124|FG001|On Study Treatment|Withdrawal by Subject|3|||
130412922|NCT02347761|469474125|FG002|On Study Treatment|Withdrawal by Subject|5|||
130412923|NCT02347761|469474123|FG000|On Study Treatment|move/travel|2|||
130412924|NCT02347761|469474124|FG001|On Study Treatment|move/travel|6|||
130412925|NCT02347761|469474125|FG002|On Study Treatment|move/travel|5|||
130412926|NCT02347761|469474123|FG000|On Study Treatment|dissastisfaction with device|2|||
130412927|NCT02347761|469474124|FG001|On Study Treatment|dissastisfaction with device|1|||
130412928|NCT02347761|469474125|FG002|On Study Treatment|dissastisfaction with device|4|||
130474299|NCT02783300|469704784|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130474300|NCT02783300|469704785|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
130474301|NCT02783300|469704786|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
130474302|NCT02783300|469704787|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130474303|NCT02783300|469704788|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130474304|NCT02783300|469704789|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
130474305|NCT02783300|469704790|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130412929|NCT02347761|469474123|FG000|On Study Treatment|Lost to Follow-up|2|||
130412930|NCT02347761|469474124|FG001|On Study Treatment|Lost to Follow-up|1|||
130412931|NCT02347761|469474125|FG002|On Study Treatment|Lost to Follow-up|1|||
130412932|NCT02347761|469474123|FG000|On Study Treatment|investigator discretion|2|||
130412933|NCT02347761|469474124|FG001|On Study Treatment|investigator discretion|0|||
130412934|NCT02347761|469474125|FG002|On Study Treatment|investigator discretion|0|||
130412935|NCT02347761|469474123|FG000|On Study Treatment|durg not working|0|||
130412936|NCT02347761|469474124|FG001|On Study Treatment|durg not working|1|||
130412937|NCT02347761|469474125|FG002|On Study Treatment|durg not working|1|||
130412938|NCT02347761|469474123|FG000|On Study Treatment|Adverse Event|10|||
130412939|NCT02347761|469474124|FG001|On Study Treatment|Adverse Event|8|||
130412940|NCT02347761|469474125|FG002|On Study Treatment|Adverse Event|20|||
130412941|NCT03879798|469474126|FG000|Overall Study|Adverse Event|0|||
130412942|NCT03879798|469474127|FG001|Overall Study|Adverse Event|0|||
130412943|NCT03879798|469474128|FG002|Overall Study|Adverse Event|0|||
130412944|NCT03879798|469474129|FG003|Overall Study|Adverse Event|0|||
130412945|NCT03879798|469474130|FG004|Overall Study|Adverse Event|0|||
130412946|NCT03879798|469474131|FG005|Overall Study|Adverse Event|1|||
130412947|NCT03879798|469474126|FG000|Overall Study|Lack of Efficacy|0|||
130412948|NCT03879798|469474127|FG001|Overall Study|Lack of Efficacy|0|||
130412949|NCT03879798|469474128|FG002|Overall Study|Lack of Efficacy|0|||
130412950|NCT03879798|469474129|FG003|Overall Study|Lack of Efficacy|0|||
130412951|NCT03879798|469474130|FG004|Overall Study|Lack of Efficacy|0|||
130412952|NCT03879798|469474131|FG005|Overall Study|Lack of Efficacy|1|||
130412953|NCT03879798|469474126|FG000|Overall Study|Withdrawal by Subject|0|||
130412954|NCT03879798|469474127|FG001|Overall Study|Withdrawal by Subject|0|||
130412955|NCT03879798|469474128|FG002|Overall Study|Withdrawal by Subject|0|||
130412956|NCT03879798|469474129|FG003|Overall Study|Withdrawal by Subject|0|||
130412957|NCT03879798|469474130|FG004|Overall Study|Withdrawal by Subject|0|||
130412958|NCT03879798|469474131|FG005|Overall Study|Withdrawal by Subject|1|||
130412959|NCT03625570|469474132|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
130412960|NCT03625570|469474133|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
130412961|NCT03625570|469474132|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
130412962|NCT03625570|469474133|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
130412963|NCT03625570|469474132|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
130412964|NCT03625570|469474133|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
130412965|NCT01040130|469474139|FG000|Overall Study|Adverse Event|1|||
130412966|NCT01040130|469474140|FG001|Overall Study|Adverse Event|1|||
130412967|NCT01040130|469474141|FG002|Overall Study|Adverse Event|0|||
130412968|NCT01040130|469474142|FG003|Overall Study|Adverse Event|5|||
130412969|NCT01040130|469474143|FG004|Overall Study|Adverse Event|0|||
130412970|NCT01040130|469474144|FG005|Overall Study|Adverse Event|3|||
130412971|NCT01040130|469474139|FG000|Overall Study|Protocol Violation|0|||
130412972|NCT01040130|469474140|FG001|Overall Study|Protocol Violation|0|||
130412973|NCT01040130|469474141|FG002|Overall Study|Protocol Violation|2|||
130412974|NCT01040130|469474142|FG003|Overall Study|Protocol Violation|0|||
130412975|NCT01040130|469474143|FG004|Overall Study|Protocol Violation|0|||
130412976|NCT01040130|469474144|FG005|Overall Study|Protocol Violation|0|||
130412977|NCT01040130|469474139|FG000|Overall Study|Withdrawal by Subject|0|||
130412978|NCT01040130|469474140|FG001|Overall Study|Withdrawal by Subject|2|||
130412979|NCT01040130|469474141|FG002|Overall Study|Withdrawal by Subject|0|||
130412980|NCT01040130|469474142|FG003|Overall Study|Withdrawal by Subject|0|||
130412981|NCT01040130|469474143|FG004|Overall Study|Withdrawal by Subject|0|||
130412982|NCT01040130|469474144|FG005|Overall Study|Withdrawal by Subject|1|||
130412983|NCT01040130|469474139|FG000|Overall Study|Other reasons not listed above|2|||
130412984|NCT01040130|469474140|FG001|Overall Study|Other reasons not listed above|0|||
130412985|NCT01040130|469474141|FG002|Overall Study|Other reasons not listed above|0|||
130412986|NCT01040130|469474142|FG003|Overall Study|Other reasons not listed above|0|||
130412987|NCT01040130|469474143|FG004|Overall Study|Other reasons not listed above|0|||
130412988|NCT01040130|469474144|FG005|Overall Study|Other reasons not listed above|0|||
130474306|NCT02783300|469704791|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
130474307|NCT02783300|469704792|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
130474308|NCT02783300|469704793|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130474309|NCT02783300|469704767|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474310|NCT02783300|469704768|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474311|NCT02783300|469704769|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474312|NCT02783300|469704770|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474313|NCT02783300|469704771|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474314|NCT02783300|469704772|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474315|NCT02783300|469704773|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474316|NCT02783300|469704774|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474317|NCT02783300|469704775|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474318|NCT02783300|469704776|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474319|NCT02783300|469704777|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474320|NCT02783300|469704778|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130727223|NCT02883049|470625439|FG015|Post Induction|Physician Decision|5|||
130727224|NCT02883049|470625424|FG000|Post Induction|Protocol Violation|0|||
130412989|NCT01310036|469474147|FG000|Overall Study|Administrative/other|10|||
130412990|NCT01310036|469474147|FG000|Overall Study|Withdrew Consent|11|||
130412991|NCT01310036|469474147|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
130412992|NCT01310036|469474147|FG000|Overall Study|Progression of Disease|164|||
130412993|NCT01310036|469474147|FG000|Overall Study|Death|1|||
130412994|NCT01310036|469474147|FG000|Overall Study|Adverse event or intercurrent illness|12|||
130412995|NCT00553267|469474148|FG000|Overall Study|Adverse Event|8|||
130412996|NCT00553267|469474149|FG001|Overall Study|Adverse Event|10|||
130412997|NCT00553267|469474150|FG002|Overall Study|Adverse Event|5|||
130412998|NCT00553267|469474148|FG000|Overall Study|Non compliant with protocol|3|||
130412999|NCT00553267|469474149|FG001|Overall Study|Non compliant with protocol|3|||
130413000|NCT00553267|469474150|FG002|Overall Study|Non compliant with protocol|2|||
130413001|NCT00553267|469474148|FG000|Overall Study|Lost to Follow-up|0|||
130413002|NCT00553267|469474149|FG001|Overall Study|Lost to Follow-up|0|||
130413003|NCT00553267|469474150|FG002|Overall Study|Lost to Follow-up|1|||
130413004|NCT00553267|469474148|FG000|Overall Study|Consent withdrawn|2|||
130413005|NCT00553267|469474149|FG001|Overall Study|Consent withdrawn|3|||
130413006|NCT00553267|469474150|FG002|Overall Study|Consent withdrawn|1|||
130413007|NCT00553267|469474148|FG000|Overall Study|Specified category|1|||
130413008|NCT00553267|469474149|FG001|Overall Study|Specified category|2|||
130413009|NCT00553267|469474150|FG002|Overall Study|Specified category|1|||
130413010|NCT01175668|469474151|FG000|Overall Study|Withdrawal by Subject|2|||
130413011|NCT01175668|469474152|FG001|Overall Study|Withdrawal by Subject|0|||
130413012|NCT02937545|469474154|FG000|Overall Study|Withdrawal by Subject|1|||
130413013|NCT02937545|469474155|FG001|Overall Study|Withdrawal by Subject|2|||
130413014|NCT02937545|469474156|FG002|Overall Study|Withdrawal by Subject|6|||
130413015|NCT02937545|469474157|FG003|Overall Study|Withdrawal by Subject|7|||
130413016|NCT02937545|469474154|FG000|Overall Study|Lost to Follow-up|1|||
130413017|NCT02937545|469474155|FG001|Overall Study|Lost to Follow-up|0|||
130413018|NCT02937545|469474156|FG002|Overall Study|Lost to Follow-up|0|||
130413019|NCT02937545|469474157|FG003|Overall Study|Lost to Follow-up|0|||
130413020|NCT01985126|469474162|FG000|Overall Study|Death|15|||
130413021|NCT01985126|469474163|FG001|Overall Study|Death|69|||
130413022|NCT01985126|469474162|FG000|Overall Study|Lost to Follow-up|0|||
130413023|NCT01985126|469474163|FG001|Overall Study|Lost to Follow-up|8|||
130413024|NCT01985126|469474162|FG000|Overall Study|Study Terminated By Sponsor|1|||
130413025|NCT01985126|469474163|FG001|Overall Study|Study Terminated By Sponsor|22|||
130413026|NCT01985126|469474162|FG000|Overall Study|Withdrawal by Subject|2|||
130413027|NCT01985126|469474163|FG001|Overall Study|Withdrawal by Subject|7|||
130413028|NCT01618838|469474164|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
130413029|NCT03835533|469474167|FG000|Overall Study|Death|5|||
130413030|NCT03835533|469474168|FG001|Overall Study|Death|10|||
130413031|NCT03835533|469474169|FG002|Overall Study|Death|9|||
130413032|NCT03835533|469474167|FG000|Overall Study|Withdrawal by Subject|2|||
130413033|NCT03835533|469474168|FG001|Overall Study|Withdrawal by Subject|2|||
130413034|NCT03835533|469474169|FG002|Overall Study|Withdrawal by Subject|2|||
130413035|NCT03835533|469474167|FG000|Overall Study|Lost to Follow-up|1|||
130413036|NCT03835533|469474168|FG001|Overall Study|Lost to Follow-up|0|||
130413037|NCT03835533|469474169|FG002|Overall Study|Lost to Follow-up|0|||
130413038|NCT01136291|469474170|FG000|Overall Study|Lost to Follow-up|1|||
130413039|NCT01136291|469474171|FG001|Overall Study|Lost to Follow-up|1|||
130413040|NCT01870843|469474182|FG000|Overall Study|Adverse Event|10|||
130413041|NCT01870843|469474182|FG000|Overall Study|Lost to Follow-up|24|||
130413042|NCT01870843|469474182|FG000|Overall Study|Death|1|||
130413043|NCT01870843|469474182|FG000|Overall Study|Withdrawal by Subject|18|||
130413044|NCT00345397|469474183|FG000|Overall Study|Death|1|||
130413045|NCT01910519|469474184|FG000|Overall Study|Withdrawal by Subject|2|||
130413046|NCT01910519|469474185|FG001|Overall Study|Withdrawal by Subject|0|||
130413047|NCT01910519|469474184|FG000|Overall Study|Adverse Event|2|||
130413048|NCT01910519|469474185|FG001|Overall Study|Adverse Event|0|||
130413049|NCT04266028|469474188|FG000|Overall Study|Adverse Event|0|||
130413050|NCT04266028|469474189|FG001|Overall Study|Adverse Event|0|||
130413051|NCT04266028|469474190|FG002|Overall Study|Adverse Event|1|||
130413052|NCT04266028|469474191|FG003|Overall Study|Adverse Event|0|||
130413053|NCT04266028|469474192|FG004|Overall Study|Adverse Event|1|||
130413054|NCT04266028|469474193|FG005|Overall Study|Adverse Event|0|||
130413055|NCT04266028|469474194|FG006|Overall Study|Adverse Event|2|||
130413056|NCT04266028|469474195|FG007|Overall Study|Adverse Event|0|||
130413057|NCT04266028|469474188|FG000|Overall Study|temporary halt of the study|0|||
130413058|NCT04266028|469474189|FG001|Overall Study|temporary halt of the study|0|||
130413059|NCT04266028|469474190|FG002|Overall Study|temporary halt of the study|0|||
130413060|NCT04266028|469474191|FG003|Overall Study|temporary halt of the study|0|||
130413061|NCT04266028|469474192|FG004|Overall Study|temporary halt of the study|0|||
130474321|NCT02783300|469704779|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474322|NCT02783300|469704780|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474323|NCT02783300|469704781|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474324|NCT02783300|469704782|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474325|NCT02783300|469704783|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130413062|NCT04266028|469474193|FG005|Overall Study|temporary halt of the study|0|||
130413063|NCT04266028|469474194|FG006|Overall Study|temporary halt of the study|2|||
130413064|NCT04266028|469474195|FG007|Overall Study|temporary halt of the study|1|||
130413065|NCT04266028|469474188|FG000|Overall Study|Onset of birch pollen season|0|||
130413066|NCT04266028|469474189|FG001|Overall Study|Onset of birch pollen season|0|||
130413067|NCT04266028|469474190|FG002|Overall Study|Onset of birch pollen season|0|||
130413068|NCT04266028|469474191|FG003|Overall Study|Onset of birch pollen season|0|||
130413069|NCT04266028|469474192|FG004|Overall Study|Onset of birch pollen season|1|||
130413070|NCT04266028|469474193|FG005|Overall Study|Onset of birch pollen season|0|||
130563565|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563566|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563567|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563568|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
130563569|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
130563570|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563571|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563572|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563573|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563574|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563575|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563576|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130563577|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
130563578|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563579|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563580|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563581|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563582|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563583|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
130563584|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563585|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130413071|NCT04266028|469474194|FG006|Overall Study|Onset of birch pollen season|0|||
130413072|NCT04266028|469474195|FG007|Overall Study|Onset of birch pollen season|0|||
130413073|NCT03021187|469474198|FG000|Overall Study|Death|0|||
130413074|NCT03021187|469474199|FG001|Overall Study|Death|0|||
130413075|NCT03021187|469474200|FG002|Overall Study|Death|3|||
130413076|NCT03021187|469474201|FG003|Overall Study|Death|0|||
130413077|NCT03021187|469474198|FG000|Overall Study|Withdrawal by Subject|0|||
130413078|NCT03021187|469474199|FG001|Overall Study|Withdrawal by Subject|6|||
130413079|NCT03021187|469474200|FG002|Overall Study|Withdrawal by Subject|2|||
130413080|NCT03021187|469474201|FG003|Overall Study|Withdrawal by Subject|5|||
130413081|NCT03021187|469474198|FG000|Overall Study|Lost to Follow-up|10|||
130413082|NCT03021187|469474199|FG001|Overall Study|Lost to Follow-up|3|||
130413083|NCT03021187|469474200|FG002|Overall Study|Lost to Follow-up|1|||
130413084|NCT03021187|469474201|FG003|Overall Study|Lost to Follow-up|4|||
130413085|NCT01664078|469474202|FG000|Overall Study|Death|9|||
130413086|NCT01664078|469474202|FG000|Overall Study|Withdrawal by Subject|4|||
130413087|NCT01664078|469474202|FG000|Overall Study|Lost to Follow-up|2|||
130413088|NCT01664078|469474202|FG000|Overall Study|missed 5 year visit|1|||
130413089|NCT01664078|469474202|FG000|Overall Study|Other|53|||
130413090|NCT03351049|469474205|FG000|Overall Study|Withdrawal|26|||
130413091|NCT03351049|469474206|FG001|Overall Study|Withdrawal|22|||
130413092|NCT02720484|469474215|FG000|Treatment on Study|Adverse Event|1|||
130413093|NCT02720484|469474215|FG000|Treatment on Study|Withdrawal by Subject|1|||
130413094|NCT02720484|469474215|FG000|Treatment on Study|Progressive Disease|4|||
130413095|NCT02720484|469474215|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
130413096|NCT02720484|469474215|FG000|Follow Up for 2 Years|Death|3|||
130413097|NCT02720484|469474215|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
130413098|NCT05070897|469474218|FG000|Overall Study|Protocol Violation|123|||
130413099|NCT05070897|469474219|FG001|Overall Study|Protocol Violation|68|||
130413100|NCT01617629|469474220|FG000|Overall Study|Death|2|||
130413101|NCT01617629|469474220|FG000|Overall Study|Investigator's Clinical Judgement|1|||
130413102|NCT01617629|469474220|FG000|Overall Study|Reason Not Specified|1|||
130413103|NCT01617629|469474220|FG000|Overall Study|Participant Withdrew Consent|2|||
130413104|NCT01337245|469474221|FG000|Overall Study|Lost to Follow-up|1|||
130413105|NCT01663636|469474222|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
130413106|NCT01663636|469474223|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
130413107|NCT03832946|469474224|FG000|Overall Study|Adverse Event|3|||
130413108|NCT03832946|469474225|FG001|Overall Study|Adverse Event|1|||
130413109|NCT03832946|469474224|FG000|Overall Study|Lost to Follow-up|1|||
130413110|NCT03832946|469474225|FG001|Overall Study|Lost to Follow-up|0|||
130563586|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563587|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130413111|NCT03832946|469474224|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
130413112|NCT03832946|469474225|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
130413113|NCT03832946|469474224|FG000|Overall Study|Lack of Efficacy|1|||
130413114|NCT03832946|469474225|FG001|Overall Study|Lack of Efficacy|0|||
130413115|NCT03832946|469474224|FG000|Overall Study|Withdrawal by Subject|12|||
130413116|NCT03832946|469474225|FG001|Overall Study|Withdrawal by Subject|9|||
130413117|NCT02863991|469474230|FG000|Overall Study|Death|0|||
130413118|NCT02863991|469474231|FG001|Overall Study|Death|3|||
130413119|NCT02863991|469474230|FG000|Overall Study|Lack of Efficacy|0|||
130413120|NCT02863991|469474231|FG001|Overall Study|Lack of Efficacy|1|||
130413121|NCT02863991|469474230|FG000|Overall Study|Study Terminated|2|||
130413122|NCT02863991|469474231|FG001|Overall Study|Study Terminated|8|||
130413123|NCT00364858|469474232|FG000|Overall Study|Adverse Event|1|||
130413124|NCT00364858|469474233|FG001|Overall Study|Adverse Event|5|||
130413125|NCT00364858|469474232|FG000|Overall Study|Withdrawal by Subject|1|||
130413126|NCT00364858|469474233|FG001|Overall Study|Withdrawal by Subject|1|||
130413127|NCT00364858|469474232|FG000|Overall Study|Pregnancy|1|||
130413128|NCT00364858|469474233|FG001|Overall Study|Pregnancy|1|||
130413129|NCT00364858|469474232|FG000|Overall Study|Clinical failure|2|||
130413130|NCT00364858|469474233|FG001|Overall Study|Clinical failure|13|||
130413131|NCT00364858|469474232|FG000|Overall Study|Discontinuation at baseline|1|||
130413132|NCT00364858|469474233|FG001|Overall Study|Discontinuation at baseline|0|||
130413133|NCT00364858|469474232|FG000|Overall Study|Non-compliant|1|||
130413134|NCT00364858|469474233|FG001|Overall Study|Non-compliant|0|||
130413135|NCT00364858|469474232|FG000|Overall Study|Return to Q2 regimen|0|||
130413136|NCT00364858|469474233|FG001|Overall Study|Return to Q2 regimen|1|||
130413137|NCT00364858|469474232|FG000|Overall Study|Clinical baseline issue|0|||
130413138|NCT00364858|469474233|FG001|Overall Study|Clinical baseline issue|1|||
130413139|NCT01307501|469474234|FG000|Overall Study|Treatment Failure|1|||
130413140|NCT01307501|469474234|FG000|Overall Study|Death|20|||
130413141|NCT01307501|469474234|FG000|Overall Study|Lost to Follow-up|1|||
130413142|NCT01307501|469474234|FG000|Overall Study|Starting Hospice|1|||
130413143|NCT00558285|469474235|FG000|Overall Study|Adverse Event|1|||
130413144|NCT00558285|469474236|FG001|Overall Study|Adverse Event|1|||
130413145|NCT00558285|469474237|FG002|Overall Study|Adverse Event|4|||
130413146|NCT00558285|469474238|FG003|Overall Study|Adverse Event|1|||
130413147|NCT00558285|469474239|FG004|Overall Study|Adverse Event|2|||
130413148|NCT00558285|469474235|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130413149|NCT00558285|469474236|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130413150|NCT00558285|469474237|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130413151|NCT00558285|469474238|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130413152|NCT00558285|469474239|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130413153|NCT00558285|469474235|FG000|Overall Study|Subject withdrew consent|2|||
130413154|NCT00558285|469474236|FG001|Overall Study|Subject withdrew consent|0|||
130413155|NCT00558285|469474237|FG002|Overall Study|Subject withdrew consent|1|||
130413156|NCT00558285|469474238|FG003|Overall Study|Subject withdrew consent|1|||
130413157|NCT00558285|469474239|FG004|Overall Study|Subject withdrew consent|1|||
130413158|NCT00558285|469474235|FG000|Overall Study|Lost to Follow-up|1|||
130413159|NCT00558285|469474236|FG001|Overall Study|Lost to Follow-up|1|||
130413160|NCT00558285|469474237|FG002|Overall Study|Lost to Follow-up|0|||
130413161|NCT00558285|469474238|FG003|Overall Study|Lost to Follow-up|0|||
130413162|NCT00558285|469474239|FG004|Overall Study|Lost to Follow-up|0|||
130413163|NCT00558285|469474235|FG000|Overall Study|Administrative problems|0|||
130413164|NCT00558285|469474236|FG001|Overall Study|Administrative problems|0|||
130413165|NCT00558285|469474237|FG002|Overall Study|Administrative problems|0|||
130413166|NCT00558285|469474238|FG003|Overall Study|Administrative problems|1|||
130413167|NCT00558285|469474239|FG004|Overall Study|Administrative problems|1|||
130413168|NCT00558285|469474235|FG000|Overall Study|Protocol deviation|1|||
130413169|NCT00558285|469474236|FG001|Overall Study|Protocol deviation|1|||
130413170|NCT00558285|469474237|FG002|Overall Study|Protocol deviation|0|||
130413171|NCT00558285|469474238|FG003|Overall Study|Protocol deviation|1|||
130413172|NCT00558285|469474239|FG004|Overall Study|Protocol deviation|0|||
130413173|NCT02730819|469474240|FG000|Overall Study|Lost to Follow-up|9|||
130413174|NCT02121847|469474241|FG000|Overall Study|Administrative Reasons|1|||
130413175|NCT02121847|469474241|FG000|Overall Study|Adverse Event|2|||
130413176|NCT01660906|469474242|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
130413177|NCT02663817|469474244|FG000|Overall Study|Screen failure|2|||
130413178|NCT03478891|469474245|FG000|Overall Study|Enrolled, but product never administered|0|||
130413179|NCT03478891|469474246|FG001|Overall Study|Enrolled, but product never administered|0|||
130413180|NCT03478891|469474247|FG002|Overall Study|Enrolled, but product never administered|1|||
130413181|NCT03478891|469474245|FG000|Overall Study|Moved from area|0|||
130413182|NCT03478891|469474246|FG001|Overall Study|Moved from area|0|||
130474326|NCT02783300|469704784|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474327|NCT02783300|469704785|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474328|NCT02783300|469704786|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474329|NCT02783300|469704787|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474330|NCT02783300|469704788|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474331|NCT02783300|469704789|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474332|NCT02783300|469704790|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474333|NCT02783300|469704791|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474334|NCT02783300|469704792|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130474335|NCT02783300|469704793|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
130413183|NCT03478891|469474247|FG002|Overall Study|Moved from area|1|||
130413184|NCT03478891|469474245|FG000|Overall Study|Lost to Follow-up|1|||
130413185|NCT03478891|469474246|FG001|Overall Study|Lost to Follow-up|0|||
130413186|NCT03478891|469474247|FG002|Overall Study|Lost to Follow-up|1|||
130413187|NCT01438541|469474251|FG000|Overall Study|Physician Decision|1|||
130474336|NCT02783300|469704767|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474337|NCT02783300|469704768|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474338|NCT02783300|469704769|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474339|NCT02783300|469704770|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474340|NCT02783300|469704771|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474341|NCT02783300|469704772|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474342|NCT02783300|469704773|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474343|NCT02783300|469704774|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
130563588|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563589|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563590|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130563591|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563592|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563593|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563594|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563595|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563596|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
130563597|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
130563598|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563599|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563600|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130413188|NCT01438541|469474251|FG000|Overall Study|Withdrawal by Subject|1|||
130563601|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563602|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563603|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563604|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130563605|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563606|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563607|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563608|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563609|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563610|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563611|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
130563612|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563613|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563614|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563615|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563616|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563617|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563618|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130563619|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130563620|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130563621|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130563622|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563623|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563624|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
130727225|NCT02883049|470625425|FG001|Post Induction|Protocol Violation|0|||
130413189|NCT01438541|469474251|FG000|Overall Study|discharge from the hospital|5|||
130413190|NCT05349617|469476263|FG000|Overall Study|Death|1|||
130413191|NCT05349617|469476264|FG001|Overall Study|Death|1|||
130413192|NCT05349617|469476263|FG000|Overall Study|Lost to Follow-up|3|||
130413193|NCT05349617|469476264|FG001|Overall Study|Lost to Follow-up|8|||
130413194|NCT05349617|469476263|FG000|Overall Study|Withdrawal by Subject|2|||
130413195|NCT05349617|469476264|FG001|Overall Study|Withdrawal by Subject|10|||
130413196|NCT02367911|469476267|FG000|Overall Study|Withdrawal by Subject|3|||
130413197|NCT02367911|469476268|FG001|Overall Study|Withdrawal by Subject|2|||
130413198|NCT02367911|469476267|FG000|Overall Study|Lost to Follow-up|2|||
130413199|NCT02367911|469476268|FG001|Overall Study|Lost to Follow-up|2|||
130413200|NCT00902304|469476269|FG000|Overall Study|Adverse Event|4|||
130413201|NCT00902304|469476270|FG001|Overall Study|Adverse Event|10|||
130413202|NCT00902304|469476271|FG002|Overall Study|Adverse Event|25|||
130413203|NCT00902304|469476269|FG000|Overall Study|Investigator discretion|3|||
130413204|NCT00902304|469476270|FG001|Overall Study|Investigator discretion|5|||
130727226|NCT02883049|470625426|FG002|Post Induction|Protocol Violation|0|||
130727227|NCT02883049|470625427|FG003|Post Induction|Protocol Violation|0|||
130413205|NCT00902304|469476271|FG002|Overall Study|Investigator discretion|13|||
130474344|NCT02783300|469704775|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474345|NCT02783300|469704776|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
130413206|NCT00902304|469476269|FG000|Overall Study|Lost to Follow-up|7|||
130413207|NCT00902304|469476270|FG001|Overall Study|Lost to Follow-up|7|||
130563625|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
130563626|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563627|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563628|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563629|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130413208|NCT00902304|469476271|FG002|Overall Study|Lost to Follow-up|7|||
130413209|NCT00902304|469476269|FG000|Overall Study|Protocol Violation|9|||
130413210|NCT00902304|469476270|FG001|Overall Study|Protocol Violation|18|||
130413211|NCT00902304|469476271|FG002|Overall Study|Protocol Violation|20|||
130413212|NCT00902304|469476269|FG000|Overall Study|Withdrawal by Subject|32|||
130413213|NCT00902304|469476270|FG001|Overall Study|Withdrawal by Subject|22|||
130413214|NCT00902304|469476271|FG002|Overall Study|Withdrawal by Subject|43|||
130413215|NCT00902304|469476269|FG000|Overall Study|includes pregnancy|3|||
130413216|NCT00902304|469476270|FG001|Overall Study|includes pregnancy|9|||
130413217|NCT00902304|469476271|FG002|Overall Study|includes pregnancy|2|||
130413218|NCT05706506|469476272|FG000|Overall Study|Adverse Event|1|||
130413219|NCT05706506|469476272|FG000|Overall Study|Withdrawal by Subject|4|||
130413220|NCT05706506|469476272|FG000|Overall Study|Lost to Follow-up|2|||
130413221|NCT05706506|469476272|FG000|Overall Study|Inadvertent Enrolment|12|||
130413222|NCT05706506|469476272|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
130413223|NCT05706506|469476272|FG000|Overall Study|Participant Moved Out of State|1|||
130413224|NCT05732454|469476273|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
130413225|NCT05732454|469476274|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
130563630|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563631|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130413226|NCT05732454|469476273|FG000|Part 1: DB Period|Adverse Event|1|||
130413227|NCT05732454|469476274|FG001|Part 1: DB Period|Adverse Event|0|||
130413228|NCT05732454|469476273|FG000|Part 1: DB Period|Lost to Follow-up|1|||
130413229|NCT05732454|469476274|FG001|Part 1: DB Period|Lost to Follow-up|0|||
130413230|NCT05732454|469476273|FG000|Part 1: DB Period|Protocol Violation|0|||
130413231|NCT05732454|469476274|FG001|Part 1: DB Period|Protocol Violation|1|||
130413232|NCT05732454|469476273|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
130413233|NCT05732454|469476274|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
130413234|NCT05732454|469476273|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
130413235|NCT05732454|469476274|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
130413236|NCT05732454|469476273|FG000|Part 1: OLE Period|Adverse Event|0|||
130413237|NCT05732454|469476274|FG001|Part 1: OLE Period|Adverse Event|1|||
130413238|NCT05732454|469476273|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
130413239|NCT05732454|469476274|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
130413240|NCT01153633|469476275|FG000|Overall Study|Protocol Violation|1|||
130413241|NCT01153633|469476276|FG001|Overall Study|Protocol Violation|1|||
130413242|NCT01153633|469476275|FG000|Overall Study|Therapeutic failure|3|||
130413243|NCT01153633|469476276|FG001|Overall Study|Therapeutic failure|3|||
130413244|NCT00384085|469476277|FG000|Overall Study|Adverse Event|5|||
130413245|NCT00384085|469476278|FG001|Overall Study|Adverse Event|5|||
130413246|NCT00384085|469476279|FG002|Overall Study|Adverse Event|4|||
130413247|NCT00384085|469476277|FG000|Overall Study|Lack of Efficacy|0|||
130413248|NCT00384085|469476278|FG001|Overall Study|Lack of Efficacy|3|||
130413249|NCT00384085|469476279|FG002|Overall Study|Lack of Efficacy|2|||
130413250|NCT00384085|469476277|FG000|Overall Study|No longer Requires Study Treatment|1|||
130413251|NCT00384085|469476278|FG001|Overall Study|No longer Requires Study Treatment|0|||
130413252|NCT00384085|469476279|FG002|Overall Study|No longer Requires Study Treatment|1|||
130413253|NCT00384085|469476277|FG000|Overall Study|Protocol Violation|2|||
130413254|NCT00384085|469476278|FG001|Overall Study|Protocol Violation|2|||
130413255|NCT00384085|469476279|FG002|Overall Study|Protocol Violation|2|||
130413256|NCT00384085|469476277|FG000|Overall Study|Lost to Follow-up|9|||
130413257|NCT00384085|469476278|FG001|Overall Study|Lost to Follow-up|9|||
130413258|NCT00384085|469476279|FG002|Overall Study|Lost to Follow-up|10|||
130413259|NCT00384085|469476277|FG000|Overall Study|Progressive Disease|0|||
130413260|NCT00384085|469476278|FG001|Overall Study|Progressive Disease|1|||
130413261|NCT00384085|469476279|FG002|Overall Study|Progressive Disease|0|||
130413262|NCT00384085|469476277|FG000|Overall Study|Withdrawal by Subject|14|||
130413263|NCT00384085|469476278|FG001|Overall Study|Withdrawal by Subject|19|||
130413264|NCT00384085|469476279|FG002|Overall Study|Withdrawal by Subject|29|||
130413265|NCT00384085|469476277|FG000|Overall Study|Patient non-compliant|4|||
130413266|NCT00384085|469476278|FG001|Overall Study|Patient non-compliant|4|||
130474346|NCT02783300|469704777|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474347|NCT02783300|469704778|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474348|NCT02783300|469704779|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474349|NCT02783300|469704780|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474350|NCT02783300|469704781|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474351|NCT02783300|469704782|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474352|NCT02783300|469704783|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474353|NCT02783300|469704784|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474354|NCT02783300|469704785|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474355|NCT02783300|469704786|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474356|NCT02783300|469704787|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474357|NCT02783300|469704788|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474358|NCT02783300|469704789|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474359|NCT02783300|469704790|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474360|NCT02783300|469704791|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474361|NCT02783300|469704792|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
130474362|NCT02783300|469704793|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
130474363|NCT00378105|469704796|FG000|Overall Study|Adverse Event|3|||
130474364|NCT00378105|469704797|FG001|Overall Study|Adverse Event|1|||
130474365|NCT00378105|469704796|FG000|Overall Study|Withdrawal by Subject|3|||
130474366|NCT00378105|469704797|FG001|Overall Study|Withdrawal by Subject|3|||
130474367|NCT00378105|469704796|FG000|Overall Study|Death|1|||
130474368|NCT00378105|469704797|FG001|Overall Study|Death|0|||
130474369|NCT00378105|469704796|FG000|Overall Study|Going to transplant|7|||
130474370|NCT00378105|469704797|FG001|Overall Study|Going to transplant|8|||
130474371|NCT00378105|469704796|FG000|Overall Study|Progressive disease|3|||
130474372|NCT00378105|469704797|FG001|Overall Study|Progressive disease|3|||
130474373|NCT00378105|469704796|FG000|Overall Study|remain on study|3|||
130474374|NCT00378105|469704797|FG001|Overall Study|remain on study|11|||
130474375|NCT00378105|469704796|FG000|Overall Study|Physician Decision|0|||
130474376|NCT00378105|469704797|FG001|Overall Study|Physician Decision|2|||
130474377|NCT00378105|469704796|FG000|Overall Study|Going non-protocol therapy|0|||
130474378|NCT00378105|469704797|FG001|Overall Study|Going non-protocol therapy|1|||
130474379|NCT00378105|469704796|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
130474380|NCT00378105|469704797|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
130413267|NCT00384085|469476279|FG002|Overall Study|Patient non-compliant|5|||
130413268|NCT00384085|469476277|FG000|Overall Study|Physician Decision|1|||
130413269|NCT00384085|469476278|FG001|Overall Study|Physician Decision|0|||
130413270|NCT00384085|469476279|FG002|Overall Study|Physician Decision|0|||
130413271|NCT00384085|469476277|FG000|Overall Study|Loss of site personnel|1|||
130474381|NCT05192200|469704798|FG000|Treatment Period|Other|1|||
130474382|NCT05192200|469704798|FG000|Treatment Period|Lack of Efficacy|1|||
130474383|NCT05192200|469704798|FG000|Treatment Period|Withdrawal by Subject|1|||
130413272|NCT00384085|469476278|FG001|Overall Study|Loss of site personnel|0|||
130413273|NCT00384085|469476279|FG002|Overall Study|Loss of site personnel|1|||
130413274|NCT00384085|469476277|FG000|Overall Study|Sponsor decision|1|||
130413275|NCT00384085|469476278|FG001|Overall Study|Sponsor decision|2|||
130413276|NCT00384085|469476279|FG002|Overall Study|Sponsor decision|1|||
130413277|NCT00384085|469476277|FG000|Overall Study|Patient moved|1|||
130413278|NCT00384085|469476278|FG001|Overall Study|Patient moved|0|||
130413279|NCT00384085|469476279|FG002|Overall Study|Patient moved|1|||
130413280|NCT00384085|469476277|FG000|Overall Study|Patient required surgery|0|||
130413281|NCT00384085|469476278|FG001|Overall Study|Patient required surgery|1|||
130413282|NCT00384085|469476279|FG002|Overall Study|Patient required surgery|0|||
130413283|NCT00352365|469476280|FG000|Induction Therapy|Adverse Event|7|||
130413284|NCT00352365|469476280|FG000|Induction Therapy|Progression/Relapse|8|||
130413285|NCT00352365|469476280|FG000|Induction Therapy|Death|7|||
130413286|NCT00352365|469476280|FG000|Induction Therapy|Not protocol specified|1|||
130413287|NCT00352365|469476280|FG000|Induction Therapy|Not eligible|3|||
130413288|NCT00352365|469476280|FG000|Induction Therapy|Death before starting protocol therapy|1|||
130413289|NCT00352365|469476280|FG000|Maintenance Therapy|Progression/Relapse|3|||
130413290|NCT00352365|469476280|FG000|Maintenance Therapy|Death|2|||
130413291|NCT00352365|469476280|FG000|Maintenance Therapy|Not protocol specified|3|||
130413292|NCT00352365|469476280|FG000|Maintenance Therapy|Not eligible|4|||
130413293|NCT04837482|469476281|FG000|Period 2|Withdrawal by Subject|0|||
130413294|NCT04837482|469476282|FG001|Period 2|Withdrawal by Subject|1|||
130413295|NCT00987467|469476286|FG000|Overall Study|Lost to Follow-up|2|||
130413296|NCT00512135|469476287|FG000|Overall Study|Not Treated|5|||
130413297|NCT00512135|469476287|FG000|Overall Study|Lack of Efficacy|2|||
130413298|NCT00512135|469476287|FG000|Overall Study|Adverse Event|6|||
130413299|NCT00512135|469476287|FG000|Overall Study|Withdrawal by Subject|22|||
130413300|NCT00512135|469476287|FG000|Overall Study|Lost to Follow-up|27|||
130413301|NCT00512135|469476287|FG000|Overall Study|Other|22|||
130413302|NCT02646423|469476288|FG000|Overall Study|Adverse Event|5|||
130413303|NCT02646423|469476289|FG001|Overall Study|Adverse Event|7|||
130413304|NCT02646423|469476288|FG000|Overall Study|Ineligible|2|||
130413305|NCT02646423|469476289|FG001|Overall Study|Ineligible|1|||
130413306|NCT00377819|469476290|FG000|Overall Study|Adverse Event|2|||
130413307|NCT00377819|469476291|FG001|Overall Study|Adverse Event|3|||
130413308|NCT00377819|469476290|FG000|Overall Study|Withdrawal by Subject|10|||
130413309|NCT00377819|469476291|FG001|Overall Study|Withdrawal by Subject|4|||
130413310|NCT00377819|469476290|FG000|Overall Study|Death|0|||
130413311|NCT00377819|469476291|FG001|Overall Study|Death|1|||
130413312|NCT00377819|469476290|FG000|Overall Study|Lost to Follow-up|0|||
130413313|NCT00377819|469476291|FG001|Overall Study|Lost to Follow-up|1|||
130413314|NCT00377819|469476290|FG000|Overall Study|Protocol Violation|1|||
130413315|NCT00377819|469476291|FG001|Overall Study|Protocol Violation|1|||
130413316|NCT02807948|469476292|FG000|Overall Study|Physician Decision|1|||
130413317|NCT02807948|469476293|FG001|Overall Study|Physician Decision|0|||
130413318|NCT03727750|469476294|FG000|Overall Study|Death|45|||
130413319|NCT03727750|469476294|FG000|Overall Study|Withdrawal by Subject|2|||
130413320|NCT03727750|469476294|FG000|Overall Study|Lost to Follow-up|1|||
130413321|NCT03727750|469476294|FG000|Overall Study|Other|1|||
130413322|NCT02624804|469476295|FG000|Overall Study|Screen Failure|5|||
130413323|NCT00760929|469476299|FG000|Overall Study|Adverse Event|2|||
130413324|NCT00760929|469476300|FG001|Overall Study|Adverse Event|0|||
130413325|NCT00760929|469476301|FG002|Overall Study|Adverse Event|6|||
130413326|NCT00760929|469476302|FG003|Overall Study|Adverse Event|10|||
130413327|NCT00760929|469476299|FG000|Overall Study|Lack of Efficacy|0|||
130413328|NCT00760929|469476300|FG001|Overall Study|Lack of Efficacy|2|||
130413329|NCT00760929|469476301|FG002|Overall Study|Lack of Efficacy|1|||
130413330|NCT00760929|469476302|FG003|Overall Study|Lack of Efficacy|0|||
130413331|NCT00760929|469476299|FG000|Overall Study|Withdrawal by Subject|1|||
130413332|NCT00760929|469476300|FG001|Overall Study|Withdrawal by Subject|0|||
130413333|NCT00760929|469476301|FG002|Overall Study|Withdrawal by Subject|9|||
130413334|NCT00760929|469476302|FG003|Overall Study|Withdrawal by Subject|1|||
130413335|NCT00760929|469476299|FG000|Overall Study|Lost to Follow-up|0|||
130413336|NCT00760929|469476300|FG001|Overall Study|Lost to Follow-up|0|||
130413337|NCT00760929|469476301|FG002|Overall Study|Lost to Follow-up|1|||
130413338|NCT00760929|469476302|FG003|Overall Study|Lost to Follow-up|0|||
130413339|NCT00760929|469476299|FG000|Overall Study|Progression of Disease|21|||
130413340|NCT00760929|469476300|FG001|Overall Study|Progression of Disease|26|||
130413341|NCT00760929|469476301|FG002|Overall Study|Progression of Disease|38|||
130413342|NCT00760929|469476302|FG003|Overall Study|Progression of Disease|42|||
130413343|NCT00760929|469476299|FG000|Overall Study|Other|2|||
130413344|NCT00760929|469476300|FG001|Overall Study|Other|0|||
130474384|NCT05192200|469704798|FG000|Follow-up|Withdrawal by Subject|1|||
130413345|NCT00760929|469476301|FG002|Overall Study|Other|2|||
130413346|NCT00760929|469476302|FG003|Overall Study|Other|1|||
130413347|NCT00760929|469476299|FG000|Overall Study|Death|0|||
130413348|NCT00760929|469476300|FG001|Overall Study|Death|0|||
130413349|NCT00760929|469476301|FG002|Overall Study|Death|1|||
130413350|NCT00760929|469476302|FG003|Overall Study|Death|0|||
130413351|NCT00760929|469476299|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130413352|NCT00760929|469476300|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130563632|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130563633|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563634|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
130563635|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563636|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563637|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563638|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
130563639|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563640|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563641|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563642|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130563643|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130413353|NCT00760929|469476301|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
130413354|NCT00760929|469476302|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
130413355|NCT03073603|469476309|FG000|Overall Study|Noncompliance|3|||
130413356|NCT03073603|469476310|FG001|Overall Study|Noncompliance|1|||
130413357|NCT03073603|469476309|FG000|Overall Study|Adverse Event|5|||
130413358|NCT03073603|469476310|FG001|Overall Study|Adverse Event|3|||
130413359|NCT03073603|469476309|FG000|Overall Study|Physician Decision|1|||
130413360|NCT03073603|469476310|FG001|Overall Study|Physician Decision|2|||
130413361|NCT03073603|469476309|FG000|Overall Study|Required treatment not allowed by protocol|1|||
130413362|NCT03073603|469476310|FG001|Overall Study|Required treatment not allowed by protocol|0|||
130413363|NCT03073603|469476309|FG000|Overall Study|Financial or insurance-related|8|||
130413364|NCT03073603|469476310|FG001|Overall Study|Financial or insurance-related|0|||
130413365|NCT03073603|469476309|FG000|Overall Study|Withdrawal by Subject|0|||
130413366|NCT03073603|469476310|FG001|Overall Study|Withdrawal by Subject|1|||
130413367|NCT03073603|469476309|FG000|Overall Study|Discontinued DMT|4|||
130413368|NCT03073603|469476310|FG001|Overall Study|Discontinued DMT|0|||
130413369|NCT03073603|469476309|FG000|Overall Study|Restarted DMT|0|||
130413370|NCT03073603|469476310|FG001|Overall Study|Restarted DMT|1|||
130413371|NCT04360824|469476311|FG000|Overall Study|Withdrawal by Subject|2|||
130413372|NCT04360824|469476312|FG001|Overall Study|Withdrawal by Subject|1|||
130413373|NCT04360824|469476311|FG000|Overall Study|Did not receive assigned treatment|1|||
130413374|NCT04360824|469476312|FG001|Overall Study|Did not receive assigned treatment|3|||
130413375|NCT00304070|469476313|FG000|Overall Study|Death|0|||
130413376|NCT00304070|469476314|FG001|Overall Study|Death|0|||
130413377|NCT00304070|469476315|FG002|Overall Study|Death|3|||
130413378|NCT00304070|469476313|FG000|Overall Study|Lost to Follow-up|0|||
130413379|NCT00304070|469476314|FG001|Overall Study|Lost to Follow-up|0|||
130413380|NCT00304070|469476315|FG002|Overall Study|Lost to Follow-up|1|||
130413381|NCT00304070|469476313|FG000|Overall Study|Physician Decision|0|||
130413382|NCT00304070|469476314|FG001|Overall Study|Physician Decision|0|||
130413383|NCT00304070|469476315|FG002|Overall Study|Physician Decision|3|||
130413384|NCT00304070|469476313|FG000|Overall Study|Withdrawal by Subject|0|||
130413385|NCT00304070|469476314|FG001|Overall Study|Withdrawal by Subject|0|||
130413386|NCT00304070|469476315|FG002|Overall Study|Withdrawal by Subject|1|||
130413387|NCT00304070|469476313|FG000|Overall Study|Progressive Disease|3|||
130413388|NCT00304070|469476314|FG001|Overall Study|Progressive Disease|7|||
130413389|NCT00304070|469476315|FG002|Overall Study|Progressive Disease|4|||
130413390|NCT00320216|469476316|FG000|Overall Study|Adverse Event|0|||
130413391|NCT00320216|469476317|FG001|Overall Study|Adverse Event|6|||
130413392|NCT00320216|469476318|FG002|Overall Study|Adverse Event|0|||
130413393|NCT00320216|469476319|FG003|Overall Study|Adverse Event|2|||
130413394|NCT00320216|469476320|FG004|Overall Study|Adverse Event|2|||
130413395|NCT00320216|469476316|FG000|Overall Study|Lack of Efficacy|6|||
130413396|NCT00320216|469476317|FG001|Overall Study|Lack of Efficacy|2|||
130413397|NCT00320216|469476318|FG002|Overall Study|Lack of Efficacy|1|||
130413398|NCT00320216|469476319|FG003|Overall Study|Lack of Efficacy|0|||
130413399|NCT00320216|469476320|FG004|Overall Study|Lack of Efficacy|1|||
130413400|NCT00320216|469476316|FG000|Overall Study|Lost to Follow-up|3|||
130413401|NCT00320216|469476317|FG001|Overall Study|Lost to Follow-up|0|||
130413402|NCT00320216|469476318|FG002|Overall Study|Lost to Follow-up|0|||
130413403|NCT00320216|469476319|FG003|Overall Study|Lost to Follow-up|0|||
130413404|NCT00320216|469476320|FG004|Overall Study|Lost to Follow-up|0|||
130413405|NCT00320216|469476316|FG000|Overall Study|Other|7|||
130413406|NCT00320216|469476317|FG001|Overall Study|Other|2|||
130413407|NCT00320216|469476318|FG002|Overall Study|Other|5|||
130413408|NCT00320216|469476319|FG003|Overall Study|Other|1|||
130413409|NCT00320216|469476320|FG004|Overall Study|Other|3|||
130413410|NCT00377676|469476321|FG000|Overall Study|Adverse Event|498|||
130413411|NCT00377676|469476322|FG001|Overall Study|Adverse Event|107|||
130413412|NCT00377676|469476321|FG000|Overall Study|Protocol Violation|33|||
130413413|NCT00377676|469476322|FG001|Overall Study|Protocol Violation|27|||
130413414|NCT00377676|469476321|FG000|Overall Study|Death|5|||
130413415|NCT00377676|469476322|FG001|Overall Study|Death|2|||
130413416|NCT00377676|469476321|FG000|Overall Study|Withdrawal by Subject|187|||
130413417|NCT00377676|469476322|FG001|Overall Study|Withdrawal by Subject|72|||
130413418|NCT00377676|469476321|FG000|Overall Study|Lost to Follow-up|120|||
130413419|NCT00377676|469476322|FG001|Overall Study|Lost to Follow-up|56|||
130413420|NCT00377676|469476321|FG000|Overall Study|Other|118|||
130413421|NCT00377676|469476322|FG001|Overall Study|Other|58|||
130413422|NCT05348681|469476327|FG000|Overall Study|Study terminated by Sponsor|8|||
130413423|NCT05348681|469476328|FG001|Overall Study|Study terminated by Sponsor|3|||
130413424|NCT05348681|469476327|FG000|Overall Study|Withdrawal by Subject|1|||
130413425|NCT05348681|469476328|FG001|Overall Study|Withdrawal by Subject|1|||
130413426|NCT05348681|469476327|FG000|Overall Study|Lost to Follow-up|1|||
130413427|NCT05348681|469476328|FG001|Overall Study|Lost to Follow-up|1|||
130413428|NCT05348681|469476327|FG000|Overall Study|Adverse Event|1|||
130413429|NCT05348681|469476328|FG001|Overall Study|Adverse Event|0|||
130413430|NCT05348681|469476327|FG000|Overall Study|Other|2|||
130413431|NCT05348681|469476328|FG001|Overall Study|Other|1|||
130413432|NCT00782340|469476329|FG000|Open Label Titration|Adverse Event|12|||
130413433|NCT00782340|469476330|FG001|Open Label Titration|Adverse Event|0|||
130413434|NCT00782340|469476331|FG002|Open Label Titration|Adverse Event|0|||
130413435|NCT00782340|469476329|FG000|Open Label Titration|Treatment failure|50|||
130413436|NCT00782340|469476330|FG001|Open Label Titration|Treatment failure|0|||
130413437|NCT00782340|469476331|FG002|Open Label Titration|Treatment failure|0|||
130413438|NCT00782340|469476329|FG000|Open Label Titration|Protocol Violation|5|||
130413439|NCT00782340|469476330|FG001|Open Label Titration|Protocol Violation|0|||
130413440|NCT00782340|469476331|FG002|Open Label Titration|Protocol Violation|0|||
130413441|NCT00782340|469476329|FG000|Open Label Titration|Withdrawal by Subject|5|||
130413442|NCT00782340|469476330|FG001|Open Label Titration|Withdrawal by Subject|0|||
130413443|NCT00782340|469476331|FG002|Open Label Titration|Withdrawal by Subject|0|||
130413444|NCT00782340|469476329|FG000|Open Label Titration|Enrollment capped|16|||
130413445|NCT00782340|469476330|FG001|Open Label Titration|Enrollment capped|0|||
130413446|NCT00782340|469476331|FG002|Open Label Titration|Enrollment capped|0|||
130413447|NCT00782340|469476329|FG000|Open Label Titration|Did not meet responder criteria|2|||
130413448|NCT00782340|469476330|FG001|Open Label Titration|Did not meet responder criteria|0|||
130413449|NCT00782340|469476331|FG002|Open Label Titration|Did not meet responder criteria|0|||
130413450|NCT00782340|469476329|FG000|Open Label Titration|Lost to Follow-up|5|||
130413451|NCT00782340|469476330|FG001|Open Label Titration|Lost to Follow-up|0|||
130413452|NCT00782340|469476331|FG002|Open Label Titration|Lost to Follow-up|0|||
130413453|NCT00782340|469476329|FG000|Open Label Titration|Randomized in error|6|||
130413454|NCT00782340|469476330|FG001|Open Label Titration|Randomized in error|0|||
130413455|NCT00782340|469476331|FG002|Open Label Titration|Randomized in error|0|||
130413456|NCT01568047|469476337|FG000|Overall Study|Ineligibility|1|||
130413457|NCT01568047|469476338|FG001|Overall Study|Ineligibility|0|||
130413458|NCT01568047|469476339|FG002|Overall Study|Ineligibility|0|||
130413459|NCT01568047|469476340|FG003|Overall Study|Ineligibility|0|||
130413460|NCT01568047|469476337|FG000|Overall Study|Withdrawal by Subject|0|||
130413461|NCT01568047|469476338|FG001|Overall Study|Withdrawal by Subject|1|||
130413462|NCT01568047|469476339|FG002|Overall Study|Withdrawal by Subject|0|||
130413463|NCT01568047|469476340|FG003|Overall Study|Withdrawal by Subject|0|||
130413464|NCT01568047|469476337|FG000|Overall Study|Adverse Event|0|||
130413465|NCT01568047|469476338|FG001|Overall Study|Adverse Event|0|||
130413466|NCT01568047|469476339|FG002|Overall Study|Adverse Event|1|||
130413467|NCT01568047|469476340|FG003|Overall Study|Adverse Event|1|||
130413468|NCT03359096|469476341|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
130413469|NCT03359096|469476342|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
130413470|NCT03359096|469476341|FG000|First Intervention (4 Weeks)|Death|1|||
130413471|NCT03359096|469476342|FG001|First Intervention (4 Weeks)|Death|0|||
130413472|NCT03359096|469476341|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
130413473|NCT03359096|469476342|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
130413474|NCT01944046|469476343|FG000|Randomized to DB|Adverse Event|5|||
130413475|NCT01944046|469476344|FG001|Randomized to DB|Adverse Event|2|||
130413476|NCT01944046|469476343|FG000|Randomized to DB|Clinical Worsening|3|||
130413477|NCT01944046|469476344|FG001|Randomized to DB|Clinical Worsening|2|||
130413478|NCT01944046|469476343|FG000|Randomized to DB|Lost to Follow-up|3|||
130413479|NCT01944046|469476344|FG001|Randomized to DB|Lost to Follow-up|3|||
130413480|NCT01944046|469476343|FG000|Randomized to DB|Withdrawal by Subject|2|||
130413481|NCT01944046|469476344|FG001|Randomized to DB|Withdrawal by Subject|4|||
130413482|NCT01944046|469476343|FG000|Randomized to DB|Physician Decision|1|||
130413483|NCT01944046|469476344|FG001|Randomized to DB|Physician Decision|2|||
130413484|NCT01944046|469476343|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
130413485|NCT01944046|469476344|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
130413486|NCT01944046|469476343|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
130413487|NCT01944046|469476344|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
130413488|NCT01944046|469476343|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
130413489|NCT01944046|469476344|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
130413490|NCT01944046|469476343|FG000|Open Label Eligible and Consented|Adverse Event|6|||
130413491|NCT01944046|469476344|FG001|Open Label Eligible and Consented|Adverse Event|1|||
130413492|NCT01944046|469476343|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
130413493|NCT01944046|469476344|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
130413494|NCT01944046|469476343|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
130413495|NCT01944046|469476344|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
130413496|NCT02007577|469476346|FG000|Overall Study|Adverse Event|1|||
130413497|NCT02007577|469476347|FG001|Overall Study|Adverse Event|0|||
130413498|NCT02007577|469476346|FG000|Overall Study|Withdrawal by Subject|0|||
130413499|NCT02007577|469476347|FG001|Overall Study|Withdrawal by Subject|1|||
130413500|NCT02504294|469476348|FG000|Overall Study|Adverse Event|15|||
130413501|NCT02504294|469476349|FG001|Overall Study|Adverse Event|12|||
130413502|NCT02504294|469476348|FG000|Overall Study|Withdrawal by Subject|7|||
130413503|NCT02504294|469476349|FG001|Overall Study|Withdrawal by Subject|1|||
130413504|NCT02504294|469476348|FG000|Overall Study|Protocol Violation|27|||
130413505|NCT02504294|469476349|FG001|Overall Study|Protocol Violation|26|||
130413506|NCT02504294|469476348|FG000|Overall Study|Physician Decision|1|||
130413507|NCT02504294|469476349|FG001|Overall Study|Physician Decision|2|||
130413508|NCT02504294|469476348|FG000|Overall Study|Lost to Follow-up|6|||
130413509|NCT02504294|469476349|FG001|Overall Study|Lost to Follow-up|7|||
130413510|NCT01953926|469476350|FG000|Overall Study|Withdrawal by Subject|23|||
130413511|NCT01953926|469476351|FG001|Overall Study|Withdrawal by Subject|3|||
130413512|NCT01953926|469476352|FG002|Overall Study|Withdrawal by Subject|3|||
130413513|NCT01953926|469476353|FG003|Overall Study|Withdrawal by Subject|5|||
130413514|NCT01953926|469476354|FG004|Overall Study|Withdrawal by Subject|6|||
130413515|NCT01953926|469476355|FG005|Overall Study|Withdrawal by Subject|0|||
130413516|NCT01953926|469476356|FG006|Overall Study|Withdrawal by Subject|1|||
130413517|NCT01953926|469476350|FG000|Overall Study|Physician Decision|1|||
130413518|NCT01953926|469476351|FG001|Overall Study|Physician Decision|0|||
130413519|NCT01953926|469476352|FG002|Overall Study|Physician Decision|0|||
130413520|NCT01953926|469476353|FG003|Overall Study|Physician Decision|0|||
130413521|NCT01953926|469476354|FG004|Overall Study|Physician Decision|2|||
130413522|NCT01953926|469476355|FG005|Overall Study|Physician Decision|0|||
130413523|NCT01953926|469476356|FG006|Overall Study|Physician Decision|0|||
130413524|NCT01953926|469476350|FG000|Overall Study|Lost to Follow-up|18|||
130413525|NCT01953926|469476351|FG001|Overall Study|Lost to Follow-up|3|||
130413526|NCT01953926|469476352|FG002|Overall Study|Lost to Follow-up|0|||
130413527|NCT01953926|469476353|FG003|Overall Study|Lost to Follow-up|5|||
130413528|NCT01953926|469476354|FG004|Overall Study|Lost to Follow-up|3|||
130413529|NCT01953926|469476355|FG005|Overall Study|Lost to Follow-up|0|||
130413530|NCT01953926|469476356|FG006|Overall Study|Lost to Follow-up|0|||
130413531|NCT01953926|469476350|FG000|Overall Study|Protocol Violation|1|||
130413532|NCT01953926|469476351|FG001|Overall Study|Protocol Violation|0|||
130413533|NCT01953926|469476352|FG002|Overall Study|Protocol Violation|0|||
130413534|NCT01953926|469476353|FG003|Overall Study|Protocol Violation|0|||
130413535|NCT01953926|469476354|FG004|Overall Study|Protocol Violation|0|||
130413536|NCT01953926|469476355|FG005|Overall Study|Protocol Violation|0|||
130413537|NCT01953926|469476356|FG006|Overall Study|Protocol Violation|0|||
130413538|NCT01953926|469476350|FG000|Overall Study|Other, Disease progression|2|||
130413539|NCT01953926|469476351|FG001|Overall Study|Other, Disease progression|1|||
130413540|NCT01953926|469476352|FG002|Overall Study|Other, Disease progression|0|||
130413541|NCT01953926|469476353|FG003|Overall Study|Other, Disease progression|0|||
130413542|NCT01953926|469476354|FG004|Overall Study|Other, Disease progression|1|||
130413543|NCT01953926|469476355|FG005|Overall Study|Other, Disease progression|0|||
130413544|NCT01953926|469476356|FG006|Overall Study|Other, Disease progression|0|||
130413545|NCT01953926|469476350|FG000|Overall Study|Discontinuation of study by sponsor|41|||
130413546|NCT01953926|469476351|FG001|Overall Study|Discontinuation of study by sponsor|7|||
130413547|NCT01953926|469476352|FG002|Overall Study|Discontinuation of study by sponsor|5|||
130413548|NCT01953926|469476353|FG003|Overall Study|Discontinuation of study by sponsor|12|||
130413549|NCT01953926|469476354|FG004|Overall Study|Discontinuation of study by sponsor|46|||
130413550|NCT01953926|469476355|FG005|Overall Study|Discontinuation of study by sponsor|5|||
130413551|NCT01953926|469476356|FG006|Overall Study|Discontinuation of study by sponsor|6|||
130413552|NCT01953926|469476350|FG000|Overall Study|Not Treated|1|||
130413553|NCT01953926|469476351|FG001|Overall Study|Not Treated|0|||
130413554|NCT01953926|469476352|FG002|Overall Study|Not Treated|1|||
130413555|NCT01953926|469476353|FG003|Overall Study|Not Treated|0|||
130413556|NCT01953926|469476354|FG004|Overall Study|Not Treated|0|||
130413557|NCT01953926|469476355|FG005|Overall Study|Not Treated|0|||
130413558|NCT01953926|469476356|FG006|Overall Study|Not Treated|0|||
130413559|NCT02338362|469476357|FG000|Overall Study|Withdrawal by Subject|1|||
130727228|NCT02883049|470625428|FG004|Post Induction|Protocol Violation|0|||
130413560|NCT02338362|469476358|FG001|Overall Study|Withdrawal by Subject|1|||
130413561|NCT03585244|469476363|FG000|Overall Study|Withdrawal by Subject|15|||
130413562|NCT06281548|469476365|FG000|Overall Study|Lost to Follow-up|3|||
130413563|NCT03538626|469476367|FG000|Overall Study|Withdrawal by Subject|0|||
130413564|NCT03538626|469476368|FG001|Overall Study|Withdrawal by Subject|1|||
130413565|NCT03538626|469476369|FG002|Overall Study|Withdrawal by Subject|0|||
130413566|NCT03538626|469476370|FG003|Overall Study|Withdrawal by Subject|0|||
130413567|NCT03538626|469476371|FG004|Overall Study|Withdrawal by Subject|0|||
130413568|NCT03538626|469476372|FG005|Overall Study|Withdrawal by Subject|0|||
130413569|NCT03538626|469476373|FG006|Overall Study|Withdrawal by Subject|0|||
130413570|NCT03538626|469476374|FG007|Overall Study|Withdrawal by Subject|0|||
130413571|NCT03538626|469476367|FG000|Overall Study|Lost to Follow-up|0|||
130413572|NCT03538626|469476368|FG001|Overall Study|Lost to Follow-up|0|||
130413573|NCT03538626|469476369|FG002|Overall Study|Lost to Follow-up|0|||
130413574|NCT03538626|469476370|FG003|Overall Study|Lost to Follow-up|0|||
130413575|NCT03538626|469476371|FG004|Overall Study|Lost to Follow-up|0|||
130413576|NCT03538626|469476372|FG005|Overall Study|Lost to Follow-up|0|||
130413577|NCT03538626|469476373|FG006|Overall Study|Lost to Follow-up|1|||
130413578|NCT03538626|469476374|FG007|Overall Study|Lost to Follow-up|0|||
130413579|NCT00288587|469476375|FG000|Overall Study|Death|4|||
130413580|NCT00288587|469476376|FG001|Overall Study|Death|4|||
130413581|NCT00288587|469476375|FG000|Overall Study|Transplant|0|||
130413582|NCT00288587|469476376|FG001|Overall Study|Transplant|3|||
130413583|NCT00288587|469476375|FG000|Overall Study|Adverse Event|0|||
130413584|NCT00288587|469476376|FG001|Overall Study|Adverse Event|1|||
130413585|NCT00288587|469476375|FG000|Overall Study|Physician Decision|0|||
130413586|NCT00288587|469476376|FG001|Overall Study|Physician Decision|2|||
130413587|NCT00288587|469476375|FG000|Overall Study|Severe Aortic Stenosis|1|||
130413588|NCT00288587|469476376|FG001|Overall Study|Severe Aortic Stenosis|0|||
130413589|NCT01434602|469476381|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130413590|NCT01434602|469476382|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
130413591|NCT01434602|469476383|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130413592|NCT01434602|469476384|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130413593|NCT01434602|469476385|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130413594|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130413595|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130413596|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130413597|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
130413598|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130413599|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130413600|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130413601|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130413602|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
130413603|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130413604|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130413605|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130413606|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130413607|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
130413608|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130413609|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130413610|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130413611|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130413612|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
130413613|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130413614|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130413615|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130413616|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130413617|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
130413618|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130413619|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130413620|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130474385|NCT04533347|469704801|FG000|Overall Study|Adverse Event|1|||
130474386|NCT04533347|469704802|FG001|Overall Study|Adverse Event|2|||
130474387|NCT04533347|469704801|FG000|Overall Study|Lost to Follow-up|2|||
130474388|NCT04533347|469704802|FG001|Overall Study|Lost to Follow-up|0|||
130474389|NCT04533347|469704801|FG000|Overall Study|Withdrawal by Subject|1|||
130474390|NCT04533347|469704802|FG001|Overall Study|Withdrawal by Subject|0|||
130474391|NCT03907397|469704803|FG000|Overall Study|Lost to Follow-up|0|||
130474392|NCT03907397|469704804|FG001|Overall Study|Lost to Follow-up|1|||
130474393|NCT03907397|469704803|FG000|Overall Study|Physician Decision|2|||
130474394|NCT03907397|469704804|FG001|Overall Study|Physician Decision|1|||
130474395|NCT03907397|469704803|FG000|Overall Study|Withdrawal by Subject|5|||
130474396|NCT03907397|469704804|FG001|Overall Study|Withdrawal by Subject|4|||
130474397|NCT03907397|469704803|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
130413621|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130413622|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130413623|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
130413624|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130413625|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130413626|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130413627|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
130413628|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
130413629|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130413630|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130413631|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130413632|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
130413633|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130413634|NCT01434602|469476381|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130413635|NCT01434602|469476382|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130413636|NCT01434602|469476383|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130413637|NCT01434602|469476384|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
130413638|NCT01434602|469476385|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130413639|NCT01764945|469476391|FG000|Overall Study|Adverse Event|0|||
130413640|NCT01764945|469476392|FG001|Overall Study|Adverse Event|1|||
130413641|NCT01764945|469476393|FG002|Overall Study|Adverse Event|0|||
130413642|NCT01764945|469476394|FG003|Overall Study|Adverse Event|0|||
130413643|NCT01764945|469476395|FG004|Overall Study|Adverse Event|0|||
130413644|NCT01764945|469476396|FG005|Overall Study|Adverse Event|0|||
130413645|NCT01764945|469476397|FG006|Overall Study|Adverse Event|1|||
130413646|NCT01764945|469476398|FG007|Overall Study|Adverse Event|0|||
130413647|NCT05077267|469476400|FG000|Treatment Period|Lost to Follow-up|0|||
130413648|NCT05077267|469476401|FG001|Treatment Period|Lost to Follow-up|1|||
130413649|NCT05077267|469476402|FG002|Treatment Period|Lost to Follow-up|0|||
130413650|NCT05077267|469476400|FG000|Treatment Period|Withdrawal by Subject|0|||
130413651|NCT05077267|469476401|FG001|Treatment Period|Withdrawal by Subject|1|||
130413652|NCT05077267|469476402|FG002|Treatment Period|Withdrawal by Subject|0|||
130413653|NCT05077267|469476400|FG000|Follow-up Period|Lost to Follow-up|0|||
130413654|NCT05077267|469476401|FG001|Follow-up Period|Lost to Follow-up|5|||
130413655|NCT05077267|469476402|FG002|Follow-up Period|Lost to Follow-up|7|||
130413656|NCT05077267|469476400|FG000|Follow-up Period|Withdrawal by Subject|0|||
130413657|NCT05077267|469476401|FG001|Follow-up Period|Withdrawal by Subject|2|||
130413658|NCT05077267|469476402|FG002|Follow-up Period|Withdrawal by Subject|5|||
130413659|NCT05077267|469476400|FG000|Follow-up Period|Study terminated by sponsor|0|||
130413660|NCT05077267|469476401|FG001|Follow-up Period|Study terminated by sponsor|27|||
130413661|NCT05077267|469476402|FG002|Follow-up Period|Study terminated by sponsor|23|||
130413662|NCT05077267|469476400|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
130413663|NCT05077267|469476401|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
130413664|NCT05077267|469476402|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
130413665|NCT05077267|469476400|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
130413666|NCT05077267|469476401|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
130413667|NCT05077267|469476402|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
130413668|NCT02911948|469476403|FG000|Overall Study|Protocol Violation|0|||
130413669|NCT02911948|469476404|FG001|Overall Study|Protocol Violation|1|||
130413670|NCT02911948|469476403|FG000|Overall Study|Withdrawal by Subject|0|||
130413671|NCT02911948|469476404|FG001|Overall Study|Withdrawal by Subject|2|||
130413672|NCT02911948|469476403|FG000|Overall Study|Lack of Efficacy|0|||
130413673|NCT02911948|469476404|FG001|Overall Study|Lack of Efficacy|1|||
130413674|NCT02911948|469476403|FG000|Overall Study|Unclassified|0|||
130413675|NCT02911948|469476404|FG001|Overall Study|Unclassified|3|||
130413676|NCT00586105|469476405|FG000|Overall Study|Adverse Event|4|||
130413677|NCT00586105|469476405|FG000|Overall Study|Death|2|||
130413678|NCT00586105|469476405|FG000|Overall Study|Protocol Violation|1|||
130413679|NCT00586105|469476405|FG000|Overall Study|Withdrawal by Subject|3|||
130413680|NCT00586105|469476405|FG000|Overall Study|Disease progression|19|||
130413681|NCT00586105|469476405|FG000|Overall Study|Switched to commercial drug|9|||
130413682|NCT00586105|469476405|FG000|Overall Study|Reason not reported|1|||
130413683|NCT02308033|469476408|FG000|Overall Study|Normal Gram stain at Baseline|13|||
130413684|NCT02308033|469476409|FG001|Overall Study|Normal Gram stain at Baseline|10|||
130413685|NCT02308033|469476408|FG000|Overall Study|Positive for STD at Baseline|7|||
130413686|NCT02308033|469476409|FG001|Overall Study|Positive for STD at Baseline|4|||
130413687|NCT02308033|469476408|FG000|Overall Study|Lost to Follow-up|6|||
130413688|NCT02308033|469476409|FG001|Overall Study|Lost to Follow-up|5|||
130413689|NCT00809757|469476410|FG000|Overall Study|Adverse Event|2|||
130413690|NCT00809757|469476411|FG001|Overall Study|Adverse Event|3|||
130413691|NCT00809757|469476412|FG002|Overall Study|Adverse Event|3|||
130413692|NCT00809757|469476410|FG000|Overall Study|Lost to Follow-up|0|||
130413693|NCT00809757|469476411|FG001|Overall Study|Lost to Follow-up|0|||
130413694|NCT00809757|469476412|FG002|Overall Study|Lost to Follow-up|1|||
130413695|NCT00809757|469476410|FG000|Overall Study|Protocol Violation|1|||
130413696|NCT00809757|469476411|FG001|Overall Study|Protocol Violation|1|||
130413697|NCT00809757|469476412|FG002|Overall Study|Protocol Violation|1|||
130413698|NCT00809757|469476410|FG000|Overall Study|Withdrawal by Subject|2|||
130413699|NCT00809757|469476411|FG001|Overall Study|Withdrawal by Subject|1|||
130413700|NCT00809757|469476412|FG002|Overall Study|Withdrawal by Subject|3|||
130413701|NCT00809757|469476410|FG000|Overall Study|Subject Uncooperative|1|||
130413702|NCT00809757|469476411|FG001|Overall Study|Subject Uncooperative|0|||
130413703|NCT00809757|469476412|FG002|Overall Study|Subject Uncooperative|2|||
130413704|NCT00809757|469476410|FG000|Overall Study|Noncompliance with Medication|0|||
130413705|NCT00809757|469476411|FG001|Overall Study|Noncompliance with Medication|0|||
130413706|NCT00809757|469476412|FG002|Overall Study|Noncompliance with Medication|1|||
130413707|NCT00253864|469476413|FG000|Overall Study|Lost to Follow-up|5|||
130413708|NCT00253864|469476414|FG001|Overall Study|Lost to Follow-up|8|||
130413709|NCT01410448|469476418|FG000|Overall Study|No conversion to everolimus|0|||
130413710|NCT01410448|469476419|FG001|Overall Study|No conversion to everolimus|24|||
130413711|NCT01410448|469476418|FG000|Overall Study|Graft loss|4|||
130413712|NCT01410448|469476419|FG001|Overall Study|Graft loss|1|||
130413713|NCT01410448|469476418|FG000|Overall Study|Administrative issues|2|||
130413714|NCT01410448|469476419|FG001|Overall Study|Administrative issues|1|||
130413715|NCT01410448|469476418|FG000|Overall Study|Lost to Follow-up|1|||
130413716|NCT01410448|469476419|FG001|Overall Study|Lost to Follow-up|0|||
130413717|NCT01410448|469476418|FG000|Overall Study|Withdrawal by Subject|3|||
130413718|NCT01410448|469476419|FG001|Overall Study|Withdrawal by Subject|2|||
130413719|NCT01410448|469476418|FG000|Overall Study|Protocol Violation|0|||
130413720|NCT01410448|469476419|FG001|Overall Study|Protocol Violation|4|||
130413721|NCT01410448|469476418|FG000|Overall Study|Death|2|||
130413722|NCT01410448|469476419|FG001|Overall Study|Death|3|||
130413723|NCT00360529|469476420|FG000|Overall Study|Adverse Event|10|||
130413724|NCT00360529|469476421|FG001|Overall Study|Adverse Event|23|||
130413725|NCT00360529|469476422|FG002|Overall Study|Adverse Event|33|||
130413726|NCT00360529|469476420|FG000|Overall Study|Protocol Violation|3|||
130413727|NCT00360529|469476421|FG001|Overall Study|Protocol Violation|3|||
130413728|NCT00360529|469476422|FG002|Overall Study|Protocol Violation|11|||
130413729|NCT00360529|469476420|FG000|Overall Study|Lost to Follow-up|14|||
130413730|NCT00360529|469476421|FG001|Overall Study|Lost to Follow-up|10|||
130413731|NCT00360529|469476422|FG002|Overall Study|Lost to Follow-up|13|||
130413732|NCT00360529|469476420|FG000|Overall Study|Withdrawal by Subject|22|||
130413733|NCT00360529|469476421|FG001|Overall Study|Withdrawal by Subject|14|||
130413734|NCT00360529|469476422|FG002|Overall Study|Withdrawal by Subject|18|||
130413735|NCT00360529|469476420|FG000|Overall Study|Lack of Efficacy|8|||
130413736|NCT00360529|469476421|FG001|Overall Study|Lack of Efficacy|6|||
130413737|NCT00360529|469476422|FG002|Overall Study|Lack of Efficacy|5|||
130413738|NCT00360529|469476420|FG000|Overall Study|Reason discontinued not explained above|4|||
130413739|NCT00360529|469476421|FG001|Overall Study|Reason discontinued not explained above|9|||
130413740|NCT00360529|469476422|FG002|Overall Study|Reason discontinued not explained above|11|||
130413741|NCT03712917|469476423|FG000|Overall Study|Pregnancy|0|||
130413742|NCT03712917|469476424|FG001|Overall Study|Pregnancy|0|||
130413743|NCT03712917|469476425|FG002|Overall Study|Pregnancy|1|||
130413744|NCT03712917|469476423|FG000|Overall Study|Adverse Event|0|||
130413745|NCT03712917|469476424|FG001|Overall Study|Adverse Event|4|||
130413746|NCT03712917|469476425|FG002|Overall Study|Adverse Event|3|||
130413747|NCT03712917|469476423|FG000|Overall Study|Lost to Follow-up|9|||
130413748|NCT03712917|469476424|FG001|Overall Study|Lost to Follow-up|4|||
130413749|NCT03712917|469476425|FG002|Overall Study|Lost to Follow-up|5|||
130413750|NCT01218438|469476426|FG000|Epoch 1|Physician Decision|2|||
130413751|NCT01218438|469476426|FG000|Epoch 1|Adverse Event|1|||
130413752|NCT01218438|469476426|FG000|Epoch 3|Withdrawal by Subject|3|||
130413753|NCT01218438|469476426|FG000|Epoch 3|Adverse Event|1|||
130413754|NCT01218438|469476426|FG000|Epoch 4|Physician Decision|1|||
130413755|NCT01218438|469476426|FG000|Epoch 4|Withdrawal by Subject|2|||
130413756|NCT02091167|469476428|FG000|Overall Study|Lost to Follow-up|0|||
130413757|NCT02091167|469476429|FG001|Overall Study|Lost to Follow-up|2|||
130413758|NCT03662750|469476430|FG000|Overall Study|Withdrawal by Subject|1|||
130413759|NCT03096782|469476431|FG000|Overall Study|Death|1|||
130413760|NCT03096782|469476431|FG000|Overall Study|Participant Relapsed|1|||
130413761|NCT00932893|469476438|FG000|Overall Study|Death|115|||
130413762|NCT00932893|469476439|FG001|Overall Study|Death|24|||
130413763|NCT00932893|469476438|FG000|Overall Study|Lost to Follow-up|8|||
130413764|NCT00932893|469476439|FG001|Overall Study|Lost to Follow-up|0|||
130413765|NCT00932893|469476438|FG000|Overall Study|Withdrawal by Subject|5|||
130413766|NCT00932893|469476439|FG001|Overall Study|Withdrawal by Subject|2|||
130413767|NCT00932893|469476438|FG000|Overall Study|Other|5|||
130413768|NCT00932893|469476439|FG001|Overall Study|Other|144|||
130413769|NCT00724282|469478290|FG000|Overall Study|Withdrawal by Subject|3|||
130413770|NCT00724282|469478290|FG000|Overall Study|Physician Decision|1|||
130727229|NCT02883049|470625429|FG005|Post Induction|Protocol Violation|0|||
130474398|NCT03907397|469704804|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
130474399|NCT01180634|469706347|FG000|Overall Study|Adverse Event|4|||
130474400|NCT01180634|469706348|FG001|Overall Study|Adverse Event|1|||
130474401|NCT01180634|469706347|FG000|Overall Study|Miscellaneous|2|||
130413771|NCT00993447|469478291|FG000|Overall Study|Withdrawal by Subject|23|||
130413772|NCT00993447|469478292|FG001|Overall Study|Withdrawal by Subject|8|||
130413773|NCT00993447|469478291|FG000|Overall Study|Protocol Violation|12|||
130413774|NCT00993447|469478292|FG001|Overall Study|Protocol Violation|8|||
130413775|NCT00993447|469478291|FG000|Overall Study|Lost to Follow-up|1|||
130413776|NCT00993447|469478292|FG001|Overall Study|Lost to Follow-up|3|||
130413777|NCT00993447|469478291|FG000|Overall Study|Adverse Event|1|||
130413778|NCT00993447|469478292|FG001|Overall Study|Adverse Event|0|||
130413779|NCT00970502|469478294|FG000|Overall Study|Withdrawal by Subject|1|||
130413780|NCT03811912|469478295|FG000|Overall Study|Withdrew Consent|4|||
130413781|NCT03811912|469478296|FG001|Overall Study|Withdrew Consent|2|||
130413782|NCT01438411|469478297|FG000|Overall Study|Adverse Event|8|||
130413783|NCT01438411|469478297|FG000|Overall Study|Lost to Follow-up|1|||
130413784|NCT01438411|469478297|FG000|Overall Study|Lack of Efficacy|1|||
130413785|NCT01438411|469478297|FG000|Overall Study|Withdrawal by Subject|3|||
130413786|NCT01863680|469478298|FG000|Overall Study|Adverse Event|17|||
130413787|NCT01863680|469478298|FG000|Overall Study|Risk of OHSS|17|||
130413788|NCT01863680|469478298|FG000|Overall Study|Spontaneous pregnancy|2|||
130413789|NCT01863680|469478298|FG000|Overall Study|Withdrawal by Subject|1|||
130413790|NCT01863680|469478298|FG000|Overall Study|Did not undergo IVF/ET|14|||
130413791|NCT01863680|469478298|FG000|Overall Study|Other|6|||
130413792|NCT00618514|469478299|FG000|Overall Study|Lost to Follow-up|11|||
130413793|NCT00618514|469478300|FG001|Overall Study|Lost to Follow-up|12|||
130413794|NCT00618514|469478301|FG002|Overall Study|Lost to Follow-up|4|||
130413795|NCT00566228|469478302|FG000|Overall Study|Withdrawal by Subject|1|||
130413796|NCT00566228|469478303|FG001|Overall Study|Withdrawal by Subject|0|||
130413797|NCT00566228|469478302|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
130413798|NCT00566228|469478303|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
130413799|NCT00566228|469478302|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
130413800|NCT00566228|469478303|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
130413801|NCT00566228|469478302|FG000|Overall Study|progressed before infusion could occur|0|||
130413802|NCT00566228|469478303|FG001|Overall Study|progressed before infusion could occur|1|||
130413803|NCT02053350|469478306|FG000|Overall Study|Withdrawal by Subject|1|||
130413804|NCT02053350|469478306|FG000|Overall Study|Adverse Event|4|||
130413805|NCT02244944|469478307|FG000|Overall Study|Withdrawal by Subject|1|||
130413806|NCT02244944|469478307|FG000|Overall Study|Study Terminated|1|||
130413807|NCT01159691|469478308|FG000|Overall Study|Lost to Follow-up|2|||
130413808|NCT01159691|469478308|FG000|Overall Study|Unknown reasons|1|||
130413809|NCT01159691|469478308|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
130413810|NCT01159691|469478308|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
130413811|NCT01159691|469478308|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
130413812|NCT01159691|469478308|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
130413813|NCT01159691|469478308|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
130413814|NCT01159691|469478308|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
130413815|NCT01928719|469478309|FG000|Overall Study|Lost to Follow-up|26|||
130474402|NCT01180634|469706348|FG001|Overall Study|Miscellaneous|0|||
130474403|NCT01180634|469706347|FG000|Overall Study|Withdrawal by Subject|4|||
130413816|NCT01928719|469478310|FG001|Overall Study|Lost to Follow-up|11|||
130413817|NCT01928719|469478309|FG000|Overall Study|Withdrawal by Subject|22|||
130413818|NCT01928719|469478310|FG001|Overall Study|Withdrawal by Subject|7|||
130413819|NCT01928719|469478309|FG000|Overall Study|Protocol Violation|3|||
130413820|NCT01928719|469478310|FG001|Overall Study|Protocol Violation|1|||
130413821|NCT01928719|469478309|FG000|Overall Study|Adverse Event|1|||
130413822|NCT01928719|469478310|FG001|Overall Study|Adverse Event|0|||
130413823|NCT04579757|469478313|FG000|Overall Study|Adverse Event|0|||
130474404|NCT01180634|469706348|FG001|Overall Study|Withdrawal by Subject|0|||
130474405|NCT04419168|469706349|FG000|Overall Study|Protocol Violation|1|||
130413824|NCT04579757|469478314|FG001|Overall Study|Adverse Event|0|||
130413825|NCT04579757|469478315|FG002|Overall Study|Adverse Event|0|||
130413826|NCT04579757|469478316|FG003|Overall Study|Adverse Event|2|||
130413827|NCT04579757|469478317|FG004|Overall Study|Adverse Event|1|||
130413828|NCT04579757|469478318|FG005|Overall Study|Adverse Event|1|||
130413829|NCT04579757|469478319|FG006|Overall Study|Adverse Event|0|||
130413830|NCT04579757|469478320|FG007|Overall Study|Adverse Event|0|||
130563644|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130413831|NCT04579757|469478321|FG008|Overall Study|Adverse Event|0|||
130413832|NCT04579757|469478313|FG000|Overall Study|Death|4|||
130413833|NCT04579757|469478314|FG001|Overall Study|Death|1|||
130413834|NCT04579757|469478315|FG002|Overall Study|Death|14|||
130474406|NCT04419168|469706350|FG001|Overall Study|Protocol Violation|1|||
130413835|NCT04579757|469478316|FG003|Overall Study|Death|3|||
130413836|NCT04579757|469478317|FG004|Overall Study|Death|2|||
130413837|NCT04579757|469478318|FG005|Overall Study|Death|7|||
130413838|NCT04579757|469478319|FG006|Overall Study|Death|0|||
130413839|NCT04579757|469478320|FG007|Overall Study|Death|1|||
130413840|NCT04579757|469478321|FG008|Overall Study|Death|3|||
130413841|NCT04579757|469478313|FG000|Overall Study|Physician Decision|0|||
130413842|NCT04579757|469478314|FG001|Overall Study|Physician Decision|0|||
130413843|NCT04579757|469478315|FG002|Overall Study|Physician Decision|0|||
130413844|NCT04579757|469478316|FG003|Overall Study|Physician Decision|2|||
130413845|NCT04579757|469478317|FG004|Overall Study|Physician Decision|1|||
130413846|NCT04579757|469478318|FG005|Overall Study|Physician Decision|1|||
130413847|NCT04579757|469478319|FG006|Overall Study|Physician Decision|1|||
130413848|NCT04579757|469478320|FG007|Overall Study|Physician Decision|0|||
130413849|NCT04579757|469478321|FG008|Overall Study|Physician Decision|0|||
130413850|NCT04579757|469478313|FG000|Overall Study|Study Terminated By Sponsor|0|||
130413851|NCT04579757|469478314|FG001|Overall Study|Study Terminated By Sponsor|0|||
130413852|NCT04579757|469478315|FG002|Overall Study|Study Terminated By Sponsor|0|||
130413853|NCT04579757|469478316|FG003|Overall Study|Study Terminated By Sponsor|0|||
130413854|NCT04579757|469478317|FG004|Overall Study|Study Terminated By Sponsor|2|||
130413855|NCT04579757|469478318|FG005|Overall Study|Study Terminated By Sponsor|0|||
130413856|NCT04579757|469478319|FG006|Overall Study|Study Terminated By Sponsor|0|||
130413857|NCT04579757|469478320|FG007|Overall Study|Study Terminated By Sponsor|2|||
130413858|NCT04579757|469478321|FG008|Overall Study|Study Terminated By Sponsor|0|||
130413859|NCT04579757|469478313|FG000|Overall Study|Withdrawal by Subject|1|||
130413860|NCT04579757|469478314|FG001|Overall Study|Withdrawal by Subject|1|||
130413861|NCT04579757|469478315|FG002|Overall Study|Withdrawal by Subject|0|||
130413862|NCT04579757|469478316|FG003|Overall Study|Withdrawal by Subject|0|||
130413863|NCT04579757|469478317|FG004|Overall Study|Withdrawal by Subject|2|||
130413864|NCT04579757|469478318|FG005|Overall Study|Withdrawal by Subject|1|||
130413865|NCT04579757|469478319|FG006|Overall Study|Withdrawal by Subject|0|||
130413866|NCT04579757|469478320|FG007|Overall Study|Withdrawal by Subject|3|||
130413867|NCT04579757|469478321|FG008|Overall Study|Withdrawal by Subject|0|||
130413868|NCT04579757|469478313|FG000|Overall Study|Radiological or Clinical PD|1|||
130413869|NCT04579757|469478314|FG001|Overall Study|Radiological or Clinical PD|4|||
130413870|NCT04579757|469478315|FG002|Overall Study|Radiological or Clinical PD|1|||
130413871|NCT04579757|469478316|FG003|Overall Study|Radiological or Clinical PD|3|||
130413872|NCT04579757|469478317|FG004|Overall Study|Radiological or Clinical PD|9|||
130413873|NCT04579757|469478318|FG005|Overall Study|Radiological or Clinical PD|4|||
130413874|NCT04579757|469478319|FG006|Overall Study|Radiological or Clinical PD|2|||
130413875|NCT04579757|469478320|FG007|Overall Study|Radiological or Clinical PD|2|||
130413876|NCT04579757|469478321|FG008|Overall Study|Radiological or Clinical PD|0|||
130413877|NCT04579757|469478313|FG000|Overall Study|Start of New Therapy|0|||
130413878|NCT04579757|469478314|FG001|Overall Study|Start of New Therapy|0|||
130413879|NCT04579757|469478315|FG002|Overall Study|Start of New Therapy|0|||
130413880|NCT04579757|469478316|FG003|Overall Study|Start of New Therapy|0|||
130413881|NCT04579757|469478317|FG004|Overall Study|Start of New Therapy|2|||
130413882|NCT04579757|469478318|FG005|Overall Study|Start of New Therapy|1|||
130413883|NCT04579757|469478319|FG006|Overall Study|Start of New Therapy|0|||
130413884|NCT04579757|469478320|FG007|Overall Study|Start of New Therapy|0|||
130413885|NCT04579757|469478321|FG008|Overall Study|Start of New Therapy|0|||
130413886|NCT02332720|469478322|FG000|Part A and Part B|Lost to Follow-up|1|||
130413887|NCT02332720|469478323|FG001|Part A and Part B|Lost to Follow-up|0|||
130413888|NCT02332720|469478324|FG002|Part A and Part B|Lost to Follow-up|0|||
130413889|NCT02332720|469478325|FG003|Part A and Part B|Lost to Follow-up|0|||
130413890|NCT02332720|469478326|FG004|Part A and Part B|Lost to Follow-up|0|||
130413891|NCT02332720|469478327|FG005|Part A and Part B|Lost to Follow-up|2|||
130413892|NCT02332720|469478328|FG006|Part A and Part B|Lost to Follow-up|1|||
130413893|NCT02332720|469478329|FG007|Part A and Part B|Lost to Follow-up|1|||
130413894|NCT02332720|469478330|FG008|Part A and Part B|Lost to Follow-up|0|||
130413895|NCT02332720|469478331|FG009|Part A and Part B|Lost to Follow-up|0|||
130413896|NCT02332720|469478332|FG010|Part A and Part B|Lost to Follow-up|0|||
130413897|NCT02332720|469478333|FG011|Part A and Part B|Lost to Follow-up|0|||
130413898|NCT02332720|469478334|FG012|Part A and Part B|Lost to Follow-up|0|||
130413899|NCT02332720|469478335|FG013|Part A and Part B|Lost to Follow-up|0|||
130413900|NCT02332720|469478336|FG014|Part A and Part B|Lost to Follow-up|0|||
130413901|NCT02332720|469478337|FG015|Part A and Part B|Lost to Follow-up|1|||
130413902|NCT02332720|469478338|FG016|Part A and Part B|Lost to Follow-up|0|||
130413903|NCT02332720|469478339|FG017|Part A and Part B|Lost to Follow-up|0|||
130413904|NCT02332720|469478340|FG018|Part A and Part B|Lost to Follow-up|0|||
130413905|NCT02332720|469478341|FG019|Part A and Part B|Lost to Follow-up|0|||
130413906|NCT02332720|469478342|FG020|Part A and Part B|Lost to Follow-up|0|||
130413907|NCT02332720|469478343|FG021|Part A and Part B|Lost to Follow-up|0|||
130413908|NCT02332720|469478344|FG022|Part A and Part B|Lost to Follow-up|0|||
130413909|NCT02332720|469478322|FG000|Part A and Part B|Adverse Event|0|||
130413910|NCT02332720|469478323|FG001|Part A and Part B|Adverse Event|0|||
130413911|NCT02332720|469478324|FG002|Part A and Part B|Adverse Event|0|||
130413912|NCT02332720|469478325|FG003|Part A and Part B|Adverse Event|0|||
130413913|NCT02332720|469478326|FG004|Part A and Part B|Adverse Event|0|||
130413914|NCT02332720|469478327|FG005|Part A and Part B|Adverse Event|0|||
130413915|NCT02332720|469478328|FG006|Part A and Part B|Adverse Event|0|||
130413916|NCT02332720|469478329|FG007|Part A and Part B|Adverse Event|0|||
130413917|NCT02332720|469478330|FG008|Part A and Part B|Adverse Event|0|||
130413918|NCT02332720|469478331|FG009|Part A and Part B|Adverse Event|0|||
130413919|NCT02332720|469478332|FG010|Part A and Part B|Adverse Event|0|||
130413920|NCT02332720|469478333|FG011|Part A and Part B|Adverse Event|0|||
130413921|NCT02332720|469478334|FG012|Part A and Part B|Adverse Event|0|||
130413922|NCT02332720|469478335|FG013|Part A and Part B|Adverse Event|0|||
130413923|NCT02332720|469478336|FG014|Part A and Part B|Adverse Event|0|||
130413924|NCT02332720|469478337|FG015|Part A and Part B|Adverse Event|0|||
130413925|NCT02332720|469478338|FG016|Part A and Part B|Adverse Event|0|||
130413926|NCT02332720|469478339|FG017|Part A and Part B|Adverse Event|1|||
130413927|NCT02332720|469478340|FG018|Part A and Part B|Adverse Event|0|||
130413928|NCT02332720|469478341|FG019|Part A and Part B|Adverse Event|0|||
130413929|NCT02332720|469478342|FG020|Part A and Part B|Adverse Event|0|||
130413930|NCT02332720|469478343|FG021|Part A and Part B|Adverse Event|0|||
130413931|NCT02332720|469478344|FG022|Part A and Part B|Adverse Event|0|||
130413932|NCT02332720|469478322|FG000|Part A and Part B|Physician Decision|0|||
130413933|NCT02332720|469478323|FG001|Part A and Part B|Physician Decision|0|||
130413934|NCT02332720|469478324|FG002|Part A and Part B|Physician Decision|0|||
130413935|NCT02332720|469478325|FG003|Part A and Part B|Physician Decision|0|||
130413936|NCT02332720|469478326|FG004|Part A and Part B|Physician Decision|0|||
130413937|NCT02332720|469478327|FG005|Part A and Part B|Physician Decision|0|||
130413938|NCT02332720|469478328|FG006|Part A and Part B|Physician Decision|0|||
130413939|NCT02332720|469478329|FG007|Part A and Part B|Physician Decision|0|||
130413940|NCT02332720|469478330|FG008|Part A and Part B|Physician Decision|0|||
130413941|NCT02332720|469478331|FG009|Part A and Part B|Physician Decision|0|||
130413942|NCT02332720|469478332|FG010|Part A and Part B|Physician Decision|0|||
130413943|NCT02332720|469478333|FG011|Part A and Part B|Physician Decision|0|||
130413944|NCT02332720|469478334|FG012|Part A and Part B|Physician Decision|0|||
130413945|NCT02332720|469478335|FG013|Part A and Part B|Physician Decision|0|||
130413946|NCT02332720|469478336|FG014|Part A and Part B|Physician Decision|0|||
130413947|NCT02332720|469478337|FG015|Part A and Part B|Physician Decision|0|||
130413948|NCT02332720|469478338|FG016|Part A and Part B|Physician Decision|0|||
130413949|NCT02332720|469478339|FG017|Part A and Part B|Physician Decision|0|||
130413950|NCT02332720|469478340|FG018|Part A and Part B|Physician Decision|1|||
130413951|NCT02332720|469478341|FG019|Part A and Part B|Physician Decision|0|||
130413952|NCT02332720|469478342|FG020|Part A and Part B|Physician Decision|0|||
130413953|NCT02332720|469478343|FG021|Part A and Part B|Physician Decision|0|||
130413954|NCT02332720|469478344|FG022|Part A and Part B|Physician Decision|0|||
130413955|NCT02332720|469478322|FG000|Part A and Part B|Withdrawal by Subject|0|||
130413956|NCT02332720|469478323|FG001|Part A and Part B|Withdrawal by Subject|0|||
130413957|NCT02332720|469478324|FG002|Part A and Part B|Withdrawal by Subject|0|||
130413958|NCT02332720|469478325|FG003|Part A and Part B|Withdrawal by Subject|0|||
130413959|NCT02332720|469478326|FG004|Part A and Part B|Withdrawal by Subject|0|||
130413960|NCT02332720|469478327|FG005|Part A and Part B|Withdrawal by Subject|1|||
130413961|NCT02332720|469478328|FG006|Part A and Part B|Withdrawal by Subject|0|||
130474407|NCT04419168|469706349|FG000|Overall Study|Lost to Follow-up|7|||
130474408|NCT04419168|469706350|FG001|Overall Study|Lost to Follow-up|7|||
130413962|NCT02332720|469478329|FG007|Part A and Part B|Withdrawal by Subject|0|||
130413963|NCT02332720|469478330|FG008|Part A and Part B|Withdrawal by Subject|0|||
130413964|NCT02332720|469478331|FG009|Part A and Part B|Withdrawal by Subject|0|||
130413965|NCT02332720|469478332|FG010|Part A and Part B|Withdrawal by Subject|0|||
130413966|NCT02332720|469478333|FG011|Part A and Part B|Withdrawal by Subject|0|||
130413967|NCT02332720|469478334|FG012|Part A and Part B|Withdrawal by Subject|0|||
130413968|NCT02332720|469478335|FG013|Part A and Part B|Withdrawal by Subject|0|||
130413969|NCT02332720|469478336|FG014|Part A and Part B|Withdrawal by Subject|0|||
130413970|NCT02332720|469478337|FG015|Part A and Part B|Withdrawal by Subject|0|||
130474409|NCT04419168|469706349|FG000|Overall Study|Missed 6-month Visit|48|||
130474410|NCT04419168|469706350|FG001|Overall Study|Missed 6-month Visit|45|||
130474411|NCT05009251|469706351|FG000|Overall Study|Protocol Violation|100|||
130474412|NCT05009251|469706352|FG001|Overall Study|Protocol Violation|105|||
130413971|NCT02332720|469478338|FG016|Part A and Part B|Withdrawal by Subject|0|||
130474413|NCT05009251|469706353|FG002|Overall Study|Protocol Violation|119|||
130474414|NCT05009251|469706354|FG003|Overall Study|Protocol Violation|120|||
130413972|NCT02332720|469478339|FG017|Part A and Part B|Withdrawal by Subject|0|||
130413973|NCT02332720|469478340|FG018|Part A and Part B|Withdrawal by Subject|0|||
130413974|NCT02332720|469478341|FG019|Part A and Part B|Withdrawal by Subject|1|||
130413975|NCT02332720|469478342|FG020|Part A and Part B|Withdrawal by Subject|0|||
130413976|NCT02332720|469478343|FG021|Part A and Part B|Withdrawal by Subject|0|||
130413977|NCT02332720|469478344|FG022|Part A and Part B|Withdrawal by Subject|0|||
130413978|NCT03725982|469478347|FG000|First Intervention|Withdrawal by Subject|0|||
130563645|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130413979|NCT03725982|469478348|FG001|First Intervention|Withdrawal by Subject|1|||
130413980|NCT03725982|469478347|FG000|First Intervention|Physician Decision|1|||
130413981|NCT03725982|469478348|FG001|First Intervention|Physician Decision|1|||
130474415|NCT05009251|469706355|FG004|Overall Study|Protocol Violation|119|||
130413982|NCT03832010|469478351|FG000|Overall Study|Withdrawal by Subject|2|||
130413983|NCT03832010|469478352|FG001|Overall Study|Withdrawal by Subject|1|||
130413984|NCT03832010|469478353|FG002|Overall Study|Withdrawal by Subject|0|||
130413985|NCT03832010|469478351|FG000|Overall Study|Lost to Follow-up|2|||
130413986|NCT03832010|469478352|FG001|Overall Study|Lost to Follow-up|1|||
130413987|NCT03832010|469478353|FG002|Overall Study|Lost to Follow-up|1|||
130413988|NCT04743908|469478354|FG000|Overall Study|Death|1|||
130413989|NCT04743908|469478355|FG001|Overall Study|Death|0|||
130413990|NCT04743908|469478354|FG000|Overall Study|Lost to Follow-up|181|||
130413991|NCT04743908|469478355|FG001|Overall Study|Lost to Follow-up|180|||
130413992|NCT04743908|469478354|FG000|Overall Study|Withdrawal by Subject|1|||
130413993|NCT04743908|469478355|FG001|Overall Study|Withdrawal by Subject|2|||
130413994|NCT00328510|469478356|FG000|Overall Study|Gag disorder, could not use frame|4|||
130413995|NCT00328510|469478357|FG001|Overall Study|Gag disorder, could not use frame|0|||
130413996|NCT00328510|469478356|FG000|Overall Study|Dentition problems, could not use frame|1|||
130413997|NCT00328510|469478357|FG001|Overall Study|Dentition problems, could not use frame|0|||
130413998|NCT00328510|469478356|FG000|Overall Study|Withdrawal by Subject|4|||
130413999|NCT00328510|469478357|FG001|Overall Study|Withdrawal by Subject|2|||
130414000|NCT00328510|469478356|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
130414001|NCT00328510|469478357|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
130414002|NCT00328510|469478356|FG000|Overall Study|Treatment changed to a single fraction|1|||
130414003|NCT00328510|469478357|FG001|Overall Study|Treatment changed to a single fraction|1|||
130414004|NCT03240588|469478361|FG000|Overall Study|Death|3|||
130414005|NCT03240588|469478362|FG001|Overall Study|Death|0|||
130414006|NCT03240588|469478363|FG002|Overall Study|Death|0|||
130414007|NCT03240588|469478361|FG000|Overall Study|Adverse Event|5|||
130414008|NCT03240588|469478362|FG001|Overall Study|Adverse Event|4|||
130414009|NCT03240588|469478363|FG002|Overall Study|Adverse Event|0|||
130414010|NCT03240588|469478361|FG000|Overall Study|Lost to Follow-up|9|||
130414011|NCT03240588|469478362|FG001|Overall Study|Lost to Follow-up|4|||
130414012|NCT03240588|469478363|FG002|Overall Study|Lost to Follow-up|0|||
130414013|NCT03240588|469478361|FG000|Overall Study|Physician Decision|3|||
130414014|NCT03240588|469478362|FG001|Overall Study|Physician Decision|2|||
130414015|NCT03240588|469478363|FG002|Overall Study|Physician Decision|0|||
130414016|NCT03240588|469478361|FG000|Overall Study|Did not meet eligibility criteria|0|||
130414017|NCT03240588|469478362|FG001|Overall Study|Did not meet eligibility criteria|6|||
130414018|NCT03240588|469478363|FG002|Overall Study|Did not meet eligibility criteria|0|||
130414019|NCT03240588|469478361|FG000|Overall Study|No longer meets protocol criteria|12|||
130414020|NCT03240588|469478362|FG001|Overall Study|No longer meets protocol criteria|7|||
130414021|NCT03240588|469478363|FG002|Overall Study|No longer meets protocol criteria|0|||
130414022|NCT03240588|469478361|FG000|Overall Study|Withdrawal by Subject|60|||
130414023|NCT03240588|469478362|FG001|Overall Study|Withdrawal by Subject|52|||
130414024|NCT03240588|469478363|FG002|Overall Study|Withdrawal by Subject|7|||
130414025|NCT03240588|469478361|FG000|Overall Study|Other, additional details not available.|0|||
130414026|NCT03240588|469478362|FG001|Overall Study|Other, additional details not available.|12|||
130414027|NCT03240588|469478363|FG002|Overall Study|Other, additional details not available.|1|||
130414028|NCT03240588|469478361|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
130414029|NCT03240588|469478362|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
130414030|NCT03240588|469478363|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
130414031|NCT03240588|469478361|FG000|Overall Study|Closure of study|55|||
130414032|NCT03240588|469478362|FG001|Overall Study|Closure of study|3|||
130414033|NCT03240588|469478363|FG002|Overall Study|Closure of study|0|||
130414034|NCT03240588|469478361|FG000|Overall Study|Subject non-compliance|23|||
130474416|NCT05009251|469706351|FG000|Overall Study|Death|25|||
130474417|NCT05009251|469706352|FG001|Overall Study|Death|22|||
130474418|NCT05009251|469706353|FG002|Overall Study|Death|24|||
130474419|NCT05009251|469706354|FG003|Overall Study|Death|19|||
130474420|NCT05009251|469706355|FG004|Overall Study|Death|15|||
130474421|NCT00616967|469706360|FG000|Overall Study|Withdrawal by Subject|0|||
130474422|NCT00616967|469706361|FG001|Overall Study|Withdrawal by Subject|0|||
130474423|NCT00616967|469706362|FG002|Overall Study|Withdrawal by Subject|1|||
130414035|NCT03240588|469478362|FG001|Overall Study|Subject non-compliance|2|||
130414036|NCT03240588|469478363|FG002|Overall Study|Subject non-compliance|1|||
130414037|NCT03240588|469478361|FG000|Overall Study|Device Deficiency|1|||
130414038|NCT03240588|469478362|FG001|Overall Study|Device Deficiency|0|||
130414039|NCT03240588|469478363|FG002|Overall Study|Device Deficiency|0|||
130474424|NCT02910583|469706363|FG000|Overall Study|Death|7|||
130474425|NCT02910583|469706364|FG001|Overall Study|Death|3|||
130474426|NCT02910583|469706363|FG000|Overall Study|Lost to Follow-up|1|||
130474427|NCT02910583|469706364|FG001|Overall Study|Lost to Follow-up|0|||
130474428|NCT02910583|469706363|FG000|Overall Study|Withdrawal by Subject|12|||
130474429|NCT02910583|469706364|FG001|Overall Study|Withdrawal by Subject|8|||
130474430|NCT02910583|469706363|FG000|Overall Study|Other, Not Specified|6|||
130474431|NCT02910583|469706364|FG001|Overall Study|Other, Not Specified|3|||
130474432|NCT01331005|469706366|FG000|Overall Study|Lost to Follow-up|2|||
130414040|NCT03240588|469478361|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
130414041|NCT03240588|469478362|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
130414042|NCT03240588|469478363|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
130414043|NCT03422250|469478364|FG000|Intervention|Adverse Event|0|||
130414044|NCT03422250|469478365|FG001|Intervention|Adverse Event|1|||
130414045|NCT03422250|469478366|FG002|Intervention|Adverse Event|0|||
130414046|NCT03422250|469478367|FG003|Intervention|Adverse Event|1|||
130414047|NCT03422250|469478364|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
130414048|NCT03422250|469478365|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
130414049|NCT03422250|469478366|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
130414050|NCT03422250|469478367|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
130414051|NCT03422250|469478364|FG000|Follow-up|Withdrawal by Subject|0|||
130414052|NCT03422250|469478365|FG001|Follow-up|Withdrawal by Subject|0|||
130414053|NCT03422250|469478366|FG002|Follow-up|Withdrawal by Subject|0|||
130414054|NCT03422250|469478367|FG003|Follow-up|Withdrawal by Subject|1|||
130414055|NCT03422250|469478364|FG000|Follow-up|Adverse Event|0|||
130414056|NCT03422250|469478365|FG001|Follow-up|Adverse Event|0|||
130414057|NCT03422250|469478366|FG002|Follow-up|Adverse Event|0|||
130414058|NCT03422250|469478367|FG003|Follow-up|Adverse Event|1|||
130414059|NCT02091726|469478370|FG000|Overall Study|Lost to Follow-up|6|||
130414060|NCT00467870|469478371|FG000|Overall Study|Adverse Event|13|||
130414061|NCT00467870|469478372|FG001|Overall Study|Adverse Event|9|||
130414062|NCT00467870|469478373|FG002|Overall Study|Adverse Event|1|||
130414063|NCT00467870|469478374|FG003|Overall Study|Adverse Event|15|||
130414064|NCT00467870|469478375|FG004|Overall Study|Adverse Event|15|||
130414065|NCT00467870|469478376|FG005|Overall Study|Adverse Event|1|||
130414066|NCT00467870|469478371|FG000|Overall Study|Protocol Violation|2|||
130414067|NCT00467870|469478372|FG001|Overall Study|Protocol Violation|1|||
130414068|NCT00467870|469478373|FG002|Overall Study|Protocol Violation|1|||
130414069|NCT00467870|469478374|FG003|Overall Study|Protocol Violation|2|||
130414070|NCT00467870|469478375|FG004|Overall Study|Protocol Violation|0|||
130414071|NCT00467870|469478376|FG005|Overall Study|Protocol Violation|0|||
130414072|NCT00467870|469478371|FG000|Overall Study|Withdrawal by Subject|14|||
130414073|NCT00467870|469478372|FG001|Overall Study|Withdrawal by Subject|21|||
130414074|NCT00467870|469478373|FG002|Overall Study|Withdrawal by Subject|0|||
130414075|NCT00467870|469478374|FG003|Overall Study|Withdrawal by Subject|9|||
130414076|NCT00467870|469478375|FG004|Overall Study|Withdrawal by Subject|10|||
130414077|NCT00467870|469478376|FG005|Overall Study|Withdrawal by Subject|1|||
130414078|NCT00467870|469478371|FG000|Overall Study|Lost to Follow-up|5|||
130414079|NCT00467870|469478372|FG001|Overall Study|Lost to Follow-up|3|||
130414080|NCT00467870|469478373|FG002|Overall Study|Lost to Follow-up|1|||
130414081|NCT00467870|469478374|FG003|Overall Study|Lost to Follow-up|1|||
130414082|NCT00467870|469478375|FG004|Overall Study|Lost to Follow-up|3|||
130414083|NCT00467870|469478376|FG005|Overall Study|Lost to Follow-up|0|||
130414084|NCT00467870|469478371|FG000|Overall Study|Subject Non-compliance|3|||
130414085|NCT00467870|469478372|FG001|Overall Study|Subject Non-compliance|4|||
130414086|NCT00467870|469478373|FG002|Overall Study|Subject Non-compliance|0|||
130414087|NCT00467870|469478374|FG003|Overall Study|Subject Non-compliance|1|||
130414088|NCT00467870|469478375|FG004|Overall Study|Subject Non-compliance|5|||
130414089|NCT00467870|469478376|FG005|Overall Study|Subject Non-compliance|0|||
130414090|NCT00467870|469478371|FG000|Overall Study|Other/Unknown|8|||
130414091|NCT00467870|469478372|FG001|Overall Study|Other/Unknown|5|||
130414092|NCT00467870|469478373|FG002|Overall Study|Other/Unknown|1|||
130414093|NCT00467870|469478374|FG003|Overall Study|Other/Unknown|5|||
130414094|NCT00467870|469478375|FG004|Overall Study|Other/Unknown|4|||
130414095|NCT00467870|469478376|FG005|Overall Study|Other/Unknown|0|||
130414096|NCT04757649|469478380|FG000|Overall Study|Withdrawal by Subject|1|||
130474433|NCT01331005|469706367|FG001|Overall Study|Lost to Follow-up|1|||
130474434|NCT01331005|469706366|FG000|Overall Study|Withdrawal by Subject|2|||
130474435|NCT01331005|469706367|FG001|Overall Study|Withdrawal by Subject|3|||
130474436|NCT05059262|469706368|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
130474437|NCT05059262|469706369|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
130474438|NCT05059262|469706368|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
130414097|NCT04757649|469478380|FG000|Overall Study|Adverse Event|1|||
130414098|NCT01286779|469478381|FG000|Overall Study|Withdrawal by Subject|9|||
130414099|NCT01286779|469478381|FG000|Overall Study|Protocol Violation|5|||
130414100|NCT01286779|469478381|FG000|Overall Study|Physician Decision|2|||
130414101|NCT01286779|469478381|FG000|Overall Study|Participant had scheduled surgery|1|||
130414102|NCT01286779|469478381|FG000|Overall Study|Participant moved to another country|1|||
130414103|NCT01286779|469478381|FG000|Overall Study|Discontinued by sponsor|1|||
130414104|NCT02896855|469478386|FG000|Overall Study|Death|50|||
130414105|NCT02896855|469478387|FG001|Overall Study|Death|40|||
130414106|NCT02896855|469478386|FG000|Overall Study|Lost to Follow-up|15|||
130414107|NCT02896855|469478387|FG001|Overall Study|Lost to Follow-up|9|||
130414108|NCT02896855|469478386|FG000|Overall Study|Withdrawal by Subject|7|||
130414109|NCT02896855|469478387|FG001|Overall Study|Withdrawal by Subject|4|||
130414110|NCT01659021|469478388|FG000|Main Study|Adverse Event|2|||
130414111|NCT01659021|469478389|FG001|Main Study|Adverse Event|3|||
130414112|NCT01659021|469478388|FG000|Main Study|Lost to Follow-up|1|||
130414113|NCT01659021|469478389|FG001|Main Study|Lost to Follow-up|0|||
130414114|NCT01659021|469478388|FG000|Main Study|Unknown Reasons|2|||
130414115|NCT01659021|469478389|FG001|Main Study|Unknown Reasons|1|||
130414116|NCT01659021|469478388|FG000|Main Study|Physician Decision|34|||
130414117|NCT01659021|469478389|FG001|Main Study|Physician Decision|16|||
130414118|NCT01659021|469478388|FG000|Main Study|Withdrawal by Subject|19|||
130414119|NCT01659021|469478389|FG001|Main Study|Withdrawal by Subject|16|||
130414120|NCT01659021|469478388|FG000|Main Study|Study Terminated by Sponsor|16|||
130414121|NCT01659021|469478389|FG001|Main Study|Study Terminated by Sponsor|1|||
130414122|NCT01659021|469478388|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
130414123|NCT01659021|469478389|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
130414124|NCT01659021|469478388|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
130414125|NCT01659021|469478389|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
130414126|NCT02508311|469478390|FG000|Overall Study|Withdrawal by Subject|1|||
130414127|NCT02508311|469478391|FG001|Overall Study|Withdrawal by Subject|0|||
130414128|NCT01205685|469478392|FG000|Overall Study|Disease Progression|10|||
130414129|NCT01205685|469478392|FG000|Overall Study|Withdrawal by Subject|1|||
130414130|NCT02169674|469478393|FG000|Overall Study|Withdrawal by Subject|2|||
130414131|NCT02169674|469478394|FG001|Overall Study|Withdrawal by Subject|1|||
130414132|NCT02169674|469478393|FG000|Overall Study|Seroprotected|30|||
130414133|NCT02169674|469478394|FG001|Overall Study|Seroprotected|76|||
130414134|NCT02169674|469478393|FG000|Overall Study|Lost to Follow-up|0|||
130414135|NCT02169674|469478394|FG001|Overall Study|Lost to Follow-up|1|||
130414136|NCT03058679|469478400|FG000|Baseline to Week 6|Lost to Follow-up|3|||
130414137|NCT03058679|469478401|FG001|Baseline to Week 6|Lost to Follow-up|2|||
130414138|NCT03058679|469478400|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
130414139|NCT03058679|469478401|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
130414140|NCT03058679|469478400|FG000|Baseline to Week 6|Adverse Event|6|||
130414141|NCT03058679|469478401|FG001|Baseline to Week 6|Adverse Event|6|||
130414142|NCT03058679|469478400|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
130414143|NCT03058679|469478401|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
130414144|NCT03058679|469478400|FG000|Baseline to Week 6|Difficulty following the diet|0|||
130414145|NCT03058679|469478401|FG001|Baseline to Week 6|Difficulty following the diet|2|||
130414146|NCT03058679|469478400|FG000|Baseline to Week 6|Physician Decision|1|||
130474439|NCT05059262|469706369|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
130474440|NCT05059262|469706368|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
130474441|NCT05059262|469706369|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
130474442|NCT05059262|469706368|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
130474443|NCT05059262|469706369|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
130414147|NCT03058679|469478401|FG001|Baseline to Week 6|Physician Decision|0|||
130414148|NCT03058679|469478400|FG000|Week 6 to Week 12|Change in medication|5|||
130414149|NCT03058679|469478401|FG001|Week 6 to Week 12|Change in medication|7|||
130414150|NCT03058679|469478400|FG000|Week 6 to Week 12|Adverse Event|4|||
130414151|NCT03058679|469478401|FG001|Week 6 to Week 12|Adverse Event|3|||
130414152|NCT03058679|469478400|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
130474444|NCT05059262|469706368|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
130474445|NCT05059262|469706369|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
130474446|NCT05059262|469706368|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
130474447|NCT05059262|469706369|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
130474448|NCT05059262|469706368|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
130474449|NCT05059262|469706369|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
130474450|NCT05059262|469706368|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
130474451|NCT05059262|469706369|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
130474452|NCT05059262|469706368|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
130474453|NCT05059262|469706369|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
130474454|NCT02029443|469706383|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
130474455|NCT02029443|469706384|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
130474456|NCT02029443|469706385|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
130474457|NCT02029443|469706386|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
130474458|NCT02029443|469706387|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
130474459|NCT02029443|469706383|FG000|Overall Study|Death|13|||
130474460|NCT02029443|469706384|FG001|Overall Study|Death|2|||
130474461|NCT02029443|469706385|FG002|Overall Study|Death|2|||
130474462|NCT02029443|469706386|FG003|Overall Study|Death|11|||
130474463|NCT02029443|469706387|FG004|Overall Study|Death|2|||
130474464|NCT02029443|469706383|FG000|Overall Study|Lost to Follow-up|1|||
130474465|NCT02029443|469706384|FG001|Overall Study|Lost to Follow-up|0|||
130474466|NCT02029443|469706385|FG002|Overall Study|Lost to Follow-up|1|||
130474467|NCT02029443|469706386|FG003|Overall Study|Lost to Follow-up|1|||
130474468|NCT02029443|469706387|FG004|Overall Study|Lost to Follow-up|0|||
130474469|NCT02029443|469706383|FG000|Overall Study|Started other anti-cancer therapy|17|||
130474470|NCT02029443|469706384|FG001|Overall Study|Started other anti-cancer therapy|4|||
130563646|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130414153|NCT03058679|469478401|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
130414154|NCT03058679|469478400|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
130414155|NCT03058679|469478401|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
130414156|NCT00574080|469478402|FG000|Overall Study|Death|10|||
130414157|NCT00574080|469478403|FG001|Overall Study|Death|10|||
130414158|NCT00599326|469478404|FG000|Overall Study|Lost to Follow-up|1|||
130414159|NCT00599326|469478404|FG000|Overall Study|Noncompliant|1|||
130414160|NCT00784810|469478407|FG000|Overall Study|Adverse Event|32|||
130414161|NCT00784810|469478408|FG001|Overall Study|Adverse Event|20|||
130414162|NCT00784810|469478407|FG000|Overall Study|Lack of Efficacy|14|||
130414163|NCT00784810|469478408|FG001|Overall Study|Lack of Efficacy|11|||
130414164|NCT00784810|469478407|FG000|Overall Study|Withdrawal by Subject|11|||
130414165|NCT00784810|469478408|FG001|Overall Study|Withdrawal by Subject|9|||
130414166|NCT00784810|469478407|FG000|Overall Study|Administrative|5|||
130414167|NCT00784810|469478408|FG001|Overall Study|Administrative|8|||
130414168|NCT00784810|469478407|FG000|Overall Study|Lost to Follow-up|1|||
130414169|NCT00784810|469478408|FG001|Overall Study|Lost to Follow-up|1|||
130414170|NCT02862106|469478409|FG000|Overall Study|Adverse Event|4|||
130414171|NCT02862106|469478410|FG001|Overall Study|Adverse Event|0|||
130414172|NCT02862106|469478409|FG000|Overall Study|Protocol Violation|16|||
130414173|NCT02862106|469478410|FG001|Overall Study|Protocol Violation|1|||
130414174|NCT02862106|469478409|FG000|Overall Study|Lost to Follow-up|15|||
130414175|NCT02862106|469478410|FG001|Overall Study|Lost to Follow-up|5|||
130414176|NCT02862106|469478409|FG000|Overall Study|Withdrawal by Subject|2|||
130414177|NCT02862106|469478410|FG001|Overall Study|Withdrawal by Subject|0|||
130414178|NCT02862106|469478409|FG000|Overall Study|Subjects moved to other city|1|||
130414179|NCT02862106|469478410|FG001|Overall Study|Subjects moved to other city|0|||
130414180|NCT00563784|469478413|FG000|Overall Study|Withdrawal by Subject|2|||
130414181|NCT00563784|469478413|FG000|Overall Study|Screen Failures|20|||
130414182|NCT01380327|469478414|FG000|Overall Study|Lost to Follow-up|0|||
130414183|NCT01380327|469478415|FG001|Overall Study|Lost to Follow-up|1|||
130414184|NCT01380327|469478416|FG002|Overall Study|Lost to Follow-up|1|||
130414185|NCT01380327|469478414|FG000|Overall Study|Protocol Violation|3|||
130414186|NCT01380327|469478415|FG001|Overall Study|Protocol Violation|2|||
130414187|NCT01380327|469478416|FG002|Overall Study|Protocol Violation|3|||
130414188|NCT01380327|469478414|FG000|Overall Study|Withdrawal by Subject|0|||
130414189|NCT01380327|469478415|FG001|Overall Study|Withdrawal by Subject|0|||
130414190|NCT01380327|469478416|FG002|Overall Study|Withdrawal by Subject|1|||
130414191|NCT01380327|469478414|FG000|Overall Study|Housing situation precluded ability to k|0|||
130414192|NCT01380327|469478415|FG001|Overall Study|Housing situation precluded ability to k|0|||
130414193|NCT01380327|469478416|FG002|Overall Study|Housing situation precluded ability to k|1|||
130414194|NCT01380327|469478414|FG000|Overall Study|Questionable onset of epilepsy|0|||
130414195|NCT01380327|469478415|FG001|Overall Study|Questionable onset of epilepsy|0|||
130414196|NCT01380327|469478416|FG002|Overall Study|Questionable onset of epilepsy|1|||
130414197|NCT03646513|469478420|FG000|Overall Study|Premature study termination|4|||
130414198|NCT02105948|469478423|FG000|Overall Study|Adverse Event|10|||
130414199|NCT02105948|469478424|FG001|Overall Study|Adverse Event|7|||
130414200|NCT02105948|469478425|FG002|Overall Study|Adverse Event|11|||
130414201|NCT02105948|469478426|FG003|Overall Study|Adverse Event|11|||
130414202|NCT02105948|469478423|FG000|Overall Study|Lack of Efficacy|0|||
130414203|NCT02105948|469478424|FG001|Overall Study|Lack of Efficacy|1|||
130414204|NCT02105948|469478425|FG002|Overall Study|Lack of Efficacy|3|||
130563647|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
130563648|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130414205|NCT02105948|469478426|FG003|Overall Study|Lack of Efficacy|2|||
130414206|NCT02105948|469478423|FG000|Overall Study|Lost to Follow-up|0|||
130414207|NCT02105948|469478424|FG001|Overall Study|Lost to Follow-up|0|||
130414208|NCT02105948|469478425|FG002|Overall Study|Lost to Follow-up|2|||
130414209|NCT02105948|469478426|FG003|Overall Study|Lost to Follow-up|1|||
130414210|NCT02105948|469478423|FG000|Overall Study|Physician Decision|2|||
130414211|NCT02105948|469478424|FG001|Overall Study|Physician Decision|2|||
130414212|NCT02105948|469478425|FG002|Overall Study|Physician Decision|2|||
130414213|NCT02105948|469478426|FG003|Overall Study|Physician Decision|2|||
130414214|NCT02105948|469478423|FG000|Overall Study|Withdrawal by Subject|15|||
130414215|NCT02105948|469478424|FG001|Overall Study|Withdrawal by Subject|10|||
130414216|NCT02105948|469478425|FG002|Overall Study|Withdrawal by Subject|10|||
130414217|NCT02105948|469478426|FG003|Overall Study|Withdrawal by Subject|11|||
130414218|NCT01934218|469478428|FG000|Double-blind Phase|Adverse Event|8|||
130414219|NCT01934218|469478429|FG001|Double-blind Phase|Adverse Event|8|||
130414220|NCT01934218|469478428|FG000|Double-blind Phase|Lack of Efficacy|6|||
130414221|NCT01934218|469478429|FG001|Double-blind Phase|Lack of Efficacy|7|||
130414222|NCT01934218|469478428|FG000|Double-blind Phase|Lost to Follow-up|7|||
130414223|NCT01934218|469478429|FG001|Double-blind Phase|Lost to Follow-up|14|||
130414224|NCT01934218|469478428|FG000|Double-blind Phase|Physician Decision|1|||
130414225|NCT01934218|469478429|FG001|Double-blind Phase|Physician Decision|2|||
130414226|NCT01934218|469478428|FG000|Double-blind Phase|Protocol Violation|4|||
130414227|NCT01934218|469478429|FG001|Double-blind Phase|Protocol Violation|0|||
130414228|NCT01934218|469478428|FG000|Double-blind Phase|Withdrawal by Subject|16|||
130414229|NCT01934218|469478429|FG001|Double-blind Phase|Withdrawal by Subject|13|||
130414230|NCT01934218|469478428|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
130414231|NCT01934218|469478429|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
130414232|NCT01934218|469478428|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
130414233|NCT01934218|469478429|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
130414234|NCT01934218|469478428|FG000|Open-Label Phase|Adverse Event|2|||
130414235|NCT01934218|469478429|FG001|Open-Label Phase|Adverse Event|4|||
130414236|NCT01934218|469478428|FG000|Open-Label Phase|Lack of Efficacy|1|||
130414237|NCT01934218|469478429|FG001|Open-Label Phase|Lack of Efficacy|4|||
130414238|NCT01934218|469478428|FG000|Open-Label Phase|Lost to Follow-up|4|||
130414239|NCT01934218|469478429|FG001|Open-Label Phase|Lost to Follow-up|2|||
130414240|NCT01934218|469478428|FG000|Open-Label Phase|Physician Decision|1|||
130414241|NCT01934218|469478429|FG001|Open-Label Phase|Physician Decision|0|||
130414242|NCT01934218|469478428|FG000|Open-Label Phase|Protocol Violation|1|||
130414243|NCT01934218|469478429|FG001|Open-Label Phase|Protocol Violation|0|||
130414244|NCT01934218|469478428|FG000|Open-Label Phase|Withdrawal by Subject|13|||
130414245|NCT01934218|469478429|FG001|Open-Label Phase|Withdrawal by Subject|11|||
130414246|NCT01934218|469478428|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
130414247|NCT01934218|469478429|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
130414248|NCT01934218|469478428|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
130414249|NCT01934218|469478429|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
130414250|NCT02232893|469478430|FG000|Overall Study|Withdrawal by Subject|4|||
130414251|NCT02232893|469478431|FG001|Overall Study|Withdrawal by Subject|1|||
130414252|NCT02232893|469478430|FG000|Overall Study|Adverse Event|0|||
130414253|NCT02232893|469478431|FG001|Overall Study|Adverse Event|1|||
130414254|NCT02232893|469478430|FG000|Overall Study|Sponsor request early termination|0|||
130414255|NCT02232893|469478431|FG001|Overall Study|Sponsor request early termination|1|||
130414256|NCT02232893|469478430|FG000|Overall Study|Developed exclusion criteria|0|||
130414257|NCT02232893|469478431|FG001|Overall Study|Developed exclusion criteria|1|||
130414258|NCT02232893|469478430|FG000|Overall Study|Other|0|||
130414259|NCT02232893|469478431|FG001|Overall Study|Other|3|||
130414260|NCT01587651|469478435|FG000|Overall Study|Adverse Event|0|||
130414261|NCT01587651|469478436|FG001|Overall Study|Adverse Event|1|||
130414262|NCT01587651|469478437|FG002|Overall Study|Adverse Event|0|||
130414263|NCT01587651|469478435|FG000|Overall Study|Protocol Violation|0|||
130414264|NCT01587651|469478436|FG001|Overall Study|Protocol Violation|1|||
130414265|NCT01587651|469478437|FG002|Overall Study|Protocol Violation|1|||
130414266|NCT01587651|469478435|FG000|Overall Study|Withdrawal by Subject|0|||
130414267|NCT01587651|469478436|FG001|Overall Study|Withdrawal by Subject|1|||
130414268|NCT01587651|469478437|FG002|Overall Study|Withdrawal by Subject|0|||
130414269|NCT01660763|469478441|FG000|Overall Study|Lack of Efficacy|45|||
130414270|NCT01660763|469478442|FG001|Overall Study|Lack of Efficacy|50|||
130414271|NCT01660763|469478441|FG000|Overall Study|Adverse Event|22|||
130414272|NCT01660763|469478442|FG001|Overall Study|Adverse Event|7|||
130414273|NCT01660763|469478441|FG000|Overall Study|Protocol Violation|1|||
130414274|NCT01660763|469478442|FG001|Overall Study|Protocol Violation|0|||
130414275|NCT01660763|469478441|FG000|Overall Study|Withdrawal by Subject|4|||
130414276|NCT01660763|469478442|FG001|Overall Study|Withdrawal by Subject|0|||
130414277|NCT01660763|469478441|FG000|Overall Study|Patient ready for early discharge|28|||
130414278|NCT01660763|469478442|FG001|Overall Study|Patient ready for early discharge|4|||
130414279|NCT03325712|469478443|FG000|Overall Study|Protocol Violation|0|||
130414280|NCT03325712|469478444|FG001|Overall Study|Protocol Violation|0|||
130414281|NCT03325712|469478445|FG002|Overall Study|Protocol Violation|0|||
130414282|NCT03325712|469478446|FG003|Overall Study|Protocol Violation|0|||
130414283|NCT03325712|469478447|FG004|Overall Study|Protocol Violation|1|||
130414284|NCT03325712|469478448|FG005|Overall Study|Protocol Violation|0|||
130414285|NCT03325712|469478449|FG006|Overall Study|Protocol Violation|0|||
130414286|NCT03325712|469478450|FG007|Overall Study|Protocol Violation|0|||
130414287|NCT03325712|469478443|FG000|Overall Study|Adverse Event|0|||
130414288|NCT03325712|469478444|FG001|Overall Study|Adverse Event|0|||
130474471|NCT02029443|469706385|FG002|Overall Study|Started other anti-cancer therapy|7|||
130474472|NCT02029443|469706386|FG003|Overall Study|Started other anti-cancer therapy|9|||
130414289|NCT03325712|469478445|FG002|Overall Study|Adverse Event|0|||
130414290|NCT03325712|469478446|FG003|Overall Study|Adverse Event|0|||
130414291|NCT03325712|469478447|FG004|Overall Study|Adverse Event|1|||
130414292|NCT03325712|469478448|FG005|Overall Study|Adverse Event|0|||
130414293|NCT03325712|469478449|FG006|Overall Study|Adverse Event|0|||
130414294|NCT03325712|469478450|FG007|Overall Study|Adverse Event|0|||
130414295|NCT02265237|469478452|FG000|As Treated (Overall Study)|Adverse Event|1|||
130414296|NCT02265237|469478453|FG001|As Treated (Overall Study)|Adverse Event|1|||
130414297|NCT02265237|469478454|FG002|As Treated (Overall Study)|Adverse Event|0|||
130414298|NCT02265237|469478455|FG003|As Treated (Overall Study)|Adverse Event|0|||
130474473|NCT02029443|469706387|FG004|Overall Study|Started other anti-cancer therapy|3|||
130414299|NCT02265237|469478452|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
130414300|NCT02265237|469478453|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
130414301|NCT02265237|469478454|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
130414302|NCT02265237|469478455|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
130414303|NCT02265237|469478452|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
130414304|NCT02265237|469478453|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
130414305|NCT02265237|469478454|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
130414306|NCT02265237|469478455|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
130414307|NCT02265237|469478452|FG000|As Treated (Overall Study)|Other|2|||
130414308|NCT02265237|469478453|FG001|As Treated (Overall Study)|Other|0|||
130414309|NCT02265237|469478454|FG002|As Treated (Overall Study)|Other|3|||
130414310|NCT02265237|469478455|FG003|As Treated (Overall Study)|Other|1|||
130414311|NCT01178853|469478456|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
130414312|NCT01178853|469478457|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
130414313|NCT01178853|469478456|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
130414314|NCT01178853|469478457|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
130414315|NCT01178853|469478456|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
130563649|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563650|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130414316|NCT01178853|469478457|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
130414317|NCT01178853|469478456|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
130414318|NCT01178853|469478457|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
130414319|NCT01178853|469478456|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
130414320|NCT01178853|469478457|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
130414321|NCT03550313|469478458|FG000|Overall Study|Adverse Event|0|||
130414322|NCT03550313|469478459|FG001|Overall Study|Adverse Event|1|||
130414323|NCT03550313|469478460|FG002|Overall Study|Adverse Event|0|||
130414324|NCT03550313|469478458|FG000|Overall Study|Lost to Follow-up|5|||
130414325|NCT03550313|469478459|FG001|Overall Study|Lost to Follow-up|7|||
130414326|NCT03550313|469478460|FG002|Overall Study|Lost to Follow-up|12|||
130414327|NCT03550313|469478458|FG000|Overall Study|Study terminated by sponsor|44|||
130414328|NCT03550313|469478459|FG001|Overall Study|Study terminated by sponsor|37|||
130414329|NCT03550313|469478460|FG002|Overall Study|Study terminated by sponsor|48|||
130414330|NCT03550313|469478458|FG000|Overall Study|No longer met eligibility criteria|3|||
130414331|NCT03550313|469478459|FG001|Overall Study|No longer met eligibility criteria|5|||
130414332|NCT03550313|469478460|FG002|Overall Study|No longer met eligibility criteria|6|||
130414333|NCT03550313|469478458|FG000|Overall Study|Withdrawal by parent/guardian|20|||
130414334|NCT03550313|469478459|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130414335|NCT03550313|469478460|FG002|Overall Study|Withdrawal by parent/guardian|26|||
130414336|NCT03550313|469478458|FG000|Overall Study|Other|4|||
130414337|NCT03550313|469478459|FG001|Overall Study|Other|2|||
130414338|NCT03550313|469478460|FG002|Overall Study|Other|2|||
130414339|NCT03550313|469478458|FG000|Overall Study|Randomized but not vaccinated|3|||
130414340|NCT03550313|469478459|FG001|Overall Study|Randomized but not vaccinated|23|||
130414341|NCT03550313|469478460|FG002|Overall Study|Randomized but not vaccinated|2|||
130414342|NCT03550313|469478458|FG000|Overall Study|Sites terminated due to quality issues|18|||
130414343|NCT03550313|469478459|FG001|Overall Study|Sites terminated due to quality issues|17|||
130414344|NCT03550313|469478460|FG002|Overall Study|Sites terminated due to quality issues|18|||
130414345|NCT00380068|469478462|FG000|Overall Study|Adverse Event|40|||
130414346|NCT00380068|469478462|FG000|Overall Study|Withdrawal by Subject|10|||
130414347|NCT00380068|469478462|FG000|Overall Study|Not compliant|6|||
130414348|NCT00380068|469478462|FG000|Overall Study|Lost to Follow-up|1|||
130414349|NCT00380068|469478462|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
130414350|NCT00380068|469478462|FG000|Overall Study|Lung transplant|3|||
130414351|NCT00380068|469478462|FG000|Overall Study|Physician Decision|2|||
130414352|NCT00380068|469478462|FG000|Overall Study|Partipant moved away|1|||
130414353|NCT00380068|469478462|FG000|Overall Study|Lack of Efficacy|5|||
130414354|NCT01297062|469478463|FG000|Overall Study|Adverse Event|2|||
130414355|NCT01297062|469478464|FG001|Overall Study|Adverse Event|0|||
130414356|NCT01297062|469478465|FG002|Overall Study|Adverse Event|1|||
130414357|NCT01297062|469478466|FG003|Overall Study|Adverse Event|0|||
130414358|NCT01297062|469478467|FG004|Overall Study|Adverse Event|0|||
130414359|NCT01297062|469478468|FG005|Overall Study|Adverse Event|0|||
130414360|NCT01297062|469478469|FG006|Overall Study|Adverse Event|0|||
130414361|NCT01297062|469478463|FG000|Overall Study|Physician Decision|1|||
130414362|NCT01297062|469478464|FG001|Overall Study|Physician Decision|0|||
130414363|NCT01297062|469478465|FG002|Overall Study|Physician Decision|1|||
130414364|NCT01297062|469478466|FG003|Overall Study|Physician Decision|0|||
130414365|NCT01297062|469478467|FG004|Overall Study|Physician Decision|0|||
130414366|NCT01297062|469478468|FG005|Overall Study|Physician Decision|0|||
130563651|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130414367|NCT01297062|469478469|FG006|Overall Study|Physician Decision|6|||
130563652|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
130414368|NCT01297062|469478463|FG000|Overall Study|Protocol Violation|0|||
130414369|NCT01297062|469478464|FG001|Overall Study|Protocol Violation|0|||
130414370|NCT01297062|469478465|FG002|Overall Study|Protocol Violation|0|||
130414371|NCT01297062|469478466|FG003|Overall Study|Protocol Violation|0|||
130414372|NCT01297062|469478467|FG004|Overall Study|Protocol Violation|1|||
130414373|NCT01297062|469478468|FG005|Overall Study|Protocol Violation|0|||
130414374|NCT01297062|469478469|FG006|Overall Study|Protocol Violation|0|||
130414375|NCT01297062|469478463|FG000|Overall Study|Subject Decision|1|||
130414376|NCT01297062|469478464|FG001|Overall Study|Subject Decision|1|||
130414377|NCT01297062|469478465|FG002|Overall Study|Subject Decision|0|||
130414378|NCT01297062|469478466|FG003|Overall Study|Subject Decision|1|||
130414379|NCT01297062|469478467|FG004|Overall Study|Subject Decision|1|||
130414380|NCT01297062|469478468|FG005|Overall Study|Subject Decision|1|||
130414381|NCT01297062|469478469|FG006|Overall Study|Subject Decision|2|||
130414382|NCT04964089|469478470|FG000|Overall Study|Adverse Event|8|||
130414383|NCT04964089|469478471|FG001|Overall Study|Adverse Event|6|||
130414384|NCT04964089|469478470|FG000|Overall Study|Non-compliance with study schedule|1|||
130414385|NCT04964089|469478471|FG001|Overall Study|Non-compliance with study schedule|0|||
130414386|NCT04964089|469478470|FG000|Overall Study|Withdrawal by Subject|6|||
130414387|NCT04964089|469478471|FG001|Overall Study|Withdrawal by Subject|5|||
130414388|NCT04964089|469478470|FG000|Overall Study|Lost to Follow-up|1|||
130414389|NCT04964089|469478471|FG001|Overall Study|Lost to Follow-up|1|||
130414390|NCT04964089|469478470|FG000|Overall Study|Progressive disease|4|||
130414391|NCT04964089|469478471|FG001|Overall Study|Progressive disease|0|||
130414392|NCT04964089|469478470|FG000|Overall Study|Physician Decision|1|||
130414393|NCT04964089|469478471|FG001|Overall Study|Physician Decision|0|||
130414394|NCT04964089|469478470|FG000|Overall Study|Participant did not want to continue study treatment|1|||
130414395|NCT04964089|469478471|FG001|Overall Study|Participant did not want to continue study treatment|0|||
130414396|NCT04964089|469478470|FG000|Overall Study|Participant moved to different state|1|||
130414397|NCT04964089|469478471|FG001|Overall Study|Participant moved to different state|0|||
130414398|NCT04964089|469478470|FG000|Overall Study|Participant decided to discontinue|0|||
130414399|NCT04964089|469478471|FG001|Overall Study|Participant decided to discontinue|1|||
130414400|NCT01165281|469478477|FG000|Overall Study|Adverse Event|12|||
130414401|NCT01165281|469478478|FG001|Overall Study|Adverse Event|14|||
130414402|NCT01165281|469478477|FG000|Overall Study|Death|3|||
130414403|NCT01165281|469478478|FG001|Overall Study|Death|4|||
130414404|NCT01165281|469478477|FG000|Overall Study|Lack of Efficacy|4|||
130414405|NCT01165281|469478478|FG001|Overall Study|Lack of Efficacy|1|||
130414406|NCT01165281|469478477|FG000|Overall Study|Lost to Follow-up|0|||
130414407|NCT01165281|469478478|FG001|Overall Study|Lost to Follow-up|1|||
130414408|NCT01165281|469478477|FG000|Overall Study|Physician Decision|8|||
130414409|NCT01165281|469478478|FG001|Overall Study|Physician Decision|1|||
130414410|NCT01165281|469478477|FG000|Overall Study|Protocol Violation|6|||
130414411|NCT01165281|469478478|FG001|Overall Study|Protocol Violation|5|||
130414412|NCT01165281|469478477|FG000|Overall Study|Withdrawal by Subject|8|||
130414413|NCT01165281|469478478|FG001|Overall Study|Withdrawal by Subject|7|||
130414414|NCT01165281|469478477|FG000|Overall Study|Noncompliance with Study Drug|1|||
130414415|NCT01165281|469478478|FG001|Overall Study|Noncompliance with Study Drug|4|||
130414416|NCT01165281|469478477|FG000|Overall Study|Progressive Disease|10|||
130414417|NCT01165281|469478478|FG001|Overall Study|Progressive Disease|14|||
130414418|NCT01165281|469478477|FG000|Overall Study|Other|6|||
130414419|NCT01165281|469478478|FG001|Overall Study|Other|0|||
130414420|NCT02005471|469478483|FG000|Main Study|Adverse Event|0|||
130414421|NCT02005471|469478484|FG001|Main Study|Adverse Event|1|||
130474474|NCT02029443|469706383|FG000|Overall Study|Withdrawal by Subject|3|||
130474475|NCT02029443|469706384|FG001|Overall Study|Withdrawal by Subject|1|||
130474476|NCT02029443|469706385|FG002|Overall Study|Withdrawal by Subject|1|||
130474477|NCT02029443|469706386|FG003|Overall Study|Withdrawal by Subject|1|||
130474478|NCT02029443|469706387|FG004|Overall Study|Withdrawal by Subject|0|||
130474479|NCT02029443|469706383|FG000|Overall Study|Other|6|||
130474480|NCT02029443|469706384|FG001|Overall Study|Other|6|||
130474481|NCT02029443|469706385|FG002|Overall Study|Other|4|||
130474482|NCT02029443|469706386|FG003|Overall Study|Other|2|||
130474483|NCT02029443|469706387|FG004|Overall Study|Other|0|||
130474484|NCT03393975|469706389|FG000|Urgent Treatment Period|Physician Decision|0|||
130474485|NCT03393975|469706390|FG001|Urgent Treatment Period|Physician Decision|0|||
130474486|NCT03393975|469706391|FG002|Urgent Treatment Period|Physician Decision|0|||
130474487|NCT03393975|469706392|FG003|Urgent Treatment Period|Physician Decision|1|||
130474488|NCT03393975|469706389|FG000|Prophylaxis Period 1|Reason not Specified|0|||
130474489|NCT03393975|469706390|FG001|Prophylaxis Period 1|Reason not Specified|1|||
130414422|NCT02005471|469478485|FG002|Main Study|Adverse Event|0|||
130474490|NCT03393975|469706391|FG002|Prophylaxis Period 1|Reason not Specified|0|||
130474491|NCT03393975|469706392|FG003|Prophylaxis Period 1|Reason not Specified|0|||
130474492|NCT03393975|469706389|FG000|Prophylaxis Period 2|Reason not Specified|0|||
130414423|NCT02005471|469478486|FG003|Main Study|Adverse Event|0|||
130414424|NCT02005471|469478483|FG000|Main Study|Death|83|||
130414425|NCT02005471|469478484|FG001|Main Study|Death|52|||
130414426|NCT02005471|469478485|FG002|Main Study|Death|0|||
130414427|NCT02005471|469478486|FG003|Main Study|Death|0|||
130414428|NCT02005471|469478483|FG000|Main Study|Lost to Follow-up|4|||
130414429|NCT02005471|469478484|FG001|Main Study|Lost to Follow-up|5|||
130414430|NCT02005471|469478485|FG002|Main Study|Lost to Follow-up|0|||
130414431|NCT02005471|469478486|FG003|Main Study|Lost to Follow-up|0|||
130414432|NCT02005471|469478483|FG000|Main Study|Physician Decision|3|||
130414433|NCT02005471|469478484|FG001|Main Study|Physician Decision|1|||
130414434|NCT02005471|469478485|FG002|Main Study|Physician Decision|0|||
130414435|NCT02005471|469478486|FG003|Main Study|Physician Decision|0|||
130414436|NCT02005471|469478483|FG000|Main Study|Withdrawal by Subject|26|||
130414437|NCT02005471|469478484|FG001|Main Study|Withdrawal by Subject|11|||
130414438|NCT02005471|469478485|FG002|Main Study|Withdrawal by Subject|0|||
130414439|NCT02005471|469478486|FG003|Main Study|Withdrawal by Subject|0|||
130414440|NCT02005471|469478483|FG000|Main Study|Reason not Specified|0|||
130414441|NCT02005471|469478484|FG001|Main Study|Reason not Specified|6|||
130414442|NCT02005471|469478485|FG002|Main Study|Reason not Specified|0|||
130414443|NCT02005471|469478486|FG003|Main Study|Reason not Specified|0|||
130474493|NCT03393975|469706390|FG001|Prophylaxis Period 2|Reason not Specified|1|||
130474494|NCT03393975|469706391|FG002|Prophylaxis Period 2|Reason not Specified|0|||
130474495|NCT03393975|469706392|FG003|Prophylaxis Period 2|Reason not Specified|0|||
130474496|NCT05021640|469706396|FG000|Overall Study|Lost to Follow-up|0|||
130563653|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563654|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563655|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563656|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563657|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563658|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563659|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563660|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130563661|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563662|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563663|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563664|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
130563665|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
130563666|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563667|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563668|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
130563669|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
130563670|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563671|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563672|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563673|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563674|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130563675|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563676|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563677|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563678|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563679|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563680|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563681|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563682|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
130563683|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
130563684|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563685|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563686|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563687|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563688|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130563689|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563690|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130474497|NCT05021640|469706397|FG001|Overall Study|Lost to Follow-up|0|||
130474498|NCT05021640|469706398|FG002|Overall Study|Lost to Follow-up|0|||
130474499|NCT05021640|469706399|FG003|Overall Study|Lost to Follow-up|0|||
130474500|NCT05021640|469706400|FG004|Overall Study|Lost to Follow-up|1|||
130474501|NCT04737772|469706401|FG000|Phase 2 Study|Lost to Follow-up|15|||
130474502|NCT04737772|469706402|FG001|Phase 2 Study|Lost to Follow-up|15|||
130474503|NCT04737772|469706401|FG000|Phase 2 Study|Withdrawal by Subject|0|||
130563691|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563692|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130414444|NCT02005471|469478483|FG000|Main Study|Randomized but not Dosed|8|||
130414445|NCT02005471|469478484|FG001|Main Study|Randomized but not Dosed|0|||
130414446|NCT02005471|469478485|FG002|Main Study|Randomized but not Dosed|0|||
130474504|NCT04737772|469706402|FG001|Phase 2 Study|Withdrawal by Subject|1|||
130474505|NCT04737772|469706401|FG000|Phase 2 Study|Did not take any coaching calls|4|||
130414447|NCT02005471|469478486|FG003|Main Study|Randomized but not Dosed|0|||
130414448|NCT02005471|469478483|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130414449|NCT02005471|469478484|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130414450|NCT02005471|469478485|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130414451|NCT02005471|469478486|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
130414452|NCT02005471|469478483|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
130414453|NCT02005471|469478484|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
130414454|NCT02005471|469478485|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
130414455|NCT02005471|469478486|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
130414456|NCT02005471|469478483|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
130414457|NCT02005471|469478484|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
130414458|NCT02005471|469478485|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
130414459|NCT02005471|469478486|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
130414460|NCT00363766|469478487|FG000|Overall Study|Progressive Disease|15|||
130414461|NCT00363766|469478488|FG001|Overall Study|Progressive Disease|9|||
130414462|NCT00363766|469478487|FG000|Overall Study|Adverse Event|10|||
130414463|NCT00363766|469478488|FG001|Overall Study|Adverse Event|2|||
130414464|NCT00363766|469478487|FG000|Overall Study|Disease Related Death|1|||
130414465|NCT00363766|469478488|FG001|Overall Study|Disease Related Death|3|||
130414466|NCT00363766|469478487|FG000|Overall Study|Not Disease Related Death|3|||
130414467|NCT00363766|469478488|FG001|Overall Study|Not Disease Related Death|4|||
130414468|NCT00363766|469478487|FG000|Overall Study|Withdrawal by Subject|2|||
130414469|NCT00363766|469478488|FG001|Overall Study|Withdrawal by Subject|0|||
130414470|NCT00363766|469478487|FG000|Overall Study|Physician Decision|1|||
130414471|NCT00363766|469478488|FG001|Overall Study|Physician Decision|2|||
130414472|NCT00627705|469478489|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
130414473|NCT00627705|469478490|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
130414474|NCT00627705|469478489|FG000|Overall Study|Adverse Event|1|||
130414475|NCT00627705|469478490|FG001|Overall Study|Adverse Event|0|||
130414476|NCT00627705|469478489|FG000|Overall Study|Withdrawal by Subject|0|||
130414477|NCT00627705|469478490|FG001|Overall Study|Withdrawal by Subject|2|||
130414478|NCT00627705|469478489|FG000|Overall Study|Lost to Follow-up|0|||
130414479|NCT00627705|469478490|FG001|Overall Study|Lost to Follow-up|1|||
130414480|NCT04295564|469480592|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
130563693|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563694|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563695|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563696|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563697|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
130563698|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563699|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563700|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563701|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130563702|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130474506|NCT04737772|469706402|FG001|Phase 2 Study|Did not take any coaching calls|0|||
130474507|NCT04737772|469706401|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
130474508|NCT04737772|469706402|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
130474509|NCT04737772|469706401|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
130474510|NCT04737772|469706402|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
130474511|NCT04083235|469706405|FG000|Overall Study|Death|252|||
130474512|NCT04083235|469706406|FG001|Overall Study|Death|277|||
130474513|NCT04083235|469706405|FG000|Overall Study|Withdrawal by Subject|13|||
130474514|NCT04083235|469706406|FG001|Overall Study|Withdrawal by Subject|17|||
130474515|NCT04083235|469706405|FG000|Overall Study|Lost to Follow-up|1|||
130474516|NCT04083235|469706406|FG001|Overall Study|Lost to Follow-up|1|||
130474517|NCT04083235|469706405|FG000|Overall Study|Does not meet entry criteria|1|||
130474518|NCT04083235|469706406|FG001|Overall Study|Does not meet entry criteria|0|||
130474519|NCT04083235|469706405|FG000|Overall Study|Did not receive treatment|13|||
130474520|NCT04083235|469706406|FG001|Overall Study|Did not receive treatment|8|||
130474521|NCT04083235|469706405|FG000|Overall Study|Ongoing at the time of DCO|44|||
130414481|NCT04295564|469480593|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
130414482|NCT01682460|469480594|FG000|Overall Study|Withdrawal by Subject|2|||
130414483|NCT01682460|469480594|FG000|Overall Study|Did not meet inclusion criteria|2|||
130414484|NCT02105116|469480595|FG000|Overall Study|not eligible for step 2 of trial|5|||
130414485|NCT02105116|469480595|FG000|Overall Study|Death|1|||
130414486|NCT00773968|469480596|FG000|Overall Study|Adverse Event|2|||
130474522|NCT04083235|469706406|FG001|Overall Study|Ongoing at the time of DCO|7|||
130474523|NCT05691309|469706409|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
130474524|NCT05691309|469706409|FG000|Overall Study|vancomycin levels not evaluable|2|||
130563703|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563704|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563705|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563706|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
130563707|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563708|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563709|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563710|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130414487|NCT00773968|469480596|FG000|Overall Study|Death|1|||
130414488|NCT00773968|469480596|FG000|Overall Study|Failure to Return|2|||
130414489|NCT00773968|469480596|FG000|Overall Study|Lack of Efficacy|3|||
130414490|NCT00773968|469480596|FG000|Overall Study|Protocol Violation|1|||
130414491|NCT00773968|469480596|FG000|Overall Study|Withdrawal by Subject|11|||
130414492|NCT00773968|469480596|FG000|Overall Study|Screen Failure|17|||
130414493|NCT00773968|469480596|FG000|Overall Study|Other|8|||
130414494|NCT00263666|469480597|FG000|Overall Study|Adverse Event|6|||
130414495|NCT00263666|469480598|FG001|Overall Study|Adverse Event|8|||
130414496|NCT00263666|469480597|FG000|Overall Study|Lost to Follow-up|1|||
130414497|NCT00263666|469480598|FG001|Overall Study|Lost to Follow-up|2|||
130414498|NCT00263666|469480597|FG000|Overall Study|Withdrawal by Subject|0|||
130414499|NCT00263666|469480598|FG001|Overall Study|Withdrawal by Subject|1|||
130414500|NCT02492100|469480599|FG000|Overall Study|Death|1|||
130414501|NCT00321919|469480600|FG000|Overall Study|Adverse Event|17|||
130414502|NCT00321919|469480601|FG001|Overall Study|Adverse Event|10|||
130414503|NCT00321919|469480600|FG000|Overall Study|Death|21|||
130414504|NCT00321919|469480601|FG001|Overall Study|Death|17|||
130414505|NCT00321919|469480600|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130414506|NCT00321919|469480601|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130414507|NCT00321919|469480600|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130414508|NCT00321919|469480601|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130414509|NCT00321919|469480600|FG000|Overall Study|Refused Treatment|23|||
130414510|NCT00321919|469480601|FG001|Overall Study|Refused Treatment|14|||
130414511|NCT00321919|469480600|FG000|Overall Study|Other Protocol Violation|2|||
130414512|NCT00321919|469480601|FG001|Overall Study|Other Protocol Violation|3|||
130414513|NCT00321919|469480600|FG000|Overall Study|Failure to Return|3|||
130414514|NCT00321919|469480601|FG001|Overall Study|Failure to Return|1|||
130414515|NCT00321919|469480600|FG000|Overall Study|Other withdrawal reason|7|||
130414516|NCT00321919|469480601|FG001|Overall Study|Other withdrawal reason|6|||
130414517|NCT02261363|469480602|FG000|Overall Study|Lost to Follow-up|21|||
130414518|NCT01517802|469480603|FG000|Overall Study|Death|1|||
130414519|NCT02590354|469480604|FG000|Phase 1|Active hepatitis B or C infection|1|||
130414520|NCT02590354|469480604|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
130414521|NCT02590354|469480604|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
130414522|NCT02590354|469480604|FG000|Phase 1|Subject does not want to participate|20|||
130414523|NCT02590354|469480604|FG000|Phase 1|Lost to Follow-up|1|||
130414524|NCT02590354|469480604|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
130414525|NCT02099838|469480605|FG000|Overall Study|Death|1|||
130414526|NCT02099838|469480606|FG001|Overall Study|Death|0|||
130414527|NCT02099838|469480605|FG000|Overall Study|Lost to Follow-up|3|||
130414528|NCT02099838|469480606|FG001|Overall Study|Lost to Follow-up|1|||
130414529|NCT02099838|469480605|FG000|Overall Study|Withdrawal by Subject|0|||
130414530|NCT02099838|469480606|FG001|Overall Study|Withdrawal by Subject|1|||
130414531|NCT02301143|469480607|FG000|Induction Period|Enrolled But Not Treated|1|||
130414532|NCT02301143|469480608|FG001|Induction Period|Enrolled But Not Treated|0|||
130414533|NCT02301143|469480607|FG000|Induction Period|Death|1|||
130414534|NCT02301143|469480608|FG001|Induction Period|Death|0|||
130414535|NCT02301143|469480607|FG000|Induction Period|Adverse Event|22|||
130414536|NCT02301143|469480608|FG001|Induction Period|Adverse Event|0|||
130414537|NCT02301143|469480607|FG000|Induction Period|Progressive Disease|8|||
130414538|NCT02301143|469480608|FG001|Induction Period|Progressive Disease|0|||
130414539|NCT02301143|469480607|FG000|Induction Period|Withdrawal by Subject|3|||
130414540|NCT02301143|469480608|FG001|Induction Period|Withdrawal by Subject|0|||
130414541|NCT02301143|469480607|FG000|Induction Period|Noncompliance with Study Drug|1|||
130414542|NCT02301143|469480608|FG001|Induction Period|Noncompliance with Study Drug|0|||
130414543|NCT02301143|469480607|FG000|Induction Period|Physician Decision|4|||
130414544|NCT02301143|469480608|FG001|Induction Period|Physician Decision|0|||
130414545|NCT02301143|469480607|FG000|Induction Period|Symptomatic Deterioration|2|||
130414546|NCT02301143|469480608|FG001|Induction Period|Symptomatic Deterioration|0|||
130414547|NCT02301143|469480607|FG000|Induction Period|Protocol Violation|2|||
130414548|NCT02301143|469480608|FG001|Induction Period|Protocol Violation|0|||
130414549|NCT02301143|469480607|FG000|Induction Period|Other|1|||
130414550|NCT02301143|469480608|FG001|Induction Period|Other|0|||
130414551|NCT02301143|469480607|FG000|Investigator's Choice|Adverse Event|0|||
130414552|NCT02301143|469480608|FG001|Investigator's Choice|Adverse Event|3|||
130414553|NCT02301143|469480607|FG000|Investigator's Choice|Progressive Disease|0|||
130414554|NCT02301143|469480608|FG001|Investigator's Choice|Progressive Disease|3|||
130414555|NCT02301143|469480607|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
130414556|NCT02301143|469480608|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
130414557|NCT02301143|469480607|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
130414558|NCT02301143|469480608|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
130414559|NCT02301143|469480607|FG000|Investigator's Choice|Other|0|||
130414560|NCT02301143|469480608|FG001|Investigator's Choice|Other|1|||
130414561|NCT02301143|469480607|FG000|Investigator's Choice|Unresectable Surgery|0|||
130414562|NCT02301143|469480608|FG001|Investigator's Choice|Unresectable Surgery|1|||
130414563|NCT02536508|469480611|FG000|Overall Study|Withdrawal by Subject|18|||
130414564|NCT02536508|469480612|FG001|Overall Study|Withdrawal by Subject|13|||
130414565|NCT02536508|469480613|FG002|Overall Study|Withdrawal by Subject|7|||
130414566|NCT02536508|469480611|FG000|Overall Study|Adverse Event|14|||
130414567|NCT02536508|469480612|FG001|Overall Study|Adverse Event|13|||
130414568|NCT02536508|469480613|FG002|Overall Study|Adverse Event|6|||
130414569|NCT02536508|469480611|FG000|Overall Study|Lost to Follow-up|12|||
130414570|NCT02536508|469480612|FG001|Overall Study|Lost to Follow-up|4|||
130414571|NCT02536508|469480613|FG002|Overall Study|Lost to Follow-up|0|||
130474525|NCT01804816|469706410|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
130474526|NCT01804816|469706410|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
130474527|NCT04421378|469706416|FG000|Overall Study|Adverse Event|2|||
130474528|NCT04421378|469706417|FG001|Overall Study|Adverse Event|7|||
130563711|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563712|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563713|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563714|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563715|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130563716|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130727230|NCT02883049|470625430|FG006|Post Induction|Protocol Violation|0|||
130727231|NCT02883049|470625431|FG007|Post Induction|Protocol Violation|1|||
130727232|NCT02883049|470625432|FG008|Post Induction|Protocol Violation|0|||
130727233|NCT02883049|470625433|FG009|Post Induction|Protocol Violation|0|||
130727234|NCT02883049|470625434|FG010|Post Induction|Protocol Violation|0|||
130727235|NCT02883049|470625435|FG011|Post Induction|Protocol Violation|0|||
130414572|NCT02536508|469480611|FG000|Overall Study|Lack of Efficacy|3|||
130563717|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563718|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563719|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563720|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563721|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130414573|NCT02536508|469480612|FG001|Overall Study|Lack of Efficacy|5|||
130414574|NCT02536508|469480613|FG002|Overall Study|Lack of Efficacy|4|||
130474529|NCT04421378|469706418|FG002|Overall Study|Adverse Event|0|||
130474530|NCT04421378|469706419|FG003|Overall Study|Adverse Event|1|||
130474531|NCT04421378|469706420|FG004|Overall Study|Adverse Event|0|||
130474532|NCT04421378|469706416|FG000|Overall Study|Physician Decision|1|||
130474533|NCT04421378|469706417|FG001|Overall Study|Physician Decision|2|||
130474534|NCT04421378|469706418|FG002|Overall Study|Physician Decision|0|||
130474535|NCT04421378|469706419|FG003|Overall Study|Physician Decision|0|||
130474536|NCT04421378|469706420|FG004|Overall Study|Physician Decision|0|||
130474537|NCT04421378|469706416|FG000|Overall Study|Progressive Disease|16|||
130474538|NCT04421378|469706417|FG001|Overall Study|Progressive Disease|4|||
130474539|NCT04421378|469706418|FG002|Overall Study|Progressive Disease|18|||
130474540|NCT04421378|469706419|FG003|Overall Study|Progressive Disease|11|||
130474541|NCT04421378|469706420|FG004|Overall Study|Progressive Disease|3|||
130474542|NCT04421378|469706416|FG000|Overall Study|Study Terminated by Sponsor|0|||
130474543|NCT04421378|469706417|FG001|Overall Study|Study Terminated by Sponsor|1|||
130474544|NCT04421378|469706418|FG002|Overall Study|Study Terminated by Sponsor|1|||
130474545|NCT04421378|469706419|FG003|Overall Study|Study Terminated by Sponsor|0|||
130474546|NCT04421378|469706420|FG004|Overall Study|Study Terminated by Sponsor|0|||
130474547|NCT04421378|469706416|FG000|Overall Study|Withdrawal by Subject|3|||
130474548|NCT04421378|469706417|FG001|Overall Study|Withdrawal by Subject|1|||
130414575|NCT02536508|469480611|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
130414576|NCT02536508|469480612|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
130414577|NCT02536508|469480613|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
130563722|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130727236|NCT02883049|470625436|FG012|Post Induction|Protocol Violation|0|||
130414578|NCT02536508|469480611|FG000|Overall Study|Physician Decision|0|||
130414579|NCT02536508|469480612|FG001|Overall Study|Physician Decision|4|||
130727237|NCT02883049|470625437|FG013|Post Induction|Protocol Violation|0|||
130414580|NCT02536508|469480613|FG002|Overall Study|Physician Decision|2|||
130414581|NCT02536508|469480611|FG000|Overall Study|Major Protocol Deviation|2|||
130474549|NCT04421378|469706418|FG002|Overall Study|Withdrawal by Subject|0|||
130474550|NCT04421378|469706419|FG003|Overall Study|Withdrawal by Subject|2|||
130474551|NCT04421378|469706420|FG004|Overall Study|Withdrawal by Subject|0|||
130474552|NCT04421378|469706416|FG000|Overall Study|Other|1|||
130727238|NCT02883049|470625438|FG014|Post Induction|Protocol Violation|0|||
130414582|NCT02536508|469480612|FG001|Overall Study|Major Protocol Deviation|2|||
130414583|NCT02536508|469480613|FG002|Overall Study|Major Protocol Deviation|2|||
130414584|NCT02536508|469480611|FG000|Overall Study|Administrative Reasons|0|||
130414585|NCT02536508|469480612|FG001|Overall Study|Administrative Reasons|1|||
130414586|NCT02536508|469480613|FG002|Overall Study|Administrative Reasons|0|||
130414587|NCT00823719|469480616|FG000|Overall Study|Adverse Event|1|||
130414588|NCT00823719|469480617|FG001|Overall Study|Adverse Event|2|||
130414589|NCT00823719|469480616|FG000|Overall Study|Physician Decision|1|||
130414590|NCT00823719|469480617|FG001|Overall Study|Physician Decision|4|||
130414591|NCT00823719|469480616|FG000|Overall Study|Withdrawal by Subject|0|||
130414592|NCT00823719|469480617|FG001|Overall Study|Withdrawal by Subject|1|||
130414593|NCT00823719|469480616|FG000|Overall Study|Disease Progression|4|||
130414594|NCT00823719|469480617|FG001|Overall Study|Disease Progression|4|||
130414595|NCT06027216|469480620|FG000|Overall Study|Did not qualify|8|||
130414596|NCT02219932|469480626|FG000|Overall Study|Other|5|||
130414597|NCT02219932|469480627|FG001|Overall Study|Other|11|||
130414598|NCT02219932|469480626|FG000|Overall Study|Death|1|||
130414599|NCT02219932|469480627|FG001|Overall Study|Death|1|||
130414600|NCT02219932|469480626|FG000|Overall Study|Investigator Decision|0|||
130414601|NCT02219932|469480627|FG001|Overall Study|Investigator Decision|1|||
130414602|NCT02219932|469480626|FG000|Overall Study|Consent Withdrawn|11|||
130414603|NCT02219932|469480627|FG001|Overall Study|Consent Withdrawn|7|||
130414604|NCT02219932|469480626|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
130414605|NCT02219932|469480627|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
130414606|NCT02219932|469480626|FG000|Overall Study|Protocol Violation|10|||
130414607|NCT02219932|469480627|FG001|Overall Study|Protocol Violation|6|||
130414608|NCT02219932|469480626|FG000|Overall Study|Pregnancy|1|||
130414609|NCT02219932|469480627|FG001|Overall Study|Pregnancy|0|||
130414610|NCT02219932|469480626|FG000|Overall Study|Lost to Follow-up|4|||
130414611|NCT02219932|469480627|FG001|Overall Study|Lost to Follow-up|2|||
130414612|NCT02219932|469480626|FG000|Overall Study|Adverse Event|23|||
130414613|NCT02219932|469480627|FG001|Overall Study|Adverse Event|21|||
130414614|NCT00093145|469480628|FG000|Overall Study|Unacceptable Toxicity Only|2|||
130414615|NCT00093145|469480628|FG000|Overall Study|Physician Decision|5|||
130414616|NCT00093145|469480628|FG000|Overall Study|Withdrawal by Subject|9|||
130414617|NCT00093145|469480628|FG000|Overall Study|Other|1|||
130414618|NCT04389840|469480629|FG000|Overall Study|Adverse Event|0|||
130414619|NCT04389840|469480630|FG001|Overall Study|Adverse Event|0|||
130414620|NCT04389840|469480631|FG002|Overall Study|Adverse Event|0|||
130414621|NCT04389840|469480632|FG003|Overall Study|Adverse Event|1|||
130414622|NCT04389840|469480633|FG004|Overall Study|Adverse Event|0|||
130414623|NCT04389840|469480634|FG005|Overall Study|Adverse Event|0|||
130414624|NCT04389840|469480629|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
130414625|NCT04389840|469480630|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
130414626|NCT04389840|469480631|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
130414627|NCT04389840|469480632|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
130414628|NCT04389840|469480633|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
130414629|NCT04389840|469480634|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
130414630|NCT04389840|469480629|FG000|Overall Study|Death|0|||
130414631|NCT04389840|469480630|FG001|Overall Study|Death|1|||
130414632|NCT04389840|469480631|FG002|Overall Study|Death|0|||
130414633|NCT04389840|469480632|FG003|Overall Study|Death|0|||
130414634|NCT04389840|469480633|FG004|Overall Study|Death|0|||
130414635|NCT04389840|469480634|FG005|Overall Study|Death|0|||
130414636|NCT02365467|469480635|FG000|Overall Study|Death|3|||
130414637|NCT02043782|469480636|FG000|Period 1|Adverse Event|0|||
130414638|NCT02043782|469480637|FG001|Period 1|Adverse Event|0|||
130414639|NCT02043782|469480638|FG002|Period 1|Adverse Event|1|||
130414640|NCT02043782|469480639|FG003|Period 1|Adverse Event|0|||
130414641|NCT02043782|469480640|FG004|Period 1|Adverse Event|0|||
130414642|NCT02043782|469480641|FG005|Period 1|Adverse Event|0|||
130414643|NCT01306162|469480644|FG000|Period 1|Adverse Event|0|||
130474553|NCT04421378|469706417|FG001|Overall Study|Other|0|||
130474554|NCT04421378|469706418|FG002|Overall Study|Other|0|||
130414644|NCT01306162|469480645|FG001|Period 1|Adverse Event|0|||
130414645|NCT01306162|469480646|FG002|Period 1|Adverse Event|0|||
130414646|NCT01306162|469480647|FG003|Period 1|Adverse Event|1|||
130414647|NCT01306162|469480644|FG000|Washout 1|Non-compliance to protocol|0|||
130414648|NCT01306162|469480645|FG001|Washout 1|Non-compliance to protocol|1|||
130414649|NCT01306162|469480646|FG002|Washout 1|Non-compliance to protocol|0|||
130414650|NCT01306162|469480647|FG003|Washout 1|Non-compliance to protocol|0|||
130414651|NCT02959437|469480648|FG000|Overall Study|Death|33|||
130414652|NCT02959437|469480649|FG001|Overall Study|Death|3|||
130414653|NCT02959437|469480650|FG002|Overall Study|Death|0|||
130414654|NCT02959437|469480651|FG003|Overall Study|Death|0|||
130414655|NCT02959437|469480648|FG000|Overall Study|Lost to Follow-up|3|||
130414656|NCT02959437|469480649|FG001|Overall Study|Lost to Follow-up|1|||
130414657|NCT02959437|469480650|FG002|Overall Study|Lost to Follow-up|0|||
130414658|NCT02959437|469480651|FG003|Overall Study|Lost to Follow-up|0|||
130474555|NCT04421378|469706419|FG003|Overall Study|Other|0|||
130414659|NCT02959437|469480648|FG000|Overall Study|Withdrawal by Subject|11|||
130414660|NCT02959437|469480649|FG001|Overall Study|Withdrawal by Subject|3|||
130414661|NCT02959437|469480650|FG002|Overall Study|Withdrawal by Subject|0|||
130414662|NCT02959437|469480651|FG003|Overall Study|Withdrawal by Subject|0|||
130414663|NCT02959437|469480648|FG000|Overall Study|Progressive Disease|9|||
130414664|NCT02959437|469480649|FG001|Overall Study|Progressive Disease|1|||
130414665|NCT02959437|469480650|FG002|Overall Study|Progressive Disease|0|||
130414666|NCT02959437|469480651|FG003|Overall Study|Progressive Disease|0|||
130414667|NCT02959437|469480648|FG000|Overall Study|Study Terminated by Sponsor|4|||
130414668|NCT02959437|469480649|FG001|Overall Study|Study Terminated by Sponsor|0|||
130414669|NCT02959437|469480650|FG002|Overall Study|Study Terminated by Sponsor|0|||
130414670|NCT02959437|469480651|FG003|Overall Study|Study Terminated by Sponsor|0|||
130414671|NCT02959437|469480648|FG000|Overall Study|Other Unspecified|2|||
130414672|NCT02959437|469480649|FG001|Overall Study|Other Unspecified|0|||
130414673|NCT02959437|469480650|FG002|Overall Study|Other Unspecified|0|||
130414674|NCT02959437|469480651|FG003|Overall Study|Other Unspecified|0|||
130414675|NCT02252211|469480655|FG000|Overall Study|Adverse Event|0|||
130414676|NCT02252211|469480656|FG001|Overall Study|Adverse Event|1|||
130414677|NCT02252211|469480657|FG002|Overall Study|Adverse Event|0|||
130414678|NCT02252211|469480655|FG000|Overall Study|Progressive disease|3|||
130414679|NCT02252211|469480656|FG001|Overall Study|Progressive disease|2|||
130414680|NCT02252211|469480657|FG002|Overall Study|Progressive disease|0|||
130414681|NCT02252211|469480655|FG000|Overall Study|Withdrawal by Subject|1|||
130414682|NCT02252211|469480656|FG001|Overall Study|Withdrawal by Subject|0|||
130414683|NCT02252211|469480657|FG002|Overall Study|Withdrawal by Subject|0|||
130414684|NCT02252211|469480655|FG000|Overall Study|Serious Adverse Event During Screening|1|||
130414685|NCT02252211|469480656|FG001|Overall Study|Serious Adverse Event During Screening|0|||
130414686|NCT02252211|469480657|FG002|Overall Study|Serious Adverse Event During Screening|1|||
130414687|NCT00968669|469480658|FG000|Overall Study|Lost to Follow-up|5|||
130414688|NCT00968669|469480659|FG001|Overall Study|Lost to Follow-up|2|||
130414689|NCT00968669|469480660|FG002|Overall Study|Lost to Follow-up|1|||
130414690|NCT00968669|469480661|FG003|Overall Study|Lost to Follow-up|4|||
130414691|NCT00968669|469480658|FG000|Overall Study|Withdrawal by Subject|9|||
130414692|NCT00968669|469480659|FG001|Overall Study|Withdrawal by Subject|7|||
130414693|NCT00968669|469480660|FG002|Overall Study|Withdrawal by Subject|5|||
130414694|NCT00968669|469480661|FG003|Overall Study|Withdrawal by Subject|3|||
130414695|NCT00968669|469480658|FG000|Overall Study|Pregnancy|0|||
130414696|NCT00968669|469480659|FG001|Overall Study|Pregnancy|0|||
130414697|NCT00968669|469480660|FG002|Overall Study|Pregnancy|2|||
130414698|NCT00968669|469480661|FG003|Overall Study|Pregnancy|0|||
130414699|NCT00968669|469480658|FG000|Overall Study|AE|1|||
130414700|NCT00968669|469480659|FG001|Overall Study|AE|0|||
130414701|NCT00968669|469480660|FG002|Overall Study|AE|0|||
130414702|NCT00968669|469480661|FG003|Overall Study|AE|0|||
130414703|NCT00968669|469480658|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130414704|NCT00968669|469480659|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130474556|NCT04421378|469706420|FG004|Overall Study|Other|0|||
130474557|NCT04263311|469706421|FG000|Overall Study|Lost to Follow-up|1|||
130474558|NCT04263311|469706422|FG001|Overall Study|Lost to Follow-up|2|||
130474559|NCT04263311|469706423|FG002|Overall Study|Lost to Follow-up|0|||
130474560|NCT04263311|469706421|FG000|Overall Study|Health Issues|1|||
130474561|NCT04263311|469706422|FG001|Overall Study|Health Issues|0|||
130474562|NCT04263311|469706423|FG002|Overall Study|Health Issues|0|||
130474563|NCT04263311|469706421|FG000|Overall Study|Left the country|1|||
130474564|NCT04263311|469706422|FG001|Overall Study|Left the country|0|||
130474565|NCT04263311|469706423|FG002|Overall Study|Left the country|0|||
130474566|NCT04263311|469706421|FG000|Overall Study|Unable to maintain time commitment|1|||
130474567|NCT04263311|469706422|FG001|Overall Study|Unable to maintain time commitment|0|||
130474568|NCT04263311|469706423|FG002|Overall Study|Unable to maintain time commitment|0|||
130474569|NCT04263311|469706421|FG000|Overall Study|No longer interested|1|||
130414705|NCT00968669|469480660|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130474570|NCT04263311|469706422|FG001|Overall Study|No longer interested|0|||
130414706|NCT00968669|469480661|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
130414707|NCT00968669|469480658|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
130414708|NCT00968669|469480659|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130414709|NCT00968669|469480660|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130414710|NCT00968669|469480661|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130414711|NCT00968669|469480658|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
130414712|NCT00968669|469480659|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130414713|NCT00968669|469480660|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130414714|NCT00968669|469480661|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130474571|NCT04263311|469706423|FG002|Overall Study|No longer interested|0|||
130474572|NCT04263311|469706421|FG000|Overall Study|Ineligible post consent|0|||
130474573|NCT04263311|469706422|FG001|Overall Study|Ineligible post consent|0|||
130474574|NCT04263311|469706423|FG002|Overall Study|Ineligible post consent|5|||
130474575|NCT02592330|469706424|FG000|Overall Study|Withdrawal by Subject|1|||
130474576|NCT02592330|469706425|FG001|Overall Study|Withdrawal by Subject|0|||
130414715|NCT00968669|469480658|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130414716|NCT00968669|469480659|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130414717|NCT00968669|469480660|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
130414718|NCT00968669|469480661|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130414719|NCT00968669|469480658|FG000|Overall Study|EARLY WITHDRAWAL|0|||
130414720|NCT00968669|469480659|FG001|Overall Study|EARLY WITHDRAWAL|1|||
130414721|NCT00968669|469480660|FG002|Overall Study|EARLY WITHDRAWAL|0|||
130414722|NCT00968669|469480661|FG003|Overall Study|EARLY WITHDRAWAL|0|||
130414723|NCT00968669|469480658|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130414724|NCT00968669|469480659|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130414725|NCT00968669|469480660|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
130414726|NCT00968669|469480661|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130414727|NCT00968669|469480658|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
130414728|NCT00968669|469480659|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130414729|NCT00968669|469480660|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130414730|NCT00968669|469480661|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130414731|NCT00968669|469480658|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130414732|NCT00968669|469480659|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
130414733|NCT00968669|469480660|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130414734|NCT00968669|469480661|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130414735|NCT00968669|469480658|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130414736|NCT00968669|469480659|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
130414737|NCT00968669|469480660|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130414738|NCT00968669|469480661|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130414739|NCT00968669|469480658|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130414740|NCT00968669|469480659|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
130474577|NCT02592330|469706424|FG000|Overall Study|Failed Biopsy|1|||
130474578|NCT02592330|469706425|FG001|Overall Study|Failed Biopsy|0|||
130474579|NCT03090152|469706426|FG000|Overall Study|Withdrawal by Subject|0|||
130414741|NCT00968669|469480660|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130414742|NCT00968669|469480661|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130414743|NCT00968669|469480658|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130414744|NCT00968669|469480659|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
130414745|NCT00968669|469480660|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130414746|NCT00968669|469480661|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130414747|NCT00968669|469480658|FG000|Overall Study|SPONSOR DECISION|0|||
130414748|NCT00968669|469480659|FG001|Overall Study|SPONSOR DECISION|1|||
130414749|NCT00968669|469480660|FG002|Overall Study|SPONSOR DECISION|0|||
130414750|NCT00968669|469480661|FG003|Overall Study|SPONSOR DECISION|0|||
130414751|NCT00968669|469480658|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130414752|NCT00968669|469480659|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130414753|NCT00968669|469480660|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
130414754|NCT00968669|469480661|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130414755|NCT00968669|469480658|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130414756|NCT00968669|469480659|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
130414757|NCT00968669|469480660|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130414758|NCT00968669|469480661|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130414759|NCT00968669|469480658|FG000|Overall Study|SUBJECT INCARCERATED|0|||
130414760|NCT00968669|469480659|FG001|Overall Study|SUBJECT INCARCERATED|1|||
130414761|NCT00968669|469480660|FG002|Overall Study|SUBJECT INCARCERATED|0|||
130414762|NCT00968669|469480661|FG003|Overall Study|SUBJECT INCARCERATED|0|||
130414763|NCT00968669|469480658|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130414764|NCT00968669|469480659|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
130414765|NCT00968669|469480660|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130414766|NCT00968669|469480661|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130563723|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563724|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
130414767|NCT00968669|469480658|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
130474580|NCT03090152|469706427|FG001|Overall Study|Withdrawal by Subject|2|||
130474581|NCT03090152|469706428|FG002|Overall Study|Withdrawal by Subject|1|||
130474582|NCT03090152|469706426|FG000|Overall Study|Surgery Canceled|1|||
130474583|NCT03090152|469706427|FG001|Overall Study|Surgery Canceled|0|||
130474584|NCT03090152|469706428|FG002|Overall Study|Surgery Canceled|0|||
130414768|NCT00968669|469480659|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
130414769|NCT00968669|469480660|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
130414770|NCT00968669|469480661|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
130414771|NCT00833989|469480663|FG000|Overall Study|Physician Decision|0|||
130414772|NCT00833989|469480664|FG001|Overall Study|Physician Decision|0|||
130474585|NCT03090152|469706426|FG000|Overall Study|Epidural catheter could not be placed|0|||
130414773|NCT00833989|469480665|FG002|Overall Study|Physician Decision|0|||
130474586|NCT03090152|469706427|FG001|Overall Study|Epidural catheter could not be placed|2|||
130474587|NCT03090152|469706428|FG002|Overall Study|Epidural catheter could not be placed|0|||
130563725|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
130563726|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563727|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563728|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563729|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563730|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130563731|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563732|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130414774|NCT00833989|469480666|FG003|Overall Study|Physician Decision|1|||
130414775|NCT00833989|469480663|FG000|Overall Study|Withdrawal by Subject|3|||
130414776|NCT00833989|469480664|FG001|Overall Study|Withdrawal by Subject|0|||
130414777|NCT00833989|469480665|FG002|Overall Study|Withdrawal by Subject|1|||
130414778|NCT00833989|469480666|FG003|Overall Study|Withdrawal by Subject|1|||
130414779|NCT01949480|469480667|FG000|Overall Study|Physician Decision|5|||
130414780|NCT01949480|469480668|FG001|Overall Study|Physician Decision|8|||
130414781|NCT00144339|469480669|FG000|Overall Study|Adverse Event|746|||
130414782|NCT00144339|469480670|FG001|Overall Study|Adverse Event|627|||
130414783|NCT00144339|469480669|FG000|Overall Study|Protocol Violation|75|||
130414784|NCT00144339|469480670|FG001|Overall Study|Protocol Violation|48|||
130414785|NCT00144339|469480669|FG000|Overall Study|Withdrawal by Subject|403|||
130414786|NCT00144339|469480670|FG001|Overall Study|Withdrawal by Subject|300|||
130414787|NCT00144339|469480669|FG000|Overall Study|Lost to Follow-up|76|||
130414788|NCT00144339|469480670|FG001|Overall Study|Lost to Follow-up|64|||
130414789|NCT00144339|469480669|FG000|Overall Study|Other|58|||
130414790|NCT00144339|469480670|FG001|Overall Study|Other|60|||
130414791|NCT01109992|469480671|FG000|Overall Study|Withdrawal by Subject|0|||
130414792|NCT01109992|469480672|FG001|Overall Study|Withdrawal by Subject|1|||
130414793|NCT01109992|469480671|FG000|Overall Study|Movement during rest scan.|0|||
130414794|NCT01109992|469480672|FG001|Overall Study|Movement during rest scan.|1|||
130414795|NCT00690755|469480673|FG000|Overall Study|Physician Decision|2|||
130414796|NCT00690755|469480674|FG001|Overall Study|Physician Decision|0|||
130414797|NCT00690755|469480675|FG002|Overall Study|Physician Decision|46|||
130414798|NCT00690755|469480676|FG003|Overall Study|Physician Decision|5|||
130414799|NCT00690755|469480677|FG004|Overall Study|Physician Decision|0|||
130414800|NCT00690755|469480678|FG005|Overall Study|Physician Decision|4|||
130414801|NCT00690755|469480679|FG006|Overall Study|Physician Decision|0|||
130414802|NCT02952924|469480680|FG000|Overall Study|Protocol Violation|0|||
130414803|NCT02952924|469480681|FG001|Overall Study|Protocol Violation|0|||
130414804|NCT02952924|469480682|FG002|Overall Study|Protocol Violation|0|||
130414805|NCT02952924|469480683|FG003|Overall Study|Protocol Violation|0|||
130414806|NCT02952924|469480684|FG004|Overall Study|Protocol Violation|0|||
130414807|NCT02952924|469480685|FG005|Overall Study|Protocol Violation|0|||
130414808|NCT02952924|469480686|FG006|Overall Study|Protocol Violation|0|||
130414809|NCT02952924|469480687|FG007|Overall Study|Protocol Violation|0|||
130414810|NCT02952924|469480688|FG008|Overall Study|Protocol Violation|0|||
130414811|NCT02952924|469480689|FG009|Overall Study|Protocol Violation|0|||
130414812|NCT02952924|469480690|FG010|Overall Study|Protocol Violation|0|||
130414813|NCT02952924|469480691|FG011|Overall Study|Protocol Violation|0|||
130414814|NCT02952924|469480692|FG012|Overall Study|Protocol Violation|0|||
130414815|NCT02952924|469480693|FG013|Overall Study|Protocol Violation|0|||
130414816|NCT02952924|469480694|FG014|Overall Study|Protocol Violation|0|||
130474588|NCT04673929|469706429|FG000|Overall Study|Death|73|||
130474589|NCT04673929|469706429|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
130474590|NCT02927769|469706431|FG000|Induction Phase|Study drug toxicity|1|||
130474591|NCT02927769|469706432|FG001|Induction Phase|Study drug toxicity|1|||
130474592|NCT02927769|469706431|FG000|Induction Phase|Disease progression|0|||
130474593|NCT02927769|469706432|FG001|Induction Phase|Disease progression|1|||
130474594|NCT02927769|469706431|FG000|Intensification Phase|Study drug toxicity|1|||
130474595|NCT02927769|469706432|FG001|Intensification Phase|Study drug toxicity|0|||
130474596|NCT02807636|469706435|FG000|Overall Study|Lost to Follow-up|10|||
130474597|NCT02807636|469706436|FG001|Overall Study|Lost to Follow-up|13|||
130474598|NCT02807636|469706437|FG002|Overall Study|Lost to Follow-up|6|||
130474599|NCT02807636|469706435|FG000|Overall Study|Protocol Deviation|1|||
130414817|NCT02952924|469480695|FG015|Overall Study|Protocol Violation|0|||
130414818|NCT02952924|469480696|FG016|Overall Study|Protocol Violation|0|||
130414819|NCT02952924|469480697|FG017|Overall Study|Protocol Violation|0|||
130414820|NCT02952924|469480698|FG018|Overall Study|Protocol Violation|0|||
130414821|NCT02952924|469480699|FG019|Overall Study|Protocol Violation|1|||
130474600|NCT02807636|469706436|FG001|Overall Study|Protocol Deviation|0|||
130474601|NCT02807636|469706437|FG002|Overall Study|Protocol Deviation|0|||
130474602|NCT02807636|469706435|FG000|Overall Study|Symptomatic Deterioration|0|||
130414822|NCT02952924|469480700|FG020|Overall Study|Protocol Violation|0|||
130414823|NCT02952924|469480701|FG021|Overall Study|Protocol Violation|0|||
130414824|NCT02952924|469480680|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
130414825|NCT02952924|469480681|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
130414826|NCT02952924|469480682|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
130414827|NCT02952924|469480683|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
130414828|NCT02952924|469480684|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
130414829|NCT02952924|469480685|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
130414830|NCT02952924|469480686|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
130414831|NCT02952924|469480687|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
130414832|NCT02952924|469480688|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
130414833|NCT02952924|469480689|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
130563733|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563734|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563735|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563736|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563737|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563738|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
130563739|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563740|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563741|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563742|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563743|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563744|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130563745|NCT04033445|470030525|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563746|NCT04033445|470030526|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563747|NCT04033445|470030527|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563748|NCT04033445|470030528|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563749|NCT04033445|470030529|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563750|NCT04033445|470030530|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130727239|NCT02883049|470625439|FG015|Post Induction|Protocol Violation|0|||
130563751|NCT04033445|470030531|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130414834|NCT02952924|469480690|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
130414835|NCT02952924|469480691|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
130414836|NCT02952924|469480692|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
130414837|NCT02952924|469480693|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
130414838|NCT02952924|469480694|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
130414839|NCT02952924|469480695|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
130414840|NCT02952924|469480696|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
130414841|NCT02952924|469480697|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
130414842|NCT02952924|469480698|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
130414843|NCT02952924|469480699|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
130414844|NCT02952924|469480700|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
130414845|NCT02952924|469480701|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
130414846|NCT02952924|469480680|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414847|NCT02952924|469480681|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414848|NCT02952924|469480682|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414849|NCT02952924|469480683|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414850|NCT02952924|469480684|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414851|NCT02952924|469480685|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414852|NCT02952924|469480686|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414853|NCT02952924|469480687|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414854|NCT02952924|469480688|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414855|NCT02952924|469480689|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414856|NCT02952924|469480690|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414857|NCT02952924|469480691|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414858|NCT02952924|469480692|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414859|NCT02952924|469480693|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414860|NCT02952924|469480694|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414861|NCT02952924|469480695|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414862|NCT02952924|469480696|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414863|NCT02952924|469480697|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414864|NCT02952924|469480698|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414865|NCT02952924|469480699|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
130648299|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
130648300|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
130648301|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
130414866|NCT02952924|469480700|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
130414867|NCT02952924|469480701|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
130414868|NCT02952924|469480680|FG000|Overall Study|Noncompliance with study drug|0|||
130414869|NCT02952924|469480681|FG001|Overall Study|Noncompliance with study drug|0|||
130414870|NCT02952924|469480682|FG002|Overall Study|Noncompliance with study drug|0|||
130414871|NCT02952924|469480683|FG003|Overall Study|Noncompliance with study drug|0|||
130414872|NCT02952924|469480684|FG004|Overall Study|Noncompliance with study drug|0|||
130414873|NCT02952924|469480685|FG005|Overall Study|Noncompliance with study drug|0|||
130414874|NCT02952924|469480686|FG006|Overall Study|Noncompliance with study drug|0|||
130414875|NCT02952924|469480687|FG007|Overall Study|Noncompliance with study drug|0|||
130414876|NCT02952924|469480688|FG008|Overall Study|Noncompliance with study drug|0|||
130414877|NCT02952924|469480689|FG009|Overall Study|Noncompliance with study drug|0|||
130414878|NCT02952924|469480690|FG010|Overall Study|Noncompliance with study drug|0|||
130414879|NCT02952924|469480691|FG011|Overall Study|Noncompliance with study drug|0|||
130414880|NCT02952924|469480692|FG012|Overall Study|Noncompliance with study drug|0|||
130414881|NCT02952924|469480693|FG013|Overall Study|Noncompliance with study drug|0|||
130414882|NCT02952924|469480694|FG014|Overall Study|Noncompliance with study drug|0|||
130414883|NCT02952924|469480695|FG015|Overall Study|Noncompliance with study drug|0|||
130414884|NCT02952924|469480696|FG016|Overall Study|Noncompliance with study drug|0|||
130414885|NCT02952924|469480697|FG017|Overall Study|Noncompliance with study drug|0|||
130414886|NCT02952924|469480698|FG018|Overall Study|Noncompliance with study drug|0|||
130414887|NCT02952924|469480699|FG019|Overall Study|Noncompliance with study drug|0|||
130414888|NCT02952924|469480700|FG020|Overall Study|Noncompliance with study drug|0|||
130414889|NCT02952924|469480701|FG021|Overall Study|Noncompliance with study drug|1|||
130414890|NCT03867734|469480704|FG000|Overall Study|Lost to Follow-up|2|||
130414891|NCT04323436|469480710|FG000|Overall Study|Adverse Event|7|||
130414892|NCT04323436|469480711|FG001|Overall Study|Adverse Event|0|||
130414893|NCT04323436|469480712|FG002|Overall Study|Adverse Event|0|||
130414894|NCT04323436|469480710|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
130414895|NCT04323436|469480711|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
130414896|NCT04323436|469480712|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
130414897|NCT04323436|469480710|FG000|Overall Study|Death|1|||
130414898|NCT04323436|469480711|FG001|Overall Study|Death|0|||
130414899|NCT04323436|469480712|FG002|Overall Study|Death|0|||
130414900|NCT04323436|469480710|FG000|Overall Study|Physician Decision|2|||
130414901|NCT04323436|469480711|FG001|Overall Study|Physician Decision|0|||
130414902|NCT04323436|469480712|FG002|Overall Study|Physician Decision|0|||
130414903|NCT04323436|469480710|FG000|Overall Study|Progressive disease|10|||
130414904|NCT04323436|469480711|FG001|Overall Study|Progressive disease|0|||
130414905|NCT04323436|469480712|FG002|Overall Study|Progressive disease|0|||
130414906|NCT04323436|469480710|FG000|Overall Study|Subject decision|3|||
130414907|NCT04323436|469480711|FG001|Overall Study|Subject decision|0|||
130414908|NCT04323436|469480712|FG002|Overall Study|Subject decision|0|||
130414909|NCT00839072|469480714|FG000|First Intervention Period|Withdrawal by Subject|1|||
130414910|NCT00839072|469480715|FG001|First Intervention Period|Withdrawal by Subject|0|||
130414911|NCT00839072|469480714|FG000|First Intervention Period|Adverse Event|1|||
130414912|NCT00839072|469480715|FG001|First Intervention Period|Adverse Event|1|||
130414913|NCT00839072|469480714|FG000|Second Intervention Period|Withdrawal by Subject|1|||
130414914|NCT00839072|469480715|FG001|Second Intervention Period|Withdrawal by Subject|0|||
130414915|NCT01458574|469480716|FG000|Overall Study|Adverse Event|5|||
130414916|NCT01458574|469480717|FG001|Overall Study|Adverse Event|9|||
130414917|NCT01458574|469480718|FG002|Overall Study|Adverse Event|7|||
130414918|NCT01458574|469480716|FG000|Overall Study|Lack of Efficacy|70|||
130414919|NCT01458574|469480717|FG001|Overall Study|Lack of Efficacy|53|||
130414920|NCT01458574|469480718|FG002|Overall Study|Lack of Efficacy|132|||
130414921|NCT01458574|469480716|FG000|Overall Study|Lost to Follow-up|3|||
130414922|NCT01458574|469480717|FG001|Overall Study|Lost to Follow-up|2|||
130414923|NCT01458574|469480718|FG002|Overall Study|Lost to Follow-up|1|||
130414924|NCT01458574|469480716|FG000|Overall Study|Pregnancy|1|||
130414925|NCT01458574|469480717|FG001|Overall Study|Pregnancy|1|||
130414926|NCT01458574|469480718|FG002|Overall Study|Pregnancy|0|||
130414927|NCT01458574|469480716|FG000|Overall Study|Protocol Violation|0|||
130414928|NCT01458574|469480717|FG001|Overall Study|Protocol Violation|1|||
130414929|NCT01458574|469480718|FG002|Overall Study|Protocol Violation|0|||
130414930|NCT01458574|469480716|FG000|Overall Study|Withdrawal by Subject|6|||
130414931|NCT01458574|469480717|FG001|Overall Study|Withdrawal by Subject|3|||
130414932|NCT01458574|469480718|FG002|Overall Study|Withdrawal by Subject|5|||
130414933|NCT01458574|469480716|FG000|Overall Study|Other|2|||
130414934|NCT01458574|469480717|FG001|Overall Study|Other|1|||
130414935|NCT01458574|469480718|FG002|Overall Study|Other|0|||
130414936|NCT01458574|469480716|FG000|Overall Study|Randomized but not treated|0|||
130414937|NCT01458574|469480717|FG001|Overall Study|Randomized but not treated|1|||
130414938|NCT01458574|469480718|FG002|Overall Study|Randomized but not treated|0|||
130414939|NCT02125786|469480719|FG000|Overall Study|Still in Follow-up|3|||
130414940|NCT02125786|469480719|FG000|Overall Study|Screen Failure|2|||
130414941|NCT02125786|469480719|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
130414942|NCT02125786|469480719|FG000|Overall Study|Progressive Disease|44|||
130414943|NCT02125786|469480719|FG000|Overall Study|Death|8|||
130414944|NCT01682837|469480720|FG000|Baseline|Withdrawal by Subject|5|||
130414945|NCT04782323|469480723|FG000|Overall Study|Death|1|||
130414946|NCT04782323|469480724|FG001|Overall Study|Death|0|||
130414947|NCT04782323|469480725|FG002|Overall Study|Death|0|||
130414948|NCT04782323|469480726|FG003|Overall Study|Death|0|||
130414949|NCT04782323|469480727|FG004|Overall Study|Death|1|||
130414950|NCT04782323|469480728|FG005|Overall Study|Death|1|||
130414951|NCT04782323|469480729|FG006|Overall Study|Death|1|||
130414952|NCT04782323|469480730|FG007|Overall Study|Death|0|||
130414953|NCT04782323|469480723|FG000|Overall Study|Withdrawal by Subject|0|||
130414954|NCT04782323|469480724|FG001|Overall Study|Withdrawal by Subject|0|||
130414955|NCT04782323|469480725|FG002|Overall Study|Withdrawal by Subject|1|||
130414956|NCT04782323|469480726|FG003|Overall Study|Withdrawal by Subject|0|||
130414957|NCT04782323|469480727|FG004|Overall Study|Withdrawal by Subject|0|||
130414958|NCT04782323|469480728|FG005|Overall Study|Withdrawal by Subject|1|||
130414959|NCT04782323|469480729|FG006|Overall Study|Withdrawal by Subject|0|||
130414960|NCT04782323|469480730|FG007|Overall Study|Withdrawal by Subject|1|||
130414961|NCT04782323|469480723|FG000|Overall Study|Lost to Follow-up|0|||
130414962|NCT04782323|469480724|FG001|Overall Study|Lost to Follow-up|1|||
130414963|NCT04782323|469480725|FG002|Overall Study|Lost to Follow-up|1|||
130414964|NCT04782323|469480726|FG003|Overall Study|Lost to Follow-up|0|||
130414965|NCT04782323|469480727|FG004|Overall Study|Lost to Follow-up|0|||
130414966|NCT04782323|469480728|FG005|Overall Study|Lost to Follow-up|1|||
130414967|NCT04782323|469480729|FG006|Overall Study|Lost to Follow-up|1|||
130414968|NCT04782323|469480730|FG007|Overall Study|Lost to Follow-up|2|||
130414969|NCT04782323|469480723|FG000|Overall Study|randomization in error|1|||
130414970|NCT04782323|469480724|FG001|Overall Study|randomization in error|0|||
130414971|NCT04782323|469480725|FG002|Overall Study|randomization in error|0|||
130414972|NCT04782323|469480726|FG003|Overall Study|randomization in error|0|||
130414973|NCT04782323|469480727|FG004|Overall Study|randomization in error|0|||
130414974|NCT04782323|469480728|FG005|Overall Study|randomization in error|0|||
130414975|NCT04782323|469480729|FG006|Overall Study|randomization in error|0|||
130414976|NCT04782323|469480730|FG007|Overall Study|randomization in error|0|||
130414977|NCT03832192|469480735|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
130414978|NCT03832192|469480736|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
130414979|NCT03738150|469480737|FG000|Base Study|Withdrawal by Subject|1|||
130414980|NCT03738150|469480737|FG000|Extension Study|Withdrawal by Subject|1|||
130414981|NCT00724971|469480740|FG000|Overall Study|Adverse Event|5|||
130414982|NCT00724971|469480740|FG000|Overall Study|Withdrawal by Subject|1|||
130414983|NCT01692197|469480741|FG000|Overall Study|Failed Screening|3|||
130414984|NCT03086447|469480743|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130414985|NCT03086447|469480744|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130414986|NCT03086447|469480743|FG000|Overall Study|Lost Lens|2|||
130414987|NCT03086447|469480744|FG001|Overall Study|Lost Lens|5|||
130414988|NCT03086447|469480743|FG000|Overall Study|Product quality complaint|0|||
130414989|NCT03086447|469480744|FG001|Overall Study|Product quality complaint|1|||
130414990|NCT03086447|469480743|FG000|Overall Study|Lens Damage|1|||
130414991|NCT03086447|469480744|FG001|Overall Study|Lens Damage|6|||
130414992|NCT03086447|469480743|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130414993|NCT03086447|469480744|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130414994|NCT03086447|469480743|FG000|Overall Study|Test Article No Longer Available|1|||
130414995|NCT03086447|469480744|FG001|Overall Study|Test Article No Longer Available|0|||
130414996|NCT03086447|469480743|FG000|Overall Study|Protocol Violation|2|||
130414997|NCT03086447|469480744|FG001|Overall Study|Protocol Violation|4|||
130414998|NCT03086447|469480743|FG000|Overall Study|Lost to Follow-up|0|||
130414999|NCT03086447|469480744|FG001|Overall Study|Lost to Follow-up|1|||
130415000|NCT03086447|469480743|FG000|Overall Study|Adverse Event|3|||
130415001|NCT03086447|469480744|FG001|Overall Study|Adverse Event|0|||
130415002|NCT03086447|469480743|FG000|Overall Study|Lens Discomfort|2|||
130415003|NCT03086447|469480744|FG001|Overall Study|Lens Discomfort|1|||
130415004|NCT02276482|469480747|FG000|Overall Study|Adverse Event|1|||
130415005|NCT02276482|469480748|FG001|Overall Study|Adverse Event|0|||
130415006|NCT02276482|469480747|FG000|Overall Study|Withdrawal by Subject|1|||
130415007|NCT02276482|469480748|FG001|Overall Study|Withdrawal by Subject|0|||
130415008|NCT02276482|469480747|FG000|Overall Study|Gram-negative infection|1|||
130415009|NCT02276482|469480748|FG001|Overall Study|Gram-negative infection|0|||
130415010|NCT02276482|469480747|FG000|Overall Study|Reason not specified|0|||
130415011|NCT02276482|469480748|FG001|Overall Study|Reason not specified|1|||
130415012|NCT03588572|469480749|FG000|Visitation 1|Lack of Efficacy|1|||
130415013|NCT03588572|469480750|FG001|Visitation 1|Lack of Efficacy|1|||
130415014|NCT03588572|469480749|FG000|Visitation 2|Lost to Follow-up|1|||
130415015|NCT03588572|469480750|FG001|Visitation 2|Lost to Follow-up|1|||
130415016|NCT03588572|469480749|FG000|Visitation 2|Lack of Efficacy|0|||
130415017|NCT03588572|469480750|FG001|Visitation 2|Lack of Efficacy|1|||
130415018|NCT03588572|469480749|FG000|Visitation 2|Withdrawal by Subject|1|||
130415019|NCT03588572|469480750|FG001|Visitation 2|Withdrawal by Subject|0|||
130415020|NCT03588572|469480749|FG000|Visitation 3|Lost to Follow-up|1|||
130415021|NCT03588572|469480750|FG001|Visitation 3|Lost to Follow-up|1|||
130415022|NCT03588572|469480749|FG000|Visitation 3|Physician Decision|1|||
130415023|NCT03588572|469480750|FG001|Visitation 3|Physician Decision|1|||
130415024|NCT03588572|469480749|FG000|Visitation 3|Withdrawal by Subject|1|||
130415025|NCT03588572|469480750|FG001|Visitation 3|Withdrawal by Subject|0|||
130415026|NCT01174342|469480758|FG000|Overall Study|Conversion to cesarean section|4|||
130415027|NCT01308580|469480759|FG000|Overall Study|Lost to Follow-up|12|||
130415028|NCT01308580|469480760|FG001|Overall Study|Lost to Follow-up|7|||
130415029|NCT02535065|469480761|FG000|Overall Study|Death|13|||
130415030|NCT02535065|469480761|FG000|Overall Study|Lost to Follow-up|1|||
130415031|NCT02535065|469480761|FG000|Overall Study|Withdrawal by Subject|6|||
130415032|NCT00110617|469480763|FG000|Overall Study|Adverse Event|2|||
130415033|NCT00110617|469480764|FG001|Overall Study|Adverse Event|4|||
130415034|NCT00110617|469480763|FG000|Overall Study|Abnormal Laboratory Value|4|||
130415035|NCT00110617|469480764|FG001|Overall Study|Abnormal Laboratory Value|2|||
130415036|NCT00110617|469480763|FG000|Overall Study|Lack of Efficacy|1|||
130415037|NCT00110617|469480764|FG001|Overall Study|Lack of Efficacy|0|||
130415038|NCT00110617|469480763|FG000|Overall Study|Patient no longer requires study drug|1|||
130415039|NCT00110617|469480764|FG001|Overall Study|Patient no longer requires study drug|0|||
130415040|NCT00110617|469480763|FG000|Overall Study|Protocol Violation|5|||
130415041|NCT00110617|469480764|FG001|Overall Study|Protocol Violation|0|||
130415042|NCT00110617|469480763|FG000|Overall Study|Withdrawal by Subject|10|||
130415043|NCT00110617|469480764|FG001|Overall Study|Withdrawal by Subject|4|||
130415044|NCT00110617|469480763|FG000|Overall Study|Lost to Follow-up|9|||
130415045|NCT00110617|469480764|FG001|Overall Study|Lost to Follow-up|1|||
130415046|NCT00110617|469480763|FG000|Overall Study|Administrative problems|6|||
130415047|NCT00110617|469480764|FG001|Overall Study|Administrative problems|5|||
130415048|NCT00110617|469480763|FG000|Overall Study|Death|1|||
130415049|NCT00110617|469480764|FG001|Overall Study|Death|1|||
130415050|NCT00110617|469480763|FG000|Overall Study|Did not receive study drug|0|||
130415051|NCT00110617|469480764|FG001|Overall Study|Did not receive study drug|12|||
130415052|NCT00838110|469482726|FG000|Overall Study|Death|0|||
130415053|NCT00838110|469482727|FG001|Overall Study|Death|0|||
130415054|NCT00838110|469482728|FG002|Overall Study|Death|1|||
130415055|NCT00838110|469482729|FG003|Overall Study|Death|2|||
130415056|NCT00838110|469482726|FG000|Overall Study|Adverse Event|11|||
130415057|NCT00838110|469482727|FG001|Overall Study|Adverse Event|10|||
130415058|NCT00838110|469482728|FG002|Overall Study|Adverse Event|8|||
130415059|NCT00838110|469482729|FG003|Overall Study|Adverse Event|7|||
130415060|NCT00838110|469482726|FG000|Overall Study|Withdrawal by Subject|5|||
130415061|NCT00838110|469482727|FG001|Overall Study|Withdrawal by Subject|6|||
130415062|NCT00838110|469482728|FG002|Overall Study|Withdrawal by Subject|3|||
130415063|NCT00838110|469482729|FG003|Overall Study|Withdrawal by Subject|4|||
130415064|NCT00838110|469482726|FG000|Overall Study|Other|3|||
130415065|NCT00838110|469482727|FG001|Overall Study|Other|3|||
130415066|NCT00838110|469482728|FG002|Overall Study|Other|3|||
130415067|NCT00838110|469482729|FG003|Overall Study|Other|2|||
130415068|NCT00838110|469482726|FG000|Overall Study|Protocol Violation|0|||
130415069|NCT00838110|469482727|FG001|Overall Study|Protocol Violation|2|||
130415070|NCT00838110|469482728|FG002|Overall Study|Protocol Violation|1|||
130415071|NCT00838110|469482729|FG003|Overall Study|Protocol Violation|1|||
130415072|NCT00838110|469482726|FG000|Overall Study|Lost to Follow-up|3|||
130415073|NCT00838110|469482727|FG001|Overall Study|Lost to Follow-up|0|||
130415074|NCT00838110|469482728|FG002|Overall Study|Lost to Follow-up|0|||
130415075|NCT00838110|469482729|FG003|Overall Study|Lost to Follow-up|0|||
130415076|NCT00838110|469482726|FG000|Overall Study|Did not meet eligibility criteria|0|||
130415077|NCT00838110|469482727|FG001|Overall Study|Did not meet eligibility criteria|0|||
130415078|NCT00838110|469482728|FG002|Overall Study|Did not meet eligibility criteria|1|||
130415079|NCT00838110|469482729|FG003|Overall Study|Did not meet eligibility criteria|2|||
130415080|NCT00838110|469482726|FG000|Overall Study|Randomized but not treated|0|||
130415081|NCT00838110|469482727|FG001|Overall Study|Randomized but not treated|1|||
130415082|NCT00838110|469482728|FG002|Overall Study|Randomized but not treated|0|||
130415083|NCT00838110|469482729|FG003|Overall Study|Randomized but not treated|0|||
130415084|NCT01262651|469482730|FG000|Overall Study|Adverse Event|40|||
130415085|NCT01262651|469482731|FG001|Overall Study|Adverse Event|35|||
130415086|NCT01262651|469482730|FG000|Overall Study|Withdrawal by Subject|15|||
130415087|NCT01262651|469482731|FG001|Overall Study|Withdrawal by Subject|11|||
130415088|NCT01262651|469482730|FG000|Overall Study|Withdrawal by Investigator|2|||
130415089|NCT01262651|469482731|FG001|Overall Study|Withdrawal by Investigator|2|||
130415090|NCT01262651|469482730|FG000|Overall Study|Met Withdrawal Criteria|1|||
130415091|NCT01262651|469482731|FG001|Overall Study|Met Withdrawal Criteria|0|||
130415092|NCT04969783|469482737|FG000|Overall Study|Lost to Follow-up|2|||
130415093|NCT04969783|469482738|FG001|Overall Study|Lost to Follow-up|0|||
130415094|NCT04969783|469482737|FG000|Overall Study|Withdrawal by Subject|4|||
130415095|NCT04969783|469482738|FG001|Overall Study|Withdrawal by Subject|0|||
130415096|NCT04969783|469482737|FG000|Overall Study|Physician Decision|6|||
130415097|NCT04969783|469482738|FG001|Overall Study|Physician Decision|0|||
130474603|NCT02807636|469706436|FG001|Overall Study|Symptomatic Deterioration|1|||
130474604|NCT02807636|469706437|FG002|Overall Study|Symptomatic Deterioration|0|||
130474605|NCT02807636|469706435|FG000|Overall Study|Withdrawal by Subject|39|||
130474606|NCT02807636|469706436|FG001|Overall Study|Withdrawal by Subject|28|||
130474607|NCT02807636|469706437|FG002|Overall Study|Withdrawal by Subject|24|||
130474608|NCT02807636|469706435|FG000|Overall Study|Death|303|||
130474609|NCT02807636|469706436|FG001|Overall Study|Death|332|||
130474610|NCT02807636|469706437|FG002|Overall Study|Death|272|||
130474611|NCT02807636|469706435|FG000|Overall Study|Study Terminated By Sponsor|47|||
130474612|NCT02807636|469706436|FG001|Overall Study|Study Terminated By Sponsor|76|||
130474613|NCT02807636|469706437|FG002|Overall Study|Study Terminated By Sponsor|60|||
130474614|NCT02807636|469706435|FG000|Overall Study|Physician Decision|0|||
130474615|NCT02807636|469706436|FG001|Overall Study|Physician Decision|1|||
130474616|NCT02807636|469706437|FG002|Overall Study|Physician Decision|0|||
130474617|NCT05082909|469706438|FG000|Overall Study|Protocol Violation|0|||
130474618|NCT05082909|469706439|FG001|Overall Study|Protocol Violation|0|||
130474619|NCT05082909|469706440|FG002|Overall Study|Protocol Violation|1|||
130474620|NCT05082909|469706441|FG003|Overall Study|Protocol Violation|0|||
130474621|NCT05082909|469706442|FG004|Overall Study|Protocol Violation|0|||
130474622|NCT05082909|469706443|FG005|Overall Study|Protocol Violation|0|||
130474623|NCT04088630|469706444|FG000|Overall Study|Lost to Follow-up|3|||
130474624|NCT04088630|469706445|FG001|Overall Study|Lost to Follow-up|2|||
130474625|NCT04088630|469706446|FG002|Overall Study|Lost to Follow-up|6|||
130474626|NCT04088630|469706444|FG000|Overall Study|Death|3|||
130474627|NCT04088630|469706445|FG001|Overall Study|Death|1|||
130474628|NCT04088630|469706446|FG002|Overall Study|Death|1|||
130474629|NCT04088630|469706444|FG000|Overall Study|Physician Decision|0|||
130474630|NCT04088630|469706445|FG001|Overall Study|Physician Decision|1|||
130474631|NCT04088630|469706446|FG002|Overall Study|Physician Decision|1|||
130415098|NCT02349295|469482739|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
130415099|NCT02349295|469482740|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
130563752|NCT04033445|470030532|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
130563753|NCT04033445|470030533|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563754|NCT04033445|470030534|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563755|NCT04033445|470030535|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130415100|NCT02349295|469482741|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
130415101|NCT02349295|469482742|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415102|NCT02349295|469482743|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415103|NCT02349295|469482744|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415104|NCT02349295|469482745|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415105|NCT02349295|469482746|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415106|NCT02349295|469482747|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415107|NCT02349295|469482748|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415108|NCT02349295|469482749|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415109|NCT02349295|469482750|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415110|NCT02349295|469482751|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415111|NCT02349295|469482752|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130415112|NCT02349295|469482739|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
130415113|NCT02349295|469482740|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
130415114|NCT02349295|469482741|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
130415115|NCT02349295|469482742|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415116|NCT02349295|469482743|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415117|NCT02349295|469482744|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415118|NCT02349295|469482745|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415119|NCT02349295|469482746|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415120|NCT02349295|469482747|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415121|NCT02349295|469482748|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130474632|NCT03315754|469706449|FG000|Overall Study|COVID-19 complications leading to death|1|||
130474633|NCT03315754|469706449|FG000|Overall Study|insurance coverage issue|1|||
130474634|NCT02954341|469706450|FG000|Overall Study|Attempted Implant unsuccessful|5|||
130474635|NCT02954341|469706450|FG000|Overall Study|Death|90|||
130474636|NCT02954341|469706450|FG000|Overall Study|Withdrawal by Subject|4|||
130474637|NCT02954341|469706450|FG000|Overall Study|Physician Decision|13|||
130474638|NCT02954341|469706450|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
130474639|NCT02954341|469706450|FG000|Overall Study|Not implanted due to physician's decision|1|||
130474640|NCT02954341|469706450|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
130474641|NCT05227209|469706454|FG000|Overall Study|Adverse Event|11|||
130474642|NCT05227209|469706454|FG000|Overall Study|Lost to Follow-up|1|||
130474643|NCT05227209|469706454|FG000|Overall Study|Withdrawal by Subject|7|||
130474644|NCT05227209|469706454|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
130474645|NCT04245501|469706457|FG000|Overall Study|Adverse Event|2|||
130474646|NCT04245501|469706458|FG001|Overall Study|Adverse Event|0|||
130563756|NCT04033445|470030536|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130415122|NCT02349295|469482749|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415123|NCT02349295|469482750|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415124|NCT02349295|469482751|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415125|NCT02349295|469482752|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130415126|NCT02349295|469482739|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
130415127|NCT02349295|469482740|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
130415128|NCT02349295|469482741|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
130415129|NCT02349295|469482742|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415130|NCT02349295|469482743|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415131|NCT02349295|469482744|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415132|NCT02349295|469482745|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415133|NCT02349295|469482746|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415134|NCT02349295|469482747|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415135|NCT02349295|469482748|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415136|NCT02349295|469482749|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415137|NCT02349295|469482750|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415138|NCT02349295|469482751|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415139|NCT02349295|469482752|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130415140|NCT02349295|469482739|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
130415141|NCT02349295|469482740|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
130415142|NCT02349295|469482741|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
130415143|NCT02349295|469482742|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415144|NCT02349295|469482743|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415145|NCT02349295|469482744|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130474647|NCT04245501|469706457|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
130474648|NCT04245501|469706458|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
130474649|NCT00170573|469706460|FG000|Overall Study|Violation of inclusion criteria|13|||
130474650|NCT03846505|469706462|FG000|Treatment Phase|Withdrawal by Subject|9|||
130474651|NCT03846505|469706463|FG001|Treatment Phase|Withdrawal by Subject|11|||
130474652|NCT03846505|469706462|FG000|Treatment Phase|Lost to Follow-up|6|||
130474653|NCT03846505|469706463|FG001|Treatment Phase|Lost to Follow-up|2|||
130474654|NCT03846505|469706462|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
130474655|NCT03846505|469706463|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
130474656|NCT03846505|469706462|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
130474657|NCT03846505|469706463|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
130474658|NCT03535272|469706466|FG000|Overall Study|Lost to Follow-up|71|||
130474659|NCT03535272|469706467|FG001|Overall Study|Lost to Follow-up|73|||
130474660|NCT03892616|469706468|FG000|Washout Period 2|Met discontinuation criterion|0|||
130474661|NCT03892616|469706469|FG001|Washout Period 2|Met discontinuation criterion|0|||
130474662|NCT03892616|469706470|FG002|Washout Period 2|Met discontinuation criterion|0|||
130474663|NCT03892616|469706471|FG003|Washout Period 2|Met discontinuation criterion|0|||
130474664|NCT03892616|469706472|FG004|Washout Period 2|Met discontinuation criterion|0|||
130474665|NCT03892616|469706473|FG005|Washout Period 2|Met discontinuation criterion|0|||
130474666|NCT03892616|469706474|FG006|Washout Period 2|Met discontinuation criterion|0|||
130474667|NCT03892616|469706475|FG007|Washout Period 2|Met discontinuation criterion|0|||
130474668|NCT03892616|469706476|FG008|Washout Period 2|Met discontinuation criterion|1|||
130474669|NCT03892616|469706477|FG009|Washout Period 2|Met discontinuation criterion|0|||
130474670|NCT03892616|469706478|FG010|Washout Period 2|Met discontinuation criterion|0|||
130474671|NCT03892616|469706479|FG011|Washout Period 2|Met discontinuation criterion|0|||
130474672|NCT03930342|469706488|FG000|Overall Study|Lost to Follow-up|70|||
130474673|NCT03930342|469706489|FG001|Overall Study|Lost to Follow-up|77|||
130474674|NCT04024813|469708414|FG000|Overall Study|Study terminated by Sponsor|1|||
130474675|NCT02729311|469708415|FG000|Overall Study|Withdrawal by Subject|8|||
130474676|NCT02729311|469708416|FG001|Overall Study|Withdrawal by Subject|2|||
130474677|NCT05034952|469708417|FG000|Overall Study|Adverse Event|1|||
130474678|NCT05034952|469708418|FG001|Overall Study|Adverse Event|0|||
130474679|NCT05034952|469708419|FG002|Overall Study|Adverse Event|0|||
130474680|NCT05034952|469708420|FG003|Overall Study|Adverse Event|0|||
130474681|NCT05034952|469708417|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130474682|NCT05034952|469708418|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130474683|NCT05034952|469708419|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
130474684|NCT05034952|469708420|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
130474685|NCT05034952|469708417|FG000|Overall Study|Lost to Follow-up|1|||
130474686|NCT05034952|469708418|FG001|Overall Study|Lost to Follow-up|4|||
130415146|NCT02349295|469482745|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130474687|NCT05034952|469708419|FG002|Overall Study|Lost to Follow-up|3|||
130415147|NCT02349295|469482746|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130474688|NCT05034952|469708420|FG003|Overall Study|Lost to Follow-up|3|||
130474689|NCT05034952|469708417|FG000|Overall Study|Other|0|||
130474690|NCT05034952|469708418|FG001|Overall Study|Other|0|||
130474691|NCT05034952|469708419|FG002|Overall Study|Other|0|||
130415148|NCT02349295|469482747|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415149|NCT02349295|469482748|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415150|NCT02349295|469482749|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415151|NCT02349295|469482750|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415152|NCT02349295|469482751|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415153|NCT02349295|469482752|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130415154|NCT02349295|469482739|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415155|NCT02349295|469482740|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
130415156|NCT02349295|469482741|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
130415157|NCT02349295|469482742|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415158|NCT02349295|469482743|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415159|NCT02349295|469482744|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415160|NCT02349295|469482745|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415161|NCT02349295|469482746|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415162|NCT02349295|469482747|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415163|NCT02349295|469482748|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415164|NCT02349295|469482749|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415165|NCT02349295|469482750|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415166|NCT02349295|469482751|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415167|NCT02349295|469482752|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130415168|NCT02349295|469482739|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
130415169|NCT02349295|469482740|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
130415170|NCT02349295|469482741|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
130415171|NCT02349295|469482742|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
130415172|NCT02349295|469482743|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
130415173|NCT02349295|469482744|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
130415174|NCT02349295|469482745|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
130415175|NCT02349295|469482746|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
130415176|NCT02349295|469482747|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
130415177|NCT02349295|469482748|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
130415178|NCT02349295|469482749|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
130415179|NCT02349295|469482750|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
130415180|NCT02349295|469482751|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
130415181|NCT02349295|469482752|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
130415182|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130474692|NCT05034952|469708420|FG003|Overall Study|Other|1|||
130474693|NCT04950660|469708421|FG000|Overall Study|Protocol Violation|4|||
130474694|NCT04950660|469708422|FG001|Overall Study|Protocol Violation|2|||
130474695|NCT04950660|469708421|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
130474696|NCT04950660|469708422|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
130474697|NCT04950660|469708421|FG000|Overall Study|Withdrawal by Subject|0|||
130474698|NCT04950660|469708422|FG001|Overall Study|Withdrawal by Subject|1|||
130474699|NCT04950660|469708421|FG000|Overall Study|Hypotension|1|||
130474700|NCT04950660|469708422|FG001|Overall Study|Hypotension|0|||
130474701|NCT02437318|469708429|FG000|Overall Study|Progressive disease|207|||
130474702|NCT02437318|469708430|FG001|Overall Study|Progressive disease|240|||
130474703|NCT02437318|469708429|FG000|Overall Study|Subject/guardian decision|24|||
130474704|NCT02437318|469708430|FG001|Overall Study|Subject/guardian decision|11|||
130474705|NCT02437318|469708429|FG000|Overall Study|Physician Decision|29|||
130474706|NCT02437318|469708430|FG001|Overall Study|Physician Decision|22|||
130474707|NCT02437318|469708429|FG000|Overall Study|Adverse Event|14|||
130474708|NCT02437318|469708430|FG001|Overall Study|Adverse Event|4|||
130474709|NCT02437318|469708429|FG000|Overall Study|Death|4|||
130474710|NCT02437318|469708430|FG001|Overall Study|Death|4|||
130474711|NCT02437318|469708429|FG000|Overall Study|Protocol deviation|5|||
130474712|NCT02437318|469708430|FG001|Overall Study|Protocol deviation|7|||
130415183|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415184|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130474713|NCT02437318|469708429|FG000|Overall Study|Sponsor decision|1|||
130474714|NCT02437318|469708430|FG001|Overall Study|Sponsor decision|0|||
130474715|NCT00920621|469708432|FG000|Overall Study|Lost to Follow-up|16|||
130563757|NCT04033445|470030537|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130563758|NCT04033445|470030538|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130415185|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130474716|NCT00920621|469708433|FG001|Overall Study|Lost to Follow-up|17|||
130474717|NCT00920621|469708434|FG002|Overall Study|Lost to Follow-up|19|||
130563759|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130474718|NCT00920621|469708435|FG003|Overall Study|Lost to Follow-up|21|||
130474719|NCT00920621|469708432|FG000|Overall Study|Fetal/neonatal deaths|16|||
130474720|NCT00920621|469708433|FG001|Overall Study|Fetal/neonatal deaths|14|||
130563760|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130415186|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415187|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415188|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415189|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
130415190|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
130415191|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
130415192|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
130415193|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415194|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415195|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130415196|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415197|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415198|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415199|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415200|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415201|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415202|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415203|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
130415204|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
130415205|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
130415206|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
130415207|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415208|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415209|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130415210|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415211|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415212|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415213|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415214|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415215|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415216|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415217|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
130415218|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415219|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
130415220|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415221|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415222|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415223|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130415224|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
130415225|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
130415226|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
130415227|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
130415228|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
130415229|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
130415230|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
130415231|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
130415232|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
130415233|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
130415234|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
130415235|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
130415236|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
130415237|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
130415238|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415239|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415240|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415241|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415242|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415243|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415244|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415245|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
130415246|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
130415247|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
130415248|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
130415249|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130727240|NCT02883049|470625424|FG000|Post Induction|Withdrawal by Subject|0|||
130727241|NCT02883049|470625425|FG001|Post Induction|Withdrawal by Subject|0|||
130415250|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415251|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130415252|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415253|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415254|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415255|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415256|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415257|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415258|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415259|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
130415260|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
130415261|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415262|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415263|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415264|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415265|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130415266|NCT02349295|469482739|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415267|NCT02349295|469482740|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415268|NCT02349295|469482741|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415269|NCT02349295|469482742|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415270|NCT02349295|469482743|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415271|NCT02349295|469482744|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415272|NCT02349295|469482745|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415273|NCT02349295|469482746|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
130415274|NCT02349295|469482747|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
130415275|NCT02349295|469482748|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415276|NCT02349295|469482749|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415277|NCT02349295|469482750|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415278|NCT02349295|469482751|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415279|NCT02349295|469482752|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130415280|NCT02349295|469482739|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415281|NCT02349295|469482740|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415282|NCT02349295|469482741|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415283|NCT02349295|469482742|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415284|NCT02349295|469482743|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415285|NCT02349295|469482744|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415286|NCT02349295|469482745|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415287|NCT02349295|469482746|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415288|NCT02349295|469482747|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415289|NCT02349295|469482748|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415290|NCT02349295|469482749|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130415291|NCT02349295|469482750|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
130415292|NCT02349295|469482751|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
130415293|NCT02349295|469482752|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
130415294|NCT02349295|469482739|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415295|NCT02349295|469482740|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415296|NCT02349295|469482741|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415297|NCT02349295|469482742|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415298|NCT02349295|469482743|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415299|NCT02349295|469482744|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415300|NCT02349295|469482745|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415301|NCT02349295|469482746|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415302|NCT02349295|469482747|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415303|NCT02349295|469482748|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415304|NCT02349295|469482749|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415305|NCT02349295|469482750|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
130415306|NCT02349295|469482751|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
130415307|NCT02349295|469482752|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130415308|NCT02349295|469482739|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415309|NCT02349295|469482740|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415310|NCT02349295|469482741|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415311|NCT02349295|469482742|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415312|NCT02349295|469482743|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415313|NCT02349295|469482744|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415314|NCT02349295|469482745|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415315|NCT02349295|469482746|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415316|NCT02349295|469482747|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415317|NCT02349295|469482748|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415318|NCT02349295|469482749|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415319|NCT02349295|469482750|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
130415320|NCT02349295|469482751|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
130415321|NCT02349295|469482752|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130415322|NCT02349295|469482739|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415323|NCT02349295|469482740|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415324|NCT02349295|469482741|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415325|NCT02349295|469482742|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415326|NCT02349295|469482743|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415327|NCT02349295|469482744|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415328|NCT02349295|469482745|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415329|NCT02349295|469482746|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415330|NCT02349295|469482747|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415331|NCT02349295|469482748|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415332|NCT02349295|469482749|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415333|NCT02349295|469482750|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
130415334|NCT02349295|469482751|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415335|NCT02349295|469482752|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130415336|NCT02349295|469482739|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415337|NCT02349295|469482740|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415338|NCT02349295|469482741|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415339|NCT02349295|469482742|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415340|NCT02349295|469482743|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415341|NCT02349295|469482744|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415342|NCT02349295|469482745|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415343|NCT02349295|469482746|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415344|NCT02349295|469482747|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415345|NCT02349295|469482748|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415346|NCT02349295|469482749|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415347|NCT02349295|469482750|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
130415348|NCT02349295|469482751|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415349|NCT02349295|469482752|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130415350|NCT02863926|469482753|FG000|Overall Study|Physician Decision|1|||
130415351|NCT02863926|469482754|FG001|Overall Study|Physician Decision|0|||
130415352|NCT02863926|469482753|FG000|Overall Study|Lost to Follow-up|1|||
130415353|NCT02863926|469482754|FG001|Overall Study|Lost to Follow-up|1|||
130415354|NCT01914926|469482770|FG000|Overall Study|Adverse Event|1|||
130415355|NCT01914926|469482771|FG001|Overall Study|Adverse Event|0|||
130415356|NCT01914926|469482770|FG000|Overall Study|uncooperative, agitated and removed|0|||
130415357|NCT01914926|469482771|FG001|Overall Study|uncooperative, agitated and removed|1|||
130415358|NCT01917526|469482772|FG000|Overall Study|Protocol Violation|1|||
130415359|NCT01917526|469482773|FG001|Overall Study|Protocol Violation|1|||
130415360|NCT00434057|469482774|FG000|Overall Study|Withdrawal by Subject|1|||
130415361|NCT02117570|469482775|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
130415362|NCT02117570|469482776|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
130415363|NCT02117570|469482777|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
130415364|NCT02117570|469482775|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
130415365|NCT02117570|469482776|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
130415366|NCT02117570|469482777|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
130415367|NCT02117570|469482775|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
130415368|NCT02117570|469482776|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
130415369|NCT02117570|469482777|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
130415370|NCT02117570|469482775|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
130415371|NCT02117570|469482776|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
130415372|NCT02117570|469482777|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
130415373|NCT02117570|469482775|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
130415374|NCT02117570|469482776|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
130415375|NCT02117570|469482777|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
130415376|NCT02117570|469482775|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
130415377|NCT02117570|469482776|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
130415378|NCT02117570|469482777|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
130415379|NCT02117570|469482775|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
130415380|NCT02117570|469482776|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
130415381|NCT02117570|469482777|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
130415382|NCT03701555|469482778|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
130415383|NCT03701555|469482779|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
130415384|NCT03701555|469482780|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
130415385|NCT03701555|469482781|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
130415386|NCT03701555|469482782|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
130415387|NCT03701555|469482783|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
130415388|NCT03701555|469482784|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
130415389|NCT03701555|469482785|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
130415390|NCT03701555|469482786|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
130415391|NCT03701555|469482787|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
130415392|NCT03701555|469482788|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
130415393|NCT03701555|469482789|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
130415394|NCT03701555|469482790|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
130415395|NCT03701555|469482791|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
130415396|NCT03701555|469482792|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
130415397|NCT03701555|469482793|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
130415398|NCT03701555|469482794|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
130415399|NCT03701555|469482795|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
130415400|NCT03701555|469482796|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
130415401|NCT03701555|469482797|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
130415402|NCT03701555|469482798|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
130415403|NCT03701555|469482799|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
130415404|NCT03701555|469482800|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
130415405|NCT03701555|469482801|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
130415406|NCT03701555|469482802|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
130415407|NCT03701555|469482803|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
130415408|NCT03701555|469482804|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
130415409|NCT03701555|469482805|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
130415410|NCT03701555|469482806|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
130415411|NCT03701555|469482807|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
130415412|NCT03701555|469482808|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
130415413|NCT03701555|469482809|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
130415414|NCT03701555|469482810|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
130415415|NCT03701555|469482811|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
130415416|NCT03701555|469482812|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
130415417|NCT03701555|469482813|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
130415418|NCT03701555|469482778|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
130415419|NCT03701555|469482779|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
130415420|NCT03701555|469482780|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
130415421|NCT03701555|469482781|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
130415422|NCT03701555|469482782|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
130415423|NCT03701555|469482783|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
130415424|NCT03701555|469482784|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
130415425|NCT03701555|469482785|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
130415426|NCT03701555|469482786|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
130415427|NCT03701555|469482787|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
130415428|NCT03701555|469482788|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
130415429|NCT03701555|469482789|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
130415430|NCT03701555|469482790|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
130415431|NCT03701555|469482791|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
130415432|NCT03701555|469482792|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
130415433|NCT03701555|469482793|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
130415434|NCT03701555|469482794|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
130415435|NCT03701555|469482795|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
130415436|NCT03701555|469482796|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
130415437|NCT03701555|469482797|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
130415438|NCT03701555|469482798|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
130415439|NCT03701555|469482799|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
130415440|NCT03701555|469482800|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
130415441|NCT03701555|469482801|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
130415442|NCT03701555|469482802|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
130415443|NCT03701555|469482803|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
130415444|NCT03701555|469482804|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
130415445|NCT03701555|469482805|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
130415446|NCT03701555|469482806|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
130415447|NCT03701555|469482807|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
130415448|NCT03701555|469482808|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
130415449|NCT03701555|469482809|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
130415450|NCT03701555|469482810|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
130415451|NCT03701555|469482811|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
130415452|NCT03701555|469482812|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
130415453|NCT03701555|469482813|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
130415454|NCT03701555|469482778|FG000|Part 2 (Day 1)|Other|0|||
130415455|NCT03701555|469482779|FG001|Part 2 (Day 1)|Other|0|||
130415456|NCT03701555|469482780|FG002|Part 2 (Day 1)|Other|0|||
130415457|NCT03701555|469482781|FG003|Part 2 (Day 1)|Other|0|||
130415458|NCT03701555|469482782|FG004|Part 2 (Day 1)|Other|0|||
130415459|NCT03701555|469482783|FG005|Part 2 (Day 1)|Other|0|||
130415460|NCT03701555|469482784|FG006|Part 2 (Day 1)|Other|0|||
130415461|NCT03701555|469482785|FG007|Part 2 (Day 1)|Other|0|||
130415462|NCT03701555|469482786|FG008|Part 2 (Day 1)|Other|0|||
130415463|NCT03701555|469482787|FG009|Part 2 (Day 1)|Other|0|||
130415464|NCT03701555|469482788|FG010|Part 2 (Day 1)|Other|3|||
130415465|NCT03701555|469482789|FG011|Part 2 (Day 1)|Other|1|||
130415466|NCT03701555|469482790|FG012|Part 2 (Day 1)|Other|0|||
130415467|NCT03701555|469482791|FG013|Part 2 (Day 1)|Other|1|||
130415468|NCT03701555|469482792|FG014|Part 2 (Day 1)|Other|0|||
130415469|NCT03701555|469482793|FG015|Part 2 (Day 1)|Other|2|||
130415470|NCT03701555|469482794|FG016|Part 2 (Day 1)|Other|2|||
130415471|NCT03701555|469482795|FG017|Part 2 (Day 1)|Other|0|||
130415472|NCT03701555|469482796|FG018|Part 2 (Day 1)|Other|0|||
130415473|NCT03701555|469482797|FG019|Part 2 (Day 1)|Other|0|||
130415474|NCT03701555|469482798|FG020|Part 2 (Day 1)|Other|0|||
130415475|NCT03701555|469482799|FG021|Part 2 (Day 1)|Other|0|||
130415476|NCT03701555|469482800|FG022|Part 2 (Day 1)|Other|0|||
130415477|NCT03701555|469482801|FG023|Part 2 (Day 1)|Other|0|||
130415478|NCT03701555|469482802|FG024|Part 2 (Day 1)|Other|0|||
130415479|NCT03701555|469482803|FG025|Part 2 (Day 1)|Other|0|||
130415480|NCT03701555|469482804|FG026|Part 2 (Day 1)|Other|0|||
130415481|NCT03701555|469482805|FG027|Part 2 (Day 1)|Other|0|||
130415482|NCT03701555|469482806|FG028|Part 2 (Day 1)|Other|0|||
130415483|NCT03701555|469482807|FG029|Part 2 (Day 1)|Other|0|||
130415484|NCT03701555|469482808|FG030|Part 2 (Day 1)|Other|0|||
130415485|NCT03701555|469482809|FG031|Part 2 (Day 1)|Other|0|||
130415486|NCT03701555|469482810|FG032|Part 2 (Day 1)|Other|0|||
130415487|NCT03701555|469482811|FG033|Part 2 (Day 1)|Other|0|||
130415488|NCT03701555|469482812|FG034|Part 2 (Day 1)|Other|0|||
130415489|NCT03701555|469482813|FG035|Part 2 (Day 1)|Other|0|||
130415490|NCT03701555|469482778|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
130415491|NCT03701555|469482779|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
130415492|NCT03701555|469482780|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
130415493|NCT03701555|469482781|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
130415494|NCT03701555|469482782|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
130415495|NCT03701555|469482783|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
130415496|NCT03701555|469482784|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
130415497|NCT03701555|469482785|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
130415498|NCT03701555|469482786|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
130415499|NCT03701555|469482787|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
130415500|NCT03701555|469482788|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
130415501|NCT03701555|469482789|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
130415502|NCT03701555|469482790|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
130415503|NCT03701555|469482791|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
130415504|NCT03701555|469482792|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
130474721|NCT00920621|469708434|FG002|Overall Study|Fetal/neonatal deaths|16|||
130474722|NCT00920621|469708435|FG003|Overall Study|Fetal/neonatal deaths|14|||
130474723|NCT00920621|469708432|FG000|Overall Study|Blood sample not collected|22|||
130415505|NCT03701555|469482793|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
130415506|NCT03701555|469482794|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
130415507|NCT03701555|469482795|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
130415508|NCT03701555|469482796|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
130415509|NCT03701555|469482797|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
130474724|NCT00920621|469708433|FG001|Overall Study|Blood sample not collected|14|||
130415510|NCT03701555|469482798|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
130415511|NCT03701555|469482799|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
130415512|NCT03701555|469482800|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
130415513|NCT03701555|469482801|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
130415514|NCT03701555|469482802|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
130415515|NCT03701555|469482803|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
130415516|NCT03701555|469482804|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
130415517|NCT03701555|469482805|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
130415518|NCT03701555|469482806|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
130415519|NCT03701555|469482807|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
130415520|NCT03701555|469482808|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
130415521|NCT03701555|469482809|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
130415522|NCT03701555|469482810|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
130474725|NCT00920621|469708434|FG002|Overall Study|Blood sample not collected|0|||
130474726|NCT00920621|469708435|FG003|Overall Study|Blood sample not collected|0|||
130415523|NCT03701555|469482811|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
130415524|NCT03701555|469482812|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
130415525|NCT03701555|469482813|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
130415526|NCT03701555|469482778|FG000|Part 3 (Day 1)|Subject Decision|0|||
130415527|NCT03701555|469482779|FG001|Part 3 (Day 1)|Subject Decision|0|||
130415528|NCT03701555|469482780|FG002|Part 3 (Day 1)|Subject Decision|0|||
130415529|NCT03701555|469482781|FG003|Part 3 (Day 1)|Subject Decision|0|||
130415530|NCT03701555|469482782|FG004|Part 3 (Day 1)|Subject Decision|0|||
130415531|NCT03701555|469482783|FG005|Part 3 (Day 1)|Subject Decision|0|||
130415532|NCT03701555|469482784|FG006|Part 3 (Day 1)|Subject Decision|0|||
130415533|NCT03701555|469482785|FG007|Part 3 (Day 1)|Subject Decision|0|||
130415534|NCT03701555|469482786|FG008|Part 3 (Day 1)|Subject Decision|0|||
130415535|NCT03701555|469482787|FG009|Part 3 (Day 1)|Subject Decision|0|||
130415536|NCT03701555|469482788|FG010|Part 3 (Day 1)|Subject Decision|0|||
130415537|NCT03701555|469482789|FG011|Part 3 (Day 1)|Subject Decision|0|||
130415538|NCT03701555|469482790|FG012|Part 3 (Day 1)|Subject Decision|0|||
130415539|NCT03701555|469482791|FG013|Part 3 (Day 1)|Subject Decision|0|||
130415540|NCT03701555|469482792|FG014|Part 3 (Day 1)|Subject Decision|0|||
130415541|NCT03701555|469482793|FG015|Part 3 (Day 1)|Subject Decision|0|||
130415542|NCT03701555|469482794|FG016|Part 3 (Day 1)|Subject Decision|0|||
130415543|NCT03701555|469482795|FG017|Part 3 (Day 1)|Subject Decision|0|||
130415544|NCT03701555|469482796|FG018|Part 3 (Day 1)|Subject Decision|0|||
130415545|NCT03701555|469482797|FG019|Part 3 (Day 1)|Subject Decision|0|||
130415546|NCT03701555|469482798|FG020|Part 3 (Day 1)|Subject Decision|0|||
130415547|NCT03701555|469482799|FG021|Part 3 (Day 1)|Subject Decision|0|||
130415548|NCT03701555|469482800|FG022|Part 3 (Day 1)|Subject Decision|0|||
130415549|NCT03701555|469482801|FG023|Part 3 (Day 1)|Subject Decision|0|||
130415550|NCT03701555|469482802|FG024|Part 3 (Day 1)|Subject Decision|0|||
130415551|NCT03701555|469482803|FG025|Part 3 (Day 1)|Subject Decision|0|||
130415552|NCT03701555|469482804|FG026|Part 3 (Day 1)|Subject Decision|1|||
130415553|NCT03701555|469482805|FG027|Part 3 (Day 1)|Subject Decision|0|||
130415554|NCT03701555|469482806|FG028|Part 3 (Day 1)|Subject Decision|0|||
130415555|NCT03701555|469482807|FG029|Part 3 (Day 1)|Subject Decision|0|||
130415556|NCT03701555|469482808|FG030|Part 3 (Day 1)|Subject Decision|0|||
130415557|NCT03701555|469482809|FG031|Part 3 (Day 1)|Subject Decision|2|||
130415558|NCT03701555|469482810|FG032|Part 3 (Day 1)|Subject Decision|1|||
130415559|NCT03701555|469482811|FG033|Part 3 (Day 1)|Subject Decision|1|||
130415560|NCT03701555|469482812|FG034|Part 3 (Day 1)|Subject Decision|0|||
130415561|NCT03701555|469482813|FG035|Part 3 (Day 1)|Subject Decision|0|||
130415562|NCT03701555|469482778|FG000|Part 3 (Day 1)|Other|0|||
130415563|NCT03701555|469482779|FG001|Part 3 (Day 1)|Other|0|||
130415564|NCT03701555|469482780|FG002|Part 3 (Day 1)|Other|0|||
130415565|NCT03701555|469482781|FG003|Part 3 (Day 1)|Other|0|||
130415566|NCT03701555|469482782|FG004|Part 3 (Day 1)|Other|0|||
130415567|NCT03701555|469482783|FG005|Part 3 (Day 1)|Other|0|||
130415568|NCT03701555|469482784|FG006|Part 3 (Day 1)|Other|0|||
130415569|NCT03701555|469482785|FG007|Part 3 (Day 1)|Other|0|||
130415570|NCT03701555|469482786|FG008|Part 3 (Day 1)|Other|0|||
130415571|NCT03701555|469482787|FG009|Part 3 (Day 1)|Other|0|||
130415572|NCT03701555|469482788|FG010|Part 3 (Day 1)|Other|0|||
130415573|NCT03701555|469482789|FG011|Part 3 (Day 1)|Other|0|||
130415574|NCT03701555|469482790|FG012|Part 3 (Day 1)|Other|0|||
130415575|NCT03701555|469482791|FG013|Part 3 (Day 1)|Other|0|||
130415576|NCT03701555|469482792|FG014|Part 3 (Day 1)|Other|0|||
130415577|NCT03701555|469482793|FG015|Part 3 (Day 1)|Other|0|||
130415578|NCT03701555|469482794|FG016|Part 3 (Day 1)|Other|0|||
130415579|NCT03701555|469482795|FG017|Part 3 (Day 1)|Other|0|||
130415580|NCT03701555|469482796|FG018|Part 3 (Day 1)|Other|0|||
130415581|NCT03701555|469482797|FG019|Part 3 (Day 1)|Other|0|||
130415582|NCT03701555|469482798|FG020|Part 3 (Day 1)|Other|0|||
130415583|NCT03701555|469482799|FG021|Part 3 (Day 1)|Other|0|||
130415584|NCT03701555|469482800|FG022|Part 3 (Day 1)|Other|0|||
130415585|NCT03701555|469482801|FG023|Part 3 (Day 1)|Other|0|||
130474727|NCT04321031|469708438|FG000|Overall Study|Adverse Event|0|||
130474728|NCT04321031|469708439|FG001|Overall Study|Adverse Event|2|||
130474729|NCT04321031|469708440|FG002|Overall Study|Adverse Event|2|||
130474730|NCT04321031|469708441|FG003|Overall Study|Adverse Event|2|||
130474731|NCT04321031|469708442|FG004|Overall Study|Adverse Event|2|||
130474732|NCT04321031|469708443|FG005|Overall Study|Adverse Event|2|||
130474733|NCT04321031|469708444|FG006|Overall Study|Adverse Event|0|||
130474734|NCT04321031|469708438|FG000|Overall Study|Lost to Follow-up|0|||
130474735|NCT04321031|469708439|FG001|Overall Study|Lost to Follow-up|0|||
130415586|NCT03701555|469482802|FG024|Part 3 (Day 1)|Other|1|||
130415587|NCT03701555|469482803|FG025|Part 3 (Day 1)|Other|1|||
130415588|NCT03701555|469482804|FG026|Part 3 (Day 1)|Other|0|||
130415589|NCT03701555|469482805|FG027|Part 3 (Day 1)|Other|0|||
130415590|NCT03701555|469482806|FG028|Part 3 (Day 1)|Other|0|||
130415591|NCT03701555|469482807|FG029|Part 3 (Day 1)|Other|1|||
130415592|NCT03701555|469482808|FG030|Part 3 (Day 1)|Other|1|||
130415593|NCT03701555|469482809|FG031|Part 3 (Day 1)|Other|0|||
130415594|NCT03701555|469482810|FG032|Part 3 (Day 1)|Other|1|||
130415595|NCT03701555|469482811|FG033|Part 3 (Day 1)|Other|1|||
130415596|NCT03701555|469482812|FG034|Part 3 (Day 1)|Other|0|||
130415597|NCT03701555|469482813|FG035|Part 3 (Day 1)|Other|0|||
130474736|NCT04321031|469708440|FG002|Overall Study|Lost to Follow-up|0|||
130415598|NCT03349710|469482814|FG000|Treatment Period|Death|0|||
130415599|NCT03349710|469482815|FG001|Treatment Period|Death|0|||
130415600|NCT03349710|469482816|FG002|Treatment Period|Death|1|||
130415601|NCT03349710|469482817|FG003|Treatment Period|Death|0|||
130415602|NCT03349710|469482814|FG000|Treatment Period|Disease Progression|0|||
130415603|NCT03349710|469482815|FG001|Treatment Period|Disease Progression|2|||
130474737|NCT04321031|469708441|FG003|Overall Study|Lost to Follow-up|1|||
130415604|NCT03349710|469482816|FG002|Treatment Period|Disease Progression|0|||
130415605|NCT03349710|469482817|FG003|Treatment Period|Disease Progression|1|||
130415606|NCT03349710|469482814|FG000|Treatment Period|Study Drug Toxicity|1|||
130415607|NCT03349710|469482815|FG001|Treatment Period|Study Drug Toxicity|0|||
130415608|NCT03349710|469482816|FG002|Treatment Period|Study Drug Toxicity|1|||
130415609|NCT03349710|469482817|FG003|Treatment Period|Study Drug Toxicity|1|||
130415610|NCT03349710|469482814|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
130415611|NCT03349710|469482815|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
130415612|NCT03349710|469482816|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
130415613|NCT03349710|469482817|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
130415614|NCT03349710|469482814|FG000|Treatment Period|admin reason by sponsor|0|||
130415615|NCT03349710|469482815|FG001|Treatment Period|admin reason by sponsor|7|||
130415616|NCT03349710|469482816|FG002|Treatment Period|admin reason by sponsor|0|||
130415617|NCT03349710|469482817|FG003|Treatment Period|admin reason by sponsor|19|||
130415618|NCT03349710|469482814|FG000|Treatment Period|Other Reason|2|||
130415619|NCT03349710|469482815|FG001|Treatment Period|Other Reason|0|||
130415620|NCT03349710|469482816|FG002|Treatment Period|Other Reason|2|||
130415621|NCT03349710|469482817|FG003|Treatment Period|Other Reason|1|||
130415622|NCT03349710|469482814|FG000|Treatment Period|completed|6|||
130415623|NCT03349710|469482815|FG001|Treatment Period|completed|0|||
130415624|NCT03349710|469482816|FG002|Treatment Period|completed|18|||
130415625|NCT03349710|469482817|FG003|Treatment Period|completed|1|||
130415626|NCT03349710|469482814|FG000|Treatment Period|participant request to discontinue|0|||
130415627|NCT03349710|469482815|FG001|Treatment Period|participant request to discontinue|0|||
130415628|NCT03349710|469482816|FG002|Treatment Period|participant request to discontinue|4|||
130415629|NCT03349710|469482817|FG003|Treatment Period|participant request to discontinue|0|||
130415630|NCT03349710|469482814|FG000|Treatment Period|participant withdrew consent|1|||
130415631|NCT03349710|469482815|FG001|Treatment Period|participant withdrew consent|0|||
130415632|NCT03349710|469482816|FG002|Treatment Period|participant withdrew consent|0|||
130415633|NCT03349710|469482817|FG003|Treatment Period|participant withdrew consent|0|||
130474738|NCT04321031|469708442|FG004|Overall Study|Lost to Follow-up|0|||
130474739|NCT04321031|469708443|FG005|Overall Study|Lost to Follow-up|2|||
130474740|NCT04321031|469708444|FG006|Overall Study|Lost to Follow-up|1|||
130474741|NCT04321031|469708438|FG000|Overall Study|Withdrawal by Subject|2|||
130474742|NCT04321031|469708439|FG001|Overall Study|Withdrawal by Subject|2|||
130474743|NCT04321031|469708440|FG002|Overall Study|Withdrawal by Subject|1|||
130474744|NCT04321031|469708441|FG003|Overall Study|Withdrawal by Subject|3|||
130474745|NCT04321031|469708442|FG004|Overall Study|Withdrawal by Subject|1|||
130474746|NCT04321031|469708443|FG005|Overall Study|Withdrawal by Subject|0|||
130474747|NCT04321031|469708444|FG006|Overall Study|Withdrawal by Subject|1|||
130474748|NCT04321031|469708438|FG000|Overall Study|Non-compliance with study drug|0|||
130474749|NCT04321031|469708439|FG001|Overall Study|Non-compliance with study drug|0|||
130474750|NCT04321031|469708440|FG002|Overall Study|Non-compliance with study drug|0|||
130474751|NCT04321031|469708441|FG003|Overall Study|Non-compliance with study drug|0|||
130474752|NCT04321031|469708442|FG004|Overall Study|Non-compliance with study drug|0|||
130474753|NCT04321031|469708443|FG005|Overall Study|Non-compliance with study drug|1|||
130474754|NCT04321031|469708444|FG006|Overall Study|Non-compliance with study drug|0|||
130474755|NCT04321031|469708438|FG000|Overall Study|Other|0|||
130474756|NCT04321031|469708439|FG001|Overall Study|Other|0|||
130474757|NCT04321031|469708440|FG002|Overall Study|Other|0|||
130474758|NCT04321031|469708441|FG003|Overall Study|Other|1|||
130474759|NCT04321031|469708442|FG004|Overall Study|Other|0|||
130474760|NCT04321031|469708443|FG005|Overall Study|Other|0|||
130474761|NCT04321031|469708444|FG006|Overall Study|Other|0|||
130474762|NCT03143153|469708447|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
130474763|NCT03143153|469708448|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
130474764|NCT03143153|469708449|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
130474765|NCT03143153|469708447|FG000|Pre-Treatment|Participant withdrew consent|0|||
130474766|NCT03143153|469708448|FG001|Pre-Treatment|Participant withdrew consent|1|||
130474767|NCT03143153|469708449|FG002|Pre-Treatment|Participant withdrew consent|12|||
130474768|NCT03143153|469708447|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
130563761|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130474769|NCT03143153|469708448|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
130474770|NCT03143153|469708449|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
130474771|NCT03143153|469708447|FG000|Pre-Treatment|Other Reasons|1|||
130474772|NCT03143153|469708448|FG001|Pre-Treatment|Other Reasons|2|||
130474773|NCT03143153|469708449|FG002|Pre-Treatment|Other Reasons|1|||
130415634|NCT01296568|469482818|FG000|Continued Access Phase|Lost to Follow-up|1|||
130415635|NCT01296568|469482818|FG000|Continued Access Phase|Withdrawal by Subject|1|||
130415636|NCT01296568|469482818|FG000|Continued Access Phase|Disease Progression|1|||
130415637|NCT04258020|469482819|FG000|Overall Study|Withdrawal by Subject|1|||
130415638|NCT04258020|469482820|FG001|Overall Study|Withdrawal by Subject|0|||
130415639|NCT03305016|469482821|FG000|Overall Study|Withdrawal by Subject|2|||
130415640|NCT01519206|469482824|FG000|Overall Study|Lost to Follow-up|3|||
130415641|NCT01519206|469482824|FG000|Overall Study|Missed Visit|2|||
130415642|NCT05046795|469482825|FG000|Overall Study|Adverse Event|13|||
130415643|NCT05046795|469482826|FG001|Overall Study|Adverse Event|15|||
130415644|NCT05046795|469482825|FG000|Overall Study|Withdrawal by Subject|4|||
130415645|NCT05046795|469482826|FG001|Overall Study|Withdrawal by Subject|7|||
130415646|NCT05046795|469482825|FG000|Overall Study|Physician Decision|1|||
130415647|NCT05046795|469482826|FG001|Overall Study|Physician Decision|2|||
130415648|NCT05046795|469482825|FG000|Overall Study|Protocol Violation|1|||
130415649|NCT05046795|469482826|FG001|Overall Study|Protocol Violation|2|||
130415650|NCT05046795|469482825|FG000|Overall Study|Death|1|||
130415651|NCT05046795|469482826|FG001|Overall Study|Death|0|||
130415652|NCT05046795|469482825|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
130415653|NCT05046795|469482826|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
130474774|NCT03143153|469708447|FG000|Pre-Treatment|Disease Progression|1|||
130415654|NCT02864082|469482827|FG000|Overall Study|Adverse Event|1|||
130415655|NCT02864082|469482828|FG001|Overall Study|Adverse Event|1|||
130415656|NCT02864082|469482827|FG000|Overall Study|Lost to Follow-up|0|||
130415657|NCT02864082|469482828|FG001|Overall Study|Lost to Follow-up|1|||
130415658|NCT02864082|469482827|FG000|Overall Study|Withdrawal by Subject|2|||
130415659|NCT02864082|469482828|FG001|Overall Study|Withdrawal by Subject|2|||
130415660|NCT01127178|469482829|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
130415661|NCT01127178|469482830|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
130415662|NCT01127178|469482829|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
130415663|NCT01127178|469482830|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
130415664|NCT01127178|469482829|FG000|Dose Escalation: Treatment Phase|Other|2|||
130415665|NCT01127178|469482830|FG001|Dose Escalation: Treatment Phase|Other|0|||
130415666|NCT01127178|469482829|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
130415667|NCT01127178|469482830|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
130415668|NCT01127178|469482829|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
130415669|NCT01127178|469482830|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
130415670|NCT01127178|469482829|FG000|Dose Escalation: Extension Phase|Other|1|||
130415671|NCT01127178|469482830|FG001|Dose Escalation: Extension Phase|Other|0|||
130415672|NCT04139317|469482831|FG000|Overall Study|Adverse Event|10|||
130415673|NCT04139317|469482832|FG001|Overall Study|Adverse Event|2|||
130415674|NCT04139317|469482831|FG000|Overall Study|Death|6|||
130415675|NCT04139317|469482832|FG001|Overall Study|Death|4|||
130415676|NCT04139317|469482831|FG000|Overall Study|Lost to Follow-up|1|||
130415677|NCT04139317|469482832|FG001|Overall Study|Lost to Follow-up|0|||
130415678|NCT04139317|469482831|FG000|Overall Study|Physician Decision|3|||
130415679|NCT04139317|469482832|FG001|Overall Study|Physician Decision|1|||
130415680|NCT04139317|469482831|FG000|Overall Study|Progressive Disease|19|||
130415681|NCT04139317|469482832|FG001|Overall Study|Progressive Disease|9|||
130415682|NCT04139317|469482831|FG000|Overall Study|Subject Decision|2|||
130415683|NCT04139317|469482832|FG001|Overall Study|Subject Decision|2|||
130415684|NCT03621696|469482833|FG000|Overall Study|Not eligible|0|||
130415685|NCT03621696|469482834|FG001|Overall Study|Not eligible|0|||
130415686|NCT03621696|469482835|FG002|Overall Study|Not eligible|0|||
130415687|NCT03621696|469482836|FG003|Overall Study|Not eligible|5|||
130415688|NCT03621696|469482833|FG000|Overall Study|Withdrawal by Subject|1|||
130474775|NCT03143153|469708448|FG001|Pre-Treatment|Disease Progression|1|||
130474776|NCT03143153|469708449|FG002|Pre-Treatment|Disease Progression|2|||
130474777|NCT03143153|469708447|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130474778|NCT03143153|469708448|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
130474779|NCT03143153|469708449|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
130474780|NCT03143153|469708447|FG000|Treatment|Disease progression|174|||
130474781|NCT03143153|469708448|FG001|Treatment|Disease progression|184|||
130474782|NCT03143153|469708449|FG002|Treatment|Disease progression|193|||
130474783|NCT03143153|469708447|FG000|Treatment|Study drug toxicity|59|||
130474784|NCT03143153|469708448|FG001|Treatment|Study drug toxicity|33|||
130474785|NCT03143153|469708449|FG002|Treatment|Study drug toxicity|40|||
130415689|NCT03621696|469482834|FG001|Overall Study|Withdrawal by Subject|1|||
130415690|NCT03621696|469482835|FG002|Overall Study|Withdrawal by Subject|1|||
130415691|NCT03621696|469482836|FG003|Overall Study|Withdrawal by Subject|0|||
130415692|NCT03621696|469482833|FG000|Overall Study|Physician Decision|0|||
130415693|NCT03621696|469482834|FG001|Overall Study|Physician Decision|0|||
130415694|NCT03621696|469482835|FG002|Overall Study|Physician Decision|1|||
130415695|NCT03621696|469482836|FG003|Overall Study|Physician Decision|0|||
130415696|NCT04349553|469482837|FG000|Overall Study|Withdrawal by Subject|1|||
130415697|NCT04349553|469482838|FG001|Overall Study|Withdrawal by Subject|0|||
130415698|NCT04349553|469482839|FG002|Overall Study|Withdrawal by Subject|1|||
130415699|NCT04349553|469482840|FG003|Overall Study|Withdrawal by Subject|0|||
130415700|NCT00214136|469482841|FG000|Overall Study|Death|5|||
130415701|NCT04287920|469482842|FG000|Overall Study|Lost to Follow-up|1|||
130415702|NCT04287920|469482843|FG001|Overall Study|Lost to Follow-up|1|||
130415703|NCT04287920|469482842|FG000|Overall Study|Withdrawal by Subject|0|||
130415704|NCT04287920|469482843|FG001|Overall Study|Withdrawal by Subject|3|||
130474786|NCT03143153|469708447|FG000|Treatment|Death|5|||
130474787|NCT03143153|469708448|FG001|Treatment|Death|3|||
130474788|NCT03143153|469708449|FG002|Treatment|Death|4|||
130474789|NCT03143153|469708447|FG000|Treatment|Adverse event unrelated to study drug|19|||
130474790|NCT03143153|469708448|FG001|Treatment|Adverse event unrelated to study drug|28|||
130474791|NCT03143153|469708449|FG002|Treatment|Adverse event unrelated to study drug|12|||
130474792|NCT03143153|469708447|FG000|Treatment|Participant request to discontinue study treatment|13|||
130415705|NCT04313634|469482844|FG000|Overall Study|Adverse Event|2|||
130415706|NCT04313634|469482845|FG001|Overall Study|Adverse Event|2|||
130415707|NCT04313634|469482846|FG002|Overall Study|Adverse Event|0|||
130415708|NCT04313634|469482844|FG000|Overall Study|Withdrawal by Subject|1|||
130415709|NCT04313634|469482845|FG001|Overall Study|Withdrawal by Subject|0|||
130415710|NCT04313634|469482846|FG002|Overall Study|Withdrawal by Subject|1|||
130415711|NCT04313634|469482844|FG000|Overall Study|Protocol Violation|0|||
130415712|NCT04313634|469482845|FG001|Overall Study|Protocol Violation|0|||
130415713|NCT04313634|469482846|FG002|Overall Study|Protocol Violation|1|||
130415714|NCT01220557|469482852|FG000|Overall Study|Lost to Follow-up|5|||
130415715|NCT01220557|469482853|FG001|Overall Study|Lost to Follow-up|3|||
130474793|NCT03143153|469708448|FG001|Treatment|Participant request to discontinue study treatment|15|||
130474794|NCT03143153|469708449|FG002|Treatment|Participant request to discontinue study treatment|20|||
130474795|NCT03143153|469708447|FG000|Treatment|Participant withdrew consent|3|||
130474796|NCT03143153|469708448|FG001|Treatment|Participant withdrew consent|4|||
130474797|NCT03143153|469708449|FG002|Treatment|Participant withdrew consent|12|||
130474798|NCT03143153|469708447|FG000|Treatment|Pregnancy|1|||
130415716|NCT01220557|469482852|FG000|Overall Study|attended less than 6 lessons|1|||
130415717|NCT01220557|469482853|FG001|Overall Study|attended less than 6 lessons|2|||
130474799|NCT03143153|469708448|FG001|Treatment|Pregnancy|0|||
130474800|NCT03143153|469708449|FG002|Treatment|Pregnancy|0|||
130474801|NCT03143153|469708447|FG000|Treatment|Maximum clinical benefit|1|||
130474802|NCT03143153|469708448|FG001|Treatment|Maximum clinical benefit|3|||
130474803|NCT03143153|469708449|FG002|Treatment|Maximum clinical benefit|4|||
130474804|NCT03143153|469708447|FG000|Treatment|Completed treatment as per Protocol|13|||
130474805|NCT03143153|469708448|FG001|Treatment|Completed treatment as per Protocol|8|||
130474806|NCT03143153|469708449|FG002|Treatment|Completed treatment as per Protocol|0|||
130474807|NCT03143153|469708447|FG000|Treatment|Other reasons|12|||
130474808|NCT03143153|469708448|FG001|Treatment|Other reasons|7|||
130474809|NCT03143153|469708449|FG002|Treatment|Other reasons|15|||
130474810|NCT03143153|469708447|FG000|Treatment|Not reported|1|||
130474811|NCT03143153|469708448|FG001|Treatment|Not reported|0|||
130474812|NCT03143153|469708449|FG002|Treatment|Not reported|0|||
130474813|NCT02312557|469708450|FG000|Overall Study|Survival follow-up|4|||
130474814|NCT04237298|469708451|FG000|Overall Study|Lost to Follow-up|4|||
130474815|NCT04237298|469708452|FG001|Overall Study|Lost to Follow-up|5|||
130474816|NCT02530671|469708453|FG000|Overall Study|Lost to Follow-up|2|||
130474817|NCT02530671|469708454|FG001|Overall Study|Lost to Follow-up|0|||
130474818|NCT02530671|469708453|FG000|Overall Study|Withdrawal by Subject|1|||
130474819|NCT02530671|469708454|FG001|Overall Study|Withdrawal by Subject|0|||
130474820|NCT02736409|469708455|FG000|Overall Study|Withdrawal by Subject|4|||
130474821|NCT02736409|469708456|FG001|Overall Study|Withdrawal by Subject|2|||
130474822|NCT02736409|469708457|FG002|Overall Study|Withdrawal by Subject|17|||
130474823|NCT02736409|469708458|FG003|Overall Study|Withdrawal by Subject|3|||
130474824|NCT02736409|469708455|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130474825|NCT02736409|469708456|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130474826|NCT02736409|469708457|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130474827|NCT02736409|469708458|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130474828|NCT02736409|469708455|FG000|Overall Study|Adverse Event|0|||
130474829|NCT02736409|469708456|FG001|Overall Study|Adverse Event|1|||
130474830|NCT02736409|469708457|FG002|Overall Study|Adverse Event|5|||
130474831|NCT02736409|469708458|FG003|Overall Study|Adverse Event|4|||
130474832|NCT02736409|469708455|FG000|Overall Study|Other|0|||
130474833|NCT02736409|469708456|FG001|Overall Study|Other|0|||
130474834|NCT02736409|469708457|FG002|Overall Study|Other|1|||
130474835|NCT02736409|469708458|FG003|Overall Study|Other|1|||
130474836|NCT02736409|469708455|FG000|Overall Study|Pregnancy|0|||
130474837|NCT02736409|469708456|FG001|Overall Study|Pregnancy|0|||
130563762|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130474838|NCT02736409|469708457|FG002|Overall Study|Pregnancy|1|||
130474839|NCT02736409|469708458|FG003|Overall Study|Pregnancy|0|||
130474840|NCT02736409|469708455|FG000|Overall Study|Lost to Follow-up|0|||
130474841|NCT02736409|469708456|FG001|Overall Study|Lost to Follow-up|0|||
130474842|NCT02736409|469708457|FG002|Overall Study|Lost to Follow-up|2|||
130474843|NCT02736409|469708458|FG003|Overall Study|Lost to Follow-up|1|||
130474844|NCT02736409|469708455|FG000|Overall Study|Physician Decision|0|||
130474845|NCT02736409|469708456|FG001|Overall Study|Physician Decision|0|||
130415718|NCT01196975|469482857|FG000|Overall Study|Adverse Event|2|||
130415719|NCT01196975|469482858|FG001|Overall Study|Adverse Event|2|||
130415720|NCT01196975|469482859|FG002|Overall Study|Adverse Event|0|||
130415721|NCT01196975|469482860|FG003|Overall Study|Adverse Event|0|||
130474846|NCT02736409|469708457|FG002|Overall Study|Physician Decision|0|||
130415722|NCT01196975|469482861|FG004|Overall Study|Adverse Event|2|||
130415723|NCT01196975|469482857|FG000|Overall Study|Withdrawal by Subject|2|||
130415724|NCT01196975|469482858|FG001|Overall Study|Withdrawal by Subject|1|||
130415725|NCT01196975|469482859|FG002|Overall Study|Withdrawal by Subject|0|||
130415726|NCT01196975|469482860|FG003|Overall Study|Withdrawal by Subject|1|||
130415727|NCT01196975|469482861|FG004|Overall Study|Withdrawal by Subject|0|||
130415728|NCT01196975|469482857|FG000|Overall Study|Lost to Follow-up|11|||
130415729|NCT01196975|469482858|FG001|Overall Study|Lost to Follow-up|6|||
130415730|NCT01196975|469482859|FG002|Overall Study|Lost to Follow-up|5|||
130415731|NCT01196975|469482860|FG003|Overall Study|Lost to Follow-up|5|||
130415732|NCT01196975|469482861|FG004|Overall Study|Lost to Follow-up|11|||
130415733|NCT01365494|469482862|FG000|Overall Study|Adverse Event|1|||
130415734|NCT01365494|469482863|FG001|Overall Study|Adverse Event|0|||
130415735|NCT01365494|469482862|FG000|Overall Study|Withdrawal by Subject|0|||
130415736|NCT01365494|469482863|FG001|Overall Study|Withdrawal by Subject|1|||
130415737|NCT01365494|469482862|FG000|Overall Study|Lost to Follow-up|1|||
130415738|NCT01365494|469482863|FG001|Overall Study|Lost to Follow-up|2|||
130415739|NCT04558346|469482874|FG000|Overall Study|Withdrawal by Subject|2|||
130415740|NCT04558346|469482875|FG001|Overall Study|Withdrawal by Subject|0|||
130415741|NCT04558346|469482874|FG000|Overall Study|Lost to Follow-up|0|||
130415742|NCT04558346|469482875|FG001|Overall Study|Lost to Follow-up|1|||
130415743|NCT04558346|469482874|FG000|Overall Study|Adverse Event|0|||
130415744|NCT04558346|469482875|FG001|Overall Study|Adverse Event|1|||
130415745|NCT02715765|469482876|FG000|Overall Study|Study Termination|3|||
130415746|NCT02715765|469482877|FG001|Overall Study|Study Termination|0|||
130415747|NCT02715765|469482878|FG002|Overall Study|Study Termination|0|||
130415748|NCT01462344|469482879|FG000|Overall Study|Withdrawal by Subject|245|||
130415749|NCT01462344|469482880|FG001|Overall Study|Withdrawal by Subject|226|||
130415750|NCT01462344|469482879|FG000|Overall Study|Adverse Event|24|||
130415751|NCT01462344|469482880|FG001|Overall Study|Adverse Event|23|||
130415752|NCT01462344|469482879|FG000|Overall Study|Asthma Exacerbation|34|||
130415753|NCT01462344|469482880|FG001|Overall Study|Asthma Exacerbation|35|||
130415754|NCT01462344|469482879|FG000|Overall Study|Lack of Efficacy|5|||
130415755|NCT01462344|469482880|FG001|Overall Study|Lack of Efficacy|6|||
130415756|NCT01462344|469482879|FG000|Overall Study|Protocol Violation|68|||
130415757|NCT01462344|469482880|FG001|Overall Study|Protocol Violation|53|||
130415758|NCT01462344|469482879|FG000|Overall Study|Lost to Follow-up|7|||
130415759|NCT01462344|469482880|FG001|Overall Study|Lost to Follow-up|7|||
130474847|NCT02736409|469708458|FG003|Overall Study|Physician Decision|2|||
130474848|NCT01415154|469708459|FG000|Overall Study|Lack of Efficacy|4|||
130474849|NCT01415154|469708460|FG001|Overall Study|Lack of Efficacy|5|||
130474850|NCT01415154|469708459|FG000|Overall Study|Withdrawal by Subject|7|||
130474851|NCT01415154|469708460|FG001|Overall Study|Withdrawal by Subject|8|||
130474852|NCT01415154|469708459|FG000|Overall Study|Lost to Follow-up|1|||
130474853|NCT01415154|469708460|FG001|Overall Study|Lost to Follow-up|4|||
130474854|NCT01415154|469708459|FG000|Overall Study|Protocol Violation|0|||
130474855|NCT01415154|469708460|FG001|Overall Study|Protocol Violation|1|||
130474856|NCT01415154|469708459|FG000|Overall Study|Satisfactory Response|0|||
130474857|NCT01415154|469708460|FG001|Overall Study|Satisfactory Response|1|||
130563763|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130563764|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130563765|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130563766|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130563767|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130563768|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
130563769|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
130563770|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
130563771|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
130563772|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
130563773|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563774|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563775|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563776|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563777|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130415760|NCT01003249|469482881|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130415761|NCT01003249|469482882|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130415762|NCT01003249|469482881|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
130415763|NCT01003249|469482882|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
130415764|NCT01003249|469482881|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130415765|NCT01003249|469482882|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130474858|NCT01415154|469708459|FG000|Overall Study|Adverse Event|1|||
130474859|NCT01415154|469708460|FG001|Overall Study|Adverse Event|1|||
130474860|NCT05536440|469708479|FG000|Overall Study|Adverse Event|0|||
130474861|NCT05536440|469708480|FG001|Overall Study|Adverse Event|0|||
130415766|NCT01003249|469482881|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
130415767|NCT01003249|469482882|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
130415768|NCT01962974|469482885|FG000|Overall Study|Study termination|7|||
130415769|NCT03394924|469482889|FG000|Overall Study|Adverse Event|0|||
130415770|NCT03394924|469482890|FG001|Overall Study|Adverse Event|5|||
130415771|NCT03394924|469482891|FG002|Overall Study|Adverse Event|0|||
130415772|NCT03394924|469482889|FG000|Overall Study|Withdrawal by Subject|2|||
130415773|NCT03394924|469482890|FG001|Overall Study|Withdrawal by Subject|0|||
130415774|NCT03394924|469482891|FG002|Overall Study|Withdrawal by Subject|0|||
130415775|NCT03394924|469482889|FG000|Overall Study|Lost to Follow-up|0|||
130415776|NCT03394924|469482890|FG001|Overall Study|Lost to Follow-up|1|||
130415777|NCT03394924|469482891|FG002|Overall Study|Lost to Follow-up|0|||
130415778|NCT03394924|469482889|FG000|Overall Study|Did not meet all inclusion criteria|1|||
130415779|NCT03394924|469482890|FG001|Overall Study|Did not meet all inclusion criteria|0|||
130415780|NCT03394924|469482891|FG002|Overall Study|Did not meet all inclusion criteria|0|||
130415781|NCT03387852|469482892|FG000|Overall Study|Adverse event (AE)|3|||
130415782|NCT03387852|469482893|FG001|Overall Study|Adverse event (AE)|0|||
130415783|NCT03387852|469482894|FG002|Overall Study|Adverse event (AE)|2|||
130415784|NCT03387852|469482895|FG003|Overall Study|Adverse event (AE)|0|||
130415785|NCT03387852|469482892|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
130415786|NCT03387852|469482893|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
130415787|NCT03387852|469482894|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
130415788|NCT03387852|469482895|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
130415789|NCT03387852|469482892|FG000|Overall Study|Withdrawal by participant|1|||
130415790|NCT03387852|469482893|FG001|Overall Study|Withdrawal by participant|1|||
130415791|NCT03387852|469482894|FG002|Overall Study|Withdrawal by participant|3|||
130415792|NCT03387852|469482895|FG003|Overall Study|Withdrawal by participant|2|||
130415793|NCT03387852|469482892|FG000|Overall Study|Other- Unspecified|1|||
130415794|NCT03387852|469482893|FG001|Overall Study|Other- Unspecified|1|||
130415795|NCT03387852|469482894|FG002|Overall Study|Other- Unspecified|2|||
130415796|NCT03387852|469482895|FG003|Overall Study|Other- Unspecified|1|||
130415797|NCT03387852|469482892|FG000|Overall Study|Poor compliance to protocol|0|||
130415798|NCT03387852|469482893|FG001|Overall Study|Poor compliance to protocol|0|||
130415799|NCT03387852|469482894|FG002|Overall Study|Poor compliance to protocol|0|||
130415800|NCT03387852|469482895|FG003|Overall Study|Poor compliance to protocol|1|||
130415801|NCT03387852|469482892|FG000|Overall Study|Randomized and not treated|0|||
130415802|NCT03387852|469482893|FG001|Overall Study|Randomized and not treated|0|||
130415803|NCT03387852|469482894|FG002|Overall Study|Randomized and not treated|0|||
130415804|NCT03387852|469482895|FG003|Overall Study|Randomized and not treated|1|||
130415805|NCT00659334|469482899|FG000|Overall Study|Screen Failure|8|||
130415806|NCT00659334|469482900|FG001|Overall Study|Screen Failure|5|||
130415807|NCT00659334|469482901|FG002|Overall Study|Screen Failure|0|||
130415808|NCT00659334|469482902|FG003|Overall Study|Screen Failure|0|||
130415809|NCT00659334|469482903|FG004|Overall Study|Screen Failure|0|||
130415810|NCT00659334|469482904|FG005|Overall Study|Screen Failure|0|||
130415811|NCT00659334|469482905|FG006|Overall Study|Screen Failure|1|||
130415812|NCT04177758|469482906|FG000|Overall Study|Lost to Follow-up|19|||
130415813|NCT04177758|469482907|FG001|Overall Study|Lost to Follow-up|11|||
130415814|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
130415815|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
130415816|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
130415817|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
130415818|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
130415819|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
130415820|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
130415821|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
130415822|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
130415823|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
130474862|NCT05536440|469708481|FG002|Overall Study|Adverse Event|0|||
130474863|NCT05536440|469708482|FG003|Overall Study|Adverse Event|0|||
130474864|NCT05536440|469708483|FG004|Overall Study|Adverse Event|0|||
130474865|NCT05536440|469708484|FG005|Overall Study|Adverse Event|0|||
130474866|NCT05536440|469708485|FG006|Overall Study|Adverse Event|0|||
130474867|NCT05536440|469708486|FG007|Overall Study|Adverse Event|0|||
130474868|NCT05536440|469708487|FG008|Overall Study|Adverse Event|1|||
130474869|NCT06283173|469708488|FG000|Overall Study|Did not show for first visit|10|||
130474870|NCT06283173|469708488|FG000|Overall Study|Lost to Follow-up|12|||
130474871|NCT06283173|469708488|FG000|Overall Study|Physician Decision|7|||
130474872|NCT05470400|469708493|FG000|Overall Study|Lost to Follow-up|0|||
130474873|NCT05470400|469708494|FG001|Overall Study|Lost to Follow-up|0|||
130474874|NCT05470400|469708495|FG002|Overall Study|Lost to Follow-up|0|||
130474875|NCT05470400|469708496|FG003|Overall Study|Lost to Follow-up|0|||
130474876|NCT05470400|469708497|FG004|Overall Study|Lost to Follow-up|0|||
130474877|NCT05470400|469708498|FG005|Overall Study|Lost to Follow-up|0|||
130474878|NCT05470400|469708499|FG006|Overall Study|Lost to Follow-up|0|||
130474879|NCT05470400|469708500|FG007|Overall Study|Lost to Follow-up|1|||
130474880|NCT05470400|469708493|FG000|Overall Study|Withdrawal by Subject|1|||
130415824|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
130474881|NCT05470400|469708494|FG001|Overall Study|Withdrawal by Subject|0|||
130474882|NCT05470400|469708495|FG002|Overall Study|Withdrawal by Subject|0|||
130474883|NCT05470400|469708496|FG003|Overall Study|Withdrawal by Subject|0|||
130474884|NCT05470400|469708497|FG004|Overall Study|Withdrawal by Subject|0|||
130474885|NCT05470400|469708498|FG005|Overall Study|Withdrawal by Subject|1|||
130474886|NCT05470400|469708499|FG006|Overall Study|Withdrawal by Subject|0|||
130563778|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563779|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563780|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563781|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130563782|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
130563783|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
130563784|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
130563785|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
130563786|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
130563787|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563788|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563789|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563790|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130415825|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
130415826|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
130415827|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
130415828|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
130415829|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
130415830|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
130415831|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
130415832|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
130415833|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
130563791|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563792|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563793|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563794|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563795|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563796|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563797|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130563798|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130563799|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130563800|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130563801|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563802|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563803|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563804|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563805|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563806|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130415834|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
130415835|NCT01781572|469482909|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
130415836|NCT01781572|469482910|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
130415837|NCT01781572|469482911|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
130415838|NCT01781572|469482909|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
130415839|NCT01781572|469482910|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
130415840|NCT01781572|469482911|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
130415841|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
130415842|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
130415843|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
130415844|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
130415845|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
130415846|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
130474887|NCT05470400|469708500|FG007|Overall Study|Withdrawal by Subject|2|||
130474888|NCT03138512|469708501|FG000|Randomization|Participants withdrew consent|0|||
130474889|NCT03138512|469708502|FG001|Randomization|Participants withdrew consent|1|||
130474890|NCT03138512|469708503|FG002|Randomization|Participants withdrew consent|1|||
130474891|NCT03138512|469708504|FG003|Randomization|Participants withdrew consent|0|||
130563807|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563808|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563809|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130563810|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130474892|NCT03138512|469708505|FG004|Randomization|Participants withdrew consent|0|||
130415847|NCT01781572|469482909|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
130415848|NCT01781572|469482910|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
130415849|NCT01781572|469482911|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
130415850|NCT01781572|469482909|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
130415851|NCT01781572|469482910|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
130415852|NCT01781572|469482911|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
130415853|NCT01781572|469482909|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
130415854|NCT01781572|469482910|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
130415855|NCT01781572|469482911|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
130415856|NCT01781572|469482909|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
130415857|NCT01781572|469482910|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
130415858|NCT01781572|469482911|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
130415859|NCT01781572|469482909|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
130415860|NCT01781572|469482910|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
130415861|NCT01781572|469482911|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
130415862|NCT01781572|469482909|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
130415863|NCT01781572|469482910|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
130415864|NCT01781572|469482911|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
130415865|NCT01781572|469482909|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
130415866|NCT01781572|469482910|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
130415867|NCT01781572|469482911|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
130415868|NCT00045110|469482912|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
130415869|NCT00045110|469482913|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
130415870|NCT00045110|469482914|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
130474893|NCT03138512|469708501|FG000|Randomization|Participant no longer meets study criteria|0|||
130474894|NCT03138512|469708502|FG001|Randomization|Participant no longer meets study criteria|3|||
130474895|NCT03138512|469708503|FG002|Randomization|Participant no longer meets study criteria|1|||
130474896|NCT03138512|469708504|FG003|Randomization|Participant no longer meets study criteria|1|||
130474897|NCT03138512|469708505|FG004|Randomization|Participant no longer meets study criteria|3|||
130474898|NCT03138512|469708501|FG000|Randomization|Other reasons|1|||
130474899|NCT03138512|469708502|FG001|Randomization|Other reasons|0|||
130474900|NCT03138512|469708503|FG002|Randomization|Other reasons|0|||
130474901|NCT03138512|469708504|FG003|Randomization|Other reasons|0|||
130474902|NCT03138512|469708505|FG004|Randomization|Other reasons|0|||
130474903|NCT03138512|469708501|FG000|Treatment Part A|Disease recurrence|10|||
130474904|NCT03138512|469708502|FG001|Treatment Part A|Disease recurrence|20|||
130474905|NCT03138512|469708503|FG002|Treatment Part A|Disease recurrence|0|||
130474906|NCT03138512|469708504|FG003|Treatment Part A|Disease recurrence|0|||
130474907|NCT03138512|469708505|FG004|Treatment Part A|Disease recurrence|0|||
130474908|NCT03138512|469708501|FG000|Treatment Part A|Study Drug Toxicity|132|||
130474909|NCT03138512|469708502|FG001|Treatment Part A|Study Drug Toxicity|5|||
130474910|NCT03138512|469708503|FG002|Treatment Part A|Study Drug Toxicity|0|||
130563811|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
130563812|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
130563813|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
130563814|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
130563815|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563816|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563817|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563818|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563819|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563820|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563821|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563822|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563823|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130563824|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
130563825|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
130563826|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
130563827|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
130563828|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
130563829|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130415871|NCT00045110|469482912|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
130415872|NCT00045110|469482913|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
130415873|NCT00045110|469482914|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
130415874|NCT00045110|469482912|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
130415875|NCT00045110|469482913|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
130474911|NCT03138512|469708504|FG003|Treatment Part A|Study Drug Toxicity|0|||
130474912|NCT03138512|469708505|FG004|Treatment Part A|Study Drug Toxicity|0|||
130474913|NCT03138512|469708501|FG000|Treatment Part A|Death|1|||
130474914|NCT03138512|469708502|FG001|Treatment Part A|Death|0|||
130474915|NCT03138512|469708503|FG002|Treatment Part A|Death|0|||
130474916|NCT03138512|469708504|FG003|Treatment Part A|Death|0|||
130474917|NCT03138512|469708505|FG004|Treatment Part A|Death|0|||
130474918|NCT03138512|469708501|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
130474919|NCT03138512|469708502|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
130474920|NCT03138512|469708503|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
130474921|NCT03138512|469708504|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
130474922|NCT03138512|469708505|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
130474923|NCT03138512|469708501|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
130474924|NCT03138512|469708502|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
130474925|NCT03138512|469708503|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
130474926|NCT03138512|469708504|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
130474927|NCT03138512|469708505|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
130474928|NCT03138512|469708501|FG000|Treatment Part A|Participant withdrew consent|2|||
130474929|NCT03138512|469708502|FG001|Treatment Part A|Participant withdrew consent|4|||
130474930|NCT03138512|469708503|FG002|Treatment Part A|Participant withdrew consent|0|||
130474931|NCT03138512|469708504|FG003|Treatment Part A|Participant withdrew consent|0|||
130474932|NCT03138512|469708505|FG004|Treatment Part A|Participant withdrew consent|0|||
130474933|NCT03138512|469708501|FG000|Treatment Part A|Lost to Follow-up|0|||
130474934|NCT03138512|469708502|FG001|Treatment Part A|Lost to Follow-up|1|||
130474935|NCT03138512|469708503|FG002|Treatment Part A|Lost to Follow-up|0|||
130474936|NCT03138512|469708504|FG003|Treatment Part A|Lost to Follow-up|0|||
130474937|NCT03138512|469708505|FG004|Treatment Part A|Lost to Follow-up|0|||
130474938|NCT03138512|469708501|FG000|Treatment Part A|Poor/non-compliance|1|||
130474939|NCT03138512|469708502|FG001|Treatment Part A|Poor/non-compliance|0|||
130474940|NCT03138512|469708503|FG002|Treatment Part A|Poor/non-compliance|0|||
130474941|NCT03138512|469708504|FG003|Treatment Part A|Poor/non-compliance|0|||
130474942|NCT03138512|469708505|FG004|Treatment Part A|Poor/non-compliance|0|||
130474943|NCT03138512|469708501|FG000|Treatment Part A|Pregnancy|0|||
130563830|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130563831|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130563832|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130474944|NCT03138512|469708502|FG001|Treatment Part A|Pregnancy|1|||
130474945|NCT03138512|469708503|FG002|Treatment Part A|Pregnancy|0|||
130474946|NCT03138512|469708504|FG003|Treatment Part A|Pregnancy|0|||
130474947|NCT03138512|469708505|FG004|Treatment Part A|Pregnancy|0|||
130474948|NCT03138512|469708501|FG000|Treatment Part A|Other reasons|11|||
130474949|NCT03138512|469708502|FG001|Treatment Part A|Other reasons|8|||
130474950|NCT03138512|469708503|FG002|Treatment Part A|Other reasons|0|||
130474951|NCT03138512|469708504|FG003|Treatment Part A|Other reasons|0|||
130474952|NCT03138512|469708505|FG004|Treatment Part A|Other reasons|0|||
130474953|NCT03138512|469708501|FG000|Treatment Part B|Disease recurrence|0|||
130474954|NCT03138512|469708502|FG001|Treatment Part B|Disease recurrence|0|||
130563833|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130563834|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130415876|NCT00045110|469482914|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
130415877|NCT01218646|469482915|FG000|Overall Study|Adverse Event|0|||
130415878|NCT01218646|469482916|FG001|Overall Study|Adverse Event|0|||
130415879|NCT01218646|469482917|FG002|Overall Study|Adverse Event|1|||
130415880|NCT01218646|469482918|FG003|Overall Study|Adverse Event|0|||
130415881|NCT01218646|469482915|FG000|Overall Study|Lost to Follow-up|1|||
130415882|NCT01218646|469482916|FG001|Overall Study|Lost to Follow-up|0|||
130415883|NCT01218646|469482917|FG002|Overall Study|Lost to Follow-up|0|||
130415884|NCT01218646|469482918|FG003|Overall Study|Lost to Follow-up|0|||
130415885|NCT01218646|469482915|FG000|Overall Study|Protocol Violation|0|||
130415886|NCT01218646|469482916|FG001|Overall Study|Protocol Violation|0|||
130415887|NCT01218646|469482917|FG002|Overall Study|Protocol Violation|1|||
130415888|NCT01218646|469482918|FG003|Overall Study|Protocol Violation|1|||
130415889|NCT03156023|469482924|FG000|Overall Study|Withdrawal by Subject|1|||
130415890|NCT03156023|469482925|FG001|Overall Study|Withdrawal by Subject|0|||
130415891|NCT03156023|469482926|FG002|Overall Study|Withdrawal by Subject|2|||
130474955|NCT03138512|469708503|FG002|Treatment Part B|Disease recurrence|6|||
130474956|NCT03138512|469708504|FG003|Treatment Part B|Disease recurrence|12|||
130474957|NCT03138512|469708505|FG004|Treatment Part B|Disease recurrence|10|||
130474958|NCT03138512|469708501|FG000|Treatment Part B|Study drug toxicity|0|||
130474959|NCT03138512|469708502|FG001|Treatment Part B|Study drug toxicity|0|||
130474960|NCT03138512|469708503|FG002|Treatment Part B|Study drug toxicity|63|||
130474961|NCT03138512|469708504|FG003|Treatment Part B|Study drug toxicity|3|||
130415892|NCT03156023|469482927|FG003|Overall Study|Withdrawal by Subject|1|||
130415893|NCT03156023|469482928|FG004|Overall Study|Withdrawal by Subject|1|||
130415894|NCT03156023|469482924|FG000|Overall Study|Lost to Follow-up|0|||
130415895|NCT03156023|469482925|FG001|Overall Study|Lost to Follow-up|0|||
130415896|NCT03156023|469482926|FG002|Overall Study|Lost to Follow-up|0|||
130415897|NCT03156023|469482927|FG003|Overall Study|Lost to Follow-up|0|||
130415898|NCT03156023|469482928|FG004|Overall Study|Lost to Follow-up|1|||
130415899|NCT00726752|469482929|FG000|Overall Study|Lack of Efficacy|6|||
130415900|NCT04827576|469485228|FG000|Overall Study|Death|5|||
130415901|NCT04827576|469485229|FG001|Overall Study|Death|17|||
130415902|NCT04827576|469485230|FG002|Overall Study|Death|17|||
130415903|NCT04827576|469485231|FG003|Overall Study|Death|32|||
130415904|NCT04827576|469485228|FG000|Overall Study|Study Terminated by Sponsor|2|||
130415905|NCT04827576|469485229|FG001|Overall Study|Study Terminated by Sponsor|9|||
130415906|NCT04827576|469485230|FG002|Overall Study|Study Terminated by Sponsor|7|||
130415907|NCT04827576|469485231|FG003|Overall Study|Study Terminated by Sponsor|5|||
130415908|NCT04827576|469485228|FG000|Overall Study|Investigator's Discretion|1|||
130415909|NCT04827576|469485229|FG001|Overall Study|Investigator's Discretion|0|||
130415910|NCT04827576|469485230|FG002|Overall Study|Investigator's Discretion|2|||
130415911|NCT04827576|469485231|FG003|Overall Study|Investigator's Discretion|5|||
130415912|NCT04827576|469485228|FG000|Overall Study|Withdrew Consent|0|||
130415913|NCT04827576|469485229|FG001|Overall Study|Withdrew Consent|3|||
130415914|NCT04827576|469485230|FG002|Overall Study|Withdrew Consent|0|||
130415915|NCT04827576|469485231|FG003|Overall Study|Withdrew Consent|0|||
130415916|NCT04827576|469485228|FG000|Overall Study|Lost to Follow-up|1|||
130415917|NCT04827576|469485229|FG001|Overall Study|Lost to Follow-up|0|||
130415918|NCT04827576|469485230|FG002|Overall Study|Lost to Follow-up|0|||
130415919|NCT04827576|469485231|FG003|Overall Study|Lost to Follow-up|0|||
130415920|NCT04537923|469485232|FG000|Overall Study|Adverse Event|2|||
130415921|NCT04537923|469485233|FG001|Overall Study|Adverse Event|1|||
130415922|NCT04537923|469485234|FG002|Overall Study|Adverse Event|2|||
130415923|NCT04537923|469485235|FG003|Overall Study|Adverse Event|4|||
130415924|NCT04537923|469485232|FG000|Overall Study|Death|3|||
130415925|NCT04537923|469485233|FG001|Overall Study|Death|3|||
130415926|NCT04537923|469485234|FG002|Overall Study|Death|1|||
130415927|NCT04537923|469485235|FG003|Overall Study|Death|11|||
130415928|NCT04537923|469485232|FG000|Overall Study|Lost to Follow-up|1|||
130415929|NCT04537923|469485233|FG001|Overall Study|Lost to Follow-up|2|||
130415930|NCT04537923|469485234|FG002|Overall Study|Lost to Follow-up|1|||
130415931|NCT04537923|469485235|FG003|Overall Study|Lost to Follow-up|6|||
130415932|NCT04537923|469485232|FG000|Overall Study|Physician Decision|1|||
130415933|NCT04537923|469485233|FG001|Overall Study|Physician Decision|0|||
130415934|NCT04537923|469485234|FG002|Overall Study|Physician Decision|2|||
130415935|NCT04537923|469485235|FG003|Overall Study|Physician Decision|5|||
130415936|NCT04537923|469485232|FG000|Overall Study|Pregnancy|1|||
130415937|NCT04537923|469485233|FG001|Overall Study|Pregnancy|0|||
130415938|NCT04537923|469485234|FG002|Overall Study|Pregnancy|0|||
130415939|NCT04537923|469485235|FG003|Overall Study|Pregnancy|0|||
130415940|NCT04537923|469485232|FG000|Overall Study|Withdrawal by Subject|4|||
130415941|NCT04537923|469485233|FG001|Overall Study|Withdrawal by Subject|4|||
130415942|NCT04537923|469485234|FG002|Overall Study|Withdrawal by Subject|4|||
130415943|NCT04537923|469485235|FG003|Overall Study|Withdrawal by Subject|58|||
130415944|NCT04537923|469485232|FG000|Overall Study|Missed study visits|2|||
130415945|NCT04537923|469485233|FG001|Overall Study|Missed study visits|0|||
130415946|NCT04537923|469485234|FG002|Overall Study|Missed study visits|0|||
130415947|NCT04537923|469485235|FG003|Overall Study|Missed study visits|3|||
130415948|NCT04537923|469485232|FG000|Overall Study|Sponsor's decision|0|||
130415949|NCT04537923|469485233|FG001|Overall Study|Sponsor's decision|0|||
130415950|NCT04537923|469485234|FG002|Overall Study|Sponsor's decision|1|||
130415951|NCT04537923|469485235|FG003|Overall Study|Sponsor's decision|1|||
130415952|NCT04537923|469485232|FG000|Overall Study|Safety reasons|1|||
130415953|NCT04537923|469485233|FG001|Overall Study|Safety reasons|0|||
130415954|NCT04537923|469485234|FG002|Overall Study|Safety reasons|0|||
130415955|NCT04537923|469485235|FG003|Overall Study|Safety reasons|0|||
130415956|NCT01261611|469485236|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
130474962|NCT03138512|469708505|FG004|Treatment Part B|Study drug toxicity|45|||
130474963|NCT03138512|469708501|FG000|Treatment Part B|Death|0|||
130474964|NCT03138512|469708502|FG001|Treatment Part B|Death|0|||
130474965|NCT03138512|469708503|FG002|Treatment Part B|Death|1|||
130474966|NCT03138512|469708504|FG003|Treatment Part B|Death|0|||
130415957|NCT01261611|469485237|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
130415958|NCT01261611|469485238|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
130415959|NCT01261611|469485236|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130415960|NCT01261611|469485237|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
130415961|NCT01261611|469485238|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
130415962|NCT01261611|469485236|FG000|Treatment Cycle 1|Adverse Event|0|||
130415963|NCT01261611|469485237|FG001|Treatment Cycle 1|Adverse Event|1|||
130415964|NCT01261611|469485238|FG002|Treatment Cycle 1|Adverse Event|0|||
130415965|NCT01261611|469485236|FG000|Treatment Cycle 1|Protocol Violation|0|||
130415966|NCT01261611|469485237|FG001|Treatment Cycle 1|Protocol Violation|0|||
130415967|NCT01261611|469485238|FG002|Treatment Cycle 1|Protocol Violation|2|||
130415968|NCT01261611|469485236|FG000|Treatment Cycle 2|Completed study|4|||
130415969|NCT01261611|469485237|FG001|Treatment Cycle 2|Completed study|0|||
130415970|NCT01261611|469485238|FG002|Treatment Cycle 2|Completed study|0|||
130474967|NCT03138512|469708505|FG004|Treatment Part B|Death|0|||
130474968|NCT03138512|469708501|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
130474969|NCT03138512|469708502|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
130474970|NCT03138512|469708503|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
130474971|NCT03138512|469708504|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
130474972|NCT03138512|469708505|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
130474973|NCT03138512|469708501|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
130474974|NCT03138512|469708502|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
130474975|NCT03138512|469708503|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
130474976|NCT03138512|469708504|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
130415971|NCT01261611|469485236|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
130415972|NCT01261611|469485237|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
130415973|NCT01261611|469485238|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
130415974|NCT01261611|469485236|FG000|Treatment Cycle 2|Adverse Event|1|||
130415975|NCT01261611|469485237|FG001|Treatment Cycle 2|Adverse Event|0|||
130415976|NCT01261611|469485238|FG002|Treatment Cycle 2|Adverse Event|0|||
130415977|NCT01261611|469485236|FG000|Treatment Cycle 2|Protocol Violation|2|||
130415978|NCT01261611|469485237|FG001|Treatment Cycle 2|Protocol Violation|0|||
130415979|NCT01261611|469485238|FG002|Treatment Cycle 2|Protocol Violation|0|||
130415980|NCT01261611|469485236|FG000|Treatment Cycle 2|Not otherwise specified|2|||
130415981|NCT01261611|469485237|FG001|Treatment Cycle 2|Not otherwise specified|0|||
130415982|NCT01261611|469485238|FG002|Treatment Cycle 2|Not otherwise specified|0|||
130415983|NCT01261611|469485236|FG000|Treatment Cycle 3|Completed study|24|||
130415984|NCT01261611|469485237|FG001|Treatment Cycle 3|Completed study|0|||
130415985|NCT01261611|469485238|FG002|Treatment Cycle 3|Completed study|0|||
130415986|NCT01261611|469485236|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
130415987|NCT01261611|469485237|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
130415988|NCT01261611|469485238|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
130415989|NCT01261611|469485236|FG000|Treatment Cycle 3|Adverse Event|1|||
130415990|NCT01261611|469485237|FG001|Treatment Cycle 3|Adverse Event|0|||
130415991|NCT01261611|469485238|FG002|Treatment Cycle 3|Adverse Event|0|||
130415992|NCT01261611|469485236|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
130415993|NCT01261611|469485237|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
130415994|NCT01261611|469485238|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
130415995|NCT01261611|469485236|FG000|Treatment Cycle 4|Completed study|87|||
130415996|NCT01261611|469485237|FG001|Treatment Cycle 4|Completed study|0|||
130415997|NCT01261611|469485238|FG002|Treatment Cycle 4|Completed study|0|||
130415998|NCT01261611|469485236|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
130415999|NCT01261611|469485237|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
130416000|NCT01261611|469485238|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
130416001|NCT01261611|469485236|FG000|Treatment Cycle 4|Adverse Event|1|||
130416002|NCT01261611|469485237|FG001|Treatment Cycle 4|Adverse Event|0|||
130416003|NCT01261611|469485238|FG002|Treatment Cycle 4|Adverse Event|0|||
130416004|NCT01261611|469485236|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
130416005|NCT01261611|469485237|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
130416006|NCT01261611|469485238|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
130416007|NCT01261611|469485236|FG000|Treatment Cycle 4|Not otherwise specified|3|||
130416008|NCT01261611|469485237|FG001|Treatment Cycle 4|Not otherwise specified|0|||
130416009|NCT01261611|469485238|FG002|Treatment Cycle 4|Not otherwise specified|0|||
130416010|NCT01261611|469485236|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
130416011|NCT01261611|469485237|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
130416012|NCT01261611|469485238|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
130416013|NCT01261611|469485236|FG000|Treatment Cycle 5|Adverse Event|1|||
130416014|NCT01261611|469485237|FG001|Treatment Cycle 5|Adverse Event|0|||
130416015|NCT01261611|469485238|FG002|Treatment Cycle 5|Adverse Event|0|||
130474977|NCT03138512|469708505|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
130474978|NCT03138512|469708501|FG000|Treatment Part B|Participant withdrew consent|0|||
130474979|NCT03138512|469708502|FG001|Treatment Part B|Participant withdrew consent|0|||
130474980|NCT03138512|469708503|FG002|Treatment Part B|Participant withdrew consent|1|||
130474981|NCT03138512|469708504|FG003|Treatment Part B|Participant withdrew consent|1|||
130474982|NCT03138512|469708505|FG004|Treatment Part B|Participant withdrew consent|2|||
130474983|NCT03138512|469708501|FG000|Treatment Part B|Lost to Follow-up|0|||
130474984|NCT03138512|469708502|FG001|Treatment Part B|Lost to Follow-up|0|||
130416016|NCT01261611|469485236|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
130416017|NCT01261611|469485237|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
130416018|NCT01261611|469485238|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
130416019|NCT02527798|469485239|FG000|Overall Study|Physician Decision|1|||
130416020|NCT02527798|469485240|FG001|Overall Study|Physician Decision|0|||
130416021|NCT02527798|469485241|FG002|Overall Study|Physician Decision|1|||
130416022|NCT02527798|469485242|FG003|Overall Study|Physician Decision|1|||
130416023|NCT02527798|469485243|FG004|Overall Study|Physician Decision|0|||
130416024|NCT02527798|469485244|FG005|Overall Study|Physician Decision|0|||
130416025|NCT02527798|469485239|FG000|Overall Study|Death|0|||
130416026|NCT02527798|469485240|FG001|Overall Study|Death|0|||
130416027|NCT02527798|469485241|FG002|Overall Study|Death|1|||
130416028|NCT02527798|469485242|FG003|Overall Study|Death|0|||
130416029|NCT02527798|469485243|FG004|Overall Study|Death|0|||
130416030|NCT02527798|469485244|FG005|Overall Study|Death|0|||
130416031|NCT02527798|469485239|FG000|Overall Study|Withdrawal by Subject|0|||
130416032|NCT02527798|469485240|FG001|Overall Study|Withdrawal by Subject|1|||
130416033|NCT02527798|469485241|FG002|Overall Study|Withdrawal by Subject|2|||
130416034|NCT02527798|469485242|FG003|Overall Study|Withdrawal by Subject|0|||
130416035|NCT02527798|469485243|FG004|Overall Study|Withdrawal by Subject|0|||
130416036|NCT02527798|469485244|FG005|Overall Study|Withdrawal by Subject|0|||
130416037|NCT02527798|469485239|FG000|Overall Study|Reason undisclosed|1|||
130416038|NCT02527798|469485240|FG001|Overall Study|Reason undisclosed|0|||
130416039|NCT02527798|469485241|FG002|Overall Study|Reason undisclosed|1|||
130416040|NCT02527798|469485242|FG003|Overall Study|Reason undisclosed|0|||
130416041|NCT02527798|469485243|FG004|Overall Study|Reason undisclosed|0|||
130416042|NCT02527798|469485244|FG005|Overall Study|Reason undisclosed|0|||
130416043|NCT02527798|469485239|FG000|Overall Study|Did not receive intervention|1|||
130416044|NCT02527798|469485240|FG001|Overall Study|Did not receive intervention|1|||
130416045|NCT02527798|469485241|FG002|Overall Study|Did not receive intervention|0|||
130416046|NCT02527798|469485242|FG003|Overall Study|Did not receive intervention|0|||
130416047|NCT02527798|469485243|FG004|Overall Study|Did not receive intervention|0|||
130416048|NCT02527798|469485244|FG005|Overall Study|Did not receive intervention|0|||
130416049|NCT04745169|469485246|FG000|Overall Study|Kidney transplantation|1|||
130416050|NCT04745169|469485246|FG000|Overall Study|Participant health problems|3|||
130416051|NCT04745169|469485246|FG000|Overall Study|Physician Decision|2|||
130416052|NCT02041195|469485247|FG000|Overall Study|Adverse Event|1|||
130416053|NCT02041195|469485248|FG001|Overall Study|Adverse Event|2|||
130416054|NCT02041195|469485249|FG002|Overall Study|Adverse Event|0|||
130416055|NCT02041195|469485250|FG003|Overall Study|Adverse Event|0|||
130416056|NCT02041195|469485251|FG004|Overall Study|Adverse Event|0|||
130416057|NCT02041195|469485252|FG005|Overall Study|Adverse Event|0|||
130416058|NCT02041195|469485253|FG006|Overall Study|Adverse Event|3|||
130416059|NCT02041195|469485254|FG007|Overall Study|Adverse Event|0|||
130416060|NCT02041195|469485247|FG000|Overall Study|Withdrawal by Subject|1|||
130416061|NCT02041195|469485248|FG001|Overall Study|Withdrawal by Subject|0|||
130416062|NCT02041195|469485249|FG002|Overall Study|Withdrawal by Subject|0|||
130416063|NCT02041195|469485250|FG003|Overall Study|Withdrawal by Subject|0|||
130416064|NCT02041195|469485251|FG004|Overall Study|Withdrawal by Subject|0|||
130416065|NCT02041195|469485252|FG005|Overall Study|Withdrawal by Subject|0|||
130416066|NCT02041195|469485253|FG006|Overall Study|Withdrawal by Subject|4|||
130416067|NCT02041195|469485254|FG007|Overall Study|Withdrawal by Subject|3|||
130416068|NCT02041195|469485247|FG000|Overall Study|Unable to comply with study visits|0|||
130416069|NCT02041195|469485248|FG001|Overall Study|Unable to comply with study visits|1|||
130416070|NCT02041195|469485249|FG002|Overall Study|Unable to comply with study visits|0|||
130416071|NCT02041195|469485250|FG003|Overall Study|Unable to comply with study visits|0|||
130416072|NCT02041195|469485251|FG004|Overall Study|Unable to comply with study visits|1|||
130416073|NCT02041195|469485252|FG005|Overall Study|Unable to comply with study visits|0|||
130474985|NCT03138512|469708503|FG002|Treatment Part B|Lost to Follow-up|0|||
130474986|NCT03138512|469708504|FG003|Treatment Part B|Lost to Follow-up|1|||
130474987|NCT03138512|469708505|FG004|Treatment Part B|Lost to Follow-up|0|||
130474988|NCT03138512|469708501|FG000|Treatment Part B|Poor/non-compliance|0|||
130474989|NCT03138512|469708502|FG001|Treatment Part B|Poor/non-compliance|0|||
130474990|NCT03138512|469708503|FG002|Treatment Part B|Poor/non-compliance|1|||
130474991|NCT03138512|469708504|FG003|Treatment Part B|Poor/non-compliance|1|||
130474992|NCT03138512|469708505|FG004|Treatment Part B|Poor/non-compliance|1|||
130474993|NCT03138512|469708501|FG000|Treatment Part B|Other reasons|0|||
130474994|NCT03138512|469708502|FG001|Treatment Part B|Other reasons|0|||
130474995|NCT03138512|469708503|FG002|Treatment Part B|Other reasons|3|||
130474996|NCT03138512|469708504|FG003|Treatment Part B|Other reasons|1|||
130474997|NCT03138512|469708505|FG004|Treatment Part B|Other reasons|5|||
130474998|NCT05323084|469708507|FG000|Period 2 - Washout|Lost to Follow-up|0|||
130474999|NCT05323084|469708508|FG001|Period 2 - Washout|Lost to Follow-up|1|||
130563835|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130416074|NCT02041195|469485253|FG006|Overall Study|Unable to comply with study visits|0|||
130563836|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130416075|NCT02041195|469485254|FG007|Overall Study|Unable to comply with study visits|0|||
130475000|NCT04382404|469708509|FG000|Overall Study|Adverse Event|1|||
130475001|NCT04382404|469708509|FG000|Overall Study|Lost to Follow-up|2|||
130475002|NCT05687916|469708512|FG000|Overall Study|Adverse Event|1|||
130475003|NCT05687916|469708513|FG001|Overall Study|Adverse Event|2|||
130475004|NCT05687916|469708514|FG002|Overall Study|Adverse Event|0|||
130563837|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130416076|NCT00674986|469485255|FG000|Overall Study|Adverse Event|2|||
130416077|NCT00674986|469485256|FG001|Overall Study|Adverse Event|1|||
130416078|NCT00674986|469485255|FG000|Overall Study|Subject withdrew consent|12|||
130416079|NCT00674986|469485256|FG001|Overall Study|Subject withdrew consent|19|||
130416080|NCT00674986|469485255|FG000|Overall Study|Lost to Follow-up|25|||
130416081|NCT00674986|469485256|FG001|Overall Study|Lost to Follow-up|53|||
130416082|NCT00674986|469485255|FG000|Overall Study|Other reasons|4|||
130416083|NCT00674986|469485256|FG001|Overall Study|Other reasons|8|||
130416084|NCT04546581|469485259|FG000|Overall Study|Adverse Event|9|||
130416085|NCT04546581|469485260|FG001|Overall Study|Adverse Event|3|||
130416086|NCT04546581|469485259|FG000|Overall Study|Physician Decision|0|||
130416087|NCT04546581|469485260|FG001|Overall Study|Physician Decision|1|||
130416088|NCT04546581|469485259|FG000|Overall Study|Protocol Violation|1|||
130416089|NCT04546581|469485260|FG001|Overall Study|Protocol Violation|2|||
130416090|NCT04546581|469485259|FG000|Overall Study|Withdrawal by Subject|3|||
130416091|NCT04546581|469485260|FG001|Overall Study|Withdrawal by Subject|7|||
130416092|NCT01983293|469485261|FG000|Overall Study|Withdrawal by Subject|29|||
130416093|NCT01983293|469485262|FG001|Overall Study|Withdrawal by Subject|15|||
130416094|NCT01983293|469485261|FG000|Overall Study|Missing 12-month visit|3|||
130416095|NCT01983293|469485262|FG001|Overall Study|Missing 12-month visit|3|||
130416096|NCT01983293|469485261|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
130416097|NCT01983293|469485262|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
130416098|NCT01275625|469485263|FG000|Overall Study|Death|1|||
130416099|NCT01275625|469485263|FG000|Overall Study|Lack of Efficacy|2|||
130416100|NCT01275625|469485263|FG000|Overall Study|Lost to Follow-up|1|||
130416101|NCT01275625|469485263|FG000|Overall Study|Withdrawal by Subject|3|||
130416102|NCT01275625|469485263|FG000|Overall Study|Protocol Violation|1|||
130416103|NCT01275625|469485263|FG000|Overall Study|Adverse Event|4|||
130416104|NCT01275625|469485263|FG000|Overall Study|Other|1|||
130416105|NCT01585103|469485265|FG000|Overall Study|Unable to swallow Cytosponge|6|||
130416106|NCT01349569|469485267|FG000|Overall Study|Lack of Efficacy|4|||
130416107|NCT01747772|469485268|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
130416108|NCT00626522|469485269|FG000|Overall Study|Protocol Violation|0|||
130416109|NCT00626522|469485270|FG001|Overall Study|Protocol Violation|0|||
130416110|NCT00626522|469485271|FG002|Overall Study|Protocol Violation|0|||
130416111|NCT00626522|469485272|FG003|Overall Study|Protocol Violation|0|||
130416112|NCT00626522|469485273|FG004|Overall Study|Protocol Violation|1|||
130416113|NCT00626522|469485274|FG005|Overall Study|Protocol Violation|0|||
130416114|NCT00626522|469485269|FG000|Overall Study|Adverse Event|2|||
130416115|NCT00626522|469485270|FG001|Overall Study|Adverse Event|1|||
130416116|NCT00626522|469485271|FG002|Overall Study|Adverse Event|2|||
130416117|NCT00626522|469485272|FG003|Overall Study|Adverse Event|0|||
130416118|NCT00626522|469485273|FG004|Overall Study|Adverse Event|1|||
130416119|NCT00626522|469485274|FG005|Overall Study|Adverse Event|1|||
130416120|NCT00626522|469485269|FG000|Overall Study|Withdrawal by Subject|2|||
130416121|NCT00626522|469485270|FG001|Overall Study|Withdrawal by Subject|5|||
130416122|NCT00626522|469485271|FG002|Overall Study|Withdrawal by Subject|5|||
130416123|NCT00626522|469485272|FG003|Overall Study|Withdrawal by Subject|0|||
130416124|NCT00626522|469485273|FG004|Overall Study|Withdrawal by Subject|4|||
130416125|NCT00626522|469485274|FG005|Overall Study|Withdrawal by Subject|1|||
130416126|NCT00626522|469485269|FG000|Overall Study|COPD exacerbation|0|||
130416127|NCT00626522|469485270|FG001|Overall Study|COPD exacerbation|0|||
130416128|NCT00626522|469485271|FG002|Overall Study|COPD exacerbation|0|||
130416129|NCT00626522|469485272|FG003|Overall Study|COPD exacerbation|1|||
130416130|NCT00626522|469485273|FG004|Overall Study|COPD exacerbation|1|||
130416131|NCT00626522|469485274|FG005|Overall Study|COPD exacerbation|0|||
130416132|NCT00626522|469485269|FG000|Overall Study|Lost to Follow-up|0|||
130416133|NCT00626522|469485270|FG001|Overall Study|Lost to Follow-up|1|||
130416134|NCT00626522|469485271|FG002|Overall Study|Lost to Follow-up|0|||
130416135|NCT00626522|469485272|FG003|Overall Study|Lost to Follow-up|0|||
130416136|NCT00626522|469485273|FG004|Overall Study|Lost to Follow-up|0|||
130416137|NCT00626522|469485274|FG005|Overall Study|Lost to Follow-up|0|||
130416138|NCT00626522|469485269|FG000|Overall Study|Inconsistent reason reported|1|||
130416139|NCT00626522|469485270|FG001|Overall Study|Inconsistent reason reported|0|||
130416140|NCT00626522|469485271|FG002|Overall Study|Inconsistent reason reported|0|||
130416141|NCT00626522|469485272|FG003|Overall Study|Inconsistent reason reported|0|||
130416142|NCT00626522|469485273|FG004|Overall Study|Inconsistent reason reported|0|||
130416143|NCT00626522|469485274|FG005|Overall Study|Inconsistent reason reported|0|||
130416144|NCT00626522|469485269|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
130563838|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130563839|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130563840|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130416145|NCT00626522|469485270|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130416146|NCT00626522|469485271|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
130416147|NCT00626522|469485272|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
130416148|NCT00626522|469485273|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130416149|NCT00626522|469485274|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130416150|NCT02280044|469485275|FG000|Overall Study|Planned alternate|0|||
130416151|NCT02280044|469485276|FG001|Overall Study|Planned alternate|2|||
130416152|NCT00896168|469485278|FG000|Overall Study|Adverse Event|4|||
130416153|NCT00896168|469485279|FG001|Overall Study|Adverse Event|7|||
130416154|NCT00896168|469485278|FG000|Overall Study|Treatment failure|8|||
130475005|NCT05687916|469708512|FG000|Overall Study|Withdrawal by Subject|1|||
130416155|NCT00896168|469485279|FG001|Overall Study|Treatment failure|10|||
130416156|NCT00896168|469485278|FG000|Overall Study|Lost to Follow-up|1|||
130416157|NCT00896168|469485279|FG001|Overall Study|Lost to Follow-up|1|||
130416158|NCT00896168|469485278|FG000|Overall Study|Other|1|||
130416159|NCT00896168|469485279|FG001|Overall Study|Other|1|||
130416160|NCT01944631|469485288|FG000|Overall Study|Adverse Event|1|||
130416161|NCT01944631|469485289|FG001|Overall Study|Adverse Event|0|||
130416162|NCT01944631|469485288|FG000|Overall Study|Lost to Follow-up|3|||
130416163|NCT01944631|469485289|FG001|Overall Study|Lost to Follow-up|1|||
130416164|NCT01944631|469485288|FG000|Overall Study|Withdrawal by Subject|0|||
130416165|NCT01944631|469485289|FG001|Overall Study|Withdrawal by Subject|1|||
130416166|NCT03822533|469485291|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
130416167|NCT03822533|469485292|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
130416168|NCT03822533|469485291|FG000|3 Month Follow-up|Lost to Follow-up|2|||
130416169|NCT03822533|469485292|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130416170|NCT03822533|469485291|FG000|6 Month Follow-up|Lost to Follow-up|3|||
130416171|NCT03822533|469485292|FG001|6 Month Follow-up|Lost to Follow-up|0|||
130416172|NCT03822533|469485291|FG000|12 Month Follow-up|Lost to Follow-up|2|||
130416173|NCT03822533|469485292|FG001|12 Month Follow-up|Lost to Follow-up|3|||
130416174|NCT03822533|469485291|FG000|12 Month Follow-up|Pregnancy|0|||
130416175|NCT03822533|469485292|FG001|12 Month Follow-up|Pregnancy|1|||
130416176|NCT03822533|469485291|FG000|12 Month Follow-up|Surgery|2|||
130416177|NCT03822533|469485292|FG001|12 Month Follow-up|Surgery|0|||
130416178|NCT03822533|469485291|FG000|12 Month Follow-up|Wrong address|1|||
130416179|NCT03822533|469485292|FG001|12 Month Follow-up|Wrong address|0|||
130416180|NCT03822533|469485291|FG000|12 Month Follow-up|No symptoms|1|||
130416181|NCT03822533|469485292|FG001|12 Month Follow-up|No symptoms|0|||
130416182|NCT03822533|469485291|FG000|12 Month Follow-up|Changed primary care center|0|||
130416183|NCT03822533|469485292|FG001|12 Month Follow-up|Changed primary care center|1|||
130416184|NCT02489500|469485293|FG000|Overall Study|Death|1|||
130416185|NCT02489500|469485294|FG001|Overall Study|Death|1|||
130416186|NCT04717596|469485295|FG000|Overall Study|Withdrawal by Subject|4|||
130416187|NCT02460991|469485297|FG000|Overall Study|Withdrawal by Subject|0|||
130416188|NCT02460991|469485298|FG001|Overall Study|Withdrawal by Subject|2|||
130416189|NCT02473952|469485300|FG000|Overall Study|Adverse Event|2|||
130475006|NCT05687916|469708513|FG001|Overall Study|Withdrawal by Subject|0|||
130475007|NCT05687916|469708514|FG002|Overall Study|Withdrawal by Subject|1|||
130475008|NCT05687916|469708512|FG000|Overall Study|Protocol Violation|0|||
130475009|NCT05687916|469708513|FG001|Overall Study|Protocol Violation|2|||
130475010|NCT05687916|469708514|FG002|Overall Study|Protocol Violation|1|||
130475011|NCT05687916|469708512|FG000|Overall Study|Reason not Specified|1|||
130475012|NCT05687916|469708513|FG001|Overall Study|Reason not Specified|0|||
130475013|NCT05687916|469708514|FG002|Overall Study|Reason not Specified|0|||
130475014|NCT03332017|469708515|FG000|Overall Study|Lost to Follow-up|1|||
130475015|NCT03332017|469708516|FG001|Overall Study|Lost to Follow-up|2|||
130475016|NCT03332017|469708515|FG000|Overall Study|Death|17|||
130475017|NCT03332017|469708516|FG001|Overall Study|Death|16|||
130475018|NCT03332017|469708515|FG000|Overall Study|Withdrawal by Subject|6|||
130475019|NCT03332017|469708516|FG001|Overall Study|Withdrawal by Subject|14|||
130475020|NCT03332017|469708515|FG000|Overall Study|Other|1|||
130475021|NCT03332017|469708516|FG001|Overall Study|Other|3|||
130475022|NCT03332017|469708515|FG000|Overall Study|Remained in Study (Ongoing)|47|||
130475023|NCT03332017|469708516|FG001|Overall Study|Remained in Study (Ongoing)|110|||
130475024|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
130475025|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
130475026|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
130475027|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475028|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475029|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130416190|NCT02473952|469485301|FG001|Overall Study|Adverse Event|2|||
130563841|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130416191|NCT02473952|469485300|FG000|Overall Study|Withdrawal by Subject|0|||
130416192|NCT02473952|469485301|FG001|Overall Study|Withdrawal by Subject|6|||
130475030|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475031|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475032|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475033|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130648302|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
130416193|NCT00455195|469485302|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
130416194|NCT00455195|469485303|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
130416195|NCT00455195|469485302|FG000|Double-blind Study AGLU02704|Death|1|||
130416196|NCT00455195|469485303|FG001|Double-blind Study AGLU02704|Death|0|||
130416197|NCT00455195|469485302|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
130416198|NCT00455195|469485303|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
130416199|NCT00455195|469485302|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
130416200|NCT00455195|469485303|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
130416201|NCT02148250|469485304|FG000|Screening|Withdrawal by Subject|5|||
130416202|NCT02148250|469485305|FG001|Screening|Withdrawal by Subject|0|||
130416203|NCT02370602|469485308|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130416204|NCT02370602|469485309|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130416205|NCT02370602|469485310|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130416206|NCT02370602|469485311|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
130416207|NCT02370602|469485312|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130416208|NCT02370602|469485313|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
130416209|NCT00237744|469485314|FG000|Overall Study|Withdrawal by Subject|3|||
130416210|NCT00237744|469485315|FG001|Overall Study|Withdrawal by Subject|1|||
130416211|NCT00237744|469485316|FG002|Overall Study|Withdrawal by Subject|0|||
130416212|NCT02097472|469485317|FG000|Received Vaccination 2|Adverse Event|0|||
130416213|NCT02097472|469485318|FG001|Received Vaccination 2|Adverse Event|0|||
130416214|NCT02097472|469485319|FG002|Received Vaccination 2|Adverse Event|0|||
130416215|NCT02097472|469485320|FG003|Received Vaccination 2|Adverse Event|0|||
130416216|NCT02097472|469485321|FG004|Received Vaccination 2|Adverse Event|0|||
130416217|NCT02097472|469485322|FG005|Received Vaccination 2|Adverse Event|0|||
130416218|NCT02097472|469485323|FG006|Received Vaccination 2|Adverse Event|1|||
130416219|NCT02097472|469485324|FG007|Received Vaccination 2|Adverse Event|0|||
130416220|NCT02119416|469485325|FG000|Overall Study|Protocol Violation|1|||
130416221|NCT02119416|469485326|FG001|Overall Study|Protocol Violation|1|||
130416222|NCT02119416|469485327|FG002|Overall Study|Protocol Violation|1|||
130416223|NCT02119416|469485325|FG000|Overall Study|wrong pubertal stage|1|||
130416224|NCT02119416|469485326|FG001|Overall Study|wrong pubertal stage|0|||
130416225|NCT02119416|469485327|FG002|Overall Study|wrong pubertal stage|1|||
130416226|NCT03043664|469485328|FG000|Overall Study|Lost to Follow-up|1|||
130416227|NCT03593655|469485329|FG000|First Product Use Period|Withdrawal by Subject|1|||
130416228|NCT03593655|469485330|FG001|First Product Use Period|Withdrawal by Subject|1|||
130416229|NCT03593655|469485329|FG000|First Product Use Period|Lost to Follow-up|1|||
130416230|NCT03593655|469485330|FG001|First Product Use Period|Lost to Follow-up|3|||
130416231|NCT03593655|469485329|FG000|Second Product Use Period|Withdrawal by Subject|1|||
130416232|NCT03593655|469485330|FG001|Second Product Use Period|Withdrawal by Subject|1|||
130416233|NCT03593655|469485329|FG000|Second Product Use Period|Lost to Follow-up|1|||
130416234|NCT03593655|469485330|FG001|Second Product Use Period|Lost to Follow-up|0|||
130416235|NCT03593655|469485329|FG000|Third Product Use Period|Lost to Follow-up|1|||
130416236|NCT03593655|469485330|FG001|Third Product Use Period|Lost to Follow-up|2|||
130416237|NCT03593655|469485329|FG000|Third Product Use Period|Physician Decision|0|||
130416238|NCT03593655|469485330|FG001|Third Product Use Period|Physician Decision|1|||
130416239|NCT03593655|469485329|FG000|Third Product Use Period|Withdrawal by Subject|0|||
130416240|NCT03593655|469485330|FG001|Third Product Use Period|Withdrawal by Subject|1|||
130416241|NCT03732209|469485333|FG000|Overall Study|Lost to Follow-up|4|||
130416242|NCT03732209|469485334|FG001|Overall Study|Lost to Follow-up|4|||
130416243|NCT03732209|469485333|FG000|Overall Study|Withdrawal by Subject|8|||
130416244|NCT03732209|469485334|FG001|Overall Study|Withdrawal by Subject|9|||
130416245|NCT02063724|469485335|FG000|Overall Study|Disease progression|1|||
130416246|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
130416247|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
130416248|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
130416249|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
130416250|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
130416251|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130416252|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130416253|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130416254|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
130416255|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130416256|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130416257|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130416258|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
130416259|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130416260|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130416261|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130416262|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
130416263|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130416264|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130416265|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130416266|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
130416267|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130416268|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130416269|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130416270|NCT01715805|469485336|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
130416271|NCT01715805|469485337|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130416272|NCT01715805|469485338|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130416273|NCT01715805|469485339|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130416274|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130416275|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130416276|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130416277|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
130416278|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
130416279|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
130416280|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
130416281|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
130416282|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
130416283|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
130416284|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
130416285|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
130416286|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
130416287|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
130416288|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
130416289|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
130416290|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
130416291|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
130416292|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
130416293|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
130416294|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
130416295|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
130416296|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
130416297|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
130416298|NCT01715805|469485336|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130416299|NCT01715805|469485337|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
130416300|NCT01715805|469485338|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130416301|NCT01715805|469485339|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130416302|NCT01618864|469485342|FG000|Overall Study|Withdrawal by Subject|2|||
130416303|NCT01618864|469485342|FG000|Overall Study|Lost to Follow-up|2|||
130416304|NCT05177770|469485343|FG000|Overall Study|Death|4|||
130416305|NCT05177770|469485343|FG000|Overall Study|Withdrawal by Subject|1|||
130416306|NCT05177770|469485343|FG000|Overall Study|Adverse Event prior to dosing|1|||
130416307|NCT00709722|469485348|FG000|Overall Study|Adverse Event|1|||
130416308|NCT04667117|469485349|FG000|Investigational Period|Lost to Follow-up|0|||
130416309|NCT04667117|469485350|FG001|Investigational Period|Lost to Follow-up|0|||
130416310|NCT04667117|469485351|FG002|Investigational Period|Lost to Follow-up|1|||
130416311|NCT04667117|469485349|FG000|Investigational Period|Protocol Deviation|0|||
130416312|NCT04667117|469485350|FG001|Investigational Period|Protocol Deviation|1|||
130416313|NCT04667117|469485351|FG002|Investigational Period|Protocol Deviation|0|||
130416314|NCT04667117|469485349|FG000|Extension Period|Lost to Follow-up|1|||
130416315|NCT04667117|469485350|FG001|Extension Period|Lost to Follow-up|0|||
130416316|NCT04667117|469485351|FG002|Extension Period|Lost to Follow-up|0|||
130416317|NCT02372396|469485365|FG000|Overall Study|Lost to Follow-up|7|||
130416318|NCT02372396|469485366|FG001|Overall Study|Lost to Follow-up|9|||
130416319|NCT01272934|469485369|FG000|Overall Study|Adverse Event|0|||
130416320|NCT01272934|469485370|FG001|Overall Study|Adverse Event|1|||
130416321|NCT01272934|469485369|FG000|Overall Study|Abnormal Laboratory Value|0|||
130475034|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475035|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475036|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
130475037|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
130475038|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
130475039|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475040|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475041|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475042|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130416322|NCT01272934|469485370|FG001|Overall Study|Abnormal Laboratory Value|1|||
130416323|NCT02310750|469485373|FG000|HP Period 1|Lost to Follow-up|0|||
130416324|NCT02310750|469485374|FG001|HP Period 1|Lost to Follow-up|0|||
130563842|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
130563843|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
130416325|NCT02310750|469485375|FG002|HP Period 1|Lost to Follow-up|0|||
130416326|NCT02310750|469485376|FG003|HP Period 1|Lost to Follow-up|0|||
130416327|NCT02310750|469485377|FG004|HP Period 1|Lost to Follow-up|0|||
130416328|NCT02310750|469485378|FG005|HP Period 1|Lost to Follow-up|0|||
130416329|NCT02310750|469485379|FG006|HP Period 1|Lost to Follow-up|1|||
130416330|NCT02310750|469485380|FG007|HP Period 1|Lost to Follow-up|0|||
130416331|NCT02310750|469485381|FG008|HP Period 1|Lost to Follow-up|0|||
130416332|NCT02310750|469485382|FG009|HP Period 1|Lost to Follow-up|0|||
130416333|NCT02310750|469485383|FG010|HP Period 1|Lost to Follow-up|0|||
130416334|NCT02310750|469485384|FG011|HP Period 1|Lost to Follow-up|0|||
130416335|NCT02310750|469485385|FG012|HP Period 1|Lost to Follow-up|0|||
130416336|NCT02310750|469485386|FG013|HP Period 1|Lost to Follow-up|0|||
130416337|NCT02310750|469485387|FG014|HP Period 1|Lost to Follow-up|0|||
130416338|NCT02310750|469485388|FG015|HP Period 1|Lost to Follow-up|0|||
130416339|NCT02310750|469485373|FG000|HP Period 1|Withdrawal by Subject|1|||
130416340|NCT02310750|469485374|FG001|HP Period 1|Withdrawal by Subject|0|||
130416341|NCT02310750|469485375|FG002|HP Period 1|Withdrawal by Subject|0|||
130416342|NCT02310750|469485376|FG003|HP Period 1|Withdrawal by Subject|1|||
130416343|NCT02310750|469485377|FG004|HP Period 1|Withdrawal by Subject|0|||
130416344|NCT02310750|469485378|FG005|HP Period 1|Withdrawal by Subject|0|||
130416345|NCT02310750|469485379|FG006|HP Period 1|Withdrawal by Subject|0|||
130416346|NCT02310750|469485380|FG007|HP Period 1|Withdrawal by Subject|0|||
130416347|NCT02310750|469485381|FG008|HP Period 1|Withdrawal by Subject|0|||
130416348|NCT02310750|469485382|FG009|HP Period 1|Withdrawal by Subject|0|||
130416349|NCT02310750|469485383|FG010|HP Period 1|Withdrawal by Subject|0|||
130416350|NCT02310750|469485384|FG011|HP Period 1|Withdrawal by Subject|0|||
130416351|NCT02310750|469485385|FG012|HP Period 1|Withdrawal by Subject|0|||
130416352|NCT02310750|469485386|FG013|HP Period 1|Withdrawal by Subject|0|||
130416353|NCT02310750|469485387|FG014|HP Period 1|Withdrawal by Subject|0|||
130416354|NCT02310750|469485388|FG015|HP Period 1|Withdrawal by Subject|0|||
130416355|NCT02310750|469485373|FG000|HP Washout 1|Lost to Follow-up|0|||
130416356|NCT02310750|469485374|FG001|HP Washout 1|Lost to Follow-up|0|||
130416357|NCT02310750|469485375|FG002|HP Washout 1|Lost to Follow-up|1|||
130416358|NCT02310750|469485376|FG003|HP Washout 1|Lost to Follow-up|1|||
130416359|NCT02310750|469485377|FG004|HP Washout 1|Lost to Follow-up|2|||
130416360|NCT02310750|469485378|FG005|HP Washout 1|Lost to Follow-up|2|||
130416361|NCT02310750|469485379|FG006|HP Washout 1|Lost to Follow-up|3|||
130416362|NCT02310750|469485380|FG007|HP Washout 1|Lost to Follow-up|0|||
130416363|NCT02310750|469485381|FG008|HP Washout 1|Lost to Follow-up|0|||
130416364|NCT02310750|469485382|FG009|HP Washout 1|Lost to Follow-up|0|||
130416365|NCT02310750|469485383|FG010|HP Washout 1|Lost to Follow-up|0|||
130416366|NCT02310750|469485384|FG011|HP Washout 1|Lost to Follow-up|0|||
130416367|NCT02310750|469485385|FG012|HP Washout 1|Lost to Follow-up|0|||
130416368|NCT02310750|469485386|FG013|HP Washout 1|Lost to Follow-up|0|||
130416369|NCT02310750|469485387|FG014|HP Washout 1|Lost to Follow-up|0|||
130416370|NCT02310750|469485388|FG015|HP Washout 1|Lost to Follow-up|0|||
130416371|NCT02310750|469485373|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416372|NCT02310750|469485374|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416373|NCT02310750|469485375|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416374|NCT02310750|469485376|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
130416375|NCT02310750|469485377|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416376|NCT02310750|469485378|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
130416377|NCT02310750|469485379|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416378|NCT02310750|469485380|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416379|NCT02310750|469485381|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
130416380|NCT02310750|469485382|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
130416381|NCT02310750|469485383|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416382|NCT02310750|469485384|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416383|NCT02310750|469485385|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416384|NCT02310750|469485386|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416385|NCT02310750|469485387|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130416386|NCT02310750|469485388|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130475043|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475044|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475045|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475046|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130416387|NCT02310750|469485373|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416388|NCT02310750|469485374|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416389|NCT02310750|469485375|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416390|NCT02310750|469485376|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416391|NCT02310750|469485377|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416392|NCT02310750|469485378|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416393|NCT02310750|469485379|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416394|NCT02310750|469485380|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416395|NCT02310750|469485381|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130475047|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130416396|NCT02310750|469485382|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
130416397|NCT02310750|469485383|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416398|NCT02310750|469485384|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416399|NCT02310750|469485385|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416400|NCT02310750|469485386|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416401|NCT02310750|469485387|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416402|NCT02310750|469485388|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130416403|NCT02310750|469485373|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416404|NCT02310750|469485374|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416405|NCT02310750|469485375|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416406|NCT02310750|469485376|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416407|NCT02310750|469485377|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416408|NCT02310750|469485378|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416409|NCT02310750|469485379|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416410|NCT02310750|469485380|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130416411|NCT02310750|469485381|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130416412|NCT02310750|469485382|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130416413|NCT02310750|469485383|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416414|NCT02310750|469485384|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416415|NCT02310750|469485385|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416416|NCT02310750|469485386|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416417|NCT02310750|469485387|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416418|NCT02310750|469485388|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130416419|NCT02310750|469485373|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416420|NCT02310750|469485374|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416421|NCT02310750|469485375|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416422|NCT02310750|469485376|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416423|NCT02310750|469485377|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416424|NCT02310750|469485378|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416425|NCT02310750|469485379|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416426|NCT02310750|469485380|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
130416427|NCT02310750|469485381|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
130416428|NCT02310750|469485382|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416429|NCT02310750|469485383|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416430|NCT02310750|469485384|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416431|NCT02310750|469485385|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416432|NCT02310750|469485386|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416433|NCT02310750|469485387|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416434|NCT02310750|469485388|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130416435|NCT02310750|469485373|FG000|HP Washout 2|Lost to Follow-up|0|||
130416436|NCT02310750|469485374|FG001|HP Washout 2|Lost to Follow-up|0|||
130416437|NCT02310750|469485375|FG002|HP Washout 2|Lost to Follow-up|0|||
130416438|NCT02310750|469485376|FG003|HP Washout 2|Lost to Follow-up|0|||
130416439|NCT02310750|469485377|FG004|HP Washout 2|Lost to Follow-up|1|||
130416440|NCT02310750|469485378|FG005|HP Washout 2|Lost to Follow-up|0|||
130416441|NCT02310750|469485379|FG006|HP Washout 2|Lost to Follow-up|7|||
130416442|NCT02310750|469485380|FG007|HP Washout 2|Lost to Follow-up|0|||
130416443|NCT02310750|469485381|FG008|HP Washout 2|Lost to Follow-up|0|||
130416444|NCT02310750|469485382|FG009|HP Washout 2|Lost to Follow-up|0|||
130416445|NCT02310750|469485383|FG010|HP Washout 2|Lost to Follow-up|0|||
130416446|NCT02310750|469485384|FG011|HP Washout 2|Lost to Follow-up|0|||
130416447|NCT02310750|469485385|FG012|HP Washout 2|Lost to Follow-up|0|||
130416448|NCT02310750|469485386|FG013|HP Washout 2|Lost to Follow-up|0|||
130416449|NCT02310750|469485387|FG014|HP Washout 2|Lost to Follow-up|0|||
130416450|NCT02310750|469485388|FG015|HP Washout 2|Lost to Follow-up|0|||
130416451|NCT01226745|469485389|FG000|Overall Study|Did not complete schedule of assessments|8|||
130475048|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475049|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
130475050|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
130475051|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
130475052|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475053|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475054|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475055|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475056|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475057|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130416452|NCT01226745|469485390|FG001|Overall Study|Did not complete schedule of assessments|3|||
130416453|NCT01226745|469485391|FG002|Overall Study|Did not complete schedule of assessments|6|||
130416454|NCT01226745|469485392|FG003|Overall Study|Did not complete schedule of assessments|0|||
130416455|NCT01226745|469485393|FG004|Overall Study|Did not complete schedule of assessments|0|||
130416456|NCT01226745|469485394|FG005|Overall Study|Did not complete schedule of assessments|1|||
130416457|NCT01226745|469485389|FG000|Overall Study|Lost to Follow-up|2|||
130416458|NCT01226745|469485390|FG001|Overall Study|Lost to Follow-up|6|||
130416459|NCT01226745|469485391|FG002|Overall Study|Lost to Follow-up|6|||
130416460|NCT01226745|469485392|FG003|Overall Study|Lost to Follow-up|1|||
130416461|NCT01226745|469485393|FG004|Overall Study|Lost to Follow-up|1|||
130416462|NCT01226745|469485394|FG005|Overall Study|Lost to Follow-up|2|||
130416463|NCT01226745|469485389|FG000|Overall Study|Death|1|||
130416464|NCT01226745|469485390|FG001|Overall Study|Death|0|||
130416465|NCT01226745|469485391|FG002|Overall Study|Death|0|||
130416466|NCT01226745|469485392|FG003|Overall Study|Death|0|||
130416467|NCT01226745|469485393|FG004|Overall Study|Death|0|||
130416468|NCT01226745|469485394|FG005|Overall Study|Death|1|||
130416469|NCT01226745|469485389|FG000|Overall Study|Other|6|||
130416470|NCT01226745|469485390|FG001|Overall Study|Other|7|||
130416471|NCT01226745|469485391|FG002|Overall Study|Other|8|||
130416472|NCT01226745|469485392|FG003|Overall Study|Other|4|||
130416473|NCT01226745|469485393|FG004|Overall Study|Other|3|||
130416474|NCT01226745|469485394|FG005|Overall Study|Other|1|||
130416475|NCT01435577|469485395|FG000|Overall Study|Adverse Event|10|||
130416476|NCT01435577|469485396|FG001|Overall Study|Adverse Event|0|||
130416477|NCT01435577|469485395|FG000|Overall Study|Lack of Efficacy|7|||
130416478|NCT01435577|469485396|FG001|Overall Study|Lack of Efficacy|51|||
130416479|NCT01435577|469485395|FG000|Overall Study|Alternative treatment started|0|||
130416480|NCT01435577|469485396|FG001|Overall Study|Alternative treatment started|1|||
130416481|NCT00718718|469485399|FG000|Prior to Week 12|Adverse Event|0|||
130416482|NCT00718718|469485400|FG001|Prior to Week 12|Adverse Event|0|||
130416483|NCT00718718|469485401|FG002|Prior to Week 12|Adverse Event|0|||
130416484|NCT00718718|469485402|FG003|Prior to Week 12|Adverse Event|0|||
130416485|NCT00718718|469485403|FG004|Prior to Week 12|Adverse Event|0|||
130416486|NCT00718718|469485404|FG005|Prior to Week 12|Adverse Event|0|||
130416487|NCT00718718|469485405|FG006|Prior to Week 12|Adverse Event|0|||
130416488|NCT00718718|469485406|FG007|Prior to Week 12|Adverse Event|1|||
130416489|NCT00718718|469485407|FG008|Prior to Week 12|Adverse Event|1|||
130416490|NCT00718718|469485408|FG009|Prior to Week 12|Adverse Event|0|||
130416491|NCT00718718|469485399|FG000|Prior to Week 12|Withdrawal by Subject|0|||
130416492|NCT00718718|469485400|FG001|Prior to Week 12|Withdrawal by Subject|0|||
130416493|NCT00718718|469485401|FG002|Prior to Week 12|Withdrawal by Subject|0|||
130416494|NCT00718718|469485402|FG003|Prior to Week 12|Withdrawal by Subject|0|||
130416495|NCT00718718|469485403|FG004|Prior to Week 12|Withdrawal by Subject|3|||
130416496|NCT00718718|469485404|FG005|Prior to Week 12|Withdrawal by Subject|0|||
130416497|NCT00718718|469485405|FG006|Prior to Week 12|Withdrawal by Subject|1|||
130416498|NCT00718718|469485406|FG007|Prior to Week 12|Withdrawal by Subject|1|||
130416499|NCT00718718|469485407|FG008|Prior to Week 12|Withdrawal by Subject|1|||
130416500|NCT00718718|469485408|FG009|Prior to Week 12|Withdrawal by Subject|0|||
130416501|NCT00718718|469485399|FG000|Prior to Week 12|Other|1|||
130416502|NCT00718718|469485400|FG001|Prior to Week 12|Other|0|||
130416503|NCT00718718|469485401|FG002|Prior to Week 12|Other|1|||
130416504|NCT00718718|469485402|FG003|Prior to Week 12|Other|0|||
130416505|NCT00718718|469485403|FG004|Prior to Week 12|Other|0|||
130416506|NCT00718718|469485404|FG005|Prior to Week 12|Other|0|||
130416507|NCT00718718|469485405|FG006|Prior to Week 12|Other|0|||
130416508|NCT00718718|469485406|FG007|Prior to Week 12|Other|0|||
130416509|NCT00718718|469485407|FG008|Prior to Week 12|Other|0|||
130416510|NCT00718718|469485408|FG009|Prior to Week 12|Other|0|||
130416511|NCT00718718|469485399|FG000|Week 12 to End of Study|Adverse Event|0|||
130416512|NCT00718718|469485400|FG001|Week 12 to End of Study|Adverse Event|0|||
130475058|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475059|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475060|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475061|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130475062|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130416513|NCT00718718|469485401|FG002|Week 12 to End of Study|Adverse Event|0|||
130416514|NCT00718718|469485402|FG003|Week 12 to End of Study|Adverse Event|0|||
130416515|NCT00718718|469485403|FG004|Week 12 to End of Study|Adverse Event|0|||
130475063|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
130416516|NCT00718718|469485404|FG005|Week 12 to End of Study|Adverse Event|0|||
130416517|NCT00718718|469485405|FG006|Week 12 to End of Study|Adverse Event|0|||
130416518|NCT00718718|469485406|FG007|Week 12 to End of Study|Adverse Event|1|||
130416519|NCT00718718|469485407|FG008|Week 12 to End of Study|Adverse Event|0|||
130416520|NCT00718718|469485408|FG009|Week 12 to End of Study|Adverse Event|0|||
130475064|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
130416521|NCT00718718|469485399|FG000|Week 12 to End of Study|Death|0|||
130416522|NCT00718718|469485400|FG001|Week 12 to End of Study|Death|0|||
130416523|NCT00718718|469485401|FG002|Week 12 to End of Study|Death|0|||
130416524|NCT00718718|469485402|FG003|Week 12 to End of Study|Death|0|||
130416525|NCT00718718|469485403|FG004|Week 12 to End of Study|Death|0|||
130416526|NCT00718718|469485404|FG005|Week 12 to End of Study|Death|1|||
130416527|NCT00718718|469485405|FG006|Week 12 to End of Study|Death|0|||
130416528|NCT00718718|469485406|FG007|Week 12 to End of Study|Death|0|||
130416529|NCT00718718|469485407|FG008|Week 12 to End of Study|Death|0|||
130416530|NCT00718718|469485408|FG009|Week 12 to End of Study|Death|0|||
130416531|NCT00718718|469485399|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
130416532|NCT00718718|469485400|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
130416533|NCT00718718|469485401|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
130416534|NCT00718718|469485402|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
130416535|NCT00718718|469485403|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
130416536|NCT00718718|469485404|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
130416537|NCT00718718|469485405|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
130416538|NCT00718718|469485406|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
130416539|NCT00718718|469485407|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
130416540|NCT00718718|469485408|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
130416541|NCT00718718|469485399|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
130416542|NCT00718718|469485400|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
130416543|NCT00718718|469485401|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
130416544|NCT00718718|469485402|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
130416545|NCT00718718|469485403|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
130416546|NCT00718718|469485404|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
130416547|NCT00718718|469485405|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
130416548|NCT00718718|469485406|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
130416549|NCT00718718|469485407|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
130416550|NCT00718718|469485408|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
130416551|NCT00718718|469485399|FG000|Week 12 to End of Study|Other|0|||
130416552|NCT00718718|469485400|FG001|Week 12 to End of Study|Other|1|||
130416553|NCT00718718|469485401|FG002|Week 12 to End of Study|Other|0|||
130416554|NCT00718718|469485402|FG003|Week 12 to End of Study|Other|1|||
130416555|NCT00718718|469485403|FG004|Week 12 to End of Study|Other|0|||
130416556|NCT00718718|469485404|FG005|Week 12 to End of Study|Other|0|||
130416557|NCT00718718|469485405|FG006|Week 12 to End of Study|Other|1|||
130416558|NCT00718718|469485406|FG007|Week 12 to End of Study|Other|0|||
130416559|NCT00718718|469485407|FG008|Week 12 to End of Study|Other|0|||
130416560|NCT00718718|469485408|FG009|Week 12 to End of Study|Other|0|||
130416561|NCT02891187|469486745|FG000|Overall Study|Lost to Follow-up|1|||
130416562|NCT02891187|469486746|FG001|Overall Study|Lost to Follow-up|2|||
130416563|NCT02395120|469486749|FG000|Overall Study|Missed follow-up dental exam|57|||
130416564|NCT02395120|469486750|FG001|Overall Study|Missed follow-up dental exam|62|||
130416565|NCT02395120|469486751|FG002|Overall Study|Missed follow-up dental exam|6|||
130416566|NCT02395120|469486752|FG003|Overall Study|Missed follow-up dental exam|6|||
130416567|NCT02395120|469486753|FG004|Overall Study|Missed follow-up dental exam|51|||
130416568|NCT02526693|469486757|FG000|Overall Study|Physician Decision|3|||
130416569|NCT02526693|469486758|FG001|Overall Study|Physician Decision|1|||
130416570|NCT03581305|469486759|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
130416571|NCT03581305|469486760|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
130416572|NCT03581305|469486759|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
130416573|NCT03581305|469486760|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
130416574|NCT03581305|469486759|FG000|Serotonergic Study|Withdrawal by Subject|5|||
130416575|NCT03581305|469486760|FG001|Serotonergic Study|Withdrawal by Subject|1|||
130416576|NCT01798927|469486763|FG000|Overall Study|Withdrawal by Subject|1|||
130416577|NCT03750552|469486764|FG000|Overall Study|Adverse Event|5|||
130416578|NCT03750552|469486765|FG001|Overall Study|Adverse Event|1|||
130416579|NCT03750552|469486764|FG000|Overall Study|Withdrawal by Subject|1|||
130416580|NCT03750552|469486765|FG001|Overall Study|Withdrawal by Subject|1|||
130416581|NCT03750552|469486764|FG000|Overall Study|Other|2|||
130416582|NCT03750552|469486765|FG001|Overall Study|Other|0|||
130416583|NCT01003899|469486766|FG000|Overall Study|Other Adverse Event|8|||
130475065|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475066|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475067|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475068|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475069|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475070|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475071|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475072|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475073|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475074|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475075|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
130475076|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
130475077|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
130475078|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
130416584|NCT01003899|469486766|FG000|Overall Study|Not entered|4|||
130416585|NCT01003899|469486766|FG000|Overall Study|Not treated|1|||
130416586|NCT01003899|469486766|FG000|Overall Study|Progressive disease|34|||
130563844|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
130416587|NCT01412944|469486768|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130416588|NCT01412944|469486769|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130416589|NCT01412944|469486770|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
130416590|NCT01412944|469486771|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130416591|NCT01412944|469486772|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130416592|NCT01412944|469486773|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130416593|NCT01412944|469486768|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130416594|NCT01412944|469486769|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130416595|NCT01412944|469486770|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130416596|NCT01412944|469486771|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130416597|NCT01412944|469486772|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130416598|NCT01412944|469486773|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
130416599|NCT01412944|469486768|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130416600|NCT01412944|469486769|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130416601|NCT01412944|469486770|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130416602|NCT01412944|469486771|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130416603|NCT01412944|469486772|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130416604|NCT01412944|469486773|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
130416605|NCT01412944|469486768|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
130416606|NCT01412944|469486769|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130416607|NCT01412944|469486770|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130416608|NCT01412944|469486771|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130416609|NCT01412944|469486772|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130416610|NCT01412944|469486773|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130416611|NCT01412944|469486768|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
130416612|NCT01412944|469486769|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
130416613|NCT01412944|469486770|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
130416614|NCT01412944|469486771|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
130416615|NCT01412944|469486772|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
130416616|NCT01412944|469486773|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
130416617|NCT01412944|469486768|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130416618|NCT01412944|469486769|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
130416619|NCT01412944|469486770|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130416620|NCT01412944|469486771|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130416621|NCT01412944|469486772|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130416622|NCT01412944|469486773|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130416623|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416624|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416625|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130416626|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130416627|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130416628|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416629|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Adverse Event|0|||
130416630|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Adverse Event|0|||
130416631|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Adverse Event|0|||
130416632|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Adverse Event|0|||
130416633|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Adverse Event|1|||
130416634|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Adverse Event|0|||
130416635|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
130416636|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
130416637|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
130416638|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
130416639|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
130416640|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
130416641|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416642|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416643|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416644|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416645|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416646|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
130416647|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416648|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416649|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416650|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416651|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
130416652|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416653|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
130563845|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563846|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
130416654|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130416655|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416656|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416657|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416658|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130416659|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
130416660|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
130416661|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
130416662|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
130416663|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
130416664|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
130416665|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416666|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
130416667|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416668|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416669|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416670|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
130416671|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416672|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
130416673|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416674|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416675|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416676|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
130416677|NCT01412944|469486768|FG000|Entire: IV + Maintenance|Adverse Event|0|||
130416678|NCT01412944|469486769|FG001|Entire: IV + Maintenance|Adverse Event|1|||
130416679|NCT01412944|469486770|FG002|Entire: IV + Maintenance|Adverse Event|0|||
130416680|NCT01412944|469486771|FG003|Entire: IV + Maintenance|Adverse Event|0|||
130475079|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475080|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475081|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475082|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475083|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475084|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475085|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475086|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475087|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130563847|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563848|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563849|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563850|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563851|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
130563852|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
130563853|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
130563854|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
130563855|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
130563856|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
130563857|NCT04033445|470030525|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563858|NCT04033445|470030526|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563859|NCT04033445|470030527|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563860|NCT04033445|470030528|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563861|NCT04033445|470030529|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563862|NCT04033445|470030530|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563863|NCT04033445|470030531|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563864|NCT04033445|470030532|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563865|NCT04033445|470030533|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563866|NCT04033445|470030534|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130563867|NCT04033445|470030535|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563868|NCT04033445|470030536|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130563869|NCT04033445|470030537|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130563870|NCT04033445|470030538|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130563871|NCT05807464|470030544|FG000|Overall Study|Adverse Event|1|||
130563872|NCT05525689|470030546|FG000|Overall Study|Lost to Follow-up|1|||
130563873|NCT05525689|470030547|FG001|Overall Study|Lost to Follow-up|0|||
130563874|NCT01671111|470030550|FG000|Overall Study|Adverse Event|2|||
130563875|NCT01671111|470030550|FG000|Overall Study|Lack of Efficacy|1|||
130563876|NCT01671111|470030550|FG000|Overall Study|Withdrawal by Subject|2|||
130727242|NCT02883049|470625426|FG002|Post Induction|Withdrawal by Subject|0|||
130727243|NCT02883049|470625427|FG003|Post Induction|Withdrawal by Subject|5|||
130416681|NCT01412944|469486772|FG004|Entire: IV + Maintenance|Adverse Event|0|||
130416682|NCT01412944|469486773|FG005|Entire: IV + Maintenance|Adverse Event|0|||
130416683|NCT01990950|469486774|FG000|Overall Study|Death|3|||
130416684|NCT01990950|469486774|FG000|Overall Study|Lost to Follow-up|2|||
130416685|NCT01990950|469486774|FG000|Overall Study|Withdrawal by Subject|6|||
130416686|NCT01259713|469486776|FG000|Overall Study|Adverse Event|54|||
130416687|NCT01259713|469486777|FG001|Overall Study|Adverse Event|23|||
130416688|NCT01259713|469486776|FG000|Overall Study|Death Not Related to IFI|8|||
130416689|NCT01259713|469486777|FG001|Overall Study|Death Not Related to IFI|1|||
130416690|NCT01259713|469486776|FG000|Overall Study|Investigators Discretion|14|||
130416691|NCT01259713|469486777|FG001|Overall Study|Investigators Discretion|6|||
130416692|NCT01259713|469486776|FG000|Overall Study|Lack of Efficacy|2|||
130416693|NCT01259713|469486777|FG001|Overall Study|Lack of Efficacy|0|||
130416694|NCT01259713|469486776|FG000|Overall Study|Protocol Violation|5|||
130416695|NCT01259713|469486777|FG001|Overall Study|Protocol Violation|4|||
130416696|NCT01259713|469486776|FG000|Overall Study|Subject Withdrew Consent|12|||
130416697|NCT01259713|469486777|FG001|Overall Study|Subject Withdrew Consent|7|||
130416698|NCT06111742|469486778|FG000|Overall Study|Did not receive intervention|1|||
130416699|NCT06111742|469486779|FG001|Overall Study|Did not receive intervention|0|||
130416700|NCT06111742|469486780|FG002|Overall Study|Did not receive intervention|0|||
130416701|NCT06111742|469486778|FG000|Overall Study|Withdrawal by Subject|2|||
130416702|NCT06111742|469486779|FG001|Overall Study|Withdrawal by Subject|0|||
130416703|NCT06111742|469486780|FG002|Overall Study|Withdrawal by Subject|0|||
130416704|NCT00922428|469486785|FG000|Overall Study|retrospective/extremely implausible data|2|||
130416705|NCT00922428|469486785|FG000|Overall Study|no medication use or questionable use|13|||
130416706|NCT00448539|469486786|FG000|Overall Study|Medication non-compliance|4|||
130416707|NCT00448539|469486787|FG001|Overall Study|Medication non-compliance|1|||
130416708|NCT00448539|469486786|FG000|Overall Study|Protocol Violation|1|||
130416709|NCT00448539|469486787|FG001|Overall Study|Protocol Violation|0|||
130416710|NCT00448539|469486786|FG000|Overall Study|Request of the investigator or sponsor|67|||
130416711|NCT00448539|469486787|FG001|Overall Study|Request of the investigator or sponsor|54|||
130416712|NCT00448539|469486786|FG000|Overall Study|Withdrawal by Subject|20|||
130416713|NCT00448539|469486787|FG001|Overall Study|Withdrawal by Subject|24|||
130416714|NCT00448539|469486786|FG000|Overall Study|Diary non-compliance|1|||
130416715|NCT00448539|469486787|FG001|Overall Study|Diary non-compliance|0|||
130416716|NCT00448539|469486786|FG000|Overall Study|Adverse Event|9|||
130416717|NCT00448539|469486787|FG001|Overall Study|Adverse Event|26|||
130416718|NCT00448539|469486786|FG000|Overall Study|Lack of Efficacy|27|||
130416719|NCT00448539|469486787|FG001|Overall Study|Lack of Efficacy|40|||
130416720|NCT00448539|469486786|FG000|Overall Study|Miscellaneous|2|||
130416721|NCT00448539|469486787|FG001|Overall Study|Miscellaneous|1|||
130416722|NCT00448539|469486786|FG000|Overall Study|Change of meds|2|||
130416723|NCT00448539|469486787|FG001|Overall Study|Change of meds|3|||
130416724|NCT00448539|469486786|FG000|Overall Study|Lost to Follow-up|1|||
130416725|NCT00448539|469486787|FG001|Overall Study|Lost to Follow-up|3|||
130416726|NCT02103439|469486788|FG000|Overall Study|Adverse Event|0|||
130416727|NCT02103439|469486789|FG001|Overall Study|Adverse Event|2|||
130416728|NCT02103439|469486788|FG000|Overall Study|Withdrawal by Subject|3|||
130416729|NCT02103439|469486789|FG001|Overall Study|Withdrawal by Subject|1|||
130416730|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
130416731|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
130416732|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
130416733|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
130416734|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
130416735|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
130475088|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130475089|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
130475090|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
130475091|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
130475092|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475093|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475094|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475095|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475096|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475097|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475098|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475099|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475100|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475101|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130475102|NCT01261312|469708517|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
130563877|NCT01671111|470030550|FG000|Overall Study|Physician Decision|1|||
130563878|NCT01671111|470030550|FG000|Overall Study|Other|24|||
130563879|NCT00596947|470030551|FG000|Overall Study|study halted due to low enrollment|5|||
130563880|NCT00596947|470030552|FG001|Overall Study|study halted due to low enrollment|3|||
130563881|NCT00596947|470030551|FG000|Overall Study|Lost to Follow-up|1|||
130563882|NCT00596947|470030552|FG001|Overall Study|Lost to Follow-up|0|||
130563883|NCT00496730|470030553|FG000|Overall Study|Lost to Follow-up|4|||
130563884|NCT00496730|470030554|FG001|Overall Study|Lost to Follow-up|3|||
130563885|NCT00496730|470030553|FG000|Overall Study|Withdrawal by Subject|2|||
130563886|NCT00496730|470030554|FG001|Overall Study|Withdrawal by Subject|2|||
130563887|NCT00113074|470030555|FG000|Overall Study|Lost to Follow-up|10|||
130563888|NCT00113074|470030556|FG001|Overall Study|Lost to Follow-up|10|||
130416736|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
130416737|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
130416738|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
130416739|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
130416740|NCT00695903|469486790|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
130416741|NCT00695903|469486791|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
130416742|NCT00695903|469486790|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
130416743|NCT00695903|469486791|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
130416744|NCT00695903|469486790|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
130416745|NCT00695903|469486791|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
130416746|NCT00695903|469486790|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
130416747|NCT00695903|469486791|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
130416748|NCT03966157|469486792|FG000|Overall Study|Physician Decision|1|||
130416749|NCT03966157|469486793|FG001|Overall Study|Physician Decision|0|||
130416750|NCT02384759|469486795|FG000|Overall Study|Patients not treated|3|||
130416751|NCT02384759|469486796|FG001|Overall Study|Patients not treated|2|||
130727244|NCT02883049|470625428|FG004|Post Induction|Withdrawal by Subject|2|||
130727245|NCT02883049|470625429|FG005|Post Induction|Withdrawal by Subject|1|||
130416752|NCT01650259|469486802|FG000|Overall Study|Improvement|105|||
130416753|NCT01650259|469486803|FG001|Overall Study|Improvement|0|||
130416754|NCT01650259|469486802|FG000|Overall Study|Adverse Event|127|||
130416755|NCT01650259|469486803|FG001|Overall Study|Adverse Event|0|||
130416756|NCT01650259|469486802|FG000|Overall Study|Lack of Efficacy|143|||
130416757|NCT01650259|469486803|FG001|Overall Study|Lack of Efficacy|0|||
130416758|NCT01650259|469486802|FG000|Overall Study|Lost to Follow-up|435|||
130416759|NCT01650259|469486803|FG001|Overall Study|Lost to Follow-up|0|||
130416760|NCT01650259|469486802|FG000|Overall Study|Patients had no visit after entry|70|||
130416761|NCT01650259|469486803|FG001|Overall Study|Patients had no visit after entry|0|||
130416762|NCT01650259|469486802|FG000|Overall Study|CRF not collected|98|||
130416763|NCT01650259|469486803|FG001|Overall Study|CRF not collected|82|||
130416764|NCT01650259|469486802|FG000|Overall Study|Not treated|1|||
130416765|NCT01650259|469486803|FG001|Overall Study|Not treated|7|||
130416766|NCT01650259|469486802|FG000|Overall Study|Other than listed|64|||
130416767|NCT01650259|469486803|FG001|Overall Study|Other than listed|146|||
130416768|NCT02663128|469486810|FG000|Period 2|Physician Decision|0|||
130416769|NCT02663128|469486811|FG001|Period 2|Physician Decision|0|||
130416770|NCT02663128|469486812|FG002|Period 2|Physician Decision|0|||
130416771|NCT02663128|469486813|FG003|Period 2|Physician Decision|0|||
130416772|NCT02663128|469486814|FG004|Period 2|Physician Decision|1|||
130416773|NCT02663128|469486815|FG005|Period 2|Physician Decision|0|||
130416774|NCT01358526|469486816|FG000|Open-label Titration Period|Adverse Event|95|||
130416775|NCT01358526|469486817|FG001|Open-label Titration Period|Adverse Event|0|||
130416776|NCT01358526|469486818|FG002|Open-label Titration Period|Adverse Event|0|||
130727246|NCT02883049|470625430|FG006|Post Induction|Withdrawal by Subject|0|||
130727247|NCT02883049|470625431|FG007|Post Induction|Withdrawal by Subject|0|||
130727248|NCT02883049|470625432|FG008|Post Induction|Withdrawal by Subject|2|||
130727249|NCT02883049|470625433|FG009|Post Induction|Withdrawal by Subject|0|||
130416777|NCT01358526|469486816|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
130416778|NCT01358526|469486817|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130416779|NCT01358526|469486818|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130416780|NCT01358526|469486816|FG000|Open-label Titration Period|Lost to Follow-up|25|||
130416781|NCT01358526|469486817|FG001|Open-label Titration Period|Lost to Follow-up|0|||
130416782|NCT01358526|469486818|FG002|Open-label Titration Period|Lost to Follow-up|0|||
130416783|NCT01358526|469486816|FG000|Open-label Titration Period|Lack of Efficacy|107|||
130416784|NCT01358526|469486817|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130416785|NCT01358526|469486818|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130416786|NCT01358526|469486816|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
130416787|NCT01358526|469486817|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
130563889|NCT00113074|470030557|FG002|Overall Study|Lost to Follow-up|14|||
130416788|NCT01358526|469486818|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
130416789|NCT01358526|469486816|FG000|Open-label Titration Period|Administrative|8|||
130563890|NCT03680911|470030558|FG000|At Home Treatment|Study Termination|3|||
130475103|NCT01261312|469708518|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475104|NCT01261312|469708519|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
130475105|NCT01261312|469708520|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475106|NCT01261312|469708521|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475107|NCT01261312|469708522|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475108|NCT01261312|469708523|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475109|NCT01261312|469708524|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475110|NCT01261312|469708525|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475111|NCT01261312|469708526|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475112|NCT01261312|469708527|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475113|NCT01261312|469708528|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475114|NCT01261312|469708529|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
130475115|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475116|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475117|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475118|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
130475119|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
130475120|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
130475121|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475122|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475123|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475124|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475125|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475126|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475127|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
130475128|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475129|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475130|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475131|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475132|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
130475133|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
130727250|NCT02883049|470625434|FG010|Post Induction|Withdrawal by Subject|1|||
130727251|NCT02883049|470625435|FG011|Post Induction|Withdrawal by Subject|1|||
130727252|NCT02883049|470625436|FG012|Post Induction|Withdrawal by Subject|0|||
130727253|NCT02883049|470625437|FG013|Post Induction|Withdrawal by Subject|0|||
130727254|NCT02883049|470625438|FG014|Post Induction|Withdrawal by Subject|1|||
130727255|NCT02883049|470625439|FG015|Post Induction|Withdrawal by Subject|0|||
130727256|NCT02883049|470625424|FG000|Post Induction|Ineligible|0|||
130416790|NCT01358526|469486817|FG001|Open-label Titration Period|Administrative|0|||
130416791|NCT01358526|469486818|FG002|Open-label Titration Period|Administrative|0|||
130416792|NCT01358526|469486816|FG000|Open-label Titration Period|Did not qualify|178|||
130416793|NCT01358526|469486817|FG001|Open-label Titration Period|Did not qualify|0|||
130416794|NCT01358526|469486818|FG002|Open-label Titration Period|Did not qualify|0|||
130416795|NCT01358526|469486816|FG000|Double-blind Phase|Adverse Event|0|||
130416796|NCT01358526|469486817|FG001|Double-blind Phase|Adverse Event|24|||
130416797|NCT01358526|469486818|FG002|Double-blind Phase|Adverse Event|23|||
130416798|NCT01358526|469486816|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130416799|NCT01358526|469486817|FG001|Double-blind Phase|Withdrawal by Subject|10|||
130416800|NCT01358526|469486818|FG002|Double-blind Phase|Withdrawal by Subject|8|||
130416801|NCT01358526|469486816|FG000|Double-blind Phase|Lost to Follow-up|0|||
130416802|NCT01358526|469486817|FG001|Double-blind Phase|Lost to Follow-up|4|||
130416803|NCT01358526|469486818|FG002|Double-blind Phase|Lost to Follow-up|1|||
130416804|NCT01358526|469486816|FG000|Double-blind Phase|Lack of Efficacy|0|||
130416805|NCT01358526|469486817|FG001|Double-blind Phase|Lack of Efficacy|31|||
130416806|NCT01358526|469486818|FG002|Double-blind Phase|Lack of Efficacy|73|||
130416807|NCT01358526|469486816|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
130416808|NCT01358526|469486817|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
130416809|NCT01358526|469486818|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
130416810|NCT01358526|469486816|FG000|Double-blind Phase|Administrative|0|||
130416811|NCT01358526|469486817|FG001|Double-blind Phase|Administrative|6|||
130416812|NCT01358526|469486818|FG002|Double-blind Phase|Administrative|10|||
130416813|NCT03277313|469486838|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
130416814|NCT03277313|469486839|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
130563891|NCT03680911|470030559|FG001|At Home Treatment|Study Termination|0|||
130563892|NCT03680911|470030558|FG000|At Home Treatment|Lost to Follow-up|0|||
130727257|NCT02883049|470625425|FG001|Post Induction|Ineligible|0|||
130416815|NCT03277313|469486838|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
130416816|NCT03277313|469486839|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
130416817|NCT03277313|469486838|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
130416818|NCT03277313|469486839|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
130416819|NCT03277313|469486838|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
130416820|NCT03277313|469486839|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
130416821|NCT03277313|469486838|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
130416822|NCT03277313|469486839|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
130416823|NCT02132611|469486840|FG000|Overall Study|Death|2|||
130416824|NCT02194621|469486849|FG000|Overall Study|6 withdrew prior to randomization|2|||
130416825|NCT02194621|469486850|FG001|Overall Study|6 withdrew prior to randomization|2|||
130416826|NCT02194621|469486851|FG002|Overall Study|6 withdrew prior to randomization|2|||
130416827|NCT02194621|469486849|FG000|Overall Study|Withdrawal by Subject|4|||
130416828|NCT02194621|469486850|FG001|Overall Study|Withdrawal by Subject|4|||
130475134|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475135|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475136|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475137|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475138|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475139|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475140|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
130475141|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475142|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475143|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475144|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475145|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
130475146|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
130475147|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475148|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475149|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475150|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475151|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475152|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475153|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
130475154|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475155|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475156|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475157|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
130475158|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
130475159|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
130475160|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475161|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475162|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475163|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475164|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475165|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475166|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
130475167|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475168|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475169|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475170|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475171|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475172|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
130475173|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475174|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475175|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475176|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475177|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475178|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475179|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
130475180|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475181|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475182|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475183|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
130563893|NCT03680911|470030559|FG001|At Home Treatment|Lost to Follow-up|1|||
130563894|NCT03680911|470030558|FG000|At Home Treatment|Withdrawal by Subject|0|||
130563895|NCT03680911|470030559|FG001|At Home Treatment|Withdrawal by Subject|2|||
130563896|NCT03680911|470030558|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
130563897|NCT03680911|470030559|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
130475184|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
130475185|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
130563898|NCT02114268|470030560|FG000|Overall Study|Lost to Follow-up|4|||
130563899|NCT02114268|470030561|FG001|Overall Study|Lost to Follow-up|1|||
130416829|NCT02194621|469486851|FG002|Overall Study|Withdrawal by Subject|7|||
130416830|NCT02493127|469486852|FG000|Overall Study|Lost to Follow-up|1|||
130416831|NCT02493127|469486853|FG001|Overall Study|Lost to Follow-up|1|||
130416832|NCT02763384|469486854|FG000|Overall Study|Physician Decision|1|||
130416833|NCT02763384|469486854|FG000|Overall Study|Rapid decline - went on hospice|1|||
130416834|NCT02096900|469486856|FG000|Overall Study|Did not receive medication|3|||
130416835|NCT02096900|469486857|FG001|Overall Study|Did not receive medication|1|||
130416836|NCT02096900|469486856|FG000|Overall Study|Surgery cancelled- medication received|1|||
130416837|NCT02096900|469486857|FG001|Overall Study|Surgery cancelled- medication received|1|||
130416838|NCT03034577|469486858|FG000|Overall Study|Withdrawal by Subject|6|||
130416839|NCT03034577|469486859|FG001|Overall Study|Withdrawal by Subject|9|||
130416840|NCT03034577|469486858|FG000|Overall Study|Lost to Follow-up|25|||
130416841|NCT03034577|469486859|FG001|Overall Study|Lost to Follow-up|26|||
130416842|NCT03230916|469486871|FG000|Overall Study|Withdrawal by Subject|0|||
130416843|NCT03230916|469486872|FG001|Overall Study|Withdrawal by Subject|0|||
130416844|NCT03230916|469486873|FG002|Overall Study|Withdrawal by Subject|0|||
130416845|NCT03230916|469486874|FG003|Overall Study|Withdrawal by Subject|0|||
130416846|NCT03230916|469486875|FG004|Overall Study|Withdrawal by Subject|0|||
130416847|NCT03230916|469486876|FG005|Overall Study|Withdrawal by Subject|1|||
130416848|NCT03230916|469486877|FG006|Overall Study|Withdrawal by Subject|0|||
130416849|NCT03230916|469486878|FG007|Overall Study|Withdrawal by Subject|0|||
130416850|NCT03230916|469486879|FG008|Overall Study|Withdrawal by Subject|0|||
130416851|NCT03230916|469486880|FG009|Overall Study|Withdrawal by Subject|0|||
130416852|NCT03230916|469486881|FG010|Overall Study|Withdrawal by Subject|0|||
130416853|NCT01128413|469486882|FG000|Overall Study|Withdrawal by Subject|1|||
130416854|NCT01128413|469486883|FG001|Overall Study|Withdrawal by Subject|0|||
130416855|NCT01128413|469486882|FG000|Overall Study|NICOM Monitor Problems|2|||
130416856|NCT01128413|469486883|FG001|Overall Study|NICOM Monitor Problems|1|||
130416857|NCT01128413|469486882|FG000|Overall Study|Pt made DNR|1|||
130416858|NCT01128413|469486883|FG001|Overall Study|Pt made DNR|0|||
130416859|NCT02075593|469486887|FG000|Overall Study|Withdrawal by Subject|1|||
130416860|NCT02010060|469486888|FG000|Overall Study|Lost to Follow-up|1|||
130416861|NCT02010060|469486889|FG001|Overall Study|Lost to Follow-up|2|||
130416862|NCT02010060|469486890|FG002|Overall Study|Lost to Follow-up|2|||
130416863|NCT02010060|469486888|FG000|Overall Study|Injury|0|||
130416864|NCT02010060|469486889|FG001|Overall Study|Injury|1|||
130416865|NCT02010060|469486890|FG002|Overall Study|Injury|0|||
130416866|NCT00660010|469486893|FG000|Overall Study|Withdrawal by Subject|2|||
130416867|NCT00660010|469486893|FG000|Overall Study|Lost to Follow-up|3|||
130416868|NCT00660010|469486893|FG000|Overall Study|Adverse Event|1|||
130416869|NCT00660010|469486893|FG000|Overall Study|Noncompliance with visit schedule|3|||
130416870|NCT00680407|469486894|FG000|Overall Study|Lost to Follow-up|3|||
130416871|NCT00680407|469486895|FG001|Overall Study|Lost to Follow-up|3|||
130416872|NCT00680407|469486896|FG002|Overall Study|Lost to Follow-up|1|||
130416873|NCT00680407|469486894|FG000|Overall Study|Withdrawal by Subject|5|||
130416874|NCT00680407|469486895|FG001|Overall Study|Withdrawal by Subject|2|||
130416875|NCT00680407|469486896|FG002|Overall Study|Withdrawal by Subject|2|||
130416876|NCT06167031|469486897|FG000|Overall Study|Lost to Follow-up|5|||
130416877|NCT06167031|469486898|FG001|Overall Study|Lost to Follow-up|1|||
130416878|NCT00920426|469488831|FG000|ITZ111451|Adverse Event|1|||
130416879|NCT00920426|469488832|FG001|ITZ111451|Adverse Event|0|||
130416880|NCT00920426|469488833|FG002|ITZ111451|Adverse Event|0|||
130416881|NCT00920426|469488834|FG003|ITZ111451|Adverse Event|0|||
130416882|NCT01432366|469488835|FG000|Overall Study|Non-Responder|7|||
130416883|NCT01432366|469488835|FG000|Overall Study|Adverse Event|8|||
130416884|NCT01432366|469488835|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
130416885|NCT01432366|469488835|FG000|Overall Study|Pregnancy|1|||
130416886|NCT01432366|469488835|FG000|Overall Study|Lost to Follow-up|13|||
130416887|NCT01432366|469488835|FG000|Overall Study|Lack of Efficacy|1|||
130416888|NCT01432366|469488835|FG000|Overall Study|Site Closed|20|||
130416889|NCT01432366|469488835|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
130416890|NCT01432366|469488835|FG000|Overall Study|Other|14|||
130416891|NCT01808690|469488836|FG000|Overall Study|Withdrawal by Subject|1|||
130416892|NCT01808690|469488837|FG001|Overall Study|Withdrawal by Subject|2|||
130416893|NCT00377234|469488844|FG000|Overall Study|Adverse Event|14|||
130416894|NCT00377234|469488845|FG001|Overall Study|Adverse Event|17|||
130416895|NCT00377234|469488844|FG000|Overall Study|Withdrawal by Subject|11|||
130416896|NCT00377234|469488845|FG001|Overall Study|Withdrawal by Subject|9|||
130416897|NCT00377234|469488844|FG000|Overall Study|Lost to Follow-up|4|||
130416898|NCT00377234|469488845|FG001|Overall Study|Lost to Follow-up|2|||
130416899|NCT00377234|469488844|FG000|Overall Study|Administrative|2|||
130416900|NCT00377234|469488845|FG001|Overall Study|Administrative|1|||
130416901|NCT00377234|469488844|FG000|Overall Study|Not assigned|3|||
130416902|NCT00377234|469488845|FG001|Overall Study|Not assigned|2|||
130416903|NCT01880424|469488846|FG000|Overall Study|Adverse Event|7|||
130416904|NCT01880424|469488847|FG001|Overall Study|Adverse Event|6|||
130416905|NCT01880424|469488846|FG000|Overall Study|Lack of Efficacy|1|||
130416906|NCT01880424|469488847|FG001|Overall Study|Lack of Efficacy|4|||
130416907|NCT01880424|469488846|FG000|Overall Study|Lost to Follow-up|3|||
130416908|NCT01880424|469488847|FG001|Overall Study|Lost to Follow-up|2|||
130416909|NCT01880424|469488846|FG000|Overall Study|Protocol Violation|11|||
130416910|NCT01880424|469488847|FG001|Overall Study|Protocol Violation|13|||
130416911|NCT01880424|469488846|FG000|Overall Study|Withdrawal by Subject|10|||
130416912|NCT01880424|469488847|FG001|Overall Study|Withdrawal by Subject|30|||
130416913|NCT01880424|469488846|FG000|Overall Study|Other|1|||
130416914|NCT01880424|469488847|FG001|Overall Study|Other|0|||
130416915|NCT02062632|469488848|FG000|Overall Study|No treatment data|1|||
130416916|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
130416917|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
130416918|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
130416919|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
130416920|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
130416921|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
130416922|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
130416923|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
130416924|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
130416925|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
130416926|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
130416927|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
130416928|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
130416929|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
130416930|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
130416931|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
130416932|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
130416933|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
130416934|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
130416935|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
130416936|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
130416937|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
130416938|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
130416939|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
130416940|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416941|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416942|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416943|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416944|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416945|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416946|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416947|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416948|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416949|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416950|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416951|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416952|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416953|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416954|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416955|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130416956|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416957|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416958|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
130416959|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
130416960|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
130416961|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416962|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416963|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416964|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416965|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416966|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130563900|NCT02114268|470030562|FG002|Overall Study|Lost to Follow-up|1|||
130563901|NCT02114268|470030563|FG003|Overall Study|Lost to Follow-up|0|||
130416967|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416968|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416969|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416970|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416971|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416972|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416973|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416974|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130416975|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130563902|NCT02114268|470030564|FG004|Overall Study|Lost to Follow-up|0|||
130475186|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475187|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475188|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475189|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475190|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475191|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475192|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
130475193|NCT01261312|469708517|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475194|NCT01261312|469708518|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475195|NCT01261312|469708519|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475196|NCT01261312|469708520|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
130475197|NCT01261312|469708521|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
130475198|NCT01261312|469708522|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
130475199|NCT01261312|469708523|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475200|NCT01261312|469708524|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475201|NCT01261312|469708525|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475202|NCT01261312|469708526|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475203|NCT01261312|469708527|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475204|NCT01261312|469708528|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475205|NCT01261312|469708529|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130475206|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475207|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475208|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475209|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475210|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475211|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475212|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
130475213|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
130475214|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
130475215|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475216|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475217|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475218|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
130475219|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475220|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475221|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130563903|NCT02114268|470030565|FG005|Overall Study|Lost to Follow-up|2|||
130563904|NCT02114268|470030560|FG000|Overall Study|Withdrawal by Subject|1|||
130563905|NCT02114268|470030561|FG001|Overall Study|Withdrawal by Subject|0|||
130563906|NCT02114268|470030562|FG002|Overall Study|Withdrawal by Subject|0|||
130563907|NCT02114268|470030563|FG003|Overall Study|Withdrawal by Subject|0|||
130563908|NCT02114268|470030564|FG004|Overall Study|Withdrawal by Subject|0|||
130563909|NCT02114268|470030565|FG005|Overall Study|Withdrawal by Subject|1|||
130563910|NCT02114268|470030560|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
130563911|NCT02114268|470030561|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
130563912|NCT02114268|470030562|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
130416976|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
130416977|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
130416978|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
130416979|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
130416980|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
130416981|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
130416982|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
130416983|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
130416984|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
130416985|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
130563913|NCT02114268|470030563|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
130416986|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
130416987|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
130416988|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
130475222|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475223|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475224|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130563914|NCT02114268|470030564|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
130475225|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130563915|NCT02114268|470030565|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
130475226|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
130563916|NCT03962738|470030568|FG000|Overall Study|Protocol Deviation|3|||
130416989|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
130416990|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
130416991|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
130416992|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
130416993|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
130416994|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
130416995|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
130416996|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
130416997|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
130416998|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
130416999|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417000|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417001|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417002|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417003|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417004|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417005|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417006|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417007|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417008|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417009|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417010|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417011|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417012|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417013|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417014|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417015|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
130417016|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130417017|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130417018|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417019|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
130417020|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130417021|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417022|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417023|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417024|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417025|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417026|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417027|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417028|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417029|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417030|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417031|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417032|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417033|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417034|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417035|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130417036|NCT01490632|469488853|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417037|NCT01490632|469488854|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417038|NCT01490632|469488855|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417039|NCT01490632|469488856|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417040|NCT01490632|469488857|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
130417041|NCT01490632|469488858|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417042|NCT01490632|469488859|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417043|NCT01490632|469488860|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417044|NCT01490632|469488861|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417045|NCT01490632|469488862|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417046|NCT01490632|469488863|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417047|NCT01490632|469488864|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417048|NCT01490632|469488865|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417049|NCT01490632|469488866|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417050|NCT01490632|469488867|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130563917|NCT03962738|470030569|FG001|Overall Study|Protocol Deviation|0|||
130563918|NCT03962738|470030570|FG002|Overall Study|Protocol Deviation|1|||
130563919|NCT03962738|470030571|FG003|Overall Study|Protocol Deviation|1|||
130727258|NCT02883049|470625426|FG002|Post Induction|Ineligible|2|||
130417051|NCT01490632|469488868|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417052|NCT01490632|469488869|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417053|NCT01490632|469488870|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417054|NCT01490632|469488871|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417055|NCT01490632|469488872|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130417056|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417057|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417058|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417059|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417060|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417061|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
130417062|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
130417063|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417064|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417065|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
130417066|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
130417067|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
130417068|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417069|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417070|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417071|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417072|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417073|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417074|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417075|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
130417076|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417077|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417078|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417079|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417080|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417081|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417082|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130417083|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417084|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130417085|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
130417086|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130417087|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417088|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417089|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417090|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417091|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417092|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417093|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417094|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417095|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130417096|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417097|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417098|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417099|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417100|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417101|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417102|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
130417103|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417104|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417105|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
130417106|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417107|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417108|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417109|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417110|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417111|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417112|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417113|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417114|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417115|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130417116|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
130475227|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
130475228|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475229|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475230|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475231|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
130475232|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475233|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475234|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475235|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475236|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475237|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475238|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
130475239|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
130475240|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
130475241|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475242|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475243|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475244|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
130475245|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
130475246|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
130475247|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
130475248|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
130475249|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
130475250|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
130417117|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417118|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417119|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417120|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417121|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417122|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
130417123|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417124|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417125|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417126|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417127|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417128|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417129|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417130|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417131|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417132|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417133|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417134|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417135|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
130417136|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417137|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417138|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417139|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417140|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417141|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
130417142|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417143|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417144|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417145|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417146|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417147|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417148|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417149|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130475251|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
130475252|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
130475253|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
130475254|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
130475255|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
130475256|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
130475257|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
130475258|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475259|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130417150|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130475260|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475261|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475262|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475263|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475264|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
130475265|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
130475266|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
130475267|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475268|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475269|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475270|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
130475271|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475272|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475273|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475274|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475275|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475276|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475277|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
130475278|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
130475279|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
130475280|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475281|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475282|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475283|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130475284|NCT01261312|469708517|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475285|NCT01261312|469708518|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475286|NCT01261312|469708519|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475287|NCT01261312|469708520|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475288|NCT01261312|469708521|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475289|NCT01261312|469708522|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475290|NCT01261312|469708523|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
130475291|NCT01261312|469708524|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
130475292|NCT01261312|469708525|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
130475293|NCT01261312|469708526|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475294|NCT01261312|469708527|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475295|NCT01261312|469708528|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475296|NCT01261312|469708529|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
130475297|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475298|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475299|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475300|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475301|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475302|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475303|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475304|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475305|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
130475306|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
130475307|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
130475308|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
130475309|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
130475310|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475311|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475312|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475313|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475314|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475315|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475316|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475317|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475318|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475319|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
130475320|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130475321|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
130475322|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
130563920|NCT03962738|470030568|FG000|Overall Study|Withdrawal by Subject|4|||
130417151|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417152|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417153|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417154|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417155|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130417156|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417157|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417158|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417159|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417160|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417161|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417162|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130417163|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417164|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130417165|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417166|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130417167|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
130417168|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417169|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417170|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417171|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417172|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417173|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417174|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417175|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130417176|NCT01490632|469488853|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417177|NCT01490632|469488854|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417178|NCT01490632|469488855|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417179|NCT01490632|469488856|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417180|NCT01490632|469488857|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417181|NCT01490632|469488858|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
130417182|NCT01490632|469488859|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
130417183|NCT01490632|469488860|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
130417184|NCT01490632|469488861|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
130417185|NCT01490632|469488862|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
130417186|NCT01490632|469488863|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
130417187|NCT01490632|469488864|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
130417188|NCT01490632|469488865|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417189|NCT01490632|469488866|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417190|NCT01490632|469488867|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417191|NCT01490632|469488868|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417192|NCT01490632|469488869|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417193|NCT01490632|469488870|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417194|NCT01490632|469488871|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130417195|NCT01490632|469488872|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130475323|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475324|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475325|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475326|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475327|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475328|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475329|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475330|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475331|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
130475332|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
130475333|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
130475334|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
130475335|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
130475336|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475337|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475338|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475339|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130417196|NCT01490632|469488853|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417197|NCT01490632|469488854|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417198|NCT01490632|469488855|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417199|NCT01490632|469488856|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417200|NCT01490632|469488857|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417201|NCT01490632|469488858|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417202|NCT01490632|469488859|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417203|NCT01490632|469488860|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417204|NCT01490632|469488861|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417205|NCT01490632|469488862|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417206|NCT01490632|469488863|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417207|NCT01490632|469488864|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417208|NCT01490632|469488865|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417209|NCT01490632|469488866|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417210|NCT01490632|469488867|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
130417211|NCT01490632|469488868|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
130417212|NCT01490632|469488869|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417213|NCT01490632|469488870|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417214|NCT01490632|469488871|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417215|NCT01490632|469488872|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
130417216|NCT01490632|469488853|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417217|NCT01490632|469488854|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417218|NCT01490632|469488855|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417219|NCT01490632|469488856|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417220|NCT01490632|469488857|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417221|NCT01490632|469488858|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417222|NCT01490632|469488859|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417223|NCT01490632|469488860|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417224|NCT01490632|469488861|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417225|NCT01490632|469488862|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417226|NCT01490632|469488863|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417227|NCT01490632|469488864|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417228|NCT01490632|469488865|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417229|NCT01490632|469488866|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
130417230|NCT01490632|469488867|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417231|NCT01490632|469488868|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417232|NCT01490632|469488869|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417233|NCT01490632|469488870|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417234|NCT01490632|469488871|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417235|NCT01490632|469488872|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130417236|NCT01490632|469488853|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417237|NCT01490632|469488854|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417238|NCT01490632|469488855|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417239|NCT01490632|469488856|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417240|NCT01490632|469488857|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417241|NCT01490632|469488858|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417242|NCT01490632|469488859|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417243|NCT01490632|469488860|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417244|NCT01490632|469488861|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417245|NCT01490632|469488862|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417246|NCT01490632|469488863|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417247|NCT01490632|469488864|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417248|NCT01490632|469488865|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417249|NCT01490632|469488866|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417250|NCT01490632|469488867|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
130417251|NCT01490632|469488868|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
130417252|NCT01490632|469488869|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417253|NCT01490632|469488870|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417254|NCT01490632|469488871|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417255|NCT01490632|469488872|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130417256|NCT01490632|469488853|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417257|NCT01490632|469488854|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417258|NCT01490632|469488855|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417259|NCT01490632|469488856|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417260|NCT01490632|469488857|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130563921|NCT03962738|470030569|FG001|Overall Study|Withdrawal by Subject|0|||
130417261|NCT01490632|469488858|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417262|NCT01490632|469488859|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417263|NCT01490632|469488860|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417264|NCT01490632|469488861|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417265|NCT01490632|469488862|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417266|NCT01490632|469488863|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417267|NCT01490632|469488864|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417268|NCT01490632|469488865|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
130417269|NCT01490632|469488866|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
130417270|NCT01490632|469488867|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
130417271|NCT01490632|469488868|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
130417272|NCT01490632|469488869|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417273|NCT01490632|469488870|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417274|NCT01490632|469488871|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417275|NCT01490632|469488872|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130417276|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
130417277|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
130417278|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
130417279|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
130417280|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
130417281|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
130417282|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
130417283|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
130417284|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
130417285|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
130417286|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
130563922|NCT03962738|470030570|FG002|Overall Study|Withdrawal by Subject|0|||
130563923|NCT03962738|470030571|FG003|Overall Study|Withdrawal by Subject|0|||
130563924|NCT03962738|470030568|FG000|Overall Study|Lost to Follow-up|0|||
130563925|NCT03962738|470030569|FG001|Overall Study|Lost to Follow-up|0|||
130563926|NCT03962738|470030570|FG002|Overall Study|Lost to Follow-up|1|||
130563927|NCT03962738|470030571|FG003|Overall Study|Lost to Follow-up|0|||
130563928|NCT00509067|470030572|FG000|Overall Study|Lost to Follow-up|1|||
130563929|NCT00509067|470030573|FG001|Overall Study|Lost to Follow-up|1|||
130417287|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
130417288|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
130417289|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
130417290|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
130417291|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
130417292|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
130417293|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
130417294|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
130417295|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
130417296|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Death|0|||
130417297|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Death|0|||
130417298|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Death|0|||
130417299|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Death|0|||
130417300|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Death|0|||
130417301|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Death|0|||
130417302|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Death|0|||
130417303|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Death|0|||
130417304|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Death|0|||
130417305|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Death|0|||
130417306|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Death|0|||
130417307|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Death|0|||
130417308|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Death|0|||
130417309|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Death|0|||
130417310|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Death|0|||
130417311|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Death|0|||
130417312|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Death|0|||
130417313|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Death|0|||
130417314|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Death|1|||
130417315|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Death|0|||
130563930|NCT00509067|470030572|FG000|Overall Study|Adverse Event|3|||
130417316|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417317|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417318|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417319|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417320|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417321|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130563931|NCT00509067|470030573|FG001|Overall Study|Adverse Event|1|||
130417322|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417323|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417324|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417325|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417326|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417327|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417328|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417329|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417330|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417331|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417332|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130417333|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
130417334|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
130417335|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
130417336|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417337|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417338|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417339|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417340|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417341|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417342|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417343|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417344|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417345|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417346|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417347|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417348|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417349|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417350|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417351|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417352|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417353|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417354|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
130417355|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130417356|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
130417357|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
130417358|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
130417359|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
130417360|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
130417361|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
130417362|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
130417363|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
130417364|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
130417365|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
130417366|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
130417367|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
130417368|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
130417369|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
130417370|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
130417371|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
130417372|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
130417373|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
130417374|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
130417375|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
130417376|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
130417377|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
130417378|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
130417379|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
130417380|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
130417381|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
130417382|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
130417383|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
130417384|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
130417385|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
130475340|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475341|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475342|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475343|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475344|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
130475345|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
130563932|NCT00509067|470030572|FG000|Overall Study|Protocol Violation|0|||
130563933|NCT00509067|470030573|FG001|Overall Study|Protocol Violation|3|||
130563934|NCT00574288|470030574|FG000|Overall Study|Adverse Event|2|||
130563935|NCT00574288|470030575|FG001|Overall Study|Adverse Event|0|||
130563936|NCT00574288|470030576|FG002|Overall Study|Adverse Event|0|||
130563937|NCT00574288|470030577|FG003|Overall Study|Adverse Event|0|||
130563938|NCT00574288|470030578|FG004|Overall Study|Adverse Event|1|||
130563939|NCT00574288|470030579|FG005|Overall Study|Adverse Event|0|||
130563940|NCT00574288|470030580|FG006|Overall Study|Adverse Event|0|||
130563941|NCT00574288|470030574|FG000|Overall Study|Death|0|||
130563942|NCT00574288|470030575|FG001|Overall Study|Death|0|||
130563943|NCT00574288|470030576|FG002|Overall Study|Death|0|||
130563944|NCT00574288|470030577|FG003|Overall Study|Death|0|||
130563945|NCT00574288|470030578|FG004|Overall Study|Death|0|||
130563946|NCT00574288|470030579|FG005|Overall Study|Death|25|||
130563947|NCT00574288|470030580|FG006|Overall Study|Death|21|||
130563948|NCT00574288|470030574|FG000|Overall Study|Lost to Follow-up|0|||
130563949|NCT00574288|470030575|FG001|Overall Study|Lost to Follow-up|0|||
130563950|NCT00574288|470030576|FG002|Overall Study|Lost to Follow-up|0|||
130563951|NCT00574288|470030577|FG003|Overall Study|Lost to Follow-up|0|||
130563952|NCT00574288|470030578|FG004|Overall Study|Lost to Follow-up|0|||
130563953|NCT00574288|470030579|FG005|Overall Study|Lost to Follow-up|1|||
130563954|NCT00574288|470030580|FG006|Overall Study|Lost to Follow-up|2|||
130563955|NCT00574288|470030574|FG000|Overall Study|Study Terminated By Sponsor|0|||
130563956|NCT00574288|470030575|FG001|Overall Study|Study Terminated By Sponsor|0|||
130563957|NCT00574288|470030576|FG002|Overall Study|Study Terminated By Sponsor|0|||
130563958|NCT00574288|470030577|FG003|Overall Study|Study Terminated By Sponsor|0|||
130563959|NCT00574288|470030578|FG004|Overall Study|Study Terminated By Sponsor|0|||
130563960|NCT00574288|470030579|FG005|Overall Study|Study Terminated By Sponsor|0|||
130563961|NCT00574288|470030580|FG006|Overall Study|Study Terminated By Sponsor|5|||
130563962|NCT00574288|470030574|FG000|Overall Study|Progressive Disease|17|||
130563963|NCT00574288|470030575|FG001|Overall Study|Progressive Disease|2|||
130563964|NCT00574288|470030576|FG002|Overall Study|Progressive Disease|3|||
130563965|NCT00574288|470030577|FG003|Overall Study|Progressive Disease|2|||
130563966|NCT00574288|470030578|FG004|Overall Study|Progressive Disease|1|||
130563967|NCT00574288|470030579|FG005|Overall Study|Progressive Disease|0|||
130563968|NCT00574288|470030580|FG006|Overall Study|Progressive Disease|0|||
130563969|NCT00574288|470030574|FG000|Overall Study|Other|1|||
130563970|NCT00574288|470030575|FG001|Overall Study|Other|1|||
130563971|NCT00574288|470030576|FG002|Overall Study|Other|0|||
130563972|NCT00574288|470030577|FG003|Overall Study|Other|0|||
130563973|NCT00574288|470030578|FG004|Overall Study|Other|0|||
130563974|NCT00574288|470030579|FG005|Overall Study|Other|0|||
130563975|NCT00574288|470030580|FG006|Overall Study|Other|0|||
130563976|NCT02361944|470030583|FG000|Overall Study|surgery cancellation|0|||
130417386|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
130417387|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
130417388|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
130417389|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
130417390|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
130417391|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
130417392|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
130417393|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
130417394|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
130417395|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
130417396|NCT01490632|469488853|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417397|NCT01490632|469488854|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130563977|NCT02361944|470030584|FG001|Overall Study|surgery cancellation|1|||
130563978|NCT03654976|470030587|FG000|Overall Study|Withdrawal by Subject|12|||
130563979|NCT03654976|470030588|FG001|Overall Study|Withdrawal by Subject|11|||
130563980|NCT03654976|470030587|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
130563981|NCT03654976|470030588|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
130563982|NCT03654976|470030587|FG000|Overall Study|Adverse Event|5|||
130417398|NCT01490632|469488855|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417399|NCT01490632|469488856|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130563983|NCT03654976|470030588|FG001|Overall Study|Adverse Event|0|||
130563984|NCT03654976|470030587|FG000|Overall Study|Lost to Follow-up|2|||
130563985|NCT03654976|470030588|FG001|Overall Study|Lost to Follow-up|0|||
130563986|NCT03654976|470030587|FG000|Overall Study|Lack of Efficacy|0|||
130417400|NCT01490632|469488857|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417401|NCT01490632|469488858|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130563987|NCT03654976|470030588|FG001|Overall Study|Lack of Efficacy|1|||
130563988|NCT03098836|470030589|FG000|Overall Study|Adverse Event|1|||
130563989|NCT03098836|470030590|FG001|Overall Study|Adverse Event|3|||
130563990|NCT03098836|470030589|FG000|Overall Study|Lack of Efficacy|30|||
130563991|NCT03098836|470030590|FG001|Overall Study|Lack of Efficacy|15|||
130563992|NCT03098836|470030589|FG000|Overall Study|Physician Decision|2|||
130563993|NCT03098836|470030590|FG001|Overall Study|Physician Decision|1|||
130727259|NCT02883049|470625427|FG003|Post Induction|Ineligible|0|||
130417402|NCT01490632|469488859|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130475346|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
130475347|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
130475348|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
130475349|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475350|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475351|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475352|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475353|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475354|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475355|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475356|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475357|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
130475358|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
130475359|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
130417403|NCT01490632|469488860|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130475360|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
130475361|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
130475362|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475363|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475364|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475365|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475366|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475367|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475368|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475369|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475370|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
130475371|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
130475372|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
130475373|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
130475374|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
130475375|NCT01261312|469708517|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475376|NCT01261312|469708518|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475377|NCT01261312|469708519|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475378|NCT01261312|469708520|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475379|NCT01261312|469708521|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475380|NCT01261312|469708522|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475381|NCT01261312|469708523|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475382|NCT01261312|469708524|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475383|NCT01261312|469708525|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130475384|NCT01261312|469708526|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
130475385|NCT01261312|469708527|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
130475386|NCT01261312|469708528|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
130417404|NCT01490632|469488861|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417405|NCT01490632|469488862|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417406|NCT01490632|469488863|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417407|NCT01490632|469488864|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417408|NCT01490632|469488865|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417409|NCT01490632|469488866|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417410|NCT01490632|469488867|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417411|NCT01490632|469488868|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417412|NCT01490632|469488869|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130417413|NCT01490632|469488870|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130417414|NCT01490632|469488871|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130417415|NCT01490632|469488872|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130417416|NCT00856856|469488878|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
130417417|NCT00856856|469488878|FG000|4-year Clinical Follow-up|Missed visit|1|||
130417418|NCT02696317|469488882|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
130417419|NCT02696317|469488883|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
130417420|NCT02696317|469488882|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
130417421|NCT02696317|469488883|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
130417422|NCT01343368|469488884|FG000|Overall Study|Death|1|||
130417423|NCT01343368|469488885|FG001|Overall Study|Death|0|||
130417424|NCT01343368|469488884|FG000|Overall Study|Lost to Follow-up|1|||
130417425|NCT01343368|469488885|FG001|Overall Study|Lost to Follow-up|0|||
130417426|NCT04955639|469488886|FG000|Overall Study|Withdrawal by Subject|2|||
130417427|NCT04955639|469488887|FG001|Overall Study|Withdrawal by Subject|2|||
130417428|NCT04955639|469488886|FG000|Overall Study|Week 26 survey not completed|2|||
130417429|NCT04955639|469488887|FG001|Overall Study|Week 26 survey not completed|2|||
130417430|NCT04447404|469488888|FG000|Overall Study|Death|2|||
130417431|NCT04447404|469488889|FG001|Overall Study|Death|0|||
130417432|NCT01369342|469488890|FG000|Overall Study|Withdrawal by Subject|7|||
130417433|NCT01369342|469488891|FG001|Overall Study|Withdrawal by Subject|7|||
130417434|NCT01369342|469488892|FG002|Overall Study|Withdrawal by Subject|2|||
130417435|NCT01369342|469488890|FG000|Overall Study|Lost to Follow-up|5|||
130417436|NCT01369342|469488891|FG001|Overall Study|Lost to Follow-up|2|||
130417437|NCT01369342|469488892|FG002|Overall Study|Lost to Follow-up|1|||
130417438|NCT01369342|469488890|FG000|Overall Study|Not Treated|1|||
130417439|NCT01369342|469488891|FG001|Overall Study|Not Treated|0|||
130417440|NCT01369342|469488892|FG002|Overall Study|Not Treated|0|||
130417441|NCT00321854|469488893|FG000|Overall Study|Adverse Event|41|||
130417442|NCT00321854|469488894|FG001|Overall Study|Adverse Event|43|||
130417443|NCT00321854|469488893|FG000|Overall Study|Lack of Efficacy|9|||
130417444|NCT00321854|469488894|FG001|Overall Study|Lack of Efficacy|14|||
130417445|NCT00321854|469488893|FG000|Overall Study|Protocol Violation|6|||
130417446|NCT00321854|469488894|FG001|Overall Study|Protocol Violation|5|||
130417447|NCT00321854|469488893|FG000|Overall Study|Lost to Follow-up|0|||
130417448|NCT00321854|469488894|FG001|Overall Study|Lost to Follow-up|2|||
130417449|NCT00321854|469488893|FG000|Overall Study|Withdrawal by Subject|6|||
130417450|NCT00321854|469488894|FG001|Overall Study|Withdrawal by Subject|17|||
130417451|NCT00321854|469488893|FG000|Overall Study|Other|1|||
130417452|NCT00321854|469488894|FG001|Overall Study|Other|1|||
130417453|NCT04723576|469488895|FG000|Overall Study|Withdrawal by Subject|2133|||
130417454|NCT04723576|469488896|FG001|Overall Study|Withdrawal by Subject|3234|||
130417455|NCT00413153|469488897|FG000|Overall Study|Withdrawal by Subject|1|||
130417456|NCT00413153|469488898|FG001|Overall Study|Withdrawal by Subject|1|||
130417457|NCT00413153|469488897|FG000|Overall Study|Adverse Event|1|||
130417458|NCT00413153|469488898|FG001|Overall Study|Adverse Event|0|||
130417459|NCT03204279|469488899|FG000|Overall Study|Withdrawal by Subject|0|||
130417460|NCT03204279|469488900|FG001|Overall Study|Withdrawal by Subject|1|||
130417461|NCT04969250|469488901|FG000|Overall Study|Protocol Violation|0|||
130417462|NCT04969250|469488902|FG001|Overall Study|Protocol Violation|2|||
130417463|NCT04969250|469488903|FG002|Overall Study|Protocol Violation|3|||
130417464|NCT04969250|469488904|FG003|Overall Study|Protocol Violation|8|||
130417465|NCT04969250|469488901|FG000|Overall Study|Withdrawal by Subject|0|||
130417466|NCT04969250|469488902|FG001|Overall Study|Withdrawal by Subject|1|||
130417467|NCT04969250|469488903|FG002|Overall Study|Withdrawal by Subject|0|||
130417468|NCT04969250|469488904|FG003|Overall Study|Withdrawal by Subject|0|||
130417469|NCT02278328|469488905|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
130417470|NCT02278328|469488906|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
130417471|NCT02278328|469488907|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
130417472|NCT02278328|469488905|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
130417473|NCT02278328|469488906|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
130417474|NCT02278328|469488907|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
130417475|NCT02278328|469488905|FG000|Neuropsych Screening|incomplete consent|0|||
130417476|NCT02278328|469488906|FG001|Neuropsych Screening|incomplete consent|0|||
130563994|NCT03098836|470030589|FG000|Overall Study|Withdrawal by Subject|3|||
130563995|NCT03098836|470030590|FG001|Overall Study|Withdrawal by Subject|2|||
130563996|NCT01770912|470030591|FG000|Overall Study|Lost to Follow-up|2|||
130563997|NCT01770912|470030592|FG001|Overall Study|Lost to Follow-up|0|||
130563998|NCT01817751|470030595|FG000|Overall Study|Physician Decision|1|||
130417477|NCT02278328|469488907|FG002|Neuropsych Screening|incomplete consent|2|||
130563999|NCT01846624|470030598|FG000|Overall Study|Died during induction, no midostaurin|1|||
130564000|NCT03472924|470030602|FG000|Overall Study|Adverse Event|1|||
130417478|NCT03834779|469488913|FG000|Overall Study|Death|1|||
130417479|NCT03834779|469488914|FG001|Overall Study|Death|2|||
130417480|NCT03834779|469488913|FG000|Overall Study|Lost to Follow-up|6|||
130417481|NCT03834779|469488914|FG001|Overall Study|Lost to Follow-up|4|||
130417482|NCT01292928|469488916|FG000|Overall Study|Death|8|||
130417483|NCT01292928|469488916|FG000|Overall Study|Withdrawal by Subject|8|||
130417484|NCT01292928|469488916|FG000|Overall Study|Lost to Follow-up|6|||
130417485|NCT01292928|469488916|FG000|Overall Study|Physician Decision|2|||
130417486|NCT00130533|469488921|FG000|Overall Study|Withdrawal by Subject|33|||
130417487|NCT00130533|469488922|FG001|Overall Study|Withdrawal by Subject|6|||
130417488|NCT00130533|469488921|FG000|Overall Study|Adverse Event|34|||
130417489|NCT00130533|469488922|FG001|Overall Study|Adverse Event|1|||
130417490|NCT00130533|469488921|FG000|Overall Study|Disease relapse|9|||
130417491|NCT00130533|469488922|FG001|Overall Study|Disease relapse|13|||
130417492|NCT00130533|469488921|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
130417493|NCT00130533|469488922|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
130417494|NCT00130533|469488921|FG000|Overall Study|Death|4|||
130417495|NCT00130533|469488922|FG001|Overall Study|Death|2|||
130564001|NCT03472924|470030603|FG001|Overall Study|Adverse Event|0|||
130564002|NCT00427349|470030604|FG000|Overall Study|Lack of Efficacy|23|||
130564003|NCT00427349|470030604|FG000|Overall Study|Adverse Event|14|||
130564004|NCT00427349|470030604|FG000|Overall Study|Death|1|||
130564005|NCT00427349|470030604|FG000|Overall Study|Withdrawal by Subject|3|||
130564006|NCT00427349|470030604|FG000|Overall Study|Alternative therapy|1|||
130564007|NCT00427349|470030604|FG000|Overall Study|Other|2|||
130564008|NCT00427349|470030604|FG000|Overall Study|Ineligible|1|||
130564009|NCT00427349|470030604|FG000|Overall Study|Never started therapy|1|||
130564010|NCT00698997|470030606|FG000|Overall Study|Lost to Follow-up|3|||
130564011|NCT00698997|470030607|FG001|Overall Study|Lost to Follow-up|0|||
130564012|NCT00698997|470030606|FG000|Overall Study|Withdrawal by Subject|7|||
130564013|NCT00698997|470030607|FG001|Overall Study|Withdrawal by Subject|27|||
130564014|NCT05082376|470030610|FG000|Overall Study|Lost to Follow-up|2|||
130564015|NCT04425720|470030611|FG000|Overall Study|Withdrawal by Subject|0|||
130564016|NCT04425720|470030612|FG001|Overall Study|Withdrawal by Subject|20|||
130564017|NCT00290186|470030613|FG000|Overall Study|Adverse Event|1|||
130564018|NCT00290186|470030614|FG001|Overall Study|Adverse Event|1|||
130564019|NCT00290186|470030613|FG000|Overall Study|Lost to Follow-up|3|||
130564020|NCT00290186|470030614|FG001|Overall Study|Lost to Follow-up|2|||
130564021|NCT00290186|470030613|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
130564022|NCT00290186|470030614|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
130564023|NCT00290186|470030613|FG000|Overall Study|Withdrawal by Subject|0|||
130564024|NCT00290186|470030614|FG001|Overall Study|Withdrawal by Subject|1|||
130564025|NCT04085523|470030616|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130564026|NCT04085523|470030617|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130564027|NCT04085523|470030618|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130564028|NCT04085523|470030619|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130564029|NCT04085523|470030620|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130564030|NCT04085523|470030621|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
130564031|NCT03697720|470032087|FG000|Overall Study|Lost to Follow-up|7|||
130564032|NCT03496012|470032094|FG000|Overall Study|Withdrawal by Subject|2|||
130564033|NCT03496012|470032095|FG001|Overall Study|Withdrawal by Subject|0|||
130564034|NCT03496012|470032096|FG002|Overall Study|Withdrawal by Subject|2|||
130564035|NCT03496012|470032094|FG000|Overall Study|Adverse Event|0|||
130564036|NCT03496012|470032095|FG001|Overall Study|Adverse Event|0|||
130564037|NCT03496012|470032096|FG002|Overall Study|Adverse Event|1|||
130564038|NCT03496012|470032094|FG000|Overall Study|Reason Not Specified|2|||
130564039|NCT03496012|470032095|FG001|Overall Study|Reason Not Specified|0|||
130564040|NCT03496012|470032096|FG002|Overall Study|Reason Not Specified|1|||
130564041|NCT02322125|470032097|FG000|Overall Study|Withdrawal by Subject|2|||
130564042|NCT00449670|470032099|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
130564043|NCT00449670|470032100|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
130564044|NCT00449670|470032099|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
130564045|NCT00449670|470032100|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
130564046|NCT00449670|470032099|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
130564047|NCT00449670|470032100|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
130564048|NCT00449670|470032099|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
130564049|NCT00449670|470032100|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
130564050|NCT00449670|470032099|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
130564051|NCT00449670|470032100|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
130564052|NCT00449670|470032099|FG000|Booster Phase (Study no.109873)|Other|0|||
130564053|NCT00449670|470032100|FG001|Booster Phase (Study no.109873)|Other|2|||
130564054|NCT04183790|470032101|FG000|Overall Study|Participants did not rollover to Part B|12|||
130564055|NCT04183790|470032102|FG001|Overall Study|Participants did not rollover to Part B|0|||
130564056|NCT04183790|470032101|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
130564057|NCT04183790|470032102|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130564058|NCT04183790|470032101|FG000|Overall Study|Commercial drug is available for participant|6|||
130564059|NCT04183790|470032102|FG001|Overall Study|Commercial drug is available for participant|0|||
130564060|NCT04183790|470032101|FG000|Overall Study|Adverse Event|1|||
130564061|NCT04183790|470032102|FG001|Overall Study|Adverse Event|0|||
130417496|NCT00130533|469488921|FG000|Overall Study|Protocol Violation|5|||
130417497|NCT00130533|469488922|FG001|Overall Study|Protocol Violation|1|||
130417498|NCT00130533|469488921|FG000|Overall Study|Lost to Follow-up|1|||
130564062|NCT04183790|470032101|FG000|Overall Study|Not enrolled in 107 study|0|||
130564063|NCT04183790|470032102|FG001|Overall Study|Not enrolled in 107 study|2|||
130564064|NCT00937937|470032103|FG000|Overall Study|Adverse Event|6|||
130564065|NCT00937937|470032103|FG000|Overall Study|Withdrawal by Subject|2|||
130417499|NCT00130533|469488922|FG001|Overall Study|Lost to Follow-up|1|||
130417500|NCT00130533|469488921|FG000|Overall Study|Sponsor´s decision|2|||
130417501|NCT00130533|469488922|FG001|Overall Study|Sponsor´s decision|0|||
130564066|NCT00937937|470032103|FG000|Overall Study|Progression/relapse|61|||
130564067|NCT00937937|470032103|FG000|Overall Study|Death|1|||
130564068|NCT00937937|470032103|FG000|Overall Study|Other|2|||
130564069|NCT03197493|470032104|FG000|Overall Study|Withdrawal by Subject|5|||
130417502|NCT00130533|469488921|FG000|Overall Study|Second Primary Malignancy|0|||
130417503|NCT00130533|469488922|FG001|Overall Study|Second Primary Malignancy|1|||
130417504|NCT00130533|469488921|FG000|Overall Study|Other|12|||
130417505|NCT00130533|469488922|FG001|Overall Study|Other|5|||
130417506|NCT01059565|469488923|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
130417507|NCT01059565|469488924|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
130417508|NCT01059565|469488923|FG000|24-Week Randomized Phase|Adverse Event|5|||
130417509|NCT01059565|469488924|FG001|24-Week Randomized Phase|Adverse Event|0|||
130417510|NCT01059565|469488923|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
130417511|NCT01059565|469488924|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
130417512|NCT01059565|469488923|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
130417513|NCT01059565|469488924|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
130417514|NCT01059565|469488923|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
130417515|NCT01059565|469488924|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
130417516|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Adverse Event|2|||
130417517|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Adverse Event|0|||
130417518|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
130417519|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
130417520|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
130417521|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
130417522|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
130417523|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
130417524|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
130417525|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
130417526|NCT01059565|469488923|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
130417527|NCT01059565|469488924|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
130417528|NCT03263429|469488929|FG000|Overall Study|Withdrawal by Subject|0|||
130417529|NCT03263429|469488930|FG001|Overall Study|Withdrawal by Subject|1|||
130417530|NCT03263429|469488931|FG002|Overall Study|Withdrawal by Subject|0|||
130417531|NCT03263429|469488929|FG000|Overall Study|Follow-Up Period Completed|0|||
130417532|NCT03263429|469488930|FG001|Overall Study|Follow-Up Period Completed|2|||
130417533|NCT03263429|469488931|FG002|Overall Study|Follow-Up Period Completed|0|||
130417534|NCT03263429|469488929|FG000|Overall Study|Death|3|||
130417535|NCT03263429|469488930|FG001|Overall Study|Death|5|||
130417536|NCT03263429|469488931|FG002|Overall Study|Death|16|||
130417537|NCT03263429|469488929|FG000|Overall Study|Participant unable to return|0|||
130417538|NCT03263429|469488930|FG001|Overall Study|Participant unable to return|0|||
130417539|NCT03263429|469488931|FG002|Overall Study|Participant unable to return|1|||
130417540|NCT03263429|469488929|FG000|Overall Study|Study Closed|0|||
130417541|NCT03263429|469488930|FG001|Overall Study|Study Closed|0|||
130417542|NCT03263429|469488931|FG002|Overall Study|Study Closed|1|||
130417543|NCT01605617|469488932|FG000|First Intervention|Adverse Event|0|||
130417544|NCT01605617|469488933|FG001|First Intervention|Adverse Event|1|||
130417545|NCT01605617|469488932|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
130417546|NCT01605617|469488933|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
130417547|NCT03759873|469488938|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
130417548|NCT03759873|469488939|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
130417549|NCT03759873|469488940|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
130417550|NCT03759873|469488941|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
130417551|NCT03759873|469488938|FG000|Overall Study|Moved outside eligible area|0|||
130417552|NCT03759873|469488939|FG001|Overall Study|Moved outside eligible area|2|||
130417553|NCT03759873|469488940|FG002|Overall Study|Moved outside eligible area|0|||
130417554|NCT03759873|469488941|FG003|Overall Study|Moved outside eligible area|0|||
130417555|NCT03759873|469488938|FG000|Overall Study|Withdrawal by Subject|0|||
130417556|NCT03759873|469488939|FG001|Overall Study|Withdrawal by Subject|0|||
130417557|NCT03759873|469488940|FG002|Overall Study|Withdrawal by Subject|1|||
130417558|NCT03759873|469488941|FG003|Overall Study|Withdrawal by Subject|0|||
130417559|NCT03579563|469488942|FG000|Overall Study|Lost to Follow-up|0|||
130417560|NCT03579563|469488943|FG001|Overall Study|Lost to Follow-up|0|||
130417561|NCT03579563|469488944|FG002|Overall Study|Lost to Follow-up|0|||
130417562|NCT03579563|469488945|FG003|Overall Study|Lost to Follow-up|0|||
130417563|NCT03579563|469488946|FG004|Overall Study|Lost to Follow-up|1|||
130417564|NCT03579563|469488947|FG005|Overall Study|Lost to Follow-up|0|||
130417565|NCT03579563|469488942|FG000|Overall Study|Lack of Efficacy|1|||
130417566|NCT03579563|469488943|FG001|Overall Study|Lack of Efficacy|1|||
130417567|NCT03579563|469488944|FG002|Overall Study|Lack of Efficacy|4|||
130417568|NCT03579563|469488945|FG003|Overall Study|Lack of Efficacy|1|||
130417569|NCT03579563|469488946|FG004|Overall Study|Lack of Efficacy|2|||
130417570|NCT03579563|469488947|FG005|Overall Study|Lack of Efficacy|3|||
130417571|NCT03579563|469488942|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130417572|NCT03579563|469488943|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130417573|NCT03579563|469488944|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130417574|NCT03579563|469488945|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
130564070|NCT02248259|470032105|FG000|Treatment Period 1|Adverse Event|0|||
130564071|NCT02248259|470032106|FG001|Treatment Period 1|Adverse Event|0|||
130564072|NCT02248259|470032107|FG002|Treatment Period 1|Adverse Event|1|||
130564073|NCT02248259|470032108|FG003|Treatment Period 1|Adverse Event|0|||
130564074|NCT02807480|470032109|FG000|Overall Study|Withdrawal by Subject|14|||
130417575|NCT03579563|469488946|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130417576|NCT03579563|469488947|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130417577|NCT03579563|469488942|FG000|Overall Study|Time/distance concern|0|||
130417578|NCT03579563|469488943|FG001|Overall Study|Time/distance concern|0|||
130417579|NCT03579563|469488944|FG002|Overall Study|Time/distance concern|1|||
130417580|NCT03579563|469488945|FG003|Overall Study|Time/distance concern|0|||
130417581|NCT03579563|469488946|FG004|Overall Study|Time/distance concern|0|||
130417582|NCT03579563|469488947|FG005|Overall Study|Time/distance concern|1|||
130417583|NCT03579563|469488942|FG000|Overall Study|COVID shutdown|2|||
130417584|NCT03579563|469488943|FG001|Overall Study|COVID shutdown|3|||
130417585|NCT03579563|469488944|FG002|Overall Study|COVID shutdown|4|||
130417586|NCT03579563|469488945|FG003|Overall Study|COVID shutdown|3|||
130417587|NCT03579563|469488946|FG004|Overall Study|COVID shutdown|1|||
130417588|NCT03579563|469488947|FG005|Overall Study|COVID shutdown|2|||
130417589|NCT03579563|469488942|FG000|Overall Study|Protocol administration error|1|||
130417590|NCT03579563|469488943|FG001|Overall Study|Protocol administration error|0|||
130417591|NCT03579563|469488944|FG002|Overall Study|Protocol administration error|1|||
130417592|NCT03579563|469488945|FG003|Overall Study|Protocol administration error|0|||
130417593|NCT03579563|469488946|FG004|Overall Study|Protocol administration error|1|||
130417594|NCT03579563|469488947|FG005|Overall Study|Protocol administration error|5|||
130417595|NCT03526250|469488948|FG000|Overall Study|Adverse Event|4|||
130417596|NCT03526250|469488948|FG000|Overall Study|Progressive Disease|16|||
130417597|NCT03526250|469488948|FG000|Overall Study|No Treatment|3|||
130417598|NCT02647359|469488949|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
130417599|NCT02647359|469488950|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
130417600|NCT02647359|469488949|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
130417601|NCT02647359|469488950|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
130417602|NCT02647359|469488949|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
130417603|NCT02647359|469488950|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
130417604|NCT02647359|469488949|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
130417605|NCT02647359|469488950|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
130417606|NCT02647359|469488949|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
130417607|NCT02647359|469488950|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
130417608|NCT02647359|469488949|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
130417609|NCT02647359|469488950|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
130417610|NCT00511004|469488951|FG000|Overall Study|Lost to Follow-up|0|||
130417611|NCT00511004|469488952|FG001|Overall Study|Lost to Follow-up|0|||
130417612|NCT00511004|469488953|FG002|Overall Study|Lost to Follow-up|4|||
130417613|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
130417614|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
130417615|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
130417616|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
130417617|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
130417618|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
130417619|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
130417620|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
130417621|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
130417622|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
130417623|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
130417624|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
130417625|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
130417626|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
130417627|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
130417628|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
130417629|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
130417630|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
130417631|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
130417632|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
130417633|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
130417634|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130417635|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130564075|NCT02807480|470032110|FG001|Overall Study|Withdrawal by Subject|10|||
130564076|NCT02369848|470032111|FG000|Overall Study|Death|1|||
130564077|NCT02369848|470032111|FG000|Overall Study|Withdrawal by Subject|2|||
130564078|NCT02369848|470032111|FG000|Overall Study|Lost to Follow-up|1|||
130417636|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130417637|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
130417638|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130417639|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130417640|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130417641|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130417642|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130417643|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
130417644|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130417645|NCT04818346|469488958|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130417646|NCT04818346|469488959|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130417647|NCT04818346|469488960|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130417648|NCT04818346|469488961|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
130417649|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
130417650|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
130417651|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
130417652|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
130417653|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130417654|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
130417655|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130417656|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130417657|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
130417658|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
130417659|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
130417660|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
130417661|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
130417662|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
130417663|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
130417664|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
130417665|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130417666|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
130417667|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130417668|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130417669|NCT04818346|469488958|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130417670|NCT04818346|469488959|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130417671|NCT04818346|469488960|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130417672|NCT04818346|469488961|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
130417673|NCT01672801|469488962|FG000|Overall Study|Screen Failure|0|||
130417674|NCT01672801|469488963|FG001|Overall Study|Screen Failure|1|||
130417675|NCT01362140|469488964|FG000|Overall Study|Noncompliance|1|||
130417676|NCT01362140|469488965|FG001|Overall Study|Noncompliance|0|||
130417677|NCT01362140|469488964|FG000|Overall Study|Adverse Event|2|||
130417678|NCT01362140|469488965|FG001|Overall Study|Adverse Event|2|||
130417679|NCT01362140|469488964|FG000|Overall Study|Withdrawal by Subject|3|||
130417680|NCT01362140|469488965|FG001|Overall Study|Withdrawal by Subject|3|||
130417681|NCT01362140|469488964|FG000|Overall Study|Administrative Decision|0|||
130417682|NCT01362140|469488965|FG001|Overall Study|Administrative Decision|1|||
130417683|NCT01362140|469488964|FG000|Overall Study|Death|2|||
130417684|NCT01362140|469488965|FG001|Overall Study|Death|1|||
130417685|NCT01362140|469488964|FG000|Overall Study|Other|1|||
130417686|NCT01362140|469488965|FG001|Overall Study|Other|1|||
130564079|NCT03281668|470032113|FG000|Overall Study|Physician Decision|1|||
130564080|NCT03281668|470032113|FG000|Overall Study|scheduling conflict, family circumstance|2|||
130564081|NCT03281668|470032113|FG000|Overall Study|Withdrawal by Subject|4|||
130564082|NCT03281668|470032113|FG000|Overall Study|Lost to Follow-up|1|||
130564083|NCT01543152|470032114|FG000|Overall Study|Withdrawal by Subject|0|||
130564084|NCT01543152|470032115|FG001|Overall Study|Withdrawal by Subject|2|||
130564085|NCT01543152|470032116|FG002|Overall Study|Withdrawal by Subject|0|||
130564086|NCT01543152|470032117|FG003|Overall Study|Withdrawal by Subject|0|||
130564087|NCT01543152|470032118|FG004|Overall Study|Withdrawal by Subject|0|||
130564088|NCT02932410|470032119|FG000|Overall Study|Death|7|||
130564089|NCT02932410|470032120|FG001|Overall Study|Death|6|||
130564090|NCT02932410|470032121|FG002|Overall Study|Death|0|||
130564091|NCT02932410|470032122|FG003|Overall Study|Death|0|||
130564092|NCT02932410|470032119|FG000|Overall Study|Lost to Follow-up|1|||
130564093|NCT02932410|470032120|FG001|Overall Study|Lost to Follow-up|2|||
130564094|NCT02932410|470032121|FG002|Overall Study|Lost to Follow-up|0|||
130564095|NCT02932410|470032122|FG003|Overall Study|Lost to Follow-up|0|||
130564096|NCT02932410|470032119|FG000|Overall Study|Parent/Subjects decision|6|||
130564097|NCT02932410|470032120|FG001|Overall Study|Parent/Subjects decision|6|||
130564098|NCT02932410|470032121|FG002|Overall Study|Parent/Subjects decision|1|||
130564099|NCT02932410|470032122|FG003|Overall Study|Parent/Subjects decision|0|||
130564100|NCT02932410|470032119|FG000|Overall Study|Physician Decision|0|||
130564101|NCT02932410|470032120|FG001|Overall Study|Physician Decision|1|||
130564102|NCT02932410|470032121|FG002|Overall Study|Physician Decision|0|||
130564103|NCT02932410|470032122|FG003|Overall Study|Physician Decision|0|||
130564104|NCT04702737|470032132|FG000|Overall Study|Decision by Sponsor|1|||
130564105|NCT04702737|470032132|FG000|Overall Study|Withdrawal of Consent from Study|3|||
130564106|NCT04702737|470032132|FG000|Overall Study|Lost to Follow-up|1|||
130564107|NCT04702737|470032132|FG000|Overall Study|Death|35|||
130564108|NCT03184077|470032133|FG000|Overall Study|Lost to Follow-up|21|||
130564109|NCT03184077|470032134|FG001|Overall Study|Lost to Follow-up|21|||
130564110|NCT03159091|470032137|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
130564111|NCT03159091|470032138|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
130564112|NCT03159091|470032137|FG000|Overall Study|Patient has taken no dose of study drug|0|||
130564113|NCT03159091|470032138|FG001|Overall Study|Patient has taken no dose of study drug|1|||
130564114|NCT00262522|470032139|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
130564115|NCT00262522|470032140|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
130564116|NCT00262522|470032141|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
130564117|NCT00262522|470032142|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
130564118|NCT00262522|470032139|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
130727260|NCT02883049|470625428|FG004|Post Induction|Ineligible|0|||
130727261|NCT02883049|470625429|FG005|Post Induction|Ineligible|0|||
130727262|NCT02883049|470625430|FG006|Post Induction|Ineligible|1|||
130564119|NCT00262522|470032140|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
130564120|NCT00262522|470032141|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
130564121|NCT00262522|470032142|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
130564122|NCT00262522|470032139|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
130564123|NCT00262522|470032140|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
130564124|NCT00262522|470032141|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
130564125|NCT00262522|470032142|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
130564126|NCT00262522|470032139|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
130417687|NCT01362140|469488964|FG000|Overall Study|Protocol-specified Criteria|1|||
130417688|NCT01362140|469488965|FG001|Overall Study|Protocol-specified Criteria|2|||
130417689|NCT01362140|469488964|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
130417690|NCT01362140|469488965|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
130417691|NCT00492284|469488967|FG000|Overall Study|Adverse Event|0|||
130417692|NCT00492284|469488968|FG001|Overall Study|Adverse Event|1|||
130417693|NCT00492284|469488969|FG002|Overall Study|Adverse Event|1|||
130417694|NCT00492284|469488970|FG003|Overall Study|Adverse Event|2|||
130417695|NCT00492284|469488967|FG000|Overall Study|Lost to Follow-up|0|||
130417696|NCT00492284|469488968|FG001|Overall Study|Lost to Follow-up|0|||
130417697|NCT00492284|469488969|FG002|Overall Study|Lost to Follow-up|3|||
130417698|NCT00492284|469488970|FG003|Overall Study|Lost to Follow-up|1|||
130417699|NCT00492284|469488967|FG000|Overall Study|Death|0|||
130417700|NCT00492284|469488968|FG001|Overall Study|Death|3|||
130417701|NCT00492284|469488969|FG002|Overall Study|Death|2|||
130417702|NCT00492284|469488970|FG003|Overall Study|Death|5|||
130417703|NCT00492284|469488967|FG000|Overall Study|Withdrawal by Subject|1|||
130417704|NCT00492284|469488968|FG001|Overall Study|Withdrawal by Subject|0|||
130417705|NCT00492284|469488969|FG002|Overall Study|Withdrawal by Subject|0|||
130417706|NCT00492284|469488970|FG003|Overall Study|Withdrawal by Subject|2|||
130417707|NCT06476366|469488971|FG000|Overall Study|Lost to Follow-up|1|||
130417708|NCT06476366|469488972|FG001|Overall Study|Lost to Follow-up|3|||
130417709|NCT06476366|469488971|FG000|Overall Study|Adverse Event|1|||
130417710|NCT06476366|469488972|FG001|Overall Study|Adverse Event|0|||
130564127|NCT00262522|470032140|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
130564128|NCT00262522|470032141|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
130564129|NCT00262522|470032142|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
130564130|NCT00262522|470032139|FG000|Study Start Through 8 Weeks|Death|1|||
130564131|NCT00262522|470032140|FG001|Study Start Through 8 Weeks|Death|0|||
130564132|NCT00262522|470032141|FG002|Study Start Through 8 Weeks|Death|0|||
130564133|NCT00262522|470032142|FG003|Study Start Through 8 Weeks|Death|0|||
130564134|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
130417711|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
130417712|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
130564135|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
130564136|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
130727263|NCT02883049|470625431|FG007|Post Induction|Ineligible|0|||
130417713|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
130417714|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
130417715|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
130417716|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
130417717|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
130417718|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
130417719|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
130417720|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
130417721|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
130417722|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
130417723|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
130417724|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
130417725|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
130417726|NCT00355082|469488980|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
130417727|NCT00355082|469488981|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
130417728|NCT00355082|469488982|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
130417729|NCT00355082|469488980|FG000|Continuation Phase|Adverse Event|2|||
130417730|NCT00355082|469488981|FG001|Continuation Phase|Adverse Event|0|||
130417731|NCT00355082|469488982|FG002|Continuation Phase|Adverse Event|1|||
130417732|NCT00355082|469488980|FG000|Continuation Phase|Lost to Follow-up|2|||
130417733|NCT00355082|469488981|FG001|Continuation Phase|Lost to Follow-up|0|||
130417734|NCT00355082|469488982|FG002|Continuation Phase|Lost to Follow-up|1|||
130417735|NCT00355082|469488980|FG000|Continuation Phase|Protocol Violation|1|||
130417736|NCT00355082|469488981|FG001|Continuation Phase|Protocol Violation|0|||
130417737|NCT00355082|469488982|FG002|Continuation Phase|Protocol Violation|1|||
130417738|NCT00355082|469488980|FG000|Continuation Phase|Withdrawal by Subject|4|||
130417739|NCT00355082|469488981|FG001|Continuation Phase|Withdrawal by Subject|0|||
130417740|NCT00355082|469488982|FG002|Continuation Phase|Withdrawal by Subject|0|||
130417741|NCT00355082|469488980|FG000|Continuation Phase|Lack of Efficacy|5|||
130417742|NCT00355082|469488981|FG001|Continuation Phase|Lack of Efficacy|0|||
130417743|NCT00355082|469488982|FG002|Continuation Phase|Lack of Efficacy|0|||
130417744|NCT00355082|469488980|FG000|Continuation Phase|Site Closed by Sponsor|8|||
130417745|NCT00355082|469488981|FG001|Continuation Phase|Site Closed by Sponsor|0|||
130417746|NCT00355082|469488982|FG002|Continuation Phase|Site Closed by Sponsor|0|||
130417747|NCT00355082|469488980|FG000|Continuation Phase|Scheduling Error|1|||
130417748|NCT00355082|469488981|FG001|Continuation Phase|Scheduling Error|0|||
130417749|NCT00355082|469488982|FG002|Continuation Phase|Scheduling Error|0|||
130417750|NCT00355082|469488980|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
130417751|NCT00355082|469488981|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
130417752|NCT00355082|469488982|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
130417753|NCT04598152|469488986|FG000|Overall Study|Lost to Follow-up|0|||
130417754|NCT04598152|469488987|FG001|Overall Study|Lost to Follow-up|1|||
130417755|NCT03346759|469488988|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
130417756|NCT03346759|469488989|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
130417757|NCT03346759|469488988|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
130417758|NCT03346759|469488989|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
130417759|NCT03346759|469488988|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
130417760|NCT03346759|469488989|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
130417761|NCT03069482|469490810|FG000|Overall Study|Lost to Follow-up|0|||
130417762|NCT03069482|469490811|FG001|Overall Study|Lost to Follow-up|1|||
130417763|NCT03069482|469490810|FG000|Overall Study|Physician Decision|1|||
130417764|NCT03069482|469490811|FG001|Overall Study|Physician Decision|0|||
130417765|NCT00791765|469490812|FG000|Weeks 1 to 12|Adverse Event|0|||
130417766|NCT00791765|469490813|FG001|Weeks 1 to 12|Adverse Event|1|||
130417767|NCT00791765|469490812|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
130417768|NCT00791765|469490813|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
130417769|NCT00791765|469490812|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
130417770|NCT00791765|469490813|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
130417771|NCT00791765|469490812|FG000|Weeks 1 to 12|Physician Decision|1|||
130417772|NCT00791765|469490813|FG001|Weeks 1 to 12|Physician Decision|0|||
130417773|NCT00791765|469490812|FG000|Weeks 1 to 12|Disease progression|3|||
130417774|NCT00791765|469490813|FG001|Weeks 1 to 12|Disease progression|0|||
130417775|NCT00791765|469490812|FG000|Weeks 1 to 12|Ineligibility determined|0|||
130417776|NCT00791765|469490813|FG001|Weeks 1 to 12|Ineligibility determined|3|||
130417777|NCT00791765|469490812|FG000|Weeks 13 to 24|Protocol deviation|2|||
130417778|NCT00791765|469490813|FG001|Weeks 13 to 24|Protocol deviation|0|||
130417779|NCT00791765|469490812|FG000|Weeks 13 to 24|Adverse Event|0|||
130417780|NCT00791765|469490813|FG001|Weeks 13 to 24|Adverse Event|3|||
130417781|NCT00791765|469490812|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
130417782|NCT00791765|469490813|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
130417783|NCT00791765|469490812|FG000|Weeks 13 to 24|Disease progression|0|||
130417784|NCT00791765|469490813|FG001|Weeks 13 to 24|Disease progression|1|||
130417785|NCT00791765|469490812|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
130417786|NCT00791765|469490813|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
130417787|NCT00791765|469490812|FG000|Weeks 13 to 24|Other|0|||
130417788|NCT00791765|469490813|FG001|Weeks 13 to 24|Other|1|||
130417789|NCT01877408|469490824|FG000|Overall Study|Lost to Follow-up|0|||
130417790|NCT01877408|469490825|FG001|Overall Study|Lost to Follow-up|2|||
130417791|NCT00156065|469490826|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
130417792|NCT00156065|469490827|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
130417793|NCT00156065|469490828|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
130417794|NCT00156065|469490826|FG000|Overall Study|Adverse Event|8|||
130417795|NCT00156065|469490827|FG001|Overall Study|Adverse Event|11|||
130417796|NCT00156065|469490828|FG002|Overall Study|Adverse Event|4|||
130417797|NCT00156065|469490826|FG000|Overall Study|Lack of Efficacy|2|||
130564137|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
130564138|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
130564139|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
130417798|NCT00156065|469490827|FG001|Overall Study|Lack of Efficacy|9|||
130417799|NCT00156065|469490828|FG002|Overall Study|Lack of Efficacy|3|||
130417800|NCT00156065|469490826|FG000|Overall Study|Withdrawal by Subject|13|||
130417801|NCT00156065|469490827|FG001|Overall Study|Withdrawal by Subject|26|||
130417802|NCT00156065|469490828|FG002|Overall Study|Withdrawal by Subject|16|||
130417803|NCT00156065|469490826|FG000|Overall Study|Lost to Follow-up|5|||
130417804|NCT00156065|469490827|FG001|Overall Study|Lost to Follow-up|7|||
130417805|NCT00156065|469490828|FG002|Overall Study|Lost to Follow-up|1|||
130417806|NCT00156065|469490826|FG000|Overall Study|Other|2|||
130417807|NCT00156065|469490827|FG001|Overall Study|Other|9|||
130417808|NCT00156065|469490828|FG002|Overall Study|Other|3|||
130417809|NCT01292603|469490829|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130417810|NCT01292603|469490830|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130417811|NCT01292603|469490831|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130417812|NCT01292603|469490832|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
130417813|NCT01292603|469490833|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130417814|NCT01292603|469490834|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130417815|NCT01292603|469490829|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
130417816|NCT01292603|469490830|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
130417817|NCT01292603|469490831|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
130417818|NCT01292603|469490832|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
130417819|NCT01292603|469490833|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
130417820|NCT01292603|469490834|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
130417821|NCT01292603|469490829|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130417822|NCT01292603|469490830|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130417823|NCT01292603|469490831|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130417824|NCT01292603|469490832|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
130417825|NCT01292603|469490833|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130417826|NCT01292603|469490834|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130417827|NCT01292603|469490829|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130417828|NCT01292603|469490830|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130417829|NCT01292603|469490831|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130417830|NCT01292603|469490832|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
130417831|NCT01292603|469490833|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130417832|NCT01292603|469490834|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130417833|NCT01292603|469490829|FG000|Part 1: Regular Follow-Up Period|Death|3|||
130417834|NCT01292603|469490830|FG001|Part 1: Regular Follow-Up Period|Death|1|||
130417835|NCT01292603|469490831|FG002|Part 1: Regular Follow-Up Period|Death|3|||
130417836|NCT01292603|469490832|FG003|Part 1: Regular Follow-Up Period|Death|1|||
130417837|NCT01292603|469490833|FG004|Part 1: Regular Follow-Up Period|Death|0|||
130417838|NCT01292603|469490834|FG005|Part 1: Regular Follow-Up Period|Death|0|||
130417839|NCT01292603|469490829|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
130417840|NCT01292603|469490830|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
130417841|NCT01292603|469490831|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
130417842|NCT01292603|469490832|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130417843|NCT01292603|469490833|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130417844|NCT01292603|469490834|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130417845|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Death|0|||
130417846|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Death|0|||
130417847|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Death|0|||
130417848|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Death|0|||
130417849|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Death|1|||
130417850|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Death|0|||
130417851|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
130417852|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
130417853|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
130564140|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
130417854|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
130417855|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
130417856|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
130417857|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130417858|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130417859|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130417860|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130417861|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
130417862|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
130417863|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
130417864|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
130417865|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
130417866|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
130417867|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
130417868|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
130417869|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130417870|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130417871|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130417872|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130417873|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
130417874|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
130417875|NCT01292603|469490829|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130417876|NCT01292603|469490830|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130417877|NCT01292603|469490831|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130417878|NCT01292603|469490832|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130417879|NCT01292603|469490833|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130417880|NCT01292603|469490834|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
130417881|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Death|0|||
130417882|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Death|0|||
130417883|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Death|0|||
130417884|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Death|0|||
130417885|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Death|6|||
130417886|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Death|3|||
130417887|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
130417888|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
130417889|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
130417890|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
130417891|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
130417892|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
130417893|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
130417894|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
130417895|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
130417896|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
130417897|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
130417898|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
130417899|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130417900|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130417901|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130417902|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130417903|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130417904|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
130417905|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
130417906|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
130417907|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
130417908|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
130417909|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
130417910|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
130417911|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
130417912|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
130417913|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
130417914|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
130417915|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
130417916|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
130417917|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130417918|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130417919|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130417920|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130417921|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
130417922|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
130417923|NCT01292603|469490829|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
130417924|NCT01292603|469490830|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
130417925|NCT01292603|469490831|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
130417926|NCT01292603|469490832|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
130417927|NCT01292603|469490833|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
130417928|NCT01292603|469490834|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
130417929|NCT01292603|469490829|FG000|Overall Survival Status|Death|3|||
130417930|NCT01292603|469490830|FG001|Overall Survival Status|Death|1|||
130417931|NCT01292603|469490831|FG002|Overall Survival Status|Death|3|||
130417932|NCT01292603|469490832|FG003|Overall Survival Status|Death|1|||
130417933|NCT01292603|469490833|FG004|Overall Survival Status|Death|16|||
130417934|NCT01292603|469490834|FG005|Overall Survival Status|Death|10|||
130417935|NCT03870763|469490837|FG000|Overall Study|Study terminated by sponsor|0|||
130417936|NCT03870763|469490838|FG001|Overall Study|Study terminated by sponsor|2|||
130417937|NCT03870763|469490839|FG002|Overall Study|Study terminated by sponsor|0|||
130417938|NCT03870763|469490837|FG000|Overall Study|Withdrawal by Subject|0|||
130417939|NCT03870763|469490838|FG001|Overall Study|Withdrawal by Subject|1|||
130417940|NCT03870763|469490839|FG002|Overall Study|Withdrawal by Subject|0|||
130417941|NCT03870763|469490837|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
130417942|NCT03870763|469490838|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
130417943|NCT03870763|469490839|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
130417944|NCT03586648|469490842|FG000|Period 1|Withdrawal by Subject|0|||
130417945|NCT03586648|469490843|FG001|Period 1|Withdrawal by Subject|1|||
130417946|NCT03586648|469490842|FG000|Period 1|Lost to Follow-up|1|||
130417947|NCT03586648|469490843|FG001|Period 1|Lost to Follow-up|1|||
130417948|NCT03586648|469490842|FG000|Period 1|Adverse Event|1|||
130417949|NCT03586648|469490843|FG001|Period 1|Adverse Event|0|||
130417950|NCT03586648|469490842|FG000|Period 1|Study related symptoms or complaints|2|||
130417951|NCT03586648|469490843|FG001|Period 1|Study related symptoms or complaints|1|||
130417952|NCT03586648|469490842|FG000|Period 1|Physician Decision|0|||
130417953|NCT03586648|469490843|FG001|Period 1|Physician Decision|1|||
130417954|NCT03586648|469490842|FG000|Period 2|Adverse Event|1|||
130417955|NCT03586648|469490843|FG001|Period 2|Adverse Event|0|||
130417956|NCT00907153|469490844|FG000|Overall Study|Lost to Follow-up|1|||
130417957|NCT00907153|469490845|FG001|Overall Study|Lost to Follow-up|1|||
130417958|NCT00907153|469490844|FG000|Overall Study|Withdrawal by Subject|1|||
130417959|NCT00907153|469490845|FG001|Overall Study|Withdrawal by Subject|3|||
130417960|NCT03147248|469490846|FG000|Overall Study|Adverse Event|0|||
130417961|NCT03147248|469490847|FG001|Overall Study|Adverse Event|2|||
130417962|NCT03147248|469490848|FG002|Overall Study|Adverse Event|2|||
130417963|NCT03147248|469490849|FG003|Overall Study|Adverse Event|2|||
130417964|NCT03147248|469490850|FG004|Overall Study|Adverse Event|6|||
130417965|NCT03147248|469490851|FG005|Overall Study|Adverse Event|11|||
130417966|NCT03147248|469490846|FG000|Overall Study|Disease progression|1|||
130417967|NCT03147248|469490847|FG001|Overall Study|Disease progression|0|||
130417968|NCT03147248|469490848|FG002|Overall Study|Disease progression|0|||
130417969|NCT03147248|469490849|FG003|Overall Study|Disease progression|0|||
130417970|NCT03147248|469490850|FG004|Overall Study|Disease progression|0|||
130417971|NCT03147248|469490851|FG005|Overall Study|Disease progression|2|||
130417972|NCT03147248|469490846|FG000|Overall Study|Withdrawal by Subject|0|||
130417973|NCT03147248|469490847|FG001|Overall Study|Withdrawal by Subject|0|||
130417974|NCT03147248|469490848|FG002|Overall Study|Withdrawal by Subject|0|||
130417975|NCT03147248|469490849|FG003|Overall Study|Withdrawal by Subject|0|||
130417976|NCT03147248|469490850|FG004|Overall Study|Withdrawal by Subject|12|||
130417977|NCT03147248|469490851|FG005|Overall Study|Withdrawal by Subject|9|||
130417978|NCT03147248|469490846|FG000|Overall Study|Protocol Violation|0|||
130417979|NCT03147248|469490847|FG001|Overall Study|Protocol Violation|0|||
130417980|NCT03147248|469490848|FG002|Overall Study|Protocol Violation|0|||
130417981|NCT03147248|469490849|FG003|Overall Study|Protocol Violation|0|||
130417982|NCT03147248|469490850|FG004|Overall Study|Protocol Violation|2|||
130417983|NCT03147248|469490851|FG005|Overall Study|Protocol Violation|0|||
130417984|NCT03147248|469490846|FG000|Overall Study|Lost to Follow-up|0|||
130417985|NCT03147248|469490847|FG001|Overall Study|Lost to Follow-up|0|||
130417986|NCT03147248|469490848|FG002|Overall Study|Lost to Follow-up|0|||
130417987|NCT03147248|469490849|FG003|Overall Study|Lost to Follow-up|0|||
130417988|NCT03147248|469490850|FG004|Overall Study|Lost to Follow-up|2|||
130417989|NCT03147248|469490851|FG005|Overall Study|Lost to Follow-up|0|||
130417990|NCT03147248|469490846|FG000|Overall Study|Pregnancy|0|||
130417991|NCT03147248|469490847|FG001|Overall Study|Pregnancy|0|||
130417992|NCT03147248|469490848|FG002|Overall Study|Pregnancy|0|||
130417993|NCT03147248|469490849|FG003|Overall Study|Pregnancy|0|||
130417994|NCT03147248|469490850|FG004|Overall Study|Pregnancy|1|||
130417995|NCT03147248|469490851|FG005|Overall Study|Pregnancy|0|||
130417996|NCT03147248|469490846|FG000|Overall Study|Death|0|||
130417997|NCT03147248|469490847|FG001|Overall Study|Death|0|||
130417998|NCT03147248|469490848|FG002|Overall Study|Death|0|||
130417999|NCT03147248|469490849|FG003|Overall Study|Death|0|||
130418000|NCT03147248|469490850|FG004|Overall Study|Death|0|||
130418001|NCT03147248|469490851|FG005|Overall Study|Death|4|||
130418002|NCT03147248|469490846|FG000|Overall Study|Physician Decision|0|||
130418003|NCT03147248|469490847|FG001|Overall Study|Physician Decision|0|||
130418004|NCT03147248|469490848|FG002|Overall Study|Physician Decision|0|||
130418005|NCT03147248|469490849|FG003|Overall Study|Physician Decision|0|||
130564141|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
130564142|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
130564143|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
130564144|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
130564145|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
130564146|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
130564147|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
130564148|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
130564149|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
130418006|NCT03147248|469490850|FG004|Overall Study|Physician Decision|2|||
130418007|NCT03147248|469490851|FG005|Overall Study|Physician Decision|4|||
130418008|NCT03147248|469490846|FG000|Overall Study|Prolonged Dosing Interval|0|||
130418009|NCT03147248|469490847|FG001|Overall Study|Prolonged Dosing Interval|0|||
130418010|NCT03147248|469490848|FG002|Overall Study|Prolonged Dosing Interval|0|||
130418011|NCT03147248|469490849|FG003|Overall Study|Prolonged Dosing Interval|0|||
130418012|NCT03147248|469490850|FG004|Overall Study|Prolonged Dosing Interval|1|||
130418013|NCT03147248|469490851|FG005|Overall Study|Prolonged Dosing Interval|1|||
130418014|NCT02388724|469490854|FG000|Overall Study|Reason not Specified|0|||
130418015|NCT02388724|469490855|FG001|Overall Study|Reason not Specified|1|||
130418016|NCT02388724|469490854|FG000|Overall Study|Major Protocol Deviation|3|||
130418017|NCT02388724|469490855|FG001|Overall Study|Major Protocol Deviation|3|||
130418018|NCT02388724|469490854|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130418019|NCT02388724|469490855|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130418020|NCT02388724|469490854|FG000|Overall Study|Voluntary Withdrawal|6|||
130418021|NCT02388724|469490855|FG001|Overall Study|Voluntary Withdrawal|5|||
130418022|NCT02388724|469490854|FG000|Overall Study|Randomized but not Treated|0|||
130418023|NCT02388724|469490855|FG001|Overall Study|Randomized but not Treated|2|||
130418024|NCT02605954|469490856|FG000|Overall Study|Adverse Event|5|||
130418025|NCT02605954|469490857|FG001|Overall Study|Adverse Event|1|||
130418026|NCT02605954|469490856|FG000|Overall Study|Investigator's Discretion|1|||
130418027|NCT02605954|469490857|FG001|Overall Study|Investigator's Discretion|0|||
130418028|NCT02605954|469490856|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130418029|NCT02605954|469490857|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130418030|NCT02605954|469490856|FG000|Overall Study|Withdrew Consent|2|||
130418031|NCT02605954|469490857|FG001|Overall Study|Withdrew Consent|2|||
130418032|NCT02605954|469490856|FG000|Overall Study|Lost to Follow-up|3|||
130418033|NCT02605954|469490857|FG001|Overall Study|Lost to Follow-up|0|||
130418034|NCT02605954|469490856|FG000|Overall Study|Randomized but not treated|0|||
130418035|NCT02605954|469490857|FG001|Overall Study|Randomized but not treated|1|||
130418036|NCT03214367|469490858|FG000|Lead-in Period|Withdrawal by Subject|50|||
130418037|NCT03214367|469490859|FG001|Lead-in Period|Withdrawal by Subject|0|||
130418038|NCT03214367|469490860|FG002|Lead-in Period|Withdrawal by Subject|0|||
130418039|NCT03214367|469490861|FG003|Lead-in Period|Withdrawal by Subject|0|||
130418040|NCT03214367|469490862|FG004|Lead-in Period|Withdrawal by Subject|2|||
130418041|NCT03214367|469490863|FG005|Lead-in Period|Withdrawal by Subject|0|||
130418042|NCT03214367|469490864|FG006|Lead-in Period|Withdrawal by Subject|0|||
130418043|NCT03214367|469490865|FG007|Lead-in Period|Withdrawal by Subject|0|||
130418044|NCT03214367|469490858|FG000|Lead-in Period|Adverse Event|3|||
130418045|NCT03214367|469490859|FG001|Lead-in Period|Adverse Event|0|||
130475387|NCT01261312|469708529|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
130475388|NCT03436745|469708533|FG000|Overall Study|Ineligible|0|||
130475389|NCT03436745|469708534|FG001|Overall Study|Ineligible|0|||
130475390|NCT03436745|469708535|FG002|Overall Study|Ineligible|1|||
130475391|NCT01809691|469708536|FG000|Overall Study|Currently on Treatment|192|||
130475392|NCT01809691|469708537|FG001|Overall Study|Currently on Treatment|100|||
130475393|NCT01809691|469708536|FG000|Overall Study|No Protocol Treatment|10|||
130475394|NCT01809691|469708537|FG001|Overall Study|No Protocol Treatment|11|||
130475395|NCT01809691|469708536|FG000|Overall Study|Adverse Event|80|||
130475396|NCT01809691|469708537|FG001|Overall Study|Adverse Event|21|||
130475397|NCT01809691|469708536|FG000|Overall Study|Disease Progression|226|||
130475398|NCT01809691|469708537|FG001|Overall Study|Disease Progression|372|||
130475399|NCT01809691|469708536|FG000|Overall Study|Death|26|||
130475400|NCT01809691|469708537|FG001|Overall Study|Death|13|||
130475401|NCT01809691|469708536|FG000|Overall Study|Participant Refusal|70|||
130475402|NCT01809691|469708537|FG001|Overall Study|Participant Refusal|72|||
130475403|NCT01809691|469708536|FG000|Overall Study|Other, Not Specified|34|||
130475404|NCT01809691|469708537|FG001|Overall Study|Other, Not Specified|52|||
130475405|NCT01580488|469708540|FG000|Overall Study|Withdrawal by Subject|1|||
130475406|NCT04401800|469708543|FG000|Overall Study|Death|17|||
130475407|NCT04401800|469708543|FG000|Overall Study|Lost to Follow-up|5|||
130475408|NCT04401800|469708543|FG000|Overall Study|Withdrawal by Subject|4|||
130475409|NCT03338790|469708550|FG000|Overall Study|Disease Progression|65|||
130475410|NCT03338790|469708551|FG001|Overall Study|Disease Progression|43|||
130475411|NCT03338790|469708552|FG002|Overall Study|Disease Progression|50|||
130475412|NCT03338790|469708553|FG003|Overall Study|Disease Progression|37|||
130475413|NCT03338790|469708550|FG000|Overall Study|Study Drug Toxicity|9|||
130418046|NCT03214367|469490860|FG002|Lead-in Period|Adverse Event|0|||
130418047|NCT03214367|469490861|FG003|Lead-in Period|Adverse Event|0|||
130418048|NCT03214367|469490862|FG004|Lead-in Period|Adverse Event|0|||
130418049|NCT03214367|469490863|FG005|Lead-in Period|Adverse Event|0|||
130418050|NCT03214367|469490864|FG006|Lead-in Period|Adverse Event|0|||
130418051|NCT03214367|469490865|FG007|Lead-in Period|Adverse Event|0|||
130418052|NCT03214367|469490858|FG000|Lead-in Period|Lost to Follow-up|12|||
130418053|NCT03214367|469490859|FG001|Lead-in Period|Lost to Follow-up|0|||
130418054|NCT03214367|469490860|FG002|Lead-in Period|Lost to Follow-up|0|||
130418055|NCT03214367|469490861|FG003|Lead-in Period|Lost to Follow-up|0|||
130418056|NCT03214367|469490862|FG004|Lead-in Period|Lost to Follow-up|0|||
130418057|NCT03214367|469490863|FG005|Lead-in Period|Lost to Follow-up|0|||
130418058|NCT03214367|469490864|FG006|Lead-in Period|Lost to Follow-up|0|||
130418059|NCT03214367|469490865|FG007|Lead-in Period|Lost to Follow-up|0|||
130418060|NCT03214367|469490858|FG000|Lead-in Period|Sponsor Decision|11|||
130418061|NCT03214367|469490859|FG001|Lead-in Period|Sponsor Decision|0|||
130418062|NCT03214367|469490860|FG002|Lead-in Period|Sponsor Decision|0|||
130418063|NCT03214367|469490861|FG003|Lead-in Period|Sponsor Decision|0|||
130418064|NCT03214367|469490862|FG004|Lead-in Period|Sponsor Decision|0|||
130418065|NCT03214367|469490863|FG005|Lead-in Period|Sponsor Decision|0|||
130418066|NCT03214367|469490864|FG006|Lead-in Period|Sponsor Decision|0|||
130418067|NCT03214367|469490865|FG007|Lead-in Period|Sponsor Decision|0|||
130418068|NCT03214367|469490858|FG000|Lead-in Period|Physician Decision|12|||
130418069|NCT03214367|469490859|FG001|Lead-in Period|Physician Decision|0|||
130418070|NCT03214367|469490860|FG002|Lead-in Period|Physician Decision|0|||
130418071|NCT03214367|469490861|FG003|Lead-in Period|Physician Decision|0|||
130418072|NCT03214367|469490862|FG004|Lead-in Period|Physician Decision|0|||
130418073|NCT03214367|469490863|FG005|Lead-in Period|Physician Decision|0|||
130418074|NCT03214367|469490864|FG006|Lead-in Period|Physician Decision|0|||
130418075|NCT03214367|469490865|FG007|Lead-in Period|Physician Decision|0|||
130418076|NCT03214367|469490858|FG000|Lead-in Period|Protocol Violation|5|||
130418077|NCT03214367|469490859|FG001|Lead-in Period|Protocol Violation|0|||
130418078|NCT03214367|469490860|FG002|Lead-in Period|Protocol Violation|0|||
130418079|NCT03214367|469490861|FG003|Lead-in Period|Protocol Violation|0|||
130418080|NCT03214367|469490862|FG004|Lead-in Period|Protocol Violation|0|||
130418081|NCT03214367|469490863|FG005|Lead-in Period|Protocol Violation|0|||
130418082|NCT03214367|469490864|FG006|Lead-in Period|Protocol Violation|0|||
130418083|NCT03214367|469490865|FG007|Lead-in Period|Protocol Violation|0|||
130418084|NCT03214367|469490858|FG000|Lead-in Period|Treatment Interruption|1|||
130418085|NCT03214367|469490859|FG001|Lead-in Period|Treatment Interruption|0|||
130418086|NCT03214367|469490860|FG002|Lead-in Period|Treatment Interruption|0|||
130418087|NCT03214367|469490861|FG003|Lead-in Period|Treatment Interruption|0|||
130418088|NCT03214367|469490862|FG004|Lead-in Period|Treatment Interruption|0|||
130418089|NCT03214367|469490863|FG005|Lead-in Period|Treatment Interruption|0|||
130418090|NCT03214367|469490864|FG006|Lead-in Period|Treatment Interruption|0|||
130418091|NCT03214367|469490865|FG007|Lead-in Period|Treatment Interruption|0|||
130418092|NCT03214367|469490858|FG000|Treatment Period|Adverse Event|0|||
130418093|NCT03214367|469490859|FG001|Treatment Period|Adverse Event|1|||
130418094|NCT03214367|469490860|FG002|Treatment Period|Adverse Event|4|||
130418095|NCT03214367|469490861|FG003|Treatment Period|Adverse Event|2|||
130418096|NCT03214367|469490862|FG004|Treatment Period|Adverse Event|0|||
130418097|NCT03214367|469490863|FG005|Treatment Period|Adverse Event|0|||
130418098|NCT03214367|469490864|FG006|Treatment Period|Adverse Event|0|||
130418099|NCT03214367|469490865|FG007|Treatment Period|Adverse Event|0|||
130418100|NCT03214367|469490858|FG000|Treatment Period|Death|0|||
130418101|NCT03214367|469490859|FG001|Treatment Period|Death|1|||
130418102|NCT03214367|469490860|FG002|Treatment Period|Death|1|||
130475414|NCT03338790|469708551|FG001|Overall Study|Study Drug Toxicity|8|||
130475415|NCT03338790|469708552|FG002|Overall Study|Study Drug Toxicity|15|||
130475416|NCT03338790|469708553|FG003|Overall Study|Study Drug Toxicity|0|||
130475417|NCT03338790|469708550|FG000|Overall Study|Death|1|||
130475418|NCT03338790|469708551|FG001|Overall Study|Death|1|||
130475419|NCT03338790|469708552|FG002|Overall Study|Death|1|||
130475420|NCT03338790|469708553|FG003|Overall Study|Death|0|||
130418103|NCT03214367|469490861|FG003|Treatment Period|Death|1|||
130418104|NCT03214367|469490862|FG004|Treatment Period|Death|0|||
130418105|NCT03214367|469490863|FG005|Treatment Period|Death|0|||
130418106|NCT03214367|469490864|FG006|Treatment Period|Death|0|||
130475421|NCT03338790|469708550|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
130475422|NCT03338790|469708551|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
130475423|NCT03338790|469708552|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
130475424|NCT03338790|469708553|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
130475425|NCT03338790|469708550|FG000|Overall Study|Participant request to discontinue study treatment|3|||
130475426|NCT03338790|469708551|FG001|Overall Study|Participant request to discontinue study treatment|3|||
130475427|NCT03338790|469708552|FG002|Overall Study|Participant request to discontinue study treatment|2|||
130418107|NCT03214367|469490865|FG007|Treatment Period|Death|0|||
130418108|NCT03214367|469490858|FG000|Treatment Period|Lost to Follow-up|0|||
130418109|NCT03214367|469490859|FG001|Treatment Period|Lost to Follow-up|5|||
130564150|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Death|2|||
130564151|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Death|0|||
130564152|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Death|1|||
130564153|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Death|0|||
130564154|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
130564155|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
130564156|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
130564157|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
130564158|NCT00262522|470032139|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
130564159|NCT00262522|470032140|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
130418110|NCT03214367|469490860|FG002|Treatment Period|Lost to Follow-up|3|||
130418111|NCT03214367|469490861|FG003|Treatment Period|Lost to Follow-up|2|||
130418112|NCT03214367|469490862|FG004|Treatment Period|Lost to Follow-up|0|||
130418113|NCT03214367|469490863|FG005|Treatment Period|Lost to Follow-up|2|||
130418114|NCT03214367|469490864|FG006|Treatment Period|Lost to Follow-up|1|||
130418115|NCT03214367|469490865|FG007|Treatment Period|Lost to Follow-up|0|||
130418116|NCT03214367|469490858|FG000|Treatment Period|Sponsor Decision|0|||
130418117|NCT03214367|469490859|FG001|Treatment Period|Sponsor Decision|3|||
130418118|NCT03214367|469490860|FG002|Treatment Period|Sponsor Decision|0|||
130418119|NCT03214367|469490861|FG003|Treatment Period|Sponsor Decision|0|||
130418120|NCT03214367|469490862|FG004|Treatment Period|Sponsor Decision|0|||
130418121|NCT03214367|469490863|FG005|Treatment Period|Sponsor Decision|0|||
130418122|NCT03214367|469490864|FG006|Treatment Period|Sponsor Decision|0|||
130418123|NCT03214367|469490865|FG007|Treatment Period|Sponsor Decision|0|||
130418124|NCT03214367|469490858|FG000|Treatment Period|Physician Decision|0|||
130418125|NCT03214367|469490859|FG001|Treatment Period|Physician Decision|1|||
130418126|NCT03214367|469490860|FG002|Treatment Period|Physician Decision|2|||
130418127|NCT03214367|469490861|FG003|Treatment Period|Physician Decision|0|||
130418128|NCT03214367|469490862|FG004|Treatment Period|Physician Decision|0|||
130418129|NCT03214367|469490863|FG005|Treatment Period|Physician Decision|0|||
130418130|NCT03214367|469490864|FG006|Treatment Period|Physician Decision|0|||
130418131|NCT03214367|469490865|FG007|Treatment Period|Physician Decision|0|||
130418132|NCT03214367|469490858|FG000|Treatment Period|Protocol Violation|0|||
130418133|NCT03214367|469490859|FG001|Treatment Period|Protocol Violation|3|||
130418134|NCT03214367|469490860|FG002|Treatment Period|Protocol Violation|0|||
130418135|NCT03214367|469490861|FG003|Treatment Period|Protocol Violation|0|||
130418136|NCT03214367|469490862|FG004|Treatment Period|Protocol Violation|0|||
130418137|NCT03214367|469490863|FG005|Treatment Period|Protocol Violation|0|||
130418138|NCT03214367|469490864|FG006|Treatment Period|Protocol Violation|0|||
130418139|NCT03214367|469490865|FG007|Treatment Period|Protocol Violation|0|||
130418140|NCT03214367|469490858|FG000|Treatment Period|Withdrawal by Subject|0|||
130418141|NCT03214367|469490859|FG001|Treatment Period|Withdrawal by Subject|20|||
130418142|NCT03214367|469490860|FG002|Treatment Period|Withdrawal by Subject|23|||
130418143|NCT03214367|469490861|FG003|Treatment Period|Withdrawal by Subject|14|||
130418144|NCT03214367|469490862|FG004|Treatment Period|Withdrawal by Subject|0|||
130418145|NCT03214367|469490863|FG005|Treatment Period|Withdrawal by Subject|1|||
130418146|NCT03214367|469490864|FG006|Treatment Period|Withdrawal by Subject|1|||
130418147|NCT03214367|469490865|FG007|Treatment Period|Withdrawal by Subject|1|||
130418148|NCT03508843|469490866|FG000|Overall Study|Withdrawal by Subject|1|||
130418149|NCT03508843|469490866|FG000|Overall Study|technical difficulties|2|||
130418150|NCT03555396|469490867|FG000|Overall Study|Death|3|||
130418151|NCT03555396|469490868|FG001|Overall Study|Death|1|||
130418152|NCT03555396|469490867|FG000|Overall Study|Lost to Follow-up|0|||
130418153|NCT03555396|469490868|FG001|Overall Study|Lost to Follow-up|2|||
130418154|NCT01816594|469490878|FG000|Overall Study|Local Progress|0|||
130418155|NCT01816594|469490879|FG001|Overall Study|Local Progress|2|||
130418156|NCT01816594|469490878|FG000|Overall Study|Adverse Event|9|||
130564160|NCT00262522|470032141|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
130564161|NCT00262522|470032142|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
130564162|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
130564163|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
130564164|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
130564165|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
130418157|NCT01816594|469490879|FG001|Overall Study|Adverse Event|0|||
130418158|NCT01816594|469490878|FG000|Overall Study|Withdrawal by Subject|1|||
130418159|NCT01816594|469490879|FG001|Overall Study|Withdrawal by Subject|0|||
130418160|NCT01816594|469490878|FG000|Overall Study|Physician Decision|1|||
130418161|NCT01816594|469490879|FG001|Overall Study|Physician Decision|0|||
130418162|NCT03905655|469490880|FG000|Overall Study|Adverse Event|1|||
130418163|NCT03905655|469490881|FG001|Overall Study|Adverse Event|0|||
130418164|NCT03905655|469490882|FG002|Overall Study|Adverse Event|1|||
130418165|NCT03905655|469490883|FG003|Overall Study|Adverse Event|1|||
130564166|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
130418166|NCT02566031|469490884|FG000|Overall Study|Patient/guardian decision|14|||
130418167|NCT02566031|469490885|FG001|Overall Study|Patient/guardian decision|7|||
130418168|NCT02566031|469490884|FG000|Overall Study|Protocol deviation|2|||
130418169|NCT02566031|469490885|FG001|Overall Study|Protocol deviation|3|||
130418170|NCT02566031|469490884|FG000|Overall Study|Adverse Event|3|||
130418171|NCT02566031|469490885|FG001|Overall Study|Adverse Event|1|||
130418172|NCT02566031|469490884|FG000|Overall Study|Lost to Follow-up|1|||
130418173|NCT02566031|469490885|FG001|Overall Study|Lost to Follow-up|1|||
130418174|NCT00121238|469490887|FG000|Overall Study|disease progression before intervention|1|||
130418175|NCT00121238|469490887|FG000|Overall Study|Protocol Violation|2|||
130418176|NCT01026974|469490896|FG000|Overall Study|Withdrawal by Subject|0|||
130418177|NCT01026974|469490897|FG001|Overall Study|Withdrawal by Subject|1|||
130418178|NCT01026974|469490898|FG002|Overall Study|Withdrawal by Subject|7|||
130418179|NCT01026974|469490899|FG003|Overall Study|Withdrawal by Subject|2|||
130418180|NCT01026974|469490896|FG000|Overall Study|Lost to Follow-up|1|||
130418181|NCT01026974|469490897|FG001|Overall Study|Lost to Follow-up|1|||
130418182|NCT01026974|469490898|FG002|Overall Study|Lost to Follow-up|4|||
130418183|NCT01026974|469490899|FG003|Overall Study|Lost to Follow-up|0|||
130418184|NCT01026974|469490896|FG000|Overall Study|Adverse Event|0|||
130418185|NCT01026974|469490897|FG001|Overall Study|Adverse Event|0|||
130418186|NCT01026974|469490898|FG002|Overall Study|Adverse Event|0|||
130418187|NCT01026974|469490899|FG003|Overall Study|Adverse Event|1|||
130418188|NCT01026974|469490896|FG000|Overall Study|Inappropriate enrollment|0|||
130418189|NCT01026974|469490897|FG001|Overall Study|Inappropriate enrollment|0|||
130418190|NCT01026974|469490898|FG002|Overall Study|Inappropriate enrollment|1|||
130418191|NCT01026974|469490899|FG003|Overall Study|Inappropriate enrollment|0|||
130418192|NCT00325468|469490901|FG000|Overall Study|Adverse Event|1|||
130418193|NCT00325468|469490902|FG001|Overall Study|Adverse Event|1|||
130418194|NCT00325468|469490903|FG002|Overall Study|Adverse Event|0|||
130418195|NCT00325468|469490904|FG003|Overall Study|Adverse Event|5|||
130418196|NCT00325468|469490905|FG004|Overall Study|Adverse Event|1|||
130418197|NCT00325468|469490901|FG000|Overall Study|Death|2|||
130418198|NCT00325468|469490902|FG001|Overall Study|Death|0|||
130418199|NCT00325468|469490903|FG002|Overall Study|Death|2|||
130418200|NCT00325468|469490904|FG003|Overall Study|Death|4|||
130418201|NCT00325468|469490905|FG004|Overall Study|Death|0|||
130418202|NCT00325468|469490901|FG000|Overall Study|Lost to Follow-up|0|||
130418203|NCT00325468|469490902|FG001|Overall Study|Lost to Follow-up|0|||
130418204|NCT00325468|469490903|FG002|Overall Study|Lost to Follow-up|1|||
130418205|NCT00325468|469490904|FG003|Overall Study|Lost to Follow-up|2|||
130418206|NCT00325468|469490905|FG004|Overall Study|Lost to Follow-up|2|||
130418207|NCT00325468|469490901|FG000|Overall Study|Physician Decision|1|||
130418208|NCT00325468|469490902|FG001|Overall Study|Physician Decision|1|||
130418209|NCT00325468|469490903|FG002|Overall Study|Physician Decision|0|||
130418210|NCT00325468|469490904|FG003|Overall Study|Physician Decision|1|||
130418211|NCT00325468|469490905|FG004|Overall Study|Physician Decision|0|||
130418212|NCT00325468|469490901|FG000|Overall Study|Withdrawal by Subject|3|||
130418213|NCT00325468|469490902|FG001|Overall Study|Withdrawal by Subject|1|||
130418214|NCT00325468|469490903|FG002|Overall Study|Withdrawal by Subject|0|||
130418215|NCT00325468|469490904|FG003|Overall Study|Withdrawal by Subject|14|||
130418216|NCT00325468|469490905|FG004|Overall Study|Withdrawal by Subject|4|||
130418217|NCT00325468|469490901|FG000|Overall Study|site closure etc|4|||
130418218|NCT00325468|469490902|FG001|Overall Study|site closure etc|2|||
130418219|NCT00325468|469490903|FG002|Overall Study|site closure etc|1|||
130418220|NCT00325468|469490904|FG003|Overall Study|site closure etc|8|||
130418221|NCT00325468|469490905|FG004|Overall Study|site closure etc|1|||
130418222|NCT03280121|469490906|FG000|Overall Study|Physician Decision|1|||
130418223|NCT03280121|469490906|FG000|Overall Study|Lost to Follow-up|1|||
130418224|NCT03280121|469490906|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
130418225|NCT01314118|469490907|FG000|Overall Study|Adverse Event|9|||
130418226|NCT01314118|469490907|FG000|Overall Study|Progressive disease|27|||
130418227|NCT01314118|469490907|FG000|Overall Study|Physician Decision|11|||
130418228|NCT01314118|469490907|FG000|Overall Study|Death|4|||
130418229|NCT01314118|469490907|FG000|Overall Study|Protocol Violation|5|||
130418230|NCT01314118|469490907|FG000|Overall Study|Withdrawal by Subject|11|||
130418231|NCT01314118|469490907|FG000|Overall Study|Other|2|||
130418232|NCT01314118|469490907|FG000|Overall Study|Ongoing|62|||
130418233|NCT03638141|469490913|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
130418234|NCT05585307|469490914|FG000|Overall Study|Lost to Follow-up|0|||
130418235|NCT05585307|469490915|FG001|Overall Study|Lost to Follow-up|0|||
130418236|NCT05585307|469490916|FG002|Overall Study|Lost to Follow-up|0|||
130418237|NCT05585307|469490917|FG003|Overall Study|Lost to Follow-up|0|||
130418238|NCT05585307|469490918|FG004|Overall Study|Lost to Follow-up|0|||
130418239|NCT05585307|469490919|FG005|Overall Study|Lost to Follow-up|0|||
130418240|NCT05585307|469490920|FG006|Overall Study|Lost to Follow-up|1|||
130418241|NCT05585307|469490921|FG007|Overall Study|Lost to Follow-up|0|||
130418242|NCT04420221|469490925|FG000|Overall Study|Withdrawal by Subject|0|||
130418243|NCT04420221|469490926|FG001|Overall Study|Withdrawal by Subject|0|||
130418244|NCT04420221|469490927|FG002|Overall Study|Withdrawal by Subject|0|||
130418245|NCT04420221|469490928|FG003|Overall Study|Withdrawal by Subject|0|||
130418246|NCT04420221|469490929|FG004|Overall Study|Withdrawal by Subject|0|||
130418247|NCT04420221|469490930|FG005|Overall Study|Withdrawal by Subject|20|||
130418248|NCT04420221|469490931|FG006|Overall Study|Withdrawal by Subject|5|||
130418249|NCT04420221|469490925|FG000|Overall Study|Other|0|||
130418250|NCT04420221|469490926|FG001|Overall Study|Other|0|||
130418251|NCT04420221|469490927|FG002|Overall Study|Other|0|||
130418252|NCT04420221|469490928|FG003|Overall Study|Other|0|||
130418253|NCT04420221|469490929|FG004|Overall Study|Other|0|||
130418254|NCT04420221|469490930|FG005|Overall Study|Other|1|||
130418255|NCT04420221|469490931|FG006|Overall Study|Other|1|||
130418256|NCT04420221|469490925|FG000|Overall Study|Lost to Follow-up|0|||
130418257|NCT04420221|469490926|FG001|Overall Study|Lost to Follow-up|0|||
130418258|NCT04420221|469490927|FG002|Overall Study|Lost to Follow-up|0|||
130418259|NCT04420221|469490928|FG003|Overall Study|Lost to Follow-up|0|||
130418260|NCT04420221|469490929|FG004|Overall Study|Lost to Follow-up|0|||
130418261|NCT04420221|469490930|FG005|Overall Study|Lost to Follow-up|3|||
130418262|NCT04420221|469490931|FG006|Overall Study|Lost to Follow-up|2|||
130418263|NCT04420221|469490925|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
130418264|NCT04420221|469490926|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
130418265|NCT04420221|469490927|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
130418266|NCT04420221|469490928|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
130418267|NCT04420221|469490929|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
130418268|NCT04420221|469490930|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
130418269|NCT04420221|469490931|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
130418270|NCT02513563|469490932|FG000|Overall Study|Death|4|||
130418271|NCT02513563|469490932|FG000|Overall Study|Withdrawal by Subject|4|||
130418272|NCT02513563|469490932|FG000|Overall Study|Physician Decision|1|||
130418273|NCT01556438|469490935|FG000|Overall Study|Adverse Event|4|||
130418274|NCT01556438|469490936|FG001|Overall Study|Adverse Event|2|||
130418275|NCT01556438|469490935|FG000|Overall Study|Sponsor Decision|0|||
130418276|NCT01556438|469490936|FG001|Overall Study|Sponsor Decision|2|||
130418277|NCT01556438|469490935|FG000|Overall Study|Progressive Disease|0|||
130418278|NCT01556438|469490936|FG001|Overall Study|Progressive Disease|6|||
130418279|NCT01556438|469490935|FG000|Overall Study|Death|0|||
130418280|NCT01556438|469490936|FG001|Overall Study|Death|1|||
130418281|NCT03695172|469490937|FG000|Overall Study|Withdrawal by Subject|1|||
130418282|NCT03695172|469490938|FG001|Overall Study|Withdrawal by Subject|1|||
130418283|NCT03695172|469490939|FG002|Overall Study|Withdrawal by Subject|0|||
130418284|NCT02734212|469490943|FG000|Overall Study|Lost to Follow-up|5|||
130418285|NCT02734212|469490944|FG001|Overall Study|Lost to Follow-up|10|||
130418286|NCT00688636|469490947|FG000|Overall Study|Adverse Event|2|||
130418287|NCT00688636|469490948|FG001|Overall Study|Adverse Event|1|||
130418288|NCT04053764|469490949|FG000|Overall Study|Withdrawal by Subject|6|||
130418289|NCT04053764|469490950|FG001|Overall Study|Withdrawal by Subject|2|||
130418290|NCT04053764|469490949|FG000|Overall Study|Physician Decision|2|||
130418291|NCT04053764|469490950|FG001|Overall Study|Physician Decision|1|||
130418292|NCT04053764|469490949|FG000|Overall Study|Adverse Event|1|||
130418293|NCT04053764|469490950|FG001|Overall Study|Adverse Event|0|||
130418294|NCT04053764|469490949|FG000|Overall Study|Pregnancy|1|||
130418295|NCT04053764|469490950|FG001|Overall Study|Pregnancy|0|||
130418296|NCT02384954|469490954|FG000|Phase 1|Progressive Disease|2|||
130418297|NCT02384954|469490955|FG001|Phase 1|Progressive Disease|0|||
130418298|NCT02384954|469490956|FG002|Phase 1|Progressive Disease|1|||
130418299|NCT02384954|469490957|FG003|Phase 1|Progressive Disease|1|||
130418300|NCT02384954|469490958|FG004|Phase 1|Progressive Disease|0|||
130418301|NCT02384954|469490959|FG005|Phase 1|Progressive Disease|0|||
130418302|NCT02384954|469490960|FG006|Phase 1|Progressive Disease|0|||
130418303|NCT02384954|469490961|FG007|Phase 1|Progressive Disease|0|||
130418304|NCT02384954|469490962|FG008|Phase 1|Progressive Disease|0|||
130418305|NCT02384954|469490954|FG000|Phase 1|Adverse Event|0|||
130418306|NCT02384954|469490955|FG001|Phase 1|Adverse Event|0|||
130418307|NCT02384954|469490956|FG002|Phase 1|Adverse Event|1|||
130418308|NCT02384954|469490957|FG003|Phase 1|Adverse Event|0|||
130418309|NCT02384954|469490958|FG004|Phase 1|Adverse Event|0|||
130418310|NCT02384954|469490959|FG005|Phase 1|Adverse Event|0|||
130418311|NCT02384954|469490960|FG006|Phase 1|Adverse Event|0|||
130418312|NCT02384954|469490961|FG007|Phase 1|Adverse Event|0|||
130418313|NCT02384954|469490962|FG008|Phase 1|Adverse Event|0|||
130418314|NCT02384954|469490954|FG000|Phase 2|Progressive Disease|0|||
130418315|NCT02384954|469490955|FG001|Phase 2|Progressive Disease|0|||
130418316|NCT02384954|469490956|FG002|Phase 2|Progressive Disease|0|||
130418317|NCT02384954|469490957|FG003|Phase 2|Progressive Disease|0|||
130418318|NCT02384954|469490958|FG004|Phase 2|Progressive Disease|0|||
130418319|NCT02384954|469490959|FG005|Phase 2|Progressive Disease|0|||
130418320|NCT02384954|469490960|FG006|Phase 2|Progressive Disease|0|||
130418321|NCT02384954|469490961|FG007|Phase 2|Progressive Disease|1|||
130418322|NCT02384954|469490962|FG008|Phase 2|Progressive Disease|2|||
130418323|NCT02384954|469490954|FG000|Phase 2|Adverse Event|0|||
130418324|NCT02384954|469490955|FG001|Phase 2|Adverse Event|0|||
130418325|NCT02384954|469490956|FG002|Phase 2|Adverse Event|0|||
130418326|NCT02384954|469490957|FG003|Phase 2|Adverse Event|0|||
130418327|NCT02384954|469490958|FG004|Phase 2|Adverse Event|0|||
130418328|NCT02384954|469490959|FG005|Phase 2|Adverse Event|0|||
130418329|NCT02384954|469490960|FG006|Phase 2|Adverse Event|0|||
130418330|NCT02384954|469490961|FG007|Phase 2|Adverse Event|1|||
130418331|NCT02384954|469490962|FG008|Phase 2|Adverse Event|1|||
130418332|NCT02384954|469490954|FG000|Phase 2|Failure to meet continuation criteria|0|||
130418333|NCT02384954|469490955|FG001|Phase 2|Failure to meet continuation criteria|0|||
130418334|NCT02384954|469490956|FG002|Phase 2|Failure to meet continuation criteria|0|||
130418335|NCT02384954|469490957|FG003|Phase 2|Failure to meet continuation criteria|0|||
130418336|NCT02384954|469490958|FG004|Phase 2|Failure to meet continuation criteria|0|||
130418337|NCT02384954|469490959|FG005|Phase 2|Failure to meet continuation criteria|0|||
130418338|NCT02384954|469490960|FG006|Phase 2|Failure to meet continuation criteria|0|||
130418339|NCT02384954|469490961|FG007|Phase 2|Failure to meet continuation criteria|1|||
130418340|NCT02384954|469490962|FG008|Phase 2|Failure to meet continuation criteria|0|||
130418341|NCT01910129|469490967|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
130418342|NCT01910129|469490968|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
130418343|NCT01910129|469490969|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
130418344|NCT01910129|469490967|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
130418345|NCT01910129|469490968|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
130418346|NCT01910129|469490969|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
130418347|NCT03150056|469490970|FG000|Overall Study|Withdrawal by Subject|0|||
130418348|NCT03150056|469490971|FG001|Overall Study|Withdrawal by Subject|0|||
130418349|NCT03150056|469490972|FG002|Overall Study|Withdrawal by Subject|0|||
130418350|NCT03150056|469490973|FG003|Overall Study|Withdrawal by Subject|0|||
130418351|NCT03150056|469490974|FG004|Overall Study|Withdrawal by Subject|0|||
130418352|NCT03150056|469490975|FG005|Overall Study|Withdrawal by Subject|2|||
130418353|NCT03150056|469490970|FG000|Overall Study|Study terminated by Sponsor|1|||
130418354|NCT03150056|469490971|FG001|Overall Study|Study terminated by Sponsor|3|||
130418355|NCT03150056|469490972|FG002|Overall Study|Study terminated by Sponsor|1|||
130418356|NCT03150056|469490973|FG003|Overall Study|Study terminated by Sponsor|1|||
130418357|NCT03150056|469490974|FG004|Overall Study|Study terminated by Sponsor|5|||
130418358|NCT03150056|469490975|FG005|Overall Study|Study terminated by Sponsor|6|||
130418359|NCT03150056|469490970|FG000|Overall Study|Death|9|||
130418360|NCT03150056|469490971|FG001|Overall Study|Death|2|||
130418361|NCT03150056|469490972|FG002|Overall Study|Death|2|||
130418362|NCT03150056|469490973|FG003|Overall Study|Death|7|||
130418363|NCT03150056|469490974|FG004|Overall Study|Death|8|||
130418364|NCT03150056|469490975|FG005|Overall Study|Death|10|||
130418365|NCT03595904|469490976|FG000|Overall Study|Protocol Violation|3|||
130418366|NCT03595904|469490977|FG001|Overall Study|Protocol Violation|1|||
130418367|NCT03595904|469490976|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
130418368|NCT03595904|469490977|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
130418369|NCT03595904|469490976|FG000|Overall Study|Insurance complications|1|||
130418370|NCT03595904|469490977|FG001|Overall Study|Insurance complications|0|||
130418371|NCT03595904|469490976|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
130418372|NCT03595904|469490977|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
130418373|NCT01581281|469490978|FG000|Overall Study|Early Study Closure|15|||
130418374|NCT01581281|469490979|FG001|Overall Study|Early Study Closure|6|||
130418375|NCT01581281|469490980|FG002|Overall Study|Early Study Closure|12|||
130418376|NCT02187991|469490981|FG000|Overall Study|Adverse Event|13|||
130418377|NCT02187991|469490982|FG001|Overall Study|Adverse Event|14|||
130418378|NCT02187991|469490983|FG002|Overall Study|Adverse Event|3|||
130418379|NCT02187991|469490984|FG003|Overall Study|Adverse Event|2|||
130418380|NCT02187991|469490981|FG000|Overall Study|Withdrawal by Subject|9|||
130418381|NCT02187991|469490982|FG001|Overall Study|Withdrawal by Subject|6|||
130418382|NCT02187991|469490983|FG002|Overall Study|Withdrawal by Subject|3|||
130418383|NCT02187991|469490984|FG003|Overall Study|Withdrawal by Subject|2|||
130418384|NCT02187991|469490981|FG000|Overall Study|Physician Decision|4|||
130418385|NCT02187991|469490982|FG001|Overall Study|Physician Decision|4|||
130418386|NCT02187991|469490983|FG002|Overall Study|Physician Decision|0|||
130418387|NCT02187991|469490984|FG003|Overall Study|Physician Decision|2|||
130418388|NCT02187991|469490981|FG000|Overall Study|Other, unrelated complication|7|||
130418389|NCT02187991|469490982|FG001|Overall Study|Other, unrelated complication|1|||
130418390|NCT02187991|469490983|FG002|Overall Study|Other, unrelated complication|1|||
130418391|NCT02187991|469490984|FG003|Overall Study|Other, unrelated complication|2|||
130418392|NCT02187991|469490981|FG000|Overall Study|Death|1|||
130418393|NCT02187991|469490982|FG001|Overall Study|Death|3|||
130418394|NCT02187991|469490983|FG002|Overall Study|Death|0|||
130418395|NCT02187991|469490984|FG003|Overall Study|Death|0|||
130418396|NCT01392560|469490985|FG000|Overall Study|Adverse Event|2|||
130418397|NCT01392560|469490985|FG000|Overall Study|not entered|8|||
130418398|NCT01392560|469490985|FG000|Overall Study|discontinued during placebo run-in|2|||
130418399|NCT00700401|469490990|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
130418400|NCT00700401|469490990|FG000|Overall Study|Adverse Event|5|||
130418401|NCT00700401|469490990|FG000|Overall Study|Refused Treatment|2|||
130418402|NCT00700401|469490990|FG000|Overall Study|Lost to Follow-up|1|||
130418403|NCT00700401|469490990|FG000|Overall Study|Treatment never started|1|||
130418404|NCT00700401|469490990|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
130418405|NCT00700401|469490990|FG000|Overall Study|Withdrawal by Subject|2|||
130418406|NCT03273946|469490991|FG000|Overall Study|Withdrawal by Subject|5|||
130418407|NCT03273946|469490991|FG000|Overall Study|Unwillingness of the guardian|1|||
130418408|NCT03273946|469490991|FG000|Overall Study|Participant refused to use the drug|2|||
130418409|NCT03273946|469490991|FG000|Overall Study|Participant relative refused to use drug|1|||
130418410|NCT00295750|469490994|FG000|Overall Study|Adverse Event|19|||
130418411|NCT00295750|469490995|FG001|Overall Study|Adverse Event|15|||
130418412|NCT00295750|469490996|FG002|Overall Study|Adverse Event|12|||
130418413|NCT00295750|469490994|FG000|Overall Study|Lack of Efficacy|1|||
130418414|NCT00295750|469490995|FG001|Overall Study|Lack of Efficacy|1|||
130418415|NCT00295750|469490996|FG002|Overall Study|Lack of Efficacy|0|||
130418416|NCT00295750|469490994|FG000|Overall Study|Lost to Follow-up|1|||
130418417|NCT00295750|469490995|FG001|Overall Study|Lost to Follow-up|4|||
130418418|NCT00295750|469490996|FG002|Overall Study|Lost to Follow-up|1|||
130418419|NCT00295750|469490994|FG000|Overall Study|Taking prohibited therapy|2|||
130475428|NCT03338790|469708553|FG003|Overall Study|Participant request to discontinue study treatment|1|||
130475429|NCT03338790|469708550|FG000|Overall Study|Poor/non-compliance|0|||
130475430|NCT03338790|469708551|FG001|Overall Study|Poor/non-compliance|1|||
130475431|NCT03338790|469708552|FG002|Overall Study|Poor/non-compliance|0|||
130418420|NCT00295750|469490995|FG001|Overall Study|Taking prohibited therapy|3|||
130418421|NCT00295750|469490996|FG002|Overall Study|Taking prohibited therapy|2|||
130418422|NCT00295750|469490994|FG000|Overall Study|Administrative errors|2|||
130418423|NCT00295750|469490995|FG001|Overall Study|Administrative errors|4|||
130418424|NCT00295750|469490996|FG002|Overall Study|Administrative errors|5|||
130418425|NCT00295750|469490994|FG000|Overall Study|Trial drug errors|1|||
130418426|NCT00295750|469490995|FG001|Overall Study|Trial drug errors|1|||
130418427|NCT00295750|469490996|FG002|Overall Study|Trial drug errors|0|||
130418428|NCT00295750|469490994|FG000|Overall Study|Disease progression|2|||
130418429|NCT00295750|469490995|FG001|Overall Study|Disease progression|1|||
130418430|NCT00295750|469490996|FG002|Overall Study|Disease progression|0|||
130418431|NCT00295750|469490994|FG000|Overall Study|Personal reasons|0|||
130418432|NCT00295750|469490995|FG001|Overall Study|Personal reasons|1|||
130418433|NCT00295750|469490996|FG002|Overall Study|Personal reasons|0|||
130418434|NCT00295750|469490994|FG000|Overall Study|Randomized but never received trial drug|4|||
130418435|NCT00295750|469490995|FG001|Overall Study|Randomized but never received trial drug|3|||
130418436|NCT00295750|469490996|FG002|Overall Study|Randomized but never received trial drug|3|||
130418437|NCT00295750|469490994|FG000|Overall Study|Withdrawal by Subject|9|||
130418438|NCT00295750|469490995|FG001|Overall Study|Withdrawal by Subject|4|||
130418439|NCT00295750|469490996|FG002|Overall Study|Withdrawal by Subject|7|||
130475432|NCT03338790|469708553|FG003|Overall Study|Poor/non-compliance|0|||
130475433|NCT03338790|469708550|FG000|Overall Study|Participant withdrew consent|1|||
130475434|NCT03338790|469708551|FG001|Overall Study|Participant withdrew consent|0|||
130475435|NCT03338790|469708552|FG002|Overall Study|Participant withdrew consent|1|||
130475436|NCT03338790|469708553|FG003|Overall Study|Participant withdrew consent|1|||
130475437|NCT03338790|469708550|FG000|Overall Study|Other reasons|0|||
130475438|NCT03338790|469708551|FG001|Overall Study|Other reasons|5|||
130475439|NCT03338790|469708552|FG002|Overall Study|Other reasons|0|||
130475440|NCT03338790|469708553|FG003|Overall Study|Other reasons|2|||
130475441|NCT03338790|469708550|FG000|Overall Study|Not reported|0|||
130475442|NCT03338790|469708551|FG001|Overall Study|Not reported|0|||
130475443|NCT03338790|469708552|FG002|Overall Study|Not reported|1|||
130475444|NCT03338790|469708553|FG003|Overall Study|Not reported|0|||
130475445|NCT03338790|469708550|FG000|Overall Study|Completed treatment period|1|||
130475446|NCT03338790|469708551|FG001|Overall Study|Completed treatment period|2|||
130475447|NCT03338790|469708552|FG002|Overall Study|Completed treatment period|0|||
130418440|NCT00295750|469490994|FG000|Overall Study|Protocol Violation|2|||
130418441|NCT00295750|469490995|FG001|Overall Study|Protocol Violation|4|||
130418442|NCT00295750|469490996|FG002|Overall Study|Protocol Violation|2|||
130418443|NCT02199028|469491002|FG000|Week 1|Adverse Event|1|||
130418444|NCT02199028|469491003|FG001|Week 1|Adverse Event|0|||
130418445|NCT02199028|469491002|FG000|Week 3|Adverse Event|1|||
130418446|NCT02199028|469491003|FG001|Week 3|Adverse Event|0|||
130418447|NCT04370054|469491004|FG000|Treatment Phase|Lost to Follow-up|1|||
130475448|NCT03338790|469708553|FG003|Overall Study|Completed treatment period|0|||
130475449|NCT04588298|469708560|FG000|Overall Study|Adverse Event|0|||
130475450|NCT04588298|469708561|FG001|Overall Study|Adverse Event|0|||
130475451|NCT04588298|469708562|FG002|Overall Study|Adverse Event|1|||
130475452|NCT04588298|469708563|FG003|Overall Study|Adverse Event|0|||
130475453|NCT04588298|469708564|FG004|Overall Study|Adverse Event|2|||
130475454|NCT04588298|469708560|FG000|Overall Study|Withdrawal by Subject|1|||
130475455|NCT04588298|469708561|FG001|Overall Study|Withdrawal by Subject|0|||
130475456|NCT04588298|469708562|FG002|Overall Study|Withdrawal by Subject|0|||
130475457|NCT04588298|469708563|FG003|Overall Study|Withdrawal by Subject|1|||
130475458|NCT04588298|469708564|FG004|Overall Study|Withdrawal by Subject|0|||
130475459|NCT05592418|469708565|FG000|Overall Study|Adverse Event|1|||
130475460|NCT05592418|469708566|FG001|Overall Study|Adverse Event|0|||
130418448|NCT04370054|469491004|FG000|Treatment Phase|Withdrawal by Subject|1|||
130418449|NCT04370054|469491004|FG000|Follow-Up Phase|Ongoing|75|||
130418450|NCT00722761|469491005|FG000|Overall Study|Lost to Follow-up|1|||
130418451|NCT00722761|469491006|FG001|Overall Study|Lost to Follow-up|4|||
130418452|NCT00722761|469491005|FG000|Overall Study|Withdrawal by Subject|5|||
130418453|NCT00722761|469491006|FG001|Overall Study|Withdrawal by Subject|2|||
130418454|NCT06273774|469491008|FG000|Overall Study|Participant was out of state.|0|||
130418455|NCT06273774|469491009|FG001|Overall Study|Participant was out of state.|0|||
130418456|NCT06273774|469491010|FG002|Overall Study|Participant was out of state.|0|||
130418457|NCT06273774|469491011|FG003|Overall Study|Participant was out of state.|0|||
130418458|NCT06273774|469491012|FG004|Overall Study|Participant was out of state.|0|||
130418459|NCT06273774|469491013|FG005|Overall Study|Participant was out of state.|1|||
130418460|NCT06273774|469491008|FG000|Overall Study|Lost to Follow-up|0|||
130418461|NCT06273774|469491009|FG001|Overall Study|Lost to Follow-up|0|||
130418462|NCT06273774|469491010|FG002|Overall Study|Lost to Follow-up|0|||
130418463|NCT06273774|469491011|FG003|Overall Study|Lost to Follow-up|0|||
130418464|NCT06273774|469491012|FG004|Overall Study|Lost to Follow-up|1|||
130418465|NCT06273774|469491013|FG005|Overall Study|Lost to Follow-up|0|||
130418466|NCT05819749|469491018|FG000|Overall Study|Lost to Follow-up|1|||
130418467|NCT00924287|469493394|FG000|Overall Study|Death|1|||
130418468|NCT01625897|469493395|FG000|Overall Study|Adverse Event|27|||
130418469|NCT01625897|469493396|FG001|Overall Study|Adverse Event|10|||
130418470|NCT01625897|469493395|FG000|Overall Study|Physician Decision|0|||
130418471|NCT01625897|469493396|FG001|Overall Study|Physician Decision|1|||
130418472|NCT01625897|469493395|FG000|Overall Study|Withdrawal by Subject|25|||
130418473|NCT01625897|469493396|FG001|Overall Study|Withdrawal by Subject|3|||
130418474|NCT01912612|469493399|FG000|Overall Study|Adverse Event|4|||
130418475|NCT01912612|469493400|FG001|Overall Study|Adverse Event|0|||
130418476|NCT01912612|469493401|FG002|Overall Study|Adverse Event|0|||
130418477|NCT01912612|469493399|FG000|Overall Study|Withdrew consent|1|||
130418478|NCT01912612|469493400|FG001|Overall Study|Withdrew consent|0|||
130418479|NCT01912612|469493401|FG002|Overall Study|Withdrew consent|0|||
130418480|NCT01912612|469493399|FG000|Overall Study|Study design change|0|||
130418481|NCT01912612|469493400|FG001|Overall Study|Study design change|0|||
130418482|NCT01912612|469493401|FG002|Overall Study|Study design change|3|||
130418483|NCT02008890|469493403|FG000|Period 1|Withdrawal by Subject|7|||
130418484|NCT02008890|469493404|FG001|Period 1|Withdrawal by Subject|7|||
130418485|NCT02008890|469493405|FG002|Period 1|Withdrawal by Subject|5|||
130418486|NCT02008890|469493406|FG003|Period 1|Withdrawal by Subject|0|||
130418487|NCT02008890|469493407|FG004|Period 1|Withdrawal by Subject|0|||
130418488|NCT02008890|469493403|FG000|Period 1|Pregnancy|1|||
130418489|NCT02008890|469493404|FG001|Period 1|Pregnancy|0|||
130418490|NCT02008890|469493405|FG002|Period 1|Pregnancy|0|||
130418491|NCT02008890|469493406|FG003|Period 1|Pregnancy|0|||
130418492|NCT02008890|469493407|FG004|Period 1|Pregnancy|0|||
130418493|NCT02008890|469493403|FG000|Period 1|Physician Decision|1|||
130418494|NCT02008890|469493404|FG001|Period 1|Physician Decision|0|||
130418495|NCT02008890|469493405|FG002|Period 1|Physician Decision|1|||
130418496|NCT02008890|469493406|FG003|Period 1|Physician Decision|0|||
130418497|NCT02008890|469493407|FG004|Period 1|Physician Decision|0|||
130418498|NCT02008890|469493403|FG000|Period 1|Adverse Event|6|||
130727264|NCT02883049|470625432|FG008|Post Induction|Ineligible|0|||
130727265|NCT02883049|470625433|FG009|Post Induction|Ineligible|0|||
130418499|NCT02008890|469493404|FG001|Period 1|Adverse Event|8|||
130418500|NCT02008890|469493405|FG002|Period 1|Adverse Event|6|||
130418501|NCT02008890|469493406|FG003|Period 1|Adverse Event|0|||
130418502|NCT02008890|469493407|FG004|Period 1|Adverse Event|0|||
130418503|NCT02008890|469493403|FG000|Period 2|Adverse Event|12|||
130418504|NCT02008890|469493404|FG001|Period 2|Adverse Event|7|||
130418505|NCT02008890|469493405|FG002|Period 2|Adverse Event|0|||
130418506|NCT02008890|469493406|FG003|Period 2|Adverse Event|5|||
130418507|NCT02008890|469493407|FG004|Period 2|Adverse Event|5|||
130418508|NCT02008890|469493403|FG000|Period 2|Withdrawal by Subject|11|||
130418509|NCT02008890|469493404|FG001|Period 2|Withdrawal by Subject|8|||
130418510|NCT02008890|469493405|FG002|Period 2|Withdrawal by Subject|0|||
130418511|NCT02008890|469493406|FG003|Period 2|Withdrawal by Subject|7|||
130418512|NCT02008890|469493407|FG004|Period 2|Withdrawal by Subject|2|||
130418513|NCT02008890|469493403|FG000|Period 2|Physician Decision|4|||
130418514|NCT02008890|469493404|FG001|Period 2|Physician Decision|0|||
130418515|NCT02008890|469493405|FG002|Period 2|Physician Decision|0|||
130418516|NCT02008890|469493406|FG003|Period 2|Physician Decision|2|||
130418517|NCT02008890|469493407|FG004|Period 2|Physician Decision|1|||
130418518|NCT02008890|469493403|FG000|Period 2|Lost to Follow-up|0|||
130418519|NCT02008890|469493404|FG001|Period 2|Lost to Follow-up|0|||
130418520|NCT02008890|469493405|FG002|Period 2|Lost to Follow-up|1|||
130418521|NCT02008890|469493406|FG003|Period 2|Lost to Follow-up|0|||
130418522|NCT02008890|469493407|FG004|Period 2|Lost to Follow-up|0|||
130418523|NCT02008890|469493403|FG000|Extension Period|Withdrawal by Subject|3|||
130418524|NCT02008890|469493404|FG001|Extension Period|Withdrawal by Subject|2|||
130418525|NCT02008890|469493405|FG002|Extension Period|Withdrawal by Subject|0|||
130418526|NCT02008890|469493406|FG003|Extension Period|Withdrawal by Subject|4|||
130418527|NCT02008890|469493407|FG004|Extension Period|Withdrawal by Subject|2|||
130418528|NCT02008890|469493403|FG000|Extension Period|Lost to Follow-up|1|||
130418529|NCT02008890|469493404|FG001|Extension Period|Lost to Follow-up|0|||
130418530|NCT02008890|469493405|FG002|Extension Period|Lost to Follow-up|0|||
130418531|NCT02008890|469493406|FG003|Extension Period|Lost to Follow-up|0|||
130418532|NCT02008890|469493407|FG004|Extension Period|Lost to Follow-up|0|||
130418533|NCT02008890|469493403|FG000|Extension Period|Adverse Event|1|||
130418534|NCT02008890|469493404|FG001|Extension Period|Adverse Event|3|||
130418535|NCT02008890|469493405|FG002|Extension Period|Adverse Event|0|||
130418536|NCT02008890|469493406|FG003|Extension Period|Adverse Event|0|||
130418537|NCT02008890|469493407|FG004|Extension Period|Adverse Event|2|||
130418538|NCT02207816|469493408|FG000|Overall Study|Serious Adverse Event|0|||
130418539|NCT02207816|469493409|FG001|Overall Study|Serious Adverse Event|5|||
130418540|NCT02207816|469493410|FG002|Overall Study|Serious Adverse Event|2|||
130418541|NCT02207816|469493408|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130418542|NCT02207816|469493409|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
130418543|NCT02207816|469493410|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130418544|NCT02207816|469493408|FG000|Overall Study|Withdrawal by Subject|4|||
130418545|NCT02207816|469493409|FG001|Overall Study|Withdrawal by Subject|9|||
130418546|NCT02207816|469493410|FG002|Overall Study|Withdrawal by Subject|7|||
130418547|NCT02207816|469493408|FG000|Overall Study|Migrated/Moved From Study Area|41|||
130418548|NCT02207816|469493409|FG001|Overall Study|Migrated/Moved From Study Area|60|||
130418549|NCT02207816|469493410|FG002|Overall Study|Migrated/Moved From Study Area|51|||
130418550|NCT02207816|469493408|FG000|Overall Study|Lost to Follow-up|3|||
130418551|NCT02207816|469493409|FG001|Overall Study|Lost to Follow-up|9|||
130418552|NCT02207816|469493410|FG002|Overall Study|Lost to Follow-up|1|||
130418553|NCT02207816|469493408|FG000|Overall Study|Other|1|||
130418554|NCT02207816|469493409|FG001|Overall Study|Other|2|||
130418555|NCT02207816|469493410|FG002|Overall Study|Other|4|||
130418556|NCT00765843|469493413|FG000|Overall Study|Lost to Follow-up|1|||
130418557|NCT00765843|469493414|FG001|Overall Study|Lost to Follow-up|3|||
130418558|NCT00765843|469493415|FG002|Overall Study|Lost to Follow-up|2|||
130418559|NCT00765843|469493413|FG000|Overall Study|did not return to receive intervention|0|||
130418560|NCT00765843|469493414|FG001|Overall Study|did not return to receive intervention|1|||
130418561|NCT00765843|469493415|FG002|Overall Study|did not return to receive intervention|0|||
130418562|NCT00765843|469493413|FG000|Overall Study|Adverse Event|0|||
130418563|NCT00765843|469493414|FG001|Overall Study|Adverse Event|0|||
130418564|NCT00765843|469493415|FG002|Overall Study|Adverse Event|1|||
130418565|NCT02277106|469493416|FG000|Stage 2|Adverse Event|0|||
130418566|NCT02277106|469493417|FG001|Stage 2|Adverse Event|0|||
130418567|NCT02277106|469493418|FG002|Stage 2|Adverse Event|1|||
130418568|NCT01064739|469493419|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
130418569|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
130418570|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
130418571|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
130418572|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
130418573|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
130418574|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
130418575|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
130418576|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
130418577|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
130418578|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
130418579|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
130418580|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
130418581|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
130418582|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
130418583|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
130418584|NCT01571362|469493422|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
130418585|NCT01571362|469493423|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
130418586|NCT01571362|469493424|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
130418587|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130418588|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
130418589|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
130475461|NCT05592418|469708565|FG000|Overall Study|Lost to Follow-up|1|||
130475462|NCT05592418|469708566|FG001|Overall Study|Lost to Follow-up|3|||
130475463|NCT05592418|469708565|FG000|Overall Study|Withdrawal by Subject|2|||
130475464|NCT05592418|469708566|FG001|Overall Study|Withdrawal by Subject|7|||
130475465|NCT05569252|469708570|FG000|Overall Study|Adverse event (central vision loss)|1|||
130475466|NCT05569252|469708571|FG001|Overall Study|Adverse event (central vision loss)|0|||
130475467|NCT05569252|469708572|FG002|Overall Study|Adverse event (central vision loss)|0|||
130475468|NCT05569252|469708573|FG003|Overall Study|Adverse event (central vision loss)|0|||
130475469|NCT03665597|469708574|FG000|Period 1|Adverse Event|1|||
130564167|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
130564168|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
130564169|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
130564170|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
130418590|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130418591|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
130418592|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
130418593|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130418594|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Adverse Event|9|||
130418595|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Adverse Event|14|||
130418596|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130418597|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
130418598|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
130418599|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
130418600|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
130418601|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
130418602|NCT01571362|469493422|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
130418603|NCT01571362|469493423|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
130418604|NCT01571362|469493424|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
130418605|NCT01669629|469493426|FG000|Period 1|protocol deviation|1|||
130418606|NCT01669629|469493427|FG001|Period 1|protocol deviation|2|||
130418607|NCT01221597|469493428|FG000|Overall Study|Adverse Event|4|||
130418608|NCT01221597|469493429|FG001|Overall Study|Adverse Event|1|||
130418609|NCT01221597|469493428|FG000|Overall Study|Withdrawal by Subject|20|||
130418610|NCT01221597|469493429|FG001|Overall Study|Withdrawal by Subject|6|||
130418611|NCT01221597|469493428|FG000|Overall Study|Lost to Follow-up|6|||
130418612|NCT01221597|469493429|FG001|Overall Study|Lost to Follow-up|5|||
130418613|NCT01221597|469493428|FG000|Overall Study|Protocol Violation|1|||
130564171|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
130564172|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
130564173|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
130564174|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
130564175|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
130564176|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
130564177|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
130564178|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Death|2|||
130564179|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Death|0|||
130564180|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Death|2|||
130564181|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Death|0|||
130564182|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
130564183|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
130564184|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
130418614|NCT01221597|469493429|FG001|Overall Study|Protocol Violation|0|||
130418615|NCT01221597|469493428|FG000|Overall Study|Other|3|||
130418616|NCT01221597|469493429|FG001|Overall Study|Other|4|||
130564185|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
130564186|NCT00262522|470032139|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
130564187|NCT00262522|470032140|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
130564188|NCT00262522|470032141|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
130564189|NCT00262522|470032142|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
130564190|NCT04814823|470032143|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
130564191|NCT03462719|470032144|FG000|Overall Study|Withdrawal by Subject|4|||
130564192|NCT03462719|470032145|FG001|Overall Study|Withdrawal by Subject|3|||
130564193|NCT03462719|470032144|FG000|Overall Study|Ongoing|87|||
130564194|NCT03462719|470032145|FG001|Overall Study|Ongoing|72|||
130564195|NCT03740165|470032146|FG000|Overall Study|Death|232|||
130564196|NCT03740165|470032147|FG001|Overall Study|Death|242|||
130564197|NCT03740165|470032148|FG002|Overall Study|Death|229|||
130564198|NCT03740165|470032146|FG000|Overall Study|Lost to Follow-up|0|||
130564199|NCT03740165|470032147|FG001|Overall Study|Lost to Follow-up|0|||
130564200|NCT03740165|470032148|FG002|Overall Study|Lost to Follow-up|1|||
130564201|NCT03740165|470032146|FG000|Overall Study|Withdrawal by Subject|7|||
130564202|NCT03740165|470032147|FG001|Overall Study|Withdrawal by Subject|4|||
130564203|NCT03740165|470032148|FG002|Overall Study|Withdrawal by Subject|3|||
130564204|NCT03740165|470032146|FG000|Overall Study|Ongoing in Study|216|||
130564205|NCT03740165|470032147|FG001|Overall Study|Ongoing in Study|212|||
130418617|NCT01221597|469493428|FG000|Overall Study|Death|2|||
130418618|NCT01221597|469493429|FG001|Overall Study|Death|0|||
130418619|NCT04642638|469493432|FG000|Overall Study|Withdrawal by Subject|23|||
130418620|NCT04642638|469493433|FG001|Overall Study|Withdrawal by Subject|29|||
130418621|NCT04642638|469493434|FG002|Overall Study|Withdrawal by Subject|9|||
130418622|NCT04642638|469493435|FG003|Overall Study|Withdrawal by Subject|7|||
130564206|NCT03740165|470032148|FG002|Overall Study|Ongoing in Study|221|||
130475470|NCT03665597|469708575|FG001|Period 1|Adverse Event|0|||
130475471|NCT03665597|469708576|FG002|Period 1|Adverse Event|0|||
130475472|NCT03665597|469708577|FG003|Period 1|Adverse Event|1|||
130475473|NCT03665597|469708578|FG004|Period 1|Adverse Event|0|||
130475474|NCT03665597|469708579|FG005|Period 1|Adverse Event|0|||
130475475|NCT03665597|469708580|FG006|Period 1|Adverse Event|0|||
130475476|NCT03665597|469708574|FG000|Period 1|Screen Failure|0|||
130475477|NCT03665597|469708575|FG001|Period 1|Screen Failure|0|||
130475478|NCT03665597|469708576|FG002|Period 1|Screen Failure|0|||
130475479|NCT03665597|469708577|FG003|Period 1|Screen Failure|1|||
130475480|NCT03665597|469708578|FG004|Period 1|Screen Failure|0|||
130475481|NCT03665597|469708579|FG005|Period 1|Screen Failure|0|||
130475482|NCT03665597|469708580|FG006|Period 1|Screen Failure|0|||
130475483|NCT03665597|469708574|FG000|Period 1|Death|0|||
130475484|NCT03665597|469708575|FG001|Period 1|Death|0|||
130475485|NCT03665597|469708576|FG002|Period 1|Death|0|||
130475486|NCT03665597|469708577|FG003|Period 1|Death|0|||
130475487|NCT03665597|469708578|FG004|Period 1|Death|0|||
130475488|NCT03665597|469708579|FG005|Period 1|Death|0|||
130475489|NCT03665597|469708580|FG006|Period 1|Death|45|||
130475490|NCT03665597|469708574|FG000|Period 1|Withdrawal by Subject|0|||
130475491|NCT03665597|469708575|FG001|Period 1|Withdrawal by Subject|0|||
130475492|NCT03665597|469708576|FG002|Period 1|Withdrawal by Subject|0|||
130475493|NCT03665597|469708577|FG003|Period 1|Withdrawal by Subject|0|||
130475494|NCT03665597|469708578|FG004|Period 1|Withdrawal by Subject|0|||
130475495|NCT03665597|469708579|FG005|Period 1|Withdrawal by Subject|0|||
130475496|NCT03665597|469708580|FG006|Period 1|Withdrawal by Subject|5|||
130475497|NCT03665597|469708574|FG000|Period 2|Adverse Event|0|||
130475498|NCT03665597|469708575|FG001|Period 2|Adverse Event|0|||
130475499|NCT03665597|469708576|FG002|Period 2|Adverse Event|0|||
130475500|NCT03665597|469708577|FG003|Period 2|Adverse Event|0|||
130475501|NCT03665597|469708578|FG004|Period 2|Adverse Event|0|||
130475502|NCT03665597|469708579|FG005|Period 2|Adverse Event|1|||
130475503|NCT03665597|469708580|FG006|Period 2|Adverse Event|0|||
130475504|NCT03665597|469708574|FG000|Period 3|Adverse Event|0|||
130475505|NCT03665597|469708575|FG001|Period 3|Adverse Event|1|||
130475506|NCT03665597|469708576|FG002|Period 3|Adverse Event|0|||
130475507|NCT03665597|469708577|FG003|Period 3|Adverse Event|0|||
130475508|NCT03665597|469708578|FG004|Period 3|Adverse Event|0|||
130475509|NCT03665597|469708579|FG005|Period 3|Adverse Event|0|||
130475510|NCT03665597|469708580|FG006|Period 3|Adverse Event|0|||
130475511|NCT03665597|469708574|FG000|Period 3|Death|0|||
130475512|NCT03665597|469708575|FG001|Period 3|Death|0|||
130475513|NCT03665597|469708576|FG002|Period 3|Death|0|||
130475514|NCT03665597|469708577|FG003|Period 3|Death|0|||
130475515|NCT03665597|469708578|FG004|Period 3|Death|1|||
130475516|NCT03665597|469708579|FG005|Period 3|Death|0|||
130475517|NCT03665597|469708580|FG006|Period 3|Death|0|||
130475518|NCT03665597|469708574|FG000|Period 4|Adverse Event|2|||
130475519|NCT03665597|469708575|FG001|Period 4|Adverse Event|2|||
130475520|NCT03665597|469708576|FG002|Period 4|Adverse Event|2|||
130475521|NCT03665597|469708577|FG003|Period 4|Adverse Event|2|||
130475522|NCT03665597|469708578|FG004|Period 4|Adverse Event|1|||
130475523|NCT03665597|469708579|FG005|Period 4|Adverse Event|0|||
130475524|NCT03665597|469708580|FG006|Period 4|Adverse Event|0|||
130475525|NCT03665597|469708574|FG000|Period 4|Death|0|||
130475526|NCT03665597|469708575|FG001|Period 4|Death|0|||
130475527|NCT03665597|469708576|FG002|Period 4|Death|2|||
130475528|NCT03665597|469708577|FG003|Period 4|Death|0|||
130475529|NCT03665597|469708578|FG004|Period 4|Death|0|||
130475530|NCT03665597|469708579|FG005|Period 4|Death|0|||
130475531|NCT03665597|469708580|FG006|Period 4|Death|0|||
130475532|NCT03665597|469708574|FG000|Period 4|Physician Decision|1|||
130475533|NCT03665597|469708575|FG001|Period 4|Physician Decision|2|||
130475534|NCT03665597|469708576|FG002|Period 4|Physician Decision|0|||
130475535|NCT03665597|469708577|FG003|Period 4|Physician Decision|0|||
130475536|NCT03665597|469708578|FG004|Period 4|Physician Decision|0|||
130475537|NCT03665597|469708579|FG005|Period 4|Physician Decision|0|||
130475538|NCT03665597|469708580|FG006|Period 4|Physician Decision|0|||
130475539|NCT04831216|469708581|FG000|Overall Study|Lost to Follow-up|32|||
130475540|NCT03110315|469708588|FG000|Overall Study|Withdrawal by Subject|1|||
130475541|NCT03110315|469708589|FG001|Overall Study|Withdrawal by Subject|0|||
130475542|NCT04727554|469708591|FG000|Overall Study|Lost to Follow-up|0|||
130475543|NCT04727554|469708592|FG001|Overall Study|Lost to Follow-up|1|||
130475544|NCT04727554|469708591|FG000|Overall Study|Death|2|||
130475545|NCT04727554|469708592|FG001|Overall Study|Death|6|||
130475546|NCT04727554|469708591|FG000|Overall Study|Withdrawal by Subject|1|||
130475547|NCT04727554|469708592|FG001|Overall Study|Withdrawal by Subject|0|||
130475548|NCT05371652|469708593|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
130475549|NCT05371652|469708593|FG000|Overall Study|Withdrawal by Subject|12|||
130475550|NCT05371652|469708593|FG000|Overall Study|Adverse Event|1|||
130475551|NCT05371652|469708593|FG000|Overall Study|Other|11|||
130475552|NCT04060355|469709814|FG000|Overall Study|Lost to Follow-up|41|||
130475553|NCT01140880|469709815|FG000|Overall Study|Death|0|||
130475554|NCT01140880|469709816|FG001|Overall Study|Death|1|||
130475555|NCT01140880|469709815|FG000|Overall Study|Withdrawal by Subject|6|||
130475556|NCT01140880|469709816|FG001|Overall Study|Withdrawal by Subject|3|||
130475557|NCT01140880|469709815|FG000|Overall Study|Lost to Follow-up|8|||
130475558|NCT01140880|469709816|FG001|Overall Study|Lost to Follow-up|10|||
130475559|NCT01140880|469709815|FG000|Overall Study|Protocol Violation|0|||
130475560|NCT01140880|469709816|FG001|Overall Study|Protocol Violation|30|||
130475561|NCT04812535|469709823|FG000|Overall Study|Withdrawal by Subject|0|||
130475562|NCT04812535|469709824|FG001|Overall Study|Withdrawal by Subject|0|||
130475563|NCT04812535|469709825|FG002|Overall Study|Withdrawal by Subject|0|||
130475564|NCT04812535|469709826|FG003|Overall Study|Withdrawal by Subject|1|||
130475565|NCT04812535|469709823|FG000|Overall Study|Death|7|||
130475566|NCT04812535|469709824|FG001|Overall Study|Death|2|||
130475567|NCT04812535|469709825|FG002|Overall Study|Death|4|||
130475568|NCT04812535|469709826|FG003|Overall Study|Death|1|||
130475569|NCT04812535|469709823|FG000|Overall Study|Due to premature study termination by sponsor|2|||
130475570|NCT04812535|469709824|FG001|Overall Study|Due to premature study termination by sponsor|0|||
130475571|NCT04812535|469709825|FG002|Overall Study|Due to premature study termination by sponsor|1|||
130475572|NCT04812535|469709826|FG003|Overall Study|Due to premature study termination by sponsor|3|||
130475573|NCT03336333|469709827|FG000|Overall Study|Remained on study at time of data cut-off|202|||
130475574|NCT03336333|469709828|FG001|Overall Study|Remained on study at time of data cut-off|219|||
130475575|NCT03336333|469709829|FG002|Overall Study|Remained on study at time of data cut-off|102|||
130475576|NCT03336333|469709827|FG000|Overall Study|Death|14|||
130475577|NCT03336333|469709828|FG001|Overall Study|Death|16|||
130475578|NCT03336333|469709829|FG002|Overall Study|Death|8|||
130475579|NCT03336333|469709827|FG000|Overall Study|Withdrawal by Subject|16|||
130475580|NCT03336333|469709828|FG001|Overall Study|Withdrawal by Subject|5|||
130475581|NCT03336333|469709829|FG002|Overall Study|Withdrawal by Subject|1|||
130475582|NCT03336333|469709827|FG000|Overall Study|Physician Decision|5|||
130475583|NCT03336333|469709828|FG001|Overall Study|Physician Decision|1|||
130475584|NCT03336333|469709829|FG002|Overall Study|Physician Decision|0|||
130475585|NCT03336333|469709827|FG000|Overall Study|Lost to Follow-up|1|||
130475586|NCT03336333|469709828|FG001|Overall Study|Lost to Follow-up|0|||
130475587|NCT03336333|469709829|FG002|Overall Study|Lost to Follow-up|0|||
130475588|NCT03673111|469709837|FG000|Overall Study|Protocol Violation|0|||
130475589|NCT03673111|469709838|FG001|Overall Study|Protocol Violation|0|||
130475590|NCT03673111|469709839|FG002|Overall Study|Protocol Violation|0|||
130475591|NCT03673111|469709840|FG003|Overall Study|Protocol Violation|0|||
130475592|NCT03673111|469709841|FG004|Overall Study|Protocol Violation|0|||
130475593|NCT03673111|469709842|FG005|Overall Study|Protocol Violation|0|||
130475594|NCT03673111|469709843|FG006|Overall Study|Protocol Violation|0|||
130475595|NCT03673111|469709844|FG007|Overall Study|Protocol Violation|0|||
130475596|NCT03673111|469709845|FG008|Overall Study|Protocol Violation|0|||
130475597|NCT03673111|469709846|FG009|Overall Study|Protocol Violation|0|||
130475598|NCT03673111|469709847|FG010|Overall Study|Protocol Violation|1|||
130475599|NCT03673111|469709848|FG011|Overall Study|Protocol Violation|0|||
130475600|NCT03673111|469709849|FG012|Overall Study|Protocol Violation|0|||
130475601|NCT03673111|469709850|FG013|Overall Study|Protocol Violation|0|||
130475602|NCT03673111|469709837|FG000|Overall Study|Adverse Event|1|||
130475603|NCT03673111|469709838|FG001|Overall Study|Adverse Event|0|||
130475604|NCT03673111|469709839|FG002|Overall Study|Adverse Event|0|||
130475605|NCT03673111|469709840|FG003|Overall Study|Adverse Event|0|||
130475606|NCT03673111|469709841|FG004|Overall Study|Adverse Event|0|||
130475607|NCT03673111|469709842|FG005|Overall Study|Adverse Event|0|||
130475608|NCT03673111|469709843|FG006|Overall Study|Adverse Event|0|||
130475609|NCT03673111|469709844|FG007|Overall Study|Adverse Event|0|||
130475610|NCT03673111|469709845|FG008|Overall Study|Adverse Event|0|||
130475611|NCT03673111|469709846|FG009|Overall Study|Adverse Event|0|||
130475612|NCT03673111|469709847|FG010|Overall Study|Adverse Event|0|||
130475613|NCT03673111|469709848|FG011|Overall Study|Adverse Event|0|||
130475614|NCT03673111|469709849|FG012|Overall Study|Adverse Event|0|||
130475615|NCT03673111|469709850|FG013|Overall Study|Adverse Event|0|||
130475616|NCT03792555|469709853|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
130564207|NCT05318937|470032153|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130564208|NCT05318937|470032154|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130475617|NCT03792555|469709854|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
130475618|NCT03792555|469709855|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
130475619|NCT03792555|469709853|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
130475620|NCT03792555|469709854|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
130475621|NCT03792555|469709855|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
130475622|NCT03792555|469709853|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
130475623|NCT03792555|469709854|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
130475624|NCT03792555|469709855|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
130475625|NCT04485039|469709856|FG000|TPOXX Only|Adverse Event|2|||
130475626|NCT04485039|469709856|FG000|TPOXX Only|Physician Decision|1|||
130475627|NCT04485039|469709856|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
130475628|NCT04485039|469709856|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
130475629|NCT04005716|469709860|FG000|Overall Study|Death|175|||
130418623|NCT04642638|469493436|FG004|Overall Study|Withdrawal by Subject|61|||
130418624|NCT04642638|469493437|FG005|Overall Study|Withdrawal by Subject|27|||
130418625|NCT04642638|469493432|FG000|Overall Study|Lost to Follow-up|17|||
130418626|NCT04642638|469493433|FG001|Overall Study|Lost to Follow-up|18|||
130418627|NCT04642638|469493434|FG002|Overall Study|Lost to Follow-up|5|||
130418628|NCT04642638|469493435|FG003|Overall Study|Lost to Follow-up|5|||
130418629|NCT04642638|469493436|FG004|Overall Study|Lost to Follow-up|6|||
130418630|NCT04642638|469493437|FG005|Overall Study|Lost to Follow-up|3|||
130418631|NCT04642638|469493432|FG000|Overall Study|Adverse Event|0|||
130418632|NCT04642638|469493433|FG001|Overall Study|Adverse Event|0|||
130418633|NCT04642638|469493434|FG002|Overall Study|Adverse Event|1|||
130418634|NCT04642638|469493435|FG003|Overall Study|Adverse Event|0|||
130418635|NCT04642638|469493436|FG004|Overall Study|Adverse Event|10|||
130418636|NCT04642638|469493437|FG005|Overall Study|Adverse Event|3|||
130418637|NCT04642638|469493432|FG000|Overall Study|Reason Not Specified|1|||
130418638|NCT04642638|469493433|FG001|Overall Study|Reason Not Specified|4|||
130418639|NCT04642638|469493434|FG002|Overall Study|Reason Not Specified|0|||
130418640|NCT04642638|469493435|FG003|Overall Study|Reason Not Specified|0|||
130418641|NCT04642638|469493436|FG004|Overall Study|Reason Not Specified|38|||
130418642|NCT04642638|469493437|FG005|Overall Study|Reason Not Specified|16|||
130418643|NCT04642638|469493432|FG000|Overall Study|Physician Decision|0|||
130418644|NCT04642638|469493433|FG001|Overall Study|Physician Decision|0|||
130418645|NCT04642638|469493434|FG002|Overall Study|Physician Decision|0|||
130418646|NCT04642638|469493435|FG003|Overall Study|Physician Decision|0|||
130418647|NCT04642638|469493436|FG004|Overall Study|Physician Decision|2|||
130418648|NCT04642638|469493437|FG005|Overall Study|Physician Decision|1|||
130418649|NCT04642638|469493432|FG000|Overall Study|Protocol Deviation|0|||
130418650|NCT04642638|469493433|FG001|Overall Study|Protocol Deviation|0|||
130418651|NCT04642638|469493434|FG002|Overall Study|Protocol Deviation|0|||
130418652|NCT04642638|469493435|FG003|Overall Study|Protocol Deviation|0|||
130418653|NCT04642638|469493436|FG004|Overall Study|Protocol Deviation|1|||
130418654|NCT04642638|469493437|FG005|Overall Study|Protocol Deviation|3|||
130418655|NCT04642638|469493432|FG000|Overall Study|Study Terminated|0|||
130418656|NCT04642638|469493433|FG001|Overall Study|Study Terminated|0|||
130418657|NCT04642638|469493434|FG002|Overall Study|Study Terminated|0|||
130418658|NCT04642638|469493435|FG003|Overall Study|Study Terminated|0|||
130418659|NCT04642638|469493436|FG004|Overall Study|Study Terminated|484|||
130418660|NCT04642638|469493437|FG005|Overall Study|Study Terminated|250|||
130418661|NCT04642638|469493432|FG000|Overall Study|Pregnancy|0|||
130418662|NCT04642638|469493433|FG001|Overall Study|Pregnancy|0|||
130418663|NCT04642638|469493434|FG002|Overall Study|Pregnancy|0|||
130418664|NCT04642638|469493435|FG003|Overall Study|Pregnancy|0|||
130418665|NCT04642638|469493436|FG004|Overall Study|Pregnancy|1|||
130418666|NCT04642638|469493437|FG005|Overall Study|Pregnancy|0|||
130418667|NCT00990652|469493438|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
130418668|NCT00990652|469493438|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
130418669|NCT02085408|469493440|FG000|Step 1: Induction|Disease Progression|19|||
130418670|NCT02085408|469493441|FG001|Step 1: Induction|Disease Progression|19|||
130418671|NCT02085408|469493440|FG000|Step 1: Induction|Adverse Event|18|||
130418672|NCT02085408|469493441|FG001|Step 1: Induction|Adverse Event|17|||
130418673|NCT02085408|469493440|FG000|Step 1: Induction|Death|33|||
130418674|NCT02085408|469493441|FG001|Step 1: Induction|Death|30|||
130418675|NCT02085408|469493440|FG000|Step 1: Induction|Withdrawal by Subject|16|||
130418676|NCT02085408|469493441|FG001|Step 1: Induction|Withdrawal by Subject|8|||
130418677|NCT02085408|469493440|FG000|Step 1: Induction|Alternative Therapy|15|||
130418678|NCT02085408|469493441|FG001|Step 1: Induction|Alternative Therapy|19|||
130418679|NCT02085408|469493440|FG000|Step 1: Induction|Complicating Disease|2|||
130418680|NCT02085408|469493441|FG001|Step 1: Induction|Complicating Disease|3|||
130418681|NCT02085408|469493440|FG000|Step 1: Induction|Other|27|||
130418682|NCT02085408|469493441|FG001|Step 1: Induction|Other|39|||
130418683|NCT02085408|469493440|FG000|Step 1: Induction|Never started treatment|6|||
130418684|NCT02085408|469493441|FG001|Step 1: Induction|Never started treatment|4|||
130418685|NCT02085408|469493440|FG000|Step 2: Consolidation|Disease Progression|5|||
130418686|NCT02085408|469493441|FG001|Step 2: Consolidation|Disease Progression|20|||
130475630|NCT04005716|469709861|FG001|Overall Study|Death|196|||
130475631|NCT04005716|469709860|FG000|Overall Study|Withdrawal by Subject|1|||
130418687|NCT02085408|469493440|FG000|Step 2: Consolidation|Adverse Event|9|||
130418688|NCT02085408|469493441|FG001|Step 2: Consolidation|Adverse Event|8|||
130418689|NCT02085408|469493440|FG000|Step 2: Consolidation|Death|4|||
130418690|NCT02085408|469493441|FG001|Step 2: Consolidation|Death|3|||
130418691|NCT02085408|469493440|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
130418692|NCT02085408|469493441|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
130418693|NCT02085408|469493440|FG000|Step 2: Consolidation|Alternative Therapy|9|||
130418694|NCT02085408|469493441|FG001|Step 2: Consolidation|Alternative Therapy|3|||
130418695|NCT02085408|469493440|FG000|Step 2: Consolidation|Complicating Disease|0|||
130418696|NCT02085408|469493441|FG001|Step 2: Consolidation|Complicating Disease|2|||
130418697|NCT02085408|469493440|FG000|Step 2: Consolidation|Other|6|||
130418698|NCT02085408|469493441|FG001|Step 2: Consolidation|Other|6|||
130475632|NCT04005716|469709861|FG001|Overall Study|Withdrawal by Subject|6|||
130564209|NCT05318937|470032153|FG000|Overall Study|Lost to Follow-up|0|||
130564210|NCT05318937|470032154|FG001|Overall Study|Lost to Follow-up|1|||
130564211|NCT05318937|470032153|FG000|Overall Study|Withdrawal by Subject|0|||
130564212|NCT05318937|470032154|FG001|Overall Study|Withdrawal by Subject|2|||
130564213|NCT05318937|470032153|FG000|Overall Study|Protocol Violation|0|||
130564214|NCT05318937|470032154|FG001|Overall Study|Protocol Violation|1|||
130564215|NCT01877915|470032162|FG000|Overall Study|Lost to Follow-up|10|||
130564216|NCT01877915|470032163|FG001|Overall Study|Lost to Follow-up|9|||
130564217|NCT01877915|470032162|FG000|Overall Study|Withdrawal by Subject|42|||
130564218|NCT01877915|470032163|FG001|Overall Study|Withdrawal by Subject|55|||
130564219|NCT01877915|470032162|FG000|Overall Study|Other|2|||
130564220|NCT01877915|470032163|FG001|Overall Study|Other|4|||
130564221|NCT05678257|470032164|FG000|Overall Study|Withdrawal by Subject|2|||
130564222|NCT05678257|470032165|FG001|Overall Study|Withdrawal by Subject|0|||
130564223|NCT05678257|470032166|FG002|Overall Study|Withdrawal by Subject|5|||
130564224|NCT05678257|470032164|FG000|Overall Study|Physician Decision|1|||
130475633|NCT04005716|469709860|FG000|Overall Study|Lost to Follow-up|2|||
130564225|NCT05678257|470032165|FG001|Overall Study|Physician Decision|0|||
130564226|NCT05678257|470032166|FG002|Overall Study|Physician Decision|1|||
130564227|NCT05678257|470032164|FG000|Overall Study|Adverse Event|1|||
130564228|NCT05678257|470032165|FG001|Overall Study|Adverse Event|3|||
130564229|NCT05678257|470032166|FG002|Overall Study|Adverse Event|1|||
130564230|NCT05678257|470032164|FG000|Overall Study|Progressive disease|11|||
130564231|NCT05678257|470032165|FG001|Overall Study|Progressive disease|18|||
130564232|NCT05678257|470032166|FG002|Overall Study|Progressive disease|7|||
130564233|NCT05678257|470032164|FG000|Overall Study|No longer clinically benefitting|2|||
130564234|NCT05678257|470032165|FG001|Overall Study|No longer clinically benefitting|1|||
130564235|NCT05678257|470032166|FG002|Overall Study|No longer clinically benefitting|0|||
130564236|NCT05678257|470032164|FG000|Overall Study|Sponsor decision|5|||
130564237|NCT05678257|470032165|FG001|Overall Study|Sponsor decision|9|||
130564238|NCT05678257|470032166|FG002|Overall Study|Sponsor decision|8|||
130564239|NCT05678257|470032164|FG000|Overall Study|Protocol Violation|0|||
130564240|NCT05678257|470032165|FG001|Overall Study|Protocol Violation|0|||
130564241|NCT05678257|470032166|FG002|Overall Study|Protocol Violation|1|||
130564242|NCT05678257|470032164|FG000|Overall Study|Patient non-compliance|0|||
130564243|NCT05678257|470032165|FG001|Overall Study|Patient non-compliance|0|||
130564244|NCT05678257|470032166|FG002|Overall Study|Patient non-compliance|3|||
130564245|NCT02046096|470032167|FG000|Overall Study|Death|28|||
130564246|NCT02046096|470032168|FG001|Overall Study|Death|45|||
130564247|NCT02046096|470032167|FG000|Overall Study|Lost to Follow-up|9|||
130564248|NCT02046096|470032168|FG001|Overall Study|Lost to Follow-up|20|||
130564249|NCT02046096|470032167|FG000|Overall Study|Withdrawal by Subject|5|||
130564250|NCT02046096|470032168|FG001|Overall Study|Withdrawal by Subject|17|||
130564251|NCT02046096|470032167|FG000|Overall Study|Other endpoint|2|||
130564252|NCT02046096|470032168|FG001|Overall Study|Other endpoint|19|||
130564253|NCT03520959|470032169|FG000|Overall Study|Study terminated by Sponsor|0|||
130564254|NCT03520959|470032170|FG001|Overall Study|Study terminated by Sponsor|1|||
130564255|NCT01449461|470032171|FG000|Overall Study|Adverse Event|0|||
130564256|NCT01449461|470032172|FG001|Overall Study|Adverse Event|3|||
130564257|NCT01449461|470032173|FG002|Overall Study|Adverse Event|2|||
130564258|NCT01449461|470032174|FG003|Overall Study|Adverse Event|3|||
130564259|NCT01449461|470032175|FG004|Overall Study|Adverse Event|4|||
130564260|NCT01449461|470032176|FG005|Overall Study|Adverse Event|4|||
130564261|NCT01449461|470032171|FG000|Overall Study|Death|0|||
130564262|NCT01449461|470032172|FG001|Overall Study|Death|2|||
130564263|NCT01449461|470032173|FG002|Overall Study|Death|0|||
130564264|NCT01449461|470032174|FG003|Overall Study|Death|0|||
130564265|NCT01449461|470032175|FG004|Overall Study|Death|7|||
130475634|NCT04005716|469709861|FG001|Overall Study|Lost to Follow-up|2|||
130475635|NCT04021602|469709862|FG000|Overall Study|Lost to Follow-up|3|||
130475636|NCT04021602|469709863|FG001|Overall Study|Lost to Follow-up|3|||
130475637|NCT04021602|469709864|FG002|Overall Study|Lost to Follow-up|1|||
130475638|NCT04021602|469709862|FG000|Overall Study|Adverse Event|1|||
130475639|NCT04021602|469709863|FG001|Overall Study|Adverse Event|0|||
130475640|NCT04021602|469709864|FG002|Overall Study|Adverse Event|1|||
130475641|NCT02120456|469709865|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130475642|NCT02120456|469709866|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130475643|NCT02120456|469709867|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130564266|NCT01449461|470032176|FG005|Overall Study|Death|1|||
130564267|NCT01449461|470032171|FG000|Overall Study|Physician Decision|0|||
130564268|NCT01449461|470032172|FG001|Overall Study|Physician Decision|1|||
130564269|NCT01449461|470032173|FG002|Overall Study|Physician Decision|0|||
130475644|NCT02120456|469709868|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130475645|NCT02120456|469709869|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130475646|NCT02120456|469709870|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130564270|NCT01449461|470032174|FG003|Overall Study|Physician Decision|4|||
130564271|NCT01449461|470032175|FG004|Overall Study|Physician Decision|1|||
130564272|NCT01449461|470032176|FG005|Overall Study|Physician Decision|0|||
130564273|NCT01449461|470032171|FG000|Overall Study|Documented Progressive Disease|4|||
130564274|NCT01449461|470032172|FG001|Overall Study|Documented Progressive Disease|7|||
130564275|NCT01449461|470032173|FG002|Overall Study|Documented Progressive Disease|14|||
130564276|NCT01449461|470032174|FG003|Overall Study|Documented Progressive Disease|15|||
130564277|NCT01449461|470032175|FG004|Overall Study|Documented Progressive Disease|24|||
130564278|NCT01449461|470032176|FG005|Overall Study|Documented Progressive Disease|5|||
130564279|NCT01449461|470032171|FG000|Overall Study|Clinical Progressive Disease|2|||
130564280|NCT01449461|470032172|FG001|Overall Study|Clinical Progressive Disease|2|||
130564281|NCT01449461|470032173|FG002|Overall Study|Clinical Progressive Disease|0|||
130564282|NCT01449461|470032174|FG003|Overall Study|Clinical Progressive Disease|3|||
130564283|NCT01449461|470032175|FG004|Overall Study|Clinical Progressive Disease|4|||
130564284|NCT01449461|470032176|FG005|Overall Study|Clinical Progressive Disease|2|||
130564285|NCT01449461|470032171|FG000|Overall Study|Protocol Violation|0|||
130564286|NCT01449461|470032172|FG001|Overall Study|Protocol Violation|0|||
130564287|NCT01449461|470032173|FG002|Overall Study|Protocol Violation|0|||
130564288|NCT01449461|470032174|FG003|Overall Study|Protocol Violation|1|||
130564289|NCT01449461|470032175|FG004|Overall Study|Protocol Violation|0|||
130418699|NCT02085408|469493440|FG000|Step 2: Consolidation|Never started treatment|4|||
130418700|NCT02085408|469493441|FG001|Step 2: Consolidation|Never started treatment|3|||
130418701|NCT02085408|469493440|FG000|Step 3: Maintenance|Disease Progression|13|||
130564290|NCT01449461|470032176|FG005|Overall Study|Protocol Violation|0|||
130564291|NCT01449461|470032171|FG000|Overall Study|Site Terminated by Sponsor|0|||
130564292|NCT01449461|470032172|FG001|Overall Study|Site Terminated by Sponsor|1|||
130564293|NCT01449461|470032173|FG002|Overall Study|Site Terminated by Sponsor|2|||
130564294|NCT01449461|470032174|FG003|Overall Study|Site Terminated by Sponsor|3|||
130564295|NCT01449461|470032175|FG004|Overall Study|Site Terminated by Sponsor|4|||
130564296|NCT01449461|470032176|FG005|Overall Study|Site Terminated by Sponsor|1|||
130564297|NCT01449461|470032171|FG000|Overall Study|Withdrawal by Subject|0|||
130564298|NCT01449461|470032172|FG001|Overall Study|Withdrawal by Subject|1|||
130564299|NCT01449461|470032173|FG002|Overall Study|Withdrawal by Subject|0|||
130564300|NCT01449461|470032174|FG003|Overall Study|Withdrawal by Subject|0|||
130564301|NCT01449461|470032175|FG004|Overall Study|Withdrawal by Subject|2|||
130564302|NCT01449461|470032176|FG005|Overall Study|Withdrawal by Subject|1|||
130564303|NCT01449461|470032171|FG000|Overall Study|Reason not Specified|0|||
130564304|NCT01449461|470032172|FG001|Overall Study|Reason not Specified|1|||
130564305|NCT01449461|470032173|FG002|Overall Study|Reason not Specified|0|||
130564306|NCT01449461|470032174|FG003|Overall Study|Reason not Specified|3|||
130564307|NCT01449461|470032175|FG004|Overall Study|Reason not Specified|2|||
130564308|NCT01449461|470032176|FG005|Overall Study|Reason not Specified|1|||
130564309|NCT05314517|470032177|FG000|Double-blind Period|Adverse Event|4|||
130564310|NCT05314517|470032178|FG001|Double-blind Period|Adverse Event|0|||
130564311|NCT05314517|470032179|FG002|Double-blind Period|Adverse Event|0|||
130564312|NCT05314517|470032180|FG003|Double-blind Period|Adverse Event|0|||
130564313|NCT05314517|470032177|FG000|Double-blind Period|Noncompliance|0|||
130564314|NCT05314517|470032178|FG001|Double-blind Period|Noncompliance|1|||
130564315|NCT05314517|470032179|FG002|Double-blind Period|Noncompliance|0|||
130564316|NCT05314517|470032180|FG003|Double-blind Period|Noncompliance|0|||
130564317|NCT05314517|470032177|FG000|Double-blind Period|Randomized, not treated|1|||
130564318|NCT05314517|470032178|FG001|Double-blind Period|Randomized, not treated|0|||
130564319|NCT05314517|470032179|FG002|Double-blind Period|Randomized, not treated|0|||
130564320|NCT05314517|470032180|FG003|Double-blind Period|Randomized, not treated|0|||
130564321|NCT05314517|470032177|FG000|Open-label Extension|Adverse Event|0|||
130564322|NCT05314517|470032178|FG001|Open-label Extension|Adverse Event|0|||
130564323|NCT05314517|470032179|FG002|Open-label Extension|Adverse Event|1|||
130564324|NCT05314517|470032180|FG003|Open-label Extension|Adverse Event|2|||
130418702|NCT02085408|469493441|FG001|Step 3: Maintenance|Disease Progression|11|||
130418703|NCT02085408|469493440|FG000|Step 3: Maintenance|Adverse Event|2|||
130418704|NCT02085408|469493441|FG001|Step 3: Maintenance|Adverse Event|4|||
130418705|NCT02085408|469493440|FG000|Step 3: Maintenance|Death|1|||
130418706|NCT02085408|469493441|FG001|Step 3: Maintenance|Death|2|||
130418707|NCT02085408|469493440|FG000|Step 3: Maintenance|Alternative Therapy|1|||
130418708|NCT02085408|469493441|FG001|Step 3: Maintenance|Alternative Therapy|1|||
130418709|NCT02085408|469493440|FG000|Step 3: Maintenance|Complicating Disease|0|||
130564325|NCT05314517|470032177|FG000|Open-label Extension|Investigator decision|0|||
130564326|NCT05314517|470032178|FG001|Open-label Extension|Investigator decision|0|||
130564327|NCT05314517|470032179|FG002|Open-label Extension|Investigator decision|1|||
130564328|NCT05314517|470032180|FG003|Open-label Extension|Investigator decision|0|||
130564329|NCT05314517|470032177|FG000|Open-label Extension|Lost to Follow-up|0|||
130564330|NCT05314517|470032178|FG001|Open-label Extension|Lost to Follow-up|0|||
130564331|NCT05314517|470032179|FG002|Open-label Extension|Lost to Follow-up|0|||
130418710|NCT02085408|469493441|FG001|Step 3: Maintenance|Complicating Disease|1|||
130418711|NCT02085408|469493440|FG000|Step 3: Maintenance|Other|3|||
130418712|NCT02085408|469493441|FG001|Step 3: Maintenance|Other|2|||
130564332|NCT05314517|470032180|FG003|Open-label Extension|Lost to Follow-up|1|||
130564333|NCT05314517|470032177|FG000|Open-label Extension|Withdrawal by Subject|0|||
130564334|NCT05314517|470032178|FG001|Open-label Extension|Withdrawal by Subject|0|||
130418713|NCT02085408|469493440|FG000|Step 3: Maintenance|Never started treatment|5|||
130418714|NCT02085408|469493441|FG001|Step 3: Maintenance|Never started treatment|1|||
130418715|NCT04732286|469493444|FG000|Overall Study|Progressive Disease|2|||
130418716|NCT04732286|469493444|FG000|Overall Study|Physician Decision|1|||
130418717|NCT04732286|469493444|FG000|Overall Study|Study Terminated by Sponsor|31|||
130418718|NCT04732286|469493444|FG000|Overall Study|Withdrawal by Subject|10|||
130418719|NCT04732286|469493444|FG000|Overall Study|Non-compliance With Study Drug|1|||
130418720|NCT04732286|469493444|FG000|Overall Study|Lost to Follow-up|4|||
130418721|NCT04732286|469493444|FG000|Overall Study|Death|51|||
130418722|NCT00319098|469493445|FG000|Overall Study|Serious adverse event|3|||
130418723|NCT00319098|469493446|FG001|Overall Study|Serious adverse event|0|||
130418724|NCT00319098|469493445|FG000|Overall Study|Adverse Event|20|||
130418725|NCT00319098|469493446|FG001|Overall Study|Adverse Event|1|||
130418726|NCT00319098|469493445|FG000|Overall Study|Withdrawal by Subject|37|||
130418727|NCT00319098|469493446|FG001|Overall Study|Withdrawal by Subject|8|||
130418728|NCT00319098|469493445|FG000|Overall Study|Migrated/moved from study area|2|||
130418729|NCT00319098|469493446|FG001|Overall Study|Migrated/moved from study area|1|||
130418730|NCT00319098|469493445|FG000|Overall Study|Lost to Follow-up|37|||
130418731|NCT00319098|469493446|FG001|Overall Study|Lost to Follow-up|13|||
130418732|NCT00319098|469493445|FG000|Overall Study|Others|33|||
130418733|NCT00319098|469493446|FG001|Overall Study|Others|8|||
130418734|NCT00319098|469493445|FG000|Overall Study|Protocol Violation|3|||
130418735|NCT00319098|469493446|FG001|Overall Study|Protocol Violation|1|||
130418736|NCT00965523|469493447|FG000|Study 221|Progressive Disease|4|||
130418737|NCT00965523|469493447|FG000|Study 221|Physician Decision|3|||
130418738|NCT00965523|469493447|FG000|Study 224|Progressive Disease|5|||
130418739|NCT00965523|469493447|FG000|Study 224|Physician Decision|1|||
130418740|NCT01939028|469493449|FG000|Overall Study|Withdrawal by Subject|5|||
130418741|NCT01939028|469493449|FG000|Overall Study|Physician Decision|7|||
130418742|NCT01881126|469493473|FG000|Overall Study|Non-compliance|1|||
130418743|NCT01881126|469493474|FG001|Overall Study|Non-compliance|1|||
130418744|NCT01881126|469493473|FG000|Overall Study|Adverse Event|0|||
130418745|NCT01881126|469493474|FG001|Overall Study|Adverse Event|1|||
130418746|NCT01090453|469493477|FG000|Overall Study|Withdrawal by Subject|1|||
130418747|NCT01090453|469493478|FG001|Overall Study|Withdrawal by Subject|2|||
130418748|NCT01090453|469493477|FG000|Overall Study|Lost to Follow-up|7|||
130418749|NCT01090453|469493478|FG001|Overall Study|Lost to Follow-up|7|||
130418750|NCT01090453|469493477|FG000|Overall Study|Non serious AEs|1|||
130418751|NCT01090453|469493478|FG001|Overall Study|Non serious AEs|0|||
130418752|NCT01090453|469493477|FG000|Overall Study|Protocol Violation|2|||
130418753|NCT01090453|469493478|FG001|Overall Study|Protocol Violation|0|||
130418754|NCT01090453|469493477|FG000|Overall Study|Other|2|||
130418755|NCT01090453|469493478|FG001|Overall Study|Other|4|||
130418756|NCT01090453|469493477|FG000|Overall Study|Eligibility Criteria|0|||
130418757|NCT01090453|469493478|FG001|Overall Study|Eligibility Criteria|1|||
130418758|NCT04072159|469493479|FG000|Overall Study|Lost to Follow-up|6|||
130418759|NCT04072159|469493480|FG001|Overall Study|Lost to Follow-up|6|||
130418760|NCT04072159|469493479|FG000|Overall Study|Withdrawal by Subject|2|||
130418761|NCT04072159|469493480|FG001|Overall Study|Withdrawal by Subject|0|||
130418762|NCT00522275|469493485|FG000|Overall Study|Adverse Event|35|||
130418763|NCT00522275|469493485|FG000|Overall Study|Lack of Efficacy|80|||
130418764|NCT00522275|469493485|FG000|Overall Study|Subject withdrew consent|16|||
130418765|NCT00522275|469493485|FG000|Overall Study|Protocol deviation|1|||
130418766|NCT00522275|469493485|FG000|Overall Study|Unsatisfactory compliance|11|||
130418767|NCT00522275|469493485|FG000|Overall Study|Lost to Follow-up|8|||
130418768|NCT00522275|469493485|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
130418769|NCT00522275|469493485|FG000|Overall Study|Other: Subject is pregnant|2|||
130418770|NCT00522275|469493485|FG000|Overall Study|Other: Subject relocated|2|||
130418771|NCT00522275|469493485|FG000|Overall Study|Other: Subject arrested|1|||
130418772|NCT00522275|469493485|FG000|Overall Study|Other: Site / clinic closed|4|||
130418773|NCT00522275|469493485|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
130418774|NCT00522275|469493485|FG000|Overall Study|Other: Sponsor request|2|||
130418775|NCT00522275|469493485|FG000|Overall Study|Other: Subject ran out of medication|1|||
130418776|NCT00522275|469493485|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
130475647|NCT02120456|469709871|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
130475648|NCT02120456|469709872|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130418777|NCT00695669|469493487|FG000|Overall Study|Adverse Event|0|||
130418778|NCT00695669|469493488|FG001|Overall Study|Adverse Event|0|||
130418779|NCT00695669|469493489|FG002|Overall Study|Adverse Event|2|||
130418780|NCT00695669|469493490|FG003|Overall Study|Adverse Event|0|||
130418781|NCT00695669|469493487|FG000|Overall Study|Lost to Follow-up|4|||
130475649|NCT02120456|469709873|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130418782|NCT00695669|469493488|FG001|Overall Study|Lost to Follow-up|4|||
130418783|NCT00695669|469493489|FG002|Overall Study|Lost to Follow-up|1|||
130418784|NCT00695669|469493490|FG003|Overall Study|Lost to Follow-up|4|||
130418785|NCT05045625|469493491|FG000|Overall Study|Lost to Follow-up|3|||
130418786|NCT00092131|469493492|FG000|Treatment Period I|Adverse Event|1|||
130418787|NCT00092131|469493493|FG001|Treatment Period I|Adverse Event|0|||
130564335|NCT05314517|470032179|FG002|Open-label Extension|Withdrawal by Subject|1|||
130564336|NCT05314517|470032180|FG003|Open-label Extension|Withdrawal by Subject|2|||
130564337|NCT05314517|470032177|FG000|Open-label Extension|Use of prohibited medication|0|||
130564338|NCT05314517|470032178|FG001|Open-label Extension|Use of prohibited medication|0|||
130564339|NCT05314517|470032179|FG002|Open-label Extension|Use of prohibited medication|1|||
130564340|NCT05314517|470032180|FG003|Open-label Extension|Use of prohibited medication|0|||
130564341|NCT05314517|470032177|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
130564342|NCT05314517|470032178|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
130564343|NCT05314517|470032179|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
130564344|NCT05314517|470032180|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
130564345|NCT04969276|470032181|FG000|Overall Study|Protocol Deviation|0|||
130564346|NCT04969276|470032182|FG001|Overall Study|Protocol Deviation|1|||
130564347|NCT04969276|470032183|FG002|Overall Study|Protocol Deviation|0|||
130564348|NCT04969276|470032181|FG000|Overall Study|Withdrawal by Subject|1|||
130564349|NCT04969276|470032182|FG001|Overall Study|Withdrawal by Subject|10|||
130564350|NCT04969276|470032183|FG002|Overall Study|Withdrawal by Subject|0|||
130564351|NCT04969276|470032181|FG000|Overall Study|Lost to Follow-up|0|||
130564352|NCT04969276|470032182|FG001|Overall Study|Lost to Follow-up|1|||
130564353|NCT04969276|470032183|FG002|Overall Study|Lost to Follow-up|0|||
130564354|NCT04655144|470032187|FG000|Overall Study|Consumed THC|1|||
130564355|NCT04655144|470032188|FG001|Overall Study|Consumed THC|0|||
130564356|NCT04655144|470032187|FG000|Overall Study|Unilateral embolization|0|||
130564357|NCT04655144|470032188|FG001|Overall Study|Unilateral embolization|1|||
130564358|NCT04490018|470032192|FG000|Overall Study|Protocol Violation|0|||
130564359|NCT04490018|470032193|FG001|Overall Study|Protocol Violation|2|||
130564360|NCT04490018|470032194|FG002|Overall Study|Protocol Violation|1|||
130564361|NCT04490018|470032192|FG000|Overall Study|Lost to Follow-up|2|||
130564362|NCT04490018|470032193|FG001|Overall Study|Lost to Follow-up|2|||
130564363|NCT04490018|470032194|FG002|Overall Study|Lost to Follow-up|0|||
130564364|NCT04490018|470032192|FG000|Overall Study|Withdrawal by Subject|2|||
130564365|NCT04490018|470032193|FG001|Overall Study|Withdrawal by Subject|1|||
130564366|NCT04490018|470032194|FG002|Overall Study|Withdrawal by Subject|0|||
130564367|NCT04490018|470032192|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130564368|NCT04490018|470032193|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130564369|NCT04490018|470032194|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130564370|NCT00943579|470032196|FG000|Overall Study|Adverse Event|4|||
130564371|NCT00943579|470032197|FG001|Overall Study|Adverse Event|3|||
130564372|NCT00943579|470032196|FG000|Overall Study|Lack of Efficacy|2|||
130564373|NCT00943579|470032197|FG001|Overall Study|Lack of Efficacy|2|||
130564374|NCT03337542|470032198|FG000|Overall Study|Withdrew Consent|17|||
130564375|NCT03337542|470032198|FG000|Overall Study|Allergic Adverse Event|1|||
130564376|NCT03337542|470032198|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
130564377|NCT03337542|470032198|FG000|Overall Study|Lost to Follow-up|1|||
130564378|NCT03337542|470032198|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
130564379|NCT01401842|470032199|FG000|Overall Study|Withdrawal by Subject|3|||
130564380|NCT01401842|470032200|FG001|Overall Study|Withdrawal by Subject|2|||
130564381|NCT01401842|470032199|FG000|Overall Study|academic reason|4|||
130564382|NCT01401842|470032200|FG001|Overall Study|academic reason|1|||
130727266|NCT02883049|470625434|FG010|Post Induction|Ineligible|1|||
130727267|NCT02883049|470625435|FG011|Post Induction|Ineligible|0|||
130727268|NCT02883049|470625436|FG012|Post Induction|Ineligible|0|||
130727269|NCT02883049|470625437|FG013|Post Induction|Ineligible|0|||
130727270|NCT02883049|470625438|FG014|Post Induction|Ineligible|0|||
130727271|NCT02883049|470625439|FG015|Post Induction|Ineligible|1|||
130727272|NCT02883049|470625424|FG000|Post Induction|Refusal of further protocol therapy|0|||
130475650|NCT02120456|469709865|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475651|NCT02120456|469709866|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475652|NCT02120456|469709867|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475653|NCT02120456|469709868|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475654|NCT02120456|469709869|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475655|NCT02120456|469709870|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475656|NCT02120456|469709871|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
130475657|NCT02120456|469709872|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475658|NCT02120456|469709873|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130475659|NCT02120456|469709865|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475660|NCT02120456|469709866|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475661|NCT02120456|469709867|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130564383|NCT01401842|470032199|FG000|Overall Study|changed companies|20|||
130564384|NCT01401842|470032200|FG001|Overall Study|changed companies|34|||
130564385|NCT01401842|470032199|FG000|Overall Study|discharged from US Army|3|||
130564386|NCT01401842|470032200|FG001|Overall Study|discharged from US Army|4|||
130564387|NCT01401842|470032199|FG000|Overall Study|invalid follow-up strength data|1|||
130564388|NCT01401842|470032200|FG001|Overall Study|invalid follow-up strength data|4|||
130727273|NCT02883049|470625425|FG001|Post Induction|Refusal of further protocol therapy|0|||
130727274|NCT02883049|470625426|FG002|Post Induction|Refusal of further protocol therapy|0|||
130727275|NCT02883049|470625427|FG003|Post Induction|Refusal of further protocol therapy|11|||
130727276|NCT02883049|470625428|FG004|Post Induction|Refusal of further protocol therapy|15|||
130727277|NCT02883049|470625429|FG005|Post Induction|Refusal of further protocol therapy|9|||
130727278|NCT02883049|470625430|FG006|Post Induction|Refusal of further protocol therapy|13|||
130727279|NCT02883049|470625431|FG007|Post Induction|Refusal of further protocol therapy|5|||
130727280|NCT02883049|470625432|FG008|Post Induction|Refusal of further protocol therapy|21|||
130727281|NCT02883049|470625433|FG009|Post Induction|Refusal of further protocol therapy|7|||
130727282|NCT02883049|470625434|FG010|Post Induction|Refusal of further protocol therapy|0|||
130727283|NCT02883049|470625435|FG011|Post Induction|Refusal of further protocol therapy|7|||
130727284|NCT02883049|470625436|FG012|Post Induction|Refusal of further protocol therapy|3|||
130727285|NCT02883049|470625437|FG013|Post Induction|Refusal of further protocol therapy|0|||
130727286|NCT02883049|470625438|FG014|Post Induction|Refusal of further protocol therapy|4|||
130727287|NCT02883049|470625439|FG015|Post Induction|Refusal of further protocol therapy|1|||
130727288|NCT02883049|470625424|FG000|Post Induction|Inevaluable|0|||
130418788|NCT00092131|469493492|FG000|Treatment Period II|Adverse Event|0|||
130418789|NCT00092131|469493493|FG001|Treatment Period II|Adverse Event|1|||
130418790|NCT02341417|469493494|FG000|Overall Study|Withdrawal by Subject|0|||
130418791|NCT02341417|469493495|FG001|Overall Study|Withdrawal by Subject|2|||
130418792|NCT02341417|469493496|FG002|Overall Study|Withdrawal by Subject|0|||
130418793|NCT02341417|469493494|FG000|Overall Study|Decision by sponsor|2|||
130418794|NCT02341417|469493495|FG001|Overall Study|Decision by sponsor|0|||
130418795|NCT02341417|469493496|FG002|Overall Study|Decision by sponsor|0|||
130418796|NCT02341417|469493494|FG000|Overall Study|Death|0|||
130418797|NCT02341417|469493495|FG001|Overall Study|Death|0|||
130418798|NCT02341417|469493496|FG002|Overall Study|Death|1|||
130418799|NCT01857531|469493510|FG000|Overall Study|Withdrawal by Subject|4|||
130418800|NCT02576067|469493511|FG000|Overall Study|Death|0|||
130418801|NCT02576067|469493512|FG001|Overall Study|Death|1|||
130418802|NCT02576067|469493511|FG000|Overall Study|Lack of Efficacy|1|||
130418803|NCT02576067|469493512|FG001|Overall Study|Lack of Efficacy|0|||
130418804|NCT02576067|469493511|FG000|Overall Study|Lost to Follow-up|11|||
130418805|NCT02576067|469493512|FG001|Overall Study|Lost to Follow-up|0|||
130418806|NCT02576067|469493511|FG000|Overall Study|Withdrawal by Subject|11|||
130418807|NCT02576067|469493512|FG001|Overall Study|Withdrawal by Subject|2|||
130418808|NCT02576067|469493511|FG000|Overall Study|study closure of main CIRT trial)|0|||
130418809|NCT02576067|469493512|FG001|Overall Study|study closure of main CIRT trial)|8|||
130418810|NCT02576067|469493511|FG000|Overall Study|not randomized, failed run-in|7|||
130418811|NCT02576067|469493512|FG001|Overall Study|not randomized, failed run-in|0|||
130418812|NCT02576067|469493511|FG000|Overall Study|screen failure/ re-enrolled|0|||
130418813|NCT02576067|469493512|FG001|Overall Study|screen failure/ re-enrolled|25|||
130418814|NCT02576067|469493511|FG000|Overall Study|Physician Decision|4|||
130418815|NCT02576067|469493512|FG001|Overall Study|Physician Decision|0|||
130418816|NCT04773587|469493515|FG000|Overall Study|Lost to Follow-up|11|||
130418817|NCT04773587|469493516|FG001|Overall Study|Lost to Follow-up|3|||
130418818|NCT04773587|469493515|FG000|Overall Study|Adverse Event|6|||
130418819|NCT04773587|469493516|FG001|Overall Study|Adverse Event|3|||
130418820|NCT04773587|469493515|FG000|Overall Study|Lack of Efficacy|5|||
130418821|NCT04773587|469493516|FG001|Overall Study|Lack of Efficacy|2|||
130418822|NCT04773587|469493515|FG000|Overall Study|Withdrawal by Subject|4|||
130418823|NCT04773587|469493516|FG001|Overall Study|Withdrawal by Subject|5|||
130418824|NCT04773587|469493515|FG000|Overall Study|Noncompliance|1|||
130418825|NCT04773587|469493516|FG001|Overall Study|Noncompliance|0|||
130418826|NCT04773587|469493515|FG000|Overall Study|Protocol Violation|1|||
130418827|NCT04773587|469493516|FG001|Overall Study|Protocol Violation|0|||
130418828|NCT04773587|469493515|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
130418829|NCT04773587|469493516|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
130418830|NCT02372409|469493517|FG000|Overall Study|Lost to Follow-up|1|||
130418831|NCT02372409|469493518|FG001|Overall Study|Lost to Follow-up|0|||
130418832|NCT02372409|469493517|FG000|Overall Study|Disease progression|1|||
130418833|NCT02372409|469493518|FG001|Overall Study|Disease progression|1|||
130418834|NCT01808313|469493519|FG000|Overall Study|Adverse Event|5|||
130727289|NCT02883049|470625425|FG001|Post Induction|Inevaluable|0|||
130727290|NCT02883049|470625426|FG002|Post Induction|Inevaluable|0|||
130418835|NCT01808313|469493519|FG000|Overall Study|Protocol Violation|2|||
130418836|NCT01808313|469493519|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130418837|NCT01808313|469493519|FG000|Overall Study|Lost to Follow-up|1|||
130418838|NCT01808313|469493519|FG000|Overall Study|Physician Decision|1|||
130418839|NCT04656847|469493522|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
130418840|NCT03301051|469493523|FG000|Overall Study|Adverse Event|0|||
130418841|NCT03301051|469493524|FG001|Overall Study|Adverse Event|4|||
130418842|NCT03301051|469493523|FG000|Overall Study|Withdrawal by Subject|59|||
130418843|NCT03301051|469493524|FG001|Overall Study|Withdrawal by Subject|65|||
130418844|NCT03301051|469493523|FG000|Overall Study|Lost to Follow-up|263|||
130418845|NCT03301051|469493524|FG001|Overall Study|Lost to Follow-up|282|||
130564389|NCT01401842|470032199|FG000|Overall Study|on profile|9|||
130418846|NCT03301051|469493523|FG000|Overall Study|Protocol Violation|1|||
130418847|NCT03301051|469493524|FG001|Overall Study|Protocol Violation|3|||
130418848|NCT03301051|469493523|FG000|Overall Study|Physician Decision|1|||
130418849|NCT03301051|469493524|FG001|Overall Study|Physician Decision|3|||
130418850|NCT03301051|469493523|FG000|Overall Study|Death|1|||
130418851|NCT03301051|469493524|FG001|Overall Study|Death|1|||
130418852|NCT03301051|469493523|FG000|Overall Study|Miscellaneous|8|||
130418853|NCT03301051|469493524|FG001|Overall Study|Miscellaneous|4|||
130418854|NCT03301051|469493523|FG000|Overall Study|Randomized, not vaccinated|13|||
130418855|NCT03301051|469493524|FG001|Overall Study|Randomized, not vaccinated|10|||
130418856|NCT00047879|469493525|FG000|Overall Study|Progressive disease|4|||
130418857|NCT00047879|469493526|FG001|Overall Study|Progressive disease|3|||
130418858|NCT00622167|469493527|FG000|Overall Study|Did not meet angiographic criteria|20|||
130418859|NCT01954017|469493530|FG000|Overall Study|Adverse Event|0|||
130418860|NCT01954017|469493531|FG001|Overall Study|Adverse Event|0|||
130418861|NCT01954017|469493532|FG002|Overall Study|Adverse Event|1|||
130418862|NCT01954017|469493530|FG000|Overall Study|Death|2|||
130418863|NCT01954017|469493531|FG001|Overall Study|Death|1|||
130418864|NCT01954017|469493532|FG002|Overall Study|Death|1|||
130418865|NCT01954017|469493530|FG000|Overall Study|Withdrawal by Subject|0|||
130418866|NCT01954017|469493531|FG001|Overall Study|Withdrawal by Subject|1|||
130418867|NCT01954017|469493532|FG002|Overall Study|Withdrawal by Subject|0|||
130418868|NCT01954017|469493530|FG000|Overall Study|Protocol Violation|0|||
130418869|NCT01954017|469493531|FG001|Overall Study|Protocol Violation|3|||
130418870|NCT01954017|469493532|FG002|Overall Study|Protocol Violation|2|||
130418871|NCT01954017|469493530|FG000|Overall Study|Necrotizing enterocolitis|1|||
130418872|NCT01954017|469493531|FG001|Overall Study|Necrotizing enterocolitis|0|||
130418873|NCT01954017|469493532|FG002|Overall Study|Necrotizing enterocolitis|1|||
130418874|NCT01954017|469493530|FG000|Overall Study|Enteral intake stopped >7 days|0|||
130418875|NCT01954017|469493531|FG001|Overall Study|Enteral intake stopped >7 days|1|||
130418876|NCT01954017|469493532|FG002|Overall Study|Enteral intake stopped >7 days|1|||
130418877|NCT01954017|469493530|FG000|Overall Study|All other reasons|2|||
130418878|NCT01954017|469493531|FG001|Overall Study|All other reasons|2|||
130418879|NCT01954017|469493532|FG002|Overall Study|All other reasons|7|||
130418880|NCT00435370|469493537|FG000|Overall Study|Adverse Event|8|||
130418881|NCT00435370|469493538|FG001|Overall Study|Adverse Event|8|||
130418882|NCT00435370|469493537|FG000|Overall Study|Withdrawal by Subject|10|||
130418883|NCT00435370|469493538|FG001|Overall Study|Withdrawal by Subject|10|||
130418884|NCT00435370|469493537|FG000|Overall Study|Antipsychotic medication changed|4|||
130418885|NCT00435370|469493538|FG001|Overall Study|Antipsychotic medication changed|2|||
130418886|NCT03674177|469493542|FG000|Overall Study|Lost to Follow-up|2|||
130418887|NCT03674177|469493543|FG001|Overall Study|Lost to Follow-up|1|||
130418888|NCT03674177|469493544|FG002|Overall Study|Lost to Follow-up|0|||
130418889|NCT03674177|469493545|FG003|Overall Study|Lost to Follow-up|2|||
130418890|NCT00714168|469493546|FG000|Overall Study|Pregnancy|5|||
130418891|NCT00714168|469493547|FG001|Overall Study|Pregnancy|4|||
130418892|NCT00714168|469493546|FG000|Overall Study|Lost to Follow-up|32|||
130418893|NCT00714168|469493547|FG001|Overall Study|Lost to Follow-up|50|||
130418894|NCT00714168|469493546|FG000|Overall Study|Relocation|4|||
130418895|NCT00714168|469493547|FG001|Overall Study|Relocation|3|||
130418896|NCT00714168|469493546|FG000|Overall Study|Non-study medical condition|3|||
130418897|NCT00714168|469493547|FG001|Overall Study|Non-study medical condition|2|||
130418898|NCT02298192|469493551|FG000|Overall Study|Unclassified|3|||
130418899|NCT02298192|469493552|FG001|Overall Study|Unclassified|2|||
130418900|NCT02298192|469493551|FG000|Overall Study|Withdrawal criteria|2|||
130418901|NCT02298192|469493552|FG001|Overall Study|Withdrawal criteria|0|||
130418902|NCT02298192|469493551|FG000|Overall Study|Withdrawal by Subject|6|||
130418903|NCT02298192|469493552|FG001|Overall Study|Withdrawal by Subject|1|||
130418904|NCT02298192|469493551|FG000|Overall Study|Lost to Follow-up|2|||
130564390|NCT01401842|470032200|FG001|Overall Study|on profile|5|||
130418905|NCT02298192|469493552|FG001|Overall Study|Lost to Follow-up|1|||
130418906|NCT02298192|469493551|FG000|Overall Study|Adverse Event|6|||
130418907|NCT02298192|469493552|FG001|Overall Study|Adverse Event|2|||
130418908|NCT04764396|469493556|FG000|Overall Study|Physician Decision|1|||
130418909|NCT04764396|469493557|FG001|Overall Study|Physician Decision|0|||
130418910|NCT02653482|469493559|FG000|Overall Study|Death|1|||
130418911|NCT02653482|469493560|FG001|Overall Study|Death|1|||
130418912|NCT01864564|469493563|FG000|Overall Study|Lost to Follow-up|17|||
130418913|NCT01864564|469493564|FG001|Overall Study|Lost to Follow-up|23|||
130418914|NCT01864564|469493563|FG000|Overall Study|Withdrawal by Subject|20|||
130418915|NCT01864564|469493564|FG001|Overall Study|Withdrawal by Subject|11|||
130418916|NCT01864564|469493563|FG000|Overall Study|Protocol Violation|0|||
130418917|NCT01864564|469493564|FG001|Overall Study|Protocol Violation|27|||
130418918|NCT01864564|469493563|FG000|Overall Study|not reported|0|||
130418919|NCT01864564|469493564|FG001|Overall Study|not reported|34|||
130418920|NCT03077724|469493565|FG000|Overall Study|Lost to Follow-up|5|||
130418921|NCT03077724|469493566|FG001|Overall Study|Lost to Follow-up|1|||
130418922|NCT03077724|469493565|FG000|Overall Study|Withdrawal by Subject|3|||
130418923|NCT03077724|469493566|FG001|Overall Study|Withdrawal by Subject|1|||
130418924|NCT04414696|469493569|FG000|3-month Follow up|Withdrawal by Subject|1|||
130418925|NCT04414696|469493570|FG001|3-month Follow up|Withdrawal by Subject|0|||
130418926|NCT04414696|469493569|FG000|3-month Follow up|Lost to Follow-up|22|||
130418927|NCT04414696|469493570|FG001|3-month Follow up|Lost to Follow-up|23|||
130418928|NCT04414696|469493569|FG000|6-month Follow up|Withdrawal by Subject|1|||
130418929|NCT04414696|469493570|FG001|6-month Follow up|Withdrawal by Subject|2|||
130418930|NCT04414696|469493569|FG000|6-month Follow up|Lost to Follow-up|5|||
130418931|NCT04414696|469493570|FG001|6-month Follow up|Lost to Follow-up|2|||
130418932|NCT01588184|469496033|FG000|Overall Study|Death|1|||
130418933|NCT01588184|469496034|FG001|Overall Study|Death|0|||
130418934|NCT01588184|469496035|FG002|Overall Study|Death|0|||
130418935|NCT01588184|469496036|FG003|Overall Study|Death|1|||
130418936|NCT01588184|469496037|FG004|Overall Study|Death|1|||
130418937|NCT01588184|469496038|FG005|Overall Study|Death|1|||
130418938|NCT01588184|469496033|FG000|Overall Study|Withdrawal by Subject|2|||
130418939|NCT01588184|469496034|FG001|Overall Study|Withdrawal by Subject|4|||
130418940|NCT01588184|469496035|FG002|Overall Study|Withdrawal by Subject|0|||
130418941|NCT01588184|469496036|FG003|Overall Study|Withdrawal by Subject|1|||
130418942|NCT01588184|469496037|FG004|Overall Study|Withdrawal by Subject|0|||
130418943|NCT01588184|469496038|FG005|Overall Study|Withdrawal by Subject|0|||
130418944|NCT01588184|469496033|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
130418945|NCT01588184|469496034|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
130418946|NCT01588184|469496035|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
130418947|NCT01588184|469496036|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
130418948|NCT01588184|469496037|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
130418949|NCT01588184|469496038|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
130418950|NCT01588184|469496033|FG000|Overall Study|multiple reasons|0|||
130418951|NCT01588184|469496034|FG001|Overall Study|multiple reasons|3|||
130418952|NCT01588184|469496035|FG002|Overall Study|multiple reasons|0|||
130475662|NCT02120456|469709868|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475663|NCT02120456|469709869|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475664|NCT02120456|469709870|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475665|NCT02120456|469709871|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475666|NCT02120456|469709872|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130475667|NCT02120456|469709873|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
130475668|NCT03623321|469709874|FG000|Overall Study|Adverse Event|32|||
130475669|NCT03623321|469709874|FG000|Overall Study|Death|9|||
130475670|NCT03623321|469709874|FG000|Overall Study|Lack of Efficacy|9|||
130475671|NCT03623321|469709874|FG000|Overall Study|Lost to Follow-up|6|||
130564391|NCT01401842|470032199|FG000|Overall Study|other/unknown|28|||
130564392|NCT01401842|470032200|FG001|Overall Study|other/unknown|17|||
130564393|NCT00282295|470032201|FG000|Overall Study|Adverse Event|0|||
130564394|NCT00282295|470032202|FG001|Overall Study|Adverse Event|1|||
130564395|NCT00282295|470032203|FG002|Overall Study|Adverse Event|0|||
130727291|NCT02883049|470625427|FG003|Post Induction|Inevaluable|1|||
130727292|NCT02883049|470625428|FG004|Post Induction|Inevaluable|1|||
130727293|NCT02883049|470625429|FG005|Post Induction|Inevaluable|2|||
130727294|NCT02883049|470625430|FG006|Post Induction|Inevaluable|7|||
130727295|NCT02883049|470625431|FG007|Post Induction|Inevaluable|6|||
130727296|NCT02883049|470625432|FG008|Post Induction|Inevaluable|4|||
130727297|NCT02883049|470625433|FG009|Post Induction|Inevaluable|4|||
130727298|NCT02883049|470625434|FG010|Post Induction|Inevaluable|1|||
130727299|NCT02883049|470625435|FG011|Post Induction|Inevaluable|1|||
130727300|NCT02883049|470625436|FG012|Post Induction|Inevaluable|2|||
130727301|NCT02883049|470625437|FG013|Post Induction|Inevaluable|0|||
130727302|NCT02883049|470625438|FG014|Post Induction|Inevaluable|0|||
130727303|NCT02883049|470625439|FG015|Post Induction|Inevaluable|1|||
130727304|NCT02883049|470625424|FG000|Post Induction|Moved to another non-COG institution|0|||
130727305|NCT02883049|470625425|FG001|Post Induction|Moved to another non-COG institution|0|||
130727306|NCT02883049|470625426|FG002|Post Induction|Moved to another non-COG institution|0|||
130727307|NCT02883049|470625427|FG003|Post Induction|Moved to another non-COG institution|0|||
130727308|NCT02883049|470625428|FG004|Post Induction|Moved to another non-COG institution|0|||
130727309|NCT02883049|470625429|FG005|Post Induction|Moved to another non-COG institution|0|||
130727310|NCT02883049|470625430|FG006|Post Induction|Moved to another non-COG institution|0|||
130727311|NCT02883049|470625431|FG007|Post Induction|Moved to another non-COG institution|2|||
130727312|NCT02883049|470625432|FG008|Post Induction|Moved to another non-COG institution|2|||
130418953|NCT01588184|469496036|FG003|Overall Study|multiple reasons|1|||
130418954|NCT01588184|469496037|FG004|Overall Study|multiple reasons|0|||
130418955|NCT01588184|469496038|FG005|Overall Study|multiple reasons|0|||
130475672|NCT03623321|469709874|FG000|Overall Study|Noncompliance with study drug|6|||
130475673|NCT03623321|469709874|FG000|Overall Study|Use of prohibited medication|3|||
130727313|NCT02883049|470625433|FG009|Post Induction|Moved to another non-COG institution|0|||
130418956|NCT05912400|469496039|FG000|Overall Study|Lost to Follow-up|1|||
130418957|NCT05912400|469496040|FG001|Overall Study|Lost to Follow-up|0|||
130418958|NCT05912400|469496039|FG000|Overall Study|Physician Decision|6|||
130418959|NCT05912400|469496040|FG001|Overall Study|Physician Decision|0|||
130418960|NCT05912400|469496039|FG000|Overall Study|Withdrawal by Subject|1|||
130418961|NCT05912400|469496040|FG001|Overall Study|Withdrawal by Subject|0|||
130418962|NCT02522494|469496041|FG000|Overall Study|Lost to Follow-up|6|||
130418963|NCT02522494|469496042|FG001|Overall Study|Lost to Follow-up|2|||
130418964|NCT02522494|469496041|FG000|Overall Study|Withdrawal by Subject|1|||
130418965|NCT02522494|469496042|FG001|Overall Study|Withdrawal by Subject|0|||
130418966|NCT02522494|469496041|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
130418967|NCT02522494|469496042|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
130418968|NCT02522494|469496041|FG000|Overall Study|Participant did not watch the video|1|||
130418969|NCT02522494|469496042|FG001|Overall Study|Participant did not watch the video|0|||
130418970|NCT02522494|469496041|FG000|Overall Study|Death|0|||
130418971|NCT02522494|469496042|FG001|Overall Study|Death|1|||
130418972|NCT02811861|469496043|FG000|Overall Study|Radiological Disease Progression|123|||
130418973|NCT02811861|469496044|FG001|Overall Study|Radiological Disease Progression|97|||
130418974|NCT02811861|469496045|FG002|Overall Study|Radiological Disease Progression|174|||
130418975|NCT02811861|469496043|FG000|Overall Study|Clinical Disease Progression|20|||
130418976|NCT02811861|469496044|FG001|Overall Study|Clinical Disease Progression|19|||
130418977|NCT02811861|469496045|FG002|Overall Study|Clinical Disease Progression|22|||
130418978|NCT02811861|469496043|FG000|Overall Study|Adverse Event|63|||
130418979|NCT02811861|469496044|FG001|Overall Study|Adverse Event|60|||
130418980|NCT02811861|469496045|FG002|Overall Study|Adverse Event|41|||
130418981|NCT02811861|469496043|FG000|Overall Study|Lost to Follow-up|0|||
130418982|NCT02811861|469496044|FG001|Overall Study|Lost to Follow-up|0|||
130418983|NCT02811861|469496045|FG002|Overall Study|Lost to Follow-up|1|||
130418984|NCT02811861|469496043|FG000|Overall Study|Subject Choice|29|||
130418985|NCT02811861|469496044|FG001|Overall Study|Subject Choice|17|||
130418986|NCT02811861|469496045|FG002|Overall Study|Subject Choice|23|||
130418987|NCT02811861|469496043|FG000|Overall Study|Withdrawal by Subject|4|||
130418988|NCT02811861|469496044|FG001|Overall Study|Withdrawal by Subject|4|||
130418989|NCT02811861|469496045|FG002|Overall Study|Withdrawal by Subject|9|||
130418990|NCT02811861|469496043|FG000|Overall Study|Other|4|||
130418991|NCT02811861|469496044|FG001|Overall Study|Other|13|||
130418992|NCT02811861|469496045|FG002|Overall Study|Other|3|||
130418993|NCT02811861|469496043|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
130418994|NCT02811861|469496044|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
130418995|NCT02811861|469496045|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
130418996|NCT02811861|469496043|FG000|Overall Study|Randomized but not treated|2|||
130418997|NCT02811861|469496044|FG001|Overall Study|Randomized but not treated|3|||
130418998|NCT02811861|469496045|FG002|Overall Study|Randomized but not treated|17|||
130418999|NCT00360308|469496046|FG000|Overall Study|Adverse Event|15|||
130419000|NCT00360308|469496047|FG001|Overall Study|Adverse Event|14|||
130419001|NCT00360308|469496048|FG002|Overall Study|Adverse Event|25|||
130419002|NCT00360308|469496046|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
130419003|NCT00360308|469496047|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130419004|NCT00360308|469496048|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130419005|NCT00360308|469496046|FG000|Overall Study|Protocol Violation|2|||
130419006|NCT00360308|469496047|FG001|Overall Study|Protocol Violation|1|||
130419007|NCT00360308|469496048|FG002|Overall Study|Protocol Violation|2|||
130419008|NCT00360308|469496046|FG000|Overall Study|Withdrawal by Subject|11|||
130419009|NCT00360308|469496047|FG001|Overall Study|Withdrawal by Subject|7|||
130419010|NCT00360308|469496048|FG002|Overall Study|Withdrawal by Subject|14|||
130419011|NCT00360308|469496046|FG000|Overall Study|Lack of Efficacy|3|||
130419012|NCT00360308|469496047|FG001|Overall Study|Lack of Efficacy|0|||
130419013|NCT00360308|469496048|FG002|Overall Study|Lack of Efficacy|2|||
130419014|NCT00360308|469496046|FG000|Overall Study|Other|2|||
130419015|NCT00360308|469496047|FG001|Overall Study|Other|1|||
130419016|NCT00360308|469496048|FG002|Overall Study|Other|1|||
130419017|NCT00360308|469496046|FG000|Overall Study|Study termination by sponsor|43|||
130419018|NCT00360308|469496047|FG001|Overall Study|Study termination by sponsor|55|||
130419019|NCT00360308|469496048|FG002|Overall Study|Study termination by sponsor|44|||
130419020|NCT03461003|469496049|FG000|Overall Study|Lost to Follow-up|2|||
130419021|NCT03461003|469496050|FG001|Overall Study|Lost to Follow-up|2|||
130419022|NCT03461003|469496049|FG000|Overall Study|Withdrawal by Subject|3|||
130419023|NCT03461003|469496050|FG001|Overall Study|Withdrawal by Subject|1|||
130419024|NCT03489304|469496051|FG000|Overall Study|Lost to Follow-up|4|||
130419025|NCT02239679|469496055|FG000|Overall Study|Lost to Follow-up|1|||
130419026|NCT02239679|469496056|FG001|Overall Study|Lost to Follow-up|0|||
130419027|NCT02239679|469496057|FG002|Overall Study|Lost to Follow-up|0|||
130419028|NCT02239679|469496055|FG000|Overall Study|Withdrawal by Subject|2|||
130419029|NCT02239679|469496056|FG001|Overall Study|Withdrawal by Subject|3|||
130419030|NCT02239679|469496057|FG002|Overall Study|Withdrawal by Subject|1|||
130419031|NCT01217073|469496058|FG000|Base Period|Adverse Event|1|||
130419032|NCT01217073|469496059|FG001|Base Period|Adverse Event|0|||
130419033|NCT01217073|469496060|FG002|Base Period|Adverse Event|1|||
130419034|NCT01217073|469496061|FG003|Base Period|Adverse Event|0|||
130419035|NCT01217073|469496062|FG004|Base Period|Adverse Event|4|||
130419036|NCT01217073|469496063|FG005|Base Period|Adverse Event|1|||
130419037|NCT01217073|469496064|FG006|Base Period|Adverse Event|0|||
130419038|NCT01217073|469496065|FG007|Base Period|Adverse Event|0|||
130419039|NCT01217073|469496058|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
130419040|NCT01217073|469496059|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419041|NCT01217073|469496060|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419042|NCT01217073|469496061|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419043|NCT01217073|469496062|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419044|NCT01217073|469496063|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419045|NCT01217073|469496064|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130475674|NCT03623321|469709874|FG000|Overall Study|Physician Decision|5|||
130475675|NCT03623321|469709874|FG000|Overall Study|Protocol Violation|1|||
130475676|NCT03623321|469709874|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
130475677|NCT03623321|469709874|FG000|Overall Study|Not further specified|43|||
130475678|NCT02243709|469709876|FG000|Phase 1|Lost to Follow-up|0|||
130475679|NCT02243709|469709877|FG001|Phase 1|Lost to Follow-up|1|||
130475680|NCT02243709|469709876|FG000|Phase 1|Withdrawal by Subject|1|||
130475681|NCT02243709|469709877|FG001|Phase 1|Withdrawal by Subject|0|||
130475682|NCT02243709|469709876|FG000|Phase 1|Protocol Violation|0|||
130475683|NCT02243709|469709877|FG001|Phase 1|Protocol Violation|1|||
130419046|NCT01217073|469496065|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130419047|NCT01217073|469496058|FG000|Base Period|Excluded medication|0|||
130419048|NCT01217073|469496059|FG001|Base Period|Excluded medication|0|||
130419049|NCT01217073|469496060|FG002|Base Period|Excluded medication|0|||
130419050|NCT01217073|469496061|FG003|Base Period|Excluded medication|0|||
130419051|NCT01217073|469496062|FG004|Base Period|Excluded medication|1|||
130419052|NCT01217073|469496063|FG005|Base Period|Excluded medication|0|||
130419053|NCT01217073|469496064|FG006|Base Period|Excluded medication|0|||
130419054|NCT01217073|469496065|FG007|Base Period|Excluded medication|0|||
130419055|NCT01217073|469496058|FG000|Base Period|Lack of Efficacy|0|||
130419056|NCT01217073|469496059|FG001|Base Period|Lack of Efficacy|0|||
130419057|NCT01217073|469496060|FG002|Base Period|Lack of Efficacy|0|||
130419058|NCT01217073|469496061|FG003|Base Period|Lack of Efficacy|0|||
130419059|NCT01217073|469496062|FG004|Base Period|Lack of Efficacy|0|||
130419060|NCT01217073|469496063|FG005|Base Period|Lack of Efficacy|1|||
130419061|NCT01217073|469496064|FG006|Base Period|Lack of Efficacy|0|||
130419062|NCT01217073|469496065|FG007|Base Period|Lack of Efficacy|0|||
130419063|NCT01217073|469496058|FG000|Base Period|Lost to Follow-up|0|||
130419064|NCT01217073|469496059|FG001|Base Period|Lost to Follow-up|0|||
130419065|NCT01217073|469496060|FG002|Base Period|Lost to Follow-up|1|||
130419066|NCT01217073|469496061|FG003|Base Period|Lost to Follow-up|1|||
130419067|NCT01217073|469496062|FG004|Base Period|Lost to Follow-up|3|||
130419068|NCT01217073|469496063|FG005|Base Period|Lost to Follow-up|0|||
130419069|NCT01217073|469496064|FG006|Base Period|Lost to Follow-up|0|||
130419070|NCT01217073|469496065|FG007|Base Period|Lost to Follow-up|0|||
130419071|NCT01217073|469496058|FG000|Base Period|Physician Decision|0|||
130419072|NCT01217073|469496059|FG001|Base Period|Physician Decision|0|||
130419073|NCT01217073|469496060|FG002|Base Period|Physician Decision|0|||
130419074|NCT01217073|469496061|FG003|Base Period|Physician Decision|0|||
130419075|NCT01217073|469496062|FG004|Base Period|Physician Decision|1|||
130419076|NCT01217073|469496063|FG005|Base Period|Physician Decision|0|||
130419077|NCT01217073|469496064|FG006|Base Period|Physician Decision|0|||
130475684|NCT02243709|469709876|FG000|Phase 1|Adverse Event|0|||
130475685|NCT02243709|469709877|FG001|Phase 1|Adverse Event|1|||
130475686|NCT04347161|469709880|FG000|Overall Study|Death|0|||
130475687|NCT04347161|469709881|FG001|Overall Study|Death|2|||
130564396|NCT00282295|470032201|FG000|Overall Study|Serious Adverse Events|0|||
130564397|NCT00282295|470032202|FG001|Overall Study|Serious Adverse Events|0|||
130564398|NCT00282295|470032203|FG002|Overall Study|Serious Adverse Events|1|||
130419078|NCT01217073|469496065|FG007|Base Period|Physician Decision|0|||
130419079|NCT01217073|469496058|FG000|Base Period|Protocol Violation|1|||
130419080|NCT01217073|469496059|FG001|Base Period|Protocol Violation|0|||
130419081|NCT01217073|469496060|FG002|Base Period|Protocol Violation|0|||
130419082|NCT01217073|469496061|FG003|Base Period|Protocol Violation|0|||
130564399|NCT00282295|470032201|FG000|Overall Study|Protocol Violation|0|||
130564400|NCT00282295|470032202|FG001|Overall Study|Protocol Violation|2|||
130564401|NCT00282295|470032203|FG002|Overall Study|Protocol Violation|1|||
130419083|NCT01217073|469496062|FG004|Base Period|Protocol Violation|1|||
130419084|NCT01217073|469496063|FG005|Base Period|Protocol Violation|2|||
130419085|NCT01217073|469496064|FG006|Base Period|Protocol Violation|0|||
130419086|NCT01217073|469496065|FG007|Base Period|Protocol Violation|0|||
130419087|NCT01217073|469496058|FG000|Base Period|Withdrawal by Subject|4|||
130419088|NCT01217073|469496059|FG001|Base Period|Withdrawal by Subject|5|||
130419089|NCT01217073|469496060|FG002|Base Period|Withdrawal by Subject|5|||
130419090|NCT01217073|469496061|FG003|Base Period|Withdrawal by Subject|1|||
130475688|NCT04347161|469709880|FG000|Overall Study|Withdrawal by Subject|1|||
130475689|NCT04347161|469709881|FG001|Overall Study|Withdrawal by Subject|0|||
130475690|NCT04347161|469709880|FG000|Overall Study|Lost to Follow-up|0|||
130475691|NCT04347161|469709881|FG001|Overall Study|Lost to Follow-up|1|||
130475692|NCT04347161|469709880|FG000|Overall Study|No longer on study medication|1|||
130419091|NCT01217073|469496062|FG004|Base Period|Withdrawal by Subject|5|||
130419092|NCT01217073|469496063|FG005|Base Period|Withdrawal by Subject|5|||
130419093|NCT01217073|469496064|FG006|Base Period|Withdrawal by Subject|0|||
130419094|NCT01217073|469496065|FG007|Base Period|Withdrawal by Subject|0|||
130419095|NCT01217073|469496058|FG000|Extension Period|Adverse Event|0|||
130419096|NCT01217073|469496059|FG001|Extension Period|Adverse Event|0|||
130419097|NCT01217073|469496060|FG002|Extension Period|Adverse Event|0|||
130419098|NCT01217073|469496061|FG003|Extension Period|Adverse Event|0|||
130419099|NCT01217073|469496062|FG004|Extension Period|Adverse Event|0|||
130419100|NCT01217073|469496063|FG005|Extension Period|Adverse Event|0|||
130419101|NCT01217073|469496064|FG006|Extension Period|Adverse Event|19|||
130419102|NCT01217073|469496065|FG007|Extension Period|Adverse Event|5|||
130419103|NCT01217073|469496058|FG000|Extension Period|ALT/AST|0|||
130419104|NCT01217073|469496059|FG001|Extension Period|ALT/AST|0|||
130419105|NCT01217073|469496060|FG002|Extension Period|ALT/AST|0|||
130419106|NCT01217073|469496061|FG003|Extension Period|ALT/AST|0|||
130419107|NCT01217073|469496062|FG004|Extension Period|ALT/AST|0|||
130419108|NCT01217073|469496063|FG005|Extension Period|ALT/AST|0|||
130419109|NCT01217073|469496064|FG006|Extension Period|ALT/AST|2|||
130419110|NCT01217073|469496065|FG007|Extension Period|ALT/AST|0|||
130419111|NCT01217073|469496058|FG000|Extension Period|Contraindication to study medication|0|||
130419112|NCT01217073|469496059|FG001|Extension Period|Contraindication to study medication|0|||
130419113|NCT01217073|469496060|FG002|Extension Period|Contraindication to study medication|0|||
130419114|NCT01217073|469496061|FG003|Extension Period|Contraindication to study medication|0|||
130419115|NCT01217073|469496062|FG004|Extension Period|Contraindication to study medication|0|||
130419116|NCT01217073|469496063|FG005|Extension Period|Contraindication to study medication|0|||
130419117|NCT01217073|469496064|FG006|Extension Period|Contraindication to study medication|1|||
130419118|NCT01217073|469496065|FG007|Extension Period|Contraindication to study medication|0|||
130419119|NCT01217073|469496058|FG000|Extension Period|Creatinine/eGFR|0|||
130419120|NCT01217073|469496059|FG001|Extension Period|Creatinine/eGFR|0|||
130419121|NCT01217073|469496060|FG002|Extension Period|Creatinine/eGFR|0|||
130419122|NCT01217073|469496061|FG003|Extension Period|Creatinine/eGFR|0|||
130419123|NCT01217073|469496062|FG004|Extension Period|Creatinine/eGFR|0|||
130419124|NCT01217073|469496063|FG005|Extension Period|Creatinine/eGFR|0|||
130419125|NCT01217073|469496064|FG006|Extension Period|Creatinine/eGFR|11|||
130419126|NCT01217073|469496065|FG007|Extension Period|Creatinine/eGFR|1|||
130419127|NCT01217073|469496058|FG000|Extension Period|Death|0|||
130419128|NCT01217073|469496059|FG001|Extension Period|Death|0|||
130419129|NCT01217073|469496060|FG002|Extension Period|Death|0|||
130419130|NCT01217073|469496061|FG003|Extension Period|Death|0|||
130419131|NCT01217073|469496062|FG004|Extension Period|Death|0|||
130419132|NCT01217073|469496063|FG005|Extension Period|Death|0|||
130419133|NCT01217073|469496064|FG006|Extension Period|Death|1|||
130475693|NCT04347161|469709881|FG001|Overall Study|No longer on study medication|1|||
130475694|NCT04169373|469709882|FG000|Week 1 to Week 14|Adverse Event|1|||
130475695|NCT04169373|469709883|FG001|Week 1 to Week 14|Adverse Event|0|||
130475696|NCT04169373|469709884|FG002|Week 1 to Week 14|Adverse Event|1|||
130475697|NCT04169373|469709885|FG003|Week 1 to Week 14|Adverse Event|2|||
130475698|NCT04169373|469709882|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
130475699|NCT04169373|469709883|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
130475700|NCT04169373|469709884|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
130475701|NCT04169373|469709885|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
130475702|NCT04169373|469709882|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
130475703|NCT04169373|469709883|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
130475704|NCT04169373|469709884|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
130475705|NCT04169373|469709885|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
130475706|NCT04169373|469709882|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
130475707|NCT04169373|469709883|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
130475708|NCT04169373|469709884|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
130475709|NCT04169373|469709885|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
130475710|NCT04169373|469709882|FG000|Week 1 to Week 14|Other|1|||
130475711|NCT04169373|469709883|FG001|Week 1 to Week 14|Other|3|||
130419134|NCT01217073|469496065|FG007|Extension Period|Death|0|||
130419135|NCT01217073|469496058|FG000|Extension Period|Excluded medication|0|||
130419136|NCT01217073|469496059|FG001|Extension Period|Excluded medication|0|||
130419137|NCT01217073|469496060|FG002|Extension Period|Excluded medication|0|||
130419138|NCT01217073|469496061|FG003|Extension Period|Excluded medication|0|||
130419139|NCT01217073|469496062|FG004|Extension Period|Excluded medication|0|||
130475712|NCT04169373|469709884|FG002|Week 1 to Week 14|Other|3|||
130475713|NCT04169373|469709885|FG003|Week 1 to Week 14|Other|5|||
130475714|NCT04169373|469709882|FG000|Week 14 to Week 52|Adverse Event|1|||
130419140|NCT01217073|469496063|FG005|Extension Period|Excluded medication|0|||
130419141|NCT01217073|469496064|FG006|Extension Period|Excluded medication|2|||
130419142|NCT01217073|469496065|FG007|Extension Period|Excluded medication|0|||
130419143|NCT01217073|469496058|FG000|Extension Period|Lack of Efficacy|0|||
130419144|NCT01217073|469496059|FG001|Extension Period|Lack of Efficacy|0|||
130475715|NCT04169373|469709883|FG001|Week 14 to Week 52|Adverse Event|0|||
130475716|NCT04169373|469709884|FG002|Week 14 to Week 52|Adverse Event|0|||
130419145|NCT01217073|469496060|FG002|Extension Period|Lack of Efficacy|0|||
130419146|NCT01217073|469496061|FG003|Extension Period|Lack of Efficacy|0|||
130419147|NCT01217073|469496062|FG004|Extension Period|Lack of Efficacy|0|||
130419148|NCT01217073|469496063|FG005|Extension Period|Lack of Efficacy|0|||
130419149|NCT01217073|469496064|FG006|Extension Period|Lack of Efficacy|3|||
130419150|NCT01217073|469496065|FG007|Extension Period|Lack of Efficacy|0|||
130419151|NCT01217073|469496058|FG000|Extension Period|Lost to Follow-up|0|||
130419152|NCT01217073|469496059|FG001|Extension Period|Lost to Follow-up|0|||
130419153|NCT01217073|469496060|FG002|Extension Period|Lost to Follow-up|0|||
130419154|NCT01217073|469496061|FG003|Extension Period|Lost to Follow-up|0|||
130419155|NCT01217073|469496062|FG004|Extension Period|Lost to Follow-up|0|||
130419156|NCT01217073|469496063|FG005|Extension Period|Lost to Follow-up|0|||
130419157|NCT01217073|469496064|FG006|Extension Period|Lost to Follow-up|9|||
130419158|NCT01217073|469496065|FG007|Extension Period|Lost to Follow-up|1|||
130419159|NCT01217073|469496058|FG000|Extension Period|Non-compliance with study drug|0|||
130419160|NCT01217073|469496059|FG001|Extension Period|Non-compliance with study drug|0|||
130419161|NCT01217073|469496060|FG002|Extension Period|Non-compliance with study drug|0|||
130419162|NCT01217073|469496061|FG003|Extension Period|Non-compliance with study drug|0|||
130419163|NCT01217073|469496062|FG004|Extension Period|Non-compliance with study drug|0|||
130419164|NCT01217073|469496063|FG005|Extension Period|Non-compliance with study drug|0|||
130419165|NCT01217073|469496064|FG006|Extension Period|Non-compliance with study drug|0|||
130419166|NCT01217073|469496065|FG007|Extension Period|Non-compliance with study drug|1|||
130419167|NCT01217073|469496058|FG000|Extension Period|Physician Decision|0|||
130419168|NCT01217073|469496059|FG001|Extension Period|Physician Decision|0|||
130419169|NCT01217073|469496060|FG002|Extension Period|Physician Decision|0|||
130419170|NCT01217073|469496061|FG003|Extension Period|Physician Decision|0|||
130419171|NCT01217073|469496062|FG004|Extension Period|Physician Decision|0|||
130419172|NCT01217073|469496063|FG005|Extension Period|Physician Decision|0|||
130419173|NCT01217073|469496064|FG006|Extension Period|Physician Decision|4|||
130419174|NCT01217073|469496065|FG007|Extension Period|Physician Decision|1|||
130419175|NCT01217073|469496058|FG000|Extension Period|Protocol Violation|0|||
130419176|NCT01217073|469496059|FG001|Extension Period|Protocol Violation|0|||
130419177|NCT01217073|469496060|FG002|Extension Period|Protocol Violation|0|||
130419178|NCT01217073|469496061|FG003|Extension Period|Protocol Violation|0|||
130419179|NCT01217073|469496062|FG004|Extension Period|Protocol Violation|0|||
130419180|NCT01217073|469496063|FG005|Extension Period|Protocol Violation|0|||
130419181|NCT01217073|469496064|FG006|Extension Period|Protocol Violation|2|||
130419182|NCT01217073|469496065|FG007|Extension Period|Protocol Violation|1|||
130419183|NCT01217073|469496058|FG000|Extension Period|Site discontinued study participation|0|||
130419184|NCT01217073|469496059|FG001|Extension Period|Site discontinued study participation|0|||
130419185|NCT01217073|469496060|FG002|Extension Period|Site discontinued study participation|0|||
130419186|NCT01217073|469496061|FG003|Extension Period|Site discontinued study participation|0|||
130419187|NCT01217073|469496062|FG004|Extension Period|Site discontinued study participation|0|||
130419188|NCT01217073|469496063|FG005|Extension Period|Site discontinued study participation|0|||
130419189|NCT01217073|469496064|FG006|Extension Period|Site discontinued study participation|7|||
130419190|NCT01217073|469496065|FG007|Extension Period|Site discontinued study participation|2|||
130419191|NCT01217073|469496058|FG000|Extension Period|Withdrawal by Subject|0|||
130419192|NCT01217073|469496059|FG001|Extension Period|Withdrawal by Subject|0|||
130419193|NCT01217073|469496060|FG002|Extension Period|Withdrawal by Subject|0|||
130419194|NCT01217073|469496061|FG003|Extension Period|Withdrawal by Subject|0|||
130419195|NCT01217073|469496062|FG004|Extension Period|Withdrawal by Subject|0|||
130419196|NCT01217073|469496063|FG005|Extension Period|Withdrawal by Subject|0|||
130419197|NCT01217073|469496064|FG006|Extension Period|Withdrawal by Subject|30|||
130419198|NCT01217073|469496065|FG007|Extension Period|Withdrawal by Subject|8|||
130419199|NCT02047045|469496066|FG000|Baseline|Withdrawal by Subject|3|||
130419200|NCT02047045|469496067|FG001|Baseline|Withdrawal by Subject|2|||
130419201|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
130419202|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
130475717|NCT04169373|469709885|FG003|Week 14 to Week 52|Adverse Event|1|||
130419203|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
130419204|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
130419205|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
130419206|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
130419207|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
130419208|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
130419209|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
130419210|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
130419211|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
130419212|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
130419213|NCT02047045|469496066|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
130419214|NCT02047045|469496067|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
130419215|NCT02047045|469496066|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
130419216|NCT02047045|469496067|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
130419217|NCT04066114|469496068|FG000|Overall Study|Adverse Event|1|||
130419218|NCT04066114|469496069|FG001|Overall Study|Adverse Event|0|||
130419219|NCT04066114|469496070|FG002|Overall Study|Adverse Event|0|||
130419220|NCT04066114|469496068|FG000|Overall Study|Withdrawal by Subject|1|||
130419221|NCT04066114|469496069|FG001|Overall Study|Withdrawal by Subject|0|||
130419222|NCT04066114|469496070|FG002|Overall Study|Withdrawal by Subject|0|||
130419223|NCT04066114|469496068|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130419224|NCT04066114|469496069|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
130419225|NCT04066114|469496070|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
130419226|NCT02564523|469496073|FG000|Overall Study|Withdrawal by Subject|3|||
130419227|NCT02564523|469496074|FG001|Overall Study|Withdrawal by Subject|0|||
130419228|NCT02564523|469496075|FG002|Overall Study|Withdrawal by Subject|1|||
130419229|NCT02564523|469496076|FG003|Overall Study|Withdrawal by Subject|0|||
130419230|NCT02564523|469496077|FG004|Overall Study|Withdrawal by Subject|1|||
130419231|NCT02564523|469496078|FG005|Overall Study|Withdrawal by Subject|0|||
130419232|NCT02564523|469496079|FG006|Overall Study|Withdrawal by Subject|1|||
130419233|NCT02564523|469496080|FG007|Overall Study|Withdrawal by Subject|0|||
130419234|NCT02564523|469496081|FG008|Overall Study|Withdrawal by Subject|0|||
130419235|NCT02564523|469496082|FG009|Overall Study|Withdrawal by Subject|0|||
130419236|NCT02564523|469496083|FG010|Overall Study|Withdrawal by Subject|1|||
130419237|NCT02564523|469496084|FG011|Overall Study|Withdrawal by Subject|0|||
130419238|NCT02564523|469496085|FG012|Overall Study|Withdrawal by Subject|1|||
130419239|NCT02564523|469496086|FG013|Overall Study|Withdrawal by Subject|0|||
130419240|NCT02564523|469496087|FG014|Overall Study|Withdrawal by Subject|0|||
130419241|NCT02564523|469496088|FG015|Overall Study|Withdrawal by Subject|0|||
130419242|NCT02564523|469496089|FG016|Overall Study|Withdrawal by Subject|0|||
130419243|NCT02564523|469496090|FG017|Overall Study|Withdrawal by Subject|0|||
130419244|NCT02564523|469496073|FG000|Overall Study|Adverse Event|0|||
130419245|NCT02564523|469496074|FG001|Overall Study|Adverse Event|0|||
130419246|NCT02564523|469496075|FG002|Overall Study|Adverse Event|0|||
130419247|NCT02564523|469496076|FG003|Overall Study|Adverse Event|0|||
130419248|NCT02564523|469496077|FG004|Overall Study|Adverse Event|0|||
130419249|NCT02564523|469496078|FG005|Overall Study|Adverse Event|0|||
130419250|NCT02564523|469496079|FG006|Overall Study|Adverse Event|0|||
130419251|NCT02564523|469496080|FG007|Overall Study|Adverse Event|0|||
130419252|NCT02564523|469496081|FG008|Overall Study|Adverse Event|0|||
130419253|NCT02564523|469496082|FG009|Overall Study|Adverse Event|0|||
130419254|NCT02564523|469496083|FG010|Overall Study|Adverse Event|0|||
130419255|NCT02564523|469496084|FG011|Overall Study|Adverse Event|0|||
130419256|NCT02564523|469496085|FG012|Overall Study|Adverse Event|0|||
130419257|NCT02564523|469496086|FG013|Overall Study|Adverse Event|0|||
130419258|NCT02564523|469496087|FG014|Overall Study|Adverse Event|0|||
130419259|NCT02564523|469496088|FG015|Overall Study|Adverse Event|0|||
130419260|NCT02564523|469496089|FG016|Overall Study|Adverse Event|0|||
130419261|NCT02564523|469496090|FG017|Overall Study|Adverse Event|1|||
130419262|NCT02564523|469496073|FG000|Overall Study|Death|0|||
130419263|NCT02564523|469496074|FG001|Overall Study|Death|0|||
130419264|NCT02564523|469496075|FG002|Overall Study|Death|0|||
130419265|NCT02564523|469496076|FG003|Overall Study|Death|0|||
130727314|NCT02883049|470625434|FG010|Post Induction|Moved to another non-COG institution|0|||
130727315|NCT02883049|470625435|FG011|Post Induction|Moved to another non-COG institution|1|||
130727316|NCT02883049|470625436|FG012|Post Induction|Moved to another non-COG institution|0|||
130727317|NCT02883049|470625437|FG013|Post Induction|Moved to another non-COG institution|0|||
130727318|NCT02883049|470625438|FG014|Post Induction|Moved to another non-COG institution|0|||
130727319|NCT02883049|470625439|FG015|Post Induction|Moved to another non-COG institution|0|||
130727320|NCT02883049|470625424|FG000|Post Induction|Randomization closed|0|||
130727321|NCT02883049|470625425|FG001|Post Induction|Randomization closed|0|||
130419266|NCT02564523|469496077|FG004|Overall Study|Death|0|||
130419267|NCT02564523|469496078|FG005|Overall Study|Death|0|||
130564402|NCT00282295|470032201|FG000|Overall Study|Withdrawal by Subject|2|||
130564403|NCT00282295|470032202|FG001|Overall Study|Withdrawal by Subject|6|||
130564404|NCT00282295|470032203|FG002|Overall Study|Withdrawal by Subject|4|||
130564405|NCT00282295|470032201|FG000|Overall Study|Lost to Follow-up|1|||
130419268|NCT02564523|469496079|FG006|Overall Study|Death|1|||
130419269|NCT02564523|469496080|FG007|Overall Study|Death|0|||
130419270|NCT02564523|469496081|FG008|Overall Study|Death|0|||
130419271|NCT02564523|469496082|FG009|Overall Study|Death|0|||
130419272|NCT02564523|469496083|FG010|Overall Study|Death|1|||
130564406|NCT00282295|470032202|FG001|Overall Study|Lost to Follow-up|7|||
130564407|NCT00282295|470032203|FG002|Overall Study|Lost to Follow-up|2|||
130419273|NCT02564523|469496084|FG011|Overall Study|Death|0|||
130419274|NCT02564523|469496085|FG012|Overall Study|Death|0|||
130419275|NCT02564523|469496086|FG013|Overall Study|Death|0|||
130419276|NCT02564523|469496087|FG014|Overall Study|Death|0|||
130419277|NCT02564523|469496088|FG015|Overall Study|Death|0|||
130419278|NCT02564523|469496089|FG016|Overall Study|Death|0|||
130564408|NCT00282295|470032201|FG000|Overall Study|Other|0|||
130564409|NCT00282295|470032202|FG001|Overall Study|Other|1|||
130564410|NCT00282295|470032203|FG002|Overall Study|Other|0|||
130564411|NCT00121108|470032204|FG000|Overall Study|Lost to Follow-up|10|||
130564412|NCT00121108|470032205|FG001|Overall Study|Lost to Follow-up|22|||
130564413|NCT00121108|470032204|FG000|Overall Study|Withdrawal by Subject|106|||
130564414|NCT00121108|470032205|FG001|Overall Study|Withdrawal by Subject|195|||
130564415|NCT00121108|470032204|FG000|Overall Study|Death|5|||
130419279|NCT02564523|469496090|FG017|Overall Study|Death|0|||
130419280|NCT02564523|469496073|FG000|Overall Study|Lost to Follow-up|2|||
130419281|NCT02564523|469496074|FG001|Overall Study|Lost to Follow-up|1|||
130419282|NCT02564523|469496075|FG002|Overall Study|Lost to Follow-up|4|||
130419283|NCT02564523|469496076|FG003|Overall Study|Lost to Follow-up|0|||
130419284|NCT02564523|469496077|FG004|Overall Study|Lost to Follow-up|1|||
130419285|NCT02564523|469496078|FG005|Overall Study|Lost to Follow-up|0|||
130419286|NCT02564523|469496079|FG006|Overall Study|Lost to Follow-up|1|||
130419287|NCT02564523|469496080|FG007|Overall Study|Lost to Follow-up|0|||
130419288|NCT02564523|469496081|FG008|Overall Study|Lost to Follow-up|0|||
130419289|NCT02564523|469496082|FG009|Overall Study|Lost to Follow-up|0|||
130419290|NCT02564523|469496083|FG010|Overall Study|Lost to Follow-up|0|||
130419291|NCT02564523|469496084|FG011|Overall Study|Lost to Follow-up|1|||
130419292|NCT02564523|469496085|FG012|Overall Study|Lost to Follow-up|1|||
130419293|NCT02564523|469496086|FG013|Overall Study|Lost to Follow-up|0|||
130419294|NCT02564523|469496087|FG014|Overall Study|Lost to Follow-up|0|||
130419295|NCT02564523|469496088|FG015|Overall Study|Lost to Follow-up|0|||
130419296|NCT02564523|469496089|FG016|Overall Study|Lost to Follow-up|0|||
130419297|NCT02564523|469496090|FG017|Overall Study|Lost to Follow-up|0|||
130419298|NCT02564523|469496073|FG000|Overall Study|Physician Decision|0|||
130419299|NCT02564523|469496074|FG001|Overall Study|Physician Decision|0|||
130419300|NCT02564523|469496075|FG002|Overall Study|Physician Decision|0|||
130419301|NCT02564523|469496076|FG003|Overall Study|Physician Decision|0|||
130419302|NCT02564523|469496077|FG004|Overall Study|Physician Decision|1|||
130419303|NCT02564523|469496078|FG005|Overall Study|Physician Decision|0|||
130419304|NCT02564523|469496079|FG006|Overall Study|Physician Decision|0|||
130419305|NCT02564523|469496080|FG007|Overall Study|Physician Decision|0|||
130419306|NCT02564523|469496081|FG008|Overall Study|Physician Decision|0|||
130419307|NCT02564523|469496082|FG009|Overall Study|Physician Decision|0|||
130419308|NCT02564523|469496083|FG010|Overall Study|Physician Decision|1|||
130419309|NCT02564523|469496084|FG011|Overall Study|Physician Decision|0|||
130564416|NCT00121108|470032205|FG001|Overall Study|Death|8|||
130564417|NCT01380379|470032206|FG000|Overall Study|Pregnancy|1|||
130564418|NCT01357577|470032209|FG000|Overall Study|Lost to Follow-up|20|||
130564419|NCT01357577|470032210|FG001|Overall Study|Lost to Follow-up|16|||
130564420|NCT01357577|470032209|FG000|Overall Study|Withdrawal by Subject|16|||
130564421|NCT01357577|470032210|FG001|Overall Study|Withdrawal by Subject|8|||
130564422|NCT01357577|470032209|FG000|Overall Study|look at data in database?|1|||
130564423|NCT01357577|470032210|FG001|Overall Study|look at data in database?|2|||
130564424|NCT06156215|470032213|FG000|Overall Study|Withdrawal by Subject|2|||
130564425|NCT06156215|470032214|FG001|Overall Study|Withdrawal by Subject|4|||
130564426|NCT06156215|470032215|FG002|Overall Study|Withdrawal by Subject|4|||
130564427|NCT06156215|470032216|FG003|Overall Study|Withdrawal by Subject|0|||
130419310|NCT02564523|469496085|FG012|Overall Study|Physician Decision|0|||
130419311|NCT02564523|469496086|FG013|Overall Study|Physician Decision|0|||
130419312|NCT02564523|469496087|FG014|Overall Study|Physician Decision|0|||
130419313|NCT02564523|469496088|FG015|Overall Study|Physician Decision|0|||
130419314|NCT02564523|469496089|FG016|Overall Study|Physician Decision|0|||
130419315|NCT02564523|469496090|FG017|Overall Study|Physician Decision|0|||
130419316|NCT02564523|469496073|FG000|Overall Study|Protocol Violation|2|||
130419317|NCT02564523|469496074|FG001|Overall Study|Protocol Violation|2|||
130419318|NCT02564523|469496075|FG002|Overall Study|Protocol Violation|5|||
130419319|NCT02564523|469496076|FG003|Overall Study|Protocol Violation|0|||
130419320|NCT02564523|469496077|FG004|Overall Study|Protocol Violation|1|||
130419321|NCT02564523|469496078|FG005|Overall Study|Protocol Violation|0|||
130419322|NCT02564523|469496079|FG006|Overall Study|Protocol Violation|0|||
130419323|NCT02564523|469496080|FG007|Overall Study|Protocol Violation|0|||
130419324|NCT02564523|469496081|FG008|Overall Study|Protocol Violation|0|||
130419325|NCT02564523|469496082|FG009|Overall Study|Protocol Violation|0|||
130564428|NCT06156215|470032217|FG004|Overall Study|Withdrawal by Subject|2|||
130419326|NCT02564523|469496083|FG010|Overall Study|Protocol Violation|0|||
130419327|NCT02564523|469496084|FG011|Overall Study|Protocol Violation|0|||
130419328|NCT02564523|469496085|FG012|Overall Study|Protocol Violation|0|||
130419329|NCT02564523|469496086|FG013|Overall Study|Protocol Violation|0|||
130419330|NCT02564523|469496087|FG014|Overall Study|Protocol Violation|0|||
130419331|NCT02564523|469496088|FG015|Overall Study|Protocol Violation|0|||
130419332|NCT02564523|469496089|FG016|Overall Study|Protocol Violation|0|||
130419333|NCT02564523|469496090|FG017|Overall Study|Protocol Violation|0|||
130419334|NCT02564523|469496073|FG000|Overall Study|Other|3|||
130419335|NCT02564523|469496074|FG001|Overall Study|Other|0|||
130419336|NCT02564523|469496075|FG002|Overall Study|Other|0|||
130564429|NCT06156215|470032218|FG005|Overall Study|Withdrawal by Subject|2|||
130564430|NCT06156215|470032213|FG000|Overall Study|Left ED without completing study|9|||
130564431|NCT06156215|470032214|FG001|Overall Study|Left ED without completing study|3|||
130419337|NCT02564523|469496076|FG003|Overall Study|Other|1|||
130419338|NCT02564523|469496077|FG004|Overall Study|Other|0|||
130419339|NCT02564523|469496078|FG005|Overall Study|Other|0|||
130419340|NCT02564523|469496079|FG006|Overall Study|Other|0|||
130419341|NCT02564523|469496080|FG007|Overall Study|Other|0|||
130419342|NCT02564523|469496081|FG008|Overall Study|Other|0|||
130419343|NCT02564523|469496082|FG009|Overall Study|Other|0|||
130419344|NCT02564523|469496083|FG010|Overall Study|Other|0|||
130419345|NCT02564523|469496084|FG011|Overall Study|Other|0|||
130419346|NCT02564523|469496085|FG012|Overall Study|Other|0|||
130419347|NCT02564523|469496086|FG013|Overall Study|Other|0|||
130419348|NCT02564523|469496087|FG014|Overall Study|Other|0|||
130419349|NCT02564523|469496088|FG015|Overall Study|Other|0|||
130419350|NCT02564523|469496089|FG016|Overall Study|Other|0|||
130419351|NCT02564523|469496090|FG017|Overall Study|Other|0|||
130419352|NCT04862143|469496105|FG000|Overall Study|Adverse Event|1|||
130419353|NCT04862143|469496105|FG000|Overall Study|Study terminated by sponsor|1|||
130419354|NCT03031938|469496106|FG000|Overall Study|Death|1|||
130419355|NCT03031938|469496107|FG001|Overall Study|Death|0|||
130419356|NCT02479412|469496110|FG000|Overall Study|Adverse Event|0|||
130419357|NCT02479412|469496111|FG001|Overall Study|Adverse Event|0|||
130419358|NCT02479412|469496112|FG002|Overall Study|Adverse Event|1|||
130419359|NCT02479412|469496113|FG003|Overall Study|Adverse Event|0|||
130419360|NCT02479412|469496114|FG004|Overall Study|Adverse Event|0|||
130419361|NCT02479412|469496115|FG005|Overall Study|Adverse Event|0|||
130419362|NCT02479412|469496116|FG006|Overall Study|Adverse Event|0|||
130419363|NCT02479412|469496117|FG007|Overall Study|Adverse Event|0|||
130419364|NCT02479412|469496118|FG008|Overall Study|Adverse Event|0|||
130419365|NCT02479412|469496110|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130419366|NCT02479412|469496111|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130419367|NCT02479412|469496112|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130419368|NCT02479412|469496113|FG003|Overall Study|Study-specific withdrawal criteria|1|||
130419369|NCT02479412|469496114|FG004|Overall Study|Study-specific withdrawal criteria|0|||
130419370|NCT02479412|469496115|FG005|Overall Study|Study-specific withdrawal criteria|0|||
130419371|NCT02479412|469496116|FG006|Overall Study|Study-specific withdrawal criteria|0|||
130419372|NCT02479412|469496117|FG007|Overall Study|Study-specific withdrawal criteria|1|||
130419373|NCT02479412|469496118|FG008|Overall Study|Study-specific withdrawal criteria|1|||
130419374|NCT02479412|469496110|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
130419375|NCT02479412|469496111|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
130419376|NCT02479412|469496112|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
130419377|NCT02479412|469496113|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
130419378|NCT02479412|469496114|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
130419379|NCT02479412|469496115|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
130419380|NCT02479412|469496116|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
130419381|NCT02479412|469496117|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
130419382|NCT02479412|469496118|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
130419383|NCT00454051|469496119|FG000|Overall Study|Adverse Event|1|||
130419384|NCT00454051|469496120|FG001|Overall Study|Adverse Event|2|||
130419385|NCT00454051|469496119|FG000|Overall Study|Withdrawal by Subject|1|||
130419386|NCT00454051|469496120|FG001|Overall Study|Withdrawal by Subject|0|||
130419387|NCT00454051|469496119|FG000|Overall Study|Protocol Violation|1|||
130419388|NCT00454051|469496120|FG001|Overall Study|Protocol Violation|1|||
130419389|NCT03117738|469496121|FG000|Overall Study|Withdrawal by Subject|3|||
130419390|NCT03117738|469496122|FG001|Overall Study|Withdrawal by Subject|1|||
130419391|NCT03117738|469496121|FG000|Overall Study|Lost to Follow-up|1|||
130419392|NCT03117738|469496122|FG001|Overall Study|Lost to Follow-up|4|||
130419393|NCT03667053|469496124|FG000|Overall Study|Withdrawal by Subject|1|||
130419394|NCT03667053|469496125|FG001|Overall Study|Withdrawal by Subject|0|||
130564432|NCT06156215|470032215|FG002|Overall Study|Left ED without completing study|9|||
130727322|NCT02883049|470625426|FG002|Post Induction|Randomization closed|0|||
130727323|NCT02883049|470625427|FG003|Post Induction|Randomization closed|0|||
130419395|NCT03667053|469496126|FG002|Overall Study|Withdrawal by Subject|0|||
130419396|NCT00487162|469496133|FG000|Overall Study|Adverse Event|0|||
130419397|NCT00487162|469496134|FG001|Overall Study|Adverse Event|1|||
130419398|NCT00487162|469496133|FG000|Overall Study|Physician Decision|0|||
130419399|NCT00487162|469496134|FG001|Overall Study|Physician Decision|1|||
130564433|NCT06156215|470032216|FG003|Overall Study|Left ED without completing study|0|||
130419400|NCT00487162|469496133|FG000|Overall Study|Withdrawal by Subject|2|||
130419401|NCT00487162|469496134|FG001|Overall Study|Withdrawal by Subject|3|||
130419402|NCT02732938|469496135|FG000|Overall Study|Death|0|||
130419403|NCT02732938|469496136|FG001|Overall Study|Death|11|||
130419404|NCT02732938|469496137|FG002|Overall Study|Death|0|||
130419405|NCT02732938|469496135|FG000|Overall Study|Randomized but did not receive treatment|0|||
130419406|NCT02732938|469496136|FG001|Overall Study|Randomized but did not receive treatment|1|||
130419407|NCT02732938|469496137|FG002|Overall Study|Randomized but did not receive treatment|0|||
130419408|NCT02732938|469496135|FG000|Overall Study|Refused further follow-up|1|||
130419409|NCT02732938|469496136|FG001|Overall Study|Refused further follow-up|0|||
130419410|NCT02732938|469496137|FG002|Overall Study|Refused further follow-up|0|||
130419411|NCT02732938|469496135|FG000|Overall Study|Study terminated by sponsor|3|||
130419412|NCT02732938|469496136|FG001|Overall Study|Study terminated by sponsor|6|||
130727324|NCT02883049|470625428|FG004|Post Induction|Randomization closed|0|||
130727325|NCT02883049|470625429|FG005|Post Induction|Randomization closed|0|||
130727326|NCT02883049|470625430|FG006|Post Induction|Randomization closed|0|||
130727327|NCT02883049|470625431|FG007|Post Induction|Randomization closed|20|||
130419413|NCT02732938|469496137|FG002|Overall Study|Study terminated by sponsor|0|||
130419414|NCT03927950|469496138|FG000|Overall Study|Adverse Event|9|||
130419415|NCT04530448|469496139|FG000|Overall Study|Physician Decision|3|||
130419416|NCT04530448|469496140|FG001|Overall Study|Physician Decision|0|||
130419417|NCT01491854|469496141|FG000|Overall Study|mainly due to premature termination|93|||
130419418|NCT01491854|469496141|FG000|Overall Study|Death|1|||
130419419|NCT01491854|469496141|FG000|Overall Study|Withdrawal by Subject|3|||
130419420|NCT01491854|469496141|FG000|Overall Study|Lost to Follow-up|33|||
130419421|NCT01433354|469496142|FG000|Overall Study|Adverse Event|6|||
130419422|NCT01433354|469496142|FG000|Overall Study|Lost to Follow-up|1|||
130419423|NCT01433354|469496142|FG000|Overall Study|Administrative problems|90|||
130419424|NCT01433354|469496142|FG000|Overall Study|Protocol Violation|2|||
130419425|NCT01433354|469496142|FG000|Overall Study|Lack of Efficacy|17|||
130419426|NCT01433354|469496142|FG000|Overall Study|Subject Withdrew Consent|3|||
130419427|NCT05545072|469496148|FG000|Overall Study|Lost to Follow-up|1|||
130419428|NCT05545072|469496149|FG001|Overall Study|Lost to Follow-up|0|||
130419429|NCT05545072|469496148|FG000|Overall Study|Study ended prematurely due to funding|2|||
130419430|NCT05545072|469496149|FG001|Overall Study|Study ended prematurely due to funding|2|||
130419431|NCT02273141|469496152|FG000|Overall Study|Adverse Event|0|||
130419432|NCT02273141|469496153|FG001|Overall Study|Adverse Event|1|||
130419433|NCT02273141|469496152|FG000|Overall Study|Lost to Follow-up|1|||
130419434|NCT02273141|469496153|FG001|Overall Study|Lost to Follow-up|3|||
130419435|NCT02273141|469496152|FG000|Overall Study|Withdrawal by Subject|10|||
130419436|NCT02273141|469496153|FG001|Overall Study|Withdrawal by Subject|15|||
130419437|NCT02273141|469496152|FG000|Overall Study|Various|6|||
130419438|NCT02273141|469496153|FG001|Overall Study|Various|6|||
130419439|NCT04313881|469496157|FG000|Overall Study|Death|138|||
130419440|NCT04313881|469496158|FG001|Overall Study|Death|126|||
130419441|NCT04313881|469496157|FG000|Overall Study|Study terminated by sponsor|108|||
130419442|NCT04313881|469496158|FG001|Overall Study|Study terminated by sponsor|129|||
130419443|NCT04313881|469496157|FG000|Overall Study|Consent withdrawn|19|||
130419444|NCT04313881|469496158|FG001|Overall Study|Consent withdrawn|15|||
130419445|NCT04313881|469496157|FG000|Overall Study|Reason not Specified|3|||
130419446|NCT04313881|469496158|FG001|Overall Study|Reason not Specified|1|||
130419447|NCT01572727|469496159|FG000|Overall Study|Adverse Event|43|||
130419448|NCT01572727|469496160|FG001|Overall Study|Adverse Event|15|||
130419449|NCT01572727|469496159|FG000|Overall Study|Lost to Follow-up|1|||
130419450|NCT01572727|469496160|FG001|Overall Study|Lost to Follow-up|1|||
130419451|NCT01572727|469496159|FG000|Overall Study|Physician Decision|23|||
130419452|NCT01572727|469496160|FG001|Overall Study|Physician Decision|9|||
130419453|NCT01572727|469496159|FG000|Overall Study|Progressive disease|59|||
130419454|NCT01572727|469496160|FG001|Overall Study|Progressive disease|82|||
130419455|NCT01572727|469496159|FG000|Overall Study|Protocol Violation|0|||
130727328|NCT02883049|470625432|FG008|Post Induction|Randomization closed|0|||
130727329|NCT02883049|470625433|FG009|Post Induction|Randomization closed|0|||
130727330|NCT02883049|470625434|FG010|Post Induction|Randomization closed|0|||
130727331|NCT02883049|470625435|FG011|Post Induction|Randomization closed|0|||
130727332|NCT02883049|470625436|FG012|Post Induction|Randomization closed|0|||
130727333|NCT02883049|470625437|FG013|Post Induction|Randomization closed|0|||
130419456|NCT01572727|469496160|FG001|Overall Study|Protocol Violation|1|||
130419457|NCT01572727|469496159|FG000|Overall Study|Study terminated by sponsor|61|||
130419458|NCT01572727|469496160|FG001|Overall Study|Study terminated by sponsor|83|||
130419459|NCT01572727|469496159|FG000|Overall Study|Parent/guardian decision|14|||
130419460|NCT01572727|469496160|FG001|Overall Study|Parent/guardian decision|9|||
130419461|NCT01572727|469496159|FG000|Overall Study|Death|2|||
130419462|NCT01572727|469496160|FG001|Overall Study|Death|2|||
130419463|NCT01572727|469496159|FG000|Overall Study|Untreated|4|||
130419464|NCT01572727|469496160|FG001|Overall Study|Untreated|7|||
130419465|NCT01474681|469496161|FG000|Overall Study|Death|0|||
130419466|NCT01474681|469496162|FG001|Overall Study|Death|3|||
130419467|NCT01474681|469496163|FG002|Overall Study|Death|2|||
130419468|NCT01474681|469496164|FG003|Overall Study|Death|6|||
130419469|NCT03998618|469496167|FG000|Overall Study|Death|7|||
130419470|NCT03998618|469496168|FG001|Overall Study|Death|11|||
130419471|NCT03998618|469496167|FG000|Overall Study|hospice enrollment|3|||
130419472|NCT03998618|469496168|FG001|Overall Study|hospice enrollment|3|||
130419473|NCT03998618|469496167|FG000|Overall Study|Not feeling well/health problems|3|||
130419474|NCT03998618|469496168|FG001|Overall Study|Not feeling well/health problems|5|||
130419475|NCT03998618|469496167|FG000|Overall Study|Lost to Follow-up|6|||
130419476|NCT03998618|469496168|FG001|Overall Study|Lost to Follow-up|6|||
130419477|NCT03998618|469496167|FG000|Overall Study|Withdrawal by Subject|0|||
130419478|NCT03998618|469496168|FG001|Overall Study|Withdrawal by Subject|4|||
130419479|NCT02195986|469496169|FG000|Overall Study|Adverse Event|3|||
130419480|NCT02195986|469496170|FG001|Overall Study|Adverse Event|0|||
130419481|NCT02195986|469496171|FG002|Overall Study|Adverse Event|0|||
130419482|NCT02195986|469496169|FG000|Overall Study|Withdrawal by Subject|0|||
130419483|NCT02195986|469496170|FG001|Overall Study|Withdrawal by Subject|3|||
130419484|NCT02195986|469496171|FG002|Overall Study|Withdrawal by Subject|0|||
130419485|NCT02195986|469496169|FG000|Overall Study|Family Emergency|0|||
130419486|NCT02195986|469496170|FG001|Overall Study|Family Emergency|0|||
130419487|NCT02195986|469496171|FG002|Overall Study|Family Emergency|1|||
130419488|NCT02195986|469496169|FG000|Overall Study|Protocol Violation|0|||
130419489|NCT02195986|469496170|FG001|Overall Study|Protocol Violation|1|||
130419490|NCT02195986|469496171|FG002|Overall Study|Protocol Violation|1|||
130419491|NCT02195986|469496169|FG000|Overall Study|Non-compliance|0|||
130419492|NCT02195986|469496170|FG001|Overall Study|Non-compliance|1|||
130419493|NCT02195986|469496171|FG002|Overall Study|Non-compliance|0|||
130419494|NCT02834780|469496172|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
130419495|NCT02834780|469496173|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130419496|NCT02834780|469496174|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
130475718|NCT04169373|469709882|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
130475719|NCT04169373|469709883|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
130475720|NCT04169373|469709884|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
130475721|NCT04169373|469709885|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
130475722|NCT04169373|469709882|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
130475723|NCT04169373|469709883|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
130475724|NCT04169373|469709884|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
130475725|NCT04169373|469709885|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
130475726|NCT04169373|469709882|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
130475727|NCT04169373|469709883|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
130475728|NCT04169373|469709884|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
130475729|NCT04169373|469709885|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
130475730|NCT04169373|469709882|FG000|Week 14 to Week 52|Other|4|||
130475731|NCT04169373|469709883|FG001|Week 14 to Week 52|Other|5|||
130475732|NCT04169373|469709884|FG002|Week 14 to Week 52|Other|4|||
130475733|NCT04169373|469709885|FG003|Week 14 to Week 52|Other|5|||
130475734|NCT04169373|469709882|FG000|Week 14 to Week 52|Ongoing|0|||
130475735|NCT04169373|469709883|FG001|Week 14 to Week 52|Ongoing|1|||
130475736|NCT04169373|469709884|FG002|Week 14 to Week 52|Ongoing|0|||
130475737|NCT04169373|469709885|FG003|Week 14 to Week 52|Ongoing|0|||
130475738|NCT03135548|469709887|FG000|Overall Study|Lost to Follow-up|3|||
130475739|NCT03135548|469709888|FG001|Overall Study|Lost to Follow-up|0|||
130475740|NCT03135548|469709889|FG002|Overall Study|Lost to Follow-up|0|||
130475741|NCT03135548|469709887|FG000|Overall Study|Withdrawal by Subject|2|||
130475742|NCT03135548|469709888|FG001|Overall Study|Withdrawal by Subject|2|||
130475743|NCT03135548|469709889|FG002|Overall Study|Withdrawal by Subject|1|||
130475744|NCT03135548|469709887|FG000|Overall Study|Other than listed|0|||
130475745|NCT03135548|469709888|FG001|Overall Study|Other than listed|2|||
130475746|NCT03135548|469709889|FG002|Overall Study|Other than listed|2|||
130475747|NCT03445988|469709895|FG000|Overall Study|Lost to Follow-up|14|||
130475748|NCT03445988|469709896|FG001|Overall Study|Lost to Follow-up|26|||
130475749|NCT03445988|469709897|FG002|Overall Study|Lost to Follow-up|27|||
130475750|NCT03445988|469709898|FG003|Overall Study|Lost to Follow-up|66|||
130475751|NCT03445988|469709895|FG000|Overall Study|Withdrawal by Subject|7|||
130475752|NCT03445988|469709896|FG001|Overall Study|Withdrawal by Subject|4|||
130475753|NCT03445988|469709897|FG002|Overall Study|Withdrawal by Subject|3|||
130475754|NCT03445988|469709898|FG003|Overall Study|Withdrawal by Subject|5|||
130475755|NCT03445988|469709895|FG000|Overall Study|Death (unrelated to study)|5|||
130475756|NCT03445988|469709896|FG001|Overall Study|Death (unrelated to study)|1|||
130475757|NCT03445988|469709897|FG002|Overall Study|Death (unrelated to study)|2|||
130475758|NCT03445988|469709898|FG003|Overall Study|Death (unrelated to study)|4|||
130475759|NCT03988608|469709904|FG000|Overall Study|Adverse Event|1|||
130419497|NCT02834780|469496175|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
130419498|NCT02834780|469496176|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
130419499|NCT02834780|469496177|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
130419500|NCT02834780|469496178|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
130419501|NCT02834780|469496179|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
130475760|NCT03988608|469709904|FG000|Overall Study|Lost to Follow-up|1|||
130475761|NCT03988608|469709904|FG000|Overall Study|Withdrawal by Subject|3|||
130475762|NCT03988608|469709904|FG000|Overall Study|Death|1|||
130475763|NCT02689284|469709909|FG000|Overall Study|Adverse Event|1|||
130475764|NCT02689284|469709910|FG001|Overall Study|Adverse Event|8|||
130475765|NCT02689284|469709909|FG000|Overall Study|Death|0|||
130475766|NCT02689284|469709910|FG001|Overall Study|Death|1|||
130419502|NCT02834780|469496180|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130419503|NCT02834780|469496181|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
130419504|NCT02834780|469496182|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130419505|NCT02834780|469496183|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
130419506|NCT02834780|469496184|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
130419507|NCT02834780|469496172|FG000|Overall Study|Withdrawal by Subject|0|||
130419508|NCT02834780|469496173|FG001|Overall Study|Withdrawal by Subject|0|||
130419509|NCT02834780|469496174|FG002|Overall Study|Withdrawal by Subject|1|||
130419510|NCT02834780|469496175|FG003|Overall Study|Withdrawal by Subject|0|||
130419511|NCT02834780|469496176|FG004|Overall Study|Withdrawal by Subject|0|||
130419512|NCT02834780|469496177|FG005|Overall Study|Withdrawal by Subject|0|||
130419513|NCT02834780|469496178|FG006|Overall Study|Withdrawal by Subject|0|||
130419514|NCT02834780|469496179|FG007|Overall Study|Withdrawal by Subject|0|||
130419515|NCT02834780|469496180|FG008|Overall Study|Withdrawal by Subject|0|||
130419516|NCT02834780|469496181|FG009|Overall Study|Withdrawal by Subject|0|||
130419517|NCT02834780|469496182|FG010|Overall Study|Withdrawal by Subject|1|||
130419518|NCT02834780|469496183|FG011|Overall Study|Withdrawal by Subject|0|||
130419519|NCT02834780|469496184|FG012|Overall Study|Withdrawal by Subject|0|||
130419520|NCT02834780|469496172|FG000|Overall Study|Adverse Event|0|||
130419521|NCT02834780|469496173|FG001|Overall Study|Adverse Event|0|||
130419522|NCT02834780|469496174|FG002|Overall Study|Adverse Event|0|||
130419523|NCT02834780|469496175|FG003|Overall Study|Adverse Event|0|||
130419524|NCT02834780|469496176|FG004|Overall Study|Adverse Event|1|||
130419525|NCT02834780|469496177|FG005|Overall Study|Adverse Event|0|||
130419526|NCT02834780|469496178|FG006|Overall Study|Adverse Event|1|||
130419527|NCT02834780|469496179|FG007|Overall Study|Adverse Event|1|||
130419528|NCT02834780|469496180|FG008|Overall Study|Adverse Event|0|||
130727334|NCT02883049|470625438|FG014|Post Induction|Randomization closed|0|||
130727335|NCT02883049|470625439|FG015|Post Induction|Randomization closed|0|||
130419529|NCT02834780|469496181|FG009|Overall Study|Adverse Event|2|||
130419530|NCT02834780|469496182|FG010|Overall Study|Adverse Event|0|||
130419531|NCT02834780|469496183|FG011|Overall Study|Adverse Event|3|||
130419532|NCT02834780|469496184|FG012|Overall Study|Adverse Event|2|||
130419533|NCT02834780|469496172|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
130419534|NCT02834780|469496173|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
130419535|NCT02834780|469496174|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
130419536|NCT02834780|469496175|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
130475767|NCT02689284|469709909|FG000|Overall Study|Physician Decision|1|||
130475768|NCT02689284|469709910|FG001|Overall Study|Physician Decision|2|||
130475769|NCT02689284|469709909|FG000|Overall Study|Withdrawal by Subject|0|||
130475770|NCT02689284|469709910|FG001|Overall Study|Withdrawal by Subject|1|||
130475771|NCT02689284|469709909|FG000|Overall Study|progression of cancer|1|||
130475772|NCT02689284|469709910|FG001|Overall Study|progression of cancer|72|||
130475773|NCT02689284|469709909|FG000|Overall Study|decreased heart function|0|||
130475774|NCT02689284|469709910|FG001|Overall Study|decreased heart function|1|||
130475775|NCT02689284|469709909|FG000|Overall Study|concern for anemia|0|||
130475776|NCT02689284|469709910|FG001|Overall Study|concern for anemia|1|||
130475777|NCT02689284|469709909|FG000|Overall Study|no measurable cancer for evaluation|0|||
130475778|NCT02689284|469709910|FG001|Overall Study|no measurable cancer for evaluation|1|||
130475779|NCT03519581|469709913|FG000|Overall Study|Lost to Follow-up|3|||
130475780|NCT03519581|469709914|FG001|Overall Study|Lost to Follow-up|2|||
130475781|NCT03519581|469709913|FG000|Overall Study|Adverse Event|5|||
130475782|NCT03519581|469709914|FG001|Overall Study|Adverse Event|2|||
130475783|NCT03519581|469709913|FG000|Overall Study|Withdrawal by Subject|2|||
130475784|NCT03519581|469709914|FG001|Overall Study|Withdrawal by Subject|0|||
130475785|NCT03519581|469709913|FG000|Overall Study|Change to insurance|2|||
130475786|NCT03519581|469709914|FG001|Overall Study|Change to insurance|1|||
130475787|NCT03519581|469709913|FG000|Overall Study|Other|2|||
130475788|NCT03519581|469709914|FG001|Overall Study|Other|4|||
130475789|NCT05268393|469709915|FG000|Overall Study|Withdrawal by Subject|2|||
130475790|NCT05268393|469709916|FG001|Overall Study|Withdrawal by Subject|1|||
130475791|NCT04410042|469709920|FG000|Overall Study|Not Eligible|1|||
130475792|NCT04410042|469709921|FG001|Overall Study|Not Eligible|1|||
130475793|NCT03720795|469709925|FG000|Phase 1|Lost to Follow-up|4|||
130475794|NCT03720795|469709925|FG000|Phase 1|Withdrawal by Subject|6|||
130475795|NCT03720795|469709925|FG000|Phase 1|Protocol Violation|1|||
130475796|NCT03720795|469709925|FG000|Phase 1|Other|1|||
130475797|NCT03720795|469709925|FG000|Phase 2|Lost to Follow-up|5|||
130475798|NCT03720795|469709925|FG000|Phase 2|Withdrawal by Subject|10|||
130475799|NCT03720795|469709925|FG000|Phase 2|Protocol Violation|2|||
130475800|NCT03720795|469709925|FG000|3 Month Follow Up|Lost to Follow-up|2|||
130475801|NCT01494662|469709926|FG000|Overall Study|Withdrawal by Subject|0|||
130475802|NCT01494662|469709927|FG001|Overall Study|Withdrawal by Subject|0|||
130475803|NCT01494662|469709928|FG002|Overall Study|Withdrawal by Subject|1|||
130475804|NCT01494662|469709929|FG003|Overall Study|Withdrawal by Subject|0|||
130419537|NCT02834780|469496176|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
130419538|NCT02834780|469496177|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
130419539|NCT02834780|469496178|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
130419540|NCT02834780|469496179|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
130419541|NCT02834780|469496180|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
130419542|NCT02834780|469496181|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
130419543|NCT02834780|469496182|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
130419544|NCT02834780|469496183|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
130419545|NCT02834780|469496184|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
130419546|NCT02834780|469496172|FG000|Overall Study|Other|1|||
130419547|NCT02834780|469496173|FG001|Overall Study|Other|0|||
130419548|NCT02834780|469496174|FG002|Overall Study|Other|1|||
130419549|NCT02834780|469496175|FG003|Overall Study|Other|2|||
130419550|NCT02834780|469496176|FG004|Overall Study|Other|0|||
130419551|NCT02834780|469496177|FG005|Overall Study|Other|0|||
130419552|NCT02834780|469496178|FG006|Overall Study|Other|0|||
130419553|NCT02834780|469496179|FG007|Overall Study|Other|0|||
130419554|NCT02834780|469496180|FG008|Overall Study|Other|0|||
130419555|NCT02834780|469496181|FG009|Overall Study|Other|0|||
130419556|NCT02834780|469496182|FG010|Overall Study|Other|0|||
130419557|NCT02834780|469496183|FG011|Overall Study|Other|0|||
130419558|NCT02834780|469496184|FG012|Overall Study|Other|1|||
130419559|NCT03449030|469496185|FG000|Overall Study|Withdrawal by Subject|0|||
130419560|NCT03449030|469496186|FG001|Overall Study|Withdrawal by Subject|0|||
130419561|NCT03449030|469496187|FG002|Overall Study|Withdrawal by Subject|0|||
130419562|NCT03449030|469496188|FG003|Overall Study|Withdrawal by Subject|1|||
130419563|NCT03449030|469496189|FG004|Overall Study|Withdrawal by Subject|1|||
130419564|NCT03449030|469496190|FG005|Overall Study|Withdrawal by Subject|1|||
130419565|NCT03449030|469496191|FG006|Overall Study|Withdrawal by Subject|1|||
130419566|NCT03449030|469496192|FG007|Overall Study|Withdrawal by Subject|2|||
130419567|NCT03449030|469496193|FG008|Overall Study|Withdrawal by Subject|0|||
130419568|NCT03449030|469496194|FG009|Overall Study|Withdrawal by Subject|0|||
130419569|NCT03449030|469496185|FG000|Overall Study|Symptomatic Deterioration|0|||
130419570|NCT03449030|469496186|FG001|Overall Study|Symptomatic Deterioration|1|||
130419571|NCT03449030|469496187|FG002|Overall Study|Symptomatic Deterioration|0|||
130419572|NCT03449030|469496188|FG003|Overall Study|Symptomatic Deterioration|0|||
130419573|NCT03449030|469496189|FG004|Overall Study|Symptomatic Deterioration|0|||
130419574|NCT03449030|469496190|FG005|Overall Study|Symptomatic Deterioration|1|||
130419575|NCT03449030|469496191|FG006|Overall Study|Symptomatic Deterioration|1|||
130419576|NCT03449030|469496192|FG007|Overall Study|Symptomatic Deterioration|0|||
130419577|NCT03449030|469496193|FG008|Overall Study|Symptomatic Deterioration|2|||
130419578|NCT03449030|469496194|FG009|Overall Study|Symptomatic Deterioration|0|||
130419579|NCT03449030|469496185|FG000|Overall Study|Progressive Disease|1|||
130419580|NCT03449030|469496186|FG001|Overall Study|Progressive Disease|0|||
130419581|NCT03449030|469496187|FG002|Overall Study|Progressive Disease|1|||
130419582|NCT03449030|469496188|FG003|Overall Study|Progressive Disease|4|||
130419583|NCT03449030|469496189|FG004|Overall Study|Progressive Disease|5|||
130419584|NCT03449030|469496190|FG005|Overall Study|Progressive Disease|3|||
130419585|NCT03449030|469496191|FG006|Overall Study|Progressive Disease|0|||
130419586|NCT03449030|469496192|FG007|Overall Study|Progressive Disease|1|||
130419587|NCT03449030|469496193|FG008|Overall Study|Progressive Disease|1|||
130419588|NCT03449030|469496194|FG009|Overall Study|Progressive Disease|1|||
130419589|NCT03449030|469496185|FG000|Overall Study|Adverse Event|0|||
130419590|NCT03449030|469496186|FG001|Overall Study|Adverse Event|0|||
130419591|NCT03449030|469496187|FG002|Overall Study|Adverse Event|0|||
130419592|NCT03449030|469496188|FG003|Overall Study|Adverse Event|0|||
130419593|NCT03449030|469496189|FG004|Overall Study|Adverse Event|0|||
130419594|NCT03449030|469496190|FG005|Overall Study|Adverse Event|2|||
130419595|NCT03449030|469496191|FG006|Overall Study|Adverse Event|0|||
130419596|NCT03449030|469496192|FG007|Overall Study|Adverse Event|0|||
130419597|NCT03449030|469496193|FG008|Overall Study|Adverse Event|0|||
130419598|NCT03449030|469496194|FG009|Overall Study|Adverse Event|0|||
130419599|NCT03449030|469496185|FG000|Overall Study|Death|0|||
130419600|NCT03449030|469496186|FG001|Overall Study|Death|0|||
130419601|NCT03449030|469496187|FG002|Overall Study|Death|0|||
130419602|NCT03449030|469496188|FG003|Overall Study|Death|0|||
130419603|NCT03449030|469496189|FG004|Overall Study|Death|1|||
130419604|NCT03449030|469496190|FG005|Overall Study|Death|0|||
130419605|NCT03449030|469496191|FG006|Overall Study|Death|0|||
130419606|NCT03449030|469496192|FG007|Overall Study|Death|0|||
130419607|NCT03449030|469496193|FG008|Overall Study|Death|0|||
130419608|NCT03449030|469496194|FG009|Overall Study|Death|0|||
130419609|NCT02081846|469496195|FG000|Overall Study|Withdrawal by Subject|1|||
130419610|NCT02081846|469496196|FG001|Overall Study|Withdrawal by Subject|0|||
130419611|NCT02081846|469496195|FG000|Overall Study|invalid consent|1|||
130419612|NCT02081846|469496196|FG001|Overall Study|invalid consent|0|||
130727336|NCT02883049|470625424|FG000|Post Induction|MRD negative|0|||
130419613|NCT03282227|469496197|FG000|Overall Study|Exposure Goals Achieved|60|||
130419614|NCT03282227|469496197|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
130419615|NCT03282227|469496197|FG000|Overall Study|Adverse Event|15|||
130419616|NCT03282227|469496197|FG000|Overall Study|Lost to Follow-up|21|||
130419617|NCT03282227|469496197|FG000|Overall Study|Withdrawal by Subject|20|||
130419618|NCT03282227|469496197|FG000|Overall Study|Lack of Efficacy|12|||
130419619|NCT03282227|469496197|FG000|Overall Study|Sponsor decision|3|||
130419620|NCT03282227|469496197|FG000|Overall Study|Physician Decision|2|||
130419621|NCT03282227|469496197|FG000|Overall Study|Pregnancy|2|||
130419622|NCT03282227|469496197|FG000|Overall Study|Other|1|||
130419623|NCT03943095|469496201|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
130419624|NCT03943095|469496202|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
130419625|NCT03943095|469496201|FG000|Overall Study|Withdrawal by Subject|1|||
130419626|NCT03943095|469496202|FG001|Overall Study|Withdrawal by Subject|0|||
130419627|NCT00679939|469496204|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
130419628|NCT00679939|469496205|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
130419629|NCT00679939|469496204|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
130419630|NCT00679939|469496205|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
130419631|NCT00679939|469496204|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
130419632|NCT00679939|469496205|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
130419633|NCT00679939|469496204|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
130419634|NCT00679939|469496205|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
130419635|NCT00679939|469496204|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130419636|NCT00679939|469496205|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
130419637|NCT00679939|469496204|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
130419638|NCT00679939|469496205|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
130419639|NCT00679939|469496204|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
130419640|NCT00679939|469496205|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
130419641|NCT00679939|469496204|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
130419642|NCT00679939|469496205|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
130419643|NCT00679939|469496204|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
130419644|NCT00679939|469496205|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
130419645|NCT00679939|469496204|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
130419646|NCT00679939|469496205|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
130419647|NCT02269670|469496210|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
130419648|NCT04657211|469496213|FG000|Overall Study|Withdrawal by Subject|21|||
130419649|NCT04657211|469496213|FG000|Overall Study|Lost to Follow-up|113|||
130419650|NCT04657211|469496213|FG000|Overall Study|Death|47|||
130419651|NCT04657211|469496213|FG000|Overall Study|Transfer to another institution|21|||
130419652|NCT04657211|469496213|FG000|Overall Study|Other|29|||
130419653|NCT02693665|469496214|FG000|Overall Study|Death|3|||
130419654|NCT02693665|469496215|FG001|Overall Study|Death|2|||
130419655|NCT02693665|469496214|FG000|Overall Study|Lost to Follow-up|7|||
130419656|NCT02693665|469496215|FG001|Overall Study|Lost to Follow-up|3|||
130419657|NCT02693665|469496214|FG000|Overall Study|Protocol Violation|1|||
130419658|NCT02693665|469496215|FG001|Overall Study|Protocol Violation|0|||
130419659|NCT02693665|469496214|FG000|Overall Study|Withdrawal by Subject|2|||
130419660|NCT02693665|469496215|FG001|Overall Study|Withdrawal by Subject|0|||
130419661|NCT02693665|469496214|FG000|Overall Study|patient wanted to leave it behind|1|||
130419662|NCT02693665|469496215|FG001|Overall Study|patient wanted to leave it behind|0|||
130419663|NCT02693665|469496214|FG000|Overall Study|anxiety|1|||
130419664|NCT02693665|469496215|FG001|Overall Study|anxiety|0|||
130419665|NCT02693665|469496214|FG000|Overall Study|family issues|1|||
130419666|NCT02693665|469496215|FG001|Overall Study|family issues|0|||
130475805|NCT01494662|469709930|FG004|Overall Study|Withdrawal by Subject|0|||
130475806|NCT01494662|469709931|FG005|Overall Study|Withdrawal by Subject|0|||
130475807|NCT01494662|469709932|FG006|Overall Study|Withdrawal by Subject|0|||
130475808|NCT01494662|469709926|FG000|Overall Study|Physician Decision|0|||
130475809|NCT01494662|469709927|FG001|Overall Study|Physician Decision|0|||
130475810|NCT01494662|469709928|FG002|Overall Study|Physician Decision|1|||
130475811|NCT01494662|469709929|FG003|Overall Study|Physician Decision|0|||
130475812|NCT01494662|469709930|FG004|Overall Study|Physician Decision|0|||
130475813|NCT01494662|469709931|FG005|Overall Study|Physician Decision|0|||
130475814|NCT01494662|469709932|FG006|Overall Study|Physician Decision|0|||
130475815|NCT05311384|469709933|FG000|Overall Study|Uncontrolled health conditions|2|||
130475816|NCT05311384|469709933|FG000|Overall Study|Withdrawal by Subject|1|||
130419667|NCT02693665|469496214|FG000|Overall Study|no reason given|1|||
130419668|NCT02693665|469496215|FG001|Overall Study|no reason given|0|||
130419669|NCT00710424|469496218|FG000|Overall Study|Adverse Event|30|||
130419670|NCT00710424|469496219|FG001|Overall Study|Adverse Event|12|||
130419671|NCT00710424|469496218|FG000|Overall Study|Lack of Efficacy|4|||
130419672|NCT00710424|469496219|FG001|Overall Study|Lack of Efficacy|5|||
130419673|NCT00710424|469496218|FG000|Overall Study|Withdrawal by Subject|5|||
130419674|NCT00710424|469496219|FG001|Overall Study|Withdrawal by Subject|3|||
130475817|NCT02724631|469709936|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
130475818|NCT05089734|469709941|FG000|Overall Study|Still on study|122|||
130475819|NCT05089734|469709942|FG001|Overall Study|Still on study|101|||
130419675|NCT00710424|469496218|FG000|Overall Study|Lost to Follow-up|0|||
130419676|NCT00710424|469496219|FG001|Overall Study|Lost to Follow-up|1|||
130419677|NCT00710424|469496218|FG000|Overall Study|Refused medication, no side effects|1|||
130419678|NCT00710424|469496219|FG001|Overall Study|Refused medication, no side effects|0|||
130419679|NCT00710424|469496218|FG000|Overall Study|Non-compliance with stable analgesia|1|||
130419680|NCT00710424|469496219|FG001|Overall Study|Non-compliance with stable analgesia|0|||
130419681|NCT00710424|469496218|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
130419682|NCT00710424|469496219|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
130419683|NCT00710424|469496218|FG000|Overall Study|Subject thought medication changed|1|||
130419684|NCT00710424|469496219|FG001|Overall Study|Subject thought medication changed|0|||
130419685|NCT00710424|469496218|FG000|Overall Study|Ceased treatment due to travel|1|||
130419686|NCT00710424|469496219|FG001|Overall Study|Ceased treatment due to travel|0|||
130419687|NCT00710424|469496218|FG000|Overall Study|Subject preferred paracetamol|0|||
130419688|NCT00710424|469496219|FG001|Overall Study|Subject preferred paracetamol|1|||
130419689|NCT00710424|469496218|FG000|Overall Study|Felt good so stopped treatment|0|||
130419690|NCT00710424|469496219|FG001|Overall Study|Felt good so stopped treatment|1|||
130419691|NCT01962493|469496220|FG000|Overall Study|Adverse Event|1|||
130419692|NCT01962493|469496221|FG001|Overall Study|Adverse Event|2|||
130419693|NCT01962493|469496220|FG000|Overall Study|Protocol Violation|0|||
130419694|NCT01962493|469496221|FG001|Overall Study|Protocol Violation|1|||
130419695|NCT01962493|469496220|FG000|Overall Study|Withdrawal by Subject|4|||
130419696|NCT01962493|469496221|FG001|Overall Study|Withdrawal by Subject|2|||
130419697|NCT03776136|469496222|FG000|Overall Study|Death|85|||
130419698|NCT03776136|469496222|FG000|Overall Study|Withdrawal by Subject|3|||
130419699|NCT03776136|469496222|FG000|Overall Study|Sponsor Decision|15|||
130419700|NCT02621931|469497857|FG000|Overall Study|Death|0|||
130419701|NCT02621931|469497858|FG001|Overall Study|Death|1|||
130419702|NCT02621931|469497859|FG002|Overall Study|Death|0|||
130419703|NCT02621931|469497857|FG000|Overall Study|Adverse Event|8|||
130419704|NCT02621931|469497858|FG001|Overall Study|Adverse Event|5|||
130419705|NCT02621931|469497859|FG002|Overall Study|Adverse Event|7|||
130419706|NCT02621931|469497857|FG000|Overall Study|Withdrawal by Subject|12|||
130419707|NCT02621931|469497858|FG001|Overall Study|Withdrawal by Subject|10|||
130419708|NCT02621931|469497859|FG002|Overall Study|Withdrawal by Subject|11|||
130419709|NCT02621931|469497857|FG000|Overall Study|Protocol Violation|2|||
130419710|NCT02621931|469497858|FG001|Overall Study|Protocol Violation|2|||
130419711|NCT02621931|469497859|FG002|Overall Study|Protocol Violation|2|||
130419712|NCT02621931|469497857|FG000|Overall Study|Pregnancy|2|||
130419713|NCT02621931|469497858|FG001|Overall Study|Pregnancy|0|||
130419714|NCT02621931|469497859|FG002|Overall Study|Pregnancy|0|||
130419715|NCT02621931|469497857|FG000|Overall Study|Noncompliance to study procedures|0|||
130419716|NCT02621931|469497858|FG001|Overall Study|Noncompliance to study procedures|1|||
130419717|NCT02621931|469497859|FG002|Overall Study|Noncompliance to study procedures|2|||
130419718|NCT02621931|469497857|FG000|Overall Study|Lost to Follow-up|8|||
130419719|NCT02621931|469497858|FG001|Overall Study|Lost to Follow-up|7|||
130419720|NCT02621931|469497859|FG002|Overall Study|Lost to Follow-up|10|||
130419721|NCT02621931|469497857|FG000|Overall Study|Lack of Efficacy|0|||
130419722|NCT02621931|469497858|FG001|Overall Study|Lack of Efficacy|0|||
130419723|NCT02621931|469497859|FG002|Overall Study|Lack of Efficacy|1|||
130419724|NCT02621931|469497857|FG000|Overall Study|Other|1|||
130419725|NCT02621931|469497858|FG001|Overall Study|Other|1|||
130419726|NCT02621931|469497859|FG002|Overall Study|Other|3|||
130419727|NCT02925455|469497860|FG000|Overall Study|Withdrawal by Subject|2|||
130419728|NCT02925455|469497861|FG001|Overall Study|Withdrawal by Subject|0|||
130475820|NCT05089734|469709941|FG000|Overall Study|Death|161|||
130475821|NCT05089734|469709942|FG001|Overall Study|Death|179|||
130475822|NCT05089734|469709941|FG000|Overall Study|Withdrew consent|11|||
130419729|NCT04004611|469497864|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419730|NCT04004611|469497865|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419731|NCT04004611|469497866|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419732|NCT04004611|469497867|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419733|NCT04004611|469497868|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419734|NCT04004611|469497869|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419735|NCT04004611|469497870|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130419736|NCT04004611|469497871|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130727337|NCT02883049|470625425|FG001|Post Induction|MRD negative|0|||
130419737|NCT04004611|469497872|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
130419738|NCT04004611|469497864|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130419739|NCT04004611|469497865|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130419740|NCT04004611|469497866|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130419741|NCT04004611|469497867|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130419742|NCT04004611|469497868|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130419743|NCT04004611|469497869|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
130419744|NCT04004611|469497870|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
130419745|NCT04004611|469497871|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130475823|NCT05089734|469709942|FG001|Overall Study|Withdrew consent|24|||
130727338|NCT02883049|470625426|FG002|Post Induction|MRD negative|0|||
130419746|NCT04004611|469497872|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
130419747|NCT04004611|469497864|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419748|NCT04004611|469497865|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419749|NCT04004611|469497866|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419750|NCT04004611|469497867|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419751|NCT04004611|469497868|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
130419752|NCT04004611|469497869|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419753|NCT04004611|469497870|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419754|NCT04004611|469497871|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419755|NCT04004611|469497872|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130419756|NCT04004611|469497864|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
130419757|NCT04004611|469497865|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
130419758|NCT04004611|469497866|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
130419759|NCT04004611|469497867|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
130419760|NCT04004611|469497868|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
130419761|NCT04004611|469497869|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
130419762|NCT04004611|469497870|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
130419763|NCT04004611|469497871|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
130419764|NCT04004611|469497872|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
130419765|NCT04004611|469497864|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
130419766|NCT04004611|469497865|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419767|NCT04004611|469497866|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
130419768|NCT04004611|469497867|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419769|NCT04004611|469497868|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419770|NCT04004611|469497869|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419771|NCT04004611|469497870|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419772|NCT04004611|469497871|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419773|NCT04004611|469497872|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130419774|NCT04004611|469497864|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419775|NCT04004611|469497865|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
130419776|NCT04004611|469497866|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419777|NCT04004611|469497867|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419778|NCT04004611|469497868|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419779|NCT04004611|469497869|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419780|NCT04004611|469497870|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419781|NCT04004611|469497871|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419782|NCT04004611|469497872|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130419783|NCT04420689|469497873|FG000|Overall Study|COVID-19 related hospitalization|0|||
130419784|NCT04420689|469497874|FG001|Overall Study|COVID-19 related hospitalization|0|||
130419785|NCT04420689|469497875|FG002|Overall Study|COVID-19 related hospitalization|0|||
130419786|NCT04420689|469497876|FG003|Overall Study|COVID-19 related hospitalization|0|||
130419787|NCT04420689|469497877|FG004|Overall Study|COVID-19 related hospitalization|1|||
130419788|NCT04420689|469497878|FG005|Overall Study|COVID-19 related hospitalization|0|||
130419789|NCT04420689|469497879|FG006|Overall Study|COVID-19 related hospitalization|0|||
130419790|NCT04420689|469497873|FG000|Overall Study|Physician Decision|0|||
130419791|NCT04420689|469497874|FG001|Overall Study|Physician Decision|0|||
130419792|NCT04420689|469497875|FG002|Overall Study|Physician Decision|0|||
130419793|NCT04420689|469497876|FG003|Overall Study|Physician Decision|0|||
130419794|NCT04420689|469497877|FG004|Overall Study|Physician Decision|0|||
130419795|NCT04420689|469497878|FG005|Overall Study|Physician Decision|1|||
130419796|NCT04420689|469497879|FG006|Overall Study|Physician Decision|0|||
130419797|NCT00515502|469497880|FG000|Treatment Period 1|Adverse Event|0|||
130419798|NCT00515502|469497881|FG001|Treatment Period 1|Adverse Event|0|||
130419799|NCT00515502|469497882|FG002|Treatment Period 1|Adverse Event|0|||
130419800|NCT00515502|469497883|FG003|Treatment Period 1|Adverse Event|0|||
130419801|NCT00515502|469497884|FG004|Treatment Period 1|Adverse Event|0|||
130419802|NCT00515502|469497885|FG005|Treatment Period 1|Adverse Event|0|||
130727339|NCT02883049|470625427|FG003|Post Induction|MRD negative|0|||
130727340|NCT02883049|470625428|FG004|Post Induction|MRD negative|0|||
130419803|NCT00515502|469497886|FG006|Treatment Period 1|Adverse Event|1|||
130419804|NCT00515502|469497887|FG007|Treatment Period 1|Adverse Event|0|||
130419805|NCT00515502|469497888|FG008|Treatment Period 1|Adverse Event|1|||
130419806|NCT00515502|469497889|FG009|Treatment Period 1|Adverse Event|0|||
130419807|NCT00515502|469497890|FG010|Treatment Period 1|Adverse Event|0|||
130419808|NCT00515502|469497891|FG011|Treatment Period 1|Adverse Event|1|||
130419809|NCT00515502|469497880|FG000|Treatment Period 2|Adverse Event|0|||
130419810|NCT00515502|469497881|FG001|Treatment Period 2|Adverse Event|1|||
130727341|NCT02883049|470625429|FG005|Post Induction|MRD negative|0|||
130727342|NCT02883049|470625430|FG006|Post Induction|MRD negative|0|||
130419811|NCT00515502|469497882|FG002|Treatment Period 2|Adverse Event|0|||
130419812|NCT00515502|469497883|FG003|Treatment Period 2|Adverse Event|0|||
130419813|NCT00515502|469497884|FG004|Treatment Period 2|Adverse Event|0|||
130419814|NCT00515502|469497885|FG005|Treatment Period 2|Adverse Event|0|||
130419815|NCT00515502|469497886|FG006|Treatment Period 2|Adverse Event|0|||
130419816|NCT00515502|469497887|FG007|Treatment Period 2|Adverse Event|0|||
130419817|NCT00515502|469497888|FG008|Treatment Period 2|Adverse Event|0|||
130419818|NCT00515502|469497889|FG009|Treatment Period 2|Adverse Event|0|||
130419819|NCT00515502|469497890|FG010|Treatment Period 2|Adverse Event|0|||
130419820|NCT00515502|469497891|FG011|Treatment Period 2|Adverse Event|0|||
130419821|NCT03647501|469497895|FG000|Overall Study|Lost to Follow-up|1|||
130419822|NCT03647501|469497896|FG001|Overall Study|Lost to Follow-up|1|||
130419823|NCT03647501|469497895|FG000|Overall Study|Withdrawal by Subject|0|||
130419824|NCT03647501|469497896|FG001|Overall Study|Withdrawal by Subject|1|||
130419825|NCT01540851|469497902|FG000|Overall Study|Lost to Follow-up|14|||
130419826|NCT01540851|469497903|FG001|Overall Study|Lost to Follow-up|15|||
130419827|NCT01540851|469497902|FG000|Overall Study|Withdrawal by Subject|7|||
130419828|NCT01540851|469497903|FG001|Overall Study|Withdrawal by Subject|3|||
130419829|NCT02013622|469497904|FG000|Overall Study|Lost to Follow-up|10|||
130419830|NCT02013622|469497904|FG000|Overall Study|Adverse Event|3|||
130419831|NCT02013622|469497904|FG000|Overall Study|Met Withdrawal Criteria|3|||
130419832|NCT02013622|469497904|FG000|Overall Study|Withdrawal by Subject|6|||
130419833|NCT02013622|469497904|FG000|Overall Study|Protocol Deviation|1|||
130419834|NCT02013622|469497904|FG000|Overall Study|Lack of Efficacy|1|||
130419835|NCT04307004|469497912|FG000|Randomization 1|Withdrawal by Subject|25|||
130419836|NCT04307004|469497913|FG001|Randomization 1|Withdrawal by Subject|26|||
130419837|NCT04307004|469497914|FG002|Randomization 1|Withdrawal by Subject|0|||
130419838|NCT04307004|469497915|FG003|Randomization 1|Withdrawal by Subject|0|||
130419839|NCT04307004|469497912|FG000|Randomization 2|Withdrawal by Subject|0|||
130419840|NCT04307004|469497913|FG001|Randomization 2|Withdrawal by Subject|0|||
130419841|NCT04307004|469497914|FG002|Randomization 2|Withdrawal by Subject|28|||
130419842|NCT04307004|469497915|FG003|Randomization 2|Withdrawal by Subject|23|||
130419843|NCT01324271|469497916|FG000|Overall Study|Lost to Follow-up|3|||
130419844|NCT01324271|469497917|FG001|Overall Study|Lost to Follow-up|0|||
130419845|NCT01324271|469497916|FG000|Overall Study|Physician Decision|1|||
130419846|NCT01324271|469497917|FG001|Overall Study|Physician Decision|0|||
130419847|NCT05130970|469497918|FG000|Overall Study|Adverse Event|1|||
130419848|NCT05130970|469497919|FG001|Overall Study|Adverse Event|1|||
130419849|NCT05130970|469497918|FG000|Overall Study|Death|0|||
130419850|NCT05130970|469497919|FG001|Overall Study|Death|1|||
130419851|NCT05130970|469497918|FG000|Overall Study|Lost to Follow-up|0|||
130419852|NCT05130970|469497919|FG001|Overall Study|Lost to Follow-up|1|||
130419853|NCT05130970|469497918|FG000|Overall Study|Physician Decision|0|||
130419854|NCT05130970|469497919|FG001|Overall Study|Physician Decision|1|||
130475824|NCT05089734|469709941|FG000|Overall Study|Lost to Follow-up|5|||
130475825|NCT05089734|469709942|FG001|Overall Study|Lost to Follow-up|0|||
130475826|NCT02992925|469711589|FG000|Cohort 2|Physician Decision|0|||
130475827|NCT02992925|469711590|FG001|Cohort 2|Physician Decision|0|||
130475828|NCT02992925|469711591|FG002|Cohort 2|Physician Decision|1|||
130727343|NCT02883049|470625431|FG007|Post Induction|MRD negative|11|||
130727344|NCT02883049|470625432|FG008|Post Induction|MRD negative|0|||
130727345|NCT02883049|470625433|FG009|Post Induction|MRD negative|0|||
130727346|NCT02883049|470625434|FG010|Post Induction|MRD negative|0|||
130727347|NCT02883049|470625435|FG011|Post Induction|MRD negative|0|||
130727348|NCT02883049|470625436|FG012|Post Induction|MRD negative|0|||
130727349|NCT02883049|470625437|FG013|Post Induction|MRD negative|0|||
130419855|NCT05130970|469497918|FG000|Overall Study|Withdrawal by Subject|1|||
130419856|NCT05130970|469497919|FG001|Overall Study|Withdrawal by Subject|1|||
130419857|NCT03996473|469497920|FG000|Treatment Assignment|Withdrawal by Subject|1|||
130419858|NCT03996473|469497920|FG000|Treatment Assignment|Progressive disease|6|||
130419859|NCT03996473|469497920|FG000|Treatment Assignment|Study drug never administered|1|||
130419860|NCT03996473|469497920|FG000|Active Follow-up|Death|1|||
130419861|NCT03996473|469497920|FG000|Long-term Follow-up|Death|5|||
130419862|NCT06116591|469497921|FG000|Overall Study|No longer met eligibility criteria|0|||
130419863|NCT06116591|469497922|FG001|Overall Study|No longer met eligibility criteria|1|||
130419864|NCT06116591|469497921|FG000|Overall Study|Other: Change in life situation|0|||
130419865|NCT06116591|469497922|FG001|Overall Study|Other: Change in life situation|1|||
130419866|NCT01381692|469497923|FG000|Overall Study|Adverse Event|1|||
130419867|NCT01381692|469497924|FG001|Overall Study|Adverse Event|0|||
130419868|NCT01381692|469497925|FG002|Overall Study|Adverse Event|0|||
130419869|NCT01381692|469497926|FG003|Overall Study|Adverse Event|0|||
130419870|NCT01381692|469497927|FG004|Overall Study|Adverse Event|0|||
130419871|NCT01381692|469497928|FG005|Overall Study|Adverse Event|0|||
130419872|NCT01270347|469497929|FG000|Core Phase|Adverse Event|1|||
130475829|NCT02992925|469711592|FG003|Cohort 2|Physician Decision|0|||
130419873|NCT01270347|469497930|FG001|Core Phase|Adverse Event|6|||
130419874|NCT01270347|469497929|FG000|Core Phase|Withdrawal by Subject|1|||
130419875|NCT01270347|469497930|FG001|Core Phase|Withdrawal by Subject|2|||
130419876|NCT01270347|469497929|FG000|Core Phase|Lost to Follow-up|0|||
130419877|NCT01270347|469497930|FG001|Core Phase|Lost to Follow-up|1|||
130419878|NCT01270347|469497929|FG000|Core Phase|Miscellaneous|8|||
130419879|NCT01270347|469497930|FG001|Core Phase|Miscellaneous|14|||
130419880|NCT01270347|469497929|FG000|Extension Phase|Adverse Event|1|||
130419881|NCT01270347|469497930|FG001|Extension Phase|Adverse Event|3|||
130419882|NCT01270347|469497929|FG000|Extension Phase|Withdrawal by Subject|3|||
130419883|NCT01270347|469497930|FG001|Extension Phase|Withdrawal by Subject|4|||
130419884|NCT01270347|469497929|FG000|Extension Phase|Miscellaneous|2|||
130419885|NCT01270347|469497930|FG001|Extension Phase|Miscellaneous|2|||
130419886|NCT02189798|469497931|FG000|Extended Use Phase|Withdrawal by Subject|0|||
130419887|NCT02189798|469497932|FG001|Extended Use Phase|Withdrawal by Subject|4|||
130419888|NCT02189798|469497931|FG000|Extended Use Phase|Physician Decision|1|||
130419889|NCT02189798|469497932|FG001|Extended Use Phase|Physician Decision|0|||
130419890|NCT02189798|469497931|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
130419891|NCT02189798|469497932|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
130419892|NCT02189798|469497931|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
130419893|NCT02189798|469497932|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
130419894|NCT02189798|469497931|FG000|Extended Use Phase|Travel Issues|2|||
130419895|NCT02189798|469497932|FG001|Extended Use Phase|Travel Issues|1|||
130419896|NCT02189798|469497931|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
130419897|NCT02189798|469497932|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
130419898|NCT00529399|469497933|FG000|Overall Study|Lost to Follow-up|1|||
130419899|NCT00529399|469497934|FG001|Overall Study|Lost to Follow-up|0|||
130419900|NCT00529399|469497935|FG002|Overall Study|Lost to Follow-up|1|||
130419901|NCT00529399|469497933|FG000|Overall Study|Withdrawal by Subject|1|||
130419902|NCT00529399|469497934|FG001|Overall Study|Withdrawal by Subject|0|||
130419903|NCT00529399|469497935|FG002|Overall Study|Withdrawal by Subject|1|||
130419904|NCT00529399|469497933|FG000|Overall Study|Non-compliant|0|||
130419905|NCT00529399|469497934|FG001|Overall Study|Non-compliant|1|||
130419906|NCT00529399|469497935|FG002|Overall Study|Non-compliant|0|||
130419907|NCT00727272|469497944|FG000|Washout Period A|Adverse Event|0|||
130419908|NCT00727272|469497945|FG001|Washout Period A|Adverse Event|0|||
130419909|NCT00727272|469497946|FG002|Washout Period A|Adverse Event|1|||
130419910|NCT00727272|469497944|FG000|Washout Period B|Withdrawal by Subject|0|||
130419911|NCT00727272|469497945|FG001|Washout Period B|Withdrawal by Subject|0|||
130419912|NCT00727272|469497946|FG002|Washout Period B|Withdrawal by Subject|1|||
130419913|NCT00651664|469497947|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
130419914|NCT00651664|469497948|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
130419915|NCT00651664|469497949|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
130419916|NCT00651664|469497950|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
130419917|NCT00651664|469497951|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
130419918|NCT00651664|469497952|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
130419919|NCT00651664|469497953|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
130419920|NCT00651664|469497954|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
130419921|NCT00651664|469497955|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
130419922|NCT00651664|469497956|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
130419923|NCT00651664|469497947|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419924|NCT00651664|469497948|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419925|NCT00651664|469497949|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419926|NCT00651664|469497950|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419927|NCT00651664|469497951|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
130419928|NCT00651664|469497952|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
130419929|NCT00651664|469497953|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419930|NCT00651664|469497954|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
130419931|NCT00651664|469497955|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
130419932|NCT00651664|469497956|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
130419933|NCT00651664|469497947|FG000|Overall Study|Progressive Disease|3|||
130419934|NCT00651664|469497948|FG001|Overall Study|Progressive Disease|3|||
130419935|NCT00651664|469497949|FG002|Overall Study|Progressive Disease|3|||
130419936|NCT00651664|469497950|FG003|Overall Study|Progressive Disease|12|||
130727350|NCT02883049|470625438|FG014|Post Induction|MRD negative|0|||
130727351|NCT02883049|470625439|FG015|Post Induction|MRD negative|0|||
130564434|NCT06156215|470032217|FG004|Overall Study|Left ED without completing study|8|||
130564435|NCT06156215|470032218|FG005|Overall Study|Left ED without completing study|16|||
130564436|NCT06156215|470032213|FG000|Overall Study|Physician Decision|1|||
130419937|NCT00651664|469497951|FG004|Overall Study|Progressive Disease|4|||
130419938|NCT00651664|469497952|FG005|Overall Study|Progressive Disease|1|||
130419939|NCT00651664|469497953|FG006|Overall Study|Progressive Disease|3|||
130419940|NCT00651664|469497954|FG007|Overall Study|Progressive Disease|6|||
130419941|NCT00651664|469497955|FG008|Overall Study|Progressive Disease|5|||
130419942|NCT00651664|469497956|FG009|Overall Study|Progressive Disease|5|||
130564437|NCT06156215|470032214|FG001|Overall Study|Physician Decision|0|||
130419943|NCT00651664|469497947|FG000|Overall Study|Patient Declined Further Treatment|0|||
130419944|NCT00651664|469497948|FG001|Overall Study|Patient Declined Further Treatment|0|||
130419945|NCT00651664|469497949|FG002|Overall Study|Patient Declined Further Treatment|0|||
130419946|NCT00651664|469497950|FG003|Overall Study|Patient Declined Further Treatment|1|||
130419947|NCT00651664|469497951|FG004|Overall Study|Patient Declined Further Treatment|1|||
130419948|NCT00651664|469497952|FG005|Overall Study|Patient Declined Further Treatment|1|||
130419949|NCT00651664|469497953|FG006|Overall Study|Patient Declined Further Treatment|0|||
130419950|NCT00651664|469497954|FG007|Overall Study|Patient Declined Further Treatment|0|||
130419951|NCT00651664|469497955|FG008|Overall Study|Patient Declined Further Treatment|0|||
130419952|NCT00651664|469497956|FG009|Overall Study|Patient Declined Further Treatment|1|||
130419953|NCT00651664|469497947|FG000|Overall Study|Symptomatic Deterioration|0|||
130419954|NCT00651664|469497948|FG001|Overall Study|Symptomatic Deterioration|0|||
130419955|NCT00651664|469497949|FG002|Overall Study|Symptomatic Deterioration|0|||
130419956|NCT00651664|469497950|FG003|Overall Study|Symptomatic Deterioration|1|||
130419957|NCT00651664|469497951|FG004|Overall Study|Symptomatic Deterioration|0|||
130419958|NCT00651664|469497952|FG005|Overall Study|Symptomatic Deterioration|0|||
130419959|NCT00651664|469497953|FG006|Overall Study|Symptomatic Deterioration|1|||
130419960|NCT00651664|469497954|FG007|Overall Study|Symptomatic Deterioration|0|||
130419961|NCT00651664|469497955|FG008|Overall Study|Symptomatic Deterioration|1|||
130419962|NCT00651664|469497956|FG009|Overall Study|Symptomatic Deterioration|0|||
130419963|NCT00651664|469497947|FG000|Overall Study|Reason not Specified|0|||
130419964|NCT00651664|469497948|FG001|Overall Study|Reason not Specified|0|||
130419965|NCT00651664|469497949|FG002|Overall Study|Reason not Specified|0|||
130419966|NCT00651664|469497950|FG003|Overall Study|Reason not Specified|0|||
130419967|NCT00651664|469497951|FG004|Overall Study|Reason not Specified|0|||
130419968|NCT00651664|469497952|FG005|Overall Study|Reason not Specified|0|||
130419969|NCT00651664|469497953|FG006|Overall Study|Reason not Specified|1|||
130419970|NCT00651664|469497954|FG007|Overall Study|Reason not Specified|0|||
130419971|NCT00651664|469497955|FG008|Overall Study|Reason not Specified|0|||
130419972|NCT00651664|469497956|FG009|Overall Study|Reason not Specified|0|||
130419973|NCT02415400|469497959|FG000|Overall Study|Adverse Event|0|||
130419974|NCT02415400|469497960|FG001|Overall Study|Adverse Event|1|||
130419975|NCT02415400|469497961|FG002|Overall Study|Adverse Event|1|||
130419976|NCT02415400|469497962|FG003|Overall Study|Adverse Event|2|||
130419977|NCT02415400|469497959|FG000|Overall Study|Participant request to stop therapy|4|||
130419978|NCT02415400|469497960|FG001|Overall Study|Participant request to stop therapy|3|||
130419979|NCT02415400|469497961|FG002|Overall Study|Participant request to stop therapy|8|||
130419980|NCT02415400|469497962|FG003|Overall Study|Participant request to stop therapy|6|||
130419981|NCT02415400|469497959|FG000|Overall Study|Participant withdrew consent|14|||
130419982|NCT02415400|469497960|FG001|Overall Study|Participant withdrew consent|12|||
130419983|NCT02415400|469497961|FG002|Overall Study|Participant withdrew consent|30|||
130419984|NCT02415400|469497962|FG003|Overall Study|Participant withdrew consent|21|||
130419985|NCT02415400|469497959|FG000|Overall Study|Death|39|||
130419986|NCT02415400|469497960|FG001|Overall Study|Death|41|||
130419987|NCT02415400|469497961|FG002|Overall Study|Death|35|||
130419988|NCT02415400|469497962|FG003|Overall Study|Death|42|||
130419989|NCT02415400|469497959|FG000|Overall Study|Lost to Follow-up|3|||
130419990|NCT02415400|469497960|FG001|Overall Study|Lost to Follow-up|3|||
130419991|NCT02415400|469497961|FG002|Overall Study|Lost to Follow-up|2|||
130419992|NCT02415400|469497962|FG003|Overall Study|Lost to Follow-up|5|||
130419993|NCT02415400|469497959|FG000|Overall Study|Poor/Non-Compliance|0|||
130419994|NCT02415400|469497960|FG001|Overall Study|Poor/Non-Compliance|1|||
130419995|NCT02415400|469497961|FG002|Overall Study|Poor/Non-Compliance|3|||
130419996|NCT02415400|469497962|FG003|Overall Study|Poor/Non-Compliance|4|||
130419997|NCT02415400|469497959|FG000|Overall Study|Participant no longer meets criteria|2|||
130419998|NCT02415400|469497960|FG001|Overall Study|Participant no longer meets criteria|0|||
130419999|NCT02415400|469497961|FG002|Overall Study|Participant no longer meets criteria|0|||
130420000|NCT02415400|469497962|FG003|Overall Study|Participant no longer meets criteria|1|||
130420001|NCT02415400|469497959|FG000|Overall Study|Participant doesn't answer phone|1|||
130420002|NCT02415400|469497960|FG001|Overall Study|Participant doesn't answer phone|0|||
130420003|NCT02415400|469497961|FG002|Overall Study|Participant doesn't answer phone|0|||
130475830|NCT02992925|469711589|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
130475831|NCT02992925|469711590|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
130475832|NCT02992925|469711591|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
130475833|NCT02992925|469711592|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
130475834|NCT03779204|469711593|FG000|Overall Study|Lost to Follow-up|2|||
130475835|NCT03779204|469711594|FG001|Overall Study|Lost to Follow-up|0|||
130420004|NCT02415400|469497962|FG003|Overall Study|Participant doesn't answer phone|0|||
130420005|NCT02415400|469497959|FG000|Overall Study|Participant wanted home visits|1|||
130420006|NCT02415400|469497960|FG001|Overall Study|Participant wanted home visits|0|||
130420007|NCT02415400|469497961|FG002|Overall Study|Participant wanted home visits|0|||
130420008|NCT02415400|469497962|FG003|Overall Study|Participant wanted home visits|0|||
130420009|NCT02415400|469497959|FG000|Overall Study|Randomized in error|2|||
130420010|NCT02415400|469497960|FG001|Overall Study|Randomized in error|0|||
130420011|NCT02415400|469497961|FG002|Overall Study|Randomized in error|0|||
130420012|NCT02415400|469497962|FG003|Overall Study|Randomized in error|0|||
130475836|NCT04150718|469711595|FG000|Overall Study|Withdrawal by Subject|2|||
130420013|NCT02415400|469497959|FG000|Overall Study|No study drug on site|0|||
130420014|NCT02415400|469497960|FG001|Overall Study|No study drug on site|1|||
130420015|NCT02415400|469497961|FG002|Overall Study|No study drug on site|0|||
130420016|NCT02415400|469497962|FG003|Overall Study|No study drug on site|0|||
130420017|NCT02415400|469497959|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
130420018|NCT02415400|469497960|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
130420019|NCT02415400|469497961|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
130420020|NCT02415400|469497962|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
130420021|NCT02415400|469497959|FG000|Overall Study|Coagulation values cannot be set|0|||
130420022|NCT02415400|469497960|FG001|Overall Study|Coagulation values cannot be set|0|||
130420023|NCT02415400|469497961|FG002|Overall Study|Coagulation values cannot be set|1|||
130420024|NCT02415400|469497962|FG003|Overall Study|Coagulation values cannot be set|0|||
130420025|NCT02415400|469497959|FG000|Overall Study|State regulations prevent participation|0|||
130420026|NCT02415400|469497960|FG001|Overall Study|State regulations prevent participation|0|||
130420027|NCT02415400|469497961|FG002|Overall Study|State regulations prevent participation|1|||
130420028|NCT02415400|469497962|FG003|Overall Study|State regulations prevent participation|0|||
130420029|NCT02415400|469497959|FG000|Overall Study|Poor treatment monitoring|0|||
130420030|NCT02415400|469497960|FG001|Overall Study|Poor treatment monitoring|0|||
130420031|NCT02415400|469497961|FG002|Overall Study|Poor treatment monitoring|1|||
130420032|NCT02415400|469497962|FG003|Overall Study|Poor treatment monitoring|0|||
130420033|NCT02415400|469497959|FG000|Overall Study|Participant in jail|0|||
130420034|NCT02415400|469497960|FG001|Overall Study|Participant in jail|0|||
130420035|NCT02415400|469497961|FG002|Overall Study|Participant in jail|1|||
130420036|NCT02415400|469497962|FG003|Overall Study|Participant in jail|0|||
130420037|NCT02415400|469497959|FG000|Overall Study|Investigator decision|0|||
130420038|NCT02415400|469497960|FG001|Overall Study|Investigator decision|0|||
130420039|NCT02415400|469497961|FG002|Overall Study|Investigator decision|1|||
130420040|NCT02415400|469497962|FG003|Overall Study|Investigator decision|1|||
130420041|NCT02415400|469497959|FG000|Overall Study|Site closure; participant won't transfer|0|||
130420042|NCT02415400|469497960|FG001|Overall Study|Site closure; participant won't transfer|0|||
130420043|NCT02415400|469497961|FG002|Overall Study|Site closure; participant won't transfer|0|||
130420044|NCT02415400|469497962|FG003|Overall Study|Site closure; participant won't transfer|1|||
130420045|NCT02270450|469497963|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130420046|NCT02270450|469497964|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130420047|NCT02270450|469497965|FG002|Overall Study|Refusal unrelated to adverse event|5|||
130420048|NCT02270450|469497966|FG003|Overall Study|Refusal unrelated to adverse event|14|||
130420049|NCT02270450|469497963|FG000|Overall Study|Progression/relapse|1|||
130420050|NCT02270450|469497964|FG001|Overall Study|Progression/relapse|2|||
130420051|NCT02270450|469497965|FG002|Overall Study|Progression/relapse|4|||
130420052|NCT02270450|469497966|FG003|Overall Study|Progression/relapse|9|||
130420053|NCT02270450|469497963|FG000|Overall Study|Death|19|||
130420054|NCT02270450|469497964|FG001|Overall Study|Death|19|||
130420055|NCT02270450|469497965|FG002|Overall Study|Death|31|||
130420056|NCT02270450|469497966|FG003|Overall Study|Death|59|||
130420057|NCT02363738|469497967|FG000|Overall Study|Adverse Event|5|||
130420058|NCT02363738|469497968|FG001|Overall Study|Adverse Event|2|||
130420059|NCT02363738|469497967|FG000|Overall Study|Lack of Efficacy|1|||
130420060|NCT02363738|469497968|FG001|Overall Study|Lack of Efficacy|2|||
130420061|NCT02363738|469497967|FG000|Overall Study|Lost to Follow-up|2|||
130420062|NCT02363738|469497968|FG001|Overall Study|Lost to Follow-up|1|||
130420063|NCT02576678|469497974|FG000|Overall Study|Adverse Event|0|||
130420064|NCT02576678|469497975|FG001|Overall Study|Adverse Event|0|||
130420065|NCT02576678|469497976|FG002|Overall Study|Adverse Event|2|||
130420066|NCT02576678|469497974|FG000|Overall Study|Withdrawal by Subject|3|||
130420067|NCT02576678|469497975|FG001|Overall Study|Withdrawal by Subject|1|||
130420068|NCT02576678|469497976|FG002|Overall Study|Withdrawal by Subject|2|||
130420069|NCT02576678|469497974|FG000|Overall Study|Lost to Follow-up|0|||
130420070|NCT02576678|469497975|FG001|Overall Study|Lost to Follow-up|0|||
130420071|NCT02576678|469497976|FG002|Overall Study|Lost to Follow-up|1|||
130420072|NCT02576678|469497974|FG000|Overall Study|Miscellaneous|2|||
130420073|NCT02576678|469497975|FG001|Overall Study|Miscellaneous|0|||
130420074|NCT02576678|469497976|FG002|Overall Study|Miscellaneous|0|||
130475837|NCT04150718|469711596|FG001|Overall Study|Withdrawal by Subject|7|||
130475838|NCT04150718|469711597|FG002|Overall Study|Withdrawal by Subject|1|||
130475839|NCT04150718|469711595|FG000|Overall Study|Lost to Follow-up|1|||
130475840|NCT04150718|469711596|FG001|Overall Study|Lost to Follow-up|2|||
130475841|NCT04150718|469711597|FG002|Overall Study|Lost to Follow-up|0|||
130475842|NCT04150718|469711595|FG000|Overall Study|Ineligible|1|||
130475843|NCT04150718|469711596|FG001|Overall Study|Ineligible|0|||
130475844|NCT04150718|469711597|FG002|Overall Study|Ineligible|10|||
130420075|NCT02491671|469497977|FG000|Overall Study|Adverse Event|6|||
130420076|NCT02491671|469497978|FG001|Overall Study|Adverse Event|8|||
130420077|NCT02491671|469497977|FG000|Overall Study|Death|0|||
130420078|NCT02491671|469497978|FG001|Overall Study|Death|2|||
130475845|NCT05633953|469711598|FG000|Overall Study|Adverse Event|7|||
130475846|NCT05633953|469711598|FG000|Overall Study|Death|30|||
130475847|NCT05633953|469711598|FG000|Overall Study|Lost to Follow-up|1|||
130420079|NCT02491671|469497977|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
130420080|NCT02491671|469497978|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
130420081|NCT02251990|469497982|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
130420082|NCT02251990|469497983|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
130420083|NCT02251990|469497982|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
130420084|NCT02251990|469497983|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
130420085|NCT02251990|469497982|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
130420086|NCT02251990|469497983|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
130420087|NCT02251990|469497982|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
130420088|NCT02251990|469497983|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
130420089|NCT02251990|469497982|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
130420090|NCT02251990|469497983|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
130420091|NCT02251990|469497982|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
130420092|NCT02251990|469497983|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
130420093|NCT03265600|469497984|FG000|Overall Study|Lost to Follow-up|17|||
130420094|NCT03265600|469497985|FG001|Overall Study|Lost to Follow-up|5|||
130420095|NCT03265600|469497984|FG000|Overall Study|Withdrawal by Subject|4|||
130420096|NCT03265600|469497985|FG001|Overall Study|Withdrawal by Subject|2|||
130420097|NCT03265600|469497984|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
130420098|NCT03265600|469497985|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
130420099|NCT00535730|469497986|FG000|Overall Study|Adverse Event|1|||
130420100|NCT00535730|469497987|FG001|Overall Study|Adverse Event|1|||
130420101|NCT00535730|469497986|FG000|Overall Study|Lost to Follow-up|0|||
130420102|NCT00535730|469497987|FG001|Overall Study|Lost to Follow-up|1|||
130420103|NCT00535730|469497986|FG000|Overall Study|Physician Decision|0|||
130420104|NCT00535730|469497987|FG001|Overall Study|Physician Decision|1|||
130420105|NCT00535730|469497986|FG000|Overall Study|Protocol Violation|1|||
130420106|NCT00535730|469497987|FG001|Overall Study|Protocol Violation|0|||
130420107|NCT00535730|469497986|FG000|Overall Study|Withdrawal by Subject|0|||
130420108|NCT00535730|469497987|FG001|Overall Study|Withdrawal by Subject|4|||
130420109|NCT04330638|469497988|FG000|Overall Study|Adverse Event|9|||
130420110|NCT04330638|469497989|FG001|Overall Study|Adverse Event|10|||
130420111|NCT04330638|469497990|FG002|Overall Study|Adverse Event|15|||
130420112|NCT04330638|469497991|FG003|Overall Study|Adverse Event|6|||
130420113|NCT04330638|469497992|FG004|Overall Study|Adverse Event|10|||
130420114|NCT04330638|469497993|FG005|Overall Study|Adverse Event|5|||
130420115|NCT04330638|469497988|FG000|Overall Study|Other|2|||
130420116|NCT04330638|469497989|FG001|Overall Study|Other|2|||
130420117|NCT04330638|469497990|FG002|Overall Study|Other|5|||
130420118|NCT04330638|469497991|FG003|Overall Study|Other|1|||
130420119|NCT04330638|469497992|FG004|Overall Study|Other|3|||
130420120|NCT04330638|469497993|FG005|Overall Study|Other|2|||
130420121|NCT04330638|469497988|FG000|Overall Study|Withdrawal by Subject|4|||
130420122|NCT04330638|469497989|FG001|Overall Study|Withdrawal by Subject|0|||
130420123|NCT04330638|469497990|FG002|Overall Study|Withdrawal by Subject|0|||
130420124|NCT04330638|469497991|FG003|Overall Study|Withdrawal by Subject|0|||
130420125|NCT04330638|469497992|FG004|Overall Study|Withdrawal by Subject|0|||
130420126|NCT04330638|469497993|FG005|Overall Study|Withdrawal by Subject|0|||
130420127|NCT04330638|469497988|FG000|Overall Study|Lost to Follow-up|3|||
130420128|NCT04330638|469497989|FG001|Overall Study|Lost to Follow-up|2|||
130420129|NCT04330638|469497990|FG002|Overall Study|Lost to Follow-up|3|||
130420130|NCT04330638|469497991|FG003|Overall Study|Lost to Follow-up|2|||
130420131|NCT04330638|469497992|FG004|Overall Study|Lost to Follow-up|3|||
130420132|NCT04330638|469497993|FG005|Overall Study|Lost to Follow-up|0|||
130420133|NCT02293538|469497994|FG000|Overall Study|Adverse Event|0|||
130420134|NCT02293538|469497995|FG001|Overall Study|Adverse Event|1|||
130420135|NCT02293538|469497994|FG000|Overall Study|Lost to Follow-up|1|||
130420136|NCT02293538|469497995|FG001|Overall Study|Lost to Follow-up|0|||
130420137|NCT02293538|469497994|FG000|Overall Study|Withdrawal by Subject|0|||
130420138|NCT02293538|469497995|FG001|Overall Study|Withdrawal by Subject|1|||
130420139|NCT00322348|469497996|FG000|Overall Study|Adverse Event|0|||
130420140|NCT00322348|469497997|FG001|Overall Study|Adverse Event|1|||
130420141|NCT00322348|469497996|FG000|Overall Study|Withdrawal by Subject|1|||
130420142|NCT00322348|469497997|FG001|Overall Study|Withdrawal by Subject|4|||
130420143|NCT00322348|469497996|FG000|Overall Study|Lost to Follow-up|1|||
130420144|NCT00322348|469497997|FG001|Overall Study|Lost to Follow-up|0|||
130420145|NCT00322348|469497996|FG000|Overall Study|Death|0|||
130420146|NCT00322348|469497997|FG001|Overall Study|Death|2|||
130420147|NCT00322348|469497996|FG000|Overall Study|Disease Progression|30|||
130420148|NCT00322348|469497997|FG001|Overall Study|Disease Progression|25|||
130420149|NCT00322348|469497996|FG000|Overall Study|Reasons not specified|5|||
130420150|NCT00322348|469497997|FG001|Overall Study|Reasons not specified|1|||
130420151|NCT00936858|469497998|FG000|Overall Study|Death|3|||
130420152|NCT00936858|469497998|FG000|Overall Study|Progression|29|||
130420153|NCT00936858|469497998|FG000|Overall Study|Withdrawal by Subject|5|||
130420154|NCT00936858|469497998|FG000|Overall Study|Adverse Event|1|||
130420155|NCT00936858|469497998|FG000|Overall Study|Physician Decision|7|||
130420156|NCT00936858|469497998|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
130420157|NCT00936858|469497998|FG000|Overall Study|Lost to Follow-up|1|||
130420158|NCT00989287|469498001|FG000|Overall Study|Adverse Event|1|||
130420159|NCT00989287|469498002|FG001|Overall Study|Adverse Event|0|||
130420160|NCT00989287|469498001|FG000|Overall Study|Lost to Follow-up|0|||
130420161|NCT00989287|469498002|FG001|Overall Study|Lost to Follow-up|1|||
130420162|NCT00729833|469498003|FG000|Overall Study|Death|5|||
130420163|NCT00729833|469498004|FG001|Overall Study|Death|1|||
130420164|NCT00729833|469498005|FG002|Overall Study|Death|3|||
130420165|NCT00729833|469498006|FG003|Overall Study|Death|5|||
130420166|NCT00729833|469498003|FG000|Overall Study|Study Terminated by Sponsor|0|||
130420167|NCT00729833|469498004|FG001|Overall Study|Study Terminated by Sponsor|0|||
130420168|NCT00729833|469498005|FG002|Overall Study|Study Terminated by Sponsor|1|||
130420169|NCT00729833|469498006|FG003|Overall Study|Study Terminated by Sponsor|0|||
130420170|NCT00729833|469498003|FG000|Overall Study|Lost to Follow-up|1|||
130420171|NCT00729833|469498004|FG001|Overall Study|Lost to Follow-up|0|||
130420172|NCT00729833|469498005|FG002|Overall Study|Lost to Follow-up|0|||
130420173|NCT00729833|469498006|FG003|Overall Study|Lost to Follow-up|0|||
130420174|NCT00729833|469498003|FG000|Overall Study|Withdrawal by Subject|3|||
130420175|NCT00729833|469498004|FG001|Overall Study|Withdrawal by Subject|1|||
130420176|NCT00729833|469498005|FG002|Overall Study|Withdrawal by Subject|3|||
130420177|NCT00729833|469498006|FG003|Overall Study|Withdrawal by Subject|0|||
130420178|NCT00729833|469498003|FG000|Overall Study|Unspecified Reasons|11|||
130420179|NCT00729833|469498004|FG001|Overall Study|Unspecified Reasons|5|||
130420180|NCT00729833|469498005|FG002|Overall Study|Unspecified Reasons|5|||
130420181|NCT00729833|469498006|FG003|Overall Study|Unspecified Reasons|1|||
130420182|NCT00417079|469498007|FG000|Overall Study|Disease progression|267|||
130420183|NCT00417079|469498008|FG001|Overall Study|Disease progression|180|||
130420184|NCT00417079|469498007|FG000|Overall Study|Adverse Event|32|||
130420185|NCT00417079|469498008|FG001|Overall Study|Adverse Event|67|||
130420186|NCT00417079|469498007|FG000|Overall Study|Non-compliance to protocol|0|||
130420187|NCT00417079|469498008|FG001|Overall Study|Non-compliance to protocol|1|||
130420188|NCT00417079|469498007|FG000|Overall Study|Lost to Follow-up|2|||
130420189|NCT00417079|469498008|FG001|Overall Study|Lost to Follow-up|0|||
130420190|NCT00417079|469498007|FG000|Overall Study|Withdrawal by Subject|17|||
130420191|NCT00417079|469498008|FG001|Overall Study|Withdrawal by Subject|8|||
130420192|NCT00417079|469498007|FG000|Overall Study|Not treated|6|||
130420193|NCT00417079|469498008|FG001|Overall Study|Not treated|7|||
130420194|NCT00417079|469498007|FG000|Overall Study|Screened failure|2|||
130420195|NCT00417079|469498008|FG001|Overall Study|Screened failure|1|||
130420196|NCT00417079|469498007|FG000|Overall Study|Investigator's decision|1|||
130420197|NCT00417079|469498008|FG001|Overall Study|Investigator's decision|4|||
130420198|NCT00417079|469498007|FG000|Overall Study|Non-confirmed Disease progression|1|||
130420199|NCT00417079|469498008|FG001|Overall Study|Non-confirmed Disease progression|1|||
130420200|NCT00417079|469498007|FG000|Overall Study|Clinical deterioration|1|||
130420201|NCT00417079|469498008|FG001|Overall Study|Clinical deterioration|0|||
130420202|NCT00417079|469498007|FG000|Overall Study|Screening error|2|||
130420203|NCT00417079|469498008|FG001|Overall Study|Screening error|1|||
130420204|NCT00417079|469498007|FG000|Overall Study|Withdrawal by subject's family|0|||
130420205|NCT00417079|469498008|FG001|Overall Study|Withdrawal by subject's family|1|||
130420206|NCT00417079|469498007|FG000|Overall Study|Patient unable to come to the clinic|0|||
130420207|NCT00417079|469498008|FG001|Overall Study|Patient unable to come to the clinic|1|||
130420208|NCT00417079|469498007|FG000|Overall Study|abnormal liver function tests|0|||
130420209|NCT00417079|469498008|FG001|Overall Study|abnormal liver function tests|1|||
130420210|NCT01687257|469498010|FG000|Overall Study|Efficacy Failure|6|||
130420211|NCT01687257|469498011|FG001|Overall Study|Efficacy Failure|0|||
130420212|NCT01687257|469498012|FG002|Overall Study|Efficacy Failure|5|||
130420213|NCT01687257|469498010|FG000|Overall Study|Subject Withdrew Consent|1|||
130420214|NCT01687257|469498011|FG001|Overall Study|Subject Withdrew Consent|1|||
130420215|NCT01687257|469498012|FG002|Overall Study|Subject Withdrew Consent|1|||
130420216|NCT01687257|469498010|FG000|Overall Study|Adverse Event|1|||
130475848|NCT05633953|469711598|FG000|Overall Study|Osilodrostat discontinued|4|||
130420217|NCT01687257|469498011|FG001|Overall Study|Adverse Event|0|||
130420218|NCT01687257|469498012|FG002|Overall Study|Adverse Event|0|||
130420219|NCT01687257|469498010|FG000|Overall Study|Investigator's Discretion|0|||
130420220|NCT01687257|469498011|FG001|Overall Study|Investigator's Discretion|3|||
130420221|NCT01687257|469498012|FG002|Overall Study|Investigator's Discretion|0|||
130420222|NCT04403698|469498014|FG000|Overall Study|Adverse Event|1|||
130420223|NCT04403698|469498015|FG001|Overall Study|Adverse Event|1|||
130420224|NCT04403698|469498014|FG000|Overall Study|Lost to Follow-up|1|||
130420225|NCT04403698|469498015|FG001|Overall Study|Lost to Follow-up|0|||
130420226|NCT04403698|469498014|FG000|Overall Study|Protocol Violation|0|||
130420227|NCT04403698|469498015|FG001|Overall Study|Protocol Violation|1|||
130420228|NCT04899349|469498016|FG000|Overall Study|Study terminated by Sponsor|2|||
130420229|NCT04899349|469498017|FG001|Overall Study|Study terminated by Sponsor|0|||
130420230|NCT03336619|469498018|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
130475849|NCT05633953|469711598|FG000|Overall Study|Physician Decision|1|||
130564438|NCT06156215|470032215|FG002|Overall Study|Physician Decision|0|||
130564439|NCT06156215|470032216|FG003|Overall Study|Physician Decision|0|||
130564440|NCT06156215|470032217|FG004|Overall Study|Physician Decision|0|||
130727352|NCT02883049|470625424|FG000|Post Induction|Developed SMN|0|||
130727353|NCT02883049|470625425|FG001|Post Induction|Developed SMN|0|||
130727354|NCT02883049|470625426|FG002|Post Induction|Developed SMN|0|||
130727355|NCT02883049|470625427|FG003|Post Induction|Developed SMN|0|||
130727356|NCT02883049|470625428|FG004|Post Induction|Developed SMN|1|||
130727357|NCT02883049|470625429|FG005|Post Induction|Developed SMN|0|||
130727358|NCT02883049|470625430|FG006|Post Induction|Developed SMN|1|||
130727359|NCT02883049|470625431|FG007|Post Induction|Developed SMN|0|||
130727360|NCT02883049|470625432|FG008|Post Induction|Developed SMN|0|||
130727361|NCT02883049|470625433|FG009|Post Induction|Developed SMN|0|||
130727362|NCT02883049|470625434|FG010|Post Induction|Developed SMN|1|||
130727363|NCT02883049|470625435|FG011|Post Induction|Developed SMN|1|||
130727364|NCT02883049|470625436|FG012|Post Induction|Developed SMN|0|||
130727365|NCT02883049|470625437|FG013|Post Induction|Developed SMN|0|||
130727366|NCT02883049|470625438|FG014|Post Induction|Developed SMN|1|||
130727367|NCT02883049|470625439|FG015|Post Induction|Developed SMN|0|||
130727368|NCT02883049|470625424|FG000|Post Induction|Enrolled onto another COG study|0|||
130727369|NCT02883049|470625425|FG001|Post Induction|Enrolled onto another COG study|0|||
130727370|NCT02883049|470625426|FG002|Post Induction|Enrolled onto another COG study|0|||
130727371|NCT02883049|470625427|FG003|Post Induction|Enrolled onto another COG study|1|||
130727372|NCT02883049|470625428|FG004|Post Induction|Enrolled onto another COG study|1|||
130727373|NCT02883049|470625429|FG005|Post Induction|Enrolled onto another COG study|0|||
130727374|NCT02883049|470625430|FG006|Post Induction|Enrolled onto another COG study|0|||
130420231|NCT03336619|469498019|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
130420232|NCT03336619|469498018|FG000|Overall Study|Withdrawal by Subject|17|||
130420233|NCT03336619|469498019|FG001|Overall Study|Withdrawal by Subject|16|||
130420234|NCT03336619|469498018|FG000|Overall Study|Adverse Event|2|||
130420235|NCT03336619|469498019|FG001|Overall Study|Adverse Event|5|||
130727375|NCT02883049|470625431|FG007|Post Induction|Enrolled onto another COG study|4|||
130420236|NCT03336619|469498018|FG000|Overall Study|Physician Decision|3|||
130420237|NCT03336619|469498019|FG001|Overall Study|Physician Decision|0|||
130420238|NCT02820623|469498020|FG000|Overall Study|Withdrawal by Subject|1|||
130475850|NCT05633953|469711598|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
130475851|NCT05633953|469711598|FG000|Overall Study|Progressive disease|2|||
130475852|NCT04034251|469711599|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
130475853|NCT04034251|469711600|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
130475854|NCT04034251|469711601|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
130475855|NCT04783935|469711614|FG000|Overall Study|Withdrawal by Subject|6|||
130475856|NCT04783935|469711614|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
130475857|NCT04783935|469711614|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
130475858|NCT04783935|469711614|FG000|Overall Study|Lost to Follow-up|3|||
130475859|NCT04783935|469711614|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
130475860|NCT06074523|469711618|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
130475861|NCT06074523|469711618|FG000|Overall Study|Withdrawal by Subject|1|||
130475862|NCT05273749|469711619|FG000|Overall Study|Adverse Event|14|||
130475863|NCT05273749|469711620|FG001|Overall Study|Adverse Event|8|||
130475864|NCT05273749|469711619|FG000|Overall Study|Lack of Efficacy|2|||
130475865|NCT05273749|469711620|FG001|Overall Study|Lack of Efficacy|8|||
130475866|NCT05273749|469711619|FG000|Overall Study|Physician Decision|0|||
130475867|NCT05273749|469711620|FG001|Overall Study|Physician Decision|2|||
130475868|NCT05273749|469711619|FG000|Overall Study|Withdrawal by Subject|14|||
130475869|NCT05273749|469711620|FG001|Overall Study|Withdrawal by Subject|16|||
130475870|NCT05273749|469711619|FG000|Overall Study|Lost to Follow-up|10|||
130475871|NCT05273749|469711620|FG001|Overall Study|Lost to Follow-up|10|||
130475872|NCT05273749|469711619|FG000|Overall Study|Pregnancy|1|||
130475873|NCT05273749|469711620|FG001|Overall Study|Pregnancy|0|||
130475874|NCT05273749|469711619|FG000|Overall Study|Non-Compliance|3|||
130475875|NCT05273749|469711620|FG001|Overall Study|Non-Compliance|2|||
130475876|NCT05273749|469711619|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
130475877|NCT05273749|469711620|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
130475878|NCT04956861|469711625|FG000|Overall Study|Withdrawal by Subject|4|||
130727376|NCT02883049|470625432|FG008|Post Induction|Enrolled onto another COG study|0|||
130727377|NCT02883049|470625433|FG009|Post Induction|Enrolled onto another COG study|0|||
130564441|NCT06156215|470032218|FG005|Overall Study|Physician Decision|0|||
130727378|NCT02883049|470625434|FG010|Post Induction|Enrolled onto another COG study|0|||
130727379|NCT02883049|470625435|FG011|Post Induction|Enrolled onto another COG study|2|||
130727380|NCT02883049|470625436|FG012|Post Induction|Enrolled onto another COG study|0|||
130727381|NCT02883049|470625437|FG013|Post Induction|Enrolled onto another COG study|1|||
130420239|NCT02820623|469498021|FG001|Overall Study|Withdrawal by Subject|3|||
130420240|NCT02820623|469498022|FG002|Overall Study|Withdrawal by Subject|3|||
130420241|NCT02820623|469498020|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
130420242|NCT02820623|469498021|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
130420243|NCT02820623|469498022|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
130420244|NCT02820623|469498020|FG000|Overall Study|Therapist unable to enroll clients|1|||
130420245|NCT02820623|469498021|FG001|Overall Study|Therapist unable to enroll clients|1|||
130420246|NCT02820623|469498022|FG002|Overall Study|Therapist unable to enroll clients|3|||
130420247|NCT02820623|469498020|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
130420248|NCT02820623|469498021|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
130420249|NCT02820623|469498022|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
130420250|NCT01965834|469498023|FG000|Overall Study|Lack of Efficacy|4|||
130420251|NCT00744653|469498025|FG000|Overall Study|antineoplastic treatment|11|||
130420252|NCT00744653|469498025|FG000|Overall Study|Death|1|||
130420253|NCT00744653|469498025|FG000|Overall Study|Lost to Follow-up|1|||
130420254|NCT00744653|469498025|FG000|Overall Study|Physician Decision|3|||
130420255|NCT03826667|469498026|FG000|Overall Study|Protocol deviation|21|||
130420256|NCT00617344|469498027|FG000|Overall Study|Serious adverse event|1|||
130420257|NCT00617344|469498028|FG001|Overall Study|Serious adverse event|0|||
130420258|NCT00617344|469498029|FG002|Overall Study|Serious adverse event|0|||
130420259|NCT00617344|469498027|FG000|Overall Study|Other Adverse Event|1|||
130420260|NCT00617344|469498028|FG001|Overall Study|Other Adverse Event|1|||
130420261|NCT00617344|469498029|FG002|Overall Study|Other Adverse Event|0|||
130420262|NCT00617344|469498027|FG000|Overall Study|Protocol Violation|10|||
130420263|NCT00617344|469498028|FG001|Overall Study|Protocol Violation|8|||
130420264|NCT00617344|469498029|FG002|Overall Study|Protocol Violation|5|||
130420265|NCT00617344|469498027|FG000|Overall Study|Lost to Follow-up|5|||
130420266|NCT00617344|469498028|FG001|Overall Study|Lost to Follow-up|4|||
130420267|NCT00617344|469498029|FG002|Overall Study|Lost to Follow-up|1|||
130420268|NCT00617344|469498027|FG000|Overall Study|Withdrawal by Subject|8|||
130420269|NCT00617344|469498028|FG001|Overall Study|Withdrawal by Subject|9|||
130420270|NCT00617344|469498029|FG002|Overall Study|Withdrawal by Subject|2|||
130420271|NCT00941330|469498031|FG000|Overall Study|Other|1|||
130420272|NCT00941330|469498032|FG001|Overall Study|Other|0|||
130420273|NCT00941330|469498031|FG000|Overall Study|Physician Decision|0|||
130420274|NCT00941330|469498032|FG001|Overall Study|Physician Decision|2|||
130475879|NCT04956861|469711626|FG001|Overall Study|Withdrawal by Subject|4|||
130475880|NCT04956861|469711627|FG002|Overall Study|Withdrawal by Subject|2|||
130475881|NCT04956861|469711625|FG000|Overall Study|Physician Decision|4|||
130475882|NCT04956861|469711626|FG001|Overall Study|Physician Decision|5|||
130475883|NCT04956861|469711627|FG002|Overall Study|Physician Decision|1|||
130475884|NCT05337748|469711628|FG000|Overall Study|Withdrawal by Subject|1|||
130475885|NCT05337748|469711629|FG001|Overall Study|Withdrawal by Subject|0|||
130475886|NCT05337748|469711628|FG000|Overall Study|Death|1|||
130475887|NCT05337748|469711629|FG001|Overall Study|Death|0|||
130475888|NCT04806594|469711640|FG000|Overall Study|Withdrawal by Subject|2|||
130475889|NCT04806594|469711640|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
130475890|NCT02543281|469711641|FG000|Overall Study|Lost to Follow-up|0|||
130475891|NCT02543281|469711642|FG001|Overall Study|Lost to Follow-up|0|||
130475892|NCT02543281|469711643|FG002|Overall Study|Lost to Follow-up|1|||
130475893|NCT04318548|469711644|FG000|Overall Study|Adverse Event|0|||
130475894|NCT04318548|469711645|FG001|Overall Study|Adverse Event|0|||
130475895|NCT04318548|469711646|FG002|Overall Study|Adverse Event|1|||
130475896|NCT04318548|469711644|FG000|Overall Study|Lost to Follow-up|6|||
130475897|NCT04318548|469711645|FG001|Overall Study|Lost to Follow-up|13|||
130475898|NCT04318548|469711646|FG002|Overall Study|Lost to Follow-up|9|||
130475899|NCT04318548|469711644|FG000|Overall Study|Protocol Violation|1|||
130475900|NCT04318548|469711645|FG001|Overall Study|Protocol Violation|0|||
130475901|NCT04318548|469711646|FG002|Overall Study|Protocol Violation|2|||
130420275|NCT00506493|469498033|FG000|Overall Study|Death|6|||
130420276|NCT00506493|469498033|FG000|Overall Study|Withdrawal by Subject|5|||
130420277|NCT02985866|469499528|FG000|Overall Study|Poor CGM data|1|||
130420278|NCT02985866|469499529|FG001|Overall Study|Poor CGM data|1|||
130420279|NCT00686166|469499534|FG000|Overall Study|Adverse Event|7|||
130420280|NCT00686166|469499534|FG000|Overall Study|Withdrawal by Subject|1|||
130420281|NCT00686166|469499534|FG000|Overall Study|Progression/Relapse|1|||
130420282|NCT00686166|469499534|FG000|Overall Study|Death|1|||
130420283|NCT00686166|469499534|FG000|Overall Study|Not Protocol Specified|1|||
130420284|NCT00686166|469499534|FG000|Overall Study|Ineligible|5|||
130420285|NCT00686166|469499534|FG000|Overall Study|Did not begin protocol therapy|4|||
130475902|NCT04318548|469711644|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
130420286|NCT01549613|469499537|FG000|Overall Study|Lost to Follow-up|11|||
130420287|NCT01549613|469499538|FG001|Overall Study|Lost to Follow-up|11|||
130475903|NCT04318548|469711645|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
130475904|NCT04318548|469711646|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
130475905|NCT04318548|469711644|FG000|Overall Study|Migrated / moved from the study area|0|||
130475906|NCT04318548|469711645|FG001|Overall Study|Migrated / moved from the study area|0|||
130420288|NCT02216123|469499539|FG000|Overall Study|Lost to Follow-up|4|||
130420289|NCT02216123|469499540|FG001|Overall Study|Lost to Follow-up|2|||
130420290|NCT02216123|469499539|FG000|Overall Study|Withdrawal by Subject|2|||
130420291|NCT02216123|469499540|FG001|Overall Study|Withdrawal by Subject|0|||
130420292|NCT04477187|469499543|FG000|Overall Study|Lost to Follow-up|2|||
130420293|NCT00464815|469499545|FG000|Overall Study|Withdrawal by Subject|6|||
130420294|NCT00464815|469499546|FG001|Overall Study|Withdrawal by Subject|3|||
130420295|NCT00254982|469499547|FG000|Overall Study|Other|2|||
130420296|NCT00254982|469499548|FG001|Overall Study|Other|1|||
130420297|NCT00254982|469499547|FG000|Overall Study|Lack of Efficacy|5|||
130420298|NCT00254982|469499548|FG001|Overall Study|Lack of Efficacy|3|||
130420299|NCT00254982|469499547|FG000|Overall Study|Lost to Follow-up|5|||
130420300|NCT00254982|469499548|FG001|Overall Study|Lost to Follow-up|3|||
130420301|NCT00254982|469499547|FG000|Overall Study|Adverse Event|18|||
130420302|NCT00254982|469499548|FG001|Overall Study|Adverse Event|16|||
130420303|NCT00254982|469499547|FG000|Overall Study|Withdrawal by Subject|1|||
130420304|NCT00254982|469499548|FG001|Overall Study|Withdrawal by Subject|1|||
130420305|NCT00254982|469499547|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
130420306|NCT00254982|469499548|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
130420307|NCT00254982|469499547|FG000|Overall Study|Protocol deviation|1|||
130420308|NCT00254982|469499548|FG001|Overall Study|Protocol deviation|1|||
130420309|NCT00254982|469499547|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
130420310|NCT00254982|469499548|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
130420311|NCT00254982|469499547|FG000|Overall Study|Malignancy|0|||
130420312|NCT00254982|469499548|FG001|Overall Study|Malignancy|2|||
130420313|NCT00254982|469499547|FG000|Overall Study|Opportunistic infection|1|||
130420314|NCT00254982|469499548|FG001|Overall Study|Opportunistic infection|0|||
130420315|NCT00254982|469499547|FG000|Overall Study|Abnormal liver function tests|2|||
130475907|NCT04318548|469711646|FG002|Overall Study|Migrated / moved from the study area|1|||
130475908|NCT04318548|469711644|FG000|Overall Study|Other|1|||
130475909|NCT04318548|469711645|FG001|Overall Study|Other|2|||
130475910|NCT04318548|469711646|FG002|Overall Study|Other|3|||
130475911|NCT05247489|469711647|FG000|Overall Study|Lost to Follow-up|5|||
130475912|NCT05247489|469711648|FG001|Overall Study|Lost to Follow-up|1|||
130475913|NCT05247489|469711647|FG000|Overall Study|Withdrawal by Subject|6|||
130475914|NCT05247489|469711648|FG001|Overall Study|Withdrawal by Subject|7|||
130475915|NCT05247489|469711647|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
130475916|NCT05247489|469711648|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
130475917|NCT05247489|469711647|FG000|Overall Study|Left Country|1|||
130475918|NCT05247489|469711648|FG001|Overall Study|Left Country|0|||
130475919|NCT05247489|469711647|FG000|Overall Study|Noncompliance with Investigational Product|1|||
130475920|NCT05247489|469711648|FG001|Overall Study|Noncompliance with Investigational Product|0|||
130564442|NCT06156215|470032213|FG000|Overall Study|Became or found ineligible|2|||
130420316|NCT00254982|469499548|FG001|Overall Study|Abnormal liver function tests|1|||
130420317|NCT01613248|469499553|FG000|Overall Study|Adverse Event|0|||
130420318|NCT01613248|469499554|FG001|Overall Study|Adverse Event|0|||
130420319|NCT01613248|469499555|FG002|Overall Study|Adverse Event|0|||
130420320|NCT01613248|469499556|FG003|Overall Study|Adverse Event|1|||
130420321|NCT01613248|469499557|FG004|Overall Study|Adverse Event|0|||
130420322|NCT01613248|469499558|FG005|Overall Study|Adverse Event|0|||
130420323|NCT01613248|469499553|FG000|Overall Study|Withdrawal by Subject|3|||
130420324|NCT01613248|469499554|FG001|Overall Study|Withdrawal by Subject|2|||
130420325|NCT01613248|469499555|FG002|Overall Study|Withdrawal by Subject|2|||
130420326|NCT01613248|469499556|FG003|Overall Study|Withdrawal by Subject|5|||
130420327|NCT01613248|469499557|FG004|Overall Study|Withdrawal by Subject|0|||
130420328|NCT01613248|469499558|FG005|Overall Study|Withdrawal by Subject|1|||
130420329|NCT01613248|469499553|FG000|Overall Study|Lost to Follow-up|5|||
130420330|NCT01613248|469499554|FG001|Overall Study|Lost to Follow-up|7|||
130420331|NCT01613248|469499555|FG002|Overall Study|Lost to Follow-up|4|||
130420332|NCT01613248|469499556|FG003|Overall Study|Lost to Follow-up|8|||
130420333|NCT01613248|469499557|FG004|Overall Study|Lost to Follow-up|4|||
130420334|NCT01613248|469499558|FG005|Overall Study|Lost to Follow-up|2|||
130420335|NCT01613248|469499553|FG000|Overall Study|Study Terminated by Sponsor|4|||
130420336|NCT01613248|469499554|FG001|Overall Study|Study Terminated by Sponsor|6|||
130420337|NCT01613248|469499555|FG002|Overall Study|Study Terminated by Sponsor|8|||
130475921|NCT05247489|469711647|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
130564443|NCT06156215|470032214|FG001|Overall Study|Became or found ineligible|0|||
130564444|NCT06156215|470032215|FG002|Overall Study|Became or found ineligible|2|||
130564445|NCT06156215|470032216|FG003|Overall Study|Became or found ineligible|0|||
130420338|NCT01613248|469499556|FG003|Overall Study|Study Terminated by Sponsor|8|||
130420339|NCT01613248|469499557|FG004|Overall Study|Study Terminated by Sponsor|9|||
130420340|NCT01613248|469499558|FG005|Overall Study|Study Terminated by Sponsor|11|||
130420341|NCT01613248|469499553|FG000|Overall Study|Physician Decision|8|||
130420342|NCT01613248|469499554|FG001|Overall Study|Physician Decision|8|||
130420343|NCT01613248|469499555|FG002|Overall Study|Physician Decision|9|||
130420344|NCT01613248|469499556|FG003|Overall Study|Physician Decision|4|||
130475922|NCT05247489|469711648|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
130420345|NCT01613248|469499557|FG004|Overall Study|Physician Decision|7|||
130420346|NCT01613248|469499558|FG005|Overall Study|Physician Decision|6|||
130420347|NCT01613248|469499553|FG000|Overall Study|Lack of Qualifying Event|9|||
130420348|NCT01613248|469499554|FG001|Overall Study|Lack of Qualifying Event|11|||
130420349|NCT01613248|469499555|FG002|Overall Study|Lack of Qualifying Event|10|||
130420350|NCT01613248|469499556|FG003|Overall Study|Lack of Qualifying Event|11|||
130420351|NCT01613248|469499557|FG004|Overall Study|Lack of Qualifying Event|15|||
130420352|NCT01613248|469499558|FG005|Overall Study|Lack of Qualifying Event|18|||
130420353|NCT01613248|469499553|FG000|Overall Study|Pregnancy|0|||
130420354|NCT01613248|469499554|FG001|Overall Study|Pregnancy|0|||
130420355|NCT01613248|469499555|FG002|Overall Study|Pregnancy|0|||
130420356|NCT01613248|469499556|FG003|Overall Study|Pregnancy|1|||
130420357|NCT01613248|469499557|FG004|Overall Study|Pregnancy|0|||
130420358|NCT01613248|469499558|FG005|Overall Study|Pregnancy|0|||
130475923|NCT03771898|469711649|FG000|Overall Study|Adverse Event|1|||
130475924|NCT03771898|469711650|FG001|Overall Study|Adverse Event|0|||
130475925|NCT03771898|469711651|FG002|Overall Study|Adverse Event|0|||
130475926|NCT03771898|469711652|FG003|Overall Study|Adverse Event|0|||
130475927|NCT03771898|469711653|FG004|Overall Study|Adverse Event|0|||
130475928|NCT03771898|469711649|FG000|Overall Study|Lost to Follow-up|1|||
130475929|NCT03771898|469711650|FG001|Overall Study|Lost to Follow-up|1|||
130475930|NCT03771898|469711651|FG002|Overall Study|Lost to Follow-up|1|||
130475931|NCT03771898|469711652|FG003|Overall Study|Lost to Follow-up|0|||
130475932|NCT03771898|469711653|FG004|Overall Study|Lost to Follow-up|0|||
130475933|NCT03771898|469711649|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130475934|NCT03771898|469711650|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130475935|NCT03771898|469711651|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130475936|NCT03771898|469711652|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130475937|NCT03771898|469711653|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130475938|NCT03771898|469711649|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
130475939|NCT03771898|469711650|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
130475940|NCT03771898|469711651|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
130475941|NCT03771898|469711652|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
130475942|NCT03771898|469711653|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
130475943|NCT04541706|469711654|FG000|Overall Study|Withdrawal by Subject|3|||
130475944|NCT04541706|469711654|FG000|Overall Study|Progressive disease|33|||
130475945|NCT04541706|469711654|FG000|Overall Study|Physician Decision|1|||
130475946|NCT04541706|469711654|FG000|Overall Study|Lost to Follow-up|2|||
130475947|NCT04541706|469711654|FG000|Overall Study|Death|5|||
130475948|NCT04541706|469711654|FG000|Overall Study|Adverse Event|1|||
130475949|NCT05563246|469711655|FG000|Overall Study|Withdrawal by Subject|1|||
130475950|NCT05563246|469711656|FG001|Overall Study|Withdrawal by Subject|2|||
130475951|NCT05563246|469711657|FG002|Overall Study|Withdrawal by Subject|0|||
130475952|NCT05563246|469711658|FG003|Overall Study|Withdrawal by Subject|0|||
130475953|NCT05563246|469711655|FG000|Overall Study|Protocol Deviation|0|||
130475954|NCT05563246|469711656|FG001|Overall Study|Protocol Deviation|1|||
130475955|NCT05563246|469711657|FG002|Overall Study|Protocol Deviation|0|||
130475956|NCT05563246|469711658|FG003|Overall Study|Protocol Deviation|0|||
130475957|NCT05563246|469711655|FG000|Overall Study|Physician Decision|0|||
130475958|NCT05563246|469711656|FG001|Overall Study|Physician Decision|1|||
130475959|NCT05563246|469711657|FG002|Overall Study|Physician Decision|0|||
130475960|NCT05563246|469711658|FG003|Overall Study|Physician Decision|0|||
130475961|NCT05563246|469711655|FG000|Overall Study|Adverse Event|0|||
130475962|NCT05563246|469711656|FG001|Overall Study|Adverse Event|0|||
130475963|NCT05563246|469711657|FG002|Overall Study|Adverse Event|2|||
130475964|NCT05563246|469711658|FG003|Overall Study|Adverse Event|0|||
130475965|NCT05563246|469711655|FG000|Overall Study|Lost to Follow-up|0|||
130475966|NCT05563246|469711656|FG001|Overall Study|Lost to Follow-up|0|||
130475967|NCT05563246|469711657|FG002|Overall Study|Lost to Follow-up|1|||
130475968|NCT05563246|469711658|FG003|Overall Study|Lost to Follow-up|0|||
130475969|NCT01416831|469711662|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
130420359|NCT02015676|469499570|FG000|Overall Study|Adverse Event|2|||
130420360|NCT02015676|469499571|FG001|Overall Study|Adverse Event|18|||
130420361|NCT02015676|469499572|FG002|Overall Study|Adverse Event|0|||
130420362|NCT02015676|469499570|FG000|Overall Study|Lack of Efficacy|2|||
130420363|NCT02015676|469499571|FG001|Overall Study|Lack of Efficacy|4|||
130475970|NCT01416831|469711663|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
130475971|NCT05215314|469711664|FG000|Overall Study|Lost to Follow-up|2|||
130475972|NCT05215314|469711665|FG001|Overall Study|Lost to Follow-up|2|||
130420364|NCT02015676|469499572|FG002|Overall Study|Lack of Efficacy|0|||
130420365|NCT02015676|469499570|FG000|Overall Study|Protocol Violation|1|||
130475973|NCT05215314|469711664|FG000|Overall Study|Withdrawal by Subject|2|||
130475974|NCT05215314|469711665|FG001|Overall Study|Withdrawal by Subject|0|||
130475975|NCT05215314|469711664|FG000|Overall Study|Physician Decision|1|||
130475976|NCT05215314|469711665|FG001|Overall Study|Physician Decision|0|||
130475977|NCT04784559|469711666|FG000|Overall Study|Withdrawal by Subject|3|||
130420366|NCT02015676|469499571|FG001|Overall Study|Protocol Violation|0|||
130727382|NCT02883049|470625438|FG014|Post Induction|Enrolled onto another COG study|0|||
130727383|NCT02883049|470625439|FG015|Post Induction|Enrolled onto another COG study|0|||
130727384|NCT02883049|470625424|FG000|Post Induction|Recurrent leukemia|0|||
130727385|NCT02883049|470625425|FG001|Post Induction|Recurrent leukemia|0|||
130727386|NCT02883049|470625426|FG002|Post Induction|Recurrent leukemia|0|||
130727387|NCT02883049|470625427|FG003|Post Induction|Recurrent leukemia|17|||
130727388|NCT02883049|470625428|FG004|Post Induction|Recurrent leukemia|12|||
130727389|NCT02883049|470625429|FG005|Post Induction|Recurrent leukemia|4|||
130727390|NCT02883049|470625430|FG006|Post Induction|Recurrent leukemia|1|||
130727391|NCT02883049|470625431|FG007|Post Induction|Recurrent leukemia|13|||
130727392|NCT02883049|470625432|FG008|Post Induction|Recurrent leukemia|27|||
130727393|NCT02883049|470625433|FG009|Post Induction|Recurrent leukemia|5|||
130727394|NCT02883049|470625434|FG010|Post Induction|Recurrent leukemia|3|||
130727395|NCT02883049|470625435|FG011|Post Induction|Recurrent leukemia|12|||
130727396|NCT02883049|470625436|FG012|Post Induction|Recurrent leukemia|1|||
130727397|NCT02883049|470625437|FG013|Post Induction|Recurrent leukemia|1|||
130727398|NCT02883049|470625438|FG014|Post Induction|Recurrent leukemia|9|||
130727399|NCT02883049|470625439|FG015|Post Induction|Recurrent leukemia|3|||
130727400|NCT02883049|470625424|FG000|Post Induction|Induction Failure|0|||
130727401|NCT02883049|470625425|FG001|Post Induction|Induction Failure|0|||
130727402|NCT02883049|470625426|FG002|Post Induction|Induction Failure|0|||
130727403|NCT02883049|470625427|FG003|Post Induction|Induction Failure|0|||
130727404|NCT02883049|470625428|FG004|Post Induction|Induction Failure|0|||
130727405|NCT02883049|470625429|FG005|Post Induction|Induction Failure|0|||
130727406|NCT02883049|470625430|FG006|Post Induction|Induction Failure|0|||
130727407|NCT02883049|470625431|FG007|Post Induction|Induction Failure|2|||
130727408|NCT02883049|470625432|FG008|Post Induction|Induction Failure|2|||
130727409|NCT02883049|470625433|FG009|Post Induction|Induction Failure|0|||
130727410|NCT02883049|470625434|FG010|Post Induction|Induction Failure|0|||
130727411|NCT02883049|470625435|FG011|Post Induction|Induction Failure|0|||
130727412|NCT02883049|470625436|FG012|Post Induction|Induction Failure|0|||
130727413|NCT02883049|470625437|FG013|Post Induction|Induction Failure|2|||
130727414|NCT02883049|470625438|FG014|Post Induction|Induction Failure|0|||
130727415|NCT02883049|470625439|FG015|Post Induction|Induction Failure|0|||
130727416|NCT01924754|470625445|FG000|Overall Study|Lost to Follow-up|1|||
130727417|NCT01924754|470625446|FG001|Overall Study|Lost to Follow-up|2|||
130420367|NCT02015676|469499572|FG002|Overall Study|Protocol Violation|0|||
130420368|NCT02015676|469499570|FG000|Overall Study|Withdrawal by Subject|1|||
130420369|NCT02015676|469499571|FG001|Overall Study|Withdrawal by Subject|7|||
130420370|NCT02015676|469499572|FG002|Overall Study|Withdrawal by Subject|1|||
130420371|NCT02015676|469499570|FG000|Overall Study|Administrative reasons|0|||
130420372|NCT02015676|469499571|FG001|Overall Study|Administrative reasons|3|||
130420373|NCT02015676|469499572|FG002|Overall Study|Administrative reasons|1|||
130420374|NCT02015676|469499570|FG000|Overall Study|Death|0|||
130420375|NCT02015676|469499571|FG001|Overall Study|Death|1|||
130420376|NCT02015676|469499572|FG002|Overall Study|Death|0|||
130420377|NCT02015676|469499570|FG000|Overall Study|Disease progression|3|||
130475978|NCT04784559|469711667|FG001|Overall Study|Withdrawal by Subject|2|||
130475979|NCT04784559|469711668|FG002|Overall Study|Withdrawal by Subject|1|||
130475980|NCT04784559|469711666|FG000|Overall Study|Death|2|||
130475981|NCT04784559|469711667|FG001|Overall Study|Death|1|||
130475982|NCT04784559|469711668|FG002|Overall Study|Death|2|||
130475983|NCT04784559|469711666|FG000|Overall Study|Lost to Follow-up|0|||
130475984|NCT04784559|469711667|FG001|Overall Study|Lost to Follow-up|0|||
130475985|NCT04784559|469711668|FG002|Overall Study|Lost to Follow-up|2|||
130475986|NCT04784559|469711666|FG000|Overall Study|Participant worsened, PI decision|1|||
130475987|NCT04784559|469711667|FG001|Overall Study|Participant worsened, PI decision|0|||
130475988|NCT04784559|469711668|FG002|Overall Study|Participant worsened, PI decision|0|||
130475989|NCT04784559|469711666|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
130475990|NCT04784559|469711667|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
130475991|NCT04784559|469711668|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
130727418|NCT01924754|470625447|FG002|Overall Study|Lost to Follow-up|1|||
130727419|NCT01924754|470625445|FG000|Overall Study|Pregnancy|0|||
130727420|NCT01924754|470625446|FG001|Overall Study|Pregnancy|1|||
130727421|NCT01924754|470625447|FG002|Overall Study|Pregnancy|2|||
130727422|NCT01392963|470625448|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
130420378|NCT02015676|469499571|FG001|Overall Study|Disease progression|1|||
130420379|NCT02015676|469499572|FG002|Overall Study|Disease progression|1|||
130420380|NCT00476476|469499573|FG000|Overall Study|Adverse Event|2|||
130475992|NCT04784559|469711666|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
130564446|NCT06156215|470032217|FG004|Overall Study|Became or found ineligible|1|||
130727423|NCT01392963|470625449|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
130727424|NCT01392963|470625448|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
130727425|NCT01392963|470625449|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
130727426|NCT01392963|470625448|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
130727427|NCT01392963|470625449|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
130727428|NCT00369486|470625450|FG000|4-Week Visit|Missed visit|2|||
130727429|NCT00369486|470625451|FG001|4-Week Visit|Missed visit|2|||
130727430|NCT00369486|470625452|FG002|4-Week Visit|Missed visit|0|||
130420381|NCT00476476|469499574|FG001|Overall Study|Adverse Event|7|||
130420382|NCT00476476|469499573|FG000|Overall Study|Progressive Disease|0|||
130420383|NCT00476476|469499574|FG001|Overall Study|Progressive Disease|17|||
130420384|NCT00971048|469499575|FG000|Overall Study|Protocol Violation|1|||
130420385|NCT00971048|469499576|FG001|Overall Study|Protocol Violation|2|||
130420386|NCT00971048|469499577|FG002|Overall Study|Protocol Violation|0|||
130420387|NCT00971048|469499578|FG003|Overall Study|Protocol Violation|1|||
130420388|NCT00971048|469499575|FG000|Overall Study|Adverse Event|0|||
130420389|NCT00971048|469499576|FG001|Overall Study|Adverse Event|0|||
130420390|NCT00971048|469499577|FG002|Overall Study|Adverse Event|1|||
130420391|NCT00971048|469499578|FG003|Overall Study|Adverse Event|0|||
130420392|NCT00971048|469499575|FG000|Overall Study|Physician Decision|0|||
130420393|NCT00971048|469499576|FG001|Overall Study|Physician Decision|0|||
130420394|NCT00971048|469499577|FG002|Overall Study|Physician Decision|0|||
130420395|NCT00971048|469499578|FG003|Overall Study|Physician Decision|1|||
130420396|NCT03321396|469499582|FG000|Overall Study|Physician Decision|1|||
130420397|NCT01654549|469499583|FG000|Overall Study|H.pylori eradication not successful|0|||
130420398|NCT01654549|469499584|FG001|Overall Study|H.pylori eradication not successful|1|||
130420399|NCT03644186|469499591|FG000|Overall Study|Withdrawal by Subject|1|||
130420400|NCT03644186|469499592|FG001|Overall Study|Withdrawal by Subject|1|||
130420401|NCT04391023|469499593|FG000|Overall Study|Withdrawal by Subject|2|||
130420402|NCT04391023|469499594|FG001|Overall Study|Withdrawal by Subject|2|||
130420403|NCT01869491|469499595|FG000|Overall Study|Adverse Event|3|||
130420404|NCT01869491|469499596|FG001|Overall Study|Adverse Event|5|||
130420405|NCT01869491|469499595|FG000|Overall Study|Lack of Efficacy|0|||
130420406|NCT01869491|469499596|FG001|Overall Study|Lack of Efficacy|3|||
130420407|NCT01869491|469499595|FG000|Overall Study|Withdrawal by Subject|6|||
130420408|NCT01869491|469499596|FG001|Overall Study|Withdrawal by Subject|7|||
130420409|NCT01869491|469499595|FG000|Overall Study|Lost to Follow-up|11|||
130420410|NCT01869491|469499596|FG001|Overall Study|Lost to Follow-up|9|||
130420411|NCT01869491|469499595|FG000|Overall Study|No further need of investigational product|1|||
130420412|NCT01869491|469499596|FG001|Overall Study|No further need of investigational product|0|||
130420413|NCT04009291|469499597|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130420414|NCT04009291|469499598|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130420415|NCT04009291|469499599|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130420416|NCT04009291|469499600|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130420417|NCT04009291|469499601|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
130420418|NCT04009291|469499597|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130420419|NCT04009291|469499598|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130420420|NCT04009291|469499599|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130420421|NCT04009291|469499600|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130420422|NCT04009291|469499601|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
130420423|NCT05553808|469499604|FG000|Overall Study|Death|25|||
130420424|NCT05553808|469499605|FG001|Overall Study|Death|62|||
130420425|NCT05553808|469499604|FG000|Overall Study|Site Closed|6|||
130420426|NCT05553808|469499605|FG001|Overall Study|Site Closed|6|||
130420427|NCT05553808|469499604|FG000|Overall Study|Lost to Follow-up|1|||
130420428|NCT05553808|469499605|FG001|Overall Study|Lost to Follow-up|0|||
130420429|NCT05553808|469499604|FG000|Overall Study|Withdrawal by Subject|3|||
130420430|NCT05553808|469499605|FG001|Overall Study|Withdrawal by Subject|2|||
130420431|NCT01041638|469499608|FG000|Overall Study|Adverse Event|4|||
130420432|NCT01041638|469499608|FG000|Overall Study|Death|1|||
130420433|NCT01041638|469499608|FG000|Overall Study|Lack of Efficacy|7|||
130420434|NCT01041638|469499608|FG000|Overall Study|Physician Decision|4|||
130420435|NCT01041638|469499608|FG000|Overall Study|Withdrawal by Subject|11|||
130420436|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
130420437|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
130420438|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
130420439|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
130420440|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
130420441|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130420442|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
130420443|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130420444|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130420445|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130420446|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
130420447|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
130420448|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
130420449|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
130420450|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
130420451|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130420452|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130420453|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130420454|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130727431|NCT00369486|470625453|FG003|4-Week Visit|Missed visit|2|||
130727432|NCT00369486|470625454|FG004|4-Week Visit|Missed visit|1|||
130420455|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130420456|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130420457|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130420458|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
130420459|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130420460|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130420461|NCT03152552|469499609|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130420462|NCT03152552|469499610|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130420463|NCT03152552|469499611|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130420464|NCT03152552|469499612|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
130420465|NCT03152552|469499613|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130420466|NCT03152552|469499609|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
130420467|NCT03152552|469499610|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
130420468|NCT03152552|469499611|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
130420469|NCT03152552|469499612|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
130420470|NCT03152552|469499613|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
130420471|NCT01022762|469499617|FG000|Overall Study|Adverse Event|3|||
130420472|NCT01022762|469499618|FG001|Overall Study|Adverse Event|1|||
130420473|NCT01022762|469499617|FG000|Overall Study|Lack of Efficacy|0|||
130727433|NCT00369486|470625450|FG000|4-Week Visit|Dropped|0|||
130727434|NCT00369486|470625451|FG001|4-Week Visit|Dropped|0|||
130727435|NCT00369486|470625452|FG002|4-Week Visit|Dropped|1|||
130420474|NCT01022762|469499618|FG001|Overall Study|Lack of Efficacy|1|||
130420475|NCT01022762|469499617|FG000|Overall Study|Protocol Violation|7|||
130420476|NCT01022762|469499618|FG001|Overall Study|Protocol Violation|6|||
130420477|NCT01022762|469499617|FG000|Overall Study|Unclassified|12|||
130420478|NCT01022762|469499618|FG001|Overall Study|Unclassified|20|||
130420479|NCT01302119|469499619|FG000|Overall Study|Withdrawal by Subject|30|||
130420480|NCT01302119|469499620|FG001|Overall Study|Withdrawal by Subject|20|||
130420481|NCT01302119|469499619|FG000|Overall Study|Lost to Follow-up|10|||
130420482|NCT01302119|469499620|FG001|Overall Study|Lost to Follow-up|4|||
130420483|NCT01302119|469499619|FG000|Overall Study|Adverse Event|2|||
130420484|NCT01302119|469499620|FG001|Overall Study|Adverse Event|1|||
130420485|NCT01302119|469499619|FG000|Overall Study|Non-compliance|4|||
130420486|NCT01302119|469499620|FG001|Overall Study|Non-compliance|2|||
130420487|NCT01302119|469499619|FG000|Overall Study|Non-specific|4|||
130420488|NCT01302119|469499620|FG001|Overall Study|Non-specific|1|||
130420489|NCT04084314|469499621|FG000|Overall Study|Subject/guardian decision|91|||
130420490|NCT04084314|469499621|FG000|Overall Study|Adverse Event|24|||
130420491|NCT04084314|469499621|FG000|Overall Study|Lost to Follow-up|19|||
130420492|NCT04084314|469499621|FG000|Overall Study|New therapy for study indication|9|||
130420493|NCT04084314|469499621|FG000|Overall Study|Pregnancy|9|||
130420494|NCT04084314|469499621|FG000|Overall Study|Withdrawal of informed consent|8|||
130420495|NCT04084314|469499621|FG000|Overall Study|Physician Decision|4|||
130420496|NCT04084314|469499621|FG000|Overall Study|Protocol Deviation|3|||
130420497|NCT00802074|469499625|FG000|Overall Study|Adverse Event|1|||
130420498|NCT00802074|469499626|FG001|Overall Study|Adverse Event|1|||
130420499|NCT00802074|469499627|FG002|Overall Study|Adverse Event|1|||
130420500|NCT00802074|469499628|FG003|Overall Study|Adverse Event|0|||
130420501|NCT00802074|469499629|FG004|Overall Study|Adverse Event|0|||
130420502|NCT00802074|469499630|FG005|Overall Study|Adverse Event|0|||
130420503|NCT00802074|469499625|FG000|Overall Study|Withdrawal by Subject|1|||
130420504|NCT00802074|469499626|FG001|Overall Study|Withdrawal by Subject|0|||
130420505|NCT00802074|469499627|FG002|Overall Study|Withdrawal by Subject|0|||
130420506|NCT00802074|469499628|FG003|Overall Study|Withdrawal by Subject|0|||
130420507|NCT00802074|469499629|FG004|Overall Study|Withdrawal by Subject|0|||
130420508|NCT00802074|469499630|FG005|Overall Study|Withdrawal by Subject|0|||
130420509|NCT03743038|469499631|FG000|Overall Study|Physician Decision|1|||
130420510|NCT01300546|469499632|FG000|Overall Study|Withdrawal by Subject|1|||
130420511|NCT01300546|469499633|FG001|Overall Study|Withdrawal by Subject|0|||
130420512|NCT01300546|469499632|FG000|Overall Study|Lost to Follow-up|0|||
130420513|NCT01300546|469499633|FG001|Overall Study|Lost to Follow-up|2|||
130420514|NCT01300546|469499632|FG000|Overall Study|Lack of Efficacy|0|||
130420515|NCT01300546|469499633|FG001|Overall Study|Lack of Efficacy|3|||
130420516|NCT01300546|469499632|FG000|Overall Study|Adverse Event|0|||
130420517|NCT01300546|469499633|FG001|Overall Study|Adverse Event|1|||
130420518|NCT04988308|469499634|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
130420519|NCT04988308|469499635|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130420520|NCT04988308|469499636|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130727436|NCT00369486|470625453|FG003|4-Week Visit|Dropped|0|||
130420521|NCT04988308|469499637|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130420522|NCT04988308|469499638|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130420523|NCT04988308|469499639|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130420524|NCT04988308|469499634|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130420525|NCT04988308|469499635|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130420526|NCT04988308|469499636|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
130420527|NCT04988308|469499637|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130420528|NCT04988308|469499638|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130420529|NCT04988308|469499639|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130420530|NCT04988308|469499634|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
130420531|NCT04988308|469499635|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
130420532|NCT04988308|469499636|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130420533|NCT04988308|469499637|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130420534|NCT04988308|469499638|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130420535|NCT04988308|469499639|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130420536|NCT04988308|469499634|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
130420537|NCT04988308|469499635|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
130420538|NCT04988308|469499636|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
130420539|NCT04988308|469499637|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130475993|NCT04784559|469711667|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
130475994|NCT04784559|469711668|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
130475995|NCT04784559|469711666|FG000|Overall Study|Did not meet all inclusion criteria|0|||
130475996|NCT04784559|469711667|FG001|Overall Study|Did not meet all inclusion criteria|1|||
130475997|NCT04784559|469711668|FG002|Overall Study|Did not meet all inclusion criteria|0|||
130475998|NCT04784559|469711666|FG000|Overall Study|The participant was transferred to IRCU|0|||
130475999|NCT04784559|469711667|FG001|Overall Study|The participant was transferred to IRCU|1|||
130476000|NCT04784559|469711668|FG002|Overall Study|The participant was transferred to IRCU|0|||
130476001|NCT04784559|469711666|FG000|Overall Study|SAE|0|||
130476002|NCT04784559|469711667|FG001|Overall Study|SAE|1|||
130476003|NCT04784559|469711668|FG002|Overall Study|SAE|0|||
130564447|NCT06156215|470032218|FG005|Overall Study|Became or found ineligible|2|||
130564448|NCT03977974|470032223|FG000|Period 2|Adverse Event|0|||
130420540|NCT04988308|469499638|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130420541|NCT04988308|469499639|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130420542|NCT04988308|469499634|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
130420543|NCT04988308|469499635|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
130420544|NCT04988308|469499636|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
130420545|NCT04988308|469499637|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130420546|NCT04988308|469499638|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130420547|NCT04988308|469499639|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130420548|NCT04988308|469499634|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130420549|NCT04988308|469499635|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130420550|NCT04988308|469499636|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130420551|NCT04988308|469499637|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
130420552|NCT04988308|469499638|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
130420553|NCT04988308|469499639|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
130420554|NCT04988308|469499634|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130420555|NCT04988308|469499635|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130420556|NCT04988308|469499636|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130420557|NCT04988308|469499637|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130420558|NCT04988308|469499638|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130476004|NCT04784559|469711666|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
130476005|NCT04784559|469711667|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
130476006|NCT04784559|469711668|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
130564449|NCT03977974|470032224|FG001|Period 2|Adverse Event|0|||
130564450|NCT03977974|470032225|FG002|Period 2|Adverse Event|0|||
130564451|NCT03977974|470032226|FG003|Period 2|Adverse Event|0|||
130727437|NCT00369486|470625454|FG004|4-Week Visit|Dropped|0|||
130727438|NCT00369486|470625450|FG000|8-Week Visit|Missed visit|0|||
130727439|NCT00369486|470625451|FG001|8-Week Visit|Missed visit|1|||
130727440|NCT00369486|470625452|FG002|8-Week Visit|Missed visit|0|||
130727441|NCT00369486|470625453|FG003|8-Week Visit|Missed visit|0|||
130727442|NCT00369486|470625454|FG004|8-Week Visit|Missed visit|1|||
130420559|NCT04988308|469499639|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
130476007|NCT04294225|469711673|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
130476008|NCT04294225|469711673|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
130476009|NCT04294225|469711673|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
130564452|NCT03977974|470032227|FG004|Period 2|Adverse Event|1|||
130564453|NCT03977974|470032228|FG005|Period 2|Adverse Event|0|||
130727443|NCT00369486|470625450|FG000|8-Week Visit|Dropped|0|||
130727444|NCT00369486|470625451|FG001|8-Week Visit|Dropped|0|||
130727445|NCT00369486|470625452|FG002|8-Week Visit|Dropped|0|||
130727446|NCT00369486|470625453|FG003|8-Week Visit|Dropped|1|||
130420560|NCT04988308|469499634|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130420561|NCT04988308|469499635|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130420562|NCT04988308|469499636|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130420563|NCT04988308|469499637|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
130420564|NCT04988308|469499638|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
130420565|NCT04988308|469499639|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
130420566|NCT04988308|469499634|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130420567|NCT04988308|469499635|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130420568|NCT04988308|469499636|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130420569|NCT04988308|469499637|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
130420570|NCT04988308|469499638|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
130420571|NCT04988308|469499639|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
130420572|NCT02625623|469499647|FG000|Overall Study|Participants randomized but not treated|9|||
130420573|NCT02625623|469499648|FG001|Overall Study|Participants randomized but not treated|1|||
130420574|NCT00808808|469499651|FG000|Overall Study|Vaccinated; survey not completed|131|||
130420575|NCT00808808|469499652|FG001|Overall Study|Vaccinated; survey not completed|169|||
130420576|NCT00808808|469499653|FG002|Overall Study|Vaccinated; survey not completed|302|||
130420577|NCT00808808|469499651|FG000|Overall Study|Employee was not vaccinated.|2686|||
130420578|NCT00808808|469499652|FG001|Overall Study|Employee was not vaccinated.|2268|||
130420579|NCT00808808|469499653|FG002|Overall Study|Employee was not vaccinated.|2255|||
130420580|NCT02352948|469499654|FG000|Overall Study|Death|47|||
130420581|NCT02352948|469499655|FG001|Overall Study|Death|48|||
130420582|NCT02352948|469499656|FG002|Overall Study|Death|114|||
130420583|NCT02352948|469499657|FG003|Overall Study|Death|74|||
130420584|NCT02352948|469499658|FG004|Overall Study|Death|77|||
130420585|NCT02352948|469499659|FG005|Overall Study|Death|44|||
130420586|NCT02352948|469499654|FG000|Overall Study|Lost to Follow-up|1|||
130420587|NCT02352948|469499655|FG001|Overall Study|Lost to Follow-up|0|||
130420588|NCT02352948|469499656|FG002|Overall Study|Lost to Follow-up|2|||
130420589|NCT02352948|469499657|FG003|Overall Study|Lost to Follow-up|1|||
130420590|NCT02352948|469499658|FG004|Overall Study|Lost to Follow-up|2|||
130420591|NCT02352948|469499659|FG005|Overall Study|Lost to Follow-up|1|||
130420592|NCT02352948|469499654|FG000|Overall Study|Withdrawal by Subject|1|||
130420593|NCT02352948|469499655|FG001|Overall Study|Withdrawal by Subject|10|||
130420594|NCT02352948|469499656|FG002|Overall Study|Withdrawal by Subject|11|||
130420595|NCT02352948|469499657|FG003|Overall Study|Withdrawal by Subject|23|||
130420596|NCT02352948|469499658|FG004|Overall Study|Withdrawal by Subject|9|||
130420597|NCT02352948|469499659|FG005|Overall Study|Withdrawal by Subject|4|||
130420598|NCT02352948|469499654|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130420599|NCT02352948|469499655|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130420600|NCT02352948|469499656|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130420601|NCT02352948|469499657|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130420602|NCT02352948|469499658|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130420603|NCT02352948|469499659|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
130420604|NCT02352948|469499654|FG000|Overall Study|Other|0|||
130420605|NCT02352948|469499655|FG001|Overall Study|Other|0|||
130476010|NCT04294225|469711673|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
130476011|NCT04294225|469711673|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
130476012|NCT04927065|469711675|FG000|First Booster|Adverse Event|1|||
130476013|NCT04927065|469711676|FG001|First Booster|Adverse Event|0|||
130476014|NCT04927065|469711677|FG002|First Booster|Adverse Event|0|||
130476015|NCT04927065|469711678|FG003|First Booster|Adverse Event|0|||
130476016|NCT04927065|469711679|FG004|First Booster|Adverse Event|0|||
130476017|NCT04927065|469711680|FG005|First Booster|Adverse Event|0|||
130476018|NCT04927065|469711681|FG006|First Booster|Adverse Event|0|||
130476019|NCT04927065|469711682|FG007|First Booster|Adverse Event|1|||
130476020|NCT04927065|469711683|FG008|First Booster|Adverse Event|0|||
130476021|NCT04927065|469711684|FG009|First Booster|Adverse Event|0|||
130420606|NCT02352948|469499656|FG002|Overall Study|Other|2|||
130420607|NCT02352948|469499657|FG003|Overall Study|Other|0|||
130420608|NCT02352948|469499658|FG004|Overall Study|Other|0|||
130420609|NCT02352948|469499659|FG005|Overall Study|Other|0|||
130420610|NCT00983073|469499661|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
130476022|NCT04927065|469711685|FG010|First Booster|Adverse Event|0|||
130476023|NCT04927065|469711686|FG011|First Booster|Adverse Event|0|||
130476024|NCT04927065|469711687|FG012|First Booster|Adverse Event|0|||
130476025|NCT04927065|469711688|FG013|First Booster|Adverse Event|0|||
130476026|NCT04927065|469711689|FG014|First Booster|Adverse Event|0|||
130476027|NCT04927065|469711690|FG015|First Booster|Adverse Event|0|||
130476028|NCT04927065|469711675|FG000|First Booster|Death|1|||
130476029|NCT04927065|469711676|FG001|First Booster|Death|0|||
130476030|NCT04927065|469711677|FG002|First Booster|Death|0|||
130476031|NCT04927065|469711678|FG003|First Booster|Death|1|||
130476032|NCT04927065|469711679|FG004|First Booster|Death|0|||
130476033|NCT04927065|469711680|FG005|First Booster|Death|1|||
130476034|NCT04927065|469711681|FG006|First Booster|Death|0|||
130420611|NCT00983073|469499661|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
130420612|NCT00983073|469499661|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
130420613|NCT00983073|469499661|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
130420614|NCT00983073|469499661|FG000|Titration and Optimal Dose Period|Other reason|4|||
130420615|NCT00983073|469499661|FG000|Maintenance Period|Adverse Event|5|||
130420616|NCT00983073|469499661|FG000|Maintenance Period|Withdrawal by Subject|2|||
130420617|NCT00983073|469499661|FG000|Maintenance Period|Lack of Efficacy|2|||
130420618|NCT00983073|469499661|FG000|Maintenance Period|Other Reason|7|||
130420619|NCT01453595|469499662|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130420620|NCT01453595|469499663|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130420621|NCT01453595|469499664|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130420622|NCT00613951|469499665|FG000|Overall Study|Adverse Event|1|||
130420623|NCT00613951|469499666|FG001|Overall Study|Adverse Event|0|||
130420624|NCT00613951|469499667|FG002|Overall Study|Adverse Event|1|||
130420625|NCT00613951|469499665|FG000|Overall Study|Lack of Efficacy|0|||
130420626|NCT00613951|469499666|FG001|Overall Study|Lack of Efficacy|1|||
130420627|NCT00613951|469499667|FG002|Overall Study|Lack of Efficacy|1|||
130420628|NCT00613951|469499665|FG000|Overall Study|Protocol Violation|1|||
130420629|NCT00613951|469499666|FG001|Overall Study|Protocol Violation|1|||
130420630|NCT00613951|469499667|FG002|Overall Study|Protocol Violation|1|||
130420631|NCT00613951|469499665|FG000|Overall Study|Unclassified|5|||
130420632|NCT00613951|469499666|FG001|Overall Study|Unclassified|3|||
130420633|NCT00613951|469499667|FG002|Overall Study|Unclassified|2|||
130420634|NCT04439110|469499668|FG000|Overall Study|Ineligible|2|||
130420635|NCT04439110|469499668|FG000|Overall Study|Adverse Event|4|||
130420636|NCT04439110|469499668|FG000|Overall Study|Death|2|||
130420637|NCT04439110|469499668|FG000|Overall Study|Disease proression|25|||
130420638|NCT04439110|469499668|FG000|Overall Study|Withdrawal by Subject|1|||
130420639|NCT04439110|469499668|FG000|Overall Study|Alternative therapy|1|||
130420640|NCT04439110|469499668|FG000|Overall Study|Other complicating disease|1|||
130420641|NCT04439110|469499668|FG000|Overall Study|Personal reasons|1|||
130420642|NCT04439110|469499668|FG000|Overall Study|Still on treatment|1|||
130420645|NCT04348604|469499673|FG000|Week 8|Withdrawal by Subject|1|||
130420646|NCT04348604|469499674|FG001|Week 8|Withdrawal by Subject|1|||
130420647|NCT04348604|469499673|FG000|Week 8|Lost to Follow-up|1|||
130420648|NCT04348604|469499674|FG001|Week 8|Lost to Follow-up|2|||
130420649|NCT04348604|469499673|FG000|Week 8|Suspended|0|||
130420650|NCT04348604|469499674|FG001|Week 8|Suspended|1|||
130420651|NCT04348604|469499673|FG000|Week 12|Lost to Follow-up|1|||
130420652|NCT04348604|469499674|FG001|Week 12|Lost to Follow-up|2|||
130420653|NCT04348604|469499673|FG000|Week 12|Withdrawal by Subject|1|||
130420654|NCT04348604|469499674|FG001|Week 12|Withdrawal by Subject|0|||
130420655|NCT04348604|469499673|FG000|Week 24|Lost to Follow-up|2|||
130420656|NCT04348604|469499674|FG001|Week 24|Lost to Follow-up|1|||
130420657|NCT02097108|469499675|FG000|Overall Study|Adverse Event|1|||
130420658|NCT02097108|469499675|FG000|Overall Study|patient was abroad for 6 months|1|||
130420659|NCT00127608|469499676|FG000|Overall Study|VZV DNA negative|1|||
130420660|NCT05245864|469499677|FG000|Overall Study|Withdrawal by Subject|1|||
130420661|NCT05245864|469499678|FG001|Overall Study|Withdrawal by Subject|1|||
130420662|NCT01329029|469499679|FG000|Overall Study|Withdrawal by Subject|117|||
130420663|NCT01329029|469499680|FG001|Overall Study|Withdrawal by Subject|87|||
130420664|NCT01329029|469499679|FG000|Overall Study|Adverse Event|82|||
130420665|NCT01329029|469499680|FG001|Overall Study|Adverse Event|29|||
130420666|NCT01329029|469499679|FG000|Overall Study|Death|16|||
130420667|NCT01329029|469499680|FG001|Overall Study|Death|19|||
130420668|NCT01329029|469499679|FG000|Overall Study|Other|14|||
130420669|NCT01329029|469499680|FG001|Overall Study|Other|20|||
130420670|NCT01329029|469499679|FG000|Overall Study|COPD Exacerbation|11|||
130420671|NCT01329029|469499680|FG001|Overall Study|COPD Exacerbation|18|||
130420672|NCT01329029|469499679|FG000|Overall Study|Physician Decision|16|||
130420673|NCT01329029|469499680|FG001|Overall Study|Physician Decision|13|||
130420674|NCT01329029|469499679|FG000|Overall Study|Lost to Follow-up|8|||
130420675|NCT01329029|469499680|FG001|Overall Study|Lost to Follow-up|5|||
130420676|NCT01329029|469499679|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
130420677|NCT01329029|469499680|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
130420678|NCT01266642|469499686|FG000|Overall Study|Protocol Violation|0|||
130420679|NCT01266642|469499687|FG001|Overall Study|Protocol Violation|1|||
130420680|NCT00857207|469501457|FG000|Overall Study|Withdrawal by Subject|13|||
130420681|NCT00857207|469501458|FG001|Overall Study|Withdrawal by Subject|0|||
130420682|NCT00857207|469501457|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
130420683|NCT00857207|469501458|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
130420684|NCT00857207|469501457|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
130420685|NCT00857207|469501458|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
130420686|NCT00955357|469501460|FG000|Titration Phase|Adverse Event|9|||
130420687|NCT00955357|469501461|FG001|Titration Phase|Adverse Event|46|||
130727447|NCT00369486|470625454|FG004|8-Week Visit|Dropped|0|||
130727448|NCT00369486|470625450|FG000|17-Week Visit|Missed visit|0|||
130727449|NCT00369486|470625451|FG001|17-Week Visit|Missed visit|0|||
130727450|NCT00369486|470625452|FG002|17-Week Visit|Missed visit|1|||
130420688|NCT00955357|469501460|FG000|Titration Phase|Lack of Efficacy|0|||
130420689|NCT00955357|469501461|FG001|Titration Phase|Lack of Efficacy|2|||
130476035|NCT04927065|469711682|FG007|First Booster|Death|0|||
130476036|NCT04927065|469711683|FG008|First Booster|Death|0|||
130476037|NCT04927065|469711684|FG009|First Booster|Death|0|||
130476038|NCT04927065|469711685|FG010|First Booster|Death|0|||
130476039|NCT04927065|469711686|FG011|First Booster|Death|0|||
130476040|NCT04927065|469711687|FG012|First Booster|Death|0|||
130476041|NCT04927065|469711688|FG013|First Booster|Death|0|||
130476042|NCT04927065|469711689|FG014|First Booster|Death|0|||
130420690|NCT00955357|469501460|FG000|Titration Phase|Protocol Violation|3|||
130420691|NCT00955357|469501461|FG001|Titration Phase|Protocol Violation|7|||
130420692|NCT00955357|469501460|FG000|Titration Phase|Lost to Follow-up|1|||
130420693|NCT00955357|469501461|FG001|Titration Phase|Lost to Follow-up|3|||
130420694|NCT00955357|469501460|FG000|Titration Phase|Withdrawal by Subject|3|||
130420695|NCT00955357|469501461|FG001|Titration Phase|Withdrawal by Subject|5|||
130420696|NCT00955357|469501460|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
130420697|NCT00955357|469501461|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
130420698|NCT00955357|469501460|FG000|Titration Phase|Study medication not tolerated|0|||
130420699|NCT00955357|469501461|FG001|Titration Phase|Study medication not tolerated|1|||
130420700|NCT00955357|469501460|FG000|Titration Phase|Non compliance to study procedures|0|||
130420701|NCT00955357|469501461|FG001|Titration Phase|Non compliance to study procedures|1|||
130420702|NCT00955357|469501460|FG000|Maintenance Phase|Adverse Event|3|||
130420703|NCT00955357|469501461|FG001|Maintenance Phase|Adverse Event|23|||
130420704|NCT00955357|469501460|FG000|Maintenance Phase|Lack of Efficacy|0|||
130420705|NCT00955357|469501461|FG001|Maintenance Phase|Lack of Efficacy|4|||
130420706|NCT00955357|469501460|FG000|Maintenance Phase|Protocol Violation|2|||
130420707|NCT00955357|469501461|FG001|Maintenance Phase|Protocol Violation|6|||
130420708|NCT00955357|469501460|FG000|Maintenance Phase|Lost to Follow-up|2|||
130420709|NCT00955357|469501461|FG001|Maintenance Phase|Lost to Follow-up|7|||
130420710|NCT00955357|469501460|FG000|Maintenance Phase|Withdrawal by Subject|4|||
130420711|NCT00955357|469501461|FG001|Maintenance Phase|Withdrawal by Subject|4|||
130420712|NCT00955357|469501460|FG000|Maintenance Phase|Patient moving out of area|0|||
130420713|NCT00955357|469501461|FG001|Maintenance Phase|Patient moving out of area|1|||
130420714|NCT00955357|469501460|FG000|Maintenance Phase|Non compliance to study procedures|1|||
130420715|NCT00955357|469501461|FG001|Maintenance Phase|Non compliance to study procedures|0|||
130420716|NCT01258608|469501462|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
130420717|NCT01258608|469501463|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
130420718|NCT01258608|469501462|FG000|Overall Study|Clinical progression|1|||
130420719|NCT01258608|469501463|FG001|Overall Study|Clinical progression|0|||
130420720|NCT01258608|469501462|FG000|Overall Study|Sponsor decision|0|||
130420721|NCT01258608|469501463|FG001|Overall Study|Sponsor decision|1|||
130420722|NCT01258608|469501462|FG000|Overall Study|Physician Decision|6|||
130420723|NCT01258608|469501463|FG001|Overall Study|Physician Decision|1|||
130420724|NCT01258608|469501462|FG000|Overall Study|Lost to Follow-up|0|||
130420725|NCT01258608|469501463|FG001|Overall Study|Lost to Follow-up|1|||
130420726|NCT01258608|469501462|FG000|Overall Study|Lack of compliance|1|||
130420727|NCT01258608|469501463|FG001|Overall Study|Lack of compliance|0|||
130476043|NCT04927065|469711690|FG015|First Booster|Death|0|||
130476044|NCT04927065|469711675|FG000|First Booster|Lost to Follow-up|8|||
130476045|NCT04927065|469711676|FG001|First Booster|Lost to Follow-up|20|||
130476046|NCT04927065|469711677|FG002|First Booster|Lost to Follow-up|0|||
130476047|NCT04927065|469711678|FG003|First Booster|Lost to Follow-up|11|||
130476048|NCT04927065|469711679|FG004|First Booster|Lost to Follow-up|43|||
130476049|NCT04927065|469711680|FG005|First Booster|Lost to Follow-up|30|||
130476050|NCT04927065|469711681|FG006|First Booster|Lost to Follow-up|28|||
130727451|NCT00369486|470625453|FG003|17-Week Visit|Missed visit|1|||
130727452|NCT00369486|470625454|FG004|17-Week Visit|Missed visit|1|||
130476051|NCT04927065|469711682|FG007|First Booster|Lost to Follow-up|23|||
130727453|NCT00369486|470625450|FG000|34-Week Visit|Dropped|0|||
130420728|NCT01258608|469501462|FG000|Overall Study|Lack of Efficacy|0|||
130420729|NCT01258608|469501463|FG001|Overall Study|Lack of Efficacy|1|||
130420730|NCT01258608|469501462|FG000|Overall Study|Adverse Event|6|||
130420731|NCT01258608|469501463|FG001|Overall Study|Adverse Event|10|||
130420732|NCT01258608|469501462|FG000|Overall Study|Withdrawal by Subject|6|||
130420733|NCT01258608|469501463|FG001|Overall Study|Withdrawal by Subject|5|||
130420734|NCT02943408|469501466|FG000|Overall Study|Lost to Follow-up|7|||
130420735|NCT02943408|469501467|FG001|Overall Study|Lost to Follow-up|1|||
130420736|NCT02943408|469501466|FG000|Overall Study|Withdrawal by Subject|0|||
130420737|NCT02943408|469501467|FG001|Overall Study|Withdrawal by Subject|1|||
130476052|NCT04927065|469711683|FG008|First Booster|Lost to Follow-up|4|||
130476053|NCT04927065|469711684|FG009|First Booster|Lost to Follow-up|15|||
130727454|NCT00369486|470625451|FG001|34-Week Visit|Dropped|1|||
130727455|NCT00369486|470625452|FG002|34-Week Visit|Dropped|1|||
130420738|NCT01621126|469501470|FG000|Overall Study|Physician Decision|6|||
130420739|NCT00886340|469501472|FG000|Overall Study|Withdrawal by Subject|0|||
130420740|NCT00886340|469501473|FG001|Overall Study|Withdrawal by Subject|7|||
130420741|NCT01949311|469501474|FG000|Overall Study|Lost to Follow-up|73|||
130420742|NCT01949311|469501474|FG000|Overall Study|Terminated by Sponsor|708|||
130420743|NCT01949311|469501474|FG000|Overall Study|Withdrawal by Subject|375|||
130420744|NCT01949311|469501474|FG000|Overall Study|Lack of Efficacy|50|||
130420745|NCT01949311|469501474|FG000|Overall Study|Protocol Deviation|34|||
130420746|NCT01949311|469501474|FG000|Overall Study|Pregnancy|20|||
130420747|NCT01949311|469501474|FG000|Overall Study|Physician Decision|9|||
130420748|NCT01949311|469501474|FG000|Overall Study|Other|4|||
130420749|NCT01949311|469501474|FG000|Overall Study|Adverse Event|107|||
130420750|NCT02338154|469501475|FG000|Overall Study|Death|46|||
130420751|NCT02338154|469501475|FG000|Overall Study|Valve Implant Failure|17|||
130420752|NCT02338154|469501475|FG000|Overall Study|Valve Explant|11|||
130420753|NCT02338154|469501475|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
130420754|NCT02338154|469501475|FG000|Overall Study|Lost to Follow-up|8|||
130420755|NCT02338154|469501475|FG000|Overall Study|Other Reason|3|||
130420756|NCT02338154|469501475|FG000|Overall Study|Patients Without Exit Form|47|||
130420757|NCT02338154|469501475|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
130420758|NCT02120027|469501478|FG000|Overall Study|Adverse Event|4|||
130420759|NCT02120027|469501479|FG001|Overall Study|Adverse Event|5|||
130420760|NCT02120027|469501478|FG000|Overall Study|Lack of Efficacy|3|||
130420761|NCT02120027|469501479|FG001|Overall Study|Lack of Efficacy|5|||
130420762|NCT02120027|469501478|FG000|Overall Study|Lost to Follow-up|5|||
130420763|NCT02120027|469501479|FG001|Overall Study|Lost to Follow-up|13|||
130420764|NCT02120027|469501478|FG000|Overall Study|Other|4|||
130420765|NCT02120027|469501479|FG001|Overall Study|Other|0|||
130420766|NCT02120027|469501478|FG000|Overall Study|Physician Decision|4|||
130420767|NCT02120027|469501479|FG001|Overall Study|Physician Decision|3|||
130420768|NCT02120027|469501478|FG000|Overall Study|Protocol Violation|18|||
130420769|NCT02120027|469501479|FG001|Overall Study|Protocol Violation|21|||
130420770|NCT02120027|469501478|FG000|Overall Study|Study terminated by Sponsor|45|||
130420771|NCT02120027|469501479|FG001|Overall Study|Study terminated by Sponsor|47|||
130420772|NCT02120027|469501478|FG000|Overall Study|Withdrawal by Subject|33|||
130420773|NCT02120027|469501479|FG001|Overall Study|Withdrawal by Subject|25|||
130420774|NCT01925950|469501485|FG000|Part 2|Withdrawal by Subject|1|||
130420775|NCT01925950|469501486|FG001|Part 2|Withdrawal by Subject|0|||
130420776|NCT00381940|469501487|FG000|Overall Study|Lack of Efficacy|3|||
130420777|NCT00381940|469501487|FG000|Overall Study|Protocol Violation|1|||
130420778|NCT00381940|469501487|FG000|Overall Study|Ineligible|1|||
130420779|NCT03162224|469501488|FG000|Overall Study|Death|4|||
130420780|NCT03162224|469501489|FG001|Overall Study|Death|5|||
130420781|NCT03162224|469501490|FG002|Overall Study|Death|8|||
130420782|NCT03162224|469501488|FG000|Overall Study|Withdrawal by Subject|1|||
130420783|NCT03162224|469501489|FG001|Overall Study|Withdrawal by Subject|0|||
130420784|NCT03162224|469501490|FG002|Overall Study|Withdrawal by Subject|1|||
130420785|NCT03162224|469501488|FG000|Overall Study|Lost to Follow-up|0|||
130420786|NCT03162224|469501489|FG001|Overall Study|Lost to Follow-up|1|||
130420787|NCT03162224|469501490|FG002|Overall Study|Lost to Follow-up|0|||
130420788|NCT03162224|469501488|FG000|Overall Study|Other|6|||
130420789|NCT03162224|469501489|FG001|Overall Study|Other|2|||
130420790|NCT03162224|469501490|FG002|Overall Study|Other|1|||
130420791|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
130420792|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
130420793|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
130420794|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
130420795|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
130420796|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
130420797|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
130420798|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
130420799|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
130420800|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
130420801|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
130420802|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
130420803|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
130420804|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
130420805|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
130420806|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
130420807|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
130420808|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
130420809|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
130420810|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
130420811|NCT04162769|469501491|FG000|Double-blind Treatment (12-Week)|Other|0|||
130420812|NCT04162769|469501492|FG001|Double-blind Treatment (12-Week)|Other|1|||
130420813|NCT04162769|469501493|FG002|Double-blind Treatment (12-Week)|Other|1|||
130420814|NCT04162769|469501494|FG003|Double-blind Treatment (12-Week)|Other|0|||
130420815|NCT04162769|469501491|FG000|OLE Period (52-Week)|Adverse Event|0|||
130420816|NCT04162769|469501492|FG001|OLE Period (52-Week)|Adverse Event|0|||
130420817|NCT04162769|469501493|FG002|OLE Period (52-Week)|Adverse Event|0|||
130420818|NCT04162769|469501494|FG003|OLE Period (52-Week)|Adverse Event|5|||
130420819|NCT04162769|469501491|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
130420820|NCT04162769|469501492|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
130420821|NCT04162769|469501493|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
130420822|NCT04162769|469501494|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
130420823|NCT04162769|469501491|FG000|OLE Period (52-Week)|Physician Decision|0|||
130420824|NCT04162769|469501492|FG001|OLE Period (52-Week)|Physician Decision|0|||
130420825|NCT04162769|469501493|FG002|OLE Period (52-Week)|Physician Decision|0|||
130420826|NCT04162769|469501494|FG003|OLE Period (52-Week)|Physician Decision|1|||
130420827|NCT04162769|469501491|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
130420828|NCT04162769|469501492|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
130420829|NCT04162769|469501493|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
130420830|NCT04162769|469501494|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
130420831|NCT04162769|469501491|FG000|OLE Period (52-Week)|Protocol deviation|0|||
130420832|NCT04162769|469501492|FG001|OLE Period (52-Week)|Protocol deviation|0|||
130420833|NCT04162769|469501493|FG002|OLE Period (52-Week)|Protocol deviation|0|||
130420834|NCT04162769|469501494|FG003|OLE Period (52-Week)|Protocol deviation|2|||
130420835|NCT00725452|469501498|FG000|Overall Study|Adverse Event|3|||
130420836|NCT00725452|469501498|FG000|Overall Study|Lack of Efficacy|2|||
130420837|NCT00725452|469501498|FG000|Overall Study|Reason not specified|1|||
130420838|NCT00725452|469501498|FG000|Overall Study|Physician Decision|1|||
130420839|NCT00725452|469501498|FG000|Overall Study|Withdrawal by Subject|3|||
130420840|NCT00725452|469501498|FG000|Overall Study|Lost to Follow-up|1|||
130420841|NCT00620750|469501499|FG000|Overall Study|Lost to Follow-up|25|||
130420842|NCT00746590|469501500|FG000|Overall Study|Death|1|||
130420843|NCT04402866|469501501|FG000|Overall Study|Discontinued Prior to Treatment|0|||
130420844|NCT04402866|469501502|FG001|Overall Study|Discontinued Prior to Treatment|0|||
130420845|NCT04402866|469501503|FG002|Overall Study|Discontinued Prior to Treatment|0|||
130420846|NCT04402866|469501504|FG003|Overall Study|Discontinued Prior to Treatment|0|||
130420847|NCT04402866|469501505|FG004|Overall Study|Discontinued Prior to Treatment|2|||
130420848|NCT04402866|469501506|FG005|Overall Study|Discontinued Prior to Treatment|3|||
130420849|NCT04402866|469501501|FG000|Overall Study|Adverse Event|2|||
130420850|NCT04402866|469501502|FG001|Overall Study|Adverse Event|1|||
130420851|NCT04402866|469501503|FG002|Overall Study|Adverse Event|0|||
130420852|NCT04402866|469501504|FG003|Overall Study|Adverse Event|0|||
130420853|NCT04402866|469501505|FG004|Overall Study|Adverse Event|13|||
130420854|NCT04402866|469501506|FG005|Overall Study|Adverse Event|8|||
130420855|NCT04402866|469501501|FG000|Overall Study|Miscellaneous|0|||
130420856|NCT04402866|469501502|FG001|Overall Study|Miscellaneous|0|||
130420857|NCT04402866|469501503|FG002|Overall Study|Miscellaneous|1|||
130420858|NCT04402866|469501504|FG003|Overall Study|Miscellaneous|0|||
130420859|NCT04402866|469501505|FG004|Overall Study|Miscellaneous|0|||
130420860|NCT04402866|469501506|FG005|Overall Study|Miscellaneous|0|||
130420861|NCT04402866|469501501|FG000|Overall Study|Lost to Follow-up|0|||
130420862|NCT04402866|469501502|FG001|Overall Study|Lost to Follow-up|0|||
130420863|NCT04402866|469501503|FG002|Overall Study|Lost to Follow-up|0|||
130420864|NCT04402866|469501504|FG003|Overall Study|Lost to Follow-up|0|||
130420865|NCT04402866|469501505|FG004|Overall Study|Lost to Follow-up|0|||
130420866|NCT04402866|469501506|FG005|Overall Study|Lost to Follow-up|1|||
130420867|NCT04402866|469501501|FG000|Overall Study|Withdrawal by Subject|0|||
130420868|NCT04402866|469501502|FG001|Overall Study|Withdrawal by Subject|0|||
130420869|NCT04402866|469501503|FG002|Overall Study|Withdrawal by Subject|0|||
130420870|NCT04402866|469501504|FG003|Overall Study|Withdrawal by Subject|0|||
130420871|NCT04402866|469501505|FG004|Overall Study|Withdrawal by Subject|0|||
130420872|NCT04402866|469501506|FG005|Overall Study|Withdrawal by Subject|2|||
130420873|NCT02633137|469501509|FG000|Overall Study|Adverse Event|1|||
130420874|NCT02633137|469501509|FG000|Overall Study|Lack of Efficacy|2|||
130420875|NCT02633137|469501509|FG000|Overall Study|Withdrawal by Subject|1|||
130420876|NCT01972841|469501510|FG000|Overall Study|Randomized but Never Received Treatment|2|||
130564454|NCT03977974|470032229|FG006|Period 2|Adverse Event|0|||
130420877|NCT01972841|469501511|FG001|Overall Study|Randomized but Never Received Treatment|5|||
130420878|NCT01972841|469501512|FG002|Overall Study|Randomized but Never Received Treatment|4|||
130420879|NCT01972841|469501513|FG003|Overall Study|Randomized but Never Received Treatment|2|||
130420880|NCT01972841|469501514|FG004|Overall Study|Randomized but Never Received Treatment|6|||
130420881|NCT01972841|469501515|FG005|Overall Study|Randomized but Never Received Treatment|13|||
130420882|NCT01972841|469501510|FG000|Overall Study|Adverse Event|13|||
130420883|NCT01972841|469501511|FG001|Overall Study|Adverse Event|8|||
130420884|NCT01972841|469501512|FG002|Overall Study|Adverse Event|12|||
130420885|NCT01972841|469501513|FG003|Overall Study|Adverse Event|9|||
130420886|NCT01972841|469501514|FG004|Overall Study|Adverse Event|21|||
130420887|NCT01972841|469501515|FG005|Overall Study|Adverse Event|26|||
130420888|NCT01972841|469501510|FG000|Overall Study|Lack of Efficacy|1|||
130420889|NCT01972841|469501511|FG001|Overall Study|Lack of Efficacy|0|||
130420890|NCT01972841|469501512|FG002|Overall Study|Lack of Efficacy|0|||
130420891|NCT01972841|469501513|FG003|Overall Study|Lack of Efficacy|2|||
130420892|NCT01972841|469501514|FG004|Overall Study|Lack of Efficacy|4|||
130420893|NCT01972841|469501515|FG005|Overall Study|Lack of Efficacy|1|||
130420894|NCT01972841|469501510|FG000|Overall Study|Lost to Follow-up|4|||
130420895|NCT01972841|469501511|FG001|Overall Study|Lost to Follow-up|2|||
130420896|NCT01972841|469501512|FG002|Overall Study|Lost to Follow-up|4|||
130420897|NCT01972841|469501513|FG003|Overall Study|Lost to Follow-up|2|||
130420898|NCT01972841|469501514|FG004|Overall Study|Lost to Follow-up|9|||
130420899|NCT01972841|469501515|FG005|Overall Study|Lost to Follow-up|3|||
130420900|NCT01972841|469501510|FG000|Overall Study|Protocol Violation|2|||
130420901|NCT01972841|469501511|FG001|Overall Study|Protocol Violation|2|||
130420902|NCT01972841|469501512|FG002|Overall Study|Protocol Violation|3|||
130420903|NCT01972841|469501513|FG003|Overall Study|Protocol Violation|5|||
130420904|NCT01972841|469501514|FG004|Overall Study|Protocol Violation|9|||
130420905|NCT01972841|469501515|FG005|Overall Study|Protocol Violation|4|||
130420906|NCT01972841|469501510|FG000|Overall Study|Withdrawal by participants|21|||
130420907|NCT01972841|469501511|FG001|Overall Study|Withdrawal by participants|27|||
130420908|NCT01972841|469501512|FG002|Overall Study|Withdrawal by participants|23|||
130420909|NCT01972841|469501513|FG003|Overall Study|Withdrawal by participants|16|||
130420910|NCT01972841|469501514|FG004|Overall Study|Withdrawal by participants|33|||
130420911|NCT01972841|469501515|FG005|Overall Study|Withdrawal by participants|34|||
130420912|NCT01972841|469501510|FG000|Overall Study|Miscellaneous|0|||
130420913|NCT01972841|469501511|FG001|Overall Study|Miscellaneous|0|||
130420914|NCT01972841|469501512|FG002|Overall Study|Miscellaneous|4|||
130420915|NCT01972841|469501513|FG003|Overall Study|Miscellaneous|1|||
130420916|NCT01972841|469501514|FG004|Overall Study|Miscellaneous|0|||
130420917|NCT01972841|469501515|FG005|Overall Study|Miscellaneous|4|||
130420918|NCT01972841|469501510|FG000|Overall Study|Did not have end of treatment page|0|||
130420919|NCT01972841|469501511|FG001|Overall Study|Did not have end of treatment page|0|||
130420920|NCT01972841|469501512|FG002|Overall Study|Did not have end of treatment page|0|||
130420921|NCT01972841|469501513|FG003|Overall Study|Did not have end of treatment page|0|||
130420922|NCT01972841|469501514|FG004|Overall Study|Did not have end of treatment page|1|||
130420923|NCT01972841|469501515|FG005|Overall Study|Did not have end of treatment page|0|||
130420924|NCT02308748|469501524|FG000|Period 1|Withdrawal by Subject|0|||
130420925|NCT02308748|469501525|FG001|Period 1|Withdrawal by Subject|0|||
130420926|NCT02308748|469501526|FG002|Period 1|Withdrawal by Subject|1|||
130420927|NCT02308748|469501527|FG003|Period 1|Withdrawal by Subject|0|||
130420928|NCT02308748|469501528|FG004|Period 1|Withdrawal by Subject|0|||
130420929|NCT02308748|469501529|FG005|Period 1|Withdrawal by Subject|0|||
130420930|NCT02308748|469501530|FG006|Period 1|Withdrawal by Subject|0|||
130420931|NCT02308748|469501531|FG007|Period 1|Withdrawal by Subject|0|||
130420932|NCT02308748|469501532|FG008|Period 1|Withdrawal by Subject|0|||
130420933|NCT02308748|469501533|FG009|Period 1|Withdrawal by Subject|0|||
130420934|NCT02308748|469501524|FG000|Period 2|Adverse Event|0|||
130420935|NCT02308748|469501525|FG001|Period 2|Adverse Event|0|||
130420936|NCT02308748|469501526|FG002|Period 2|Adverse Event|0|||
130420937|NCT02308748|469501527|FG003|Period 2|Adverse Event|0|||
130420938|NCT02308748|469501528|FG004|Period 2|Adverse Event|0|||
130420939|NCT02308748|469501529|FG005|Period 2|Adverse Event|0|||
130420940|NCT02308748|469501530|FG006|Period 2|Adverse Event|0|||
130420941|NCT02308748|469501531|FG007|Period 2|Adverse Event|1|||
130420942|NCT02308748|469501532|FG008|Period 2|Adverse Event|0|||
130420943|NCT02308748|469501533|FG009|Period 2|Adverse Event|0|||
130420944|NCT02308748|469501524|FG000|Period 3|Protocol Violation|0|||
130420945|NCT02308748|469501525|FG001|Period 3|Protocol Violation|0|||
130420946|NCT02308748|469501526|FG002|Period 3|Protocol Violation|0|||
130420947|NCT02308748|469501527|FG003|Period 3|Protocol Violation|0|||
130420948|NCT02308748|469501528|FG004|Period 3|Protocol Violation|0|||
130420949|NCT02308748|469501529|FG005|Period 3|Protocol Violation|0|||
130420950|NCT02308748|469501530|FG006|Period 3|Protocol Violation|0|||
130420951|NCT02308748|469501531|FG007|Period 3|Protocol Violation|0|||
130420952|NCT02308748|469501532|FG008|Period 3|Protocol Violation|0|||
130420953|NCT02308748|469501533|FG009|Period 3|Protocol Violation|1|||
130420954|NCT02308748|469501524|FG000|Period 5|Adverse Event|1|||
130420955|NCT02308748|469501525|FG001|Period 5|Adverse Event|0|||
130420956|NCT02308748|469501526|FG002|Period 5|Adverse Event|0|||
130420957|NCT02308748|469501527|FG003|Period 5|Adverse Event|0|||
130420958|NCT02308748|469501528|FG004|Period 5|Adverse Event|0|||
130420959|NCT02308748|469501529|FG005|Period 5|Adverse Event|0|||
130420960|NCT02308748|469501530|FG006|Period 5|Adverse Event|0|||
130420961|NCT02308748|469501531|FG007|Period 5|Adverse Event|0|||
130420962|NCT02308748|469501532|FG008|Period 5|Adverse Event|1|||
130420963|NCT02308748|469501533|FG009|Period 5|Adverse Event|0|||
130420964|NCT03570619|469501539|FG000|Overall Study|Adverse Event|2|||
130420965|NCT03570619|469501540|FG001|Overall Study|Adverse Event|0|||
130420966|NCT03570619|469501541|FG002|Overall Study|Adverse Event|1|||
130420967|NCT03570619|469501539|FG000|Overall Study|new diagnosis of new malignancy|1|||
130420968|NCT03570619|469501540|FG001|Overall Study|new diagnosis of new malignancy|0|||
130420969|NCT03570619|469501541|FG002|Overall Study|new diagnosis of new malignancy|0|||
130420970|NCT03570619|469501539|FG000|Overall Study|Physician Decision|1|||
130420971|NCT03570619|469501540|FG001|Overall Study|Physician Decision|1|||
130420972|NCT03570619|469501541|FG002|Overall Study|Physician Decision|0|||
130420973|NCT03570619|469501539|FG000|Overall Study|Withdrawal by Subject|0|||
130420974|NCT03570619|469501540|FG001|Overall Study|Withdrawal by Subject|2|||
130420975|NCT03570619|469501541|FG002|Overall Study|Withdrawal by Subject|0|||
130420976|NCT01565707|469501544|FG000|Overall Study|Adverse Event|1|||
130420977|NCT01565707|469501545|FG001|Overall Study|Adverse Event|6|||
130420978|NCT01565707|469501546|FG002|Overall Study|Adverse Event|2|||
130420979|NCT01565707|469501547|FG003|Overall Study|Adverse Event|1|||
130420980|NCT01565707|469501544|FG000|Overall Study|Lost to Follow-up|1|||
130420981|NCT01565707|469501545|FG001|Overall Study|Lost to Follow-up|0|||
130420982|NCT01565707|469501546|FG002|Overall Study|Lost to Follow-up|0|||
130420983|NCT01565707|469501547|FG003|Overall Study|Lost to Follow-up|0|||
130420984|NCT01565707|469501544|FG000|Overall Study|Protocol Violation|1|||
130420985|NCT01565707|469501545|FG001|Overall Study|Protocol Violation|0|||
130420986|NCT01565707|469501546|FG002|Overall Study|Protocol Violation|0|||
130420987|NCT01565707|469501547|FG003|Overall Study|Protocol Violation|1|||
130420988|NCT01565707|469501544|FG000|Overall Study|Withdrawal by Subject|3|||
130420989|NCT01565707|469501545|FG001|Overall Study|Withdrawal by Subject|1|||
130420990|NCT01565707|469501546|FG002|Overall Study|Withdrawal by Subject|1|||
130420991|NCT01565707|469501547|FG003|Overall Study|Withdrawal by Subject|1|||
130420992|NCT01565707|469501544|FG000|Overall Study|Randomized but not evaluable|2|||
130420993|NCT01565707|469501545|FG001|Overall Study|Randomized but not evaluable|0|||
130420994|NCT01565707|469501546|FG002|Overall Study|Randomized but not evaluable|0|||
130420995|NCT01565707|469501547|FG003|Overall Study|Randomized but not evaluable|0|||
130420996|NCT01565707|469501544|FG000|Overall Study|Miscellaneous|1|||
130420997|NCT01565707|469501545|FG001|Overall Study|Miscellaneous|1|||
130420998|NCT01565707|469501546|FG002|Overall Study|Miscellaneous|0|||
130420999|NCT01565707|469501547|FG003|Overall Study|Miscellaneous|2|||
130421000|NCT05207813|469501548|FG000|Overall Study|Lost to Follow-up|2|||
130421001|NCT01371851|469501553|FG000|Overall Study|Lost to Follow-up|5|||
130421002|NCT01371851|469501554|FG001|Overall Study|Lost to Follow-up|8|||
130421003|NCT01371851|469501553|FG000|Overall Study|was arrested and put in jail|0|||
130421004|NCT01371851|469501554|FG001|Overall Study|was arrested and put in jail|1|||
130421005|NCT01371851|469501553|FG000|Overall Study|non study related adverse event|1|||
130421006|NCT01371851|469501554|FG001|Overall Study|non study related adverse event|0|||
130421007|NCT01371851|469501553|FG000|Overall Study|Blood Pressure outside study parameters|2|||
130421008|NCT01371851|469501554|FG001|Overall Study|Blood Pressure outside study parameters|0|||
130421009|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
130421010|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
130421011|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
130421012|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
130421013|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
130421014|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
130421015|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
130421016|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
130421017|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
130421018|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
130421019|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
130421020|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
130421021|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
130421022|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
130421023|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
130421024|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
130421025|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
130421026|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
130421027|NCT00833638|469501555|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
130421028|NCT00833638|469501556|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
130421029|NCT00833638|469501557|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
130476054|NCT04927065|469711685|FG010|First Booster|Lost to Follow-up|0|||
130476055|NCT04927065|469711686|FG011|First Booster|Lost to Follow-up|0|||
130421030|NCT00833638|469501555|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
130421031|NCT00833638|469501556|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
130421032|NCT00833638|469501557|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
130421033|NCT00833638|469501555|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
130421034|NCT00833638|469501556|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
130421035|NCT00833638|469501557|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
130421036|NCT00490646|469501558|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
130421037|NCT00490646|469501559|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
130421038|NCT00490646|469501558|FG000|Overall Study|Never Treated (had an adverse event)|1|||
130421039|NCT00490646|469501559|FG001|Overall Study|Never Treated (had an adverse event)|0|||
130421040|NCT00490646|469501558|FG000|Overall Study|Never Treated (withdrew consent)|0|||
130421041|NCT00490646|469501559|FG001|Overall Study|Never Treated (withdrew consent)|1|||
130421042|NCT05608629|469501560|FG000|Overall Study|Lost to Follow-up|2|||
130421043|NCT02962908|469501563|FG000|Overall Study|Lost to Follow-up|0|||
130421044|NCT02962908|469501564|FG001|Overall Study|Lost to Follow-up|3|||
130421045|NCT02962908|469501565|FG002|Overall Study|Lost to Follow-up|0|||
130421046|NCT02962908|469501566|FG003|Overall Study|Lost to Follow-up|1|||
130421047|NCT02962908|469501563|FG000|Overall Study|Withdrawal by Subject|0|||
130421048|NCT02962908|469501564|FG001|Overall Study|Withdrawal by Subject|3|||
130421049|NCT02962908|469501565|FG002|Overall Study|Withdrawal by Subject|0|||
130421050|NCT02962908|469501566|FG003|Overall Study|Withdrawal by Subject|2|||
130421051|NCT02962908|469501563|FG000|Overall Study|Protocol Violation|0|||
130421052|NCT02962908|469501564|FG001|Overall Study|Protocol Violation|1|||
130421053|NCT02962908|469501565|FG002|Overall Study|Protocol Violation|0|||
130421054|NCT02962908|469501566|FG003|Overall Study|Protocol Violation|0|||
130421055|NCT02962908|469501563|FG000|Overall Study|Physician Decision|0|||
130421056|NCT02962908|469501564|FG001|Overall Study|Physician Decision|1|||
130421057|NCT02962908|469501565|FG002|Overall Study|Physician Decision|0|||
130421058|NCT02962908|469501566|FG003|Overall Study|Physician Decision|0|||
130421059|NCT01261338|469501567|FG000|Overall Study|Withdrawal by Subject|3|||
130421060|NCT01261338|469501568|FG001|Overall Study|Withdrawal by Subject|2|||
130421061|NCT02313428|469501569|FG000|Overall Study|Lost to Follow-up|1|||
130421062|NCT02313428|469501570|FG001|Overall Study|Lost to Follow-up|1|||
130421063|NCT05374421|469501571|FG000|Overall Study|Withdrawal by Subject|3|||
130421064|NCT05374421|469501572|FG001|Overall Study|Withdrawal by Subject|4|||
130421065|NCT02899728|469501573|FG000|Overall Study|Withdrawal by Subject|1|||
130421066|NCT02899728|469501574|FG001|Overall Study|Withdrawal by Subject|1|||
130421067|NCT05557942|469501575|FG000|Overall Study|Death|0|||
130421068|NCT05557942|469501576|FG001|Overall Study|Death|0|||
130421069|NCT05557942|469501577|FG002|Overall Study|Death|0|||
130421070|NCT05557942|469501578|FG003|Overall Study|Death|2|||
130421071|NCT05557942|469501579|FG004|Overall Study|Death|1|||
130421072|NCT05557942|469501580|FG005|Overall Study|Death|1|||
130421073|NCT05557942|469501575|FG000|Overall Study|Physician Decision|1|||
130421074|NCT05557942|469501576|FG001|Overall Study|Physician Decision|1|||
130421075|NCT05557942|469501577|FG002|Overall Study|Physician Decision|2|||
130421076|NCT05557942|469501578|FG003|Overall Study|Physician Decision|3|||
130421077|NCT05557942|469501579|FG004|Overall Study|Physician Decision|0|||
130421078|NCT05557942|469501580|FG005|Overall Study|Physician Decision|2|||
130421079|NCT05557942|469501575|FG000|Overall Study|Study terminated by sponsor|17|||
130421080|NCT05557942|469501576|FG001|Overall Study|Study terminated by sponsor|17|||
130421081|NCT05557942|469501577|FG002|Overall Study|Study terminated by sponsor|14|||
130421082|NCT05557942|469501578|FG003|Overall Study|Study terminated by sponsor|40|||
130421083|NCT05557942|469501579|FG004|Overall Study|Study terminated by sponsor|45|||
130421084|NCT05557942|469501580|FG005|Overall Study|Study terminated by sponsor|37|||
130421085|NCT05557942|469501575|FG000|Overall Study|Protocol Violation|0|||
130421086|NCT05557942|469501576|FG001|Overall Study|Protocol Violation|0|||
130421087|NCT05557942|469501577|FG002|Overall Study|Protocol Violation|0|||
130421088|NCT05557942|469501578|FG003|Overall Study|Protocol Violation|0|||
130421089|NCT05557942|469501579|FG004|Overall Study|Protocol Violation|0|||
130421090|NCT05557942|469501580|FG005|Overall Study|Protocol Violation|1|||
130421091|NCT05557942|469501575|FG000|Overall Study|Withdrawal by Subject|0|||
130421092|NCT05557942|469501576|FG001|Overall Study|Withdrawal by Subject|0|||
130421093|NCT05557942|469501577|FG002|Overall Study|Withdrawal by Subject|0|||
130421094|NCT05557942|469501578|FG003|Overall Study|Withdrawal by Subject|0|||
130421095|NCT05557942|469501579|FG004|Overall Study|Withdrawal by Subject|2|||
130421096|NCT05557942|469501580|FG005|Overall Study|Withdrawal by Subject|0|||
130421097|NCT00655980|469501585|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
130421098|NCT00655980|469501586|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
130421099|NCT00655980|469501587|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
130421100|NCT05540522|469501588|FG000|Overall Study|Adverse Event|1|||
130421101|NCT05540522|469501589|FG001|Overall Study|Adverse Event|0|||
130421102|NCT05540522|469501590|FG002|Overall Study|Adverse Event|2|||
130421103|NCT05540522|469501591|FG003|Overall Study|Adverse Event|5|||
130421104|NCT05540522|469501588|FG000|Overall Study|Lost to Follow-up|487|||
130421105|NCT05540522|469501589|FG001|Overall Study|Lost to Follow-up|427|||
130421106|NCT05540522|469501590|FG002|Overall Study|Lost to Follow-up|146|||
130421107|NCT05540522|469501591|FG003|Overall Study|Lost to Follow-up|166|||
130421108|NCT05540522|469501588|FG000|Overall Study|Physician Decision|11|||
130421109|NCT05540522|469501589|FG001|Overall Study|Physician Decision|19|||
130421110|NCT05540522|469501590|FG002|Overall Study|Physician Decision|8|||
130421111|NCT05540522|469501591|FG003|Overall Study|Physician Decision|13|||
130421112|NCT05540522|469501588|FG000|Overall Study|Pregnancy|1|||
130421113|NCT05540522|469501589|FG001|Overall Study|Pregnancy|0|||
130421114|NCT05540522|469501590|FG002|Overall Study|Pregnancy|0|||
130421115|NCT05540522|469501591|FG003|Overall Study|Pregnancy|0|||
130421116|NCT05540522|469501588|FG000|Overall Study|Protocol Violation|3|||
130421117|NCT05540522|469501589|FG001|Overall Study|Protocol Violation|1|||
130421118|NCT05540522|469501590|FG002|Overall Study|Protocol Violation|9|||
130421119|NCT05540522|469501591|FG003|Overall Study|Protocol Violation|7|||
130421120|NCT05540522|469501588|FG000|Overall Study|Withdrawal by Subject|168|||
130421121|NCT05540522|469501589|FG001|Overall Study|Withdrawal by Subject|134|||
130421122|NCT05540522|469501590|FG002|Overall Study|Withdrawal by Subject|331|||
130421123|NCT05540522|469501591|FG003|Overall Study|Withdrawal by Subject|322|||
130421124|NCT05540522|469501588|FG000|Overall Study|Death|7|||
130421125|NCT05540522|469501589|FG001|Overall Study|Death|9|||
130421126|NCT05540522|469501590|FG002|Overall Study|Death|49|||
130421127|NCT05540522|469501591|FG003|Overall Study|Death|46|||
130421128|NCT05540522|469501588|FG000|Overall Study|Not vaccinated|34|||
130421129|NCT05540522|469501589|FG001|Overall Study|Not vaccinated|53|||
130421130|NCT05540522|469501590|FG002|Overall Study|Not vaccinated|57|||
130421131|NCT05540522|469501591|FG003|Overall Study|Not vaccinated|50|||
130421132|NCT05540522|469501588|FG000|Overall Study|No longer meets eligibility criteria|0|||
130421133|NCT05540522|469501589|FG001|Overall Study|No longer meets eligibility criteria|0|||
130421134|NCT05540522|469501590|FG002|Overall Study|No longer meets eligibility criteria|3|||
130421135|NCT05540522|469501591|FG003|Overall Study|No longer meets eligibility criteria|2|||
130421136|NCT05540522|469501588|FG000|Overall Study|Other (Unspecified)|8|||
130421137|NCT05540522|469501589|FG001|Overall Study|Other (Unspecified)|10|||
130421138|NCT05540522|469501590|FG002|Overall Study|Other (Unspecified)|4|||
130476056|NCT04927065|469711687|FG012|First Booster|Lost to Follow-up|0|||
130476057|NCT04927065|469711688|FG013|First Booster|Lost to Follow-up|0|||
130421139|NCT05540522|469501591|FG003|Overall Study|Other (Unspecified)|2|||
130421140|NCT03754803|469501592|FG000|Overall Study|Withdrawal by Subject|2|||
130421141|NCT05239039|469501593|FG000|Overall Study|Withdrawal by Subject|0|||
130421142|NCT05239039|469501594|FG001|Overall Study|Withdrawal by Subject|1|||
130421143|NCT00593567|469503432|FG000|Overall Study|Adverse Event|2|||
130421144|NCT00593567|469503433|FG001|Overall Study|Adverse Event|0|||
130421145|NCT00593567|469503432|FG000|Overall Study|Physician Decision|2|||
130421146|NCT00593567|469503433|FG001|Overall Study|Physician Decision|0|||
130476058|NCT04927065|469711689|FG014|First Booster|Lost to Follow-up|0|||
130476059|NCT04927065|469711690|FG015|First Booster|Lost to Follow-up|0|||
130476060|NCT04927065|469711675|FG000|First Booster|Physician Decision|1|||
130476061|NCT04927065|469711676|FG001|First Booster|Physician Decision|0|||
130476062|NCT04927065|469711677|FG002|First Booster|Physician Decision|0|||
130476063|NCT04927065|469711678|FG003|First Booster|Physician Decision|3|||
130476064|NCT04927065|469711679|FG004|First Booster|Physician Decision|1|||
130476065|NCT04927065|469711680|FG005|First Booster|Physician Decision|1|||
130476066|NCT04927065|469711681|FG006|First Booster|Physician Decision|0|||
130476067|NCT04927065|469711682|FG007|First Booster|Physician Decision|3|||
130476068|NCT04927065|469711683|FG008|First Booster|Physician Decision|0|||
130476069|NCT04927065|469711684|FG009|First Booster|Physician Decision|0|||
130476070|NCT04927065|469711685|FG010|First Booster|Physician Decision|0|||
130564455|NCT03977974|470032230|FG007|Period 2|Adverse Event|0|||
130564456|NCT03977974|470032231|FG008|Period 2|Adverse Event|0|||
130564457|NCT03977974|470032232|FG009|Period 2|Adverse Event|0|||
130564458|NCT03977974|470032233|FG010|Period 2|Adverse Event|0|||
130564459|NCT03977974|470032234|FG011|Period 2|Adverse Event|0|||
130564460|NCT03977974|470032235|FG012|Period 2|Adverse Event|0|||
130564461|NCT04419610|470033633|FG000|Overall Study|Withdrawal by Subject|3|||
130564462|NCT04419610|470033634|FG001|Overall Study|Withdrawal by Subject|1|||
130564463|NCT04419610|470033633|FG000|Overall Study|Adverse Event|1|||
130564464|NCT04419610|470033634|FG001|Overall Study|Adverse Event|0|||
130564465|NCT04419610|470033633|FG000|Overall Study|discharged early|1|||
130564466|NCT04419610|470033634|FG001|Overall Study|discharged early|1|||
130564467|NCT01524198|470033635|FG000|Overall Study|Protocol Violation|8|||
130564468|NCT01524198|470033636|FG001|Overall Study|Protocol Violation|6|||
130564469|NCT01524198|470033635|FG000|Overall Study|Withdrawal by Subject|15|||
130564470|NCT01524198|470033636|FG001|Overall Study|Withdrawal by Subject|10|||
130564471|NCT01439282|470033637|FG000|Overall Study|Adverse Event|5|||
130421147|NCT00593567|469503432|FG000|Overall Study|Protocol Violation|13|||
130421148|NCT00593567|469503433|FG001|Overall Study|Protocol Violation|7|||
130421149|NCT00593567|469503432|FG000|Overall Study|Lack of Efficacy|2|||
130421150|NCT00593567|469503433|FG001|Overall Study|Lack of Efficacy|1|||
130421151|NCT00593567|469503432|FG000|Overall Study|Withdrawal by Subject|1|||
130421152|NCT00593567|469503433|FG001|Overall Study|Withdrawal by Subject|2|||
130421153|NCT02119260|469503436|FG000|Overall Study|Adverse Event|1|||
130421154|NCT02119260|469503437|FG001|Overall Study|Adverse Event|0|||
130476071|NCT04927065|469711686|FG011|First Booster|Physician Decision|0|||
130564472|NCT01439282|470033638|FG001|Overall Study|Adverse Event|0|||
130564473|NCT01439282|470033637|FG000|Overall Study|Withdrawal by Subject|2|||
130564474|NCT01439282|470033638|FG001|Overall Study|Withdrawal by Subject|0|||
130421155|NCT02119260|469503438|FG002|Overall Study|Adverse Event|0|||
130564475|NCT01439282|470033637|FG000|Overall Study|Other|1|||
130421156|NCT02119260|469503439|FG003|Overall Study|Adverse Event|0|||
130476072|NCT04927065|469711687|FG012|First Booster|Physician Decision|0|||
130476073|NCT04927065|469711688|FG013|First Booster|Physician Decision|0|||
130564476|NCT01439282|470033638|FG001|Overall Study|Other|1|||
130564477|NCT02232802|470033639|FG000|Period 1|Sponsor request|1|||
130421157|NCT02119260|469503440|FG004|Overall Study|Adverse Event|0|||
130421158|NCT02119260|469503441|FG005|Overall Study|Adverse Event|0|||
130421159|NCT02119260|469503442|FG006|Overall Study|Adverse Event|0|||
130421160|NCT02119260|469503436|FG000|Overall Study|Withdrew consent|0|||
130421161|NCT02119260|469503437|FG001|Overall Study|Withdrew consent|1|||
130421162|NCT02119260|469503438|FG002|Overall Study|Withdrew consent|1|||
130421163|NCT02119260|469503439|FG003|Overall Study|Withdrew consent|0|||
130421164|NCT02119260|469503440|FG004|Overall Study|Withdrew consent|0|||
130421165|NCT02119260|469503441|FG005|Overall Study|Withdrew consent|0|||
130421166|NCT02119260|469503442|FG006|Overall Study|Withdrew consent|0|||
130421167|NCT00844857|469503443|FG000|Overall Study|Adverse Event|24|||
130421168|NCT00844857|469503444|FG001|Overall Study|Adverse Event|5|||
130421169|NCT00844857|469503443|FG000|Overall Study|Sponsor Decision|1|||
130421170|NCT00844857|469503444|FG001|Overall Study|Sponsor Decision|1|||
130421171|NCT00844857|469503443|FG000|Overall Study|Physician Decision|2|||
130421172|NCT00844857|469503444|FG001|Overall Study|Physician Decision|0|||
130421173|NCT00844857|469503443|FG000|Overall Study|Parent/Caregiver Decision|6|||
130421174|NCT00844857|469503444|FG001|Overall Study|Parent/Caregiver Decision|2|||
130476074|NCT04927065|469711689|FG014|First Booster|Physician Decision|0|||
130421175|NCT00844857|469503443|FG000|Overall Study|Withdrawal by Subject|8|||
130421176|NCT00844857|469503444|FG001|Overall Study|Withdrawal by Subject|7|||
130421177|NCT00844857|469503443|FG000|Overall Study|Protocol Violation|6|||
130421178|NCT00844857|469503444|FG001|Overall Study|Protocol Violation|0|||
130421179|NCT00844857|469503443|FG000|Overall Study|Lack of Efficacy|5|||
130421180|NCT00844857|469503444|FG001|Overall Study|Lack of Efficacy|5|||
130421181|NCT00844857|469503443|FG000|Overall Study|Clinical Relapse|0|||
130421182|NCT00844857|469503444|FG001|Overall Study|Clinical Relapse|1|||
130421183|NCT00844857|469503443|FG000|Overall Study|Entry Criteria Not Met|0|||
130421184|NCT00844857|469503444|FG001|Overall Study|Entry Criteria Not Met|1|||
130421185|NCT00844857|469503443|FG000|Overall Study|Lost to Follow-up|2|||
130421186|NCT00844857|469503444|FG001|Overall Study|Lost to Follow-up|3|||
130421187|NCT00844857|469503443|FG000|Overall Study|Did Not Take Study Drug|3|||
130421188|NCT00844857|469503444|FG001|Overall Study|Did Not Take Study Drug|1|||
130421189|NCT00844857|469503443|FG000|Overall Study|Good Clinical Practice Violations|21|||
130421190|NCT00844857|469503444|FG001|Overall Study|Good Clinical Practice Violations|11|||
130421191|NCT02057874|469503445|FG000|Overall Study|participant did not return for scan|1|||
130421192|NCT01738984|469503446|FG000|Overall Study|Pregnancy|4|||
130421193|NCT01738984|469503447|FG001|Overall Study|Pregnancy|0|||
130421194|NCT01738984|469503446|FG000|Overall Study|Withdrawal by Subject|1|||
130421195|NCT01738984|469503447|FG001|Overall Study|Withdrawal by Subject|0|||
130421196|NCT01738984|469503446|FG000|Overall Study|Lost to Follow-up|59|||
130421197|NCT01738984|469503447|FG001|Overall Study|Lost to Follow-up|39|||
130421198|NCT00440531|469503451|FG000|Overall Study|Adverse Event|1|||
130421199|NCT00440531|469503452|FG001|Overall Study|Adverse Event|0|||
130421200|NCT00440531|469503453|FG002|Overall Study|Adverse Event|2|||
130421201|NCT00440531|469503451|FG000|Overall Study|Withdrawal by Subject|2|||
130421202|NCT00440531|469503452|FG001|Overall Study|Withdrawal by Subject|0|||
130421203|NCT00440531|469503453|FG002|Overall Study|Withdrawal by Subject|0|||
130421204|NCT00440531|469503451|FG000|Overall Study|Protocol Violation|1|||
130421205|NCT00440531|469503452|FG001|Overall Study|Protocol Violation|2|||
130421206|NCT00440531|469503453|FG002|Overall Study|Protocol Violation|0|||
130421207|NCT00440531|469503451|FG000|Overall Study|Lost to Follow-up|4|||
130421208|NCT00440531|469503452|FG001|Overall Study|Lost to Follow-up|3|||
130421209|NCT00440531|469503453|FG002|Overall Study|Lost to Follow-up|5|||
130421210|NCT00440531|469503451|FG000|Overall Study|see pre-assignment details|2|||
130421211|NCT00440531|469503452|FG001|Overall Study|see pre-assignment details|0|||
130421212|NCT00440531|469503453|FG002|Overall Study|see pre-assignment details|0|||
130421213|NCT00447057|469503454|FG000|Overall Study|Adverse Event|4|||
130421214|NCT00447057|469503455|FG001|Overall Study|Adverse Event|10|||
130421215|NCT00447057|469503456|FG002|Overall Study|Adverse Event|0|||
130421216|NCT00447057|469503457|FG003|Overall Study|Adverse Event|3|||
130421217|NCT00447057|469503454|FG000|Overall Study|Death due to study disease|6|||
130421218|NCT00447057|469503455|FG001|Overall Study|Death due to study disease|4|||
130421219|NCT00447057|469503456|FG002|Overall Study|Death due to study disease|1|||
130421220|NCT00447057|469503457|FG003|Overall Study|Death due to study disease|1|||
130421221|NCT00447057|469503454|FG000|Overall Study|Lost to Follow-up|0|||
130421222|NCT00447057|469503455|FG001|Overall Study|Lost to Follow-up|1|||
130421223|NCT00447057|469503456|FG002|Overall Study|Lost to Follow-up|0|||
130421224|NCT00447057|469503457|FG003|Overall Study|Lost to Follow-up|0|||
130421225|NCT00447057|469503454|FG000|Overall Study|Entry criteria not met|1|||
130421226|NCT00447057|469503455|FG001|Overall Study|Entry criteria not met|1|||
130421227|NCT00447057|469503456|FG002|Overall Study|Entry criteria not met|0|||
130421228|NCT00447057|469503457|FG003|Overall Study|Entry criteria not met|0|||
130421229|NCT00447057|469503454|FG000|Overall Study|Protocol Violation|0|||
130421230|NCT00447057|469503455|FG001|Overall Study|Protocol Violation|1|||
130421231|NCT00447057|469503456|FG002|Overall Study|Protocol Violation|0|||
130421232|NCT00447057|469503457|FG003|Overall Study|Protocol Violation|0|||
130421233|NCT00447057|469503454|FG000|Overall Study|Withdrawal by Subject|4|||
130421234|NCT00447057|469503455|FG001|Overall Study|Withdrawal by Subject|5|||
130421235|NCT00447057|469503456|FG002|Overall Study|Withdrawal by Subject|1|||
130727456|NCT00369486|470625453|FG003|34-Week Visit|Dropped|3|||
130727457|NCT00369486|470625454|FG004|34-Week Visit|Dropped|3|||
130727458|NCT00402116|470625455|FG000|Overall Study|Jaw infection after surgery-other|1|||
130727459|NCT00402116|470625456|FG001|Overall Study|Jaw infection after surgery-other|0|||
130727460|NCT00402116|470625457|FG002|Overall Study|Jaw infection after surgery-other|0|||
130727461|NCT00402116|470625455|FG000|Overall Study|Withdrawal by Subject|1|||
130421236|NCT00447057|469503457|FG003|Overall Study|Withdrawal by Subject|1|||
130421237|NCT00447057|469503454|FG000|Overall Study|Physician Decision|9|||
130421238|NCT00447057|469503455|FG001|Overall Study|Physician Decision|6|||
130421239|NCT00447057|469503456|FG002|Overall Study|Physician Decision|3|||
130421240|NCT00447057|469503457|FG003|Overall Study|Physician Decision|1|||
130421241|NCT00447057|469503454|FG000|Overall Study|Sponsor decision|1|||
130421242|NCT00447057|469503455|FG001|Overall Study|Sponsor decision|1|||
130421243|NCT00447057|469503456|FG002|Overall Study|Sponsor decision|0|||
130421244|NCT00447057|469503457|FG003|Overall Study|Sponsor decision|0|||
130421245|NCT00447057|469503454|FG000|Overall Study|Progressive disease|58|||
130421246|NCT00447057|469503455|FG001|Overall Study|Progressive disease|43|||
130421247|NCT00447057|469503456|FG002|Overall Study|Progressive disease|13|||
130421248|NCT00447057|469503457|FG003|Overall Study|Progressive disease|18|||
130421249|NCT00447057|469503454|FG000|Overall Study|Death due to adverse event|0|||
130421250|NCT00447057|469503455|FG001|Overall Study|Death due to adverse event|0|||
130421251|NCT00447057|469503456|FG002|Overall Study|Death due to adverse event|1|||
130421252|NCT00447057|469503457|FG003|Overall Study|Death due to adverse event|2|||
130421253|NCT00447057|469503454|FG000|Overall Study|Death, study drug related|0|||
130421254|NCT00447057|469503455|FG001|Overall Study|Death, study drug related|1|||
130421255|NCT00447057|469503456|FG002|Overall Study|Death, study drug related|0|||
130421256|NCT00447057|469503457|FG003|Overall Study|Death, study drug related|0|||
130421257|NCT01843192|469503461|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
130421258|NCT01843192|469503462|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
130421259|NCT01843192|469503463|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
130421260|NCT01471054|469503464|FG000|Overall Study|Study terminated prematurely|4|||
130421261|NCT01471054|469503465|FG001|Overall Study|Study terminated prematurely|0|||
130421262|NCT04493216|469503466|FG000|Overall Study|Study terminated by sponsor|30|||
130421263|NCT04493216|469503467|FG001|Overall Study|Study terminated by sponsor|33|||
130421264|NCT04493216|469503468|FG002|Overall Study|Study terminated by sponsor|28|||
130421265|NCT04493216|469503469|FG003|Overall Study|Study terminated by sponsor|27|||
130421266|NCT04493216|469503466|FG000|Overall Study|Withdrawal by Subject|2|||
130421267|NCT04493216|469503467|FG001|Overall Study|Withdrawal by Subject|1|||
130421268|NCT04493216|469503468|FG002|Overall Study|Withdrawal by Subject|1|||
130421269|NCT04493216|469503469|FG003|Overall Study|Withdrawal by Subject|2|||
130421270|NCT04493216|469503466|FG000|Overall Study|Protocol Violation|1|||
130421271|NCT04493216|469503467|FG001|Overall Study|Protocol Violation|2|||
130421272|NCT04493216|469503468|FG002|Overall Study|Protocol Violation|0|||
130421273|NCT04493216|469503469|FG003|Overall Study|Protocol Violation|2|||
130421274|NCT04493216|469503466|FG000|Overall Study|Physician Decision|0|||
130421275|NCT04493216|469503467|FG001|Overall Study|Physician Decision|0|||
130421276|NCT04493216|469503468|FG002|Overall Study|Physician Decision|1|||
130421277|NCT04493216|469503469|FG003|Overall Study|Physician Decision|0|||
130421278|NCT04493216|469503466|FG000|Overall Study|Lost to Follow-up|2|||
130421279|NCT04493216|469503467|FG001|Overall Study|Lost to Follow-up|1|||
130421280|NCT04493216|469503468|FG002|Overall Study|Lost to Follow-up|0|||
130421281|NCT04493216|469503469|FG003|Overall Study|Lost to Follow-up|1|||
130421282|NCT04493216|469503466|FG000|Overall Study|Adverse Event|1|||
130727462|NCT00402116|470625456|FG001|Overall Study|Withdrawal by Subject|0|||
130727463|NCT00402116|470625457|FG002|Overall Study|Withdrawal by Subject|5|||
130727464|NCT00402116|470625455|FG000|Overall Study|Treatment completed per protocol|1|||
130727465|NCT00402116|470625456|FG001|Overall Study|Treatment completed per protocol|1|||
130727466|NCT00402116|470625457|FG002|Overall Study|Treatment completed per protocol|2|||
130727467|NCT00402116|470625455|FG000|Overall Study|other complicating disease|0|||
130421283|NCT04493216|469503467|FG001|Overall Study|Adverse Event|4|||
130421284|NCT04493216|469503468|FG002|Overall Study|Adverse Event|5|||
130421285|NCT04493216|469503469|FG003|Overall Study|Adverse Event|2|||
130421286|NCT04493216|469503466|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
130421287|NCT04493216|469503467|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
130421288|NCT04493216|469503468|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
130421289|NCT04493216|469503469|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
130421290|NCT01559844|469503470|FG000|Overall Study|Consent Withdrawn|7|||
130421291|NCT01559844|469503470|FG000|Overall Study|Death|5|||
130421292|NCT01559844|469503470|FG000|Overall Study|Efficacy Failure|10|||
130421293|NCT01559844|469503470|FG000|Overall Study|No Longer A Transplant Candidate|3|||
130421294|NCT02181803|469503473|FG000|Overall Study|Withdrawal by Subject|0|||
130421295|NCT02181803|469503474|FG001|Overall Study|Withdrawal by Subject|2|||
130421296|NCT02181803|469503475|FG002|Overall Study|Withdrawal by Subject|0|||
130421297|NCT02181803|469503476|FG003|Overall Study|Withdrawal by Subject|0|||
130727468|NCT00402116|470625456|FG001|Overall Study|other complicating disease|0|||
130421298|NCT02181803|469503477|FG004|Overall Study|Withdrawal by Subject|0|||
130421299|NCT02181803|469503478|FG005|Overall Study|Withdrawal by Subject|0|||
130421300|NCT02181803|469503479|FG006|Overall Study|Withdrawal by Subject|0|||
130421301|NCT02181803|469503480|FG007|Overall Study|Withdrawal by Subject|0|||
130421302|NCT02181803|469503481|FG008|Overall Study|Withdrawal by Subject|0|||
130421303|NCT02181803|469503473|FG000|Overall Study|Physician Decision|0|||
130421304|NCT02181803|469503474|FG001|Overall Study|Physician Decision|0|||
130421305|NCT02181803|469503475|FG002|Overall Study|Physician Decision|0|||
130421306|NCT02181803|469503476|FG003|Overall Study|Physician Decision|1|||
130421307|NCT02181803|469503477|FG004|Overall Study|Physician Decision|0|||
130421308|NCT02181803|469503478|FG005|Overall Study|Physician Decision|0|||
130421309|NCT02181803|469503479|FG006|Overall Study|Physician Decision|0|||
130421310|NCT02181803|469503480|FG007|Overall Study|Physician Decision|1|||
130421311|NCT02181803|469503481|FG008|Overall Study|Physician Decision|0|||
130421312|NCT02181803|469503473|FG000|Overall Study|Adverse Event|0|||
130421313|NCT02181803|469503474|FG001|Overall Study|Adverse Event|2|||
130421314|NCT02181803|469503475|FG002|Overall Study|Adverse Event|0|||
130421315|NCT02181803|469503476|FG003|Overall Study|Adverse Event|1|||
130421316|NCT02181803|469503477|FG004|Overall Study|Adverse Event|0|||
130421317|NCT02181803|469503478|FG005|Overall Study|Adverse Event|0|||
130421318|NCT02181803|469503479|FG006|Overall Study|Adverse Event|1|||
130421319|NCT02181803|469503480|FG007|Overall Study|Adverse Event|0|||
130421320|NCT02181803|469503481|FG008|Overall Study|Adverse Event|0|||
130421321|NCT00951041|469503482|FG000|Overall Study|Withdrawal by Subject|1|||
130421322|NCT00951041|469503483|FG001|Overall Study|Withdrawal by Subject|1|||
130421323|NCT00951041|469503482|FG000|Overall Study|Lost to Follow-up|1|||
130421324|NCT00951041|469503483|FG001|Overall Study|Lost to Follow-up|0|||
130421325|NCT00951041|469503482|FG000|Overall Study|Other|3|||
130421326|NCT00951041|469503483|FG001|Overall Study|Other|0|||
130421327|NCT01514448|469503484|FG000|Overall Study|Death|7|||
130421328|NCT01514448|469503485|FG001|Overall Study|Death|8|||
130421329|NCT01514448|469503484|FG000|Overall Study|Withdrawal by Subject|2|||
130421330|NCT01514448|469503485|FG001|Overall Study|Withdrawal by Subject|0|||
130421331|NCT01514448|469503484|FG000|Overall Study|Lost to Follow-up|2|||
130421332|NCT01514448|469503485|FG001|Overall Study|Lost to Follow-up|0|||
130421333|NCT01514448|469503484|FG000|Overall Study|New Cancer Therapy|1|||
130421334|NCT01514448|469503485|FG001|Overall Study|New Cancer Therapy|0|||
130421335|NCT02314624|469503486|FG000|Overall Study|No participating patient|16|||
130421336|NCT02314624|469503487|FG001|Overall Study|No participating patient|13|||
130421337|NCT02314624|469503486|FG000|Overall Study|Participant withdrew|7|||
130421338|NCT02314624|469503487|FG001|Overall Study|Participant withdrew|2|||
130421339|NCT02314624|469503486|FG000|Overall Study|Lost to Follow-up|2|||
130421340|NCT02314624|469503487|FG001|Overall Study|Lost to Follow-up|5|||
130421341|NCT02314624|469503486|FG000|Overall Study|Dropped/Excluded by PI|6|||
130421342|NCT02314624|469503487|FG001|Overall Study|Dropped/Excluded by PI|6|||
130421343|NCT03151005|469503488|FG000|Overall Study|Lost to Follow-up|5|||
130421344|NCT03151005|469503489|FG001|Overall Study|Lost to Follow-up|5|||
130421345|NCT03912259|469503492|FG000|Overall Study|Adverse Event (AE)|2|||
130421346|NCT03912259|469503493|FG001|Overall Study|Adverse Event (AE)|4|||
130421347|NCT03912259|469503492|FG000|Overall Study|Lack of Efficacy|4|||
130421348|NCT03912259|469503493|FG001|Overall Study|Lack of Efficacy|1|||
130421349|NCT03912259|469503492|FG000|Overall Study|Withdrawal by Subject|11|||
130421350|NCT03912259|469503493|FG001|Overall Study|Withdrawal by Subject|1|||
130421351|NCT04786444|469503494|FG000|Overall Study|Withdrawal by Subject|4|||
130421352|NCT04786444|469503495|FG001|Overall Study|Withdrawal by Subject|7|||
130421353|NCT04786444|469503496|FG002|Overall Study|Withdrawal by Subject|2|||
130421354|NCT04786444|469503494|FG000|Overall Study|Lost to Follow-up|11|||
130421355|NCT04786444|469503495|FG001|Overall Study|Lost to Follow-up|9|||
130421356|NCT04786444|469503496|FG002|Overall Study|Lost to Follow-up|10|||
130421357|NCT04786444|469503494|FG000|Overall Study|Subject would like to become pregnant|0|||
130421358|NCT04786444|469503495|FG001|Overall Study|Subject would like to become pregnant|1|||
130421359|NCT04786444|469503496|FG002|Overall Study|Subject would like to become pregnant|0|||
130421360|NCT02131272|469503497|FG000|Overall Study|Withdrawal by parent|0|||
130421361|NCT02131272|469503498|FG001|Overall Study|Withdrawal by parent|1|||
130421362|NCT02131272|469503497|FG000|Overall Study|Withdrawal by Subject|0|||
130421363|NCT02131272|469503498|FG001|Overall Study|Withdrawal by Subject|1|||
130421364|NCT02131272|469503497|FG000|Overall Study|Withdrawal Criteria|1|||
130421365|NCT02131272|469503498|FG001|Overall Study|Withdrawal Criteria|0|||
130421366|NCT02462876|469503499|FG000|Overall Study|Death|3|||
130421367|NCT02462876|469503499|FG000|Overall Study|Lost to Follow-up|7|||
130421368|NCT02462876|469503499|FG000|Overall Study|Surgical Bypass|9|||
130421369|NCT02462876|469503499|FG000|Overall Study|Amputation Above the Metatarsals|1|||
130421370|NCT02462876|469503499|FG000|Overall Study|36 months follow-up visit missed|1|||
130421371|NCT02462876|469503499|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
130476075|NCT04927065|469711690|FG015|First Booster|Physician Decision|0|||
130476076|NCT04927065|469711675|FG000|First Booster|Protocol Violation|4|||
130421372|NCT02462876|469503499|FG000|Overall Study|Patient did not come back to the vascular department|1|||
130476077|NCT04927065|469711676|FG001|First Booster|Protocol Violation|4|||
130421373|NCT02462876|469503499|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
130421374|NCT02462876|469503499|FG000|Overall Study|Patient refused to come back|1|||
130421375|NCT02462876|469503499|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
130421376|NCT02462876|469503499|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
130421377|NCT01786512|469503504|FG000|Overall Study|Lost to Follow-up|0|||
130421378|NCT01786512|469503505|FG001|Overall Study|Lost to Follow-up|0|||
130421379|NCT01786512|469503506|FG002|Overall Study|Lost to Follow-up|0|||
130421380|NCT01786512|469503507|FG003|Overall Study|Lost to Follow-up|0|||
130421381|NCT01786512|469503508|FG004|Overall Study|Lost to Follow-up|0|||
130421382|NCT01786512|469503509|FG005|Overall Study|Lost to Follow-up|0|||
130421383|NCT01786512|469503510|FG006|Overall Study|Lost to Follow-up|0|||
130421384|NCT01786512|469503511|FG007|Overall Study|Lost to Follow-up|0|||
130421385|NCT01786512|469503512|FG008|Overall Study|Lost to Follow-up|0|||
130421386|NCT01786512|469503513|FG009|Overall Study|Lost to Follow-up|1|||
130421387|NCT01786512|469503514|FG010|Overall Study|Lost to Follow-up|0|||
130421388|NCT01786512|469503504|FG000|Overall Study|Decision by sponsor|0|||
130421389|NCT01786512|469503505|FG001|Overall Study|Decision by sponsor|0|||
130421390|NCT01786512|469503506|FG002|Overall Study|Decision by sponsor|0|||
130421391|NCT01786512|469503507|FG003|Overall Study|Decision by sponsor|0|||
130421392|NCT01786512|469503508|FG004|Overall Study|Decision by sponsor|0|||
130421393|NCT01786512|469503509|FG005|Overall Study|Decision by sponsor|0|||
130421394|NCT01786512|469503510|FG006|Overall Study|Decision by sponsor|0|||
130421395|NCT01786512|469503511|FG007|Overall Study|Decision by sponsor|0|||
130421396|NCT01786512|469503512|FG008|Overall Study|Decision by sponsor|0|||
130421397|NCT01786512|469503513|FG009|Overall Study|Decision by sponsor|0|||
130421398|NCT01786512|469503514|FG010|Overall Study|Decision by sponsor|2|||
130421399|NCT01786512|469503504|FG000|Overall Study|Withdrawal by Subject|0|||
130421400|NCT01786512|469503505|FG001|Overall Study|Withdrawal by Subject|1|||
130421401|NCT01786512|469503506|FG002|Overall Study|Withdrawal by Subject|0|||
130421402|NCT01786512|469503507|FG003|Overall Study|Withdrawal by Subject|0|||
130421403|NCT01786512|469503508|FG004|Overall Study|Withdrawal by Subject|0|||
130421404|NCT01786512|469503509|FG005|Overall Study|Withdrawal by Subject|0|||
130421405|NCT01786512|469503510|FG006|Overall Study|Withdrawal by Subject|1|||
130421406|NCT01786512|469503511|FG007|Overall Study|Withdrawal by Subject|0|||
130421407|NCT01786512|469503512|FG008|Overall Study|Withdrawal by Subject|0|||
130421408|NCT01786512|469503513|FG009|Overall Study|Withdrawal by Subject|3|||
130421409|NCT01786512|469503514|FG010|Overall Study|Withdrawal by Subject|7|||
130421410|NCT01786512|469503504|FG000|Overall Study|Death|0|||
130421411|NCT01786512|469503505|FG001|Overall Study|Death|0|||
130421412|NCT01786512|469503506|FG002|Overall Study|Death|0|||
130421413|NCT01786512|469503507|FG003|Overall Study|Death|0|||
130421414|NCT01786512|469503508|FG004|Overall Study|Death|0|||
130421415|NCT01786512|469503509|FG005|Overall Study|Death|0|||
130421416|NCT01786512|469503510|FG006|Overall Study|Death|0|||
130421417|NCT01786512|469503511|FG007|Overall Study|Death|0|||
130421418|NCT01786512|469503512|FG008|Overall Study|Death|4|||
130421419|NCT01786512|469503513|FG009|Overall Study|Death|1|||
130421420|NCT01786512|469503514|FG010|Overall Study|Death|3|||
130421421|NCT03166618|469503515|FG000|Overall Study|Study was Terminated|0|||
130421422|NCT03166618|469503516|FG001|Overall Study|Study was Terminated|1|||
130421423|NCT00605293|469503517|FG000|Overall Study|Death|2|||
130421424|NCT00605293|469503518|FG001|Overall Study|Death|1|||
130421425|NCT00605293|469503517|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130421426|NCT00605293|469503518|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130421427|NCT00605293|469503517|FG000|Overall Study|Adverse Event|1|||
130421428|NCT00605293|469503518|FG001|Overall Study|Adverse Event|0|||
130421429|NCT00605293|469503517|FG000|Overall Study|Holidays Dialysis Out|1|||
130421430|NCT00605293|469503518|FG001|Overall Study|Holidays Dialysis Out|0|||
130421431|NCT00605293|469503517|FG000|Overall Study|Blood Transfusion|7|||
130727469|NCT00402116|470625457|FG002|Overall Study|other complicating disease|2|||
130727470|NCT00402116|470625455|FG000|Overall Study|Disease Progression|0|||
130421432|NCT00605293|469503518|FG001|Overall Study|Blood Transfusion|1|||
130421433|NCT00605293|469503517|FG000|Overall Study|Renal Transplantation|3|||
130727471|NCT00402116|470625456|FG001|Overall Study|Disease Progression|4|||
130727472|NCT00402116|470625457|FG002|Overall Study|Disease Progression|38|||
130727473|NCT00402116|470625455|FG000|Overall Study|mistaken thrombocytopenia|0|||
130727474|NCT00402116|470625456|FG001|Overall Study|mistaken thrombocytopenia|0|||
130421434|NCT00605293|469503518|FG001|Overall Study|Renal Transplantation|1|||
130421435|NCT00605293|469503517|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
130421436|NCT00605293|469503518|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
130421437|NCT00605293|469503517|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
130421438|NCT00605293|469503518|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
130421439|NCT00605293|469503517|FG000|Overall Study|Principal Investigator Decision|0|||
130421440|NCT00605293|469503518|FG001|Overall Study|Principal Investigator Decision|1|||
130421441|NCT03137303|469503520|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
130421442|NCT03137303|469503521|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
130421443|NCT03137303|469503520|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
130421444|NCT03137303|469503521|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
130421445|NCT03137303|469503520|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
130421446|NCT03137303|469503521|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
130421447|NCT03137303|469503520|FG000|T3: 9-month Follow-up|Death|1|||
130421448|NCT03137303|469503521|FG001|T3: 9-month Follow-up|Death|0|||
130421449|NCT03137303|469503520|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
130421450|NCT03137303|469503521|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
130421451|NCT03137303|469503520|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
130421452|NCT03137303|469503521|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
130421453|NCT03137303|469503520|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
130421454|NCT03137303|469503521|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
130421455|NCT03561090|469503524|FG000|Overall Study|Adverse Event|11|||
130421456|NCT03561090|469503525|FG001|Overall Study|Adverse Event|7|||
130421457|NCT03561090|469503524|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130421458|NCT03561090|469503525|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130421459|NCT03561090|469503524|FG000|Overall Study|Protocol Violation|2|||
130421460|NCT03561090|469503525|FG001|Overall Study|Protocol Violation|2|||
130421461|NCT03561090|469503524|FG000|Overall Study|Withdrawal by Subject|7|||
130421462|NCT03561090|469503525|FG001|Overall Study|Withdrawal by Subject|7|||
130421463|NCT03561090|469503524|FG000|Overall Study|Lost to Follow-up|7|||
130421464|NCT03561090|469503525|FG001|Overall Study|Lost to Follow-up|2|||
130421465|NCT03561090|469503524|FG000|Overall Study|Study Terminated by Sponsor|10|||
130421466|NCT03561090|469503525|FG001|Overall Study|Study Terminated by Sponsor|15|||
130421467|NCT03561090|469503524|FG000|Overall Study|Randomized by Mistake|1|||
130421468|NCT03561090|469503525|FG001|Overall Study|Randomized by Mistake|1|||
130421469|NCT03561090|469503524|FG000|Overall Study|Other Not Specified|0|||
130421470|NCT03561090|469503525|FG001|Overall Study|Other Not Specified|2|||
130421471|NCT02163733|469503532|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
130421472|NCT02163733|469503533|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
130421473|NCT02163733|469503534|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
130421474|NCT02163733|469503532|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
130421475|NCT02163733|469503533|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
130421476|NCT02163733|469503534|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
130421477|NCT00713648|469503535|FG000|Overall Study|Adverse Event|1|||
130421478|NCT00713648|469503535|FG000|Overall Study|Unclassified|2|||
130421479|NCT00713648|469503535|FG000|Overall Study|According to Protocol|2|||
130421480|NCT00713648|469503535|FG000|Overall Study|Development of antibodies|3|||
130421481|NCT02633800|469503536|FG000|Overall Study|Death|3|||
130421482|NCT02633800|469503537|FG001|Overall Study|Death|3|||
130421483|NCT02633800|469503536|FG000|Overall Study|Reason not provided|1|||
130421484|NCT02633800|469503537|FG001|Overall Study|Reason not provided|0|||
130421485|NCT02633800|469503536|FG000|Overall Study|Radiologic(al) progression|23|||
130421486|NCT02633800|469503537|FG001|Overall Study|Radiologic(al) progression|23|||
130421487|NCT02633800|469503536|FG000|Overall Study|Clinical progression|3|||
130421488|NCT02633800|469503537|FG001|Overall Study|Clinical progression|6|||
130421489|NCT02633800|469503536|FG000|Overall Study|Study terminated by sponsor|6|||
130421490|NCT02633800|469503537|FG001|Overall Study|Study terminated by sponsor|5|||
130421491|NCT02633800|469503536|FG000|Overall Study|Adverse event, non-fatal|7|||
130421492|NCT02633800|469503537|FG001|Overall Study|Adverse event, non-fatal|2|||
130421493|NCT02633800|469503536|FG000|Overall Study|Withdrawal by Subject|0|||
130421494|NCT02633800|469503537|FG001|Overall Study|Withdrawal by Subject|3|||
130421495|NCT02633800|469503536|FG000|Overall Study|Patient Request|1|||
130421496|NCT02633800|469503537|FG001|Overall Study|Patient Request|1|||
130421497|NCT00082173|469503538|FG000|Overall Study|Withdrawal by Subject|3|||
130421498|NCT00082173|469503539|FG001|Overall Study|Withdrawal by Subject|5|||
130421499|NCT00082173|469503538|FG000|Overall Study|Lost to Follow-up|1|||
130421500|NCT00082173|469503539|FG001|Overall Study|Lost to Follow-up|0|||
130421501|NCT00082173|469503538|FG000|Overall Study|Adverse Event|1|||
130421502|NCT00082173|469503539|FG001|Overall Study|Adverse Event|0|||
130421503|NCT00082173|469503538|FG000|Overall Study|Culture negative or resistant at baselin|5|||
130421504|NCT00082173|469503539|FG001|Overall Study|Culture negative or resistant at baselin|6|||
130421505|NCT01733732|469503540|FG000|Overall Study|Adverse Event|1|||
130421506|NCT01733732|469503541|FG001|Overall Study|Adverse Event|0|||
130421507|NCT01733732|469503540|FG000|Overall Study|Did not attend all study visits|1|||
130421508|NCT01733732|469503541|FG001|Overall Study|Did not attend all study visits|0|||
130421509|NCT01260350|469503553|FG000|Overall Study|Lack of Efficacy|0|||
130727475|NCT00402116|470625457|FG002|Overall Study|mistaken thrombocytopenia|1|||
130727476|NCT00402116|470625455|FG000|Overall Study|decline related hyponatremia/tumor|0|||
130421510|NCT01260350|469503554|FG001|Overall Study|Lack of Efficacy|0|||
130421511|NCT01260350|469503555|FG002|Overall Study|Lack of Efficacy|0|||
130421512|NCT01260350|469503556|FG003|Overall Study|Lack of Efficacy|0|||
130421513|NCT01260350|469503557|FG004|Overall Study|Lack of Efficacy|0|||
130421514|NCT01260350|469503558|FG005|Overall Study|Lack of Efficacy|0|||
130421515|NCT01260350|469503559|FG006|Overall Study|Lack of Efficacy|0|||
130421516|NCT01260350|469503560|FG007|Overall Study|Lack of Efficacy|0|||
130421517|NCT01260350|469503561|FG008|Overall Study|Lack of Efficacy|0|||
130421518|NCT01260350|469503562|FG009|Overall Study|Lack of Efficacy|0|||
130421519|NCT01260350|469503563|FG010|Overall Study|Lack of Efficacy|0|||
130421520|NCT01260350|469503564|FG011|Overall Study|Lack of Efficacy|0|||
130421521|NCT01260350|469503565|FG012|Overall Study|Lack of Efficacy|0|||
130421522|NCT01260350|469503566|FG013|Overall Study|Lack of Efficacy|0|||
130421523|NCT01260350|469503567|FG014|Overall Study|Lack of Efficacy|0|||
130421524|NCT01260350|469503568|FG015|Overall Study|Lack of Efficacy|0|||
130421525|NCT01260350|469503569|FG016|Overall Study|Lack of Efficacy|0|||
130421526|NCT01260350|469503570|FG017|Overall Study|Lack of Efficacy|1|||
130421527|NCT01260350|469503571|FG018|Overall Study|Lack of Efficacy|0|||
130421528|NCT01260350|469503572|FG019|Overall Study|Lack of Efficacy|0|||
130421529|NCT01260350|469503573|FG020|Overall Study|Lack of Efficacy|3|||
130421530|NCT01260350|469503574|FG021|Overall Study|Lack of Efficacy|0|||
130421531|NCT01260350|469503553|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421532|NCT01260350|469503554|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421533|NCT01260350|469503555|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421534|NCT01260350|469503556|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421535|NCT01260350|469503557|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421536|NCT01260350|469503558|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421537|NCT01260350|469503559|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421538|NCT01260350|469503560|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421539|NCT01260350|469503561|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
130421540|NCT01260350|469503562|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421541|NCT01260350|469503563|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421542|NCT01260350|469503564|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421543|NCT01260350|469503565|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421544|NCT01260350|469503566|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421545|NCT01260350|469503567|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421546|NCT01260350|469503568|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421547|NCT01260350|469503569|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421548|NCT01260350|469503570|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421549|NCT01260350|469503571|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421550|NCT01260350|469503572|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421551|NCT01260350|469503573|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421552|NCT01260350|469503574|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130421553|NCT02794285|469503577|FG000|Overall Study|Adverse Event|11|||
130421554|NCT02794285|469503578|FG001|Overall Study|Adverse Event|4|||
130421555|NCT02794285|469503579|FG002|Overall Study|Adverse Event|5|||
130421556|NCT02794285|469503580|FG003|Overall Study|Adverse Event|8|||
130421557|NCT02794285|469503577|FG000|Overall Study|Condition Under Investigation Improved|1|||
130421558|NCT02794285|469503578|FG001|Overall Study|Condition Under Investigation Improved|0|||
130421559|NCT02794285|469503579|FG002|Overall Study|Condition Under Investigation Improved|0|||
130421560|NCT02794285|469503580|FG003|Overall Study|Condition Under Investigation Improved|0|||
130421561|NCT02794285|469503577|FG000|Overall Study|Condition Under Investigation Worsened|0|||
130421562|NCT02794285|469503578|FG001|Overall Study|Condition Under Investigation Worsened|2|||
130421563|NCT02794285|469503579|FG002|Overall Study|Condition Under Investigation Worsened|1|||
130421564|NCT02794285|469503580|FG003|Overall Study|Condition Under Investigation Worsened|0|||
130476078|NCT04927065|469711677|FG002|First Booster|Protocol Violation|0|||
130476079|NCT04927065|469711678|FG003|First Booster|Protocol Violation|3|||
130476080|NCT04927065|469711679|FG004|First Booster|Protocol Violation|0|||
130476081|NCT04927065|469711680|FG005|First Booster|Protocol Violation|0|||
130476082|NCT04927065|469711681|FG006|First Booster|Protocol Violation|0|||
130476083|NCT04927065|469711682|FG007|First Booster|Protocol Violation|2|||
130476084|NCT04927065|469711683|FG008|First Booster|Protocol Violation|0|||
130476085|NCT04927065|469711684|FG009|First Booster|Protocol Violation|0|||
130476086|NCT04927065|469711685|FG010|First Booster|Protocol Violation|0|||
130564478|NCT02232802|470033640|FG001|Period 1|Sponsor request|0|||
130564479|NCT02232802|470033639|FG000|Period 1|Adverse Event|1|||
130564480|NCT02232802|470033640|FG001|Period 1|Adverse Event|1|||
130564481|NCT00885703|470033648|FG000|Overall Study|Death|9|||
130564482|NCT00885703|470033649|FG001|Overall Study|Death|7|||
130564483|NCT00885703|470033650|FG002|Overall Study|Death|8|||
130564484|NCT00885703|470033651|FG003|Overall Study|Death|7|||
130421565|NCT02794285|469503577|FG000|Overall Study|Death|2|||
130476087|NCT04927065|469711686|FG011|First Booster|Protocol Violation|0|||
130476088|NCT04927065|469711687|FG012|First Booster|Protocol Violation|0|||
130421566|NCT02794285|469503578|FG001|Overall Study|Death|1|||
130421567|NCT02794285|469503579|FG002|Overall Study|Death|2|||
130421568|NCT02794285|469503580|FG003|Overall Study|Death|0|||
130421569|NCT02794285|469503577|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
130476089|NCT04927065|469711688|FG013|First Booster|Protocol Violation|0|||
130476090|NCT04927065|469711689|FG014|First Booster|Protocol Violation|0|||
130421570|NCT02794285|469503578|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
130421571|NCT02794285|469503579|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
130564485|NCT00885703|470033652|FG004|Overall Study|Death|7|||
130564486|NCT00885703|470033653|FG005|Overall Study|Death|8|||
130564487|NCT00885703|470033654|FG006|Overall Study|Death|4|||
130564488|NCT00885703|470033648|FG000|Overall Study|Lost to Follow-up|0|||
130421572|NCT02794285|469503580|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
130421573|NCT02794285|469503577|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
130421574|NCT02794285|469503578|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
130421575|NCT02794285|469503579|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
130421576|NCT02794285|469503580|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
130421577|NCT02794285|469503577|FG000|Overall Study|Lack of Efficacy|10|||
130421578|NCT02794285|469503578|FG001|Overall Study|Lack of Efficacy|6|||
130421579|NCT02794285|469503579|FG002|Overall Study|Lack of Efficacy|3|||
130421580|NCT02794285|469503580|FG003|Overall Study|Lack of Efficacy|3|||
130421581|NCT02794285|469503577|FG000|Overall Study|Lost to Follow-up|5|||
130421582|NCT02794285|469503578|FG001|Overall Study|Lost to Follow-up|6|||
130421583|NCT02794285|469503579|FG002|Overall Study|Lost to Follow-up|3|||
130421584|NCT02794285|469503580|FG003|Overall Study|Lost to Follow-up|1|||
130421585|NCT02794285|469503577|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
130421586|NCT02794285|469503578|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
130421587|NCT02794285|469503579|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
130421588|NCT02794285|469503580|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
130421589|NCT02794285|469503577|FG000|Overall Study|Withdrawal by Subject|38|||
130421590|NCT02794285|469503578|FG001|Overall Study|Withdrawal by Subject|29|||
130421591|NCT02794285|469503579|FG002|Overall Study|Withdrawal by Subject|20|||
130421592|NCT02794285|469503580|FG003|Overall Study|Withdrawal by Subject|12|||
130421593|NCT02794285|469503577|FG000|Overall Study|Missing|1|||
130421594|NCT02794285|469503578|FG001|Overall Study|Missing|0|||
130421595|NCT02794285|469503579|FG002|Overall Study|Missing|0|||
130421596|NCT02794285|469503580|FG003|Overall Study|Missing|0|||
130421597|NCT02794285|469503577|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
130421598|NCT02794285|469503578|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
130421599|NCT02794285|469503579|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
130421600|NCT02794285|469503580|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
130421601|NCT02794285|469503577|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
130421602|NCT02794285|469503578|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
130421603|NCT02794285|469503579|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
130421604|NCT02794285|469503580|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
130421605|NCT00868439|469503581|FG000|Overall Study|Adverse Event|4|||
130421606|NCT00868439|469503582|FG001|Overall Study|Adverse Event|3|||
130421607|NCT00868439|469503581|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
130421608|NCT00868439|469503582|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
130421609|NCT00868439|469503581|FG000|Overall Study|Death|0|||
130421610|NCT00868439|469503582|FG001|Overall Study|Death|1|||
130421611|NCT00868439|469503581|FG000|Overall Study|Protocol Violation|1|||
130421612|NCT00868439|469503582|FG001|Overall Study|Protocol Violation|1|||
130421613|NCT00868439|469503581|FG000|Overall Study|Physician Decision|1|||
130421614|NCT00868439|469503582|FG001|Overall Study|Physician Decision|0|||
130421615|NCT00868439|469503581|FG000|Overall Study|Withdrawal by Subject|0|||
130421616|NCT00868439|469503582|FG001|Overall Study|Withdrawal by Subject|1|||
130421617|NCT00937924|469503593|FG000|Overall Study|Lost to Follow-up|44|||
130421618|NCT00937924|469503594|FG001|Overall Study|Lost to Follow-up|44|||
130421619|NCT00937924|469503595|FG002|Overall Study|Lost to Follow-up|41|||
130421620|NCT00224874|469503596|FG000|Overall Study|Withdrawal by Subject|0|||
130421621|NCT00224874|469503597|FG001|Overall Study|Withdrawal by Subject|0|||
130421622|NCT00224874|469503598|FG002|Overall Study|Withdrawal by Subject|1|||
130421623|NCT00224874|469503599|FG003|Overall Study|Withdrawal by Subject|0|||
130421624|NCT05072080|469503602|FG000|Overall Study|Death|0|||
130421625|NCT05072080|469503603|FG001|Overall Study|Death|0|||
130564489|NCT00885703|470033649|FG001|Overall Study|Lost to Follow-up|0|||
130564490|NCT00885703|470033650|FG002|Overall Study|Lost to Follow-up|1|||
130564491|NCT00885703|470033651|FG003|Overall Study|Lost to Follow-up|0|||
130727477|NCT00402116|470625456|FG001|Overall Study|decline related hyponatremia/tumor|0|||
130727478|NCT00402116|470625457|FG002|Overall Study|decline related hyponatremia/tumor|1|||
130727479|NCT00402116|470625455|FG000|Overall Study|Adverse Event|0|||
130421626|NCT05072080|469503604|FG002|Overall Study|Death|1|||
130421627|NCT05072080|469503605|FG003|Overall Study|Death|0|||
130421628|NCT05072080|469503602|FG000|Overall Study|Lost to Follow-up|65|||
130727480|NCT00402116|470625456|FG001|Overall Study|Adverse Event|1|||
130727481|NCT00402116|470625457|FG002|Overall Study|Adverse Event|6|||
130421629|NCT05072080|469503603|FG001|Overall Study|Lost to Follow-up|70|||
130421630|NCT05072080|469503604|FG002|Overall Study|Lost to Follow-up|58|||
130421631|NCT05072080|469503605|FG003|Overall Study|Lost to Follow-up|23|||
130421632|NCT05072080|469503602|FG000|Overall Study|Physician Decision|2|||
130421633|NCT05072080|469503603|FG001|Overall Study|Physician Decision|1|||
130421634|NCT05072080|469503604|FG002|Overall Study|Physician Decision|1|||
130421635|NCT05072080|469503605|FG003|Overall Study|Physician Decision|0|||
130421636|NCT05072080|469503602|FG000|Overall Study|Withdrawal by Subject|45|||
130421637|NCT05072080|469503603|FG001|Overall Study|Withdrawal by Subject|30|||
130421638|NCT05072080|469503604|FG002|Overall Study|Withdrawal by Subject|27|||
130421639|NCT05072080|469503605|FG003|Overall Study|Withdrawal by Subject|7|||
130421640|NCT05072080|469503602|FG000|Overall Study|Sponsor Decision|0|||
130421641|NCT05072080|469503603|FG001|Overall Study|Sponsor Decision|1|||
130421642|NCT05072080|469503604|FG002|Overall Study|Sponsor Decision|0|||
130421643|NCT05072080|469503605|FG003|Overall Study|Sponsor Decision|0|||
130421644|NCT05072080|469503602|FG000|Overall Study|Subject moved|1|||
130421645|NCT05072080|469503603|FG001|Overall Study|Subject moved|3|||
130421646|NCT05072080|469503604|FG002|Overall Study|Subject moved|5|||
130421647|NCT05072080|469503605|FG003|Overall Study|Subject moved|2|||
130421648|NCT05072080|469503602|FG000|Overall Study|Withdrawal by parent|0|||
130421649|NCT05072080|469503603|FG001|Overall Study|Withdrawal by parent|0|||
130421650|NCT05072080|469503604|FG002|Overall Study|Withdrawal by parent|1|||
130421651|NCT05072080|469503605|FG003|Overall Study|Withdrawal by parent|0|||
130421652|NCT05072080|469503602|FG000|Overall Study|Subject was deployed|0|||
130421653|NCT05072080|469503603|FG001|Overall Study|Subject was deployed|1|||
130421654|NCT05072080|469503604|FG002|Overall Study|Subject was deployed|0|||
130421655|NCT05072080|469503605|FG003|Overall Study|Subject was deployed|0|||
130421656|NCT05072080|469503602|FG000|Overall Study|Subject left site without receiving dose|0|||
130421657|NCT05072080|469503603|FG001|Overall Study|Subject left site without receiving dose|1|||
130421658|NCT05072080|469503604|FG002|Overall Study|Subject left site without receiving dose|0|||
130421659|NCT05072080|469503605|FG003|Overall Study|Subject left site without receiving dose|0|||
130421660|NCT05072080|469503602|FG000|Overall Study|Subject incarcerated|0|||
130421661|NCT05072080|469503603|FG001|Overall Study|Subject incarcerated|1|||
130421662|NCT05072080|469503604|FG002|Overall Study|Subject incarcerated|0|||
130421663|NCT05072080|469503605|FG003|Overall Study|Subject incarcerated|1|||
130421664|NCT05072080|469503602|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
130421665|NCT05072080|469503603|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
130421666|NCT05072080|469503604|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
130421667|NCT05072080|469503605|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
130421668|NCT05072080|469503602|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
130421669|NCT05072080|469503603|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
130421670|NCT05072080|469503604|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
130421671|NCT05072080|469503605|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
130421672|NCT03152526|469503606|FG000|Overall Study|Withdrawal by Subject|0|||
130421673|NCT03152526|469503607|FG001|Overall Study|Withdrawal by Subject|1|||
130421674|NCT02395042|469503608|FG000|Treatment 1 Period|Adverse Event|1|||
130421675|NCT02395042|469503609|FG001|Treatment 1 Period|Adverse Event|3|||
130421676|NCT02395042|469503610|FG002|Treatment 1 Period|Adverse Event|1|||
130421677|NCT02395042|469503608|FG000|Treatment 1 Period|Lack of Efficacy|1|||
130421678|NCT02395042|469503609|FG001|Treatment 1 Period|Lack of Efficacy|1|||
130421679|NCT02395042|469503610|FG002|Treatment 1 Period|Lack of Efficacy|0|||
130421680|NCT02395042|469503608|FG000|Treatment 1 Period|Lost to Follow-up|1|||
130421681|NCT02395042|469503609|FG001|Treatment 1 Period|Lost to Follow-up|0|||
130421682|NCT02395042|469503610|FG002|Treatment 1 Period|Lost to Follow-up|0|||
130421683|NCT02395042|469503608|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
130421684|NCT02395042|469503609|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
130421685|NCT02395042|469503610|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
130421686|NCT02395042|469503608|FG000|Treatment 2 Period|Lack of Efficacy|1|||
130421687|NCT02395042|469503609|FG001|Treatment 2 Period|Lack of Efficacy|1|||
130421688|NCT02395042|469503610|FG002|Treatment 2 Period|Lack of Efficacy|0|||
130421689|NCT02807558|469503611|FG000|Overall Study|Consent withdrawn by participant|4|||
130421690|NCT02807558|469503612|FG001|Overall Study|Consent withdrawn by participant|0|||
130421691|NCT02807558|469503613|FG002|Overall Study|Consent withdrawn by participant|4|||
130421692|NCT02807558|469503614|FG003|Overall Study|Consent withdrawn by participant|2|||
130421693|NCT02807558|469503615|FG004|Overall Study|Consent withdrawn by participant|1|||
130421694|NCT02807558|469503616|FG005|Overall Study|Consent withdrawn by participant|0|||
130421695|NCT02807558|469503611|FG000|Overall Study|Non-compliance with Study Drug|0|||
130476091|NCT04927065|469711690|FG015|First Booster|Protocol Violation|0|||
130476092|NCT04927065|469711675|FG000|First Booster|Withdrawal by Subject|8|||
130727482|NCT04778904|470625458|FG000|Overall Study|Protocol Violation|1|||
130727483|NCT04778904|470625459|FG001|Overall Study|Protocol Violation|0|||
130421696|NCT02807558|469503612|FG001|Overall Study|Non-compliance with Study Drug|0|||
130421697|NCT02807558|469503613|FG002|Overall Study|Non-compliance with Study Drug|1|||
130476093|NCT04927065|469711676|FG001|First Booster|Withdrawal by Subject|23|||
130476094|NCT04927065|469711677|FG002|First Booster|Withdrawal by Subject|0|||
130421698|NCT02807558|469503614|FG003|Overall Study|Non-compliance with Study Drug|0|||
130421699|NCT02807558|469503615|FG004|Overall Study|Non-compliance with Study Drug|0|||
130421700|NCT02807558|469503616|FG005|Overall Study|Non-compliance with Study Drug|0|||
130421701|NCT02807558|469503611|FG000|Overall Study|Adverse Event|0|||
130421702|NCT02807558|469503612|FG001|Overall Study|Adverse Event|0|||
130476095|NCT04927065|469711678|FG003|First Booster|Withdrawal by Subject|19|||
130476096|NCT04927065|469711679|FG004|First Booster|Withdrawal by Subject|20|||
130727484|NCT04778904|470625460|FG002|Overall Study|Protocol Violation|0|||
130421703|NCT02807558|469503613|FG002|Overall Study|Adverse Event|9|||
130421704|NCT02807558|469503614|FG003|Overall Study|Adverse Event|0|||
130421705|NCT02807558|469503615|FG004|Overall Study|Adverse Event|0|||
130421706|NCT02807558|469503616|FG005|Overall Study|Adverse Event|0|||
130421707|NCT02807558|469503611|FG000|Overall Study|Death|23|||
130421708|NCT02807558|469503612|FG001|Overall Study|Death|2|||
130421709|NCT02807558|469503613|FG002|Overall Study|Death|3|||
130421710|NCT02807558|469503614|FG003|Overall Study|Death|43|||
130421711|NCT02807558|469503615|FG004|Overall Study|Death|24|||
130421712|NCT02807558|469503616|FG005|Overall Study|Death|15|||
130421713|NCT02807558|469503611|FG000|Overall Study|Progressive Disease|0|||
130421714|NCT02807558|469503612|FG001|Overall Study|Progressive Disease|0|||
130421715|NCT02807558|469503613|FG002|Overall Study|Progressive Disease|1|||
130421716|NCT02807558|469503614|FG003|Overall Study|Progressive Disease|0|||
130421717|NCT02807558|469503615|FG004|Overall Study|Progressive Disease|0|||
130421718|NCT02807558|469503616|FG005|Overall Study|Progressive Disease|0|||
130421719|NCT02807558|469503611|FG000|Overall Study|Other than specified|1|||
130421720|NCT02807558|469503612|FG001|Overall Study|Other than specified|0|||
130421721|NCT02807558|469503613|FG002|Overall Study|Other than specified|2|||
130421722|NCT02807558|469503614|FG003|Overall Study|Other than specified|0|||
130421723|NCT02807558|469503615|FG004|Overall Study|Other than specified|1|||
130421724|NCT02807558|469503616|FG005|Overall Study|Other than specified|1|||
130421725|NCT02807558|469503611|FG000|Overall Study|Lack of Efficacy|0|||
130421726|NCT02807558|469503612|FG001|Overall Study|Lack of Efficacy|0|||
130421727|NCT02807558|469503613|FG002|Overall Study|Lack of Efficacy|9|||
130421728|NCT02807558|469503614|FG003|Overall Study|Lack of Efficacy|0|||
130421729|NCT02807558|469503615|FG004|Overall Study|Lack of Efficacy|0|||
130421730|NCT02807558|469503616|FG005|Overall Study|Lack of Efficacy|0|||
130421731|NCT04969198|469503617|FG000|Overall Study|Withdrawal by Subject|20|||
130421732|NCT04969198|469503617|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
130421733|NCT04969198|469503617|FG000|Overall Study|Lost to Follow-up|20|||
130421734|NCT02701985|469503618|FG000|Overall Study|Withdrawal by Subject|1|||
130421735|NCT02701985|469503619|FG001|Overall Study|Withdrawal by Subject|1|||
130421736|NCT02701985|469503618|FG000|Overall Study|Lost to Follow-up|1|||
130421737|NCT02701985|469503619|FG001|Overall Study|Lost to Follow-up|0|||
130421738|NCT02701985|469503618|FG000|Overall Study|Death|1|||
130421739|NCT02701985|469503619|FG001|Overall Study|Death|0|||
130421740|NCT02701985|469503618|FG000|Overall Study|Adverse Event|0|||
130421741|NCT02701985|469503619|FG001|Overall Study|Adverse Event|5|||
130421742|NCT01640808|469503620|FG000|Overall Study|Unable to continue dynamic CT|14|||
130421743|NCT01640808|469503621|FG001|Overall Study|Unable to continue dynamic CT|4|||
130421744|NCT01640808|469503620|FG000|Overall Study|Withdrawal by Subject|12|||
130421745|NCT01640808|469503621|FG001|Overall Study|Withdrawal by Subject|4|||
130421746|NCT01640808|469503620|FG000|Overall Study|Lost to Follow-up|4|||
130421747|NCT01640808|469503621|FG001|Overall Study|Lost to Follow-up|0|||
130421748|NCT01640808|469503620|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
130421749|NCT01640808|469503621|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
130421750|NCT01640808|469503620|FG000|Overall Study|Administration of anticancer drugs|2|||
130421751|NCT01640808|469503621|FG001|Overall Study|Administration of anticancer drugs|1|||
130421752|NCT01640808|469503620|FG000|Overall Study|Physician Decision|19|||
130421753|NCT01640808|469503621|FG001|Overall Study|Physician Decision|5|||
130421754|NCT01640808|469503620|FG000|Overall Study|Randomized but not treated|4|||
130421755|NCT01640808|469503621|FG001|Overall Study|Randomized but not treated|2|||
130421756|NCT01178086|469503622|FG000|Overall Study|Participant refusal|7|||
130421757|NCT01178086|469503622|FG000|Overall Study|Physician Decision|44|||
130421758|NCT01178086|469503622|FG000|Overall Study|Switch to other CLL therapy|113|||
130421759|NCT01178086|469503622|FG000|Overall Study|Death|59|||
130421760|NCT01178086|469503622|FG000|Overall Study|Other unspecified|89|||
130421761|NCT01178086|469503622|FG000|Overall Study|Excluded from EAS|20|||
130421762|NCT03543254|469503623|FG000|Overall Study|Lost to Follow-up|1|||
130421763|NCT00234065|469503624|FG000|Overall Study|Adverse Event|268|||
130421764|NCT00234065|469503625|FG001|Overall Study|Adverse Event|166|||
130421765|NCT00234065|469503624|FG000|Overall Study|Withdrawal by Subject|73|||
130421766|NCT00234065|469503625|FG001|Overall Study|Withdrawal by Subject|56|||
130421767|NCT00234065|469503624|FG000|Overall Study|Physician Decision|23|||
130421768|NCT00234065|469503625|FG001|Overall Study|Physician Decision|22|||
130421769|NCT00234065|469503624|FG000|Overall Study|Not Classified|111|||
130421770|NCT00234065|469503625|FG001|Overall Study|Not Classified|112|||
130421771|NCT00126438|469503626|FG000|Overall Study|Withdrawal due to adverse event|1|||
130421772|NCT00126438|469503627|FG001|Overall Study|Withdrawal due to adverse event|0|||
130421773|NCT00126438|469503626|FG000|Overall Study|Lost to Follow-up|22|||
130421774|NCT00126438|469503627|FG001|Overall Study|Lost to Follow-up|0|||
130421775|NCT00126438|469503626|FG000|Overall Study|Protocol Violation|8|||
130421776|NCT00126438|469503627|FG001|Overall Study|Protocol Violation|8|||
130421777|NCT00126438|469503626|FG000|Overall Study|Withdrawal by Subject|3|||
130421778|NCT00126438|469503627|FG001|Overall Study|Withdrawal by Subject|2|||
130421779|NCT00570674|469505678|FG000|Overall Study|Withdrawal by Subject|0|||
130421780|NCT00570674|469505679|FG001|Overall Study|Withdrawal by Subject|0|||
130564492|NCT00885703|470033652|FG004|Overall Study|Lost to Follow-up|0|||
130421781|NCT00570674|469505680|FG002|Overall Study|Withdrawal by Subject|1|||
130421782|NCT00570674|469505681|FG003|Overall Study|Withdrawal by Subject|0|||
130421783|NCT00570674|469505682|FG004|Overall Study|Withdrawal by Subject|0|||
130421784|NCT00570674|469505683|FG005|Overall Study|Withdrawal by Subject|0|||
130421785|NCT00570674|469505684|FG006|Overall Study|Withdrawal by Subject|0|||
130421786|NCT03393000|469505689|FG000|Overall Study|Death|11|||
130421787|NCT03393000|469505689|FG000|Overall Study|Withdrawal by Subject|2|||
130421788|NCT03393000|469505689|FG000|Overall Study|Physician Decision|1|||
130421789|NCT00160680|469505690|FG000|Overall Study|Adverse Event|0|||
130421790|NCT00160680|469505691|FG001|Overall Study|Adverse Event|1|||
130421791|NCT00160680|469505690|FG000|Overall Study|Lack of Efficacy|2|||
130421792|NCT00160680|469505691|FG001|Overall Study|Lack of Efficacy|1|||
130421793|NCT00160680|469505690|FG000|Overall Study|Lost to Follow-up|3|||
130421794|NCT00160680|469505691|FG001|Overall Study|Lost to Follow-up|2|||
130421795|NCT00160680|469505690|FG000|Overall Study|Withdrawal by Subject|4|||
130421796|NCT00160680|469505691|FG001|Overall Study|Withdrawal by Subject|9|||
130421797|NCT01773070|469505692|FG000|Overall Study|Withdrawal by Subject|24|||
130421798|NCT01773070|469505692|FG000|Overall Study|Lost to Follow-up|39|||
130421799|NCT01773070|469505692|FG000|Overall Study|Other|15|||
130421800|NCT01773070|469505692|FG000|Overall Study|Death (unrelated to study procedures)|3|||
130421801|NCT02450331|469505693|FG000|Overall Study|Death|162|||
130421802|NCT02450331|469505694|FG001|Overall Study|Death|171|||
130421803|NCT02450331|469505693|FG000|Overall Study|Lost to Follow-up|14|||
130421804|NCT02450331|469505694|FG001|Overall Study|Lost to Follow-up|12|||
130421805|NCT02450331|469505693|FG000|Overall Study|Withdrawal by Subject|55|||
130421806|NCT02450331|469505694|FG001|Overall Study|Withdrawal by Subject|44|||
130421807|NCT02450331|469505693|FG000|Overall Study|Non-specified other|1|||
130421808|NCT02450331|469505694|FG001|Overall Study|Non-specified other|1|||
130421809|NCT02723864|469505695|FG000|Overall Study|Refused further treatment|1|||
130421810|NCT02723864|469505696|FG001|Overall Study|Refused further treatment|0|||
130421811|NCT02723864|469505697|FG002|Overall Study|Refused further treatment|0|||
130421812|NCT02723864|469505698|FG003|Overall Study|Refused further treatment|0|||
130421813|NCT02723864|469505699|FG004|Overall Study|Refused further treatment|1|||
130421814|NCT02723864|469505700|FG005|Overall Study|Refused further treatment|2|||
130421815|NCT02723864|469505701|FG006|Overall Study|Refused further treatment|0|||
130421816|NCT02723864|469505695|FG000|Overall Study|Exceed treatment hold time|0|||
130421817|NCT02723864|469505696|FG001|Overall Study|Exceed treatment hold time|1|||
130421818|NCT02723864|469505697|FG002|Overall Study|Exceed treatment hold time|0|||
130421819|NCT02723864|469505698|FG003|Overall Study|Exceed treatment hold time|0|||
130421820|NCT02723864|469505699|FG004|Overall Study|Exceed treatment hold time|0|||
130421821|NCT02723864|469505700|FG005|Overall Study|Exceed treatment hold time|0|||
130421822|NCT02723864|469505701|FG006|Overall Study|Exceed treatment hold time|0|||
130421823|NCT02723864|469505695|FG000|Overall Study|Clinical progression|0|||
130421824|NCT02723864|469505696|FG001|Overall Study|Clinical progression|0|||
130421825|NCT02723864|469505697|FG002|Overall Study|Clinical progression|1|||
130421826|NCT02723864|469505698|FG003|Overall Study|Clinical progression|0|||
130421827|NCT02723864|469505699|FG004|Overall Study|Clinical progression|0|||
130421828|NCT02723864|469505700|FG005|Overall Study|Clinical progression|3|||
130421829|NCT02723864|469505701|FG006|Overall Study|Clinical progression|1|||
130421830|NCT02723864|469505695|FG000|Overall Study|Physician Decision|0|||
130421831|NCT02723864|469505696|FG001|Overall Study|Physician Decision|0|||
130421832|NCT02723864|469505697|FG002|Overall Study|Physician Decision|0|||
130421833|NCT02723864|469505698|FG003|Overall Study|Physician Decision|0|||
130421834|NCT02723864|469505699|FG004|Overall Study|Physician Decision|0|||
130421835|NCT02723864|469505700|FG005|Overall Study|Physician Decision|0|||
130421836|NCT02723864|469505701|FG006|Overall Study|Physician Decision|1|||
130421837|NCT02723864|469505695|FG000|Overall Study|Changes in patient condition|0|||
130727485|NCT04778904|470625461|FG003|Overall Study|Protocol Violation|0|||
130727486|NCT04778904|470625458|FG000|Overall Study|Withdrawal by Subject|0|||
130421838|NCT02723864|469505696|FG001|Overall Study|Changes in patient condition|0|||
130421839|NCT02723864|469505697|FG002|Overall Study|Changes in patient condition|0|||
130421840|NCT02723864|469505698|FG003|Overall Study|Changes in patient condition|0|||
130476097|NCT04927065|469711680|FG005|First Booster|Withdrawal by Subject|15|||
130476098|NCT04927065|469711681|FG006|First Booster|Withdrawal by Subject|6|||
130727487|NCT04778904|470625459|FG001|Overall Study|Withdrawal by Subject|0|||
130421841|NCT02723864|469505699|FG004|Overall Study|Changes in patient condition|0|||
130421842|NCT02723864|469505700|FG005|Overall Study|Changes in patient condition|1|||
130421843|NCT02723864|469505701|FG006|Overall Study|Changes in patient condition|0|||
130421844|NCT02723864|469505695|FG000|Overall Study|Patient choice|0|||
130476099|NCT04927065|469711682|FG007|First Booster|Withdrawal by Subject|24|||
130421845|NCT02723864|469505696|FG001|Overall Study|Patient choice|0|||
130421846|NCT02723864|469505697|FG002|Overall Study|Patient choice|0|||
130476100|NCT04927065|469711683|FG008|First Booster|Withdrawal by Subject|0|||
130727488|NCT04778904|470625460|FG002|Overall Study|Withdrawal by Subject|1|||
130476101|NCT04927065|469711684|FG009|First Booster|Withdrawal by Subject|4|||
130727489|NCT04778904|470625461|FG003|Overall Study|Withdrawal by Subject|0|||
130727490|NCT05048329|470625468|FG000|Overall Study|Withdrawal by Subject|1|||
130421847|NCT02723864|469505698|FG003|Overall Study|Patient choice|0|||
130421848|NCT02723864|469505699|FG004|Overall Study|Patient choice|0|||
130421849|NCT02723864|469505700|FG005|Overall Study|Patient choice|1|||
130421850|NCT02723864|469505701|FG006|Overall Study|Patient choice|0|||
130421851|NCT02723864|469505695|FG000|Overall Study|Adverse Event|0|||
130421852|NCT02723864|469505696|FG001|Overall Study|Adverse Event|0|||
130421853|NCT02723864|469505697|FG002|Overall Study|Adverse Event|0|||
130421854|NCT02723864|469505698|FG003|Overall Study|Adverse Event|0|||
130421855|NCT02723864|469505699|FG004|Overall Study|Adverse Event|0|||
130421856|NCT02723864|469505700|FG005|Overall Study|Adverse Event|1|||
130421857|NCT02723864|469505701|FG006|Overall Study|Adverse Event|0|||
130421858|NCT02723864|469505695|FG000|Overall Study|Started new treatment|0|||
130421859|NCT02723864|469505696|FG001|Overall Study|Started new treatment|0|||
130421860|NCT02723864|469505697|FG002|Overall Study|Started new treatment|0|||
130421861|NCT02723864|469505698|FG003|Overall Study|Started new treatment|0|||
130421862|NCT02723864|469505699|FG004|Overall Study|Started new treatment|0|||
130421863|NCT02723864|469505700|FG005|Overall Study|Started new treatment|1|||
130421864|NCT02723864|469505701|FG006|Overall Study|Started new treatment|0|||
130421865|NCT02723864|469505695|FG000|Overall Study|Switched to alternative treatment|0|||
130421866|NCT02723864|469505696|FG001|Overall Study|Switched to alternative treatment|0|||
130421867|NCT02723864|469505697|FG002|Overall Study|Switched to alternative treatment|0|||
130421868|NCT02723864|469505698|FG003|Overall Study|Switched to alternative treatment|0|||
130421869|NCT02723864|469505699|FG004|Overall Study|Switched to alternative treatment|0|||
130421870|NCT02723864|469505700|FG005|Overall Study|Switched to alternative treatment|1|||
130421871|NCT02723864|469505701|FG006|Overall Study|Switched to alternative treatment|0|||
130421872|NCT02723864|469505695|FG000|Overall Study|Late determination of ineligibility|0|||
130421873|NCT02723864|469505696|FG001|Overall Study|Late determination of ineligibility|0|||
130421874|NCT02723864|469505697|FG002|Overall Study|Late determination of ineligibility|0|||
130421875|NCT02723864|469505698|FG003|Overall Study|Late determination of ineligibility|0|||
130421876|NCT02723864|469505699|FG004|Overall Study|Late determination of ineligibility|0|||
130421877|NCT02723864|469505700|FG005|Overall Study|Late determination of ineligibility|1|||
130421878|NCT02723864|469505701|FG006|Overall Study|Late determination of ineligibility|0|||
130421879|NCT03643952|469505706|FG000|Overall Study|Lack of Efficacy|1|||
130421880|NCT01358968|469505707|FG000|Period 2|Adverse Event|0|||
130421881|NCT01358968|469505708|FG001|Period 2|Adverse Event|1|||
130421882|NCT01358968|469505709|FG002|Period 2|Adverse Event|0|||
130421883|NCT01358968|469505710|FG003|Period 2|Adverse Event|0|||
130421884|NCT01358968|469505707|FG000|Continued Access Phase|Progression of Disease|0|||
130421885|NCT01358968|469505708|FG001|Continued Access Phase|Progression of Disease|0|||
130421886|NCT01358968|469505709|FG002|Continued Access Phase|Progression of Disease|8|||
130421887|NCT01358968|469505710|FG003|Continued Access Phase|Progression of Disease|4|||
130421888|NCT01358968|469505707|FG000|Continued Access Phase|Protocol Violation|0|||
130421889|NCT01358968|469505708|FG001|Continued Access Phase|Protocol Violation|0|||
130421890|NCT01358968|469505709|FG002|Continued Access Phase|Protocol Violation|0|||
130421891|NCT01358968|469505710|FG003|Continued Access Phase|Protocol Violation|2|||
130421892|NCT01358968|469505707|FG000|Continued Access Phase|Withdrawal by Subject|0|||
130421893|NCT01358968|469505708|FG001|Continued Access Phase|Withdrawal by Subject|0|||
130421894|NCT01358968|469505709|FG002|Continued Access Phase|Withdrawal by Subject|3|||
130421895|NCT01358968|469505710|FG003|Continued Access Phase|Withdrawal by Subject|0|||
130421896|NCT01358968|469505707|FG000|Continued Access Phase|Death|0|||
130421897|NCT01358968|469505708|FG001|Continued Access Phase|Death|0|||
130421898|NCT01358968|469505709|FG002|Continued Access Phase|Death|1|||
130421899|NCT01358968|469505710|FG003|Continued Access Phase|Death|1|||
130421900|NCT00815295|469505714|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
130421901|NCT00815295|469505715|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
130421902|NCT00815295|469505716|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
130421903|NCT00530855|469505717|FG000|Overall Study|Lack of Efficacy|20|||
130421904|NCT00530855|469505717|FG000|Overall Study|Withdrawal by Subject|30|||
130421905|NCT00530855|469505717|FG000|Overall Study|Fatal Serious AE|3|||
130476102|NCT04927065|469711685|FG010|First Booster|Withdrawal by Subject|0|||
130476103|NCT04927065|469711686|FG011|First Booster|Withdrawal by Subject|0|||
130476104|NCT04927065|469711687|FG012|First Booster|Withdrawal by Subject|0|||
130476105|NCT04927065|469711688|FG013|First Booster|Withdrawal by Subject|0|||
130421906|NCT00530855|469505717|FG000|Overall Study|Non Fatal Serious AE|7|||
130421907|NCT00530855|469505717|FG000|Overall Study|Non Fatal Non Serious AE|12|||
130421908|NCT00530855|469505717|FG000|Overall Study|Protocol Violation|3|||
130421909|NCT00530855|469505717|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
130421910|NCT00530855|469505717|FG000|Overall Study|Lost to Follow-up|9|||
130421911|NCT00530855|469505717|FG000|Overall Study|Other reason for premature termination|17|||
130421912|NCT01292876|469505718|FG000|Overall Study|Physician Decision|4|||
130421913|NCT01814371|469505725|FG000|Overall Study|Lost to Follow-up|30|||
130421914|NCT01814371|469505726|FG001|Overall Study|Lost to Follow-up|27|||
130421915|NCT01692782|469505727|FG000|Overall Study|Adverse Event|12|||
130476106|NCT04927065|469711689|FG014|First Booster|Withdrawal by Subject|0|||
130476107|NCT04927065|469711690|FG015|First Booster|Withdrawal by Subject|0|||
130564493|NCT00885703|470033653|FG005|Overall Study|Lost to Follow-up|1|||
130564494|NCT00885703|470033654|FG006|Overall Study|Lost to Follow-up|0|||
130564495|NCT00885703|470033648|FG000|Overall Study|Withdrawal by Subject|0|||
130564496|NCT00885703|470033649|FG001|Overall Study|Withdrawal by Subject|0|||
130564497|NCT00885703|470033650|FG002|Overall Study|Withdrawal by Subject|0|||
130564498|NCT00885703|470033651|FG003|Overall Study|Withdrawal by Subject|1|||
130564499|NCT00885703|470033652|FG004|Overall Study|Withdrawal by Subject|3|||
130564500|NCT00885703|470033653|FG005|Overall Study|Withdrawal by Subject|1|||
130564501|NCT00885703|470033654|FG006|Overall Study|Withdrawal by Subject|1|||
130564502|NCT00885703|470033648|FG000|Overall Study|Ineligible (no CM)|1|||
130564503|NCT00885703|470033649|FG001|Overall Study|Ineligible (no CM)|3|||
130564504|NCT00885703|470033650|FG002|Overall Study|Ineligible (no CM)|2|||
130564505|NCT00885703|470033651|FG003|Overall Study|Ineligible (no CM)|1|||
130564506|NCT00885703|470033652|FG004|Overall Study|Ineligible (no CM)|2|||
130564507|NCT00885703|470033653|FG005|Overall Study|Ineligible (no CM)|3|||
130564508|NCT00885703|470033654|FG006|Overall Study|Ineligible (no CM)|1|||
130564509|NCT01183143|470033656|FG000|Overall Study|Protocol Violation|115|||
130564510|NCT01183143|470033656|FG000|Overall Study|Withdrawal by Subject|19|||
130564511|NCT01183143|470033656|FG000|Overall Study|Subject Questionnaires not returned|5|||
130564512|NCT01183143|470033656|FG000|Overall Study|Subjects enrolled, but not treated|11|||
130564513|NCT01502709|470033657|FG000|Overall Study|Lost to Follow-up|4|||
130564514|NCT01502709|470033658|FG001|Overall Study|Lost to Follow-up|0|||
130564515|NCT04096274|470033659|FG000|Phase I|Lost to Follow-up|5|||
130564516|NCT04096274|470033660|FG001|Phase I|Lost to Follow-up|5|||
130564517|NCT04096274|470033659|FG000|Phase II|Lost to Follow-up|11|||
130564518|NCT04096274|470033660|FG001|Phase II|Lost to Follow-up|11|||
130564519|NCT01490450|470033662|FG000|Period 1|Lack of Efficacy|2|||
130564520|NCT01490450|470033663|FG001|Period 1|Lack of Efficacy|0|||
130564521|NCT01490450|470033664|FG002|Period 1|Lack of Efficacy|3|||
130564522|NCT01490450|470033665|FG003|Period 1|Lack of Efficacy|0|||
130564523|NCT01490450|470033662|FG000|Period 1|Adverse Event|0|||
130564524|NCT01490450|470033663|FG001|Period 1|Adverse Event|0|||
130564525|NCT01490450|470033664|FG002|Period 1|Adverse Event|0|||
130564526|NCT01490450|470033665|FG003|Period 1|Adverse Event|5|||
130564527|NCT01490450|470033662|FG000|Period 1|Request to discontinue treatment|1|||
130564528|NCT01490450|470033663|FG001|Period 1|Request to discontinue treatment|0|||
130564529|NCT01490450|470033664|FG002|Period 1|Request to discontinue treatment|0|||
130564530|NCT01490450|470033665|FG003|Period 1|Request to discontinue treatment|0|||
130564531|NCT01490450|470033662|FG000|Period 1|Withdrawal by Subject|0|||
130564532|NCT01490450|470033663|FG001|Period 1|Withdrawal by Subject|0|||
130564533|NCT01490450|470033664|FG002|Period 1|Withdrawal by Subject|0|||
130564534|NCT01490450|470033665|FG003|Period 1|Withdrawal by Subject|3|||
130421916|NCT01692782|469505728|FG001|Overall Study|Adverse Event|32|||
130421917|NCT01692782|469505729|FG002|Overall Study|Adverse Event|2|||
130421918|NCT01692782|469505727|FG000|Overall Study|Lack of Efficacy|1|||
130421919|NCT01692782|469505728|FG001|Overall Study|Lack of Efficacy|2|||
130421920|NCT01692782|469505729|FG002|Overall Study|Lack of Efficacy|0|||
130421921|NCT01692782|469505727|FG000|Overall Study|Lost to Follow-up|2|||
130421922|NCT01692782|469505728|FG001|Overall Study|Lost to Follow-up|7|||
130421923|NCT01692782|469505729|FG002|Overall Study|Lost to Follow-up|1|||
130421924|NCT01692782|469505727|FG000|Overall Study|Pregnancy|1|||
130421925|NCT01692782|469505728|FG001|Overall Study|Pregnancy|0|||
130421926|NCT01692782|469505729|FG002|Overall Study|Pregnancy|0|||
130421927|NCT01692782|469505727|FG000|Overall Study|Protocol Violation|1|||
130564535|NCT01490450|470033662|FG000|Period 1|No longer met study criteria|0|||
130421928|NCT01692782|469505728|FG001|Overall Study|Protocol Violation|0|||
130421929|NCT01692782|469505729|FG002|Overall Study|Protocol Violation|2|||
130421930|NCT01692782|469505727|FG000|Overall Study|Non-complance with study drug|0|||
130421931|NCT01692782|469505728|FG001|Overall Study|Non-complance with study drug|4|||
130421932|NCT01692782|469505729|FG002|Overall Study|Non-complance with study drug|1|||
130421933|NCT01692782|469505727|FG000|Overall Study|Non-compliant with study visits|0|||
130421934|NCT01692782|469505728|FG001|Overall Study|Non-compliant with study visits|0|||
130421935|NCT01692782|469505729|FG002|Overall Study|Non-compliant with study visits|1|||
130421936|NCT01692782|469505727|FG000|Overall Study|SAE not related to study drug|0|||
130564536|NCT01490450|470033663|FG001|Period 1|No longer met study criteria|1|||
130564537|NCT01490450|470033664|FG002|Period 1|No longer met study criteria|1|||
130421937|NCT01692782|469505728|FG001|Overall Study|SAE not related to study drug|1|||
130421938|NCT01692782|469505729|FG002|Overall Study|SAE not related to study drug|0|||
130421939|NCT01692782|469505727|FG000|Overall Study|Withdrawal by Subject|3|||
130421940|NCT01692782|469505728|FG001|Overall Study|Withdrawal by Subject|10|||
130421941|NCT01692782|469505729|FG002|Overall Study|Withdrawal by Subject|3|||
130421942|NCT03252587|469505730|FG000|Overall Study|Adverse Event|3|||
130564538|NCT01490450|470033665|FG003|Period 1|No longer met study criteria|0|||
130564539|NCT01490450|470033662|FG000|Period 2|Lack of Efficacy|0|||
130564540|NCT01490450|470033663|FG001|Period 2|Lack of Efficacy|0|||
130564541|NCT01490450|470033664|FG002|Period 2|Lack of Efficacy|0|||
130564542|NCT01490450|470033665|FG003|Period 2|Lack of Efficacy|1|||
130564543|NCT01490450|470033662|FG000|Period 2|Adverse Event|1|||
130564544|NCT01490450|470033663|FG001|Period 2|Adverse Event|1|||
130564545|NCT01490450|470033664|FG002|Period 2|Adverse Event|0|||
130421943|NCT03252587|469505731|FG001|Overall Study|Adverse Event|8|||
130421944|NCT03252587|469505732|FG002|Overall Study|Adverse Event|6|||
130421945|NCT03252587|469505733|FG003|Overall Study|Adverse Event|12|||
130421946|NCT03252587|469505730|FG000|Overall Study|Lack of Efficacy|7|||
130421947|NCT03252587|469505731|FG001|Overall Study|Lack of Efficacy|2|||
130421948|NCT03252587|469505732|FG002|Overall Study|Lack of Efficacy|2|||
130421949|NCT03252587|469505733|FG003|Overall Study|Lack of Efficacy|4|||
130421950|NCT03252587|469505730|FG000|Overall Study|Lost to Follow-up|2|||
130421951|NCT03252587|469505731|FG001|Overall Study|Lost to Follow-up|0|||
130421952|NCT03252587|469505732|FG002|Overall Study|Lost to Follow-up|0|||
130421953|NCT03252587|469505733|FG003|Overall Study|Lost to Follow-up|2|||
130421954|NCT03252587|469505730|FG000|Overall Study|Pregnancy|2|||
130564546|NCT01490450|470033665|FG003|Period 2|Adverse Event|1|||
130564547|NCT01490450|470033662|FG000|Period 2|Withdrawal by Subject|1|||
130564548|NCT01490450|470033663|FG001|Period 2|Withdrawal by Subject|0|||
130564549|NCT01490450|470033664|FG002|Period 2|Withdrawal by Subject|0|||
130564550|NCT01490450|470033665|FG003|Period 2|Withdrawal by Subject|0|||
130421955|NCT03252587|469505731|FG001|Overall Study|Pregnancy|1|||
130421956|NCT03252587|469505732|FG002|Overall Study|Pregnancy|0|||
130421957|NCT03252587|469505733|FG003|Overall Study|Pregnancy|1|||
130421958|NCT03252587|469505730|FG000|Overall Study|Withdrawal by Subject|8|||
130421959|NCT03252587|469505731|FG001|Overall Study|Withdrawal by Subject|4|||
130421960|NCT03252587|469505732|FG002|Overall Study|Withdrawal by Subject|4|||
130421961|NCT03252587|469505733|FG003|Overall Study|Withdrawal by Subject|4|||
130421962|NCT03252587|469505730|FG000|Overall Study|Other Reasons|2|||
130421963|NCT03252587|469505731|FG001|Overall Study|Other Reasons|5|||
130421964|NCT03252587|469505732|FG002|Overall Study|Other Reasons|5|||
130421965|NCT03252587|469505733|FG003|Overall Study|Other Reasons|4|||
130421966|NCT04052204|469505734|FG000|Overall Study|Death|1|||
130421967|NCT04052204|469505735|FG001|Overall Study|Death|0|||
130421968|NCT04052204|469505736|FG002|Overall Study|Death|0|||
130421969|NCT04052204|469505734|FG000|Overall Study|Progressive disease|1|||
130421970|NCT04052204|469505735|FG001|Overall Study|Progressive disease|0|||
130421971|NCT04052204|469505736|FG002|Overall Study|Progressive disease|0|||
130421972|NCT04052204|469505734|FG000|Overall Study|Other|1|||
130421973|NCT04052204|469505735|FG001|Overall Study|Other|0|||
130421974|NCT04052204|469505736|FG002|Overall Study|Other|0|||
130421975|NCT03945188|469505737|FG000|Overall Study|Protocol Violation|1|||
130421976|NCT03945188|469505738|FG001|Overall Study|Protocol Violation|0|||
130421977|NCT03945188|469505737|FG000|Overall Study|Disease worsening|79|||
130421978|NCT03945188|469505738|FG001|Overall Study|Disease worsening|73|||
130421979|NCT03945188|469505737|FG000|Overall Study|Physician Decision|2|||
130421980|NCT03945188|469505738|FG001|Overall Study|Physician Decision|2|||
130421981|NCT03945188|469505737|FG000|Overall Study|Lack of Efficacy|7|||
130421982|NCT03945188|469505738|FG001|Overall Study|Lack of Efficacy|4|||
130421983|NCT03945188|469505737|FG000|Overall Study|Pregnancy|2|||
130421984|NCT03945188|469505738|FG001|Overall Study|Pregnancy|0|||
130421985|NCT03945188|469505737|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
130421986|NCT03945188|469505738|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
130421987|NCT03945188|469505737|FG000|Overall Study|Adverse Event|10|||
130421988|NCT03945188|469505738|FG001|Overall Study|Adverse Event|5|||
130421989|NCT03945188|469505737|FG000|Overall Study|Other|2|||
130421990|NCT03945188|469505738|FG001|Overall Study|Other|2|||
130421991|NCT03945188|469505737|FG000|Overall Study|Lost to Follow-up|1|||
130421992|NCT03945188|469505738|FG001|Overall Study|Lost to Follow-up|2|||
130421993|NCT01618162|469505759|FG000|Overall Study|Protocol Violation|13|||
130421994|NCT01618162|469505760|FG001|Overall Study|Protocol Violation|10|||
130421995|NCT01618162|469505759|FG000|Overall Study|Adverse Event|9|||
130421996|NCT01618162|469505760|FG001|Overall Study|Adverse Event|2|||
130421997|NCT01618162|469505759|FG000|Overall Study|Withdrawal Criteria|2|||
130421998|NCT01618162|469505760|FG001|Overall Study|Withdrawal Criteria|10|||
130421999|NCT01618162|469505759|FG000|Overall Study|Unclassified|14|||
130422000|NCT01618162|469505760|FG001|Overall Study|Unclassified|13|||
130422001|NCT02477111|469505766|FG000|Overall Study|Death|28|||
130422002|NCT02477111|469505766|FG000|Overall Study|Withdrawal by Subject|19|||
130422003|NCT02477111|469505766|FG000|Overall Study|Lost to Follow-up|4|||
130422004|NCT02192502|469505768|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
130422005|NCT02192502|469505769|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
130422006|NCT02192502|469505768|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
130422007|NCT02192502|469505769|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
130422008|NCT02192502|469505768|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
130422009|NCT02192502|469505769|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
130422010|NCT01328574|469505778|FG000|Overall Study|Refused further treatment|1|||
130422011|NCT00003298|469505779|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
130422012|NCT00003298|469505779|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
130422013|NCT00003298|469505779|FG000|Surgery|Unresectable at surgery|3|||
130422014|NCT00003298|469505779|FG000|Surgery|Progression before surgery|2|||
130564551|NCT01490450|470033662|FG000|Period 2|Lost to Follow-up|0|||
130564552|NCT01490450|470033663|FG001|Period 2|Lost to Follow-up|0|||
130422015|NCT00003298|469505779|FG000|Surgery|Unevaluable and off study|2|||
130422016|NCT00003298|469505779|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
130422017|NCT00003298|469505779|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
130422018|NCT00003298|469505779|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
130422019|NCT00003298|469505779|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
130422020|NCT00003298|469505779|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
130422021|NCT00003298|469505779|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
130422022|NCT00003298|469505779|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
130422023|NCT00003298|469505779|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
130422024|NCT00003298|469505779|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
130422025|NCT00003298|469505779|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
130422026|NCT01994954|469505784|FG000|Overall Study|Death|1|||
130422027|NCT01994954|469505785|FG001|Overall Study|Death|0|||
130422028|NCT01994954|469505784|FG000|Overall Study|Withdrawal by Subject|9|||
130422029|NCT01994954|469505785|FG001|Overall Study|Withdrawal by Subject|14|||
130422030|NCT01994954|469505784|FG000|Overall Study|Physician Decision|2|||
130422031|NCT01994954|469505785|FG001|Overall Study|Physician Decision|2|||
130422032|NCT01994954|469505784|FG000|Overall Study|Lost to Follow-up|8|||
130422033|NCT01994954|469505785|FG001|Overall Study|Lost to Follow-up|10|||
130422034|NCT01994954|469505784|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
130422035|NCT01994954|469505785|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
130422036|NCT00675766|469505786|FG000|Overall Study|Lost to Follow-up|6|||
130422037|NCT00675766|469505787|FG001|Overall Study|Lost to Follow-up|5|||
130422038|NCT00675766|469505788|FG002|Overall Study|Lost to Follow-up|21|||
130476108|NCT04927065|469711675|FG000|First Booster|Other Than Specified|1|||
130476109|NCT04927065|469711676|FG001|First Booster|Other Than Specified|1|||
130476110|NCT04927065|469711677|FG002|First Booster|Other Than Specified|0|||
130476111|NCT04927065|469711678|FG003|First Booster|Other Than Specified|1|||
130476112|NCT04927065|469711679|FG004|First Booster|Other Than Specified|2|||
130476113|NCT04927065|469711680|FG005|First Booster|Other Than Specified|3|||
130476114|NCT04927065|469711681|FG006|First Booster|Other Than Specified|2|||
130476115|NCT04927065|469711682|FG007|First Booster|Other Than Specified|6|||
130476116|NCT04927065|469711683|FG008|First Booster|Other Than Specified|0|||
130476117|NCT04927065|469711684|FG009|First Booster|Other Than Specified|4|||
130476118|NCT04927065|469711685|FG010|First Booster|Other Than Specified|0|||
130476119|NCT04927065|469711686|FG011|First Booster|Other Than Specified|0|||
130476120|NCT04927065|469711687|FG012|First Booster|Other Than Specified|0|||
130476121|NCT04927065|469711688|FG013|First Booster|Other Than Specified|0|||
130476122|NCT04927065|469711689|FG014|First Booster|Other Than Specified|0|||
130476123|NCT04927065|469711690|FG015|First Booster|Other Than Specified|0|||
130476124|NCT04927065|469711675|FG000|Second Booster|Death|0|||
130476125|NCT04927065|469711676|FG001|Second Booster|Death|0|||
130476126|NCT04927065|469711677|FG002|Second Booster|Death|0|||
130476127|NCT04927065|469711678|FG003|Second Booster|Death|0|||
130476128|NCT04927065|469711679|FG004|Second Booster|Death|0|||
130476129|NCT04927065|469711680|FG005|Second Booster|Death|0|||
130476130|NCT04927065|469711681|FG006|Second Booster|Death|0|||
130476131|NCT04927065|469711682|FG007|Second Booster|Death|0|||
130476132|NCT04927065|469711683|FG008|Second Booster|Death|0|||
130476133|NCT04927065|469711684|FG009|Second Booster|Death|0|||
130476134|NCT04927065|469711685|FG010|Second Booster|Death|2|||
130476135|NCT04927065|469711686|FG011|Second Booster|Death|0|||
130476136|NCT04927065|469711687|FG012|Second Booster|Death|2|||
130476137|NCT04927065|469711688|FG013|Second Booster|Death|2|||
130476138|NCT04927065|469711689|FG014|Second Booster|Death|0|||
130476139|NCT04927065|469711690|FG015|Second Booster|Death|0|||
130476140|NCT04927065|469711675|FG000|Second Booster|Lost to Follow-up|0|||
130476141|NCT04927065|469711676|FG001|Second Booster|Lost to Follow-up|0|||
130476142|NCT04927065|469711677|FG002|Second Booster|Lost to Follow-up|3|||
130422039|NCT00675766|469505789|FG003|Overall Study|Lost to Follow-up|26|||
130422040|NCT01454583|469505796|FG000|1st Year|Lost to Follow-up|1057|||
130422041|NCT01454583|469505797|FG001|1st Year|Lost to Follow-up|318|||
130422042|NCT01454583|469505798|FG002|1st Year|Lost to Follow-up|180|||
130422043|NCT01454583|469505796|FG000|2nd Year|Lost to Follow-up|3965|||
130422044|NCT01454583|469505797|FG001|2nd Year|Lost to Follow-up|1049|||
130476143|NCT04927065|469711678|FG003|Second Booster|Lost to Follow-up|0|||
130422045|NCT01454583|469505798|FG002|2nd Year|Lost to Follow-up|737|||
130476144|NCT04927065|469711679|FG004|Second Booster|Lost to Follow-up|0|||
130476145|NCT04927065|469711680|FG005|Second Booster|Lost to Follow-up|0|||
130476146|NCT04927065|469711681|FG006|Second Booster|Lost to Follow-up|0|||
130476147|NCT04927065|469711682|FG007|Second Booster|Lost to Follow-up|0|||
130476148|NCT04927065|469711683|FG008|Second Booster|Lost to Follow-up|0|||
130476149|NCT04927065|469711684|FG009|Second Booster|Lost to Follow-up|0|||
130476150|NCT04927065|469711685|FG010|Second Booster|Lost to Follow-up|14|||
130476151|NCT04927065|469711686|FG011|Second Booster|Lost to Follow-up|10|||
130476152|NCT04927065|469711687|FG012|Second Booster|Lost to Follow-up|13|||
130476153|NCT04927065|469711688|FG013|Second Booster|Lost to Follow-up|16|||
130476154|NCT04927065|469711689|FG014|Second Booster|Lost to Follow-up|0|||
130476155|NCT04927065|469711690|FG015|Second Booster|Lost to Follow-up|0|||
130564553|NCT01490450|470033664|FG002|Period 2|Lost to Follow-up|0|||
130564554|NCT01490450|470033665|FG003|Period 2|Lost to Follow-up|2|||
130564555|NCT02234479|470033670|FG000|Overall Study|Withdrawal by Subject|1|||
130564556|NCT02234479|470033671|FG001|Overall Study|Withdrawal by Subject|3|||
130564557|NCT00003535|470033672|FG000|Overall Study|Not evaluable|5|||
130564558|NCT00383084|470033673|FG000|Overall Study|Withdrawal by Subject|12|||
130422046|NCT01454583|469505796|FG000|3rd Year|Lost to Follow-up|1959|||
130422047|NCT01454583|469505797|FG001|3rd Year|Lost to Follow-up|512|||
130422048|NCT01454583|469505798|FG002|3rd Year|Lost to Follow-up|297|||
130422049|NCT02677116|469505801|FG000|Overall Study|Adverse Event|0|||
130422050|NCT02677116|469505802|FG001|Overall Study|Adverse Event|1|||
130422051|NCT02677116|469505803|FG002|Overall Study|Adverse Event|0|||
130422052|NCT02677116|469505804|FG003|Overall Study|Adverse Event|0|||
130422053|NCT02677116|469505805|FG004|Overall Study|Adverse Event|0|||
130422054|NCT02677116|469505806|FG005|Overall Study|Adverse Event|1|||
130422055|NCT02677116|469505807|FG006|Overall Study|Adverse Event|1|||
130422056|NCT02677116|469505808|FG007|Overall Study|Adverse Event|0|||
130422057|NCT02677116|469505809|FG008|Overall Study|Adverse Event|0|||
130422058|NCT02677116|469505801|FG000|Overall Study|Physician Decision|0|||
130422059|NCT02677116|469505802|FG001|Overall Study|Physician Decision|2|||
130422060|NCT02677116|469505803|FG002|Overall Study|Physician Decision|3|||
130564559|NCT00383084|470033674|FG001|Overall Study|Withdrawal by Subject|10|||
130564560|NCT02113436|470033675|FG000|Period 1: 8 Weeks|Adverse Event|1|||
130564561|NCT02113436|470033676|FG001|Period 1: 8 Weeks|Adverse Event|0|||
130564562|NCT02113436|470033677|FG002|Period 1: 8 Weeks|Adverse Event|0|||
130564563|NCT02113436|470033678|FG003|Period 1: 8 Weeks|Adverse Event|0|||
130564564|NCT02113436|470033675|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
130564565|NCT02113436|470033676|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
130564566|NCT02113436|470033677|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
130564567|NCT02113436|470033678|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
130564568|NCT02113436|470033675|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
130564569|NCT02113436|470033676|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
130564570|NCT02113436|470033677|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
130564571|NCT02113436|470033678|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
130564572|NCT02113436|470033675|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
130564573|NCT02113436|470033676|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130564574|NCT02113436|470033677|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130564575|NCT02113436|470033678|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130564576|NCT02113436|470033675|FG000|Period 2: 16 Weeks|Adverse Event|0|||
130564577|NCT02113436|470033676|FG001|Period 2: 16 Weeks|Adverse Event|0|||
130564578|NCT02113436|470033677|FG002|Period 2: 16 Weeks|Adverse Event|4|||
130564579|NCT02113436|470033678|FG003|Period 2: 16 Weeks|Adverse Event|5|||
130564580|NCT02113436|470033675|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
130564581|NCT02113436|470033676|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
130564582|NCT02113436|470033677|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
130564583|NCT02113436|470033678|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
130564584|NCT02113436|470033675|FG000|Period 2: 16 Weeks|Physician Decision|0|||
130564585|NCT02113436|470033676|FG001|Period 2: 16 Weeks|Physician Decision|0|||
130564586|NCT02113436|470033677|FG002|Period 2: 16 Weeks|Physician Decision|2|||
130564587|NCT02113436|470033678|FG003|Period 2: 16 Weeks|Physician Decision|0|||
130564588|NCT02113436|470033675|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
130564589|NCT02113436|470033676|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
130564590|NCT02113436|470033677|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
130564591|NCT02113436|470033678|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
130564592|NCT01263483|470033679|FG000|Overall Study|Adverse Event|4|||
130564593|NCT01263483|470033680|FG001|Overall Study|Adverse Event|0|||
130564594|NCT01263483|470033681|FG002|Overall Study|Adverse Event|3|||
130564595|NCT01263483|470033679|FG000|Overall Study|Withdrawal by Subject|1|||
130564596|NCT01263483|470033680|FG001|Overall Study|Withdrawal by Subject|0|||
130564597|NCT01263483|470033681|FG002|Overall Study|Withdrawal by Subject|0|||
130564598|NCT01263483|470033679|FG000|Overall Study|Lack of Efficacy|2|||
130564599|NCT01263483|470033680|FG001|Overall Study|Lack of Efficacy|0|||
130564600|NCT01263483|470033681|FG002|Overall Study|Lack of Efficacy|0|||
130564601|NCT01263483|470033679|FG000|Overall Study|Protocol Violation|0|||
130564602|NCT01263483|470033680|FG001|Overall Study|Protocol Violation|1|||
130422061|NCT02677116|469505804|FG003|Overall Study|Physician Decision|2|||
130422062|NCT02677116|469505805|FG004|Overall Study|Physician Decision|1|||
130422063|NCT02677116|469505806|FG005|Overall Study|Physician Decision|3|||
130422064|NCT02677116|469505807|FG006|Overall Study|Physician Decision|1|||
130422065|NCT02677116|469505808|FG007|Overall Study|Physician Decision|1|||
130422066|NCT02677116|469505809|FG008|Overall Study|Physician Decision|2|||
130564603|NCT01263483|470033681|FG002|Overall Study|Protocol Violation|1|||
130564604|NCT01263483|470033679|FG000|Overall Study|Participant Unavailability|0|||
130564605|NCT01263483|470033680|FG001|Overall Study|Participant Unavailability|1|||
130564606|NCT01263483|470033681|FG002|Overall Study|Participant Unavailability|1|||
130564607|NCT00326209|470033682|FG000|Overall Study|Adverse Event|28|||
130564608|NCT00326209|470033682|FG000|Overall Study|Withdrawal by Subject|22|||
130564609|NCT00326209|470033682|FG000|Overall Study|Lack of Efficacy|31|||
130422067|NCT02677116|469505801|FG000|Overall Study|Withdrawal by parent or guardian|2|||
130422068|NCT02677116|469505802|FG001|Overall Study|Withdrawal by parent or guardian|1|||
130422069|NCT02677116|469505803|FG002|Overall Study|Withdrawal by parent or guardian|0|||
130422070|NCT02677116|469505804|FG003|Overall Study|Withdrawal by parent or guardian|1|||
130422071|NCT02677116|469505805|FG004|Overall Study|Withdrawal by parent or guardian|0|||
130422072|NCT02677116|469505806|FG005|Overall Study|Withdrawal by parent or guardian|0|||
130422073|NCT02677116|469505807|FG006|Overall Study|Withdrawal by parent or guardian|2|||
130422074|NCT02677116|469505808|FG007|Overall Study|Withdrawal by parent or guardian|1|||
130422075|NCT02677116|469505809|FG008|Overall Study|Withdrawal by parent or guardian|0|||
130422076|NCT02677116|469505801|FG000|Overall Study|Withdrawal by Subject|1|||
130422077|NCT02677116|469505802|FG001|Overall Study|Withdrawal by Subject|0|||
130422078|NCT02677116|469505803|FG002|Overall Study|Withdrawal by Subject|0|||
130422079|NCT02677116|469505804|FG003|Overall Study|Withdrawal by Subject|0|||
130422080|NCT02677116|469505805|FG004|Overall Study|Withdrawal by Subject|0|||
130422081|NCT02677116|469505806|FG005|Overall Study|Withdrawal by Subject|0|||
130422082|NCT02677116|469505807|FG006|Overall Study|Withdrawal by Subject|0|||
130422083|NCT02677116|469505808|FG007|Overall Study|Withdrawal by Subject|0|||
130422084|NCT02677116|469505809|FG008|Overall Study|Withdrawal by Subject|0|||
130422085|NCT03182868|469505810|FG000|Overall Study|Protocol Violation|3|||
130422086|NCT03182868|469505811|FG001|Overall Study|Protocol Violation|0|||
130422087|NCT03182868|469505812|FG002|Overall Study|Protocol Violation|4|||
130422088|NCT03182868|469505813|FG003|Overall Study|Protocol Violation|1|||
130422089|NCT03182868|469505814|FG004|Overall Study|Protocol Violation|8|||
130422090|NCT02363946|469505816|FG000|Overall Study|Lost to Follow-up|0|||
130422091|NCT02363946|469505817|FG001|Overall Study|Lost to Follow-up|0|||
130422092|NCT02363946|469505818|FG002|Overall Study|Lost to Follow-up|0|||
130422093|NCT02363946|469505819|FG003|Overall Study|Lost to Follow-up|0|||
130422094|NCT02363946|469505820|FG004|Overall Study|Lost to Follow-up|0|||
130422095|NCT02363946|469505821|FG005|Overall Study|Lost to Follow-up|0|||
130422096|NCT02363946|469505822|FG006|Overall Study|Lost to Follow-up|0|||
130422097|NCT02363946|469505823|FG007|Overall Study|Lost to Follow-up|1|||
130422098|NCT02363946|469505824|FG008|Overall Study|Lost to Follow-up|0|||
130422099|NCT02363946|469505825|FG009|Overall Study|Lost to Follow-up|0|||
130422100|NCT02363946|469505826|FG010|Overall Study|Lost to Follow-up|0|||
130422101|NCT02363946|469505827|FG011|Overall Study|Lost to Follow-up|0|||
130422102|NCT02363946|469505828|FG012|Overall Study|Lost to Follow-up|0|||
130422103|NCT01967732|469505829|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130422104|NCT01967732|469505830|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
130422105|NCT01967732|469505831|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130422106|NCT01967732|469505832|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130422107|NCT01967732|469505829|FG000|First Intervention (Day 1)|Poor venous access|0|||
130422108|NCT01967732|469505830|FG001|First Intervention (Day 1)|Poor venous access|1|||
130422109|NCT01967732|469505831|FG002|First Intervention (Day 1)|Poor venous access|0|||
130422110|NCT01967732|469505832|FG003|First Intervention (Day 1)|Poor venous access|0|||
130422111|NCT03342638|469505833|FG000|Overall Study|Withdrawal by Subject|1|||
130422112|NCT03342638|469505834|FG001|Overall Study|Withdrawal by Subject|0|||
130422113|NCT03342638|469505833|FG000|Overall Study|Physician Decision|0|||
130422114|NCT03342638|469505834|FG001|Overall Study|Physician Decision|1|||
130422115|NCT00113568|469505850|FG000|Overall Study|Adverse Event|97|||
130422116|NCT00113568|469505850|FG000|Overall Study|Death|1|||
130422117|NCT00113568|469505850|FG000|Overall Study|Lack of Efficacy|30|||
130422118|NCT00113568|469505850|FG000|Overall Study|Lost to Follow-up|156|||
130422119|NCT00113568|469505850|FG000|Overall Study|Protocol Violation|32|||
130422120|NCT00113568|469505850|FG000|Overall Study|Withdrawal by Subject|117|||
130422121|NCT00113568|469505850|FG000|Overall Study|Other|112|||
130422122|NCT01292239|469505851|FG000|Overall Study|Other|1|||
130476156|NCT04927065|469711675|FG000|Second Booster|Physician Decision|0|||
130476157|NCT04927065|469711676|FG001|Second Booster|Physician Decision|0|||
130476158|NCT04927065|469711677|FG002|Second Booster|Physician Decision|0|||
130476159|NCT04927065|469711678|FG003|Second Booster|Physician Decision|0|||
130476160|NCT04927065|469711679|FG004|Second Booster|Physician Decision|0|||
130727491|NCT05048329|470625468|FG000|Overall Study|Screenfail|1|||
130422123|NCT01292239|469505852|FG001|Overall Study|Other|1|||
130422124|NCT01292239|469505851|FG000|Overall Study|Withdrawal by Subject|3|||
130422125|NCT01292239|469505852|FG001|Overall Study|Withdrawal by Subject|6|||
130422126|NCT00262821|469505853|FG000|Overall Study|Ineligible - wrong stage|0|||
130422127|NCT00262821|469505854|FG001|Overall Study|Ineligible - wrong stage|3|||
130422128|NCT00262821|469505853|FG000|Overall Study|Ineligible - wrong cell type|2|||
130476161|NCT04927065|469711680|FG005|Second Booster|Physician Decision|0|||
130476162|NCT04927065|469711681|FG006|Second Booster|Physician Decision|0|||
130476163|NCT04927065|469711682|FG007|Second Booster|Physician Decision|0|||
130422129|NCT00262821|469505854|FG001|Overall Study|Ineligible - wrong cell type|2|||
130422130|NCT00262821|469505853|FG000|Overall Study|Ineligible - wrong primary|0|||
130422131|NCT00262821|469505854|FG001|Overall Study|Ineligible - wrong primary|1|||
130422132|NCT00262821|469505853|FG000|Overall Study|Ineligible - inadequate pathology|1|||
130476164|NCT04927065|469711683|FG008|Second Booster|Physician Decision|0|||
130422133|NCT00262821|469505854|FG001|Overall Study|Ineligible - inadequate pathology|3|||
130422134|NCT00262821|469505853|FG000|Overall Study|Ineligible - elevated creatinine|0|||
130422135|NCT00262821|469505854|FG001|Overall Study|Ineligible - elevated creatinine|2|||
130422136|NCT00262821|469505853|FG000|Overall Study|Ineligible - required test not done|1|||
130422137|NCT00262821|469505854|FG001|Overall Study|Ineligible - required test not done|4|||
130422138|NCT00262821|469505853|FG000|Overall Study|Inevaluable - inadequate data|0|||
130422139|NCT00262821|469505854|FG001|Overall Study|Inevaluable - inadequate data|4|||
130422140|NCT01988779|469505856|FG000|Overall Study|Withdrawal by Subject|2|||
130422141|NCT01988779|469505857|FG001|Overall Study|Withdrawal by Subject|2|||
130422142|NCT01988779|469505856|FG000|Overall Study|Protocol Violation|1|||
130422143|NCT01988779|469505857|FG001|Overall Study|Protocol Violation|0|||
130422144|NCT00584727|469505858|FG000|First Intervention|Discontinuation|0|||
130422145|NCT00584727|469505859|FG001|First Intervention|Discontinuation|0|||
130422146|NCT00584727|469505860|FG002|First Intervention|Discontinuation|1|||
130422147|NCT00584727|469505861|FG003|First Intervention|Discontinuation|0|||
130422148|NCT00584727|469505862|FG004|First Intervention|Discontinuation|0|||
130422149|NCT00584727|469505863|FG005|First Intervention|Discontinuation|0|||
130422150|NCT00584727|469505858|FG000|Third Intervention|Protocol Violation|0|||
130422151|NCT00584727|469505859|FG001|Third Intervention|Protocol Violation|0|||
130422152|NCT00584727|469505860|FG002|Third Intervention|Protocol Violation|1|||
130422153|NCT00584727|469505861|FG003|Third Intervention|Protocol Violation|0|||
130422154|NCT00584727|469505862|FG004|Third Intervention|Protocol Violation|4|||
130422155|NCT00584727|469505863|FG005|Third Intervention|Protocol Violation|2|||
130422156|NCT00377403|469505865|FG000|Overall Study|Unable to contact for telephone intervie|4|||
130422157|NCT00377403|469505866|FG001|Overall Study|Unable to contact for telephone intervie|7|||
130422158|NCT01922076|469505867|FG000|Overall Study|Adverse Event|0|||
130476165|NCT04927065|469711684|FG009|Second Booster|Physician Decision|0|||
130476166|NCT04927065|469711685|FG010|Second Booster|Physician Decision|0|||
130476167|NCT04927065|469711686|FG011|Second Booster|Physician Decision|3|||
130476168|NCT04927065|469711687|FG012|Second Booster|Physician Decision|0|||
130476169|NCT04927065|469711688|FG013|Second Booster|Physician Decision|1|||
130476170|NCT04927065|469711689|FG014|Second Booster|Physician Decision|0|||
130476171|NCT04927065|469711690|FG015|Second Booster|Physician Decision|0|||
130476172|NCT04927065|469711675|FG000|Second Booster|Withdrawal by Subject|0|||
130476173|NCT04927065|469711676|FG001|Second Booster|Withdrawal by Subject|0|||
130476174|NCT04927065|469711677|FG002|Second Booster|Withdrawal by Subject|4|||
130476175|NCT04927065|469711678|FG003|Second Booster|Withdrawal by Subject|0|||
130476176|NCT04927065|469711679|FG004|Second Booster|Withdrawal by Subject|0|||
130476177|NCT04927065|469711680|FG005|Second Booster|Withdrawal by Subject|0|||
130422159|NCT01922076|469505868|FG001|Overall Study|Adverse Event|0|||
130422160|NCT01922076|469505869|FG002|Overall Study|Adverse Event|0|||
130422161|NCT01922076|469505870|FG003|Overall Study|Adverse Event|0|||
130422162|NCT01922076|469505871|FG004|Overall Study|Adverse Event|1|||
130422163|NCT01922076|469505872|FG005|Overall Study|Adverse Event|0|||
130422164|NCT01922076|469505873|FG006|Overall Study|Adverse Event|0|||
130422165|NCT01922076|469505867|FG000|Overall Study|Physician Decision|0|||
130422166|NCT01922076|469505868|FG001|Overall Study|Physician Decision|0|||
130422167|NCT01922076|469505869|FG002|Overall Study|Physician Decision|1|||
130422168|NCT01922076|469505870|FG003|Overall Study|Physician Decision|0|||
130422169|NCT01922076|469505871|FG004|Overall Study|Physician Decision|0|||
130422170|NCT01922076|469505872|FG005|Overall Study|Physician Decision|0|||
130422171|NCT01922076|469505873|FG006|Overall Study|Physician Decision|0|||
130422172|NCT01922076|469505867|FG000|Overall Study|Withdrawal by Subject|0|||
130476178|NCT04927065|469711681|FG006|Second Booster|Withdrawal by Subject|0|||
130422173|NCT01922076|469505868|FG001|Overall Study|Withdrawal by Subject|0|||
130476179|NCT04927065|469711682|FG007|Second Booster|Withdrawal by Subject|0|||
130476180|NCT04927065|469711683|FG008|Second Booster|Withdrawal by Subject|0|||
130476181|NCT04927065|469711684|FG009|Second Booster|Withdrawal by Subject|0|||
130476182|NCT04927065|469711685|FG010|Second Booster|Withdrawal by Subject|3|||
130476183|NCT04927065|469711686|FG011|Second Booster|Withdrawal by Subject|16|||
130476184|NCT04927065|469711687|FG012|Second Booster|Withdrawal by Subject|13|||
130476185|NCT04927065|469711688|FG013|Second Booster|Withdrawal by Subject|9|||
130476186|NCT04927065|469711689|FG014|Second Booster|Withdrawal by Subject|0|||
130476187|NCT04927065|469711690|FG015|Second Booster|Withdrawal by Subject|0|||
130422174|NCT01922076|469505869|FG002|Overall Study|Withdrawal by Subject|0|||
130422175|NCT01922076|469505870|FG003|Overall Study|Withdrawal by Subject|1|||
130476188|NCT04927065|469711675|FG000|Second Booster|Other Than Specified|0|||
130564610|NCT00326209|470033682|FG000|Overall Study|Lost to Follow-up|18|||
130422176|NCT01922076|469505871|FG004|Overall Study|Withdrawal by Subject|0|||
130422177|NCT01922076|469505872|FG005|Overall Study|Withdrawal by Subject|1|||
130422178|NCT01922076|469505873|FG006|Overall Study|Withdrawal by Subject|1|||
130422179|NCT01018394|469505876|FG000|Overall Study|Withdrawal by Subject|5|||
130476189|NCT04927065|469711676|FG001|Second Booster|Other Than Specified|0|||
130476190|NCT04927065|469711677|FG002|Second Booster|Other Than Specified|0|||
130476191|NCT04927065|469711678|FG003|Second Booster|Other Than Specified|0|||
130422180|NCT01018394|469505877|FG001|Overall Study|Withdrawal by Subject|5|||
130422181|NCT01018394|469505876|FG000|Overall Study|Lost to Follow-up|4|||
130422182|NCT01018394|469505877|FG001|Overall Study|Lost to Follow-up|3|||
130422183|NCT00683644|469505878|FG000|Overall Study|Withdrawal by Subject|4|||
130422184|NCT00683644|469505879|FG001|Overall Study|Withdrawal by Subject|2|||
130422185|NCT00683644|469505878|FG000|Overall Study|Lost to Follow-up|1|||
130422186|NCT00683644|469505879|FG001|Overall Study|Lost to Follow-up|4|||
130422187|NCT00683644|469505878|FG000|Overall Study|Adverse Event|1|||
130422188|NCT00683644|469505879|FG001|Overall Study|Adverse Event|2|||
130422189|NCT00683644|469505878|FG000|Overall Study|Low copper, other health problems,|7|||
130422190|NCT00683644|469505879|FG001|Overall Study|Low copper, other health problems,|6|||
130422191|NCT01669122|469505882|FG000|Period I|Lost to Follow-up|1|||
130422192|NCT01669122|469505882|FG000|Washout Period II|Protocol Violation|2|||
130422193|NCT03762473|469505883|FG000|Overall Study|Death|1|||
130422194|NCT03762473|469505884|FG001|Overall Study|Death|0|||
130422195|NCT05132699|469505885|FG000|Overall Study|Withdrawal by Subject|3|||
130422196|NCT05132699|469505886|FG001|Overall Study|Withdrawal by Subject|0|||
130422197|NCT02858895|469505889|FG000|Overall Study|Disease progression|31|||
130422198|NCT02858895|469505889|FG000|Overall Study|Death|2|||
130422199|NCT02858895|469505889|FG000|Overall Study|Adverse Event|1|||
130422200|NCT02858895|469505889|FG000|Overall Study|Withdrawal by Subject|3|||
130422201|NCT02858895|469505889|FG000|Overall Study|hospice,|1|||
130422202|NCT02858895|469505889|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
130422203|NCT02277444|469505898|FG000|Overall Study|Adverse Event|10|||
130422204|NCT02277444|469505898|FG000|Overall Study|Withdrawal by Subject|3|||
130422205|NCT02277444|469505898|FG000|Overall Study|Other|1|||
130422206|NCT02277444|469505898|FG000|Overall Study|Enrolled and not Treated|3|||
130422207|NCT02277444|469505898|FG000|Overall Study|Ongoing|113|||
130422208|NCT03576768|469508238|FG000|Overall Study|Lost to Follow-up|3|||
130422209|NCT03576768|469508239|FG001|Overall Study|Lost to Follow-up|3|||
130422210|NCT03576768|469508240|FG002|Overall Study|Lost to Follow-up|0|||
130422211|NCT03576768|469508241|FG003|Overall Study|Lost to Follow-up|0|||
130422212|NCT00785291|469508242|FG000|Overall Study|Never began treatment|8|||
130422213|NCT00785291|469508243|FG001|Overall Study|Never began treatment|4|||
130422214|NCT00785291|469508244|FG002|Overall Study|Never began treatment|4|||
130422215|NCT00785291|469508242|FG000|Overall Study|Adverse Event|39|||
130422216|NCT00785291|469508243|FG001|Overall Study|Adverse Event|70|||
130422217|NCT00785291|469508244|FG002|Overall Study|Adverse Event|56|||
130422218|NCT00785291|469508242|FG000|Overall Study|Death|7|||
130422219|NCT00785291|469508243|FG001|Overall Study|Death|4|||
130422220|NCT00785291|469508244|FG002|Overall Study|Death|3|||
130422221|NCT00785291|469508242|FG000|Overall Study|Withdrawal by Subject|35|||
130422222|NCT00785291|469508243|FG001|Overall Study|Withdrawal by Subject|36|||
130422223|NCT00785291|469508244|FG002|Overall Study|Withdrawal by Subject|17|||
130422224|NCT00785291|469508242|FG000|Overall Study|Alternative Therapy|12|||
130422225|NCT00785291|469508243|FG001|Overall Study|Alternative Therapy|6|||
130422226|NCT00785291|469508244|FG002|Overall Study|Alternative Therapy|7|||
130422227|NCT00785291|469508242|FG000|Overall Study|Complicating illness|6|||
130422228|NCT00785291|469508243|FG001|Overall Study|Complicating illness|4|||
130422229|NCT00785291|469508244|FG002|Overall Study|Complicating illness|4|||
130422230|NCT00785291|469508242|FG000|Overall Study|Other Medical Reasons|29|||
130422231|NCT00785291|469508243|FG001|Overall Study|Other Medical Reasons|25|||
130422232|NCT00785291|469508244|FG002|Overall Study|Other Medical Reasons|15|||
130422233|NCT02979639|469508245|FG000|Overall Study|Withdrawal based on medical judgement|1|||
130422234|NCT02979639|469508245|FG000|Overall Study|Lost to Follow-up|8|||
130422235|NCT02979639|469508245|FG000|Overall Study|Withdrawal by Subject|3|||
130422236|NCT02979639|469508245|FG000|Overall Study|Adverse Event|2|||
130422237|NCT04050865|469508246|FG000|Overall Study|Adverse Event|1|||
130422238|NCT04050865|469508247|FG001|Overall Study|Adverse Event|0|||
130422239|NCT04050865|469508246|FG000|Overall Study|no insert|1|||
130476192|NCT04927065|469711679|FG004|Second Booster|Other Than Specified|0|||
130476193|NCT04927065|469711680|FG005|Second Booster|Other Than Specified|0|||
130422240|NCT04050865|469508247|FG001|Overall Study|no insert|0|||
130422241|NCT04050865|469508246|FG000|Overall Study|Only 1 insert|2|||
130422242|NCT04050865|469508247|FG001|Overall Study|Only 1 insert|3|||
130422243|NCT04050865|469508246|FG000|Overall Study|Physician Decision|0|||
130422244|NCT04050865|469508247|FG001|Overall Study|Physician Decision|1|||
130422245|NCT04050865|469508246|FG000|Overall Study|Withdrawal by Subject|0|||
130422246|NCT04050865|469508247|FG001|Overall Study|Withdrawal by Subject|1|||
130422247|NCT04205630|469508256|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
130422248|NCT04205630|469508256|FG000|Overall Study|Disease clinical progression|7|||
130422249|NCT04205630|469508256|FG000|Overall Study|Withdrawal by Subject|2|||
130422250|NCT04205630|469508256|FG000|Overall Study|Adverse Event|17|||
130422251|NCT04205630|469508256|FG000|Overall Study|Other|1|||
130422252|NCT03232983|469508265|FG000|Period 1|Physician Decision|0|||
130476194|NCT04927065|469711681|FG006|Second Booster|Other Than Specified|0|||
130422253|NCT03232983|469508266|FG001|Period 1|Physician Decision|0|||
130422254|NCT03232983|469508267|FG002|Period 1|Physician Decision|1|||
130422255|NCT03232983|469508268|FG003|Period 1|Physician Decision|0|||
130422256|NCT03232983|469508265|FG000|Washout Period 2|Physician Decision|0|||
130422257|NCT03232983|469508266|FG001|Washout Period 2|Physician Decision|0|||
130422258|NCT03232983|469508267|FG002|Washout Period 2|Physician Decision|1|||
130476195|NCT04927065|469711682|FG007|Second Booster|Other Than Specified|0|||
130476196|NCT04927065|469711683|FG008|Second Booster|Other Than Specified|0|||
130476197|NCT04927065|469711684|FG009|Second Booster|Other Than Specified|0|||
130476198|NCT04927065|469711685|FG010|Second Booster|Other Than Specified|1|||
130422259|NCT03232983|469508268|FG003|Washout Period 2|Physician Decision|0|||
130422260|NCT03232983|469508265|FG000|Washout Period 2|Withdrawal by Subject|0|||
130422261|NCT03232983|469508266|FG001|Washout Period 2|Withdrawal by Subject|0|||
130422262|NCT03232983|469508267|FG002|Washout Period 2|Withdrawal by Subject|0|||
130422263|NCT03232983|469508268|FG003|Washout Period 2|Withdrawal by Subject|1|||
130422264|NCT03232983|469508265|FG000|Period 4|Withdrawal by Subject|1|||
130422265|NCT03232983|469508266|FG001|Period 4|Withdrawal by Subject|0|||
130422266|NCT03232983|469508267|FG002|Period 4|Withdrawal by Subject|0|||
130422267|NCT03232983|469508268|FG003|Period 4|Withdrawal by Subject|0|||
130422268|NCT01627327|469508269|FG000|Overall Study|Adverse Event|6|||
130422269|NCT01627327|469508270|FG001|Overall Study|Adverse Event|12|||
130422270|NCT01627327|469508269|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
130422271|NCT01627327|469508270|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
130422272|NCT01627327|469508269|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
130422273|NCT01627327|469508270|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
130422274|NCT01627327|469508269|FG000|Overall Study|Protocol Violation|4|||
130422275|NCT01627327|469508270|FG001|Overall Study|Protocol Violation|10|||
130422276|NCT01627327|469508269|FG000|Overall Study|Lost to Follow-up|1|||
130422277|NCT01627327|469508270|FG001|Overall Study|Lost to Follow-up|3|||
130422278|NCT01627327|469508269|FG000|Overall Study|Physician Decision|1|||
130422279|NCT01627327|469508270|FG001|Overall Study|Physician Decision|0|||
130422280|NCT01627327|469508269|FG000|Overall Study|Withdrawal by Subject|3|||
130422281|NCT01627327|469508270|FG001|Overall Study|Withdrawal by Subject|3|||
130422282|NCT04528069|469508274|FG000|Overall Study|Adverse Event|1|||
130422283|NCT04528069|469508274|FG000|Overall Study|Lost to Follow-up|1|||
130422284|NCT04528069|469508274|FG000|Overall Study|Patient Unable to Come|1|||
130422285|NCT04528069|469508274|FG000|Overall Study|Patient Unable to Attend|1|||
130422286|NCT02525874|469508275|FG000|Overall Study|Other|1|||
130422287|NCT02525874|469508275|FG000|Overall Study|Investigator Decision|1|||
130422288|NCT02525874|469508275|FG000|Overall Study|Consent withdrawn|22|||
130422289|NCT02525874|469508275|FG000|Overall Study|Non-compliance with study drug|3|||
130422290|NCT02525874|469508275|FG000|Overall Study|Adverse Event|17|||
130422291|NCT02525874|469508275|FG000|Overall Study|Lost to Follow-up|7|||
130422292|NCT02525874|469508275|FG000|Overall Study|Disease progression, defined by protocol|2|||
130422293|NCT02525874|469508275|FG000|Overall Study|Disease relapse|4|||
130422294|NCT02525874|469508275|FG000|Overall Study|Alternative Treatment for MS|2|||
130422295|NCT02525874|469508275|FG000|Overall Study|New lesions in Brain|1|||
130422296|NCT04794803|469508288|FG000|Overall Study|Death|1|||
130422297|NCT04794803|469508289|FG001|Overall Study|Death|3|||
130422298|NCT04794803|469508288|FG000|Overall Study|Lost to Follow-up|2|||
130422299|NCT04794803|469508289|FG001|Overall Study|Lost to Follow-up|2|||
130422300|NCT04794803|469508288|FG000|Overall Study|Withdrawal by Subject|1|||
130422301|NCT04794803|469508289|FG001|Overall Study|Withdrawal by Subject|0|||
130422302|NCT04794803|469508288|FG000|Overall Study|Physician Decision|1|||
130422303|NCT04794803|469508289|FG001|Overall Study|Physician Decision|1|||
130422304|NCT04794803|469508288|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
130422305|NCT04794803|469508289|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
130422306|NCT04794803|469508288|FG000|Overall Study|Refused to continue the treatment|1|||
130422307|NCT04794803|469508289|FG001|Overall Study|Refused to continue the treatment|0|||
130422308|NCT04794803|469508288|FG000|Overall Study|Patient admitted to ICU|0|||
130422309|NCT04794803|469508289|FG001|Overall Study|Patient admitted to ICU|1|||
130476199|NCT04927065|469711686|FG011|Second Booster|Other Than Specified|1|||
130476200|NCT04927065|469711687|FG012|Second Booster|Other Than Specified|4|||
130476201|NCT04927065|469711688|FG013|Second Booster|Other Than Specified|0|||
130476202|NCT04927065|469711689|FG014|Second Booster|Other Than Specified|0|||
130422310|NCT04124926|469508290|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
130422311|NCT04124926|469508291|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
130422312|NCT04124926|469508292|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
130422313|NCT04124926|469508293|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
130422314|NCT04124926|469508294|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
130476203|NCT04927065|469711690|FG015|Second Booster|Other Than Specified|0|||
130422315|NCT04124926|469508290|FG000|Healing Phase|Protocol Violation|0|||
130422316|NCT04124926|469508291|FG001|Healing Phase|Protocol Violation|1|||
130422317|NCT04124926|469508292|FG002|Healing Phase|Protocol Violation|0|||
130422318|NCT04124926|469508293|FG003|Healing Phase|Protocol Violation|0|||
130422319|NCT04124926|469508294|FG004|Healing Phase|Protocol Violation|0|||
130422320|NCT04124926|469508290|FG000|Healing Phase|Lost to Follow-up|5|||
130422321|NCT04124926|469508291|FG001|Healing Phase|Lost to Follow-up|4|||
130476204|NCT04927065|469711675|FG000|Third Booster|Lost to Follow-up|0|||
130476205|NCT04927065|469711676|FG001|Third Booster|Lost to Follow-up|0|||
130422322|NCT04124926|469508292|FG002|Healing Phase|Lost to Follow-up|0|||
130422323|NCT04124926|469508293|FG003|Healing Phase|Lost to Follow-up|0|||
130422324|NCT04124926|469508294|FG004|Healing Phase|Lost to Follow-up|0|||
130422325|NCT04124926|469508290|FG000|Healing Phase|Voluntary Withdrawal|10|||
130422326|NCT04124926|469508291|FG001|Healing Phase|Voluntary Withdrawal|7|||
130422327|NCT04124926|469508292|FG002|Healing Phase|Voluntary Withdrawal|0|||
130422328|NCT04124926|469508293|FG003|Healing Phase|Voluntary Withdrawal|0|||
130422329|NCT04124926|469508294|FG004|Healing Phase|Voluntary Withdrawal|0|||
130422330|NCT04124926|469508290|FG000|Healing Phase|Withdrawal of Consent|5|||
130422331|NCT04124926|469508291|FG001|Healing Phase|Withdrawal of Consent|3|||
130422332|NCT04124926|469508292|FG002|Healing Phase|Withdrawal of Consent|0|||
130422333|NCT04124926|469508293|FG003|Healing Phase|Withdrawal of Consent|0|||
130422334|NCT04124926|469508294|FG004|Healing Phase|Withdrawal of Consent|0|||
130422335|NCT04124926|469508290|FG000|Healing Phase|Miscellaneous|8|||
130422336|NCT04124926|469508291|FG001|Healing Phase|Miscellaneous|7|||
130422337|NCT04124926|469508292|FG002|Healing Phase|Miscellaneous|0|||
130422338|NCT04124926|469508293|FG003|Healing Phase|Miscellaneous|0|||
130422339|NCT04124926|469508294|FG004|Healing Phase|Miscellaneous|0|||
130422340|NCT04124926|469508290|FG000|Healing Phase|Randomized but not Treated|0|||
130422341|NCT04124926|469508291|FG001|Healing Phase|Randomized but not Treated|3|||
130422342|NCT04124926|469508292|FG002|Healing Phase|Randomized but not Treated|0|||
130422343|NCT04124926|469508293|FG003|Healing Phase|Randomized but not Treated|0|||
130422344|NCT04124926|469508294|FG004|Healing Phase|Randomized but not Treated|0|||
130422345|NCT04124926|469508290|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
130422346|NCT04124926|469508291|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
130422347|NCT04124926|469508292|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
130422348|NCT04124926|469508293|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
130422349|NCT04124926|469508294|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
130422350|NCT04124926|469508290|FG000|Maintenance Phase|Protocol Violation|0|||
130422351|NCT04124926|469508291|FG001|Maintenance Phase|Protocol Violation|0|||
130422352|NCT04124926|469508292|FG002|Maintenance Phase|Protocol Violation|3|||
130422353|NCT04124926|469508293|FG003|Maintenance Phase|Protocol Violation|0|||
130422354|NCT04124926|469508294|FG004|Maintenance Phase|Protocol Violation|0|||
130422355|NCT04124926|469508290|FG000|Maintenance Phase|Lost to Follow-up|0|||
130422356|NCT04124926|469508291|FG001|Maintenance Phase|Lost to Follow-up|0|||
130422357|NCT04124926|469508292|FG002|Maintenance Phase|Lost to Follow-up|7|||
130422358|NCT04124926|469508293|FG003|Maintenance Phase|Lost to Follow-up|8|||
130422359|NCT04124926|469508294|FG004|Maintenance Phase|Lost to Follow-up|9|||
130422360|NCT04124926|469508290|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
130422361|NCT04124926|469508291|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
130422362|NCT04124926|469508292|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
130422363|NCT04124926|469508293|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
130422364|NCT04124926|469508294|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
130422365|NCT04124926|469508290|FG000|Maintenance Phase|Pregnancy|0|||
130422366|NCT04124926|469508291|FG001|Maintenance Phase|Pregnancy|0|||
130422367|NCT04124926|469508292|FG002|Maintenance Phase|Pregnancy|0|||
130422368|NCT04124926|469508293|FG003|Maintenance Phase|Pregnancy|1|||
130422369|NCT04124926|469508294|FG004|Maintenance Phase|Pregnancy|0|||
130422370|NCT04124926|469508290|FG000|Maintenance Phase|Lack of Efficacy|0|||
130422371|NCT04124926|469508291|FG001|Maintenance Phase|Lack of Efficacy|0|||
130422372|NCT04124926|469508292|FG002|Maintenance Phase|Lack of Efficacy|0|||
130422373|NCT04124926|469508293|FG003|Maintenance Phase|Lack of Efficacy|0|||
130422374|NCT04124926|469508294|FG004|Maintenance Phase|Lack of Efficacy|1|||
130422375|NCT04124926|469508290|FG000|Maintenance Phase|Withdrawal of Consent|0|||
130422376|NCT04124926|469508291|FG001|Maintenance Phase|Withdrawal of Consent|0|||
130476206|NCT04927065|469711677|FG002|Third Booster|Lost to Follow-up|0|||
130476207|NCT04927065|469711678|FG003|Third Booster|Lost to Follow-up|0|||
130476208|NCT04927065|469711679|FG004|Third Booster|Lost to Follow-up|0|||
130476209|NCT04927065|469711680|FG005|Third Booster|Lost to Follow-up|0|||
130476210|NCT04927065|469711681|FG006|Third Booster|Lost to Follow-up|0|||
130476211|NCT04927065|469711682|FG007|Third Booster|Lost to Follow-up|0|||
130422377|NCT04124926|469508292|FG002|Maintenance Phase|Withdrawal of Consent|5|||
130422378|NCT04124926|469508293|FG003|Maintenance Phase|Withdrawal of Consent|5|||
130422379|NCT04124926|469508294|FG004|Maintenance Phase|Withdrawal of Consent|5|||
130422380|NCT04124926|469508290|FG000|Maintenance Phase|Miscellaneous|0|||
130422381|NCT04124926|469508291|FG001|Maintenance Phase|Miscellaneous|0|||
130422382|NCT04124926|469508292|FG002|Maintenance Phase|Miscellaneous|1|||
130422383|NCT04124926|469508293|FG003|Maintenance Phase|Miscellaneous|2|||
130422384|NCT04124926|469508294|FG004|Maintenance Phase|Miscellaneous|4|||
130422385|NCT04124926|469508290|FG000|Maintenance Phase|Randomized but not Treated|0|||
130422386|NCT04124926|469508291|FG001|Maintenance Phase|Randomized but not Treated|0|||
130422387|NCT04124926|469508292|FG002|Maintenance Phase|Randomized but not Treated|2|||
130422388|NCT04124926|469508293|FG003|Maintenance Phase|Randomized but not Treated|2|||
130476212|NCT04927065|469711683|FG008|Third Booster|Lost to Follow-up|0|||
130476213|NCT04927065|469711684|FG009|Third Booster|Lost to Follow-up|0|||
130422389|NCT04124926|469508294|FG004|Maintenance Phase|Randomized but not Treated|0|||
130422390|NCT00423176|469508295|FG000|Overall Study|Adverse Event|4|||
130422391|NCT00423176|469508296|FG001|Overall Study|Adverse Event|6|||
130422392|NCT00423176|469508295|FG000|Overall Study|Treatment Failure|1|||
130422393|NCT00423176|469508296|FG001|Overall Study|Treatment Failure|6|||
130422394|NCT00423176|469508295|FG000|Overall Study|Lost to Follow-up|4|||
130422395|NCT00423176|469508296|FG001|Overall Study|Lost to Follow-up|7|||
130422396|NCT00423176|469508295|FG000|Overall Study|Withdrawal by Subject|4|||
130422397|NCT00423176|469508296|FG001|Overall Study|Withdrawal by Subject|3|||
130422398|NCT00423176|469508295|FG000|Overall Study|Protocol Violation|1|||
130422399|NCT00423176|469508296|FG001|Overall Study|Protocol Violation|3|||
130422400|NCT00423176|469508295|FG000|Overall Study|Did not meet protocol eligibility|2|||
130422401|NCT00423176|469508296|FG001|Overall Study|Did not meet protocol eligibility|4|||
130422402|NCT04867369|469508299|FG000|Overall Study|Withdrawal by Subject|1|||
130422403|NCT04867369|469508300|FG001|Overall Study|Withdrawal by Subject|0|||
130422404|NCT05554237|469508301|FG000|Part 2 (7 Days)|Adverse Event|0|||
130422405|NCT05554237|469508302|FG001|Part 2 (7 Days)|Adverse Event|0|||
130422406|NCT05554237|469508303|FG002|Part 2 (7 Days)|Adverse Event|0|||
130422407|NCT05554237|469508304|FG003|Part 2 (7 Days)|Adverse Event|0|||
130422408|NCT05554237|469508305|FG004|Part 2 (7 Days)|Adverse Event|2|||
130422409|NCT05554237|469508306|FG005|Part 2 (7 Days)|Adverse Event|0|||
130422410|NCT05554237|469508307|FG006|Part 2 (7 Days)|Adverse Event|0|||
130422411|NCT05554237|469508308|FG007|Part 2 (7 Days)|Adverse Event|0|||
130422412|NCT05554237|469508309|FG008|Part 2 (7 Days)|Adverse Event|0|||
130422413|NCT05554237|469508310|FG009|Part 2 (7 Days)|Adverse Event|1|||
130422414|NCT05554237|469508311|FG010|Part 2 (7 Days)|Adverse Event|0|||
130422415|NCT05554237|469508312|FG011|Part 2 (7 Days)|Adverse Event|0|||
130422416|NCT05554237|469508313|FG012|Part 2 (7 Days)|Adverse Event|1|||
130422417|NCT05554237|469508314|FG013|Part 2 (7 Days)|Adverse Event|0|||
130422418|NCT04435366|469508315|FG000|Year 1 (12 Months)|Adverse Event|3|||
130422419|NCT04435366|469508316|FG001|Year 1 (12 Months)|Adverse Event|0|||
130422420|NCT04435366|469508317|FG002|Year 1 (12 Months)|Adverse Event|2|||
130422421|NCT04435366|469508315|FG000|Year 1 (12 Months)|Death|2|||
130422422|NCT04435366|469508316|FG001|Year 1 (12 Months)|Death|0|||
130422423|NCT04435366|469508317|FG002|Year 1 (12 Months)|Death|1|||
130422424|NCT04435366|469508315|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
130422425|NCT04435366|469508316|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
130422426|NCT04435366|469508317|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
130422427|NCT04435366|469508315|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
130422428|NCT04435366|469508316|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
130422429|NCT04435366|469508317|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
130422430|NCT04435366|469508315|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
130422431|NCT04435366|469508316|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
130422432|NCT04435366|469508317|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
130422433|NCT04435366|469508315|FG000|Year 1 (12 Months)|Not treated|0|||
130422434|NCT04435366|469508316|FG001|Year 1 (12 Months)|Not treated|0|||
130422435|NCT04435366|469508317|FG002|Year 1 (12 Months)|Not treated|1|||
130422436|NCT04435366|469508315|FG000|Year 2 (12 Months)|Death|1|||
130422437|NCT04435366|469508316|FG001|Year 2 (12 Months)|Death|4|||
130422438|NCT04435366|469508317|FG002|Year 2 (12 Months)|Death|6|||
130422439|NCT04435366|469508315|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
130422440|NCT04435366|469508316|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
130422441|NCT04435366|469508317|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
130422442|NCT04435366|469508315|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
130476214|NCT04927065|469711685|FG010|Third Booster|Lost to Follow-up|0|||
130476215|NCT04927065|469711686|FG011|Third Booster|Lost to Follow-up|0|||
130476216|NCT04927065|469711687|FG012|Third Booster|Lost to Follow-up|0|||
130476217|NCT04927065|469711688|FG013|Third Booster|Lost to Follow-up|0|||
130476218|NCT04927065|469711689|FG014|Third Booster|Lost to Follow-up|0|||
130422443|NCT04435366|469508316|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
130422444|NCT04435366|469508317|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
130422445|NCT04435366|469508315|FG000|Year 2 (12 Months)|Adverse Event|2|||
130422446|NCT04435366|469508316|FG001|Year 2 (12 Months)|Adverse Event|1|||
130422447|NCT04435366|469508317|FG002|Year 2 (12 Months)|Adverse Event|6|||
130422448|NCT03896035|469508321|FG000|Overall Study|Lost to Follow-up|2|||
130422449|NCT03896035|469508322|FG001|Overall Study|Lost to Follow-up|6|||
130422450|NCT03896035|469508321|FG000|Overall Study|Withdrawal by Subject|0|||
130422451|NCT03896035|469508322|FG001|Overall Study|Withdrawal by Subject|1|||
130422452|NCT03896035|469508321|FG000|Overall Study|Health/family health issues during COVID|0|||
130422453|NCT03896035|469508322|FG001|Overall Study|Health/family health issues during COVID|4|||
130422454|NCT03492281|469508323|FG000|Overall Study|Withdrawal by Subject|21|||
130422455|NCT03492281|469508324|FG001|Overall Study|Withdrawal by Subject|14|||
130422456|NCT03492281|469508325|FG002|Overall Study|Withdrawal by Subject|13|||
130422457|NCT03492281|469508323|FG000|Overall Study|Lost to Follow-up|14|||
130422458|NCT03492281|469508324|FG001|Overall Study|Lost to Follow-up|15|||
130422459|NCT03492281|469508325|FG002|Overall Study|Lost to Follow-up|10|||
130422460|NCT03492281|469508323|FG000|Overall Study|Adverse Event|6|||
130476219|NCT04927065|469711690|FG015|Third Booster|Lost to Follow-up|1|||
130476220|NCT04927065|469711675|FG000|Third Booster|Withdrawal by Subject|0|||
130422461|NCT03492281|469508324|FG001|Overall Study|Adverse Event|8|||
130422462|NCT03492281|469508325|FG002|Overall Study|Adverse Event|13|||
130422463|NCT03492281|469508323|FG000|Overall Study|Lack of Efficacy|3|||
130422464|NCT03492281|469508324|FG001|Overall Study|Lack of Efficacy|0|||
130422465|NCT03492281|469508325|FG002|Overall Study|Lack of Efficacy|1|||
130422466|NCT03492281|469508323|FG000|Overall Study|Physician Decision|1|||
130422467|NCT03492281|469508324|FG001|Overall Study|Physician Decision|0|||
130422468|NCT03492281|469508325|FG002|Overall Study|Physician Decision|3|||
130422469|NCT03492281|469508323|FG000|Overall Study|Protocol Violation|0|||
130422470|NCT03492281|469508324|FG001|Overall Study|Protocol Violation|2|||
130422471|NCT03492281|469508325|FG002|Overall Study|Protocol Violation|1|||
130422472|NCT03492281|469508323|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
130422473|NCT03492281|469508324|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
130422474|NCT03492281|469508325|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
130422475|NCT03492281|469508323|FG000|Overall Study|Death|0|||
130422476|NCT03492281|469508324|FG001|Overall Study|Death|0|||
130422477|NCT03492281|469508325|FG002|Overall Study|Death|1|||
130422478|NCT03492281|469508323|FG000|Overall Study|Captured as Other in Database|8|||
130422479|NCT03492281|469508324|FG001|Overall Study|Captured as Other in Database|6|||
130422480|NCT03492281|469508325|FG002|Overall Study|Captured as Other in Database|3|||
130422481|NCT01506193|469508326|FG000|Overall Study|Protocol Violation|1|||
130422482|NCT01506193|469508327|FG001|Overall Study|Protocol Violation|0|||
130422483|NCT01506193|469508328|FG002|Overall Study|Protocol Violation|1|||
130422484|NCT01506193|469508326|FG000|Overall Study|Migrated/moved from study area|0|||
130422485|NCT01506193|469508327|FG001|Overall Study|Migrated/moved from study area|0|||
130422486|NCT01506193|469508328|FG002|Overall Study|Migrated/moved from study area|1|||
130422487|NCT01506193|469508326|FG000|Overall Study|Adverse event, non-fatal|0|||
130422488|NCT01506193|469508327|FG001|Overall Study|Adverse event, non-fatal|0|||
130422489|NCT01506193|469508328|FG002|Overall Study|Adverse event, non-fatal|1|||
130422490|NCT01506193|469508326|FG000|Overall Study|Withdrawal by Subject|5|||
130422491|NCT01506193|469508327|FG001|Overall Study|Withdrawal by Subject|1|||
130422492|NCT01506193|469508328|FG002|Overall Study|Withdrawal by Subject|8|||
130422493|NCT01506193|469508326|FG000|Overall Study|Lost to Follow-up|8|||
130422494|NCT01506193|469508327|FG001|Overall Study|Lost to Follow-up|3|||
130422495|NCT01506193|469508328|FG002|Overall Study|Lost to Follow-up|3|||
130422496|NCT04575467|469508329|FG000|Overall Study|Adverse Event|0|||
130422497|NCT04575467|469508330|FG001|Overall Study|Adverse Event|1|||
130422498|NCT04575467|469508331|FG002|Overall Study|Adverse Event|0|||
130422499|NCT04575467|469508332|FG003|Overall Study|Adverse Event|0|||
130422500|NCT00743366|469508333|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
130422501|NCT00743366|469508334|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
130422502|NCT03206203|469508335|FG000|Treatment|Death|38|||
130422503|NCT03206203|469508336|FG001|Treatment|Death|26|||
130422504|NCT03206203|469508337|FG002|Treatment|Death|0|||
130422505|NCT03206203|469508335|FG000|Treatment|Withdrawal by Subject|1|||
130422506|NCT03206203|469508336|FG001|Treatment|Withdrawal by Subject|0|||
130422507|NCT03206203|469508337|FG002|Treatment|Withdrawal by Subject|0|||
130422508|NCT03206203|469508335|FG000|Treatment|Lost to Follow-up|4|||
130422509|NCT03206203|469508336|FG001|Treatment|Lost to Follow-up|0|||
130422510|NCT03206203|469508337|FG002|Treatment|Lost to Follow-up|0|||
130422511|NCT03206203|469508335|FG000|Treatment|N/A in Follow-Up|8|||
130422512|NCT03206203|469508336|FG001|Treatment|N/A in Follow-Up|1|||
130422513|NCT03206203|469508337|FG002|Treatment|N/A in Follow-Up|0|||
130422514|NCT03206203|469508335|FG000|Treatment|Disease progression|0|||
130422515|NCT03206203|469508336|FG001|Treatment|Disease progression|1|||
130422516|NCT03206203|469508337|FG002|Treatment|Disease progression|0|||
130422517|NCT03206203|469508335|FG000|Treatment|Refused follow-up|0|||
130422518|NCT03206203|469508336|FG001|Treatment|Refused follow-up|1|||
130422519|NCT03206203|469508337|FG002|Treatment|Refused follow-up|0|||
130422520|NCT03206203|469508335|FG000|Treatment|Cross over to Arm 1|0|||
130422521|NCT03206203|469508336|FG001|Treatment|Cross over to Arm 1|19|||
130422522|NCT03206203|469508337|FG002|Treatment|Cross over to Arm 1|0|||
130422523|NCT03206203|469508335|FG000|Optional Cross-Over|Death|0|||
130422524|NCT03206203|469508336|FG001|Optional Cross-Over|Death|0|||
130422525|NCT03206203|469508337|FG002|Optional Cross-Over|Death|14|||
130422526|NCT03206203|469508335|FG000|Optional Cross-Over|Refused follow-up|0|||
130422527|NCT03206203|469508336|FG001|Optional Cross-Over|Refused follow-up|0|||
130422528|NCT03206203|469508337|FG002|Optional Cross-Over|Refused follow-up|2|||
130422529|NCT01483924|469508338|FG000|Overall Study|Withdrawal by Subject|2|||
130422530|NCT01483924|469508339|FG001|Overall Study|Withdrawal by Subject|0|||
130422531|NCT01483924|469508340|FG002|Overall Study|Withdrawal by Subject|0|||
130422532|NCT01483924|469508341|FG003|Overall Study|Withdrawal by Subject|1|||
130422533|NCT01483924|469508342|FG004|Overall Study|Withdrawal by Subject|1|||
130422534|NCT01483924|469508338|FG000|Overall Study|Adverse Event|0|||
130422535|NCT01483924|469508339|FG001|Overall Study|Adverse Event|0|||
130422536|NCT01483924|469508340|FG002|Overall Study|Adverse Event|1|||
130422537|NCT01483924|469508341|FG003|Overall Study|Adverse Event|1|||
130422538|NCT01483924|469508342|FG004|Overall Study|Adverse Event|0|||
130422539|NCT01483924|469508338|FG000|Overall Study|Non-compliance|0|||
130422540|NCT01483924|469508339|FG001|Overall Study|Non-compliance|0|||
130564611|NCT00326209|470033682|FG000|Overall Study|Participant non-compliant|6|||
130422541|NCT01483924|469508340|FG002|Overall Study|Non-compliance|0|||
130422542|NCT01483924|469508341|FG003|Overall Study|Non-compliance|1|||
130564612|NCT00326209|470033682|FG000|Overall Study|Sponsor closed study|173|||
130422543|NCT01483924|469508342|FG004|Overall Study|Non-compliance|1|||
130422544|NCT01483924|469508338|FG000|Overall Study|Sponsor concern over ECG result|0|||
130422545|NCT01483924|469508339|FG001|Overall Study|Sponsor concern over ECG result|0|||
130422546|NCT01483924|469508340|FG002|Overall Study|Sponsor concern over ECG result|0|||
130422547|NCT01483924|469508341|FG003|Overall Study|Sponsor concern over ECG result|1|||
130422548|NCT01483924|469508342|FG004|Overall Study|Sponsor concern over ECG result|0|||
130422549|NCT03565887|469508348|FG000|Overall Study|Adverse Event|1|||
130422550|NCT03565887|469508349|FG001|Overall Study|Adverse Event|0|||
130422551|NCT03565887|469508348|FG000|Overall Study|Withdrawal by Subject|0|||
130422552|NCT03565887|469508349|FG001|Overall Study|Withdrawal by Subject|2|||
130422553|NCT01152580|469508350|FG000|Overall Study|Withdrawal by Subject|0|||
130422554|NCT01152580|469508351|FG001|Overall Study|Withdrawal by Subject|1|||
130422555|NCT00449176|469508353|FG000|Overall Study|Withdrawal by Subject|39|||
130422556|NCT00449176|469508354|FG001|Overall Study|Withdrawal by Subject|43|||
130422557|NCT00449176|469508355|FG002|Overall Study|Withdrawal by Subject|59|||
130422558|NCT00449176|469508353|FG000|Overall Study|Lost to Follow-up|13|||
130422559|NCT00449176|469508354|FG001|Overall Study|Lost to Follow-up|8|||
130422560|NCT00449176|469508355|FG002|Overall Study|Lost to Follow-up|12|||
130422561|NCT00449176|469508353|FG000|Overall Study|Adverse Event|51|||
130422562|NCT00449176|469508354|FG001|Overall Study|Adverse Event|107|||
130422563|NCT00449176|469508355|FG002|Overall Study|Adverse Event|15|||
130422564|NCT00449176|469508353|FG000|Overall Study|Lack of Efficacy|13|||
130422565|NCT00449176|469508354|FG001|Overall Study|Lack of Efficacy|7|||
130422566|NCT00449176|469508355|FG002|Overall Study|Lack of Efficacy|50|||
130422567|NCT00449176|469508353|FG000|Overall Study|Study drug non-compliant|14|||
130422568|NCT00449176|469508354|FG001|Overall Study|Study drug non-compliant|11|||
130422569|NCT00449176|469508355|FG002|Overall Study|Study drug non-compliant|11|||
130422570|NCT00449176|469508353|FG000|Overall Study|all other|22|||
130422571|NCT00449176|469508354|FG001|Overall Study|all other|19|||
130422572|NCT00449176|469508355|FG002|Overall Study|all other|20|||
130422573|NCT03015402|469508357|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130422574|NCT03015402|469508358|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
130422575|NCT03015402|469508357|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130422576|NCT03015402|469508358|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
130422577|NCT03213158|469508359|FG000|Overall Study|Withdrawal by Subject|1|||
130422578|NCT03213158|469508359|FG000|Overall Study|Physician Decision|2|||
130422579|NCT01995461|469508362|FG000|Overall Study|Death|1|||
130422580|NCT01995461|469508362|FG000|Overall Study|Lost to Follow-up|2|||
130422581|NCT01995461|469508362|FG000|Overall Study|Withdrawal by Subject|2|||
130422582|NCT00736645|469508363|FG000|Overall Study|Adverse Event|0|||
130422583|NCT00736645|469508364|FG001|Overall Study|Adverse Event|2|||
130422584|NCT00736645|469508365|FG002|Overall Study|Adverse Event|0|||
130476221|NCT04927065|469711676|FG001|Third Booster|Withdrawal by Subject|0|||
130476222|NCT04927065|469711677|FG002|Third Booster|Withdrawal by Subject|0|||
130476223|NCT04927065|469711678|FG003|Third Booster|Withdrawal by Subject|0|||
130476224|NCT04927065|469711679|FG004|Third Booster|Withdrawal by Subject|0|||
130476225|NCT04927065|469711680|FG005|Third Booster|Withdrawal by Subject|0|||
130476226|NCT04927065|469711681|FG006|Third Booster|Withdrawal by Subject|0|||
130476227|NCT04927065|469711682|FG007|Third Booster|Withdrawal by Subject|0|||
130476228|NCT04927065|469711683|FG008|Third Booster|Withdrawal by Subject|0|||
130476229|NCT04927065|469711684|FG009|Third Booster|Withdrawal by Subject|0|||
130476230|NCT04927065|469711685|FG010|Third Booster|Withdrawal by Subject|0|||
130476231|NCT04927065|469711686|FG011|Third Booster|Withdrawal by Subject|0|||
130476232|NCT04927065|469711687|FG012|Third Booster|Withdrawal by Subject|0|||
130476233|NCT04927065|469711688|FG013|Third Booster|Withdrawal by Subject|0|||
130476234|NCT04927065|469711689|FG014|Third Booster|Withdrawal by Subject|0|||
130422585|NCT00736645|469508366|FG003|Overall Study|Adverse Event|0|||
130422586|NCT00295022|469508369|FG000|Overall Study|Adverse Event|1|||
130422587|NCT00295022|469508370|FG001|Overall Study|Adverse Event|1|||
130476235|NCT04927065|469711690|FG015|Third Booster|Withdrawal by Subject|1|||
130564613|NCT00326209|470033682|FG000|Overall Study|Prohibited medication use|1|||
130564614|NCT00326209|470033682|FG000|Overall Study|Violation of entry criteria|1|||
130564615|NCT00326209|470033682|FG000|Overall Study|Withdrawn in error|1|||
130422588|NCT00295022|469508371|FG002|Overall Study|Adverse Event|2|||
130422589|NCT00295022|469508369|FG000|Overall Study|Lost to Follow-up|0|||
130422590|NCT00295022|469508370|FG001|Overall Study|Lost to Follow-up|0|||
130422591|NCT00295022|469508371|FG002|Overall Study|Lost to Follow-up|1|||
130422592|NCT00295022|469508369|FG000|Overall Study|Withdrawal by Subject|0|||
130422593|NCT00295022|469508370|FG001|Overall Study|Withdrawal by Subject|0|||
130422594|NCT00295022|469508371|FG002|Overall Study|Withdrawal by Subject|2|||
130422595|NCT00734630|469508372|FG000|Overall Study|Lack of Efficacy|4|||
130422596|NCT00734630|469508373|FG001|Overall Study|Lack of Efficacy|4|||
130476236|NCT03406871|469711691|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
130476237|NCT03406871|469711692|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
130476238|NCT03406871|469711693|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
130476239|NCT03406871|469711691|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
130476240|NCT03406871|469711692|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
130476241|NCT03406871|469711693|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
130476242|NCT03406871|469711691|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
130476243|NCT03406871|469711692|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
130476244|NCT03406871|469711693|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
130476245|NCT03406871|469711691|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
130476246|NCT03406871|469711692|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
130476247|NCT03406871|469711693|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
130476248|NCT03406871|469711691|FG000|Expansion Cohort(Final Analysis)|Death|0|||
130476249|NCT03406871|469711692|FG001|Expansion Cohort(Final Analysis)|Death|1|||
130476250|NCT03406871|469711693|FG002|Expansion Cohort(Final Analysis)|Death|0|||
130476251|NCT03406871|469711691|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
130476252|NCT03406871|469711692|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
130476253|NCT03406871|469711693|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
130476254|NCT03366649|469711694|FG000|Overall Study|Failed preoperative screening|4|||
130476255|NCT03366649|469711695|FG001|Overall Study|Failed preoperative screening|0|||
130476256|NCT03366649|469711696|FG002|Overall Study|Failed preoperative screening|0|||
130476257|NCT03366649|469711694|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
130476258|NCT03366649|469711695|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
130476259|NCT03366649|469711696|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
130476260|NCT01744782|469711702|FG000|Overall Study|Death|1|||
130476261|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Physician Decision|1|||
130476262|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Physician Decision|0|||
130476263|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
130476264|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
130476265|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
130476266|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
130476267|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Pregnancy|0|||
130476268|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Pregnancy|2|||
130476269|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
130476270|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
130476271|NCT01785719|469711706|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
130476272|NCT01785719|469711707|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
130476273|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
130476274|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
130476275|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
130476276|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
130476277|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
130476278|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
130476279|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
130476280|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
130476281|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
130476282|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
130476283|NCT01785719|469711706|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
130476284|NCT01785719|469711707|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
130476285|NCT01785719|469711706|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
130476286|NCT01785719|469711707|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
130476287|NCT01785719|469711706|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
130476288|NCT01785719|469711707|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
130476289|NCT01785719|469711706|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
130476290|NCT01785719|469711707|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
130476291|NCT03443323|469711708|FG000|Overall Study|Lost to Follow-up|2|||
130564616|NCT00326209|470033682|FG000|Overall Study|Pregnancy|1|||
130564617|NCT00714285|470033683|FG000|Overall Study|Lost to Follow-up|0|||
130564618|NCT00714285|470033684|FG001|Overall Study|Lost to Follow-up|2|||
130564619|NCT00714285|470033685|FG002|Overall Study|Lost to Follow-up|0|||
130564620|NCT00714285|470033686|FG003|Overall Study|Lost to Follow-up|1|||
130564621|NCT00714285|470033683|FG000|Overall Study|Migrated/moved from study area|0|||
130564622|NCT00714285|470033684|FG001|Overall Study|Migrated/moved from study area|1|||
130564623|NCT00714285|470033685|FG002|Overall Study|Migrated/moved from study area|0|||
130564624|NCT00714285|470033686|FG003|Overall Study|Migrated/moved from study area|0|||
130564625|NCT01372384|470033687|FG000|Overall Study|Progression of disease|3|||
130564626|NCT00829179|470033693|FG000|Overall Study|Withdrawal by Subject|1|||
130422597|NCT00734630|469508372|FG000|Overall Study|Withdrawal by Subject|7|||
130422598|NCT00734630|469508373|FG001|Overall Study|Withdrawal by Subject|9|||
130422599|NCT00734630|469508372|FG000|Overall Study|Lost to Follow-up|13|||
130422600|NCT00734630|469508373|FG001|Overall Study|Lost to Follow-up|7|||
130422601|NCT00734630|469508372|FG000|Overall Study|Protocol Violation|0|||
130422602|NCT00734630|469508373|FG001|Overall Study|Protocol Violation|3|||
130422603|NCT00734630|469508372|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130422604|NCT00734630|469508373|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130422605|NCT00734630|469508372|FG000|Overall Study|Adverse Event|3|||
130422606|NCT00734630|469508373|FG001|Overall Study|Adverse Event|6|||
130422607|NCT00734630|469508372|FG000|Overall Study|Randomized in Error|0|||
130422608|NCT00734630|469508373|FG001|Overall Study|Randomized in Error|1|||
130422609|NCT00734630|469508372|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
130422610|NCT00734630|469508373|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
130422611|NCT00734630|469508372|FG000|Overall Study|Poor Compliance|1|||
130422612|NCT00734630|469508373|FG001|Overall Study|Poor Compliance|1|||
130422613|NCT03792126|469508381|FG000|Overall Study|Adverse Event|1|||
130422614|NCT03792126|469508382|FG001|Overall Study|Adverse Event|2|||
130422615|NCT03792126|469508381|FG000|Overall Study|Death|0|||
130422616|NCT03792126|469508382|FG001|Overall Study|Death|1|||
130422617|NCT03792126|469508381|FG000|Overall Study|Lost to Follow-up|1|||
130422618|NCT03792126|469508382|FG001|Overall Study|Lost to Follow-up|0|||
130422619|NCT03792126|469508381|FG000|Overall Study|Withdrawal by Subject|0|||
130422620|NCT03792126|469508382|FG001|Overall Study|Withdrawal by Subject|1|||
130422621|NCT03792126|469508381|FG000|Overall Study|COVID-19 Restrictions|1|||
130422622|NCT03792126|469508382|FG001|Overall Study|COVID-19 Restrictions|3|||
130422623|NCT03792126|469508381|FG000|Overall Study|Symptoms resolved|0|||
130422624|NCT03792126|469508382|FG001|Overall Study|Symptoms resolved|3|||
130422625|NCT03240692|469508383|FG000|Overall Study|Physician Decision|1|||
130422626|NCT03240692|469508383|FG000|Overall Study|Withdrawal by Subject|1|||
130422627|NCT02300220|469508384|FG000|Overall Study|Lost to Follow-up|1|||
130422628|NCT02300220|469508385|FG001|Overall Study|Lost to Follow-up|2|||
130422629|NCT02300220|469508384|FG000|Overall Study|Death|1|||
130422630|NCT02300220|469508385|FG001|Overall Study|Death|1|||
130422631|NCT02300220|469508384|FG000|Overall Study|Adverse Event|1|||
130422632|NCT02300220|469508385|FG001|Overall Study|Adverse Event|1|||
130422633|NCT02300220|469508384|FG000|Overall Study|Protocol Violation|1|||
130422634|NCT02300220|469508385|FG001|Overall Study|Protocol Violation|0|||
130422635|NCT02300220|469508384|FG000|Overall Study|Withdrawal by Subject|0|||
130422636|NCT02300220|469508385|FG001|Overall Study|Withdrawal by Subject|2|||
130422637|NCT02300220|469508384|FG000|Overall Study|Did not tolerate IMP|0|||
130422638|NCT02300220|469508385|FG001|Overall Study|Did not tolerate IMP|1|||
130422639|NCT04322682|469508386|FG000|Overall Study|Withdrawal by Subject|33|||
130422640|NCT04322682|469508387|FG001|Overall Study|Withdrawal by Subject|47|||
130422641|NCT04322682|469508386|FG000|Overall Study|Death|5|||
130422642|NCT04322682|469508387|FG001|Overall Study|Death|9|||
130422643|NCT04322682|469508386|FG000|Overall Study|Lost to Follow-up|4|||
130422644|NCT04322682|469508387|FG001|Overall Study|Lost to Follow-up|8|||
130422645|NCT04322682|469508386|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
130476292|NCT03443323|469711709|FG001|Overall Study|Lost to Follow-up|2|||
130476293|NCT03443323|469711708|FG000|Overall Study|PI withdrawal|1|||
130476294|NCT03443323|469711709|FG001|Overall Study|PI withdrawal|0|||
130476295|NCT04610892|469711717|FG000|Overall Study|Adverse Event|1|||
130476296|NCT04610892|469711718|FG001|Overall Study|Adverse Event|0|||
130476297|NCT04610892|469711719|FG002|Overall Study|Adverse Event|0|||
130476298|NCT04610892|469711720|FG003|Overall Study|Adverse Event|1|||
130476299|NCT04610892|469711721|FG004|Overall Study|Adverse Event|3|||
130422646|NCT04322682|469508387|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
130422647|NCT02238379|469508389|FG000|Overall Study|Lost to Follow-up|1|||
130422648|NCT02238379|469508390|FG001|Overall Study|Lost to Follow-up|0|||
130422649|NCT04123067|469508391|FG000|Overall Study|Lost to Follow-up|0|||
130422650|NCT04123067|469508392|FG001|Overall Study|Lost to Follow-up|1|||
130422651|NCT00441090|469508393|FG000|Overall Study|Adverse Event|0|||
130422652|NCT00441090|469508394|FG001|Overall Study|Adverse Event|1|||
130422653|NCT00441090|469508395|FG002|Overall Study|Adverse Event|1|||
130422654|NCT00441090|469508396|FG003|Overall Study|Adverse Event|0|||
130422655|NCT00441090|469508397|FG004|Overall Study|Adverse Event|0|||
130476300|NCT04610892|469711717|FG000|Overall Study|Death|0|||
130422656|NCT00441090|469508393|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130422657|NCT00441090|469508394|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130476301|NCT04610892|469711718|FG001|Overall Study|Death|1|||
130422658|NCT00441090|469508395|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130422659|NCT00441090|469508396|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
130422660|NCT00441090|469508397|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130422661|NCT00441090|469508393|FG000|Overall Study|Withdrawal by Subject|1|||
130476302|NCT04610892|469711719|FG002|Overall Study|Death|0|||
130476303|NCT04610892|469711720|FG003|Overall Study|Death|1|||
130476304|NCT04610892|469711721|FG004|Overall Study|Death|0|||
130422662|NCT00441090|469508394|FG001|Overall Study|Withdrawal by Subject|0|||
130422663|NCT00441090|469508395|FG002|Overall Study|Withdrawal by Subject|1|||
130422664|NCT00441090|469508396|FG003|Overall Study|Withdrawal by Subject|0|||
130422665|NCT00441090|469508397|FG004|Overall Study|Withdrawal by Subject|0|||
130422666|NCT00441090|469508393|FG000|Overall Study|Lack of Efficacy|1|||
130422667|NCT00441090|469508394|FG001|Overall Study|Lack of Efficacy|0|||
130422668|NCT00441090|469508395|FG002|Overall Study|Lack of Efficacy|0|||
130476305|NCT04610892|469711717|FG000|Overall Study|Withdrawal by Subject|3|||
130476306|NCT04610892|469711718|FG001|Overall Study|Withdrawal by Subject|2|||
130476307|NCT04610892|469711719|FG002|Overall Study|Withdrawal by Subject|0|||
130476308|NCT04610892|469711720|FG003|Overall Study|Withdrawal by Subject|6|||
130476309|NCT04610892|469711721|FG004|Overall Study|Withdrawal by Subject|6|||
130476310|NCT04610892|469711717|FG000|Overall Study|Subjects who did not receive treatment|1|||
130476311|NCT04610892|469711718|FG001|Overall Study|Subjects who did not receive treatment|0|||
130476312|NCT04610892|469711719|FG002|Overall Study|Subjects who did not receive treatment|0|||
130476313|NCT04610892|469711720|FG003|Overall Study|Subjects who did not receive treatment|0|||
130476314|NCT04610892|469711721|FG004|Overall Study|Subjects who did not receive treatment|2|||
130476315|NCT05520190|469711722|FG000|Overall Study|Lost to Follow-up|7|||
130564627|NCT03000179|470033694|FG000|Overall Study|Lost to Follow-up|2|||
130564628|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
130564629|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
130476316|NCT05520190|469711722|FG000|Overall Study|Withdrawal by Subject|2|||
130476317|NCT01999075|469711723|FG000|Overall Study|Lost to Follow-up|0|||
130476318|NCT01999075|469711724|FG001|Overall Study|Lost to Follow-up|2|||
130476319|NCT01999075|469711723|FG000|Overall Study|Withdrawal by Subject|2|||
130476320|NCT01999075|469711724|FG001|Overall Study|Withdrawal by Subject|7|||
130476321|NCT01999075|469711723|FG000|Overall Study|Enrolled in drug trial|3|||
130476322|NCT01999075|469711724|FG001|Overall Study|Enrolled in drug trial|1|||
130476323|NCT01999075|469711723|FG000|Overall Study|Became ineligible|0|||
130476324|NCT01999075|469711724|FG001|Overall Study|Became ineligible|2|||
130476325|NCT03683719|469711725|FG000|Overall Study|Lack of Efficacy|1|||
130476326|NCT03683719|469711726|FG001|Overall Study|Lack of Efficacy|3|||
130476327|NCT03683719|469711727|FG002|Overall Study|Lack of Efficacy|4|||
130476328|NCT03683719|469711728|FG003|Overall Study|Lack of Efficacy|0|||
130476329|NCT03683719|469711729|FG004|Overall Study|Lack of Efficacy|4|||
130476330|NCT03683719|469711725|FG000|Overall Study|Adverse Event|6|||
130476331|NCT03683719|469711726|FG001|Overall Study|Adverse Event|6|||
130476332|NCT03683719|469711727|FG002|Overall Study|Adverse Event|0|||
130476333|NCT03683719|469711728|FG003|Overall Study|Adverse Event|1|||
130476334|NCT03683719|469711729|FG004|Overall Study|Adverse Event|3|||
130476335|NCT03683719|469711725|FG000|Overall Study|Withdrawal by Subject|4|||
130476336|NCT03683719|469711726|FG001|Overall Study|Withdrawal by Subject|4|||
130476337|NCT03683719|469711727|FG002|Overall Study|Withdrawal by Subject|3|||
130476338|NCT03683719|469711728|FG003|Overall Study|Withdrawal by Subject|5|||
130476339|NCT03683719|469711729|FG004|Overall Study|Withdrawal by Subject|5|||
130476340|NCT03683719|469711725|FG000|Overall Study|Lost to Follow-up|1|||
130476341|NCT03683719|469711726|FG001|Overall Study|Lost to Follow-up|0|||
130476342|NCT03683719|469711727|FG002|Overall Study|Lost to Follow-up|0|||
130476343|NCT03683719|469711728|FG003|Overall Study|Lost to Follow-up|1|||
130476344|NCT03683719|469711729|FG004|Overall Study|Lost to Follow-up|1|||
130476345|NCT03683719|469711725|FG000|Overall Study|Other personal reasons|0|||
130476346|NCT03683719|469711726|FG001|Overall Study|Other personal reasons|0|||
130564630|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
130564631|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
130564632|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
130564633|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
130564634|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
130564635|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
130422669|NCT00441090|469508396|FG003|Overall Study|Lack of Efficacy|0|||
130422670|NCT00441090|469508397|FG004|Overall Study|Lack of Efficacy|0|||
130422671|NCT01441102|469508398|FG000|Overall Study|Adverse Event|1|||
130476347|NCT03683719|469711727|FG002|Overall Study|Other personal reasons|1|||
130564636|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
130564637|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
130422672|NCT01441102|469508398|FG000|Overall Study|Withdrawal by Subject|2|||
130422673|NCT03085485|469508399|FG000|Overall Study|Death|1|||
130422674|NCT03085485|469508400|FG001|Overall Study|Death|0|||
130422675|NCT03085485|469508399|FG000|Overall Study|Lost to Follow-up|1|||
130476348|NCT03683719|469711728|FG003|Overall Study|Other personal reasons|0|||
130476349|NCT03683719|469711729|FG004|Overall Study|Other personal reasons|1|||
130476350|NCT03056040|469711735|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
130476351|NCT03056040|469711736|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
130476352|NCT03056040|469711735|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
130476353|NCT03056040|469711736|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
130422676|NCT03085485|469508400|FG001|Overall Study|Lost to Follow-up|0|||
130422677|NCT00605280|469508401|FG000|Year 1|Protocol Violation|0|||
130422678|NCT00605280|469508402|FG001|Year 1|Protocol Violation|0|||
130422679|NCT00605280|469508403|FG002|Year 1|Protocol Violation|0|||
130422680|NCT00605280|469508404|FG003|Year 1|Protocol Violation|1|||
130422681|NCT00605280|469508401|FG000|Year 1|Adverse Event|3|||
130422682|NCT00605280|469508402|FG001|Year 1|Adverse Event|1|||
130422683|NCT00605280|469508403|FG002|Year 1|Adverse Event|1|||
130422684|NCT00605280|469508404|FG003|Year 1|Adverse Event|5|||
130422685|NCT00605280|469508401|FG000|Year 1|Physician Decision|7|||
130422686|NCT00605280|469508402|FG001|Year 1|Physician Decision|4|||
130422687|NCT00605280|469508403|FG002|Year 1|Physician Decision|0|||
130422688|NCT00605280|469508404|FG003|Year 1|Physician Decision|6|||
130422689|NCT00605280|469508401|FG000|Year 1|Withdrawal by Subject|2|||
130422690|NCT00605280|469508402|FG001|Year 1|Withdrawal by Subject|4|||
130422691|NCT00605280|469508403|FG002|Year 1|Withdrawal by Subject|0|||
130422692|NCT00605280|469508404|FG003|Year 1|Withdrawal by Subject|4|||
130422693|NCT00605280|469508401|FG000|Year 1|Other|2|||
130422694|NCT00605280|469508402|FG001|Year 1|Other|1|||
130422695|NCT00605280|469508403|FG002|Year 1|Other|0|||
130422696|NCT00605280|469508404|FG003|Year 1|Other|1|||
130422697|NCT00605280|469508401|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
130422698|NCT00605280|469508402|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
130422699|NCT00605280|469508403|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
130422700|NCT00605280|469508404|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
130422701|NCT00605280|469508401|FG000|Year 2|Adverse Event|4|||
130422702|NCT00605280|469508402|FG001|Year 2|Adverse Event|0|||
130422703|NCT00605280|469508403|FG002|Year 2|Adverse Event|2|||
130422704|NCT00605280|469508404|FG003|Year 2|Adverse Event|4|||
130422705|NCT00605280|469508401|FG000|Year 2|Physician Decision|11|||
130422706|NCT00605280|469508402|FG001|Year 2|Physician Decision|6|||
130422707|NCT00605280|469508403|FG002|Year 2|Physician Decision|4|||
130422708|NCT00605280|469508404|FG003|Year 2|Physician Decision|11|||
130422709|NCT00605280|469508401|FG000|Year 2|Withdrawal by Subject|4|||
130422710|NCT00605280|469508402|FG001|Year 2|Withdrawal by Subject|0|||
130422711|NCT00605280|469508403|FG002|Year 2|Withdrawal by Subject|0|||
130422712|NCT00605280|469508404|FG003|Year 2|Withdrawal by Subject|4|||
130422713|NCT00605280|469508401|FG000|Year 2|Other|1|||
130422714|NCT00605280|469508402|FG001|Year 2|Other|0|||
130422715|NCT00605280|469508403|FG002|Year 2|Other|0|||
130422716|NCT00605280|469508404|FG003|Year 2|Other|1|||
130422717|NCT00605280|469508401|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
130422718|NCT00605280|469508402|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
130422719|NCT00605280|469508403|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
130422720|NCT00605280|469508404|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
130422721|NCT00605280|469508401|FG000|Year 3 Extension|Adverse Event|2|||
130422722|NCT00605280|469508402|FG001|Year 3 Extension|Adverse Event|0|||
130422723|NCT00605280|469508403|FG002|Year 3 Extension|Adverse Event|0|||
130422724|NCT00605280|469508404|FG003|Year 3 Extension|Adverse Event|2|||
130422725|NCT00605280|469508401|FG000|Year 3 Extension|Physician Decision|0|||
130422726|NCT00605280|469508402|FG001|Year 3 Extension|Physician Decision|0|||
130476354|NCT03056040|469711735|FG000|Primary Evaluation Period|Pregnancy|0|||
130476355|NCT03056040|469711736|FG001|Primary Evaluation Period|Pregnancy|1|||
130476356|NCT03056040|469711735|FG000|Primary Evaluation Period|Randomized, not treated|1|||
130476357|NCT03056040|469711736|FG001|Primary Evaluation Period|Randomized, not treated|1|||
130476358|NCT03056040|469711735|FG000|Extension Period|Physician Decision|3|||
130422727|NCT00605280|469508403|FG002|Year 3 Extension|Physician Decision|0|||
130422728|NCT00605280|469508404|FG003|Year 3 Extension|Physician Decision|2|||
130422729|NCT00605280|469508401|FG000|Year 3 Extension|Withdrawal by Subject|2|||
130422730|NCT00605280|469508402|FG001|Year 3 Extension|Withdrawal by Subject|0|||
130422731|NCT00605280|469508403|FG002|Year 3 Extension|Withdrawal by Subject|0|||
130422732|NCT00605280|469508404|FG003|Year 3 Extension|Withdrawal by Subject|5|||
130422733|NCT00605280|469508401|FG000|Year 3 Extension|Other|2|||
130422734|NCT00605280|469508402|FG001|Year 3 Extension|Other|0|||
130422735|NCT00605280|469508403|FG002|Year 3 Extension|Other|0|||
130422736|NCT00605280|469508404|FG003|Year 3 Extension|Other|0|||
130422737|NCT00605280|469508401|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
130422738|NCT00605280|469508402|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130422739|NCT00605280|469508403|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130422740|NCT00605280|469508404|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130422741|NCT00843167|469508408|FG000|Treatment Period|Adverse Event|1|||
130422742|NCT00843167|469508409|FG001|Treatment Period|Adverse Event|5|||
130422743|NCT00843167|469508408|FG000|Treatment Period|Withdrawal by Subject|2|||
130422744|NCT00843167|469508409|FG001|Treatment Period|Withdrawal by Subject|3|||
130422745|NCT02291614|469508412|FG000|Overall Study|Lost to Follow-up|0|||
130422746|NCT02291614|469508413|FG001|Overall Study|Lost to Follow-up|0|||
130422747|NCT02291614|469508414|FG002|Overall Study|Lost to Follow-up|0|||
130422748|NCT02291614|469508415|FG003|Overall Study|Lost to Follow-up|0|||
130422749|NCT02291614|469508416|FG004|Overall Study|Lost to Follow-up|0|||
130422750|NCT02291614|469508417|FG005|Overall Study|Lost to Follow-up|0|||
130422751|NCT02291614|469508418|FG006|Overall Study|Lost to Follow-up|0|||
130422752|NCT02291614|469508419|FG007|Overall Study|Lost to Follow-up|1|||
130422753|NCT02291614|469508420|FG008|Overall Study|Lost to Follow-up|0|||
130422754|NCT02291614|469508421|FG009|Overall Study|Lost to Follow-up|0|||
130422755|NCT02291614|469508422|FG010|Overall Study|Lost to Follow-up|0|||
130422756|NCT02291614|469508412|FG000|Overall Study|Withdrawal by Subject|0|||
130422757|NCT02291614|469508413|FG001|Overall Study|Withdrawal by Subject|1|||
130422758|NCT02291614|469508414|FG002|Overall Study|Withdrawal by Subject|0|||
130422759|NCT02291614|469508415|FG003|Overall Study|Withdrawal by Subject|0|||
130422760|NCT02291614|469508416|FG004|Overall Study|Withdrawal by Subject|0|||
130422761|NCT02291614|469508417|FG005|Overall Study|Withdrawal by Subject|0|||
130422762|NCT02291614|469508418|FG006|Overall Study|Withdrawal by Subject|0|||
130422763|NCT02291614|469508419|FG007|Overall Study|Withdrawal by Subject|0|||
130422764|NCT02291614|469508420|FG008|Overall Study|Withdrawal by Subject|0|||
130422765|NCT02291614|469508421|FG009|Overall Study|Withdrawal by Subject|2|||
130422766|NCT02291614|469508422|FG010|Overall Study|Withdrawal by Subject|2|||
130422767|NCT02291614|469508412|FG000|Overall Study|Decision by sponsor|0|||
130422768|NCT02291614|469508413|FG001|Overall Study|Decision by sponsor|0|||
130422769|NCT02291614|469508414|FG002|Overall Study|Decision by sponsor|0|||
130422770|NCT02291614|469508415|FG003|Overall Study|Decision by sponsor|1|||
130422771|NCT02291614|469508416|FG004|Overall Study|Decision by sponsor|0|||
130422772|NCT02291614|469508417|FG005|Overall Study|Decision by sponsor|0|||
130422773|NCT02291614|469508418|FG006|Overall Study|Decision by sponsor|0|||
130422774|NCT02291614|469508419|FG007|Overall Study|Decision by sponsor|0|||
130422775|NCT02291614|469508420|FG008|Overall Study|Decision by sponsor|0|||
130422776|NCT02291614|469508421|FG009|Overall Study|Decision by sponsor|0|||
130422777|NCT02291614|469508422|FG010|Overall Study|Decision by sponsor|0|||
130422778|NCT02291614|469508412|FG000|Overall Study|Death|0|||
130422779|NCT02291614|469508413|FG001|Overall Study|Death|0|||
130422780|NCT02291614|469508414|FG002|Overall Study|Death|1|||
130422781|NCT02291614|469508415|FG003|Overall Study|Death|0|||
130422782|NCT02291614|469508416|FG004|Overall Study|Death|1|||
130422783|NCT02291614|469508417|FG005|Overall Study|Death|1|||
130422784|NCT02291614|469508418|FG006|Overall Study|Death|1|||
130422785|NCT02291614|469508419|FG007|Overall Study|Death|0|||
130422786|NCT02291614|469508420|FG008|Overall Study|Death|0|||
130422787|NCT02291614|469508421|FG009|Overall Study|Death|0|||
130422788|NCT02291614|469508422|FG010|Overall Study|Death|0|||
130422789|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
130422790|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
130422791|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
130422792|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
130422793|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
130422794|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
130422795|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130422796|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130422797|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130422798|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130422799|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
130422800|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130422801|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130422802|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130422803|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130422804|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
130422805|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
130422806|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
130422807|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
130422808|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
130422809|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
130422810|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130422811|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130422812|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130422813|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130422814|NCT01662310|469508423|FG000|Run-In or Stabilization Phase|Other|1|||
130422815|NCT01662310|469508424|FG001|Run-In or Stabilization Phase|Other|0|||
130422816|NCT01662310|469508425|FG002|Run-In or Stabilization Phase|Other|0|||
130422817|NCT01662310|469508426|FG003|Run-In or Stabilization Phase|Other|0|||
130422818|NCT01662310|469508427|FG004|Run-In or Stabilization Phase|Other|0|||
130422819|NCT01662310|469508423|FG000|Double-Blind Phase|Adverse Event|0|||
130422820|NCT01662310|469508424|FG001|Double-Blind Phase|Adverse Event|0|||
130422821|NCT01662310|469508425|FG002|Double-Blind Phase|Adverse Event|1|||
130422822|NCT01662310|469508426|FG003|Double-Blind Phase|Adverse Event|0|||
130422823|NCT01662310|469508427|FG004|Double-Blind Phase|Adverse Event|0|||
130422824|NCT01662310|469508423|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130422825|NCT01662310|469508424|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130422826|NCT01662310|469508425|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130422827|NCT01662310|469508426|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130422828|NCT01662310|469508427|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130564638|NCT01299376|470033695|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
130564639|NCT01299376|470033696|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
130564640|NCT01299376|470033695|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
130422829|NCT01662310|469508423|FG000|Double-Blind Phase|Pregnancy|0|||
130422830|NCT01662310|469508424|FG001|Double-Blind Phase|Pregnancy|2|||
130422831|NCT01662310|469508425|FG002|Double-Blind Phase|Pregnancy|0|||
130422832|NCT01662310|469508426|FG003|Double-Blind Phase|Pregnancy|0|||
130422833|NCT01662310|469508427|FG004|Double-Blind Phase|Pregnancy|0|||
130422834|NCT01662310|469508423|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130422835|NCT01662310|469508424|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
130422836|NCT01662310|469508425|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
130422837|NCT01662310|469508426|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130422838|NCT01662310|469508427|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130422839|NCT01662310|469508423|FG000|Double-Blind Phase|Other|0|||
130422840|NCT01662310|469508424|FG001|Double-Blind Phase|Other|0|||
130422841|NCT01662310|469508425|FG002|Double-Blind Phase|Other|1|||
130422842|NCT01662310|469508426|FG003|Double-Blind Phase|Other|0|||
130422843|NCT01662310|469508427|FG004|Double-Blind Phase|Other|0|||
130422844|NCT01662310|469508423|FG000|Double-Blind Phase|Randomized but not treated|0|||
130422845|NCT01662310|469508424|FG001|Double-Blind Phase|Randomized but not treated|1|||
130422846|NCT01662310|469508425|FG002|Double-Blind Phase|Randomized but not treated|0|||
130422847|NCT01662310|469508426|FG003|Double-Blind Phase|Randomized but not treated|0|||
130422848|NCT01662310|469508427|FG004|Double-Blind Phase|Randomized but not treated|0|||
130422849|NCT01662310|469508423|FG000|Open-Label Extension Phase|Adverse Event|0|||
130422850|NCT01662310|469508424|FG001|Open-Label Extension Phase|Adverse Event|0|||
130422851|NCT01662310|469508425|FG002|Open-Label Extension Phase|Adverse Event|0|||
130422852|NCT01662310|469508426|FG003|Open-Label Extension Phase|Adverse Event|3|||
130422853|NCT01662310|469508427|FG004|Open-Label Extension Phase|Adverse Event|0|||
130422854|NCT01662310|469508423|FG000|Open-Label Extension Phase|Death|0|||
130422855|NCT01662310|469508424|FG001|Open-Label Extension Phase|Death|0|||
130422856|NCT01662310|469508425|FG002|Open-Label Extension Phase|Death|0|||
130422857|NCT01662310|469508426|FG003|Open-Label Extension Phase|Death|1|||
130422858|NCT01662310|469508427|FG004|Open-Label Extension Phase|Death|0|||
130422859|NCT01662310|469508423|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
130422860|NCT01662310|469508424|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
130422861|NCT01662310|469508425|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
130422862|NCT01662310|469508426|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
130422863|NCT01662310|469508427|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
130422864|NCT01662310|469508423|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130422865|NCT01662310|469508424|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130422866|NCT01662310|469508425|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130422867|NCT01662310|469508426|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
130422868|NCT01662310|469508427|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
130422869|NCT01662310|469508423|FG000|Open-Label Extension Phase|Pregnancy|0|||
130422870|NCT01662310|469508424|FG001|Open-Label Extension Phase|Pregnancy|0|||
130422871|NCT01662310|469508425|FG002|Open-Label Extension Phase|Pregnancy|0|||
130422872|NCT01662310|469508426|FG003|Open-Label Extension Phase|Pregnancy|1|||
130422873|NCT01662310|469508427|FG004|Open-Label Extension Phase|Pregnancy|0|||
130422874|NCT01662310|469508423|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
130422875|NCT01662310|469508424|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
130422876|NCT01662310|469508425|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130422877|NCT01662310|469508426|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
130422878|NCT01662310|469508427|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
130422879|NCT04302350|469508433|FG000|Overall Study|Physician Decision|1|||
130422880|NCT04302350|469508434|FG001|Overall Study|Physician Decision|1|||
130422881|NCT04302350|469508435|FG002|Overall Study|Physician Decision|2|||
130422882|NCT04302350|469508433|FG000|Overall Study|Lack of Efficacy|1|||
130422883|NCT04302350|469508434|FG001|Overall Study|Lack of Efficacy|1|||
130422884|NCT04302350|469508435|FG002|Overall Study|Lack of Efficacy|4|||
130422885|NCT04302350|469508433|FG000|Overall Study|Adverse Event|0|||
130422886|NCT04302350|469508434|FG001|Overall Study|Adverse Event|1|||
130422887|NCT04302350|469508435|FG002|Overall Study|Adverse Event|2|||
130422888|NCT02012491|469508438|FG000|Overall Study|Lost to Follow-up|1|||
130422889|NCT02012491|469508439|FG001|Overall Study|Lost to Follow-up|0|||
130422890|NCT02012491|469508438|FG000|Overall Study|Protocol Violation|0|||
130422891|NCT02012491|469508439|FG001|Overall Study|Protocol Violation|1|||
130422892|NCT02012491|469508438|FG000|Overall Study|Withdrawal by Subject|1|||
130422893|NCT02012491|469508439|FG001|Overall Study|Withdrawal by Subject|0|||
130422894|NCT00450411|469508440|FG000|Overall Study|Protocol Violation|6|||
130422895|NCT00450411|469508440|FG000|Overall Study|No protocol treatment|2|||
130422896|NCT02137369|469508441|FG000|Overall Study|Withdrawal by Subject|3|||
130422897|NCT02137369|469508442|FG001|Overall Study|Withdrawal by Subject|2|||
130422898|NCT02137369|469508441|FG000|Overall Study|Adverse Event|2|||
130422899|NCT02137369|469508442|FG001|Overall Study|Adverse Event|0|||
130422900|NCT02137369|469508441|FG000|Overall Study|Lost to Follow-up|1|||
130422901|NCT02137369|469508442|FG001|Overall Study|Lost to Follow-up|0|||
130422902|NCT02137369|469508441|FG000|Overall Study|Moved away|2|||
130422903|NCT02137369|469508442|FG001|Overall Study|Moved away|0|||
130422904|NCT03969719|469508453|FG000|Overall Study|Other reasons not specified|1|||
130422905|NCT03969719|469508454|FG001|Overall Study|Other reasons not specified|1|||
130422906|NCT03969719|469508455|FG002|Overall Study|Other reasons not specified|3|||
130422907|NCT03969719|469508453|FG000|Overall Study|Withdrawal by Subject|2|||
130422908|NCT03969719|469508454|FG001|Overall Study|Withdrawal by Subject|3|||
130422909|NCT03969719|469508455|FG002|Overall Study|Withdrawal by Subject|2|||
130422910|NCT03969719|469508453|FG000|Overall Study|Protocol Violation|1|||
130422911|NCT03969719|469508454|FG001|Overall Study|Protocol Violation|2|||
130422912|NCT03969719|469508455|FG002|Overall Study|Protocol Violation|0|||
130422913|NCT03969719|469508453|FG000|Overall Study|Adverse Event|0|||
130422914|NCT03969719|469508454|FG001|Overall Study|Adverse Event|2|||
130422915|NCT03969719|469508455|FG002|Overall Study|Adverse Event|0|||
130422916|NCT03969719|469508453|FG000|Overall Study|Lost to Follow-up|0|||
130422917|NCT03969719|469508454|FG001|Overall Study|Lost to Follow-up|1|||
130422918|NCT03969719|469508455|FG002|Overall Study|Lost to Follow-up|0|||
130422919|NCT02130193|469508457|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
130422920|NCT02130193|469508458|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
130422921|NCT02130193|469508459|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
130422922|NCT02130193|469508457|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
130422923|NCT02130193|469508458|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
130422924|NCT02130193|469508459|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
130422925|NCT02130193|469508457|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
130422926|NCT02130193|469508458|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
130422927|NCT02130193|469508459|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
130422928|NCT02130193|469508457|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
130422929|NCT02130193|469508458|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
130422930|NCT02130193|469508459|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
130422931|NCT01297959|469508460|FG000|Overall Study|Adverse Event|0|||
130422932|NCT01297959|469508461|FG001|Overall Study|Adverse Event|1|||
130422933|NCT01297959|469508460|FG000|Overall Study|Protocol Violation|2|||
130422934|NCT01297959|469508461|FG001|Overall Study|Protocol Violation|1|||
130422935|NCT01297959|469508460|FG000|Overall Study|Withdrawal by Subject|5|||
130422936|NCT01297959|469508461|FG001|Overall Study|Withdrawal by Subject|4|||
130422937|NCT01297959|469508460|FG000|Overall Study|Physician Decision|0|||
130422938|NCT01297959|469508461|FG001|Overall Study|Physician Decision|1|||
130422939|NCT01297959|469508460|FG000|Overall Study|Unrelated medical illness / complication|0|||
130422940|NCT01297959|469508461|FG001|Overall Study|Unrelated medical illness / complication|2|||
130422941|NCT01297959|469508460|FG000|Overall Study|Other|13|||
130422942|NCT01297959|469508461|FG001|Overall Study|Other|7|||
130422943|NCT01667432|469508462|FG000|Overall Study|Premature Study Termination|26|||
130422944|NCT01667432|469508462|FG000|Overall Study|Failure to Return|10|||
130422945|NCT01667432|469508462|FG000|Overall Study|Moved to Another Center|3|||
130422946|NCT01667432|469508462|FG000|Overall Study|Lost to Follow-up|3|||
130422947|NCT01667432|469508462|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
130422948|NCT01667432|469508462|FG000|Overall Study|Insufficient Therapeutic Response|4|||
130422949|NCT01667432|469508462|FG000|Overall Study|Adverse Event|1|||
130422950|NCT01667432|469508462|FG000|Overall Study|Protocol Deviation|2|||
130422951|NCT01667432|469508462|FG000|Overall Study|Principal Investigator Decision|1|||
130422952|NCT01667432|469508462|FG000|Overall Study|Reason Not Specified|2|||
130422953|NCT01667432|469508462|FG000|Overall Study|Missing Information|4|||
130422954|NCT02077166|469508463|FG000|Overall Study|Death|6|||
130422955|NCT02077166|469508464|FG001|Overall Study|Death|7|||
130422956|NCT02077166|469508465|FG002|Overall Study|Death|5|||
130422957|NCT02077166|469508466|FG003|Overall Study|Death|6|||
130422958|NCT02077166|469508467|FG004|Overall Study|Death|4|||
130422959|NCT02077166|469508468|FG005|Overall Study|Death|32|||
130422960|NCT02077166|469508469|FG006|Overall Study|Death|22|||
130422961|NCT02077166|469508463|FG000|Overall Study|Study Closure by Sponsor|3|||
130422962|NCT02077166|469508464|FG001|Overall Study|Study Closure by Sponsor|0|||
130422963|NCT02077166|469508465|FG002|Overall Study|Study Closure by Sponsor|2|||
130422964|NCT02077166|469508466|FG003|Overall Study|Study Closure by Sponsor|2|||
130422965|NCT02077166|469508467|FG004|Overall Study|Study Closure by Sponsor|2|||
130422966|NCT02077166|469508468|FG005|Overall Study|Study Closure by Sponsor|12|||
130422967|NCT02077166|469508469|FG006|Overall Study|Study Closure by Sponsor|4|||
130422968|NCT02077166|469508463|FG000|Overall Study|Lost to Follow-up|0|||
130422969|NCT02077166|469508464|FG001|Overall Study|Lost to Follow-up|0|||
130422970|NCT02077166|469508465|FG002|Overall Study|Lost to Follow-up|0|||
130422971|NCT02077166|469508466|FG003|Overall Study|Lost to Follow-up|0|||
130422972|NCT02077166|469508467|FG004|Overall Study|Lost to Follow-up|0|||
130422973|NCT02077166|469508468|FG005|Overall Study|Lost to Follow-up|1|||
130422974|NCT02077166|469508469|FG006|Overall Study|Lost to Follow-up|0|||
130422975|NCT02077166|469508463|FG000|Overall Study|Withdrawal by Subject|3|||
130422976|NCT02077166|469508464|FG001|Overall Study|Withdrawal by Subject|0|||
130422977|NCT02077166|469508465|FG002|Overall Study|Withdrawal by Subject|1|||
130422978|NCT02077166|469508466|FG003|Overall Study|Withdrawal by Subject|1|||
130422979|NCT02077166|469508467|FG004|Overall Study|Withdrawal by Subject|1|||
130422980|NCT02077166|469508468|FG005|Overall Study|Withdrawal by Subject|3|||
130422981|NCT02077166|469508469|FG006|Overall Study|Withdrawal by Subject|0|||
130727492|NCT03772717|470625469|FG000|Overall Study|Withdrawal by Subject|2|||
130422982|NCT02077166|469508463|FG000|Overall Study|Other, Not Specified|0|||
130422983|NCT02077166|469508464|FG001|Overall Study|Other, Not Specified|0|||
130422984|NCT02077166|469508465|FG002|Overall Study|Other, Not Specified|1|||
130422985|NCT02077166|469508466|FG003|Overall Study|Other, Not Specified|0|||
130422986|NCT02077166|469508467|FG004|Overall Study|Other, Not Specified|1|||
130422987|NCT02077166|469508468|FG005|Overall Study|Other, Not Specified|7|||
130422988|NCT02077166|469508469|FG006|Overall Study|Other, Not Specified|8|||
130422989|NCT00003508|469510804|FG000|Overall Study|Not evaluable|5|||
130422990|NCT01712009|469510805|FG000|Overall Study|Withdrawal by Subject|24|||
130422991|NCT01712009|469510806|FG001|Overall Study|Withdrawal by Subject|15|||
130422992|NCT01712009|469510807|FG002|Overall Study|Withdrawal by Subject|8|||
130422993|NCT01712009|469510805|FG000|Overall Study|Lost to Follow-up|2|||
130422994|NCT01712009|469510806|FG001|Overall Study|Lost to Follow-up|0|||
130422995|NCT01712009|469510807|FG002|Overall Study|Lost to Follow-up|1|||
130422996|NCT01712009|469510805|FG000|Overall Study|Decision by Sponsor|12|||
130422997|NCT01712009|469510806|FG001|Overall Study|Decision by Sponsor|14|||
130422998|NCT01712009|469510807|FG002|Overall Study|Decision by Sponsor|12|||
130422999|NCT02160314|469510808|FG000|Overall Study|Adverse Event|0|||
130423000|NCT02160314|469510809|FG001|Overall Study|Adverse Event|6|||
130423001|NCT02160314|469510808|FG000|Overall Study|Protocol Violation|0|||
130423002|NCT02160314|469510809|FG001|Overall Study|Protocol Violation|4|||
130423003|NCT02160314|469510808|FG000|Overall Study|Withdrawal by Subject|1|||
130423004|NCT02160314|469510809|FG001|Overall Study|Withdrawal by Subject|2|||
130423005|NCT02160314|469510808|FG000|Overall Study|Lost to Follow-up|0|||
130423006|NCT02160314|469510809|FG001|Overall Study|Lost to Follow-up|1|||
130423007|NCT01377480|469510813|FG000|Overall Study|Protocol Violation|0|||
130423008|NCT01377480|469510814|FG001|Overall Study|Protocol Violation|0|||
130423009|NCT01377480|469510815|FG002|Overall Study|Protocol Violation|0|||
130423010|NCT01377480|469510816|FG003|Overall Study|Protocol Violation|4|||
130476359|NCT03056040|469711736|FG001|Extension Period|Physician Decision|3|||
130476360|NCT03056040|469711735|FG000|Extension Period|Lost to Follow-up|0|||
130476361|NCT03056040|469711736|FG001|Extension Period|Lost to Follow-up|1|||
130476362|NCT03056040|469711735|FG000|Extension Period|Death|0|||
130476363|NCT03056040|469711736|FG001|Extension Period|Death|3|||
130476364|NCT03056040|469711735|FG000|Extension Period|Withdrawal by Subject|1|||
130476365|NCT03056040|469711736|FG001|Extension Period|Withdrawal by Subject|0|||
130476366|NCT03396926|469711739|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
130476367|NCT03396926|469711740|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
130476368|NCT00450658|469711741|FG000|Overall Study|Adverse Event|24|||
130476369|NCT00450658|469711742|FG001|Overall Study|Adverse Event|15|||
130476370|NCT00450658|469711741|FG000|Overall Study|Withdrawal by Subject|43|||
130476371|NCT00450658|469711742|FG001|Overall Study|Withdrawal by Subject|26|||
130476372|NCT00450658|469711741|FG000|Overall Study|Lost to Follow-up|22|||
130476373|NCT00450658|469711742|FG001|Overall Study|Lost to Follow-up|5|||
130476374|NCT00450658|469711741|FG000|Overall Study|UGI ulcer|33|||
130476375|NCT00450658|469711742|FG001|Overall Study|UGI ulcer|34|||
130476376|NCT00450658|469711741|FG000|Overall Study|misc|21|||
130476377|NCT00450658|469711742|FG001|Overall Study|misc|10|||
130476378|NCT05763823|469711743|FG000|Overall Study|Death|6|||
130476379|NCT05763823|469711743|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130476380|NCT05763823|469711743|FG000|Overall Study|Withdrawal by Subject|6|||
130476381|NCT03302494|469711746|FG000|Overall Study|Other|7|||
130727493|NCT04138043|470625470|FG000|Overall Study|Withdrawal by Subject|0|||
130423011|NCT01377480|469510813|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
130423012|NCT01377480|469510814|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
130423013|NCT01377480|469510815|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
130423014|NCT01377480|469510816|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
130423015|NCT01377480|469510813|FG000|Overall Study|Withdrawal by Subject|0|||
130423016|NCT01377480|469510814|FG001|Overall Study|Withdrawal by Subject|0|||
130423017|NCT01377480|469510815|FG002|Overall Study|Withdrawal by Subject|1|||
130476382|NCT03302494|469711747|FG001|Overall Study|Other|4|||
130476383|NCT03302494|469711748|FG002|Overall Study|Other|6|||
130476384|NCT03302494|469711746|FG000|Overall Study|Withdrawal by Subject|10|||
130476385|NCT03302494|469711747|FG001|Overall Study|Withdrawal by Subject|2|||
130476386|NCT03302494|469711748|FG002|Overall Study|Withdrawal by Subject|9|||
130727494|NCT04138043|470625471|FG001|Overall Study|Withdrawal by Subject|1|||
130423018|NCT01377480|469510816|FG003|Overall Study|Withdrawal by Subject|0|||
130423019|NCT01377480|469510813|FG000|Overall Study|Serious adverse event|0|||
130423020|NCT01377480|469510814|FG001|Overall Study|Serious adverse event|0|||
130423021|NCT01377480|469510815|FG002|Overall Study|Serious adverse event|1|||
130423022|NCT01377480|469510816|FG003|Overall Study|Serious adverse event|1|||
130423023|NCT01377480|469510813|FG000|Overall Study|Other|0|||
130476387|NCT03302494|469711746|FG000|Overall Study|Study Terminated by Sponsor|32|||
130476388|NCT03302494|469711747|FG001|Overall Study|Study Terminated by Sponsor|29|||
130476389|NCT03302494|469711748|FG002|Overall Study|Study Terminated by Sponsor|30|||
130476390|NCT03302494|469711746|FG000|Overall Study|Physician Decision|1|||
130476391|NCT03302494|469711747|FG001|Overall Study|Physician Decision|0|||
130476392|NCT03302494|469711748|FG002|Overall Study|Physician Decision|1|||
130476393|NCT03302494|469711746|FG000|Overall Study|Lost to Follow-up|1|||
130476394|NCT03302494|469711747|FG001|Overall Study|Lost to Follow-up|3|||
130476395|NCT03302494|469711748|FG002|Overall Study|Lost to Follow-up|3|||
130476396|NCT03302494|469711746|FG000|Overall Study|Death|13|||
130476397|NCT03302494|469711747|FG001|Overall Study|Death|11|||
130727495|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130423024|NCT01377480|469510814|FG001|Overall Study|Other|0|||
130423025|NCT01377480|469510815|FG002|Overall Study|Other|7|||
130423026|NCT01377480|469510816|FG003|Overall Study|Other|6|||
130423027|NCT00590902|469510820|FG000|Overall Study|Death|1|||
130423028|NCT01986881|469510821|FG000|Overall Study|Death|228|||
130423029|NCT01986881|469510822|FG001|Overall Study|Death|233|||
130423030|NCT01986881|469510823|FG002|Overall Study|Death|247|||
130423031|NCT01986881|469510821|FG000|Overall Study|Lost to Follow-up|51|||
130423032|NCT01986881|469510822|FG001|Overall Study|Lost to Follow-up|44|||
130423033|NCT01986881|469510823|FG002|Overall Study|Lost to Follow-up|55|||
130423034|NCT01986881|469510821|FG000|Overall Study|Physician Decision|7|||
130423035|NCT01986881|469510822|FG001|Overall Study|Physician Decision|4|||
130423036|NCT01986881|469510823|FG002|Overall Study|Physician Decision|6|||
130423037|NCT01986881|469510821|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
130423038|NCT01986881|469510822|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
130423039|NCT01986881|469510823|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
130423040|NCT01986881|469510821|FG000|Overall Study|Withdrawal by Subject|41|||
130423041|NCT01986881|469510822|FG001|Overall Study|Withdrawal by Subject|60|||
130423042|NCT01986881|469510823|FG002|Overall Study|Withdrawal by Subject|45|||
130423043|NCT01986881|469510821|FG000|Overall Study|Subject Moved|0|||
130423044|NCT01986881|469510822|FG001|Overall Study|Subject Moved|1|||
130423045|NCT01986881|469510823|FG002|Overall Study|Subject Moved|0|||
130476398|NCT03302494|469711748|FG002|Overall Study|Death|4|||
130476399|NCT03302494|469711746|FG000|Overall Study|Adverse Event|1|||
130476400|NCT03302494|469711747|FG001|Overall Study|Adverse Event|2|||
130476401|NCT03302494|469711748|FG002|Overall Study|Adverse Event|0|||
130476402|NCT03302494|469711746|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
130476403|NCT03302494|469711747|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
130476404|NCT03302494|469711748|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
130476405|NCT05134233|469711749|FG000|Overall Study|Pregnancy|1|||
130476406|NCT05134233|469711749|FG000|Overall Study|MEP value too low|2|||
130476407|NCT05134233|469711749|FG000|Overall Study|Lost to Follow-up|1|||
130476408|NCT04763265|469711750|FG000|Overall Study|Adverse Event|1|||
130476409|NCT04763265|469711751|FG001|Overall Study|Adverse Event|0|||
130476410|NCT04763265|469711750|FG000|Overall Study|Lost to Follow-up|2|||
130476411|NCT04763265|469711751|FG001|Overall Study|Lost to Follow-up|4|||
130476412|NCT04763265|469711750|FG000|Overall Study|Withdrawal by Subject|0|||
130476413|NCT04763265|469711751|FG001|Overall Study|Withdrawal by Subject|1|||
130476414|NCT05071807|469711754|FG000|Overall Study|Withdrawal by Subject|4|||
130476415|NCT05071807|469711755|FG001|Overall Study|Withdrawal by Subject|0|||
130476416|NCT05071807|469711754|FG000|Overall Study|Unrelated medical issues|3|||
130476417|NCT05071807|469711755|FG001|Overall Study|Unrelated medical issues|0|||
130476418|NCT05071807|469711754|FG000|Overall Study|Relocated|0|||
130476419|NCT05071807|469711755|FG001|Overall Study|Relocated|1|||
130476420|NCT05609760|469711766|FG000|Overall Study|Lost to Follow-up|0|||
130476421|NCT05609760|469711767|FG001|Overall Study|Lost to Follow-up|1|||
130476422|NCT05609760|469711766|FG000|Overall Study|Withdrawal by Subject|1|||
130476423|NCT05609760|469711767|FG001|Overall Study|Withdrawal by Subject|0|||
130423046|NCT01986881|469510821|FG000|Overall Study|Other|1|||
130476424|NCT04049643|469711768|FG000|Overall Study|Lack of Efficacy|1|||
130476425|NCT04049643|469711769|FG001|Overall Study|Lack of Efficacy|1|||
130476426|NCT04049643|469711770|FG002|Overall Study|Lack of Efficacy|0|||
130476427|NCT04049643|469711768|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130476428|NCT04049643|469711769|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130476429|NCT04049643|469711770|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
130476430|NCT05302596|469711771|FG000|Overall Study|Withdrawal by Subject|1|||
130476431|NCT05302596|469711772|FG001|Overall Study|Withdrawal by Subject|1|||
130423047|NCT01986881|469510822|FG001|Overall Study|Other|2|||
130423048|NCT01986881|469510823|FG002|Overall Study|Other|2|||
130423049|NCT03224182|469510829|FG000|Overall Study|Study Drug Not Instilled|6|||
130423050|NCT03224182|469510830|FG001|Overall Study|Study Drug Not Instilled|1|||
130476432|NCT03376321|469713227|FG000|Overall Study|Other|5|||
130476433|NCT03376321|469713228|FG001|Overall Study|Other|1|||
130423051|NCT03224182|469510829|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
130423052|NCT03224182|469510830|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
130423053|NCT03224182|469510829|FG000|Overall Study|Withdrew of Consent|4|||
130423054|NCT03224182|469510830|FG001|Overall Study|Withdrew of Consent|2|||
130423055|NCT03224182|469510829|FG000|Overall Study|Investigator Decision|3|||
130423056|NCT03224182|469510830|FG001|Overall Study|Investigator Decision|1|||
130423057|NCT03224182|469510829|FG000|Overall Study|Sponsor Decision|26|||
130423058|NCT03224182|469510830|FG001|Overall Study|Sponsor Decision|12|||
130423059|NCT03224182|469510829|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
130423060|NCT03224182|469510830|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
130423061|NCT03224182|469510829|FG000|Overall Study|Lost to Follow-up|1|||
130423062|NCT03224182|469510830|FG001|Overall Study|Lost to Follow-up|0|||
130423063|NCT03224182|469510829|FG000|Overall Study|Participant Had Recurrence|11|||
130423064|NCT03224182|469510830|FG001|Overall Study|Participant Had Recurrence|5|||
130423065|NCT03224182|469510829|FG000|Overall Study|Death|0|||
130423066|NCT03224182|469510830|FG001|Overall Study|Death|1|||
130423067|NCT03224182|469510829|FG000|Overall Study|Reason not Specified|3|||
130423068|NCT03224182|469510830|FG001|Overall Study|Reason not Specified|3|||
130423069|NCT03224182|469510829|FG000|Overall Study|Other|1|||
130423070|NCT03224182|469510830|FG001|Overall Study|Other|0|||
130423071|NCT02822222|469510831|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
130423072|NCT02822222|469510832|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
130423073|NCT04279314|469510833|FG000|Overall Study|Adverse Event|55|||
130423074|NCT04279314|469510833|FG000|Overall Study|Withdrawal by Subject|5|||
130423075|NCT04279314|469510833|FG000|Overall Study|Lack of Efficacy|5|||
130423076|NCT04279314|469510833|FG000|Overall Study|Protocol Violation|3|||
130423077|NCT04279314|469510833|FG000|Overall Study|Other (not COVID-19 related)|2|||
130423078|NCT02481310|469510834|FG000|Follow up|Still in follow up|0|||
130423079|NCT02481310|469510835|FG001|Follow up|Still in follow up|3|||
130423080|NCT02481310|469510836|FG002|Follow up|Still in follow up|0|||
130423081|NCT00643916|469510837|FG000|Overall Study|Protocol Violation|0|||
130423082|NCT00643916|469510838|FG001|Overall Study|Protocol Violation|1|||
130423083|NCT00643916|469510839|FG002|Overall Study|Protocol Violation|1|||
130423084|NCT00643916|469510840|FG003|Overall Study|Protocol Violation|1|||
130423085|NCT00643916|469510841|FG004|Overall Study|Protocol Violation|0|||
130423086|NCT00643916|469510842|FG005|Overall Study|Protocol Violation|0|||
130423087|NCT00643916|469510837|FG000|Overall Study|Lost to Follow-up|0|||
130423088|NCT00643916|469510838|FG001|Overall Study|Lost to Follow-up|1|||
130423089|NCT00643916|469510839|FG002|Overall Study|Lost to Follow-up|0|||
130423090|NCT00643916|469510840|FG003|Overall Study|Lost to Follow-up|0|||
130423091|NCT00643916|469510841|FG004|Overall Study|Lost to Follow-up|0|||
130423092|NCT00643916|469510842|FG005|Overall Study|Lost to Follow-up|0|||
130423093|NCT00643916|469510837|FG000|Overall Study|Withdrawal by Subject|2|||
130423094|NCT00643916|469510838|FG001|Overall Study|Withdrawal by Subject|2|||
130423095|NCT00643916|469510839|FG002|Overall Study|Withdrawal by Subject|2|||
130423096|NCT00643916|469510840|FG003|Overall Study|Withdrawal by Subject|1|||
130423097|NCT00643916|469510841|FG004|Overall Study|Withdrawal by Subject|0|||
130423098|NCT00643916|469510842|FG005|Overall Study|Withdrawal by Subject|1|||
130423099|NCT00643916|469510837|FG000|Overall Study|Not Vaccinated|2|||
130423100|NCT00643916|469510838|FG001|Overall Study|Not Vaccinated|2|||
130423101|NCT00643916|469510839|FG002|Overall Study|Not Vaccinated|3|||
130423102|NCT00643916|469510840|FG003|Overall Study|Not Vaccinated|0|||
130423103|NCT00643916|469510841|FG004|Overall Study|Not Vaccinated|2|||
130423104|NCT00643916|469510842|FG005|Overall Study|Not Vaccinated|0|||
130423105|NCT00499031|469510843|FG000|Overall Study|Improper pre-protocol treatment|1|||
130423106|NCT00499031|469510843|FG000|Overall Study|Required test not done|1|||
130423107|NCT00499031|469510843|FG000|Overall Study|Never treated|1|||
130423108|NCT02606279|469510851|FG000|Overall Study|Lost to Follow-up|0|||
130423109|NCT02606279|469510852|FG001|Overall Study|Lost to Follow-up|1|||
130423110|NCT02184611|469510853|FG000|Overall Study|Lack of Efficacy|11|||
130423111|NCT02184611|469510854|FG001|Overall Study|Lack of Efficacy|15|||
130423112|NCT02184611|469510853|FG000|Overall Study|Withdrawal by Subject|5|||
130423113|NCT02184611|469510854|FG001|Overall Study|Withdrawal by Subject|6|||
130423114|NCT02184611|469510853|FG000|Overall Study|Adverse Event|4|||
130423115|NCT02184611|469510854|FG001|Overall Study|Adverse Event|5|||
130423116|NCT02184611|469510853|FG000|Overall Study|Protocol Violation|1|||
130423117|NCT02184611|469510854|FG001|Overall Study|Protocol Violation|1|||
130423118|NCT02184611|469510853|FG000|Overall Study|Protocol defined stopping criteria|0|||
130423119|NCT02184611|469510854|FG001|Overall Study|Protocol defined stopping criteria|1|||
130423120|NCT00985725|469510860|FG000|Overall Study|Adverse Event|4|||
130423121|NCT00985725|469510861|FG001|Overall Study|Adverse Event|1|||
130423122|NCT00985725|469510860|FG000|Overall Study|Protocol Violation|1|||
130423123|NCT00985725|469510861|FG001|Overall Study|Protocol Violation|3|||
130423124|NCT00985725|469510860|FG000|Overall Study|Withdrawal by Subject|4|||
130423125|NCT00985725|469510861|FG001|Overall Study|Withdrawal by Subject|4|||
130423126|NCT00985725|469510860|FG000|Overall Study|Lost to Follow-up|1|||
130423127|NCT00985725|469510861|FG001|Overall Study|Lost to Follow-up|1|||
130423128|NCT00985725|469510860|FG000|Overall Study|Lack of Efficacy|0|||
130423129|NCT00985725|469510861|FG001|Overall Study|Lack of Efficacy|1|||
130423130|NCT00985725|469510860|FG000|Overall Study|Non-compliance|1|||
130423131|NCT00985725|469510861|FG001|Overall Study|Non-compliance|2|||
130423132|NCT00985725|469510860|FG000|Overall Study|Out-of-window visits|0|||
130423133|NCT00985725|469510861|FG001|Overall Study|Out-of-window visits|1|||
130423134|NCT03563716|469510862|FG000|Overall Study|Death|20|||
130423135|NCT03563716|469510863|FG001|Overall Study|Death|14|||
130423136|NCT03563716|469510862|FG000|Overall Study|Withdrawal by Subject|3|||
130423137|NCT03563716|469510863|FG001|Overall Study|Withdrawal by Subject|3|||
130423138|NCT03563716|469510862|FG000|Overall Study|Still on Study|45|||
130423139|NCT03563716|469510863|FG001|Overall Study|Still on Study|50|||
130423140|NCT02583425|469510866|FG000|Screening|Did not meet entry criteria|12|||
130423141|NCT02583425|469510866|FG000|Baseline|Did not meet continued criteria|5|||
130423142|NCT02583425|469510866|FG000|Treatment Period|Adverse Event|1|||
130423143|NCT01597050|469510869|FG000|Overall Study|Withdrawal by Subject|1|||
130423144|NCT01597050|469510870|FG001|Overall Study|Withdrawal by Subject|0|||
130423145|NCT00483184|469510871|FG000|Overall Study|Withdrawal by Subject|2|||
130423146|NCT00483184|469510872|FG001|Overall Study|Withdrawal by Subject|2|||
130423147|NCT00483184|469510873|FG002|Overall Study|Withdrawal by Subject|0|||
130423148|NCT00483184|469510871|FG000|Overall Study|Lost to Follow-up|1|||
130423149|NCT00483184|469510872|FG001|Overall Study|Lost to Follow-up|0|||
130423150|NCT00483184|469510873|FG002|Overall Study|Lost to Follow-up|0|||
130423151|NCT00483184|469510871|FG000|Overall Study|Adverse Event|1|||
130423152|NCT00483184|469510872|FG001|Overall Study|Adverse Event|2|||
130423153|NCT00483184|469510873|FG002|Overall Study|Adverse Event|2|||
130423154|NCT00483184|469510871|FG000|Overall Study|Protocol Violation|1|||
130423155|NCT00483184|469510872|FG001|Overall Study|Protocol Violation|0|||
130423156|NCT00483184|469510873|FG002|Overall Study|Protocol Violation|1|||
130423157|NCT00558428|469510874|FG000|Overall Study|Adverse Event|6|||
130423158|NCT00558428|469510875|FG001|Overall Study|Adverse Event|22|||
130423159|NCT00558428|469510876|FG002|Overall Study|Adverse Event|3|||
130423160|NCT00558428|469510877|FG003|Overall Study|Adverse Event|4|||
130423161|NCT00558428|469510874|FG000|Overall Study|Lost to Follow-up|0|||
130423162|NCT00558428|469510875|FG001|Overall Study|Lost to Follow-up|1|||
130423163|NCT00558428|469510876|FG002|Overall Study|Lost to Follow-up|0|||
130423164|NCT00558428|469510877|FG003|Overall Study|Lost to Follow-up|0|||
130423165|NCT00558428|469510874|FG000|Overall Study|Lack of Efficacy|0|||
130423166|NCT00558428|469510875|FG001|Overall Study|Lack of Efficacy|0|||
130423167|NCT00558428|469510876|FG002|Overall Study|Lack of Efficacy|1|||
130423168|NCT00558428|469510877|FG003|Overall Study|Lack of Efficacy|2|||
130423169|NCT00558428|469510874|FG000|Overall Study|Non compliant with protocol|1|||
130423170|NCT00558428|469510875|FG001|Overall Study|Non compliant with protocol|0|||
130423171|NCT00558428|469510876|FG002|Overall Study|Non compliant with protocol|0|||
130423172|NCT00558428|469510877|FG003|Overall Study|Non compliant with protocol|3|||
130423173|NCT00558428|469510874|FG000|Overall Study|Consent withdrawn|2|||
130423174|NCT00558428|469510875|FG001|Overall Study|Consent withdrawn|1|||
130423175|NCT00558428|469510876|FG002|Overall Study|Consent withdrawn|0|||
130423176|NCT00558428|469510877|FG003|Overall Study|Consent withdrawn|1|||
130423177|NCT00558428|469510874|FG000|Overall Study|Other|3|||
130423178|NCT00558428|469510875|FG001|Overall Study|Other|0|||
130423179|NCT00558428|469510876|FG002|Overall Study|Other|0|||
130423180|NCT00558428|469510877|FG003|Overall Study|Other|1|||
130423181|NCT05224050|469510878|FG000|Overall Study|Withdrawal by Subject|9|||
130423182|NCT05224050|469510878|FG000|Overall Study|Lost to Follow-up|3|||
130423183|NCT01137474|469510879|FG000|Overall Study|Adverse Event|3|||
130423184|NCT01137474|469510880|FG001|Overall Study|Adverse Event|5|||
130423185|NCT01137474|469510881|FG002|Overall Study|Adverse Event|1|||
130423186|NCT01137474|469510882|FG003|Overall Study|Adverse Event|3|||
130423187|NCT01137474|469510879|FG000|Overall Study|Withdrawal by Subject|7|||
130423188|NCT01137474|469510880|FG001|Overall Study|Withdrawal by Subject|2|||
130423189|NCT01137474|469510881|FG002|Overall Study|Withdrawal by Subject|6|||
130423190|NCT01137474|469510882|FG003|Overall Study|Withdrawal by Subject|9|||
130423191|NCT01137474|469510879|FG000|Overall Study|No longer met study criteria|6|||
130423192|NCT01137474|469510880|FG001|Overall Study|No longer met study criteria|1|||
130423193|NCT01137474|469510881|FG002|Overall Study|No longer met study criteria|0|||
130423194|NCT01137474|469510882|FG003|Overall Study|No longer met study criteria|5|||
130423195|NCT01137474|469510879|FG000|Overall Study|Lost to Follow-up|5|||
130423196|NCT01137474|469510880|FG001|Overall Study|Lost to Follow-up|1|||
130423197|NCT01137474|469510881|FG002|Overall Study|Lost to Follow-up|0|||
130423198|NCT01137474|469510882|FG003|Overall Study|Lost to Follow-up|2|||
130423199|NCT01137474|469510879|FG000|Overall Study|Lack of Efficacy|0|||
130423200|NCT01137474|469510880|FG001|Overall Study|Lack of Efficacy|0|||
130423201|NCT01137474|469510881|FG002|Overall Study|Lack of Efficacy|0|||
130423202|NCT01137474|469510882|FG003|Overall Study|Lack of Efficacy|2|||
130423203|NCT01137474|469510879|FG000|Overall Study|Other|3|||
130423204|NCT01137474|469510880|FG001|Overall Study|Other|1|||
130423205|NCT01137474|469510881|FG002|Overall Study|Other|0|||
130423206|NCT01137474|469510882|FG003|Overall Study|Other|0|||
130423207|NCT01137474|469510879|FG000|Overall Study|Pregnancy|0|||
130423208|NCT01137474|469510880|FG001|Overall Study|Pregnancy|1|||
130423209|NCT01137474|469510881|FG002|Overall Study|Pregnancy|0|||
130423210|NCT01137474|469510882|FG003|Overall Study|Pregnancy|0|||
130423211|NCT01137474|469510879|FG000|Overall Study|Administrative reason by sponsor|0|||
130423212|NCT01137474|469510880|FG001|Overall Study|Administrative reason by sponsor|1|||
130423213|NCT01137474|469510881|FG002|Overall Study|Administrative reason by sponsor|0|||
130423214|NCT01137474|469510882|FG003|Overall Study|Administrative reason by sponsor|0|||
130423215|NCT02219048|469510883|FG000|Overall Study|Adverse Event|2|||
130423216|NCT02219048|469510884|FG001|Overall Study|Adverse Event|5|||
130423217|NCT02219048|469510883|FG000|Overall Study|No longer meets eligibility criteria|1|||
130423218|NCT02219048|469510884|FG001|Overall Study|No longer meets eligibility criteria|0|||
130423219|NCT02219048|469510883|FG000|Overall Study|Study terminated by sponsor|16|||
130423220|NCT02219048|469510884|FG001|Overall Study|Study terminated by sponsor|15|||
130423221|NCT02219048|469510883|FG000|Overall Study|Withdrawal by Subject|2|||
130423222|NCT02219048|469510884|FG001|Overall Study|Withdrawal by Subject|0|||
130423223|NCT02219048|469510883|FG000|Overall Study|Other|0|||
130423224|NCT02219048|469510884|FG001|Overall Study|Other|1|||
130423225|NCT00911534|469510885|FG000|Overall Study|Adverse Event|4|||
130423226|NCT00911534|469510886|FG001|Overall Study|Adverse Event|4|||
130423227|NCT00911534|469510885|FG000|Overall Study|Lost to Follow-up|2|||
130423228|NCT00911534|469510886|FG001|Overall Study|Lost to Follow-up|4|||
130423229|NCT00911534|469510885|FG000|Overall Study|Withdrawal by Subject|2|||
130423230|NCT00911534|469510886|FG001|Overall Study|Withdrawal by Subject|1|||
130423231|NCT00911534|469510885|FG000|Overall Study|Lack of Efficacy|4|||
130423232|NCT00911534|469510886|FG001|Overall Study|Lack of Efficacy|1|||
130423233|NCT00911534|469510885|FG000|Overall Study|Withdrawal of consent|1|||
130423234|NCT00911534|469510886|FG001|Overall Study|Withdrawal of consent|4|||
130423235|NCT00911534|469510885|FG000|Overall Study|Other|2|||
130423236|NCT00911534|469510886|FG001|Overall Study|Other|2|||
130423237|NCT01388816|469510887|FG000|Overall Study|Adverse Event|0|||
130423238|NCT01388816|469510888|FG001|Overall Study|Adverse Event|2|||
130423239|NCT01388816|469510889|FG002|Overall Study|Adverse Event|0|||
130423240|NCT01388816|469510890|FG003|Overall Study|Adverse Event|0|||
130423241|NCT01388816|469510887|FG000|Overall Study|Lost to Follow-up|0|||
130423242|NCT01388816|469510888|FG001|Overall Study|Lost to Follow-up|1|||
130423243|NCT01388816|469510889|FG002|Overall Study|Lost to Follow-up|0|||
130423244|NCT01388816|469510890|FG003|Overall Study|Lost to Follow-up|0|||
130423245|NCT01388816|469510887|FG000|Overall Study|Withdrawal by Subject|2|||
130423246|NCT01388816|469510888|FG001|Overall Study|Withdrawal by Subject|1|||
130423247|NCT01388816|469510889|FG002|Overall Study|Withdrawal by Subject|1|||
130423248|NCT01388816|469510890|FG003|Overall Study|Withdrawal by Subject|0|||
130423249|NCT01388816|469510887|FG000|Overall Study|Protocol Violation|0|||
130423250|NCT01388816|469510888|FG001|Overall Study|Protocol Violation|0|||
130423251|NCT01388816|469510889|FG002|Overall Study|Protocol Violation|2|||
130423252|NCT01388816|469510890|FG003|Overall Study|Protocol Violation|0|||
130423253|NCT00335322|469510891|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
130423254|NCT00335322|469510892|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
130423255|NCT00335322|469510893|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
130423256|NCT02275065|469510894|FG000|Overall Study|Randomized but not treated|1|||
130423257|NCT02275065|469510895|FG001|Overall Study|Randomized but not treated|0|||
130423258|NCT02275065|469510896|FG002|Overall Study|Randomized but not treated|1|||
130423259|NCT02275065|469510897|FG003|Overall Study|Randomized but not treated|1|||
130423260|NCT02275065|469510898|FG004|Overall Study|Randomized but not treated|0|||
130423261|NCT01775904|469510899|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
130423262|NCT01775904|469510899|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
130423263|NCT00518115|469510900|FG000|Overall Study|Adverse Event|6|||
130423264|NCT00518115|469510901|FG001|Overall Study|Adverse Event|1|||
130423265|NCT00518115|469510902|FG002|Overall Study|Adverse Event|5|||
130423266|NCT00518115|469510903|FG003|Overall Study|Adverse Event|6|||
130423267|NCT00518115|469510904|FG004|Overall Study|Adverse Event|5|||
130727496|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
130727497|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130727498|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130727499|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
130727500|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
130423268|NCT00518115|469510905|FG005|Overall Study|Adverse Event|5|||
130423269|NCT00518115|469510906|FG006|Overall Study|Adverse Event|5|||
130423270|NCT00518115|469510907|FG007|Overall Study|Adverse Event|10|||
130423271|NCT00518115|469510908|FG008|Overall Study|Adverse Event|2|||
130423272|NCT00518115|469510909|FG009|Overall Study|Adverse Event|9|||
130423273|NCT00518115|469510900|FG000|Overall Study|Lost to Follow-up|0|||
130423274|NCT00518115|469510901|FG001|Overall Study|Lost to Follow-up|0|||
130423275|NCT00518115|469510902|FG002|Overall Study|Lost to Follow-up|2|||
130423276|NCT00518115|469510903|FG003|Overall Study|Lost to Follow-up|3|||
130423277|NCT00518115|469510904|FG004|Overall Study|Lost to Follow-up|1|||
130423278|NCT00518115|469510905|FG005|Overall Study|Lost to Follow-up|3|||
130423279|NCT00518115|469510906|FG006|Overall Study|Lost to Follow-up|0|||
130423280|NCT00518115|469510907|FG007|Overall Study|Lost to Follow-up|1|||
130423281|NCT00518115|469510908|FG008|Overall Study|Lost to Follow-up|1|||
130727501|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
130476434|NCT03376321|469713227|FG000|Overall Study|Withdrawal by Subject|8|||
130476435|NCT03376321|469713228|FG001|Overall Study|Withdrawal by Subject|14|||
130476436|NCT03376321|469713227|FG000|Overall Study|Lost to Follow-up|1|||
130476437|NCT03376321|469713228|FG001|Overall Study|Lost to Follow-up|7|||
130476438|NCT03376321|469713227|FG000|Overall Study|Death|4|||
130476439|NCT03376321|469713228|FG001|Overall Study|Death|0|||
130476440|NCT03376321|469713227|FG000|Overall Study|Randomized, not treated|5|||
130476441|NCT03376321|469713228|FG001|Overall Study|Randomized, not treated|3|||
130476442|NCT02671903|469713229|FG000|Period 0 (Run-In)|Death|0|||
130476443|NCT02671903|469713230|FG001|Period 0 (Run-In)|Death|0|||
130476444|NCT02671903|469713231|FG002|Period 0 (Run-In)|Death|3|||
130476445|NCT02671903|469713229|FG000|Period 0 (Run-In)|Physician Decision|0|||
130476446|NCT02671903|469713230|FG001|Period 0 (Run-In)|Physician Decision|0|||
130476447|NCT02671903|469713231|FG002|Period 0 (Run-In)|Physician Decision|4|||
130476448|NCT02671903|469713229|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
130476449|NCT02671903|469713230|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
130476450|NCT02671903|469713231|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
130476451|NCT02671903|469713229|FG000|Period 0 (Run-In)|Protocol Violation|0|||
130476452|NCT02671903|469713230|FG001|Period 0 (Run-In)|Protocol Violation|0|||
130476453|NCT02671903|469713231|FG002|Period 0 (Run-In)|Protocol Violation|1|||
130476454|NCT02671903|469713229|FG000|Period 0 (Run-In)|Adverse Event|0|||
130476455|NCT02671903|469713230|FG001|Period 0 (Run-In)|Adverse Event|0|||
130476456|NCT02671903|469713231|FG002|Period 0 (Run-In)|Adverse Event|1|||
130476457|NCT02671903|469713229|FG000|Period 0 (Run-In)|Implantation Failure|0|||
130476458|NCT02671903|469713230|FG001|Period 0 (Run-In)|Implantation Failure|0|||
130476459|NCT02671903|469713231|FG002|Period 0 (Run-In)|Implantation Failure|2|||
130476460|NCT02671903|469713229|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
130476461|NCT02671903|469713230|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
130476462|NCT02671903|469713231|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
130476463|NCT04258709|469713232|FG000|Overall Study|Lost to Follow-up|10|||
130476464|NCT04258709|469713233|FG001|Overall Study|Lost to Follow-up|4|||
130476465|NCT04258709|469713232|FG000|Overall Study|Withdrawal by Subject|1|||
130476466|NCT04258709|469713233|FG001|Overall Study|Withdrawal by Subject|0|||
130476467|NCT04258709|469713232|FG000|Overall Study|Fetal demise|0|||
130476468|NCT04258709|469713233|FG001|Overall Study|Fetal demise|1|||
130476469|NCT04258709|469713232|FG000|Overall Study|Protocol Violation|1|||
130476470|NCT04258709|469713233|FG001|Overall Study|Protocol Violation|1|||
130476471|NCT02287610|469713234|FG000|Overall Study|Lost to Follow-up|3|||
130476472|NCT02287610|469713234|FG000|Overall Study|Withdrawal by Subject|8|||
130476473|NCT02287610|469713234|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
130476474|NCT04241068|469713235|FG000|Core Treatment Period|Adverse Event|91|||
130476475|NCT04241068|469713235|FG000|Core Treatment Period|Change of Treatment|4|||
130476476|NCT04241068|469713235|FG000|Core Treatment Period|Consent Withdrawn|143|||
130476477|NCT04241068|469713235|FG000|Core Treatment Period|Death|26|||
130476478|NCT04241068|469713235|FG000|Core Treatment Period|Disease Progression|67|||
130476479|NCT04241068|469713235|FG000|Core Treatment Period|Investigator Decision|40|||
130476480|NCT04241068|469713235|FG000|Core Treatment Period|Loss of Capacity|9|||
130476481|NCT04241068|469713235|FG000|Core Treatment Period|Lost to Follow-up|11|||
130476482|NCT04241068|469713235|FG000|Core Treatment Period|Relocation|4|||
130476483|NCT04241068|469713235|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
130476484|NCT04241068|469713235|FG000|Core Treatment Period|Study Visit Burden|40|||
130476485|NCT04241068|469713235|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
130476486|NCT04241068|469713235|FG000|Core Treatment Period|Missing|2|||
130476487|NCT04241068|469713235|FG000|Core Treatment Period|Reason Not Specified|41|||
130476488|NCT04241068|469713235|FG000|LTE Period|Adverse Event|19|||
130476489|NCT04241068|469713235|FG000|LTE Period|Change of Treatment|1|||
130476490|NCT04241068|469713235|FG000|LTE Period|Consent Withdrawn|71|||
130476491|NCT04241068|469713235|FG000|LTE Period|Death|8|||
130476492|NCT04241068|469713235|FG000|LTE Period|Disease Progression|11|||
130476493|NCT04241068|469713235|FG000|LTE Period|Investigator Decision|12|||
130476494|NCT04241068|469713235|FG000|LTE Period|Loss of Capacity|2|||
130476495|NCT04241068|469713235|FG000|LTE Period|Lost to Follow-up|7|||
130476496|NCT04241068|469713235|FG000|LTE Period|Relocation|6|||
130476497|NCT04241068|469713235|FG000|LTE Period|Site Terminated by Sponsor|26|||
130476498|NCT04241068|469713235|FG000|LTE Period|Study Terminated by Sponsor|276|||
130476499|NCT04241068|469713235|FG000|LTE Period|Study Visit Burden|10|||
130476500|NCT04241068|469713235|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
130727502|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
130476501|NCT04241068|469713235|FG000|LTE Period|Reason Not Specified|65|||
130476502|NCT01413100|469713236|FG000|Overall Study|Withdrawal by Subject|1|||
130476503|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
130476504|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
130476505|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
130476506|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
130476507|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
130727503|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
130423282|NCT00518115|469510909|FG009|Overall Study|Lost to Follow-up|1|||
130423283|NCT00518115|469510900|FG000|Overall Study|Protocol Violation|1|||
130423284|NCT00518115|469510901|FG001|Overall Study|Protocol Violation|3|||
130423285|NCT00518115|469510902|FG002|Overall Study|Protocol Violation|1|||
130423286|NCT00518115|469510903|FG003|Overall Study|Protocol Violation|0|||
130423287|NCT00518115|469510904|FG004|Overall Study|Protocol Violation|0|||
130423288|NCT00518115|469510905|FG005|Overall Study|Protocol Violation|0|||
130423289|NCT00518115|469510906|FG006|Overall Study|Protocol Violation|0|||
130423290|NCT00518115|469510907|FG007|Overall Study|Protocol Violation|0|||
130423291|NCT00518115|469510908|FG008|Overall Study|Protocol Violation|0|||
130423292|NCT00518115|469510909|FG009|Overall Study|Protocol Violation|0|||
130423293|NCT00518115|469510900|FG000|Overall Study|Withdrawal by Subject|1|||
130423294|NCT00518115|469510901|FG001|Overall Study|Withdrawal by Subject|1|||
130423295|NCT00518115|469510902|FG002|Overall Study|Withdrawal by Subject|5|||
130423296|NCT00518115|469510903|FG003|Overall Study|Withdrawal by Subject|0|||
130423297|NCT00518115|469510904|FG004|Overall Study|Withdrawal by Subject|2|||
130423298|NCT00518115|469510905|FG005|Overall Study|Withdrawal by Subject|1|||
130423299|NCT00518115|469510906|FG006|Overall Study|Withdrawal by Subject|0|||
130423300|NCT00518115|469510907|FG007|Overall Study|Withdrawal by Subject|2|||
130423301|NCT00518115|469510908|FG008|Overall Study|Withdrawal by Subject|1|||
130423302|NCT00518115|469510909|FG009|Overall Study|Withdrawal by Subject|3|||
130423303|NCT00518115|469510900|FG000|Overall Study|Lack of Efficacy|1|||
130423304|NCT00518115|469510901|FG001|Overall Study|Lack of Efficacy|0|||
130423305|NCT00518115|469510902|FG002|Overall Study|Lack of Efficacy|1|||
130423306|NCT00518115|469510903|FG003|Overall Study|Lack of Efficacy|1|||
130423307|NCT00518115|469510904|FG004|Overall Study|Lack of Efficacy|0|||
130423308|NCT00518115|469510905|FG005|Overall Study|Lack of Efficacy|0|||
130423309|NCT00518115|469510906|FG006|Overall Study|Lack of Efficacy|0|||
130423310|NCT00518115|469510907|FG007|Overall Study|Lack of Efficacy|1|||
130423311|NCT00518115|469510908|FG008|Overall Study|Lack of Efficacy|0|||
130423312|NCT00518115|469510909|FG009|Overall Study|Lack of Efficacy|0|||
130423313|NCT00518115|469510900|FG000|Overall Study|Non-Compliance|1|||
130423314|NCT00518115|469510901|FG001|Overall Study|Non-Compliance|0|||
130423315|NCT00518115|469510902|FG002|Overall Study|Non-Compliance|1|||
130423316|NCT00518115|469510903|FG003|Overall Study|Non-Compliance|0|||
130423317|NCT00518115|469510904|FG004|Overall Study|Non-Compliance|1|||
130423318|NCT00518115|469510905|FG005|Overall Study|Non-Compliance|1|||
130423319|NCT00518115|469510906|FG006|Overall Study|Non-Compliance|1|||
130423320|NCT00518115|469510907|FG007|Overall Study|Non-Compliance|1|||
130423321|NCT00518115|469510908|FG008|Overall Study|Non-Compliance|0|||
130423322|NCT00518115|469510909|FG009|Overall Study|Non-Compliance|1|||
130423323|NCT00518115|469510900|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
130423324|NCT00518115|469510901|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
130423325|NCT00518115|469510902|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423326|NCT00518115|469510903|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423327|NCT00518115|469510904|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423328|NCT00518115|469510905|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
130564641|NCT01299376|470033696|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
130564642|NCT01299376|470033695|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
130423329|NCT00518115|469510906|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423330|NCT00518115|469510907|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423331|NCT00518115|469510908|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423332|NCT00518115|469510909|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130423333|NCT00518115|469510900|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
130423334|NCT00518115|469510901|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423335|NCT00518115|469510902|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423336|NCT00518115|469510903|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423337|NCT00518115|469510904|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423338|NCT00518115|469510905|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130564643|NCT01299376|470033696|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
130564644|NCT01299376|470033695|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
130564645|NCT01299376|470033696|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
130564646|NCT01299376|470033695|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
130423339|NCT00518115|469510906|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423340|NCT00518115|469510907|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423341|NCT00518115|469510908|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130423342|NCT00518115|469510909|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130564647|NCT01299376|470033696|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
130423343|NCT00518115|469510900|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423344|NCT00518115|469510901|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423345|NCT00518115|469510902|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
130423346|NCT00518115|469510903|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423347|NCT00518115|469510904|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423348|NCT00518115|469510905|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423349|NCT00518115|469510906|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423350|NCT00518115|469510907|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423351|NCT00518115|469510908|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
130423352|NCT00518115|469510909|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
130423353|NCT00518115|469510900|FG000|Overall Study|Wrong Monotherapy Administered|0|||
130423354|NCT00518115|469510901|FG001|Overall Study|Wrong Monotherapy Administered|0|||
130423355|NCT00518115|469510902|FG002|Overall Study|Wrong Monotherapy Administered|1|||
130423356|NCT00518115|469510903|FG003|Overall Study|Wrong Monotherapy Administered|0|||
130423357|NCT00518115|469510904|FG004|Overall Study|Wrong Monotherapy Administered|0|||
130423358|NCT00518115|469510905|FG005|Overall Study|Wrong Monotherapy Administered|0|||
130423359|NCT00518115|469510906|FG006|Overall Study|Wrong Monotherapy Administered|1|||
130423360|NCT00518115|469510907|FG007|Overall Study|Wrong Monotherapy Administered|0|||
130423361|NCT00518115|469510908|FG008|Overall Study|Wrong Monotherapy Administered|0|||
130423362|NCT00518115|469510909|FG009|Overall Study|Wrong Monotherapy Administered|0|||
130423363|NCT00518115|469510900|FG000|Overall Study|Violation of Exclusion Criteria|0|||
130423364|NCT00518115|469510901|FG001|Overall Study|Violation of Exclusion Criteria|0|||
130423365|NCT00518115|469510902|FG002|Overall Study|Violation of Exclusion Criteria|0|||
130423366|NCT00518115|469510903|FG003|Overall Study|Violation of Exclusion Criteria|1|||
130423367|NCT00518115|469510904|FG004|Overall Study|Violation of Exclusion Criteria|0|||
130423368|NCT00518115|469510905|FG005|Overall Study|Violation of Exclusion Criteria|0|||
130423369|NCT00518115|469510906|FG006|Overall Study|Violation of Exclusion Criteria|1|||
130423370|NCT00518115|469510907|FG007|Overall Study|Violation of Exclusion Criteria|0|||
130423371|NCT00518115|469510908|FG008|Overall Study|Violation of Exclusion Criteria|0|||
130423372|NCT00518115|469510909|FG009|Overall Study|Violation of Exclusion Criteria|0|||
130423373|NCT00518115|469510900|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
130423374|NCT00518115|469510901|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
130423375|NCT00518115|469510902|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
130423376|NCT00518115|469510903|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
130423377|NCT00518115|469510904|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
130423378|NCT00518115|469510905|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
130423379|NCT00518115|469510906|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
130423380|NCT00518115|469510907|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
130423381|NCT00518115|469510908|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
130423382|NCT00518115|469510909|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
130423383|NCT00518115|469510900|FG000|Overall Study|Withdrew Consent|0|||
130423384|NCT00518115|469510901|FG001|Overall Study|Withdrew Consent|0|||
130423385|NCT00518115|469510902|FG002|Overall Study|Withdrew Consent|0|||
130423386|NCT00518115|469510903|FG003|Overall Study|Withdrew Consent|0|||
130423387|NCT00518115|469510904|FG004|Overall Study|Withdrew Consent|0|||
130423388|NCT00518115|469510905|FG005|Overall Study|Withdrew Consent|1|||
130423389|NCT00518115|469510906|FG006|Overall Study|Withdrew Consent|0|||
130423390|NCT00518115|469510907|FG007|Overall Study|Withdrew Consent|0|||
130423391|NCT00518115|469510908|FG008|Overall Study|Withdrew Consent|0|||
130423392|NCT00518115|469510909|FG009|Overall Study|Withdrew Consent|0|||
130423393|NCT00518115|469510900|FG000|Overall Study|Moved Out of State|0|||
130423394|NCT00518115|469510901|FG001|Overall Study|Moved Out of State|0|||
130423395|NCT00518115|469510902|FG002|Overall Study|Moved Out of State|0|||
130423396|NCT00518115|469510903|FG003|Overall Study|Moved Out of State|0|||
130423397|NCT00518115|469510904|FG004|Overall Study|Moved Out of State|0|||
130423398|NCT00518115|469510905|FG005|Overall Study|Moved Out of State|0|||
130423399|NCT00518115|469510906|FG006|Overall Study|Moved Out of State|0|||
130423400|NCT00518115|469510907|FG007|Overall Study|Moved Out of State|0|||
130423401|NCT00518115|469510908|FG008|Overall Study|Moved Out of State|0|||
130423402|NCT00518115|469510909|FG009|Overall Study|Moved Out of State|1|||
130423403|NCT04891419|469510910|FG000|Overall Study|Withdrawal by Subject|4|||
130423404|NCT04891419|469510911|FG001|Overall Study|Withdrawal by Subject|0|||
130423405|NCT04891419|469510910|FG000|Overall Study|Lost to Follow-up|1|||
130423406|NCT04891419|469510911|FG001|Overall Study|Lost to Follow-up|3|||
130423407|NCT00827918|469510912|FG000|Overall Study|Adverse Event|4|||
130423408|NCT00827918|469510913|FG001|Overall Study|Adverse Event|0|||
130423409|NCT00827918|469510914|FG002|Overall Study|Adverse Event|0|||
130476508|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
130423410|NCT00827918|469510912|FG000|Overall Study|Lack of Efficacy|16|||
130476509|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
130423411|NCT00827918|469510913|FG001|Overall Study|Lack of Efficacy|4|||
130423412|NCT00827918|469510914|FG002|Overall Study|Lack of Efficacy|15|||
130476510|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
130423413|NCT00827918|469510912|FG000|Overall Study|Physician Decision|1|||
130423414|NCT00827918|469510913|FG001|Overall Study|Physician Decision|0|||
130423415|NCT00827918|469510914|FG002|Overall Study|Physician Decision|0|||
130423416|NCT00827918|469510912|FG000|Overall Study|Pregnancy|0|||
130423417|NCT00827918|469510913|FG001|Overall Study|Pregnancy|1|||
130423418|NCT00827918|469510914|FG002|Overall Study|Pregnancy|0|||
130423419|NCT00827918|469510912|FG000|Overall Study|Progressive Disease|1|||
130423420|NCT00827918|469510913|FG001|Overall Study|Progressive Disease|1|||
130423421|NCT00827918|469510914|FG002|Overall Study|Progressive Disease|0|||
130423422|NCT00827918|469510912|FG000|Overall Study|Protocol Violation|0|||
130423423|NCT00827918|469510913|FG001|Overall Study|Protocol Violation|1|||
130423424|NCT00827918|469510914|FG002|Overall Study|Protocol Violation|0|||
130423425|NCT00827918|469510912|FG000|Overall Study|Withdrawal by Subject|6|||
130423426|NCT00827918|469510913|FG001|Overall Study|Withdrawal by Subject|2|||
130423427|NCT00827918|469510914|FG002|Overall Study|Withdrawal by Subject|6|||
130423428|NCT00127101|469510915|FG000|Base Protocol|Adverse Event|0|||
130423429|NCT00127101|469510916|FG001|Base Protocol|Adverse Event|2|||
130423430|NCT00127101|469510917|FG002|Base Protocol|Adverse Event|1|||
130423431|NCT00127101|469510918|FG003|Base Protocol|Adverse Event|0|||
130423432|NCT00127101|469510919|FG004|Base Protocol|Adverse Event|0|||
130423433|NCT00127101|469510920|FG005|Base Protocol|Adverse Event|0|||
130423434|NCT00127101|469510915|FG000|Base Protocol|Lack of Efficacy|1|||
130423435|NCT00127101|469510916|FG001|Base Protocol|Lack of Efficacy|0|||
130423436|NCT00127101|469510917|FG002|Base Protocol|Lack of Efficacy|0|||
130423437|NCT00127101|469510918|FG003|Base Protocol|Lack of Efficacy|0|||
130423438|NCT00127101|469510919|FG004|Base Protocol|Lack of Efficacy|2|||
130423439|NCT00127101|469510920|FG005|Base Protocol|Lack of Efficacy|0|||
130423440|NCT00127101|469510915|FG000|Base Protocol|Withdrawal by Subject|1|||
130423441|NCT00127101|469510916|FG001|Base Protocol|Withdrawal by Subject|2|||
130423442|NCT00127101|469510917|FG002|Base Protocol|Withdrawal by Subject|1|||
130423443|NCT00127101|469510918|FG003|Base Protocol|Withdrawal by Subject|0|||
130423444|NCT00127101|469510919|FG004|Base Protocol|Withdrawal by Subject|0|||
130423445|NCT00127101|469510920|FG005|Base Protocol|Withdrawal by Subject|1|||
130423446|NCT00127101|469510915|FG000|Continuation Phase|Adverse Event|0|||
130423447|NCT00127101|469510916|FG001|Continuation Phase|Adverse Event|0|||
130423448|NCT00127101|469510917|FG002|Continuation Phase|Adverse Event|0|||
130423449|NCT00127101|469510918|FG003|Continuation Phase|Adverse Event|0|||
130423450|NCT00127101|469510919|FG004|Continuation Phase|Adverse Event|1|||
130423451|NCT00127101|469510920|FG005|Continuation Phase|Adverse Event|1|||
130423452|NCT00127101|469510915|FG000|Continuation Phase|Lack of Efficacy|0|||
130423453|NCT00127101|469510916|FG001|Continuation Phase|Lack of Efficacy|0|||
130423454|NCT00127101|469510917|FG002|Continuation Phase|Lack of Efficacy|0|||
130423455|NCT00127101|469510918|FG003|Continuation Phase|Lack of Efficacy|0|||
130423456|NCT00127101|469510919|FG004|Continuation Phase|Lack of Efficacy|0|||
130423457|NCT00127101|469510920|FG005|Continuation Phase|Lack of Efficacy|1|||
130423458|NCT00127101|469510915|FG000|Continuation Phase|Withdrawal by Subject|0|||
130423459|NCT00127101|469510916|FG001|Continuation Phase|Withdrawal by Subject|0|||
130423460|NCT00127101|469510917|FG002|Continuation Phase|Withdrawal by Subject|1|||
130423461|NCT00127101|469510918|FG003|Continuation Phase|Withdrawal by Subject|0|||
130423462|NCT00127101|469510919|FG004|Continuation Phase|Withdrawal by Subject|2|||
130423463|NCT00127101|469510920|FG005|Continuation Phase|Withdrawal by Subject|1|||
130423464|NCT01302847|469510921|FG000|Overall Study|Death|0|||
130423465|NCT01302847|469510922|FG001|Overall Study|Death|1|||
130423466|NCT01302847|469510923|FG002|Overall Study|Death|0|||
130423467|NCT01302847|469510924|FG003|Overall Study|Death|0|||
130423468|NCT01302847|469510925|FG004|Overall Study|Death|0|||
130423469|NCT01302847|469510926|FG005|Overall Study|Death|1|||
130423470|NCT01302847|469510927|FG006|Overall Study|Death|1|||
130423471|NCT01302847|469510928|FG007|Overall Study|Death|0|||
130423472|NCT01302847|469510921|FG000|Overall Study|Pregnancy|2|||
130423473|NCT01302847|469510922|FG001|Overall Study|Pregnancy|0|||
130423474|NCT01302847|469510923|FG002|Overall Study|Pregnancy|0|||
130423475|NCT01302847|469510924|FG003|Overall Study|Pregnancy|0|||
130423476|NCT01302847|469510925|FG004|Overall Study|Pregnancy|0|||
130423477|NCT01302847|469510926|FG005|Overall Study|Pregnancy|0|||
130423478|NCT01302847|469510927|FG006|Overall Study|Pregnancy|0|||
130423479|NCT01302847|469510928|FG007|Overall Study|Pregnancy|0|||
130423480|NCT01302847|469510921|FG000|Overall Study|Virologic failure|0|||
130423481|NCT01302847|469510922|FG001|Overall Study|Virologic failure|2|||
130423482|NCT01302847|469510923|FG002|Overall Study|Virologic failure|0|||
130423483|NCT01302847|469510924|FG003|Overall Study|Virologic failure|2|||
130423484|NCT01302847|469510925|FG004|Overall Study|Virologic failure|1|||
130423485|NCT01302847|469510926|FG005|Overall Study|Virologic failure|3|||
130423486|NCT01302847|469510927|FG006|Overall Study|Virologic failure|1|||
130423487|NCT01302847|469510928|FG007|Overall Study|Virologic failure|2|||
130423488|NCT01302847|469510921|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130423489|NCT01302847|469510922|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130423490|NCT01302847|469510923|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130423491|NCT01302847|469510924|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130423492|NCT01302847|469510925|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130423493|NCT01302847|469510926|FG005|Overall Study|Severe debilitation, unable to continue|1|||
130423494|NCT01302847|469510927|FG006|Overall Study|Severe debilitation, unable to continue|1|||
130423495|NCT01302847|469510928|FG007|Overall Study|Severe debilitation, unable to continue|0|||
130423496|NCT01302847|469510921|FG000|Overall Study|Not able to get to clinic|1|||
130423497|NCT01302847|469510922|FG001|Overall Study|Not able to get to clinic|1|||
130423498|NCT01302847|469510923|FG002|Overall Study|Not able to get to clinic|0|||
130423499|NCT01302847|469510924|FG003|Overall Study|Not able to get to clinic|0|||
130423500|NCT01302847|469510925|FG004|Overall Study|Not able to get to clinic|0|||
130423501|NCT01302847|469510926|FG005|Overall Study|Not able to get to clinic|0|||
130423502|NCT01302847|469510927|FG006|Overall Study|Not able to get to clinic|0|||
130423503|NCT01302847|469510928|FG007|Overall Study|Not able to get to clinic|0|||
130423504|NCT01302847|469510921|FG000|Overall Study|Site closing|2|||
130423505|NCT01302847|469510922|FG001|Overall Study|Site closing|2|||
130423506|NCT01302847|469510923|FG002|Overall Study|Site closing|0|||
130423507|NCT01302847|469510924|FG003|Overall Study|Site closing|0|||
130423508|NCT01302847|469510925|FG004|Overall Study|Site closing|0|||
130423509|NCT01302847|469510926|FG005|Overall Study|Site closing|0|||
130423510|NCT01302847|469510927|FG006|Overall Study|Site closing|0|||
130423511|NCT01302847|469510928|FG007|Overall Study|Site closing|0|||
130423512|NCT01302847|469510921|FG000|Overall Study|Withdrawal by Subject|1|||
130423513|NCT01302847|469510922|FG001|Overall Study|Withdrawal by Subject|0|||
130423514|NCT01302847|469510923|FG002|Overall Study|Withdrawal by Subject|0|||
130423515|NCT01302847|469510924|FG003|Overall Study|Withdrawal by Subject|0|||
130423516|NCT01302847|469510925|FG004|Overall Study|Withdrawal by Subject|1|||
130476511|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
130476512|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
130476513|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
130476514|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
130476515|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
130476516|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
130476517|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
130476518|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
130476519|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
130476520|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
130476521|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
130476522|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
130476523|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
130476524|NCT05369403|469713237|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
130476525|NCT05369403|469713238|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
130476526|NCT05369403|469713239|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
130476527|NCT05369403|469713237|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
130476528|NCT05369403|469713238|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
130476529|NCT05369403|469713239|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
130476530|NCT05369403|469713237|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
130476531|NCT05369403|469713238|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
130476532|NCT05369403|469713239|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
130476533|NCT05369403|469713237|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
130476534|NCT05369403|469713238|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
130476535|NCT05369403|469713239|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
130476536|NCT04896476|469713249|FG000|Overall Study|Withdrawal by Subject|1|||
130476537|NCT04896476|469713249|FG000|Overall Study|Lost to Follow-up|2|||
130476538|NCT03476187|469713252|FG000|Overall Study|Protocol Violation|7|||
130476539|NCT03476187|469713252|FG000|Overall Study|Physician Decision|5|||
130476540|NCT03924986|469713253|FG000|Overall Study|Death|57|||
130476541|NCT03924986|469713254|FG001|Overall Study|Death|66|||
130476542|NCT03924986|469713253|FG000|Overall Study|Study Concluded by Sponsor|51|||
130476543|NCT03924986|469713254|FG001|Overall Study|Study Concluded by Sponsor|41|||
130476544|NCT03924986|469713253|FG000|Overall Study|Withdrawal by Subject|15|||
130476545|NCT03924986|469713254|FG001|Overall Study|Withdrawal by Subject|20|||
130476546|NCT03924986|469713253|FG000|Overall Study|Lost to Follow-up|7|||
130476547|NCT03924986|469713254|FG001|Overall Study|Lost to Follow-up|5|||
130476548|NCT03924986|469713253|FG000|Overall Study|Miscellaneous|1|||
130476549|NCT03924986|469713254|FG001|Overall Study|Miscellaneous|0|||
130476550|NCT05948670|469713256|FG000|Overall Study|Protocol Violation|6|||
130476551|NCT05948670|469713257|FG001|Overall Study|Protocol Violation|8|||
130476552|NCT05948670|469713256|FG000|Overall Study|Withdrawal by Subject|0|||
130423517|NCT01302847|469510926|FG005|Overall Study|Withdrawal by Subject|0|||
130423518|NCT01302847|469510927|FG006|Overall Study|Withdrawal by Subject|0|||
130423519|NCT01302847|469510928|FG007|Overall Study|Withdrawal by Subject|1|||
130423520|NCT01302847|469510921|FG000|Overall Study|Not willing to adhere to requirements|5|||
130423521|NCT01302847|469510922|FG001|Overall Study|Not willing to adhere to requirements|0|||
130476553|NCT05948670|469713257|FG001|Overall Study|Withdrawal by Subject|1|||
130476554|NCT03699709|469713258|FG000|Overall Study|Death|1|||
130423522|NCT01302847|469510923|FG002|Overall Study|Not willing to adhere to requirements|1|||
130423523|NCT01302847|469510924|FG003|Overall Study|Not willing to adhere to requirements|0|||
130423524|NCT01302847|469510925|FG004|Overall Study|Not willing to adhere to requirements|0|||
130423525|NCT01302847|469510926|FG005|Overall Study|Not willing to adhere to requirements|0|||
130423526|NCT01302847|469510927|FG006|Overall Study|Not willing to adhere to requirements|0|||
130423527|NCT01302847|469510928|FG007|Overall Study|Not willing to adhere to requirements|2|||
130423528|NCT01302847|469510921|FG000|Overall Study|Site unable to contact participant|2|||
130423529|NCT01302847|469510922|FG001|Overall Study|Site unable to contact participant|1|||
130423530|NCT01302847|469510923|FG002|Overall Study|Site unable to contact participant|0|||
130423531|NCT01302847|469510924|FG003|Overall Study|Site unable to contact participant|0|||
130423532|NCT01302847|469510925|FG004|Overall Study|Site unable to contact participant|0|||
130423533|NCT01302847|469510926|FG005|Overall Study|Site unable to contact participant|0|||
130423534|NCT01302847|469510927|FG006|Overall Study|Site unable to contact participant|2|||
130423535|NCT01302847|469510928|FG007|Overall Study|Site unable to contact participant|0|||
130423536|NCT00374322|469510929|FG000|Overall Study|Lost to Follow-up|92|||
130423537|NCT00374322|469510930|FG001|Overall Study|Lost to Follow-up|90|||
130423538|NCT00374322|469510929|FG000|Overall Study|Protocol Violation|8|||
130423539|NCT00374322|469510930|FG001|Overall Study|Protocol Violation|3|||
130423540|NCT00374322|469510929|FG000|Overall Study|Withdrawal by Subject|235|||
130423541|NCT00374322|469510930|FG001|Overall Study|Withdrawal by Subject|167|||
130423542|NCT00374322|469510929|FG000|Overall Study|Sponsor Terminated Study|866|||
130423543|NCT00374322|469510930|FG001|Overall Study|Sponsor Terminated Study|990|||
130423544|NCT00374322|469510929|FG000|Overall Study|Physician Decision|36|||
130423545|NCT00374322|469510930|FG001|Overall Study|Physician Decision|32|||
130423546|NCT00374322|469510929|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
130423547|NCT00374322|469510930|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
130423548|NCT00374322|469510929|FG000|Overall Study|Sponsor Decision|2|||
130423549|NCT00374322|469510930|FG001|Overall Study|Sponsor Decision|3|||
130423550|NCT00374322|469510929|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
130423551|NCT00374322|469510930|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
130423552|NCT00374322|469510929|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
130423553|NCT00374322|469510930|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
130423554|NCT00374322|469510929|FG000|Overall Study|Severe Toxicity|1|||
130423555|NCT00374322|469510930|FG001|Overall Study|Severe Toxicity|0|||
130423556|NCT00374322|469510929|FG000|Overall Study|Site Closed|2|||
130423557|NCT00374322|469510930|FG001|Overall Study|Site Closed|2|||
130423558|NCT00374322|469510929|FG000|Overall Study|Participant Changed Physician|1|||
130423559|NCT00374322|469510930|FG001|Overall Study|Participant Changed Physician|0|||
130423560|NCT00374322|469510929|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
130423561|NCT00374322|469510930|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
130423562|NCT00374322|469510929|FG000|Overall Study|Noncompliance with Study Requirements|0|||
130423563|NCT00374322|469510930|FG001|Overall Study|Noncompliance with Study Requirements|1|||
130423564|NCT00374322|469510929|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
130423565|NCT00374322|469510930|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
130423566|NCT00374322|469510929|FG000|Overall Study|Did Not Receive Study Medication|8|||
130423567|NCT00374322|469510930|FG001|Overall Study|Did Not Receive Study Medication|6|||
130423568|NCT00829387|469510931|FG000|Overall Study|Withdrawal by Subject|2|||
130423569|NCT00829387|469510932|FG001|Overall Study|Withdrawal by Subject|3|||
130423570|NCT00829387|469510931|FG000|Overall Study|Disqualified by PI|1|||
130423571|NCT00829387|469510932|FG001|Overall Study|Disqualified by PI|0|||
130423572|NCT00707031|469510933|FG000|Overall Study|Adverse Event|45|||
130423573|NCT00707031|469510934|FG001|Overall Study|Adverse Event|45|||
130423574|NCT00707031|469510933|FG000|Overall Study|Lack of Efficacy|19|||
130423575|NCT00707031|469510934|FG001|Overall Study|Lack of Efficacy|6|||
130423576|NCT00707031|469510933|FG000|Overall Study|Lost to Follow-up|2|||
130423577|NCT00707031|469510934|FG001|Overall Study|Lost to Follow-up|1|||
130423578|NCT00707031|469510933|FG000|Overall Study|Protocol Violation|1|||
130423579|NCT00707031|469510934|FG001|Overall Study|Protocol Violation|0|||
130423580|NCT00707031|469510933|FG000|Overall Study|Withdrawal by Subject|7|||
130423581|NCT00707031|469510934|FG001|Overall Study|Withdrawal by Subject|8|||
130423582|NCT00707031|469510933|FG000|Overall Study|Poor Compliance to Protocol|7|||
130423583|NCT00707031|469510934|FG001|Overall Study|Poor Compliance to Protocol|13|||
130423584|NCT00707031|469510933|FG000|Overall Study|Familial or Personal Reasons|12|||
130423585|NCT00707031|469510934|FG001|Overall Study|Familial or Personal Reasons|15|||
130423586|NCT00707031|469510933|FG000|Overall Study|Serious Noncompliance|2|||
130423587|NCT00707031|469510934|FG001|Overall Study|Serious Noncompliance|3|||
130423588|NCT00707031|469510933|FG000|Overall Study|Sponsor Decision|9|||
130423589|NCT00707031|469510934|FG001|Overall Study|Sponsor Decision|8|||
130423590|NCT03519854|469510935|FG000|Overall Study|Technical Error|0|||
130423591|NCT03519854|469510936|FG001|Overall Study|Technical Error|0|||
130476555|NCT03699709|469713259|FG001|Overall Study|Death|2|||
130476556|NCT03699709|469713258|FG000|Overall Study|Lost to Follow-up|10|||
130476557|NCT03699709|469713259|FG001|Overall Study|Lost to Follow-up|3|||
130476558|NCT03699709|469713258|FG000|Overall Study|Withdrawal by Subject|5|||
130476559|NCT03699709|469713259|FG001|Overall Study|Withdrawal by Subject|0|||
130476560|NCT03699709|469713258|FG000|Overall Study|incarcerated|1|||
130476561|NCT03699709|469713259|FG001|Overall Study|incarcerated|0|||
130423592|NCT03519854|469510937|FG002|Overall Study|Technical Error|1|||
130423593|NCT03519854|469510938|FG003|Overall Study|Technical Error|0|||
130423594|NCT03519854|469510939|FG004|Overall Study|Technical Error|0|||
130423595|NCT03519854|469510940|FG005|Overall Study|Technical Error|0|||
130423596|NCT03519854|469510941|FG006|Overall Study|Technical Error|0|||
130423597|NCT03519854|469510942|FG007|Overall Study|Technical Error|0|||
130423598|NCT03519854|469510943|FG008|Overall Study|Technical Error|0|||
130423599|NCT03519854|469510944|FG009|Overall Study|Technical Error|0|||
130423600|NCT03519854|469510945|FG010|Overall Study|Technical Error|0|||
130423601|NCT03519854|469510946|FG011|Overall Study|Technical Error|0|||
130423602|NCT03519854|469510947|FG012|Overall Study|Technical Error|0|||
130423603|NCT03519854|469510948|FG013|Overall Study|Technical Error|0|||
130423604|NCT03519854|469510949|FG014|Overall Study|Technical Error|0|||
130423605|NCT03519854|469510950|FG015|Overall Study|Technical Error|0|||
130423606|NCT03519854|469510951|FG016|Overall Study|Technical Error|0|||
130423607|NCT03519854|469510952|FG017|Overall Study|Technical Error|0|||
130423608|NCT02747238|469510953|FG000|Overall Study|Lack of Efficacy|0|||
130423609|NCT02747238|469510954|FG001|Overall Study|Lack of Efficacy|1|||
130423610|NCT02747238|469510953|FG000|Overall Study|Data lost|3|||
130423611|NCT02747238|469510954|FG001|Overall Study|Data lost|5|||
130423612|NCT00951275|469510955|FG000|Overall Study|Administrative Reason|1|||
130423613|NCT00951275|469510955|FG000|Overall Study|Adverse Event|7|||
130423614|NCT00951275|469510955|FG000|Overall Study|Withdrawal by Subject|4|||
130423615|NCT00951275|469510955|FG000|Overall Study|Protocol Violation|1|||
130423616|NCT01389973|469510964|FG000|Overall Study|Lost to Follow-up|1|||
130423617|NCT01389973|469510964|FG000|Overall Study|Trial Stopped by Sponsor|9|||
130423618|NCT01389973|469510964|FG000|Overall Study|Other|10|||
130423619|NCT02626780|469510965|FG000|Overall Study|Withdrawal by Subject|3|||
130423620|NCT04304833|469510966|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
130423621|NCT04304833|469510967|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
130423622|NCT03456700|469510968|FG000|Overall Study|Withdrawal by Subject|1|||
130423623|NCT04154787|469510969|FG000|Overall Study|Adverse Event|0|||
130423624|NCT04154787|469510970|FG001|Overall Study|Adverse Event|1|||
130423625|NCT04154787|469510971|FG002|Overall Study|Adverse Event|0|||
130423626|NCT04154787|469510969|FG000|Overall Study|Patient Requires Other Treatment|0|||
130423627|NCT04154787|469510970|FG001|Overall Study|Patient Requires Other Treatment|1|||
130476562|NCT03699709|469713258|FG000|Overall Study|scheduled, but no show|0|||
130476563|NCT03699709|469713259|FG001|Overall Study|scheduled, but no show|1|||
130476564|NCT04562649|469713261|FG000|Overall Study|Withdrawal by Subject|11|||
130476565|NCT04562649|469713262|FG001|Overall Study|Withdrawal by Subject|8|||
130476566|NCT04562649|469713261|FG000|Overall Study|Lost to Follow-up|26|||
130476567|NCT04562649|469713262|FG001|Overall Study|Lost to Follow-up|20|||
130476568|NCT04029688|469713266|FG000|Overall Study|Death|8|||
130476569|NCT04029688|469713267|FG001|Overall Study|Death|3|||
130476570|NCT04029688|469713268|FG002|Overall Study|Death|6|||
130476571|NCT04029688|469713269|FG003|Overall Study|Death|2|||
130476572|NCT04029688|469713270|FG004|Overall Study|Death|5|||
130476573|NCT04029688|469713271|FG005|Overall Study|Death|0|||
130476574|NCT04029688|469713272|FG006|Overall Study|Death|2|||
130476575|NCT04029688|469713273|FG007|Overall Study|Death|3|||
130476576|NCT04029688|469713266|FG000|Overall Study|Study Terminated by Sponsor|0|||
130476577|NCT04029688|469713267|FG001|Overall Study|Study Terminated by Sponsor|0|||
130476578|NCT04029688|469713268|FG002|Overall Study|Study Terminated by Sponsor|0|||
130476579|NCT04029688|469713269|FG003|Overall Study|Study Terminated by Sponsor|0|||
130476580|NCT04029688|469713270|FG004|Overall Study|Study Terminated by Sponsor|1|||
130476581|NCT04029688|469713271|FG005|Overall Study|Study Terminated by Sponsor|3|||
130476582|NCT04029688|469713272|FG006|Overall Study|Study Terminated by Sponsor|1|||
130476583|NCT04029688|469713273|FG007|Overall Study|Study Terminated by Sponsor|3|||
130476584|NCT04029688|469713266|FG000|Overall Study|Withdrawal by Subject|0|||
130423628|NCT04154787|469510971|FG002|Overall Study|Patient Requires Other Treatment|0|||
130423629|NCT04154787|469510969|FG000|Overall Study|Study Terminated By Sponsor|0|||
130476585|NCT04029688|469713267|FG001|Overall Study|Withdrawal by Subject|0|||
130476586|NCT04029688|469713268|FG002|Overall Study|Withdrawal by Subject|0|||
130476587|NCT04029688|469713269|FG003|Overall Study|Withdrawal by Subject|1|||
130476588|NCT04029688|469713270|FG004|Overall Study|Withdrawal by Subject|0|||
130476589|NCT04029688|469713271|FG005|Overall Study|Withdrawal by Subject|0|||
130476590|NCT04029688|469713272|FG006|Overall Study|Withdrawal by Subject|0|||
130476591|NCT04029688|469713273|FG007|Overall Study|Withdrawal by Subject|0|||
130423630|NCT04154787|469510970|FG001|Overall Study|Study Terminated By Sponsor|6|||
130423631|NCT04154787|469510971|FG002|Overall Study|Study Terminated By Sponsor|1|||
130423632|NCT04154787|469510969|FG000|Overall Study|Subject Decision|0|||
130423633|NCT04154787|469510970|FG001|Overall Study|Subject Decision|1|||
130423634|NCT04154787|469510971|FG002|Overall Study|Subject Decision|0|||
130423635|NCT04154787|469510969|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
130423636|NCT04154787|469510970|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
130423637|NCT04154787|469510971|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
130423638|NCT01951625|469510972|FG000|Treatment Period|Protocol Violation|2|||
130423639|NCT01951625|469510973|FG001|Treatment Period|Protocol Violation|0|||
130476592|NCT05784662|469713274|FG000|Overall Study|Lost to Follow-up|21|||
130476593|NCT05784662|469713275|FG001|Overall Study|Lost to Follow-up|17|||
130423640|NCT01951625|469510974|FG002|Treatment Period|Protocol Violation|1|||
130423641|NCT01951625|469510975|FG003|Treatment Period|Protocol Violation|3|||
130423642|NCT01951625|469510976|FG004|Treatment Period|Protocol Violation|2|||
130423643|NCT01951625|469510972|FG000|Treatment Period|Physician Decision|0|||
130423644|NCT01951625|469510973|FG001|Treatment Period|Physician Decision|0|||
130423645|NCT01951625|469510974|FG002|Treatment Period|Physician Decision|0|||
130423646|NCT01951625|469510975|FG003|Treatment Period|Physician Decision|0|||
130423647|NCT01951625|469510976|FG004|Treatment Period|Physician Decision|1|||
130423648|NCT01951625|469510972|FG000|Treatment Period|Protocol driven decision point|0|||
130423649|NCT01951625|469510973|FG001|Treatment Period|Protocol driven decision point|5|||
130423650|NCT01951625|469510974|FG002|Treatment Period|Protocol driven decision point|0|||
130423651|NCT01951625|469510975|FG003|Treatment Period|Protocol driven decision point|2|||
130423652|NCT01951625|469510976|FG004|Treatment Period|Protocol driven decision point|1|||
130423653|NCT01951625|469510972|FG000|Treatment Period|Non compliance with study drug|1|||
130423654|NCT01951625|469510973|FG001|Treatment Period|Non compliance with study drug|2|||
130423655|NCT01951625|469510974|FG002|Treatment Period|Non compliance with study drug|2|||
130423656|NCT01951625|469510975|FG003|Treatment Period|Non compliance with study drug|0|||
130423657|NCT01951625|469510976|FG004|Treatment Period|Non compliance with study drug|0|||
130423658|NCT01951625|469510972|FG000|Treatment Period|Death|3|||
130423659|NCT01951625|469510973|FG001|Treatment Period|Death|2|||
130423660|NCT01951625|469510974|FG002|Treatment Period|Death|2|||
130423661|NCT01951625|469510975|FG003|Treatment Period|Death|1|||
130423662|NCT01951625|469510976|FG004|Treatment Period|Death|2|||
130423663|NCT01951625|469510972|FG000|Treatment Period|Adverse Event|7|||
130423664|NCT01951625|469510973|FG001|Treatment Period|Adverse Event|10|||
130423665|NCT01951625|469510974|FG002|Treatment Period|Adverse Event|9|||
130423666|NCT01951625|469510975|FG003|Treatment Period|Adverse Event|8|||
130423667|NCT01951625|469510976|FG004|Treatment Period|Adverse Event|8|||
130423668|NCT01951625|469510972|FG000|Treatment Period|Withdrawal by Subject|5|||
130423669|NCT01951625|469510973|FG001|Treatment Period|Withdrawal by Subject|2|||
130423670|NCT01951625|469510974|FG002|Treatment Period|Withdrawal by Subject|1|||
130423671|NCT01951625|469510975|FG003|Treatment Period|Withdrawal by Subject|7|||
130423672|NCT01951625|469510976|FG004|Treatment Period|Withdrawal by Subject|3|||
130423673|NCT01951625|469510972|FG000|Treatment Period|Lost to Follow-up|1|||
130423674|NCT01951625|469510973|FG001|Treatment Period|Lost to Follow-up|0|||
130423675|NCT01951625|469510974|FG002|Treatment Period|Lost to Follow-up|0|||
130423676|NCT01951625|469510975|FG003|Treatment Period|Lost to Follow-up|1|||
130423677|NCT01951625|469510976|FG004|Treatment Period|Lost to Follow-up|0|||
130423678|NCT01951625|469510972|FG000|Follow Up Period|Non-compliance with study drug|1|||
130423679|NCT01951625|469510973|FG001|Follow Up Period|Non-compliance with study drug|0|||
130423680|NCT01951625|469510974|FG002|Follow Up Period|Non-compliance with study drug|0|||
130423681|NCT01951625|469510975|FG003|Follow Up Period|Non-compliance with study drug|0|||
130423682|NCT01951625|469510976|FG004|Follow Up Period|Non-compliance with study drug|0|||
130423683|NCT01951625|469510972|FG000|Follow Up Period|Death|1|||
130423684|NCT01951625|469510973|FG001|Follow Up Period|Death|3|||
130423685|NCT01951625|469510974|FG002|Follow Up Period|Death|2|||
130423686|NCT01951625|469510975|FG003|Follow Up Period|Death|2|||
130423687|NCT01951625|469510976|FG004|Follow Up Period|Death|1|||
130423688|NCT01951625|469510972|FG000|Follow Up Period|Logistical difficulties|1|||
130423689|NCT01951625|469510973|FG001|Follow Up Period|Logistical difficulties|2|||
130423690|NCT01951625|469510974|FG002|Follow Up Period|Logistical difficulties|0|||
130476594|NCT04739956|469713283|FG000|Overall Study|Withdrawal by Subject|1|||
130476595|NCT04739956|469713284|FG001|Overall Study|Withdrawal by Subject|1|||
130476596|NCT03920111|469713285|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
130476597|NCT03920111|469713286|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
130476598|NCT03920111|469713287|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
130476599|NCT03853746|469713289|FG000|Overall Study|Withdrawal by Subject|1|||
130476600|NCT00999804|469713290|FG000|Overall Study|Lack of Efficacy|9|||
130476601|NCT00999804|469713291|FG001|Overall Study|Lack of Efficacy|2|||
130476602|NCT00999804|469713290|FG000|Overall Study|Adverse Event|4|||
130423691|NCT01951625|469510975|FG003|Follow Up Period|Logistical difficulties|0|||
130423692|NCT01951625|469510976|FG004|Follow Up Period|Logistical difficulties|0|||
130423693|NCT01951625|469510972|FG000|Follow Up Period|Adverse Event|0|||
130423694|NCT01951625|469510973|FG001|Follow Up Period|Adverse Event|3|||
130423695|NCT01951625|469510974|FG002|Follow Up Period|Adverse Event|2|||
130423696|NCT01951625|469510975|FG003|Follow Up Period|Adverse Event|3|||
130423697|NCT01951625|469510976|FG004|Follow Up Period|Adverse Event|5|||
130423698|NCT01951625|469510972|FG000|Follow Up Period|Withdrawal by Subject|4|||
130423699|NCT01951625|469510973|FG001|Follow Up Period|Withdrawal by Subject|1|||
130423700|NCT01951625|469510974|FG002|Follow Up Period|Withdrawal by Subject|0|||
130423701|NCT01951625|469510975|FG003|Follow Up Period|Withdrawal by Subject|5|||
130423702|NCT01951625|469510976|FG004|Follow Up Period|Withdrawal by Subject|3|||
130423703|NCT01951625|469510972|FG000|Follow Up Period|Lost to Follow-up|1|||
130423704|NCT01951625|469510973|FG001|Follow Up Period|Lost to Follow-up|0|||
130423705|NCT01951625|469510974|FG002|Follow Up Period|Lost to Follow-up|0|||
130423706|NCT01951625|469510975|FG003|Follow Up Period|Lost to Follow-up|1|||
130423707|NCT01951625|469510976|FG004|Follow Up Period|Lost to Follow-up|1|||
130423708|NCT03053050|469510979|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
130423709|NCT03053050|469510980|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
130423710|NCT03053050|469510981|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
130423711|NCT03053050|469510982|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
130423712|NCT03053050|469510979|FG000|Randomized Phase|Withdrew Consent|16|||
130423713|NCT03053050|469510980|FG001|Randomized Phase|Withdrew Consent|8|||
130423714|NCT03053050|469510981|FG002|Randomized Phase|Withdrew Consent|9|||
130423715|NCT03053050|469510982|FG003|Randomized Phase|Withdrew Consent|0|||
130423716|NCT03053050|469510979|FG000|Randomized Phase|Investigator's Discretion|6|||
130423717|NCT03053050|469510980|FG001|Randomized Phase|Investigator's Discretion|6|||
130423718|NCT03053050|469510981|FG002|Randomized Phase|Investigator's Discretion|3|||
130423719|NCT03053050|469510982|FG003|Randomized Phase|Investigator's Discretion|0|||
130423720|NCT03053050|469510979|FG000|Randomized Phase|Lost to Follow-up|5|||
130423721|NCT03053050|469510980|FG001|Randomized Phase|Lost to Follow-up|1|||
130423722|NCT03053050|469510981|FG002|Randomized Phase|Lost to Follow-up|1|||
130423723|NCT03053050|469510982|FG003|Randomized Phase|Lost to Follow-up|0|||
130423724|NCT03053050|469510979|FG000|Randomized Phase|Adverse Event|0|||
130423725|NCT03053050|469510980|FG001|Randomized Phase|Adverse Event|1|||
130423726|NCT03053050|469510981|FG002|Randomized Phase|Adverse Event|0|||
130423727|NCT03053050|469510982|FG003|Randomized Phase|Adverse Event|0|||
130423728|NCT03053050|469510979|FG000|Randomized Phase|Randomized but Never Treated|2|||
130423729|NCT03053050|469510980|FG001|Randomized Phase|Randomized but Never Treated|2|||
130423730|NCT03053050|469510981|FG002|Randomized Phase|Randomized but Never Treated|2|||
130423731|NCT03053050|469510982|FG003|Randomized Phase|Randomized but Never Treated|0|||
130423732|NCT03053050|469510979|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
130423733|NCT03053050|469510980|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
130423734|NCT03053050|469510981|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
130423735|NCT03053050|469510982|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
130423736|NCT03053050|469510979|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
130423737|NCT03053050|469510980|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
130423738|NCT03053050|469510981|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
130423739|NCT03053050|469510982|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
130423740|NCT03053050|469510979|FG000|Open-label Phase|Withdrew Consent|0|||
130423741|NCT03053050|469510980|FG001|Open-label Phase|Withdrew Consent|0|||
130423742|NCT03053050|469510981|FG002|Open-label Phase|Withdrew Consent|0|||
130423743|NCT03053050|469510982|FG003|Open-label Phase|Withdrew Consent|6|||
130423744|NCT03053050|469510979|FG000|Open-label Phase|Investigator's Discretion|0|||
130423745|NCT03053050|469510980|FG001|Open-label Phase|Investigator's Discretion|0|||
130423746|NCT03053050|469510981|FG002|Open-label Phase|Investigator's Discretion|0|||
130423747|NCT03053050|469510982|FG003|Open-label Phase|Investigator's Discretion|4|||
130423748|NCT05338333|469510983|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
130423749|NCT05338333|469510984|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
130423750|NCT02459574|469510988|FG000|Overall Study|Withdrawal by Subject|6|||
130423751|NCT02459574|469510989|FG001|Overall Study|Withdrawal by Subject|6|||
130423752|NCT02459574|469510990|FG002|Overall Study|Withdrawal by Subject|2|||
130423753|NCT02459574|469510988|FG000|Overall Study|Lost to Follow-up|1|||
130423754|NCT02459574|469510989|FG001|Overall Study|Lost to Follow-up|1|||
130423755|NCT02459574|469510990|FG002|Overall Study|Lost to Follow-up|0|||
130423756|NCT02459574|469510988|FG000|Overall Study|Death|0|||
130423757|NCT02459574|469510989|FG001|Overall Study|Death|1|||
130423758|NCT02459574|469510990|FG002|Overall Study|Death|0|||
130423759|NCT00251745|469510991|FG000|Overall Study|Adverse Event|7|||
130423760|NCT00251745|469510992|FG001|Overall Study|Adverse Event|9|||
130423761|NCT00251745|469510993|FG002|Overall Study|Adverse Event|11|||
130423762|NCT00251745|469510991|FG000|Overall Study|Lost to Follow-up|4|||
130423763|NCT00251745|469510992|FG001|Overall Study|Lost to Follow-up|2|||
130564648|NCT01299376|470033695|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
130564649|NCT01299376|470033696|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
130564650|NCT02343159|470033697|FG000|Overall Study|Early Study Termination|16|||
130564651|NCT02343159|470033698|FG001|Overall Study|Early Study Termination|19|||
130564652|NCT02343159|470033699|FG002|Overall Study|Early Study Termination|23|||
130423764|NCT00251745|469510993|FG002|Overall Study|Lost to Follow-up|5|||
130423765|NCT00251745|469510991|FG000|Overall Study|Withdrawal by Subject|13|||
130423766|NCT00251745|469510992|FG001|Overall Study|Withdrawal by Subject|7|||
130423767|NCT00251745|469510993|FG002|Overall Study|Withdrawal by Subject|3|||
130423768|NCT00251745|469510991|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130423769|NCT00251745|469510992|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
130423770|NCT00251745|469510993|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130564653|NCT02343159|470033697|FG000|Overall Study|Physician Decision|2|||
130564654|NCT02343159|470033698|FG001|Overall Study|Physician Decision|0|||
130727504|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
130423771|NCT00251745|469510991|FG000|Overall Study|Lack of Efficacy|3|||
130423772|NCT00251745|469510992|FG001|Overall Study|Lack of Efficacy|0|||
130423773|NCT00251745|469510993|FG002|Overall Study|Lack of Efficacy|0|||
130423774|NCT00251745|469510991|FG000|Overall Study|Noncompliant|0|||
130423775|NCT00251745|469510992|FG001|Overall Study|Noncompliant|2|||
130423776|NCT00251745|469510993|FG002|Overall Study|Noncompliant|2|||
130423777|NCT00251745|469510991|FG000|Overall Study|Pregnancy|0|||
130423778|NCT00251745|469510992|FG001|Overall Study|Pregnancy|1|||
130423779|NCT00251745|469510993|FG002|Overall Study|Pregnancy|0|||
130423780|NCT00251745|469510991|FG000|Overall Study|Per Subject Request|0|||
130423781|NCT00251745|469510992|FG001|Overall Study|Per Subject Request|0|||
130423782|NCT00251745|469510993|FG002|Overall Study|Per Subject Request|1|||
130423783|NCT00251745|469510991|FG000|Overall Study|Per Investigator Request|1|||
130423784|NCT00251745|469510992|FG001|Overall Study|Per Investigator Request|0|||
130423785|NCT00251745|469510993|FG002|Overall Study|Per Investigator Request|0|||
130423786|NCT04866017|469510996|FG000|Overall Study|Study Terminated by Sponsor|13|||
130423787|NCT04866017|469510997|FG001|Overall Study|Study Terminated by Sponsor|14|||
130423788|NCT04866017|469510998|FG002|Overall Study|Study Terminated by Sponsor|13|||
130423789|NCT04866017|469510996|FG000|Overall Study|Death|8|||
130423790|NCT04866017|469510997|FG001|Overall Study|Death|4|||
130423791|NCT04866017|469510998|FG002|Overall Study|Death|8|||
130423792|NCT04866017|469510996|FG000|Overall Study|Withdrawal by Subject|1|||
130423793|NCT04866017|469510997|FG001|Overall Study|Withdrawal by Subject|0|||
130423794|NCT04866017|469510998|FG002|Overall Study|Withdrawal by Subject|1|||
130423795|NCT04866017|469510996|FG000|Overall Study|Physician Decision|0|||
130423796|NCT04866017|469510997|FG001|Overall Study|Physician Decision|1|||
130423797|NCT04866017|469510998|FG002|Overall Study|Physician Decision|0|||
130423798|NCT01475136|469510999|FG000|Overall Study|Sponsor Decision|0|||
130423799|NCT01475136|469511000|FG001|Overall Study|Sponsor Decision|1|||
130423800|NCT01475136|469511001|FG002|Overall Study|Sponsor Decision|0|||
130423801|NCT01475136|469511002|FG003|Overall Study|Sponsor Decision|0|||
130423802|NCT01475136|469510999|FG000|Overall Study|Entry Criteria Not Met|0|||
130423803|NCT01475136|469511000|FG001|Overall Study|Entry Criteria Not Met|2|||
130423804|NCT01475136|469511001|FG002|Overall Study|Entry Criteria Not Met|3|||
130423805|NCT01475136|469511002|FG003|Overall Study|Entry Criteria Not Met|1|||
130423806|NCT01475136|469510999|FG000|Overall Study|Withdrawal by Subject|0|||
130423807|NCT01475136|469511000|FG001|Overall Study|Withdrawal by Subject|0|||
130423808|NCT01475136|469511001|FG002|Overall Study|Withdrawal by Subject|0|||
130423809|NCT01475136|469511002|FG003|Overall Study|Withdrawal by Subject|2|||
130423810|NCT01475136|469510999|FG000|Overall Study|Adverse Event|1|||
130423811|NCT01475136|469511000|FG001|Overall Study|Adverse Event|0|||
130423812|NCT01475136|469511001|FG002|Overall Study|Adverse Event|0|||
130423813|NCT01475136|469511002|FG003|Overall Study|Adverse Event|1|||
130423814|NCT01475136|469510999|FG000|Overall Study|Death|0|||
130423815|NCT01475136|469511000|FG001|Overall Study|Death|0|||
130423816|NCT01475136|469511001|FG002|Overall Study|Death|0|||
130423817|NCT01475136|469511002|FG003|Overall Study|Death|1|||
130423818|NCT04918784|469512720|FG000|Overall Study|Amputation - no longer eligible|1|||
130423819|NCT04918784|469512721|FG001|Overall Study|Amputation - no longer eligible|2|||
130423820|NCT04918784|469512720|FG000|Overall Study|Death|1|||
130423821|NCT04918784|469512721|FG001|Overall Study|Death|0|||
130423822|NCT04918784|469512720|FG000|Overall Study|patient non-compliance|3|||
130423823|NCT04918784|469512721|FG001|Overall Study|patient non-compliance|1|||
130423824|NCT04918784|469512720|FG000|Overall Study|Adverse Event|1|||
130423825|NCT04918784|469512721|FG001|Overall Study|Adverse Event|0|||
130423826|NCT04179175|469512725|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
130423827|NCT04179175|469512726|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
130423828|NCT04179175|469512727|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
130423829|NCT04179175|469512728|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
130423830|NCT04179175|469512729|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
130423831|NCT04179175|469512730|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
130423832|NCT04179175|469512725|FG000|Overall Study|Adverse Event|5|||
130423833|NCT04179175|469512726|FG001|Overall Study|Adverse Event|3|||
130423834|NCT04179175|469512727|FG002|Overall Study|Adverse Event|3|||
130423835|NCT04179175|469512728|FG003|Overall Study|Adverse Event|4|||
130423836|NCT04179175|469512729|FG004|Overall Study|Adverse Event|6|||
130423837|NCT04179175|469512730|FG005|Overall Study|Adverse Event|6|||
130423838|NCT04179175|469512725|FG000|Overall Study|Lack of Efficacy|5|||
130423839|NCT04179175|469512726|FG001|Overall Study|Lack of Efficacy|1|||
130423840|NCT04179175|469512727|FG002|Overall Study|Lack of Efficacy|3|||
130423841|NCT04179175|469512728|FG003|Overall Study|Lack of Efficacy|2|||
130423842|NCT04179175|469512729|FG004|Overall Study|Lack of Efficacy|18|||
130423843|NCT04179175|469512730|FG005|Overall Study|Lack of Efficacy|7|||
130423844|NCT04179175|469512725|FG000|Overall Study|Lost to Follow-up|5|||
130423845|NCT04179175|469512726|FG001|Overall Study|Lost to Follow-up|3|||
130423846|NCT04179175|469512727|FG002|Overall Study|Lost to Follow-up|2|||
130423847|NCT04179175|469512728|FG003|Overall Study|Lost to Follow-up|2|||
130423848|NCT04179175|469512729|FG004|Overall Study|Lost to Follow-up|4|||
130727505|NCT02856802|470625472|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
130727506|NCT02856802|470625473|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
130727507|NCT03092219|470625474|FG000|Overall Study|Protocol Violation|7|||
130727508|NCT03092219|470625475|FG001|Overall Study|Protocol Violation|4|||
130727509|NCT00459355|470625484|FG000|Overall Study|Subject no longer met inc criteria|20|||
130423849|NCT04179175|469512730|FG005|Overall Study|Lost to Follow-up|5|||
130423850|NCT04179175|469512725|FG000|Overall Study|Physician Decision|2|||
130423851|NCT04179175|469512726|FG001|Overall Study|Physician Decision|0|||
130423852|NCT04179175|469512727|FG002|Overall Study|Physician Decision|2|||
130423853|NCT04179175|469512728|FG003|Overall Study|Physician Decision|3|||
130423854|NCT04179175|469512729|FG004|Overall Study|Physician Decision|1|||
130423855|NCT04179175|469512730|FG005|Overall Study|Physician Decision|1|||
130423856|NCT04179175|469512725|FG000|Overall Study|Pregnancy|3|||
130423857|NCT04179175|469512726|FG001|Overall Study|Pregnancy|0|||
130423858|NCT04179175|469512727|FG002|Overall Study|Pregnancy|3|||
130423859|NCT04179175|469512728|FG003|Overall Study|Pregnancy|0|||
130423860|NCT04179175|469512729|FG004|Overall Study|Pregnancy|1|||
130423861|NCT04179175|469512730|FG005|Overall Study|Pregnancy|2|||
130423862|NCT04179175|469512725|FG000|Overall Study|Withdrawal by Subject|22|||
130423863|NCT04179175|469512726|FG001|Overall Study|Withdrawal by Subject|10|||
130423864|NCT04179175|469512727|FG002|Overall Study|Withdrawal by Subject|12|||
130423865|NCT04179175|469512728|FG003|Overall Study|Withdrawal by Subject|8|||
130423866|NCT04179175|469512729|FG004|Overall Study|Withdrawal by Subject|23|||
130423867|NCT04179175|469512730|FG005|Overall Study|Withdrawal by Subject|31|||
130423868|NCT04179175|469512725|FG000|Overall Study|Technical problems|0|||
130423869|NCT04179175|469512726|FG001|Overall Study|Technical problems|0|||
130423870|NCT04179175|469512727|FG002|Overall Study|Technical problems|1|||
130423871|NCT04179175|469512728|FG003|Overall Study|Technical problems|1|||
130423872|NCT04179175|469512729|FG004|Overall Study|Technical problems|0|||
130423873|NCT04179175|469512730|FG005|Overall Study|Technical problems|0|||
130423874|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
130423875|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
130423876|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
130423877|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
130423878|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
130423879|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
130423880|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Death|1|||
130423881|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Death|0|||
130423882|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Adverse Event|1|||
130423883|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Adverse Event|0|||
130423884|NCT02586025|469512740|FG000|Neoadjuvant Treatment|Physician Decision|2|||
130423885|NCT02586025|469512741|FG001|Neoadjuvant Treatment|Physician Decision|1|||
130423886|NCT02586025|469512740|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
130423887|NCT02586025|469512741|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
130423888|NCT02586025|469512740|FG000|Adjuvant Treatment|Recurrent Disease|4|||
130423889|NCT02586025|469512741|FG001|Adjuvant Treatment|Recurrent Disease|5|||
130423890|NCT02586025|469512740|FG000|Adjuvant Treatment|Physician Decision|0|||
130423891|NCT02586025|469512741|FG001|Adjuvant Treatment|Physician Decision|1|||
130423892|NCT02586025|469512740|FG000|Adjuvant Treatment|Pregnancy|1|||
130423893|NCT02586025|469512741|FG001|Adjuvant Treatment|Pregnancy|0|||
130423894|NCT02586025|469512740|FG000|Treatment-Free Follow-Up|Death|11|||
130423895|NCT02586025|469512741|FG001|Treatment-Free Follow-Up|Death|11|||
130423896|NCT02586025|469512740|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
130423897|NCT02586025|469512741|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
130423898|NCT02586025|469512740|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
130423899|NCT02586025|469512741|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
130423900|NCT02586025|469512740|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
130423901|NCT02586025|469512741|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
130727510|NCT00459355|470625485|FG001|Overall Study|Subject no longer met inc criteria|18|||
130423902|NCT02586025|469512740|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
130727511|NCT00287586|470625486|FG000|Overall Study|Withdrew Consent|19|||
130727512|NCT00287586|470625487|FG001|Overall Study|Withdrew Consent|30|||
130727513|NCT00287586|470625486|FG000|Overall Study|Lost to Follow-up|5|||
130423903|NCT02586025|469512741|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
130423904|NCT00175825|469512742|FG000|Overall Study|Adverse Event|3|||
130423905|NCT00175825|469512743|FG001|Overall Study|Adverse Event|2|||
130423906|NCT00175825|469512744|FG002|Overall Study|Adverse Event|1|||
130727514|NCT00287586|470625487|FG001|Overall Study|Lost to Follow-up|4|||
130423907|NCT00175825|469512745|FG003|Overall Study|Adverse Event|1|||
130423908|NCT00175825|469512742|FG000|Overall Study|Lost to Follow-up|1|||
130423909|NCT00175825|469512743|FG001|Overall Study|Lost to Follow-up|2|||
130423910|NCT00175825|469512744|FG002|Overall Study|Lost to Follow-up|0|||
130423911|NCT00175825|469512745|FG003|Overall Study|Lost to Follow-up|0|||
130423912|NCT00175825|469512742|FG000|Overall Study|Withdrawal by Subject|1|||
130423913|NCT00175825|469512743|FG001|Overall Study|Withdrawal by Subject|0|||
130727515|NCT00287586|470625486|FG000|Overall Study|Death|2|||
130727516|NCT00287586|470625487|FG001|Overall Study|Death|3|||
130727517|NCT00287586|470625486|FG000|Overall Study|Elevated Hematocrit|3|||
130727518|NCT00287586|470625487|FG001|Overall Study|Elevated Hematocrit|0|||
130727519|NCT00287586|470625486|FG000|Overall Study|Rash|3|||
130727520|NCT00287586|470625487|FG001|Overall Study|Rash|0|||
130727521|NCT00287586|470625486|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
130423914|NCT00175825|469512744|FG002|Overall Study|Withdrawal by Subject|0|||
130423915|NCT00175825|469512745|FG003|Overall Study|Withdrawal by Subject|0|||
130423916|NCT02030015|469512746|FG000|Overall Study|Withdrawal by Subject|3|||
130423917|NCT02030015|469512746|FG000|Overall Study|Death|13|||
130423918|NCT03014674|469512748|FG000|Overall Study|Withdrawal by Subject|1|||
130423919|NCT03014674|469512749|FG001|Overall Study|Withdrawal by Subject|0|||
130423920|NCT03014674|469512750|FG002|Overall Study|Withdrawal by Subject|0|||
130423921|NCT00833560|469512751|FG000|Overall Study|Toxicity|13|||
130423922|NCT00833560|469512751|FG000|Overall Study|Adverse Event|11|||
130423923|NCT00833560|469512751|FG000|Overall Study|Protocol Violation|6|||
130423924|NCT00833560|469512751|FG000|Overall Study|Lack of Efficacy|4|||
130423925|NCT00833560|469512751|FG000|Overall Study|Death|2|||
130423926|NCT00833560|469512751|FG000|Overall Study|Pregression of other disease|1|||
130423927|NCT00833560|469512751|FG000|Overall Study|Other|5|||
130423928|NCT02080871|469512756|FG000|Overall Study|Death|1|||
130423929|NCT02080871|469512756|FG000|Overall Study|Lost to Follow-up|1|||
130423930|NCT00234052|469512757|FG000|Treatment|Withdrawal by Subject|3|||
130423931|NCT00234052|469512757|FG000|Treatment|Adverse Event|5|||
130423932|NCT00234052|469512757|FG000|Treatment|Death|2|||
130423933|NCT00234052|469512757|FG000|Treatment|Progressive Disease|11|||
130423934|NCT00234052|469512757|FG000|Follow-up for 5 Years|Death|41|||
130423935|NCT00234052|469512757|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
130423936|NCT00234052|469512757|FG000|Follow-up for 5 Years|Other|7|||
130423937|NCT02428296|469512758|FG000|Overall Study|Adverse Event|7|||
130423938|NCT02428296|469512758|FG000|Overall Study|Withdrawal by Subject|2|||
130423939|NCT01615328|469512759|FG000|Overall Study|Lost to Follow-up|3|||
130423940|NCT01615328|469512760|FG001|Overall Study|Lost to Follow-up|5|||
130423941|NCT02548455|469512763|FG000|Overall Study|Withdrawal by Subject|27|||
130423942|NCT02548455|469512763|FG000|Overall Study|Death|26|||
130423943|NCT02548455|469512763|FG000|Overall Study|Lost to Follow-up|14|||
130423944|NCT02548455|469512763|FG000|Overall Study|Visit not completed|173|||
130423945|NCT02261493|469512767|FG000|Overall Study|Noncompliance|0|||
130423946|NCT02261493|469512768|FG001|Overall Study|Noncompliance|0|||
130423947|NCT02261493|469512769|FG002|Overall Study|Noncompliance|2|||
130423948|NCT02261493|469512767|FG000|Overall Study|Physician Decision|0|||
130423949|NCT02261493|469512768|FG001|Overall Study|Physician Decision|1|||
130423950|NCT02261493|469512769|FG002|Overall Study|Physician Decision|0|||
130423951|NCT02261493|469512767|FG000|Overall Study|Undisclosed alcohol abuse|0|||
130423952|NCT02261493|469512768|FG001|Overall Study|Undisclosed alcohol abuse|1|||
130423953|NCT02261493|469512769|FG002|Overall Study|Undisclosed alcohol abuse|0|||
130423954|NCT02261493|469512767|FG000|Overall Study|Protocol Violation|1|||
130423955|NCT02261493|469512768|FG001|Overall Study|Protocol Violation|0|||
130423956|NCT02261493|469512769|FG002|Overall Study|Protocol Violation|0|||
130423957|NCT02261493|469512767|FG000|Overall Study|Personal Reasons|14|||
130423958|NCT02261493|469512768|FG001|Overall Study|Personal Reasons|14|||
130423959|NCT02261493|469512769|FG002|Overall Study|Personal Reasons|16|||
130423960|NCT02261493|469512767|FG000|Overall Study|Lost to Follow-up|14|||
130423961|NCT02261493|469512768|FG001|Overall Study|Lost to Follow-up|27|||
130423962|NCT02261493|469512769|FG002|Overall Study|Lost to Follow-up|8|||
130423963|NCT02261493|469512767|FG000|Overall Study|Pregnancy|1|||
130423964|NCT02261493|469512768|FG001|Overall Study|Pregnancy|2|||
130423965|NCT02261493|469512769|FG002|Overall Study|Pregnancy|0|||
130423966|NCT02261493|469512767|FG000|Overall Study|Lack of Efficacy|0|||
130423967|NCT02261493|469512768|FG001|Overall Study|Lack of Efficacy|1|||
130423968|NCT02261493|469512769|FG002|Overall Study|Lack of Efficacy|0|||
130423969|NCT02261493|469512767|FG000|Overall Study|Adverse Event|0|||
130423970|NCT02261493|469512768|FG001|Overall Study|Adverse Event|1|||
130423971|NCT02261493|469512769|FG002|Overall Study|Adverse Event|0|||
130423972|NCT02230956|469512770|FG000|Overall Study|Adverse Event|1|||
130423973|NCT02230956|469512771|FG001|Overall Study|Adverse Event|1|||
130423974|NCT02230956|469512772|FG002|Overall Study|Adverse Event|0|||
130423975|NCT02230956|469512770|FG000|Overall Study|Lack of Efficacy|1|||
130423976|NCT02230956|469512771|FG001|Overall Study|Lack of Efficacy|1|||
130423977|NCT02230956|469512772|FG002|Overall Study|Lack of Efficacy|1|||
130423978|NCT02230956|469512770|FG000|Overall Study|Lost to Follow-up|1|||
130423979|NCT02230956|469512771|FG001|Overall Study|Lost to Follow-up|1|||
130423980|NCT02230956|469512772|FG002|Overall Study|Lost to Follow-up|2|||
130423981|NCT02230956|469512770|FG000|Overall Study|Personal Reasons|2|||
130423982|NCT02230956|469512771|FG001|Overall Study|Personal Reasons|1|||
130423983|NCT02230956|469512772|FG002|Overall Study|Personal Reasons|1|||
130423984|NCT02230956|469512770|FG000|Overall Study|Protocol Violation|0|||
130423985|NCT02230956|469512771|FG001|Overall Study|Protocol Violation|1|||
130423986|NCT02230956|469512772|FG002|Overall Study|Protocol Violation|1|||
130423987|NCT02230956|469512770|FG000|Overall Study|Other Miscellaneous Reason|0|||
130727522|NCT00287586|470625487|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
130476603|NCT00999804|469713291|FG001|Overall Study|Adverse Event|3|||
130476604|NCT00999804|469713290|FG000|Overall Study|Withdrawal by Subject|4|||
130476605|NCT00999804|469713291|FG001|Overall Study|Withdrawal by Subject|0|||
130476606|NCT00999804|469713290|FG000|Overall Study|Death|1|||
130476607|NCT00999804|469713291|FG001|Overall Study|Death|0|||
130476608|NCT00999804|469713290|FG000|Overall Study|Ineligible|3|||
130476609|NCT00999804|469713291|FG001|Overall Study|Ineligible|0|||
130476610|NCT05256706|469713293|FG000|Overall Study|Lost to Follow-up|9|||
130476611|NCT05256706|469713294|FG001|Overall Study|Lost to Follow-up|3|||
130476612|NCT05256706|469713293|FG000|Overall Study|Withdrawal by Subject|7|||
130476613|NCT05256706|469713294|FG001|Overall Study|Withdrawal by Subject|11|||
130476614|NCT05256706|469713293|FG000|Overall Study|Screen Failures|3|||
130476615|NCT05256706|469713294|FG001|Overall Study|Screen Failures|0|||
130476616|NCT01997840|469713295|FG000|Overall Study|Lost to Follow-up|0|||
130564655|NCT02343159|470033699|FG002|Overall Study|Physician Decision|1|||
130564656|NCT02343159|470033697|FG000|Overall Study|Withdrawal by Subject|3|||
130564657|NCT02343159|470033698|FG001|Overall Study|Withdrawal by Subject|0|||
130564658|NCT02343159|470033699|FG002|Overall Study|Withdrawal by Subject|2|||
130564659|NCT02343159|470033697|FG000|Overall Study|Lost to Follow-up|0|||
130564660|NCT02343159|470033698|FG001|Overall Study|Lost to Follow-up|2|||
130564661|NCT02343159|470033699|FG002|Overall Study|Lost to Follow-up|2|||
130423988|NCT02230956|469512771|FG001|Overall Study|Other Miscellaneous Reason|1|||
130423989|NCT02230956|469512772|FG002|Overall Study|Other Miscellaneous Reason|2|||
130423990|NCT00338884|469512773|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
130423991|NCT00338884|469512773|FG000|Overall Study|Adverse Event|14|||
130423992|NCT00338884|469512773|FG000|Overall Study|Death|8|||
130423993|NCT00338884|469512773|FG000|Overall Study|Other|4|||
130423994|NCT00338884|469512773|FG000|Overall Study|Global Deterioration of Health Status|3|||
130423995|NCT00338884|469512773|FG000|Overall Study|Withdrawal by Subject|3|||
130423996|NCT00338884|469512773|FG000|Overall Study|Lost to Follow-up|1|||
130423997|NCT00338884|469512773|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
130423998|NCT01970982|469512775|FG000|Overall Study|Withdrawal by Subject|0|||
130423999|NCT01970982|469512776|FG001|Overall Study|Withdrawal by Subject|0|||
130424000|NCT01970982|469512777|FG002|Overall Study|Withdrawal by Subject|2|||
130424001|NCT01984684|469512782|FG000|Overall Study|Lost to Follow-up|25|||
130424002|NCT01984684|469512783|FG001|Overall Study|Lost to Follow-up|24|||
130424003|NCT01984684|469512782|FG000|Overall Study|Adverse Event|8|||
130424004|NCT01984684|469512783|FG001|Overall Study|Adverse Event|12|||
130424005|NCT01984684|469512782|FG000|Overall Study|Withdrawal by Subject|9|||
130424006|NCT01984684|469512783|FG001|Overall Study|Withdrawal by Subject|9|||
130424007|NCT01984684|469512782|FG000|Overall Study|Lack of Efficacy|3|||
130424008|NCT01984684|469512783|FG001|Overall Study|Lack of Efficacy|6|||
130424009|NCT01984684|469512782|FG000|Overall Study|Physician Decision|4|||
130424010|NCT01984684|469512783|FG001|Overall Study|Physician Decision|2|||
130424011|NCT01984684|469512782|FG000|Overall Study|Protocol Violation|4|||
130424012|NCT01984684|469512783|FG001|Overall Study|Protocol Violation|2|||
130424013|NCT01984684|469512782|FG000|Overall Study|Death|0|||
130424014|NCT01984684|469512783|FG001|Overall Study|Death|1|||
130424015|NCT01984684|469512782|FG000|Overall Study|Noncompliance with study drug|2|||
130424016|NCT01984684|469512783|FG001|Overall Study|Noncompliance with study drug|1|||
130424017|NCT01984684|469512782|FG000|Overall Study|Subject incarcerated|1|||
130424018|NCT01984684|469512783|FG001|Overall Study|Subject incarcerated|0|||
130424019|NCT01984684|469512782|FG000|Overall Study|Study drug not available at site|1|||
130424020|NCT01984684|469512783|FG001|Overall Study|Study drug not available at site|1|||
130424021|NCT01984684|469512782|FG000|Overall Study|Subject had inadequate IV access|0|||
130424022|NCT01984684|469512783|FG001|Overall Study|Subject had inadequate IV access|1|||
130424023|NCT05711641|469512788|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
130424024|NCT05711641|469512789|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
130424025|NCT05711641|469512788|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
130564662|NCT02343159|470033697|FG000|Overall Study|Adverse Event|4|||
130564663|NCT02343159|470033698|FG001|Overall Study|Adverse Event|4|||
130424026|NCT05711641|469512789|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
130424027|NCT04575051|469512790|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
130424028|NCT04575051|469512791|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
130424029|NCT04575051|469512792|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
130424030|NCT04575051|469512793|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
130424031|NCT04575051|469512794|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
130424032|NCT04575051|469512790|FG000|Time Period 1|Missing follow up|1|||
130424033|NCT04575051|469512791|FG001|Time Period 1|Missing follow up|3|||
130476617|NCT01997840|469713296|FG001|Overall Study|Lost to Follow-up|0|||
130476618|NCT01997840|469713297|FG002|Overall Study|Lost to Follow-up|1|||
130476619|NCT01997840|469713298|FG003|Overall Study|Lost to Follow-up|0|||
130476620|NCT01997840|469713295|FG000|Overall Study|Withdrawal by participant|0|||
130476621|NCT01997840|469713296|FG001|Overall Study|Withdrawal by participant|0|||
130564664|NCT02343159|470033699|FG002|Overall Study|Adverse Event|2|||
130424034|NCT04575051|469512792|FG002|Time Period 1|Missing follow up|1|||
130424035|NCT04575051|469512793|FG003|Time Period 1|Missing follow up|3|||
130424036|NCT04575051|469512794|FG004|Time Period 1|Missing follow up|2|||
130424037|NCT04575051|469512790|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
130424038|NCT04575051|469512791|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
130424039|NCT04575051|469512792|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
130424040|NCT04575051|469512793|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
130424041|NCT04575051|469512794|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
130424042|NCT04575051|469512790|FG000|Time Period 2|Missing follow up|1|||
130424043|NCT04575051|469512791|FG001|Time Period 2|Missing follow up|8|||
130424044|NCT04575051|469512792|FG002|Time Period 2|Missing follow up|7|||
130424045|NCT04575051|469512793|FG003|Time Period 2|Missing follow up|0|||
130424046|NCT04575051|469512794|FG004|Time Period 2|Missing follow up|1|||
130424047|NCT04575051|469512790|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
130424048|NCT04575051|469512791|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
130424049|NCT04575051|469512792|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
130424050|NCT04575051|469512793|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
130424051|NCT04575051|469512794|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
130424052|NCT04575051|469512790|FG000|Time Period 3|Missing follow up|8|||
130424053|NCT04575051|469512791|FG001|Time Period 3|Missing follow up|6|||
130424054|NCT04575051|469512792|FG002|Time Period 3|Missing follow up|4|||
130424055|NCT04575051|469512793|FG003|Time Period 3|Missing follow up|3|||
130424056|NCT04575051|469512794|FG004|Time Period 3|Missing follow up|0|||
130424057|NCT04575051|469512790|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
130424058|NCT04575051|469512791|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
130424059|NCT04575051|469512792|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
130424060|NCT04575051|469512793|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
130424061|NCT04575051|469512794|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
130424062|NCT04575051|469512790|FG000|Time Period 4|Missing follow up|17|||
130424063|NCT04575051|469512791|FG001|Time Period 4|Missing follow up|3|||
130424064|NCT04575051|469512792|FG002|Time Period 4|Missing follow up|4|||
130424065|NCT04575051|469512793|FG003|Time Period 4|Missing follow up|2|||
130424066|NCT04575051|469512794|FG004|Time Period 4|Missing follow up|1|||
130424067|NCT04575051|469512790|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
130424068|NCT04575051|469512791|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
130424069|NCT04575051|469512792|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
130424070|NCT04575051|469512793|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
130424071|NCT04575051|469512794|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
130424072|NCT04575051|469512790|FG000|Time Period 5|Missing follow up|11|||
130424073|NCT04575051|469512791|FG001|Time Period 5|Missing follow up|8|||
130424074|NCT04575051|469512792|FG002|Time Period 5|Missing follow up|12|||
130424075|NCT04575051|469512793|FG003|Time Period 5|Missing follow up|3|||
130424076|NCT04575051|469512794|FG004|Time Period 5|Missing follow up|11|||
130424077|NCT03624504|469512795|FG000|Overall Study|Unsuccessful Implant|1|||
130424078|NCT02862457|469512796|FG000|Overall Study|Death|1|||
130424079|NCT02862457|469512797|FG001|Overall Study|Death|3|||
130424080|NCT02862457|469512798|FG002|Overall Study|Death|2|||
130424081|NCT02862457|469512799|FG003|Overall Study|Death|3|||
130424082|NCT02862457|469512800|FG004|Overall Study|Death|0|||
130424083|NCT02862457|469512801|FG005|Overall Study|Death|2|||
130424084|NCT02862457|469512802|FG006|Overall Study|Death|1|||
130424085|NCT02862457|469512796|FG000|Overall Study|Lost to Follow-up|1|||
130424086|NCT02862457|469512797|FG001|Overall Study|Lost to Follow-up|0|||
130424087|NCT02862457|469512798|FG002|Overall Study|Lost to Follow-up|0|||
130424088|NCT02862457|469512799|FG003|Overall Study|Lost to Follow-up|1|||
130424089|NCT02862457|469512800|FG004|Overall Study|Lost to Follow-up|0|||
130424090|NCT02862457|469512801|FG005|Overall Study|Lost to Follow-up|0|||
130424091|NCT02862457|469512802|FG006|Overall Study|Lost to Follow-up|0|||
130424092|NCT02862457|469512796|FG000|Overall Study|Withdrawal by Subject|0|||
130424093|NCT02862457|469512797|FG001|Overall Study|Withdrawal by Subject|0|||
130424094|NCT02862457|469512798|FG002|Overall Study|Withdrawal by Subject|1|||
130424095|NCT02862457|469512799|FG003|Overall Study|Withdrawal by Subject|0|||
130424096|NCT02862457|469512800|FG004|Overall Study|Withdrawal by Subject|0|||
130424097|NCT02862457|469512801|FG005|Overall Study|Withdrawal by Subject|1|||
130424098|NCT02862457|469512802|FG006|Overall Study|Withdrawal by Subject|0|||
130424099|NCT00951483|469512805|FG000|Overall Study|Physician Decision|4|||
130424100|NCT00951483|469512806|FG001|Overall Study|Physician Decision|0|||
130424101|NCT00951483|469512805|FG000|Overall Study|Withdrawal by Subject|15|||
130424102|NCT00951483|469512806|FG001|Overall Study|Withdrawal by Subject|0|||
130424103|NCT03364751|469512809|FG000|Overall Study|Withdrawal by Subject|1|||
130424104|NCT03364751|469512810|FG001|Overall Study|Withdrawal by Subject|0|||
130564665|NCT02343159|470033697|FG000|Overall Study|Sponsor Decision|0|||
130424105|NCT03364751|469512811|FG002|Overall Study|Withdrawal by Subject|0|||
130424106|NCT03364751|469512812|FG003|Overall Study|Withdrawal by Subject|0|||
130424107|NCT03364751|469512809|FG000|Overall Study|Lost to Follow-up|0|||
130424108|NCT03364751|469512810|FG001|Overall Study|Lost to Follow-up|1|||
130424109|NCT03364751|469512811|FG002|Overall Study|Lost to Follow-up|0|||
130424110|NCT03364751|469512812|FG003|Overall Study|Lost to Follow-up|0|||
130424111|NCT03583554|469512813|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
130424112|NCT03583554|469512814|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
130424113|NCT03583554|469512815|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
130424114|NCT03178266|469512816|FG000|Overall Study|Death|0|||
130424115|NCT03178266|469512817|FG001|Overall Study|Death|1|||
130424116|NCT03178266|469512816|FG000|Overall Study|Disont. Early|0|||
130424117|NCT03178266|469512817|FG001|Overall Study|Disont. Early|1|||
130424118|NCT03178266|469512816|FG000|Overall Study|Withdrawal by Subject|0|||
130424119|NCT03178266|469512817|FG001|Overall Study|Withdrawal by Subject|2|||
130424120|NCT02342886|469512818|FG000|Overall Study|Treatment non-compliance|1|||
130424121|NCT02342886|469512819|FG001|Overall Study|Treatment non-compliance|0|||
130424122|NCT02342886|469512820|FG002|Overall Study|Treatment non-compliance|0|||
130424123|NCT02342886|469512821|FG003|Overall Study|Treatment non-compliance|1|||
130424124|NCT02342886|469512822|FG004|Overall Study|Treatment non-compliance|0|||
130424125|NCT02342886|469512818|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
130424126|NCT02342886|469512819|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
130424127|NCT02342886|469512820|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
130424128|NCT02342886|469512821|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
130424129|NCT02342886|469512822|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
130424130|NCT02342886|469512818|FG000|Overall Study|Adverse event/specific toxicity|4|||
130424131|NCT02342886|469512819|FG001|Overall Study|Adverse event/specific toxicity|3|||
130424132|NCT02342886|469512820|FG002|Overall Study|Adverse event/specific toxicity|11|||
130424133|NCT02342886|469512821|FG003|Overall Study|Adverse event/specific toxicity|2|||
130424134|NCT02342886|469512822|FG004|Overall Study|Adverse event/specific toxicity|1|||
130424135|NCT02342886|469512818|FG000|Overall Study|Lost to Follow-up|1|||
130424136|NCT02342886|469512819|FG001|Overall Study|Lost to Follow-up|0|||
130424137|NCT02342886|469512820|FG002|Overall Study|Lost to Follow-up|0|||
130424138|NCT02342886|469512821|FG003|Overall Study|Lost to Follow-up|0|||
130424139|NCT02342886|469512822|FG004|Overall Study|Lost to Follow-up|0|||
130424140|NCT02342886|469512818|FG000|Overall Study|Death|1|||
130424141|NCT02342886|469512819|FG001|Overall Study|Death|2|||
130424142|NCT02342886|469512820|FG002|Overall Study|Death|1|||
130424143|NCT02342886|469512821|FG003|Overall Study|Death|0|||
130424144|NCT02342886|469512822|FG004|Overall Study|Death|1|||
130424145|NCT02342886|469512818|FG000|Overall Study|Withdrawal by Subject|0|||
130424146|NCT02342886|469512819|FG001|Overall Study|Withdrawal by Subject|1|||
130424147|NCT02342886|469512820|FG002|Overall Study|Withdrawal by Subject|0|||
130424148|NCT02342886|469512821|FG003|Overall Study|Withdrawal by Subject|1|||
130424149|NCT02342886|469512822|FG004|Overall Study|Withdrawal by Subject|0|||
130424150|NCT02342886|469512818|FG000|Overall Study|Investigator/sponsor decision|0|||
130424151|NCT02342886|469512819|FG001|Overall Study|Investigator/sponsor decision|2|||
130424152|NCT02342886|469512820|FG002|Overall Study|Investigator/sponsor decision|0|||
130424153|NCT02342886|469512821|FG003|Overall Study|Investigator/sponsor decision|3|||
130476622|NCT01997840|469713297|FG002|Overall Study|Withdrawal by participant|8|||
130476623|NCT01997840|469713298|FG003|Overall Study|Withdrawal by participant|1|||
130476624|NCT01997840|469713295|FG000|Overall Study|Physician Decision|0|||
130476625|NCT01997840|469713296|FG001|Overall Study|Physician Decision|0|||
130476626|NCT01997840|469713297|FG002|Overall Study|Physician Decision|3|||
130476627|NCT01997840|469713298|FG003|Overall Study|Physician Decision|0|||
130476628|NCT01997840|469713295|FG000|Overall Study|Progressive disease|3|||
130476629|NCT01997840|469713296|FG001|Overall Study|Progressive disease|4|||
130476630|NCT01997840|469713297|FG002|Overall Study|Progressive disease|57|||
130476631|NCT01997840|469713298|FG003|Overall Study|Progressive disease|8|||
130476632|NCT01997840|469713295|FG000|Overall Study|Other reasons|0|||
130476633|NCT01997840|469713296|FG001|Overall Study|Other reasons|0|||
130424154|NCT02342886|469512822|FG004|Overall Study|Investigator/sponsor decision|1|||
130424155|NCT02342886|469512818|FG000|Overall Study|Pregnancy|0|||
130424156|NCT02342886|469512819|FG001|Overall Study|Pregnancy|0|||
130424157|NCT02342886|469512820|FG002|Overall Study|Pregnancy|2|||
130424158|NCT02342886|469512821|FG003|Overall Study|Pregnancy|0|||
130424159|NCT02342886|469512822|FG004|Overall Study|Pregnancy|0|||
130424160|NCT02342886|469512818|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130424161|NCT02342886|469512819|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130424162|NCT02342886|469512820|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
130424163|NCT02342886|469512821|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130424164|NCT02342886|469512822|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130424165|NCT02342886|469512818|FG000|Overall Study|Protocol Violation|0|||
130424166|NCT02342886|469512819|FG001|Overall Study|Protocol Violation|0|||
130424167|NCT02342886|469512820|FG002|Overall Study|Protocol Violation|0|||
130476634|NCT01997840|469713297|FG002|Overall Study|Other reasons|1|||
130476635|NCT01997840|469713298|FG003|Overall Study|Other reasons|0|||
130424168|NCT02342886|469512821|FG003|Overall Study|Protocol Violation|2|||
130424169|NCT02342886|469512822|FG004|Overall Study|Protocol Violation|0|||
130424170|NCT01328080|469512823|FG000|Overall Study|Lost to Follow-up|5|||
130424171|NCT00862134|469512824|FG000|Overall Study|Death|1|||
130424172|NCT00862134|469512825|FG001|Overall Study|Death|0|||
130424173|NCT00862134|469512824|FG000|Overall Study|Physician Decision|0|||
130424174|NCT00862134|469512825|FG001|Overall Study|Physician Decision|1|||
130424175|NCT00862134|469512824|FG000|Overall Study|Withdrawal by Subject|1|||
130424176|NCT00862134|469512825|FG001|Overall Study|Withdrawal by Subject|2|||
130424177|NCT00862134|469512824|FG000|Overall Study|Sponsor terminated study|5|||
130424178|NCT00862134|469512825|FG001|Overall Study|Sponsor terminated study|7|||
130424179|NCT00862134|469512824|FG000|Overall Study|Adverse Event|2|||
130424180|NCT00862134|469512825|FG001|Overall Study|Adverse Event|2|||
130424181|NCT00862134|469512824|FG000|Overall Study|Withdrew prior to dosing|2|||
130424182|NCT00862134|469512825|FG001|Overall Study|Withdrew prior to dosing|0|||
130424183|NCT02191267|469512826|FG000|Overall Study|Withdrawal by Subject|1|||
130424184|NCT02191267|469512827|FG001|Overall Study|Withdrawal by Subject|0|||
130424185|NCT02191267|469512828|FG002|Overall Study|Withdrawal by Subject|0|||
130424186|NCT00765674|469512829|FG000|Overall Study|Adverse Event|7|||
130424187|NCT00765674|469512830|FG001|Overall Study|Adverse Event|2|||
130424188|NCT00765674|469512831|FG002|Overall Study|Adverse Event|8|||
130424189|NCT00765674|469512832|FG003|Overall Study|Adverse Event|11|||
130424190|NCT00765674|469512829|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
130424191|NCT00765674|469512830|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
130424192|NCT00765674|469512831|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
130424193|NCT00765674|469512832|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
130424194|NCT00765674|469512829|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130424195|NCT00765674|469512830|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
130424196|NCT00765674|469512831|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
130424197|NCT00765674|469512832|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
130424198|NCT00765674|469512829|FG000|Overall Study|Lack of Efficacy|2|||
130424199|NCT00765674|469512830|FG001|Overall Study|Lack of Efficacy|3|||
130424200|NCT00765674|469512831|FG002|Overall Study|Lack of Efficacy|1|||
130424201|NCT00765674|469512832|FG003|Overall Study|Lack of Efficacy|2|||
130424202|NCT00765674|469512829|FG000|Overall Study|Protocol Violation|2|||
130424203|NCT00765674|469512830|FG001|Overall Study|Protocol Violation|0|||
130424204|NCT00765674|469512831|FG002|Overall Study|Protocol Violation|1|||
130424205|NCT00765674|469512832|FG003|Overall Study|Protocol Violation|0|||
130424206|NCT00765674|469512829|FG000|Overall Study|Withdrawal by Subject|5|||
130424207|NCT00765674|469512830|FG001|Overall Study|Withdrawal by Subject|7|||
130424208|NCT00765674|469512831|FG002|Overall Study|Withdrawal by Subject|3|||
130424209|NCT00765674|469512832|FG003|Overall Study|Withdrawal by Subject|8|||
130424210|NCT00765674|469512829|FG000|Overall Study|Lost to Follow-up|4|||
130424211|NCT00765674|469512830|FG001|Overall Study|Lost to Follow-up|6|||
130424212|NCT00765674|469512831|FG002|Overall Study|Lost to Follow-up|2|||
130424213|NCT00765674|469512832|FG003|Overall Study|Lost to Follow-up|1|||
130424214|NCT00765674|469512829|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
130424215|NCT00765674|469512830|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
130424216|NCT00765674|469512831|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
130424217|NCT00765674|469512832|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
130424218|NCT01813474|469512833|FG000|Overall Study|Withdrawal by Subject|0|||
130424219|NCT01813474|469512834|FG001|Overall Study|Withdrawal by Subject|0|||
130424220|NCT01813474|469512835|FG002|Overall Study|Withdrawal by Subject|1|||
130424221|NCT01813474|469512833|FG000|Overall Study|Adverse Event|1|||
130424222|NCT01813474|469512834|FG001|Overall Study|Adverse Event|1|||
130424223|NCT01813474|469512835|FG002|Overall Study|Adverse Event|0|||
130424224|NCT01813474|469512833|FG000|Overall Study|Lack of Efficacy|2|||
130424225|NCT01813474|469512834|FG001|Overall Study|Lack of Efficacy|6|||
130476636|NCT01997840|469713295|FG000|Overall Study|Adverse Event|0|||
130424226|NCT01813474|469512835|FG002|Overall Study|Lack of Efficacy|9|||
130424227|NCT01813474|469512833|FG000|Overall Study|Death|0|||
130424228|NCT01813474|469512834|FG001|Overall Study|Death|0|||
130424229|NCT01813474|469512835|FG002|Overall Study|Death|1|||
130424230|NCT00316082|469512838|FG000|Overall Study|Lack of Efficacy|2|||
130424231|NCT00316082|469512839|FG001|Overall Study|Lack of Efficacy|3|||
130424232|NCT00316082|469512840|FG002|Overall Study|Lack of Efficacy|3|||
130424233|NCT00316082|469512841|FG003|Overall Study|Lack of Efficacy|4|||
130424234|NCT00316082|469512842|FG004|Overall Study|Lack of Efficacy|6|||
130424235|NCT00316082|469512838|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
130424236|NCT00316082|469512839|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
130424237|NCT00316082|469512840|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
130424238|NCT00316082|469512841|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
130424239|NCT00316082|469512842|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
130424240|NCT00316082|469512838|FG000|Overall Study|Lost to Follow-up|7|||
130424241|NCT00316082|469512839|FG001|Overall Study|Lost to Follow-up|6|||
130424242|NCT00316082|469512840|FG002|Overall Study|Lost to Follow-up|7|||
130424243|NCT00316082|469512841|FG003|Overall Study|Lost to Follow-up|8|||
130424244|NCT00316082|469512842|FG004|Overall Study|Lost to Follow-up|6|||
130476637|NCT01997840|469713296|FG001|Overall Study|Adverse Event|0|||
130476638|NCT01997840|469713297|FG002|Overall Study|Adverse Event|15|||
130476639|NCT01997840|469713298|FG003|Overall Study|Adverse Event|2|||
130476640|NCT03850678|469713299|FG000|Overall Study|Withdrawal by Subject|3|||
130476641|NCT03850678|469713300|FG001|Overall Study|Withdrawal by Subject|0|||
130424245|NCT00316082|469512838|FG000|Overall Study|Poor/noncompliance|6|||
130424246|NCT00316082|469512839|FG001|Overall Study|Poor/noncompliance|1|||
130424247|NCT00316082|469512840|FG002|Overall Study|Poor/noncompliance|4|||
130424248|NCT00316082|469512841|FG003|Overall Study|Poor/noncompliance|1|||
130424249|NCT00316082|469512842|FG004|Overall Study|Poor/noncompliance|4|||
130424250|NCT00316082|469512838|FG000|Overall Study|Adverse Event|4|||
130424251|NCT00316082|469512839|FG001|Overall Study|Adverse Event|2|||
130424252|NCT00316082|469512840|FG002|Overall Study|Adverse Event|5|||
130424253|NCT00316082|469512841|FG003|Overall Study|Adverse Event|1|||
130424254|NCT00316082|469512842|FG004|Overall Study|Adverse Event|3|||
130424255|NCT00316082|469512838|FG000|Overall Study|Subject no longer meets study criteria|3|||
130424256|NCT00316082|469512839|FG001|Overall Study|Subject no longer meets study criteria|1|||
130424257|NCT00316082|469512840|FG002|Overall Study|Subject no longer meets study criteria|2|||
130424258|NCT00316082|469512841|FG003|Overall Study|Subject no longer meets study criteria|2|||
130424259|NCT00316082|469512842|FG004|Overall Study|Subject no longer meets study criteria|1|||
130424260|NCT00316082|469512838|FG000|Overall Study|Physician Decision|1|||
130424261|NCT00316082|469512839|FG001|Overall Study|Physician Decision|1|||
130424262|NCT00316082|469512840|FG002|Overall Study|Physician Decision|2|||
130424263|NCT00316082|469512841|FG003|Overall Study|Physician Decision|1|||
130424264|NCT00316082|469512842|FG004|Overall Study|Physician Decision|1|||
130424265|NCT00316082|469512838|FG000|Overall Study|Death|0|||
130424266|NCT00316082|469512839|FG001|Overall Study|Death|0|||
130424267|NCT00316082|469512840|FG002|Overall Study|Death|1|||
130424268|NCT00316082|469512841|FG003|Overall Study|Death|0|||
130424269|NCT00316082|469512842|FG004|Overall Study|Death|0|||
130424270|NCT00316082|469512838|FG000|Overall Study|Administrative reason by sponsor|0|||
130424271|NCT00316082|469512839|FG001|Overall Study|Administrative reason by sponsor|0|||
130424272|NCT00316082|469512840|FG002|Overall Study|Administrative reason by sponsor|1|||
130424273|NCT00316082|469512841|FG003|Overall Study|Administrative reason by sponsor|0|||
130424274|NCT00316082|469512842|FG004|Overall Study|Administrative reason by sponsor|0|||
130424275|NCT00528775|469512845|FG000|Overall Study|Other not specified|1|||
130424276|NCT01569438|469512853|FG000|Overall Study|Lack of Efficacy|1|||
130424277|NCT01569438|469512854|FG001|Overall Study|Lack of Efficacy|2|||
130424278|NCT01569438|469512853|FG000|Overall Study|Withdrawal by Subject|0|||
130424279|NCT01569438|469512854|FG001|Overall Study|Withdrawal by Subject|3|||
130424280|NCT01569438|469512853|FG000|Overall Study|Adverse Event|2|||
130424281|NCT01569438|469512854|FG001|Overall Study|Adverse Event|15|||
130476642|NCT03850678|469713299|FG000|Overall Study|Experimenter Error|1|||
130476643|NCT03850678|469713300|FG001|Overall Study|Experimenter Error|1|||
130476644|NCT03850678|469713299|FG000|Overall Study|Did Not Condition To Experiment|7|||
130476645|NCT03850678|469713300|FG001|Overall Study|Did Not Condition To Experiment|2|||
130476646|NCT01573442|469713303|FG000|Overall Study|Cancels|9|||
130476647|NCT01573442|469713304|FG001|Overall Study|Cancels|10|||
130476648|NCT05710107|469713306|FG000|Overall Study|Withdrawal by Subject|1|||
130476649|NCT05710107|469713307|FG001|Overall Study|Withdrawal by Subject|1|||
130476650|NCT05710107|469713306|FG000|Overall Study|Lost to Follow-up|8|||
130476651|NCT05710107|469713307|FG001|Overall Study|Lost to Follow-up|9|||
130476652|NCT05710107|469713306|FG000|Overall Study|Unable to place assigned block|2|||
130476653|NCT05710107|469713307|FG001|Overall Study|Unable to place assigned block|0|||
130476654|NCT05710107|469713306|FG000|Overall Study|Withdrawn by study team|0|||
130476655|NCT05710107|469713307|FG001|Overall Study|Withdrawn by study team|1|||
130476656|NCT04166773|469713308|FG000|Overall Study|Adverse Event|2|||
130476657|NCT04166773|469713309|FG001|Overall Study|Adverse Event|0|||
130476658|NCT04166773|469713310|FG002|Overall Study|Adverse Event|2|||
130476659|NCT04166773|469713311|FG003|Overall Study|Adverse Event|1|||
130476660|NCT04166773|469713308|FG000|Overall Study|Lost to Follow-up|4|||
130476661|NCT04166773|469713309|FG001|Overall Study|Lost to Follow-up|2|||
130476662|NCT04166773|469713310|FG002|Overall Study|Lost to Follow-up|1|||
130424282|NCT01569438|469512853|FG000|Overall Study|Protocol Violation|2|||
130424283|NCT01569438|469512854|FG001|Overall Study|Protocol Violation|0|||
130564666|NCT02343159|470033698|FG001|Overall Study|Sponsor Decision|1|||
130424284|NCT01569438|469512853|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
130424285|NCT01569438|469512854|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
130424286|NCT01569438|469512853|FG000|Overall Study|Sponsor/Physician decision|1|||
130424287|NCT01569438|469512854|FG001|Overall Study|Sponsor/Physician decision|1|||
130424288|NCT01569438|469512853|FG000|Overall Study|Unable to adhere to study schedule|0|||
130424289|NCT01569438|469512854|FG001|Overall Study|Unable to adhere to study schedule|1|||
130424290|NCT02432105|469512859|FG000|Overall Study|Lost to Follow-up|1|||
130424291|NCT02432105|469512860|FG001|Overall Study|Lost to Follow-up|1|||
130476663|NCT04166773|469713311|FG003|Overall Study|Lost to Follow-up|3|||
130476664|NCT04166773|469713308|FG000|Overall Study|Physician Decision|0|||
130476665|NCT04166773|469713309|FG001|Overall Study|Physician Decision|0|||
130564667|NCT02343159|470033699|FG002|Overall Study|Sponsor Decision|0|||
130564668|NCT02343159|470033697|FG000|Overall Study|Enrollment Error|1|||
130564669|NCT02343159|470033698|FG001|Overall Study|Enrollment Error|0|||
130564670|NCT02343159|470033699|FG002|Overall Study|Enrollment Error|0|||
130564671|NCT01075412|470033705|FG000|Overall Study|Withdrawal by Subject|0|||
130564672|NCT01075412|470033706|FG001|Overall Study|Withdrawal by Subject|1|||
130727523|NCT00287586|470625486|FG000|Overall Study|Stroke|2|||
130727524|NCT00287586|470625487|FG001|Overall Study|Stroke|0|||
130424292|NCT02432105|469512861|FG002|Overall Study|Lost to Follow-up|0|||
130424293|NCT02432105|469512859|FG000|Overall Study|Withdrawal by Subject|1|||
130424294|NCT02432105|469512860|FG001|Overall Study|Withdrawal by Subject|0|||
130424295|NCT02432105|469512861|FG002|Overall Study|Withdrawal by Subject|1|||
130424296|NCT02432105|469512859|FG000|Overall Study|Culture positive for yeast|0|||
130424297|NCT02432105|469512860|FG001|Overall Study|Culture positive for yeast|1|||
130424298|NCT02432105|469512861|FG002|Overall Study|Culture positive for yeast|0|||
130424299|NCT02432105|469512859|FG000|Overall Study|Randomized in error|0|||
130424300|NCT02432105|469512860|FG001|Overall Study|Randomized in error|0|||
130424301|NCT02432105|469512861|FG002|Overall Study|Randomized in error|2|||
130424302|NCT01400503|469512862|FG000|Overall Study|Withdrawal by Subject|1|||
130424303|NCT01400503|469512862|FG000|Overall Study|Study Terminated by Sponsor|58|||
130424304|NCT01400503|469512862|FG000|Overall Study|Other|1|||
130424305|NCT00058123|469512863|FG000|Overall Study|Wrong histology|9|||
130424306|NCT00058123|469512863|FG000|Overall Study|Received >3 prior treatments|1|||
130424307|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
130424308|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
130424309|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
130424310|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424311|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424312|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424313|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424314|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424315|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130424316|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
130424317|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
130424318|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
130424319|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424320|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424321|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424322|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424323|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424324|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130424325|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
130424326|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130424327|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
130424328|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424329|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424330|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424331|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424332|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424333|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130424334|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130424335|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424336|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
130424337|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424338|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424339|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424340|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424341|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424342|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130424343|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424344|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424345|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130424346|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424347|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424348|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130564673|NCT00865904|470033711|FG000|Overall Study|Randomized but not Treated|2|||
130564674|NCT00865904|470033712|FG001|Overall Study|Randomized but not Treated|0|||
130727525|NCT00287586|470625486|FG000|Overall Study|Myocardial Infarction|1|||
130727526|NCT00287586|470625487|FG001|Overall Study|Myocardial Infarction|0|||
130727527|NCT00287586|470625486|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
130424349|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424350|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424351|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130424352|NCT01212770|469512864|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
130476666|NCT04166773|469713310|FG002|Overall Study|Physician Decision|0|||
130476667|NCT04166773|469713311|FG003|Overall Study|Physician Decision|1|||
130476668|NCT04166773|469713308|FG000|Overall Study|Withdrawal by Subject|1|||
130476669|NCT04166773|469713309|FG001|Overall Study|Withdrawal by Subject|1|||
130476670|NCT04166773|469713310|FG002|Overall Study|Withdrawal by Subject|2|||
130476671|NCT04166773|469713311|FG003|Overall Study|Withdrawal by Subject|5|||
130476672|NCT04717492|469713313|FG000|Overall Study|Withdrawal by Subject|2|||
130476673|NCT04717492|469713314|FG001|Overall Study|Withdrawal by Subject|13|||
130564675|NCT00865904|470033713|FG002|Overall Study|Randomized but not Treated|0|||
130564676|NCT00865904|470033714|FG003|Overall Study|Randomized but not Treated|1|||
130564677|NCT00865904|470033715|FG004|Overall Study|Randomized but not Treated|1|||
130564678|NCT03625687|470033716|FG000|Overall Study|Death|1|||
130564679|NCT04315181|470033721|FG000|Overall Study|Non-responsive to drug conditions.|1|||
130564680|NCT00711425|470033722|FG000|Overall Study|Protocol Violation|1|||
130564681|NCT00711425|470033722|FG000|Overall Study|Death|2|||
130564682|NCT00711425|470033722|FG000|Overall Study|Lost to Follow-up|1|||
130564683|NCT05879107|470033725|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
130564684|NCT05879107|470033726|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
130564685|NCT05879107|470033725|FG000|Overall Study|Migrated / moved from the study area|1|||
130564686|NCT05879107|470033726|FG001|Overall Study|Migrated / moved from the study area|1|||
130564687|NCT05879107|470033725|FG000|Overall Study|Lost to Follow-up|8|||
130564688|NCT05879107|470033726|FG001|Overall Study|Lost to Follow-up|13|||
130564689|NCT05879107|470033725|FG000|Overall Study|Death|0|||
130564690|NCT05879107|470033726|FG001|Overall Study|Death|2|||
130564691|NCT05879107|470033725|FG000|Overall Study|Other|0|||
130564692|NCT05879107|470033726|FG001|Overall Study|Other|3|||
130564693|NCT04607148|470033729|FG000|Overall Study|Withdrawal by Subject|0|||
130564694|NCT04607148|470033730|FG001|Overall Study|Withdrawal by Subject|4|||
130564695|NCT04607148|470033731|FG002|Overall Study|Withdrawal by Subject|2|||
130564696|NCT04607148|470033732|FG003|Overall Study|Withdrawal by Subject|8|||
130564697|NCT04607148|470033729|FG000|Overall Study|Study Terminated by Sponsor|14|||
130564698|NCT04607148|470033730|FG001|Overall Study|Study Terminated by Sponsor|59|||
130564699|NCT04607148|470033731|FG002|Overall Study|Study Terminated by Sponsor|9|||
130564700|NCT04607148|470033732|FG003|Overall Study|Study Terminated by Sponsor|39|||
130564701|NCT04607148|470033729|FG000|Overall Study|Sponsor Decision|0|||
130564702|NCT04607148|470033730|FG001|Overall Study|Sponsor Decision|0|||
130424353|NCT01212770|469512865|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
130424354|NCT01212770|469512866|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
130424355|NCT01212770|469512867|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424356|NCT01212770|469512868|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424357|NCT01212770|469512869|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424358|NCT01212770|469512870|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424359|NCT01212770|469512871|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424360|NCT01212770|469512872|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130424361|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130424362|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
130424363|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
130424364|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
130424365|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130424366|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130424367|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
130424368|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130424369|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130476674|NCT04717492|469713313|FG000|Overall Study|Lost to Follow-up|2|||
130476675|NCT04717492|469713314|FG001|Overall Study|Lost to Follow-up|9|||
130476676|NCT04456517|469713315|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
130564703|NCT04607148|470033731|FG002|Overall Study|Sponsor Decision|1|||
130727528|NCT00287586|470625487|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
130424370|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130476677|NCT04456517|469713316|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
130476678|NCT03903146|469713317|FG000|Overall Study|Lost to Follow-up|6|||
130476679|NCT03903146|469713318|FG001|Overall Study|Lost to Follow-up|4|||
130476680|NCT03903146|469713317|FG000|Overall Study|Withdrawal by Subject|0|||
130564704|NCT04607148|470033732|FG003|Overall Study|Sponsor Decision|0|||
130564705|NCT04607148|470033729|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130564706|NCT04607148|470033730|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130564707|NCT04607148|470033731|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130564708|NCT04607148|470033732|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130476681|NCT03903146|469713318|FG001|Overall Study|Withdrawal by Subject|1|||
130476682|NCT04176965|469713319|FG000|Overall Study|Death|1|||
130476683|NCT04176965|469713320|FG001|Overall Study|Death|2|||
130476684|NCT04176965|469713319|FG000|Overall Study|Lost to Follow-up|10|||
130476685|NCT04176965|469713320|FG001|Overall Study|Lost to Follow-up|2|||
130476686|NCT04176965|469713319|FG000|Overall Study|Withdrawal by Subject|6|||
130476687|NCT04176965|469713320|FG001|Overall Study|Withdrawal by Subject|1|||
130476688|NCT02919683|469713321|FG000|Post-Surgery Follow-Up|Death|2|||
130476689|NCT02919683|469713322|FG001|Post-Surgery Follow-Up|Death|2|||
130476690|NCT02919683|469713321|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
130476691|NCT02919683|469713322|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
130727529|NCT00287586|470625486|FG000|Overall Study|Cognitive Impairment|1|||
130424371|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
130424372|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
130424373|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
130424374|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
130424375|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
130424376|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130424377|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130424378|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130424379|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130424380|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
130424381|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
130424382|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
130424383|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130424384|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130424385|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130424386|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130424387|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130424388|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424389|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424390|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
130424391|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424392|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424393|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424394|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130727530|NCT00287586|470625487|FG001|Overall Study|Cognitive Impairment|0|||
130727531|NCT00287586|470625486|FG000|Overall Study|Pancreatic Cancer|1|||
130727532|NCT00287586|470625487|FG001|Overall Study|Pancreatic Cancer|3|||
130727533|NCT00287586|470625486|FG000|Overall Study|Sleep Apnea|1|||
130424395|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424396|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130424397|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424398|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424399|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424400|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
130424401|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424402|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424403|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424404|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424405|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130424406|NCT01212770|469512864|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424407|NCT01212770|469512865|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424408|NCT01212770|469512866|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
130424409|NCT01212770|469512867|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
130424410|NCT01212770|469512868|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424411|NCT01212770|469512869|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424412|NCT01212770|469512870|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424413|NCT01212770|469512871|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424414|NCT01212770|469512872|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130424415|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130476692|NCT04072380|469713324|FG000|Overall Study|Adverse Event|4|||
130727534|NCT00287586|470625487|FG001|Overall Study|Sleep Apnea|0|||
130727535|NCT00287586|470625486|FG000|Overall Study|Shoulder Pain|1|||
130727536|NCT00287586|470625487|FG001|Overall Study|Shoulder Pain|0|||
130476693|NCT04072380|469713325|FG001|Overall Study|Adverse Event|6|||
130727537|NCT00287586|470625486|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
130727538|NCT00287586|470625487|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
130727539|NCT00287586|470625486|FG000|Overall Study|Nonadherence|1|||
130424416|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
130424417|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
130424418|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130424419|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130424420|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130424421|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130424422|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130424423|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
130424424|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130424425|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
130424426|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
130424427|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130424428|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130424429|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130424430|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130424431|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
130424432|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
130424433|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424434|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
130424435|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424436|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424437|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424438|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424439|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424440|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424441|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130424442|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130424443|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
130424444|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
130424445|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130424446|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130424447|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130424448|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130424449|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
130424450|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
130424451|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130424452|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
130424453|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130424454|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130424455|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130424456|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130424457|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130424458|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130424459|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130424460|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130424461|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
130424462|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130424463|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130424464|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130424465|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130424466|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130476694|NCT04072380|469713326|FG002|Overall Study|Adverse Event|0|||
130476695|NCT04072380|469713324|FG000|Overall Study|Withdrawal by Subject|3|||
130476696|NCT04072380|469713325|FG001|Overall Study|Withdrawal by Subject|1|||
130476697|NCT04072380|469713326|FG002|Overall Study|Withdrawal by Subject|1|||
130476698|NCT04072380|469713324|FG000|Overall Study|Physician Decision|2|||
130476699|NCT04072380|469713325|FG001|Overall Study|Physician Decision|0|||
130476700|NCT04072380|469713326|FG002|Overall Study|Physician Decision|0|||
130564709|NCT04607148|470033729|FG000|Overall Study|Lost to Follow-up|0|||
130564710|NCT04607148|470033730|FG001|Overall Study|Lost to Follow-up|2|||
130424467|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130424468|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130424469|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130424470|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130476701|NCT04072380|469713324|FG000|Overall Study|Protocol Violation|0|||
130564711|NCT04607148|470033731|FG002|Overall Study|Lost to Follow-up|0|||
130564712|NCT04607148|470033732|FG003|Overall Study|Lost to Follow-up|0|||
130476702|NCT04072380|469713325|FG001|Overall Study|Protocol Violation|2|||
130476703|NCT04072380|469713326|FG002|Overall Study|Protocol Violation|3|||
130564713|NCT04607148|470033729|FG000|Overall Study|Death|0|||
130476704|NCT04072380|469713324|FG000|Overall Study|Intercurrent Illness and Others|3|||
130476705|NCT04072380|469713325|FG001|Overall Study|Intercurrent Illness and Others|5|||
130476706|NCT04072380|469713326|FG002|Overall Study|Intercurrent Illness and Others|6|||
130476707|NCT05551637|469713327|FG000|Overall Study|Lack of Efficacy|0|||
130476708|NCT05551637|469713328|FG001|Overall Study|Lack of Efficacy|6|||
130476709|NCT05551637|469713327|FG000|Overall Study|Lost to Follow-up|1|||
130476710|NCT05551637|469713328|FG001|Overall Study|Lost to Follow-up|1|||
130476711|NCT03033576|469713331|FG000|Overall Study|Ineligible|1|||
130424471|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130476712|NCT03033576|469713332|FG001|Overall Study|Ineligible|1|||
130424472|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130424473|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130424474|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130424475|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130424476|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130424477|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
130424478|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130424479|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
130424480|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
130424481|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130424482|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130424483|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130424484|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130424485|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130424486|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130424487|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130424488|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
130424489|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
130424490|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130424491|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130424492|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130424493|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130424494|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130424495|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130424496|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424497|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130424498|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424499|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424500|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424501|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424502|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424503|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424504|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130424505|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424506|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424507|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424508|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424509|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424510|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424511|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424512|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
130424513|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130424514|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130476713|NCT03033576|469713331|FG000|Overall Study|Adverse Event|4|||
130476714|NCT03033576|469713332|FG001|Overall Study|Adverse Event|20|||
130476715|NCT03033576|469713331|FG000|Overall Study|Progression/relapse|9|||
130476716|NCT03033576|469713332|FG001|Overall Study|Progression/relapse|36|||
130476717|NCT03033576|469713331|FG000|Overall Study|Death|1|||
130476718|NCT03033576|469713332|FG001|Overall Study|Death|1|||
130564714|NCT04607148|470033730|FG001|Overall Study|Death|3|||
130564715|NCT04607148|470033731|FG002|Overall Study|Death|0|||
130476719|NCT03033576|469713331|FG000|Overall Study|Patient refusal|1|||
130476720|NCT03033576|469713332|FG001|Overall Study|Patient refusal|6|||
130476721|NCT03033576|469713331|FG000|Overall Study|Other, unspecified reasons|0|||
130727540|NCT00287586|470625487|FG001|Overall Study|Nonadherence|1|||
130727541|NCT00287586|470625486|FG000|Overall Study|Enrolled in Another Study|1|||
130424515|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
130424516|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130476722|NCT03033576|469713332|FG001|Overall Study|Other, unspecified reasons|4|||
130476723|NCT03033576|469713331|FG000|Overall Study|Currently on protocol therapy|0|||
130564716|NCT04607148|470033732|FG003|Overall Study|Death|1|||
130564717|NCT04607148|470033729|FG000|Overall Study|Adverse Event|0|||
130424517|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130424518|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130424519|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130424520|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130424521|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130424522|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130424523|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424524|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130424525|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130424526|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424527|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424528|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424529|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424530|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130424531|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130424532|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130727542|NCT00287586|470625487|FG001|Overall Study|Enrolled in Another Study|0|||
130727543|NCT00287586|470625486|FG000|Overall Study|Major Depression|0|||
130727544|NCT00287586|470625487|FG001|Overall Study|Major Depression|2|||
130424533|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130727545|NCT00287586|470625486|FG000|Overall Study|Lung Cancer|0|||
130424534|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
130424535|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130424536|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130424537|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130424538|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130424539|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
130424540|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130424541|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424542|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130424543|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130424544|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424545|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424546|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424547|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424548|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130424549|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130424550|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424551|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
130424552|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
130424553|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424554|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424555|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424556|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424557|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424558|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130424559|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424560|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424561|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
130476724|NCT03033576|469713332|FG001|Overall Study|Currently on protocol therapy|2|||
130476725|NCT05179837|469713333|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
130476726|NCT05179837|469713333|FG000|Overall Study|Device malfunctioned|1|||
130476727|NCT05179837|469713333|FG000|Overall Study|Image quality too low|2|||
130476728|NCT06491433|469713334|FG000|Overall Study|Protocol Violation|51|||
130476729|NCT06491433|469713334|FG000|Overall Study|consent withdrawal|2|||
130476730|NCT06491433|469713334|FG000|Overall Study|screen failure|1|||
130476731|NCT01606215|469713343|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
130476732|NCT01606215|469713344|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
130476733|NCT04592549|469713345|FG000|Overall Study|Withdrawal by Subject|0|||
130476734|NCT04592549|469713346|FG001|Overall Study|Withdrawal by Subject|1|||
130476735|NCT04592549|469713347|FG002|Overall Study|Withdrawal by Subject|0|||
130727546|NCT00287586|470625487|FG001|Overall Study|Lung Cancer|2|||
130424562|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424563|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424564|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424565|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424566|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424567|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130424568|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424569|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130424570|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424571|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424572|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424573|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424574|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424575|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130424576|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130424577|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
130424578|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
130424579|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
130424580|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
130424581|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
130424582|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
130424583|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
130424584|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
130424585|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
130424586|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424587|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424588|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
130424589|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424590|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424591|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424592|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424593|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424594|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130424595|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424596|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424597|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
130424598|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424599|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424600|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424601|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424602|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130424603|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130424604|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424605|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424606|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
130424607|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130476736|NCT04592549|469713348|FG003|Overall Study|Withdrawal by Subject|1|||
130476737|NCT04592549|469713349|FG004|Overall Study|Withdrawal by Subject|1|||
130476738|NCT04592549|469713350|FG005|Overall Study|Withdrawal by Subject|0|||
130476739|NCT04592549|469713345|FG000|Overall Study|Lost to Follow-up|2|||
130476740|NCT04592549|469713346|FG001|Overall Study|Lost to Follow-up|0|||
130476741|NCT04592549|469713347|FG002|Overall Study|Lost to Follow-up|0|||
130476742|NCT04592549|469713348|FG003|Overall Study|Lost to Follow-up|1|||
130476743|NCT04592549|469713349|FG004|Overall Study|Lost to Follow-up|1|||
130476744|NCT04592549|469713350|FG005|Overall Study|Lost to Follow-up|1|||
130476745|NCT05184192|469713351|FG000|Overall Study|Lost to Follow-up|4|||
130476746|NCT05184192|469713352|FG001|Overall Study|Lost to Follow-up|7|||
130476747|NCT05184192|469713351|FG000|Overall Study|Adverse Event|1|||
130476748|NCT05184192|469713352|FG001|Overall Study|Adverse Event|4|||
130476749|NCT05184192|469713351|FG000|Overall Study|PI withdrawal|1|||
130476750|NCT05184192|469713352|FG001|Overall Study|PI withdrawal|2|||
130424608|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424609|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424610|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424611|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424612|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130424613|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130424614|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
130424615|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130424616|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130476751|NCT05184192|469713351|FG000|Overall Study|Withdrew due to adverse effect|1|||
130476752|NCT05184192|469713352|FG001|Overall Study|Withdrew due to adverse effect|0|||
130476753|NCT05184192|469713351|FG000|Overall Study|Medication schedule|1|||
130476754|NCT05184192|469713352|FG001|Overall Study|Medication schedule|0|||
130476755|NCT05184192|469713351|FG000|Overall Study|Concern for adverse effects|0|||
130424617|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130424618|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130476756|NCT05184192|469713352|FG001|Overall Study|Concern for adverse effects|4|||
130476757|NCT02727699|469715338|FG000|Overall Study|Adverse Event|2|||
130727547|NCT00287586|470625486|FG000|Overall Study|Elevated IPSS Score|0|||
130727548|NCT00287586|470625487|FG001|Overall Study|Elevated IPSS Score|1|||
130727549|NCT00287586|470625486|FG000|Overall Study|Retroperitoneal Cancer|0|||
130727550|NCT00287586|470625487|FG001|Overall Study|Retroperitoneal Cancer|1|||
130424619|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130424620|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130424621|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130424622|NCT01212770|469512864|FG000|Long-term Safety Phase (Year 5)|Death|0|||
130424623|NCT01212770|469512865|FG001|Long-term Safety Phase (Year 5)|Death|0|||
130424624|NCT01212770|469512866|FG002|Long-term Safety Phase (Year 5)|Death|0|||
130424625|NCT01212770|469512867|FG003|Long-term Safety Phase (Year 5)|Death|0|||
130424626|NCT01212770|469512868|FG004|Long-term Safety Phase (Year 5)|Death|0|||
130424627|NCT01212770|469512869|FG005|Long-term Safety Phase (Year 5)|Death|0|||
130424628|NCT01212770|469512870|FG006|Long-term Safety Phase (Year 5)|Death|0|||
130424629|NCT01212770|469512871|FG007|Long-term Safety Phase (Year 5)|Death|1|||
130424630|NCT01212770|469512872|FG008|Long-term Safety Phase (Year 5)|Death|0|||
130424631|NCT01112579|469512877|FG000|Overall Study|Missed Visit|1|||
130424632|NCT01112579|469512878|FG001|Overall Study|Missed Visit|1|||
130424633|NCT01112579|469512877|FG000|Overall Study|Death|0|||
130424634|NCT01112579|469512878|FG001|Overall Study|Death|2|||
130424635|NCT00818753|469512879|FG000|Overall Study|Protocol Violation|1|||
130424636|NCT00818753|469512880|FG001|Overall Study|Protocol Violation|0|||
130424637|NCT00818753|469512881|FG002|Overall Study|Protocol Violation|0|||
130424638|NCT00818753|469512879|FG000|Overall Study|Other reason (not specified)|0|||
130424639|NCT00818753|469512880|FG001|Overall Study|Other reason (not specified)|0|||
130424640|NCT00818753|469512881|FG002|Overall Study|Other reason (not specified)|1|||
130424641|NCT00818753|469512879|FG000|Overall Study|Randomised and not treated|2|||
130424642|NCT00818753|469512880|FG001|Overall Study|Randomised and not treated|0|||
130424643|NCT00818753|469512881|FG002|Overall Study|Randomised and not treated|0|||
130424644|NCT03703466|469512882|FG000|Overall Study|Death|2|||
130424645|NCT03703466|469512883|FG001|Overall Study|Death|1|||
130424646|NCT03703466|469512884|FG002|Overall Study|Death|0|||
130424647|NCT03703466|469512882|FG000|Overall Study|Withdrawal by Subject|0|||
130424648|NCT03703466|469512883|FG001|Overall Study|Withdrawal by Subject|3|||
130424649|NCT03703466|469512884|FG002|Overall Study|Withdrawal by Subject|0|||
130424650|NCT03703466|469512882|FG000|Overall Study|Completed < 3 Cycles|2|||
130424651|NCT03703466|469512883|FG001|Overall Study|Completed < 3 Cycles|2|||
130424652|NCT03703466|469512884|FG002|Overall Study|Completed < 3 Cycles|2|||
130424653|NCT04508699|469512886|FG000|Overall Study|Lack of Efficacy|2|||
130424654|NCT04508699|469512887|FG001|Overall Study|Lack of Efficacy|15|||
130424655|NCT04508699|469512886|FG000|Overall Study|Withdrawal by Subject|0|||
130424656|NCT04508699|469512887|FG001|Overall Study|Withdrawal by Subject|2|||
130424657|NCT03355326|469512888|FG000|Overall Study|Protocol Violation|3|||
130424658|NCT03355326|469512889|FG001|Overall Study|Protocol Violation|3|||
130424659|NCT00608582|469512892|FG000|Overall Study|Lost to Follow-up|2|||
130424660|NCT00608582|469512893|FG001|Overall Study|Lost to Follow-up|0|||
130424661|NCT00608582|469512892|FG000|Overall Study|No Best Response in Phase 1 located|1|||
130424662|NCT00608582|469512893|FG001|Overall Study|No Best Response in Phase 1 located|1|||
130424663|NCT00608582|469512892|FG000|Overall Study|Illicit Drug Use|1|||
130424664|NCT00608582|469512893|FG001|Overall Study|Illicit Drug Use|0|||
130424665|NCT00608582|469512892|FG000|Overall Study|Early stage Design Change|0|||
130476758|NCT02727699|469715339|FG001|Overall Study|Adverse Event|0|||
130476759|NCT02727699|469715338|FG000|Overall Study|Withdrawal by Subject|5|||
130476760|NCT02727699|469715339|FG001|Overall Study|Withdrawal by Subject|3|||
130476761|NCT02727699|469715338|FG000|Overall Study|Protocol Violation|0|||
130727551|NCT00287586|470625486|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
130727552|NCT00287586|470625487|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
130424666|NCT00608582|469512893|FG001|Overall Study|Early stage Design Change|3|||
130424667|NCT04605978|469514432|FG000|Overall Study|Adverse Event|2|||
130424668|NCT04605978|469514433|FG001|Overall Study|Adverse Event|1|||
130424669|NCT04605978|469514432|FG000|Overall Study|Withdrawal nonmedical reason|1|||
130424670|NCT04605978|469514433|FG001|Overall Study|Withdrawal nonmedical reason|1|||
130424671|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
130424672|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
130424673|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
130424674|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
130424675|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
130424676|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130424677|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
130424678|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
130424679|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
130424680|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
130424681|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
130424682|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
130727553|NCT00287586|470625486|FG000|Overall Study|Mood Swings and Irritability|0|||
130424683|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Death|6|||
130424684|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Death|3|||
130424685|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Death|0|||
130424686|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Death|1|||
130424687|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Death|1|||
130424688|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Death|0|||
130424689|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
130424690|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
130424691|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
130424692|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
130424693|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
130424694|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
130424695|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130424696|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
130424697|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
130424698|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130424699|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130424700|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130424701|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
130424702|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
130424703|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
130424704|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
130424705|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
130424706|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
130424707|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
130424708|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
130424709|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
130424710|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
130424711|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
130424712|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
130424713|NCT03104699|469514434|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
130424714|NCT03104699|469514435|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
130424715|NCT03104699|469514436|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
130424716|NCT03104699|469514437|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
130424717|NCT03104699|469514438|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
130424718|NCT03104699|469514439|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
130424719|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130424720|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130424721|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130424722|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130424723|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130424724|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
130424725|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Death|0|||
130424726|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Death|0|||
130424727|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Death|0|||
130424728|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Death|0|||
130424729|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Death|0|||
130424730|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Death|107|||
130424731|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130424732|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130424733|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130424734|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130424735|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130424736|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
130424737|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130424738|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130424739|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130476762|NCT02727699|469715339|FG001|Overall Study|Protocol Violation|1|||
130476763|NCT02727699|469715338|FG000|Overall Study|Physician Decision|0|||
130476764|NCT02727699|469715339|FG001|Overall Study|Physician Decision|1|||
130476765|NCT02727699|469715338|FG000|Overall Study|Lost to Follow-up|1|||
130476766|NCT02727699|469715339|FG001|Overall Study|Lost to Follow-up|0|||
130424740|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130424741|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130476767|NCT02727699|469715338|FG000|Overall Study|Sponsor Decision|1|||
130424742|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
130424743|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130424744|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130476768|NCT02727699|469715339|FG001|Overall Study|Sponsor Decision|0|||
130424745|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130727554|NCT00287586|470625487|FG001|Overall Study|Mood Swings and Irritability|1|||
130727555|NCT00287586|470625486|FG000|Overall Study|Bradycardia|0|||
130727556|NCT00287586|470625487|FG001|Overall Study|Bradycardia|1|||
130727557|NCT00287586|470625486|FG000|Overall Study|Itchy Swollen Eyes|0|||
130727558|NCT00287586|470625487|FG001|Overall Study|Itchy Swollen Eyes|1|||
130727559|NCT00287586|470625486|FG000|Overall Study|Recurrent Melanoma|0|||
130424746|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130424747|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130424748|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
130424749|NCT03104699|469514434|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
130424750|NCT03104699|469514435|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
130424751|NCT03104699|469514436|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
130424752|NCT03104699|469514437|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
130424753|NCT03104699|469514438|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
130424754|NCT03104699|469514439|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
130424755|NCT01690130|469514440|FG000|Overall Study|Subject have cancelled visit.|1|||
130424756|NCT01690130|469514441|FG001|Overall Study|Subject have cancelled visit.|0|||
130424757|NCT01644734|469514442|FG000|Overall Study|Adverse Event|4|||
130424758|NCT01644734|469514442|FG000|Overall Study|Lost to Follow-up|17|||
130424759|NCT01644734|469514442|FG000|Overall Study|Reasons other than stated above|7|||
130424760|NCT01644734|469514442|FG000|Overall Study|Missing documentation|238|||
130424761|NCT05159622|469514443|FG000|Overall Study|Lost to Follow-up|4|||
130424762|NCT05159622|469514444|FG001|Overall Study|Lost to Follow-up|5|||
130424763|NCT03318523|469514445|FG000|PC Period: Up to Year 1|Adverse Event|1|||
130424764|NCT03318523|469514446|FG001|PC Period: Up to Year 1|Adverse Event|0|||
130424765|NCT03318523|469514447|FG002|PC Period: Up to Year 1|Adverse Event|2|||
130424766|NCT03318523|469514448|FG003|PC Period: Up to Year 1|Adverse Event|0|||
130424767|NCT03318523|469514449|FG004|PC Period: Up to Year 1|Adverse Event|0|||
130424768|NCT03318523|469514450|FG005|PC Period: Up to Year 1|Adverse Event|0|||
130424769|NCT03318523|469514451|FG006|PC Period: Up to Year 1|Adverse Event|0|||
130424770|NCT03318523|469514452|FG007|PC Period: Up to Year 1|Adverse Event|0|||
130424771|NCT03318523|469514453|FG008|PC Period: Up to Year 1|Adverse Event|0|||
130424772|NCT03318523|469514454|FG009|PC Period: Up to Year 1|Adverse Event|0|||
130424773|NCT03318523|469514445|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
130424774|NCT03318523|469514446|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
130424775|NCT03318523|469514447|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424776|NCT03318523|469514448|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
130424777|NCT03318523|469514449|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424778|NCT03318523|469514450|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424779|NCT03318523|469514451|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424780|NCT03318523|469514452|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424781|NCT03318523|469514453|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424782|NCT03318523|469514454|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
130424783|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424784|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424785|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424786|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424787|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
130424788|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424789|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424790|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
130424791|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130424792|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
130424793|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424794|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424795|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424796|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424797|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
130424798|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424799|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130424800|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
130424801|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
130424802|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
130424803|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424804|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424805|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130476769|NCT03131648|469715344|FG000|Initial Treatment Period|Not dosed|2|||
130727560|NCT00287586|470625487|FG001|Overall Study|Recurrent Melanoma|1|||
130727561|NCT03743415|470625489|FG000|Overall Study|Death|5|||
130727562|NCT03743415|470625490|FG001|Overall Study|Death|3|||
130727563|NCT03743415|470625491|FG002|Overall Study|Death|1|||
130727564|NCT03743415|470625492|FG003|Overall Study|Death|4|||
130476770|NCT03131648|469715345|FG001|Initial Treatment Period|Not dosed|2|||
130476771|NCT03131648|469715346|FG002|Initial Treatment Period|Not dosed|0|||
130476772|NCT03131648|469715347|FG003|Initial Treatment Period|Not dosed|0|||
130476773|NCT03131648|469715348|FG004|Initial Treatment Period|Not dosed|0|||
130476774|NCT03131648|469715349|FG005|Initial Treatment Period|Not dosed|0|||
130476775|NCT03131648|469715350|FG006|Initial Treatment Period|Not dosed|0|||
130476776|NCT03131648|469715351|FG007|Initial Treatment Period|Not dosed|0|||
130476777|NCT03131648|469715344|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
130476778|NCT03131648|469715345|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
130476779|NCT03131648|469715346|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476780|NCT03131648|469715347|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476781|NCT03131648|469715348|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476782|NCT03131648|469715349|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476783|NCT03131648|469715350|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476784|NCT03131648|469715351|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130476785|NCT03131648|469715344|FG000|Open-label Treatment|Discontinued IMP|0|||
130476786|NCT03131648|469715345|FG001|Open-label Treatment|Discontinued IMP|0|||
130476787|NCT03131648|469715346|FG002|Open-label Treatment|Discontinued IMP|0|||
130476788|NCT03131648|469715347|FG003|Open-label Treatment|Discontinued IMP|0|||
130476789|NCT03131648|469715348|FG004|Open-label Treatment|Discontinued IMP|0|||
130476790|NCT03131648|469715349|FG005|Open-label Treatment|Discontinued IMP|0|||
130476791|NCT03131648|469715350|FG006|Open-label Treatment|Discontinued IMP|112|||
130476792|NCT03131648|469715351|FG007|Open-label Treatment|Discontinued IMP|0|||
130476793|NCT03131648|469715344|FG000|Open-label Treatment|Completed Week 50|0|||
130424806|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424807|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424808|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
130424809|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424810|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424811|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424812|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130424813|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424814|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424815|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424816|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424817|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424818|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424819|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424820|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424821|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130424822|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
130424823|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130424824|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130424825|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130424826|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130424827|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
130424828|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
130424829|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
130424830|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
130424831|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
130424832|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
130424833|NCT03318523|469514445|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424834|NCT03318523|469514446|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424835|NCT03318523|469514447|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424836|NCT03318523|469514448|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424837|NCT03318523|469514449|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
130424838|NCT03318523|469514450|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424839|NCT03318523|469514451|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424840|NCT03318523|469514452|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
130476794|NCT03131648|469715345|FG001|Open-label Treatment|Completed Week 50|0|||
130476795|NCT03131648|469715346|FG002|Open-label Treatment|Completed Week 50|0|||
130476796|NCT03131648|469715347|FG003|Open-label Treatment|Completed Week 50|0|||
130476797|NCT03131648|469715348|FG004|Open-label Treatment|Completed Week 50|0|||
130476798|NCT03131648|469715349|FG005|Open-label Treatment|Completed Week 50|0|||
130476799|NCT03131648|469715350|FG006|Open-label Treatment|Completed Week 50|6|||
130476800|NCT03131648|469715351|FG007|Open-label Treatment|Completed Week 50|0|||
130476801|NCT03131648|469715344|FG000|Maintenance Treatment Period|Not dosed|0|||
130727565|NCT03743415|470625493|FG004|Overall Study|Death|0|||
130564718|NCT04607148|470033730|FG001|Overall Study|Adverse Event|1|||
130564719|NCT04607148|470033731|FG002|Overall Study|Adverse Event|0|||
130564720|NCT04607148|470033732|FG003|Overall Study|Adverse Event|0|||
130564721|NCT00916149|470033735|FG000|Overall Study|Lost to Follow-up|3|||
130424841|NCT03318523|469514453|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
130424842|NCT03318523|469514454|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130424843|NCT03581981|469514458|FG000|Overall Study|Withdrawal by Subject|12|||
130424844|NCT03581981|469514459|FG001|Overall Study|Withdrawal by Subject|13|||
130424845|NCT03581981|469514458|FG000|Overall Study|Physician Decision|1|||
130424846|NCT03581981|469514459|FG001|Overall Study|Physician Decision|2|||
130424847|NCT03581981|469514458|FG000|Overall Study|Lost to Follow-up|0|||
130424848|NCT03581981|469514459|FG001|Overall Study|Lost to Follow-up|4|||
130424849|NCT01410474|469514460|FG000|Overall Study|Withdrawal by Subject|0|||
130424850|NCT01410474|469514461|FG001|Overall Study|Withdrawal by Subject|1|||
130424851|NCT00828984|469514463|FG000|Overall Study|Adverse Event|2|||
130424852|NCT00828984|469514464|FG001|Overall Study|Adverse Event|3|||
130424853|NCT00828984|469514465|FG002|Overall Study|Adverse Event|0|||
130424854|NCT00828984|469514463|FG000|Overall Study|Lost to Follow-up|5|||
130424855|NCT00828984|469514464|FG001|Overall Study|Lost to Follow-up|3|||
130424856|NCT00828984|469514465|FG002|Overall Study|Lost to Follow-up|1|||
130424857|NCT00828984|469514463|FG000|Overall Study|Withdrawal by Subject|4|||
130424858|NCT00828984|469514464|FG001|Overall Study|Withdrawal by Subject|4|||
130424859|NCT00828984|469514465|FG002|Overall Study|Withdrawal by Subject|4|||
130424860|NCT00828984|469514463|FG000|Overall Study|Ineligable|1|||
130424861|NCT00828984|469514464|FG001|Overall Study|Ineligable|2|||
130424862|NCT00828984|469514465|FG002|Overall Study|Ineligable|0|||
130424863|NCT00828984|469514463|FG000|Overall Study|Medical Contraindication|0|||
130424864|NCT00828984|469514464|FG001|Overall Study|Medical Contraindication|1|||
130424865|NCT00828984|469514465|FG002|Overall Study|Medical Contraindication|0|||
130424866|NCT00828984|469514463|FG000|Overall Study|Noncompliant|1|||
130424867|NCT00828984|469514464|FG001|Overall Study|Noncompliant|2|||
130424868|NCT00828984|469514465|FG002|Overall Study|Noncompliant|3|||
130424869|NCT00828984|469514463|FG000|Overall Study|ConMed|1|||
130424870|NCT00828984|469514464|FG001|Overall Study|ConMed|1|||
130424871|NCT00828984|469514465|FG002|Overall Study|ConMed|1|||
130424872|NCT00863655|469514469|FG000|Overall Study|Protocol Violation|4|||
130424873|NCT00863655|469514470|FG001|Overall Study|Protocol Violation|0|||
130424874|NCT00863655|469514469|FG000|Overall Study|Adverse Event|52|||
130424875|NCT00863655|469514470|FG001|Overall Study|Adverse Event|8|||
130424876|NCT00863655|469514469|FG000|Overall Study|Withdrawal by Subject|47|||
130424877|NCT00863655|469514470|FG001|Overall Study|Withdrawal by Subject|7|||
130424878|NCT00863655|469514469|FG000|Overall Study|Administrative problems|1|||
130424879|NCT00863655|469514470|FG001|Overall Study|Administrative problems|0|||
130424880|NCT00863655|469514469|FG000|Overall Study|Death|7|||
130424881|NCT00863655|469514470|FG001|Overall Study|Death|1|||
130424882|NCT00863655|469514469|FG000|Overall Study|New cancer therapy|5|||
130424883|NCT00863655|469514470|FG001|Overall Study|New cancer therapy|1|||
130424884|NCT00863655|469514469|FG000|Overall Study|Disease progression|364|||
130424885|NCT00863655|469514470|FG001|Overall Study|Disease progression|221|||
130424886|NCT00863655|469514469|FG000|Overall Study|Treatment completed as per protocol|5|||
130424887|NCT00863655|469514470|FG001|Overall Study|Treatment completed as per protocol|1|||
130424888|NCT02157779|469514473|FG000|Overall Study|Logistical|9|||
130424889|NCT02157779|469514474|FG001|Overall Study|Logistical|3|||
130424890|NCT02157779|469514473|FG000|Overall Study|Stopped attending, reason unknown|11|||
130424891|NCT02157779|469514474|FG001|Overall Study|Stopped attending, reason unknown|7|||
130424892|NCT02157779|469514473|FG000|Overall Study|No response to outreach after Baseline|1|||
130424893|NCT02157779|469514474|FG001|Overall Study|No response to outreach after Baseline|1|||
130424894|NCT02157779|469514473|FG000|Overall Study|Moved|1|||
130424895|NCT02157779|469514474|FG001|Overall Study|Moved|0|||
130424896|NCT02157779|469514473|FG000|Overall Study|Medical|1|||
130424897|NCT02157779|469514474|FG001|Overall Study|Medical|0|||
130424898|NCT02157779|469514473|FG000|Overall Study|Legal issue|1|||
130424899|NCT02157779|469514474|FG001|Overall Study|Legal issue|0|||
130424900|NCT00002558|469514478|FG000|Overall Study|Withdrawal by Subject|0|||
130564722|NCT00916149|470033736|FG001|Overall Study|Lost to Follow-up|2|||
130564723|NCT00916149|470033737|FG002|Overall Study|Lost to Follow-up|0|||
130564724|NCT00916149|470033735|FG000|Overall Study|Unable to place scalp EEG leads|1|||
130564725|NCT00916149|470033736|FG001|Overall Study|Unable to place scalp EEG leads|0|||
130424901|NCT00002558|469514479|FG001|Overall Study|Withdrawal by Subject|1|||
130424902|NCT02065336|469514480|FG000|Extension Phase|Study Terminated by Sponsor|0|||
130424903|NCT02065336|469514481|FG001|Extension Phase|Study Terminated by Sponsor|0|||
130424904|NCT02065336|469514482|FG002|Extension Phase|Study Terminated by Sponsor|0|||
130424905|NCT02065336|469514483|FG003|Extension Phase|Study Terminated by Sponsor|0|||
130424906|NCT02065336|469514484|FG004|Extension Phase|Study Terminated by Sponsor|0|||
130424907|NCT02065336|469514485|FG005|Extension Phase|Study Terminated by Sponsor|0|||
130424908|NCT02065336|469514486|FG006|Extension Phase|Study Terminated by Sponsor|0|||
130424909|NCT02065336|469514487|FG007|Extension Phase|Study Terminated by Sponsor|0|||
130564726|NCT00916149|470033737|FG002|Overall Study|Unable to place scalp EEG leads|0|||
130424910|NCT02065336|469514488|FG008|Extension Phase|Study Terminated by Sponsor|2|||
130424911|NCT02065336|469514489|FG009|Extension Phase|Study Terminated by Sponsor|8|||
130424912|NCT00626028|469514490|FG000|Overall Study|Adverse Event|1|||
130424913|NCT00626028|469514491|FG001|Overall Study|Adverse Event|1|||
130424914|NCT00626028|469514490|FG000|Overall Study|Device Failure|0|||
130424915|NCT00626028|469514491|FG001|Overall Study|Device Failure|1|||
130424916|NCT00626028|469514490|FG000|Overall Study|Physician Decision|2|||
130424917|NCT00626028|469514491|FG001|Overall Study|Physician Decision|1|||
130424918|NCT00626028|469514490|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
130424919|NCT00626028|469514491|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
130424920|NCT00831779|469514493|FG000|Overall Study|Lost to Follow-up|1|||
130424921|NCT00831779|469514494|FG001|Overall Study|Lost to Follow-up|0|||
130424922|NCT00831779|469514493|FG000|Overall Study|No longer met criteria|0|||
130424923|NCT00831779|469514494|FG001|Overall Study|No longer met criteria|1|||
130424924|NCT02436330|469514495|FG000|Cohort 1|Lost to Follow-up|5|||
130424925|NCT02436330|469514496|FG001|Cohort 1|Lost to Follow-up|2|||
130424926|NCT02436330|469514495|FG000|Cohort 1|Withdrawal by Subject|0|||
130424927|NCT02436330|469514496|FG001|Cohort 1|Withdrawal by Subject|1|||
130424928|NCT02436330|469514495|FG000|Cohort 2|Lost to Follow-up|2|||
130424929|NCT02436330|469514496|FG001|Cohort 2|Lost to Follow-up|0|||
130424930|NCT02436330|469514495|FG000|Cohort 2|Withdrawal by Subject|2|||
130424931|NCT02436330|469514496|FG001|Cohort 2|Withdrawal by Subject|3|||
130424932|NCT02436330|469514495|FG000|Cohort 3|Lost to Follow-up|1|||
130424933|NCT02436330|469514496|FG001|Cohort 3|Lost to Follow-up|0|||
130424934|NCT02436330|469514495|FG000|Cohort 3|Withdrawal by Subject|4|||
130424935|NCT02436330|469514496|FG001|Cohort 3|Withdrawal by Subject|0|||
130424936|NCT02436330|469514495|FG000|Cohort 4|Lost to Follow-up|1|||
130424937|NCT02436330|469514496|FG001|Cohort 4|Lost to Follow-up|0|||
130424938|NCT02436330|469514495|FG000|Cohort 4|Withdrawal by Subject|1|||
130424939|NCT02436330|469514496|FG001|Cohort 4|Withdrawal by Subject|0|||
130424940|NCT02436330|469514495|FG000|Cohort 5|Lost to Follow-up|3|||
130424941|NCT02436330|469514496|FG001|Cohort 5|Lost to Follow-up|2|||
130424942|NCT02436330|469514495|FG000|Cohort 5|Withdrawal by Subject|3|||
130424943|NCT02436330|469514496|FG001|Cohort 5|Withdrawal by Subject|2|||
130424944|NCT02436330|469514495|FG000|Cohort 6|Lost to Follow-up|2|||
130424945|NCT02436330|469514496|FG001|Cohort 6|Lost to Follow-up|0|||
130424946|NCT02436330|469514495|FG000|Cohort 6|Withdrawal by Subject|1|||
130424947|NCT02436330|469514496|FG001|Cohort 6|Withdrawal by Subject|1|||
130424948|NCT01375114|469514498|FG000|Overall Study|Lost to Follow-up|1|||
130727566|NCT03743415|470625494|FG005|Overall Study|Death|0|||
130727567|NCT03743415|470625495|FG006|Overall Study|Death|0|||
130727568|NCT03743415|470625496|FG007|Overall Study|Death|0|||
130727569|NCT03743415|470625497|FG008|Overall Study|Death|1|||
130727570|NCT03743415|470625498|FG009|Overall Study|Death|0|||
130727571|NCT03743415|470625489|FG000|Overall Study|Withdrawal by Subject|1|||
130727572|NCT03743415|470625490|FG001|Overall Study|Withdrawal by Subject|0|||
130727573|NCT03743415|470625491|FG002|Overall Study|Withdrawal by Subject|4|||
130727574|NCT03743415|470625492|FG003|Overall Study|Withdrawal by Subject|5|||
130727575|NCT03743415|470625493|FG004|Overall Study|Withdrawal by Subject|5|||
130424949|NCT01375114|469514499|FG001|Overall Study|Lost to Follow-up|0|||
130424950|NCT01375114|469514500|FG002|Overall Study|Lost to Follow-up|1|||
130424951|NCT01375114|469514498|FG000|Overall Study|Disease Progression|3|||
130424952|NCT01375114|469514499|FG001|Overall Study|Disease Progression|2|||
130424953|NCT01375114|469514500|FG002|Overall Study|Disease Progression|2|||
130424954|NCT01375114|469514498|FG000|Overall Study|Patient Changed Mind|0|||
130424955|NCT01375114|469514499|FG001|Overall Study|Patient Changed Mind|0|||
130424956|NCT01375114|469514500|FG002|Overall Study|Patient Changed Mind|2|||
130424957|NCT01375114|469514498|FG000|Overall Study|Pruritus|0|||
130424958|NCT01375114|469514499|FG001|Overall Study|Pruritus|0|||
130424959|NCT01375114|469514500|FG002|Overall Study|Pruritus|1|||
130424960|NCT01375114|469514498|FG000|Overall Study|Restlessness|0|||
130424961|NCT01375114|469514499|FG001|Overall Study|Restlessness|0|||
130564727|NCT00589420|470033738|FG000|Overall Study|screen failure|1|||
130727576|NCT03743415|470625494|FG005|Overall Study|Withdrawal by Subject|2|||
130727577|NCT03743415|470625495|FG006|Overall Study|Withdrawal by Subject|2|||
130727578|NCT03743415|470625496|FG007|Overall Study|Withdrawal by Subject|5|||
130424962|NCT01375114|469514500|FG002|Overall Study|Restlessness|1|||
130424963|NCT01375114|469514498|FG000|Overall Study|Diarrhea|0|||
130424964|NCT01375114|469514499|FG001|Overall Study|Diarrhea|0|||
130424965|NCT01375114|469514500|FG002|Overall Study|Diarrhea|1|||
130424966|NCT01375114|469514498|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
130424967|NCT01375114|469514499|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
130424968|NCT01375114|469514500|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
130424969|NCT01375114|469514498|FG000|Overall Study|Nausea|0|||
130424970|NCT01375114|469514499|FG001|Overall Study|Nausea|1|||
130424971|NCT01375114|469514500|FG002|Overall Study|Nausea|0|||
130424972|NCT01375114|469514498|FG000|Overall Study|Increased AST/ALT|0|||
130424973|NCT01375114|469514499|FG001|Overall Study|Increased AST/ALT|1|||
130424974|NCT01375114|469514500|FG002|Overall Study|Increased AST/ALT|0|||
130424975|NCT01375114|469514498|FG000|Overall Study|Vaginal Hemorrhage|0|||
130424976|NCT01375114|469514499|FG001|Overall Study|Vaginal Hemorrhage|1|||
130424977|NCT01375114|469514500|FG002|Overall Study|Vaginal Hemorrhage|0|||
130424978|NCT01375114|469514498|FG000|Overall Study|Family problem|0|||
130424979|NCT01375114|469514499|FG001|Overall Study|Family problem|1|||
130424980|NCT01375114|469514500|FG002|Overall Study|Family problem|0|||
130424981|NCT01375114|469514498|FG000|Overall Study|Protocol Violation|2|||
130424982|NCT01375114|469514499|FG001|Overall Study|Protocol Violation|0|||
130424983|NCT01375114|469514500|FG002|Overall Study|Protocol Violation|0|||
130424984|NCT03575325|469514501|FG000|Overall Study|Death|1|||
130424985|NCT00162370|469514502|FG000|Efficacy Population|Lost to Follow-up|51|||
130424986|NCT04040751|469514503|FG000|Overall Study|Withdrawal by Subject|2|||
130424987|NCT04040751|469514504|FG001|Overall Study|Withdrawal by Subject|0|||
130424988|NCT04040751|469514505|FG002|Overall Study|Withdrawal by Subject|2|||
130424989|NCT04040751|469514506|FG003|Overall Study|Withdrawal by Subject|0|||
130424990|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
130424991|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
130424992|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|disease progression|58|||
130424993|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|disease progression|47|||
130424994|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Death|3|||
130424995|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Death|6|||
130424996|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
130424997|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
130424998|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
130424999|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
130425000|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
130425001|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
130425002|NCT02472964|469514507|FG000|Part 1 (up to Week 24)|Other|2|||
130425003|NCT02472964|469514508|FG001|Part 1 (up to Week 24)|Other|1|||
130425004|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
130425005|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
130425006|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
130425007|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
130425008|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Death|0|||
130425009|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Death|1|||
130425010|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
130425011|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
130425012|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
130425013|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
130425014|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
130425015|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
130425016|NCT02472964|469514507|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
130425017|NCT02472964|469514508|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
130425018|NCT01749982|469514509|FG000|Overall Study|Physician Decision|0|||
130425019|NCT01749982|469514510|FG001|Overall Study|Physician Decision|0|||
130425020|NCT01749982|469514511|FG002|Overall Study|Physician Decision|0|||
130425021|NCT01749982|469514512|FG003|Overall Study|Physician Decision|1|||
130425022|NCT01749982|469514509|FG000|Overall Study|Lost to Follow-up|0|||
130425023|NCT01749982|469514510|FG001|Overall Study|Lost to Follow-up|0|||
130425024|NCT01749982|469514511|FG002|Overall Study|Lost to Follow-up|0|||
130425025|NCT01749982|469514512|FG003|Overall Study|Lost to Follow-up|1|||
130425026|NCT01749982|469514509|FG000|Overall Study|Withdrawal by Subject|0|||
130425027|NCT01749982|469514510|FG001|Overall Study|Withdrawal by Subject|0|||
130425028|NCT01749982|469514511|FG002|Overall Study|Withdrawal by Subject|0|||
130425029|NCT01749982|469514512|FG003|Overall Study|Withdrawal by Subject|1|||
130425030|NCT01596582|469514513|FG000|Overall Study|Deemed ineligible after study visit|3|||
130425031|NCT01596582|469514514|FG001|Overall Study|Deemed ineligible after study visit|6|||
130425032|NCT01596582|469514513|FG000|Overall Study|Missing all outcome data|1|||
130425033|NCT01596582|469514514|FG001|Overall Study|Missing all outcome data|1|||
130425034|NCT03923933|469514519|FG000|Overall Study|Lost to Follow-up|1|||
130425035|NCT03923933|469514520|FG001|Overall Study|Lost to Follow-up|0|||
130425036|NCT03923933|469514519|FG000|Overall Study|Withdrawal by Subject|0|||
130425037|NCT03923933|469514520|FG001|Overall Study|Withdrawal by Subject|1|||
130425038|NCT00419263|469514521|FG000|Overall Study|Lost to Follow-up|2|||
130425039|NCT00419263|469514522|FG001|Overall Study|Lost to Follow-up|1|||
130425040|NCT00419263|469514523|FG002|Overall Study|Lost to Follow-up|1|||
130425041|NCT00419263|469514521|FG000|Overall Study|Randomized in Error, Not Treated|1|||
130425042|NCT00419263|469514522|FG001|Overall Study|Randomized in Error, Not Treated|1|||
130425043|NCT00419263|469514523|FG002|Overall Study|Randomized in Error, Not Treated|0|||
130425044|NCT00419263|469514521|FG000|Overall Study|Adverse Event|0|||
130425045|NCT00419263|469514522|FG001|Overall Study|Adverse Event|0|||
130425046|NCT00419263|469514523|FG002|Overall Study|Adverse Event|1|||
130425047|NCT00419263|469514521|FG000|Overall Study|Withdrawal by Subject|0|||
130425048|NCT00419263|469514522|FG001|Overall Study|Withdrawal by Subject|0|||
130425049|NCT00419263|469514523|FG002|Overall Study|Withdrawal by Subject|1|||
130425050|NCT00587964|469514524|FG000|Overall Study|Withdrawal by Subject|1|||
130425051|NCT00587964|469514524|FG000|Overall Study|Lost to Follow-up|1|||
130425052|NCT00587964|469514524|FG000|Overall Study|Patient found to be ineligible|1|||
130425053|NCT00587964|469514524|FG000|Overall Study|Patient did not receive intervention|5|||
130425054|NCT00587964|469514524|FG000|Overall Study|Progression of Disease|4|||
130425055|NCT00540124|469514526|FG000|Overall Study|Adverse Event|0|||
130425056|NCT00540124|469514527|FG001|Overall Study|Adverse Event|2|||
130425057|NCT00540124|469514528|FG002|Overall Study|Adverse Event|1|||
130425058|NCT00540124|469514526|FG000|Overall Study|Entry Criteria Not Met|2|||
130425059|NCT00540124|469514527|FG001|Overall Study|Entry Criteria Not Met|0|||
130425060|NCT00540124|469514528|FG002|Overall Study|Entry Criteria Not Met|0|||
130425061|NCT00540124|469514526|FG000|Overall Study|Lack of Efficacy|1|||
130425062|NCT00540124|469514527|FG001|Overall Study|Lack of Efficacy|0|||
130425063|NCT00540124|469514528|FG002|Overall Study|Lack of Efficacy|0|||
130425064|NCT00540124|469514526|FG000|Overall Study|Withdrawal by Subject|1|||
130425065|NCT00540124|469514527|FG001|Overall Study|Withdrawal by Subject|1|||
130425066|NCT00540124|469514528|FG002|Overall Study|Withdrawal by Subject|0|||
130425067|NCT01207102|469514531|FG000|Overall Study|Withdrawal by Subject|5|||
130425068|NCT01207102|469514531|FG000|Overall Study|Adverse Event|2|||
130425069|NCT01207102|469514531|FG000|Overall Study|progression|2|||
130425070|NCT01207102|469514531|FG000|Overall Study|Withdrawal by Treating Physician|1|||
130425071|NCT01777854|469514534|FG000|Overall Study|Physician Decision|3|||
130425072|NCT01777854|469514535|FG001|Overall Study|Physician Decision|3|||
130425073|NCT03649230|469514536|FG000|Overall Study|Adverse Event|12|||
130425074|NCT03649230|469514536|FG000|Overall Study|Death|8|||
130425075|NCT03649230|469514536|FG000|Overall Study|Withdrawal by Subject|6|||
130425076|NCT03649230|469514536|FG000|Overall Study|Physician Decision|5|||
130425077|NCT03649230|469514536|FG000|Overall Study|Disease progression|5|||
130425078|NCT03649230|469514536|FG000|Overall Study|Switched to non-HEC|5|||
130425079|NCT03649230|469514536|FG000|Overall Study|Chemotherapy discontinued|4|||
130425080|NCT03649230|469514536|FG000|Overall Study|Received only 3 HEC cycles|4|||
130425081|NCT03649230|469514536|FG000|Overall Study|Screen Failure|3|||
130425082|NCT03649230|469514536|FG000|Overall Study|Patient stopped treatment|2|||
130425083|NCT03649230|469514536|FG000|Overall Study|Protocol Violation|1|||
130425084|NCT03649230|469514536|FG000|Overall Study|Non-compliance|1|||
130425085|NCT03649230|469514536|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
130425086|NCT01693068|469514542|FG000|Randomization Period|On-study|2|||
130425087|NCT01693068|469514543|FG001|Randomization Period|On-study|5|||
130425088|NCT01693068|469514544|FG002|Randomization Period|On-study|0|||
130425089|NCT01693068|469514542|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
130425090|NCT01693068|469514543|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
130425091|NCT01693068|469514544|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
130425092|NCT03311373|469514547|FG000|Overall Study|Adverse Event|1|||
130425093|NCT03311373|469514547|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
130425094|NCT03311373|469514547|FG000|Overall Study|Lost to Follow-up|1|||
130425095|NCT03311373|469514547|FG000|Overall Study|Physician Decision|1|||
130425096|NCT03311373|469514547|FG000|Overall Study|Withdrawal by Subject|3|||
130425097|NCT01239030|469514551|FG000|Double Blind|Adverse Event|0|||
130425098|NCT01239030|469514552|FG001|Double Blind|Adverse Event|1|||
130425099|NCT01239030|469514553|FG002|Double Blind|Adverse Event|0|||
130425100|NCT01239030|469514554|FG003|Double Blind|Adverse Event|2|||
130425101|NCT01239030|469514555|FG004|Double Blind|Adverse Event|0|||
130425102|NCT01239030|469514551|FG000|Double Blind|Withdrawal by Subject|0|||
130425103|NCT01239030|469514552|FG001|Double Blind|Withdrawal by Subject|1|||
130425104|NCT01239030|469514553|FG002|Double Blind|Withdrawal by Subject|1|||
130425105|NCT01239030|469514554|FG003|Double Blind|Withdrawal by Subject|0|||
130425106|NCT01239030|469514555|FG004|Double Blind|Withdrawal by Subject|1|||
130425107|NCT01239030|469514551|FG000|Double Blind|Lost to Follow-up|1|||
130425108|NCT01239030|469514552|FG001|Double Blind|Lost to Follow-up|1|||
130476802|NCT03131648|469715345|FG001|Maintenance Treatment Period|Not dosed|0|||
130476803|NCT03131648|469715346|FG002|Maintenance Treatment Period|Not dosed|3|||
130476804|NCT03131648|469715347|FG003|Maintenance Treatment Period|Not dosed|2|||
130476805|NCT03131648|469715348|FG004|Maintenance Treatment Period|Not dosed|1|||
130476806|NCT03131648|469715349|FG005|Maintenance Treatment Period|Not dosed|0|||
130425109|NCT01239030|469514553|FG002|Double Blind|Lost to Follow-up|0|||
130425110|NCT01239030|469514554|FG003|Double Blind|Lost to Follow-up|0|||
130425111|NCT01239030|469514555|FG004|Double Blind|Lost to Follow-up|0|||
130425112|NCT01239030|469514551|FG000|Double Blind|Physician Decision|0|||
130425113|NCT01239030|469514552|FG001|Double Blind|Physician Decision|1|||
130425114|NCT01239030|469514553|FG002|Double Blind|Physician Decision|0|||
130476807|NCT03131648|469715350|FG006|Maintenance Treatment Period|Not dosed|0|||
130425115|NCT01239030|469514554|FG003|Double Blind|Physician Decision|0|||
130425116|NCT01239030|469514555|FG004|Double Blind|Physician Decision|0|||
130476808|NCT03131648|469715351|FG007|Maintenance Treatment Period|Not dosed|0|||
130425117|NCT01239030|469514551|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
130425118|NCT01239030|469514552|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
130425119|NCT01239030|469514553|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
130425120|NCT01239030|469514554|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
130425121|NCT01239030|469514555|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
130476809|NCT03131648|469715344|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
130476810|NCT03131648|469715345|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
130476811|NCT03131648|469715346|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
130476812|NCT03131648|469715347|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
130476813|NCT03131648|469715348|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
130476814|NCT03131648|469715349|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
130476815|NCT03131648|469715350|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
130476816|NCT03131648|469715351|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
130476817|NCT03131648|469715344|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130476818|NCT03131648|469715345|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130476819|NCT03131648|469715346|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
130476820|NCT03131648|469715347|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
130476821|NCT03131648|469715348|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
130476822|NCT03131648|469715349|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
130476823|NCT03131648|469715350|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130476824|NCT03131648|469715351|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130476825|NCT03131648|469715344|FG000|Maintenance Treatment Period|Completed Week 50|0|||
130476826|NCT03131648|469715345|FG001|Maintenance Treatment Period|Completed Week 50|0|||
130476827|NCT03131648|469715346|FG002|Maintenance Treatment Period|Completed Week 50|0|||
130476828|NCT03131648|469715347|FG003|Maintenance Treatment Period|Completed Week 50|0|||
130476829|NCT03131648|469715348|FG004|Maintenance Treatment Period|Completed Week 50|1|||
130476830|NCT03131648|469715349|FG005|Maintenance Treatment Period|Completed Week 50|0|||
130476831|NCT03131648|469715350|FG006|Maintenance Treatment Period|Completed Week 50|0|||
130476832|NCT03131648|469715351|FG007|Maintenance Treatment Period|Completed Week 50|0|||
130476833|NCT03131648|469715344|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476834|NCT03131648|469715345|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476835|NCT03131648|469715346|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476836|NCT03131648|469715347|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476837|NCT03131648|469715348|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476838|NCT03131648|469715349|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
130476839|NCT03131648|469715350|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
130425122|NCT01239030|469514551|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
130425123|NCT01239030|469514552|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
130425124|NCT01239030|469514553|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
130425125|NCT01239030|469514554|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
130425126|NCT01239030|469514555|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
130425127|NCT01239030|469514551|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130425128|NCT01239030|469514552|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130425129|NCT01239030|469514553|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
130425130|NCT01239030|469514554|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
130425131|NCT01239030|469514555|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130425132|NCT01239030|469514551|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
130425133|NCT01239030|469514552|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
130425134|NCT01239030|469514553|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
130425135|NCT01239030|469514554|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
130425136|NCT01239030|469514555|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
130425137|NCT02085252|469514569|FG000|Overall Study|Withdrawal of Consent|1|||
130425138|NCT02085252|469514570|FG001|Overall Study|Withdrawal of Consent|0|||
130425139|NCT02085252|469514569|FG000|Overall Study|Adverse Event|0|||
130425140|NCT02085252|469514570|FG001|Overall Study|Adverse Event|1|||
130425141|NCT02085252|469514569|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
130425142|NCT02085252|469514570|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
130425143|NCT02085252|469514569|FG000|Overall Study|Reason Not Specified|0|||
130425144|NCT02085252|469514570|FG001|Overall Study|Reason Not Specified|1|||
130425145|NCT02085252|469514569|FG000|Overall Study|Reason Unknown|0|||
130425146|NCT02085252|469514570|FG001|Overall Study|Reason Unknown|1|||
130425147|NCT02925676|469514572|FG000|Overall Study|Withdrawal by Subject|1|||
130564728|NCT00912028|470033739|FG000|Overall Study|Lost to Follow-up|2|||
130564729|NCT00912028|470033740|FG001|Overall Study|Lost to Follow-up|3|||
130425148|NCT03260868|469514576|FG000|Overall Study|Poor Compliance to Protocol|0|||
130425149|NCT03260868|469514577|FG001|Overall Study|Poor Compliance to Protocol|2|||
130425150|NCT03260868|469514576|FG000|Overall Study|Study Terminated By Sponsor|2|||
130425151|NCT03260868|469514577|FG001|Overall Study|Study Terminated By Sponsor|1|||
130425152|NCT03260868|469514576|FG000|Overall Study|Other than specified above|1|||
130425153|NCT03260868|469514577|FG001|Overall Study|Other than specified above|0|||
130425154|NCT00541450|469514578|FG000|Phase A|Adverse Event|3|||
130425155|NCT00541450|469514579|FG001|Phase A|Adverse Event|0|||
130425156|NCT00541450|469514578|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
130425157|NCT00541450|469514579|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
130425158|NCT00541450|469514578|FG000|Phase A|Hyperglycemia|0|||
130476840|NCT03131648|469715351|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
130476841|NCT05324124|469715352|FG000|Period 1|Withdrawal by Subject|1|||
130476842|NCT05324124|469715353|FG001|Period 1|Withdrawal by Subject|0|||
130476843|NCT05324124|469715352|FG000|Period 1|Physician Decision|0|||
130476844|NCT05324124|469715353|FG001|Period 1|Physician Decision|1|||
130476845|NCT03792256|469715354|FG000|Overall Study|Death|0|||
130476846|NCT03792256|469715355|FG001|Overall Study|Death|1|||
130476847|NCT03792256|469715354|FG000|Overall Study|Lack of Efficacy|0|||
130476848|NCT03792256|469715355|FG001|Overall Study|Lack of Efficacy|1|||
130476849|NCT03792256|469715354|FG000|Overall Study|Withdrawal by Subject|0|||
130476850|NCT03792256|469715355|FG001|Overall Study|Withdrawal by Subject|1|||
130476851|NCT04760678|469715358|FG000|Overall Study|Death|13|||
130476852|NCT04760678|469715358|FG000|Overall Study|Lost to Follow-up|48|||
130476853|NCT04760678|469715358|FG000|Overall Study|Withdrawal by Subject|1|||
130476854|NCT01748448|469715361|FG000|Treatment Period|Consent withdrawn by subject|1|||
130476855|NCT01748448|469715362|FG001|Treatment Period|Consent withdrawn by subject|0|||
130476856|NCT01748448|469715361|FG000|Treatment Period|Adverse Event|1|||
130476857|NCT01748448|469715362|FG001|Treatment Period|Adverse Event|0|||
130476858|NCT01748448|469715361|FG000|Treatment Period|Personal|0|||
130476859|NCT01748448|469715362|FG001|Treatment Period|Personal|1|||
130476860|NCT02907099|469715363|FG000|Overall Study|Adverse Event|1|||
130476861|NCT02907099|469715363|FG000|Overall Study|Withdrawal by Subject|2|||
130476862|NCT02907099|469715363|FG000|Overall Study|Screen Fail|2|||
130476863|NCT05368103|469715364|FG000|Overall Study|Withdrawal by Subject|4|||
130476864|NCT05368103|469715364|FG000|Overall Study|Lost to Follow-up|1|||
130476865|NCT05368103|469715364|FG000|Overall Study|Lack of Efficacy|3|||
130476866|NCT03675282|469715365|FG000|Overall Study|Lost to Follow-up|4|||
130476867|NCT03675282|469715366|FG001|Overall Study|Lost to Follow-up|8|||
130476868|NCT03675282|469715367|FG002|Overall Study|Lost to Follow-up|1|||
130476869|NCT03675282|469715368|FG003|Overall Study|Lost to Follow-up|0|||
130476870|NCT03675282|469715369|FG004|Overall Study|Lost to Follow-up|2|||
130476871|NCT03675282|469715370|FG005|Overall Study|Lost to Follow-up|7|||
130476872|NCT03675282|469715365|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
130476873|NCT03675282|469715366|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
130476874|NCT03675282|469715367|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
130476875|NCT03675282|469715368|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
130476876|NCT03675282|469715369|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
130476877|NCT03675282|469715370|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
130476878|NCT03675282|469715365|FG000|Overall Study|Physician Decision|1|||
130476879|NCT03675282|469715366|FG001|Overall Study|Physician Decision|0|||
130476880|NCT03675282|469715367|FG002|Overall Study|Physician Decision|0|||
130476881|NCT03675282|469715368|FG003|Overall Study|Physician Decision|0|||
130476882|NCT03675282|469715369|FG004|Overall Study|Physician Decision|0|||
130476883|NCT03675282|469715370|FG005|Overall Study|Physician Decision|0|||
130476884|NCT05875142|469715371|FG000|Overall Study|Lost to Follow-up|0|||
130476885|NCT05875142|469715372|FG001|Overall Study|Lost to Follow-up|1|||
130476886|NCT05875142|469715373|FG002|Overall Study|Lost to Follow-up|1|||
130476887|NCT03232138|469715375|FG000|Overall Study|Physician Decision|1|||
130476888|NCT03232138|469715376|FG001|Overall Study|Physician Decision|0|||
130476889|NCT03232138|469715375|FG000|Overall Study|Adverse Event|2|||
130476890|NCT03232138|469715376|FG001|Overall Study|Adverse Event|0|||
130476891|NCT03232138|469715375|FG000|Overall Study|Withdrawal by Subject|1|||
130476892|NCT03232138|469715376|FG001|Overall Study|Withdrawal by Subject|2|||
130476893|NCT04142788|469715377|FG000|Overall Study|Trial terminated prematurely|2|||
130476894|NCT04142788|469715378|FG001|Overall Study|Trial terminated prematurely|2|||
130476895|NCT04322643|469715389|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
130564730|NCT00912028|470033741|FG002|Overall Study|Lost to Follow-up|0|||
130564731|NCT00912028|470033742|FG003|Overall Study|Lost to Follow-up|1|||
130564732|NCT00912028|470033743|FG004|Overall Study|Lost to Follow-up|3|||
130564733|NCT00912028|470033739|FG000|Overall Study|Withdrawal by Subject|3|||
130564734|NCT00912028|470033740|FG001|Overall Study|Withdrawal by Subject|0|||
130564735|NCT00912028|470033741|FG002|Overall Study|Withdrawal by Subject|0|||
130564736|NCT00912028|470033742|FG003|Overall Study|Withdrawal by Subject|0|||
130727579|NCT03743415|470625497|FG008|Overall Study|Withdrawal by Subject|9|||
130476896|NCT03891667|469715390|FG000|Overall Study|Physician Decision|1|||
130476897|NCT03891667|469715391|FG001|Overall Study|Physician Decision|1|||
130476898|NCT03891667|469715390|FG000|Overall Study|COVID related pause|1|||
130476899|NCT03891667|469715391|FG001|Overall Study|COVID related pause|0|||
130476900|NCT03891667|469715390|FG000|Overall Study|Withdrawal by Subject|0|||
130476901|NCT03891667|469715391|FG001|Overall Study|Withdrawal by Subject|1|||
130476902|NCT03891667|469715390|FG000|Overall Study|Adverse Event|0|||
130476903|NCT03891667|469715391|FG001|Overall Study|Adverse Event|1|||
130564737|NCT00912028|470033743|FG004|Overall Study|Withdrawal by Subject|0|||
130727580|NCT03743415|470625498|FG009|Overall Study|Withdrawal by Subject|10|||
130727581|NCT03743415|470625489|FG000|Overall Study|Lost to Follow-up|2|||
130476904|NCT05076708|469715401|FG000|Overall Study|Withdrawal by Subject|4|||
130727582|NCT03743415|470625490|FG001|Overall Study|Lost to Follow-up|0|||
130476905|NCT05076708|469715401|FG000|Overall Study|Lost to study during switch phase|8|||
130476906|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Other|0|||
130476907|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Other|0|||
130476908|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Other|0|||
130476909|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Other|0|||
130476910|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Other|0|||
130476911|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Other|0|||
130476912|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Other|0|||
130476913|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Other|0|||
130476914|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Other|0|||
130476915|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Other|0|||
130476916|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Other|1|||
130476917|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Other|1|||
130476918|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Other|1|||
130476919|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Other|0|||
130476920|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Other|3|||
130476921|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Other|1|||
130476922|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Other|1|||
130476923|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Other|0|||
130476924|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476925|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476926|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476927|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476928|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476929|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476930|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
130476931|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476932|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
130476933|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476934|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476935|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476936|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
130476937|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476938|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476939|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476940|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476941|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
130476942|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476943|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476944|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476945|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476946|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476947|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130564738|NCT00942175|470033744|FG000|Overall Study|Adverse Event|2|||
130564739|NCT00942175|470033745|FG001|Overall Study|Adverse Event|1|||
130564740|NCT00942175|470033746|FG002|Overall Study|Adverse Event|0|||
130564741|NCT00942175|470033747|FG003|Overall Study|Adverse Event|0|||
130564742|NCT00942175|470033744|FG000|Overall Study|Protocol Violation|0|||
130564743|NCT00942175|470033745|FG001|Overall Study|Protocol Violation|1|||
130564744|NCT00942175|470033746|FG002|Overall Study|Protocol Violation|2|||
130476948|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476949|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
130476950|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476951|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476952|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476953|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476954|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130564745|NCT00942175|470033747|FG003|Overall Study|Protocol Violation|0|||
130564746|NCT00942175|470033744|FG000|Overall Study|Pregnancy|0|||
130564747|NCT00942175|470033745|FG001|Overall Study|Pregnancy|0|||
130476955|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476956|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476957|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476958|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130476959|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
130564748|NCT00942175|470033746|FG002|Overall Study|Pregnancy|0|||
130564749|NCT00942175|470033747|FG003|Overall Study|Pregnancy|1|||
130564750|NCT00942175|470033744|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
130564751|NCT00942175|470033745|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
130564752|NCT00942175|470033746|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
130564753|NCT00942175|470033747|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
130564754|NCT00942175|470033744|FG000|Overall Study|Low Platelet Count|0|||
130425159|NCT00541450|469514579|FG001|Phase A|Hyperglycemia|1|||
130425160|NCT00541450|469514578|FG000|Phase A|Lost to Follow-up|6|||
130425161|NCT00541450|469514579|FG001|Phase A|Lost to Follow-up|4|||
130425162|NCT00541450|469514578|FG000|Phase A|Physician Decision|2|||
130425163|NCT00541450|469514579|FG001|Phase A|Physician Decision|0|||
130425164|NCT00541450|469514578|FG000|Phase A|Protocol Violation|2|||
130425165|NCT00541450|469514579|FG001|Phase A|Protocol Violation|3|||
130425166|NCT00541450|469514578|FG000|Phase A|Withdrawal by Subject|7|||
130425167|NCT00541450|469514579|FG001|Phase A|Withdrawal by Subject|7|||
130425168|NCT00541450|469514578|FG000|Phase B|Adverse Event|6|||
130425169|NCT00541450|469514579|FG001|Phase B|Adverse Event|6|||
130425170|NCT00541450|469514578|FG000|Phase B|Hyperglycemia|10|||
130425171|NCT00541450|469514579|FG001|Phase B|Hyperglycemia|9|||
130425172|NCT00541450|469514578|FG000|Phase B|Lost to Follow-up|6|||
130425173|NCT00541450|469514579|FG001|Phase B|Lost to Follow-up|4|||
130425174|NCT00541450|469514578|FG000|Phase B|Physician Decision|4|||
130425175|NCT00541450|469514579|FG001|Phase B|Physician Decision|2|||
130425176|NCT00541450|469514578|FG000|Phase B|Pregnancy|0|||
130425177|NCT00541450|469514579|FG001|Phase B|Pregnancy|1|||
130425178|NCT00541450|469514578|FG000|Phase B|Protocol Violation|3|||
130425179|NCT00541450|469514579|FG001|Phase B|Protocol Violation|3|||
130425180|NCT00541450|469514578|FG000|Phase B|Withdrawal by Subject|8|||
130425181|NCT00541450|469514579|FG001|Phase B|Withdrawal by Subject|6|||
130425182|NCT01298999|469514580|FG000|Overall Study|Physician Decision|0|||
130425183|NCT01298999|469514581|FG001|Overall Study|Physician Decision|1|||
130425184|NCT01298999|469514580|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
130425185|NCT01298999|469514581|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
130425186|NCT02151266|469514582|FG000|Overall Study|Lost to Follow-up|1|||
130425187|NCT02151266|469514583|FG001|Overall Study|Lost to Follow-up|4|||
130425188|NCT02151266|469514584|FG002|Overall Study|Lost to Follow-up|1|||
130425189|NCT02151266|469514582|FG000|Overall Study|Did NOT receive intervention|3|||
130425190|NCT02151266|469514583|FG001|Overall Study|Did NOT receive intervention|6|||
130425191|NCT02151266|469514584|FG002|Overall Study|Did NOT receive intervention|2|||
130425192|NCT02151266|469514582|FG000|Overall Study|Not able to exercise|4|||
130425193|NCT02151266|469514583|FG001|Overall Study|Not able to exercise|5|||
130425194|NCT02151266|469514584|FG002|Overall Study|Not able to exercise|4|||
130425195|NCT00803452|469514585|FG000|Overall Study|Adverse Event|0|||
130425196|NCT00803452|469514586|FG001|Overall Study|Adverse Event|2|||
130425197|NCT00803452|469514585|FG000|Overall Study|Lost to Follow-up|0|||
130425198|NCT00803452|469514586|FG001|Overall Study|Lost to Follow-up|3|||
130425199|NCT02291679|469514587|FG000|Overall Study|Adverse Event|2|||
130425200|NCT02291679|469514588|FG001|Overall Study|Adverse Event|12|||
130425201|NCT02291679|469514589|FG002|Overall Study|Adverse Event|19|||
130425202|NCT02291679|469514587|FG000|Overall Study|Protocol Violation|5|||
130425203|NCT02291679|469514588|FG001|Overall Study|Protocol Violation|1|||
130425204|NCT02291679|469514589|FG002|Overall Study|Protocol Violation|7|||
130425205|NCT02291679|469514587|FG000|Overall Study|Withdrew Consent|18|||
130425206|NCT02291679|469514588|FG001|Overall Study|Withdrew Consent|10|||
130425207|NCT02291679|469514589|FG002|Overall Study|Withdrew Consent|15|||
130425208|NCT02291679|469514587|FG000|Overall Study|Lost to Follow-up|12|||
130425209|NCT02291679|469514588|FG001|Overall Study|Lost to Follow-up|10|||
130425210|NCT02291679|469514589|FG002|Overall Study|Lost to Follow-up|9|||
130425211|NCT02291679|469514587|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130425212|NCT02291679|469514588|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130425213|NCT02291679|469514589|FG002|Overall Study|Insufficient Therapeutic Response|7|||
130425214|NCT02291679|469514587|FG000|Overall Study|Other|2|||
130425215|NCT02291679|469514588|FG001|Overall Study|Other|4|||
130727583|NCT03743415|470625491|FG002|Overall Study|Lost to Follow-up|2|||
130425216|NCT02291679|469514589|FG002|Overall Study|Other|2|||
130425217|NCT00725296|469514590|FG000|Overall Study|Adverse Event|11|||
130425218|NCT00725296|469514590|FG000|Overall Study|Lack of Efficacy|7|||
130425219|NCT00725296|469514590|FG000|Overall Study|Withdrawal by Subject|3|||
130425220|NCT00725296|469514590|FG000|Overall Study|Non-Compliance|2|||
130425221|NCT00725296|469514590|FG000|Overall Study|Lost to Follow-up|1|||
130425222|NCT00725296|469514590|FG000|Overall Study|Other|38|||
130425223|NCT03360942|469514591|FG000|Overall Study|Device explanted|2|||
130425224|NCT03360942|469514591|FG000|Overall Study|Study closure|1|||
130425225|NCT03360942|469514591|FG000|Overall Study|Withdrawal by Subject|2|||
130425226|NCT05073133|469514592|FG000|Overall Study|Death|2|||
130425227|NCT00289887|469516014|FG000|Overall Study|Adverse Event|3|||
130425228|NCT00289887|469516015|FG001|Overall Study|Adverse Event|3|||
130425229|NCT00289887|469516014|FG000|Overall Study|Lack of Efficacy|3|||
130425230|NCT00289887|469516015|FG001|Overall Study|Lack of Efficacy|11|||
130425231|NCT00289887|469516014|FG000|Overall Study|Lost to Follow-up|3|||
130425232|NCT00289887|469516015|FG001|Overall Study|Lost to Follow-up|3|||
130425233|NCT00289887|469516014|FG000|Overall Study|Protocol Violation|3|||
130425234|NCT00289887|469516015|FG001|Overall Study|Protocol Violation|1|||
130425235|NCT00289887|469516014|FG000|Overall Study|Withdrawal by Subject|3|||
130425236|NCT00289887|469516015|FG001|Overall Study|Withdrawal by Subject|8|||
130425237|NCT00289887|469516014|FG000|Overall Study|Other|7|||
130476960|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476961|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476962|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476963|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476964|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476965|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476966|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476967|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476968|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476969|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
130476970|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476971|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476972|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476973|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476974|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476975|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476976|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476977|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
130476978|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Death|0|||
130564755|NCT00942175|470033745|FG001|Overall Study|Low Platelet Count|2|||
130564756|NCT00942175|470033746|FG002|Overall Study|Low Platelet Count|0|||
130564757|NCT00942175|470033747|FG003|Overall Study|Low Platelet Count|0|||
130425238|NCT00289887|469516015|FG001|Overall Study|Other|3|||
130425239|NCT01266850|469516016|FG000|Overall Study|Lost to Follow-up|19|||
130425240|NCT01266850|469516017|FG001|Overall Study|Lost to Follow-up|19|||
130425241|NCT01266850|469516018|FG002|Overall Study|Lost to Follow-up|13|||
130425242|NCT01266850|469516019|FG003|Overall Study|Lost to Follow-up|13|||
130425243|NCT01266850|469516020|FG004|Overall Study|Lost to Follow-up|12|||
130425244|NCT01266850|469516016|FG000|Overall Study|Withdrawal by Subject|8|||
130425245|NCT01266850|469516017|FG001|Overall Study|Withdrawal by Subject|9|||
130425246|NCT01266850|469516018|FG002|Overall Study|Withdrawal by Subject|6|||
130425247|NCT01266850|469516019|FG003|Overall Study|Withdrawal by Subject|9|||
130425248|NCT01266850|469516020|FG004|Overall Study|Withdrawal by Subject|12|||
130425249|NCT01266850|469516016|FG000|Overall Study|Physician Decision|3|||
130425250|NCT01266850|469516017|FG001|Overall Study|Physician Decision|6|||
130425251|NCT01266850|469516018|FG002|Overall Study|Physician Decision|4|||
130425252|NCT01266850|469516019|FG003|Overall Study|Physician Decision|4|||
130425253|NCT01266850|469516020|FG004|Overall Study|Physician Decision|3|||
130425254|NCT01266850|469516016|FG000|Overall Study|Protocol Violation|0|||
130425255|NCT01266850|469516017|FG001|Overall Study|Protocol Violation|1|||
130425256|NCT01266850|469516018|FG002|Overall Study|Protocol Violation|0|||
130425257|NCT01266850|469516019|FG003|Overall Study|Protocol Violation|1|||
130425258|NCT01266850|469516020|FG004|Overall Study|Protocol Violation|2|||
130425259|NCT01266850|469516016|FG000|Overall Study|Adverse Event|0|||
130425260|NCT01266850|469516017|FG001|Overall Study|Adverse Event|0|||
130425261|NCT01266850|469516018|FG002|Overall Study|Adverse Event|0|||
130425262|NCT01266850|469516019|FG003|Overall Study|Adverse Event|0|||
130425263|NCT01266850|469516020|FG004|Overall Study|Adverse Event|1|||
130425264|NCT01266850|469516016|FG000|Overall Study|Site Closure|0|||
130425265|NCT01266850|469516017|FG001|Overall Study|Site Closure|1|||
130425266|NCT01266850|469516018|FG002|Overall Study|Site Closure|1|||
130425267|NCT01266850|469516019|FG003|Overall Study|Site Closure|1|||
130425268|NCT01266850|469516020|FG004|Overall Study|Site Closure|0|||
130425269|NCT00437645|469516024|FG000|Overall Study|Adverse Event|15|||
130425270|NCT00437645|469516025|FG001|Overall Study|Adverse Event|84|||
130425271|NCT00437645|469516024|FG000|Overall Study|Withdrawal by Subject|10|||
130425272|NCT00437645|469516025|FG001|Overall Study|Withdrawal by Subject|22|||
130425273|NCT00437645|469516024|FG000|Overall Study|Protocol Violation|3|||
130425274|NCT00437645|469516025|FG001|Overall Study|Protocol Violation|3|||
130425275|NCT00437645|469516024|FG000|Overall Study|Lost to Follow-up|2|||
130425276|NCT00437645|469516025|FG001|Overall Study|Lost to Follow-up|3|||
130425277|NCT00437645|469516024|FG000|Overall Study|Administrative problems|2|||
130425278|NCT00437645|469516025|FG001|Overall Study|Administrative problems|1|||
130425279|NCT00437645|469516024|FG000|Overall Study|Lack of Efficacy|2|||
130425280|NCT00437645|469516025|FG001|Overall Study|Lack of Efficacy|1|||
130476979|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Death|0|||
130476980|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Death|0|||
130564758|NCT02664272|470033748|FG000|Overall Study|Fluoroscopic images not made available|2|||
130425281|NCT00437645|469516024|FG000|Overall Study|Condition no longer requires study drug|1|||
130476981|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Death|0|||
130727584|NCT03743415|470625492|FG003|Overall Study|Lost to Follow-up|1|||
130425282|NCT00437645|469516025|FG001|Overall Study|Condition no longer requires study drug|1|||
130425283|NCT03751631|469516029|FG000|Overall Study|Withdrawal by Subject|0|||
130425284|NCT03751631|469516030|FG001|Overall Study|Withdrawal by Subject|0|||
130425285|NCT03751631|469516031|FG002|Overall Study|Withdrawal by Subject|1|||
130425286|NCT03751631|469516032|FG003|Overall Study|Withdrawal by Subject|1|||
130425287|NCT03751631|469516033|FG004|Overall Study|Withdrawal by Subject|0|||
130425288|NCT03751631|469516034|FG005|Overall Study|Withdrawal by Subject|0|||
130476982|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Death|0|||
130476983|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Death|0|||
130476984|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Death|0|||
130476985|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Death|0|||
130476986|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Death|0|||
130476987|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Death|1|||
130476988|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Death|0|||
130476989|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Death|1|||
130476990|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Death|0|||
130476991|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Death|1|||
130476992|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Death|0|||
130476993|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Death|0|||
130476994|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Death|2|||
130476995|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Death|0|||
130476996|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
130476997|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
130476998|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
130476999|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
130477000|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
130477001|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
130477002|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
130477003|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
130477004|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
130477005|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
130477006|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
130477007|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
130477008|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
130477009|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
130477010|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
130477011|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
130477012|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
130477013|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
130477014|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Adverse Event|0|||
130477015|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Adverse Event|0|||
130477016|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Adverse Event|0|||
130477017|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Adverse Event|0|||
130477018|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Adverse Event|0|||
130477019|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Adverse Event|0|||
130477020|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Adverse Event|2|||
130477021|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Adverse Event|0|||
130477022|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Adverse Event|0|||
130477023|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Adverse Event|0|||
130477024|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Adverse Event|1|||
130477025|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Adverse Event|2|||
130477026|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Adverse Event|0|||
130477027|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Adverse Event|1|||
130477028|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Adverse Event|0|||
130477029|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Adverse Event|0|||
130477030|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Adverse Event|1|||
130477031|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Adverse Event|0|||
130477032|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
130477033|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
130477034|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
130477035|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
130477036|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
130477037|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
130477038|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
130477039|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
130477040|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
130477041|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
130477042|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
130477043|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
130477044|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
130477045|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
130477046|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
130477047|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
130477048|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
130477049|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
130564759|NCT03073980|470033749|FG000|Overall Study|Lost to Follow-up|10|||
130477050|NCT03269136|469715404|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477051|NCT03269136|469715405|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477052|NCT03269136|469715406|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477053|NCT03269136|469715407|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477054|NCT03269136|469715408|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130564760|NCT03073980|470033750|FG001|Overall Study|Lost to Follow-up|2|||
130425289|NCT03382782|469516039|FG000|Cohort 1|Withdrawal by Subject|11|||
130425290|NCT03382782|469516040|FG001|Cohort 1|Withdrawal by Subject|5|||
130425291|NCT03382782|469516041|FG002|Cohort 1|Withdrawal by Subject|0|||
130425292|NCT03382782|469516039|FG000|Cohort 2|Withdrawal by Subject|1|||
130425293|NCT03382782|469516040|FG001|Cohort 2|Withdrawal by Subject|1|||
130425294|NCT03382782|469516041|FG002|Cohort 2|Withdrawal by Subject|0|||
130425295|NCT03382782|469516039|FG000|Cohort 3|Withdrawal by Subject|1|||
130425296|NCT03382782|469516040|FG001|Cohort 3|Withdrawal by Subject|2|||
130425297|NCT03382782|469516041|FG002|Cohort 3|Withdrawal by Subject|0|||
130425298|NCT00428090|469516044|FG000|Overall Study|Adverse Event|10|||
130425299|NCT00428090|469516045|FG001|Overall Study|Adverse Event|8|||
130425300|NCT00428090|469516046|FG002|Overall Study|Adverse Event|10|||
130425301|NCT00428090|469516047|FG003|Overall Study|Adverse Event|11|||
130425302|NCT00428090|469516044|FG000|Overall Study|Lost to Follow-up|3|||
130425303|NCT00428090|469516045|FG001|Overall Study|Lost to Follow-up|6|||
130425304|NCT00428090|469516046|FG002|Overall Study|Lost to Follow-up|1|||
130425305|NCT00428090|469516047|FG003|Overall Study|Lost to Follow-up|4|||
130425306|NCT00428090|469516044|FG000|Overall Study|Protocol Violation|3|||
130425307|NCT00428090|469516045|FG001|Overall Study|Protocol Violation|1|||
130425308|NCT00428090|469516046|FG002|Overall Study|Protocol Violation|3|||
130425309|NCT00428090|469516047|FG003|Overall Study|Protocol Violation|3|||
130425310|NCT00428090|469516044|FG000|Overall Study|Withdrawal by Subject|10|||
130425311|NCT00428090|469516045|FG001|Overall Study|Withdrawal by Subject|12|||
130425312|NCT00428090|469516046|FG002|Overall Study|Withdrawal by Subject|15|||
130425313|NCT00428090|469516047|FG003|Overall Study|Withdrawal by Subject|5|||
130425314|NCT00428090|469516044|FG000|Overall Study|Sponsor terminated study|0|||
130425315|NCT00428090|469516045|FG001|Overall Study|Sponsor terminated study|1|||
130425316|NCT00428090|469516046|FG002|Overall Study|Sponsor terminated study|0|||
130425317|NCT00428090|469516047|FG003|Overall Study|Sponsor terminated study|0|||
130425318|NCT00428090|469516044|FG000|Overall Study|Non-compliance|4|||
130425319|NCT00428090|469516045|FG001|Overall Study|Non-compliance|0|||
130425320|NCT00428090|469516046|FG002|Overall Study|Non-compliance|1|||
130425321|NCT00428090|469516047|FG003|Overall Study|Non-compliance|3|||
130425322|NCT00428090|469516044|FG000|Overall Study|Par. did not returned to visit|1|||
130425323|NCT00428090|469516045|FG001|Overall Study|Par. did not returned to visit|0|||
130425324|NCT00428090|469516046|FG002|Overall Study|Par. did not returned to visit|0|||
130425325|NCT00428090|469516047|FG003|Overall Study|Par. did not returned to visit|1|||
130425326|NCT00428090|469516044|FG000|Overall Study|Follow-Up visit not possible|1|||
130425327|NCT00428090|469516045|FG001|Overall Study|Follow-Up visit not possible|0|||
130425328|NCT00428090|469516046|FG002|Overall Study|Follow-Up visit not possible|0|||
130425329|NCT00428090|469516047|FG003|Overall Study|Follow-Up visit not possible|0|||
130425330|NCT00428090|469516044|FG000|Overall Study|Prohibited medication used for SAE|1|||
130425331|NCT00428090|469516045|FG001|Overall Study|Prohibited medication used for SAE|0|||
130425332|NCT00428090|469516046|FG002|Overall Study|Prohibited medication used for SAE|0|||
130425333|NCT00428090|469516047|FG003|Overall Study|Prohibited medication used for SAE|0|||
130425334|NCT00428090|469516044|FG000|Overall Study|Death of par.|1|||
130425335|NCT00428090|469516045|FG001|Overall Study|Death of par.|0|||
130425336|NCT00428090|469516046|FG002|Overall Study|Death of par.|1|||
130425337|NCT00428090|469516047|FG003|Overall Study|Death of par.|0|||
130425338|NCT00428090|469516044|FG000|Overall Study|Visit 7 exceed the visit window|0|||
130425339|NCT00428090|469516045|FG001|Overall Study|Visit 7 exceed the visit window|1|||
130425340|NCT00428090|469516046|FG002|Overall Study|Visit 7 exceed the visit window|0|||
130425341|NCT00428090|469516047|FG003|Overall Study|Visit 7 exceed the visit window|0|||
130425342|NCT00428090|469516044|FG000|Overall Study|Medical monitor terminated par.|0|||
130425343|NCT00428090|469516045|FG001|Overall Study|Medical monitor terminated par.|1|||
130425344|NCT00428090|469516046|FG002|Overall Study|Medical monitor terminated par.|0|||
130425345|NCT00428090|469516047|FG003|Overall Study|Medical monitor terminated par.|0|||
130425346|NCT00428090|469516044|FG000|Overall Study|Mental status of par. was|0|||
130425347|NCT00428090|469516045|FG001|Overall Study|Mental status of par. was|1|||
130477055|NCT03269136|469715409|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477056|NCT03269136|469715410|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130425348|NCT00428090|469516046|FG002|Overall Study|Mental status of par. was|0|||
130425349|NCT00428090|469516047|FG003|Overall Study|Mental status of par. was|0|||
130425350|NCT00428090|469516044|FG000|Overall Study|Worsening of AD|0|||
130477057|NCT03269136|469715411|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130425351|NCT00428090|469516045|FG001|Overall Study|Worsening of AD|0|||
130425352|NCT00428090|469516046|FG002|Overall Study|Worsening of AD|1|||
130477058|NCT03269136|469715412|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477059|NCT03269136|469715413|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130425353|NCT00428090|469516047|FG003|Overall Study|Worsening of AD|0|||
130425354|NCT00428090|469516044|FG000|Overall Study|Excluded for concerning QTc value|0|||
130425355|NCT00428090|469516045|FG001|Overall Study|Excluded for concerning QTc value|0|||
130477060|NCT03269136|469715414|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130425356|NCT00428090|469516046|FG002|Overall Study|Excluded for concerning QTc value|1|||
130425357|NCT00428090|469516047|FG003|Overall Study|Excluded for concerning QTc value|0|||
130425358|NCT00428090|469516044|FG000|Overall Study|Insufficient AD documentation|0|||
130425359|NCT00428090|469516045|FG001|Overall Study|Insufficient AD documentation|0|||
130425360|NCT00428090|469516046|FG002|Overall Study|Insufficient AD documentation|1|||
130425361|NCT00428090|469516047|FG003|Overall Study|Insufficient AD documentation|0|||
130425362|NCT00428090|469516044|FG000|Overall Study|High MMSE scores|0|||
130425363|NCT00428090|469516045|FG001|Overall Study|High MMSE scores|0|||
130425364|NCT00428090|469516046|FG002|Overall Study|High MMSE scores|1|||
130425365|NCT00428090|469516047|FG003|Overall Study|High MMSE scores|0|||
130425366|NCT00428090|469516044|FG000|Overall Study|Deterioration of cognitive status|0|||
130425367|NCT00428090|469516045|FG001|Overall Study|Deterioration of cognitive status|0|||
130425368|NCT00428090|469516046|FG002|Overall Study|Deterioration of cognitive status|1|||
130425369|NCT00428090|469516047|FG003|Overall Study|Deterioration of cognitive status|0|||
130425370|NCT00428090|469516044|FG000|Overall Study|Serious adverse event|0|||
130425371|NCT00428090|469516045|FG001|Overall Study|Serious adverse event|0|||
130425372|NCT00428090|469516046|FG002|Overall Study|Serious adverse event|1|||
130425373|NCT00428090|469516047|FG003|Overall Study|Serious adverse event|0|||
130425374|NCT00428090|469516044|FG000|Overall Study|Excluded for heart insufficiency|0|||
130425375|NCT00428090|469516045|FG001|Overall Study|Excluded for heart insufficiency|0|||
130425376|NCT00428090|469516046|FG002|Overall Study|Excluded for heart insufficiency|1|||
130425377|NCT00428090|469516047|FG003|Overall Study|Excluded for heart insufficiency|0|||
130425378|NCT00428090|469516044|FG000|Overall Study|Raised Creatinine Value|0|||
130425379|NCT00428090|469516045|FG001|Overall Study|Raised Creatinine Value|0|||
130425380|NCT00428090|469516046|FG002|Overall Study|Raised Creatinine Value|0|||
130425381|NCT00428090|469516047|FG003|Overall Study|Raised Creatinine Value|1|||
130425382|NCT03409666|469516048|FG000|Overall Study|Physician Decision|0|||
130425383|NCT03409666|469516049|FG001|Overall Study|Physician Decision|1|||
130425384|NCT03409666|469516048|FG000|Overall Study|Protocol Violation|0|||
130425385|NCT03409666|469516049|FG001|Overall Study|Protocol Violation|3|||
130425386|NCT01791725|469516053|FG000|Overall Study|Withdrawal by Subject|0|||
130425387|NCT01791725|469516054|FG001|Overall Study|Withdrawal by Subject|1|||
130425388|NCT01791725|469516055|FG002|Overall Study|Withdrawal by Subject|0|||
130425389|NCT00512148|469516056|FG000|Primay Study Period|Withdrawal by Subject|1|||
130477061|NCT03269136|469715415|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477062|NCT03269136|469715416|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130477063|NCT03269136|469715417|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
130477064|NCT03269136|469715418|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
130477065|NCT03269136|469715419|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477066|NCT03269136|469715420|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130477067|NCT03269136|469715421|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130477068|NCT03269136|469715404|FG000|Part 2A: Dose Expansion|Other|0|||
130477069|NCT03269136|469715405|FG001|Part 2A: Dose Expansion|Other|0|||
130477070|NCT03269136|469715406|FG002|Part 2A: Dose Expansion|Other|0|||
130477071|NCT03269136|469715407|FG003|Part 2A: Dose Expansion|Other|0|||
130477072|NCT03269136|469715408|FG004|Part 2A: Dose Expansion|Other|0|||
130477073|NCT03269136|469715409|FG005|Part 2A: Dose Expansion|Other|0|||
130477074|NCT03269136|469715410|FG006|Part 2A: Dose Expansion|Other|0|||
130477075|NCT03269136|469715411|FG007|Part 2A: Dose Expansion|Other|0|||
130477076|NCT03269136|469715412|FG008|Part 2A: Dose Expansion|Other|0|||
130477077|NCT03269136|469715413|FG009|Part 2A: Dose Expansion|Other|0|||
130477078|NCT03269136|469715414|FG010|Part 2A: Dose Expansion|Other|0|||
130477079|NCT03269136|469715415|FG011|Part 2A: Dose Expansion|Other|0|||
130477080|NCT03269136|469715416|FG012|Part 2A: Dose Expansion|Other|0|||
130477081|NCT03269136|469715417|FG013|Part 2A: Dose Expansion|Other|0|||
130477082|NCT03269136|469715418|FG014|Part 2A: Dose Expansion|Other|0|||
130477083|NCT03269136|469715419|FG015|Part 2A: Dose Expansion|Other|0|||
130477084|NCT03269136|469715420|FG016|Part 2A: Dose Expansion|Other|0|||
130477085|NCT03269136|469715421|FG017|Part 2A: Dose Expansion|Other|1|||
130477086|NCT03269136|469715404|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477087|NCT03269136|469715405|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477088|NCT03269136|469715406|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477089|NCT03269136|469715407|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477090|NCT03269136|469715408|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477091|NCT03269136|469715409|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477092|NCT03269136|469715410|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477093|NCT03269136|469715411|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477094|NCT03269136|469715412|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477095|NCT03269136|469715413|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477096|NCT03269136|469715414|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130425390|NCT03255824|469516057|FG000|Overall Study|Under-sedation|2|||
130425391|NCT03255824|469516058|FG001|Overall Study|Under-sedation|1|||
130425392|NCT00677833|469516059|FG000|Overall Study|Withdrawal by Subject|4|||
130425393|NCT00677833|469516060|FG001|Overall Study|Withdrawal by Subject|0|||
130425394|NCT00677833|469516061|FG002|Overall Study|Withdrawal by Subject|1|||
130425395|NCT00677833|469516062|FG003|Overall Study|Withdrawal by Subject|3|||
130477097|NCT03269136|469715415|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477098|NCT03269136|469715416|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477099|NCT03269136|469715417|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477100|NCT03269136|469715418|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477101|NCT03269136|469715419|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477102|NCT03269136|469715420|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130477103|NCT03269136|469715421|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
130477104|NCT03269136|469715404|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
130477105|NCT03269136|469715405|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
130477106|NCT03269136|469715406|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
130477107|NCT03269136|469715407|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
130477108|NCT03269136|469715408|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
130477109|NCT03269136|469715409|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
130477110|NCT03269136|469715410|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
130477111|NCT03269136|469715411|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
130477112|NCT03269136|469715412|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
130477113|NCT03269136|469715413|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
130477114|NCT03269136|469715414|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
130477115|NCT03269136|469715415|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
130477116|NCT03269136|469715416|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
130477117|NCT03269136|469715417|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
130477118|NCT03269136|469715418|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
130477119|NCT03269136|469715419|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
130477120|NCT03269136|469715420|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
130477121|NCT03269136|469715421|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
130477122|NCT03269136|469715404|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
130477123|NCT03269136|469715405|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
130477124|NCT03269136|469715406|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
130477125|NCT03269136|469715407|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
130477126|NCT03269136|469715408|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
130477127|NCT03269136|469715409|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
130477128|NCT03269136|469715410|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
130477129|NCT03269136|469715411|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
130477130|NCT03269136|469715412|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
130477131|NCT03269136|469715413|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
130477132|NCT03269136|469715414|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
130477133|NCT03269136|469715415|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
130477134|NCT03269136|469715416|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
130477135|NCT03269136|469715417|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
130477136|NCT03269136|469715418|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
130477137|NCT03269136|469715419|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
130477138|NCT03269136|469715420|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
130477139|NCT03269136|469715421|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
130477140|NCT03269136|469715404|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
130477141|NCT03269136|469715405|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
130477142|NCT03269136|469715406|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
130477143|NCT03269136|469715407|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
130477144|NCT03269136|469715408|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
130477145|NCT03269136|469715409|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
130477146|NCT03269136|469715410|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
130477147|NCT03269136|469715411|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
130477148|NCT03269136|469715412|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
130564761|NCT03073980|470033751|FG002|Overall Study|Lost to Follow-up|9|||
130564762|NCT03073980|470033749|FG000|Overall Study|No post-procedure data|0|||
130564763|NCT03073980|470033750|FG001|Overall Study|No post-procedure data|0|||
130564764|NCT03073980|470033751|FG002|Overall Study|No post-procedure data|2|||
130564765|NCT00545064|470033752|FG000|Overall Study|Lost to Follow-up|3|||
130564766|NCT00545064|470033752|FG000|Overall Study|Withdrawal by Subject|2|||
130564767|NCT00545064|470033752|FG000|Overall Study|did not complete course of treatment|1|||
130564768|NCT00545064|470033752|FG000|Overall Study|cancel all appointments, no rebooking|1|||
130564769|NCT00545064|470033752|FG000|Overall Study|inclement weather|1|||
130564770|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
130564771|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
130564772|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
130727585|NCT03743415|470625493|FG004|Overall Study|Lost to Follow-up|1|||
130564773|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
130564774|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
130727586|NCT03743415|470625494|FG005|Overall Study|Lost to Follow-up|0|||
130564775|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
130727587|NCT03743415|470625495|FG006|Overall Study|Lost to Follow-up|1|||
130727588|NCT03743415|470625496|FG007|Overall Study|Lost to Follow-up|4|||
130477149|NCT03269136|469715413|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
130477150|NCT03269136|469715414|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
130477151|NCT03269136|469715415|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
130564776|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130564777|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130727589|NCT03743415|470625497|FG008|Overall Study|Lost to Follow-up|13|||
130425396|NCT00677833|469516059|FG000|Overall Study|Lost to Follow-up|0|||
130425397|NCT00677833|469516060|FG001|Overall Study|Lost to Follow-up|0|||
130425398|NCT00677833|469516061|FG002|Overall Study|Lost to Follow-up|1|||
130425399|NCT00677833|469516062|FG003|Overall Study|Lost to Follow-up|0|||
130425400|NCT02001194|469516064|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
130425401|NCT02001194|469516065|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
130425402|NCT02001194|469516066|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
130425403|NCT02001194|469516067|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
130425404|NCT02001194|469516064|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
130425405|NCT02001194|469516065|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
130425406|NCT02001194|469516066|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
130425407|NCT02001194|469516067|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
130425408|NCT02690974|469516070|FG000|Overall Study|Adverse Event|16|||
130425409|NCT02690974|469516070|FG000|Overall Study|Death|9|||
130425410|NCT02690974|469516070|FG000|Overall Study|Subject/guardian decision|4|||
130425411|NCT02690974|469516070|FG000|Overall Study|Lost to Follow-up|3|||
130425412|NCT02690974|469516070|FG000|Overall Study|Withdrawal of Informed Consent|3|||
130425413|NCT02690974|469516070|FG000|Overall Study|Physician Decision|2|||
130425414|NCT02690974|469516070|FG000|Overall Study|Non-compliance with study treatment|1|||
130425415|NCT02690974|469516070|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130425416|NCT02690974|469516070|FG000|Overall Study|Protocol Deviation|1|||
130425417|NCT00522301|469516076|FG000|Overall Study|Withdrawal by Subject|1|||
130425418|NCT00522301|469516076|FG000|Overall Study|Adverse Event|5|||
130425419|NCT01666951|469516077|FG000|Overall Study|Not dosed|1|||
130425420|NCT01666951|469516078|FG001|Overall Study|Not dosed|1|||
130425421|NCT00337272|469516079|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
130425422|NCT00337272|469516080|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
130425423|NCT00337272|469516079|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
130425424|NCT00337272|469516080|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
130425425|NCT00337272|469516079|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
130425426|NCT00337272|469516080|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
130425427|NCT00337272|469516079|FG000|Treatment Period|Non-compliance|1|||
130425428|NCT00337272|469516080|FG001|Treatment Period|Non-compliance|1|||
130425429|NCT00337272|469516079|FG000|Treatment Period|Withdrawal by Subject|0|||
130425430|NCT00337272|469516080|FG001|Treatment Period|Withdrawal by Subject|1|||
130425431|NCT00337272|469516079|FG000|Withdrawal Period|Non-compliance|0|||
130425432|NCT00337272|469516080|FG001|Withdrawal Period|Non-compliance|1|||
130425433|NCT02366910|469516084|FG000|Overall Study|Withdrawal by Subject|2|||
130425434|NCT02366910|469516084|FG000|Overall Study|Screen Failure|3|||
130425435|NCT02623322|469516088|FG000|Overall Study|Lost to Follow-up|2|||
130425436|NCT02623322|469516089|FG001|Overall Study|Lost to Follow-up|1|||
130425437|NCT02623322|469516090|FG002|Overall Study|Lost to Follow-up|0|||
130425438|NCT03284788|469516091|FG000|Overall Study|Withdrawal by Subject|2|||
130425439|NCT03813238|469516098|FG000|Overall Study|Adverse Event|0|||
130425440|NCT03813238|469516099|FG001|Overall Study|Adverse Event|6|||
130425441|NCT03813238|469516098|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130425442|NCT03813238|469516099|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130425443|NCT03813238|469516098|FG000|Overall Study|Lost to Follow-up|0|||
130425444|NCT03813238|469516099|FG001|Overall Study|Lost to Follow-up|1|||
130425445|NCT03813238|469516098|FG000|Overall Study|Other than specified|1|||
130425446|NCT03813238|469516099|FG001|Overall Study|Other than specified|2|||
130425447|NCT03338894|469516100|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
130425448|NCT04465357|469516101|FG000|Overall Study|Adverse Event|2|||
130425449|NCT04465357|469516101|FG000|Overall Study|Lack of Efficacy|1|||
130425450|NCT04465357|469516101|FG000|Overall Study|Lost to Follow-up|2|||
130425451|NCT04465357|469516101|FG000|Overall Study|Withdrawal by Subject|6|||
130425452|NCT04465357|469516101|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
130425453|NCT00420199|469516102|FG000|Overall Study|Participant no longer met study criteria|1|||
130425454|NCT00420199|469516103|FG001|Overall Study|Participant no longer met study criteria|0|||
130425455|NCT02618967|469516105|FG000|Overall Study|Lost to Follow-up|0|||
130425456|NCT02618967|469516106|FG001|Overall Study|Lost to Follow-up|0|||
130425457|NCT02618967|469516107|FG002|Overall Study|Lost to Follow-up|1|||
130425458|NCT02618967|469516108|FG003|Overall Study|Lost to Follow-up|0|||
130425459|NCT02618967|469516109|FG004|Overall Study|Lost to Follow-up|2|||
130425460|NCT02618967|469516110|FG005|Overall Study|Lost to Follow-up|0|||
130425461|NCT02618967|469516111|FG006|Overall Study|Lost to Follow-up|0|||
130425462|NCT02618967|469516112|FG007|Overall Study|Lost to Follow-up|0|||
130425463|NCT02618967|469516105|FG000|Overall Study|Withdrawal by Subject|1|||
130425464|NCT02618967|469516106|FG001|Overall Study|Withdrawal by Subject|0|||
130425465|NCT02618967|469516107|FG002|Overall Study|Withdrawal by Subject|0|||
130425466|NCT02618967|469516108|FG003|Overall Study|Withdrawal by Subject|0|||
130425467|NCT02618967|469516109|FG004|Overall Study|Withdrawal by Subject|0|||
130727590|NCT03743415|470625498|FG009|Overall Study|Lost to Follow-up|13|||
130727591|NCT02242045|470625499|FG000|Overall Study|Investigator's Discretion|1|||
130425468|NCT02618967|469516110|FG005|Overall Study|Withdrawal by Subject|0|||
130727592|NCT02242045|470625499|FG000|Overall Study|Progressive Disease|2|||
130727593|NCT02242045|470625499|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
130727594|NCT02242045|470625499|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
130727595|NCT02473523|470625500|FG000|Overall Study|Death|1|||
130727596|NCT02473523|470625500|FG000|Overall Study|Lost to Follow-up|1|||
130727597|NCT00976911|470625506|FG000|Overall Study|Withdrawal by Subject|4|||
130425469|NCT02618967|469516111|FG006|Overall Study|Withdrawal by Subject|0|||
130425470|NCT02618967|469516112|FG007|Overall Study|Withdrawal by Subject|0|||
130425471|NCT02612311|469516113|FG000|Overall Study|Adverse Event|16|||
130425472|NCT02612311|469516114|FG001|Overall Study|Adverse Event|12|||
130425473|NCT02612311|469516115|FG002|Overall Study|Adverse Event|7|||
130425474|NCT02612311|469516116|FG003|Overall Study|Adverse Event|13|||
130425475|NCT02612311|469516113|FG000|Overall Study|Death|29|||
130425476|NCT02612311|469516114|FG001|Overall Study|Death|10|||
130425477|NCT02612311|469516115|FG002|Overall Study|Death|11|||
130425478|NCT02612311|469516116|FG003|Overall Study|Death|11|||
130425479|NCT02612311|469516113|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
130477152|NCT03269136|469715416|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
130477153|NCT03269136|469715417|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
130477154|NCT03269136|469715418|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
130477155|NCT03269136|469715419|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
130477156|NCT03269136|469715420|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
130477157|NCT03269136|469715421|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
130477158|NCT03150810|469715424|FG000|Overall Study|Death|4|||
130477159|NCT03150810|469715425|FG001|Overall Study|Death|8|||
130477160|NCT03150810|469715426|FG002|Overall Study|Death|7|||
130477161|NCT03150810|469715427|FG003|Overall Study|Death|2|||
130477162|NCT03150810|469715428|FG004|Overall Study|Death|2|||
130477163|NCT03150810|469715429|FG005|Overall Study|Death|10|||
130477164|NCT03150810|469715430|FG006|Overall Study|Death|8|||
130477165|NCT03150810|469715431|FG007|Overall Study|Death|6|||
130477166|NCT03150810|469715432|FG008|Overall Study|Death|18|||
130477167|NCT03150810|469715433|FG009|Overall Study|Death|3|||
130477168|NCT03150810|469715434|FG010|Overall Study|Death|19|||
130477169|NCT03150810|469715435|FG011|Overall Study|Death|1|||
130477170|NCT03150810|469715436|FG012|Overall Study|Death|19|||
130477171|NCT03150810|469715424|FG000|Overall Study|Withdrawal by Subject|0|||
130477172|NCT03150810|469715425|FG001|Overall Study|Withdrawal by Subject|1|||
130477173|NCT03150810|469715426|FG002|Overall Study|Withdrawal by Subject|1|||
130477174|NCT03150810|469715427|FG003|Overall Study|Withdrawal by Subject|1|||
130477175|NCT03150810|469715428|FG004|Overall Study|Withdrawal by Subject|0|||
130477176|NCT03150810|469715429|FG005|Overall Study|Withdrawal by Subject|0|||
130477177|NCT03150810|469715430|FG006|Overall Study|Withdrawal by Subject|2|||
130477178|NCT03150810|469715431|FG007|Overall Study|Withdrawal by Subject|0|||
130477179|NCT03150810|469715432|FG008|Overall Study|Withdrawal by Subject|2|||
130477180|NCT03150810|469715433|FG009|Overall Study|Withdrawal by Subject|0|||
130477181|NCT03150810|469715434|FG010|Overall Study|Withdrawal by Subject|1|||
130477182|NCT03150810|469715435|FG011|Overall Study|Withdrawal by Subject|0|||
130477183|NCT03150810|469715436|FG012|Overall Study|Withdrawal by Subject|1|||
130477184|NCT03150810|469715424|FG000|Overall Study|Sponsor Decision|0|||
130477185|NCT03150810|469715425|FG001|Overall Study|Sponsor Decision|2|||
130477186|NCT03150810|469715426|FG002|Overall Study|Sponsor Decision|0|||
130477187|NCT03150810|469715427|FG003|Overall Study|Sponsor Decision|0|||
130477188|NCT03150810|469715428|FG004|Overall Study|Sponsor Decision|1|||
130477189|NCT03150810|469715429|FG005|Overall Study|Sponsor Decision|1|||
130477190|NCT03150810|469715430|FG006|Overall Study|Sponsor Decision|0|||
130477191|NCT03150810|469715431|FG007|Overall Study|Sponsor Decision|0|||
130477192|NCT03150810|469715432|FG008|Overall Study|Sponsor Decision|1|||
130477193|NCT03150810|469715433|FG009|Overall Study|Sponsor Decision|0|||
130477194|NCT03150810|469715434|FG010|Overall Study|Sponsor Decision|0|||
130477195|NCT03150810|469715435|FG011|Overall Study|Sponsor Decision|0|||
130477196|NCT03150810|469715436|FG012|Overall Study|Sponsor Decision|5|||
130477197|NCT03150810|469715424|FG000|Overall Study|Lost to Follow-up|0|||
130477198|NCT03150810|469715425|FG001|Overall Study|Lost to Follow-up|1|||
130477199|NCT03150810|469715426|FG002|Overall Study|Lost to Follow-up|1|||
130477200|NCT03150810|469715427|FG003|Overall Study|Lost to Follow-up|0|||
130477201|NCT03150810|469715428|FG004|Overall Study|Lost to Follow-up|0|||
130564778|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
130564779|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
130425480|NCT02612311|469516114|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
130477202|NCT03150810|469715429|FG005|Overall Study|Lost to Follow-up|0|||
130477203|NCT03150810|469715430|FG006|Overall Study|Lost to Follow-up|1|||
130477204|NCT03150810|469715431|FG007|Overall Study|Lost to Follow-up|0|||
130477205|NCT03150810|469715432|FG008|Overall Study|Lost to Follow-up|0|||
130477206|NCT03150810|469715433|FG009|Overall Study|Lost to Follow-up|0|||
130477207|NCT03150810|469715434|FG010|Overall Study|Lost to Follow-up|1|||
130425481|NCT02612311|469516115|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
130425482|NCT02612311|469516116|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
130425483|NCT02612311|469516113|FG000|Overall Study|Investigator's Decision|11|||
130425484|NCT02612311|469516114|FG001|Overall Study|Investigator's Decision|15|||
130425485|NCT02612311|469516115|FG002|Overall Study|Investigator's Decision|6|||
130425486|NCT02612311|469516116|FG003|Overall Study|Investigator's Decision|6|||
130425487|NCT02612311|469516113|FG000|Overall Study|Lack of Efficacy|0|||
130425488|NCT02612311|469516114|FG001|Overall Study|Lack of Efficacy|0|||
130425489|NCT02612311|469516115|FG002|Overall Study|Lack of Efficacy|1|||
130425490|NCT02612311|469516116|FG003|Overall Study|Lack of Efficacy|1|||
130425491|NCT02612311|469516113|FG000|Overall Study|Lost to Follow-up|2|||
130425492|NCT02612311|469516114|FG001|Overall Study|Lost to Follow-up|2|||
130425493|NCT02612311|469516115|FG002|Overall Study|Lost to Follow-up|1|||
130425494|NCT02612311|469516116|FG003|Overall Study|Lost to Follow-up|2|||
130425495|NCT02612311|469516113|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
130425496|NCT02612311|469516114|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
130425497|NCT02612311|469516115|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
130425498|NCT02612311|469516116|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
130425499|NCT02612311|469516113|FG000|Overall Study|Site Terminated by Sponsor|29|||
130425500|NCT02612311|469516114|FG001|Overall Study|Site Terminated by Sponsor|12|||
130425501|NCT02612311|469516115|FG002|Overall Study|Site Terminated by Sponsor|13|||
130425502|NCT02612311|469516116|FG003|Overall Study|Site Terminated by Sponsor|5|||
130425503|NCT02612311|469516113|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
130425504|NCT02612311|469516114|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
130425505|NCT02612311|469516115|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
130425506|NCT02612311|469516116|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
130425507|NCT02612311|469516113|FG000|Overall Study|Reason Not Specified|3|||
130425508|NCT02612311|469516114|FG001|Overall Study|Reason Not Specified|7|||
130425509|NCT02612311|469516115|FG002|Overall Study|Reason Not Specified|4|||
130425510|NCT02612311|469516116|FG003|Overall Study|Reason Not Specified|5|||
130425511|NCT02612311|469516113|FG000|Overall Study|Unknown/Missing|10|||
130425512|NCT02612311|469516114|FG001|Overall Study|Unknown/Missing|13|||
130425513|NCT02612311|469516115|FG002|Overall Study|Unknown/Missing|4|||
130425514|NCT02612311|469516116|FG003|Overall Study|Unknown/Missing|0|||
130425515|NCT02612311|469516113|FG000|Overall Study|Non-Compliance with Study|1|||
130425516|NCT02612311|469516114|FG001|Overall Study|Non-Compliance with Study|0|||
130425517|NCT02612311|469516115|FG002|Overall Study|Non-Compliance with Study|0|||
130425518|NCT02612311|469516116|FG003|Overall Study|Non-Compliance with Study|0|||
130425519|NCT04393441|469516117|FG000|Overall Study|Adverse Event|0|||
130425520|NCT04393441|469516118|FG001|Overall Study|Adverse Event|3|||
130425521|NCT04393441|469516117|FG000|Overall Study|Withdrawal by Subject|5|||
130425522|NCT04393441|469516118|FG001|Overall Study|Withdrawal by Subject|7|||
130425523|NCT04393441|469516117|FG000|Overall Study|Lost to Follow-up|0|||
130425524|NCT04393441|469516118|FG001|Overall Study|Lost to Follow-up|2|||
130425525|NCT04393441|469516117|FG000|Overall Study|Protocol Deviation|2|||
130425526|NCT04393441|469516118|FG001|Overall Study|Protocol Deviation|1|||
130425527|NCT04393441|469516117|FG000|Overall Study|Reason not Specified|1|||
130425528|NCT04393441|469516118|FG001|Overall Study|Reason not Specified|1|||
130425529|NCT00977665|469516126|FG000|Overall Study|Withdrawal by Subject|1|||
130425530|NCT00977665|469516127|FG001|Overall Study|Withdrawal by Subject|3|||
130425531|NCT00977665|469516126|FG000|Overall Study|Physician Decision|2|||
130425532|NCT00977665|469516127|FG001|Overall Study|Physician Decision|1|||
130425533|NCT00977665|469516126|FG000|Overall Study|Sponsor requested withdrawal|0|||
130425534|NCT00977665|469516127|FG001|Overall Study|Sponsor requested withdrawal|1|||
130425535|NCT00977665|469516126|FG000|Overall Study|Lost to Follow-up|1|||
130425536|NCT00977665|469516127|FG001|Overall Study|Lost to Follow-up|0|||
130425537|NCT00977665|469516126|FG000|Overall Study|Death|3|||
130477208|NCT03150810|469715435|FG011|Overall Study|Lost to Follow-up|0|||
130477209|NCT03150810|469715436|FG012|Overall Study|Lost to Follow-up|0|||
130477210|NCT03150810|469715424|FG000|Overall Study|Physician Decision|0|||
130477211|NCT03150810|469715425|FG001|Overall Study|Physician Decision|0|||
130477212|NCT03150810|469715426|FG002|Overall Study|Physician Decision|0|||
130477213|NCT03150810|469715427|FG003|Overall Study|Physician Decision|0|||
130477214|NCT03150810|469715428|FG004|Overall Study|Physician Decision|0|||
130425538|NCT00977665|469516127|FG001|Overall Study|Death|2|||
130425539|NCT00977665|469516126|FG000|Overall Study|Adverse Event|14|||
130425540|NCT00977665|469516127|FG001|Overall Study|Adverse Event|7|||
130425541|NCT00977665|469516126|FG000|Overall Study|Treatment failure|0|||
130425542|NCT00977665|469516127|FG001|Overall Study|Treatment failure|1|||
130425543|NCT02816138|469516136|FG000|Overall Study|Adverse Event|1|||
130425544|NCT00981084|469516137|FG000|Post Intervention (Data Analysis)|poor effort|1|||
130425545|NCT00981084|469516138|FG001|Post Intervention (Data Analysis)|poor effort|1|||
130425546|NCT00981084|469516137|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
130425547|NCT00981084|469516138|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
130477215|NCT03150810|469715429|FG005|Overall Study|Physician Decision|1|||
130425548|NCT04969263|469516139|FG000|Overall Study|Death|1|||
130425549|NCT04969263|469516139|FG000|Overall Study|Lost to Follow-up|2|||
130425550|NCT04969263|469516139|FG000|Overall Study|Withdrawal by Subject|5|||
130425551|NCT04969263|469516139|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
130425552|NCT02693743|469516141|FG000|Overall Study|Physician Decision|1|||
130425553|NCT02693743|469516142|FG001|Overall Study|Physician Decision|0|||
130425554|NCT02127372|469517801|FG000|Overall Study|Withdrawal by Subject|1|||
130425555|NCT02127372|469517802|FG001|Overall Study|Withdrawal by Subject|0|||
130425556|NCT03320018|469517805|FG000|Treatment Period|Withdrawal by Subject|1|||
130425557|NCT03320018|469517806|FG001|Treatment Period|Withdrawal by Subject|0|||
130425558|NCT03320018|469517805|FG000|Day 90 Follow up|Death|0|||
130425559|NCT03320018|469517806|FG001|Day 90 Follow up|Death|1|||
130425560|NCT04020341|469517809|FG000|Overall Study|Adverse Event|8|||
130425561|NCT04020341|469517810|FG001|Overall Study|Adverse Event|6|||
130425562|NCT04020341|469517809|FG000|Overall Study|Lost to Follow-up|8|||
130425563|NCT04020341|469517810|FG001|Overall Study|Lost to Follow-up|2|||
130425564|NCT04020341|469517809|FG000|Overall Study|Withdrawal by Subject|16|||
130425565|NCT04020341|469517810|FG001|Overall Study|Withdrawal by Subject|16|||
130425566|NCT04020341|469517809|FG000|Overall Study|Participant not able to swallow the tablet|1|||
130425567|NCT04020341|469517810|FG001|Overall Study|Participant not able to swallow the tablet|0|||
130425568|NCT04020341|469517809|FG000|Overall Study|Physician Decision|0|||
130425569|NCT04020341|469517810|FG001|Overall Study|Physician Decision|2|||
130425570|NCT04020341|469517809|FG000|Overall Study|Protocol Deviation|0|||
130425571|NCT04020341|469517810|FG001|Overall Study|Protocol Deviation|2|||
130425572|NCT05763628|469517811|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
130425573|NCT05763628|469517812|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
130425574|NCT05763628|469517811|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
130425575|NCT05763628|469517812|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
130425576|NCT05763628|469517811|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
130425577|NCT05763628|469517812|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
130425578|NCT04683926|469517813|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
130425579|NCT04683926|469517814|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
130425580|NCT04683926|469517815|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
130425581|NCT04683926|469517816|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
130425582|NCT02123108|469517819|FG000|Overall Study|Death|2|||
130425583|NCT02123108|469517820|FG001|Overall Study|Death|3|||
130425584|NCT00716092|469517821|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
130425585|NCT00716092|469517822|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
130425586|NCT00716092|469517823|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
130425587|NCT01132326|469517824|FG000|Overall Study|Lack of Efficacy|25|||
130425588|NCT01132326|469517824|FG000|Overall Study|Adverse Event|37|||
130425589|NCT01132326|469517824|FG000|Overall Study|Protocol Violation|1|||
130425590|NCT01132326|469517824|FG000|Overall Study|Lost to Follow-up|16|||
130425591|NCT01132326|469517824|FG000|Overall Study|Withdrawal by Subject|40|||
130425592|NCT01132326|469517824|FG000|Overall Study|Physician Decision|10|||
130425593|NCT01132326|469517824|FG000|Overall Study|Study Termination|80|||
130425594|NCT01132326|469517824|FG000|Overall Study|Declining Health|1|||
130425595|NCT01132326|469517824|FG000|Overall Study|Pregnancy|1|||
130425596|NCT01132326|469517824|FG000|Overall Study|Caregiver Withdrew Consent|1|||
130425597|NCT01132326|469517824|FG000|Overall Study|Death|5|||
130425598|NCT01132326|469517824|FG000|Overall Study|Subject Unable to Come To Visits|1|||
130425599|NCT00677235|469517825|FG000|Overall Study|Withdrawal by Subject|1|||
130425600|NCT00677235|469517826|FG001|Overall Study|Withdrawal by Subject|1|||
130425601|NCT00677235|469517825|FG000|Overall Study|Lost to Follow-up|2|||
130425602|NCT00677235|469517826|FG001|Overall Study|Lost to Follow-up|1|||
130425603|NCT00677235|469517825|FG000|Overall Study|Death|37|||
130425604|NCT00677235|469517826|FG001|Overall Study|Death|36|||
130425605|NCT00677235|469517825|FG000|Overall Study|Adverse Experience|1|||
130425606|NCT00677235|469517826|FG001|Overall Study|Adverse Experience|0|||
130477216|NCT03150810|469715430|FG006|Overall Study|Physician Decision|1|||
130477217|NCT03150810|469715431|FG007|Overall Study|Physician Decision|0|||
130477218|NCT03150810|469715432|FG008|Overall Study|Physician Decision|0|||
130477219|NCT03150810|469715433|FG009|Overall Study|Physician Decision|0|||
130425607|NCT00952367|469517827|FG000|Overall Study|Withdrawal by Subject|2|||
130425608|NCT00952367|469517827|FG000|Overall Study|Noncoordination|1|||
130425609|NCT00952367|469517827|FG000|Overall Study|Protocol Violation|3|||
130425610|NCT01040260|469517828|FG000|Overall Study|Withdrawal by Subject|12|||
130425611|NCT01040260|469517829|FG001|Overall Study|Withdrawal by Subject|6|||
130425612|NCT01040260|469517828|FG000|Overall Study|Lost to Follow-up|3|||
130425613|NCT01040260|469517829|FG001|Overall Study|Lost to Follow-up|5|||
130425614|NCT04570436|469517833|FG000|Overall Study|Adverse Event|0|||
130425615|NCT04570436|469517834|FG001|Overall Study|Adverse Event|0|||
130425616|NCT04570436|469517835|FG002|Overall Study|Adverse Event|1|||
130425617|NCT04570436|469517836|FG003|Overall Study|Adverse Event|0|||
130425618|NCT04570436|469517837|FG004|Overall Study|Adverse Event|0|||
130477220|NCT03150810|469715434|FG010|Overall Study|Physician Decision|0|||
130477221|NCT03150810|469715435|FG011|Overall Study|Physician Decision|0|||
130564780|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130727598|NCT00976911|470625507|FG001|Overall Study|Withdrawal by Subject|6|||
130727599|NCT00976911|470625506|FG000|Overall Study|Death|138|||
130425619|NCT04570436|469517838|FG005|Overall Study|Adverse Event|0|||
130425620|NCT04570436|469517839|FG006|Overall Study|Adverse Event|0|||
130425621|NCT04570436|469517840|FG007|Overall Study|Adverse Event|0|||
130425622|NCT04570436|469517841|FG008|Overall Study|Adverse Event|0|||
130425623|NCT04570436|469517842|FG009|Overall Study|Adverse Event|0|||
130425624|NCT04570436|469517833|FG000|Overall Study|Physician Decision|1|||
130425625|NCT04570436|469517834|FG001|Overall Study|Physician Decision|0|||
130425626|NCT04570436|469517835|FG002|Overall Study|Physician Decision|0|||
130425627|NCT04570436|469517836|FG003|Overall Study|Physician Decision|0|||
130425628|NCT04570436|469517837|FG004|Overall Study|Physician Decision|0|||
130425629|NCT04570436|469517838|FG005|Overall Study|Physician Decision|0|||
130425630|NCT04570436|469517839|FG006|Overall Study|Physician Decision|0|||
130425631|NCT04570436|469517840|FG007|Overall Study|Physician Decision|0|||
130425632|NCT04570436|469517841|FG008|Overall Study|Physician Decision|0|||
130425633|NCT04570436|469517842|FG009|Overall Study|Physician Decision|0|||
130425634|NCT00781391|469517843|FG000|Overall Study|never received study drug|24|||
130425635|NCT00781391|469517844|FG001|Overall Study|never received study drug|23|||
130425636|NCT00781391|469517845|FG002|Overall Study|never received study drug|32|||
130425637|NCT00781391|469517843|FG000|Overall Study|Protocol Violation|19|||
130425638|NCT00781391|469517844|FG001|Overall Study|Protocol Violation|17|||
130425639|NCT00781391|469517845|FG002|Overall Study|Protocol Violation|20|||
130425640|NCT00781391|469517843|FG000|Overall Study|Death|789|||
130425641|NCT00781391|469517844|FG001|Overall Study|Death|730|||
130425642|NCT00781391|469517845|FG002|Overall Study|Death|706|||
130425643|NCT00781391|469517843|FG000|Overall Study|Withdrawal by Subject|47|||
130425644|NCT00781391|469517844|FG001|Overall Study|Withdrawal by Subject|37|||
130425645|NCT00781391|469517845|FG002|Overall Study|Withdrawal by Subject|25|||
130425646|NCT00781391|469517843|FG000|Overall Study|Lost to Follow-up|0|||
130425647|NCT00781391|469517844|FG001|Overall Study|Lost to Follow-up|0|||
130425648|NCT00781391|469517845|FG002|Overall Study|Lost to Follow-up|1|||
130425649|NCT03205371|469517853|FG000|Overall Study|Withdrawal by Subject|4|||
130425650|NCT03205371|469517854|FG001|Overall Study|Withdrawal by Subject|1|||
130425651|NCT03205371|469517855|FG002|Overall Study|Withdrawal by Subject|0|||
130425652|NCT03205371|469517856|FG003|Overall Study|Withdrawal by Subject|0|||
130425653|NCT03205371|469517857|FG004|Overall Study|Withdrawal by Subject|0|||
130425654|NCT03205371|469517858|FG005|Overall Study|Withdrawal by Subject|0|||
130425655|NCT03205371|469517859|FG006|Overall Study|Withdrawal by Subject|4|||
130425656|NCT03205371|469517860|FG007|Overall Study|Withdrawal by Subject|0|||
130425657|NCT03205371|469517861|FG008|Overall Study|Withdrawal by Subject|2|||
130425658|NCT03205371|469517862|FG009|Overall Study|Withdrawal by Subject|0|||
130425659|NCT03205371|469517863|FG010|Overall Study|Withdrawal by Subject|0|||
130425660|NCT03205371|469517864|FG011|Overall Study|Withdrawal by Subject|1|||
130425661|NCT03205371|469517853|FG000|Overall Study|Lost to Follow-up|0|||
130425662|NCT03205371|469517854|FG001|Overall Study|Lost to Follow-up|0|||
130425663|NCT03205371|469517855|FG002|Overall Study|Lost to Follow-up|0|||
130425664|NCT03205371|469517856|FG003|Overall Study|Lost to Follow-up|0|||
130425665|NCT03205371|469517857|FG004|Overall Study|Lost to Follow-up|0|||
130425666|NCT03205371|469517858|FG005|Overall Study|Lost to Follow-up|0|||
130425667|NCT03205371|469517859|FG006|Overall Study|Lost to Follow-up|5|||
130425668|NCT03205371|469517860|FG007|Overall Study|Lost to Follow-up|2|||
130425669|NCT03205371|469517861|FG008|Overall Study|Lost to Follow-up|3|||
130425670|NCT03205371|469517862|FG009|Overall Study|Lost to Follow-up|0|||
130425671|NCT03205371|469517863|FG010|Overall Study|Lost to Follow-up|0|||
130425672|NCT03205371|469517864|FG011|Overall Study|Lost to Follow-up|0|||
130425673|NCT03205371|469517853|FG000|Overall Study|Protocol Violation|0|||
130425674|NCT03205371|469517854|FG001|Overall Study|Protocol Violation|0|||
130425675|NCT03205371|469517855|FG002|Overall Study|Protocol Violation|0|||
130425676|NCT03205371|469517856|FG003|Overall Study|Protocol Violation|0|||
130425677|NCT03205371|469517857|FG004|Overall Study|Protocol Violation|0|||
130425678|NCT03205371|469517858|FG005|Overall Study|Protocol Violation|0|||
130425679|NCT03205371|469517859|FG006|Overall Study|Protocol Violation|1|||
130425680|NCT03205371|469517860|FG007|Overall Study|Protocol Violation|0|||
130425681|NCT03205371|469517861|FG008|Overall Study|Protocol Violation|0|||
130425682|NCT03205371|469517862|FG009|Overall Study|Protocol Violation|0|||
130425683|NCT03205371|469517863|FG010|Overall Study|Protocol Violation|0|||
130425684|NCT03205371|469517864|FG011|Overall Study|Protocol Violation|0|||
130425685|NCT03205371|469517853|FG000|Overall Study|Adverse Event|0|||
130425686|NCT03205371|469517854|FG001|Overall Study|Adverse Event|0|||
130425687|NCT03205371|469517855|FG002|Overall Study|Adverse Event|0|||
130425688|NCT03205371|469517856|FG003|Overall Study|Adverse Event|0|||
130425689|NCT03205371|469517857|FG004|Overall Study|Adverse Event|0|||
130425690|NCT03205371|469517858|FG005|Overall Study|Adverse Event|0|||
130425691|NCT03205371|469517859|FG006|Overall Study|Adverse Event|0|||
130425692|NCT03205371|469517860|FG007|Overall Study|Adverse Event|1|||
130425693|NCT03205371|469517861|FG008|Overall Study|Adverse Event|0|||
130425694|NCT03205371|469517862|FG009|Overall Study|Adverse Event|0|||
130425695|NCT03205371|469517863|FG010|Overall Study|Adverse Event|0|||
130425696|NCT03205371|469517864|FG011|Overall Study|Adverse Event|0|||
130425697|NCT04542018|469517867|FG000|Overall Study|Withdrawal by Subject|0|||
130425698|NCT04542018|469517868|FG001|Overall Study|Withdrawal by Subject|0|||
130425699|NCT04542018|469517869|FG002|Overall Study|Withdrawal by Subject|4|||
130425700|NCT04542018|469517867|FG000|Overall Study|Protocol Violation|0|||
130425701|NCT04542018|469517868|FG001|Overall Study|Protocol Violation|0|||
130425702|NCT04542018|469517869|FG002|Overall Study|Protocol Violation|2|||
130425703|NCT00689221|469517870|FG000|Overall Study|Ongoing at cut-off date|39|||
130425704|NCT00689221|469517871|FG001|Overall Study|Ongoing at cut-off date|36|||
130425705|NCT01812655|469517872|FG000|Overall Study|Protocol Violation|1|||
130425706|NCT01812655|469517873|FG001|Overall Study|Protocol Violation|1|||
130425707|NCT01812655|469517874|FG002|Overall Study|Protocol Violation|0|||
130425708|NCT04435665|469517876|FG000|Overall Study|Lost to Follow-up|0|||
130425709|NCT04435665|469517877|FG001|Overall Study|Lost to Follow-up|0|||
130425710|NCT04435665|469517878|FG002|Overall Study|Lost to Follow-up|0|||
130425711|NCT04435665|469517879|FG003|Overall Study|Lost to Follow-up|1|||
130425712|NCT04672941|469517880|FG000|Overall Study|Investigator decision|1|||
130425713|NCT04672941|469517880|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
130425714|NCT04672941|469517880|FG000|Overall Study|COVID-19 related but no adverse event|1|||
130425715|NCT04672941|469517880|FG000|Overall Study|Adverse Event|2|||
130425716|NCT04672941|469517880|FG000|Overall Study|Lost to Follow-up|2|||
130425717|NCT00765388|469517881|FG000|Period 1|Lack of Efficacy|1|||
130425718|NCT00765388|469517882|FG001|Period 1|Lack of Efficacy|2|||
130425719|NCT00765388|469517881|FG000|Period 1|Lost to Follow-up|0|||
130425720|NCT00765388|469517882|FG001|Period 1|Lost to Follow-up|1|||
130425721|NCT00765388|469517881|FG000|Period 1|Herpes Zoster|0|||
130425722|NCT00765388|469517882|FG001|Period 1|Herpes Zoster|1|||
130425723|NCT00765388|469517881|FG000|Period 1|Hip operation|0|||
130425724|NCT00765388|469517882|FG001|Period 1|Hip operation|1|||
130425725|NCT01563536|469517891|FG000|Overall Study|Withdrawal by Subject|0|||
130425726|NCT01563536|469517892|FG001|Overall Study|Withdrawal by Subject|2|||
130425727|NCT01563536|469517891|FG000|Overall Study|Lost to Follow-up|1|||
130425728|NCT01563536|469517892|FG001|Overall Study|Lost to Follow-up|0|||
130425729|NCT00538590|469517895|FG000|Overall Study|Death|1|||
130425730|NCT00538590|469517896|FG001|Overall Study|Death|0|||
130425731|NCT01256567|469517897|FG000|Overall Study|Withdrawal by Subject|1|||
130425732|NCT00567190|469517903|FG000|Overall Study|Death|235|||
130425733|NCT00567190|469517904|FG001|Overall Study|Death|280|||
130425734|NCT00567190|469517903|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
130425735|NCT00567190|469517904|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
130425736|NCT00344461|469517915|FG000|Overall Study|Adverse Event|6|||
130425737|NCT00344461|469517915|FG000|Overall Study|Death|1|||
130425738|NCT00344461|469517915|FG000|Overall Study|Lack of Efficacy|2|||
130425739|NCT00344461|469517915|FG000|Overall Study|Lost to Follow-up|2|||
130425740|NCT00344461|469517915|FG000|Overall Study|Physician Decision|2|||
130425741|NCT00344461|469517915|FG000|Overall Study|Protocol Violation|6|||
130425742|NCT00344461|469517915|FG000|Overall Study|Withdrawal by Subject|2|||
130425743|NCT00636610|469517916|FG000|Overall Study|Adverse Event|4|||
130425744|NCT00636610|469517917|FG001|Overall Study|Adverse Event|4|||
130425745|NCT00636610|469517916|FG000|Overall Study|Death|6|||
130425746|NCT00636610|469517917|FG001|Overall Study|Death|3|||
130425747|NCT00636610|469517916|FG000|Overall Study|Physician decision to withdraw patient|15|||
130425748|NCT00636610|469517917|FG001|Overall Study|Physician decision to withdraw patient|9|||
130425749|NCT00636610|469517916|FG000|Overall Study|Subject decision to withdraw|15|||
130425750|NCT00636610|469517917|FG001|Overall Study|Subject decision to withdraw|11|||
130425751|NCT00636610|469517916|FG000|Overall Study|Disease progression - radiographic|41|||
130425752|NCT00636610|469517917|FG001|Overall Study|Disease progression - radiographic|51|||
130425753|NCT00636610|469517916|FG000|Overall Study|Disease progression - clinical|8|||
130425754|NCT00636610|469517917|FG001|Overall Study|Disease progression - clinical|3|||
130425755|NCT00636610|469517916|FG000|Overall Study|Reason for discontinuation not available|3|||
130425756|NCT00636610|469517917|FG001|Overall Study|Reason for discontinuation not available|2|||
130425757|NCT00671931|469517918|FG000|Overall Study|Physician Decision|1|||
130425758|NCT00671931|469517919|FG001|Overall Study|Physician Decision|0|||
130425759|NCT00671931|469517920|FG002|Overall Study|Physician Decision|0|||
130425760|NCT00671931|469517921|FG003|Overall Study|Physician Decision|2|||
130425761|NCT00671931|469517922|FG004|Overall Study|Physician Decision|1|||
130425762|NCT01169675|469517925|FG000|Overall Study|Progressive disease|13|||
130425763|NCT01169675|469517926|FG001|Overall Study|Progressive disease|2|||
130425764|NCT01169675|469517927|FG002|Overall Study|Progressive disease|5|||
130425765|NCT01169675|469517928|FG003|Overall Study|Progressive disease|15|||
130425766|NCT01169675|469517929|FG004|Overall Study|Progressive disease|1|||
130425767|NCT01169675|469517925|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130425768|NCT01169675|469517926|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130425769|NCT01169675|469517927|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130425770|NCT01169675|469517928|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130425771|NCT01169675|469517929|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130425772|NCT01169675|469517925|FG000|Overall Study|Adverse Event|5|||
130425773|NCT01169675|469517926|FG001|Overall Study|Adverse Event|1|||
130425774|NCT01169675|469517927|FG002|Overall Study|Adverse Event|2|||
130425775|NCT01169675|469517928|FG003|Overall Study|Adverse Event|0|||
130727600|NCT00976911|470625507|FG001|Overall Study|Death|126|||
130727601|NCT00976911|470625506|FG000|Overall Study|Adverse Event|0|||
130727602|NCT00976911|470625507|FG001|Overall Study|Adverse Event|1|||
130727603|NCT00976911|470625506|FG000|Overall Study|Protocol Violation|2|||
130727604|NCT00976911|470625507|FG001|Overall Study|Protocol Violation|0|||
130727605|NCT00976911|470625506|FG000|Overall Study|Other|8|||
130425776|NCT01169675|469517929|FG004|Overall Study|Adverse Event|0|||
130425777|NCT01169675|469517925|FG000|Overall Study|Withdrawal by Subject|1|||
130425778|NCT01169675|469517926|FG001|Overall Study|Withdrawal by Subject|0|||
130425779|NCT01169675|469517927|FG002|Overall Study|Withdrawal by Subject|0|||
130425780|NCT01169675|469517928|FG003|Overall Study|Withdrawal by Subject|1|||
130425781|NCT01169675|469517929|FG004|Overall Study|Withdrawal by Subject|2|||
130425782|NCT01169675|469517925|FG000|Overall Study|Other Reason Not Defined Above|0|||
130425783|NCT01169675|469517926|FG001|Overall Study|Other Reason Not Defined Above|0|||
130425784|NCT01169675|469517927|FG002|Overall Study|Other Reason Not Defined Above|0|||
130425785|NCT01169675|469517928|FG003|Overall Study|Other Reason Not Defined Above|1|||
130425786|NCT01169675|469517929|FG004|Overall Study|Other Reason Not Defined Above|1|||
130425787|NCT04839965|469517930|FG000|Overall Study|Death|6|||
130425788|NCT04839965|469517931|FG001|Overall Study|Death|6|||
130425789|NCT04839965|469517930|FG000|Overall Study|Lost to Follow-up|1|||
130425790|NCT04839965|469517931|FG001|Overall Study|Lost to Follow-up|0|||
130425791|NCT02365519|469517932|FG000|Randomized and Treated|Adverse Event|0|||
130425792|NCT02365519|469517933|FG001|Randomized and Treated|Adverse Event|1|||
130425793|NCT02365519|469517934|FG002|Randomized and Treated|Adverse Event|0|||
130425794|NCT02365519|469517932|FG000|Randomized and Treated|Withdrawal by Subject|0|||
130425795|NCT02365519|469517933|FG001|Randomized and Treated|Withdrawal by Subject|1|||
130425796|NCT02365519|469517934|FG002|Randomized and Treated|Withdrawal by Subject|1|||
130425797|NCT02048072|469517935|FG000|Overall Study|Adverse Event|3|||
130425798|NCT02048072|469517935|FG000|Overall Study|Lost to Follow-up|1|||
130425799|NCT02355028|469517936|FG000|Overall Study|Adverse Event|2|||
130425800|NCT02355028|469517937|FG001|Overall Study|Adverse Event|0|||
130425801|NCT02355028|469517936|FG000|Overall Study|Withdrawal by Subject|1|||
130425802|NCT02355028|469517937|FG001|Overall Study|Withdrawal by Subject|1|||
130425803|NCT02355028|469517936|FG000|Overall Study|Deemed ineligible after randomization|8|||
130425804|NCT02355028|469517937|FG001|Overall Study|Deemed ineligible after randomization|4|||
130425805|NCT02276222|469517938|FG000|Overall Study|Adverse Event|62|||
130425806|NCT02276222|469517939|FG001|Overall Study|Adverse Event|11|||
130425807|NCT02276222|469517938|FG000|Overall Study|Death|3|||
130425808|NCT02276222|469517939|FG001|Overall Study|Death|4|||
130425809|NCT02276222|469517938|FG000|Overall Study|Lack of Efficacy|13|||
130425810|NCT02276222|469517939|FG001|Overall Study|Lack of Efficacy|3|||
130425811|NCT02276222|469517938|FG000|Overall Study|Protocol Violation|3|||
130425812|NCT02276222|469517939|FG001|Overall Study|Protocol Violation|2|||
130425813|NCT02276222|469517938|FG000|Overall Study|Withdrawal by Subject|79|||
130425814|NCT02276222|469517939|FG001|Overall Study|Withdrawal by Subject|33|||
130425815|NCT02276222|469517938|FG000|Overall Study|non compliance with study medication|6|||
130425816|NCT02276222|469517939|FG001|Overall Study|non compliance with study medication|2|||
130425817|NCT02276222|469517938|FG000|Overall Study|sponsor decision|0|||
130425818|NCT02276222|469517939|FG001|Overall Study|sponsor decision|3|||
130425819|NCT02276222|469517938|FG000|Overall Study|Lost to Follow-up|15|||
130425820|NCT02276222|469517939|FG001|Overall Study|Lost to Follow-up|5|||
130425821|NCT02276222|469517938|FG000|Overall Study|Physician Decision|2|||
130425822|NCT02276222|469517939|FG001|Overall Study|Physician Decision|1|||
130425823|NCT02276222|469517938|FG000|Overall Study|sheduling conflict|1|||
130425824|NCT02276222|469517939|FG001|Overall Study|sheduling conflict|0|||
130425825|NCT02276222|469517938|FG000|Overall Study|subject withdrew after randomization|1|||
130425826|NCT02276222|469517939|FG001|Overall Study|subject withdrew after randomization|0|||
130425827|NCT01971723|469517940|FG000|Overall Study|Withdrawal by Subject|1|||
130727606|NCT00976911|470625507|FG001|Overall Study|Other|9|||
130425828|NCT01971723|469517941|FG001|Overall Study|Withdrawal by Subject|1|||
130425829|NCT01971723|469517940|FG000|Overall Study|Protocol Violation|1|||
130425830|NCT01971723|469517941|FG001|Overall Study|Protocol Violation|2|||
130727607|NCT00976911|470625506|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
130425831|NCT03645759|469517942|FG000|Overall Study|Lost to Follow-up|3|||
130425832|NCT03645759|469517943|FG001|Overall Study|Lost to Follow-up|2|||
130425833|NCT01648270|469517944|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
130425834|NCT00902694|469517945|FG000|Overall Study|Death|1|||
130425835|NCT00902694|469517946|FG001|Overall Study|Death|3|||
130425836|NCT00902694|469517945|FG000|Overall Study|Lost to Follow-up|1|||
130425837|NCT00902694|469517946|FG001|Overall Study|Lost to Follow-up|0|||
130425838|NCT00902694|469517945|FG000|Overall Study|Censored per protocol|3|||
130425839|NCT00902694|469517946|FG001|Overall Study|Censored per protocol|1|||
130425840|NCT00902694|469517945|FG000|Overall Study|Pregnancy|1|||
130425841|NCT00902694|469517946|FG001|Overall Study|Pregnancy|1|||
130727608|NCT00976911|470625507|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
130727609|NCT02954991|470625508|FG000|Overall Study|Death|92|||
130425842|NCT00902694|469517945|FG000|Overall Study|Incarceration|1|||
130425843|NCT00902694|469517946|FG001|Overall Study|Incarceration|0|||
130425844|NCT01024608|469517947|FG000|Overall Study|Adverse Event|1|||
130727610|NCT02954991|470625509|FG001|Overall Study|Death|11|||
130727611|NCT02954991|470625510|FG002|Overall Study|Death|2|||
130727612|NCT02954991|470625508|FG000|Overall Study|Lost to Follow-up|3|||
130727613|NCT02954991|470625509|FG001|Overall Study|Lost to Follow-up|2|||
130425845|NCT01024608|469517948|FG001|Overall Study|Adverse Event|0|||
130425846|NCT01024608|469517947|FG000|Overall Study|Withdrawal by Subject|1|||
130425847|NCT01024608|469517948|FG001|Overall Study|Withdrawal by Subject|0|||
130425848|NCT01024608|469517947|FG000|Overall Study|Lost to Follow-up|0|||
130425849|NCT01024608|469517948|FG001|Overall Study|Lost to Follow-up|1|||
130425850|NCT01024608|469517947|FG000|Overall Study|Protocol Violation|0|||
130425851|NCT01024608|469517948|FG001|Overall Study|Protocol Violation|3|||
130425852|NCT01024608|469517947|FG000|Overall Study|Never received study treatment|2|||
130425853|NCT01024608|469517948|FG001|Overall Study|Never received study treatment|0|||
130425854|NCT01592370|469517953|FG000|Overall Study|Disease Progression|62|||
130425855|NCT01592370|469517954|FG001|Overall Study|Disease Progression|16|||
130425856|NCT01592370|469517955|FG002|Overall Study|Disease Progression|52|||
130425857|NCT01592370|469517956|FG003|Overall Study|Disease Progression|3|||
130425858|NCT01592370|469517957|FG004|Overall Study|Disease Progression|3|||
130425859|NCT01592370|469517958|FG005|Overall Study|Disease Progression|31|||
130425860|NCT01592370|469517959|FG006|Overall Study|Disease Progression|14|||
130425861|NCT01592370|469517953|FG000|Overall Study|Study Drug Toxicity|14|||
130425862|NCT01592370|469517954|FG001|Overall Study|Study Drug Toxicity|3|||
130425863|NCT01592370|469517955|FG002|Overall Study|Study Drug Toxicity|0|||
130425864|NCT01592370|469517956|FG003|Overall Study|Study Drug Toxicity|0|||
130425865|NCT01592370|469517957|FG004|Overall Study|Study Drug Toxicity|0|||
130425866|NCT01592370|469517958|FG005|Overall Study|Study Drug Toxicity|0|||
130425867|NCT01592370|469517959|FG006|Overall Study|Study Drug Toxicity|1|||
130425868|NCT01592370|469517953|FG000|Overall Study|AE unrelated to study drug|4|||
130425869|NCT01592370|469517954|FG001|Overall Study|AE unrelated to study drug|3|||
130425870|NCT01592370|469517955|FG002|Overall Study|AE unrelated to study drug|0|||
130425871|NCT01592370|469517956|FG003|Overall Study|AE unrelated to study drug|0|||
130425872|NCT01592370|469517957|FG004|Overall Study|AE unrelated to study drug|0|||
130425873|NCT01592370|469517958|FG005|Overall Study|AE unrelated to study drug|0|||
130425874|NCT01592370|469517959|FG006|Overall Study|AE unrelated to study drug|1|||
130425875|NCT01592370|469517953|FG000|Overall Study|Request to discontinue study treatment|5|||
130425876|NCT01592370|469517954|FG001|Overall Study|Request to discontinue study treatment|0|||
130477222|NCT03150810|469715436|FG012|Overall Study|Physician Decision|0|||
130477223|NCT03150810|469715424|FG000|Overall Study|Site withdrawal from study|0|||
130477224|NCT03150810|469715425|FG001|Overall Study|Site withdrawal from study|1|||
130477225|NCT03150810|469715426|FG002|Overall Study|Site withdrawal from study|0|||
130477226|NCT03150810|469715427|FG003|Overall Study|Site withdrawal from study|0|||
130477227|NCT03150810|469715428|FG004|Overall Study|Site withdrawal from study|0|||
130477228|NCT03150810|469715429|FG005|Overall Study|Site withdrawal from study|0|||
130477229|NCT03150810|469715430|FG006|Overall Study|Site withdrawal from study|0|||
130477230|NCT03150810|469715431|FG007|Overall Study|Site withdrawal from study|0|||
130477231|NCT03150810|469715432|FG008|Overall Study|Site withdrawal from study|0|||
130477232|NCT03150810|469715433|FG009|Overall Study|Site withdrawal from study|1|||
130477233|NCT03150810|469715434|FG010|Overall Study|Site withdrawal from study|1|||
130477234|NCT03150810|469715435|FG011|Overall Study|Site withdrawal from study|0|||
130477235|NCT03150810|469715436|FG012|Overall Study|Site withdrawal from study|0|||
130477236|NCT03150810|469715424|FG000|Overall Study|Hospice|0|||
130477237|NCT03150810|469715425|FG001|Overall Study|Hospice|0|||
130477238|NCT03150810|469715426|FG002|Overall Study|Hospice|0|||
130477239|NCT03150810|469715427|FG003|Overall Study|Hospice|0|||
130727614|NCT02954991|470625510|FG002|Overall Study|Lost to Follow-up|0|||
130425877|NCT01592370|469517955|FG002|Overall Study|Request to discontinue study treatment|2|||
130425878|NCT01592370|469517956|FG003|Overall Study|Request to discontinue study treatment|0|||
130425879|NCT01592370|469517957|FG004|Overall Study|Request to discontinue study treatment|1|||
130425880|NCT01592370|469517958|FG005|Overall Study|Request to discontinue study treatment|2|||
130425881|NCT01592370|469517959|FG006|Overall Study|Request to discontinue study treatment|0|||
130425882|NCT01592370|469517953|FG000|Overall Study|Withdrew consent|1|||
130425883|NCT01592370|469517954|FG001|Overall Study|Withdrew consent|2|||
130425884|NCT01592370|469517955|FG002|Overall Study|Withdrew consent|1|||
130425885|NCT01592370|469517956|FG003|Overall Study|Withdrew consent|1|||
130425886|NCT01592370|469517957|FG004|Overall Study|Withdrew consent|0|||
130425887|NCT01592370|469517958|FG005|Overall Study|Withdrew consent|0|||
130425888|NCT01592370|469517959|FG006|Overall Study|Withdrew consent|0|||
130425889|NCT01592370|469517953|FG000|Overall Study|Maximum clinical benefit|11|||
130425890|NCT01592370|469517954|FG001|Overall Study|Maximum clinical benefit|1|||
130425891|NCT01592370|469517955|FG002|Overall Study|Maximum clinical benefit|7|||
130425892|NCT01592370|469517956|FG003|Overall Study|Maximum clinical benefit|1|||
130425893|NCT01592370|469517957|FG004|Overall Study|Maximum clinical benefit|0|||
130425894|NCT01592370|469517958|FG005|Overall Study|Maximum clinical benefit|0|||
130727615|NCT02954991|470625508|FG000|Overall Study|Withdrawal by Subject|9|||
130425895|NCT01592370|469517959|FG006|Overall Study|Maximum clinical benefit|0|||
130425896|NCT01592370|469517953|FG000|Overall Study|No longer meets study criteria|1|||
130425897|NCT01592370|469517954|FG001|Overall Study|No longer meets study criteria|0|||
130425898|NCT01592370|469517955|FG002|Overall Study|No longer meets study criteria|0|||
130425899|NCT01592370|469517956|FG003|Overall Study|No longer meets study criteria|0|||
130425900|NCT01592370|469517957|FG004|Overall Study|No longer meets study criteria|0|||
130425901|NCT01592370|469517958|FG005|Overall Study|No longer meets study criteria|0|||
130425902|NCT01592370|469517959|FG006|Overall Study|No longer meets study criteria|0|||
130425903|NCT01592370|469517953|FG000|Overall Study|Other Reasons|6|||
130425904|NCT01592370|469517954|FG001|Overall Study|Other Reasons|0|||
130425905|NCT01592370|469517955|FG002|Overall Study|Other Reasons|10|||
130425906|NCT01592370|469517956|FG003|Overall Study|Other Reasons|0|||
130425907|NCT01592370|469517957|FG004|Overall Study|Other Reasons|0|||
130425908|NCT01592370|469517958|FG005|Overall Study|Other Reasons|1|||
130425909|NCT01592370|469517959|FG006|Overall Study|Other Reasons|0|||
130425910|NCT02412137|469517964|FG000|Overall Study|Withdrawal by Subject|2|||
130425911|NCT02412137|469517965|FG001|Overall Study|Withdrawal by Subject|0|||
130425912|NCT02412137|469517964|FG000|Overall Study|Lost to Follow-up|21|||
130425913|NCT02412137|469517965|FG001|Overall Study|Lost to Follow-up|14|||
130425914|NCT02412137|469517964|FG000|Overall Study|Physician Decision|28|||
130425915|NCT02412137|469517965|FG001|Overall Study|Physician Decision|9|||
130425916|NCT01323530|469519965|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
130425917|NCT01323530|469519966|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130425918|NCT01323530|469519967|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130425919|NCT01323530|469519968|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130425920|NCT01323530|469519969|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130425921|NCT01323530|469519970|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
130425922|NCT01323530|469519971|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130425923|NCT01323530|469519965|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130425924|NCT01323530|469519966|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130425925|NCT01323530|469519967|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130425926|NCT01323530|469519968|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130425927|NCT01323530|469519969|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
130425928|NCT01323530|469519970|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130425929|NCT01323530|469519971|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130425930|NCT01323530|469519965|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130425931|NCT01323530|469519966|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
130425932|NCT01323530|469519967|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130425933|NCT01323530|469519968|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130425934|NCT01323530|469519969|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
130425935|NCT01323530|469519970|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
130425936|NCT01323530|469519971|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130425937|NCT01323530|469519965|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425938|NCT01323530|469519966|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425939|NCT01323530|469519967|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425940|NCT01323530|469519968|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425941|NCT01323530|469519969|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425942|NCT01323530|469519970|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130425943|NCT01323530|469519971|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
130425944|NCT01323530|469519965|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130425945|NCT01323530|469519966|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130425946|NCT01323530|469519967|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130425947|NCT01323530|469519968|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130425948|NCT01323530|469519969|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130425949|NCT01323530|469519970|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130727616|NCT02954991|470625509|FG001|Overall Study|Withdrawal by Subject|8|||
130727617|NCT02954991|470625510|FG002|Overall Study|Withdrawal by Subject|1|||
130727618|NCT02954991|470625508|FG000|Overall Study|Study Terminated by Sponsor|18|||
130727619|NCT02954991|470625509|FG001|Overall Study|Study Terminated by Sponsor|10|||
130727620|NCT02954991|470625510|FG002|Overall Study|Study Terminated by Sponsor|1|||
130727621|NCT02954991|470625508|FG000|Overall Study|Miscellaneous|2|||
130727622|NCT02954991|470625509|FG001|Overall Study|Miscellaneous|1|||
130727623|NCT02954991|470625510|FG002|Overall Study|Miscellaneous|1|||
130727624|NCT00576316|470625511|FG000|Overall Study|Adverse Event|9|||
130727625|NCT00576316|470625511|FG000|Overall Study|Withdrawal by Subject|2|||
130425950|NCT01323530|469519971|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
130425951|NCT01323530|469519965|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425952|NCT01323530|469519966|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425953|NCT01323530|469519967|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425954|NCT01323530|469519968|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425955|NCT01323530|469519969|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425956|NCT01323530|469519970|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130425957|NCT01323530|469519971|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
130425958|NCT01323530|469519965|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425959|NCT01323530|469519966|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425960|NCT01323530|469519967|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425961|NCT01323530|469519968|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425962|NCT01323530|469519969|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425963|NCT01323530|469519970|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130425964|NCT01323530|469519971|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
130425965|NCT01323530|469519965|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425966|NCT01323530|469519966|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425967|NCT01323530|469519967|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425968|NCT01323530|469519968|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425969|NCT01323530|469519969|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425970|NCT01323530|469519970|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130425971|NCT01323530|469519971|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
130425972|NCT02532179|469519972|FG000|Overall Study|Lost to Follow-up|1|||
130425973|NCT02532179|469519972|FG000|Overall Study|Pregnancy|1|||
130425974|NCT02532179|469519972|FG000|Overall Study|Subject received depot steroid injection|1|||
130425975|NCT01735201|469519977|FG000|Overall Study|Adverse Event|1|||
130425976|NCT01735201|469519978|FG001|Overall Study|Adverse Event|1|||
130425977|NCT01735201|469519979|FG002|Overall Study|Adverse Event|0|||
130425978|NCT01735201|469519980|FG003|Overall Study|Adverse Event|1|||
130425979|NCT01735201|469519981|FG004|Overall Study|Adverse Event|1|||
130425980|NCT01735201|469519982|FG005|Overall Study|Adverse Event|3|||
130425981|NCT01735201|469519983|FG006|Overall Study|Adverse Event|2|||
130425982|NCT01735201|469519984|FG007|Overall Study|Adverse Event|1|||
130425983|NCT01735201|469519977|FG000|Overall Study|Personal Reasons|1|||
130425984|NCT01735201|469519978|FG001|Overall Study|Personal Reasons|0|||
130425985|NCT01735201|469519979|FG002|Overall Study|Personal Reasons|0|||
130425986|NCT01735201|469519980|FG003|Overall Study|Personal Reasons|0|||
130425987|NCT01735201|469519981|FG004|Overall Study|Personal Reasons|0|||
130425988|NCT01735201|469519982|FG005|Overall Study|Personal Reasons|0|||
130425989|NCT01735201|469519983|FG006|Overall Study|Personal Reasons|0|||
130425990|NCT01735201|469519984|FG007|Overall Study|Personal Reasons|0|||
130425991|NCT01735201|469519977|FG000|Overall Study|Protocol Violation|1|||
130425992|NCT01735201|469519978|FG001|Overall Study|Protocol Violation|0|||
130425993|NCT01735201|469519979|FG002|Overall Study|Protocol Violation|0|||
130425994|NCT01735201|469519980|FG003|Overall Study|Protocol Violation|0|||
130425995|NCT01735201|469519981|FG004|Overall Study|Protocol Violation|0|||
130425996|NCT01735201|469519982|FG005|Overall Study|Protocol Violation|0|||
130477240|NCT03150810|469715428|FG004|Overall Study|Hospice|0|||
130477241|NCT03150810|469715429|FG005|Overall Study|Hospice|1|||
130477242|NCT03150810|469715430|FG006|Overall Study|Hospice|0|||
130477243|NCT03150810|469715431|FG007|Overall Study|Hospice|0|||
130477244|NCT03150810|469715432|FG008|Overall Study|Hospice|0|||
130477245|NCT03150810|469715433|FG009|Overall Study|Hospice|0|||
130477246|NCT03150810|469715434|FG010|Overall Study|Hospice|0|||
130477247|NCT03150810|469715435|FG011|Overall Study|Hospice|0|||
130477248|NCT03150810|469715436|FG012|Overall Study|Hospice|0|||
130477249|NCT03150810|469715424|FG000|Overall Study|Participant relocated abroad.|0|||
130477250|NCT03150810|469715425|FG001|Overall Study|Participant relocated abroad.|0|||
130477251|NCT03150810|469715426|FG002|Overall Study|Participant relocated abroad.|0|||
130477252|NCT03150810|469715427|FG003|Overall Study|Participant relocated abroad.|0|||
130477253|NCT03150810|469715428|FG004|Overall Study|Participant relocated abroad.|0|||
130477254|NCT03150810|469715429|FG005|Overall Study|Participant relocated abroad.|1|||
130477255|NCT03150810|469715430|FG006|Overall Study|Participant relocated abroad.|0|||
130477256|NCT03150810|469715431|FG007|Overall Study|Participant relocated abroad.|0|||
130477257|NCT03150810|469715432|FG008|Overall Study|Participant relocated abroad.|0|||
130477258|NCT03150810|469715433|FG009|Overall Study|Participant relocated abroad.|0|||
130477259|NCT03150810|469715434|FG010|Overall Study|Participant relocated abroad.|0|||
130477260|NCT03150810|469715435|FG011|Overall Study|Participant relocated abroad.|0|||
130477261|NCT03150810|469715436|FG012|Overall Study|Participant relocated abroad.|0|||
130477262|NCT03150810|469715424|FG000|Overall Study|Transferred care to oncologist|0|||
130477263|NCT03150810|469715425|FG001|Overall Study|Transferred care to oncologist|0|||
130477264|NCT03150810|469715426|FG002|Overall Study|Transferred care to oncologist|0|||
130477265|NCT03150810|469715427|FG003|Overall Study|Transferred care to oncologist|0|||
130477266|NCT03150810|469715428|FG004|Overall Study|Transferred care to oncologist|0|||
130425997|NCT01735201|469519983|FG006|Overall Study|Protocol Violation|0|||
130425998|NCT01735201|469519984|FG007|Overall Study|Protocol Violation|0|||
130425999|NCT01735201|469519977|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130426000|NCT01735201|469519978|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130426001|NCT01735201|469519979|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130426002|NCT01735201|469519980|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130426003|NCT01735201|469519981|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130426004|NCT01735201|469519982|FG005|Overall Study|Other Miscellaneous Reasons|2|||
130426005|NCT01735201|469519983|FG006|Overall Study|Other Miscellaneous Reasons|1|||
130426006|NCT01735201|469519984|FG007|Overall Study|Other Miscellaneous Reasons|1|||
130426007|NCT01553318|469519985|FG000|Overall Study|Protocol Violation|3|||
130426008|NCT01553318|469519986|FG001|Overall Study|Protocol Violation|2|||
130426009|NCT04128293|469519987|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130426010|NCT04128293|469519988|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130426011|NCT04128293|469519989|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130426012|NCT04128293|469519990|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130426013|NCT01357616|469519991|FG000|Overall Study|Adverse Event|1|||
130426014|NCT01357616|469519992|FG001|Overall Study|Adverse Event|1|||
130426015|NCT01357616|469519991|FG000|Overall Study|Lost to Follow-up|4|||
130426016|NCT01357616|469519992|FG001|Overall Study|Lost to Follow-up|3|||
130426017|NCT01357616|469519991|FG000|Overall Study|Protocol Violation|0|||
130426018|NCT01357616|469519992|FG001|Overall Study|Protocol Violation|2|||
130426019|NCT01357616|469519991|FG000|Overall Study|Inadequate Control of IOP|1|||
130426020|NCT01357616|469519992|FG001|Overall Study|Inadequate Control of IOP|2|||
130426021|NCT01357616|469519991|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
130426022|NCT01357616|469519992|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
130426023|NCT01357616|469519991|FG000|Overall Study|Withdrawal by Subject|1|||
130426024|NCT01357616|469519992|FG001|Overall Study|Withdrawal by Subject|0|||
130426025|NCT03432364|469519994|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
130426026|NCT01699022|469519999|FG000|Overall Study|Early discontinuation from the study|3|||
130426027|NCT02066402|469520002|FG000|Overall Study|Adverse Event|1|||
130426028|NCT02066402|469520003|FG001|Overall Study|Adverse Event|2|||
130426029|NCT02066402|469520002|FG000|Overall Study|Lost to Follow-up|11|||
130426030|NCT02066402|469520003|FG001|Overall Study|Lost to Follow-up|8|||
130426031|NCT02066402|469520002|FG000|Overall Study|Withdrawal by Subject|14|||
130426032|NCT02066402|469520003|FG001|Overall Study|Withdrawal by Subject|11|||
130426033|NCT02066402|469520002|FG000|Overall Study|Progressive disease-clinical progression|0|||
130426034|NCT02066402|469520003|FG001|Overall Study|Progressive disease-clinical progression|1|||
130426035|NCT02066402|469520002|FG000|Overall Study|Protocol driven decision point|0|||
130426036|NCT02066402|469520003|FG001|Overall Study|Protocol driven decision point|1|||
130426037|NCT00152464|469520004|FG000|Overall Study|Adverse Event|3|||
130426038|NCT00152464|469520005|FG001|Overall Study|Adverse Event|6|||
130426039|NCT00152464|469520004|FG000|Overall Study|Lost to Follow-up|8|||
130426040|NCT00152464|469520005|FG001|Overall Study|Lost to Follow-up|4|||
130426041|NCT00152464|469520004|FG000|Overall Study|Protocol Violation|3|||
130426042|NCT00152464|469520005|FG001|Overall Study|Protocol Violation|1|||
130426043|NCT00152464|469520004|FG000|Overall Study|Withdrawal by Subject|21|||
130426044|NCT00152464|469520005|FG001|Overall Study|Withdrawal by Subject|22|||
130426045|NCT00152464|469520004|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
130426046|NCT00152464|469520005|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
130426047|NCT00152464|469520004|FG000|Overall Study|Eczema deterioration|0|||
130426048|NCT00152464|469520005|FG001|Overall Study|Eczema deterioration|1|||
130426049|NCT00152464|469520004|FG000|Overall Study|Parent decision|1|||
130426050|NCT00152464|469520005|FG001|Overall Study|Parent decision|1|||
130426051|NCT00152464|469520004|FG000|Overall Study|Investigator decision|1|||
130426052|NCT00152464|469520005|FG001|Overall Study|Investigator decision|0|||
130426053|NCT00152464|469520004|FG000|Overall Study|Lack of Efficacy|1|||
130426054|NCT00152464|469520005|FG001|Overall Study|Lack of Efficacy|0|||
130426055|NCT00152464|469520004|FG000|Overall Study|Eczema poorly controlled|1|||
130426056|NCT00152464|469520005|FG001|Overall Study|Eczema poorly controlled|0|||
130426057|NCT00152464|469520004|FG000|Overall Study|Patient relocated|1|||
130426058|NCT00152464|469520005|FG001|Overall Study|Patient relocated|0|||
130426059|NCT04493931|469520007|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
130426060|NCT04493931|469520008|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130426061|NCT04493931|469520009|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130477267|NCT03150810|469715429|FG005|Overall Study|Transferred care to oncologist|0|||
130477268|NCT03150810|469715430|FG006|Overall Study|Transferred care to oncologist|2|||
130477269|NCT03150810|469715431|FG007|Overall Study|Transferred care to oncologist|0|||
130477270|NCT03150810|469715432|FG008|Overall Study|Transferred care to oncologist|0|||
130477271|NCT03150810|469715433|FG009|Overall Study|Transferred care to oncologist|0|||
130477272|NCT03150810|469715434|FG010|Overall Study|Transferred care to oncologist|0|||
130426062|NCT04493931|469520010|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130426063|NCT04493931|469520011|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130426064|NCT04493931|469520012|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130477273|NCT03150810|469715435|FG011|Overall Study|Transferred care to oncologist|0|||
130477274|NCT03150810|469715436|FG012|Overall Study|Transferred care to oncologist|0|||
130477275|NCT05116787|469715437|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
130477276|NCT05116787|469715438|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
130426065|NCT04493931|469520013|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130426066|NCT04493931|469520007|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426067|NCT04493931|469520008|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
130426068|NCT04493931|469520009|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426069|NCT04493931|469520010|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426070|NCT04493931|469520011|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426071|NCT04493931|469520012|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426072|NCT04493931|469520013|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130426073|NCT04493931|469520007|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426074|NCT04493931|469520008|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
130426075|NCT04493931|469520009|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426076|NCT04493931|469520010|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426077|NCT04493931|469520011|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426078|NCT04493931|469520012|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426079|NCT04493931|469520013|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130426080|NCT04493931|469520007|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426081|NCT04493931|469520008|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426082|NCT04493931|469520009|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
130426083|NCT04493931|469520010|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426084|NCT04493931|469520011|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426085|NCT04493931|469520012|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426086|NCT04493931|469520013|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130426087|NCT00430248|469520015|FG000|Overall Study|Adverse Event|49|||
130426088|NCT00430248|469520016|FG001|Overall Study|Adverse Event|61|||
130426089|NCT00430248|469520017|FG002|Overall Study|Adverse Event|64|||
130426090|NCT00430248|469520015|FG000|Overall Study|Protocol Violation|10|||
130426091|NCT00430248|469520016|FG001|Overall Study|Protocol Violation|2|||
130426092|NCT00430248|469520017|FG002|Overall Study|Protocol Violation|4|||
130426093|NCT00430248|469520015|FG000|Overall Study|Personal Reasons|12|||
130426094|NCT00430248|469520016|FG001|Overall Study|Personal Reasons|24|||
130426095|NCT00430248|469520017|FG002|Overall Study|Personal Reasons|9|||
130426096|NCT00430248|469520015|FG000|Overall Study|Lost to Follow-up|28|||
130477277|NCT05116787|469715437|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
130477278|NCT05116787|469715438|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
130477279|NCT05116787|469715437|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
130477280|NCT05116787|469715438|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
130477281|NCT05116787|469715437|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
130477282|NCT05116787|469715438|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
130477283|NCT04359108|469715439|FG000|Overall Study|Withdrawal by Subject|1|||
130477284|NCT04359108|469715440|FG001|Overall Study|Withdrawal by Subject|0|||
130477285|NCT04359108|469715439|FG000|Overall Study|Unable or too feeble to walk independently|0|||
130477286|NCT04359108|469715440|FG001|Overall Study|Unable or too feeble to walk independently|2|||
130477287|NCT04359108|469715439|FG000|Overall Study|Argus II system stopped functioning|0|||
130477288|NCT04359108|469715440|FG001|Overall Study|Argus II system stopped functioning|1|||
130477289|NCT04359108|469715439|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
130477290|NCT04359108|469715440|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
130477291|NCT06393088|469715442|FG000|Overall Study|Withdrawal by Subject|0|||
130477292|NCT06393088|469715443|FG001|Overall Study|Withdrawal by Subject|2|||
130477293|NCT02515773|469715444|FG000|Overall Study|Withdrawal by Subject|12|||
130477294|NCT02515773|469715445|FG001|Overall Study|Withdrawal by Subject|2|||
130477295|NCT02515773|469715444|FG000|Overall Study|Lost to Follow-up|119|||
130477296|NCT02515773|469715445|FG001|Overall Study|Lost to Follow-up|126|||
130477297|NCT02515773|469715444|FG000|Overall Study|Discharged from Clinic Services|53|||
130477298|NCT02515773|469715445|FG001|Overall Study|Discharged from Clinic Services|84|||
130477299|NCT02515773|469715444|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
130477300|NCT02515773|469715445|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
130477301|NCT02515773|469715444|FG000|Overall Study|Follow-up at non-study site|8|||
130477302|NCT02515773|469715445|FG001|Overall Study|Follow-up at non-study site|16|||
130477303|NCT02515773|469715444|FG000|Overall Study|Moved from area|9|||
130477304|NCT02515773|469715445|FG001|Overall Study|Moved from area|14|||
130477305|NCT05051124|469715446|FG000|Overall Study|Lost to Follow-up|2|||
130477306|NCT05051124|469715446|FG000|Overall Study|Withdrawal by Subject|1|||
130477307|NCT05051124|469715446|FG000|Overall Study|Residential relocation|2|||
130477308|NCT05051124|469715446|FG000|Overall Study|Death|1|||
130477309|NCT04782973|469715447|FG000|Overall Study|Withdrawal by Subject|5|||
130477310|NCT04782973|469715447|FG000|Overall Study|Protocol Violation|6|||
130477311|NCT04782973|469715447|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
130477312|NCT03557697|469715448|FG000|Overall Study|Withdrawal by Subject|2|||
130477313|NCT03557697|469715449|FG001|Overall Study|Withdrawal by Subject|4|||
130477314|NCT04749615|469715450|FG000|Overall Study|Lost to Follow-up|6|||
130727626|NCT00576316|470625511|FG000|Overall Study|Protocol Violation|9|||
130727627|NCT00425373|470625514|FG000|Overall Study|Adverse Event|2|||
130727628|NCT00425373|470625515|FG001|Overall Study|Adverse Event|2|||
130727629|NCT00425373|470625516|FG002|Overall Study|Adverse Event|0|||
130727630|NCT00425373|470625517|FG003|Overall Study|Adverse Event|1|||
130727631|NCT00425373|470625518|FG004|Overall Study|Adverse Event|4|||
130727632|NCT00425373|470625519|FG005|Overall Study|Adverse Event|6|||
130426097|NCT00430248|469520016|FG001|Overall Study|Lost to Follow-up|33|||
130426098|NCT00430248|469520017|FG002|Overall Study|Lost to Follow-up|28|||
130426099|NCT00430248|469520015|FG000|Overall Study|Therapeutic Failure|1|||
130426100|NCT00430248|469520016|FG001|Overall Study|Therapeutic Failure|1|||
130426101|NCT00430248|469520017|FG002|Overall Study|Therapeutic Failure|1|||
130426102|NCT00430248|469520015|FG000|Overall Study|Withdrawal by Subject|14|||
130426103|NCT00430248|469520016|FG001|Overall Study|Withdrawal by Subject|20|||
130426104|NCT00430248|469520017|FG002|Overall Study|Withdrawal by Subject|16|||
130477315|NCT04749615|469715451|FG001|Overall Study|Lost to Follow-up|10|||
130477316|NCT03611491|469715452|FG000|Overall Study|Lost to Follow-up|1|||
130477317|NCT05478499|469715469|FG000|Overall Study|Adverse Event|4|||
130477318|NCT05478499|469715470|FG001|Overall Study|Adverse Event|2|||
130477319|NCT05478499|469715469|FG000|Overall Study|Withdrawal by Subject|3|||
130477320|NCT05478499|469715470|FG001|Overall Study|Withdrawal by Subject|2|||
130477321|NCT05478499|469715469|FG000|Overall Study|Lack of Efficacy|1|||
130477322|NCT05478499|469715470|FG001|Overall Study|Lack of Efficacy|0|||
130477323|NCT05478499|469715469|FG000|Overall Study|Lost to Follow-up|1|||
130477324|NCT05478499|469715470|FG001|Overall Study|Lost to Follow-up|0|||
130477325|NCT05478499|469715469|FG000|Overall Study|Other reasons|0|||
130477326|NCT05478499|469715470|FG001|Overall Study|Other reasons|1|||
130477327|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
130477328|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
130477329|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
130477330|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
130477331|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
130477332|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
130477333|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
130477334|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477335|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
130477336|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477337|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477338|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477339|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477340|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130477341|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
130477342|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
130477343|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
130477344|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
130477345|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
130477346|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
130477347|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
130477348|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
130477349|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477350|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477351|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477352|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477353|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477354|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
130477355|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130477356|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
130477357|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130477358|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130477359|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130477360|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130727633|NCT00425373|470625520|FG006|Overall Study|Adverse Event|2|||
130727634|NCT00425373|470625521|FG007|Overall Study|Adverse Event|3|||
130727635|NCT00425373|470625522|FG008|Overall Study|Adverse Event|8|||
130727636|NCT00425373|470625514|FG000|Overall Study|Lost to Follow-up|0|||
130727637|NCT00425373|470625515|FG001|Overall Study|Lost to Follow-up|1|||
130727638|NCT00425373|470625516|FG002|Overall Study|Lost to Follow-up|0|||
130426105|NCT00430248|469520015|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130477361|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
130477362|NCT02962895|469715471|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477363|NCT02962895|469715472|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477364|NCT02962895|469715473|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477365|NCT02962895|469715474|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
130477366|NCT02962895|469715475|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477367|NCT02962895|469715476|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477368|NCT02962895|469715477|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
130477369|NCT02962895|469715471|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477370|NCT02962895|469715472|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477371|NCT02962895|469715473|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477372|NCT02962895|469715474|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477373|NCT02962895|469715475|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477374|NCT02962895|469715476|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
130477375|NCT02962895|469715477|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
130477376|NCT02962895|469715471|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130477377|NCT02962895|469715472|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130477378|NCT02962895|469715473|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130477379|NCT02962895|469715474|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130477380|NCT02962895|469715475|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
130477381|NCT02962895|469715476|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130477382|NCT02962895|469715477|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
130477383|NCT02962895|469715471|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477384|NCT02962895|469715472|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477385|NCT02962895|469715473|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477386|NCT02962895|469715474|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477387|NCT02962895|469715475|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477388|NCT02962895|469715476|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
130477389|NCT02962895|469715477|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
130477390|NCT02962895|469715471|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130477391|NCT02962895|469715472|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
130477392|NCT02962895|469715473|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130477393|NCT02962895|469715474|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130477394|NCT02962895|469715475|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130727639|NCT00425373|470625517|FG003|Overall Study|Lost to Follow-up|0|||
130727640|NCT00425373|470625518|FG004|Overall Study|Lost to Follow-up|1|||
130426106|NCT00430248|469520016|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130426107|NCT00430248|469520017|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130426108|NCT00430248|469520015|FG000|Overall Study|Gout Flare|3|||
130426109|NCT00430248|469520016|FG001|Overall Study|Gout Flare|7|||
130426110|NCT00430248|469520017|FG002|Overall Study|Gout Flare|2|||
130426111|NCT00430248|469520015|FG000|Overall Study|Reason Not Specified|8|||
130426112|NCT00430248|469520016|FG001|Overall Study|Reason Not Specified|8|||
130426113|NCT00430248|469520017|FG002|Overall Study|Reason Not Specified|11|||
130426114|NCT01754467|469520024|FG000|Overall Study|Lost to Follow-up|1|||
130426115|NCT01970462|469520025|FG000|Overall Study|Lost to Follow-up|0|||
130426116|NCT01970462|469520026|FG001|Overall Study|Lost to Follow-up|2|||
130426117|NCT00754338|469520027|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130426118|NCT00754338|469520028|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
130426119|NCT00754338|469520029|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
130426120|NCT00754338|469520030|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130426121|NCT00754338|469520027|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130426122|NCT00754338|469520028|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
130426123|NCT00754338|469520029|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130426124|NCT00754338|469520030|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
130426125|NCT04385368|469520031|FG000|Overall Study|Death|5|||
130426126|NCT04385368|469520032|FG001|Overall Study|Death|5|||
130426127|NCT04385368|469520031|FG000|Overall Study|Physician Decision|3|||
130477395|NCT02962895|469715476|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130426128|NCT04385368|469520032|FG001|Overall Study|Physician Decision|0|||
130426129|NCT04385368|469520031|FG000|Overall Study|Withdrawal by Subject|4|||
130426130|NCT04385368|469520032|FG001|Overall Study|Withdrawal by Subject|3|||
130426131|NCT02054806|469520033|FG000|Overall Study|Sponsor Decision|31|||
130426132|NCT02054806|469520033|FG000|Overall Study|Withdrawal by Subject|43|||
130426133|NCT02054806|469520033|FG000|Overall Study|Protocol Violation|2|||
130426134|NCT02054806|469520033|FG000|Overall Study|Lost to Follow-up|10|||
130426135|NCT02054806|469520033|FG000|Overall Study|Death|391|||
130477396|NCT02962895|469715477|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
130727641|NCT00425373|470625519|FG005|Overall Study|Lost to Follow-up|0|||
130564781|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130564782|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
130564783|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
130564784|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130426136|NCT04721925|469520034|FG000|2-Month Assessment|Lost to Follow-up|5|||
130426137|NCT04721925|469520035|FG001|2-Month Assessment|Lost to Follow-up|3|||
130426138|NCT04721925|469520034|FG000|4-Month Assessment|Lost to Follow-up|3|||
130426139|NCT04721925|469520035|FG001|4-Month Assessment|Lost to Follow-up|6|||
130426140|NCT01113502|469520037|FG000|Overall Study|Withdrawal by Subject|1|||
130426141|NCT01113502|469520038|FG001|Overall Study|Withdrawal by Subject|0|||
130426142|NCT01113502|469520039|FG002|Overall Study|Withdrawal by Subject|1|||
130426143|NCT01113502|469520040|FG003|Overall Study|Withdrawal by Subject|1|||
130426144|NCT01113502|469520041|FG004|Overall Study|Withdrawal by Subject|0|||
130426145|NCT01113502|469520037|FG000|Overall Study|Adverse Event|0|||
130426146|NCT01113502|469520038|FG001|Overall Study|Adverse Event|0|||
130426147|NCT01113502|469520039|FG002|Overall Study|Adverse Event|3|||
130426148|NCT01113502|469520040|FG003|Overall Study|Adverse Event|2|||
130426149|NCT01113502|469520041|FG004|Overall Study|Adverse Event|0|||
130426150|NCT00929162|469520044|FG000|Overall Study|Adverse Event|8|||
130426151|NCT00929162|469520045|FG001|Overall Study|Adverse Event|5|||
130426152|NCT00929162|469520044|FG000|Overall Study|Withdrawal by Subject|3|||
130426153|NCT00929162|469520045|FG001|Overall Study|Withdrawal by Subject|1|||
130426154|NCT00929162|469520044|FG000|Overall Study|Protocol Violation|32|||
130426155|NCT00929162|469520045|FG001|Overall Study|Protocol Violation|30|||
130426156|NCT00929162|469520044|FG000|Overall Study|Other termination reason|5|||
130426157|NCT00929162|469520045|FG001|Overall Study|Other termination reason|6|||
130426158|NCT01822587|469520046|FG000|Overall Study|Lost to Follow-up|7|||
130426159|NCT01822587|469520047|FG001|Overall Study|Lost to Follow-up|9|||
130426160|NCT01822587|469520048|FG002|Overall Study|Lost to Follow-up|12|||
130426161|NCT01822587|469520046|FG000|Overall Study|Physician Decision|9|||
130426162|NCT01822587|469520047|FG001|Overall Study|Physician Decision|6|||
130426163|NCT01822587|469520048|FG002|Overall Study|Physician Decision|6|||
130426164|NCT01274182|469520049|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130426165|NCT01274182|469520050|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130426166|NCT01274182|469520051|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130426167|NCT01274182|469520049|FG000|Overall Study|Adverse Event|4|||
130426168|NCT01274182|469520050|FG001|Overall Study|Adverse Event|5|||
130426169|NCT01274182|469520051|FG002|Overall Study|Adverse Event|3|||
130426170|NCT01274182|469520049|FG000|Overall Study|Withdrawal by Subject|5|||
130426171|NCT01274182|469520050|FG001|Overall Study|Withdrawal by Subject|5|||
130426172|NCT01274182|469520051|FG002|Overall Study|Withdrawal by Subject|3|||
130426173|NCT01274182|469520049|FG000|Overall Study|Lost to Follow-up|2|||
130426174|NCT01274182|469520050|FG001|Overall Study|Lost to Follow-up|3|||
130426175|NCT01274182|469520051|FG002|Overall Study|Lost to Follow-up|1|||
130426176|NCT01274182|469520049|FG000|Overall Study|Protocol Violation|3|||
130426177|NCT01274182|469520050|FG001|Overall Study|Protocol Violation|2|||
130426178|NCT01274182|469520051|FG002|Overall Study|Protocol Violation|0|||
130426179|NCT01274182|469520049|FG000|Overall Study|Death|1|||
130426180|NCT01274182|469520050|FG001|Overall Study|Death|0|||
130426181|NCT01274182|469520051|FG002|Overall Study|Death|1|||
130426182|NCT02355002|469520052|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
130426183|NCT02355002|469520053|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
130426184|NCT02355002|469520052|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
130564785|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130564786|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
130564787|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
130426185|NCT02355002|469520053|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
130426186|NCT02355002|469520052|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
130426187|NCT02355002|469520053|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
130426188|NCT02355002|469520052|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
130564788|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130564789|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130426189|NCT02355002|469520053|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
130426190|NCT02355002|469520052|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
130426191|NCT02355002|469520053|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
130426192|NCT02355002|469520052|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
130426193|NCT02355002|469520053|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
130426194|NCT02355002|469520052|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
130426195|NCT02355002|469520053|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
130426196|NCT00708916|469520054|FG000|Overall Study|Subject Noncompliance|2|||
130426197|NCT00708916|469520054|FG000|Overall Study|Adverse Event|2|||
130564790|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
130426198|NCT00658567|469520056|FG000|Overall Study|Adverse Event|5|||
130426199|NCT00658567|469520057|FG001|Overall Study|Adverse Event|2|||
130426200|NCT00658567|469520058|FG002|Overall Study|Adverse Event|3|||
130426201|NCT00658567|469520056|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
130426202|NCT00658567|469520057|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
130426203|NCT00658567|469520058|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
130426204|NCT00658567|469520056|FG000|Overall Study|Physician Decision|0|||
130426205|NCT00658567|469520057|FG001|Overall Study|Physician Decision|1|||
130426206|NCT00658567|469520058|FG002|Overall Study|Physician Decision|0|||
130426207|NCT00658567|469520056|FG000|Overall Study|At Discretion of Sponsor|1|||
130426208|NCT00658567|469520057|FG001|Overall Study|At Discretion of Sponsor|1|||
130426209|NCT00658567|469520058|FG002|Overall Study|At Discretion of Sponsor|1|||
130426210|NCT02835339|469520065|FG000|Overall Study|Did not receive allocated intervention|13|||
130426211|NCT02835339|469520066|FG001|Overall Study|Did not receive allocated intervention|16|||
130426212|NCT01077544|469520067|FG000|Overall Study|New Cancer Therapy|3|||
130426213|NCT01077544|469520068|FG001|Overall Study|New Cancer Therapy|3|||
130426214|NCT01077544|469520067|FG000|Overall Study|Adverse Event|0|||
130426215|NCT01077544|469520068|FG001|Overall Study|Adverse Event|1|||
130426216|NCT01077544|469520067|FG000|Overall Study|Disease Progression|0|||
130426217|NCT01077544|469520068|FG001|Overall Study|Disease Progression|1|||
130426218|NCT03923959|469520069|FG000|Overall Study|Death|16|||
130426219|NCT03923959|469520070|FG001|Overall Study|Death|12|||
130426220|NCT03923959|469520069|FG000|Overall Study|Lost to Follow-up|56|||
130426221|NCT03923959|469520070|FG001|Overall Study|Lost to Follow-up|56|||
130426222|NCT03923959|469520069|FG000|Overall Study|Withdrawal by Subject|1|||
130426223|NCT03923959|469520070|FG001|Overall Study|Withdrawal by Subject|1|||
130426224|NCT03923959|469520069|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
130426225|NCT03923959|469520070|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
130426226|NCT04918147|469520071|FG000|Overall Study|Disease flare as defined in protocol|0|||
130426227|NCT04918147|469520072|FG001|Overall Study|Disease flare as defined in protocol|2|||
130426228|NCT02954354|469520074|FG000|Overall Study|Adverse Event|2|||
130426229|NCT02954354|469520075|FG001|Overall Study|Adverse Event|2|||
130426230|NCT02954354|469520076|FG002|Overall Study|Adverse Event|4|||
130426231|NCT02954354|469520074|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
130426232|NCT02954354|469520075|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
130564791|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
130564792|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130564793|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
130426233|NCT02954354|469520076|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
130426234|NCT02954354|469520074|FG000|Overall Study|Lack of Efficacy|0|||
130426235|NCT02954354|469520075|FG001|Overall Study|Lack of Efficacy|2|||
130426236|NCT02954354|469520076|FG002|Overall Study|Lack of Efficacy|0|||
130426237|NCT02954354|469520074|FG000|Overall Study|Withdrawal by Subject|17|||
130426238|NCT02954354|469520075|FG001|Overall Study|Withdrawal by Subject|9|||
130426239|NCT02954354|469520076|FG002|Overall Study|Withdrawal by Subject|11|||
130426240|NCT02954354|469520074|FG000|Overall Study|Lost to Follow-up|12|||
130426241|NCT02954354|469520075|FG001|Overall Study|Lost to Follow-up|5|||
130426242|NCT02954354|469520076|FG002|Overall Study|Lost to Follow-up|0|||
130426243|NCT02954354|469520074|FG000|Overall Study|Miscellaneous|2|||
130426244|NCT02954354|469520075|FG001|Overall Study|Miscellaneous|2|||
130426245|NCT02954354|469520076|FG002|Overall Study|Miscellaneous|1|||
130426246|NCT03804710|469520077|FG000|Overall Study|Adverse Event|0|||
130426247|NCT03804710|469520078|FG001|Overall Study|Adverse Event|3|||
130426248|NCT03804710|469520077|FG000|Overall Study|Withdrawal by Subject|2|||
130426249|NCT03804710|469520078|FG001|Overall Study|Withdrawal by Subject|1|||
130426250|NCT03804710|469520077|FG000|Overall Study|Other|0|||
130426251|NCT03804710|469520078|FG001|Overall Study|Other|1|||
130426252|NCT02454101|469520079|FG000|Overall Study|Adverse Event|2|||
130426253|NCT02454101|469520080|FG001|Overall Study|Adverse Event|3|||
130426254|NCT02454101|469520079|FG000|Overall Study|Lost to Follow-up|3|||
130426255|NCT02454101|469520080|FG001|Overall Study|Lost to Follow-up|4|||
130426256|NCT04510675|469520081|FG000|Overall Study|Withdrawal by Subject|5|||
130426257|NCT04198805|469520082|FG000|Overall Study|Death|0|||
130426258|NCT04198805|469520083|FG001|Overall Study|Death|0|||
130426259|NCT04198805|469520084|FG002|Overall Study|Death|0|||
130426260|NCT04198805|469520085|FG003|Overall Study|Death|1|||
130426261|NCT04198805|469520082|FG000|Overall Study|Early Termination|8|||
130426262|NCT04198805|469520083|FG001|Overall Study|Early Termination|4|||
130426263|NCT04198805|469520084|FG002|Overall Study|Early Termination|6|||
130426264|NCT04198805|469520085|FG003|Overall Study|Early Termination|9|||
130426265|NCT01330433|469520086|FG000|Overall Study|Death|1|||
130426266|NCT01330433|469520087|FG001|Overall Study|Death|3|||
130426267|NCT01330433|469520086|FG000|Overall Study|Lost to Follow-up|1|||
130426268|NCT01330433|469520087|FG001|Overall Study|Lost to Follow-up|0|||
130426269|NCT01494584|469520088|FG000|Overall Study|Study Closed/Terminated|1|||
130426270|NCT01499082|469520089|FG000|Overall Study|Randomized but not Treated|0|||
130564794|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Death|2|||
130477397|NCT02962895|469715471|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477398|NCT02962895|469715472|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477399|NCT02962895|469715473|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477400|NCT02962895|469715474|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477401|NCT02962895|469715475|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
130477402|NCT02962895|469715476|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477403|NCT02962895|469715477|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
130477404|NCT02962895|469715471|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477405|NCT02962895|469715472|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477406|NCT02962895|469715473|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477407|NCT02962895|469715474|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477408|NCT02962895|469715475|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
130477409|NCT02962895|469715476|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477410|NCT02962895|469715477|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
130477411|NCT02962895|469715471|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
130477412|NCT02962895|469715472|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
130477413|NCT02962895|469715473|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
130477414|NCT02962895|469715474|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
130477415|NCT02962895|469715475|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
130477416|NCT02962895|469715476|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
130477417|NCT02962895|469715477|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
130477418|NCT02962895|469715471|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
130477419|NCT02962895|469715472|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
130477420|NCT02962895|469715473|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
130477421|NCT02962895|469715474|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
130477422|NCT02962895|469715475|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
130477423|NCT02962895|469715476|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
130477424|NCT02962895|469715477|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
130477425|NCT05481320|469715478|FG000|Overall Study|Withdrawal by Subject|1|||
130477426|NCT05481320|469715479|FG001|Overall Study|Withdrawal by Subject|1|||
130477427|NCT05481320|469715478|FG000|Overall Study|Care recipent passed away|0|||
130477428|NCT05481320|469715479|FG001|Overall Study|Care recipent passed away|1|||
130477429|NCT05481320|469715478|FG000|Overall Study|Out-of-window assessment|0|||
130477430|NCT05481320|469715479|FG001|Overall Study|Out-of-window assessment|1|||
130477431|NCT05481320|469715478|FG000|Overall Study|No longer a primary caregiver|3|||
130477432|NCT05481320|469715479|FG001|Overall Study|No longer a primary caregiver|0|||
130477433|NCT05481320|469715478|FG000|Overall Study|Unable to contact|1|||
130477434|NCT05481320|469715479|FG001|Overall Study|Unable to contact|0|||
130477435|NCT05894577|469715480|FG000|Overall Study|No receipt of study drug|14|||
130477436|NCT05894577|469715481|FG001|Overall Study|No receipt of study drug|13|||
130477437|NCT05894577|469715480|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
130477438|NCT05894577|469715481|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
130477439|NCT05894577|469715480|FG000|Overall Study|Screen Fail|2|||
130477440|NCT05894577|469715481|FG001|Overall Study|Screen Fail|0|||
130477441|NCT05894577|469715480|FG000|Overall Study|Study drug recall|86|||
130477442|NCT05894577|469715481|FG001|Overall Study|Study drug recall|63|||
130477443|NCT05282173|469715484|FG000|Overall Study|Missed|3|||
130477444|NCT05282173|469715485|FG001|Overall Study|Missed|2|||
130477445|NCT05282173|469715486|FG002|Overall Study|Missed|4|||
130477446|NCT03364647|469715488|FG000|Overall Study|Withdrawal by Subject|3|||
130477447|NCT03364647|469715489|FG001|Overall Study|Withdrawal by Subject|1|||
130477448|NCT03476460|469715490|FG000|Overall Study|Withdrawal by Subject|3|||
130477449|NCT03476460|469715491|FG001|Overall Study|Withdrawal by Subject|2|||
130477450|NCT03476460|469715490|FG000|Overall Study|Non-compliance with treatment|3|||
130477451|NCT03476460|469715491|FG001|Overall Study|Non-compliance with treatment|0|||
130477452|NCT03476460|469715490|FG000|Overall Study|Missing laboratory tests|5|||
130477453|NCT03476460|469715491|FG001|Overall Study|Missing laboratory tests|5|||
130477454|NCT03476460|469715490|FG000|Overall Study|Adverse Event|0|||
130477455|NCT03476460|469715491|FG001|Overall Study|Adverse Event|1|||
130477456|NCT04015167|469715501|FG000|Overall Study|Lost to Follow-up|40|||
130477457|NCT04015167|469715501|FG000|Overall Study|Adverse Event|5|||
130477458|NCT04015167|469715501|FG000|Overall Study|Withdrawal by Subject|2|||
130477459|NCT04015167|469715501|FG000|Overall Study|Subject went to jail|1|||
130477460|NCT03640312|469715502|FG000|Overall Study|Lost to Follow-up|3|||
130477461|NCT03640312|469715503|FG001|Overall Study|Lost to Follow-up|6|||
130477462|NCT06037369|469715511|FG000|Overall Study|Lost to Follow-up|0|||
130477463|NCT06037369|469715512|FG001|Overall Study|Lost to Follow-up|1|||
130477464|NCT04876118|469715517|FG000|Overall Study|Pregnancy|1|||
130477465|NCT04876118|469715517|FG000|Overall Study|Withdrawal by Subject|14|||
130477466|NCT05351554|469715520|FG000|Overall Study|Study terminated by sponsor|1|||
130477467|NCT03774082|469715521|FG000|Overall Study|Death|6|||
130477468|NCT03774082|469715522|FG001|Overall Study|Death|3|||
130477469|NCT03774082|469715523|FG002|Overall Study|Death|2|||
130426271|NCT01499082|469520090|FG001|Overall Study|Randomized but not Treated|1|||
130426272|NCT01499082|469520089|FG000|Overall Study|Adverse Event|12|||
130426273|NCT01499082|469520090|FG001|Overall Study|Adverse Event|16|||
130426274|NCT01499082|469520089|FG000|Overall Study|Lack of Efficacy|1|||
130426275|NCT01499082|469520090|FG001|Overall Study|Lack of Efficacy|1|||
130426276|NCT01499082|469520089|FG000|Overall Study|Protocol Violation|6|||
130477470|NCT03774082|469715521|FG000|Overall Study|Subject decision|0|||
130477471|NCT03774082|469715522|FG001|Overall Study|Subject decision|3|||
130477472|NCT03774082|469715523|FG002|Overall Study|Subject decision|0|||
130477473|NCT03774082|469715521|FG000|Overall Study|Lost to Follow-up|2|||
130477474|NCT03774082|469715522|FG001|Overall Study|Lost to Follow-up|0|||
130477475|NCT03774082|469715523|FG002|Overall Study|Lost to Follow-up|0|||
130477476|NCT03774082|469715521|FG000|Overall Study|Guardian decision|0|||
130477477|NCT03774082|469715522|FG001|Overall Study|Guardian decision|0|||
130477478|NCT03774082|469715523|FG002|Overall Study|Guardian decision|1|||
130477479|NCT03774082|469715521|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
130477480|NCT03774082|469715522|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
130477481|NCT03774082|469715523|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
130477482|NCT05093829|469715524|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
130477483|NCT05093829|469715525|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
130477484|NCT05093829|469715526|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
130477485|NCT05093829|469715527|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
130477486|NCT05093829|469715528|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
130477487|NCT04353661|469717354|FG000|Overall Study|Protocol Violation|0|||
130477488|NCT04353661|469717355|FG001|Overall Study|Protocol Violation|0|||
130477489|NCT04353661|469717356|FG002|Overall Study|Protocol Violation|1|||
130477490|NCT04353661|469717354|FG000|Overall Study|Study termination by the Sponsor|1|||
130477491|NCT04353661|469717355|FG001|Overall Study|Study termination by the Sponsor|1|||
130477492|NCT04353661|469717356|FG002|Overall Study|Study termination by the Sponsor|1|||
130477493|NCT00667251|469717357|FG000|Overall Study|Disease progression|232|||
130477494|NCT00667251|469717358|FG001|Overall Study|Disease progression|203|||
130477495|NCT00667251|469717357|FG000|Overall Study|Toxicity|44|||
130477496|NCT00667251|469717358|FG001|Overall Study|Toxicity|23|||
130477497|NCT00667251|469717357|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
130477498|NCT00667251|469717358|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
130477499|NCT00667251|469717357|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
130477500|NCT00667251|469717358|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
130477501|NCT00667251|469717357|FG000|Overall Study|Symptomatic progression|8|||
130477502|NCT00667251|469717358|FG001|Overall Study|Symptomatic progression|4|||
130477503|NCT00667251|469717357|FG000|Overall Study|Death|6|||
130477504|NCT00667251|469717358|FG001|Overall Study|Death|11|||
130477505|NCT00667251|469717357|FG000|Overall Study|Intercurrent illness|5|||
130477506|NCT00667251|469717358|FG001|Overall Study|Intercurrent illness|6|||
130477507|NCT00667251|469717357|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
130477508|NCT00667251|469717358|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
130477509|NCT00667251|469717357|FG000|Overall Study|Randomized not Treated|4|||
130477510|NCT00667251|469717358|FG001|Overall Study|Randomized not Treated|1|||
130477511|NCT02995434|469717363|FG000|Overall Study|Adverse Event|1|||
130477512|NCT02995434|469717364|FG001|Overall Study|Adverse Event|0|||
130477513|NCT02995434|469717363|FG000|Overall Study|Withdrawal by Subject|6|||
130477514|NCT02995434|469717364|FG001|Overall Study|Withdrawal by Subject|3|||
130477515|NCT03047928|469717365|FG000|Overall Study|Adverse Event|0|||
130477516|NCT03047928|469717366|FG001|Overall Study|Adverse Event|2|||
130477517|NCT03047928|469717367|FG002|Overall Study|Adverse Event|0|||
130477518|NCT03047928|469717365|FG000|Overall Study|Protocol Violation|0|||
130477519|NCT03047928|469717366|FG001|Overall Study|Protocol Violation|1|||
130477520|NCT03047928|469717367|FG002|Overall Study|Protocol Violation|0|||
130477521|NCT03047928|469717365|FG000|Overall Study|included in another protocol|0|||
130477522|NCT03047928|469717366|FG001|Overall Study|included in another protocol|1|||
130477523|NCT03047928|469717367|FG002|Overall Study|included in another protocol|0|||
130477524|NCT04179500|469717368|FG000|Treatment|Withdrawal by Subject|1|||
130477525|NCT04179500|469717368|FG000|Treatment|Adverse Event|2|||
130426277|NCT01499082|469520090|FG001|Overall Study|Protocol Violation|8|||
130477526|NCT04179500|469717368|FG000|Treatment|pyrazinamide resistance|1|||
130477527|NCT04492007|469717369|FG000|Overall Study|Lost to Follow-up|1|||
130477528|NCT04492007|469717370|FG001|Overall Study|Lost to Follow-up|1|||
130477529|NCT04492007|469717371|FG002|Overall Study|Lost to Follow-up|2|||
130477530|NCT04492007|469717372|FG003|Overall Study|Lost to Follow-up|2|||
130426278|NCT01499082|469520089|FG000|Overall Study|Diverse Reasons|18|||
130426279|NCT01499082|469520090|FG001|Overall Study|Diverse Reasons|14|||
130477531|NCT04492007|469717369|FG000|Overall Study|Protocol Violation|1|||
130477532|NCT04492007|469717370|FG001|Overall Study|Protocol Violation|1|||
130426280|NCT01499082|469520089|FG000|Overall Study|Site Closure for Noncompliance|5|||
130426281|NCT01499082|469520090|FG001|Overall Study|Site Closure for Noncompliance|2|||
130426282|NCT01499082|469520089|FG000|Overall Study|Hypoglycemia|2|||
130426283|NCT01499082|469520090|FG001|Overall Study|Hypoglycemia|3|||
130426284|NCT01499082|469520089|FG000|Overall Study|Lost to Follow-up|1|||
130426285|NCT01499082|469520090|FG001|Overall Study|Lost to Follow-up|3|||
130426286|NCT03599349|469520091|FG000|Overall Study|Lost to Follow-up|1|||
130426287|NCT01830127|469520092|FG000|Overall Study|Adverse Event|1|||
130426288|NCT01830127|469520093|FG001|Overall Study|Adverse Event|6|||
130426289|NCT01830127|469520092|FG000|Overall Study|Lack of Efficacy|3|||
130426290|NCT01830127|469520093|FG001|Overall Study|Lack of Efficacy|0|||
130426291|NCT01830127|469520092|FG000|Overall Study|Withdrawal by Subject|1|||
130426292|NCT01830127|469520093|FG001|Overall Study|Withdrawal by Subject|1|||
130426293|NCT01830127|469520092|FG000|Overall Study|Other reason not defined above|0|||
130426294|NCT01830127|469520093|FG001|Overall Study|Other reason not defined above|2|||
130426295|NCT00553696|469520106|FG000|Overall Study|Adverse Event|2|||
130426296|NCT00553696|469520107|FG001|Overall Study|Adverse Event|4|||
130426297|NCT00553696|469520108|FG002|Overall Study|Adverse Event|0|||
130426298|NCT00553696|469520109|FG003|Overall Study|Adverse Event|1|||
130426299|NCT00553696|469520106|FG000|Overall Study|Global deterioration of health status|0|||
130426300|NCT00553696|469520107|FG001|Overall Study|Global deterioration of health status|2|||
130426301|NCT00553696|469520108|FG002|Overall Study|Global deterioration of health status|0|||
130426302|NCT00553696|469520109|FG003|Overall Study|Global deterioration of health status|0|||
130426303|NCT00553696|469520106|FG000|Overall Study|Objective progression or relapse|2|||
130426304|NCT00553696|469520107|FG001|Overall Study|Objective progression or relapse|9|||
130426305|NCT00553696|469520108|FG002|Overall Study|Objective progression or relapse|6|||
130426306|NCT00553696|469520109|FG003|Overall Study|Objective progression or relapse|0|||
130426307|NCT00553696|469520106|FG000|Overall Study|Withdrawal by Subject|0|||
130426308|NCT00553696|469520107|FG001|Overall Study|Withdrawal by Subject|1|||
130426309|NCT00553696|469520108|FG002|Overall Study|Withdrawal by Subject|0|||
130426310|NCT00553696|469520109|FG003|Overall Study|Withdrawal by Subject|0|||
130426311|NCT00686881|469520110|FG000|Overall Study|Withdrawal by Subject|11|||
130426312|NCT00686881|469520111|FG001|Overall Study|Withdrawal by Subject|18|||
130426313|NCT00686881|469520110|FG000|Overall Study|Lost to Follow-up|0|||
130426314|NCT00686881|469520111|FG001|Overall Study|Lost to Follow-up|1|||
130426315|NCT00686881|469520110|FG000|Overall Study|Treatment-related adverse event|10|||
130426316|NCT00686881|469520111|FG001|Overall Study|Treatment-related adverse event|9|||
130426317|NCT00686881|469520110|FG000|Overall Study|Met discontinuation criteria|5|||
130426318|NCT00686881|469520111|FG001|Overall Study|Met discontinuation criteria|0|||
130426319|NCT00686881|469520110|FG000|Overall Study|Onset of malignant tumor|11|||
130426320|NCT00686881|469520111|FG001|Overall Study|Onset of malignant tumor|11|||
130426321|NCT00686881|469520110|FG000|Overall Study|Lack of Efficacy|4|||
130426322|NCT00686881|469520111|FG001|Overall Study|Lack of Efficacy|3|||
130426323|NCT00686881|469520110|FG000|Overall Study|Physician Decision|1|||
130426324|NCT00686881|469520111|FG001|Overall Study|Physician Decision|0|||
130426325|NCT00686881|469520110|FG000|Overall Study|Circumstances of site|1|||
130426326|NCT00686881|469520111|FG001|Overall Study|Circumstances of site|1|||
130426327|NCT00686881|469520110|FG000|Overall Study|Did not meet protocol eligibility|1|||
130426328|NCT00686881|469520111|FG001|Overall Study|Did not meet protocol eligibility|0|||
130426329|NCT00686881|469520110|FG000|Overall Study|Irregular visits|1|||
130426330|NCT00686881|469520111|FG001|Overall Study|Irregular visits|0|||
130426331|NCT00686881|469520110|FG000|Overall Study|Study discontinuation|35|||
130426332|NCT00686881|469520111|FG001|Overall Study|Study discontinuation|32|||
130426333|NCT00686881|469520110|FG000|Overall Study|Never received study drug|2|||
130426334|NCT00686881|469520111|FG001|Overall Study|Never received study drug|6|||
130426335|NCT05899686|469520112|FG000|Overall Study|Protocol Violation|1|||
130426336|NCT02170025|469520113|FG000|Overall Study|Adverse Event|2|||
130477533|NCT04492007|469717371|FG002|Overall Study|Protocol Violation|1|||
130477534|NCT04492007|469717372|FG003|Overall Study|Protocol Violation|1|||
130477535|NCT04492007|469717369|FG000|Overall Study|Withdrawal by Subject|0|||
130477536|NCT04492007|469717370|FG001|Overall Study|Withdrawal by Subject|0|||
130477537|NCT04492007|469717371|FG002|Overall Study|Withdrawal by Subject|1|||
130477538|NCT04492007|469717372|FG003|Overall Study|Withdrawal by Subject|1|||
130477539|NCT04177823|469717375|FG000|Overall Study|Physician Decision|1|||
130426337|NCT02170025|469520114|FG001|Overall Study|Adverse Event|0|||
130426338|NCT00572195|469520115|FG000|Overall Study|Withdrawal by Subject|50|||
130426339|NCT00572195|469520115|FG000|Overall Study|Death|9|||
130426340|NCT00572195|469520115|FG000|Overall Study|Adverse Event|4|||
130426341|NCT00572195|469520115|FG000|Overall Study|Lost to Follow-up|5|||
130426342|NCT03657277|469520116|FG000|Overall Study|Physician Decision|2|||
130426343|NCT03657277|469520116|FG000|Overall Study|Lost to Follow-up|1|||
130426344|NCT03657277|469520116|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
130477540|NCT04177823|469717375|FG000|Overall Study|Withdrawal by Subject|1|||
130426345|NCT04349280|469520117|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
130426346|NCT04349280|469520118|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
130426347|NCT04349280|469520117|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
130477541|NCT05178316|469717378|FG000|Overall Study|Adverse Event|5|||
130477542|NCT05178316|469717379|FG001|Overall Study|Adverse Event|4|||
130426348|NCT04349280|469520118|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
130426349|NCT04349280|469520117|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
130426350|NCT04349280|469520118|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
130426351|NCT00657618|469520119|FG000|Overall Study|Adverse Event|32|||
130426352|NCT00657618|469520119|FG000|Overall Study|Withdrawal by Subject|8|||
130426353|NCT00657618|469520119|FG000|Overall Study|negative for leishmaniasis|2|||
130426354|NCT00657618|469520119|FG000|Overall Study|didn't start due to schedule conflicts|1|||
130426355|NCT04981678|469520120|FG000|Overall Study|Lost to Follow-up|0|||
130426356|NCT04981678|469520121|FG001|Overall Study|Lost to Follow-up|1|||
130426357|NCT04922554|469520122|FG000|Overall Study|Adverse Event|4|||
130426358|NCT04922554|469520123|FG001|Overall Study|Adverse Event|0|||
130426359|NCT04922554|469520122|FG000|Overall Study|Withdrawal by Subject|1|||
130426360|NCT04922554|469520123|FG001|Overall Study|Withdrawal by Subject|0|||
130426361|NCT01111123|469521974|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
130426362|NCT01111123|469521975|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
130426363|NCT01111123|469521974|FG000|Maintenance Phase|Lost to Follow-up|0|||
130426364|NCT01111123|469521975|FG001|Maintenance Phase|Lost to Follow-up|2|||
130426365|NCT00119405|469521976|FG000|Overall Study|Withdrawal by Subject|1|||
130426366|NCT03597568|469521996|FG000|Overall Study|Withdrawal by Subject|1|||
130426367|NCT03597568|469521997|FG001|Overall Study|Withdrawal by Subject|1|||
130426368|NCT03597568|469521996|FG000|Overall Study|Unable to analyze vascular data|1|||
130426369|NCT03597568|469521997|FG001|Overall Study|Unable to analyze vascular data|1|||
130426370|NCT02052310|469521998|FG000|Overall Study|Death|64|||
130426371|NCT02052310|469521999|FG001|Overall Study|Death|54|||
130426372|NCT02052310|469521998|FG000|Overall Study|Withdrawal by Subject|37|||
130426373|NCT02052310|469521999|FG001|Overall Study|Withdrawal by Subject|49|||
130426374|NCT02052310|469521998|FG000|Overall Study|Other than specified|32|||
130426375|NCT02052310|469521999|FG001|Overall Study|Other than specified|29|||
130426376|NCT02052310|469521998|FG000|Overall Study|Adverse Event|29|||
130426377|NCT02052310|469521999|FG001|Overall Study|Adverse Event|22|||
130426378|NCT02052310|469521998|FG000|Overall Study|Kidney Transplant|23|||
130426379|NCT02052310|469521999|FG001|Overall Study|Kidney Transplant|29|||
130426380|NCT02052310|469521998|FG000|Overall Study|Physician Decision|14|||
130426381|NCT02052310|469521999|FG001|Overall Study|Physician Decision|7|||
130426382|NCT02052310|469521998|FG000|Overall Study|Lack of Efficacy|6|||
130426383|NCT02052310|469521999|FG001|Overall Study|Lack of Efficacy|1|||
130426384|NCT02052310|469521998|FG000|Overall Study|Site Terminated by Sponsor|5|||
130426385|NCT02052310|469521999|FG001|Overall Study|Site Terminated by Sponsor|13|||
130426386|NCT02052310|469521998|FG000|Overall Study|Lost to Follow-up|4|||
130426387|NCT02052310|469521999|FG001|Overall Study|Lost to Follow-up|2|||
130426388|NCT02052310|469521998|FG000|Overall Study|Protocol Violation|1|||
130426389|NCT02052310|469521999|FG001|Overall Study|Protocol Violation|6|||
130426390|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
130426391|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
130426392|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
130477543|NCT05178316|469717380|FG002|Overall Study|Adverse Event|9|||
130477544|NCT05178316|469717378|FG000|Overall Study|Enrolled in Error|1|||
130477545|NCT05178316|469717379|FG001|Overall Study|Enrolled in Error|2|||
130477546|NCT05178316|469717380|FG002|Overall Study|Enrolled in Error|1|||
130477547|NCT05178316|469717378|FG000|Overall Study|Lost to Follow-up|3|||
130477548|NCT05178316|469717379|FG001|Overall Study|Lost to Follow-up|15|||
130426393|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
130426394|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
130426395|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
130426396|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
130426397|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
130426398|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Other|18|||
130426399|NCT02565914|469522002|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
130477549|NCT05178316|469717380|FG002|Overall Study|Lost to Follow-up|11|||
130477550|NCT05178316|469717378|FG000|Overall Study|Noncompliance|1|||
130477551|NCT05178316|469717379|FG001|Overall Study|Noncompliance|3|||
130564795|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Death|1|||
130564796|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Death|0|||
130564797|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Death|0|||
130426400|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
130426401|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Other|1|||
130426402|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
130426403|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
130426404|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
130426405|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
130564798|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130426406|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
130477552|NCT05178316|469717380|FG002|Overall Study|Noncompliance|1|||
130477553|NCT05178316|469717378|FG000|Overall Study|Other|0|||
130426407|NCT02565914|469522002|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
130426408|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
130426409|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
130426410|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
130426411|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
130426412|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
130426413|NCT02565914|469522002|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
130426414|NCT01505387|469522003|FG000|Overall Study|Protocol Violation|1|||
130426415|NCT01505387|469522004|FG001|Overall Study|Protocol Violation|0|||
130426416|NCT01505387|469522003|FG000|Overall Study|Withdrawal by Subject|1|||
130426417|NCT01505387|469522004|FG001|Overall Study|Withdrawal by Subject|1|||
130426418|NCT01197508|469522011|FG000|Overall Study|Withdrawal by Subject|8|||
130426419|NCT01197508|469522012|FG001|Overall Study|Withdrawal by Subject|7|||
130426420|NCT01197508|469522013|FG002|Overall Study|Withdrawal by Subject|15|||
130426421|NCT01197508|469522014|FG003|Overall Study|Withdrawal by Subject|4|||
130426422|NCT01197508|469522011|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
130426423|NCT01197508|469522012|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
130426424|NCT01197508|469522013|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
130426425|NCT01197508|469522014|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
130426426|NCT01197508|469522011|FG000|Overall Study|Adverse Event|10|||
130426427|NCT01197508|469522012|FG001|Overall Study|Adverse Event|13|||
130426428|NCT01197508|469522013|FG002|Overall Study|Adverse Event|23|||
130426429|NCT01197508|469522014|FG003|Overall Study|Adverse Event|3|||
130426430|NCT01197508|469522011|FG000|Overall Study|Severe non-compliance to protocol|0|||
130426431|NCT01197508|469522012|FG001|Overall Study|Severe non-compliance to protocol|3|||
130426432|NCT01197508|469522013|FG002|Overall Study|Severe non-compliance to protocol|1|||
130426433|NCT01197508|469522014|FG003|Overall Study|Severe non-compliance to protocol|3|||
130426434|NCT01197508|469522011|FG000|Overall Study|Condition under investigation worsened|1|||
130426435|NCT01197508|469522012|FG001|Overall Study|Condition under investigation worsened|1|||
130426436|NCT01197508|469522013|FG002|Overall Study|Condition under investigation worsened|1|||
130426437|NCT01197508|469522014|FG003|Overall Study|Condition under investigation worsened|1|||
130426438|NCT01197508|469522011|FG000|Overall Study|Lack of Efficacy|1|||
130426439|NCT01197508|469522012|FG001|Overall Study|Lack of Efficacy|2|||
130426440|NCT01197508|469522013|FG002|Overall Study|Lack of Efficacy|2|||
130426441|NCT01197508|469522014|FG003|Overall Study|Lack of Efficacy|1|||
130426442|NCT01197508|469522011|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130426443|NCT01197508|469522012|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130426444|NCT01197508|469522013|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130426445|NCT01197508|469522014|FG003|Overall Study|Study-specific withdrawal criteria|2|||
130426446|NCT01197508|469522011|FG000|Overall Study|Lost to Follow-up|1|||
130426447|NCT01197508|469522012|FG001|Overall Study|Lost to Follow-up|1|||
130426448|NCT01197508|469522013|FG002|Overall Study|Lost to Follow-up|2|||
130426449|NCT01197508|469522014|FG003|Overall Study|Lost to Follow-up|0|||
130426450|NCT01197508|469522011|FG000|Overall Study|Other|2|||
130426451|NCT01197508|469522012|FG001|Overall Study|Other|3|||
130426452|NCT01197508|469522013|FG002|Overall Study|Other|2|||
130426453|NCT01197508|469522014|FG003|Overall Study|Other|2|||
130426454|NCT00266825|469522015|FG000|Completed Follow-Up|Lost to Follow-up|14|||
130426455|NCT00266825|469522016|FG001|Completed Follow-Up|Lost to Follow-up|19|||
130426456|NCT00266825|469522015|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
130426457|NCT00266825|469522016|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
130426458|NCT01301391|469522019|FG000|Overall Study|Death|13|||
130426459|NCT01301391|469522019|FG000|Overall Study|Lost to Follow-up|3|||
130426460|NCT01301391|469522019|FG000|Overall Study|Physician Decision|2|||
130426461|NCT01301391|469522019|FG000|Overall Study|Sponsor's decision|8|||
130426462|NCT02799784|469522023|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
130426463|NCT02799784|469522024|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
130426464|NCT02799784|469522023|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
130426465|NCT02799784|469522024|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
130426466|NCT02799784|469522023|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
130426467|NCT02799784|469522024|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
130477554|NCT05178316|469717379|FG001|Overall Study|Other|1|||
130477555|NCT05178316|469717380|FG002|Overall Study|Other|0|||
130477556|NCT05178316|469717378|FG000|Overall Study|Physician Decision|0|||
130477557|NCT05178316|469717379|FG001|Overall Study|Physician Decision|3|||
130477558|NCT05178316|469717380|FG002|Overall Study|Physician Decision|2|||
130477559|NCT05178316|469717378|FG000|Overall Study|Protocol deviation|1|||
130477560|NCT05178316|469717379|FG001|Overall Study|Protocol deviation|0|||
130477561|NCT05178316|469717380|FG002|Overall Study|Protocol deviation|1|||
130477562|NCT05178316|469717378|FG000|Overall Study|Sponsor decision|1|||
130477563|NCT05178316|469717379|FG001|Overall Study|Sponsor decision|0|||
130477564|NCT05178316|469717380|FG002|Overall Study|Sponsor decision|1|||
130477565|NCT05178316|469717378|FG000|Overall Study|Withdrawal by Subject|5|||
130477566|NCT05178316|469717379|FG001|Overall Study|Withdrawal by Subject|11|||
130426468|NCT02799784|469522023|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
130426469|NCT02799784|469522024|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
130426470|NCT02799784|469522023|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
130426471|NCT02799784|469522024|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
130426472|NCT02799784|469522023|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
130426473|NCT02799784|469522024|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
130426474|NCT02570126|469522028|FG000|Overall Study|Lost to Follow-up|2|||
130426475|NCT02570126|469522029|FG001|Overall Study|Lost to Follow-up|0|||
130426476|NCT02570126|469522028|FG000|Overall Study|Unable To Arrange Visit 3|1|||
130426477|NCT02570126|469522029|FG001|Overall Study|Unable To Arrange Visit 3|0|||
130426478|NCT02570126|469522028|FG000|Overall Study|Violation Of Procedures GSK|0|||
130426479|NCT02570126|469522029|FG001|Overall Study|Violation Of Procedures GSK|1|||
130426480|NCT02570126|469522028|FG000|Overall Study|Protocol Violation|0|||
130426481|NCT02570126|469522029|FG001|Overall Study|Protocol Violation|1|||
130426482|NCT02570126|469522028|FG000|Overall Study|Withdrawal by Subject|3|||
130426483|NCT02570126|469522029|FG001|Overall Study|Withdrawal by Subject|7|||
130426484|NCT00917579|469522030|FG000|Washout >= 2 Weeks|Adverse Event|1|||
130426485|NCT00917579|469522031|FG001|Washout >= 2 Weeks|Adverse Event|0|||
130426486|NCT00917579|469522030|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
130426487|NCT00917579|469522031|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
130426488|NCT01235546|469522040|FG000|Overall Study|Staff error, medication not administered|1|||
130426489|NCT01235546|469522041|FG001|Overall Study|Staff error, medication not administered|0|||
130426490|NCT01235546|469522040|FG000|Overall Study|Protocol Violation|1|||
130426491|NCT01235546|469522041|FG001|Overall Study|Protocol Violation|1|||
130426492|NCT01256411|469522043|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
130426493|NCT01256411|469522044|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
130426494|NCT01256411|469522045|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
130426495|NCT01256411|469522046|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
130426496|NCT01256411|469522047|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
130426497|NCT01256411|469522048|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
130426498|NCT01256411|469522043|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
130426499|NCT01256411|469522044|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
130426500|NCT01256411|469522045|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
130426501|NCT01256411|469522046|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
130426502|NCT01256411|469522047|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
130426503|NCT01256411|469522048|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
130426504|NCT01256411|469522043|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
130426505|NCT01256411|469522044|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
130426506|NCT01256411|469522045|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
130426507|NCT01256411|469522046|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130426508|NCT01256411|469522047|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130426509|NCT01256411|469522048|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130426510|NCT01256411|469522043|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
130426511|NCT01256411|469522044|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
130426512|NCT01256411|469522045|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
130426513|NCT01256411|469522046|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
130426514|NCT01256411|469522047|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
130426515|NCT01256411|469522048|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
130477567|NCT05178316|469717380|FG002|Overall Study|Withdrawal by Subject|5|||
130727642|NCT00425373|470625520|FG006|Overall Study|Lost to Follow-up|0|||
130727643|NCT00425373|470625521|FG007|Overall Study|Lost to Follow-up|0|||
130426516|NCT01256411|469522043|FG000|Extension by Maximum Treatment|Adverse Event|4|||
130426517|NCT01256411|469522044|FG001|Extension by Maximum Treatment|Adverse Event|2|||
130426518|NCT01256411|469522045|FG002|Extension by Maximum Treatment|Adverse Event|1|||
130426519|NCT01256411|469522046|FG003|Extension by Maximum Treatment|Adverse Event|0|||
130426520|NCT01256411|469522047|FG004|Extension by Maximum Treatment|Adverse Event|0|||
130426521|NCT01256411|469522048|FG005|Extension by Maximum Treatment|Adverse Event|0|||
130426522|NCT01256411|469522043|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
130426523|NCT01256411|469522044|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
130426524|NCT01256411|469522045|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
130426525|NCT01256411|469522046|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
130426526|NCT01256411|469522047|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
130426527|NCT01256411|469522048|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
130426528|NCT01256411|469522043|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130426529|NCT01256411|469522044|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130426530|NCT01256411|469522045|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130426531|NCT01256411|469522046|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130426532|NCT01256411|469522047|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130426533|NCT01256411|469522048|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
130727644|NCT00425373|470625522|FG008|Overall Study|Lost to Follow-up|0|||
130727645|NCT00425373|470625514|FG000|Overall Study|Protocol Violation|1|||
130727646|NCT00425373|470625515|FG001|Overall Study|Protocol Violation|0|||
130727647|NCT00425373|470625516|FG002|Overall Study|Protocol Violation|1|||
130727648|NCT00425373|470625517|FG003|Overall Study|Protocol Violation|0|||
130727649|NCT00425373|470625518|FG004|Overall Study|Protocol Violation|0|||
130727650|NCT00425373|470625519|FG005|Overall Study|Protocol Violation|0|||
130727651|NCT00425373|470625520|FG006|Overall Study|Protocol Violation|0|||
130727652|NCT00425373|470625521|FG007|Overall Study|Protocol Violation|5|||
130727653|NCT00425373|470625522|FG008|Overall Study|Protocol Violation|3|||
130727654|NCT00425373|470625514|FG000|Overall Study|Withdrawal by Subject|2|||
130727655|NCT00425373|470625515|FG001|Overall Study|Withdrawal by Subject|0|||
130727656|NCT00425373|470625516|FG002|Overall Study|Withdrawal by Subject|2|||
130426534|NCT01256411|469522043|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130426535|NCT01256411|469522044|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130426536|NCT01256411|469522045|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130426537|NCT01256411|469522046|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130727657|NCT00425373|470625517|FG003|Overall Study|Withdrawal by Subject|1|||
130727658|NCT00425373|470625518|FG004|Overall Study|Withdrawal by Subject|4|||
130727659|NCT00425373|470625519|FG005|Overall Study|Withdrawal by Subject|0|||
130727660|NCT00425373|470625520|FG006|Overall Study|Withdrawal by Subject|2|||
130426538|NCT01256411|469522047|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
130426539|NCT01256411|469522048|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130426540|NCT01256411|469522043|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130426541|NCT01256411|469522044|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130426542|NCT01256411|469522045|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130426543|NCT01256411|469522046|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130426544|NCT01256411|469522047|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
130426545|NCT01256411|469522048|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
130426546|NCT01256411|469522043|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130727661|NCT00425373|470625521|FG007|Overall Study|Withdrawal by Subject|2|||
130426547|NCT01256411|469522044|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130426548|NCT01256411|469522045|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130426549|NCT01256411|469522046|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130426550|NCT01256411|469522047|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
130426551|NCT01256411|469522048|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
130426552|NCT02740049|469522049|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
130426553|NCT02316769|469522050|FG000|Overall Study|Physician Decision|1|||
130426554|NCT02316769|469522051|FG001|Overall Study|Physician Decision|0|||
130426555|NCT02316769|469522050|FG000|Overall Study|Withdrawal by Subject|1|||
130426556|NCT02316769|469522051|FG001|Overall Study|Withdrawal by Subject|0|||
130426557|NCT04535947|469522054|FG000|Overall Study|Adverse Event|1|||
130426558|NCT04535947|469522055|FG001|Overall Study|Adverse Event|4|||
130426559|NCT04535947|469522054|FG000|Overall Study|Other reasons not specified|2|||
130727662|NCT00425373|470625522|FG008|Overall Study|Withdrawal by Subject|2|||
130727663|NCT00425373|470625514|FG000|Overall Study|Lack of Efficacy|0|||
130727664|NCT00425373|470625515|FG001|Overall Study|Lack of Efficacy|0|||
130426560|NCT04535947|469522055|FG001|Overall Study|Other reasons not specified|0|||
130426561|NCT04535947|469522054|FG000|Overall Study|Withdrawal by Subject|1|||
130426562|NCT04535947|469522055|FG001|Overall Study|Withdrawal by Subject|1|||
130477568|NCT03457142|469717381|FG000|Overall Study|Death|1|||
130477569|NCT04060654|469717382|FG000|Overall Study|Withdrawal by Subject|1|||
130477570|NCT04060654|469717382|FG000|Overall Study|Lost to Follow-up|5|||
130477571|NCT03707951|469717383|FG000|Overall Study|Lost to Follow-up|8|||
130477572|NCT03707951|469717384|FG001|Overall Study|Lost to Follow-up|17|||
130477573|NCT03707951|469717383|FG000|Overall Study|Withdrawal by Subject|6|||
130477574|NCT03707951|469717384|FG001|Overall Study|Withdrawal by Subject|6|||
130477575|NCT04887129|469717385|FG000|Overall Study|Lost to Follow-up|0|||
130477576|NCT04887129|469717386|FG001|Overall Study|Lost to Follow-up|24|||
130477577|NCT04887129|469717385|FG000|Overall Study|Withdrawal by Subject|9|||
130477578|NCT04887129|469717386|FG001|Overall Study|Withdrawal by Subject|57|||
130477579|NCT04887129|469717385|FG000|Overall Study|Other|2|||
130477580|NCT04887129|469717386|FG001|Overall Study|Other|9|||
130477581|NCT04977947|469717389|FG000|Overall Study|Lost to Follow-up|1|||
130477582|NCT04977947|469717390|FG001|Overall Study|Lost to Follow-up|1|||
130477583|NCT03436290|469717391|FG000|Overall Study|Post-randomization Exclusion|1|||
130477584|NCT03436290|469717392|FG001|Overall Study|Post-randomization Exclusion|0|||
130477585|NCT03436290|469717391|FG000|Overall Study|Death|6|||
130477586|NCT03436290|469717392|FG001|Overall Study|Death|0|||
130477587|NCT03436290|469717391|FG000|Overall Study|Withdrawal by Subject|4|||
130477588|NCT03436290|469717392|FG001|Overall Study|Withdrawal by Subject|0|||
130727665|NCT00425373|470625516|FG002|Overall Study|Lack of Efficacy|0|||
130727666|NCT00425373|470625517|FG003|Overall Study|Lack of Efficacy|0|||
130727667|NCT00425373|470625518|FG004|Overall Study|Lack of Efficacy|1|||
130426563|NCT03002610|469522064|FG000|Overall Study|Withdrawal by Subject|6|||
130426564|NCT03002610|469522065|FG001|Overall Study|Withdrawal by Subject|25|||
130426565|NCT03002610|469522066|FG002|Overall Study|Withdrawal by Subject|13|||
130426566|NCT03802123|469522067|FG000|Overall Study|Withdrawal by Subject|3|||
130426567|NCT03802123|469522067|FG000|Overall Study|Physician Decision|1|||
130426568|NCT03802123|469522067|FG000|Overall Study|Subject moved to hospice care|1|||
130426569|NCT03802123|469522067|FG000|Overall Study|technician error|1|||
130426570|NCT03802123|469522067|FG000|Overall Study|Death|3|||
130426571|NCT01362439|469522071|FG000|Overall Study|Adverse Event|1|||
130426572|NCT01362439|469522071|FG000|Overall Study|Lack of Efficacy|3|||
130426573|NCT01362439|469522071|FG000|Overall Study|Lost to Follow-up|2|||
130426574|NCT01362439|469522071|FG000|Overall Study|Study medication non-compliant|1|||
130426575|NCT01362439|469522071|FG000|Overall Study|Participant who withdrew consent|8|||
130426576|NCT01281644|469522072|FG000|Overall Study|Lost to Follow-up|3|||
130426577|NCT01281644|469522072|FG000|Overall Study|Withdrawal by Subject|2|||
130426578|NCT01755702|469522073|FG000|Wash Out Period I|Other Reason|3|||
130426579|NCT01755702|469522073|FG000|Washout Period II|Other Reason|5|||
130426580|NCT03172702|469522074|FG000|Overall Study|Adverse Event|9|||
130426581|NCT03172702|469522074|FG000|Overall Study|Death|2|||
130426582|NCT03172702|469522074|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
130426583|NCT03172702|469522074|FG000|Overall Study|Withdrawal by Subject|5|||
130426584|NCT03172702|469522074|FG000|Overall Study|Other|2|||
130426585|NCT06134180|469522085|FG000|Overall Study|Lost to Follow-up|4|||
130426586|NCT02152982|469522086|FG000|Overall Study|Ineligible|4|||
130426587|NCT02152982|469522087|FG001|Overall Study|Ineligible|4|||
130426588|NCT02152982|469522086|FG000|Overall Study|Did not start treatment|12|||
130426589|NCT02152982|469522087|FG001|Overall Study|Did not start treatment|6|||
130426590|NCT03338829|469522088|FG000|Overall Study|Lost to Follow-up|4|||
130426591|NCT03338829|469522089|FG001|Overall Study|Lost to Follow-up|2|||
130426592|NCT03338829|469522090|FG002|Overall Study|Lost to Follow-up|4|||
130426593|NCT03338829|469522088|FG000|Overall Study|Pregnancy loss|1|||
130426594|NCT03338829|469522089|FG001|Overall Study|Pregnancy loss|1|||
130426595|NCT03338829|469522090|FG002|Overall Study|Pregnancy loss|0|||
130426596|NCT03338829|469522088|FG000|Overall Study|Protocol Violation|0|||
130426597|NCT03338829|469522089|FG001|Overall Study|Protocol Violation|1|||
130426598|NCT03338829|469522090|FG002|Overall Study|Protocol Violation|0|||
130426599|NCT02684006|469522091|FG000|Overall Study|Other|18|||
130426600|NCT02684006|469522092|FG001|Overall Study|Other|6|||
130426601|NCT02684006|469522091|FG000|Overall Study|Protocol Violation|2|||
130426602|NCT02684006|469522092|FG001|Overall Study|Protocol Violation|1|||
130426603|NCT02684006|469522091|FG000|Overall Study|Non-compliance with study drug|1|||
130426604|NCT02684006|469522092|FG001|Overall Study|Non-compliance with study drug|1|||
130426605|NCT02684006|469522091|FG000|Overall Study|No longer met eligibility criteria|6|||
130426606|NCT02684006|469522092|FG001|Overall Study|No longer met eligibility criteria|2|||
130426607|NCT02684006|469522091|FG000|Overall Study|Lost to Follow-up|0|||
130426608|NCT02684006|469522092|FG001|Overall Study|Lost to Follow-up|1|||
130426609|NCT02684006|469522091|FG000|Overall Study|Death|25|||
130426610|NCT02684006|469522092|FG001|Overall Study|Death|22|||
130426611|NCT02684006|469522091|FG000|Overall Study|Global deterioration of health status|18|||
130426612|NCT02684006|469522092|FG001|Overall Study|Global deterioration of health status|20|||
130426613|NCT02684006|469522091|FG000|Overall Study|Physician Decision|15|||
130426614|NCT02684006|469522092|FG001|Overall Study|Physician Decision|8|||
130426615|NCT02684006|469522091|FG000|Overall Study|Adverse Event|86|||
130426616|NCT02684006|469522092|FG001|Overall Study|Adverse Event|65|||
130426617|NCT02684006|469522091|FG000|Overall Study|Withdrawal by Subject|29|||
130426618|NCT02684006|469522092|FG001|Overall Study|Withdrawal by Subject|43|||
130426619|NCT02684006|469522091|FG000|Overall Study|Progressive disease|236|||
130426620|NCT02684006|469522092|FG001|Overall Study|Progressive disease|266|||
130426621|NCT02684006|469522091|FG000|Overall Study|Participation terminated by sponsor|6|||
130426622|NCT02684006|469522092|FG001|Overall Study|Participation terminated by sponsor|9|||
130426623|NCT04495179|469522093|FG000|Overall Study|Lost to Follow-up|0|||
130426624|NCT04495179|469522094|FG001|Overall Study|Lost to Follow-up|1|||
130426625|NCT04495179|469522093|FG000|Overall Study|Withdrawal by Subject|2|||
130426626|NCT04495179|469522094|FG001|Overall Study|Withdrawal by Subject|4|||
130426627|NCT04495179|469522093|FG000|Overall Study|Study terminated by sponsor|0|||
130426628|NCT04495179|469522094|FG001|Overall Study|Study terminated by sponsor|18|||
130426629|NCT04495179|469522093|FG000|Overall Study|Death|0|||
130727668|NCT00425373|470625519|FG005|Overall Study|Lack of Efficacy|3|||
130426630|NCT04495179|469522094|FG001|Overall Study|Death|4|||
130426631|NCT04495179|469522093|FG000|Overall Study|Adverse Event|0|||
130426632|NCT04495179|469522094|FG001|Overall Study|Adverse Event|1|||
130426633|NCT01368965|469522098|FG000|Overall Study|Lost to Follow-up|12|||
130426634|NCT02355743|469522109|FG000|Overall Study|Withdrawal by Subject|1|||
130426635|NCT02355743|469522109|FG000|Overall Study|Lost to Follow-up|1|||
130426636|NCT04212091|469522110|FG000|Overall Study|Lost to Follow-up|0|||
130426637|NCT04212091|469522111|FG001|Overall Study|Lost to Follow-up|0|||
130426638|NCT04212091|469522112|FG002|Overall Study|Lost to Follow-up|0|||
130426639|NCT04212091|469522113|FG003|Overall Study|Lost to Follow-up|0|||
130426640|NCT04212091|469522114|FG004|Overall Study|Lost to Follow-up|1|||
130426641|NCT04212091|469522115|FG005|Overall Study|Lost to Follow-up|1|||
130426642|NCT04212091|469522110|FG000|Overall Study|Participant unable to adhere to visit|0|||
130426643|NCT04212091|469522111|FG001|Overall Study|Participant unable to adhere to visit|0|||
130426644|NCT04212091|469522112|FG002|Overall Study|Participant unable to adhere to visit|0|||
130426645|NCT04212091|469522113|FG003|Overall Study|Participant unable to adhere to visit|0|||
130426646|NCT04212091|469522114|FG004|Overall Study|Participant unable to adhere to visit|1|||
130426647|NCT04212091|469522115|FG005|Overall Study|Participant unable to adhere to visit|0|||
130426648|NCT00715429|469522116|FG000|Overall Study|Did not complete the study diary|0|||
130426649|NCT00715429|469522117|FG001|Overall Study|Did not complete the study diary|1|||
130426650|NCT04085328|469522118|FG000|Overall Study|Witihdrew Consent|16|||
130426651|NCT04085328|469522119|FG001|Overall Study|Witihdrew Consent|16|||
130426652|NCT04085328|469522118|FG000|Overall Study|Adverse Event|8|||
130426653|NCT04085328|469522119|FG001|Overall Study|Adverse Event|7|||
130426654|NCT04085328|469522118|FG000|Overall Study|Lost to Follow-up|7|||
130426655|NCT04085328|469522119|FG001|Overall Study|Lost to Follow-up|2|||
130477589|NCT03436290|469717391|FG000|Overall Study|Protocol Violation|30|||
130477590|NCT03436290|469717392|FG001|Overall Study|Protocol Violation|0|||
130477591|NCT04274764|469717393|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
130477592|NCT04274764|469717394|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
130477593|NCT02677298|469717399|FG000|Double Blind Phase|Adverse Event|2|||
130477594|NCT02677298|469717400|FG001|Double Blind Phase|Adverse Event|1|||
130477595|NCT02677298|469717401|FG002|Double Blind Phase|Adverse Event|0|||
130477596|NCT02677298|469717399|FG000|Double Blind Phase|Physician Decision|5|||
130477597|NCT02677298|469717400|FG001|Double Blind Phase|Physician Decision|0|||
130477598|NCT02677298|469717401|FG002|Double Blind Phase|Physician Decision|0|||
130477599|NCT02677298|469717399|FG000|Double Blind Phase|Lost to Follow-up|11|||
130477600|NCT02677298|469717400|FG001|Double Blind Phase|Lost to Follow-up|7|||
130477601|NCT02677298|469717401|FG002|Double Blind Phase|Lost to Follow-up|0|||
130477602|NCT02677298|469717399|FG000|Double Blind Phase|Withdrawal by Subject|11|||
130477603|NCT02677298|469717400|FG001|Double Blind Phase|Withdrawal by Subject|8|||
130477604|NCT02677298|469717401|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130477605|NCT02677298|469717399|FG000|Double Blind Phase|No study drug available at site|0|||
130477606|NCT02677298|469717400|FG001|Double Blind Phase|No study drug available at site|1|||
130477607|NCT02677298|469717401|FG002|Double Blind Phase|No study drug available at site|0|||
130477608|NCT02677298|469717399|FG000|Open Label Phase|Adverse Event|0|||
130477609|NCT02677298|469717400|FG001|Open Label Phase|Adverse Event|0|||
130477610|NCT02677298|469717401|FG002|Open Label Phase|Adverse Event|4|||
130477611|NCT02677298|469717399|FG000|Open Label Phase|Physician Decision|0|||
130477612|NCT02677298|469717400|FG001|Open Label Phase|Physician Decision|0|||
130477613|NCT02677298|469717401|FG002|Open Label Phase|Physician Decision|1|||
130477614|NCT02677298|469717399|FG000|Open Label Phase|Lost to Follow-up|0|||
130477615|NCT02677298|469717400|FG001|Open Label Phase|Lost to Follow-up|0|||
130477616|NCT02677298|469717401|FG002|Open Label Phase|Lost to Follow-up|17|||
130477617|NCT02677298|469717399|FG000|Open Label Phase|Withdrawal by Subject|0|||
130477618|NCT02677298|469717400|FG001|Open Label Phase|Withdrawal by Subject|0|||
130477619|NCT02677298|469717401|FG002|Open Label Phase|Withdrawal by Subject|38|||
130477620|NCT03611621|469717415|FG000|Overall Study|Graft loss|3|||
130477621|NCT03611621|469717415|FG000|Overall Study|Death|3|||
130477622|NCT03611621|469717415|FG000|Overall Study|Lost to Follow-up|1|||
130477623|NCT03039023|469717416|FG000|Overall Study|Withdrawal by Subject|1|||
130477624|NCT03039023|469717417|FG001|Overall Study|Withdrawal by Subject|0|||
130477625|NCT03039023|469717418|FG002|Overall Study|Withdrawal by Subject|1|||
130477626|NCT03039023|469717419|FG003|Overall Study|Withdrawal by Subject|1|||
130477627|NCT03039023|469717420|FG004|Overall Study|Withdrawal by Subject|0|||
130477628|NCT03039023|469717416|FG000|Overall Study|Physician Decision|0|||
130477629|NCT03039023|469717417|FG001|Overall Study|Physician Decision|0|||
130477630|NCT03039023|469717418|FG002|Overall Study|Physician Decision|0|||
130477631|NCT03039023|469717419|FG003|Overall Study|Physician Decision|1|||
130477632|NCT03039023|469717420|FG004|Overall Study|Physician Decision|0|||
130426656|NCT04085328|469522118|FG000|Overall Study|Physician Decision|0|||
130426657|NCT04085328|469522119|FG001|Overall Study|Physician Decision|1|||
130477633|NCT04130438|469717421|FG000|Overall Study|Lost to Follow-up|0|||
130477634|NCT04130438|469717422|FG001|Overall Study|Lost to Follow-up|0|||
130477635|NCT04130438|469717423|FG002|Overall Study|Lost to Follow-up|1|||
130477636|NCT05516147|469717427|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
130477637|NCT04764448|469717429|FG000|Overall Study|Study terminated by sponsor|2|||
130477638|NCT04764448|469717430|FG001|Overall Study|Study terminated by sponsor|2|||
130477639|NCT04764448|469717431|FG002|Overall Study|Study terminated by sponsor|5|||
130426658|NCT04085328|469522118|FG000|Overall Study|Pregnancy|0|||
130426659|NCT04085328|469522119|FG001|Overall Study|Pregnancy|1|||
130426660|NCT04085328|469522118|FG000|Overall Study|Reasons Related to COVID-19|5|||
130477640|NCT04764448|469717429|FG000|Overall Study|Withdrawal by Subject|3|||
130477641|NCT04764448|469717430|FG001|Overall Study|Withdrawal by Subject|3|||
130727669|NCT00425373|470625520|FG006|Overall Study|Lack of Efficacy|3|||
130727670|NCT00425373|470625521|FG007|Overall Study|Lack of Efficacy|0|||
130426661|NCT04085328|469522119|FG001|Overall Study|Reasons Related to COVID-19|8|||
130426662|NCT04085328|469522118|FG000|Overall Study|Did not meet inclusion criteria|1|||
130426663|NCT04085328|469522119|FG001|Overall Study|Did not meet inclusion criteria|1|||
130426664|NCT04085328|469522118|FG000|Overall Study|Early termination|1|||
130426665|NCT04085328|469522119|FG001|Overall Study|Early termination|0|||
130426666|NCT00514735|469522120|FG000|Overall Study|Withdrawal by Subject|13|||
130426667|NCT00514735|469522121|FG001|Overall Study|Withdrawal by Subject|5|||
130477642|NCT04764448|469717431|FG002|Overall Study|Withdrawal by Subject|1|||
130477643|NCT02924272|469717442|FG000|Overall Study|Site Terminated by Sponsor|4|||
130477644|NCT02924272|469717443|FG001|Overall Study|Site Terminated by Sponsor|1|||
130477645|NCT02924272|469717442|FG000|Overall Study|Withdrawal by Subject|2|||
130477646|NCT02924272|469717443|FG001|Overall Study|Withdrawal by Subject|0|||
130477647|NCT02924272|469717442|FG000|Overall Study|Adverse Event|3|||
130477648|NCT02924272|469717443|FG001|Overall Study|Adverse Event|0|||
130477649|NCT02924272|469717442|FG000|Overall Study|Progressive Disease|11|||
130477650|NCT02924272|469717443|FG001|Overall Study|Progressive Disease|8|||
130477651|NCT02924272|469717442|FG000|Overall Study|Clinical Deterioration|1|||
130477652|NCT02924272|469717443|FG001|Overall Study|Clinical Deterioration|0|||
130477653|NCT02924272|469717442|FG000|Overall Study|Death|1|||
130477654|NCT02924272|469717443|FG001|Overall Study|Death|0|||
130477655|NCT02924272|469717442|FG000|Overall Study|Reason Not Specified|1|||
130477656|NCT02924272|469717443|FG001|Overall Study|Reason Not Specified|0|||
130477657|NCT04952909|469717448|FG000|Overall Study|Death|3|||
130477658|NCT05308004|469717449|FG000|Overall Study|Not seen by Palliative Care NP|0|||
130477659|NCT05308004|469717450|FG001|Overall Study|Not seen by Palliative Care NP|1|||
130477660|NCT03575897|469717451|FG000|Overall Study|Lost to Follow-up|12|||
130477661|NCT03575897|469717452|FG001|Overall Study|Lost to Follow-up|13|||
130477662|NCT03652688|469717459|FG000|Baseline|Withdrawal by Subject|0|||
130477663|NCT03652688|469717460|FG001|Baseline|Withdrawal by Subject|3|||
130477664|NCT03652688|469717459|FG000|Follow-up|Lost to Follow-up|56|||
130477665|NCT03652688|469717460|FG001|Follow-up|Lost to Follow-up|54|||
130477666|NCT03468218|469717461|FG000|Overall Study|Adverse Event|5|||
130477667|NCT03468218|469717461|FG000|Overall Study|Progressive Disease|16|||
130477668|NCT03468218|469717461|FG000|Overall Study|Death|1|||
130477669|NCT03468218|469717461|FG000|Overall Study|Alternate therapy|1|||
130727671|NCT00425373|470625522|FG008|Overall Study|Lack of Efficacy|5|||
130727672|NCT01266031|470625524|FG000|Overall Study|Not treated|0|||
130727673|NCT01266031|470625525|FG001|Overall Study|Not treated|3|||
130727674|NCT01266031|470625526|FG002|Overall Study|Not treated|2|||
130727675|NCT01434810|470625527|FG000|Overall Study|Did not receive treatment|11|||
130727676|NCT01434810|470625528|FG001|Overall Study|Did not receive treatment|3|||
130727677|NCT01434810|470625527|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
130727678|NCT01434810|470625528|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
130727679|NCT04893018|470625530|FG000|Overall Study|Lost to Follow-up|1|||
130727680|NCT04893018|470625531|FG001|Overall Study|Lost to Follow-up|0|||
130727681|NCT04893018|470625530|FG000|Overall Study|Withdrawal by Subject|2|||
130727682|NCT04893018|470625531|FG001|Overall Study|Withdrawal by Subject|0|||
130727683|NCT04893018|470625530|FG000|Overall Study|Study Terminated|1|||
130727684|NCT04893018|470625531|FG001|Overall Study|Study Terminated|2|||
130727685|NCT02533180|470625535|FG000|Overall Study|Death|0|||
130727686|NCT02533180|470625536|FG001|Overall Study|Death|2|||
130426668|NCT00514735|469522120|FG000|Overall Study|Death|1|||
130426669|NCT00514735|469522121|FG001|Overall Study|Death|0|||
130426670|NCT00514735|469522120|FG000|Overall Study|Lost to Follow-up|0|||
130426671|NCT00514735|469522121|FG001|Overall Study|Lost to Follow-up|1|||
130426672|NCT01428076|469522132|FG000|Overall Study|Adverse Event|0|||
130477670|NCT03468218|469717461|FG000|Overall Study|Withdrawal by Subject|2|||
130477671|NCT03719443|469717462|FG000|Overall Study|Lost to Follow-up|0|||
130477672|NCT03719443|469717463|FG001|Overall Study|Lost to Follow-up|0|||
130477673|NCT03719443|469717464|FG002|Overall Study|Lost to Follow-up|1|||
130426673|NCT01428076|469522133|FG001|Overall Study|Adverse Event|1|||
130426674|NCT02216773|469522134|FG000|Overall Study|Disease progression|4|||
130477674|NCT03719443|469717465|FG003|Overall Study|Lost to Follow-up|0|||
130477675|NCT03719443|469717466|FG004|Overall Study|Lost to Follow-up|1|||
130477676|NCT03719443|469717467|FG005|Overall Study|Lost to Follow-up|0|||
130477677|NCT03719443|469717468|FG006|Overall Study|Lost to Follow-up|1|||
130477678|NCT03719443|469717462|FG000|Overall Study|Withdrawal by Subject|0|||
130477679|NCT03719443|469717463|FG001|Overall Study|Withdrawal by Subject|0|||
130477680|NCT03719443|469717464|FG002|Overall Study|Withdrawal by Subject|1|||
130477681|NCT03719443|469717465|FG003|Overall Study|Withdrawal by Subject|0|||
130477682|NCT03719443|469717466|FG004|Overall Study|Withdrawal by Subject|0|||
130727687|NCT02533180|470625535|FG000|Overall Study|Lost to Follow-up|0|||
130727688|NCT02533180|470625536|FG001|Overall Study|Lost to Follow-up|1|||
130727689|NCT02533180|470625535|FG000|Overall Study|Physician Decision|0|||
130727690|NCT02533180|470625536|FG001|Overall Study|Physician Decision|1|||
130727691|NCT02533180|470625535|FG000|Overall Study|Withdrawal by Subject|2|||
130477683|NCT03719443|469717467|FG005|Overall Study|Withdrawal by Subject|0|||
130426675|NCT02216773|469522135|FG001|Overall Study|Disease progression|2|||
130426676|NCT02216773|469522134|FG000|Overall Study|Insufficient FLRV|4|||
130426677|NCT02216773|469522135|FG001|Overall Study|Insufficient FLRV|0|||
130426678|NCT02216773|469522134|FG000|Overall Study|Abandoned|4|||
130426679|NCT02216773|469522135|FG001|Overall Study|Abandoned|3|||
130564799|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130564800|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130564801|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130564802|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
130564803|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
130564804|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
130564805|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
130564806|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130564807|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130564808|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130564809|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130564810|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
130564811|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130564812|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130564813|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130564814|NCT01940471|470033755|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
130564815|NCT01940471|470033756|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
130564816|NCT01940471|470033757|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
130564817|NCT01940471|470033758|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
130564818|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130564819|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130564820|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
130564821|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
130564822|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130564823|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130564824|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
130564825|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
130564826|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130564827|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130564828|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
130727692|NCT02533180|470625536|FG001|Overall Study|Withdrawal by Subject|5|||
130727693|NCT02533180|470625535|FG000|Overall Study|Screen Failure|37|||
130727694|NCT02533180|470625536|FG001|Overall Study|Screen Failure|0|||
130727695|NCT02533180|470625535|FG000|Overall Study|Protocol Deviation|0|||
130727696|NCT02533180|470625536|FG001|Overall Study|Protocol Deviation|1|||
130426680|NCT04274894|469522136|FG000|Overall Study|Adverse Event|7|||
130426681|NCT04274894|469522136|FG000|Overall Study|Withdrew consent|5|||
130426682|NCT04274894|469522136|FG000|Overall Study|Lost to Follow-up|9|||
130426683|NCT04274894|469522136|FG000|Overall Study|COVID-19 infection|1|||
130426684|NCT04274894|469522136|FG000|Overall Study|Other, not specified|20|||
130426685|NCT01936857|469522137|FG000|Overall Study|Sent to prison or 06 center|11|||
130426686|NCT01936857|469522138|FG001|Overall Study|Sent to prison or 06 center|12|||
130426687|NCT01936857|469522137|FG000|Overall Study|Lost to Follow-up|10|||
130426688|NCT01936857|469522138|FG001|Overall Study|Lost to Follow-up|7|||
130426689|NCT01936857|469522137|FG000|Overall Study|Death|7|||
130426690|NCT01936857|469522138|FG001|Overall Study|Death|3|||
130426691|NCT01936857|469522137|FG000|Overall Study|Moved|2|||
130426692|NCT01936857|469522138|FG001|Overall Study|Moved|1|||
130426693|NCT01936857|469522137|FG000|Overall Study|Withdrawal by Subject|1|||
130477684|NCT03719443|469717468|FG006|Overall Study|Withdrawal by Subject|0|||
130477685|NCT04924660|469717469|FG000|United States|Death|29|||
130477686|NCT04924660|469717470|FG001|United States|Death|32|||
130477687|NCT04924660|469717471|FG002|United States|Death|34|||
130477688|NCT04924660|469717472|FG003|United States|Death|25|||
130477689|NCT04924660|469717473|FG004|United States|Death|26|||
130477690|NCT04924660|469717474|FG005|United States|Death|23|||
130477691|NCT04924660|469717469|FG000|United States|Lost to Follow-up|15|||
130477692|NCT04924660|469717470|FG001|United States|Lost to Follow-up|10|||
130477693|NCT04924660|469717471|FG002|United States|Lost to Follow-up|13|||
130477694|NCT04924660|469717472|FG003|United States|Lost to Follow-up|5|||
130426694|NCT01936857|469522138|FG001|Overall Study|Withdrawal by Subject|0|||
130727697|NCT02533180|470625535|FG000|Overall Study|Non-compliance|0|||
130426695|NCT01936857|469522137|FG000|Overall Study|Side effect of medication|1|||
130477695|NCT04924660|469717473|FG004|United States|Lost to Follow-up|19|||
130477696|NCT04924660|469717474|FG005|United States|Lost to Follow-up|20|||
130477697|NCT04924660|469717469|FG000|United States|Withdrawal by Subject|8|||
130727698|NCT02533180|470625536|FG001|Overall Study|Non-compliance|1|||
130477698|NCT04924660|469717470|FG001|United States|Withdrawal by Subject|3|||
130477699|NCT04924660|469717471|FG002|United States|Withdrawal by Subject|3|||
130477700|NCT04924660|469717472|FG003|United States|Withdrawal by Subject|3|||
130477701|NCT04924660|469717473|FG004|United States|Withdrawal by Subject|8|||
130477702|NCT04924660|469717474|FG005|United States|Withdrawal by Subject|4|||
130477703|NCT04924660|469717469|FG000|Spain|Death|0|||
130477704|NCT04924660|469717470|FG001|Spain|Death|0|||
130426696|NCT01936857|469522138|FG001|Overall Study|Side effect of medication|0|||
130426697|NCT01936857|469522137|FG000|Overall Study|Other|2|||
130426698|NCT01936857|469522138|FG001|Overall Study|Other|2|||
130426699|NCT02279043|469522139|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
130426700|NCT02279043|469522140|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
130426701|NCT02279043|469522141|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
130426702|NCT02279043|469522139|FG000|Overall Study|Lost to Follow-up|46|||
130426703|NCT02279043|469522140|FG001|Overall Study|Lost to Follow-up|88|||
130426704|NCT02279043|469522141|FG002|Overall Study|Lost to Follow-up|0|||
130426705|NCT02124265|469522142|FG000|Overall Study|Adverse Event|1|||
130426706|NCT00490282|469522143|FG000|Overall Study|Withdrawal by Subject|3|||
130426707|NCT01666808|469522144|FG000|Overall Study|Lost to Follow-up|9|||
130426708|NCT01666808|469522145|FG001|Overall Study|Lost to Follow-up|15|||
130426709|NCT01666808|469522144|FG000|Overall Study|Withdrawal by Subject|3|||
130426710|NCT01666808|469522145|FG001|Overall Study|Withdrawal by Subject|1|||
130426711|NCT01666808|469522144|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
130426712|NCT01666808|469522145|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
130426713|NCT01525602|469522146|FG000|Overall Study|Adverse Event|1|||
130426714|NCT01525602|469522147|FG001|Overall Study|Adverse Event|0|||
130426715|NCT01525602|469522148|FG002|Overall Study|Adverse Event|1|||
130426716|NCT01525602|469522149|FG003|Overall Study|Adverse Event|1|||
130426717|NCT01525602|469522150|FG004|Overall Study|Adverse Event|3|||
130426718|NCT01525602|469522151|FG005|Overall Study|Adverse Event|3|||
130426719|NCT01525602|469522152|FG006|Overall Study|Adverse Event|0|||
130426720|NCT01525602|469522153|FG007|Overall Study|Adverse Event|1|||
130426721|NCT01525602|469522146|FG000|Overall Study|Disease progression|6|||
130426722|NCT01525602|469522147|FG001|Overall Study|Disease progression|3|||
130477705|NCT04924660|469717471|FG002|Spain|Death|0|||
130477706|NCT04924660|469717472|FG003|Spain|Death|0|||
130477707|NCT04924660|469717473|FG004|Spain|Death|0|||
130477708|NCT04924660|469717474|FG005|Spain|Death|2|||
130477709|NCT04924660|469717469|FG000|Spain|Lost to Follow-up|0|||
130477710|NCT04924660|469717470|FG001|Spain|Lost to Follow-up|0|||
130477711|NCT04924660|469717471|FG002|Spain|Lost to Follow-up|0|||
130477712|NCT04924660|469717472|FG003|Spain|Lost to Follow-up|0|||
130477713|NCT04924660|469717473|FG004|Spain|Lost to Follow-up|1|||
130477714|NCT04924660|469717474|FG005|Spain|Lost to Follow-up|0|||
130477715|NCT04924660|469717469|FG000|Brazil|Death|0|||
130477716|NCT04924660|469717470|FG001|Brazil|Death|0|||
130477717|NCT04924660|469717471|FG002|Brazil|Death|0|||
130477718|NCT04924660|469717472|FG003|Brazil|Death|0|||
130477719|NCT04924660|469717473|FG004|Brazil|Death|1|||
130477720|NCT04924660|469717474|FG005|Brazil|Death|0|||
130477721|NCT04924660|469717469|FG000|Italy|Lost to Follow-up|0|||
130477722|NCT04924660|469717470|FG001|Italy|Lost to Follow-up|0|||
130477723|NCT04924660|469717471|FG002|Italy|Lost to Follow-up|0|||
130477724|NCT04924660|469717472|FG003|Italy|Lost to Follow-up|0|||
130477725|NCT04924660|469717473|FG004|Italy|Lost to Follow-up|0|||
130477726|NCT04924660|469717474|FG005|Italy|Lost to Follow-up|1|||
130477727|NCT04924660|469717469|FG000|South Africa|Death|0|||
130477728|NCT04924660|469717470|FG001|South Africa|Death|0|||
130477729|NCT04924660|469717471|FG002|South Africa|Death|0|||
130477730|NCT04924660|469717472|FG003|South Africa|Death|0|||
130477731|NCT04924660|469717473|FG004|South Africa|Death|0|||
130477732|NCT04924660|469717474|FG005|South Africa|Death|1|||
130477733|NCT04924660|469717469|FG000|South Africa|Lost to Follow-up|0|||
130564829|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
130564830|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
130727699|NCT00447876|470625537|FG000|Overall Study|Withdrawal by Subject|1|||
130564831|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
130727700|NCT00447876|470625538|FG001|Overall Study|Withdrawal by Subject|4|||
130727701|NCT00447876|470625537|FG000|Overall Study|Lost to Follow-up|1|||
130727702|NCT00447876|470625538|FG001|Overall Study|Lost to Follow-up|0|||
130477734|NCT04924660|469717470|FG001|South Africa|Lost to Follow-up|0|||
130477735|NCT04924660|469717471|FG002|South Africa|Lost to Follow-up|0|||
130477736|NCT04924660|469717472|FG003|South Africa|Lost to Follow-up|0|||
130477737|NCT04924660|469717473|FG004|South Africa|Lost to Follow-up|0|||
130477738|NCT04924660|469717474|FG005|South Africa|Lost to Follow-up|1|||
130477739|NCT06205407|469717475|FG000|Period 2|Withdrawal by Subject|0|||
130477740|NCT06205407|469717476|FG001|Period 2|Withdrawal by Subject|1|||
130477741|NCT06205407|469717475|FG000|Period 2|Adverse Event|2|||
130477742|NCT06205407|469717476|FG001|Period 2|Adverse Event|1|||
130477743|NCT04676022|469717478|FG000|Overall Study|Screen Failure/|1|||
130477744|NCT04676022|469717479|FG001|Overall Study|Screen Failure/|1|||
130477745|NCT04676022|469717480|FG002|Overall Study|Screen Failure/|85|||
130426723|NCT01525602|469522148|FG002|Overall Study|Disease progression|2|||
130426724|NCT01525602|469522149|FG003|Overall Study|Disease progression|5|||
130426725|NCT01525602|469522150|FG004|Overall Study|Disease progression|22|||
130426726|NCT01525602|469522151|FG005|Overall Study|Disease progression|2|||
130426727|NCT01525602|469522152|FG006|Overall Study|Disease progression|3|||
130426728|NCT01525602|469522153|FG007|Overall Study|Disease progression|3|||
130426729|NCT01525602|469522146|FG000|Overall Study|Clinical progression|2|||
130426730|NCT01525602|469522147|FG001|Overall Study|Clinical progression|0|||
130426731|NCT01525602|469522148|FG002|Overall Study|Clinical progression|0|||
130426732|NCT01525602|469522149|FG003|Overall Study|Clinical progression|0|||
130426733|NCT01525602|469522150|FG004|Overall Study|Clinical progression|0|||
130426734|NCT01525602|469522151|FG005|Overall Study|Clinical progression|0|||
130426735|NCT01525602|469522152|FG006|Overall Study|Clinical progression|1|||
130426736|NCT01525602|469522153|FG007|Overall Study|Clinical progression|1|||
130426737|NCT01525602|469522146|FG000|Overall Study|Non-compliance|0|||
130426738|NCT01525602|469522147|FG001|Overall Study|Non-compliance|0|||
130426739|NCT01525602|469522148|FG002|Overall Study|Non-compliance|0|||
130426740|NCT01525602|469522149|FG003|Overall Study|Non-compliance|0|||
130426741|NCT01525602|469522150|FG004|Overall Study|Non-compliance|1|||
130426742|NCT01525602|469522151|FG005|Overall Study|Non-compliance|0|||
130426743|NCT01525602|469522152|FG006|Overall Study|Non-compliance|0|||
130426744|NCT01525602|469522153|FG007|Overall Study|Non-compliance|0|||
130426745|NCT01525602|469522146|FG000|Overall Study|Withdrawal by Subject|0|||
130426746|NCT01525602|469522147|FG001|Overall Study|Withdrawal by Subject|0|||
130426747|NCT01525602|469522148|FG002|Overall Study|Withdrawal by Subject|0|||
130426748|NCT01525602|469522149|FG003|Overall Study|Withdrawal by Subject|0|||
130426749|NCT01525602|469522150|FG004|Overall Study|Withdrawal by Subject|3|||
130426750|NCT01525602|469522151|FG005|Overall Study|Withdrawal by Subject|1|||
130426751|NCT01525602|469522152|FG006|Overall Study|Withdrawal by Subject|0|||
130426752|NCT01525602|469522153|FG007|Overall Study|Withdrawal by Subject|1|||
130426753|NCT01525602|469522146|FG000|Overall Study|Physician Decision|0|||
130426754|NCT01525602|469522147|FG001|Overall Study|Physician Decision|0|||
130426755|NCT01525602|469522148|FG002|Overall Study|Physician Decision|0|||
130426756|NCT01525602|469522149|FG003|Overall Study|Physician Decision|0|||
130426757|NCT01525602|469522150|FG004|Overall Study|Physician Decision|3|||
130426758|NCT01525602|469522151|FG005|Overall Study|Physician Decision|0|||
130426759|NCT01525602|469522152|FG006|Overall Study|Physician Decision|1|||
130426760|NCT01525602|469522153|FG007|Overall Study|Physician Decision|0|||
130426761|NCT01525602|469522146|FG000|Overall Study|Death|0|||
130426762|NCT01525602|469522147|FG001|Overall Study|Death|0|||
130426763|NCT01525602|469522148|FG002|Overall Study|Death|0|||
130426764|NCT01525602|469522149|FG003|Overall Study|Death|0|||
130426765|NCT01525602|469522150|FG004|Overall Study|Death|1|||
130426766|NCT01525602|469522151|FG005|Overall Study|Death|1|||
130426767|NCT01525602|469522152|FG006|Overall Study|Death|0|||
130426768|NCT01525602|469522153|FG007|Overall Study|Death|0|||
130426769|NCT01525602|469522146|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426770|NCT01525602|469522147|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426771|NCT01525602|469522148|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426772|NCT01525602|469522149|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426773|NCT01525602|469522150|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426774|NCT01525602|469522151|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
130426775|NCT01525602|469522152|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
130426776|NCT01525602|469522153|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
130426777|NCT01194570|469523749|FG000|Overall Study|Adverse Event|22|||
130426778|NCT01194570|469523750|FG001|Overall Study|Adverse Event|40|||
130426779|NCT01194570|469523749|FG000|Overall Study|Death|6|||
130426780|NCT01194570|469523750|FG001|Overall Study|Death|20|||
130426781|NCT01194570|469523749|FG000|Overall Study|Lack of Efficacy|32|||
130426782|NCT01194570|469523750|FG001|Overall Study|Lack of Efficacy|33|||
130426783|NCT01194570|469523749|FG000|Overall Study|Lost to Follow-up|4|||
130426784|NCT01194570|469523750|FG001|Overall Study|Lost to Follow-up|15|||
130426785|NCT01194570|469523749|FG000|Overall Study|Non-Compliance|2|||
130426786|NCT01194570|469523750|FG001|Overall Study|Non-Compliance|2|||
130426787|NCT01194570|469523749|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130426788|NCT01194570|469523750|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130426789|NCT01194570|469523749|FG000|Overall Study|Other|18|||
130477746|NCT04676022|469717478|FG000|Overall Study|Lost to Follow-up|1|||
130426790|NCT01194570|469523750|FG001|Overall Study|Other|47|||
130426791|NCT01194570|469523749|FG000|Overall Study|Physician Decision|10|||
130426792|NCT01194570|469523750|FG001|Overall Study|Physician Decision|25|||
130426793|NCT01194570|469523749|FG000|Overall Study|Protocol Violation|1|||
130426794|NCT01194570|469523750|FG001|Overall Study|Protocol Violation|2|||
130426795|NCT01194570|469523749|FG000|Overall Study|Study Terminated By Sponsor|0|||
130426796|NCT01194570|469523750|FG001|Overall Study|Study Terminated By Sponsor|1|||
130426797|NCT01194570|469523749|FG000|Overall Study|Withdrawal by Subject|57|||
130426798|NCT01194570|469523750|FG001|Overall Study|Withdrawal by Subject|82|||
130477747|NCT04676022|469717479|FG001|Overall Study|Lost to Follow-up|1|||
130426799|NCT01194570|469523749|FG000|Overall Study|Pregnancy|1|||
130426800|NCT01194570|469523750|FG001|Overall Study|Pregnancy|1|||
130426801|NCT03076970|469523754|FG000|Washout Period 2|Adverse Event|0|||
130426802|NCT03076970|469523755|FG001|Washout Period 2|Adverse Event|0|||
130426803|NCT03076970|469523756|FG002|Washout Period 2|Adverse Event|0|||
130426804|NCT03076970|469523757|FG003|Washout Period 2|Adverse Event|0|||
130426805|NCT03076970|469523758|FG004|Washout Period 2|Adverse Event|1|||
130426806|NCT03076970|469523759|FG005|Washout Period 2|Adverse Event|0|||
130426807|NCT03076970|469523754|FG000|Period 3|Withdrawal by Subject|0|||
130426808|NCT03076970|469523755|FG001|Period 3|Withdrawal by Subject|0|||
130426809|NCT03076970|469523756|FG002|Period 3|Withdrawal by Subject|0|||
130426810|NCT03076970|469523757|FG003|Period 3|Withdrawal by Subject|0|||
130426811|NCT03076970|469523758|FG004|Period 3|Withdrawal by Subject|0|||
130426812|NCT03076970|469523759|FG005|Period 3|Withdrawal by Subject|1|||
130426813|NCT03076970|469523754|FG000|Period 3|Failure to meet I/E criteria|0|||
130426814|NCT03076970|469523755|FG001|Period 3|Failure to meet I/E criteria|0|||
130426815|NCT03076970|469523756|FG002|Period 3|Failure to meet I/E criteria|0|||
130426816|NCT03076970|469523757|FG003|Period 3|Failure to meet I/E criteria|0|||
130426817|NCT03076970|469523758|FG004|Period 3|Failure to meet I/E criteria|1|||
130426818|NCT03076970|469523759|FG005|Period 3|Failure to meet I/E criteria|0|||
130426819|NCT02543658|469523760|FG000|Overall Study|Lack of Efficacy|0|||
130426820|NCT02543658|469523761|FG001|Overall Study|Lack of Efficacy|4|||
130426821|NCT00789815|469523762|FG000|Overall Study|Protocol Violation|6|||
130426822|NCT00789815|469523763|FG001|Overall Study|Protocol Violation|1|||
130426823|NCT00789815|469523762|FG000|Overall Study|Intubation due to massive bleeding|1|||
130426824|NCT00789815|469523763|FG001|Overall Study|Intubation due to massive bleeding|0|||
130426825|NCT02035332|469523764|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
130426826|NCT00662857|469523765|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
130426827|NCT00662857|469523766|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
130426828|NCT00662857|469523765|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
130426829|NCT00662857|469523766|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
130426830|NCT00662857|469523765|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
130426831|NCT00662857|469523766|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
130426832|NCT03966053|469523767|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
130426833|NCT01332227|469523769|FG000|Overall Study|Adverse Event|4|||
130426834|NCT01332227|469523770|FG001|Overall Study|Adverse Event|1|||
130426835|NCT01332227|469523769|FG000|Overall Study|Withdrawal by Subject|5|||
130426836|NCT01332227|469523770|FG001|Overall Study|Withdrawal by Subject|1|||
130426837|NCT01332227|469523769|FG000|Overall Study|Lost to Follow-up|2|||
130426838|NCT01332227|469523770|FG001|Overall Study|Lost to Follow-up|0|||
130426839|NCT01332227|469523769|FG000|Overall Study|Lack of Efficacy|3|||
130426840|NCT01332227|469523770|FG001|Overall Study|Lack of Efficacy|1|||
130426841|NCT01332227|469523769|FG000|Overall Study|Poor compliance/noncompliance|1|||
130426842|NCT01332227|469523770|FG001|Overall Study|Poor compliance/noncompliance|1|||
130426843|NCT01332227|469523769|FG000|Overall Study|Patient moved from area|1|||
130426844|NCT01332227|469523770|FG001|Overall Study|Patient moved from area|0|||
130426845|NCT01332227|469523769|FG000|Overall Study|Patient began prohibited medication|0|||
130426846|NCT01332227|469523770|FG001|Overall Study|Patient began prohibited medication|1|||
130426847|NCT00514943|469523771|FG000|Stage 1|Progressive disease|4|||
130426848|NCT00514943|469523772|FG001|Stage 1|Progressive disease|8|||
130426849|NCT00514943|469523771|FG000|Stage 1|Other Adverse Event|16|||
130426850|NCT00514943|469523772|FG001|Stage 1|Other Adverse Event|6|||
130426851|NCT00514943|469523771|FG000|Stage 1|Not treated|1|||
130426852|NCT00514943|469523772|FG001|Stage 1|Not treated|2|||
130426853|NCT00514943|469523771|FG000|Stage 1|Patient refused to continue study meds|8|||
130426854|NCT00514943|469523772|FG001|Stage 1|Patient refused to continue study meds|3|||
130426855|NCT00514943|469523771|FG000|Stage 1|Other than stated above|1|||
130426856|NCT00514943|469523772|FG001|Stage 1|Other than stated above|7|||
130426857|NCT00514943|469523771|FG000|Stage 2|Progressive disease|27|||
130426858|NCT00514943|469523772|FG001|Stage 2|Progressive disease|24|||
130426859|NCT00514943|469523771|FG000|Stage 2|Other Adverse Event|3|||
130564832|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
130648303|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
130426860|NCT00514943|469523772|FG001|Stage 2|Other Adverse Event|10|||
130426861|NCT00514943|469523771|FG000|Stage 2|Patient refused to continue study meds|2|||
130426862|NCT00514943|469523772|FG001|Stage 2|Patient refused to continue study meds|0|||
130426863|NCT00514943|469523771|FG000|Stage 2|Other than stated above|0|||
130426864|NCT00514943|469523772|FG001|Stage 2|Other than stated above|2|||
130426865|NCT01783418|469523777|FG000|Overall Study|Withdrawal by Subject|1|||
130426866|NCT01783418|469523778|FG001|Overall Study|Withdrawal by Subject|0|||
130426867|NCT03548207|469523779|FG000|Overall Study|Death|10|||
130426868|NCT03548207|469523780|FG001|Overall Study|Death|23|||
130426869|NCT03548207|469523781|FG002|Overall Study|Death|3|||
130426870|NCT03548207|469523779|FG000|Overall Study|Lost to Follow-up|0|||
130426871|NCT03548207|469523780|FG001|Overall Study|Lost to Follow-up|2|||
130426872|NCT03548207|469523781|FG002|Overall Study|Lost to Follow-up|0|||
130426873|NCT03548207|469523779|FG000|Overall Study|Withdrawal by Subject|0|||
130477748|NCT04676022|469717480|FG002|Overall Study|Lost to Follow-up|0|||
130477749|NCT04676022|469717478|FG000|Overall Study|Adverse Event|2|||
130477750|NCT04676022|469717479|FG001|Overall Study|Adverse Event|0|||
130477751|NCT04676022|469717480|FG002|Overall Study|Adverse Event|1|||
130477752|NCT04676022|469717478|FG000|Overall Study|Physician Decision|2|||
130477753|NCT04676022|469717479|FG001|Overall Study|Physician Decision|0|||
130477754|NCT04676022|469717480|FG002|Overall Study|Physician Decision|1|||
130477755|NCT04676022|469717478|FG000|Overall Study|Withdrawal by Subject|3|||
130477756|NCT04676022|469717479|FG001|Overall Study|Withdrawal by Subject|1|||
130477757|NCT04676022|469717480|FG002|Overall Study|Withdrawal by Subject|6|||
130477758|NCT04676022|469717478|FG000|Overall Study|Will not move forward with permanent implant|6|||
130477759|NCT04676022|469717479|FG001|Overall Study|Will not move forward with permanent implant|0|||
130477760|NCT04676022|469717480|FG002|Overall Study|Will not move forward with permanent implant|0|||
130477761|NCT04676022|469717478|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
130477762|NCT04676022|469717479|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
130477763|NCT04676022|469717480|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
130477764|NCT05409183|469717484|FG000|Complete Study|Adverse Event|1|||
130477765|NCT05409183|469717485|FG001|Complete Study|Adverse Event|2|||
130477766|NCT05409183|469717484|FG000|Complete Study|Withdrawal by Subject|3|||
130477767|NCT05409183|469717485|FG001|Complete Study|Withdrawal by Subject|0|||
130477768|NCT02274662|469717486|FG000|Overall Study|Death|1|||
130477769|NCT02274662|469717486|FG000|Overall Study|Lost to Follow-up|3|||
130477770|NCT03194217|469717487|FG000|Overall Study|Adverse Event|0|||
130477771|NCT03194217|469717488|FG001|Overall Study|Adverse Event|2|||
130477772|NCT03194217|469717489|FG002|Overall Study|Adverse Event|3|||
130477773|NCT03194217|469717490|FG003|Overall Study|Adverse Event|3|||
130477774|NCT03194217|469717487|FG000|Overall Study|Failure to meet randomisation criteria|0|||
130477775|NCT03194217|469717488|FG001|Overall Study|Failure to meet randomisation criteria|0|||
130477776|NCT03194217|469717489|FG002|Overall Study|Failure to meet randomisation criteria|0|||
130477777|NCT03194217|469717490|FG003|Overall Study|Failure to meet randomisation criteria|1|||
130477778|NCT03194217|469717487|FG000|Overall Study|Other|0|||
130477779|NCT03194217|469717488|FG001|Overall Study|Other|1|||
130477780|NCT03194217|469717489|FG002|Overall Study|Other|1|||
130477781|NCT03194217|469717490|FG003|Overall Study|Other|0|||
130477782|NCT02936752|469717491|FG000|Overall Study|Death|2|||
130477783|NCT02936752|469717492|FG001|Overall Study|Death|1|||
130477784|NCT02936752|469717491|FG000|Overall Study|Physician Decision|4|||
130477785|NCT02936752|469717492|FG001|Overall Study|Physician Decision|0|||
130477786|NCT02936752|469717491|FG000|Overall Study|Withdrawal by Subject|0|||
130477787|NCT02936752|469717492|FG001|Overall Study|Withdrawal by Subject|2|||
130477788|NCT04489771|469717493|FG000|Overall Study|Death|27|||
130477789|NCT04489771|469717494|FG001|Overall Study|Death|25|||
130477790|NCT04489771|469717493|FG000|Overall Study|Withdrawal by Subject|1|||
130477791|NCT04489771|469717494|FG001|Overall Study|Withdrawal by Subject|0|||
130477792|NCT04489771|469717493|FG000|Overall Study|Participants Ongoing in Study|50|||
130477793|NCT04489771|469717494|FG001|Overall Study|Participants Ongoing in Study|51|||
130477794|NCT02761057|469717503|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
130477795|NCT02761057|469717504|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
130477796|NCT02761057|469717505|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
130477797|NCT02761057|469717506|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
130477798|NCT02761057|469717503|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
130477799|NCT02761057|469717504|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
130477800|NCT02761057|469717505|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
130564833|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
130426874|NCT03548207|469523780|FG001|Overall Study|Withdrawal by Subject|3|||
130426875|NCT03548207|469523781|FG002|Overall Study|Withdrawal by Subject|0|||
130426876|NCT03548207|469523779|FG000|Overall Study|Sponsor decision|19|||
130426877|NCT03548207|469523780|FG001|Overall Study|Sponsor decision|40|||
130426878|NCT03548207|469523781|FG002|Overall Study|Sponsor decision|6|||
130426879|NCT03548207|469523779|FG000|Overall Study|Randomized but not treated|6|||
130426880|NCT03548207|469523780|FG001|Overall Study|Randomized but not treated|10|||
130426881|NCT03548207|469523781|FG002|Overall Study|Randomized but not treated|4|||
130426882|NCT00999466|469523782|FG000|Main Part|Withdrawal by Subject|0|||
130426883|NCT00999466|469523783|FG001|Main Part|Withdrawal by Subject|0|||
130426884|NCT00999466|469523784|FG002|Main Part|Withdrawal by Subject|2|||
130426885|NCT00999466|469523782|FG000|Main Part|Adverse Event|0|||
130477801|NCT02761057|469717506|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
130477802|NCT02761057|469717503|FG000|Overall Study|Currently On Study Treatment|0|||
130477803|NCT02761057|469717504|FG001|Overall Study|Currently On Study Treatment|3|||
130477804|NCT02761057|469717505|FG002|Overall Study|Currently On Study Treatment|0|||
130477805|NCT02761057|469717506|FG003|Overall Study|Currently On Study Treatment|0|||
130477806|NCT02761057|469717503|FG000|Overall Study|Adverse Event|11|||
130426886|NCT00999466|469523783|FG001|Main Part|Adverse Event|4|||
130426887|NCT00999466|469523784|FG002|Main Part|Adverse Event|2|||
130727703|NCT00447876|470625537|FG000|Overall Study|Deterioration of symptomology|1|||
130727704|NCT00447876|470625538|FG001|Overall Study|Deterioration of symptomology|0|||
130727705|NCT00005957|470625541|FG000|Overall Study|No treated|3|||
130727706|NCT00005957|470625542|FG001|Overall Study|No treated|9|||
130727707|NCT00005957|470625541|FG000|Overall Study|Crossover to the other arm|5|||
130727708|NCT00005957|470625542|FG001|Overall Study|Crossover to the other arm|19|||
130727709|NCT01609023|470625543|FG000|Overall Study|Lack of Efficacy|3|||
130727710|NCT01609023|470625543|FG000|Overall Study|Withdrawal by Subject|4|||
130426888|NCT03040713|469523785|FG000|Overall Study|Positive amyloid scan|3|||
130426889|NCT02563002|469523786|FG000|Overall Study|Death|72|||
130426890|NCT02563002|469523787|FG001|Overall Study|Death|87|||
130426891|NCT02563002|469523786|FG000|Overall Study|Lost to Follow-up|5|||
130426892|NCT02563002|469523787|FG001|Overall Study|Lost to Follow-up|0|||
130426893|NCT02563002|469523786|FG000|Overall Study|Physician Decision|0|||
130426894|NCT02563002|469523787|FG001|Overall Study|Physician Decision|2|||
130426895|NCT02563002|469523786|FG000|Overall Study|Withdrawal by Subject|2|||
130426896|NCT02563002|469523787|FG001|Overall Study|Withdrawal by Subject|10|||
130426897|NCT02563002|469523786|FG000|Overall Study|Sponsor decision|74|||
130426898|NCT02563002|469523787|FG001|Overall Study|Sponsor decision|55|||
130426899|NCT03466086|469523788|FG000|Period 1|Sponsor decision due to study timeline|1|||
130426900|NCT03466086|469523789|FG001|Period 1|Sponsor decision due to study timeline|0|||
130426901|NCT03466086|469523788|FG000|Period 1|Withdrawal by Subject|1|||
130426902|NCT03466086|469523789|FG001|Period 1|Withdrawal by Subject|0|||
130426903|NCT00595504|469523790|FG000|Overall Study|Withdrawal by Subject|1|||
130426904|NCT00595504|469523791|FG001|Overall Study|Withdrawal by Subject|3|||
130426905|NCT00595504|469523790|FG000|Overall Study|Physician Decision|1|||
130426906|NCT00595504|469523791|FG001|Overall Study|Physician Decision|0|||
130426907|NCT01949870|469523792|FG000|Overall Study|Lack of Efficacy|2|||
130426908|NCT01949870|469523792|FG000|Overall Study|Adverse Event|1|||
130426909|NCT01949870|469523792|FG000|Overall Study|Study termination|1|||
130426910|NCT01949870|469523792|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
130426911|NCT00677352|469523793|FG000|Treatment Phase|Adverse Event|14|||
130426912|NCT00677352|469523794|FG001|Treatment Phase|Adverse Event|22|||
130426913|NCT00677352|469523793|FG000|Treatment Phase|Lack of Efficacy|2|||
130426914|NCT00677352|469523794|FG001|Treatment Phase|Lack of Efficacy|3|||
130426915|NCT00677352|469523793|FG000|Treatment Phase|Lost to Follow-up|0|||
130426916|NCT00677352|469523794|FG001|Treatment Phase|Lost to Follow-up|1|||
130426917|NCT00677352|469523793|FG000|Treatment Phase|Withdrawal by Subject|7|||
130426918|NCT00677352|469523794|FG001|Treatment Phase|Withdrawal by Subject|7|||
130426919|NCT00677352|469523793|FG000|Treatment Phase|Physician Decision|1|||
130426920|NCT00677352|469523794|FG001|Treatment Phase|Physician Decision|0|||
130426921|NCT00677352|469523793|FG000|Treatment Phase|Pregnancy|0|||
130426922|NCT00677352|469523794|FG001|Treatment Phase|Pregnancy|1|||
130426923|NCT00677352|469523793|FG000|Treatment Phase|Protocol Violation|1|||
130426924|NCT00677352|469523794|FG001|Treatment Phase|Protocol Violation|1|||
130426925|NCT00677352|469523793|FG000|Treatment Phase|Transference or work related matter|0|||
130426926|NCT00677352|469523794|FG001|Treatment Phase|Transference or work related matter|5|||
130426927|NCT00677352|469523793|FG000|Treatment Phase|Not treated|0|||
130426928|NCT00677352|469523794|FG001|Treatment Phase|Not treated|2|||
130426929|NCT00677352|469523793|FG000|Tapering Phase|Adverse Event|1|||
130426930|NCT00677352|469523794|FG001|Tapering Phase|Adverse Event|5|||
130426931|NCT00677352|469523793|FG000|Tapering Phase|Withdrawal by Subject|5|||
130426932|NCT00677352|469523794|FG001|Tapering Phase|Withdrawal by Subject|3|||
130426933|NCT00677352|469523793|FG000|Tapering Phase|Pregnancy|0|||
130426934|NCT00677352|469523794|FG001|Tapering Phase|Pregnancy|1|||
130426935|NCT00677352|469523793|FG000|Tapering Phase|Job transfer|0|||
130426936|NCT00677352|469523794|FG001|Tapering Phase|Job transfer|1|||
130426937|NCT02182973|469523795|FG000|Overall Study|Withdrawal by Subject|3|||
130426938|NCT02182973|469523796|FG001|Overall Study|Withdrawal by Subject|0|||
130426939|NCT01123382|469523797|FG000|Overall Study|Withdrawal by Subject|1|||
130426940|NCT01123382|469523798|FG001|Overall Study|Withdrawal by Subject|4|||
130426941|NCT01123382|469523797|FG000|Overall Study|Lost to Follow-up|1|||
130426942|NCT01123382|469523798|FG001|Overall Study|Lost to Follow-up|2|||
130426943|NCT00594854|469523799|FG000|Overall Study|Study terminated|7|||
130426944|NCT00594854|469523800|FG001|Overall Study|Study terminated|10|||
130426945|NCT00569582|469523801|FG000|Overall Study|Withdrawal by Subject|5|||
130426946|NCT00569582|469523801|FG000|Overall Study|Death|2|||
130564834|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130727711|NCT01609023|470625543|FG000|Overall Study|Lost to Follow-up|8|||
130426947|NCT00569582|469523801|FG000|Overall Study|Adverse Event|7|||
130426948|NCT00569582|469523801|FG000|Overall Study|Subject was too ill to travel.|1|||
130426949|NCT00569582|469523801|FG000|Overall Study|Subject was non-compliant.|1|||
130426950|NCT02782169|469523810|FG000|Overall Study|Lost to Follow-up|1|||
130564835|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130426951|NCT02782169|469523811|FG001|Overall Study|Lost to Follow-up|2|||
130426952|NCT02975973|469523812|FG000|Overall Study|Adverse Event|1|||
130426953|NCT02975973|469523813|FG001|Overall Study|Adverse Event|1|||
130426954|NCT02975973|469523814|FG002|Overall Study|Adverse Event|1|||
130426955|NCT02975973|469523815|FG003|Overall Study|Adverse Event|0|||
130477807|NCT02761057|469717504|FG001|Overall Study|Adverse Event|9|||
130426956|NCT00771810|469523816|FG000|Overall Study|Adverse Event|3|||
130426957|NCT00771810|469523817|FG001|Overall Study|Adverse Event|0|||
130426958|NCT00771810|469523818|FG002|Overall Study|Adverse Event|2|||
130426959|NCT00771810|469523816|FG000|Overall Study|Lost to Follow-up|0|||
130426960|NCT00771810|469523817|FG001|Overall Study|Lost to Follow-up|0|||
130426961|NCT00771810|469523818|FG002|Overall Study|Lost to Follow-up|1|||
130426962|NCT00771810|469523816|FG000|Overall Study|Physician Decision|1|||
130426963|NCT00771810|469523817|FG001|Overall Study|Physician Decision|2|||
130426964|NCT00771810|469523818|FG002|Overall Study|Physician Decision|2|||
130477808|NCT02761057|469717505|FG002|Overall Study|Adverse Event|5|||
130477809|NCT02761057|469717506|FG003|Overall Study|Adverse Event|3|||
130477810|NCT02761057|469717503|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
130477811|NCT02761057|469717504|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
130477812|NCT02761057|469717505|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
130477813|NCT02761057|469717506|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
130477814|NCT02761057|469717503|FG000|Overall Study|Progression/Relapse|29|||
130477815|NCT02761057|469717504|FG001|Overall Study|Progression/Relapse|27|||
130477816|NCT02761057|469717505|FG002|Overall Study|Progression/Relapse|20|||
130477817|NCT02761057|469717506|FG003|Overall Study|Progression/Relapse|23|||
130477818|NCT02761057|469717503|FG000|Overall Study|Death|2|||
130477819|NCT02761057|469717504|FG001|Overall Study|Death|2|||
130477820|NCT02761057|469717505|FG002|Overall Study|Death|1|||
130477821|NCT02761057|469717506|FG003|Overall Study|Death|1|||
130477822|NCT02761057|469717503|FG000|Overall Study|Other - Not Protocol Specified|2|||
130477823|NCT02761057|469717504|FG001|Overall Study|Other - Not Protocol Specified|1|||
130477824|NCT02761057|469717505|FG002|Overall Study|Other - Not Protocol Specified|2|||
130477825|NCT02761057|469717506|FG003|Overall Study|Other - Not Protocol Specified|0|||
130477826|NCT04948697|469717507|FG000|Overall Study|Progressive disease|27|||
130477827|NCT04948697|469717508|FG001|Overall Study|Progressive disease|18|||
130477828|NCT04948697|469717507|FG000|Overall Study|Adverse Event|14|||
130477829|NCT04948697|469717508|FG001|Overall Study|Adverse Event|4|||
130477830|NCT04948697|469717507|FG000|Overall Study|Participant moved to long term extension study|7|||
130477831|NCT04948697|469717508|FG001|Overall Study|Participant moved to long term extension study|4|||
130477832|NCT04948697|469717507|FG000|Overall Study|Withdrawal by Subject|10|||
130477833|NCT04948697|469717508|FG001|Overall Study|Withdrawal by Subject|0|||
130477834|NCT04948697|469717507|FG000|Overall Study|Closed by Sponsor|3|||
130477835|NCT04948697|469717508|FG001|Overall Study|Closed by Sponsor|2|||
130477836|NCT04948697|469717507|FG000|Overall Study|Physician Decision|0|||
130477837|NCT04948697|469717508|FG001|Overall Study|Physician Decision|2|||
130477838|NCT04948697|469717507|FG000|Overall Study|Lost to Follow-up|0|||
130477839|NCT04948697|469717508|FG001|Overall Study|Lost to Follow-up|1|||
130477840|NCT04948697|469717507|FG000|Overall Study|Other-Miscellaneous|1|||
130477841|NCT04948697|469717508|FG001|Overall Study|Other-Miscellaneous|0|||
130477842|NCT04948697|469717507|FG000|Overall Study|Randomized but not treated|0|||
130477843|NCT04948697|469717508|FG001|Overall Study|Randomized but not treated|1|||
130477844|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
130477845|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
130477846|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
130477847|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
130477848|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
130477849|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
130477850|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
130477851|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
130477852|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
130477853|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
130477854|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
130477855|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
130477856|NCT04338061|469717509|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
130477857|NCT04338061|469717510|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
130564836|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
130564837|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
130564838|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130477858|NCT04338061|469717509|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
130477859|NCT04338061|469717510|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
130477860|NCT04338061|469717509|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
130477861|NCT04338061|469717510|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
130477862|NCT04338061|469717509|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
130564839|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130426965|NCT00771810|469523816|FG000|Overall Study|Protocol Violation|0|||
130426966|NCT00771810|469523817|FG001|Overall Study|Protocol Violation|1|||
130477863|NCT04338061|469717510|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
130477864|NCT04338061|469717509|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
130477865|NCT04338061|469717510|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
130477866|NCT04338061|469717509|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
130477867|NCT04338061|469717510|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
130477868|NCT03365882|469717511|FG000|Randomization|Still Receiving Protocol Treatment|2|||
130477869|NCT03365882|469717512|FG001|Randomization|Still Receiving Protocol Treatment|0|||
130477870|NCT03365882|469717511|FG000|Randomization|Adverse Event|1|||
130477871|NCT03365882|469717512|FG001|Randomization|Adverse Event|2|||
130477872|NCT03365882|469717511|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
130477873|NCT03365882|469717512|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
130477874|NCT03365882|469717511|FG000|Randomization|Progression/Relapse|21|||
130477875|NCT03365882|469717512|FG001|Randomization|Progression/Relapse|3|||
130477876|NCT03365882|469717511|FG000|Randomization|Death|1|||
130477877|NCT03365882|469717512|FG001|Randomization|Death|0|||
130477878|NCT03365882|469717511|FG000|Randomization|Other - Not Protocol Specified|1|||
130477879|NCT03365882|469717512|FG001|Randomization|Other - Not Protocol Specified|1|||
130477880|NCT03365882|469717511|FG000|Randomization|Major Protocol Deviation|0|||
130477881|NCT03365882|469717512|FG001|Randomization|Major Protocol Deviation|1|||
130477882|NCT03365882|469717511|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
130477883|NCT03365882|469717512|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
130477884|NCT03365882|469717511|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
130477885|NCT03365882|469717512|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
130477886|NCT03365882|469717511|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
130477887|NCT03365882|469717512|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
130477888|NCT03365882|469717511|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
130477889|NCT03365882|469717512|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
130426967|NCT00771810|469523818|FG002|Overall Study|Protocol Violation|1|||
130426968|NCT00771810|469523816|FG000|Overall Study|Withdrawal by Subject|1|||
130477890|NCT04229992|469720015|FG000|Overall Study|Withdrawal by Subject|0|||
130477891|NCT04229992|469720016|FG001|Overall Study|Withdrawal by Subject|2|||
130477892|NCT04229992|469720017|FG002|Overall Study|Withdrawal by Subject|1|||
130477893|NCT04229992|469720018|FG003|Overall Study|Withdrawal by Subject|1|||
130477894|NCT04229992|469720015|FG000|Overall Study|Adverse Event|1|||
130477895|NCT04229992|469720016|FG001|Overall Study|Adverse Event|1|||
130477896|NCT04229992|469720017|FG002|Overall Study|Adverse Event|3|||
130477897|NCT04229992|469720018|FG003|Overall Study|Adverse Event|1|||
130477898|NCT04229992|469720015|FG000|Overall Study|Lost to Follow-up|0|||
130477899|NCT04229992|469720016|FG001|Overall Study|Lost to Follow-up|0|||
130477900|NCT04229992|469720017|FG002|Overall Study|Lost to Follow-up|0|||
130477901|NCT04229992|469720018|FG003|Overall Study|Lost to Follow-up|1|||
130477902|NCT03770273|469720019|FG000|Overall Study|Adverse Event|2|||
130477903|NCT03770273|469720020|FG001|Overall Study|Adverse Event|0|||
130477904|NCT03770273|469720019|FG000|Overall Study|Lost to Follow-up|1|||
130477905|NCT03770273|469720020|FG001|Overall Study|Lost to Follow-up|1|||
130477906|NCT00418886|469720021|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
130477907|NCT00418886|469720022|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
130477908|NCT00418886|469720021|FG000|Randomized Period|Death|122|||
130564840|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
130727712|NCT01609023|470625543|FG000|Overall Study|Toxicity|3|||
130727713|NCT01609023|470625543|FG000|Overall Study|Disease progression|10|||
130426969|NCT00771810|469523817|FG001|Overall Study|Withdrawal by Subject|2|||
130426970|NCT00771810|469523818|FG002|Overall Study|Withdrawal by Subject|0|||
130426971|NCT00771810|469523816|FG000|Overall Study|Other|0|||
130426972|NCT00771810|469523817|FG001|Overall Study|Other|0|||
130426973|NCT00771810|469523818|FG002|Overall Study|Other|1|||
130426974|NCT00045305|469523822|FG000|Overall Study|Lack of Efficacy|6|||
130426975|NCT00045305|469523822|FG000|Overall Study|Adverse Event|3|||
130426976|NCT00045305|469523822|FG000|Overall Study|Death|3|||
130426977|NCT00045305|469523822|FG000|Overall Study|site error|2|||
130426978|NCT03848403|469523828|FG000|Period 2 (Day 8)|Adverse Event|1|||
130426979|NCT03848403|469523829|FG001|Period 2 (Day 8)|Adverse Event|2|||
130426980|NCT03848403|469523830|FG002|Period 2 (Day 8)|Adverse Event|2|||
130477909|NCT00418886|469720022|FG001|Randomized Period|Death|147|||
130477910|NCT00418886|469720021|FG000|Randomized Period|Withdrawal by Subject|9|||
130477911|NCT00418886|469720022|FG001|Randomized Period|Withdrawal by Subject|10|||
130477912|NCT00418886|469720021|FG000|Randomized Period|Lost to Follow-up|4|||
130477913|NCT00418886|469720022|FG001|Randomized Period|Lost to Follow-up|6|||
130477914|NCT00418886|469720021|FG000|Randomized Period|withdrawn due to other reason|1|||
130477915|NCT00418886|469720022|FG001|Randomized Period|withdrawn due to other reason|0|||
130477916|NCT00418886|469720021|FG000|Randomized Period|randomised but no treatment received|0|||
130564841|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
130426981|NCT03848403|469523828|FG000|Period 2 (Day 8)|Physician Decision|0|||
130426982|NCT03848403|469523829|FG001|Period 2 (Day 8)|Physician Decision|1|||
130477917|NCT00418886|469720022|FG001|Randomized Period|randomised but no treatment received|1|||
130477918|NCT05177848|469720023|FG000|Overall Study|Lost to Follow-up|1|||
130727714|NCT01609023|470625543|FG000|Overall Study|Physician Decision|2|||
130426983|NCT03848403|469523830|FG002|Period 2 (Day 8)|Physician Decision|0|||
130426984|NCT03848403|469523828|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
130426985|NCT03848403|469523829|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
130426986|NCT03848403|469523830|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
130426987|NCT01939548|469523831|FG000|Overall Study|Non compliance|0|||
130426988|NCT01939548|469523832|FG001|Overall Study|Non compliance|2|||
130426989|NCT01939548|469523833|FG002|Overall Study|Non compliance|0|||
130426990|NCT01939548|469523831|FG000|Overall Study|Study Terminated by Sponsor|17|||
130426991|NCT01939548|469523832|FG001|Overall Study|Study Terminated by Sponsor|19|||
130426992|NCT01939548|469523833|FG002|Overall Study|Study Terminated by Sponsor|12|||
130426993|NCT01939548|469523831|FG000|Overall Study|Insufficient Clinical Response|1|||
130426994|NCT01939548|469523832|FG001|Overall Study|Insufficient Clinical Response|0|||
130426995|NCT01939548|469523833|FG002|Overall Study|Insufficient Clinical Response|0|||
130426996|NCT01939548|469523831|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130426997|NCT01939548|469523832|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130426998|NCT01939548|469523833|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
130426999|NCT01939548|469523831|FG000|Overall Study|Withdrawal by Subject|4|||
130427000|NCT01939548|469523832|FG001|Overall Study|Withdrawal by Subject|4|||
130427001|NCT01939548|469523833|FG002|Overall Study|Withdrawal by Subject|1|||
130427002|NCT01939548|469523831|FG000|Overall Study|Protocol Violation|7|||
130427003|NCT01939548|469523832|FG001|Overall Study|Protocol Violation|6|||
130427004|NCT01939548|469523833|FG002|Overall Study|Protocol Violation|5|||
130427005|NCT01939548|469523831|FG000|Overall Study|Lost to Follow-up|5|||
130427006|NCT01939548|469523832|FG001|Overall Study|Lost to Follow-up|5|||
130427007|NCT01939548|469523833|FG002|Overall Study|Lost to Follow-up|3|||
130427008|NCT01939548|469523831|FG000|Overall Study|Adverse Event|2|||
130427009|NCT01939548|469523832|FG001|Overall Study|Adverse Event|9|||
130427010|NCT01939548|469523833|FG002|Overall Study|Adverse Event|7|||
130427011|NCT01939548|469523831|FG000|Overall Study|Death|0|||
130427012|NCT01939548|469523832|FG001|Overall Study|Death|0|||
130427013|NCT01939548|469523833|FG002|Overall Study|Death|1|||
130427014|NCT01939548|469523831|FG000|Overall Study|Participant dropped|0|||
130427015|NCT01939548|469523832|FG001|Overall Study|Participant dropped|0|||
130427016|NCT01939548|469523833|FG002|Overall Study|Participant dropped|1|||
130427017|NCT01939548|469523831|FG000|Overall Study|Participant unwilling to continue|0|||
130427018|NCT01939548|469523832|FG001|Overall Study|Participant unwilling to continue|1|||
130427019|NCT01939548|469523833|FG002|Overall Study|Participant unwilling to continue|0|||
130427020|NCT01939548|469523831|FG000|Overall Study|Participant withdrew consent|0|||
130427021|NCT01939548|469523832|FG001|Overall Study|Participant withdrew consent|2|||
130427022|NCT01939548|469523833|FG002|Overall Study|Participant withdrew consent|0|||
130427023|NCT01939548|469523831|FG000|Overall Study|Did not complete follow-up|0|||
130427024|NCT01939548|469523832|FG001|Overall Study|Did not complete follow-up|1|||
130427025|NCT01939548|469523833|FG002|Overall Study|Did not complete follow-up|0|||
130427026|NCT02114151|469523841|FG000|Overall Study|Death|1|||
130427027|NCT02114151|469523841|FG000|Overall Study|Lost to Follow-up|1|||
130427028|NCT02114151|469523841|FG000|Overall Study|Withdrawal by Subject|5|||
130427029|NCT02638948|469523844|FG000|Overall Study|Withdrawal by Subject|4|||
130427030|NCT02638948|469523845|FG001|Overall Study|Withdrawal by Subject|5|||
130427031|NCT02638948|469523846|FG002|Overall Study|Withdrawal by Subject|3|||
130427032|NCT02638948|469523847|FG003|Overall Study|Withdrawal by Subject|1|||
130427033|NCT02638948|469523844|FG000|Overall Study|Administrative Reason by Sponsor|0|||
130427034|NCT02638948|469523845|FG001|Overall Study|Administrative Reason by Sponsor|1|||
130427035|NCT02638948|469523846|FG002|Overall Study|Administrative Reason by Sponsor|0|||
130427036|NCT02638948|469523847|FG003|Overall Study|Administrative Reason by Sponsor|4|||
130427037|NCT02638948|469523844|FG000|Overall Study|Adverse Event|0|||
130427038|NCT02638948|469523845|FG001|Overall Study|Adverse Event|0|||
130427039|NCT02638948|469523846|FG002|Overall Study|Adverse Event|1|||
130427040|NCT02638948|469523847|FG003|Overall Study|Adverse Event|1|||
130427041|NCT02638948|469523844|FG000|Overall Study|Lack of Efficacy|1|||
130427042|NCT02638948|469523845|FG001|Overall Study|Lack of Efficacy|1|||
130427043|NCT02638948|469523846|FG002|Overall Study|Lack of Efficacy|0|||
130427044|NCT02638948|469523847|FG003|Overall Study|Lack of Efficacy|0|||
130427045|NCT02638948|469523844|FG000|Overall Study|Lost to Follow-up|0|||
130427046|NCT02638948|469523845|FG001|Overall Study|Lost to Follow-up|0|||
130427047|NCT02638948|469523846|FG002|Overall Study|Lost to Follow-up|1|||
130427048|NCT02638948|469523847|FG003|Overall Study|Lost to Follow-up|1|||
130427049|NCT02638948|469523844|FG000|Overall Study|Poor/Non-Compliance|0|||
130427050|NCT02638948|469523845|FG001|Overall Study|Poor/Non-Compliance|2|||
130427051|NCT02638948|469523846|FG002|Overall Study|Poor/Non-Compliance|1|||
130427052|NCT02638948|469523847|FG003|Overall Study|Poor/Non-Compliance|0|||
130427053|NCT02638948|469523844|FG000|Overall Study|Participant no longer met study criteria|0|||
130427054|NCT02638948|469523845|FG001|Overall Study|Participant no longer met study criteria|1|||
130427055|NCT02638948|469523846|FG002|Overall Study|Participant no longer met study criteria|0|||
130427056|NCT02638948|469523847|FG003|Overall Study|Participant no longer met study criteria|0|||
130427057|NCT02638948|469523844|FG000|Overall Study|Other than specified above|4|||
130427058|NCT02638948|469523845|FG001|Overall Study|Other than specified above|1|||
130427059|NCT02638948|469523846|FG002|Overall Study|Other than specified above|1|||
130427060|NCT02638948|469523847|FG003|Overall Study|Other than specified above|1|||
130427061|NCT00810264|469523851|FG000|Overall Study|Lost to Follow-up|191|||
130427062|NCT00810264|469523851|FG000|Overall Study|Withdrawal by subject or physician|721|||
130427063|NCT00810264|469523851|FG000|Overall Study|Death|641|||
130427064|NCT06213701|469523852|FG000|Overall Study|Withdrawal by Subject|2|||
130427065|NCT06213701|469523853|FG001|Overall Study|Withdrawal by Subject|1|||
130427066|NCT06213701|469523854|FG002|Overall Study|Withdrawal by Subject|0|||
130427067|NCT02495025|469523861|FG000|Overall Study|Lost to Follow-up|21|||
130427068|NCT02495025|469523862|FG001|Overall Study|Lost to Follow-up|14|||
130427069|NCT02495025|469523861|FG000|Overall Study|Withdrawal by Subject|5|||
130427070|NCT02495025|469523862|FG001|Overall Study|Withdrawal by Subject|0|||
130427071|NCT02134587|469523866|FG000|Overall Study|Did not completed all meetings|30|||
130427072|NCT00265889|469523867|FG000|Overall Study|Physician Decision|1|||
130427073|NCT00265889|469523867|FG000|Overall Study|Protocol Violation|1|||
130427074|NCT00265889|469523867|FG000|Overall Study|Insurance denied the request|3|||
130427075|NCT01515748|469523871|FG000|Overall Study|Withdrawal by Subject|32|||
130427076|NCT01515748|469523872|FG001|Overall Study|Withdrawal by Subject|41|||
130427077|NCT01515748|469523871|FG000|Overall Study|Lost to Follow-up|2|||
130427078|NCT01515748|469523872|FG001|Overall Study|Lost to Follow-up|4|||
130427079|NCT01515748|469523871|FG000|Overall Study|Other than specified above|5|||
130427080|NCT01515748|469523872|FG001|Overall Study|Other than specified above|10|||
130427081|NCT03221387|469523875|FG000|Overall Study|Lost to Follow-up|1|||
130427082|NCT03221387|469523875|FG000|Overall Study|Lung transplant|1|||
130427083|NCT04102579|469523879|FG000|Overall Study|Withdrawal by Subject|3|||
130427084|NCT04102579|469523880|FG001|Overall Study|Withdrawal by Subject|4|||
130427085|NCT04102579|469523879|FG000|Overall Study|Lost to Follow-up|0|||
130427086|NCT04102579|469523880|FG001|Overall Study|Lost to Follow-up|1|||
130427087|NCT04102579|469523879|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
130427088|NCT04102579|469523880|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
130427089|NCT04102579|469523879|FG000|Overall Study|Other than Specified|1|||
130427090|NCT04102579|469523880|FG001|Overall Study|Other than Specified|0|||
130427091|NCT04102579|469523879|FG000|Overall Study|Not Dosed with Study Drug|0|||
130427092|NCT04102579|469523880|FG001|Overall Study|Not Dosed with Study Drug|1|||
130427093|NCT01337674|469525071|FG000|Treatment Period 1|Adverse Event|0|||
130427094|NCT01337674|469525072|FG001|Treatment Period 1|Adverse Event|1|||
130427095|NCT01337674|469525073|FG002|Treatment Period 1|Adverse Event|0|||
130427096|NCT01337674|469525074|FG003|Treatment Period 1|Adverse Event|0|||
130427097|NCT01337674|469525071|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
130427098|NCT01337674|469525072|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
130427099|NCT01337674|469525073|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
130427100|NCT01337674|469525074|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
130427101|NCT01337674|469525071|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130427102|NCT01337674|469525072|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130427103|NCT01337674|469525073|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130427104|NCT01337674|469525074|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130427105|NCT01203930|469525075|FG000|Overall Study|Disease Progression|0|||
130427106|NCT01203930|469525076|FG001|Overall Study|Disease Progression|4|||
130427107|NCT01203930|469525075|FG000|Overall Study|Death|3|||
130427108|NCT01203930|469525076|FG001|Overall Study|Death|1|||
130427109|NCT01203930|469525075|FG000|Overall Study|Withdrew Consent|1|||
130427110|NCT01203930|469525076|FG001|Overall Study|Withdrew Consent|10|||
130427111|NCT01203930|469525075|FG000|Overall Study|Investigator Request|0|||
130427112|NCT01203930|469525076|FG001|Overall Study|Investigator Request|8|||
130427113|NCT01203930|469525075|FG000|Overall Study|Study Terminated by Sponsor|0|||
130427114|NCT01203930|469525076|FG001|Overall Study|Study Terminated by Sponsor|12|||
130427115|NCT01203930|469525075|FG000|Overall Study|Poor tolerance of study drug|0|||
130477919|NCT05177848|469720024|FG001|Overall Study|Lost to Follow-up|4|||
130477920|NCT05177848|469720023|FG000|Overall Study|Discontinued|2|||
130477921|NCT05177848|469720024|FG001|Overall Study|Discontinued|1|||
130427116|NCT01203930|469525076|FG001|Overall Study|Poor tolerance of study drug|1|||
130427117|NCT01203930|469525075|FG000|Overall Study|Adverse Event|17|||
130427118|NCT01203930|469525076|FG001|Overall Study|Adverse Event|5|||
130427119|NCT02178059|469525077|FG000|Washout|Physician Decision|1|||
130427120|NCT02178059|469525078|FG001|Washout|Physician Decision|0|||
130477922|NCT02035787|469720025|FG000|Overall Study- 12 Months|Adverse Event|3|||
130477923|NCT02035787|469720026|FG001|Overall Study- 12 Months|Adverse Event|0|||
130477924|NCT02035787|469720025|FG000|Overall Study- 12 Months|Complete response|4|||
130427121|NCT05178121|469525079|FG000|Overall Study|Other|4|||
130427122|NCT05178121|469525079|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
130477925|NCT02035787|469720026|FG001|Overall Study- 12 Months|Complete response|1|||
130477926|NCT02035787|469720025|FG000|Overall Study- 12 Months|Protocol Violation|1|||
130477927|NCT02035787|469720026|FG001|Overall Study- 12 Months|Protocol Violation|1|||
130477928|NCT06414213|469720027|FG000|Overall Study|Lost to Follow-up|1|||
130427123|NCT00838682|469525083|FG000|Overall Study|Lost to Follow-up|21|||
130427124|NCT00838682|469525084|FG001|Overall Study|Lost to Follow-up|14|||
130427125|NCT00838682|469525083|FG000|Overall Study|detection of exclusion criteria|4|||
130427126|NCT00838682|469525084|FG001|Overall Study|detection of exclusion criteria|3|||
130427127|NCT00838682|469525083|FG000|Overall Study|Protocol Violation|0|||
130427128|NCT00838682|469525084|FG001|Overall Study|Protocol Violation|1|||
130427129|NCT00838682|469525083|FG000|Overall Study|Withdrawal by Subject|0|||
130427130|NCT00838682|469525084|FG001|Overall Study|Withdrawal by Subject|1|||
130427131|NCT00989092|469525087|FG000|Overall Study|Physician Decision|9|||
130427132|NCT00989092|469525088|FG001|Overall Study|Physician Decision|6|||
130427133|NCT00989092|469525087|FG000|Overall Study|Adverse Event|20|||
130427134|NCT00989092|469525088|FG001|Overall Study|Adverse Event|1|||
130427135|NCT00989092|469525087|FG000|Overall Study|Chemotherapy initiated|12|||
130427136|NCT00989092|469525088|FG001|Overall Study|Chemotherapy initiated|4|||
130427137|NCT00989092|469525087|FG000|Overall Study|Withdrawal by Subject|17|||
130427138|NCT00989092|469525088|FG001|Overall Study|Withdrawal by Subject|9|||
130427139|NCT00989092|469525087|FG000|Overall Study|Death|14|||
130427140|NCT00989092|469525088|FG001|Overall Study|Death|2|||
130427141|NCT00989092|469525087|FG000|Overall Study|Ineligibility determined|3|||
130427142|NCT00989092|469525088|FG001|Overall Study|Ineligibility determined|3|||
130427143|NCT00989092|469525087|FG000|Overall Study|Lost to Follow-up|6|||
130427144|NCT00989092|469525088|FG001|Overall Study|Lost to Follow-up|2|||
130427145|NCT00989092|469525087|FG000|Overall Study|Other|3|||
130427146|NCT00989092|469525088|FG001|Overall Study|Other|1|||
130427147|NCT00989092|469525087|FG000|Overall Study|Protocol deviation|2|||
130427148|NCT00989092|469525088|FG001|Overall Study|Protocol deviation|0|||
130427149|NCT00989092|469525087|FG000|Overall Study|Erythropoietin therapy initiated|2|||
130427150|NCT00989092|469525088|FG001|Overall Study|Erythropoietin therapy initiated|0|||
130427151|NCT00989092|469525087|FG000|Overall Study|Did not receive study drug|2|||
130427152|NCT00989092|469525088|FG001|Overall Study|Did not receive study drug|0|||
130427153|NCT04098406|469525091|FG000|Overall Study|Adverse Event|2|||
130427154|NCT04098406|469525092|FG001|Overall Study|Adverse Event|1|||
130427155|NCT04098406|469525091|FG000|Overall Study|Withdrawal by Subject|1|||
130427156|NCT04098406|469525092|FG001|Overall Study|Withdrawal by Subject|0|||
130427157|NCT02173548|469525093|FG000|Overall Study|Lost to Follow-up|0|||
130427158|NCT02173548|469525094|FG001|Overall Study|Lost to Follow-up|2|||
130427159|NCT02173548|469525093|FG000|Overall Study|Withdrawal by Subject|1|||
130427160|NCT02173548|469525094|FG001|Overall Study|Withdrawal by Subject|0|||
130427161|NCT00415610|469525098|FG000|Overall Study|Death|3|||
130427162|NCT00415610|469525099|FG001|Overall Study|Death|2|||
130427163|NCT00415610|469525100|FG002|Overall Study|Death|5|||
130427164|NCT04539821|469525103|FG000|Overall Study|Withdrawal by Subject|2|||
130427165|NCT04539821|469525103|FG000|Overall Study|continued care with their physician|20|||
130427166|NCT04539821|469525103|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
130427167|NCT02641392|469525104|FG000|Overall Study|Lost to Follow-up|0|||
130427168|NCT02641392|469525105|FG001|Overall Study|Lost to Follow-up|0|||
130427169|NCT02641392|469525106|FG002|Overall Study|Lost to Follow-up|2|||
130427170|NCT02641392|469525104|FG000|Overall Study|Withdrawal by Subject|0|||
130427171|NCT02641392|469525105|FG001|Overall Study|Withdrawal by Subject|0|||
130427172|NCT02641392|469525106|FG002|Overall Study|Withdrawal by Subject|17|||
130427173|NCT02641392|469525104|FG000|Overall Study|Adverse Event|0|||
130427174|NCT02641392|469525105|FG001|Overall Study|Adverse Event|1|||
130427175|NCT02641392|469525106|FG002|Overall Study|Adverse Event|25|||
130427176|NCT02641392|469525104|FG000|Overall Study|Study Terminated by Sponsor|4|||
130427177|NCT02641392|469525105|FG001|Overall Study|Study Terminated by Sponsor|12|||
130427178|NCT02641392|469525106|FG002|Overall Study|Study Terminated by Sponsor|144|||
130427179|NCT02641392|469525104|FG000|Overall Study|Lack of Efficacy|0|||
130427180|NCT02641392|469525105|FG001|Overall Study|Lack of Efficacy|0|||
130427181|NCT02641392|469525106|FG002|Overall Study|Lack of Efficacy|101|||
130427182|NCT02641392|469525104|FG000|Overall Study|Miscellaneous|0|||
130427183|NCT02641392|469525105|FG001|Overall Study|Miscellaneous|0|||
130427184|NCT02641392|469525106|FG002|Overall Study|Miscellaneous|3|||
130427185|NCT02641392|469525104|FG000|Overall Study|Death|0|||
130427186|NCT02641392|469525105|FG001|Overall Study|Death|0|||
130427187|NCT02641392|469525106|FG002|Overall Study|Death|1|||
130427188|NCT02691182|469525107|FG000|Overall Study|Withdrawal by Subject|4|||
130727715|NCT01609023|470625543|FG000|Overall Study|Death|2|||
130427189|NCT02691182|469525108|FG001|Overall Study|Withdrawal by Subject|7|||
130427190|NCT02691182|469525109|FG002|Overall Study|Withdrawal by Subject|6|||
130427191|NCT02691182|469525110|FG003|Overall Study|Withdrawal by Subject|8|||
130427192|NCT02691182|469525107|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
130427193|NCT02691182|469525108|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
130727716|NCT01609023|470625543|FG000|Overall Study|Personal reasons|1|||
130427194|NCT02691182|469525109|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
130427195|NCT02691182|469525110|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
130427196|NCT02691182|469525107|FG000|Overall Study|Lost to Follow-up|8|||
130427197|NCT02691182|469525108|FG001|Overall Study|Lost to Follow-up|33|||
130427198|NCT02691182|469525109|FG002|Overall Study|Lost to Follow-up|19|||
130427199|NCT02691182|469525110|FG003|Overall Study|Lost to Follow-up|22|||
130427200|NCT02691182|469525107|FG000|Overall Study|Adverse Event|3|||
130427201|NCT02691182|469525108|FG001|Overall Study|Adverse Event|10|||
130427202|NCT02691182|469525109|FG002|Overall Study|Adverse Event|10|||
130427203|NCT02691182|469525110|FG003|Overall Study|Adverse Event|11|||
130427204|NCT02691182|469525107|FG000|Overall Study|Physician Decision|3|||
130427205|NCT02691182|469525108|FG001|Overall Study|Physician Decision|7|||
130427206|NCT02691182|469525109|FG002|Overall Study|Physician Decision|14|||
130427207|NCT02691182|469525110|FG003|Overall Study|Physician Decision|8|||
130427208|NCT02691182|469525107|FG000|Overall Study|Lack of Efficacy|0|||
130427209|NCT02691182|469525108|FG001|Overall Study|Lack of Efficacy|0|||
130427210|NCT02691182|469525109|FG002|Overall Study|Lack of Efficacy|0|||
130427211|NCT02691182|469525110|FG003|Overall Study|Lack of Efficacy|4|||
130427212|NCT02691182|469525107|FG000|Overall Study|Protocol Violation|2|||
130427213|NCT02691182|469525108|FG001|Overall Study|Protocol Violation|6|||
130427214|NCT02691182|469525109|FG002|Overall Study|Protocol Violation|6|||
130427215|NCT02691182|469525110|FG003|Overall Study|Protocol Violation|8|||
130427216|NCT02691182|469525107|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
130427217|NCT02691182|469525108|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
130427218|NCT02691182|469525109|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
130477929|NCT06414213|469720028|FG001|Overall Study|Lost to Follow-up|1|||
130477930|NCT06414213|469720029|FG002|Overall Study|Lost to Follow-up|3|||
130477931|NCT03338933|469720030|FG000|Screening Visit|Lost to Follow-up|1|||
130477932|NCT03338933|469720031|FG001|Screening Visit|Lost to Follow-up|3|||
130477933|NCT03338933|469720032|FG002|Screening Visit|Lost to Follow-up|1|||
130477934|NCT03338933|469720033|FG003|Screening Visit|Lost to Follow-up|4|||
130477935|NCT03338933|469720030|FG000|Screening Visit|Screen fail after consent|2|||
130477936|NCT03338933|469720031|FG001|Screening Visit|Screen fail after consent|7|||
130477937|NCT03338933|469720032|FG002|Screening Visit|Screen fail after consent|1|||
130477938|NCT03338933|469720033|FG003|Screening Visit|Screen fail after consent|4|||
130477939|NCT03338933|469720030|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
130477940|NCT03338933|469720031|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
130477941|NCT03338933|469720032|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
130477942|NCT03338933|469720033|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
130477943|NCT03338933|469720030|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
130477944|NCT03338933|469720031|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
130477945|NCT03338933|469720032|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
130477946|NCT03338933|469720033|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
130477947|NCT03338933|469720030|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
130477948|NCT03338933|469720031|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
130477949|NCT03338933|469720032|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
130477950|NCT03338933|469720033|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
130477951|NCT01084876|469720035|FG000|Main Study Treatment Period|Adverse Event|12|||
130477952|NCT01084876|469720036|FG001|Main Study Treatment Period|Adverse Event|7|||
130477953|NCT01084876|469720035|FG000|Main Study Treatment Period|Disease Progression|41|||
130477954|NCT01084876|469720036|FG001|Main Study Treatment Period|Disease Progression|24|||
130477955|NCT01084876|469720035|FG000|Main Study Treatment Period|Physician Decision|2|||
130477956|NCT01084876|469720036|FG001|Main Study Treatment Period|Physician Decision|0|||
130477957|NCT01084876|469720035|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
130477958|NCT01084876|469720036|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
130477959|NCT01084876|469720035|FG000|Main Study Treatment Period|Other Reason|0|||
130477960|NCT01084876|469720036|FG001|Main Study Treatment Period|Other Reason|1|||
130477961|NCT01084876|469720035|FG000|Main Study Treatment Period|Other|0|||
130477962|NCT01084876|469720036|FG001|Main Study Treatment Period|Other|1|||
130477963|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
130477964|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
130477965|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
130477966|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
130477967|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
130477968|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
130427219|NCT02691182|469525110|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
130427220|NCT02691182|469525107|FG000|Overall Study|Missing|0|||
130477969|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
130477970|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
130477971|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
130477972|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
130477973|NCT01084876|469720035|FG000|Treatment Period Beyond Cycle 8|Other|6|||
130427221|NCT02691182|469525108|FG001|Overall Study|Missing|5|||
130477974|NCT01084876|469720036|FG001|Treatment Period Beyond Cycle 8|Other|9|||
130477975|NCT05434078|469720049|FG000|Overall Study|Lost to Follow-up|2|||
130477976|NCT05434078|469720050|FG001|Overall Study|Lost to Follow-up|1|||
130477977|NCT05434078|469720049|FG000|Overall Study|Withdrawal by Subject|1|||
130477978|NCT05434078|469720050|FG001|Overall Study|Withdrawal by Subject|0|||
130477979|NCT03829410|469720055|FG000|Overall Study|Adverse Event|1|||
130477980|NCT03829410|469720056|FG001|Overall Study|Adverse Event|0|||
130477981|NCT03829410|469720057|FG002|Overall Study|Adverse Event|1|||
130477982|NCT03829410|469720058|FG003|Overall Study|Adverse Event|4|||
130477983|NCT03829410|469720055|FG000|Overall Study|Physician Decision|0|||
130477984|NCT03829410|469720056|FG001|Overall Study|Physician Decision|0|||
130477985|NCT03829410|469720057|FG002|Overall Study|Physician Decision|0|||
130477986|NCT03829410|469720058|FG003|Overall Study|Physician Decision|2|||
130477987|NCT03829410|469720055|FG000|Overall Study|Disease Progressing|3|||
130477988|NCT03829410|469720056|FG001|Overall Study|Disease Progressing|4|||
130477989|NCT03829410|469720057|FG002|Overall Study|Disease Progressing|2|||
130477990|NCT03829410|469720058|FG003|Overall Study|Disease Progressing|31|||
130477991|NCT03829410|469720055|FG000|Overall Study|Miscellaneous|2|||
130477992|NCT03829410|469720056|FG001|Overall Study|Miscellaneous|4|||
130477993|NCT03829410|469720057|FG002|Overall Study|Miscellaneous|3|||
130477994|NCT03829410|469720058|FG003|Overall Study|Miscellaneous|10|||
130477995|NCT02577835|469720059|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
130477996|NCT04509674|469720062|FG000|Overall Study|Not treated|33|||
130477997|NCT04509674|469720063|FG001|Overall Study|Not treated|26|||
130477998|NCT04509674|469720062|FG000|Overall Study|Protocol Violation|9|||
130477999|NCT04509674|469720063|FG001|Overall Study|Protocol Violation|10|||
130478000|NCT04509674|469720062|FG000|Overall Study|Lost to Follow-up|31|||
130478001|NCT04509674|469720063|FG001|Overall Study|Lost to Follow-up|39|||
130478002|NCT04509674|469720062|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
130478003|NCT04509674|469720063|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
130478004|NCT04509674|469720062|FG000|Overall Study|Adverse event, serious fatal event|11|||
130478005|NCT04509674|469720063|FG001|Overall Study|Adverse event, serious fatal event|4|||
130478006|NCT04509674|469720062|FG000|Overall Study|Adverse event, non-fatal event|107|||
130478007|NCT04509674|469720063|FG001|Overall Study|Adverse event, non-fatal event|118|||
130478008|NCT04509674|469720062|FG000|Overall Study|Other reason than listed|106|||
130478009|NCT04509674|469720063|FG001|Overall Study|Other reason than listed|95|||
130478010|NCT02979522|469720064|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
130478011|NCT02979522|469720065|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
130478012|NCT02979522|469720064|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
130478013|NCT02979522|469720065|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
130478014|NCT03197662|469720066|FG000|Overall Study|Withdrawn by family|0|||
130478015|NCT03197662|469720067|FG001|Overall Study|Withdrawn by family|2|||
130478016|NCT01214616|469720068|FG000|Overall Study|Progressive disease|2|||
130478017|NCT01214616|469720069|FG001|Overall Study|Progressive disease|2|||
130478018|NCT01214616|469720070|FG002|Overall Study|Progressive disease|2|||
130478019|NCT01214616|469720071|FG003|Overall Study|Progressive disease|4|||
130478020|NCT01214616|469720068|FG000|Overall Study|Dose limiting toxicity|0|||
130478021|NCT01214616|469720069|FG001|Overall Study|Dose limiting toxicity|2|||
130478022|NCT01214616|469720070|FG002|Overall Study|Dose limiting toxicity|0|||
130478023|NCT01214616|469720071|FG003|Overall Study|Dose limiting toxicity|0|||
130478024|NCT01214616|469720068|FG000|Overall Study|Other adverse events|0|||
130478025|NCT01214616|469720069|FG001|Overall Study|Other adverse events|1|||
130478026|NCT01214616|469720070|FG002|Overall Study|Other adverse events|1|||
130478027|NCT01214616|469720071|FG003|Overall Study|Other adverse events|1|||
130478028|NCT01214616|469720068|FG000|Overall Study|Withdrawal by Subject|1|||
130478029|NCT01214616|469720069|FG001|Overall Study|Withdrawal by Subject|0|||
130478030|NCT01214616|469720070|FG002|Overall Study|Withdrawal by Subject|0|||
130478031|NCT01214616|469720071|FG003|Overall Study|Withdrawal by Subject|1|||
130478032|NCT03721952|469720072|FG000|Overall Study|Lost to Follow-up|0|||
130478033|NCT03721952|469720073|FG001|Overall Study|Lost to Follow-up|0|||
130478034|NCT03721952|469720074|FG002|Overall Study|Lost to Follow-up|2|||
130478035|NCT03721952|469720075|FG003|Overall Study|Lost to Follow-up|0|||
130478036|NCT03721952|469720076|FG004|Overall Study|Lost to Follow-up|0|||
130478037|NCT03721952|469720072|FG000|Overall Study|Protocol Violation|0|||
130478038|NCT03721952|469720073|FG001|Overall Study|Protocol Violation|1|||
130727717|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Death|0|||
130727718|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Death|1|||
130727719|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
130478039|NCT03721952|469720074|FG002|Overall Study|Protocol Violation|0|||
130478040|NCT03721952|469720075|FG003|Overall Study|Protocol Violation|0|||
130478041|NCT03721952|469720076|FG004|Overall Study|Protocol Violation|0|||
130478042|NCT03721952|469720072|FG000|Overall Study|Withdrawal by Subject|1|||
130478043|NCT03721952|469720073|FG001|Overall Study|Withdrawal by Subject|0|||
130478044|NCT03721952|469720074|FG002|Overall Study|Withdrawal by Subject|40|||
130564842|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130478045|NCT03721952|469720075|FG003|Overall Study|Withdrawal by Subject|28|||
130427222|NCT02691182|469525109|FG002|Overall Study|Missing|1|||
130427223|NCT02691182|469525110|FG003|Overall Study|Missing|5|||
130427224|NCT00645164|469525111|FG000|Overall Study|Lost to Follow-up|2|||
130427225|NCT00645164|469525111|FG000|Overall Study|Withdrawal by Subject|4|||
130427226|NCT00645164|469525111|FG000|Overall Study|Protocol Violation|1|||
130427227|NCT00117676|469525112|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
130427228|NCT00117676|469525113|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
130427229|NCT00117676|469525112|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
130427230|NCT00117676|469525113|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
130427231|NCT00117676|469525112|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
130427232|NCT00117676|469525113|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
130427233|NCT00117676|469525112|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
130427234|NCT00117676|469525113|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
130427235|NCT00117676|469525112|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
130427236|NCT00117676|469525113|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
130427237|NCT00117676|469525112|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
130427238|NCT00117676|469525113|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
130427239|NCT00117676|469525112|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
130427240|NCT00117676|469525113|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
130427241|NCT00117676|469525112|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
130427242|NCT00117676|469525113|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
130427243|NCT00117676|469525112|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
130427244|NCT00117676|469525113|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
130427245|NCT00117676|469525112|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
130427246|NCT00117676|469525113|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
130427247|NCT00117676|469525112|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
130427248|NCT00117676|469525113|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
130427249|NCT00117676|469525112|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
130427250|NCT00117676|469525113|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
130427251|NCT00117676|469525112|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
130427252|NCT00117676|469525113|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
130427253|NCT00117676|469525112|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
130427254|NCT00117676|469525113|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
130427255|NCT00117676|469525112|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
130427256|NCT00117676|469525113|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
130427257|NCT00117676|469525112|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
130427258|NCT00117676|469525113|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
130427259|NCT00117676|469525112|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
130427260|NCT00117676|469525113|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
130427261|NCT00117676|469525112|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
130427262|NCT00117676|469525113|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
130427263|NCT00117676|469525112|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
130427264|NCT00117676|469525113|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
130427265|NCT00117676|469525112|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
130427266|NCT00117676|469525113|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
130427267|NCT00117676|469525112|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
130427268|NCT00117676|469525113|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
130427269|NCT00117676|469525112|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
130427270|NCT00117676|469525113|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
130427271|NCT00117676|469525112|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
130727720|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
130727721|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
130427272|NCT00117676|469525113|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
130427273|NCT00117676|469525112|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
130427274|NCT00117676|469525113|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
130427275|NCT00117676|469525112|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
130427276|NCT00117676|469525113|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
130427277|NCT00117676|469525112|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
130427278|NCT00117676|469525113|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
130427279|NCT00117676|469525112|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
130427280|NCT00117676|469525113|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
130427281|NCT00117676|469525112|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
130427282|NCT00117676|469525113|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
130427283|NCT00117676|469525112|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
130564843|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130564844|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
130564845|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130564846|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130427284|NCT00117676|469525113|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
130427285|NCT00117676|469525112|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
130427286|NCT00117676|469525113|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
130427287|NCT00117676|469525112|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
130427288|NCT00117676|469525113|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
130427289|NCT00117676|469525112|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
130427290|NCT00117676|469525113|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
130427291|NCT00117676|469525112|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
130427292|NCT00117676|469525113|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
130427293|NCT00117676|469525112|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
130427294|NCT00117676|469525113|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
130427295|NCT00117676|469525112|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
130427296|NCT00117676|469525113|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
130427297|NCT00952822|469525114|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130427298|NCT00952822|469525115|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
130427299|NCT00952822|469525116|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130427300|NCT00952822|469525117|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130427301|NCT00952822|469525114|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130427302|NCT00952822|469525115|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130427303|NCT00952822|469525116|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
130427304|NCT00952822|469525117|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130427305|NCT00691938|469525120|FG000|Overall Study|QTc prolongation|1|||
130427306|NCT00691938|469525121|FG001|Overall Study|QTc prolongation|0|||
130427307|NCT00691938|469525122|FG002|Overall Study|QTc prolongation|0|||
130427308|NCT00691938|469525123|FG003|Overall Study|QTc prolongation|0|||
130427309|NCT00691938|469525124|FG004|Overall Study|QTc prolongation|0|||
130427310|NCT00691938|469525125|FG005|Overall Study|QTc prolongation|0|||
130427311|NCT00691938|469525126|FG006|Overall Study|QTc prolongation|0|||
130427312|NCT04860518|469525130|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
130427313|NCT04860518|469525131|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
130427314|NCT04555096|469525136|FG000|Overall Study|Death|4|||
130427315|NCT04555096|469525137|FG001|Overall Study|Death|4|||
130427316|NCT04555096|469525136|FG000|Overall Study|Withdrawal by Subject|1|||
130427317|NCT04555096|469525137|FG001|Overall Study|Withdrawal by Subject|0|||
130427318|NCT04555096|469525136|FG000|Overall Study|Other|0|||
130427319|NCT04555096|469525137|FG001|Overall Study|Other|1|||
130427320|NCT03641313|469525140|FG000|Overall Study|Death|1|||
130427321|NCT03641313|469525140|FG000|Overall Study|Withdrawal by Subject|2|||
130427322|NCT03641313|469525140|FG000|Overall Study|Declining health|1|||
130427323|NCT03641313|469525140|FG000|Overall Study|Adverse Event|1|||
130427324|NCT04642898|469525141|FG000|Overall Study|Withdrawal by Subject|2|||
130427325|NCT04642898|469525142|FG001|Overall Study|Withdrawal by Subject|4|||
130427326|NCT04642898|469525143|FG002|Overall Study|Withdrawal by Subject|4|||
130427327|NCT04642898|469525144|FG003|Overall Study|Withdrawal by Subject|6|||
130427328|NCT04642898|469525145|FG004|Overall Study|Withdrawal by Subject|2|||
130427329|NCT04642898|469525146|FG005|Overall Study|Withdrawal by Subject|6|||
130427330|NCT04642898|469525141|FG000|Overall Study|Lost to Follow-up|0|||
130427331|NCT04642898|469525142|FG001|Overall Study|Lost to Follow-up|0|||
130427332|NCT04642898|469525143|FG002|Overall Study|Lost to Follow-up|0|||
130427333|NCT04642898|469525144|FG003|Overall Study|Lost to Follow-up|2|||
130427334|NCT04642898|469525145|FG004|Overall Study|Lost to Follow-up|0|||
130427335|NCT04642898|469525146|FG005|Overall Study|Lost to Follow-up|1|||
130427336|NCT04642898|469525141|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
130427337|NCT04642898|469525142|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
130427338|NCT04642898|469525143|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
130427339|NCT04642898|469525144|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
130427340|NCT04642898|469525145|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
130564847|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130427341|NCT04642898|469525146|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
130564848|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
130427342|NCT04642898|469525141|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130427343|NCT04642898|469525142|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130427344|NCT04642898|469525143|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130427345|NCT04642898|469525144|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130727722|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
130478046|NCT03721952|469720076|FG004|Overall Study|Withdrawal by Subject|0|||
130478047|NCT05292365|469720079|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
130478048|NCT05292365|469720080|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
130478049|NCT05292365|469720081|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
130478050|NCT05292365|469720082|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
130478051|NCT04495894|469720091|FG000|Overall Study|Withdrawal by Subject|2|||
130478052|NCT04495894|469720092|FG001|Overall Study|Withdrawal by Subject|0|||
130478053|NCT04495894|469720093|FG002|Overall Study|Withdrawal by Subject|2|||
130478054|NCT04495894|469720094|FG003|Overall Study|Withdrawal by Subject|3|||
130478055|NCT04495894|469720091|FG000|Overall Study|Early termination|0|||
130478056|NCT04495894|469720092|FG001|Overall Study|Early termination|0|||
130478057|NCT04495894|469720093|FG002|Overall Study|Early termination|3|||
130478058|NCT04495894|469720094|FG003|Overall Study|Early termination|0|||
130478059|NCT05579899|469720096|FG000|Overall Study|Lost to Follow-up|3|||
130478060|NCT05579899|469720097|FG001|Overall Study|Lost to Follow-up|1|||
130478061|NCT05579899|469720096|FG000|Overall Study|Adverse Event|0|||
130478062|NCT05579899|469720097|FG001|Overall Study|Adverse Event|3|||
130478063|NCT05579899|469720096|FG000|Overall Study|Pregnancy|0|||
130478064|NCT05579899|469720097|FG001|Overall Study|Pregnancy|1|||
130478065|NCT05579899|469720096|FG000|Overall Study|Withdrawal by Subject|0|||
130478066|NCT05579899|469720097|FG001|Overall Study|Withdrawal by Subject|3|||
130478067|NCT04064164|469720100|FG000|Overall Study|Withdrawal by Subject|8|||
130478068|NCT04064164|469720101|FG001|Overall Study|Withdrawal by Subject|8|||
130478069|NCT04059484|469720103|FG000|Overall Study|Adverse Event|2|||
130478070|NCT04059484|469720104|FG001|Overall Study|Adverse Event|5|||
130478071|NCT04059484|469720103|FG000|Overall Study|Withdrawal by Subject|5|||
130478072|NCT04059484|469720104|FG001|Overall Study|Withdrawal by Subject|3|||
130478073|NCT04059484|469720103|FG000|Overall Study|Progressive disease|112|||
130478074|NCT04059484|469720104|FG001|Overall Study|Progressive disease|112|||
130478075|NCT04059484|469720103|FG000|Overall Study|Other|8|||
130478076|NCT04059484|469720104|FG001|Overall Study|Other|3|||
130478077|NCT04059484|469720103|FG000|Overall Study|Ongoing|20|||
130478078|NCT04059484|469720104|FG001|Overall Study|Ongoing|20|||
130478079|NCT02949362|469720105|FG000|Retrospective Period|Inform consent not signed by participant|4|||
130478080|NCT02949362|469720106|FG001|Retrospective Period|Inform consent not signed by participant|1|||
130478081|NCT02949362|469720107|FG002|Retrospective Period|Inform consent not signed by participant|0|||
130478082|NCT02949362|469720108|FG003|Retrospective Period|Inform consent not signed by participant|0|||
130478083|NCT02949362|469720105|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
130478084|NCT02949362|469720106|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
130478085|NCT02949362|469720107|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
130478086|NCT02949362|469720108|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
130478087|NCT02949362|469720105|FG000|Prospective Period|Other|0|||
130478088|NCT02949362|469720106|FG001|Prospective Period|Other|0|||
130478089|NCT02949362|469720107|FG002|Prospective Period|Other|0|||
130478090|NCT02949362|469720108|FG003|Prospective Period|Other|4|||
130478091|NCT01000961|469720109|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130478092|NCT01000961|469720110|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130478093|NCT01000961|469720109|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
130478094|NCT01000961|469720110|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
130478095|NCT04633122|469720117|FG000|Overall Study|Remained on treatment|19|||
130478096|NCT04633122|469720118|FG001|Overall Study|Remained on treatment|14|||
130478097|NCT04633122|469720117|FG000|Overall Study|Survival follow-up stopped|22|||
130478098|NCT04633122|469720118|FG001|Overall Study|Survival follow-up stopped|25|||
130478099|NCT03307343|469720119|FG000|Overall Study|Withdrawal by Subject|1|||
130478100|NCT03307343|469720120|FG001|Overall Study|Withdrawal by Subject|2|||
130478101|NCT03307343|469720119|FG000|Overall Study|Pregnancy|0|||
130478102|NCT03307343|469720120|FG001|Overall Study|Pregnancy|2|||
130478103|NCT03307343|469720119|FG000|Overall Study|Physician Decision|1|||
130478104|NCT03307343|469720120|FG001|Overall Study|Physician Decision|0|||
130478105|NCT03307343|469720119|FG000|Overall Study|Lost to Follow-up|0|||
130478106|NCT03307343|469720120|FG001|Overall Study|Lost to Follow-up|2|||
130478107|NCT04185298|469720121|FG000|Overall Study|Lost to Follow-up|1|||
130478108|NCT04185298|469720122|FG001|Overall Study|Lost to Follow-up|3|||
130478109|NCT04185298|469720121|FG000|Overall Study|Withdrawal by Subject|0|||
130478110|NCT04185298|469720122|FG001|Overall Study|Withdrawal by Subject|3|||
130478111|NCT01798498|469720123|FG000|Overall Study|Lost to Follow-up|1|||
130478112|NCT03896789|469720124|FG000|Baseline|Lost to Follow-up|1|||
130478113|NCT03896789|469720125|FG001|Baseline|Lost to Follow-up|2|||
130478114|NCT03896789|469720124|FG000|Baseline|Death|3|||
130478115|NCT03896789|469720125|FG001|Baseline|Death|6|||
130478116|NCT03896789|469720124|FG000|Post-Randomization|Lost to Follow-up|12|||
130478117|NCT03896789|469720125|FG001|Post-Randomization|Lost to Follow-up|11|||
130478118|NCT03896789|469720124|FG000|Post-Randomization|Death|12|||
130727723|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
130427346|NCT04642898|469525145|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
130427347|NCT04642898|469525146|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130427348|NCT03574597|469525147|FG000|Overall Study|Withdrawal by Subject|67|||
130427349|NCT03574597|469525148|FG001|Overall Study|Withdrawal by Subject|96|||
130427350|NCT03574597|469525147|FG000|Overall Study|Lost to Follow-up|192|||
130427351|NCT03574597|469525148|FG001|Overall Study|Lost to Follow-up|188|||
130427352|NCT03434678|469525149|FG000|Overall Study|Withdrawal by Subject|13|||
130427353|NCT03434678|469525150|FG001|Overall Study|Withdrawal by Subject|13|||
130427354|NCT03434678|469525149|FG000|Overall Study|Found to be ineligible post randomization|2|||
130427355|NCT03434678|469525150|FG001|Overall Study|Found to be ineligible post randomization|1|||
130427356|NCT06060457|469525153|FG000|Overall Study|Adverse Event|1|||
130427357|NCT06060457|469525154|FG001|Overall Study|Adverse Event|1|||
130427358|NCT06060457|469525153|FG000|Overall Study|Death|2|||
130427359|NCT06060457|469525154|FG001|Overall Study|Death|2|||
130427360|NCT06060457|469525153|FG000|Overall Study|Lost to Follow-up|17|||
130427361|NCT06060457|469525154|FG001|Overall Study|Lost to Follow-up|19|||
130427362|NCT06060457|469525153|FG000|Overall Study|Physician Decision|0|||
130427363|NCT06060457|469525154|FG001|Overall Study|Physician Decision|1|||
130427364|NCT06060457|469525153|FG000|Overall Study|Protocol Violation|1|||
130427365|NCT06060457|469525154|FG001|Overall Study|Protocol Violation|1|||
130427366|NCT06060457|469525153|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
130427367|NCT06060457|469525154|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
130427368|NCT06060457|469525153|FG000|Overall Study|Withdrawal by Subject|12|||
130427369|NCT06060457|469525154|FG001|Overall Study|Withdrawal by Subject|15|||
130427370|NCT06060457|469525153|FG000|Overall Study|Other Than Specified|2|||
130427371|NCT06060457|469525154|FG001|Overall Study|Other Than Specified|1|||
130427372|NCT02061202|469525155|FG000|Overall Study|Lost to Follow-up|1|||
130427373|NCT02061202|469525156|FG001|Overall Study|Lost to Follow-up|1|||
130427374|NCT01533493|469525157|FG000|Overall Study|Adverse Event|2|||
130427375|NCT01533493|469525158|FG001|Overall Study|Adverse Event|1|||
130427376|NCT01533493|469525157|FG000|Overall Study|Withdrawal by Subject|1|||
130427377|NCT01533493|469525158|FG001|Overall Study|Withdrawal by Subject|2|||
130427378|NCT01533493|469525157|FG000|Overall Study|Lost to Follow-up|2|||
130427379|NCT01533493|469525158|FG001|Overall Study|Lost to Follow-up|0|||
130427380|NCT05163522|469525161|FG000|Overall Study|Withdrawal by Subject|0|||
130427381|NCT05163522|469525162|FG001|Overall Study|Withdrawal by Subject|0|||
130427382|NCT05163522|469525163|FG002|Overall Study|Withdrawal by Subject|1|||
130427383|NCT05163522|469525164|FG003|Overall Study|Withdrawal by Subject|0|||
130427384|NCT05163522|469525165|FG004|Overall Study|Withdrawal by Subject|0|||
130427385|NCT05163522|469525166|FG005|Overall Study|Withdrawal by Subject|0|||
130427386|NCT05163522|469525167|FG006|Overall Study|Withdrawal by Subject|0|||
130427387|NCT05163522|469525168|FG007|Overall Study|Withdrawal by Subject|0|||
130427388|NCT05163522|469525169|FG008|Overall Study|Withdrawal by Subject|0|||
130427389|NCT05163522|469525170|FG009|Overall Study|Withdrawal by Subject|0|||
130427390|NCT05163522|469525171|FG010|Overall Study|Withdrawal by Subject|0|||
130427391|NCT02660827|469525172|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
130427392|NCT02660827|469525172|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
130427393|NCT02660827|469525172|FG000|From Study to End of Continued Access|Adverse Event|3|||
130427394|NCT02660827|469525172|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
130427395|NCT02660827|469525172|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
130427396|NCT02660827|469525172|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
130427397|NCT02660827|469525172|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
130427398|NCT02660827|469525172|FG000|Period 2: Continued Access Period|Adverse Event|3|||
130427399|NCT02953938|469525173|FG000|Overall Study|Adverse Event|0|||
130427400|NCT02953938|469525174|FG001|Overall Study|Adverse Event|1|||
130427401|NCT02953938|469525173|FG000|Overall Study|Withdrawal by Subject|1|||
130427402|NCT02953938|469525174|FG001|Overall Study|Withdrawal by Subject|1|||
130427403|NCT00313820|469525178|FG000|Assigned to Treatment|Other|1|||
130427404|NCT00313820|469525179|FG001|Assigned to Treatment|Other|0|||
130427405|NCT00313820|469525178|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
130427406|NCT00313820|469525179|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
130427407|NCT00313820|469525178|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
130478119|NCT03896789|469720125|FG001|Post-Randomization|Death|13|||
130478120|NCT03447470|469720126|FG000|Overall Study|Death|0|||
130727724|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
130427408|NCT00313820|469525179|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
130427409|NCT00313820|469525178|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
130427410|NCT00313820|469525179|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
130427411|NCT00313820|469525178|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
130427412|NCT00313820|469525179|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
130427413|NCT00313820|469525178|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
130427414|NCT00313820|469525179|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
130478121|NCT03447470|469720127|FG001|Overall Study|Death|1|||
130478122|NCT03447470|469720128|FG002|Overall Study|Death|3|||
130478123|NCT03447470|469720129|FG003|Overall Study|Death|0|||
130478124|NCT03447470|469720130|FG004|Overall Study|Death|1|||
130478125|NCT03447470|469720131|FG005|Overall Study|Death|0|||
130478126|NCT03447470|469720132|FG006|Overall Study|Death|3|||
130478127|NCT03447470|469720133|FG007|Overall Study|Death|3|||
130478128|NCT03447470|469720134|FG008|Overall Study|Death|1|||
130478129|NCT03447470|469720126|FG000|Overall Study|Withdrawal by Subject|1|||
130478130|NCT03447470|469720127|FG001|Overall Study|Withdrawal by Subject|0|||
130478131|NCT03447470|469720128|FG002|Overall Study|Withdrawal by Subject|0|||
130727725|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
130727726|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
130727727|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130727728|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130727729|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
130727730|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
130727731|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
130478132|NCT03447470|469720129|FG003|Overall Study|Withdrawal by Subject|0|||
130478133|NCT03447470|469720130|FG004|Overall Study|Withdrawal by Subject|1|||
130478134|NCT03447470|469720131|FG005|Overall Study|Withdrawal by Subject|0|||
130478135|NCT03447470|469720132|FG006|Overall Study|Withdrawal by Subject|1|||
130478136|NCT03447470|469720133|FG007|Overall Study|Withdrawal by Subject|1|||
130478137|NCT03447470|469720134|FG008|Overall Study|Withdrawal by Subject|3|||
130478138|NCT03447470|469720126|FG000|Overall Study|Treatment discontinued|3|||
130478139|NCT03447470|469720127|FG001|Overall Study|Treatment discontinued|2|||
130478140|NCT03447470|469720128|FG002|Overall Study|Treatment discontinued|4|||
130478141|NCT03447470|469720129|FG003|Overall Study|Treatment discontinued|6|||
130478142|NCT03447470|469720130|FG004|Overall Study|Treatment discontinued|2|||
130478143|NCT03447470|469720131|FG005|Overall Study|Treatment discontinued|1|||
130478144|NCT03447470|469720132|FG006|Overall Study|Treatment discontinued|2|||
130478145|NCT03447470|469720133|FG007|Overall Study|Treatment discontinued|4|||
130478146|NCT03447470|469720134|FG008|Overall Study|Treatment discontinued|3|||
130478147|NCT03382652|469720135|FG000|Overall Study|Lost to Follow-up|6|||
130478148|NCT03382652|469720135|FG000|Overall Study|Death|4|||
130478149|NCT03382652|469720135|FG000|Overall Study|Revision|5|||
130478150|NCT03382652|469720135|FG000|Overall Study|Patient withdrew|3|||
130478151|NCT03382652|469720135|FG000|Overall Study|Other reasons|21|||
130478152|NCT04810650|469720136|FG000|Overall Study|Disenrolled in error|0|||
130478153|NCT04810650|469720137|FG001|Overall Study|Disenrolled in error|0|||
130478154|NCT04810650|469720138|FG002|Overall Study|Disenrolled in error|0|||
130478155|NCT04810650|469720139|FG003|Overall Study|Disenrolled in error|0|||
130478156|NCT04810650|469720140|FG004|Overall Study|Disenrolled in error|0|||
130478157|NCT04810650|469720141|FG005|Overall Study|Disenrolled in error|0|||
130478158|NCT04810650|469720142|FG006|Overall Study|Disenrolled in error|0|||
130478159|NCT04810650|469720143|FG007|Overall Study|Disenrolled in error|0|||
130478160|NCT04810650|469720144|FG008|Overall Study|Disenrolled in error|1|||
130478161|NCT04810650|469720145|FG009|Overall Study|Disenrolled in error|0|||
130478162|NCT04810650|469720146|FG010|Overall Study|Disenrolled in error|0|||
130478163|NCT04810650|469720147|FG011|Overall Study|Disenrolled in error|0|||
130478164|NCT04810650|469720148|FG012|Overall Study|Disenrolled in error|0|||
130478165|NCT04810650|469720149|FG013|Overall Study|Disenrolled in error|0|||
130478166|NCT04810650|469720136|FG000|Overall Study|Death|0|||
130478167|NCT04810650|469720137|FG001|Overall Study|Death|0|||
130478168|NCT04810650|469720138|FG002|Overall Study|Death|0|||
130478169|NCT04810650|469720139|FG003|Overall Study|Death|0|||
130478170|NCT04810650|469720140|FG004|Overall Study|Death|0|||
130478171|NCT04810650|469720141|FG005|Overall Study|Death|0|||
130478172|NCT04810650|469720142|FG006|Overall Study|Death|2|||
130478173|NCT04810650|469720143|FG007|Overall Study|Death|2|||
130478174|NCT04810650|469720144|FG008|Overall Study|Death|0|||
130478175|NCT04810650|469720145|FG009|Overall Study|Death|1|||
130478176|NCT04810650|469720146|FG010|Overall Study|Death|0|||
130478177|NCT04810650|469720147|FG011|Overall Study|Death|0|||
130478178|NCT04810650|469720148|FG012|Overall Study|Death|2|||
130478179|NCT04810650|469720149|FG013|Overall Study|Death|1|||
130478180|NCT04810650|469720136|FG000|Overall Study|Moved/transferred care|0|||
130478181|NCT04810650|469720137|FG001|Overall Study|Moved/transferred care|0|||
130478182|NCT04810650|469720138|FG002|Overall Study|Moved/transferred care|0|||
130478183|NCT04810650|469720139|FG003|Overall Study|Moved/transferred care|0|||
130478184|NCT04810650|469720140|FG004|Overall Study|Moved/transferred care|0|||
130478185|NCT04810650|469720141|FG005|Overall Study|Moved/transferred care|0|||
130478186|NCT04810650|469720142|FG006|Overall Study|Moved/transferred care|0|||
130478187|NCT04810650|469720143|FG007|Overall Study|Moved/transferred care|1|||
130478188|NCT04810650|469720144|FG008|Overall Study|Moved/transferred care|12|||
130478189|NCT04810650|469720145|FG009|Overall Study|Moved/transferred care|10|||
130478190|NCT04810650|469720146|FG010|Overall Study|Moved/transferred care|0|||
130478191|NCT04810650|469720147|FG011|Overall Study|Moved/transferred care|0|||
130478192|NCT04810650|469720148|FG012|Overall Study|Moved/transferred care|0|||
130478193|NCT04810650|469720149|FG013|Overall Study|Moved/transferred care|0|||
130478194|NCT04810650|469720136|FG000|Overall Study|Lost to Follow-up|15|||
130478195|NCT04810650|469720137|FG001|Overall Study|Lost to Follow-up|12|||
130478196|NCT04810650|469720138|FG002|Overall Study|Lost to Follow-up|7|||
130478197|NCT04810650|469720139|FG003|Overall Study|Lost to Follow-up|9|||
130478198|NCT04810650|469720140|FG004|Overall Study|Lost to Follow-up|10|||
130478199|NCT04810650|469720141|FG005|Overall Study|Lost to Follow-up|6|||
130478200|NCT04810650|469720142|FG006|Overall Study|Lost to Follow-up|0|||
130478201|NCT04810650|469720143|FG007|Overall Study|Lost to Follow-up|0|||
130478202|NCT04810650|469720144|FG008|Overall Study|Lost to Follow-up|0|||
130478203|NCT04810650|469720145|FG009|Overall Study|Lost to Follow-up|0|||
130478204|NCT04810650|469720146|FG010|Overall Study|Lost to Follow-up|1|||
130478205|NCT04810650|469720147|FG011|Overall Study|Lost to Follow-up|0|||
130478206|NCT04810650|469720148|FG012|Overall Study|Lost to Follow-up|3|||
130478207|NCT04810650|469720149|FG013|Overall Study|Lost to Follow-up|9|||
130478208|NCT04810650|469720136|FG000|Overall Study|Participant declined|0|||
130478209|NCT04810650|469720137|FG001|Overall Study|Participant declined|0|||
130478210|NCT04810650|469720138|FG002|Overall Study|Participant declined|0|||
130478211|NCT04810650|469720139|FG003|Overall Study|Participant declined|0|||
130478212|NCT04810650|469720140|FG004|Overall Study|Participant declined|0|||
130478213|NCT04810650|469720141|FG005|Overall Study|Participant declined|0|||
130478214|NCT04810650|469720142|FG006|Overall Study|Participant declined|0|||
130478215|NCT04810650|469720143|FG007|Overall Study|Participant declined|0|||
130727732|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
130727733|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
130727734|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
130478216|NCT04810650|469720144|FG008|Overall Study|Participant declined|0|||
130478217|NCT04810650|469720145|FG009|Overall Study|Participant declined|0|||
130478218|NCT04810650|469720146|FG010|Overall Study|Participant declined|2|||
130478219|NCT04810650|469720147|FG011|Overall Study|Participant declined|0|||
130478220|NCT04810650|469720148|FG012|Overall Study|Participant declined|0|||
130478221|NCT04810650|469720149|FG013|Overall Study|Participant declined|0|||
130478222|NCT05794243|469720150|FG000|Overall Study|Withdrawal by Subject|1|||
130478223|NCT05794243|469720151|FG001|Overall Study|Withdrawal by Subject|0|||
130478224|NCT05794243|469720152|FG002|Overall Study|Withdrawal by Subject|1|||
130478225|NCT05794243|469720150|FG000|Overall Study|Physician Decision|0|||
130478226|NCT05794243|469720151|FG001|Overall Study|Physician Decision|3|||
130478227|NCT05794243|469720152|FG002|Overall Study|Physician Decision|1|||
130478228|NCT04788511|469720153|FG000|Overall Study|Withdrawal by Subject|2|||
130478229|NCT04788511|469720154|FG001|Overall Study|Withdrawal by Subject|1|||
130478230|NCT04788511|469720153|FG000|Overall Study|Lost to Follow-up|2|||
130478231|NCT04788511|469720154|FG001|Overall Study|Lost to Follow-up|7|||
130478232|NCT04788511|469720153|FG000|Overall Study|Death|3|||
130478233|NCT04788511|469720154|FG001|Overall Study|Death|4|||
130478234|NCT04652700|469720157|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
130478235|NCT04652700|469720158|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
130478236|NCT04652700|469720157|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
130478237|NCT04652700|469720158|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
130478238|NCT04652700|469720157|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
130478239|NCT04652700|469720158|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
130478240|NCT04652700|469720157|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
130478241|NCT04652700|469720158|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
130478242|NCT04652700|469720157|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
130478243|NCT04652700|469720158|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
130478244|NCT04652700|469720157|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
130478245|NCT04652700|469720158|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
130478246|NCT04652700|469720157|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
130478247|NCT04652700|469720158|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
130478248|NCT04652700|469720157|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
130478249|NCT04652700|469720158|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
130478250|NCT04652700|469720157|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
130478251|NCT04652700|469720158|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
130727735|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
130478252|NCT04187833|469720159|FG000|Overall Study|Withdrawal by Subject|1|||
130478253|NCT05603143|469720160|FG000|Overall Study|Withdrew consent|6|||
130478254|NCT05603143|469720161|FG001|Overall Study|Withdrew consent|2|||
130478255|NCT05603143|469720160|FG000|Overall Study|Randomized but never treated|0|||
130478256|NCT05603143|469720161|FG001|Overall Study|Randomized but never treated|3|||
130478257|NCT05603143|469720160|FG000|Overall Study|Adverse Event|2|||
130478258|NCT05603143|469720161|FG001|Overall Study|Adverse Event|0|||
130478259|NCT05603143|469720160|FG000|Overall Study|Death|0|||
130478260|NCT05603143|469720161|FG001|Overall Study|Death|1|||
130478261|NCT05603143|469720160|FG000|Overall Study|Investigator's discretion|1|||
130478262|NCT05603143|469720161|FG001|Overall Study|Investigator's discretion|0|||
130478263|NCT05603143|469720160|FG000|Overall Study|Lost to Follow-up|0|||
130478264|NCT05603143|469720161|FG001|Overall Study|Lost to Follow-up|1|||
130478265|NCT05603143|469720160|FG000|Overall Study|Protocol Violation|0|||
130478266|NCT05603143|469720161|FG001|Overall Study|Protocol Violation|1|||
130478267|NCT04209465|469720162|FG000|Overall Study|Adverse Event|0|||
130478268|NCT04209465|469720163|FG001|Overall Study|Adverse Event|0|||
130478269|NCT04209465|469720164|FG002|Overall Study|Adverse Event|0|||
130478270|NCT04209465|469720165|FG003|Overall Study|Adverse Event|0|||
130478271|NCT04209465|469720166|FG004|Overall Study|Adverse Event|0|||
130478272|NCT04209465|469720167|FG005|Overall Study|Adverse Event|1|||
130478273|NCT04209465|469720168|FG006|Overall Study|Adverse Event|0|||
130478274|NCT04209465|469720169|FG007|Overall Study|Adverse Event|0|||
130478275|NCT04209465|469720170|FG008|Overall Study|Adverse Event|1|||
130478276|NCT04209465|469720171|FG009|Overall Study|Adverse Event|0|||
130478277|NCT04209465|469720172|FG010|Overall Study|Adverse Event|2|||
130478278|NCT04209465|469720173|FG011|Overall Study|Adverse Event|1|||
130478279|NCT04209465|469720174|FG012|Overall Study|Adverse Event|1|||
130478280|NCT04209465|469720162|FG000|Overall Study|Death|1|||
130478281|NCT04209465|469720163|FG001|Overall Study|Death|0|||
130478282|NCT04209465|469720164|FG002|Overall Study|Death|0|||
130478283|NCT04209465|469720165|FG003|Overall Study|Death|0|||
130478284|NCT04209465|469720166|FG004|Overall Study|Death|2|||
130478285|NCT04209465|469720167|FG005|Overall Study|Death|7|||
130478286|NCT04209465|469720168|FG006|Overall Study|Death|2|||
130478287|NCT04209465|469720169|FG007|Overall Study|Death|2|||
130478288|NCT04209465|469720170|FG008|Overall Study|Death|1|||
130478289|NCT04209465|469720171|FG009|Overall Study|Death|1|||
130478290|NCT04209465|469720172|FG010|Overall Study|Death|1|||
130478291|NCT04209465|469720173|FG011|Overall Study|Death|0|||
130478292|NCT04209465|469720174|FG012|Overall Study|Death|10|||
130478293|NCT04209465|469720162|FG000|Overall Study|Physician Decision|0|||
130478294|NCT04209465|469720163|FG001|Overall Study|Physician Decision|1|||
130478295|NCT04209465|469720164|FG002|Overall Study|Physician Decision|0|||
130478296|NCT04209465|469720165|FG003|Overall Study|Physician Decision|0|||
130478297|NCT04209465|469720166|FG004|Overall Study|Physician Decision|0|||
130478298|NCT04209465|469720167|FG005|Overall Study|Physician Decision|0|||
130478299|NCT04209465|469720168|FG006|Overall Study|Physician Decision|0|||
130478300|NCT04209465|469720169|FG007|Overall Study|Physician Decision|0|||
130478301|NCT04209465|469720170|FG008|Overall Study|Physician Decision|0|||
130478302|NCT04209465|469720171|FG009|Overall Study|Physician Decision|0|||
130478303|NCT04209465|469720172|FG010|Overall Study|Physician Decision|0|||
130478304|NCT04209465|469720173|FG011|Overall Study|Physician Decision|0|||
130478305|NCT04209465|469720174|FG012|Overall Study|Physician Decision|0|||
130727736|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
130727737|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
130478306|NCT04209465|469720162|FG000|Overall Study|Progressive Disease|0|||
130478307|NCT04209465|469720163|FG001|Overall Study|Progressive Disease|0|||
130478308|NCT04209465|469720164|FG002|Overall Study|Progressive Disease|1|||
130478309|NCT04209465|469720165|FG003|Overall Study|Progressive Disease|2|||
130478310|NCT04209465|469720166|FG004|Overall Study|Progressive Disease|8|||
130478311|NCT04209465|469720167|FG005|Overall Study|Progressive Disease|5|||
130478312|NCT04209465|469720168|FG006|Overall Study|Progressive Disease|3|||
130478313|NCT04209465|469720169|FG007|Overall Study|Progressive Disease|4|||
130478314|NCT04209465|469720170|FG008|Overall Study|Progressive Disease|1|||
130478315|NCT04209465|469720171|FG009|Overall Study|Progressive Disease|3|||
130478316|NCT04209465|469720172|FG010|Overall Study|Progressive Disease|2|||
130478317|NCT04209465|469720173|FG011|Overall Study|Progressive Disease|1|||
130478318|NCT04209465|469720174|FG012|Overall Study|Progressive Disease|0|||
130727738|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
130727739|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Death|3|||
130478319|NCT04209465|469720162|FG000|Overall Study|Withdrawal by Subject|0|||
130478320|NCT04209465|469720163|FG001|Overall Study|Withdrawal by Subject|0|||
130478321|NCT04209465|469720164|FG002|Overall Study|Withdrawal by Subject|0|||
130478322|NCT04209465|469720165|FG003|Overall Study|Withdrawal by Subject|0|||
130478323|NCT04209465|469720166|FG004|Overall Study|Withdrawal by Subject|0|||
130478324|NCT04209465|469720167|FG005|Overall Study|Withdrawal by Subject|1|||
130727740|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Death|8|||
130727741|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
130478325|NCT04209465|469720168|FG006|Overall Study|Withdrawal by Subject|2|||
130478326|NCT04209465|469720169|FG007|Overall Study|Withdrawal by Subject|0|||
130478327|NCT04209465|469720170|FG008|Overall Study|Withdrawal by Subject|1|||
130478328|NCT04209465|469720171|FG009|Overall Study|Withdrawal by Subject|0|||
130478329|NCT04209465|469720172|FG010|Overall Study|Withdrawal by Subject|0|||
130478330|NCT04209465|469720173|FG011|Overall Study|Withdrawal by Subject|2|||
130478331|NCT04209465|469720174|FG012|Overall Study|Withdrawal by Subject|2|||
130478332|NCT04209465|469720162|FG000|Overall Study|Lost to Follow-up|0|||
130478333|NCT04209465|469720163|FG001|Overall Study|Lost to Follow-up|0|||
130478334|NCT04209465|469720164|FG002|Overall Study|Lost to Follow-up|0|||
130478335|NCT04209465|469720165|FG003|Overall Study|Lost to Follow-up|0|||
130478336|NCT04209465|469720166|FG004|Overall Study|Lost to Follow-up|0|||
130478337|NCT04209465|469720167|FG005|Overall Study|Lost to Follow-up|1|||
130478338|NCT04209465|469720168|FG006|Overall Study|Lost to Follow-up|0|||
130478339|NCT04209465|469720169|FG007|Overall Study|Lost to Follow-up|0|||
130478340|NCT04209465|469720170|FG008|Overall Study|Lost to Follow-up|1|||
130478341|NCT04209465|469720171|FG009|Overall Study|Lost to Follow-up|0|||
130478342|NCT04209465|469720172|FG010|Overall Study|Lost to Follow-up|0|||
130478343|NCT04209465|469720173|FG011|Overall Study|Lost to Follow-up|1|||
130478344|NCT04209465|469720174|FG012|Overall Study|Lost to Follow-up|0|||
130478345|NCT04209465|469720162|FG000|Overall Study|Started new therapy|0|||
130478346|NCT04209465|469720163|FG001|Overall Study|Started new therapy|0|||
130478347|NCT04209465|469720164|FG002|Overall Study|Started new therapy|0|||
130478348|NCT04209465|469720165|FG003|Overall Study|Started new therapy|0|||
130478349|NCT04209465|469720166|FG004|Overall Study|Started new therapy|0|||
130478350|NCT04209465|469720167|FG005|Overall Study|Started new therapy|1|||
130478351|NCT04209465|469720168|FG006|Overall Study|Started new therapy|0|||
130478352|NCT04209465|469720169|FG007|Overall Study|Started new therapy|0|||
130478353|NCT04209465|469720170|FG008|Overall Study|Started new therapy|0|||
130478354|NCT04209465|469720171|FG009|Overall Study|Started new therapy|0|||
130478355|NCT04209465|469720172|FG010|Overall Study|Started new therapy|0|||
130478356|NCT04209465|469720173|FG011|Overall Study|Started new therapy|0|||
130478357|NCT04209465|469720174|FG012|Overall Study|Started new therapy|0|||
130478358|NCT04209465|469720162|FG000|Overall Study|Study terminated early by sponsor|0|||
130478359|NCT04209465|469720163|FG001|Overall Study|Study terminated early by sponsor|0|||
130478360|NCT04209465|469720164|FG002|Overall Study|Study terminated early by sponsor|0|||
130478361|NCT04209465|469720165|FG003|Overall Study|Study terminated early by sponsor|0|||
130478362|NCT04209465|469720166|FG004|Overall Study|Study terminated early by sponsor|0|||
130478363|NCT04209465|469720167|FG005|Overall Study|Study terminated early by sponsor|0|||
130478364|NCT04209465|469720168|FG006|Overall Study|Study terminated early by sponsor|3|||
130478365|NCT04209465|469720169|FG007|Overall Study|Study terminated early by sponsor|0|||
130478366|NCT04209465|469720170|FG008|Overall Study|Study terminated early by sponsor|0|||
130478367|NCT04209465|469720171|FG009|Overall Study|Study terminated early by sponsor|0|||
130478368|NCT04209465|469720172|FG010|Overall Study|Study terminated early by sponsor|0|||
130478369|NCT04209465|469720173|FG011|Overall Study|Study terminated early by sponsor|0|||
130478370|NCT04209465|469720174|FG012|Overall Study|Study terminated early by sponsor|3|||
130478371|NCT04209465|469720162|FG000|Overall Study|Other|0|||
130478372|NCT04209465|469720163|FG001|Overall Study|Other|0|||
130478373|NCT04209465|469720164|FG002|Overall Study|Other|0|||
130478374|NCT04209465|469720165|FG003|Overall Study|Other|0|||
130478375|NCT04209465|469720166|FG004|Overall Study|Other|0|||
130478376|NCT04209465|469720167|FG005|Overall Study|Other|0|||
130478377|NCT04209465|469720168|FG006|Overall Study|Other|0|||
130478378|NCT04209465|469720169|FG007|Overall Study|Other|0|||
130478379|NCT04209465|469720170|FG008|Overall Study|Other|1|||
130478380|NCT04209465|469720171|FG009|Overall Study|Other|0|||
130478381|NCT04209465|469720172|FG010|Overall Study|Other|0|||
130478382|NCT04209465|469720173|FG011|Overall Study|Other|0|||
130478383|NCT04209465|469720174|FG012|Overall Study|Other|0|||
130478384|NCT03097549|469720175|FG000|Overall Study|Withdrawal by Subject|1|||
130478385|NCT03097549|469720176|FG001|Overall Study|Withdrawal by Subject|0|||
130478386|NCT03097549|469720175|FG000|Overall Study|Lost to Follow-up|1|||
130478387|NCT03097549|469720176|FG001|Overall Study|Lost to Follow-up|0|||
130478388|NCT05783102|469720177|FG000|Overall Study|Lost to Follow-up|1|||
130478389|NCT05783102|469720177|FG000|Overall Study|Withdrawal by Subject|2|||
130478390|NCT05008835|469720179|FG000|Overall Study|Adverse Event|5|||
130478391|NCT05008835|469720180|FG001|Overall Study|Adverse Event|2|||
130478392|NCT05008835|469720181|FG002|Overall Study|Adverse Event|1|||
130478393|NCT05008835|469720179|FG000|Overall Study|Lack of Efficacy|0|||
130478394|NCT05008835|469720180|FG001|Overall Study|Lack of Efficacy|0|||
130478395|NCT05008835|469720181|FG002|Overall Study|Lack of Efficacy|1|||
130478396|NCT05008835|469720179|FG000|Overall Study|Study terminated by sponsor|0|||
130478397|NCT05008835|469720180|FG001|Overall Study|Study terminated by sponsor|0|||
130478398|NCT05008835|469720181|FG002|Overall Study|Study terminated by sponsor|1|||
130478399|NCT05008835|469720179|FG000|Overall Study|Not further specified|3|||
130478400|NCT05008835|469720180|FG001|Overall Study|Not further specified|2|||
130478401|NCT05008835|469720181|FG002|Overall Study|Not further specified|1|||
130478402|NCT04171999|469720182|FG000|Overall Study|deemed ineligible after randomization|2|||
130478403|NCT04171999|469720183|FG001|Overall Study|deemed ineligible after randomization|1|||
130478404|NCT04505904|469720184|FG000|Overall Study|Withdrawal by Subject|1|||
130478405|NCT04505904|469720185|FG001|Overall Study|Withdrawal by Subject|2|||
130478406|NCT04505904|469720186|FG002|Overall Study|Withdrawal by Subject|0|||
130478407|NCT04505904|469720187|FG003|Overall Study|Withdrawal by Subject|0|||
130478408|NCT04505904|469720184|FG000|Overall Study|Physician Decision|1|||
130478409|NCT04505904|469720185|FG001|Overall Study|Physician Decision|0|||
130478410|NCT04505904|469720186|FG002|Overall Study|Physician Decision|0|||
130478411|NCT04505904|469720187|FG003|Overall Study|Physician Decision|0|||
130478412|NCT04505904|469720184|FG000|Overall Study|Adverse Event|0|||
130427415|NCT00522626|469525180|FG000|Overall Study|Lost to Follow-up|7|||
130427416|NCT03419364|469525183|FG000|Overall Study|Delivery due to maternal condition|2|||
130427417|NCT03419364|469525184|FG001|Overall Study|Delivery due to maternal condition|0|||
130427418|NCT03419364|469525185|FG002|Overall Study|Delivery due to maternal condition|0|||
130427419|NCT04120233|469525188|FG000|Overall Study|Adverse Event|0|||
130427420|NCT04120233|469525189|FG001|Overall Study|Adverse Event|0|||
130427421|NCT04120233|469525190|FG002|Overall Study|Adverse Event|0|||
130427422|NCT04120233|469525191|FG003|Overall Study|Adverse Event|0|||
130427423|NCT04120233|469525192|FG004|Overall Study|Adverse Event|1|||
130427424|NCT04120233|469525193|FG005|Overall Study|Adverse Event|0|||
130427425|NCT03779906|469525194|FG000|Overall Study|Lost to Follow-up|7|||
130427426|NCT03779906|469525194|FG000|Overall Study|COVID pandemic|1|||
130427427|NCT02553460|469525197|FG000|Overall Study|Death|3|||
130427428|NCT02553460|469525197|FG000|Overall Study|Withdrawal by Subject|1|||
130427429|NCT02553460|469525197|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
130427430|NCT02553460|469525197|FG000|Overall Study|Relapse or Transplant|14|||
130427431|NCT02553460|469525197|FG000|Overall Study|No response to treatment|2|||
130427432|NCT02553460|469525197|FG000|Overall Study|CAR T cells|2|||
130427433|NCT04814368|469525198|FG000|Overall Study|Study Terminated by Sponsor|0|||
130427434|NCT04814368|469525199|FG001|Overall Study|Study Terminated by Sponsor|3|||
130427435|NCT04814368|469525200|FG002|Overall Study|Study Terminated by Sponsor|0|||
130427436|NCT04814368|469525201|FG003|Overall Study|Study Terminated by Sponsor|2|||
130427437|NCT04814368|469525198|FG000|Overall Study|Subject Decision|1|||
130427438|NCT04814368|469525199|FG001|Overall Study|Subject Decision|2|||
130427439|NCT04814368|469525200|FG002|Overall Study|Subject Decision|0|||
130427440|NCT04814368|469525201|FG003|Overall Study|Subject Decision|0|||
130427441|NCT00939484|469526785|FG000|Overall Study|Progression/Relapse|8|||
130427442|NCT00939484|469526786|FG001|Overall Study|Progression/Relapse|20|||
130427443|NCT00939484|469526787|FG002|Overall Study|Progression/Relapse|3|||
130427444|NCT01224925|469526788|FG000|Overall Study|Lost to Follow-up|3|||
130427445|NCT01224925|469526789|FG001|Overall Study|Lost to Follow-up|2|||
130427446|NCT00245102|469526791|FG000|Overall Study|Not Treated|1|||
130427447|NCT00245102|469526792|FG001|Overall Study|Not Treated|0|||
130427448|NCT00245102|469526793|FG002|Overall Study|Not Treated|1|||
130427449|NCT00245102|469526794|FG003|Overall Study|Not Treated|0|||
130427450|NCT00245102|469526795|FG004|Overall Study|Not Treated|0|||
130427451|NCT00245102|469526796|FG005|Overall Study|Not Treated|0|||
130427452|NCT00245102|469526791|FG000|Overall Study|Protocol Violation|1|||
130427453|NCT00245102|469526792|FG001|Overall Study|Protocol Violation|0|||
130427454|NCT00245102|469526793|FG002|Overall Study|Protocol Violation|0|||
130427455|NCT00245102|469526794|FG003|Overall Study|Protocol Violation|0|||
130427456|NCT00245102|469526795|FG004|Overall Study|Protocol Violation|0|||
130427457|NCT00245102|469526796|FG005|Overall Study|Protocol Violation|0|||
130427458|NCT00245102|469526791|FG000|Overall Study|Death|0|||
130427459|NCT00245102|469526792|FG001|Overall Study|Death|0|||
130427460|NCT00245102|469526793|FG002|Overall Study|Death|0|||
130427461|NCT00245102|469526794|FG003|Overall Study|Death|1|||
130427462|NCT00245102|469526795|FG004|Overall Study|Death|0|||
130427463|NCT00245102|469526796|FG005|Overall Study|Death|0|||
130427464|NCT00245102|469526791|FG000|Overall Study|Adverse Event|4|||
130427465|NCT00245102|469526792|FG001|Overall Study|Adverse Event|2|||
130427466|NCT00245102|469526793|FG002|Overall Study|Adverse Event|5|||
130427467|NCT00245102|469526794|FG003|Overall Study|Adverse Event|1|||
130427468|NCT00245102|469526795|FG004|Overall Study|Adverse Event|0|||
130427469|NCT00245102|469526796|FG005|Overall Study|Adverse Event|2|||
130427470|NCT00245102|469526791|FG000|Overall Study|Decline in performance|0|||
130427471|NCT00245102|469526792|FG001|Overall Study|Decline in performance|2|||
130427472|NCT00245102|469526793|FG002|Overall Study|Decline in performance|0|||
130427473|NCT00245102|469526794|FG003|Overall Study|Decline in performance|1|||
130427474|NCT00245102|469526795|FG004|Overall Study|Decline in performance|0|||
130427475|NCT00245102|469526796|FG005|Overall Study|Decline in performance|2|||
130478413|NCT04505904|469720185|FG001|Overall Study|Adverse Event|1|||
130478414|NCT04505904|469720186|FG002|Overall Study|Adverse Event|0|||
130427476|NCT00245102|469526791|FG000|Overall Study|Participant needed surgery|0|||
130427477|NCT00245102|469526792|FG001|Overall Study|Participant needed surgery|0|||
130427478|NCT00245102|469526793|FG002|Overall Study|Participant needed surgery|1|||
130427479|NCT00245102|469526794|FG003|Overall Study|Participant needed surgery|0|||
130427480|NCT00245102|469526795|FG004|Overall Study|Participant needed surgery|0|||
130427481|NCT00245102|469526796|FG005|Overall Study|Participant needed surgery|0|||
130427482|NCT00245102|469526791|FG000|Overall Study|Clinical progression|1|||
130427483|NCT00245102|469526792|FG001|Overall Study|Clinical progression|0|||
130427484|NCT00245102|469526793|FG002|Overall Study|Clinical progression|0|||
130427485|NCT00245102|469526794|FG003|Overall Study|Clinical progression|0|||
130427486|NCT00245102|469526795|FG004|Overall Study|Clinical progression|0|||
130427487|NCT00245102|469526796|FG005|Overall Study|Clinical progression|0|||
130427488|NCT01756352|469526799|FG000|Overall Study|moved away and lost to followup|1|||
130427489|NCT03315143|469526800|FG000|Overall Study|Death|240|||
130427490|NCT03315143|469526801|FG001|Overall Study|Death|246|||
130427491|NCT03315143|469526800|FG000|Overall Study|Withdrawal by Subject|57|||
130427492|NCT03315143|469526801|FG001|Overall Study|Withdrawal by Subject|68|||
130427493|NCT03315143|469526800|FG000|Overall Study|Site Terminated by Sponsor|256|||
130427494|NCT03315143|469526801|FG001|Overall Study|Site Terminated by Sponsor|282|||
130427495|NCT03315143|469526800|FG000|Overall Study|Study Terminated by Sponsor|4723|||
130427496|NCT03315143|469526801|FG001|Overall Study|Study Terminated by Sponsor|4664|||
130427497|NCT03315143|469526800|FG000|Overall Study|Reason not Specified|16|||
130427498|NCT03315143|469526801|FG001|Overall Study|Reason not Specified|32|||
130427499|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
130427500|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
130427501|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
130427502|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
130427503|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
130427504|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
130427505|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
130427506|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
130427507|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
130427508|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
130427509|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
130427510|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
130427511|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
130427512|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
130427513|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
130427514|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
130427515|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
130427516|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
130427517|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
130427518|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
130427519|NCT00549757|469526802|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
130427520|NCT00549757|469526803|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
130427521|NCT00549757|469526802|FG000|Extension Period (in Average 9 Months)|Death|143|||
130427522|NCT00549757|469526803|FG001|Extension Period (in Average 9 Months)|Death|136|||
130427523|NCT00549757|469526802|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
130427524|NCT00549757|469526803|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
130427525|NCT00549757|469526802|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
130427526|NCT00549757|469526803|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
130427527|NCT00549757|469526802|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
130427528|NCT00549757|469526803|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
130427529|NCT01127646|469526804|FG000|Overall Study|Entry Criteria Not Met|1|||
130427530|NCT01127646|469526805|FG001|Overall Study|Entry Criteria Not Met|0|||
130427531|NCT01127646|469526804|FG000|Overall Study|Protocol Violation|0|||
130427532|NCT01127646|469526805|FG001|Overall Study|Protocol Violation|1|||
130427533|NCT04067401|469526806|FG000|Overall Study|Withdrawal by Subject|7|||
130427534|NCT04067401|469526807|FG001|Overall Study|Withdrawal by Subject|0|||
130427535|NCT04067401|469526806|FG000|Overall Study|no data provided|1|||
130427536|NCT04067401|469526807|FG001|Overall Study|no data provided|0|||
130427537|NCT01662063|469526810|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
130427538|NCT01662063|469526811|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
130427539|NCT01662063|469526812|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
130427540|NCT01662063|469526810|FG000|Overall Study|Lack of Efficacy|1|||
130427541|NCT01662063|469526811|FG001|Overall Study|Lack of Efficacy|6|||
130427542|NCT01662063|469526812|FG002|Overall Study|Lack of Efficacy|0|||
130427543|NCT01662063|469526810|FG000|Overall Study|Lost to Follow-up|0|||
130427544|NCT01662063|469526811|FG001|Overall Study|Lost to Follow-up|4|||
130427545|NCT01662063|469526812|FG002|Overall Study|Lost to Follow-up|0|||
130427546|NCT01662063|469526810|FG000|Overall Study|Protocol Violation|1|||
130427547|NCT01662063|469526811|FG001|Overall Study|Protocol Violation|0|||
130427548|NCT01662063|469526812|FG002|Overall Study|Protocol Violation|0|||
130427549|NCT01662063|469526810|FG000|Overall Study|Withdrawal by Subject|2|||
130427550|NCT01662063|469526811|FG001|Overall Study|Withdrawal by Subject|4|||
130427551|NCT01662063|469526812|FG002|Overall Study|Withdrawal by Subject|1|||
130478415|NCT04505904|469720187|FG003|Overall Study|Adverse Event|0|||
130478416|NCT04277442|469720190|FG000|Overall Study|Death|1|||
130478417|NCT03544281|469720191|FG000|Main Study Phase|Death|3|||
130478418|NCT03544281|469720192|FG001|Main Study Phase|Death|2|||
130478419|NCT03544281|469720193|FG002|Main Study Phase|Death|6|||
130427552|NCT01662063|469526810|FG000|Overall Study|Physician Decision|0|||
130427553|NCT01662063|469526811|FG001|Overall Study|Physician Decision|2|||
130427554|NCT01662063|469526812|FG002|Overall Study|Physician Decision|0|||
130427555|NCT01662063|469526810|FG000|Overall Study|Other|0|||
130427556|NCT01662063|469526811|FG001|Overall Study|Other|1|||
130427557|NCT01662063|469526812|FG002|Overall Study|Other|0|||
130478420|NCT03544281|469720194|FG003|Main Study Phase|Death|8|||
130427558|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
130427559|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
130427560|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130427561|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130427562|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
130427563|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
130427564|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
130427565|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130427566|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
130427567|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
130427568|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130427569|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130564849|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130564850|NCT01940471|470033755|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130564851|NCT01940471|470033756|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130564852|NCT01940471|470033757|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130564853|NCT01940471|470033758|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130564854|NCT00258674|470033759|FG000|Overall Study|Death|32|||
130564855|NCT00258674|470033760|FG001|Overall Study|Death|53|||
130727742|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
130727743|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
130427570|NCT00293267|469526813|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
130427571|NCT00293267|469526814|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
130427572|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
130427573|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
130427574|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
130427575|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
130427576|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
130427577|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
130427578|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
130427579|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
130427580|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Death|3|||
130427581|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Death|0|||
130427582|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
130427583|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
130427584|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
130427585|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
130427586|NCT00293267|469526813|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
130427587|NCT00293267|469526814|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
130427588|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
130427589|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
130427590|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
130427591|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
130427592|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
130427593|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
130427594|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
130427595|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
130427596|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
130427597|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
130427598|NCT00293267|469526813|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
130427599|NCT00293267|469526814|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
130427600|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
130427601|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
130427602|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
130427603|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
130427604|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
130427605|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
130427606|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
130427607|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
130427608|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
130427609|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
130427610|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
130427611|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
130427612|NCT00293267|469526813|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
130427613|NCT00293267|469526814|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
130427614|NCT01477853|469526815|FG000|Phase A|Adverse Event|1|||
130427615|NCT01477853|469526816|FG001|Phase A|Adverse Event|2|||
130427616|NCT01477853|469526817|FG002|Phase A|Adverse Event|2|||
130427617|NCT01477853|469526815|FG000|Phase A|Lost to Follow-up|4|||
130427618|NCT01477853|469526816|FG001|Phase A|Lost to Follow-up|3|||
130427619|NCT01477853|469526817|FG002|Phase A|Lost to Follow-up|2|||
130427620|NCT01477853|469526815|FG000|Phase A|Physician Decision|1|||
130427621|NCT01477853|469526816|FG001|Phase A|Physician Decision|0|||
130427622|NCT01477853|469526817|FG002|Phase A|Physician Decision|1|||
130427623|NCT01477853|469526815|FG000|Phase A|Study terminated by sponsor|37|||
130427624|NCT01477853|469526816|FG001|Phase A|Study terminated by sponsor|40|||
130427625|NCT01477853|469526817|FG002|Phase A|Study terminated by sponsor|39|||
130427626|NCT01477853|469526815|FG000|Phase B|Lost to Follow-up|0|||
130427627|NCT01477853|469526816|FG001|Phase B|Lost to Follow-up|1|||
130427628|NCT01477853|469526817|FG002|Phase B|Lost to Follow-up|0|||
130427629|NCT01477853|469526815|FG000|Phase B|Study terminated by sponsor|12|||
130427630|NCT01477853|469526816|FG001|Phase B|Study terminated by sponsor|10|||
130427631|NCT01477853|469526817|FG002|Phase B|Study terminated by sponsor|11|||
130427632|NCT01050816|469526818|FG000|Overall Study|Lost to Follow-up|2|||
130427633|NCT01050816|469526818|FG000|Overall Study|patient's refusal|2|||
130427634|NCT03086330|469526819|FG000|Overall Study|Withdrawal by Subject|3|||
130427635|NCT03086330|469526820|FG001|Overall Study|Withdrawal by Subject|2|||
130427636|NCT03086330|469526819|FG000|Overall Study|Lost to Follow-up|1|||
130427637|NCT03086330|469526820|FG001|Overall Study|Lost to Follow-up|2|||
130427638|NCT01814748|469526828|FG000|Overall Study|Lost to Follow-up|1|||
130427639|NCT01814748|469526829|FG001|Overall Study|Lost to Follow-up|2|||
130427640|NCT01814748|469526828|FG000|Overall Study|Study site terminated by sponsor|1|||
130427641|NCT01814748|469526829|FG001|Overall Study|Study site terminated by sponsor|1|||
130427642|NCT01814748|469526828|FG000|Overall Study|Withdrawal by Subject|6|||
130427643|NCT01814748|469526829|FG001|Overall Study|Withdrawal by Subject|4|||
130427644|NCT04044456|469526830|FG000|Overall Study|Lost to Follow-up|4|||
130427645|NCT04044456|469526831|FG001|Overall Study|Lost to Follow-up|1|||
130427646|NCT04044456|469526830|FG000|Overall Study|Withdrawal by Subject|1|||
130427647|NCT04044456|469526831|FG001|Overall Study|Withdrawal by Subject|0|||
130427648|NCT01972529|469526832|FG000|Overall Study|Adverse Event|0|||
130427649|NCT01972529|469526833|FG001|Overall Study|Adverse Event|1|||
130427650|NCT01972529|469526834|FG002|Overall Study|Adverse Event|0|||
130427651|NCT01972529|469526835|FG003|Overall Study|Adverse Event|0|||
130427652|NCT01972529|469526832|FG000|Overall Study|Lost to Follow-up|1|||
130427653|NCT01972529|469526833|FG001|Overall Study|Lost to Follow-up|0|||
130427654|NCT01972529|469526834|FG002|Overall Study|Lost to Follow-up|0|||
130427655|NCT01972529|469526835|FG003|Overall Study|Lost to Follow-up|0|||
130478421|NCT03544281|469720195|FG004|Main Study Phase|Death|4|||
130478422|NCT03544281|469720196|FG005|Main Study Phase|Death|2|||
130478423|NCT03544281|469720197|FG006|Main Study Phase|Death|4|||
130478424|NCT03544281|469720198|FG007|Main Study Phase|Death|5|||
130478425|NCT03544281|469720199|FG008|Main Study Phase|Death|5|||
130478426|NCT03544281|469720200|FG009|Main Study Phase|Death|8|||
130478427|NCT03544281|469720201|FG010|Main Study Phase|Death|6|||
130478428|NCT03544281|469720202|FG011|Main Study Phase|Death|4|||
130478429|NCT03544281|469720203|FG012|Main Study Phase|Death|0|||
130478430|NCT03544281|469720204|FG013|Main Study Phase|Death|0|||
130478431|NCT03544281|469720205|FG014|Main Study Phase|Death|0|||
130478432|NCT03544281|469720206|FG015|Main Study Phase|Death|0|||
130478433|NCT03544281|469720207|FG016|Main Study Phase|Death|0|||
130478434|NCT03544281|469720208|FG017|Main Study Phase|Death|0|||
130478435|NCT03544281|469720209|FG018|Main Study Phase|Death|0|||
130478436|NCT03544281|469720210|FG019|Main Study Phase|Death|0|||
130478437|NCT03544281|469720211|FG020|Main Study Phase|Death|0|||
130478438|NCT03544281|469720212|FG021|Main Study Phase|Death|0|||
130478439|NCT03544281|469720191|FG000|Main Study Phase|Lost to Follow-up|0|||
130478440|NCT03544281|469720192|FG001|Main Study Phase|Lost to Follow-up|0|||
130478441|NCT03544281|469720193|FG002|Main Study Phase|Lost to Follow-up|0|||
130478442|NCT03544281|469720194|FG003|Main Study Phase|Lost to Follow-up|0|||
130478443|NCT03544281|469720195|FG004|Main Study Phase|Lost to Follow-up|0|||
130478444|NCT03544281|469720196|FG005|Main Study Phase|Lost to Follow-up|0|||
130727744|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
130427656|NCT01972529|469526832|FG000|Overall Study|Participant Choice|0|||
130427657|NCT01972529|469526833|FG001|Overall Study|Participant Choice|1|||
130427658|NCT01972529|469526834|FG002|Overall Study|Participant Choice|0|||
130427659|NCT01972529|469526835|FG003|Overall Study|Participant Choice|0|||
130427660|NCT01972529|469526832|FG000|Overall Study|Withdrawl of Consent|1|||
130427661|NCT01972529|469526833|FG001|Overall Study|Withdrawl of Consent|2|||
130427662|NCT01972529|469526834|FG002|Overall Study|Withdrawl of Consent|0|||
130478445|NCT03544281|469720197|FG006|Main Study Phase|Lost to Follow-up|0|||
130478446|NCT03544281|469720198|FG007|Main Study Phase|Lost to Follow-up|0|||
130478447|NCT03544281|469720199|FG008|Main Study Phase|Lost to Follow-up|0|||
130427663|NCT01972529|469526835|FG003|Overall Study|Withdrawl of Consent|1|||
130478448|NCT03544281|469720200|FG009|Main Study Phase|Lost to Follow-up|0|||
130478449|NCT03544281|469720201|FG010|Main Study Phase|Lost to Follow-up|1|||
130478450|NCT03544281|469720202|FG011|Main Study Phase|Lost to Follow-up|0|||
130478451|NCT03544281|469720203|FG012|Main Study Phase|Lost to Follow-up|0|||
130478452|NCT03544281|469720204|FG013|Main Study Phase|Lost to Follow-up|0|||
130478453|NCT03544281|469720205|FG014|Main Study Phase|Lost to Follow-up|0|||
130478454|NCT03544281|469720206|FG015|Main Study Phase|Lost to Follow-up|0|||
130478455|NCT03544281|469720207|FG016|Main Study Phase|Lost to Follow-up|0|||
130478456|NCT03544281|469720208|FG017|Main Study Phase|Lost to Follow-up|0|||
130478457|NCT03544281|469720209|FG018|Main Study Phase|Lost to Follow-up|0|||
130478458|NCT03544281|469720210|FG019|Main Study Phase|Lost to Follow-up|0|||
130478459|NCT03544281|469720211|FG020|Main Study Phase|Lost to Follow-up|0|||
130478460|NCT03544281|469720212|FG021|Main Study Phase|Lost to Follow-up|0|||
130478461|NCT03544281|469720191|FG000|Main Study Phase|Physician Decision|0|||
130478462|NCT03544281|469720192|FG001|Main Study Phase|Physician Decision|0|||
130478463|NCT03544281|469720193|FG002|Main Study Phase|Physician Decision|0|||
130478464|NCT03544281|469720194|FG003|Main Study Phase|Physician Decision|0|||
130478465|NCT03544281|469720195|FG004|Main Study Phase|Physician Decision|0|||
130478466|NCT03544281|469720196|FG005|Main Study Phase|Physician Decision|0|||
130478467|NCT03544281|469720197|FG006|Main Study Phase|Physician Decision|0|||
130478468|NCT03544281|469720198|FG007|Main Study Phase|Physician Decision|1|||
130478469|NCT03544281|469720199|FG008|Main Study Phase|Physician Decision|0|||
130478470|NCT03544281|469720200|FG009|Main Study Phase|Physician Decision|0|||
130478471|NCT03544281|469720201|FG010|Main Study Phase|Physician Decision|0|||
130478472|NCT03544281|469720202|FG011|Main Study Phase|Physician Decision|0|||
130478473|NCT03544281|469720203|FG012|Main Study Phase|Physician Decision|0|||
130478474|NCT03544281|469720204|FG013|Main Study Phase|Physician Decision|0|||
130478475|NCT03544281|469720205|FG014|Main Study Phase|Physician Decision|0|||
130478476|NCT03544281|469720206|FG015|Main Study Phase|Physician Decision|0|||
130478477|NCT03544281|469720207|FG016|Main Study Phase|Physician Decision|0|||
130478478|NCT03544281|469720208|FG017|Main Study Phase|Physician Decision|0|||
130478479|NCT03544281|469720209|FG018|Main Study Phase|Physician Decision|0|||
130478480|NCT03544281|469720210|FG019|Main Study Phase|Physician Decision|0|||
130478481|NCT03544281|469720211|FG020|Main Study Phase|Physician Decision|0|||
130478482|NCT03544281|469720212|FG021|Main Study Phase|Physician Decision|0|||
130478483|NCT03544281|469720191|FG000|Main Study Phase|Withdrawal by Subject|2|||
130478484|NCT03544281|469720192|FG001|Main Study Phase|Withdrawal by Subject|0|||
130478485|NCT03544281|469720193|FG002|Main Study Phase|Withdrawal by Subject|1|||
130478486|NCT03544281|469720194|FG003|Main Study Phase|Withdrawal by Subject|2|||
130478487|NCT03544281|469720195|FG004|Main Study Phase|Withdrawal by Subject|0|||
130478488|NCT03544281|469720196|FG005|Main Study Phase|Withdrawal by Subject|0|||
130478489|NCT03544281|469720197|FG006|Main Study Phase|Withdrawal by Subject|0|||
130478490|NCT03544281|469720198|FG007|Main Study Phase|Withdrawal by Subject|0|||
130478491|NCT03544281|469720199|FG008|Main Study Phase|Withdrawal by Subject|2|||
130478492|NCT03544281|469720200|FG009|Main Study Phase|Withdrawal by Subject|3|||
130478493|NCT03544281|469720201|FG010|Main Study Phase|Withdrawal by Subject|0|||
130478494|NCT03544281|469720202|FG011|Main Study Phase|Withdrawal by Subject|4|||
130478495|NCT03544281|469720203|FG012|Main Study Phase|Withdrawal by Subject|0|||
130478496|NCT03544281|469720204|FG013|Main Study Phase|Withdrawal by Subject|0|||
130478497|NCT03544281|469720205|FG014|Main Study Phase|Withdrawal by Subject|0|||
130478498|NCT03544281|469720206|FG015|Main Study Phase|Withdrawal by Subject|0|||
130478499|NCT03544281|469720207|FG016|Main Study Phase|Withdrawal by Subject|0|||
130478500|NCT03544281|469720208|FG017|Main Study Phase|Withdrawal by Subject|0|||
130478501|NCT03544281|469720209|FG018|Main Study Phase|Withdrawal by Subject|0|||
130478502|NCT03544281|469720210|FG019|Main Study Phase|Withdrawal by Subject|0|||
130478503|NCT03544281|469720211|FG020|Main Study Phase|Withdrawal by Subject|0|||
130478504|NCT03544281|469720212|FG021|Main Study Phase|Withdrawal by Subject|0|||
130478505|NCT03544281|469720191|FG000|Main Study Phase|Ongoing|3|||
130478506|NCT03544281|469720192|FG001|Main Study Phase|Ongoing|1|||
130478507|NCT03544281|469720193|FG002|Main Study Phase|Ongoing|2|||
130478508|NCT03544281|469720194|FG003|Main Study Phase|Ongoing|4|||
130478509|NCT03544281|469720195|FG004|Main Study Phase|Ongoing|2|||
130478510|NCT03544281|469720196|FG005|Main Study Phase|Ongoing|4|||
130478511|NCT03544281|469720197|FG006|Main Study Phase|Ongoing|4|||
130478512|NCT03544281|469720198|FG007|Main Study Phase|Ongoing|0|||
130478513|NCT03544281|469720199|FG008|Main Study Phase|Ongoing|2|||
130478514|NCT03544281|469720200|FG009|Main Study Phase|Ongoing|2|||
130478515|NCT03544281|469720201|FG010|Main Study Phase|Ongoing|1|||
130478516|NCT03544281|469720202|FG011|Main Study Phase|Ongoing|0|||
130478517|NCT03544281|469720203|FG012|Main Study Phase|Ongoing|0|||
130727745|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
130727746|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
130478518|NCT03544281|469720204|FG013|Main Study Phase|Ongoing|0|||
130478519|NCT03544281|469720205|FG014|Main Study Phase|Ongoing|0|||
130478520|NCT03544281|469720206|FG015|Main Study Phase|Ongoing|0|||
130478521|NCT03544281|469720207|FG016|Main Study Phase|Ongoing|0|||
130478522|NCT03544281|469720208|FG017|Main Study Phase|Ongoing|0|||
130478523|NCT03544281|469720209|FG018|Main Study Phase|Ongoing|0|||
130727747|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
130478524|NCT03544281|469720210|FG019|Main Study Phase|Ongoing|0|||
130427664|NCT01972529|469526832|FG000|Overall Study|Other|0|||
130427665|NCT01972529|469526833|FG001|Overall Study|Other|0|||
130427666|NCT01972529|469526834|FG002|Overall Study|Other|0|||
130427667|NCT01972529|469526835|FG003|Overall Study|Other|2|||
130427668|NCT01972529|469526832|FG000|Overall Study|Not treated|0|||
130427669|NCT01972529|469526833|FG001|Overall Study|Not treated|1|||
130427670|NCT01972529|469526834|FG002|Overall Study|Not treated|2|||
130427671|NCT01972529|469526835|FG003|Overall Study|Not treated|1|||
130427672|NCT02274857|469526836|FG000|Overall Study|Adverse Event|1|||
130427673|NCT02274857|469526837|FG001|Overall Study|Adverse Event|0|||
130427674|NCT02274857|469526836|FG000|Overall Study|Death|1|||
130427675|NCT02274857|469526837|FG001|Overall Study|Death|2|||
130427676|NCT02274857|469526836|FG000|Overall Study|Lost to Follow-up|3|||
130427677|NCT02274857|469526837|FG001|Overall Study|Lost to Follow-up|0|||
130427678|NCT02274857|469526836|FG000|Overall Study|Physician Decision|2|||
130427679|NCT02274857|469526837|FG001|Overall Study|Physician Decision|0|||
130427680|NCT02274857|469526836|FG000|Overall Study|Trial screen failure|0|||
130427681|NCT02274857|469526837|FG001|Overall Study|Trial screen failure|2|||
130427682|NCT02274857|469526836|FG000|Overall Study|Withdrawal by Subject|11|||
130427683|NCT02274857|469526837|FG001|Overall Study|Withdrawal by Subject|2|||
130427684|NCT02274857|469526836|FG000|Overall Study|Other|2|||
130427685|NCT02274857|469526837|FG001|Overall Study|Other|0|||
130427686|NCT00330174|469526840|FG000|Overall Study|Withdrawal by Subject|7|||
130427687|NCT00330174|469526841|FG001|Overall Study|Withdrawal by Subject|7|||
130427688|NCT00330174|469526840|FG000|Overall Study|Lost to Follow-up|4|||
130427689|NCT00330174|469526841|FG001|Overall Study|Lost to Follow-up|1|||
130427690|NCT00330174|469526840|FG000|Overall Study|Clinical deterioration|1|||
130427691|NCT00330174|469526841|FG001|Overall Study|Clinical deterioration|2|||
130427692|NCT00330174|469526840|FG000|Overall Study|Excessive missed visits|3|||
130427693|NCT00330174|469526841|FG001|Overall Study|Excessive missed visits|8|||
130427694|NCT00330174|469526840|FG000|Overall Study|Miscellaneous reasons|7|||
130427695|NCT00330174|469526841|FG001|Overall Study|Miscellaneous reasons|1|||
130427696|NCT00611858|469526842|FG000|Overall Study|Adverse Event|2|||
130427697|NCT00611858|469526842|FG000|Overall Study|Withdrawal by Subject|2|||
130427698|NCT01844284|469526843|FG000|Overall Study|Lost to Follow-up|12|||
130427699|NCT01844284|469526844|FG001|Overall Study|Lost to Follow-up|7|||
130427700|NCT01058304|469526845|FG000|Overall Study|Withdrawal by Subject|8|||
130427701|NCT01058304|469526846|FG001|Overall Study|Withdrawal by Subject|5|||
130427702|NCT01058304|469526845|FG000|Overall Study|Lost to Follow-up|13|||
130427703|NCT01058304|469526846|FG001|Overall Study|Lost to Follow-up|16|||
130427704|NCT01058304|469526845|FG000|Overall Study|Developed exclusion criterion|6|||
130427705|NCT01058304|469526846|FG001|Overall Study|Developed exclusion criterion|12|||
130427706|NCT01820559|469526847|FG000|Overall Study|Adverse Event|4|||
130427707|NCT01820559|469526848|FG001|Overall Study|Adverse Event|6|||
130427708|NCT01820559|469526849|FG002|Overall Study|Adverse Event|13|||
130427709|NCT01820559|469526847|FG000|Overall Study|Withdrawal by Subject|1|||
130427710|NCT01820559|469526848|FG001|Overall Study|Withdrawal by Subject|2|||
130427711|NCT01820559|469526849|FG002|Overall Study|Withdrawal by Subject|5|||
130427712|NCT01820559|469526847|FG000|Overall Study|Protocol Violation|2|||
130427713|NCT01820559|469526848|FG001|Overall Study|Protocol Violation|1|||
130427714|NCT01820559|469526849|FG002|Overall Study|Protocol Violation|3|||
130427715|NCT01820559|469526847|FG000|Overall Study|Subject's non-compliance|1|||
130427716|NCT01820559|469526848|FG001|Overall Study|Subject's non-compliance|0|||
130427717|NCT01820559|469526849|FG002|Overall Study|Subject's non-compliance|2|||
130427718|NCT01820559|469526847|FG000|Overall Study|Lost to Follow-up|3|||
130427719|NCT01820559|469526848|FG001|Overall Study|Lost to Follow-up|2|||
130427720|NCT01820559|469526849|FG002|Overall Study|Lost to Follow-up|2|||
130427721|NCT01820559|469526847|FG000|Overall Study|At sponsor request|0|||
130427722|NCT01820559|469526848|FG001|Overall Study|At sponsor request|0|||
130427723|NCT01820559|469526849|FG002|Overall Study|At sponsor request|1|||
130427724|NCT01820559|469526847|FG000|Overall Study|Lack of Efficacy|3|||
130427725|NCT01820559|469526848|FG001|Overall Study|Lack of Efficacy|2|||
130427726|NCT01820559|469526849|FG002|Overall Study|Lack of Efficacy|3|||
130427727|NCT02755597|469526850|FG000|Overall Study|Withdrew consent|27|||
130427728|NCT02755597|469526851|FG001|Overall Study|Withdrew consent|11|||
130427729|NCT02755597|469526850|FG000|Overall Study|Lost to Follow-up|1|||
130427730|NCT02755597|469526851|FG001|Overall Study|Lost to Follow-up|0|||
130427731|NCT02755597|469526850|FG000|Overall Study|Death|78|||
130427732|NCT02755597|469526851|FG001|Overall Study|Death|36|||
130478525|NCT03544281|469720211|FG020|Main Study Phase|Ongoing|0|||
130427733|NCT02755597|469526850|FG000|Overall Study|Study terminated by Sponsor|67|||
130427734|NCT02755597|469526851|FG001|Overall Study|Study terminated by Sponsor|47|||
130427735|NCT02755597|469526850|FG000|Overall Study|Other, not specified|20|||
130427736|NCT02755597|469526851|FG001|Overall Study|Other, not specified|3|||
130427737|NCT02755597|469526850|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
130427738|NCT02755597|469526851|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
130427739|NCT02753595|469526864|FG000|Overall Study|Sponsor termination|2|||
130427740|NCT02753595|469526865|FG001|Overall Study|Sponsor termination|2|||
130427741|NCT01570868|469526866|FG000|Overall Study|Adverse Event|8|||
130564856|NCT00258674|470033761|FG002|Overall Study|Death|34|||
130564857|NCT03715153|470033762|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
130564858|NCT03715153|470033763|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
130427742|NCT01570868|469526867|FG001|Overall Study|Adverse Event|1|||
130427743|NCT01570868|469526866|FG000|Overall Study|FDA Recommendation|23|||
130427744|NCT01570868|469526867|FG001|Overall Study|FDA Recommendation|3|||
130427745|NCT01570868|469526866|FG000|Overall Study|Physician Decision|10|||
130427746|NCT01570868|469526867|FG001|Overall Study|Physician Decision|4|||
130427747|NCT01570868|469526866|FG000|Overall Study|Lost to Follow-up|1|||
130427748|NCT01570868|469526867|FG001|Overall Study|Lost to Follow-up|0|||
130427749|NCT01570868|469526866|FG000|Overall Study|Withdrawal by Subject|1|||
130427750|NCT01570868|469526867|FG001|Overall Study|Withdrawal by Subject|0|||
130427751|NCT02515279|469526873|FG000|Overall Study|Adverse Event|7|||
130427752|NCT02515279|469526873|FG000|Overall Study|Lack of Efficacy|31|||
130427753|NCT02515279|469526873|FG000|Overall Study|Lost to Follow-up|9|||
130427754|NCT02515279|469526873|FG000|Overall Study|Withdrawal by Subject|18|||
130427755|NCT02515279|469526873|FG000|Overall Study|End-of-treatment visit not attended|17|||
130427756|NCT02515279|469526873|FG000|Overall Study|Other|22|||
130427757|NCT01800968|469526875|FG000|Overall Study|Death|23|||
130427758|NCT01800968|469526876|FG001|Overall Study|Death|16|||
130478526|NCT03544281|469720212|FG021|Main Study Phase|Ongoing|0|||
130478527|NCT03544281|469720191|FG000|Main Study Phase|Investigator Site Closed|0|||
130478528|NCT03544281|469720192|FG001|Main Study Phase|Investigator Site Closed|0|||
130478529|NCT03544281|469720193|FG002|Main Study Phase|Investigator Site Closed|0|||
130478530|NCT03544281|469720194|FG003|Main Study Phase|Investigator Site Closed|0|||
130478531|NCT03544281|469720195|FG004|Main Study Phase|Investigator Site Closed|0|||
130478532|NCT03544281|469720196|FG005|Main Study Phase|Investigator Site Closed|0|||
130478533|NCT03544281|469720197|FG006|Main Study Phase|Investigator Site Closed|0|||
130478534|NCT03544281|469720198|FG007|Main Study Phase|Investigator Site Closed|0|||
130478535|NCT03544281|469720199|FG008|Main Study Phase|Investigator Site Closed|0|||
130478536|NCT03544281|469720200|FG009|Main Study Phase|Investigator Site Closed|1|||
130478537|NCT03544281|469720201|FG010|Main Study Phase|Investigator Site Closed|0|||
130478538|NCT03544281|469720202|FG011|Main Study Phase|Investigator Site Closed|0|||
130478539|NCT03544281|469720203|FG012|Main Study Phase|Investigator Site Closed|0|||
130478540|NCT03544281|469720204|FG013|Main Study Phase|Investigator Site Closed|0|||
130478541|NCT03544281|469720205|FG014|Main Study Phase|Investigator Site Closed|0|||
130478542|NCT03544281|469720206|FG015|Main Study Phase|Investigator Site Closed|0|||
130478543|NCT03544281|469720207|FG016|Main Study Phase|Investigator Site Closed|0|||
130478544|NCT03544281|469720208|FG017|Main Study Phase|Investigator Site Closed|0|||
130478545|NCT03544281|469720209|FG018|Main Study Phase|Investigator Site Closed|0|||
130478546|NCT03544281|469720210|FG019|Main Study Phase|Investigator Site Closed|0|||
130478547|NCT03544281|469720211|FG020|Main Study Phase|Investigator Site Closed|0|||
130478548|NCT03544281|469720212|FG021|Main Study Phase|Investigator Site Closed|0|||
130478549|NCT03544281|469720191|FG000|Main Study Phase|Did not receive study treatment|0|||
130478550|NCT03544281|469720192|FG001|Main Study Phase|Did not receive study treatment|0|||
130478551|NCT03544281|469720193|FG002|Main Study Phase|Did not receive study treatment|0|||
130478552|NCT03544281|469720194|FG003|Main Study Phase|Did not receive study treatment|0|||
130478553|NCT03544281|469720195|FG004|Main Study Phase|Did not receive study treatment|0|||
130478554|NCT03544281|469720196|FG005|Main Study Phase|Did not receive study treatment|0|||
130478555|NCT03544281|469720197|FG006|Main Study Phase|Did not receive study treatment|1|||
130478556|NCT03544281|469720198|FG007|Main Study Phase|Did not receive study treatment|0|||
130478557|NCT03544281|469720199|FG008|Main Study Phase|Did not receive study treatment|0|||
130478558|NCT03544281|469720200|FG009|Main Study Phase|Did not receive study treatment|0|||
130478559|NCT03544281|469720201|FG010|Main Study Phase|Did not receive study treatment|0|||
130478560|NCT03544281|469720202|FG011|Main Study Phase|Did not receive study treatment|0|||
130478561|NCT03544281|469720203|FG012|Main Study Phase|Did not receive study treatment|0|||
130478562|NCT03544281|469720204|FG013|Main Study Phase|Did not receive study treatment|0|||
130478563|NCT03544281|469720205|FG014|Main Study Phase|Did not receive study treatment|0|||
130478564|NCT03544281|469720206|FG015|Main Study Phase|Did not receive study treatment|0|||
130478565|NCT03544281|469720207|FG016|Main Study Phase|Did not receive study treatment|0|||
130478566|NCT03544281|469720208|FG017|Main Study Phase|Did not receive study treatment|0|||
130478567|NCT03544281|469720209|FG018|Main Study Phase|Did not receive study treatment|0|||
130478568|NCT03544281|469720210|FG019|Main Study Phase|Did not receive study treatment|0|||
130478569|NCT03544281|469720211|FG020|Main Study Phase|Did not receive study treatment|0|||
130564859|NCT03715153|470033762|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
130564860|NCT03715153|470033763|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
130427759|NCT01800968|469526875|FG000|Overall Study|Lost to Follow-up|5|||
130427760|NCT01800968|469526876|FG001|Overall Study|Lost to Follow-up|7|||
130427761|NCT01800968|469526875|FG000|Overall Study|Withdrawal by Subject|7|||
130427762|NCT01800968|469526876|FG001|Overall Study|Withdrawal by Subject|9|||
130427763|NCT01800968|469526875|FG000|Overall Study|Physician Decision|1|||
130427764|NCT01800968|469526876|FG001|Overall Study|Physician Decision|0|||
130427765|NCT01422408|469526880|FG000|Overall Study|Adverse Event|1|||
130427766|NCT01422408|469526880|FG000|Overall Study|Withdrawal by Subject|3|||
130478570|NCT03544281|469720212|FG021|Main Study Phase|Did not receive study treatment|0|||
130478571|NCT03544281|469720191|FG000|PACT Phase|Adverse Event|0|||
130478572|NCT03544281|469720192|FG001|PACT Phase|Adverse Event|0|||
130478573|NCT03544281|469720193|FG002|PACT Phase|Adverse Event|0|||
130478574|NCT03544281|469720194|FG003|PACT Phase|Adverse Event|0|||
130478575|NCT03544281|469720195|FG004|PACT Phase|Adverse Event|0|||
130478576|NCT03544281|469720196|FG005|PACT Phase|Adverse Event|0|||
130478577|NCT03544281|469720197|FG006|PACT Phase|Adverse Event|0|||
130478578|NCT03544281|469720198|FG007|PACT Phase|Adverse Event|0|||
130478579|NCT03544281|469720199|FG008|PACT Phase|Adverse Event|0|||
130478580|NCT03544281|469720200|FG009|PACT Phase|Adverse Event|0|||
130478581|NCT03544281|469720201|FG010|PACT Phase|Adverse Event|0|||
130478582|NCT03544281|469720202|FG011|PACT Phase|Adverse Event|0|||
130478583|NCT03544281|469720203|FG012|PACT Phase|Adverse Event|1|||
130478584|NCT03544281|469720204|FG013|PACT Phase|Adverse Event|0|||
130478585|NCT03544281|469720205|FG014|PACT Phase|Adverse Event|0|||
130478586|NCT03544281|469720206|FG015|PACT Phase|Adverse Event|0|||
130478587|NCT03544281|469720207|FG016|PACT Phase|Adverse Event|0|||
130478588|NCT03544281|469720208|FG017|PACT Phase|Adverse Event|1|||
130478589|NCT03544281|469720209|FG018|PACT Phase|Adverse Event|1|||
130478590|NCT03544281|469720210|FG019|PACT Phase|Adverse Event|0|||
130478591|NCT03544281|469720211|FG020|PACT Phase|Adverse Event|0|||
130478592|NCT03544281|469720212|FG021|PACT Phase|Adverse Event|0|||
130478593|NCT02547987|469720213|FG000|Overall Study|Withdrawal by Subject|1|||
130478594|NCT02547987|469720213|FG000|Overall Study|Adverse Event|2|||
130478595|NCT04282148|469720214|FG000|Overall Study|Death|7|||
130478596|NCT04282148|469720214|FG000|Overall Study|Withdrawal by Subject|1|||
130478597|NCT04282148|469720214|FG000|Overall Study|Physician Decision|1|||
130478598|NCT02146378|469720215|FG000|Overall Study|No information of administration|2|||
130478599|NCT04925986|469720216|FG000|Overall Study|Death|0|||
130478600|NCT04925986|469720217|FG001|Overall Study|Death|0|||
130478601|NCT04925986|469720218|FG002|Overall Study|Death|2|||
130478602|NCT04925986|469720219|FG003|Overall Study|Death|0|||
130478603|NCT04925986|469720216|FG000|Overall Study|Lack of Efficacy|1|||
130478604|NCT04925986|469720217|FG001|Overall Study|Lack of Efficacy|2|||
130478605|NCT04925986|469720218|FG002|Overall Study|Lack of Efficacy|0|||
130478606|NCT04925986|469720219|FG003|Overall Study|Lack of Efficacy|1|||
130478607|NCT04925986|469720216|FG000|Overall Study|Withdrawal by Subject|0|||
130478608|NCT04925986|469720217|FG001|Overall Study|Withdrawal by Subject|0|||
130478609|NCT04925986|469720218|FG002|Overall Study|Withdrawal by Subject|1|||
130478610|NCT04925986|469720219|FG003|Overall Study|Withdrawal by Subject|2|||
130478611|NCT06181760|469720220|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
130478612|NCT06181760|469720221|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
130478613|NCT06181760|469720222|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
130478614|NCT06181760|469720223|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
130478615|NCT03524612|469720224|FG000|Overall Study|Lack of Efficacy|10|||
130478616|NCT03524612|469720224|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
130478617|NCT03524612|469720224|FG000|Overall Study|Adverse Event|10|||
130478618|NCT03524612|469720224|FG000|Overall Study|Withdrawal by Subject|7|||
130478619|NCT03524612|469720224|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
130478620|NCT03524612|469720224|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
130478621|NCT03524612|469720224|FG000|Overall Study|New therapy for study indication|6|||
130478622|NCT03524612|469720224|FG000|Overall Study|Death|3|||
130478623|NCT03524612|469720224|FG000|Overall Study|Lost to Follow-up|2|||
130478624|NCT03524612|469720224|FG000|Overall Study|Protocol Violation|1|||
130478625|NCT04770532|469720225|FG000|Overall Study|Withdrawal by Subject|0|||
130478626|NCT04770532|469720226|FG001|Overall Study|Withdrawal by Subject|3|||
130478627|NCT04770532|469720225|FG000|Overall Study|Physician Decision|1|||
130478628|NCT04770532|469720226|FG001|Overall Study|Physician Decision|0|||
130478629|NCT04770532|469720225|FG000|Overall Study|Death|2|||
130478630|NCT04770532|469720226|FG001|Overall Study|Death|2|||
130478631|NCT05457647|469720228|FG000|Overall Study|Lost to Follow-up|3|||
130478632|NCT04938492|469720229|FG000|Overall Study|Lost to Follow-up|17|||
130478633|NCT04938492|469720230|FG001|Overall Study|Lost to Follow-up|18|||
130478634|NCT02683447|469720231|FG000|Overall Study|Lost to Follow-up|2|||
130478635|NCT03448107|469720232|FG000|Overall Study|Lost to Follow-up|229|||
130478636|NCT03448107|469720233|FG001|Overall Study|Lost to Follow-up|258|||
130478637|NCT04025554|469720234|FG000|Overall Study|Adverse Event|3|||
130478638|NCT05030233|469720235|FG000|Overall Study|withdrawn for transfer|1|||
130478639|NCT05030233|469720236|FG001|Overall Study|withdrawn for transfer|0|||
130478640|NCT04437615|469720237|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
130478641|NCT02921230|469721909|FG000|Overall Study|Withdrawal by Subject|20|||
130478642|NCT02921230|469721910|FG001|Overall Study|Withdrawal by Subject|8|||
130478643|NCT02921230|469721909|FG000|Overall Study|Death|12|||
130478644|NCT02921230|469721910|FG001|Overall Study|Death|3|||
130478645|NCT02921230|469721909|FG000|Overall Study|Protocol Violation|17|||
130478646|NCT02921230|469721910|FG001|Overall Study|Protocol Violation|6|||
130478647|NCT02921230|469721909|FG000|Overall Study|Early completion|5|||
130478648|NCT02921230|469721910|FG001|Overall Study|Early completion|1|||
130478649|NCT02921230|469721909|FG000|Overall Study|Pending data entry|1|||
130427767|NCT03185481|469526881|FG000|Overall Study|Adverse Event|1|||
130427768|NCT03185481|469526881|FG000|Overall Study|Study Terminated by Sponsor|4|||
130427769|NCT03266770|469526886|FG000|Overall Study|Physician Decision|3|||
130427770|NCT03266770|469526886|FG000|Overall Study|Insufficient study supplies|1|||
130427771|NCT03266770|469526886|FG000|Overall Study|Adverse Event|1|||
130427772|NCT02657031|469526887|FG000|Overall Study|Adverse Event|1|||
130427773|NCT02657031|469526888|FG001|Overall Study|Adverse Event|2|||
130427774|NCT05007392|469526889|FG000|Overall Study|Randomized but not treated|1|||
130427775|NCT05007392|469526890|FG001|Overall Study|Randomized but not treated|2|||
130427776|NCT05007392|469526889|FG000|Overall Study|Other|5|||
130427777|NCT05007392|469526890|FG001|Overall Study|Other|4|||
130427778|NCT05007392|469526889|FG000|Overall Study|Lost to Follow-up|1|||
130427779|NCT05007392|469526890|FG001|Overall Study|Lost to Follow-up|2|||
130427780|NCT05007392|469526889|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
130427781|NCT05007392|469526890|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
130427782|NCT05007392|469526889|FG000|Overall Study|Use of prohibited concomitant drug|1|||
130427783|NCT05007392|469526890|FG001|Overall Study|Use of prohibited concomitant drug|1|||
130427784|NCT05007392|469526889|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
130427785|NCT05007392|469526890|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
130427786|NCT05007392|469526889|FG000|Overall Study|Adverse Event|10|||
130427787|NCT05007392|469526890|FG001|Overall Study|Adverse Event|6|||
130427788|NCT05007392|469526889|FG000|Overall Study|Participant choice|5|||
130427789|NCT05007392|469526890|FG001|Overall Study|Participant choice|10|||
130427790|NCT05007392|469526889|FG000|Overall Study|Withdrawal of consent|5|||
130427791|NCT05007392|469526890|FG001|Overall Study|Withdrawal of consent|4|||
130427792|NCT01218126|469526891|FG000|Overall Study|Adverse Event|8|||
130427793|NCT01218126|469526892|FG001|Overall Study|Adverse Event|10|||
130427794|NCT01218126|469526893|FG002|Overall Study|Adverse Event|12|||
130427795|NCT01218126|469526894|FG003|Overall Study|Adverse Event|16|||
130427796|NCT01218126|469526891|FG000|Overall Study|Lack of Efficacy|7|||
130427797|NCT01218126|469526892|FG001|Overall Study|Lack of Efficacy|2|||
130427798|NCT01218126|469526893|FG002|Overall Study|Lack of Efficacy|2|||
130427799|NCT01218126|469526894|FG003|Overall Study|Lack of Efficacy|6|||
130727748|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
130727749|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130727750|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130727751|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Other|1|||
130427800|NCT01218126|469526891|FG000|Overall Study|Protocol Violation|5|||
130427801|NCT01218126|469526892|FG001|Overall Study|Protocol Violation|2|||
130427802|NCT01218126|469526893|FG002|Overall Study|Protocol Violation|2|||
130427803|NCT01218126|469526894|FG003|Overall Study|Protocol Violation|3|||
130427804|NCT01218126|469526891|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130427805|NCT01218126|469526892|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130427806|NCT01218126|469526893|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130427807|NCT01218126|469526894|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130427808|NCT01218126|469526891|FG000|Overall Study|Lost to Follow-up|0|||
130427809|NCT01218126|469526892|FG001|Overall Study|Lost to Follow-up|0|||
130478650|NCT02921230|469721910|FG001|Overall Study|Pending data entry|0|||
130478651|NCT01396278|469721913|FG000|Overall Study|Adverse Event|0|||
130478652|NCT01396278|469721914|FG001|Overall Study|Adverse Event|0|||
130478653|NCT01396278|469721915|FG002|Overall Study|Adverse Event|0|||
130478654|NCT01396278|469721916|FG003|Overall Study|Adverse Event|2|||
130478655|NCT01396278|469721917|FG004|Overall Study|Adverse Event|0|||
130478656|NCT01396278|469721913|FG000|Overall Study|Withdraw due to trial termination|2|||
130478657|NCT01396278|469721914|FG001|Overall Study|Withdraw due to trial termination|1|||
130478658|NCT01396278|469721915|FG002|Overall Study|Withdraw due to trial termination|1|||
130478659|NCT01396278|469721916|FG003|Overall Study|Withdraw due to trial termination|0|||
130478660|NCT01396278|469721917|FG004|Overall Study|Withdraw due to trial termination|2|||
130478661|NCT04515576|469721920|FG000|Overall Study|Withdrawal by Subject|0|||
130478662|NCT04515576|469721921|FG001|Overall Study|Withdrawal by Subject|0|||
130727752|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Other|1|||
130727753|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Death|5|||
130727754|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Death|8|||
130427810|NCT01218126|469526893|FG002|Overall Study|Lost to Follow-up|0|||
130427811|NCT01218126|469526894|FG003|Overall Study|Lost to Follow-up|2|||
130427812|NCT01218126|469526891|FG000|Overall Study|Physician Decision|1|||
130427813|NCT01218126|469526892|FG001|Overall Study|Physician Decision|2|||
130427814|NCT01218126|469526893|FG002|Overall Study|Physician Decision|4|||
130427815|NCT01218126|469526894|FG003|Overall Study|Physician Decision|2|||
130427816|NCT01218126|469526891|FG000|Overall Study|Withdrawal by Subject|2|||
130478663|NCT04515576|469721922|FG002|Overall Study|Withdrawal by Subject|0|||
130427817|NCT01218126|469526892|FG001|Overall Study|Withdrawal by Subject|5|||
130427818|NCT01218126|469526893|FG002|Overall Study|Withdrawal by Subject|4|||
130478664|NCT04515576|469721923|FG003|Overall Study|Withdrawal by Subject|0|||
130478665|NCT04515576|469721924|FG004|Overall Study|Withdrawal by Subject|0|||
130427819|NCT01218126|469526894|FG003|Overall Study|Withdrawal by Subject|6|||
130427820|NCT01860703|469526895|FG000|Overall Study|Adverse Event|1|||
130427821|NCT01860703|469526896|FG001|Overall Study|Adverse Event|4|||
130427822|NCT01860703|469526897|FG002|Overall Study|Adverse Event|0|||
130427823|NCT01860703|469526898|FG003|Overall Study|Adverse Event|2|||
130427824|NCT01860703|469526895|FG000|Overall Study|Withdrawal by Subject|0|||
130427825|NCT01860703|469526896|FG001|Overall Study|Withdrawal by Subject|1|||
130427826|NCT01860703|469526897|FG002|Overall Study|Withdrawal by Subject|0|||
130427827|NCT01860703|469526898|FG003|Overall Study|Withdrawal by Subject|0|||
130427828|NCT01860703|469526895|FG000|Overall Study|Personal reason|1|||
130427829|NCT01860703|469526896|FG001|Overall Study|Personal reason|0|||
130427830|NCT01860703|469526897|FG002|Overall Study|Personal reason|1|||
130427831|NCT01860703|469526898|FG003|Overall Study|Personal reason|0|||
130427832|NCT02453685|469526903|FG000|Overall Study|Adverse Event|0|||
130427833|NCT02453685|469526904|FG001|Overall Study|Adverse Event|1|||
130427834|NCT02453685|469526903|FG000|Overall Study|Protocol Violation|7|||
130427835|NCT02453685|469526904|FG001|Overall Study|Protocol Violation|4|||
130427836|NCT02453685|469526903|FG000|Overall Study|Lost to Follow-up|0|||
130427837|NCT02453685|469526904|FG001|Overall Study|Lost to Follow-up|1|||
130427838|NCT02453685|469526903|FG000|Overall Study|Withdrawal by Subject|8|||
130427839|NCT02453685|469526904|FG001|Overall Study|Withdrawal by Subject|4|||
130427840|NCT02453685|469526903|FG000|Overall Study|Unclassified|4|||
130427841|NCT02453685|469526904|FG001|Overall Study|Unclassified|2|||
130427842|NCT00453986|469526905|FG000|Overall Study|Lost to Follow-up|6|||
130427843|NCT00453986|469526906|FG001|Overall Study|Lost to Follow-up|5|||
130427844|NCT00453986|469526907|FG002|Overall Study|Lost to Follow-up|6|||
130427845|NCT00453986|469526908|FG003|Overall Study|Lost to Follow-up|2|||
130427846|NCT00453986|469526909|FG004|Overall Study|Lost to Follow-up|0|||
130427847|NCT02778100|469526914|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
130427848|NCT02778100|469526915|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
130427849|NCT01338025|469526921|FG000|Overall Study|Unexpected closure of study|10|||
130427850|NCT01338025|469526922|FG001|Overall Study|Unexpected closure of study|9|||
130427851|NCT01338025|469526921|FG000|Overall Study|Withdrawal by Subject|0|||
130427852|NCT01338025|469526922|FG001|Overall Study|Withdrawal by Subject|2|||
130427853|NCT01338025|469526921|FG000|Overall Study|Found ineligible after starting|1|||
130427854|NCT01338025|469526922|FG001|Overall Study|Found ineligible after starting|0|||
130427855|NCT00949884|469528798|FG000|Overall Study|Adverse Event|14|||
130427856|NCT00949884|469528799|FG001|Overall Study|Adverse Event|3|||
130427857|NCT00949884|469528800|FG002|Overall Study|Adverse Event|12|||
130427858|NCT00949884|469528798|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
130427859|NCT00949884|469528799|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
130427860|NCT00949884|469528800|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
130427861|NCT00949884|469528798|FG000|Overall Study|Lost to Follow-up|7|||
130427862|NCT00949884|469528799|FG001|Overall Study|Lost to Follow-up|5|||
130427863|NCT00949884|469528800|FG002|Overall Study|Lost to Follow-up|5|||
130427864|NCT00949884|469528798|FG000|Overall Study|Physician Decision|5|||
130427865|NCT00949884|469528799|FG001|Overall Study|Physician Decision|0|||
130427866|NCT00949884|469528800|FG002|Overall Study|Physician Decision|6|||
130427867|NCT00949884|469528798|FG000|Overall Study|Treatment non-compliance|5|||
130427868|NCT00949884|469528799|FG001|Overall Study|Treatment non-compliance|0|||
130427869|NCT00949884|469528800|FG002|Overall Study|Treatment non-compliance|8|||
130427870|NCT00949884|469528798|FG000|Overall Study|Withdrawal by Subject|13|||
130427871|NCT00949884|469528799|FG001|Overall Study|Withdrawal by Subject|4|||
130427872|NCT00949884|469528800|FG002|Overall Study|Withdrawal by Subject|16|||
130427873|NCT00949884|469528798|FG000|Overall Study|Lack of Efficacy|4|||
130427874|NCT00949884|469528799|FG001|Overall Study|Lack of Efficacy|2|||
130427875|NCT00949884|469528800|FG002|Overall Study|Lack of Efficacy|7|||
130427876|NCT00949884|469528798|FG000|Overall Study|Study terminated by sponsor|0|||
130427877|NCT00949884|469528799|FG001|Overall Study|Study terminated by sponsor|0|||
130427878|NCT00949884|469528800|FG002|Overall Study|Study terminated by sponsor|1|||
130427879|NCT01953003|469528801|FG000|Overall Study|Not treated|0|||
130427880|NCT01953003|469528802|FG001|Overall Study|Not treated|1|||
130427881|NCT01953003|469528801|FG000|Overall Study|Progressive disease|35|||
130427882|NCT01953003|469528802|FG001|Overall Study|Progressive disease|45|||
130427883|NCT01953003|469528801|FG000|Overall Study|Related Adverse events|7|||
130427884|NCT01953003|469528802|FG001|Overall Study|Related Adverse events|2|||
130427885|NCT01953003|469528801|FG000|Overall Study|Non-related adverse events|0|||
130427886|NCT01953003|469528802|FG001|Overall Study|Non-related adverse events|2|||
130427887|NCT01953003|469528801|FG000|Overall Study|Protocol Violation|0|||
130727755|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
130427888|NCT01953003|469528802|FG001|Overall Study|Protocol Violation|1|||
130427889|NCT01953003|469528801|FG000|Overall Study|Withdrawal by Subject|14|||
130427890|NCT01953003|469528802|FG001|Overall Study|Withdrawal by Subject|4|||
130427891|NCT03092375|469528803|FG000|Overall Study|Lack of Efficacy|0|||
130427892|NCT03092375|469528804|FG001|Overall Study|Lack of Efficacy|1|||
130427893|NCT03092375|469528805|FG002|Overall Study|Lack of Efficacy|1|||
130427894|NCT03092375|469528806|FG003|Overall Study|Lack of Efficacy|0|||
130427895|NCT00224770|469528815|FG000|Overall Study|Lost to Follow-up|4|||
130427896|NCT00224770|469528816|FG001|Overall Study|Lost to Follow-up|2|||
130427897|NCT00224770|469528817|FG002|Overall Study|Lost to Follow-up|0|||
130427898|NCT01106430|469528818|FG000|Overall Study|Adverse Event|8|||
130427899|NCT01106430|469528819|FG001|Overall Study|Adverse Event|10|||
130427900|NCT01106430|469528818|FG000|Overall Study|Lack of Efficacy|2|||
130427901|NCT01106430|469528819|FG001|Overall Study|Lack of Efficacy|13|||
130427902|NCT01106430|469528818|FG000|Overall Study|Lost to Follow-up|5|||
130427903|NCT01106430|469528819|FG001|Overall Study|Lost to Follow-up|1|||
130427904|NCT01106430|469528818|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
130427905|NCT01106430|469528819|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
130427906|NCT01106430|469528818|FG000|Overall Study|Moved Out Of State|0|||
130427907|NCT01106430|469528819|FG001|Overall Study|Moved Out Of State|1|||
130427908|NCT01106430|469528818|FG000|Overall Study|Refused To Take Medication|0|||
130427909|NCT01106430|469528819|FG001|Overall Study|Refused To Take Medication|1|||
130427910|NCT01106430|469528818|FG000|Overall Study|Noncompliance|0|||
130427911|NCT01106430|469528819|FG001|Overall Study|Noncompliance|1|||
130427912|NCT01106430|469528818|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
130427913|NCT01106430|469528819|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
130427914|NCT01106430|469528818|FG000|Overall Study|Previous Use Of Marijuana|1|||
130427915|NCT01106430|469528819|FG001|Overall Study|Previous Use Of Marijuana|0|||
130427916|NCT01106430|469528818|FG000|Overall Study|Protocol Violation|7|||
130427917|NCT01106430|469528819|FG001|Overall Study|Protocol Violation|2|||
130427918|NCT01106430|469528818|FG000|Overall Study|Withdrawal by Subject|8|||
130427919|NCT01106430|469528819|FG001|Overall Study|Withdrawal by Subject|4|||
130427920|NCT01255592|469528822|FG000|Overall Study|Adverse Event|5|||
130427921|NCT01255592|469528823|FG001|Overall Study|Adverse Event|0|||
130427922|NCT01255592|469528822|FG000|Overall Study|Withdrawal by Subject|1|||
130427923|NCT01255592|469528823|FG001|Overall Study|Withdrawal by Subject|0|||
130427924|NCT01255592|469528822|FG000|Overall Study|Other|0|||
130427925|NCT01255592|469528823|FG001|Overall Study|Other|1|||
130427926|NCT03704584|469528825|FG000|Overall Study|Withdrawal by Subject|1|||
130427927|NCT03704584|469528826|FG001|Overall Study|Withdrawal by Subject|0|||
130427928|NCT03439189|469528827|FG000|Overall Study|Protocol Violation|19|||
130427929|NCT03439189|469528827|FG000|Overall Study|Lack of Efficacy|63|||
130427930|NCT01777321|469528828|FG000|Overall Study|Withdrawal by Subject|0|||
130427931|NCT01777321|469528829|FG001|Overall Study|Withdrawal by Subject|1|||
130427932|NCT04791761|469528833|FG000|Overall Study|Lost to Follow-up|8|||
130427933|NCT04791761|469528834|FG001|Overall Study|Lost to Follow-up|6|||
130427934|NCT04791761|469528835|FG002|Overall Study|Lost to Follow-up|10|||
130427935|NCT04791761|469528833|FG000|Overall Study|Withdrawal by Subject|0|||
130427936|NCT04791761|469528834|FG001|Overall Study|Withdrawal by Subject|1|||
130427937|NCT04791761|469528835|FG002|Overall Study|Withdrawal by Subject|1|||
130427938|NCT04791761|469528833|FG000|Overall Study|Protocol Violation|0|||
130427939|NCT04791761|469528834|FG001|Overall Study|Protocol Violation|1|||
130427940|NCT04791761|469528835|FG002|Overall Study|Protocol Violation|1|||
130427941|NCT00089141|469528836|FG000|Overall Study|Termination of trial|18|||
130427942|NCT00089141|469528837|FG001|Overall Study|Termination of trial|24|||
130427943|NCT00508261|469528840|FG000|Overall Study|Other|0|||
130427944|NCT00508261|469528841|FG001|Overall Study|Other|1|||
130427945|NCT00508261|469528842|FG002|Overall Study|Other|1|||
130427946|NCT00508261|469528843|FG003|Overall Study|Other|0|||
130427947|NCT00508261|469528840|FG000|Overall Study|Serious Adverse Event|0|||
130427948|NCT00508261|469528841|FG001|Overall Study|Serious Adverse Event|1|||
130427949|NCT00508261|469528842|FG002|Overall Study|Serious Adverse Event|0|||
130427950|NCT00508261|469528843|FG003|Overall Study|Serious Adverse Event|0|||
130427951|NCT00508261|469528840|FG000|Overall Study|Withdrawal by Subject|3|||
130427952|NCT00508261|469528841|FG001|Overall Study|Withdrawal by Subject|4|||
130427953|NCT00508261|469528842|FG002|Overall Study|Withdrawal by Subject|4|||
130427954|NCT00508261|469528843|FG003|Overall Study|Withdrawal by Subject|0|||
130427955|NCT00508261|469528840|FG000|Overall Study|Migrated/ moved from study area|0|||
130427956|NCT00508261|469528841|FG001|Overall Study|Migrated/ moved from study area|1|||
130427957|NCT00508261|469528842|FG002|Overall Study|Migrated/ moved from study area|0|||
130427958|NCT00508261|469528843|FG003|Overall Study|Migrated/ moved from study area|0|||
130427959|NCT00508261|469528840|FG000|Overall Study|Lost to Follow-up|0|||
130427960|NCT00508261|469528841|FG001|Overall Study|Lost to Follow-up|1|||
130427961|NCT00508261|469528842|FG002|Overall Study|Lost to Follow-up|1|||
130564861|NCT03715153|470033762|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
130427962|NCT00508261|469528843|FG003|Overall Study|Lost to Follow-up|1|||
130427963|NCT00180479|469528844|FG000|Overall Study|Death|4|||
130427964|NCT00180479|469528845|FG001|Overall Study|Death|2|||
130427965|NCT00180479|469528844|FG000|Overall Study|Lost to Follow-up|9|||
130427966|NCT00180479|469528845|FG001|Overall Study|Lost to Follow-up|7|||
130427967|NCT00180479|469528844|FG000|Overall Study|Withdrawal by Subject|3|||
130427968|NCT00180479|469528845|FG001|Overall Study|Withdrawal by Subject|3|||
130427969|NCT00180479|469528844|FG000|Overall Study|Informed consent not signed|0|||
130427970|NCT00180479|469528845|FG001|Overall Study|Informed consent not signed|1|||
130427971|NCT05131165|469528846|FG000|Overall Study|Death|1|||
130427972|NCT05131165|469528847|FG001|Overall Study|Death|1|||
130478666|NCT04515576|469721925|FG005|Overall Study|Withdrawal by Subject|1|||
130478667|NCT04971395|469721927|FG000|Overall Study|Withdrawal by Subject|0|||
130478668|NCT04971395|469721928|FG001|Overall Study|Withdrawal by Subject|1|||
130478669|NCT04971395|469721929|FG002|Overall Study|Withdrawal by Subject|0|||
130478670|NCT03953508|469721930|FG000|Baseline|Lost to Follow-up|3|||
130478671|NCT03953508|469721931|FG001|Baseline|Lost to Follow-up|2|||
130478672|NCT03953508|469721930|FG000|6-month Follow-up|Lost to Follow-up|62|||
130478673|NCT03953508|469721931|FG001|6-month Follow-up|Lost to Follow-up|70|||
130478674|NCT03771417|469721932|FG000|Overall Study|Withdrawal by Subject|1|||
130478675|NCT03771417|469721933|FG001|Overall Study|Withdrawal by Subject|0|||
130478676|NCT03771417|469721934|FG002|Overall Study|Withdrawal by Subject|0|||
130478677|NCT03771417|469721932|FG000|Overall Study|Covid-19 Shutdown|0|||
130478678|NCT03771417|469721933|FG001|Overall Study|Covid-19 Shutdown|1|||
130478679|NCT03771417|469721934|FG002|Overall Study|Covid-19 Shutdown|0|||
130478680|NCT02100813|469721935|FG000|Overall Study|Adverse Event|0|||
130478681|NCT02100813|469721936|FG001|Overall Study|Adverse Event|0|||
130478682|NCT02100813|469721937|FG002|Overall Study|Adverse Event|0|||
130478683|NCT02100813|469721938|FG003|Overall Study|Adverse Event|0|||
130478684|NCT02100813|469721939|FG004|Overall Study|Adverse Event|0|||
130478685|NCT02100813|469721940|FG005|Overall Study|Adverse Event|0|||
130478686|NCT02100813|469721941|FG006|Overall Study|Adverse Event|0|||
130478687|NCT02100813|469721942|FG007|Overall Study|Adverse Event|1|||
130478688|NCT04552223|469721943|FG000|Overall Study|Withdrawal by Subject|1|||
130478689|NCT04856163|469721944|FG000|Overall Study|Lost to Follow-up|97|||
130478690|NCT04856163|469721945|FG001|Overall Study|Lost to Follow-up|100|||
130478691|NCT00881621|469721951|FG000|Overall Study|Physician Decision|34|||
130478692|NCT03936322|469721956|FG000|Overall Study|Lost to Follow-up|1|||
130478693|NCT03936322|469721956|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
130478694|NCT01160211|469721958|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
130478695|NCT01160211|469721959|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
130478696|NCT01160211|469721960|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
130478697|NCT01160211|469721958|FG000|Overall Study|Lost to Follow-up|4|||
130478698|NCT01160211|469721959|FG001|Overall Study|Lost to Follow-up|8|||
130478699|NCT01160211|469721960|FG002|Overall Study|Lost to Follow-up|4|||
130478700|NCT01160211|469721958|FG000|Overall Study|Physician Decision|1|||
130478701|NCT01160211|469721959|FG001|Overall Study|Physician Decision|0|||
130427973|NCT05131165|469528848|FG002|Overall Study|Death|0|||
130427974|NCT05131165|469528846|FG000|Overall Study|Lost to Follow-up|2|||
130427975|NCT05131165|469528847|FG001|Overall Study|Lost to Follow-up|2|||
130427976|NCT05131165|469528848|FG002|Overall Study|Lost to Follow-up|5|||
130427977|NCT05131165|469528846|FG000|Overall Study|Transferred out of clinic|1|||
130427978|NCT05131165|469528847|FG001|Overall Study|Transferred out of clinic|0|||
130427979|NCT05131165|469528848|FG002|Overall Study|Transferred out of clinic|3|||
130427980|NCT05131165|469528846|FG000|Overall Study|Dropped out|1|||
130427981|NCT05131165|469528847|FG001|Overall Study|Dropped out|2|||
130427982|NCT05131165|469528848|FG002|Overall Study|Dropped out|0|||
130427983|NCT00526630|469528862|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
130427984|NCT00526630|469528863|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
130427985|NCT00526630|469528862|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
130427986|NCT00526630|469528863|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
130427987|NCT02459262|469528864|FG000|Overall Study|Withdrawal by Subject|0|||
130427988|NCT02459262|469528865|FG001|Overall Study|Withdrawal by Subject|0|||
130427989|NCT02459262|469528866|FG002|Overall Study|Withdrawal by Subject|0|||
130427990|NCT02459262|469528867|FG003|Overall Study|Withdrawal by Subject|0|||
130427991|NCT02459262|469528868|FG004|Overall Study|Withdrawal by Subject|0|||
130427992|NCT02459262|469528869|FG005|Overall Study|Withdrawal by Subject|0|||
130427993|NCT02459262|469528870|FG006|Overall Study|Withdrawal by Subject|0|||
130427994|NCT02459262|469528871|FG007|Overall Study|Withdrawal by Subject|0|||
130427995|NCT02459262|469528872|FG008|Overall Study|Withdrawal by Subject|0|||
130427996|NCT02459262|469528873|FG009|Overall Study|Withdrawal by Subject|1|||
130427997|NCT02459262|469528874|FG010|Overall Study|Withdrawal by Subject|0|||
130427998|NCT01242748|469528875|FG000|Overall Study|Adverse Event|10|||
130478702|NCT01160211|469721960|FG002|Overall Study|Physician Decision|0|||
130478703|NCT01160211|469721958|FG000|Overall Study|Withdrawal by Subject|4|||
130478704|NCT01160211|469721959|FG001|Overall Study|Withdrawal by Subject|2|||
130427999|NCT01242748|469528876|FG001|Overall Study|Adverse Event|5|||
130428000|NCT01242748|469528875|FG000|Overall Study|Lost to Follow-up|6|||
130428001|NCT01242748|469528876|FG001|Overall Study|Lost to Follow-up|2|||
130428002|NCT01242748|469528875|FG000|Overall Study|Physician Decision|3|||
130478705|NCT01160211|469721960|FG002|Overall Study|Withdrawal by Subject|2|||
130478706|NCT01160211|469721958|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
130478707|NCT01160211|469721959|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
130478708|NCT01160211|469721960|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
130478709|NCT02734290|469721961|FG000|Overall Study|Adverse Event|1|||
130478710|NCT02734290|469721962|FG001|Overall Study|Adverse Event|0|||
130478711|NCT02734290|469721961|FG000|Overall Study|Death|1|||
130478712|NCT02734290|469721962|FG001|Overall Study|Death|0|||
130428003|NCT01242748|469528876|FG001|Overall Study|Physician Decision|2|||
130428004|NCT01242748|469528875|FG000|Overall Study|Protocol Violation|1|||
130428005|NCT01242748|469528876|FG001|Overall Study|Protocol Violation|0|||
130428006|NCT01242748|469528875|FG000|Overall Study|Withdrawal by Subject|10|||
130428007|NCT01242748|469528876|FG001|Overall Study|Withdrawal by Subject|2|||
130428008|NCT01242748|469528875|FG000|Overall Study|Miscellaneous reasons|8|||
130428009|NCT01242748|469528876|FG001|Overall Study|Miscellaneous reasons|3|||
130428010|NCT00840801|469528877|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
130428011|NCT00840801|469528878|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
130428012|NCT00840801|469528879|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
130428013|NCT00840801|469528877|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
130428014|NCT00840801|469528878|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
130428015|NCT00840801|469528879|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
130428016|NCT00840801|469528877|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
130428017|NCT00840801|469528878|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
130428018|NCT00840801|469528879|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
130428019|NCT00840801|469528877|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
130428020|NCT00840801|469528878|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
130428021|NCT00840801|469528879|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
130428022|NCT01750879|469528888|FG000|Overall Study|Adverse Event|8|||
130428023|NCT01750879|469528889|FG001|Overall Study|Adverse Event|0|||
130428024|NCT01750879|469528888|FG000|Overall Study|Lack of Efficacy|1|||
130428025|NCT01750879|469528889|FG001|Overall Study|Lack of Efficacy|0|||
130428026|NCT01750879|469528888|FG000|Overall Study|Withdrawal by Subject|1|||
130428027|NCT01750879|469528889|FG001|Overall Study|Withdrawal by Subject|0|||
130428028|NCT01750879|469528888|FG000|Overall Study|Did not complete per protocol|0|||
130428029|NCT01750879|469528889|FG001|Overall Study|Did not complete per protocol|3|||
130428030|NCT03518125|469528894|FG000|Overall Study|Lost to Follow-up|0|||
130428031|NCT03518125|469528895|FG001|Overall Study|Lost to Follow-up|2|||
130428032|NCT03518125|469528896|FG002|Overall Study|Lost to Follow-up|0|||
130428033|NCT03518125|469528897|FG003|Overall Study|Lost to Follow-up|0|||
130428034|NCT03518125|469528898|FG004|Overall Study|Lost to Follow-up|3|||
130428035|NCT03518125|469528899|FG005|Overall Study|Lost to Follow-up|5|||
130428036|NCT03518125|469528894|FG000|Overall Study|Physician Decision|0|||
130428037|NCT03518125|469528895|FG001|Overall Study|Physician Decision|1|||
130428038|NCT03518125|469528896|FG002|Overall Study|Physician Decision|0|||
130428039|NCT03518125|469528897|FG003|Overall Study|Physician Decision|0|||
130428040|NCT03518125|469528898|FG004|Overall Study|Physician Decision|0|||
130428041|NCT03518125|469528899|FG005|Overall Study|Physician Decision|0|||
130428042|NCT03518125|469528894|FG000|Overall Study|Withdrawal by Subject|1|||
130428043|NCT03518125|469528895|FG001|Overall Study|Withdrawal by Subject|1|||
130428044|NCT03518125|469528896|FG002|Overall Study|Withdrawal by Subject|0|||
130428045|NCT03518125|469528897|FG003|Overall Study|Withdrawal by Subject|1|||
130428046|NCT03518125|469528898|FG004|Overall Study|Withdrawal by Subject|1|||
130428047|NCT03518125|469528899|FG005|Overall Study|Withdrawal by Subject|3|||
130428048|NCT03518125|469528894|FG000|Overall Study|Missed Day 394 Visit|1|||
130428049|NCT03518125|469528895|FG001|Overall Study|Missed Day 394 Visit|0|||
130428050|NCT03518125|469528896|FG002|Overall Study|Missed Day 394 Visit|0|||
130428051|NCT03518125|469528897|FG003|Overall Study|Missed Day 394 Visit|0|||
130428052|NCT03518125|469528898|FG004|Overall Study|Missed Day 394 Visit|0|||
130428053|NCT03518125|469528899|FG005|Overall Study|Missed Day 394 Visit|0|||
130428054|NCT02093663|469528904|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
130428055|NCT02093663|469528905|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130428056|NCT02093663|469528906|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130428057|NCT02093663|469528907|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130727756|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
130727757|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
130428058|NCT02093663|469528908|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130428059|NCT02093663|469528904|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
130428060|NCT02093663|469528905|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428061|NCT02093663|469528906|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428062|NCT02093663|469528907|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428063|NCT02093663|469528908|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130478713|NCT03158129|469721963|FG000|Overall Study|Adverse Event|0|||
130478714|NCT03158129|469721964|FG001|Overall Study|Adverse Event|1|||
130478715|NCT03158129|469721965|FG002|Overall Study|Adverse Event|0|||
130428064|NCT02093663|469528904|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
130428065|NCT02093663|469528905|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
130428066|NCT02093663|469528906|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130428067|NCT02093663|469528907|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130428068|NCT02093663|469528908|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130478716|NCT03158129|469721966|FG003|Overall Study|Adverse Event|0|||
130428069|NCT02093663|469528904|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130428070|NCT02093663|469528905|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130428071|NCT02093663|469528906|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
130428072|NCT02093663|469528907|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130428073|NCT02093663|469528908|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130428074|NCT02093663|469528904|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428075|NCT02093663|469528905|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428076|NCT02093663|469528906|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
130428077|NCT02093663|469528907|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428078|NCT02093663|469528908|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130428079|NCT02093663|469528904|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130428080|NCT02093663|469528905|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130428081|NCT02093663|469528906|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130428082|NCT02093663|469528907|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
130428083|NCT02093663|469528908|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
130428084|NCT02093663|469528904|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130428085|NCT02093663|469528905|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130428086|NCT02093663|469528906|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130428087|NCT02093663|469528907|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
130428088|NCT02093663|469528908|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
130428089|NCT02093663|469528904|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130428090|NCT02093663|469528905|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130428091|NCT02093663|469528906|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130428092|NCT02093663|469528907|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
130428093|NCT02093663|469528908|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
130428094|NCT02093663|469528904|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130428095|NCT02093663|469528905|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130428096|NCT02093663|469528906|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130428097|NCT02093663|469528907|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130428098|NCT02093663|469528908|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
130428099|NCT00508404|469528911|FG000|Overall Study|Ongoing at Data Cut-off|12|||
130428100|NCT00508404|469528911|FG000|Overall Study|Adverse Event|2|||
130428101|NCT00508404|469528911|FG000|Overall Study|Death|16|||
130428102|NCT00508404|469528911|FG000|Overall Study|Physician Decision|2|||
130428103|NCT00508404|469528911|FG000|Overall Study|Withdrawal by Subject|3|||
130428104|NCT00508404|469528911|FG000|Overall Study|Protocol-specified Criteria|2|||
130428105|NCT00508404|469528911|FG000|Overall Study|Lost to Follow-up|2|||
130428106|NCT00508404|469528911|FG000|Overall Study|Other - Not Specified|3|||
130428107|NCT01078155|469528913|FG000|Overall Study|Adverse Event|7|||
130428108|NCT01078155|469528913|FG000|Overall Study|Lack of Efficacy|16|||
130428109|NCT01078155|469528913|FG000|Overall Study|Participant's Decision|6|||
130428110|NCT01078155|469528913|FG000|Overall Study|Lost to Follow-up|15|||
130428111|NCT03286751|469528914|FG000|Washout Period 1|Withdrawal by Subject|0|||
130428112|NCT03286751|469528915|FG001|Washout Period 1|Withdrawal by Subject|0|||
130428113|NCT03286751|469528916|FG002|Washout Period 1|Withdrawal by Subject|0|||
130428114|NCT03286751|469528917|FG003|Washout Period 1|Withdrawal by Subject|0|||
130428115|NCT03286751|469528918|FG004|Washout Period 1|Withdrawal by Subject|1|||
130428116|NCT03286751|469528919|FG005|Washout Period 1|Withdrawal by Subject|0|||
130428117|NCT03286751|469528914|FG000|Washout Period 2|Personal Reasons|0|||
130428118|NCT03286751|469528915|FG001|Washout Period 2|Personal Reasons|1|||
130428119|NCT03286751|469528916|FG002|Washout Period 2|Personal Reasons|0|||
130428120|NCT03286751|469528917|FG003|Washout Period 2|Personal Reasons|0|||
130428121|NCT03286751|469528918|FG004|Washout Period 2|Personal Reasons|0|||
130428122|NCT03286751|469528919|FG005|Washout Period 2|Personal Reasons|0|||
130428123|NCT03286751|469528914|FG000|Washout Period 5|Adverse Event|0|||
130428124|NCT03286751|469528915|FG001|Washout Period 5|Adverse Event|0|||
130478717|NCT03158129|469721963|FG000|Overall Study|Death|0|||
130428125|NCT03286751|469528916|FG002|Washout Period 5|Adverse Event|0|||
130428126|NCT03286751|469528917|FG003|Washout Period 5|Adverse Event|0|||
130428127|NCT03286751|469528918|FG004|Washout Period 5|Adverse Event|1|||
130428128|NCT03286751|469528919|FG005|Washout Period 5|Adverse Event|0|||
130428129|NCT00238433|469528920|FG000|Overall Study|Screen failure|1|||
130428130|NCT00238433|469528920|FG000|Overall Study|Lost to Follow-up|1|||
130428131|NCT00238433|469528920|FG000|Overall Study|Death|1|||
130428132|NCT02403180|469528926|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
130428133|NCT02403180|469528927|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
130428134|NCT02403180|469528926|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
130428135|NCT02403180|469528927|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
130478718|NCT03158129|469721964|FG001|Overall Study|Death|0|||
130478719|NCT03158129|469721965|FG002|Overall Study|Death|0|||
130428136|NCT01445652|469528931|FG000|Overall Study|Not comfortable in lenses|5|||
130428137|NCT01445652|469528932|FG001|Overall Study|Not comfortable in lenses|0|||
130478720|NCT03158129|469721966|FG003|Overall Study|Death|1|||
130428138|NCT01445652|469528931|FG000|Overall Study|Failed to attend scheduled visit|2|||
130428139|NCT01445652|469528932|FG001|Overall Study|Failed to attend scheduled visit|3|||
130428140|NCT01445652|469528931|FG000|Overall Study|Failed teach session|2|||
130428141|NCT01445652|469528932|FG001|Overall Study|Failed teach session|0|||
130428142|NCT01445652|469528931|FG000|Overall Study|Adverse Event|1|||
130428143|NCT01445652|469528932|FG001|Overall Study|Adverse Event|0|||
130428144|NCT03595332|469528935|FG000|Overall Study|Lost to Follow-up|16|||
130428145|NCT03595332|469528936|FG001|Overall Study|Lost to Follow-up|22|||
130428146|NCT03595332|469528935|FG000|Overall Study|Unable to retrieve ID from school|0|||
130428147|NCT03595332|469528936|FG001|Overall Study|Unable to retrieve ID from school|2|||
130428148|NCT02227875|469528937|FG000|Overall Study|Protocol Violation|10|||
130428149|NCT02227875|469528938|FG001|Overall Study|Protocol Violation|7|||
130428150|NCT02227875|469528937|FG000|Overall Study|Other|1|||
130428151|NCT02227875|469528938|FG001|Overall Study|Other|3|||
130428152|NCT02227875|469528937|FG000|Overall Study|Physician Decision|1|||
130428153|NCT02227875|469528938|FG001|Overall Study|Physician Decision|0|||
130428154|NCT02227875|469528937|FG000|Overall Study|Adverse Event|3|||
130428155|NCT02227875|469528938|FG001|Overall Study|Adverse Event|0|||
130428156|NCT02227875|469528937|FG000|Overall Study|Withdrawal by Subject|12|||
130428157|NCT02227875|469528938|FG001|Overall Study|Withdrawal by Subject|13|||
130428158|NCT02227875|469528937|FG000|Overall Study|Lost to Follow-up|10|||
130428159|NCT02227875|469528938|FG001|Overall Study|Lost to Follow-up|10|||
130428160|NCT04209725|469528939|FG000|Overall Study|Adverse Event|1|||
130428161|NCT00166296|469528942|FG000|Overall Study|Withdrawal by Subject|1|||
130428162|NCT00166296|469528943|FG001|Overall Study|Withdrawal by Subject|3|||
130428163|NCT00166296|469528942|FG000|Overall Study|Adverse Event|2|||
130428164|NCT00166296|469528943|FG001|Overall Study|Adverse Event|4|||
130428165|NCT00166296|469528942|FG000|Overall Study|Lost to Follow-up|4|||
130428166|NCT00166296|469528943|FG001|Overall Study|Lost to Follow-up|2|||
130428167|NCT03412396|469528952|FG000|Overall Study|Withdrawal by Subject|2|||
130428168|NCT03412396|469528952|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
130428169|NCT03412396|469528952|FG000|Overall Study|Did not undergo RP|2|||
130428170|NCT04899245|469528961|FG000|Overall Study|Withdrawal by Subject|3|||
130428171|NCT04899245|469528962|FG001|Overall Study|Withdrawal by Subject|5|||
130428172|NCT04899245|469528963|FG002|Overall Study|Withdrawal by Subject|2|||
130428173|NCT04899245|469528961|FG000|Overall Study|No longer eligible - Left staff position|0|||
130428174|NCT04899245|469528962|FG001|Overall Study|No longer eligible - Left staff position|0|||
130428175|NCT04899245|469528963|FG002|Overall Study|No longer eligible - Left staff position|1|||
130428176|NCT04899245|469528961|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
130428177|NCT04899245|469528962|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
130428178|NCT04899245|469528963|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
130428179|NCT04899245|469528961|FG000|Overall Study|No longer eligible - Moved away from area|2|||
130428180|NCT04899245|469528962|FG001|Overall Study|No longer eligible - Moved away from area|2|||
130428181|NCT04899245|469528963|FG002|Overall Study|No longer eligible - Moved away from area|0|||
130428182|NCT03371940|469528971|FG000|Overall Study|Withdrawal by Subject|8|||
130428183|NCT03371940|469528972|FG001|Overall Study|Withdrawal by Subject|1|||
130428184|NCT03371940|469528973|FG002|Overall Study|Withdrawal by Subject|3|||
130428185|NCT03371940|469528974|FG003|Overall Study|Withdrawal by Subject|4|||
130428186|NCT05099926|469528982|FG000|Overall Study|Lost to Follow-up|1|||
130428187|NCT00724152|469528984|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
130428188|NCT00724152|469528985|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
130428189|NCT00724152|469528986|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
130428190|NCT00724152|469528984|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
130428191|NCT00724152|469528985|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
130428192|NCT00724152|469528986|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
130478721|NCT03158129|469721963|FG000|Overall Study|High surgical risk|1|||
130478722|NCT03158129|469721964|FG001|Overall Study|High surgical risk|1|||
130428193|NCT00386022|469528988|FG000|Plus Estrogen|Lost to Follow-up|2|||
130428194|NCT00386022|469528989|FG001|Plus Estrogen|Lost to Follow-up|0|||
130428195|NCT00386022|469528988|FG000|Plus Estrogen|Adverse Event|0|||
130428196|NCT00386022|469528989|FG001|Plus Estrogen|Adverse Event|1|||
130428197|NCT00031486|469528993|FG000|Overall Study|Adverse Event|1|||
130428198|NCT00031486|469528994|FG001|Overall Study|Adverse Event|0|||
130428199|NCT00031486|469528993|FG000|Overall Study|Lost to Follow-up|0|||
130428200|NCT00031486|469528994|FG001|Overall Study|Lost to Follow-up|1|||
130428201|NCT00031486|469528993|FG000|Overall Study|Withdrawal by Subject|3|||
130428202|NCT00031486|469528994|FG001|Overall Study|Withdrawal by Subject|2|||
130428203|NCT00031486|469528993|FG000|Overall Study|Death|0|||
130478723|NCT03158129|469721965|FG002|Overall Study|High surgical risk|0|||
130428204|NCT00031486|469528994|FG001|Overall Study|Death|3|||
130428205|NCT00031486|469528993|FG000|Overall Study|Non-compliant|0|||
130428206|NCT00031486|469528994|FG001|Overall Study|Non-compliant|4|||
130428207|NCT00031486|469528993|FG000|Overall Study|Did not meet eligibility requirement|2|||
130478724|NCT03158129|469721966|FG003|Overall Study|High surgical risk|0|||
130478725|NCT03158129|469721963|FG000|Overall Study|Progression|1|||
130428208|NCT00031486|469528994|FG001|Overall Study|Did not meet eligibility requirement|1|||
130428209|NCT00031486|469528993|FG000|Overall Study|Other|1|||
130428210|NCT00031486|469528994|FG001|Overall Study|Other|1|||
130428211|NCT03078816|469528995|FG000|Overall Study|Withdrawal by Subject|1|||
130428212|NCT05168579|469530304|FG000|Overall Study|Lack of Consent|1|||
130428213|NCT05168579|469530305|FG001|Overall Study|Lack of Consent|0|||
130428214|NCT05168579|469530304|FG000|Overall Study|Conflicts with time|2|||
130428215|NCT05168579|469530305|FG001|Overall Study|Conflicts with time|0|||
130428216|NCT05168579|469530304|FG000|Overall Study|Time slots were full|3|||
130428217|NCT05168579|469530305|FG001|Overall Study|Time slots were full|0|||
130428218|NCT05168579|469530304|FG000|Overall Study|Lost to Follow-up|0|||
130428219|NCT05168579|469530305|FG001|Overall Study|Lost to Follow-up|15|||
130428220|NCT01424930|469530306|FG000|Overall Study|Adverse Event|0|||
130428221|NCT01424930|469530307|FG001|Overall Study|Adverse Event|1|||
130428222|NCT01424930|469530306|FG000|Overall Study|Death|1|||
130428223|NCT01424930|469530307|FG001|Overall Study|Death|0|||
130428224|NCT01424930|469530306|FG000|Overall Study|Progressive Disease|3|||
130428225|NCT01424930|469530307|FG001|Overall Study|Progressive Disease|6|||
130428226|NCT01424930|469530306|FG000|Overall Study|Screen Failure|0|||
130428227|NCT01424930|469530307|FG001|Overall Study|Screen Failure|1|||
130428228|NCT01424930|469530306|FG000|Overall Study|Reason not specified|0|||
130428229|NCT01424930|469530307|FG001|Overall Study|Reason not specified|6|||
130428230|NCT01621880|469530308|FG000|Overall Study|Adverse Event|5|||
130428231|NCT01621880|469530309|FG001|Overall Study|Adverse Event|1|||
130428232|NCT01621880|469530308|FG000|Overall Study|Withdrawal by Subject|5|||
130428233|NCT01621880|469530309|FG001|Overall Study|Withdrawal by Subject|4|||
130428234|NCT00106184|469530311|FG000|Overall Study|Withdrawal by Subject|3|||
130428235|NCT00106184|469530312|FG001|Overall Study|Withdrawal by Subject|2|||
130428236|NCT02313909|469530313|FG000|Overall Study|Consent withdrawn by participant|33|||
130428237|NCT02313909|469530314|FG001|Overall Study|Consent withdrawn by participant|33|||
130428238|NCT02313909|469530313|FG000|Overall Study|Lost to Follow-up|24|||
130428239|NCT02313909|469530314|FG001|Overall Study|Lost to Follow-up|17|||
130428240|NCT00948974|469530320|FG000|Overall Study|Lost to Follow-up|23|||
130428241|NCT00948974|469530321|FG001|Overall Study|Lost to Follow-up|20|||
130428242|NCT00409682|469530329|FG000|Open-label Induction Period|Adverse Event|1|||
130428243|NCT00409682|469530330|FG001|Open-label Induction Period|Adverse Event|0|||
130428244|NCT00409682|469530331|FG002|Open-label Induction Period|Adverse Event|0|||
130428245|NCT00409682|469530329|FG000|Open-label Induction Period|Lack of Efficacy|1|||
130428246|NCT00409682|469530330|FG001|Open-label Induction Period|Lack of Efficacy|0|||
130428247|NCT00409682|469530331|FG002|Open-label Induction Period|Lack of Efficacy|0|||
130428248|NCT00409682|469530329|FG000|Open-label Induction Period|Protocol Violation|1|||
130428249|NCT00409682|469530330|FG001|Open-label Induction Period|Protocol Violation|0|||
130428250|NCT00409682|469530331|FG002|Open-label Induction Period|Protocol Violation|0|||
130428251|NCT00409682|469530329|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
130428252|NCT00409682|469530330|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
130428253|NCT00409682|469530331|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
130428254|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
130428255|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
130428256|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
130428257|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
130428258|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
130428259|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
130428260|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
130428261|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
130478726|NCT03158129|469721964|FG001|Overall Study|Progression|1|||
130478727|NCT03158129|469721965|FG002|Overall Study|Progression|0|||
130478728|NCT03158129|469721966|FG003|Overall Study|Progression|0|||
130478729|NCT03158129|469721963|FG000|Overall Study|Lack of resectability|0|||
130478730|NCT03158129|469721964|FG001|Overall Study|Lack of resectability|1|||
130478731|NCT03158129|469721965|FG002|Overall Study|Lack of resectability|0|||
130478732|NCT03158129|469721966|FG003|Overall Study|Lack of resectability|0|||
130478733|NCT03158129|469721963|FG000|Overall Study|Declined surgery|0|||
130478734|NCT03158129|469721964|FG001|Overall Study|Declined surgery|1|||
130478735|NCT03158129|469721965|FG002|Overall Study|Declined surgery|0|||
130478736|NCT03158129|469721966|FG003|Overall Study|Declined surgery|0|||
130428262|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
130428263|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
130428264|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
130428265|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
130428266|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
130478737|NCT03158129|469721963|FG000|Overall Study|No longer surgical candidate|0|||
130478738|NCT03158129|469721964|FG001|Overall Study|No longer surgical candidate|0|||
130478739|NCT03158129|469721965|FG002|Overall Study|No longer surgical candidate|0|||
130564862|NCT03715153|470033763|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
130727758|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
130727759|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
130727760|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
130727761|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
130727762|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
130428267|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
130428268|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
130428269|NCT00409682|469530329|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
130428270|NCT00409682|469530330|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
130428271|NCT00409682|469530331|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
130428272|NCT01896869|469530334|FG000|Overall Study|Withdrawal by Subject|0|||
130428273|NCT01896869|469530335|FG001|Overall Study|Withdrawal by Subject|6|||
130428274|NCT01896869|469530334|FG000|Overall Study|Lost to Follow-up|1|||
130428275|NCT01896869|469530335|FG001|Overall Study|Lost to Follow-up|0|||
130428276|NCT00118716|469530342|FG000|Overall Study|Adverse Event|2|||
130428277|NCT00118716|469530343|FG001|Overall Study|Adverse Event|7|||
130428278|NCT00118716|469530342|FG000|Overall Study|Protocol Violation|5|||
130428279|NCT00118716|469530343|FG001|Overall Study|Protocol Violation|4|||
130428280|NCT00118716|469530342|FG000|Overall Study|Withdrawal by Subject|0|||
130428281|NCT00118716|469530343|FG001|Overall Study|Withdrawal by Subject|1|||
130428282|NCT00118716|469530342|FG000|Overall Study|Exacerbation|2|||
130428283|NCT00118716|469530343|FG001|Overall Study|Exacerbation|2|||
130428284|NCT00118716|469530342|FG000|Overall Study|Discontinued by sponsor|1|||
130428285|NCT00118716|469530343|FG001|Overall Study|Discontinued by sponsor|1|||
130428286|NCT00118716|469530342|FG000|Overall Study|Non-compliance|1|||
130428287|NCT00118716|469530343|FG001|Overall Study|Non-compliance|3|||
130428288|NCT00118716|469530342|FG000|Overall Study|misrandomized|1|||
130428289|NCT00118716|469530343|FG001|Overall Study|misrandomized|1|||
130428290|NCT00118716|469530342|FG000|Overall Study|Expired drug use|1|||
130428291|NCT00118716|469530343|FG001|Overall Study|Expired drug use|2|||
130428292|NCT00118716|469530342|FG000|Overall Study|Investigator discretion|0|||
130428293|NCT00118716|469530343|FG001|Overall Study|Investigator discretion|1|||
130428294|NCT00454571|469530344|FG000|Overall Study|Adverse Event|2|||
130428295|NCT00454571|469530345|FG001|Overall Study|Adverse Event|0|||
130428296|NCT00454571|469530344|FG000|Overall Study|Physician Decision|0|||
130428297|NCT00454571|469530345|FG001|Overall Study|Physician Decision|1|||
130428298|NCT00454571|469530344|FG000|Overall Study|Protocol Violation|1|||
130428299|NCT00454571|469530345|FG001|Overall Study|Protocol Violation|0|||
130428300|NCT00454571|469530344|FG000|Overall Study|Withdrawal by Subject|10|||
130428301|NCT00454571|469530345|FG001|Overall Study|Withdrawal by Subject|5|||
130428302|NCT02436811|469530346|FG000|Overall Study|Lost to Follow-up|2|||
130428303|NCT02436811|469530347|FG001|Overall Study|Lost to Follow-up|9|||
130428304|NCT02436811|469530348|FG002|Overall Study|Lost to Follow-up|7|||
130428305|NCT01201811|469530349|FG000|Overall Study|Adverse Event|6|||
130428306|NCT01201811|469530349|FG000|Overall Study|Disease progression|3|||
130428307|NCT01201811|469530349|FG000|Overall Study|Withdrawal by Subject|3|||
130428308|NCT01201811|469530349|FG000|Overall Study|Death|4|||
130428309|NCT01201811|469530349|FG000|Overall Study|Treatment Failure|2|||
130428310|NCT01201811|469530349|FG000|Overall Study|Physician Decision|1|||
130428311|NCT01089374|469530350|FG000|Overall Study|Lost to Follow-up|3|||
130428312|NCT01089374|469530351|FG001|Overall Study|Lost to Follow-up|0|||
130428313|NCT01089374|469530350|FG000|Overall Study|Withdrawal by Subject|1|||
130428314|NCT01089374|469530351|FG001|Overall Study|Withdrawal by Subject|0|||
130428315|NCT01089374|469530350|FG000|Overall Study|Study closed early - low accrual|6|||
130428316|NCT01089374|469530351|FG001|Overall Study|Study closed early - low accrual|0|||
130428317|NCT02657317|469530352|FG000|Overall Study|Withdrawal by Subject|2|||
130428318|NCT02657317|469530353|FG001|Overall Study|Withdrawal by Subject|0|||
130428319|NCT02657317|469530352|FG000|Overall Study|Lost to Follow-up|3|||
130428320|NCT02657317|469530353|FG001|Overall Study|Lost to Follow-up|3|||
130428321|NCT02856113|469530354|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130727763|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Other|1|||
130727764|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Other|0|||
130428322|NCT02856113|469530355|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130428323|NCT02856113|469530354|FG000|Overall Study|Significant Protocol Deviation|1|||
130428324|NCT02856113|469530355|FG001|Overall Study|Significant Protocol Deviation|0|||
130428325|NCT02856113|469530354|FG000|Overall Study|Lost to Follow-up|3|||
130428326|NCT02856113|469530355|FG001|Overall Study|Lost to Follow-up|5|||
130428327|NCT02856113|469530354|FG000|Overall Study|Voluntary Withdrawal|3|||
130428328|NCT02856113|469530355|FG001|Overall Study|Voluntary Withdrawal|5|||
130428329|NCT02856113|469530354|FG000|Overall Study|Pregnancy|0|||
130428330|NCT02856113|469530355|FG001|Overall Study|Pregnancy|1|||
130428331|NCT02856113|469530354|FG000|Overall Study|Principal Investigator Discretion|2|||
130428332|NCT02856113|469530355|FG001|Overall Study|Principal Investigator Discretion|1|||
130428333|NCT02856113|469530354|FG000|Overall Study|Randomized but not Treated|1|||
130428334|NCT02856113|469530355|FG001|Overall Study|Randomized but not Treated|0|||
130428335|NCT02856113|469530354|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
130428336|NCT02856113|469530355|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
130428337|NCT03494166|469530356|FG000|Overall Study|Death|0|||
130428338|NCT03494166|469530357|FG001|Overall Study|Death|0|||
130428339|NCT03494166|469530358|FG002|Overall Study|Death|0|||
130428340|NCT03494166|469530359|FG003|Overall Study|Death|1|||
130428341|NCT03494166|469530360|FG004|Overall Study|Death|3|||
130428342|NCT03494166|469530361|FG005|Overall Study|Death|0|||
130428343|NCT03494166|469530356|FG000|Overall Study|Lost to Follow-up|2|||
130428344|NCT03494166|469530357|FG001|Overall Study|Lost to Follow-up|2|||
130428345|NCT03494166|469530358|FG002|Overall Study|Lost to Follow-up|2|||
130428346|NCT03494166|469530359|FG003|Overall Study|Lost to Follow-up|2|||
130428347|NCT03494166|469530360|FG004|Overall Study|Lost to Follow-up|14|||
130428348|NCT03494166|469530361|FG005|Overall Study|Lost to Follow-up|0|||
130428349|NCT03494166|469530356|FG000|Overall Study|Withdrawal by Subject|10|||
130428350|NCT03494166|469530357|FG001|Overall Study|Withdrawal by Subject|7|||
130428351|NCT03494166|469530358|FG002|Overall Study|Withdrawal by Subject|0|||
130428352|NCT03494166|469530359|FG003|Overall Study|Withdrawal by Subject|5|||
130428353|NCT03494166|469530360|FG004|Overall Study|Withdrawal by Subject|3|||
130428354|NCT03494166|469530361|FG005|Overall Study|Withdrawal by Subject|17|||
130428355|NCT03494166|469530356|FG000|Overall Study|Screen failure|1|||
130428356|NCT03494166|469530357|FG001|Overall Study|Screen failure|0|||
130428357|NCT03494166|469530358|FG002|Overall Study|Screen failure|0|||
130478740|NCT03158129|469721966|FG003|Overall Study|No longer surgical candidate|1|||
130478741|NCT03134196|469721973|FG000|Overall Study|Death|2|||
130478742|NCT03134196|469721974|FG001|Overall Study|Death|1|||
130478743|NCT03134196|469721973|FG000|Overall Study|Lost to Follow-up|13|||
130478744|NCT03134196|469721974|FG001|Overall Study|Lost to Follow-up|15|||
130428358|NCT03494166|469530359|FG003|Overall Study|Screen failure|0|||
130428359|NCT03494166|469530360|FG004|Overall Study|Screen failure|1|||
130428360|NCT03494166|469530361|FG005|Overall Study|Screen failure|0|||
130428361|NCT02857426|469530362|FG000|Overall Study|Disease progression|34|||
130428362|NCT02857426|469530363|FG001|Overall Study|Disease progression|13|||
130428363|NCT02857426|469530362|FG000|Overall Study|Study drug toxicity|4|||
130428364|NCT02857426|469530363|FG001|Overall Study|Study drug toxicity|1|||
130428365|NCT02857426|469530362|FG000|Overall Study|Death|1|||
130428366|NCT02857426|469530363|FG001|Overall Study|Death|0|||
130428367|NCT02857426|469530362|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130428368|NCT02857426|469530363|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130428369|NCT02857426|469530362|FG000|Overall Study|Participant withdrew consent|1|||
130428370|NCT02857426|469530363|FG001|Overall Study|Participant withdrew consent|1|||
130478745|NCT03134196|469721973|FG000|Overall Study|Physician Decision|0|||
130478746|NCT03134196|469721974|FG001|Overall Study|Physician Decision|1|||
130478747|NCT03134196|469721973|FG000|Overall Study|Withdrawal by Subject|19|||
130478748|NCT03134196|469721974|FG001|Overall Study|Withdrawal by Subject|12|||
130478749|NCT03134196|469721973|FG000|Overall Study|Site Unable to Contact Participant|2|||
130478750|NCT03134196|469721974|FG001|Overall Study|Site Unable to Contact Participant|0|||
130478751|NCT03134196|469721973|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
130478752|NCT03134196|469721974|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
130478753|NCT03134196|469721973|FG000|Overall Study|Scheduling Conflict|1|||
130478754|NCT03134196|469721974|FG001|Overall Study|Scheduling Conflict|0|||
130478755|NCT06516705|469721983|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
130478756|NCT06516705|469721984|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
130428371|NCT02857426|469530362|FG000|Overall Study|Maximum clinical benefit|1|||
130428372|NCT02857426|469530363|FG001|Overall Study|Maximum clinical benefit|0|||
130428373|NCT02857426|469530362|FG000|Overall Study|Completed treatment|0|||
130428374|NCT02857426|469530363|FG001|Overall Study|Completed treatment|2|||
130478757|NCT06516705|469721983|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
130478758|NCT06516705|469721984|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
130478759|NCT06516705|469721983|FG000|T3 ( 3 Month After Education)|covid-19|1|||
130478760|NCT06516705|469721984|FG001|T3 ( 3 Month After Education)|covid-19|2|||
130478761|NCT06516705|469721983|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
130478762|NCT06516705|469721984|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
130478763|NCT06516705|469721983|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
130428375|NCT02831257|469530367|FG000|Overall Study|Lack of Efficacy|3|||
130428376|NCT02831257|469530367|FG000|Overall Study|Adverse Event|2|||
130428377|NCT02831257|469530367|FG000|Overall Study|Physician Decision|1|||
130428378|NCT02831257|469530367|FG000|Overall Study|Withdrawal by Subject|6|||
130428379|NCT01780935|469530368|FG000|Overall Study|Admin problems due to early termination|321|||
130428380|NCT01780935|469530369|FG001|Overall Study|Admin problems due to early termination|309|||
130428381|NCT01780935|469530368|FG000|Overall Study|Adverse Event|2|||
130428382|NCT01780935|469530369|FG001|Overall Study|Adverse Event|4|||
130428383|NCT01780935|469530368|FG000|Overall Study|Death|1|||
130428384|NCT01780935|469530369|FG001|Overall Study|Death|6|||
130478764|NCT06516705|469721984|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
130478765|NCT06516705|469721983|FG000|T4 ( 6 Month After Education)|covid-19|3|||
130478766|NCT06516705|469721984|FG001|T4 ( 6 Month After Education)|covid-19|2|||
130478767|NCT06516705|469721983|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
130428385|NCT01780935|469530368|FG000|Overall Study|Lost to Follow-up|2|||
130428386|NCT01780935|469530369|FG001|Overall Study|Lost to Follow-up|6|||
130428387|NCT01780935|469530368|FG000|Overall Study|Physician Decision|1|||
130428388|NCT01780935|469530369|FG001|Overall Study|Physician Decision|1|||
130428389|NCT01780935|469530368|FG000|Overall Study|Protocol deviation|0|||
130428390|NCT01780935|469530369|FG001|Overall Study|Protocol deviation|1|||
130428391|NCT01780935|469530368|FG000|Overall Study|Patient withdrew consent|8|||
130428392|NCT01780935|469530369|FG001|Overall Study|Patient withdrew consent|9|||
130428393|NCT00855595|469530370|FG000|Overall Study|Withdrawal by Subject|1|||
130428394|NCT00855595|469530371|FG001|Overall Study|Withdrawal by Subject|2|||
130428395|NCT00855595|469530370|FG000|Overall Study|Lost to Follow-up|3|||
130428396|NCT00855595|469530371|FG001|Overall Study|Lost to Follow-up|3|||
130428397|NCT00855595|469530370|FG000|Overall Study|Adverse Event|1|||
130428398|NCT00855595|469530371|FG001|Overall Study|Adverse Event|1|||
130428399|NCT00855595|469530370|FG000|Overall Study|patient moved out of state|1|||
130428400|NCT00855595|469530371|FG001|Overall Study|patient moved out of state|0|||
130428401|NCT00855595|469530370|FG000|Overall Study|patient left country|0|||
130428402|NCT00855595|469530371|FG001|Overall Study|patient left country|1|||
130428403|NCT04035200|469530372|FG000|Overall Study|Lost to Follow-up|0|||
130428404|NCT04035200|469530373|FG001|Overall Study|Lost to Follow-up|1|||
130428405|NCT04035200|469530374|FG002|Overall Study|Lost to Follow-up|0|||
130428406|NCT04035200|469530372|FG000|Overall Study|Withdrawal by Subject|1|||
130428407|NCT04035200|469530373|FG001|Overall Study|Withdrawal by Subject|4|||
130428408|NCT04035200|469530374|FG002|Overall Study|Withdrawal by Subject|4|||
130428409|NCT04035200|469530372|FG000|Overall Study|COVID-19|1|||
130428410|NCT04035200|469530373|FG001|Overall Study|COVID-19|0|||
130428411|NCT04035200|469530374|FG002|Overall Study|COVID-19|0|||
130428412|NCT04035200|469530372|FG000|Overall Study|Early Termination|0|||
130428413|NCT04035200|469530373|FG001|Overall Study|Early Termination|1|||
130428414|NCT04035200|469530374|FG002|Overall Study|Early Termination|0|||
130428415|NCT04035200|469530372|FG000|Overall Study|Non-compliance|0|||
130428416|NCT04035200|469530373|FG001|Overall Study|Non-compliance|1|||
130428417|NCT04035200|469530374|FG002|Overall Study|Non-compliance|0|||
130428418|NCT03033225|469530375|FG000|Overall Study|Withdrawal by Subject|5|||
130428419|NCT03685591|469530383|FG000|Overall Study|Global Deterioration of Health Status|0|||
130428420|NCT03685591|469530384|FG001|Overall Study|Global Deterioration of Health Status|0|||
130428421|NCT03685591|469530385|FG002|Overall Study|Global Deterioration of Health Status|0|||
130428422|NCT03685591|469530386|FG003|Overall Study|Global Deterioration of Health Status|1|||
130428423|NCT03685591|469530387|FG004|Overall Study|Global Deterioration of Health Status|2|||
130428424|NCT03685591|469530388|FG005|Overall Study|Global Deterioration of Health Status|4|||
130428425|NCT03685591|469530389|FG006|Overall Study|Global Deterioration of Health Status|1|||
130428426|NCT03685591|469530390|FG007|Overall Study|Global Deterioration of Health Status|1|||
130428427|NCT03685591|469530391|FG008|Overall Study|Global Deterioration of Health Status|0|||
130428428|NCT03685591|469530383|FG000|Overall Study|Progressive Disease|1|||
130428429|NCT03685591|469530384|FG001|Overall Study|Progressive Disease|1|||
130428430|NCT03685591|469530385|FG002|Overall Study|Progressive Disease|0|||
130428431|NCT03685591|469530386|FG003|Overall Study|Progressive Disease|3|||
130428432|NCT03685591|469530387|FG004|Overall Study|Progressive Disease|5|||
130428433|NCT03685591|469530388|FG005|Overall Study|Progressive Disease|4|||
130428434|NCT03685591|469530389|FG006|Overall Study|Progressive Disease|3|||
130428435|NCT03685591|469530390|FG007|Overall Study|Progressive Disease|2|||
130428436|NCT03685591|469530391|FG008|Overall Study|Progressive Disease|1|||
130428437|NCT03685591|469530383|FG000|Overall Study|Other|0|||
130428438|NCT03685591|469530384|FG001|Overall Study|Other|0|||
130428439|NCT03685591|469530385|FG002|Overall Study|Other|1|||
130428440|NCT03685591|469530386|FG003|Overall Study|Other|0|||
130428441|NCT03685591|469530387|FG004|Overall Study|Other|2|||
130428442|NCT03685591|469530388|FG005|Overall Study|Other|3|||
130428443|NCT03685591|469530389|FG006|Overall Study|Other|0|||
130564863|NCT03715153|470033762|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
130428444|NCT03685591|469530390|FG007|Overall Study|Other|0|||
130428445|NCT03685591|469530391|FG008|Overall Study|Other|0|||
130428446|NCT03685591|469530383|FG000|Overall Study|Withdrawal by Subject|0|||
130428447|NCT03685591|469530384|FG001|Overall Study|Withdrawal by Subject|0|||
130428448|NCT03685591|469530385|FG002|Overall Study|Withdrawal by Subject|0|||
130428449|NCT03685591|469530386|FG003|Overall Study|Withdrawal by Subject|0|||
130428450|NCT03685591|469530387|FG004|Overall Study|Withdrawal by Subject|3|||
130428451|NCT03685591|469530388|FG005|Overall Study|Withdrawal by Subject|2|||
130428452|NCT03685591|469530389|FG006|Overall Study|Withdrawal by Subject|0|||
130428453|NCT03685591|469530390|FG007|Overall Study|Withdrawal by Subject|0|||
130428454|NCT03685591|469530391|FG008|Overall Study|Withdrawal by Subject|1|||
130564864|NCT03715153|470033763|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
130428455|NCT03685591|469530383|FG000|Overall Study|Adverse Event|0|||
130428456|NCT03685591|469530384|FG001|Overall Study|Adverse Event|0|||
130428457|NCT03685591|469530385|FG002|Overall Study|Adverse Event|0|||
130428458|NCT03685591|469530386|FG003|Overall Study|Adverse Event|1|||
130428459|NCT03685591|469530387|FG004|Overall Study|Adverse Event|1|||
130428460|NCT03685591|469530388|FG005|Overall Study|Adverse Event|4|||
130428461|NCT03685591|469530389|FG006|Overall Study|Adverse Event|0|||
130428462|NCT03685591|469530390|FG007|Overall Study|Adverse Event|1|||
130428463|NCT03685591|469530391|FG008|Overall Study|Adverse Event|1|||
130428464|NCT00168038|469530392|FG000|Overall Study|Adverse Event|1|||
130428465|NCT00168038|469530392|FG000|Overall Study|Therapy failure|1|||
130428466|NCT01685138|469530393|FG000|Overall Study|Lost to Follow-up|1|||
130428467|NCT01685138|469530393|FG000|Overall Study|Protocol Violation|1|||
130428468|NCT01685138|469530393|FG000|Overall Study|No longer requires treatment|1|||
130428469|NCT01685138|469530393|FG000|Overall Study|Subject/guardian decision|2|||
130428470|NCT01685138|469530393|FG000|Overall Study|Physician Decision|6|||
130428471|NCT01685138|469530393|FG000|Overall Study|Death|10|||
130428472|NCT01685138|469530393|FG000|Overall Study|Adverse Event|18|||
130428473|NCT01685138|469530393|FG000|Overall Study|Progressive disease|53|||
130428474|NCT02220894|469530398|FG000|Overall Study|Adverse Event|127|||
130428475|NCT02220894|469530399|FG001|Overall Study|Adverse Event|74|||
130428476|NCT02220894|469530398|FG000|Overall Study|Death|418|||
130428477|NCT02220894|469530399|FG001|Overall Study|Death|508|||
130428478|NCT02220894|469530398|FG000|Overall Study|Lost to Follow-up|0|||
130428479|NCT02220894|469530399|FG001|Overall Study|Lost to Follow-up|4|||
130428480|NCT02220894|469530398|FG000|Overall Study|Site Terminated by Sponsor|2|||
130428481|NCT02220894|469530399|FG001|Overall Study|Site Terminated by Sponsor|0|||
130428482|NCT02220894|469530398|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
130428483|NCT02220894|469530399|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
130428484|NCT02220894|469530398|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130428485|NCT02220894|469530399|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130428486|NCT02220894|469530398|FG000|Overall Study|Withdrawal by Subject|10|||
130428487|NCT02220894|469530399|FG001|Overall Study|Withdrawal by Subject|9|||
130428488|NCT00500903|469530404|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
130428489|NCT00500903|469530405|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
130428490|NCT00500903|469530406|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
130428491|NCT00500903|469530404|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
130428492|NCT00500903|469530405|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130428493|NCT00500903|469530406|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130428494|NCT00500903|469530404|FG000|Overall Study|Progressive Disease|41|||
130428495|NCT00500903|469530405|FG001|Overall Study|Progressive Disease|2|||
130428496|NCT00500903|469530406|FG002|Overall Study|Progressive Disease|15|||
130428497|NCT00500903|469530404|FG000|Overall Study|Patient Declined Further Treatment|0|||
130428498|NCT00500903|469530405|FG001|Overall Study|Patient Declined Further Treatment|0|||
130428499|NCT00500903|469530406|FG002|Overall Study|Patient Declined Further Treatment|3|||
130428500|NCT00500903|469530404|FG000|Overall Study|Symptomatic Deterioration|2|||
130428501|NCT00500903|469530405|FG001|Overall Study|Symptomatic Deterioration|0|||
130428502|NCT00500903|469530406|FG002|Overall Study|Symptomatic Deterioration|0|||
130428503|NCT00500903|469530404|FG000|Overall Study|Reason Not Specified|10|||
130428504|NCT00500903|469530405|FG001|Overall Study|Reason Not Specified|0|||
130428505|NCT00500903|469530406|FG002|Overall Study|Reason Not Specified|2|||
130428506|NCT01648348|469530411|FG000|Overall Study|Cancel|1|||
130428507|NCT01648348|469530412|FG001|Overall Study|Cancel|0|||
130428508|NCT01648348|469530413|FG002|Overall Study|Cancel|0|||
130428509|NCT01648348|469530414|FG003|Overall Study|Cancel|0|||
130428510|NCT01648348|469530415|FG004|Overall Study|Cancel|3|||
130428511|NCT01648348|469530416|FG005|Overall Study|Cancel|6|||
130428512|NCT01648348|469530411|FG000|Overall Study|Replaced for MTD analysis|1|||
130428513|NCT01648348|469530412|FG001|Overall Study|Replaced for MTD analysis|0|||
130428514|NCT01648348|469530413|FG002|Overall Study|Replaced for MTD analysis|1|||
130428515|NCT01648348|469530414|FG003|Overall Study|Replaced for MTD analysis|0|||
130428516|NCT01648348|469530415|FG004|Overall Study|Replaced for MTD analysis|0|||
130428517|NCT01648348|469530416|FG005|Overall Study|Replaced for MTD analysis|0|||
130428518|NCT00696410|469530417|FG000|Overall Study|Lost to Follow-up|2|||
130428519|NCT00696410|469530418|FG001|Overall Study|Lost to Follow-up|0|||
130428520|NCT00696410|469530417|FG000|Overall Study|Withdrawal by Subject|8|||
130428521|NCT00696410|469530418|FG001|Overall Study|Withdrawal by Subject|0|||
130428522|NCT00696410|469530417|FG000|Overall Study|Physician Decision|3|||
130428523|NCT00696410|469530418|FG001|Overall Study|Physician Decision|0|||
130428524|NCT01951638|469530419|FG000|Treatment Period|Protocol Violation|0|||
130428525|NCT01951638|469530420|FG001|Treatment Period|Protocol Violation|0|||
130428526|NCT01951638|469530421|FG002|Treatment Period|Protocol Violation|0|||
130428527|NCT01951638|469530422|FG003|Treatment Period|Protocol Violation|2|||
130428528|NCT01951638|469530423|FG004|Treatment Period|Protocol Violation|0|||
130428529|NCT01951638|469530419|FG000|Treatment Period|Protocol-driven decision point|1|||
130428530|NCT01951638|469530420|FG001|Treatment Period|Protocol-driven decision point|3|||
130428531|NCT01951638|469530421|FG002|Treatment Period|Protocol-driven decision point|0|||
130428532|NCT01951638|469530422|FG003|Treatment Period|Protocol-driven decision point|0|||
130428533|NCT01951638|469530423|FG004|Treatment Period|Protocol-driven decision point|0|||
130428534|NCT01951638|469530419|FG000|Treatment Period|Logistical difficulties|0|||
130428535|NCT01951638|469530420|FG001|Treatment Period|Logistical difficulties|1|||
130428536|NCT01951638|469530421|FG002|Treatment Period|Logistical difficulties|1|||
130428537|NCT01951638|469530422|FG003|Treatment Period|Logistical difficulties|0|||
130428538|NCT01951638|469530423|FG004|Treatment Period|Logistical difficulties|0|||
130428539|NCT01951638|469530419|FG000|Treatment Period|Withdrawal by Subject|9|||
130428540|NCT01951638|469530420|FG001|Treatment Period|Withdrawal by Subject|6|||
130428541|NCT01951638|469530421|FG002|Treatment Period|Withdrawal by Subject|4|||
130428542|NCT01951638|469530422|FG003|Treatment Period|Withdrawal by Subject|5|||
130428543|NCT01951638|469530423|FG004|Treatment Period|Withdrawal by Subject|4|||
130428544|NCT01951638|469530419|FG000|Treatment Period|Death|0|||
130428545|NCT01951638|469530420|FG001|Treatment Period|Death|0|||
130428546|NCT01951638|469530421|FG002|Treatment Period|Death|0|||
130428547|NCT01951638|469530422|FG003|Treatment Period|Death|3|||
130428548|NCT01951638|469530423|FG004|Treatment Period|Death|1|||
130428549|NCT01951638|469530419|FG000|Treatment Period|Adverse Event|3|||
130428550|NCT01951638|469530420|FG001|Treatment Period|Adverse Event|4|||
130428551|NCT01951638|469530421|FG002|Treatment Period|Adverse Event|8|||
130428552|NCT01951638|469530422|FG003|Treatment Period|Adverse Event|6|||
130428553|NCT01951638|469530423|FG004|Treatment Period|Adverse Event|5|||
130428554|NCT01951638|469530419|FG000|Follow-up Period|Protocol Violation|0|||
130428555|NCT01951638|469530420|FG001|Follow-up Period|Protocol Violation|0|||
130428556|NCT01951638|469530421|FG002|Follow-up Period|Protocol Violation|0|||
130428557|NCT01951638|469530422|FG003|Follow-up Period|Protocol Violation|1|||
130428558|NCT01951638|469530423|FG004|Follow-up Period|Protocol Violation|0|||
130428559|NCT01951638|469530419|FG000|Follow-up Period|Logistical difficulties|0|||
130428560|NCT01951638|469530420|FG001|Follow-up Period|Logistical difficulties|2|||
130428561|NCT01951638|469530421|FG002|Follow-up Period|Logistical difficulties|0|||
130428562|NCT01951638|469530422|FG003|Follow-up Period|Logistical difficulties|0|||
130428563|NCT01951638|469530423|FG004|Follow-up Period|Logistical difficulties|1|||
130428564|NCT01951638|469530419|FG000|Follow-up Period|Withdrawal by Subject|1|||
130428565|NCT01951638|469530420|FG001|Follow-up Period|Withdrawal by Subject|5|||
130428566|NCT01951638|469530421|FG002|Follow-up Period|Withdrawal by Subject|2|||
130428567|NCT01951638|469530422|FG003|Follow-up Period|Withdrawal by Subject|1|||
130428568|NCT01951638|469530423|FG004|Follow-up Period|Withdrawal by Subject|2|||
130428569|NCT01951638|469530419|FG000|Follow-up Period|Lost to Follow-up|0|||
130428570|NCT01951638|469530420|FG001|Follow-up Period|Lost to Follow-up|1|||
130428571|NCT01951638|469530421|FG002|Follow-up Period|Lost to Follow-up|0|||
130428572|NCT01951638|469530422|FG003|Follow-up Period|Lost to Follow-up|1|||
130428573|NCT01951638|469530423|FG004|Follow-up Period|Lost to Follow-up|0|||
130428574|NCT01951638|469530419|FG000|Follow-up Period|Death|1|||
130428575|NCT01951638|469530420|FG001|Follow-up Period|Death|0|||
130428576|NCT01951638|469530421|FG002|Follow-up Period|Death|1|||
130428577|NCT01951638|469530422|FG003|Follow-up Period|Death|4|||
130428578|NCT01951638|469530423|FG004|Follow-up Period|Death|1|||
130428579|NCT01951638|469530419|FG000|Follow-up Period|Adverse Event|0|||
130428580|NCT01951638|469530420|FG001|Follow-up Period|Adverse Event|1|||
130428581|NCT01951638|469530421|FG002|Follow-up Period|Adverse Event|2|||
130428582|NCT01951638|469530422|FG003|Follow-up Period|Adverse Event|1|||
130428583|NCT01951638|469530423|FG004|Follow-up Period|Adverse Event|1|||
130428584|NCT00459342|469530424|FG000|Overall Study|Not eligible|1|||
130428585|NCT02686034|469530425|FG000|Run-In Period 1|Eligibility|12|||
130428586|NCT02686034|469530426|FG001|Run-In Period 1|Eligibility|10|||
130428587|NCT02686034|469530425|FG000|Run-In Period 1|Withdrawal by Subject|4|||
130428588|NCT02686034|469530426|FG001|Run-In Period 1|Withdrawal by Subject|3|||
130428589|NCT02686034|469530425|FG000|Run-In Period 1|Lost to Follow-up|4|||
130428590|NCT02686034|469530426|FG001|Run-In Period 1|Lost to Follow-up|4|||
130428591|NCT02686034|469530425|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
130428592|NCT02686034|469530426|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
130428593|NCT02686034|469530425|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
130428594|NCT02686034|469530426|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
130428595|NCT02686034|469530425|FG000|Randomized Controlled Period 2|Adverse Event|0|||
130428596|NCT02686034|469530426|FG001|Randomized Controlled Period 2|Adverse Event|2|||
130428597|NCT02686034|469530425|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
130478768|NCT06516705|469721984|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
130478769|NCT04292223|469721988|FG000|Overall Study|Adverse Event|1|||
130428598|NCT02686034|469530426|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
130428599|NCT02686034|469530425|FG000|Open Label Period 3|Lost to Follow-up|0|||
130428600|NCT02686034|469530426|FG001|Open Label Period 3|Lost to Follow-up|1|||
130428601|NCT00552084|469530427|FG000|Overall Study|Adverse Event|2|||
130428602|NCT00552084|469530428|FG001|Overall Study|Adverse Event|3|||
130428603|NCT00552084|469530427|FG000|Overall Study|Withdrawal by Subject|4|||
130428604|NCT00552084|469530428|FG001|Overall Study|Withdrawal by Subject|5|||
130428605|NCT00552084|469530427|FG000|Overall Study|Protocol Violation|1|||
130428606|NCT00552084|469530428|FG001|Overall Study|Protocol Violation|0|||
130428607|NCT00552084|469530427|FG000|Overall Study|change in anti-arrythmic drug|1|||
130428608|NCT00552084|469530428|FG001|Overall Study|change in anti-arrythmic drug|1|||
130428609|NCT03017079|469530429|FG000|Overall Study|Physician Decision|1|||
130428610|NCT03017079|469530430|FG001|Overall Study|Physician Decision|1|||
130428611|NCT03017079|469530429|FG000|Overall Study|Death|3|||
130428612|NCT03017079|469530430|FG001|Overall Study|Death|2|||
130727765|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Death|17|||
130727766|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Death|11|||
130428613|NCT03017079|469530429|FG000|Overall Study|Lack of Efficacy|2|||
130428614|NCT03017079|469530430|FG001|Overall Study|Lack of Efficacy|2|||
130428615|NCT03017079|469530429|FG000|Overall Study|Protocol Violation|0|||
130428616|NCT03017079|469530430|FG001|Overall Study|Protocol Violation|1|||
130428617|NCT02240108|469531681|FG000|Overall Study|Other than specified|8|||
130428618|NCT02240108|469531682|FG001|Overall Study|Other than specified|6|||
130428619|NCT02240108|469531681|FG000|Overall Study|Adverse Event|1|||
130428620|NCT02240108|469531682|FG001|Overall Study|Adverse Event|9|||
130428621|NCT02240108|469531681|FG000|Overall Study|Pregnancy|1|||
130428622|NCT02240108|469531682|FG001|Overall Study|Pregnancy|0|||
130428623|NCT02240108|469531681|FG000|Overall Study|Withdrawal by Subject|4|||
130428624|NCT02240108|469531682|FG001|Overall Study|Withdrawal by Subject|9|||
130428625|NCT02240108|469531681|FG000|Overall Study|StudyTerminated by Sponsor|0|||
130428626|NCT02240108|469531682|FG001|Overall Study|StudyTerminated by Sponsor|1|||
130428627|NCT01345630|469531683|FG000|Overall Study|Adverse Event|22|||
130428628|NCT01345630|469531684|FG001|Overall Study|Adverse Event|23|||
130428629|NCT01345630|469531683|FG000|Overall Study|Lost to Follow-up|17|||
130428630|NCT01345630|469531684|FG001|Overall Study|Lost to Follow-up|16|||
130428631|NCT01345630|469531683|FG000|Overall Study|Protocol Violation|4|||
130428632|NCT01345630|469531684|FG001|Overall Study|Protocol Violation|1|||
130428633|NCT01345630|469531683|FG000|Overall Study|Medication error without associated AE|0|||
130428634|NCT01345630|469531684|FG001|Overall Study|Medication error without associated AE|1|||
130428635|NCT01345630|469531683|FG000|Overall Study|Study terminated by sponsor|254|||
130428636|NCT01345630|469531684|FG001|Overall Study|Study terminated by sponsor|285|||
130428637|NCT01345630|469531683|FG000|Overall Study|Other reasons|6|||
130428638|NCT01345630|469531684|FG001|Overall Study|Other reasons|8|||
130428639|NCT01345630|469531683|FG000|Overall Study|Withdrawn due to pregnancy|1|||
130428640|NCT01345630|469531684|FG001|Overall Study|Withdrawn due to pregnancy|2|||
130428641|NCT01345630|469531683|FG000|Overall Study|No longer willing to participate|9|||
130428642|NCT01345630|469531684|FG001|Overall Study|No longer willing to participate|12|||
130428643|NCT01345630|469531683|FG000|Overall Study|Insufficient clinical response|48|||
130428644|NCT01345630|469531684|FG001|Overall Study|Insufficient clinical response|11|||
130428645|NCT04233372|469531685|FG000|Overall Study|Lost to Follow-up|104|||
130428646|NCT04233372|469531685|FG000|Overall Study|Adverse Event|8|||
130428647|NCT04233372|469531685|FG000|Overall Study|Withdrawal by Subject|2|||
130428648|NCT03938454|469531686|FG000|Overall Study|Protocol Violation|1|||
130428649|NCT03938454|469531686|FG000|Overall Study|Withdrawal by Subject|2|||
130428650|NCT03938454|469531686|FG000|Overall Study|Lost to Follow-up|3|||
130428651|NCT01090310|469531687|FG000|Core Study|Adverse Event|2|||
130428652|NCT01090310|469531688|FG001|Core Study|Adverse Event|2|||
130428653|NCT01090310|469531689|FG002|Core Study|Adverse Event|1|||
130428654|NCT01090310|469531690|FG003|Core Study|Adverse Event|1|||
130428655|NCT01090310|469531687|FG000|Core Study|Subject withdrew consent|0|||
130428656|NCT01090310|469531688|FG001|Core Study|Subject withdrew consent|3|||
130428657|NCT01090310|469531689|FG002|Core Study|Subject withdrew consent|1|||
130428658|NCT01090310|469531690|FG003|Core Study|Subject withdrew consent|1|||
130428659|NCT01090310|469531687|FG000|Core Study|Abnormal test procedure result|0|||
130428660|NCT01090310|469531688|FG001|Core Study|Abnormal test procedure result|0|||
130428661|NCT01090310|469531689|FG002|Core Study|Abnormal test procedure result|1|||
130428662|NCT01090310|469531690|FG003|Core Study|Abnormal test procedure result|0|||
130478770|NCT04292223|469721988|FG000|Overall Study|Lost to Follow-up|1|||
130727767|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
130727768|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
130727769|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
130727770|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
130727771|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
130727772|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
130428663|NCT01090310|469531687|FG000|Core Study|Administrative reasons|5|||
130428664|NCT01090310|469531688|FG001|Core Study|Administrative reasons|6|||
130428665|NCT01090310|469531689|FG002|Core Study|Administrative reasons|4|||
130428666|NCT01090310|469531690|FG003|Core Study|Administrative reasons|4|||
130428667|NCT01090310|469531687|FG000|Core Study|Protocol deviation|1|||
130428668|NCT01090310|469531688|FG001|Core Study|Protocol deviation|0|||
130428669|NCT01090310|469531689|FG002|Core Study|Protocol deviation|0|||
130428670|NCT01090310|469531690|FG003|Core Study|Protocol deviation|1|||
130428671|NCT01090310|469531687|FG000|Extension Study|Aministrative problems|13|||
130428672|NCT01090310|469531688|FG001|Extension Study|Aministrative problems|15|||
130428673|NCT01090310|469531689|FG002|Extension Study|Aministrative problems|14|||
130428674|NCT01090310|469531690|FG003|Extension Study|Aministrative problems|18|||
130428675|NCT01090310|469531687|FG000|Extension Study|Adverse Event|0|||
130428676|NCT01090310|469531688|FG001|Extension Study|Adverse Event|0|||
130428677|NCT01090310|469531689|FG002|Extension Study|Adverse Event|0|||
130428678|NCT01090310|469531690|FG003|Extension Study|Adverse Event|1|||
130428679|NCT01090310|469531687|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
130428680|NCT01090310|469531688|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130428681|NCT01090310|469531689|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
130428682|NCT01090310|469531690|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
130428683|NCT01090310|469531687|FG000|Extension Study|Subject withdrew consent|0|||
130428684|NCT01090310|469531688|FG001|Extension Study|Subject withdrew consent|1|||
130428685|NCT01090310|469531689|FG002|Extension Study|Subject withdrew consent|0|||
130428686|NCT01090310|469531690|FG003|Extension Study|Subject withdrew consent|0|||
130428687|NCT01142388|469531691|FG000|Overall Study|Lack of Efficacy|21|||
130428688|NCT01142388|469531692|FG001|Overall Study|Lack of Efficacy|31|||
130428689|NCT01142388|469531691|FG000|Overall Study|Adverse Event|9|||
130428690|NCT01142388|469531692|FG001|Overall Study|Adverse Event|5|||
130428691|NCT01142388|469531691|FG000|Overall Study|Death|3|||
130428692|NCT01142388|469531692|FG001|Overall Study|Death|2|||
130428693|NCT01142388|469531691|FG000|Overall Study|Withdrawal by Subject|5|||
130428694|NCT01142388|469531692|FG001|Overall Study|Withdrawal by Subject|3|||
130428695|NCT01142388|469531691|FG000|Overall Study|Alternative therapy|1|||
130428696|NCT01142388|469531692|FG001|Overall Study|Alternative therapy|0|||
130428697|NCT01142388|469531691|FG000|Overall Study|Other complications|0|||
130428698|NCT01142388|469531692|FG001|Overall Study|Other complications|2|||
130428699|NCT01142388|469531691|FG000|Overall Study|Other|1|||
130428700|NCT01142388|469531692|FG001|Overall Study|Other|1|||
130428701|NCT01142388|469531691|FG000|Overall Study|Never started therapy|7|||
130428702|NCT01142388|469531692|FG001|Overall Study|Never started therapy|3|||
130428703|NCT00695786|469531693|FG000|Overall Study|Adverse Event|0|||
130428704|NCT00695786|469531694|FG001|Overall Study|Adverse Event|3|||
130428705|NCT00695786|469531695|FG002|Overall Study|Adverse Event|4|||
130428706|NCT00695786|469531696|FG003|Overall Study|Adverse Event|2|||
130428707|NCT00695786|469531693|FG000|Overall Study|Lost to Follow-up|0|||
130727773|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
130727774|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
130727775|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
130428708|NCT00695786|469531694|FG001|Overall Study|Lost to Follow-up|5|||
130428709|NCT00695786|469531695|FG002|Overall Study|Lost to Follow-up|1|||
130428710|NCT00695786|469531696|FG003|Overall Study|Lost to Follow-up|1|||
130428711|NCT00695786|469531693|FG000|Overall Study|Withdrawal by Subject|0|||
130428712|NCT00695786|469531694|FG001|Overall Study|Withdrawal by Subject|4|||
130428713|NCT00695786|469531695|FG002|Overall Study|Withdrawal by Subject|3|||
130428714|NCT00695786|469531696|FG003|Overall Study|Withdrawal by Subject|1|||
130428715|NCT00695786|469531693|FG000|Overall Study|Deemed Ineligible|1|||
130428716|NCT00695786|469531694|FG001|Overall Study|Deemed Ineligible|0|||
130428717|NCT00695786|469531695|FG002|Overall Study|Deemed Ineligible|0|||
130428718|NCT00695786|469531696|FG003|Overall Study|Deemed Ineligible|0|||
130428719|NCT00695786|469531693|FG000|Overall Study|Lack of Efficacy|0|||
130428720|NCT00695786|469531694|FG001|Overall Study|Lack of Efficacy|0|||
130428721|NCT00695786|469531695|FG002|Overall Study|Lack of Efficacy|0|||
130428722|NCT00695786|469531696|FG003|Overall Study|Lack of Efficacy|4|||
130727776|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
130727777|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
130428723|NCT01364922|469531700|FG000|Open-label (OL) Period|Adverse Event|7|||
130428724|NCT01364922|469531701|FG001|Open-label (OL) Period|Adverse Event|0|||
130428725|NCT01364922|469531702|FG002|Open-label (OL) Period|Adverse Event|0|||
130428726|NCT01364922|469531700|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
130727778|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
130727779|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
130727780|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
130727781|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Other|2|||
130428727|NCT01364922|469531701|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
130428728|NCT01364922|469531702|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
130428729|NCT01364922|469531700|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
130428730|NCT01364922|469531701|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
130428731|NCT01364922|469531702|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
130428732|NCT01364922|469531700|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
130428733|NCT01364922|469531701|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
130428734|NCT01364922|469531702|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
130428735|NCT01364922|469531700|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
130428736|NCT01364922|469531701|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
130428737|NCT01364922|469531702|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
130428738|NCT01364922|469531700|FG000|Open-label (OL) Period|Other, Unspecified|1|||
130428739|NCT01364922|469531701|FG001|Open-label (OL) Period|Other, Unspecified|0|||
130428740|NCT01364922|469531702|FG002|Open-label (OL) Period|Other, Unspecified|0|||
130428741|NCT01364922|469531700|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
130727782|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Other|1|||
130727783|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
130428742|NCT01364922|469531701|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
130428743|NCT01364922|469531702|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
130428744|NCT01364922|469531700|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
130428745|NCT01364922|469531701|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
130428746|NCT01364922|469531702|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
130428747|NCT01364922|469531700|FG000|Double-Blind (DB) Period|Adverse Event|0|||
130428748|NCT01364922|469531701|FG001|Double-Blind (DB) Period|Adverse Event|0|||
130428749|NCT01364922|469531702|FG002|Double-Blind (DB) Period|Adverse Event|1|||
130428750|NCT01364922|469531700|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
130428751|NCT01364922|469531701|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
130428752|NCT01364922|469531702|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
130428753|NCT04244396|469531703|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
130428754|NCT04244396|469531703|FG000|Overall Study|Withdrawal by Subject|2|||
130428755|NCT04244396|469531703|FG000|Overall Study|Study termination|37|||
130428756|NCT01787097|469531704|FG000|Overall Study|Withdrawal by Subject|1|||
130428757|NCT01787097|469531705|FG001|Overall Study|Withdrawal by Subject|0|||
130428758|NCT01787097|469531706|FG002|Overall Study|Withdrawal by Subject|0|||
130428759|NCT01787097|469531707|FG003|Overall Study|Withdrawal by Subject|0|||
130428760|NCT00553501|469531714|FG000|Overall Study|Adverse Event|2|||
130428761|NCT00553501|469531714|FG000|Overall Study|Death|1|||
130428762|NCT00553501|469531714|FG000|Overall Study|Progression|1|||
130428763|NCT02293395|469531715|FG000|Overall Study|Lost to Follow-up|1|||
130428764|NCT02293395|469531716|FG001|Overall Study|Lost to Follow-up|0|||
130428765|NCT02293395|469531715|FG000|Overall Study|Withdrawal by Subject|8|||
130428766|NCT02293395|469531716|FG001|Overall Study|Withdrawal by Subject|7|||
130428767|NCT01464021|469531719|FG000|Overall Study|Withdrawal by Subject|13|||
130428768|NCT01464021|469531719|FG000|Overall Study|Lost to Follow-up|1|||
130428769|NCT01464021|469531719|FG000|Overall Study|Lack of Efficacy|1|||
130428770|NCT01464021|469531719|FG000|Overall Study|various|11|||
130428771|NCT00861614|469531720|FG000|Overall Study|Disease Progression|182|||
130428772|NCT00861614|469531721|FG001|Overall Study|Disease Progression|263|||
130428773|NCT00861614|469531720|FG000|Overall Study|Study Drug Toxicity|79|||
130428774|NCT00861614|469531721|FG001|Overall Study|Study Drug Toxicity|6|||
130428775|NCT00861614|469531720|FG000|Overall Study|Death|32|||
130428776|NCT00861614|469531721|FG001|Overall Study|Death|19|||
130428777|NCT00861614|469531720|FG000|Overall Study|Adverse Event|27|||
130428778|NCT00861614|469531721|FG001|Overall Study|Adverse Event|23|||
130428779|NCT00861614|469531720|FG000|Overall Study|Withdrawal by Subject|34|||
130428780|NCT00861614|469531721|FG001|Overall Study|Withdrawal by Subject|35|||
130428781|NCT00861614|469531720|FG000|Overall Study|Other|17|||
130428782|NCT00861614|469531721|FG001|Overall Study|Other|22|||
130428783|NCT03391765|469531722|FG000|Overall Study|Adverse Event|2|||
130428784|NCT03391765|469531723|FG001|Overall Study|Adverse Event|0|||
130428785|NCT03391765|469531724|FG002|Overall Study|Adverse Event|0|||
130428786|NCT03391765|469531725|FG003|Overall Study|Adverse Event|2|||
130428787|NCT03391765|469531722|FG000|Overall Study|Withdrew consent|5|||
130428788|NCT03391765|469531723|FG001|Overall Study|Withdrew consent|7|||
130428789|NCT03391765|469531724|FG002|Overall Study|Withdrew consent|2|||
130428790|NCT03391765|469531725|FG003|Overall Study|Withdrew consent|5|||
130428791|NCT03391765|469531722|FG000|Overall Study|Other, not specified|44|||
130428792|NCT03391765|469531723|FG001|Overall Study|Other, not specified|38|||
130428793|NCT03391765|469531724|FG002|Overall Study|Other, not specified|21|||
130428794|NCT03391765|469531725|FG003|Overall Study|Other, not specified|16|||
130428795|NCT00944658|469531726|FG000|Treatment 12 Weeks|Adverse Event|0|||
130428796|NCT00944658|469531727|FG001|Treatment 12 Weeks|Adverse Event|2|||
130428797|NCT01289418|469531731|FG000|Day 8 Survey|email address invalid|283|||
130428798|NCT01289418|469531731|FG000|Day 8 Survey|participants did not complete the survey|1935|||
130428799|NCT01289418|469531731|FG000|Day 29 Survey|email address invalid|283|||
130428800|NCT01289418|469531731|FG000|Day 29 Survey|participants did not complete the survey|2185|||
130428801|NCT02832622|469531737|FG000|Overall Study|MPP not programmed|1259|||
130428802|NCT02832622|469531737|FG000|Overall Study|Withdrawal by Subject|123|||
130428803|NCT02832622|469531737|FG000|Overall Study|Death|119|||
130727784|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
130727785|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Death|12|||
130727786|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Death|10|||
130727787|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
130428804|NCT02832622|469531737|FG000|Overall Study|Unsuccessful CRT implant|93|||
130727788|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
130727789|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
130428805|NCT02832622|469531737|FG000|Overall Study|Lost to Follow-up|45|||
130428806|NCT02832622|469531737|FG000|Overall Study|Patient non-compliance|42|||
130428807|NCT02832622|469531737|FG000|Overall Study|Withdrawal by other reasons|25|||
130428808|NCT02832622|469531737|FG000|Overall Study|System explant|24|||
130428809|NCT02832622|469531737|FG000|Overall Study|Physician Decision|6|||
130428810|NCT02472652|469531738|FG000|Overall Study|Lost to Follow-up|1|||
130428811|NCT00998400|469531743|FG000|Overall Study|Lack of interest/motivation|1|||
130727790|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
130727791|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Other|7|||
130428812|NCT00998400|469531744|FG001|Overall Study|Lack of interest/motivation|2|||
130428813|NCT00998400|469531743|FG000|Overall Study|Logistical problems|1|||
130428814|NCT00998400|469531744|FG001|Overall Study|Logistical problems|0|||
130428815|NCT03185832|469531745|FG000|Overall Study|Death|9|||
130428816|NCT03185832|469531746|FG001|Overall Study|Death|14|||
130428817|NCT03185832|469531747|FG002|Overall Study|Death|9|||
130428818|NCT03185832|469531748|FG003|Overall Study|Death|7|||
130428819|NCT03185832|469531745|FG000|Overall Study|Withdrawn - vital status available|0|||
130428820|NCT03185832|469531746|FG001|Overall Study|Withdrawn - vital status available|1|||
130428821|NCT03185832|469531747|FG002|Overall Study|Withdrawn - vital status available|1|||
130428822|NCT03185832|469531748|FG003|Overall Study|Withdrawn - vital status available|4|||
130428823|NCT01083641|469531749|FG000|Overall Study|Withdrawal by Subject|2|||
130428824|NCT03386032|469531750|FG000|Overall Study|Lack of Efficacy|6|||
130428825|NCT03386032|469531751|FG001|Overall Study|Lack of Efficacy|2|||
130428826|NCT03386032|469531752|FG002|Overall Study|Lack of Efficacy|0|||
130428827|NCT03386032|469531750|FG000|Overall Study|Adverse Event|2|||
130428828|NCT03386032|469531751|FG001|Overall Study|Adverse Event|2|||
130428829|NCT03386032|469531752|FG002|Overall Study|Adverse Event|0|||
130428830|NCT03386032|469531750|FG000|Overall Study|Withdrawal by Subject|1|||
130428831|NCT03386032|469531751|FG001|Overall Study|Withdrawal by Subject|0|||
130428832|NCT03386032|469531752|FG002|Overall Study|Withdrawal by Subject|0|||
130428833|NCT03386032|469531750|FG000|Overall Study|Lost to Follow-up|9|||
130428834|NCT03386032|469531751|FG001|Overall Study|Lost to Follow-up|3|||
130428835|NCT03386032|469531752|FG002|Overall Study|Lost to Follow-up|0|||
130428836|NCT01807156|469531753|FG000|Overall Study|Physician Decision|1|||
130428837|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
130428838|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
130428839|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
130428840|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
130428841|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
130428842|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
130428843|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
130428844|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
130428845|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
130478771|NCT04292223|469721988|FG000|Overall Study|Noncompliance with study drug|2|||
130478772|NCT04292223|469721988|FG000|Overall Study|Patient moved out of the state|1|||
130478773|NCT00753545|469721989|FG000|Overall Study|Death|98|||
130478774|NCT00753545|469721990|FG001|Overall Study|Death|112|||
130478775|NCT00753545|469721989|FG000|Overall Study|Lost to Follow-up|2|||
130478776|NCT00753545|469721990|FG001|Overall Study|Lost to Follow-up|3|||
130478777|NCT00753545|469721989|FG000|Overall Study|Protocol Violation|1|||
130478778|NCT00753545|469721990|FG001|Overall Study|Protocol Violation|0|||
130478779|NCT00753545|469721989|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
130478780|NCT00753545|469721990|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
130478781|NCT04963270|469721992|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
130478782|NCT04963270|469721993|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
130478783|NCT04963270|469721994|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
130478784|NCT04963270|469721995|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
130478785|NCT04963270|469721992|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130478786|NCT04963270|469721993|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
130478787|NCT04963270|469721994|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130478788|NCT04963270|469721995|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130478789|NCT04963270|469721992|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
130478790|NCT04963270|469721993|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130478791|NCT04963270|469721994|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130478792|NCT04963270|469721995|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130478793|NCT04963270|469721992|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
130478794|NCT04963270|469721993|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
130478795|NCT04963270|469721994|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
130478796|NCT04963270|469721995|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
130428846|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
130428847|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
130428848|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
130428849|NCT01493687|469531760|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
130428850|NCT01493687|469531761|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
130428851|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
130428852|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
130478797|NCT04963270|469721992|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
130478798|NCT04963270|469721993|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
130478799|NCT04963270|469721994|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
130478800|NCT04963270|469721995|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
130428853|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
130428854|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
130428855|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
130428856|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
130428857|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
130428858|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
130428859|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
130428860|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
130428861|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
130428862|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
130428863|NCT01493687|469531760|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
130428864|NCT01493687|469531761|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
130428865|NCT01493687|469531760|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
130428866|NCT01493687|469531761|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
130428867|NCT02364180|469531765|FG000|Overall Study|Screen Fail|1|||
130428868|NCT02323646|469531766|FG000|Treatment Course 1|Adverse Event|1|||
130428869|NCT02323646|469531767|FG001|Treatment Course 1|Adverse Event|0|||
130428870|NCT02323646|469531768|FG002|Treatment Course 1|Adverse Event|1|||
130428871|NCT02323646|469531766|FG000|Treatment Course 1|Heavy Bleeding|1|||
130428872|NCT02323646|469531767|FG001|Treatment Course 1|Heavy Bleeding|1|||
130428873|NCT02323646|469531768|FG002|Treatment Course 1|Heavy Bleeding|0|||
130428874|NCT02323646|469531766|FG000|Treatment Course 1|Lost to Follow-up|1|||
130428875|NCT02323646|469531767|FG001|Treatment Course 1|Lost to Follow-up|0|||
130428876|NCT02323646|469531768|FG002|Treatment Course 1|Lost to Follow-up|2|||
130428877|NCT02323646|469531766|FG000|Treatment Course 1|Withdrawal by Subject|0|||
130428878|NCT02323646|469531767|FG001|Treatment Course 1|Withdrawal by Subject|2|||
130428879|NCT02323646|469531768|FG002|Treatment Course 1|Withdrawal by Subject|0|||
130428880|NCT02323646|469531766|FG000|Treatment Course 2|Adverse Event|1|||
130428881|NCT02323646|469531767|FG001|Treatment Course 2|Adverse Event|0|||
130428882|NCT02323646|469531768|FG002|Treatment Course 2|Adverse Event|1|||
130428883|NCT02323646|469531766|FG000|Treatment Course 2|Lost to Follow-up|0|||
130428884|NCT02323646|469531767|FG001|Treatment Course 2|Lost to Follow-up|0|||
130428885|NCT02323646|469531768|FG002|Treatment Course 2|Lost to Follow-up|1|||
130428886|NCT02323646|469531766|FG000|Treatment Course 2|Non-compliance|0|||
130428887|NCT02323646|469531767|FG001|Treatment Course 2|Non-compliance|1|||
130428888|NCT02323646|469531768|FG002|Treatment Course 2|Non-compliance|1|||
130428889|NCT00521144|469531769|FG000|Overall Study|Not Treated|0|||
130428890|NCT00521144|469531770|FG001|Overall Study|Not Treated|0|||
130428891|NCT00521144|469531771|FG002|Overall Study|Not Treated|0|||
130428892|NCT00521144|469531772|FG003|Overall Study|Not Treated|1|||
130428893|NCT00521144|469531773|FG004|Overall Study|Not Treated|0|||
130428894|NCT00521144|469531769|FG000|Overall Study|Adverse Event|0|||
130428895|NCT00521144|469531770|FG001|Overall Study|Adverse Event|1|||
130428896|NCT00521144|469531771|FG002|Overall Study|Adverse Event|0|||
130428897|NCT00521144|469531772|FG003|Overall Study|Adverse Event|0|||
130428898|NCT00521144|469531773|FG004|Overall Study|Adverse Event|1|||
130428899|NCT00521144|469531769|FG000|Overall Study|Progressive Disease|4|||
130428900|NCT00521144|469531770|FG001|Overall Study|Progressive Disease|2|||
130428901|NCT00521144|469531771|FG002|Overall Study|Progressive Disease|2|||
130428902|NCT00521144|469531772|FG003|Overall Study|Progressive Disease|0|||
130428903|NCT00521144|469531773|FG004|Overall Study|Progressive Disease|6|||
130428904|NCT01370525|469531774|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
130428905|NCT01370525|469531775|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
130428906|NCT01370525|469531774|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130428907|NCT01370525|469531775|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130428908|NCT01370525|469531774|FG000|Overall Study|Adverse Event|0|||
130428909|NCT01370525|469531775|FG001|Overall Study|Adverse Event|1|||
130428910|NCT01370525|469531774|FG000|Overall Study|Protocol Violation|2|||
130428911|NCT01370525|469531775|FG001|Overall Study|Protocol Violation|1|||
130428912|NCT01370525|469531774|FG000|Overall Study|Lost to follow up|2|||
130428913|NCT01370525|469531775|FG001|Overall Study|Lost to follow up|6|||
130428914|NCT02940574|469531782|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
130428915|NCT02940574|469531783|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
130478801|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
130478802|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
130478803|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
130428916|NCT02940574|469531782|FG000|1-year Follow-up|Lost to Follow-up|3|||
130428917|NCT02940574|469531783|FG001|1-year Follow-up|Lost to Follow-up|4|||
130428918|NCT00387894|469531784|FG000|Overall Study|Withdrawal by Subject|1|||
130428919|NCT02421666|469531787|FG000|6-month Follow-up|Lost to Follow-up|8|||
130428920|NCT02421666|469531788|FG001|6-month Follow-up|Lost to Follow-up|7|||
130428921|NCT02421666|469531787|FG000|6-month Follow-up|Withdrawal by Subject|5|||
130428922|NCT02421666|469531788|FG001|6-month Follow-up|Withdrawal by Subject|6|||
130428923|NCT02421666|469531787|FG000|12-month Follow-up|Lost to Follow-up|5|||
130564865|NCT03715153|470033762|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
130564866|NCT03715153|470033763|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
130564867|NCT03715153|470033762|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
130564868|NCT03715153|470033763|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
130564869|NCT01358760|470033768|FG000|Overall Study|Adverse Event|3|||
130564870|NCT01358760|470033769|FG001|Overall Study|Adverse Event|4|||
130564871|NCT01358760|470033770|FG002|Overall Study|Adverse Event|3|||
130564872|NCT01358760|470033768|FG000|Overall Study|Lost to Follow-up|1|||
130564873|NCT01358760|470033769|FG001|Overall Study|Lost to Follow-up|1|||
130564874|NCT01358760|470033770|FG002|Overall Study|Lost to Follow-up|3|||
130564875|NCT01358760|470033768|FG000|Overall Study|Withdrawal by Subject|5|||
130564876|NCT01358760|470033769|FG001|Overall Study|Withdrawal by Subject|3|||
130564877|NCT01358760|470033770|FG002|Overall Study|Withdrawal by Subject|2|||
130564878|NCT01358760|470033768|FG000|Overall Study|Physician Decision|1|||
130564879|NCT01358760|470033769|FG001|Overall Study|Physician Decision|0|||
130564880|NCT01358760|470033770|FG002|Overall Study|Physician Decision|1|||
130564881|NCT01358760|470033768|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
130564882|NCT01358760|470033769|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
130564883|NCT01358760|470033770|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
130564884|NCT01506960|470033773|FG000|Overall Study|Did not meet angiographic criteria|47|||
130564885|NCT00450723|470033775|FG000|Overall Study|Physician Decision|5|||
130564886|NCT03574753|470033778|FG000|Overall Study|Adverse Event|3|||
130564887|NCT03574753|470033778|FG000|Overall Study|Progression/relapse|19|||
130564888|NCT03574753|470033778|FG000|Overall Study|Death|1|||
130564889|NCT01436084|470033781|FG000|Overall Study|Disease Progression|2|||
130564890|NCT01436084|470033781|FG000|Overall Study|Withdrawal by Subject|1|||
130564891|NCT01436084|470033781|FG000|Overall Study|Early Closure of Study|1|||
130564892|NCT01744665|470033782|FG000|Monitoring Phase|Adverse Event|4|||
130564893|NCT01744665|470033782|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
130564894|NCT01744665|470033782|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
130564895|NCT01744665|470033782|FG000|Monitoring Phase|Withdrawal by Subject|5|||
130564896|NCT01744665|470033782|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
130727792|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Other|5|||
130727793|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
130727794|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
130727795|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Death|51|||
130727796|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Death|31|||
130727797|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
130727798|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
130727799|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
130428924|NCT02421666|469531788|FG001|12-month Follow-up|Lost to Follow-up|5|||
130428925|NCT02421666|469531787|FG000|12-month Follow-up|Withdrawal by Subject|6|||
130428926|NCT02421666|469531788|FG001|12-month Follow-up|Withdrawal by Subject|11|||
130428927|NCT01119768|469531793|FG000|Treatment Period|Lack of Efficacy|18|||
130428928|NCT01119768|469531794|FG001|Treatment Period|Lack of Efficacy|25|||
130428929|NCT01059643|469531795|FG000|Overall Study|Adverse Event|3|||
130428930|NCT01059643|469531795|FG000|Overall Study|Withdrawal by Subject|2|||
130428931|NCT01059643|469531795|FG000|Overall Study|Physician Decision|1|||
130428932|NCT00643123|469531811|FG000|Overall Study|Lost to Follow-up|4|||
130428933|NCT00643123|469531812|FG001|Overall Study|Lost to Follow-up|0|||
130428934|NCT00643123|469531811|FG000|Overall Study|Withdrawal by Subject|1|||
130428935|NCT00643123|469531812|FG001|Overall Study|Withdrawal by Subject|1|||
130428936|NCT02923739|469531813|FG000|Overall Study|Withdrawal by Subject|2|||
130428937|NCT02923739|469531814|FG001|Overall Study|Withdrawal by Subject|0|||
130428938|NCT02923739|469531815|FG002|Overall Study|Withdrawal by Subject|0|||
130428939|NCT02923739|469531816|FG003|Overall Study|Withdrawal by Subject|0|||
130428940|NCT02923739|469531813|FG000|Overall Study|Failed Screening|3|||
130428941|NCT02923739|469531814|FG001|Overall Study|Failed Screening|0|||
130428942|NCT02923739|469531815|FG002|Overall Study|Failed Screening|0|||
130428943|NCT02923739|469531816|FG003|Overall Study|Failed Screening|0|||
130428944|NCT01591382|469531819|FG000|Overall Study|Discharged Prior to Study Completion|2|||
130428945|NCT01591382|469531820|FG001|Overall Study|Discharged Prior to Study Completion|1|||
130428946|NCT01591382|469531819|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
130428947|NCT01591382|469531820|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
130428948|NCT02277990|469531825|FG000|Overall Study|Death|170|||
130428949|NCT02277990|469531826|FG001|Overall Study|Death|188|||
130428950|NCT02277990|469531825|FG000|Overall Study|Withdrawal by Subject|64|||
130428951|NCT02277990|469531826|FG001|Overall Study|Withdrawal by Subject|53|||
130564897|NCT01744665|470033782|FG000|Consolidation Phase|Adverse Event|2|||
130564898|NCT01744665|470033782|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
130564899|NCT01744665|470033782|FG000|Consolidation Phase|Withdrawal by Subject|4|||
130564900|NCT01744665|470033782|FG000|Consolidation Phase|Administrative problems|9|||
130564901|NCT01744665|470033782|FG000|Re-initiation Phase|Administrative problems|10|||
130564902|NCT01744665|470033782|FG000|Re-initiation Phase|Adverse Event|1|||
130727800|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
130428952|NCT02277990|469531825|FG000|Overall Study|Physician Decision|40|||
130428953|NCT02277990|469531826|FG001|Overall Study|Physician Decision|34|||
130428954|NCT02277990|469531825|FG000|Overall Study|Lost to Follow-up|66|||
130428955|NCT02277990|469531826|FG001|Overall Study|Lost to Follow-up|69|||
130428956|NCT02277990|469531825|FG000|Overall Study|Had other reason|26|||
130428957|NCT02277990|469531826|FG001|Overall Study|Had other reason|32|||
130428958|NCT03138733|469531829|FG000|Overall Study|Death|17|||
130428959|NCT03138733|469531830|FG001|Overall Study|Death|18|||
130428960|NCT03138733|469531829|FG000|Overall Study|Withdrawal by Subject|11|||
130428961|NCT03138733|469531830|FG001|Overall Study|Withdrawal by Subject|6|||
130428962|NCT03138733|469531829|FG000|Overall Study|Lost to Follow-up|3|||
130428963|NCT03138733|469531830|FG001|Overall Study|Lost to Follow-up|2|||
130727801|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
130727802|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
130428964|NCT03138733|469531829|FG000|Overall Study|Adverse Event|1|||
130428965|NCT03138733|469531830|FG001|Overall Study|Adverse Event|0|||
130428966|NCT03138733|469531829|FG000|Overall Study|Protocol Violation|1|||
130428967|NCT03138733|469531830|FG001|Overall Study|Protocol Violation|3|||
130428968|NCT03138733|469531829|FG000|Overall Study|Administrative or logistical reason|1|||
130428969|NCT03138733|469531830|FG001|Overall Study|Administrative or logistical reason|0|||
130428970|NCT03138733|469531829|FG000|Overall Study|The patient was transferred to another hospital|1|||
130428971|NCT03138733|469531830|FG001|Overall Study|The patient was transferred to another hospital|0|||
130428972|NCT04252742|469531834|FG000|Overall Study|Decision by sponsor|0|||
130428973|NCT04252742|469531835|FG001|Overall Study|Decision by sponsor|2|||
130428974|NCT04252742|469531834|FG000|Overall Study|Withdrawal by Subject|15|||
130428975|NCT04252742|469531835|FG001|Overall Study|Withdrawal by Subject|9|||
130428976|NCT04252742|469531834|FG000|Overall Study|Lost to Follow-up|0|||
130428977|NCT04252742|469531835|FG001|Overall Study|Lost to Follow-up|1|||
130428978|NCT00689026|469531838|FG000|Overall Study|Withdrawal by Subject|13|||
130428979|NCT00689026|469531839|FG001|Overall Study|Withdrawal by Subject|6|||
130428980|NCT00394355|469531840|FG000|Overall Study|Adverse Event|10|||
130428981|NCT00394355|469531841|FG001|Overall Study|Adverse Event|6|||
130428982|NCT00394355|469531842|FG002|Overall Study|Adverse Event|7|||
130428983|NCT00394355|469531843|FG003|Overall Study|Adverse Event|8|||
130428984|NCT00394355|469531840|FG000|Overall Study|Did not meet protocol eligibility|1|||
130428985|NCT00394355|469531841|FG001|Overall Study|Did not meet protocol eligibility|5|||
130428986|NCT00394355|469531842|FG002|Overall Study|Did not meet protocol eligibility|4|||
130428987|NCT00394355|469531843|FG003|Overall Study|Did not meet protocol eligibility|2|||
130428988|NCT00394355|469531840|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
130428989|NCT00394355|469531841|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
130428990|NCT00394355|469531842|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
130428991|NCT00394355|469531843|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
130428992|NCT00394355|469531840|FG000|Overall Study|Subject withdrawal - related to drug|1|||
130428993|NCT00394355|469531841|FG001|Overall Study|Subject withdrawal - related to drug|0|||
130428994|NCT00394355|469531842|FG002|Overall Study|Subject withdrawal - related to drug|0|||
130428995|NCT00394355|469531843|FG003|Overall Study|Subject withdrawal - related to drug|0|||
130428996|NCT00394355|469531840|FG000|Overall Study|Lost to Follow-up|7|||
130428997|NCT00394355|469531841|FG001|Overall Study|Lost to Follow-up|5|||
130428998|NCT00394355|469531842|FG002|Overall Study|Lost to Follow-up|4|||
130428999|NCT00394355|469531843|FG003|Overall Study|Lost to Follow-up|3|||
130429000|NCT00394355|469531840|FG000|Overall Study|Noncompliance with protocol|4|||
130727803|NCT02910011|470625552|FG000|Overall Study|Physician Decision|2|||
130727804|NCT03280381|470625553|FG000|Overall Study|Physician Decision|0|||
130727805|NCT03280381|470625554|FG001|Overall Study|Physician Decision|2|||
130727806|NCT01822366|470625555|FG000|Overall Study|Lost to Follow-up|5|||
130429001|NCT00394355|469531841|FG001|Overall Study|Noncompliance with protocol|3|||
130429002|NCT00394355|469531842|FG002|Overall Study|Noncompliance with protocol|10|||
130429003|NCT00394355|469531843|FG003|Overall Study|Noncompliance with protocol|8|||
130429004|NCT00394355|469531840|FG000|Overall Study|Administrative|0|||
130429005|NCT00394355|469531841|FG001|Overall Study|Administrative|1|||
130429006|NCT00394355|469531842|FG002|Overall Study|Administrative|1|||
130429007|NCT00394355|469531843|FG003|Overall Study|Administrative|1|||
130478804|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
130478805|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
130478806|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
130478807|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
130429008|NCT00394355|469531840|FG000|Overall Study|Lack of Efficacy|0|||
130727807|NCT01822366|470625556|FG001|Overall Study|Lost to Follow-up|1|||
130727808|NCT01822366|470625557|FG002|Overall Study|Lost to Follow-up|5|||
130727809|NCT01822366|470625558|FG003|Overall Study|Lost to Follow-up|1|||
130727810|NCT01822366|470625555|FG000|Overall Study|Withdrawal by Subject|0|||
130429009|NCT00394355|469531841|FG001|Overall Study|Lack of Efficacy|0|||
130478808|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
130727811|NCT01822366|470625556|FG001|Overall Study|Withdrawal by Subject|6|||
130727812|NCT01822366|470625557|FG002|Overall Study|Withdrawal by Subject|0|||
130564903|NCT01744665|470033782|FG000|Re-initiation Phase|No longer required treatment|1|||
130727813|NCT01822366|470625558|FG003|Overall Study|Withdrawal by Subject|6|||
130727814|NCT01822366|470625555|FG000|Overall Study|Partial Intervention Completion|0|||
130429010|NCT00394355|469531842|FG002|Overall Study|Lack of Efficacy|2|||
130429011|NCT00394355|469531843|FG003|Overall Study|Lack of Efficacy|3|||
130429012|NCT02618616|469531844|FG000|Overall Study|Lack of Efficacy|4|||
130429013|NCT02618616|469531845|FG001|Overall Study|Lack of Efficacy|0|||
130429014|NCT02618616|469531844|FG000|Overall Study|Pregnancy|0|||
130429015|NCT02618616|469531845|FG001|Overall Study|Pregnancy|1|||
130429016|NCT02618616|469531844|FG000|Overall Study|Adverse Event|8|||
130429017|NCT02618616|469531845|FG001|Overall Study|Adverse Event|0|||
130429018|NCT02618616|469531844|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
130429019|NCT02618616|469531845|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
130429020|NCT02618616|469531844|FG000|Overall Study|Consent withdrawn by subject|8|||
130429021|NCT02618616|469531845|FG001|Overall Study|Consent withdrawn by subject|5|||
130429022|NCT02618616|469531844|FG000|Overall Study|Lost to Follow-up|0|||
130429023|NCT02618616|469531845|FG001|Overall Study|Lost to Follow-up|1|||
130429024|NCT04225988|469531848|FG000|Overall Study|Withdrawal by Subject|2|||
130429025|NCT04225988|469531849|FG001|Overall Study|Withdrawal by Subject|0|||
130429026|NCT03538951|469531854|FG000|Overall Study|Withdrawal by Subject|1|||
130429027|NCT03538951|469531855|FG001|Overall Study|Withdrawal by Subject|2|||
130429028|NCT00949715|469533089|FG000|Overall Study|Physician Decision|1|||
130429029|NCT00949715|469533090|FG001|Overall Study|Physician Decision|0|||
130429030|NCT00949715|469533089|FG000|Overall Study|Lost to Follow-up|1|||
130429031|NCT00949715|469533090|FG001|Overall Study|Lost to Follow-up|0|||
130429032|NCT00949715|469533089|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
130429033|NCT00949715|469533090|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
130429034|NCT01352585|469533091|FG000|Overall Study|Adverse Event|2|||
130429035|NCT01352585|469533092|FG001|Overall Study|Adverse Event|1|||
130429036|NCT01352585|469533091|FG000|Overall Study|Lost to Follow-up|1|||
130429037|NCT01352585|469533092|FG001|Overall Study|Lost to Follow-up|0|||
130429038|NCT01352585|469533091|FG000|Overall Study|Other|5|||
130429039|NCT01352585|469533092|FG001|Overall Study|Other|2|||
130429040|NCT05050578|469533095|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
130429041|NCT05050578|469533096|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
130429042|NCT05050578|469533095|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
130429043|NCT05050578|469533096|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
130429044|NCT05050578|469533095|FG000|Period 2, 30 Days|Protocol Violation|0|||
130429045|NCT05050578|469533096|FG001|Period 2, 30 Days|Protocol Violation|1|||
130429046|NCT02243280|469533097|FG000|Treated|Adverse Event|1|||
130429047|NCT02243280|469533098|FG001|Treated|Adverse Event|0|||
130429048|NCT02243280|469533099|FG002|Treated|Adverse Event|0|||
130429049|NCT02243280|469533100|FG003|Treated|Adverse Event|0|||
130429050|NCT02243280|469533101|FG004|Treated|Adverse Event|0|||
130429051|NCT02243280|469533102|FG005|Treated|Adverse Event|0|||
130429052|NCT02243280|469533103|FG006|Treated|Adverse Event|0|||
130429053|NCT02243280|469533104|FG007|Treated|Adverse Event|0|||
130429054|NCT02243280|469533105|FG008|Treated|Adverse Event|0|||
130429055|NCT02243280|469533106|FG009|Treated|Adverse Event|0|||
130429056|NCT02243280|469533107|FG010|Treated|Adverse Event|1|||
130429057|NCT02243280|469533097|FG000|Treated|Lost to Follow-up|0|||
130429058|NCT02243280|469533098|FG001|Treated|Lost to Follow-up|0|||
130429059|NCT02243280|469533099|FG002|Treated|Lost to Follow-up|0|||
130429060|NCT02243280|469533100|FG003|Treated|Lost to Follow-up|0|||
130429061|NCT02243280|469533101|FG004|Treated|Lost to Follow-up|0|||
130429062|NCT02243280|469533102|FG005|Treated|Lost to Follow-up|0|||
130429063|NCT02243280|469533103|FG006|Treated|Lost to Follow-up|0|||
130429064|NCT02243280|469533104|FG007|Treated|Lost to Follow-up|0|||
130429065|NCT02243280|469533105|FG008|Treated|Lost to Follow-up|1|||
130429066|NCT02243280|469533106|FG009|Treated|Lost to Follow-up|0|||
130429067|NCT02243280|469533107|FG010|Treated|Lost to Follow-up|2|||
130429068|NCT03928028|469533108|FG000|Overall Study|Physician Decision|9|||
130564904|NCT01744665|470033782|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
130429069|NCT03928028|469533109|FG001|Overall Study|Physician Decision|6|||
130727815|NCT01822366|470625556|FG001|Overall Study|Partial Intervention Completion|15|||
130429070|NCT03928028|469533110|FG002|Overall Study|Physician Decision|3|||
130429071|NCT03928028|469533108|FG000|Overall Study|Withdrawal by Subject|12|||
130429072|NCT03928028|469533109|FG001|Overall Study|Withdrawal by Subject|3|||
130429073|NCT03928028|469533110|FG002|Overall Study|Withdrawal by Subject|3|||
130429074|NCT04525547|469533111|FG000|Overall Study|Not treated with Ofev|2|||
130429075|NCT04525547|469533111|FG000|Overall Study|Off-label use|2|||
130429076|NCT04525547|469533111|FG000|Overall Study|Lost to Follow-up|1|||
130429077|NCT03122119|469533112|FG000|Overall Study|Did not meet eligibility critria|1|||
130429078|NCT00800202|469533113|FG000|Overall Study|Adverse Event|7|||
130429079|NCT00800202|469533114|FG001|Overall Study|Adverse Event|6|||
130429080|NCT00800202|469533113|FG000|Overall Study|Death|1|||
130429081|NCT00800202|469533114|FG001|Overall Study|Death|0|||
130429082|NCT00800202|469533113|FG000|Overall Study|Other|5|||
130429083|NCT00800202|469533114|FG001|Overall Study|Other|0|||
130564905|NCT02044133|470033784|FG000|Overall Study|Lost to Follow-up|1|||
130727816|NCT01822366|470625557|FG002|Overall Study|Partial Intervention Completion|0|||
130429084|NCT00800202|469533113|FG000|Overall Study|Disease Progression|54|||
130429085|NCT00800202|469533114|FG001|Overall Study|Disease Progression|18|||
130429086|NCT04425902|469533115|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
130429087|NCT04669600|469533119|FG000|Overall Study|Withdrawal by Subject|1|||
130429088|NCT04669600|469533119|FG000|Overall Study|Other|6|||
130429089|NCT00855062|469533129|FG000|Step1|Early Study Closure|5|||
130429090|NCT00855062|469533130|FG001|Step1|Early Study Closure|7|||
130429091|NCT00855062|469533129|FG000|Step1|Adverse Event|1|||
130429092|NCT00855062|469533130|FG001|Step1|Adverse Event|1|||
130429093|NCT00855062|469533129|FG000|Step1|Protocol Violation|1|||
130429094|NCT00855062|469533130|FG001|Step1|Protocol Violation|0|||
130429095|NCT00855062|469533129|FG000|Step1|Pregnancy|1|||
130429096|NCT00855062|469533130|FG001|Step1|Pregnancy|0|||
130429097|NCT00855062|469533129|FG000|Step1|Withdrawal by Subject|2|||
130429098|NCT00855062|469533130|FG001|Step1|Withdrawal by Subject|3|||
130429099|NCT00855062|469533129|FG000|Step2|Early Study Closure|6|||
130429100|NCT00855062|469533130|FG001|Step2|Early Study Closure|2|||
130429101|NCT00855062|469533129|FG000|Step2|Adverse Event|0|||
130429102|NCT00855062|469533130|FG001|Step2|Adverse Event|3|||
130429103|NCT00855062|469533129|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
130429104|NCT00855062|469533130|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
130429105|NCT01960725|469533131|FG000|Overall Study|Lost to Follow-up|4|||
130429106|NCT01960725|469533132|FG001|Overall Study|Lost to Follow-up|3|||
130429107|NCT01960725|469533131|FG000|Overall Study|Withdrawal by Subject|1|||
130429108|NCT01960725|469533132|FG001|Overall Study|Withdrawal by Subject|0|||
130429109|NCT01960725|469533131|FG000|Overall Study|unable to obtain blood sample|1|||
130429110|NCT01960725|469533132|FG001|Overall Study|unable to obtain blood sample|2|||
130429111|NCT02110901|469533133|FG000|Overall Study|Death|6|||
130429112|NCT02110901|469533134|FG001|Overall Study|Death|3|||
130429113|NCT02110901|469533133|FG000|Overall Study|Lost to Follow-up|12|||
130429114|NCT02110901|469533134|FG001|Overall Study|Lost to Follow-up|8|||
130429115|NCT02110901|469533133|FG000|Overall Study|Withdrawal by Subject|7|||
130429116|NCT02110901|469533134|FG001|Overall Study|Withdrawal by Subject|3|||
130429117|NCT02110901|469533133|FG000|Overall Study|received a kidney transplant|5|||
130429118|NCT02110901|469533134|FG001|Overall Study|received a kidney transplant|0|||
130429119|NCT02634788|469533135|FG000|Overall Study|Adverse Event|0|||
130429120|NCT02634788|469533136|FG001|Overall Study|Adverse Event|8|||
130429121|NCT02634788|469533137|FG002|Overall Study|Adverse Event|3|||
130429122|NCT02634788|469533138|FG003|Overall Study|Adverse Event|1|||
130429123|NCT02634788|469533135|FG000|Overall Study|Lack of Efficacy|4|||
130429124|NCT02634788|469533136|FG001|Overall Study|Lack of Efficacy|0|||
130429125|NCT02634788|469533137|FG002|Overall Study|Lack of Efficacy|1|||
130429126|NCT02634788|469533138|FG003|Overall Study|Lack of Efficacy|4|||
130429127|NCT02634788|469533135|FG000|Overall Study|Lost to Follow-up|0|||
130429128|NCT02634788|469533136|FG001|Overall Study|Lost to Follow-up|1|||
130429129|NCT02634788|469533137|FG002|Overall Study|Lost to Follow-up|0|||
130429130|NCT02634788|469533138|FG003|Overall Study|Lost to Follow-up|0|||
130429131|NCT02634788|469533135|FG000|Overall Study|Withdrawal by Subject|0|||
130429132|NCT02634788|469533136|FG001|Overall Study|Withdrawal by Subject|1|||
130429133|NCT02634788|469533137|FG002|Overall Study|Withdrawal by Subject|1|||
130429134|NCT02634788|469533138|FG003|Overall Study|Withdrawal by Subject|0|||
130429135|NCT00758459|469533139|FG000|Overall Study|Adverse Event|3|||
130429136|NCT00758459|469533140|FG001|Overall Study|Adverse Event|2|||
130429137|NCT00758459|469533139|FG000|Overall Study|Protocol Violation|0|||
130429138|NCT00758459|469533140|FG001|Overall Study|Protocol Violation|1|||
130429139|NCT00758459|469533139|FG000|Overall Study|Withdrawal by Subject|0|||
130429140|NCT00758459|469533140|FG001|Overall Study|Withdrawal by Subject|1|||
130429141|NCT02496767|469533155|FG000|Open-label Lead-in Phase|Adverse Event|176|||
130429142|NCT02496767|469533156|FG001|Open-label Lead-in Phase|Adverse Event|0|||
130429143|NCT02496767|469533157|FG002|Open-label Lead-in Phase|Adverse Event|0|||
130727817|NCT01822366|470625558|FG003|Overall Study|Partial Intervention Completion|15|||
130727818|NCT00025259|470625559|FG000|Overall Study|Death|1|||
130429144|NCT02496767|469533158|FG003|Open-label Lead-in Phase|Adverse Event|0|||
130429145|NCT02496767|469533159|FG004|Open-label Lead-in Phase|Adverse Event|0|||
130429146|NCT02496767|469533160|FG005|Open-label Lead-in Phase|Adverse Event|0|||
130429147|NCT02496767|469533161|FG006|Open-label Lead-in Phase|Adverse Event|0|||
130429148|NCT02496767|469533162|FG007|Open-label Lead-in Phase|Adverse Event|0|||
130429149|NCT02496767|469533155|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
130429150|NCT02496767|469533156|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
130727819|NCT00025259|470625560|FG001|Overall Study|Death|3|||
130429151|NCT02496767|469533157|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
130429152|NCT02496767|469533158|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
130429153|NCT02496767|469533159|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
130429154|NCT02496767|469533160|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
130429155|NCT02496767|469533161|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
130429156|NCT02496767|469533162|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
130429157|NCT02496767|469533155|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
130429158|NCT02496767|469533156|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429159|NCT02496767|469533157|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429160|NCT02496767|469533158|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429161|NCT02496767|469533159|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429162|NCT02496767|469533160|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429163|NCT02496767|469533161|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429164|NCT02496767|469533162|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
130429165|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130429166|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
130429167|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
130429168|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
130429169|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
130429170|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130429171|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130429172|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130429173|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130429174|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
130429175|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
130429176|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
130429177|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
130429178|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130429179|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130429180|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130429181|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
130429182|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
130429183|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
130429184|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
130429185|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
130429186|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
130429187|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
130429188|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
130429189|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
130429190|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
130429191|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
130429192|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
130429193|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
130429194|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
130429195|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
130429196|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
130429197|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130429198|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
130429199|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
130429200|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
130429201|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
130429202|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130429203|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130429204|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130429205|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429206|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
130429207|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
130429208|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429209|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429210|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429211|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429212|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130429213|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130429214|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
130429215|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130429216|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
130429217|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
130429218|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130429219|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130429220|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130429221|NCT02496767|469533155|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429222|NCT02496767|469533156|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
130429223|NCT02496767|469533157|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429224|NCT02496767|469533158|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429225|NCT02496767|469533159|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429226|NCT02496767|469533160|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429227|NCT02496767|469533161|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429228|NCT02496767|469533162|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130429229|NCT02496767|469533155|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429230|NCT02496767|469533156|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429231|NCT02496767|469533157|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429232|NCT02496767|469533158|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429233|NCT02496767|469533159|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429234|NCT02496767|469533160|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
130429235|NCT02496767|469533161|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
130429236|NCT02496767|469533162|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
130429237|NCT02496767|469533155|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
130429238|NCT02496767|469533156|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
130429239|NCT02496767|469533157|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
130429240|NCT02496767|469533158|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
130429241|NCT02496767|469533159|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
130429242|NCT02496767|469533160|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
130429243|NCT02496767|469533161|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
130429244|NCT02496767|469533162|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
130429245|NCT02496767|469533155|FG000|Double-blind, Withdrawal Phase|Death|0|||
130429246|NCT02496767|469533156|FG001|Double-blind, Withdrawal Phase|Death|0|||
130429247|NCT02496767|469533157|FG002|Double-blind, Withdrawal Phase|Death|0|||
130429248|NCT02496767|469533158|FG003|Double-blind, Withdrawal Phase|Death|0|||
130429249|NCT02496767|469533159|FG004|Double-blind, Withdrawal Phase|Death|0|||
130429250|NCT02496767|469533160|FG005|Double-blind, Withdrawal Phase|Death|0|||
130429251|NCT02496767|469533161|FG006|Double-blind, Withdrawal Phase|Death|1|||
130429252|NCT02496767|469533162|FG007|Double-blind, Withdrawal Phase|Death|2|||
130429253|NCT02496767|469533155|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130429254|NCT02496767|469533156|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130429255|NCT02496767|469533157|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130429256|NCT02496767|469533158|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130429257|NCT02496767|469533159|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130429258|NCT02496767|469533160|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130429259|NCT02496767|469533161|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130429260|NCT02496767|469533162|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130429261|NCT01281202|469533166|FG000|Overall Study|Adverse Event|2|||
130429262|NCT01281202|469533167|FG001|Overall Study|Adverse Event|0|||
130429263|NCT01281202|469533166|FG000|Overall Study|Withdrawal by Subject|2|||
130429264|NCT01281202|469533167|FG001|Overall Study|Withdrawal by Subject|2|||
130429265|NCT01281202|469533166|FG000|Overall Study|Protocol Violation|11|||
130429266|NCT01281202|469533167|FG001|Overall Study|Protocol Violation|10|||
130429267|NCT01281202|469533166|FG000|Overall Study|Administrative|2|||
130429268|NCT01281202|469533167|FG001|Overall Study|Administrative|8|||
130429269|NCT01281202|469533166|FG000|Overall Study|Lost to Follow-up|11|||
130429270|NCT01281202|469533167|FG001|Overall Study|Lost to Follow-up|13|||
130429271|NCT01281202|469533166|FG000|Overall Study|Incarceration|0|||
130429272|NCT01281202|469533167|FG001|Overall Study|Incarceration|3|||
130429273|NCT02889133|469533168|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
130429274|NCT02889133|469533169|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
130429275|NCT02889133|469533168|FG000|Completed Primary Outcome|Manufacturing error|3|||
130429276|NCT02889133|469533169|FG001|Completed Primary Outcome|Manufacturing error|8|||
130429277|NCT02889133|469533168|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
130429278|NCT02889133|469533169|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
130429279|NCT02889133|469533168|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
130429280|NCT02889133|469533169|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
130429281|NCT02889133|469533168|FG000|Completed Primary Outcome|Protocol Violation|1|||
130429282|NCT02889133|469533169|FG001|Completed Primary Outcome|Protocol Violation|0|||
130727820|NCT00025259|470625561|FG002|Overall Study|Death|0|||
130429283|NCT02889133|469533168|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
130429284|NCT02889133|469533169|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
130727821|NCT00025259|470625562|FG003|Overall Study|Death|3|||
130429285|NCT02889133|469533168|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
130478809|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
130478810|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
130429286|NCT02889133|469533169|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
130429287|NCT02889133|469533168|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
130429288|NCT02889133|469533169|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
130429289|NCT02889133|469533168|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
130727822|NCT00025259|470625563|FG004|Overall Study|Death|0|||
130727823|NCT00025259|470625564|FG005|Overall Study|Death|1|||
130727824|NCT00025259|470625565|FG006|Overall Study|Death|2|||
130727825|NCT00025259|470625559|FG000|Overall Study|Lack of Efficacy|2|||
130727826|NCT00025259|470625560|FG001|Overall Study|Lack of Efficacy|46|||
130727827|NCT00025259|470625561|FG002|Overall Study|Lack of Efficacy|60|||
130727828|NCT00025259|470625562|FG003|Overall Study|Lack of Efficacy|78|||
130727829|NCT00025259|470625563|FG004|Overall Study|Lack of Efficacy|11|||
130429290|NCT02889133|469533169|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
130429291|NCT02889133|469533168|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
130429292|NCT02889133|469533169|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
130429293|NCT04711603|469533170|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
130429294|NCT04711603|469533171|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
130429295|NCT04711603|469533172|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
130429296|NCT04711603|469533173|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
130429297|NCT04711603|469533170|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130429298|NCT04711603|469533171|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
130429299|NCT04711603|469533172|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130429300|NCT04711603|469533173|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130429301|NCT04711603|469533170|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130429302|NCT04711603|469533171|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
130429303|NCT04711603|469533172|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130429304|NCT04711603|469533173|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130429305|NCT04711603|469533170|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130429306|NCT04711603|469533171|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
130429307|NCT04711603|469533172|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130478811|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
130478812|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
130478813|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
130478814|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
130429308|NCT04711603|469533173|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130429309|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
130429310|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
130429311|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
130429312|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
130429313|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130429314|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130429315|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130429316|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
130429317|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
130429318|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
130429319|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
130429320|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
130429321|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
130429322|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
130429323|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
130429324|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
130429325|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130429326|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130429327|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130478815|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
130478816|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
130478817|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
130478818|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
130478819|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
130478820|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
130478821|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
130478822|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
130727830|NCT00025259|470625564|FG005|Overall Study|Lack of Efficacy|30|||
130727831|NCT00025259|470625565|FG006|Overall Study|Lack of Efficacy|38|||
130727832|NCT00025259|470625559|FG000|Overall Study|Lost to Follow-up|2|||
130727833|NCT00025259|470625560|FG001|Overall Study|Lost to Follow-up|9|||
130478823|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
130727834|NCT00025259|470625561|FG002|Overall Study|Lost to Follow-up|13|||
130727835|NCT00025259|470625562|FG003|Overall Study|Lost to Follow-up|13|||
130727836|NCT00025259|470625563|FG004|Overall Study|Lost to Follow-up|1|||
130727837|NCT00025259|470625564|FG005|Overall Study|Lost to Follow-up|3|||
130478824|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
130429328|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
130429329|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130429330|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130429331|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130429332|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
130429333|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130429334|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130429335|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130429336|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
130429337|NCT04711603|469533170|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130429338|NCT04711603|469533171|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130429339|NCT04711603|469533172|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
130429340|NCT04711603|469533173|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130429341|NCT05479604|469533176|FG000|Overall Study|Lost to Follow-up|1|||
130429342|NCT05479604|469533177|FG001|Overall Study|Lost to Follow-up|5|||
130429343|NCT04270747|469533184|FG000|Through Week 16|Adverse Event|1|||
130429344|NCT04270747|469533185|FG001|Through Week 16|Adverse Event|2|||
130429345|NCT04270747|469533186|FG002|Through Week 16|Adverse Event|0|||
130429346|NCT04270747|469533184|FG000|Through Week 16|Death|0|||
130429347|NCT04270747|469533185|FG001|Through Week 16|Death|2|||
130429348|NCT04270747|469533186|FG002|Through Week 16|Death|0|||
130429349|NCT04270747|469533184|FG000|Through Week 16|Consent Withdrawn|3|||
130429350|NCT04270747|469533185|FG001|Through Week 16|Consent Withdrawn|3|||
130429351|NCT04270747|469533186|FG002|Through Week 16|Consent Withdrawn|0|||
130429352|NCT04270747|469533184|FG000|Through Week 16|Physician Decision|1|||
130429353|NCT04270747|469533185|FG001|Through Week 16|Physician Decision|1|||
130429354|NCT04270747|469533186|FG002|Through Week 16|Physician Decision|0|||
130429355|NCT04270747|469533184|FG000|Through Week 16|Lost to Follow-up|2|||
130429356|NCT04270747|469533185|FG001|Through Week 16|Lost to Follow-up|0|||
130429357|NCT04270747|469533186|FG002|Through Week 16|Lost to Follow-up|0|||
130429358|NCT04270747|469533184|FG000|Through Week 16|Protocol Violation|1|||
130429359|NCT04270747|469533185|FG001|Through Week 16|Protocol Violation|2|||
130429360|NCT04270747|469533186|FG002|Through Week 16|Protocol Violation|0|||
130429361|NCT04270747|469533184|FG000|Through Week 16|Protocol Specified Criteria|6|||
130429362|NCT04270747|469533185|FG001|Through Week 16|Protocol Specified Criteria|7|||
130429363|NCT04270747|469533186|FG002|Through Week 16|Protocol Specified Criteria|0|||
130429364|NCT04270747|469533184|FG000|Through Week 16|Miscellaneous|1|||
130429365|NCT04270747|469533185|FG001|Through Week 16|Miscellaneous|1|||
130429366|NCT04270747|469533186|FG002|Through Week 16|Miscellaneous|0|||
130429367|NCT04270747|469533184|FG000|Post Week 16|Adverse Event|7|||
130429368|NCT04270747|469533185|FG001|Post Week 16|Adverse Event|5|||
130429369|NCT04270747|469533186|FG002|Post Week 16|Adverse Event|1|||
130429370|NCT04270747|469533184|FG000|Post Week 16|Death|2|||
130429371|NCT04270747|469533185|FG001|Post Week 16|Death|0|||
130429372|NCT04270747|469533186|FG002|Post Week 16|Death|2|||
130429373|NCT04270747|469533184|FG000|Post Week 16|Consent Withdrawn|4|||
130429374|NCT04270747|469533185|FG001|Post Week 16|Consent Withdrawn|3|||
130429375|NCT04270747|469533186|FG002|Post Week 16|Consent Withdrawn|6|||
130429376|NCT04270747|469533184|FG000|Post Week 16|Physician Decision|3|||
130429377|NCT04270747|469533185|FG001|Post Week 16|Physician Decision|1|||
130429378|NCT04270747|469533186|FG002|Post Week 16|Physician Decision|1|||
130429379|NCT04270747|469533184|FG000|Post Week 16|Lost to Follow-up|2|||
130429380|NCT04270747|469533185|FG001|Post Week 16|Lost to Follow-up|1|||
130429381|NCT04270747|469533186|FG002|Post Week 16|Lost to Follow-up|0|||
130429382|NCT04270747|469533184|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
130429383|NCT04270747|469533185|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
130429384|NCT04270747|469533186|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
130429385|NCT04270747|469533184|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
130429386|NCT04270747|469533185|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
130429387|NCT04270747|469533186|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
130429388|NCT04270747|469533184|FG000|Post Week 16|Miscellaneous|1|||
130429389|NCT04270747|469533185|FG001|Post Week 16|Miscellaneous|0|||
130429390|NCT04270747|469533186|FG002|Post Week 16|Miscellaneous|1|||
130429391|NCT01784068|469533190|FG000|NTCS Phase|Adverse Event|5|||
130429392|NCT01784068|469533191|FG001|NTCS Phase|Adverse Event|0|||
130429393|NCT01784068|469533190|FG000|NTCS Phase|Physician Decision|2|||
130478825|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
130429394|NCT01784068|469533191|FG001|NTCS Phase|Physician Decision|0|||
130429395|NCT01784068|469533190|FG000|NTCS Phase|Patient/guardian decision|3|||
130429396|NCT01784068|469533191|FG001|NTCS Phase|Patient/guardian decision|0|||
130429397|NCT01784068|469533190|FG000|NTCS Phase|Death|2|||
130429398|NCT01784068|469533191|FG001|NTCS Phase|Death|0|||
130429399|NCT01784068|469533190|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
130429400|NCT01784068|469533191|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
130429401|NCT01784068|469533190|FG000|TFR Phase|Physician Decision|0|||
130429402|NCT01784068|469533191|FG001|TFR Phase|Physician Decision|1|||
130429403|NCT01784068|469533190|FG000|TFR Phase|Patient/guardian decision|0|||
130429404|NCT01784068|469533191|FG001|TFR Phase|Patient/guardian decision|3|||
130429405|NCT01784068|469533190|FG000|TFR Phase|Death|0|||
130429406|NCT01784068|469533191|FG001|TFR Phase|Death|1|||
130429407|NCT01784068|469533190|FG000|TFR Phase|Lack of Efficacy|0|||
130429408|NCT01784068|469533191|FG001|TFR Phase|Lack of Efficacy|88|||
130429409|NCT00946296|469533192|FG000|Overall Study|Physician Decision|3|||
130429410|NCT00946296|469533193|FG001|Overall Study|Physician Decision|0|||
130429411|NCT02068495|469533199|FG000|Overall Study|Case Report Forms Uncollected|60|||
130429412|NCT02068495|469533199|FG000|Overall Study|Protocol Deviation|49|||
130429413|NCT04992546|469533201|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130429414|NCT04992546|469533201|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
130429415|NCT04992546|469533201|FG000|Open-Label Treatment Period|Adverse Event|3|||
130429416|NCT04992546|469533201|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
130429417|NCT02703922|469533202|FG000|Overall Study|Death|5|||
130429418|NCT02703922|469533203|FG001|Overall Study|Death|8|||
130429419|NCT02703922|469533202|FG000|Overall Study|Lost to Follow-up|10|||
130429420|NCT02703922|469533203|FG001|Overall Study|Lost to Follow-up|10|||
130478826|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
130478827|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
130478828|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
130478829|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
130478830|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
130478831|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
130478832|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
130478833|NCT04963270|469721992|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
130478834|NCT04963270|469721993|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
130478835|NCT04963270|469721994|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
130478836|NCT04963270|469721995|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
130478837|NCT04624633|469722002|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
130478838|NCT04624633|469722003|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
130478839|NCT04624633|469722002|FG000|Overall Study|Death|1|||
130478840|NCT04624633|469722003|FG001|Overall Study|Death|0|||
130478841|NCT04316871|469722004|FG000|Overall Study|Protocol Violation|2|||
130478842|NCT04316871|469722005|FG001|Overall Study|Protocol Violation|2|||
130478843|NCT04316871|469722006|FG002|Overall Study|Protocol Violation|2|||
130478844|NCT04316871|469722007|FG003|Overall Study|Protocol Violation|2|||
130478845|NCT05087992|469722008|FG000|Overall Study|Adverse Event|0|||
130478846|NCT05087992|469722009|FG001|Overall Study|Adverse Event|1|||
130478847|NCT05087992|469722010|FG002|Overall Study|Adverse Event|0|||
130478848|NCT05087992|469722008|FG000|Overall Study|Withdrawal by Subject|2|||
130478849|NCT05087992|469722009|FG001|Overall Study|Withdrawal by Subject|0|||
130478850|NCT05087992|469722010|FG002|Overall Study|Withdrawal by Subject|0|||
130478851|NCT05087992|469722008|FG000|Overall Study|clinical disease progression|3|||
130478852|NCT05087992|469722009|FG001|Overall Study|clinical disease progression|1|||
130478853|NCT05087992|469722010|FG002|Overall Study|clinical disease progression|0|||
130478854|NCT05087992|469722008|FG000|Overall Study|objective disease progression|4|||
130478855|NCT05087992|469722009|FG001|Overall Study|objective disease progression|1|||
130478856|NCT05087992|469722010|FG002|Overall Study|objective disease progression|0|||
130478857|NCT01842542|469722011|FG000|Overall Study|Withdrawal by Subject|2|||
130478858|NCT01842542|469722011|FG000|Overall Study|Lack of Efficacy|1|||
130478859|NCT01842542|469722011|FG000|Overall Study|Protocol Non-compliance|2|||
130478860|NCT01842542|469722011|FG000|Overall Study|Lost to Follow-up|1|||
130478861|NCT01824394|469722017|FG000|Overall Study|Early Termination|1|||
130478862|NCT01824394|469722018|FG001|Overall Study|Early Termination|1|||
130478863|NCT01824394|469722019|FG002|Overall Study|Early Termination|3|||
130478864|NCT01824394|469722017|FG000|Overall Study|Withdrawn due to Study Termination|91|||
130478865|NCT01824394|469722018|FG001|Overall Study|Withdrawn due to Study Termination|83|||
130478866|NCT01824394|469722019|FG002|Overall Study|Withdrawn due to Study Termination|41|||
130478867|NCT01824394|469722017|FG000|Overall Study|Lost to Follow-up|0|||
130478868|NCT01824394|469722018|FG001|Overall Study|Lost to Follow-up|9|||
130478869|NCT01824394|469722019|FG002|Overall Study|Lost to Follow-up|3|||
130478870|NCT01824394|469722017|FG000|Overall Study|Death|3|||
130478871|NCT01824394|469722018|FG001|Overall Study|Death|2|||
130564906|NCT02044133|470033785|FG001|Overall Study|Lost to Follow-up|1|||
130727838|NCT00025259|470625565|FG006|Overall Study|Lost to Follow-up|1|||
130478872|NCT01824394|469722019|FG002|Overall Study|Death|4|||
130478873|NCT01824394|469722017|FG000|Overall Study|Discontinued Subjects|1|||
130478874|NCT01824394|469722018|FG001|Overall Study|Discontinued Subjects|1|||
130478875|NCT01824394|469722019|FG002|Overall Study|Discontinued Subjects|2|||
130478876|NCT01824394|469722017|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
130478877|NCT01824394|469722018|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
130478878|NCT01824394|469722019|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
130478879|NCT05780437|469722020|FG000|Overall Study|Withdrawal by Subject|22|||
130478880|NCT05780437|469722021|FG001|Overall Study|Withdrawal by Subject|16|||
130478881|NCT03452579|469722022|FG000|Overall Study|Death|0|||
130478882|NCT03452579|469722023|FG001|Overall Study|Death|1|||
130478883|NCT03452579|469722022|FG000|Overall Study|Withdrawal by Subject|2|||
130478884|NCT03452579|469722023|FG001|Overall Study|Withdrawal by Subject|0|||
130478885|NCT03452579|469722022|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
130478886|NCT03452579|469722023|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
130478887|NCT03452579|469722022|FG000|Overall Study|Physician Decision|1|||
130478888|NCT03452579|469722023|FG001|Overall Study|Physician Decision|1|||
130478889|NCT03452579|469722022|FG000|Overall Study|Adverse Event|1|||
130478890|NCT03452579|469722023|FG001|Overall Study|Adverse Event|4|||
130478891|NCT03092518|469722027|FG000|Overall Study|Ineligible|2|||
130478892|NCT03115476|469722030|FG000|LP0084-1369|Death|1|||
130478893|NCT03115476|469722031|FG001|LP0084-1369|Death|0|||
130478894|NCT03115476|469722032|FG002|LP0084-1369|Death|2|||
130478895|NCT03115476|469722030|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
130478896|NCT03115476|469722031|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
130478897|NCT03115476|469722032|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
130478898|NCT05257486|469722036|FG000|Overall Study|Protocol Violation|3|||
130478899|NCT03976362|469722037|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
130478900|NCT03976362|469722038|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130478901|NCT03976362|469722039|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130478902|NCT03976362|469722037|FG000|Induction Phase|Death|62|||
130478903|NCT03976362|469722038|FG001|Induction Phase|Death|0|||
130478904|NCT03976362|469722039|FG002|Induction Phase|Death|0|||
130478905|NCT03976362|469722037|FG000|Maintenance Phase|Participants Ongoing|0|||
130478906|NCT03976362|469722038|FG001|Maintenance Phase|Participants Ongoing|106|||
130478907|NCT03976362|469722039|FG002|Maintenance Phase|Participants Ongoing|103|||
130478908|NCT03976362|469722037|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130478909|NCT03976362|469722038|FG001|Maintenance Phase|Withdrawal by Subject|4|||
130478910|NCT03976362|469722039|FG002|Maintenance Phase|Withdrawal by Subject|4|||
130478911|NCT03976362|469722037|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
130478912|NCT03976362|469722038|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
130478913|NCT03976362|469722039|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
130478914|NCT03976362|469722037|FG000|Maintenance Phase|Death|0|||
130478915|NCT03976362|469722038|FG001|Maintenance Phase|Death|186|||
130478916|NCT03976362|469722039|FG002|Maintenance Phase|Death|187|||
130478917|NCT00613106|469722040|FG000|Overall Study|Adverse Event|3|||
130478918|NCT00613106|469722041|FG001|Overall Study|Adverse Event|1|||
130478919|NCT00613106|469722040|FG000|Overall Study|Withdrawal by Subject|6|||
130478920|NCT00613106|469722041|FG001|Overall Study|Withdrawal by Subject|3|||
130478921|NCT00613106|469722040|FG000|Overall Study|Lost to Follow-up|7|||
130478922|NCT00613106|469722041|FG001|Overall Study|Lost to Follow-up|2|||
130478923|NCT00613106|469722040|FG000|Overall Study|misc|4|||
130478924|NCT00613106|469722041|FG001|Overall Study|misc|3|||
130478925|NCT05084508|469722050|FG000|Overall Study|Lost to Follow-up|6|||
130478926|NCT05084508|469722051|FG001|Overall Study|Lost to Follow-up|3|||
130478927|NCT05084508|469722052|FG002|Overall Study|Lost to Follow-up|7|||
130478928|NCT05084508|469722053|FG003|Overall Study|Lost to Follow-up|3|||
130478929|NCT05084508|469722050|FG000|Overall Study|Withdrawal by Subject|0|||
130478930|NCT05084508|469722051|FG001|Overall Study|Withdrawal by Subject|2|||
130478931|NCT05084508|469722052|FG002|Overall Study|Withdrawal by Subject|3|||
130478932|NCT05084508|469722053|FG003|Overall Study|Withdrawal by Subject|1|||
130478933|NCT05084508|469722050|FG000|Overall Study|Other|0|||
130478934|NCT05084508|469722051|FG001|Overall Study|Other|0|||
130478935|NCT05084508|469722052|FG002|Overall Study|Other|0|||
130478936|NCT05084508|469722053|FG003|Overall Study|Other|1|||
130478937|NCT05296525|469722054|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
130478938|NCT05296525|469722055|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
130478939|NCT05296525|469722056|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
130478940|NCT05296525|469722057|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
130478941|NCT04065841|469722062|FG000|Overall Study|Adverse Event|4|||
130478942|NCT04065841|469722063|FG001|Overall Study|Adverse Event|2|||
130478943|NCT04065841|469722064|FG002|Overall Study|Adverse Event|10|||
130478944|NCT04065841|469722065|FG003|Overall Study|Adverse Event|1|||
130478945|NCT04065841|469722062|FG000|Overall Study|Lost to Follow-up|1|||
130478946|NCT04065841|469722063|FG001|Overall Study|Lost to Follow-up|2|||
130478947|NCT04065841|469722064|FG002|Overall Study|Lost to Follow-up|2|||
130478948|NCT04065841|469722065|FG003|Overall Study|Lost to Follow-up|2|||
130478949|NCT04065841|469722062|FG000|Overall Study|Physician Decision|1|||
130478950|NCT04065841|469722063|FG001|Overall Study|Physician Decision|0|||
130478951|NCT04065841|469722064|FG002|Overall Study|Physician Decision|0|||
130478952|NCT04065841|469722065|FG003|Overall Study|Physician Decision|0|||
130478953|NCT04065841|469722062|FG000|Overall Study|Protocol Violation|0|||
130478954|NCT04065841|469722063|FG001|Overall Study|Protocol Violation|1|||
130478955|NCT04065841|469722064|FG002|Overall Study|Protocol Violation|0|||
130478956|NCT04065841|469722065|FG003|Overall Study|Protocol Violation|0|||
130478957|NCT04065841|469722062|FG000|Overall Study|Study terminated by Sponsor|22|||
130478958|NCT04065841|469722063|FG001|Overall Study|Study terminated by Sponsor|16|||
130478959|NCT04065841|469722064|FG002|Overall Study|Study terminated by Sponsor|28|||
130478960|NCT04065841|469722065|FG003|Overall Study|Study terminated by Sponsor|17|||
130478961|NCT04065841|469722062|FG000|Overall Study|Withdrawal by Subject|1|||
130478962|NCT04065841|469722063|FG001|Overall Study|Withdrawal by Subject|1|||
130478963|NCT04065841|469722064|FG002|Overall Study|Withdrawal by Subject|2|||
130478964|NCT04065841|469722065|FG003|Overall Study|Withdrawal by Subject|0|||
130478965|NCT01420237|469722066|FG000|Overall Study|Death|13|||
130478966|NCT01420237|469722066|FG000|Overall Study|Withdrawal by Subject|41|||
130478967|NCT01420237|469722066|FG000|Overall Study|Lost to Follow-up|32|||
130478968|NCT01420237|469722066|FG000|Overall Study|Adverse Event|10|||
130478969|NCT01420237|469722066|FG000|Overall Study|Investigative Site Termination|43|||
130478970|NCT01420237|469722066|FG000|Overall Study|Censored because study device not implanted|21|||
130478971|NCT01420237|469722066|FG000|Overall Study|Censored because surgery not performed|2|||
130478972|NCT01420237|469722066|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
130478973|NCT01420237|469722066|FG000|Overall Study|Sponsor terminated study early|127|||
130478974|NCT04492722|469722067|FG000|Overall Study|Adverse Event|7|||
130478975|NCT04492722|469722068|FG001|Overall Study|Adverse Event|2|||
130478976|NCT04492722|469722069|FG002|Overall Study|Adverse Event|3|||
130478977|NCT04492722|469722070|FG003|Overall Study|Adverse Event|0|||
130478978|NCT04492722|469722067|FG000|Overall Study|Death|0|||
130478979|NCT04492722|469722068|FG001|Overall Study|Death|0|||
130478980|NCT04492722|469722069|FG002|Overall Study|Death|0|||
130478981|NCT04492722|469722070|FG003|Overall Study|Death|1|||
130478982|NCT04492722|469722067|FG000|Overall Study|Lost to Follow-up|0|||
130478983|NCT04492722|469722068|FG001|Overall Study|Lost to Follow-up|1|||
130478984|NCT04492722|469722069|FG002|Overall Study|Lost to Follow-up|0|||
130478985|NCT04492722|469722070|FG003|Overall Study|Lost to Follow-up|1|||
130478986|NCT04492722|469722067|FG000|Overall Study|Physician Decision|0|||
130478987|NCT04492722|469722068|FG001|Overall Study|Physician Decision|3|||
130478988|NCT04492722|469722069|FG002|Overall Study|Physician Decision|1|||
130478989|NCT04492722|469722070|FG003|Overall Study|Physician Decision|1|||
130478990|NCT04492722|469722067|FG000|Overall Study|Withdrawal by Subject|6|||
130478991|NCT04492722|469722068|FG001|Overall Study|Withdrawal by Subject|6|||
130478992|NCT04492722|469722069|FG002|Overall Study|Withdrawal by Subject|0|||
130478993|NCT04492722|469722070|FG003|Overall Study|Withdrawal by Subject|3|||
130478994|NCT04492722|469722067|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
130478995|NCT04492722|469722068|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
130478996|NCT04492722|469722069|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
130478997|NCT04492722|469722070|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
130478998|NCT04492722|469722067|FG000|Overall Study|Due to Covid-19 pandemic|7|||
130478999|NCT04492722|469722068|FG001|Overall Study|Due to Covid-19 pandemic|3|||
130479000|NCT04492722|469722069|FG002|Overall Study|Due to Covid-19 pandemic|7|||
130479001|NCT04492722|469722070|FG003|Overall Study|Due to Covid-19 pandemic|6|||
130479002|NCT04492722|469722067|FG000|Overall Study|Failure to meet randomisation criteria|2|||
130479003|NCT04492722|469722068|FG001|Overall Study|Failure to meet randomisation criteria|3|||
130479004|NCT04492722|469722069|FG002|Overall Study|Failure to meet randomisation criteria|4|||
130479005|NCT04492722|469722070|FG003|Overall Study|Failure to meet randomisation criteria|2|||
130479006|NCT04492722|469722067|FG000|Overall Study|Early termination from the study|54|||
130479007|NCT04492722|469722068|FG001|Overall Study|Early termination from the study|51|||
130479008|NCT04492722|469722069|FG002|Overall Study|Early termination from the study|50|||
130479009|NCT04492722|469722070|FG003|Overall Study|Early termination from the study|50|||
130479010|NCT04492722|469722067|FG000|Overall Study|Missing|3|||
130479011|NCT04492722|469722068|FG001|Overall Study|Missing|0|||
130479012|NCT04492722|469722069|FG002|Overall Study|Missing|0|||
130479013|NCT04492722|469722070|FG003|Overall Study|Missing|5|||
130479014|NCT04492722|469722067|FG000|Overall Study|Participants who did not receive treatment|0|||
130479015|NCT04492722|469722068|FG001|Overall Study|Participants who did not receive treatment|1|||
130479016|NCT04492722|469722069|FG002|Overall Study|Participants who did not receive treatment|4|||
130479017|NCT04492722|469722070|FG003|Overall Study|Participants who did not receive treatment|0|||
130479018|NCT03631784|469722072|FG000|Overall Study|Participants Ongoing|1|||
130479019|NCT03631784|469722073|FG001|Overall Study|Participants Ongoing|0|||
130479020|NCT03631784|469722072|FG000|Overall Study|Withdrawal by Subject|3|||
130479021|NCT03631784|469722073|FG001|Overall Study|Withdrawal by Subject|3|||
130479022|NCT03631784|469722072|FG000|Overall Study|Sponsor's Decision|36|||
130479023|NCT03631784|469722073|FG001|Overall Study|Sponsor's Decision|52|||
130479024|NCT03631784|469722072|FG000|Overall Study|Lost to Follow-up|1|||
130479025|NCT03631784|469722073|FG001|Overall Study|Lost to Follow-up|0|||
130479026|NCT03631784|469722072|FG000|Overall Study|Death|71|||
130479027|NCT03631784|469722073|FG001|Overall Study|Death|49|||
130479028|NCT02908477|469724183|FG000|Overall Study|Withdrawal by Subject|8|||
130479029|NCT02908477|469724184|FG001|Overall Study|Withdrawal by Subject|28|||
130479030|NCT02140554|469724185|FG000|Overall Study|Withdrawal of consent|1|||
130479031|NCT02140554|469724186|FG001|Overall Study|Withdrawal of consent|0|||
130479032|NCT02140554|469724187|FG002|Overall Study|Withdrawal of consent|4|||
130479033|NCT02140554|469724185|FG000|Overall Study|Physician Decision|1|||
130479034|NCT02140554|469724186|FG001|Overall Study|Physician Decision|0|||
130479035|NCT02140554|469724187|FG002|Overall Study|Physician Decision|2|||
130479036|NCT02140554|469724185|FG000|Overall Study|Death|0|||
130479037|NCT02140554|469724186|FG001|Overall Study|Death|0|||
130479038|NCT02140554|469724187|FG002|Overall Study|Death|1|||
130479039|NCT02140554|469724185|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
130479040|NCT02140554|469724186|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
130479041|NCT02140554|469724187|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
130479042|NCT05590403|469724188|FG000|Overall Study|Lost to Follow-up|13|||
130479043|NCT05590403|469724189|FG001|Overall Study|Lost to Follow-up|1|||
130479044|NCT05590403|469724190|FG002|Overall Study|Lost to Follow-up|7|||
130479045|NCT05590403|469724191|FG003|Overall Study|Lost to Follow-up|3|||
130479046|NCT05590403|469724192|FG004|Overall Study|Lost to Follow-up|4|||
130479047|NCT05590403|469724188|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
130479048|NCT05590403|469724189|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
130479049|NCT05590403|469724190|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
130479050|NCT05590403|469724191|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
130479051|NCT05590403|469724192|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
130479052|NCT05590403|469724188|FG000|Overall Study|Other|2|||
130479053|NCT05590403|469724189|FG001|Overall Study|Other|0|||
130479054|NCT05590403|469724190|FG002|Overall Study|Other|2|||
130479055|NCT05590403|469724191|FG003|Overall Study|Other|2|||
130479056|NCT05590403|469724192|FG004|Overall Study|Other|0|||
130479057|NCT05590403|469724188|FG000|Overall Study|Migrated / moved from the study area|1|||
130479058|NCT05590403|469724189|FG001|Overall Study|Migrated / moved from the study area|1|||
130479059|NCT05590403|469724190|FG002|Overall Study|Migrated / moved from the study area|0|||
130479060|NCT05590403|469724191|FG003|Overall Study|Migrated / moved from the study area|3|||
130479061|NCT05590403|469724192|FG004|Overall Study|Migrated / moved from the study area|1|||
130479062|NCT05590403|469724188|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
130479063|NCT05590403|469724189|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
130479064|NCT05590403|469724190|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
130479065|NCT05590403|469724191|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
130479066|NCT05590403|469724192|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
130479067|NCT05659537|469724193|FG000|Overall Study|Adverse Event|5|||
130479068|NCT05659537|469724193|FG000|Overall Study|Lost to Follow-up|4|||
130479069|NCT05659537|469724193|FG000|Overall Study|Withdrawal by Subject|13|||
130479070|NCT05659537|469724193|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
130479071|NCT05659537|469724193|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
130479072|NCT05659537|469724193|FG000|Overall Study|Participant was suffering from anaemia|1|||
130479073|NCT03701399|469724198|FG000|Overall Study|Adverse Event|3|||
130479074|NCT03701399|469724199|FG001|Overall Study|Adverse Event|5|||
130479075|NCT03701399|469724198|FG000|Overall Study|Withdrawal by Subject|6|||
130479076|NCT03701399|469724199|FG001|Overall Study|Withdrawal by Subject|3|||
130479077|NCT03701399|469724198|FG000|Overall Study|Investigators decision|1|||
130479078|NCT03701399|469724199|FG001|Overall Study|Investigators decision|2|||
130479079|NCT03701399|469724198|FG000|Overall Study|Lost to Follow-up|1|||
130479080|NCT03701399|469724199|FG001|Overall Study|Lost to Follow-up|2|||
130479081|NCT03701399|469724198|FG000|Overall Study|Death|1|||
130479082|NCT03701399|469724199|FG001|Overall Study|Death|1|||
130479083|NCT03701399|469724198|FG000|Overall Study|Randomized but not treated|1|||
130479084|NCT03701399|469724199|FG001|Overall Study|Randomized but not treated|0|||
130479085|NCT04342494|469724200|FG000|Overall Study|Questionnaire partially completed|1|||
130479086|NCT04342494|469724201|FG001|Overall Study|Questionnaire partially completed|0|||
130479087|NCT04342494|469724202|FG002|Overall Study|Questionnaire partially completed|2|||
130479088|NCT04342494|469724203|FG003|Overall Study|Questionnaire partially completed|0|||
130479089|NCT04342494|469724204|FG004|Overall Study|Questionnaire partially completed|1|||
130479090|NCT04342494|469724200|FG000|Overall Study|Lost to Follow-up|49|||
130479091|NCT04342494|469724201|FG001|Overall Study|Lost to Follow-up|38|||
130479092|NCT04342494|469724202|FG002|Overall Study|Lost to Follow-up|34|||
130479093|NCT04342494|469724203|FG003|Overall Study|Lost to Follow-up|34|||
130479094|NCT04342494|469724204|FG004|Overall Study|Lost to Follow-up|35|||
130479095|NCT05119023|469724205|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
130479096|NCT05119023|469724205|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
130479097|NCT05119023|469724205|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
130479098|NCT04806451|469724209|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
130479099|NCT04806451|469724210|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
130479100|NCT04806451|469724209|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
130479101|NCT04806451|469724210|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
130479102|NCT04806451|469724209|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
130479103|NCT04806451|469724210|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
130479104|NCT05835336|469724211|FG000|Overall Study|Withdrawal by Subject|5|||
130479105|NCT05835336|469724211|FG000|Overall Study|Did not complete the personalization process|3|||
130479106|NCT04719390|469724213|FG000|Overall Study|Withdrawal by Subject|1|||
130479107|NCT05746455|469724214|FG000|Overall Study|Discharged from Clinical Service|1|||
130479108|NCT05746455|469724214|FG000|Overall Study|Lost to Follow-up|1|||
130479109|NCT05453773|469724215|FG000|Overall Study|Withdrawal by Subject|3|||
130479110|NCT05453773|469724215|FG000|Overall Study|Lost to Follow-up|3|||
130479111|NCT05453773|469724215|FG000|Overall Study|Difficult Blood Draw|3|||
130479112|NCT02023866|469724219|FG000|Overall Study|Non-compliance|2|||
130479113|NCT02023866|469724219|FG000|Overall Study|Adverse Event|3|||
130479114|NCT02023866|469724219|FG000|Overall Study|Withdrawal by Subject|1|||
130479115|NCT03023410|469724220|FG000|Overall Study|study termination|0|||
130479116|NCT03023410|469724221|FG001|Overall Study|study termination|1|||
130479117|NCT04799899|469724222|FG000|Overall Study|Lost to Follow-up|2|||
130479118|NCT04799899|469724223|FG001|Overall Study|Lost to Follow-up|4|||
130479119|NCT00470704|469724224|FG000|Overall Study|Withdrawal by Subject|4|||
130479120|NCT00470704|469724225|FG001|Overall Study|Withdrawal by Subject|3|||
130479121|NCT00470704|469724224|FG000|Overall Study|Relapse/Progression|37|||
130479122|NCT00470704|469724225|FG001|Overall Study|Relapse/Progression|42|||
130479123|NCT00470704|469724224|FG000|Overall Study|toxicity|0|||
130479124|NCT00470704|469724225|FG001|Overall Study|toxicity|1|||
130479125|NCT04019873|469724226|FG000|Overall Study|Discontinued from the treatment|1|||
130479126|NCT04019873|469724227|FG001|Overall Study|Discontinued from the treatment|39|||
130479127|NCT04019873|469724228|FG002|Overall Study|Discontinued from the treatment|2|||
130479128|NCT04683744|469724235|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
130479129|NCT04683744|469724236|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
130479130|NCT04683744|469724237|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
130479131|NCT04295798|469724244|FG000|Overall Study|Lost to Follow-up|1|||
130479132|NCT04927364|469724248|FG000|Overall Study|Withdrawal by Subject|3|||
130479133|NCT04927364|469724248|FG000|Overall Study|Unable to complete preassessment MRI|1|||
130479134|NCT04650269|469724254|FG000|Overall Study|Death|3|||
130479135|NCT04650269|469724254|FG000|Overall Study|Lost to Follow-up|6|||
130479136|NCT01437709|469724255|FG000|Overall Study|Adverse Event|0|||
130479137|NCT01437709|469724256|FG001|Overall Study|Adverse Event|1|||
130479138|NCT01437709|469724257|FG002|Overall Study|Adverse Event|0|||
130479139|NCT01437709|469724255|FG000|Overall Study|Pt trasnferred care|0|||
130479140|NCT01437709|469724256|FG001|Overall Study|Pt trasnferred care|1|||
130479141|NCT01437709|469724257|FG002|Overall Study|Pt trasnferred care|0|||
130479142|NCT04091750|469724258|FG000|Overall Study|Adverse Event|4|||
130479143|NCT04091750|469724258|FG000|Overall Study|Withdrawal by Subject|1|||
130479144|NCT03560609|469724259|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
130479145|NCT03560609|469724260|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
130479146|NCT04293055|469724261|FG000|Overall Study|Lost to Follow-up|1|||
130479147|NCT04293055|469724262|FG001|Overall Study|Lost to Follow-up|1|||
130479148|NCT04293055|469724261|FG000|Overall Study|Did not trigger randomization|6|||
130479149|NCT04293055|469724262|FG001|Overall Study|Did not trigger randomization|5|||
130479150|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
130479151|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
130479152|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
130479153|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
130479154|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
130479155|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
130479156|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
130479157|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
130479158|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
130479159|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
130479160|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
130479161|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
130479162|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
130479163|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
130479164|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
130479165|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
130479166|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
130479167|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
130479168|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479169|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
130479170|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
130479171|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479172|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479173|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
130479174|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479175|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479176|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
130479177|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
130479178|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
130479179|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
130479180|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
130479181|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
130479182|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
130479183|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
130479184|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
130479185|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
130479186|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
130479187|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
130479188|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
130479189|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
130479190|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
130479191|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
130479192|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
130479193|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
130479194|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
130479195|NCT01369355|469724272|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
130479196|NCT01369355|469724273|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
130479197|NCT01369355|469724274|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
130479198|NCT01369355|469724275|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
130479199|NCT01369355|469724276|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
130479200|NCT01369355|469724277|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
130479201|NCT01369355|469724278|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
130479202|NCT01369355|469724279|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
130479203|NCT01369355|469724280|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
130479204|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479205|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479206|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479207|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479208|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479209|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
130479210|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
130479211|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
130479212|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
130479213|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Death|0|||
130479214|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Death|0|||
130479215|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Death|0|||
130479216|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Death|0|||
130479217|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Death|0|||
130479218|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Death|0|||
130479219|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Death|0|||
130479220|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Death|1|||
130479221|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Death|3|||
130479222|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479223|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479224|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479225|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479226|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479227|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
130479228|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
130479229|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
130479230|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
130479231|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479232|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479233|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479234|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479235|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479236|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479237|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
130479238|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
130479239|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
130479240|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479241|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479242|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479243|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479244|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479245|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
130479246|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
130479247|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
130479248|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
130479249|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479250|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479251|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479252|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479253|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479254|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
130479255|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
130479256|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
130479257|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
130479258|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479259|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479260|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479261|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479262|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479263|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130479264|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
130479265|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
130479266|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
130479267|NCT01369355|469724272|FG000|Long-term Extension (Week 44-272)|Other|0|||
130479268|NCT01369355|469724273|FG001|Long-term Extension (Week 44-272)|Other|0|||
130479269|NCT01369355|469724274|FG002|Long-term Extension (Week 44-272)|Other|0|||
130479270|NCT01369355|469724275|FG003|Long-term Extension (Week 44-272)|Other|0|||
130479271|NCT01369355|469724276|FG004|Long-term Extension (Week 44-272)|Other|0|||
130479272|NCT01369355|469724277|FG005|Long-term Extension (Week 44-272)|Other|0|||
130479273|NCT01369355|469724278|FG006|Long-term Extension (Week 44-272)|Other|110|||
130479274|NCT01369355|469724279|FG007|Long-term Extension (Week 44-272)|Other|9|||
130479275|NCT01369355|469724280|FG008|Long-term Extension (Week 44-272)|Other|17|||
130479276|NCT01902173|469724281|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
130479277|NCT01902173|469724282|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130479278|NCT01902173|469724283|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130479279|NCT01902173|469724284|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130479280|NCT01902173|469724285|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130479281|NCT01902173|469724286|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130479282|NCT01902173|469724281|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
130479283|NCT01902173|469724282|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
130479284|NCT01902173|469724283|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
130479285|NCT01902173|469724284|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
130479286|NCT01902173|469724285|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
130479287|NCT01902173|469724286|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
130479288|NCT01902173|469724281|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
130479289|NCT01902173|469724282|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
130479290|NCT01902173|469724283|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
130479291|NCT01902173|469724284|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
130479292|NCT01902173|469724285|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
130479293|NCT01902173|469724286|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
130479294|NCT01902173|469724281|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
130479295|NCT01902173|469724282|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
130479296|NCT01902173|469724283|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
130479297|NCT01902173|469724284|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
130479298|NCT01902173|469724285|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
130479299|NCT01902173|469724286|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
130479300|NCT01902173|469724281|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
130479301|NCT01902173|469724282|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
130479302|NCT01902173|469724283|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
130479303|NCT01902173|469724284|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
130479304|NCT01902173|469724285|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
130479305|NCT01902173|469724286|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
130479306|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
130479307|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
130479308|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
130479309|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
130479310|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
130479311|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
130479312|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
130479313|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
130479314|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
130479315|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
130479316|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
130479317|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
130479318|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
130479319|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
130479320|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
130479321|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
130479322|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
130479323|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
130479324|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
130479325|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
130479326|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
130479327|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
130479328|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
130479329|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
130479330|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
130479331|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
130479332|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
130479333|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
130479334|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
130479335|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
130479336|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
130479337|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
130479338|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
130479339|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
130479340|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
130479341|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
130479342|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
130479343|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
130479344|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
130479345|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
130479346|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
130479347|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
130479348|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130479349|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130479350|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130479351|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130479352|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130479353|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
130479354|NCT01902173|469724281|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
130479355|NCT01902173|469724282|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
130479356|NCT01902173|469724283|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
130479357|NCT01902173|469724284|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
130479358|NCT01902173|469724285|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
130479359|NCT01902173|469724286|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
130479360|NCT02262728|469724287|FG000|Follow-up Phase (3 Years)|Death|0|||
130479361|NCT02262728|469724288|FG001|Follow-up Phase (3 Years)|Death|1|||
130479362|NCT02262728|469724287|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
130479363|NCT02262728|469724288|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
130479364|NCT02262728|469724287|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
130479365|NCT02262728|469724288|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
130479366|NCT00227344|469724291|FG000|Overall Study|study terminated early|12|||
130479367|NCT00227344|469724292|FG001|Overall Study|study terminated early|5|||
130479368|NCT01987895|469724293|FG000|Overall Study|Withdrawal by Subject|12|||
130479369|NCT01987895|469724294|FG001|Overall Study|Withdrawal by Subject|7|||
130479370|NCT01987895|469724293|FG000|Overall Study|Physician Decision|8|||
130479371|NCT01987895|469724294|FG001|Overall Study|Physician Decision|10|||
130479372|NCT01987895|469724293|FG000|Overall Study|Death|7|||
130479373|NCT01987895|469724294|FG001|Overall Study|Death|7|||
130479374|NCT01987895|469724293|FG000|Overall Study|Lost to Follow-up|3|||
130479375|NCT01987895|469724294|FG001|Overall Study|Lost to Follow-up|5|||
130479376|NCT01987895|469724293|FG000|Overall Study|randomized before giving IC|0|||
130479377|NCT01987895|469724294|FG001|Overall Study|randomized before giving IC|1|||
130479378|NCT05364671|469724295|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
130479379|NCT05364671|469724296|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
130479380|NCT05364671|469724295|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
130564907|NCT02044133|470033784|FG000|Overall Study|Death|1|||
130479381|NCT05364671|469724296|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
130479382|NCT05364671|469724295|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
130479383|NCT05364671|469724296|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
130479384|NCT05364671|469724295|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
130479385|NCT05364671|469724296|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
130479386|NCT05364671|469724295|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
130479387|NCT05364671|469724296|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
130479388|NCT02359890|469724297|FG000|Overall Study|Not meeting eligibility|4|||
130479389|NCT02359890|469724297|FG000|Overall Study|Never treated with study catheter|6|||
130479390|NCT05256017|469724298|FG000|Treatment Period|Withdrawal by Subject|1|||
130479391|NCT05256017|469724299|FG001|Treatment Period|Withdrawal by Subject|1|||
130479392|NCT05256017|469724298|FG000|Follow-up|Lost to Follow-up|7|||
130479393|NCT05256017|469724299|FG001|Follow-up|Lost to Follow-up|1|||
130479394|NCT05256017|469724298|FG000|Follow-up|Withdrawal by Subject|1|||
130479395|NCT05256017|469724299|FG001|Follow-up|Withdrawal by Subject|0|||
130479396|NCT05256017|469724298|FG000|Follow-up|Death|0|||
130479397|NCT05256017|469724299|FG001|Follow-up|Death|1|||
130479398|NCT03536754|469724304|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
130479399|NCT03536754|469724305|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
130479400|NCT03536754|469724306|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
130479401|NCT03536754|469724307|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
130479402|NCT03536754|469724308|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
130479403|NCT03536754|469724304|FG000|Open Label Extension|Other|0|||
130479404|NCT03536754|469724305|FG001|Open Label Extension|Other|0|||
130479405|NCT03536754|469724306|FG002|Open Label Extension|Other|0|||
130479406|NCT03536754|469724307|FG003|Open Label Extension|Other|0|||
130479407|NCT03536754|469724308|FG004|Open Label Extension|Other|1|||
130479408|NCT04858321|469724310|FG000|Overall Study|Withdrawal by Subject|3|||
130479409|NCT05057247|469724311|FG000|Overall Study|Death|4|||
130479410|NCT05057247|469724311|FG000|Overall Study|Physician Decision|3|||
130479411|NCT05057247|469724311|FG000|Overall Study|Progressive Disease|7|||
130479412|NCT05057247|469724311|FG000|Overall Study|Withdrawal by Subject|3|||
130479413|NCT05057247|469724311|FG000|Overall Study|Adverse Event|6|||
130479414|NCT05057247|469724311|FG000|Overall Study|Subject Non-Compliance|1|||
130479415|NCT05057247|469724311|FG000|Overall Study|On treatment|2|||
130479416|NCT04632992|469724322|FG000|Overall Study|Adverse Event|0|||
130479417|NCT04632992|469724323|FG001|Overall Study|Adverse Event|0|||
130479418|NCT04632992|469724324|FG002|Overall Study|Adverse Event|0|||
130479419|NCT04632992|469724325|FG003|Overall Study|Adverse Event|0|||
130479420|NCT04632992|469724326|FG004|Overall Study|Adverse Event|0|||
130479421|NCT04632992|469724327|FG005|Overall Study|Adverse Event|0|||
130479422|NCT04632992|469724328|FG006|Overall Study|Adverse Event|0|||
130479423|NCT04632992|469724329|FG007|Overall Study|Adverse Event|0|||
130479424|NCT04632992|469724330|FG008|Overall Study|Adverse Event|0|||
130479425|NCT04632992|469724331|FG009|Overall Study|Adverse Event|0|||
130479426|NCT04632992|469724332|FG010|Overall Study|Adverse Event|0|||
130479427|NCT04632992|469724333|FG011|Overall Study|Adverse Event|0|||
130479428|NCT04632992|469724334|FG012|Overall Study|Adverse Event|1|||
130479429|NCT04632992|469724335|FG013|Overall Study|Adverse Event|0|||
130479430|NCT04632992|469724322|FG000|Overall Study|Death|17|||
130479431|NCT04632992|469724323|FG001|Overall Study|Death|1|||
130479432|NCT04632992|469724324|FG002|Overall Study|Death|14|||
130479433|NCT04632992|469724325|FG003|Overall Study|Death|14|||
130479434|NCT04632992|469724326|FG004|Overall Study|Death|13|||
130479435|NCT04632992|469724327|FG005|Overall Study|Death|6|||
130479436|NCT04632992|469724328|FG006|Overall Study|Death|7|||
130479437|NCT04632992|469724329|FG007|Overall Study|Death|12|||
130479438|NCT04632992|469724330|FG008|Overall Study|Death|15|||
130479439|NCT04632992|469724331|FG009|Overall Study|Death|20|||
130479440|NCT04632992|469724332|FG010|Overall Study|Death|8|||
130479441|NCT04632992|469724333|FG011|Overall Study|Death|2|||
130479442|NCT04632992|469724334|FG012|Overall Study|Death|10|||
130479443|NCT04632992|469724335|FG013|Overall Study|Death|1|||
130479444|NCT04632992|469724322|FG000|Overall Study|Lost to Follow-up|1|||
130479445|NCT04632992|469724323|FG001|Overall Study|Lost to Follow-up|0|||
130479446|NCT04632992|469724324|FG002|Overall Study|Lost to Follow-up|1|||
130479447|NCT04632992|469724325|FG003|Overall Study|Lost to Follow-up|0|||
130479448|NCT04632992|469724326|FG004|Overall Study|Lost to Follow-up|2|||
130479449|NCT04632992|469724327|FG005|Overall Study|Lost to Follow-up|0|||
130479450|NCT04632992|469724328|FG006|Overall Study|Lost to Follow-up|1|||
130479451|NCT04632992|469724329|FG007|Overall Study|Lost to Follow-up|1|||
130479452|NCT04632992|469724330|FG008|Overall Study|Lost to Follow-up|1|||
130479453|NCT04632992|469724331|FG009|Overall Study|Lost to Follow-up|1|||
130479454|NCT04632992|469724332|FG010|Overall Study|Lost to Follow-up|2|||
130479455|NCT04632992|469724333|FG011|Overall Study|Lost to Follow-up|0|||
130479456|NCT04632992|469724334|FG012|Overall Study|Lost to Follow-up|0|||
130479457|NCT04632992|469724335|FG013|Overall Study|Lost to Follow-up|0|||
130479458|NCT04632992|469724322|FG000|Overall Study|Reason not Specified|2|||
130479459|NCT04632992|469724323|FG001|Overall Study|Reason not Specified|0|||
130479460|NCT04632992|469724324|FG002|Overall Study|Reason not Specified|1|||
130479461|NCT04632992|469724325|FG003|Overall Study|Reason not Specified|1|||
130479462|NCT04632992|469724326|FG004|Overall Study|Reason not Specified|0|||
130479463|NCT04632992|469724327|FG005|Overall Study|Reason not Specified|0|||
130479464|NCT04632992|469724328|FG006|Overall Study|Reason not Specified|0|||
130479465|NCT04632992|469724329|FG007|Overall Study|Reason not Specified|0|||
130479466|NCT04632992|469724330|FG008|Overall Study|Reason not Specified|0|||
130479467|NCT04632992|469724331|FG009|Overall Study|Reason not Specified|0|||
130479468|NCT04632992|469724332|FG010|Overall Study|Reason not Specified|1|||
130479469|NCT04632992|469724333|FG011|Overall Study|Reason not Specified|0|||
130479470|NCT04632992|469724334|FG012|Overall Study|Reason not Specified|0|||
130479471|NCT04632992|469724335|FG013|Overall Study|Reason not Specified|0|||
130479472|NCT04632992|469724322|FG000|Overall Study|Physician Decision|0|||
130479473|NCT04632992|469724323|FG001|Overall Study|Physician Decision|0|||
130479474|NCT04632992|469724324|FG002|Overall Study|Physician Decision|0|||
130479475|NCT04632992|469724325|FG003|Overall Study|Physician Decision|2|||
130479476|NCT04632992|469724326|FG004|Overall Study|Physician Decision|1|||
130479477|NCT04632992|469724327|FG005|Overall Study|Physician Decision|0|||
130479478|NCT04632992|469724328|FG006|Overall Study|Physician Decision|0|||
130479479|NCT04632992|469724329|FG007|Overall Study|Physician Decision|0|||
130479480|NCT04632992|469724330|FG008|Overall Study|Physician Decision|0|||
130479481|NCT04632992|469724331|FG009|Overall Study|Physician Decision|0|||
130479482|NCT04632992|469724332|FG010|Overall Study|Physician Decision|0|||
130479483|NCT04632992|469724333|FG011|Overall Study|Physician Decision|0|||
130479484|NCT04632992|469724334|FG012|Overall Study|Physician Decision|3|||
130479485|NCT04632992|469724335|FG013|Overall Study|Physician Decision|0|||
130479486|NCT04632992|469724322|FG000|Overall Study|Progressive Disease|0|||
130479487|NCT04632992|469724323|FG001|Overall Study|Progressive Disease|0|||
130479488|NCT04632992|469724324|FG002|Overall Study|Progressive Disease|0|||
130479489|NCT04632992|469724325|FG003|Overall Study|Progressive Disease|0|||
130479490|NCT04632992|469724326|FG004|Overall Study|Progressive Disease|1|||
130479491|NCT04632992|469724327|FG005|Overall Study|Progressive Disease|0|||
130479492|NCT04632992|469724328|FG006|Overall Study|Progressive Disease|0|||
130479493|NCT04632992|469724329|FG007|Overall Study|Progressive Disease|0|||
130479494|NCT04632992|469724330|FG008|Overall Study|Progressive Disease|0|||
130479495|NCT04632992|469724331|FG009|Overall Study|Progressive Disease|1|||
130479496|NCT04632992|469724332|FG010|Overall Study|Progressive Disease|1|||
130479497|NCT04632992|469724333|FG011|Overall Study|Progressive Disease|0|||
130479498|NCT04632992|469724334|FG012|Overall Study|Progressive Disease|2|||
130479499|NCT04632992|469724335|FG013|Overall Study|Progressive Disease|0|||
130479500|NCT04632992|469724322|FG000|Overall Study|Withdrawal by Subject|4|||
130479501|NCT04632992|469724323|FG001|Overall Study|Withdrawal by Subject|1|||
130479502|NCT04632992|469724324|FG002|Overall Study|Withdrawal by Subject|5|||
130479503|NCT04632992|469724325|FG003|Overall Study|Withdrawal by Subject|4|||
130479504|NCT04632992|469724326|FG004|Overall Study|Withdrawal by Subject|3|||
130479505|NCT04632992|469724327|FG005|Overall Study|Withdrawal by Subject|3|||
130479506|NCT04632992|469724328|FG006|Overall Study|Withdrawal by Subject|0|||
130479507|NCT04632992|469724329|FG007|Overall Study|Withdrawal by Subject|5|||
130479508|NCT04632992|469724330|FG008|Overall Study|Withdrawal by Subject|0|||
130479509|NCT04632992|469724331|FG009|Overall Study|Withdrawal by Subject|2|||
130479510|NCT04632992|469724332|FG010|Overall Study|Withdrawal by Subject|8|||
130479511|NCT04632992|469724333|FG011|Overall Study|Withdrawal by Subject|0|||
130479512|NCT04632992|469724334|FG012|Overall Study|Withdrawal by Subject|1|||
130479513|NCT04632992|469724335|FG013|Overall Study|Withdrawal by Subject|1|||
130479514|NCT05647304|469724336|FG000|Overall Study|Withdrawal by Subject|1|||
130479515|NCT05647304|469724337|FG001|Overall Study|Withdrawal by Subject|0|||
130479516|NCT03603600|469724338|FG000|Overall Study|Withdrawal by Subject|5|||
130479517|NCT03603600|469724339|FG001|Overall Study|Withdrawal by Subject|7|||
130479518|NCT03603600|469724338|FG000|Overall Study|Lost to Follow-up|2|||
130479519|NCT03603600|469724339|FG001|Overall Study|Lost to Follow-up|3|||
130479520|NCT03603600|469724338|FG000|Overall Study|Death|3|||
130479521|NCT03603600|469724339|FG001|Overall Study|Death|1|||
130479522|NCT03603600|469724338|FG000|Overall Study|Physician Decision|2|||
130479523|NCT03603600|469724339|FG001|Overall Study|Physician Decision|1|||
130479524|NCT03603600|469724338|FG000|Overall Study|Other reason|1|||
130479525|NCT03603600|469724339|FG001|Overall Study|Other reason|0|||
130479526|NCT03812679|469726455|FG000|Overall Study|Adverse Event|2|||
130479527|NCT03812679|469726455|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
130479528|NCT03812679|469726455|FG000|Overall Study|Renal transplant|1|||
130479529|NCT03812679|469726455|FG000|Overall Study|Withdrawal by Subject|1|||
130479530|NCT03812679|469726455|FG000|Overall Study|Termination of study|2|||
130479531|NCT03812679|469726455|FG000|Overall Study|Water device replacement|1|||
130479532|NCT05653427|469726456|FG000|Overall Study|Study Terminated by Sponsor|13|||
130479533|NCT05028634|469726457|FG000|Overall Study|Withdrawal by Subject|0|||
130479534|NCT05028634|469726458|FG001|Overall Study|Withdrawal by Subject|1|||
130479535|NCT05486078|469726466|FG000|Overall Study|4 drop out and one withdrawn|5|||
130479536|NCT04256941|469726467|FG000|Overall Study|Withdrawal by Subject|0|||
130479537|NCT04256941|469726468|FG001|Overall Study|Withdrawal by Subject|1|||
130479538|NCT04256941|469726467|FG000|Overall Study|Death|1|||
130479539|NCT04256941|469726468|FG001|Overall Study|Death|0|||
130479540|NCT04256941|469726467|FG000|Overall Study|Disease Progession|0|||
130479541|NCT04256941|469726468|FG001|Overall Study|Disease Progession|2|||
130479542|NCT04728347|469726475|FG000|Overall Study|Sponsor decision|0|||
130479543|NCT04728347|469726476|FG001|Overall Study|Sponsor decision|0|||
130479544|NCT04728347|469726477|FG002|Overall Study|Sponsor decision|1|||
130479545|NCT04728347|469726478|FG003|Overall Study|Sponsor decision|0|||
130479546|NCT03766009|469726480|FG000|Usual Care|Death|0|||
130479547|NCT03766009|469726481|FG001|Usual Care|Death|0|||
130479548|NCT03766009|469726482|FG002|Usual Care|Death|0|||
130479549|NCT03766009|469726483|FG003|Usual Care|Death|1|||
130479550|NCT03766009|469726484|FG004|Usual Care|Death|0|||
130479551|NCT03766009|469726485|FG005|Usual Care|Death|0|||
130479552|NCT03766009|469726480|FG000|Usual Care|Lost to Follow-up|0|||
130479553|NCT03766009|469726481|FG001|Usual Care|Lost to Follow-up|0|||
130479554|NCT03766009|469726482|FG002|Usual Care|Lost to Follow-up|0|||
130479555|NCT03766009|469726483|FG003|Usual Care|Lost to Follow-up|1|||
130479556|NCT03766009|469726484|FG004|Usual Care|Lost to Follow-up|0|||
130479557|NCT03766009|469726485|FG005|Usual Care|Lost to Follow-up|0|||
130479558|NCT03766009|469726480|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
130479559|NCT03766009|469726481|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
130479560|NCT03766009|469726482|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
130479561|NCT03766009|469726483|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
130479562|NCT03766009|469726484|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
130479563|NCT03766009|469726485|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
130479564|NCT03766009|469726480|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
130479565|NCT03766009|469726481|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
130479566|NCT03766009|469726482|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
130479567|NCT03766009|469726483|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
130479568|NCT03766009|469726484|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
130479569|NCT03766009|469726485|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
130479570|NCT03766009|469726480|FG000|Usual Care|No treatment or declined surgery|0|||
130479571|NCT03766009|469726481|FG001|Usual Care|No treatment or declined surgery|0|||
130479572|NCT03766009|469726482|FG002|Usual Care|No treatment or declined surgery|0|||
130479573|NCT03766009|469726483|FG003|Usual Care|No treatment or declined surgery|2|||
130479574|NCT03766009|469726484|FG004|Usual Care|No treatment or declined surgery|0|||
130479575|NCT03766009|469726485|FG005|Usual Care|No treatment or declined surgery|0|||
130479576|NCT03766009|469726480|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
130479577|NCT03766009|469726481|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
130479578|NCT03766009|469726482|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
130479579|NCT03766009|469726483|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
130479580|NCT03766009|469726484|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
130479581|NCT03766009|469726485|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
130479582|NCT03766009|469726480|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130479583|NCT03766009|469726481|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
130479584|NCT03766009|469726482|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130479585|NCT03766009|469726483|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130479586|NCT03766009|469726484|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130479587|NCT03766009|469726485|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130479588|NCT03766009|469726480|FG000|Usual Care|Ineligible|0|||
130479589|NCT03766009|469726481|FG001|Usual Care|Ineligible|1|||
130479590|NCT03766009|469726482|FG002|Usual Care|Ineligible|0|||
130479591|NCT03766009|469726483|FG003|Usual Care|Ineligible|0|||
130479592|NCT03766009|469726484|FG004|Usual Care|Ineligible|0|||
130479593|NCT03766009|469726485|FG005|Usual Care|Ineligible|0|||
130479594|NCT03766009|469726480|FG000|Usual Care|Other: Staff turnover|0|||
130479595|NCT03766009|469726481|FG001|Usual Care|Other: Staff turnover|0|||
130727839|NCT00025259|470625559|FG000|Overall Study|Physician Decision|12|||
130727840|NCT00025259|470625560|FG001|Overall Study|Physician Decision|1|||
130727841|NCT00025259|470625561|FG002|Overall Study|Physician Decision|0|||
130727842|NCT00025259|470625562|FG003|Overall Study|Physician Decision|5|||
130727843|NCT00025259|470625563|FG004|Overall Study|Physician Decision|4|||
130727844|NCT00025259|470625564|FG005|Overall Study|Physician Decision|2|||
130727845|NCT00025259|470625565|FG006|Overall Study|Physician Decision|1|||
130727846|NCT00025259|470625559|FG000|Overall Study|Protocol Violation|3|||
130727847|NCT00025259|470625560|FG001|Overall Study|Protocol Violation|2|||
130727848|NCT00025259|470625561|FG002|Overall Study|Protocol Violation|2|||
130727849|NCT00025259|470625562|FG003|Overall Study|Protocol Violation|1|||
130727850|NCT00025259|470625563|FG004|Overall Study|Protocol Violation|2|||
130727851|NCT00025259|470625564|FG005|Overall Study|Protocol Violation|1|||
130479596|NCT03766009|469726482|FG002|Usual Care|Other: Staff turnover|0|||
130479597|NCT03766009|469726483|FG003|Usual Care|Other: Staff turnover|0|||
130479598|NCT03766009|469726484|FG004|Usual Care|Other: Staff turnover|0|||
130479599|NCT03766009|469726485|FG005|Usual Care|Other: Staff turnover|2|||
130479600|NCT04526704|469726490|FG000|Overall Study|Adverse Event|1|||
130479601|NCT04526704|469726491|FG001|Overall Study|Adverse Event|0|||
130479602|NCT04526704|469726490|FG000|Overall Study|Physician Decision|1|||
130479603|NCT04526704|469726491|FG001|Overall Study|Physician Decision|0|||
130479604|NCT04526704|469726490|FG000|Overall Study|Withdrawal by Subject|2|||
130479605|NCT04526704|469726491|FG001|Overall Study|Withdrawal by Subject|0|||
130479606|NCT02737436|469726492|FG000|Washout Period|Lost to Follow-up|5|||
130479607|NCT02737436|469726493|FG001|Washout Period|Lost to Follow-up|11|||
130479608|NCT02737436|469726492|FG000|Data Analysis|Scanning data problems|5|||
130479609|NCT02737436|469726493|FG001|Data Analysis|Scanning data problems|8|||
130479610|NCT02105766|469726494|FG000|Overall Study|Physician Decision|1|||
130479611|NCT02105766|469726495|FG001|Overall Study|Physician Decision|1|||
130479612|NCT02105766|469726496|FG002|Overall Study|Physician Decision|0|||
130479613|NCT02105766|469726494|FG000|Overall Study|Lost to Follow-up|2|||
130479614|NCT02105766|469726495|FG001|Overall Study|Lost to Follow-up|0|||
130479615|NCT02105766|469726496|FG002|Overall Study|Lost to Follow-up|0|||
130479616|NCT02105766|469726494|FG000|Overall Study|Death|1|||
130479617|NCT02105766|469726495|FG001|Overall Study|Death|1|||
130479618|NCT02105766|469726496|FG002|Overall Study|Death|0|||
130479619|NCT00554788|469726497|FG000|Overall Study|Adverse Event|0|||
130479620|NCT00554788|469726498|FG001|Overall Study|Adverse Event|1|||
130479621|NCT00554788|469726499|FG002|Overall Study|Adverse Event|2|||
130479622|NCT00554788|469726497|FG000|Overall Study|Lost to Follow-up|4|||
130479623|NCT00554788|469726498|FG001|Overall Study|Lost to Follow-up|3|||
130479624|NCT00554788|469726499|FG002|Overall Study|Lost to Follow-up|3|||
130479625|NCT00554788|469726497|FG000|Overall Study|Physician Decision|1|||
130479626|NCT00554788|469726498|FG001|Overall Study|Physician Decision|1|||
130479627|NCT00554788|469726499|FG002|Overall Study|Physician Decision|3|||
130479628|NCT00554788|469726497|FG000|Overall Study|Withdrawal by Subject|0|||
130479629|NCT00554788|469726498|FG001|Overall Study|Withdrawal by Subject|0|||
130479630|NCT00554788|469726499|FG002|Overall Study|Withdrawal by Subject|1|||
130479631|NCT00554788|469726497|FG000|Overall Study|Refusal of further protocol therapy|0|||
130479632|NCT00554788|469726498|FG001|Overall Study|Refusal of further protocol therapy|1|||
130479633|NCT00554788|469726499|FG002|Overall Study|Refusal of further protocol therapy|1|||
130479634|NCT00554788|469726497|FG000|Overall Study|Progressive disease|0|||
130479635|NCT00554788|469726498|FG001|Overall Study|Progressive disease|0|||
130479636|NCT00554788|469726499|FG002|Overall Study|Progressive disease|3|||
130479637|NCT00554788|469726497|FG000|Overall Study|Ineligible|2|||
130479638|NCT00554788|469726498|FG001|Overall Study|Ineligible|0|||
130479639|NCT00554788|469726499|FG002|Overall Study|Ineligible|1|||
130479640|NCT03897465|469726501|FG000|Overall Study|Lost to Follow-up|2|||
130479641|NCT03897465|469726502|FG001|Overall Study|Lost to Follow-up|1|||
130479642|NCT03897465|469726501|FG000|Overall Study|Adverse Event|2|||
130479643|NCT03897465|469726502|FG001|Overall Study|Adverse Event|0|||
130479644|NCT03897465|469726501|FG000|Overall Study|complete healing by V2|1|||
130479645|NCT03897465|469726502|FG001|Overall Study|complete healing by V2|0|||
130479646|NCT03897465|469726501|FG000|Overall Study|occurence of exclusion criterion|1|||
130479647|NCT03897465|469726502|FG001|Overall Study|occurence of exclusion criterion|1|||
130479648|NCT03897465|469726501|FG000|Overall Study|Other|1|||
130479649|NCT03897465|469726502|FG001|Overall Study|Other|0|||
130479650|NCT02985957|469726503|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479651|NCT02985957|469726504|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479652|NCT02985957|469726505|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479653|NCT02985957|469726506|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479654|NCT02985957|469726507|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130479655|NCT02985957|469726508|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479656|NCT02985957|469726509|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130479657|NCT02985957|469726503|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130479658|NCT02985957|469726504|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130479659|NCT02985957|469726505|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
130479660|NCT02985957|469726506|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
130479661|NCT02985957|469726507|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
130479662|NCT02985957|469726508|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
130479663|NCT02985957|469726509|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
130479664|NCT02985957|469726503|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479665|NCT02985957|469726504|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479666|NCT02985957|469726505|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479667|NCT02985957|469726506|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479668|NCT02985957|469726507|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479669|NCT02985957|469726508|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130479670|NCT02985957|469726509|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130479671|NCT02985957|469726503|FG000|Treatment Period|Death|0|||
130479672|NCT02985957|469726504|FG001|Treatment Period|Death|0|||
130479673|NCT02985957|469726505|FG002|Treatment Period|Death|0|||
130479674|NCT02985957|469726506|FG003|Treatment Period|Death|0|||
130479675|NCT02985957|469726507|FG004|Treatment Period|Death|1|||
130479676|NCT02985957|469726508|FG005|Treatment Period|Death|0|||
130479677|NCT02985957|469726509|FG006|Treatment Period|Death|0|||
130479678|NCT02985957|469726503|FG000|Treatment Period|Participant withdrew consent|0|||
130479679|NCT02985957|469726504|FG001|Treatment Period|Participant withdrew consent|0|||
130479680|NCT02985957|469726505|FG002|Treatment Period|Participant withdrew consent|0|||
130479681|NCT02985957|469726506|FG003|Treatment Period|Participant withdrew consent|1|||
130479682|NCT02985957|469726507|FG004|Treatment Period|Participant withdrew consent|3|||
130479683|NCT02985957|469726508|FG005|Treatment Period|Participant withdrew consent|0|||
130479684|NCT02985957|469726509|FG006|Treatment Period|Participant withdrew consent|1|||
130479685|NCT02985957|469726503|FG000|Treatment Period|Lost to Follow-up|0|||
130479686|NCT02985957|469726504|FG001|Treatment Period|Lost to Follow-up|0|||
130479687|NCT02985957|469726505|FG002|Treatment Period|Lost to Follow-up|0|||
130479688|NCT02985957|469726506|FG003|Treatment Period|Lost to Follow-up|0|||
130479689|NCT02985957|469726507|FG004|Treatment Period|Lost to Follow-up|1|||
130479690|NCT02985957|469726508|FG005|Treatment Period|Lost to Follow-up|0|||
130479691|NCT02985957|469726509|FG006|Treatment Period|Lost to Follow-up|0|||
130479692|NCT02985957|469726503|FG000|Treatment Period|Other reasons|0|||
130479693|NCT02985957|469726504|FG001|Treatment Period|Other reasons|0|||
130479694|NCT02985957|469726505|FG002|Treatment Period|Other reasons|1|||
130479695|NCT02985957|469726506|FG003|Treatment Period|Other reasons|3|||
130479696|NCT02985957|469726507|FG004|Treatment Period|Other reasons|6|||
130479697|NCT02985957|469726508|FG005|Treatment Period|Other reasons|0|||
130479698|NCT02985957|469726509|FG006|Treatment Period|Other reasons|1|||
130479699|NCT02985957|469726503|FG000|Treatment Period|Not reported|0|||
130479700|NCT02985957|469726504|FG001|Treatment Period|Not reported|1|||
130479701|NCT02985957|469726505|FG002|Treatment Period|Not reported|2|||
130479702|NCT02985957|469726506|FG003|Treatment Period|Not reported|5|||
130479703|NCT02985957|469726507|FG004|Treatment Period|Not reported|0|||
130479704|NCT02985957|469726508|FG005|Treatment Period|Not reported|0|||
130479705|NCT02985957|469726509|FG006|Treatment Period|Not reported|0|||
130479706|NCT02985957|469726503|FG000|Treatment Period|Maximum clinical benefit|0|||
130479707|NCT02985957|469726504|FG001|Treatment Period|Maximum clinical benefit|0|||
130479708|NCT02985957|469726505|FG002|Treatment Period|Maximum clinical benefit|1|||
130479709|NCT02985957|469726506|FG003|Treatment Period|Maximum clinical benefit|1|||
130479710|NCT02985957|469726507|FG004|Treatment Period|Maximum clinical benefit|0|||
130479711|NCT02985957|469726508|FG005|Treatment Period|Maximum clinical benefit|0|||
130479712|NCT02985957|469726509|FG006|Treatment Period|Maximum clinical benefit|2|||
130479713|NCT02985957|469726503|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
130479714|NCT02985957|469726504|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
130479715|NCT02985957|469726505|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
130479716|NCT02985957|469726506|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
130479717|NCT02985957|469726507|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
130479718|NCT02985957|469726508|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
130479719|NCT02985957|469726509|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
130479720|NCT02985957|469726503|FG000|Treatment Period|Study drug toxicity|1|||
130479721|NCT02985957|469726504|FG001|Treatment Period|Study drug toxicity|23|||
130479722|NCT02985957|469726505|FG002|Treatment Period|Study drug toxicity|20|||
130479723|NCT02985957|469726506|FG003|Treatment Period|Study drug toxicity|11|||
130479724|NCT02985957|469726507|FG004|Treatment Period|Study drug toxicity|19|||
130479725|NCT02985957|469726508|FG005|Treatment Period|Study drug toxicity|3|||
130479726|NCT02985957|469726509|FG006|Treatment Period|Study drug toxicity|5|||
130479727|NCT02985957|469726503|FG000|Treatment Period|Disease progression|0|||
130479728|NCT02985957|469726504|FG001|Treatment Period|Disease progression|16|||
130479729|NCT02985957|469726505|FG002|Treatment Period|Disease progression|20|||
130479730|NCT02985957|469726506|FG003|Treatment Period|Disease progression|39|||
130479731|NCT02985957|469726507|FG004|Treatment Period|Disease progression|29|||
130479732|NCT02985957|469726508|FG005|Treatment Period|Disease progression|11|||
130479733|NCT02985957|469726509|FG006|Treatment Period|Disease progression|28|||
130479734|NCT02985957|469726503|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
130479735|NCT02985957|469726504|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
130479736|NCT02985957|469726505|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
130479737|NCT02985957|469726506|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
130479738|NCT02985957|469726507|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
130479739|NCT02985957|469726508|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
130479740|NCT02985957|469726509|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
130479741|NCT02985957|469726503|FG000|Treatment Period|Poor/Non-Compliance|0|||
130479742|NCT02985957|469726504|FG001|Treatment Period|Poor/Non-Compliance|0|||
130479743|NCT02985957|469726505|FG002|Treatment Period|Poor/Non-Compliance|0|||
130479744|NCT02985957|469726506|FG003|Treatment Period|Poor/Non-Compliance|0|||
130479745|NCT02985957|469726507|FG004|Treatment Period|Poor/Non-Compliance|1|||
130479746|NCT02985957|469726508|FG005|Treatment Period|Poor/Non-Compliance|1|||
130479747|NCT02985957|469726509|FG006|Treatment Period|Poor/Non-Compliance|0|||
130479748|NCT02985957|469726503|FG000|Treatment Period|Continuing in Treatment Period|0|||
130479749|NCT02985957|469726504|FG001|Treatment Period|Continuing in Treatment Period|1|||
130479750|NCT02985957|469726505|FG002|Treatment Period|Continuing in Treatment Period|0|||
130479751|NCT02985957|469726506|FG003|Treatment Period|Continuing in Treatment Period|4|||
130479752|NCT02985957|469726507|FG004|Treatment Period|Continuing in Treatment Period|4|||
130479753|NCT02985957|469726508|FG005|Treatment Period|Continuing in Treatment Period|0|||
130479754|NCT02985957|469726509|FG006|Treatment Period|Continuing in Treatment Period|0|||
130479755|NCT06190691|469726521|FG000|Overall Study|Adverse Event|2|||
130479756|NCT06190691|469726522|FG001|Overall Study|Adverse Event|0|||
130479757|NCT06190691|469726523|FG002|Overall Study|Adverse Event|0|||
130479758|NCT06190691|469726524|FG003|Overall Study|Adverse Event|0|||
130479759|NCT02485938|469726525|FG000|Overall Study|Withdrawal of consent|2|||
130479760|NCT02485938|469726526|FG001|Overall Study|Withdrawal of consent|0|||
130479761|NCT03016754|469726529|FG000|Overall Study|Death|5|||
130479762|NCT03016754|469726530|FG001|Overall Study|Death|4|||
130479763|NCT03016754|469726531|FG002|Overall Study|Death|5|||
130479764|NCT03016754|469726532|FG003|Overall Study|Death|1|||
130479765|NCT03016754|469726529|FG000|Overall Study|Lost to Follow-up|23|||
130479766|NCT03016754|469726530|FG001|Overall Study|Lost to Follow-up|17|||
130479767|NCT03016754|469726531|FG002|Overall Study|Lost to Follow-up|4|||
130479768|NCT03016754|469726532|FG003|Overall Study|Lost to Follow-up|2|||
130479769|NCT03016754|469726529|FG000|Overall Study|Withdrawal by Subject|6|||
130479770|NCT03016754|469726530|FG001|Overall Study|Withdrawal by Subject|6|||
130479771|NCT03016754|469726531|FG002|Overall Study|Withdrawal by Subject|2|||
130479772|NCT03016754|469726532|FG003|Overall Study|Withdrawal by Subject|2|||
130479773|NCT03016754|469726529|FG000|Overall Study|Other/Unknown|2|||
130479774|NCT03016754|469726530|FG001|Overall Study|Other/Unknown|4|||
130479775|NCT03016754|469726531|FG002|Overall Study|Other/Unknown|2|||
130479776|NCT03016754|469726532|FG003|Overall Study|Other/Unknown|1|||
130479777|NCT03016754|469726529|FG000|Overall Study|Protocol Violation|0|||
130479778|NCT03016754|469726530|FG001|Overall Study|Protocol Violation|0|||
130479779|NCT03016754|469726531|FG002|Overall Study|Protocol Violation|0|||
130479780|NCT03016754|469726532|FG003|Overall Study|Protocol Violation|4|||
130479781|NCT03839940|469726533|FG000|Overall Study|Withdrawal by Subject|3|||
130479782|NCT03839940|469726534|FG001|Overall Study|Withdrawal by Subject|0|||
130479783|NCT03839940|469726533|FG000|Overall Study|Protocol Violation|0|||
130479784|NCT03839940|469726534|FG001|Overall Study|Protocol Violation|1|||
130479785|NCT03839940|469726533|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
130479786|NCT03839940|469726534|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
130479787|NCT03241745|469726535|FG000|Overall Study|Adverse Event|7|||
130479788|NCT03241745|469726535|FG000|Overall Study|Death|1|||
130479789|NCT03241745|469726535|FG000|Overall Study|Withdrawal by Subject|5|||
130479790|NCT03241745|469726535|FG000|Overall Study|Treatment delay >28 days|2|||
130479791|NCT03241745|469726535|FG000|Overall Study|Lack of Efficacy|14|||
130479792|NCT00085735|469726537|FG000|Overall Study|Adverse Event|1|||
130479793|NCT00085735|469726538|FG001|Overall Study|Adverse Event|0|||
130479794|NCT00085735|469726539|FG002|Overall Study|Adverse Event|0|||
130479795|NCT00085735|469726540|FG003|Overall Study|Adverse Event|0|||
130479796|NCT00085735|469726541|FG004|Overall Study|Adverse Event|0|||
130479797|NCT00085735|469726542|FG005|Overall Study|Adverse Event|0|||
130479798|NCT00085735|469726537|FG000|Overall Study|Lack of Efficacy|2|||
130479799|NCT00085735|469726538|FG001|Overall Study|Lack of Efficacy|4|||
130479800|NCT00085735|469726539|FG002|Overall Study|Lack of Efficacy|6|||
130479801|NCT00085735|469726540|FG003|Overall Study|Lack of Efficacy|3|||
130479802|NCT00085735|469726541|FG004|Overall Study|Lack of Efficacy|4|||
130479803|NCT00085735|469726542|FG005|Overall Study|Lack of Efficacy|3|||
130479804|NCT00085735|469726537|FG000|Overall Study|Lost to Follow-up|0|||
130479805|NCT00085735|469726538|FG001|Overall Study|Lost to Follow-up|1|||
130479806|NCT00085735|469726539|FG002|Overall Study|Lost to Follow-up|0|||
130479807|NCT00085735|469726540|FG003|Overall Study|Lost to Follow-up|0|||
130479808|NCT00085735|469726541|FG004|Overall Study|Lost to Follow-up|1|||
130479809|NCT00085735|469726542|FG005|Overall Study|Lost to Follow-up|0|||
130479810|NCT00085735|469726537|FG000|Overall Study|Physician Decision|2|||
130479811|NCT00085735|469726538|FG001|Overall Study|Physician Decision|3|||
130479812|NCT00085735|469726539|FG002|Overall Study|Physician Decision|2|||
130479813|NCT00085735|469726540|FG003|Overall Study|Physician Decision|3|||
130479814|NCT00085735|469726541|FG004|Overall Study|Physician Decision|11|||
130479815|NCT00085735|469726542|FG005|Overall Study|Physician Decision|8|||
130479816|NCT00085735|469726537|FG000|Overall Study|Protocol Violation|1|||
130479817|NCT00085735|469726538|FG001|Overall Study|Protocol Violation|0|||
130479818|NCT00085735|469726539|FG002|Overall Study|Protocol Violation|0|||
130479819|NCT00085735|469726540|FG003|Overall Study|Protocol Violation|0|||
130479820|NCT00085735|469726541|FG004|Overall Study|Protocol Violation|0|||
130479821|NCT00085735|469726542|FG005|Overall Study|Protocol Violation|0|||
130479822|NCT00085735|469726537|FG000|Overall Study|Withdrawal by Subject|1|||
130479823|NCT00085735|469726538|FG001|Overall Study|Withdrawal by Subject|0|||
130479824|NCT00085735|469726539|FG002|Overall Study|Withdrawal by Subject|4|||
130479825|NCT00085735|469726540|FG003|Overall Study|Withdrawal by Subject|5|||
130479826|NCT00085735|469726541|FG004|Overall Study|Withdrawal by Subject|7|||
130479827|NCT00085735|469726542|FG005|Overall Study|Withdrawal by Subject|8|||
130479828|NCT00085735|469726537|FG000|Overall Study|Patient ineligible|1|||
130479829|NCT00085735|469726538|FG001|Overall Study|Patient ineligible|0|||
130479830|NCT00085735|469726539|FG002|Overall Study|Patient ineligible|3|||
130479831|NCT00085735|469726540|FG003|Overall Study|Patient ineligible|7|||
130479832|NCT00085735|469726541|FG004|Overall Study|Patient ineligible|17|||
130479833|NCT00085735|469726542|FG005|Overall Study|Patient ineligible|8|||
130479834|NCT00085735|469726537|FG000|Overall Study|Excess residual disease|2|||
130479835|NCT00085735|469726538|FG001|Overall Study|Excess residual disease|2|||
130479836|NCT00085735|469726539|FG002|Overall Study|Excess residual disease|1|||
130479837|NCT00085735|469726540|FG003|Overall Study|Excess residual disease|1|||
130479838|NCT00085735|469726541|FG004|Overall Study|Excess residual disease|1|||
130479839|NCT00085735|469726542|FG005|Overall Study|Excess residual disease|4|||
130479840|NCT00085735|469726537|FG000|Overall Study|Reason not documented|1|||
130479841|NCT00085735|469726538|FG001|Overall Study|Reason not documented|0|||
130479842|NCT00085735|469726539|FG002|Overall Study|Reason not documented|1|||
130479843|NCT00085735|469726540|FG003|Overall Study|Reason not documented|0|||
130479844|NCT00085735|469726541|FG004|Overall Study|Reason not documented|1|||
130479845|NCT00085735|469726542|FG005|Overall Study|Reason not documented|0|||
130479846|NCT00085735|469726537|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
130479847|NCT00085735|469726538|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
130479848|NCT00085735|469726539|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
130479849|NCT00085735|469726540|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
130479850|NCT00085735|469726541|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
130479851|NCT00085735|469726542|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
130479852|NCT04473222|469726543|FG000|Overall Study|Lost to Follow-up|13|||
130479853|NCT04473222|469726544|FG001|Overall Study|Lost to Follow-up|13|||
130479854|NCT04473222|469726543|FG000|Overall Study|Withdrawal by Subject|0|||
130479855|NCT04473222|469726544|FG001|Overall Study|Withdrawal by Subject|1|||
130479856|NCT04473222|469726543|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
130479857|NCT04473222|469726544|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
130479858|NCT02919306|469726545|FG000|Overall Study|Withdrawal by Subject|1|||
130479859|NCT02919306|469726546|FG001|Overall Study|Withdrawal by Subject|0|||
130479860|NCT02919306|469726545|FG000|Overall Study|Protocol Violation|1|||
130479861|NCT02919306|469726546|FG001|Overall Study|Protocol Violation|0|||
130479862|NCT04195698|469726549|FG000|Overall Study|Adverse Event|4|||
130479863|NCT04195698|469726550|FG001|Overall Study|Adverse Event|11|||
130479864|NCT04195698|469726549|FG000|Overall Study|Withdrawal by Subject|9|||
130479865|NCT04195698|469726550|FG001|Overall Study|Withdrawal by Subject|10|||
130479866|NCT04195698|469726549|FG000|Overall Study|Lost to Follow-up|5|||
130479867|NCT04195698|469726550|FG001|Overall Study|Lost to Follow-up|4|||
130479868|NCT04195698|469726549|FG000|Overall Study|Lack of Efficacy|2|||
130479869|NCT04195698|469726550|FG001|Overall Study|Lack of Efficacy|10|||
130479870|NCT04195698|469726549|FG000|Overall Study|Other|5|||
130479871|NCT04195698|469726550|FG001|Overall Study|Other|4|||
130479872|NCT05459688|469726551|FG000|Overall Study|Lost to Follow-up|6|||
130479873|NCT05459688|469726551|FG000|Overall Study|Physician Decision|1|||
130479874|NCT05459688|469726551|FG000|Overall Study|Withdrawal by Subject|19|||
130479875|NCT05459688|469726551|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
130479876|NCT04908722|469726552|FG000|Overall Study|Protocol deviation|1|||
130479877|NCT04908722|469726553|FG001|Overall Study|Protocol deviation|0|||
130479878|NCT04908722|469726554|FG002|Overall Study|Protocol deviation|0|||
130479879|NCT04908722|469726555|FG003|Overall Study|Protocol deviation|0|||
130479880|NCT04908722|469726556|FG004|Overall Study|Protocol deviation|0|||
130479881|NCT04908722|469726557|FG005|Overall Study|Protocol deviation|1|||
130479882|NCT04908722|469726552|FG000|Overall Study|Lost to Follow-up|33|||
130479883|NCT04908722|469726553|FG001|Overall Study|Lost to Follow-up|33|||
130479884|NCT04908722|469726554|FG002|Overall Study|Lost to Follow-up|36|||
130479885|NCT04908722|469726555|FG003|Overall Study|Lost to Follow-up|30|||
130479886|NCT04908722|469726556|FG004|Overall Study|Lost to Follow-up|32|||
130479887|NCT04908722|469726557|FG005|Overall Study|Lost to Follow-up|34|||
130479888|NCT04908722|469726552|FG000|Overall Study|Physician Decision|1|||
130479889|NCT04908722|469726553|FG001|Overall Study|Physician Decision|1|||
130479890|NCT04908722|469726554|FG002|Overall Study|Physician Decision|1|||
130479891|NCT04908722|469726555|FG003|Overall Study|Physician Decision|2|||
130479892|NCT04908722|469726556|FG004|Overall Study|Physician Decision|0|||
130479893|NCT04908722|469726557|FG005|Overall Study|Physician Decision|0|||
130479894|NCT04908722|469726552|FG000|Overall Study|Death|1|||
130479895|NCT04908722|469726553|FG001|Overall Study|Death|0|||
130479896|NCT04908722|469726554|FG002|Overall Study|Death|0|||
130479897|NCT04908722|469726555|FG003|Overall Study|Death|0|||
130479898|NCT04908722|469726556|FG004|Overall Study|Death|0|||
130479899|NCT04908722|469726557|FG005|Overall Study|Death|1|||
130479900|NCT04908722|469726552|FG000|Overall Study|Withdrawal by Subject|12|||
130479901|NCT04908722|469726553|FG001|Overall Study|Withdrawal by Subject|8|||
130479902|NCT04908722|469726554|FG002|Overall Study|Withdrawal by Subject|7|||
130479903|NCT04908722|469726555|FG003|Overall Study|Withdrawal by Subject|6|||
130479904|NCT04908722|469726556|FG004|Overall Study|Withdrawal by Subject|12|||
130479905|NCT04908722|469726557|FG005|Overall Study|Withdrawal by Subject|14|||
130479906|NCT04908722|469726552|FG000|Overall Study|Other|3|||
130479907|NCT04908722|469726553|FG001|Overall Study|Other|1|||
130479908|NCT04908722|469726554|FG002|Overall Study|Other|3|||
130479909|NCT04908722|469726555|FG003|Overall Study|Other|2|||
130479910|NCT04908722|469726556|FG004|Overall Study|Other|4|||
130479911|NCT04908722|469726557|FG005|Overall Study|Other|1|||
130479912|NCT04908722|469726552|FG000|Overall Study|Initiated prohibited medication|0|||
130479913|NCT04908722|469726553|FG001|Overall Study|Initiated prohibited medication|0|||
130479914|NCT04908722|469726554|FG002|Overall Study|Initiated prohibited medication|0|||
130479915|NCT04908722|469726555|FG003|Overall Study|Initiated prohibited medication|1|||
130479916|NCT04908722|469726556|FG004|Overall Study|Initiated prohibited medication|0|||
130479917|NCT04908722|469726557|FG005|Overall Study|Initiated prohibited medication|1|||
130479918|NCT04908722|469726552|FG000|Overall Study|Randomized but not vaccinated|3|||
130479919|NCT04908722|469726553|FG001|Overall Study|Randomized but not vaccinated|1|||
130479920|NCT04908722|469726554|FG002|Overall Study|Randomized but not vaccinated|2|||
130479921|NCT04908722|469726555|FG003|Overall Study|Randomized but not vaccinated|2|||
130479922|NCT04908722|469726556|FG004|Overall Study|Randomized but not vaccinated|3|||
130479923|NCT04908722|469726557|FG005|Overall Study|Randomized but not vaccinated|4|||
130479924|NCT02319759|469726558|FG000|Week 0 - 16|Lack of Efficacy|1|||
130479925|NCT02319759|469726559|FG001|Week 0 - 16|Lack of Efficacy|0|||
130479926|NCT02319759|469726560|FG002|Week 0 - 16|Lack of Efficacy|0|||
130479927|NCT02319759|469726561|FG003|Week 0 - 16|Lack of Efficacy|0|||
130479928|NCT02319759|469726562|FG004|Week 0 - 16|Lack of Efficacy|0|||
130479929|NCT02319759|469726558|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
130479930|NCT02319759|469726559|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
130479931|NCT02319759|469726560|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
130479932|NCT02319759|469726561|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
130479933|NCT02319759|469726562|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
130479934|NCT02319759|469726558|FG000|Week 16 - 24|Lack of Efficacy|1|||
130479935|NCT02319759|469726559|FG001|Week 16 - 24|Lack of Efficacy|0|||
130479936|NCT02319759|469726560|FG002|Week 16 - 24|Lack of Efficacy|1|||
130479937|NCT02319759|469726561|FG003|Week 16 - 24|Lack of Efficacy|0|||
130479938|NCT02319759|469726562|FG004|Week 16 - 24|Lack of Efficacy|0|||
130479939|NCT02319759|469726558|FG000|Week 16 - 24|Lost to Follow-up|1|||
130479940|NCT02319759|469726559|FG001|Week 16 - 24|Lost to Follow-up|0|||
130479941|NCT02319759|469726560|FG002|Week 16 - 24|Lost to Follow-up|0|||
130479942|NCT02319759|469726561|FG003|Week 16 - 24|Lost to Follow-up|0|||
130479943|NCT02319759|469726562|FG004|Week 16 - 24|Lost to Follow-up|0|||
130479944|NCT02319759|469726558|FG000|Week 16 - 24|Withdrawal by Subject|0|||
130479945|NCT02319759|469726559|FG001|Week 16 - 24|Withdrawal by Subject|0|||
130479946|NCT02319759|469726560|FG002|Week 16 - 24|Withdrawal by Subject|2|||
130479947|NCT02319759|469726561|FG003|Week 16 - 24|Withdrawal by Subject|0|||
130479948|NCT02319759|469726562|FG004|Week 16 - 24|Withdrawal by Subject|0|||
130479949|NCT02319759|469726558|FG000|Week 24 - 56|Adverse Event|0|||
130479950|NCT02319759|469726559|FG001|Week 24 - 56|Adverse Event|0|||
130479951|NCT02319759|469726560|FG002|Week 24 - 56|Adverse Event|2|||
130479952|NCT02319759|469726561|FG003|Week 24 - 56|Adverse Event|0|||
130479953|NCT02319759|469726562|FG004|Week 24 - 56|Adverse Event|0|||
130479954|NCT02319759|469726558|FG000|Week 24 - 56|Lack of Efficacy|0|||
130479955|NCT02319759|469726559|FG001|Week 24 - 56|Lack of Efficacy|0|||
130479956|NCT02319759|469726560|FG002|Week 24 - 56|Lack of Efficacy|0|||
130479957|NCT02319759|469726561|FG003|Week 24 - 56|Lack of Efficacy|2|||
130479958|NCT02319759|469726562|FG004|Week 24 - 56|Lack of Efficacy|1|||
130479959|NCT02319759|469726558|FG000|Week 24 - 56|Withdrawal by Subject|0|||
130479960|NCT02319759|469726559|FG001|Week 24 - 56|Withdrawal by Subject|1|||
130479961|NCT02319759|469726560|FG002|Week 24 - 56|Withdrawal by Subject|0|||
130479962|NCT02319759|469726561|FG003|Week 24 - 56|Withdrawal by Subject|0|||
130479963|NCT02319759|469726562|FG004|Week 24 - 56|Withdrawal by Subject|0|||
130479964|NCT02319759|469726558|FG000|Week 24 - 56|Lost to Follow-up|0|||
130479965|NCT02319759|469726559|FG001|Week 24 - 56|Lost to Follow-up|0|||
130479966|NCT02319759|469726560|FG002|Week 24 - 56|Lost to Follow-up|0|||
130479967|NCT02319759|469726561|FG003|Week 24 - 56|Lost to Follow-up|0|||
130479968|NCT02319759|469726562|FG004|Week 24 - 56|Lost to Follow-up|1|||
130479969|NCT06424236|469726565|FG000|Overall Study|Adverse Event|0|||
130479970|NCT06424236|469726566|FG001|Overall Study|Adverse Event|1|||
130479971|NCT06424236|469726567|FG002|Overall Study|Adverse Event|0|||
130479972|NCT06424236|469726565|FG000|Overall Study|Withdrawal by Subject|3|||
130479973|NCT06424236|469726566|FG001|Overall Study|Withdrawal by Subject|1|||
130479974|NCT06424236|469726567|FG002|Overall Study|Withdrawal by Subject|2|||
130479975|NCT06424236|469726565|FG000|Overall Study|Physician Decision|0|||
130479976|NCT06424236|469726566|FG001|Overall Study|Physician Decision|1|||
130479977|NCT06424236|469726567|FG002|Overall Study|Physician Decision|0|||
130564908|NCT02044133|470033785|FG001|Overall Study|Death|0|||
130479978|NCT06424236|469726565|FG000|Overall Study|Study Terminated by Sponsor|11|||
130479979|NCT06424236|469726566|FG001|Overall Study|Study Terminated by Sponsor|20|||
130479980|NCT06424236|469726567|FG002|Overall Study|Study Terminated by Sponsor|16|||
130479981|NCT06424236|469726565|FG000|Overall Study|Lost to Follow-up|0|||
130479982|NCT06424236|469726566|FG001|Overall Study|Lost to Follow-up|1|||
130479983|NCT06424236|469726567|FG002|Overall Study|Lost to Follow-up|0|||
130479984|NCT06424236|469726565|FG000|Overall Study|Disease Progression|0|||
130479985|NCT06424236|469726566|FG001|Overall Study|Disease Progression|1|||
130479986|NCT06424236|469726567|FG002|Overall Study|Disease Progression|2|||
130479987|NCT06424236|469726565|FG000|Overall Study|Other|0|||
130479988|NCT06424236|469726566|FG001|Overall Study|Other|0|||
130479989|NCT06424236|469726567|FG002|Overall Study|Other|1|||
130479990|NCT03339713|469726569|FG000|Overall Study|Lost to Follow-up|2|||
130479991|NCT03339713|469726570|FG001|Overall Study|Lost to Follow-up|1|||
130479992|NCT03339713|469726569|FG000|Overall Study|Protocol Violation|1|||
130479993|NCT03339713|469726570|FG001|Overall Study|Protocol Violation|0|||
130479994|NCT03339713|469726569|FG000|Overall Study|Withdrawal by Subject|1|||
130479995|NCT03339713|469726570|FG001|Overall Study|Withdrawal by Subject|1|||
130479996|NCT01959425|469726571|FG000|Overall Study|Withdrawal by Subject|5|||
130479997|NCT01959425|469726572|FG001|Overall Study|Withdrawal by Subject|4|||
130479998|NCT01959425|469726571|FG000|Overall Study|Lost to Follow-up|1|||
130479999|NCT01959425|469726572|FG001|Overall Study|Lost to Follow-up|0|||
130480000|NCT01959425|469726571|FG000|Overall Study|Discontinued Subjects|6|||
130480001|NCT01959425|469726572|FG001|Overall Study|Discontinued Subjects|4|||
130480002|NCT05540665|469726574|FG000|Overall Study|Study terminated by sponsor|6|||
130480003|NCT05540665|469726575|FG001|Overall Study|Study terminated by sponsor|6|||
130480004|NCT05540665|469726576|FG002|Overall Study|Study terminated by sponsor|7|||
130480005|NCT02619838|469726577|FG000|Overall Study|Lost to Follow-up|9|||
130480006|NCT02619838|469726577|FG000|Overall Study|Withdrawal by Subject|15|||
130480007|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
130480008|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
130480009|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
130480010|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
130480011|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
130480012|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
130480013|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
130480014|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
130480015|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
130480016|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
130480017|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
130480018|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
130480019|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
130480020|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
130480021|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
130480022|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
130480023|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
130480024|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
130480025|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
130480026|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
130480027|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
130480028|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
130480029|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
130480030|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
130480031|NCT01715285|469726578|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
130480032|NCT01715285|469726579|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
130480033|NCT01715285|469726580|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
130480034|NCT01715285|469726578|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
130480035|NCT01715285|469726579|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
130480036|NCT01715285|469726580|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
130480037|NCT01715285|469726578|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
130480038|NCT01715285|469726579|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
130480039|NCT01715285|469726580|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
130480040|NCT01715285|469726578|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
130480041|NCT01715285|469726579|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
130480042|NCT01715285|469726580|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
130480043|NCT01715285|469726578|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
130480044|NCT01715285|469726579|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
130480045|NCT01715285|469726580|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
130480046|NCT01715285|469726578|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
130480047|NCT01715285|469726579|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
130480048|NCT01715285|469726580|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
130480049|NCT02677805|469726591|FG000|Double Blind Phase|Lost to Follow-up|8|||
130480050|NCT02677805|469726592|FG001|Double Blind Phase|Lost to Follow-up|3|||
130480051|NCT02677805|469726593|FG002|Double Blind Phase|Lost to Follow-up|0|||
130480052|NCT02677805|469726591|FG000|Double Blind Phase|Withdrawal by Subject|5|||
130480053|NCT02677805|469726592|FG001|Double Blind Phase|Withdrawal by Subject|2|||
130480054|NCT02677805|469726593|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130480055|NCT02677805|469726591|FG000|Open Label Phase|Lost to Follow-up|0|||
130480056|NCT02677805|469726592|FG001|Open Label Phase|Lost to Follow-up|0|||
130480057|NCT02677805|469726593|FG002|Open Label Phase|Lost to Follow-up|10|||
130480058|NCT02677805|469726591|FG000|Open Label Phase|Withdrawal by Subject|0|||
130480059|NCT02677805|469726592|FG001|Open Label Phase|Withdrawal by Subject|0|||
130480060|NCT02677805|469726593|FG002|Open Label Phase|Withdrawal by Subject|6|||
130480061|NCT04350463|469726598|FG000|Overall Study|Other reason|0|||
130480062|NCT04350463|469726599|FG001|Overall Study|Other reason|0|||
130480063|NCT04350463|469726600|FG002|Overall Study|Other reason|0|||
130480064|NCT04350463|469726601|FG003|Overall Study|Other reason|1|||
130480065|NCT04350463|469726598|FG000|Overall Study|Lost to Follow-up|0|||
130480066|NCT04350463|469726599|FG001|Overall Study|Lost to Follow-up|0|||
130480067|NCT04350463|469726600|FG002|Overall Study|Lost to Follow-up|0|||
130480068|NCT04350463|469726601|FG003|Overall Study|Lost to Follow-up|2|||
130480069|NCT04350463|469726598|FG000|Overall Study|Withdrawal by Subject|4|||
130480070|NCT04350463|469726599|FG001|Overall Study|Withdrawal by Subject|0|||
130480071|NCT04350463|469726600|FG002|Overall Study|Withdrawal by Subject|1|||
130480072|NCT04350463|469726601|FG003|Overall Study|Withdrawal by Subject|4|||
130480073|NCT04350463|469726598|FG000|Overall Study|Adverse Event|0|||
130480074|NCT04350463|469726599|FG001|Overall Study|Adverse Event|0|||
130480075|NCT04350463|469726600|FG002|Overall Study|Adverse Event|0|||
130480076|NCT04350463|469726601|FG003|Overall Study|Adverse Event|2|||
130480077|NCT04350463|469726598|FG000|Overall Study|Death|27|||
130480078|NCT04350463|469726599|FG001|Overall Study|Death|2|||
130480079|NCT04350463|469726600|FG002|Overall Study|Death|13|||
130480080|NCT04350463|469726601|FG003|Overall Study|Death|26|||
130480081|NCT04111536|469726602|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130480082|NCT04111536|469726603|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130480083|NCT04111536|469726602|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
130480084|NCT04111536|469726603|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
130480085|NCT04111536|469726602|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
130480086|NCT04111536|469726603|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130480087|NCT04111536|469726602|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
130480088|NCT04111536|469726603|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
130480089|NCT05714761|469726604|FG000|Overall Study|Lost to Follow-up|3|||
130480090|NCT05714761|469726604|FG000|Overall Study|Withdrawal by Subject|3|||
130480091|NCT05714761|469726604|FG000|Overall Study|unblinding of sensor data|1|||
130480092|NCT05714761|469726604|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
130480093|NCT05714761|469726604|FG000|Overall Study|did not return second CGM sensor|4|||
130480094|NCT02547233|469726606|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
130480095|NCT02547233|469726607|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
130480096|NCT02547233|469726606|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
130480097|NCT02547233|469726607|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
130480098|NCT02547233|469726606|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
130480099|NCT02547233|469726607|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
130480100|NCT02547233|469726606|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
130480101|NCT02547233|469726607|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
130480102|NCT02547233|469726606|FG000|12-month Follow-up|Withdrawal by Subject|10|||
130480103|NCT02547233|469726607|FG001|12-month Follow-up|Withdrawal by Subject|10|||
130480104|NCT02547233|469726606|FG000|12-month Follow-up|Lost to Follow-up|3|||
130480105|NCT02547233|469726607|FG001|12-month Follow-up|Lost to Follow-up|3|||
130480106|NCT02547233|469726606|FG000|12-month Follow-up|Lack of Efficacy|1|||
130480107|NCT02547233|469726607|FG001|12-month Follow-up|Lack of Efficacy|2|||
130480108|NCT02547233|469726606|FG000|12-month Follow-up|Protocol Violation|0|||
130480109|NCT02547233|469726607|FG001|12-month Follow-up|Protocol Violation|1|||
130480110|NCT02547233|469726606|FG000|12-month Follow-up|Other|0|||
130480111|NCT02547233|469726607|FG001|12-month Follow-up|Other|1|||
130480112|NCT02489903|469726611|FG000|Screening|Screen Failure|24|||
130480113|NCT02489903|469726612|FG001|Screening|Screen Failure|0|||
130480114|NCT02489903|469726613|FG002|Screening|Screen Failure|0|||
130480115|NCT02489903|469726614|FG003|Screening|Screen Failure|8|||
130480116|NCT02489903|469726611|FG000|Randomized and Received Treatment|Protocol Violation|0|||
130480117|NCT02489903|469726612|FG001|Randomized and Received Treatment|Protocol Violation|1|||
130480118|NCT02489903|469726613|FG002|Randomized and Received Treatment|Protocol Violation|0|||
130480119|NCT02489903|469726614|FG003|Randomized and Received Treatment|Protocol Violation|0|||
130480120|NCT02489903|469726611|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
130480121|NCT02489903|469726612|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
130480122|NCT02489903|469726613|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
130480123|NCT02489903|469726614|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
130480124|NCT02489903|469726611|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
130480125|NCT02489903|469726612|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
130480126|NCT02489903|469726613|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
130480127|NCT02489903|469726614|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
130480128|NCT02489903|469726611|FG000|Randomized and Received Treatment|Death|10|||
130480129|NCT02489903|469726612|FG001|Randomized and Received Treatment|Death|1|||
130480130|NCT02489903|469726613|FG002|Randomized and Received Treatment|Death|0|||
130480131|NCT02489903|469726614|FG003|Randomized and Received Treatment|Death|0|||
130480132|NCT05126433|469726615|FG000|Overall Study|Withdrawal by Subject|3|||
130480133|NCT05126433|469726616|FG001|Overall Study|Withdrawal by Subject|0|||
130480134|NCT05126433|469726617|FG002|Overall Study|Withdrawal by Subject|4|||
130480135|NCT05126433|469726615|FG000|Overall Study|Death|9|||
130480136|NCT05126433|469726616|FG001|Overall Study|Death|3|||
130480137|NCT05126433|469726617|FG002|Overall Study|Death|5|||
130480138|NCT05126433|469726615|FG000|Overall Study|Study Terminated by sponsor|0|||
130480139|NCT05126433|469726616|FG001|Overall Study|Study Terminated by sponsor|1|||
130480140|NCT05126433|469726617|FG002|Overall Study|Study Terminated by sponsor|2|||
130480141|NCT05126433|469726615|FG000|Overall Study|Progressive Disease|1|||
130480142|NCT05126433|469726616|FG001|Overall Study|Progressive Disease|4|||
130480143|NCT05126433|469726617|FG002|Overall Study|Progressive Disease|3|||
130480144|NCT05126433|469726615|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
130480145|NCT05126433|469726616|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
130480146|NCT05126433|469726617|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
130480147|NCT04137289|469726618|FG000|Overall Study|Death|0|||
130480148|NCT04137289|469726619|FG001|Overall Study|Death|0|||
130480149|NCT04137289|469726620|FG002|Overall Study|Death|0|||
130480150|NCT04137289|469726621|FG003|Overall Study|Death|0|||
130480151|NCT04137289|469726622|FG004|Overall Study|Death|0|||
130480152|NCT04137289|469726623|FG005|Overall Study|Death|0|||
130480153|NCT04137289|469726624|FG006|Overall Study|Death|1|||
130480154|NCT04137289|469726625|FG007|Overall Study|Death|0|||
130480155|NCT04137289|469726626|FG008|Overall Study|Death|0|||
130480156|NCT04137289|469726618|FG000|Overall Study|Clinical disease progression|0|||
130480157|NCT04137289|469726619|FG001|Overall Study|Clinical disease progression|0|||
130480158|NCT04137289|469726620|FG002|Overall Study|Clinical disease progression|0|||
130480159|NCT04137289|469726621|FG003|Overall Study|Clinical disease progression|4|||
130480160|NCT04137289|469726622|FG004|Overall Study|Clinical disease progression|4|||
130480161|NCT04137289|469726623|FG005|Overall Study|Clinical disease progression|2|||
130480162|NCT04137289|469726624|FG006|Overall Study|Clinical disease progression|5|||
130480163|NCT04137289|469726625|FG007|Overall Study|Clinical disease progression|1|||
130480164|NCT04137289|469726626|FG008|Overall Study|Clinical disease progression|0|||
130480165|NCT04137289|469726618|FG000|Overall Study|Lost to Follow-up|0|||
130480166|NCT04137289|469726619|FG001|Overall Study|Lost to Follow-up|0|||
130480167|NCT04137289|469726620|FG002|Overall Study|Lost to Follow-up|0|||
130480168|NCT04137289|469726621|FG003|Overall Study|Lost to Follow-up|1|||
130480169|NCT04137289|469726622|FG004|Overall Study|Lost to Follow-up|0|||
130480170|NCT04137289|469726623|FG005|Overall Study|Lost to Follow-up|0|||
130480171|NCT04137289|469726624|FG006|Overall Study|Lost to Follow-up|0|||
130480172|NCT04137289|469726625|FG007|Overall Study|Lost to Follow-up|0|||
130480173|NCT04137289|469726626|FG008|Overall Study|Lost to Follow-up|0|||
130480174|NCT04137289|469726618|FG000|Overall Study|Adverse Event|0|||
130480175|NCT04137289|469726619|FG001|Overall Study|Adverse Event|0|||
130480176|NCT04137289|469726620|FG002|Overall Study|Adverse Event|1|||
130480177|NCT04137289|469726621|FG003|Overall Study|Adverse Event|0|||
130480178|NCT04137289|469726622|FG004|Overall Study|Adverse Event|0|||
130480179|NCT04137289|469726623|FG005|Overall Study|Adverse Event|1|||
130480180|NCT04137289|469726624|FG006|Overall Study|Adverse Event|0|||
130480181|NCT04137289|469726625|FG007|Overall Study|Adverse Event|0|||
130480182|NCT04137289|469726626|FG008|Overall Study|Adverse Event|0|||
130480183|NCT04137289|469726618|FG000|Overall Study|Lack of clinical benefit|0|||
130480184|NCT04137289|469726619|FG001|Overall Study|Lack of clinical benefit|0|||
130480185|NCT04137289|469726620|FG002|Overall Study|Lack of clinical benefit|0|||
130480186|NCT04137289|469726621|FG003|Overall Study|Lack of clinical benefit|0|||
130480187|NCT04137289|469726622|FG004|Overall Study|Lack of clinical benefit|0|||
130480188|NCT04137289|469726623|FG005|Overall Study|Lack of clinical benefit|0|||
130480189|NCT04137289|469726624|FG006|Overall Study|Lack of clinical benefit|0|||
130480190|NCT04137289|469726625|FG007|Overall Study|Lack of clinical benefit|0|||
130480191|NCT04137289|469726626|FG008|Overall Study|Lack of clinical benefit|1|||
130480192|NCT04137289|469726618|FG000|Overall Study|Objective disease progression|1|||
130480193|NCT04137289|469726619|FG001|Overall Study|Objective disease progression|1|||
130480194|NCT04137289|469726620|FG002|Overall Study|Objective disease progression|6|||
130480195|NCT04137289|469726621|FG003|Overall Study|Objective disease progression|18|||
130480196|NCT04137289|469726622|FG004|Overall Study|Objective disease progression|12|||
130480197|NCT04137289|469726623|FG005|Overall Study|Objective disease progression|20|||
130480198|NCT04137289|469726624|FG006|Overall Study|Objective disease progression|18|||
130564909|NCT02044133|470033784|FG000|Overall Study|Release|3|||
130564910|NCT02044133|470033785|FG001|Overall Study|Release|4|||
130564911|NCT02044133|470033784|FG000|Overall Study|Transfer|1|||
130564912|NCT02044133|470033785|FG001|Overall Study|Transfer|0|||
130480199|NCT04137289|469726625|FG007|Overall Study|Objective disease progression|7|||
130480200|NCT04137289|469726626|FG008|Overall Study|Objective disease progression|6|||
130480201|NCT05329220|469726629|FG000|Active Trial Period|Adverse Event|0|||
130480202|NCT05329220|469726630|FG001|Active Trial Period|Adverse Event|0|||
130480203|NCT05329220|469726631|FG002|Active Trial Period|Adverse Event|0|||
130480204|NCT05329220|469726632|FG003|Active Trial Period|Adverse Event|0|||
130480205|NCT05329220|469726633|FG004|Active Trial Period|Adverse Event|1|||
130480206|NCT05329220|469726634|FG005|Active Trial Period|Adverse Event|0|||
130480207|NCT05329220|469726629|FG000|Active Trial Period|Lost to Follow-up|0|||
130480208|NCT05329220|469726630|FG001|Active Trial Period|Lost to Follow-up|0|||
130480209|NCT05329220|469726631|FG002|Active Trial Period|Lost to Follow-up|0|||
130480210|NCT05329220|469726632|FG003|Active Trial Period|Lost to Follow-up|0|||
130480211|NCT05329220|469726633|FG004|Active Trial Period|Lost to Follow-up|32|||
130480212|NCT05329220|469726634|FG005|Active Trial Period|Lost to Follow-up|28|||
130480213|NCT05329220|469726629|FG000|Active Trial Period|Physician Decision|0|||
130480214|NCT05329220|469726630|FG001|Active Trial Period|Physician Decision|0|||
130480215|NCT05329220|469726631|FG002|Active Trial Period|Physician Decision|0|||
130480216|NCT05329220|469726632|FG003|Active Trial Period|Physician Decision|0|||
130480217|NCT05329220|469726633|FG004|Active Trial Period|Physician Decision|2|||
130480218|NCT05329220|469726634|FG005|Active Trial Period|Physician Decision|0|||
130480219|NCT05329220|469726629|FG000|Active Trial Period|Protocol Violation|0|||
130480220|NCT05329220|469726630|FG001|Active Trial Period|Protocol Violation|0|||
130480221|NCT05329220|469726631|FG002|Active Trial Period|Protocol Violation|0|||
130480222|NCT05329220|469726632|FG003|Active Trial Period|Protocol Violation|0|||
130480223|NCT05329220|469726633|FG004|Active Trial Period|Protocol Violation|1|||
130480224|NCT05329220|469726634|FG005|Active Trial Period|Protocol Violation|3|||
130480225|NCT05329220|469726629|FG000|Active Trial Period|Withdrawal by Subject|0|||
130480226|NCT05329220|469726630|FG001|Active Trial Period|Withdrawal by Subject|0|||
130480227|NCT05329220|469726631|FG002|Active Trial Period|Withdrawal by Subject|0|||
130480228|NCT05329220|469726632|FG003|Active Trial Period|Withdrawal by Subject|1|||
130480229|NCT05329220|469726633|FG004|Active Trial Period|Withdrawal by Subject|12|||
130480230|NCT05329220|469726634|FG005|Active Trial Period|Withdrawal by Subject|13|||
130480231|NCT05329220|469726629|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130480232|NCT05329220|469726630|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130480233|NCT05329220|469726631|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130480234|NCT05329220|469726632|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130480235|NCT05329220|469726633|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130480236|NCT05329220|469726634|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
130564913|NCT02044133|470033784|FG000|Overall Study|refusal of blood sampling|0|||
130564914|NCT02044133|470033785|FG001|Overall Study|refusal of blood sampling|1|||
130564915|NCT00766038|470035330|FG000|Overall Study|Lost to Follow-up|15|||
130564916|NCT00766038|470035331|FG001|Overall Study|Lost to Follow-up|14|||
130564917|NCT01251653|470035336|FG000|Overall Study|Progressive Disease|1|||
130564918|NCT01251653|470035337|FG001|Overall Study|Progressive Disease|7|||
130564919|NCT01251653|470035338|FG002|Overall Study|Progressive Disease|16|||
130564920|NCT01251653|470035339|FG003|Overall Study|Progressive Disease|4|||
130564921|NCT01251653|470035340|FG004|Overall Study|Progressive Disease|0|||
130564922|NCT01251653|470035341|FG005|Overall Study|Progressive Disease|17|||
130564923|NCT01251653|470035342|FG006|Overall Study|Progressive Disease|14|||
130480237|NCT05329220|469726629|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
130480238|NCT05329220|469726630|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
130480239|NCT05329220|469726631|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
130480240|NCT05329220|469726632|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
130480241|NCT05329220|469726633|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
130480242|NCT05329220|469726634|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
130480243|NCT05329220|469726629|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
130480244|NCT05329220|469726630|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
130480245|NCT05329220|469726631|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
130480246|NCT05329220|469726632|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
130480247|NCT05329220|469726633|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
130480248|NCT05329220|469726634|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
130480249|NCT05329220|469726629|FG000|Follow-up Period|Adverse Event|0|||
130480250|NCT05329220|469726630|FG001|Follow-up Period|Adverse Event|0|||
130480251|NCT05329220|469726631|FG002|Follow-up Period|Adverse Event|0|||
130480252|NCT05329220|469726632|FG003|Follow-up Period|Adverse Event|0|||
130480253|NCT05329220|469726633|FG004|Follow-up Period|Adverse Event|2|||
130480254|NCT05329220|469726634|FG005|Follow-up Period|Adverse Event|1|||
130480255|NCT05329220|469726629|FG000|Follow-up Period|Death|0|||
130480256|NCT05329220|469726630|FG001|Follow-up Period|Death|0|||
130480257|NCT05329220|469726631|FG002|Follow-up Period|Death|1|||
130480258|NCT05329220|469726632|FG003|Follow-up Period|Death|1|||
130480259|NCT05329220|469726633|FG004|Follow-up Period|Death|0|||
130480260|NCT05329220|469726634|FG005|Follow-up Period|Death|1|||
130480261|NCT05329220|469726629|FG000|Follow-up Period|Lost to Follow-up|0|||
130480262|NCT05329220|469726630|FG001|Follow-up Period|Lost to Follow-up|1|||
130480263|NCT05329220|469726631|FG002|Follow-up Period|Lost to Follow-up|2|||
130480264|NCT05329220|469726632|FG003|Follow-up Period|Lost to Follow-up|2|||
130480265|NCT05329220|469726633|FG004|Follow-up Period|Lost to Follow-up|113|||
130480266|NCT05329220|469726634|FG005|Follow-up Period|Lost to Follow-up|89|||
130480267|NCT05329220|469726629|FG000|Follow-up Period|Physician Decision|0|||
130480268|NCT05329220|469726630|FG001|Follow-up Period|Physician Decision|0|||
130480269|NCT05329220|469726631|FG002|Follow-up Period|Physician Decision|0|||
130480270|NCT05329220|469726632|FG003|Follow-up Period|Physician Decision|0|||
130480271|NCT05329220|469726633|FG004|Follow-up Period|Physician Decision|2|||
130480272|NCT05329220|469726634|FG005|Follow-up Period|Physician Decision|2|||
130480273|NCT05329220|469726629|FG000|Follow-up Period|Protocol Violation|0|||
130480274|NCT05329220|469726630|FG001|Follow-up Period|Protocol Violation|0|||
130480275|NCT05329220|469726631|FG002|Follow-up Period|Protocol Violation|0|||
130480276|NCT05329220|469726632|FG003|Follow-up Period|Protocol Violation|0|||
130480277|NCT05329220|469726633|FG004|Follow-up Period|Protocol Violation|0|||
130480278|NCT05329220|469726634|FG005|Follow-up Period|Protocol Violation|1|||
130480279|NCT05329220|469726629|FG000|Follow-up Period|Withdrawal by Subject|0|||
130480280|NCT05329220|469726630|FG001|Follow-up Period|Withdrawal by Subject|0|||
130480281|NCT05329220|469726631|FG002|Follow-up Period|Withdrawal by Subject|1|||
130480282|NCT05329220|469726632|FG003|Follow-up Period|Withdrawal by Subject|1|||
130480283|NCT05329220|469726633|FG004|Follow-up Period|Withdrawal by Subject|34|||
130480284|NCT05329220|469726634|FG005|Follow-up Period|Withdrawal by Subject|35|||
130480285|NCT05329220|469726629|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130480286|NCT05329220|469726630|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130480287|NCT05329220|469726631|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
130480288|NCT05329220|469726632|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130480289|NCT05329220|469726633|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130480290|NCT05329220|469726634|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130480291|NCT05329220|469726629|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130480292|NCT05329220|469726630|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130480293|NCT05329220|469726631|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130480294|NCT05329220|469726632|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130480295|NCT05329220|469726633|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
130480296|NCT05329220|469726634|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130480297|NCT05329220|469726629|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130480298|NCT05329220|469726630|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130480299|NCT05329220|469726631|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130480300|NCT05329220|469726632|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130480301|NCT05329220|469726633|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
130480302|NCT05329220|469726634|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130480303|NCT05329220|469726629|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
130480304|NCT05329220|469726630|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
130480305|NCT05329220|469726631|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
130480306|NCT05329220|469726632|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
130480307|NCT05329220|469726633|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
130480308|NCT05329220|469726634|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
130480309|NCT05329220|469726629|FG000|Follow-up Period|EARLY TERMINATION|0|||
130480310|NCT05329220|469726630|FG001|Follow-up Period|EARLY TERMINATION|0|||
130480311|NCT05329220|469726631|FG002|Follow-up Period|EARLY TERMINATION|0|||
130480312|NCT05329220|469726632|FG003|Follow-up Period|EARLY TERMINATION|0|||
130480313|NCT05329220|469726633|FG004|Follow-up Period|EARLY TERMINATION|0|||
130480314|NCT05329220|469726634|FG005|Follow-up Period|EARLY TERMINATION|1|||
130480315|NCT05329220|469726629|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
130480316|NCT05329220|469726630|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
130480317|NCT05329220|469726631|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
130480318|NCT05329220|469726632|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
130480319|NCT05329220|469726633|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
130480320|NCT05329220|469726634|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
130480321|NCT05329220|469726629|FG000|Follow-up Period|DROPPED|0|||
130480322|NCT05329220|469726630|FG001|Follow-up Period|DROPPED|0|||
130480323|NCT05329220|469726631|FG002|Follow-up Period|DROPPED|0|||
130480324|NCT05329220|469726632|FG003|Follow-up Period|DROPPED|0|||
130480325|NCT05329220|469726633|FG004|Follow-up Period|DROPPED|0|||
130480326|NCT05329220|469726634|FG005|Follow-up Period|DROPPED|1|||
130480327|NCT05329220|469726629|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
130480328|NCT05329220|469726630|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
130480329|NCT05329220|469726631|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
130480330|NCT05329220|469726632|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
130480331|NCT05329220|469726633|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
130480332|NCT05329220|469726634|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
130480333|NCT03931174|469726637|FG000|Providers|Staff left organization|26|||
130480334|NCT03931174|469726638|FG001|Providers|Staff left organization|25|||
130480335|NCT03931174|469726637|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
130480336|NCT03931174|469726638|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
130480337|NCT03931174|469726637|FG000|Providers|Lost to Follow-up|4|||
130480338|NCT03931174|469726638|FG001|Providers|Lost to Follow-up|4|||
130480339|NCT03931174|469726637|FG000|Patients|Post-consent screening failure|1|||
130480340|NCT03931174|469726638|FG001|Patients|Post-consent screening failure|1|||
130480341|NCT03931174|469726637|FG000|Patients|Death|1|||
130480342|NCT03931174|469726638|FG001|Patients|Death|1|||
130480343|NCT03931174|469726637|FG000|Patients|Lost to Follow-up|60|||
130480344|NCT03931174|469726638|FG001|Patients|Lost to Follow-up|89|||
130480345|NCT03322267|469726639|FG000|Overall Study|Lack of Efficacy|11|||
130480346|NCT03322267|469726639|FG000|Overall Study|Adverse Event|1|||
130480347|NCT03322267|469726639|FG000|Overall Study|Withdrawal by Subject|2|||
130480348|NCT01467427|469726643|FG000|Overall Study|Withdrawal by Subject|1|||
130480349|NCT01467427|469726644|FG001|Overall Study|Withdrawal by Subject|0|||
130480350|NCT01467427|469726643|FG000|Overall Study|Not continuing in extension phase|0|||
130480351|NCT01467427|469726644|FG001|Overall Study|Not continuing in extension phase|2|||
130480352|NCT01467427|469726643|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
130480353|NCT01467427|469726644|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
130480354|NCT01467427|469726643|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
130480355|NCT01467427|469726644|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
130480356|NCT01467427|469726643|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
130480357|NCT01467427|469726644|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
130480358|NCT01467427|469726643|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
130480359|NCT01467427|469726644|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
130480360|NCT03492216|469726645|FG000|Overall Study|Death|1|||
130480361|NCT03492216|469726646|FG001|Overall Study|Death|0|||
130480362|NCT03492216|469726647|FG002|Overall Study|Death|4|||
130480363|NCT03492216|469726648|FG003|Overall Study|Death|0|||
130480364|NCT03492216|469726645|FG000|Overall Study|Withdrawal by Subject|5|||
130480365|NCT03492216|469726646|FG001|Overall Study|Withdrawal by Subject|3|||
130480366|NCT03492216|469726647|FG002|Overall Study|Withdrawal by Subject|1|||
130480367|NCT03492216|469726648|FG003|Overall Study|Withdrawal by Subject|1|||
130480368|NCT03492216|469726645|FG000|Overall Study|Lost to Follow-up|9|||
130480369|NCT03492216|469726646|FG001|Overall Study|Lost to Follow-up|2|||
130480370|NCT03492216|469726647|FG002|Overall Study|Lost to Follow-up|7|||
130480371|NCT03492216|469726648|FG003|Overall Study|Lost to Follow-up|8|||
130480372|NCT03492216|469726645|FG000|Overall Study|Moved|5|||
130480373|NCT03492216|469726646|FG001|Overall Study|Moved|3|||
130727852|NCT00025259|470625565|FG006|Overall Study|Protocol Violation|3|||
130480374|NCT03492216|469726647|FG002|Overall Study|Moved|3|||
130480375|NCT03492216|469726648|FG003|Overall Study|Moved|5|||
130480376|NCT03492216|469726645|FG000|Overall Study|Too ill|0|||
130480377|NCT03492216|469726646|FG001|Overall Study|Too ill|1|||
130480378|NCT03492216|469726647|FG002|Overall Study|Too ill|0|||
130480379|NCT03492216|469726648|FG003|Overall Study|Too ill|0|||
130480380|NCT03492216|469726645|FG000|Overall Study|Incarcerated|0|||
130480381|NCT03492216|469726646|FG001|Overall Study|Incarcerated|0|||
130480382|NCT03492216|469726647|FG002|Overall Study|Incarcerated|2|||
130480383|NCT03492216|469726648|FG003|Overall Study|Incarcerated|0|||
130480384|NCT03869866|469728411|FG000|Overall Study|Protocol Violation|1|||
130480385|NCT03869866|469728411|FG000|Overall Study|Withdrawal by Subject|3|||
130480386|NCT04625283|469728412|FG000|Overall Study|post randomization exclusion|28|||
130480387|NCT04625283|469728413|FG001|Overall Study|post randomization exclusion|20|||
130480388|NCT03462030|469728416|FG000|Overall Study|Withdrawal by Subject|1|||
130480389|NCT03462030|469728417|FG001|Overall Study|Withdrawal by Subject|1|||
130480390|NCT05020249|469728418|FG000|Overall Study|Protocol Violation|1|||
130480391|NCT05020249|469728419|FG001|Overall Study|Protocol Violation|0|||
130480392|NCT04066244|469728420|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
130480393|NCT04066244|469728421|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
130480394|NCT04066244|469728422|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
130480395|NCT04066244|469728423|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
130480396|NCT04066244|469728424|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
130480397|NCT04066244|469728425|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
130480398|NCT04066244|469728420|FG000|Part 2 (Cohort 5)|Death|0|||
130480399|NCT04066244|469728421|FG001|Part 2 (Cohort 5)|Death|0|||
130480400|NCT04066244|469728422|FG002|Part 2 (Cohort 5)|Death|0|||
130480401|NCT04066244|469728423|FG003|Part 2 (Cohort 5)|Death|0|||
130480402|NCT04066244|469728424|FG004|Part 2 (Cohort 5)|Death|0|||
130480403|NCT04066244|469728425|FG005|Part 2 (Cohort 5)|Death|2|||
130480404|NCT04066244|469728420|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
130480405|NCT04066244|469728421|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
130480406|NCT04066244|469728422|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
130480407|NCT04066244|469728423|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
130480408|NCT04066244|469728424|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
130480409|NCT04066244|469728425|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
130480410|NCT04066244|469728420|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
130480411|NCT04066244|469728421|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
130480412|NCT04066244|469728422|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
130480413|NCT04066244|469728423|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
130480414|NCT04066244|469728424|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
130480415|NCT04066244|469728425|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
130480416|NCT01073566|469728426|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
130480417|NCT01073566|469728427|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
130480418|NCT05006872|469728441|FG000|Overall Study|Lost to Follow-up|37|||
130480419|NCT05006872|469728442|FG001|Overall Study|Lost to Follow-up|31|||
130480420|NCT05499377|469728448|FG000|Overall Study|Withdrawal by Subject|2|||
130480421|NCT05499377|469728449|FG001|Overall Study|Withdrawal by Subject|0|||
130480422|NCT05499377|469728448|FG000|Overall Study|Physician Decision|1|||
130480423|NCT05499377|469728449|FG001|Overall Study|Physician Decision|0|||
130480424|NCT04971681|469728451|FG000|Followup|Lost to Follow-up|1|||
130480425|NCT04971681|469728452|FG001|Followup|Lost to Follow-up|0|||
130480426|NCT00686335|469728453|FG000|Run-in Period|Adverse Event|1|||
130480427|NCT00686335|469728453|FG000|Run-in Period|asthma exacerbation|1|||
130480428|NCT00686335|469728453|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
130480429|NCT02268253|469728454|FG000|Stage 1|Withdrawal by Subject|1|||
130480430|NCT02268253|469728455|FG001|Stage 1|Withdrawal by Subject|0|||
130480431|NCT02268253|469728456|FG002|Stage 1|Withdrawal by Subject|0|||
130480432|NCT02268253|469728457|FG003|Stage 1|Withdrawal by Subject|0|||
130480433|NCT02268253|469728458|FG004|Stage 1|Withdrawal by Subject|0|||
130480434|NCT02268253|469728459|FG005|Stage 1|Withdrawal by Subject|0|||
130480435|NCT02268253|469728460|FG006|Stage 1|Withdrawal by Subject|0|||
130480436|NCT02268253|469728454|FG000|Stage 1|Death|0|||
130480437|NCT02268253|469728455|FG001|Stage 1|Death|2|||
130480438|NCT02268253|469728456|FG002|Stage 1|Death|2|||
130480439|NCT02268253|469728457|FG003|Stage 1|Death|2|||
130480440|NCT02268253|469728458|FG004|Stage 1|Death|1|||
130564924|NCT01251653|470035343|FG007|Overall Study|Progressive Disease|7|||
130564925|NCT01251653|470035344|FG008|Overall Study|Progressive Disease|5|||
130480441|NCT02268253|469728459|FG005|Stage 1|Death|1|||
130480442|NCT02268253|469728460|FG006|Stage 1|Death|0|||
130480443|NCT02268253|469728454|FG000|Stage 2|Disease Recurrence/ Progression|0|||
130480444|NCT02268253|469728455|FG001|Stage 2|Disease Recurrence/ Progression|0|||
130480445|NCT02268253|469728456|FG002|Stage 2|Disease Recurrence/ Progression|1|||
130480446|NCT02268253|469728457|FG003|Stage 2|Disease Recurrence/ Progression|0|||
130480447|NCT02268253|469728458|FG004|Stage 2|Disease Recurrence/ Progression|0|||
130480448|NCT02268253|469728459|FG005|Stage 2|Disease Recurrence/ Progression|0|||
130480449|NCT02268253|469728460|FG006|Stage 2|Disease Recurrence/ Progression|0|||
130480450|NCT02268253|469728454|FG000|Stage 2|Withdrawal by Subject|0|||
130480451|NCT02268253|469728455|FG001|Stage 2|Withdrawal by Subject|0|||
130480452|NCT02268253|469728456|FG002|Stage 2|Withdrawal by Subject|2|||
130727853|NCT00025259|470625559|FG000|Overall Study|Withdrawal by Subject|9|||
130480453|NCT02268253|469728457|FG003|Stage 2|Withdrawal by Subject|0|||
130480454|NCT02268253|469728458|FG004|Stage 2|Withdrawal by Subject|0|||
130480455|NCT02268253|469728459|FG005|Stage 2|Withdrawal by Subject|2|||
130480456|NCT02268253|469728460|FG006|Stage 2|Withdrawal by Subject|0|||
130480457|NCT02268253|469728454|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
130480458|NCT02268253|469728455|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
130480459|NCT02268253|469728456|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
130480460|NCT02268253|469728457|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
130480461|NCT02268253|469728458|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
130480462|NCT02268253|469728459|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
130480463|NCT02268253|469728460|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
130480464|NCT02268253|469728454|FG000|Stage 2|Death|0|||
130480465|NCT02268253|469728455|FG001|Stage 2|Death|0|||
130480466|NCT02268253|469728456|FG002|Stage 2|Death|19|||
130480467|NCT02268253|469728457|FG003|Stage 2|Death|0|||
130480468|NCT02268253|469728458|FG004|Stage 2|Death|0|||
130480469|NCT02268253|469728459|FG005|Stage 2|Death|20|||
130480470|NCT02268253|469728460|FG006|Stage 2|Death|1|||
130480471|NCT02268253|469728454|FG000|Stage 2|Lost to Follow-up|0|||
130480472|NCT02268253|469728455|FG001|Stage 2|Lost to Follow-up|0|||
130480473|NCT02268253|469728456|FG002|Stage 2|Lost to Follow-up|0|||
130480474|NCT02268253|469728457|FG003|Stage 2|Lost to Follow-up|0|||
130480475|NCT02268253|469728458|FG004|Stage 2|Lost to Follow-up|0|||
130480476|NCT02268253|469728459|FG005|Stage 2|Lost to Follow-up|4|||
130480477|NCT02268253|469728460|FG006|Stage 2|Lost to Follow-up|0|||
130480478|NCT02268253|469728454|FG000|Stage 2|Transferred to Hospice|0|||
130727854|NCT00025259|470625560|FG001|Overall Study|Withdrawal by Subject|27|||
130727855|NCT00025259|470625561|FG002|Overall Study|Withdrawal by Subject|6|||
130727856|NCT00025259|470625562|FG003|Overall Study|Withdrawal by Subject|14|||
130727857|NCT00025259|470625563|FG004|Overall Study|Withdrawal by Subject|11|||
130727858|NCT00025259|470625564|FG005|Overall Study|Withdrawal by Subject|8|||
130727859|NCT00025259|470625565|FG006|Overall Study|Withdrawal by Subject|3|||
130727860|NCT00025259|470625559|FG000|Overall Study|Ineligible|14|||
130727861|NCT00025259|470625560|FG001|Overall Study|Ineligible|1|||
130727862|NCT00025259|470625561|FG002|Overall Study|Ineligible|0|||
130480479|NCT02268253|469728455|FG001|Stage 2|Transferred to Hospice|0|||
130480480|NCT02268253|469728456|FG002|Stage 2|Transferred to Hospice|0|||
130480481|NCT02268253|469728457|FG003|Stage 2|Transferred to Hospice|0|||
130480482|NCT02268253|469728458|FG004|Stage 2|Transferred to Hospice|0|||
130727863|NCT00025259|470625562|FG003|Overall Study|Ineligible|0|||
130727864|NCT00025259|470625563|FG004|Overall Study|Ineligible|6|||
130727865|NCT00025259|470625564|FG005|Overall Study|Ineligible|0|||
130727866|NCT00025259|470625565|FG006|Overall Study|Ineligible|1|||
130727867|NCT00025259|470625559|FG000|Overall Study|Randomization error|1|||
130727868|NCT00025259|470625560|FG001|Overall Study|Randomization error|0|||
130727869|NCT00025259|470625561|FG002|Overall Study|Randomization error|0|||
130480483|NCT02268253|469728459|FG005|Stage 2|Transferred to Hospice|2|||
130480484|NCT02268253|469728460|FG006|Stage 2|Transferred to Hospice|0|||
130480485|NCT02268253|469728454|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
130480486|NCT02268253|469728455|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
130480487|NCT02268253|469728456|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
130480488|NCT02268253|469728457|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
130480489|NCT02268253|469728458|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
130480490|NCT02268253|469728459|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
130480491|NCT02268253|469728460|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
130480492|NCT02268253|469728454|FG000|Stage 3A|Withdrawal by Subject|0|||
130480493|NCT02268253|469728455|FG001|Stage 3A|Withdrawal by Subject|0|||
130480494|NCT02268253|469728456|FG002|Stage 3A|Withdrawal by Subject|2|||
130727870|NCT00025259|470625562|FG003|Overall Study|Randomization error|0|||
130727871|NCT00025259|470625563|FG004|Overall Study|Randomization error|1|||
130727872|NCT00025259|470625564|FG005|Overall Study|Randomization error|7|||
130727873|NCT00025259|470625565|FG006|Overall Study|Randomization error|2|||
130480495|NCT02268253|469728457|FG003|Stage 3A|Withdrawal by Subject|0|||
130480496|NCT02268253|469728458|FG004|Stage 3A|Withdrawal by Subject|0|||
130480497|NCT02268253|469728459|FG005|Stage 3A|Withdrawal by Subject|0|||
130480498|NCT02268253|469728460|FG006|Stage 3A|Withdrawal by Subject|0|||
130480499|NCT02268253|469728454|FG000|Stage 3A|Physician Decision|0|||
130480500|NCT02268253|469728455|FG001|Stage 3A|Physician Decision|0|||
130480501|NCT02268253|469728456|FG002|Stage 3A|Physician Decision|2|||
130480502|NCT02268253|469728457|FG003|Stage 3A|Physician Decision|0|||
130480503|NCT02268253|469728458|FG004|Stage 3A|Physician Decision|0|||
130480504|NCT02268253|469728459|FG005|Stage 3A|Physician Decision|0|||
130480505|NCT02268253|469728460|FG006|Stage 3A|Physician Decision|0|||
130480506|NCT02268253|469728454|FG000|Stage 3A|Study Terminated by Sponsor|0|||
130480507|NCT02268253|469728455|FG001|Stage 3A|Study Terminated by Sponsor|0|||
130480508|NCT02268253|469728456|FG002|Stage 3A|Study Terminated by Sponsor|2|||
130727874|NCT00025259|470625559|FG000|Overall Study|Adverse Event|1|||
130727875|NCT00025259|470625560|FG001|Overall Study|Adverse Event|0|||
130727876|NCT00025259|470625561|FG002|Overall Study|Adverse Event|0|||
130727877|NCT00025259|470625562|FG003|Overall Study|Adverse Event|0|||
130727878|NCT00025259|470625563|FG004|Overall Study|Adverse Event|0|||
130727879|NCT00025259|470625564|FG005|Overall Study|Adverse Event|0|||
130727880|NCT00025259|470625565|FG006|Overall Study|Adverse Event|0|||
130727881|NCT01449370|470625566|FG000|Overall Study|Disease Progression|5|||
130727882|NCT01449370|470625567|FG001|Overall Study|Disease Progression|4|||
130727883|NCT01449370|470625568|FG002|Overall Study|Disease Progression|8|||
130727884|NCT01449370|470625569|FG003|Overall Study|Disease Progression|3|||
130727885|NCT01449370|470625570|FG004|Overall Study|Disease Progression|3|||
130727886|NCT01449370|470625571|FG005|Overall Study|Disease Progression|3|||
130727887|NCT01449370|470625572|FG006|Overall Study|Disease Progression|3|||
130727888|NCT01449370|470625573|FG007|Overall Study|Disease Progression|2|||
130727889|NCT01449370|470625574|FG008|Overall Study|Disease Progression|9|||
130727890|NCT01449370|470625575|FG009|Overall Study|Disease Progression|1|||
130727891|NCT01449370|470625576|FG010|Overall Study|Disease Progression|3|||
130727892|NCT01449370|470625577|FG011|Overall Study|Disease Progression|3|||
130727893|NCT01449370|470625578|FG012|Overall Study|Disease Progression|2|||
130727894|NCT01449370|470625579|FG013|Overall Study|Disease Progression|8|||
130727895|NCT01449370|470625580|FG014|Overall Study|Disease Progression|3|||
130727896|NCT01449370|470625581|FG015|Overall Study|Disease Progression|1|||
130727897|NCT01449370|470625582|FG016|Overall Study|Disease Progression|4|||
130727898|NCT01449370|470625583|FG017|Overall Study|Disease Progression|3|||
130727899|NCT01449370|470625584|FG018|Overall Study|Disease Progression|1|||
130727900|NCT01449370|470625585|FG019|Overall Study|Disease Progression|2|||
130727901|NCT01449370|470625586|FG020|Overall Study|Disease Progression|5|||
130727902|NCT01449370|470625587|FG021|Overall Study|Disease Progression|2|||
130727903|NCT01449370|470625588|FG022|Overall Study|Disease Progression|3|||
130727904|NCT01449370|470625589|FG023|Overall Study|Disease Progression|7|||
130727905|NCT01449370|470625590|FG024|Overall Study|Disease Progression|3|||
130727906|NCT01449370|470625566|FG000|Overall Study|Adverse Event|1|||
130727907|NCT01449370|470625567|FG001|Overall Study|Adverse Event|2|||
130727908|NCT01449370|470625568|FG002|Overall Study|Adverse Event|0|||
130727909|NCT01449370|470625569|FG003|Overall Study|Adverse Event|1|||
130727910|NCT01449370|470625570|FG004|Overall Study|Adverse Event|0|||
130727911|NCT01449370|470625571|FG005|Overall Study|Adverse Event|0|||
130727912|NCT01449370|470625572|FG006|Overall Study|Adverse Event|0|||
130727913|NCT01449370|470625573|FG007|Overall Study|Adverse Event|0|||
130727914|NCT01449370|470625574|FG008|Overall Study|Adverse Event|1|||
130727915|NCT01449370|470625575|FG009|Overall Study|Adverse Event|1|||
130727916|NCT01449370|470625576|FG010|Overall Study|Adverse Event|0|||
130727917|NCT01449370|470625577|FG011|Overall Study|Adverse Event|0|||
130727918|NCT01449370|470625578|FG012|Overall Study|Adverse Event|0|||
130727919|NCT01449370|470625579|FG013|Overall Study|Adverse Event|2|||
130727920|NCT01449370|470625580|FG014|Overall Study|Adverse Event|0|||
130727921|NCT01449370|470625581|FG015|Overall Study|Adverse Event|1|||
130727922|NCT01449370|470625582|FG016|Overall Study|Adverse Event|0|||
130727923|NCT01449370|470625583|FG017|Overall Study|Adverse Event|0|||
130727924|NCT01449370|470625584|FG018|Overall Study|Adverse Event|1|||
130727925|NCT01449370|470625585|FG019|Overall Study|Adverse Event|1|||
130727926|NCT01449370|470625586|FG020|Overall Study|Adverse Event|0|||
130727927|NCT01449370|470625587|FG021|Overall Study|Adverse Event|1|||
130727928|NCT01449370|470625588|FG022|Overall Study|Adverse Event|0|||
130727929|NCT01449370|470625589|FG023|Overall Study|Adverse Event|1|||
130727930|NCT01449370|470625590|FG024|Overall Study|Adverse Event|3|||
130727931|NCT01449370|470625566|FG000|Overall Study|Participant Decision|0|||
130727932|NCT01449370|470625567|FG001|Overall Study|Participant Decision|0|||
130727933|NCT01449370|470625568|FG002|Overall Study|Participant Decision|0|||
130727934|NCT01449370|470625569|FG003|Overall Study|Participant Decision|0|||
130727935|NCT01449370|470625570|FG004|Overall Study|Participant Decision|0|||
130727936|NCT01449370|470625571|FG005|Overall Study|Participant Decision|0|||
130727937|NCT01449370|470625572|FG006|Overall Study|Participant Decision|0|||
130727938|NCT01449370|470625573|FG007|Overall Study|Participant Decision|1|||
130727939|NCT01449370|470625574|FG008|Overall Study|Participant Decision|1|||
130727940|NCT01449370|470625575|FG009|Overall Study|Participant Decision|0|||
130727941|NCT01449370|470625576|FG010|Overall Study|Participant Decision|0|||
130727942|NCT01449370|470625577|FG011|Overall Study|Participant Decision|0|||
130727943|NCT01449370|470625578|FG012|Overall Study|Participant Decision|1|||
130727944|NCT01449370|470625579|FG013|Overall Study|Participant Decision|1|||
130727945|NCT01449370|470625580|FG014|Overall Study|Participant Decision|0|||
130727946|NCT01449370|470625581|FG015|Overall Study|Participant Decision|1|||
130727947|NCT01449370|470625582|FG016|Overall Study|Participant Decision|3|||
130727948|NCT01449370|470625583|FG017|Overall Study|Participant Decision|0|||
130727949|NCT01449370|470625584|FG018|Overall Study|Participant Decision|1|||
130727950|NCT01449370|470625585|FG019|Overall Study|Participant Decision|0|||
130727951|NCT01449370|470625586|FG020|Overall Study|Participant Decision|0|||
130727952|NCT01449370|470625587|FG021|Overall Study|Participant Decision|1|||
130727953|NCT01449370|470625588|FG022|Overall Study|Participant Decision|0|||
130727954|NCT01449370|470625589|FG023|Overall Study|Participant Decision|0|||
130727955|NCT01449370|470625590|FG024|Overall Study|Participant Decision|1|||
130480509|NCT02268253|469728457|FG003|Stage 3A|Study Terminated by Sponsor|0|||
130480510|NCT02268253|469728458|FG004|Stage 3A|Study Terminated by Sponsor|0|||
130480511|NCT02268253|469728459|FG005|Stage 3A|Study Terminated by Sponsor|0|||
130480512|NCT02268253|469728460|FG006|Stage 3A|Study Terminated by Sponsor|0|||
130480513|NCT02268253|469728454|FG000|Stage 3A|Lost to Follow-up|0|||
130480514|NCT02268253|469728455|FG001|Stage 3A|Lost to Follow-up|0|||
130480515|NCT02268253|469728456|FG002|Stage 3A|Lost to Follow-up|1|||
130480516|NCT02268253|469728457|FG003|Stage 3A|Lost to Follow-up|0|||
130480517|NCT02268253|469728458|FG004|Stage 3A|Lost to Follow-up|0|||
130480518|NCT02268253|469728459|FG005|Stage 3A|Lost to Follow-up|0|||
130480519|NCT02268253|469728460|FG006|Stage 3A|Lost to Follow-up|0|||
130480520|NCT02268253|469728454|FG000|Stage 3A|Death|0|||
130480521|NCT02268253|469728455|FG001|Stage 3A|Death|0|||
130564926|NCT01251653|470035336|FG000|Overall Study|Dose-limiting toxicity|0|||
130564927|NCT01251653|470035337|FG001|Overall Study|Dose-limiting toxicity|1|||
130564928|NCT01251653|470035338|FG002|Overall Study|Dose-limiting toxicity|1|||
130564929|NCT01251653|470035339|FG003|Overall Study|Dose-limiting toxicity|1|||
130564930|NCT01251653|470035340|FG004|Overall Study|Dose-limiting toxicity|0|||
130480522|NCT02268253|469728456|FG002|Stage 3A|Death|5|||
130480523|NCT02268253|469728457|FG003|Stage 3A|Death|0|||
130480524|NCT02268253|469728458|FG004|Stage 3A|Death|0|||
130480525|NCT02268253|469728459|FG005|Stage 3A|Death|0|||
130564931|NCT01251653|470035341|FG005|Overall Study|Dose-limiting toxicity|0|||
130564932|NCT01251653|470035342|FG006|Overall Study|Dose-limiting toxicity|2|||
130564933|NCT01251653|470035343|FG007|Overall Study|Dose-limiting toxicity|0|||
130564934|NCT01251653|470035344|FG008|Overall Study|Dose-limiting toxicity|0|||
130564935|NCT01251653|470035336|FG000|Overall Study|Adverse Event|1|||
130564936|NCT01251653|470035337|FG001|Overall Study|Adverse Event|0|||
130564937|NCT01251653|470035338|FG002|Overall Study|Adverse Event|2|||
130564938|NCT01251653|470035339|FG003|Overall Study|Adverse Event|1|||
130564939|NCT01251653|470035340|FG004|Overall Study|Adverse Event|1|||
130564940|NCT01251653|470035341|FG005|Overall Study|Adverse Event|0|||
130564941|NCT01251653|470035342|FG006|Overall Study|Adverse Event|2|||
130564942|NCT01251653|470035343|FG007|Overall Study|Adverse Event|2|||
130564943|NCT01251653|470035344|FG008|Overall Study|Adverse Event|1|||
130564944|NCT01251653|470035336|FG000|Overall Study|Withdrawal by Subject|1|||
130564945|NCT01251653|470035337|FG001|Overall Study|Withdrawal by Subject|0|||
130564946|NCT01251653|470035338|FG002|Overall Study|Withdrawal by Subject|1|||
130564947|NCT01251653|470035339|FG003|Overall Study|Withdrawal by Subject|0|||
130564948|NCT01251653|470035340|FG004|Overall Study|Withdrawal by Subject|1|||
130564949|NCT01251653|470035341|FG005|Overall Study|Withdrawal by Subject|1|||
130564950|NCT01251653|470035342|FG006|Overall Study|Withdrawal by Subject|0|||
130564951|NCT01251653|470035343|FG007|Overall Study|Withdrawal by Subject|1|||
130564952|NCT01251653|470035344|FG008|Overall Study|Withdrawal by Subject|0|||
130564953|NCT01251653|470035336|FG000|Overall Study|Other reason not mentioned above|0|||
130564954|NCT01251653|470035337|FG001|Overall Study|Other reason not mentioned above|0|||
130564955|NCT01251653|470035338|FG002|Overall Study|Other reason not mentioned above|0|||
130564956|NCT01251653|470035339|FG003|Overall Study|Other reason not mentioned above|0|||
130564957|NCT01251653|470035340|FG004|Overall Study|Other reason not mentioned above|0|||
130564958|NCT01251653|470035341|FG005|Overall Study|Other reason not mentioned above|0|||
130564959|NCT01251653|470035342|FG006|Overall Study|Other reason not mentioned above|0|||
130564960|NCT01251653|470035343|FG007|Overall Study|Other reason not mentioned above|2|||
130480526|NCT02268253|469728460|FG006|Stage 3A|Death|0|||
130480527|NCT05672069|469728461|FG000|Overall Study|Implant removal|1|||
130480528|NCT05672069|469728461|FG000|Overall Study|Lost to Follow-up|2|||
130480529|NCT05949788|469728462|FG000|Overall Study|severe birth deformity|2|||
130480530|NCT05949788|469728463|FG001|Overall Study|severe birth deformity|7|||
130480531|NCT05949788|469728462|FG000|Overall Study|twin-twin transfusion syndrome|2|||
130480532|NCT05949788|469728463|FG001|Overall Study|twin-twin transfusion syndrome|7|||
130480533|NCT05949788|469728462|FG000|Overall Study|neonatal hemolytic disease|3|||
130480534|NCT05949788|469728463|FG001|Overall Study|neonatal hemolytic disease|8|||
130564961|NCT01251653|470035344|FG008|Overall Study|Other reason not mentioned above|0|||
130564962|NCT00847145|470035345|FG000|Overall Study|AE or Death|0|||
130564963|NCT00847145|470035346|FG001|Overall Study|AE or Death|1|||
130564964|NCT00847145|470035347|FG002|Overall Study|AE or Death|1|||
130564965|NCT00847145|470035348|FG003|Overall Study|AE or Death|0|||
130564966|NCT00847145|470035349|FG004|Overall Study|AE or Death|0|||
130564967|NCT00847145|470035350|FG005|Overall Study|AE or Death|0|||
130564968|NCT00847145|470035351|FG006|Overall Study|AE or Death|0|||
130727956|NCT01449370|470625566|FG000|Overall Study|Lost to Follow-up|0|||
130727957|NCT01449370|470625567|FG001|Overall Study|Lost to Follow-up|0|||
130480535|NCT05949788|469728462|FG000|Overall Study|death within 14 days after birth|2|||
130480536|NCT05949788|469728463|FG001|Overall Study|death within 14 days after birth|6|||
130480537|NCT05949788|469728462|FG000|Overall Study|transfer to another hospital|2|||
130480538|NCT05949788|469728463|FG001|Overall Study|transfer to another hospital|6|||
130480539|NCT01824537|469728464|FG000|Overall Study|Lost to Follow-up|78|||
130480540|NCT01824537|469728465|FG001|Overall Study|Lost to Follow-up|87|||
130480541|NCT05362487|469728466|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
130480542|NCT04096040|469728475|FG000|Overall Study|Protocol Violation|12|||
130480543|NCT04096040|469728475|FG000|Overall Study|Non-compliant site|4|||
130480544|NCT04973254|469728478|FG000|Overall Study|Not adherent|0|||
130480545|NCT04973254|469728479|FG001|Overall Study|Not adherent|1|||
130480546|NCT04973254|469728480|FG002|Overall Study|Not adherent|0|||
130480547|NCT05170009|469728481|FG000|Overall Study|Physician Decision|0|||
130480548|NCT05170009|469728482|FG001|Overall Study|Physician Decision|1|||
130480549|NCT03808818|469728487|FG000|Overall Study|Death|6|||
130480550|NCT03808818|469728488|FG001|Overall Study|Death|6|||
130480551|NCT03808818|469728487|FG000|Overall Study|Withdrawal by Subject|7|||
130480552|NCT03808818|469728488|FG001|Overall Study|Withdrawal by Subject|18|||
130480553|NCT03808818|469728487|FG000|Overall Study|Lost to Follow-up|31|||
130480554|NCT03808818|469728488|FG001|Overall Study|Lost to Follow-up|33|||
130480555|NCT05415722|469728490|FG000|Overall Study|Lost to Follow-up|0|||
130480556|NCT05415722|469728491|FG001|Overall Study|Lost to Follow-up|2|||
130480557|NCT05415722|469728492|FG002|Overall Study|Lost to Follow-up|0|||
130480558|NCT05415722|469728493|FG003|Overall Study|Lost to Follow-up|1|||
130480559|NCT05415722|469728494|FG004|Overall Study|Lost to Follow-up|0|||
130480560|NCT05415722|469728495|FG005|Overall Study|Lost to Follow-up|0|||
130480561|NCT05415722|469728496|FG006|Overall Study|Lost to Follow-up|1|||
130480562|NCT05415722|469728490|FG000|Overall Study|Physician Decision|0|||
130480563|NCT05415722|469728491|FG001|Overall Study|Physician Decision|0|||
130480564|NCT05415722|469728492|FG002|Overall Study|Physician Decision|0|||
130480565|NCT05415722|469728493|FG003|Overall Study|Physician Decision|1|||
130480566|NCT05415722|469728494|FG004|Overall Study|Physician Decision|0|||
130480567|NCT05415722|469728495|FG005|Overall Study|Physician Decision|0|||
130480568|NCT05415722|469728496|FG006|Overall Study|Physician Decision|1|||
130480569|NCT05415722|469728490|FG000|Overall Study|Protocol Violation|0|||
130480570|NCT05415722|469728491|FG001|Overall Study|Protocol Violation|0|||
130480571|NCT05415722|469728492|FG002|Overall Study|Protocol Violation|0|||
130480572|NCT05415722|469728493|FG003|Overall Study|Protocol Violation|1|||
130480573|NCT05415722|469728494|FG004|Overall Study|Protocol Violation|0|||
130480574|NCT05415722|469728495|FG005|Overall Study|Protocol Violation|0|||
130480575|NCT05415722|469728496|FG006|Overall Study|Protocol Violation|0|||
130480576|NCT05415722|469728490|FG000|Overall Study|Sponsor Discretion|0|||
130480577|NCT05415722|469728491|FG001|Overall Study|Sponsor Discretion|0|||
130480578|NCT05415722|469728492|FG002|Overall Study|Sponsor Discretion|0|||
130480579|NCT05415722|469728493|FG003|Overall Study|Sponsor Discretion|0|||
130480580|NCT05415722|469728494|FG004|Overall Study|Sponsor Discretion|1|||
130480581|NCT05415722|469728495|FG005|Overall Study|Sponsor Discretion|1|||
130480582|NCT05415722|469728496|FG006|Overall Study|Sponsor Discretion|0|||
130480583|NCT05415722|469728490|FG000|Overall Study|Withdrawal by Subject|0|||
130480584|NCT05415722|469728491|FG001|Overall Study|Withdrawal by Subject|1|||
130480585|NCT05415722|469728492|FG002|Overall Study|Withdrawal by Subject|0|||
130480586|NCT05415722|469728493|FG003|Overall Study|Withdrawal by Subject|1|||
130480587|NCT05415722|469728494|FG004|Overall Study|Withdrawal by Subject|1|||
130480588|NCT05415722|469728495|FG005|Overall Study|Withdrawal by Subject|0|||
130480589|NCT05415722|469728496|FG006|Overall Study|Withdrawal by Subject|1|||
130480590|NCT04629716|469728499|FG000|Overall Study|Lost to Follow-up|7|||
130480591|NCT04629716|469728500|FG001|Overall Study|Lost to Follow-up|3|||
130480592|NCT04537715|469728507|FG000|Overall Study|Death|3|||
130480593|NCT04537715|469728508|FG001|Overall Study|Death|1|||
130480594|NCT04537715|469728507|FG000|Overall Study|Withdrawal by Subject|3|||
130480595|NCT04537715|469728508|FG001|Overall Study|Withdrawal by Subject|1|||
130480596|NCT04537715|469728507|FG000|Overall Study|Other|4|||
130480597|NCT04537715|469728508|FG001|Overall Study|Other|3|||
130480598|NCT04537715|469728507|FG000|Overall Study|Progressive disease|1|||
130480599|NCT04537715|469728508|FG001|Overall Study|Progressive disease|0|||
130480600|NCT02191618|469728509|FG000|Overall Study|Withdrawal by Subject|3|||
130480601|NCT02191618|469728509|FG000|Overall Study|Missed Visit|4|||
130480602|NCT03031470|469728512|FG000|Overall Study|Adverse Event|3|||
130480603|NCT03031470|469728513|FG001|Overall Study|Adverse Event|0|||
130480604|NCT03031470|469728512|FG000|Overall Study|Death|3|||
130480605|NCT03031470|469728513|FG001|Overall Study|Death|1|||
130480606|NCT03031470|469728512|FG000|Overall Study|Lost to Follow-up|1|||
130480607|NCT03031470|469728513|FG001|Overall Study|Lost to Follow-up|1|||
130480608|NCT03031470|469728512|FG000|Overall Study|Withdrawal by Subject|1|||
130480609|NCT03031470|469728513|FG001|Overall Study|Withdrawal by Subject|0|||
130480610|NCT03031470|469728512|FG000|Overall Study|Protocol entry criteria not met|0|||
130480611|NCT03031470|469728513|FG001|Overall Study|Protocol entry criteria not met|1|||
130480612|NCT03031470|469728512|FG000|Overall Study|Cancel the operation|0|||
130480613|NCT03031470|469728513|FG001|Overall Study|Cancel the operation|1|||
130480614|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
130480615|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
130480616|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
130480617|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
130480618|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
130480619|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
130480620|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
130480621|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
130480622|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
130480623|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
130480624|NCT03461276|469728514|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
130480625|NCT03461276|469728515|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
130480626|NCT03461276|469728514|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
130480627|NCT03461276|469728515|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
130480628|NCT03461276|469728514|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
130480629|NCT03461276|469728515|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
130480630|NCT03461276|469728514|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
130480631|NCT03461276|469728515|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
130480632|NCT03461276|469728514|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
130480633|NCT03461276|469728515|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
130480634|NCT04623671|469728516|FG000|Overall Study|Adverse Event|0|||
130480635|NCT04623671|469728517|FG001|Overall Study|Adverse Event|1|||
130480636|NCT04623671|469728516|FG000|Overall Study|Lost to Follow-up|2|||
130480637|NCT04623671|469728517|FG001|Overall Study|Lost to Follow-up|1|||
130480638|NCT04623671|469728516|FG000|Overall Study|Death|5|||
130480639|NCT04623671|469728517|FG001|Overall Study|Death|5|||
130480640|NCT04542317|469728518|FG000|Overall Study|Care recipients passed away|18|||
130480641|NCT04542317|469728519|FG001|Overall Study|Care recipients passed away|13|||
130480642|NCT04542317|469728518|FG000|Overall Study|No longer a primary caregiver|5|||
130480643|NCT04542317|469728519|FG001|Overall Study|No longer a primary caregiver|1|||
130480644|NCT04542317|469728518|FG000|Overall Study|Withdrawal by Subject|4|||
130480645|NCT04542317|469728519|FG001|Overall Study|Withdrawal by Subject|2|||
130480646|NCT04542317|469728518|FG000|Overall Study|Caregivers passed away|0|||
130480647|NCT04542317|469728519|FG001|Overall Study|Caregivers passed away|2|||
130480648|NCT03848065|469728522|FG000|Overall Study|Death|0|||
130480649|NCT03848065|469728523|FG001|Overall Study|Death|1|||
130480650|NCT03848065|469728524|FG002|Overall Study|Death|0|||
130480651|NCT03848065|469728522|FG000|Overall Study|Lost to Follow-up|0|||
130480652|NCT03848065|469728523|FG001|Overall Study|Lost to Follow-up|0|||
130480653|NCT03848065|469728524|FG002|Overall Study|Lost to Follow-up|1|||
130480654|NCT03848065|469728522|FG000|Overall Study|Physician Decision|0|||
130480655|NCT03848065|469728523|FG001|Overall Study|Physician Decision|0|||
130480656|NCT03848065|469728524|FG002|Overall Study|Physician Decision|1|||
130480657|NCT03496168|469728531|FG000|Overall Study|Other Reasons|1|||
130480658|NCT03496168|469728531|FG000|Overall Study|Adverse Event|1|||
130480659|NCT03865498|469728532|FG000|Overall Study|Lack of Efficacy|12|||
130480660|NCT03865498|469728533|FG001|Overall Study|Lack of Efficacy|11|||
130480661|NCT03865498|469728532|FG000|Overall Study|Lost to Follow-up|125|||
130480662|NCT03865498|469728533|FG001|Overall Study|Lost to Follow-up|133|||
130480663|NCT03865498|469728532|FG000|Overall Study|Withdrawal by Subject|2|||
130480664|NCT03865498|469728533|FG001|Overall Study|Withdrawal by Subject|4|||
130480665|NCT05869383|469728536|FG000|Overall Study|Withdrawal by Subject|2|||
130480666|NCT05869383|469728537|FG001|Overall Study|Withdrawal by Subject|0|||
130480667|NCT03907878|469728542|FG000|Treatment Period|Withdrawal by Subject|5|||
130480668|NCT03907878|469728542|FG000|Treatment Period|Adverse Event|4|||
130480669|NCT03907878|469728542|FG000|Treatment Period|Lack of Efficacy|1|||
130480670|NCT03907878|469728542|FG000|Treatment Period|Protocol Violation|1|||
130480671|NCT03907878|469728542|FG000|Follow-up Period|Adverse Event|3|||
130480672|NCT03907878|469728542|FG000|Follow-up Period|Withdrawal by Subject|3|||
130480673|NCT05144009|469728543|FG000|Overall Study|Lost to Follow-up|0|||
130480674|NCT05144009|469728544|FG001|Overall Study|Lost to Follow-up|1|||
130727958|NCT01449370|470625568|FG002|Overall Study|Lost to Follow-up|0|||
130727959|NCT01449370|470625569|FG003|Overall Study|Lost to Follow-up|0|||
130727960|NCT01449370|470625570|FG004|Overall Study|Lost to Follow-up|0|||
130727961|NCT01449370|470625571|FG005|Overall Study|Lost to Follow-up|0|||
130727962|NCT01449370|470625572|FG006|Overall Study|Lost to Follow-up|0|||
130727963|NCT01449370|470625573|FG007|Overall Study|Lost to Follow-up|0|||
130480675|NCT05144009|469728543|FG000|Overall Study|Study Termination by the Sponsor|11|||
130480676|NCT05144009|469728544|FG001|Overall Study|Study Termination by the Sponsor|11|||
130480677|NCT05144009|469728543|FG000|Overall Study|Disease Progression|1|||
130480678|NCT05144009|469728544|FG001|Overall Study|Disease Progression|0|||
130480679|NCT05144009|469728543|FG000|Overall Study|Participant Decision|0|||
130480680|NCT05144009|469728544|FG001|Overall Study|Participant Decision|2|||
130480681|NCT05144009|469728543|FG000|Overall Study|Death|5|||
130480682|NCT05144009|469728544|FG001|Overall Study|Death|10|||
130480683|NCT03270501|469728545|FG000|Overall Study|Screen failure|6|||
130480684|NCT03270501|469728545|FG000|Overall Study|Lost to Follow-up|2|||
130480685|NCT03270501|469728545|FG000|Overall Study|Adverse Event|1|||
130480686|NCT04599062|469728550|FG000|Overall Study|Physician Decision|1|||
130480687|NCT04599062|469728551|FG001|Overall Study|Physician Decision|0|||
130480688|NCT04074759|469728553|FG000|Overall Study|Withdrawal by Subject|0|||
130480689|NCT04074759|469728554|FG001|Overall Study|Withdrawal by Subject|0|||
130480690|NCT04074759|469728555|FG002|Overall Study|Withdrawal by Subject|0|||
130480691|NCT04074759|469728556|FG003|Overall Study|Withdrawal by Subject|0|||
130480692|NCT04074759|469728557|FG004|Overall Study|Withdrawal by Subject|0|||
130480693|NCT04074759|469728558|FG005|Overall Study|Withdrawal by Subject|2|||
130480694|NCT04074759|469728559|FG006|Overall Study|Withdrawal by Subject|0|||
130480695|NCT04074759|469728560|FG007|Overall Study|Withdrawal by Subject|2|||
130480696|NCT04074759|469728561|FG008|Overall Study|Withdrawal by Subject|1|||
130480697|NCT04074759|469728562|FG009|Overall Study|Withdrawal by Subject|2|||
130480698|NCT04074759|469728563|FG010|Overall Study|Withdrawal by Subject|9|||
130480699|NCT04074759|469728564|FG011|Overall Study|Withdrawal by Subject|2|||
130480700|NCT04074759|469728565|FG012|Overall Study|Withdrawal by Subject|1|||
130480701|NCT04074759|469728566|FG013|Overall Study|Withdrawal by Subject|3|||
130480702|NCT04074759|469728567|FG014|Overall Study|Withdrawal by Subject|2|||
130480703|NCT04074759|469728568|FG015|Overall Study|Withdrawal by Subject|0|||
130480704|NCT04074759|469728569|FG016|Overall Study|Withdrawal by Subject|0|||
130480705|NCT04074759|469728570|FG017|Overall Study|Withdrawal by Subject|3|||
130727964|NCT01449370|470625574|FG008|Overall Study|Lost to Follow-up|0|||
130727965|NCT01449370|470625575|FG009|Overall Study|Lost to Follow-up|0|||
130727966|NCT01449370|470625576|FG010|Overall Study|Lost to Follow-up|0|||
130727967|NCT01449370|470625577|FG011|Overall Study|Lost to Follow-up|0|||
130727968|NCT01449370|470625578|FG012|Overall Study|Lost to Follow-up|0|||
130727969|NCT01449370|470625579|FG013|Overall Study|Lost to Follow-up|0|||
130727970|NCT01449370|470625580|FG014|Overall Study|Lost to Follow-up|0|||
130727971|NCT01449370|470625581|FG015|Overall Study|Lost to Follow-up|0|||
130727972|NCT01449370|470625582|FG016|Overall Study|Lost to Follow-up|0|||
130727973|NCT01449370|470625583|FG017|Overall Study|Lost to Follow-up|0|||
130727974|NCT01449370|470625584|FG018|Overall Study|Lost to Follow-up|0|||
130727975|NCT01449370|470625585|FG019|Overall Study|Lost to Follow-up|0|||
130727976|NCT01449370|470625586|FG020|Overall Study|Lost to Follow-up|1|||
130727977|NCT01449370|470625587|FG021|Overall Study|Lost to Follow-up|0|||
130727978|NCT01449370|470625588|FG022|Overall Study|Lost to Follow-up|0|||
130727979|NCT01449370|470625589|FG023|Overall Study|Lost to Follow-up|0|||
130480706|NCT04074759|469728571|FG018|Overall Study|Withdrawal by Subject|1|||
130480707|NCT04074759|469728553|FG000|Overall Study|Death|1|||
130480708|NCT04074759|469728554|FG001|Overall Study|Death|0|||
130480709|NCT04074759|469728555|FG002|Overall Study|Death|1|||
130480710|NCT04074759|469728556|FG003|Overall Study|Death|1|||
130480711|NCT04074759|469728557|FG004|Overall Study|Death|2|||
130480712|NCT04074759|469728558|FG005|Overall Study|Death|0|||
130480713|NCT04074759|469728559|FG006|Overall Study|Death|1|||
130480714|NCT04074759|469728560|FG007|Overall Study|Death|0|||
130480715|NCT04074759|469728561|FG008|Overall Study|Death|3|||
130480716|NCT04074759|469728562|FG009|Overall Study|Death|2|||
130480717|NCT04074759|469728563|FG010|Overall Study|Death|4|||
130480718|NCT04074759|469728564|FG011|Overall Study|Death|1|||
130480719|NCT04074759|469728565|FG012|Overall Study|Death|0|||
130480720|NCT04074759|469728566|FG013|Overall Study|Death|2|||
130480721|NCT04074759|469728567|FG014|Overall Study|Death|1|||
130480722|NCT04074759|469728568|FG015|Overall Study|Death|0|||
130480723|NCT04074759|469728569|FG016|Overall Study|Death|1|||
130480724|NCT04074759|469728570|FG017|Overall Study|Death|0|||
130480725|NCT04074759|469728571|FG018|Overall Study|Death|1|||
130480726|NCT04074759|469728553|FG000|Overall Study|Lost to Follow-up|0|||
130480727|NCT04074759|469728554|FG001|Overall Study|Lost to Follow-up|0|||
130480728|NCT04074759|469728555|FG002|Overall Study|Lost to Follow-up|0|||
130480729|NCT04074759|469728556|FG003|Overall Study|Lost to Follow-up|0|||
130480730|NCT04074759|469728557|FG004|Overall Study|Lost to Follow-up|0|||
130480731|NCT04074759|469728558|FG005|Overall Study|Lost to Follow-up|0|||
130480732|NCT04074759|469728559|FG006|Overall Study|Lost to Follow-up|0|||
130480733|NCT04074759|469728560|FG007|Overall Study|Lost to Follow-up|0|||
130480734|NCT04074759|469728561|FG008|Overall Study|Lost to Follow-up|0|||
130480735|NCT04074759|469728562|FG009|Overall Study|Lost to Follow-up|0|||
130480736|NCT04074759|469728563|FG010|Overall Study|Lost to Follow-up|1|||
130564969|NCT00847145|470035352|FG007|Overall Study|AE or Death|0|||
130727980|NCT01449370|470625590|FG024|Overall Study|Lost to Follow-up|0|||
130727981|NCT01449370|470625566|FG000|Overall Study|Other|0|||
130727982|NCT01449370|470625567|FG001|Overall Study|Other|0|||
130480737|NCT04074759|469728564|FG011|Overall Study|Lost to Follow-up|0|||
130480738|NCT04074759|469728565|FG012|Overall Study|Lost to Follow-up|0|||
130480739|NCT04074759|469728566|FG013|Overall Study|Lost to Follow-up|0|||
130564970|NCT00847145|470035345|FG000|Overall Study|Withdrawal by Subject|3|||
130727983|NCT01449370|470625568|FG002|Overall Study|Other|0|||
130727984|NCT01449370|470625569|FG003|Overall Study|Other|0|||
130727985|NCT01449370|470625570|FG004|Overall Study|Other|0|||
130727986|NCT01449370|470625571|FG005|Overall Study|Other|0|||
130727987|NCT01449370|470625572|FG006|Overall Study|Other|0|||
130480740|NCT04074759|469728567|FG014|Overall Study|Lost to Follow-up|0|||
130480741|NCT04074759|469728568|FG015|Overall Study|Lost to Follow-up|0|||
130480742|NCT04074759|469728569|FG016|Overall Study|Lost to Follow-up|1|||
130480743|NCT04074759|469728570|FG017|Overall Study|Lost to Follow-up|0|||
130480744|NCT04074759|469728571|FG018|Overall Study|Lost to Follow-up|1|||
130480745|NCT04074759|469728553|FG000|Overall Study|Other|0|||
130727988|NCT01449370|470625573|FG007|Overall Study|Other|0|||
130727989|NCT01449370|470625574|FG008|Overall Study|Other|1|||
130480746|NCT04074759|469728554|FG001|Overall Study|Other|1|||
130480747|NCT04074759|469728555|FG002|Overall Study|Other|1|||
130480748|NCT04074759|469728556|FG003|Overall Study|Other|0|||
130480749|NCT04074759|469728557|FG004|Overall Study|Other|2|||
130480750|NCT04074759|469728558|FG005|Overall Study|Other|1|||
130480751|NCT04074759|469728559|FG006|Overall Study|Other|2|||
130480752|NCT04074759|469728560|FG007|Overall Study|Other|1|||
130480753|NCT04074759|469728561|FG008|Overall Study|Other|1|||
130480754|NCT04074759|469728562|FG009|Overall Study|Other|4|||
130480755|NCT04074759|469728563|FG010|Overall Study|Other|4|||
130480756|NCT04074759|469728564|FG011|Overall Study|Other|2|||
130480757|NCT04074759|469728565|FG012|Overall Study|Other|0|||
130480758|NCT04074759|469728566|FG013|Overall Study|Other|0|||
130480759|NCT04074759|469728567|FG014|Overall Study|Other|0|||
130480760|NCT04074759|469728568|FG015|Overall Study|Other|1|||
130480761|NCT04074759|469728569|FG016|Overall Study|Other|0|||
130480762|NCT04074759|469728570|FG017|Overall Study|Other|0|||
130480763|NCT04074759|469728571|FG018|Overall Study|Other|0|||
130480764|NCT04074759|469728553|FG000|Overall Study|Missing end of study status|0|||
130480765|NCT04074759|469728554|FG001|Overall Study|Missing end of study status|0|||
130480766|NCT04074759|469728555|FG002|Overall Study|Missing end of study status|0|||
130480767|NCT04074759|469728556|FG003|Overall Study|Missing end of study status|0|||
130480768|NCT04074759|469728557|FG004|Overall Study|Missing end of study status|0|||
130480769|NCT04074759|469728558|FG005|Overall Study|Missing end of study status|0|||
130480770|NCT04074759|469728559|FG006|Overall Study|Missing end of study status|0|||
130480771|NCT04074759|469728560|FG007|Overall Study|Missing end of study status|0|||
130480772|NCT04074759|469728561|FG008|Overall Study|Missing end of study status|0|||
130480773|NCT04074759|469728562|FG009|Overall Study|Missing end of study status|0|||
130480774|NCT04074759|469728563|FG010|Overall Study|Missing end of study status|2|||
130480775|NCT04074759|469728564|FG011|Overall Study|Missing end of study status|0|||
130480776|NCT04074759|469728565|FG012|Overall Study|Missing end of study status|0|||
130480777|NCT04074759|469728566|FG013|Overall Study|Missing end of study status|0|||
130480778|NCT04074759|469728567|FG014|Overall Study|Missing end of study status|0|||
130480779|NCT04074759|469728568|FG015|Overall Study|Missing end of study status|0|||
130480780|NCT04074759|469728569|FG016|Overall Study|Missing end of study status|1|||
130480781|NCT04074759|469728570|FG017|Overall Study|Missing end of study status|0|||
130480782|NCT04074759|469728571|FG018|Overall Study|Missing end of study status|0|||
130480783|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
130480784|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
130480785|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
130480786|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
130480787|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
130480788|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
130480789|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
130480790|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
130480791|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
130480792|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
130480793|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
130480794|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
130480795|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
130480796|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
130480797|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
130480798|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
130480799|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
130480800|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
130480801|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
130480802|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
130480803|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
130480804|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
130480805|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
130480806|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
130480807|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
130480808|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
130480809|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
130480810|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
130480811|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
130480812|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
130480813|NCT03852472|469728578|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
130480814|NCT03852472|469728579|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
130480815|NCT03852472|469728580|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
130480816|NCT03852472|469728581|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
130480817|NCT03852472|469728582|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
130480818|NCT03852472|469728578|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
130480819|NCT03852472|469728579|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
130480820|NCT03852472|469728580|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
130480821|NCT03852472|469728581|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
130480822|NCT03852472|469728582|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
130480823|NCT03852472|469728578|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
130480824|NCT03852472|469728579|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
130727990|NCT01449370|470625575|FG009|Overall Study|Other|1|||
130727991|NCT01449370|470625576|FG010|Overall Study|Other|0|||
130727992|NCT01449370|470625577|FG011|Overall Study|Other|0|||
130727993|NCT01449370|470625578|FG012|Overall Study|Other|0|||
130727994|NCT01449370|470625579|FG013|Overall Study|Other|0|||
130727995|NCT01449370|470625580|FG014|Overall Study|Other|0|||
130727996|NCT01449370|470625581|FG015|Overall Study|Other|0|||
130480825|NCT03852472|469728580|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
130480826|NCT03852472|469728581|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
130480827|NCT03852472|469728582|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
130727997|NCT01449370|470625582|FG016|Overall Study|Other|0|||
130480828|NCT03852472|469728578|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
130480829|NCT03852472|469728579|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
130480830|NCT03852472|469728580|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
130480831|NCT03852472|469728581|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
130480832|NCT03852472|469728582|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
130480833|NCT03852472|469728578|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
130480834|NCT03852472|469728579|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
130480835|NCT03852472|469728580|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
130480836|NCT03852472|469728581|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
130480837|NCT03852472|469728582|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
130480838|NCT03852472|469728578|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
130480839|NCT03852472|469728579|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
130480840|NCT03852472|469728580|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
130480841|NCT03852472|469728581|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
130480842|NCT03852472|469728582|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
130480843|NCT03852472|469728578|FG000|Period 2 - Week 44|Adverse Event|0|||
130480844|NCT03852472|469728579|FG001|Period 2 - Week 44|Adverse Event|3|||
130480845|NCT03852472|469728580|FG002|Period 2 - Week 44|Adverse Event|1|||
130480846|NCT03852472|469728581|FG003|Period 2 - Week 44|Adverse Event|2|||
130480847|NCT03852472|469728582|FG004|Period 2 - Week 44|Adverse Event|2|||
130480848|NCT03852472|469728578|FG000|Period 2 - Week 44|COVID-19 Related|0|||
130480849|NCT03852472|469728579|FG001|Period 2 - Week 44|COVID-19 Related|0|||
130480850|NCT03852472|469728580|FG002|Period 2 - Week 44|COVID-19 Related|0|||
130480851|NCT03852472|469728581|FG003|Period 2 - Week 44|COVID-19 Related|1|||
130480852|NCT03852472|469728582|FG004|Period 2 - Week 44|COVID-19 Related|0|||
130480853|NCT03852472|469728578|FG000|Period 2 - Week 44|Reason not stated|0|||
130480854|NCT03852472|469728579|FG001|Period 2 - Week 44|Reason not stated|0|||
130480855|NCT03852472|469728580|FG002|Period 2 - Week 44|Reason not stated|0|||
130480856|NCT03852472|469728581|FG003|Period 2 - Week 44|Reason not stated|0|||
130480857|NCT03852472|469728582|FG004|Period 2 - Week 44|Reason not stated|1|||
130480858|NCT06457802|469728583|FG000|Overall Study|Early termination of study prior to participant completion|2|||
130480859|NCT06457802|469728584|FG001|Overall Study|Early termination of study prior to participant completion|2|||
130480860|NCT03161028|469728585|FG000|Overall Study|Withdrawal by Subject|6|||
130480861|NCT03161028|469728586|FG001|Overall Study|Withdrawal by Subject|4|||
130480862|NCT03161028|469728585|FG000|Overall Study|Adverse Event|5|||
130480863|NCT03161028|469728586|FG001|Overall Study|Adverse Event|1|||
130480864|NCT03161028|469728585|FG000|Overall Study|Study drug side effects|2|||
130480865|NCT03161028|469728586|FG001|Overall Study|Study drug side effects|2|||
130480866|NCT03161028|469728585|FG000|Overall Study|Administrative PD/UP|4|||
130480867|NCT03161028|469728586|FG001|Overall Study|Administrative PD/UP|2|||
130480868|NCT03161028|469728585|FG000|Overall Study|Lost to Follow-up|2|||
130480869|NCT03161028|469728586|FG001|Overall Study|Lost to Follow-up|0|||
130480870|NCT03161028|469728585|FG000|Overall Study|Unable to comply with procedures|1|||
130480871|NCT03161028|469728586|FG001|Overall Study|Unable to comply with procedures|1|||
130727998|NCT01449370|470625583|FG017|Overall Study|Other|0|||
130727999|NCT01449370|470625584|FG018|Overall Study|Other|0|||
130480872|NCT00736723|469728587|FG000|Overall Study|Withdrawal by Subject|4|||
130480873|NCT00736723|469728588|FG001|Overall Study|Withdrawal by Subject|3|||
130480874|NCT04797897|469728589|FG000|Overall Study|Study Termination by Sponsor|1|||
130480875|NCT04797897|469728590|FG001|Overall Study|Study Termination by Sponsor|1|||
130480876|NCT03024437|469728596|FG000|Overall Study|Adverse Event|0|||
130564971|NCT00847145|470035346|FG001|Overall Study|Withdrawal by Subject|4|||
130728000|NCT01449370|470625585|FG019|Overall Study|Other|0|||
130728001|NCT01449370|470625586|FG020|Overall Study|Other|0|||
130728002|NCT01449370|470625587|FG021|Overall Study|Other|0|||
130728003|NCT01449370|470625588|FG022|Overall Study|Other|1|||
130728004|NCT01449370|470625589|FG023|Overall Study|Other|1|||
130480877|NCT03024437|469728597|FG001|Overall Study|Adverse Event|1|||
130480878|NCT03024437|469728598|FG002|Overall Study|Adverse Event|3|||
130480879|NCT03024437|469728599|FG003|Overall Study|Adverse Event|5|||
130480880|NCT03024437|469728600|FG004|Overall Study|Adverse Event|0|||
130480881|NCT03024437|469728596|FG000|Overall Study|Physician Decision|1|||
130480882|NCT03024437|469728597|FG001|Overall Study|Physician Decision|0|||
130480883|NCT03024437|469728598|FG002|Overall Study|Physician Decision|0|||
130480884|NCT03024437|469728599|FG003|Overall Study|Physician Decision|1|||
130480885|NCT03024437|469728600|FG004|Overall Study|Physician Decision|0|||
130480886|NCT03024437|469728596|FG000|Overall Study|Disease progression, relapse|1|||
130480887|NCT03024437|469728597|FG001|Overall Study|Disease progression, relapse|0|||
130480888|NCT03024437|469728598|FG002|Overall Study|Disease progression, relapse|0|||
130480889|NCT03024437|469728599|FG003|Overall Study|Disease progression, relapse|3|||
130480890|NCT03024437|469728600|FG004|Overall Study|Disease progression, relapse|0|||
130480891|NCT03024437|469728596|FG000|Overall Study|Disease progression, refractory disease|4|||
130480892|NCT03024437|469728597|FG001|Overall Study|Disease progression, refractory disease|4|||
130480893|NCT03024437|469728598|FG002|Overall Study|Disease progression, refractory disease|2|||
130480894|NCT03024437|469728599|FG003|Overall Study|Disease progression, refractory disease|2|||
130480895|NCT03024437|469728600|FG004|Overall Study|Disease progression, refractory disease|1|||
130480896|NCT03024437|469728596|FG000|Overall Study|Newly diagnosed cancer|0|||
130480897|NCT03024437|469728597|FG001|Overall Study|Newly diagnosed cancer|0|||
130480898|NCT03024437|469728598|FG002|Overall Study|Newly diagnosed cancer|0|||
130480899|NCT03024437|469728599|FG003|Overall Study|Newly diagnosed cancer|1|||
130480900|NCT03024437|469728600|FG004|Overall Study|Newly diagnosed cancer|0|||
130480901|NCT03024437|469728596|FG000|Overall Study|Moved out of state|0|||
130480902|NCT03024437|469728597|FG001|Overall Study|Moved out of state|1|||
130480903|NCT03024437|469728598|FG002|Overall Study|Moved out of state|0|||
130480904|NCT03024437|469728599|FG003|Overall Study|Moved out of state|0|||
130480905|NCT03024437|469728600|FG004|Overall Study|Moved out of state|0|||
130480906|NCT03024437|469728596|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
130480907|NCT03024437|469728597|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
130480908|NCT03024437|469728598|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
130480909|NCT03024437|469728599|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
130480910|NCT03024437|469728600|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
130480911|NCT02601313|469728601|FG000|Overall Study|Death|2|||
130480912|NCT02601313|469728602|FG001|Overall Study|Death|41|||
130480913|NCT02601313|469728603|FG002|Overall Study|Death|6|||
130480914|NCT02601313|469728601|FG000|Overall Study|Enrolled but never treated|0|||
130480915|NCT02601313|469728602|FG001|Overall Study|Enrolled but never treated|6|||
130480916|NCT02601313|469728603|FG002|Overall Study|Enrolled but never treated|3|||
130480917|NCT02601313|469728601|FG000|Overall Study|Enrolled, did not initiate AC|4|||
130480918|NCT02601313|469728602|FG001|Overall Study|Enrolled, did not initiate AC|0|||
130480919|NCT02601313|469728603|FG002|Overall Study|Enrolled, did not initiate AC|0|||
130480920|NCT02601313|469728601|FG000|Overall Study|Full consent withdrawal|0|||
130480921|NCT02601313|469728602|FG001|Overall Study|Full consent withdrawal|3|||
130480922|NCT02601313|469728603|FG002|Overall Study|Full consent withdrawal|2|||
130480923|NCT02601313|469728601|FG000|Overall Study|Lost to Follow-up|0|||
130480924|NCT02601313|469728602|FG001|Overall Study|Lost to Follow-up|1|||
130480925|NCT02601313|469728603|FG002|Overall Study|Lost to Follow-up|1|||
130480928|NCT04828005|469728606|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
130480929|NCT04828005|469728607|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
130480930|NCT04828005|469728608|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
130480931|NCT04828005|469728609|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
130480932|NCT04828005|469728606|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
130480933|NCT04828005|469728607|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
130480934|NCT04828005|469728608|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
130480935|NCT04828005|469728609|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
130480936|NCT04828005|469728606|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
130480937|NCT04828005|469728607|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
130480938|NCT04828005|469728608|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
130480939|NCT04828005|469728609|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
130480940|NCT04828005|469728606|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
130480941|NCT04828005|469728607|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
130480942|NCT04828005|469728608|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
130480943|NCT04828005|469728609|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
130480944|NCT04828005|469728606|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
130480945|NCT04828005|469728607|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
130480946|NCT04828005|469728608|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
130564972|NCT00847145|470035347|FG002|Overall Study|Withdrawal by Subject|6|||
130564973|NCT00847145|470035348|FG003|Overall Study|Withdrawal by Subject|1|||
130728005|NCT01449370|470625590|FG024|Overall Study|Other|0|||
130728006|NCT01449370|470625566|FG000|Overall Study|Medication Prohibited by Protocol|0|||
130728007|NCT01449370|470625567|FG001|Overall Study|Medication Prohibited by Protocol|0|||
130480947|NCT04828005|469728609|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
130480948|NCT04828005|469728606|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
130480949|NCT04828005|469728607|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
130480950|NCT04828005|469728608|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
130480951|NCT04828005|469728609|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
130480952|NCT04828005|469728606|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
130480953|NCT04828005|469728607|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
130480954|NCT04828005|469728608|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
130480955|NCT04828005|469728609|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
130480956|NCT04828005|469728606|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
130480957|NCT04828005|469728607|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
130480958|NCT04828005|469728608|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
130480959|NCT04828005|469728609|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
130480960|NCT04828005|469728606|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
130480961|NCT04828005|469728607|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
130480962|NCT04828005|469728608|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
130480963|NCT04828005|469728609|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
130480964|NCT02975882|469730554|FG000|Overall Study|Adverse Event|1|||
130480965|NCT02975882|469730555|FG001|Overall Study|Adverse Event|2|||
130480966|NCT02975882|469730556|FG002|Overall Study|Adverse Event|1|||
130480967|NCT02975882|469730557|FG003|Overall Study|Adverse Event|1|||
130480968|NCT02975882|469730554|FG000|Overall Study|Death|0|||
130480969|NCT02975882|469730555|FG001|Overall Study|Death|1|||
130480970|NCT02975882|469730556|FG002|Overall Study|Death|0|||
130480971|NCT02975882|469730557|FG003|Overall Study|Death|0|||
130480972|NCT02975882|469730554|FG000|Overall Study|Lack of Efficacy|3|||
130480973|NCT02975882|469730555|FG001|Overall Study|Lack of Efficacy|7|||
130480974|NCT02975882|469730556|FG002|Overall Study|Lack of Efficacy|4|||
130480975|NCT02975882|469730557|FG003|Overall Study|Lack of Efficacy|3|||
130480976|NCT02975882|469730554|FG000|Overall Study|Physician Decision|0|||
130480977|NCT02975882|469730555|FG001|Overall Study|Physician Decision|2|||
130480978|NCT02975882|469730556|FG002|Overall Study|Physician Decision|4|||
130480979|NCT02975882|469730557|FG003|Overall Study|Physician Decision|2|||
130480980|NCT02975882|469730554|FG000|Overall Study|Ineligible|0|||
130480981|NCT02975882|469730555|FG001|Overall Study|Ineligible|1|||
130480982|NCT02975882|469730556|FG002|Overall Study|Ineligible|0|||
130480983|NCT02975882|469730557|FG003|Overall Study|Ineligible|0|||
130480984|NCT03867500|469730558|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
130480985|NCT04802967|469730565|FG000|Part B|Withdrawal by Subject|0|||
130480986|NCT04802967|469730566|FG001|Part B|Withdrawal by Subject|0|||
130480987|NCT04802967|469730567|FG002|Part B|Withdrawal by Subject|0|||
130480988|NCT04802967|469730568|FG003|Part B|Withdrawal by Subject|0|||
130480989|NCT04802967|469730569|FG004|Part B|Withdrawal by Subject|0|||
130480990|NCT04802967|469730570|FG005|Part B|Withdrawal by Subject|1|||
130480991|NCT04802967|469730571|FG006|Part B|Withdrawal by Subject|0|||
130480992|NCT04802967|469730572|FG007|Part B|Withdrawal by Subject|0|||
130480993|NCT04802967|469730573|FG008|Part B|Withdrawal by Subject|0|||
130480994|NCT04802967|469730574|FG009|Part B|Withdrawal by Subject|0|||
130480995|NCT03524118|469730579|FG000|Overall Study|Lost to Follow-up|0|||
130480996|NCT03524118|469730580|FG001|Overall Study|Lost to Follow-up|0|||
130480997|NCT03524118|469730581|FG002|Overall Study|Lost to Follow-up|0|||
130480998|NCT03524118|469730582|FG003|Overall Study|Lost to Follow-up|0|||
130480999|NCT03524118|469730583|FG004|Overall Study|Lost to Follow-up|1|||
130481000|NCT03524118|469730584|FG005|Overall Study|Lost to Follow-up|0|||
130481001|NCT03524118|469730579|FG000|Overall Study|Other|0|||
130481002|NCT03524118|469730580|FG001|Overall Study|Other|1|||
130481003|NCT03524118|469730581|FG002|Overall Study|Other|0|||
130481004|NCT03524118|469730582|FG003|Overall Study|Other|0|||
130728008|NCT01449370|470625568|FG002|Overall Study|Medication Prohibited by Protocol|0|||
130728009|NCT01449370|470625569|FG003|Overall Study|Medication Prohibited by Protocol|0|||
130728010|NCT01449370|470625570|FG004|Overall Study|Medication Prohibited by Protocol|0|||
130728011|NCT01449370|470625571|FG005|Overall Study|Medication Prohibited by Protocol|0|||
130728012|NCT01449370|470625572|FG006|Overall Study|Medication Prohibited by Protocol|0|||
130728013|NCT01449370|470625573|FG007|Overall Study|Medication Prohibited by Protocol|0|||
130481005|NCT03524118|469730583|FG004|Overall Study|Other|1|||
130481006|NCT03524118|469730584|FG005|Overall Study|Other|1|||
130481007|NCT03524118|469730579|FG000|Overall Study|Physician Decision|0|||
130481008|NCT03524118|469730580|FG001|Overall Study|Physician Decision|0|||
130481009|NCT03524118|469730581|FG002|Overall Study|Physician Decision|0|||
130481010|NCT03524118|469730582|FG003|Overall Study|Physician Decision|0|||
130481011|NCT03524118|469730583|FG004|Overall Study|Physician Decision|1|||
130481012|NCT03524118|469730584|FG005|Overall Study|Physician Decision|0|||
130481013|NCT03524118|469730579|FG000|Overall Study|Protocol Violation|0|||
130481014|NCT03524118|469730580|FG001|Overall Study|Protocol Violation|0|||
130481015|NCT03524118|469730581|FG002|Overall Study|Protocol Violation|1|||
130481016|NCT03524118|469730582|FG003|Overall Study|Protocol Violation|0|||
130481017|NCT03524118|469730583|FG004|Overall Study|Protocol Violation|1|||
130481018|NCT03524118|469730584|FG005|Overall Study|Protocol Violation|0|||
130481019|NCT03524118|469730579|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130481020|NCT03524118|469730580|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130481021|NCT03524118|469730581|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130481022|NCT03524118|469730582|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
130481023|NCT03524118|469730583|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
130481024|NCT03524118|469730584|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130481025|NCT01824875|469730585|FG000|Overall Study|Disease progression|22|||
130481026|NCT01824875|469730586|FG001|Overall Study|Disease progression|15|||
130481027|NCT01824875|469730585|FG000|Overall Study|Withdrawal by Subject|5|||
130481028|NCT01824875|469730586|FG001|Overall Study|Withdrawal by Subject|4|||
130481029|NCT01824875|469730585|FG000|Overall Study|Adverse Event|4|||
130481030|NCT01824875|469730586|FG001|Overall Study|Adverse Event|10|||
130481031|NCT01824875|469730585|FG000|Overall Study|Alternative therapy|3|||
130481032|NCT01824875|469730586|FG001|Overall Study|Alternative therapy|0|||
130481033|NCT01824875|469730585|FG000|Overall Study|Complicating disease|1|||
130481034|NCT01824875|469730586|FG001|Overall Study|Complicating disease|0|||
130481035|NCT01824875|469730585|FG000|Overall Study|Physician Decision|0|||
130481036|NCT01824875|469730586|FG001|Overall Study|Physician Decision|1|||
130481037|NCT01824875|469730585|FG000|Overall Study|Non-compliance|1|||
130481038|NCT01824875|469730586|FG001|Overall Study|Non-compliance|1|||
130481039|NCT01824875|469730585|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
130481040|NCT01824875|469730586|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
130481041|NCT01824875|469730585|FG000|Overall Study|Administrative issues|0|||
130481042|NCT01824875|469730586|FG001|Overall Study|Administrative issues|2|||
130481043|NCT01824875|469730585|FG000|Overall Study|Ineligible or never started treatment|9|||
130481044|NCT01824875|469730586|FG001|Overall Study|Ineligible or never started treatment|5|||
130481045|NCT01824875|469730585|FG000|Overall Study|Other|0|||
130481046|NCT01824875|469730586|FG001|Overall Study|Other|2|||
130481047|NCT01098812|469730589|FG000|Overall Study|Death|2|||
130481048|NCT01098812|469730590|FG001|Overall Study|Death|0|||
130728014|NCT01449370|470625574|FG008|Overall Study|Medication Prohibited by Protocol|0|||
130481049|NCT01098812|469730591|FG002|Overall Study|Death|1|||
130481050|NCT01098812|469730589|FG000|Overall Study|Lost to Follow-up|0|||
130481051|NCT01098812|469730590|FG001|Overall Study|Lost to Follow-up|1|||
130481052|NCT01098812|469730591|FG002|Overall Study|Lost to Follow-up|0|||
130481053|NCT01129102|469730592|FG000|Overall Study|No study drug treatment|2|||
130481054|NCT01129102|469730593|FG001|Overall Study|No study drug treatment|3|||
130481055|NCT01129102|469730594|FG002|Overall Study|No study drug treatment|1|||
130481056|NCT01129102|469730592|FG000|Overall Study|Withdrawal by Subject|2|||
130481057|NCT01129102|469730593|FG001|Overall Study|Withdrawal by Subject|0|||
130481058|NCT01129102|469730594|FG002|Overall Study|Withdrawal by Subject|3|||
130481059|NCT01129102|469730592|FG000|Overall Study|Protocol Violation|0|||
130481060|NCT01129102|469730593|FG001|Overall Study|Protocol Violation|1|||
130481061|NCT01129102|469730594|FG002|Overall Study|Protocol Violation|1|||
130481062|NCT01129102|469730592|FG000|Overall Study|Pregnancy|0|||
130481063|NCT01129102|469730593|FG001|Overall Study|Pregnancy|0|||
130481064|NCT01129102|469730594|FG002|Overall Study|Pregnancy|1|||
130481065|NCT01129102|469730592|FG000|Overall Study|Adverse Event|2|||
130481066|NCT01129102|469730593|FG001|Overall Study|Adverse Event|2|||
130481067|NCT01129102|469730594|FG002|Overall Study|Adverse Event|1|||
130481068|NCT01129102|469730592|FG000|Overall Study|Lost to Follow-up|2|||
130481069|NCT01129102|469730593|FG001|Overall Study|Lost to Follow-up|0|||
130481070|NCT01129102|469730594|FG002|Overall Study|Lost to Follow-up|0|||
130481071|NCT03379675|469730597|FG000|Overall Study|Lost to Follow-up|0|||
130481072|NCT03379675|469730598|FG001|Overall Study|Lost to Follow-up|1|||
130481073|NCT03379675|469730599|FG002|Overall Study|Lost to Follow-up|0|||
130481074|NCT03379675|469730597|FG000|Overall Study|Adverse Event|2|||
130564974|NCT00847145|470035349|FG004|Overall Study|Withdrawal by Subject|0|||
130728015|NCT01449370|470625575|FG009|Overall Study|Medication Prohibited by Protocol|0|||
130728016|NCT01449370|470625576|FG010|Overall Study|Medication Prohibited by Protocol|0|||
130481075|NCT03379675|469730598|FG001|Overall Study|Adverse Event|0|||
130481076|NCT03379675|469730599|FG002|Overall Study|Adverse Event|0|||
130481077|NCT03379675|469730597|FG000|Overall Study|Withdrawal by Subject|2|||
130481078|NCT03379675|469730598|FG001|Overall Study|Withdrawal by Subject|1|||
130481079|NCT03379675|469730599|FG002|Overall Study|Withdrawal by Subject|2|||
130481080|NCT02817776|469730601|FG000|Overall Study|Excluded|33|||
130481081|NCT02817776|469730601|FG000|Overall Study|Lost to Follow-up|20|||
130481082|NCT02817776|469730601|FG000|Overall Study|Withdrawal by Subject|33|||
130481083|NCT02817776|469730601|FG000|Overall Study|Death|2|||
130481084|NCT02598388|469730602|FG000|Overall Study|Lost to Follow-up|1|||
130481085|NCT02598388|469730603|FG001|Overall Study|Lost to Follow-up|0|||
130481086|NCT02598388|469730604|FG002|Overall Study|Lost to Follow-up|1|||
130481087|NCT02598388|469730605|FG003|Overall Study|Lost to Follow-up|0|||
130481088|NCT02598388|469730606|FG004|Overall Study|Lost to Follow-up|5|||
130481089|NCT02598388|469730607|FG005|Overall Study|Lost to Follow-up|1|||
130481090|NCT02598388|469730608|FG006|Overall Study|Lost to Follow-up|2|||
130481091|NCT02598388|469730609|FG007|Overall Study|Lost to Follow-up|1|||
130481092|NCT02598388|469730610|FG008|Overall Study|Lost to Follow-up|0|||
130481093|NCT02598388|469730611|FG009|Overall Study|Lost to Follow-up|0|||
130481094|NCT02598388|469730612|FG010|Overall Study|Lost to Follow-up|1|||
130481095|NCT02598388|469730613|FG011|Overall Study|Lost to Follow-up|0|||
130481096|NCT02598388|469730602|FG000|Overall Study|Withdrawal by Subject|0|||
130481097|NCT02598388|469730603|FG001|Overall Study|Withdrawal by Subject|0|||
130481098|NCT02598388|469730604|FG002|Overall Study|Withdrawal by Subject|0|||
130481099|NCT02598388|469730605|FG003|Overall Study|Withdrawal by Subject|0|||
130481100|NCT02598388|469730606|FG004|Overall Study|Withdrawal by Subject|2|||
130481101|NCT02598388|469730607|FG005|Overall Study|Withdrawal by Subject|0|||
130481102|NCT02598388|469730608|FG006|Overall Study|Withdrawal by Subject|2|||
130481103|NCT02598388|469730609|FG007|Overall Study|Withdrawal by Subject|0|||
130481104|NCT02598388|469730610|FG008|Overall Study|Withdrawal by Subject|0|||
130481105|NCT02598388|469730611|FG009|Overall Study|Withdrawal by Subject|1|||
130481106|NCT02598388|469730612|FG010|Overall Study|Withdrawal by Subject|0|||
130481107|NCT02598388|469730613|FG011|Overall Study|Withdrawal by Subject|0|||
130481108|NCT02598388|469730602|FG000|Overall Study|Other|0|||
130481109|NCT02598388|469730603|FG001|Overall Study|Other|0|||
130481110|NCT02598388|469730604|FG002|Overall Study|Other|1|||
130481111|NCT02598388|469730605|FG003|Overall Study|Other|0|||
130481112|NCT02598388|469730606|FG004|Overall Study|Other|3|||
130481113|NCT02598388|469730607|FG005|Overall Study|Other|0|||
130481114|NCT02598388|469730608|FG006|Overall Study|Other|1|||
130481115|NCT02598388|469730609|FG007|Overall Study|Other|0|||
130481116|NCT02598388|469730610|FG008|Overall Study|Other|0|||
130481117|NCT02598388|469730611|FG009|Overall Study|Other|0|||
130481118|NCT02598388|469730612|FG010|Overall Study|Other|0|||
130481119|NCT02598388|469730613|FG011|Overall Study|Other|0|||
130481120|NCT02979327|469730614|FG000|First Intervention|Protocol Violation|1|||
130481121|NCT02979327|469730615|FG001|First Intervention|Protocol Violation|0|||
130481122|NCT03474679|469730624|FG000|Overall Study|Death|7|||
130481123|NCT03474679|469730624|FG000|Overall Study|Withdrawal by Subject|1|||
130481124|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
130481125|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
130481126|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
130481127|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
130481128|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
130481129|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
130481130|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Death|6|||
130481131|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Death|0|||
130481132|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Death|0|||
130481133|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
130481134|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
130481135|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
130481136|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
130481137|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
130481138|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
130481139|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
130481140|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
130481141|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
130481142|NCT01539083|469730627|FG000|Before Randomization (VCD Induction)|Other|5|||
130481143|NCT01539083|469730628|FG001|Before Randomization (VCD Induction)|Other|0|||
130481144|NCT01539083|469730629|FG002|Before Randomization (VCD Induction)|Other|0|||
130481145|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
130481146|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
130481147|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
130481148|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Other|0|||
130481149|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Other|1|||
130481150|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Other|1|||
130481151|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
130481152|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
130481153|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
130481154|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
130481155|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
130481156|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
130481157|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
130481158|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
130481159|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
130481160|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
130481161|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
130481162|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
130481163|NCT01539083|469730627|FG000|After Randomization (TP and VTP)|Death|0|||
130481164|NCT01539083|469730628|FG001|After Randomization (TP and VTP)|Death|6|||
130481165|NCT01539083|469730629|FG002|After Randomization (TP and VTP)|Death|11|||
130481166|NCT02573493|469730638|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
130481167|NCT02573493|469730639|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
130481168|NCT02573493|469730640|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
130481169|NCT02573493|469730641|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
130481170|NCT04149704|469730642|FG000|Three Month Follow-up|Death|2|||
130481171|NCT04149704|469730643|FG001|Three Month Follow-up|Death|0|||
130481172|NCT04149704|469730644|FG002|Three Month Follow-up|Death|0|||
130481173|NCT04149704|469730645|FG003|Three Month Follow-up|Death|0|||
130481174|NCT04149704|469730642|FG000|Three Month Follow-up|Lost to Follow-up|1|||
130481175|NCT04149704|469730643|FG001|Three Month Follow-up|Lost to Follow-up|4|||
130481176|NCT04149704|469730644|FG002|Three Month Follow-up|Lost to Follow-up|5|||
130481177|NCT04149704|469730645|FG003|Three Month Follow-up|Lost to Follow-up|5|||
130481178|NCT04149704|469730642|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
130481179|NCT04149704|469730643|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
130481180|NCT04149704|469730644|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
130481181|NCT04149704|469730645|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
130481182|NCT04149704|469730642|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
130481183|NCT04149704|469730643|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
130481184|NCT04149704|469730644|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
130481185|NCT04149704|469730645|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
130481186|NCT04332926|469730646|FG000|Overall Study|Withdrawal by Subject|6|||
130481187|NCT04332926|469730646|FG000|Overall Study|Physician Decision|6|||
130481188|NCT05213390|469730654|FG000|Overall Study|Withdrawal by Subject|2|||
130481189|NCT05213390|469730654|FG000|Overall Study|Lost to Follow-up|12|||
130481190|NCT05213390|469730654|FG000|Overall Study|Protocol Violation|9|||
130481191|NCT04663737|469730658|FG000|Overall Study|Withdrawal by Subject|2|||
130481192|NCT04663737|469730659|FG001|Overall Study|Withdrawal by Subject|0|||
130481193|NCT01943409|469730663|FG000|Overall Study|resumed oral/entral|24|||
130481194|NCT01943409|469730664|FG001|Overall Study|resumed oral/entral|20|||
130481195|NCT01943409|469730663|FG000|Overall Study|Protocol Violation|14|||
130481196|NCT01943409|469730664|FG001|Overall Study|Protocol Violation|24|||
130481197|NCT01943409|469730663|FG000|Overall Study|Death|3|||
130481198|NCT01943409|469730664|FG001|Overall Study|Death|1|||
130481199|NCT01943409|469730663|FG000|Overall Study|Withdrawal by Subject|4|||
130481200|NCT01943409|469730664|FG001|Overall Study|Withdrawal by Subject|3|||
130481201|NCT02310646|469730665|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
130481202|NCT02310646|469730666|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
130481203|NCT02310646|469730665|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
130481204|NCT02310646|469730666|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
130481205|NCT04700163|469730667|FG000|Overall Study|Lost to Follow-up|0|||
130481206|NCT04700163|469730668|FG001|Overall Study|Lost to Follow-up|0|||
130481207|NCT04700163|469730669|FG002|Overall Study|Lost to Follow-up|0|||
130481208|NCT04700163|469730670|FG003|Overall Study|Lost to Follow-up|0|||
130481209|NCT04700163|469730671|FG004|Overall Study|Lost to Follow-up|0|||
130481210|NCT04700163|469730672|FG005|Overall Study|Lost to Follow-up|1|||
130481211|NCT04137367|469730673|FG000|Overall Study|Lost to Follow-up|8|||
130481212|NCT04137367|469730674|FG001|Overall Study|Lost to Follow-up|6|||
130481213|NCT04137367|469730675|FG002|Overall Study|Lost to Follow-up|4|||
130481214|NCT04499924|469730676|FG000|Overall Study|Study termination by sponsor|4|||
130481215|NCT04499924|469730677|FG001|Overall Study|Study termination by sponsor|6|||
130481216|NCT04499924|469730676|FG000|Overall Study|Withdrawal by Subject|1|||
130481217|NCT04499924|469730677|FG001|Overall Study|Withdrawal by Subject|3|||
130481218|NCT01648023|469730682|FG000|Overall Study|Screen Fail Post Randomization|1|||
130481219|NCT01648023|469730683|FG001|Overall Study|Screen Fail Post Randomization|2|||
130481220|NCT02231164|469730688|FG000|Overall Study|Adverse Event|1|||
130481221|NCT02231164|469730689|FG001|Overall Study|Adverse Event|1|||
130481222|NCT02231164|469730688|FG000|Overall Study|Lack of Efficacy|4|||
130564975|NCT00847145|470035350|FG005|Overall Study|Withdrawal by Subject|0|||
130481223|NCT02231164|469730689|FG001|Overall Study|Lack of Efficacy|3|||
130481224|NCT02231164|469730688|FG000|Overall Study|Withdrawal by Subject|1|||
130481225|NCT02231164|469730689|FG001|Overall Study|Withdrawal by Subject|2|||
130481226|NCT02547363|469730690|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
130481227|NCT02547363|469730691|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
130481228|NCT02547363|469730690|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
130481229|NCT02547363|469730691|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
130481230|NCT02547363|469730690|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
130564976|NCT00847145|470035351|FG006|Overall Study|Withdrawal by Subject|1|||
130481231|NCT02547363|469730691|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
130481232|NCT02547363|469730690|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
130481233|NCT02547363|469730691|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
130481234|NCT02547363|469730690|FG000|12-month Follow-up|Withdrawal by Subject|4|||
130481235|NCT02547363|469730691|FG001|12-month Follow-up|Withdrawal by Subject|3|||
130481236|NCT02547363|469730690|FG000|12-month Follow-up|Lost to Follow-up|4|||
130481237|NCT02547363|469730691|FG001|12-month Follow-up|Lost to Follow-up|1|||
130481238|NCT02547363|469730690|FG000|12-month Follow-up|Lack of Efficacy|1|||
130481239|NCT02547363|469730691|FG001|12-month Follow-up|Lack of Efficacy|1|||
130481240|NCT02547363|469730690|FG000|12-month Follow-up|Other|1|||
130481241|NCT02547363|469730691|FG001|12-month Follow-up|Other|0|||
130481242|NCT05281562|469730694|FG000|Overall Study|Ineligible patient|1|||
130481243|NCT05281562|469730695|FG001|Overall Study|Ineligible patient|0|||
130481244|NCT04436276|469730696|FG000|Overall Study|Adverse Event|0|||
130481245|NCT04436276|469730697|FG001|Overall Study|Adverse Event|0|||
130481246|NCT04436276|469730698|FG002|Overall Study|Adverse Event|0|||
130481247|NCT04436276|469730699|FG003|Overall Study|Adverse Event|0|||
130481248|NCT04436276|469730700|FG004|Overall Study|Adverse Event|0|||
130481249|NCT04436276|469730701|FG005|Overall Study|Adverse Event|0|||
130481250|NCT04436276|469730702|FG006|Overall Study|Adverse Event|0|||
130481251|NCT04436276|469730703|FG007|Overall Study|Adverse Event|0|||
130481252|NCT04436276|469730704|FG008|Overall Study|Adverse Event|0|||
130481253|NCT04436276|469730705|FG009|Overall Study|Adverse Event|0|||
130481254|NCT04436276|469730706|FG010|Overall Study|Adverse Event|0|||
130481255|NCT04436276|469730707|FG011|Overall Study|Adverse Event|0|||
130481256|NCT04436276|469730708|FG012|Overall Study|Adverse Event|0|||
130481257|NCT04436276|469730709|FG013|Overall Study|Adverse Event|0|||
130481258|NCT04436276|469730710|FG014|Overall Study|Adverse Event|0|||
130481259|NCT04436276|469730711|FG015|Overall Study|Adverse Event|0|||
130481260|NCT04436276|469730712|FG016|Overall Study|Adverse Event|1|||
130481261|NCT04436276|469730713|FG017|Overall Study|Adverse Event|0|||
130481262|NCT04436276|469730714|FG018|Overall Study|Adverse Event|0|||
130481263|NCT04436276|469730715|FG019|Overall Study|Adverse Event|0|||
130481264|NCT04436276|469730716|FG020|Overall Study|Adverse Event|0|||
130481265|NCT04436276|469730717|FG021|Overall Study|Adverse Event|0|||
130481266|NCT04436276|469730718|FG022|Overall Study|Adverse Event|0|||
130481267|NCT04436276|469730696|FG000|Overall Study|Death|0|||
130481268|NCT04436276|469730697|FG001|Overall Study|Death|0|||
130481269|NCT04436276|469730698|FG002|Overall Study|Death|0|||
130481270|NCT04436276|469730699|FG003|Overall Study|Death|0|||
130481271|NCT04436276|469730700|FG004|Overall Study|Death|0|||
130481272|NCT04436276|469730701|FG005|Overall Study|Death|0|||
130481273|NCT04436276|469730702|FG006|Overall Study|Death|0|||
130481274|NCT04436276|469730703|FG007|Overall Study|Death|0|||
130481275|NCT04436276|469730704|FG008|Overall Study|Death|0|||
130481276|NCT04436276|469730705|FG009|Overall Study|Death|0|||
130481277|NCT04436276|469730706|FG010|Overall Study|Death|0|||
130481278|NCT04436276|469730707|FG011|Overall Study|Death|0|||
130481279|NCT04436276|469730708|FG012|Overall Study|Death|1|||
130481280|NCT04436276|469730709|FG013|Overall Study|Death|0|||
130481281|NCT04436276|469730710|FG014|Overall Study|Death|1|||
130481282|NCT04436276|469730711|FG015|Overall Study|Death|0|||
130481283|NCT04436276|469730712|FG016|Overall Study|Death|0|||
130481284|NCT04436276|469730713|FG017|Overall Study|Death|0|||
130481285|NCT04436276|469730714|FG018|Overall Study|Death|0|||
130481286|NCT04436276|469730715|FG019|Overall Study|Death|2|||
130481287|NCT04436276|469730716|FG020|Overall Study|Death|0|||
130481288|NCT04436276|469730717|FG021|Overall Study|Death|1|||
130481289|NCT04436276|469730718|FG022|Overall Study|Death|0|||
130481290|NCT04436276|469730696|FG000|Overall Study|Lost to Follow-up|0|||
130481291|NCT04436276|469730697|FG001|Overall Study|Lost to Follow-up|2|||
130481292|NCT04436276|469730698|FG002|Overall Study|Lost to Follow-up|2|||
130481293|NCT04436276|469730699|FG003|Overall Study|Lost to Follow-up|1|||
130481294|NCT04436276|469730700|FG004|Overall Study|Lost to Follow-up|4|||
130481295|NCT04436276|469730701|FG005|Overall Study|Lost to Follow-up|1|||
130481296|NCT04436276|469730702|FG006|Overall Study|Lost to Follow-up|0|||
130564977|NCT00847145|470035352|FG007|Overall Study|Withdrawal by Subject|1|||
130564978|NCT00847145|470035345|FG000|Overall Study|Lost to Follow-up|3|||
130481297|NCT04436276|469730703|FG007|Overall Study|Lost to Follow-up|0|||
130481298|NCT04436276|469730704|FG008|Overall Study|Lost to Follow-up|1|||
130481299|NCT04436276|469730705|FG009|Overall Study|Lost to Follow-up|0|||
130481300|NCT04436276|469730706|FG010|Overall Study|Lost to Follow-up|5|||
130481301|NCT04436276|469730707|FG011|Overall Study|Lost to Follow-up|5|||
130481302|NCT04436276|469730708|FG012|Overall Study|Lost to Follow-up|4|||
130481303|NCT04436276|469730709|FG013|Overall Study|Lost to Follow-up|1|||
130481304|NCT04436276|469730710|FG014|Overall Study|Lost to Follow-up|7|||
130481305|NCT04436276|469730711|FG015|Overall Study|Lost to Follow-up|7|||
130481306|NCT04436276|469730712|FG016|Overall Study|Lost to Follow-up|1|||
130481307|NCT04436276|469730713|FG017|Overall Study|Lost to Follow-up|0|||
130481308|NCT04436276|469730714|FG018|Overall Study|Lost to Follow-up|1|||
130481309|NCT04436276|469730715|FG019|Overall Study|Lost to Follow-up|1|||
130481310|NCT04436276|469730716|FG020|Overall Study|Lost to Follow-up|2|||
130481311|NCT04436276|469730717|FG021|Overall Study|Lost to Follow-up|1|||
130481312|NCT04436276|469730718|FG022|Overall Study|Lost to Follow-up|1|||
130481313|NCT04436276|469730696|FG000|Overall Study|Physician Decision|1|||
130481314|NCT04436276|469730697|FG001|Overall Study|Physician Decision|0|||
130481315|NCT04436276|469730698|FG002|Overall Study|Physician Decision|2|||
130481316|NCT04436276|469730699|FG003|Overall Study|Physician Decision|1|||
130481317|NCT04436276|469730700|FG004|Overall Study|Physician Decision|0|||
130481318|NCT04436276|469730701|FG005|Overall Study|Physician Decision|0|||
130481319|NCT04436276|469730702|FG006|Overall Study|Physician Decision|0|||
130481320|NCT04436276|469730703|FG007|Overall Study|Physician Decision|0|||
130481321|NCT04436276|469730704|FG008|Overall Study|Physician Decision|0|||
130481322|NCT04436276|469730705|FG009|Overall Study|Physician Decision|0|||
130481323|NCT04436276|469730706|FG010|Overall Study|Physician Decision|0|||
130481324|NCT04436276|469730707|FG011|Overall Study|Physician Decision|1|||
130481325|NCT04436276|469730708|FG012|Overall Study|Physician Decision|2|||
130481326|NCT04436276|469730709|FG013|Overall Study|Physician Decision|0|||
130481327|NCT04436276|469730710|FG014|Overall Study|Physician Decision|0|||
130481328|NCT04436276|469730711|FG015|Overall Study|Physician Decision|0|||
130481329|NCT04436276|469730712|FG016|Overall Study|Physician Decision|0|||
130481330|NCT04436276|469730713|FG017|Overall Study|Physician Decision|0|||
130481331|NCT04436276|469730714|FG018|Overall Study|Physician Decision|0|||
130481332|NCT04436276|469730715|FG019|Overall Study|Physician Decision|0|||
130481333|NCT04436276|469730716|FG020|Overall Study|Physician Decision|1|||
130481334|NCT04436276|469730717|FG021|Overall Study|Physician Decision|2|||
130481335|NCT04436276|469730718|FG022|Overall Study|Physician Decision|0|||
130481336|NCT04436276|469730696|FG000|Overall Study|Protocol Violation|0|||
130481337|NCT04436276|469730697|FG001|Overall Study|Protocol Violation|0|||
130481338|NCT04436276|469730698|FG002|Overall Study|Protocol Violation|0|||
130481339|NCT04436276|469730699|FG003|Overall Study|Protocol Violation|0|||
130481340|NCT04436276|469730700|FG004|Overall Study|Protocol Violation|0|||
130481341|NCT04436276|469730701|FG005|Overall Study|Protocol Violation|0|||
130481342|NCT04436276|469730702|FG006|Overall Study|Protocol Violation|0|||
130481343|NCT04436276|469730703|FG007|Overall Study|Protocol Violation|0|||
130481344|NCT04436276|469730704|FG008|Overall Study|Protocol Violation|0|||
130481345|NCT04436276|469730705|FG009|Overall Study|Protocol Violation|0|||
130481346|NCT04436276|469730706|FG010|Overall Study|Protocol Violation|0|||
130481347|NCT04436276|469730707|FG011|Overall Study|Protocol Violation|0|||
130481348|NCT04436276|469730708|FG012|Overall Study|Protocol Violation|0|||
130481349|NCT04436276|469730709|FG013|Overall Study|Protocol Violation|1|||
130481350|NCT04436276|469730710|FG014|Overall Study|Protocol Violation|0|||
130481351|NCT04436276|469730711|FG015|Overall Study|Protocol Violation|1|||
130481352|NCT04436276|469730712|FG016|Overall Study|Protocol Violation|0|||
130481353|NCT04436276|469730713|FG017|Overall Study|Protocol Violation|0|||
130481354|NCT04436276|469730714|FG018|Overall Study|Protocol Violation|0|||
130481355|NCT04436276|469730715|FG019|Overall Study|Protocol Violation|0|||
130481356|NCT04436276|469730716|FG020|Overall Study|Protocol Violation|0|||
130481357|NCT04436276|469730717|FG021|Overall Study|Protocol Violation|0|||
130481358|NCT04436276|469730718|FG022|Overall Study|Protocol Violation|0|||
130481359|NCT04436276|469730696|FG000|Overall Study|Withdrawal by Subject|25|||
130481360|NCT04436276|469730697|FG001|Overall Study|Withdrawal by Subject|22|||
130481361|NCT04436276|469730698|FG002|Overall Study|Withdrawal by Subject|24|||
130481362|NCT04436276|469730699|FG003|Overall Study|Withdrawal by Subject|23|||
130481363|NCT04436276|469730700|FG004|Overall Study|Withdrawal by Subject|14|||
130481364|NCT04436276|469730701|FG005|Overall Study|Withdrawal by Subject|0|||
130481365|NCT04436276|469730702|FG006|Overall Study|Withdrawal by Subject|0|||
130481366|NCT04436276|469730703|FG007|Overall Study|Withdrawal by Subject|1|||
130481367|NCT04436276|469730704|FG008|Overall Study|Withdrawal by Subject|0|||
130481368|NCT04436276|469730705|FG009|Overall Study|Withdrawal by Subject|1|||
130481369|NCT04436276|469730706|FG010|Overall Study|Withdrawal by Subject|17|||
130481370|NCT04436276|469730707|FG011|Overall Study|Withdrawal by Subject|7|||
130481371|NCT04436276|469730708|FG012|Overall Study|Withdrawal by Subject|10|||
130481372|NCT04436276|469730709|FG013|Overall Study|Withdrawal by Subject|6|||
130481373|NCT04436276|469730710|FG014|Overall Study|Withdrawal by Subject|20|||
130481374|NCT04436276|469730711|FG015|Overall Study|Withdrawal by Subject|6|||
130481375|NCT04436276|469730712|FG016|Overall Study|Withdrawal by Subject|11|||
130481376|NCT04436276|469730713|FG017|Overall Study|Withdrawal by Subject|4|||
130481377|NCT04436276|469730714|FG018|Overall Study|Withdrawal by Subject|14|||
130481378|NCT04436276|469730715|FG019|Overall Study|Withdrawal by Subject|24|||
130481379|NCT04436276|469730716|FG020|Overall Study|Withdrawal by Subject|24|||
130481380|NCT04436276|469730717|FG021|Overall Study|Withdrawal by Subject|16|||
130481381|NCT04436276|469730718|FG022|Overall Study|Withdrawal by Subject|14|||
130481382|NCT04436276|469730696|FG000|Overall Study|Other|3|||
130481383|NCT04436276|469730697|FG001|Overall Study|Other|2|||
130481384|NCT04436276|469730698|FG002|Overall Study|Other|5|||
130481385|NCT04436276|469730699|FG003|Overall Study|Other|9|||
130481386|NCT04436276|469730700|FG004|Overall Study|Other|23|||
130481387|NCT04436276|469730701|FG005|Overall Study|Other|1|||
130481388|NCT04436276|469730702|FG006|Overall Study|Other|0|||
130481389|NCT04436276|469730703|FG007|Overall Study|Other|0|||
130481390|NCT04436276|469730704|FG008|Overall Study|Other|0|||
130481391|NCT04436276|469730705|FG009|Overall Study|Other|0|||
130481392|NCT04436276|469730706|FG010|Overall Study|Other|3|||
130481393|NCT04436276|469730707|FG011|Overall Study|Other|1|||
130481394|NCT04436276|469730708|FG012|Overall Study|Other|1|||
130481395|NCT04436276|469730709|FG013|Overall Study|Other|2|||
130481396|NCT04436276|469730710|FG014|Overall Study|Other|3|||
130481397|NCT04436276|469730711|FG015|Overall Study|Other|0|||
130481398|NCT04436276|469730712|FG016|Overall Study|Other|0|||
130481399|NCT04436276|469730713|FG017|Overall Study|Other|6|||
130481400|NCT04436276|469730714|FG018|Overall Study|Other|1|||
130481401|NCT04436276|469730715|FG019|Overall Study|Other|0|||
130481402|NCT04436276|469730716|FG020|Overall Study|Other|2|||
130481403|NCT04436276|469730717|FG021|Overall Study|Other|2|||
130481404|NCT04436276|469730718|FG022|Overall Study|Other|60|||
130481405|NCT05977530|469730720|FG000|Overall Study|Withdrawal by Subject|1|||
130481406|NCT05977530|469730720|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
130481407|NCT01733316|469730725|FG000|RP103 Phase|Non-compliance|1|||
130481408|NCT01733316|469730725|FG000|Long Term Extension Phase|Adverse Event|1|||
130481409|NCT01733316|469730725|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
130481410|NCT01733316|469730725|FG000|Long Term Extension Phase|Sponsor Decision|2|||
130481411|NCT05239455|469730735|FG000|Overall Study|Adverse Event|1|||
130481412|NCT05239455|469730735|FG000|Overall Study|Sponsor Decision|5|||
130481413|NCT05239455|469730735|FG000|Overall Study|Incomplete Blood Collection|1|||
130481414|NCT03459729|469730736|FG000|Overall Study|Physician Decision|2|||
130481415|NCT04200456|469730741|FG000|Overall Study|Physician Decision|0|||
130481416|NCT04200456|469730742|FG001|Overall Study|Physician Decision|1|||
130481417|NCT04200456|469730741|FG000|Overall Study|Withdrawal by Subject|2|||
130481418|NCT04200456|469730742|FG001|Overall Study|Withdrawal by Subject|2|||
130481419|NCT04200456|469730741|FG000|Overall Study|Lack of Efficacy|1|||
130481420|NCT04200456|469730742|FG001|Overall Study|Lack of Efficacy|1|||
130481421|NCT04200456|469730741|FG000|Overall Study|Adverse event, non-fatal|0|||
130481422|NCT04200456|469730742|FG001|Overall Study|Adverse event, non-fatal|1|||
130481423|NCT04200456|469730741|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
130481424|NCT04200456|469730742|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
130481425|NCT00506519|469732759|FG000|Overall Study|Death|4|||
130481426|NCT00506519|469732760|FG001|Overall Study|Death|6|||
130481427|NCT00506519|469732761|FG002|Overall Study|Death|0|||
130481428|NCT00506519|469732759|FG000|Overall Study|Adverse Event|1|||
130481429|NCT00506519|469732760|FG001|Overall Study|Adverse Event|0|||
130481430|NCT00506519|469732761|FG002|Overall Study|Adverse Event|0|||
130481431|NCT01186367|469732762|FG000|Overall Study|Lost to Follow-up|7|||
130481432|NCT01186367|469732763|FG001|Overall Study|Lost to Follow-up|4|||
130481433|NCT01186367|469732764|FG002|Overall Study|Lost to Follow-up|7|||
130481434|NCT01186367|469732762|FG000|Overall Study|Did not receive study treatment|0|||
130481435|NCT01186367|469732763|FG001|Overall Study|Did not receive study treatment|1|||
130481436|NCT01186367|469732764|FG002|Overall Study|Did not receive study treatment|0|||
130481437|NCT03945292|469732765|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
130481438|NCT03945292|469732766|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481439|NCT03945292|469732767|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
130481440|NCT03945292|469732768|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481441|NCT03945292|469732769|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481442|NCT03945292|469732770|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481443|NCT03945292|469732771|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481444|NCT03945292|469732772|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
130481445|NCT03945292|469732765|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481446|NCT03945292|469732766|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481447|NCT03945292|469732767|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
130481448|NCT03945292|469732768|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481449|NCT03945292|469732769|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481450|NCT03945292|469732770|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481451|NCT03945292|469732771|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481452|NCT03945292|469732772|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130481453|NCT03945292|469732765|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481454|NCT03945292|469732766|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481455|NCT03945292|469732767|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481456|NCT03945292|469732768|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481457|NCT03945292|469732769|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481458|NCT03945292|469732770|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130481459|NCT03945292|469732771|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130564979|NCT00847145|470035346|FG001|Overall Study|Lost to Follow-up|1|||
130481460|NCT03945292|469732772|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
130481461|NCT04987320|469732773|FG000|Overall Study|Withdrawal by Subject|0|||
130481462|NCT04987320|469732774|FG001|Overall Study|Withdrawal by Subject|1|||
130481463|NCT02675751|469732777|FG000|Overall Study|Lost to Follow-up|16|||
130481464|NCT03371381|469732778|FG000|Overall Study|Death|5|||
130481465|NCT03371381|469732778|FG000|Overall Study|Study terminated by sponsor|3|||
130481466|NCT03371381|469732778|FG000|Overall Study|Other|4|||
130481467|NCT03628924|469732779|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
130481468|NCT03628924|469732780|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481469|NCT03628924|469732781|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481470|NCT03628924|469732782|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481471|NCT03628924|469732783|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481472|NCT03628924|469732784|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481473|NCT03628924|469732785|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
130481474|NCT03628924|469732779|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481475|NCT03628924|469732780|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481476|NCT03628924|469732781|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
130481477|NCT03628924|469732782|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481478|NCT03628924|469732783|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481479|NCT03628924|469732784|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481480|NCT03628924|469732785|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130481481|NCT03628924|469732779|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
130481482|NCT03628924|469732780|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
130481483|NCT03628924|469732781|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
130481484|NCT03628924|469732782|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
130481485|NCT03628924|469732783|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
130481486|NCT03628924|469732784|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
130481487|NCT03628924|469732785|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
130481488|NCT03628924|469732779|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481489|NCT03628924|469732780|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
130481490|NCT03628924|469732781|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481491|NCT03628924|469732782|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481492|NCT03628924|469732783|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481493|NCT03628924|469732784|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481494|NCT03628924|469732785|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130481495|NCT03628924|469732779|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
130481496|NCT03628924|469732780|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130481497|NCT03628924|469732781|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
130481498|NCT03628924|469732782|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130481499|NCT03628924|469732783|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130481500|NCT03628924|469732784|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130481501|NCT03628924|469732785|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130481502|NCT03628924|469732779|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
130481503|NCT03628924|469732780|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
130481504|NCT03628924|469732781|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
130481505|NCT03628924|469732782|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
130481506|NCT03628924|469732783|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
130481507|NCT03628924|469732784|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
130481508|NCT03628924|469732785|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
130481509|NCT03628924|469732779|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
130481510|NCT03628924|469732780|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
130481511|NCT03628924|469732781|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
130481512|NCT03628924|469732782|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
130481513|NCT03628924|469732783|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
130481514|NCT03628924|469732784|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
130481515|NCT03628924|469732785|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
130481516|NCT03628924|469732779|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
130481517|NCT03628924|469732780|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
130481518|NCT03628924|469732781|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
130481519|NCT03628924|469732782|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
130481520|NCT03628924|469732783|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
130481521|NCT03628924|469732784|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
130481522|NCT03628924|469732785|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
130481523|NCT03628924|469732779|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
130481524|NCT03628924|469732780|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
130481525|NCT03628924|469732781|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
130481526|NCT03628924|469732782|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
130481527|NCT03628924|469732783|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
130481528|NCT03628924|469732784|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
130481529|NCT03628924|469732785|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
130481530|NCT03628924|469732779|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
130481531|NCT03628924|469732780|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
130481532|NCT03628924|469732781|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
130481533|NCT03628924|469732782|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
130481534|NCT03628924|469732783|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
130481535|NCT03628924|469732784|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
130481536|NCT03628924|469732785|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
130481537|NCT04016662|469732788|FG000|Run-In Phase|Death|1|||
130481538|NCT04016662|469732788|FG000|Run-In Phase|Withdrawal by Subject|11|||
130481539|NCT04016662|469732788|FG000|Run-In Phase|Not meeting screening eligibility|9|||
130481540|NCT04016662|469732788|FG000|Run-In Phase|Physician Decision|3|||
130481541|NCT04016662|469732788|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
130481542|NCT04016662|469732788|FG000|PLGS (12 Weeks)|Death|1|||
130481543|NCT04016662|469732788|FG000|SAP (12 Weeks)|Death|1|||
130481544|NCT01802788|469732789|FG000|Overall Study|Withdrawal by Subject|102|||
130481545|NCT01802788|469732790|FG001|Overall Study|Withdrawal by Subject|5|||
130481546|NCT01802788|469732789|FG000|Overall Study|Death|382|||
130481547|NCT01802788|469732790|FG001|Overall Study|Death|18|||
130481548|NCT01802788|469732789|FG000|Overall Study|Lost to Follow-up|31|||
130481549|NCT01802788|469732790|FG001|Overall Study|Lost to Follow-up|2|||
130481550|NCT01802788|469732789|FG000|Overall Study|Physician Decision|3|||
130481551|NCT01802788|469732790|FG001|Overall Study|Physician Decision|0|||
130481552|NCT01802788|469732789|FG000|Overall Study|Patient Non-Compliance|1|||
130481553|NCT01802788|469732790|FG001|Overall Study|Patient Non-Compliance|0|||
130481554|NCT01802788|469732789|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
130481555|NCT01802788|469732790|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
130481556|NCT01802788|469732789|FG000|Overall Study|Other Reasons|19|||
130481557|NCT01802788|469732790|FG001|Overall Study|Other Reasons|0|||
130481558|NCT03021096|469732791|FG000|Overall Study|Lost to Follow-up|4|||
130481559|NCT03021096|469732791|FG000|Overall Study|Protocol Violation|2|||
130481560|NCT02043678|469732794|FG000|Overall Study|Never treated|11|||
130481561|NCT02043678|469732795|FG001|Overall Study|Never treated|9|||
130481562|NCT02043678|469732794|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
130481563|NCT02043678|469732795|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
130481564|NCT02043678|469732794|FG000|Overall Study|AE without clinical PD|54|||
130481565|NCT02043678|469732795|FG001|Overall Study|AE without clinical PD|36|||
130481566|NCT02043678|469732794|FG000|Overall Study|Lost to Follow-up|1|||
130481567|NCT02043678|469732795|FG001|Overall Study|Lost to Follow-up|1|||
130481568|NCT02043678|469732794|FG000|Overall Study|Other|10|||
130481569|NCT02043678|469732795|FG001|Overall Study|Other|14|||
130481570|NCT02043678|469732794|FG000|Overall Study|Clinical PD|114|||
130481571|NCT02043678|469732795|FG001|Overall Study|Clinical PD|148|||
130481572|NCT02043678|469732794|FG000|Overall Study|Radiological PD|100|||
130481573|NCT02043678|469732795|FG001|Overall Study|Radiological PD|90|||
130481574|NCT02043678|469732794|FG000|Overall Study|Protocol-driven decision point|59|||
130481575|NCT02043678|469732795|FG001|Overall Study|Protocol-driven decision point|58|||
130481576|NCT02043678|469732794|FG000|Overall Study|Withdrawal by Subject|16|||
130481577|NCT02043678|469732795|FG001|Overall Study|Withdrawal by Subject|20|||
130481578|NCT02043678|469732794|FG000|Overall Study|Protocol Violation|1|||
130481579|NCT02043678|469732795|FG001|Overall Study|Protocol Violation|0|||
130481580|NCT02043678|469732794|FG000|Overall Study|Deterioration of general conditions|1|||
130481581|NCT02043678|469732795|FG001|Overall Study|Deterioration of general conditions|1|||
130481582|NCT02043678|469732794|FG000|Overall Study|Logistical difficulties|2|||
130481583|NCT02043678|469732795|FG001|Overall Study|Logistical difficulties|0|||
130481584|NCT02043678|469732794|FG000|Overall Study|Non-compliance with study drug|3|||
130481585|NCT02043678|469732795|FG001|Overall Study|Non-compliance with study drug|1|||
130564980|NCT00847145|470035347|FG002|Overall Study|Lost to Follow-up|1|||
130481586|NCT02043678|469732794|FG000|Overall Study|Physician Decision|4|||
130481587|NCT02043678|469732795|FG001|Overall Study|Physician Decision|3|||
130481588|NCT02043678|469732794|FG000|Overall Study|Subject decision|0|||
130481589|NCT02043678|469732795|FG001|Overall Study|Subject decision|1|||
130481590|NCT02043678|469732794|FG000|Overall Study|Switching to other therapy|3|||
130481591|NCT02043678|469732795|FG001|Overall Study|Switching to other therapy|2|||
130564981|NCT00847145|470035348|FG003|Overall Study|Lost to Follow-up|0|||
130564982|NCT00847145|470035349|FG004|Overall Study|Lost to Follow-up|4|||
130564983|NCT00847145|470035350|FG005|Overall Study|Lost to Follow-up|4|||
130481592|NCT02043678|469732794|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
130481593|NCT02043678|469732795|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
130481594|NCT02043678|469732794|FG000|Overall Study|Missing|1|||
130481595|NCT02043678|469732795|FG001|Overall Study|Missing|0|||
130481596|NCT02043678|469732794|FG000|Overall Study|Adverse Event|0|||
130481597|NCT02043678|469732795|FG001|Overall Study|Adverse Event|1|||
130481598|NCT05543629|469732796|FG000|Overall Study|Death|1|||
130481599|NCT05543629|469732797|FG001|Overall Study|Death|0|||
130564984|NCT00847145|470035351|FG006|Overall Study|Lost to Follow-up|8|||
130481600|NCT05543629|469732798|FG002|Overall Study|Death|1|||
130481601|NCT05543629|469732799|FG003|Overall Study|Death|0|||
130481602|NCT05543629|469732800|FG004|Overall Study|Death|0|||
130481603|NCT05543629|469732801|FG005|Overall Study|Death|1|||
130481604|NCT05543629|469732802|FG006|Overall Study|Death|2|||
130481605|NCT05543629|469732803|FG007|Overall Study|Death|2|||
130481606|NCT05543629|469732796|FG000|Overall Study|Other Reasons|0|||
130481607|NCT05543629|469732797|FG001|Overall Study|Other Reasons|0|||
130481608|NCT05543629|469732798|FG002|Overall Study|Other Reasons|0|||
130481609|NCT05543629|469732799|FG003|Overall Study|Other Reasons|0|||
130481610|NCT05543629|469732800|FG004|Overall Study|Other Reasons|1|||
130481611|NCT05543629|469732801|FG005|Overall Study|Other Reasons|0|||
130481612|NCT05543629|469732802|FG006|Overall Study|Other Reasons|0|||
130481613|NCT05543629|469732803|FG007|Overall Study|Other Reasons|0|||
130481614|NCT05543629|469732796|FG000|Overall Study|Physician Decision|0|||
130481615|NCT05543629|469732797|FG001|Overall Study|Physician Decision|0|||
130481616|NCT05543629|469732798|FG002|Overall Study|Physician Decision|3|||
130481617|NCT05543629|469732799|FG003|Overall Study|Physician Decision|0|||
130481618|NCT05543629|469732800|FG004|Overall Study|Physician Decision|0|||
130481619|NCT05543629|469732801|FG005|Overall Study|Physician Decision|0|||
130481620|NCT05543629|469732802|FG006|Overall Study|Physician Decision|1|||
130481621|NCT05543629|469732803|FG007|Overall Study|Physician Decision|0|||
130481622|NCT05543629|469732796|FG000|Overall Study|Study terminated by Sponsor|1|||
130481623|NCT05543629|469732797|FG001|Overall Study|Study terminated by Sponsor|0|||
130481624|NCT05543629|469732798|FG002|Overall Study|Study terminated by Sponsor|0|||
130481625|NCT05543629|469732799|FG003|Overall Study|Study terminated by Sponsor|1|||
130481626|NCT05543629|469732800|FG004|Overall Study|Study terminated by Sponsor|0|||
130481627|NCT05543629|469732801|FG005|Overall Study|Study terminated by Sponsor|4|||
130481628|NCT05543629|469732802|FG006|Overall Study|Study terminated by Sponsor|1|||
130481629|NCT05543629|469732803|FG007|Overall Study|Study terminated by Sponsor|0|||
130481630|NCT05543629|469732796|FG000|Overall Study|Withdrawal by Subject|1|||
130481631|NCT05543629|469732797|FG001|Overall Study|Withdrawal by Subject|1|||
130481632|NCT05543629|469732798|FG002|Overall Study|Withdrawal by Subject|0|||
130481633|NCT05543629|469732799|FG003|Overall Study|Withdrawal by Subject|2|||
130481634|NCT05543629|469732800|FG004|Overall Study|Withdrawal by Subject|1|||
130481635|NCT05543629|469732801|FG005|Overall Study|Withdrawal by Subject|1|||
130481636|NCT05543629|469732802|FG006|Overall Study|Withdrawal by Subject|1|||
130481637|NCT05543629|469732803|FG007|Overall Study|Withdrawal by Subject|1|||
130481638|NCT05543629|469732796|FG000|Overall Study|Not Reported|2|||
130481639|NCT05543629|469732797|FG001|Overall Study|Not Reported|2|||
130481640|NCT05543629|469732798|FG002|Overall Study|Not Reported|0|||
130481641|NCT05543629|469732799|FG003|Overall Study|Not Reported|0|||
130481642|NCT05543629|469732800|FG004|Overall Study|Not Reported|1|||
130481643|NCT05543629|469732801|FG005|Overall Study|Not Reported|1|||
130481644|NCT05543629|469732802|FG006|Overall Study|Not Reported|3|||
130481645|NCT05543629|469732803|FG007|Overall Study|Not Reported|0|||
130481646|NCT03216057|469732804|FG000|Overall Study|Lost to Follow-up|2|||
130481647|NCT03216057|469732805|FG001|Overall Study|Lost to Follow-up|2|||
130481648|NCT04568603|469732806|FG000|Overall Study|Physician Decision|1|||
130481649|NCT04564742|469732807|FG000|Overall Study|Lost to Follow-up|1|||
130481650|NCT04564742|469732808|FG001|Overall Study|Lost to Follow-up|0|||
130481651|NCT04564742|469732807|FG000|Overall Study|Consent Withdrawal|4|||
130481652|NCT04564742|469732808|FG001|Overall Study|Consent Withdrawal|4|||
130481653|NCT03313076|469732812|FG000|Overall Study|Withdrawal by Subject|2|||
130481654|NCT03313076|469732813|FG001|Overall Study|Withdrawal by Subject|0|||
130481655|NCT03313076|469732814|FG002|Overall Study|Withdrawal by Subject|0|||
130481656|NCT03313076|469732815|FG003|Overall Study|Withdrawal by Subject|0|||
130481657|NCT03313076|469732812|FG000|Overall Study|Lost to Follow-up|0|||
130481658|NCT03313076|469732813|FG001|Overall Study|Lost to Follow-up|2|||
130481659|NCT03313076|469732814|FG002|Overall Study|Lost to Follow-up|2|||
130481660|NCT03313076|469732815|FG003|Overall Study|Lost to Follow-up|2|||
130481661|NCT03904147|469732818|FG000|Overall Study|Death|15|||
130481662|NCT03904147|469732819|FG001|Overall Study|Death|13|||
130481663|NCT03904147|469732820|FG002|Overall Study|Death|15|||
130728017|NCT01449370|470625577|FG011|Overall Study|Medication Prohibited by Protocol|0|||
130481664|NCT03904147|469732818|FG000|Overall Study|Withdrawal by Subject|7|||
130481665|NCT03904147|469732819|FG001|Overall Study|Withdrawal by Subject|12|||
130481666|NCT03904147|469732820|FG002|Overall Study|Withdrawal by Subject|1|||
130481667|NCT03904147|469732818|FG000|Overall Study|1Y visit completed after 365 days|1|||
130481668|NCT03904147|469732819|FG001|Overall Study|1Y visit completed after 365 days|1|||
130481669|NCT03904147|469732820|FG002|Overall Study|1Y visit completed after 365 days|0|||
130481670|NCT00764751|469732828|FG000|Overall Study|Adverse Event|1|||
130481671|NCT00764751|469732829|FG001|Overall Study|Adverse Event|1|||
130481672|NCT00764751|469732828|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
130481673|NCT00764751|469732829|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
130481674|NCT03011333|469732835|FG000|Overall Study|Lost to Follow-up|0|||
130481675|NCT03011333|469732836|FG001|Overall Study|Lost to Follow-up|1|||
130481676|NCT03011333|469732837|FG002|Overall Study|Lost to Follow-up|0|||
130481677|NCT03011333|469732838|FG003|Overall Study|Lost to Follow-up|1|||
130481678|NCT03011333|469732839|FG004|Overall Study|Lost to Follow-up|4|||
130481679|NCT03011333|469732840|FG005|Overall Study|Lost to Follow-up|4|||
130481680|NCT03011333|469732841|FG006|Overall Study|Lost to Follow-up|5|||
130481681|NCT04307355|469732842|FG000|Overall Study|Non-Compliance|3|||
130481682|NCT04307355|469732843|FG001|Overall Study|Non-Compliance|3|||
130481683|NCT04307355|469732844|FG002|Overall Study|Non-Compliance|0|||
130481684|NCT02998268|469732848|FG000|Overall Study|Adverse Event|0|||
130481685|NCT02998268|469732849|FG001|Overall Study|Adverse Event|2|||
130481686|NCT02998268|469732848|FG000|Overall Study|Withdrawal by Subject|0|||
130481687|NCT02998268|469732849|FG001|Overall Study|Withdrawal by Subject|1|||
130481688|NCT05269667|469732850|FG000|Overall Study|Study Terminated by Sponsor|4|||
130481689|NCT04413708|469732851|FG000|Overall Study|Lost to Follow-up|1|||
130481690|NCT04413708|469732852|FG001|Overall Study|Lost to Follow-up|2|||
130481691|NCT04032704|469732860|FG000|Part A|Withdrawal by Subject|0|||
130481692|NCT04032704|469732861|FG001|Part A|Withdrawal by Subject|0|||
130481693|NCT04032704|469732862|FG002|Part A|Withdrawal by Subject|3|||
130481694|NCT04032704|469732863|FG003|Part A|Withdrawal by Subject|0|||
130481695|NCT04032704|469732864|FG004|Part A|Withdrawal by Subject|1|||
130481696|NCT04032704|469732865|FG005|Part A|Withdrawal by Subject|7|||
130481697|NCT04032704|469732866|FG006|Part A|Withdrawal by Subject|0|||
130481698|NCT04032704|469732867|FG007|Part A|Withdrawal by Subject|0|||
130481699|NCT04032704|469732868|FG008|Part A|Withdrawal by Subject|0|||
130481700|NCT04032704|469732869|FG009|Part A|Withdrawal by Subject|0|||
130481701|NCT04032704|469732870|FG010|Part A|Withdrawal by Subject|0|||
130481702|NCT04032704|469732871|FG011|Part A|Withdrawal by Subject|0|||
130481703|NCT04032704|469732872|FG012|Part A|Withdrawal by Subject|0|||
130481704|NCT04032704|469732873|FG013|Part A|Withdrawal by Subject|0|||
130481705|NCT04032704|469732874|FG014|Part A|Withdrawal by Subject|0|||
130481706|NCT04032704|469732875|FG015|Part A|Withdrawal by Subject|0|||
130481707|NCT04032704|469732876|FG016|Part A|Withdrawal by Subject|0|||
130481708|NCT04032704|469732877|FG017|Part A|Withdrawal by Subject|0|||
130481709|NCT04032704|469732860|FG000|Part A|Lost to Follow-up|1|||
130481710|NCT04032704|469732861|FG001|Part A|Lost to Follow-up|0|||
130481711|NCT04032704|469732862|FG002|Part A|Lost to Follow-up|0|||
130481712|NCT04032704|469732863|FG003|Part A|Lost to Follow-up|0|||
130481713|NCT04032704|469732864|FG004|Part A|Lost to Follow-up|0|||
130481714|NCT04032704|469732865|FG005|Part A|Lost to Follow-up|0|||
130481715|NCT04032704|469732866|FG006|Part A|Lost to Follow-up|0|||
130481716|NCT04032704|469732867|FG007|Part A|Lost to Follow-up|0|||
130481717|NCT04032704|469732868|FG008|Part A|Lost to Follow-up|0|||
130481718|NCT04032704|469732869|FG009|Part A|Lost to Follow-up|0|||
130481719|NCT04032704|469732870|FG010|Part A|Lost to Follow-up|0|||
130481720|NCT04032704|469732871|FG011|Part A|Lost to Follow-up|0|||
130481721|NCT04032704|469732872|FG012|Part A|Lost to Follow-up|0|||
130481722|NCT04032704|469732873|FG013|Part A|Lost to Follow-up|0|||
130481723|NCT04032704|469732874|FG014|Part A|Lost to Follow-up|0|||
130481724|NCT04032704|469732875|FG015|Part A|Lost to Follow-up|0|||
130481725|NCT04032704|469732876|FG016|Part A|Lost to Follow-up|0|||
130481726|NCT04032704|469732877|FG017|Part A|Lost to Follow-up|0|||
130481727|NCT04032704|469732860|FG000|Part A|Death|9|||
130481728|NCT04032704|469732861|FG001|Part A|Death|2|||
130481729|NCT04032704|469732862|FG002|Part A|Death|10|||
130481730|NCT04032704|469732863|FG003|Part A|Death|7|||
130481731|NCT04032704|469732864|FG004|Part A|Death|4|||
130481732|NCT04032704|469732865|FG005|Part A|Death|5|||
130481733|NCT04032704|469732866|FG006|Part A|Death|0|||
130481734|NCT04032704|469732867|FG007|Part A|Death|0|||
130481735|NCT04032704|469732868|FG008|Part A|Death|0|||
130481736|NCT04032704|469732869|FG009|Part A|Death|0|||
130481737|NCT04032704|469732870|FG010|Part A|Death|0|||
130481738|NCT04032704|469732871|FG011|Part A|Death|0|||
130481739|NCT04032704|469732872|FG012|Part A|Death|0|||
130481740|NCT04032704|469732873|FG013|Part A|Death|0|||
130481741|NCT04032704|469732874|FG014|Part A|Death|0|||
130481742|NCT04032704|469732875|FG015|Part A|Death|0|||
130481743|NCT04032704|469732876|FG016|Part A|Death|0|||
130481744|NCT04032704|469732877|FG017|Part A|Death|0|||
130481745|NCT04032704|469732860|FG000|Part B|Other|0|||
130481746|NCT04032704|469732861|FG001|Part B|Other|0|||
130481747|NCT04032704|469732862|FG002|Part B|Other|0|||
130481748|NCT04032704|469732863|FG003|Part B|Other|0|||
130481749|NCT04032704|469732864|FG004|Part B|Other|0|||
130481750|NCT04032704|469732865|FG005|Part B|Other|0|||
130481751|NCT04032704|469732866|FG006|Part B|Other|0|||
130481752|NCT04032704|469732867|FG007|Part B|Other|1|||
130481753|NCT04032704|469732868|FG008|Part B|Other|2|||
130481754|NCT04032704|469732869|FG009|Part B|Other|1|||
130564985|NCT00847145|470035352|FG007|Overall Study|Lost to Follow-up|2|||
130481755|NCT04032704|469732870|FG010|Part B|Other|1|||
130481756|NCT04032704|469732871|FG011|Part B|Other|1|||
130481757|NCT04032704|469732872|FG012|Part B|Other|5|||
130481758|NCT04032704|469732873|FG013|Part B|Other|13|||
130481759|NCT04032704|469732874|FG014|Part B|Other|0|||
130481760|NCT04032704|469732875|FG015|Part B|Other|0|||
130481761|NCT04032704|469732876|FG016|Part B|Other|0|||
130481762|NCT04032704|469732877|FG017|Part B|Other|0|||
130481763|NCT04032704|469732860|FG000|Part B|Study termination by Sponsor|0|||
130481764|NCT04032704|469732861|FG001|Part B|Study termination by Sponsor|0|||
130481765|NCT04032704|469732862|FG002|Part B|Study termination by Sponsor|0|||
130481766|NCT04032704|469732863|FG003|Part B|Study termination by Sponsor|0|||
130481767|NCT04032704|469732864|FG004|Part B|Study termination by Sponsor|0|||
130481768|NCT04032704|469732865|FG005|Part B|Study termination by Sponsor|0|||
130481769|NCT04032704|469732866|FG006|Part B|Study termination by Sponsor|0|||
130481770|NCT04032704|469732867|FG007|Part B|Study termination by Sponsor|0|||
130481771|NCT04032704|469732868|FG008|Part B|Study termination by Sponsor|1|||
130481772|NCT04032704|469732869|FG009|Part B|Study termination by Sponsor|0|||
130481773|NCT04032704|469732870|FG010|Part B|Study termination by Sponsor|0|||
130481774|NCT04032704|469732871|FG011|Part B|Study termination by Sponsor|0|||
130481775|NCT04032704|469732872|FG012|Part B|Study termination by Sponsor|0|||
130481776|NCT04032704|469732873|FG013|Part B|Study termination by Sponsor|0|||
130481777|NCT04032704|469732874|FG014|Part B|Study termination by Sponsor|0|||
130481778|NCT04032704|469732875|FG015|Part B|Study termination by Sponsor|0|||
130481779|NCT04032704|469732876|FG016|Part B|Study termination by Sponsor|0|||
130481780|NCT04032704|469732877|FG017|Part B|Study termination by Sponsor|0|||
130481781|NCT04032704|469732860|FG000|Part B|Withdrawal by Subject|0|||
130481782|NCT04032704|469732861|FG001|Part B|Withdrawal by Subject|0|||
130481783|NCT04032704|469732862|FG002|Part B|Withdrawal by Subject|0|||
130481784|NCT04032704|469732863|FG003|Part B|Withdrawal by Subject|0|||
130481785|NCT04032704|469732864|FG004|Part B|Withdrawal by Subject|0|||
130481786|NCT04032704|469732865|FG005|Part B|Withdrawal by Subject|0|||
130481787|NCT04032704|469732866|FG006|Part B|Withdrawal by Subject|3|||
130481788|NCT04032704|469732867|FG007|Part B|Withdrawal by Subject|2|||
130481789|NCT04032704|469732868|FG008|Part B|Withdrawal by Subject|2|||
130481790|NCT04032704|469732869|FG009|Part B|Withdrawal by Subject|1|||
130481791|NCT04032704|469732870|FG010|Part B|Withdrawal by Subject|4|||
130481792|NCT04032704|469732871|FG011|Part B|Withdrawal by Subject|6|||
130481793|NCT04032704|469732872|FG012|Part B|Withdrawal by Subject|2|||
130481794|NCT04032704|469732873|FG013|Part B|Withdrawal by Subject|1|||
130481795|NCT04032704|469732874|FG014|Part B|Withdrawal by Subject|0|||
130481796|NCT04032704|469732875|FG015|Part B|Withdrawal by Subject|1|||
130481797|NCT04032704|469732876|FG016|Part B|Withdrawal by Subject|0|||
130481798|NCT04032704|469732877|FG017|Part B|Withdrawal by Subject|0|||
130481799|NCT04032704|469732860|FG000|Part B|Lost to Follow-up|0|||
130481800|NCT04032704|469732861|FG001|Part B|Lost to Follow-up|0|||
130481801|NCT04032704|469732862|FG002|Part B|Lost to Follow-up|0|||
130481802|NCT04032704|469732863|FG003|Part B|Lost to Follow-up|0|||
130481803|NCT04032704|469732864|FG004|Part B|Lost to Follow-up|0|||
130481804|NCT04032704|469732865|FG005|Part B|Lost to Follow-up|0|||
130481805|NCT04032704|469732866|FG006|Part B|Lost to Follow-up|0|||
130481806|NCT04032704|469732867|FG007|Part B|Lost to Follow-up|0|||
130728018|NCT01449370|470625578|FG012|Overall Study|Medication Prohibited by Protocol|0|||
130481807|NCT04032704|469732868|FG008|Part B|Lost to Follow-up|0|||
130481808|NCT04032704|469732869|FG009|Part B|Lost to Follow-up|0|||
130481809|NCT04032704|469732870|FG010|Part B|Lost to Follow-up|0|||
130481810|NCT04032704|469732871|FG011|Part B|Lost to Follow-up|1|||
130481811|NCT04032704|469732872|FG012|Part B|Lost to Follow-up|0|||
130481812|NCT04032704|469732873|FG013|Part B|Lost to Follow-up|0|||
130481813|NCT04032704|469732874|FG014|Part B|Lost to Follow-up|0|||
130481814|NCT04032704|469732875|FG015|Part B|Lost to Follow-up|0|||
130481815|NCT04032704|469732876|FG016|Part B|Lost to Follow-up|0|||
130481816|NCT04032704|469732877|FG017|Part B|Lost to Follow-up|0|||
130481817|NCT04032704|469732860|FG000|Part B|Death|0|||
130481818|NCT04032704|469732861|FG001|Part B|Death|0|||
130481819|NCT04032704|469732862|FG002|Part B|Death|0|||
130481820|NCT04032704|469732863|FG003|Part B|Death|0|||
130481821|NCT04032704|469732864|FG004|Part B|Death|0|||
130481822|NCT04032704|469732865|FG005|Part B|Death|0|||
130481823|NCT04032704|469732866|FG006|Part B|Death|13|||
130481824|NCT04032704|469732867|FG007|Part B|Death|13|||
130481825|NCT04032704|469732868|FG008|Part B|Death|14|||
130481826|NCT04032704|469732869|FG009|Part B|Death|12|||
130481827|NCT04032704|469732870|FG010|Part B|Death|12|||
130481828|NCT04032704|469732871|FG011|Part B|Death|13|||
130481829|NCT04032704|469732872|FG012|Part B|Death|7|||
130481830|NCT04032704|469732873|FG013|Part B|Death|17|||
130481831|NCT04032704|469732874|FG014|Part B|Death|2|||
130481832|NCT04032704|469732875|FG015|Part B|Death|1|||
130481833|NCT04032704|469732876|FG016|Part B|Death|2|||
130481834|NCT04032704|469732877|FG017|Part B|Death|2|||
130481835|NCT02861300|469732878|FG000|Overall Study|Death|0|||
130481836|NCT02861300|469732879|FG001|Overall Study|Death|0|||
130481837|NCT02861300|469732880|FG002|Overall Study|Death|0|||
130481838|NCT02861300|469732881|FG003|Overall Study|Death|0|||
130481839|NCT02861300|469732882|FG004|Overall Study|Death|0|||
130481840|NCT02861300|469732883|FG005|Overall Study|Death|0|||
130481841|NCT02861300|469732884|FG006|Overall Study|Death|24|||
130481842|NCT02861300|469732878|FG000|Overall Study|Delay in treatment|0|||
130481843|NCT02861300|469732879|FG001|Overall Study|Delay in treatment|0|||
130481844|NCT02861300|469732880|FG002|Overall Study|Delay in treatment|0|||
130481845|NCT02861300|469732881|FG003|Overall Study|Delay in treatment|0|||
130481846|NCT02861300|469732882|FG004|Overall Study|Delay in treatment|0|||
130481847|NCT02861300|469732883|FG005|Overall Study|Delay in treatment|1|||
130481848|NCT02861300|469732884|FG006|Overall Study|Delay in treatment|0|||
130481849|NCT02861300|469732878|FG000|Overall Study|Disease Progression|0|||
130481850|NCT02861300|469732879|FG001|Overall Study|Disease Progression|1|||
130481851|NCT02861300|469732880|FG002|Overall Study|Disease Progression|0|||
130481852|NCT02861300|469732881|FG003|Overall Study|Disease Progression|0|||
130481853|NCT02861300|469732882|FG004|Overall Study|Disease Progression|0|||
130481854|NCT02861300|469732883|FG005|Overall Study|Disease Progression|0|||
130481855|NCT02861300|469732884|FG006|Overall Study|Disease Progression|2|||
130481856|NCT02861300|469732878|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
130481857|NCT02861300|469732879|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
130481858|NCT02861300|469732880|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
130481859|NCT02861300|469732881|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
130481860|NCT02861300|469732882|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
130481861|NCT02861300|469732883|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
130481862|NCT02861300|469732884|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
130481863|NCT02861300|469732878|FG000|Overall Study|Clinical Complications|0|||
130481864|NCT02861300|469732879|FG001|Overall Study|Clinical Complications|0|||
130481865|NCT02861300|469732880|FG002|Overall Study|Clinical Complications|0|||
130481866|NCT02861300|469732881|FG003|Overall Study|Clinical Complications|0|||
130481867|NCT02861300|469732882|FG004|Overall Study|Clinical Complications|0|||
130481868|NCT02861300|469732883|FG005|Overall Study|Clinical Complications|0|||
130481869|NCT02861300|469732884|FG006|Overall Study|Clinical Complications|1|||
130481870|NCT02465268|469732885|FG000|Overall Study|Withdrawal by Subject|4|||
130481871|NCT02465268|469732886|FG001|Overall Study|Withdrawal by Subject|3|||
130481872|NCT02465268|469732887|FG002|Overall Study|Withdrawal by Subject|1|||
130481873|NCT02465268|469732885|FG000|Overall Study|Not evaluable per protocol criteria|3|||
130481874|NCT02465268|469732886|FG001|Overall Study|Not evaluable per protocol criteria|2|||
130481875|NCT02465268|469732887|FG002|Overall Study|Not evaluable per protocol criteria|1|||
130481876|NCT02465268|469732885|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
130481877|NCT02465268|469732886|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
130481878|NCT02465268|469732887|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
130481879|NCT02465268|469732885|FG000|Overall Study|Study drug did not pass QA/QC|1|||
130481880|NCT02465268|469732886|FG001|Overall Study|Study drug did not pass QA/QC|0|||
130481881|NCT02465268|469732887|FG002|Overall Study|Study drug did not pass QA/QC|0|||
130481882|NCT02465268|469732885|FG000|Overall Study|Adverse Event|0|||
130481883|NCT02465268|469732886|FG001|Overall Study|Adverse Event|1|||
130481884|NCT02465268|469732887|FG002|Overall Study|Adverse Event|0|||
130481885|NCT02465268|469732885|FG000|Overall Study|Physician Decision|0|||
130481886|NCT02465268|469732886|FG001|Overall Study|Physician Decision|1|||
130481887|NCT02465268|469732887|FG002|Overall Study|Physician Decision|0|||
130481888|NCT03133546|469732892|FG000|Overall Study|Death|46|||
130481889|NCT03133546|469732893|FG001|Overall Study|Death|43|||
130481890|NCT03133546|469732892|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
130481891|NCT03133546|469732893|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
130481892|NCT05399459|469732896|FG000|Overall Study|Randomized but not treated|29|||
130481893|NCT05399459|469732897|FG001|Overall Study|Randomized but not treated|30|||
130481894|NCT05399459|469732898|FG002|Overall Study|Randomized but not treated|38|||
130481895|NCT05399459|469732896|FG000|Overall Study|Lost to Follow-up|1|||
130481896|NCT05399459|469732897|FG001|Overall Study|Lost to Follow-up|0|||
130481897|NCT05399459|469732898|FG002|Overall Study|Lost to Follow-up|0|||
130481898|NCT03020199|469732901|FG000|Treatment Period|Adverse Event|0|||
130481899|NCT03020199|469732902|FG001|Treatment Period|Adverse Event|2|||
130481900|NCT03020199|469732901|FG000|Treatment Period|Lack of Efficacy|1|||
130481901|NCT03020199|469732902|FG001|Treatment Period|Lack of Efficacy|6|||
130481902|NCT03020199|469732901|FG000|Treatment Period|Lost to Follow-up|1|||
130481903|NCT03020199|469732902|FG001|Treatment Period|Lost to Follow-up|6|||
130481904|NCT03020199|469732901|FG000|Treatment Period|Physician Decision|0|||
130481905|NCT03020199|469732902|FG001|Treatment Period|Physician Decision|1|||
130481906|NCT03020199|469732901|FG000|Treatment Period|Subject/guardian decision|8|||
130481907|NCT03020199|469732902|FG001|Treatment Period|Subject/guardian decision|15|||
130481908|NCT03020199|469732901|FG000|Treatment Period|Subjects not treated|3|||
130481909|NCT03020199|469732902|FG001|Treatment Period|Subjects not treated|4|||
130481910|NCT03020199|469732901|FG000|Follow-up Period|Disease relapse|32|||
130481911|NCT03020199|469732902|FG001|Follow-up Period|Disease relapse|7|||
130481912|NCT03020199|469732901|FG000|Follow-up Period|Lack of Efficacy|1|||
130481913|NCT03020199|469732902|FG001|Follow-up Period|Lack of Efficacy|2|||
130481914|NCT03020199|469732901|FG000|Follow-up Period|Lost to Follow-up|4|||
130481915|NCT03020199|469732902|FG001|Follow-up Period|Lost to Follow-up|6|||
130481916|NCT03020199|469732901|FG000|Follow-up Period|Physician Decision|2|||
130481917|NCT03020199|469732902|FG001|Follow-up Period|Physician Decision|2|||
130481918|NCT03020199|469732901|FG000|Follow-up Period|Protocol Violation|1|||
130481919|NCT03020199|469732902|FG001|Follow-up Period|Protocol Violation|2|||
130481920|NCT03020199|469732901|FG000|Follow-up Period|Study terminated by Sponsor|6|||
130481921|NCT03020199|469732902|FG001|Follow-up Period|Study terminated by Sponsor|3|||
130481922|NCT03020199|469732901|FG000|Follow-up Period|Subject/guardian decision|14|||
130728019|NCT01449370|470625579|FG013|Overall Study|Medication Prohibited by Protocol|0|||
130728020|NCT01449370|470625580|FG014|Overall Study|Medication Prohibited by Protocol|0|||
130728021|NCT01449370|470625581|FG015|Overall Study|Medication Prohibited by Protocol|0|||
130728022|NCT01449370|470625582|FG016|Overall Study|Medication Prohibited by Protocol|0|||
130728023|NCT01449370|470625583|FG017|Overall Study|Medication Prohibited by Protocol|0|||
130481923|NCT03020199|469732902|FG001|Follow-up Period|Subject/guardian decision|9|||
130481924|NCT05583578|469732903|FG000|Overall Study|Withdrawal by Subject|2|||
130481925|NCT05583578|469732904|FG001|Overall Study|Withdrawal by Subject|0|||
130481926|NCT05201079|469732905|FG000|Overall Study|Adverse Event|7|||
130481927|NCT05201079|469732906|FG001|Overall Study|Adverse Event|11|||
130481928|NCT05201079|469732905|FG000|Overall Study|Death|1|||
130481929|NCT05201079|469732906|FG001|Overall Study|Death|1|||
130481930|NCT05201079|469732905|FG000|Overall Study|Lack of Efficacy|0|||
130481931|NCT05201079|469732906|FG001|Overall Study|Lack of Efficacy|2|||
130481932|NCT05201079|469732905|FG000|Overall Study|Lost to Follow-up|0|||
130481933|NCT05201079|469732906|FG001|Overall Study|Lost to Follow-up|1|||
130481934|NCT05201079|469732905|FG000|Overall Study|Physician Decision|1|||
130481935|NCT05201079|469732906|FG001|Overall Study|Physician Decision|1|||
130481936|NCT05201079|469732905|FG000|Overall Study|Protocol Violation|1|||
130481937|NCT05201079|469732906|FG001|Overall Study|Protocol Violation|0|||
130481938|NCT05201079|469732905|FG000|Overall Study|Withdrawal by Subject|1|||
130481939|NCT05201079|469732906|FG001|Overall Study|Withdrawal by Subject|0|||
130481940|NCT05201079|469732905|FG000|Overall Study|Forbidden medication|9|||
130481941|NCT05201079|469732906|FG001|Overall Study|Forbidden medication|5|||
130481942|NCT05201079|469732905|FG000|Overall Study|Transfer to another hospital|0|||
130481943|NCT05201079|469732906|FG001|Overall Study|Transfer to another hospital|1|||
130481944|NCT05201079|469732905|FG000|Overall Study|Clinical condition|1|||
130481945|NCT05201079|469732906|FG001|Overall Study|Clinical condition|0|||
130481946|NCT05201079|469732905|FG000|Overall Study|SAE and sepsis|1|||
130481947|NCT05201079|469732906|FG001|Overall Study|SAE and sepsis|0|||
130481948|NCT05386030|469732912|FG000|Overall Study|Death|1|||
130481949|NCT05386030|469732913|FG001|Overall Study|Death|0|||
130481950|NCT05386030|469732912|FG000|Overall Study|Physician Decision|2|||
130481951|NCT05386030|469732913|FG001|Overall Study|Physician Decision|1|||
130481952|NCT05386030|469732912|FG000|Overall Study|Lost to Follow-up|19|||
130481953|NCT05386030|469732913|FG001|Overall Study|Lost to Follow-up|7|||
130481954|NCT05386030|469732912|FG000|Overall Study|Withdrawal by Subject|20|||
130481955|NCT05386030|469732913|FG001|Overall Study|Withdrawal by Subject|10|||
130481956|NCT05386030|469732912|FG000|Overall Study|Eligibility criteria violation|1|||
130481957|NCT05386030|469732913|FG001|Overall Study|Eligibility criteria violation|1|||
130481958|NCT05386030|469732912|FG000|Overall Study|Personal Reasons|1|||
130481959|NCT05386030|469732913|FG001|Overall Study|Personal Reasons|0|||
130481960|NCT04524442|469732914|FG000|Overall Study|Subject Decision|1|||
130481961|NCT04719832|469732915|FG000|Overall Study|Adverse Event|2|||
130481962|NCT04719832|469732916|FG001|Overall Study|Adverse Event|0|||
130481963|NCT04719832|469732915|FG000|Overall Study|Lack of Efficacy|2|||
130481964|NCT04719832|469732916|FG001|Overall Study|Lack of Efficacy|4|||
130481965|NCT04719832|469732915|FG000|Overall Study|Lost to Follow-up|0|||
130481966|NCT04719832|469732916|FG001|Overall Study|Lost to Follow-up|2|||
130481967|NCT04719832|469732915|FG000|Overall Study|Physician Decision|0|||
130481968|NCT04719832|469732916|FG001|Overall Study|Physician Decision|1|||
130481969|NCT04719832|469732915|FG000|Overall Study|Pregnancy|1|||
130481970|NCT04719832|469732916|FG001|Overall Study|Pregnancy|1|||
130481971|NCT04719832|469732915|FG000|Overall Study|Withdrawal by Subject|5|||
130481972|NCT04719832|469732916|FG001|Overall Study|Withdrawal by Subject|5|||
130481973|NCT04719832|469732915|FG000|Overall Study|Randomized, not treated|0|||
130481974|NCT04719832|469732916|FG001|Overall Study|Randomized, not treated|2|||
130481975|NCT04719832|469732915|FG000|Overall Study|GCP violations|4|||
130481976|NCT04719832|469732916|FG001|Overall Study|GCP violations|7|||
130481977|NCT05228457|469732917|FG000|Overall Study|Withdrawal by Subject|1|||
130481978|NCT05228457|469732918|FG001|Overall Study|Withdrawal by Subject|1|||
130481979|NCT04880863|469732921|FG000|Overall Study|Adverse Event|1|||
130481980|NCT04880863|469732921|FG000|Overall Study|Patient decision|2|||
130728024|NCT01449370|470625584|FG018|Overall Study|Medication Prohibited by Protocol|0|||
130728025|NCT01449370|470625585|FG019|Overall Study|Medication Prohibited by Protocol|0|||
130728026|NCT01449370|470625586|FG020|Overall Study|Medication Prohibited by Protocol|0|||
130481981|NCT04880863|469732921|FG000|Overall Study|Confirmed Disease Progression|15|||
130481982|NCT04880863|469732921|FG000|Overall Study|Death|3|||
130481983|NCT04880863|469732921|FG000|Overall Study|Physician Decision|4|||
130481984|NCT04880863|469732921|FG000|Overall Study|Unconfirmed Disease Progression|4|||
130481985|NCT04880863|469732921|FG000|Overall Study|Withdrawal by Subject|2|||
130481986|NCT04880863|469732921|FG000|Overall Study|Study discontinuation by the sponsor|4|||
130481987|NCT04880863|469732921|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
130481988|NCT04880863|469732921|FG000|Overall Study|Not received study drug NAP|2|||
130481989|NCT03213691|469732922|FG000|Overall Study|Adverse Event|2|||
130481990|NCT03213691|469732922|FG000|Overall Study|Death|3|||
130728027|NCT01449370|470625587|FG021|Overall Study|Medication Prohibited by Protocol|0|||
130481991|NCT03213691|469732922|FG000|Overall Study|Physician Decision|1|||
130481992|NCT03213691|469732922|FG000|Overall Study|Progressive Disease|14|||
130481993|NCT03213691|469732922|FG000|Overall Study|Ineligible|1|||
130481994|NCT04898673|469732923|FG000|Overall Study|Screenfail|1|||
130481995|NCT04898673|469732924|FG001|Overall Study|Screenfail|0|||
130481996|NCT01152450|469732929|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
130481997|NCT01152450|469732930|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
130481998|NCT01152450|469732931|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
130481999|NCT01152450|469732932|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
130482000|NCT01152450|469732933|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
130482001|NCT01152450|469732934|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
130482002|NCT01152450|469732929|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
130482003|NCT01152450|469732930|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
130482004|NCT01152450|469732931|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
130482005|NCT01152450|469732932|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
130482006|NCT01152450|469732933|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
130482007|NCT01152450|469732934|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
130482008|NCT01152450|469732929|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130482009|NCT01152450|469732930|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
130482010|NCT01152450|469732931|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
130482011|NCT01152450|469732932|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130482012|NCT01152450|469732933|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130482013|NCT01152450|469732934|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130482014|NCT01544114|469732938|FG000|Overall Study|Withdrawal by Subject|0|||
130482015|NCT01544114|469732939|FG001|Overall Study|Withdrawal by Subject|0|||
130482016|NCT01544114|469732940|FG002|Overall Study|Withdrawal by Subject|3|||
130482017|NCT01544114|469732938|FG000|Overall Study|Lost to Follow-up|0|||
130482018|NCT01544114|469732939|FG001|Overall Study|Lost to Follow-up|2|||
130482019|NCT01544114|469732940|FG002|Overall Study|Lost to Follow-up|0|||
130482020|NCT01544114|469732938|FG000|Overall Study|Adverse Event|1|||
130482021|NCT01544114|469732939|FG001|Overall Study|Adverse Event|1|||
130482022|NCT01544114|469732940|FG002|Overall Study|Adverse Event|2|||
130482023|NCT01544114|469732938|FG000|Overall Study|Protocol Violation|0|||
130482024|NCT01544114|469732939|FG001|Overall Study|Protocol Violation|1|||
130482025|NCT01544114|469732940|FG002|Overall Study|Protocol Violation|0|||
130482026|NCT03058289|469732945|FG000|Overall Study|Radiographic Deterioration|0|||
130482027|NCT03058289|469732946|FG001|Overall Study|Radiographic Deterioration|3|||
130482028|NCT03058289|469732947|FG002|Overall Study|Radiographic Deterioration|1|||
130482029|NCT03058289|469732948|FG003|Overall Study|Radiographic Deterioration|2|||
130482030|NCT03058289|469732949|FG004|Overall Study|Radiographic Deterioration|6|||
130482031|NCT03058289|469732950|FG005|Overall Study|Radiographic Deterioration|3|||
130482032|NCT03058289|469732951|FG006|Overall Study|Radiographic Deterioration|0|||
130482033|NCT03058289|469732952|FG007|Overall Study|Radiographic Deterioration|4|||
130482034|NCT03058289|469732953|FG008|Overall Study|Radiographic Deterioration|2|||
130482035|NCT03058289|469732945|FG000|Overall Study|Adverse Event|2|||
130482036|NCT03058289|469732946|FG001|Overall Study|Adverse Event|0|||
130482037|NCT03058289|469732947|FG002|Overall Study|Adverse Event|1|||
130482038|NCT03058289|469732948|FG003|Overall Study|Adverse Event|3|||
130482039|NCT03058289|469732949|FG004|Overall Study|Adverse Event|1|||
130482040|NCT03058289|469732950|FG005|Overall Study|Adverse Event|0|||
130482041|NCT03058289|469732951|FG006|Overall Study|Adverse Event|1|||
130482042|NCT03058289|469732952|FG007|Overall Study|Adverse Event|3|||
130482043|NCT03058289|469732953|FG008|Overall Study|Adverse Event|0|||
130482044|NCT03058289|469732945|FG000|Overall Study|Withdrawal by Subject|0|||
130482045|NCT03058289|469732946|FG001|Overall Study|Withdrawal by Subject|0|||
130482046|NCT03058289|469732947|FG002|Overall Study|Withdrawal by Subject|0|||
130482047|NCT03058289|469732948|FG003|Overall Study|Withdrawal by Subject|2|||
130482048|NCT03058289|469732949|FG004|Overall Study|Withdrawal by Subject|0|||
130482049|NCT03058289|469732950|FG005|Overall Study|Withdrawal by Subject|2|||
130482050|NCT03058289|469732951|FG006|Overall Study|Withdrawal by Subject|0|||
130482051|NCT03058289|469732952|FG007|Overall Study|Withdrawal by Subject|4|||
130482052|NCT03058289|469732953|FG008|Overall Study|Withdrawal by Subject|1|||
130482053|NCT03058289|469732945|FG000|Overall Study|Physician Decision|1|||
130482054|NCT03058289|469732946|FG001|Overall Study|Physician Decision|0|||
130482055|NCT03058289|469732947|FG002|Overall Study|Physician Decision|0|||
130482056|NCT03058289|469732948|FG003|Overall Study|Physician Decision|2|||
130482057|NCT03058289|469732949|FG004|Overall Study|Physician Decision|1|||
130482058|NCT03058289|469732950|FG005|Overall Study|Physician Decision|0|||
130482059|NCT03058289|469732951|FG006|Overall Study|Physician Decision|2|||
130482060|NCT03058289|469732952|FG007|Overall Study|Physician Decision|3|||
130482061|NCT03058289|469732953|FG008|Overall Study|Physician Decision|0|||
130482062|NCT03058289|469732945|FG000|Overall Study|Clinical Deterioration|2|||
130482063|NCT03058289|469732946|FG001|Overall Study|Clinical Deterioration|0|||
130482064|NCT03058289|469732947|FG002|Overall Study|Clinical Deterioration|0|||
130482065|NCT03058289|469732948|FG003|Overall Study|Clinical Deterioration|2|||
130482066|NCT03058289|469732949|FG004|Overall Study|Clinical Deterioration|1|||
130482067|NCT03058289|469732950|FG005|Overall Study|Clinical Deterioration|1|||
130482068|NCT03058289|469732951|FG006|Overall Study|Clinical Deterioration|0|||
130482069|NCT03058289|469732952|FG007|Overall Study|Clinical Deterioration|3|||
130482070|NCT03058289|469732953|FG008|Overall Study|Clinical Deterioration|2|||
130482071|NCT03058289|469732945|FG000|Overall Study|Lost to Follow-up|0|||
130482072|NCT03058289|469732946|FG001|Overall Study|Lost to Follow-up|0|||
130482073|NCT03058289|469732947|FG002|Overall Study|Lost to Follow-up|0|||
130482074|NCT03058289|469732948|FG003|Overall Study|Lost to Follow-up|0|||
130482075|NCT03058289|469732949|FG004|Overall Study|Lost to Follow-up|1|||
130482076|NCT03058289|469732950|FG005|Overall Study|Lost to Follow-up|0|||
130482077|NCT03058289|469732951|FG006|Overall Study|Lost to Follow-up|0|||
130482078|NCT03058289|469732952|FG007|Overall Study|Lost to Follow-up|0|||
130482079|NCT03058289|469732953|FG008|Overall Study|Lost to Follow-up|0|||
130482080|NCT03058289|469732945|FG000|Overall Study|Refused Further Treatment|0|||
130482081|NCT03058289|469732946|FG001|Overall Study|Refused Further Treatment|0|||
130482082|NCT03058289|469732947|FG002|Overall Study|Refused Further Treatment|1|||
130482083|NCT03058289|469732948|FG003|Overall Study|Refused Further Treatment|0|||
130482084|NCT03058289|469732949|FG004|Overall Study|Refused Further Treatment|1|||
130482085|NCT03058289|469732950|FG005|Overall Study|Refused Further Treatment|0|||
130482086|NCT03058289|469732951|FG006|Overall Study|Refused Further Treatment|0|||
130482087|NCT03058289|469732952|FG007|Overall Study|Refused Further Treatment|0|||
130482088|NCT03058289|469732953|FG008|Overall Study|Refused Further Treatment|0|||
130482089|NCT03058289|469732945|FG000|Overall Study|Rapid Progression of Disease|0|||
130482090|NCT03058289|469732946|FG001|Overall Study|Rapid Progression of Disease|0|||
130482091|NCT03058289|469732947|FG002|Overall Study|Rapid Progression of Disease|0|||
130482092|NCT03058289|469732948|FG003|Overall Study|Rapid Progression of Disease|1|||
130482093|NCT03058289|469732949|FG004|Overall Study|Rapid Progression of Disease|0|||
130482094|NCT03058289|469732950|FG005|Overall Study|Rapid Progression of Disease|0|||
130482095|NCT03058289|469732951|FG006|Overall Study|Rapid Progression of Disease|0|||
130482096|NCT03058289|469732952|FG007|Overall Study|Rapid Progression of Disease|0|||
130482097|NCT03058289|469732953|FG008|Overall Study|Rapid Progression of Disease|0|||
130482098|NCT01799265|469732954|FG000|Overall Study|Lost to Follow-up|1|||
130482099|NCT01799265|469732955|FG001|Overall Study|Lost to Follow-up|0|||
130482100|NCT01799265|469732954|FG000|Overall Study|Protocol Violation|2|||
130482101|NCT01799265|469732955|FG001|Overall Study|Protocol Violation|1|||
130482102|NCT01799265|469732954|FG000|Overall Study|inadequate sleep study|0|||
130482103|NCT01799265|469732955|FG001|Overall Study|inadequate sleep study|2|||
130482104|NCT05251909|469734699|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
130482105|NCT05251909|469734700|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
130482106|NCT05543915|469734701|FG000|Overall Study|Lost to Follow-up|0|||
130482107|NCT05543915|469734702|FG001|Overall Study|Lost to Follow-up|1|||
130482108|NCT03381196|469734703|FG000|Overall Study|Withdrawal by Subject|7|||
130482109|NCT03381196|469734704|FG001|Overall Study|Withdrawal by Subject|7|||
130482110|NCT03381196|469734703|FG000|Overall Study|Other|0|||
130482111|NCT03381196|469734704|FG001|Overall Study|Other|1|||
130482112|NCT03381196|469734703|FG000|Overall Study|Lost to Follow-up|5|||
130482113|NCT03381196|469734704|FG001|Overall Study|Lost to Follow-up|4|||
130482114|NCT03381196|469734703|FG000|Overall Study|Death|0|||
130482115|NCT03381196|469734704|FG001|Overall Study|Death|1|||
130482116|NCT03381196|469734703|FG000|Overall Study|Adverse Event|1|||
130482117|NCT03381196|469734704|FG001|Overall Study|Adverse Event|0|||
130482118|NCT03381196|469734703|FG000|Overall Study|Randomized, not treated|3|||
130482119|NCT03381196|469734704|FG001|Overall Study|Randomized, not treated|6|||
130482120|NCT06019559|469734706|FG000|Overall Study|Withdrawal by Subject|7|||
130482121|NCT06019559|469734707|FG001|Overall Study|Withdrawal by Subject|6|||
130482122|NCT06019559|469734708|FG002|Overall Study|Withdrawal by Subject|5|||
130482123|NCT06019559|469734706|FG000|Overall Study|Lost to Follow-up|2|||
130482124|NCT06019559|469734707|FG001|Overall Study|Lost to Follow-up|0|||
130482125|NCT06019559|469734708|FG002|Overall Study|Lost to Follow-up|3|||
130482126|NCT06215521|469734710|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
130482127|NCT06215521|469734711|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
130482128|NCT06215521|469734712|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
130482129|NCT06215521|469734713|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
130482130|NCT06215521|469734714|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
130482131|NCT06215521|469734715|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
130482132|NCT04044768|469734716|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
130482133|NCT04044768|469734717|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
130482134|NCT01574274|469734718|FG000|Overall Study|Ineligible|0|||
130482135|NCT01574274|469734719|FG001|Overall Study|Ineligible|1|||
130482136|NCT01574274|469734718|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
130482137|NCT01574274|469734719|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
130482138|NCT01574274|469734718|FG000|Overall Study|Ph+ B-ALL|3|||
130482139|NCT01574274|469734719|FG001|Overall Study|Ph+ B-ALL|4|||
130482140|NCT01574274|469734718|FG000|Overall Study|Induction Death|2|||
130482141|NCT01574274|469734719|FG001|Overall Study|Induction Death|0|||
130482142|NCT01574274|469734718|FG000|Overall Study|Induction Failure|4|||
130482143|NCT01574274|469734719|FG001|Overall Study|Induction Failure|1|||
130482144|NCT01574274|469734718|FG000|Overall Study|Adverse Event|16|||
130482145|NCT01574274|469734719|FG001|Overall Study|Adverse Event|13|||
130482146|NCT01574274|469734718|FG000|Overall Study|Remission Death|1|||
130482147|NCT01574274|469734719|FG001|Overall Study|Remission Death|0|||
130482148|NCT01574274|469734718|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
130482149|NCT01574274|469734719|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
130482150|NCT01574274|469734718|FG000|Overall Study|Other, unknown|3|||
130482151|NCT01574274|469734719|FG001|Overall Study|Other, unknown|2|||
130482152|NCT05089019|469734723|FG000|Period 1|Withdrawal by Subject|0|||
130482153|NCT05089019|469734724|FG001|Period 1|Withdrawal by Subject|1|||
130482154|NCT05089019|469734723|FG000|Washout Period|Adverse Event|3|||
130482155|NCT05089019|469734724|FG001|Washout Period|Adverse Event|4|||
130482156|NCT05089019|469734723|FG000|Washout Period|Lost to Follow-up|1|||
130482157|NCT05089019|469734724|FG001|Washout Period|Lost to Follow-up|0|||
130482158|NCT05089019|469734723|FG000|Washout Period|Physician Decision|2|||
130482159|NCT05089019|469734724|FG001|Washout Period|Physician Decision|0|||
130482160|NCT05089019|469734723|FG000|Washout Period|Withdrawal by Subject|6|||
130482161|NCT05089019|469734724|FG001|Washout Period|Withdrawal by Subject|3|||
130482162|NCT05089019|469734723|FG000|Period 2|Adverse Event|4|||
130482163|NCT05089019|469734724|FG001|Period 2|Adverse Event|2|||
130482164|NCT05089019|469734723|FG000|Period 2|Lost to Follow-up|1|||
130482165|NCT05089019|469734724|FG001|Period 2|Lost to Follow-up|0|||
130482166|NCT05089019|469734723|FG000|Period 2|Withdrawal by Subject|0|||
130482167|NCT05089019|469734724|FG001|Period 2|Withdrawal by Subject|1|||
130482168|NCT03858634|469734725|FG000|Overall Study|Withdrawal by Subject|1|||
130482169|NCT03858634|469734726|FG001|Overall Study|Withdrawal by Subject|0|||
130482170|NCT03858634|469734725|FG000|Overall Study|Adverse Event|1|||
130482171|NCT03858634|469734726|FG001|Overall Study|Adverse Event|0|||
130482172|NCT03858634|469734725|FG000|Overall Study|Lost to Follow-up|0|||
130482173|NCT03858634|469734726|FG001|Overall Study|Lost to Follow-up|1|||
130482174|NCT03858634|469734725|FG000|Overall Study|Other, Not Specified|1|||
130482175|NCT03858634|469734726|FG001|Overall Study|Other, Not Specified|1|||
130482176|NCT04676763|469734727|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
130482177|NCT04676763|469734728|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
130482178|NCT04676763|469734729|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
130482179|NCT04676763|469734727|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
130482180|NCT04676763|469734728|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
130482181|NCT04676763|469734729|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
130482182|NCT04676763|469734727|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
130482183|NCT04676763|469734728|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
130482184|NCT04676763|469734729|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
130482185|NCT03150173|469734730|FG000|Overall Study|Lost to Follow-up|13|||
130482186|NCT03150173|469734731|FG001|Overall Study|Lost to Follow-up|5|||
130482187|NCT01593917|469734732|FG000|Overall Study|Death|67|||
130482188|NCT01593917|469734732|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
130482189|NCT01593917|469734732|FG000|Overall Study|Withdrawal by Subject|23|||
130482190|NCT01593917|469734732|FG000|Overall Study|Lost to Follow-up|12|||
130482191|NCT01593917|469734732|FG000|Overall Study|Protocol Violation|5|||
130482192|NCT01593917|469734732|FG000|Overall Study|Physician Decision|3|||
130482193|NCT04225273|469734745|FG000|Overall Study|Lost to Follow-up|3|||
130482194|NCT05270408|469734747|FG000|Started Treatment|Withdrawal by Subject|0|||
130482195|NCT05270408|469734748|FG001|Started Treatment|Withdrawal by Subject|0|||
130482196|NCT05270408|469734749|FG002|Started Treatment|Withdrawal by Subject|3|||
130482197|NCT05270408|469734747|FG000|Started Treatment|Adverse Event|0|||
130482198|NCT05270408|469734748|FG001|Started Treatment|Adverse Event|0|||
130482199|NCT05270408|469734749|FG002|Started Treatment|Adverse Event|1|||
130482200|NCT05270408|469734747|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
130482201|NCT05270408|469734748|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
130482202|NCT05270408|469734749|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
130482203|NCT03768505|469734750|FG000|Overall Study|sponsor decision|76|||
130482204|NCT03768505|469734750|FG000|Overall Study|Death|35|||
130482205|NCT03768505|469734750|FG000|Overall Study|Other -Various|30|||
130482206|NCT03768505|469734750|FG000|Overall Study|Withdrawal by Subject|22|||
130482207|NCT03768505|469734750|FG000|Overall Study|Lost to Follow-up|6|||
130482208|NCT02815566|469734751|FG000|Overall Study|Adverse Event|1|||
130482209|NCT02815566|469734752|FG001|Overall Study|Adverse Event|1|||
130482210|NCT02815566|469734751|FG000|Overall Study|Withdrawal by Subject|1|||
130482211|NCT02815566|469734752|FG001|Overall Study|Withdrawal by Subject|0|||
130482212|NCT02815566|469734751|FG000|Overall Study|Lost to Follow-up|0|||
130482213|NCT02815566|469734752|FG001|Overall Study|Lost to Follow-up|1|||
130482214|NCT03252847|469734753|FG000|Overall Study|Withdrawal by Subject|0|||
130482215|NCT03252847|469734754|FG001|Overall Study|Withdrawal by Subject|0|||
130482216|NCT03252847|469734755|FG002|Overall Study|Withdrawal by Subject|1|||
130482217|NCT03252847|469734756|FG003|Overall Study|Withdrawal by Subject|0|||
130482218|NCT03252847|469734757|FG004|Overall Study|Withdrawal by Subject|0|||
130482219|NCT03252847|469734758|FG005|Overall Study|Withdrawal by Subject|0|||
130482220|NCT03252847|469734759|FG006|Overall Study|Withdrawal by Subject|0|||
130482221|NCT03252847|469734753|FG000|Overall Study|Other: Patient decision|0|||
130482222|NCT03252847|469734754|FG001|Overall Study|Other: Patient decision|0|||
130482223|NCT03252847|469734755|FG002|Overall Study|Other: Patient decision|0|||
130482224|NCT03252847|469734756|FG003|Overall Study|Other: Patient decision|0|||
130482225|NCT03252847|469734757|FG004|Overall Study|Other: Patient decision|1|||
130482226|NCT03252847|469734758|FG005|Overall Study|Other: Patient decision|0|||
130482227|NCT03252847|469734759|FG006|Overall Study|Other: Patient decision|0|||
130482228|NCT02993159|469734760|FG000|Overall Study|Withdrawal by Subject|1|||
130482229|NCT02993159|469734761|FG001|Overall Study|Withdrawal by Subject|3|||
130482230|NCT02993159|469734760|FG000|Overall Study|Protocol Violation|1|||
130482231|NCT02993159|469734761|FG001|Overall Study|Protocol Violation|0|||
130482232|NCT02993159|469734760|FG000|Overall Study|Opted out of surgery|2|||
130482233|NCT02993159|469734761|FG001|Overall Study|Opted out of surgery|0|||
130482234|NCT02993159|469734760|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
130482235|NCT02993159|469734761|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
130482236|NCT02993159|469734760|FG000|Overall Study|Physician Decision|0|||
130482237|NCT02993159|469734761|FG001|Overall Study|Physician Decision|1|||
130482238|NCT04042233|469734763|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
130482239|NCT04042233|469734764|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
130482240|NCT04042233|469734763|FG000|Overall Study|Protocol Violation|0|||
130482241|NCT04042233|469734764|FG001|Overall Study|Protocol Violation|2|||
130482242|NCT04907851|469734767|FG000|Overall Study|Consent withdrawn|1|||
130482243|NCT04907851|469734768|FG001|Overall Study|Consent withdrawn|2|||
130482244|NCT04907851|469734769|FG002|Overall Study|Consent withdrawn|0|||
130482245|NCT04907851|469734767|FG000|Overall Study|Death|5|||
130482246|NCT04907851|469734768|FG001|Overall Study|Death|15|||
130482247|NCT04907851|469734769|FG002|Overall Study|Death|10|||
130482248|NCT01210807|469734774|FG000|Overall Study|Lost to Follow-up|1|||
130482249|NCT01210807|469734775|FG001|Overall Study|Lost to Follow-up|2|||
130482250|NCT01210807|469734774|FG000|Overall Study|Not implanted bilaterally|2|||
130482251|NCT01210807|469734775|FG001|Overall Study|Not implanted bilaterally|1|||
130482252|NCT05477186|469734780|FG000|Overall Study|Vaccine not administered|0|||
130482253|NCT05477186|469734781|FG001|Overall Study|Vaccine not administered|2|||
130482254|NCT05477186|469734782|FG002|Overall Study|Vaccine not administered|1|||
130482255|NCT05477186|469734783|FG003|Overall Study|Vaccine not administered|0|||
130482256|NCT05477186|469734784|FG004|Overall Study|Vaccine not administered|1|||
130482257|NCT05477186|469734785|FG005|Overall Study|Vaccine not administered|0|||
130482258|NCT05477186|469734786|FG006|Overall Study|Vaccine not administered|0|||
130482259|NCT05477186|469734780|FG000|Overall Study|Withdrawal by Subject|1|||
130482260|NCT05477186|469734781|FG001|Overall Study|Withdrawal by Subject|0|||
130482261|NCT05477186|469734782|FG002|Overall Study|Withdrawal by Subject|0|||
130482262|NCT05477186|469734783|FG003|Overall Study|Withdrawal by Subject|0|||
130482263|NCT05477186|469734784|FG004|Overall Study|Withdrawal by Subject|0|||
130482264|NCT05477186|469734785|FG005|Overall Study|Withdrawal by Subject|1|||
130482265|NCT05477186|469734786|FG006|Overall Study|Withdrawal by Subject|0|||
130482266|NCT05477186|469734780|FG000|Overall Study|Lost to Follow-up|1|||
130482267|NCT05477186|469734781|FG001|Overall Study|Lost to Follow-up|0|||
130482268|NCT05477186|469734782|FG002|Overall Study|Lost to Follow-up|2|||
130482269|NCT05477186|469734783|FG003|Overall Study|Lost to Follow-up|1|||
130482270|NCT05477186|469734784|FG004|Overall Study|Lost to Follow-up|1|||
130482271|NCT05477186|469734785|FG005|Overall Study|Lost to Follow-up|0|||
130482272|NCT05477186|469734786|FG006|Overall Study|Lost to Follow-up|2|||
130482273|NCT00324805|469734787|FG000|Overall Study|Adverse Event|62|||
130482274|NCT00324805|469734788|FG001|Overall Study|Adverse Event|203|||
130482275|NCT00324805|469734787|FG000|Overall Study|Progression|7|||
130482276|NCT00324805|469734788|FG001|Overall Study|Progression|35|||
130482277|NCT00324805|469734787|FG000|Overall Study|Withdrawal by Subject|51|||
130482278|NCT00324805|469734788|FG001|Overall Study|Withdrawal by Subject|174|||
130482279|NCT00324805|469734787|FG000|Overall Study|Death|6|||
130482280|NCT00324805|469734788|FG001|Overall Study|Death|9|||
130482281|NCT00324805|469734787|FG000|Overall Study|Alternative therapy|4|||
130564986|NCT00847145|470035345|FG000|Overall Study|Inappropriate enrollment|0|||
130564987|NCT00847145|470035346|FG001|Overall Study|Inappropriate enrollment|0|||
130564988|NCT00847145|470035347|FG002|Overall Study|Inappropriate enrollment|0|||
130564989|NCT00847145|470035348|FG003|Overall Study|Inappropriate enrollment|0|||
130482282|NCT00324805|469734788|FG001|Overall Study|Alternative therapy|8|||
130482283|NCT00324805|469734787|FG000|Overall Study|Other complicating disease|1|||
130482284|NCT00324805|469734788|FG001|Overall Study|Other complicating disease|9|||
130482285|NCT00324805|469734787|FG000|Overall Study|Other reasons|7|||
130482286|NCT00324805|469734788|FG001|Overall Study|Other reasons|26|||
130482287|NCT00324805|469734787|FG000|Overall Study|Other|0|||
130482288|NCT00324805|469734788|FG001|Overall Study|Other|2|||
130482289|NCT00324805|469734787|FG000|Overall Study|Did not start therapy|12|||
130482290|NCT00324805|469734788|FG001|Overall Study|Did not start therapy|17|||
130482291|NCT05792085|469734790|FG000|Overall Study|Death|0|||
130482292|NCT05792085|469734791|FG001|Overall Study|Death|0|||
130482293|NCT05792085|469734792|FG002|Overall Study|Death|0|||
130482294|NCT05792085|469734793|FG003|Overall Study|Death|0|||
130482295|NCT05792085|469734794|FG004|Overall Study|Death|1|||
130482296|NCT01919554|469734795|FG000|Overall Study|Withdrawal by Subject|0|||
130482297|NCT01919554|469734796|FG001|Overall Study|Withdrawal by Subject|0|||
130482298|NCT01919554|469734797|FG002|Overall Study|Withdrawal by Subject|1|||
130482299|NCT01919554|469734798|FG003|Overall Study|Withdrawal by Subject|1|||
130482300|NCT01197378|469734799|FG000|Overall Study|Adverse Event|3|||
130482301|NCT01197378|469734799|FG000|Overall Study|Withdrawal by Subject|1|||
130482302|NCT01197378|469734799|FG000|Overall Study|Physician Decision|1|||
130482303|NCT01197378|469734799|FG000|Overall Study|Other|2|||
130482304|NCT05546411|469734801|FG000|Overall Study|Progressive Disease|1|||
130482305|NCT05546411|469734802|FG001|Overall Study|Progressive Disease|0|||
130482306|NCT05546411|469734801|FG000|Overall Study|Adverse Event|0|||
130482307|NCT05546411|469734802|FG001|Overall Study|Adverse Event|1|||
130482308|NCT05546411|469734801|FG000|Overall Study|Metastatic disease|1|||
130482309|NCT05546411|469734802|FG001|Overall Study|Metastatic disease|0|||
130482310|NCT02606422|469734803|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
130482311|NCT02606422|469734804|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
130482312|NCT02606422|469734803|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
130482313|NCT02606422|469734804|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
130482314|NCT02606422|469734803|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
130482315|NCT02606422|469734804|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
130482316|NCT02606422|469734803|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
130482317|NCT02606422|469734804|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
130482318|NCT04625465|469734805|FG000|Overall Study|Lost to Follow-up|2|||
130482319|NCT04625465|469734806|FG001|Overall Study|Lost to Follow-up|2|||
130482320|NCT04625465|469734807|FG002|Overall Study|Lost to Follow-up|1|||
130482321|NCT04625465|469734808|FG003|Overall Study|Lost to Follow-up|0|||
130482322|NCT04625465|469734809|FG004|Overall Study|Lost to Follow-up|0|||
130482323|NCT04625465|469734810|FG005|Overall Study|Lost to Follow-up|2|||
130482324|NCT04625465|469734811|FG006|Overall Study|Lost to Follow-up|0|||
130482325|NCT04625465|469734812|FG007|Overall Study|Lost to Follow-up|0|||
130482326|NCT04625465|469734805|FG000|Overall Study|Death|1|||
130482327|NCT04625465|469734806|FG001|Overall Study|Death|0|||
130482328|NCT04625465|469734807|FG002|Overall Study|Death|0|||
130482329|NCT04625465|469734808|FG003|Overall Study|Death|0|||
130482330|NCT04625465|469734809|FG004|Overall Study|Death|0|||
130482331|NCT04625465|469734810|FG005|Overall Study|Death|0|||
130482332|NCT04625465|469734811|FG006|Overall Study|Death|0|||
130482333|NCT04625465|469734812|FG007|Overall Study|Death|0|||
130482334|NCT04625465|469734805|FG000|Overall Study|Withdrawal by Subject|1|||
130482335|NCT04625465|469734806|FG001|Overall Study|Withdrawal by Subject|0|||
130482336|NCT04625465|469734807|FG002|Overall Study|Withdrawal by Subject|4|||
130482337|NCT04625465|469734808|FG003|Overall Study|Withdrawal by Subject|4|||
130482338|NCT04625465|469734809|FG004|Overall Study|Withdrawal by Subject|4|||
130482339|NCT04625465|469734810|FG005|Overall Study|Withdrawal by Subject|0|||
130482340|NCT04625465|469734811|FG006|Overall Study|Withdrawal by Subject|0|||
130482341|NCT04625465|469734812|FG007|Overall Study|Withdrawal by Subject|0|||
130482342|NCT05704543|469734813|FG000|Overall Study|Withdrawal by Subject|1|||
130482343|NCT05704543|469734814|FG001|Overall Study|Withdrawal by Subject|1|||
130482344|NCT05704543|469734815|FG002|Overall Study|Withdrawal by Subject|0|||
130482345|NCT05704543|469734816|FG003|Overall Study|Withdrawal by Subject|2|||
130564990|NCT00847145|470035349|FG004|Overall Study|Inappropriate enrollment|1|||
130482346|NCT05704543|469734813|FG000|Overall Study|Lost to Follow-up|1|||
130482347|NCT05704543|469734814|FG001|Overall Study|Lost to Follow-up|2|||
130482348|NCT05704543|469734815|FG002|Overall Study|Lost to Follow-up|0|||
130482349|NCT05704543|469734816|FG003|Overall Study|Lost to Follow-up|0|||
130564991|NCT00847145|470035350|FG005|Overall Study|Inappropriate enrollment|0|||
130564992|NCT00847145|470035351|FG006|Overall Study|Inappropriate enrollment|0|||
130564993|NCT00847145|470035352|FG007|Overall Study|Inappropriate enrollment|0|||
130564994|NCT00847145|470035345|FG000|Overall Study|Protocol Violation|0|||
130482350|NCT03691935|469734818|FG000|Overall Study|Physician Decision|2|||
130482351|NCT03691935|469734819|FG001|Overall Study|Physician Decision|1|||
130482352|NCT03691935|469734818|FG000|Overall Study|Adverse Event|3|||
130482353|NCT03691935|469734819|FG001|Overall Study|Adverse Event|0|||
130482354|NCT02151981|469734822|FG000|Overall Study|Death|184|||
130482355|NCT02151981|469734823|FG001|Overall Study|Death|88|||
130482356|NCT02151981|469734822|FG000|Overall Study|Lost to Follow-up|7|||
130482357|NCT02151981|469734823|FG001|Overall Study|Lost to Follow-up|1|||
130482358|NCT02151981|469734822|FG000|Overall Study|Withdrawal by Subject|27|||
130564995|NCT00847145|470035346|FG001|Overall Study|Protocol Violation|0|||
130482359|NCT02151981|469734823|FG001|Overall Study|Withdrawal by Subject|21|||
130482360|NCT02151981|469734822|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130482361|NCT02151981|469734823|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130482362|NCT02151981|469734822|FG000|Overall Study|Other reasons|1|||
130482363|NCT02151981|469734823|FG001|Overall Study|Other reasons|2|||
130482364|NCT05446168|469734824|FG000|Overall Study|Physician Decision|0|||
130482365|NCT05446168|469734825|FG001|Overall Study|Physician Decision|1|||
130482366|NCT01946789|469734831|FG000|Overall Study|Death|0|||
130482367|NCT01946789|469734832|FG001|Overall Study|Death|2|||
130482368|NCT01946789|469734833|FG002|Overall Study|Death|1|||
130482369|NCT01946789|469734834|FG003|Overall Study|Death|1|||
130482370|NCT01946789|469734835|FG004|Overall Study|Death|1|||
130482371|NCT01946789|469734836|FG005|Overall Study|Death|1|||
130482372|NCT01946789|469734837|FG006|Overall Study|Death|3|||
130482373|NCT01946789|469734838|FG007|Overall Study|Death|1|||
130482374|NCT01946789|469734839|FG008|Overall Study|Death|2|||
130482375|NCT01946789|469734831|FG000|Overall Study|Progressive Disease|0|||
130482376|NCT01946789|469734832|FG001|Overall Study|Progressive Disease|0|||
130482377|NCT01946789|469734833|FG002|Overall Study|Progressive Disease|1|||
130482378|NCT01946789|469734834|FG003|Overall Study|Progressive Disease|0|||
130482379|NCT01946789|469734835|FG004|Overall Study|Progressive Disease|0|||
130482380|NCT01946789|469734836|FG005|Overall Study|Progressive Disease|2|||
130482381|NCT01946789|469734837|FG006|Overall Study|Progressive Disease|0|||
130482382|NCT01946789|469734838|FG007|Overall Study|Progressive Disease|0|||
130482383|NCT01946789|469734839|FG008|Overall Study|Progressive Disease|0|||
130482384|NCT01946789|469734831|FG000|Overall Study|Withdrawal by Subject|0|||
130482385|NCT01946789|469734832|FG001|Overall Study|Withdrawal by Subject|0|||
130482386|NCT01946789|469734833|FG002|Overall Study|Withdrawal by Subject|0|||
130482387|NCT01946789|469734834|FG003|Overall Study|Withdrawal by Subject|2|||
130482388|NCT01946789|469734835|FG004|Overall Study|Withdrawal by Subject|1|||
130482389|NCT01946789|469734836|FG005|Overall Study|Withdrawal by Subject|0|||
130482390|NCT01946789|469734837|FG006|Overall Study|Withdrawal by Subject|1|||
130482391|NCT01946789|469734838|FG007|Overall Study|Withdrawal by Subject|0|||
130482392|NCT01946789|469734839|FG008|Overall Study|Withdrawal by Subject|0|||
130482393|NCT05374798|469734840|FG000|Overall Study|Lost to Follow-up|2|||
130482394|NCT05374798|469734840|FG000|Overall Study|Withdrawal by Subject|2|||
130482395|NCT05374798|469734840|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
130482396|NCT05576155|469734841|FG000|Overall Study|Withdrawal by Subject|1|||
130482397|NCT05576155|469734842|FG001|Overall Study|Withdrawal by Subject|1|||
130482398|NCT01275677|469734843|FG000|Overall Study|Not at risk for recurrence.|1|||
130482399|NCT01275677|469734844|FG001|Overall Study|Not at risk for recurrence.|1|||
130482400|NCT01275677|469734843|FG000|Overall Study|No follow-up|26|||
130482401|NCT01275677|469734844|FG001|Overall Study|No follow-up|37|||
130482402|NCT01275677|469734843|FG000|Overall Study|No clinical follow up.|1|||
130482403|NCT01275677|469734844|FG001|Overall Study|No clinical follow up.|4|||
130482404|NCT04409353|469734852|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
130482405|NCT04409353|469734853|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
130482406|NCT04409353|469734854|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
130482407|NCT04409353|469734852|FG000|Overall Study|Lost to Follow-up|6|||
130482408|NCT04409353|469734853|FG001|Overall Study|Lost to Follow-up|8|||
130482409|NCT04409353|469734854|FG002|Overall Study|Lost to Follow-up|7|||
130482410|NCT04409353|469734852|FG000|Overall Study|Major surgery during participation window|4|||
130482411|NCT04409353|469734853|FG001|Overall Study|Major surgery during participation window|3|||
130482412|NCT04409353|469734854|FG002|Overall Study|Major surgery during participation window|3|||
130482413|NCT04409353|469734852|FG000|Overall Study|Life event occurred during participation window|3|||
130482414|NCT04409353|469734853|FG001|Overall Study|Life event occurred during participation window|2|||
130482415|NCT04409353|469734854|FG002|Overall Study|Life event occurred during participation window|4|||
130482416|NCT04409353|469734852|FG000|Overall Study|Lack of Efficacy|4|||
130482417|NCT04409353|469734853|FG001|Overall Study|Lack of Efficacy|1|||
130482418|NCT04409353|469734854|FG002|Overall Study|Lack of Efficacy|3|||
130482419|NCT04409353|469734852|FG000|Overall Study|Adverse Event|2|||
130482420|NCT04409353|469734853|FG001|Overall Study|Adverse Event|1|||
130482421|NCT04409353|469734854|FG002|Overall Study|Adverse Event|1|||
130482422|NCT04409353|469734852|FG000|Overall Study|Disease burden - unable to participate|0|||
130482423|NCT04409353|469734853|FG001|Overall Study|Disease burden - unable to participate|1|||
130482424|NCT04409353|469734854|FG002|Overall Study|Disease burden - unable to participate|1|||
130482425|NCT04409353|469734852|FG000|Overall Study|Intervention too complicated|1|||
130482426|NCT04409353|469734853|FG001|Overall Study|Intervention too complicated|0|||
130482427|NCT04409353|469734854|FG002|Overall Study|Intervention too complicated|1|||
130482428|NCT04081103|469734855|FG000|Overall Study|Adverse Event|1|||
130482429|NCT04081103|469734856|FG001|Overall Study|Adverse Event|1|||
130482430|NCT04081103|469734857|FG002|Overall Study|Adverse Event|1|||
130482431|NCT04081103|469734855|FG000|Overall Study|Physician Decision|0|||
130482432|NCT04081103|469734856|FG001|Overall Study|Physician Decision|0|||
130482433|NCT04081103|469734857|FG002|Overall Study|Physician Decision|1|||
130482434|NCT05309291|469734858|FG000|Overall Study|Adverse Event|0|||
130482435|NCT05309291|469734859|FG001|Overall Study|Adverse Event|1|||
130482436|NCT05209152|469734862|FG000|Overall Study|Sponsor decision|1|||
130482437|NCT05209152|469734863|FG001|Overall Study|Sponsor decision|2|||
130482438|NCT05209152|469734862|FG000|Overall Study|Death|3|||
130482439|NCT05209152|469734863|FG001|Overall Study|Death|1|||
130482440|NCT02696707|469736095|FG000|Per Protocol Population|Physician Decision|2|||
130482441|NCT02696707|469736096|FG001|Per Protocol Population|Physician Decision|1|||
130482442|NCT02696707|469736095|FG000|Per Protocol Population|Participant Decision|0|||
130482443|NCT02696707|469736096|FG001|Per Protocol Population|Participant Decision|2|||
130482444|NCT02696707|469736095|FG000|Completed Study as Planned|Reason = LVEF|2|||
130482445|NCT02696707|469736096|FG001|Completed Study as Planned|Reason = LVEF|2|||
130482446|NCT02696707|469736095|FG000|Completed Study as Planned|Protocol Violation|2|||
130482447|NCT02696707|469736096|FG001|Completed Study as Planned|Protocol Violation|6|||
130482448|NCT02696707|469736095|FG000|Completed Study as Planned|Metastatic disease|3|||
130482449|NCT02696707|469736096|FG001|Completed Study as Planned|Metastatic disease|0|||
130482450|NCT02696707|469736095|FG000|Completed Study as Planned|Location|1|||
130482451|NCT02696707|469736096|FG001|Completed Study as Planned|Location|1|||
130482452|NCT06181227|469736101|FG000|Overall Study|Study terminated by sponsor|7|||
130482453|NCT06181227|469736102|FG001|Overall Study|Study terminated by sponsor|9|||
130482454|NCT00433329|469736105|FG000|Overall Study|Adverse Event|9|||
130482455|NCT00433329|469736105|FG000|Overall Study|Death|4|||
130482456|NCT00433329|469736105|FG000|Overall Study|Withdrew consent|3|||
130482457|NCT00433329|469736105|FG000|Overall Study|Discontinued sildenafil|2|||
130482458|NCT00433329|469736105|FG000|Overall Study|Moved out of state|1|||
130482459|NCT00433329|469736105|FG000|Overall Study|Lost to Follow-up|1|||
130482460|NCT00433329|469736105|FG000|Overall Study|Physician Decision|1|||
130482461|NCT04376502|469736108|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
130482462|NCT03748953|469736109|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
130482463|NCT03748953|469736110|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
130482464|NCT03748953|469736109|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
130482465|NCT03748953|469736110|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
130482466|NCT03748953|469736109|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
130482467|NCT03748953|469736110|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
130482468|NCT03748953|469736109|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
130482469|NCT03748953|469736110|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
130482470|NCT03748953|469736109|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
130482471|NCT03748953|469736110|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
130482472|NCT04992520|469736118|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
130482473|NCT04992520|469736119|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
130482474|NCT04992520|469736120|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
130482475|NCT04992520|469736121|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
130482476|NCT04992520|469736122|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
130482477|NCT04992520|469736123|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
130482478|NCT04992520|469736118|FG000|Part A: First Challenge|Non-compliance|0|||
130482479|NCT04992520|469736119|FG001|Part A: First Challenge|Non-compliance|0|||
130482480|NCT04992520|469736120|FG002|Part A: First Challenge|Non-compliance|0|||
130482481|NCT04992520|469736121|FG003|Part A: First Challenge|Non-compliance|1|||
130482482|NCT04992520|469736122|FG004|Part A: First Challenge|Non-compliance|0|||
130482483|NCT04992520|469736123|FG005|Part A: First Challenge|Non-compliance|0|||
130482484|NCT04992520|469736118|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
130482485|NCT04992520|469736119|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
130482486|NCT04992520|469736120|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
130482487|NCT04992520|469736121|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
130482488|NCT04992520|469736122|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
130482489|NCT04992520|469736123|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
130482490|NCT04992520|469736118|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
130482491|NCT04992520|469736119|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
130482492|NCT04992520|469736120|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
130482493|NCT04992520|469736121|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
130482494|NCT04992520|469736122|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
130482495|NCT04992520|469736123|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
130482496|NCT06103188|469736126|FG000|Overall Study|Lost to Follow-up|1|||
130482497|NCT06103188|469736127|FG001|Overall Study|Lost to Follow-up|6|||
130482498|NCT06103188|469736128|FG002|Overall Study|Lost to Follow-up|4|||
130482499|NCT04979442|469736133|FG000|Overall Study|Death|43|||
130482500|NCT04979442|469736134|FG001|Overall Study|Death|30|||
130482501|NCT04979442|469736133|FG000|Overall Study|Withdrawal by Subject|8|||
130482502|NCT04979442|469736134|FG001|Overall Study|Withdrawal by Subject|13|||
130482503|NCT04979442|469736133|FG000|Overall Study|Physician Decision|1|||
130482504|NCT04979442|469736134|FG001|Overall Study|Physician Decision|1|||
130482505|NCT04979442|469736133|FG000|Overall Study|Lost to Follow-up|0|||
130482506|NCT04979442|469736134|FG001|Overall Study|Lost to Follow-up|2|||
130482507|NCT04979442|469736133|FG000|Overall Study|do not want to continue|0|||
130482508|NCT04979442|469736134|FG001|Overall Study|do not want to continue|1|||
130482509|NCT01175356|469736135|FG000|Overall Study|Death|1|||
130482510|NCT01175356|469736135|FG000|Overall Study|Lack of Efficacy|12|||
130482511|NCT01175356|469736135|FG000|Overall Study|Lost to Follow-up|1|||
130482512|NCT01175356|469736135|FG000|Overall Study|Physician Decision|23|||
130482513|NCT01175356|469736135|FG000|Overall Study|Ineligible|1|||
130482514|NCT01175356|469736135|FG000|Overall Study|Treatment Slot Not Available|18|||
130482515|NCT01175356|469736135|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
130482516|NCT01175356|469736135|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
130482517|NCT01175356|469736135|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
130482518|NCT01175356|469736135|FG000|Overall Study|Inadequate stem cell for transplant|1|||
130482519|NCT01175356|469736135|FG000|Overall Study|Initiation other tx prior to completion|9|||
130482520|NCT04005794|469736140|FG000|Overall Study|Lost to Follow-up|0|||
130482521|NCT04005794|469736141|FG001|Overall Study|Lost to Follow-up|4|||
130482522|NCT04005794|469736142|FG002|Overall Study|Lost to Follow-up|0|||
130482523|NCT04313972|469736145|FG000|Overall Study|Withdrawal by Subject|0|||
130482524|NCT04313972|469736146|FG001|Overall Study|Withdrawal by Subject|1|||
130482525|NCT02714257|469736162|FG000|Overall Study|Withdrawal by Subject|6|||
130482526|NCT02714257|469736163|FG001|Overall Study|Withdrawal by Subject|11|||
130482527|NCT02714257|469736162|FG000|Overall Study|Death|3|||
130482528|NCT02714257|469736163|FG001|Overall Study|Death|4|||
130482529|NCT02714257|469736162|FG000|Overall Study|Lost to Follow-up|1|||
130482530|NCT02714257|469736163|FG001|Overall Study|Lost to Follow-up|6|||
130482531|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
130482532|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
130482533|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
130482534|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
130482535|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
130482536|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
130482537|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
130482538|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
130482539|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
130482540|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
130482541|NCT04103580|469736166|FG000|Phase 1 Active Caregiving|Other|3|||
130482542|NCT04103580|469736167|FG001|Phase 1 Active Caregiving|Other|3|||
130482543|NCT04103580|469736166|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
130482544|NCT04103580|469736167|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
130482545|NCT04103580|469736166|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
130482546|NCT04103580|469736167|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
130482547|NCT04103580|469736166|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
130728028|NCT01449370|470625588|FG022|Overall Study|Medication Prohibited by Protocol|0|||
130728029|NCT01449370|470625589|FG023|Overall Study|Medication Prohibited by Protocol|1|||
130728030|NCT01449370|470625590|FG024|Overall Study|Medication Prohibited by Protocol|0|||
130482548|NCT04103580|469736167|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
130482549|NCT04103580|469736166|FG000|Phase 2 Bereavement|Other|8|||
130482550|NCT04103580|469736167|FG001|Phase 2 Bereavement|Other|6|||
130482551|NCT04145440|469736168|FG000|Overall Study|Physician Decision|3|||
130482552|NCT04145440|469736169|FG001|Overall Study|Physician Decision|0|||
130482553|NCT04145440|469736168|FG000|Overall Study|Use of prohibited therapy|2|||
130482554|NCT04145440|469736169|FG001|Overall Study|Use of prohibited therapy|3|||
130482555|NCT00104676|469736170|FG000|Overall Study|Death|3|||
130482556|NCT00104676|469736171|FG001|Overall Study|Death|2|||
130482557|NCT00104676|469736170|FG000|Overall Study|Withdrawal by Subject|0|||
130482558|NCT00104676|469736171|FG001|Overall Study|Withdrawal by Subject|2|||
130482559|NCT00104676|469736170|FG000|Overall Study|treatment interruption|4|||
130482560|NCT00104676|469736171|FG001|Overall Study|treatment interruption|10|||
130482561|NCT05808257|469736174|FG000|Overall Study|Lost to Follow-up|8|||
130482562|NCT05808257|469736175|FG001|Overall Study|Lost to Follow-up|8|||
130482563|NCT04568486|469736176|FG000|Overall Study|Withdrawal by Subject|26|||
130482564|NCT04568486|469736176|FG000|Overall Study|Lost to Follow-up|7|||
130482565|NCT05297565|469736183|FG000|Overall Study|Other Reasons|0|||
130482566|NCT05297565|469736184|FG001|Overall Study|Other Reasons|1|||
130482567|NCT05297565|469736183|FG000|Overall Study|Physician Decision|0|||
130482568|NCT05297565|469736184|FG001|Overall Study|Physician Decision|1|||
130482569|NCT05297565|469736183|FG000|Overall Study|Disease recurrence|1|||
130482570|NCT05297565|469736184|FG001|Overall Study|Disease recurrence|0|||
130482571|NCT03899259|469736199|FG000|Overall Study|Adverse Event|5|||
130482572|NCT03899259|469736200|FG001|Overall Study|Adverse Event|4|||
130482573|NCT03899259|469736201|FG002|Overall Study|Adverse Event|6|||
130482574|NCT03899259|469736199|FG000|Overall Study|Lack of Efficacy|5|||
130482575|NCT03899259|469736200|FG001|Overall Study|Lack of Efficacy|0|||
130482576|NCT03899259|469736201|FG002|Overall Study|Lack of Efficacy|2|||
130482577|NCT03899259|469736199|FG000|Overall Study|Pregnancy|3|||
130482578|NCT03899259|469736200|FG001|Overall Study|Pregnancy|0|||
130482579|NCT03899259|469736201|FG002|Overall Study|Pregnancy|1|||
130482580|NCT03899259|469736199|FG000|Overall Study|Physician Decision|0|||
130482581|NCT03899259|469736200|FG001|Overall Study|Physician Decision|1|||
130482582|NCT03899259|469736201|FG002|Overall Study|Physician Decision|0|||
130482583|NCT03899259|469736199|FG000|Overall Study|Protocol Deviation|1|||
130482584|NCT03899259|469736200|FG001|Overall Study|Protocol Deviation|1|||
130564996|NCT00847145|470035347|FG002|Overall Study|Protocol Violation|3|||
130564997|NCT00847145|470035348|FG003|Overall Study|Protocol Violation|0|||
130728031|NCT01449370|470625566|FG000|Overall Study|Death|0|||
130482585|NCT03899259|469736201|FG002|Overall Study|Protocol Deviation|1|||
130482586|NCT03899259|469736199|FG000|Overall Study|Withdrawal by Subject|8|||
130482587|NCT03899259|469736200|FG001|Overall Study|Withdrawal by Subject|10|||
130482588|NCT03899259|469736201|FG002|Overall Study|Withdrawal by Subject|12|||
130482589|NCT03899259|469736199|FG000|Overall Study|Lost to Follow-up|5|||
130482590|NCT03899259|469736200|FG001|Overall Study|Lost to Follow-up|6|||
130482591|NCT03899259|469736201|FG002|Overall Study|Lost to Follow-up|2|||
130482592|NCT03899259|469736199|FG000|Overall Study|Lack of Adherence|1|||
130482593|NCT03899259|469736200|FG001|Overall Study|Lack of Adherence|0|||
130482594|NCT03899259|469736201|FG002|Overall Study|Lack of Adherence|0|||
130482595|NCT03899259|469736199|FG000|Overall Study|Screen Failure|1|||
130482596|NCT03899259|469736200|FG001|Overall Study|Screen Failure|0|||
130482597|NCT03899259|469736201|FG002|Overall Study|Screen Failure|0|||
130482598|NCT03899259|469736199|FG000|Overall Study|Ongoing Study Participation|127|||
130482599|NCT03899259|469736200|FG001|Overall Study|Ongoing Study Participation|134|||
130482600|NCT03899259|469736201|FG002|Overall Study|Ongoing Study Participation|210|||
130482601|NCT05139810|469736202|FG000|Overall Study|Voluntary Withdrawal|2|||
130482602|NCT05139810|469736203|FG001|Overall Study|Voluntary Withdrawal|1|||
130482603|NCT05139810|469736204|FG002|Overall Study|Voluntary Withdrawal|0|||
130482604|NCT05139810|469736202|FG000|Overall Study|Pregnancy|1|||
130482605|NCT05139810|469736203|FG001|Overall Study|Pregnancy|0|||
130482606|NCT05139810|469736204|FG002|Overall Study|Pregnancy|0|||
130482607|NCT05139810|469736202|FG000|Overall Study|Roll Over to CS7|19|||
130482608|NCT05139810|469736203|FG001|Overall Study|Roll Over to CS7|44|||
130482609|NCT05139810|469736204|FG002|Overall Study|Roll Over to CS7|20|||
130482610|NCT05566639|469736207|FG000|Overall Study|Adverse Event|1|||
130482611|NCT05566639|469736208|FG001|Overall Study|Adverse Event|1|||
130482612|NCT05566639|469736207|FG000|Overall Study|Serious Adverse Event|1|||
130482613|NCT05566639|469736208|FG001|Overall Study|Serious Adverse Event|3|||
130482614|NCT05566639|469736207|FG000|Overall Study|Death|44|||
130482615|NCT05566639|469736208|FG001|Overall Study|Death|45|||
130482616|NCT05566639|469736207|FG000|Overall Study|Lost to Follow-up|467|||
130482617|NCT05566639|469736208|FG001|Overall Study|Lost to Follow-up|461|||
130482618|NCT05566639|469736207|FG000|Overall Study|Physician Decision|45|||
130482619|NCT05566639|469736208|FG001|Overall Study|Physician Decision|44|||
130482620|NCT05566639|469736207|FG000|Overall Study|Protocol Deviation|4|||
130482621|NCT05566639|469736208|FG001|Overall Study|Protocol Deviation|4|||
130482622|NCT05566639|469736207|FG000|Overall Study|Withdrawal by Subject|277|||
130482623|NCT05566639|469736208|FG001|Overall Study|Withdrawal by Subject|271|||
130482624|NCT05566639|469736207|FG000|Overall Study|Other Than Specified|52|||
130482625|NCT05566639|469736208|FG001|Overall Study|Other Than Specified|64|||
130482626|NCT04159415|469736210|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482627|NCT04159415|469736211|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482628|NCT04159415|469736212|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482629|NCT04159415|469736213|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482630|NCT04159415|469736214|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482631|NCT04159415|469736215|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
130482632|NCT04159415|469736216|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
130482633|NCT04159415|469736217|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
130482634|NCT03800654|469736218|FG000|Overall Study|Time constraints|3|||
130482635|NCT03800654|469736219|FG001|Overall Study|Time constraints|3|||
130482636|NCT03800654|469736220|FG002|Overall Study|Time constraints|3|||
130482637|NCT03800654|469736218|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
130728032|NCT01449370|470625567|FG001|Overall Study|Death|0|||
130482638|NCT03800654|469736219|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
130482639|NCT03800654|469736220|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
130482640|NCT03800654|469736218|FG000|Overall Study|Lost to Follow-up|2|||
130482641|NCT03800654|469736219|FG001|Overall Study|Lost to Follow-up|1|||
130482642|NCT03800654|469736220|FG002|Overall Study|Lost to Follow-up|6|||
130482643|NCT03800654|469736218|FG000|Overall Study|Medical Health Issue|0|||
130482644|NCT03800654|469736219|FG001|Overall Study|Medical Health Issue|0|||
130482645|NCT03800654|469736220|FG002|Overall Study|Medical Health Issue|1|||
130482646|NCT03800654|469736218|FG000|Overall Study|Personal Issues|0|||
130482647|NCT03800654|469736219|FG001|Overall Study|Personal Issues|2|||
130482648|NCT03800654|469736220|FG002|Overall Study|Personal Issues|0|||
130482649|NCT03800654|469736218|FG000|Overall Study|Protocol Violation|0|||
130482650|NCT03800654|469736219|FG001|Overall Study|Protocol Violation|1|||
130728033|NCT01449370|470625568|FG002|Overall Study|Death|0|||
130482651|NCT03800654|469736220|FG002|Overall Study|Protocol Violation|0|||
130482652|NCT06182033|469736221|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
130482653|NCT06182033|469736222|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
130482654|NCT06182033|469736221|FG000|Overall Study|Target child relocation|1|||
130482655|NCT06182033|469736222|FG001|Overall Study|Target child relocation|1|||
130482656|NCT06182033|469736221|FG000|Overall Study|Withdrawal by Subject|1|||
130482657|NCT06182033|469736222|FG001|Overall Study|Withdrawal by Subject|0|||
130482658|NCT03710603|469736224|FG000|Overall Study|Adverse Event|1|||
130482659|NCT03710603|469736225|FG001|Overall Study|Adverse Event|0|||
130482660|NCT03710603|469736224|FG000|Overall Study|Death|44|||
130482661|NCT03710603|469736225|FG001|Overall Study|Death|34|||
130482662|NCT03710603|469736224|FG000|Overall Study|Lost to Follow-up|3|||
130482663|NCT03710603|469736225|FG001|Overall Study|Lost to Follow-up|5|||
130482664|NCT03710603|469736224|FG000|Overall Study|Withdrawal by Subject|11|||
130482665|NCT03710603|469736225|FG001|Overall Study|Withdrawal by Subject|10|||
130482666|NCT01456949|469736226|FG000|Enrollment|PI death- incomplete data|6|||
130482667|NCT01456949|469736226|FG000|Enrollment|Death|1|||
130482668|NCT01456949|469736226|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
130482669|NCT01456949|469736226|FG000|Enrollment|Physician Decision|10|||
130482670|NCT01456949|469736226|FG000|Enrollment|Withdrawal by Subject|7|||
130482671|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
130482672|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
130482673|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
130482674|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
130482675|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
130482676|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
130482677|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
130482678|NCT01456949|469736226|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
130482679|NCT02723591|469736227|FG000|Overall Study|Adverse Event|48|||
130482680|NCT02723591|469736228|FG001|Overall Study|Adverse Event|40|||
130482681|NCT02723591|469736227|FG000|Overall Study|Death|2|||
130482682|NCT02723591|469736228|FG001|Overall Study|Death|2|||
130482683|NCT02723591|469736227|FG000|Overall Study|Lack of Efficacy|4|||
130482684|NCT02723591|469736228|FG001|Overall Study|Lack of Efficacy|3|||
130482685|NCT02723591|469736227|FG000|Overall Study|Lost to Follow-up|1|||
130482686|NCT02723591|469736228|FG001|Overall Study|Lost to Follow-up|7|||
130482687|NCT02723591|469736227|FG000|Overall Study|Protocol Violation|20|||
130482688|NCT02723591|469736228|FG001|Overall Study|Protocol Violation|23|||
130482689|NCT02723591|469736227|FG000|Overall Study|Withdrawal by Subject|4|||
130482690|NCT02723591|469736228|FG001|Overall Study|Withdrawal by Subject|8|||
130564998|NCT00847145|470035349|FG004|Overall Study|Protocol Violation|1|||
130482691|NCT02723591|469736227|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
130482692|NCT02723591|469736228|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
130482693|NCT02723591|469736227|FG000|Overall Study|Miscellaneous|5|||
130482694|NCT02723591|469736228|FG001|Overall Study|Miscellaneous|6|||
130482695|NCT03034356|469736229|FG000|Baseline|Lost to Follow-up|2|||
130482696|NCT03034356|469736230|FG001|Baseline|Lost to Follow-up|4|||
130482697|NCT03034356|469736229|FG000|Baseline|Withdrawal by Subject|2|||
130482698|NCT03034356|469736230|FG001|Baseline|Withdrawal by Subject|0|||
130482699|NCT03034356|469736229|FG000|Baseline|Physician Decision|0|||
130482700|NCT03034356|469736230|FG001|Baseline|Physician Decision|1|||
130482701|NCT03034356|469736229|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
130482702|NCT03034356|469736230|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
130482703|NCT03034356|469736229|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
130482704|NCT03034356|469736230|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
130482705|NCT03034356|469736229|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
130482706|NCT03034356|469736230|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
130482707|NCT03034356|469736229|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
130482708|NCT03034356|469736230|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
130482709|NCT05809453|469738133|FG000|Overall Study|Withdrawal by Subject|1|||
130482710|NCT05809453|469738134|FG001|Overall Study|Withdrawal by Subject|0|||
130482711|NCT05809453|469738135|FG002|Overall Study|Withdrawal by Subject|0|||
130482712|NCT05809453|469738136|FG003|Overall Study|Withdrawal by Subject|0|||
130482713|NCT03287817|469738137|FG000|Overall Study|Progressive disease|4|||
130482714|NCT03287817|469738138|FG001|Overall Study|Progressive disease|2|||
130482715|NCT03287817|469738139|FG002|Overall Study|Progressive disease|3|||
130564999|NCT00847145|470035350|FG005|Overall Study|Protocol Violation|0|||
130565000|NCT00847145|470035351|FG006|Overall Study|Protocol Violation|0|||
130565001|NCT00847145|470035352|FG007|Overall Study|Protocol Violation|1|||
130565002|NCT02833974|470035354|FG000|Overall Study|Lost to Follow-up|1|||
130565003|NCT02833974|470035355|FG001|Overall Study|Lost to Follow-up|0|||
130565004|NCT02833974|470035354|FG000|Overall Study|Adverse Event|0|||
130565005|NCT02833974|470035355|FG001|Overall Study|Adverse Event|3|||
130565006|NCT00307151|470035357|FG000|Overall Study|Death|4|||
130565007|NCT00307151|470035358|FG001|Overall Study|Death|3|||
130482716|NCT03287817|469738140|FG003|Overall Study|Progressive disease|10|||
130482717|NCT03287817|469738141|FG004|Overall Study|Progressive disease|8|||
130482718|NCT03287817|469738137|FG000|Overall Study|Death|0|||
130482719|NCT03287817|469738138|FG001|Overall Study|Death|0|||
130482720|NCT03287817|469738139|FG002|Overall Study|Death|2|||
130482721|NCT03287817|469738140|FG003|Overall Study|Death|3|||
130482722|NCT03287817|469738141|FG004|Overall Study|Death|4|||
130482723|NCT03287817|469738137|FG000|Overall Study|Physician Decision|0|||
130482724|NCT03287817|469738138|FG001|Overall Study|Physician Decision|0|||
130482725|NCT03287817|469738139|FG002|Overall Study|Physician Decision|0|||
130565008|NCT00307151|470035359|FG002|Overall Study|Death|10|||
130482726|NCT03287817|469738140|FG003|Overall Study|Physician Decision|1|||
130482727|NCT03287817|469738141|FG004|Overall Study|Physician Decision|0|||
130482728|NCT03287817|469738137|FG000|Overall Study|Withdrawal by Subject|0|||
130482729|NCT03287817|469738138|FG001|Overall Study|Withdrawal by Subject|0|||
130482730|NCT03287817|469738139|FG002|Overall Study|Withdrawal by Subject|0|||
130482731|NCT03287817|469738140|FG003|Overall Study|Withdrawal by Subject|0|||
130482732|NCT03287817|469738141|FG004|Overall Study|Withdrawal by Subject|4|||
130482733|NCT03854227|469738142|FG000|Overall Study|Adverse Event|0|||
130482734|NCT03854227|469738143|FG001|Overall Study|Adverse Event|0|||
130482735|NCT03854227|469738144|FG002|Overall Study|Adverse Event|0|||
130482736|NCT03854227|469738145|FG003|Overall Study|Adverse Event|1|||
130482737|NCT03854227|469738146|FG004|Overall Study|Adverse Event|0|||
130482738|NCT03854227|469738147|FG005|Overall Study|Adverse Event|0|||
130482739|NCT03854227|469738148|FG006|Overall Study|Adverse Event|1|||
130482740|NCT03854227|469738149|FG007|Overall Study|Adverse Event|0|||
130482741|NCT03854227|469738150|FG008|Overall Study|Adverse Event|0|||
130482742|NCT03854227|469738151|FG009|Overall Study|Adverse Event|3|||
130482743|NCT03854227|469738152|FG010|Overall Study|Adverse Event|0|||
130482744|NCT03854227|469738153|FG011|Overall Study|Adverse Event|1|||
130482745|NCT03854227|469738142|FG000|Overall Study|Death|0|||
130482746|NCT03854227|469738143|FG001|Overall Study|Death|0|||
130482747|NCT03854227|469738144|FG002|Overall Study|Death|0|||
130482748|NCT03854227|469738145|FG003|Overall Study|Death|0|||
130482749|NCT03854227|469738146|FG004|Overall Study|Death|0|||
130482750|NCT03854227|469738147|FG005|Overall Study|Death|1|||
130482751|NCT03854227|469738148|FG006|Overall Study|Death|0|||
130482752|NCT03854227|469738149|FG007|Overall Study|Death|0|||
130482753|NCT03854227|469738150|FG008|Overall Study|Death|0|||
130482754|NCT03854227|469738151|FG009|Overall Study|Death|1|||
130482755|NCT03854227|469738152|FG010|Overall Study|Death|0|||
130482756|NCT03854227|469738153|FG011|Overall Study|Death|1|||
130482757|NCT03854227|469738142|FG000|Overall Study|Physician Decision|0|||
130482758|NCT03854227|469738143|FG001|Overall Study|Physician Decision|0|||
130482759|NCT03854227|469738144|FG002|Overall Study|Physician Decision|0|||
130482760|NCT03854227|469738145|FG003|Overall Study|Physician Decision|0|||
130482761|NCT03854227|469738146|FG004|Overall Study|Physician Decision|0|||
130482762|NCT03854227|469738147|FG005|Overall Study|Physician Decision|1|||
130482763|NCT03854227|469738148|FG006|Overall Study|Physician Decision|0|||
130482764|NCT03854227|469738149|FG007|Overall Study|Physician Decision|0|||
130482765|NCT03854227|469738150|FG008|Overall Study|Physician Decision|1|||
130482766|NCT03854227|469738151|FG009|Overall Study|Physician Decision|1|||
130482767|NCT03854227|469738152|FG010|Overall Study|Physician Decision|0|||
130482768|NCT03854227|469738153|FG011|Overall Study|Physician Decision|1|||
130482769|NCT03854227|469738142|FG000|Overall Study|Progressive disease|1|||
130482770|NCT03854227|469738143|FG001|Overall Study|Progressive disease|1|||
130482771|NCT03854227|469738144|FG002|Overall Study|Progressive disease|1|||
130482772|NCT03854227|469738145|FG003|Overall Study|Progressive disease|2|||
130482773|NCT03854227|469738146|FG004|Overall Study|Progressive disease|3|||
130482774|NCT03854227|469738147|FG005|Overall Study|Progressive disease|1|||
130482775|NCT03854227|469738148|FG006|Overall Study|Progressive disease|2|||
130482776|NCT03854227|469738149|FG007|Overall Study|Progressive disease|5|||
130482777|NCT03854227|469738150|FG008|Overall Study|Progressive disease|2|||
130482778|NCT03854227|469738151|FG009|Overall Study|Progressive disease|5|||
130482779|NCT03854227|469738152|FG010|Overall Study|Progressive disease|1|||
130482780|NCT03854227|469738153|FG011|Overall Study|Progressive disease|6|||
130482781|NCT03854227|469738142|FG000|Overall Study|Study terminated by sponsor|0|||
130482782|NCT03854227|469738143|FG001|Overall Study|Study terminated by sponsor|0|||
130482783|NCT03854227|469738144|FG002|Overall Study|Study terminated by sponsor|0|||
130482784|NCT03854227|469738145|FG003|Overall Study|Study terminated by sponsor|0|||
130482785|NCT03854227|469738146|FG004|Overall Study|Study terminated by sponsor|0|||
130482786|NCT03854227|469738147|FG005|Overall Study|Study terminated by sponsor|0|||
130482787|NCT03854227|469738148|FG006|Overall Study|Study terminated by sponsor|0|||
130482788|NCT03854227|469738149|FG007|Overall Study|Study terminated by sponsor|0|||
130482789|NCT03854227|469738150|FG008|Overall Study|Study terminated by sponsor|0|||
130728034|NCT01449370|470625569|FG003|Overall Study|Death|0|||
130728035|NCT01449370|470625570|FG004|Overall Study|Death|0|||
130482790|NCT03854227|469738151|FG009|Overall Study|Study terminated by sponsor|1|||
130482791|NCT03854227|469738152|FG010|Overall Study|Study terminated by sponsor|0|||
130482792|NCT03854227|469738153|FG011|Overall Study|Study terminated by sponsor|0|||
130482793|NCT03854227|469738142|FG000|Overall Study|Withdrawal by Subject|0|||
130482794|NCT03854227|469738143|FG001|Overall Study|Withdrawal by Subject|0|||
130482795|NCT03854227|469738144|FG002|Overall Study|Withdrawal by Subject|1|||
130482796|NCT03854227|469738145|FG003|Overall Study|Withdrawal by Subject|0|||
130482797|NCT03854227|469738146|FG004|Overall Study|Withdrawal by Subject|0|||
130482798|NCT03854227|469738147|FG005|Overall Study|Withdrawal by Subject|0|||
130482799|NCT03854227|469738148|FG006|Overall Study|Withdrawal by Subject|0|||
130482800|NCT03854227|469738149|FG007|Overall Study|Withdrawal by Subject|0|||
130482801|NCT03854227|469738150|FG008|Overall Study|Withdrawal by Subject|0|||
130482802|NCT03854227|469738151|FG009|Overall Study|Withdrawal by Subject|1|||
130482803|NCT03854227|469738152|FG010|Overall Study|Withdrawal by Subject|1|||
130482804|NCT03854227|469738153|FG011|Overall Study|Withdrawal by Subject|0|||
130482805|NCT03854227|469738142|FG000|Overall Study|Disease relapse|0|||
130482806|NCT03854227|469738143|FG001|Overall Study|Disease relapse|0|||
130482807|NCT03854227|469738144|FG002|Overall Study|Disease relapse|0|||
130565009|NCT00307151|470035360|FG003|Overall Study|Death|3|||
130565010|NCT00307151|470035357|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130565011|NCT00307151|470035358|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130565012|NCT00307151|470035359|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130565013|NCT00307151|470035360|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130482808|NCT03854227|469738145|FG003|Overall Study|Disease relapse|0|||
130482809|NCT03854227|469738146|FG004|Overall Study|Disease relapse|0|||
130482810|NCT03854227|469738147|FG005|Overall Study|Disease relapse|0|||
130482811|NCT03854227|469738148|FG006|Overall Study|Disease relapse|0|||
130482812|NCT03854227|469738149|FG007|Overall Study|Disease relapse|0|||
130482813|NCT03854227|469738150|FG008|Overall Study|Disease relapse|1|||
130482814|NCT03854227|469738151|FG009|Overall Study|Disease relapse|0|||
130482815|NCT03854227|469738152|FG010|Overall Study|Disease relapse|0|||
130482816|NCT03854227|469738153|FG011|Overall Study|Disease relapse|0|||
130482817|NCT03854227|469738142|FG000|Overall Study|Global deterioration of health status|0|||
130482818|NCT03854227|469738143|FG001|Overall Study|Global deterioration of health status|0|||
130482819|NCT03854227|469738144|FG002|Overall Study|Global deterioration of health status|0|||
130482820|NCT03854227|469738145|FG003|Overall Study|Global deterioration of health status|0|||
130482821|NCT03854227|469738146|FG004|Overall Study|Global deterioration of health status|0|||
130482822|NCT03854227|469738147|FG005|Overall Study|Global deterioration of health status|1|||
130482823|NCT03854227|469738148|FG006|Overall Study|Global deterioration of health status|0|||
130482824|NCT03854227|469738149|FG007|Overall Study|Global deterioration of health status|1|||
130482825|NCT03854227|469738150|FG008|Overall Study|Global deterioration of health status|0|||
130482826|NCT03854227|469738151|FG009|Overall Study|Global deterioration of health status|0|||
130482827|NCT03854227|469738152|FG010|Overall Study|Global deterioration of health status|0|||
130482828|NCT03854227|469738153|FG011|Overall Study|Global deterioration of health status|0|||
130482829|NCT03854227|469738142|FG000|Overall Study|Refused further treatment|0|||
130482830|NCT03854227|469738143|FG001|Overall Study|Refused further treatment|0|||
130482831|NCT03854227|469738144|FG002|Overall Study|Refused further treatment|0|||
130482832|NCT03854227|469738145|FG003|Overall Study|Refused further treatment|0|||
130482833|NCT03854227|469738146|FG004|Overall Study|Refused further treatment|0|||
130482834|NCT03854227|469738147|FG005|Overall Study|Refused further treatment|0|||
130482835|NCT03854227|469738148|FG006|Overall Study|Refused further treatment|0|||
130482836|NCT03854227|469738149|FG007|Overall Study|Refused further treatment|0|||
130482837|NCT03854227|469738150|FG008|Overall Study|Refused further treatment|0|||
130482838|NCT03854227|469738151|FG009|Overall Study|Refused further treatment|1|||
130482839|NCT03854227|469738152|FG010|Overall Study|Refused further treatment|0|||
130482840|NCT03854227|469738153|FG011|Overall Study|Refused further treatment|1|||
130482841|NCT03854227|469738142|FG000|Overall Study|Other|0|||
130482842|NCT03854227|469738143|FG001|Overall Study|Other|0|||
130482843|NCT03854227|469738144|FG002|Overall Study|Other|0|||
130482844|NCT03854227|469738145|FG003|Overall Study|Other|0|||
130482845|NCT03854227|469738146|FG004|Overall Study|Other|0|||
130482846|NCT03854227|469738147|FG005|Overall Study|Other|0|||
130482847|NCT03854227|469738148|FG006|Overall Study|Other|0|||
130482848|NCT03854227|469738149|FG007|Overall Study|Other|0|||
130482849|NCT03854227|469738150|FG008|Overall Study|Other|1|||
130482850|NCT03854227|469738151|FG009|Overall Study|Other|1|||
130482851|NCT03854227|469738152|FG010|Overall Study|Other|0|||
130482852|NCT03854227|469738153|FG011|Overall Study|Other|0|||
130482853|NCT03668236|469738154|FG000|90-day Follow-up|Withdrawal by Subject|3|||
130482854|NCT03668236|469738155|FG001|90-day Follow-up|Withdrawal by Subject|2|||
130482855|NCT03668236|469738154|FG000|90-day Follow-up|Lost to Follow-up|3|||
130482856|NCT03668236|469738155|FG001|90-day Follow-up|Lost to Follow-up|1|||
130482857|NCT03668236|469738154|FG000|Baseline Characteristics|Lost to Follow-up|9|||
130482858|NCT03668236|469738155|FG001|Baseline Characteristics|Lost to Follow-up|5|||
130482859|NCT03668236|469738154|FG000|1-year Follow-up|Withdrawal by Subject|17|||
130482860|NCT03668236|469738155|FG001|1-year Follow-up|Withdrawal by Subject|15|||
130482861|NCT06132282|469738161|FG000|Overall Study|Lost to Follow-up|31|||
130565014|NCT00307151|470035357|FG000|Overall Study|Subject unable to get to clinic|1|||
130482862|NCT04119843|469738165|FG000|Overall Study|Adverse Event|3|||
130482863|NCT04119843|469738165|FG000|Overall Study|Death|1|||
130482864|NCT02841579|469738166|FG000|Overall Study|Death|1|||
130482865|NCT02841579|469738166|FG000|Overall Study|Adverse Event|1|||
130482866|NCT02841579|469738166|FG000|Overall Study|Lack of Efficacy|9|||
130482867|NCT01501955|469738168|FG000|Overall Study|Withdrawal by Subject|1|||
130482868|NCT01501955|469738169|FG001|Overall Study|Withdrawal by Subject|0|||
130482869|NCT01501955|469738168|FG000|Overall Study|Adverse Event|1|||
130482870|NCT01501955|469738169|FG001|Overall Study|Adverse Event|3|||
130482871|NCT05034328|469738170|FG000|Overall Study|Protocol Violation|1|||
130482872|NCT05034328|469738171|FG001|Overall Study|Protocol Violation|0|||
130482873|NCT05034328|469738170|FG000|Overall Study|Lost to Follow-up|0|||
130482874|NCT05034328|469738171|FG001|Overall Study|Lost to Follow-up|10|||
130728036|NCT01449370|470625571|FG005|Overall Study|Death|0|||
130728037|NCT01449370|470625572|FG006|Overall Study|Death|0|||
130728038|NCT01449370|470625573|FG007|Overall Study|Death|0|||
130728039|NCT01449370|470625574|FG008|Overall Study|Death|0|||
130482875|NCT03625167|469738176|FG000|Overall Study|Protocol Violation|5|||
130482876|NCT02969707|469738177|FG000|Overall Study|Withdrawal by Subject|6|||
130482877|NCT02969707|469738178|FG001|Overall Study|Withdrawal by Subject|5|||
130482878|NCT02969707|469738177|FG000|Overall Study|Severe anxiety|0|||
130482879|NCT02969707|469738178|FG001|Overall Study|Severe anxiety|1|||
130482880|NCT02969707|469738177|FG000|Overall Study|Positive toxicology screen|0|||
130482881|NCT02969707|469738178|FG001|Overall Study|Positive toxicology screen|2|||
130482882|NCT02969707|469738177|FG000|Overall Study|Claustrophobia|2|||
130482883|NCT02969707|469738178|FG001|Overall Study|Claustrophobia|2|||
130482884|NCT02969707|469738177|FG000|Overall Study|Non-compliance|1|||
130482885|NCT02969707|469738178|FG001|Overall Study|Non-compliance|2|||
130482886|NCT04314713|469738181|FG000|Overall Study|Lost to Follow-up|0|||
130482887|NCT04314713|469738182|FG001|Overall Study|Lost to Follow-up|0|||
130482888|NCT04314713|469738183|FG002|Overall Study|Lost to Follow-up|0|||
130482889|NCT04314713|469738184|FG003|Overall Study|Lost to Follow-up|1|||
130482890|NCT04314713|469738185|FG004|Overall Study|Lost to Follow-up|0|||
130482891|NCT04314713|469738186|FG005|Overall Study|Lost to Follow-up|0|||
130482892|NCT00248287|469738188|FG000|Overall Study|Adverse Event|11|||
130482893|NCT00248287|469738189|FG001|Overall Study|Adverse Event|10|||
130482894|NCT00248287|469738188|FG000|Overall Study|Death|1|||
130482895|NCT00248287|469738189|FG001|Overall Study|Death|0|||
130482896|NCT00248287|469738188|FG000|Overall Study|Lost to Follow-up|0|||
130482897|NCT00248287|469738189|FG001|Overall Study|Lost to Follow-up|1|||
130482898|NCT00248287|469738188|FG000|Overall Study|Investigator Request|4|||
130482899|NCT00248287|469738189|FG001|Overall Study|Investigator Request|3|||
130482900|NCT00248287|469738188|FG000|Overall Study|Patient Request|5|||
130482901|NCT00248287|469738189|FG001|Overall Study|Patient Request|3|||
130482902|NCT00248287|469738188|FG000|Overall Study|Other|3|||
130482903|NCT00248287|469738189|FG001|Overall Study|Other|2|||
130482904|NCT05670587|469738190|FG000|Overall Study|Withdrawal by Subject|3|||
130482905|NCT05940194|469738191|FG000|Overall Study|Adverse Event|0|||
130482906|NCT05940194|469738192|FG001|Overall Study|Adverse Event|1|||
130482907|NCT05940194|469738193|FG002|Overall Study|Adverse Event|0|||
130482908|NCT05940194|469738191|FG000|Overall Study|Migrated/Moved from the study area|2|||
130482909|NCT05940194|469738192|FG001|Overall Study|Migrated/Moved from the study area|2|||
130482910|NCT05940194|469738193|FG002|Overall Study|Migrated/Moved from the study area|4|||
130482911|NCT04054193|469738206|FG000|Cycle 1|Physician Decision|1|||
130482912|NCT04054193|469738206|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
130482913|NCT04054193|469738206|FG000|Cycle 1|Allocated but not treated|3|||
130482914|NCT04054193|469738206|FG000|Cycles 2-3|Physician Decision|2|||
130482915|NCT04054193|469738206|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
130482916|NCT04054193|469738206|FG000|Cycles 2-3|Various reasons|17|||
130482917|NCT02966873|469738207|FG000|Overall Study|Lost to Follow-up|16|||
130482918|NCT02966873|469738208|FG001|Overall Study|Lost to Follow-up|15|||
130482919|NCT03084536|469738209|FG000|Overall Study|Determined to be ineligible|0|||
130482920|NCT03084536|469738210|FG001|Overall Study|Determined to be ineligible|0|||
130482921|NCT03084536|469738211|FG002|Overall Study|Determined to be ineligible|16|||
130482922|NCT03084536|469738209|FG000|Overall Study|Withdrawal by Subject|0|||
130482923|NCT03084536|469738210|FG001|Overall Study|Withdrawal by Subject|0|||
130482924|NCT03084536|469738211|FG002|Overall Study|Withdrawal by Subject|4|||
130482925|NCT03084536|469738209|FG000|Overall Study|Physician Decision|0|||
130482926|NCT03084536|469738210|FG001|Overall Study|Physician Decision|0|||
130482927|NCT03084536|469738211|FG002|Overall Study|Physician Decision|3|||
130482928|NCT03084536|469738209|FG000|Overall Study|Death|0|||
130482929|NCT03084536|469738210|FG001|Overall Study|Death|0|||
130482930|NCT03084536|469738211|FG002|Overall Study|Death|1|||
130482931|NCT03084536|469738209|FG000|Overall Study|Lost to Follow-up|0|||
130482932|NCT03084536|469738210|FG001|Overall Study|Lost to Follow-up|0|||
130482933|NCT03084536|469738211|FG002|Overall Study|Lost to Follow-up|1|||
130482934|NCT03084536|469738209|FG000|Overall Study|Protocol Violation|0|||
130728040|NCT01449370|470625575|FG009|Overall Study|Death|0|||
130482935|NCT03084536|469738210|FG001|Overall Study|Protocol Violation|0|||
130482936|NCT03084536|469738211|FG002|Overall Study|Protocol Violation|1|||
130482937|NCT03084536|469738209|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
130482938|NCT03084536|469738210|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
130482939|NCT03084536|469738211|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
130482940|NCT05073458|469738217|FG000|24-week Double-blind Period|Adverse Event|1|||
130482941|NCT05073458|469738218|FG001|24-week Double-blind Period|Adverse Event|0|||
130482942|NCT05073458|469738217|FG000|24-week Double-blind Period|Physician Decision|1|||
130482943|NCT05073458|469738218|FG001|24-week Double-blind Period|Physician Decision|0|||
130482944|NCT05073458|469738217|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
130482945|NCT05073458|469738218|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
130728041|NCT01449370|470625576|FG010|Overall Study|Death|0|||
130728042|NCT01449370|470625577|FG011|Overall Study|Death|0|||
130482946|NCT05073458|469738217|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
130482947|NCT05073458|469738218|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
130482948|NCT05073458|469738217|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
130482949|NCT05073458|469738218|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
130482950|NCT05073458|469738217|FG000|24-week Open-label Period|Adverse Event|1|||
130482951|NCT05073458|469738218|FG001|24-week Open-label Period|Adverse Event|2|||
130482952|NCT03235544|469738224|FG000|Overall Study|Death|11|||
130482953|NCT03235544|469738225|FG001|Overall Study|Death|31|||
130482954|NCT03235544|469738226|FG002|Overall Study|Death|19|||
130482955|NCT03235544|469738227|FG003|Overall Study|Death|34|||
130482956|NCT03235544|469738224|FG000|Overall Study|Lost to Follow-up|0|||
130482957|NCT03235544|469738225|FG001|Overall Study|Lost to Follow-up|1|||
130482958|NCT03235544|469738226|FG002|Overall Study|Lost to Follow-up|1|||
130482959|NCT03235544|469738227|FG003|Overall Study|Lost to Follow-up|1|||
130482960|NCT03235544|469738224|FG000|Overall Study|Withdrawal by Subject|0|||
130482961|NCT03235544|469738225|FG001|Overall Study|Withdrawal by Subject|3|||
130482962|NCT03235544|469738226|FG002|Overall Study|Withdrawal by Subject|1|||
130482963|NCT03235544|469738227|FG003|Overall Study|Withdrawal by Subject|5|||
130482964|NCT03235544|469738224|FG000|Overall Study|Disease Progression|0|||
130482965|NCT03235544|469738225|FG001|Overall Study|Disease Progression|1|||
130482966|NCT03235544|469738226|FG002|Overall Study|Disease Progression|0|||
130482967|NCT03235544|469738227|FG003|Overall Study|Disease Progression|2|||
130482968|NCT03235544|469738224|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
130482969|NCT03235544|469738225|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
130482970|NCT03235544|469738226|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
130482971|NCT03235544|469738227|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
130482972|NCT03235544|469738224|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
130482973|NCT03235544|469738225|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
130482974|NCT03235544|469738226|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
130482975|NCT03235544|469738227|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
130482976|NCT04830800|469738228|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
130482977|NCT04830800|469738229|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
130482978|NCT04830800|469738230|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
130482979|NCT04830800|469738231|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
130482980|NCT04830800|469738232|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
130482981|NCT02626533|469738235|FG000|Overall Study|Protocol Violation|14|||
130482982|NCT02626533|469738235|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
130482983|NCT02626533|469738235|FG000|Overall Study|Withdrawal by Subject|1|||
130482984|NCT04753697|469738236|FG000|Induction Phase|Withdrawal by Subject|12|||
130482985|NCT04753697|469738237|FG001|Induction Phase|Withdrawal by Subject|5|||
130482986|NCT04753697|469738238|FG002|Induction Phase|Withdrawal by Subject|6|||
130482987|NCT04753697|469738236|FG000|Induction Phase|Physician Decision|1|||
130482988|NCT04753697|469738237|FG001|Induction Phase|Physician Decision|0|||
130482989|NCT04753697|469738238|FG002|Induction Phase|Physician Decision|0|||
130482990|NCT04753697|469738236|FG000|Induction Phase|Lost to Follow-up|2|||
130482991|NCT04753697|469738237|FG001|Induction Phase|Lost to Follow-up|2|||
130482992|NCT04753697|469738238|FG002|Induction Phase|Lost to Follow-up|1|||
130482993|NCT04753697|469738236|FG000|Induction Phase|Lack of Efficacy|1|||
130482994|NCT04753697|469738237|FG001|Induction Phase|Lack of Efficacy|0|||
130482995|NCT04753697|469738238|FG002|Induction Phase|Lack of Efficacy|0|||
130482996|NCT04753697|469738236|FG000|Maintenance Phase|Physician Decision|0|||
130482997|NCT04753697|469738237|FG001|Maintenance Phase|Physician Decision|0|||
130482998|NCT04753697|469738238|FG002|Maintenance Phase|Physician Decision|1|||
130482999|NCT04753697|469738236|FG000|Maintenance Phase|Withdrawal by Subject|3|||
130483000|NCT04753697|469738237|FG001|Maintenance Phase|Withdrawal by Subject|4|||
130483001|NCT04753697|469738238|FG002|Maintenance Phase|Withdrawal by Subject|6|||
130483002|NCT04753697|469738236|FG000|Maintenance Phase|Lost to Follow-up|2|||
130483003|NCT04753697|469738237|FG001|Maintenance Phase|Lost to Follow-up|2|||
130483004|NCT04753697|469738238|FG002|Maintenance Phase|Lost to Follow-up|0|||
130483005|NCT04753697|469738236|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
130483006|NCT04753697|469738237|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
130483007|NCT04753697|469738238|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
130483008|NCT04753697|469738236|FG000|Maintenance Phase|Adverse Event|0|||
130483009|NCT04753697|469738237|FG001|Maintenance Phase|Adverse Event|1|||
130483010|NCT04753697|469738238|FG002|Maintenance Phase|Adverse Event|1|||
130483011|NCT04753697|469738236|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
130483012|NCT04753697|469738237|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
130483013|NCT04753697|469738238|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
130483014|NCT04850898|469738241|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
130565015|NCT00307151|470035358|FG001|Overall Study|Subject unable to get to clinic|0|||
130565016|NCT00307151|470035359|FG002|Overall Study|Subject unable to get to clinic|6|||
130483015|NCT04850898|469738242|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
130483016|NCT03701763|469738243|FG000|Placebo-controlled Phase|Adverse Event|1|||
130483017|NCT03701763|469738244|FG001|Placebo-controlled Phase|Adverse Event|5|||
130483018|NCT03701763|469738245|FG002|Placebo-controlled Phase|Adverse Event|0|||
130483019|NCT03701763|469738246|FG003|Placebo-controlled Phase|Adverse Event|0|||
130483020|NCT03701763|469738243|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
130483021|NCT03701763|469738244|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
130483022|NCT03701763|469738245|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
130483023|NCT03701763|469738246|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
130483024|NCT03701763|469738243|FG000|Placebo-controlled Phase|Miscellaneous|2|||
130483025|NCT03701763|469738244|FG001|Placebo-controlled Phase|Miscellaneous|0|||
130483026|NCT03701763|469738245|FG002|Placebo-controlled Phase|Miscellaneous|0|||
130483027|NCT03701763|469738246|FG003|Placebo-controlled Phase|Miscellaneous|0|||
130483028|NCT03701763|469738243|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
130483029|NCT03701763|469738244|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
130483030|NCT03701763|469738245|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
130483031|NCT03701763|469738246|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
130483032|NCT03701763|469738243|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
130483033|NCT03701763|469738244|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
130483034|NCT03701763|469738245|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
130483035|NCT03701763|469738246|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
130483036|NCT03701763|469738243|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
130483037|NCT03701763|469738244|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
130483038|NCT03701763|469738245|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
130483039|NCT03701763|469738246|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
130483040|NCT03701763|469738243|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
130483041|NCT03701763|469738244|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
130483042|NCT03701763|469738245|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
130483043|NCT03701763|469738246|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
130483044|NCT03701763|469738243|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
130483045|NCT03701763|469738244|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
130483046|NCT03701763|469738245|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
130483047|NCT03701763|469738246|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
130483048|NCT03701763|469738243|FG000|Apremilast Extension Phase|Adverse Event|0|||
130483049|NCT03701763|469738244|FG001|Apremilast Extension Phase|Adverse Event|0|||
130483050|NCT03701763|469738245|FG002|Apremilast Extension Phase|Adverse Event|3|||
130483051|NCT03701763|469738246|FG003|Apremilast Extension Phase|Adverse Event|1|||
130483052|NCT03701763|469738243|FG000|Apremilast Extension Phase|Miscellaneous|0|||
130483053|NCT03701763|469738244|FG001|Apremilast Extension Phase|Miscellaneous|0|||
130483054|NCT03701763|469738245|FG002|Apremilast Extension Phase|Miscellaneous|2|||
130483055|NCT03701763|469738246|FG003|Apremilast Extension Phase|Miscellaneous|1|||
130483056|NCT03701763|469738243|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
130483057|NCT03701763|469738244|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
130483058|NCT03701763|469738245|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
130483059|NCT03701763|469738246|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
130483060|NCT03701763|469738243|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
130483061|NCT03701763|469738244|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
130483062|NCT03701763|469738245|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
130483063|NCT03701763|469738246|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
130483064|NCT03701763|469738243|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
130483065|NCT03701763|469738244|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
130483066|NCT03701763|469738245|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
130483067|NCT03701763|469738246|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
130483068|NCT03701763|469738243|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
130483069|NCT03701763|469738244|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
130483070|NCT03701763|469738245|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
130483071|NCT03701763|469738246|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
130483072|NCT03701763|469738243|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
130483073|NCT03701763|469738244|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
130483074|NCT03701763|469738245|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
130483075|NCT03701763|469738246|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
130728043|NCT01449370|470625578|FG012|Overall Study|Death|0|||
130483076|NCT03701763|469738243|FG000|14-Week Observational Follow-up Phase|Other|0|||
130483077|NCT03701763|469738244|FG001|14-Week Observational Follow-up Phase|Other|0|||
130483078|NCT03701763|469738245|FG002|14-Week Observational Follow-up Phase|Other|1|||
130483079|NCT03701763|469738246|FG003|14-Week Observational Follow-up Phase|Other|0|||
130483080|NCT03701763|469738243|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
130483081|NCT03701763|469738244|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
130483082|NCT03701763|469738245|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
130728044|NCT01449370|470625579|FG013|Overall Study|Death|0|||
130483083|NCT03701763|469738246|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
130483084|NCT03701763|469738243|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
130483085|NCT03701763|469738244|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
130483086|NCT03701763|469738245|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
130483087|NCT03701763|469738246|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
130483088|NCT03511664|469738252|FG000|Overall Study|Death|457|||
130483089|NCT03511664|469738253|FG001|Overall Study|Death|201|||
130483090|NCT03511664|469738254|FG002|Overall Study|Death|21|||
130483091|NCT03511664|469738252|FG000|Overall Study|Withdrew consent|40|||
130483092|NCT03511664|469738253|FG001|Overall Study|Withdrew consent|63|||
130483093|NCT03511664|469738254|FG002|Overall Study|Withdrew consent|3|||
130483094|NCT03511664|469738252|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
130483095|NCT03511664|469738253|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
130483096|NCT03511664|469738254|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
130483097|NCT03511664|469738252|FG000|Overall Study|Lost to Follow-up|8|||
130483098|NCT03511664|469738253|FG001|Overall Study|Lost to Follow-up|5|||
130483099|NCT03511664|469738254|FG002|Overall Study|Lost to Follow-up|0|||
130483100|NCT03511664|469738252|FG000|Overall Study|Physician Decision|2|||
130483101|NCT03511664|469738253|FG001|Overall Study|Physician Decision|1|||
130483102|NCT03511664|469738254|FG002|Overall Study|Physician Decision|0|||
130483103|NCT03511664|469738252|FG000|Overall Study|Patient non-compliance|1|||
130483104|NCT03511664|469738253|FG001|Overall Study|Patient non-compliance|0|||
130483105|NCT03511664|469738254|FG002|Overall Study|Patient non-compliance|0|||
130483106|NCT06473662|469738255|FG000|Overall Study|Withdrawal by Subject|1|||
130483107|NCT06473662|469738256|FG001|Overall Study|Withdrawal by Subject|6|||
130483108|NCT06473662|469738257|FG002|Overall Study|Withdrawal by Subject|5|||
130483109|NCT06473662|469738255|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
130483110|NCT06473662|469738256|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
130483111|NCT06473662|469738257|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
130483112|NCT06473662|469738255|FG000|Overall Study|Starting HbA1c below 7%|0|||
130483113|NCT06473662|469738256|FG001|Overall Study|Starting HbA1c below 7%|1|||
130483114|NCT06473662|469738257|FG002|Overall Study|Starting HbA1c below 7%|1|||
130483115|NCT06473662|469738255|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
130483116|NCT06473662|469738256|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
130483117|NCT06473662|469738257|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
130483118|NCT06473662|469738255|FG000|Overall Study|Did not take medication|2|||
130483119|NCT06473662|469738256|FG001|Overall Study|Did not take medication|3|||
130483120|NCT06473662|469738257|FG002|Overall Study|Did not take medication|2|||
130483121|NCT04515849|469738258|FG000|Overall Study|Adverse Event|0|||
130483122|NCT04515849|469738259|FG001|Overall Study|Adverse Event|0|||
130483123|NCT04515849|469738260|FG002|Overall Study|Adverse Event|0|||
130483124|NCT04515849|469738261|FG003|Overall Study|Adverse Event|1|||
130483125|NCT04515849|469738262|FG004|Overall Study|Adverse Event|2|||
130483126|NCT04515849|469738258|FG000|Overall Study|Death|2|||
130483127|NCT04515849|469738259|FG001|Overall Study|Death|0|||
130483128|NCT04515849|469738260|FG002|Overall Study|Death|0|||
130483129|NCT04515849|469738261|FG003|Overall Study|Death|0|||
130483130|NCT04515849|469738262|FG004|Overall Study|Death|0|||
130483131|NCT04515849|469738258|FG000|Overall Study|Other:family emergency|0|||
130483132|NCT04515849|469738259|FG001|Overall Study|Other:family emergency|0|||
130483133|NCT04515849|469738260|FG002|Overall Study|Other:family emergency|0|||
130483134|NCT04515849|469738261|FG003|Overall Study|Other:family emergency|1|||
130483135|NCT04515849|469738262|FG004|Overall Study|Other:family emergency|0|||
130483136|NCT04515849|469738258|FG000|Overall Study|Other:randomised by error|0|||
130483137|NCT04515849|469738259|FG001|Overall Study|Other:randomised by error|1|||
130483138|NCT04515849|469738260|FG002|Overall Study|Other:randomised by error|0|||
130483139|NCT04515849|469738261|FG003|Overall Study|Other:randomised by error|0|||
130483140|NCT04515849|469738262|FG004|Overall Study|Other:randomised by error|0|||
130483141|NCT04515849|469738258|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
130483142|NCT04515849|469738259|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
130483143|NCT04515849|469738260|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
130483144|NCT04515849|469738261|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
130483145|NCT04515849|469738262|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
130483146|NCT04515849|469738258|FG000|Overall Study|Physician Decision|0|||
130483147|NCT04515849|469738259|FG001|Overall Study|Physician Decision|1|||
130483148|NCT04515849|469738260|FG002|Overall Study|Physician Decision|0|||
130483149|NCT04515849|469738261|FG003|Overall Study|Physician Decision|0|||
130483150|NCT04515849|469738262|FG004|Overall Study|Physician Decision|0|||
130483151|NCT04515849|469738258|FG000|Overall Study|Withdrawal by Subject|1|||
130483152|NCT04515849|469738259|FG001|Overall Study|Withdrawal by Subject|2|||
130483153|NCT04515849|469738260|FG002|Overall Study|Withdrawal by Subject|1|||
130483154|NCT04515849|469738261|FG003|Overall Study|Withdrawal by Subject|0|||
130483155|NCT04515849|469738262|FG004|Overall Study|Withdrawal by Subject|0|||
130483156|NCT04577963|469738276|FG000|Part 2|Death|0|||
130483157|NCT04577963|469738277|FG001|Part 2|Death|1|||
130483158|NCT04577963|469738278|FG002|Part 2|Death|8|||
130483159|NCT04577963|469738279|FG003|Part 2|Death|0|||
130483160|NCT04577963|469738280|FG004|Part 2|Death|20|||
130483161|NCT04577963|469738276|FG000|Part 2|Lost to Follow-up|0|||
130483162|NCT04577963|469738277|FG001|Part 2|Lost to Follow-up|0|||
130728045|NCT01449370|470625580|FG014|Overall Study|Death|0|||
130483163|NCT04577963|469738278|FG002|Part 2|Lost to Follow-up|0|||
130483164|NCT04577963|469738279|FG003|Part 2|Lost to Follow-up|0|||
130483165|NCT04577963|469738280|FG004|Part 2|Lost to Follow-up|2|||
130483166|NCT04577963|469738276|FG000|Part 2|Withdrawal by Subject|0|||
130483167|NCT04577963|469738277|FG001|Part 2|Withdrawal by Subject|0|||
130483168|NCT04577963|469738278|FG002|Part 2|Withdrawal by Subject|0|||
130483169|NCT04577963|469738279|FG003|Part 2|Withdrawal by Subject|0|||
130483170|NCT04577963|469738280|FG004|Part 2|Withdrawal by Subject|10|||
130483171|NCT04577963|469738276|FG000|Part 2|Progressive disease|0|||
130483172|NCT04577963|469738277|FG001|Part 2|Progressive disease|0|||
130483173|NCT04577963|469738278|FG002|Part 2|Progressive disease|0|||
130483174|NCT04577963|469738279|FG003|Part 2|Progressive disease|0|||
130483175|NCT04577963|469738280|FG004|Part 2|Progressive disease|2|||
130483176|NCT04577963|469738276|FG000|Part 2|Investigator decision|0|||
130483177|NCT04577963|469738277|FG001|Part 2|Investigator decision|0|||
130483178|NCT04577963|469738278|FG002|Part 2|Investigator decision|0|||
130483179|NCT04577963|469738279|FG003|Part 2|Investigator decision|0|||
130483180|NCT04577963|469738280|FG004|Part 2|Investigator decision|1|||
130483181|NCT04577963|469738276|FG000|Part 2|Sponsor terminated study|0|||
130483182|NCT04577963|469738277|FG001|Part 2|Sponsor terminated study|0|||
130483183|NCT04577963|469738278|FG002|Part 2|Sponsor terminated study|3|||
130483184|NCT04577963|469738279|FG003|Part 2|Sponsor terminated study|1|||
130483185|NCT04577963|469738280|FG004|Part 2|Sponsor terminated study|4|||
130483186|NCT02823145|469738281|FG000|Enrollment|Other|1|||
130483187|NCT02823145|469738282|FG001|Enrollment|Other|0|||
130483188|NCT02823145|469738281|FG000|Treatment|Adverse Event|0|||
130483189|NCT02823145|469738282|FG001|Treatment|Adverse Event|11|||
130483190|NCT02823145|469738281|FG000|Treatment|Death|0|||
130483191|NCT02823145|469738282|FG001|Treatment|Death|3|||
130483192|NCT02823145|469738281|FG000|Treatment|Family Decision|0|||
130483193|NCT02823145|469738282|FG001|Treatment|Family Decision|1|||
130483194|NCT02823145|469738281|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
130483195|NCT02823145|469738282|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
130483196|NCT02823145|469738281|FG000|Treatment|Lack of Efficacy|0|||
130483197|NCT02823145|469738282|FG001|Treatment|Lack of Efficacy|48|||
130483198|NCT02823145|469738281|FG000|Treatment|Non-Compliance With E-Diary|0|||
130483199|NCT02823145|469738282|FG001|Treatment|Non-Compliance With E-Diary|1|||
130483200|NCT02823145|469738281|FG000|Treatment|Physician Decision|0|||
130483201|NCT02823145|469738282|FG001|Treatment|Physician Decision|2|||
130483202|NCT02823145|469738281|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
130483203|NCT02823145|469738282|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
130483204|NCT02823145|469738281|FG000|Treatment|Subject needed to take prohibited medication|0|||
130483205|NCT02823145|469738282|FG001|Treatment|Subject needed to take prohibited medication|1|||
130483206|NCT02823145|469738281|FG000|Treatment|Subject transferred to direct access programme|0|||
130483207|NCT02823145|469738282|FG001|Treatment|Subject transferred to direct access programme|1|||
130483208|NCT02823145|469738281|FG000|Treatment|Switching to commercially available drug|0|||
130483209|NCT02823145|469738282|FG001|Treatment|Switching to commercially available drug|11|||
130483210|NCT02823145|469738281|FG000|Treatment|Transitioned to commercial supply of medication|0|||
130483211|NCT02823145|469738282|FG001|Treatment|Transitioned to commercial supply of medication|1|||
130483212|NCT02823145|469738281|FG000|Treatment|Withdrawal By Caregiver|0|||
130483213|NCT02823145|469738282|FG001|Treatment|Withdrawal By Caregiver|1|||
130483214|NCT02823145|469738281|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
130483215|NCT02823145|469738282|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
130483216|NCT02823145|469738281|FG000|Treatment|Withdrawal by Subject|0|||
130483217|NCT02823145|469738282|FG001|Treatment|Withdrawal by Subject|16|||
130483218|NCT02823145|469738281|FG000|Treatment|Reason unknown|0|||
130483219|NCT02823145|469738282|FG001|Treatment|Reason unknown|1|||
130483220|NCT05292391|469738283|FG000|Overall Study|Lost to Follow-up|0|||
130483221|NCT05292391|469738284|FG001|Overall Study|Lost to Follow-up|0|||
130483222|NCT05292391|469738285|FG002|Overall Study|Lost to Follow-up|0|||
130483223|NCT05292391|469738286|FG003|Overall Study|Lost to Follow-up|1|||
130483224|NCT05292391|469738287|FG004|Overall Study|Lost to Follow-up|0|||
130483225|NCT04857723|469738288|FG000|Overall Study|Withdrawal by Subject|2|||
130483226|NCT03221426|469738289|FG000|Overall Study|Ongoing in study|212|||
130483227|NCT03221426|469738290|FG001|Overall Study|Ongoing in study|193|||
130483228|NCT03221426|469738291|FG002|Overall Study|Ongoing in study|61|||
130483229|NCT03221426|469738292|FG003|Overall Study|Ongoing in study|55|||
130483230|NCT03221426|469738289|FG000|Overall Study|Withdrawal by Subject|12|||
130483231|NCT03221426|469738290|FG001|Overall Study|Withdrawal by Subject|4|||
130728046|NCT01449370|470625581|FG015|Overall Study|Death|0|||
130728047|NCT01449370|470625582|FG016|Overall Study|Death|0|||
130728048|NCT01449370|470625583|FG017|Overall Study|Death|0|||
130728049|NCT01449370|470625584|FG018|Overall Study|Death|0|||
130728050|NCT01449370|470625585|FG019|Overall Study|Death|0|||
130728051|NCT01449370|470625586|FG020|Overall Study|Death|0|||
130728052|NCT01449370|470625587|FG021|Overall Study|Death|0|||
130728053|NCT01449370|470625588|FG022|Overall Study|Death|0|||
130728054|NCT01449370|470625589|FG023|Overall Study|Death|0|||
130728055|NCT01449370|470625590|FG024|Overall Study|Death|1|||
130728056|NCT02290223|470625591|FG000|6 Months|Lost to Follow-up|9|||
130728057|NCT02290223|470625592|FG001|6 Months|Lost to Follow-up|6|||
130728058|NCT02290223|470625591|FG000|6 Months|Withdrawal by Subject|5|||
130728059|NCT02290223|470625592|FG001|6 Months|Withdrawal by Subject|0|||
130728060|NCT02290223|470625591|FG000|6 Months|deceased (not related to study)|2|||
130728061|NCT02290223|470625592|FG001|6 Months|deceased (not related to study)|0|||
130728062|NCT02290223|470625591|FG000|12 Months|Lost to Follow-up|16|||
130728063|NCT02290223|470625592|FG001|12 Months|Lost to Follow-up|10|||
130728064|NCT02290223|470625591|FG000|12 Months|Refusal|0|||
130483232|NCT03221426|469738291|FG002|Overall Study|Withdrawal by Subject|2|||
130483233|NCT03221426|469738292|FG003|Overall Study|Withdrawal by Subject|3|||
130483234|NCT03221426|469738289|FG000|Overall Study|Lost to Follow-up|4|||
130483235|NCT03221426|469738290|FG001|Overall Study|Lost to Follow-up|1|||
130483236|NCT03221426|469738291|FG002|Overall Study|Lost to Follow-up|1|||
130483237|NCT03221426|469738292|FG003|Overall Study|Lost to Follow-up|0|||
130483238|NCT03221426|469738289|FG000|Overall Study|Death|174|||
130483239|NCT03221426|469738290|FG001|Overall Study|Death|204|||
130483240|NCT03221426|469738291|FG002|Overall Study|Death|36|||
130483241|NCT03221426|469738292|FG003|Overall Study|Death|45|||
130483242|NCT03257410|469740145|FG000|Overall Study|Adverse Event|2|||
130483243|NCT03257410|469740146|FG001|Overall Study|Adverse Event|3|||
130483244|NCT03257410|469740145|FG000|Overall Study|Protocol Violation|1|||
130483245|NCT03257410|469740146|FG001|Overall Study|Protocol Violation|2|||
130483246|NCT03257410|469740145|FG000|Overall Study|Lost to Follow-up|1|||
130483247|NCT03257410|469740146|FG001|Overall Study|Lost to Follow-up|0|||
130483248|NCT03257410|469740145|FG000|Overall Study|Withdrawal by Subject|1|||
130483249|NCT03257410|469740146|FG001|Overall Study|Withdrawal by Subject|2|||
130483250|NCT03257410|469740145|FG000|Overall Study|Physician Decision|1|||
130483251|NCT03257410|469740146|FG001|Overall Study|Physician Decision|1|||
130483252|NCT03257410|469740145|FG000|Overall Study|Renal transplantation|2|||
130483253|NCT03257410|469740146|FG001|Overall Study|Renal transplantation|0|||
130483254|NCT03257410|469740145|FG000|Overall Study|Switch to peritoneal dialysis|1|||
130483255|NCT03257410|469740146|FG001|Overall Study|Switch to peritoneal dialysis|0|||
130483256|NCT03257410|469740145|FG000|Overall Study|Death|3|||
130483257|NCT03257410|469740146|FG001|Overall Study|Death|2|||
130483258|NCT03257410|469740145|FG000|Overall Study|Change to another dialysis center|2|||
130483259|NCT03257410|469740146|FG001|Overall Study|Change to another dialysis center|2|||
130483260|NCT03257410|469740145|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
130483261|NCT03257410|469740146|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
130483262|NCT03257410|469740145|FG000|Overall Study|Miscellaneous|2|||
130483263|NCT03257410|469740146|FG001|Overall Study|Miscellaneous|2|||
130483264|NCT03257410|469740145|FG000|Overall Study|Other|0|||
130483265|NCT03257410|469740146|FG001|Overall Study|Other|1|||
130483266|NCT02276885|469740147|FG000|Overall Study|Withdrawal by Subject|2|||
130483267|NCT02276885|469740148|FG001|Overall Study|Withdrawal by Subject|0|||
130483268|NCT02276885|469740147|FG000|Overall Study|Lost to Follow-up|5|||
130483269|NCT02276885|469740148|FG001|Overall Study|Lost to Follow-up|2|||
130483270|NCT04171141|469740152|FG000|Overall Study|Adverse Event|0|||
130483271|NCT04171141|469740153|FG001|Overall Study|Adverse Event|0|||
130483272|NCT04171141|469740154|FG002|Overall Study|Adverse Event|2|||
130483273|NCT04171141|469740155|FG003|Overall Study|Adverse Event|0|||
130483274|NCT04171141|469740156|FG004|Overall Study|Adverse Event|0|||
130483275|NCT04171141|469740157|FG005|Overall Study|Adverse Event|0|||
130483276|NCT04171141|469740158|FG006|Overall Study|Adverse Event|0|||
130483277|NCT04171141|469740159|FG007|Overall Study|Adverse Event|0|||
130483278|NCT04171141|469740160|FG008|Overall Study|Adverse Event|0|||
130483279|NCT04171141|469740161|FG009|Overall Study|Adverse Event|0|||
130483280|NCT04171141|469740162|FG010|Overall Study|Adverse Event|0|||
130483281|NCT04171141|469740163|FG011|Overall Study|Adverse Event|0|||
130483282|NCT04171141|469740164|FG012|Overall Study|Adverse Event|0|||
130728065|NCT02290223|470625592|FG001|12 Months|Refusal|1|||
130483283|NCT04171141|469740165|FG013|Overall Study|Adverse Event|2|||
130483284|NCT04171141|469740166|FG014|Overall Study|Adverse Event|0|||
130483285|NCT04171141|469740167|FG015|Overall Study|Adverse Event|0|||
130728066|NCT00534404|470625593|FG000|Overall Study|Death|0|||
130728067|NCT00534404|470625594|FG001|Overall Study|Death|0|||
130483286|NCT04171141|469740152|FG000|Overall Study|Physician Decision|0|||
130483287|NCT04171141|469740153|FG001|Overall Study|Physician Decision|0|||
130483288|NCT04171141|469740154|FG002|Overall Study|Physician Decision|0|||
130728068|NCT00534404|470625595|FG002|Overall Study|Death|2|||
130728069|NCT00534404|470625593|FG000|Overall Study|Withdrawal by Subject|8|||
130483289|NCT04171141|469740155|FG003|Overall Study|Physician Decision|0|||
130483290|NCT04171141|469740156|FG004|Overall Study|Physician Decision|1|||
130483291|NCT04171141|469740157|FG005|Overall Study|Physician Decision|0|||
130483292|NCT04171141|469740158|FG006|Overall Study|Physician Decision|0|||
130483293|NCT04171141|469740159|FG007|Overall Study|Physician Decision|0|||
130483294|NCT04171141|469740160|FG008|Overall Study|Physician Decision|0|||
130483295|NCT04171141|469740161|FG009|Overall Study|Physician Decision|0|||
130483296|NCT04171141|469740162|FG010|Overall Study|Physician Decision|0|||
130483297|NCT04171141|469740163|FG011|Overall Study|Physician Decision|0|||
130483298|NCT04171141|469740164|FG012|Overall Study|Physician Decision|0|||
130483299|NCT04171141|469740165|FG013|Overall Study|Physician Decision|0|||
130483300|NCT04171141|469740166|FG014|Overall Study|Physician Decision|0|||
130483301|NCT04171141|469740167|FG015|Overall Study|Physician Decision|1|||
130483302|NCT04171141|469740152|FG000|Overall Study|Progressive disease|2|||
130483303|NCT04171141|469740153|FG001|Overall Study|Progressive disease|3|||
130483304|NCT04171141|469740154|FG002|Overall Study|Progressive disease|4|||
130483305|NCT04171141|469740155|FG003|Overall Study|Progressive disease|7|||
130483306|NCT04171141|469740156|FG004|Overall Study|Progressive disease|1|||
130483307|NCT04171141|469740157|FG005|Overall Study|Progressive disease|8|||
130483308|NCT04171141|469740158|FG006|Overall Study|Progressive disease|4|||
130483309|NCT04171141|469740159|FG007|Overall Study|Progressive disease|6|||
130483310|NCT04171141|469740160|FG008|Overall Study|Progressive disease|7|||
130483311|NCT04171141|469740161|FG009|Overall Study|Progressive disease|3|||
130483312|NCT04171141|469740162|FG010|Overall Study|Progressive disease|4|||
130483313|NCT04171141|469740163|FG011|Overall Study|Progressive disease|3|||
130483314|NCT04171141|469740164|FG012|Overall Study|Progressive disease|4|||
130483315|NCT04171141|469740165|FG013|Overall Study|Progressive disease|2|||
130483316|NCT04171141|469740166|FG014|Overall Study|Progressive disease|4|||
130483317|NCT04171141|469740167|FG015|Overall Study|Progressive disease|1|||
130483318|NCT04171141|469740152|FG000|Overall Study|Withdrawal by Subject|0|||
130483319|NCT04171141|469740153|FG001|Overall Study|Withdrawal by Subject|0|||
130483320|NCT04171141|469740154|FG002|Overall Study|Withdrawal by Subject|0|||
130483321|NCT04171141|469740155|FG003|Overall Study|Withdrawal by Subject|1|||
130483322|NCT04171141|469740156|FG004|Overall Study|Withdrawal by Subject|0|||
130483323|NCT04171141|469740157|FG005|Overall Study|Withdrawal by Subject|0|||
130483324|NCT04171141|469740158|FG006|Overall Study|Withdrawal by Subject|1|||
130483325|NCT04171141|469740159|FG007|Overall Study|Withdrawal by Subject|0|||
130483326|NCT04171141|469740160|FG008|Overall Study|Withdrawal by Subject|0|||
130483327|NCT04171141|469740161|FG009|Overall Study|Withdrawal by Subject|1|||
130483328|NCT04171141|469740162|FG010|Overall Study|Withdrawal by Subject|0|||
130483329|NCT04171141|469740163|FG011|Overall Study|Withdrawal by Subject|0|||
130483330|NCT04171141|469740164|FG012|Overall Study|Withdrawal by Subject|0|||
130483331|NCT04171141|469740165|FG013|Overall Study|Withdrawal by Subject|0|||
130483332|NCT04171141|469740166|FG014|Overall Study|Withdrawal by Subject|0|||
130483333|NCT04171141|469740167|FG015|Overall Study|Withdrawal by Subject|0|||
130483334|NCT04171141|469740152|FG000|Overall Study|Global deterioration of health status|0|||
130483335|NCT04171141|469740153|FG001|Overall Study|Global deterioration of health status|0|||
130483336|NCT04171141|469740154|FG002|Overall Study|Global deterioration of health status|0|||
130483337|NCT04171141|469740155|FG003|Overall Study|Global deterioration of health status|1|||
130483338|NCT04171141|469740156|FG004|Overall Study|Global deterioration of health status|0|||
130483339|NCT04171141|469740157|FG005|Overall Study|Global deterioration of health status|2|||
130483340|NCT04171141|469740158|FG006|Overall Study|Global deterioration of health status|1|||
130483341|NCT04171141|469740159|FG007|Overall Study|Global deterioration of health status|0|||
130483342|NCT04171141|469740160|FG008|Overall Study|Global deterioration of health status|1|||
130483343|NCT04171141|469740161|FG009|Overall Study|Global deterioration of health status|0|||
130483344|NCT04171141|469740162|FG010|Overall Study|Global deterioration of health status|0|||
130483345|NCT04171141|469740163|FG011|Overall Study|Global deterioration of health status|0|||
130483346|NCT04171141|469740164|FG012|Overall Study|Global deterioration of health status|0|||
130483347|NCT04171141|469740165|FG013|Overall Study|Global deterioration of health status|0|||
130483348|NCT04171141|469740166|FG014|Overall Study|Global deterioration of health status|1|||
130483349|NCT04171141|469740167|FG015|Overall Study|Global deterioration of health status|1|||
130483350|NCT03314454|469740170|FG000|Overall Study|Protocol Violation|1|||
130483351|NCT04233216|469740171|FG000|Overall Study|Lost to Follow-up|1|||
130483352|NCT04233216|469740172|FG001|Overall Study|Lost to Follow-up|0|||
130483353|NCT04233216|469740173|FG002|Overall Study|Lost to Follow-up|2|||
130483354|NCT04233216|469740174|FG003|Overall Study|Lost to Follow-up|0|||
130483355|NCT04233216|469740171|FG000|Overall Study|Physician Decision|0|||
130483356|NCT04233216|469740172|FG001|Overall Study|Physician Decision|3|||
130483357|NCT04233216|469740173|FG002|Overall Study|Physician Decision|0|||
130483358|NCT04233216|469740174|FG003|Overall Study|Physician Decision|2|||
130483359|NCT04233216|469740171|FG000|Overall Study|Withdrawal by Subject|0|||
130483360|NCT04233216|469740172|FG001|Overall Study|Withdrawal by Subject|2|||
130483361|NCT04233216|469740173|FG002|Overall Study|Withdrawal by Subject|1|||
130483362|NCT04233216|469740174|FG003|Overall Study|Withdrawal by Subject|0|||
130483363|NCT03652389|469740175|FG000|Overall Study|Lost to Follow-up|1|||
130483364|NCT03652389|469740176|FG001|Overall Study|Lost to Follow-up|5|||
130483365|NCT03652389|469740175|FG000|Overall Study|Withdrawal by Subject|5|||
130483366|NCT03652389|469740176|FG001|Overall Study|Withdrawal by Subject|1|||
130483367|NCT03652389|469740175|FG000|Overall Study|New diagnosis|2|||
130483368|NCT03652389|469740176|FG001|Overall Study|New diagnosis|0|||
130483369|NCT05496231|469740196|FG000|Overall Study|Adverse Event|1|||
130483370|NCT05496231|469740197|FG001|Overall Study|Adverse Event|1|||
130483371|NCT05496231|469740198|FG002|Overall Study|Adverse Event|0|||
130483372|NCT05496231|469740199|FG003|Overall Study|Adverse Event|4|||
130483373|NCT05496231|469740196|FG000|Overall Study|Withdrawal by Subject|5|||
130483374|NCT05496231|469740197|FG001|Overall Study|Withdrawal by Subject|5|||
130483375|NCT05496231|469740198|FG002|Overall Study|Withdrawal by Subject|4|||
130483376|NCT05496231|469740199|FG003|Overall Study|Withdrawal by Subject|11|||
130483377|NCT05496231|469740196|FG000|Overall Study|Migrated/moved from the study area|3|||
130483378|NCT05496231|469740197|FG001|Overall Study|Migrated/moved from the study area|5|||
130483379|NCT05496231|469740198|FG002|Overall Study|Migrated/moved from the study area|3|||
130483380|NCT05496231|469740199|FG003|Overall Study|Migrated/moved from the study area|3|||
130483381|NCT05496231|469740196|FG000|Overall Study|Lost to Follow-up|13|||
130483382|NCT05496231|469740197|FG001|Overall Study|Lost to Follow-up|6|||
130483383|NCT05496231|469740198|FG002|Overall Study|Lost to Follow-up|11|||
130483384|NCT05496231|469740199|FG003|Overall Study|Lost to Follow-up|6|||
130483385|NCT05496231|469740196|FG000|Overall Study|Other|9|||
130483386|NCT05496231|469740197|FG001|Overall Study|Other|7|||
130483387|NCT05496231|469740198|FG002|Overall Study|Other|7|||
130483388|NCT05496231|469740199|FG003|Overall Study|Other|8|||
130483389|NCT05029622|469740202|FG000|Overall Study|Lost to Follow-up|1|||
130483390|NCT05526430|469740207|FG000|Overall Study|Withdrawal by Subject|0|||
130483391|NCT05526430|469740208|FG001|Overall Study|Withdrawal by Subject|2|||
130483392|NCT05526430|469740209|FG002|Overall Study|Withdrawal by Subject|0|||
130483393|NCT05526430|469740210|FG003|Overall Study|Withdrawal by Subject|0|||
130483394|NCT03085810|469740211|FG000|Main Study|Withdrawal by Subject|77|||
130483395|NCT03085810|469740212|FG001|Main Study|Withdrawal by Subject|0|||
130483396|NCT03085810|469740213|FG002|Main Study|Withdrawal by Subject|0|||
130483397|NCT03085810|469740211|FG000|Main Study|Terminated By Sponsor|14|||
130483398|NCT03085810|469740212|FG001|Main Study|Terminated By Sponsor|0|||
130483399|NCT03085810|469740213|FG002|Main Study|Terminated By Sponsor|0|||
130483400|NCT03085810|469740211|FG000|Main Study|Protocol Violation|15|||
130483401|NCT03085810|469740212|FG001|Main Study|Protocol Violation|0|||
130483402|NCT03085810|469740213|FG002|Main Study|Protocol Violation|0|||
130483403|NCT03085810|469740211|FG000|Main Study|Physician Decision|13|||
130483404|NCT03085810|469740212|FG001|Main Study|Physician Decision|0|||
130483405|NCT03085810|469740213|FG002|Main Study|Physician Decision|0|||
130483406|NCT03085810|469740211|FG000|Main Study|Lost to Follow-up|17|||
130483407|NCT03085810|469740212|FG001|Main Study|Lost to Follow-up|0|||
130483408|NCT03085810|469740213|FG002|Main Study|Lost to Follow-up|0|||
130483409|NCT03085810|469740211|FG000|Main Study|Adverse Event|25|||
130483410|NCT03085810|469740212|FG001|Main Study|Adverse Event|0|||
130483411|NCT03085810|469740213|FG002|Main Study|Adverse Event|0|||
130483412|NCT03085810|469740211|FG000|Main Study|Pregnancy|7|||
130483413|NCT03085810|469740212|FG001|Main Study|Pregnancy|0|||
130483414|NCT03085810|469740213|FG002|Main Study|Pregnancy|0|||
130483415|NCT03085810|469740211|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
130483416|NCT03085810|469740212|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
130483417|NCT03085810|469740213|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
130483418|NCT03085810|469740211|FG000|Main Study|Lack of Efficacy|10|||
130483419|NCT03085810|469740212|FG001|Main Study|Lack of Efficacy|0|||
130483420|NCT03085810|469740213|FG002|Main Study|Lack of Efficacy|0|||
130483421|NCT03085810|469740211|FG000|Main Study|Death|12|||
130483422|NCT03085810|469740212|FG001|Main Study|Death|0|||
130483423|NCT03085810|469740213|FG002|Main Study|Death|0|||
130483424|NCT03085810|469740211|FG000|Main Study|Disease progression|1|||
130483425|NCT03085810|469740212|FG001|Main Study|Disease progression|0|||
130483426|NCT03085810|469740213|FG002|Main Study|Disease progression|0|||
130565017|NCT00307151|470035360|FG003|Overall Study|Subject unable to get to clinic|2|||
130565018|NCT00307151|470035357|FG000|Overall Study|Withdrew consent|0|||
130565019|NCT00307151|470035358|FG001|Overall Study|Withdrew consent|1|||
130565020|NCT00307151|470035359|FG002|Overall Study|Withdrew consent|1|||
130565021|NCT00307151|470035360|FG003|Overall Study|Withdrew consent|3|||
130565022|NCT00307151|470035357|FG000|Overall Study|Not willing to adhere to study reqs|2|||
130565023|NCT00307151|470035358|FG001|Overall Study|Not willing to adhere to study reqs|0|||
130483427|NCT03085810|469740211|FG000|Main Study|Site Closure|3|||
130483428|NCT03085810|469740212|FG001|Main Study|Site Closure|0|||
130483429|NCT03085810|469740213|FG002|Main Study|Site Closure|0|||
130483430|NCT03085810|469740211|FG000|Main Study|Planned pregnancy|17|||
130483431|NCT03085810|469740212|FG001|Main Study|Planned pregnancy|0|||
130483432|NCT03085810|469740213|FG002|Main Study|Planned pregnancy|0|||
130483433|NCT03085810|469740211|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
130483434|NCT03085810|469740212|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
130483435|NCT03085810|469740213|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
130565024|NCT00307151|470035359|FG002|Overall Study|Not willing to adhere to study reqs|2|||
130483436|NCT03085810|469740211|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
130483437|NCT03085810|469740212|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
130483438|NCT03085810|469740213|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
130483439|NCT03085810|469740211|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
130483440|NCT03085810|469740212|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
130483441|NCT03085810|469740213|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
130483442|NCT03085810|469740211|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
130483443|NCT03085810|469740212|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
130483444|NCT03085810|469740213|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
130483445|NCT05200403|469740216|FG000|Overall Study|Withdrawal by Subject|4|||
130483446|NCT05200403|469740217|FG001|Overall Study|Withdrawal by Subject|2|||
130483447|NCT05200403|469740218|FG002|Overall Study|Withdrawal by Subject|6|||
130483448|NCT01959607|469740219|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130483449|NCT01959607|469740220|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
130483450|NCT01959607|469740221|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130483451|NCT01959607|469740222|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
130483452|NCT03785964|469740223|FG000|Overall Study|Adverse Event|14|||
130483453|NCT03785964|469740224|FG001|Overall Study|Adverse Event|1|||
130483454|NCT03785964|469740223|FG000|Overall Study|Unqualified Clinical Progression|1|||
130483455|NCT03785964|469740224|FG001|Overall Study|Unqualified Clinical Progression|1|||
130483456|NCT03785964|469740223|FG000|Overall Study|Participant non-compliance|1|||
130483457|NCT03785964|469740224|FG001|Overall Study|Participant non-compliance|1|||
130483458|NCT03785964|469740223|FG000|Overall Study|Not treated|1|||
130483459|NCT03785964|469740224|FG001|Overall Study|Not treated|0|||
130483460|NCT03785964|469740223|FG000|Overall Study|Other reason|5|||
130483461|NCT03785964|469740224|FG001|Overall Study|Other reason|11|||
130483462|NCT03785964|469740223|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
130483463|NCT03785964|469740224|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
130483464|NCT04117347|469740231|FG000|Overall Study|Adverse Event|0|||
130483465|NCT04117347|469740232|FG001|Overall Study|Adverse Event|0|||
130483466|NCT04117347|469740233|FG002|Overall Study|Adverse Event|1|||
130483467|NCT04117347|469740231|FG000|Overall Study|No time for study|0|||
130483468|NCT04117347|469740232|FG001|Overall Study|No time for study|2|||
130483469|NCT04117347|469740233|FG002|Overall Study|No time for study|0|||
130483470|NCT04117347|469740231|FG000|Overall Study|Family emergency|1|||
130483471|NCT04117347|469740232|FG001|Overall Study|Family emergency|0|||
130483472|NCT04117347|469740233|FG002|Overall Study|Family emergency|0|||
130483473|NCT02505984|469740234|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
130483474|NCT02505984|469740235|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
130483475|NCT02505984|469740234|FG000|Overall Study|Unreliable self-report data|1|||
130483476|NCT02505984|469740235|FG001|Overall Study|Unreliable self-report data|0|||
130483477|NCT02505984|469740234|FG000|Overall Study|Study blind opened during assessment|0|||
130483478|NCT02505984|469740235|FG001|Overall Study|Study blind opened during assessment|1|||
130483479|NCT02505984|469740234|FG000|Overall Study|Noncompliance with study protocol|0|||
130483480|NCT02505984|469740235|FG001|Overall Study|Noncompliance with study protocol|1|||
130483481|NCT03687086|469740236|FG000|Overall Study|Withdrawal by Subject|3|||
130483482|NCT03687086|469740237|FG001|Overall Study|Withdrawal by Subject|4|||
130483483|NCT03687086|469740236|FG000|Overall Study|Lost to Follow-up|1|||
130483484|NCT03687086|469740237|FG001|Overall Study|Lost to Follow-up|1|||
130483485|NCT03687086|469740236|FG000|Overall Study|Death|1|||
130483486|NCT03687086|469740237|FG001|Overall Study|Death|0|||
130483487|NCT03687086|469740236|FG000|Overall Study|Incomplete assessment|0|||
130483488|NCT03687086|469740237|FG001|Overall Study|Incomplete assessment|2|||
130483489|NCT03463044|469740266|FG000|Overall Study|Lost to Follow-up|0|||
130483490|NCT03463044|469740267|FG001|Overall Study|Lost to Follow-up|0|||
130483491|NCT03463044|469740268|FG002|Overall Study|Lost to Follow-up|0|||
130483492|NCT03463044|469740269|FG003|Overall Study|Lost to Follow-up|0|||
130483493|NCT03463044|469740270|FG004|Overall Study|Lost to Follow-up|0|||
130483494|NCT03463044|469740271|FG005|Overall Study|Lost to Follow-up|0|||
130483495|NCT03463044|469740272|FG006|Overall Study|Lost to Follow-up|0|||
130483496|NCT03463044|469740273|FG007|Overall Study|Lost to Follow-up|1|||
130483497|NCT03463044|469740274|FG008|Overall Study|Lost to Follow-up|0|||
130483498|NCT05192109|469740275|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130483499|NCT05192109|469740276|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130483500|NCT05192109|469740277|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130483501|NCT05192109|469740278|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130483502|NCT05192109|469740275|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130483503|NCT05192109|469740276|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130483504|NCT05192109|469740277|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130483505|NCT05192109|469740278|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130483506|NCT04498390|469740279|FG000|Overall Study|Adverse Event|0|||
130483507|NCT04498390|469740280|FG001|Overall Study|Adverse Event|0|||
130483508|NCT04498390|469740281|FG002|Overall Study|Adverse Event|1|||
130483509|NCT04498390|469740282|FG003|Overall Study|Adverse Event|0|||
130483510|NCT04498390|469740283|FG004|Overall Study|Adverse Event|0|||
130483511|NCT04498390|469740279|FG000|Overall Study|Withdrawal by Subject|0|||
130483512|NCT04498390|469740280|FG001|Overall Study|Withdrawal by Subject|0|||
130483513|NCT04498390|469740281|FG002|Overall Study|Withdrawal by Subject|0|||
130483514|NCT04498390|469740282|FG003|Overall Study|Withdrawal by Subject|1|||
130483515|NCT04498390|469740283|FG004|Overall Study|Withdrawal by Subject|0|||
130483516|NCT03478956|469740284|FG000|Randomized Treatment Period|Adverse Event|1|||
130483517|NCT03478956|469740285|FG001|Randomized Treatment Period|Adverse Event|0|||
130483518|NCT03478956|469740286|FG002|Randomized Treatment Period|Adverse Event|0|||
130483519|NCT03478956|469740287|FG003|Randomized Treatment Period|Adverse Event|0|||
130483520|NCT03478956|469740284|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
130483521|NCT03478956|469740285|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
130483522|NCT03478956|469740286|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
130483523|NCT03478956|469740287|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
130483524|NCT03478956|469740284|FG000|Open Label Extension Period|Adverse Event|0|||
130483525|NCT03478956|469740285|FG001|Open Label Extension Period|Adverse Event|0|||
130483526|NCT03478956|469740286|FG002|Open Label Extension Period|Adverse Event|4|||
130483527|NCT03478956|469740287|FG003|Open Label Extension Period|Adverse Event|0|||
130483528|NCT03478956|469740284|FG000|Open Label Extension Period|Lack of Efficacy|0|||
130483529|NCT03478956|469740285|FG001|Open Label Extension Period|Lack of Efficacy|0|||
130483530|NCT03478956|469740286|FG002|Open Label Extension Period|Lack of Efficacy|8|||
130483531|NCT03478956|469740287|FG003|Open Label Extension Period|Lack of Efficacy|0|||
130483532|NCT03478956|469740284|FG000|Open Label Extension Period|Reason Not Provided|0|||
130483533|NCT03478956|469740285|FG001|Open Label Extension Period|Reason Not Provided|0|||
130483534|NCT03478956|469740286|FG002|Open Label Extension Period|Reason Not Provided|1|||
130483535|NCT03478956|469740287|FG003|Open Label Extension Period|Reason Not Provided|0|||
130483536|NCT03478956|469740284|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
130483537|NCT03478956|469740285|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
130483538|NCT03478956|469740286|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
130483539|NCT03478956|469740287|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
130483540|NCT03478956|469740284|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
130483541|NCT03478956|469740285|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
130483542|NCT03478956|469740286|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
130483543|NCT03478956|469740287|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
130483544|NCT03478956|469740284|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130483545|NCT03478956|469740285|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130483546|NCT03478956|469740286|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130483547|NCT03478956|469740287|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
130483548|NCT04865289|469740288|FG000|Overall Study|Participant ongoing in study|47|||
130483549|NCT04865289|469740289|FG001|Overall Study|Participant ongoing in study|35|||
130483550|NCT04865289|469740288|FG000|Overall Study|Death|27|||
130483551|NCT04865289|469740289|FG001|Overall Study|Death|21|||
130483552|NCT02561247|469741890|FG000|Overall Study|Protocol Violation|1|||
130483553|NCT02561247|469741890|FG000|Overall Study|Withdrawal by Subject|1|||
130483554|NCT02561247|469741890|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
130483555|NCT04858451|469741891|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
130483556|NCT04858451|469741892|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483557|NCT04858451|469741893|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483558|NCT04858451|469741894|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483559|NCT04858451|469741895|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483560|NCT04858451|469741896|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483561|NCT04858451|469741897|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483562|NCT04858451|469741898|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483563|NCT04858451|469741899|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
130483564|NCT04858451|469741891|FG000|Part 2|Discontinued|0|||
130483565|NCT04858451|469741892|FG001|Part 2|Discontinued|0|||
130483566|NCT04858451|469741893|FG002|Part 2|Discontinued|0|||
130483567|NCT04858451|469741894|FG003|Part 2|Discontinued|0|||
130483568|NCT04858451|469741895|FG004|Part 2|Discontinued|0|||
130483569|NCT04858451|469741896|FG005|Part 2|Discontinued|0|||
130565025|NCT00307151|470035360|FG003|Overall Study|Not willing to adhere to study reqs|2|||
130565026|NCT00307151|470035357|FG000|Overall Study|Clinic unable to contact subject|3|||
130565027|NCT00307151|470035358|FG001|Overall Study|Clinic unable to contact subject|3|||
130565028|NCT00307151|470035359|FG002|Overall Study|Clinic unable to contact subject|1|||
130483570|NCT04858451|469741897|FG006|Part 2|Discontinued|0|||
130483571|NCT04858451|469741898|FG007|Part 2|Discontinued|0|||
130483572|NCT04858451|469741899|FG008|Part 2|Discontinued|63|||
130483573|NCT03663569|469741901|FG000|Overall Study|Discontinuation of study|11|||
130483574|NCT03663569|469741901|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
130483575|NCT03663569|469741901|FG000|Overall Study|Deceased patient|6|||
130483576|NCT03663569|469741901|FG000|Overall Study|Lost to Follow-up|18|||
130483577|NCT03663569|469741901|FG000|Overall Study|Withdrawal of consent|5|||
130483578|NCT03663569|469741901|FG000|Overall Study|Patient's request|11|||
130483579|NCT03663569|469741901|FG000|Overall Study|Adverse Event|4|||
130483580|NCT03663569|469741901|FG000|Overall Study|Not come to second visit|3|||
130483581|NCT03663569|469741901|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
130483582|NCT03663569|469741901|FG000|Overall Study|Serious adverse event|1|||
130483583|NCT04298983|469741902|FG000|Overall Study|Adverse Event|4|||
130483584|NCT04298983|469741902|FG000|Overall Study|Lack of Efficacy|3|||
130483585|NCT04248725|469741904|FG000|Post-Treatment|Lost to Follow-up|6|||
130483586|NCT04248725|469741905|FG001|Post-Treatment|Lost to Follow-up|5|||
130483587|NCT04248725|469741904|FG000|6-Month Follow Up|Lost to Follow-up|9|||
130483588|NCT04248725|469741905|FG001|6-Month Follow Up|Lost to Follow-up|8|||
130483589|NCT02116530|469741906|FG000|Overall Study|Withdrawal by Subject|1|||
130483590|NCT02116530|469741907|FG001|Overall Study|Withdrawal by Subject|2|||
130483591|NCT02116530|469741906|FG000|Overall Study|Adverse Event|4|||
130483592|NCT02116530|469741907|FG001|Overall Study|Adverse Event|0|||
130483593|NCT02116530|469741906|FG000|Overall Study|Physician Decision|1|||
130483594|NCT02116530|469741907|FG001|Overall Study|Physician Decision|0|||
130483595|NCT02116530|469741906|FG000|Overall Study|Lost to Follow-up|1|||
130483596|NCT02116530|469741907|FG001|Overall Study|Lost to Follow-up|0|||
130483597|NCT02116530|469741906|FG000|Overall Study|Other Medical Problems|2|||
130483598|NCT02116530|469741907|FG001|Overall Study|Other Medical Problems|2|||
130483599|NCT03766685|469741908|FG000|Overall Study|Lost to Follow-up|1|||
130483600|NCT03766685|469741909|FG001|Overall Study|Lost to Follow-up|1|||
130483601|NCT03766685|469741910|FG002|Overall Study|Lost to Follow-up|0|||
130483602|NCT03766685|469741911|FG003|Overall Study|Lost to Follow-up|0|||
130483603|NCT03766685|469741908|FG000|Overall Study|Adverse Event, not fatal|0|||
130483604|NCT03766685|469741909|FG001|Overall Study|Adverse Event, not fatal|1|||
130483605|NCT03766685|469741910|FG002|Overall Study|Adverse Event, not fatal|0|||
130483606|NCT03766685|469741911|FG003|Overall Study|Adverse Event, not fatal|1|||
130483607|NCT03766685|469741908|FG000|Overall Study|Withdrawal by Subject|0|||
130483608|NCT03766685|469741909|FG001|Overall Study|Withdrawal by Subject|2|||
130483609|NCT03766685|469741910|FG002|Overall Study|Withdrawal by Subject|0|||
130483610|NCT03766685|469741911|FG003|Overall Study|Withdrawal by Subject|0|||
130483611|NCT03766685|469741908|FG000|Overall Study|Protocol Violation|0|||
130483612|NCT03766685|469741909|FG001|Overall Study|Protocol Violation|1|||
130483613|NCT03766685|469741910|FG002|Overall Study|Protocol Violation|0|||
130483614|NCT03766685|469741911|FG003|Overall Study|Protocol Violation|0|||
130483615|NCT03766685|469741908|FG000|Overall Study|Non-compliance|0|||
130483616|NCT03766685|469741909|FG001|Overall Study|Non-compliance|2|||
130483617|NCT03766685|469741910|FG002|Overall Study|Non-compliance|0|||
130483618|NCT03766685|469741911|FG003|Overall Study|Non-compliance|0|||
130483619|NCT02927236|469741914|FG000|Characterization Phase|Physician Decision|0|||
130483620|NCT02927236|469741915|FG001|Characterization Phase|Physician Decision|3|||
130483621|NCT02927236|469741916|FG002|Characterization Phase|Physician Decision|0|||
130483622|NCT02927236|469741917|FG003|Characterization Phase|Physician Decision|2|||
130483623|NCT02927236|469741914|FG000|Characterization Phase|Lost to Follow-up|0|||
130483624|NCT02927236|469741915|FG001|Characterization Phase|Lost to Follow-up|0|||
130483625|NCT02927236|469741916|FG002|Characterization Phase|Lost to Follow-up|0|||
130483626|NCT02927236|469741917|FG003|Characterization Phase|Lost to Follow-up|3|||
130483627|NCT02927236|469741914|FG000|Characterization Phase|Withdrawal by Subject|1|||
130483628|NCT02927236|469741915|FG001|Characterization Phase|Withdrawal by Subject|0|||
130728070|NCT00534404|470625594|FG001|Overall Study|Withdrawal by Subject|2|||
130728071|NCT00534404|470625595|FG002|Overall Study|Withdrawal by Subject|38|||
130728072|NCT00534404|470625593|FG000|Overall Study|Removed by study staff|2|||
130728073|NCT00534404|470625594|FG001|Overall Study|Removed by study staff|3|||
130728074|NCT00534404|470625595|FG002|Overall Study|Removed by study staff|1|||
130728075|NCT00534404|470625593|FG000|Overall Study|Lost to Follow-up|170|||
130728076|NCT00534404|470625594|FG001|Overall Study|Lost to Follow-up|138|||
130728077|NCT00534404|470625595|FG002|Overall Study|Lost to Follow-up|201|||
130483629|NCT02927236|469741916|FG002|Characterization Phase|Withdrawal by Subject|0|||
130483630|NCT02927236|469741917|FG003|Characterization Phase|Withdrawal by Subject|1|||
130483631|NCT02927236|469741914|FG000|Treatment Phase|Adverse Event|1|||
130483632|NCT02927236|469741915|FG001|Treatment Phase|Adverse Event|0|||
130483633|NCT02927236|469741916|FG002|Treatment Phase|Adverse Event|1|||
130483634|NCT02927236|469741917|FG003|Treatment Phase|Adverse Event|1|||
130483635|NCT02927236|469741914|FG000|Treatment Phase|Protocol Violation|3|||
130483636|NCT02927236|469741915|FG001|Treatment Phase|Protocol Violation|0|||
130483637|NCT02927236|469741916|FG002|Treatment Phase|Protocol Violation|0|||
130483638|NCT02927236|469741917|FG003|Treatment Phase|Protocol Violation|1|||
130728078|NCT03371459|470625599|FG000|Washout|Lost to Follow-up|0|||
130728079|NCT03371459|470625600|FG001|Washout|Lost to Follow-up|1|||
130728080|NCT03597464|470625603|FG000|Overall Study|Withdrawal by Subject|4|||
130483639|NCT02927236|469741914|FG000|Treatment Phase|Lost to Follow-up|1|||
130483640|NCT02927236|469741915|FG001|Treatment Phase|Lost to Follow-up|0|||
130483641|NCT02927236|469741916|FG002|Treatment Phase|Lost to Follow-up|0|||
130728081|NCT03597464|470625604|FG001|Overall Study|Withdrawal by Subject|5|||
130483642|NCT02927236|469741917|FG003|Treatment Phase|Lost to Follow-up|0|||
130483643|NCT02927236|469741914|FG000|Follow-up Phase|Lost to Follow-up|1|||
130483644|NCT02927236|469741915|FG001|Follow-up Phase|Lost to Follow-up|0|||
130483645|NCT02927236|469741916|FG002|Follow-up Phase|Lost to Follow-up|1|||
130483646|NCT02927236|469741917|FG003|Follow-up Phase|Lost to Follow-up|0|||
130483647|NCT03656510|469741921|FG000|Overall Study|Lost to Follow-up|1|||
130483648|NCT03656510|469741922|FG001|Overall Study|Lost to Follow-up|0|||
130483649|NCT03656510|469741923|FG002|Overall Study|Lost to Follow-up|0|||
130483650|NCT03656510|469741924|FG003|Overall Study|Lost to Follow-up|0|||
130483651|NCT03656510|469741925|FG004|Overall Study|Lost to Follow-up|0|||
130483652|NCT03656510|469741926|FG005|Overall Study|Lost to Follow-up|0|||
130483653|NCT03656510|469741921|FG000|Overall Study|Withdrawal by Subject|1|||
130483654|NCT03656510|469741922|FG001|Overall Study|Withdrawal by Subject|1|||
130483655|NCT03656510|469741923|FG002|Overall Study|Withdrawal by Subject|0|||
130483656|NCT03656510|469741924|FG003|Overall Study|Withdrawal by Subject|1|||
130483657|NCT03656510|469741925|FG004|Overall Study|Withdrawal by Subject|0|||
130483658|NCT03656510|469741926|FG005|Overall Study|Withdrawal by Subject|0|||
130483659|NCT03819153|469741933|FG000|Overall Study|Withdrawal by Subject|20|||
130483660|NCT03819153|469741934|FG001|Overall Study|Withdrawal by Subject|28|||
130483661|NCT03819153|469741933|FG000|Overall Study|Lost to Follow-up|23|||
130483662|NCT03819153|469741934|FG001|Overall Study|Lost to Follow-up|30|||
130483663|NCT03974178|469741935|FG000|Overall Study|Death|0|||
130483664|NCT03974178|469741936|FG001|Overall Study|Death|1|||
130483665|NCT04508309|469741937|FG000|Overall Study|Death|0|||
130483666|NCT04508309|469741938|FG001|Overall Study|Death|0|||
130483667|NCT04508309|469741939|FG002|Overall Study|Death|0|||
130483668|NCT04508309|469741940|FG003|Overall Study|Death|0|||
130483669|NCT04508309|469741941|FG004|Overall Study|Death|1|||
130483670|NCT04508309|469741937|FG000|Overall Study|Lost to Follow-up|0|||
130483671|NCT04508309|469741938|FG001|Overall Study|Lost to Follow-up|0|||
130483672|NCT04508309|469741939|FG002|Overall Study|Lost to Follow-up|1|||
130483673|NCT04508309|469741940|FG003|Overall Study|Lost to Follow-up|1|||
130483674|NCT04508309|469741941|FG004|Overall Study|Lost to Follow-up|0|||
130483675|NCT04508309|469741937|FG000|Overall Study|Withdrawal by Subject|0|||
130483676|NCT04508309|469741938|FG001|Overall Study|Withdrawal by Subject|0|||
130483677|NCT04508309|469741939|FG002|Overall Study|Withdrawal by Subject|0|||
130483678|NCT04508309|469741940|FG003|Overall Study|Withdrawal by Subject|0|||
130483679|NCT04508309|469741941|FG004|Overall Study|Withdrawal by Subject|1|||
130483680|NCT04914676|469741945|FG000|Overall Study|Study termination|3|||
130483681|NCT04914676|469741946|FG001|Overall Study|Study termination|0|||
130483682|NCT03240016|469741947|FG000|Overall Study|Adverse Event|9|||
130483683|NCT03240016|469741947|FG000|Overall Study|Withdrawal by Subject|7|||
130483684|NCT03240016|469741947|FG000|Overall Study|Death|1|||
130483685|NCT03240016|469741947|FG000|Overall Study|Physician Decision|2|||
130483686|NCT03913442|469741948|FG000|Overall Study|Adverse Event|0|||
130483687|NCT03913442|469741949|FG001|Overall Study|Adverse Event|3|||
130483688|NCT03913442|469741948|FG000|Overall Study|Withdrawal by Subject|5|||
130483689|NCT03913442|469741949|FG001|Overall Study|Withdrawal by Subject|5|||
130483690|NCT03913442|469741948|FG000|Overall Study|Terminations|2|||
130483691|NCT03913442|469741949|FG001|Overall Study|Terminations|1|||
130483692|NCT03913442|469741948|FG000|Overall Study|Lost to Follow-up|2|||
130483693|NCT03913442|469741949|FG001|Overall Study|Lost to Follow-up|2|||
130483694|NCT00950742|469741950|FG000|Overall Study|Other Adverse Event|1|||
130483695|NCT00950742|469741951|FG001|Overall Study|Other Adverse Event|0|||
130483696|NCT00950742|469741950|FG000|Overall Study|Withdrawal by Subject|3|||
130483697|NCT00950742|469741951|FG001|Overall Study|Withdrawal by Subject|0|||
130483698|NCT00950742|469741950|FG000|Overall Study|Progressive Disease|6|||
130483699|NCT00950742|469741951|FG001|Overall Study|Progressive Disease|2|||
130483700|NCT00950742|469741950|FG000|Overall Study|Dose limiting toxicity|6|||
130483701|NCT00950742|469741951|FG001|Overall Study|Dose limiting toxicity|0|||
130483702|NCT05436262|469741953|FG000|Pre-Randomization|Withdrawal by Subject|1|||
130483703|NCT05436262|469741954|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130483704|NCT05436262|469741955|FG002|Pre-Randomization|Withdrawal by Subject|0|||
130483705|NCT05436262|469741953|FG000|Randomization|Withdrawal by Subject|0|||
130483706|NCT05436262|469741954|FG001|Randomization|Withdrawal by Subject|1|||
130483707|NCT05436262|469741955|FG002|Randomization|Withdrawal by Subject|0|||
130483708|NCT05299073|469741956|FG000|Overall Study|Withdrawal by Subject|0|||
130483709|NCT05299073|469741957|FG001|Overall Study|Withdrawal by Subject|0|||
130483710|NCT05299073|469741958|FG002|Overall Study|Withdrawal by Subject|1|||
130483711|NCT05299073|469741956|FG000|Overall Study|Adverse Event|0|||
130483712|NCT05299073|469741957|FG001|Overall Study|Adverse Event|1|||
130483713|NCT05299073|469741958|FG002|Overall Study|Adverse Event|0|||
130483714|NCT05299073|469741956|FG000|Overall Study|Lost to Follow-up|0|||
130483715|NCT05299073|469741957|FG001|Overall Study|Lost to Follow-up|1|||
130483716|NCT05299073|469741958|FG002|Overall Study|Lost to Follow-up|0|||
130483717|NCT00592852|469741959|FG000|Overall Study|Non-compliance|1|||
130483718|NCT00592852|469741959|FG000|Overall Study|Adverse Event|3|||
130483719|NCT00592852|469741959|FG000|Overall Study|Found ineligible|1|||
130483720|NCT00592852|469741959|FG000|Overall Study|Withdrawal by Subject|1|||
130483721|NCT05002088|469741960|FG000|Overall Study|Withdrawal by Subject|9|||
130483722|NCT05002088|469741961|FG001|Overall Study|Withdrawal by Subject|0|||
130483723|NCT05002088|469741960|FG000|Overall Study|Lost to Follow-up|0|||
130483724|NCT05002088|469741961|FG001|Overall Study|Lost to Follow-up|1|||
130483725|NCT05002088|469741960|FG000|Overall Study|Death|16|||
130483726|NCT05002088|469741961|FG001|Overall Study|Death|2|||
130483727|NCT05002088|469741960|FG000|Overall Study|Protocol Violation|25|||
130483728|NCT05002088|469741961|FG001|Overall Study|Protocol Violation|7|||
130483729|NCT04068181|469741963|FG000|Overall Study|Death|17|||
130483730|NCT04068181|469741964|FG001|Overall Study|Death|12|||
130483731|NCT04068181|469741965|FG002|Overall Study|Death|4|||
130483732|NCT04068181|469741966|FG003|Overall Study|Death|7|||
130483733|NCT04068181|469741963|FG000|Overall Study|Lost to Follow-up|1|||
130483734|NCT04068181|469741964|FG001|Overall Study|Lost to Follow-up|0|||
130483735|NCT04068181|469741965|FG002|Overall Study|Lost to Follow-up|0|||
130483736|NCT04068181|469741966|FG003|Overall Study|Lost to Follow-up|0|||
130483737|NCT04068181|469741963|FG000|Overall Study|Withdrawal of consent from study|3|||
130483738|NCT04068181|469741964|FG001|Overall Study|Withdrawal of consent from study|0|||
130483739|NCT04068181|469741965|FG002|Overall Study|Withdrawal of consent from study|0|||
130483740|NCT04068181|469741966|FG003|Overall Study|Withdrawal of consent from study|0|||
130483741|NCT04770402|469741967|FG000|Overall Study|Lost to Follow-up|1|||
130483742|NCT04770402|469741968|FG001|Overall Study|Lost to Follow-up|2|||
130483743|NCT04770402|469741967|FG000|Overall Study|Non-compliance|1|||
130483744|NCT04770402|469741968|FG001|Overall Study|Non-compliance|0|||
130483745|NCT04770402|469741967|FG000|Overall Study|Withdrawal by Subject|0|||
130483746|NCT04770402|469741968|FG001|Overall Study|Withdrawal by Subject|1|||
130483747|NCT05194956|469741970|FG000|Washout Period|Withdrawal by Subject|0|||
130483748|NCT05194956|469741971|FG001|Washout Period|Withdrawal by Subject|2|||
130483749|NCT01828099|469741975|FG000|Treatment Period|Adverse Event|24|||
130483750|NCT01828099|469741976|FG001|Treatment Period|Adverse Event|23|||
130483751|NCT01828099|469741975|FG000|Treatment Period|Death|10|||
130483752|NCT01828099|469741976|FG001|Treatment Period|Death|12|||
130483753|NCT01828099|469741975|FG000|Treatment Period|Lost to Follow-up|2|||
130483754|NCT01828099|469741976|FG001|Treatment Period|Lost to Follow-up|1|||
130483755|NCT01828099|469741975|FG000|Treatment Period|Non-compliance with study treatment|1|||
130483756|NCT01828099|469741976|FG001|Treatment Period|Non-compliance with study treatment|0|||
130483757|NCT01828099|469741975|FG000|Treatment Period|Physician Decision|17|||
130483758|NCT01828099|469741976|FG001|Treatment Period|Physician Decision|16|||
130483759|NCT01828099|469741975|FG000|Treatment Period|Progressive disease|99|||
130483760|NCT01828099|469741976|FG001|Treatment Period|Progressive disease|107|||
130483761|NCT01828099|469741975|FG000|Treatment Period|Subject/guardian decision|22|||
130483762|NCT01828099|469741976|FG001|Treatment Period|Subject/guardian decision|26|||
130483763|NCT01828099|469741975|FG000|Treatment Period|Study terminated by Sponsor|13|||
130483764|NCT01828099|469741976|FG001|Treatment Period|Study terminated by Sponsor|1|||
130483765|NCT01828099|469741975|FG000|Treatment Period|Protocol deviation|1|||
130483766|NCT01828099|469741976|FG001|Treatment Period|Protocol deviation|0|||
130483767|NCT01828099|469741975|FG000|Treatment Period|No longer requires treatment|0|||
130483768|NCT01828099|469741976|FG001|Treatment Period|No longer requires treatment|1|||
130483769|NCT01828099|469741975|FG000|Extension-treatment Phase|Adverse Event|0|||
130483770|NCT01828099|469741976|FG001|Extension-treatment Phase|Adverse Event|17|||
130483771|NCT01828099|469741975|FG000|Extension-treatment Phase|Death|0|||
130483772|NCT01828099|469741976|FG001|Extension-treatment Phase|Death|11|||
130483773|NCT01828099|469741975|FG000|Extension-treatment Phase|Physician Decision|0|||
130483774|NCT01828099|469741976|FG001|Extension-treatment Phase|Physician Decision|5|||
130483775|NCT01828099|469741975|FG000|Extension-treatment Phase|Progressive disease|0|||
130483776|NCT01828099|469741976|FG001|Extension-treatment Phase|Progressive disease|54|||
130483777|NCT01828099|469741975|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
130483778|NCT01828099|469741976|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
130728082|NCT03597464|470625603|FG000|Overall Study|Lost to Follow-up|3|||
130483779|NCT01828099|469741975|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
130483780|NCT01828099|469741976|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
130483781|NCT05934942|469741980|FG000|Run-in Period|Not treated|1|||
130483782|NCT05934942|469741980|FG000|Run-in Period|Withdrawal by Subject|1|||
130483783|NCT03905798|469741981|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
130483784|NCT00321048|469741982|FG000|Overall Study|Withdrawal by Subject|6|||
130483785|NCT00321048|469741983|FG001|Overall Study|Withdrawal by Subject|8|||
130483786|NCT04433208|469741984|FG000|Overall Study|Withdrawal by Subject|0|||
130483787|NCT04433208|469741985|FG001|Overall Study|Withdrawal by Subject|1|||
130483788|NCT04433208|469741986|FG002|Overall Study|Withdrawal by Subject|1|||
130483789|NCT04433208|469741987|FG003|Overall Study|Withdrawal by Subject|0|||
130483790|NCT04433208|469741988|FG004|Overall Study|Withdrawal by Subject|2|||
130483791|NCT04433208|469741989|FG005|Overall Study|Withdrawal by Subject|1|||
130483792|NCT04433208|469741984|FG000|Overall Study|Lost to Follow-up|0|||
130483793|NCT04433208|469741985|FG001|Overall Study|Lost to Follow-up|0|||
130483794|NCT04433208|469741986|FG002|Overall Study|Lost to Follow-up|0|||
130483795|NCT04433208|469741987|FG003|Overall Study|Lost to Follow-up|0|||
130483796|NCT04433208|469741988|FG004|Overall Study|Lost to Follow-up|0|||
130483797|NCT04433208|469741989|FG005|Overall Study|Lost to Follow-up|1|||
130483798|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
130483799|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
130483800|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
130483801|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
130483802|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
130483803|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
130483804|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
130483805|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
130483806|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
130483807|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
130483808|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
130483809|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
130483810|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
130483811|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
130483812|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
130483813|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
130483814|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
130483815|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
130483816|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
130483817|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
130483818|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
130483819|NCT04800211|469741990|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
130483820|NCT04800211|469741991|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
130483821|NCT04800211|469741992|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
130483822|NCT04800211|469741990|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
130483823|NCT04800211|469741991|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
130483824|NCT04800211|469741992|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
130483825|NCT04800211|469741990|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
130483826|NCT04800211|469741991|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
130483827|NCT04800211|469741992|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
130483828|NCT04800211|469741990|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
130483829|NCT04800211|469741991|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
130483830|NCT04800211|469741992|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
130483831|NCT05170841|469741993|FG000|Single Dose Phase|Adverse Event|1|||
130483832|NCT05170841|469741994|FG001|Single Dose Phase|Adverse Event|2|||
130483833|NCT05170841|469741995|FG002|Single Dose Phase|Adverse Event|0|||
130483834|NCT05170841|469741996|FG003|Single Dose Phase|Adverse Event|2|||
130483835|NCT05170841|469741993|FG000|Multiple Dose Phase|Adverse Event|1|||
130483836|NCT05170841|469741994|FG001|Multiple Dose Phase|Adverse Event|2|||
130483837|NCT05170841|469741995|FG002|Multiple Dose Phase|Adverse Event|1|||
130483838|NCT05170841|469741996|FG003|Multiple Dose Phase|Adverse Event|4|||
130483839|NCT05170841|469741993|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
130483840|NCT05170841|469741994|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
130483841|NCT05170841|469741995|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
130483842|NCT05170841|469741996|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
130483843|NCT05123586|469741999|FG000|Overall Study|Physician Decision|1|||
130483844|NCT05123586|469742000|FG001|Overall Study|Physician Decision|1|||
130483845|NCT05123586|469741999|FG000|Overall Study|Withdrawal by Subject|0|||
130483846|NCT05123586|469742000|FG001|Overall Study|Withdrawal by Subject|3|||
130483847|NCT03734679|469742006|FG000|Overall Study|Missed Visit|1|||
130483848|NCT02733159|469742008|FG000|Overall Study|Adverse Event|1|||
130483849|NCT02733159|469742008|FG000|Overall Study|Lack of disease progression|1|||
130483850|NCT06122194|469742009|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
130483851|NCT06122194|469742010|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
130483852|NCT06122194|469742011|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
130483853|NCT06122194|469742012|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
130483854|NCT02887521|469742021|FG000|Overall Study|Withdrawal by Subject|0|||
130483855|NCT02887521|469742022|FG001|Overall Study|Withdrawal by Subject|3|||
130483856|NCT02709161|469742025|FG000|Overall Study|Withdrawal by Subject|1|||
130483857|NCT02709161|469742026|FG001|Overall Study|Withdrawal by Subject|0|||
130483858|NCT03626220|469742028|FG000|Overall Study|Withdrawal by Subject|2|||
130483859|NCT03626220|469742029|FG001|Overall Study|Withdrawal by Subject|0|||
130483860|NCT05671653|469743937|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
130483861|NCT05671653|469743938|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
130483862|NCT05671653|469743939|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
130483863|NCT05671653|469743940|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
130483864|NCT05671653|469743941|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
130483865|NCT05671653|469743942|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
130483866|NCT05671653|469743943|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
130483867|NCT05671653|469743944|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
130483868|NCT05671653|469743945|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
130483869|NCT05671653|469743946|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
130483870|NCT05671653|469743947|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
130483871|NCT05671653|469743948|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
130483872|NCT05671653|469743949|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
130483873|NCT05671653|469743937|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483874|NCT05671653|469743938|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483875|NCT05671653|469743939|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483876|NCT05671653|469743940|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483877|NCT05671653|469743941|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483878|NCT05671653|469743942|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
130483879|NCT05671653|469743943|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483880|NCT05671653|469743944|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483881|NCT05671653|469743945|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483882|NCT05671653|469743946|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483883|NCT05671653|469743947|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483884|NCT05671653|469743948|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483885|NCT05671653|469743949|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
130483886|NCT05671653|469743937|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483887|NCT05671653|469743938|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483888|NCT05671653|469743939|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483889|NCT05671653|469743940|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483890|NCT05671653|469743941|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483891|NCT05671653|469743942|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
130483892|NCT05671653|469743943|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483893|NCT05671653|469743944|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483894|NCT05671653|469743945|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483895|NCT05671653|469743946|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483896|NCT05671653|469743947|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483897|NCT05671653|469743948|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483898|NCT05671653|469743949|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
130483899|NCT05671653|469743937|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483900|NCT05671653|469743938|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130728083|NCT03597464|470625604|FG001|Overall Study|Lost to Follow-up|1|||
130728084|NCT03597464|470625603|FG000|Overall Study|Pregnancy|3|||
130728085|NCT03597464|470625604|FG001|Overall Study|Pregnancy|1|||
130728086|NCT03597464|470625603|FG000|Overall Study|Lack of Efficacy|2|||
130728087|NCT03597464|470625604|FG001|Overall Study|Lack of Efficacy|0|||
130483901|NCT05671653|469743939|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483902|NCT05671653|469743940|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483903|NCT05671653|469743941|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483904|NCT05671653|469743942|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483905|NCT05671653|469743943|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483906|NCT05671653|469743944|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483907|NCT05671653|469743945|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
130483908|NCT05671653|469743946|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483909|NCT05671653|469743947|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483910|NCT05671653|469743948|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483911|NCT05671653|469743949|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
130483912|NCT05671653|469743937|FG000|Cohort 2 Period 2|Adverse Event|0|||
130483913|NCT05671653|469743938|FG001|Cohort 2 Period 2|Adverse Event|0|||
130483914|NCT05671653|469743939|FG002|Cohort 2 Period 2|Adverse Event|0|||
130483915|NCT05671653|469743940|FG003|Cohort 2 Period 2|Adverse Event|0|||
130483916|NCT05671653|469743941|FG004|Cohort 2 Period 2|Adverse Event|0|||
130483917|NCT05671653|469743942|FG005|Cohort 2 Period 2|Adverse Event|0|||
130483918|NCT05671653|469743943|FG006|Cohort 2 Period 2|Adverse Event|0|||
130483919|NCT05671653|469743944|FG007|Cohort 2 Period 2|Adverse Event|0|||
130483920|NCT05671653|469743945|FG008|Cohort 2 Period 2|Adverse Event|0|||
130483921|NCT05671653|469743946|FG009|Cohort 2 Period 2|Adverse Event|0|||
130483922|NCT05671653|469743947|FG010|Cohort 2 Period 2|Adverse Event|1|||
130483923|NCT05671653|469743948|FG011|Cohort 2 Period 2|Adverse Event|0|||
130483924|NCT05671653|469743949|FG012|Cohort 2 Period 2|Adverse Event|0|||
130483925|NCT05671653|469743937|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
130483926|NCT05671653|469743938|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
130483927|NCT05671653|469743939|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
130483928|NCT05671653|469743940|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
130483929|NCT05671653|469743941|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
130483930|NCT05671653|469743942|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
130728088|NCT03597464|470625603|FG000|Overall Study|Physician Decision|2|||
130483931|NCT05671653|469743943|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
130483932|NCT05671653|469743944|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
130728089|NCT03597464|470625604|FG001|Overall Study|Physician Decision|2|||
130728090|NCT03597464|470625603|FG000|Overall Study|Protocol Violation|1|||
130565029|NCT00307151|470035360|FG003|Overall Study|Clinic unable to contact subject|1|||
130565030|NCT02966509|470035364|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
130483933|NCT05671653|469743945|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
130483934|NCT05671653|469743946|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
130483935|NCT05671653|469743947|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
130483936|NCT05671653|469743948|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
130483937|NCT05671653|469743949|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
130483938|NCT05671653|469743937|FG000|Cohort 2 Period 2|Pregnancy|0|||
130483939|NCT05671653|469743938|FG001|Cohort 2 Period 2|Pregnancy|0|||
130483940|NCT05671653|469743939|FG002|Cohort 2 Period 2|Pregnancy|0|||
130483941|NCT05671653|469743940|FG003|Cohort 2 Period 2|Pregnancy|0|||
130483942|NCT05671653|469743941|FG004|Cohort 2 Period 2|Pregnancy|0|||
130483943|NCT05671653|469743942|FG005|Cohort 2 Period 2|Pregnancy|0|||
130483944|NCT05671653|469743943|FG006|Cohort 2 Period 2|Pregnancy|0|||
130483945|NCT05671653|469743944|FG007|Cohort 2 Period 2|Pregnancy|0|||
130483946|NCT05671653|469743945|FG008|Cohort 2 Period 2|Pregnancy|0|||
130483947|NCT05671653|469743946|FG009|Cohort 2 Period 2|Pregnancy|0|||
130483948|NCT05671653|469743947|FG010|Cohort 2 Period 2|Pregnancy|1|||
130483949|NCT05671653|469743948|FG011|Cohort 2 Period 2|Pregnancy|0|||
130483950|NCT05671653|469743949|FG012|Cohort 2 Period 2|Pregnancy|0|||
130483951|NCT05671653|469743937|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483952|NCT05671653|469743938|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483953|NCT05671653|469743939|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483954|NCT05671653|469743940|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483955|NCT05671653|469743941|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483956|NCT05671653|469743942|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483957|NCT05671653|469743943|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483958|NCT05671653|469743944|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483959|NCT05671653|469743945|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483960|NCT05671653|469743946|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483961|NCT05671653|469743947|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
130483962|NCT05671653|469743948|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483963|NCT05671653|469743949|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
130483964|NCT05671653|469743937|FG000|Cohort 2 Period 2|Other|0|||
130483965|NCT05671653|469743938|FG001|Cohort 2 Period 2|Other|0|||
130483966|NCT05671653|469743939|FG002|Cohort 2 Period 2|Other|0|||
130483967|NCT05671653|469743940|FG003|Cohort 2 Period 2|Other|0|||
130483968|NCT05671653|469743941|FG004|Cohort 2 Period 2|Other|0|||
130483969|NCT05671653|469743942|FG005|Cohort 2 Period 2|Other|0|||
130483970|NCT05671653|469743943|FG006|Cohort 2 Period 2|Other|0|||
130483971|NCT05671653|469743944|FG007|Cohort 2 Period 2|Other|0|||
130483972|NCT05671653|469743945|FG008|Cohort 2 Period 2|Other|0|||
130483973|NCT05671653|469743946|FG009|Cohort 2 Period 2|Other|0|||
130483974|NCT05671653|469743947|FG010|Cohort 2 Period 2|Other|1|||
130483975|NCT05671653|469743948|FG011|Cohort 2 Period 2|Other|0|||
130483976|NCT05671653|469743949|FG012|Cohort 2 Period 2|Other|0|||
130483977|NCT05671653|469743937|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483978|NCT05671653|469743938|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483979|NCT05671653|469743939|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483980|NCT05671653|469743940|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483981|NCT05671653|469743941|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483982|NCT05671653|469743942|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483983|NCT05671653|469743943|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483984|NCT05671653|469743944|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483985|NCT05671653|469743945|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483986|NCT05671653|469743946|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483987|NCT05671653|469743947|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483988|NCT05671653|469743948|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
130483989|NCT05671653|469743949|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130483990|NCT02305888|469743956|FG000|Overall Study|Lost to Follow-up|0|||
130483991|NCT02305888|469743957|FG001|Overall Study|Lost to Follow-up|0|||
130483992|NCT02305888|469743958|FG002|Overall Study|Lost to Follow-up|1|||
130483993|NCT02305888|469743956|FG000|Overall Study|Adverse Event|0|||
130483994|NCT02305888|469743957|FG001|Overall Study|Adverse Event|1|||
130483995|NCT02305888|469743958|FG002|Overall Study|Adverse Event|0|||
130483996|NCT06232590|469743959|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
130483997|NCT06232590|469743960|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
130483998|NCT03220035|469743961|FG000|Overall Study|Adverse Event|1|||
130483999|NCT03220035|469743961|FG000|Overall Study|Protocol Violation|1|||
130484000|NCT03220035|469743961|FG000|Overall Study|Progressive Disease|2|||
130484001|NCT02433379|469743965|FG000|Overall Study|Screen Failures|55|||
130484002|NCT02433379|469743965|FG000|Overall Study|Death|57|||
130484003|NCT02433379|469743965|FG000|Overall Study|Total Withdrawals|209|||
130484004|NCT05070728|469743970|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
130484005|NCT05070728|469743971|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
130484006|NCT02589795|469743979|FG000|Overall Study|Lost to Follow-up|1|||
130484007|NCT02589795|469743980|FG001|Overall Study|Lost to Follow-up|0|||
130484008|NCT02589795|469743981|FG002|Overall Study|Lost to Follow-up|0|||
130484009|NCT02589795|469743979|FG000|Overall Study|Withdrawal by Subject|0|||
130484010|NCT02589795|469743980|FG001|Overall Study|Withdrawal by Subject|0|||
130484011|NCT02589795|469743981|FG002|Overall Study|Withdrawal by Subject|2|||
130484012|NCT02589795|469743979|FG000|Overall Study|Protocol Violation|0|||
130484013|NCT02589795|469743980|FG001|Overall Study|Protocol Violation|0|||
130484014|NCT02589795|469743981|FG002|Overall Study|Protocol Violation|1|||
130484015|NCT03599661|469743982|FG000|Overall Study|Lost to Follow-up|9|||
130484016|NCT04909801|469743985|FG000|Overall Study|Lack of Efficacy|2|||
130484017|NCT04909801|469743986|FG001|Overall Study|Lack of Efficacy|1|||
130484018|NCT04909801|469743985|FG000|Overall Study|Adverse Event|1|||
130484019|NCT04909801|469743986|FG001|Overall Study|Adverse Event|2|||
130484020|NCT04909801|469743985|FG000|Overall Study|Participant request to discontinue study treatment|1|||
130484021|NCT04909801|469743986|FG001|Overall Study|Participant request to discontinue study treatment|2|||
130484022|NCT04909801|469743985|FG000|Overall Study|Withdrawal by Subject|2|||
130484023|NCT04909801|469743986|FG001|Overall Study|Withdrawal by Subject|1|||
130484024|NCT04909801|469743985|FG000|Overall Study|other reasons|1|||
130484025|NCT04909801|469743986|FG001|Overall Study|other reasons|1|||
130484026|NCT04550221|469743989|FG000|Overall Study|Lost to Follow-up|0|||
130484027|NCT04550221|469743990|FG001|Overall Study|Lost to Follow-up|4|||
130484028|NCT04550221|469743989|FG000|Overall Study|Withdrawn|3|||
130484029|NCT04550221|469743990|FG001|Overall Study|Withdrawn|0|||
130484030|NCT04550221|469743989|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
130484031|NCT04550221|469743990|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
130484032|NCT04811040|469743991|FG000|Overall Study|Lost to Follow-up|2|||
130484033|NCT04811040|469743992|FG001|Overall Study|Lost to Follow-up|0|||
130484034|NCT04811040|469743993|FG002|Overall Study|Lost to Follow-up|0|||
130484035|NCT04811040|469743994|FG003|Overall Study|Lost to Follow-up|0|||
130484036|NCT04811040|469743991|FG000|Overall Study|Withdrew consent|1|||
130484037|NCT04811040|469743992|FG001|Overall Study|Withdrew consent|1|||
130484038|NCT04811040|469743993|FG002|Overall Study|Withdrew consent|0|||
130484039|NCT04811040|469743994|FG003|Overall Study|Withdrew consent|0|||
130484040|NCT05274074|469743995|FG000|Overall Study|Lost to Follow-up|2|||
130484041|NCT05274074|469743996|FG001|Overall Study|Lost to Follow-up|3|||
130484042|NCT05274074|469743995|FG000|Overall Study|Withdrawal by Subject|1|||
130484043|NCT05274074|469743996|FG001|Overall Study|Withdrawal by Subject|2|||
130484044|NCT04362254|469744003|FG000|Overall Study|Adverse Event|1|||
130484045|NCT04362254|469744003|FG000|Overall Study|Protocol Violation|1|||
130484046|NCT04362254|469744003|FG000|Overall Study|Due to early termination of the trial|10|||
130484047|NCT04568434|469744004|FG000|Overall Study|Voluntary Withdrawal|0|||
130484048|NCT04568434|469744005|FG001|Overall Study|Voluntary Withdrawal|1|||
130484049|NCT04568434|469744006|FG002|Overall Study|Voluntary Withdrawal|1|||
130484050|NCT04568434|469744004|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
130484051|NCT04568434|469744005|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
130484052|NCT04568434|469744006|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
130484053|NCT04568434|469744004|FG000|Overall Study|Investigator Judgement|1|||
130484054|NCT04568434|469744005|FG001|Overall Study|Investigator Judgement|0|||
130484055|NCT04568434|469744006|FG002|Overall Study|Investigator Judgement|0|||
130484056|NCT05469464|469744007|FG000|Overall Study|Withdrawal by Subject|8|||
130565031|NCT02966509|470035365|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
130565032|NCT02966509|470035364|FG000|Baseline Satisfaction Survey|Death|0|||
130565033|NCT02966509|470035365|FG001|Baseline Satisfaction Survey|Death|1|||
130565034|NCT02966509|470035364|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
130565035|NCT02966509|470035365|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
130565036|NCT02966509|470035364|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
130565037|NCT02966509|470035365|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
130565038|NCT02966509|470035364|FG000|6 Month Satisfaction Decision Survey|Death|22|||
130565039|NCT02966509|470035365|FG001|6 Month Satisfaction Decision Survey|Death|25|||
130565040|NCT02966509|470035364|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
130565041|NCT02966509|470035365|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
130484057|NCT05469464|469744008|FG001|Overall Study|Withdrawal by Subject|7|||
130484058|NCT05469464|469744009|FG002|Overall Study|Withdrawal by Subject|4|||
130484059|NCT05469464|469744010|FG003|Overall Study|Withdrawal by Subject|5|||
130484060|NCT05469464|469744007|FG000|Overall Study|Adverse Event|8|||
130484061|NCT05469464|469744008|FG001|Overall Study|Adverse Event|14|||
130484062|NCT05469464|469744009|FG002|Overall Study|Adverse Event|13|||
130484063|NCT05469464|469744010|FG003|Overall Study|Adverse Event|2|||
130484064|NCT05469464|469744007|FG000|Overall Study|Lost to Follow-up|2|||
130484065|NCT05469464|469744008|FG001|Overall Study|Lost to Follow-up|5|||
130484066|NCT05469464|469744009|FG002|Overall Study|Lost to Follow-up|3|||
130484067|NCT05469464|469744010|FG003|Overall Study|Lost to Follow-up|3|||
130484068|NCT05469464|469744007|FG000|Overall Study|Lack of Efficacy|4|||
130484069|NCT05469464|469744008|FG001|Overall Study|Lack of Efficacy|1|||
130484070|NCT05469464|469744009|FG002|Overall Study|Lack of Efficacy|2|||
130565042|NCT02966509|470035364|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
130484071|NCT05469464|469744010|FG003|Overall Study|Lack of Efficacy|2|||
130484072|NCT05469464|469744007|FG000|Overall Study|Physician Decision|0|||
130484073|NCT05469464|469744008|FG001|Overall Study|Physician Decision|0|||
130484074|NCT05469464|469744009|FG002|Overall Study|Physician Decision|0|||
130484075|NCT05469464|469744010|FG003|Overall Study|Physician Decision|1|||
130484076|NCT05485779|469744011|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484077|NCT05485779|469744012|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484078|NCT05485779|469744013|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484079|NCT05485779|469744014|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484080|NCT05485779|469744015|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484081|NCT05485779|469744016|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484082|NCT05485779|469744017|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484083|NCT05485779|469744018|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
130484084|NCT05485779|469744019|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
130484085|NCT05485779|469744020|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484086|NCT05485779|469744021|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
130484087|NCT05485779|469744011|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484088|NCT05485779|469744012|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484089|NCT05485779|469744013|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484090|NCT05485779|469744014|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484091|NCT05485779|469744015|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484092|NCT05485779|469744016|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484093|NCT05485779|469744017|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484094|NCT05485779|469744018|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484095|NCT05485779|469744019|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484096|NCT05485779|469744020|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
130484097|NCT05485779|469744021|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
130484098|NCT05485779|469744011|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484099|NCT05485779|469744012|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484100|NCT05485779|469744013|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484101|NCT05485779|469744014|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
130484102|NCT05485779|469744015|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484103|NCT05485779|469744016|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484104|NCT05485779|469744017|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484105|NCT05485779|469744018|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484106|NCT05485779|469744019|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484107|NCT05485779|469744020|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484108|NCT05485779|469744021|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130484109|NCT05764525|469744024|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
130484110|NCT05764525|469744025|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
130484111|NCT05764525|469744024|FG000|Overall Study|Withdrawal by Subject|4|||
130484112|NCT05764525|469744025|FG001|Overall Study|Withdrawal by Subject|8|||
130484113|NCT05764525|469744024|FG000|Overall Study|Physician Decision|1|||
130484114|NCT05764525|469744025|FG001|Overall Study|Physician Decision|0|||
130484115|NCT03334630|469744026|FG000|Overall Study|Withdrawal by Subject|7|||
130484116|NCT03334630|469744027|FG001|Overall Study|Withdrawal by Subject|7|||
130484117|NCT03334630|469744026|FG000|Overall Study|Lost to Follow-up|3|||
130484118|NCT03334630|469744027|FG001|Overall Study|Lost to Follow-up|1|||
130484119|NCT03334630|469744026|FG000|Overall Study|Adverse Event|0|||
130484120|NCT03334630|469744027|FG001|Overall Study|Adverse Event|1|||
130484121|NCT03334630|469744026|FG000|Overall Study|Physician Decision|1|||
130484122|NCT03334630|469744027|FG001|Overall Study|Physician Decision|1|||
130484123|NCT03334630|469744026|FG000|Overall Study|Enrollment closed|2|||
130484124|NCT03334630|469744027|FG001|Overall Study|Enrollment closed|1|||
130484125|NCT03334630|469744026|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
130484126|NCT03334630|469744027|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
130484127|NCT03334630|469744026|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
130484128|NCT03334630|469744027|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
130484129|NCT03030261|469744029|FG000|Overall Study|Still receiving continuation therapy|5|||
130484130|NCT05370040|469744039|FG000|Overall Study|Lost to Follow-up|0|||
130484131|NCT05370040|469744040|FG001|Overall Study|Lost to Follow-up|0|||
130484132|NCT05370040|469744041|FG002|Overall Study|Lost to Follow-up|1|||
130484133|NCT05370040|469744042|FG003|Overall Study|Lost to Follow-up|0|||
130484134|NCT05370040|469744043|FG004|Overall Study|Lost to Follow-up|1|||
130565043|NCT02966509|470035365|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
130484135|NCT05370040|469744044|FG005|Overall Study|Lost to Follow-up|0|||
130484136|NCT03910478|469744047|FG000|Overall Study|Death|13|||
130484137|NCT03910478|469744048|FG001|Overall Study|Death|6|||
130484138|NCT03910478|469744047|FG000|Overall Study|Withdrawal by Subject|23|||
130484139|NCT03910478|469744048|FG001|Overall Study|Withdrawal by Subject|2|||
130484140|NCT03910478|469744047|FG000|Overall Study|Physician Decision|5|||
130484141|NCT03910478|469744048|FG001|Overall Study|Physician Decision|0|||
130484142|NCT03910478|469744047|FG000|Overall Study|Protocol Violation|1|||
130484143|NCT03910478|469744048|FG001|Overall Study|Protocol Violation|0|||
130484144|NCT03910478|469744047|FG000|Overall Study|Failure to meet continuation criteria|2|||
130484145|NCT03910478|469744048|FG001|Overall Study|Failure to meet continuation criteria|0|||
130484146|NCT03910478|469744047|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
130484147|NCT03910478|469744048|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
130484148|NCT04971109|469744049|FG000|Overall Study|Adverse Event|4|||
130484149|NCT04971109|469744050|FG001|Overall Study|Adverse Event|3|||
130484150|NCT04971109|469744049|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
130484151|NCT04971109|469744050|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
130484152|NCT04971109|469744049|FG000|Overall Study|Lost to Follow-up|8|||
130484153|NCT04971109|469744050|FG001|Overall Study|Lost to Follow-up|2|||
130484154|NCT04971109|469744049|FG000|Overall Study|Physician Decision|5|||
130484155|NCT04971109|469744050|FG001|Overall Study|Physician Decision|0|||
130484156|NCT04971109|469744049|FG000|Overall Study|Protocol Violation|0|||
130484157|NCT04971109|469744050|FG001|Overall Study|Protocol Violation|1|||
130484158|NCT04971109|469744049|FG000|Overall Study|Withdrawal by Subject|18|||
130484159|NCT04971109|469744050|FG001|Overall Study|Withdrawal by Subject|3|||
130484160|NCT04971109|469744049|FG000|Overall Study|Subject was randomized in error|1|||
130484161|NCT04971109|469744050|FG001|Overall Study|Subject was randomized in error|0|||
130484162|NCT05293171|469744052|FG000|Washout 5 to 7 Days|Adverse Event|1|||
130484163|NCT05293171|469744053|FG001|Washout 5 to 7 Days|Adverse Event|1|||
130484164|NCT05293171|469744054|FG002|Washout 5 to 7 Days|Adverse Event|0|||
130484165|NCT05293171|469744055|FG003|Washout 5 to 7 Days|Adverse Event|0|||
130484166|NCT05293171|469744056|FG004|Washout 5 to 7 Days|Adverse Event|0|||
130484167|NCT05293171|469744057|FG005|Washout 5 to 7 Days|Adverse Event|0|||
130484168|NCT05293171|469744058|FG006|Washout 5 to 7 Days|Adverse Event|0|||
130484169|NCT05293171|469744059|FG007|Washout 5 to 7 Days|Adverse Event|0|||
130484170|NCT05293171|469744060|FG008|Washout 5 to 7 Days|Adverse Event|0|||
130484171|NCT05293171|469744061|FG009|Washout 5 to 7 Days|Adverse Event|0|||
130484172|NCT05293171|469744062|FG010|Washout 5 to 7 Days|Adverse Event|0|||
130484173|NCT05293171|469744063|FG011|Washout 5 to 7 Days|Adverse Event|0|||
130484174|NCT05293171|469744052|FG000|Washout 5 to 7 Days|Adverse Event|0|||
130484175|NCT05293171|469744053|FG001|Washout 5 to 7 Days|Adverse Event|0|||
130484176|NCT05293171|469744054|FG002|Washout 5 to 7 Days|Adverse Event|0|||
130484177|NCT05293171|469744055|FG003|Washout 5 to 7 Days|Adverse Event|0|||
130484178|NCT05293171|469744056|FG004|Washout 5 to 7 Days|Adverse Event|0|||
130484179|NCT05293171|469744057|FG005|Washout 5 to 7 Days|Adverse Event|1|||
130484180|NCT05293171|469744058|FG006|Washout 5 to 7 Days|Adverse Event|0|||
130484181|NCT05293171|469744059|FG007|Washout 5 to 7 Days|Adverse Event|0|||
130484182|NCT05293171|469744060|FG008|Washout 5 to 7 Days|Adverse Event|0|||
130484183|NCT05293171|469744061|FG009|Washout 5 to 7 Days|Adverse Event|0|||
130484184|NCT05293171|469744062|FG010|Washout 5 to 7 Days|Adverse Event|0|||
130484185|NCT05293171|469744063|FG011|Washout 5 to 7 Days|Adverse Event|0|||
130484186|NCT01712490|469744069|FG000|Overall Study|Ongoing|601|||
130484187|NCT01712490|469744070|FG001|Overall Study|Ongoing|586|||
130484188|NCT01712490|469744069|FG000|Overall Study|Other|11|||
130484189|NCT01712490|469744070|FG001|Overall Study|Other|11|||
130484190|NCT01712490|469744069|FG000|Overall Study|Withdrawal by Subject|36|||
130484191|NCT01712490|469744070|FG001|Overall Study|Withdrawal by Subject|44|||
130484192|NCT01712490|469744069|FG000|Overall Study|Lost to Follow-up|16|||
130484193|NCT01712490|469744070|FG001|Overall Study|Lost to Follow-up|29|||
130728091|NCT03597464|470625604|FG001|Overall Study|Protocol Violation|1|||
130484194|NCT03987022|469744073|FG000|Overall Study|Lost to Follow-up|2|||
130484195|NCT03987022|469744074|FG001|Overall Study|Lost to Follow-up|2|||
130484196|NCT03987022|469744073|FG000|Overall Study|Withdrawal by Subject|1|||
130484197|NCT03987022|469744074|FG001|Overall Study|Withdrawal by Subject|0|||
130484198|NCT02724969|469744092|FG000|Overall Study|Lost to Follow-up|12|||
130484199|NCT02724969|469744093|FG001|Overall Study|Lost to Follow-up|6|||
130484200|NCT02724969|469744092|FG000|Overall Study|Withdrawal by Subject|3|||
130484201|NCT02724969|469744093|FG001|Overall Study|Withdrawal by Subject|3|||
130728092|NCT03597464|470625603|FG000|Overall Study|Adverse Event|0|||
130728093|NCT03597464|470625604|FG001|Overall Study|Adverse Event|2|||
130728094|NCT03597464|470625603|FG000|Overall Study|Death|0|||
130728095|NCT03597464|470625604|FG001|Overall Study|Death|3|||
130728096|NCT02542605|470625607|FG000|Part B: Challenge Phase|Sponsor decision|1|||
130484202|NCT02724969|469744092|FG000|Overall Study|Infant demise|0|||
130484203|NCT02724969|469744093|FG001|Overall Study|Infant demise|2|||
130484204|NCT01346540|469744094|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
130484205|NCT01346540|469744095|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
130484206|NCT01346540|469744094|FG000|Overall Study|Adverse Event|0|||
130484207|NCT01346540|469744095|FG001|Overall Study|Adverse Event|4|||
130484208|NCT03362476|469744100|FG000|Overall Study|Withdrawal by Subject|0|||
130484209|NCT03362476|469744101|FG001|Overall Study|Withdrawal by Subject|1|||
130484210|NCT03672916|469744103|FG000|Overall Study|Death|6|||
130484211|NCT03672916|469744103|FG000|Overall Study|Lost to Follow-up|29|||
130484212|NCT03672916|469744103|FG000|Overall Study|Adverse Event|6|||
130484213|NCT03672916|469744103|FG000|Overall Study|Withdrawal by Subject|11|||
130484214|NCT04141891|469744106|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
130484215|NCT04141891|469744107|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
130484216|NCT04141891|469744106|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
130484217|NCT04141891|469744107|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
130484218|NCT04141891|469744106|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
130484219|NCT04141891|469744107|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
130484220|NCT04141891|469744106|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
130484221|NCT04141891|469744107|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
130484222|NCT04141891|469744106|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
130484223|NCT04141891|469744107|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
130484224|NCT04141891|469744106|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
130484225|NCT04141891|469744107|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
130484226|NCT04141891|469744106|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
130484227|NCT04141891|469744107|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
130484228|NCT04141891|469744106|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
130484229|NCT04141891|469744107|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
130484230|NCT04141891|469744106|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
130484231|NCT04141891|469744107|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
130484232|NCT04141891|469744106|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
130484233|NCT04141891|469744107|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
130484234|NCT04141891|469744106|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
130484235|NCT04141891|469744107|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
130484236|NCT04141891|469744106|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
130484237|NCT04141891|469744107|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
130484238|NCT04141891|469744106|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
130484239|NCT04141891|469744107|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
130484240|NCT04141891|469744106|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
130484241|NCT04141891|469744107|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
130484242|NCT04737330|469744108|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
130484243|NCT04737330|469744109|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
130484244|NCT04737330|469744108|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
130484245|NCT04737330|469744109|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
130484246|NCT04737330|469744108|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
130484247|NCT04737330|469744109|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
130484248|NCT04737330|469744108|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
130484249|NCT04737330|469744109|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
130484250|NCT04737330|469744108|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
130484251|NCT04737330|469744109|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
130484252|NCT04737330|469744108|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
130484253|NCT04737330|469744109|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
130484254|NCT01651403|469744114|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
130484255|NCT01651403|469744115|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
130484256|NCT01651403|469744114|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
130484257|NCT01651403|469744115|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
130484258|NCT01651403|469744114|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
130484259|NCT01651403|469744115|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
130484260|NCT01651403|469744114|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
130484261|NCT01651403|469744115|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
130484262|NCT01651403|469744114|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
130484263|NCT01651403|469744115|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
130484264|NCT01651403|469744114|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
130484265|NCT01651403|469744115|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
130484266|NCT04231149|469745325|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
130484267|NCT04231149|469745326|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
130484268|NCT04231149|469745327|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
130484269|NCT04231149|469745328|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
130484270|NCT04231149|469745329|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
130484271|NCT05877976|469745330|FG000|Overall Study|Lost to Follow-up|31|||
130484272|NCT05622812|469745331|FG000|Overall Study|Withdrawal by Subject|1|||
130728097|NCT02542605|470625608|FG001|Part B: Challenge Phase|Sponsor decision|0|||
130728098|NCT02542605|470625609|FG002|Part B: Challenge Phase|Sponsor decision|0|||
130728099|NCT02542605|470625607|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
130728100|NCT02542605|470625608|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
130728101|NCT02542605|470625609|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
130728102|NCT02682927|470625610|FG000|Overall Study|Adverse Event|0|||
130728103|NCT02682927|470625611|FG001|Overall Study|Adverse Event|0|||
130728104|NCT02682927|470625612|FG002|Overall Study|Adverse Event|5|||
130484273|NCT05622812|469745332|FG001|Overall Study|Withdrawal by Subject|4|||
130484274|NCT05622812|469745331|FG000|Overall Study|Lost to Follow-up|2|||
130484275|NCT05622812|469745332|FG001|Overall Study|Lost to Follow-up|1|||
130484276|NCT03916185|469745333|FG000|Overall Study|Lost to Follow-up|0|||
130484277|NCT03916185|469745334|FG001|Overall Study|Lost to Follow-up|1|||
130484278|NCT03916185|469745335|FG002|Overall Study|Lost to Follow-up|0|||
130484279|NCT03916185|469745336|FG003|Overall Study|Lost to Follow-up|0|||
130484280|NCT03916185|469745333|FG000|Overall Study|Moved|1|||
130484281|NCT03916185|469745334|FG001|Overall Study|Moved|0|||
130484282|NCT03916185|469745335|FG002|Overall Study|Moved|0|||
130484283|NCT03916185|469745336|FG003|Overall Study|Moved|1|||
130484284|NCT03916185|469745333|FG000|Overall Study|Not Able to Get to Clinic|1|||
130484285|NCT03916185|469745334|FG001|Overall Study|Not Able to Get to Clinic|0|||
130484286|NCT03916185|469745335|FG002|Overall Study|Not Able to Get to Clinic|0|||
130484287|NCT03916185|469745336|FG003|Overall Study|Not Able to Get to Clinic|0|||
130484288|NCT02844465|469745338|FG000|Overall Study|Screen Failure|36|||
130484289|NCT02844465|469745338|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
130484290|NCT02844465|469745338|FG000|Overall Study|Withdrawal by Subject|5|||
130484291|NCT02844465|469745338|FG000|Overall Study|Lost to Follow-up|1|||
130484292|NCT02844465|469745338|FG000|Overall Study|Retreatment|1|||
130484293|NCT02460458|469745339|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
130484294|NCT02460458|469745339|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
130484295|NCT02460458|469745339|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
130484296|NCT02460458|469745339|FG000|First Prospective Phase|Lost to Follow-up|84|||
130484297|NCT02460458|469745339|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
130484298|NCT03952338|469745340|FG000|Overall Study|Lost to Follow-up|11|||
130484299|NCT03952338|469745341|FG001|Overall Study|Lost to Follow-up|17|||
130484300|NCT03952338|469745340|FG000|Overall Study|Withdrawal by Subject|1|||
130484301|NCT03952338|469745341|FG001|Overall Study|Withdrawal by Subject|1|||
130484302|NCT03952338|469745340|FG000|Overall Study|Protocol Violation|1|||
130484303|NCT03952338|469745341|FG001|Overall Study|Protocol Violation|0|||
130484304|NCT04076618|469745342|FG000|Overall Study|Lost to Follow-up|2|||
130484305|NCT04076618|469745343|FG001|Overall Study|Lost to Follow-up|1|||
130484306|NCT04076618|469745344|FG002|Overall Study|Lost to Follow-up|3|||
130484307|NCT04076618|469745342|FG000|Overall Study|Withdrawal by Subject|3|||
130484308|NCT04076618|469745343|FG001|Overall Study|Withdrawal by Subject|1|||
130484309|NCT04076618|469745344|FG002|Overall Study|Withdrawal by Subject|2|||
130484310|NCT04076618|469745342|FG000|Overall Study|Relocated out of state|0|||
130484311|NCT04076618|469745343|FG001|Overall Study|Relocated out of state|2|||
130484312|NCT04076618|469745344|FG002|Overall Study|Relocated out of state|0|||
130484313|NCT04076618|469745342|FG000|Overall Study|COVID concerns|0|||
130484314|NCT04076618|469745343|FG001|Overall Study|COVID concerns|1|||
130484315|NCT04076618|469745344|FG002|Overall Study|COVID concerns|0|||
130484316|NCT04076618|469745342|FG000|Overall Study|Adverse Event|0|||
130484317|NCT04076618|469745343|FG001|Overall Study|Adverse Event|0|||
130484318|NCT04076618|469745344|FG002|Overall Study|Adverse Event|2|||
130484319|NCT01928394|469745345|FG000|Treatment Period|Disease progression|17|||
130484320|NCT01928394|469745346|FG001|Treatment Period|Disease progression|2|||
130484321|NCT01928394|469745347|FG002|Treatment Period|Disease progression|12|||
130484322|NCT01928394|469745348|FG003|Treatment Period|Disease progression|48|||
130484323|NCT01928394|469745349|FG004|Treatment Period|Disease progression|3|||
130484324|NCT01928394|469745350|FG005|Treatment Period|Disease progression|25|||
130484325|NCT01928394|469745351|FG006|Treatment Period|Disease progression|38|||
130728105|NCT02682927|470625613|FG003|Overall Study|Adverse Event|1|||
130728106|NCT02682927|470625614|FG004|Overall Study|Adverse Event|0|||
130728107|NCT02682927|470625615|FG005|Overall Study|Adverse Event|2|||
130484326|NCT01928394|469745352|FG007|Treatment Period|Disease progression|16|||
130484327|NCT01928394|469745353|FG008|Treatment Period|Disease progression|3|||
130484328|NCT01928394|469745354|FG009|Treatment Period|Disease progression|11|||
130728108|NCT02682927|470625610|FG000|Overall Study|Death|0|||
130728109|NCT02682927|470625611|FG001|Overall Study|Death|0|||
130484329|NCT01928394|469745355|FG010|Treatment Period|Disease progression|22|||
130484330|NCT01928394|469745356|FG011|Treatment Period|Disease progression|73|||
130728110|NCT02682927|470625612|FG002|Overall Study|Death|0|||
130484331|NCT01928394|469745357|FG012|Treatment Period|Disease progression|38|||
130484332|NCT01928394|469745358|FG013|Treatment Period|Disease progression|118|||
130484333|NCT01928394|469745359|FG014|Treatment Period|Disease progression|59|||
130484334|NCT01928394|469745360|FG015|Treatment Period|Disease progression|1|||
130484335|NCT01928394|469745361|FG016|Treatment Period|Disease progression|43|||
130484336|NCT01928394|469745362|FG017|Treatment Period|Disease progression|56|||
130484337|NCT01928394|469745363|FG018|Treatment Period|Disease progression|50|||
130484338|NCT01928394|469745364|FG019|Treatment Period|Disease progression|71|||
130484339|NCT01928394|469745365|FG020|Treatment Period|Disease progression|30|||
130484340|NCT01928394|469745366|FG021|Treatment Period|Disease progression|31|||
130484341|NCT01928394|469745367|FG022|Treatment Period|Disease progression|31|||
130484342|NCT01928394|469745345|FG000|Treatment Period|Study drug toxicity|1|||
130484343|NCT01928394|469745346|FG001|Treatment Period|Study drug toxicity|1|||
130484344|NCT01928394|469745347|FG002|Treatment Period|Study drug toxicity|3|||
130728111|NCT02682927|470625613|FG003|Overall Study|Death|1|||
130484345|NCT01928394|469745348|FG003|Treatment Period|Study drug toxicity|3|||
130484346|NCT01928394|469745349|FG004|Treatment Period|Study drug toxicity|0|||
130484347|NCT01928394|469745350|FG005|Treatment Period|Study drug toxicity|9|||
130484348|NCT01928394|469745351|FG006|Treatment Period|Study drug toxicity|7|||
130484349|NCT01928394|469745352|FG007|Treatment Period|Study drug toxicity|1|||
130484350|NCT01928394|469745353|FG008|Treatment Period|Study drug toxicity|0|||
130484351|NCT01928394|469745354|FG009|Treatment Period|Study drug toxicity|5|||
130484352|NCT01928394|469745355|FG010|Treatment Period|Study drug toxicity|2|||
130484353|NCT01928394|469745356|FG011|Treatment Period|Study drug toxicity|3|||
130484354|NCT01928394|469745357|FG012|Treatment Period|Study drug toxicity|7|||
130484355|NCT01928394|469745358|FG013|Treatment Period|Study drug toxicity|5|||
130484356|NCT01928394|469745359|FG014|Treatment Period|Study drug toxicity|12|||
130484357|NCT01928394|469745360|FG015|Treatment Period|Study drug toxicity|0|||
130484358|NCT01928394|469745361|FG016|Treatment Period|Study drug toxicity|3|||
130484359|NCT01928394|469745362|FG017|Treatment Period|Study drug toxicity|3|||
130484360|NCT01928394|469745363|FG018|Treatment Period|Study drug toxicity|12|||
130484361|NCT01928394|469745364|FG019|Treatment Period|Study drug toxicity|15|||
130484362|NCT01928394|469745365|FG020|Treatment Period|Study drug toxicity|4|||
130484363|NCT01928394|469745366|FG021|Treatment Period|Study drug toxicity|7|||
130484364|NCT01928394|469745367|FG022|Treatment Period|Study drug toxicity|4|||
130484365|NCT01928394|469745345|FG000|Treatment Period|AE unrelated to study drug|0|||
130484366|NCT01928394|469745346|FG001|Treatment Period|AE unrelated to study drug|0|||
130484367|NCT01928394|469745347|FG002|Treatment Period|AE unrelated to study drug|2|||
130484368|NCT01928394|469745348|FG003|Treatment Period|AE unrelated to study drug|3|||
130484369|NCT01928394|469745349|FG004|Treatment Period|AE unrelated to study drug|0|||
130484370|NCT01928394|469745350|FG005|Treatment Period|AE unrelated to study drug|5|||
130484371|NCT01928394|469745351|FG006|Treatment Period|AE unrelated to study drug|1|||
130484372|NCT01928394|469745352|FG007|Treatment Period|AE unrelated to study drug|0|||
130484373|NCT01928394|469745353|FG008|Treatment Period|AE unrelated to study drug|0|||
130484374|NCT01928394|469745354|FG009|Treatment Period|AE unrelated to study drug|2|||
130484375|NCT01928394|469745355|FG010|Treatment Period|AE unrelated to study drug|0|||
130484376|NCT01928394|469745356|FG011|Treatment Period|AE unrelated to study drug|12|||
130484377|NCT01928394|469745357|FG012|Treatment Period|AE unrelated to study drug|6|||
130484378|NCT01928394|469745358|FG013|Treatment Period|AE unrelated to study drug|13|||
130484379|NCT01928394|469745359|FG014|Treatment Period|AE unrelated to study drug|6|||
130484380|NCT01928394|469745360|FG015|Treatment Period|AE unrelated to study drug|1|||
130484381|NCT01928394|469745361|FG016|Treatment Period|AE unrelated to study drug|1|||
130484382|NCT01928394|469745362|FG017|Treatment Period|AE unrelated to study drug|6|||
130484383|NCT01928394|469745363|FG018|Treatment Period|AE unrelated to study drug|3|||
130484384|NCT01928394|469745364|FG019|Treatment Period|AE unrelated to study drug|5|||
130484385|NCT01928394|469745365|FG020|Treatment Period|AE unrelated to study drug|1|||
130484386|NCT01928394|469745366|FG021|Treatment Period|AE unrelated to study drug|1|||
130484387|NCT01928394|469745367|FG022|Treatment Period|AE unrelated to study drug|0|||
130484388|NCT01928394|469745345|FG000|Treatment Period|Participant request to stop therapy|0|||
130484389|NCT01928394|469745346|FG001|Treatment Period|Participant request to stop therapy|0|||
130484390|NCT01928394|469745347|FG002|Treatment Period|Participant request to stop therapy|0|||
130484391|NCT01928394|469745348|FG003|Treatment Period|Participant request to stop therapy|0|||
130484392|NCT01928394|469745349|FG004|Treatment Period|Participant request to stop therapy|0|||
130484393|NCT01928394|469745350|FG005|Treatment Period|Participant request to stop therapy|3|||
130484394|NCT01928394|469745351|FG006|Treatment Period|Participant request to stop therapy|3|||
130484395|NCT01928394|469745352|FG007|Treatment Period|Participant request to stop therapy|0|||
130565044|NCT02966509|470035364|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
130728112|NCT02682927|470625614|FG004|Overall Study|Death|0|||
130728113|NCT02682927|470625615|FG005|Overall Study|Death|0|||
130484396|NCT01928394|469745353|FG008|Treatment Period|Participant request to stop therapy|0|||
130484397|NCT01928394|469745354|FG009|Treatment Period|Participant request to stop therapy|0|||
130484398|NCT01928394|469745355|FG010|Treatment Period|Participant request to stop therapy|3|||
130484399|NCT01928394|469745356|FG011|Treatment Period|Participant request to stop therapy|2|||
130484400|NCT01928394|469745357|FG012|Treatment Period|Participant request to stop therapy|1|||
130484401|NCT01928394|469745358|FG013|Treatment Period|Participant request to stop therapy|2|||
130484402|NCT01928394|469745359|FG014|Treatment Period|Participant request to stop therapy|4|||
130728114|NCT02682927|470625610|FG000|Overall Study|Lack of Efficacy|1|||
130484403|NCT01928394|469745360|FG015|Treatment Period|Participant request to stop therapy|0|||
130484404|NCT01928394|469745361|FG016|Treatment Period|Participant request to stop therapy|1|||
130484405|NCT01928394|469745362|FG017|Treatment Period|Participant request to stop therapy|3|||
130484406|NCT01928394|469745363|FG018|Treatment Period|Participant request to stop therapy|1|||
130484407|NCT01928394|469745364|FG019|Treatment Period|Participant request to stop therapy|1|||
130484408|NCT01928394|469745365|FG020|Treatment Period|Participant request to stop therapy|3|||
130484409|NCT01928394|469745366|FG021|Treatment Period|Participant request to stop therapy|1|||
130484410|NCT01928394|469745367|FG022|Treatment Period|Participant request to stop therapy|3|||
130484411|NCT01928394|469745345|FG000|Treatment Period|Participant withdrew consent|0|||
130484412|NCT01928394|469745346|FG001|Treatment Period|Participant withdrew consent|0|||
130484413|NCT01928394|469745347|FG002|Treatment Period|Participant withdrew consent|1|||
130484414|NCT01928394|469745348|FG003|Treatment Period|Participant withdrew consent|1|||
130484415|NCT01928394|469745349|FG004|Treatment Period|Participant withdrew consent|0|||
130484416|NCT01928394|469745350|FG005|Treatment Period|Participant withdrew consent|1|||
130484417|NCT01928394|469745351|FG006|Treatment Period|Participant withdrew consent|0|||
130484418|NCT01928394|469745352|FG007|Treatment Period|Participant withdrew consent|1|||
130484419|NCT01928394|469745353|FG008|Treatment Period|Participant withdrew consent|0|||
130484420|NCT01928394|469745354|FG009|Treatment Period|Participant withdrew consent|0|||
130484421|NCT01928394|469745355|FG010|Treatment Period|Participant withdrew consent|1|||
130484422|NCT01928394|469745356|FG011|Treatment Period|Participant withdrew consent|1|||
130484423|NCT01928394|469745357|FG012|Treatment Period|Participant withdrew consent|1|||
130484424|NCT01928394|469745358|FG013|Treatment Period|Participant withdrew consent|0|||
130484425|NCT01928394|469745359|FG014|Treatment Period|Participant withdrew consent|2|||
130484426|NCT01928394|469745360|FG015|Treatment Period|Participant withdrew consent|0|||
130484427|NCT01928394|469745361|FG016|Treatment Period|Participant withdrew consent|2|||
130484428|NCT01928394|469745362|FG017|Treatment Period|Participant withdrew consent|1|||
130484429|NCT01928394|469745363|FG018|Treatment Period|Participant withdrew consent|1|||
130484430|NCT01928394|469745364|FG019|Treatment Period|Participant withdrew consent|1|||
130484431|NCT01928394|469745365|FG020|Treatment Period|Participant withdrew consent|0|||
130484432|NCT01928394|469745366|FG021|Treatment Period|Participant withdrew consent|2|||
130484433|NCT01928394|469745367|FG022|Treatment Period|Participant withdrew consent|0|||
130484434|NCT01928394|469745345|FG000|Treatment Period|Poor/non-compliance|0|||
130484435|NCT01928394|469745346|FG001|Treatment Period|Poor/non-compliance|0|||
130484436|NCT01928394|469745347|FG002|Treatment Period|Poor/non-compliance|0|||
130484437|NCT01928394|469745348|FG003|Treatment Period|Poor/non-compliance|1|||
130484438|NCT01928394|469745349|FG004|Treatment Period|Poor/non-compliance|0|||
130484439|NCT01928394|469745350|FG005|Treatment Period|Poor/non-compliance|0|||
130484440|NCT01928394|469745351|FG006|Treatment Period|Poor/non-compliance|0|||
130484441|NCT01928394|469745352|FG007|Treatment Period|Poor/non-compliance|0|||
130484442|NCT01928394|469745353|FG008|Treatment Period|Poor/non-compliance|0|||
130484443|NCT01928394|469745354|FG009|Treatment Period|Poor/non-compliance|0|||
130484444|NCT01928394|469745355|FG010|Treatment Period|Poor/non-compliance|0|||
130484445|NCT01928394|469745356|FG011|Treatment Period|Poor/non-compliance|0|||
130484446|NCT01928394|469745357|FG012|Treatment Period|Poor/non-compliance|1|||
130484447|NCT01928394|469745358|FG013|Treatment Period|Poor/non-compliance|0|||
130484448|NCT01928394|469745359|FG014|Treatment Period|Poor/non-compliance|1|||
130484449|NCT01928394|469745360|FG015|Treatment Period|Poor/non-compliance|0|||
130484450|NCT01928394|469745361|FG016|Treatment Period|Poor/non-compliance|0|||
130484451|NCT01928394|469745362|FG017|Treatment Period|Poor/non-compliance|1|||
130484452|NCT01928394|469745363|FG018|Treatment Period|Poor/non-compliance|0|||
130484453|NCT01928394|469745364|FG019|Treatment Period|Poor/non-compliance|1|||
130728115|NCT02682927|470625611|FG001|Overall Study|Lack of Efficacy|0|||
130728116|NCT02682927|470625612|FG002|Overall Study|Lack of Efficacy|0|||
130728117|NCT02682927|470625613|FG003|Overall Study|Lack of Efficacy|1|||
130728118|NCT02682927|470625614|FG004|Overall Study|Lack of Efficacy|0|||
130728119|NCT02682927|470625615|FG005|Overall Study|Lack of Efficacy|0|||
130728120|NCT02682927|470625610|FG000|Overall Study|Other|0|||
130728121|NCT02682927|470625611|FG001|Overall Study|Other|0|||
130728122|NCT02682927|470625612|FG002|Overall Study|Other|0|||
130728123|NCT02682927|470625613|FG003|Overall Study|Other|2|||
130728124|NCT02682927|470625614|FG004|Overall Study|Other|0|||
130728125|NCT02682927|470625615|FG005|Overall Study|Other|0|||
130484454|NCT01928394|469745365|FG020|Treatment Period|Poor/non-compliance|0|||
130484455|NCT01928394|469745366|FG021|Treatment Period|Poor/non-compliance|0|||
130484456|NCT01928394|469745367|FG022|Treatment Period|Poor/non-compliance|0|||
130565045|NCT02966509|470035365|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
130565046|NCT02966509|470035364|FG000|6 Month Satisfaction Survey|Death|36|||
130728126|NCT02682927|470625610|FG000|Overall Study|Withdrawal by Subject|2|||
130728127|NCT02682927|470625611|FG001|Overall Study|Withdrawal by Subject|0|||
130728128|NCT02682927|470625612|FG002|Overall Study|Withdrawal by Subject|1|||
130484457|NCT01928394|469745345|FG000|Treatment Period|other reason|0|||
130484458|NCT01928394|469745346|FG001|Treatment Period|other reason|0|||
130484459|NCT01928394|469745347|FG002|Treatment Period|other reason|0|||
130728129|NCT02682927|470625613|FG003|Overall Study|Withdrawal by Subject|0|||
130484460|NCT01928394|469745348|FG003|Treatment Period|other reason|0|||
130484461|NCT01928394|469745349|FG004|Treatment Period|other reason|0|||
130484462|NCT01928394|469745350|FG005|Treatment Period|other reason|0|||
130484463|NCT01928394|469745351|FG006|Treatment Period|other reason|0|||
130484464|NCT01928394|469745352|FG007|Treatment Period|other reason|0|||
130484465|NCT01928394|469745353|FG008|Treatment Period|other reason|0|||
130484466|NCT01928394|469745354|FG009|Treatment Period|other reason|0|||
130484467|NCT01928394|469745355|FG010|Treatment Period|other reason|1|||
130484468|NCT01928394|469745356|FG011|Treatment Period|other reason|1|||
130484469|NCT01928394|469745357|FG012|Treatment Period|other reason|1|||
130484470|NCT01928394|469745358|FG013|Treatment Period|other reason|0|||
130484471|NCT01928394|469745359|FG014|Treatment Period|other reason|1|||
130484472|NCT01928394|469745360|FG015|Treatment Period|other reason|0|||
130484473|NCT01928394|469745361|FG016|Treatment Period|other reason|0|||
130484474|NCT01928394|469745362|FG017|Treatment Period|other reason|0|||
130484475|NCT01928394|469745363|FG018|Treatment Period|other reason|2|||
130484476|NCT01928394|469745364|FG019|Treatment Period|other reason|2|||
130484477|NCT01928394|469745365|FG020|Treatment Period|other reason|0|||
130484478|NCT01928394|469745366|FG021|Treatment Period|other reason|0|||
130484479|NCT01928394|469745367|FG022|Treatment Period|other reason|0|||
130484480|NCT01928394|469745345|FG000|Treatment Period|Maximum clinical benefit|0|||
130484481|NCT01928394|469745346|FG001|Treatment Period|Maximum clinical benefit|0|||
130484482|NCT01928394|469745347|FG002|Treatment Period|Maximum clinical benefit|0|||
130484483|NCT01928394|469745348|FG003|Treatment Period|Maximum clinical benefit|0|||
130484484|NCT01928394|469745349|FG004|Treatment Period|Maximum clinical benefit|0|||
130484485|NCT01928394|469745350|FG005|Treatment Period|Maximum clinical benefit|0|||
130484486|NCT01928394|469745351|FG006|Treatment Period|Maximum clinical benefit|0|||
130484487|NCT01928394|469745352|FG007|Treatment Period|Maximum clinical benefit|0|||
130484488|NCT01928394|469745353|FG008|Treatment Period|Maximum clinical benefit|0|||
130484489|NCT01928394|469745354|FG009|Treatment Period|Maximum clinical benefit|0|||
130484490|NCT01928394|469745355|FG010|Treatment Period|Maximum clinical benefit|1|||
130484491|NCT01928394|469745356|FG011|Treatment Period|Maximum clinical benefit|1|||
130484492|NCT01928394|469745357|FG012|Treatment Period|Maximum clinical benefit|0|||
130484493|NCT01928394|469745358|FG013|Treatment Period|Maximum clinical benefit|0|||
130484494|NCT01928394|469745359|FG014|Treatment Period|Maximum clinical benefit|1|||
130484495|NCT01928394|469745360|FG015|Treatment Period|Maximum clinical benefit|0|||
130484496|NCT01928394|469745361|FG016|Treatment Period|Maximum clinical benefit|0|||
130484497|NCT01928394|469745362|FG017|Treatment Period|Maximum clinical benefit|1|||
130484498|NCT01928394|469745363|FG018|Treatment Period|Maximum clinical benefit|1|||
130484499|NCT01928394|469745364|FG019|Treatment Period|Maximum clinical benefit|0|||
130484500|NCT01928394|469745365|FG020|Treatment Period|Maximum clinical benefit|2|||
130484501|NCT01928394|469745366|FG021|Treatment Period|Maximum clinical benefit|0|||
130484502|NCT01928394|469745367|FG022|Treatment Period|Maximum clinical benefit|0|||
130484503|NCT01928394|469745345|FG000|Treatment Period|Lost to Follow-up|0|||
130484504|NCT01928394|469745346|FG001|Treatment Period|Lost to Follow-up|0|||
130484505|NCT01928394|469745347|FG002|Treatment Period|Lost to Follow-up|0|||
130484506|NCT01928394|469745348|FG003|Treatment Period|Lost to Follow-up|0|||
130484507|NCT01928394|469745349|FG004|Treatment Period|Lost to Follow-up|0|||
130484508|NCT01928394|469745350|FG005|Treatment Period|Lost to Follow-up|0|||
130484509|NCT01928394|469745351|FG006|Treatment Period|Lost to Follow-up|0|||
130484510|NCT01928394|469745352|FG007|Treatment Period|Lost to Follow-up|0|||
130484511|NCT01928394|469745353|FG008|Treatment Period|Lost to Follow-up|0|||
130484512|NCT01928394|469745354|FG009|Treatment Period|Lost to Follow-up|0|||
130484513|NCT01928394|469745355|FG010|Treatment Period|Lost to Follow-up|0|||
130484514|NCT01928394|469745356|FG011|Treatment Period|Lost to Follow-up|0|||
130484515|NCT01928394|469745357|FG012|Treatment Period|Lost to Follow-up|0|||
130484516|NCT01928394|469745358|FG013|Treatment Period|Lost to Follow-up|0|||
130484517|NCT01928394|469745359|FG014|Treatment Period|Lost to Follow-up|0|||
130484518|NCT01928394|469745360|FG015|Treatment Period|Lost to Follow-up|0|||
130484519|NCT01928394|469745361|FG016|Treatment Period|Lost to Follow-up|0|||
130484520|NCT01928394|469745362|FG017|Treatment Period|Lost to Follow-up|0|||
130484521|NCT01928394|469745363|FG018|Treatment Period|Lost to Follow-up|0|||
130484522|NCT01928394|469745364|FG019|Treatment Period|Lost to Follow-up|0|||
130565047|NCT02966509|470035365|FG001|6 Month Satisfaction Survey|Death|33|||
130484523|NCT01928394|469745365|FG020|Treatment Period|Lost to Follow-up|0|||
130484524|NCT01928394|469745366|FG021|Treatment Period|Lost to Follow-up|0|||
130484525|NCT01928394|469745367|FG022|Treatment Period|Lost to Follow-up|1|||
130484526|NCT01928394|469745345|FG000|Treatment Period|Death|0|||
130484527|NCT01928394|469745346|FG001|Treatment Period|Death|0|||
130484528|NCT01928394|469745347|FG002|Treatment Period|Death|0|||
130484529|NCT01928394|469745348|FG003|Treatment Period|Death|0|||
130484530|NCT01928394|469745349|FG004|Treatment Period|Death|0|||
130484531|NCT01928394|469745350|FG005|Treatment Period|Death|0|||
130484532|NCT01928394|469745351|FG006|Treatment Period|Death|0|||
130484533|NCT01928394|469745352|FG007|Treatment Period|Death|0|||
130484534|NCT01928394|469745353|FG008|Treatment Period|Death|0|||
130484535|NCT01928394|469745354|FG009|Treatment Period|Death|0|||
130484536|NCT01928394|469745355|FG010|Treatment Period|Death|0|||
130484537|NCT01928394|469745356|FG011|Treatment Period|Death|0|||
130484538|NCT01928394|469745357|FG012|Treatment Period|Death|0|||
130484539|NCT01928394|469745358|FG013|Treatment Period|Death|1|||
130484540|NCT01928394|469745359|FG014|Treatment Period|Death|2|||
130484541|NCT01928394|469745360|FG015|Treatment Period|Death|0|||
130484542|NCT01928394|469745361|FG016|Treatment Period|Death|0|||
130484543|NCT01928394|469745362|FG017|Treatment Period|Death|0|||
130484544|NCT01928394|469745363|FG018|Treatment Period|Death|0|||
130484545|NCT01928394|469745364|FG019|Treatment Period|Death|0|||
130484546|NCT01928394|469745365|FG020|Treatment Period|Death|0|||
130484547|NCT01928394|469745366|FG021|Treatment Period|Death|0|||
130484548|NCT01928394|469745367|FG022|Treatment Period|Death|0|||
130484549|NCT01928394|469745345|FG000|Follow-up Period|Participant withdrew consent|3|||
130484550|NCT01928394|469745346|FG001|Follow-up Period|Participant withdrew consent|0|||
130484551|NCT01928394|469745347|FG002|Follow-up Period|Participant withdrew consent|1|||
130484552|NCT01928394|469745348|FG003|Follow-up Period|Participant withdrew consent|4|||
130484553|NCT01928394|469745349|FG004|Follow-up Period|Participant withdrew consent|0|||
130484554|NCT01928394|469745350|FG005|Follow-up Period|Participant withdrew consent|2|||
130484555|NCT01928394|469745351|FG006|Follow-up Period|Participant withdrew consent|5|||
130565048|NCT02966509|470035364|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
130565049|NCT02966509|470035365|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
130565050|NCT02966509|470035364|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
130565051|NCT02966509|470035365|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
130565052|NCT02966509|470035364|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
130565053|NCT02966509|470035365|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
130565054|NCT02966509|470035364|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
130565055|NCT02966509|470035365|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
130565056|NCT02966509|470035364|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
130565057|NCT02966509|470035365|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
130565058|NCT01717287|470035368|FG000|Overall Study|Lost to Follow-up|0|||
130565059|NCT01717287|470035369|FG001|Overall Study|Lost to Follow-up|2|||
130565060|NCT01717287|470035368|FG000|Overall Study|Protocol Violation|0|||
130565061|NCT01717287|470035369|FG001|Overall Study|Protocol Violation|1|||
130565062|NCT00516048|470035374|FG000|Overall Study|Death|0|||
130565063|NCT00516048|470035375|FG001|Overall Study|Death|0|||
130565064|NCT00516048|470035376|FG002|Overall Study|Death|1|||
130565065|NCT00516048|470035374|FG000|Overall Study|Subject Decision|0|||
130565066|NCT00516048|470035375|FG001|Overall Study|Subject Decision|2|||
130565067|NCT00516048|470035376|FG002|Overall Study|Subject Decision|0|||
130565068|NCT00054704|470035379|FG000|Overall Study|Lack of Efficacy|2|||
130565069|NCT00054704|470035380|FG001|Overall Study|Lack of Efficacy|3|||
130565070|NCT00054704|470035379|FG000|Overall Study|Adverse Event|3|||
130565071|NCT00054704|470035380|FG001|Overall Study|Adverse Event|1|||
130565072|NCT00054704|470035379|FG000|Overall Study|Lost to Follow-up|0|||
130565073|NCT00054704|470035380|FG001|Overall Study|Lost to Follow-up|1|||
130565074|NCT00362414|470035381|FG000|Overall Study|Death|2|||
130565075|NCT00362414|470035381|FG000|Overall Study|Adverse Event|1|||
130565076|NCT01469182|470035384|FG000|Overall Study|Adverse Event|21|||
130565077|NCT01469182|470035385|FG001|Overall Study|Adverse Event|3|||
130565078|NCT01469182|470035384|FG000|Overall Study|Lost to Follow-up|3|||
130565079|NCT01469182|470035385|FG001|Overall Study|Lost to Follow-up|0|||
130565080|NCT01469182|470035384|FG000|Overall Study|Withdrawal by Subject|4|||
130565081|NCT01469182|470035385|FG001|Overall Study|Withdrawal by Subject|1|||
130565082|NCT01469182|470035384|FG000|Overall Study|Protocol Violation|4|||
130565083|NCT01469182|470035385|FG001|Overall Study|Protocol Violation|2|||
130565084|NCT01469182|470035384|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
130484556|NCT01928394|469745352|FG007|Follow-up Period|Participant withdrew consent|1|||
130484557|NCT01928394|469745353|FG008|Follow-up Period|Participant withdrew consent|0|||
130484558|NCT01928394|469745354|FG009|Follow-up Period|Participant withdrew consent|0|||
130484559|NCT01928394|469745355|FG010|Follow-up Period|Participant withdrew consent|5|||
130484560|NCT01928394|469745356|FG011|Follow-up Period|Participant withdrew consent|8|||
130484561|NCT01928394|469745357|FG012|Follow-up Period|Participant withdrew consent|2|||
130484562|NCT01928394|469745358|FG013|Follow-up Period|Participant withdrew consent|12|||
130484563|NCT01928394|469745359|FG014|Follow-up Period|Participant withdrew consent|7|||
130484564|NCT01928394|469745360|FG015|Follow-up Period|Participant withdrew consent|0|||
130565085|NCT01469182|470035385|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
130565086|NCT02053168|470035386|FG000|Overall Study|Withdrawal by Subject|1|||
130565087|NCT02053168|470035386|FG000|Overall Study|Physician Decision|1|||
130565088|NCT02053168|470035386|FG000|Overall Study|Lost to Follow-up|1|||
130565089|NCT02687542|470035387|FG000|Overall Study|Medication error without associated AEs|0|||
130484565|NCT01928394|469745361|FG016|Follow-up Period|Participant withdrew consent|5|||
130484566|NCT01928394|469745362|FG017|Follow-up Period|Participant withdrew consent|3|||
130484567|NCT01928394|469745363|FG018|Follow-up Period|Participant withdrew consent|2|||
130484568|NCT01928394|469745364|FG019|Follow-up Period|Participant withdrew consent|7|||
130484569|NCT01928394|469745365|FG020|Follow-up Period|Participant withdrew consent|4|||
130484570|NCT01928394|469745366|FG021|Follow-up Period|Participant withdrew consent|6|||
130484571|NCT01928394|469745367|FG022|Follow-up Period|Participant withdrew consent|2|||
130484572|NCT01928394|469745345|FG000|Follow-up Period|Death|0|||
130484573|NCT01928394|469745346|FG001|Follow-up Period|Death|0|||
130484574|NCT01928394|469745347|FG002|Follow-up Period|Death|2|||
130484575|NCT01928394|469745348|FG003|Follow-up Period|Death|6|||
130484576|NCT01928394|469745349|FG004|Follow-up Period|Death|0|||
130484577|NCT01928394|469745350|FG005|Follow-up Period|Death|6|||
130484578|NCT01928394|469745351|FG006|Follow-up Period|Death|6|||
130484579|NCT01928394|469745352|FG007|Follow-up Period|Death|2|||
130484580|NCT01928394|469745353|FG008|Follow-up Period|Death|1|||
130484581|NCT01928394|469745354|FG009|Follow-up Period|Death|2|||
130484582|NCT01928394|469745355|FG010|Follow-up Period|Death|4|||
130484583|NCT01928394|469745356|FG011|Follow-up Period|Death|12|||
130484584|NCT01928394|469745357|FG012|Follow-up Period|Death|11|||
130484585|NCT01928394|469745358|FG013|Follow-up Period|Death|25|||
130484586|NCT01928394|469745359|FG014|Follow-up Period|Death|18|||
130484587|NCT01928394|469745360|FG015|Follow-up Period|Death|0|||
130484588|NCT01928394|469745361|FG016|Follow-up Period|Death|6|||
130484589|NCT01928394|469745362|FG017|Follow-up Period|Death|5|||
130484590|NCT01928394|469745363|FG018|Follow-up Period|Death|13|||
130484591|NCT01928394|469745364|FG019|Follow-up Period|Death|13|||
130484592|NCT01928394|469745365|FG020|Follow-up Period|Death|5|||
130484593|NCT01928394|469745366|FG021|Follow-up Period|Death|3|||
130484594|NCT01928394|469745367|FG022|Follow-up Period|Death|2|||
130484595|NCT01928394|469745345|FG000|Follow-up Period|other reason|0|||
130484596|NCT01928394|469745346|FG001|Follow-up Period|other reason|0|||
130484597|NCT01928394|469745347|FG002|Follow-up Period|other reason|0|||
130484598|NCT01928394|469745348|FG003|Follow-up Period|other reason|0|||
130484599|NCT01928394|469745349|FG004|Follow-up Period|other reason|0|||
130484600|NCT01928394|469745350|FG005|Follow-up Period|other reason|0|||
130484601|NCT01928394|469745351|FG006|Follow-up Period|other reason|1|||
130484602|NCT01928394|469745352|FG007|Follow-up Period|other reason|3|||
130484603|NCT01928394|469745353|FG008|Follow-up Period|other reason|0|||
130484604|NCT01928394|469745354|FG009|Follow-up Period|other reason|0|||
130484605|NCT01928394|469745355|FG010|Follow-up Period|other reason|2|||
130484606|NCT01928394|469745356|FG011|Follow-up Period|other reason|1|||
130484607|NCT01928394|469745357|FG012|Follow-up Period|other reason|0|||
130484608|NCT01928394|469745358|FG013|Follow-up Period|other reason|1|||
130484609|NCT01928394|469745359|FG014|Follow-up Period|other reason|4|||
130484610|NCT01928394|469745360|FG015|Follow-up Period|other reason|0|||
130484611|NCT01928394|469745361|FG016|Follow-up Period|other reason|2|||
130484612|NCT01928394|469745362|FG017|Follow-up Period|other reason|0|||
130484613|NCT01928394|469745363|FG018|Follow-up Period|other reason|1|||
130484614|NCT01928394|469745364|FG019|Follow-up Period|other reason|1|||
130484615|NCT01928394|469745365|FG020|Follow-up Period|other reason|0|||
130484616|NCT01928394|469745366|FG021|Follow-up Period|other reason|0|||
130484617|NCT01928394|469745367|FG022|Follow-up Period|other reason|1|||
130484618|NCT01928394|469745345|FG000|Follow-up Period|Lost to Follow-up|0|||
130484619|NCT01928394|469745346|FG001|Follow-up Period|Lost to Follow-up|0|||
130484620|NCT01928394|469745347|FG002|Follow-up Period|Lost to Follow-up|0|||
130484621|NCT01928394|469745348|FG003|Follow-up Period|Lost to Follow-up|0|||
130484622|NCT01928394|469745349|FG004|Follow-up Period|Lost to Follow-up|0|||
130484623|NCT01928394|469745350|FG005|Follow-up Period|Lost to Follow-up|0|||
130484624|NCT01928394|469745351|FG006|Follow-up Period|Lost to Follow-up|0|||
130484625|NCT01928394|469745352|FG007|Follow-up Period|Lost to Follow-up|0|||
130484626|NCT01928394|469745353|FG008|Follow-up Period|Lost to Follow-up|0|||
130484627|NCT01928394|469745354|FG009|Follow-up Period|Lost to Follow-up|0|||
130484628|NCT01928394|469745355|FG010|Follow-up Period|Lost to Follow-up|0|||
130484629|NCT01928394|469745356|FG011|Follow-up Period|Lost to Follow-up|1|||
130484630|NCT01928394|469745357|FG012|Follow-up Period|Lost to Follow-up|1|||
130484631|NCT01928394|469745358|FG013|Follow-up Period|Lost to Follow-up|0|||
130484632|NCT01928394|469745359|FG014|Follow-up Period|Lost to Follow-up|1|||
130484633|NCT01928394|469745360|FG015|Follow-up Period|Lost to Follow-up|0|||
130484634|NCT01928394|469745361|FG016|Follow-up Period|Lost to Follow-up|1|||
130484635|NCT01928394|469745362|FG017|Follow-up Period|Lost to Follow-up|0|||
130484636|NCT01928394|469745363|FG018|Follow-up Period|Lost to Follow-up|0|||
130484637|NCT01928394|469745364|FG019|Follow-up Period|Lost to Follow-up|0|||
130484638|NCT01928394|469745365|FG020|Follow-up Period|Lost to Follow-up|0|||
130484639|NCT01928394|469745366|FG021|Follow-up Period|Lost to Follow-up|0|||
130484640|NCT01928394|469745367|FG022|Follow-up Period|Lost to Follow-up|1|||
130484641|NCT04707625|469745368|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
130484642|NCT04471246|469745371|FG000|Overall Study|Lost to Follow-up|2|||
130484643|NCT04471246|469745372|FG001|Overall Study|Lost to Follow-up|2|||
130484644|NCT03386578|469745373|FG000|PK Component|Lost to Follow-up|0|||
130484645|NCT03386578|469745374|FG001|PK Component|Lost to Follow-up|1|||
130484646|NCT03386578|469745375|FG002|PK Component|Lost to Follow-up|0|||
130484647|NCT03386578|469745376|FG003|PK Component|Lost to Follow-up|0|||
130484648|NCT03386578|469745377|FG004|PK Component|Lost to Follow-up|0|||
130484649|NCT03386578|469745378|FG005|PK Component|Lost to Follow-up|0|||
130484650|NCT03386578|469745379|FG006|PK Component|Lost to Follow-up|1|||
130484651|NCT03386578|469745380|FG007|PK Component|Lost to Follow-up|0|||
130484652|NCT03386578|469745381|FG008|PK Component|Lost to Follow-up|0|||
130484653|NCT03386578|469745382|FG009|PK Component|Lost to Follow-up|0|||
130484654|NCT03386578|469745373|FG000|PK Component|Stillbirth/Abortion|0|||
130484655|NCT03386578|469745374|FG001|PK Component|Stillbirth/Abortion|0|||
130484656|NCT03386578|469745375|FG002|PK Component|Stillbirth/Abortion|0|||
130484657|NCT03386578|469745376|FG003|PK Component|Stillbirth/Abortion|0|||
130484658|NCT03386578|469745377|FG004|PK Component|Stillbirth/Abortion|0|||
130484659|NCT03386578|469745378|FG005|PK Component|Stillbirth/Abortion|2|||
130484660|NCT03386578|469745379|FG006|PK Component|Stillbirth/Abortion|0|||
130484661|NCT03386578|469745380|FG007|PK Component|Stillbirth/Abortion|0|||
130484662|NCT03386578|469745381|FG008|PK Component|Stillbirth/Abortion|0|||
130484663|NCT03386578|469745382|FG009|PK Component|Stillbirth/Abortion|0|||
130484664|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484665|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484666|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
130484667|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
130484668|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484669|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484670|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484671|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
130484672|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
130484673|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
130484674|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484675|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484676|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
130484677|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
130484678|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484679|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484680|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484681|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
130484682|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
130484683|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
130484684|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Death|0|||
130484685|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Death|0|||
130484686|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Death|1|||
130484687|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Death|0|||
130484688|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Death|0|||
130484689|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Death|0|||
130484690|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Death|0|||
130484691|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Death|9|||
130484692|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Death|5|||
130484693|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Death|0|||
130484694|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484695|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484696|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484697|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
130484698|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484699|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484700|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484701|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484702|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
130484703|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130484704|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484705|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484706|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484707|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484708|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484709|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484710|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484711|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
130484712|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
130484713|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
130484714|NCT03386578|469745373|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484715|NCT03386578|469745374|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484716|NCT03386578|469745375|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484717|NCT03386578|469745376|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484718|NCT03386578|469745377|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484719|NCT03386578|469745378|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130728130|NCT02682927|470625614|FG004|Overall Study|Withdrawal by Subject|1|||
130728131|NCT02682927|470625615|FG005|Overall Study|Withdrawal by Subject|1|||
130728132|NCT05314816|470625617|FG000|Overall Study|Lost to Follow-up|5|||
130728133|NCT05314816|470625618|FG001|Overall Study|Lost to Follow-up|0|||
130728134|NCT05314816|470625619|FG002|Overall Study|Lost to Follow-up|1|||
130728135|NCT05314816|470625617|FG000|Overall Study|Protocol Violation|13|||
130484720|NCT03386578|469745379|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484721|NCT03386578|469745380|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
130728136|NCT05314816|470625618|FG001|Overall Study|Protocol Violation|8|||
130728137|NCT05314816|470625619|FG002|Overall Study|Protocol Violation|0|||
130728138|NCT04981717|470627395|FG000|Overall Study|Protocol Violation|0|||
130728139|NCT04981717|470627396|FG001|Overall Study|Protocol Violation|3|||
130484722|NCT03386578|469745381|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
130484723|NCT03386578|469745382|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
130484724|NCT05907174|469745383|FG000|3-Month Assessment|Withdrawal by Subject|0|||
130484725|NCT05907174|469745384|FG001|3-Month Assessment|Withdrawal by Subject|0|||
130484726|NCT05907174|469745385|FG002|3-Month Assessment|Withdrawal by Subject|0|||
130484727|NCT05907174|469745386|FG003|3-Month Assessment|Withdrawal by Subject|1|||
130484728|NCT05907174|469745383|FG000|3-Month Assessment|Lost to Follow-up|1|||
130484729|NCT05907174|469745384|FG001|3-Month Assessment|Lost to Follow-up|1|||
130484730|NCT05907174|469745385|FG002|3-Month Assessment|Lost to Follow-up|1|||
130484731|NCT05907174|469745386|FG003|3-Month Assessment|Lost to Follow-up|1|||
130484732|NCT05907174|469745383|FG000|6-Month Assessment|Death|0|||
130484733|NCT05907174|469745384|FG001|6-Month Assessment|Death|0|||
130484734|NCT05907174|469745385|FG002|6-Month Assessment|Death|3|||
130484735|NCT05907174|469745386|FG003|6-Month Assessment|Death|0|||
130484736|NCT05907174|469745383|FG000|6-Month Assessment|Withdrawal by Subject|0|||
130484737|NCT05907174|469745384|FG001|6-Month Assessment|Withdrawal by Subject|0|||
130484738|NCT05907174|469745385|FG002|6-Month Assessment|Withdrawal by Subject|1|||
130484739|NCT05907174|469745386|FG003|6-Month Assessment|Withdrawal by Subject|1|||
130484740|NCT05907174|469745383|FG000|6-Month Assessment|Lost to Follow-up|0|||
130484741|NCT05907174|469745384|FG001|6-Month Assessment|Lost to Follow-up|1|||
130484742|NCT05907174|469745385|FG002|6-Month Assessment|Lost to Follow-up|1|||
130484743|NCT05907174|469745386|FG003|6-Month Assessment|Lost to Follow-up|1|||
130484744|NCT05093842|469745387|FG000|Overall Study|Pregnancy loss|1|||
130484745|NCT05093842|469745388|FG001|Overall Study|Pregnancy loss|1|||
130484746|NCT05093842|469745387|FG000|Overall Study|Lost to Follow-up|6|||
130484747|NCT05093842|469745388|FG001|Overall Study|Lost to Follow-up|0|||
130484748|NCT05093842|469745387|FG000|Overall Study|Physician Decision|0|||
130484749|NCT05093842|469745388|FG001|Overall Study|Physician Decision|1|||
130484750|NCT05147116|469745394|FG000|Overall Study|Withdrawal by Subject|0|||
130484751|NCT05147116|469745395|FG001|Overall Study|Withdrawal by Subject|1|||
130484752|NCT04197336|469745396|FG000|Overall Study|Withdrawal by Subject|1|||
130484753|NCT05868382|469745397|FG000|Overall Study|Lost to Follow-up|5|||
130484754|NCT05868382|469745398|FG001|Overall Study|Lost to Follow-up|0|||
130484755|NCT05868382|469745399|FG002|Overall Study|Lost to Follow-up|6|||
130484756|NCT05868382|469745400|FG003|Overall Study|Lost to Follow-up|4|||
130484757|NCT05868382|469745401|FG004|Overall Study|Lost to Follow-up|2|||
130484758|NCT05868382|469745402|FG005|Overall Study|Lost to Follow-up|6|||
130484759|NCT05868382|469745397|FG000|Overall Study|Withdrawal by Subject|1|||
130484760|NCT05868382|469745398|FG001|Overall Study|Withdrawal by Subject|0|||
130484761|NCT05868382|469745399|FG002|Overall Study|Withdrawal by Subject|0|||
130484762|NCT05868382|469745400|FG003|Overall Study|Withdrawal by Subject|0|||
130484763|NCT05868382|469745401|FG004|Overall Study|Withdrawal by Subject|1|||
130484764|NCT05868382|469745402|FG005|Overall Study|Withdrawal by Subject|0|||
130484765|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
130484766|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
130484767|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
130484768|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
130484769|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
130484770|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
130565090|NCT02687542|470035388|FG001|Overall Study|Medication error without associated AEs|0|||
130484771|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
130484772|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Death|0|||
130484773|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Death|1|||
130484774|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Death|0|||
130484775|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Death|0|||
130484776|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Death|0|||
130484777|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Death|0|||
130484778|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Death|0|||
130484779|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
130484780|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130728140|NCT04981717|470627395|FG000|Overall Study|Adverse Event|1|||
130728141|NCT04981717|470627396|FG001|Overall Study|Adverse Event|3|||
130728142|NCT04981717|470627395|FG000|Overall Study|Pregnancy|1|||
130484781|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130484782|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130484783|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130484784|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130484785|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
130484786|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484787|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
130484788|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484789|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484790|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484791|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484792|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
130484793|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Other|1|||
130484794|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Other|0|||
130484795|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Other|0|||
130484796|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Other|0|||
130484797|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Other|0|||
130484798|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Other|0|||
130484799|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Other|0|||
130484800|NCT04585815|469745403|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
130484801|NCT04585815|469745404|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
130484802|NCT04585815|469745405|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
130484803|NCT04585815|469745406|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
130484804|NCT04585815|469745407|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
130484805|NCT04585815|469745408|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
130484806|NCT04585815|469745409|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
130484807|NCT04585815|469745403|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484808|NCT04585815|469745404|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
130484809|NCT04585815|469745405|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484810|NCT04585815|469745406|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484811|NCT04585815|469745407|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484812|NCT04585815|469745408|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484813|NCT04585815|469745409|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
130484814|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
130484815|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
130484816|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
130484817|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
130728143|NCT04981717|470627396|FG001|Overall Study|Pregnancy|0|||
130728144|NCT04981717|470627395|FG000|Overall Study|Physician Decision|1|||
130728145|NCT04981717|470627396|FG001|Overall Study|Physician Decision|0|||
130728146|NCT04981717|470627395|FG000|Overall Study|Sponsor Request|157|||
130728147|NCT04981717|470627396|FG001|Overall Study|Sponsor Request|172|||
130728148|NCT04981717|470627395|FG000|Overall Study|Lost to Follow-up|4|||
130728149|NCT04981717|470627396|FG001|Overall Study|Lost to Follow-up|5|||
130728150|NCT04981717|470627395|FG000|Overall Study|Withdrawal by Subject|50|||
130728151|NCT04981717|470627396|FG001|Overall Study|Withdrawal by Subject|37|||
130728152|NCT02207634|470627397|FG000|Overall Study|Withdrawal by Subject|21|||
130728153|NCT02207634|470627398|FG001|Overall Study|Withdrawal by Subject|31|||
130728154|NCT02207634|470627397|FG000|Overall Study|Lost to Follow-up|1|||
130728155|NCT02207634|470627398|FG001|Overall Study|Lost to Follow-up|0|||
130728156|NCT00887289|470627399|FG000|Overall Study|Lack of Efficacy|14|||
130728157|NCT00887289|470627399|FG000|Overall Study|Adverse Event|27|||
130728158|NCT00887289|470627399|FG000|Overall Study|Withdrawal by Subject|26|||
130728159|NCT00887289|470627399|FG000|Overall Study|Lost to Follow-up|8|||
130728160|NCT00887289|470627399|FG000|Overall Study|Other|20|||
130728161|NCT00591773|470627400|FG000|Overall Study|Adverse Event|9|||
130728162|NCT00591773|470627401|FG001|Overall Study|Adverse Event|9|||
130484818|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
130484819|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
130484820|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
130484821|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Death|0|||
130484822|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Death|0|||
130484823|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Death|0|||
130484824|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Death|1|||
130484825|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Death|0|||
130484826|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Death|0|||
130484827|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Death|0|||
130728163|NCT00591773|470627402|FG002|Overall Study|Adverse Event|6|||
130728164|NCT00591773|470627400|FG000|Overall Study|Protocol Violation|2|||
130728165|NCT00591773|470627401|FG001|Overall Study|Protocol Violation|3|||
130484828|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
130484829|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
130484830|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
130484831|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
130484832|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
130484833|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
130484834|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
130484835|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130484836|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130728166|NCT00591773|470627402|FG002|Overall Study|Protocol Violation|0|||
130728167|NCT00591773|470627400|FG000|Overall Study|Lost to Follow-up|1|||
130728168|NCT00591773|470627401|FG001|Overall Study|Lost to Follow-up|4|||
130728169|NCT00591773|470627402|FG002|Overall Study|Lost to Follow-up|1|||
130484837|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130484838|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
130484839|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130484840|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130484841|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
130484842|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484843|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484844|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484845|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484846|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484847|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
130484848|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
130484849|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
130484850|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
130484851|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
130484852|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
130484853|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
130484854|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
130484855|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
130484856|NCT04585815|469745403|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
130484857|NCT04585815|469745404|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
130484858|NCT04585815|469745405|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
130484859|NCT04585815|469745406|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
130484860|NCT04585815|469745407|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
130484861|NCT04585815|469745408|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
130484862|NCT04585815|469745409|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
130484863|NCT04585815|469745403|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
130484864|NCT04585815|469745404|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
130484865|NCT04585815|469745405|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
130484866|NCT04585815|469745406|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
130484867|NCT04585815|469745407|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
130484868|NCT04585815|469745408|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
130484869|NCT04585815|469745409|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
130484870|NCT04585815|469745403|FG000|Sub-study B- Follow-up Phase|Death|0|||
130484871|NCT04585815|469745404|FG001|Sub-study B- Follow-up Phase|Death|0|||
130484872|NCT04585815|469745405|FG002|Sub-study B- Follow-up Phase|Death|1|||
130484873|NCT04585815|469745406|FG003|Sub-study B- Follow-up Phase|Death|3|||
130484874|NCT04585815|469745407|FG004|Sub-study B- Follow-up Phase|Death|0|||
130484875|NCT04585815|469745408|FG005|Sub-study B- Follow-up Phase|Death|0|||
130484876|NCT04585815|469745409|FG006|Sub-study B- Follow-up Phase|Death|1|||
130484877|NCT01221948|469745417|FG000|Overall Study|Physician Decision|5|||
130484878|NCT01221948|469745417|FG000|Overall Study|Withdrawal by Subject|2|||
130484879|NCT01221948|469745417|FG000|Overall Study|not disclosed|2|||
130484880|NCT01221948|469745417|FG000|Overall Study|Death|1|||
130484881|NCT01221948|469745417|FG000|Overall Study|Protocol Violation|4|||
130484882|NCT00746096|469745418|FG000|Overall Study|Adverse Event|1|||
130484883|NCT00746096|469745419|FG001|Overall Study|Adverse Event|0|||
130484884|NCT00746096|469745418|FG000|Overall Study|Withdrawal by Subject|5|||
130728170|NCT00591773|470627400|FG000|Overall Study|Withdrawal by Subject|2|||
130484885|NCT00746096|469745419|FG001|Overall Study|Withdrawal by Subject|1|||
130484886|NCT00746096|469745418|FG000|Overall Study|Lost to Follow-up|2|||
130484887|NCT00746096|469745419|FG001|Overall Study|Lost to Follow-up|1|||
130484888|NCT00746096|469745418|FG000|Overall Study|Protocol Violation|1|||
130484889|NCT00746096|469745419|FG001|Overall Study|Protocol Violation|0|||
130484890|NCT00746096|469745418|FG000|Overall Study|No study drug treatment|1|||
130728171|NCT00591773|470627401|FG001|Overall Study|Withdrawal by Subject|5|||
130484891|NCT00746096|469745419|FG001|Overall Study|No study drug treatment|1|||
130484892|NCT04295512|469745420|FG000|Overall Study|Lack of family response to schedule assessment|0|||
130484893|NCT04295512|469745421|FG001|Overall Study|Lack of family response to schedule assessment|0|||
130484894|NCT04295512|469745422|FG002|Overall Study|Lack of family response to schedule assessment|0|||
130484895|NCT04295512|469745423|FG003|Overall Study|Lack of family response to schedule assessment|2|||
130484896|NCT04295512|469745420|FG000|Overall Study|Therapist did not refer eligible family|7|||
130484897|NCT04295512|469745421|FG001|Overall Study|Therapist did not refer eligible family|7|||
130484898|NCT04295512|469745422|FG002|Overall Study|Therapist did not refer eligible family|0|||
130484899|NCT04295512|469745423|FG003|Overall Study|Therapist did not refer eligible family|0|||
130484900|NCT03571581|469745428|FG000|Overall Study|Death|2|||
130484901|NCT03571581|469745428|FG000|Overall Study|Withdrawal by Subject|2|||
130484902|NCT01309672|469745430|FG000|Overall Study|Lack of Efficacy|20|||
130484903|NCT01309672|469745430|FG000|Overall Study|Other|9|||
130484904|NCT01309672|469745430|FG000|Overall Study|Adverse Event|5|||
130484905|NCT01309672|469745430|FG000|Overall Study|Withdrawal by Subject|3|||
130484906|NCT05623228|469745432|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
130484907|NCT05623228|469745433|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484908|NCT05623228|469745434|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484909|NCT05623228|469745435|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484910|NCT05623228|469745436|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484911|NCT05623228|469745437|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484912|NCT05623228|469745438|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484913|NCT05623228|469745439|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
130484914|NCT05623228|469745432|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
130484915|NCT05623228|469745433|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130484916|NCT05623228|469745434|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
130484917|NCT05623228|469745435|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
130484918|NCT05623228|469745436|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130484919|NCT05623228|469745437|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130484920|NCT05623228|469745438|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130484921|NCT05623228|469745439|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130484922|NCT04625725|469745440|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
130484923|NCT04625725|469745441|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130484924|NCT04625725|469745442|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130484925|NCT04625725|469745443|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130484926|NCT04625725|469745444|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130484927|NCT04625725|469745445|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130484928|NCT04625725|469745440|FG000|Provent Main Study|Withdrawal by Subject|242|||
130484929|NCT04625725|469745441|FG001|Provent Main Study|Withdrawal by Subject|144|||
130484930|NCT04625725|469745442|FG002|Provent Main Study|Withdrawal by Subject|0|||
130484931|NCT04625725|469745443|FG003|Provent Main Study|Withdrawal by Subject|0|||
130484932|NCT04625725|469745444|FG004|Provent Main Study|Withdrawal by Subject|0|||
130484933|NCT04625725|469745445|FG005|Provent Main Study|Withdrawal by Subject|0|||
130484934|NCT04625725|469745440|FG000|Provent Main Study|Physician Decision|5|||
130484935|NCT04625725|469745441|FG001|Provent Main Study|Physician Decision|0|||
130484936|NCT04625725|469745442|FG002|Provent Main Study|Physician Decision|0|||
130484937|NCT04625725|469745443|FG003|Provent Main Study|Physician Decision|0|||
130484938|NCT04625725|469745444|FG004|Provent Main Study|Physician Decision|0|||
130484939|NCT04625725|469745445|FG005|Provent Main Study|Physician Decision|0|||
130484940|NCT04625725|469745440|FG000|Provent Main Study|Protocol Violation|1|||
130484941|NCT04625725|469745441|FG001|Provent Main Study|Protocol Violation|0|||
130484942|NCT04625725|469745442|FG002|Provent Main Study|Protocol Violation|0|||
130484943|NCT04625725|469745443|FG003|Provent Main Study|Protocol Violation|0|||
130484944|NCT04625725|469745444|FG004|Provent Main Study|Protocol Violation|0|||
130484945|NCT04625725|469745445|FG005|Provent Main Study|Protocol Violation|0|||
130484946|NCT04625725|469745440|FG000|Provent Main Study|Lost to Follow-up|357|||
130484947|NCT04625725|469745441|FG001|Provent Main Study|Lost to Follow-up|200|||
130484948|NCT04625725|469745442|FG002|Provent Main Study|Lost to Follow-up|0|||
130565091|NCT02687542|470035389|FG002|Overall Study|Medication error without associated AEs|0|||
130565092|NCT02687542|470035390|FG003|Overall Study|Medication error without associated AEs|0|||
130728172|NCT00591773|470627402|FG002|Overall Study|Withdrawal by Subject|3|||
130728173|NCT00591773|470627400|FG000|Overall Study|Lack of Efficacy|1|||
130484949|NCT04625725|469745443|FG003|Provent Main Study|Lost to Follow-up|0|||
130484950|NCT04625725|469745444|FG004|Provent Main Study|Lost to Follow-up|0|||
130484951|NCT04625725|469745445|FG005|Provent Main Study|Lost to Follow-up|0|||
130484952|NCT04625725|469745440|FG000|Provent Main Study|Death|22|||
130484953|NCT04625725|469745441|FG001|Provent Main Study|Death|10|||
130484954|NCT04625725|469745442|FG002|Provent Main Study|Death|0|||
130484955|NCT04625725|469745443|FG003|Provent Main Study|Death|0|||
130484956|NCT04625725|469745444|FG004|Provent Main Study|Death|0|||
130484957|NCT04625725|469745445|FG005|Provent Main Study|Death|0|||
130484958|NCT04625725|469745440|FG000|Provent Main Study|Adverse Event|2|||
130484959|NCT04625725|469745441|FG001|Provent Main Study|Adverse Event|1|||
130565093|NCT02687542|470035391|FG004|Overall Study|Medication error without associated AEs|1|||
130565094|NCT02687542|470035387|FG000|Overall Study|Lost to Follow-up|0|||
130565095|NCT02687542|470035388|FG001|Overall Study|Lost to Follow-up|0|||
130484960|NCT04625725|469745442|FG002|Provent Main Study|Adverse Event|0|||
130484961|NCT04625725|469745443|FG003|Provent Main Study|Adverse Event|0|||
130484962|NCT04625725|469745444|FG004|Provent Main Study|Adverse Event|0|||
130484963|NCT04625725|469745445|FG005|Provent Main Study|Adverse Event|0|||
130484964|NCT04625725|469745440|FG000|Provent Main Study|Participants dosed in sub-study|310|||
130484965|NCT04625725|469745441|FG001|Provent Main Study|Participants dosed in sub-study|193|||
130484966|NCT04625725|469745442|FG002|Provent Main Study|Participants dosed in sub-study|0|||
130484967|NCT04625725|469745443|FG003|Provent Main Study|Participants dosed in sub-study|0|||
130484968|NCT04625725|469745444|FG004|Provent Main Study|Participants dosed in sub-study|0|||
130484969|NCT04625725|469745445|FG005|Provent Main Study|Participants dosed in sub-study|0|||
130484970|NCT04625725|469745440|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
130484971|NCT04625725|469745441|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
130484972|NCT04625725|469745442|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
130484973|NCT04625725|469745443|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
130484974|NCT04625725|469745444|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
130728174|NCT00591773|470627401|FG001|Overall Study|Lack of Efficacy|2|||
130728175|NCT00591773|470627402|FG002|Overall Study|Lack of Efficacy|2|||
130728176|NCT00591773|470627400|FG000|Overall Study|Other|1|||
130728177|NCT00591773|470627401|FG001|Overall Study|Other|1|||
130484975|NCT04625725|469745445|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
130484976|NCT04625725|469745440|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
130484977|NCT04625725|469745441|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
130484978|NCT04625725|469745442|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
130484979|NCT04625725|469745443|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
130484980|NCT04625725|469745444|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
130728178|NCT00591773|470627402|FG002|Overall Study|Other|4|||
130728179|NCT02047734|470627403|FG000|Overall Study|Adverse Event|18|||
130728180|NCT02047734|470627404|FG001|Overall Study|Adverse Event|13|||
130728181|NCT02047734|470627405|FG002|Overall Study|Adverse Event|13|||
130728182|NCT02047734|470627403|FG000|Overall Study|Lack of Efficacy|4|||
130728183|NCT02047734|470627404|FG001|Overall Study|Lack of Efficacy|5|||
130728184|NCT02047734|470627405|FG002|Overall Study|Lack of Efficacy|1|||
130728185|NCT02047734|470627403|FG000|Overall Study|Protocol Violation|3|||
130728186|NCT02047734|470627404|FG001|Overall Study|Protocol Violation|1|||
130728187|NCT02047734|470627405|FG002|Overall Study|Protocol Violation|1|||
130728188|NCT02047734|470627403|FG000|Overall Study|Lost to Follow-up|1|||
130728189|NCT02047734|470627404|FG001|Overall Study|Lost to Follow-up|4|||
130728190|NCT02047734|470627405|FG002|Overall Study|Lost to Follow-up|0|||
130728191|NCT02047734|470627403|FG000|Overall Study|Death|0|||
130728192|NCT02047734|470627404|FG001|Overall Study|Death|1|||
130728193|NCT02047734|470627405|FG002|Overall Study|Death|0|||
130728194|NCT02047734|470627403|FG000|Overall Study|Withdrawal by Subject|30|||
130728195|NCT02047734|470627404|FG001|Overall Study|Withdrawal by Subject|31|||
130728196|NCT02047734|470627405|FG002|Overall Study|Withdrawal by Subject|19|||
130728197|NCT02047734|470627403|FG000|Overall Study|Physician Decision|7|||
130728198|NCT02047734|470627404|FG001|Overall Study|Physician Decision|6|||
130728199|NCT02047734|470627405|FG002|Overall Study|Physician Decision|5|||
130728200|NCT02047734|470627403|FG000|Overall Study|Miscellaneous|2|||
130728201|NCT02047734|470627404|FG001|Overall Study|Miscellaneous|4|||
130728202|NCT02047734|470627405|FG002|Overall Study|Miscellaneous|6|||
130728203|NCT02047734|470627403|FG000|Overall Study|Did Not Receive Study Drug|2|||
130728204|NCT02047734|470627404|FG001|Overall Study|Did Not Receive Study Drug|4|||
130728205|NCT02047734|470627405|FG002|Overall Study|Did Not Receive Study Drug|1|||
130728206|NCT00799825|470627408|FG000|Overall Study|Adverse Event|1|||
130728207|NCT00799825|470627408|FG000|Overall Study|Withdrawal by Subject|6|||
130728208|NCT00799825|470627408|FG000|Overall Study|Lost to Follow-up|38|||
130728209|NCT00799825|470627408|FG000|Overall Study|Pregnancy|3|||
130728210|NCT02439970|470627409|FG000|Overall Study|Study Terminated|2|||
130728211|NCT02439970|470627410|FG001|Overall Study|Study Terminated|3|||
130728212|NCT00492778|470627411|FG000|Overall Study|Ineligible by Pathology Review|8|||
130728213|NCT00492778|470627412|FG001|Overall Study|Ineligible by Pathology Review|1|||
130484981|NCT04625725|469745445|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
130484982|NCT04625725|469745440|FG000|Provent Main Study|INCARCERATION|3|||
130484983|NCT04625725|469745441|FG001|Provent Main Study|INCARCERATION|0|||
130484984|NCT04625725|469745442|FG002|Provent Main Study|INCARCERATION|0|||
130728214|NCT01371539|470627413|FG000|Period One: One Week|Lost to Follow-up|0|||
130728215|NCT01371539|470627414|FG001|Period One: One Week|Lost to Follow-up|1|||
130728216|NCT01371539|470627413|FG000|Period Two: One Week|Lost to Follow-up|0|||
130484985|NCT04625725|469745443|FG003|Provent Main Study|INCARCERATION|0|||
130484986|NCT04625725|469745444|FG004|Provent Main Study|INCARCERATION|0|||
130484987|NCT04625725|469745445|FG005|Provent Main Study|INCARCERATION|0|||
130484988|NCT04625725|469745440|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
130728217|NCT01371539|470627414|FG001|Period Two: One Week|Lost to Follow-up|1|||
130728218|NCT01371539|470627413|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
130484989|NCT04625725|469745441|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
130484990|NCT04625725|469745442|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
130484991|NCT04625725|469745443|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
130484992|NCT04625725|469745444|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
130728219|NCT01371539|470627414|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
130728220|NCT01371539|470627413|FG000|Period Two: One Week|Time/job conflict|0|||
130728221|NCT01371539|470627414|FG001|Period Two: One Week|Time/job conflict|1|||
130728222|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
130728223|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
130484993|NCT04625725|469745445|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
130484994|NCT04625725|469745440|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
130484995|NCT04625725|469745441|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
130484996|NCT04625725|469745442|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
130484997|NCT04625725|469745443|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
130484998|NCT04625725|469745444|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
130484999|NCT04625725|469745445|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
130485000|NCT04625725|469745440|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
130485001|NCT04625725|469745441|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
130485002|NCT04625725|469745442|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
130485003|NCT04625725|469745443|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
130485004|NCT04625725|469745444|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
130485005|NCT04625725|469745445|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
130485006|NCT04625725|469745440|FG000|Provent Main Study|MISSING REASON|0|||
130485007|NCT04625725|469745441|FG001|Provent Main Study|MISSING REASON|1|||
130485008|NCT04625725|469745442|FG002|Provent Main Study|MISSING REASON|0|||
130485009|NCT04625725|469745443|FG003|Provent Main Study|MISSING REASON|0|||
130485010|NCT04625725|469745444|FG004|Provent Main Study|MISSING REASON|0|||
130485011|NCT04625725|469745445|FG005|Provent Main Study|MISSING REASON|0|||
130485012|NCT04625725|469745440|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
130485013|NCT04625725|469745441|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
130485014|NCT04625725|469745442|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
130485015|NCT04625725|469745443|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
130485016|NCT04625725|469745444|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
130485017|NCT04625725|469745445|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
130485018|NCT04625725|469745440|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130485019|NCT04625725|469745441|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130485020|NCT04625725|469745442|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
130485021|NCT04625725|469745443|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130485022|NCT04625725|469745444|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130485023|NCT04625725|469745445|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130485024|NCT04625725|469745440|FG000|Provent Sub Study|Lost to Follow-up|0|||
130485025|NCT04625725|469745441|FG001|Provent Sub Study|Lost to Follow-up|0|||
130485026|NCT04625725|469745442|FG002|Provent Sub Study|Lost to Follow-up|20|||
130485027|NCT04625725|469745443|FG003|Provent Sub Study|Lost to Follow-up|10|||
130485028|NCT04625725|469745444|FG004|Provent Sub Study|Lost to Follow-up|6|||
130485029|NCT04625725|469745445|FG005|Provent Sub Study|Lost to Follow-up|4|||
130485030|NCT04625725|469745440|FG000|Provent Sub Study|Death|0|||
130485031|NCT04625725|469745441|FG001|Provent Sub Study|Death|0|||
130485032|NCT04625725|469745442|FG002|Provent Sub Study|Death|8|||
130485033|NCT04625725|469745443|FG003|Provent Sub Study|Death|5|||
130485034|NCT04625725|469745444|FG004|Provent Sub Study|Death|0|||
130485035|NCT04625725|469745445|FG005|Provent Sub Study|Death|1|||
130485036|NCT04625725|469745440|FG000|Provent Sub Study|Adverse Event|0|||
130485037|NCT04625725|469745441|FG001|Provent Sub Study|Adverse Event|0|||
130485038|NCT04625725|469745442|FG002|Provent Sub Study|Adverse Event|0|||
130485039|NCT04625725|469745443|FG003|Provent Sub Study|Adverse Event|0|||
130485040|NCT04625725|469745444|FG004|Provent Sub Study|Adverse Event|0|||
130485041|NCT04625725|469745445|FG005|Provent Sub Study|Adverse Event|1|||
130485042|NCT04625725|469745440|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130485043|NCT04625725|469745441|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130485044|NCT04625725|469745442|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130728224|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
130728225|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130728226|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130485045|NCT04625725|469745443|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130485046|NCT04625725|469745444|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
130485047|NCT04625725|469745445|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130728227|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130728228|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130485048|NCT04625725|469745440|FG000|Provent Sub Study|Withdrawal by Subject|0|||
130485049|NCT04625725|469745441|FG001|Provent Sub Study|Withdrawal by Subject|0|||
130485050|NCT04625725|469745442|FG002|Provent Sub Study|Withdrawal by Subject|11|||
130485051|NCT04625725|469745443|FG003|Provent Sub Study|Withdrawal by Subject|13|||
130485052|NCT04625725|469745444|FG004|Provent Sub Study|Withdrawal by Subject|5|||
130485053|NCT04625725|469745445|FG005|Provent Sub Study|Withdrawal by Subject|6|||
130485054|NCT04625725|469745440|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
130485055|NCT04625725|469745441|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
130485056|NCT04625725|469745442|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
130485057|NCT04625725|469745443|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
130485058|NCT04625725|469745444|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
130485059|NCT04625725|469745445|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
130485060|NCT05090683|469745449|FG000|Overall Study|Lost to Follow-up|10|||
130485061|NCT05090683|469745450|FG001|Overall Study|Lost to Follow-up|2|||
130485062|NCT05090683|469745449|FG000|Overall Study|Withdrawal by Subject|15|||
130485063|NCT05090683|469745450|FG001|Overall Study|Withdrawal by Subject|0|||
130485064|NCT05873556|469745451|FG000|Overall Study|Lost to Follow-up|4|||
130485065|NCT05873556|469745452|FG001|Overall Study|Lost to Follow-up|1|||
130485066|NCT04689256|469745453|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
130485067|NCT04689256|469745454|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
130485068|NCT05104463|469745455|FG000|Overall Study|Adverse Event|1|||
130485069|NCT05104463|469745456|FG001|Overall Study|Adverse Event|1|||
130485070|NCT05104463|469745455|FG000|Overall Study|Lost to Follow-up|1|||
130485071|NCT05104463|469745456|FG001|Overall Study|Lost to Follow-up|1|||
130485072|NCT05104463|469745455|FG000|Overall Study|Physician Decision|1|||
130485073|NCT05104463|469745456|FG001|Overall Study|Physician Decision|0|||
130485074|NCT05104463|469745455|FG000|Overall Study|Protocol Violation|0|||
130485075|NCT05104463|469745456|FG001|Overall Study|Protocol Violation|2|||
130485076|NCT05104463|469745455|FG000|Overall Study|Withdrawal by Subject|1|||
130485077|NCT05104463|469745456|FG001|Overall Study|Withdrawal by Subject|1|||
130485078|NCT05267470|469745460|FG000|Overall Study|Decision by sponsor|0|||
130485079|NCT05267470|469745461|FG001|Overall Study|Decision by sponsor|3|||
130485080|NCT05267470|469745462|FG002|Overall Study|Decision by sponsor|19|||
130485081|NCT05267470|469745463|FG003|Overall Study|Decision by sponsor|7|||
130485082|NCT05267470|469745464|FG004|Overall Study|Decision by sponsor|3|||
130485083|NCT05267470|469745460|FG000|Overall Study|Withdrawal by Subject|1|||
130485084|NCT05267470|469745461|FG001|Overall Study|Withdrawal by Subject|1|||
130485085|NCT05267470|469745462|FG002|Overall Study|Withdrawal by Subject|2|||
130485086|NCT05267470|469745463|FG003|Overall Study|Withdrawal by Subject|2|||
130485087|NCT05267470|469745464|FG004|Overall Study|Withdrawal by Subject|0|||
130485088|NCT05267470|469745460|FG000|Overall Study|Death|3|||
130485089|NCT05267470|469745461|FG001|Overall Study|Death|5|||
130485090|NCT05267470|469745462|FG002|Overall Study|Death|8|||
130485091|NCT05267470|469745463|FG003|Overall Study|Death|18|||
130485092|NCT05267470|469745464|FG004|Overall Study|Death|1|||
130485093|NCT05267470|469745460|FG000|Overall Study|Lost to Follow-up|0|||
130485094|NCT05267470|469745461|FG001|Overall Study|Lost to Follow-up|0|||
130485095|NCT05267470|469745462|FG002|Overall Study|Lost to Follow-up|0|||
130485096|NCT05267470|469745463|FG003|Overall Study|Lost to Follow-up|1|||
130485097|NCT05267470|469745464|FG004|Overall Study|Lost to Follow-up|0|||
130485098|NCT03381586|469745465|FG000|Overall Study|Adverse Event|1|||
130485099|NCT03381586|469745466|FG001|Overall Study|Adverse Event|1|||
130485100|NCT03381586|469745465|FG000|Overall Study|Protocol Violation|1|||
130485101|NCT03381586|469745466|FG001|Overall Study|Protocol Violation|0|||
130485102|NCT03381586|469745465|FG000|Overall Study|Withdrawal by Subject|1|||
130485103|NCT03381586|469745466|FG001|Overall Study|Withdrawal by Subject|2|||
130485104|NCT05299723|469746562|FG000|Overall Study|Withdrawal by Subject|0|||
130485105|NCT05299723|469746563|FG001|Overall Study|Withdrawal by Subject|2|||
130485106|NCT05299723|469746564|FG002|Overall Study|Withdrawal by Subject|0|||
130485107|NCT00696111|469746565|FG000|Overall Study|Withdrawal by Subject|17|||
130485108|NCT02593773|469746566|FG000|Overall Study|Voluntary Withdrawal|3|||
130485109|NCT02593773|469746566|FG000|Overall Study|Study Terminated by Sponsor|31|||
130485110|NCT02593773|469746566|FG000|Overall Study|Death|1|||
130485111|NCT05452460|469746568|FG000|Overall Study|Lost to Follow-up|3|||
130485112|NCT05452460|469746569|FG001|Overall Study|Lost to Follow-up|3|||
130485113|NCT05452460|469746568|FG000|Overall Study|Did not receive intervention|1|||
130485114|NCT05452460|469746569|FG001|Overall Study|Did not receive intervention|0|||
130485115|NCT04447040|469746572|FG000|Overall Study|Lost to Follow-up|2|||
130485116|NCT04447040|469746573|FG001|Overall Study|Lost to Follow-up|1|||
130485117|NCT04447040|469746574|FG002|Overall Study|Lost to Follow-up|3|||
130728229|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130728230|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130728231|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130485118|NCT04447040|469746575|FG003|Overall Study|Lost to Follow-up|3|||
130485119|NCT04447040|469746576|FG004|Overall Study|Lost to Follow-up|1|||
130485120|NCT04447040|469746577|FG005|Overall Study|Lost to Follow-up|3|||
130485121|NCT04447040|469746572|FG000|Overall Study|Withdrawal by Subject|0|||
130485122|NCT04447040|469746573|FG001|Overall Study|Withdrawal by Subject|1|||
130485123|NCT04447040|469746574|FG002|Overall Study|Withdrawal by Subject|1|||
130485124|NCT04447040|469746575|FG003|Overall Study|Withdrawal by Subject|1|||
130485125|NCT04447040|469746576|FG004|Overall Study|Withdrawal by Subject|0|||
130485126|NCT04447040|469746577|FG005|Overall Study|Withdrawal by Subject|0|||
130485127|NCT01208662|469746578|FG000|Induction and Consolidation|Disease Progression|23|||
130485128|NCT01208662|469746579|FG001|Induction and Consolidation|Disease Progression|13|||
130485129|NCT01208662|469746580|FG002|Induction and Consolidation|Disease Progression|0|||
130485130|NCT01208662|469746578|FG000|Induction and Consolidation|Adverse Event|16|||
130485131|NCT01208662|469746579|FG001|Induction and Consolidation|Adverse Event|18|||
130485132|NCT01208662|469746580|FG002|Induction and Consolidation|Adverse Event|2|||
130485133|NCT01208662|469746578|FG000|Induction and Consolidation|MD or Participant Decision|16|||
130485134|NCT01208662|469746579|FG001|Induction and Consolidation|MD or Participant Decision|34|||
130485135|NCT01208662|469746580|FG002|Induction and Consolidation|MD or Participant Decision|4|||
130485136|NCT01208662|469746578|FG000|Induction and Consolidation|Death|1|||
130485137|NCT01208662|469746579|FG001|Induction and Consolidation|Death|3|||
130485138|NCT01208662|469746580|FG002|Induction and Consolidation|Death|1|||
130485139|NCT01208662|469746578|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
130485140|NCT01208662|469746579|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
130485141|NCT01208662|469746580|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
130485142|NCT01208662|469746578|FG000|Maintenance|Disease Progression|156|||
130485143|NCT01208662|469746579|FG001|Maintenance|Disease Progression|102|||
130485144|NCT01208662|469746580|FG002|Maintenance|Disease Progression|0|||
130485145|NCT01208662|469746578|FG000|Maintenance|Adverse Event|12|||
130485146|NCT01208662|469746579|FG001|Maintenance|Adverse Event|28|||
130485147|NCT01208662|469746580|FG002|Maintenance|Adverse Event|0|||
130485148|NCT01208662|469746578|FG000|Maintenance|MD or Participant Decision|24|||
130485149|NCT01208662|469746579|FG001|Maintenance|MD or Participant Decision|36|||
130485150|NCT01208662|469746580|FG002|Maintenance|MD or Participant Decision|0|||
130485151|NCT01208662|469746578|FG000|Maintenance|Death|0|||
130485152|NCT01208662|469746579|FG001|Maintenance|Death|3|||
130485153|NCT01208662|469746580|FG002|Maintenance|Death|0|||
130485154|NCT01208662|469746578|FG000|Maintenance|Discontinued for other reasons|21|||
130485155|NCT01208662|469746579|FG001|Maintenance|Discontinued for other reasons|31|||
130485156|NCT01208662|469746580|FG002|Maintenance|Discontinued for other reasons|0|||
130485157|NCT01208662|469746578|FG000|Maintenance|Still on Treatment|78|||
130485158|NCT01208662|469746579|FG001|Maintenance|Still on Treatment|89|||
130485159|NCT01208662|469746580|FG002|Maintenance|Still on Treatment|0|||
130485160|NCT04066205|469746590|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
130485161|NCT04066205|469746591|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
130485162|NCT04066205|469746590|FG000|T2 Immediate Post-Intervention|did not respond|5|||
130485163|NCT04066205|469746591|FG001|T2 Immediate Post-Intervention|did not respond|3|||
130485164|NCT02052882|469746592|FG000|Overall Study|Not treated|11|||
130485165|NCT02052882|469746592|FG000|Overall Study|Protocol Violation|1|||
130485166|NCT02052882|469746592|FG000|Overall Study|Inadequate testing|1|||
130485167|NCT04314778|469746599|FG000|Overall Study|Lost to Follow-up|5|||
130485168|NCT04314778|469746600|FG001|Overall Study|Lost to Follow-up|3|||
130485169|NCT04024020|469746603|FG000|Overall Study|Withdrawal by Subject|2|||
130485170|NCT04024020|469746604|FG001|Overall Study|Withdrawal by Subject|2|||
130485171|NCT05646355|469746605|FG000|Overall Study|Lost to Follow-up|1|||
130485172|NCT05646355|469746606|FG001|Overall Study|Lost to Follow-up|0|||
130485173|NCT05646355|469746605|FG000|Overall Study|translated materials not available for pilot|2|||
130485174|NCT05646355|469746606|FG001|Overall Study|translated materials not available for pilot|0|||
130485175|NCT05646355|469746605|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
130485176|NCT05646355|469746606|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
130485177|NCT04685135|469746607|FG000|Overall Study|Death|126|||
130485178|NCT04685135|469746608|FG001|Overall Study|Death|53|||
130728232|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728233|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728234|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728235|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130485179|NCT04685135|469746607|FG000|Overall Study|Withdrawal by Subject|12|||
130485180|NCT04685135|469746608|FG001|Overall Study|Withdrawal by Subject|16|||
130485181|NCT05216406|469746609|FG000|Overall Study|Lost to Follow-up|8|||
130485182|NCT05216406|469746610|FG001|Overall Study|Lost to Follow-up|9|||
130485183|NCT03711474|469746613|FG000|Overall Study|Physician Decision|2|||
130485184|NCT03711474|469746614|FG001|Overall Study|Physician Decision|0|||
130485185|NCT01236781|469746622|FG000|Overall Study|Ineligible|2|||
130728236|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130485186|NCT01236781|469746623|FG001|Overall Study|Ineligible|1|||
130485187|NCT01236781|469746622|FG000|Overall Study|Did not complete study imaging|5|||
130485188|NCT01236781|469746623|FG001|Overall Study|Did not complete study imaging|0|||
130485189|NCT04059185|469746624|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
130485190|NCT04059185|469746625|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
130485191|NCT04059185|469746626|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
130485192|NCT04059185|469746624|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
130485193|NCT04059185|469746625|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
130485194|NCT04059185|469746626|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
130485195|NCT04059185|469746624|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
130485196|NCT04059185|469746625|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
130485197|NCT04059185|469746626|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
130485198|NCT04059185|469746624|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
130485199|NCT04059185|469746625|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
130485200|NCT04059185|469746626|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
130485201|NCT04059185|469746624|FG000|Longitudinal Assessment-Adults Only|Death|4|||
130485202|NCT04059185|469746625|FG001|Longitudinal Assessment-Adults Only|Death|4|||
130485203|NCT04059185|469746626|FG002|Longitudinal Assessment-Adults Only|Death|3|||
130485204|NCT03756662|469746627|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
130485205|NCT04587453|469746628|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
130485206|NCT04587453|469746629|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
130485219|NCT04032847|469746646|FG000|Overall Study|Study termination by sponsor|8|||
130485220|NCT04032847|469746647|FG001|Overall Study|Study termination by sponsor|0|||
130485221|NCT04032847|469746648|FG002|Overall Study|Study termination by sponsor|4|||
130485222|NCT04032847|469746646|FG000|Overall Study|Death|12|||
130485223|NCT04032847|469746647|FG001|Overall Study|Death|0|||
130485224|NCT04032847|469746648|FG002|Overall Study|Death|0|||
130485225|NCT04032847|469746646|FG000|Overall Study|Progressive disease|2|||
130485226|NCT04032847|469746647|FG001|Overall Study|Progressive disease|0|||
130485227|NCT04032847|469746648|FG002|Overall Study|Progressive disease|1|||
130485228|NCT03213665|469746649|FG000|Overall Study|Adverse Event|1|||
130485229|NCT03213665|469746649|FG000|Overall Study|Physician Decision|2|||
130485230|NCT03213665|469746649|FG000|Overall Study|Withdrawal by Subject|3|||
130485231|NCT03213665|469746649|FG000|Overall Study|Progressive Disease|13|||
130485232|NCT03056573|469746650|FG000|Overall Study|Death|2|||
130485233|NCT03056573|469746651|FG001|Overall Study|Death|4|||
130485234|NCT03056573|469746650|FG000|Overall Study|Withdrawal by Subject|2|||
130485235|NCT03056573|469746651|FG001|Overall Study|Withdrawal by Subject|0|||
130485236|NCT03056573|469746650|FG000|Overall Study|Lost to Follow-up|1|||
130485237|NCT03056573|469746651|FG001|Overall Study|Lost to Follow-up|1|||
130485238|NCT02684227|469746653|FG000|Overall Study|Adverse Event|1|||
130485239|NCT02684227|469746654|FG001|Overall Study|Adverse Event|7|||
130485240|NCT02684227|469746653|FG000|Overall Study|Death|0|||
130485241|NCT02684227|469746654|FG001|Overall Study|Death|2|||
130485242|NCT02684227|469746653|FG000|Overall Study|Withdrawal by Subject|0|||
130485243|NCT02684227|469746654|FG001|Overall Study|Withdrawal by Subject|1|||
130485244|NCT02684227|469746653|FG000|Overall Study|Progressive Disease|0|||
130485245|NCT02684227|469746654|FG001|Overall Study|Progressive Disease|2|||
130485246|NCT03606408|469746655|FG000|Overall Study|Adverse Event|13|||
130485247|NCT03606408|469746655|FG000|Overall Study|Withdrawal by Subject|7|||
130485248|NCT03606408|469746655|FG000|Overall Study|Physician Decision|4|||
130485249|NCT03606408|469746655|FG000|Overall Study|Lack of Efficacy|2|||
130485250|NCT03606408|469746655|FG000|Overall Study|Death|1|||
130485251|NCT03606408|469746655|FG000|Overall Study|new therapy for study indication|1|||
130485252|NCT05828017|469746658|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
130485253|NCT02852655|469746659|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
130485254|NCT02852655|469746660|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
130485255|NCT02852655|469746661|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
130485256|NCT02852655|469746659|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
130485257|NCT02852655|469746660|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
130485258|NCT02852655|469746661|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
130485259|NCT02852655|469746659|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
130485260|NCT02852655|469746660|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
130485261|NCT02852655|469746661|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
130485262|NCT02852655|469746659|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
130485263|NCT02852655|469746660|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
130485264|NCT02852655|469746661|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
130485265|NCT02852655|469746659|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
130485266|NCT02852655|469746660|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
130485267|NCT02852655|469746661|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
130485268|NCT02852655|469746659|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
130485269|NCT02852655|469746660|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
130485270|NCT02852655|469746661|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
130485271|NCT02852655|469746659|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
130485272|NCT02852655|469746660|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
130485273|NCT02852655|469746661|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
130485274|NCT02852655|469746659|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
130485275|NCT02852655|469746660|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
130485276|NCT02852655|469746661|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
130485277|NCT02852655|469746659|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
130485278|NCT02852655|469746660|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
130485279|NCT02852655|469746661|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
130485280|NCT04230681|469746662|FG000|Overall Study|Physician Decision|2|||
130485281|NCT04230681|469746663|FG001|Overall Study|Physician Decision|3|||
130485282|NCT04230681|469746662|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
130485283|NCT04230681|469746663|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
130485284|NCT04230681|469746662|FG000|Overall Study|IV inadvertently removed|0|||
130485285|NCT04230681|469746663|FG001|Overall Study|IV inadvertently removed|1|||
130565096|NCT02687542|470035389|FG002|Overall Study|Lost to Follow-up|0|||
130565097|NCT02687542|470035390|FG003|Overall Study|Lost to Follow-up|0|||
130565098|NCT02687542|470035391|FG004|Overall Study|Lost to Follow-up|1|||
130565099|NCT02687542|470035387|FG000|Overall Study|Protocol Violation|0|||
130565100|NCT02687542|470035388|FG001|Overall Study|Protocol Violation|1|||
130565101|NCT02687542|470035389|FG002|Overall Study|Protocol Violation|0|||
130565102|NCT02687542|470035390|FG003|Overall Study|Protocol Violation|0|||
130565103|NCT02687542|470035391|FG004|Overall Study|Protocol Violation|0|||
130565104|NCT02687542|470035387|FG000|Overall Study|Other|5|||
130565105|NCT02687542|470035388|FG001|Overall Study|Other|9|||
130565106|NCT02687542|470035389|FG002|Overall Study|Other|10|||
130565107|NCT02687542|470035390|FG003|Overall Study|Other|6|||
130565108|NCT02687542|470035391|FG004|Overall Study|Other|5|||
130565109|NCT02687542|470035387|FG000|Overall Study|Adverse Event|3|||
130565110|NCT02687542|470035388|FG001|Overall Study|Adverse Event|1|||
130565111|NCT02687542|470035389|FG002|Overall Study|Adverse Event|3|||
130565112|NCT02687542|470035390|FG003|Overall Study|Adverse Event|2|||
130565113|NCT02687542|470035391|FG004|Overall Study|Adverse Event|9|||
130565114|NCT02687542|470035387|FG000|Overall Study|Withdrawal by Subject|0|||
130565115|NCT02687542|470035388|FG001|Overall Study|Withdrawal by Subject|1|||
130565116|NCT02687542|470035389|FG002|Overall Study|Withdrawal by Subject|1|||
130565117|NCT02687542|470035390|FG003|Overall Study|Withdrawal by Subject|2|||
130565118|NCT02687542|470035391|FG004|Overall Study|Withdrawal by Subject|4|||
130565119|NCT00636675|470035394|FG000|Overall Study|Lost to Follow-up|121|||
130565120|NCT00636675|470035395|FG001|Overall Study|Lost to Follow-up|31|||
130565121|NCT00636675|470035394|FG000|Overall Study|Withdrawal by Subject|19|||
130565122|NCT00636675|470035395|FG001|Overall Study|Withdrawal by Subject|10|||
130565123|NCT00096785|470035396|FG000|Overall Study|Lost to Follow-up|1|||
130565124|NCT00096785|470035397|FG001|Overall Study|Lost to Follow-up|0|||
130565125|NCT00096785|470035396|FG000|Overall Study|Withdrawal by Subject|0|||
130565126|NCT00096785|470035397|FG001|Overall Study|Withdrawal by Subject|1|||
130565127|NCT00096785|470035396|FG000|Overall Study|Relocated|1|||
130565128|NCT00096785|470035397|FG001|Overall Study|Relocated|0|||
130565129|NCT04053868|470035398|FG000|Overall Study|Withdrawal by Subject|1|||
130565130|NCT04053868|470035399|FG001|Overall Study|Withdrawal by Subject|0|||
130565131|NCT01838616|470035400|FG000|Titration Period|Adverse Event|18|||
130565132|NCT01838616|470035401|FG001|Titration Period|Adverse Event|48|||
130565133|NCT01838616|470035400|FG000|Titration Period|Lack of Efficacy|5|||
130565134|NCT01838616|470035401|FG001|Titration Period|Lack of Efficacy|12|||
130565135|NCT01838616|470035400|FG000|Titration Period|Withdrawal by Subject|5|||
130565136|NCT01838616|470035401|FG001|Titration Period|Withdrawal by Subject|5|||
130565137|NCT01838616|470035400|FG000|Titration Period|Technical problems|1|||
130565138|NCT01838616|470035401|FG001|Titration Period|Technical problems|0|||
130565139|NCT01838616|470035400|FG000|Titration Period|Other|1|||
130565140|NCT01838616|470035401|FG001|Titration Period|Other|0|||
130565141|NCT01838616|470035400|FG000|Titration Period|Protocol Violation|0|||
130565142|NCT01838616|470035401|FG001|Titration Period|Protocol Violation|1|||
130565143|NCT01838616|470035400|FG000|Continuation Period|Lack of Efficacy|3|||
130565144|NCT01838616|470035401|FG001|Continuation Period|Lack of Efficacy|5|||
130565145|NCT01838616|470035400|FG000|Continuation Period|Adverse Event|8|||
130565146|NCT01838616|470035401|FG001|Continuation Period|Adverse Event|4|||
130565147|NCT01838616|470035400|FG000|Continuation Period|Protocol Violation|2|||
130485286|NCT05645757|469749272|FG000|Overall Study|Enrolled but treatment not administered|0|||
130485287|NCT05645757|469749273|FG001|Overall Study|Enrolled but treatment not administered|0|||
130485288|NCT05645757|469749274|FG002|Overall Study|Enrolled but treatment not administered|0|||
130485289|NCT05645757|469749275|FG003|Overall Study|Enrolled but treatment not administered|0|||
130485290|NCT05645757|469749276|FG004|Overall Study|Enrolled but treatment not administered|1|||
130485291|NCT05645757|469749277|FG005|Overall Study|Enrolled but treatment not administered|1|||
130485292|NCT05645757|469749278|FG006|Overall Study|Enrolled but treatment not administered|0|||
130485293|NCT05645757|469749279|FG007|Overall Study|Enrolled but treatment not administered|0|||
130485294|NCT03924635|469749280|FG000|Overall Study|Withdrawal by Subject|2|||
130485295|NCT03924635|469749281|FG001|Overall Study|Withdrawal by Subject|4|||
130485296|NCT00539591|469749282|FG000|Overall Study|Toxicity|3|||
130485297|NCT00539591|469749283|FG001|Overall Study|Toxicity|0|||
130485298|NCT00539591|469749284|FG002|Overall Study|Toxicity|0|||
130485299|NCT00539591|469749282|FG000|Overall Study|Disease progression|2|||
130485300|NCT00539591|469749283|FG001|Overall Study|Disease progression|2|||
130485301|NCT00539591|469749284|FG002|Overall Study|Disease progression|3|||
130485302|NCT02038777|469749287|FG000|Overall Study|Death|0|||
130485303|NCT02038777|469749288|FG001|Overall Study|Death|2|||
130485304|NCT02038777|469749289|FG002|Overall Study|Death|0|||
130485305|NCT02038777|469749290|FG003|Overall Study|Death|1|||
130485306|NCT02038777|469749291|FG004|Overall Study|Death|2|||
130485307|NCT02038777|469749292|FG005|Overall Study|Death|4|||
130485308|NCT02038777|469749293|FG006|Overall Study|Death|0|||
130485309|NCT02038777|469749294|FG007|Overall Study|Death|11|||
130485310|NCT02038777|469749287|FG000|Overall Study|Lost to Follow-up|0|||
130485311|NCT02038777|469749288|FG001|Overall Study|Lost to Follow-up|0|||
130485312|NCT02038777|469749289|FG002|Overall Study|Lost to Follow-up|0|||
130485313|NCT02038777|469749290|FG003|Overall Study|Lost to Follow-up|1|||
130485314|NCT02038777|469749291|FG004|Overall Study|Lost to Follow-up|0|||
130485315|NCT02038777|469749292|FG005|Overall Study|Lost to Follow-up|0|||
130485316|NCT02038777|469749293|FG006|Overall Study|Lost to Follow-up|0|||
130485317|NCT02038777|469749294|FG007|Overall Study|Lost to Follow-up|0|||
130485318|NCT02038777|469749287|FG000|Overall Study|Other|0|||
130485319|NCT02038777|469749288|FG001|Overall Study|Other|1|||
130485320|NCT02038777|469749289|FG002|Overall Study|Other|0|||
130485321|NCT02038777|469749290|FG003|Overall Study|Other|2|||
130485322|NCT02038777|469749291|FG004|Overall Study|Other|1|||
130485323|NCT02038777|469749292|FG005|Overall Study|Other|0|||
130485324|NCT02038777|469749293|FG006|Overall Study|Other|0|||
130485325|NCT02038777|469749294|FG007|Overall Study|Other|0|||
130485326|NCT02038777|469749287|FG000|Overall Study|Randomized but not treated|0|||
130485327|NCT02038777|469749288|FG001|Overall Study|Randomized but not treated|1|||
130485328|NCT02038777|469749289|FG002|Overall Study|Randomized but not treated|0|||
130485329|NCT02038777|469749290|FG003|Overall Study|Randomized but not treated|0|||
130485330|NCT02038777|469749291|FG004|Overall Study|Randomized but not treated|0|||
130485331|NCT02038777|469749292|FG005|Overall Study|Randomized but not treated|0|||
130485332|NCT02038777|469749293|FG006|Overall Study|Randomized but not treated|0|||
130485333|NCT02038777|469749294|FG007|Overall Study|Randomized but not treated|0|||
130485334|NCT02038777|469749287|FG000|Overall Study|Started Chemotherapy|1|||
130485335|NCT02038777|469749288|FG001|Overall Study|Started Chemotherapy|0|||
130485336|NCT02038777|469749289|FG002|Overall Study|Started Chemotherapy|3|||
130485337|NCT02038777|469749290|FG003|Overall Study|Started Chemotherapy|0|||
130485338|NCT02038777|469749291|FG004|Overall Study|Started Chemotherapy|0|||
130485339|NCT02038777|469749292|FG005|Overall Study|Started Chemotherapy|0|||
130485340|NCT02038777|469749293|FG006|Overall Study|Started Chemotherapy|0|||
130485341|NCT02038777|469749294|FG007|Overall Study|Started Chemotherapy|0|||
130485342|NCT02038777|469749287|FG000|Overall Study|participation terminated by sponsor|0|||
130485343|NCT02038777|469749288|FG001|Overall Study|participation terminated by sponsor|0|||
130485344|NCT02038777|469749289|FG002|Overall Study|participation terminated by sponsor|0|||
130485345|NCT02038777|469749290|FG003|Overall Study|participation terminated by sponsor|0|||
130485346|NCT02038777|469749291|FG004|Overall Study|participation terminated by sponsor|0|||
130485347|NCT02038777|469749292|FG005|Overall Study|participation terminated by sponsor|0|||
130485348|NCT02038777|469749293|FG006|Overall Study|participation terminated by sponsor|1|||
130485349|NCT02038777|469749294|FG007|Overall Study|participation terminated by sponsor|1|||
130485350|NCT04299464|469749295|FG000|Overall Study|Adverse Event|1|||
130485351|NCT04299464|469749296|FG001|Overall Study|Adverse Event|0|||
130485352|NCT04299464|469749297|FG002|Overall Study|Adverse Event|2|||
130485353|NCT04299464|469749295|FG000|Overall Study|Non-compliance with Study Drug|1|||
130485354|NCT04299464|469749296|FG001|Overall Study|Non-compliance with Study Drug|0|||
130485355|NCT04299464|469749297|FG002|Overall Study|Non-compliance with Study Drug|0|||
130485356|NCT04299464|469749295|FG000|Overall Study|Reason not Specified|0|||
130485357|NCT04299464|469749296|FG001|Overall Study|Reason not Specified|1|||
130485358|NCT04299464|469749297|FG002|Overall Study|Reason not Specified|3|||
130485359|NCT04299464|469749295|FG000|Overall Study|Physician Decision|0|||
130485360|NCT04299464|469749296|FG001|Overall Study|Physician Decision|1|||
130485361|NCT04299464|469749297|FG002|Overall Study|Physician Decision|1|||
130485362|NCT04299464|469749295|FG000|Overall Study|Withdrawal by Subject|0|||
130485363|NCT04299464|469749296|FG001|Overall Study|Withdrawal by Subject|2|||
130485364|NCT04299464|469749297|FG002|Overall Study|Withdrawal by Subject|1|||
130728237|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130728238|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728239|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130728240|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728241|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728242|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130485365|NCT03676192|469749298|FG000|Induction Study Period|Adverse Event|21|||
130485366|NCT03676192|469749299|FG001|Induction Study Period|Adverse Event|20|||
130485367|NCT03676192|469749298|FG000|Induction Study Period|Death|23|||
130485368|NCT03676192|469749299|FG001|Induction Study Period|Death|20|||
130485369|NCT03676192|469749298|FG000|Induction Study Period|Lost to Follow-up|3|||
130485370|NCT03676192|469749299|FG001|Induction Study Period|Lost to Follow-up|3|||
130485371|NCT03676192|469749298|FG000|Induction Study Period|Physician Decision|6|||
130485372|NCT03676192|469749299|FG001|Induction Study Period|Physician Decision|3|||
130485373|NCT03676192|469749298|FG000|Induction Study Period|Progressive Disease|32|||
130485374|NCT03676192|469749299|FG001|Induction Study Period|Progressive Disease|21|||
130485375|NCT03676192|469749298|FG000|Induction Study Period|Protocol Violation|1|||
130485376|NCT03676192|469749299|FG001|Induction Study Period|Protocol Violation|2|||
130485377|NCT03676192|469749298|FG000|Induction Study Period|Withdrawal by Subject|20|||
130485378|NCT03676192|469749299|FG001|Induction Study Period|Withdrawal by Subject|15|||
130485379|NCT04079218|469749300|FG000|Overall Study|Death|1|||
130485380|NCT04079218|469749301|FG001|Overall Study|Death|0|||
130485381|NCT04079218|469749300|FG000|Overall Study|Withdrawal by Subject|3|||
130485382|NCT04079218|469749301|FG001|Overall Study|Withdrawal by Subject|0|||
130485383|NCT04079218|469749300|FG000|Overall Study|Physician Decision|4|||
130485384|NCT04079218|469749301|FG001|Overall Study|Physician Decision|0|||
130485385|NCT04079218|469749300|FG000|Overall Study|Lost to Follow-up|0|||
130485386|NCT04079218|469749301|FG001|Overall Study|Lost to Follow-up|1|||
130485387|NCT02694822|469749304|FG000|Phase 1|Death|2|||
130485388|NCT02694822|469749305|FG001|Phase 1|Death|1|||
130485389|NCT02694822|469749306|FG002|Phase 1|Death|6|||
130485390|NCT02694822|469749307|FG003|Phase 1|Death|6|||
130485391|NCT02694822|469749308|FG004|Phase 1|Death|3|||
130485392|NCT02694822|469749309|FG005|Phase 1|Death|0|||
130485393|NCT02694822|469749304|FG000|Phase 1|Withdrawal by Subject|2|||
130485394|NCT02694822|469749305|FG001|Phase 1|Withdrawal by Subject|2|||
130485395|NCT02694822|469749306|FG002|Phase 1|Withdrawal by Subject|4|||
130485396|NCT02694822|469749307|FG003|Phase 1|Withdrawal by Subject|8|||
130485397|NCT02694822|469749308|FG004|Phase 1|Withdrawal by Subject|1|||
130485398|NCT02694822|469749309|FG005|Phase 1|Withdrawal by Subject|0|||
130485399|NCT02694822|469749304|FG000|Phase 2|Death|0|||
130485400|NCT02694822|469749305|FG001|Phase 2|Death|0|||
130485401|NCT02694822|469749306|FG002|Phase 2|Death|0|||
130485402|NCT02694822|469749307|FG003|Phase 2|Death|0|||
130485403|NCT02694822|469749308|FG004|Phase 2|Death|0|||
130485404|NCT02694822|469749309|FG005|Phase 2|Death|26|||
130485405|NCT02694822|469749304|FG000|Phase 2|Withdrawal by Subject|0|||
130485406|NCT02694822|469749305|FG001|Phase 2|Withdrawal by Subject|0|||
130485407|NCT02694822|469749306|FG002|Phase 2|Withdrawal by Subject|0|||
130485408|NCT02694822|469749307|FG003|Phase 2|Withdrawal by Subject|0|||
130485409|NCT02694822|469749308|FG004|Phase 2|Withdrawal by Subject|0|||
130485410|NCT02694822|469749309|FG005|Phase 2|Withdrawal by Subject|13|||
130485411|NCT02694822|469749304|FG000|Phase 2|Administrative Study Closure|0|||
130485412|NCT02694822|469749305|FG001|Phase 2|Administrative Study Closure|0|||
130485413|NCT02694822|469749306|FG002|Phase 2|Administrative Study Closure|0|||
130485414|NCT02694822|469749307|FG003|Phase 2|Administrative Study Closure|0|||
130485415|NCT02694822|469749308|FG004|Phase 2|Administrative Study Closure|0|||
130485416|NCT02694822|469749309|FG005|Phase 2|Administrative Study Closure|2|||
130485417|NCT02694822|469749304|FG000|Phase 2|Lost to Follow-up|0|||
130485418|NCT02694822|469749305|FG001|Phase 2|Lost to Follow-up|0|||
130485419|NCT02694822|469749306|FG002|Phase 2|Lost to Follow-up|0|||
130485420|NCT02694822|469749307|FG003|Phase 2|Lost to Follow-up|0|||
130485421|NCT02694822|469749308|FG004|Phase 2|Lost to Follow-up|0|||
130485422|NCT02694822|469749309|FG005|Phase 2|Lost to Follow-up|1|||
130485423|NCT02694822|469749304|FG000|Phase 2|Participant Transferred to Another Site|0|||
130485424|NCT02694822|469749305|FG001|Phase 2|Participant Transferred to Another Site|0|||
130485425|NCT02694822|469749306|FG002|Phase 2|Participant Transferred to Another Site|0|||
130485426|NCT02694822|469749307|FG003|Phase 2|Participant Transferred to Another Site|0|||
130485427|NCT02694822|469749308|FG004|Phase 2|Participant Transferred to Another Site|0|||
130485428|NCT02694822|469749309|FG005|Phase 2|Participant Transferred to Another Site|1|||
130485429|NCT02424617|469749312|FG000|Overall Study|Adverse Event|0|||
130565148|NCT01838616|470035401|FG001|Continuation Period|Protocol Violation|0|||
130485430|NCT02424617|469749313|FG001|Overall Study|Adverse Event|1|||
130485431|NCT02424617|469749314|FG002|Overall Study|Adverse Event|0|||
130485432|NCT02424617|469749315|FG003|Overall Study|Adverse Event|0|||
130485433|NCT02424617|469749312|FG000|Overall Study|Investigator Decision|0|||
130728243|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130485434|NCT02424617|469749313|FG001|Overall Study|Investigator Decision|0|||
130485435|NCT02424617|469749314|FG002|Overall Study|Investigator Decision|0|||
130485436|NCT02424617|469749315|FG003|Overall Study|Investigator Decision|1|||
130485437|NCT02424617|469749312|FG000|Overall Study|Withdrawal by Subject|1|||
130485438|NCT02424617|469749313|FG001|Overall Study|Withdrawal by Subject|1|||
130485439|NCT02424617|469749314|FG002|Overall Study|Withdrawal by Subject|0|||
130485440|NCT02424617|469749315|FG003|Overall Study|Withdrawal by Subject|1|||
130485441|NCT02424617|469749312|FG000|Overall Study|Progressive Disease|7|||
130485442|NCT02424617|469749313|FG001|Overall Study|Progressive Disease|6|||
130485443|NCT02424617|469749314|FG002|Overall Study|Progressive Disease|11|||
130485444|NCT02424617|469749315|FG003|Overall Study|Progressive Disease|10|||
130485445|NCT02424617|469749312|FG000|Overall Study|Other|0|||
130485446|NCT02424617|469749313|FG001|Overall Study|Other|0|||
130485447|NCT02424617|469749314|FG002|Overall Study|Other|0|||
130485448|NCT02424617|469749315|FG003|Overall Study|Other|1|||
130485449|NCT01868997|469749316|FG000|Overall Study|Adverse Event|2|||
130485450|NCT01868997|469749317|FG001|Overall Study|Adverse Event|5|||
130485451|NCT01868997|469749316|FG000|Overall Study|Lack of Efficacy|2|||
130485452|NCT01868997|469749317|FG001|Overall Study|Lack of Efficacy|0|||
130485453|NCT01868997|469749316|FG000|Overall Study|Other|3|||
130485454|NCT01868997|469749317|FG001|Overall Study|Other|1|||
130485455|NCT01960452|469749318|FG000|Overall Study|Withdrawal by Subject|2|||
130485456|NCT01960452|469749319|FG001|Overall Study|Withdrawal by Subject|1|||
130485457|NCT01960452|469749318|FG000|Overall Study|Sleep apnea in Night 1|1|||
130485458|NCT01960452|469749319|FG001|Overall Study|Sleep apnea in Night 1|0|||
130485459|NCT01960452|469749318|FG000|Overall Study|Poor Sleep in Night 1|0|||
130485460|NCT01960452|469749319|FG001|Overall Study|Poor Sleep in Night 1|2|||
130485461|NCT01960452|469749318|FG000|Overall Study|No Sex/Age Match Night 1|1|||
130485462|NCT01960452|469749319|FG001|Overall Study|No Sex/Age Match Night 1|0|||
130485463|NCT01960452|469749318|FG000|Overall Study|No Sex/Age Match Night 2|0|||
130485464|NCT01960452|469749319|FG001|Overall Study|No Sex/Age Match Night 2|2|||
130485465|NCT01960452|469749318|FG000|Overall Study|Technical Difficulties Night 2|2|||
130485466|NCT01960452|469749319|FG001|Overall Study|Technical Difficulties Night 2|0|||
130485467|NCT03209973|469749325|FG000|Overall Study|Withdrawal by Subject|7|||
130485468|NCT03209973|469749325|FG000|Overall Study|Lost to Follow-up|2|||
130485469|NCT03209973|469749325|FG000|Overall Study|Death|8|||
130485470|NCT03209973|469749325|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
130485471|NCT03209973|469749325|FG000|Overall Study|Sponsor Decision|18|||
130485472|NCT03209973|469749325|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
130485473|NCT03209973|469749325|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
130485474|NCT04766892|469749326|FG000|Overall Study|Withdrawal by Subject|1|||
130485475|NCT04766892|469749326|FG000|Overall Study|Lost to Follow-up|1|||
130485476|NCT04766892|469749326|FG000|Overall Study|Adverse Event|3|||
130485477|NCT04766892|469749326|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
130485478|NCT04778397|469749327|FG000|Overall Study|Death|59|||
130485479|NCT04778397|469749328|FG001|Overall Study|Death|54|||
130485480|NCT04778397|469749329|FG002|Overall Study|Death|11|||
130485481|NCT04778397|469749330|FG003|Overall Study|Death|9|||
130485482|NCT04778397|469749327|FG000|Overall Study|Study Terminated by Sponsor|34|||
130485483|NCT04778397|469749328|FG001|Overall Study|Study Terminated by Sponsor|42|||
130485484|NCT04778397|469749329|FG002|Overall Study|Study Terminated by Sponsor|15|||
130485485|NCT04778397|469749330|FG003|Overall Study|Study Terminated by Sponsor|12|||
130485486|NCT04778397|469749327|FG000|Overall Study|Withdrew Consent|5|||
130485487|NCT04778397|469749328|FG001|Overall Study|Withdrew Consent|4|||
130485488|NCT04778397|469749329|FG002|Overall Study|Withdrew Consent|1|||
130485489|NCT04778397|469749330|FG003|Overall Study|Withdrew Consent|1|||
130485490|NCT04778397|469749327|FG000|Overall Study|Reason Not Specified|1|||
130485491|NCT04778397|469749328|FG001|Overall Study|Reason Not Specified|3|||
130485492|NCT04778397|469749329|FG002|Overall Study|Reason Not Specified|0|||
130485493|NCT04778397|469749330|FG003|Overall Study|Reason Not Specified|2|||
130485494|NCT04778397|469749327|FG000|Overall Study|Lost to Follow-up|2|||
130485495|NCT04778397|469749328|FG001|Overall Study|Lost to Follow-up|1|||
130485496|NCT04778397|469749329|FG002|Overall Study|Lost to Follow-up|0|||
130485497|NCT04778397|469749330|FG003|Overall Study|Lost to Follow-up|1|||
130485498|NCT03249090|469749331|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
130485499|NCT03249090|469749332|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
130485500|NCT03249090|469749331|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
130485501|NCT03249090|469749332|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
130485502|NCT03249090|469749331|FG000|3 Month Time Point|Voluntary withdrawal|6|||
130485503|NCT03249090|469749332|FG001|3 Month Time Point|Voluntary withdrawal|3|||
130485504|NCT03249090|469749331|FG000|3 Month Time Point|Changed oncology practice|4|||
130485505|NCT03249090|469749332|FG001|3 Month Time Point|Changed oncology practice|2|||
130485506|NCT03249090|469749331|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
130485507|NCT03249090|469749332|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
130485508|NCT03249090|469749331|FG000|12 Month Time Point|Voluntary withdrawal|35|||
130485509|NCT03249090|469749332|FG001|12 Month Time Point|Voluntary withdrawal|4|||
130485510|NCT03249090|469749331|FG000|12 Month Time Point|Changed oncology practice|20|||
130485511|NCT03249090|469749332|FG001|12 Month Time Point|Changed oncology practice|9|||
130485512|NCT04359654|469749336|FG000|Overall Study|Withdrawal by Subject|1|||
130485513|NCT04359654|469749337|FG001|Overall Study|Withdrawal by Subject|0|||
130485514|NCT04359654|469749336|FG000|Overall Study|Adverse Event|0|||
130485515|NCT04359654|469749337|FG001|Overall Study|Adverse Event|1|||
130485516|NCT03523572|469749338|FG000|Dose Escalation|Progressive disease|1|||
130485517|NCT03523572|469749339|FG001|Dose Escalation|Progressive disease|0|||
130485518|NCT03523572|469749340|FG002|Dose Escalation|Progressive disease|0|||
130485519|NCT03523572|469749341|FG003|Dose Escalation|Progressive disease|0|||
130485520|NCT03523572|469749342|FG004|Dose Escalation|Progressive disease|0|||
130485521|NCT03523572|469749343|FG005|Dose Escalation|Progressive disease|0|||
130485522|NCT03523572|469749338|FG000|Dose Escalation|Clinical Progression|0|||
130485523|NCT03523572|469749339|FG001|Dose Escalation|Clinical Progression|1|||
130485524|NCT03523572|469749340|FG002|Dose Escalation|Clinical Progression|0|||
130485525|NCT03523572|469749341|FG003|Dose Escalation|Clinical Progression|0|||
130485526|NCT03523572|469749342|FG004|Dose Escalation|Clinical Progression|0|||
130485527|NCT03523572|469749343|FG005|Dose Escalation|Clinical Progression|0|||
130485528|NCT03523572|469749338|FG000|Dose Escalation|Adverse Event|2|||
130485529|NCT03523572|469749339|FG001|Dose Escalation|Adverse Event|0|||
130485530|NCT03523572|469749340|FG002|Dose Escalation|Adverse Event|0|||
130485531|NCT03523572|469749341|FG003|Dose Escalation|Adverse Event|0|||
130485532|NCT03523572|469749342|FG004|Dose Escalation|Adverse Event|0|||
130485533|NCT03523572|469749343|FG005|Dose Escalation|Adverse Event|0|||
130485534|NCT03523572|469749338|FG000|Dose Escalation|Physician Decision|1|||
130485535|NCT03523572|469749339|FG001|Dose Escalation|Physician Decision|1|||
130485536|NCT03523572|469749340|FG002|Dose Escalation|Physician Decision|0|||
130485537|NCT03523572|469749341|FG003|Dose Escalation|Physician Decision|0|||
130485538|NCT03523572|469749342|FG004|Dose Escalation|Physician Decision|0|||
130485539|NCT03523572|469749343|FG005|Dose Escalation|Physician Decision|0|||
130485540|NCT03523572|469749338|FG000|Dose Expansion|Progressive Disease|0|||
130485541|NCT03523572|469749339|FG001|Dose Expansion|Progressive Disease|0|||
130485542|NCT03523572|469749340|FG002|Dose Expansion|Progressive Disease|9|||
130485543|NCT03523572|469749341|FG003|Dose Expansion|Progressive Disease|11|||
130485544|NCT03523572|469749342|FG004|Dose Expansion|Progressive Disease|15|||
130485545|NCT03523572|469749343|FG005|Dose Expansion|Progressive Disease|2|||
130485546|NCT03523572|469749338|FG000|Dose Expansion|Clinical Progression|0|||
130485547|NCT03523572|469749339|FG001|Dose Expansion|Clinical Progression|0|||
130485548|NCT03523572|469749340|FG002|Dose Expansion|Clinical Progression|2|||
130565149|NCT01838616|470035400|FG000|Continuation Period|Lost to Follow-up|1|||
130565150|NCT01838616|470035401|FG001|Continuation Period|Lost to Follow-up|0|||
130565151|NCT01838616|470035400|FG000|Continuation Period|Withdrawal by Subject|0|||
130565152|NCT01838616|470035401|FG001|Continuation Period|Withdrawal by Subject|4|||
130565153|NCT01838616|470035400|FG000|Continuation Period|Technical problems|0|||
130565154|NCT01838616|470035401|FG001|Continuation Period|Technical problems|1|||
130565155|NCT01838616|470035400|FG000|Pick-up Arm|Lack of Efficacy|4|||
130565156|NCT01838616|470035401|FG001|Pick-up Arm|Lack of Efficacy|0|||
130565157|NCT01838616|470035400|FG000|Pick-up Arm|Adverse Event|9|||
130565158|NCT01838616|470035401|FG001|Pick-up Arm|Adverse Event|0|||
130565159|NCT01838616|470035400|FG000|Pick-up Arm|Withdrawal by Subject|1|||
130565160|NCT01838616|470035401|FG001|Pick-up Arm|Withdrawal by Subject|0|||
130565161|NCT01838616|470035400|FG000|Pick-up Arm|Technical problems|1|||
130565162|NCT01838616|470035401|FG001|Pick-up Arm|Technical problems|0|||
130565163|NCT01566773|470035404|FG000|Overall Study|Protocol specified criteria|4|||
130565164|NCT01566773|470035404|FG000|Overall Study|Protocol Violation|4|||
130565165|NCT01566773|470035404|FG000|Overall Study|Withdrawal by Subject|9|||
130565166|NCT01566773|470035404|FG000|Overall Study|Administrative reason|1|||
130565167|NCT01566773|470035404|FG000|Overall Study|Adverse Event|10|||
130565168|NCT01566773|470035404|FG000|Overall Study|Physician Decision|2|||
130565169|NCT00833053|470035405|FG000|Overall Study|Adverse Event|4|||
130565170|NCT00833053|470035406|FG001|Overall Study|Adverse Event|0|||
130565171|NCT00833053|470035405|FG000|Overall Study|Treatment Failure|3|||
130565172|NCT00833053|470035406|FG001|Overall Study|Treatment Failure|1|||
130565173|NCT00833053|470035405|FG000|Overall Study|Withdrawal by Subject|0|||
130565174|NCT00833053|470035406|FG001|Overall Study|Withdrawal by Subject|1|||
130565175|NCT00833053|470035405|FG000|Overall Study|Protocol Violation|2|||
130485549|NCT03523572|469749341|FG003|Dose Expansion|Clinical Progression|2|||
130485550|NCT03523572|469749342|FG004|Dose Expansion|Clinical Progression|2|||
130485551|NCT03523572|469749343|FG005|Dose Expansion|Clinical Progression|0|||
130485552|NCT03523572|469749338|FG000|Dose Expansion|Adverse Event|0|||
130565176|NCT00833053|470035406|FG001|Overall Study|Protocol Violation|1|||
130565177|NCT02187471|470035409|FG000|Overall Study|Protocol Violation|4|||
130565178|NCT02187471|470035410|FG001|Overall Study|Protocol Violation|5|||
130565179|NCT02187471|470035411|FG002|Overall Study|Protocol Violation|4|||
130485553|NCT03523572|469749339|FG001|Dose Expansion|Adverse Event|0|||
130565180|NCT02187471|470035412|FG003|Overall Study|Protocol Violation|4|||
130565181|NCT02187471|470035409|FG000|Overall Study|Missing|0|||
130565182|NCT02187471|470035410|FG001|Overall Study|Missing|0|||
130485554|NCT03523572|469749340|FG002|Dose Expansion|Adverse Event|10|||
130485555|NCT03523572|469749341|FG003|Dose Expansion|Adverse Event|1|||
130485556|NCT03523572|469749342|FG004|Dose Expansion|Adverse Event|5|||
130485557|NCT03523572|469749343|FG005|Dose Expansion|Adverse Event|2|||
130485558|NCT03523572|469749338|FG000|Dose Expansion|Withdrawal by Subject|0|||
130485559|NCT03523572|469749339|FG001|Dose Expansion|Withdrawal by Subject|0|||
130728244|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130728245|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130728246|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130728247|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130728248|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130728249|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
130485560|NCT03523572|469749340|FG002|Dose Expansion|Withdrawal by Subject|1|||
130485561|NCT03523572|469749341|FG003|Dose Expansion|Withdrawal by Subject|1|||
130485562|NCT03523572|469749342|FG004|Dose Expansion|Withdrawal by Subject|0|||
130485563|NCT03523572|469749343|FG005|Dose Expansion|Withdrawal by Subject|0|||
130485564|NCT03523572|469749338|FG000|Dose Expansion|Physician Decision|0|||
130485565|NCT03523572|469749339|FG001|Dose Expansion|Physician Decision|0|||
130485566|NCT03523572|469749340|FG002|Dose Expansion|Physician Decision|1|||
130485567|NCT03523572|469749341|FG003|Dose Expansion|Physician Decision|0|||
130485568|NCT03523572|469749342|FG004|Dose Expansion|Physician Decision|1|||
130485569|NCT03523572|469749343|FG005|Dose Expansion|Physician Decision|0|||
130485570|NCT03523572|469749338|FG000|Dose Expansion|Miscellaneous|0|||
130485571|NCT03523572|469749339|FG001|Dose Expansion|Miscellaneous|0|||
130485572|NCT03523572|469749340|FG002|Dose Expansion|Miscellaneous|0|||
130485573|NCT03523572|469749341|FG003|Dose Expansion|Miscellaneous|0|||
130485574|NCT03523572|469749342|FG004|Dose Expansion|Miscellaneous|3|||
130485575|NCT03523572|469749343|FG005|Dose Expansion|Miscellaneous|0|||
130485576|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
130485577|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
130485578|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
130485579|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
130485580|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
130485581|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
130485582|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
130485583|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
130485584|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
130485585|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
130485586|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
130485587|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
130485588|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130485589|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
130485590|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130485591|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130485592|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485593|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485594|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485595|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485596|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485597|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
130565183|NCT02187471|470035411|FG002|Overall Study|Missing|0|||
130565184|NCT02187471|470035412|FG003|Overall Study|Missing|1|||
130565185|NCT02187471|470035409|FG000|Overall Study|Lack of Efficacy|18|||
130565186|NCT02187471|470035410|FG001|Overall Study|Lack of Efficacy|9|||
130565187|NCT02187471|470035411|FG002|Overall Study|Lack of Efficacy|13|||
130565188|NCT02187471|470035412|FG003|Overall Study|Lack of Efficacy|11|||
130565189|NCT02187471|470035409|FG000|Overall Study|Adverse Event|24|||
130565190|NCT02187471|470035410|FG001|Overall Study|Adverse Event|34|||
130565191|NCT02187471|470035411|FG002|Overall Study|Adverse Event|44|||
130565192|NCT02187471|470035412|FG003|Overall Study|Adverse Event|36|||
130565193|NCT02187471|470035409|FG000|Overall Study|Withdrawal by Subject|23|||
130565194|NCT02187471|470035410|FG001|Overall Study|Withdrawal by Subject|29|||
130565195|NCT02187471|470035411|FG002|Overall Study|Withdrawal by Subject|22|||
130565196|NCT02187471|470035412|FG003|Overall Study|Withdrawal by Subject|24|||
130565197|NCT02187471|470035409|FG000|Overall Study|Other|7|||
130565198|NCT02187471|470035410|FG001|Overall Study|Other|5|||
130565199|NCT02187471|470035411|FG002|Overall Study|Other|3|||
130565200|NCT02187471|470035412|FG003|Overall Study|Other|4|||
130565201|NCT02236520|470035413|FG000|Overall Study|Physician Decision|0|||
130565202|NCT02236520|470035414|FG001|Overall Study|Physician Decision|5|||
130565203|NCT02236520|470035415|FG002|Overall Study|Physician Decision|0|||
130565204|NCT02236520|470035416|FG003|Overall Study|Physician Decision|0|||
130565205|NCT02236520|470035413|FG000|Overall Study|Withdrawal by Subject|1|||
130728250|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130485598|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
130485599|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
130485600|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485601|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485602|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485603|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485604|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485605|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485606|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
130485607|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
130485608|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
130485609|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
130485610|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
130485611|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
130485612|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
130485613|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
130485614|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
130485615|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
130485616|NCT02315703|469749359|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
130485617|NCT02315703|469749360|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
130485618|NCT02315703|469749361|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
130485619|NCT02315703|469749362|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
130485620|NCT02315703|469749363|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
130485621|NCT02315703|469749364|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
130485622|NCT02315703|469749365|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
130485623|NCT02315703|469749366|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
130485624|NCT02315703|469749359|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
130485625|NCT02315703|469749360|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
130485626|NCT02315703|469749361|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485627|NCT02315703|469749362|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485628|NCT02315703|469749363|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485629|NCT02315703|469749364|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485630|NCT02315703|469749365|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485631|NCT02315703|469749366|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
130485632|NCT02315703|469749359|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485633|NCT02315703|469749360|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
130485634|NCT02315703|469749361|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485635|NCT02315703|469749362|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485636|NCT02315703|469749363|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485637|NCT02315703|469749364|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485638|NCT02315703|469749365|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485639|NCT02315703|469749366|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
130485640|NCT02315703|469749359|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
130485641|NCT02315703|469749360|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
130485642|NCT02315703|469749361|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
130485643|NCT02315703|469749362|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
130485644|NCT02315703|469749363|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
130485645|NCT02315703|469749364|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
130485646|NCT02315703|469749365|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
130485647|NCT02315703|469749366|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
130485648|NCT03519178|469749367|FG000|PF-06873600 Treatment|Adverse Event|0|||
130485649|NCT03519178|469749368|FG001|PF-06873600 Treatment|Adverse Event|0|||
130485650|NCT03519178|469749369|FG002|PF-06873600 Treatment|Adverse Event|0|||
130485651|NCT03519178|469749370|FG003|PF-06873600 Treatment|Adverse Event|0|||
130485652|NCT03519178|469749371|FG004|PF-06873600 Treatment|Adverse Event|0|||
130485653|NCT03519178|469749372|FG005|PF-06873600 Treatment|Adverse Event|0|||
130485654|NCT03519178|469749373|FG006|PF-06873600 Treatment|Adverse Event|0|||
130485655|NCT03519178|469749374|FG007|PF-06873600 Treatment|Adverse Event|2|||
130485656|NCT03519178|469749375|FG008|PF-06873600 Treatment|Adverse Event|1|||
130485657|NCT03519178|469749376|FG009|PF-06873600 Treatment|Adverse Event|0|||
130485658|NCT03519178|469749377|FG010|PF-06873600 Treatment|Adverse Event|0|||
130485659|NCT03519178|469749378|FG011|PF-06873600 Treatment|Adverse Event|0|||
130485660|NCT03519178|469749379|FG012|PF-06873600 Treatment|Adverse Event|1|||
130485661|NCT03519178|469749380|FG013|PF-06873600 Treatment|Adverse Event|3|||
130485662|NCT03519178|469749381|FG014|PF-06873600 Treatment|Adverse Event|2|||
130485663|NCT03519178|469749367|FG000|PF-06873600 Treatment|Death|0|||
130485664|NCT03519178|469749368|FG001|PF-06873600 Treatment|Death|0|||
130485665|NCT03519178|469749369|FG002|PF-06873600 Treatment|Death|0|||
130485666|NCT03519178|469749370|FG003|PF-06873600 Treatment|Death|0|||
130485667|NCT03519178|469749371|FG004|PF-06873600 Treatment|Death|0|||
130728251|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130485668|NCT03519178|469749372|FG005|PF-06873600 Treatment|Death|0|||
130485669|NCT03519178|469749373|FG006|PF-06873600 Treatment|Death|0|||
130485670|NCT03519178|469749374|FG007|PF-06873600 Treatment|Death|0|||
130485671|NCT03519178|469749375|FG008|PF-06873600 Treatment|Death|1|||
130485672|NCT03519178|469749376|FG009|PF-06873600 Treatment|Death|1|||
130485673|NCT03519178|469749377|FG010|PF-06873600 Treatment|Death|0|||
130485674|NCT03519178|469749378|FG011|PF-06873600 Treatment|Death|0|||
130485675|NCT03519178|469749379|FG012|PF-06873600 Treatment|Death|0|||
130485676|NCT03519178|469749380|FG013|PF-06873600 Treatment|Death|0|||
130485677|NCT03519178|469749381|FG014|PF-06873600 Treatment|Death|1|||
130485678|NCT03519178|469749367|FG000|PF-06873600 Treatment|Physician Decision|0|||
130485679|NCT03519178|469749368|FG001|PF-06873600 Treatment|Physician Decision|0|||
130485680|NCT03519178|469749369|FG002|PF-06873600 Treatment|Physician Decision|0|||
130485681|NCT03519178|469749370|FG003|PF-06873600 Treatment|Physician Decision|0|||
130485682|NCT03519178|469749371|FG004|PF-06873600 Treatment|Physician Decision|0|||
130485683|NCT03519178|469749372|FG005|PF-06873600 Treatment|Physician Decision|0|||
130485684|NCT03519178|469749373|FG006|PF-06873600 Treatment|Physician Decision|0|||
130485685|NCT03519178|469749374|FG007|PF-06873600 Treatment|Physician Decision|1|||
130485686|NCT03519178|469749375|FG008|PF-06873600 Treatment|Physician Decision|0|||
130485687|NCT03519178|469749376|FG009|PF-06873600 Treatment|Physician Decision|0|||
130485688|NCT03519178|469749377|FG010|PF-06873600 Treatment|Physician Decision|1|||
130485689|NCT03519178|469749378|FG011|PF-06873600 Treatment|Physician Decision|0|||
130485690|NCT03519178|469749379|FG012|PF-06873600 Treatment|Physician Decision|0|||
130485691|NCT03519178|469749380|FG013|PF-06873600 Treatment|Physician Decision|4|||
130485692|NCT03519178|469749381|FG014|PF-06873600 Treatment|Physician Decision|1|||
130485693|NCT03519178|469749367|FG000|PF-06873600 Treatment|Progressive disease|1|||
130485694|NCT03519178|469749368|FG001|PF-06873600 Treatment|Progressive disease|1|||
130485695|NCT03519178|469749369|FG002|PF-06873600 Treatment|Progressive disease|1|||
130485696|NCT03519178|469749370|FG003|PF-06873600 Treatment|Progressive disease|1|||
130485697|NCT03519178|469749371|FG004|PF-06873600 Treatment|Progressive disease|6|||
130485698|NCT03519178|469749372|FG005|PF-06873600 Treatment|Progressive disease|7|||
130485699|NCT03519178|469749373|FG006|PF-06873600 Treatment|Progressive disease|3|||
130485700|NCT03519178|469749374|FG007|PF-06873600 Treatment|Progressive disease|7|||
130485701|NCT03519178|469749375|FG008|PF-06873600 Treatment|Progressive disease|3|||
130485702|NCT03519178|469749376|FG009|PF-06873600 Treatment|Progressive disease|5|||
130485703|NCT03519178|469749377|FG010|PF-06873600 Treatment|Progressive disease|4|||
130485704|NCT03519178|469749378|FG011|PF-06873600 Treatment|Progressive disease|3|||
130485705|NCT03519178|469749379|FG012|PF-06873600 Treatment|Progressive disease|4|||
130485706|NCT03519178|469749380|FG013|PF-06873600 Treatment|Progressive disease|28|||
130485707|NCT03519178|469749381|FG014|PF-06873600 Treatment|Progressive disease|7|||
130485708|NCT03519178|469749367|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485709|NCT03519178|469749368|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485710|NCT03519178|469749369|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
130485711|NCT03519178|469749370|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485712|NCT03519178|469749371|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
130485713|NCT03519178|469749372|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485714|NCT03519178|469749373|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485715|NCT03519178|469749374|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
130485716|NCT03519178|469749375|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
130485717|NCT03519178|469749376|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
130485718|NCT03519178|469749377|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
130485719|NCT03519178|469749378|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
130485720|NCT03519178|469749379|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
130485721|NCT03519178|469749380|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
130485722|NCT03519178|469749381|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
130485723|NCT03519178|469749367|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
130485724|NCT03519178|469749368|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
130485725|NCT03519178|469749369|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
130485726|NCT03519178|469749370|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
130485727|NCT03519178|469749371|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
130485728|NCT03519178|469749372|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
130485729|NCT03519178|469749373|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
130485730|NCT03519178|469749374|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
130485731|NCT03519178|469749375|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
130485732|NCT03519178|469749376|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
130485733|NCT03519178|469749377|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
130485734|NCT03519178|469749378|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
130485735|NCT03519178|469749379|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
130485736|NCT03519178|469749380|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
130565206|NCT02236520|470035414|FG001|Overall Study|Withdrawal by Subject|0|||
130485737|NCT03519178|469749381|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
130485738|NCT03519178|469749367|FG000|PF-06873600 Treatment|Refused further treatment|0|||
130485739|NCT03519178|469749368|FG001|PF-06873600 Treatment|Refused further treatment|1|||
130485740|NCT03519178|469749369|FG002|PF-06873600 Treatment|Refused further treatment|0|||
130485741|NCT03519178|469749370|FG003|PF-06873600 Treatment|Refused further treatment|0|||
130485742|NCT03519178|469749371|FG004|PF-06873600 Treatment|Refused further treatment|1|||
130485743|NCT03519178|469749372|FG005|PF-06873600 Treatment|Refused further treatment|0|||
130485744|NCT03519178|469749373|FG006|PF-06873600 Treatment|Refused further treatment|0|||
130485745|NCT03519178|469749374|FG007|PF-06873600 Treatment|Refused further treatment|0|||
130485746|NCT03519178|469749375|FG008|PF-06873600 Treatment|Refused further treatment|0|||
130485747|NCT03519178|469749376|FG009|PF-06873600 Treatment|Refused further treatment|0|||
130485748|NCT03519178|469749377|FG010|PF-06873600 Treatment|Refused further treatment|0|||
130485749|NCT03519178|469749378|FG011|PF-06873600 Treatment|Refused further treatment|0|||
130485750|NCT03519178|469749379|FG012|PF-06873600 Treatment|Refused further treatment|0|||
130485751|NCT03519178|469749380|FG013|PF-06873600 Treatment|Refused further treatment|0|||
130485752|NCT03519178|469749381|FG014|PF-06873600 Treatment|Refused further treatment|1|||
130485753|NCT03519178|469749367|FG000|PF-06873600 Treatment|Other|0|||
130485754|NCT03519178|469749368|FG001|PF-06873600 Treatment|Other|0|||
130485755|NCT03519178|469749369|FG002|PF-06873600 Treatment|Other|0|||
130485756|NCT03519178|469749370|FG003|PF-06873600 Treatment|Other|0|||
130485757|NCT03519178|469749371|FG004|PF-06873600 Treatment|Other|0|||
130485758|NCT03519178|469749372|FG005|PF-06873600 Treatment|Other|0|||
130485759|NCT03519178|469749373|FG006|PF-06873600 Treatment|Other|0|||
130485760|NCT03519178|469749374|FG007|PF-06873600 Treatment|Other|0|||
130485761|NCT03519178|469749375|FG008|PF-06873600 Treatment|Other|1|||
130485762|NCT03519178|469749376|FG009|PF-06873600 Treatment|Other|0|||
130485763|NCT03519178|469749377|FG010|PF-06873600 Treatment|Other|0|||
130485764|NCT03519178|469749378|FG011|PF-06873600 Treatment|Other|0|||
130485765|NCT03519178|469749379|FG012|PF-06873600 Treatment|Other|0|||
130485766|NCT03519178|469749380|FG013|PF-06873600 Treatment|Other|1|||
130485767|NCT03519178|469749381|FG014|PF-06873600 Treatment|Other|3|||
130485768|NCT03519178|469749367|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
130485769|NCT03519178|469749368|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
130485770|NCT03519178|469749369|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
130485771|NCT03519178|469749370|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
130485772|NCT03519178|469749371|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
130485773|NCT03519178|469749372|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
130485774|NCT03519178|469749373|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
130485775|NCT03519178|469749374|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
130485776|NCT03519178|469749375|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
130485777|NCT03519178|469749376|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
130485778|NCT03519178|469749377|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
130485779|NCT03519178|469749378|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
130485780|NCT03519178|469749379|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
130485781|NCT03519178|469749380|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
130485782|NCT03519178|469749381|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
130485783|NCT03519178|469749367|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485784|NCT03519178|469749368|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485785|NCT03519178|469749369|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485786|NCT03519178|469749370|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485787|NCT03519178|469749371|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485788|NCT03519178|469749372|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485789|NCT03519178|469749373|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485790|NCT03519178|469749374|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485791|NCT03519178|469749375|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485792|NCT03519178|469749376|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485793|NCT03519178|469749377|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485794|NCT03519178|469749378|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485795|NCT03519178|469749379|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
130485796|NCT03519178|469749380|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
130485797|NCT03519178|469749381|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
130485798|NCT03519178|469749367|FG000|PF-06873600 Treatment|Ongoing|0|||
130485799|NCT03519178|469749368|FG001|PF-06873600 Treatment|Ongoing|0|||
130485800|NCT03519178|469749369|FG002|PF-06873600 Treatment|Ongoing|0|||
130485801|NCT03519178|469749370|FG003|PF-06873600 Treatment|Ongoing|0|||
130485802|NCT03519178|469749371|FG004|PF-06873600 Treatment|Ongoing|0|||
130485803|NCT03519178|469749372|FG005|PF-06873600 Treatment|Ongoing|0|||
130485804|NCT03519178|469749373|FG006|PF-06873600 Treatment|Ongoing|0|||
130485805|NCT03519178|469749374|FG007|PF-06873600 Treatment|Ongoing|0|||
130485806|NCT03519178|469749375|FG008|PF-06873600 Treatment|Ongoing|0|||
130485807|NCT03519178|469749376|FG009|PF-06873600 Treatment|Ongoing|0|||
130485808|NCT03519178|469749377|FG010|PF-06873600 Treatment|Ongoing|0|||
130485809|NCT03519178|469749378|FG011|PF-06873600 Treatment|Ongoing|0|||
130485810|NCT03519178|469749379|FG012|PF-06873600 Treatment|Ongoing|0|||
130485811|NCT03519178|469749380|FG013|PF-06873600 Treatment|Ongoing|1|||
130485812|NCT03519178|469749381|FG014|PF-06873600 Treatment|Ongoing|6|||
130485813|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485814|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485815|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485816|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485817|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485818|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485819|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485820|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485821|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485822|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485823|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485824|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485825|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485826|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
130485827|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
130485828|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Death|0|||
130485829|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Death|0|||
130485830|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Death|0|||
130485831|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Death|0|||
130485832|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Death|0|||
130485833|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Death|0|||
130485834|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Death|0|||
130485835|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Death|0|||
130485836|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Death|0|||
130485837|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Death|1|||
130485838|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Death|0|||
130485839|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Death|0|||
130485840|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Death|0|||
130485841|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Death|0|||
130485842|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Death|1|||
130485843|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485844|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485845|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485846|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485847|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485848|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485849|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485850|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485851|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485852|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485853|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485854|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485855|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485856|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130485857|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
130485858|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130728252|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
130728253|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130728254|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130728255|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130485859|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485860|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485861|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485862|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485863|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485864|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485865|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485866|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485867|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485868|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485869|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485870|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130485871|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
130485872|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
130485873|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130728256|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130485874|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485875|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485876|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485877|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485878|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485879|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485880|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485881|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485882|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
130485883|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485884|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485885|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
130485886|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
130485887|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
130485888|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485889|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485890|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485891|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485892|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485893|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485894|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485895|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485896|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485897|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485898|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485899|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485900|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130485901|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
130485902|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
130485903|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485904|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485905|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485906|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485907|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485908|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485909|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485910|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485911|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485912|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
130485913|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485914|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485915|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
130485916|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
130485917|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
130485918|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485919|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485920|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485921|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485922|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485923|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485924|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485925|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485926|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485927|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
130485928|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485929|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485930|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485931|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
130485932|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
130485933|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485934|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485935|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485936|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485937|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485938|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485939|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485940|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485941|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485942|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485943|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485944|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485945|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485946|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130485947|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
130485948|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Other|0|||
130485949|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Other|0|||
130485950|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Other|0|||
130485951|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Other|0|||
130485952|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Other|0|||
130485953|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Other|0|||
130485954|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Other|0|||
130485955|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Other|0|||
130485956|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Other|0|||
130485957|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Other|0|||
130485958|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Other|0|||
130485959|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Other|0|||
130485960|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Other|0|||
130485961|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Other|1|||
130485962|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Other|3|||
130485963|NCT03519178|469749367|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485964|NCT03519178|469749368|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485965|NCT03519178|469749369|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485966|NCT03519178|469749370|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485967|NCT03519178|469749371|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485968|NCT03519178|469749372|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485969|NCT03519178|469749373|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485970|NCT03519178|469749374|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485971|NCT03519178|469749375|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485972|NCT03519178|469749376|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485973|NCT03519178|469749377|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485974|NCT03519178|469749378|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485975|NCT03519178|469749379|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
130485976|NCT03519178|469749380|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
130485977|NCT03519178|469749381|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
130485978|NCT03519178|469749367|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
130485979|NCT03519178|469749368|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
130485980|NCT03519178|469749369|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
130485981|NCT03519178|469749370|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
130485982|NCT03519178|469749371|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
130485983|NCT03519178|469749372|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
130485984|NCT03519178|469749373|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
130485985|NCT03519178|469749374|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
130485986|NCT03519178|469749375|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
130485987|NCT03519178|469749376|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
130485988|NCT03519178|469749377|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
130485989|NCT03519178|469749378|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
130485990|NCT03519178|469749379|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
130485991|NCT03519178|469749380|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
130485992|NCT03519178|469749381|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
130485993|NCT03519178|469749367|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
130485994|NCT03519178|469749368|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
130485995|NCT03519178|469749369|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
130485996|NCT03519178|469749370|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
130485997|NCT03519178|469749371|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
130485998|NCT03519178|469749372|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
130485999|NCT03519178|469749373|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
130486000|NCT03519178|469749374|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
130486001|NCT03519178|469749375|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
130486002|NCT03519178|469749376|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
130486003|NCT03519178|469749377|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
130486004|NCT03519178|469749378|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
130486005|NCT03519178|469749379|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
130486006|NCT03519178|469749380|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
130486007|NCT03519178|469749381|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
130486008|NCT03519178|469749367|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486009|NCT03519178|469749368|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486010|NCT03519178|469749369|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486011|NCT03519178|469749370|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486012|NCT03519178|469749371|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486013|NCT03519178|469749372|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486014|NCT03519178|469749373|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486015|NCT03519178|469749374|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486016|NCT03519178|469749375|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486017|NCT03519178|469749376|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486018|NCT03519178|469749377|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
130486019|NCT03519178|469749378|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486020|NCT03519178|469749379|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486021|NCT03519178|469749380|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486022|NCT03519178|469749381|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130486023|NCT03519178|469749367|FG000|Follow-Up|Death|0|||
130486024|NCT03519178|469749368|FG001|Follow-Up|Death|0|||
130486025|NCT03519178|469749369|FG002|Follow-Up|Death|1|||
130486026|NCT03519178|469749370|FG003|Follow-Up|Death|0|||
130486027|NCT03519178|469749371|FG004|Follow-Up|Death|0|||
130486028|NCT03519178|469749372|FG005|Follow-Up|Death|0|||
130486029|NCT03519178|469749373|FG006|Follow-Up|Death|0|||
130486030|NCT03519178|469749374|FG007|Follow-Up|Death|0|||
130486031|NCT03519178|469749375|FG008|Follow-Up|Death|3|||
130486032|NCT03519178|469749376|FG009|Follow-Up|Death|1|||
130486033|NCT03519178|469749377|FG010|Follow-Up|Death|0|||
130486034|NCT03519178|469749378|FG011|Follow-Up|Death|0|||
130565207|NCT02236520|470035415|FG002|Overall Study|Withdrawal by Subject|0|||
130486035|NCT03519178|469749379|FG012|Follow-Up|Death|2|||
130486036|NCT03519178|469749380|FG013|Follow-Up|Death|0|||
130486037|NCT03519178|469749381|FG014|Follow-Up|Death|0|||
130486038|NCT03519178|469749367|FG000|Follow-Up|Lost to Follow-up|0|||
130486039|NCT03519178|469749368|FG001|Follow-Up|Lost to Follow-up|0|||
130486040|NCT03519178|469749369|FG002|Follow-Up|Lost to Follow-up|0|||
130486041|NCT03519178|469749370|FG003|Follow-Up|Lost to Follow-up|0|||
130486042|NCT03519178|469749371|FG004|Follow-Up|Lost to Follow-up|0|||
130486043|NCT03519178|469749372|FG005|Follow-Up|Lost to Follow-up|3|||
130486044|NCT03519178|469749373|FG006|Follow-Up|Lost to Follow-up|1|||
130486045|NCT03519178|469749374|FG007|Follow-Up|Lost to Follow-up|4|||
130486046|NCT03519178|469749375|FG008|Follow-Up|Lost to Follow-up|1|||
130486047|NCT03519178|469749376|FG009|Follow-Up|Lost to Follow-up|0|||
130486048|NCT03519178|469749377|FG010|Follow-Up|Lost to Follow-up|0|||
130486049|NCT03519178|469749378|FG011|Follow-Up|Lost to Follow-up|0|||
130486050|NCT03519178|469749379|FG012|Follow-Up|Lost to Follow-up|0|||
130486051|NCT03519178|469749380|FG013|Follow-Up|Lost to Follow-up|0|||
130486052|NCT03519178|469749381|FG014|Follow-Up|Lost to Follow-up|0|||
130486053|NCT03519178|469749367|FG000|Follow-Up|Withdrawal by Subject|1|||
130486054|NCT03519178|469749368|FG001|Follow-Up|Withdrawal by Subject|2|||
130486055|NCT03519178|469749369|FG002|Follow-Up|Withdrawal by Subject|2|||
130486056|NCT03519178|469749370|FG003|Follow-Up|Withdrawal by Subject|3|||
130486057|NCT03519178|469749371|FG004|Follow-Up|Withdrawal by Subject|5|||
130486058|NCT03519178|469749372|FG005|Follow-Up|Withdrawal by Subject|1|||
130486059|NCT03519178|469749373|FG006|Follow-Up|Withdrawal by Subject|2|||
130486060|NCT03519178|469749374|FG007|Follow-Up|Withdrawal by Subject|6|||
130486061|NCT03519178|469749375|FG008|Follow-Up|Withdrawal by Subject|5|||
130565208|NCT02236520|470035416|FG003|Overall Study|Withdrawal by Subject|1|||
130565209|NCT02236520|470035413|FG000|Overall Study|Pregnancy|1|||
130565210|NCT02236520|470035414|FG001|Overall Study|Pregnancy|0|||
130565211|NCT02236520|470035415|FG002|Overall Study|Pregnancy|0|||
130565212|NCT02236520|470035416|FG003|Overall Study|Pregnancy|0|||
130565213|NCT01785160|470035417|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
130565214|NCT01785160|470035417|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
130565215|NCT00957528|470035418|FG000|Overall Study|Protocol Violation|0|||
130565216|NCT00957528|470035419|FG001|Overall Study|Protocol Violation|1|||
130565217|NCT00957528|470035420|FG002|Overall Study|Protocol Violation|0|||
130565218|NCT00957528|470035418|FG000|Overall Study|Withdrawal by Subject|0|||
130565219|NCT00957528|470035419|FG001|Overall Study|Withdrawal by Subject|0|||
130565220|NCT00957528|470035420|FG002|Overall Study|Withdrawal by Subject|1|||
130565221|NCT02081534|470035421|FG000|Overall Study|Adverse Event|5|||
130565222|NCT02081534|470035422|FG001|Overall Study|Adverse Event|4|||
130565223|NCT02081534|470035423|FG002|Overall Study|Adverse Event|3|||
130565224|NCT02081534|470035424|FG003|Overall Study|Adverse Event|10|||
130565225|NCT02081534|470035425|FG004|Overall Study|Adverse Event|2|||
130565226|NCT02081534|470035426|FG005|Overall Study|Adverse Event|8|||
130565227|NCT02081534|470035427|FG006|Overall Study|Adverse Event|2|||
130565228|NCT02081534|470035421|FG000|Overall Study|Withdrawal by Subject|0|||
130565229|NCT02081534|470035422|FG001|Overall Study|Withdrawal by Subject|1|||
130565230|NCT02081534|470035423|FG002|Overall Study|Withdrawal by Subject|1|||
130565231|NCT02081534|470035424|FG003|Overall Study|Withdrawal by Subject|1|||
130565232|NCT02081534|470035425|FG004|Overall Study|Withdrawal by Subject|1|||
130565233|NCT02081534|470035426|FG005|Overall Study|Withdrawal by Subject|0|||
130565234|NCT02081534|470035427|FG006|Overall Study|Withdrawal by Subject|1|||
130565235|NCT02081534|470035421|FG000|Overall Study|Protocol Violation|0|||
130565236|NCT02081534|470035422|FG001|Overall Study|Protocol Violation|3|||
130565237|NCT02081534|470035423|FG002|Overall Study|Protocol Violation|0|||
130565238|NCT02081534|470035424|FG003|Overall Study|Protocol Violation|0|||
130565239|NCT02081534|470035425|FG004|Overall Study|Protocol Violation|0|||
130565240|NCT02081534|470035426|FG005|Overall Study|Protocol Violation|0|||
130565241|NCT02081534|470035427|FG006|Overall Study|Protocol Violation|1|||
130728257|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130728258|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
130728259|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130728260|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130728261|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
130565242|NCT02081534|470035421|FG000|Overall Study|Lost to Follow-up|0|||
130565243|NCT02081534|470035422|FG001|Overall Study|Lost to Follow-up|0|||
130565244|NCT02081534|470035423|FG002|Overall Study|Lost to Follow-up|0|||
130565245|NCT02081534|470035424|FG003|Overall Study|Lost to Follow-up|2|||
130565246|NCT02081534|470035425|FG004|Overall Study|Lost to Follow-up|1|||
130565247|NCT02081534|470035426|FG005|Overall Study|Lost to Follow-up|1|||
130565248|NCT02081534|470035427|FG006|Overall Study|Lost to Follow-up|0|||
130565249|NCT02318667|470035428|FG000|Overall Study|Adverse Event|1|||
130565250|NCT02318667|470035428|FG000|Overall Study|Lack of Efficacy|6|||
130565251|NCT02318667|470035428|FG000|Overall Study|Protocol Violation|2|||
130565252|NCT01033734|470035429|FG000|Overall Study|Withdrawal by Subject|1|||
130565253|NCT02289742|470035431|FG000|First Wear Period|Adverse event prior to treatment|0|||
130565254|NCT02289742|470035432|FG001|First Wear Period|Adverse event prior to treatment|1|||
130565255|NCT02289742|470035433|FG002|First Wear Period|Adverse event prior to treatment|0|||
130565256|NCT02289742|470035434|FG003|First Wear Period|Adverse event prior to treatment|0|||
130486062|NCT03519178|469749376|FG009|Follow-Up|Withdrawal by Subject|2|||
130486063|NCT03519178|469749377|FG010|Follow-Up|Withdrawal by Subject|3|||
130486064|NCT03519178|469749378|FG011|Follow-Up|Withdrawal by Subject|5|||
130486065|NCT03519178|469749379|FG012|Follow-Up|Withdrawal by Subject|2|||
130486066|NCT03519178|469749380|FG013|Follow-Up|Withdrawal by Subject|0|||
130486067|NCT03519178|469749381|FG014|Follow-Up|Withdrawal by Subject|0|||
130486068|NCT03519178|469749367|FG000|Follow-Up|Other|0|||
130486069|NCT03519178|469749368|FG001|Follow-Up|Other|0|||
130486070|NCT03519178|469749369|FG002|Follow-Up|Other|0|||
130486071|NCT03519178|469749370|FG003|Follow-Up|Other|0|||
130728262|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
130486072|NCT03519178|469749371|FG004|Follow-Up|Other|0|||
130486073|NCT03519178|469749372|FG005|Follow-Up|Other|0|||
130486074|NCT03519178|469749373|FG006|Follow-Up|Other|0|||
130486075|NCT03519178|469749374|FG007|Follow-Up|Other|1|||
130486076|NCT03519178|469749375|FG008|Follow-Up|Other|0|||
130486077|NCT03519178|469749376|FG009|Follow-Up|Other|0|||
130486078|NCT03519178|469749377|FG010|Follow-Up|Other|0|||
130486079|NCT03519178|469749378|FG011|Follow-Up|Other|0|||
130486080|NCT03519178|469749379|FG012|Follow-Up|Other|0|||
130486081|NCT03519178|469749380|FG013|Follow-Up|Other|0|||
130486082|NCT03519178|469749381|FG014|Follow-Up|Other|0|||
130486083|NCT03519178|469749367|FG000|Long-term Follow-up|Death|0|||
130486084|NCT03519178|469749368|FG001|Long-term Follow-up|Death|0|||
130486085|NCT03519178|469749369|FG002|Long-term Follow-up|Death|0|||
130486086|NCT03519178|469749370|FG003|Long-term Follow-up|Death|0|||
130486087|NCT03519178|469749371|FG004|Long-term Follow-up|Death|0|||
130486088|NCT03519178|469749372|FG005|Long-term Follow-up|Death|0|||
130486089|NCT03519178|469749373|FG006|Long-term Follow-up|Death|0|||
130486090|NCT03519178|469749374|FG007|Long-term Follow-up|Death|0|||
130486091|NCT03519178|469749375|FG008|Long-term Follow-up|Death|0|||
130486092|NCT03519178|469749376|FG009|Long-term Follow-up|Death|0|||
130486093|NCT03519178|469749377|FG010|Long-term Follow-up|Death|0|||
130486094|NCT03519178|469749378|FG011|Long-term Follow-up|Death|0|||
130486095|NCT03519178|469749379|FG012|Long-term Follow-up|Death|0|||
130486096|NCT03519178|469749380|FG013|Long-term Follow-up|Death|4|||
130486097|NCT03519178|469749381|FG014|Long-term Follow-up|Death|4|||
130486098|NCT03519178|469749367|FG000|Long-term Follow-up|Lost to Follow-up|0|||
130486099|NCT03519178|469749368|FG001|Long-term Follow-up|Lost to Follow-up|0|||
130486100|NCT03519178|469749369|FG002|Long-term Follow-up|Lost to Follow-up|0|||
130486101|NCT03519178|469749370|FG003|Long-term Follow-up|Lost to Follow-up|0|||
130486102|NCT03519178|469749371|FG004|Long-term Follow-up|Lost to Follow-up|0|||
130486103|NCT03519178|469749372|FG005|Long-term Follow-up|Lost to Follow-up|0|||
130486104|NCT03519178|469749373|FG006|Long-term Follow-up|Lost to Follow-up|0|||
130486105|NCT03519178|469749374|FG007|Long-term Follow-up|Lost to Follow-up|0|||
130486106|NCT03519178|469749375|FG008|Long-term Follow-up|Lost to Follow-up|0|||
130486107|NCT03519178|469749376|FG009|Long-term Follow-up|Lost to Follow-up|0|||
130486108|NCT03519178|469749377|FG010|Long-term Follow-up|Lost to Follow-up|0|||
130486109|NCT03519178|469749378|FG011|Long-term Follow-up|Lost to Follow-up|0|||
130486110|NCT03519178|469749379|FG012|Long-term Follow-up|Lost to Follow-up|0|||
130486111|NCT03519178|469749380|FG013|Long-term Follow-up|Lost to Follow-up|1|||
130486112|NCT03519178|469749381|FG014|Long-term Follow-up|Lost to Follow-up|1|||
130486113|NCT03519178|469749367|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
130486114|NCT03519178|469749368|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
130486115|NCT03519178|469749369|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
130486116|NCT03519178|469749370|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
130486117|NCT03519178|469749371|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
130486118|NCT03519178|469749372|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
130728263|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
130728264|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130728265|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130728266|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130728267|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130728268|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130728269|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
130486119|NCT03519178|469749373|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
130486120|NCT03519178|469749374|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
130486121|NCT03519178|469749375|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
130486122|NCT03519178|469749376|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
130486123|NCT03519178|469749377|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
130486124|NCT03519178|469749378|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
130486125|NCT03519178|469749379|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
130486126|NCT03519178|469749380|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
130486127|NCT03519178|469749381|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
130486128|NCT03519178|469749367|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
130486129|NCT03519178|469749368|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
130486130|NCT03519178|469749369|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
130486131|NCT03519178|469749370|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
130486132|NCT03519178|469749371|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
130728270|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
130728271|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
130728272|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130728273|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
130728274|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130728275|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130728276|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130728277|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130728278|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130728279|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130728280|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130728281|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130728282|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
130728283|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728284|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728285|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728286|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728287|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Death|0|||
130486133|NCT03519178|469749372|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
130486134|NCT03519178|469749373|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
130486135|NCT03519178|469749374|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
130486136|NCT03519178|469749375|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
130486137|NCT03519178|469749376|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
130486138|NCT03519178|469749377|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
130486139|NCT03519178|469749378|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
130486140|NCT03519178|469749379|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
130486141|NCT03519178|469749380|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
130486142|NCT03519178|469749381|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
130486143|NCT03519178|469749367|FG000|Long-term Follow-up|Other|0|||
130486144|NCT03519178|469749368|FG001|Long-term Follow-up|Other|0|||
130486145|NCT03519178|469749369|FG002|Long-term Follow-up|Other|0|||
130486146|NCT03519178|469749370|FG003|Long-term Follow-up|Other|0|||
130486147|NCT03519178|469749371|FG004|Long-term Follow-up|Other|0|||
130486148|NCT03519178|469749372|FG005|Long-term Follow-up|Other|0|||
130486149|NCT03519178|469749373|FG006|Long-term Follow-up|Other|0|||
130486150|NCT03519178|469749374|FG007|Long-term Follow-up|Other|0|||
130486151|NCT03519178|469749375|FG008|Long-term Follow-up|Other|0|||
130486152|NCT03519178|469749376|FG009|Long-term Follow-up|Other|0|||
130486153|NCT03519178|469749377|FG010|Long-term Follow-up|Other|0|||
130486154|NCT03519178|469749378|FG011|Long-term Follow-up|Other|0|||
130486155|NCT03519178|469749379|FG012|Long-term Follow-up|Other|0|||
130486156|NCT03519178|469749380|FG013|Long-term Follow-up|Other|0|||
130486157|NCT03519178|469749381|FG014|Long-term Follow-up|Other|1|||
130486158|NCT03519178|469749367|FG000|Long-term Follow-up|Ongoing|0|||
130486159|NCT03519178|469749368|FG001|Long-term Follow-up|Ongoing|0|||
130486160|NCT03519178|469749369|FG002|Long-term Follow-up|Ongoing|0|||
130486161|NCT03519178|469749370|FG003|Long-term Follow-up|Ongoing|0|||
130486162|NCT03519178|469749371|FG004|Long-term Follow-up|Ongoing|0|||
130486163|NCT03519178|469749372|FG005|Long-term Follow-up|Ongoing|0|||
130486164|NCT03519178|469749373|FG006|Long-term Follow-up|Ongoing|0|||
130486165|NCT03519178|469749374|FG007|Long-term Follow-up|Ongoing|0|||
130486166|NCT03519178|469749375|FG008|Long-term Follow-up|Ongoing|0|||
130728288|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Death|1|||
130728289|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Death|0|||
130728290|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Death|0|||
130728291|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Death|0|||
130728292|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728293|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130728294|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728295|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728296|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728297|NCT01098474|470627420|FG000|Active Phase|Other|0|||
130728298|NCT01098474|470627421|FG001|Active Phase|Other|0|||
130728299|NCT01098474|470627422|FG002|Active Phase|Other|3|||
130728300|NCT01098474|470627423|FG003|Active Phase|Other|0|||
130486167|NCT03519178|469749376|FG009|Long-term Follow-up|Ongoing|0|||
130486168|NCT03519178|469749377|FG010|Long-term Follow-up|Ongoing|0|||
130486169|NCT03519178|469749378|FG011|Long-term Follow-up|Ongoing|0|||
130486170|NCT03519178|469749379|FG012|Long-term Follow-up|Ongoing|0|||
130728301|NCT01098474|470627424|FG004|Active Phase|Other|0|||
130728302|NCT01098474|470627425|FG005|Active Phase|Other|0|||
130486171|NCT03519178|469749380|FG013|Long-term Follow-up|Ongoing|1|||
130486172|NCT03519178|469749381|FG014|Long-term Follow-up|Ongoing|0|||
130486173|NCT02240238|469749382|FG000|Phase 1|Adverse Event|0|||
130486174|NCT02240238|469749383|FG001|Phase 1|Adverse Event|0|||
130486175|NCT02240238|469749384|FG002|Phase 1|Adverse Event|0|||
130486176|NCT02240238|469749385|FG003|Phase 1|Adverse Event|0|||
130728303|NCT01098474|470627420|FG000|Active Phase|Withdrawal by Subject|1|||
130728304|NCT01098474|470627421|FG001|Active Phase|Withdrawal by Subject|1|||
130728305|NCT01098474|470627422|FG002|Active Phase|Withdrawal by Subject|2|||
130486177|NCT02240238|469749386|FG004|Phase 1|Adverse Event|0|||
130486178|NCT02240238|469749387|FG005|Phase 1|Adverse Event|0|||
130486179|NCT02240238|469749388|FG006|Phase 1|Adverse Event|3|||
130486180|NCT02240238|469749389|FG007|Phase 1|Adverse Event|1|||
130486181|NCT02240238|469749390|FG008|Phase 1|Adverse Event|0|||
130486182|NCT02240238|469749391|FG009|Phase 1|Adverse Event|0|||
130486183|NCT02240238|469749392|FG010|Phase 1|Adverse Event|0|||
130486184|NCT02240238|469749393|FG011|Phase 1|Adverse Event|0|||
130728306|NCT01098474|470627423|FG003|Active Phase|Withdrawal by Subject|0|||
130728307|NCT01098474|470627424|FG004|Active Phase|Withdrawal by Subject|0|||
130728308|NCT01098474|470627425|FG005|Active Phase|Withdrawal by Subject|0|||
130728309|NCT01098474|470627420|FG000|Active Phase|Lost to Follow-up|1|||
130728310|NCT01098474|470627421|FG001|Active Phase|Lost to Follow-up|0|||
130728311|NCT01098474|470627422|FG002|Active Phase|Lost to Follow-up|0|||
130728312|NCT01098474|470627423|FG003|Active Phase|Lost to Follow-up|0|||
130728313|NCT01098474|470627424|FG004|Active Phase|Lost to Follow-up|0|||
130728314|NCT01098474|470627425|FG005|Active Phase|Lost to Follow-up|0|||
130486185|NCT02240238|469749382|FG000|Phase 1|Death|0|||
130486186|NCT02240238|469749383|FG001|Phase 1|Death|0|||
130486187|NCT02240238|469749384|FG002|Phase 1|Death|0|||
130486188|NCT02240238|469749385|FG003|Phase 1|Death|0|||
130486189|NCT02240238|469749386|FG004|Phase 1|Death|0|||
130486190|NCT02240238|469749387|FG005|Phase 1|Death|1|||
130486191|NCT02240238|469749388|FG006|Phase 1|Death|0|||
130486192|NCT02240238|469749389|FG007|Phase 1|Death|0|||
130486193|NCT02240238|469749390|FG008|Phase 1|Death|0|||
130486194|NCT02240238|469749391|FG009|Phase 1|Death|0|||
130486195|NCT02240238|469749392|FG010|Phase 1|Death|0|||
130486196|NCT02240238|469749393|FG011|Phase 1|Death|0|||
130486197|NCT02240238|469749382|FG000|Phase 1|Sponsor termination|0|||
130486198|NCT02240238|469749383|FG001|Phase 1|Sponsor termination|0|||
130486199|NCT02240238|469749384|FG002|Phase 1|Sponsor termination|0|||
130486200|NCT02240238|469749385|FG003|Phase 1|Sponsor termination|0|||
130486201|NCT02240238|469749386|FG004|Phase 1|Sponsor termination|0|||
130486202|NCT02240238|469749387|FG005|Phase 1|Sponsor termination|1|||
130486203|NCT02240238|469749388|FG006|Phase 1|Sponsor termination|0|||
130486204|NCT02240238|469749389|FG007|Phase 1|Sponsor termination|0|||
130486205|NCT02240238|469749390|FG008|Phase 1|Sponsor termination|0|||
130486206|NCT02240238|469749391|FG009|Phase 1|Sponsor termination|0|||
130486207|NCT02240238|469749392|FG010|Phase 1|Sponsor termination|0|||
130486208|NCT02240238|469749393|FG011|Phase 1|Sponsor termination|0|||
130486209|NCT02240238|469749382|FG000|Phase 1|Withdrawal by Subject|0|||
130486210|NCT02240238|469749383|FG001|Phase 1|Withdrawal by Subject|0|||
130486211|NCT02240238|469749384|FG002|Phase 1|Withdrawal by Subject|0|||
130486212|NCT02240238|469749385|FG003|Phase 1|Withdrawal by Subject|0|||
130486213|NCT02240238|469749386|FG004|Phase 1|Withdrawal by Subject|0|||
130486214|NCT02240238|469749387|FG005|Phase 1|Withdrawal by Subject|2|||
130486215|NCT02240238|469749388|FG006|Phase 1|Withdrawal by Subject|0|||
130486216|NCT02240238|469749389|FG007|Phase 1|Withdrawal by Subject|0|||
130486217|NCT02240238|469749390|FG008|Phase 1|Withdrawal by Subject|0|||
130486218|NCT02240238|469749391|FG009|Phase 1|Withdrawal by Subject|0|||
130486219|NCT02240238|469749392|FG010|Phase 1|Withdrawal by Subject|0|||
130486220|NCT02240238|469749393|FG011|Phase 1|Withdrawal by Subject|0|||
130486221|NCT02240238|469749382|FG000|Phase 1|Physician Decision|0|||
130486222|NCT02240238|469749383|FG001|Phase 1|Physician Decision|0|||
130486223|NCT02240238|469749384|FG002|Phase 1|Physician Decision|0|||
130486224|NCT02240238|469749385|FG003|Phase 1|Physician Decision|0|||
130728315|NCT01098474|470627420|FG000|Follow Up Phase|Travelled out of study area|0|||
130728316|NCT01098474|470627421|FG001|Follow Up Phase|Travelled out of study area|0|||
130728317|NCT01098474|470627422|FG002|Follow Up Phase|Travelled out of study area|0|||
130728318|NCT01098474|470627423|FG003|Follow Up Phase|Travelled out of study area|0|||
130728319|NCT01098474|470627424|FG004|Follow Up Phase|Travelled out of study area|1|||
130728320|NCT01098474|470627425|FG005|Follow Up Phase|Travelled out of study area|0|||
130486225|NCT02240238|469749386|FG004|Phase 1|Physician Decision|0|||
130486226|NCT02240238|469749387|FG005|Phase 1|Physician Decision|2|||
130486227|NCT02240238|469749388|FG006|Phase 1|Physician Decision|0|||
130486228|NCT02240238|469749389|FG007|Phase 1|Physician Decision|0|||
130486229|NCT02240238|469749390|FG008|Phase 1|Physician Decision|0|||
130486230|NCT02240238|469749391|FG009|Phase 1|Physician Decision|0|||
130486231|NCT02240238|469749392|FG010|Phase 1|Physician Decision|0|||
130486232|NCT02240238|469749393|FG011|Phase 1|Physician Decision|0|||
130486233|NCT02240238|469749382|FG000|Phase 2|Adverse Event|0|||
130486234|NCT02240238|469749383|FG001|Phase 2|Adverse Event|0|||
130486235|NCT02240238|469749384|FG002|Phase 2|Adverse Event|0|||
130486236|NCT02240238|469749385|FG003|Phase 2|Adverse Event|0|||
130486237|NCT02240238|469749386|FG004|Phase 2|Adverse Event|0|||
130486238|NCT02240238|469749387|FG005|Phase 2|Adverse Event|0|||
130486239|NCT02240238|469749388|FG006|Phase 2|Adverse Event|0|||
130728321|NCT01098474|470627420|FG000|Follow Up Phase|Other|0|||
130486240|NCT02240238|469749389|FG007|Phase 2|Adverse Event|0|||
130486241|NCT02240238|469749390|FG008|Phase 2|Adverse Event|0|||
130486242|NCT02240238|469749391|FG009|Phase 2|Adverse Event|7|||
130486243|NCT02240238|469749392|FG010|Phase 2|Adverse Event|14|||
130486244|NCT02240238|469749393|FG011|Phase 2|Adverse Event|2|||
130486245|NCT02240238|469749382|FG000|Phase 2|Death|0|||
130486246|NCT02240238|469749383|FG001|Phase 2|Death|0|||
130486247|NCT02240238|469749384|FG002|Phase 2|Death|0|||
130486248|NCT02240238|469749385|FG003|Phase 2|Death|0|||
130486249|NCT02240238|469749386|FG004|Phase 2|Death|0|||
130486250|NCT02240238|469749387|FG005|Phase 2|Death|0|||
130486251|NCT02240238|469749388|FG006|Phase 2|Death|0|||
130486252|NCT02240238|469749389|FG007|Phase 2|Death|0|||
130486253|NCT02240238|469749390|FG008|Phase 2|Death|0|||
130486254|NCT02240238|469749391|FG009|Phase 2|Death|3|||
130486255|NCT02240238|469749392|FG010|Phase 2|Death|2|||
130486256|NCT02240238|469749393|FG011|Phase 2|Death|1|||
130486257|NCT02240238|469749382|FG000|Phase 2|Disease progression|0|||
130486258|NCT02240238|469749383|FG001|Phase 2|Disease progression|0|||
130486259|NCT02240238|469749384|FG002|Phase 2|Disease progression|0|||
130486260|NCT02240238|469749385|FG003|Phase 2|Disease progression|0|||
130486261|NCT02240238|469749386|FG004|Phase 2|Disease progression|0|||
130486262|NCT02240238|469749387|FG005|Phase 2|Disease progression|0|||
130486263|NCT02240238|469749388|FG006|Phase 2|Disease progression|0|||
130486264|NCT02240238|469749389|FG007|Phase 2|Disease progression|0|||
130486265|NCT02240238|469749390|FG008|Phase 2|Disease progression|0|||
130486266|NCT02240238|469749391|FG009|Phase 2|Disease progression|5|||
130486267|NCT02240238|469749392|FG010|Phase 2|Disease progression|11|||
130486268|NCT02240238|469749393|FG011|Phase 2|Disease progression|1|||
130486269|NCT02240238|469749382|FG000|Phase 2|Withdrawal by Subject|0|||
130486270|NCT02240238|469749383|FG001|Phase 2|Withdrawal by Subject|0|||
130486271|NCT02240238|469749384|FG002|Phase 2|Withdrawal by Subject|0|||
130486272|NCT02240238|469749385|FG003|Phase 2|Withdrawal by Subject|0|||
130486273|NCT02240238|469749386|FG004|Phase 2|Withdrawal by Subject|0|||
130486274|NCT02240238|469749387|FG005|Phase 2|Withdrawal by Subject|0|||
130486275|NCT02240238|469749388|FG006|Phase 2|Withdrawal by Subject|0|||
130486276|NCT02240238|469749389|FG007|Phase 2|Withdrawal by Subject|0|||
130486277|NCT02240238|469749390|FG008|Phase 2|Withdrawal by Subject|0|||
130486278|NCT02240238|469749391|FG009|Phase 2|Withdrawal by Subject|1|||
130486279|NCT02240238|469749392|FG010|Phase 2|Withdrawal by Subject|1|||
130486280|NCT02240238|469749393|FG011|Phase 2|Withdrawal by Subject|0|||
130486281|NCT02240238|469749382|FG000|Phase 2|Physician Decision|0|||
130486282|NCT02240238|469749383|FG001|Phase 2|Physician Decision|0|||
130486283|NCT02240238|469749384|FG002|Phase 2|Physician Decision|0|||
130486284|NCT02240238|469749385|FG003|Phase 2|Physician Decision|0|||
130486285|NCT02240238|469749386|FG004|Phase 2|Physician Decision|0|||
130486286|NCT02240238|469749387|FG005|Phase 2|Physician Decision|0|||
130486287|NCT02240238|469749388|FG006|Phase 2|Physician Decision|0|||
130486288|NCT02240238|469749389|FG007|Phase 2|Physician Decision|0|||
130486289|NCT02240238|469749390|FG008|Phase 2|Physician Decision|0|||
130486290|NCT02240238|469749391|FG009|Phase 2|Physician Decision|1|||
130486291|NCT02240238|469749392|FG010|Phase 2|Physician Decision|3|||
130486292|NCT02240238|469749393|FG011|Phase 2|Physician Decision|0|||
130486293|NCT02240238|469749382|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486294|NCT02240238|469749383|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486295|NCT02240238|469749384|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486296|NCT02240238|469749385|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486297|NCT02240238|469749386|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486298|NCT02240238|469749387|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486299|NCT02240238|469749388|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486300|NCT02240238|469749389|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486301|NCT02240238|469749390|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486302|NCT02240238|469749391|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
130486303|NCT02240238|469749392|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486304|NCT02240238|469749393|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
130486305|NCT02240238|469749382|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486306|NCT02240238|469749383|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486307|NCT02240238|469749384|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486308|NCT02240238|469749385|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486309|NCT02240238|469749386|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486310|NCT02240238|469749387|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130565257|NCT02289742|470035431|FG000|First Wear Period|Adverse Event|0|||
130565258|NCT02289742|470035432|FG001|First Wear Period|Adverse Event|0|||
130728322|NCT01098474|470627421|FG001|Follow Up Phase|Other|0|||
130728323|NCT01098474|470627422|FG002|Follow Up Phase|Other|0|||
130728324|NCT01098474|470627423|FG003|Follow Up Phase|Other|0|||
130728325|NCT01098474|470627424|FG004|Follow Up Phase|Other|0|||
130728326|NCT01098474|470627425|FG005|Follow Up Phase|Other|4|||
130728327|NCT01098474|470627420|FG000|Follow Up Phase|Withdrawal by Subject|0|||
130728328|NCT01098474|470627421|FG001|Follow Up Phase|Withdrawal by Subject|0|||
130728329|NCT01098474|470627422|FG002|Follow Up Phase|Withdrawal by Subject|0|||
130728330|NCT01098474|470627423|FG003|Follow Up Phase|Withdrawal by Subject|2|||
130728331|NCT01098474|470627424|FG004|Follow Up Phase|Withdrawal by Subject|0|||
130728332|NCT01098474|470627425|FG005|Follow Up Phase|Withdrawal by Subject|1|||
130728333|NCT01098474|470627420|FG000|Follow Up Phase|Lost to Follow-up|0|||
130728334|NCT01098474|470627421|FG001|Follow Up Phase|Lost to Follow-up|0|||
130728335|NCT01098474|470627422|FG002|Follow Up Phase|Lost to Follow-up|0|||
130728336|NCT01098474|470627423|FG003|Follow Up Phase|Lost to Follow-up|0|||
130728337|NCT01098474|470627424|FG004|Follow Up Phase|Lost to Follow-up|1|||
130728338|NCT01098474|470627425|FG005|Follow Up Phase|Lost to Follow-up|0|||
130728339|NCT02165735|470627428|FG000|Overall Study|Lost to Follow-up|12|||
130486311|NCT02240238|469749388|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486312|NCT02240238|469749389|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486313|NCT02240238|469749390|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486314|NCT02240238|469749391|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
130486315|NCT02240238|469749392|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486316|NCT02240238|469749393|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
130486317|NCT02240238|469749382|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486318|NCT02240238|469749383|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486319|NCT02240238|469749384|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486320|NCT02240238|469749385|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486321|NCT02240238|469749386|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486322|NCT02240238|469749387|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486323|NCT02240238|469749388|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486324|NCT02240238|469749389|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486325|NCT02240238|469749390|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486326|NCT02240238|469749391|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486327|NCT02240238|469749392|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
130486328|NCT02240238|469749393|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
130486329|NCT02240238|469749382|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486330|NCT02240238|469749383|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486331|NCT02240238|469749384|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486332|NCT02240238|469749385|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486333|NCT02240238|469749386|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486334|NCT02240238|469749387|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486335|NCT02240238|469749388|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486336|NCT02240238|469749389|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486337|NCT02240238|469749390|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486338|NCT02240238|469749391|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486339|NCT02240238|469749392|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
130486340|NCT02240238|469749393|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130486341|NCT02240238|469749382|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486342|NCT02240238|469749383|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486343|NCT02240238|469749384|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486344|NCT02240238|469749385|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486345|NCT02240238|469749386|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486346|NCT02240238|469749387|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486347|NCT02240238|469749388|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486348|NCT02240238|469749389|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486349|NCT02240238|469749390|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486350|NCT02240238|469749391|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130486351|NCT02240238|469749392|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
130728340|NCT02165735|470627429|FG001|Overall Study|Lost to Follow-up|10|||
130728341|NCT02165735|470627428|FG000|Overall Study|Withdrawal by Subject|3|||
130728342|NCT02165735|470627429|FG001|Overall Study|Withdrawal by Subject|0|||
130728343|NCT02165735|470627428|FG000|Overall Study|Participant indicated lack of time|1|||
130728344|NCT02165735|470627429|FG001|Overall Study|Participant indicated lack of time|3|||
130728345|NCT02165735|470627428|FG000|Overall Study|Protocol Violation|0|||
130728346|NCT02165735|470627429|FG001|Overall Study|Protocol Violation|1|||
130728347|NCT00101283|470627432|FG000|Overall Study|Withdrawal by Subject|0|||
130728348|NCT00101283|470627433|FG001|Overall Study|Withdrawal by Subject|1|||
130728349|NCT00101283|470627432|FG000|Overall Study|Insurance Refusal|0|||
130728350|NCT00101283|470627433|FG001|Overall Study|Insurance Refusal|1|||
130486352|NCT02240238|469749393|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
130565259|NCT02289742|470035433|FG002|First Wear Period|Adverse Event|1|||
130486353|NCT02240238|469749382|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486354|NCT02240238|469749383|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486355|NCT02240238|469749384|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486356|NCT02240238|469749385|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486357|NCT02240238|469749386|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486358|NCT02240238|469749387|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486359|NCT02240238|469749388|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486360|NCT02240238|469749389|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486361|NCT02240238|469749390|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486362|NCT02240238|469749391|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486363|NCT02240238|469749392|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
130486364|NCT02240238|469749393|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130486365|NCT02240238|469749382|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486366|NCT02240238|469749383|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486367|NCT02240238|469749384|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486368|NCT02240238|469749385|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486369|NCT02240238|469749386|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486370|NCT02240238|469749387|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486371|NCT02240238|469749388|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486372|NCT02240238|469749389|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486373|NCT02240238|469749390|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486374|NCT02240238|469749391|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486375|NCT02240238|469749392|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
130486376|NCT02240238|469749393|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
130486377|NCT02240238|469749382|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486378|NCT02240238|469749383|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486379|NCT02240238|469749384|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486380|NCT02240238|469749385|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486381|NCT02240238|469749386|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486382|NCT02240238|469749387|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486383|NCT02240238|469749388|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486384|NCT02240238|469749389|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130728351|NCT00101283|470627432|FG000|Overall Study|Prostate Cancer Recurrence|0|||
130728352|NCT00101283|470627433|FG001|Overall Study|Prostate Cancer Recurrence|1|||
130728353|NCT00398866|470627435|FG000|Overall Study|Adverse Event|1|||
130728354|NCT00398866|470627436|FG001|Overall Study|Adverse Event|0|||
130728355|NCT00398866|470627437|FG002|Overall Study|Adverse Event|0|||
130728356|NCT00398866|470627435|FG000|Overall Study|Lack of Efficacy|0|||
130728357|NCT00398866|470627436|FG001|Overall Study|Lack of Efficacy|0|||
130728358|NCT00398866|470627437|FG002|Overall Study|Lack of Efficacy|1|||
130728359|NCT00398866|470627435|FG000|Overall Study|Lost to Follow-up|7|||
130728360|NCT00398866|470627436|FG001|Overall Study|Lost to Follow-up|6|||
130728361|NCT00398866|470627437|FG002|Overall Study|Lost to Follow-up|4|||
130728362|NCT00398866|470627435|FG000|Overall Study|Withdrawal by Subject|5|||
130728363|NCT00398866|470627436|FG001|Overall Study|Withdrawal by Subject|1|||
130728364|NCT00398866|470627437|FG002|Overall Study|Withdrawal by Subject|2|||
130728365|NCT00398866|470627435|FG000|Overall Study|Unable to complete requirements of study|1|||
130728366|NCT00398866|470627436|FG001|Overall Study|Unable to complete requirements of study|1|||
130728367|NCT00398866|470627437|FG002|Overall Study|Unable to complete requirements of study|1|||
130728368|NCT04841577|470627442|FG000|Overall Study|Adverse Event|5|||
130728369|NCT04841577|470627443|FG001|Overall Study|Adverse Event|10|||
130728370|NCT04841577|470627442|FG000|Overall Study|Lost to Follow-up|8|||
130728371|NCT04841577|470627443|FG001|Overall Study|Lost to Follow-up|7|||
130728372|NCT04841577|470627442|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130728373|NCT04841577|470627443|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
130728374|NCT04841577|470627442|FG000|Overall Study|Other|0|||
130728375|NCT04841577|470627443|FG001|Overall Study|Other|1|||
130728376|NCT00182325|470627444|FG000|Overall Study|Lost to Follow-up|7|||
130728377|NCT00182325|470627445|FG001|Overall Study|Lost to Follow-up|7|||
130728378|NCT00182325|470627444|FG000|Overall Study|Miscarriage|5|||
130728379|NCT00182325|470627445|FG001|Overall Study|Miscarriage|3|||
130728380|NCT00182325|470627444|FG000|Overall Study|Did not complete survey|22|||
130728381|NCT00182325|470627445|FG001|Overall Study|Did not complete survey|43|||
130728382|NCT01420965|470627450|FG000|Overall Study|Withdrawal by Subject|1|||
130728383|NCT01420965|470627451|FG001|Overall Study|Withdrawal by Subject|0|||
130728384|NCT01420965|470627452|FG002|Overall Study|Withdrawal by Subject|0|||
130728385|NCT01420965|470627450|FG000|Overall Study|Adverse Event|0|||
130728386|NCT01420965|470627451|FG001|Overall Study|Adverse Event|1|||
130728387|NCT01420965|470627452|FG002|Overall Study|Adverse Event|0|||
130728388|NCT00339144|470627457|FG000|Overall Study|Disease progression|5|||
130728389|NCT00339144|470627458|FG001|Overall Study|Disease progression|2|||
130486385|NCT02240238|469749390|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486386|NCT02240238|469749391|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486387|NCT02240238|469749392|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130486388|NCT02240238|469749393|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
130486389|NCT03476343|469749404|FG000|Overall Study|Clinical exam moved to another scanner|7|||
130486390|NCT03476343|469749404|FG000|Overall Study|Clinical order cancelled|4|||
130486391|NCT03476343|469749404|FG000|Overall Study|Neonate did not settle down for the scan|1|||
130486392|NCT03088878|469749407|FG000|Overall Study|Adverse Event|0|||
130486393|NCT03088878|469749408|FG001|Overall Study|Adverse Event|0|||
130486394|NCT03088878|469749409|FG002|Overall Study|Adverse Event|0|||
130486395|NCT03088878|469749410|FG003|Overall Study|Adverse Event|0|||
130486396|NCT03088878|469749411|FG004|Overall Study|Adverse Event|4|||
130486397|NCT03088878|469749412|FG005|Overall Study|Adverse Event|2|||
130486398|NCT03088878|469749413|FG006|Overall Study|Adverse Event|1|||
130486399|NCT03088878|469749414|FG007|Overall Study|Adverse Event|0|||
130486400|NCT03088878|469749415|FG008|Overall Study|Adverse Event|0|||
130486401|NCT03088878|469749416|FG009|Overall Study|Adverse Event|0|||
130486402|NCT03088878|469749417|FG010|Overall Study|Adverse Event|0|||
130486403|NCT03088878|469749418|FG011|Overall Study|Adverse Event|0|||
130486404|NCT03088878|469749419|FG012|Overall Study|Adverse Event|5|||
130486405|NCT03088878|469749420|FG013|Overall Study|Adverse Event|3|||
130486406|NCT03088878|469749407|FG000|Overall Study|Clinical Progression|0|||
130486407|NCT03088878|469749408|FG001|Overall Study|Clinical Progression|0|||
130486408|NCT03088878|469749409|FG002|Overall Study|Clinical Progression|0|||
130486409|NCT03088878|469749410|FG003|Overall Study|Clinical Progression|0|||
130486410|NCT03088878|469749411|FG004|Overall Study|Clinical Progression|2|||
130486411|NCT03088878|469749412|FG005|Overall Study|Clinical Progression|0|||
130486412|NCT03088878|469749413|FG006|Overall Study|Clinical Progression|0|||
130486413|NCT03088878|469749414|FG007|Overall Study|Clinical Progression|0|||
130486414|NCT03088878|469749415|FG008|Overall Study|Clinical Progression|0|||
130486415|NCT03088878|469749416|FG009|Overall Study|Clinical Progression|0|||
130486416|NCT03088878|469749417|FG010|Overall Study|Clinical Progression|0|||
130486417|NCT03088878|469749418|FG011|Overall Study|Clinical Progression|0|||
130486418|NCT03088878|469749419|FG012|Overall Study|Clinical Progression|0|||
130486419|NCT03088878|469749420|FG013|Overall Study|Clinical Progression|0|||
130486420|NCT03088878|469749407|FG000|Overall Study|Death|0|||
130486421|NCT03088878|469749408|FG001|Overall Study|Death|0|||
130486422|NCT03088878|469749409|FG002|Overall Study|Death|0|||
130486423|NCT03088878|469749410|FG003|Overall Study|Death|0|||
130486424|NCT03088878|469749411|FG004|Overall Study|Death|2|||
130486425|NCT03088878|469749412|FG005|Overall Study|Death|0|||
130486426|NCT03088878|469749413|FG006|Overall Study|Death|0|||
130728390|NCT00339144|470627459|FG002|Overall Study|Disease progression|2|||
130728391|NCT00339144|470627457|FG000|Overall Study|Study drug toxicity|3|||
130728392|NCT00339144|470627458|FG001|Overall Study|Study drug toxicity|1|||
130486427|NCT03088878|469749414|FG007|Overall Study|Death|0|||
130486428|NCT03088878|469749415|FG008|Overall Study|Death|0|||
130486429|NCT03088878|469749416|FG009|Overall Study|Death|0|||
130486430|NCT03088878|469749417|FG010|Overall Study|Death|0|||
130486431|NCT03088878|469749418|FG011|Overall Study|Death|1|||
130486432|NCT03088878|469749419|FG012|Overall Study|Death|0|||
130486433|NCT03088878|469749420|FG013|Overall Study|Death|0|||
130486434|NCT03088878|469749407|FG000|Overall Study|Disease Progression|1|||
130486435|NCT03088878|469749408|FG001|Overall Study|Disease Progression|2|||
130486436|NCT03088878|469749409|FG002|Overall Study|Disease Progression|3|||
130486437|NCT03088878|469749410|FG003|Overall Study|Disease Progression|0|||
130486438|NCT03088878|469749411|FG004|Overall Study|Disease Progression|3|||
130486439|NCT03088878|469749412|FG005|Overall Study|Disease Progression|0|||
130486440|NCT03088878|469749413|FG006|Overall Study|Disease Progression|0|||
130486441|NCT03088878|469749414|FG007|Overall Study|Disease Progression|0|||
130486442|NCT03088878|469749415|FG008|Overall Study|Disease Progression|0|||
130486443|NCT03088878|469749416|FG009|Overall Study|Disease Progression|0|||
130486444|NCT03088878|469749417|FG010|Overall Study|Disease Progression|0|||
130486445|NCT03088878|469749418|FG011|Overall Study|Disease Progression|0|||
130486446|NCT03088878|469749419|FG012|Overall Study|Disease Progression|1|||
130486447|NCT03088878|469749420|FG013|Overall Study|Disease Progression|1|||
130486448|NCT03088878|469749407|FG000|Overall Study|Initiation of Alternative Treatment|0|||
130486449|NCT03088878|469749408|FG001|Overall Study|Initiation of Alternative Treatment|0|||
130486450|NCT03088878|469749409|FG002|Overall Study|Initiation of Alternative Treatment|0|||
130486451|NCT03088878|469749410|FG003|Overall Study|Initiation of Alternative Treatment|1|||
130728393|NCT00339144|470627459|FG002|Overall Study|Study drug toxicity|1|||
130486452|NCT03088878|469749411|FG004|Overall Study|Initiation of Alternative Treatment|0|||
130486453|NCT03088878|469749412|FG005|Overall Study|Initiation of Alternative Treatment|0|||
130486454|NCT03088878|469749413|FG006|Overall Study|Initiation of Alternative Treatment|0|||
130486455|NCT03088878|469749414|FG007|Overall Study|Initiation of Alternative Treatment|1|||
130486456|NCT03088878|469749415|FG008|Overall Study|Initiation of Alternative Treatment|1|||
130486457|NCT03088878|469749416|FG009|Overall Study|Initiation of Alternative Treatment|0|||
130486458|NCT03088878|469749417|FG010|Overall Study|Initiation of Alternative Treatment|0|||
130486459|NCT03088878|469749418|FG011|Overall Study|Initiation of Alternative Treatment|0|||
130486460|NCT03088878|469749419|FG012|Overall Study|Initiation of Alternative Treatment|0|||
130486461|NCT03088878|469749420|FG013|Overall Study|Initiation of Alternative Treatment|0|||
130486462|NCT03088878|469749407|FG000|Overall Study|Withdrawal by Subject|0|||
130486463|NCT03088878|469749408|FG001|Overall Study|Withdrawal by Subject|0|||
130486464|NCT03088878|469749409|FG002|Overall Study|Withdrawal by Subject|0|||
130486465|NCT03088878|469749410|FG003|Overall Study|Withdrawal by Subject|1|||
130486466|NCT03088878|469749411|FG004|Overall Study|Withdrawal by Subject|4|||
130486467|NCT03088878|469749412|FG005|Overall Study|Withdrawal by Subject|1|||
130486468|NCT03088878|469749413|FG006|Overall Study|Withdrawal by Subject|1|||
130486469|NCT03088878|469749414|FG007|Overall Study|Withdrawal by Subject|0|||
130486470|NCT03088878|469749415|FG008|Overall Study|Withdrawal by Subject|1|||
130486471|NCT03088878|469749416|FG009|Overall Study|Withdrawal by Subject|2|||
130486472|NCT03088878|469749417|FG010|Overall Study|Withdrawal by Subject|0|||
130486473|NCT03088878|469749418|FG011|Overall Study|Withdrawal by Subject|2|||
130486474|NCT03088878|469749419|FG012|Overall Study|Withdrawal by Subject|1|||
130565260|NCT02289742|470035434|FG003|First Wear Period|Adverse Event|0|||
130486475|NCT03088878|469749420|FG013|Overall Study|Withdrawal by Subject|0|||
130486476|NCT03088878|469749407|FG000|Overall Study|Terminated by Sponsor|2|||
130486477|NCT03088878|469749408|FG001|Overall Study|Terminated by Sponsor|1|||
130486478|NCT03088878|469749409|FG002|Overall Study|Terminated by Sponsor|0|||
130486479|NCT03088878|469749410|FG003|Overall Study|Terminated by Sponsor|1|||
130486480|NCT03088878|469749411|FG004|Overall Study|Terminated by Sponsor|6|||
130486481|NCT03088878|469749412|FG005|Overall Study|Terminated by Sponsor|0|||
130486482|NCT03088878|469749413|FG006|Overall Study|Terminated by Sponsor|0|||
130486483|NCT03088878|469749414|FG007|Overall Study|Terminated by Sponsor|0|||
130486484|NCT03088878|469749415|FG008|Overall Study|Terminated by Sponsor|0|||
130486485|NCT03088878|469749416|FG009|Overall Study|Terminated by Sponsor|0|||
130486486|NCT03088878|469749417|FG010|Overall Study|Terminated by Sponsor|3|||
130486487|NCT03088878|469749418|FG011|Overall Study|Terminated by Sponsor|13|||
130486488|NCT03088878|469749419|FG012|Overall Study|Terminated by Sponsor|2|||
130486489|NCT03088878|469749420|FG013|Overall Study|Terminated by Sponsor|1|||
130486490|NCT03088878|469749407|FG000|Overall Study|Completed 2 years of Treatment|0|||
130486491|NCT03088878|469749408|FG001|Overall Study|Completed 2 years of Treatment|0|||
130486492|NCT03088878|469749409|FG002|Overall Study|Completed 2 years of Treatment|0|||
130486493|NCT03088878|469749410|FG003|Overall Study|Completed 2 years of Treatment|0|||
130486494|NCT03088878|469749411|FG004|Overall Study|Completed 2 years of Treatment|0|||
130486495|NCT03088878|469749412|FG005|Overall Study|Completed 2 years of Treatment|0|||
130486496|NCT03088878|469749413|FG006|Overall Study|Completed 2 years of Treatment|1|||
130486497|NCT03088878|469749414|FG007|Overall Study|Completed 2 years of Treatment|0|||
130486498|NCT03088878|469749415|FG008|Overall Study|Completed 2 years of Treatment|0|||
130486499|NCT03088878|469749416|FG009|Overall Study|Completed 2 years of Treatment|1|||
130486500|NCT03088878|469749417|FG010|Overall Study|Completed 2 years of Treatment|0|||
130486501|NCT03088878|469749418|FG011|Overall Study|Completed 2 years of Treatment|0|||
130486502|NCT03088878|469749419|FG012|Overall Study|Completed 2 years of Treatment|8|||
130486503|NCT03088878|469749420|FG013|Overall Study|Completed 2 years of Treatment|3|||
130486504|NCT03088878|469749407|FG000|Overall Study|Physician Decision|0|||
130486505|NCT03088878|469749408|FG001|Overall Study|Physician Decision|0|||
130486506|NCT03088878|469749409|FG002|Overall Study|Physician Decision|0|||
130486507|NCT03088878|469749410|FG003|Overall Study|Physician Decision|0|||
130486508|NCT03088878|469749411|FG004|Overall Study|Physician Decision|0|||
130486509|NCT03088878|469749412|FG005|Overall Study|Physician Decision|0|||
130486510|NCT03088878|469749413|FG006|Overall Study|Physician Decision|0|||
130486511|NCT03088878|469749414|FG007|Overall Study|Physician Decision|2|||
130486512|NCT03088878|469749415|FG008|Overall Study|Physician Decision|1|||
130486513|NCT03088878|469749416|FG009|Overall Study|Physician Decision|0|||
130486514|NCT03088878|469749417|FG010|Overall Study|Physician Decision|0|||
130565261|NCT02289742|470035431|FG000|First Wear Period|Other prior to treatment|0|||
130565262|NCT02289742|470035432|FG001|First Wear Period|Other prior to treatment|0|||
130486515|NCT03088878|469749418|FG011|Overall Study|Physician Decision|0|||
130486516|NCT03088878|469749419|FG012|Overall Study|Physician Decision|0|||
130486517|NCT03088878|469749420|FG013|Overall Study|Physician Decision|1|||
130486518|NCT03088878|469749407|FG000|Overall Study|COVID Related noncompliance|0|||
130565263|NCT02289742|470035433|FG002|First Wear Period|Other prior to treatment|0|||
130486519|NCT03088878|469749408|FG001|Overall Study|COVID Related noncompliance|0|||
130486520|NCT03088878|469749409|FG002|Overall Study|COVID Related noncompliance|0|||
130486521|NCT03088878|469749410|FG003|Overall Study|COVID Related noncompliance|0|||
130486522|NCT03088878|469749411|FG004|Overall Study|COVID Related noncompliance|0|||
130486523|NCT03088878|469749412|FG005|Overall Study|COVID Related noncompliance|0|||
130486524|NCT03088878|469749413|FG006|Overall Study|COVID Related noncompliance|0|||
130486525|NCT03088878|469749414|FG007|Overall Study|COVID Related noncompliance|0|||
130486526|NCT03088878|469749415|FG008|Overall Study|COVID Related noncompliance|0|||
130486527|NCT03088878|469749416|FG009|Overall Study|COVID Related noncompliance|0|||
130486528|NCT03088878|469749417|FG010|Overall Study|COVID Related noncompliance|0|||
130486529|NCT03088878|469749418|FG011|Overall Study|COVID Related noncompliance|0|||
130486530|NCT03088878|469749419|FG012|Overall Study|COVID Related noncompliance|0|||
130486531|NCT03088878|469749420|FG013|Overall Study|COVID Related noncompliance|1|||
130486532|NCT03088878|469749407|FG000|Overall Study|Drug or Study Noncompliance|0|||
130486533|NCT03088878|469749408|FG001|Overall Study|Drug or Study Noncompliance|0|||
130486534|NCT03088878|469749409|FG002|Overall Study|Drug or Study Noncompliance|0|||
130486535|NCT03088878|469749410|FG003|Overall Study|Drug or Study Noncompliance|0|||
130486536|NCT03088878|469749411|FG004|Overall Study|Drug or Study Noncompliance|0|||
130486537|NCT03088878|469749412|FG005|Overall Study|Drug or Study Noncompliance|0|||
130486538|NCT03088878|469749413|FG006|Overall Study|Drug or Study Noncompliance|0|||
130486539|NCT03088878|469749414|FG007|Overall Study|Drug or Study Noncompliance|0|||
130486540|NCT03088878|469749415|FG008|Overall Study|Drug or Study Noncompliance|0|||
130486541|NCT03088878|469749416|FG009|Overall Study|Drug or Study Noncompliance|0|||
130486542|NCT03088878|469749417|FG010|Overall Study|Drug or Study Noncompliance|0|||
130486543|NCT03088878|469749418|FG011|Overall Study|Drug or Study Noncompliance|0|||
130486544|NCT03088878|469749419|FG012|Overall Study|Drug or Study Noncompliance|1|||
130486545|NCT03088878|469749420|FG013|Overall Study|Drug or Study Noncompliance|0|||
130486546|NCT04690582|469749421|FG000|Overall Study|Withdrawal by Subject|6|||
130486547|NCT04690582|469749422|FG001|Overall Study|Withdrawal by Subject|4|||
130486548|NCT05974501|469749423|FG000|Overall Study|Physician Decision|0|||
130486549|NCT05974501|469749424|FG001|Overall Study|Physician Decision|1|||
130486550|NCT04270942|469749427|FG000|Overall Study|Death|1|||
130486551|NCT03625115|469749429|FG000|Overall Study|Withdrawal by Subject|4|||
130728394|NCT00339144|470627457|FG000|Overall Study|Participant's request to discontinuation|1|||
130728395|NCT00339144|470627458|FG001|Overall Study|Participant's request to discontinuation|0|||
130728396|NCT00339144|470627459|FG002|Overall Study|Participant's request to discontinuation|1|||
130486552|NCT03625115|469749430|FG001|Overall Study|Withdrawal by Subject|7|||
130486553|NCT03625115|469749429|FG000|Overall Study|Lost to Follow-up|17|||
130486554|NCT03625115|469749430|FG001|Overall Study|Lost to Follow-up|24|||
130486555|NCT04797195|469749431|FG000|Overall Study|Death|8|||
130486556|NCT04797195|469749432|FG001|Overall Study|Death|15|||
130486557|NCT04797195|469749431|FG000|Overall Study|Change from PD|15|||
130486558|NCT04797195|469749432|FG001|Overall Study|Change from PD|15|||
130486559|NCT04797195|469749431|FG000|Overall Study|Withdrawal by Subject|3|||
130486560|NCT04797195|469749432|FG001|Overall Study|Withdrawal by Subject|2|||
130486561|NCT04101357|469749433|FG000|Overall Study|Death|1|||
130486562|NCT04101357|469749434|FG001|Overall Study|Death|1|||
130486563|NCT04101357|469749435|FG002|Overall Study|Death|1|||
130486564|NCT04101357|469749436|FG003|Overall Study|Death|2|||
130486565|NCT04101357|469749437|FG004|Overall Study|Death|4|||
130486566|NCT04101357|469749438|FG005|Overall Study|Death|11|||
130486567|NCT04101357|469749439|FG006|Overall Study|Death|4|||
130486568|NCT04101357|469749440|FG007|Overall Study|Death|4|||
130486569|NCT04101357|469749441|FG008|Overall Study|Death|5|||
130486570|NCT04101357|469749442|FG009|Overall Study|Death|2|||
130486571|NCT04101357|469749443|FG010|Overall Study|Death|3|||
130486572|NCT04101357|469749433|FG000|Overall Study|Trial closure|0|||
130486573|NCT04101357|469749434|FG001|Overall Study|Trial closure|0|||
130486574|NCT04101357|469749435|FG002|Overall Study|Trial closure|0|||
130486575|NCT04101357|469749436|FG003|Overall Study|Trial closure|0|||
130486576|NCT04101357|469749437|FG004|Overall Study|Trial closure|0|||
130486577|NCT04101357|469749438|FG005|Overall Study|Trial closure|2|||
130486578|NCT04101357|469749439|FG006|Overall Study|Trial closure|2|||
130486579|NCT04101357|469749440|FG007|Overall Study|Trial closure|0|||
130486580|NCT04101357|469749441|FG008|Overall Study|Trial closure|0|||
130486581|NCT04101357|469749442|FG009|Overall Study|Trial closure|0|||
130486582|NCT04101357|469749443|FG010|Overall Study|Trial closure|1|||
130486583|NCT04101357|469749433|FG000|Overall Study|Lost to Follow-up|0|||
130486584|NCT04101357|469749434|FG001|Overall Study|Lost to Follow-up|0|||
130728397|NCT01890434|470627460|FG000|Overall Study|Adverse Event|8|||
130728398|NCT01890434|470627460|FG000|Overall Study|PCI at external hospital|1|||
130486585|NCT04101357|469749435|FG002|Overall Study|Lost to Follow-up|0|||
130486586|NCT04101357|469749436|FG003|Overall Study|Lost to Follow-up|1|||
130486587|NCT04101357|469749437|FG004|Overall Study|Lost to Follow-up|0|||
130486588|NCT04101357|469749438|FG005|Overall Study|Lost to Follow-up|0|||
130486589|NCT04101357|469749439|FG006|Overall Study|Lost to Follow-up|0|||
130486590|NCT04101357|469749440|FG007|Overall Study|Lost to Follow-up|1|||
130486591|NCT04101357|469749441|FG008|Overall Study|Lost to Follow-up|0|||
130486592|NCT04101357|469749442|FG009|Overall Study|Lost to Follow-up|0|||
130486593|NCT04101357|469749443|FG010|Overall Study|Lost to Follow-up|0|||
130486594|NCT04101357|469749433|FG000|Overall Study|Withdrawal by Subject|1|||
130486595|NCT04101357|469749434|FG001|Overall Study|Withdrawal by Subject|0|||
130486596|NCT04101357|469749435|FG002|Overall Study|Withdrawal by Subject|0|||
130486597|NCT04101357|469749436|FG003|Overall Study|Withdrawal by Subject|0|||
130486598|NCT04101357|469749437|FG004|Overall Study|Withdrawal by Subject|0|||
130486599|NCT04101357|469749438|FG005|Overall Study|Withdrawal by Subject|0|||
130486600|NCT04101357|469749439|FG006|Overall Study|Withdrawal by Subject|0|||
130486601|NCT04101357|469749440|FG007|Overall Study|Withdrawal by Subject|0|||
130486602|NCT04101357|469749441|FG008|Overall Study|Withdrawal by Subject|1|||
130486603|NCT04101357|469749442|FG009|Overall Study|Withdrawal by Subject|1|||
130486604|NCT04101357|469749443|FG010|Overall Study|Withdrawal by Subject|0|||
130486605|NCT04101357|469749433|FG000|Overall Study|Other|0|||
130486606|NCT04101357|469749434|FG001|Overall Study|Other|0|||
130486607|NCT04101357|469749435|FG002|Overall Study|Other|0|||
130486608|NCT04101357|469749436|FG003|Overall Study|Other|0|||
130486609|NCT04101357|469749437|FG004|Overall Study|Other|0|||
130486610|NCT04101357|469749438|FG005|Overall Study|Other|1|||
130486611|NCT04101357|469749439|FG006|Overall Study|Other|2|||
130486612|NCT04101357|469749440|FG007|Overall Study|Other|1|||
130486613|NCT04101357|469749441|FG008|Overall Study|Other|0|||
130486614|NCT04101357|469749442|FG009|Overall Study|Other|0|||
130486615|NCT04101357|469749443|FG010|Overall Study|Other|0|||
130486616|NCT04101357|469749433|FG000|Overall Study|Enrolled but not treated|0|||
130486617|NCT04101357|469749434|FG001|Overall Study|Enrolled but not treated|0|||
130486618|NCT04101357|469749435|FG002|Overall Study|Enrolled but not treated|0|||
130486619|NCT04101357|469749436|FG003|Overall Study|Enrolled but not treated|0|||
130486620|NCT04101357|469749437|FG004|Overall Study|Enrolled but not treated|0|||
130486621|NCT04101357|469749438|FG005|Overall Study|Enrolled but not treated|1|||
130486622|NCT04101357|469749439|FG006|Overall Study|Enrolled but not treated|1|||
130486623|NCT04101357|469749440|FG007|Overall Study|Enrolled but not treated|0|||
130486624|NCT04101357|469749441|FG008|Overall Study|Enrolled but not treated|0|||
130486625|NCT04101357|469749442|FG009|Overall Study|Enrolled but not treated|0|||
130486626|NCT04101357|469749443|FG010|Overall Study|Enrolled but not treated|0|||
130486627|NCT02497950|469749444|FG000|Overall Study|Death|209|||
130486628|NCT02497950|469749444|FG000|Overall Study|Transplanted|85|||
130486629|NCT02497950|469749444|FG000|Overall Study|Explanted|8|||
130486630|NCT02497950|469749444|FG000|Overall Study|Device Permanently Deactivated|4|||
130486631|NCT02497950|469749444|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
130486632|NCT02497950|469749444|FG000|Overall Study|Lost to Follow-up|6|||
130486633|NCT02497950|469749444|FG000|Overall Study|Withdrawal by Subject|2|||
130486634|NCT02497950|469749444|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
130486635|NCT02497950|469749444|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
130486636|NCT04308681|469749450|FG000|Pre-Treatment|Not reported|1|||
130486637|NCT04308681|469749451|FG001|Pre-Treatment|Not reported|1|||
130486638|NCT04308681|469749452|FG002|Pre-Treatment|Not reported|0|||
130486639|NCT04308681|469749453|FG003|Pre-Treatment|Not reported|0|||
130486640|NCT04308681|469749454|FG004|Pre-Treatment|Not reported|0|||
130486641|NCT04308681|469749455|FG005|Pre-Treatment|Not reported|2|||
130486642|NCT04308681|469749456|FG006|Pre-Treatment|Not reported|0|||
130486643|NCT04308681|469749457|FG007|Pre-Treatment|Not reported|0|||
130486644|NCT04308681|469749450|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
130486645|NCT04308681|469749451|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
130486646|NCT04308681|469749452|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
130486647|NCT04308681|469749453|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
130486648|NCT04308681|469749454|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
130486649|NCT04308681|469749455|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
130486650|NCT04308681|469749456|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
130486651|NCT04308681|469749457|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
130486652|NCT04308681|469749450|FG000|Treatment up to Week 26|Other reasons|2|||
130486653|NCT04308681|469749451|FG001|Treatment up to Week 26|Other reasons|0|||
130486654|NCT04308681|469749452|FG002|Treatment up to Week 26|Other reasons|0|||
130486655|NCT04308681|469749453|FG003|Treatment up to Week 26|Other reasons|0|||
130486656|NCT04308681|469749454|FG004|Treatment up to Week 26|Other reasons|1|||
130486657|NCT04308681|469749455|FG005|Treatment up to Week 26|Other reasons|1|||
130486658|NCT04308681|469749456|FG006|Treatment up to Week 26|Other reasons|0|||
130486659|NCT04308681|469749457|FG007|Treatment up to Week 26|Other reasons|0|||
130486660|NCT04308681|469749450|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
130486661|NCT04308681|469749451|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
130486662|NCT04308681|469749452|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
130565264|NCT02289742|470035434|FG003|First Wear Period|Other prior to treatment|1|||
130486663|NCT04308681|469749453|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
130486664|NCT04308681|469749454|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
130486665|NCT04308681|469749455|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
130486666|NCT04308681|469749456|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
130486667|NCT04308681|469749457|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
130486668|NCT04308681|469749450|FG000|Treatment up to Week 26|Adverse Event|6|||
130486669|NCT04308681|469749451|FG001|Treatment up to Week 26|Adverse Event|5|||
130486670|NCT04308681|469749452|FG002|Treatment up to Week 26|Adverse Event|5|||
130728399|NCT01890434|470627460|FG000|Overall Study|Assessment discrepancy|1|||
130728400|NCT01890434|470627460|FG000|Overall Study|CRC didn't contact participant for FU|1|||
130728401|NCT01890434|470627460|FG000|Overall Study|Could not get whole set of images|1|||
130728402|NCT01890434|470627460|FG000|Overall Study|Decline to return for GSPECT|1|||
130728403|NCT01890434|470627460|FG000|Overall Study|GSPECT at rest was not done|1|||
130728404|NCT01890434|470627460|FG000|Overall Study|Participant didn't complete MRI|1|||
130728405|NCT01890434|470627460|FG000|Overall Study|Uncontactable by phone|1|||
130728406|NCT01890434|470627460|FG000|Overall Study|Moved out of position|1|||
130728407|NCT01890434|470627460|FG000|Overall Study|Unable to contact|1|||
130728408|NCT01890434|470627460|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
130728409|NCT01141205|470627461|FG000|Overall Study|Physician Decision|1|||
130486671|NCT04308681|469749453|FG003|Treatment up to Week 26|Adverse Event|0|||
130486672|NCT04308681|469749454|FG004|Treatment up to Week 26|Adverse Event|6|||
130486673|NCT04308681|469749455|FG005|Treatment up to Week 26|Adverse Event|1|||
130486674|NCT04308681|469749456|FG006|Treatment up to Week 26|Adverse Event|0|||
130486675|NCT04308681|469749457|FG007|Treatment up to Week 26|Adverse Event|0|||
130486676|NCT04308681|469749450|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486677|NCT04308681|469749451|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
130486678|NCT04308681|469749452|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
130486679|NCT04308681|469749453|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486680|NCT04308681|469749454|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486681|NCT04308681|469749455|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486682|NCT04308681|469749456|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486683|NCT04308681|469749457|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130486684|NCT04308681|469749450|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
130486685|NCT04308681|469749451|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
130486686|NCT04308681|469749452|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
130486687|NCT04308681|469749453|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
130486688|NCT04308681|469749454|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
130486689|NCT04308681|469749455|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
130486690|NCT04308681|469749456|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
130486691|NCT04308681|469749457|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
130486692|NCT04308681|469749450|FG000|OTE - 26 Weeks|Death|0|||
130486693|NCT04308681|469749451|FG001|OTE - 26 Weeks|Death|1|||
130486694|NCT04308681|469749452|FG002|OTE - 26 Weeks|Death|0|||
130486695|NCT04308681|469749453|FG003|OTE - 26 Weeks|Death|0|||
130486696|NCT04308681|469749454|FG004|OTE - 26 Weeks|Death|0|||
130486697|NCT04308681|469749455|FG005|OTE - 26 Weeks|Death|0|||
130486698|NCT04308681|469749456|FG006|OTE - 26 Weeks|Death|1|||
130486699|NCT04308681|469749457|FG007|OTE - 26 Weeks|Death|0|||
130486700|NCT04308681|469749450|FG000|OTE - 26 Weeks|Adverse Event|0|||
130486701|NCT04308681|469749451|FG001|OTE - 26 Weeks|Adverse Event|2|||
130486702|NCT04308681|469749452|FG002|OTE - 26 Weeks|Adverse Event|8|||
130486703|NCT04308681|469749453|FG003|OTE - 26 Weeks|Adverse Event|3|||
130486704|NCT04308681|469749454|FG004|OTE - 26 Weeks|Adverse Event|0|||
130486705|NCT04308681|469749455|FG005|OTE - 26 Weeks|Adverse Event|1|||
130486706|NCT04308681|469749456|FG006|OTE - 26 Weeks|Adverse Event|2|||
130486707|NCT04308681|469749457|FG007|OTE - 26 Weeks|Adverse Event|0|||
130486708|NCT04308681|469749450|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
130486709|NCT04308681|469749451|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
130486710|NCT04308681|469749452|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
130486711|NCT04308681|469749453|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
130486712|NCT04308681|469749454|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
130728410|NCT01141205|470627462|FG001|Overall Study|Physician Decision|1|||
130728411|NCT01141205|470627461|FG000|Overall Study|Lost to Follow-up|1|||
130486713|NCT04308681|469749455|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
130486714|NCT04308681|469749456|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
130486715|NCT04308681|469749457|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
130486716|NCT05565820|469749458|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
130486717|NCT05565820|469749459|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
130486718|NCT05565820|469749458|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
130486719|NCT05565820|469749459|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
130486720|NCT03295721|469749462|FG000|Overall Study|Adverse Event|1|||
130486721|NCT03295721|469749463|FG001|Overall Study|Adverse Event|0|||
130486722|NCT03295721|469749464|FG002|Overall Study|Adverse Event|0|||
130486723|NCT03295721|469749462|FG000|Overall Study|Lost to Follow-up|1|||
130486724|NCT03295721|469749463|FG001|Overall Study|Lost to Follow-up|1|||
130486725|NCT03295721|469749464|FG002|Overall Study|Lost to Follow-up|1|||
130486726|NCT03295721|469749462|FG000|Overall Study|Withdrawal by Subject|1|||
130486727|NCT03295721|469749463|FG001|Overall Study|Withdrawal by Subject|0|||
130486728|NCT03295721|469749464|FG002|Overall Study|Withdrawal by Subject|1|||
130728412|NCT01141205|470627462|FG001|Overall Study|Lost to Follow-up|0|||
130728413|NCT01141205|470627461|FG000|Overall Study|Withdrawal by Subject|1|||
130728414|NCT01141205|470627462|FG001|Overall Study|Withdrawal by Subject|1|||
130728415|NCT02257385|470627464|FG000|Overall Study|Adverse Event|12|||
130728416|NCT02257385|470627465|FG001|Overall Study|Adverse Event|8|||
130486729|NCT03295721|469749462|FG000|Overall Study|Death|0|||
130486730|NCT03295721|469749463|FG001|Overall Study|Death|0|||
130486731|NCT03295721|469749464|FG002|Overall Study|Death|1|||
130486732|NCT04786119|469749468|FG000|Overall Study|Withdrawal by Subject|2|||
130486733|NCT03325985|469749469|FG000|Overall Study|Lost to Follow-up|122|||
130486734|NCT03325985|469749470|FG001|Overall Study|Lost to Follow-up|26|||
130486735|NCT03325985|469749471|FG002|Overall Study|Lost to Follow-up|141|||
130486736|NCT03325985|469749472|FG003|Overall Study|Lost to Follow-up|28|||
130486737|NCT03325985|469749469|FG000|Overall Study|Death|99|||
130486738|NCT03325985|469749470|FG001|Overall Study|Death|36|||
130486739|NCT03325985|469749471|FG002|Overall Study|Death|94|||
130486740|NCT03325985|469749472|FG003|Overall Study|Death|32|||
130486741|NCT03556293|469749473|FG000|Overall Study|Ineligible for analysis|1904|||
130486742|NCT03556293|469749474|FG001|Overall Study|Ineligible for analysis|1471|||
130486743|NCT03556293|469749475|FG002|Overall Study|Ineligible for analysis|1091|||
130486744|NCT03556293|469749476|FG003|Overall Study|Ineligible for analysis|1269|||
130486745|NCT05012163|469749477|FG000|Overall Study|Protocol Violation|0|||
130486746|NCT05012163|469749478|FG001|Overall Study|Protocol Violation|0|||
130486747|NCT05012163|469749479|FG002|Overall Study|Protocol Violation|1|||
130486748|NCT05012163|469749480|FG003|Overall Study|Protocol Violation|1|||
130486749|NCT05524402|469749481|FG000|Overall Study|Withdrawal by Subject|3|||
130486750|NCT05524402|469749482|FG001|Overall Study|Withdrawal by Subject|1|||
130486751|NCT05524402|469749481|FG000|Overall Study|Lost to Follow-up|2|||
130486752|NCT05524402|469749482|FG001|Overall Study|Lost to Follow-up|1|||
130486753|NCT03213873|469749486|FG000|Overall Study|Withdrawal by Subject|8|||
130486754|NCT03213873|469749487|FG001|Overall Study|Withdrawal by Subject|9|||
130486755|NCT03213873|469749486|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
130486756|NCT03213873|469749487|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
130486757|NCT03213873|469749486|FG000|Overall Study|Lost to Follow-up|0|||
130486758|NCT03213873|469749487|FG001|Overall Study|Lost to Follow-up|2|||
130486759|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
130486760|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
130486761|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
130486762|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
130486763|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
130486764|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
130486765|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
130486766|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
130486767|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
130486768|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
130486769|NCT02361216|469749493|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
130486770|NCT02361216|469749494|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
130486771|NCT04294641|469750877|FG000|Overall Study|Screen failure|4|||
130486772|NCT05906784|469750879|FG000|Overall Study|Lost to Follow-up|2|||
130486773|NCT05906784|469750880|FG001|Overall Study|Lost to Follow-up|1|||
130486774|NCT05906784|469750881|FG002|Overall Study|Lost to Follow-up|1|||
130486775|NCT05906784|469750882|FG003|Overall Study|Lost to Follow-up|1|||
130486776|NCT02668692|469750883|FG000|Overall Study|Adverse Event|1|||
130486777|NCT02668692|469750884|FG001|Overall Study|Adverse Event|0|||
130486778|NCT01627574|469750888|FG000|Overall Study|Withdrawal by Subject|8|||
130486779|NCT01627574|469750889|FG001|Overall Study|Withdrawal by Subject|5|||
130486780|NCT01627574|469750888|FG000|Overall Study|Lost to Follow-up|13|||
130486781|NCT01627574|469750889|FG001|Overall Study|Lost to Follow-up|13|||
130486782|NCT04730739|469750890|FG000|Overall Study|Death|1|||
130486783|NCT03308877|469750892|FG000|Overall Study|Lost to Follow-up|32|||
130486784|NCT03308877|469750893|FG001|Overall Study|Lost to Follow-up|28|||
130486785|NCT04677738|469750903|FG000|Overall Study|Withdrawal by Subject|4|||
130728417|NCT02257385|470627464|FG000|Overall Study|Lack of Efficacy|1|||
130486786|NCT04677738|469750904|FG001|Overall Study|Withdrawal by Subject|2|||
130486787|NCT04660539|469750908|FG000|Overall Study|Adverse Event|10|||
130565265|NCT02289742|470035431|FG000|Third Wear Period|Adverse Event|0|||
130486788|NCT04660539|469750908|FG000|Overall Study|Lack of Efficacy|4|||
130486789|NCT04660539|469750908|FG000|Overall Study|Lost to Follow-up|5|||
130486790|NCT04660539|469750908|FG000|Overall Study|Non-Compliance With Study Drug|3|||
130486791|NCT04660539|469750908|FG000|Overall Study|Reason not Specified|12|||
130486792|NCT04660539|469750908|FG000|Overall Study|Pregnancy|2|||
130486793|NCT04660539|469750908|FG000|Overall Study|Protocol Violation|2|||
130486794|NCT04660539|469750908|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
130486795|NCT04660539|469750908|FG000|Overall Study|Withdrawal by Subject|21|||
130486796|NCT03655028|469750911|FG000|12-weeks Follow up|Death|1|||
130486797|NCT03655028|469750912|FG001|12-weeks Follow up|Death|0|||
130486798|NCT03655028|469750911|FG000|12-weeks Follow up|Physician Decision|3|||
130486799|NCT03655028|469750912|FG001|12-weeks Follow up|Physician Decision|3|||
130728418|NCT02257385|470627465|FG001|Overall Study|Lack of Efficacy|2|||
130486800|NCT03655028|469750911|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
130486801|NCT03655028|469750912|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
130486802|NCT03655028|469750911|FG000|12-weeks Follow up|Lost to Follow-up|4|||
130486803|NCT03655028|469750912|FG001|12-weeks Follow up|Lost to Follow-up|4|||
130486804|NCT03655028|469750911|FG000|24-weeks|Lost to Follow-up|1|||
130486805|NCT03655028|469750912|FG001|24-weeks|Lost to Follow-up|1|||
130486806|NCT03655028|469750911|FG000|24-weeks|Death|0|||
130486807|NCT03655028|469750912|FG001|24-weeks|Death|1|||
130486808|NCT03513302|469750913|FG000|First Intervention (14 Days)|Screen failure|15|||
130486809|NCT03513302|469750914|FG001|First Intervention (14 Days)|Screen failure|16|||
130486810|NCT05618587|469750915|FG000|Overall Study|Lost to Follow-up|2|||
130486811|NCT05618587|469750916|FG001|Overall Study|Lost to Follow-up|0|||
130486812|NCT05167864|469750917|FG000|Overall Study|Lost to Follow-up|7|||
130486813|NCT05167864|469750918|FG001|Overall Study|Lost to Follow-up|6|||
130486814|NCT05167864|469750919|FG002|Overall Study|Lost to Follow-up|7|||
130486815|NCT05167864|469750920|FG003|Overall Study|Lost to Follow-up|9|||
130486816|NCT03852550|469750921|FG000|Overall Study|Lost to Follow-up|4|||
130486817|NCT03852550|469750922|FG001|Overall Study|Lost to Follow-up|3|||
130486818|NCT03852550|469750921|FG000|Overall Study|Only parent outcomes completed|0|||
130486819|NCT03852550|469750922|FG001|Overall Study|Only parent outcomes completed|1|||
130486820|NCT03852550|469750921|FG000|Overall Study|Withdrawal by Subject|1|||
130486821|NCT03852550|469750922|FG001|Overall Study|Withdrawal by Subject|0|||
130486822|NCT05204654|469750923|FG000|Overall Study|Study terminated due to time restraint|2|||
130486823|NCT05204654|469750924|FG001|Overall Study|Study terminated due to time restraint|2|||
130486824|NCT01009788|469750935|FG000|Overall Study|Withdrawal by Subject|1|||
130486825|NCT01009788|469750936|FG001|Overall Study|Withdrawal by Subject|0|||
130486826|NCT02296684|469750937|FG000|Overall Study|Withdrawal by Subject|0|||
130486827|NCT02296684|469750938|FG001|Overall Study|Withdrawal by Subject|1|||
130486828|NCT02296684|469750939|FG002|Overall Study|Withdrawal by Subject|1|||
130486829|NCT02296684|469750937|FG000|Overall Study|Death|2|||
130486830|NCT02296684|469750938|FG001|Overall Study|Death|0|||
130486831|NCT02296684|469750939|FG002|Overall Study|Death|0|||
130486832|NCT05586490|469750940|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
130486833|NCT05586490|469750941|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
130486834|NCT05586490|469750942|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
130486835|NCT05586490|469750943|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
130486836|NCT05586490|469750944|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
130486837|NCT05586490|469750940|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
130486838|NCT05586490|469750941|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
130486839|NCT05586490|469750942|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
130486840|NCT05586490|469750943|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
130486841|NCT05586490|469750944|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
130486842|NCT05586490|469750940|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
130486843|NCT05586490|469750941|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
130486844|NCT05586490|469750942|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
130486845|NCT05586490|469750943|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
130486846|NCT05586490|469750944|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
130486847|NCT05076266|469750945|FG000|Overall Study|Survey not complete - Participant refusal|2|||
130486848|NCT05076266|469750946|FG001|Overall Study|Survey not complete - Participant refusal|0|||
130486849|NCT04003246|469750949|FG000|Overall Study|Death|9|||
130486850|NCT04132518|469750959|FG000|Overall Study|Prematurely withdrawn from the study|0|||
130486851|NCT04132518|469750960|FG001|Overall Study|Prematurely withdrawn from the study|9|||
130486852|NCT04132518|469750961|FG002|Overall Study|Prematurely withdrawn from the study|1|||
130486853|NCT04056611|469750963|FG000|Overall Study|Physician Decision|1|||
130486854|NCT03733925|469750964|FG000|Overall Study|Lost to Follow-up|1|||
130486855|NCT03733925|469750964|FG000|Overall Study|Withdrawal by Subject|2|||
130486856|NCT03733925|469750964|FG000|Overall Study|Adverse Event|2|||
130486857|NCT03733925|469750964|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130486858|NCT02631746|469750965|FG000|Overall Study|Lack of Efficacy|3|||
130486859|NCT02224144|469750966|FG000|Overall Study|Lost to Follow-up|3|||
130486860|NCT02224144|469750967|FG001|Overall Study|Lost to Follow-up|1|||
130486861|NCT02224144|469750966|FG000|Overall Study|Death|2|||
130486862|NCT02224144|469750967|FG001|Overall Study|Death|0|||
130486863|NCT02224144|469750966|FG000|Overall Study|Withdrawal by Subject|0|||
130486864|NCT02224144|469750967|FG001|Overall Study|Withdrawal by Subject|1|||
130486865|NCT04544007|469750971|FG000|Overall Study|Withdrawal by Subject|1|||
130486866|NCT04544007|469750971|FG000|Overall Study|Confirmed Progressive Disease|1|||
130486867|NCT02988661|469750972|FG000|Overall Study|Death|2|||
130486868|NCT02988661|469750973|FG001|Overall Study|Death|18|||
130486869|NCT02988661|469750972|FG000|Overall Study|Lost to Follow-up|0|||
130486870|NCT02988661|469750973|FG001|Overall Study|Lost to Follow-up|33|||
130565266|NCT02289742|470035432|FG001|Third Wear Period|Adverse Event|1|||
130486871|NCT02988661|469750972|FG000|Overall Study|Withdrawal by Subject|0|||
130486872|NCT02988661|469750973|FG001|Overall Study|Withdrawal by Subject|6|||
130486873|NCT02988661|469750972|FG000|Overall Study|Unable to complete the 18-month survey|1|||
130486874|NCT02988661|469750973|FG001|Overall Study|Unable to complete the 18-month survey|27|||
130486875|NCT05660434|469750976|FG000|Overall Study|Never obtained study materials|2|||
130486876|NCT05660434|469750977|FG001|Overall Study|Never obtained study materials|1|||
130486877|NCT02413489|469750993|FG000|Overall Study|Death|11|||
130486878|NCT02413489|469750994|FG001|Overall Study|Death|3|||
130486879|NCT02413489|469750995|FG002|Overall Study|Death|4|||
130486880|NCT02413489|469750993|FG000|Overall Study|Withdrawal by Subject|2|||
130486881|NCT02413489|469750994|FG001|Overall Study|Withdrawal by Subject|0|||
130486882|NCT02413489|469750995|FG002|Overall Study|Withdrawal by Subject|0|||
130486883|NCT02413489|469750993|FG000|Overall Study|Study Terminated By Sponsor|2|||
130486884|NCT02413489|469750994|FG001|Overall Study|Study Terminated By Sponsor|13|||
130486885|NCT02413489|469750995|FG002|Overall Study|Study Terminated By Sponsor|1|||
130486886|NCT02575950|469750996|FG000|Overall Study|Withdrawal by Subject|0|||
130486887|NCT02575950|469750997|FG001|Overall Study|Withdrawal by Subject|0|||
130486888|NCT02575950|469750998|FG002|Overall Study|Withdrawal by Subject|0|||
130486889|NCT02575950|469750999|FG003|Overall Study|Withdrawal by Subject|2|||
130486890|NCT02575950|469750996|FG000|Overall Study|Lost to Follow-up|0|||
130728419|NCT02257385|470627464|FG000|Overall Study|Protocol Violation|5|||
130728420|NCT02257385|470627465|FG001|Overall Study|Protocol Violation|7|||
130728421|NCT02257385|470627464|FG000|Overall Study|Lost to Follow-up|0|||
130486891|NCT02575950|469750997|FG001|Overall Study|Lost to Follow-up|1|||
130486892|NCT02575950|469750998|FG002|Overall Study|Lost to Follow-up|0|||
130486893|NCT02575950|469750999|FG003|Overall Study|Lost to Follow-up|3|||
130486894|NCT04271046|469751000|FG000|Overall Study|Death|0|||
130486895|NCT04271046|469751001|FG001|Overall Study|Death|2|||
130486896|NCT04271046|469751002|FG002|Overall Study|Death|0|||
130486897|NCT04271046|469751003|FG003|Overall Study|Death|2|||
130486898|NCT04271046|469751000|FG000|Overall Study|Lost to Follow-up|12|||
130486899|NCT04271046|469751001|FG001|Overall Study|Lost to Follow-up|12|||
130486900|NCT04271046|469751002|FG002|Overall Study|Lost to Follow-up|11|||
130486901|NCT04271046|469751003|FG003|Overall Study|Lost to Follow-up|11|||
130486902|NCT04271046|469751000|FG000|Overall Study|Patient with Dementia Died|2|||
130486903|NCT04271046|469751001|FG001|Overall Study|Patient with Dementia Died|0|||
130486904|NCT04271046|469751002|FG002|Overall Study|Patient with Dementia Died|2|||
130486905|NCT04271046|469751003|FG003|Overall Study|Patient with Dementia Died|0|||
130486906|NCT04271046|469751000|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
130486907|NCT04271046|469751001|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
130486908|NCT04271046|469751002|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
130486909|NCT04271046|469751003|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
130486910|NCT04707469|469753005|FG000|Overall Study|Site closure|0|||
130486911|NCT04707469|469753006|FG001|Overall Study|Site closure|2|||
130486912|NCT04707469|469753007|FG002|Overall Study|Site closure|0|||
130486913|NCT04707469|469753005|FG000|Overall Study|Physician Decision|2|||
130486914|NCT04707469|469753006|FG001|Overall Study|Physician Decision|2|||
130486915|NCT04707469|469753007|FG002|Overall Study|Physician Decision|2|||
130486916|NCT04707469|469753005|FG000|Overall Study|Death|1|||
130486917|NCT04707469|469753006|FG001|Overall Study|Death|6|||
130486918|NCT04707469|469753007|FG002|Overall Study|Death|2|||
130486919|NCT04707469|469753005|FG000|Overall Study|Lost to Follow-up|9|||
130486920|NCT04707469|469753006|FG001|Overall Study|Lost to Follow-up|19|||
130486921|NCT04707469|469753007|FG002|Overall Study|Lost to Follow-up|14|||
130486922|NCT04707469|469753005|FG000|Overall Study|Withdrawal by Subject|17|||
130486923|NCT04707469|469753006|FG001|Overall Study|Withdrawal by Subject|16|||
130486924|NCT04707469|469753007|FG002|Overall Study|Withdrawal by Subject|12|||
130486925|NCT05218096|469753015|FG000|Primary Evaluation|Withdrawal by Subject|0|||
130486926|NCT05218096|469753016|FG001|Primary Evaluation|Withdrawal by Subject|0|||
130486927|NCT05218096|469753017|FG002|Primary Evaluation|Withdrawal by Subject|2|||
130486928|NCT05218096|469753018|FG003|Primary Evaluation|Withdrawal by Subject|0|||
130486929|NCT05218096|469753019|FG004|Primary Evaluation|Withdrawal by Subject|0|||
130486930|NCT05218096|469753015|FG000|Primary Evaluation|Physician Decision|1|||
130486931|NCT05218096|469753016|FG001|Primary Evaluation|Physician Decision|0|||
130486932|NCT05218096|469753017|FG002|Primary Evaluation|Physician Decision|0|||
130486933|NCT05218096|469753018|FG003|Primary Evaluation|Physician Decision|0|||
130486934|NCT05218096|469753019|FG004|Primary Evaluation|Physician Decision|0|||
130486935|NCT05218096|469753015|FG000|Extended Treatment|Clinical Deterioration|1|||
130486936|NCT05218096|469753016|FG001|Extended Treatment|Clinical Deterioration|1|||
130486937|NCT05218096|469753017|FG002|Extended Treatment|Clinical Deterioration|0|||
130486938|NCT05218096|469753018|FG003|Extended Treatment|Clinical Deterioration|0|||
130486939|NCT05218096|469753019|FG004|Extended Treatment|Clinical Deterioration|0|||
130486940|NCT05218096|469753015|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
130486941|NCT05218096|469753016|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
130486942|NCT05218096|469753017|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
130486943|NCT05218096|469753018|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
130486944|NCT05218096|469753019|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
130728422|NCT02257385|470627465|FG001|Overall Study|Lost to Follow-up|1|||
130486945|NCT05218096|469753015|FG000|Extended Treatment|Withdrawal by Subject|1|||
130486946|NCT05218096|469753016|FG001|Extended Treatment|Withdrawal by Subject|3|||
130486947|NCT05218096|469753017|FG002|Extended Treatment|Withdrawal by Subject|0|||
130486948|NCT05218096|469753018|FG003|Extended Treatment|Withdrawal by Subject|2|||
130486949|NCT05218096|469753019|FG004|Extended Treatment|Withdrawal by Subject|2|||
130486950|NCT05218096|469753015|FG000|Extended Treatment|Lack of Efficacy|3|||
130486951|NCT05218096|469753016|FG001|Extended Treatment|Lack of Efficacy|0|||
130486952|NCT05218096|469753017|FG002|Extended Treatment|Lack of Efficacy|0|||
130486953|NCT05218096|469753018|FG003|Extended Treatment|Lack of Efficacy|0|||
130486954|NCT05218096|469753019|FG004|Extended Treatment|Lack of Efficacy|0|||
130486955|NCT05218096|469753015|FG000|Extended Treatment|Physician Decision|0|||
130486956|NCT05218096|469753016|FG001|Extended Treatment|Physician Decision|1|||
130486957|NCT05218096|469753017|FG002|Extended Treatment|Physician Decision|0|||
130486958|NCT05218096|469753018|FG003|Extended Treatment|Physician Decision|0|||
130486959|NCT05218096|469753019|FG004|Extended Treatment|Physician Decision|0|||
130486960|NCT05218096|469753015|FG000|Open-label Extension|Adverse Event|1|||
130486961|NCT05218096|469753016|FG001|Open-label Extension|Adverse Event|0|||
130486962|NCT05218096|469753017|FG002|Open-label Extension|Adverse Event|0|||
130486963|NCT05218096|469753018|FG003|Open-label Extension|Adverse Event|0|||
130486964|NCT05218096|469753019|FG004|Open-label Extension|Adverse Event|1|||
130486965|NCT05218096|469753015|FG000|Open-label Extension|Pregnancy|0|||
130486966|NCT05218096|469753016|FG001|Open-label Extension|Pregnancy|0|||
130486967|NCT05218096|469753017|FG002|Open-label Extension|Pregnancy|0|||
130486968|NCT05218096|469753018|FG003|Open-label Extension|Pregnancy|0|||
130486969|NCT05218096|469753019|FG004|Open-label Extension|Pregnancy|1|||
130486970|NCT05218096|469753015|FG000|Open-label Extension|Lack of Efficacy|1|||
130486971|NCT05218096|469753016|FG001|Open-label Extension|Lack of Efficacy|2|||
130486972|NCT05218096|469753017|FG002|Open-label Extension|Lack of Efficacy|0|||
130486973|NCT05218096|469753018|FG003|Open-label Extension|Lack of Efficacy|0|||
130486974|NCT05218096|469753019|FG004|Open-label Extension|Lack of Efficacy|0|||
130486975|NCT05218096|469753015|FG000|Open-label Extension|Lost to Follow-up|1|||
130486976|NCT05218096|469753016|FG001|Open-label Extension|Lost to Follow-up|0|||
130486977|NCT05218096|469753017|FG002|Open-label Extension|Lost to Follow-up|0|||
130486978|NCT05218096|469753018|FG003|Open-label Extension|Lost to Follow-up|0|||
130486979|NCT05218096|469753019|FG004|Open-label Extension|Lost to Follow-up|0|||
130486980|NCT05218096|469753015|FG000|Open-label Extension|Death|0|||
130486981|NCT05218096|469753016|FG001|Open-label Extension|Death|0|||
130486982|NCT05218096|469753017|FG002|Open-label Extension|Death|0|||
130486983|NCT05218096|469753018|FG003|Open-label Extension|Death|1|||
130486984|NCT05218096|469753019|FG004|Open-label Extension|Death|0|||
130486985|NCT05218096|469753015|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
130486986|NCT05218096|469753016|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
130486987|NCT05218096|469753017|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
130486988|NCT05218096|469753018|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
130486989|NCT05218096|469753019|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
130486990|NCT05269966|469753022|FG000|Overall Study|Adverse Event|4|||
130486991|NCT05269966|469753022|FG000|Overall Study|Withdrawal by Subject|1|||
130486992|NCT05269966|469753022|FG000|Overall Study|Lost to Follow-up|4|||
130486993|NCT05269966|469753022|FG000|Overall Study|Physician Decision|1|||
130486994|NCT05863156|469753031|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
130486995|NCT05863156|469753032|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
130486996|NCT05863156|469753033|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
130486997|NCT03442309|469753038|FG000|Overall Study|Lost to Follow-up|1676|||
130486998|NCT03442309|469753039|FG001|Overall Study|Lost to Follow-up|1642|||
130486999|NCT04862416|469753040|FG000|Overall Study|Withdrawal by Subject|0|||
130487000|NCT04862416|469753041|FG001|Overall Study|Withdrawal by Subject|1|||
130487001|NCT04862416|469753042|FG002|Overall Study|Withdrawal by Subject|0|||
130487002|NCT04862416|469753043|FG003|Overall Study|Withdrawal by Subject|1|||
130487003|NCT04862416|469753044|FG004|Overall Study|Withdrawal by Subject|0|||
130487004|NCT04862416|469753045|FG005|Overall Study|Withdrawal by Subject|0|||
130487005|NCT04862416|469753046|FG006|Overall Study|Withdrawal by Subject|0|||
130487006|NCT04862416|469753047|FG007|Overall Study|Withdrawal by Subject|0|||
130487007|NCT05207956|469753059|FG000|Overall Study|Lost to follow up|1|||
130487008|NCT05207956|469753060|FG001|Overall Study|Lost to follow up|2|||
130487009|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
130487010|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
130487011|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
130487012|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
130487013|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
130487014|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
130487015|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
130487016|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
130487017|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
130487018|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
130487019|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
130487020|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
130487021|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
130487022|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
130487023|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
130487024|NCT01254864|469753061|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
130487025|NCT01254864|469753062|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
130487026|NCT01254864|469753063|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
130487027|NCT01254864|469753061|FG000|Randomization Phase|Adverse Event|0|||
130487028|NCT01254864|469753062|FG001|Randomization Phase|Adverse Event|5|||
130487029|NCT01254864|469753063|FG002|Randomization Phase|Adverse Event|17|||
130487030|NCT01254864|469753061|FG000|Randomization Phase|Death|0|||
130487031|NCT01254864|469753062|FG001|Randomization Phase|Death|1|||
130487032|NCT01254864|469753063|FG002|Randomization Phase|Death|0|||
130487033|NCT01254864|469753061|FG000|Randomization Phase|Lost to Follow-up|0|||
130487034|NCT01254864|469753062|FG001|Randomization Phase|Lost to Follow-up|0|||
130487035|NCT01254864|469753063|FG002|Randomization Phase|Lost to Follow-up|1|||
130487036|NCT01254864|469753061|FG000|Randomization Phase|Physician Decision|0|||
130487037|NCT01254864|469753062|FG001|Randomization Phase|Physician Decision|20|||
130487038|NCT01254864|469753063|FG002|Randomization Phase|Physician Decision|25|||
130487039|NCT01254864|469753061|FG000|Randomization Phase|Withdrawal by Subject|0|||
130487040|NCT01254864|469753062|FG001|Randomization Phase|Withdrawal by Subject|4|||
130487041|NCT01254864|469753063|FG002|Randomization Phase|Withdrawal by Subject|2|||
130487042|NCT01254864|469753061|FG000|Randomization Phase|Non-Compliance|0|||
130487043|NCT01254864|469753062|FG001|Randomization Phase|Non-Compliance|1|||
130487044|NCT01254864|469753063|FG002|Randomization Phase|Non-Compliance|0|||
130487045|NCT01254864|469753061|FG000|Randomization Phase|Comorbidities|0|||
130487046|NCT01254864|469753062|FG001|Randomization Phase|Comorbidities|2|||
130487047|NCT01254864|469753063|FG002|Randomization Phase|Comorbidities|1|||
130487048|NCT01828112|469753068|FG000|Treatment Phase|Adverse Event|7|||
130487049|NCT01828112|469753069|FG001|Treatment Phase|Adverse Event|8|||
130487050|NCT01828112|469753070|FG002|Treatment Phase|Adverse Event|0|||
130487051|NCT01828112|469753068|FG000|Treatment Phase|Death|9|||
130487052|NCT01828112|469753069|FG001|Treatment Phase|Death|5|||
130487053|NCT01828112|469753070|FG002|Treatment Phase|Death|0|||
130487054|NCT01828112|469753068|FG000|Treatment Phase|No longer required treatment|0|||
130487055|NCT01828112|469753069|FG001|Treatment Phase|No longer required treatment|1|||
130487056|NCT01828112|469753070|FG002|Treatment Phase|No longer required treatment|0|||
130487057|NCT01828112|469753068|FG000|Treatment Phase|Physician Decision|6|||
130487058|NCT01828112|469753069|FG001|Treatment Phase|Physician Decision|7|||
130487059|NCT01828112|469753070|FG002|Treatment Phase|Physician Decision|0|||
130487060|NCT01828112|469753068|FG000|Treatment Phase|Pregnancy|1|||
130487061|NCT01828112|469753069|FG001|Treatment Phase|Pregnancy|0|||
130728423|NCT02257385|470627464|FG000|Overall Study|Withdrawal by Subject|4|||
130728424|NCT02257385|470627465|FG001|Overall Study|Withdrawal by Subject|4|||
130728425|NCT05199090|470627466|FG000|Overall Study|Adverse Event|1|||
130728426|NCT05199090|470627467|FG001|Overall Study|Adverse Event|4|||
130728427|NCT05199090|470627468|FG002|Overall Study|Adverse Event|0|||
130487062|NCT01828112|469753070|FG002|Treatment Phase|Pregnancy|0|||
130487063|NCT01828112|469753068|FG000|Treatment Phase|Progressive disease|79|||
130487064|NCT01828112|469753069|FG001|Treatment Phase|Progressive disease|87|||
130487065|NCT01828112|469753070|FG002|Treatment Phase|Progressive disease|0|||
130487066|NCT01828112|469753068|FG000|Treatment Phase|Study terminated by sponsor|1|||
130487067|NCT01828112|469753069|FG001|Treatment Phase|Study terminated by sponsor|0|||
130487068|NCT01828112|469753070|FG002|Treatment Phase|Study terminated by sponsor|0|||
130487069|NCT01828112|469753068|FG000|Treatment Phase|Subject/guardian decision|12|||
130487070|NCT01828112|469753069|FG001|Treatment Phase|Subject/guardian decision|8|||
130487071|NCT01828112|469753070|FG002|Treatment Phase|Subject/guardian decision|0|||
130487072|NCT01828112|469753068|FG000|Extension Treatment Phase|Adverse Event|0|||
130487073|NCT01828112|469753069|FG001|Extension Treatment Phase|Adverse Event|0|||
130728428|NCT05199090|470627469|FG003|Overall Study|Adverse Event|0|||
130728429|NCT05199090|470627470|FG004|Overall Study|Adverse Event|0|||
130487074|NCT01828112|469753070|FG002|Extension Treatment Phase|Adverse Event|6|||
130487075|NCT01828112|469753068|FG000|Extension Treatment Phase|Death|0|||
130487076|NCT01828112|469753069|FG001|Extension Treatment Phase|Death|0|||
130487077|NCT01828112|469753070|FG002|Extension Treatment Phase|Death|17|||
130487078|NCT01828112|469753068|FG000|Extension Treatment Phase|Physician Decision|0|||
130487079|NCT01828112|469753069|FG001|Extension Treatment Phase|Physician Decision|0|||
130487080|NCT01828112|469753070|FG002|Extension Treatment Phase|Physician Decision|5|||
130487081|NCT01828112|469753068|FG000|Extension Treatment Phase|Progressive disease|0|||
130728430|NCT05199090|470627471|FG005|Overall Study|Adverse Event|0|||
130728431|NCT05199090|470627466|FG000|Overall Study|Lost to Follow-up|1|||
130728432|NCT05199090|470627467|FG001|Overall Study|Lost to Follow-up|0|||
130728433|NCT05199090|470627468|FG002|Overall Study|Lost to Follow-up|1|||
130728434|NCT05199090|470627469|FG003|Overall Study|Lost to Follow-up|4|||
130728435|NCT05199090|470627470|FG004|Overall Study|Lost to Follow-up|0|||
130728436|NCT05199090|470627471|FG005|Overall Study|Lost to Follow-up|5|||
130728437|NCT05199090|470627466|FG000|Overall Study|Physician Decision|0|||
130728438|NCT05199090|470627467|FG001|Overall Study|Physician Decision|0|||
130728439|NCT05199090|470627468|FG002|Overall Study|Physician Decision|0|||
130728440|NCT05199090|470627469|FG003|Overall Study|Physician Decision|0|||
130728441|NCT05199090|470627470|FG004|Overall Study|Physician Decision|0|||
130728442|NCT05199090|470627471|FG005|Overall Study|Physician Decision|1|||
130728443|NCT05199090|470627466|FG000|Overall Study|Study terminated by sponsor|0|||
130728444|NCT05199090|470627467|FG001|Overall Study|Study terminated by sponsor|6|||
130728445|NCT05199090|470627468|FG002|Overall Study|Study terminated by sponsor|0|||
130728446|NCT05199090|470627469|FG003|Overall Study|Study terminated by sponsor|0|||
130728447|NCT05199090|470627470|FG004|Overall Study|Study terminated by sponsor|0|||
130728448|NCT05199090|470627471|FG005|Overall Study|Study terminated by sponsor|5|||
130728449|NCT05199090|470627466|FG000|Overall Study|Subject decision|0|||
130728450|NCT05199090|470627467|FG001|Overall Study|Subject decision|4|||
130728451|NCT05199090|470627468|FG002|Overall Study|Subject decision|0|||
130728452|NCT05199090|470627469|FG003|Overall Study|Subject decision|2|||
130728453|NCT05199090|470627470|FG004|Overall Study|Subject decision|5|||
130728454|NCT05199090|470627471|FG005|Overall Study|Subject decision|2|||
130728455|NCT03276078|470627473|FG000|Overall Study|Adverse Event|1|||
130728456|NCT02552732|470627474|FG000|Overall Study|Lost to Follow-up|2|||
130728457|NCT02552732|470627474|FG000|Overall Study|Physician Decision|1|||
130728458|NCT02552732|470627474|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
130728459|NCT02552732|470627474|FG000|Overall Study|Withdrawal by Subject|6|||
130728460|NCT04988087|470627477|FG000|Overall Study|Adverse Event|4|||
130728461|NCT04988087|470627478|FG001|Overall Study|Adverse Event|0|||
130728462|NCT04988087|470627479|FG002|Overall Study|Adverse Event|0|||
130728463|NCT04988087|470627480|FG003|Overall Study|Adverse Event|0|||
130728464|NCT04988087|470627477|FG000|Overall Study|Withdrawal by Subject|1|||
130728465|NCT04988087|470627478|FG001|Overall Study|Withdrawal by Subject|1|||
130728466|NCT04988087|470627479|FG002|Overall Study|Withdrawal by Subject|0|||
130728467|NCT04988087|470627480|FG003|Overall Study|Withdrawal by Subject|0|||
130728468|NCT04988087|470627477|FG000|Overall Study|Technical problems|7|||
130728469|NCT04988087|470627478|FG001|Overall Study|Technical problems|9|||
130728470|NCT04988087|470627479|FG002|Overall Study|Technical problems|1|||
130728471|NCT04988087|470627480|FG003|Overall Study|Technical problems|2|||
130487082|NCT01828112|469753069|FG001|Extension Treatment Phase|Progressive disease|0|||
130487083|NCT01828112|469753070|FG002|Extension Treatment Phase|Progressive disease|46|||
130487084|NCT01828112|469753068|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
130487085|NCT01828112|469753069|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
130487086|NCT01828112|469753070|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
130487087|NCT01828112|469753068|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
130487088|NCT01828112|469753069|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
130487089|NCT01828112|469753070|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
130487090|NCT02446236|469753080|FG000|Overall Study|Screen Failure|1|||
130487091|NCT02446236|469753081|FG001|Overall Study|Screen Failure|0|||
130487092|NCT02446236|469753082|FG002|Overall Study|Screen Failure|1|||
130487093|NCT02446236|469753080|FG000|Overall Study|Actively Receiving Therapy|0|||
130487094|NCT02446236|469753081|FG001|Overall Study|Actively Receiving Therapy|0|||
130487095|NCT02446236|469753082|FG002|Overall Study|Actively Receiving Therapy|1|||
130487096|NCT00429364|469753083|FG000|Overall Study|Withdrawal by Subject|11|||
130487097|NCT00429364|469753084|FG001|Overall Study|Withdrawal by Subject|5|||
130487098|NCT00429364|469753083|FG000|Overall Study|Physician Decision|4|||
130487099|NCT00429364|469753084|FG001|Overall Study|Physician Decision|2|||
130487100|NCT00429364|469753083|FG000|Overall Study|Lost to Follow-up|7|||
130487101|NCT00429364|469753084|FG001|Overall Study|Lost to Follow-up|6|||
130487102|NCT00429364|469753083|FG000|Overall Study|Death|0|||
130487103|NCT00429364|469753084|FG001|Overall Study|Death|1|||
130487104|NCT00429364|469753083|FG000|Overall Study|Underwent aortic root surgery|10|||
130487105|NCT00429364|469753084|FG001|Overall Study|Underwent aortic root surgery|18|||
130487106|NCT00429364|469753083|FG000|Overall Study|Pregnancy|0|||
130487107|NCT00429364|469753084|FG001|Overall Study|Pregnancy|1|||
130728472|NCT02800642|470627484|FG000|Overall Study|Death|3|||
130487108|NCT04871529|469753085|FG000|Overall Study|Withdrawal by Subject|0|||
130487109|NCT04871529|469753086|FG001|Overall Study|Withdrawal by Subject|1|||
130487110|NCT04871529|469753085|FG000|Overall Study|Death|0|||
130487111|NCT04871529|469753086|FG001|Overall Study|Death|1|||
130487112|NCT04871529|469753085|FG000|Overall Study|Not protocol specified|0|||
130728473|NCT02800642|470627484|FG000|Overall Study|Other|10|||
130728474|NCT02800642|470627484|FG000|Overall Study|Physician Decision|2|||
130728475|NCT02800642|470627484|FG000|Overall Study|Adverse Event|6|||
130728476|NCT02800642|470627484|FG000|Overall Study|Withdrawal by Subject|3|||
130728477|NCT02800642|470627484|FG000|Overall Study|Lost to Follow-up|1|||
130728478|NCT01004003|470627485|FG000|Overall Study|Progressive disease|2|||
130728479|NCT01004003|470627486|FG001|Overall Study|Progressive disease|1|||
130487113|NCT04871529|469753086|FG001|Overall Study|Not protocol specified|1|||
130487114|NCT05184452|469753087|FG000|Overall Study|Lost to Follow-up|0|||
130487115|NCT05184452|469753088|FG001|Overall Study|Lost to Follow-up|0|||
130487116|NCT05184452|469753089|FG002|Overall Study|Lost to Follow-up|0|||
130487117|NCT05184452|469753090|FG003|Overall Study|Lost to Follow-up|0|||
130487118|NCT05184452|469753091|FG004|Overall Study|Lost to Follow-up|0|||
130487119|NCT05184452|469753092|FG005|Overall Study|Lost to Follow-up|2|||
130487120|NCT05184452|469753093|FG006|Overall Study|Lost to Follow-up|0|||
130487121|NCT05184452|469753094|FG007|Overall Study|Lost to Follow-up|0|||
130487122|NCT05184452|469753095|FG008|Overall Study|Lost to Follow-up|0|||
130487123|NCT05184452|469753096|FG009|Overall Study|Lost to Follow-up|1|||
130487124|NCT05184452|469753087|FG000|Overall Study|Withdrawal by Subject|0|||
130487125|NCT05184452|469753088|FG001|Overall Study|Withdrawal by Subject|0|||
130487126|NCT05184452|469753089|FG002|Overall Study|Withdrawal by Subject|0|||
130487127|NCT05184452|469753090|FG003|Overall Study|Withdrawal by Subject|0|||
130487128|NCT05184452|469753091|FG004|Overall Study|Withdrawal by Subject|0|||
130487129|NCT05184452|469753092|FG005|Overall Study|Withdrawal by Subject|1|||
130487130|NCT05184452|469753093|FG006|Overall Study|Withdrawal by Subject|0|||
130487131|NCT05184452|469753094|FG007|Overall Study|Withdrawal by Subject|0|||
130487132|NCT05184452|469753095|FG008|Overall Study|Withdrawal by Subject|0|||
130487133|NCT05184452|469753096|FG009|Overall Study|Withdrawal by Subject|1|||
130487134|NCT04428203|469753110|FG000|Overall Study|Adverse Event|1|||
130487135|NCT04428203|469753111|FG001|Overall Study|Adverse Event|0|||
130487136|NCT04428203|469753112|FG002|Overall Study|Adverse Event|0|||
130487137|NCT04428203|469753110|FG000|Overall Study|Withdrawal by Subject|1|||
130487138|NCT04428203|469753111|FG001|Overall Study|Withdrawal by Subject|0|||
130487139|NCT04428203|469753112|FG002|Overall Study|Withdrawal by Subject|1|||
130487140|NCT05280574|469753113|FG000|Overall Study|Withdrawal by Subject|0|||
130487141|NCT05280574|469753114|FG001|Overall Study|Withdrawal by Subject|2|||
130487142|NCT05280574|469753115|FG002|Overall Study|Withdrawal by Subject|0|||
130487143|NCT05237284|469753120|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
130487144|NCT05237284|469753121|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
130487145|NCT05237284|469753122|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
130487146|NCT05237284|469753123|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
130487147|NCT05237284|469753120|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
130487148|NCT05237284|469753121|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
130487149|NCT05237284|469753122|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
130487150|NCT05237284|469753123|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
130487151|NCT05237284|469753120|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
130487152|NCT05237284|469753121|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
130487153|NCT05237284|469753122|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
130487154|NCT05237284|469753123|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
130487155|NCT05237284|469753120|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
130487156|NCT05237284|469753121|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
130487157|NCT05237284|469753122|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
130487158|NCT05237284|469753123|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
130487159|NCT05237284|469753120|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
130487160|NCT05237284|469753121|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
130487161|NCT05237284|469753122|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
130487162|NCT05237284|469753123|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
130487163|NCT05237284|469753120|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
130487164|NCT05237284|469753121|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
130487165|NCT05237284|469753122|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
130487166|NCT05237284|469753123|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
130487167|NCT05237284|469753120|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
130487168|NCT05237284|469753121|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
130487169|NCT05237284|469753122|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
130487170|NCT05237284|469753123|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
130487171|NCT05237284|469753120|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
130487172|NCT05237284|469753121|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
130487173|NCT05237284|469753122|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
130487174|NCT05237284|469753123|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
130487175|NCT05237284|469753120|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
130487176|NCT05237284|469753121|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
130487177|NCT05237284|469753122|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
130487178|NCT05237284|469753123|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
130487179|NCT04571619|469753127|FG000|Phase 1|Death|22|||
130487180|NCT04571619|469753128|FG001|Phase 1|Death|18|||
130487181|NCT04571619|469753127|FG000|Phase 1|Withdrawal by Subject|7|||
130487182|NCT04571619|469753128|FG001|Phase 1|Withdrawal by Subject|2|||
130487183|NCT04571619|469753127|FG000|Phase 2|Death|13|||
130487184|NCT04571619|469753128|FG001|Phase 2|Death|16|||
130487185|NCT04571619|469753127|FG000|Phase 2|Withdrawal by Subject|6|||
130487186|NCT04571619|469753128|FG001|Phase 2|Withdrawal by Subject|4|||
130487187|NCT02780700|469753138|FG000|Overall Study|Progressive disease|1|||
130487188|NCT04086121|469753146|FG000|Overall Study|Other than listed|8|||
130487189|NCT04086121|469753146|FG000|Overall Study|Withdrawal by Subject|3|||
130487190|NCT04086121|469753146|FG000|Overall Study|Lost to Follow-up|2|||
130487191|NCT04086121|469753146|FG000|Overall Study|Adverse Event|1|||
130487192|NCT02834390|469753147|FG000|Induction Phase|Progressive disease|0|||
130487193|NCT02834390|469753148|FG001|Induction Phase|Progressive disease|1|||
130487194|NCT02834390|469753147|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
130487195|NCT02834390|469753148|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
130487196|NCT02834390|469753147|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
130487197|NCT02834390|469753148|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
130487198|NCT02834390|469753147|FG000|Consolidation Phase|Physician Decision|1|||
130487199|NCT02834390|469753148|FG001|Consolidation Phase|Physician Decision|1|||
130487200|NCT03118518|469753149|FG000|Overall Study|Early Exit after treatment|2|||
130487201|NCT03118518|469753150|FG001|Overall Study|Early Exit after treatment|8|||
130487202|NCT03118518|469753149|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
130487203|NCT03118518|469753150|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
130487204|NCT02998528|469753156|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
130487205|NCT02998528|469753157|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
130487206|NCT02998528|469753158|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
130487207|NCT02998528|469753156|FG000|Randomization Period|Participant withdrew consent|0|||
130487208|NCT02998528|469753157|FG001|Randomization Period|Participant withdrew consent|3|||
130487209|NCT02998528|469753158|FG002|Randomization Period|Participant withdrew consent|0|||
130487210|NCT02998528|469753156|FG000|Randomization Period|Participant no longer meets study criteria|1|||
130487211|NCT02998528|469753157|FG001|Randomization Period|Participant no longer meets study criteria|3|||
130487212|NCT02998528|469753158|FG002|Randomization Period|Participant no longer meets study criteria|2|||
130487213|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
130487214|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
130487215|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
130487216|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
130487217|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
130487218|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
130487219|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
130487220|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
130487221|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
130487222|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
130487223|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
130487224|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
130487225|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
130487226|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
130487227|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
130487228|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Death|1|||
130487229|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Death|0|||
130487230|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Death|0|||
130487231|NCT02998528|469753156|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
130487232|NCT02998528|469753157|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
130487233|NCT02998528|469753158|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
130487234|NCT02998528|469753156|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
130487235|NCT02998528|469753157|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
130487236|NCT02998528|469753158|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
130487237|NCT02998528|469753156|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
130487238|NCT02998528|469753157|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
130487239|NCT02998528|469753158|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
130487240|NCT02998528|469753156|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
130487241|NCT02998528|469753157|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
130487242|NCT02998528|469753158|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
130487243|NCT02998528|469753156|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
130487244|NCT02998528|469753157|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
130487245|NCT02998528|469753158|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
130487246|NCT02998528|469753156|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
130487247|NCT02998528|469753157|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
130487248|NCT02998528|469753158|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
130487249|NCT03213678|469753162|FG000|Overall Study|Death|1|||
130728480|NCT01004003|470627487|FG002|Overall Study|Progressive disease|1|||
130728481|NCT01004003|470627488|FG003|Overall Study|Progressive disease|0|||
130728482|NCT01004003|470627489|FG004|Overall Study|Progressive disease|2|||
130728483|NCT01004003|470627490|FG005|Overall Study|Progressive disease|1|||
130728484|NCT01004003|470627491|FG006|Overall Study|Progressive disease|1|||
130728485|NCT01004003|470627492|FG007|Overall Study|Progressive disease|39|||
130728486|NCT01004003|470627493|FG008|Overall Study|Progressive disease|22|||
130728487|NCT01004003|470627485|FG000|Overall Study|Adverse Event|4|||
130728488|NCT01004003|470627486|FG001|Overall Study|Adverse Event|2|||
130728489|NCT01004003|470627487|FG002|Overall Study|Adverse Event|3|||
130728490|NCT01004003|470627488|FG003|Overall Study|Adverse Event|3|||
130728491|NCT01004003|470627489|FG004|Overall Study|Adverse Event|2|||
130728492|NCT01004003|470627490|FG005|Overall Study|Adverse Event|2|||
130728493|NCT01004003|470627491|FG006|Overall Study|Adverse Event|7|||
130487250|NCT03213678|469753162|FG000|Overall Study|Physician Decision|1|||
130487251|NCT03213678|469753162|FG000|Overall Study|Progressive disease|16|||
130487252|NCT04218851|469753163|FG000|Overall Study|Death|1|||
130487253|NCT04218851|469753164|FG001|Overall Study|Death|3|||
130487254|NCT03174275|469753165|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
130487255|NCT03174275|469753165|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
130487256|NCT03174275|469753165|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
130487257|NCT03174275|469753165|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
130487258|NCT03174275|469753165|FG000|Adjuvant Chemotherapy|Progression|1|||
130487259|NCT03174275|469753165|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
130487260|NCT03174275|469753165|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
130487261|NCT03174275|469753165|FG000|Adjuvant Durvalumab|Progression|1|||
130487262|NCT03174275|469753165|FG000|Adjuvant Durvalumab|Adverse Event|3|||
130487263|NCT03174275|469753165|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
130487264|NCT03174275|469753165|FG000|Adjuvant Radiotherapy|Progression|1|||
130487265|NCT03174275|469753165|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
130487266|NCT05285137|469753166|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130487267|NCT05285137|469753167|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130487268|NCT05285137|469753168|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
130487269|NCT05285137|469753169|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
130487270|NCT05285137|469753170|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
130487271|NCT05285137|469753171|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
130487272|NCT05285137|469753172|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
130487273|NCT05285137|469753173|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
130487274|NCT05285137|469753174|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
130487275|NCT05285137|469753166|FG000|Overall Study|Lost to Follow-up|0|||
130487276|NCT05285137|469753167|FG001|Overall Study|Lost to Follow-up|0|||
130487277|NCT05285137|469753168|FG002|Overall Study|Lost to Follow-up|1|||
130487278|NCT05285137|469753169|FG003|Overall Study|Lost to Follow-up|3|||
130487279|NCT05285137|469753170|FG004|Overall Study|Lost to Follow-up|0|||
130487280|NCT05285137|469753171|FG005|Overall Study|Lost to Follow-up|0|||
130487281|NCT05285137|469753172|FG006|Overall Study|Lost to Follow-up|1|||
130487282|NCT05285137|469753173|FG007|Overall Study|Lost to Follow-up|0|||
130487283|NCT05285137|469753174|FG008|Overall Study|Lost to Follow-up|0|||
130487284|NCT05285137|469753166|FG000|Overall Study|Physician Decision|0|||
130487285|NCT05285137|469753167|FG001|Overall Study|Physician Decision|1|||
130487286|NCT05285137|469753168|FG002|Overall Study|Physician Decision|0|||
130487287|NCT05285137|469753169|FG003|Overall Study|Physician Decision|0|||
130487288|NCT05285137|469753170|FG004|Overall Study|Physician Decision|0|||
130487289|NCT05285137|469753171|FG005|Overall Study|Physician Decision|0|||
130487290|NCT05285137|469753172|FG006|Overall Study|Physician Decision|0|||
130487291|NCT05285137|469753173|FG007|Overall Study|Physician Decision|0|||
130487292|NCT05285137|469753174|FG008|Overall Study|Physician Decision|0|||
130487293|NCT05285137|469753166|FG000|Overall Study|Pregnancy|0|||
130487294|NCT05285137|469753167|FG001|Overall Study|Pregnancy|0|||
130487295|NCT05285137|469753168|FG002|Overall Study|Pregnancy|0|||
130487296|NCT05285137|469753169|FG003|Overall Study|Pregnancy|0|||
130487297|NCT05285137|469753170|FG004|Overall Study|Pregnancy|0|||
130487298|NCT05285137|469753171|FG005|Overall Study|Pregnancy|0|||
130728494|NCT01004003|470627492|FG007|Overall Study|Adverse Event|21|||
130487299|NCT05285137|469753172|FG006|Overall Study|Pregnancy|1|||
130487300|NCT05285137|469753173|FG007|Overall Study|Pregnancy|0|||
130487301|NCT05285137|469753174|FG008|Overall Study|Pregnancy|0|||
130487302|NCT05285137|469753166|FG000|Overall Study|Withdrawal by Subject|0|||
130487303|NCT05285137|469753167|FG001|Overall Study|Withdrawal by Subject|1|||
130487304|NCT05285137|469753168|FG002|Overall Study|Withdrawal by Subject|2|||
130487305|NCT05285137|469753169|FG003|Overall Study|Withdrawal by Subject|1|||
130487306|NCT05285137|469753170|FG004|Overall Study|Withdrawal by Subject|0|||
130487307|NCT05285137|469753171|FG005|Overall Study|Withdrawal by Subject|0|||
130487308|NCT05285137|469753172|FG006|Overall Study|Withdrawal by Subject|0|||
130728495|NCT01004003|470627493|FG008|Overall Study|Adverse Event|6|||
130728496|NCT01004003|470627485|FG000|Overall Study|Refused to continue taking trial med.|0|||
130728497|NCT01004003|470627486|FG001|Overall Study|Refused to continue taking trial med.|0|||
130728498|NCT01004003|470627487|FG002|Overall Study|Refused to continue taking trial med.|0|||
130728499|NCT01004003|470627488|FG003|Overall Study|Refused to continue taking trial med.|0|||
130728500|NCT01004003|470627489|FG004|Overall Study|Refused to continue taking trial med.|0|||
130728501|NCT01004003|470627490|FG005|Overall Study|Refused to continue taking trial med.|0|||
130487309|NCT05285137|469753173|FG007|Overall Study|Withdrawal by Subject|0|||
130487310|NCT05285137|469753174|FG008|Overall Study|Withdrawal by Subject|1|||
130487311|NCT01820611|469753175|FG000|Overall Study|Death|8|||
130487312|NCT01820611|469753175|FG000|Overall Study|Adverse Event|1|||
130487313|NCT01820611|469753175|FG000|Overall Study|Withdrawal by Subject|9|||
130487314|NCT03484819|469753176|FG000|Overall Study|Death|2|||
130487315|NCT03484819|469753176|FG000|Overall Study|Adverse Event|2|||
130487316|NCT03484819|469753176|FG000|Overall Study|Physician Decision|1|||
130487317|NCT03484819|469753176|FG000|Overall Study|Withdrawal by Subject|2|||
130487318|NCT03484819|469753176|FG000|Overall Study|Disease Progression|4|||
130487319|NCT03484819|469753176|FG000|Overall Study|Complicating Condition|1|||
130487320|NCT04456296|469753177|FG000|Overall Study|Withdrawal by Subject|14|||
130487321|NCT04456296|469753178|FG001|Overall Study|Withdrawal by Subject|21|||
130487322|NCT04456296|469753179|FG002|Overall Study|Withdrawal by Subject|21|||
130487323|NCT04456296|469753177|FG000|Overall Study|Adverse Event|2|||
130487324|NCT04456296|469753178|FG001|Overall Study|Adverse Event|2|||
130487325|NCT04456296|469753179|FG002|Overall Study|Adverse Event|2|||
130487326|NCT04456296|469753177|FG000|Overall Study|Death|1|||
130487327|NCT04456296|469753178|FG001|Overall Study|Death|0|||
130487328|NCT04456296|469753179|FG002|Overall Study|Death|0|||
130487329|NCT04456296|469753177|FG000|Overall Study|Lost to Follow-up|3|||
130487330|NCT04456296|469753178|FG001|Overall Study|Lost to Follow-up|5|||
130487331|NCT04456296|469753179|FG002|Overall Study|Lost to Follow-up|6|||
130487332|NCT04456296|469753177|FG000|Overall Study|Other than specified|0|||
130487333|NCT04456296|469753178|FG001|Overall Study|Other than specified|1|||
130487334|NCT04456296|469753179|FG002|Overall Study|Other than specified|4|||
130487335|NCT04456296|469753177|FG000|Overall Study|Randomized, not treated|2|||
130487336|NCT04456296|469753178|FG001|Overall Study|Randomized, not treated|1|||
130487337|NCT04456296|469753179|FG002|Overall Study|Randomized, not treated|0|||
130487338|NCT03106740|469754883|FG000|Overall Study|Lost to Follow-up|2|||
130487339|NCT03106740|469754884|FG001|Overall Study|Lost to Follow-up|2|||
130487340|NCT03106740|469754883|FG000|Overall Study|Withdrawal by Subject|2|||
130487341|NCT03106740|469754884|FG001|Overall Study|Withdrawal by Subject|4|||
130487342|NCT03106740|469754883|FG000|Overall Study|Physician Decision|0|||
130487343|NCT03106740|469754884|FG001|Overall Study|Physician Decision|1|||
130487344|NCT03106740|469754883|FG000|Overall Study|Partial data|1|||
130487345|NCT03106740|469754884|FG001|Overall Study|Partial data|0|||
130487346|NCT04565990|469754885|FG000|Overall Study|Death|5|||
130487347|NCT04565990|469754885|FG000|Overall Study|Lost to Follow-up|1|||
130487348|NCT04565990|469754885|FG000|Overall Study|Withdrawal by Subject|1|||
130487349|NCT04797858|469754886|FG000|Overall Study|Withdrawal by Subject|0|||
130487350|NCT04797858|469754887|FG001|Overall Study|Withdrawal by Subject|1|||
130487351|NCT04797858|469754886|FG000|Overall Study|Excluded due to administrative error|7|||
130487352|NCT04797858|469754887|FG001|Overall Study|Excluded due to administrative error|8|||
130487353|NCT04826471|469754888|FG000|Overall Study|Lost to Follow-up|2|||
130487354|NCT04826471|469754888|FG000|Overall Study|Protocol Violation|3|||
130487355|NCT04826471|469754888|FG000|Overall Study|Withdrawal by Subject|1|||
130487356|NCT04414722|469754889|FG000|Overall Study|Lost to Follow-up|3|||
130487357|NCT04414722|469754890|FG001|Overall Study|Lost to Follow-up|4|||
130487358|NCT04414722|469754891|FG002|Overall Study|Lost to Follow-up|3|||
130487359|NCT04414722|469754892|FG003|Overall Study|Lost to Follow-up|2|||
130487360|NCT04414722|469754893|FG004|Overall Study|Lost to Follow-up|3|||
130487361|NCT04414722|469754889|FG000|Overall Study|Withdrawal by Subject|6|||
130487362|NCT04414722|469754890|FG001|Overall Study|Withdrawal by Subject|3|||
130487363|NCT04414722|469754891|FG002|Overall Study|Withdrawal by Subject|1|||
130487364|NCT04414722|469754892|FG003|Overall Study|Withdrawal by Subject|5|||
130487365|NCT04414722|469754893|FG004|Overall Study|Withdrawal by Subject|1|||
130728502|NCT01004003|470627491|FG006|Overall Study|Refused to continue taking trial med.|0|||
130728503|NCT01004003|470627492|FG007|Overall Study|Refused to continue taking trial med.|0|||
130487366|NCT04414722|469754889|FG000|Overall Study|Physician Decision|0|||
130487367|NCT04414722|469754890|FG001|Overall Study|Physician Decision|1|||
130487368|NCT04414722|469754891|FG002|Overall Study|Physician Decision|2|||
130487369|NCT04414722|469754892|FG003|Overall Study|Physician Decision|0|||
130487370|NCT04414722|469754893|FG004|Overall Study|Physician Decision|0|||
130487371|NCT04414722|469754889|FG000|Overall Study|Non-participatory|0|||
130487372|NCT04414722|469754890|FG001|Overall Study|Non-participatory|1|||
130487373|NCT04414722|469754891|FG002|Overall Study|Non-participatory|1|||
130487374|NCT04414722|469754892|FG003|Overall Study|Non-participatory|0|||
130728504|NCT01004003|470627493|FG008|Overall Study|Refused to continue taking trial med.|2|||
130487375|NCT04414722|469754893|FG004|Overall Study|Non-participatory|0|||
130487376|NCT04304144|469754894|FG000|DLT Observation Period|Physician Decision|0|||
130487377|NCT04304144|469754895|FG001|DLT Observation Period|Physician Decision|1|||
130565267|NCT02289742|470035433|FG002|Third Wear Period|Adverse Event|0|||
130487378|NCT04304144|469754896|FG002|DLT Observation Period|Physician Decision|0|||
130487379|NCT04304144|469754897|FG003|DLT Observation Period|Physician Decision|0|||
130487380|NCT04304144|469754894|FG000|Continued Treatment Period|Adverse Event|0|||
130487381|NCT04304144|469754895|FG001|Continued Treatment Period|Adverse Event|1|||
130487382|NCT04304144|469754896|FG002|Continued Treatment Period|Adverse Event|0|||
130487383|NCT04304144|469754897|FG003|Continued Treatment Period|Adverse Event|0|||
130487384|NCT04304144|469754894|FG000|Continued Treatment Period|Death|0|||
130487385|NCT04304144|469754895|FG001|Continued Treatment Period|Death|0|||
130487386|NCT04304144|469754896|FG002|Continued Treatment Period|Death|1|||
130487387|NCT04304144|469754897|FG003|Continued Treatment Period|Death|2|||
130487388|NCT04304144|469754894|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
130487389|NCT04304144|469754895|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
130487390|NCT04304144|469754896|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
130487391|NCT04304144|469754897|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
130487392|NCT04304144|469754894|FG000|Continued Treatment Period|Other than specified|2|||
130487393|NCT04304144|469754895|FG001|Continued Treatment Period|Other than specified|0|||
130487394|NCT04304144|469754896|FG002|Continued Treatment Period|Other than specified|1|||
130487395|NCT04304144|469754897|FG003|Continued Treatment Period|Other than specified|1|||
130487396|NCT05256654|469754898|FG000|Overall Study|Adverse Event|0|||
130487397|NCT05256654|469754899|FG001|Overall Study|Adverse Event|0|||
130487398|NCT05256654|469754900|FG002|Overall Study|Adverse Event|1|||
130487399|NCT05256654|469754901|FG003|Overall Study|Adverse Event|0|||
130487400|NCT05256654|469754898|FG000|Overall Study|Lost to Follow-up|0|||
130487401|NCT05256654|469754899|FG001|Overall Study|Lost to Follow-up|0|||
130487402|NCT05256654|469754900|FG002|Overall Study|Lost to Follow-up|0|||
130487403|NCT05256654|469754901|FG003|Overall Study|Lost to Follow-up|1|||
130487404|NCT05256654|469754898|FG000|Overall Study|Withdrawal by Subject|1|||
130487405|NCT05256654|469754899|FG001|Overall Study|Withdrawal by Subject|2|||
130487406|NCT05256654|469754900|FG002|Overall Study|Withdrawal by Subject|1|||
130487407|NCT05256654|469754901|FG003|Overall Study|Withdrawal by Subject|3|||
130487408|NCT05256654|469754898|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
130487409|NCT05256654|469754899|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
130487410|NCT05256654|469754900|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
130487411|NCT05256654|469754901|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
130487412|NCT05256654|469754898|FG000|Overall Study|Other|0|||
130487413|NCT05256654|469754899|FG001|Overall Study|Other|0|||
130487414|NCT05256654|469754900|FG002|Overall Study|Other|0|||
130487415|NCT05256654|469754901|FG003|Overall Study|Other|1|||
130487416|NCT04862234|469754906|FG000|Overall Study|Surgery cancellation|1|||
130487417|NCT04862234|469754907|FG001|Overall Study|Surgery cancellation|2|||
130487418|NCT04862234|469754906|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
130487419|NCT04862234|469754907|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
130487420|NCT04862234|469754906|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
130487421|NCT04862234|469754907|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
130487422|NCT03292484|469754908|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
130487423|NCT03292484|469754908|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
130487424|NCT03292484|469754908|FG000|Overall Study|Protocol Violation|2|||
130487425|NCT03292484|469754908|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
130487426|NCT03292484|469754908|FG000|Overall Study|Sponsor decision|349|||
130487427|NCT03292484|469754908|FG000|Overall Study|Lost to Follow-up|7|||
130487428|NCT03292484|469754908|FG000|Overall Study|Coronavirus Disease 2019|1|||
130487429|NCT03292484|469754908|FG000|Overall Study|Other|20|||
130487430|NCT05425420|469754911|FG000|Overall Study|Physician Decision|1|||
130487431|NCT05425420|469754911|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
130487432|NCT03714815|469754912|FG000|Overall Study|Physician Decision|2|||
130487433|NCT03714815|469754912|FG000|Overall Study|Withdrawal by Subject|2|||
130487434|NCT03714815|469754912|FG000|Overall Study|Death|11|||
130487435|NCT03505008|469754913|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
130487436|NCT03505008|469754914|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
130487437|NCT03505008|469754915|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
130487438|NCT03505008|469754916|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
130487439|NCT03505008|469754913|FG000|Before Week 24 Randomization|Adverse Event|10|||
130487440|NCT03505008|469754914|FG001|Before Week 24 Randomization|Adverse Event|0|||
130487441|NCT03505008|469754915|FG002|Before Week 24 Randomization|Adverse Event|0|||
130487442|NCT03505008|469754916|FG003|Before Week 24 Randomization|Adverse Event|0|||
130487443|NCT03505008|469754913|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
130487444|NCT03505008|469754914|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
130487445|NCT03505008|469754915|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
130487446|NCT03505008|469754916|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
130487447|NCT03505008|469754913|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
130487448|NCT03505008|469754914|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
130487449|NCT03505008|469754915|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
130487450|NCT03505008|469754916|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
130487451|NCT03505008|469754913|FG000|Before Week 24 Randomization|Physician Decision|2|||
130487452|NCT03505008|469754914|FG001|Before Week 24 Randomization|Physician Decision|0|||
130487453|NCT03505008|469754915|FG002|Before Week 24 Randomization|Physician Decision|0|||
130487454|NCT03505008|469754916|FG003|Before Week 24 Randomization|Physician Decision|0|||
130487455|NCT03505008|469754913|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
130487456|NCT03505008|469754914|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
130487457|NCT03505008|469754915|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
130487458|NCT03505008|469754916|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
130487459|NCT03505008|469754913|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
130487460|NCT03505008|469754914|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
130487461|NCT03505008|469754915|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
130487462|NCT03505008|469754916|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
130487463|NCT03505008|469754913|FG000|Before Week 24 Randomization|Complication|1|||
130487464|NCT03505008|469754914|FG001|Before Week 24 Randomization|Complication|0|||
130487465|NCT03505008|469754915|FG002|Before Week 24 Randomization|Complication|0|||
130487466|NCT03505008|469754916|FG003|Before Week 24 Randomization|Complication|0|||
130487467|NCT03505008|469754913|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
130487468|NCT03505008|469754914|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
130487469|NCT03505008|469754915|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
130487470|NCT03505008|469754916|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
130487471|NCT03505008|469754913|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
130487472|NCT03505008|469754914|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
130487473|NCT03505008|469754915|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
130487474|NCT03505008|469754916|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
130487475|NCT03505008|469754913|FG000|After Week 24 Randomization|Adverse Event|0|||
130487476|NCT03505008|469754914|FG001|After Week 24 Randomization|Adverse Event|1|||
130487477|NCT03505008|469754915|FG002|After Week 24 Randomization|Adverse Event|2|||
130487478|NCT03505008|469754916|FG003|After Week 24 Randomization|Adverse Event|2|||
130487479|NCT03505008|469754913|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
130487480|NCT03505008|469754914|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
130487481|NCT03505008|469754915|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
130487482|NCT03505008|469754916|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
130487483|NCT03505008|469754913|FG000|After Week 24 Randomization|Protocol Violation|0|||
130487484|NCT03505008|469754914|FG001|After Week 24 Randomization|Protocol Violation|0|||
130487485|NCT03505008|469754915|FG002|After Week 24 Randomization|Protocol Violation|1|||
130487486|NCT03505008|469754916|FG003|After Week 24 Randomization|Protocol Violation|0|||
130487487|NCT03276676|469754920|FG000|Overall Study|Withdrawal by Subject|2|||
130487488|NCT03276676|469754921|FG001|Overall Study|Withdrawal by Subject|1|||
130487489|NCT04741776|469754923|FG000|Overall Study|Withdrawal by Subject|7|||
130487490|NCT04741776|469754924|FG001|Overall Study|Withdrawal by Subject|10|||
130487491|NCT04741776|469754925|FG002|Overall Study|Withdrawal by Subject|10|||
130487492|NCT04741776|469754926|FG003|Overall Study|Withdrawal by Subject|17|||
130487493|NCT04741776|469754923|FG000|Overall Study|Death|0|||
130487494|NCT04741776|469754924|FG001|Overall Study|Death|0|||
130487495|NCT04741776|469754925|FG002|Overall Study|Death|1|||
130487496|NCT04741776|469754926|FG003|Overall Study|Death|0|||
130487497|NCT04089865|469754927|FG000|Overall Study|Withdrawal by Subject|2|||
130487498|NCT04089865|469754928|FG001|Overall Study|Withdrawal by Subject|2|||
130487499|NCT04089865|469754929|FG002|Overall Study|Withdrawal by Subject|7|||
130487500|NCT04089865|469754930|FG003|Overall Study|Withdrawal by Subject|2|||
130487501|NCT03926130|469754931|FG000|Overall Study|Adverse Event|9|||
130487502|NCT03926130|469754932|FG001|Overall Study|Adverse Event|11|||
130487503|NCT03926130|469754933|FG002|Overall Study|Adverse Event|2|||
130487504|NCT03926130|469754934|FG003|Overall Study|Adverse Event|0|||
130487505|NCT03926130|469754931|FG000|Overall Study|Death|2|||
130487506|NCT03926130|469754932|FG001|Overall Study|Death|0|||
130487507|NCT03926130|469754933|FG002|Overall Study|Death|1|||
130487508|NCT03926130|469754934|FG003|Overall Study|Death|0|||
130487509|NCT03926130|469754931|FG000|Overall Study|Lack of Efficacy|14|||
130487510|NCT03926130|469754932|FG001|Overall Study|Lack of Efficacy|11|||
130487511|NCT03926130|469754933|FG002|Overall Study|Lack of Efficacy|7|||
130487512|NCT03926130|469754934|FG003|Overall Study|Lack of Efficacy|1|||
130487513|NCT03926130|469754931|FG000|Overall Study|Lost to Follow-up|0|||
130487514|NCT03926130|469754932|FG001|Overall Study|Lost to Follow-up|7|||
130487515|NCT03926130|469754933|FG002|Overall Study|Lost to Follow-up|1|||
130487516|NCT03926130|469754934|FG003|Overall Study|Lost to Follow-up|0|||
130487517|NCT03926130|469754931|FG000|Overall Study|As Reported by Investigator|2|||
130487518|NCT03926130|469754932|FG001|Overall Study|As Reported by Investigator|6|||
130487519|NCT03926130|469754933|FG002|Overall Study|As Reported by Investigator|6|||
130487520|NCT03926130|469754934|FG003|Overall Study|As Reported by Investigator|0|||
130487521|NCT03926130|469754931|FG000|Overall Study|Physician Decision|3|||
130487522|NCT03926130|469754932|FG001|Overall Study|Physician Decision|2|||
130487523|NCT03926130|469754933|FG002|Overall Study|Physician Decision|1|||
130487524|NCT03926130|469754934|FG003|Overall Study|Physician Decision|0|||
130487525|NCT03926130|469754931|FG000|Overall Study|Pregnancy|2|||
130487526|NCT03926130|469754932|FG001|Overall Study|Pregnancy|2|||
130487527|NCT03926130|469754933|FG002|Overall Study|Pregnancy|1|||
130487528|NCT03926130|469754934|FG003|Overall Study|Pregnancy|0|||
130487529|NCT03926130|469754931|FG000|Overall Study|Withdrawal by Subject|20|||
130487530|NCT03926130|469754932|FG001|Overall Study|Withdrawal by Subject|28|||
130487531|NCT03926130|469754933|FG002|Overall Study|Withdrawal by Subject|18|||
130487532|NCT03926130|469754934|FG003|Overall Study|Withdrawal by Subject|1|||
130487533|NCT03926130|469754931|FG000|Overall Study|Non-Compliance|1|||
130487534|NCT03926130|469754932|FG001|Overall Study|Non-Compliance|1|||
130487535|NCT03926130|469754933|FG002|Overall Study|Non-Compliance|0|||
130487536|NCT03926130|469754934|FG003|Overall Study|Non-Compliance|0|||
130487537|NCT03926130|469754931|FG000|Overall Study|Disposition Not Captured|0|||
130487538|NCT03926130|469754932|FG001|Overall Study|Disposition Not Captured|2|||
130487539|NCT03926130|469754933|FG002|Overall Study|Disposition Not Captured|1|||
130487540|NCT03926130|469754934|FG003|Overall Study|Disposition Not Captured|0|||
130487541|NCT03583333|469754935|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
130487542|NCT03583333|469754936|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
130487543|NCT03583333|469754935|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
130487544|NCT03583333|469754936|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
130487545|NCT03583333|469754935|FG000|Overall Study|Withdrawal by Subject|9|||
130487546|NCT03583333|469754936|FG001|Overall Study|Withdrawal by Subject|5|||
130487547|NCT03583333|469754935|FG000|Overall Study|Physician Decision|3|||
130487548|NCT03583333|469754936|FG001|Overall Study|Physician Decision|2|||
130487549|NCT03583333|469754935|FG000|Overall Study|Death|12|||
130487550|NCT03583333|469754936|FG001|Overall Study|Death|7|||
130487551|NCT03824366|469754944|FG000|Overall Study|Death|1|||
130487552|NCT03824366|469754944|FG000|Overall Study|Previously unidentified metal artifact|1|||
130487553|NCT03824366|469754944|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
130487554|NCT03824366|469754944|FG000|Overall Study|Withdrawal by Subject|1|||
130487555|NCT05069896|469754945|FG000|Overall Study|Adverse Event|0|||
130487556|NCT05069896|469754946|FG001|Overall Study|Adverse Event|1|||
130487557|NCT05069896|469754947|FG002|Overall Study|Adverse Event|1|||
130487558|NCT05069896|469754948|FG003|Overall Study|Adverse Event|0|||
130487559|NCT05069896|469754949|FG004|Overall Study|Adverse Event|0|||
130487560|NCT05069896|469754950|FG005|Overall Study|Adverse Event|0|||
130487561|NCT05069896|469754945|FG000|Overall Study|Lost to Follow-up|0|||
130487562|NCT05069896|469754946|FG001|Overall Study|Lost to Follow-up|0|||
130487563|NCT05069896|469754947|FG002|Overall Study|Lost to Follow-up|1|||
130487564|NCT05069896|469754948|FG003|Overall Study|Lost to Follow-up|0|||
130487565|NCT05069896|469754949|FG004|Overall Study|Lost to Follow-up|1|||
130487566|NCT05069896|469754950|FG005|Overall Study|Lost to Follow-up|2|||
130487567|NCT04068831|469754951|FG000|Overall Study|Disease Progression|10|||
130487568|NCT04068831|469754952|FG001|Overall Study|Disease Progression|8|||
130487569|NCT04820322|469754953|FG000|Overall Study|Adverse Event|1|||
130487570|NCT04820322|469754954|FG001|Overall Study|Adverse Event|0|||
130487571|NCT00323856|469754958|FG000|Overall Study|Withdrawal by Subject|1|||
130487572|NCT00323856|469754958|FG000|Overall Study|Was uncooperative and noncompliant|1|||
130487573|NCT00323856|469754958|FG000|Overall Study|Reason not specified|1|||
130487574|NCT00323856|469754958|FG000|Overall Study|Missing|2|||
130487575|NCT03156465|469754959|FG000|Overall Study|Withdrawal by Subject|2|||
130487576|NCT04580914|469754971|FG000|Overall Study|Withdrawal by Subject|6|||
130487577|NCT04580914|469754971|FG000|Overall Study|Lost to Follow-up|2|||
130487578|NCT03580356|469754972|FG000|Treatment Period|Withdrawal by Subject|13|||
130487579|NCT03580356|469754973|FG001|Treatment Period|Withdrawal by Subject|0|||
130487580|NCT03580356|469754974|FG002|Treatment Period|Withdrawal by Subject|13|||
130487581|NCT03580356|469754975|FG003|Treatment Period|Withdrawal by Subject|1|||
130487582|NCT03580356|469754976|FG004|Treatment Period|Withdrawal by Subject|17|||
130487583|NCT03580356|469754977|FG005|Treatment Period|Withdrawal by Subject|0|||
130487584|NCT03580356|469754978|FG006|Treatment Period|Withdrawal by Subject|5|||
130487585|NCT03580356|469754979|FG007|Treatment Period|Withdrawal by Subject|0|||
130487586|NCT03580356|469754972|FG000|Treatment Period|Adverse Event|10|||
130487587|NCT03580356|469754973|FG001|Treatment Period|Adverse Event|0|||
130487588|NCT03580356|469754974|FG002|Treatment Period|Adverse Event|13|||
130487589|NCT03580356|469754975|FG003|Treatment Period|Adverse Event|0|||
130487590|NCT03580356|469754976|FG004|Treatment Period|Adverse Event|5|||
130487591|NCT03580356|469754977|FG005|Treatment Period|Adverse Event|0|||
130487592|NCT03580356|469754978|FG006|Treatment Period|Adverse Event|8|||
130487593|NCT03580356|469754979|FG007|Treatment Period|Adverse Event|0|||
130487594|NCT03580356|469754972|FG000|Treatment Period|Protocol Violation|5|||
130487595|NCT03580356|469754973|FG001|Treatment Period|Protocol Violation|0|||
130487596|NCT03580356|469754974|FG002|Treatment Period|Protocol Violation|6|||
130487597|NCT03580356|469754975|FG003|Treatment Period|Protocol Violation|1|||
130487598|NCT03580356|469754976|FG004|Treatment Period|Protocol Violation|9|||
130487599|NCT03580356|469754977|FG005|Treatment Period|Protocol Violation|1|||
130487600|NCT03580356|469754978|FG006|Treatment Period|Protocol Violation|1|||
130487601|NCT03580356|469754979|FG007|Treatment Period|Protocol Violation|0|||
130487602|NCT03580356|469754972|FG000|Treatment Period|Lack of Efficacy|6|||
130487603|NCT03580356|469754973|FG001|Treatment Period|Lack of Efficacy|0|||
130487604|NCT03580356|469754974|FG002|Treatment Period|Lack of Efficacy|2|||
130487605|NCT03580356|469754975|FG003|Treatment Period|Lack of Efficacy|0|||
130487606|NCT03580356|469754976|FG004|Treatment Period|Lack of Efficacy|3|||
130487607|NCT03580356|469754977|FG005|Treatment Period|Lack of Efficacy|0|||
130487608|NCT03580356|469754978|FG006|Treatment Period|Lack of Efficacy|3|||
130487609|NCT03580356|469754979|FG007|Treatment Period|Lack of Efficacy|0|||
130487610|NCT03580356|469754972|FG000|Treatment Period|Pregnancy|1|||
130487611|NCT03580356|469754973|FG001|Treatment Period|Pregnancy|0|||
130487612|NCT03580356|469754974|FG002|Treatment Period|Pregnancy|7|||
130487613|NCT03580356|469754975|FG003|Treatment Period|Pregnancy|0|||
130487614|NCT03580356|469754976|FG004|Treatment Period|Pregnancy|2|||
130487615|NCT03580356|469754977|FG005|Treatment Period|Pregnancy|0|||
130487616|NCT03580356|469754978|FG006|Treatment Period|Pregnancy|1|||
130487617|NCT03580356|469754979|FG007|Treatment Period|Pregnancy|0|||
130487618|NCT03580356|469754972|FG000|Treatment Period|Physician Decision|2|||
130487619|NCT03580356|469754973|FG001|Treatment Period|Physician Decision|0|||
130487620|NCT03580356|469754974|FG002|Treatment Period|Physician Decision|1|||
130487621|NCT03580356|469754975|FG003|Treatment Period|Physician Decision|0|||
130487622|NCT03580356|469754976|FG004|Treatment Period|Physician Decision|4|||
130487623|NCT03580356|469754977|FG005|Treatment Period|Physician Decision|0|||
130487624|NCT03580356|469754978|FG006|Treatment Period|Physician Decision|2|||
130487625|NCT03580356|469754979|FG007|Treatment Period|Physician Decision|0|||
130487626|NCT03580356|469754972|FG000|Treatment Period|Lost to Follow-up|1|||
130487627|NCT03580356|469754973|FG001|Treatment Period|Lost to Follow-up|1|||
130487628|NCT03580356|469754974|FG002|Treatment Period|Lost to Follow-up|1|||
130487629|NCT03580356|469754975|FG003|Treatment Period|Lost to Follow-up|0|||
130487630|NCT03580356|469754976|FG004|Treatment Period|Lost to Follow-up|3|||
130487631|NCT03580356|469754977|FG005|Treatment Period|Lost to Follow-up|0|||
130487632|NCT03580356|469754978|FG006|Treatment Period|Lost to Follow-up|1|||
130487633|NCT03580356|469754979|FG007|Treatment Period|Lost to Follow-up|0|||
130487634|NCT03580356|469754972|FG000|Treatment Period|Death|0|||
130487635|NCT03580356|469754973|FG001|Treatment Period|Death|0|||
130487636|NCT03580356|469754974|FG002|Treatment Period|Death|1|||
130487637|NCT03580356|469754975|FG003|Treatment Period|Death|0|||
130487638|NCT03580356|469754976|FG004|Treatment Period|Death|0|||
130487639|NCT03580356|469754977|FG005|Treatment Period|Death|0|||
130487640|NCT03580356|469754978|FG006|Treatment Period|Death|0|||
130487641|NCT03580356|469754979|FG007|Treatment Period|Death|0|||
130487642|NCT03580356|469754972|FG000|Treatment Period|Technical problems|0|||
130487643|NCT03580356|469754973|FG001|Treatment Period|Technical problems|0|||
130487644|NCT03580356|469754974|FG002|Treatment Period|Technical problems|0|||
130487645|NCT03580356|469754975|FG003|Treatment Period|Technical problems|0|||
130487646|NCT03580356|469754976|FG004|Treatment Period|Technical problems|1|||
130487647|NCT03580356|469754977|FG005|Treatment Period|Technical problems|0|||
130487648|NCT03580356|469754978|FG006|Treatment Period|Technical problems|0|||
130487649|NCT03580356|469754979|FG007|Treatment Period|Technical problems|0|||
130487650|NCT03580356|469754972|FG000|Treatment Period|Misrandomized, no treatment|0|||
130487651|NCT03580356|469754973|FG001|Treatment Period|Misrandomized, no treatment|0|||
130487652|NCT03580356|469754974|FG002|Treatment Period|Misrandomized, no treatment|1|||
130487653|NCT03580356|469754975|FG003|Treatment Period|Misrandomized, no treatment|0|||
130487654|NCT03580356|469754976|FG004|Treatment Period|Misrandomized, no treatment|2|||
130487655|NCT03580356|469754977|FG005|Treatment Period|Misrandomized, no treatment|0|||
130487656|NCT03580356|469754978|FG006|Treatment Period|Misrandomized, no treatment|0|||
130487657|NCT03580356|469754979|FG007|Treatment Period|Misrandomized, no treatment|0|||
130487658|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
130487659|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
130728505|NCT01004003|470627485|FG000|Overall Study|Other|0|||
130728506|NCT01004003|470627486|FG001|Overall Study|Other|0|||
130728507|NCT01004003|470627487|FG002|Overall Study|Other|0|||
130728508|NCT01004003|470627488|FG003|Overall Study|Other|0|||
130728509|NCT01004003|470627489|FG004|Overall Study|Other|0|||
130487660|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
130487661|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
130487662|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
130487663|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
130487664|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
130487665|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
130487666|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
130487667|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
130487668|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
130487669|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
130487670|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
130565268|NCT02289742|470035434|FG003|Third Wear Period|Adverse Event|0|||
130728510|NCT01004003|470627490|FG005|Overall Study|Other|1|||
130487671|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
130487672|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
130487673|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
130487674|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
130487675|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
130487676|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
130487677|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
130487678|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
130487679|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
130487680|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
130487681|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
130487682|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487683|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487684|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
130487685|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487686|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
130487687|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487688|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487689|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130487690|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
130487691|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
130487692|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
130487693|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
130487694|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
130487695|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
130487696|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
130487697|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
130487698|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
130487699|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
130487700|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
130487701|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
130487702|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
130487703|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
130487704|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
130487705|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
130487706|NCT03580356|469754972|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
130487707|NCT03580356|469754973|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
130487708|NCT03580356|469754974|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
130487709|NCT03580356|469754975|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
130487710|NCT03580356|469754976|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
130487711|NCT03580356|469754977|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
130487712|NCT03580356|469754978|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
130487713|NCT03580356|469754979|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
130487714|NCT05715528|469754981|FG000|Overall Study|Randomized but never treated|11|||
130487715|NCT05715528|469754982|FG001|Overall Study|Randomized but never treated|13|||
130487716|NCT05715528|469754981|FG000|Overall Study|Withdrew consent|7|||
130487717|NCT05715528|469754982|FG001|Overall Study|Withdrew consent|15|||
130487718|NCT05715528|469754981|FG000|Overall Study|Lost to Follow-up|5|||
130487719|NCT05715528|469754982|FG001|Overall Study|Lost to Follow-up|13|||
130487720|NCT05715528|469754981|FG000|Overall Study|Investigator's discretion|3|||
130487721|NCT05715528|469754982|FG001|Overall Study|Investigator's discretion|1|||
130487722|NCT05715528|469754981|FG000|Overall Study|Protocol Violation|2|||
130487723|NCT05715528|469754982|FG001|Overall Study|Protocol Violation|0|||
130487724|NCT05715528|469754981|FG000|Overall Study|Non-compliance with study drug|0|||
130487725|NCT05715528|469754982|FG001|Overall Study|Non-compliance with study drug|1|||
130487726|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
130487727|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
130487728|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487729|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487730|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487731|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487732|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487733|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487734|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487735|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487736|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130728511|NCT01004003|470627491|FG006|Overall Study|Other|0|||
130728512|NCT01004003|470627492|FG007|Overall Study|Other|0|||
130487737|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
130487738|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130728513|NCT01004003|470627493|FG008|Overall Study|Other|0|||
130728514|NCT00315731|470627508|FG000|Overall Study|Lost to Follow-up|1|||
130728515|NCT00315731|470627508|FG000|Overall Study|Death|5|||
130728516|NCT05819203|470627509|FG000|Overall Study|Protocol Violation|1|||
130728517|NCT05819203|470627510|FG001|Overall Study|Protocol Violation|2|||
130728518|NCT05819203|470627509|FG000|Overall Study|Withdrawal by Subject|1|||
130728519|NCT05819203|470627510|FG001|Overall Study|Withdrawal by Subject|0|||
130728520|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
130728521|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
130728522|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728523|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728524|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728525|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728526|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728527|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728528|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728529|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728530|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130728531|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130728532|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728533|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728534|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728535|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728536|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728537|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728538|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728539|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728540|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728541|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
130728542|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728543|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728544|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728545|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728546|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728547|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728548|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728549|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728550|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
130728551|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728552|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728553|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130487739|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
130487740|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487741|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487742|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487743|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487744|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487745|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487746|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487747|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487748|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487749|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
130487750|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
130487751|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
130487752|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130565269|NCT02289742|470035431|FG000|Third Wear Period|Reason not given|0|||
130728554|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728555|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728556|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130565270|NCT02289742|470035432|FG001|Third Wear Period|Reason not given|0|||
130565271|NCT02289742|470035433|FG002|Third Wear Period|Reason not given|0|||
130565272|NCT02289742|470035434|FG003|Third Wear Period|Reason not given|1|||
130728557|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130565273|NCT02865018|470035435|FG000|Overall Study|Withdrawal by Subject|1|||
130487753|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487754|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487755|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487756|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487757|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487758|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487759|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487760|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487761|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130487762|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487763|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
130487764|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487765|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487766|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487767|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487768|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487769|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487770|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487771|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487772|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487773|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
130487774|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487775|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
130487776|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487777|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487778|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487779|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487780|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487781|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487782|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487783|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487784|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487785|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
130487786|NCT03536884|469754983|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487787|NCT03536884|469754984|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
130487788|NCT03536884|469754985|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487789|NCT03536884|469754986|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487790|NCT03536884|469754987|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487791|NCT03536884|469754988|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487792|NCT03536884|469754989|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487793|NCT03536884|469754990|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487794|NCT03536884|469754991|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487795|NCT03536884|469754992|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487796|NCT03536884|469754993|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487797|NCT03536884|469754994|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
130487798|NCT03536884|469754983|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487799|NCT03536884|469754984|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487800|NCT03536884|469754985|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
130487801|NCT03536884|469754986|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487802|NCT03536884|469754987|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
130487803|NCT03536884|469754988|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487804|NCT03536884|469754989|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487805|NCT03536884|469754990|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487806|NCT03536884|469754991|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487807|NCT03536884|469754992|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487808|NCT03536884|469754993|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487809|NCT03536884|469754994|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
130487810|NCT03536884|469754983|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487811|NCT03536884|469754984|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487812|NCT03536884|469754985|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
130487813|NCT03536884|469754986|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
130487814|NCT03536884|469754987|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
130487815|NCT03536884|469754988|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487816|NCT03536884|469754989|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487817|NCT03536884|469754990|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487818|NCT03536884|469754991|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487819|NCT03536884|469754992|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487820|NCT03536884|469754993|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487821|NCT03536884|469754994|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
130487822|NCT03536884|469754983|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487823|NCT03536884|469754984|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487824|NCT03536884|469754985|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487825|NCT03536884|469754986|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
130487826|NCT03536884|469754987|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
130487827|NCT03536884|469754988|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487828|NCT03536884|469754989|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487829|NCT03536884|469754990|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487830|NCT03536884|469754991|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487831|NCT03536884|469754992|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487832|NCT03536884|469754993|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487833|NCT03536884|469754994|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
130487834|NCT03536884|469754983|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487835|NCT03536884|469754984|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487836|NCT03536884|469754985|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
130487837|NCT03536884|469754986|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
130487838|NCT03536884|469754987|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
130487839|NCT03536884|469754988|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487840|NCT03536884|469754989|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487841|NCT03536884|469754990|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487842|NCT03536884|469754991|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487843|NCT03536884|469754992|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487844|NCT03536884|469754993|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487845|NCT03536884|469754994|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
130487846|NCT03536884|469754983|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487847|NCT03536884|469754984|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487848|NCT03536884|469754985|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
130487849|NCT03536884|469754986|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
130487850|NCT03536884|469754987|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
130487851|NCT03536884|469754988|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487852|NCT03536884|469754989|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487853|NCT03536884|469754990|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487854|NCT03536884|469754991|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487855|NCT03536884|469754992|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487856|NCT03536884|469754993|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487857|NCT03536884|469754994|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130487858|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487859|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487860|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487861|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487862|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487863|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
130487864|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
130487865|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
130487866|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
130487867|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487868|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
130565274|NCT02181816|470035436|FG000|Overall Study|Case Report Forms Uncollected|38|||
130565275|NCT02181816|470035436|FG000|Overall Study|Protocol Deviation|21|||
130565276|NCT01365039|470035437|FG000|Overall Study|Study related symptoms and complaints|1|||
130487869|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
130487870|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487871|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487872|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487873|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487874|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487875|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
130487876|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
130487877|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
130487878|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
130565277|NCT01365039|470035438|FG001|Overall Study|Study related symptoms and complaints|0|||
130487879|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487880|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487881|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130487882|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487883|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487884|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487885|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487886|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487887|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
130487888|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487889|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
130487890|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487891|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487892|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487893|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
130487894|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487895|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487896|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487897|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487898|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487899|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
130487900|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487901|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
130487902|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
130487903|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487904|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487905|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
130487906|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487907|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487908|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487909|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487910|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487911|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
130487912|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
130487913|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
130487914|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
130487915|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487916|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487917|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130487918|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487919|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487920|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487921|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487922|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487923|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
130487924|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487925|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487926|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487927|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487928|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487929|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
130487930|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487931|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487932|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487933|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487934|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487935|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487936|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
130487937|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487938|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487939|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487940|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130565278|NCT03807349|470035441|FG000|Overall Study|Early Study Termination|9|||
130565279|NCT00294060|470035442|FG000|Overall Study|Death|225|||
130728558|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130565280|NCT00294060|470035442|FG000|Overall Study|Other|59|||
130565281|NCT00294060|470035442|FG000|Overall Study|Lost to Follow-up|55|||
130728559|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130487941|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130487942|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487943|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487944|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487945|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487946|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487947|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487948|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
130487949|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487950|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487951|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487952|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487953|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130487954|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487955|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487956|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487957|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487958|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487959|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
130487960|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487961|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487962|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487963|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487964|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487965|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
130487966|NCT03536884|469754983|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487967|NCT03536884|469754984|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487968|NCT03536884|469754985|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487969|NCT03536884|469754986|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487970|NCT03536884|469754987|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487971|NCT03536884|469754988|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487972|NCT03536884|469754989|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487973|NCT03536884|469754990|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487974|NCT03536884|469754991|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
130487975|NCT03536884|469754992|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487976|NCT03536884|469754993|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487977|NCT03536884|469754994|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130487978|NCT03536884|469754983|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487979|NCT03536884|469754984|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487980|NCT03536884|469754985|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487981|NCT03536884|469754986|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487982|NCT03536884|469754987|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487983|NCT03536884|469754988|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487984|NCT03536884|469754989|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487985|NCT03536884|469754990|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487986|NCT03536884|469754991|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130487987|NCT03536884|469754992|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
130487988|NCT03536884|469754993|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130487989|NCT03536884|469754994|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
130487990|NCT03536884|469754983|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487991|NCT03536884|469754984|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487992|NCT03536884|469754985|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487993|NCT03536884|469754986|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487994|NCT03536884|469754987|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487995|NCT03536884|469754988|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487996|NCT03536884|469754989|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487997|NCT03536884|469754990|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487998|NCT03536884|469754991|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130487999|NCT03536884|469754992|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
130488000|NCT03536884|469754993|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
130488001|NCT03536884|469754994|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
130488002|NCT03536884|469754983|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488003|NCT03536884|469754984|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488004|NCT03536884|469754985|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488005|NCT03536884|469754986|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488006|NCT03536884|469754987|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488007|NCT03536884|469754988|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488008|NCT03536884|469754989|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488009|NCT03536884|469754990|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488010|NCT03536884|469754991|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488011|NCT03536884|469754992|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488012|NCT03536884|469754993|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
130488013|NCT03536884|469754994|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
130488014|NCT03536884|469754983|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488015|NCT03536884|469754984|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488016|NCT03536884|469754985|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488017|NCT03536884|469754986|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488018|NCT03536884|469754987|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488019|NCT03536884|469754988|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488020|NCT03536884|469754989|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488021|NCT03536884|469754990|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488022|NCT03536884|469754991|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488023|NCT03536884|469754992|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488024|NCT03536884|469754993|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130488025|NCT03536884|469754994|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
130488026|NCT03536884|469754983|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488027|NCT03536884|469754984|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488028|NCT03536884|469754985|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488029|NCT03536884|469754986|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488030|NCT03536884|469754987|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488031|NCT03536884|469754988|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488032|NCT03536884|469754989|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488033|NCT03536884|469754990|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488034|NCT03536884|469754991|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488035|NCT03536884|469754992|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488036|NCT03536884|469754993|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130488037|NCT03536884|469754994|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
130488038|NCT05035654|469755000|FG000|Overall Study|Physician Decision|0|||
130488039|NCT05035654|469755001|FG001|Overall Study|Physician Decision|1|||
130488040|NCT05035654|469755002|FG002|Overall Study|Physician Decision|0|||
130488041|NCT05035654|469755000|FG000|Overall Study|Adverse Event|0|||
130488042|NCT05035654|469755001|FG001|Overall Study|Adverse Event|1|||
130488043|NCT05035654|469755002|FG002|Overall Study|Adverse Event|0|||
130488044|NCT05035654|469755000|FG000|Overall Study|Withdrawal by Subject|0|||
130488045|NCT05035654|469755001|FG001|Overall Study|Withdrawal by Subject|0|||
130488046|NCT05035654|469755002|FG002|Overall Study|Withdrawal by Subject|4|||
130488047|NCT05035654|469755000|FG000|Overall Study|Bilateral Dislodgement|1|||
130488048|NCT05035654|469755001|FG001|Overall Study|Bilateral Dislodgement|0|||
130488049|NCT05035654|469755002|FG002|Overall Study|Bilateral Dislodgement|0|||
130488050|NCT05856435|469755015|FG000|Overall Study|Lost to Follow-up|6|||
130488051|NCT02323880|469755016|FG000|Overall Study|Adverse Event|2|||
130488052|NCT02323880|469755017|FG001|Overall Study|Adverse Event|0|||
130488053|NCT02323880|469755018|FG002|Overall Study|Adverse Event|1|||
130488054|NCT02323880|469755019|FG003|Overall Study|Adverse Event|1|||
130488055|NCT02323880|469755020|FG004|Overall Study|Adverse Event|1|||
130488056|NCT02323880|469755021|FG005|Overall Study|Adverse Event|0|||
130488057|NCT02323880|469755022|FG006|Overall Study|Adverse Event|1|||
130488058|NCT02323880|469755023|FG007|Overall Study|Adverse Event|0|||
130488059|NCT02323880|469755016|FG000|Overall Study|Death|0|||
130488060|NCT02323880|469755017|FG001|Overall Study|Death|0|||
130488061|NCT02323880|469755018|FG002|Overall Study|Death|0|||
130488062|NCT02323880|469755019|FG003|Overall Study|Death|0|||
130488063|NCT02323880|469755020|FG004|Overall Study|Death|0|||
130488064|NCT02323880|469755021|FG005|Overall Study|Death|1|||
130488065|NCT02323880|469755022|FG006|Overall Study|Death|0|||
130488066|NCT02323880|469755023|FG007|Overall Study|Death|0|||
130565282|NCT00294060|470035442|FG000|Overall Study|Withdrawal by Subject|11|||
130565283|NCT00294060|470035442|FG000|Overall Study|Physician Decision|797|||
130565284|NCT00294060|470035442|FG000|Overall Study|Medical condition|3|||
130565285|NCT00294060|470035442|FG000|Overall Study|Device explanted/not replaced|23|||
130565286|NCT02159729|470035450|FG000|Overall Study|Adverse Event|0|||
130565287|NCT02159729|470035451|FG001|Overall Study|Adverse Event|1|||
130488067|NCT02323880|469755016|FG000|Overall Study|Lack of Efficacy|4|||
130488068|NCT02323880|469755017|FG001|Overall Study|Lack of Efficacy|11|||
130488069|NCT02323880|469755018|FG002|Overall Study|Lack of Efficacy|5|||
130488070|NCT02323880|469755019|FG003|Overall Study|Lack of Efficacy|5|||
130728560|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
130728561|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
130728562|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728563|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728564|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728565|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728566|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728567|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728568|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728569|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728570|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
130728571|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
130728572|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728573|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728574|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728575|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728576|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728577|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728578|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728579|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728580|NCT04784533|470627511|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728581|NCT04784533|470627512|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728582|NCT04784533|470627513|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
130728583|NCT04784533|470627514|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728584|NCT04784533|470627515|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728585|NCT04784533|470627516|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728586|NCT04784533|470627517|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130488071|NCT02323880|469755020|FG004|Overall Study|Lack of Efficacy|4|||
130488072|NCT02323880|469755021|FG005|Overall Study|Lack of Efficacy|8|||
130488073|NCT02323880|469755022|FG006|Overall Study|Lack of Efficacy|4|||
130488074|NCT02323880|469755023|FG007|Overall Study|Lack of Efficacy|6|||
130488075|NCT02323880|469755016|FG000|Overall Study|Physician Decision|0|||
130488076|NCT02323880|469755017|FG001|Overall Study|Physician Decision|0|||
130488077|NCT02323880|469755018|FG002|Overall Study|Physician Decision|0|||
130488078|NCT02323880|469755019|FG003|Overall Study|Physician Decision|0|||
130488079|NCT02323880|469755020|FG004|Overall Study|Physician Decision|1|||
130488080|NCT02323880|469755021|FG005|Overall Study|Physician Decision|1|||
130488081|NCT02323880|469755022|FG006|Overall Study|Physician Decision|1|||
130488082|NCT02323880|469755023|FG007|Overall Study|Physician Decision|0|||
130488083|NCT02323880|469755016|FG000|Overall Study|Withdrawal by Subject|0|||
130488084|NCT02323880|469755017|FG001|Overall Study|Withdrawal by Subject|2|||
130488085|NCT02323880|469755018|FG002|Overall Study|Withdrawal by Subject|0|||
130488086|NCT02323880|469755019|FG003|Overall Study|Withdrawal by Subject|0|||
130488087|NCT02323880|469755020|FG004|Overall Study|Withdrawal by Subject|0|||
130488088|NCT02323880|469755021|FG005|Overall Study|Withdrawal by Subject|0|||
130488089|NCT02323880|469755022|FG006|Overall Study|Withdrawal by Subject|0|||
130488090|NCT02323880|469755023|FG007|Overall Study|Withdrawal by Subject|0|||
130488091|NCT04934072|469755025|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
130488092|NCT04934072|469755026|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
130488093|NCT04934072|469755027|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
130488094|NCT04934072|469755028|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
130488095|NCT04934072|469755029|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
130488096|NCT04934072|469755025|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
130488097|NCT04934072|469755026|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
130488098|NCT04934072|469755027|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
130728587|NCT04784533|470627518|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728588|NCT04784533|470627519|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728589|NCT04784533|470627520|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728590|NCT04784533|470627511|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728591|NCT04784533|470627512|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130488099|NCT04934072|469755028|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
130488100|NCT04934072|469755029|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
130488101|NCT04934072|469755025|FG000|Day 0 to Week 52|Other|3|||
130488102|NCT04934072|469755026|FG001|Day 0 to Week 52|Other|1|||
130488103|NCT04934072|469755027|FG002|Day 0 to Week 52|Other|0|||
130488104|NCT04934072|469755028|FG003|Day 0 to Week 52|Other|0|||
130488105|NCT04934072|469755029|FG004|Day 0 to Week 52|Other|0|||
130488106|NCT04934072|469755025|FG000|Day 0 to Week 52|Adverse Event|1|||
130488107|NCT04934072|469755026|FG001|Day 0 to Week 52|Adverse Event|3|||
130488108|NCT04934072|469755027|FG002|Day 0 to Week 52|Adverse Event|0|||
130488109|NCT04934072|469755028|FG003|Day 0 to Week 52|Adverse Event|0|||
130488110|NCT04934072|469755029|FG004|Day 0 to Week 52|Adverse Event|0|||
130488111|NCT04934072|469755025|FG000|Week 52 to Week 78|Adverse Event|0|||
130488112|NCT04934072|469755026|FG001|Week 52 to Week 78|Adverse Event|0|||
130488113|NCT04934072|469755027|FG002|Week 52 to Week 78|Adverse Event|0|||
130488114|NCT04934072|469755028|FG003|Week 52 to Week 78|Adverse Event|1|||
130488115|NCT04934072|469755029|FG004|Week 52 to Week 78|Adverse Event|1|||
130488116|NCT04934072|469755025|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
130488117|NCT04934072|469755026|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
130488118|NCT04934072|469755027|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
130488119|NCT04934072|469755028|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
130488120|NCT04934072|469755029|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
130488121|NCT04934072|469755025|FG000|Week 52 to Week 78|Other|0|||
130488122|NCT04934072|469755026|FG001|Week 52 to Week 78|Other|0|||
130488123|NCT04934072|469755027|FG002|Week 52 to Week 78|Other|1|||
130488124|NCT04934072|469755028|FG003|Week 52 to Week 78|Other|0|||
130488125|NCT04934072|469755029|FG004|Week 52 to Week 78|Other|0|||
130488126|NCT05736458|469755033|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
130488127|NCT05736458|469755034|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
130488128|NCT05736458|469755035|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
130488129|NCT05736458|469755033|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
130488130|NCT05736458|469755034|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
130488131|NCT05736458|469755035|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
130488132|NCT05736458|469755033|FG000|TMS/fMRI #1|Physician Decision|0|||
130488133|NCT05736458|469755034|FG001|TMS/fMRI #1|Physician Decision|0|||
130488134|NCT05736458|469755035|FG002|TMS/fMRI #1|Physician Decision|2|||
130488135|NCT05736458|469755033|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
130488136|NCT05736458|469755034|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
130488137|NCT05736458|469755035|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
130488138|NCT04247802|469755036|FG000|Overall Study|Withdrawal by Subject|1|||
130488139|NCT04247802|469755037|FG001|Overall Study|Withdrawal by Subject|3|||
130488140|NCT04247802|469755036|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
130488141|NCT04247802|469755037|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
130488142|NCT05962814|469755042|FG000|Overall Study|failed eligibility|1|||
130488143|NCT02865538|469755043|FG000|Overall Study|Withdrawal by Subject|0|||
130488144|NCT02865538|469755044|FG001|Overall Study|Withdrawal by Subject|0|||
130488145|NCT02865538|469755045|FG002|Overall Study|Withdrawal by Subject|1|||
130488146|NCT02865538|469755046|FG003|Overall Study|Withdrawal by Subject|0|||
130488147|NCT02865538|469755047|FG004|Overall Study|Withdrawal by Subject|0|||
130488148|NCT02865538|469755043|FG000|Overall Study|Lost to Follow-up|1|||
130488149|NCT02865538|469755044|FG001|Overall Study|Lost to Follow-up|0|||
130488150|NCT02865538|469755045|FG002|Overall Study|Lost to Follow-up|0|||
130488151|NCT02865538|469755046|FG003|Overall Study|Lost to Follow-up|0|||
130488152|NCT02865538|469755047|FG004|Overall Study|Lost to Follow-up|0|||
130488153|NCT05290493|469756130|FG000|Overall Study|Withdrawal by Subject|2|||
130488154|NCT05290493|469756131|FG001|Overall Study|Withdrawal by Subject|2|||
130488155|NCT05290493|469756130|FG000|Overall Study|Adverse Event|1|||
130488156|NCT05290493|469756131|FG001|Overall Study|Adverse Event|0|||
130488157|NCT04615273|469756135|FG000|Overall Study|Withdrawal by Subject|3|||
130488158|NCT04615273|469756136|FG001|Overall Study|Withdrawal by Subject|1|||
130488159|NCT04615273|469756137|FG002|Overall Study|Withdrawal by Subject|2|||
130488160|NCT04615273|469756135|FG000|Overall Study|Adverse Event|1|||
130488161|NCT04615273|469756136|FG001|Overall Study|Adverse Event|0|||
130488162|NCT04615273|469756137|FG002|Overall Study|Adverse Event|1|||
130488163|NCT04615273|469756135|FG000|Overall Study|Lost to Follow-up|0|||
130488164|NCT04615273|469756136|FG001|Overall Study|Lost to Follow-up|1|||
130488165|NCT04615273|469756137|FG002|Overall Study|Lost to Follow-up|0|||
130488166|NCT04615273|469756135|FG000|Overall Study|Physician Decision|0|||
130488167|NCT04615273|469756136|FG001|Overall Study|Physician Decision|0|||
130488168|NCT04615273|469756137|FG002|Overall Study|Physician Decision|1|||
130488169|NCT04615273|469756135|FG000|Overall Study|Other|0|||
130488170|NCT04615273|469756136|FG001|Overall Study|Other|1|||
130488171|NCT04615273|469756137|FG002|Overall Study|Other|0|||
130488172|NCT04615273|469756135|FG000|Overall Study|Randomized but not treated|1|||
130488173|NCT04615273|469756136|FG001|Overall Study|Randomized but not treated|3|||
130488174|NCT04615273|469756137|FG002|Overall Study|Randomized but not treated|1|||
130488175|NCT03677141|469756141|FG000|Overall Study|Death|2|||
130488176|NCT03677141|469756142|FG001|Overall Study|Death|1|||
130488177|NCT03677141|469756143|FG002|Overall Study|Death|6|||
130488178|NCT03677141|469756144|FG003|Overall Study|Death|9|||
130488179|NCT03677141|469756145|FG004|Overall Study|Death|5|||
130488180|NCT03677141|469756146|FG005|Overall Study|Death|3|||
130488181|NCT03677141|469756141|FG000|Overall Study|Lost to Follow-up|0|||
130488182|NCT03677141|469756142|FG001|Overall Study|Lost to Follow-up|0|||
130488183|NCT03677141|469756143|FG002|Overall Study|Lost to Follow-up|0|||
130488184|NCT03677141|469756144|FG003|Overall Study|Lost to Follow-up|2|||
130488185|NCT03677141|469756145|FG004|Overall Study|Lost to Follow-up|0|||
130488186|NCT03677141|469756146|FG005|Overall Study|Lost to Follow-up|0|||
130488187|NCT03677141|469756141|FG000|Overall Study|Screen failure or enrolled in error|0|||
130488188|NCT03677141|469756142|FG001|Overall Study|Screen failure or enrolled in error|0|||
130488189|NCT03677141|469756143|FG002|Overall Study|Screen failure or enrolled in error|0|||
130488190|NCT03677141|469756144|FG003|Overall Study|Screen failure or enrolled in error|0|||
130488191|NCT03677141|469756145|FG004|Overall Study|Screen failure or enrolled in error|2|||
130488192|NCT03677141|469756146|FG005|Overall Study|Screen failure or enrolled in error|0|||
130488193|NCT03677141|469756141|FG000|Overall Study|Physician Decision|0|||
130488194|NCT03677141|469756142|FG001|Overall Study|Physician Decision|0|||
130488195|NCT03677141|469756143|FG002|Overall Study|Physician Decision|0|||
130488196|NCT03677141|469756144|FG003|Overall Study|Physician Decision|0|||
130488197|NCT03677141|469756145|FG004|Overall Study|Physician Decision|1|||
130488198|NCT03677141|469756146|FG005|Overall Study|Physician Decision|0|||
130488199|NCT03677141|469756141|FG000|Overall Study|Withdrawal by Subject|0|||
130488200|NCT03677141|469756142|FG001|Overall Study|Withdrawal by Subject|0|||
130488201|NCT03677141|469756143|FG002|Overall Study|Withdrawal by Subject|1|||
130488202|NCT03677141|469756144|FG003|Overall Study|Withdrawal by Subject|1|||
130488203|NCT03677141|469756145|FG004|Overall Study|Withdrawal by Subject|1|||
130488204|NCT03677141|469756146|FG005|Overall Study|Withdrawal by Subject|0|||
130488205|NCT03673501|469756154|FG000|Overall Study|Participants ongoing.|36|||
130488206|NCT03673501|469756155|FG001|Overall Study|Participants ongoing.|24|||
130488207|NCT05838027|469756156|FG000|Overall Study|Lost to Follow-up|5|||
130488208|NCT05838027|469756157|FG001|Overall Study|Lost to Follow-up|1|||
130488209|NCT05838027|469756156|FG000|Overall Study|Withdrawal by Subject|1|||
130488210|NCT05838027|469756157|FG001|Overall Study|Withdrawal by Subject|0|||
130488211|NCT04599634|469756158|FG000|Overall Study|Dose limiting toxicity|0|||
130488212|NCT04599634|469756159|FG001|Overall Study|Dose limiting toxicity|0|||
130488213|NCT04599634|469756160|FG002|Overall Study|Dose limiting toxicity|2|||
130488214|NCT04599634|469756161|FG003|Overall Study|Dose limiting toxicity|0|||
130488215|NCT02962076|469756164|FG000|Overall Study|MHED tracer not available|5|||
130488216|NCT02962076|469756164|FG000|Overall Study|Protocol Violation|1|||
130488217|NCT02962076|469756164|FG000|Overall Study|Physician Decision|1|||
130488218|NCT03485729|469756174|FG000|Overall Study|Withdrawal by Subject|0|||
130488219|NCT03485729|469756175|FG001|Overall Study|Withdrawal by Subject|0|||
130488220|NCT03485729|469756176|FG002|Overall Study|Withdrawal by Subject|1|||
130488221|NCT03485729|469756174|FG000|Overall Study|Disease progression|8|||
130488222|NCT03485729|469756175|FG001|Overall Study|Disease progression|13|||
130488223|NCT03485729|469756176|FG002|Overall Study|Disease progression|1|||
130488224|NCT03485729|469756174|FG000|Overall Study|Hospice care|1|||
130488225|NCT03485729|469756175|FG001|Overall Study|Hospice care|0|||
130488226|NCT03485729|469756176|FG002|Overall Study|Hospice care|0|||
130488227|NCT03485729|469756174|FG000|Overall Study|Poor performance status|1|||
130488228|NCT03485729|469756175|FG001|Overall Study|Poor performance status|0|||
130488229|NCT03485729|469756176|FG002|Overall Study|Poor performance status|0|||
130488230|NCT03485729|469756174|FG000|Overall Study|Illness|0|||
130488231|NCT03485729|469756175|FG001|Overall Study|Illness|1|||
130488232|NCT03485729|469756176|FG002|Overall Study|Illness|0|||
130488233|NCT02839265|469756181|FG000|Overall Study|Screen Failure|2|||
130488234|NCT02839265|469756181|FG000|Overall Study|Death|1|||
130488235|NCT02839265|469756181|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
130488236|NCT03635424|469756182|FG000|Overall Study|Adverse Event|1|||
130488237|NCT03635424|469756182|FG000|Overall Study|Death|1|||
130488238|NCT03635424|469756182|FG000|Overall Study|Device not implanted|1|||
130488239|NCT05533190|469756185|FG000|Overall Study|Lost to Follow-up|19|||
130488240|NCT05533190|469756186|FG001|Overall Study|Lost to Follow-up|7|||
130488241|NCT05533190|469756185|FG000|Overall Study|Failed to download app|1|||
130488242|NCT05533190|469756186|FG001|Overall Study|Failed to download app|0|||
130488243|NCT05533190|469756185|FG000|Overall Study|Thought app was a scam|1|||
130488244|NCT05533190|469756186|FG001|Overall Study|Thought app was a scam|0|||
130488245|NCT05533190|469756185|FG000|Overall Study|Withdrawal by Subject|2|||
130488246|NCT05533190|469756186|FG001|Overall Study|Withdrawal by Subject|0|||
130488247|NCT04167553|469756193|FG000|Overall Study|Withdrawal by Subject|1|||
130488248|NCT04167553|469756194|FG001|Overall Study|Withdrawal by Subject|0|||
130488249|NCT04167553|469756195|FG002|Overall Study|Withdrawal by Subject|1|||
130488250|NCT04167553|469756196|FG003|Overall Study|Withdrawal by Subject|2|||
130488251|NCT04167553|469756197|FG004|Overall Study|Withdrawal by Subject|1|||
130488252|NCT04167553|469756198|FG005|Overall Study|Withdrawal by Subject|0|||
130488253|NCT04167553|469756199|FG006|Overall Study|Withdrawal by Subject|0|||
130488254|NCT04167553|469756193|FG000|Overall Study|Physician Decision|0|||
130488255|NCT04167553|469756194|FG001|Overall Study|Physician Decision|0|||
130488256|NCT04167553|469756195|FG002|Overall Study|Physician Decision|0|||
130488257|NCT04167553|469756196|FG003|Overall Study|Physician Decision|0|||
130488258|NCT04167553|469756197|FG004|Overall Study|Physician Decision|2|||
130488259|NCT04167553|469756198|FG005|Overall Study|Physician Decision|2|||
130488260|NCT04167553|469756199|FG006|Overall Study|Physician Decision|0|||
130488261|NCT04167553|469756193|FG000|Overall Study|Lost to Follow-up|0|||
130488262|NCT04167553|469756194|FG001|Overall Study|Lost to Follow-up|0|||
130488263|NCT04167553|469756195|FG002|Overall Study|Lost to Follow-up|2|||
130488264|NCT04167553|469756196|FG003|Overall Study|Lost to Follow-up|0|||
130488265|NCT04167553|469756197|FG004|Overall Study|Lost to Follow-up|0|||
130488266|NCT04167553|469756198|FG005|Overall Study|Lost to Follow-up|0|||
130488267|NCT04167553|469756199|FG006|Overall Study|Lost to Follow-up|0|||
130488268|NCT03858517|469756203|FG000|Overall Study|Adverse Event|1|||
130488269|NCT03858517|469756203|FG000|Overall Study|Lost to Follow-up|1|||
130488270|NCT03858517|469756203|FG000|Overall Study|removed for being incarcerated|1|||
130488271|NCT03858517|469756203|FG000|Overall Study|Sponsor Closure|48|||
130488272|NCT02997202|469756212|FG000|Overall Study|Miscellaneous|2|||
130488273|NCT02997202|469756213|FG001|Overall Study|Miscellaneous|2|||
130488274|NCT02997202|469756212|FG000|Overall Study|Withdrawal by Subject|8|||
130488275|NCT02997202|469756213|FG001|Overall Study|Withdrawal by Subject|12|||
130488276|NCT02997202|469756212|FG000|Overall Study|Lost to Follow-up|5|||
130488277|NCT02997202|469756213|FG001|Overall Study|Lost to Follow-up|3|||
130488278|NCT02997202|469756212|FG000|Overall Study|Death|41|||
130488279|NCT02997202|469756213|FG001|Overall Study|Death|45|||
130488280|NCT01199133|469756214|FG000|Year 1|Adverse Event|16|||
130488281|NCT01199133|469756215|FG001|Year 1|Adverse Event|4|||
130488282|NCT01199133|469756214|FG000|Year 1|Withdrawal by Subject|8|||
130488283|NCT01199133|469756215|FG001|Year 1|Withdrawal by Subject|4|||
130488284|NCT01199133|469756214|FG000|Year 1|Any other reason not above-mentioned|6|||
130488285|NCT01199133|469756215|FG001|Year 1|Any other reason not above-mentioned|7|||
130488286|NCT01199133|469756214|FG000|Year 2|Adverse Event|1|||
130488287|NCT01199133|469756215|FG001|Year 2|Adverse Event|0|||
130488288|NCT01199133|469756214|FG000|Year 2|Withdrawal by Subject|1|||
130488289|NCT01199133|469756215|FG001|Year 2|Withdrawal by Subject|1|||
130488290|NCT01199133|469756214|FG000|Year 2|Any other reason not above-mentioned|1|||
130488291|NCT01199133|469756215|FG001|Year 2|Any other reason not above-mentioned|2|||
130488292|NCT05013385|469756217|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
130488293|NCT01447719|469756222|FG000|Overall Study|Image acquisition failure|2|||
130488294|NCT01447719|469756222|FG000|Overall Study|Invalid image or not imaged|3|||
130488295|NCT01447719|469756222|FG000|Overall Study|Subject still living at end of study|79|||
130488296|NCT01447719|469756222|FG000|Overall Study|Withdrawal by Subject|2|||
130488297|NCT01447719|469756222|FG000|Overall Study|Family withdrew autopsy consent|7|||
130488298|NCT05100628|469756223|FG000|Overall Study|Progressive Disease|1|||
130488299|NCT05100628|469756224|FG001|Overall Study|Progressive Disease|0|||
130488300|NCT05100628|469756225|FG002|Overall Study|Progressive Disease|0|||
130488301|NCT05100628|469756226|FG003|Overall Study|Progressive Disease|0|||
130488302|NCT05100628|469756223|FG000|Overall Study|Study Terminated by Sponsor|0|||
130488303|NCT05100628|469756224|FG001|Overall Study|Study Terminated by Sponsor|0|||
130488304|NCT05100628|469756225|FG002|Overall Study|Study Terminated by Sponsor|3|||
130488305|NCT05100628|469756226|FG003|Overall Study|Study Terminated by Sponsor|0|||
130488306|NCT05100628|469756223|FG000|Overall Study|unkown|0|||
130488307|NCT05100628|469756224|FG001|Overall Study|unkown|1|||
130488308|NCT05100628|469756225|FG002|Overall Study|unkown|0|||
130488309|NCT05100628|469756226|FG003|Overall Study|unkown|0|||
130488310|NCT05900154|469756232|FG000|Follow-Up Period|Lost to Follow-up|1|||
130488311|NCT05900154|469756233|FG001|Follow-Up Period|Lost to Follow-up|2|||
130488312|NCT05900154|469756234|FG002|Follow-Up Period|Lost to Follow-up|1|||
130488313|NCT05900154|469756235|FG003|Follow-Up Period|Lost to Follow-up|0|||
130488314|NCT05900154|469756236|FG004|Follow-Up Period|Lost to Follow-up|1|||
130488315|NCT05900154|469756237|FG005|Follow-Up Period|Lost to Follow-up|1|||
130488316|NCT03993392|469756242|FG000|Overall Study|Withdrawal by Subject|3|||
130488317|NCT03993392|469756242|FG000|Overall Study|Lost to Follow-up|2|||
130488318|NCT03993392|469756242|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
130488319|NCT02518048|469756245|FG000|Overall Study|Withdrawal by Subject|1|||
130488320|NCT05363163|469757522|FG000|Overall Study|Withdrawal by Subject|13|||
130488321|NCT04709419|469757528|FG000|Overall Study|Physician Decision|1|||
130488322|NCT04709419|469757529|FG001|Overall Study|Physician Decision|0|||
130488323|NCT05683340|469757530|FG000|Overall Study|Adverse Event|1|||
130488324|NCT05683340|469757531|FG001|Overall Study|Adverse Event|1|||
130488325|NCT05683340|469757530|FG000|Overall Study|Protocol Violation|1|||
130488326|NCT05683340|469757531|FG001|Overall Study|Protocol Violation|0|||
130488327|NCT05683340|469757530|FG000|Overall Study|Withdrawal by Subject|0|||
130488328|NCT05683340|469757531|FG001|Overall Study|Withdrawal by Subject|2|||
130488329|NCT02056834|469757532|FG000|Overall Study|Lost to Follow-up|7|||
130488330|NCT06106022|469757533|FG000|Overall Study|Lost to Follow-up|1|||
130488331|NCT06106022|469757534|FG001|Overall Study|Lost to Follow-up|0|||
130488332|NCT06106022|469757533|FG000|Overall Study|Voluntary Withdrawal|0|||
130488333|NCT06106022|469757534|FG001|Overall Study|Voluntary Withdrawal|2|||
130488334|NCT04451772|469757558|FG000|Overall Study|Adverse Event|1|||
130488335|NCT04451772|469757559|FG001|Overall Study|Adverse Event|0|||
130488336|NCT04451772|469757560|FG002|Overall Study|Adverse Event|1|||
130488337|NCT04451772|469757561|FG003|Overall Study|Adverse Event|1|||
130488338|NCT04451772|469757562|FG004|Overall Study|Adverse Event|0|||
130488339|NCT04451772|469757563|FG005|Overall Study|Adverse Event|3|||
130488340|NCT04451772|469757558|FG000|Overall Study|Withdrawal by Subject|2|||
130488341|NCT04451772|469757559|FG001|Overall Study|Withdrawal by Subject|7|||
130488342|NCT04451772|469757560|FG002|Overall Study|Withdrawal by Subject|2|||
130488343|NCT04451772|469757561|FG003|Overall Study|Withdrawal by Subject|1|||
130488344|NCT04451772|469757562|FG004|Overall Study|Withdrawal by Subject|1|||
130488345|NCT04451772|469757563|FG005|Overall Study|Withdrawal by Subject|0|||
130488346|NCT04451772|469757558|FG000|Overall Study|Other, not specified|1|||
130488347|NCT04451772|469757559|FG001|Overall Study|Other, not specified|2|||
130488348|NCT04451772|469757560|FG002|Overall Study|Other, not specified|1|||
130488349|NCT04451772|469757561|FG003|Overall Study|Other, not specified|0|||
130488350|NCT04451772|469757562|FG004|Overall Study|Other, not specified|0|||
130488351|NCT04451772|469757563|FG005|Overall Study|Other, not specified|1|||
130488352|NCT04451772|469757558|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
130488353|NCT04451772|469757559|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
130488354|NCT04451772|469757560|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
130488355|NCT04451772|469757561|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
130488356|NCT04451772|469757562|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
130488357|NCT04451772|469757563|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
130488358|NCT02828358|469757564|FG000|Overall Study|Physician Decision|7|||
130488359|NCT02828358|469757565|FG001|Overall Study|Physician Decision|1|||
130488360|NCT02828358|469757564|FG000|Overall Study|Treatment Failure|6|||
130488361|NCT02828358|469757565|FG001|Overall Study|Treatment Failure|0|||
130488362|NCT02828358|469757564|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
130488363|NCT02828358|469757565|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
130488364|NCT02828358|469757564|FG000|Overall Study|Refusal of further protocol therapy|2|||
130488365|NCT02828358|469757565|FG001|Overall Study|Refusal of further protocol therapy|0|||
130488366|NCT02828358|469757564|FG000|Overall Study|Relapse|25|||
130488367|NCT02828358|469757565|FG001|Overall Study|Relapse|0|||
130488368|NCT02828358|469757564|FG000|Overall Study|Still on therapy|5|||
130488369|NCT02828358|469757565|FG001|Overall Study|Still on therapy|0|||
130488370|NCT05172232|469757566|FG000|Overall Study|Lost to Follow-up|3|||
130488371|NCT01828021|469757567|FG000|Overall Study|Adverse Event|5|||
130488372|NCT01828021|469757567|FG000|Overall Study|Lack of Efficacy|17|||
130488373|NCT01828021|469757567|FG000|Overall Study|Withdrawal by Subject|2|||
130488374|NCT01828021|469757567|FG000|Overall Study|Ileal obstruction, unrelated|1|||
130488375|NCT03717935|469757573|FG000|Overall Study|Withdrawal by Subject|0|||
130488376|NCT03717935|469757574|FG001|Overall Study|Withdrawal by Subject|2|||
130488377|NCT02990338|469757575|FG000|Overall Study|Randomized and not treated|4|||
130488378|NCT02990338|469757576|FG001|Overall Study|Randomized and not treated|2|||
130488379|NCT02990338|469757575|FG000|Overall Study|Adverse Event|23|||
130488380|NCT02990338|469757576|FG001|Overall Study|Adverse Event|22|||
130488381|NCT02990338|469757575|FG000|Overall Study|Progressive disease|118|||
130488382|NCT02990338|469757576|FG001|Overall Study|Progressive disease|107|||
130488383|NCT02990338|469757575|FG000|Overall Study|Poor compliance to protocol|0|||
130488384|NCT02990338|469757576|FG001|Overall Study|Poor compliance to protocol|1|||
130488385|NCT02990338|469757575|FG000|Overall Study|Withdrawal by Subject|6|||
130488386|NCT02990338|469757576|FG001|Overall Study|Withdrawal by Subject|8|||
130488387|NCT02990338|469757575|FG000|Overall Study|Physician's decision|2|||
130488388|NCT02990338|469757576|FG001|Overall Study|Physician's decision|6|||
130488389|NCT02990338|469757575|FG000|Overall Study|Treatment extension study|0|||
130488390|NCT02990338|469757576|FG001|Overall Study|Treatment extension study|6|||
130488391|NCT02990338|469757575|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
130488392|NCT02990338|469757576|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
130488393|NCT02990338|469757575|FG000|Overall Study|Continue with therapy available commercially|0|||
130488394|NCT02990338|469757576|FG001|Overall Study|Continue with therapy available commercially|1|||
130488395|NCT04479761|469757578|FG000|Overall Study|could not perform the balance tasks|1|||
130488396|NCT04479761|469757579|FG001|Overall Study|could not perform the balance tasks|0|||
130488397|NCT04479761|469757580|FG002|Overall Study|could not perform the balance tasks|0|||
130488398|NCT04479761|469757578|FG000|Overall Study|Adverse Event|1|||
130488399|NCT04479761|469757579|FG001|Overall Study|Adverse Event|0|||
130488400|NCT04479761|469757580|FG002|Overall Study|Adverse Event|0|||
130488401|NCT04479761|469757578|FG000|Overall Study|one control did not meet screening criteria|0|||
130488402|NCT04479761|469757579|FG001|Overall Study|one control did not meet screening criteria|0|||
130488403|NCT04479761|469757580|FG002|Overall Study|one control did not meet screening criteria|1|||
130488404|NCT04479761|469757578|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
130488405|NCT04479761|469757579|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
130488406|NCT04479761|469757580|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
130488407|NCT04186819|469757581|FG000|Overall Study|Adverse Event|1|||
130488408|NCT04186819|469757581|FG000|Overall Study|Lost to Follow-up|1|||
130488409|NCT04186819|469757581|FG000|Overall Study|Opted for EBRT|1|||
130488410|NCT04186819|469757581|FG000|Overall Study|Opted SBRT|1|||
130488411|NCT04186819|469757581|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
130488412|NCT04186819|469757581|FG000|Overall Study|Physician Decision|1|||
130488413|NCT04186819|469757581|FG000|Overall Study|RP Delayed|1|||
130488414|NCT04186819|469757581|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
130488415|NCT04186819|469757581|FG000|Overall Study|Subject declined for financial reasons|1|||
130488416|NCT04186819|469757581|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
130488417|NCT04186819|469757581|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
130488418|NCT04186819|469757581|FG000|Overall Study|The subject opted for other treatment option|2|||
130488419|NCT04186819|469757581|FG000|Overall Study|The subject opted for other treatment options|1|||
130488420|NCT04186819|469757581|FG000|Overall Study|Withdrawal by Subject|3|||
130488421|NCT04186819|469757581|FG000|Overall Study|Reason not specified|1|||
130488422|NCT03252288|469757584|FG000|Overall Study|Death|1|||
130488423|NCT03252288|469757585|FG001|Overall Study|Death|0|||
130488424|NCT03252288|469757586|FG002|Overall Study|Death|0|||
130488425|NCT03252288|469757584|FG000|Overall Study|Death|11|||
130488426|NCT03252288|469757585|FG001|Overall Study|Death|0|||
130488427|NCT03252288|469757586|FG002|Overall Study|Death|0|||
130488428|NCT03252288|469757584|FG000|Overall Study|Withdrawal by Subject|2|||
130488429|NCT03252288|469757585|FG001|Overall Study|Withdrawal by Subject|0|||
130488430|NCT03252288|469757586|FG002|Overall Study|Withdrawal by Subject|0|||
130565288|NCT02159729|470035450|FG000|Overall Study|Subject's Request|13|||
130488431|NCT03252288|469757584|FG000|Overall Study|Lost to Follow-up|79|||
130488432|NCT03252288|469757585|FG001|Overall Study|Lost to Follow-up|0|||
130488433|NCT03252288|469757586|FG002|Overall Study|Lost to Follow-up|0|||
130488434|NCT03252288|469757584|FG000|Overall Study|Loss of baseline data on tablets|6|||
130488435|NCT03252288|469757585|FG001|Overall Study|Loss of baseline data on tablets|0|||
130488436|NCT03252288|469757586|FG002|Overall Study|Loss of baseline data on tablets|0|||
130488437|NCT02542631|469757594|FG000|Overall Study|Adverse Event|1|||
130488438|NCT02542631|469757595|FG001|Overall Study|Adverse Event|1|||
130488439|NCT02542631|469757594|FG000|Overall Study|Sponsor Termination|1|||
130488440|NCT02542631|469757595|FG001|Overall Study|Sponsor Termination|0|||
130488441|NCT02542631|469757594|FG000|Overall Study|Withdrawal by Subject|11|||
130488442|NCT02542631|469757595|FG001|Overall Study|Withdrawal by Subject|16|||
130488443|NCT02542631|469757594|FG000|Overall Study|Protocol Violation|1|||
130488444|NCT02542631|469757595|FG001|Overall Study|Protocol Violation|1|||
130488445|NCT02542631|469757594|FG000|Overall Study|Physician Decision|6|||
130488446|NCT02542631|469757595|FG001|Overall Study|Physician Decision|4|||
130488447|NCT02542631|469757594|FG000|Overall Study|Lost to Follow-up|6|||
130488448|NCT02542631|469757595|FG001|Overall Study|Lost to Follow-up|5|||
130488449|NCT02542631|469757594|FG000|Overall Study|Death|1|||
130488450|NCT02542631|469757595|FG001|Overall Study|Death|2|||
130488451|NCT02542631|469757594|FG000|Overall Study|Other|2|||
130488452|NCT02542631|469757595|FG001|Overall Study|Other|1|||
130488453|NCT02542631|469757594|FG000|Overall Study|Used Prohibited Medication|2|||
130488454|NCT02542631|469757595|FG001|Overall Study|Used Prohibited Medication|1|||
130488455|NCT02938923|469757596|FG000|Overall Study|Death|1|||
130488456|NCT02938923|469757597|FG001|Overall Study|Death|0|||
130488457|NCT02938923|469757598|FG002|Overall Study|Death|0|||
130488458|NCT02938923|469757596|FG000|Overall Study|Physician Decision|0|||
130488459|NCT02938923|469757597|FG001|Overall Study|Physician Decision|2|||
130488460|NCT02938923|469757598|FG002|Overall Study|Physician Decision|0|||
130488461|NCT02938923|469757596|FG000|Overall Study|Withdrawal by Subject|0|||
130488462|NCT02938923|469757597|FG001|Overall Study|Withdrawal by Subject|1|||
130488463|NCT02938923|469757598|FG002|Overall Study|Withdrawal by Subject|1|||
130488464|NCT04583280|469757603|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
130488465|NCT04583280|469757604|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
130488466|NCT00631475|469757605|FG000|Overall Study|Death|18|||
130488467|NCT00631475|469757605|FG000|Overall Study|Adverse Event|14|||
130488468|NCT00631475|469757605|FG000|Overall Study|Withdrew consent|5|||
130488469|NCT00631475|469757605|FG000|Overall Study|Preparation for lung transplant|8|||
130488470|NCT00303459|469757606|FG000|Overall Study|Death|33|||
130488471|NCT00303459|469757607|FG001|Overall Study|Death|44|||
130488472|NCT00303459|469757606|FG000|Overall Study|Withdrawal of consent|32|||
130488473|NCT00303459|469757607|FG001|Overall Study|Withdrawal of consent|26|||
130488474|NCT00303459|469757606|FG000|Overall Study|Lost to Follow-up|5|||
130488475|NCT00303459|469757607|FG001|Overall Study|Lost to Follow-up|4|||
130488476|NCT00303459|469757606|FG000|Overall Study|Administrative reason|7|||
130488477|NCT00303459|469757607|FG001|Overall Study|Administrative reason|7|||
130488478|NCT00303459|469757606|FG000|Overall Study|Decision by the investigator|5|||
130488479|NCT00303459|469757607|FG001|Overall Study|Decision by the investigator|7|||
130488480|NCT00303459|469757606|FG000|Overall Study|Lung transplantation|1|||
130488481|NCT00303459|469757607|FG001|Overall Study|Lung transplantation|1|||
130488482|NCT04129554|469757608|FG000|Overall Study|Withdrawal by Subject|4|||
130488483|NCT04129554|469757609|FG001|Overall Study|Withdrawal by Subject|3|||
130488484|NCT04129554|469757608|FG000|Overall Study|Other|0|||
130488485|NCT04129554|469757609|FG001|Overall Study|Other|2|||
130488486|NCT01570361|469757610|FG000|Overall Study|Subject discontinued|1|||
130488487|NCT01570361|469757611|FG001|Overall Study|Subject discontinued|2|||
130488488|NCT01570361|469757610|FG000|Overall Study|Sponsor closing the study|51|||
130488489|NCT01570361|469757611|FG001|Overall Study|Sponsor closing the study|50|||
130488490|NCT01570361|469757610|FG000|Overall Study|Subject excluded|5|||
130488491|NCT01570361|469757611|FG001|Overall Study|Subject excluded|3|||
130488492|NCT01570361|469757610|FG000|Overall Study|Subject withdrew consent|14|||
130488493|NCT01570361|469757611|FG001|Overall Study|Subject withdrew consent|9|||
130488494|NCT01570361|469757610|FG000|Overall Study|Adverse Event|2|||
130488495|NCT01570361|469757611|FG001|Overall Study|Adverse Event|1|||
130488496|NCT01570361|469757610|FG000|Overall Study|Lost to Follow-up|4|||
130488497|NCT01570361|469757611|FG001|Overall Study|Lost to Follow-up|4|||
130488498|NCT01570361|469757610|FG000|Overall Study|Death|5|||
130488499|NCT01570361|469757611|FG001|Overall Study|Death|4|||
130488500|NCT01570361|469757610|FG000|Overall Study|Other|0|||
130488501|NCT01570361|469757611|FG001|Overall Study|Other|2|||
130488502|NCT05158504|469757612|FG000|Overall Study|Lost to Follow-up|2|||
130488503|NCT05158504|469757613|FG001|Overall Study|Lost to Follow-up|3|||
130488504|NCT03606512|469757616|FG000|Overall Study|Lost to Follow-up|0|||
130488505|NCT03606512|469757617|FG001|Overall Study|Lost to Follow-up|1|||
130488506|NCT03606512|469757616|FG000|Overall Study|'moved from study area|0|||
130488507|NCT03606512|469757617|FG001|Overall Study|'moved from study area|1|||
130565289|NCT02159729|470035451|FG001|Overall Study|Subject's Request|10|||
130565290|NCT02159729|470035450|FG000|Overall Study|Lost to Follow-up|24|||
130488508|NCT05513937|469757618|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
130488509|NCT05513937|469757619|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
130488510|NCT05513937|469757620|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
130488511|NCT05513937|469757621|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
130488512|NCT05513937|469757618|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
130488513|NCT05513937|469757619|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
130488514|NCT05513937|469757620|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
130488515|NCT05513937|469757621|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
130488516|NCT05513937|469757618|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
130488517|NCT05513937|469757619|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
130488518|NCT05513937|469757620|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
130488519|NCT05513937|469757621|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
130488520|NCT05513937|469757618|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
130488521|NCT05513937|469757619|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
130488522|NCT05513937|469757620|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
130488523|NCT05513937|469757621|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
130488524|NCT05513937|469757618|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
130488525|NCT05513937|469757619|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
130488526|NCT05513937|469757620|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
130488527|NCT05513937|469757621|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
130488528|NCT05513937|469757618|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
130488529|NCT05513937|469757619|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
130488530|NCT05513937|469757620|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
130488531|NCT05513937|469757621|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
130488532|NCT02846545|469757622|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
130488533|NCT02846545|469757623|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
130488534|NCT02846545|469757622|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
130488535|NCT02846545|469757623|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
130488536|NCT02846545|469757622|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
130488537|NCT02846545|469757623|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
130488538|NCT02846545|469757622|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
130488539|NCT02846545|469757623|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
130488540|NCT02846545|469757622|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
130488541|NCT02846545|469757623|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
130488542|NCT03691298|469757626|FG000|Overall Study|Lost to Follow-up|8|||
130488543|NCT03691298|469757626|FG000|Overall Study|Sponsor terminated study|2|||
130488544|NCT02492711|469757630|FG000|Overall Study|Adverse Event|9|||
130488545|NCT02492711|469757631|FG001|Overall Study|Adverse Event|9|||
130488546|NCT02492711|469757632|FG002|Overall Study|Adverse Event|2|||
130488547|NCT02492711|469757630|FG000|Overall Study|Death|3|||
130488548|NCT02492711|469757631|FG001|Overall Study|Death|3|||
130488549|NCT02492711|469757632|FG002|Overall Study|Death|0|||
130488550|NCT02492711|469757630|FG000|Overall Study|Withdrawal by Subject|10|||
130488551|NCT02492711|469757631|FG001|Overall Study|Withdrawal by Subject|16|||
130488552|NCT02492711|469757632|FG002|Overall Study|Withdrawal by Subject|5|||
130488553|NCT02492711|469757630|FG000|Overall Study|Physician Decision|10|||
130488554|NCT02492711|469757631|FG001|Overall Study|Physician Decision|6|||
130488555|NCT02492711|469757632|FG002|Overall Study|Physician Decision|4|||
130488556|NCT02492711|469757630|FG000|Overall Study|Lost to Follow-up|0|||
130488557|NCT02492711|469757631|FG001|Overall Study|Lost to Follow-up|0|||
130488558|NCT02492711|469757632|FG002|Overall Study|Lost to Follow-up|1|||
130488559|NCT02492711|469757630|FG000|Overall Study|study treatment delay|2|||
130488560|NCT02492711|469757631|FG001|Overall Study|study treatment delay|1|||
130488561|NCT02492711|469757632|FG002|Overall Study|study treatment delay|0|||
130488562|NCT02492711|469757630|FG000|Overall Study|change in chemotherapy|0|||
130488563|NCT02492711|469757631|FG001|Overall Study|change in chemotherapy|1|||
130488564|NCT02492711|469757632|FG002|Overall Study|change in chemotherapy|0|||
130488565|NCT02492711|469757630|FG000|Overall Study|never treated|2|||
130488566|NCT02492711|469757631|FG001|Overall Study|never treated|4|||
130488567|NCT02492711|469757632|FG002|Overall Study|never treated|0|||
130488568|NCT02492711|469757630|FG000|Overall Study|Other|0|||
130488569|NCT02492711|469757631|FG001|Overall Study|Other|0|||
130488570|NCT02492711|469757632|FG002|Overall Study|Other|1|||
130488571|NCT03245840|469757638|FG000|Overall Study|Adverse Event|6|||
130488572|NCT03245840|469757639|FG001|Overall Study|Adverse Event|0|||
130488573|NCT03245840|469757638|FG000|Overall Study|Death|2|||
130488574|NCT03245840|469757639|FG001|Overall Study|Death|0|||
130488575|NCT03245840|469757638|FG000|Overall Study|Withdrawal by Subject|31|||
130565291|NCT02159729|470035451|FG001|Overall Study|Lost to Follow-up|9|||
130488576|NCT03245840|469757639|FG001|Overall Study|Withdrawal by Subject|1|||
130488577|NCT03245840|469757638|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130488578|NCT03245840|469757639|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130488579|NCT03245840|469757638|FG000|Overall Study|Physician Decision|4|||
130488580|NCT03245840|469757639|FG001|Overall Study|Physician Decision|1|||
130488581|NCT03245840|469757638|FG000|Overall Study|Study Terminated by Sponsor|56|||
130488582|NCT03245840|469757639|FG001|Overall Study|Study Terminated by Sponsor|6|||
130488583|NCT03245840|469757638|FG000|Overall Study|Site Terminated by Sponsor|4|||
130488584|NCT03245840|469757639|FG001|Overall Study|Site Terminated by Sponsor|0|||
130488585|NCT03245840|469757638|FG000|Overall Study|Lost to Follow-up|12|||
130488586|NCT03245840|469757639|FG001|Overall Study|Lost to Follow-up|2|||
130488587|NCT03245840|469757638|FG000|Overall Study|Pregnancy|2|||
130488588|NCT03245840|469757639|FG001|Overall Study|Pregnancy|0|||
130488589|NCT03245840|469757638|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130488590|NCT03245840|469757639|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130488591|NCT03245840|469757638|FG000|Overall Study|Not treated|1|||
130488592|NCT03245840|469757639|FG001|Overall Study|Not treated|1|||
130488593|NCT04109066|469757644|FG000|Pre-treatment|Participant withdrew consent|2|||
130488594|NCT04109066|469757645|FG001|Pre-treatment|Participant withdrew consent|0|||
130488595|NCT04109066|469757644|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
130488596|NCT04109066|469757645|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
130488597|NCT04109066|469757644|FG000|Treatment|Lack of Efficacy|2|||
130488598|NCT04109066|469757645|FG001|Treatment|Lack of Efficacy|4|||
130488599|NCT04109066|469757644|FG000|Treatment|Adverse Event|23|||
130488600|NCT04109066|469757645|FG001|Treatment|Adverse Event|7|||
130488601|NCT04109066|469757644|FG000|Treatment|Participant request to discontinue Study treatment|15|||
130488602|NCT04109066|469757645|FG001|Treatment|Participant request to discontinue Study treatment|14|||
130488603|NCT04109066|469757644|FG000|Treatment|Withdrawal by Subject|8|||
130488604|NCT04109066|469757645|FG001|Treatment|Withdrawal by Subject|8|||
130488605|NCT04109066|469757644|FG000|Treatment|Death|3|||
130488606|NCT04109066|469757645|FG001|Treatment|Death|0|||
130488607|NCT04109066|469757644|FG000|Treatment|Participant no longer meets study criteria|2|||
130488608|NCT04109066|469757645|FG001|Treatment|Participant no longer meets study criteria|2|||
130488609|NCT04109066|469757644|FG000|Treatment|Administrative reasons by sponsor|2|||
130488610|NCT04109066|469757645|FG001|Treatment|Administrative reasons by sponsor|3|||
130488611|NCT04109066|469757644|FG000|Treatment|Other reasons|17|||
130488612|NCT04109066|469757645|FG001|Treatment|Other reasons|23|||
130488613|NCT04109066|469757644|FG000|Treatment|Disease Progression|4|||
130488614|NCT04109066|469757645|FG001|Treatment|Disease Progression|7|||
130488615|NCT04109066|469757644|FG000|Treatment|Study drug toxicity|12|||
130488616|NCT04109066|469757645|FG001|Treatment|Study drug toxicity|5|||
130488617|NCT04109066|469757644|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
130488618|NCT04109066|469757645|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
130488619|NCT04109066|469757644|FG000|Treatment|Disease Recurrence|0|||
130488620|NCT04109066|469757645|FG001|Treatment|Disease Recurrence|2|||
130488621|NCT04109066|469757644|FG000|Treatment|Not reported|4|||
130488622|NCT04109066|469757645|FG001|Treatment|Not reported|8|||
130488623|NCT05890105|469757647|FG000|Overall Study|Adverse Event|1|||
130488624|NCT05890105|469757648|FG001|Overall Study|Adverse Event|0|||
130488625|NCT05890105|469757649|FG002|Overall Study|Adverse Event|0|||
130488626|NCT05890105|469757647|FG000|Overall Study|Other|1|||
130488627|NCT05890105|469757648|FG001|Overall Study|Other|2|||
130488628|NCT05890105|469757649|FG002|Overall Study|Other|0|||
130488629|NCT04505410|469757650|FG000|Overall Study|Adverse Event|2|||
130488630|NCT04505410|469757651|FG001|Overall Study|Adverse Event|0|||
130488631|NCT04505410|469757650|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
130488632|NCT04505410|469757651|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
130488633|NCT04505410|469757650|FG000|Overall Study|did not want to follow diet|1|||
130488634|NCT04505410|469757651|FG001|Overall Study|did not want to follow diet|0|||
130488635|NCT04505410|469757650|FG000|Overall Study|flare up of ulcerative colitis|0|||
130488636|NCT04505410|469757651|FG001|Overall Study|flare up of ulcerative colitis|1|||
130488637|NCT04505410|469757650|FG000|Overall Study|Lost to Follow-up|0|||
130565292|NCT02159729|470035450|FG000|Overall Study|Non compliance|2|||
130565293|NCT02159729|470035451|FG001|Overall Study|Non compliance|0|||
130488638|NCT04505410|469757651|FG001|Overall Study|Lost to Follow-up|2|||
130488639|NCT04505410|469757650|FG000|Overall Study|Lost to Follow-up|1|||
130488640|NCT04505410|469757651|FG001|Overall Study|Lost to Follow-up|0|||
130488641|NCT04505410|469757650|FG000|Overall Study|initiated another diet on their own|0|||
130488642|NCT04505410|469757651|FG001|Overall Study|initiated another diet on their own|2|||
130488643|NCT06262477|469759084|FG000|Overall Study|Withdrawal by Subject|1|||
130488644|NCT06262477|469759085|FG001|Overall Study|Withdrawal by Subject|0|||
130488645|NCT06262477|469759084|FG000|Overall Study|Adverse Event|0|||
130488646|NCT06262477|469759085|FG001|Overall Study|Adverse Event|1|||
130488647|NCT06262477|469759084|FG000|Overall Study|Lost to Follow-up|0|||
130488648|NCT06262477|469759085|FG001|Overall Study|Lost to Follow-up|1|||
130488649|NCT04183283|469759098|FG000|Period 1|Withdrawal by Subject|0|||
130488650|NCT04183283|469759099|FG001|Period 1|Withdrawal by Subject|1|||
130488651|NCT04183283|469759100|FG002|Period 1|Withdrawal by Subject|0|||
130488652|NCT04183283|469759101|FG003|Period 1|Withdrawal by Subject|0|||
130488653|NCT04183283|469759098|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
130488654|NCT04183283|469759099|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
130488655|NCT04183283|469759100|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
130488656|NCT04183283|469759101|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
130488657|NCT04999111|469759108|FG000|Overall Study|Lost to Follow-up|21|||
130488658|NCT04999111|469759109|FG001|Overall Study|Lost to Follow-up|16|||
130488659|NCT04999111|469759110|FG002|Overall Study|Lost to Follow-up|2|||
130488660|NCT04999111|469759111|FG003|Overall Study|Lost to Follow-up|26|||
130488661|NCT04999111|469759112|FG004|Overall Study|Lost to Follow-up|30|||
130488662|NCT04999111|469759113|FG005|Overall Study|Lost to Follow-up|6|||
130488663|NCT04999111|469759108|FG000|Overall Study|Physician Decision|1|||
130488664|NCT04999111|469759109|FG001|Overall Study|Physician Decision|3|||
130488665|NCT04999111|469759110|FG002|Overall Study|Physician Decision|0|||
130488666|NCT04999111|469759111|FG003|Overall Study|Physician Decision|1|||
130488667|NCT04999111|469759112|FG004|Overall Study|Physician Decision|2|||
130488668|NCT04999111|469759113|FG005|Overall Study|Physician Decision|0|||
130488669|NCT04999111|469759108|FG000|Overall Study|Withdrawal by Subject|23|||
130488670|NCT04999111|469759109|FG001|Overall Study|Withdrawal by Subject|29|||
130488671|NCT04999111|469759110|FG002|Overall Study|Withdrawal by Subject|15|||
130488672|NCT04999111|469759111|FG003|Overall Study|Withdrawal by Subject|30|||
130488673|NCT04999111|469759112|FG004|Overall Study|Withdrawal by Subject|35|||
130488674|NCT04999111|469759113|FG005|Overall Study|Withdrawal by Subject|10|||
130488675|NCT04999111|469759108|FG000|Overall Study|Other|6|||
130488676|NCT04999111|469759109|FG001|Overall Study|Other|6|||
130488677|NCT04999111|469759110|FG002|Overall Study|Other|3|||
130488678|NCT04999111|469759111|FG003|Overall Study|Other|8|||
130488679|NCT04999111|469759112|FG004|Overall Study|Other|8|||
130488680|NCT04999111|469759113|FG005|Overall Study|Other|5|||
130488681|NCT04999111|469759108|FG000|Overall Study|Non-compliance with study schedule|1|||
130488682|NCT04999111|469759109|FG001|Overall Study|Non-compliance with study schedule|0|||
130488683|NCT04999111|469759110|FG002|Overall Study|Non-compliance with study schedule|0|||
130488684|NCT04999111|469759111|FG003|Overall Study|Non-compliance with study schedule|1|||
130488685|NCT04999111|469759112|FG004|Overall Study|Non-compliance with study schedule|1|||
130488686|NCT04999111|469759113|FG005|Overall Study|Non-compliance with study schedule|1|||
130488687|NCT04999111|469759108|FG000|Overall Study|Randomized but not vaccinated|1|||
130488688|NCT04999111|469759109|FG001|Overall Study|Randomized but not vaccinated|2|||
130488689|NCT04999111|469759110|FG002|Overall Study|Randomized but not vaccinated|0|||
130488690|NCT04999111|469759111|FG003|Overall Study|Randomized but not vaccinated|3|||
130488691|NCT04999111|469759112|FG004|Overall Study|Randomized but not vaccinated|3|||
130488692|NCT04999111|469759113|FG005|Overall Study|Randomized but not vaccinated|0|||
130488693|NCT04999111|469759108|FG000|Overall Study|Adverse Event|1|||
130488694|NCT04999111|469759109|FG001|Overall Study|Adverse Event|1|||
130488695|NCT04999111|469759110|FG002|Overall Study|Adverse Event|0|||
130488696|NCT04999111|469759111|FG003|Overall Study|Adverse Event|0|||
130488697|NCT04999111|469759112|FG004|Overall Study|Adverse Event|0|||
130488698|NCT04999111|469759113|FG005|Overall Study|Adverse Event|0|||
130488699|NCT04999111|469759108|FG000|Overall Study|Initiated prohibited medication|0|||
130488700|NCT04999111|469759109|FG001|Overall Study|Initiated prohibited medication|0|||
130488701|NCT04999111|469759110|FG002|Overall Study|Initiated prohibited medication|0|||
130488702|NCT04999111|469759111|FG003|Overall Study|Initiated prohibited medication|0|||
130488703|NCT04999111|469759112|FG004|Overall Study|Initiated prohibited medication|1|||
130488704|NCT04999111|469759113|FG005|Overall Study|Initiated prohibited medication|0|||
130488705|NCT01314105|469759117|FG000|Overall Study|Progressive Disease|6|||
130488706|NCT01314105|469759118|FG001|Overall Study|Progressive Disease|10|||
130488707|NCT01314105|469759117|FG000|Overall Study|Refused to continue taking medication|0|||
130488708|NCT01314105|469759118|FG001|Overall Study|Refused to continue taking medication|1|||
130488709|NCT01314105|469759117|FG000|Overall Study|Other Adverse Event|1|||
130488710|NCT01314105|469759118|FG001|Overall Study|Other Adverse Event|1|||
130488711|NCT03640286|469759124|FG000|Overall Study|Adverse Event|6|||
130488712|NCT03640286|469759125|FG001|Overall Study|Adverse Event|6|||
130488713|NCT03640286|469759124|FG000|Overall Study|Lost to Follow-up|3|||
130488714|NCT03640286|469759125|FG001|Overall Study|Lost to Follow-up|6|||
130488715|NCT03640286|469759124|FG000|Overall Study|Pregnancy|1|||
130488716|NCT03640286|469759125|FG001|Overall Study|Pregnancy|0|||
130488717|NCT03640286|469759124|FG000|Overall Study|Withdrawal by Subject|10|||
130488718|NCT03640286|469759125|FG001|Overall Study|Withdrawal by Subject|10|||
130488719|NCT03640286|469759124|FG000|Overall Study|Non-compliance|4|||
130488720|NCT03640286|469759125|FG001|Overall Study|Non-compliance|10|||
130488721|NCT03640286|469759124|FG000|Overall Study|Medication change|1|||
130488722|NCT03640286|469759125|FG001|Overall Study|Medication change|0|||
130488723|NCT03640286|469759124|FG000|Overall Study|Other|1|||
130488724|NCT03640286|469759125|FG001|Overall Study|Other|2|||
130488725|NCT03640286|469759124|FG000|Overall Study|Joined another lifestyle program|0|||
130488726|NCT03640286|469759125|FG001|Overall Study|Joined another lifestyle program|1|||
130488727|NCT05524116|469759126|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
130488728|NCT05524116|469759127|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
130488729|NCT05524116|469759126|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
130488730|NCT05524116|469759127|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
130488731|NCT05524116|469759126|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
130488732|NCT05524116|469759127|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
130488733|NCT05524116|469759126|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
130488734|NCT05524116|469759127|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
130488735|NCT05524116|469759126|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
130488736|NCT05524116|469759127|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
130488737|NCT03181516|469759128|FG000|Overall Study|Withdrawal by Subject|14|||
130488738|NCT03181516|469759129|FG001|Overall Study|Withdrawal by Subject|7|||
130488739|NCT03181516|469759128|FG000|Overall Study|Lost to Follow-up|2|||
130488740|NCT03181516|469759129|FG001|Overall Study|Lost to Follow-up|2|||
130488741|NCT05405985|469759130|FG000|Overall Study|Withdrawal by Subject|1|||
130488742|NCT05405985|469759131|FG001|Overall Study|Withdrawal by Subject|0|||
130488743|NCT04880733|469759132|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
130488744|NCT04880733|469759133|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
130488745|NCT04880733|469759134|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
130488746|NCT04880733|469759132|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
130488747|NCT04880733|469759133|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
130488748|NCT04880733|469759134|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
130488749|NCT04880733|469759132|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
130565294|NCT02159729|470035450|FG000|Overall Study|Other Unspecified|3|||
130565295|NCT02159729|470035451|FG001|Overall Study|Other Unspecified|1|||
130565296|NCT02636582|470035452|FG000|Overall Study|Surgical Pathology|1|||
130565297|NCT02636582|470035453|FG001|Overall Study|Surgical Pathology|0|||
130565298|NCT05500274|470035454|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
130488750|NCT04880733|469759133|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
130488751|NCT04880733|469759134|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
130488752|NCT04880733|469759132|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
130488753|NCT04880733|469759133|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
130488754|NCT04880733|469759134|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
130488755|NCT04880733|469759132|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
130488756|NCT04880733|469759133|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
130488757|NCT04880733|469759134|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
130488758|NCT05552508|469759135|FG000|Overall Study|Adverse Event|3|||
130488759|NCT01917084|469759136|FG000|Overall Study|Withdrawal by Subject|1|||
130488760|NCT02278211|469759143|FG000|Overall Study|Unable to analyse PET scan|2|||
130488761|NCT05424380|469759144|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
130488762|NCT05424380|469759145|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130488763|NCT05424380|469759146|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130488764|NCT05424380|469759147|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130488765|NCT05424380|469759148|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130488766|NCT05424380|469759149|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130488767|NCT05424380|469759144|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
130488768|NCT05424380|469759145|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
130488769|NCT05424380|469759146|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
130488770|NCT05424380|469759147|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
130488771|NCT05424380|469759148|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
130488772|NCT05424380|469759149|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
130488773|NCT05424380|469759144|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
130488774|NCT05424380|469759145|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
130488775|NCT05424380|469759146|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
130488776|NCT05424380|469759147|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
130488777|NCT05424380|469759148|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
130488778|NCT05424380|469759149|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
130488779|NCT05424380|469759144|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
130488780|NCT05424380|469759145|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
130488781|NCT05424380|469759146|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
130488782|NCT05424380|469759147|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
130488783|NCT05424380|469759148|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
130488784|NCT05424380|469759149|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
130488785|NCT05424380|469759144|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
130488786|NCT05424380|469759145|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
130488787|NCT05424380|469759146|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
130488788|NCT05424380|469759147|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
130488789|NCT05424380|469759148|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
130488790|NCT05424380|469759149|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
130488791|NCT05424380|469759144|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
130488792|NCT05424380|469759145|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
130488793|NCT05424380|469759146|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
130488794|NCT05424380|469759147|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
130488795|NCT05424380|469759148|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
130488796|NCT05424380|469759149|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
130488797|NCT05424380|469759144|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
130488798|NCT05424380|469759145|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
130488799|NCT05424380|469759146|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
130488800|NCT05424380|469759147|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
130488801|NCT05424380|469759148|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
130488802|NCT05424380|469759149|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
130488803|NCT05424380|469759144|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
130488804|NCT05424380|469759145|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
130488805|NCT05424380|469759146|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
130488806|NCT05424380|469759147|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
130488807|NCT05424380|469759148|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
130488808|NCT05424380|469759149|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
130488809|NCT05424380|469759144|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488810|NCT05424380|469759145|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488811|NCT05424380|469759146|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488812|NCT05424380|469759147|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
130648304|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
130488813|NCT05424380|469759148|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488814|NCT05424380|469759149|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488815|NCT05424380|469759144|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
130488816|NCT05424380|469759145|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
130728592|NCT04784533|470627513|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728593|NCT04784533|470627514|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728594|NCT04784533|470627515|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728595|NCT04784533|470627516|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728596|NCT04784533|470627517|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728597|NCT04784533|470627518|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728598|NCT04784533|470627519|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
130728599|NCT04784533|470627520|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728600|NCT04784533|470627511|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728601|NCT04784533|470627512|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728602|NCT04784533|470627513|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728603|NCT04784533|470627514|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728604|NCT04784533|470627515|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728605|NCT04784533|470627516|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728606|NCT04784533|470627517|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728607|NCT04784533|470627518|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728608|NCT04784533|470627519|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130728609|NCT04784533|470627520|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130728610|NCT02185053|470627521|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
130728611|NCT02185053|470627522|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130728612|NCT02185053|470627523|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130728613|NCT02185053|470627521|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
130565299|NCT05500274|470035455|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
130565300|NCT05500274|470035454|FG000|Overall Study|Lost to Follow-up|76|||
130565301|NCT05500274|470035455|FG001|Overall Study|Lost to Follow-up|51|||
130565302|NCT01555151|470035456|FG000|Overall Study|Withdrawal by Subject|6|||
130565303|NCT01555151|470035457|FG001|Overall Study|Withdrawal by Subject|2|||
130565304|NCT01555151|470035458|FG002|Overall Study|Withdrawal by Subject|0|||
130565305|NCT01555151|470035459|FG003|Overall Study|Withdrawal by Subject|2|||
130565306|NCT01555151|470035456|FG000|Overall Study|Administrative|3|||
130565307|NCT01555151|470035457|FG001|Overall Study|Administrative|1|||
130565308|NCT01555151|470035458|FG002|Overall Study|Administrative|2|||
130565309|NCT01555151|470035459|FG003|Overall Study|Administrative|0|||
130565310|NCT01555151|470035456|FG000|Overall Study|Protocol Violation|3|||
130565311|NCT01555151|470035457|FG001|Overall Study|Protocol Violation|3|||
130565312|NCT01555151|470035458|FG002|Overall Study|Protocol Violation|3|||
130565313|NCT01555151|470035459|FG003|Overall Study|Protocol Violation|5|||
130565314|NCT01555151|470035456|FG000|Overall Study|Adverse Event|1|||
130565315|NCT01555151|470035457|FG001|Overall Study|Adverse Event|2|||
130565316|NCT01555151|470035458|FG002|Overall Study|Adverse Event|1|||
130565317|NCT01555151|470035459|FG003|Overall Study|Adverse Event|2|||
130565318|NCT01555151|470035456|FG000|Overall Study|Lost to Follow-up|0|||
130565319|NCT01555151|470035457|FG001|Overall Study|Lost to Follow-up|0|||
130565320|NCT01555151|470035458|FG002|Overall Study|Lost to Follow-up|0|||
130565321|NCT01555151|470035459|FG003|Overall Study|Lost to Follow-up|1|||
130565322|NCT03596866|470035460|FG000|Overall Study|Site terminated by Sponsor|64|||
130565323|NCT03596866|470035461|FG001|Overall Study|Site terminated by Sponsor|65|||
130565324|NCT03596866|470035460|FG000|Overall Study|Death|37|||
130565325|NCT03596866|470035461|FG001|Overall Study|Death|24|||
130565326|NCT03596866|470035460|FG000|Overall Study|Withdrawal by Subject|4|||
130565327|NCT03596866|470035461|FG001|Overall Study|Withdrawal by Subject|6|||
130565328|NCT03596866|470035460|FG000|Overall Study|Missing|0|||
130565329|NCT03596866|470035461|FG001|Overall Study|Missing|6|||
130565330|NCT03596866|470035460|FG000|Overall Study|Lost to Follow-up|2|||
130565331|NCT03596866|470035461|FG001|Overall Study|Lost to Follow-up|3|||
130565332|NCT03596866|470035460|FG000|Overall Study|Protocol Violation|1|||
130565333|NCT03596866|470035461|FG001|Overall Study|Protocol Violation|0|||
130565334|NCT03596866|470035460|FG000|Overall Study|Reason Not Specified|14|||
130565335|NCT03596866|470035461|FG001|Overall Study|Reason Not Specified|13|||
130565336|NCT01961349|470035462|FG000|Overall Study|Withdrawal by Subject|1|||
130565337|NCT01961349|470035463|FG001|Overall Study|Withdrawal by Subject|4|||
130565338|NCT01961349|470035464|FG002|Overall Study|Withdrawal by Subject|0|||
130565339|NCT01961349|470035462|FG000|Overall Study|Adverse Event|0|||
130565340|NCT01961349|470035463|FG001|Overall Study|Adverse Event|0|||
130565341|NCT01961349|470035464|FG002|Overall Study|Adverse Event|1|||
130565342|NCT01961349|470035462|FG000|Overall Study|registration error, personal reason etc|2|||
130565343|NCT01961349|470035463|FG001|Overall Study|registration error, personal reason etc|2|||
130565344|NCT01961349|470035464|FG002|Overall Study|registration error, personal reason etc|1|||
130565345|NCT02576444|470035465|FG000|Overall Study|Death|1|||
130565346|NCT02576444|470035466|FG001|Overall Study|Death|1|||
130565347|NCT02576444|470035467|FG002|Overall Study|Death|0|||
130565348|NCT02576444|470035468|FG003|Overall Study|Death|0|||
130565349|NCT02576444|470035465|FG000|Overall Study|Withdrawal by Subject|0|||
130565350|NCT02576444|470035466|FG001|Overall Study|Withdrawal by Subject|0|||
130565351|NCT02576444|470035467|FG002|Overall Study|Withdrawal by Subject|2|||
130488817|NCT05424380|469759146|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
130488818|NCT05424380|469759147|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
130488819|NCT05424380|469759148|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
130488820|NCT05424380|469759149|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
130488821|NCT05424380|469759144|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
130488822|NCT05424380|469759145|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
130488823|NCT05424380|469759146|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
130488824|NCT05424380|469759147|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
130488825|NCT05424380|469759148|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
130488826|NCT05424380|469759149|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
130488827|NCT05424380|469759144|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130488828|NCT05424380|469759145|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130488829|NCT05424380|469759146|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130488830|NCT05424380|469759147|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130488831|NCT05424380|469759148|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
130488832|NCT05424380|469759149|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130488833|NCT05424380|469759144|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488834|NCT05424380|469759145|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488835|NCT05424380|469759146|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488836|NCT05424380|469759147|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488837|NCT05424380|469759148|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
130488838|NCT05424380|469759149|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130488839|NCT05424380|469759144|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
130488840|NCT05424380|469759145|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
130488841|NCT05424380|469759146|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
130488842|NCT05424380|469759147|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
130488843|NCT05424380|469759148|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
130488844|NCT05424380|469759149|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
130488845|NCT02909686|469759154|FG000|Overall Study|Physician Decision|3|||
130488846|NCT02909686|469759154|FG000|Overall Study|Withdrawal by Subject|2|||
130488847|NCT06037668|469759157|FG000|Overall Study|Lost to Follow-up|1|||
130488848|NCT06037668|469759158|FG001|Overall Study|Lost to Follow-up|1|||
130488849|NCT06037668|469759157|FG000|Overall Study|Protocol Violation|1|||
130488850|NCT06037668|469759158|FG001|Overall Study|Protocol Violation|0|||
130488851|NCT06037668|469759157|FG000|Overall Study|Withdrawal by Subject|1|||
130488852|NCT06037668|469759158|FG001|Overall Study|Withdrawal by Subject|0|||
130488853|NCT06037668|469759157|FG000|Overall Study|Other Study Discontinuation Reason|1|||
130488854|NCT06037668|469759158|FG001|Overall Study|Other Study Discontinuation Reason|0|||
130488855|NCT05224544|469759159|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
130488856|NCT05224544|469759160|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
130488857|NCT04804540|469759161|FG000|Overall Study|Adverse Event|26|||
130488858|NCT04804540|469759162|FG001|Overall Study|Adverse Event|13|||
130488859|NCT00844415|469759163|FG000|Overall Study|Withdrawal by Subject|1|||
130488860|NCT02473445|469759164|FG000|Overall Study|Withdrawal by Subject|2|||
130488861|NCT02473445|469759164|FG000|Overall Study|Sponsor Decision|20|||
130488862|NCT03015532|469759165|FG000|Overall Study|Adverse Event|0|||
130488863|NCT03015532|469759166|FG001|Overall Study|Adverse Event|0|||
130488864|NCT03015532|469759167|FG002|Overall Study|Adverse Event|0|||
130488865|NCT03015532|469759168|FG003|Overall Study|Adverse Event|0|||
130488866|NCT03015532|469759169|FG004|Overall Study|Adverse Event|0|||
130488867|NCT03015532|469759170|FG005|Overall Study|Adverse Event|2|||
130488868|NCT03015532|469759171|FG006|Overall Study|Adverse Event|1|||
130488869|NCT03015532|469759172|FG007|Overall Study|Adverse Event|0|||
130488870|NCT03015532|469759165|FG000|Overall Study|Withdrawal by Subject|0|||
130488871|NCT03015532|469759166|FG001|Overall Study|Withdrawal by Subject|0|||
130488872|NCT03015532|469759167|FG002|Overall Study|Withdrawal by Subject|0|||
130488873|NCT03015532|469759168|FG003|Overall Study|Withdrawal by Subject|0|||
130488874|NCT03015532|469759169|FG004|Overall Study|Withdrawal by Subject|0|||
130488875|NCT03015532|469759170|FG005|Overall Study|Withdrawal by Subject|0|||
130488876|NCT03015532|469759171|FG006|Overall Study|Withdrawal by Subject|1|||
130488877|NCT03015532|469759172|FG007|Overall Study|Withdrawal by Subject|0|||
130488878|NCT05970861|469759173|FG000|Overall Study|Physician Decision|4|||
130488879|NCT05970861|469759174|FG001|Overall Study|Physician Decision|4|||
130488880|NCT05970861|469759173|FG000|Overall Study|Lost to Follow-up|4|||
130488881|NCT05970861|469759174|FG001|Overall Study|Lost to Follow-up|3|||
130488882|NCT03988621|469759178|FG000|Overall Study|Lost to Follow-up|16|||
130488883|NCT03988621|469759179|FG001|Overall Study|Lost to Follow-up|17|||
130488884|NCT03988621|469759178|FG000|Overall Study|Withdrawal by Subject|14|||
130488885|NCT03988621|469759179|FG001|Overall Study|Withdrawal by Subject|7|||
130488886|NCT03988621|469759178|FG000|Overall Study|Patient Lost to Follow Up|15|||
130488887|NCT03988621|469759179|FG001|Overall Study|Patient Lost to Follow Up|15|||
130488888|NCT03988621|469759178|FG000|Overall Study|Patient death|1|||
130488889|NCT03988621|469759179|FG001|Overall Study|Patient death|5|||
130488890|NCT04629339|469759180|FG000|Overall Study|Death|1|||
130488891|NCT04629339|469759181|FG001|Overall Study|Death|0|||
130488892|NCT04629339|469759182|FG002|Overall Study|Death|2|||
130488893|NCT04629339|469759183|FG003|Overall Study|Death|2|||
130488894|NCT04629339|469759184|FG004|Overall Study|Death|0|||
130488895|NCT04629339|469759180|FG000|Overall Study|Disease Progression|0|||
130488896|NCT04629339|469759181|FG001|Overall Study|Disease Progression|0|||
130488897|NCT04629339|469759182|FG002|Overall Study|Disease Progression|1|||
130488898|NCT04629339|469759183|FG003|Overall Study|Disease Progression|1|||
130488899|NCT04629339|469759184|FG004|Overall Study|Disease Progression|0|||
130488900|NCT04629339|469759180|FG000|Overall Study|Lost to Follow-up|0|||
130488901|NCT04629339|469759181|FG001|Overall Study|Lost to Follow-up|0|||
130488902|NCT04629339|469759182|FG002|Overall Study|Lost to Follow-up|0|||
130488903|NCT04629339|469759183|FG003|Overall Study|Lost to Follow-up|1|||
130488904|NCT04629339|469759184|FG004|Overall Study|Lost to Follow-up|0|||
130488905|NCT04629339|469759180|FG000|Overall Study|Physician Decision|0|||
130488906|NCT04629339|469759181|FG001|Overall Study|Physician Decision|1|||
130488907|NCT04629339|469759182|FG002|Overall Study|Physician Decision|0|||
130488908|NCT04629339|469759183|FG003|Overall Study|Physician Decision|0|||
130488909|NCT04629339|469759184|FG004|Overall Study|Physician Decision|0|||
130488910|NCT04629339|469759180|FG000|Overall Study|Study Terminated by Sponsor|0|||
130488911|NCT04629339|469759181|FG001|Overall Study|Study Terminated by Sponsor|0|||
130488912|NCT04629339|469759182|FG002|Overall Study|Study Terminated by Sponsor|0|||
130488913|NCT04629339|469759183|FG003|Overall Study|Study Terminated by Sponsor|1|||
130488914|NCT04629339|469759184|FG004|Overall Study|Study Terminated by Sponsor|0|||
130488915|NCT04629339|469759180|FG000|Overall Study|Withdrawal by Subject|0|||
130488916|NCT04629339|469759181|FG001|Overall Study|Withdrawal by Subject|0|||
130488917|NCT04629339|469759182|FG002|Overall Study|Withdrawal by Subject|2|||
130488918|NCT04629339|469759183|FG003|Overall Study|Withdrawal by Subject|2|||
130488919|NCT04629339|469759184|FG004|Overall Study|Withdrawal by Subject|0|||
130488920|NCT04158739|469759187|FG000|Overall Study|Adverse Event|1|||
130488921|NCT04158739|469759188|FG001|Overall Study|Adverse Event|0|||
130488922|NCT04158739|469759187|FG000|Overall Study|Death|0|||
130488923|NCT04158739|469759188|FG001|Overall Study|Death|1|||
130488924|NCT04158739|469759187|FG000|Overall Study|Lack of Efficacy|3|||
130488925|NCT04158739|469759188|FG001|Overall Study|Lack of Efficacy|7|||
130488926|NCT04158739|469759187|FG000|Overall Study|Physician Decision|0|||
130488927|NCT04158739|469759188|FG001|Overall Study|Physician Decision|1|||
130488928|NCT04158739|469759187|FG000|Overall Study|Withdrawal by Subject|3|||
130488929|NCT04158739|469759188|FG001|Overall Study|Withdrawal by Subject|0|||
130488930|NCT03914469|469759189|FG000|Overall Study|Lost to Follow-up|1|||
130488931|NCT03914469|469759190|FG001|Overall Study|Lost to Follow-up|4|||
130488932|NCT04778410|469759191|FG000|Safety Run-in Period|Death|5|||
130488933|NCT04778410|469759192|FG001|Safety Run-in Period|Death|6|||
130488934|NCT04778410|469759193|FG002|Safety Run-in Period|Death|0|||
130488935|NCT04778410|469759194|FG003|Safety Run-in Period|Death|0|||
130488936|NCT04778410|469759195|FG004|Safety Run-in Period|Death|0|||
130488937|NCT04778410|469759196|FG005|Safety Run-in Period|Death|0|||
130488938|NCT04778410|469759191|FG000|Phase 2 Period|Death|0|||
130488939|NCT04778410|469759192|FG001|Phase 2 Period|Death|0|||
130488940|NCT04778410|469759193|FG002|Phase 2 Period|Death|0|||
130488941|NCT04778410|469759194|FG003|Phase 2 Period|Death|5|||
130488942|NCT04778410|469759195|FG004|Phase 2 Period|Death|18|||
130488943|NCT04778410|469759196|FG005|Phase 2 Period|Death|0|||
130488944|NCT04778410|469759191|FG000|Phase 2 Period|Lost to Follow-up|0|||
130488945|NCT04778410|469759192|FG001|Phase 2 Period|Lost to Follow-up|0|||
130488946|NCT04778410|469759193|FG002|Phase 2 Period|Lost to Follow-up|0|||
130488947|NCT04778410|469759194|FG003|Phase 2 Period|Lost to Follow-up|1|||
130488948|NCT04778410|469759195|FG004|Phase 2 Period|Lost to Follow-up|1|||
130488949|NCT04778410|469759196|FG005|Phase 2 Period|Lost to Follow-up|0|||
130488950|NCT04778410|469759191|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
130488951|NCT04778410|469759192|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
130488952|NCT04778410|469759193|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
130488953|NCT04778410|469759194|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
130488954|NCT04778410|469759195|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
130488955|NCT04778410|469759196|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
130488956|NCT04778410|469759191|FG000|Phase 2 Period|Withdrew Consent|0|||
130488957|NCT04778410|469759192|FG001|Phase 2 Period|Withdrew Consent|0|||
130488958|NCT04778410|469759193|FG002|Phase 2 Period|Withdrew Consent|0|||
130488959|NCT04778410|469759194|FG003|Phase 2 Period|Withdrew Consent|0|||
130488960|NCT04778410|469759195|FG004|Phase 2 Period|Withdrew Consent|2|||
130488961|NCT04778410|469759196|FG005|Phase 2 Period|Withdrew Consent|0|||
130488962|NCT00677365|469759199|FG000|Overall Study|Adverse Event|2|||
130488963|NCT00677365|469759200|FG001|Overall Study|Adverse Event|1|||
130488964|NCT00677365|469759201|FG002|Overall Study|Adverse Event|1|||
130488965|NCT00677365|469759202|FG003|Overall Study|Adverse Event|2|||
130488966|NCT00677365|469759199|FG000|Overall Study|Withdrawal by Subject|0|||
130488967|NCT00677365|469759200|FG001|Overall Study|Withdrawal by Subject|0|||
130488968|NCT00677365|469759201|FG002|Overall Study|Withdrawal by Subject|1|||
130488969|NCT00677365|469759202|FG003|Overall Study|Withdrawal by Subject|0|||
130488970|NCT00677365|469759199|FG000|Overall Study|Other reason|0|||
130488971|NCT00677365|469759200|FG001|Overall Study|Other reason|0|||
130488972|NCT00677365|469759201|FG002|Overall Study|Other reason|0|||
130488973|NCT00677365|469759202|FG003|Overall Study|Other reason|1|||
130488974|NCT01121588|469759203|FG000|Overall Study|Death|5|||
130488975|NCT01121588|469759204|FG001|Overall Study|Death|3|||
130488976|NCT01121588|469759205|FG002|Overall Study|Death|13|||
130488977|NCT01121588|469759203|FG000|Overall Study|Study Terminated by Sponsor|1|||
130488978|NCT01121588|469759204|FG001|Overall Study|Study Terminated by Sponsor|1|||
130488979|NCT01121588|469759205|FG002|Overall Study|Study Terminated by Sponsor|0|||
130488980|NCT01121588|469759203|FG000|Overall Study|Participant Refused Further Followup|2|||
130488981|NCT01121588|469759204|FG001|Overall Study|Participant Refused Further Followup|0|||
130488982|NCT01121588|469759205|FG002|Overall Study|Participant Refused Further Followup|2|||
130488983|NCT01121588|469759203|FG000|Overall Study|Lost to Follow-up|0|||
130488984|NCT01121588|469759204|FG001|Overall Study|Lost to Follow-up|1|||
130488985|NCT01121588|469759205|FG002|Overall Study|Lost to Follow-up|1|||
130488986|NCT01121588|469759203|FG000|Overall Study|Non-Specified Reasons|9|||
130488987|NCT01121588|469759204|FG001|Overall Study|Non-Specified Reasons|4|||
130488988|NCT01121588|469759205|FG002|Overall Study|Non-Specified Reasons|2|||
130488989|NCT00721149|469759207|FG000|Overall Study|Physician Decision|1|||
130488990|NCT01586910|469760151|FG000|Overall Study|Death|4|||
130488991|NCT01586910|469760152|FG001|Overall Study|Death|4|||
130488992|NCT01586910|469760151|FG000|Overall Study|Withdrawal by Subject|6|||
130488993|NCT01586910|469760152|FG001|Overall Study|Withdrawal by Subject|43|||
130488994|NCT01586910|469760151|FG000|Overall Study|Physician withdrew Subject|5|||
130488995|NCT01586910|469760152|FG001|Overall Study|Physician withdrew Subject|24|||
130488996|NCT01064440|469760153|FG000|Overall Study|Lost to Follow-up|1|||
130488997|NCT01064440|469760154|FG001|Overall Study|Lost to Follow-up|1|||
130488998|NCT01064440|469760155|FG002|Overall Study|Lost to Follow-up|1|||
130488999|NCT01064440|469760153|FG000|Overall Study|Non-compliance|0|||
130489000|NCT01064440|469760154|FG001|Overall Study|Non-compliance|1|||
130489001|NCT01064440|469760155|FG002|Overall Study|Non-compliance|0|||
130489002|NCT01064440|469760153|FG000|Overall Study|Death|1|||
130489003|NCT01064440|469760154|FG001|Overall Study|Death|0|||
130489004|NCT01064440|469760155|FG002|Overall Study|Death|1|||
130489005|NCT01064440|469760153|FG000|Overall Study|Withdrawal by Subject|0|||
130489006|NCT01064440|469760154|FG001|Overall Study|Withdrawal by Subject|1|||
130489007|NCT01064440|469760155|FG002|Overall Study|Withdrawal by Subject|1|||
130489008|NCT01064440|469760153|FG000|Overall Study|Other: amputation|1|||
130489009|NCT01064440|469760154|FG001|Overall Study|Other: amputation|0|||
130489010|NCT01064440|469760155|FG002|Overall Study|Other: amputation|0|||
130489011|NCT04108130|469760156|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
130489012|NCT04108130|469760157|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
130489013|NCT04108130|469760156|FG000|Overall Study|Consent Withdrawn|9|||
130489014|NCT04108130|469760157|FG001|Overall Study|Consent Withdrawn|6|||
130489015|NCT04108130|469760156|FG000|Overall Study|Surgery Cancelled|4|||
130489016|NCT04108130|469760157|FG001|Overall Study|Surgery Cancelled|4|||
130489017|NCT04108130|469760156|FG000|Overall Study|Found Ineligible for Study|4|||
130489018|NCT04108130|469760157|FG001|Overall Study|Found Ineligible for Study|3|||
130489019|NCT04108130|469760156|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
130489020|NCT04108130|469760157|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
130489021|NCT04108130|469760156|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
130489022|NCT04108130|469760157|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
130489023|NCT05507333|469760158|FG000|Overall Study|Protocol Violation|1|||
130489024|NCT01130883|469760159|FG000|Overall Study|Patient Noncompliance|6|||
130489025|NCT01130883|469760159|FG000|Overall Study|Reason Unknown|1|||
130489026|NCT01130883|469760159|FG000|Overall Study|Adverse Event|3|||
130489027|NCT02585323|469760160|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
130489028|NCT02585323|469760161|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
130489029|NCT02585323|469760160|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
130489030|NCT02585323|469760161|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
130489031|NCT02585323|469760160|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
130489032|NCT02585323|469760161|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
130489033|NCT02585323|469760160|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
130489034|NCT02585323|469760161|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
130489035|NCT03981926|469760162|FG000|Overall Study|Lost to Follow-up|5|||
130489036|NCT03981926|469760163|FG001|Overall Study|Lost to Follow-up|9|||
130489037|NCT05464069|469760164|FG000|Overall Study|Protocol Violation|3|||
130489038|NCT05464069|469760165|FG001|Overall Study|Protocol Violation|2|||
130489039|NCT04136912|469760166|FG000|Overall Study|Operational reasons|0|||
130489040|NCT04136912|469760167|FG001|Overall Study|Operational reasons|0|||
130489041|NCT04136912|469760168|FG002|Overall Study|Operational reasons|2|||
130489042|NCT05976334|469760169|FG000|Part B|Death|0|||
130489043|NCT05976334|469760170|FG001|Part B|Death|1|||
130489044|NCT05976334|469760169|FG000|Part B|Study Terminated by Sponsor|0|||
130489045|NCT05976334|469760170|FG001|Part B|Study Terminated by Sponsor|1|||
130489046|NCT05976334|469760169|FG000|Part B|Reason Not Specified|0|||
130489047|NCT05976334|469760170|FG001|Part B|Reason Not Specified|1|||
130489048|NCT02437136|469760173|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
130489049|NCT02437136|469760174|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489050|NCT02437136|469760175|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489051|NCT02437136|469760176|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489052|NCT02437136|469760177|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489053|NCT02437136|469760178|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489054|NCT02437136|469760179|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130489055|NCT02437136|469760173|FG000|Expansion (Phase 2)|Death|0|||
130489056|NCT02437136|469760174|FG001|Expansion (Phase 2)|Death|0|||
130489057|NCT02437136|469760175|FG002|Expansion (Phase 2)|Death|0|||
130489058|NCT02437136|469760176|FG003|Expansion (Phase 2)|Death|6|||
130489059|NCT02437136|469760177|FG004|Expansion (Phase 2)|Death|37|||
130489060|NCT02437136|469760178|FG005|Expansion (Phase 2)|Death|29|||
130489061|NCT02437136|469760179|FG006|Expansion (Phase 2)|Death|24|||
130489062|NCT02437136|469760173|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
130489063|NCT02437136|469760174|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
130489064|NCT02437136|469760175|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
130489065|NCT02437136|469760176|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
130489066|NCT02437136|469760177|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
130489067|NCT02437136|469760178|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
130489068|NCT02437136|469760179|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
130489069|NCT02437136|469760173|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
130489070|NCT02437136|469760174|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
130489071|NCT02437136|469760175|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
130489072|NCT02437136|469760176|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
130489073|NCT02437136|469760177|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
130489074|NCT02437136|469760178|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
130489075|NCT02437136|469760179|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
130489076|NCT04526886|469760180|FG000|Overall Study|Physician Decision|4|||
130489077|NCT04282980|469760187|FG000|Overall Study|Remained on treatment|6|||
130489078|NCT04282980|469760187|FG000|Overall Study|Survival follow-up|11|||
130489079|NCT04282980|469760187|FG000|Overall Study|Withdrawal of informed consent|1|||
130489080|NCT04282980|469760187|FG000|Overall Study|Lost to Follow-up|1|||
130489081|NCT03571386|469760188|FG000|Overall Study|scheduling conflict|4|||
130489082|NCT03571386|469760189|FG001|Overall Study|scheduling conflict|0|||
130489083|NCT03571386|469760188|FG000|Overall Study|Withdrawal by Subject|15|||
130489084|NCT03571386|469760189|FG001|Overall Study|Withdrawal by Subject|5|||
130489085|NCT04311632|469760190|FG000|Overall Study|Withdrawal by Subject|0|||
130489086|NCT04311632|469760191|FG001|Overall Study|Withdrawal by Subject|0|||
130489087|NCT04311632|469760192|FG002|Overall Study|Withdrawal by Subject|1|||
130489088|NCT04632225|469760193|FG000|Overall Study|Withdrawal by Subject|2|||
130489089|NCT04632225|469760194|FG001|Overall Study|Withdrawal by Subject|2|||
130489090|NCT04605159|469760195|FG000|Overall Study|Adverse Event|6|||
130489091|NCT04605159|469760196|FG001|Overall Study|Adverse Event|3|||
130489092|NCT04605159|469760197|FG002|Overall Study|Adverse Event|21|||
130489093|NCT04605159|469760198|FG003|Overall Study|Adverse Event|4|||
130489094|NCT04605159|469760195|FG000|Overall Study|Lost to Follow-up|74|||
130489095|NCT04605159|469760196|FG001|Overall Study|Lost to Follow-up|45|||
130489096|NCT04605159|469760197|FG002|Overall Study|Lost to Follow-up|119|||
130489097|NCT04605159|469760198|FG003|Overall Study|Lost to Follow-up|80|||
130489098|NCT04605159|469760195|FG000|Overall Study|Protocol Violation|4|||
130489099|NCT04605159|469760196|FG001|Overall Study|Protocol Violation|5|||
130489100|NCT04605159|469760197|FG002|Overall Study|Protocol Violation|2|||
130489101|NCT04605159|469760198|FG003|Overall Study|Protocol Violation|0|||
130489102|NCT04605159|469760195|FG000|Overall Study|Withdrawal by Subject|66|||
130489103|NCT04605159|469760196|FG001|Overall Study|Withdrawal by Subject|37|||
130489104|NCT04605159|469760197|FG002|Overall Study|Withdrawal by Subject|68|||
130489105|NCT04605159|469760198|FG003|Overall Study|Withdrawal by Subject|50|||
130489106|NCT04605159|469760195|FG000|Overall Study|Migrated / moved from the study area|32|||
130489107|NCT04605159|469760196|FG001|Overall Study|Migrated / moved from the study area|22|||
130489108|NCT04605159|469760197|FG002|Overall Study|Migrated / moved from the study area|41|||
130489109|NCT04605159|469760198|FG003|Overall Study|Migrated / moved from the study area|21|||
130489110|NCT04605159|469760195|FG000|Overall Study|Other|1|||
130565352|NCT02576444|470035468|FG003|Overall Study|Withdrawal by Subject|0|||
130489111|NCT04605159|469760196|FG001|Overall Study|Other|2|||
130489112|NCT04605159|469760197|FG002|Overall Study|Other|7|||
130489113|NCT04605159|469760198|FG003|Overall Study|Other|3|||
130489114|NCT04881461|469760202|FG000|Overall Study|Adverse Event|2|||
130489115|NCT04881461|469760203|FG001|Overall Study|Adverse Event|4|||
130489116|NCT04881461|469760202|FG000|Overall Study|Withdrawal by Subject|19|||
130489117|NCT04881461|469760203|FG001|Overall Study|Withdrawal by Subject|19|||
130489118|NCT04881461|469760202|FG000|Overall Study|Lost to Follow-up|4|||
130489119|NCT04881461|469760203|FG001|Overall Study|Lost to Follow-up|4|||
130489120|NCT04881461|469760202|FG000|Overall Study|Lack of Efficacy|1|||
130489121|NCT04881461|469760203|FG001|Overall Study|Lack of Efficacy|0|||
130565353|NCT02576444|470035465|FG000|Overall Study|Adverse Event|0|||
130565354|NCT02576444|470035466|FG001|Overall Study|Adverse Event|0|||
130489122|NCT04881461|469760202|FG000|Overall Study|"Reason stated as other in CRF"|1|||
130489123|NCT04881461|469760203|FG001|Overall Study|"Reason stated as other in CRF"|2|||
130489124|NCT03663205|469760206|FG000|Overall Study|Death|144|||
130489125|NCT03663205|469760207|FG001|Overall Study|Death|69|||
130489126|NCT03663205|469760206|FG000|Overall Study|Sponsor decision|53|||
130489127|NCT03663205|469760207|FG001|Overall Study|Sponsor decision|19|||
130489128|NCT03663205|469760206|FG000|Overall Study|Withdrawal by Subject|8|||
130489129|NCT03663205|469760207|FG001|Overall Study|Withdrawal by Subject|11|||
130489130|NCT03663205|469760206|FG000|Overall Study|Lost to Follow-up|7|||
130489131|NCT03663205|469760207|FG001|Overall Study|Lost to Follow-up|9|||
130489132|NCT03663205|469760206|FG000|Overall Study|Transferred to long term extension study|11|||
130489133|NCT03663205|469760207|FG001|Overall Study|Transferred to long term extension study|3|||
130489134|NCT02577354|469760208|FG000|Overall Study|Lack of Efficacy|4|||
130489135|NCT02577354|469760209|FG001|Overall Study|Lack of Efficacy|4|||
130489136|NCT02577354|469760208|FG000|Overall Study|Lost to Follow-up|3|||
130489137|NCT02577354|469760209|FG001|Overall Study|Lost to Follow-up|1|||
130489138|NCT02577354|469760208|FG000|Overall Study|Missed Visit|4|||
130489139|NCT02577354|469760209|FG001|Overall Study|Missed Visit|3|||
130489140|NCT02577354|469760208|FG000|Overall Study|Adverse Event|4|||
130489141|NCT02577354|469760209|FG001|Overall Study|Adverse Event|5|||
130489142|NCT04206787|469760210|FG000|Overall Study|Other than listed|2|||
130489143|NCT04206787|469760210|FG000|Overall Study|Investigator decision|1|||
130489144|NCT04206787|469760210|FG000|Overall Study|Death|25|||
130489145|NCT04206787|469760210|FG000|Overall Study|Lost to Follow-up|9|||
130489146|NCT04206787|469760210|FG000|Overall Study|Withdrawal of consent|9|||
130489147|NCT02039401|469760212|FG000|Overall Study|Adverse Event|0|||
130489148|NCT02039401|469760213|FG001|Overall Study|Adverse Event|1|||
130489149|NCT03057054|469760214|FG000|Overall Study|Death|4|||
130489150|NCT03057054|469760215|FG001|Overall Study|Death|4|||
130489151|NCT03057054|469760214|FG000|Overall Study|Withdrawal by Subject|6|||
130489152|NCT03057054|469760215|FG001|Overall Study|Withdrawal by Subject|3|||
130489153|NCT03057054|469760214|FG000|Overall Study|Ineligible|1|||
130489154|NCT03057054|469760215|FG001|Overall Study|Ineligible|1|||
130489155|NCT03734029|469760220|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
130489156|NCT03734029|469760221|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
130489157|NCT03734029|469760220|FG000|Overall Study|Adverse Event|60|||
130489158|NCT03734029|469760221|FG001|Overall Study|Adverse Event|14|||
130489159|NCT03734029|469760220|FG000|Overall Study|Withdrawal by Subject|12|||
130489160|NCT03734029|469760221|FG001|Overall Study|Withdrawal by Subject|11|||
130489161|NCT03734029|469760220|FG000|Overall Study|Clinical progression by investigator|10|||
130489162|NCT03734029|469760221|FG001|Overall Study|Clinical progression by investigator|8|||
130489163|NCT03734029|469760220|FG000|Overall Study|Death|5|||
130489164|NCT03734029|469760221|FG001|Overall Study|Death|2|||
130489165|NCT03734029|469760220|FG000|Overall Study|Physician Decision|4|||
130489166|NCT03734029|469760221|FG001|Overall Study|Physician Decision|3|||
130489167|NCT03734029|469760220|FG000|Overall Study|Other|2|||
130489168|NCT03734029|469760221|FG001|Overall Study|Other|0|||
130489169|NCT03734029|469760220|FG000|Overall Study|Lost to Follow-up|0|||
130489170|NCT03734029|469760221|FG001|Overall Study|Lost to Follow-up|1|||
130489171|NCT03734029|469760220|FG000|Overall Study|Randomized, but not treated|2|||
130489172|NCT03734029|469760221|FG001|Overall Study|Randomized, but not treated|12|||
130489173|NCT03367156|469760842|FG000|Overall Study|Lack of interest|3|||
130489174|NCT03367156|469760843|FG001|Overall Study|Lack of interest|1|||
130489175|NCT03367156|469760842|FG000|Overall Study|Death|2|||
130489176|NCT03367156|469760843|FG001|Overall Study|Death|0|||
130489177|NCT03367156|469760842|FG000|Overall Study|Lost to Follow-up|2|||
130489178|NCT03367156|469760843|FG001|Overall Study|Lost to Follow-up|1|||
130489179|NCT03367156|469760842|FG000|Overall Study|Became ineligible|1|||
130489180|NCT03367156|469760843|FG001|Overall Study|Became ineligible|2|||
130489181|NCT03367156|469760842|FG000|Overall Study|Hospitalization|1|||
130489182|NCT03367156|469760843|FG001|Overall Study|Hospitalization|0|||
130489183|NCT03367156|469760842|FG000|Overall Study|Concerned about Treatment|11|||
130489184|NCT03367156|469760843|FG001|Overall Study|Concerned about Treatment|3|||
130489185|NCT03367156|469760842|FG000|Overall Study|Started new treatment|4|||
130489186|NCT03367156|469760843|FG001|Overall Study|Started new treatment|1|||
130489187|NCT05507437|469760844|FG000|Overall Study|Withdrawal by Subject|1|||
130565355|NCT02576444|470035467|FG002|Overall Study|Adverse Event|1|||
130565356|NCT02576444|470035468|FG003|Overall Study|Adverse Event|0|||
130565357|NCT02576444|470035465|FG000|Overall Study|Physician Decision|0|||
130489188|NCT05507437|469760845|FG001|Overall Study|Withdrawal by Subject|1|||
130489189|NCT05507437|469760844|FG000|Overall Study|Death|3|||
130489190|NCT05507437|469760845|FG001|Overall Study|Death|0|||
130489191|NCT03972150|469760846|FG000|Overall Study|Adverse Event|0|||
130489192|NCT03972150|469760847|FG001|Overall Study|Adverse Event|1|||
130489193|NCT03972150|469760848|FG002|Overall Study|Adverse Event|1|||
130489194|NCT03972150|469760849|FG003|Overall Study|Adverse Event|0|||
130489195|NCT03972150|469760850|FG004|Overall Study|Adverse Event|0|||
130489196|NCT03972150|469760846|FG000|Overall Study|Progressive disease|3|||
130489197|NCT03972150|469760847|FG001|Overall Study|Progressive disease|5|||
130489198|NCT03972150|469760848|FG002|Overall Study|Progressive disease|2|||
130489199|NCT03972150|469760849|FG003|Overall Study|Progressive disease|2|||
130489200|NCT03972150|469760850|FG004|Overall Study|Progressive disease|3|||
130489201|NCT05422885|469760864|FG000|Overall Study|Lost to Follow-up|1|||
130489202|NCT05422885|469760864|FG000|Overall Study|Withdrawal by Subject|2|||
130489203|NCT04084574|469760865|FG000|Overall Study|Lost to Follow-up|1|||
130489204|NCT04084574|469760866|FG001|Overall Study|Lost to Follow-up|0|||
130489205|NCT04084574|469760865|FG000|Overall Study|Physician Decision|1|||
130489206|NCT04084574|469760866|FG001|Overall Study|Physician Decision|0|||
130489207|NCT04084574|469760865|FG000|Overall Study|Relocated out of state|1|||
130489208|NCT04084574|469760866|FG001|Overall Study|Relocated out of state|0|||
130489209|NCT02944968|469760869|FG000|Overall Study|Subject excluded before study procedure|1|||
130489210|NCT02944968|469760869|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
130489211|NCT02905331|469760870|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
130489212|NCT02905331|469760871|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
130489213|NCT02905331|469760872|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
130489214|NCT02905331|469760870|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
130489215|NCT02905331|469760871|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
130489216|NCT02905331|469760872|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
130489217|NCT02905331|469760870|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
130489218|NCT02905331|469760871|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
130489219|NCT02905331|469760872|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
130489220|NCT02905331|469760870|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
130489221|NCT02905331|469760871|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
130489222|NCT02905331|469760872|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
130489223|NCT02905331|469760870|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
130489224|NCT02905331|469760871|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
130489225|NCT02905331|469760872|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
130489226|NCT01385202|469760873|FG000|Overall Study|Lost to Follow-up|6|||
130489227|NCT01385202|469760873|FG000|Overall Study|Not Eligible|11|||
130489228|NCT01385202|469760873|FG000|Overall Study|Withdrawn|1|||
130489229|NCT03681262|469760874|FG000|Overall Study|Continuing on study|3|||
130489230|NCT03681262|469760875|FG001|Overall Study|Continuing on study|3|||
130489231|NCT03681262|469760874|FG000|Overall Study|Lost to Follow-up|1|||
130489232|NCT03681262|469760875|FG001|Overall Study|Lost to Follow-up|0|||
130489233|NCT04102111|469760876|FG000|Overall Study|Withdrawal by Subject|2|||
130489234|NCT04102111|469760877|FG001|Overall Study|Withdrawal by Subject|3|||
130489235|NCT04102111|469760876|FG000|Overall Study|Adverse Event|1|||
130489236|NCT04102111|469760877|FG001|Overall Study|Adverse Event|1|||
130489237|NCT04102111|469760876|FG000|Overall Study|Study terminated by sponsor|1|||
130489238|NCT04102111|469760877|FG001|Overall Study|Study terminated by sponsor|3|||
130489239|NCT04707768|469760884|FG000|Overall Study|Adverse Event|9|||
130489240|NCT04707768|469760885|FG001|Overall Study|Adverse Event|18|||
130489241|NCT04707768|469760886|FG002|Overall Study|Adverse Event|3|||
130489242|NCT04707768|469760884|FG000|Overall Study|Investigator's Discretion|8|||
130489243|NCT04707768|469760885|FG001|Overall Study|Investigator's Discretion|4|||
130489244|NCT04707768|469760886|FG002|Overall Study|Investigator's Discretion|3|||
130489245|NCT04707768|469760884|FG000|Overall Study|Withdrawal by Subject|6|||
130489246|NCT04707768|469760885|FG001|Overall Study|Withdrawal by Subject|8|||
130489247|NCT04707768|469760886|FG002|Overall Study|Withdrawal by Subject|2|||
130489248|NCT04707768|469760884|FG000|Overall Study|Lack of Efficacy|1|||
130489249|NCT04707768|469760885|FG001|Overall Study|Lack of Efficacy|3|||
130489250|NCT04707768|469760886|FG002|Overall Study|Lack of Efficacy|0|||
130489251|NCT04707768|469760884|FG000|Overall Study|Lost to Follow-up|0|||
130489252|NCT04707768|469760885|FG001|Overall Study|Lost to Follow-up|0|||
130489253|NCT04707768|469760886|FG002|Overall Study|Lost to Follow-up|3|||
130489254|NCT04707768|469760884|FG000|Overall Study|Death|13|||
130728614|NCT02185053|470627522|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728615|NCT02185053|470627523|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728616|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
130489255|NCT04707768|469760885|FG001|Overall Study|Death|11|||
130489256|NCT04707768|469760886|FG002|Overall Study|Death|13|||
130489257|NCT04707768|469760884|FG000|Overall Study|Protocol Violation|2|||
130489258|NCT04707768|469760885|FG001|Overall Study|Protocol Violation|1|||
130489259|NCT04707768|469760886|FG002|Overall Study|Protocol Violation|0|||
130489260|NCT04707768|469760884|FG000|Overall Study|Non Compliance with Study Drug|1|||
130489261|NCT04707768|469760885|FG001|Overall Study|Non Compliance with Study Drug|0|||
130489262|NCT04707768|469760886|FG002|Overall Study|Non Compliance with Study Drug|0|||
130489263|NCT04707768|469760884|FG000|Overall Study|Transplant|4|||
130489264|NCT04707768|469760885|FG001|Overall Study|Transplant|4|||
130489265|NCT04707768|469760886|FG002|Overall Study|Transplant|8|||
130489266|NCT04707768|469760884|FG000|Overall Study|Other|9|||
130489267|NCT04707768|469760885|FG001|Overall Study|Other|5|||
130489268|NCT04707768|469760886|FG002|Overall Study|Other|2|||
130489269|NCT04078152|469760887|FG000|Overall Study|Other|83|||
130489270|NCT04078152|469760888|FG001|Overall Study|Other|22|||
130489271|NCT04078152|469760889|FG002|Overall Study|Other|25|||
130489272|NCT04078152|469760887|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
130489273|NCT04078152|469760888|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
130489274|NCT04078152|469760889|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
130489275|NCT04078152|469760887|FG000|Overall Study|Withdrawal by Subject|5|||
130489276|NCT04078152|469760888|FG001|Overall Study|Withdrawal by Subject|0|||
130489277|NCT04078152|469760889|FG002|Overall Study|Withdrawal by Subject|1|||
130489278|NCT04078152|469760887|FG000|Overall Study|Death|10|||
130489279|NCT04078152|469760888|FG001|Overall Study|Death|2|||
130489280|NCT04078152|469760889|FG002|Overall Study|Death|12|||
130489281|NCT04078152|469760887|FG000|Overall Study|Adverse Event|1|||
130489282|NCT04078152|469760888|FG001|Overall Study|Adverse Event|0|||
130489283|NCT04078152|469760889|FG002|Overall Study|Adverse Event|0|||
130489284|NCT02510235|469760890|FG000|Overall Study|Withdrawal by Subject|1|||
130489285|NCT02510235|469760891|FG001|Overall Study|Withdrawal by Subject|0|||
130489286|NCT00450216|469760892|FG000|Overall Study|Adverse Event|38|||
130489287|NCT00450216|469760893|FG001|Overall Study|Adverse Event|23|||
130489288|NCT00450216|469760892|FG000|Overall Study|Withdrawal by Subject|48|||
130489289|NCT00450216|469760893|FG001|Overall Study|Withdrawal by Subject|26|||
130489290|NCT00450216|469760892|FG000|Overall Study|Lost to Follow-up|16|||
130489291|NCT00450216|469760893|FG001|Overall Study|Lost to Follow-up|9|||
130489292|NCT00450216|469760892|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
130489293|NCT00450216|469760893|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
130489294|NCT00450216|469760892|FG000|Overall Study|misc|21|||
130489295|NCT00450216|469760893|FG001|Overall Study|misc|20|||
130489296|NCT03248479|469760894|FG000|Overall Study|Death|12|||
130489297|NCT03248479|469760895|FG001|Overall Study|Death|44|||
130489298|NCT03248479|469760896|FG002|Overall Study|Death|1|||
130489299|NCT03248479|469760897|FG003|Overall Study|Death|72|||
130489300|NCT03248479|469760898|FG004|Overall Study|Death|17|||
130489301|NCT03248479|469760899|FG005|Overall Study|Death|6|||
130489302|NCT03248479|469760900|FG006|Overall Study|Death|1|||
130489303|NCT03248479|469760901|FG007|Overall Study|Death|14|||
130489304|NCT03248479|469760902|FG008|Overall Study|Death|3|||
130489305|NCT03248479|469760903|FG009|Overall Study|Death|7|||
130489306|NCT03248479|469760904|FG010|Overall Study|Death|3|||
130489307|NCT03248479|469760905|FG011|Overall Study|Death|1|||
130489308|NCT03248479|469760906|FG012|Overall Study|Death|1|||
130489309|NCT03248479|469760894|FG000|Overall Study|Study terminated by sponsor|12|||
130489310|NCT03248479|469760895|FG001|Overall Study|Study terminated by sponsor|15|||
130489311|NCT03248479|469760896|FG002|Overall Study|Study terminated by sponsor|0|||
130489312|NCT03248479|469760897|FG003|Overall Study|Study terminated by sponsor|5|||
130489313|NCT03248479|469760898|FG004|Overall Study|Study terminated by sponsor|0|||
130489314|NCT03248479|469760899|FG005|Overall Study|Study terminated by sponsor|0|||
130489315|NCT03248479|469760900|FG006|Overall Study|Study terminated by sponsor|0|||
130489316|NCT03248479|469760901|FG007|Overall Study|Study terminated by sponsor|1|||
130489317|NCT03248479|469760902|FG008|Overall Study|Study terminated by sponsor|1|||
130489318|NCT03248479|469760903|FG009|Overall Study|Study terminated by sponsor|0|||
130489319|NCT03248479|469760904|FG010|Overall Study|Study terminated by sponsor|5|||
130489320|NCT03248479|469760905|FG011|Overall Study|Study terminated by sponsor|4|||
130489321|NCT03248479|469760906|FG012|Overall Study|Study terminated by sponsor|0|||
130489322|NCT03248479|469760894|FG000|Overall Study|Consent withdrawn|6|||
130489323|NCT03248479|469760895|FG001|Overall Study|Consent withdrawn|3|||
130489324|NCT03248479|469760896|FG002|Overall Study|Consent withdrawn|0|||
130489325|NCT03248479|469760897|FG003|Overall Study|Consent withdrawn|9|||
130489326|NCT03248479|469760898|FG004|Overall Study|Consent withdrawn|1|||
130489327|NCT03248479|469760899|FG005|Overall Study|Consent withdrawn|0|||
130489328|NCT03248479|469760900|FG006|Overall Study|Consent withdrawn|0|||
130489329|NCT03248479|469760901|FG007|Overall Study|Consent withdrawn|1|||
130489330|NCT03248479|469760902|FG008|Overall Study|Consent withdrawn|0|||
130489331|NCT03248479|469760903|FG009|Overall Study|Consent withdrawn|3|||
130565358|NCT02576444|470035466|FG001|Overall Study|Physician Decision|0|||
130489332|NCT03248479|469760904|FG010|Overall Study|Consent withdrawn|1|||
130489333|NCT03248479|469760905|FG011|Overall Study|Consent withdrawn|0|||
130489334|NCT03248479|469760906|FG012|Overall Study|Consent withdrawn|1|||
130489335|NCT03248479|469760894|FG000|Overall Study|Lost to Follow-up|2|||
130489336|NCT03248479|469760895|FG001|Overall Study|Lost to Follow-up|1|||
130489337|NCT03248479|469760896|FG002|Overall Study|Lost to Follow-up|0|||
130489338|NCT03248479|469760897|FG003|Overall Study|Lost to Follow-up|0|||
130489339|NCT03248479|469760898|FG004|Overall Study|Lost to Follow-up|0|||
130489340|NCT03248479|469760899|FG005|Overall Study|Lost to Follow-up|0|||
130489341|NCT03248479|469760900|FG006|Overall Study|Lost to Follow-up|0|||
130489342|NCT03248479|469760901|FG007|Overall Study|Lost to Follow-up|0|||
130489343|NCT03248479|469760902|FG008|Overall Study|Lost to Follow-up|0|||
130489344|NCT03248479|469760903|FG009|Overall Study|Lost to Follow-up|0|||
130489345|NCT03248479|469760904|FG010|Overall Study|Lost to Follow-up|0|||
130489346|NCT03248479|469760905|FG011|Overall Study|Lost to Follow-up|0|||
130489347|NCT03248479|469760906|FG012|Overall Study|Lost to Follow-up|1|||
130489348|NCT03248479|469760894|FG000|Overall Study|Not reported|0|||
130489349|NCT03248479|469760895|FG001|Overall Study|Not reported|0|||
130489350|NCT03248479|469760896|FG002|Overall Study|Not reported|0|||
130489351|NCT03248479|469760897|FG003|Overall Study|Not reported|1|||
130489352|NCT03248479|469760898|FG004|Overall Study|Not reported|1|||
130489353|NCT03248479|469760899|FG005|Overall Study|Not reported|0|||
130489354|NCT03248479|469760900|FG006|Overall Study|Not reported|0|||
130489355|NCT03248479|469760901|FG007|Overall Study|Not reported|1|||
130489356|NCT03248479|469760902|FG008|Overall Study|Not reported|1|||
130489357|NCT03248479|469760903|FG009|Overall Study|Not reported|0|||
130489358|NCT03248479|469760904|FG010|Overall Study|Not reported|0|||
130489359|NCT03248479|469760905|FG011|Overall Study|Not reported|0|||
130489360|NCT03248479|469760906|FG012|Overall Study|Not reported|0|||
130489361|NCT01475786|469760907|FG000|Overall Study|Adverse Event|0|||
130489362|NCT01475786|469760908|FG001|Overall Study|Adverse Event|1|||
130489363|NCT01475786|469760909|FG002|Overall Study|Adverse Event|0|||
130489364|NCT01475786|469760907|FG000|Overall Study|Lost to Follow-up|1|||
130489365|NCT01475786|469760908|FG001|Overall Study|Lost to Follow-up|2|||
130489366|NCT01475786|469760909|FG002|Overall Study|Lost to Follow-up|1|||
130489367|NCT01475786|469760907|FG000|Overall Study|Withdrawal by Subject|0|||
130489368|NCT01475786|469760908|FG001|Overall Study|Withdrawal by Subject|1|||
130489369|NCT01475786|469760909|FG002|Overall Study|Withdrawal by Subject|1|||
130489370|NCT01475786|469760907|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
130489371|NCT01475786|469760908|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
130489372|NCT01475786|469760909|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
130489373|NCT05247034|469762178|FG000|Overall Study|Lost to Follow-up|3|||
130489374|NCT05247034|469762179|FG001|Overall Study|Lost to Follow-up|2|||
130489375|NCT05247034|469762178|FG000|Overall Study|Organizational problems when attending appointments|1|||
130489376|NCT05247034|469762179|FG001|Overall Study|Organizational problems when attending appointments|0|||
130489377|NCT04464564|469762180|FG000|Period A (Placebo lead-in)|Other|5|||
130489378|NCT04464564|469762181|FG001|Period A (Placebo lead-in)|Other|0|||
130489379|NCT04464564|469762182|FG002|Period A (Placebo lead-in)|Other|0|||
130489380|NCT04464564|469762183|FG003|Period A (Placebo lead-in)|Other|0|||
130489381|NCT04464564|469762180|FG000|Period B (Randomization Period)|Adverse Event|0|||
130489382|NCT04464564|469762181|FG001|Period B (Randomization Period)|Adverse Event|1|||
130489383|NCT04464564|469762182|FG002|Period B (Randomization Period)|Adverse Event|2|||
130489384|NCT04464564|469762183|FG003|Period B (Randomization Period)|Adverse Event|8|||
130489385|NCT04464564|469762180|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
130489386|NCT04464564|469762181|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
130489387|NCT04464564|469762182|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
130489388|NCT04464564|469762183|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
130489389|NCT04464564|469762180|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
130489390|NCT04464564|469762181|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
130489391|NCT04464564|469762182|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
130489392|NCT04464564|469762183|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
130489393|NCT04464564|469762180|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
130489394|NCT04464564|469762181|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
130489395|NCT04464564|469762182|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
130489396|NCT04464564|469762183|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
130489397|NCT04464564|469762180|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
130489398|NCT04464564|469762181|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
130489399|NCT04464564|469762182|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
130489400|NCT04464564|469762183|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
130489401|NCT04464564|469762180|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
130489402|NCT04464564|469762181|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
130489403|NCT04464564|469762182|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
130489404|NCT04464564|469762183|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
130489405|NCT04464564|469762180|FG000|Period B (Randomization Period)|Reason not Specified|0|||
130489406|NCT04464564|469762181|FG001|Period B (Randomization Period)|Reason not Specified|3|||
130489407|NCT04464564|469762182|FG002|Period B (Randomization Period)|Reason not Specified|3|||
130489408|NCT04464564|469762183|FG003|Period B (Randomization Period)|Reason not Specified|3|||
130489409|NCT03505710|469762184|FG000|Overall Study|Progressive Disease|24|||
130489410|NCT03505710|469762185|FG001|Overall Study|Progressive Disease|17|||
130489411|NCT03505710|469762186|FG002|Overall Study|Progressive Disease|43|||
130489412|NCT03505710|469762184|FG000|Overall Study|Clinical Progression|6|||
130489413|NCT03505710|469762185|FG001|Overall Study|Clinical Progression|8|||
130489414|NCT03505710|469762186|FG002|Overall Study|Clinical Progression|3|||
130489415|NCT03505710|469762184|FG000|Overall Study|Adverse Event|12|||
130489416|NCT03505710|469762185|FG001|Overall Study|Adverse Event|6|||
130489417|NCT03505710|469762186|FG002|Overall Study|Adverse Event|28|||
130489418|NCT03505710|469762184|FG000|Overall Study|Withdrawal by Subject|1|||
130489419|NCT03505710|469762185|FG001|Overall Study|Withdrawal by Subject|3|||
130489420|NCT03505710|469762186|FG002|Overall Study|Withdrawal by Subject|7|||
130489421|NCT03505710|469762184|FG000|Overall Study|Physician Decision|1|||
130489422|NCT03505710|469762185|FG001|Overall Study|Physician Decision|1|||
130489423|NCT03505710|469762186|FG002|Overall Study|Physician Decision|2|||
130489424|NCT03505710|469762184|FG000|Overall Study|Death|4|||
130489425|NCT03505710|469762185|FG001|Overall Study|Death|5|||
130489426|NCT03505710|469762186|FG002|Overall Study|Death|6|||
130489427|NCT03505710|469762184|FG000|Overall Study|Other Reasons|1|||
130489428|NCT03505710|469762185|FG001|Overall Study|Other Reasons|1|||
130489429|NCT03505710|469762186|FG002|Overall Study|Other Reasons|1|||
130489430|NCT03505710|469762184|FG000|Overall Study|Study Terminated by Sponsor|0|||
130489431|NCT03505710|469762185|FG001|Overall Study|Study Terminated by Sponsor|0|||
130489432|NCT03505710|469762186|FG002|Overall Study|Study Terminated by Sponsor|1|||
130489433|NCT00942877|469762193|FG000|Overall Study|Refused further treatment|1|||
130489434|NCT00942877|469762194|FG001|Overall Study|Refused further treatment|1|||
130489435|NCT00942877|469762193|FG000|Overall Study|Patient was not treated|1|||
130489436|NCT00942877|469762194|FG001|Overall Study|Patient was not treated|0|||
130489437|NCT00942877|469762193|FG000|Overall Study|Adverse Event|1|||
130489438|NCT00942877|469762194|FG001|Overall Study|Adverse Event|0|||
130489439|NCT00942877|469762193|FG000|Overall Study|Progressive disease|42|||
130489440|NCT00942877|469762194|FG001|Overall Study|Progressive disease|3|||
130489441|NCT02782676|469762196|FG000|Overall Study|Lost to Follow-up|0|||
130489442|NCT02782676|469762197|FG001|Overall Study|Lost to Follow-up|1|||
130489443|NCT03334695|469762198|FG000|Overall Study|Lost to Follow-up|3|||
130489444|NCT03334695|469762199|FG001|Overall Study|Lost to Follow-up|3|||
130489445|NCT03334695|469762198|FG000|Overall Study|Physician Decision|1|||
130489446|NCT03334695|469762199|FG001|Overall Study|Physician Decision|2|||
130489447|NCT03334695|469762198|FG000|Overall Study|Protocol Violation|0|||
130489448|NCT03334695|469762199|FG001|Overall Study|Protocol Violation|1|||
130489449|NCT02641730|469762200|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
130489450|NCT02641730|469762201|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130489451|NCT02641730|469762202|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
130489452|NCT02641730|469762203|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
130489453|NCT02641730|469762204|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
130489454|NCT02641730|469762200|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130489455|NCT02641730|469762201|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
130489456|NCT02641730|469762202|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
130489457|NCT02641730|469762203|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
130489458|NCT02641730|469762204|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
130489459|NCT02641730|469762200|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
130489460|NCT02641730|469762201|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
130489461|NCT02641730|469762202|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
130489462|NCT02641730|469762203|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
130489463|NCT02641730|469762204|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
130489464|NCT02641730|469762200|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130489465|NCT02641730|469762201|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130489466|NCT02641730|469762202|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130489467|NCT02641730|469762203|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
130489468|NCT02641730|469762204|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
130489469|NCT02641730|469762200|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
130489470|NCT02641730|469762201|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
130489471|NCT02641730|469762202|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
130489472|NCT02641730|469762203|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
130489473|NCT02641730|469762204|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
130489474|NCT02641730|469762200|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
130489475|NCT02641730|469762201|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
130489476|NCT02641730|469762202|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
130489477|NCT02641730|469762203|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
130489478|NCT02641730|469762204|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
130489479|NCT02874742|469762205|FG000|Overall Study|Death|0|||
130489480|NCT02874742|469762206|FG001|Overall Study|Death|1|||
130489481|NCT02874742|469762207|FG002|Overall Study|Death|0|||
130489482|NCT02874742|469762205|FG000|Overall Study|Lost to Follow-up|5|||
130489483|NCT02874742|469762206|FG001|Overall Study|Lost to Follow-up|4|||
130489484|NCT02874742|469762207|FG002|Overall Study|Lost to Follow-up|1|||
130489485|NCT02874742|469762205|FG000|Overall Study|Withdrawal by Subject|17|||
130489486|NCT02874742|469762206|FG001|Overall Study|Withdrawal by Subject|8|||
130489487|NCT02874742|469762207|FG002|Overall Study|Withdrawal by Subject|0|||
130489488|NCT02874742|469762205|FG000|Overall Study|Other|4|||
130489489|NCT02874742|469762206|FG001|Overall Study|Other|1|||
130489490|NCT02874742|469762207|FG002|Overall Study|Other|0|||
130489491|NCT02874742|469762205|FG000|Overall Study|Progressive Disease|1|||
130489492|NCT02874742|469762206|FG001|Overall Study|Progressive Disease|0|||
130489493|NCT02874742|469762207|FG002|Overall Study|Progressive Disease|0|||
130489494|NCT02874742|469762205|FG000|Overall Study|Screen Failure|0|||
130489495|NCT02874742|469762206|FG001|Overall Study|Screen Failure|2|||
130489496|NCT02874742|469762207|FG002|Overall Study|Screen Failure|0|||
130489497|NCT02326974|469762212|FG000|Overall Study|Withdrawal by Subject|2|||
130489498|NCT02326974|469762212|FG000|Overall Study|failed heterogenity evaluation|5|||
130489499|NCT04173247|469762213|FG000|Overall Study|Withdrawal by Subject|0|||
130489500|NCT04173247|469762214|FG001|Overall Study|Withdrawal by Subject|2|||
130489501|NCT04173247|469762213|FG000|Overall Study|Death|1|||
130489502|NCT04173247|469762214|FG001|Overall Study|Death|0|||
130489503|NCT04173247|469762213|FG000|Overall Study|Physician Decision|1|||
130489504|NCT04173247|469762214|FG001|Overall Study|Physician Decision|0|||
130489505|NCT04924400|469762222|FG000|Overall Study|Lost to Follow-up|3|||
130489506|NCT04924400|469762223|FG001|Overall Study|Lost to Follow-up|0|||
130489507|NCT04424316|469762224|FG000|Overall Study|Adverse Event|0|||
130489508|NCT04424316|469762225|FG001|Overall Study|Adverse Event|1|||
130489509|NCT04424316|469762226|FG002|Overall Study|Adverse Event|0|||
130489510|NCT04424316|469762227|FG003|Overall Study|Adverse Event|0|||
130489511|NCT04424316|469762224|FG000|Overall Study|Death|1|||
130489512|NCT04424316|469762225|FG001|Overall Study|Death|0|||
130489513|NCT04424316|469762226|FG002|Overall Study|Death|8|||
130489514|NCT04424316|469762227|FG003|Overall Study|Death|14|||
130489515|NCT04424316|469762224|FG000|Overall Study|Lost to Follow-up|93|||
130489516|NCT04424316|469762225|FG001|Overall Study|Lost to Follow-up|88|||
130489517|NCT04424316|469762226|FG002|Overall Study|Lost to Follow-up|224|||
130489518|NCT04424316|469762227|FG003|Overall Study|Lost to Follow-up|211|||
130489519|NCT04424316|469762224|FG000|Overall Study|No longer met eligibility criteria|1|||
130489520|NCT04424316|469762225|FG001|Overall Study|No longer met eligibility criteria|0|||
130489521|NCT04424316|469762226|FG002|Overall Study|No longer met eligibility criteria|0|||
130489522|NCT04424316|469762227|FG003|Overall Study|No longer met eligibility criteria|0|||
130489523|NCT04424316|469762224|FG000|Overall Study|Other|15|||
130489524|NCT04424316|469762225|FG001|Overall Study|Other|11|||
130489525|NCT04424316|469762226|FG002|Overall Study|Other|34|||
130489526|NCT04424316|469762227|FG003|Overall Study|Other|45|||
130489527|NCT04424316|469762224|FG000|Overall Study|Physician Decision|1|||
130489528|NCT04424316|469762225|FG001|Overall Study|Physician Decision|0|||
130489529|NCT04424316|469762226|FG002|Overall Study|Physician Decision|1|||
130489530|NCT04424316|469762227|FG003|Overall Study|Physician Decision|1|||
130489531|NCT04424316|469762224|FG000|Overall Study|Protocol Violation|0|||
130489532|NCT04424316|469762225|FG001|Overall Study|Protocol Violation|1|||
130489533|NCT04424316|469762226|FG002|Overall Study|Protocol Violation|0|||
130489534|NCT04424316|469762227|FG003|Overall Study|Protocol Violation|0|||
130489535|NCT04424316|469762224|FG000|Overall Study|Withdrawal by Subject|71|||
130489536|NCT04424316|469762225|FG001|Overall Study|Withdrawal by Subject|77|||
130489537|NCT04424316|469762226|FG002|Overall Study|Withdrawal by Subject|0|||
130489538|NCT04424316|469762227|FG003|Overall Study|Withdrawal by Subject|0|||
130489539|NCT04424316|469762224|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130489540|NCT04424316|469762225|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130489541|NCT04424316|469762226|FG002|Overall Study|Withdrawal by parent/guardian|74|||
130489542|NCT04424316|469762227|FG003|Overall Study|Withdrawal by parent/guardian|81|||
130489543|NCT04424316|469762224|FG000|Overall Study|Randomized but not vaccinated|13|||
130489544|NCT04424316|469762225|FG001|Overall Study|Randomized but not vaccinated|21|||
130489545|NCT04424316|469762226|FG002|Overall Study|Randomized but not vaccinated|0|||
130489546|NCT04424316|469762227|FG003|Overall Study|Randomized but not vaccinated|0|||
130489547|NCT04424316|469762224|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
130489548|NCT04424316|469762225|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
130489549|NCT04424316|469762226|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
130489550|NCT04424316|469762227|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
130489551|NCT00412607|469762228|FG000|Overall Study|Withdrawal by Subject|9|||
130489552|NCT00412607|469762228|FG000|Overall Study|Lost to Follow-up|19|||
130489553|NCT00412607|469762228|FG000|Overall Study|Death|61|||
130489554|NCT00412607|469762228|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
130489555|NCT05070741|469762231|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
130489556|NCT03582033|469762234|FG000|Part A|Other|0|||
130489557|NCT03582033|469762235|FG001|Part A|Other|0|||
130489558|NCT03582033|469762236|FG002|Part A|Other|0|||
130489559|NCT03582033|469762237|FG003|Part A|Other|0|||
130489560|NCT03582033|469762238|FG004|Part A|Other|2|||
130489561|NCT03582033|469762239|FG005|Part A|Other|0|||
130489562|NCT03582033|469762240|FG006|Part A|Other|0|||
130489563|NCT03582033|469762241|FG007|Part A|Other|0|||
130489564|NCT03582033|469762242|FG008|Part A|Other|0|||
130489565|NCT03582033|469762243|FG009|Part A|Other|0|||
130489566|NCT03582033|469762234|FG000|Part A|Death|1|||
130489567|NCT03582033|469762235|FG001|Part A|Death|1|||
130489568|NCT03582033|469762236|FG002|Part A|Death|2|||
130489569|NCT03582033|469762237|FG003|Part A|Death|4|||
130489570|NCT03582033|469762238|FG004|Part A|Death|11|||
130489571|NCT03582033|469762239|FG005|Part A|Death|0|||
130489572|NCT03582033|469762240|FG006|Part A|Death|0|||
130489573|NCT03582033|469762241|FG007|Part A|Death|0|||
130489574|NCT03582033|469762242|FG008|Part A|Death|0|||
130489575|NCT03582033|469762243|FG009|Part A|Death|0|||
130489576|NCT03582033|469762234|FG000|Part A|Lost to Follow-up|0|||
130489577|NCT03582033|469762235|FG001|Part A|Lost to Follow-up|0|||
130489578|NCT03582033|469762236|FG002|Part A|Lost to Follow-up|0|||
130489579|NCT03582033|469762237|FG003|Part A|Lost to Follow-up|0|||
130489580|NCT03582033|469762238|FG004|Part A|Lost to Follow-up|1|||
130489581|NCT03582033|469762239|FG005|Part A|Lost to Follow-up|0|||
130489582|NCT03582033|469762240|FG006|Part A|Lost to Follow-up|0|||
130489583|NCT03582033|469762241|FG007|Part A|Lost to Follow-up|0|||
130489584|NCT03582033|469762242|FG008|Part A|Lost to Follow-up|0|||
130489585|NCT03582033|469762243|FG009|Part A|Lost to Follow-up|0|||
130489586|NCT03582033|469762234|FG000|Part A|Study terminated by sponsor|0|||
130489587|NCT03582033|469762235|FG001|Part A|Study terminated by sponsor|0|||
130489588|NCT03582033|469762236|FG002|Part A|Study terminated by sponsor|0|||
130489589|NCT03582033|469762237|FG003|Part A|Study terminated by sponsor|2|||
130489590|NCT03582033|469762238|FG004|Part A|Study terminated by sponsor|1|||
130489591|NCT03582033|469762239|FG005|Part A|Study terminated by sponsor|0|||
130489592|NCT03582033|469762240|FG006|Part A|Study terminated by sponsor|0|||
130489593|NCT03582033|469762241|FG007|Part A|Study terminated by sponsor|0|||
130489594|NCT03582033|469762242|FG008|Part A|Study terminated by sponsor|0|||
130489595|NCT03582033|469762243|FG009|Part A|Study terminated by sponsor|0|||
130489596|NCT03582033|469762234|FG000|Part A|Withdrawal by Subject|1|||
130489597|NCT03582033|469762235|FG001|Part A|Withdrawal by Subject|1|||
130489598|NCT03582033|469762236|FG002|Part A|Withdrawal by Subject|0|||
130489599|NCT03582033|469762237|FG003|Part A|Withdrawal by Subject|1|||
130489600|NCT03582033|469762238|FG004|Part A|Withdrawal by Subject|7|||
130489601|NCT03582033|469762239|FG005|Part A|Withdrawal by Subject|0|||
130489602|NCT03582033|469762240|FG006|Part A|Withdrawal by Subject|0|||
130489603|NCT03582033|469762241|FG007|Part A|Withdrawal by Subject|0|||
130489604|NCT03582033|469762242|FG008|Part A|Withdrawal by Subject|0|||
130489605|NCT03582033|469762243|FG009|Part A|Withdrawal by Subject|0|||
130489606|NCT03582033|469762234|FG000|Part B|Death|0|||
130489607|NCT03582033|469762235|FG001|Part B|Death|0|||
130489608|NCT03582033|469762236|FG002|Part B|Death|0|||
130489609|NCT03582033|469762237|FG003|Part B|Death|0|||
130489610|NCT03582033|469762238|FG004|Part B|Death|0|||
130489611|NCT03582033|469762239|FG005|Part B|Death|2|||
130489612|NCT03582033|469762240|FG006|Part B|Death|0|||
130489613|NCT03582033|469762241|FG007|Part B|Death|0|||
130489614|NCT03582033|469762242|FG008|Part B|Death|0|||
130489615|NCT03582033|469762243|FG009|Part B|Death|0|||
130489616|NCT03582033|469762234|FG000|Part B|Study terminated by sponsor|0|||
130489617|NCT03582033|469762235|FG001|Part B|Study terminated by sponsor|0|||
130489618|NCT03582033|469762236|FG002|Part B|Study terminated by sponsor|0|||
130489619|NCT03582033|469762237|FG003|Part B|Study terminated by sponsor|0|||
130489620|NCT03582033|469762238|FG004|Part B|Study terminated by sponsor|0|||
130489621|NCT03582033|469762239|FG005|Part B|Study terminated by sponsor|12|||
130489622|NCT03582033|469762240|FG006|Part B|Study terminated by sponsor|0|||
130489623|NCT03582033|469762241|FG007|Part B|Study terminated by sponsor|0|||
130489624|NCT03582033|469762242|FG008|Part B|Study terminated by sponsor|0|||
130489625|NCT03582033|469762243|FG009|Part B|Study terminated by sponsor|0|||
130489626|NCT03582033|469762234|FG000|Part B|Withdrawal by Subject|0|||
130489627|NCT03582033|469762235|FG001|Part B|Withdrawal by Subject|0|||
130489628|NCT03582033|469762236|FG002|Part B|Withdrawal by Subject|0|||
130489629|NCT03582033|469762237|FG003|Part B|Withdrawal by Subject|0|||
130489630|NCT03582033|469762238|FG004|Part B|Withdrawal by Subject|0|||
130489631|NCT03582033|469762239|FG005|Part B|Withdrawal by Subject|6|||
130489632|NCT03582033|469762240|FG006|Part B|Withdrawal by Subject|0|||
130489633|NCT03582033|469762241|FG007|Part B|Withdrawal by Subject|0|||
130489634|NCT03582033|469762242|FG008|Part B|Withdrawal by Subject|0|||
130489635|NCT03582033|469762243|FG009|Part B|Withdrawal by Subject|0|||
130489636|NCT03582033|469762234|FG000|Part C|Other|0|||
130489637|NCT03582033|469762235|FG001|Part C|Other|0|||
130489638|NCT03582033|469762236|FG002|Part C|Other|0|||
130489639|NCT03582033|469762237|FG003|Part C|Other|0|||
130489640|NCT03582033|469762238|FG004|Part C|Other|0|||
130489641|NCT03582033|469762239|FG005|Part C|Other|0|||
130489642|NCT03582033|469762240|FG006|Part C|Other|2|||
130489643|NCT03582033|469762241|FG007|Part C|Other|0|||
130489644|NCT03582033|469762242|FG008|Part C|Other|0|||
130489645|NCT03582033|469762243|FG009|Part C|Other|0|||
130489646|NCT03582033|469762234|FG000|Part C|Death|0|||
130489647|NCT03582033|469762235|FG001|Part C|Death|0|||
130489648|NCT03582033|469762236|FG002|Part C|Death|0|||
130489649|NCT03582033|469762237|FG003|Part C|Death|0|||
130489650|NCT03582033|469762238|FG004|Part C|Death|0|||
130489651|NCT03582033|469762239|FG005|Part C|Death|0|||
130489652|NCT03582033|469762240|FG006|Part C|Death|6|||
130489653|NCT03582033|469762241|FG007|Part C|Death|1|||
130489654|NCT03582033|469762242|FG008|Part C|Death|2|||
130489655|NCT03582033|469762243|FG009|Part C|Death|0|||
130489656|NCT03582033|469762234|FG000|Part C|Study terminated by sponsor|0|||
130489657|NCT03582033|469762235|FG001|Part C|Study terminated by sponsor|0|||
130489658|NCT03582033|469762236|FG002|Part C|Study terminated by sponsor|0|||
130489659|NCT03582033|469762237|FG003|Part C|Study terminated by sponsor|0|||
130489660|NCT03582033|469762238|FG004|Part C|Study terminated by sponsor|0|||
130489661|NCT03582033|469762239|FG005|Part C|Study terminated by sponsor|0|||
130489662|NCT03582033|469762240|FG006|Part C|Study terminated by sponsor|3|||
130728617|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
130728618|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
130728619|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
130728620|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
130728621|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
130728622|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728623|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
130728624|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728625|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130728626|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
130728627|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130489663|NCT03582033|469762241|FG007|Part C|Study terminated by sponsor|3|||
130489664|NCT03582033|469762242|FG008|Part C|Study terminated by sponsor|2|||
130489665|NCT03582033|469762243|FG009|Part C|Study terminated by sponsor|0|||
130489666|NCT03582033|469762234|FG000|Part C|Withdrawal by Subject|0|||
130489667|NCT03582033|469762235|FG001|Part C|Withdrawal by Subject|0|||
130489668|NCT03582033|469762236|FG002|Part C|Withdrawal by Subject|0|||
130489669|NCT03582033|469762237|FG003|Part C|Withdrawal by Subject|0|||
130489670|NCT03582033|469762238|FG004|Part C|Withdrawal by Subject|0|||
130489671|NCT03582033|469762239|FG005|Part C|Withdrawal by Subject|0|||
130489672|NCT03582033|469762240|FG006|Part C|Withdrawal by Subject|1|||
130489673|NCT03582033|469762241|FG007|Part C|Withdrawal by Subject|2|||
130489674|NCT03582033|469762242|FG008|Part C|Withdrawal by Subject|1|||
130489675|NCT03582033|469762243|FG009|Part C|Withdrawal by Subject|0|||
130489676|NCT03582033|469762234|FG000|Part D|Death|0|||
130489677|NCT03582033|469762235|FG001|Part D|Death|0|||
130489678|NCT03582033|469762236|FG002|Part D|Death|0|||
130489679|NCT03582033|469762237|FG003|Part D|Death|0|||
130489680|NCT03582033|469762238|FG004|Part D|Death|0|||
130489681|NCT03582033|469762239|FG005|Part D|Death|0|||
130489682|NCT03582033|469762240|FG006|Part D|Death|0|||
130489683|NCT03582033|469762241|FG007|Part D|Death|0|||
130489684|NCT03582033|469762242|FG008|Part D|Death|0|||
130489685|NCT03582033|469762243|FG009|Part D|Death|1|||
130489686|NCT03582033|469762234|FG000|Part D|Study terminated by sponsor|0|||
130489687|NCT03582033|469762235|FG001|Part D|Study terminated by sponsor|0|||
130489688|NCT03582033|469762236|FG002|Part D|Study terminated by sponsor|0|||
130489689|NCT03582033|469762237|FG003|Part D|Study terminated by sponsor|0|||
130489690|NCT03582033|469762238|FG004|Part D|Study terminated by sponsor|0|||
130489691|NCT03582033|469762239|FG005|Part D|Study terminated by sponsor|0|||
130489692|NCT03582033|469762240|FG006|Part D|Study terminated by sponsor|0|||
130489693|NCT03582033|469762241|FG007|Part D|Study terminated by sponsor|0|||
130489694|NCT03582033|469762242|FG008|Part D|Study terminated by sponsor|0|||
130489695|NCT03582033|469762243|FG009|Part D|Study terminated by sponsor|4|||
130489696|NCT04631016|469762246|FG000|Overall Study|Adverse Event|3|||
130489697|NCT04631016|469762247|FG001|Overall Study|Adverse Event|0|||
130489698|NCT04631016|469762246|FG000|Overall Study|Withdrawal by Subject|5|||
130489699|NCT04631016|469762247|FG001|Overall Study|Withdrawal by Subject|4|||
130489700|NCT04631016|469762246|FG000|Overall Study|Reason unspecified|1|||
130489701|NCT04631016|469762247|FG001|Overall Study|Reason unspecified|0|||
130489702|NCT04631016|469762246|FG000|Overall Study|Failure to meet randomization criteria|2|||
130489703|NCT04631016|469762247|FG001|Overall Study|Failure to meet randomization criteria|1|||
130489704|NCT03812614|469762248|FG000|Intervention|Withdrawal by Subject|7|||
130489705|NCT03812614|469762249|FG001|Intervention|Withdrawal by Subject|2|||
130489706|NCT03812614|469762250|FG002|Intervention|Withdrawal by Subject|7|||
130489707|NCT03812614|469762251|FG003|Intervention|Withdrawal by Subject|2|||
130489708|NCT03812614|469762248|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
130489709|NCT03812614|469762249|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
130489710|NCT03812614|469762250|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
130489711|NCT03812614|469762251|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
130489712|NCT03812614|469762248|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
130489713|NCT03812614|469762249|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
130489714|NCT03812614|469762250|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
130489715|NCT03812614|469762251|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
130489716|NCT03812614|469762248|FG000|6-month Follow-up|Lost to Follow-up|0|||
130489717|NCT03812614|469762249|FG001|6-month Follow-up|Lost to Follow-up|0|||
130489718|NCT03812614|469762250|FG002|6-month Follow-up|Lost to Follow-up|12|||
130489719|NCT03812614|469762251|FG003|6-month Follow-up|Lost to Follow-up|8|||
130489720|NCT03812614|469762248|FG000|12-month Follow-up|Lost to Follow-up|18|||
130489721|NCT03812614|469762249|FG001|12-month Follow-up|Lost to Follow-up|17|||
130489722|NCT03812614|469762250|FG002|12-month Follow-up|Lost to Follow-up|5|||
130489723|NCT03812614|469762251|FG003|12-month Follow-up|Lost to Follow-up|2|||
130489724|NCT05205161|469762252|FG000|Overall Study|Study terminated by sponsor|3|||
130489725|NCT05205161|469762253|FG001|Overall Study|Study terminated by sponsor|3|||
130489726|NCT05205161|469762254|FG002|Overall Study|Study terminated by sponsor|1|||
130489727|NCT05123027|469762261|FG000|Overall Study|Lost to Follow-up|17|||
130489728|NCT05123027|469762262|FG001|Overall Study|Lost to Follow-up|22|||
130489729|NCT05123027|469762261|FG000|Overall Study|Incarceration|3|||
130489730|NCT05123027|469762262|FG001|Overall Study|Incarceration|4|||
130489731|NCT05123027|469762261|FG000|Overall Study|Death|2|||
130489732|NCT05123027|469762262|FG001|Overall Study|Death|2|||
130489733|NCT05123027|469762261|FG000|Overall Study|Other|2|||
130489734|NCT05123027|469762262|FG001|Overall Study|Other|0|||
130489735|NCT03735979|469762263|FG000|Overall Study|Lost to Follow-up|1|||
130489736|NCT03735979|469762264|FG001|Overall Study|Lost to Follow-up|12|||
130489737|NCT03735979|469762265|FG002|Overall Study|Lost to Follow-up|14|||
130489738|NCT03735979|469762263|FG000|Overall Study|Withdrawal by Subject|1|||
130489739|NCT03735979|469762264|FG001|Overall Study|Withdrawal by Subject|5|||
130489740|NCT03735979|469762265|FG002|Overall Study|Withdrawal by Subject|2|||
130489741|NCT03735979|469762263|FG000|Overall Study|Not due to the above reasons|1|||
130489742|NCT03735979|469762264|FG001|Overall Study|Not due to the above reasons|0|||
130489743|NCT03735979|469762265|FG002|Overall Study|Not due to the above reasons|0|||
130489744|NCT05112900|469762266|FG000|Overall Study|Withdrawal by Subject|960|||
130489745|NCT05112900|469762267|FG001|Overall Study|Withdrawal by Subject|921|||
130565359|NCT02576444|470035467|FG002|Overall Study|Physician Decision|1|||
130565360|NCT02576444|470035468|FG003|Overall Study|Physician Decision|0|||
130565361|NCT00736255|470036925|FG000|Overall Study|Adverse Event|1|||
130565362|NCT00736255|470036926|FG001|Overall Study|Adverse Event|0|||
130565363|NCT00736255|470036925|FG000|Overall Study|Physician Decision|1|||
130565364|NCT00736255|470036926|FG001|Overall Study|Physician Decision|0|||
130565365|NCT00736255|470036925|FG000|Overall Study|Non-compliance|1|||
130489746|NCT05112900|469762268|FG002|Overall Study|Withdrawal by Subject|968|||
130489747|NCT00319111|469762271|FG000|Overall Study|Adverse Event|20|||
130489748|NCT00319111|469762271|FG000|Overall Study|Withdrawal of consent|11|||
130489749|NCT00319111|469762271|FG000|Overall Study|Death|9|||
130489750|NCT00319111|469762271|FG000|Overall Study|Lack of clinical improvement|4|||
130489751|NCT00319111|469762271|FG000|Overall Study|Administrative|2|||
130489752|NCT00319111|469762271|FG000|Overall Study|Treatment failure|1|||
130489753|NCT04743973|469762274|FG000|Overall Study|Withdrawal by Subject|5|||
130489754|NCT05654662|469762275|FG000|Overall Study|Withdrawal by Subject|1|||
130489755|NCT05654662|469762276|FG001|Overall Study|Withdrawal by Subject|0|||
130489756|NCT05654662|469762275|FG000|Overall Study|A death in the family|1|||
130489757|NCT05654662|469762276|FG001|Overall Study|A death in the family|0|||
130489758|NCT03165955|469762277|FG000|Treatment|Withdrawal by Subject|3|||
130489759|NCT03165955|469762277|FG000|Treatment|Death|1|||
130489760|NCT03165955|469762277|FG000|Treatment|Adverse Event|1|||
130489761|NCT03165955|469762277|FG000|Treatment|Progressive disease|3|||
130489762|NCT04499521|469762280|FG000|Overall Study|Disease Progression|1|||
130489763|NCT04499521|469762281|FG001|Overall Study|Disease Progression|0|||
130489764|NCT05525104|469762282|FG000|Overall Study|Failed caudal analgesia|1|||
130489765|NCT05525104|469762283|FG001|Overall Study|Failed caudal analgesia|3|||
130489766|NCT05525104|469762282|FG000|Overall Study|Premedication needed|0|||
130489767|NCT05525104|469762283|FG001|Overall Study|Premedication needed|1|||
130489768|NCT05525104|469762282|FG000|Overall Study|Protocol Violation|10|||
130489769|NCT05525104|469762283|FG001|Overall Study|Protocol Violation|0|||
130489770|NCT05525104|469762282|FG000|Overall Study|Cancelled operation|1|||
130489771|NCT05525104|469762283|FG001|Overall Study|Cancelled operation|0|||
130489772|NCT04678856|469762284|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
130489773|NCT04678856|469762285|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
130489774|NCT04678856|469762284|FG000|Overall Study|Withdrawal by Subject|5|||
130489775|NCT04678856|469762285|FG001|Overall Study|Withdrawal by Subject|1|||
130489776|NCT04389957|469763678|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
130489777|NCT04389957|469763679|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
130489778|NCT04389957|469763680|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
130489779|NCT04389957|469763681|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
130489780|NCT04389957|469763682|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
130489781|NCT05460871|469763683|FG000|Overall Study|Withdrawal by Subject|1|||
130489782|NCT05460871|469763684|FG001|Overall Study|Withdrawal by Subject|2|||
130489783|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
130489784|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
130489785|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
130489786|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
130489787|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
130489788|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
130489789|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
130489790|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
130489791|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
130489792|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
130489793|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
130489794|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
130489795|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
130489796|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
130489797|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
130489798|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
130489799|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
130489800|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
130489801|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
130489802|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
130489803|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
130489804|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
130489805|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
130489806|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
130489807|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
130489808|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
130565366|NCT00736255|470036926|FG001|Overall Study|Non-compliance|1|||
130489809|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
130489810|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
130489811|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
130489812|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
130489813|NCT04614948|469763685|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
130489814|NCT04614948|469763686|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
130489815|NCT04614948|469763687|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
130489816|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
130489817|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
130489818|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
130489819|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
130489820|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
130489821|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
130489822|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
130489823|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
130489824|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
130489825|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
130489826|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
130489827|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
130489828|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
130489829|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
130489830|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
130728628|NCT02185053|470627521|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130728629|NCT02185053|470627522|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130728630|NCT02185053|470627523|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
130728631|NCT02185053|470627521|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130728632|NCT02185053|470627522|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130728633|NCT02185053|470627523|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
130728634|NCT02521376|470627524|FG000|Overall Study|Enrolled, But Not Treated|1|||
130728635|NCT02521376|470627525|FG001|Overall Study|Enrolled, But Not Treated|0|||
130728636|NCT02521376|470627526|FG002|Overall Study|Enrolled, But Not Treated|0|||
130728637|NCT02521376|470627527|FG003|Overall Study|Enrolled, But Not Treated|0|||
130728638|NCT00340678|470627537|FG000|Overall Study|Lost to Follow-up|1|||
130728639|NCT00340678|470627538|FG001|Overall Study|Lost to Follow-up|0|||
130728640|NCT00340678|470627539|FG002|Overall Study|Lost to Follow-up|0|||
130728641|NCT00340678|470627540|FG003|Overall Study|Lost to Follow-up|0|||
130728642|NCT03316547|470627543|FG000|Overall Study|Death|3|||
130728643|NCT03316547|470627544|FG001|Overall Study|Death|1|||
130728644|NCT03316547|470627543|FG000|Overall Study|Lost to Follow-up|6|||
130728645|NCT03316547|470627544|FG001|Overall Study|Lost to Follow-up|6|||
130728646|NCT03316547|470627543|FG000|Overall Study|Withdrawal by Subject|3|||
130728647|NCT03316547|470627544|FG001|Overall Study|Withdrawal by Subject|2|||
130728648|NCT03316547|470627543|FG000|Overall Study|Transfer to another hospital|6|||
130728649|NCT03316547|470627544|FG001|Overall Study|Transfer to another hospital|4|||
130728650|NCT00708227|470627545|FG000|Overall Study|Physician Decision|0|||
130489831|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
130489832|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
130489833|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
130489834|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
130489835|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
130489836|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
130489837|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
130489838|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
130489839|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
130489840|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
130489841|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
130489842|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
130489843|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
130489844|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
130489845|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
130489846|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
130489847|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
130489848|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
130489849|NCT04614948|469763685|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
130489850|NCT04614948|469763686|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
130728651|NCT00708227|470627546|FG001|Overall Study|Physician Decision|3|||
130728652|NCT00708227|470627547|FG002|Overall Study|Physician Decision|1|||
130728653|NCT00708227|470627548|FG003|Overall Study|Physician Decision|2|||
130489851|NCT04614948|469763687|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
130489852|NCT00964392|469763688|FG000|Overall Study|Withdrawal by Subject|4|||
130728654|NCT00708227|470627545|FG000|Overall Study|Withdrawal by Subject|1|||
130728655|NCT00708227|470627546|FG001|Overall Study|Withdrawal by Subject|2|||
130728656|NCT00708227|470627547|FG002|Overall Study|Withdrawal by Subject|0|||
130728657|NCT00708227|470627548|FG003|Overall Study|Withdrawal by Subject|1|||
130489853|NCT00964392|469763689|FG001|Overall Study|Withdrawal by Subject|6|||
130489854|NCT00964392|469763688|FG000|Overall Study|Lost to Follow-up|4|||
130489855|NCT00964392|469763689|FG001|Overall Study|Lost to Follow-up|10|||
130489856|NCT00964392|469763688|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
130489857|NCT00964392|469763689|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
130489858|NCT00964392|469763688|FG000|Overall Study|Not completed|44|||
130489859|NCT00964392|469763689|FG001|Overall Study|Not completed|168|||
130489860|NCT03498521|469763690|FG000|Overall Study|Death|191|||
130489861|NCT03498521|469763691|FG001|Overall Study|Death|64|||
130489862|NCT03498521|469763692|FG002|Overall Study|Death|72|||
130489863|NCT03498521|469763690|FG000|Overall Study|Exclusion criteria|1|||
130489864|NCT03498521|469763691|FG001|Overall Study|Exclusion criteria|0|||
130489865|NCT03498521|469763692|FG002|Overall Study|Exclusion criteria|0|||
130489866|NCT03498521|469763690|FG000|Overall Study|Lost to Follow-up|3|||
130489867|NCT03498521|469763691|FG001|Overall Study|Lost to Follow-up|3|||
130489868|NCT03498521|469763692|FG002|Overall Study|Lost to Follow-up|3|||
130489869|NCT03498521|469763690|FG000|Overall Study|No profile due to technical failure|1|||
130489870|NCT03498521|469763691|FG001|Overall Study|No profile due to technical failure|0|||
130489871|NCT03498521|469763692|FG002|Overall Study|No profile due to technical failure|0|||
130489872|NCT03498521|469763690|FG000|Overall Study|Physician Decision|0|||
130489873|NCT03498521|469763691|FG001|Overall Study|Physician Decision|1|||
130489874|NCT03498521|469763692|FG002|Overall Study|Physician Decision|0|||
130489875|NCT03498521|469763690|FG000|Overall Study|Withdrawal by Subject|9|||
130489876|NCT03498521|469763691|FG001|Overall Study|Withdrawal by Subject|6|||
130489877|NCT03498521|469763692|FG002|Overall Study|Withdrawal by Subject|2|||
130489878|NCT03498521|469763690|FG000|Overall Study|Study ongoing|121|||
130489879|NCT03498521|469763691|FG001|Overall Study|Study ongoing|36|||
130489880|NCT03498521|469763692|FG002|Overall Study|Study ongoing|15|||
130489881|NCT04055012|469763693|FG000|Overall Study|Withdrawal by Subject|1|||
130489882|NCT04055012|469763694|FG001|Overall Study|Withdrawal by Subject|3|||
130489883|NCT04055012|469763695|FG002|Overall Study|Withdrawal by Subject|1|||
130489884|NCT04055012|469763696|FG003|Overall Study|Withdrawal by Subject|0|||
130489885|NCT04055012|469763693|FG000|Overall Study|Metformin Recall|1|||
130489886|NCT04055012|469763694|FG001|Overall Study|Metformin Recall|1|||
130489887|NCT04055012|469763695|FG002|Overall Study|Metformin Recall|1|||
130489888|NCT04055012|469763696|FG003|Overall Study|Metformin Recall|0|||
130489889|NCT05830799|469763702|FG000|Overall Study|Withdrawal by Subject|1|||
130489890|NCT03652272|469763703|FG000|3 Month|Withdrawal by Subject|1|||
130489891|NCT03652272|469763704|FG001|3 Month|Withdrawal by Subject|1|||
130489892|NCT03652272|469763703|FG000|3 Month|Lost to Follow-up|16|||
130489893|NCT03652272|469763704|FG001|3 Month|Lost to Follow-up|14|||
130489894|NCT04214834|469763707|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
130489895|NCT04214834|469763708|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
130489896|NCT03884101|469763711|FG000|Overall Study|Participant Ongoing in Study|202|||
130489897|NCT03884101|469763712|FG001|Overall Study|Participant Ongoing in Study|186|||
130489898|NCT03884101|469763711|FG000|Overall Study|Death|212|||
130489899|NCT03884101|469763712|FG001|Overall Study|Death|224|||
130489900|NCT03884101|469763711|FG000|Overall Study|Lost to Follow-up|0|||
130489901|NCT03884101|469763712|FG001|Overall Study|Lost to Follow-up|1|||
130489902|NCT03884101|469763711|FG000|Overall Study|Withdrawal by Subject|6|||
130489903|NCT03884101|469763712|FG001|Overall Study|Withdrawal by Subject|11|||
130489904|NCT03370913|469763713|FG000|Overall Study|Death|1|||
130489905|NCT03370913|469763713|FG000|Overall Study|Lost to Follow-up|1|||
130489906|NCT04633538|469763714|FG000|Overall Study|Death|1|||
130489907|NCT04633538|469763714|FG000|Overall Study|Lost to Follow-up|3|||
130489908|NCT04633538|469763714|FG000|Overall Study|Withdrawal by Subject|1|||
130489909|NCT02938520|469763717|FG000|Overall Study|On-going at the time of analysis|258|||
130489910|NCT02938520|469763718|FG001|Overall Study|On-going at the time of analysis|261|||
130489911|NCT02938520|469763717|FG000|Overall Study|Physician Decision|2|||
130489912|NCT02938520|469763718|FG001|Overall Study|Physician Decision|5|||
130489913|NCT02938520|469763717|FG000|Overall Study|Lost to Follow-up|2|||
130489914|NCT02938520|469763718|FG001|Overall Study|Lost to Follow-up|2|||
130489915|NCT02938520|469763717|FG000|Overall Study|Withdrawal by Subject|7|||
130489916|NCT02938520|469763718|FG001|Overall Study|Withdrawal by Subject|7|||
130489917|NCT02938520|469763717|FG000|Overall Study|Protocol Violation|0|||
130489918|NCT02938520|469763718|FG001|Overall Study|Protocol Violation|1|||
130489919|NCT02938520|469763717|FG000|Overall Study|Lack of Efficacy|5|||
130489920|NCT02938520|469763718|FG001|Overall Study|Lack of Efficacy|3|||
130489921|NCT02938520|469763717|FG000|Overall Study|Adverse Event|9|||
130489922|NCT02938520|469763718|FG001|Overall Study|Adverse Event|4|||
130489923|NCT05652010|469763719|FG000|First Intervention|Withdrawal by Subject|0|||
130489924|NCT05652010|469763720|FG001|First Intervention|Withdrawal by Subject|1|||
130489925|NCT05652010|469763719|FG000|Second Intervention|Withdrawal by Subject|1|||
130489926|NCT05652010|469763720|FG001|Second Intervention|Withdrawal by Subject|0|||
130489927|NCT05741294|469763721|FG000|Overall Study|Lost to Follow-up|3|||
130489928|NCT05741294|469763721|FG000|Overall Study|Protocol deviation|3|||
130565367|NCT00404820|470036927|FG000|Overall Study|Adverse Event|4|||
130489929|NCT05741294|469763721|FG000|Overall Study|Withdrawal by Subject|1|||
130728658|NCT04007991|470627549|FG000|Overall Study|Withdrawal by Subject|1|||
130728659|NCT04007991|470627550|FG001|Overall Study|Withdrawal by Subject|1|||
130728660|NCT04007991|470627549|FG000|Overall Study|Physician Decision|1|||
130728661|NCT04007991|470627550|FG001|Overall Study|Physician Decision|1|||
130728662|NCT04007991|470627549|FG000|Overall Study|Non-compliance with Study Drug|0|||
130728663|NCT04007991|470627550|FG001|Overall Study|Non-compliance with Study Drug|1|||
130728664|NCT04007991|470627549|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
130728665|NCT04007991|470627550|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
130728666|NCT04007991|470627549|FG000|Overall Study|Adverse event, non-fatal|5|||
130728667|NCT04007991|470627550|FG001|Overall Study|Adverse event, non-fatal|0|||
130728668|NCT04007991|470627549|FG000|Overall Study|Lost to Follow-up|2|||
130728669|NCT04007991|470627550|FG001|Overall Study|Lost to Follow-up|1|||
130728670|NCT01810302|470628595|FG000|Overall Study|Death|1|||
130728671|NCT01810302|470628596|FG001|Overall Study|Death|0|||
130728672|NCT01810302|470628595|FG000|Overall Study|Physician Decision|0|||
130728673|NCT01810302|470628596|FG001|Overall Study|Physician Decision|1|||
130728674|NCT02111603|470628613|FG000|Overall Study|Withdrawal by Subject|1|||
130728675|NCT03106987|470628614|FG000|Overall Study|Death|37|||
130728676|NCT03106987|470628615|FG001|Overall Study|Death|22|||
130728677|NCT03106987|470628616|FG002|Overall Study|Death|12|||
130728678|NCT03106987|470628617|FG003|Overall Study|Death|8|||
130728679|NCT03106987|470628614|FG000|Overall Study|Lost to Follow-up|2|||
130728680|NCT03106987|470628615|FG001|Overall Study|Lost to Follow-up|0|||
130728681|NCT03106987|470628616|FG002|Overall Study|Lost to Follow-up|2|||
130489930|NCT04163991|469763722|FG000|Overall Study|Adverse Event|0|||
130489931|NCT04163991|469763723|FG001|Overall Study|Adverse Event|0|||
130489932|NCT04163991|469763724|FG002|Overall Study|Adverse Event|0|||
130489933|NCT04163991|469763725|FG003|Overall Study|Adverse Event|1|||
130489934|NCT04163991|469763726|FG004|Overall Study|Adverse Event|0|||
130489935|NCT04163991|469763722|FG000|Overall Study|Death|0|||
130489936|NCT04163991|469763723|FG001|Overall Study|Death|0|||
130489937|NCT04163991|469763724|FG002|Overall Study|Death|1|||
130489938|NCT04163991|469763725|FG003|Overall Study|Death|0|||
130489939|NCT04163991|469763726|FG004|Overall Study|Death|0|||
130489940|NCT04163991|469763722|FG000|Overall Study|Lost to Follow-up|0|||
130489941|NCT04163991|469763723|FG001|Overall Study|Lost to Follow-up|1|||
130489942|NCT04163991|469763724|FG002|Overall Study|Lost to Follow-up|0|||
130489943|NCT04163991|469763725|FG003|Overall Study|Lost to Follow-up|0|||
130489944|NCT04163991|469763726|FG004|Overall Study|Lost to Follow-up|0|||
130489945|NCT04163991|469763722|FG000|Overall Study|Withdrawal by Subject|1|||
130489946|NCT04163991|469763723|FG001|Overall Study|Withdrawal by Subject|1|||
130489947|NCT04163991|469763724|FG002|Overall Study|Withdrawal by Subject|3|||
130489948|NCT04163991|469763725|FG003|Overall Study|Withdrawal by Subject|1|||
130489949|NCT04163991|469763726|FG004|Overall Study|Withdrawal by Subject|1|||
130489950|NCT04163991|469763722|FG000|Overall Study|Other, Not Specified|0|||
130489951|NCT04163991|469763723|FG001|Overall Study|Other, Not Specified|1|||
130489952|NCT04163991|469763724|FG002|Overall Study|Other, Not Specified|1|||
130489953|NCT04163991|469763725|FG003|Overall Study|Other, Not Specified|1|||
130489954|NCT04163991|469763726|FG004|Overall Study|Other, Not Specified|0|||
130565368|NCT00404820|470036928|FG001|Overall Study|Adverse Event|16|||
130565369|NCT00404820|470036927|FG000|Overall Study|Withdrawal by Subject|5|||
130565370|NCT00404820|470036928|FG001|Overall Study|Withdrawal by Subject|3|||
130565371|NCT00404820|470036927|FG000|Overall Study|Lost to Follow-up|7|||
130565372|NCT00404820|470036928|FG001|Overall Study|Lost to Follow-up|3|||
130565373|NCT00404820|470036927|FG000|Overall Study|Administrative problems|2|||
130565374|NCT00404820|470036928|FG001|Overall Study|Administrative problems|0|||
130565375|NCT00404820|470036927|FG000|Overall Study|Death|1|||
130565376|NCT00404820|470036928|FG001|Overall Study|Death|0|||
130565377|NCT00404820|470036927|FG000|Overall Study|Other|0|||
130565378|NCT00404820|470036928|FG001|Overall Study|Other|2|||
130565379|NCT01360554|470036929|FG000|Overall Study|Death|359|||
130565380|NCT01360554|470036930|FG001|Overall Study|Death|371|||
130565381|NCT01360554|470036929|FG000|Overall Study|Lost to Follow-up|4|||
130565382|NCT01360554|470036930|FG001|Overall Study|Lost to Follow-up|4|||
130565383|NCT01360554|470036929|FG000|Overall Study|Withdrawal by Subject|23|||
130728682|NCT03106987|470628617|FG003|Overall Study|Lost to Follow-up|2|||
130489955|NCT03372057|469763727|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
130489956|NCT03372057|469763728|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
130489957|NCT03372057|469763729|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
130565384|NCT01360554|470036930|FG001|Overall Study|Withdrawal by Subject|24|||
130565385|NCT01360554|470036929|FG000|Overall Study|Study terminated by sponsor|49|||
130565386|NCT01360554|470036930|FG001|Overall Study|Study terminated by sponsor|37|||
130565387|NCT01360554|470036929|FG000|Overall Study|Other, not specified|1|||
130565388|NCT01360554|470036930|FG001|Overall Study|Other, not specified|0|||
130565389|NCT01360554|470036929|FG000|Overall Study|Randomized but not treated.|3|||
130728683|NCT03106987|470628614|FG000|Overall Study|Withdrawal by Subject|5|||
130565390|NCT01360554|470036930|FG001|Overall Study|Randomized but not treated.|3|||
130728684|NCT03106987|470628615|FG001|Overall Study|Withdrawal by Subject|1|||
130728685|NCT03106987|470628616|FG002|Overall Study|Withdrawal by Subject|4|||
130489958|NCT03372057|469763727|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
130489959|NCT03372057|469763728|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
130489960|NCT03372057|469763729|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
130489961|NCT03372057|469763727|FG000|Dose Optimization Phase|Death|16|||
130489962|NCT03372057|469763728|FG001|Dose Optimization Phase|Death|11|||
130489963|NCT03372057|469763729|FG002|Dose Optimization Phase|Death|0|||
130489964|NCT03372057|469763727|FG000|Expansion Phase|Withdrawal by Subject|0|||
130489965|NCT03372057|469763728|FG001|Expansion Phase|Withdrawal by Subject|0|||
130489966|NCT03372057|469763729|FG002|Expansion Phase|Withdrawal by Subject|4|||
130489967|NCT03372057|469763727|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
130489968|NCT03372057|469763728|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
130489969|NCT03372057|469763729|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
130489970|NCT03372057|469763727|FG000|Expansion Phase|Death|0|||
130489971|NCT03372057|469763728|FG001|Expansion Phase|Death|0|||
130489972|NCT03372057|469763729|FG002|Expansion Phase|Death|78|||
130489973|NCT03372057|469763727|FG000|Expansion Phase|Progressive Disease|0|||
130489974|NCT03372057|469763728|FG001|Expansion Phase|Progressive Disease|0|||
130489975|NCT03372057|469763729|FG002|Expansion Phase|Progressive Disease|1|||
130489976|NCT03372057|469763727|FG000|Expansion Phase|Adverse Event|0|||
130489977|NCT03372057|469763728|FG001|Expansion Phase|Adverse Event|0|||
130489978|NCT03372057|469763729|FG002|Expansion Phase|Adverse Event|1|||
130489979|NCT05953740|469763730|FG000|Period 1|Physician Decision|0|||
130489980|NCT05953740|469763731|FG001|Period 1|Physician Decision|1|||
130489981|NCT05953740|469763732|FG002|Period 1|Physician Decision|0|||
130489982|NCT05953740|469763733|FG003|Period 1|Physician Decision|0|||
130489983|NCT05953740|469763734|FG004|Period 1|Physician Decision|0|||
130489984|NCT05953740|469763735|FG005|Period 1|Physician Decision|0|||
130489985|NCT05953740|469763736|FG006|Period 1|Physician Decision|0|||
130489986|NCT05953740|469763737|FG007|Period 1|Physician Decision|0|||
130489987|NCT05953740|469763730|FG000|Period 2|Withdrawal by Subject|0|||
130489988|NCT05953740|469763731|FG001|Period 2|Withdrawal by Subject|1|||
130489989|NCT05953740|469763732|FG002|Period 2|Withdrawal by Subject|1|||
130489990|NCT05953740|469763733|FG003|Period 2|Withdrawal by Subject|0|||
130489991|NCT05953740|469763734|FG004|Period 2|Withdrawal by Subject|0|||
130489992|NCT05953740|469763735|FG005|Period 2|Withdrawal by Subject|0|||
130489993|NCT05953740|469763736|FG006|Period 2|Withdrawal by Subject|0|||
130489994|NCT05953740|469763737|FG007|Period 2|Withdrawal by Subject|0|||
130489995|NCT03880955|469763738|FG000|Overall Study|Adverse Event|1|||
130489996|NCT03880955|469763738|FG000|Overall Study|Death|1|||
130489997|NCT03880955|469763738|FG000|Overall Study|Lost to Follow-up|12|||
130489998|NCT03880955|469763738|FG000|Overall Study|Withdrawal by Subject|4|||
130489999|NCT03880955|469763738|FG000|Overall Study|Missing- Study Site Closed|27|||
130490000|NCT04214418|469763741|FG000|Overall Study|Withdrawal by Subject|1|||
130490001|NCT04214418|469763742|FG001|Overall Study|Withdrawal by Subject|0|||
130490002|NCT04214418|469763743|FG002|Overall Study|Withdrawal by Subject|0|||
130490003|NCT04214418|469763744|FG003|Overall Study|Withdrawal by Subject|0|||
130490004|NCT04214418|469763745|FG004|Overall Study|Withdrawal by Subject|0|||
130490005|NCT04214418|469763746|FG005|Overall Study|Withdrawal by Subject|0|||
130490006|NCT04214418|469763741|FG000|Overall Study|Adverse Event|0|||
130490007|NCT04214418|469763742|FG001|Overall Study|Adverse Event|2|||
130490008|NCT04214418|469763743|FG002|Overall Study|Adverse Event|0|||
130490009|NCT04214418|469763744|FG003|Overall Study|Adverse Event|0|||
130490010|NCT04214418|469763745|FG004|Overall Study|Adverse Event|0|||
130490011|NCT04214418|469763746|FG005|Overall Study|Adverse Event|0|||
130490012|NCT04214418|469763741|FG000|Overall Study|Death|1|||
130728686|NCT03106987|470628617|FG003|Overall Study|Withdrawal by Subject|1|||
130490013|NCT04214418|469763742|FG001|Overall Study|Death|0|||
130490014|NCT04214418|469763743|FG002|Overall Study|Death|0|||
130490015|NCT04214418|469763744|FG003|Overall Study|Death|0|||
130728687|NCT02114385|470628619|FG000|Overall Study|Withdrawal by Subject|3|||
130490016|NCT04214418|469763745|FG004|Overall Study|Death|0|||
130490017|NCT04214418|469763746|FG005|Overall Study|Death|0|||
130490018|NCT04635059|469763748|FG000|Overall Study|Study terminated early.|4|||
130490019|NCT03011034|469763752|FG000|Overall Study|Adverse Event|1|||
130490020|NCT03011034|469763753|FG001|Overall Study|Adverse Event|0|||
130490021|NCT01438853|469763758|FG000|Overall Study|Death|0|||
130490022|NCT01438853|469763759|FG001|Overall Study|Death|0|||
130490023|NCT01438853|469763760|FG002|Overall Study|Death|0|||
130490024|NCT01438853|469763761|FG003|Overall Study|Death|1|||
130490025|NCT01438853|469763758|FG000|Overall Study|Withdrawal by Subject|0|||
130490026|NCT01438853|469763759|FG001|Overall Study|Withdrawal by Subject|0|||
130490027|NCT01438853|469763760|FG002|Overall Study|Withdrawal by Subject|1|||
130490028|NCT01438853|469763761|FG003|Overall Study|Withdrawal by Subject|0|||
130490029|NCT02624050|469763762|FG000|Overall Study|Physician Decision|4|||
130490030|NCT02624050|469763763|FG001|Overall Study|Physician Decision|0|||
130490031|NCT02624050|469763762|FG000|Overall Study|Protocol Violation|2|||
130490032|NCT02624050|469763763|FG001|Overall Study|Protocol Violation|0|||
130490033|NCT03904576|469763764|FG000|Washout Period|Protocol Violation|1|||
130490034|NCT03904576|469763765|FG001|Washout Period|Protocol Violation|1|||
130490035|NCT03279978|469763767|FG000|Overall Study|Withdrawal by Subject|0|||
130490036|NCT03279978|469763768|FG001|Overall Study|Withdrawal by Subject|1|||
130490037|NCT03279978|469763769|FG002|Overall Study|Withdrawal by Subject|0|||
130490038|NCT03279978|469763770|FG003|Overall Study|Withdrawal by Subject|0|||
130490039|NCT03279978|469763771|FG004|Overall Study|Withdrawal by Subject|0|||
130490040|NCT03279978|469763772|FG005|Overall Study|Withdrawal by Subject|0|||
130490041|NCT03279978|469763773|FG006|Overall Study|Withdrawal by Subject|0|||
130490042|NCT03279978|469763774|FG007|Overall Study|Withdrawal by Subject|0|||
130490043|NCT03279978|469763775|FG008|Overall Study|Withdrawal by Subject|0|||
130490044|NCT03279978|469763776|FG009|Overall Study|Withdrawal by Subject|1|||
130490045|NCT03279978|469763767|FG000|Overall Study|Lost to Follow-up|1|||
130490046|NCT03279978|469763768|FG001|Overall Study|Lost to Follow-up|0|||
130490047|NCT03279978|469763769|FG002|Overall Study|Lost to Follow-up|1|||
130490048|NCT03279978|469763770|FG003|Overall Study|Lost to Follow-up|0|||
130490049|NCT03279978|469763771|FG004|Overall Study|Lost to Follow-up|0|||
130490050|NCT03279978|469763772|FG005|Overall Study|Lost to Follow-up|0|||
130490051|NCT03279978|469763773|FG006|Overall Study|Lost to Follow-up|0|||
130490052|NCT03279978|469763774|FG007|Overall Study|Lost to Follow-up|0|||
130490053|NCT03279978|469763775|FG008|Overall Study|Lost to Follow-up|0|||
130490054|NCT03279978|469763776|FG009|Overall Study|Lost to Follow-up|0|||
130490055|NCT03279978|469763767|FG000|Overall Study|Other than stated above|0|||
130490056|NCT03279978|469763768|FG001|Overall Study|Other than stated above|0|||
130490057|NCT03279978|469763769|FG002|Overall Study|Other than stated above|0|||
130490058|NCT03279978|469763770|FG003|Overall Study|Other than stated above|0|||
130490059|NCT03279978|469763771|FG004|Overall Study|Other than stated above|0|||
130490060|NCT03279978|469763772|FG005|Overall Study|Other than stated above|0|||
130490061|NCT03279978|469763773|FG006|Overall Study|Other than stated above|1|||
130490062|NCT03279978|469763774|FG007|Overall Study|Other than stated above|0|||
130490063|NCT03279978|469763775|FG008|Overall Study|Other than stated above|0|||
130490064|NCT03279978|469763776|FG009|Overall Study|Other than stated above|0|||
130490065|NCT04330040|469763777|FG000|Overall Study|Other: Adverse event|5|||
130490066|NCT04330040|469763778|FG001|Overall Study|Other: Adverse event|0|||
130490067|NCT04330040|469763779|FG002|Overall Study|Other: Adverse event|0|||
130490068|NCT04330040|469763777|FG000|Overall Study|Disease progression|38|||
130490069|NCT04330040|469763778|FG001|Overall Study|Disease progression|10|||
130490070|NCT04330040|469763779|FG002|Overall Study|Disease progression|0|||
130490071|NCT04330040|469763777|FG000|Overall Study|Physician Decision|5|||
130490072|NCT04330040|469763778|FG001|Overall Study|Physician Decision|3|||
130490073|NCT04330040|469763779|FG002|Overall Study|Physician Decision|0|||
130490074|NCT04330040|469763777|FG000|Overall Study|Lost to Follow-up|1|||
130490075|NCT04330040|469763778|FG001|Overall Study|Lost to Follow-up|1|||
130490076|NCT04330040|469763779|FG002|Overall Study|Lost to Follow-up|0|||
130490077|NCT04330040|469763777|FG000|Overall Study|Death|2|||
130490078|NCT04330040|469763778|FG001|Overall Study|Death|1|||
130490079|NCT04330040|469763779|FG002|Overall Study|Death|0|||
130490080|NCT04330040|469763777|FG000|Overall Study|Withdrawal by Subject|3|||
130490081|NCT04330040|469763778|FG001|Overall Study|Withdrawal by Subject|3|||
130490082|NCT04330040|469763779|FG002|Overall Study|Withdrawal by Subject|0|||
130490083|NCT04330040|469763777|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
130490084|NCT04330040|469763778|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
130490085|NCT04330040|469763779|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
130490086|NCT04330040|469763777|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
130490087|NCT04330040|469763778|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
130490088|NCT04330040|469763779|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
130490089|NCT04330040|469763777|FG000|Overall Study|Other: Disease progression|1|||
130490090|NCT04330040|469763778|FG001|Overall Study|Other: Disease progression|0|||
130490091|NCT04330040|469763779|FG002|Overall Study|Other: Disease progression|0|||
130490092|NCT04330040|469763777|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
130490093|NCT04330040|469763778|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
130490094|NCT04330040|469763779|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
130490095|NCT04330040|469763777|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
130490096|NCT04330040|469763778|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
130490097|NCT04330040|469763779|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
130490098|NCT04330040|469763777|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
130490099|NCT04330040|469763778|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
130490100|NCT04330040|469763779|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
130490101|NCT00626795|469763782|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
130565391|NCT00187096|470036932|FG000|Overall Study|unacceptable toxicity|0|||
130565392|NCT00187096|470036933|FG001|Overall Study|unacceptable toxicity|0|||
130728688|NCT02114385|470628620|FG001|Overall Study|Withdrawal by Subject|2|||
130490102|NCT00626795|469763783|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
130490103|NCT00626795|469763784|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
130490104|NCT00626795|469763782|FG000|Blinded Treatment|Lack of Efficacy|2|||
130490105|NCT00626795|469763783|FG001|Blinded Treatment|Lack of Efficacy|0|||
130490106|NCT00626795|469763784|FG002|Blinded Treatment|Lack of Efficacy|0|||
130490107|NCT00626795|469763782|FG000|Blinded Treatment|Unacceptable adverse event|0|||
130490108|NCT00626795|469763783|FG001|Blinded Treatment|Unacceptable adverse event|0|||
130490109|NCT00626795|469763784|FG002|Blinded Treatment|Unacceptable adverse event|1|||
130490110|NCT00626795|469763782|FG000|Blinded Treatment|Protocol Violation|0|||
130490111|NCT00626795|469763783|FG001|Blinded Treatment|Protocol Violation|1|||
130490112|NCT00626795|469763784|FG002|Blinded Treatment|Protocol Violation|1|||
130490113|NCT00626795|469763782|FG000|Blinded Treatment|Withdrawal by Subject|1|||
130490114|NCT00626795|469763783|FG001|Blinded Treatment|Withdrawal by Subject|1|||
130490115|NCT00626795|469763784|FG002|Blinded Treatment|Withdrawal by Subject|0|||
130490116|NCT00626795|469763782|FG000|Blinded Treatment|Other reasons|2|||
130490117|NCT00626795|469763783|FG001|Blinded Treatment|Other reasons|0|||
130490118|NCT00626795|469763784|FG002|Blinded Treatment|Other reasons|2|||
130490119|NCT00626795|469763782|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
130490120|NCT00626795|469763783|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
130490121|NCT00626795|469763784|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
130490122|NCT01756300|469763790|FG000|Overall Study|Death|1|||
130490123|NCT01756300|469763790|FG000|Overall Study|Withdrawal by Subject|1|||
130490124|NCT03990883|469763791|FG000|Blinded Treatment Phase|Adverse Event|1|||
130490125|NCT03990883|469763792|FG001|Blinded Treatment Phase|Adverse Event|1|||
130490126|NCT03990883|469763793|FG002|Blinded Treatment Phase|Adverse Event|0|||
130490127|NCT03990883|469763791|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
130490128|NCT03990883|469763792|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
130490129|NCT03990883|469763793|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
130490130|NCT03990883|469763791|FG000|Blinded Treatment Phase|Physician Decision|1|||
130490131|NCT03990883|469763792|FG001|Blinded Treatment Phase|Physician Decision|0|||
130490132|NCT03990883|469763793|FG002|Blinded Treatment Phase|Physician Decision|0|||
130490133|NCT03990883|469763791|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
130490134|NCT03990883|469763792|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
130490135|NCT03990883|469763793|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
130490136|NCT03990883|469763791|FG000|Blinded Treatment Phase|COVID-19|3|||
130490137|NCT03990883|469763792|FG001|Blinded Treatment Phase|COVID-19|2|||
130490138|NCT03990883|469763793|FG002|Blinded Treatment Phase|COVID-19|0|||
130490139|NCT03990883|469763791|FG000|Blinded Treatment Phase|Personal Reasons|6|||
130490140|NCT03990883|469763792|FG001|Blinded Treatment Phase|Personal Reasons|3|||
130490141|NCT03990883|469763793|FG002|Blinded Treatment Phase|Personal Reasons|0|||
130490142|NCT03990883|469763791|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
130490143|NCT03990883|469763792|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
130490144|NCT03990883|469763793|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
130490145|NCT03990883|469763791|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
130490146|NCT03990883|469763792|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
130490147|NCT03990883|469763793|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
130490148|NCT03990883|469763791|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
130490149|NCT03990883|469763792|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
130490150|NCT03990883|469763793|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
130490151|NCT04427007|469764747|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
130490152|NCT04427007|469764748|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
130490153|NCT06262347|469764753|FG000|Overall Study|Lost to Follow-up|4|||
130490154|NCT06262347|469764754|FG001|Overall Study|Lost to Follow-up|3|||
130490155|NCT06262347|469764753|FG000|Overall Study|Withdrawal by Subject|0|||
130490156|NCT06262347|469764754|FG001|Overall Study|Withdrawal by Subject|1|||
130490157|NCT02095691|469764763|FG000|Overall Study|Physician Decision|1|||
130490158|NCT00887198|469764764|FG000|Randomized Period|Ongoing|42|||
130490159|NCT00887198|469764765|FG001|Randomized Period|Ongoing|0|||
130490160|NCT00887198|469764766|FG002|Randomized Period|Ongoing|0|||
130490161|NCT00887198|469764764|FG000|Randomized Period|Adverse Event|50|||
130490162|NCT00887198|469764765|FG001|Randomized Period|Adverse Event|33|||
130490163|NCT00887198|469764766|FG002|Randomized Period|Adverse Event|0|||
130490164|NCT00887198|469764764|FG000|Randomized Period|Lost to Follow-up|1|||
130565393|NCT00187096|470036934|FG002|Overall Study|unacceptable toxicity|1|||
130565394|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
130565395|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
130490165|NCT00887198|469764765|FG001|Randomized Period|Lost to Follow-up|0|||
130490166|NCT00887198|469764766|FG002|Randomized Period|Lost to Follow-up|0|||
130490167|NCT00887198|469764764|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
130490168|NCT00887198|469764765|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
130490169|NCT00887198|469764766|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
130490170|NCT00887198|469764764|FG000|Randomized Period|Withdrawal by Subject|41|||
130565396|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130565397|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130490171|NCT00887198|469764765|FG001|Randomized Period|Withdrawal by Subject|56|||
130490172|NCT00887198|469764766|FG002|Randomized Period|Withdrawal by Subject|0|||
130490173|NCT00887198|469764764|FG000|Randomized Period|Progressive disease|366|||
130490174|NCT00887198|469764765|FG001|Randomized Period|Progressive disease|370|||
130490175|NCT00887198|469764766|FG002|Randomized Period|Progressive disease|0|||
130490176|NCT00887198|469764764|FG000|Randomized Period|Other|42|||
130490177|NCT00887198|469764765|FG001|Randomized Period|Other|30|||
130490178|NCT00887198|469764766|FG002|Randomized Period|Other|0|||
130490179|NCT00887198|469764764|FG000|Randomized Period|Randomized, Not treated|4|||
130490180|NCT00887198|469764765|FG001|Randomized Period|Randomized, Not treated|2|||
130490181|NCT00887198|469764766|FG002|Randomized Period|Randomized, Not treated|0|||
130490182|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
130490183|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
130490184|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
130490185|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
130490186|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
130490187|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
130490188|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
130490189|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
130490190|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
130490191|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
130490192|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
130490193|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
130490194|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
130490195|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
130490196|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
130490197|NCT00887198|469764764|FG000|Cross Over (Placebo to AA)|Other|0|||
130490198|NCT00887198|469764765|FG001|Cross Over (Placebo to AA)|Other|0|||
130490199|NCT00887198|469764766|FG002|Cross Over (Placebo to AA)|Other|19|||
130490200|NCT05007080|469764767|FG000|Overall Study|Lost to Follow-up|0|||
130490201|NCT05007080|469764768|FG001|Overall Study|Lost to Follow-up|1|||
130490202|NCT05007080|469764769|FG002|Overall Study|Lost to Follow-up|0|||
130490203|NCT05007080|469764770|FG003|Overall Study|Lost to Follow-up|1|||
130490204|NCT05007080|469764771|FG004|Overall Study|Lost to Follow-up|1|||
130490205|NCT05007080|469764772|FG005|Overall Study|Lost to Follow-up|1|||
130490206|NCT05007080|469764767|FG000|Overall Study|Death|0|||
130490207|NCT05007080|469764768|FG001|Overall Study|Death|1|||
130490208|NCT05007080|469764769|FG002|Overall Study|Death|0|||
130490209|NCT05007080|469764770|FG003|Overall Study|Death|0|||
130490210|NCT05007080|469764771|FG004|Overall Study|Death|0|||
130490211|NCT05007080|469764772|FG005|Overall Study|Death|0|||
130490212|NCT05007080|469764767|FG000|Overall Study|Withdrawal by Subject|1|||
130490213|NCT05007080|469764768|FG001|Overall Study|Withdrawal by Subject|2|||
130490214|NCT05007080|469764769|FG002|Overall Study|Withdrawal by Subject|0|||
130490215|NCT05007080|469764770|FG003|Overall Study|Withdrawal by Subject|2|||
130490216|NCT05007080|469764771|FG004|Overall Study|Withdrawal by Subject|1|||
130490217|NCT05007080|469764772|FG005|Overall Study|Withdrawal by Subject|1|||
130490218|NCT05007080|469764767|FG000|Overall Study|Other|1|||
130490219|NCT05007080|469764768|FG001|Overall Study|Other|0|||
130490220|NCT05007080|469764769|FG002|Overall Study|Other|1|||
130490221|NCT05007080|469764770|FG003|Overall Study|Other|1|||
130490222|NCT05007080|469764771|FG004|Overall Study|Other|0|||
130490223|NCT05007080|469764772|FG005|Overall Study|Other|2|||
130490224|NCT05007080|469764767|FG000|Overall Study|Randomized not vaccinated|0|||
130490225|NCT05007080|469764768|FG001|Overall Study|Randomized not vaccinated|0|||
130490226|NCT05007080|469764769|FG002|Overall Study|Randomized not vaccinated|0|||
130490227|NCT05007080|469764770|FG003|Overall Study|Randomized not vaccinated|0|||
130490228|NCT05007080|469764771|FG004|Overall Study|Randomized not vaccinated|0|||
130490229|NCT05007080|469764772|FG005|Overall Study|Randomized not vaccinated|1|||
130490230|NCT00319046|469764773|FG000|Overall Study|withdrawal of subject's consent|7|||
130490231|NCT00319046|469764773|FG000|Overall Study|administrative reason|1|||
130490232|NCT05147584|469764774|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
130490233|NCT04623775|469764786|FG000|Randomization|No Longer Meets Study Criteria|2|||
130490234|NCT04623775|469764787|FG001|Randomization|No Longer Meets Study Criteria|1|||
130490235|NCT04623775|469764788|FG002|Randomization|No Longer Meets Study Criteria|0|||
130490236|NCT04623775|469764789|FG003|Randomization|No Longer Meets Study Criteria|0|||
130490237|NCT04623775|469764786|FG000|Randomization|Withdrew Consent|0|||
130490238|NCT04623775|469764787|FG001|Randomization|Withdrew Consent|0|||
130490239|NCT04623775|469764788|FG002|Randomization|Withdrew Consent|0|||
130565398|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
130565399|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130490240|NCT04623775|469764789|FG003|Randomization|Withdrew Consent|1|||
130490241|NCT04623775|469764786|FG000|Randomization|Other Reasons|0|||
130490242|NCT04623775|469764787|FG001|Randomization|Other Reasons|0|||
130490243|NCT04623775|469764788|FG002|Randomization|Other Reasons|0|||
130490244|NCT04623775|469764789|FG003|Randomization|Other Reasons|1|||
130490245|NCT04623775|469764786|FG000|Treatment Period|participant withdrew consent|4|||
130490246|NCT04623775|469764787|FG001|Treatment Period|participant withdrew consent|0|||
130490247|NCT04623775|469764788|FG002|Treatment Period|participant withdrew consent|1|||
130490248|NCT04623775|469764789|FG003|Treatment Period|participant withdrew consent|2|||
130490249|NCT04623775|469764786|FG000|Treatment Period|Death|3|||
130490250|NCT04623775|469764787|FG001|Treatment Period|Death|1|||
130490251|NCT04623775|469764788|FG002|Treatment Period|Death|4|||
130490252|NCT04623775|469764789|FG003|Treatment Period|Death|2|||
130490253|NCT04623775|469764786|FG000|Treatment Period|Lost to Follow-up|0|||
130490254|NCT04623775|469764787|FG001|Treatment Period|Lost to Follow-up|2|||
130490255|NCT04623775|469764788|FG002|Treatment Period|Lost to Follow-up|0|||
130490256|NCT04623775|469764789|FG003|Treatment Period|Lost to Follow-up|0|||
130490257|NCT04623775|469764786|FG000|Treatment Period|poor/non compliance|0|||
130490258|NCT04623775|469764787|FG001|Treatment Period|poor/non compliance|0|||
130490259|NCT04623775|469764788|FG002|Treatment Period|poor/non compliance|1|||
130490260|NCT04623775|469764789|FG003|Treatment Period|poor/non compliance|0|||
130490261|NCT04623775|469764786|FG000|Treatment Period|participant no longer meets study criteria|0|||
130490262|NCT04623775|469764787|FG001|Treatment Period|participant no longer meets study criteria|1|||
130490263|NCT04623775|469764788|FG002|Treatment Period|participant no longer meets study criteria|0|||
130490264|NCT04623775|469764789|FG003|Treatment Period|participant no longer meets study criteria|0|||
130490265|NCT04623775|469764786|FG000|Treatment Period|administrative reasons by sponsor|3|||
130490266|NCT04623775|469764787|FG001|Treatment Period|administrative reasons by sponsor|2|||
130490267|NCT04623775|469764788|FG002|Treatment Period|administrative reasons by sponsor|0|||
130490268|NCT04623775|469764789|FG003|Treatment Period|administrative reasons by sponsor|0|||
130490269|NCT04623775|469764786|FG000|Treatment Period|other reasons|2|||
130490270|NCT04623775|469764787|FG001|Treatment Period|other reasons|0|||
130490271|NCT04623775|469764788|FG002|Treatment Period|other reasons|1|||
130490272|NCT04623775|469764789|FG003|Treatment Period|other reasons|1|||
130490273|NCT04623775|469764786|FG000|Treatment Period|disease progression|40|||
130490274|NCT04623775|469764787|FG001|Treatment Period|disease progression|35|||
130490275|NCT04623775|469764788|FG002|Treatment Period|disease progression|63|||
130490276|NCT04623775|469764789|FG003|Treatment Period|disease progression|63|||
130490277|NCT04623775|469764786|FG000|Treatment Period|study drug toxicity|12|||
130490278|NCT04623775|469764787|FG001|Treatment Period|study drug toxicity|15|||
130490279|NCT04623775|469764788|FG002|Treatment Period|study drug toxicity|13|||
130490280|NCT04623775|469764789|FG003|Treatment Period|study drug toxicity|12|||
130490281|NCT04623775|469764786|FG000|Treatment Period|AE unrelated to study drug|4|||
130490282|NCT04623775|469764787|FG001|Treatment Period|AE unrelated to study drug|9|||
130490283|NCT04623775|469764788|FG002|Treatment Period|AE unrelated to study drug|12|||
130490284|NCT04623775|469764789|FG003|Treatment Period|AE unrelated to study drug|9|||
130490285|NCT04623775|469764786|FG000|Treatment Period|participant request to discontinue treatment|0|||
130490286|NCT04623775|469764787|FG001|Treatment Period|participant request to discontinue treatment|2|||
130490287|NCT04623775|469764788|FG002|Treatment Period|participant request to discontinue treatment|2|||
130490288|NCT04623775|469764789|FG003|Treatment Period|participant request to discontinue treatment|0|||
130490289|NCT04967599|469764798|FG000|Overall Study|Lost to Follow-up|35|||
130490290|NCT04967599|469764799|FG001|Overall Study|Lost to Follow-up|19|||
130490291|NCT04967599|469764800|FG002|Overall Study|Lost to Follow-up|23|||
130490292|NCT04369911|469764801|FG000|Overall Study|Lost to Follow-up|3|||
130490293|NCT04369911|469764802|FG001|Overall Study|Lost to Follow-up|3|||
130490294|NCT04369911|469764801|FG000|Overall Study|Withdrawal by Subject|1|||
130490295|NCT04369911|469764802|FG001|Overall Study|Withdrawal by Subject|2|||
130490296|NCT05451693|469764803|FG000|Overall Study|Withdrawal by Subject|1|||
130490297|NCT05451693|469764804|FG001|Overall Study|Withdrawal by Subject|1|||
130490298|NCT04675034|469764805|FG000|Overall Study|Lost to Follow-up|1|||
130490299|NCT04675034|469764806|FG001|Overall Study|Lost to Follow-up|1|||
130490300|NCT04675034|469764807|FG002|Overall Study|Lost to Follow-up|0|||
130490301|NCT04675034|469764808|FG003|Overall Study|Lost to Follow-up|2|||
130490302|NCT04675034|469764809|FG004|Overall Study|Lost to Follow-up|0|||
130490303|NCT04675034|469764805|FG000|Overall Study|Protocol Violation|1|||
130490304|NCT04675034|469764806|FG001|Overall Study|Protocol Violation|0|||
130490305|NCT04675034|469764807|FG002|Overall Study|Protocol Violation|0|||
130490306|NCT04675034|469764808|FG003|Overall Study|Protocol Violation|1|||
130490307|NCT04675034|469764809|FG004|Overall Study|Protocol Violation|3|||
130490308|NCT04675034|469764805|FG000|Overall Study|Withdrawal by Subject|9|||
130490309|NCT04675034|469764806|FG001|Overall Study|Withdrawal by Subject|3|||
130490310|NCT04675034|469764807|FG002|Overall Study|Withdrawal by Subject|4|||
130490311|NCT04675034|469764808|FG003|Overall Study|Withdrawal by Subject|8|||
130490312|NCT04675034|469764809|FG004|Overall Study|Withdrawal by Subject|6|||
130490313|NCT05008055|469764814|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
130490314|NCT05008055|469764815|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
130490315|NCT05008055|469764816|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
130490316|NCT04679389|469764817|FG000|Overall Study|Adverse Event|1|||
130490317|NCT04679389|469764818|FG001|Overall Study|Adverse Event|0|||
130728689|NCT02114385|470628619|FG000|Overall Study|Lost to Follow-up|0|||
130728690|NCT02114385|470628620|FG001|Overall Study|Lost to Follow-up|6|||
130728691|NCT01174043|470628624|FG000|Overall Study|Disease progression|5|||
130728692|NCT01174043|470628624|FG000|Overall Study|Adverse Event|3|||
130728693|NCT01174043|470628624|FG000|Overall Study|Death|1|||
130490318|NCT04679389|469764817|FG000|Overall Study|Protocol Violation|2|||
130490319|NCT04679389|469764818|FG001|Overall Study|Protocol Violation|0|||
130490320|NCT04679389|469764817|FG000|Overall Study|Physician Decision|3|||
130490321|NCT04679389|469764818|FG001|Overall Study|Physician Decision|5|||
130490322|NCT04679389|469764817|FG000|Overall Study|Withdrawal by Subject|5|||
130490323|NCT04679389|469764818|FG001|Overall Study|Withdrawal by Subject|7|||
130490324|NCT02919917|469764827|FG000|Overall Study|Withdrawal by Subject|4|||
130490325|NCT02919917|469764828|FG001|Overall Study|Withdrawal by Subject|8|||
130490326|NCT05215054|469764829|FG000|Overall Study|Lost to Follow-up|1|||
130490327|NCT05215054|469764830|FG001|Overall Study|Lost to Follow-up|1|||
130490328|NCT05215054|469764829|FG000|Overall Study|Protocol Violation|1|||
130490329|NCT05215054|469764830|FG001|Overall Study|Protocol Violation|1|||
130490330|NCT05215054|469764829|FG000|Overall Study|Withdrawal by Subject|4|||
130490331|NCT05215054|469764830|FG001|Overall Study|Withdrawal by Subject|4|||
130490332|NCT01651000|469764831|FG000|Overall Study|Adverse Event|2|||
130490333|NCT01651000|469764832|FG001|Overall Study|Adverse Event|8|||
130490334|NCT01651000|469764831|FG000|Overall Study|Lost to Follow-up|3|||
130490335|NCT01651000|469764832|FG001|Overall Study|Lost to Follow-up|2|||
130490336|NCT01651000|469764831|FG000|Overall Study|Protocol Violation|0|||
130490337|NCT01651000|469764832|FG001|Overall Study|Protocol Violation|3|||
130490338|NCT01651000|469764831|FG000|Overall Study|Withdrawal by Subject|2|||
130490339|NCT01651000|469764832|FG001|Overall Study|Withdrawal by Subject|10|||
130490340|NCT01651000|469764831|FG000|Overall Study|Subject noncompliance|0|||
130490341|NCT01651000|469764832|FG001|Overall Study|Subject noncompliance|3|||
130490342|NCT01651000|469764831|FG000|Overall Study|Lack of Efficacy|1|||
130490343|NCT01651000|469764832|FG001|Overall Study|Lack of Efficacy|1|||
130490344|NCT01651000|469764831|FG000|Overall Study|Physician Decision|1|||
130490345|NCT01651000|469764832|FG001|Overall Study|Physician Decision|0|||
130490346|NCT01651000|469764831|FG000|Overall Study|Administrative reason|1|||
130490347|NCT01651000|469764832|FG001|Overall Study|Administrative reason|0|||
130490348|NCT01651000|469764831|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
130490349|NCT01651000|469764832|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
130490350|NCT04633278|469765808|FG000|Overall Study|Adverse Event|1|||
130490351|NCT04633278|469765809|FG001|Overall Study|Adverse Event|0|||
130490352|NCT04633278|469765808|FG000|Overall Study|Withdrawal by Subject|1|||
130490353|NCT04633278|469765809|FG001|Overall Study|Withdrawal by Subject|0|||
130490354|NCT04633278|469765808|FG000|Overall Study|Death|11|||
130490355|NCT04633278|469765809|FG001|Overall Study|Death|7|||
130490356|NCT04633278|469765808|FG000|Overall Study|Sponsor Decision|3|||
130490357|NCT04633278|469765809|FG001|Overall Study|Sponsor Decision|0|||
130490358|NCT04633278|469765808|FG000|Overall Study|Not Listed|1|||
130490359|NCT04633278|469765809|FG001|Overall Study|Not Listed|0|||
130490360|NCT03636490|469765810|FG000|Overall Study|Dropped out or incomplete data|141|||
130490361|NCT02246127|469765811|FG000|First Course Treatment|Adverse Event|9|||
130490362|NCT02246127|469765812|FG001|First Course Treatment|Adverse Event|7|||
130490363|NCT02246127|469765811|FG000|First Course Treatment|Withdrawal by Subject|6|||
130490364|NCT02246127|469765812|FG001|First Course Treatment|Withdrawal by Subject|7|||
130490365|NCT02246127|469765811|FG000|First Course Treatment|Physician Decision|9|||
130490366|NCT02246127|469765812|FG001|First Course Treatment|Physician Decision|9|||
130490367|NCT02246127|469765811|FG000|First Course Treatment|Death|3|||
130490368|NCT02246127|469765812|FG001|First Course Treatment|Death|3|||
130490369|NCT02246127|469765811|FG000|First Course Treatment|Not reported reasons|6|||
130490370|NCT02246127|469765812|FG001|First Course Treatment|Not reported reasons|7|||
130490371|NCT02246127|469765811|FG000|First Course Treatment|Not treated|3|||
130490372|NCT02246127|469765812|FG001|First Course Treatment|Not treated|3|||
130490373|NCT06655818|469765822|FG000|Overall Study|Withdrawal by Subject|1|||
130728694|NCT01174043|470628624|FG000|Overall Study|Withdrawal by Subject|2|||
130490374|NCT04560179|469765833|FG000|Overall Study|Physician Decision|1|||
130490375|NCT04560179|469765834|FG001|Overall Study|Physician Decision|0|||
130490376|NCT04560179|469765835|FG002|Overall Study|Physician Decision|0|||
130490377|NCT04560179|469765836|FG003|Overall Study|Physician Decision|0|||
130490378|NCT04560179|469765837|FG004|Overall Study|Physician Decision|0|||
130490379|NCT04560179|469765833|FG000|Overall Study|Adverse Event|0|||
130490380|NCT04560179|469765834|FG001|Overall Study|Adverse Event|0|||
130490381|NCT04560179|469765835|FG002|Overall Study|Adverse Event|0|||
130490382|NCT04560179|469765836|FG003|Overall Study|Adverse Event|1|||
130490383|NCT04560179|469765837|FG004|Overall Study|Adverse Event|0|||
130490384|NCT06010836|469765840|FG000|Overall Study|Lost to Follow-up|2|||
130490385|NCT06010836|469765841|FG001|Overall Study|Lost to Follow-up|2|||
130490386|NCT06010836|469765840|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
130728695|NCT00582010|470628629|FG000|Overall Study|Death|0|||
130728696|NCT00582010|470628630|FG001|Overall Study|Death|1|||
130728697|NCT02681510|470628631|FG000|Overall Study|Withdrawal by Subject|1|||
130490387|NCT06010836|469765841|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
130490388|NCT06010836|469765840|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
130490389|NCT06010836|469765841|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
130490390|NCT06010836|469765840|FG000|Overall Study|Did not receive intervention discussion|0|||
130490391|NCT06010836|469765841|FG001|Overall Study|Did not receive intervention discussion|4|||
130490392|NCT04496752|469765842|FG000|Second Assessment|Lost to Follow-up|3|||
130490393|NCT04496752|469765843|FG001|Second Assessment|Lost to Follow-up|3|||
130490394|NCT04496752|469765842|FG000|Second Assessment|Adverse Event|2|||
130490395|NCT04496752|469765843|FG001|Second Assessment|Adverse Event|0|||
130490396|NCT04524689|469765844|FG000|Overall Study|Withdrawal by Subject|1|||
130490397|NCT04524689|469765845|FG001|Overall Study|Withdrawal by Subject|1|||
130490398|NCT04524689|469765846|FG002|Overall Study|Withdrawal by Subject|0|||
130490399|NCT04524689|469765847|FG003|Overall Study|Withdrawal by Subject|0|||
130490400|NCT04524689|469765848|FG004|Overall Study|Withdrawal by Subject|1|||
130490401|NCT04524689|469765849|FG005|Overall Study|Withdrawal by Subject|0|||
130490402|NCT04524689|469765844|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
130490403|NCT04524689|469765845|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
130490404|NCT04524689|469765846|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
130490405|NCT04524689|469765847|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
130490406|NCT04524689|469765848|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
130490407|NCT04524689|469765849|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
130490408|NCT04524689|469765844|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
130490409|NCT04524689|469765845|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
130490410|NCT04524689|469765846|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
130490411|NCT04524689|469765847|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
130490412|NCT04524689|469765848|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
130490413|NCT04524689|469765849|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
130490414|NCT03662022|469765852|FG000|Year 1 2019|prevalent case|83|||
130490415|NCT03662022|469765853|FG001|Year 1 2019|prevalent case|116|||
130490416|NCT03662022|469765854|FG002|Year 1 2019|prevalent case|158|||
130490417|NCT03662022|469765855|FG003|Year 1 2019|prevalent case|99|||
130490418|NCT03662022|469765852|FG000|Year 2 2020|incident case|18|||
130490419|NCT03662022|469765853|FG001|Year 2 2020|incident case|18|||
130490420|NCT03662022|469765854|FG002|Year 2 2020|incident case|16|||
130490421|NCT03662022|469765855|FG003|Year 2 2020|incident case|26|||
130490422|NCT03662022|469765852|FG000|Year 2 2020|other case|18|||
130490423|NCT03662022|469765853|FG001|Year 2 2020|other case|16|||
130490424|NCT03662022|469765854|FG002|Year 2 2020|other case|16|||
130728698|NCT02681510|470628631|FG000|Overall Study|Lost to Follow-up|9|||
130728699|NCT00741338|470628632|FG000|Overall Study|Adverse Event|0|||
130728700|NCT00741338|470628633|FG001|Overall Study|Adverse Event|1|||
130728701|NCT03066258|470628636|FG000|Overall Study|Death|1|||
130728702|NCT03066258|470628637|FG001|Overall Study|Death|0|||
130728703|NCT03066258|470628638|FG002|Overall Study|Death|0|||
130728704|NCT03066258|470628639|FG003|Overall Study|Death|0|||
130728705|NCT03066258|470628640|FG004|Overall Study|Death|1|||
130728706|NCT02784795|470628641|FG000|Overall Study|Progressive Disease|2|||
130728707|NCT02784795|470628642|FG001|Overall Study|Progressive Disease|1|||
130490425|NCT03662022|469765855|FG003|Year 2 2020|other case|24|||
130490426|NCT03662022|469765852|FG000|Year 2 2020|Lost to Follow-up|1633|||
130490427|NCT03662022|469765853|FG001|Year 2 2020|Lost to Follow-up|1183|||
130490428|NCT03662022|469765854|FG002|Year 2 2020|Lost to Follow-up|1381|||
130490429|NCT03662022|469765855|FG003|Year 2 2020|Lost to Follow-up|2858|||
130490430|NCT03662022|469765852|FG000|Year 3 2021|incident case|24|||
130490431|NCT03662022|469765853|FG001|Year 3 2021|incident case|27|||
130490432|NCT03662022|469765854|FG002|Year 3 2021|incident case|24|||
130728708|NCT02784795|470628643|FG002|Overall Study|Progressive Disease|1|||
130728709|NCT02784795|470628644|FG003|Overall Study|Progressive Disease|0|||
130490433|NCT03662022|469765855|FG003|Year 3 2021|incident case|11|||
130490434|NCT03662022|469765852|FG000|Year 3 2021|other case|4|||
130490435|NCT03662022|469765853|FG001|Year 3 2021|other case|15|||
130490436|NCT03662022|469765854|FG002|Year 3 2021|other case|10|||
130490437|NCT03662022|469765855|FG003|Year 3 2021|other case|14|||
130490438|NCT03662022|469765852|FG000|Year 3 2021|Lost to Follow-up|179|||
130490439|NCT03662022|469765853|FG001|Year 3 2021|Lost to Follow-up|244|||
130490440|NCT03662022|469765854|FG002|Year 3 2021|Lost to Follow-up|480|||
130490441|NCT03662022|469765855|FG003|Year 3 2021|Lost to Follow-up|477|||
130490442|NCT03662022|469765852|FG000|Year 4 2022|incident case|25|||
130490443|NCT03662022|469765853|FG001|Year 4 2022|incident case|41|||
130490444|NCT03662022|469765854|FG002|Year 4 2022|incident case|28|||
130490445|NCT03662022|469765855|FG003|Year 4 2022|incident case|7|||
130490446|NCT03662022|469765852|FG000|Year 4 2022|other case|8|||
130490447|NCT03662022|469765853|FG001|Year 4 2022|other case|19|||
130490448|NCT03662022|469765854|FG002|Year 4 2022|other case|13|||
130490449|NCT03662022|469765855|FG003|Year 4 2022|other case|7|||
130728710|NCT02784795|470628645|FG004|Overall Study|Progressive Disease|2|||
130728711|NCT02784795|470628646|FG005|Overall Study|Progressive Disease|0|||
130490450|NCT03662022|469765852|FG000|Year 4 2022|Lost to Follow-up|986|||
130490451|NCT03662022|469765853|FG001|Year 4 2022|Lost to Follow-up|1079|||
130490452|NCT03662022|469765854|FG002|Year 4 2022|Lost to Follow-up|1236|||
130490453|NCT03662022|469765855|FG003|Year 4 2022|Lost to Follow-up|1826|||
130490454|NCT04490109|469765866|FG000|Overall Study|Lost to Follow-up|3|||
130490455|NCT04490109|469765867|FG001|Overall Study|Lost to Follow-up|10|||
130490456|NCT04490109|469765868|FG002|Overall Study|Lost to Follow-up|4|||
130490457|NCT04490109|469765866|FG000|Overall Study|Withdrawal by Subject|8|||
130490458|NCT04490109|469765867|FG001|Overall Study|Withdrawal by Subject|6|||
130490459|NCT04490109|469765868|FG002|Overall Study|Withdrawal by Subject|9|||
130490460|NCT04490109|469765866|FG000|Overall Study|Physician Decision|0|||
130490461|NCT04490109|469765867|FG001|Overall Study|Physician Decision|2|||
130490462|NCT04490109|469765868|FG002|Overall Study|Physician Decision|3|||
130490463|NCT04490109|469765866|FG000|Overall Study|Adverse Event|2|||
130490464|NCT04490109|469765867|FG001|Overall Study|Adverse Event|1|||
130490465|NCT04490109|469765868|FG002|Overall Study|Adverse Event|0|||
130490466|NCT04490109|469765866|FG000|Overall Study|Significant Non-Compliance|2|||
130490467|NCT04490109|469765867|FG001|Overall Study|Significant Non-Compliance|4|||
130490468|NCT04490109|469765868|FG002|Overall Study|Significant Non-Compliance|4|||
130490469|NCT04490109|469765866|FG000|Overall Study|Significant Clinical Event|0|||
130490470|NCT04490109|469765867|FG001|Overall Study|Significant Clinical Event|1|||
130490471|NCT04490109|469765868|FG002|Overall Study|Significant Clinical Event|0|||
130490472|NCT04490109|469765866|FG000|Overall Study|Other Reason|4|||
130490473|NCT04490109|469765867|FG001|Overall Study|Other Reason|1|||
130490474|NCT04490109|469765868|FG002|Overall Study|Other Reason|1|||
130490475|NCT03817983|469765871|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
130490476|NCT03817983|469765872|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
130490477|NCT03817983|469765873|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
130490478|NCT03744676|469765874|FG000|Pre-Treatment Phase|Disease related complications|2|||
130490479|NCT03744676|469765874|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
130490480|NCT03744676|469765874|FG000|Pre-Treatment Phase|Death|7|||
130490481|NCT03744676|469765874|FG000|Pre-Treatment Phase|Other Reasons|7|||
130490482|NCT03744676|469765874|FG000|Treatment Phase|Participant withdrew consent|8|||
130490483|NCT03744676|469765874|FG000|Treatment Phase|Death|33|||
130490484|NCT03744676|469765874|FG000|Treatment Phase|other reasons|6|||
130490485|NCT05541484|469765886|FG000|Overall Study|Withdrawal by Subject|1|||
130490486|NCT05541484|469765887|FG001|Overall Study|Withdrawal by Subject|0|||
130490487|NCT03884439|469765893|FG000|Overall Study|No informed consent for publication of study results|38|||
130490488|NCT03884439|469765893|FG000|Overall Study|Contract violation/deficiency|7|||
130490489|NCT03547271|469765894|FG000|Overall Study|Adverse Event|1|||
130490490|NCT03547271|469765895|FG001|Overall Study|Adverse Event|1|||
130490491|NCT03547271|469765896|FG002|Overall Study|Adverse Event|0|||
130490492|NCT03547271|469765897|FG003|Overall Study|Adverse Event|0|||
130490493|NCT03547271|469765894|FG000|Overall Study|Protocol deviation|5|||
130490494|NCT03547271|469765895|FG001|Overall Study|Protocol deviation|7|||
130490495|NCT03547271|469765896|FG002|Overall Study|Protocol deviation|3|||
130490496|NCT03547271|469765897|FG003|Overall Study|Protocol deviation|0|||
130490497|NCT03547271|469765894|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
130490498|NCT03547271|469765895|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
130490499|NCT03547271|469765896|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130490500|NCT03547271|469765897|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
130490501|NCT03547271|469765894|FG000|Overall Study|Lost to Follow-up|3|||
130490502|NCT03547271|469765895|FG001|Overall Study|Lost to Follow-up|3|||
130490503|NCT03547271|469765896|FG002|Overall Study|Lost to Follow-up|1|||
130490504|NCT03547271|469765897|FG003|Overall Study|Lost to Follow-up|0|||
130490505|NCT04159519|469765906|FG000|Overall Study|Adverse Event|1|||
130490506|NCT04159519|469765907|FG001|Overall Study|Adverse Event|1|||
130490507|NCT04159519|469765906|FG000|Overall Study|Lack of Efficacy|1|||
130490508|NCT04159519|469765907|FG001|Overall Study|Lack of Efficacy|0|||
130490509|NCT04159519|469765906|FG000|Overall Study|Discontinued from study|1|||
130490510|NCT04159519|469765907|FG001|Overall Study|Discontinued from study|0|||
130490511|NCT04159519|469765906|FG000|Overall Study|Protocol Violation|1|||
130490512|NCT04159519|469765907|FG001|Overall Study|Protocol Violation|1|||
130490513|NCT04159519|469765906|FG000|Overall Study|Withdrawal by Subject|4|||
130490514|NCT04159519|469765907|FG001|Overall Study|Withdrawal by Subject|4|||
130490515|NCT02765412|469765908|FG000|Overall Study|Death|482|||
130490516|NCT02765412|469765909|FG001|Overall Study|Death|855|||
130490517|NCT05267639|469766566|FG000|Overall Study|Withdrawal by Subject|1|||
130490518|NCT05267639|469766567|FG001|Overall Study|Withdrawal by Subject|0|||
130490519|NCT04244175|469766571|FG000|Overall Study|Adverse Event|3|||
130490520|NCT04244175|469766572|FG001|Overall Study|Adverse Event|2|||
130490521|NCT04244175|469766573|FG002|Overall Study|Adverse Event|5|||
130490522|NCT04244175|469766571|FG000|Overall Study|Lack of Efficacy|1|||
130490523|NCT04244175|469766572|FG001|Overall Study|Lack of Efficacy|0|||
130490524|NCT04244175|469766573|FG002|Overall Study|Lack of Efficacy|1|||
130490525|NCT04244175|469766571|FG000|Overall Study|Lost to Follow-up|1|||
130490526|NCT04244175|469766572|FG001|Overall Study|Lost to Follow-up|0|||
130490527|NCT04244175|469766573|FG002|Overall Study|Lost to Follow-up|0|||
130490528|NCT04244175|469766571|FG000|Overall Study|Non-compliance with study drug|1|||
130490529|NCT04244175|469766572|FG001|Overall Study|Non-compliance with study drug|0|||
130490530|NCT04244175|469766573|FG002|Overall Study|Non-compliance with study drug|1|||
130490531|NCT04244175|469766571|FG000|Overall Study|Protocol deviation|0|||
130490532|NCT04244175|469766572|FG001|Overall Study|Protocol deviation|1|||
130490533|NCT04244175|469766573|FG002|Overall Study|Protocol deviation|0|||
130490534|NCT04244175|469766571|FG000|Overall Study|Withdrawal by Subject|1|||
130490535|NCT04244175|469766572|FG001|Overall Study|Withdrawal by Subject|3|||
130490536|NCT04244175|469766573|FG002|Overall Study|Withdrawal by Subject|1|||
130490537|NCT04244175|469766571|FG000|Overall Study|Other, not specified|0|||
130490538|NCT04244175|469766572|FG001|Overall Study|Other, not specified|1|||
130490539|NCT04244175|469766573|FG002|Overall Study|Other, not specified|2|||
130490540|NCT04595331|469766574|FG000|Overall Study|Withdrawal by Subject|0|||
130490541|NCT04595331|469766575|FG001|Overall Study|Withdrawal by Subject|1|||
130490542|NCT04595331|469766574|FG000|Overall Study|Lost to Follow-up|0|||
130490543|NCT04595331|469766575|FG001|Overall Study|Lost to Follow-up|5|||
130490544|NCT04595331|469766574|FG000|Overall Study|Medical reason|0|||
130728712|NCT02784795|470628647|FG006|Overall Study|Progressive Disease|2|||
130728713|NCT02784795|470628648|FG007|Overall Study|Progressive Disease|0|||
130728714|NCT02784795|470628649|FG008|Overall Study|Progressive Disease|0|||
130728715|NCT02784795|470628650|FG009|Overall Study|Progressive Disease|0|||
130728716|NCT02784795|470628651|FG010|Overall Study|Progressive Disease|1|||
130728717|NCT02784795|470628652|FG011|Overall Study|Progressive Disease|0|||
130728718|NCT02784795|470628641|FG000|Overall Study|Adverse Event|1|||
130728719|NCT02784795|470628642|FG001|Overall Study|Adverse Event|0|||
130728720|NCT02784795|470628643|FG002|Overall Study|Adverse Event|0|||
130728721|NCT02784795|470628644|FG003|Overall Study|Adverse Event|1|||
130728722|NCT02784795|470628645|FG004|Overall Study|Adverse Event|0|||
130728723|NCT02784795|470628646|FG005|Overall Study|Adverse Event|0|||
130728724|NCT02784795|470628647|FG006|Overall Study|Adverse Event|1|||
130728725|NCT02784795|470628648|FG007|Overall Study|Adverse Event|0|||
130728726|NCT02784795|470628649|FG008|Overall Study|Adverse Event|0|||
130490545|NCT04595331|469766575|FG001|Overall Study|Medical reason|1|||
130490546|NCT03781089|469766576|FG000|Overall Study|Constipation|1|||
130490547|NCT03781089|469766577|FG001|Overall Study|Constipation|0|||
130490548|NCT03781089|469766576|FG000|Overall Study|Positive pregnancy test|0|||
130490549|NCT03781089|469766577|FG001|Overall Study|Positive pregnancy test|1|||
130490550|NCT02163694|469766578|FG000|Overall Study|Adverse event- related to progression|4|||
130490551|NCT02163694|469766579|FG001|Overall Study|Adverse event- related to progression|10|||
130490552|NCT02163694|469766578|FG000|Overall Study|Adverse event- not related to progression|7|||
130490553|NCT02163694|469766579|FG001|Overall Study|Adverse event- not related to progression|22|||
130490554|NCT02163694|469766578|FG000|Overall Study|Withdrew consent|13|||
130490555|NCT02163694|469766579|FG001|Overall Study|Withdrew consent|28|||
130490556|NCT02163694|469766578|FG000|Overall Study|Lost to Follow-up|2|||
130490557|NCT02163694|469766579|FG001|Overall Study|Lost to Follow-up|2|||
130490558|NCT02163694|469766578|FG000|Overall Study|Sponsor discontinued study|3|||
130490559|NCT02163694|469766579|FG001|Overall Study|Sponsor discontinued study|29|||
130490560|NCT02163694|469766578|FG000|Overall Study|Progressive disease per protocol|125|||
130490561|NCT02163694|469766579|FG001|Overall Study|Progressive disease per protocol|224|||
130490562|NCT02163694|469766578|FG000|Overall Study|Other, not specified|17|||
130490563|NCT02163694|469766579|FG001|Overall Study|Other, not specified|22|||
130490564|NCT02163694|469766578|FG000|Overall Study|Randomized but Not Treated|1|||
130490565|NCT02163694|469766579|FG001|Overall Study|Randomized but Not Treated|0|||
130490566|NCT02163694|469766578|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
130490567|NCT02163694|469766579|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
130490568|NCT05454514|469766581|FG000|Overall Study|Withdrawal by Subject|4|||
130490569|NCT02461134|469766584|FG000|Overall Study|Adverse Event|1|||
130490570|NCT04761198|469766585|FG000|Overall Study|Progressive Disease|1|||
130490571|NCT04761198|469766586|FG001|Overall Study|Progressive Disease|0|||
130490572|NCT04761198|469766587|FG002|Overall Study|Progressive Disease|0|||
130490573|NCT04761198|469766588|FG003|Overall Study|Progressive Disease|1|||
130490574|NCT04761198|469766589|FG004|Overall Study|Progressive Disease|4|||
130490575|NCT04761198|469766590|FG005|Overall Study|Progressive Disease|1|||
130490576|NCT04761198|469766591|FG006|Overall Study|Progressive Disease|2|||
130490577|NCT04761198|469766585|FG000|Overall Study|Protocol Violation|0|||
130490578|NCT04761198|469766586|FG001|Overall Study|Protocol Violation|0|||
130490579|NCT04761198|469766587|FG002|Overall Study|Protocol Violation|0|||
130490580|NCT04761198|469766588|FG003|Overall Study|Protocol Violation|0|||
130490581|NCT04761198|469766589|FG004|Overall Study|Protocol Violation|1|||
130490582|NCT04761198|469766590|FG005|Overall Study|Protocol Violation|0|||
130728727|NCT02784795|470628650|FG009|Overall Study|Adverse Event|0|||
130728728|NCT02784795|470628651|FG010|Overall Study|Adverse Event|0|||
130728729|NCT02784795|470628652|FG011|Overall Study|Adverse Event|2|||
130728730|NCT02784795|470628641|FG000|Overall Study|Withdrawal by Subject|1|||
130728731|NCT02784795|470628642|FG001|Overall Study|Withdrawal by Subject|0|||
130728732|NCT02784795|470628643|FG002|Overall Study|Withdrawal by Subject|2|||
130490583|NCT04761198|469766591|FG006|Overall Study|Protocol Violation|0|||
130490584|NCT04761198|469766585|FG000|Overall Study|Death|2|||
130490585|NCT04761198|469766586|FG001|Overall Study|Death|1|||
130490586|NCT04761198|469766587|FG002|Overall Study|Death|2|||
130490587|NCT04761198|469766588|FG003|Overall Study|Death|5|||
130490588|NCT04761198|469766589|FG004|Overall Study|Death|14|||
130490589|NCT04761198|469766590|FG005|Overall Study|Death|2|||
130490590|NCT04761198|469766591|FG006|Overall Study|Death|5|||
130490591|NCT04761198|469766585|FG000|Overall Study|Lost to Follow-up|0|||
130490592|NCT04761198|469766586|FG001|Overall Study|Lost to Follow-up|0|||
130490593|NCT04761198|469766587|FG002|Overall Study|Lost to Follow-up|0|||
130490594|NCT04761198|469766588|FG003|Overall Study|Lost to Follow-up|0|||
130490595|NCT04761198|469766589|FG004|Overall Study|Lost to Follow-up|1|||
130490596|NCT04761198|469766590|FG005|Overall Study|Lost to Follow-up|0|||
130490597|NCT04761198|469766591|FG006|Overall Study|Lost to Follow-up|0|||
130490598|NCT04761198|469766585|FG000|Overall Study|Withdrawal by Subject|2|||
130490599|NCT04761198|469766586|FG001|Overall Study|Withdrawal by Subject|0|||
130490600|NCT04761198|469766587|FG002|Overall Study|Withdrawal by Subject|1|||
130490601|NCT04761198|469766588|FG003|Overall Study|Withdrawal by Subject|0|||
130490602|NCT04761198|469766589|FG004|Overall Study|Withdrawal by Subject|2|||
130490603|NCT04761198|469766590|FG005|Overall Study|Withdrawal by Subject|0|||
130490604|NCT04761198|469766591|FG006|Overall Study|Withdrawal by Subject|1|||
130490605|NCT04761198|469766585|FG000|Overall Study|Study Terminated by Sponsor|6|||
130490606|NCT04761198|469766586|FG001|Overall Study|Study Terminated by Sponsor|0|||
130490607|NCT04761198|469766587|FG002|Overall Study|Study Terminated by Sponsor|5|||
130490608|NCT04761198|469766588|FG003|Overall Study|Study Terminated by Sponsor|3|||
130490609|NCT04761198|469766589|FG004|Overall Study|Study Terminated by Sponsor|10|||
130490610|NCT04761198|469766590|FG005|Overall Study|Study Terminated by Sponsor|1|||
130490611|NCT04761198|469766591|FG006|Overall Study|Study Terminated by Sponsor|2|||
130490612|NCT02994927|469766592|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130490613|NCT02994927|469766593|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130490614|NCT02994927|469766592|FG000|Overall Study|Did not meet eligibility criteria|0|||
130490615|NCT02994927|469766593|FG001|Overall Study|Did not meet eligibility criteria|1|||
130490616|NCT02994927|469766592|FG000|Overall Study|Physician Decision|4|||
130490617|NCT02994927|469766593|FG001|Overall Study|Physician Decision|3|||
130490618|NCT02994927|469766592|FG000|Overall Study|Death|4|||
130490619|NCT02994927|469766593|FG001|Overall Study|Death|2|||
130490620|NCT02994927|469766592|FG000|Overall Study|Adverse Event|2|||
130490621|NCT02994927|469766593|FG001|Overall Study|Adverse Event|1|||
130490622|NCT02994927|469766592|FG000|Overall Study|Withdrawal by Subject|3|||
130490623|NCT02994927|469766593|FG001|Overall Study|Withdrawal by Subject|6|||
130490624|NCT02994927|469766592|FG000|Overall Study|Lost to Follow-up|2|||
130490625|NCT02994927|469766593|FG001|Overall Study|Lost to Follow-up|1|||
130490626|NCT03533257|469766601|FG000|Overall Study|Adverse Event|4|||
130490627|NCT03533257|469766602|FG001|Overall Study|Adverse Event|2|||
130490628|NCT03533257|469766601|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
130490629|NCT03533257|469766602|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
130490630|NCT03493542|469766603|FG000|Base Study|Withdrawal by Subject|0|||
130490631|NCT03493542|469766604|FG001|Base Study|Withdrawal by Subject|4|||
130490632|NCT03493542|469766605|FG002|Base Study|Withdrawal by Subject|0|||
130490633|NCT03493542|469766603|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
130490634|NCT03493542|469766604|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
130490635|NCT03493542|469766605|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
130490636|NCT03493542|469766603|FG000|Extension Study|Withdrawal by Subject|0|||
130490637|NCT03493542|469766604|FG001|Extension Study|Withdrawal by Subject|0|||
130490638|NCT03493542|469766605|FG002|Extension Study|Withdrawal by Subject|25|||
130490639|NCT04093869|469766606|FG000|Overall Study|Death|0|||
130490640|NCT04093869|469766607|FG001|Overall Study|Death|1|||
130490641|NCT04093869|469766606|FG000|Overall Study|Withdrawal by Subject|1|||
130490642|NCT04093869|469766607|FG001|Overall Study|Withdrawal by Subject|0|||
130490643|NCT03250676|469766608|FG000|Overall Study|Adverse Event|0|||
130490644|NCT03250676|469766609|FG001|Overall Study|Adverse Event|0|||
130490645|NCT03250676|469766610|FG002|Overall Study|Adverse Event|0|||
130490646|NCT03250676|469766611|FG003|Overall Study|Adverse Event|1|||
130490647|NCT03250676|469766612|FG004|Overall Study|Adverse Event|2|||
130490648|NCT03250676|469766613|FG005|Overall Study|Adverse Event|9|||
130490649|NCT03250676|469766608|FG000|Overall Study|Withdrawal by Subject|1|||
130490650|NCT03250676|469766609|FG001|Overall Study|Withdrawal by Subject|0|||
130490651|NCT03250676|469766610|FG002|Overall Study|Withdrawal by Subject|0|||
130490652|NCT03250676|469766611|FG003|Overall Study|Withdrawal by Subject|1|||
130490653|NCT03250676|469766612|FG004|Overall Study|Withdrawal by Subject|1|||
130490654|NCT03250676|469766613|FG005|Overall Study|Withdrawal by Subject|2|||
130490655|NCT03250676|469766608|FG000|Overall Study|Physician Decision|0|||
130490656|NCT03250676|469766609|FG001|Overall Study|Physician Decision|0|||
130490657|NCT03250676|469766610|FG002|Overall Study|Physician Decision|0|||
130490658|NCT03250676|469766611|FG003|Overall Study|Physician Decision|2|||
130490659|NCT03250676|469766612|FG004|Overall Study|Physician Decision|0|||
130490660|NCT03250676|469766613|FG005|Overall Study|Physician Decision|3|||
130490661|NCT03250676|469766608|FG000|Overall Study|Withdrawal of consent|0|||
130490662|NCT03250676|469766609|FG001|Overall Study|Withdrawal of consent|0|||
130490663|NCT03250676|469766610|FG002|Overall Study|Withdrawal of consent|2|||
130490664|NCT03250676|469766611|FG003|Overall Study|Withdrawal of consent|0|||
130490665|NCT03250676|469766612|FG004|Overall Study|Withdrawal of consent|0|||
130490666|NCT03250676|469766613|FG005|Overall Study|Withdrawal of consent|2|||
130490667|NCT03250676|469766608|FG000|Overall Study|Other|1|||
130490668|NCT03250676|469766609|FG001|Overall Study|Other|0|||
130490669|NCT03250676|469766610|FG002|Overall Study|Other|0|||
130490670|NCT03250676|469766611|FG003|Overall Study|Other|0|||
130490671|NCT03250676|469766612|FG004|Overall Study|Other|0|||
130490672|NCT03250676|469766613|FG005|Overall Study|Other|0|||
130490673|NCT03250676|469766608|FG000|Overall Study|Disease progression|4|||
130490674|NCT03250676|469766609|FG001|Overall Study|Disease progression|12|||
130490675|NCT03250676|469766610|FG002|Overall Study|Disease progression|9|||
130490676|NCT03250676|469766611|FG003|Overall Study|Disease progression|7|||
130490677|NCT03250676|469766612|FG004|Overall Study|Disease progression|4|||
130490678|NCT03250676|469766613|FG005|Overall Study|Disease progression|88|||
130490679|NCT04780581|469766614|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
130490680|NCT04780581|469766615|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
130490681|NCT04780581|469766614|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
130490682|NCT04780581|469766615|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
130490683|NCT03417284|469767435|FG000|Overall Study|Inadequate supply on study drug|1|||
130490684|NCT03417284|469767436|FG001|Overall Study|Inadequate supply on study drug|0|||
130490685|NCT03417284|469767437|FG002|Overall Study|Inadequate supply on study drug|0|||
130490686|NCT03417284|469767438|FG003|Overall Study|Inadequate supply on study drug|0|||
130490687|NCT03417284|469767435|FG000|Overall Study|Disease Progression|0|||
130490688|NCT03417284|469767436|FG001|Overall Study|Disease Progression|0|||
130490689|NCT03417284|469767437|FG002|Overall Study|Disease Progression|1|||
130490690|NCT03417284|469767438|FG003|Overall Study|Disease Progression|0|||
130490691|NCT05132400|469767439|FG000|Overall Study|Withdrawal by Subject|14|||
130490692|NCT05132400|469767440|FG001|Overall Study|Withdrawal by Subject|8|||
130490693|NCT05132400|469767439|FG000|Overall Study|Lost to Follow-up|132|||
130490694|NCT05132400|469767440|FG001|Overall Study|Lost to Follow-up|121|||
130490695|NCT05311176|469767441|FG000|Overall Study|Death|6|||
130490696|NCT05311176|469767441|FG000|Overall Study|Sponsor discontinued the study|1|||
130490697|NCT05836012|469767463|FG000|Overall Study|Lost to Follow-up|1|||
130490698|NCT05836012|469767464|FG001|Overall Study|Lost to Follow-up|0|||
130490699|NCT05836012|469767463|FG000|Overall Study|Withdrawal by Subject|1|||
130490700|NCT05836012|469767464|FG001|Overall Study|Withdrawal by Subject|3|||
130490701|NCT05836012|469767463|FG000|Overall Study|Reason not included in pre-specified categories|2|||
130490702|NCT05836012|469767464|FG001|Overall Study|Reason not included in pre-specified categories|1|||
130490703|NCT05785130|469767465|FG000|Overall Study|Withdrawal by Subject|1|||
130490704|NCT05785130|469767466|FG001|Overall Study|Withdrawal by Subject|0|||
130490705|NCT05785130|469767465|FG000|Overall Study|Lack of Efficacy|0|||
130490706|NCT05785130|469767466|FG001|Overall Study|Lack of Efficacy|1|||
130490707|NCT06065735|469767467|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
130490708|NCT06065735|469767468|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
130490709|NCT06065735|469767469|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
130490710|NCT06065735|469767467|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
130490711|NCT06065735|469767468|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
130490712|NCT06065735|469767469|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
130490713|NCT06065735|469767467|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
130490714|NCT06065735|469767468|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
130490715|NCT06065735|469767469|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
130490716|NCT06065735|469767467|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
130490717|NCT06065735|469767468|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
130490718|NCT06065735|469767469|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
130490719|NCT06065735|469767467|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
130490720|NCT06065735|469767468|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
130490721|NCT06065735|469767469|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
130490722|NCT02532621|469767470|FG000|Overall Study|Death|3|||
130565400|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
130565401|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130565402|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
130565403|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130565404|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130565405|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
130565406|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
130565407|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
130565408|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
130565409|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
130565410|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
130490723|NCT02532621|469767470|FG000|Overall Study|Lost to Follow-up|3|||
130490724|NCT02532621|469767470|FG000|Overall Study|Withdrawal by Subject|6|||
130490725|NCT02532621|469767470|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
130490726|NCT02532621|469767470|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
130490727|NCT04795245|469767473|FG000|Overall Study|Unkown reason|7|||
130490728|NCT04795245|469767473|FG000|Overall Study|Death|17|||
130490729|NCT04795245|469767473|FG000|Overall Study|Other than listed|19|||
130490730|NCT04795245|469767473|FG000|Overall Study|Adverse Event|143|||
130490731|NCT04795245|469767473|FG000|Overall Study|Progressive disease|512|||
130490732|NCT04795245|469767473|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
130490733|NCT03418740|469767474|FG000|Overall Study|Lost to Follow-up|13|||
130490734|NCT03418740|469767474|FG000|Overall Study|Scheduling Issues|7|||
130490735|NCT03418740|469767474|FG000|Overall Study|Withdrawal by Subject|2|||
130490736|NCT03418740|469767474|FG000|Overall Study|Unable to Continue Consent|1|||
130490737|NCT04157517|469767479|FG000|Overall Study|Death|1|||
130490738|NCT04157517|469767480|FG001|Overall Study|Death|2|||
130490739|NCT04157517|469767481|FG002|Overall Study|Death|2|||
130490740|NCT04157517|469767482|FG003|Overall Study|Death|3|||
130490741|NCT04157517|469767483|FG004|Overall Study|Death|3|||
130490742|NCT04157517|469767484|FG005|Overall Study|Death|4|||
130490743|NCT04157517|469767485|FG006|Overall Study|Death|1|||
130490744|NCT04157517|469767486|FG007|Overall Study|Death|2|||
130490745|NCT04157517|469767487|FG008|Overall Study|Death|4|||
130490746|NCT04157517|469767488|FG009|Overall Study|Death|0|||
130490747|NCT04157517|469767479|FG000|Overall Study|Withdrawal by Subject|1|||
130490748|NCT04157517|469767480|FG001|Overall Study|Withdrawal by Subject|1|||
130490749|NCT04157517|469767481|FG002|Overall Study|Withdrawal by Subject|1|||
130490750|NCT04157517|469767482|FG003|Overall Study|Withdrawal by Subject|0|||
130490751|NCT04157517|469767483|FG004|Overall Study|Withdrawal by Subject|0|||
130490752|NCT04157517|469767484|FG005|Overall Study|Withdrawal by Subject|1|||
130490753|NCT04157517|469767485|FG006|Overall Study|Withdrawal by Subject|0|||
130490754|NCT04157517|469767486|FG007|Overall Study|Withdrawal by Subject|0|||
130490755|NCT04157517|469767487|FG008|Overall Study|Withdrawal by Subject|1|||
130490756|NCT04157517|469767488|FG009|Overall Study|Withdrawal by Subject|0|||
130490757|NCT04157517|469767479|FG000|Overall Study|Other|1|||
130490758|NCT04157517|469767480|FG001|Overall Study|Other|0|||
130490759|NCT04157517|469767481|FG002|Overall Study|Other|0|||
130490760|NCT04157517|469767482|FG003|Overall Study|Other|0|||
130490761|NCT04157517|469767483|FG004|Overall Study|Other|0|||
130490762|NCT04157517|469767484|FG005|Overall Study|Other|1|||
130490763|NCT04157517|469767485|FG006|Overall Study|Other|2|||
130490764|NCT04157517|469767486|FG007|Overall Study|Other|7|||
130490765|NCT04157517|469767487|FG008|Overall Study|Other|7|||
130490766|NCT04157517|469767488|FG009|Overall Study|Other|0|||
130490767|NCT02933489|469767489|FG000|Overall Study|Ineligible|3|||
130490768|NCT02933489|469767490|FG001|Overall Study|Ineligible|3|||
130490769|NCT02933489|469767489|FG000|Overall Study|Withdrawal by Subject|27|||
130490770|NCT02933489|469767490|FG001|Overall Study|Withdrawal by Subject|18|||
130490771|NCT02933489|469767489|FG000|Overall Study|Unable to complete exams (other)|14|||
130490772|NCT02933489|469767490|FG001|Overall Study|Unable to complete exams (other)|7|||
130728733|NCT02784795|470628644|FG003|Overall Study|Withdrawal by Subject|1|||
130490773|NCT03587805|469767498|FG000|Overall Study|Adverse Event|72|||
130490774|NCT03587805|469767498|FG000|Overall Study|Death|1|||
130490775|NCT03587805|469767498|FG000|Overall Study|Lost to Follow-up|78|||
130490776|NCT03587805|469767498|FG000|Overall Study|Withdrawal by Subject|105|||
130490777|NCT03587805|469767498|FG000|Overall Study|Lack of Efficacy|119|||
130490778|NCT03587805|469767498|FG000|Overall Study|Reason unknown|26|||
130490779|NCT03587805|469767498|FG000|Overall Study|COVID_19 pandemic|4|||
130490780|NCT03587805|469767498|FG000|Overall Study|Various reasons|121|||
130490781|NCT03587805|469767498|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130490782|NCT03982186|469767499|FG000|Overall Study|Lost to Follow-up|0|||
130490783|NCT03982186|469767500|FG001|Overall Study|Lost to Follow-up|1|||
130490784|NCT03982186|469767501|FG002|Overall Study|Lost to Follow-up|2|||
130490785|NCT03982186|469767502|FG003|Overall Study|Lost to Follow-up|1|||
130490786|NCT03982186|469767503|FG004|Overall Study|Lost to Follow-up|1|||
130490787|NCT03982186|469767504|FG005|Overall Study|Lost to Follow-up|0|||
130490788|NCT03982186|469767499|FG000|Overall Study|Physician Decision|0|||
130490789|NCT03982186|469767500|FG001|Overall Study|Physician Decision|1|||
130490790|NCT03982186|469767501|FG002|Overall Study|Physician Decision|0|||
130490791|NCT03982186|469767502|FG003|Overall Study|Physician Decision|0|||
130490792|NCT03982186|469767503|FG004|Overall Study|Physician Decision|0|||
130490793|NCT03982186|469767504|FG005|Overall Study|Physician Decision|0|||
130490794|NCT03982186|469767499|FG000|Overall Study|Withdrawal by Subject|3|||
130490795|NCT03982186|469767500|FG001|Overall Study|Withdrawal by Subject|4|||
130490796|NCT03982186|469767501|FG002|Overall Study|Withdrawal by Subject|1|||
130490797|NCT03982186|469767502|FG003|Overall Study|Withdrawal by Subject|7|||
130490798|NCT03982186|469767503|FG004|Overall Study|Withdrawal by Subject|2|||
130490799|NCT03982186|469767504|FG005|Overall Study|Withdrawal by Subject|0|||
130490800|NCT03982186|469767499|FG000|Overall Study|Randomized and not treated|0|||
130490801|NCT03982186|469767500|FG001|Overall Study|Randomized and not treated|0|||
130490802|NCT03982186|469767501|FG002|Overall Study|Randomized and not treated|0|||
130490803|NCT03982186|469767502|FG003|Overall Study|Randomized and not treated|1|||
130490804|NCT03982186|469767503|FG004|Overall Study|Randomized and not treated|0|||
130490805|NCT03982186|469767504|FG005|Overall Study|Randomized and not treated|0|||
130490806|NCT05020353|469768057|FG000|Overall Study|Protocol Violation|7|||
130490807|NCT05020353|469768057|FG000|Overall Study|Withdrawal by Subject|33|||
130490808|NCT03635567|469768065|FG000|Overall Study|Lost to Follow-up|4|||
130490809|NCT03635567|469768066|FG001|Overall Study|Lost to Follow-up|1|||
130490810|NCT03635567|469768065|FG000|Overall Study|Withdrawal by Subject|11|||
130490811|NCT03635567|469768066|FG001|Overall Study|Withdrawal by Subject|16|||
130490812|NCT03635567|469768065|FG000|Overall Study|Sponsor Decision|99|||
130490813|NCT03635567|469768066|FG001|Overall Study|Sponsor Decision|57|||
130490814|NCT03635567|469768065|FG000|Overall Study|Death|194|||
130490815|NCT03635567|469768066|FG001|Overall Study|Death|235|||
130490816|NCT01880515|469768068|FG000|Overall Study|Lost to Follow-up|3|||
130490817|NCT01880515|469768069|FG001|Overall Study|Lost to Follow-up|2|||
130490818|NCT01880515|469768068|FG000|Overall Study|Disease Progression|5|||
130490819|NCT01880515|469768069|FG001|Overall Study|Disease Progression|7|||
130490820|NCT00942734|469768077|FG000|Overall Study|Adverse Event|2|||
130490821|NCT00942734|469768077|FG000|Overall Study|Protocol Violation|3|||
130490822|NCT00942734|469768077|FG000|Overall Study|Disease Progression|2|||
130490823|NCT00942734|469768077|FG000|Overall Study|Physician Decision|1|||
130490824|NCT05985395|469768078|FG000|Overall Study|Physician Decision|2|||
130490825|NCT05985395|469768079|FG001|Overall Study|Physician Decision|1|||
130490826|NCT05985395|469768078|FG000|Overall Study|Withdrawal by Subject|1|||
130490827|NCT05985395|469768079|FG001|Overall Study|Withdrawal by Subject|0|||
130490828|NCT03333915|469768080|FG000|Overall Study|Lost to Follow-up|0|||
130490829|NCT03333915|469768081|FG001|Overall Study|Lost to Follow-up|0|||
130490830|NCT03333915|469768082|FG002|Overall Study|Lost to Follow-up|1|||
130490831|NCT03333915|469768083|FG003|Overall Study|Lost to Follow-up|0|||
130490832|NCT03333915|469768084|FG004|Overall Study|Lost to Follow-up|0|||
130490833|NCT03333915|469768080|FG000|Overall Study|Disease Progression|0|||
130490834|NCT03333915|469768081|FG001|Overall Study|Disease Progression|1|||
130490835|NCT03333915|469768082|FG002|Overall Study|Disease Progression|0|||
130490836|NCT03333915|469768083|FG003|Overall Study|Disease Progression|0|||
130490837|NCT03333915|469768084|FG004|Overall Study|Disease Progression|0|||
130490838|NCT03333915|469768080|FG000|Overall Study|Death|0|||
130490839|NCT03333915|469768081|FG001|Overall Study|Death|0|||
130490840|NCT03333915|469768082|FG002|Overall Study|Death|0|||
130490841|NCT03333915|469768083|FG003|Overall Study|Death|37|||
130490842|NCT03333915|469768084|FG004|Overall Study|Death|18|||
130490843|NCT03333915|469768080|FG000|Overall Study|Sponsor's Decision|0|||
130490844|NCT03333915|469768081|FG001|Overall Study|Sponsor's Decision|0|||
130490845|NCT03333915|469768082|FG002|Overall Study|Sponsor's Decision|0|||
130490846|NCT03333915|469768083|FG003|Overall Study|Sponsor's Decision|48|||
130490847|NCT03333915|469768084|FG004|Overall Study|Sponsor's Decision|4|||
130490848|NCT03333915|469768080|FG000|Overall Study|Withdrawal by Subject|0|||
130490849|NCT03333915|469768081|FG001|Overall Study|Withdrawal by Subject|0|||
130490850|NCT03333915|469768082|FG002|Overall Study|Withdrawal by Subject|0|||
130490851|NCT03333915|469768083|FG003|Overall Study|Withdrawal by Subject|5|||
130490852|NCT03333915|469768084|FG004|Overall Study|Withdrawal by Subject|1|||
130490853|NCT02777593|469768096|FG000|Overall Study|Still in study|1|||
130490854|NCT02777593|469768097|FG001|Overall Study|Still in study|32|||
130490855|NCT02777593|469768098|FG002|Overall Study|Still in study|3|||
130490856|NCT02777593|469768099|FG003|Overall Study|Still in study|6|||
130490857|NCT02777593|469768100|FG004|Overall Study|Still in study|5|||
130490858|NCT02777593|469768096|FG000|Overall Study|Death|21|||
130490859|NCT02777593|469768097|FG001|Overall Study|Death|28|||
130490860|NCT02777593|469768098|FG002|Overall Study|Death|0|||
130490861|NCT02777593|469768099|FG003|Overall Study|Death|5|||
130490862|NCT02777593|469768100|FG004|Overall Study|Death|0|||
130490863|NCT02777593|469768096|FG000|Overall Study|Withdrawal by Subject|8|||
130490864|NCT02777593|469768097|FG001|Overall Study|Withdrawal by Subject|4|||
130490865|NCT02777593|469768098|FG002|Overall Study|Withdrawal by Subject|1|||
130490866|NCT02777593|469768099|FG003|Overall Study|Withdrawal by Subject|1|||
130490867|NCT02777593|469768100|FG004|Overall Study|Withdrawal by Subject|0|||
130490868|NCT02777593|469768096|FG000|Overall Study|Lost to Follow-up|8|||
130490869|NCT02777593|469768097|FG001|Overall Study|Lost to Follow-up|16|||
130490870|NCT02777593|469768098|FG002|Overall Study|Lost to Follow-up|5|||
130490871|NCT02777593|469768099|FG003|Overall Study|Lost to Follow-up|0|||
130490872|NCT02777593|469768100|FG004|Overall Study|Lost to Follow-up|1|||
130490873|NCT02777593|469768096|FG000|Overall Study|Physician Decision|2|||
130490874|NCT02777593|469768097|FG001|Overall Study|Physician Decision|2|||
130490875|NCT02777593|469768098|FG002|Overall Study|Physician Decision|0|||
130490876|NCT02777593|469768099|FG003|Overall Study|Physician Decision|0|||
130490877|NCT02777593|469768100|FG004|Overall Study|Physician Decision|0|||
130490878|NCT02777593|469768096|FG000|Overall Study|Discontinued due to Other|1|||
130490879|NCT02777593|469768097|FG001|Overall Study|Discontinued due to Other|0|||
130490880|NCT02777593|469768098|FG002|Overall Study|Discontinued due to Other|0|||
130490881|NCT02777593|469768099|FG003|Overall Study|Discontinued due to Other|0|||
130490882|NCT02777593|469768100|FG004|Overall Study|Discontinued due to Other|0|||
130490883|NCT03522298|469768107|FG000|Overall Study|Adverse Event|1|||
130490884|NCT03522298|469768108|FG001|Overall Study|Adverse Event|0|||
130490885|NCT03522298|469768109|FG002|Overall Study|Adverse Event|0|||
130490886|NCT03522298|469768110|FG003|Overall Study|Adverse Event|1|||
130490887|NCT03522298|469768107|FG000|Overall Study|Death|2|||
130490888|NCT03522298|469768108|FG001|Overall Study|Death|4|||
130490889|NCT03522298|469768109|FG002|Overall Study|Death|8|||
130490890|NCT03522298|469768110|FG003|Overall Study|Death|8|||
130490891|NCT03522298|469768107|FG000|Overall Study|Patient decision|0|||
130490892|NCT03522298|469768108|FG001|Overall Study|Patient decision|2|||
130490893|NCT03522298|469768109|FG002|Overall Study|Patient decision|2|||
130490894|NCT03522298|469768110|FG003|Overall Study|Patient decision|2|||
130490895|NCT01897441|469768111|FG000|Overall Study|Lost to Follow-up|0|||
130490896|NCT01897441|469768112|FG001|Overall Study|Lost to Follow-up|0|||
130490897|NCT01897441|469768113|FG002|Overall Study|Lost to Follow-up|1|||
130490898|NCT01897441|469768114|FG003|Overall Study|Lost to Follow-up|0|||
130490899|NCT01897441|469768115|FG004|Overall Study|Lost to Follow-up|0|||
130490900|NCT01897441|469768116|FG005|Overall Study|Lost to Follow-up|0|||
130490901|NCT01897441|469768111|FG000|Overall Study|Withdrawal by Subject|0|||
130490902|NCT01897441|469768112|FG001|Overall Study|Withdrawal by Subject|0|||
130490903|NCT01897441|469768113|FG002|Overall Study|Withdrawal by Subject|0|||
130490904|NCT01897441|469768114|FG003|Overall Study|Withdrawal by Subject|0|||
130490905|NCT01897441|469768115|FG004|Overall Study|Withdrawal by Subject|1|||
130490906|NCT01897441|469768116|FG005|Overall Study|Withdrawal by Subject|0|||
130490907|NCT01897441|469768111|FG000|Overall Study|Withdrawn by Provider|0|||
130728734|NCT02784795|470628645|FG004|Overall Study|Withdrawal by Subject|3|||
130728735|NCT02784795|470628646|FG005|Overall Study|Withdrawal by Subject|0|||
130728736|NCT02784795|470628647|FG006|Overall Study|Withdrawal by Subject|0|||
130728737|NCT02784795|470628648|FG007|Overall Study|Withdrawal by Subject|1|||
130728738|NCT02784795|470628649|FG008|Overall Study|Withdrawal by Subject|0|||
130728739|NCT02784795|470628650|FG009|Overall Study|Withdrawal by Subject|0|||
130728740|NCT02784795|470628651|FG010|Overall Study|Withdrawal by Subject|0|||
130728741|NCT02784795|470628652|FG011|Overall Study|Withdrawal by Subject|2|||
130728742|NCT02784795|470628641|FG000|Overall Study|Death|0|||
130728743|NCT02784795|470628642|FG001|Overall Study|Death|0|||
130728744|NCT02784795|470628643|FG002|Overall Study|Death|0|||
130728745|NCT02784795|470628644|FG003|Overall Study|Death|0|||
130728746|NCT02784795|470628645|FG004|Overall Study|Death|1|||
130728747|NCT02784795|470628646|FG005|Overall Study|Death|0|||
130728748|NCT02784795|470628647|FG006|Overall Study|Death|0|||
130728749|NCT02784795|470628648|FG007|Overall Study|Death|0|||
130728750|NCT02784795|470628649|FG008|Overall Study|Death|0|||
130728751|NCT02784795|470628650|FG009|Overall Study|Death|0|||
130728752|NCT02784795|470628651|FG010|Overall Study|Death|0|||
130728753|NCT02784795|470628652|FG011|Overall Study|Death|0|||
130728754|NCT02784795|470628641|FG000|Overall Study|Physician Decision|0|||
130728755|NCT02784795|470628642|FG001|Overall Study|Physician Decision|0|||
130490908|NCT01897441|469768112|FG001|Overall Study|Withdrawn by Provider|2|||
130490909|NCT01897441|469768113|FG002|Overall Study|Withdrawn by Provider|0|||
130490910|NCT01897441|469768114|FG003|Overall Study|Withdrawn by Provider|0|||
130490911|NCT01897441|469768115|FG004|Overall Study|Withdrawn by Provider|0|||
130490912|NCT01897441|469768116|FG005|Overall Study|Withdrawn by Provider|0|||
130490913|NCT02806726|469768117|FG000|Overall Study|Lost to Follow-up|1|||
130490914|NCT04281498|469768118|FG000|Overall Study|Progression of disease|1|||
130490915|NCT04281498|469768118|FG000|Overall Study|Planned SCT|1|||
130490916|NCT04281498|469768118|FG000|Overall Study|Alternative Treatment|1|||
130490917|NCT01527188|469768119|FG000|Overall Study|Adverse Event|5|||
130490918|NCT01527188|469768120|FG001|Overall Study|Adverse Event|5|||
130490919|NCT01527188|469768121|FG002|Overall Study|Adverse Event|11|||
130565411|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
130565412|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
130728756|NCT02784795|470628643|FG002|Overall Study|Physician Decision|0|||
130728757|NCT02784795|470628644|FG003|Overall Study|Physician Decision|0|||
130728758|NCT02784795|470628645|FG004|Overall Study|Physician Decision|0|||
130728759|NCT02784795|470628646|FG005|Overall Study|Physician Decision|0|||
130490920|NCT01527188|469768122|FG003|Overall Study|Adverse Event|0|||
130490921|NCT01527188|469768119|FG000|Overall Study|Withdrawal by Subject|3|||
130490922|NCT01527188|469768120|FG001|Overall Study|Withdrawal by Subject|6|||
130565413|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
130565414|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
130728760|NCT02784795|470628647|FG006|Overall Study|Physician Decision|1|||
130728761|NCT02784795|470628648|FG007|Overall Study|Physician Decision|0|||
130490923|NCT01527188|469768121|FG002|Overall Study|Withdrawal by Subject|4|||
130490924|NCT01527188|469768122|FG003|Overall Study|Withdrawal by Subject|4|||
130490925|NCT01527188|469768119|FG000|Overall Study|Any other reason not above-mentioned|6|||
130490926|NCT01527188|469768120|FG001|Overall Study|Any other reason not above-mentioned|7|||
130728762|NCT02784795|470628649|FG008|Overall Study|Physician Decision|0|||
130490927|NCT01527188|469768121|FG002|Overall Study|Any other reason not above-mentioned|8|||
130490928|NCT01527188|469768122|FG003|Overall Study|Any other reason not above-mentioned|8|||
130490929|NCT04626427|469768123|FG000|Overall Study|Death|1|||
130490930|NCT04626427|469768123|FG000|Overall Study|Withdrawal by Subject|1|||
130490931|NCT04626427|469768123|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
130490932|NCT04626427|469768123|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
130490933|NCT01265537|469768124|FG000|Overall Study|Adverse Event|2|||
130490934|NCT01265537|469768125|FG001|Overall Study|Adverse Event|1|||
130490935|NCT01265537|469768124|FG000|Overall Study|Physician Decision|0|||
130490936|NCT01265537|469768125|FG001|Overall Study|Physician Decision|1|||
130490937|NCT05866926|469768126|FG000|Overall Study|Death|16|||
130490938|NCT05866926|469768127|FG001|Overall Study|Death|9|||
130490939|NCT05866926|469768126|FG000|Overall Study|Lost to Follow-up|0|||
130490940|NCT05866926|469768127|FG001|Overall Study|Lost to Follow-up|1|||
130490941|NCT05866926|469768126|FG000|Overall Study|Adverse Event|1|||
130490942|NCT05866926|469768127|FG001|Overall Study|Adverse Event|0|||
130490943|NCT05866926|469768126|FG000|Overall Study|Withdrawal by Subject|5|||
130490944|NCT05866926|469768127|FG001|Overall Study|Withdrawal by Subject|1|||
130490945|NCT05866926|469768126|FG000|Overall Study|Disease progression|1|||
130490946|NCT05866926|469768127|FG001|Overall Study|Disease progression|0|||
130490947|NCT05866926|469768126|FG000|Overall Study|other causes|2|||
130490948|NCT05866926|469768127|FG001|Overall Study|other causes|1|||
130490949|NCT02076009|469768455|FG000|Overall Study|Death|172|||
130490950|NCT02076009|469768456|FG001|Overall Study|Death|153|||
130490951|NCT02076009|469768455|FG000|Overall Study|Withdrawal by Subject|16|||
130490952|NCT02076009|469768456|FG001|Overall Study|Withdrawal by Subject|12|||
130490953|NCT02076009|469768455|FG000|Overall Study|Lost to Follow-up|4|||
130490954|NCT02076009|469768456|FG001|Overall Study|Lost to Follow-up|2|||
130490955|NCT02076009|469768455|FG000|Overall Study|Progressive Disease|1|||
130490956|NCT02076009|469768456|FG001|Overall Study|Progressive Disease|0|||
130490957|NCT02076009|469768455|FG000|Overall Study|Physician Decision|0|||
130490958|NCT02076009|469768456|FG001|Overall Study|Physician Decision|1|||
130490959|NCT02076009|469768455|FG000|Overall Study|End of data collection|90|||
130490960|NCT02076009|469768456|FG001|Overall Study|End of data collection|118|||
130490961|NCT04165213|469768457|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
130490962|NCT04165213|469768458|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
130490963|NCT04165213|469768457|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
130490964|NCT04165213|469768458|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
130490965|NCT04165213|469768457|FG000|Clinician Enrollment|Termination from site|0|||
130490966|NCT04165213|469768458|FG001|Clinician Enrollment|Termination from site|1|||
130490967|NCT04165213|469768457|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
130490968|NCT04165213|469768458|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
130490969|NCT04165213|469768457|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
130490970|NCT04165213|469768458|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
130490971|NCT04165213|469768457|FG000|Caregiver Enrollment|Physician Decision|1|||
130490972|NCT04165213|469768458|FG001|Caregiver Enrollment|Physician Decision|0|||
130490973|NCT04165213|469768457|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
130490974|NCT04165213|469768458|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
130490975|NCT04165213|469768457|FG000|Caregiver Enrollment|PLWD death|2|||
130490976|NCT04165213|469768458|FG001|Caregiver Enrollment|PLWD death|0|||
130490977|NCT04165213|469768457|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
130490978|NCT04165213|469768458|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
130490979|NCT04165213|469768457|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
130490980|NCT04165213|469768458|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
130490981|NCT04165213|469768457|FG000|PLWD Enrollment|Lost to Follow-up|1|||
130490982|NCT04165213|469768458|FG001|PLWD Enrollment|Lost to Follow-up|1|||
130490983|NCT04165213|469768457|FG000|PLWD Enrollment|Physician Decision|1|||
130490984|NCT04165213|469768458|FG001|PLWD Enrollment|Physician Decision|0|||
130490985|NCT04165213|469768457|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
130490986|NCT04165213|469768458|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
130490987|NCT04165213|469768457|FG000|PLWD Enrollment|Death|2|||
130490988|NCT04165213|469768458|FG001|PLWD Enrollment|Death|0|||
130490989|NCT04165213|469768457|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
130490990|NCT04165213|469768458|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
130490991|NCT04933474|469768459|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
130490992|NCT04933474|469768460|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
130490993|NCT04933474|469768459|FG000|Overall Study|Lost to Follow-up|19|||
130490994|NCT04933474|469768460|FG001|Overall Study|Lost to Follow-up|9|||
130490995|NCT04933474|469768459|FG000|Overall Study|Life Burden - unable to participate|6|||
130490996|NCT04933474|469768460|FG001|Overall Study|Life Burden - unable to participate|2|||
130490997|NCT04933474|469768459|FG000|Overall Study|Disease Burden - unable to participate|4|||
130490998|NCT04933474|469768460|FG001|Overall Study|Disease Burden - unable to participate|1|||
130490999|NCT04933474|469768459|FG000|Overall Study|Surgery/Hospitalization|1|||
130491000|NCT04933474|469768460|FG001|Overall Study|Surgery/Hospitalization|2|||
130491001|NCT04933474|469768459|FG000|Overall Study|Dissatisfied with Intervention|1|||
130491002|NCT04933474|469768460|FG001|Overall Study|Dissatisfied with Intervention|1|||
130491003|NCT04933474|469768459|FG000|Overall Study|Withdrew interest in participation|1|||
130491004|NCT04933474|469768460|FG001|Overall Study|Withdrew interest in participation|0|||
130491005|NCT04933474|469768459|FG000|Overall Study|Had previously enrolled in the study|0|||
130491006|NCT04933474|469768460|FG001|Overall Study|Had previously enrolled in the study|1|||
130491007|NCT05988398|469768469|FG000|Overall Study|Lack of time|21|||
130491008|NCT05988398|469768470|FG001|Overall Study|Lack of time|0|||
130491009|NCT05988398|469768469|FG000|Overall Study|Absent from school|0|||
130491010|NCT05988398|469768470|FG001|Overall Study|Absent from school|38|||
130491011|NCT05988398|469768469|FG000|Overall Study|Chose not to participate|0|||
130491012|NCT05988398|469768470|FG001|Overall Study|Chose not to participate|42|||
130491013|NCT05988398|469768469|FG000|Overall Study|Other commitments (e.g., sports)|0|||
130491014|NCT05988398|469768470|FG001|Overall Study|Other commitments (e.g., sports)|25|||
130491015|NCT03816397|469768475|FG000|Overall Study|Censored at interim analysis date.|13|||
130491016|NCT03816397|469768476|FG001|Overall Study|Censored at interim analysis date.|6|||
130491017|NCT03816397|469768475|FG000|Overall Study|Withdrawal by Subject|1|||
130491018|NCT03816397|469768476|FG001|Overall Study|Withdrawal by Subject|1|||
130491019|NCT05485935|469768477|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
130491020|NCT05485935|469768478|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
130491021|NCT05485935|469768477|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
130491022|NCT05485935|469768478|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
130491023|NCT05485935|469768477|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
130491024|NCT05485935|469768478|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
130491025|NCT05485935|469768477|FG000|Period 2 (T2 and V3)|loss of contact|0|||
130491026|NCT05485935|469768478|FG001|Period 2 (T2 and V3)|loss of contact|1|||
130491027|NCT05129501|469768482|FG000|Overall Study|Lost to Follow-up|54|||
130491028|NCT05129501|469768483|FG001|Overall Study|Lost to Follow-up|41|||
130491029|NCT01220531|469768486|FG000|Overall Study|Death|7|||
130491030|NCT01220531|469768486|FG000|Overall Study|Lost to Follow-up|1|||
130491031|NCT02325154|469768487|FG000|Overall Study|Physician Decision|1|||
130491032|NCT00709956|469768488|FG000|Overall Study|Withdrawal by Subject|1|||
130491033|NCT00709956|469768489|FG001|Overall Study|Withdrawal by Subject|1|||
130491034|NCT00709956|469768488|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
130491035|NCT00709956|469768489|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
130491036|NCT03782116|469768490|FG000|Completed Intervetion|Lost to Follow-up|11|||
130491037|NCT03782116|469768491|FG001|Completed Intervetion|Lost to Follow-up|7|||
130491038|NCT03782116|469768490|FG000|Completed Intervetion|Withdrawal by Subject|6|||
130491039|NCT03782116|469768491|FG001|Completed Intervetion|Withdrawal by Subject|5|||
130491040|NCT03782116|469768490|FG000|Included in Analysis|Protocol Violation|5|||
130491041|NCT03782116|469768491|FG001|Included in Analysis|Protocol Violation|5|||
130491042|NCT02611687|469769144|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
130491043|NCT02611687|469769145|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
130491044|NCT00447980|469769149|FG000|Overall Study|Withdrawal by Subject|1|||
130491045|NCT00447980|469769150|FG001|Overall Study|Withdrawal by Subject|1|||
130491046|NCT00447980|469769151|FG002|Overall Study|Withdrawal by Subject|4|||
130491047|NCT00447980|469769152|FG003|Overall Study|Withdrawal by Subject|4|||
130491048|NCT00447980|469769149|FG000|Overall Study|Lost to Follow-up|1|||
130491049|NCT00447980|469769150|FG001|Overall Study|Lost to Follow-up|1|||
130491050|NCT00447980|469769151|FG002|Overall Study|Lost to Follow-up|0|||
130491051|NCT00447980|469769152|FG003|Overall Study|Lost to Follow-up|0|||
130491052|NCT00447980|469769149|FG000|Overall Study|Did not proceed with surgery|3|||
130491053|NCT00447980|469769150|FG001|Overall Study|Did not proceed with surgery|3|||
130491054|NCT00447980|469769151|FG002|Overall Study|Did not proceed with surgery|2|||
130491055|NCT00447980|469769152|FG003|Overall Study|Did not proceed with surgery|2|||
130491056|NCT05157841|469769153|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
130491057|NCT05157841|469769154|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
130491058|NCT05157841|469769155|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
130491059|NCT05157841|469769153|FG000|Part A (14 Days)|Adverse Event|1|||
130491060|NCT05157841|469769154|FG001|Part A (14 Days)|Adverse Event|0|||
130491061|NCT05157841|469769155|FG002|Part A (14 Days)|Adverse Event|0|||
130491062|NCT05157841|469769153|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
130565415|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
130565416|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
130565417|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
130565418|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
130491063|NCT05157841|469769154|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
130491064|NCT05157841|469769155|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
130565419|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130491065|NCT03242915|469769162|FG000|Overall Study|Adverse Event|5|||
130491066|NCT03242915|469769163|FG001|Overall Study|Adverse Event|1|||
130491067|NCT03242915|469769162|FG000|Overall Study|Withdrawal by Subject|0|||
130491068|NCT03242915|469769163|FG001|Overall Study|Withdrawal by Subject|2|||
130491069|NCT03242915|469769162|FG000|Overall Study|Physician Decision|4|||
130491070|NCT03242915|469769163|FG001|Overall Study|Physician Decision|1|||
130491071|NCT04908930|469769172|FG000|Overall Study|Lost to Follow-up|1|||
130491072|NCT04908930|469769173|FG001|Overall Study|Lost to Follow-up|1|||
130491073|NCT04908930|469769174|FG002|Overall Study|Lost to Follow-up|0|||
130491074|NCT04908930|469769175|FG003|Overall Study|Lost to Follow-up|0|||
130491075|NCT04908930|469769176|FG004|Overall Study|Lost to Follow-up|0|||
130491076|NCT04908930|469769172|FG000|Overall Study|hardware in mouth|1|||
130491077|NCT04908930|469769173|FG001|Overall Study|hardware in mouth|1|||
130491078|NCT04908930|469769174|FG002|Overall Study|hardware in mouth|0|||
130491079|NCT04908930|469769175|FG003|Overall Study|hardware in mouth|0|||
130491080|NCT04908930|469769176|FG004|Overall Study|hardware in mouth|0|||
130491081|NCT04908930|469769172|FG000|Overall Study|wrong team|1|||
130491082|NCT04908930|469769173|FG001|Overall Study|wrong team|0|||
130491083|NCT04908930|469769174|FG002|Overall Study|wrong team|0|||
130491084|NCT04908930|469769175|FG003|Overall Study|wrong team|0|||
130491085|NCT04908930|469769176|FG004|Overall Study|wrong team|0|||
130491086|NCT04908930|469769172|FG000|Overall Study|quit team|2|||
130491087|NCT04908930|469769173|FG001|Overall Study|quit team|4|||
130491088|NCT04908930|469769174|FG002|Overall Study|quit team|0|||
130491089|NCT04908930|469769175|FG003|Overall Study|quit team|0|||
130728763|NCT02784795|470628650|FG009|Overall Study|Physician Decision|0|||
130491090|NCT04908930|469769176|FG004|Overall Study|quit team|0|||
130491091|NCT04908930|469769172|FG000|Overall Study|Withdrawal by Subject|1|||
130491092|NCT04908930|469769173|FG001|Overall Study|Withdrawal by Subject|2|||
130491093|NCT04908930|469769174|FG002|Overall Study|Withdrawal by Subject|0|||
130491094|NCT04908930|469769175|FG003|Overall Study|Withdrawal by Subject|0|||
130491095|NCT04908930|469769176|FG004|Overall Study|Withdrawal by Subject|0|||
130491096|NCT04908930|469769172|FG000|Overall Study|parent not liking program|0|||
130491097|NCT04908930|469769173|FG001|Overall Study|parent not liking program|1|||
130491098|NCT04908930|469769174|FG002|Overall Study|parent not liking program|0|||
130491099|NCT04908930|469769175|FG003|Overall Study|parent not liking program|0|||
130491100|NCT04908930|469769176|FG004|Overall Study|parent not liking program|0|||
130491101|NCT05718687|469769184|FG000|Overall Study|Withdrawal by Subject|3|||
130491102|NCT01499368|469769185|FG000|Overall Study|Did not meet I/E criteria|8|||
130491103|NCT01499368|469769186|FG001|Overall Study|Did not meet I/E criteria|4|||
130491104|NCT01499368|469769187|FG002|Overall Study|Did not meet I/E criteria|4|||
130491105|NCT01499368|469769185|FG000|Overall Study|Prohibited Concomitant medication|1|||
130491106|NCT01499368|469769186|FG001|Overall Study|Prohibited Concomitant medication|1|||
130491107|NCT01499368|469769187|FG002|Overall Study|Prohibited Concomitant medication|0|||
130491108|NCT01499368|469769185|FG000|Overall Study|Withdrawal by Subject|11|||
130491109|NCT01499368|469769186|FG001|Overall Study|Withdrawal by Subject|10|||
130491110|NCT01499368|469769187|FG002|Overall Study|Withdrawal by Subject|8|||
130491111|NCT01499368|469769185|FG000|Overall Study|Lost to Follow-up|3|||
130491112|NCT01499368|469769186|FG001|Overall Study|Lost to Follow-up|2|||
130491113|NCT01499368|469769187|FG002|Overall Study|Lost to Follow-up|5|||
130491114|NCT01499368|469769185|FG000|Overall Study|Adverse Event|4|||
130491115|NCT01499368|469769186|FG001|Overall Study|Adverse Event|0|||
130491116|NCT01499368|469769187|FG002|Overall Study|Adverse Event|2|||
130491117|NCT01499368|469769185|FG000|Overall Study|Physician Decision|0|||
130491118|NCT01499368|469769186|FG001|Overall Study|Physician Decision|1|||
130491119|NCT01499368|469769187|FG002|Overall Study|Physician Decision|0|||
130491120|NCT01499368|469769185|FG000|Overall Study|Deviation from visit window|0|||
130491121|NCT01499368|469769186|FG001|Overall Study|Deviation from visit window|0|||
130491122|NCT01499368|469769187|FG002|Overall Study|Deviation from visit window|1|||
130491123|NCT01499368|469769185|FG000|Overall Study|Error of Prescriptions|0|||
130491124|NCT01499368|469769186|FG001|Overall Study|Error of Prescriptions|0|||
130491125|NCT01499368|469769187|FG002|Overall Study|Error of Prescriptions|1|||
130491126|NCT03092674|469769188|FG000|Overall Study|Adverse Event or Side Effects|1|||
130491127|NCT03092674|469769189|FG001|Overall Study|Adverse Event or Side Effects|4|||
130491128|NCT03092674|469769190|FG002|Overall Study|Adverse Event or Side Effects|4|||
130491129|NCT03092674|469769188|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
130491130|NCT03092674|469769189|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
130728764|NCT02784795|470628651|FG010|Overall Study|Physician Decision|0|||
130491131|NCT03092674|469769190|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
130491132|NCT03092674|469769188|FG000|Overall Study|Progression/Relapse|5|||
130491133|NCT03092674|469769189|FG001|Overall Study|Progression/Relapse|4|||
130491134|NCT03092674|469769190|FG002|Overall Study|Progression/Relapse|8|||
130728765|NCT02784795|470628652|FG011|Overall Study|Physician Decision|0|||
130728766|NCT00626561|470628653|FG000|Overall Study|Withdrawal by Subject|2|||
130491135|NCT03092674|469769188|FG000|Overall Study|Death|4|||
130491136|NCT03092674|469769189|FG001|Overall Study|Death|8|||
130491137|NCT03092674|469769190|FG002|Overall Study|Death|2|||
130728767|NCT00626561|470628653|FG000|Overall Study|Disease Progression|2|||
130491138|NCT03092674|469769188|FG000|Overall Study|Other - Not Protocol Specified|11|||
130491139|NCT03092674|469769189|FG001|Overall Study|Other - Not Protocol Specified|8|||
130491140|NCT03092674|469769190|FG002|Overall Study|Other - Not Protocol Specified|8|||
130491141|NCT05771467|469769192|FG000|Overall Study|Lost to Follow-up|6|||
130491142|NCT05771467|469769193|FG001|Overall Study|Lost to Follow-up|3|||
130491143|NCT03008382|469769196|FG000|Overall Study|Withdrawal by Subject|2|||
130491144|NCT03008382|469769197|FG001|Overall Study|Withdrawal by Subject|5|||
130491145|NCT03008382|469769198|FG002|Overall Study|Withdrawal by Subject|2|||
130491146|NCT03008382|469769199|FG003|Overall Study|Withdrawal by Subject|0|||
130491147|NCT03008382|469769196|FG000|Overall Study|Protocol Violation|1|||
130491148|NCT03008382|469769197|FG001|Overall Study|Protocol Violation|0|||
130491149|NCT03008382|469769198|FG002|Overall Study|Protocol Violation|0|||
130491150|NCT03008382|469769199|FG003|Overall Study|Protocol Violation|0|||
130491151|NCT03008382|469769196|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
130491152|NCT03008382|469769197|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
130491153|NCT03008382|469769198|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
130491154|NCT03008382|469769199|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
130491155|NCT03008382|469769196|FG000|Overall Study|Lost to Follow-up|0|||
130491156|NCT03008382|469769197|FG001|Overall Study|Lost to Follow-up|0|||
130491157|NCT03008382|469769198|FG002|Overall Study|Lost to Follow-up|1|||
130491158|NCT03008382|469769199|FG003|Overall Study|Lost to Follow-up|0|||
130491159|NCT03008382|469769196|FG000|Overall Study|Screenfail|0|||
130491160|NCT03008382|469769197|FG001|Overall Study|Screenfail|0|||
130491161|NCT03008382|469769198|FG002|Overall Study|Screenfail|2|||
130491162|NCT03008382|469769199|FG003|Overall Study|Screenfail|0|||
130491163|NCT03215706|469769200|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130491164|NCT03215706|469769201|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130491165|NCT03215706|469769200|FG000|Randomization|participant withdrew consent|1|||
130491166|NCT03215706|469769201|FG001|Randomization|participant withdrew consent|3|||
130491167|NCT03215706|469769200|FG000|Randomization|no longer meets study criteria|1|||
130491168|NCT03215706|469769201|FG001|Randomization|no longer meets study criteria|4|||
130491169|NCT03215706|469769200|FG000|Randomization|other reasons|0|||
130491170|NCT03215706|469769201|FG001|Randomization|other reasons|2|||
130491171|NCT03215706|469769200|FG000|Treatment Period|Disease Progression|150|||
130491172|NCT03215706|469769201|FG001|Treatment Period|Disease Progression|142|||
130491173|NCT03215706|469769200|FG000|Treatment Period|Study Drug Toxicity|53|||
130491174|NCT03215706|469769201|FG001|Treatment Period|Study Drug Toxicity|21|||
130491175|NCT03215706|469769200|FG000|Treatment Period|Death|2|||
130491176|NCT03215706|469769201|FG001|Treatment Period|Death|1|||
130491177|NCT03215706|469769200|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
130491178|NCT03215706|469769201|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
130491179|NCT03215706|469769200|FG000|Treatment Period|Request to D/C treatment|1|||
130491180|NCT03215706|469769201|FG001|Treatment Period|Request to D/C treatment|6|||
130491181|NCT03215706|469769200|FG000|Treatment Period|Participant withdrew consent|3|||
130728768|NCT00595309|470628654|FG000|Overall Study|Lost to Follow-up|1|||
130491182|NCT03215706|469769201|FG001|Treatment Period|Participant withdrew consent|4|||
130491183|NCT03215706|469769200|FG000|Treatment Period|Lost to Follow-up|0|||
130491184|NCT03215706|469769201|FG001|Treatment Period|Lost to Follow-up|1|||
130491185|NCT03215706|469769200|FG000|Treatment Period|Other Reasons|4|||
130491186|NCT03215706|469769201|FG001|Treatment Period|Other Reasons|5|||
130491187|NCT03215706|469769200|FG000|Treatment Period|Ongoing in the treatment period|105|||
130491188|NCT03215706|469769201|FG001|Treatment Period|Ongoing in the treatment period|43|||
130491189|NCT00945724|469769202|FG000|Overall Study|Withdrawal by Subject|2|||
130491190|NCT00945724|469769202|FG000|Overall Study|Physician Decision|1|||
130491191|NCT00945724|469769202|FG000|Overall Study|Adverse Event|5|||
130491192|NCT00945724|469769202|FG000|Overall Study|Second malignancy|1|||
130491193|NCT03512301|469769885|FG000|Overall Study|Protocol Violation|2|||
130491194|NCT03512301|469769885|FG000|Overall Study|Did Not Qualify|3|||
130491195|NCT03512301|469769885|FG000|Overall Study|Age-ineligible|1|||
130491196|NCT03512301|469769885|FG000|Overall Study|Inadequate fluency with the English language|3|||
130491197|NCT03983382|469769886|FG000|Overall Study|Death|1|||
130491198|NCT03983382|469769886|FG000|Overall Study|Lost to Follow-up|3|||
130491199|NCT03983382|469769886|FG000|Overall Study|Physician Decision|2|||
130491200|NCT03983382|469769886|FG000|Overall Study|Withdrawal by Subject|10|||
130491201|NCT03983382|469769886|FG000|Overall Study|Change in cancer treatment|2|||
130491202|NCT04174170|469769887|FG000|Placebo Run-in Period|Not Randomized|38|||
130491203|NCT04174170|469769888|FG001|Placebo Run-in Period|Not Randomized|0|||
130728769|NCT00595309|470628654|FG000|Overall Study|planned vaccination against yellow fever|1|||
130728770|NCT00595309|470628654|FG000|Overall Study|acute infection after V0|1|||
130491204|NCT04174170|469769889|FG002|Placebo Run-in Period|Not Randomized|0|||
130491205|NCT04174170|469769890|FG003|Placebo Run-in Period|Not Randomized|0|||
130491206|NCT04174170|469769887|FG000|Double Blind Treatment Period|Adverse Event|0|||
130491207|NCT04174170|469769888|FG001|Double Blind Treatment Period|Adverse Event|9|||
130491208|NCT04174170|469769889|FG002|Double Blind Treatment Period|Adverse Event|9|||
130491209|NCT04174170|469769890|FG003|Double Blind Treatment Period|Adverse Event|8|||
130491210|NCT04174170|469769887|FG000|Double Blind Treatment Period|Death|0|||
130491211|NCT04174170|469769888|FG001|Double Blind Treatment Period|Death|1|||
130491212|NCT04174170|469769889|FG002|Double Blind Treatment Period|Death|0|||
130491213|NCT04174170|469769890|FG003|Double Blind Treatment Period|Death|0|||
130491214|NCT04174170|469769887|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130491215|NCT04174170|469769888|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
130491216|NCT04174170|469769889|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
130491217|NCT04174170|469769890|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
130491218|NCT04174170|469769887|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
130491219|NCT04174170|469769888|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
130491220|NCT04174170|469769889|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
130491221|NCT04174170|469769890|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
130491222|NCT04174170|469769887|FG000|Double Blind Treatment Period|Physician Decision|0|||
130491223|NCT04174170|469769888|FG001|Double Blind Treatment Period|Physician Decision|1|||
130491224|NCT04174170|469769889|FG002|Double Blind Treatment Period|Physician Decision|0|||
130491225|NCT04174170|469769890|FG003|Double Blind Treatment Period|Physician Decision|1|||
130491226|NCT04174170|469769887|FG000|Double Blind Treatment Period|Pregnancy|0|||
130491227|NCT04174170|469769888|FG001|Double Blind Treatment Period|Pregnancy|1|||
130491228|NCT04174170|469769889|FG002|Double Blind Treatment Period|Pregnancy|0|||
130491229|NCT04174170|469769890|FG003|Double Blind Treatment Period|Pregnancy|1|||
130491230|NCT04174170|469769887|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
130491231|NCT04174170|469769888|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
130491232|NCT04174170|469769889|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
130491233|NCT04174170|469769890|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
130491234|NCT04174170|469769887|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130491235|NCT04174170|469769888|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
130491236|NCT04174170|469769889|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
130491237|NCT04174170|469769890|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
130491238|NCT04174170|469769887|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
130491239|NCT04174170|469769888|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
130491240|NCT04174170|469769889|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
130491241|NCT04174170|469769890|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
130491242|NCT04772534|469769898|FG000|Overall Study|Physician Decision|1|||
130491243|NCT04772534|469769899|FG001|Overall Study|Physician Decision|0|||
130491244|NCT04772534|469769900|FG002|Overall Study|Physician Decision|0|||
130491245|NCT04772534|469769898|FG000|Overall Study|Withdrawal by Subject|3|||
130491246|NCT04772534|469769899|FG001|Overall Study|Withdrawal by Subject|0|||
130491247|NCT04772534|469769900|FG002|Overall Study|Withdrawal by Subject|1|||
130491248|NCT04194450|469769901|FG000|Overall Study|not eligible|1|||
130491249|NCT04194450|469769902|FG001|Overall Study|not eligible|0|||
130491250|NCT03786926|469769912|FG000|Overall Study|Adverse Event|0|||
130491251|NCT03786926|469769913|FG001|Overall Study|Adverse Event|0|||
130491252|NCT03786926|469769914|FG002|Overall Study|Adverse Event|0|||
130491253|NCT03786926|469769915|FG003|Overall Study|Adverse Event|0|||
130491254|NCT03786926|469769916|FG004|Overall Study|Adverse Event|0|||
130491255|NCT03786926|469769917|FG005|Overall Study|Adverse Event|0|||
130491256|NCT03786926|469769918|FG006|Overall Study|Adverse Event|0|||
130491257|NCT03786926|469769919|FG007|Overall Study|Adverse Event|1|||
130491258|NCT03786926|469769920|FG008|Overall Study|Adverse Event|1|||
130491259|NCT03786926|469769921|FG009|Overall Study|Adverse Event|0|||
130491260|NCT03786926|469769922|FG010|Overall Study|Adverse Event|1|||
130491261|NCT03786926|469769912|FG000|Overall Study|Progressive disease|3|||
130491262|NCT03786926|469769913|FG001|Overall Study|Progressive disease|0|||
130491263|NCT03786926|469769914|FG002|Overall Study|Progressive disease|3|||
130491264|NCT03786926|469769915|FG003|Overall Study|Progressive disease|1|||
130491265|NCT03786926|469769916|FG004|Overall Study|Progressive disease|2|||
130491266|NCT03786926|469769917|FG005|Overall Study|Progressive disease|2|||
130491267|NCT03786926|469769918|FG006|Overall Study|Progressive disease|1|||
130491268|NCT03786926|469769919|FG007|Overall Study|Progressive disease|6|||
130491269|NCT03786926|469769920|FG008|Overall Study|Progressive disease|1|||
130491270|NCT03786926|469769921|FG009|Overall Study|Progressive disease|1|||
130491271|NCT03786926|469769922|FG010|Overall Study|Progressive disease|1|||
130491272|NCT03786926|469769912|FG000|Overall Study|Death|0|||
130491273|NCT03786926|469769913|FG001|Overall Study|Death|1|||
130491274|NCT03786926|469769914|FG002|Overall Study|Death|1|||
130491275|NCT03786926|469769915|FG003|Overall Study|Death|0|||
130491276|NCT03786926|469769916|FG004|Overall Study|Death|0|||
130491277|NCT03786926|469769917|FG005|Overall Study|Death|0|||
130491278|NCT03786926|469769918|FG006|Overall Study|Death|0|||
130491279|NCT03786926|469769919|FG007|Overall Study|Death|0|||
130491280|NCT03786926|469769920|FG008|Overall Study|Death|0|||
130491281|NCT03786926|469769921|FG009|Overall Study|Death|1|||
130491282|NCT03786926|469769922|FG010|Overall Study|Death|2|||
130491283|NCT03786926|469769912|FG000|Overall Study|Physician Decision|0|||
130491284|NCT03786926|469769913|FG001|Overall Study|Physician Decision|1|||
130491285|NCT03786926|469769914|FG002|Overall Study|Physician Decision|0|||
130491286|NCT03786926|469769915|FG003|Overall Study|Physician Decision|1|||
130491287|NCT03786926|469769916|FG004|Overall Study|Physician Decision|2|||
130491288|NCT03786926|469769917|FG005|Overall Study|Physician Decision|0|||
130491289|NCT03786926|469769918|FG006|Overall Study|Physician Decision|0|||
130491290|NCT03786926|469769919|FG007|Overall Study|Physician Decision|2|||
130491291|NCT03786926|469769920|FG008|Overall Study|Physician Decision|1|||
130491292|NCT03786926|469769921|FG009|Overall Study|Physician Decision|1|||
130491293|NCT03786926|469769922|FG010|Overall Study|Physician Decision|0|||
130491294|NCT03786926|469769912|FG000|Overall Study|Withdrawal by Subject|0|||
130491295|NCT03786926|469769913|FG001|Overall Study|Withdrawal by Subject|1|||
130491296|NCT03786926|469769914|FG002|Overall Study|Withdrawal by Subject|1|||
130491297|NCT03786926|469769915|FG003|Overall Study|Withdrawal by Subject|0|||
130491298|NCT03786926|469769916|FG004|Overall Study|Withdrawal by Subject|0|||
130491299|NCT03786926|469769917|FG005|Overall Study|Withdrawal by Subject|0|||
130491300|NCT03786926|469769918|FG006|Overall Study|Withdrawal by Subject|1|||
130491301|NCT03786926|469769919|FG007|Overall Study|Withdrawal by Subject|0|||
130491302|NCT03786926|469769920|FG008|Overall Study|Withdrawal by Subject|1|||
130491303|NCT03786926|469769921|FG009|Overall Study|Withdrawal by Subject|0|||
130491304|NCT03786926|469769922|FG010|Overall Study|Withdrawal by Subject|1|||
130491305|NCT03786926|469769912|FG000|Overall Study|Study terminated by Sponsor|0|||
130491306|NCT03786926|469769913|FG001|Overall Study|Study terminated by Sponsor|0|||
130491307|NCT03786926|469769914|FG002|Overall Study|Study terminated by Sponsor|0|||
130491308|NCT03786926|469769915|FG003|Overall Study|Study terminated by Sponsor|0|||
130491309|NCT03786926|469769916|FG004|Overall Study|Study terminated by Sponsor|1|||
130491310|NCT03786926|469769917|FG005|Overall Study|Study terminated by Sponsor|0|||
130491311|NCT03786926|469769918|FG006|Overall Study|Study terminated by Sponsor|0|||
130491312|NCT03786926|469769919|FG007|Overall Study|Study terminated by Sponsor|4|||
130491313|NCT03786926|469769920|FG008|Overall Study|Study terminated by Sponsor|0|||
130491314|NCT03786926|469769921|FG009|Overall Study|Study terminated by Sponsor|0|||
130491315|NCT03786926|469769922|FG010|Overall Study|Study terminated by Sponsor|0|||
130491316|NCT03786926|469769912|FG000|Overall Study|Anti-neoplasm treatment|0|||
130491317|NCT03786926|469769913|FG001|Overall Study|Anti-neoplasm treatment|0|||
130491318|NCT03786926|469769914|FG002|Overall Study|Anti-neoplasm treatment|0|||
130491319|NCT03786926|469769915|FG003|Overall Study|Anti-neoplasm treatment|0|||
130491320|NCT03786926|469769916|FG004|Overall Study|Anti-neoplasm treatment|1|||
130491321|NCT03786926|469769917|FG005|Overall Study|Anti-neoplasm treatment|0|||
130491322|NCT03786926|469769918|FG006|Overall Study|Anti-neoplasm treatment|1|||
130491323|NCT03786926|469769919|FG007|Overall Study|Anti-neoplasm treatment|0|||
130491324|NCT03786926|469769920|FG008|Overall Study|Anti-neoplasm treatment|0|||
130491325|NCT03786926|469769921|FG009|Overall Study|Anti-neoplasm treatment|0|||
130491326|NCT03786926|469769922|FG010|Overall Study|Anti-neoplasm treatment|0|||
130491327|NCT03786926|469769912|FG000|Overall Study|Other|0|||
130491328|NCT03786926|469769913|FG001|Overall Study|Other|0|||
130491329|NCT03786926|469769914|FG002|Overall Study|Other|0|||
130491330|NCT03786926|469769915|FG003|Overall Study|Other|1|||
130491331|NCT03786926|469769916|FG004|Overall Study|Other|0|||
130491332|NCT03786926|469769917|FG005|Overall Study|Other|1|||
130491333|NCT03786926|469769918|FG006|Overall Study|Other|0|||
130491334|NCT03786926|469769919|FG007|Overall Study|Other|0|||
130491335|NCT03786926|469769920|FG008|Overall Study|Other|2|||
130491336|NCT03786926|469769921|FG009|Overall Study|Other|0|||
130491337|NCT03786926|469769922|FG010|Overall Study|Other|0|||
130491338|NCT05875701|469769928|FG000|Overall Study|Lost to Follow-up|2|||
130491339|NCT05875701|469769929|FG001|Overall Study|Lost to Follow-up|0|||
130491340|NCT05875701|469769928|FG000|Overall Study|Withdrawal by Subject|1|||
130491341|NCT05875701|469769929|FG001|Overall Study|Withdrawal by Subject|1|||
130491342|NCT04408755|469769930|FG000|Period A (Placebo lead-in)|Other|11|||
130491343|NCT04408755|469769931|FG001|Period A (Placebo lead-in)|Other|0|||
130491344|NCT04408755|469769932|FG002|Period A (Placebo lead-in)|Other|0|||
130491345|NCT04408755|469769933|FG003|Period A (Placebo lead-in)|Other|0|||
130491346|NCT04408755|469769930|FG000|Period B (Randomization Period)|Adverse Event|0|||
130491347|NCT04408755|469769931|FG001|Period B (Randomization Period)|Adverse Event|3|||
130491348|NCT04408755|469769932|FG002|Period B (Randomization Period)|Adverse Event|0|||
130491349|NCT04408755|469769933|FG003|Period B (Randomization Period)|Adverse Event|1|||
130491350|NCT04408755|469769930|FG000|Period B (Randomization Period)|Death|0|||
130491351|NCT04408755|469769931|FG001|Period B (Randomization Period)|Death|0|||
130491352|NCT04408755|469769932|FG002|Period B (Randomization Period)|Death|1|||
130491353|NCT04408755|469769933|FG003|Period B (Randomization Period)|Death|0|||
130491354|NCT04408755|469769930|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
130491355|NCT04408755|469769931|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
130491356|NCT04408755|469769932|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
130491357|NCT04408755|469769933|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
130491358|NCT04408755|469769930|FG000|Period B (Randomization Period)|Physician Decision|0|||
130491359|NCT04408755|469769931|FG001|Period B (Randomization Period)|Physician Decision|0|||
130491360|NCT04408755|469769932|FG002|Period B (Randomization Period)|Physician Decision|1|||
130491361|NCT04408755|469769933|FG003|Period B (Randomization Period)|Physician Decision|0|||
130491362|NCT04408755|469769930|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
130491363|NCT04408755|469769931|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
130491364|NCT04408755|469769932|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
130491365|NCT04408755|469769933|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
130491366|NCT04408755|469769930|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
130491367|NCT04408755|469769931|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
130491368|NCT04408755|469769932|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
130491369|NCT04408755|469769933|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
130491370|NCT04408755|469769930|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
130491371|NCT04408755|469769931|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
130491372|NCT04408755|469769932|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
130491373|NCT04408755|469769933|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
130491374|NCT04408755|469769930|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
130491375|NCT04408755|469769931|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
130491376|NCT04408755|469769932|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
130491377|NCT04408755|469769933|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
130491378|NCT04408755|469769930|FG000|Period B (Randomization Period)|Reason not Specified|0|||
130491379|NCT04408755|469769931|FG001|Period B (Randomization Period)|Reason not Specified|1|||
130491380|NCT04408755|469769932|FG002|Period B (Randomization Period)|Reason not Specified|0|||
130491381|NCT04408755|469769933|FG003|Period B (Randomization Period)|Reason not Specified|2|||
130491382|NCT00308997|469769934|FG000|Overall Study|Subject feigned clinical data|0|||
130491383|NCT00308997|469769935|FG001|Overall Study|Subject feigned clinical data|1|||
130491384|NCT00308997|469769934|FG000|Overall Study|Unable to tolerate intervention|1|||
130491385|NCT00308997|469769935|FG001|Overall Study|Unable to tolerate intervention|0|||
130491386|NCT04490356|469769936|FG000|Overall Study|Lost to Follow-up|1|||
130491387|NCT06059443|469769937|FG000|Overall Study|Withdrawal by Subject|2|||
130491388|NCT06059443|469769938|FG001|Overall Study|Withdrawal by Subject|0|||
130491389|NCT06059443|469769937|FG000|Overall Study|Lost to Follow-up|2|||
130491390|NCT06059443|469769938|FG001|Overall Study|Lost to Follow-up|2|||
130491391|NCT01553149|469769939|FG000|Overall Study|Adverse Event|0|||
130491392|NCT01553149|469769940|FG001|Overall Study|Adverse Event|9|||
130491393|NCT01553149|469769939|FG000|Overall Study|Physician Decision|5|||
130491394|NCT01553149|469769940|FG001|Overall Study|Physician Decision|10|||
130491395|NCT01553149|469769939|FG000|Overall Study|Ineligible|0|||
130491396|NCT01553149|469769940|FG001|Overall Study|Ineligible|1|||
130491397|NCT01105091|469769943|FG000|Overall Study|Death|2|||
130491398|NCT01105091|469769944|FG001|Overall Study|Death|0|||
130491399|NCT03934931|469770478|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
130491400|NCT03934931|469770479|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
130491401|NCT03934931|469770480|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
130491402|NCT03733626|469770482|FG000|Overall Study|Physician Decision|4|||
130491403|NCT03733626|469770483|FG001|Overall Study|Physician Decision|4|||
130491404|NCT04586244|469770486|FG000|Overall Study|Lost to Follow-up|1|||
130491405|NCT04586244|469770487|FG001|Overall Study|Lost to Follow-up|0|||
130491406|NCT04586244|469770488|FG002|Overall Study|Lost to Follow-up|0|||
130491407|NCT04586244|469770489|FG003|Overall Study|Lost to Follow-up|1|||
130491408|NCT04586244|469770490|FG004|Overall Study|Lost to Follow-up|0|||
130491409|NCT04586244|469770486|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
130491410|NCT04586244|469770487|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
130491411|NCT04586244|469770488|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
130491412|NCT04586244|469770489|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
130491413|NCT04586244|469770490|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
130491414|NCT04174560|469770495|FG000|Overall Study|Lost to Follow-up|1|||
130491415|NCT04174560|469770496|FG001|Overall Study|Lost to Follow-up|0|||
130491416|NCT04174560|469770497|FG002|Overall Study|Lost to Follow-up|0|||
130491417|NCT04174560|469770498|FG003|Overall Study|Lost to Follow-up|0|||
130491418|NCT04174560|469770495|FG000|Overall Study|Withdrawal by Subject|0|||
130491419|NCT04174560|469770496|FG001|Overall Study|Withdrawal by Subject|0|||
130491420|NCT04174560|469770497|FG002|Overall Study|Withdrawal by Subject|2|||
130491421|NCT04174560|469770498|FG003|Overall Study|Withdrawal by Subject|0|||
130491422|NCT05424718|469770500|FG000|Overall Study|Lost to Follow-up|5|||
130491423|NCT05424718|469770501|FG001|Overall Study|Lost to Follow-up|4|||
130565420|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130565421|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
130565422|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130491424|NCT04046549|469770503|FG000|Overall Study|Adverse Event|1|||
130565423|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130491425|NCT04046549|469770503|FG000|Overall Study|Physician Decision|1|||
130491426|NCT04046549|469770503|FG000|Overall Study|Withdrawal by Subject|3|||
130491427|NCT04046549|469770503|FG000|Overall Study|Other, Not Specified|5|||
130491428|NCT03142009|469770504|FG000|Overall Study|Lost to Follow-up|45|||
130491429|NCT03142009|469770505|FG001|Overall Study|Lost to Follow-up|30|||
130491430|NCT03872466|469770506|FG000|Overall Study|Withdrawal by Subject|1|||
130491431|NCT03872466|469770507|FG001|Overall Study|Withdrawal by Subject|0|||
130491432|NCT03872466|469770506|FG000|Overall Study|Physician Decision|2|||
130491433|NCT03872466|469770507|FG001|Overall Study|Physician Decision|0|||
130491434|NCT01778686|469770508|FG000|Overall Study|Adverse Event|0|||
130491435|NCT01778686|469770509|FG001|Overall Study|Adverse Event|0|||
130491436|NCT01778686|469770510|FG002|Overall Study|Adverse Event|1|||
130491437|NCT02951052|469770511|FG000|Overall Study|Adverse Event|13|||
130491438|NCT02951052|469770512|FG001|Overall Study|Adverse Event|5|||
130491439|NCT02951052|469770511|FG000|Overall Study|Withdrawal by Subject|1|||
130491440|NCT02951052|469770512|FG001|Overall Study|Withdrawal by Subject|5|||
130491441|NCT02951052|469770511|FG000|Overall Study|Physician Decision|2|||
130491442|NCT02951052|469770512|FG001|Overall Study|Physician Decision|0|||
130491443|NCT02951052|469770511|FG000|Overall Study|Lost to Follow-up|1|||
130491444|NCT02951052|469770512|FG001|Overall Study|Lost to Follow-up|1|||
130491445|NCT02951052|469770511|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
130491446|NCT02951052|469770512|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
130491447|NCT02951052|469770511|FG000|Overall Study|Protocol Violation|5|||
130491448|NCT02951052|469770512|FG001|Overall Study|Protocol Violation|3|||
130491449|NCT02951052|469770511|FG000|Overall Study|Lack of Efficacy|3|||
130491450|NCT02951052|469770512|FG001|Overall Study|Lack of Efficacy|4|||
130491451|NCT02951052|469770511|FG000|Overall Study|Ongoing|1|||
130491452|NCT02951052|469770512|FG001|Overall Study|Ongoing|0|||
130491453|NCT00994643|469771088|FG000|Overall Study|Withdrawal by Subject|1|||
130491454|NCT05412004|469771092|FG000|Overall Study|Adverse Event|0|||
130491455|NCT05412004|469771093|FG001|Overall Study|Adverse Event|2|||
130491456|NCT05412004|469771094|FG002|Overall Study|Adverse Event|1|||
130491457|NCT05412004|469771095|FG003|Overall Study|Adverse Event|5|||
130491458|NCT05412004|469771092|FG000|Overall Study|Assigned Treatment by Mistake|5|||
130491459|NCT05412004|469771093|FG001|Overall Study|Assigned Treatment by Mistake|10|||
130491460|NCT05412004|469771094|FG002|Overall Study|Assigned Treatment by Mistake|2|||
130491461|NCT05412004|469771095|FG003|Overall Study|Assigned Treatment by Mistake|5|||
130491462|NCT05412004|469771092|FG000|Overall Study|Lost to Follow-up|3|||
130491463|NCT05412004|469771093|FG001|Overall Study|Lost to Follow-up|0|||
130491464|NCT05412004|469771094|FG002|Overall Study|Lost to Follow-up|0|||
130491465|NCT05412004|469771095|FG003|Overall Study|Lost to Follow-up|0|||
130491466|NCT05412004|469771092|FG000|Overall Study|Patient could not travel to site|0|||
130491467|NCT05412004|469771093|FG001|Overall Study|Patient could not travel to site|1|||
130491468|NCT05412004|469771094|FG002|Overall Study|Patient could not travel to site|0|||
130491469|NCT05412004|469771095|FG003|Overall Study|Patient could not travel to site|0|||
130491470|NCT05412004|469771092|FG000|Overall Study|Physician Decision|0|||
130491471|NCT05412004|469771093|FG001|Overall Study|Physician Decision|1|||
130491472|NCT05412004|469771094|FG002|Overall Study|Physician Decision|0|||
130491473|NCT05412004|469771095|FG003|Overall Study|Physician Decision|0|||
130491474|NCT05412004|469771092|FG000|Overall Study|Pregnancy|0|||
130491475|NCT05412004|469771093|FG001|Overall Study|Pregnancy|1|||
130491476|NCT05412004|469771094|FG002|Overall Study|Pregnancy|0|||
130491477|NCT05412004|469771095|FG003|Overall Study|Pregnancy|0|||
130491478|NCT05412004|469771092|FG000|Overall Study|Protocol Violation|1|||
130491479|NCT05412004|469771093|FG001|Overall Study|Protocol Violation|0|||
130491480|NCT05412004|469771094|FG002|Overall Study|Protocol Violation|0|||
130491481|NCT05412004|469771095|FG003|Overall Study|Protocol Violation|0|||
130491482|NCT05412004|469771092|FG000|Overall Study|Withdrawal by Subject|4|||
130491483|NCT05412004|469771093|FG001|Overall Study|Withdrawal by Subject|19|||
130491484|NCT05412004|469771094|FG002|Overall Study|Withdrawal by Subject|4|||
130491485|NCT05412004|469771095|FG003|Overall Study|Withdrawal by Subject|14|||
130491486|NCT05412004|469771092|FG000|Overall Study|Screen Failure|0|||
130491487|NCT05412004|469771093|FG001|Overall Study|Screen Failure|0|||
130491488|NCT05412004|469771094|FG002|Overall Study|Screen Failure|0|||
130491489|NCT05412004|469771095|FG003|Overall Study|Screen Failure|1|||
130491490|NCT05412004|469771092|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
130491491|NCT05412004|469771093|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
130491492|NCT05412004|469771094|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
130491493|NCT05412004|469771095|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
130491494|NCT04644029|469771096|FG000|Overall Study|Death|1|||
130491495|NCT04644029|469771097|FG001|Overall Study|Death|0|||
130491496|NCT04644029|469771096|FG000|Overall Study|Physician Decision|1|||
130491497|NCT04644029|469771097|FG001|Overall Study|Physician Decision|2|||
130491498|NCT04644029|469771096|FG000|Overall Study|Withdrawal by Subject|21|||
130728771|NCT00595309|470628654|FG000|Overall Study|personal reason|1|||
130491499|NCT04644029|469771097|FG001|Overall Study|Withdrawal by Subject|19|||
130491500|NCT04644029|469771096|FG000|Overall Study|Lost to Follow-up|31|||
130491501|NCT04644029|469771097|FG001|Overall Study|Lost to Follow-up|34|||
130491502|NCT04644029|469771096|FG000|Overall Study|Study Terminated by Sponsor|308|||
130491503|NCT04644029|469771097|FG001|Overall Study|Study Terminated by Sponsor|309|||
130491504|NCT04644029|469771096|FG000|Overall Study|Randomized in Error|2|||
130491505|NCT04644029|469771097|FG001|Overall Study|Randomized in Error|1|||
130491506|NCT04644029|469771096|FG000|Overall Study|Other|0|||
130491507|NCT04644029|469771097|FG001|Overall Study|Other|1|||
130491508|NCT00968149|469771098|FG000|Overall Study|Adverse Event|5|||
130491509|NCT00968149|469771099|FG001|Overall Study|Adverse Event|1|||
130491510|NCT00968149|469771098|FG000|Overall Study|Lack of Efficacy|0|||
130491511|NCT00968149|469771099|FG001|Overall Study|Lack of Efficacy|4|||
130491512|NCT00968149|469771098|FG000|Overall Study|Lost to Follow-up|0|||
130491513|NCT00968149|469771099|FG001|Overall Study|Lost to Follow-up|1|||
130491514|NCT00968149|469771098|FG000|Overall Study|Protocol Violation|4|||
130491515|NCT00968149|469771099|FG001|Overall Study|Protocol Violation|0|||
130491516|NCT00968149|469771098|FG000|Overall Study|Withdrawal by Subject|2|||
130491517|NCT00968149|469771099|FG001|Overall Study|Withdrawal by Subject|0|||
130491518|NCT00495677|469771100|FG000|Stage 1 (25 Days)|Adverse Event|0|||
130491519|NCT00495677|469771101|FG001|Stage 1 (25 Days)|Adverse Event|0|||
130491520|NCT00495677|469771102|FG002|Stage 1 (25 Days)|Adverse Event|1|||
130491521|NCT00495677|469771103|FG003|Stage 1 (25 Days)|Adverse Event|0|||
130491522|NCT00495677|469771104|FG004|Stage 1 (25 Days)|Adverse Event|0|||
130491523|NCT00495677|469771105|FG005|Stage 1 (25 Days)|Adverse Event|0|||
130491524|NCT00495677|469771106|FG006|Stage 1 (25 Days)|Adverse Event|0|||
130491525|NCT04129164|469771110|FG000|Overall Study|Non-compliance with procedures|0|||
130491526|NCT04129164|469771111|FG001|Overall Study|Non-compliance with procedures|0|||
130491527|NCT04129164|469771112|FG002|Overall Study|Non-compliance with procedures|2|||
130491528|NCT04129164|469771113|FG003|Overall Study|Non-compliance with procedures|0|||
130491529|NCT04129164|469771110|FG000|Overall Study|Adverse Event|0|||
130491530|NCT04129164|469771111|FG001|Overall Study|Adverse Event|0|||
130491531|NCT04129164|469771112|FG002|Overall Study|Adverse Event|2|||
130491532|NCT04129164|469771113|FG003|Overall Study|Adverse Event|0|||
130491533|NCT04129164|469771110|FG000|Overall Study|Pregnancy|0|||
130491534|NCT04129164|469771111|FG001|Overall Study|Pregnancy|0|||
130491535|NCT04129164|469771112|FG002|Overall Study|Pregnancy|0|||
130491536|NCT04129164|469771113|FG003|Overall Study|Pregnancy|1|||
130491537|NCT04129164|469771110|FG000|Overall Study|Withdrawal by Subject|3|||
130491538|NCT04129164|469771111|FG001|Overall Study|Withdrawal by Subject|2|||
130491539|NCT04129164|469771112|FG002|Overall Study|Withdrawal by Subject|4|||
130491540|NCT04129164|469771113|FG003|Overall Study|Withdrawal by Subject|6|||
130491541|NCT04129164|469771110|FG000|Overall Study|Death|0|||
130491542|NCT04129164|469771111|FG001|Overall Study|Death|1|||
130491543|NCT04129164|469771112|FG002|Overall Study|Death|0|||
130491544|NCT04129164|469771113|FG003|Overall Study|Death|0|||
130491545|NCT04129164|469771110|FG000|Overall Study|Lost to Follow-up|0|||
130491546|NCT04129164|469771111|FG001|Overall Study|Lost to Follow-up|1|||
130491547|NCT04129164|469771112|FG002|Overall Study|Lost to Follow-up|0|||
130491548|NCT04129164|469771113|FG003|Overall Study|Lost to Follow-up|0|||
130491549|NCT03868930|469771114|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
130491550|NCT03868930|469771115|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
130491551|NCT03868930|469771114|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
130491552|NCT03868930|469771115|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
130491553|NCT03868930|469771114|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
130491554|NCT03868930|469771115|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
130491555|NCT03868930|469771114|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
130491556|NCT03868930|469771115|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
130491557|NCT03868930|469771114|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
130491558|NCT03868930|469771115|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
130491559|NCT02231749|469771118|FG000|Overall Study|Disease progression|229|||
130491560|NCT02231749|469771119|FG001|Overall Study|Disease progression|297|||
130491561|NCT02231749|469771118|FG000|Overall Study|Study Drug Toxicity|134|||
130491562|NCT02231749|469771119|FG001|Overall Study|Study Drug Toxicity|63|||
130491563|NCT02231749|469771118|FG000|Overall Study|Death|1|||
130491564|NCT02231749|469771119|FG001|Overall Study|Death|1|||
130491565|NCT02231749|469771118|FG000|Overall Study|AE unrelated to Study drug|32|||
130491566|NCT02231749|469771119|FG001|Overall Study|AE unrelated to Study drug|31|||
130491567|NCT02231749|469771118|FG000|Overall Study|Participant's request to discontinue|10|||
130491568|NCT02231749|469771119|FG001|Overall Study|Participant's request to discontinue|21|||
130491569|NCT02231749|469771118|FG000|Overall Study|Participant withdrew Consent|8|||
130491570|NCT02231749|469771119|FG001|Overall Study|Participant withdrew Consent|15|||
130491571|NCT02231749|469771118|FG000|Overall Study|Lost to Follow-up|1|||
130491572|NCT02231749|469771119|FG001|Overall Study|Lost to Follow-up|2|||
130491573|NCT02231749|469771118|FG000|Overall Study|Maximum Clinical Benefit|5|||
130491574|NCT02231749|469771119|FG001|Overall Study|Maximum Clinical Benefit|8|||
130491575|NCT02231749|469771118|FG000|Overall Study|Poor/Non-Compliance|0|||
130491576|NCT02231749|469771119|FG001|Overall Study|Poor/Non-Compliance|3|||
130491577|NCT02231749|469771118|FG000|Overall Study|Pregnancy|1|||
130491578|NCT02231749|469771119|FG001|Overall Study|Pregnancy|0|||
130491579|NCT02231749|469771118|FG000|Overall Study|other|0|||
130491580|NCT02231749|469771119|FG001|Overall Study|other|8|||
130491581|NCT02231749|469771118|FG000|Overall Study|No longer meets Study Criteria|1|||
130491582|NCT02231749|469771119|FG001|Overall Study|No longer meets Study Criteria|0|||
130491583|NCT02989662|469771125|FG000|Overall Study|Lost to Follow-up|0|||
130491584|NCT02989662|469771126|FG001|Overall Study|Lost to Follow-up|0|||
130491585|NCT02989662|469771127|FG002|Overall Study|Lost to Follow-up|0|||
130491586|NCT02989662|469771128|FG003|Overall Study|Lost to Follow-up|2|||
130491587|NCT02989662|469771125|FG000|Overall Study|Physician Decision|3|||
130491588|NCT02989662|469771126|FG001|Overall Study|Physician Decision|0|||
130491589|NCT02989662|469771127|FG002|Overall Study|Physician Decision|0|||
130491590|NCT02989662|469771128|FG003|Overall Study|Physician Decision|0|||
130491591|NCT02989662|469771125|FG000|Overall Study|Withdrawal by Subject|1|||
130491592|NCT02989662|469771126|FG001|Overall Study|Withdrawal by Subject|0|||
130491593|NCT02989662|469771127|FG002|Overall Study|Withdrawal by Subject|0|||
130491594|NCT02989662|469771128|FG003|Overall Study|Withdrawal by Subject|0|||
130491595|NCT02726386|469771131|FG000|Overall Study|Adverse Event|17|||
130491596|NCT02726386|469771132|FG001|Overall Study|Adverse Event|20|||
130491597|NCT02726386|469771131|FG000|Overall Study|Withdrawal by Subject|14|||
130491598|NCT02726386|469771132|FG001|Overall Study|Withdrawal by Subject|28|||
130491599|NCT02726386|469771131|FG000|Overall Study|Other reasons|7|||
130491600|NCT02726386|469771132|FG001|Overall Study|Other reasons|8|||
130491601|NCT03201939|469771136|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
130491602|NCT03201939|469771137|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
130491603|NCT05707351|469771140|FG000|Overall Study|Withdrawal by Subject|2|||
130491604|NCT05707351|469771140|FG000|Overall Study|Reason Not Specified|1|||
130491605|NCT02206828|469771151|FG000|Overall Study|Lost to Follow-up|7|||
130491606|NCT03705793|469772166|FG000|Overall Study|Lost to Follow-up|3|||
130491607|NCT03705793|469772167|FG001|Overall Study|Lost to Follow-up|4|||
130491608|NCT03705793|469772166|FG000|Overall Study|Withdrawal by Subject|2|||
130491609|NCT03705793|469772167|FG001|Overall Study|Withdrawal by Subject|1|||
130491610|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Other|0|||
130565424|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565425|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130565426|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130565427|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130565428|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565429|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130565430|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130565431|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130565432|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130565433|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130565434|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130565435|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130565436|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
130565437|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
130565438|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130565439|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130565440|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130565441|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130565442|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
130565443|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130491611|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Other|2|||
130491612|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Other|1|||
130491613|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Other|2|||
130491614|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Other|2|||
130491615|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Other|0|||
130491616|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Other|0|||
130491617|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Other|0|||
130491618|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Other|0|||
130491619|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Other|0|||
130491620|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Other|0|||
130491621|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Other|0|||
130491622|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Other|0|||
130491623|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Other|0|||
130491624|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Other|0|||
130491625|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Other|0|||
130491626|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Other|0|||
130491627|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
130491628|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
130491629|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
130491630|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
130491631|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
130491632|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
130491633|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491634|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491635|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491636|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491637|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491638|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491639|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491640|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491641|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491642|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491643|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
130491644|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491645|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
130491646|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
130491647|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491648|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
130491649|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
130491650|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491651|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491652|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491653|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491654|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491655|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491656|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491657|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491658|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491659|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491660|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
130491661|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Death|2|||
130491662|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Death|1|||
130491663|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Death|1|||
130491664|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Death|0|||
130491665|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Death|0|||
130491666|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Death|0|||
130491667|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Death|0|||
130491668|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Death|0|||
130491669|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Death|0|||
130491670|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Death|0|||
130491671|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Death|0|||
130491672|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Death|0|||
130491673|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Death|0|||
130491674|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Death|0|||
130491675|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Death|0|||
130491676|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Death|0|||
130491677|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Death|0|||
130491678|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491679|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
130491680|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491681|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
130565444|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130565445|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130565446|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130565447|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130565448|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130565449|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
130565450|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130565451|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130565452|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130565453|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130565454|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130565455|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
130565456|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130648305|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
130648306|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648307|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130491682|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
130491683|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
130491684|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491685|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491686|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491687|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491688|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491689|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491690|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491691|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491692|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491693|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491694|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
130491695|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491696|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491697|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491698|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491699|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
130491700|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
130491701|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491702|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491703|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491704|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491705|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491706|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491707|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491708|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491709|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491710|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491711|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
130491712|NCT02719574|469772168|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491713|NCT02719574|469772169|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491714|NCT02719574|469772170|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
130491715|NCT02719574|469772171|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491716|NCT02719574|469772172|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491717|NCT02719574|469772173|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491718|NCT02719574|469772174|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491719|NCT02719574|469772175|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491720|NCT02719574|469772176|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491721|NCT02719574|469772177|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491722|NCT02719574|469772178|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491723|NCT02719574|469772179|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491724|NCT02719574|469772180|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491725|NCT02719574|469772181|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491726|NCT02719574|469772182|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491727|NCT02719574|469772183|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491728|NCT02719574|469772184|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130491729|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491730|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491731|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491732|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491733|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491734|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491735|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
130491736|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
130491737|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
130491738|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491739|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491740|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491741|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491742|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130565457|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130565458|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130565459|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130565460|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130491743|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491744|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491745|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
130491746|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491747|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491748|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491749|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491750|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491751|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491752|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
130491753|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
130491754|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491755|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491756|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491757|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491758|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491759|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491760|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491761|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491762|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
130491763|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|Death|0|||
130491764|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|Death|0|||
130491765|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|Death|0|||
130491766|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|Death|0|||
130491767|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|Death|0|||
130491768|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|Death|0|||
130491769|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|Death|1|||
130491770|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|Death|6|||
130491771|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|Death|0|||
130491772|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|Death|0|||
130491773|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|Death|0|||
130491774|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|Death|0|||
130491775|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|Death|0|||
130491776|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|Death|0|||
130491777|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|Death|0|||
130491778|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|Death|0|||
130491779|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|Death|0|||
130491780|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491781|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491782|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491783|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491784|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491785|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491786|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
130491787|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
130491788|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491789|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491790|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491791|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491792|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491793|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491794|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491795|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491796|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
130491797|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491798|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491799|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491800|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491801|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491802|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491803|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
130491804|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
130491805|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491806|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491807|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491808|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491809|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491810|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
130565461|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
130565462|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130565463|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130565464|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130565465|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130565466|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130491811|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491812|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491813|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
130491814|NCT02719574|469772168|FG000|Phase 1 (Dose Expansion)|Other|0|||
130491815|NCT02719574|469772169|FG001|Phase 1 (Dose Expansion)|Other|0|||
130491816|NCT02719574|469772170|FG002|Phase 1 (Dose Expansion)|Other|0|||
130491817|NCT02719574|469772171|FG003|Phase 1 (Dose Expansion)|Other|0|||
130491818|NCT02719574|469772172|FG004|Phase 1 (Dose Expansion)|Other|0|||
130491819|NCT02719574|469772173|FG005|Phase 1 (Dose Expansion)|Other|0|||
130491820|NCT02719574|469772174|FG006|Phase 1 (Dose Expansion)|Other|1|||
130491821|NCT02719574|469772175|FG007|Phase 1 (Dose Expansion)|Other|7|||
130491822|NCT02719574|469772176|FG008|Phase 1 (Dose Expansion)|Other|0|||
130491823|NCT02719574|469772177|FG009|Phase 1 (Dose Expansion)|Other|0|||
130491824|NCT02719574|469772178|FG010|Phase 1 (Dose Expansion)|Other|0|||
130491825|NCT02719574|469772179|FG011|Phase 1 (Dose Expansion)|Other|0|||
130491826|NCT02719574|469772180|FG012|Phase 1 (Dose Expansion)|Other|0|||
130491827|NCT02719574|469772181|FG013|Phase 1 (Dose Expansion)|Other|0|||
130491828|NCT02719574|469772182|FG014|Phase 1 (Dose Expansion)|Other|0|||
130491829|NCT02719574|469772183|FG015|Phase 1 (Dose Expansion)|Other|0|||
130491830|NCT02719574|469772184|FG016|Phase 1 (Dose Expansion)|Other|0|||
130491831|NCT02719574|469772168|FG000|Phase 2|Protocol Defined Disease Progression|0|||
130491832|NCT02719574|469772169|FG001|Phase 2|Protocol Defined Disease Progression|0|||
130491833|NCT02719574|469772170|FG002|Phase 2|Protocol Defined Disease Progression|0|||
130491834|NCT02719574|469772171|FG003|Phase 2|Protocol Defined Disease Progression|0|||
130491835|NCT02719574|469772172|FG004|Phase 2|Protocol Defined Disease Progression|0|||
130491836|NCT02719574|469772173|FG005|Phase 2|Protocol Defined Disease Progression|0|||
130491837|NCT02719574|469772174|FG006|Phase 2|Protocol Defined Disease Progression|0|||
130491838|NCT02719574|469772175|FG007|Phase 2|Protocol Defined Disease Progression|0|||
130491839|NCT02719574|469772176|FG008|Phase 2|Protocol Defined Disease Progression|0|||
130491840|NCT02719574|469772177|FG009|Phase 2|Protocol Defined Disease Progression|65|||
130491841|NCT02719574|469772178|FG010|Phase 2|Protocol Defined Disease Progression|8|||
130491842|NCT02719574|469772179|FG011|Phase 2|Protocol Defined Disease Progression|2|||
130491843|NCT02719574|469772180|FG012|Phase 2|Protocol Defined Disease Progression|4|||
130491844|NCT02719574|469772181|FG013|Phase 2|Protocol Defined Disease Progression|9|||
130491845|NCT02719574|469772182|FG014|Phase 2|Protocol Defined Disease Progression|11|||
130491846|NCT02719574|469772183|FG015|Phase 2|Protocol Defined Disease Progression|3|||
130491847|NCT02719574|469772184|FG016|Phase 2|Protocol Defined Disease Progression|4|||
130491848|NCT02719574|469772168|FG000|Phase 2|Adverse Event|0|||
130491849|NCT02719574|469772169|FG001|Phase 2|Adverse Event|0|||
130491850|NCT02719574|469772170|FG002|Phase 2|Adverse Event|0|||
130491851|NCT02719574|469772171|FG003|Phase 2|Adverse Event|0|||
130491852|NCT02719574|469772172|FG004|Phase 2|Adverse Event|0|||
130491853|NCT02719574|469772173|FG005|Phase 2|Adverse Event|0|||
130491854|NCT02719574|469772174|FG006|Phase 2|Adverse Event|0|||
130491855|NCT02719574|469772175|FG007|Phase 2|Adverse Event|0|||
130491856|NCT02719574|469772176|FG008|Phase 2|Adverse Event|0|||
130491857|NCT02719574|469772177|FG009|Phase 2|Adverse Event|27|||
130491858|NCT02719574|469772178|FG010|Phase 2|Adverse Event|0|||
130491859|NCT02719574|469772179|FG011|Phase 2|Adverse Event|1|||
130491860|NCT02719574|469772180|FG012|Phase 2|Adverse Event|1|||
130491861|NCT02719574|469772181|FG013|Phase 2|Adverse Event|1|||
130491862|NCT02719574|469772182|FG014|Phase 2|Adverse Event|2|||
130491863|NCT02719574|469772183|FG015|Phase 2|Adverse Event|2|||
130491864|NCT02719574|469772184|FG016|Phase 2|Adverse Event|3|||
130491865|NCT02719574|469772168|FG000|Phase 2|Other|0|||
130491866|NCT02719574|469772169|FG001|Phase 2|Other|0|||
130491867|NCT02719574|469772170|FG002|Phase 2|Other|0|||
130491868|NCT02719574|469772171|FG003|Phase 2|Other|0|||
130491869|NCT02719574|469772172|FG004|Phase 2|Other|0|||
130491870|NCT02719574|469772173|FG005|Phase 2|Other|0|||
130491871|NCT02719574|469772174|FG006|Phase 2|Other|0|||
130491872|NCT02719574|469772175|FG007|Phase 2|Other|0|||
130491873|NCT02719574|469772176|FG008|Phase 2|Other|0|||
130491874|NCT02719574|469772177|FG009|Phase 2|Other|20|||
130491875|NCT02719574|469772178|FG010|Phase 2|Other|7|||
130491876|NCT02719574|469772179|FG011|Phase 2|Other|0|||
130491877|NCT02719574|469772180|FG012|Phase 2|Other|5|||
130491878|NCT02719574|469772181|FG013|Phase 2|Other|7|||
130491879|NCT02719574|469772182|FG014|Phase 2|Other|0|||
130491880|NCT02719574|469772183|FG015|Phase 2|Other|1|||
130491881|NCT02719574|469772184|FG016|Phase 2|Other|4|||
130491882|NCT02719574|469772168|FG000|Phase 2|Transplant|0|||
130491883|NCT02719574|469772169|FG001|Phase 2|Transplant|0|||
130491884|NCT02719574|469772170|FG002|Phase 2|Transplant|0|||
130491885|NCT02719574|469772171|FG003|Phase 2|Transplant|0|||
130491886|NCT02719574|469772172|FG004|Phase 2|Transplant|0|||
130491887|NCT02719574|469772173|FG005|Phase 2|Transplant|0|||
130491888|NCT02719574|469772174|FG006|Phase 2|Transplant|0|||
130491889|NCT02719574|469772175|FG007|Phase 2|Transplant|0|||
130491890|NCT02719574|469772176|FG008|Phase 2|Transplant|0|||
130491891|NCT02719574|469772177|FG009|Phase 2|Transplant|15|||
130491892|NCT02719574|469772178|FG010|Phase 2|Transplant|2|||
130491893|NCT02719574|469772179|FG011|Phase 2|Transplant|0|||
130491894|NCT02719574|469772180|FG012|Phase 2|Transplant|6|||
130491895|NCT02719574|469772181|FG013|Phase 2|Transplant|1|||
130491896|NCT02719574|469772182|FG014|Phase 2|Transplant|1|||
130491897|NCT02719574|469772183|FG015|Phase 2|Transplant|0|||
130491898|NCT02719574|469772184|FG016|Phase 2|Transplant|0|||
130491899|NCT02719574|469772168|FG000|Phase 2|Death|0|||
130491900|NCT02719574|469772169|FG001|Phase 2|Death|0|||
130491901|NCT02719574|469772170|FG002|Phase 2|Death|0|||
130491902|NCT02719574|469772171|FG003|Phase 2|Death|0|||
130491903|NCT02719574|469772172|FG004|Phase 2|Death|0|||
130491904|NCT02719574|469772173|FG005|Phase 2|Death|0|||
130491905|NCT02719574|469772174|FG006|Phase 2|Death|0|||
130491906|NCT02719574|469772175|FG007|Phase 2|Death|0|||
130491907|NCT02719574|469772176|FG008|Phase 2|Death|0|||
130491908|NCT02719574|469772177|FG009|Phase 2|Death|14|||
130491909|NCT02719574|469772178|FG010|Phase 2|Death|0|||
130491910|NCT02719574|469772179|FG011|Phase 2|Death|0|||
130491911|NCT02719574|469772180|FG012|Phase 2|Death|1|||
130491912|NCT02719574|469772181|FG013|Phase 2|Death|1|||
130491913|NCT02719574|469772182|FG014|Phase 2|Death|2|||
130491914|NCT02719574|469772183|FG015|Phase 2|Death|0|||
130491915|NCT02719574|469772184|FG016|Phase 2|Death|0|||
130491916|NCT02719574|469772168|FG000|Phase 2|Investigator Decision|0|||
130491917|NCT02719574|469772169|FG001|Phase 2|Investigator Decision|0|||
130491918|NCT02719574|469772170|FG002|Phase 2|Investigator Decision|0|||
130491919|NCT02719574|469772171|FG003|Phase 2|Investigator Decision|0|||
130491920|NCT02719574|469772172|FG004|Phase 2|Investigator Decision|0|||
130491921|NCT02719574|469772173|FG005|Phase 2|Investigator Decision|0|||
130491922|NCT02719574|469772174|FG006|Phase 2|Investigator Decision|0|||
130491923|NCT02719574|469772175|FG007|Phase 2|Investigator Decision|0|||
130491924|NCT02719574|469772176|FG008|Phase 2|Investigator Decision|0|||
130491925|NCT02719574|469772177|FG009|Phase 2|Investigator Decision|6|||
130491926|NCT02719574|469772178|FG010|Phase 2|Investigator Decision|1|||
130491927|NCT02719574|469772179|FG011|Phase 2|Investigator Decision|2|||
130491928|NCT02719574|469772180|FG012|Phase 2|Investigator Decision|3|||
130491929|NCT02719574|469772181|FG013|Phase 2|Investigator Decision|1|||
130491930|NCT02719574|469772182|FG014|Phase 2|Investigator Decision|3|||
130491931|NCT02719574|469772183|FG015|Phase 2|Investigator Decision|2|||
130491932|NCT02719574|469772184|FG016|Phase 2|Investigator Decision|0|||
130491933|NCT02719574|469772168|FG000|Phase 2|Withdrawal by Subject|0|||
130491934|NCT02719574|469772169|FG001|Phase 2|Withdrawal by Subject|0|||
130491935|NCT02719574|469772170|FG002|Phase 2|Withdrawal by Subject|0|||
130491936|NCT02719574|469772171|FG003|Phase 2|Withdrawal by Subject|0|||
130491937|NCT02719574|469772172|FG004|Phase 2|Withdrawal by Subject|0|||
130491938|NCT02719574|469772173|FG005|Phase 2|Withdrawal by Subject|0|||
130491939|NCT02719574|469772174|FG006|Phase 2|Withdrawal by Subject|0|||
130491940|NCT02719574|469772175|FG007|Phase 2|Withdrawal by Subject|0|||
130491941|NCT02719574|469772176|FG008|Phase 2|Withdrawal by Subject|0|||
130491942|NCT02719574|469772177|FG009|Phase 2|Withdrawal by Subject|5|||
130491943|NCT02719574|469772178|FG010|Phase 2|Withdrawal by Subject|0|||
130491944|NCT02719574|469772179|FG011|Phase 2|Withdrawal by Subject|0|||
130491945|NCT02719574|469772180|FG012|Phase 2|Withdrawal by Subject|0|||
130491946|NCT02719574|469772181|FG013|Phase 2|Withdrawal by Subject|1|||
130491947|NCT02719574|469772182|FG014|Phase 2|Withdrawal by Subject|1|||
130491948|NCT02719574|469772183|FG015|Phase 2|Withdrawal by Subject|2|||
130491949|NCT02719574|469772184|FG016|Phase 2|Withdrawal by Subject|0|||
130491950|NCT02719574|469772168|FG000|Phase 2|Protocol Violation|0|||
130491951|NCT02719574|469772169|FG001|Phase 2|Protocol Violation|0|||
130491952|NCT02719574|469772170|FG002|Phase 2|Protocol Violation|0|||
130491953|NCT02719574|469772171|FG003|Phase 2|Protocol Violation|0|||
130491954|NCT02719574|469772172|FG004|Phase 2|Protocol Violation|0|||
130491955|NCT02719574|469772173|FG005|Phase 2|Protocol Violation|0|||
130491956|NCT02719574|469772174|FG006|Phase 2|Protocol Violation|0|||
130491957|NCT02719574|469772175|FG007|Phase 2|Protocol Violation|0|||
130491958|NCT02719574|469772176|FG008|Phase 2|Protocol Violation|0|||
130491959|NCT02719574|469772177|FG009|Phase 2|Protocol Violation|1|||
130491960|NCT02719574|469772178|FG010|Phase 2|Protocol Violation|0|||
130491961|NCT02719574|469772179|FG011|Phase 2|Protocol Violation|0|||
130491962|NCT02719574|469772180|FG012|Phase 2|Protocol Violation|0|||
130491963|NCT02719574|469772181|FG013|Phase 2|Protocol Violation|0|||
130491964|NCT02719574|469772182|FG014|Phase 2|Protocol Violation|0|||
130728772|NCT00704132|470628664|FG000|Overall Study|Clinical Adverse Experience|1|||
130491965|NCT02719574|469772183|FG015|Phase 2|Protocol Violation|0|||
130491966|NCT02719574|469772184|FG016|Phase 2|Protocol Violation|0|||
130728773|NCT00704132|470628665|FG001|Overall Study|Clinical Adverse Experience|0|||
130491967|NCT02720068|469772186|FG000|Overall Study|Adverse Event|0|||
130728774|NCT00704132|470628664|FG000|Overall Study|Lack of Efficacy|0|||
130491968|NCT02720068|469772187|FG001|Overall Study|Adverse Event|0|||
130491969|NCT02720068|469772188|FG002|Overall Study|Adverse Event|0|||
130491970|NCT02720068|469772189|FG003|Overall Study|Adverse Event|0|||
130491971|NCT02720068|469772190|FG004|Overall Study|Adverse Event|0|||
130491972|NCT02720068|469772191|FG005|Overall Study|Adverse Event|0|||
130491973|NCT02720068|469772192|FG006|Overall Study|Adverse Event|0|||
130491974|NCT02720068|469772193|FG007|Overall Study|Adverse Event|0|||
130491975|NCT02720068|469772194|FG008|Overall Study|Adverse Event|0|||
130491976|NCT02720068|469772195|FG009|Overall Study|Adverse Event|0|||
130491977|NCT02720068|469772196|FG010|Overall Study|Adverse Event|0|||
130491978|NCT02720068|469772197|FG011|Overall Study|Adverse Event|1|||
130491979|NCT02720068|469772198|FG012|Overall Study|Adverse Event|0|||
130491980|NCT02720068|469772199|FG013|Overall Study|Adverse Event|0|||
130491981|NCT02720068|469772200|FG014|Overall Study|Adverse Event|0|||
130728775|NCT00704132|470628665|FG001|Overall Study|Lack of Efficacy|1|||
130491982|NCT02720068|469772201|FG015|Overall Study|Adverse Event|0|||
130491983|NCT02720068|469772202|FG016|Overall Study|Adverse Event|0|||
130491984|NCT02720068|469772203|FG017|Overall Study|Adverse Event|0|||
130491985|NCT02720068|469772186|FG000|Overall Study|Death|1|||
130728776|NCT00704132|470628664|FG000|Overall Study|Withdrawal by Subject|0|||
130728777|NCT00704132|470628665|FG001|Overall Study|Withdrawal by Subject|1|||
130728778|NCT00442962|470628666|FG000|Overall Study|Pregnancy|1|||
130728779|NCT00442962|470628666|FG000|Overall Study|Lost to Follow-up|7|||
130728780|NCT03633825|470628667|FG000|Enrollment|Did not post on network|5066|||
130728781|NCT03633825|470628668|FG001|Enrollment|Did not post on network|5080|||
130491986|NCT02720068|469772187|FG001|Overall Study|Death|3|||
130728782|NCT03633825|470628667|FG000|Enrollment|Post not classified as crisis|13967|||
130728783|NCT03633825|470628668|FG001|Enrollment|Post not classified as crisis|13757|||
130728784|NCT03633825|470628667|FG000|Follow up|Lost to Follow-up|478|||
130728785|NCT03633825|470628668|FG001|Follow up|Lost to Follow-up|450|||
130728786|NCT00214383|470628669|FG000|Overall Study|Lost to Follow-up|16|||
130728787|NCT00214383|470628670|FG001|Overall Study|Lost to Follow-up|26|||
130728788|NCT00879411|470628671|FG000|Overall Study|lost to follow-up (non-AE)|162|||
130728789|NCT01267994|470628674|FG000|Overall Study|Adverse Event|2|||
130728790|NCT02655666|470628675|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
130728791|NCT03837743|470628676|FG000|Overall Study|Adverse Event|1|||
130728792|NCT03837743|470628676|FG000|Overall Study|Withdrawal by Subject|2|||
130728793|NCT01210612|470628680|FG000|Overall Study|Withdrawal by Subject|0|||
130728794|NCT01210612|470628681|FG001|Overall Study|Withdrawal by Subject|2|||
130728795|NCT00086281|470628684|FG000|Phase 1|Adverse Event|0|||
130728796|NCT00086281|470628685|FG001|Phase 1|Adverse Event|0|||
130728797|NCT00086281|470628686|FG002|Phase 1|Adverse Event|0|||
130728798|NCT00086281|470628687|FG003|Phase 1|Adverse Event|0|||
130728799|NCT00086281|470628688|FG004|Phase 1|Adverse Event|0|||
130728800|NCT00086281|470628689|FG005|Phase 1|Adverse Event|0|||
130728801|NCT00086281|470628690|FG006|Phase 1|Adverse Event|0|||
130728802|NCT00086281|470628691|FG007|Phase 1|Adverse Event|0|||
130728803|NCT00086281|470628692|FG008|Phase 1|Adverse Event|0|||
130728804|NCT00086281|470628693|FG009|Phase 1|Adverse Event|1|||
130728805|NCT00086281|470628694|FG010|Phase 1|Adverse Event|2|||
130728806|NCT00086281|470628695|FG011|Phase 1|Adverse Event|1|||
130491987|NCT02720068|469772188|FG002|Overall Study|Death|2|||
130491988|NCT02720068|469772189|FG003|Overall Study|Death|1|||
130491989|NCT02720068|469772190|FG004|Overall Study|Death|2|||
130491990|NCT02720068|469772191|FG005|Overall Study|Death|1|||
130491991|NCT02720068|469772192|FG006|Overall Study|Death|2|||
130491992|NCT02720068|469772193|FG007|Overall Study|Death|2|||
130491993|NCT02720068|469772194|FG008|Overall Study|Death|3|||
130491994|NCT02720068|469772195|FG009|Overall Study|Death|1|||
130491995|NCT02720068|469772196|FG010|Overall Study|Death|20|||
130491996|NCT02720068|469772197|FG011|Overall Study|Death|166|||
130491997|NCT02720068|469772198|FG012|Overall Study|Death|34|||
130491998|NCT02720068|469772199|FG013|Overall Study|Death|30|||
130491999|NCT02720068|469772200|FG014|Overall Study|Death|45|||
130492000|NCT02720068|469772201|FG015|Overall Study|Death|16|||
130492001|NCT02720068|469772202|FG016|Overall Study|Death|20|||
130492002|NCT02720068|469772203|FG017|Overall Study|Death|28|||
130492003|NCT02720068|469772186|FG000|Overall Study|Lost to Follow-up|0|||
130492004|NCT02720068|469772187|FG001|Overall Study|Lost to Follow-up|0|||
130492005|NCT02720068|469772188|FG002|Overall Study|Lost to Follow-up|0|||
130492006|NCT02720068|469772189|FG003|Overall Study|Lost to Follow-up|0|||
130492007|NCT02720068|469772190|FG004|Overall Study|Lost to Follow-up|0|||
130492008|NCT02720068|469772191|FG005|Overall Study|Lost to Follow-up|0|||
130492009|NCT02720068|469772192|FG006|Overall Study|Lost to Follow-up|0|||
130492010|NCT02720068|469772193|FG007|Overall Study|Lost to Follow-up|0|||
130492011|NCT02720068|469772194|FG008|Overall Study|Lost to Follow-up|0|||
130492012|NCT02720068|469772195|FG009|Overall Study|Lost to Follow-up|0|||
130492013|NCT02720068|469772196|FG010|Overall Study|Lost to Follow-up|0|||
130492014|NCT02720068|469772197|FG011|Overall Study|Lost to Follow-up|1|||
130492015|NCT02720068|469772198|FG012|Overall Study|Lost to Follow-up|0|||
130492016|NCT02720068|469772199|FG013|Overall Study|Lost to Follow-up|1|||
130728807|NCT00086281|470628696|FG012|Phase 1|Adverse Event|1|||
130728808|NCT00086281|470628697|FG013|Phase 1|Adverse Event|1|||
130728809|NCT00086281|470628698|FG014|Phase 1|Adverse Event|2|||
130492017|NCT02720068|469772200|FG014|Overall Study|Lost to Follow-up|2|||
130492018|NCT02720068|469772201|FG015|Overall Study|Lost to Follow-up|0|||
130492019|NCT02720068|469772202|FG016|Overall Study|Lost to Follow-up|0|||
130492020|NCT02720068|469772203|FG017|Overall Study|Lost to Follow-up|1|||
130492021|NCT02720068|469772186|FG000|Overall Study|Physician Decision|0|||
130492022|NCT02720068|469772187|FG001|Overall Study|Physician Decision|0|||
130492023|NCT02720068|469772188|FG002|Overall Study|Physician Decision|0|||
130492024|NCT02720068|469772189|FG003|Overall Study|Physician Decision|1|||
130728810|NCT00086281|470628684|FG000|Phase 1|Protocol Violation|0|||
130728811|NCT00086281|470628685|FG001|Phase 1|Protocol Violation|0|||
130728812|NCT00086281|470628686|FG002|Phase 1|Protocol Violation|0|||
130728813|NCT00086281|470628687|FG003|Phase 1|Protocol Violation|0|||
130492025|NCT02720068|469772190|FG004|Overall Study|Physician Decision|0|||
130492026|NCT02720068|469772191|FG005|Overall Study|Physician Decision|0|||
130492027|NCT02720068|469772192|FG006|Overall Study|Physician Decision|0|||
130492028|NCT02720068|469772193|FG007|Overall Study|Physician Decision|0|||
130492029|NCT02720068|469772194|FG008|Overall Study|Physician Decision|0|||
130728814|NCT00086281|470628688|FG004|Phase 1|Protocol Violation|0|||
130492030|NCT02720068|469772195|FG009|Overall Study|Physician Decision|0|||
130492031|NCT02720068|469772196|FG010|Overall Study|Physician Decision|0|||
130492032|NCT02720068|469772197|FG011|Overall Study|Physician Decision|1|||
130492033|NCT02720068|469772198|FG012|Overall Study|Physician Decision|0|||
130492034|NCT02720068|469772199|FG013|Overall Study|Physician Decision|0|||
130492035|NCT02720068|469772200|FG014|Overall Study|Physician Decision|0|||
130492036|NCT02720068|469772201|FG015|Overall Study|Physician Decision|0|||
130492037|NCT02720068|469772202|FG016|Overall Study|Physician Decision|0|||
130492038|NCT02720068|469772203|FG017|Overall Study|Physician Decision|1|||
130492039|NCT02720068|469772186|FG000|Overall Study|Progressive Disease|2|||
130492040|NCT02720068|469772187|FG001|Overall Study|Progressive Disease|3|||
130492041|NCT02720068|469772188|FG002|Overall Study|Progressive Disease|1|||
130492042|NCT02720068|469772189|FG003|Overall Study|Progressive Disease|1|||
130492043|NCT02720068|469772190|FG004|Overall Study|Progressive Disease|1|||
130492044|NCT02720068|469772191|FG005|Overall Study|Progressive Disease|2|||
130492045|NCT02720068|469772192|FG006|Overall Study|Progressive Disease|1|||
130492046|NCT02720068|469772193|FG007|Overall Study|Progressive Disease|1|||
130492047|NCT02720068|469772194|FG008|Overall Study|Progressive Disease|0|||
130492048|NCT02720068|469772195|FG009|Overall Study|Progressive Disease|1|||
130492049|NCT02720068|469772196|FG010|Overall Study|Progressive Disease|0|||
130492050|NCT02720068|469772197|FG011|Overall Study|Progressive Disease|4|||
130492051|NCT02720068|469772198|FG012|Overall Study|Progressive Disease|1|||
130492052|NCT02720068|469772199|FG013|Overall Study|Progressive Disease|0|||
130492053|NCT02720068|469772200|FG014|Overall Study|Progressive Disease|0|||
130492054|NCT02720068|469772201|FG015|Overall Study|Progressive Disease|0|||
130492055|NCT02720068|469772202|FG016|Overall Study|Progressive Disease|0|||
130492056|NCT02720068|469772203|FG017|Overall Study|Progressive Disease|0|||
130492057|NCT02720068|469772186|FG000|Overall Study|Sponsor Decision|0|||
130492058|NCT02720068|469772187|FG001|Overall Study|Sponsor Decision|0|||
130492059|NCT02720068|469772188|FG002|Overall Study|Sponsor Decision|0|||
130492060|NCT02720068|469772189|FG003|Overall Study|Sponsor Decision|0|||
130492061|NCT02720068|469772190|FG004|Overall Study|Sponsor Decision|0|||
130492062|NCT02720068|469772191|FG005|Overall Study|Sponsor Decision|0|||
130492063|NCT02720068|469772192|FG006|Overall Study|Sponsor Decision|0|||
130492064|NCT02720068|469772193|FG007|Overall Study|Sponsor Decision|0|||
130492065|NCT02720068|469772194|FG008|Overall Study|Sponsor Decision|0|||
130492066|NCT02720068|469772195|FG009|Overall Study|Sponsor Decision|0|||
130492067|NCT02720068|469772196|FG010|Overall Study|Sponsor Decision|0|||
130492068|NCT02720068|469772197|FG011|Overall Study|Sponsor Decision|6|||
130492069|NCT02720068|469772198|FG012|Overall Study|Sponsor Decision|3|||
130492070|NCT02720068|469772199|FG013|Overall Study|Sponsor Decision|2|||
130492071|NCT02720068|469772200|FG014|Overall Study|Sponsor Decision|4|||
130492072|NCT02720068|469772201|FG015|Overall Study|Sponsor Decision|4|||
130492073|NCT02720068|469772202|FG016|Overall Study|Sponsor Decision|0|||
130492074|NCT02720068|469772203|FG017|Overall Study|Sponsor Decision|8|||
130492075|NCT02720068|469772186|FG000|Overall Study|Withdrawal by Subject|0|||
130492076|NCT02720068|469772187|FG001|Overall Study|Withdrawal by Subject|0|||
130492077|NCT02720068|469772188|FG002|Overall Study|Withdrawal by Subject|0|||
130492078|NCT02720068|469772189|FG003|Overall Study|Withdrawal by Subject|0|||
130492079|NCT02720068|469772190|FG004|Overall Study|Withdrawal by Subject|0|||
130492080|NCT02720068|469772191|FG005|Overall Study|Withdrawal by Subject|0|||
130492081|NCT02720068|469772192|FG006|Overall Study|Withdrawal by Subject|0|||
130492082|NCT02720068|469772193|FG007|Overall Study|Withdrawal by Subject|0|||
130492083|NCT02720068|469772194|FG008|Overall Study|Withdrawal by Subject|0|||
130492084|NCT02720068|469772195|FG009|Overall Study|Withdrawal by Subject|1|||
130492085|NCT02720068|469772196|FG010|Overall Study|Withdrawal by Subject|0|||
130492086|NCT02720068|469772197|FG011|Overall Study|Withdrawal by Subject|27|||
130492087|NCT02720068|469772198|FG012|Overall Study|Withdrawal by Subject|2|||
130492088|NCT02720068|469772199|FG013|Overall Study|Withdrawal by Subject|8|||
130492089|NCT02720068|469772200|FG014|Overall Study|Withdrawal by Subject|7|||
130492090|NCT02720068|469772201|FG015|Overall Study|Withdrawal by Subject|0|||
130492091|NCT02720068|469772202|FG016|Overall Study|Withdrawal by Subject|0|||
130492092|NCT02720068|469772203|FG017|Overall Study|Withdrawal by Subject|2|||
130492093|NCT02720068|469772186|FG000|Overall Study|Protocol Violation|0|||
130492094|NCT02720068|469772187|FG001|Overall Study|Protocol Violation|0|||
130492095|NCT02720068|469772188|FG002|Overall Study|Protocol Violation|0|||
130492096|NCT02720068|469772189|FG003|Overall Study|Protocol Violation|0|||
130492097|NCT02720068|469772190|FG004|Overall Study|Protocol Violation|0|||
130492098|NCT02720068|469772191|FG005|Overall Study|Protocol Violation|0|||
130492099|NCT02720068|469772192|FG006|Overall Study|Protocol Violation|0|||
130492100|NCT02720068|469772193|FG007|Overall Study|Protocol Violation|0|||
130492101|NCT02720068|469772194|FG008|Overall Study|Protocol Violation|0|||
130492102|NCT02720068|469772195|FG009|Overall Study|Protocol Violation|0|||
130492103|NCT02720068|469772196|FG010|Overall Study|Protocol Violation|1|||
130492104|NCT02720068|469772197|FG011|Overall Study|Protocol Violation|0|||
130492105|NCT02720068|469772198|FG012|Overall Study|Protocol Violation|0|||
130492106|NCT02720068|469772199|FG013|Overall Study|Protocol Violation|0|||
130492107|NCT02720068|469772200|FG014|Overall Study|Protocol Violation|1|||
130492108|NCT02720068|469772201|FG015|Overall Study|Protocol Violation|0|||
130492109|NCT02720068|469772202|FG016|Overall Study|Protocol Violation|1|||
130492110|NCT02720068|469772203|FG017|Overall Study|Protocol Violation|0|||
130492111|NCT00113360|469772206|FG000|Overall Study|Adverse Event|3|||
130492112|NCT00113360|469772206|FG000|Overall Study|Subject required surgery|1|||
130492113|NCT00113360|469772206|FG000|Overall Study|Did not meet eligibility criteria|3|||
130492114|NCT02467270|469772221|FG000|Overall Study|Participants Never Treated|0|||
130492115|NCT02467270|469772222|FG001|Overall Study|Participants Never Treated|1|||
130492116|NCT02467270|469772223|FG002|Overall Study|Participants Never Treated|0|||
130492117|NCT02467270|469772221|FG000|Overall Study|Ongoing|50|||
130492118|NCT02467270|469772222|FG001|Overall Study|Ongoing|41|||
130492119|NCT02467270|469772223|FG002|Overall Study|Ongoing|43|||
130492120|NCT02467270|469772221|FG000|Overall Study|Adverse Event|16|||
130492121|NCT02467270|469772222|FG001|Overall Study|Adverse Event|15|||
130492122|NCT02467270|469772223|FG002|Overall Study|Adverse Event|14|||
130492123|NCT02467270|469772221|FG000|Overall Study|Progressive Disease|7|||
130492124|NCT02467270|469772222|FG001|Overall Study|Progressive Disease|7|||
130492125|NCT02467270|469772223|FG002|Overall Study|Progressive Disease|4|||
130492126|NCT02467270|469772221|FG000|Overall Study|Death|2|||
130492127|NCT02467270|469772222|FG001|Overall Study|Death|0|||
130492128|NCT02467270|469772223|FG002|Overall Study|Death|2|||
130492129|NCT02467270|469772221|FG000|Overall Study|Lack of Efficacy|12|||
130492130|NCT02467270|469772222|FG001|Overall Study|Lack of Efficacy|18|||
130492131|NCT02467270|469772223|FG002|Overall Study|Lack of Efficacy|23|||
130492132|NCT02467270|469772221|FG000|Overall Study|Non-compliance With Study Drug|0|||
130492133|NCT02467270|469772222|FG001|Overall Study|Non-compliance With Study Drug|2|||
130492134|NCT02467270|469772223|FG002|Overall Study|Non-compliance With Study Drug|1|||
130492135|NCT02467270|469772221|FG000|Overall Study|Lost to Follow-up|2|||
130492136|NCT02467270|469772222|FG001|Overall Study|Lost to Follow-up|1|||
130492137|NCT02467270|469772223|FG002|Overall Study|Lost to Follow-up|0|||
130492138|NCT02467270|469772221|FG000|Overall Study|Pregnancy|0|||
130492139|NCT02467270|469772222|FG001|Overall Study|Pregnancy|1|||
130728815|NCT00086281|470628689|FG005|Phase 1|Protocol Violation|0|||
130492140|NCT02467270|469772223|FG002|Overall Study|Pregnancy|0|||
130492141|NCT02467270|469772221|FG000|Overall Study|Physician Decision|0|||
130492142|NCT02467270|469772222|FG001|Overall Study|Physician Decision|4|||
130492143|NCT02467270|469772223|FG002|Overall Study|Physician Decision|1|||
130492144|NCT02467270|469772221|FG000|Overall Study|Withdrawal by Subject|4|||
130492145|NCT02467270|469772222|FG001|Overall Study|Withdrawal by Subject|3|||
130492146|NCT02467270|469772223|FG002|Overall Study|Withdrawal by Subject|5|||
130492147|NCT02467270|469772221|FG000|Overall Study|Reason not Specified|1|||
130492148|NCT02467270|469772222|FG001|Overall Study|Reason not Specified|2|||
130492149|NCT02467270|469772223|FG002|Overall Study|Reason not Specified|1|||
130492150|NCT00739908|469772224|FG000|Overall Study|Adverse Event|5|||
130492151|NCT00739908|469772225|FG001|Overall Study|Adverse Event|6|||
130492152|NCT00739908|469772224|FG000|Overall Study|Withdrawal by Subject|4|||
130492153|NCT00739908|469772225|FG001|Overall Study|Withdrawal by Subject|2|||
130492154|NCT00739908|469772224|FG000|Overall Study|Lost to Follow-up|14|||
130492155|NCT00739908|469772225|FG001|Overall Study|Lost to Follow-up|9|||
130492156|NCT00739908|469772224|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
130492157|NCT00739908|469772225|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
130492158|NCT00739908|469772224|FG000|Overall Study|Non-Compliance With Study Medication|0|||
130492159|NCT00739908|469772225|FG001|Overall Study|Non-Compliance With Study Medication|3|||
130492160|NCT00739908|469772224|FG000|Overall Study|Lack of Efficacy|0|||
130492161|NCT00739908|469772225|FG001|Overall Study|Lack of Efficacy|1|||
130492162|NCT00739908|469772224|FG000|Overall Study|Relocation|0|||
130492163|NCT00739908|469772225|FG001|Overall Study|Relocation|1|||
130492164|NCT04227899|469772231|FG000|Overall Study|Withdrawal by Subject|6|||
130492165|NCT04227899|469772232|FG001|Overall Study|Withdrawal by Subject|3|||
130492166|NCT04227899|469772231|FG000|Overall Study|Death|12|||
130492167|NCT04227899|469772232|FG001|Overall Study|Death|6|||
130492168|NCT04227899|469772231|FG000|Overall Study|Lost to Follow-up|2|||
130492169|NCT04227899|469772232|FG001|Overall Study|Lost to Follow-up|1|||
130728816|NCT00086281|470628690|FG006|Phase 1|Protocol Violation|0|||
130728817|NCT00086281|470628691|FG007|Phase 1|Protocol Violation|0|||
130492170|NCT01046825|469772235|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
130492171|NCT01046825|469772236|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
130492172|NCT01046825|469772237|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
130492173|NCT01046825|469772238|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
130492174|NCT01046825|469772239|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
130492175|NCT01046825|469772235|FG000|Overall Study|Physician Decision|0|||
130492176|NCT01046825|469772236|FG001|Overall Study|Physician Decision|1|||
130492177|NCT01046825|469772237|FG002|Overall Study|Physician Decision|2|||
130492178|NCT01046825|469772238|FG003|Overall Study|Physician Decision|0|||
130492179|NCT01046825|469772239|FG004|Overall Study|Physician Decision|0|||
130492180|NCT01046825|469772235|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
130492181|NCT01046825|469772236|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
130492182|NCT01046825|469772237|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
130728818|NCT00086281|470628692|FG008|Phase 1|Protocol Violation|0|||
130492183|NCT01046825|469772238|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
130492184|NCT01046825|469772239|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
130492185|NCT01046825|469772235|FG000|Overall Study|Found to be ineligible|0|||
130492186|NCT01046825|469772236|FG001|Overall Study|Found to be ineligible|1|||
130492187|NCT01046825|469772237|FG002|Overall Study|Found to be ineligible|0|||
130492188|NCT01046825|469772238|FG003|Overall Study|Found to be ineligible|0|||
130492189|NCT01046825|469772239|FG004|Overall Study|Found to be ineligible|0|||
130492190|NCT01046825|469772235|FG000|Overall Study|Death|0|||
130492191|NCT01046825|469772236|FG001|Overall Study|Death|0|||
130492192|NCT01046825|469772237|FG002|Overall Study|Death|0|||
130492193|NCT01046825|469772238|FG003|Overall Study|Death|1|||
130492194|NCT01046825|469772239|FG004|Overall Study|Death|0|||
130492195|NCT01046825|469772235|FG000|Overall Study|Did not submit biology samples|0|||
130492196|NCT01046825|469772236|FG001|Overall Study|Did not submit biology samples|0|||
130492197|NCT01046825|469772237|FG002|Overall Study|Did not submit biology samples|0|||
130492198|NCT01046825|469772238|FG003|Overall Study|Did not submit biology samples|0|||
130492199|NCT01046825|469772239|FG004|Overall Study|Did not submit biology samples|13|||
130492200|NCT01773993|469772241|FG000|Overall Study|No Visit After Treatment|35|||
130492201|NCT04664881|469772242|FG000|Overall Study|Withdrawal by Subject|1|||
130492202|NCT04664881|469772243|FG001|Overall Study|Withdrawal by Subject|8|||
130492203|NCT04664881|469772242|FG000|Overall Study|Physician Decision|0|||
130492204|NCT04664881|469772243|FG001|Overall Study|Physician Decision|5|||
130492205|NCT04664881|469772242|FG000|Overall Study|Lost to Follow-up|1|||
130492206|NCT04664881|469772243|FG001|Overall Study|Lost to Follow-up|0|||
130492207|NCT04757753|469772246|FG000|Overall Study|Lost to Follow-up|7|||
130492208|NCT04757753|469772247|FG001|Overall Study|Lost to Follow-up|7|||
130492209|NCT04757753|469772246|FG000|Overall Study|Withdrawal by Subject|0|||
130492210|NCT04757753|469772247|FG001|Overall Study|Withdrawal by Subject|3|||
130492211|NCT04757753|469772246|FG000|Overall Study|Endodontic treatment failure|1|||
130492212|NCT04757753|469772247|FG001|Overall Study|Endodontic treatment failure|2|||
130492213|NCT04757753|469772246|FG000|Overall Study|Tooth fracture/extraction|3|||
130492214|NCT04757753|469772247|FG001|Overall Study|Tooth fracture/extraction|0|||
130492215|NCT00328783|469772248|FG000|Overall Study|Could not tolerate ABC|21|||
130492216|NCT00328783|469772248|FG000|Overall Study|No heart in RT field|4|||
130492217|NCT00328783|469772248|FG000|Overall Study|Withdrawal by Subject|1|||
130492218|NCT00357682|469772249|FG000|Overall Study|Did not receive allocated Treatment|10|||
130492219|NCT00357682|469772250|FG001|Overall Study|Did not receive allocated Treatment|9|||
130492220|NCT00357682|469772251|FG002|Overall Study|Did not receive allocated Treatment|9|||
130492221|NCT00357682|469772252|FG003|Overall Study|Did not receive allocated Treatment|10|||
130492222|NCT00357682|469772249|FG000|Overall Study|Withdrew consent|6|||
130492223|NCT00357682|469772250|FG001|Overall Study|Withdrew consent|6|||
130492224|NCT00357682|469772251|FG002|Overall Study|Withdrew consent|5|||
130492225|NCT00357682|469772252|FG003|Overall Study|Withdrew consent|5|||
130492226|NCT00357682|469772249|FG000|Overall Study|Lost to Follow-up|39|||
130492227|NCT00357682|469772250|FG001|Overall Study|Lost to Follow-up|33|||
130492228|NCT00357682|469772251|FG002|Overall Study|Lost to Follow-up|26|||
130492229|NCT00357682|469772252|FG003|Overall Study|Lost to Follow-up|35|||
130492230|NCT00357682|469772249|FG000|Overall Study|Adverse Event|24|||
130492231|NCT00357682|469772250|FG001|Overall Study|Adverse Event|32|||
130492232|NCT00357682|469772251|FG002|Overall Study|Adverse Event|22|||
130492233|NCT00357682|469772252|FG003|Overall Study|Adverse Event|27|||
130492234|NCT00357682|469772249|FG000|Overall Study|Physician Decision|32|||
130492235|NCT00357682|469772250|FG001|Overall Study|Physician Decision|20|||
130492236|NCT00357682|469772251|FG002|Overall Study|Physician Decision|24|||
130492237|NCT00357682|469772252|FG003|Overall Study|Physician Decision|30|||
130492238|NCT00357682|469772249|FG000|Overall Study|Patient decision|73|||
130492239|NCT00357682|469772250|FG001|Overall Study|Patient decision|80|||
130492240|NCT00357682|469772251|FG002|Overall Study|Patient decision|51|||
130492241|NCT00357682|469772252|FG003|Overall Study|Patient decision|59|||
130492242|NCT00357682|469772249|FG000|Overall Study|Other reason|157|||
130492243|NCT00357682|469772250|FG001|Overall Study|Other reason|130|||
130492244|NCT00357682|469772251|FG002|Overall Study|Other reason|114|||
130492245|NCT00357682|469772252|FG003|Overall Study|Other reason|99|||
130492246|NCT02701283|469772263|FG000|Overall Study|Death|25|||
130492247|NCT02701283|469772264|FG001|Overall Study|Death|29|||
130492248|NCT02701283|469772265|FG002|Overall Study|Death|19|||
130492249|NCT02701283|469772263|FG000|Overall Study|Lost to Follow-up|3|||
130492250|NCT02701283|469772264|FG001|Overall Study|Lost to Follow-up|8|||
130492251|NCT02701283|469772265|FG002|Overall Study|Lost to Follow-up|1|||
130492252|NCT02701283|469772263|FG000|Overall Study|Withdrawal by Subject|12|||
130492253|NCT02701283|469772264|FG001|Overall Study|Withdrawal by Subject|41|||
130492254|NCT02701283|469772265|FG002|Overall Study|Withdrawal by Subject|1|||
130492255|NCT02701283|469772263|FG000|Overall Study|Missed 2-year visit|22|||
130492256|NCT02701283|469772264|FG001|Overall Study|Missed 2-year visit|27|||
130492257|NCT02701283|469772265|FG002|Overall Study|Missed 2-year visit|0|||
130492258|NCT02701283|469772263|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
130492259|NCT02701283|469772264|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
130492260|NCT02701283|469772265|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
130492261|NCT04012567|469772266|FG000|Overall Study|Lost to Follow-up|0|||
130492262|NCT04012567|469772267|FG001|Overall Study|Lost to Follow-up|1|||
130492263|NCT04012567|469772266|FG000|Overall Study|Withdrawal by Subject|1|||
130492264|NCT04012567|469772267|FG001|Overall Study|Withdrawal by Subject|0|||
130492265|NCT05795153|469773014|FG000|Overall Study|Adverse Event|2|||
130492266|NCT05795153|469773014|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130492267|NCT05795153|469773014|FG000|Overall Study|Lost to Follow-up|1|||
130492268|NCT05795153|469773014|FG000|Overall Study|Subject decision|2|||
130492269|NCT05180539|469773015|FG000|Overall Study|Lost to Follow-up|27|||
130492270|NCT05180539|469773016|FG001|Overall Study|Lost to Follow-up|30|||
130492271|NCT02566889|469773017|FG000|Overall Study|Withdrawal by Subject|3|||
130492272|NCT02566889|469773018|FG001|Overall Study|Withdrawal by Subject|1|||
130492273|NCT02566889|469773017|FG000|Overall Study|Adverse Event|4|||
130492274|NCT02566889|469773018|FG001|Overall Study|Adverse Event|2|||
130492275|NCT02566889|469773017|FG000|Overall Study|Other|6|||
130492276|NCT02566889|469773018|FG001|Overall Study|Other|2|||
130492277|NCT04518943|469773019|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
130492278|NCT04518943|469773020|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
130492279|NCT04518943|469773021|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
130492280|NCT04518943|469773022|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
130492281|NCT04518943|469773023|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
130492282|NCT04518943|469773024|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
130492283|NCT04518943|469773025|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
130492284|NCT04518943|469773026|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
130492285|NCT04518943|469773027|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
130492286|NCT04518943|469773028|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
130492287|NCT04518943|469773029|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
130492288|NCT04518943|469773030|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
130492289|NCT04518943|469773031|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
130492290|NCT04518943|469773032|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
130492291|NCT04518943|469773033|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
130492292|NCT04518943|469773034|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
130492293|NCT03699163|469773035|FG000|Overall Study|Physician Decision|12|||
130492294|NCT03699163|469773036|FG001|Overall Study|Physician Decision|0|||
130492295|NCT03699163|469773035|FG000|Overall Study|failed QC measures|205|||
130492296|NCT03699163|469773036|FG001|Overall Study|failed QC measures|206|||
130492297|NCT03875313|469773040|FG000|Overall Study|Withdrawal by Subject|1|||
130492298|NCT03875313|469773041|FG001|Overall Study|Withdrawal by Subject|3|||
130492299|NCT03875313|469773042|FG002|Overall Study|Withdrawal by Subject|0|||
130492300|NCT03875313|469773043|FG003|Overall Study|Withdrawal by Subject|0|||
130492301|NCT03875313|469773044|FG004|Overall Study|Withdrawal by Subject|0|||
130492302|NCT03875313|469773040|FG000|Overall Study|Death|0|||
130492303|NCT03875313|469773041|FG001|Overall Study|Death|0|||
130492304|NCT03875313|469773042|FG002|Overall Study|Death|0|||
130492305|NCT03875313|469773043|FG003|Overall Study|Death|0|||
130492306|NCT03875313|469773044|FG004|Overall Study|Death|1|||
130492307|NCT03875313|469773040|FG000|Overall Study|Lost to Follow-up|0|||
130492308|NCT03875313|469773041|FG001|Overall Study|Lost to Follow-up|0|||
130492309|NCT03875313|469773042|FG002|Overall Study|Lost to Follow-up|0|||
130492310|NCT03875313|469773043|FG003|Overall Study|Lost to Follow-up|0|||
130492311|NCT03875313|469773044|FG004|Overall Study|Lost to Follow-up|1|||
130492312|NCT03875313|469773040|FG000|Overall Study|Study Termination by Sponsor|0|||
130492313|NCT03875313|469773041|FG001|Overall Study|Study Termination by Sponsor|1|||
130492314|NCT03875313|469773042|FG002|Overall Study|Study Termination by Sponsor|1|||
130492315|NCT03875313|469773043|FG003|Overall Study|Study Termination by Sponsor|0|||
130492316|NCT03875313|469773044|FG004|Overall Study|Study Termination by Sponsor|1|||
130492317|NCT03875313|469773040|FG000|Overall Study|New Anticancer Treatment|0|||
130492318|NCT03875313|469773041|FG001|Overall Study|New Anticancer Treatment|1|||
130492319|NCT03875313|469773042|FG002|Overall Study|New Anticancer Treatment|2|||
130492320|NCT03875313|469773043|FG003|Overall Study|New Anticancer Treatment|1|||
130492321|NCT03875313|469773044|FG004|Overall Study|New Anticancer Treatment|0|||
130492322|NCT03875313|469773040|FG000|Overall Study|Other, Not Specified|2|||
130492323|NCT03875313|469773041|FG001|Overall Study|Other, Not Specified|11|||
130492324|NCT03875313|469773042|FG002|Overall Study|Other, Not Specified|3|||
130492325|NCT03875313|469773043|FG003|Overall Study|Other, Not Specified|3|||
130492326|NCT03875313|469773044|FG004|Overall Study|Other, Not Specified|1|||
130492327|NCT03286114|469773046|FG000|Overall Study|Adverse Event|6|||
130492328|NCT03286114|469773046|FG000|Overall Study|Death|3|||
130492329|NCT02075554|469773048|FG000|Overall Study|Lost to Follow-up|7|||
130492330|NCT02075554|469773048|FG000|Overall Study|Withdrawal by Subject|5|||
130492331|NCT02075554|469773048|FG000|Overall Study|Physician Decision|3|||
130492332|NCT04993677|469773055|FG000|Overall Study|Lost to Follow-up|1|||
130492333|NCT04993677|469773056|FG001|Overall Study|Lost to Follow-up|0|||
130728819|NCT00086281|470628693|FG009|Phase 1|Protocol Violation|0|||
130728820|NCT00086281|470628694|FG010|Phase 1|Protocol Violation|1|||
130728821|NCT00086281|470628695|FG011|Phase 1|Protocol Violation|0|||
130492334|NCT04993677|469773057|FG002|Overall Study|Lost to Follow-up|0|||
130492335|NCT04993677|469773058|FG003|Overall Study|Lost to Follow-up|0|||
130492336|NCT04993677|469773055|FG000|Overall Study|Death|11|||
130492337|NCT04993677|469773056|FG001|Overall Study|Death|8|||
130492338|NCT04993677|469773057|FG002|Overall Study|Death|3|||
130492339|NCT04993677|469773058|FG003|Overall Study|Death|1|||
130492340|NCT04993677|469773055|FG000|Overall Study|Subject withdrawal of consent|4|||
130492341|NCT04993677|469773056|FG001|Overall Study|Subject withdrawal of consent|3|||
130492342|NCT04993677|469773057|FG002|Overall Study|Subject withdrawal of consent|0|||
130492343|NCT04993677|469773058|FG003|Overall Study|Subject withdrawal of consent|2|||
130492344|NCT04993677|469773055|FG000|Overall Study|Study termination by sponsor|3|||
130492345|NCT04993677|469773056|FG001|Overall Study|Study termination by sponsor|25|||
130492346|NCT04993677|469773057|FG002|Overall Study|Study termination by sponsor|3|||
130492347|NCT04993677|469773058|FG003|Overall Study|Study termination by sponsor|3|||
130492348|NCT04993677|469773055|FG000|Overall Study|Other|2|||
130492349|NCT04993677|469773056|FG001|Overall Study|Other|3|||
130492350|NCT04993677|469773057|FG002|Overall Study|Other|3|||
130492351|NCT04993677|469773058|FG003|Overall Study|Other|2|||
130492352|NCT00003222|469773065|FG000|Overall Study|Physician Decision|0|||
130492353|NCT00003222|469773066|FG001|Overall Study|Physician Decision|1|||
130492354|NCT03767335|469773067|FG000|Overall Study|Physician Decision|1|||
130492355|NCT03767335|469773068|FG001|Overall Study|Physician Decision|1|||
130492356|NCT03767335|469773069|FG002|Overall Study|Physician Decision|0|||
130492357|NCT03767335|469773067|FG000|Overall Study|Withdrawal by Subject|0|||
130492358|NCT03767335|469773068|FG001|Overall Study|Withdrawal by Subject|0|||
130492359|NCT03767335|469773069|FG002|Overall Study|Withdrawal by Subject|6|||
130492360|NCT03767335|469773067|FG000|Overall Study|Participant excluded from efficacy population|0|||
130492361|NCT03767335|469773068|FG001|Overall Study|Participant excluded from efficacy population|0|||
130492362|NCT03767335|469773069|FG002|Overall Study|Participant excluded from efficacy population|1|||
130492363|NCT03767335|469773067|FG000|Overall Study|Death|0|||
130492364|NCT03767335|469773068|FG001|Overall Study|Death|0|||
130492365|NCT03767335|469773069|FG002|Overall Study|Death|2|||
130492366|NCT03767335|469773067|FG000|Overall Study|Progressive Disease|2|||
130492367|NCT03767335|469773068|FG001|Overall Study|Progressive Disease|2|||
130492368|NCT03767335|469773069|FG002|Overall Study|Progressive Disease|2|||
130492369|NCT03767335|469773067|FG000|Overall Study|Disease progression needing additional medication|0|||
130492370|NCT03767335|469773068|FG001|Overall Study|Disease progression needing additional medication|0|||
130492371|NCT03767335|469773069|FG002|Overall Study|Disease progression needing additional medication|17|||
130492372|NCT03767335|469773067|FG000|Overall Study|Sponsor decision|0|||
130492373|NCT03767335|469773068|FG001|Overall Study|Sponsor decision|0|||
130492374|NCT03767335|469773069|FG002|Overall Study|Sponsor decision|2|||
130492375|NCT03767335|469773067|FG000|Overall Study|Other Medical Reasons|0|||
130492376|NCT03767335|469773068|FG001|Overall Study|Other Medical Reasons|0|||
130492377|NCT03767335|469773069|FG002|Overall Study|Other Medical Reasons|3|||
130492378|NCT04495621|469773071|FG000|Overall Study|Withdrawal by Subject|0|||
130492379|NCT04495621|469773072|FG001|Overall Study|Withdrawal by Subject|3|||
130492380|NCT04495621|469773071|FG000|Overall Study|Death|7|||
130492381|NCT04495621|469773072|FG001|Overall Study|Death|11|||
130492382|NCT04495621|469773071|FG000|Overall Study|Investigator Decision|0|||
130492383|NCT04495621|469773072|FG001|Overall Study|Investigator Decision|7|||
130492384|NCT04495621|469773071|FG000|Overall Study|Lost to Follow-up|0|||
130492385|NCT04495621|469773072|FG001|Overall Study|Lost to Follow-up|1|||
130492386|NCT01313559|469773078|FG000|Overall Study|Withdrawal by Subject|1|||
130492387|NCT01313559|469773079|FG001|Overall Study|Withdrawal by Subject|2|||
130492388|NCT01313559|469773078|FG000|Overall Study|Disease progression|1|||
130492389|NCT01313559|469773079|FG001|Overall Study|Disease progression|0|||
130492390|NCT01313559|469773078|FG000|Overall Study|Rising PSA|2|||
130492391|NCT01313559|469773079|FG001|Overall Study|Rising PSA|0|||
130492392|NCT02656706|469773080|FG000|Overall Study|Insurance Denial|1|||
130492393|NCT03725332|469773081|FG000|Overall Study|Adverse Event|5|||
130728822|NCT00086281|470628696|FG012|Phase 1|Protocol Violation|0|||
130492394|NCT03725332|469773082|FG001|Overall Study|Adverse Event|10|||
130728823|NCT00086281|470628697|FG013|Phase 1|Protocol Violation|0|||
130492395|NCT03725332|469773081|FG000|Overall Study|Death|1|||
130492396|NCT03725332|469773082|FG001|Overall Study|Death|3|||
130492397|NCT03725332|469773081|FG000|Overall Study|Lost to Follow-up|43|||
130492398|NCT03725332|469773082|FG001|Overall Study|Lost to Follow-up|122|||
130492399|NCT03725332|469773081|FG000|Overall Study|Withdrawal by Subject|0|||
130492400|NCT03725332|469773082|FG001|Overall Study|Withdrawal by Subject|1|||
130492401|NCT03725332|469773081|FG000|Overall Study|Duplicate enrollment|0|||
130492402|NCT03725332|469773082|FG001|Overall Study|Duplicate enrollment|1|||
130728824|NCT00086281|470628698|FG014|Phase 1|Protocol Violation|0|||
130728825|NCT00086281|470628684|FG000|Phase 1|Serious Adverse Event|0|||
130492403|NCT03725332|469773081|FG000|Overall Study|Did not consent|0|||
130492404|NCT03725332|469773082|FG001|Overall Study|Did not consent|1|||
130492405|NCT04908514|469773090|FG000|Overall Study|Lost to Follow-up|2|||
130492406|NCT04908514|469773090|FG000|Overall Study|Withdrawal by Subject|1|||
130492407|NCT03248492|469773689|FG000|Overall Study|Progressive Disease|24|||
130492408|NCT03248492|469773690|FG001|Overall Study|Progressive Disease|23|||
130492409|NCT03248492|469773691|FG002|Overall Study|Progressive Disease|11|||
130492410|NCT03248492|469773692|FG003|Overall Study|Progressive Disease|66|||
130492411|NCT03248492|469773693|FG004|Overall Study|Progressive Disease|1|||
130492412|NCT03248492|469773689|FG000|Overall Study|Adverse Event|14|||
130492413|NCT03248492|469773690|FG001|Overall Study|Adverse Event|13|||
130492414|NCT03248492|469773691|FG002|Overall Study|Adverse Event|9|||
130492415|NCT03248492|469773692|FG003|Overall Study|Adverse Event|22|||
130492416|NCT03248492|469773693|FG004|Overall Study|Adverse Event|2|||
130492417|NCT03248492|469773689|FG000|Overall Study|Withdrawal by Subject|5|||
130492418|NCT03248492|469773690|FG001|Overall Study|Withdrawal by Subject|4|||
130492419|NCT03248492|469773691|FG002|Overall Study|Withdrawal by Subject|0|||
130492420|NCT03248492|469773692|FG003|Overall Study|Withdrawal by Subject|8|||
130492421|NCT03248492|469773693|FG004|Overall Study|Withdrawal by Subject|1|||
130492422|NCT03248492|469773689|FG000|Overall Study|Physician Decision|1|||
130492423|NCT03248492|469773690|FG001|Overall Study|Physician Decision|1|||
130492424|NCT03248492|469773691|FG002|Overall Study|Physician Decision|1|||
130492425|NCT03248492|469773692|FG003|Overall Study|Physician Decision|7|||
130492426|NCT03248492|469773693|FG004|Overall Study|Physician Decision|0|||
130492427|NCT03248492|469773689|FG000|Overall Study|Death|1|||
130492428|NCT03248492|469773690|FG001|Overall Study|Death|1|||
130492429|NCT03248492|469773691|FG002|Overall Study|Death|0|||
130492430|NCT03248492|469773692|FG003|Overall Study|Death|6|||
130492431|NCT03248492|469773693|FG004|Overall Study|Death|0|||
130492432|NCT03248492|469773689|FG000|Overall Study|Study Terminated by Sponsor|3|||
130492433|NCT03248492|469773690|FG001|Overall Study|Study Terminated by Sponsor|1|||
130492434|NCT03248492|469773691|FG002|Overall Study|Study Terminated by Sponsor|0|||
130492435|NCT03248492|469773692|FG003|Overall Study|Study Terminated by Sponsor|7|||
130492436|NCT03248492|469773693|FG004|Overall Study|Study Terminated by Sponsor|0|||
130492437|NCT03248492|469773689|FG000|Overall Study|Other|2|||
130492438|NCT03248492|469773690|FG001|Overall Study|Other|5|||
130492439|NCT03248492|469773691|FG002|Overall Study|Other|0|||
130492440|NCT03248492|469773692|FG003|Overall Study|Other|14|||
130492441|NCT03248492|469773693|FG004|Overall Study|Other|0|||
130492442|NCT03705390|469773694|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
130492443|NCT03705390|469773694|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
130492444|NCT01830595|469773696|FG000|First Period|Withdrawal by Subject|1|||
130492445|NCT01830595|469773697|FG001|First Period|Withdrawal by Subject|3|||
130492446|NCT01830595|469773696|FG000|Washout|Withdrawal by Subject|2|||
130492447|NCT01830595|469773697|FG001|Washout|Withdrawal by Subject|2|||
130492448|NCT04940624|469773698|FG000|Overall Study|Adverse Event|4|||
130492449|NCT04940624|469773699|FG001|Overall Study|Adverse Event|11|||
130492450|NCT04940624|469773698|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130492451|NCT04940624|469773699|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130492452|NCT04940624|469773698|FG000|Overall Study|Physician Decision|1|||
130492453|NCT04940624|469773699|FG001|Overall Study|Physician Decision|0|||
130492454|NCT04940624|469773698|FG000|Overall Study|Lost to Follow-up|1|||
130492455|NCT04940624|469773699|FG001|Overall Study|Lost to Follow-up|0|||
130492456|NCT04940624|469773698|FG000|Overall Study|Reason Not Specified|1|||
130492457|NCT04940624|469773699|FG001|Overall Study|Reason Not Specified|0|||
130492458|NCT05116774|469773703|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
130492459|NCT05116774|469773704|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
130492460|NCT05116774|469773703|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
130492461|NCT05116774|469773704|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
130492462|NCT05116774|469773703|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
130492463|NCT05116774|469773704|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
130492464|NCT05116774|469773703|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
130492465|NCT05116774|469773704|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
130492466|NCT03150862|469773706|FG000|Overall Study|Death|2|||
130492467|NCT03150862|469773707|FG001|Overall Study|Death|7|||
130728826|NCT00086281|470628685|FG001|Phase 1|Serious Adverse Event|0|||
130492468|NCT03150862|469773708|FG002|Overall Study|Death|8|||
130492469|NCT03150862|469773709|FG003|Overall Study|Death|27|||
130728827|NCT00086281|470628686|FG002|Phase 1|Serious Adverse Event|0|||
130492470|NCT03150862|469773710|FG004|Overall Study|Death|4|||
130492471|NCT03150862|469773711|FG005|Overall Study|Death|8|||
130492472|NCT03150862|469773712|FG006|Overall Study|Death|6|||
130492473|NCT03150862|469773713|FG007|Overall Study|Death|21|||
130492474|NCT03150862|469773706|FG000|Overall Study|Withdrawal by Subject|1|||
130492475|NCT03150862|469773707|FG001|Overall Study|Withdrawal by Subject|1|||
130492476|NCT03150862|469773708|FG002|Overall Study|Withdrawal by Subject|0|||
130492477|NCT03150862|469773709|FG003|Overall Study|Withdrawal by Subject|3|||
130492478|NCT03150862|469773710|FG004|Overall Study|Withdrawal by Subject|1|||
130492479|NCT03150862|469773711|FG005|Overall Study|Withdrawal by Subject|1|||
130492480|NCT03150862|469773712|FG006|Overall Study|Withdrawal by Subject|1|||
130728828|NCT00086281|470628687|FG003|Phase 1|Serious Adverse Event|0|||
130492481|NCT03150862|469773713|FG007|Overall Study|Withdrawal by Subject|3|||
130492482|NCT03150862|469773706|FG000|Overall Study|Lost to Follow-up|0|||
130492483|NCT03150862|469773707|FG001|Overall Study|Lost to Follow-up|0|||
130492484|NCT03150862|469773708|FG002|Overall Study|Lost to Follow-up|1|||
130492485|NCT03150862|469773709|FG003|Overall Study|Lost to Follow-up|0|||
130492486|NCT03150862|469773710|FG004|Overall Study|Lost to Follow-up|0|||
130492487|NCT03150862|469773711|FG005|Overall Study|Lost to Follow-up|0|||
130492488|NCT03150862|469773712|FG006|Overall Study|Lost to Follow-up|0|||
130492489|NCT03150862|469773713|FG007|Overall Study|Lost to Follow-up|2|||
130492490|NCT03150862|469773706|FG000|Overall Study|Sponsor's decision|0|||
130492491|NCT03150862|469773707|FG001|Overall Study|Sponsor's decision|0|||
130492492|NCT03150862|469773708|FG002|Overall Study|Sponsor's decision|0|||
130492493|NCT03150862|469773709|FG003|Overall Study|Sponsor's decision|10|||
130492494|NCT03150862|469773710|FG004|Overall Study|Sponsor's decision|3|||
130492495|NCT03150862|469773711|FG005|Overall Study|Sponsor's decision|0|||
130492496|NCT03150862|469773712|FG006|Overall Study|Sponsor's decision|1|||
130492497|NCT03150862|469773713|FG007|Overall Study|Sponsor's decision|1|||
130492498|NCT03150862|469773706|FG000|Overall Study|Change in Methylation status|0|||
130492499|NCT03150862|469773707|FG001|Overall Study|Change in Methylation status|0|||
130492500|NCT03150862|469773708|FG002|Overall Study|Change in Methylation status|0|||
130492501|NCT03150862|469773709|FG003|Overall Study|Change in Methylation status|0|||
130492502|NCT03150862|469773710|FG004|Overall Study|Change in Methylation status|1|||
130492503|NCT03150862|469773711|FG005|Overall Study|Change in Methylation status|0|||
130492504|NCT03150862|469773712|FG006|Overall Study|Change in Methylation status|0|||
130492505|NCT03150862|469773713|FG007|Overall Study|Change in Methylation status|0|||
130492506|NCT03150862|469773706|FG000|Overall Study|Roll over in to Long Term Extension|0|||
130492507|NCT03150862|469773707|FG001|Overall Study|Roll over in to Long Term Extension|0|||
130492508|NCT03150862|469773708|FG002|Overall Study|Roll over in to Long Term Extension|0|||
130492509|NCT03150862|469773709|FG003|Overall Study|Roll over in to Long Term Extension|0|||
130492510|NCT03150862|469773710|FG004|Overall Study|Roll over in to Long Term Extension|0|||
130492511|NCT03150862|469773711|FG005|Overall Study|Roll over in to Long Term Extension|0|||
130492512|NCT03150862|469773712|FG006|Overall Study|Roll over in to Long Term Extension|0|||
130728829|NCT00086281|470628688|FG004|Phase 1|Serious Adverse Event|0|||
130728830|NCT00086281|470628689|FG005|Phase 1|Serious Adverse Event|0|||
130728831|NCT00086281|470628690|FG006|Phase 1|Serious Adverse Event|0|||
130492513|NCT03150862|469773713|FG007|Overall Study|Roll over in to Long Term Extension|1|||
130492514|NCT03150862|469773706|FG000|Overall Study|Progressive Disease|0|||
130492515|NCT03150862|469773707|FG001|Overall Study|Progressive Disease|0|||
130492516|NCT03150862|469773708|FG002|Overall Study|Progressive Disease|0|||
130492517|NCT03150862|469773709|FG003|Overall Study|Progressive Disease|0|||
130492518|NCT03150862|469773710|FG004|Overall Study|Progressive Disease|0|||
130492519|NCT03150862|469773711|FG005|Overall Study|Progressive Disease|0|||
130492520|NCT03150862|469773712|FG006|Overall Study|Progressive Disease|0|||
130492521|NCT03150862|469773713|FG007|Overall Study|Progressive Disease|2|||
130492522|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
130492523|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
130492524|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
130492525|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
130492526|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
130492527|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
130492528|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
130492529|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
130492530|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
130492531|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
130492532|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
130492533|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
130492534|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
130492535|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
130492536|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
130492537|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
130492538|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
130492539|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
130492540|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
130492541|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
130492542|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
130492543|NCT04505722|469773715|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
130492544|NCT04505722|469773716|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
130492545|NCT04505722|469773717|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
130492546|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
130492547|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
130492548|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
130492549|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
130492550|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
130728832|NCT00086281|470628691|FG007|Phase 1|Serious Adverse Event|0|||
130492551|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
130492552|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
130492553|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
130492554|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
130492555|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
130492556|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
130492557|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
130492558|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
130492559|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
130492560|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
130492561|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
130492562|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
130492563|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
130492564|NCT04505722|469773715|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
130492565|NCT04505722|469773716|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
130492566|NCT04505722|469773717|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
130492567|NCT04755595|469773718|FG000|Overall Study|Lost to Follow-up|1|||
130492568|NCT00319696|469773719|FG000|Overall Study|Adverse Event|36|||
130492569|NCT00319696|469773719|FG000|Overall Study|withdrawal of consent|14|||
130492570|NCT00319696|469773719|FG000|Overall Study|administrative|7|||
130492571|NCT00319696|469773719|FG000|Overall Study|Lost to Follow-up|3|||
130492572|NCT03891758|469773721|FG000|Overall Study|Adverse Event|2|||
130492573|NCT03891758|469773722|FG001|Overall Study|Adverse Event|0|||
130492574|NCT03891758|469773721|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130492575|NCT03891758|469773722|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130492576|NCT05039021|469774311|FG000|Overall Study|Death|1|||
130492577|NCT05039021|469774311|FG000|Overall Study|Lost to Follow-up|3|||
130492578|NCT04977583|469774312|FG000|Overall Study|Lost to Follow-up|8|||
130492579|NCT04977583|469774313|FG001|Overall Study|Lost to Follow-up|4|||
130492580|NCT04977583|469774314|FG002|Overall Study|Lost to Follow-up|13|||
130492581|NCT04977583|469774312|FG000|Overall Study|Withdrawal by Subject|3|||
130492582|NCT04977583|469774313|FG001|Overall Study|Withdrawal by Subject|2|||
130492583|NCT04977583|469774314|FG002|Overall Study|Withdrawal by Subject|1|||
130492584|NCT02422615|469774315|FG000|Treatment Period|Progressive disease|314|||
130492585|NCT02422615|469774316|FG001|Treatment Period|Progressive disease|200|||
130492586|NCT02422615|469774315|FG000|Treatment Period|Adverse Event|51|||
130492587|NCT02422615|469774316|FG001|Treatment Period|Adverse Event|9|||
130492588|NCT02422615|469774315|FG000|Treatment Period|Physician Decision|32|||
130492589|NCT02422615|469774316|FG001|Treatment Period|Physician Decision|8|||
130492590|NCT02422615|469774315|FG000|Treatment Period|Subject/guardian decision|38|||
130492591|NCT02422615|469774316|FG001|Treatment Period|Subject/guardian decision|8|||
130492592|NCT02422615|469774315|FG000|Treatment Period|Death|2|||
130492593|NCT02422615|469774316|FG001|Treatment Period|Death|1|||
130492594|NCT02422615|469774315|FG000|Treatment Period|Technical problems|0|||
130492595|NCT02422615|469774316|FG001|Treatment Period|Technical problems|1|||
130492596|NCT02422615|469774315|FG000|Treatment Period|Protocol deviation|1|||
130492597|NCT02422615|469774316|FG001|Treatment Period|Protocol deviation|1|||
130492598|NCT02422615|469774315|FG000|Treatment Period|Study terminated as per protocol|46|||
130492599|NCT02422615|469774316|FG001|Treatment Period|Study terminated as per protocol|14|||
130492600|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130492601|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130492602|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Death|2|||
130492603|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130492604|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130492605|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130492606|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
130492607|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
130492608|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
130492609|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
130492610|NCT02422615|469774315|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
130492611|NCT02422615|469774316|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
130492612|NCT01639131|469774317|FG000|Overall Study|Disease Progression|6|||
130492613|NCT04121546|469774322|FG000|Overall Study|Lost to Follow-up|1|||
130492614|NCT04121546|469774323|FG001|Overall Study|Lost to Follow-up|3|||
130492615|NCT03653364|469774324|FG000|Overall Study|Withdrawal by Subject|1|||
130492616|NCT03653364|469774324|FG000|Overall Study|Enrolled in Error|1|||
130492617|NCT03653364|469774324|FG000|Overall Study|Death|1|||
130492618|NCT00686595|469774325|FG000|Overall Study|Adverse Event|3|||
130492619|NCT00686595|469774325|FG000|Overall Study|Protocol Violation|1|||
130492620|NCT00686595|469774325|FG000|Overall Study|Lost to Follow-up|1|||
130492621|NCT00686595|469774325|FG000|Overall Study|Lack of Efficacy|1|||
130492622|NCT00686595|469774325|FG000|Overall Study|Poor Compliance|1|||
130492623|NCT00087685|469774337|FG000|Overall Study|Adverse Event|5|||
130492624|NCT00087685|469774337|FG000|Overall Study|Non-Compliance|1|||
130492625|NCT00087685|469774337|FG000|Overall Study|Progressive Disease|5|||
130492626|NCT00087685|469774337|FG000|Overall Study|Withdrawal by Subject|3|||
130492627|NCT03213457|469774338|FG000|Screening Period|Withdrawal by Subject|0|||
130492628|NCT03213457|469774339|FG001|Screening Period|Withdrawal by Subject|1|||
130492629|NCT03213457|469774340|FG002|Screening Period|Withdrawal by Subject|0|||
130492630|NCT03213457|469774338|FG000|Screening Period|Other|1|||
130492631|NCT03213457|469774339|FG001|Screening Period|Other|0|||
130492632|NCT03213457|469774340|FG002|Screening Period|Other|0|||
130492633|NCT03213457|469774338|FG000|Double-Blind Period|Adverse Event|3|||
130492634|NCT03213457|469774339|FG001|Double-Blind Period|Adverse Event|2|||
130492635|NCT03213457|469774340|FG002|Double-Blind Period|Adverse Event|7|||
130492636|NCT03213457|469774338|FG000|Double-Blind Period|Withdrawal by Subject|14|||
130492637|NCT03213457|469774339|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130492638|NCT03213457|469774340|FG002|Double-Blind Period|Withdrawal by Subject|14|||
130492639|NCT03213457|469774338|FG000|Double-Blind Period|Lost to Follow-up|2|||
130492640|NCT03213457|469774339|FG001|Double-Blind Period|Lost to Follow-up|3|||
130492641|NCT03213457|469774340|FG002|Double-Blind Period|Lost to Follow-up|9|||
130492642|NCT03213457|469774338|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
130492643|NCT03213457|469774339|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
130492644|NCT03213457|469774340|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
130492645|NCT03213457|469774338|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
130492646|NCT03213457|469774339|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
130492647|NCT03213457|469774340|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
130492648|NCT03213457|469774338|FG000|Double-Blind Period|Pregnancy|5|||
130492649|NCT03213457|469774339|FG001|Double-Blind Period|Pregnancy|0|||
130492650|NCT03213457|469774340|FG002|Double-Blind Period|Pregnancy|0|||
130492651|NCT03213457|469774338|FG000|Double-Blind Period|Other|10|||
130492652|NCT03213457|469774339|FG001|Double-Blind Period|Other|3|||
130492653|NCT03213457|469774340|FG002|Double-Blind Period|Other|17|||
130492654|NCT03213457|469774338|FG000|Open-Label Period|Adverse Event|1|||
130492655|NCT03213457|469774339|FG001|Open-Label Period|Adverse Event|2|||
130492656|NCT03213457|469774340|FG002|Open-Label Period|Adverse Event|2|||
130492657|NCT03213457|469774338|FG000|Open-Label Period|Withdrawal by Subject|12|||
130492658|NCT03213457|469774339|FG001|Open-Label Period|Withdrawal by Subject|5|||
130492659|NCT03213457|469774340|FG002|Open-Label Period|Withdrawal by Subject|24|||
130492660|NCT03213457|469774338|FG000|Open-Label Period|Lost to Follow-up|1|||
130492661|NCT03213457|469774339|FG001|Open-Label Period|Lost to Follow-up|2|||
130492662|NCT03213457|469774340|FG002|Open-Label Period|Lost to Follow-up|8|||
130492663|NCT03213457|469774338|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
130492664|NCT03213457|469774339|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
130492665|NCT03213457|469774340|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
130492666|NCT03213457|469774338|FG000|Open-Label Period|Non-compliance with study procedures|1|||
130492667|NCT03213457|469774339|FG001|Open-Label Period|Non-compliance with study procedures|1|||
130492668|NCT03213457|469774340|FG002|Open-Label Period|Non-compliance with study procedures|2|||
130492669|NCT03213457|469774338|FG000|Open-Label Period|Exclusionary medications|0|||
130492670|NCT03213457|469774339|FG001|Open-Label Period|Exclusionary medications|0|||
130492671|NCT03213457|469774340|FG002|Open-Label Period|Exclusionary medications|1|||
130492672|NCT03213457|469774338|FG000|Open-Label Period|Other|1|||
130492673|NCT03213457|469774339|FG001|Open-Label Period|Other|1|||
130492674|NCT03213457|469774340|FG002|Open-Label Period|Other|6|||
130492675|NCT03213457|469774338|FG000|Follow-Up Period|Adverse Event|16|||
130492676|NCT03213457|469774339|FG001|Follow-Up Period|Adverse Event|8|||
130492677|NCT03213457|469774340|FG002|Follow-Up Period|Adverse Event|37|||
130492678|NCT03213457|469774338|FG000|Follow-Up Period|Withdrawal by Subject|18|||
130492679|NCT03213457|469774339|FG001|Follow-Up Period|Withdrawal by Subject|11|||
130492680|NCT03213457|469774340|FG002|Follow-Up Period|Withdrawal by Subject|55|||
130492681|NCT03213457|469774338|FG000|Follow-Up Period|Lost to Follow-up|28|||
130492682|NCT03213457|469774339|FG001|Follow-Up Period|Lost to Follow-up|15|||
130492683|NCT03213457|469774340|FG002|Follow-Up Period|Lost to Follow-up|50|||
130492684|NCT03213457|469774338|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
130492685|NCT03213457|469774339|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
130492686|NCT03213457|469774340|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
130728833|NCT00086281|470628692|FG008|Phase 1|Serious Adverse Event|0|||
130728834|NCT00086281|470628693|FG009|Phase 1|Serious Adverse Event|0|||
130728835|NCT00086281|470628694|FG010|Phase 1|Serious Adverse Event|0|||
130492687|NCT03213457|469774338|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
130492688|NCT03213457|469774339|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
130492689|NCT03213457|469774340|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
130492690|NCT03213457|469774338|FG000|Follow-Up Period|Pregnancy|7|||
130492691|NCT03213457|469774339|FG001|Follow-Up Period|Pregnancy|0|||
130728836|NCT00086281|470628695|FG011|Phase 1|Serious Adverse Event|0|||
130492692|NCT03213457|469774340|FG002|Follow-Up Period|Pregnancy|18|||
130492693|NCT03213457|469774338|FG000|Follow-Up Period|Exclusionary medications|1|||
130492694|NCT03213457|469774339|FG001|Follow-Up Period|Exclusionary medications|1|||
130492695|NCT03213457|469774340|FG002|Follow-Up Period|Exclusionary medications|5|||
130492696|NCT03213457|469774338|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
130492697|NCT03213457|469774339|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
130492698|NCT03213457|469774340|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
130492699|NCT03213457|469774338|FG000|Follow-Up Period|Other|14|||
130492700|NCT03213457|469774339|FG001|Follow-Up Period|Other|10|||
130492701|NCT03213457|469774340|FG002|Follow-Up Period|Other|31|||
130492702|NCT05934292|469774347|FG000|Overall Study|Lost to Follow-up|0|||
130492703|NCT05934292|469774348|FG001|Overall Study|Lost to Follow-up|0|||
130492704|NCT05934292|469774349|FG002|Overall Study|Lost to Follow-up|1|||
130492705|NCT05934292|469774350|FG003|Overall Study|Lost to Follow-up|0|||
130492706|NCT04479787|469774351|FG000|Through 6 Months|Withdrawal by Subject|16|||
130492707|NCT04479787|469774352|FG001|Through 6 Months|Withdrawal by Subject|14|||
130492708|NCT04479787|469774351|FG000|Through 6 Months|Unsuccessful Trial|17|||
130492709|NCT04479787|469774352|FG001|Through 6 Months|Unsuccessful Trial|0|||
130492710|NCT04479787|469774351|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
130492711|NCT04479787|469774352|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
130492712|NCT04479787|469774351|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
130492713|NCT04479787|469774352|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
130492714|NCT04479787|469774351|FG000|Through 6 Months|Lost to Follow-up|3|||
130492715|NCT04479787|469774352|FG001|Through 6 Months|Lost to Follow-up|2|||
130492716|NCT04479787|469774351|FG000|Through 6 Months|Death|3|||
130492717|NCT04479787|469774352|FG001|Through 6 Months|Death|0|||
130492718|NCT04479787|469774351|FG000|Through 6 Months|Inclusion/Exclusion|2|||
130492719|NCT04479787|469774352|FG001|Through 6 Months|Inclusion/Exclusion|1|||
130492720|NCT04479787|469774351|FG000|Through 6 Months|Subject Became Pregnant|1|||
130492721|NCT04479787|469774352|FG001|Through 6 Months|Subject Became Pregnant|1|||
130492722|NCT04479787|469774351|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
130492723|NCT04479787|469774352|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
130492724|NCT04479787|469774351|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
130492725|NCT04479787|469774352|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
130492726|NCT04479787|469774351|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
130492727|NCT04479787|469774352|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
130492728|NCT04479787|469774351|FG000|After 6 Months|Withdrawal by Subject|3|||
130492729|NCT04479787|469774352|FG001|After 6 Months|Withdrawal by Subject|13|||
130492730|NCT04479787|469774351|FG000|After 6 Months|Unsuccessful Trial|0|||
130492731|NCT04479787|469774352|FG001|After 6 Months|Unsuccessful Trial|7|||
130492732|NCT04479787|469774351|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
130492733|NCT04479787|469774352|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
130492734|NCT04479787|469774351|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
130492735|NCT04479787|469774352|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
130492736|NCT04479787|469774351|FG000|After 6 Months|Death|2|||
130492737|NCT04479787|469774352|FG001|After 6 Months|Death|0|||
130492738|NCT04479787|469774351|FG000|After 6 Months|Lost to Follow-up|1|||
130492739|NCT04479787|469774352|FG001|After 6 Months|Lost to Follow-up|1|||
130492740|NCT04479787|469774351|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
130492741|NCT04479787|469774352|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
130492742|NCT04479787|469774351|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
130492743|NCT04479787|469774352|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
130492744|NCT04479787|469774351|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
130492745|NCT04479787|469774352|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
130492746|NCT04479787|469774351|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
130492747|NCT04479787|469774352|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
130492748|NCT05714059|469774353|FG000|Overall Study|Withdrawal by Subject|2|||
130492749|NCT05714059|469774354|FG001|Overall Study|Withdrawal by Subject|2|||
130492750|NCT05714059|469774353|FG000|Overall Study|Adverse Event|0|||
130492751|NCT05714059|469774354|FG001|Overall Study|Adverse Event|1|||
130492752|NCT05714059|469774353|FG000|Overall Study|Lost to Follow-up|0|||
130492753|NCT05714059|469774354|FG001|Overall Study|Lost to Follow-up|1|||
130492754|NCT05714059|469774353|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
130492755|NCT05714059|469774354|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
130492756|NCT05714059|469774353|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
130492757|NCT05714059|469774354|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
130492758|NCT04899674|469774355|FG000|Test|Adverse Event|1|||
130492759|NCT03774472|469774356|FG000|Overall Study|Physician Decision|1|||
130565467|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
130565468|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130565469|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130728837|NCT00086281|470628696|FG012|Phase 1|Serious Adverse Event|0|||
130492760|NCT03774472|469774357|FG001|Overall Study|Physician Decision|0|||
130492761|NCT03774472|469774358|FG002|Overall Study|Physician Decision|0|||
130492762|NCT03774472|469774356|FG000|Overall Study|Progression prior to 4 weeks|0|||
130492763|NCT03774472|469774357|FG001|Overall Study|Progression prior to 4 weeks|1|||
130492764|NCT03774472|469774358|FG002|Overall Study|Progression prior to 4 weeks|0|||
130492765|NCT03774472|469774356|FG000|Overall Study|Withdrawal by Subject|0|||
130492766|NCT03774472|469774357|FG001|Overall Study|Withdrawal by Subject|1|||
130492767|NCT03774472|469774358|FG002|Overall Study|Withdrawal by Subject|0|||
130492768|NCT04059406|469774360|FG000|Overall Study|Early Treatment Termination|5|||
130492769|NCT04059406|469774361|FG001|Overall Study|Early Treatment Termination|5|||
130492770|NCT04059406|469774362|FG002|Overall Study|Early Treatment Termination|15|||
130492771|NCT05155306|469774363|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
130492772|NCT05155306|469774364|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
130492773|NCT05155306|469774365|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
130492774|NCT05155306|469774366|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
130492775|NCT05155306|469774363|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
130492776|NCT05155306|469774364|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
130492777|NCT05155306|469774365|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
130492778|NCT05155306|469774366|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
130492779|NCT01596972|469774792|FG000|Overall Study|Physician Decision|1|||
130492780|NCT01596972|469774793|FG001|Overall Study|Physician Decision|9|||
130492781|NCT01596972|469774792|FG000|Overall Study|Lost to Follow-up|0|||
130492782|NCT01596972|469774793|FG001|Overall Study|Lost to Follow-up|4|||
130492783|NCT01596972|469774792|FG000|Overall Study|Withdrawal by Subject|0|||
130492784|NCT01596972|469774793|FG001|Overall Study|Withdrawal by Subject|1|||
130492785|NCT01260896|469774795|FG000|First Intervention|Withdrawn Due to Emesis|2|||
130492786|NCT01260896|469774796|FG001|First Intervention|Withdrawn Due to Emesis|0|||
130492787|NCT05601882|469774797|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
130492788|NCT05601882|469774798|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
130728838|NCT00086281|470628697|FG013|Phase 1|Serious Adverse Event|0|||
130728839|NCT00086281|470628698|FG014|Phase 1|Serious Adverse Event|1|||
130728840|NCT00086281|470628684|FG000|Phase 2|Adverse Event|0|||
130728841|NCT00086281|470628685|FG001|Phase 2|Adverse Event|0|||
130728842|NCT00086281|470628686|FG002|Phase 2|Adverse Event|0|||
130728843|NCT00086281|470628687|FG003|Phase 2|Adverse Event|0|||
130728844|NCT00086281|470628688|FG004|Phase 2|Adverse Event|0|||
130728845|NCT00086281|470628689|FG005|Phase 2|Adverse Event|0|||
130728846|NCT00086281|470628690|FG006|Phase 2|Adverse Event|0|||
130728847|NCT00086281|470628691|FG007|Phase 2|Adverse Event|0|||
130728848|NCT00086281|470628692|FG008|Phase 2|Adverse Event|0|||
130728849|NCT00086281|470628693|FG009|Phase 2|Adverse Event|0|||
130728850|NCT00086281|470628694|FG010|Phase 2|Adverse Event|0|||
130728851|NCT00086281|470628695|FG011|Phase 2|Adverse Event|0|||
130728852|NCT00086281|470628696|FG012|Phase 2|Adverse Event|1|||
130728853|NCT00086281|470628697|FG013|Phase 2|Adverse Event|1|||
130728854|NCT00086281|470628698|FG014|Phase 2|Adverse Event|0|||
130728855|NCT04759768|470628699|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130728856|NCT04759768|470628700|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130728857|NCT04759768|470628699|FG000|Washout (7 Days)|Physician Decision|0|||
130728858|NCT04759768|470628700|FG001|Washout (7 Days)|Physician Decision|1|||
130728859|NCT02996487|470628701|FG000|Overall Study|Lost to Follow-up|1|||
130492789|NCT05601882|469774799|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
130728860|NCT02996487|470628702|FG001|Overall Study|Lost to Follow-up|1|||
130492790|NCT05601882|469774800|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
130492791|NCT05601882|469774797|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
130492792|NCT05601882|469774798|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
130492793|NCT05601882|469774799|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
130492794|NCT05601882|469774800|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
130492795|NCT05601882|469774797|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
130728861|NCT02996487|470628703|FG002|Overall Study|Lost to Follow-up|0|||
130492796|NCT05601882|469774798|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
130492797|NCT05601882|469774799|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
130492798|NCT05601882|469774800|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
130492799|NCT05601882|469774797|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
130492800|NCT05601882|469774798|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
130492801|NCT05601882|469774799|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
130492802|NCT05601882|469774800|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
130728862|NCT02996487|470628701|FG000|Overall Study|Death|0|||
130728863|NCT02996487|470628702|FG001|Overall Study|Death|1|||
130728864|NCT02996487|470628703|FG002|Overall Study|Death|0|||
130728865|NCT02996487|470628701|FG000|Overall Study|Withdrawal by Subject|2|||
130728866|NCT02996487|470628702|FG001|Overall Study|Withdrawal by Subject|3|||
130728867|NCT02996487|470628703|FG002|Overall Study|Withdrawal by Subject|0|||
130728868|NCT02027428|470628704|FG000|Induction|Never treated|7|||
130728869|NCT02027428|470628705|FG001|Induction|Never treated|0|||
130728870|NCT02027428|470628706|FG002|Induction|Never treated|0|||
130728871|NCT02027428|470628704|FG000|Induction|Progressive disease|77|||
130728872|NCT02027428|470628705|FG001|Induction|Progressive disease|0|||
130728873|NCT02027428|470628706|FG002|Induction|Progressive disease|0|||
130728874|NCT02027428|470628704|FG000|Induction|Adverse Event|51|||
130728875|NCT02027428|470628705|FG001|Induction|Adverse Event|0|||
130728876|NCT02027428|470628706|FG002|Induction|Adverse Event|0|||
130728877|NCT02027428|470628704|FG000|Induction|Withdrawal by Subject|22|||
130728878|NCT02027428|470628705|FG001|Induction|Withdrawal by Subject|0|||
130728879|NCT02027428|470628706|FG002|Induction|Withdrawal by Subject|0|||
130728880|NCT02027428|470628704|FG000|Induction|Death|21|||
130728881|NCT02027428|470628705|FG001|Induction|Death|0|||
130728882|NCT02027428|470628706|FG002|Induction|Death|0|||
130728883|NCT02027428|470628704|FG000|Induction|Symptomatic deterioration|16|||
130728884|NCT02027428|470628705|FG001|Induction|Symptomatic deterioration|0|||
130728885|NCT02027428|470628706|FG002|Induction|Symptomatic deterioration|0|||
130728886|NCT02027428|470628704|FG000|Induction|Study terminated by sponsor|12|||
130728887|NCT02027428|470628705|FG001|Induction|Study terminated by sponsor|0|||
130728888|NCT02027428|470628706|FG002|Induction|Study terminated by sponsor|0|||
130492803|NCT05601882|469774797|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
130492804|NCT05601882|469774798|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
130492805|NCT05601882|469774799|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
130492806|NCT05601882|469774800|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
130492807|NCT05601882|469774797|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
130492808|NCT05601882|469774798|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
130492809|NCT05601882|469774799|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
130728889|NCT02027428|470628704|FG000|Induction|Protocol Violation|1|||
130728890|NCT02027428|470628705|FG001|Induction|Protocol Violation|0|||
130728891|NCT02027428|470628706|FG002|Induction|Protocol Violation|0|||
130728892|NCT02027428|470628704|FG000|Induction|Miscellaneous|14|||
130728893|NCT02027428|470628705|FG001|Induction|Miscellaneous|0|||
130728894|NCT02027428|470628706|FG002|Induction|Miscellaneous|0|||
130728895|NCT02027428|470628704|FG000|Induction|Induction Treatment Ongoing|4|||
130728896|NCT02027428|470628705|FG001|Induction|Induction Treatment Ongoing|0|||
130728897|NCT02027428|470628706|FG002|Induction|Induction Treatment Ongoing|0|||
130728898|NCT02027428|470628704|FG000|Maintenance|Death|0|||
130728899|NCT02027428|470628705|FG001|Maintenance|Death|3|||
130492810|NCT05601882|469774800|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
130492811|NCT04158141|469774801|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
130492812|NCT04158141|469774802|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
130492813|NCT04158141|469774803|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
130728900|NCT02027428|470628706|FG002|Maintenance|Death|2|||
130728901|NCT02027428|470628704|FG000|Maintenance|Adverse Event|0|||
130728902|NCT02027428|470628705|FG001|Maintenance|Adverse Event|21|||
130728903|NCT02027428|470628706|FG002|Maintenance|Adverse Event|1|||
130728904|NCT02027428|470628704|FG000|Maintenance|Progressive disease|0|||
130728905|NCT02027428|470628705|FG001|Maintenance|Progressive disease|84|||
130728906|NCT02027428|470628706|FG002|Maintenance|Progressive disease|47|||
130728907|NCT02027428|470628704|FG000|Maintenance|Symptomatic deterioration|0|||
130728908|NCT02027428|470628705|FG001|Maintenance|Symptomatic deterioration|4|||
130728909|NCT02027428|470628706|FG002|Maintenance|Symptomatic deterioration|1|||
130728910|NCT02027428|470628704|FG000|Maintenance|Withdrawal by Subject|0|||
130728911|NCT02027428|470628705|FG001|Maintenance|Withdrawal by Subject|6|||
130728912|NCT02027428|470628706|FG002|Maintenance|Withdrawal by Subject|5|||
130492814|NCT04158141|469774801|FG000|Step 1: Registration|Adverse Event|1|||
130492815|NCT04158141|469774802|FG001|Step 1: Registration|Adverse Event|0|||
130492816|NCT04158141|469774803|FG002|Step 1: Registration|Adverse Event|0|||
130492817|NCT04158141|469774801|FG000|Step 1: Registration|Withdrawal by Subject|1|||
130565470|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130728913|NCT02027428|470628704|FG000|Maintenance|Protocol Violation|0|||
130728914|NCT02027428|470628705|FG001|Maintenance|Protocol Violation|0|||
130728915|NCT02027428|470628706|FG002|Maintenance|Protocol Violation|1|||
130728916|NCT02027428|470628704|FG000|Maintenance|Other|0|||
130728917|NCT02027428|470628705|FG001|Maintenance|Other|6|||
130728918|NCT02027428|470628706|FG002|Maintenance|Other|3|||
130728919|NCT02027428|470628704|FG000|Survival Follow-up|Death|0|||
130728920|NCT02027428|470628705|FG001|Survival Follow-up|Death|78|||
130728921|NCT02027428|470628706|FG002|Survival Follow-up|Death|45|||
130728922|NCT02027428|470628704|FG000|Survival Follow-up|Lost to Follow-up|0|||
130728923|NCT02027428|470628705|FG001|Survival Follow-up|Lost to Follow-up|1|||
130728924|NCT02027428|470628706|FG002|Survival Follow-up|Lost to Follow-up|1|||
130728925|NCT01130597|470628707|FG000|Overall Study|Protocol-specified (High K+)|1|||
130728926|NCT01130597|470628707|FG000|Overall Study|Adverse Event|4|||
130728927|NCT01130597|470628707|FG000|Overall Study|Death|1|||
130728928|NCT01130597|470628707|FG000|Overall Study|Protocol Violation|1|||
130728929|NCT04873934|470628708|FG000|Overall Study|Adverse Event|0|||
130728930|NCT04873934|470628709|FG001|Overall Study|Adverse Event|1|||
130728931|NCT04873934|470628708|FG000|Overall Study|Death|0|||
130728932|NCT04873934|470628709|FG001|Overall Study|Death|2|||
130728933|NCT04873934|470628708|FG000|Overall Study|Lost to Follow-up|13|||
130728934|NCT04873934|470628709|FG001|Overall Study|Lost to Follow-up|9|||
130728935|NCT04873934|470628708|FG000|Overall Study|Physician Decision|1|||
130728936|NCT04873934|470628709|FG001|Overall Study|Physician Decision|1|||
130728937|NCT04873934|470628708|FG000|Overall Study|Protocol deviation|2|||
130728938|NCT04873934|470628709|FG001|Overall Study|Protocol deviation|1|||
130728939|NCT04873934|470628708|FG000|Overall Study|Subject decision|1|||
130728940|NCT04873934|470628709|FG001|Overall Study|Subject decision|8|||
130728941|NCT04873934|470628708|FG000|Overall Study|Withdrew consent|0|||
130492818|NCT04158141|469774802|FG001|Step 1: Registration|Withdrawal by Subject|0|||
130492819|NCT04158141|469774803|FG002|Step 1: Registration|Withdrawal by Subject|0|||
130492820|NCT04158141|469774801|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
130492821|NCT04158141|469774802|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
130492822|NCT04158141|469774803|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
130492823|NCT04121741|469774807|FG000|Overall Study|Protocol Violation|1|||
130492824|NCT04121741|469774808|FG001|Overall Study|Protocol Violation|0|||
130492825|NCT04121741|469774809|FG002|Overall Study|Protocol Violation|0|||
130492826|NCT04121741|469774810|FG003|Overall Study|Protocol Violation|0|||
130492827|NCT04121741|469774811|FG004|Overall Study|Protocol Violation|0|||
130492828|NCT04121741|469774812|FG005|Overall Study|Protocol Violation|0|||
130492829|NCT03473223|469774813|FG000|Overall Study|Lost to Follow-up|1|||
130492830|NCT03473223|469774814|FG001|Overall Study|Lost to Follow-up|1|||
130492831|NCT03473223|469774813|FG000|Overall Study|Withdrawal by Subject|47|||
130492832|NCT03473223|469774814|FG001|Overall Study|Withdrawal by Subject|42|||
130492833|NCT03473223|469774813|FG000|Overall Study|Indirect contact|32|||
130492834|NCT03473223|469774814|FG001|Overall Study|Indirect contact|29|||
130492835|NCT03473223|469774813|FG000|Overall Study|Other (Not specified)|32|||
130492836|NCT03473223|469774814|FG001|Overall Study|Other (Not specified)|20|||
130492837|NCT00115934|469774817|FG000|Overall Study|Lost to Follow-up|1|||
130492838|NCT00115934|469774818|FG001|Overall Study|Lost to Follow-up|0|||
130492839|NCT00115934|469774817|FG000|Overall Study|Did not receive intervention|3|||
130492840|NCT00115934|469774818|FG001|Overall Study|Did not receive intervention|2|||
130492841|NCT05827068|469774824|FG000|Overall Study|Lost to Follow-up|1|||
130492842|NCT05827068|469774825|FG001|Overall Study|Lost to Follow-up|4|||
130492843|NCT05827068|469774826|FG002|Overall Study|Lost to Follow-up|1|||
130492844|NCT05827068|469774827|FG003|Overall Study|Lost to Follow-up|1|||
130492845|NCT05827068|469774828|FG004|Overall Study|Lost to Follow-up|2|||
130492846|NCT05827068|469774829|FG005|Overall Study|Lost to Follow-up|4|||
130492847|NCT05827068|469774830|FG006|Overall Study|Lost to Follow-up|1|||
130492848|NCT05827068|469774824|FG000|Overall Study|Withdrawal by Subject|4|||
130492849|NCT05827068|469774825|FG001|Overall Study|Withdrawal by Subject|0|||
130492850|NCT05827068|469774826|FG002|Overall Study|Withdrawal by Subject|1|||
130492851|NCT05827068|469774827|FG003|Overall Study|Withdrawal by Subject|2|||
130492852|NCT05827068|469774828|FG004|Overall Study|Withdrawal by Subject|3|||
130492853|NCT05827068|469774829|FG005|Overall Study|Withdrawal by Subject|0|||
130492854|NCT05827068|469774830|FG006|Overall Study|Withdrawal by Subject|1|||
130492855|NCT05827068|469774824|FG000|Overall Study|Physician Decision|0|||
130492856|NCT05827068|469774825|FG001|Overall Study|Physician Decision|0|||
130492857|NCT05827068|469774826|FG002|Overall Study|Physician Decision|0|||
130492858|NCT05827068|469774827|FG003|Overall Study|Physician Decision|0|||
130492859|NCT05827068|469774828|FG004|Overall Study|Physician Decision|1|||
130492860|NCT05827068|469774829|FG005|Overall Study|Physician Decision|0|||
130492861|NCT05827068|469774830|FG006|Overall Study|Physician Decision|1|||
130492862|NCT05827068|469774824|FG000|Overall Study|Other Than Specified|0|||
130492863|NCT05827068|469774825|FG001|Overall Study|Other Than Specified|1|||
130492864|NCT05827068|469774826|FG002|Overall Study|Other Than Specified|0|||
130492865|NCT05827068|469774827|FG003|Overall Study|Other Than Specified|0|||
130728942|NCT04873934|470628709|FG001|Overall Study|Withdrew consent|4|||
130492866|NCT05827068|469774828|FG004|Overall Study|Other Than Specified|0|||
130492867|NCT05827068|469774829|FG005|Overall Study|Other Than Specified|0|||
130492868|NCT05827068|469774830|FG006|Overall Study|Other Than Specified|0|||
130492869|NCT03867201|469774831|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
130728943|NCT04873934|470628708|FG000|Overall Study|Missing|1|||
130728944|NCT04873934|470628709|FG001|Overall Study|Missing|0|||
130728945|NCT05794503|470628710|FG000|Overall Study|Operation Cancelled|2|||
130492870|NCT03867201|469774832|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
130492871|NCT03867201|469774831|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
130492872|NCT03867201|469774832|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
130492873|NCT03867201|469774831|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
130728946|NCT05794503|470628711|FG001|Overall Study|Operation Cancelled|0|||
130728947|NCT05794503|470628710|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
130728948|NCT05794503|470628711|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
130492874|NCT03867201|469774832|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
130492875|NCT03867201|469774831|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
130492876|NCT03867201|469774832|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
130492877|NCT03867201|469774831|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
130492878|NCT03867201|469774832|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
130492879|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Adverse Event|5|||
130492880|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Adverse Event|11|||
130492881|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
130492882|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
130492883|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Physician Decision|6|||
130492884|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Physician Decision|3|||
130492885|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Pregnancy|2|||
130492886|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Pregnancy|2|||
130492887|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
130492888|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
130492889|NCT03867201|469774831|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
130492890|NCT03867201|469774832|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
130492891|NCT03867201|469774831|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
130492892|NCT03867201|469774832|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
130492893|NCT03867201|469774831|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
130492894|NCT03867201|469774832|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
130492895|NCT04039113|469774835|FG000|Overall Study|Withdrawal by Subject|8|||
130492896|NCT04039113|469774836|FG001|Overall Study|Withdrawal by Subject|11|||
130492897|NCT04039113|469774835|FG000|Overall Study|Lost to Follow-up|1|||
130492898|NCT04039113|469774836|FG001|Overall Study|Lost to Follow-up|1|||
130492899|NCT04039113|469774835|FG000|Overall Study|Adverse Event|2|||
130492900|NCT04039113|469774836|FG001|Overall Study|Adverse Event|2|||
130492901|NCT04039113|469774835|FG000|Overall Study|Death|2|||
130492902|NCT04039113|469774836|FG001|Overall Study|Death|4|||
130492903|NCT04039113|469774835|FG000|Overall Study|Site Closure|6|||
130492904|NCT04039113|469774836|FG001|Overall Study|Site Closure|0|||
130492905|NCT04039113|469774835|FG000|Overall Study|Failure to meet randomisation criteria|4|||
130492906|NCT04039113|469774836|FG001|Overall Study|Failure to meet randomisation criteria|0|||
130492907|NCT00353496|469774837|FG000|Overall Study|Adverse Event|1|||
130492908|NCT00353496|469774838|FG001|Overall Study|Adverse Event|0|||
130492909|NCT00353496|469774837|FG000|Overall Study|Protocol Violation|2|||
130492910|NCT00353496|469774838|FG001|Overall Study|Protocol Violation|2|||
130492911|NCT00353496|469774837|FG000|Overall Study|Withdrawal by Subject|3|||
130492912|NCT00353496|469774838|FG001|Overall Study|Withdrawal by Subject|4|||
130492913|NCT00353496|469774837|FG000|Overall Study|Physician Decision|6|||
130492914|NCT00353496|469774838|FG001|Overall Study|Physician Decision|9|||
130492915|NCT00353496|469774837|FG000|Overall Study|Not otherwise specified|4|||
130492916|NCT00353496|469774838|FG001|Overall Study|Not otherwise specified|2|||
130492917|NCT01470144|469774839|FG000|Overall Study|Adverse Event|2|||
130492918|NCT01470144|469774839|FG000|Overall Study|Death|1|||
130492919|NCT01470144|469774839|FG000|Overall Study|Lung transplant|6|||
130492920|NCT01470144|469774839|FG000|Overall Study|Patient's and investigator's decision|1|||
130492921|NCT00312208|469775582|FG000|Overall Study|Adverse Event|97|||
130492922|NCT00312208|469775583|FG001|Overall Study|Adverse Event|61|||
130492923|NCT00312208|469775582|FG000|Overall Study|Protocol Violation|5|||
130492924|NCT00312208|469775583|FG001|Overall Study|Protocol Violation|3|||
130492925|NCT00312208|469775582|FG000|Overall Study|Death|2|||
130492926|NCT00312208|469775583|FG001|Overall Study|Death|1|||
130492927|NCT00312208|469775582|FG000|Overall Study|Lack of Efficacy|7|||
130492928|NCT00312208|469775583|FG001|Overall Study|Lack of Efficacy|4|||
130492929|NCT00312208|469775582|FG000|Overall Study|Lost to Follow-up|3|||
130492930|NCT00312208|469775583|FG001|Overall Study|Lost to Follow-up|5|||
130492931|NCT00312208|469775582|FG000|Overall Study|Withdrawal by Subject|53|||
130492932|NCT00312208|469775583|FG001|Overall Study|Withdrawal by Subject|42|||
130492933|NCT00312208|469775582|FG000|Overall Study|Other|5|||
130492934|NCT00312208|469775583|FG001|Overall Study|Other|7|||
130492935|NCT02284113|469775584|FG000|Overall Study|Adverse Event|1|||
130492936|NCT02284113|469775585|FG001|Overall Study|Adverse Event|0|||
130728949|NCT05794503|470628710|FG000|Overall Study|Protocol Violation|1|||
130492937|NCT02284113|469775584|FG000|Overall Study|non-compliance|0|||
130492938|NCT02284113|469775585|FG001|Overall Study|non-compliance|1|||
130492939|NCT02284113|469775584|FG000|Overall Study|Withdrawal by Subject|0|||
130492940|NCT02284113|469775585|FG001|Overall Study|Withdrawal by Subject|1|||
130492941|NCT02284113|469775584|FG000|Overall Study|not provided|0|||
130492942|NCT02284113|469775585|FG001|Overall Study|not provided|1|||
130492943|NCT02284113|469775584|FG000|Overall Study|surgery cancelled|2|||
130492944|NCT02284113|469775585|FG001|Overall Study|surgery cancelled|0|||
130492945|NCT03885232|469775588|FG000|Overall Study|Lost to Follow-up|74|||
130492946|NCT03885232|469775589|FG001|Overall Study|Lost to Follow-up|32|||
130492947|NCT03885232|469775588|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
130492948|NCT03885232|469775589|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
130492949|NCT01315132|469775592|FG000|Overall Study|not treated due to disease progression|1|||
130492950|NCT03840902|469775595|FG000|Overall Study|Randomized but not treated|1|||
130492951|NCT03840902|469775596|FG001|Overall Study|Randomized but not treated|1|||
130492952|NCT03660930|469775597|FG000|Overall Study|Adverse Event|0|||
130492953|NCT03660930|469775598|FG001|Overall Study|Adverse Event|0|||
130492954|NCT03660930|469775599|FG002|Overall Study|Adverse Event|0|||
130492955|NCT03660930|469775600|FG003|Overall Study|Adverse Event|2|||
130492956|NCT03660930|469775601|FG004|Overall Study|Adverse Event|0|||
130492957|NCT03660930|469775602|FG005|Overall Study|Adverse Event|1|||
130492958|NCT03660930|469775603|FG006|Overall Study|Adverse Event|0|||
130492959|NCT03660930|469775604|FG007|Overall Study|Adverse Event|0|||
130492960|NCT03660930|469775597|FG000|Overall Study|Withdrawal by Subject|0|||
130492961|NCT03660930|469775598|FG001|Overall Study|Withdrawal by Subject|0|||
130492962|NCT03660930|469775599|FG002|Overall Study|Withdrawal by Subject|0|||
130492963|NCT03660930|469775600|FG003|Overall Study|Withdrawal by Subject|0|||
130492964|NCT03660930|469775601|FG004|Overall Study|Withdrawal by Subject|0|||
130492965|NCT03660930|469775602|FG005|Overall Study|Withdrawal by Subject|1|||
130492966|NCT03660930|469775603|FG006|Overall Study|Withdrawal by Subject|0|||
130492967|NCT03660930|469775604|FG007|Overall Study|Withdrawal by Subject|0|||
130492968|NCT05018143|469775607|FG000|Overall Study|Lost to Follow-up|5|||
130492969|NCT05018143|469775608|FG001|Overall Study|Lost to Follow-up|4|||
130492970|NCT05018143|469775607|FG000|Overall Study|Withdrawal by Subject|0|||
130492971|NCT05018143|469775608|FG001|Overall Study|Withdrawal by Subject|1|||
130492972|NCT06688357|469775609|FG000|Overall Study|Adverse Event|0|||
130492973|NCT06688357|469775610|FG001|Overall Study|Adverse Event|1|||
130492974|NCT04018495|469775611|FG000|Overall Study|Physician Decision|1|||
130492975|NCT01084863|469775614|FG000|Main Study Treatment Period|Disease progression|11|||
130492976|NCT01084863|469775615|FG001|Main Study Treatment Period|Disease progression|7|||
130492977|NCT01084863|469775614|FG000|Main Study Treatment Period|Adverse Event|5|||
130492978|NCT01084863|469775615|FG001|Main Study Treatment Period|Adverse Event|3|||
130492979|NCT01084863|469775614|FG000|Main Study Treatment Period|Other Reason|0|||
130492980|NCT01084863|469775615|FG001|Main Study Treatment Period|Other Reason|1|||
130492981|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
130492982|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
130492983|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
130492984|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
130492985|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
130492986|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
130492987|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
130492988|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
130492989|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Other|0|||
130492990|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Other|1|||
130492991|NCT01084863|469775614|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
130492992|NCT01084863|469775615|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
130492993|NCT03834740|469775616|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
130492994|NCT03834740|469775617|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
130492995|NCT03834740|469775618|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
130492996|NCT03275285|469775619|FG000|Overall Study|Ongoing|45|||
130492997|NCT03275285|469775620|FG001|Overall Study|Ongoing|69|||
130492998|NCT06191679|469775621|FG000|Baseline|Lost to Follow-up|1|||
130492999|NCT06191679|469775622|FG001|Baseline|Lost to Follow-up|0|||
130493000|NCT06191679|469775623|FG002|Baseline|Lost to Follow-up|1|||
130493001|NCT06191679|469775624|FG003|Baseline|Lost to Follow-up|0|||
130493002|NCT06191679|469775621|FG000|Allocation to Group|Withdrawal by Subject|0|||
130493003|NCT06191679|469775622|FG001|Allocation to Group|Withdrawal by Subject|1|||
130493004|NCT06191679|469775623|FG002|Allocation to Group|Withdrawal by Subject|2|||
130493005|NCT06191679|469775624|FG003|Allocation to Group|Withdrawal by Subject|0|||
130493006|NCT06191679|469775621|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
130493007|NCT06191679|469775622|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
130493008|NCT06191679|469775623|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
130493009|NCT06191679|469775624|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
130493010|NCT06191679|469775621|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
130493011|NCT06191679|469775622|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
130493012|NCT06191679|469775623|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
130493013|NCT06191679|469775624|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
130493014|NCT06191679|469775621|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
130493015|NCT06191679|469775622|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
130493016|NCT06191679|469775623|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
130493017|NCT06191679|469775624|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
130493018|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
130648308|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130728950|NCT05794503|470628711|FG001|Overall Study|Protocol Violation|0|||
130493019|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
130493020|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
130493021|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
130493022|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
130493023|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
130493024|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
130493025|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
130493026|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
130493027|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
130493028|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
130493029|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
130493030|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
130493031|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
130493032|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
130493033|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
130493034|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
130493035|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
130493036|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
130493037|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
130493038|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
130493039|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493040|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493041|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493042|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493043|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493044|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
130493045|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130493046|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
130493047|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
130493048|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
130493049|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
130493050|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
130565471|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130728951|NCT01589497|470628712|FG000|Overall Study|Withdrawal by Subject|0|||
130728952|NCT01589497|470628713|FG001|Overall Study|Withdrawal by Subject|1|||
130728953|NCT01589497|470628714|FG002|Overall Study|Withdrawal by Subject|0|||
130728954|NCT01589497|470628715|FG003|Overall Study|Withdrawal by Subject|1|||
130728955|NCT01589497|470628712|FG000|Overall Study|Death|1|||
130728956|NCT01589497|470628713|FG001|Overall Study|Death|0|||
130728957|NCT01589497|470628714|FG002|Overall Study|Death|0|||
130728958|NCT01589497|470628715|FG003|Overall Study|Death|0|||
130728959|NCT01589497|470628712|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728960|NCT01589497|470628713|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728961|NCT01589497|470628714|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
130728962|NCT01589497|470628715|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728963|NCT00143247|470628724|FG000|Overall Study|Death|8|||
130728964|NCT00143247|470628724|FG000|Overall Study|Adverse Event|19|||
130728965|NCT00143247|470628724|FG000|Overall Study|Lack of Efficacy|3|||
130728966|NCT00143247|470628724|FG000|Overall Study|Withdrawal by Subject|55|||
130728967|NCT00143247|470628724|FG000|Overall Study|Study terminated by sponsor|31|||
130728968|NCT00143247|470628724|FG000|Overall Study|Protocol Violation|15|||
130728969|NCT00143247|470628724|FG000|Overall Study|Lost to Follow-up|12|||
130728970|NCT00143247|470628724|FG000|Overall Study|following inaccurate lab adverse event|1|||
130728971|NCT00143247|470628724|FG000|Overall Study|Other|12|||
130728972|NCT02766283|470628725|FG000|Overall Study|Lost to Follow-up|27|||
130728973|NCT00721227|470628727|FG000|Overall Study|Lost to Follow-up|3|||
130728974|NCT00721227|470628728|FG001|Overall Study|Lost to Follow-up|0|||
130728975|NCT00721227|470628727|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
130728976|NCT00721227|470628728|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
130728977|NCT03654599|470628734|FG000|Overall Study|Lost to Follow-up|14|||
130728978|NCT03654599|470628735|FG001|Overall Study|Lost to Follow-up|12|||
130728979|NCT03654599|470628734|FG000|Overall Study|Death|8|||
130728980|NCT03654599|470628735|FG001|Overall Study|Death|6|||
130728981|NCT03654599|470628734|FG000|Overall Study|Withdrawal by Subject|6|||
130728982|NCT03654599|470628735|FG001|Overall Study|Withdrawal by Subject|4|||
130728983|NCT01243775|470628736|FG000|Overall Study|Withdrawal by Subject|2|||
130728984|NCT06390826|470630495|FG000|Overall Study|Never Start Protocol Therapy|1|||
130728985|NCT06390826|470630495|FG000|Overall Study|Adverse Event|1|||
130493051|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
130493052|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
130493053|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130493054|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130493055|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130493056|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130493057|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130493058|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
130493059|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
130493060|NCT03656718|469775625|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493061|NCT03656718|469775626|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493062|NCT03656718|469775627|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493063|NCT03656718|469775628|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493064|NCT03656718|469775629|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493065|NCT03656718|469775630|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
130493066|NCT03656718|469775631|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
130493067|NCT03656718|469775625|FG000|Treatment Period Part C|Disease progression|0|||
130493068|NCT03656718|469775626|FG001|Treatment Period Part C|Disease progression|0|||
130493069|NCT03656718|469775627|FG002|Treatment Period Part C|Disease progression|0|||
130493070|NCT03656718|469775628|FG003|Treatment Period Part C|Disease progression|0|||
130493071|NCT03656718|469775629|FG004|Treatment Period Part C|Disease progression|12|||
130493072|NCT03656718|469775630|FG005|Treatment Period Part C|Disease progression|0|||
130493073|NCT03656718|469775631|FG006|Treatment Period Part C|Disease progression|0|||
130493074|NCT03656718|469775625|FG000|Treatment Period Part C|Death|0|||
130493075|NCT03656718|469775626|FG001|Treatment Period Part C|Death|0|||
130493076|NCT03656718|469775627|FG002|Treatment Period Part C|Death|0|||
130493077|NCT03656718|469775628|FG003|Treatment Period Part C|Death|0|||
130493078|NCT03656718|469775629|FG004|Treatment Period Part C|Death|1|||
130493079|NCT03656718|469775630|FG005|Treatment Period Part C|Death|0|||
130493080|NCT03656718|469775631|FG006|Treatment Period Part C|Death|0|||
130493081|NCT03656718|469775625|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493082|NCT03656718|469775626|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493083|NCT03656718|469775627|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493084|NCT03656718|469775628|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493085|NCT03656718|469775629|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
130493086|NCT03656718|469775630|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493087|NCT03656718|469775631|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
130493088|NCT03656718|469775625|FG000|Treatment Period Part C|Other reasons|0|||
130493089|NCT03656718|469775626|FG001|Treatment Period Part C|Other reasons|0|||
130493090|NCT03656718|469775627|FG002|Treatment Period Part C|Other reasons|0|||
130493091|NCT03656718|469775628|FG003|Treatment Period Part C|Other reasons|0|||
130493092|NCT03656718|469775629|FG004|Treatment Period Part C|Other reasons|1|||
130493093|NCT03656718|469775630|FG005|Treatment Period Part C|Other reasons|0|||
130493094|NCT03656718|469775631|FG006|Treatment Period Part C|Other reasons|0|||
130493095|NCT03656718|469775625|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
130493096|NCT03656718|469775626|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
130493097|NCT03656718|469775627|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
130493098|NCT03656718|469775628|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
130493099|NCT03656718|469775629|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
130493100|NCT03656718|469775630|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
130493101|NCT03656718|469775631|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
130493102|NCT02500576|469775632|FG000|Overall Study|Adverse Event|0|||
130493103|NCT02500576|469775633|FG001|Overall Study|Adverse Event|1|||
130493104|NCT02500576|469775632|FG000|Overall Study|Death|2|||
130493105|NCT02500576|469775633|FG001|Overall Study|Death|1|||
130493106|NCT02500576|469775632|FG000|Overall Study|Lack of Efficacy|5|||
130728986|NCT06390826|470630495|FG000|Overall Study|Disease Progression|8|||
130728987|NCT01659125|470630496|FG000|Overall Study|Withdrawal by Subject|2|||
130728988|NCT01659125|470630496|FG000|Overall Study|Lost to Follow-up|7|||
130493107|NCT02500576|469775633|FG001|Overall Study|Lack of Efficacy|5|||
130493108|NCT02500576|469775632|FG000|Overall Study|Withdrawal by Subject|1|||
130493109|NCT02500576|469775633|FG001|Overall Study|Withdrawal by Subject|1|||
130493110|NCT04882917|469775636|FG000|Overall Study|Adverse Event|0|||
130493111|NCT04882917|469775637|FG001|Overall Study|Adverse Event|1|||
130493112|NCT04882917|469775638|FG002|Overall Study|Adverse Event|2|||
130728989|NCT01659125|470630496|FG000|Overall Study|Technical Problem|1|||
130728990|NCT01659125|470630496|FG000|Overall Study|Time Constraints|2|||
130493113|NCT04882917|469775639|FG003|Overall Study|Adverse Event|2|||
130493114|NCT04882917|469775636|FG000|Overall Study|Withdrawal by Subject|1|||
130493115|NCT04882917|469775637|FG001|Overall Study|Withdrawal by Subject|0|||
130493116|NCT04882917|469775638|FG002|Overall Study|Withdrawal by Subject|2|||
130493117|NCT04882917|469775639|FG003|Overall Study|Withdrawal by Subject|1|||
130493118|NCT04882917|469775636|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
130493119|NCT04882917|469775637|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
130493120|NCT04882917|469775638|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
130493121|NCT04882917|469775639|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
130493122|NCT00319020|469775640|FG000|Overall Study|Death|2|||
130493123|NCT00319020|469775641|FG001|Overall Study|Death|2|||
130493124|NCT00319020|469775640|FG000|Overall Study|Withdrawal by Subject|4|||
130493125|NCT00319020|469775641|FG001|Overall Study|Withdrawal by Subject|1|||
130493126|NCT00319020|469775640|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
130493127|NCT00319020|469775641|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
130493128|NCT00319020|469775640|FG000|Overall Study|Administrative reason|0|||
130493129|NCT00319020|469775641|FG001|Overall Study|Administrative reason|5|||
130493130|NCT00319020|469775640|FG000|Overall Study|Disease progression|0|||
130493131|NCT00319020|469775641|FG001|Overall Study|Disease progression|2|||
130493132|NCT00319020|469775640|FG000|Overall Study|Transplant|0|||
130493133|NCT00319020|469775641|FG001|Overall Study|Transplant|1|||
130493134|NCT00319020|469775640|FG000|Overall Study|Treatment failure|0|||
130493135|NCT00319020|469775641|FG001|Overall Study|Treatment failure|1|||
130493136|NCT00319020|469775640|FG000|Overall Study|Adverse Event|0|||
130493137|NCT00319020|469775641|FG001|Overall Study|Adverse Event|1|||
130493138|NCT04153890|469775646|FG000|Overall Study|Lost to Follow-up|9|||
130493139|NCT04153890|469775647|FG001|Overall Study|Lost to Follow-up|0|||
130493140|NCT04153890|469775648|FG002|Overall Study|Lost to Follow-up|9|||
130493141|NCT04153890|469775649|FG003|Overall Study|Lost to Follow-up|0|||
130493142|NCT04153890|469775646|FG000|Overall Study|Death|0|||
130493143|NCT04153890|469775647|FG001|Overall Study|Death|2|||
130493144|NCT04153890|469775648|FG002|Overall Study|Death|0|||
130493145|NCT04153890|469775649|FG003|Overall Study|Death|0|||
130493146|NCT04153890|469775646|FG000|Overall Study|Withdrawal by Subject|0|||
130493147|NCT04153890|469775647|FG001|Overall Study|Withdrawal by Subject|0|||
130493148|NCT04153890|469775648|FG002|Overall Study|Withdrawal by Subject|0|||
130493149|NCT04153890|469775649|FG003|Overall Study|Withdrawal by Subject|2|||
130493150|NCT03997474|469775650|FG000|Overall Study|Death|6|||
130493151|NCT03997474|469775651|FG001|Overall Study|Death|2|||
130493152|NCT03997474|469775652|FG002|Overall Study|Death|1|||
130493153|NCT03997474|469775650|FG000|Overall Study|Physician Decision|2|||
130493154|NCT03997474|469775651|FG001|Overall Study|Physician Decision|0|||
130493155|NCT03997474|469775652|FG002|Overall Study|Physician Decision|0|||
130493156|NCT03997474|469775650|FG000|Overall Study|study terminated by sponsor|1|||
130493157|NCT03997474|469775651|FG001|Overall Study|study terminated by sponsor|0|||
130493158|NCT03997474|469775652|FG002|Overall Study|study terminated by sponsor|1|||
130493159|NCT04980300|469775654|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
130493160|NCT04980300|469775655|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
130493161|NCT04980300|469775654|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
130493162|NCT04980300|469775655|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
130493163|NCT04980300|469775654|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
130493164|NCT04980300|469775655|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
130493165|NCT04980300|469775654|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
130493166|NCT04980300|469775655|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
130493167|NCT03140670|469776529|FG000|Overall Study|Withdrawal by Subject|2|||
130493168|NCT03140670|469776529|FG000|Overall Study|Lost to Follow-up|1|||
130493169|NCT03140670|469776529|FG000|Overall Study|Physician Decision|1|||
130493170|NCT00220805|469776530|FG000|Overall Study|Adverse Event|1|||
130493171|NCT00220805|469776531|FG001|Overall Study|Adverse Event|3|||
130493172|NCT00220805|469776530|FG000|Overall Study|Withdrawal by Subject|3|||
130493173|NCT00220805|469776531|FG001|Overall Study|Withdrawal by Subject|0|||
130493174|NCT00220805|469776530|FG000|Overall Study|Lack of Efficacy|1|||
130493175|NCT00220805|469776531|FG001|Overall Study|Lack of Efficacy|0|||
130493176|NCT00220805|469776530|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
130493177|NCT00220805|469776531|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
130493178|NCT02325466|469776532|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
130493179|NCT02325466|469776533|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
130493180|NCT02325466|469776534|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
130493181|NCT02325466|469776532|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
130493182|NCT02325466|469776533|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
130493183|NCT02325466|469776534|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
130493184|NCT02325466|469776532|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
130493185|NCT02325466|469776533|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
130493186|NCT02325466|469776534|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
130493187|NCT02325466|469776532|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
130493188|NCT02325466|469776533|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
130493189|NCT02325466|469776534|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
130493190|NCT02325466|469776532|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
130493191|NCT02325466|469776533|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
130493192|NCT02325466|469776534|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
130493193|NCT02325466|469776532|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
130493194|NCT02325466|469776533|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
130493195|NCT02325466|469776534|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
130493196|NCT02325466|469776532|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
130493197|NCT02325466|469776533|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
130493198|NCT02325466|469776534|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
130493199|NCT02325466|469776532|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
130493200|NCT02325466|469776533|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
130493201|NCT02325466|469776534|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
130493202|NCT02325466|469776532|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
130493203|NCT02325466|469776533|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
130493204|NCT02325466|469776534|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
130493205|NCT01105975|469776538|FG000|Overall Study|Adverse Event|2|||
130493206|NCT01105975|469776539|FG001|Overall Study|Adverse Event|1|||
130493207|NCT01105975|469776540|FG002|Overall Study|Adverse Event|5|||
130493208|NCT01105975|469776541|FG003|Overall Study|Adverse Event|1|||
130493209|NCT01105975|469776542|FG004|Overall Study|Adverse Event|0|||
130493210|NCT01105975|469776543|FG005|Overall Study|Adverse Event|1|||
130493211|NCT01105975|469776544|FG006|Overall Study|Adverse Event|2|||
130493212|NCT01105975|469776545|FG007|Overall Study|Adverse Event|4|||
130493213|NCT01105975|469776546|FG008|Overall Study|Adverse Event|1|||
130493214|NCT01105975|469776547|FG009|Overall Study|Adverse Event|4|||
130493215|NCT01105975|469776538|FG000|Overall Study|Withdrawal by Subject|2|||
130493216|NCT01105975|469776539|FG001|Overall Study|Withdrawal by Subject|2|||
130493217|NCT01105975|469776540|FG002|Overall Study|Withdrawal by Subject|2|||
130493218|NCT01105975|469776541|FG003|Overall Study|Withdrawal by Subject|0|||
130493219|NCT01105975|469776542|FG004|Overall Study|Withdrawal by Subject|4|||
130493220|NCT01105975|469776543|FG005|Overall Study|Withdrawal by Subject|1|||
130493221|NCT01105975|469776544|FG006|Overall Study|Withdrawal by Subject|2|||
130493222|NCT01105975|469776545|FG007|Overall Study|Withdrawal by Subject|1|||
130493223|NCT01105975|469776546|FG008|Overall Study|Withdrawal by Subject|0|||
130493224|NCT01105975|469776547|FG009|Overall Study|Withdrawal by Subject|3|||
130493225|NCT01105975|469776538|FG000|Overall Study|Lost to Follow-up|1|||
130493226|NCT01105975|469776539|FG001|Overall Study|Lost to Follow-up|0|||
130493227|NCT01105975|469776540|FG002|Overall Study|Lost to Follow-up|0|||
130493228|NCT01105975|469776541|FG003|Overall Study|Lost to Follow-up|1|||
130493229|NCT01105975|469776542|FG004|Overall Study|Lost to Follow-up|1|||
130493230|NCT01105975|469776543|FG005|Overall Study|Lost to Follow-up|0|||
130493231|NCT01105975|469776544|FG006|Overall Study|Lost to Follow-up|0|||
130493232|NCT01105975|469776545|FG007|Overall Study|Lost to Follow-up|0|||
130493233|NCT01105975|469776546|FG008|Overall Study|Lost to Follow-up|1|||
130493234|NCT01105975|469776547|FG009|Overall Study|Lost to Follow-up|0|||
130493235|NCT01105975|469776538|FG000|Overall Study|Physician Decision|0|||
130493236|NCT01105975|469776539|FG001|Overall Study|Physician Decision|0|||
130493237|NCT01105975|469776540|FG002|Overall Study|Physician Decision|0|||
130493238|NCT01105975|469776541|FG003|Overall Study|Physician Decision|0|||
130493239|NCT01105975|469776542|FG004|Overall Study|Physician Decision|0|||
130493240|NCT01105975|469776543|FG005|Overall Study|Physician Decision|0|||
130493241|NCT01105975|469776544|FG006|Overall Study|Physician Decision|2|||
130493242|NCT01105975|469776545|FG007|Overall Study|Physician Decision|0|||
130493243|NCT01105975|469776546|FG008|Overall Study|Physician Decision|0|||
130493244|NCT01105975|469776547|FG009|Overall Study|Physician Decision|0|||
130493245|NCT01105975|469776538|FG000|Overall Study|Protocol Violation|0|||
130493246|NCT01105975|469776539|FG001|Overall Study|Protocol Violation|2|||
130493247|NCT01105975|469776540|FG002|Overall Study|Protocol Violation|2|||
130493248|NCT01105975|469776541|FG003|Overall Study|Protocol Violation|0|||
130493249|NCT01105975|469776542|FG004|Overall Study|Protocol Violation|1|||
130493250|NCT01105975|469776543|FG005|Overall Study|Protocol Violation|1|||
130493251|NCT01105975|469776544|FG006|Overall Study|Protocol Violation|1|||
130493252|NCT01105975|469776545|FG007|Overall Study|Protocol Violation|1|||
130493253|NCT01105975|469776546|FG008|Overall Study|Protocol Violation|2|||
130493254|NCT01105975|469776547|FG009|Overall Study|Protocol Violation|2|||
130493255|NCT01105975|469776538|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130493256|NCT01105975|469776539|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130728991|NCT01659125|470630496|FG000|Overall Study|Failed to Start Treatment|2|||
130728992|NCT02126826|470630497|FG000|Overall Study|Withdrawal by Subject|0|||
130728993|NCT02126826|470630498|FG001|Overall Study|Withdrawal by Subject|0|||
130728994|NCT02126826|470630499|FG002|Overall Study|Withdrawal by Subject|0|||
130728995|NCT02126826|470630500|FG003|Overall Study|Withdrawal by Subject|1|||
130728996|NCT02126826|470630501|FG004|Overall Study|Withdrawal by Subject|0|||
130728997|NCT02126826|470630502|FG005|Overall Study|Withdrawal by Subject|0|||
130728998|NCT02126826|470630503|FG006|Overall Study|Withdrawal by Subject|0|||
130728999|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1|24|||
130729000|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1|0|||
130729001|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
130729002|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
130729003|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729004|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729005|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
130729006|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
130729007|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
130729008|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
130729009|NCT03888066|470630504|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130493257|NCT01105975|469776540|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130493258|NCT01105975|469776541|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130493259|NCT01105975|469776542|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130493260|NCT01105975|469776543|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
130493261|NCT01105975|469776544|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130493262|NCT01105975|469776545|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
130493263|NCT01105975|469776546|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
130493264|NCT01105975|469776547|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
130493265|NCT00982644|469776548|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
130493266|NCT00982644|469776549|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
130493267|NCT00982644|469776548|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
130493268|NCT00982644|469776549|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
130493269|NCT00982644|469776548|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
130493270|NCT00982644|469776549|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
130493271|NCT00982644|469776548|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
130493272|NCT00982644|469776549|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
130493273|NCT00982644|469776548|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
130493274|NCT00982644|469776549|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
130493275|NCT00982644|469776548|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
130493276|NCT00982644|469776549|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
130493277|NCT00982644|469776548|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
130493278|NCT00982644|469776549|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
130493279|NCT00982644|469776548|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
130493280|NCT00982644|469776549|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
130493281|NCT00982644|469776548|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
130493282|NCT00982644|469776549|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
130493283|NCT00982644|469776548|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
130493284|NCT00982644|469776549|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
130493285|NCT00943917|469776552|FG000|Stage I|Adverse Event|1|||
130493286|NCT00943917|469776553|FG001|Stage I|Adverse Event|2|||
130493287|NCT00943917|469776554|FG002|Stage I|Adverse Event|2|||
130493288|NCT00943917|469776555|FG003|Stage I|Adverse Event|0|||
130493289|NCT00943917|469776556|FG004|Stage I|Adverse Event|0|||
130493290|NCT00943917|469776557|FG005|Stage I|Adverse Event|0|||
130493291|NCT00943917|469776558|FG006|Stage I|Adverse Event|0|||
130493292|NCT00943917|469776559|FG007|Stage I|Adverse Event|0|||
130493293|NCT00943917|469776560|FG008|Stage I|Adverse Event|0|||
130493294|NCT00943917|469776561|FG009|Stage I|Adverse Event|0|||
130493295|NCT00943917|469776562|FG010|Stage I|Adverse Event|0|||
130493296|NCT00943917|469776563|FG011|Stage I|Adverse Event|0|||
130493297|NCT00943917|469776564|FG012|Stage I|Adverse Event|0|||
130493298|NCT00943917|469776565|FG013|Stage I|Adverse Event|0|||
130493299|NCT00943917|469776566|FG014|Stage I|Adverse Event|0|||
130493300|NCT00943917|469776552|FG000|Stage I|Lost to Follow-up|0|||
130493301|NCT00943917|469776553|FG001|Stage I|Lost to Follow-up|0|||
130565472|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130565473|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130493302|NCT00943917|469776554|FG002|Stage I|Lost to Follow-up|1|||
130493303|NCT00943917|469776555|FG003|Stage I|Lost to Follow-up|0|||
130493304|NCT00943917|469776556|FG004|Stage I|Lost to Follow-up|0|||
130565474|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130729010|NCT03888066|470630505|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130493305|NCT00943917|469776557|FG005|Stage I|Lost to Follow-up|0|||
130493306|NCT00943917|469776558|FG006|Stage I|Lost to Follow-up|0|||
130493307|NCT00943917|469776559|FG007|Stage I|Lost to Follow-up|0|||
130493308|NCT00943917|469776560|FG008|Stage I|Lost to Follow-up|0|||
130493309|NCT00943917|469776561|FG009|Stage I|Lost to Follow-up|0|||
130493310|NCT00943917|469776562|FG010|Stage I|Lost to Follow-up|0|||
130493311|NCT00943917|469776563|FG011|Stage I|Lost to Follow-up|0|||
130493312|NCT00943917|469776564|FG012|Stage I|Lost to Follow-up|0|||
130493313|NCT00943917|469776565|FG013|Stage I|Lost to Follow-up|0|||
130493314|NCT00943917|469776566|FG014|Stage I|Lost to Follow-up|0|||
130729011|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130493315|NCT00943917|469776552|FG000|Stage I|hyperglycemia|0|||
130493316|NCT00943917|469776553|FG001|Stage I|hyperglycemia|0|||
130493317|NCT00943917|469776554|FG002|Stage I|hyperglycemia|1|||
130493318|NCT00943917|469776555|FG003|Stage I|hyperglycemia|0|||
130493319|NCT00943917|469776556|FG004|Stage I|hyperglycemia|0|||
130493320|NCT00943917|469776557|FG005|Stage I|hyperglycemia|0|||
130493321|NCT00943917|469776558|FG006|Stage I|hyperglycemia|0|||
130493322|NCT00943917|469776559|FG007|Stage I|hyperglycemia|0|||
130493323|NCT00943917|469776560|FG008|Stage I|hyperglycemia|0|||
130493324|NCT00943917|469776561|FG009|Stage I|hyperglycemia|0|||
130493325|NCT00943917|469776562|FG010|Stage I|hyperglycemia|0|||
130493326|NCT00943917|469776563|FG011|Stage I|hyperglycemia|0|||
130493327|NCT00943917|469776564|FG012|Stage I|hyperglycemia|0|||
130493328|NCT00943917|469776565|FG013|Stage I|hyperglycemia|0|||
130493329|NCT00943917|469776566|FG014|Stage I|hyperglycemia|0|||
130493330|NCT00943917|469776552|FG000|Stage I|A1C elevation|1|||
130493331|NCT00943917|469776553|FG001|Stage I|A1C elevation|0|||
130493332|NCT00943917|469776554|FG002|Stage I|A1C elevation|0|||
130493333|NCT00943917|469776555|FG003|Stage I|A1C elevation|0|||
130493334|NCT00943917|469776556|FG004|Stage I|A1C elevation|0|||
130493335|NCT00943917|469776557|FG005|Stage I|A1C elevation|0|||
130493336|NCT00943917|469776558|FG006|Stage I|A1C elevation|0|||
130493337|NCT00943917|469776559|FG007|Stage I|A1C elevation|0|||
130493338|NCT00943917|469776560|FG008|Stage I|A1C elevation|0|||
130493339|NCT00943917|469776561|FG009|Stage I|A1C elevation|0|||
130493340|NCT00943917|469776562|FG010|Stage I|A1C elevation|0|||
130493341|NCT00943917|469776563|FG011|Stage I|A1C elevation|0|||
130493342|NCT00943917|469776564|FG012|Stage I|A1C elevation|0|||
130493343|NCT00943917|469776565|FG013|Stage I|A1C elevation|0|||
130493344|NCT00943917|469776566|FG014|Stage I|A1C elevation|0|||
130493345|NCT00943917|469776552|FG000|Stage I|Withdrawal by Subject|2|||
130493346|NCT00943917|469776553|FG001|Stage I|Withdrawal by Subject|1|||
130493347|NCT00943917|469776554|FG002|Stage I|Withdrawal by Subject|2|||
130493348|NCT00943917|469776555|FG003|Stage I|Withdrawal by Subject|0|||
130493349|NCT00943917|469776556|FG004|Stage I|Withdrawal by Subject|0|||
130493350|NCT00943917|469776557|FG005|Stage I|Withdrawal by Subject|0|||
130493351|NCT00943917|469776558|FG006|Stage I|Withdrawal by Subject|0|||
130493352|NCT00943917|469776559|FG007|Stage I|Withdrawal by Subject|0|||
130493353|NCT00943917|469776560|FG008|Stage I|Withdrawal by Subject|0|||
130493354|NCT00943917|469776561|FG009|Stage I|Withdrawal by Subject|0|||
130493355|NCT00943917|469776562|FG010|Stage I|Withdrawal by Subject|0|||
130493356|NCT00943917|469776563|FG011|Stage I|Withdrawal by Subject|0|||
130729012|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729013|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
130493357|NCT00943917|469776564|FG012|Stage I|Withdrawal by Subject|0|||
130493358|NCT00943917|469776565|FG013|Stage I|Withdrawal by Subject|0|||
130493359|NCT00943917|469776566|FG014|Stage I|Withdrawal by Subject|0|||
130493360|NCT00943917|469776552|FG000|Stage II|Adverse Event|0|||
130493361|NCT00943917|469776553|FG001|Stage II|Adverse Event|0|||
130493362|NCT00943917|469776554|FG002|Stage II|Adverse Event|0|||
130729014|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
130493363|NCT00943917|469776555|FG003|Stage II|Adverse Event|0|||
130493364|NCT00943917|469776556|FG004|Stage II|Adverse Event|0|||
130493365|NCT00943917|469776557|FG005|Stage II|Adverse Event|1|||
130493366|NCT00943917|469776558|FG006|Stage II|Adverse Event|3|||
130493367|NCT00943917|469776559|FG007|Stage II|Adverse Event|0|||
130493368|NCT00943917|469776560|FG008|Stage II|Adverse Event|1|||
130493369|NCT00943917|469776561|FG009|Stage II|Adverse Event|0|||
130493370|NCT00943917|469776562|FG010|Stage II|Adverse Event|0|||
130493371|NCT00943917|469776563|FG011|Stage II|Adverse Event|0|||
130493372|NCT00943917|469776564|FG012|Stage II|Adverse Event|0|||
130493373|NCT00943917|469776565|FG013|Stage II|Adverse Event|0|||
130493374|NCT00943917|469776566|FG014|Stage II|Adverse Event|0|||
130493375|NCT00943917|469776552|FG000|Stage II|Withdrawal by Subject|0|||
130493376|NCT00943917|469776553|FG001|Stage II|Withdrawal by Subject|0|||
130493377|NCT00943917|469776554|FG002|Stage II|Withdrawal by Subject|0|||
130493378|NCT00943917|469776555|FG003|Stage II|Withdrawal by Subject|0|||
130493379|NCT00943917|469776556|FG004|Stage II|Withdrawal by Subject|0|||
130493380|NCT00943917|469776557|FG005|Stage II|Withdrawal by Subject|1|||
130493381|NCT00943917|469776558|FG006|Stage II|Withdrawal by Subject|0|||
130493382|NCT00943917|469776559|FG007|Stage II|Withdrawal by Subject|0|||
130493383|NCT00943917|469776560|FG008|Stage II|Withdrawal by Subject|0|||
130729015|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729016|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729017|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130729018|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729019|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #2|5|||
130729020|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #2|0|||
130729021|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
130729022|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
130729023|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
130729024|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
130729025|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
130729026|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
130729027|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3|11|||
130729028|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3|0|||
130729029|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
130729030|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
130729031|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130729032|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729033|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729034|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729035|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4|3|||
130729036|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4|0|||
130729037|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
130729038|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
130729039|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
130729040|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
130493384|NCT00943917|469776561|FG009|Stage II|Withdrawal by Subject|0|||
130493385|NCT00943917|469776562|FG010|Stage II|Withdrawal by Subject|0|||
130493386|NCT00943917|469776563|FG011|Stage II|Withdrawal by Subject|0|||
130493387|NCT00943917|469776564|FG012|Stage II|Withdrawal by Subject|0|||
130493388|NCT00943917|469776565|FG013|Stage II|Withdrawal by Subject|0|||
130493389|NCT00943917|469776566|FG014|Stage II|Withdrawal by Subject|0|||
130493390|NCT00943917|469776552|FG000|Stage II|Pregnancy|0|||
130493391|NCT00943917|469776553|FG001|Stage II|Pregnancy|0|||
130493392|NCT00943917|469776554|FG002|Stage II|Pregnancy|0|||
130493393|NCT00943917|469776555|FG003|Stage II|Pregnancy|0|||
130493394|NCT00943917|469776556|FG004|Stage II|Pregnancy|0|||
130493395|NCT00943917|469776557|FG005|Stage II|Pregnancy|1|||
130493396|NCT00943917|469776558|FG006|Stage II|Pregnancy|0|||
130493397|NCT00943917|469776559|FG007|Stage II|Pregnancy|0|||
130493398|NCT00943917|469776560|FG008|Stage II|Pregnancy|0|||
130493399|NCT00943917|469776561|FG009|Stage II|Pregnancy|0|||
130493400|NCT00943917|469776562|FG010|Stage II|Pregnancy|0|||
130493401|NCT00943917|469776563|FG011|Stage II|Pregnancy|0|||
130493402|NCT00943917|469776564|FG012|Stage II|Pregnancy|0|||
130493403|NCT00943917|469776565|FG013|Stage II|Pregnancy|0|||
130493404|NCT00943917|469776566|FG014|Stage II|Pregnancy|0|||
130493405|NCT00943917|469776552|FG000|Stage II Continuation|Adverse Event|0|||
130493406|NCT00943917|469776553|FG001|Stage II Continuation|Adverse Event|0|||
130493407|NCT00943917|469776554|FG002|Stage II Continuation|Adverse Event|0|||
130493408|NCT00943917|469776555|FG003|Stage II Continuation|Adverse Event|0|||
130493409|NCT00943917|469776556|FG004|Stage II Continuation|Adverse Event|0|||
130493410|NCT00943917|469776557|FG005|Stage II Continuation|Adverse Event|0|||
130493411|NCT00943917|469776558|FG006|Stage II Continuation|Adverse Event|0|||
130493412|NCT00943917|469776559|FG007|Stage II Continuation|Adverse Event|0|||
130493413|NCT00943917|469776560|FG008|Stage II Continuation|Adverse Event|0|||
130493414|NCT00943917|469776561|FG009|Stage II Continuation|Adverse Event|0|||
130493415|NCT00943917|469776562|FG010|Stage II Continuation|Adverse Event|0|||
130493416|NCT00943917|469776563|FG011|Stage II Continuation|Adverse Event|1|||
130493417|NCT00943917|469776564|FG012|Stage II Continuation|Adverse Event|2|||
130493418|NCT00943917|469776565|FG013|Stage II Continuation|Adverse Event|1|||
130493419|NCT00943917|469776566|FG014|Stage II Continuation|Adverse Event|1|||
130493420|NCT00943917|469776552|FG000|Stage II Continuation|Withdrawal by Subject|0|||
130493421|NCT00943917|469776553|FG001|Stage II Continuation|Withdrawal by Subject|0|||
130493422|NCT00943917|469776554|FG002|Stage II Continuation|Withdrawal by Subject|0|||
130565475|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
130493423|NCT00943917|469776555|FG003|Stage II Continuation|Withdrawal by Subject|0|||
130493424|NCT00943917|469776556|FG004|Stage II Continuation|Withdrawal by Subject|0|||
130493425|NCT00943917|469776557|FG005|Stage II Continuation|Withdrawal by Subject|0|||
130493426|NCT00943917|469776558|FG006|Stage II Continuation|Withdrawal by Subject|0|||
130493427|NCT00943917|469776559|FG007|Stage II Continuation|Withdrawal by Subject|0|||
130493428|NCT00943917|469776560|FG008|Stage II Continuation|Withdrawal by Subject|0|||
130493429|NCT00943917|469776561|FG009|Stage II Continuation|Withdrawal by Subject|0|||
130493430|NCT00943917|469776562|FG010|Stage II Continuation|Withdrawal by Subject|0|||
130493431|NCT00943917|469776563|FG011|Stage II Continuation|Withdrawal by Subject|0|||
130493432|NCT00943917|469776564|FG012|Stage II Continuation|Withdrawal by Subject|0|||
130493433|NCT00943917|469776565|FG013|Stage II Continuation|Withdrawal by Subject|1|||
130493434|NCT00943917|469776566|FG014|Stage II Continuation|Withdrawal by Subject|3|||
130493435|NCT00943917|469776552|FG000|Stage II Continuation|Protocol Violation|0|||
130493436|NCT00943917|469776553|FG001|Stage II Continuation|Protocol Violation|0|||
130493437|NCT00943917|469776554|FG002|Stage II Continuation|Protocol Violation|0|||
130493438|NCT00943917|469776555|FG003|Stage II Continuation|Protocol Violation|0|||
130493439|NCT00943917|469776556|FG004|Stage II Continuation|Protocol Violation|0|||
130493440|NCT00943917|469776557|FG005|Stage II Continuation|Protocol Violation|0|||
130493441|NCT00943917|469776558|FG006|Stage II Continuation|Protocol Violation|0|||
130493442|NCT00943917|469776559|FG007|Stage II Continuation|Protocol Violation|0|||
130493443|NCT00943917|469776560|FG008|Stage II Continuation|Protocol Violation|0|||
130493444|NCT00943917|469776561|FG009|Stage II Continuation|Protocol Violation|1|||
130493445|NCT00943917|469776562|FG010|Stage II Continuation|Protocol Violation|0|||
130493446|NCT00943917|469776563|FG011|Stage II Continuation|Protocol Violation|1|||
130493447|NCT00943917|469776564|FG012|Stage II Continuation|Protocol Violation|0|||
130493448|NCT00943917|469776565|FG013|Stage II Continuation|Protocol Violation|0|||
130493449|NCT00943917|469776566|FG014|Stage II Continuation|Protocol Violation|0|||
130493450|NCT00943917|469776552|FG000|Stage II Continuation|hypoglycemia|0|||
130493451|NCT00943917|469776553|FG001|Stage II Continuation|hypoglycemia|0|||
130493452|NCT00943917|469776554|FG002|Stage II Continuation|hypoglycemia|0|||
130493453|NCT00943917|469776555|FG003|Stage II Continuation|hypoglycemia|0|||
130493454|NCT00943917|469776556|FG004|Stage II Continuation|hypoglycemia|0|||
130493455|NCT00943917|469776557|FG005|Stage II Continuation|hypoglycemia|0|||
130493456|NCT00943917|469776558|FG006|Stage II Continuation|hypoglycemia|0|||
130493457|NCT00943917|469776559|FG007|Stage II Continuation|hypoglycemia|0|||
130493458|NCT00943917|469776560|FG008|Stage II Continuation|hypoglycemia|0|||
130493459|NCT00943917|469776561|FG009|Stage II Continuation|hypoglycemia|0|||
130493460|NCT00943917|469776562|FG010|Stage II Continuation|hypoglycemia|0|||
130493461|NCT00943917|469776563|FG011|Stage II Continuation|hypoglycemia|0|||
130493462|NCT00943917|469776564|FG012|Stage II Continuation|hypoglycemia|1|||
130493463|NCT00943917|469776565|FG013|Stage II Continuation|hypoglycemia|0|||
130493464|NCT00943917|469776566|FG014|Stage II Continuation|hypoglycemia|0|||
130493465|NCT00943917|469776552|FG000|Stage II Continuation|A1C elevation|0|||
130493466|NCT00943917|469776553|FG001|Stage II Continuation|A1C elevation|0|||
130493467|NCT00943917|469776554|FG002|Stage II Continuation|A1C elevation|0|||
130493468|NCT00943917|469776555|FG003|Stage II Continuation|A1C elevation|0|||
130493469|NCT00943917|469776556|FG004|Stage II Continuation|A1C elevation|0|||
130493470|NCT00943917|469776557|FG005|Stage II Continuation|A1C elevation|0|||
130493471|NCT00943917|469776558|FG006|Stage II Continuation|A1C elevation|0|||
130493472|NCT00943917|469776559|FG007|Stage II Continuation|A1C elevation|0|||
130493473|NCT00943917|469776560|FG008|Stage II Continuation|A1C elevation|0|||
130493474|NCT00943917|469776561|FG009|Stage II Continuation|A1C elevation|0|||
130493475|NCT00943917|469776562|FG010|Stage II Continuation|A1C elevation|0|||
130493476|NCT00943917|469776563|FG011|Stage II Continuation|A1C elevation|0|||
130493477|NCT00943917|469776564|FG012|Stage II Continuation|A1C elevation|0|||
130493478|NCT00943917|469776565|FG013|Stage II Continuation|A1C elevation|1|||
130493479|NCT00943917|469776566|FG014|Stage II Continuation|A1C elevation|0|||
130493480|NCT01171976|469776567|FG000|Overall Study|Protocol Violation|0|||
130493481|NCT01171976|469776568|FG001|Overall Study|Protocol Violation|0|||
130493482|NCT01171976|469776569|FG002|Overall Study|Protocol Violation|1|||
130493483|NCT01171976|469776567|FG000|Overall Study|Death|2|||
130493484|NCT01171976|469776568|FG001|Overall Study|Death|4|||
130493485|NCT01171976|469776569|FG002|Overall Study|Death|1|||
130493486|NCT01171976|469776567|FG000|Overall Study|Lost to Follow-up|4|||
130493487|NCT01171976|469776568|FG001|Overall Study|Lost to Follow-up|0|||
130493488|NCT01171976|469776569|FG002|Overall Study|Lost to Follow-up|2|||
130493489|NCT01171976|469776567|FG000|Overall Study|Withdrawal by Subject|1|||
130565476|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130493490|NCT01171976|469776568|FG001|Overall Study|Withdrawal by Subject|5|||
130493491|NCT01171976|469776569|FG002|Overall Study|Withdrawal by Subject|6|||
130493492|NCT01171976|469776567|FG000|Overall Study|Abnormal test result|1|||
130493493|NCT01171976|469776568|FG001|Overall Study|Abnormal test result|0|||
130493494|NCT01171976|469776569|FG002|Overall Study|Abnormal test result|0|||
130493495|NCT01171976|469776567|FG000|Overall Study|Adverse Event|6|||
130493496|NCT01171976|469776568|FG001|Overall Study|Adverse Event|2|||
130493497|NCT01171976|469776569|FG002|Overall Study|Adverse Event|5|||
130493498|NCT02754596|469776573|FG000|Overall Study|Withdrawal by Subject|3|||
130493499|NCT02754596|469776574|FG001|Overall Study|Withdrawal by Subject|4|||
130493500|NCT02754596|469776575|FG002|Overall Study|Withdrawal by Subject|0|||
130493501|NCT02754596|469776573|FG000|Overall Study|Physician Decision|1|||
130493502|NCT02754596|469776574|FG001|Overall Study|Physician Decision|1|||
130493503|NCT02754596|469776575|FG002|Overall Study|Physician Decision|1|||
130493504|NCT02754596|469776573|FG000|Overall Study|Lost to Follow-up|1|||
130493505|NCT02754596|469776574|FG001|Overall Study|Lost to Follow-up|1|||
130493506|NCT02754596|469776575|FG002|Overall Study|Lost to Follow-up|2|||
130493507|NCT02754596|469776573|FG000|Overall Study|Death|0|||
130493508|NCT02754596|469776574|FG001|Overall Study|Death|2|||
130493509|NCT02754596|469776575|FG002|Overall Study|Death|0|||
130493510|NCT02754596|469776573|FG000|Overall Study|Adverse Event|1|||
130493511|NCT02754596|469776574|FG001|Overall Study|Adverse Event|0|||
130493512|NCT02754596|469776575|FG002|Overall Study|Adverse Event|1|||
130493513|NCT02754596|469776573|FG000|Overall Study|Other|1|||
130493514|NCT02754596|469776574|FG001|Overall Study|Other|0|||
130493515|NCT02754596|469776575|FG002|Overall Study|Other|0|||
130493516|NCT03357952|469776576|FG000|Overall Study|Withdrawal by Subject|0|||
130493517|NCT03357952|469776577|FG001|Overall Study|Withdrawal by Subject|1|||
130493518|NCT03357952|469776576|FG000|Overall Study|Sponsor Decision|9|||
130493519|NCT03357952|469776577|FG001|Overall Study|Sponsor Decision|0|||
130493520|NCT01371994|469776578|FG000|Overall Study|Adverse Event|3|||
130493521|NCT01371994|469776579|FG001|Overall Study|Adverse Event|6|||
130493522|NCT01371994|469776578|FG000|Overall Study|Lack of Efficacy|3|||
130493523|NCT01371994|469776579|FG001|Overall Study|Lack of Efficacy|0|||
130493524|NCT01371994|469776578|FG000|Overall Study|Withdrawal by Subject|13|||
130493525|NCT01371994|469776579|FG001|Overall Study|Withdrawal by Subject|7|||
130493526|NCT01371994|469776578|FG000|Overall Study|Lost to Follow-up|1|||
130493527|NCT01371994|469776579|FG001|Overall Study|Lost to Follow-up|1|||
130493528|NCT01371994|469776578|FG000|Overall Study|Protocol Violation|24|||
130493529|NCT01371994|469776579|FG001|Overall Study|Protocol Violation|17|||
130493530|NCT01371994|469776578|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
130493531|NCT01371994|469776579|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
130493532|NCT01371994|469776578|FG000|Overall Study|Physician Decision|1|||
130493533|NCT01371994|469776579|FG001|Overall Study|Physician Decision|1|||
130493534|NCT01371994|469776578|FG000|Overall Study|Miscellaneous Reasons|6|||
130493535|NCT01371994|469776579|FG001|Overall Study|Miscellaneous Reasons|4|||
130493536|NCT03280030|469776580|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
130493537|NCT03280030|469776581|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
130493538|NCT03280030|469776582|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
130493539|NCT03280030|469776580|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
130493540|NCT03280030|469776581|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
130493541|NCT03280030|469776582|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
130493542|NCT03280030|469776580|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
130493543|NCT03280030|469776581|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
130493544|NCT03280030|469776582|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
130493545|NCT03280030|469776580|FG000|Part 2 - Efficacy|Adverse Event|0|||
130493546|NCT03280030|469776581|FG001|Part 2 - Efficacy|Adverse Event|4|||
130493547|NCT03280030|469776582|FG002|Part 2 - Efficacy|Adverse Event|6|||
130493548|NCT03280030|469776580|FG000|Part 2 - Efficacy|Death|0|||
130493549|NCT03280030|469776581|FG001|Part 2 - Efficacy|Death|3|||
130493550|NCT03280030|469776582|FG002|Part 2 - Efficacy|Death|0|||
130493551|NCT03280030|469776580|FG000|Part 2 - Efficacy|Physician Decision|0|||
130493552|NCT03280030|469776581|FG001|Part 2 - Efficacy|Physician Decision|10|||
130493553|NCT03280030|469776582|FG002|Part 2 - Efficacy|Physician Decision|16|||
130493554|NCT03280030|469776580|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
130493555|NCT03280030|469776581|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
130493556|NCT03280030|469776582|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
130493557|NCT03280030|469776580|FG000|Part 2 - Efficacy|Progressive disease|0|||
130493558|NCT03280030|469776581|FG001|Part 2 - Efficacy|Progressive disease|7|||
130493559|NCT03280030|469776582|FG002|Part 2 - Efficacy|Progressive disease|5|||
130493560|NCT01208974|469776585|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
130493561|NCT01208974|469776586|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
130493562|NCT01208974|469776587|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
130493563|NCT01208974|469776588|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
130493564|NCT01208974|469776585|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
130493565|NCT01208974|469776586|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
130493566|NCT01208974|469776587|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
130493567|NCT01208974|469776588|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
130493568|NCT01208974|469776585|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
130493569|NCT01208974|469776586|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
130493570|NCT01208974|469776587|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
130493571|NCT01208974|469776588|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
130493572|NCT03211247|469776589|FG000|Overall Study|Adverse Event|8|||
130493573|NCT03211247|469776590|FG001|Overall Study|Adverse Event|0|||
130493574|NCT03211247|469776591|FG002|Overall Study|Adverse Event|1|||
130493575|NCT03211247|469776592|FG003|Overall Study|Adverse Event|0|||
130493576|NCT03211247|469776593|FG004|Overall Study|Adverse Event|0|||
130493577|NCT03211247|469776589|FG000|Overall Study|Lost to Follow-up|2|||
130493578|NCT03211247|469776590|FG001|Overall Study|Lost to Follow-up|1|||
130493579|NCT03211247|469776591|FG002|Overall Study|Lost to Follow-up|0|||
130493580|NCT03211247|469776592|FG003|Overall Study|Lost to Follow-up|0|||
130493581|NCT03211247|469776593|FG004|Overall Study|Lost to Follow-up|0|||
130493582|NCT03211247|469776589|FG000|Overall Study|Physician Decision|1|||
130493583|NCT03211247|469776590|FG001|Overall Study|Physician Decision|2|||
130493584|NCT03211247|469776591|FG002|Overall Study|Physician Decision|0|||
130493585|NCT03211247|469776592|FG003|Overall Study|Physician Decision|0|||
130493586|NCT03211247|469776593|FG004|Overall Study|Physician Decision|0|||
130493587|NCT03211247|469776589|FG000|Overall Study|Non-compliance with study drug|2|||
130493588|NCT03211247|469776590|FG001|Overall Study|Non-compliance with study drug|0|||
130493589|NCT03211247|469776591|FG002|Overall Study|Non-compliance with study drug|0|||
130493590|NCT03211247|469776592|FG003|Overall Study|Non-compliance with study drug|0|||
130493591|NCT03211247|469776593|FG004|Overall Study|Non-compliance with study drug|0|||
130493592|NCT03211247|469776589|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
130493593|NCT03211247|469776590|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
130493594|NCT03211247|469776591|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
130493595|NCT03211247|469776592|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
130493596|NCT03211247|469776593|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
130493597|NCT03211247|469776589|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
130493598|NCT03211247|469776590|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
130493599|NCT03211247|469776591|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
130493600|NCT03211247|469776592|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
130493601|NCT03211247|469776593|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
130493602|NCT03211247|469776589|FG000|Overall Study|Protocol Violation|0|||
130493603|NCT03211247|469776590|FG001|Overall Study|Protocol Violation|1|||
130493604|NCT03211247|469776591|FG002|Overall Study|Protocol Violation|0|||
130493605|NCT03211247|469776592|FG003|Overall Study|Protocol Violation|0|||
130493606|NCT03211247|469776593|FG004|Overall Study|Protocol Violation|0|||
130493607|NCT03691493|469776596|FG000|Overall Study|Withdrawal by Subject|1|||
130493608|NCT01983683|469776606|FG000|Overall Study|Withdrawal by Subject|14|||
130493609|NCT01983683|469776607|FG001|Overall Study|Withdrawal by Subject|18|||
130493610|NCT01983683|469776606|FG000|Overall Study|Death|11|||
130493611|NCT01983683|469776607|FG001|Overall Study|Death|15|||
130493612|NCT01983683|469776606|FG000|Overall Study|Physician Decision|8|||
130493613|NCT01983683|469776607|FG001|Overall Study|Physician Decision|9|||
130493614|NCT01983683|469776606|FG000|Overall Study|Lost to Follow-up|4|||
130493615|NCT01983683|469776607|FG001|Overall Study|Lost to Follow-up|8|||
130493616|NCT01983683|469776606|FG000|Overall Study|Sponsor Decision|1|||
130493617|NCT01983683|469776607|FG001|Overall Study|Sponsor Decision|1|||
130493618|NCT03959423|469776614|FG000|Overall Study|Withdrawal by Subject|2|||
130493619|NCT03959423|469776615|FG001|Overall Study|Withdrawal by Subject|3|||
130493620|NCT03959423|469776614|FG000|Overall Study|Physician Decision|0|||
130493621|NCT03959423|469776615|FG001|Overall Study|Physician Decision|1|||
130493622|NCT03959423|469776614|FG000|Overall Study|Lost to Follow-up|1|||
130493623|NCT03959423|469776615|FG001|Overall Study|Lost to Follow-up|0|||
130493624|NCT03959423|469776614|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
130493625|NCT03959423|469776615|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130493626|NCT05786612|469776616|FG000|Overall Study|Adverse Event|1|||
130493627|NCT05786612|469776617|FG001|Overall Study|Adverse Event|2|||
130493628|NCT05786612|469776616|FG000|Overall Study|one screening failure|0|||
130493629|NCT05786612|469776617|FG001|Overall Study|one screening failure|2|||
130493630|NCT04926740|469776618|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
130493631|NCT04926740|469776619|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
130493632|NCT04926740|469776618|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
130493633|NCT04926740|469776619|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
130493634|NCT02549352|469776620|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
130493635|NCT02549352|469776621|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
130729041|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
130729042|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729043|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
130493636|NCT02549352|469776620|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
130493637|NCT02549352|469776621|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
130493638|NCT02549352|469776620|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
130493639|NCT02549352|469776621|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
130493640|NCT02549352|469776620|FG000|12-month Follow-up|Withdrawal by Subject|4|||
130493641|NCT02549352|469776621|FG001|12-month Follow-up|Withdrawal by Subject|5|||
130493642|NCT02549352|469776620|FG000|12-month Follow-up|Lost to Follow-up|3|||
130493643|NCT02549352|469776621|FG001|12-month Follow-up|Lost to Follow-up|2|||
130493644|NCT02549352|469776620|FG000|12-month Follow-up|Death|0|||
130493645|NCT02549352|469776621|FG001|12-month Follow-up|Death|1|||
130493646|NCT02549352|469776620|FG000|12-month Follow-up|Protocol Violation|0|||
130493647|NCT02549352|469776621|FG001|12-month Follow-up|Protocol Violation|1|||
130493648|NCT02549352|469776620|FG000|12-month Follow-up|Other|1|||
130493649|NCT02549352|469776621|FG001|12-month Follow-up|Other|3|||
130493650|NCT03459196|469777991|FG000|Overall Study|Subject didn't receive study catheter|2|||
130493651|NCT00146172|469777993|FG000|Overall Study|Adverse Event|0|||
130493652|NCT00146172|469777994|FG001|Overall Study|Adverse Event|0|||
130493653|NCT00146172|469777995|FG002|Overall Study|Adverse Event|1|||
130493654|NCT00146172|469777996|FG003|Overall Study|Adverse Event|1|||
130493655|NCT00146172|469777997|FG004|Overall Study|Adverse Event|0|||
130493656|NCT00146172|469777998|FG005|Overall Study|Adverse Event|2|||
130493657|NCT00146172|469777999|FG006|Overall Study|Adverse Event|3|||
130493658|NCT00146172|469778000|FG007|Overall Study|Adverse Event|10|||
130493659|NCT00146172|469777993|FG000|Overall Study|Lost to Follow-up|0|||
130493660|NCT00146172|469777994|FG001|Overall Study|Lost to Follow-up|0|||
130493661|NCT00146172|469777995|FG002|Overall Study|Lost to Follow-up|0|||
130493662|NCT00146172|469777996|FG003|Overall Study|Lost to Follow-up|0|||
130493663|NCT00146172|469777997|FG004|Overall Study|Lost to Follow-up|0|||
130493664|NCT00146172|469777998|FG005|Overall Study|Lost to Follow-up|0|||
130493665|NCT00146172|469777999|FG006|Overall Study|Lost to Follow-up|0|||
130493666|NCT00146172|469778000|FG007|Overall Study|Lost to Follow-up|1|||
130493667|NCT00146172|469777993|FG000|Overall Study|Disease Progression|2|||
130493668|NCT00146172|469777994|FG001|Overall Study|Disease Progression|4|||
130493669|NCT00146172|469777995|FG002|Overall Study|Disease Progression|2|||
130493670|NCT00146172|469777996|FG003|Overall Study|Disease Progression|5|||
130493671|NCT00146172|469777997|FG004|Overall Study|Disease Progression|2|||
130493672|NCT00146172|469777998|FG005|Overall Study|Disease Progression|2|||
130493673|NCT00146172|469777999|FG006|Overall Study|Disease Progression|1|||
130493674|NCT00146172|469778000|FG007|Overall Study|Disease Progression|22|||
130493675|NCT00146172|469777993|FG000|Overall Study|Death|0|||
130493676|NCT00146172|469777994|FG001|Overall Study|Death|0|||
130493677|NCT00146172|469777995|FG002|Overall Study|Death|0|||
130493678|NCT00146172|469777996|FG003|Overall Study|Death|0|||
130493679|NCT00146172|469777997|FG004|Overall Study|Death|0|||
130493680|NCT00146172|469777998|FG005|Overall Study|Death|0|||
130493681|NCT00146172|469777999|FG006|Overall Study|Death|1|||
130493682|NCT00146172|469778000|FG007|Overall Study|Death|0|||
130493683|NCT00146172|469777993|FG000|Overall Study|Physician Decision|0|||
130493684|NCT00146172|469777994|FG001|Overall Study|Physician Decision|0|||
130493685|NCT00146172|469777995|FG002|Overall Study|Physician Decision|0|||
130493686|NCT00146172|469777996|FG003|Overall Study|Physician Decision|0|||
130493687|NCT00146172|469777997|FG004|Overall Study|Physician Decision|0|||
130493688|NCT00146172|469777998|FG005|Overall Study|Physician Decision|0|||
130493689|NCT00146172|469777999|FG006|Overall Study|Physician Decision|0|||
130493690|NCT00146172|469778000|FG007|Overall Study|Physician Decision|1|||
130493691|NCT00146172|469777993|FG000|Overall Study|Withdrawal by Subject|0|||
130493692|NCT00146172|469777994|FG001|Overall Study|Withdrawal by Subject|0|||
130493693|NCT00146172|469777995|FG002|Overall Study|Withdrawal by Subject|0|||
130493694|NCT00146172|469777996|FG003|Overall Study|Withdrawal by Subject|0|||
130493695|NCT00146172|469777997|FG004|Overall Study|Withdrawal by Subject|0|||
130493696|NCT00146172|469777998|FG005|Overall Study|Withdrawal by Subject|1|||
130493697|NCT00146172|469777999|FG006|Overall Study|Withdrawal by Subject|1|||
130493698|NCT00146172|469778000|FG007|Overall Study|Withdrawal by Subject|4|||
130493699|NCT00146172|469777993|FG000|Overall Study|Symptomatic Deterioration|1|||
130493700|NCT00146172|469777994|FG001|Overall Study|Symptomatic Deterioration|0|||
130493701|NCT00146172|469777995|FG002|Overall Study|Symptomatic Deterioration|1|||
130493702|NCT00146172|469777996|FG003|Overall Study|Symptomatic Deterioration|0|||
130493703|NCT00146172|469777997|FG004|Overall Study|Symptomatic Deterioration|1|||
130493704|NCT00146172|469777998|FG005|Overall Study|Symptomatic Deterioration|2|||
130493705|NCT00146172|469777999|FG006|Overall Study|Symptomatic Deterioration|0|||
130493706|NCT00146172|469778000|FG007|Overall Study|Symptomatic Deterioration|2|||
130493707|NCT03876457|469778003|FG000|Overall Study|Lost to Follow-up|1|||
130493708|NCT03876457|469778004|FG001|Overall Study|Lost to Follow-up|3|||
130493709|NCT01184326|469778005|FG000|Overall Study|Adverse Event|1|||
130493710|NCT01184326|469778006|FG001|Overall Study|Adverse Event|2|||
130493711|NCT01184326|469778007|FG002|Overall Study|Adverse Event|0|||
130493712|NCT01184326|469778005|FG000|Overall Study|Death|0|||
130493713|NCT01184326|469778006|FG001|Overall Study|Death|0|||
130493714|NCT01184326|469778007|FG002|Overall Study|Death|1|||
130493715|NCT01184326|469778005|FG000|Overall Study|Withdrawal by Subject|0|||
130493716|NCT01184326|469778006|FG001|Overall Study|Withdrawal by Subject|0|||
130493717|NCT01184326|469778007|FG002|Overall Study|Withdrawal by Subject|1|||
130493718|NCT01184326|469778005|FG000|Overall Study|Physician Decision|1|||
130493719|NCT01184326|469778006|FG001|Overall Study|Physician Decision|1|||
130493720|NCT01184326|469778007|FG002|Overall Study|Physician Decision|0|||
130493721|NCT01184326|469778005|FG000|Overall Study|Disease Progression|1|||
130493722|NCT01184326|469778006|FG001|Overall Study|Disease Progression|3|||
130493723|NCT01184326|469778007|FG002|Overall Study|Disease Progression|12|||
130493724|NCT01288443|469778008|FG000|Overall Study|Adverse Event|0|||
130493725|NCT01288443|469778009|FG001|Overall Study|Adverse Event|0|||
130493726|NCT01288443|469778010|FG002|Overall Study|Adverse Event|1|||
130493727|NCT01288443|469778011|FG003|Overall Study|Adverse Event|1|||
130493728|NCT01288443|469778012|FG004|Overall Study|Adverse Event|3|||
130493729|NCT01288443|469778013|FG005|Overall Study|Adverse Event|1|||
130493730|NCT01288443|469778008|FG000|Overall Study|Poor compliance to protocol|0|||
130493731|NCT01288443|469778009|FG001|Overall Study|Poor compliance to protocol|0|||
130493732|NCT01288443|469778010|FG002|Overall Study|Poor compliance to protocol|0|||
130493733|NCT01288443|469778011|FG003|Overall Study|Poor compliance to protocol|0|||
130493734|NCT01288443|469778012|FG004|Overall Study|Poor compliance to protocol|0|||
130493735|NCT01288443|469778013|FG005|Overall Study|Poor compliance to protocol|1|||
130493736|NCT01288443|469778008|FG000|Overall Study|Participant Moved|0|||
130493737|NCT01288443|469778009|FG001|Overall Study|Participant Moved|0|||
130493738|NCT01288443|469778010|FG002|Overall Study|Participant Moved|0|||
130493739|NCT01288443|469778011|FG003|Overall Study|Participant Moved|1|||
130493740|NCT01288443|469778012|FG004|Overall Study|Participant Moved|2|||
130493741|NCT01288443|469778013|FG005|Overall Study|Participant Moved|1|||
130493742|NCT01288443|469778008|FG000|Overall Study|Consent withdrawn by Participant|0|||
130493743|NCT01288443|469778009|FG001|Overall Study|Consent withdrawn by Participant|0|||
130493744|NCT01288443|469778010|FG002|Overall Study|Consent withdrawn by Participant|0|||
130493745|NCT01288443|469778011|FG003|Overall Study|Consent withdrawn by Participant|0|||
130493746|NCT01288443|469778012|FG004|Overall Study|Consent withdrawn by Participant|0|||
130493747|NCT01288443|469778013|FG005|Overall Study|Consent withdrawn by Participant|1|||
130493748|NCT01288443|469778008|FG000|Overall Study|Lost to Follow-up|0|||
130493749|NCT01288443|469778009|FG001|Overall Study|Lost to Follow-up|1|||
130493750|NCT01288443|469778010|FG002|Overall Study|Lost to Follow-up|0|||
130493751|NCT01288443|469778011|FG003|Overall Study|Lost to Follow-up|0|||
130493752|NCT01288443|469778012|FG004|Overall Study|Lost to Follow-up|0|||
130493753|NCT01288443|469778013|FG005|Overall Study|Lost to Follow-up|0|||
130493754|NCT01288443|469778008|FG000|Overall Study|Study drug auto-injector administration|0|||
130493755|NCT01288443|469778009|FG001|Overall Study|Study drug auto-injector administration|0|||
130493756|NCT01288443|469778010|FG002|Overall Study|Study drug auto-injector administration|0|||
130493757|NCT01288443|469778011|FG003|Overall Study|Study drug auto-injector administration|0|||
130493758|NCT01288443|469778012|FG004|Overall Study|Study drug auto-injector administration|1|||
130493759|NCT01288443|469778013|FG005|Overall Study|Study drug auto-injector administration|1|||
130493760|NCT01288443|469778008|FG000|Overall Study|Other than above|0|||
130493761|NCT01288443|469778009|FG001|Overall Study|Other than above|0|||
130493762|NCT01288443|469778010|FG002|Overall Study|Other than above|0|||
130493763|NCT01288443|469778011|FG003|Overall Study|Other than above|2|||
130493764|NCT01288443|469778012|FG004|Overall Study|Other than above|1|||
130493765|NCT01288443|469778013|FG005|Overall Study|Other than above|0|||
130493766|NCT01964300|469778015|FG000|Overall Study|Ineligible after enrollment|0|||
130493767|NCT01964300|469778016|FG001|Overall Study|Ineligible after enrollment|1|||
130493768|NCT01964300|469778015|FG000|Overall Study|Adverse Event|1|||
130493769|NCT01964300|469778016|FG001|Overall Study|Adverse Event|1|||
130493770|NCT01964300|469778015|FG000|Overall Study|Lack of Efficacy|3|||
130493771|NCT01964300|469778016|FG001|Overall Study|Lack of Efficacy|5|||
130493772|NCT01964300|469778015|FG000|Overall Study|Withdrawal by Subject|0|||
130493773|NCT01964300|469778016|FG001|Overall Study|Withdrawal by Subject|1|||
130493774|NCT01964300|469778015|FG000|Overall Study|To receive alternative therapy|1|||
130493775|NCT01964300|469778016|FG001|Overall Study|To receive alternative therapy|2|||
130493776|NCT01964300|469778015|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
130493777|NCT01964300|469778016|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
130493778|NCT01964300|469778015|FG000|Overall Study|Weight criteria not met|0|||
130493779|NCT01964300|469778016|FG001|Overall Study|Weight criteria not met|1|||
130493780|NCT00557492|469778017|FG000|Overall Study|Change in health insurance|1|||
130493781|NCT01574716|469778018|FG000|Part 1|Death|3|||
130493782|NCT01574716|469778019|FG001|Part 1|Death|1|||
130493783|NCT01574716|469778020|FG002|Part 1|Death|8|||
130493784|NCT01574716|469778021|FG003|Part 1|Death|0|||
130493785|NCT01574716|469778022|FG004|Part 1|Death|0|||
130493786|NCT01574716|469778018|FG000|Part 1|Discontinuation of study by sponsor|0|||
130493787|NCT01574716|469778019|FG001|Part 1|Discontinuation of study by sponsor|0|||
130493788|NCT01574716|469778020|FG002|Part 1|Discontinuation of study by sponsor|1|||
130493789|NCT01574716|469778021|FG003|Part 1|Discontinuation of study by sponsor|0|||
130493790|NCT01574716|469778022|FG004|Part 1|Discontinuation of study by sponsor|0|||
130565477|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130493791|NCT01574716|469778018|FG000|Part 1|Withdrawal by Subject|0|||
130493792|NCT01574716|469778019|FG001|Part 1|Withdrawal by Subject|2|||
130493793|NCT01574716|469778020|FG002|Part 1|Withdrawal by Subject|0|||
130493794|NCT01574716|469778021|FG003|Part 1|Withdrawal by Subject|0|||
130493795|NCT01574716|469778022|FG004|Part 1|Withdrawal by Subject|0|||
130493796|NCT01574716|469778018|FG000|Part 1|Lost to Follow-up|0|||
130493797|NCT01574716|469778019|FG001|Part 1|Lost to Follow-up|1|||
130493798|NCT01574716|469778020|FG002|Part 1|Lost to Follow-up|0|||
130493799|NCT01574716|469778021|FG003|Part 1|Lost to Follow-up|0|||
130493800|NCT01574716|469778022|FG004|Part 1|Lost to Follow-up|0|||
130493801|NCT01574716|469778018|FG000|Part 2|Progressive disease|0|||
130493802|NCT01574716|469778019|FG001|Part 2|Progressive disease|0|||
130493803|NCT01574716|469778020|FG002|Part 2|Progressive disease|0|||
130493804|NCT01574716|469778021|FG003|Part 2|Progressive disease|1|||
130493805|NCT01574716|469778022|FG004|Part 2|Progressive disease|0|||
130493806|NCT01574716|469778018|FG000|Part 2|Death|0|||
130493807|NCT01574716|469778019|FG001|Part 2|Death|0|||
130493808|NCT01574716|469778020|FG002|Part 2|Death|0|||
130493809|NCT01574716|469778021|FG003|Part 2|Death|76|||
130493810|NCT01574716|469778022|FG004|Part 2|Death|35|||
130493811|NCT01574716|469778018|FG000|Part 2|Discontinuation of study by sponsor|0|||
130493812|NCT01574716|469778019|FG001|Part 2|Discontinuation of study by sponsor|0|||
130493813|NCT01574716|469778020|FG002|Part 2|Discontinuation of study by sponsor|0|||
130493814|NCT01574716|469778021|FG003|Part 2|Discontinuation of study by sponsor|51|||
130493815|NCT01574716|469778022|FG004|Part 2|Discontinuation of study by sponsor|31|||
130493816|NCT01574716|469778018|FG000|Part 2|Withdrawal by Subject|0|||
130493817|NCT01574716|469778019|FG001|Part 2|Withdrawal by Subject|0|||
130493818|NCT01574716|469778020|FG002|Part 2|Withdrawal by Subject|0|||
130493819|NCT01574716|469778021|FG003|Part 2|Withdrawal by Subject|5|||
130493820|NCT01574716|469778022|FG004|Part 2|Withdrawal by Subject|4|||
130493821|NCT01574716|469778018|FG000|Part 2|Brain metastases|0|||
130493822|NCT01574716|469778019|FG001|Part 2|Brain metastases|0|||
130493823|NCT01574716|469778020|FG002|Part 2|Brain metastases|0|||
130493824|NCT01574716|469778021|FG003|Part 2|Brain metastases|1|||
130493825|NCT01574716|469778022|FG004|Part 2|Brain metastases|0|||
130493826|NCT01574716|469778018|FG000|Part 2|Lost to Follow-up|0|||
130493827|NCT01574716|469778019|FG001|Part 2|Lost to Follow-up|0|||
130493828|NCT01574716|469778020|FG002|Part 2|Lost to Follow-up|0|||
130493829|NCT01574716|469778021|FG003|Part 2|Lost to Follow-up|3|||
130493830|NCT01574716|469778022|FG004|Part 2|Lost to Follow-up|0|||
130493831|NCT02438137|469778023|FG000|Overall Study|Lost to Follow-up|3|||
130493832|NCT02438137|469778024|FG001|Overall Study|Lost to Follow-up|2|||
130493833|NCT02438137|469778023|FG000|Overall Study|Adverse Event|1|||
130493834|NCT02438137|469778024|FG001|Overall Study|Adverse Event|0|||
130493835|NCT02438137|469778023|FG000|Overall Study|Withdrawal by Subject|4|||
130493836|NCT02438137|469778024|FG001|Overall Study|Withdrawal by Subject|3|||
130493837|NCT02438137|469778023|FG000|Overall Study|Physician Decision|0|||
130493838|NCT02438137|469778024|FG001|Overall Study|Physician Decision|1|||
130493839|NCT02111096|469778025|FG000|Overall Study|Adverse Event|4|||
130493840|NCT02111096|469778026|FG001|Overall Study|Adverse Event|1|||
130493841|NCT02111096|469778027|FG002|Overall Study|Adverse Event|2|||
130493842|NCT02111096|469778025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130493843|NCT02111096|469778026|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130493844|NCT02111096|469778027|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130493845|NCT02111096|469778025|FG000|Overall Study|Lost to Follow Up|1|||
130493846|NCT02111096|469778026|FG001|Overall Study|Lost to Follow Up|1|||
130493847|NCT02111096|469778027|FG002|Overall Study|Lost to Follow Up|1|||
130493848|NCT02111096|469778025|FG000|Overall Study|Physician Decision|0|||
130493849|NCT02111096|469778026|FG001|Overall Study|Physician Decision|1|||
130493850|NCT02111096|469778027|FG002|Overall Study|Physician Decision|0|||
130493851|NCT02111096|469778025|FG000|Overall Study|Protocol Violation|1|||
130493852|NCT02111096|469778026|FG001|Overall Study|Protocol Violation|0|||
130493853|NCT02111096|469778027|FG002|Overall Study|Protocol Violation|1|||
130493854|NCT02111096|469778025|FG000|Overall Study|Terminated by Sponsor|53|||
130493855|NCT02111096|469778026|FG001|Overall Study|Terminated by Sponsor|35|||
130493856|NCT02111096|469778027|FG002|Overall Study|Terminated by Sponsor|54|||
130493857|NCT02111096|469778025|FG000|Overall Study|Withdrawal by Subject|4|||
130493858|NCT02111096|469778026|FG001|Overall Study|Withdrawal by Subject|2|||
130493859|NCT02111096|469778027|FG002|Overall Study|Withdrawal by Subject|8|||
130493860|NCT03621735|469778028|FG000|Overall Study|Withdrawal by Subject|13|||
130493861|NCT03621735|469778029|FG001|Overall Study|Withdrawal by Subject|13|||
130493862|NCT03709706|469778035|FG000|Overall Study|Adverse Event|0|||
130493863|NCT03709706|469778036|FG001|Overall Study|Adverse Event|1|||
130493864|NCT03709706|469778035|FG000|Overall Study|Physician Decision|14|||
130493865|NCT03709706|469778036|FG001|Overall Study|Physician Decision|8|||
130565478|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130493866|NCT03709706|469778035|FG000|Overall Study|Withdrawal by Subject|2|||
130493867|NCT03709706|469778036|FG001|Overall Study|Withdrawal by Subject|1|||
130493868|NCT03709706|469778035|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
130493869|NCT03709706|469778036|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
130493870|NCT04868617|469778037|FG000|Overall Study|Death|1|||
130493871|NCT04868617|469778038|FG001|Overall Study|Death|0|||
130493872|NCT04868617|469778037|FG000|Overall Study|Adverse Event|1|||
130493873|NCT04868617|469778038|FG001|Overall Study|Adverse Event|0|||
130493874|NCT04868617|469778037|FG000|Overall Study|Withdrawal by Subject|1|||
130493875|NCT04868617|469778038|FG001|Overall Study|Withdrawal by Subject|0|||
130493876|NCT04868617|469778037|FG000|Overall Study|Device deficiency|1|||
130493877|NCT04868617|469778038|FG001|Overall Study|Device deficiency|0|||
130493878|NCT03183050|469778039|FG000|Overall Study|Lost to Follow-up|23|||
130729044|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
130729045|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130729046|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729047|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
130493879|NCT02797132|469778040|FG000|Part A (15 Days)|Adverse Event|1|||
130493880|NCT02797132|469778040|FG000|Part B (24 Weeks)|Adverse Event|3|||
130493881|NCT02347332|469778041|FG000|Overall Study|Not treated|5|||
130493882|NCT02347332|469778042|FG001|Overall Study|Not treated|2|||
130493883|NCT02347332|469778041|FG000|Overall Study|Progressive disease|141|||
130493884|NCT02347332|469778042|FG001|Overall Study|Progressive disease|159|||
130493885|NCT02347332|469778041|FG000|Overall Study|Adverse Event|50|||
130493886|NCT02347332|469778042|FG001|Overall Study|Adverse Event|41|||
130493887|NCT02347332|469778041|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
130493888|NCT02347332|469778042|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
130493889|NCT02347332|469778041|FG000|Overall Study|Protocol Violation|1|||
130493890|NCT02347332|469778042|FG001|Overall Study|Protocol Violation|1|||
130493891|NCT02347332|469778041|FG000|Overall Study|Lost to Follow-up|2|||
130493892|NCT02347332|469778042|FG001|Overall Study|Lost to Follow-up|1|||
130493893|NCT02347332|469778041|FG000|Overall Study|Physician Decision|4|||
130493894|NCT02347332|469778042|FG001|Overall Study|Physician Decision|3|||
130493895|NCT02347332|469778041|FG000|Overall Study|Withdrawal by Subject|20|||
130493896|NCT02347332|469778042|FG001|Overall Study|Withdrawal by Subject|14|||
130493897|NCT02347332|469778041|FG000|Overall Study|Protocol requirement|1|||
130493898|NCT02347332|469778042|FG001|Overall Study|Protocol requirement|1|||
130493899|NCT02347332|469778041|FG000|Overall Study|Switch Post-Trial program|0|||
130729048|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729049|NCT03888066|470630504|FG000|Run-in Phase|AE (Adverse Event)|17|||
130729050|NCT03888066|470630505|FG001|Run-in Phase|AE (Adverse Event)|0|||
130729051|NCT03888066|470630504|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
130729052|NCT03888066|470630505|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
130729053|NCT03888066|470630504|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729054|NCT03888066|470630505|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729055|NCT03888066|470630504|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729056|NCT03888066|470630505|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729057|NCT03888066|470630504|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130729058|NCT03888066|470630505|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729059|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal by Subject|43|||
130729060|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal by Subject|0|||
130729061|NCT03888066|470630504|FG000|Run-in Phase|AE; Physician Decision|1|||
130729062|NCT03888066|470630505|FG001|Run-in Phase|AE; Physician Decision|0|||
130729063|NCT03888066|470630504|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
130729064|NCT03888066|470630505|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729065|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
130729066|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
130729067|NCT03888066|470630504|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
130729068|NCT03888066|470630505|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729069|NCT03888066|470630504|FG000|Run-in Phase|Death|1|||
130729070|NCT03888066|470630505|FG001|Run-in Phase|Death|0|||
130729071|NCT03888066|470630504|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
130729072|NCT03888066|470630505|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
130729073|NCT03888066|470630504|FG000|Run-in Phase|Physician Decision|1|||
130729074|NCT03888066|470630505|FG001|Run-in Phase|Physician Decision|0|||
130729075|NCT03888066|470630504|FG000|Run-in Phase|Protocol Violation|13|||
130729076|NCT03888066|470630505|FG001|Run-in Phase|Protocol Violation|0|||
130729077|NCT03888066|470630504|FG000|Run-in Phase|Sponsor Request|34|||
130729078|NCT03888066|470630505|FG001|Run-in Phase|Sponsor Request|0|||
130729079|NCT03888066|470630504|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
130729080|NCT03888066|470630505|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
130729081|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal Of Consent|1|||
130729082|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal Of Consent|0|||
130729083|NCT03888066|470630504|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
130729084|NCT03888066|470630505|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
130729085|NCT03888066|470630504|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
130729086|NCT03888066|470630505|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
130729087|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
130493900|NCT02347332|469778042|FG001|Overall Study|Switch Post-Trial program|1|||
130493901|NCT01970007|469778043|FG000|Overall Study|Death|5|||
130493902|NCT01970007|469778043|FG000|Overall Study|Withdrawal by Subject|23|||
130493903|NCT01970007|469778043|FG000|Overall Study|Lost to Follow-up|24|||
130493904|NCT01970007|469778043|FG000|Overall Study|"Other endpoint"|3|||
130729088|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
130729089|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
130729090|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
130493905|NCT00754065|469778047|FG000|Overall Study|Never received treatment|12|||
130493906|NCT00754065|469778048|FG001|Overall Study|Never received treatment|2|||
130493907|NCT00754065|469778047|FG000|Overall Study|Adverse Event|19|||
130493908|NCT00754065|469778048|FG001|Overall Study|Adverse Event|25|||
130493909|NCT00754065|469778047|FG000|Overall Study|Lost to Follow-up|7|||
130493910|NCT00754065|469778048|FG001|Overall Study|Lost to Follow-up|11|||
130493911|NCT00754065|469778047|FG000|Overall Study|Protocol Violation|12|||
130493912|NCT00754065|469778048|FG001|Overall Study|Protocol Violation|10|||
130493913|NCT00754065|469778047|FG000|Overall Study|Withdrawal by Subject|4|||
130493914|NCT00754065|469778048|FG001|Overall Study|Withdrawal by Subject|5|||
130493915|NCT00754065|469778047|FG000|Overall Study|Pregnancy|6|||
130493916|NCT00754065|469778048|FG001|Overall Study|Pregnancy|0|||
130493917|NCT00754065|469778047|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
130493918|NCT00754065|469778048|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
130493919|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
130493920|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
130493921|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
130493922|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
130493923|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
130493924|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
130493925|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
130493926|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
130493927|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
130493928|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
130493929|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
130493930|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
130493931|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
130493932|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
130493933|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
130493934|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
130493935|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
130493936|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
130493937|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
130493938|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
130493939|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
130493940|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
130493941|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
130493942|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
130493943|NCT01074294|469778049|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
130493944|NCT01074294|469778050|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
130493945|NCT01074294|469778051|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
130493946|NCT01074294|469778052|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
130493947|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
130493948|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
130493949|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
130493950|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
130493951|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
130493952|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
130493953|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
130493954|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
130729091|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
130729092|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
130493955|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
130493956|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
130493957|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
130493958|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
130493959|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
130493960|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
130493961|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
130493962|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
130493963|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
130493964|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
130729093|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
130493965|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
130493966|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
130493967|NCT01074294|469778049|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
130493968|NCT01074294|469778050|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
130493969|NCT01074294|469778051|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
130493970|NCT01074294|469778052|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
130493971|NCT00112359|469778053|FG000|Overall Study|Unrelated adverse event|16|||
130493972|NCT00112359|469778054|FG001|Overall Study|Unrelated adverse event|8|||
130493973|NCT00112359|469778053|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
130493974|NCT00112359|469778054|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
130493975|NCT00112359|469778053|FG000|Overall Study|Related adverse event|5|||
130493976|NCT00112359|469778054|FG001|Overall Study|Related adverse event|3|||
130493977|NCT00112359|469778053|FG000|Overall Study|Lost to Follow-up|0|||
130493978|NCT00112359|469778054|FG001|Overall Study|Lost to Follow-up|1|||
130493979|NCT00112359|469778053|FG000|Overall Study|Personal/administrative|1|||
130493980|NCT00112359|469778054|FG001|Overall Study|Personal/administrative|1|||
130493981|NCT00112359|469778053|FG000|Overall Study|Other|3|||
130493982|NCT00112359|469778054|FG001|Overall Study|Other|0|||
130493983|NCT00623194|469778055|FG000|Overall Study|Lack of Efficacy|1|||
130493984|NCT00623194|469778055|FG000|Overall Study|Protocol Violation|3|||
130493985|NCT00623194|469778055|FG000|Overall Study|Unclassified|1|||
130493986|NCT01988402|469778056|FG000|Overall Study|Adverse Event|1|||
130493987|NCT01988402|469778057|FG001|Overall Study|Adverse Event|2|||
130493988|NCT01988402|469778056|FG000|Overall Study|Withdrawal by Subject|1|||
130493989|NCT01988402|469778057|FG001|Overall Study|Withdrawal by Subject|0|||
130493990|NCT01961609|469778058|FG000|Initiation|Missing|3|||
130493991|NCT01961609|469778059|FG001|Initiation|Missing|2|||
130493992|NCT01961609|469778060|FG002|Initiation|Missing|0|||
130493993|NCT01961609|469778061|FG003|Initiation|Missing|0|||
130565479|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130565480|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130565481|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
130565482|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130565483|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130565484|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130565485|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130565486|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130565487|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130565488|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
130565489|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130565490|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130565491|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130565492|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130565493|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130565494|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
130565495|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130565496|NCT00111800|470036935|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130565497|NCT00111800|470036936|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130565498|NCT00111800|470036937|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130565499|NCT00111800|470036938|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130565500|NCT00111800|470036939|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130565501|NCT00111800|470036940|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
130565502|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130565503|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
130565504|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
130565505|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
130565506|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130565507|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130565508|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130729094|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
130729095|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
130729096|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
130493994|NCT01961609|469778058|FG000|Initiation|Protocol deviation|1|||
130493995|NCT01961609|469778059|FG001|Initiation|Protocol deviation|0|||
130493996|NCT01961609|469778060|FG002|Initiation|Protocol deviation|0|||
130493997|NCT01961609|469778061|FG003|Initiation|Protocol deviation|0|||
130493998|NCT01961609|469778058|FG000|Initiation|Death|0|||
130493999|NCT01961609|469778059|FG001|Initiation|Death|1|||
130494000|NCT01961609|469778060|FG002|Initiation|Death|0|||
130494001|NCT01961609|469778061|FG003|Initiation|Death|0|||
130729097|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
130729098|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
130729099|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
130729100|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
130729101|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130729102|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130729103|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
130494002|NCT01961609|469778058|FG000|Initiation|Administrative problems|1|||
130729104|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
130729105|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
130729106|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
130729107|NCT03278626|470630506|FG000|Overall Study|Death|2|||
130729108|NCT03278626|470630506|FG000|Overall Study|Toxicity|1|||
130729109|NCT03278626|470630506|FG000|Overall Study|Disease Progression|2|||
130729110|NCT05013008|470630508|FG000|Overall Study|Exclusion from mBFAS|5|||
130729111|NCT05013008|470630509|FG001|Overall Study|Exclusion from mBFAS|25|||
130494003|NCT01961609|469778059|FG001|Initiation|Administrative problems|0|||
130494004|NCT01961609|469778060|FG002|Initiation|Administrative problems|0|||
130494005|NCT01961609|469778061|FG003|Initiation|Administrative problems|0|||
130494006|NCT01961609|469778058|FG000|Initiation|Withdrawal by Subject|1|||
130494007|NCT01961609|469778059|FG001|Initiation|Withdrawal by Subject|2|||
130494008|NCT01961609|469778060|FG002|Initiation|Withdrawal by Subject|0|||
130494009|NCT01961609|469778061|FG003|Initiation|Withdrawal by Subject|0|||
130494010|NCT01961609|469778058|FG000|Initiation|Lack of Efficacy|2|||
130494011|NCT01961609|469778059|FG001|Initiation|Lack of Efficacy|1|||
130494012|NCT01961609|469778060|FG002|Initiation|Lack of Efficacy|0|||
130494013|NCT01961609|469778061|FG003|Initiation|Lack of Efficacy|0|||
130494014|NCT01961609|469778058|FG000|Initiation|Abnormal lab values|0|||
130494015|NCT01961609|469778059|FG001|Initiation|Abnormal lab values|1|||
130494016|NCT01961609|469778060|FG002|Initiation|Abnormal lab values|0|||
130494017|NCT01961609|469778061|FG003|Initiation|Abnormal lab values|0|||
130494018|NCT01961609|469778058|FG000|Initiation|Adverse Event|3|||
130494019|NCT01961609|469778059|FG001|Initiation|Adverse Event|5|||
130494020|NCT01961609|469778060|FG002|Initiation|Adverse Event|0|||
130494021|NCT01961609|469778061|FG003|Initiation|Adverse Event|0|||
130494022|NCT01961609|469778058|FG000|Initiation|Randomized but not treated|1|||
130494023|NCT01961609|469778059|FG001|Initiation|Randomized but not treated|1|||
130494024|NCT01961609|469778060|FG002|Initiation|Randomized but not treated|0|||
130494025|NCT01961609|469778061|FG003|Initiation|Randomized but not treated|0|||
130494026|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
130494027|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
130494028|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
130494029|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
130494030|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
130494031|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
130494032|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
130494033|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
130494034|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
130494035|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
130494036|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
130494037|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
130494038|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
130494039|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
130494040|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
130494041|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
130494042|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
130494043|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
130494044|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
130494045|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
130494046|NCT01961609|469778058|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
130494047|NCT01961609|469778059|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
130494048|NCT01961609|469778060|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
130494049|NCT01961609|469778061|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
130494050|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
130494051|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
130494052|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
130494053|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
130729112|NCT02077140|470630510|FG000|Overall Study|Lost to Follow-up|4|||
130729113|NCT02077140|470630511|FG001|Overall Study|Lost to Follow-up|1|||
130729114|NCT02077140|470630512|FG002|Overall Study|Lost to Follow-up|2|||
130729115|NCT02077140|470630513|FG003|Overall Study|Lost to Follow-up|2|||
130729116|NCT02077140|470630514|FG004|Overall Study|Lost to Follow-up|3|||
130729117|NCT02077140|470630510|FG000|Overall Study|Withdrawal by Subject|0|||
130729118|NCT02077140|470630511|FG001|Overall Study|Withdrawal by Subject|1|||
130729119|NCT02077140|470630512|FG002|Overall Study|Withdrawal by Subject|0|||
130729120|NCT02077140|470630513|FG003|Overall Study|Withdrawal by Subject|2|||
130729121|NCT02077140|470630514|FG004|Overall Study|Withdrawal by Subject|2|||
130729122|NCT01762800|470630521|FG000|Overall Study|Adverse Event|8|||
130494054|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
130494055|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
130494056|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
130494057|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
130729123|NCT01762800|470630522|FG001|Overall Study|Adverse Event|13|||
130494058|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
130494059|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
130494060|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
130494061|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
130494062|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
130494063|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
130494064|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
130494065|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
130494066|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
130494067|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
130494068|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
130494069|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
130494070|NCT01961609|469778058|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
130494071|NCT01961609|469778059|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
130494072|NCT01961609|469778060|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
130494073|NCT01961609|469778061|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
130494074|NCT01211184|469778064|FG000|Overall Study|Withdrawal by Subject|0|||
130494075|NCT01211184|469778065|FG001|Overall Study|Withdrawal by Subject|2|||
130494076|NCT01211184|469778066|FG002|Overall Study|Withdrawal by Subject|1|||
130494077|NCT04060212|469778067|FG000|Overall Study|Withdrawal by Subject|7|||
130494078|NCT03500549|469778068|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
130494079|NCT03500549|469778069|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
130494080|NCT03500549|469778068|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
130494081|NCT03500549|469778069|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
130494082|NCT02107261|469778070|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
130494083|NCT02107261|469778071|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
130494084|NCT02107261|469778070|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
130494085|NCT02107261|469778071|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
130494086|NCT04066075|469778072|FG000|Overall Study|Lost to Follow-up|3|||
130494087|NCT04066075|469778073|FG001|Overall Study|Lost to Follow-up|3|||
130494088|NCT04066075|469778072|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
130494089|NCT04066075|469778073|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
130494090|NCT04066075|469778072|FG000|Overall Study|Withdrawal by Subject|2|||
130494091|NCT04066075|469778073|FG001|Overall Study|Withdrawal by Subject|2|||
130494092|NCT00309166|469778074|FG000|Overall Study|Adverse event, non-fatal|1|||
130494093|NCT00309166|469778075|FG001|Overall Study|Adverse event, non-fatal|0|||
130494094|NCT00309166|469778074|FG000|Overall Study|Withdrawal by Subject|4|||
130494095|NCT00309166|469778075|FG001|Overall Study|Withdrawal by Subject|3|||
130494096|NCT03222609|469778076|FG000|Overall Study|Withdrew consent|2|||
130494097|NCT03222609|469778077|FG001|Overall Study|Withdrew consent|3|||
130494098|NCT03222609|469778078|FG002|Overall Study|Withdrew consent|4|||
130494099|NCT03222609|469778079|FG003|Overall Study|Withdrew consent|2|||
130494100|NCT03222609|469778076|FG000|Overall Study|Lost to Follow-up|1|||
130494101|NCT03222609|469778077|FG001|Overall Study|Lost to Follow-up|0|||
130494102|NCT03222609|469778078|FG002|Overall Study|Lost to Follow-up|0|||
130494103|NCT03222609|469778079|FG003|Overall Study|Lost to Follow-up|0|||
130494104|NCT03222609|469778076|FG000|Overall Study|Death|16|||
130494105|NCT03222609|469778077|FG001|Overall Study|Death|13|||
130494106|NCT03222609|469778078|FG002|Overall Study|Death|9|||
130494107|NCT03222609|469778079|FG003|Overall Study|Death|6|||
130494108|NCT03222609|469778076|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
130729124|NCT01762800|470630521|FG000|Overall Study|Lack of Efficacy|3|||
130494109|NCT03222609|469778077|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
130494110|NCT03222609|469778078|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
130494111|NCT03222609|469778079|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
130494112|NCT05521516|469778080|FG000|Overall Study|Withdrawal by Subject|1|||
130494113|NCT05521516|469778081|FG001|Overall Study|Withdrawal by Subject|1|||
130494114|NCT00747565|469778082|FG000|Overall Study|Withdrawal by Subject|10|||
130729125|NCT01762800|470630522|FG001|Overall Study|Lack of Efficacy|2|||
130729126|NCT01762800|470630521|FG000|Overall Study|Study Closed/Terminated|0|||
130729127|NCT01762800|470630522|FG001|Overall Study|Study Closed/Terminated|1|||
130494115|NCT00747565|469778083|FG001|Overall Study|Withdrawal by Subject|6|||
130494116|NCT00747565|469778082|FG000|Overall Study|Lost to Follow-up|4|||
130494117|NCT00747565|469778083|FG001|Overall Study|Lost to Follow-up|1|||
130494118|NCT03777657|469778084|FG000|Overall Study|Death|397|||
130494119|NCT03777657|469778085|FG001|Overall Study|Death|431|||
130494120|NCT03777657|469778084|FG000|Overall Study|Study Closed by Sponsor|77|||
130494121|NCT03777657|469778085|FG001|Overall Study|Study Closed by Sponsor|38|||
130494122|NCT03777657|469778084|FG000|Overall Study|Withdrawal by Subject|20|||
130494123|NCT03777657|469778085|FG001|Overall Study|Withdrawal by Subject|17|||
130494124|NCT03777657|469778084|FG000|Overall Study|Lost to Follow-up|6|||
130494125|NCT03777657|469778085|FG001|Overall Study|Lost to Follow-up|10|||
130494126|NCT00545545|469778086|FG000|Overall Study|Progressive Neoplastic Disease|1|||
130494127|NCT00545545|469778087|FG001|Overall Study|Progressive Neoplastic Disease|5|||
130494128|NCT00545545|469778088|FG002|Overall Study|Progressive Neoplastic Disease|0|||
130494129|NCT00545545|469778089|FG003|Overall Study|Progressive Neoplastic Disease|4|||
130494130|NCT00545545|469778090|FG004|Overall Study|Progressive Neoplastic Disease|8|||
130494131|NCT00545545|469778091|FG005|Overall Study|Progressive Neoplastic Disease|7|||
130494132|NCT00545545|469778086|FG000|Overall Study|Withdrawal by Subject|0|||
130494133|NCT00545545|469778087|FG001|Overall Study|Withdrawal by Subject|1|||
130494134|NCT00545545|469778088|FG002|Overall Study|Withdrawal by Subject|0|||
130494135|NCT00545545|469778089|FG003|Overall Study|Withdrawal by Subject|0|||
130494136|NCT00545545|469778090|FG004|Overall Study|Withdrawal by Subject|0|||
130494137|NCT00545545|469778091|FG005|Overall Study|Withdrawal by Subject|0|||
130494138|NCT00545545|469778086|FG000|Overall Study|Physician Decision|1|||
130494139|NCT00545545|469778087|FG001|Overall Study|Physician Decision|0|||
130494140|NCT00545545|469778088|FG002|Overall Study|Physician Decision|0|||
130494141|NCT00545545|469778089|FG003|Overall Study|Physician Decision|0|||
130494142|NCT00545545|469778090|FG004|Overall Study|Physician Decision|0|||
130494143|NCT00545545|469778091|FG005|Overall Study|Physician Decision|1|||
130494144|NCT00545545|469778086|FG000|Overall Study|Irinotecan intolerance|1|||
130494145|NCT00545545|469778087|FG001|Overall Study|Irinotecan intolerance|1|||
130494146|NCT00545545|469778088|FG002|Overall Study|Irinotecan intolerance|0|||
130494147|NCT00545545|469778089|FG003|Overall Study|Irinotecan intolerance|0|||
130494148|NCT00545545|469778090|FG004|Overall Study|Irinotecan intolerance|0|||
130494149|NCT00545545|469778091|FG005|Overall Study|Irinotecan intolerance|0|||
130494150|NCT00545545|469778086|FG000|Overall Study|No target lesions to track post surgery|0|||
130494151|NCT00545545|469778087|FG001|Overall Study|No target lesions to track post surgery|0|||
130494152|NCT00545545|469778088|FG002|Overall Study|No target lesions to track post surgery|0|||
130494153|NCT00545545|469778089|FG003|Overall Study|No target lesions to track post surgery|0|||
130494154|NCT00545545|469778090|FG004|Overall Study|No target lesions to track post surgery|1|||
130494155|NCT00545545|469778091|FG005|Overall Study|No target lesions to track post surgery|1|||
130494156|NCT00227266|469778094|FG000|Overall Study|Withdrawal by Subject|0|||
130494157|NCT00227266|469778095|FG001|Overall Study|Withdrawal by Subject|0|||
130494158|NCT00227266|469778096|FG002|Overall Study|Withdrawal by Subject|1|||
130494159|NCT00227266|469778094|FG000|Overall Study|Protocol Violation|1|||
130494160|NCT00227266|469778095|FG001|Overall Study|Protocol Violation|0|||
130494161|NCT00227266|469778096|FG002|Overall Study|Protocol Violation|1|||
130494162|NCT00227266|469778094|FG000|Overall Study|Excessive weight gain|0|||
130494163|NCT00227266|469778095|FG001|Overall Study|Excessive weight gain|0|||
130494164|NCT00227266|469778096|FG002|Overall Study|Excessive weight gain|2|||
130494165|NCT02678689|469778097|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
130494166|NCT02678689|469778098|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
130494167|NCT00593840|469778104|FG000|Overall Study|Withdrawal by Subject|1|||
130494168|NCT04530487|469779156|FG000|Overall Study|Death|1|||
130494169|NCT00655499|469779157|FG000|Overall Study|not eligible|4|||
130494170|NCT01036724|469779158|FG000|Overall Study|Adverse Event|1|||
130494171|NCT01036724|469779159|FG001|Overall Study|Adverse Event|2|||
130494172|NCT01036724|469779158|FG000|Overall Study|Lack of Efficacy|1|||
130494173|NCT01036724|469779159|FG001|Overall Study|Lack of Efficacy|1|||
130494174|NCT01036724|469779158|FG000|Overall Study|Protocol Violation|4|||
130494175|NCT01036724|469779159|FG001|Overall Study|Protocol Violation|5|||
130494176|NCT01637402|469779167|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
130494177|NCT01637402|469779168|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
130494178|NCT01637402|469779167|FG000|Standard Dose Regimen|Adverse Event|1|||
130494179|NCT01637402|469779168|FG001|Standard Dose Regimen|Adverse Event|0|||
130494180|NCT01637402|469779167|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
130494181|NCT01637402|469779168|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
130494182|NCT01637402|469779167|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
130494183|NCT01637402|469779168|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
130494184|NCT01637402|469779167|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
130494185|NCT01637402|469779168|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
130494186|NCT01637402|469779167|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
130565509|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
130565510|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
130494187|NCT01637402|469779168|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
130494188|NCT02285270|469779169|FG000|Overall Study|Lost to Follow-up|1|||
130494189|NCT02285270|469779169|FG000|Overall Study|Physician Decision|3|||
130494190|NCT02285270|469779169|FG000|Overall Study|Determined to be ineligible|1|||
130494191|NCT00777049|469779170|FG000|Overall Study|Withdrawal by Subject|1|||
130494192|NCT00777049|469779171|FG001|Overall Study|Withdrawal by Subject|0|||
130494193|NCT00777049|469779170|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
130494194|NCT00777049|469779171|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
130494195|NCT00246805|469779172|FG000|Phase 1|Lost to Follow-up|1|||
130494196|NCT00246805|469779173|FG001|Phase 1|Lost to Follow-up|0|||
130494197|NCT01627561|469779174|FG000|Overall Study|Lost to Follow-up|1|||
130494198|NCT01627561|469779175|FG001|Overall Study|Lost to Follow-up|0|||
130494199|NCT01627561|469779174|FG000|Overall Study|Withdrawal by Subject|0|||
130494200|NCT01627561|469779175|FG001|Overall Study|Withdrawal by Subject|1|||
130494201|NCT01627561|469779174|FG000|Overall Study|Migrated/moved from study area|0|||
130494202|NCT01627561|469779175|FG001|Overall Study|Migrated/moved from study area|2|||
130494203|NCT00890591|469779177|FG000|Overall Study|Lack of Efficacy|20|||
130494204|NCT00739934|469779180|FG000|Voriconazole IV|Adverse Event|6|||
130494205|NCT00739934|469779180|FG000|Voriconazole Oral|Other|3|||
130494206|NCT01579318|469779183|FG000|Overall Study|Disease Progression|1|||
130494207|NCT02502526|469779184|FG000|Overall Study|Lost to Follow-up|2|||
130494208|NCT02502526|469779185|FG001|Overall Study|Lost to Follow-up|2|||
130494209|NCT02502526|469779186|FG002|Overall Study|Lost to Follow-up|3|||
130494210|NCT02502526|469779184|FG000|Overall Study|Withdrawal by Subject|0|||
130494211|NCT02502526|469779185|FG001|Overall Study|Withdrawal by Subject|1|||
130494212|NCT02502526|469779186|FG002|Overall Study|Withdrawal by Subject|1|||
130494213|NCT02502526|469779184|FG000|Overall Study|Disqualified due to cataract grading|0|||
130494214|NCT02502526|469779185|FG001|Overall Study|Disqualified due to cataract grading|0|||
130494215|NCT02502526|469779186|FG002|Overall Study|Disqualified due to cataract grading|1|||
130494216|NCT02502526|469779184|FG000|Overall Study|Enrollment suspension|4|||
130494217|NCT02502526|469779185|FG001|Overall Study|Enrollment suspension|1|||
130494218|NCT02502526|469779186|FG002|Overall Study|Enrollment suspension|1|||
130494219|NCT01342367|469779187|FG000|Overall Study|Death|1|||
130494220|NCT01342367|469779188|FG001|Overall Study|Death|0|||
130494221|NCT01342367|469779187|FG000|Overall Study|Withdrawal by Subject|1|||
130494222|NCT01342367|469779188|FG001|Overall Study|Withdrawal by Subject|2|||
130494223|NCT02844439|469779191|FG000|Overall Study|Withdrawal by Subject|1|||
130494224|NCT02844439|469779191|FG000|Overall Study|Lost to Follow-up|2|||
130494225|NCT02844439|469779191|FG000|Overall Study|Termination by Sponsor|4|||
130494226|NCT02844439|469779191|FG000|Overall Study|Death|28|||
130565511|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130565512|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130565513|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130565514|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130729128|NCT01762800|470630521|FG000|Overall Study|Physician Decision|1|||
130494227|NCT02844439|469779191|FG000|Overall Study|Other|5|||
130494228|NCT03170648|469779196|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
130494229|NCT03170648|469779196|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
130494230|NCT03509909|469779197|FG000|Overall Study|Withdrawal by Subject|16|||
130494231|NCT03509909|469779198|FG001|Overall Study|Withdrawal by Subject|9|||
130494232|NCT03509909|469779197|FG000|Overall Study|Lost to Follow-up|3|||
130494233|NCT03509909|469779198|FG001|Overall Study|Lost to Follow-up|4|||
130494234|NCT03509909|469779197|FG000|Overall Study|Adverse Event|2|||
130494235|NCT03509909|469779198|FG001|Overall Study|Adverse Event|0|||
130494236|NCT04337931|469779203|FG000|Overall Study|Death|4|||
130494237|NCT04337931|469779204|FG001|Overall Study|Death|1|||
130494238|NCT04337931|469779205|FG002|Overall Study|Death|7|||
130494239|NCT04337931|469779203|FG000|Overall Study|Withdrawal by Subject|0|||
130494240|NCT04337931|469779204|FG001|Overall Study|Withdrawal by Subject|1|||
130494241|NCT04337931|469779205|FG002|Overall Study|Withdrawal by Subject|0|||
130494242|NCT04337931|469779203|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
130729129|NCT01762800|470630522|FG001|Overall Study|Physician Decision|1|||
130729130|NCT01762800|470630521|FG000|Overall Study|Withdrawal by Subject|7|||
130494243|NCT04337931|469779204|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
130494244|NCT04337931|469779205|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
130494245|NCT04337931|469779203|FG000|Overall Study|Study terminated by sponsor|3|||
130494246|NCT04337931|469779204|FG001|Overall Study|Study terminated by sponsor|6|||
130494247|NCT04337931|469779205|FG002|Overall Study|Study terminated by sponsor|2|||
130494248|NCT04337931|469779203|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
130494249|NCT04337931|469779204|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
130494250|NCT04337931|469779205|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
130494251|NCT04337931|469779203|FG000|Overall Study|Colorectal cancer treatment|1|||
130494252|NCT04337931|469779204|FG001|Overall Study|Colorectal cancer treatment|0|||
130494253|NCT04337931|469779205|FG002|Overall Study|Colorectal cancer treatment|0|||
130494254|NCT04337931|469779203|FG000|Overall Study|Participant decision|0|||
130494255|NCT04337931|469779204|FG001|Overall Study|Participant decision|1|||
130494256|NCT04337931|469779205|FG002|Overall Study|Participant decision|0|||
130494257|NCT01738438|469779206|FG000|Overall Study|Disease Progression|32|||
130494258|NCT01738438|469779206|FG000|Overall Study|Adverse Event|3|||
130494259|NCT04436289|469779207|FG000|Overall Study|Death prior to hospital discharge|8|||
130494260|NCT04436289|469779208|FG001|Overall Study|Death prior to hospital discharge|5|||
130494261|NCT04436289|469779209|FG002|Overall Study|Death prior to hospital discharge|0|||
130494262|NCT04436289|469779210|FG003|Overall Study|Death prior to hospital discharge|1|||
130494263|NCT04436289|469779207|FG000|Overall Study|Withdrawal by Subject|0|||
130494264|NCT04436289|469779208|FG001|Overall Study|Withdrawal by Subject|1|||
130494265|NCT04436289|469779209|FG002|Overall Study|Withdrawal by Subject|4|||
130494266|NCT04436289|469779210|FG003|Overall Study|Withdrawal by Subject|0|||
130494267|NCT04436289|469779207|FG000|Overall Study|Extended hospital stay|0|||
130494268|NCT04436289|469779208|FG001|Overall Study|Extended hospital stay|1|||
130494269|NCT04436289|469779209|FG002|Overall Study|Extended hospital stay|0|||
130494270|NCT04436289|469779210|FG003|Overall Study|Extended hospital stay|0|||
130494271|NCT04436289|469779207|FG000|Overall Study|Lost to Follow-up|0|||
130494272|NCT04436289|469779208|FG001|Overall Study|Lost to Follow-up|4|||
130494273|NCT04436289|469779209|FG002|Overall Study|Lost to Follow-up|1|||
130494274|NCT04436289|469779210|FG003|Overall Study|Lost to Follow-up|3|||
130494275|NCT02928172|469779211|FG000|Overall Study|Device did not record data|1|||
130494276|NCT02016872|469779216|FG000|Overall Study|Withdrawal by Subject|10|||
130494277|NCT02016872|469779216|FG000|Overall Study|Death Progression|2|||
130494278|NCT02016872|469779216|FG000|Overall Study|No FMISO scan|1|||
130494279|NCT02016872|469779216|FG000|Overall Study|Ineligible|2|||
130494280|NCT05139992|469779219|FG000|Overall Study|Withdrawal by Subject|12|||
130494281|NCT05139992|469779219|FG000|Overall Study|Lost to Follow-up|6|||
130494282|NCT04305327|469779220|FG000|Overall Study|Study early termination|2|||
130494283|NCT04305327|469779221|FG001|Overall Study|Study early termination|5|||
130494284|NCT04305327|469779222|FG002|Overall Study|Study early termination|2|||
130494285|NCT04305327|469779223|FG003|Overall Study|Study early termination|2|||
130494286|NCT04305327|469779220|FG000|Overall Study|Withdrawal by Subject|0|||
130494287|NCT04305327|469779221|FG001|Overall Study|Withdrawal by Subject|1|||
130494288|NCT04305327|469779222|FG002|Overall Study|Withdrawal by Subject|0|||
130494289|NCT04305327|469779223|FG003|Overall Study|Withdrawal by Subject|0|||
130494290|NCT02415127|469779224|FG000|Overall Study|Adverse Event|1|||
130494291|NCT02415127|469779225|FG001|Overall Study|Adverse Event|0|||
130494292|NCT03789110|469779226|FG000|Overall Study|Adverse Event|2|||
130494293|NCT03789110|469779226|FG000|Overall Study|Physician Decision|1|||
130494294|NCT03789110|469779226|FG000|Overall Study|Withdrawal by Subject|2|||
130494295|NCT03789110|469779226|FG000|Overall Study|Lack of Efficacy|22|||
130494296|NCT03789110|469779226|FG000|Overall Study|still on treatment|3|||
130494297|NCT05464732|469779227|FG000|Overall Study|Lost to Follow-up|0|||
130494298|NCT05464732|469779228|FG001|Overall Study|Lost to Follow-up|1|||
130494299|NCT05464732|469779227|FG000|Overall Study|Adverse Event|1|||
130494300|NCT05464732|469779228|FG001|Overall Study|Adverse Event|0|||
130494301|NCT02761187|469779229|FG000|Overall Study|Too ill to Participate|13|||
130494302|NCT02761187|469779230|FG001|Overall Study|Too ill to Participate|8|||
130494303|NCT02761187|469779229|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
130494304|NCT02761187|469779230|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
130494305|NCT02761187|469779229|FG000|Overall Study|Patient withdrew consent|64|||
130494306|NCT02761187|469779230|FG001|Overall Study|Patient withdrew consent|58|||
130494307|NCT02761187|469779229|FG000|Overall Study|Physician discretion|4|||
130494308|NCT02761187|469779230|FG001|Overall Study|Physician discretion|8|||
130494309|NCT02761187|469779229|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
130494310|NCT02761187|469779230|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
130494311|NCT02761187|469779229|FG000|Overall Study|On Hospice|20|||
130494312|NCT02761187|469779230|FG001|Overall Study|On Hospice|26|||
130494313|NCT02761187|469779229|FG000|Overall Study|Deceased|474|||
130494314|NCT02761187|469779230|FG001|Overall Study|Deceased|642|||
130494315|NCT02761187|469779229|FG000|Overall Study|Lost to Follow-up|73|||
130494316|NCT02761187|469779230|FG001|Overall Study|Lost to Follow-up|63|||
130494317|NCT02761187|469779229|FG000|Overall Study|Due to study discontinued at site|100|||
130494318|NCT02761187|469779230|FG001|Overall Study|Due to study discontinued at site|85|||
130494319|NCT02761187|469779229|FG000|Overall Study|Reason not Specified|1484|||
130494320|NCT02761187|469779230|FG001|Overall Study|Reason not Specified|937|||
130494321|NCT03978637|469779231|FG000|Overall Study|Death|0|||
130494322|NCT03978637|469779232|FG001|Overall Study|Death|2|||
130494323|NCT03978637|469779233|FG002|Overall Study|Death|2|||
130494324|NCT03978637|469779234|FG003|Overall Study|Death|0|||
130494325|NCT03978637|469779231|FG000|Overall Study|Withdrawal by Subject|0|||
130494326|NCT03978637|469779232|FG001|Overall Study|Withdrawal by Subject|0|||
130494327|NCT03978637|469779233|FG002|Overall Study|Withdrawal by Subject|1|||
130494328|NCT03978637|469779234|FG003|Overall Study|Withdrawal by Subject|0|||
130494329|NCT03978637|469779231|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
130494330|NCT03978637|469779232|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
130494331|NCT03978637|469779233|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
130494332|NCT03978637|469779234|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
130494333|NCT05630833|469779235|FG000|Overall Study|Adverse Event|3|||
130494334|NCT05630833|469779236|FG001|Overall Study|Adverse Event|0|||
130494335|NCT05630833|469779235|FG000|Overall Study|Lack of Efficacy|0|||
130494336|NCT05630833|469779236|FG001|Overall Study|Lack of Efficacy|1|||
130494337|NCT05630833|469779235|FG000|Overall Study|Lost to Follow-up|1|||
130494338|NCT05630833|469779236|FG001|Overall Study|Lost to Follow-up|0|||
130494339|NCT05630833|469779235|FG000|Overall Study|Withdrawal by Subject|3|||
130494340|NCT05630833|469779236|FG001|Overall Study|Withdrawal by Subject|1|||
130494341|NCT03170349|469779238|FG000|From Implant to the 30-Day Visit|Death|1|||
130494342|NCT03170349|469779238|FG000|From 30-Day to 6-Month Visit|Death|3|||
130494343|NCT03170349|469779238|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
130494344|NCT03170349|469779238|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
130494345|NCT03170349|469779238|FG000|From 6-Month to 1-Year Visit|Death|6|||
130494346|NCT03170349|469779238|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
130494347|NCT03170349|469779238|FG000|From 1-Year to 2-Year Visit|Death|13|||
130494348|NCT03170349|469779238|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
130494349|NCT03170349|469779238|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
130494350|NCT03170349|469779238|FG000|From 2-Year to 3-Year Visit|Death|10|||
130494351|NCT03170349|469779238|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
130494352|NCT03170349|469779238|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
130494353|NCT03170349|469779238|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
130494354|NCT04213807|469780697|FG000|Overall Study|Physician Decision|0|||
130494355|NCT04213807|469780698|FG001|Overall Study|Physician Decision|0|||
130494356|NCT04213807|469780699|FG002|Overall Study|Physician Decision|1|||
130494357|NCT02866942|469780700|FG000|Overall Study|Invalid consent|1|||
130494358|NCT02185794|469780706|FG000|Overall Study|Enrolled but Never Dosed|1|||
130494359|NCT02185794|469780707|FG001|Overall Study|Enrolled but Never Dosed|6|||
130494360|NCT02185794|469780708|FG002|Overall Study|Enrolled but Never Dosed|3|||
130494361|NCT02185794|469780709|FG003|Overall Study|Enrolled but Never Dosed|1|||
130494362|NCT02185794|469780710|FG004|Overall Study|Enrolled but Never Dosed|1|||
130494363|NCT02185794|469780711|FG005|Overall Study|Enrolled but Never Dosed|0|||
130494364|NCT02185794|469780706|FG000|Overall Study|Investigator's Discretion|1|||
130494365|NCT02185794|469780707|FG001|Overall Study|Investigator's Discretion|0|||
130494366|NCT02185794|469780708|FG002|Overall Study|Investigator's Discretion|1|||
130494367|NCT02185794|469780709|FG003|Overall Study|Investigator's Discretion|2|||
130494368|NCT02185794|469780710|FG004|Overall Study|Investigator's Discretion|2|||
130494369|NCT02185794|469780711|FG005|Overall Study|Investigator's Discretion|15|||
130494370|NCT02185794|469780706|FG000|Overall Study|Withdrew Consent|2|||
130494371|NCT02185794|469780707|FG001|Overall Study|Withdrew Consent|5|||
130494372|NCT02185794|469780708|FG002|Overall Study|Withdrew Consent|10|||
130494373|NCT02185794|469780709|FG003|Overall Study|Withdrew Consent|2|||
130494374|NCT02185794|469780710|FG004|Overall Study|Withdrew Consent|0|||
130494375|NCT02185794|469780711|FG005|Overall Study|Withdrew Consent|0|||
130494376|NCT02185794|469780706|FG000|Overall Study|Lost to Follow-up|1|||
130494377|NCT02185794|469780707|FG001|Overall Study|Lost to Follow-up|2|||
130494378|NCT02185794|469780708|FG002|Overall Study|Lost to Follow-up|2|||
130494379|NCT02185794|469780709|FG003|Overall Study|Lost to Follow-up|3|||
130494380|NCT02185794|469780710|FG004|Overall Study|Lost to Follow-up|0|||
130494381|NCT02185794|469780711|FG005|Overall Study|Lost to Follow-up|1|||
130494382|NCT00336505|469780712|FG000|Overall Study|Adverse Event|10|||
130494383|NCT00336505|469780713|FG001|Overall Study|Adverse Event|9|||
130494384|NCT00336505|469780712|FG000|Overall Study|Lack of Efficacy|8|||
130494385|NCT00336505|469780713|FG001|Overall Study|Lack of Efficacy|4|||
130494386|NCT00336505|469780712|FG000|Overall Study|Lost to Follow-up|7|||
130494387|NCT00336505|469780713|FG001|Overall Study|Lost to Follow-up|4|||
130494388|NCT00336505|469780712|FG000|Overall Study|Withdrawal by Subject|5|||
130494389|NCT00336505|469780713|FG001|Overall Study|Withdrawal by Subject|3|||
130494390|NCT00336505|469780712|FG000|Overall Study|Other|7|||
130494391|NCT00336505|469780713|FG001|Overall Study|Other|7|||
130494392|NCT01092416|469780714|FG000|Enrollment|Atherectomy device not inserted|3|||
130494393|NCT01092416|469780714|FG000|30-Day Follow-up|Death|2|||
130494394|NCT01092416|469780714|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
130494395|NCT01092416|469780714|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
130494396|NCT01092416|469780714|FG000|12-Month Follow-up|Death|16|||
130494397|NCT01092416|469780714|FG000|12-Month Follow-up|Lost to Follow-up|4|||
130494398|NCT01092416|469780714|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
130494399|NCT01092416|469780714|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
130494400|NCT01092416|469780714|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
130494401|NCT00366249|469780715|FG000|Overall Study|Adverse Event|53|||
130494402|NCT00366249|469780716|FG001|Overall Study|Adverse Event|28|||
130494403|NCT00366249|469780715|FG000|Overall Study|Death|0|||
130494404|NCT00366249|469780716|FG001|Overall Study|Death|1|||
130494405|NCT00366249|469780715|FG000|Overall Study|Physician Decision|5|||
130494406|NCT00366249|469780716|FG001|Overall Study|Physician Decision|2|||
130494407|NCT00366249|469780715|FG000|Overall Study|Lost to Follow-up|2|||
130494408|NCT00366249|469780716|FG001|Overall Study|Lost to Follow-up|0|||
130494409|NCT00366249|469780715|FG000|Overall Study|Protocol Violation|1|||
130494410|NCT00366249|469780716|FG001|Overall Study|Protocol Violation|2|||
130494411|NCT00366249|469780715|FG000|Overall Study|Withdrawal by Subject|18|||
130494412|NCT00366249|469780716|FG001|Overall Study|Withdrawal by Subject|4|||
130494413|NCT00366249|469780715|FG000|Overall Study|Lack of Efficacy|21|||
130494414|NCT00366249|469780716|FG001|Overall Study|Lack of Efficacy|21|||
130494415|NCT00366249|469780715|FG000|Overall Study|Most due to osteomylitis status|31|||
130494416|NCT00366249|469780716|FG001|Overall Study|Most due to osteomylitis status|20|||
130494417|NCT01561300|469780717|FG000|Run in on Placebo|Adverse Event|1|||
130494418|NCT01561300|469780718|FG001|Run in on Placebo|Adverse Event|0|||
130494419|NCT00609869|469780719|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
130494420|NCT00609869|469780719|FG000|Overall Study|Severe hematologic toxicity|1|||
130494421|NCT00609869|469780719|FG000|Overall Study|Withdrawal by Subject|1|||
130494422|NCT00609869|469780719|FG000|Overall Study|Seizures|1|||
130494423|NCT00609869|469780719|FG000|Overall Study|Severe tumor flare reaction|1|||
130494424|NCT00609869|469780719|FG000|Overall Study|Hepatitis B infection|1|||
130494425|NCT00609869|469780719|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
130494426|NCT00609869|469780719|FG000|Overall Study|Mantle cell: not evaluable|4|||
130494427|NCT00724126|469780720|FG000|Overall Study|Adverse Event|2|||
130494428|NCT00724126|469780721|FG001|Overall Study|Adverse Event|0|||
130494429|NCT00724126|469780720|FG000|Overall Study|Withdrawal by Subject|8|||
130494430|NCT00724126|469780721|FG001|Overall Study|Withdrawal by Subject|6|||
130494431|NCT00724126|469780720|FG000|Overall Study|Lost to Follow-up|6|||
130494432|NCT00724126|469780721|FG001|Overall Study|Lost to Follow-up|6|||
130494433|NCT00724126|469780720|FG000|Overall Study|Noncompliance|2|||
130494434|NCT00724126|469780721|FG001|Overall Study|Noncompliance|1|||
130494435|NCT00724126|469780720|FG000|Overall Study|Subject randomized although ineligible|1|||
130494436|NCT00724126|469780721|FG001|Overall Study|Subject randomized although ineligible|1|||
130494437|NCT00724126|469780720|FG000|Overall Study|Subject had to leave vicinity of site|0|||
130494438|NCT00724126|469780721|FG001|Overall Study|Subject had to leave vicinity of site|1|||
130494439|NCT01952366|469780725|FG000|Overall Study|Death|22|||
130494440|NCT01952366|469780725|FG000|Overall Study|Withdrawal by Subject|9|||
130494441|NCT00571649|469780726|FG000|Treatment Period|Adverse Event|438|||
130494442|NCT00571649|469780727|FG001|Treatment Period|Adverse Event|385|||
130494443|NCT00571649|469780726|FG000|Treatment Period|Clinical endpoint reached|50|||
130494444|NCT00571649|469780727|FG001|Treatment Period|Clinical endpoint reached|56|||
130494445|NCT00571649|469780726|FG000|Treatment Period|Withdrawal by Subject|285|||
130494446|NCT00571649|469780727|FG001|Treatment Period|Withdrawal by Subject|255|||
130494447|NCT00571649|469780726|FG000|Treatment Period|Death|76|||
130494448|NCT00571649|469780727|FG001|Treatment Period|Death|59|||
130494449|NCT00571649|469780726|FG000|Treatment Period|Physician Decision|8|||
130494450|NCT00571649|469780727|FG001|Treatment Period|Physician Decision|9|||
130494451|NCT00571649|469780726|FG000|Treatment Period|Lost to Follow-up|43|||
130494452|NCT00571649|469780727|FG001|Treatment Period|Lost to Follow-up|41|||
130494453|NCT00571649|469780726|FG000|Treatment Period|Non-compliant with study medication|88|||
130494454|NCT00571649|469780727|FG001|Treatment Period|Non-compliant with study medication|89|||
130494455|NCT00571649|469780726|FG000|Treatment Period|Patient convenience|11|||
130494456|NCT00571649|469780727|FG001|Treatment Period|Patient convenience|13|||
130494457|NCT00571649|469780726|FG000|Treatment Period|Protocol Violation|90|||
130494458|NCT00571649|469780727|FG001|Treatment Period|Protocol Violation|92|||
130494459|NCT00571649|469780726|FG000|Treatment Period|Technical problems|3|||
130494460|NCT00571649|469780727|FG001|Treatment Period|Technical problems|5|||
130494461|NCT00571649|469780726|FG000|Follow-up Period|Adverse Event|46|||
130494462|NCT00571649|469780727|FG001|Follow-up Period|Adverse Event|40|||
130494463|NCT00571649|469780726|FG000|Follow-up Period|Clinical endpoint reached|5|||
130494464|NCT00571649|469780727|FG001|Follow-up Period|Clinical endpoint reached|2|||
130494465|NCT00571649|469780726|FG000|Follow-up Period|Withdrawal by Subject|119|||
130494466|NCT00571649|469780727|FG001|Follow-up Period|Withdrawal by Subject|115|||
130494467|NCT00571649|469780726|FG000|Follow-up Period|Death|132|||
130494468|NCT00571649|469780727|FG001|Follow-up Period|Death|133|||
130494469|NCT00571649|469780726|FG000|Follow-up Period|Physician Decision|7|||
130494470|NCT00571649|469780727|FG001|Follow-up Period|Physician Decision|13|||
130494471|NCT00571649|469780726|FG000|Follow-up Period|Lost to Follow-up|95|||
130494472|NCT00571649|469780727|FG001|Follow-up Period|Lost to Follow-up|92|||
130494473|NCT00571649|469780726|FG000|Follow-up Period|Patient convenience|136|||
130494474|NCT00571649|469780727|FG001|Follow-up Period|Patient convenience|121|||
130494475|NCT00571649|469780726|FG000|Follow-up Period|Protocol Violation|5|||
130494476|NCT00571649|469780727|FG001|Follow-up Period|Protocol Violation|12|||
130494477|NCT00582972|469780728|FG000|Overall Study|Protocol Violation|2|||
130494478|NCT01566890|469780731|FG000|Overall Study|Adverse Event|1|||
130494479|NCT01566890|469780732|FG001|Overall Study|Adverse Event|0|||
130494480|NCT01566890|469780733|FG002|Overall Study|Adverse Event|0|||
130494481|NCT01566890|469780734|FG003|Overall Study|Adverse Event|0|||
130494482|NCT01566890|469780735|FG004|Overall Study|Adverse Event|0|||
130494483|NCT01566890|469780731|FG000|Overall Study|Withdrawal by Subject|3|||
130494484|NCT01566890|469780732|FG001|Overall Study|Withdrawal by Subject|1|||
130494485|NCT01566890|469780733|FG002|Overall Study|Withdrawal by Subject|1|||
130494486|NCT01566890|469780734|FG003|Overall Study|Withdrawal by Subject|1|||
130494487|NCT01566890|469780735|FG004|Overall Study|Withdrawal by Subject|0|||
130494488|NCT01566890|469780731|FG000|Overall Study|Screen failure|6|||
130494489|NCT01566890|469780732|FG001|Overall Study|Screen failure|0|||
130494490|NCT01566890|469780733|FG002|Overall Study|Screen failure|1|||
130494491|NCT01566890|469780734|FG003|Overall Study|Screen failure|1|||
130494492|NCT01566890|469780735|FG004|Overall Study|Screen failure|0|||
130494493|NCT01566890|469780731|FG000|Overall Study|Incomplete CEU data|1|||
130494494|NCT01566890|469780732|FG001|Overall Study|Incomplete CEU data|3|||
130494495|NCT01566890|469780733|FG002|Overall Study|Incomplete CEU data|5|||
130494496|NCT01566890|469780734|FG003|Overall Study|Incomplete CEU data|8|||
130494497|NCT01566890|469780735|FG004|Overall Study|Incomplete CEU data|0|||
130494498|NCT01566890|469780731|FG000|Overall Study|Lost to Follow-up|0|||
130494499|NCT01566890|469780732|FG001|Overall Study|Lost to Follow-up|0|||
130494500|NCT01566890|469780733|FG002|Overall Study|Lost to Follow-up|4|||
130494501|NCT01566890|469780734|FG003|Overall Study|Lost to Follow-up|4|||
130494502|NCT01566890|469780735|FG004|Overall Study|Lost to Follow-up|0|||
130494503|NCT01566890|469780731|FG000|Overall Study|Other|0|||
130494504|NCT01566890|469780732|FG001|Overall Study|Other|0|||
130494505|NCT01566890|469780733|FG002|Overall Study|Other|0|||
130494506|NCT01566890|469780734|FG003|Overall Study|Other|0|||
130494507|NCT01566890|469780735|FG004|Overall Study|Other|7|||
130494508|NCT01421667|469780741|FG000|Overall Study|Withdrawal by Subject|0|||
130494509|NCT01421667|469780742|FG001|Overall Study|Withdrawal by Subject|1|||
130494510|NCT01421667|469780743|FG002|Overall Study|Withdrawal by Subject|2|||
130494511|NCT01421667|469780744|FG003|Overall Study|Withdrawal by Subject|1|||
130494512|NCT01421667|469780741|FG000|Overall Study|Lost to Follow-up|0|||
130494513|NCT01421667|469780742|FG001|Overall Study|Lost to Follow-up|1|||
130494514|NCT01421667|469780743|FG002|Overall Study|Lost to Follow-up|0|||
130494515|NCT01421667|469780744|FG003|Overall Study|Lost to Follow-up|0|||
130494516|NCT01324310|469780745|FG000|Overall Study|Adverse Event|1|||
130494517|NCT01324310|469780745|FG000|Overall Study|Disease Progression|1|||
130494518|NCT03170882|469780747|FG000|Overall Study|Death|17|||
130494519|NCT03170882|469780748|FG001|Overall Study|Death|29|||
130494520|NCT03170882|469780747|FG000|Overall Study|Lost to Follow-up|0|||
130494521|NCT03170882|469780748|FG001|Overall Study|Lost to Follow-up|1|||
130494522|NCT03170882|469780747|FG000|Overall Study|Withdrawal by Subject|4|||
130494523|NCT03170882|469780748|FG001|Overall Study|Withdrawal by Subject|7|||
130494524|NCT03170882|469780747|FG000|Overall Study|Reason not Specified|28|||
130494525|NCT03170882|469780748|FG001|Overall Study|Reason not Specified|36|||
130494526|NCT02787005|469780768|FG000|Overall Study|Adverse Event|24|||
130494527|NCT02787005|469780769|FG001|Overall Study|Adverse Event|9|||
130494528|NCT02787005|469780770|FG002|Overall Study|Adverse Event|9|||
130494529|NCT02787005|469780771|FG003|Overall Study|Adverse Event|7|||
130494530|NCT02787005|469780772|FG004|Overall Study|Adverse Event|2|||
130494531|NCT02787005|469780768|FG000|Overall Study|Death|100|||
130494532|NCT02787005|469780769|FG001|Overall Study|Death|53|||
130494533|NCT02787005|469780770|FG002|Overall Study|Death|48|||
130494534|NCT02787005|469780771|FG003|Overall Study|Death|69|||
130494535|NCT02787005|469780772|FG004|Overall Study|Death|38|||
130494536|NCT02787005|469780768|FG000|Overall Study|Sponsor Decision|7|||
130494537|NCT02787005|469780769|FG001|Overall Study|Sponsor Decision|4|||
130494538|NCT02787005|469780770|FG002|Overall Study|Sponsor Decision|0|||
130494539|NCT02787005|469780771|FG003|Overall Study|Sponsor Decision|4|||
130494540|NCT02787005|469780772|FG004|Overall Study|Sponsor Decision|5|||
130729131|NCT01762800|470630522|FG001|Overall Study|Withdrawal by Subject|4|||
130494541|NCT02787005|469780768|FG000|Overall Study|Withdrawal by Subject|2|||
130494542|NCT02787005|469780769|FG001|Overall Study|Withdrawal by Subject|1|||
130494543|NCT02787005|469780770|FG002|Overall Study|Withdrawal by Subject|1|||
130494544|NCT02787005|469780771|FG003|Overall Study|Withdrawal by Subject|0|||
130494545|NCT02787005|469780772|FG004|Overall Study|Withdrawal by Subject|1|||
130494546|NCT02787005|469780768|FG000|Overall Study|Screen Failure|0|||
130729132|NCT02640482|470630524|FG000|Overall Study|Lost to Follow-up|3|||
130494547|NCT02787005|469780769|FG001|Overall Study|Screen Failure|2|||
130494548|NCT02787005|469780770|FG002|Overall Study|Screen Failure|0|||
130494549|NCT02787005|469780771|FG003|Overall Study|Screen Failure|0|||
130494550|NCT02787005|469780772|FG004|Overall Study|Screen Failure|1|||
130494551|NCT02787005|469780768|FG000|Overall Study|Lost to Follow-up|0|||
130494552|NCT02787005|469780769|FG001|Overall Study|Lost to Follow-up|0|||
130494553|NCT02787005|469780770|FG002|Overall Study|Lost to Follow-up|0|||
130494554|NCT02787005|469780771|FG003|Overall Study|Lost to Follow-up|1|||
130494555|NCT02787005|469780772|FG004|Overall Study|Lost to Follow-up|0|||
130494556|NCT05580003|469780773|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494557|NCT05580003|469780774|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494558|NCT05580003|469780775|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494559|NCT05580003|469780776|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130565515|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
130494560|NCT05580003|469780777|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494561|NCT05580003|469780778|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494562|NCT05580003|469780779|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
130494563|NCT05580003|469780780|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494564|NCT05580003|469780781|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494565|NCT05580003|469780782|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494566|NCT05580003|469780783|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494567|NCT05580003|469780784|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494568|NCT05580003|469780785|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494569|NCT05580003|469780786|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494570|NCT05580003|469780787|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494571|NCT05580003|469780788|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494572|NCT05580003|469780789|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494573|NCT05580003|469780790|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494574|NCT05580003|469780791|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494575|NCT05580003|469780792|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494576|NCT05580003|469780793|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494577|NCT05580003|469780794|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494578|NCT05580003|469780795|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494579|NCT05580003|469780796|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494580|NCT05580003|469780797|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494581|NCT05580003|469780798|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494582|NCT05580003|469780799|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494583|NCT05580003|469780800|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130494584|NCT05580003|469780773|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494585|NCT05580003|469780774|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494586|NCT05580003|469780775|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494587|NCT05580003|469780776|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494588|NCT05580003|469780777|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494589|NCT05580003|469780778|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
130494590|NCT05580003|469780779|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494591|NCT05580003|469780780|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494592|NCT05580003|469780781|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494593|NCT05580003|469780782|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494594|NCT05580003|469780783|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494595|NCT05580003|469780784|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494596|NCT05580003|469780785|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494597|NCT05580003|469780786|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494598|NCT05580003|469780787|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494599|NCT05580003|469780788|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494600|NCT05580003|469780789|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494601|NCT05580003|469780790|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494602|NCT05580003|469780791|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494603|NCT05580003|469780792|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494604|NCT05580003|469780793|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494605|NCT05580003|469780794|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494606|NCT05580003|469780795|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494607|NCT05580003|469780796|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494608|NCT05580003|469780797|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494609|NCT05580003|469780798|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494610|NCT05580003|469780799|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494611|NCT05580003|469780800|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130494612|NCT05580003|469780773|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494613|NCT05580003|469780774|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494614|NCT05580003|469780775|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494615|NCT05580003|469780776|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
130494616|NCT05580003|469780777|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494617|NCT05580003|469780778|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494618|NCT05580003|469780779|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494619|NCT05580003|469780780|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494620|NCT05580003|469780781|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494621|NCT05580003|469780782|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494622|NCT05580003|469780783|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494623|NCT05580003|469780784|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130729133|NCT02640482|470630525|FG001|Overall Study|Lost to Follow-up|0|||
130494624|NCT05580003|469780785|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494625|NCT05580003|469780786|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494626|NCT05580003|469780787|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494627|NCT05580003|469780788|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494628|NCT05580003|469780789|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494629|NCT05580003|469780790|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494630|NCT05580003|469780791|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494631|NCT05580003|469780792|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494632|NCT05580003|469780793|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494633|NCT05580003|469780794|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494634|NCT05580003|469780795|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494635|NCT05580003|469780796|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494636|NCT05580003|469780797|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494637|NCT05580003|469780798|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494638|NCT05580003|469780799|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494639|NCT05580003|469780800|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
130494640|NCT05580003|469780773|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130565516|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
130565517|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130565518|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
130565519|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130565520|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130565521|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
130565522|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130565523|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130565524|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
130565525|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130565526|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565527|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565528|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130565529|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565530|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565531|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130565532|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130565533|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
130565534|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130565535|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130565536|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130565537|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130565538|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130565539|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130565540|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
130565541|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130565542|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130565543|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130565544|NCT00111800|470036935|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130565545|NCT00111800|470036936|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130565546|NCT00111800|470036937|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
130565547|NCT00111800|470036938|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130565548|NCT00111800|470036939|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130565549|NCT00111800|470036940|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130565550|NCT00253643|470036942|FG000|Overall Study|Withdrawal by Subject|0|||
130565551|NCT00253643|470036943|FG001|Overall Study|Withdrawal by Subject|0|||
130565552|NCT00253643|470036944|FG002|Overall Study|Withdrawal by Subject|1|||
130565553|NCT00253643|470036945|FG003|Overall Study|Withdrawal by Subject|1|||
130565554|NCT00253643|470036942|FG000|Overall Study|Non-Compliance|0|||
130565555|NCT00253643|470036943|FG001|Overall Study|Non-Compliance|0|||
130565556|NCT00253643|470036944|FG002|Overall Study|Non-Compliance|0|||
130565557|NCT00253643|470036945|FG003|Overall Study|Non-Compliance|2|||
130565558|NCT01549275|470036946|FG000|Overall Study|Lost to Follow-up|1|||
130494641|NCT05580003|469780774|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
130494642|NCT05580003|469780775|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494643|NCT05580003|469780776|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494644|NCT05580003|469780777|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494645|NCT05580003|469780778|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494646|NCT05580003|469780779|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130565559|NCT01549275|470036947|FG001|Overall Study|Lost to Follow-up|0|||
130565560|NCT00365456|470036950|FG000|Trial Period I (12 Months)|Adverse Event|84|||
130565561|NCT00365456|470036951|FG001|Trial Period I (12 Months)|Adverse Event|0|||
130565562|NCT00365456|470036950|FG000|Trial Period I (12 Months)|Non-compliance|3|||
130565563|NCT00365456|470036951|FG001|Trial Period I (12 Months)|Non-compliance|0|||
130565564|NCT00365456|470036950|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
130565565|NCT00365456|470036951|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
130565566|NCT00365456|470036950|FG000|Trial Period I (12 Months)|Other|11|||
130565567|NCT00365456|470036951|FG001|Trial Period I (12 Months)|Other|0|||
130565568|NCT00365456|470036950|FG000|Trial Period II (12 Months)|Adverse Event|0|||
130565569|NCT00365456|470036951|FG001|Trial Period II (12 Months)|Adverse Event|6|||
130565570|NCT00365456|470036950|FG000|Trial Period II (12 Months)|Non-compliance|0|||
130565571|NCT00365456|470036951|FG001|Trial Period II (12 Months)|Non-compliance|2|||
130565572|NCT00365456|470036950|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
130565573|NCT00365456|470036951|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
130565574|NCT00365456|470036950|FG000|Trial Period II (12 Months)|Other|0|||
130565575|NCT00365456|470036951|FG001|Trial Period II (12 Months)|Other|1|||
130565576|NCT00365456|470036950|FG000|Trial Period III (12 Months)|Adverse Event|13|||
130565577|NCT00365456|470036951|FG001|Trial Period III (12 Months)|Adverse Event|3|||
130565578|NCT00365456|470036950|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
130565579|NCT00365456|470036951|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
130565580|NCT00365456|470036950|FG000|Trial Period III (12 Months)|Other|1|||
130565581|NCT00365456|470036951|FG001|Trial Period III (12 Months)|Other|1|||
130565582|NCT03668600|470036952|FG000|Overall Study|Study Terminated by the Sponsor|157|||
130565583|NCT03668600|470036952|FG000|Overall Study|Protocol Violation|1|||
130565584|NCT03668600|470036952|FG000|Overall Study|Pregnancy|1|||
130565585|NCT03668600|470036952|FG000|Overall Study|Lost to Follow-up|7|||
130565586|NCT03668600|470036952|FG000|Overall Study|Withdrawal by Subject|56|||
130565587|NCT03668600|470036952|FG000|Overall Study|Lack of Efficacy|7|||
130565588|NCT03668600|470036952|FG000|Overall Study|Adverse Event|1|||
130565589|NCT01131676|470036953|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
130565590|NCT01131676|470036954|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
130565591|NCT01131676|470036955|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
130565592|NCT01131676|470036953|FG000|Discontinuation From Treatment|Not treated|4|||
130565593|NCT01131676|470036954|FG001|Discontinuation From Treatment|Not treated|2|||
130565594|NCT01131676|470036955|FG002|Discontinuation From Treatment|Not treated|2|||
130565595|NCT01131676|470036953|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
130565596|NCT01131676|470036954|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
130565597|NCT01131676|470036955|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
130565598|NCT01131676|470036953|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
130565599|NCT01131676|470036954|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
130494647|NCT05580003|469780780|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494648|NCT05580003|469780781|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494649|NCT05580003|469780782|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494650|NCT05580003|469780783|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494651|NCT05580003|469780784|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494652|NCT05580003|469780785|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494653|NCT05580003|469780786|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494654|NCT05580003|469780787|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494655|NCT05580003|469780788|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494656|NCT05580003|469780789|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494657|NCT05580003|469780790|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494658|NCT05580003|469780791|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494659|NCT05580003|469780792|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494660|NCT05580003|469780793|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494661|NCT05580003|469780794|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494662|NCT05580003|469780795|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494663|NCT05580003|469780796|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494664|NCT05580003|469780797|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494665|NCT05580003|469780798|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494666|NCT05580003|469780799|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494667|NCT05580003|469780800|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
130494668|NCT05580003|469780773|FG000|Part 2 (up to 10 Days)|Other|0|||
130494669|NCT05580003|469780774|FG001|Part 2 (up to 10 Days)|Other|0|||
130494670|NCT05580003|469780775|FG002|Part 2 (up to 10 Days)|Other|0|||
130494671|NCT05580003|469780776|FG003|Part 2 (up to 10 Days)|Other|0|||
130494672|NCT05580003|469780777|FG004|Part 2 (up to 10 Days)|Other|0|||
130565600|NCT01131676|470036955|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
130565601|NCT01131676|470036953|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
130494673|NCT05580003|469780778|FG005|Part 2 (up to 10 Days)|Other|0|||
130729134|NCT00517881|470630526|FG000|Overall Study|Protocol Violation|2|||
130494674|NCT05580003|469780779|FG006|Part 2 (up to 10 Days)|Other|0|||
130494675|NCT05580003|469780780|FG007|Part 2 (up to 10 Days)|Other|0|||
130494676|NCT05580003|469780781|FG008|Part 2 (up to 10 Days)|Other|0|||
130494677|NCT05580003|469780782|FG009|Part 2 (up to 10 Days)|Other|1|||
130494678|NCT05580003|469780783|FG010|Part 2 (up to 10 Days)|Other|0|||
130494679|NCT05580003|469780784|FG011|Part 2 (up to 10 Days)|Other|0|||
130494680|NCT05580003|469780785|FG012|Part 2 (up to 10 Days)|Other|0|||
130494681|NCT05580003|469780786|FG013|Part 2 (up to 10 Days)|Other|0|||
130494682|NCT05580003|469780787|FG014|Part 2 (up to 10 Days)|Other|0|||
130494683|NCT05580003|469780788|FG015|Part 2 (up to 10 Days)|Other|0|||
130494684|NCT05580003|469780789|FG016|Part 2 (up to 10 Days)|Other|0|||
130494685|NCT05580003|469780790|FG017|Part 2 (up to 10 Days)|Other|0|||
130494686|NCT05580003|469780791|FG018|Part 2 (up to 10 Days)|Other|0|||
130494687|NCT05580003|469780792|FG019|Part 2 (up to 10 Days)|Other|0|||
130494688|NCT05580003|469780793|FG020|Part 2 (up to 10 Days)|Other|0|||
130494689|NCT05580003|469780794|FG021|Part 2 (up to 10 Days)|Other|0|||
130494690|NCT05580003|469780795|FG022|Part 2 (up to 10 Days)|Other|0|||
130494691|NCT05580003|469780796|FG023|Part 2 (up to 10 Days)|Other|0|||
130494692|NCT05580003|469780797|FG024|Part 2 (up to 10 Days)|Other|0|||
130494693|NCT05580003|469780798|FG025|Part 2 (up to 10 Days)|Other|0|||
130494694|NCT05580003|469780799|FG026|Part 2 (up to 10 Days)|Other|0|||
130494695|NCT05580003|469780800|FG027|Part 2 (up to 10 Days)|Other|0|||
130494696|NCT05580003|469780773|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494697|NCT05580003|469780774|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494698|NCT05580003|469780775|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494699|NCT05580003|469780776|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494700|NCT05580003|469780777|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494701|NCT05580003|469780778|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494702|NCT05580003|469780779|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494703|NCT05580003|469780780|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494704|NCT05580003|469780781|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494705|NCT05580003|469780782|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494706|NCT05580003|469780783|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494707|NCT05580003|469780784|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494708|NCT05580003|469780785|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494709|NCT05580003|469780786|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494710|NCT05580003|469780787|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130565602|NCT01131676|470036954|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
130565603|NCT01131676|470036955|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
130565604|NCT01131676|470036953|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
130565605|NCT01131676|470036954|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
130565606|NCT01131676|470036955|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
130565607|NCT01131676|470036953|FG000|Discontinuation From Treatment|Other than those specified|162|||
130565608|NCT01131676|470036954|FG001|Discontinuation From Treatment|Other than those specified|142|||
130565609|NCT01131676|470036955|FG002|Discontinuation From Treatment|Other than those specified|125|||
130565610|NCT01131676|470036953|FG000|Discontinuation From Treatment|Adverse Event|303|||
130565611|NCT01131676|470036954|FG001|Discontinuation From Treatment|Adverse Event|267|||
130565612|NCT01131676|470036955|FG002|Discontinuation From Treatment|Adverse Event|273|||
130565613|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
130565614|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
130565615|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
130565616|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
130565617|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
130565618|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
130494711|NCT05580003|469780788|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494712|NCT05580003|469780789|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494713|NCT05580003|469780790|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494714|NCT05580003|469780791|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494715|NCT05580003|469780792|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
130494716|NCT05580003|469780793|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494717|NCT05580003|469780794|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494718|NCT05580003|469780795|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494719|NCT05580003|469780796|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494720|NCT05580003|469780797|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494721|NCT05580003|469780798|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494722|NCT05580003|469780799|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494723|NCT05580003|469780800|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
130494724|NCT05580003|469780773|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494725|NCT05580003|469780774|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494726|NCT05580003|469780775|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494727|NCT05580003|469780776|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494728|NCT05580003|469780777|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494729|NCT05580003|469780778|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494730|NCT05580003|469780779|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494731|NCT05580003|469780780|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494732|NCT05580003|469780781|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494733|NCT05580003|469780782|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494734|NCT05580003|469780783|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494735|NCT05580003|469780784|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494736|NCT05580003|469780785|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494737|NCT05580003|469780786|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494738|NCT05580003|469780787|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494739|NCT05580003|469780788|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494740|NCT05580003|469780789|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494741|NCT05580003|469780790|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494742|NCT05580003|469780791|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494743|NCT05580003|469780792|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494744|NCT05580003|469780793|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
130494745|NCT05580003|469780794|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494746|NCT05580003|469780795|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494747|NCT05580003|469780796|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494748|NCT05580003|469780797|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494749|NCT05580003|469780798|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494750|NCT05580003|469780799|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494751|NCT05580003|469780800|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
130494752|NCT05580003|469780773|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494753|NCT05580003|469780774|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494754|NCT05580003|469780775|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494755|NCT05580003|469780776|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494756|NCT05580003|469780777|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494757|NCT05580003|469780778|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494758|NCT05580003|469780779|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494759|NCT05580003|469780780|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494760|NCT05580003|469780781|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494761|NCT05580003|469780782|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494762|NCT05580003|469780783|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494763|NCT05580003|469780784|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494764|NCT05580003|469780785|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494765|NCT05580003|469780786|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494766|NCT05580003|469780787|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494767|NCT05580003|469780788|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494768|NCT05580003|469780789|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494769|NCT05580003|469780790|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494770|NCT05580003|469780791|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494771|NCT05580003|469780792|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494772|NCT05580003|469780793|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494773|NCT05580003|469780794|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
130494774|NCT05580003|469780795|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494775|NCT05580003|469780796|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494776|NCT05580003|469780797|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494777|NCT05580003|469780798|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494778|NCT05580003|469780799|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494779|NCT05580003|469780800|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130494780|NCT05580003|469780773|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494781|NCT05580003|469780774|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494782|NCT05580003|469780775|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494783|NCT05580003|469780776|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494784|NCT05580003|469780777|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494785|NCT05580003|469780778|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494786|NCT05580003|469780779|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494787|NCT05580003|469780780|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494788|NCT05580003|469780781|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494789|NCT05580003|469780782|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494790|NCT05580003|469780783|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494791|NCT05580003|469780784|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494792|NCT05580003|469780785|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494793|NCT05580003|469780786|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494794|NCT05580003|469780787|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494795|NCT05580003|469780788|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494796|NCT05580003|469780789|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130729135|NCT00517881|470630526|FG000|Overall Study|Adverse Event|1|||
130729136|NCT00517881|470630526|FG000|Overall Study|Renal transplantation|2|||
130729137|NCT02013817|470630531|FG000|Overall Study|Adverse Event|12|||
130729138|NCT02013817|470630531|FG000|Overall Study|Withdrawal by Subject|4|||
130729139|NCT02013817|470630531|FG000|Overall Study|Death|2|||
130729140|NCT02013817|470630531|FG000|Overall Study|Other|9|||
130729141|NCT03336528|470630532|FG000|Overall Study|Protocol Violation|1|||
130729142|NCT03336528|470630533|FG001|Overall Study|Protocol Violation|1|||
130729143|NCT03336528|470630532|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
130729144|NCT03336528|470630533|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
130494797|NCT05580003|469780790|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130729145|NCT03336528|470630532|FG000|Overall Study|Did not receive study medication|1|||
130729146|NCT03336528|470630533|FG001|Overall Study|Did not receive study medication|2|||
130729147|NCT00230178|470630536|FG000|Overall Study|Adverse Event|1|||
130729148|NCT00230178|470630537|FG001|Overall Study|Adverse Event|5|||
130729149|NCT00230178|470630538|FG002|Overall Study|Adverse Event|2|||
130729150|NCT00230178|470630536|FG000|Overall Study|Withdrawal by Subject|0|||
130729151|NCT00230178|470630537|FG001|Overall Study|Withdrawal by Subject|0|||
130729152|NCT00230178|470630538|FG002|Overall Study|Withdrawal by Subject|1|||
130729153|NCT00230178|470630536|FG000|Overall Study|Various other reasons|3|||
130729154|NCT00230178|470630537|FG001|Overall Study|Various other reasons|2|||
130729155|NCT00230178|470630538|FG002|Overall Study|Various other reasons|4|||
130729156|NCT01753297|470630539|FG000|Overall Study|Lost to Follow-up|7|||
130729157|NCT01753297|470630540|FG001|Overall Study|Lost to Follow-up|2|||
130729158|NCT01753297|470630539|FG000|Overall Study|Withdrawal by Subject|26|||
130729159|NCT01753297|470630540|FG001|Overall Study|Withdrawal by Subject|23|||
130729160|NCT01753297|470630539|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
130729161|NCT01753297|470630540|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
130729162|NCT01753297|470630539|FG000|Overall Study|Death|0|||
130729163|NCT01753297|470630540|FG001|Overall Study|Death|2|||
130729164|NCT01753297|470630539|FG000|Overall Study|Did not attend end of study visit|7|||
130729165|NCT01753297|470630540|FG001|Overall Study|Did not attend end of study visit|8|||
130729166|NCT04974749|470630548|FG000|Overall Study|Withdrawal by Subject|2|||
130729167|NCT04974749|470630548|FG000|Overall Study|Gestation|1|||
130729168|NCT01645787|470630549|FG000|Washout (2 Weeks)|Adverse Event|1|||
130729169|NCT01645787|470630550|FG001|Washout (2 Weeks)|Adverse Event|0|||
130729170|NCT04315506|470630561|FG000|Overall Study|Lost to Follow-up|74|||
130729171|NCT04315506|470630562|FG001|Overall Study|Lost to Follow-up|82|||
130729172|NCT04315506|470630561|FG000|Overall Study|Withdrawal by Subject|8|||
130729173|NCT04315506|470630562|FG001|Overall Study|Withdrawal by Subject|8|||
130729174|NCT04315506|470630561|FG000|Overall Study|Physician Decision|0|||
130729175|NCT04315506|470630562|FG001|Overall Study|Physician Decision|1|||
130729176|NCT00958893|470630569|FG000|Overall Study|Study prematurely terminated|4|||
130729177|NCT00606632|470630578|FG000|Overall Study|Withdrawal by Subject|13|||
130729178|NCT00606632|470630578|FG000|Overall Study|Miscellaneous reasons|9|||
130729179|NCT00711880|470630579|FG000|Overall Study|Adverse Event|11|||
130729180|NCT00711880|470630580|FG001|Overall Study|Adverse Event|2|||
130729181|NCT00711880|470630579|FG000|Overall Study|Patient non-compliance|1|||
130729182|NCT00711880|470630580|FG001|Overall Study|Patient non-compliance|0|||
130729183|NCT00711880|470630579|FG000|Overall Study|Lack of Efficacy|1|||
130729184|NCT00711880|470630580|FG001|Overall Study|Lack of Efficacy|5|||
130729185|NCT02756208|470630583|FG000|Overall Study|Withdrawal by Subject|1|||
130729186|NCT02756208|470630584|FG001|Overall Study|Withdrawal by Subject|0|||
130729187|NCT02756208|470630585|FG002|Overall Study|Withdrawal by Subject|1|||
130729188|NCT02756208|470630586|FG003|Overall Study|Withdrawal by Subject|3|||
130729189|NCT02756208|470630583|FG000|Overall Study|Lost to Follow-up|3|||
130729190|NCT02756208|470630584|FG001|Overall Study|Lost to Follow-up|1|||
130729191|NCT02756208|470630585|FG002|Overall Study|Lost to Follow-up|1|||
130729192|NCT02756208|470630586|FG003|Overall Study|Lost to Follow-up|1|||
130729193|NCT02756208|470630583|FG000|Overall Study|Physician Decision|1|||
130494798|NCT05580003|469780791|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494799|NCT05580003|469780792|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494800|NCT05580003|469780793|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494801|NCT05580003|469780794|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494802|NCT05580003|469780795|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130729194|NCT02756208|470630584|FG001|Overall Study|Physician Decision|0|||
130729195|NCT02756208|470630585|FG002|Overall Study|Physician Decision|0|||
130729196|NCT02756208|470630586|FG003|Overall Study|Physician Decision|0|||
130729197|NCT02756208|470630583|FG000|Overall Study|Protocol Violation|0|||
130729198|NCT02756208|470630584|FG001|Overall Study|Protocol Violation|1|||
130729199|NCT02756208|470630585|FG002|Overall Study|Protocol Violation|0|||
130729200|NCT02756208|470630586|FG003|Overall Study|Protocol Violation|0|||
130729201|NCT01295320|470630589|FG000|Overall Study|Adverse Event|2|||
130729202|NCT01295320|470630589|FG000|Overall Study|Lost to Follow-up|4|||
130729203|NCT01295320|470630589|FG000|Overall Study|Withdrawal by Subject|2|||
130729204|NCT01295320|470630589|FG000|Overall Study|Subject was bedridden|1|||
130729205|NCT01295320|470630589|FG000|Overall Study|Unable to travel|1|||
130729206|NCT00652340|470630590|FG000|Overall Study|Had not progressed.|4|||
130494803|NCT05580003|469780796|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494804|NCT05580003|469780797|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494805|NCT05580003|469780798|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494806|NCT05580003|469780799|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
130494807|NCT05580003|469780800|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
130494808|NCT05580003|469780773|FG000|Part 6 Period 2 (Day 1)|Other|0|||
130494809|NCT05580003|469780774|FG001|Part 6 Period 2 (Day 1)|Other|0|||
130494810|NCT05580003|469780775|FG002|Part 6 Period 2 (Day 1)|Other|0|||
130494811|NCT05580003|469780776|FG003|Part 6 Period 2 (Day 1)|Other|0|||
130494812|NCT05580003|469780777|FG004|Part 6 Period 2 (Day 1)|Other|0|||
130494813|NCT05580003|469780778|FG005|Part 6 Period 2 (Day 1)|Other|0|||
130494814|NCT05580003|469780779|FG006|Part 6 Period 2 (Day 1)|Other|0|||
130494815|NCT05580003|469780780|FG007|Part 6 Period 2 (Day 1)|Other|0|||
130494816|NCT05580003|469780781|FG008|Part 6 Period 2 (Day 1)|Other|0|||
130494817|NCT05580003|469780782|FG009|Part 6 Period 2 (Day 1)|Other|0|||
130494818|NCT05580003|469780783|FG010|Part 6 Period 2 (Day 1)|Other|0|||
130494819|NCT05580003|469780784|FG011|Part 6 Period 2 (Day 1)|Other|0|||
130494820|NCT05580003|469780785|FG012|Part 6 Period 2 (Day 1)|Other|0|||
130494821|NCT05580003|469780786|FG013|Part 6 Period 2 (Day 1)|Other|0|||
130494822|NCT05580003|469780787|FG014|Part 6 Period 2 (Day 1)|Other|0|||
130494823|NCT05580003|469780788|FG015|Part 6 Period 2 (Day 1)|Other|0|||
130494824|NCT05580003|469780789|FG016|Part 6 Period 2 (Day 1)|Other|0|||
130494825|NCT05580003|469780790|FG017|Part 6 Period 2 (Day 1)|Other|0|||
130494826|NCT05580003|469780791|FG018|Part 6 Period 2 (Day 1)|Other|0|||
130494827|NCT05580003|469780792|FG019|Part 6 Period 2 (Day 1)|Other|0|||
130494828|NCT05580003|469780793|FG020|Part 6 Period 2 (Day 1)|Other|0|||
130494829|NCT05580003|469780794|FG021|Part 6 Period 2 (Day 1)|Other|0|||
130494830|NCT05580003|469780795|FG022|Part 6 Period 2 (Day 1)|Other|0|||
130494831|NCT05580003|469780796|FG023|Part 6 Period 2 (Day 1)|Other|0|||
130494832|NCT05580003|469780797|FG024|Part 6 Period 2 (Day 1)|Other|1|||
130494833|NCT05580003|469780798|FG025|Part 6 Period 2 (Day 1)|Other|0|||
130494834|NCT05580003|469780799|FG026|Part 6 Period 2 (Day 1)|Other|0|||
130494835|NCT05580003|469780800|FG027|Part 6 Period 2 (Day 1)|Other|0|||
130494836|NCT02029235|469780801|FG000|Overall Study|Non-compliance with study meds or diary|4|||
130494837|NCT02029235|469780802|FG001|Overall Study|Non-compliance with study meds or diary|1|||
130494838|NCT01387516|469780803|FG000|Overall Study|Lost to Follow-up|4|||
130494839|NCT01387516|469780804|FG001|Overall Study|Lost to Follow-up|4|||
130494840|NCT01387516|469780805|FG002|Overall Study|Lost to Follow-up|2|||
130494841|NCT01387516|469780806|FG003|Overall Study|Lost to Follow-up|3|||
130494842|NCT01387516|469780803|FG000|Overall Study|Withdrawal by Subject|1|||
130494843|NCT01387516|469780804|FG001|Overall Study|Withdrawal by Subject|1|||
130494844|NCT01387516|469780805|FG002|Overall Study|Withdrawal by Subject|2|||
130494845|NCT01387516|469780806|FG003|Overall Study|Withdrawal by Subject|0|||
130494846|NCT01387516|469780803|FG000|Overall Study|Death|0|||
130494847|NCT01387516|469780804|FG001|Overall Study|Death|0|||
130494848|NCT01387516|469780805|FG002|Overall Study|Death|0|||
130494849|NCT01387516|469780806|FG003|Overall Study|Death|1|||
130494850|NCT00701701|469780808|FG000|Overall Study|Withdrawal by Subject|0|||
130494851|NCT00701701|469780809|FG001|Overall Study|Withdrawal by Subject|1|||
130494852|NCT00701701|469780808|FG000|Overall Study|Adverse Event|0|||
130494853|NCT00701701|469780809|FG001|Overall Study|Adverse Event|1|||
130494854|NCT00589875|469780810|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
130494855|NCT00589875|469780810|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
130494856|NCT03593226|469780811|FG000|Overall Study|Disease progression|6|||
130494857|NCT03593226|469780812|FG001|Overall Study|Disease progression|13|||
130494858|NCT03593226|469780813|FG002|Overall Study|Disease progression|5|||
130494859|NCT03593226|469780814|FG003|Overall Study|Disease progression|6|||
130494860|NCT03593226|469780811|FG000|Overall Study|Adverse Event|0|||
130494861|NCT03593226|469780812|FG001|Overall Study|Adverse Event|1|||
130494862|NCT03593226|469780813|FG002|Overall Study|Adverse Event|0|||
130494863|NCT03593226|469780814|FG003|Overall Study|Adverse Event|0|||
130494864|NCT03593226|469780811|FG000|Overall Study|Withdrawal by Subject|0|||
130494865|NCT03593226|469780812|FG001|Overall Study|Withdrawal by Subject|4|||
130729207|NCT00652340|470630591|FG001|Overall Study|Had not progressed.|3|||
130494866|NCT03593226|469780813|FG002|Overall Study|Withdrawal by Subject|1|||
130494867|NCT03593226|469780814|FG003|Overall Study|Withdrawal by Subject|0|||
130494868|NCT03593226|469780811|FG000|Overall Study|Physician Decision|0|||
130494869|NCT03593226|469780812|FG001|Overall Study|Physician Decision|1|||
130494870|NCT03593226|469780813|FG002|Overall Study|Physician Decision|0|||
130494871|NCT03593226|469780814|FG003|Overall Study|Physician Decision|0|||
130494872|NCT03593226|469780811|FG000|Overall Study|Clinical disease progression|0|||
130494873|NCT03593226|469780812|FG001|Overall Study|Clinical disease progression|0|||
130494874|NCT03593226|469780813|FG002|Overall Study|Clinical disease progression|1|||
130494875|NCT03593226|469780814|FG003|Overall Study|Clinical disease progression|0|||
130494876|NCT04517435|469780831|FG000|Overall Study|Withdrawal by Subject|0|||
130494877|NCT04517435|469780832|FG001|Overall Study|Withdrawal by Subject|0|||
130494878|NCT04517435|469780833|FG002|Overall Study|Withdrawal by Subject|1|||
130729208|NCT03682107|470630592|FG000|Overall Study|Withdrawal by Subject|0|||
130494879|NCT04517435|469780831|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
130494880|NCT04517435|469780832|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
130494881|NCT04517435|469780833|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
130494882|NCT04057131|469780834|FG000|Overall Study|Protocol Violation|24|||
130494883|NCT03160885|469780835|FG000|Initial Treatment Period|Not dosed|2|||
130494884|NCT03160885|469780836|FG001|Initial Treatment Period|Not dosed|0|||
130494885|NCT03160885|469780837|FG002|Initial Treatment Period|Not dosed|0|||
130494886|NCT03160885|469780838|FG003|Initial Treatment Period|Not dosed|0|||
130494887|NCT03160885|469780839|FG004|Initial Treatment Period|Not dosed|0|||
130494888|NCT03160885|469780840|FG005|Initial Treatment Period|Not dosed|0|||
130494889|NCT03160885|469780841|FG006|Initial Treatment Period|Not dosed|0|||
130494890|NCT03160885|469780835|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
130494891|NCT03160885|469780836|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
130494892|NCT03160885|469780837|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130494893|NCT03160885|469780838|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130494894|NCT03160885|469780839|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130494895|NCT03160885|469780840|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130494896|NCT03160885|469780841|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
130494897|NCT03160885|469780835|FG000|Open-label Treatment|Not dosed|0|||
130494898|NCT03160885|469780836|FG001|Open-label Treatment|Not dosed|0|||
130494899|NCT03160885|469780837|FG002|Open-label Treatment|Not dosed|0|||
130494900|NCT03160885|469780838|FG003|Open-label Treatment|Not dosed|0|||
130494901|NCT03160885|469780839|FG004|Open-label Treatment|Not dosed|0|||
130494902|NCT03160885|469780840|FG005|Open-label Treatment|Not dosed|0|||
130494903|NCT03160885|469780841|FG006|Open-label Treatment|Not dosed|2|||
130494904|NCT03160885|469780835|FG000|Open-label Treatment|Discontinued IMP|0|||
130494905|NCT03160885|469780836|FG001|Open-label Treatment|Discontinued IMP|0|||
130494906|NCT03160885|469780837|FG002|Open-label Treatment|Discontinued IMP|0|||
130494907|NCT03160885|469780838|FG003|Open-label Treatment|Discontinued IMP|0|||
130494908|NCT03160885|469780839|FG004|Open-label Treatment|Discontinued IMP|0|||
130494909|NCT03160885|469780840|FG005|Open-label Treatment|Discontinued IMP|0|||
130494910|NCT03160885|469780841|FG006|Open-label Treatment|Discontinued IMP|131|||
130494911|NCT03160885|469780835|FG000|Open-label Treatment|Completed Week 50|0|||
130494912|NCT03160885|469780836|FG001|Open-label Treatment|Completed Week 50|0|||
130494913|NCT03160885|469780837|FG002|Open-label Treatment|Completed Week 50|0|||
130494914|NCT03160885|469780838|FG003|Open-label Treatment|Completed Week 50|0|||
130494915|NCT03160885|469780839|FG004|Open-label Treatment|Completed Week 50|0|||
130494916|NCT03160885|469780840|FG005|Open-label Treatment|Completed Week 50|0|||
130494917|NCT03160885|469780841|FG006|Open-label Treatment|Completed Week 50|4|||
130494918|NCT03160885|469780835|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494919|NCT03160885|469780836|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494920|NCT03160885|469780837|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494921|NCT03160885|469780838|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
130494922|NCT03160885|469780839|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494923|NCT03160885|469780840|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494924|NCT03160885|469780841|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
130494925|NCT03160885|469780835|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
130494926|NCT03160885|469780836|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
130494927|NCT03160885|469780837|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
130494928|NCT03160885|469780838|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
130494929|NCT03160885|469780839|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
130494930|NCT03160885|469780840|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
130494931|NCT03160885|469780841|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
130494932|NCT03160885|469780835|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130494933|NCT03160885|469780836|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130494934|NCT03160885|469780837|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
130494935|NCT03160885|469780838|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
130494936|NCT03160885|469780839|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
130494937|NCT03160885|469780840|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
130494938|NCT03160885|469780841|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
130494939|NCT03160885|469780835|FG000|Maintenance Treatment Period|Completed Week 50|0|||
130494940|NCT03160885|469780836|FG001|Maintenance Treatment Period|Completed Week 50|0|||
130494941|NCT03160885|469780837|FG002|Maintenance Treatment Period|Completed Week 50|1|||
130494942|NCT03160885|469780838|FG003|Maintenance Treatment Period|Completed Week 50|0|||
130494943|NCT03160885|469780839|FG004|Maintenance Treatment Period|Completed Week 50|0|||
130494944|NCT03160885|469780840|FG005|Maintenance Treatment Period|Completed Week 50|0|||
130494945|NCT03160885|469780841|FG006|Maintenance Treatment Period|Completed Week 50|0|||
130494946|NCT02307682|469780844|FG000|Overall Study|Adverse Event|9|||
130494947|NCT02307682|469780845|FG001|Overall Study|Adverse Event|8|||
130494948|NCT02307682|469780846|FG002|Overall Study|Adverse Event|12|||
130729209|NCT03682107|470630593|FG001|Overall Study|Withdrawal by Subject|1|||
130494949|NCT02307682|469780844|FG000|Overall Study|Lack of Efficacy|1|||
130494950|NCT02307682|469780845|FG001|Overall Study|Lack of Efficacy|0|||
130494951|NCT02307682|469780846|FG002|Overall Study|Lack of Efficacy|1|||
130494952|NCT02307682|469780844|FG000|Overall Study|Physician Decision|2|||
130494953|NCT02307682|469780845|FG001|Overall Study|Physician Decision|2|||
130494954|NCT02307682|469780846|FG002|Overall Study|Physician Decision|8|||
130494955|NCT02307682|469780844|FG000|Overall Study|Progressive Disease|1|||
130494956|NCT02307682|469780845|FG001|Overall Study|Progressive Disease|0|||
130494957|NCT02307682|469780846|FG002|Overall Study|Progressive Disease|0|||
130494958|NCT02307682|469780844|FG000|Overall Study|Withdrawal by Subject|26|||
130494959|NCT02307682|469780845|FG001|Overall Study|Withdrawal by Subject|34|||
130494960|NCT02307682|469780846|FG002|Overall Study|Withdrawal by Subject|23|||
130494961|NCT02307682|469780844|FG000|Overall Study|Death|9|||
130494962|NCT02307682|469780845|FG001|Overall Study|Death|7|||
130494963|NCT02307682|469780846|FG002|Overall Study|Death|12|||
130494964|NCT02307682|469780844|FG000|Overall Study|Lost to Follow-up|1|||
130494965|NCT02307682|469780845|FG001|Overall Study|Lost to Follow-up|5|||
130494966|NCT02307682|469780846|FG002|Overall Study|Lost to Follow-up|6|||
130494967|NCT02307682|469780844|FG000|Overall Study|Protocol Deviation|0|||
130494968|NCT02307682|469780845|FG001|Overall Study|Protocol Deviation|0|||
130494969|NCT02307682|469780846|FG002|Overall Study|Protocol Deviation|2|||
130494970|NCT02307682|469780844|FG000|Overall Study|Other|1|||
130494971|NCT02307682|469780845|FG001|Overall Study|Other|1|||
130494972|NCT02307682|469780846|FG002|Overall Study|Other|0|||
130494973|NCT05704725|469780848|FG000|Overall Study|Lost to Follow-up|0|||
130494974|NCT05704725|469780849|FG001|Overall Study|Lost to Follow-up|1|||
130494975|NCT05704725|469780848|FG000|Overall Study|Withdrawal by Subject|1|||
130494976|NCT05704725|469780849|FG001|Overall Study|Withdrawal by Subject|0|||
130494977|NCT04484623|469780850|FG000|Overall Study|Lost to Follow-up|0|||
130494978|NCT04484623|469780851|FG001|Overall Study|Lost to Follow-up|1|||
130494979|NCT04484623|469780850|FG000|Overall Study|Protocol Deviation|1|||
130494980|NCT04484623|469780851|FG001|Overall Study|Protocol Deviation|0|||
130494981|NCT04484623|469780850|FG000|Overall Study|Physician Decision|1|||
130494982|NCT04484623|469780851|FG001|Overall Study|Physician Decision|0|||
130494983|NCT04484623|469780850|FG000|Overall Study|Withdrawal by Subject|11|||
130494984|NCT04484623|469780851|FG001|Overall Study|Withdrawal by Subject|8|||
130494985|NCT04484623|469780850|FG000|Overall Study|Ongoing|94|||
130494986|NCT04484623|469780851|FG001|Overall Study|Ongoing|84|||
130494987|NCT04551066|469780852|FG000|Overall Study|Death|5|||
130494988|NCT04551066|469780853|FG001|Overall Study|Death|3|||
130494989|NCT04551066|469780852|FG000|Overall Study|Lost to Follow-up|1|||
130494990|NCT04551066|469780853|FG001|Overall Study|Lost to Follow-up|0|||
130494991|NCT04551066|469780852|FG000|Overall Study|Sponsor Decision|103|||
130494992|NCT04551066|469780853|FG001|Overall Study|Sponsor Decision|117|||
130494993|NCT04551066|469780852|FG000|Overall Study|Withdrawal by Subject|8|||
130494994|NCT04551066|469780853|FG001|Overall Study|Withdrawal by Subject|2|||
130494995|NCT04551066|469780852|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
130494996|NCT04551066|469780853|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
130494997|NCT04551066|469780852|FG000|Overall Study|Adverse Event|2|||
130494998|NCT04551066|469780853|FG001|Overall Study|Adverse Event|0|||
130494999|NCT04551066|469780852|FG000|Overall Study|Physician Decision|2|||
130495000|NCT04551066|469780853|FG001|Overall Study|Physician Decision|0|||
130495001|NCT04551066|469780852|FG000|Overall Study|Protocol Violation|1|||
130495002|NCT04551066|469780853|FG001|Overall Study|Protocol Violation|0|||
130495003|NCT04551066|469780852|FG000|Overall Study|Lack of Efficacy|0|||
130495004|NCT04551066|469780853|FG001|Overall Study|Lack of Efficacy|1|||
130495005|NCT04551066|469780852|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
130495006|NCT04551066|469780853|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
130495007|NCT05529992|469780854|FG000|Overall Study|Withdrawal by Subject|1|||
130495008|NCT04503681|469782246|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
130495009|NCT04503681|469782247|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
130729210|NCT03682107|470630594|FG002|Overall Study|Withdrawal by Subject|0|||
130729211|NCT03682107|470630595|FG003|Overall Study|Withdrawal by Subject|0|||
130729212|NCT03682107|470630596|FG004|Overall Study|Withdrawal by Subject|0|||
130495010|NCT00210106|469782249|FG000|Overall Study|Death|1|||
130495011|NCT00210106|469782249|FG000|Overall Study|Protocol Violation|13|||
130495012|NCT01084694|469782255|FG000|Overall Study|Withdrawal by Subject|2|||
130495013|NCT01084694|469782256|FG001|Overall Study|Withdrawal by Subject|1|||
130495014|NCT01084694|469782255|FG000|Overall Study|Death|2|||
130495015|NCT01084694|469782256|FG001|Overall Study|Death|12|||
130495016|NCT01084694|469782255|FG000|Overall Study|eligibility not maintained|2|||
130495017|NCT01084694|469782256|FG001|Overall Study|eligibility not maintained|7|||
130495018|NCT00945321|469782259|FG000|Period 1|Adverse Event|0|||
130495019|NCT00945321|469782260|FG001|Period 1|Adverse Event|0|||
130495020|NCT00945321|469782261|FG002|Period 1|Adverse Event|0|||
130495021|NCT00945321|469782262|FG003|Period 1|Adverse Event|0|||
130495022|NCT00945321|469782263|FG004|Period 1|Adverse Event|1|||
130729213|NCT04342819|470630597|FG000|Overall Study|Declined|4|||
130495023|NCT00945321|469782264|FG005|Period 1|Adverse Event|0|||
130495024|NCT00945321|469782259|FG000|Period 4|Lost to Follow-up|0|||
130495025|NCT00945321|469782260|FG001|Period 4|Lost to Follow-up|0|||
130495026|NCT00945321|469782261|FG002|Period 4|Lost to Follow-up|0|||
130495027|NCT00945321|469782262|FG003|Period 4|Lost to Follow-up|0|||
130495028|NCT00945321|469782263|FG004|Period 4|Lost to Follow-up|0|||
130495029|NCT00945321|469782264|FG005|Period 4|Lost to Follow-up|1|||
130495030|NCT02633215|469782265|FG000|Overall Study|Lost to Follow-up|2|||
130495031|NCT02633215|469782266|FG001|Overall Study|Lost to Follow-up|3|||
130495032|NCT04017611|469782267|FG000|Overall Study|Withdrawn prior to completion|1|||
130495033|NCT00692913|469782268|FG000|Overall Study|Adverse Event|8|||
130495034|NCT00692913|469782269|FG001|Overall Study|Adverse Event|4|||
130495035|NCT00692913|469782268|FG000|Overall Study|Lost to Follow-up|3|||
130495036|NCT00692913|469782269|FG001|Overall Study|Lost to Follow-up|5|||
130495037|NCT00692913|469782268|FG000|Overall Study|Physician Decision|2|||
130495038|NCT00692913|469782269|FG001|Overall Study|Physician Decision|0|||
130495039|NCT00692913|469782268|FG000|Overall Study|Protocol Violation|1|||
130495040|NCT00692913|469782269|FG001|Overall Study|Protocol Violation|1|||
130495041|NCT00692913|469782268|FG000|Overall Study|Withdrawal by Subject|15|||
130495042|NCT00692913|469782269|FG001|Overall Study|Withdrawal by Subject|20|||
130495043|NCT02291913|469782278|FG000|Overall Study|Progressive Disease|32|||
130495044|NCT02291913|469782278|FG000|Overall Study|Adverse Event|11|||
130495045|NCT02291913|469782278|FG000|Overall Study|Death|2|||
130495046|NCT02291913|469782278|FG000|Overall Study|Physician Decision|1|||
130495047|NCT02291913|469782278|FG000|Overall Study|Withdrawal by Subject|1|||
130495048|NCT02291913|469782278|FG000|Overall Study|Protocol Violation|1|||
130495049|NCT01268306|469782279|FG000|Overall Study|Lost to Follow-up|1|||
130495050|NCT04334317|469782280|FG000|Overall Study|Adverse Event|1|||
130495051|NCT04334317|469782281|FG001|Overall Study|Adverse Event|2|||
130495052|NCT04334317|469782282|FG002|Overall Study|Adverse Event|0|||
130495053|NCT04334317|469782283|FG003|Overall Study|Adverse Event|0|||
130495054|NCT04334317|469782280|FG000|Overall Study|Protocol Deviation|0|||
130495055|NCT04334317|469782281|FG001|Overall Study|Protocol Deviation|1|||
130495056|NCT04334317|469782282|FG002|Overall Study|Protocol Deviation|0|||
130495057|NCT04334317|469782283|FG003|Overall Study|Protocol Deviation|0|||
130495058|NCT04334317|469782280|FG000|Overall Study|Withdrawal by Subject|2|||
130495059|NCT04334317|469782281|FG001|Overall Study|Withdrawal by Subject|2|||
130495060|NCT04334317|469782282|FG002|Overall Study|Withdrawal by Subject|0|||
130495061|NCT04334317|469782283|FG003|Overall Study|Withdrawal by Subject|0|||
130495062|NCT01128595|469782286|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130495063|NCT01128595|469782287|FG001|Treatment Period 3|Withdrawal by Subject|1|||
130495064|NCT01128595|469782288|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130495065|NCT01128595|469782289|FG003|Treatment Period 3|Withdrawal by Subject|0|||
130495066|NCT00605306|469782290|FG000|Overall Study|Adverse Event|0|||
130495067|NCT00605306|469782291|FG001|Overall Study|Adverse Event|1|||
130495068|NCT00372775|469782292|FG000|Overall Study|Adverse Event|8|||
130495069|NCT00372775|469782292|FG000|Overall Study|Death|15|||
130495070|NCT00372775|469782292|FG000|Overall Study|Objective progression or relapse|30|||
130495071|NCT00372775|469782292|FG000|Overall Study|Global deterioration of health status|6|||
130495072|NCT00372775|469782292|FG000|Overall Study|Withdrawal by Subject|1|||
130495073|NCT00372775|469782292|FG000|Overall Study|Other|1|||
130495074|NCT00372775|469782292|FG000|Overall Study|Not Treated|2|||
130495075|NCT02568215|469782294|FG000|Overall Study|Death|1|||
130495076|NCT02568215|469782295|FG001|Overall Study|Death|2|||
130495077|NCT02568215|469782296|FG002|Overall Study|Death|0|||
130495078|NCT02568215|469782294|FG000|Overall Study|Physician Decision|2|||
130495079|NCT02568215|469782295|FG001|Overall Study|Physician Decision|2|||
130495080|NCT02568215|469782296|FG002|Overall Study|Physician Decision|2|||
130495081|NCT02568215|469782294|FG000|Overall Study|Lost to Follow-up|29|||
130495082|NCT02568215|469782295|FG001|Overall Study|Lost to Follow-up|32|||
130495083|NCT02568215|469782296|FG002|Overall Study|Lost to Follow-up|41|||
130495084|NCT02568215|469782294|FG000|Overall Study|Withdrawal by Subject|21|||
130495085|NCT02568215|469782295|FG001|Overall Study|Withdrawal by Subject|19|||
130495086|NCT02568215|469782296|FG002|Overall Study|Withdrawal by Subject|22|||
130495087|NCT02568215|469782294|FG000|Overall Study|Protocol Violation|1|||
130495088|NCT02568215|469782295|FG001|Overall Study|Protocol Violation|1|||
130495089|NCT02568215|469782296|FG002|Overall Study|Protocol Violation|0|||
130495090|NCT02568215|469782294|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
130495091|NCT02568215|469782295|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
130495092|NCT02568215|469782296|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
130495093|NCT02568215|469782294|FG000|Overall Study|Other|0|||
130495094|NCT02568215|469782295|FG001|Overall Study|Other|1|||
130495095|NCT02568215|469782296|FG002|Overall Study|Other|4|||
130495096|NCT01436175|469782297|FG000|Overall Study|Adverse Event|111|||
130495097|NCT01436175|469782297|FG000|Overall Study|Protocol Violation|49|||
130495098|NCT01436175|469782297|FG000|Overall Study|Withdrawal by Subject|108|||
130495099|NCT01436175|469782297|FG000|Overall Study|Lost to Follow-up|89|||
130495100|NCT01436175|469782297|FG000|Overall Study|Lack of Efficacy|24|||
130495101|NCT01436175|469782297|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
130495102|NCT01436175|469782297|FG000|Overall Study|Other|826|||
130495103|NCT03418922|469782299|FG000|Overall Study|Withdrawal by Subject|0|||
130495104|NCT03418922|469782300|FG001|Overall Study|Withdrawal by Subject|2|||
130495105|NCT03418922|469782299|FG000|Overall Study|Adverse Event|2|||
130495106|NCT03418922|469782300|FG001|Overall Study|Adverse Event|2|||
130495107|NCT03418922|469782299|FG000|Overall Study|Death|0|||
130495108|NCT03418922|469782300|FG001|Overall Study|Death|1|||
130495109|NCT03418922|469782299|FG000|Overall Study|Physician Decision|0|||
130495110|NCT03418922|469782300|FG001|Overall Study|Physician Decision|1|||
130495111|NCT03577106|469782301|FG000|Overall Study|Withdrawal by Subject|3|||
130495112|NCT04860505|469782302|FG000|Overall Study|Lost to Follow-up|2|||
130495113|NCT03066609|469782305|FG000|INDUCTION|Pregnancy|0|||
130495114|NCT03066609|469782306|FG001|INDUCTION|Pregnancy|0|||
130495115|NCT03066609|469782307|FG002|INDUCTION|Pregnancy|1|||
130495116|NCT03066609|469782308|FG003|INDUCTION|Pregnancy|0|||
130495117|NCT03066609|469782305|FG000|INDUCTION|Lack of Efficacy|0|||
130495118|NCT03066609|469782306|FG001|INDUCTION|Lack of Efficacy|0|||
130495119|NCT03066609|469782307|FG002|INDUCTION|Lack of Efficacy|1|||
130495120|NCT03066609|469782308|FG003|INDUCTION|Lack of Efficacy|0|||
130495121|NCT03066609|469782305|FG000|INDUCTION|Adverse Event|2|||
130495122|NCT03066609|469782306|FG001|INDUCTION|Adverse Event|2|||
130495123|NCT03066609|469782307|FG002|INDUCTION|Adverse Event|0|||
130495124|NCT03066609|469782308|FG003|INDUCTION|Adverse Event|0|||
130495125|NCT03066609|469782305|FG000|MAINTENANCE|Adverse Event|0|||
130495126|NCT03066609|469782306|FG001|MAINTENANCE|Adverse Event|0|||
130495127|NCT03066609|469782307|FG002|MAINTENANCE|Adverse Event|0|||
130495128|NCT03066609|469782308|FG003|MAINTENANCE|Adverse Event|1|||
130495129|NCT03066609|469782305|FG000|MAINTENANCE|Withdrawal by Subject|4|||
130495130|NCT03066609|469782306|FG001|MAINTENANCE|Withdrawal by Subject|2|||
130495131|NCT03066609|469782307|FG002|MAINTENANCE|Withdrawal by Subject|1|||
130495132|NCT03066609|469782308|FG003|MAINTENANCE|Withdrawal by Subject|1|||
130495133|NCT03066609|469782305|FG000|MAINTENANCE|Lost to Follow-up|0|||
130495134|NCT03066609|469782306|FG001|MAINTENANCE|Lost to Follow-up|1|||
130495135|NCT03066609|469782307|FG002|MAINTENANCE|Lost to Follow-up|1|||
130495136|NCT03066609|469782308|FG003|MAINTENANCE|Lost to Follow-up|0|||
130495137|NCT03066609|469782305|FG000|MAINTENANCE|Pregnancy|1|||
130495138|NCT03066609|469782306|FG001|MAINTENANCE|Pregnancy|0|||
130495139|NCT03066609|469782307|FG002|MAINTENANCE|Pregnancy|0|||
130495140|NCT03066609|469782308|FG003|MAINTENANCE|Pregnancy|0|||
130495141|NCT03066609|469782305|FG000|MAINTENANCE|Lack of Efficacy|2|||
130495142|NCT03066609|469782306|FG001|MAINTENANCE|Lack of Efficacy|1|||
130495143|NCT03066609|469782307|FG002|MAINTENANCE|Lack of Efficacy|0|||
130495144|NCT03066609|469782308|FG003|MAINTENANCE|Lack of Efficacy|1|||
130495145|NCT03066609|469782305|FG000|OVERALL STUDY|Adverse Event|2|||
130495146|NCT03066609|469782306|FG001|OVERALL STUDY|Adverse Event|2|||
130495147|NCT03066609|469782307|FG002|OVERALL STUDY|Adverse Event|0|||
130495148|NCT03066609|469782308|FG003|OVERALL STUDY|Adverse Event|1|||
130495149|NCT03066609|469782305|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
130495150|NCT03066609|469782306|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
130495151|NCT03066609|469782307|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
130495152|NCT03066609|469782308|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
130495153|NCT03066609|469782305|FG000|OVERALL STUDY|Lost to Follow-up|1|||
130495154|NCT03066609|469782306|FG001|OVERALL STUDY|Lost to Follow-up|1|||
130495155|NCT03066609|469782307|FG002|OVERALL STUDY|Lost to Follow-up|1|||
130495156|NCT03066609|469782308|FG003|OVERALL STUDY|Lost to Follow-up|1|||
130495157|NCT03066609|469782305|FG000|OVERALL STUDY|Pregnancy|1|||
130495158|NCT03066609|469782306|FG001|OVERALL STUDY|Pregnancy|0|||
130495159|NCT03066609|469782307|FG002|OVERALL STUDY|Pregnancy|1|||
130495160|NCT03066609|469782308|FG003|OVERALL STUDY|Pregnancy|0|||
130495161|NCT03066609|469782305|FG000|OVERALL STUDY|Lack of Efficacy|2|||
130495162|NCT03066609|469782306|FG001|OVERALL STUDY|Lack of Efficacy|1|||
130495163|NCT03066609|469782307|FG002|OVERALL STUDY|Lack of Efficacy|1|||
130495164|NCT03066609|469782308|FG003|OVERALL STUDY|Lack of Efficacy|1|||
130495165|NCT03066609|469782305|FG000|OVERALL STUDY|discontinued follow up|0|||
130495166|NCT03066609|469782306|FG001|OVERALL STUDY|discontinued follow up|2|||
130495167|NCT03066609|469782307|FG002|OVERALL STUDY|discontinued follow up|0|||
130495168|NCT03066609|469782308|FG003|OVERALL STUDY|discontinued follow up|0|||
130495169|NCT00293397|469782312|FG000|Overall Study|Death|2|||
130495170|NCT00523419|469782314|FG000|Overall Study|Adverse Event|1|||
130495171|NCT00523419|469782314|FG000|Overall Study|Withdrawal by Subject|1|||
130495172|NCT00523419|469782314|FG000|Overall Study|Physician Decision|2|||
130495173|NCT00523419|469782314|FG000|Overall Study|Progressive Disease|22|||
130495174|NCT00523419|469782314|FG000|Overall Study|Death due to Study Disease|4|||
130495175|NCT00523419|469782314|FG000|Overall Study|Death due to Adverse Event|2|||
130495176|NCT00822120|469782315|FG000|Initial Registration|Adverse Event|1|||
130495177|NCT00822120|469782316|FG001|Initial Registration|Adverse Event|0|||
130495178|NCT00822120|469782317|FG002|Initial Registration|Adverse Event|0|||
130495179|NCT00822120|469782318|FG003|Initial Registration|Adverse Event|0|||
130495180|NCT00822120|469782319|FG004|Initial Registration|Adverse Event|0|||
130495181|NCT00822120|469782320|FG005|Initial Registration|Adverse Event|0|||
130495182|NCT00822120|469782315|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
130495183|NCT00822120|469782316|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130495184|NCT00822120|469782317|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130495185|NCT00822120|469782318|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130495186|NCT00822120|469782319|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130495187|NCT00822120|469782320|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130495188|NCT00822120|469782315|FG000|Initial Registration|Reasons not Protocol Specified|2|||
130495189|NCT00822120|469782316|FG001|Initial Registration|Reasons not Protocol Specified|0|||
130495190|NCT00822120|469782317|FG002|Initial Registration|Reasons not Protocol Specified|0|||
130495191|NCT00822120|469782318|FG003|Initial Registration|Reasons not Protocol Specified|0|||
130495192|NCT00822120|469782319|FG004|Initial Registration|Reasons not Protocol Specified|0|||
130495193|NCT00822120|469782320|FG005|Initial Registration|Reasons not Protocol Specified|0|||
130495194|NCT00822120|469782315|FG000|Initial Registration|Ineligible|22|||
130495195|NCT00822120|469782316|FG001|Initial Registration|Ineligible|1|||
130495196|NCT00822120|469782317|FG002|Initial Registration|Ineligible|0|||
130495197|NCT00822120|469782318|FG003|Initial Registration|Ineligible|0|||
130495198|NCT00822120|469782319|FG004|Initial Registration|Ineligible|0|||
130495199|NCT00822120|469782320|FG005|Initial Registration|Ineligible|0|||
130495200|NCT00822120|469782315|FG000|PET-directed Therapy|Adverse Event|0|||
130495201|NCT00822120|469782316|FG001|PET-directed Therapy|Adverse Event|0|||
130495202|NCT00822120|469782317|FG002|PET-directed Therapy|Adverse Event|0|||
130495203|NCT00822120|469782318|FG003|PET-directed Therapy|Adverse Event|1|||
130495204|NCT00822120|469782319|FG004|PET-directed Therapy|Adverse Event|0|||
130495205|NCT00822120|469782320|FG005|PET-directed Therapy|Adverse Event|0|||
130495206|NCT00822120|469782315|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
130495207|NCT00822120|469782316|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
130495208|NCT00822120|469782317|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
130495209|NCT00822120|469782318|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
130495210|NCT00822120|469782319|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
130495211|NCT00822120|469782320|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
130495212|NCT00822120|469782315|FG000|PET-directed Therapy|Death|0|||
130495213|NCT00822120|469782316|FG001|PET-directed Therapy|Death|0|||
130495214|NCT00822120|469782317|FG002|PET-directed Therapy|Death|0|||
130495215|NCT00822120|469782318|FG003|PET-directed Therapy|Death|2|||
130495216|NCT00822120|469782319|FG004|PET-directed Therapy|Death|0|||
130495217|NCT00822120|469782320|FG005|PET-directed Therapy|Death|0|||
130495218|NCT00822120|469782315|FG000|PET-directed Therapy|Protocol Violation|0|||
130495219|NCT00822120|469782316|FG001|PET-directed Therapy|Protocol Violation|0|||
130495220|NCT00822120|469782317|FG002|PET-directed Therapy|Protocol Violation|0|||
130495221|NCT00822120|469782318|FG003|PET-directed Therapy|Protocol Violation|6|||
130495222|NCT00822120|469782319|FG004|PET-directed Therapy|Protocol Violation|0|||
130495223|NCT00822120|469782320|FG005|PET-directed Therapy|Protocol Violation|0|||
130495224|NCT01218009|469782321|FG000|Overall Study|Protocol Violation|2|||
130495225|NCT01218009|469782322|FG001|Overall Study|Protocol Violation|1|||
130495226|NCT01218009|469782321|FG000|Overall Study|Withdrawal by Subject|3|||
130495227|NCT01218009|469782322|FG001|Overall Study|Withdrawal by Subject|1|||
130495228|NCT01218009|469782321|FG000|Overall Study|Sponsor terminated study|161|||
130495229|NCT01218009|469782322|FG001|Overall Study|Sponsor terminated study|163|||
130495230|NCT00503906|469782323|FG000|Overall Study|Withdrawal by Subject|1|||
130495231|NCT00811941|469782324|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
130495232|NCT00811941|469782325|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
130495233|NCT00811941|469782324|FG000|All Treated Patients|Adverse Event|2|||
130495234|NCT00811941|469782325|FG001|All Treated Patients|Adverse Event|43|||
130495235|NCT00811941|469782324|FG000|All Treated Patients|Lack of Efficacy|2|||
130495236|NCT00811941|469782325|FG001|All Treated Patients|Lack of Efficacy|3|||
130495237|NCT00811941|469782324|FG000|All Treated Patients|Non-compliance|1|||
130495238|NCT00811941|469782325|FG001|All Treated Patients|Non-compliance|8|||
130495239|NCT00811941|469782324|FG000|All Treated Patients|Protocol Violation|5|||
130495240|NCT00811941|469782325|FG001|All Treated Patients|Protocol Violation|17|||
130495241|NCT00811941|469782324|FG000|All Treated Patients|Withdrawal by Subject|35|||
130495242|NCT00811941|469782325|FG001|All Treated Patients|Withdrawal by Subject|94|||
130495243|NCT00811941|469782324|FG000|All Treated Patients|Lost to Follow-up|3|||
130495244|NCT00811941|469782325|FG001|All Treated Patients|Lost to Follow-up|12|||
130495245|NCT00811941|469782324|FG000|All Treated Patients|Other Reason|4|||
130495246|NCT00811941|469782325|FG001|All Treated Patients|Other Reason|14|||
130495247|NCT03802994|469782326|FG000|Overall Study|Lost to Follow-up|0|||
130495248|NCT03802994|469782327|FG001|Overall Study|Lost to Follow-up|2|||
130495249|NCT03802994|469782328|FG002|Overall Study|Lost to Follow-up|3|||
130495250|NCT03802994|469782329|FG003|Overall Study|Lost to Follow-up|2|||
130495251|NCT03802994|469782330|FG004|Overall Study|Lost to Follow-up|2|||
130495252|NCT00622700|469782334|FG000|Core Treatment Period|Randomized but Not Treated|0|||
130495253|NCT00622700|469782335|FG001|Core Treatment Period|Randomized but Not Treated|2|||
130495254|NCT00622700|469782336|FG002|Core Treatment Period|Randomized but Not Treated|2|||
130495255|NCT00622700|469782337|FG003|Core Treatment Period|Randomized but Not Treated|0|||
130495256|NCT00622700|469782338|FG004|Core Treatment Period|Randomized but Not Treated|0|||
130495257|NCT00622700|469782339|FG005|Core Treatment Period|Randomized but Not Treated|0|||
130495258|NCT00622700|469782340|FG006|Core Treatment Period|Randomized but Not Treated|0|||
130495259|NCT00622700|469782334|FG000|Core Treatment Period|Adverse Event|18|||
130729214|NCT04342819|470630597|FG000|Overall Study|Not meeeting selection criteria|1|||
130729215|NCT01569295|470630598|FG000|Overall Study|Progressive Disease|75|||
130495260|NCT00622700|469782335|FG001|Core Treatment Period|Adverse Event|25|||
130495261|NCT00622700|469782336|FG002|Core Treatment Period|Adverse Event|18|||
130495262|NCT00622700|469782337|FG003|Core Treatment Period|Adverse Event|0|||
130495263|NCT00622700|469782338|FG004|Core Treatment Period|Adverse Event|0|||
130495264|NCT00622700|469782339|FG005|Core Treatment Period|Adverse Event|0|||
130495265|NCT00622700|469782340|FG006|Core Treatment Period|Adverse Event|0|||
130495266|NCT00622700|469782334|FG000|Core Treatment Period|Lack of Efficacy|19|||
130495267|NCT00622700|469782335|FG001|Core Treatment Period|Lack of Efficacy|6|||
130495268|NCT00622700|469782336|FG002|Core Treatment Period|Lack of Efficacy|12|||
130495269|NCT00622700|469782337|FG003|Core Treatment Period|Lack of Efficacy|0|||
130495270|NCT00622700|469782338|FG004|Core Treatment Period|Lack of Efficacy|0|||
130495271|NCT00622700|469782339|FG005|Core Treatment Period|Lack of Efficacy|0|||
130495272|NCT00622700|469782340|FG006|Core Treatment Period|Lack of Efficacy|0|||
130495273|NCT00622700|469782334|FG000|Core Treatment Period|Lost to Follow-up|1|||
130495274|NCT00622700|469782335|FG001|Core Treatment Period|Lost to Follow-up|1|||
130495275|NCT00622700|469782336|FG002|Core Treatment Period|Lost to Follow-up|1|||
130495276|NCT00622700|469782337|FG003|Core Treatment Period|Lost to Follow-up|0|||
130495277|NCT00622700|469782338|FG004|Core Treatment Period|Lost to Follow-up|0|||
130495278|NCT00622700|469782339|FG005|Core Treatment Period|Lost to Follow-up|0|||
130495279|NCT00622700|469782340|FG006|Core Treatment Period|Lost to Follow-up|0|||
130495280|NCT00622700|469782334|FG000|Core Treatment Period|Death|1|||
130495281|NCT00622700|469782335|FG001|Core Treatment Period|Death|0|||
130495282|NCT00622700|469782336|FG002|Core Treatment Period|Death|0|||
130495283|NCT00622700|469782337|FG003|Core Treatment Period|Death|0|||
130495284|NCT00622700|469782338|FG004|Core Treatment Period|Death|0|||
130495285|NCT00622700|469782339|FG005|Core Treatment Period|Death|0|||
130495286|NCT00622700|469782340|FG006|Core Treatment Period|Death|0|||
130495287|NCT00622700|469782334|FG000|Core Treatment Period|Progressive Disease|3|||
130495288|NCT00622700|469782335|FG001|Core Treatment Period|Progressive Disease|1|||
130495289|NCT00622700|469782336|FG002|Core Treatment Period|Progressive Disease|0|||
130495290|NCT00622700|469782337|FG003|Core Treatment Period|Progressive Disease|0|||
130495291|NCT00622700|469782338|FG004|Core Treatment Period|Progressive Disease|0|||
130495292|NCT00622700|469782339|FG005|Core Treatment Period|Progressive Disease|0|||
130495293|NCT00622700|469782340|FG006|Core Treatment Period|Progressive Disease|0|||
130495294|NCT00622700|469782334|FG000|Core Treatment Period|Withdrawal by Subject|12|||
130495295|NCT00622700|469782335|FG001|Core Treatment Period|Withdrawal by Subject|18|||
130495296|NCT00622700|469782336|FG002|Core Treatment Period|Withdrawal by Subject|15|||
130495297|NCT00622700|469782337|FG003|Core Treatment Period|Withdrawal by Subject|0|||
130495298|NCT00622700|469782338|FG004|Core Treatment Period|Withdrawal by Subject|0|||
130495299|NCT00622700|469782339|FG005|Core Treatment Period|Withdrawal by Subject|0|||
130495300|NCT00622700|469782340|FG006|Core Treatment Period|Withdrawal by Subject|0|||
130495301|NCT00622700|469782334|FG000|Core Treatment Period|Other than specified above|2|||
130495302|NCT00622700|469782335|FG001|Core Treatment Period|Other than specified above|2|||
130495303|NCT00622700|469782336|FG002|Core Treatment Period|Other than specified above|5|||
130495304|NCT00622700|469782337|FG003|Core Treatment Period|Other than specified above|0|||
130495305|NCT00622700|469782338|FG004|Core Treatment Period|Other than specified above|0|||
130495306|NCT00622700|469782339|FG005|Core Treatment Period|Other than specified above|0|||
130729216|NCT01569295|470630599|FG001|Overall Study|Progressive Disease|139|||
130729217|NCT01569295|470630598|FG000|Overall Study|Adverse Event|39|||
130729218|NCT01569295|470630599|FG001|Overall Study|Adverse Event|14|||
130729219|NCT01569295|470630598|FG000|Overall Study|Withdrawal by Subject|25|||
130729220|NCT01569295|470630599|FG001|Overall Study|Withdrawal by Subject|12|||
130729221|NCT01569295|470630598|FG000|Overall Study|Death|19|||
130729222|NCT01569295|470630599|FG001|Overall Study|Death|15|||
130729223|NCT01569295|470630598|FG000|Overall Study|Physician Decision|13|||
130729224|NCT01569295|470630599|FG001|Overall Study|Physician Decision|18|||
130729225|NCT01569295|470630598|FG000|Overall Study|Study Terminated by Sponsor|24|||
130495307|NCT00622700|469782340|FG006|Core Treatment Period|Other than specified above|0|||
130495308|NCT00622700|469782334|FG000|Extension Treatment Period|Adverse Event|0|||
130495309|NCT00622700|469782335|FG001|Extension Treatment Period|Adverse Event|0|||
130495310|NCT00622700|469782336|FG002|Extension Treatment Period|Adverse Event|0|||
130495311|NCT00622700|469782337|FG003|Extension Treatment Period|Adverse Event|5|||
130495312|NCT00622700|469782338|FG004|Extension Treatment Period|Adverse Event|9|||
130495313|NCT00622700|469782339|FG005|Extension Treatment Period|Adverse Event|6|||
130495314|NCT00622700|469782340|FG006|Extension Treatment Period|Adverse Event|8|||
130495315|NCT00622700|469782334|FG000|Extension Treatment Period|Lack of Efficacy|0|||
130729226|NCT01569295|470630599|FG001|Overall Study|Study Terminated by Sponsor|2|||
130495316|NCT00622700|469782335|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130495317|NCT00622700|469782336|FG002|Extension Treatment Period|Lack of Efficacy|0|||
130495318|NCT00622700|469782337|FG003|Extension Treatment Period|Lack of Efficacy|2|||
130495319|NCT00622700|469782338|FG004|Extension Treatment Period|Lack of Efficacy|8|||
130495320|NCT00622700|469782339|FG005|Extension Treatment Period|Lack of Efficacy|1|||
130495321|NCT00622700|469782340|FG006|Extension Treatment Period|Lack of Efficacy|9|||
130495322|NCT00622700|469782334|FG000|Extension Treatment Period|Protocol Violation|0|||
130495323|NCT00622700|469782335|FG001|Extension Treatment Period|Protocol Violation|0|||
130495324|NCT00622700|469782336|FG002|Extension Treatment Period|Protocol Violation|0|||
130495325|NCT00622700|469782337|FG003|Extension Treatment Period|Protocol Violation|0|||
130495326|NCT00622700|469782338|FG004|Extension Treatment Period|Protocol Violation|0|||
130495327|NCT00622700|469782339|FG005|Extension Treatment Period|Protocol Violation|2|||
130495328|NCT00622700|469782340|FG006|Extension Treatment Period|Protocol Violation|0|||
130495329|NCT00622700|469782334|FG000|Extension Treatment Period|Lost to Follow-up|0|||
130495330|NCT00622700|469782335|FG001|Extension Treatment Period|Lost to Follow-up|0|||
130495331|NCT00622700|469782336|FG002|Extension Treatment Period|Lost to Follow-up|0|||
130495332|NCT00622700|469782337|FG003|Extension Treatment Period|Lost to Follow-up|0|||
130495333|NCT00622700|469782338|FG004|Extension Treatment Period|Lost to Follow-up|1|||
130495334|NCT00622700|469782339|FG005|Extension Treatment Period|Lost to Follow-up|0|||
130495335|NCT00622700|469782340|FG006|Extension Treatment Period|Lost to Follow-up|0|||
130495336|NCT00622700|469782334|FG000|Extension Treatment Period|Progressive Disease|0|||
130495337|NCT00622700|469782335|FG001|Extension Treatment Period|Progressive Disease|0|||
130495338|NCT00622700|469782336|FG002|Extension Treatment Period|Progressive Disease|0|||
130495339|NCT00622700|469782337|FG003|Extension Treatment Period|Progressive Disease|1|||
130495340|NCT00622700|469782338|FG004|Extension Treatment Period|Progressive Disease|2|||
130495341|NCT00622700|469782339|FG005|Extension Treatment Period|Progressive Disease|0|||
130495342|NCT00622700|469782340|FG006|Extension Treatment Period|Progressive Disease|2|||
130495343|NCT00622700|469782334|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
130495344|NCT00622700|469782335|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130495345|NCT00622700|469782336|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130495346|NCT00622700|469782337|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
130495347|NCT00622700|469782338|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
130495348|NCT00622700|469782339|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
130495349|NCT00622700|469782340|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
130495350|NCT00622700|469782334|FG000|Extension Treatment Period|Missing|0|||
130495351|NCT00622700|469782335|FG001|Extension Treatment Period|Missing|0|||
130495352|NCT00622700|469782336|FG002|Extension Treatment Period|Missing|0|||
130495353|NCT00622700|469782337|FG003|Extension Treatment Period|Missing|2|||
130495354|NCT00622700|469782338|FG004|Extension Treatment Period|Missing|3|||
130495355|NCT00622700|469782339|FG005|Extension Treatment Period|Missing|1|||
130495356|NCT00622700|469782340|FG006|Extension Treatment Period|Missing|0|||
130495357|NCT00622700|469782334|FG000|Extension Treatment Period|Other than specified above|0|||
130495358|NCT00622700|469782335|FG001|Extension Treatment Period|Other than specified above|0|||
130495359|NCT00622700|469782336|FG002|Extension Treatment Period|Other than specified above|0|||
130495360|NCT00622700|469782337|FG003|Extension Treatment Period|Other than specified above|0|||
130495361|NCT00622700|469782338|FG004|Extension Treatment Period|Other than specified above|0|||
130495362|NCT00622700|469782339|FG005|Extension Treatment Period|Other than specified above|1|||
130495363|NCT00622700|469782340|FG006|Extension Treatment Period|Other than specified above|1|||
130495364|NCT02646618|469782341|FG000|Overall Study|Lost to Follow-up|10|||
130495365|NCT02646618|469782342|FG001|Overall Study|Lost to Follow-up|14|||
130495366|NCT00390884|469782343|FG000|Overall Study|Withdrawal by Subject|2|||
130495367|NCT00390884|469782344|FG001|Overall Study|Withdrawal by Subject|2|||
130495368|NCT04035447|469782345|FG000|Treatment Period|Lost to Follow-up|6|||
130495369|NCT04035447|469782346|FG001|Treatment Period|Lost to Follow-up|5|||
130495370|NCT04035447|469782345|FG000|Treatment Period|Physician Decision|0|||
130495371|NCT04035447|469782346|FG001|Treatment Period|Physician Decision|2|||
130495372|NCT03304587|469782347|FG000|Overall Study|Headache after intervention|0|||
130495373|NCT03304587|469782348|FG001|Overall Study|Headache after intervention|1|||
130495374|NCT03304587|469782347|FG000|Overall Study|Withdrawal by Subject|1|||
130565619|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
130565620|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
130565621|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
130648309|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130495375|NCT03304587|469782348|FG001|Overall Study|Withdrawal by Subject|0|||
130495376|NCT01458366|469782349|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
130495377|NCT01458366|469782350|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
130495378|NCT01458366|469782351|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
130495379|NCT01458366|469782352|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
130565622|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
130565623|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
130729227|NCT01569295|470630598|FG000|Overall Study|Other Reason not Specified|3|||
130495380|NCT01458366|469782353|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
130495381|NCT01458366|469782349|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
130495382|NCT01458366|469782350|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
130495383|NCT01458366|469782351|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
130495384|NCT01458366|469782352|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
130495385|NCT01458366|469782353|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
130495386|NCT01753999|469782354|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
130495387|NCT01753999|469782355|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
130495388|NCT01753999|469782354|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
130495389|NCT01753999|469782355|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
130495390|NCT01753999|469782354|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
130495391|NCT01753999|469782355|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
130495392|NCT01753999|469782354|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
130495393|NCT01753999|469782355|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
130495394|NCT01753999|469782354|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
130495395|NCT01753999|469782355|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
130495396|NCT01753999|469782354|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
130495397|NCT01753999|469782355|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
130495398|NCT02130557|469782356|FG000|Overall Study|Withdrawal by Subject|12|||
130495399|NCT02130557|469782357|FG001|Overall Study|Withdrawal by Subject|12|||
130495400|NCT02130557|469782356|FG000|Overall Study|Investigator Request|0|||
130495401|NCT02130557|469782357|FG001|Overall Study|Investigator Request|2|||
130495402|NCT02130557|469782356|FG000|Overall Study|Deceased|14|||
130495403|NCT02130557|469782357|FG001|Overall Study|Deceased|14|||
130495404|NCT02130557|469782356|FG000|Overall Study|Lost to Follow-up|6|||
130495405|NCT02130557|469782357|FG001|Overall Study|Lost to Follow-up|7|||
130495406|NCT02130557|469782356|FG000|Overall Study|Other|2|||
130495407|NCT02130557|469782357|FG001|Overall Study|Other|1|||
130495408|NCT02130557|469782356|FG000|Overall Study|Missing|2|||
130495409|NCT02130557|469782357|FG001|Overall Study|Missing|1|||
130495410|NCT02408887|469782358|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
130495411|NCT02408887|469782359|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
130495412|NCT02408887|469782358|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
130495413|NCT02408887|469782359|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
130495414|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130495415|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130495416|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130495417|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130495418|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130495419|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130495420|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
130495421|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130495422|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
130495423|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
130495424|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
130495425|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
130495426|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
130495427|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
130495428|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
130495429|NCT03333109|469782361|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
130495430|NCT03333109|469782362|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
130495431|NCT03333109|469782363|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
130495432|NCT03333109|469782361|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
130495433|NCT03333109|469782362|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
130495434|NCT03333109|469782363|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
130495435|NCT03333109|469782361|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
130495436|NCT03333109|469782362|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
130495437|NCT03333109|469782363|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
130495438|NCT01855750|469782366|FG000|Overall Study|Death|78|||
130495439|NCT01855750|469782367|FG001|Overall Study|Death|78|||
130495440|NCT01855750|469782366|FG000|Overall Study|Lost to Follow-up|9|||
130495441|NCT01855750|469782367|FG001|Overall Study|Lost to Follow-up|23|||
130495442|NCT01855750|469782366|FG000|Overall Study|Withdrawal by Subject|35|||
130495443|NCT01855750|469782367|FG001|Overall Study|Withdrawal by Subject|28|||
130495444|NCT01855750|469782366|FG000|Overall Study|Sponsor ends the study|297|||
130495445|NCT01855750|469782367|FG001|Overall Study|Sponsor ends the study|290|||
130729228|NCT01569295|470630599|FG001|Overall Study|Other Reason not Specified|5|||
130729229|NCT01569295|470630598|FG000|Overall Study|Non-Compliance with Study Drug|6|||
130729230|NCT01569295|470630599|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130729231|NCT01569295|470630598|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
130729232|NCT01569295|470630599|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
130729233|NCT01569295|470630598|FG000|Overall Study|Lost to Follow-up|1|||
130729234|NCT01569295|470630599|FG001|Overall Study|Lost to Follow-up|1|||
130729235|NCT03607487|470630600|FG000|Overall Study|Withdrawal by Subject|2|||
130495446|NCT04300023|469782368|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
130495447|NCT04300023|469782369|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
130495448|NCT05525572|469782370|FG000|Overall Study|Lost to Follow-up|2|||
130495449|NCT03425682|469782371|FG000|Overall Study|Lost to Follow-up|2|||
130495450|NCT03425682|469782372|FG001|Overall Study|Lost to Follow-up|4|||
130495451|NCT03425682|469782371|FG000|Overall Study|Withdrawal by Subject|0|||
130495452|NCT03425682|469782372|FG001|Overall Study|Withdrawal by Subject|3|||
130495453|NCT03425682|469782371|FG000|Overall Study|Subject did not meet I/E|4|||
130495454|NCT03425682|469782372|FG001|Overall Study|Subject did not meet I/E|10|||
130495455|NCT03277989|469782375|FG000|Overall Study|Lost to Follow-up|6|||
130495456|NCT03277989|469782375|FG000|Overall Study|Adverse Event|6|||
130495457|NCT03277989|469782375|FG000|Overall Study|Withdrawal by Subject|3|||
130495458|NCT03277989|469782375|FG000|Overall Study|Didn't Receive Study Device|7|||
130495459|NCT03277989|469782375|FG000|Overall Study|Site Closure|26|||
130495460|NCT03277989|469782375|FG000|Overall Study|Sponsor Closure|107|||
130495461|NCT03227861|469782378|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
130495462|NCT03227861|469782378|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
130495463|NCT03227861|469782378|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
130495464|NCT03227861|469782378|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
130495465|NCT03227861|469782378|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
130495466|NCT03227861|469782378|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
130495467|NCT03227861|469782378|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
130495468|NCT03227861|469782378|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
130495469|NCT03227861|469782378|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
130495470|NCT03227861|469782378|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
130495471|NCT05349838|469782379|FG000|Overall Study|Virological Failure|1|||
130495472|NCT05349838|469782380|FG001|Overall Study|Virological Failure|2|||
130495473|NCT05349838|469782379|FG000|Overall Study|Withdrawal by Subject|2|||
130495474|NCT05349838|469782380|FG001|Overall Study|Withdrawal by Subject|3|||
130495475|NCT05349838|469782379|FG000|Overall Study|Adverse Event|3|||
130495476|NCT05349838|469782380|FG001|Overall Study|Adverse Event|1|||
130495477|NCT05349838|469782379|FG000|Overall Study|Lost to Follow-up|1|||
130495478|NCT05349838|469782380|FG001|Overall Study|Lost to Follow-up|2|||
130495479|NCT05349838|469782379|FG000|Overall Study|Other reasons|5|||
130495480|NCT05349838|469782380|FG001|Overall Study|Other reasons|1|||
130729236|NCT03607487|470630601|FG001|Overall Study|Withdrawal by Subject|0|||
130729237|NCT03607487|470630602|FG002|Overall Study|Withdrawal by Subject|0|||
130729238|NCT03607487|470630603|FG003|Overall Study|Withdrawal by Subject|1|||
130495481|NCT05071430|469782381|FG000|Overall Study|Adverse Event|1|||
130495482|NCT05071430|469782382|FG001|Overall Study|Adverse Event|2|||
130495483|NCT05071430|469782381|FG000|Overall Study|Lost to Follow-up|4|||
130495484|NCT05071430|469782382|FG001|Overall Study|Lost to Follow-up|4|||
130495485|NCT05071430|469782381|FG000|Overall Study|Protocol Violation|1|||
130495486|NCT05071430|469782382|FG001|Overall Study|Protocol Violation|0|||
130495487|NCT05071430|469782381|FG000|Overall Study|Withdrawal by Subject|3|||
130495488|NCT05071430|469782382|FG001|Overall Study|Withdrawal by Subject|2|||
130495489|NCT05071430|469782381|FG000|Overall Study|Other|1|||
130729239|NCT01884337|470630604|FG000|Treatment|Adverse Event|2|||
130729240|NCT01884337|470630605|FG001|Treatment|Adverse Event|2|||
130729241|NCT01884337|470630604|FG000|Treatment|Subj. request to discont. treatment|2|||
130729242|NCT01884337|470630605|FG001|Treatment|Subj. request to discont. treatment|0|||
130495490|NCT05071430|469782382|FG001|Overall Study|Other|1|||
130495491|NCT00490139|469782384|FG000|Overall Study|Lost to Follow-up|249|||
130495492|NCT00490139|469782385|FG001|Overall Study|Lost to Follow-up|216|||
130495493|NCT00490139|469782386|FG002|Overall Study|Lost to Follow-up|205|||
130495494|NCT00490139|469782387|FG003|Overall Study|Lost to Follow-up|229|||
130495495|NCT00490139|469782384|FG000|Overall Study|Withdrawal by Subject|333|||
130495496|NCT00490139|469782385|FG001|Overall Study|Withdrawal by Subject|322|||
130495497|NCT00490139|469782386|FG002|Overall Study|Withdrawal by Subject|396|||
130495498|NCT00490139|469782387|FG003|Overall Study|Withdrawal by Subject|295|||
130495499|NCT00490139|469782384|FG000|Overall Study|Patient did not sign ICF 12|169|||
130495500|NCT00490139|469782385|FG001|Overall Study|Patient did not sign ICF 12|176|||
130729243|NCT01884337|470630604|FG000|Follow-up Period|Lost to Follow-up|1|||
130729244|NCT01884337|470630605|FG001|Follow-up Period|Lost to Follow-up|1|||
130729245|NCT02455518|470630606|FG000|Overall Study|Protocol Violation|0|||
130729246|NCT02455518|470630607|FG001|Overall Study|Protocol Violation|1|||
130495501|NCT00490139|469782386|FG002|Overall Study|Patient did not sign ICF 12|139|||
130495502|NCT00490139|469782387|FG003|Overall Study|Patient did not sign ICF 12|167|||
130495503|NCT00490139|469782384|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
130495504|NCT00490139|469782385|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
130495505|NCT00490139|469782386|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
130495506|NCT00490139|469782387|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
130495507|NCT00490139|469782384|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
130495508|NCT00490139|469782385|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
130495509|NCT00490139|469782386|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
130495510|NCT00490139|469782387|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
130495511|NCT00490139|469782384|FG000|Overall Study|Other reasons as defined per protocol|98|||
130495512|NCT00490139|469782385|FG001|Overall Study|Other reasons as defined per protocol|84|||
130495513|NCT00490139|469782386|FG002|Overall Study|Other reasons as defined per protocol|82|||
130495514|NCT00490139|469782387|FG003|Overall Study|Other reasons as defined per protocol|105|||
130495515|NCT02798471|469782388|FG000|Overall Study|Adverse Event|7|||
130495516|NCT02798471|469782389|FG001|Overall Study|Adverse Event|2|||
130495517|NCT02798471|469782388|FG000|Overall Study|Physician Decision|3|||
130495518|NCT02798471|469782389|FG001|Overall Study|Physician Decision|7|||
130495519|NCT02798471|469782388|FG000|Overall Study|Death|2|||
130495520|NCT02798471|469782389|FG001|Overall Study|Death|3|||
130495521|NCT02798471|469782388|FG000|Overall Study|Lost to Follow-up|0|||
130495522|NCT02798471|469782389|FG001|Overall Study|Lost to Follow-up|1|||
130495523|NCT02798471|469782388|FG000|Overall Study|Other|5|||
130495524|NCT02798471|469782389|FG001|Overall Study|Other|3|||
130495525|NCT02798471|469782388|FG000|Overall Study|Subject withdrew consent|0|||
130495526|NCT02798471|469782389|FG001|Overall Study|Subject withdrew consent|6|||
130495527|NCT02798471|469782388|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
130729247|NCT02455518|470630608|FG002|Overall Study|Protocol Violation|1|||
130729248|NCT02455518|470630609|FG003|Overall Study|Protocol Violation|3|||
130729249|NCT01038297|470630612|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
130729250|NCT01038297|470630613|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130729251|NCT01038297|470630614|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130729252|NCT02508935|470630615|FG000|Overall Study|Withdrawal by Subject|1|||
130729253|NCT02508935|470630615|FG000|Overall Study|Withdrawal by Caregiver|8|||
130729254|NCT02508935|470630615|FG000|Overall Study|Pain Score <4|1|||
130729255|NCT02508935|470630615|FG000|Overall Study|Emesis|3|||
130729256|NCT02508935|470630615|FG000|Overall Study|Adverse Event|3|||
130729257|NCT02508935|470630615|FG000|Overall Study|Protocol Violation|1|||
130729258|NCT02508935|470630615|FG000|Overall Study|Physician Decision|1|||
130729259|NCT02508935|470630615|FG000|Overall Study|Trial terminated by sponsor|5|||
130729260|NCT01973595|470630617|FG000|Washout|Withdrawal by Subject|1|||
130729261|NCT01973595|470630618|FG001|Washout|Withdrawal by Subject|0|||
130729262|NCT01973595|470630619|FG002|Washout|Withdrawal by Subject|1|||
130729263|NCT01973595|470630620|FG003|Washout|Withdrawal by Subject|0|||
130729264|NCT01275430|470630625|FG000|Overall Study|Adverse Event|1|||
130729265|NCT01275430|470630625|FG000|Overall Study|No Contrast Injection|6|||
130729266|NCT01275430|470630625|FG000|Overall Study|Device Malfunction|1|||
130729267|NCT01275430|470630625|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
130729268|NCT00710866|470630626|FG000|Overall Study|Protocol Violation|5|||
130729269|NCT00710866|470630627|FG001|Overall Study|Protocol Violation|4|||
130729270|NCT00710866|470630626|FG000|Overall Study|Withdrawal by Subject|2|||
130729271|NCT00710866|470630627|FG001|Overall Study|Withdrawal by Subject|1|||
130729272|NCT00710866|470630626|FG000|Overall Study|Lost to Follow-up|1|||
130729273|NCT00710866|470630627|FG001|Overall Study|Lost to Follow-up|0|||
130495528|NCT02798471|469782389|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
130495529|NCT02798471|469782388|FG000|Overall Study|Randomized, but not treated|0|||
130495530|NCT02798471|469782389|FG001|Overall Study|Randomized, but not treated|2|||
130495531|NCT03752684|469783757|FG000|Overall Study|Lost to Follow-up|4|||
130495532|NCT01982682|469783760|FG000|Overall Study|Physician Decision|1|||
130495533|NCT02760654|469783761|FG000|Overall Study|Lost to Follow-up|3|||
130495534|NCT02760654|469783762|FG001|Overall Study|Lost to Follow-up|3|||
130495535|NCT02760654|469783761|FG000|Overall Study|Withdrawal by Subject|4|||
130495536|NCT02760654|469783762|FG001|Overall Study|Withdrawal by Subject|3|||
130495537|NCT00065182|469783767|FG000|Overall Study|Adverse Event|24|||
130495538|NCT00065182|469783768|FG001|Overall Study|Adverse Event|17|||
130495539|NCT00065182|469783767|FG000|Overall Study|Lost to Follow-up|0|||
130729274|NCT00710866|470630626|FG000|Overall Study|Failed to meet eligibility|1|||
130729275|NCT00710866|470630627|FG001|Overall Study|Failed to meet eligibility|1|||
130729276|NCT04036110|470630628|FG000|Overall Study|Lost to Follow-up|3|||
130729277|NCT04036110|470630629|FG001|Overall Study|Lost to Follow-up|2|||
130729278|NCT04036110|470630630|FG002|Overall Study|Lost to Follow-up|1|||
130729279|NCT04036110|470630628|FG000|Overall Study|Study Suspended|4|||
130729280|NCT04036110|470630629|FG001|Overall Study|Study Suspended|5|||
130729281|NCT04036110|470630630|FG002|Overall Study|Study Suspended|1|||
130495540|NCT00065182|469783768|FG001|Overall Study|Lost to Follow-up|4|||
130495541|NCT00065182|469783767|FG000|Overall Study|Protocol Violation|3|||
130495542|NCT00065182|469783768|FG001|Overall Study|Protocol Violation|4|||
130495543|NCT00065182|469783767|FG000|Overall Study|Serious adverse events (SAE)|1|||
130495544|NCT00065182|469783768|FG001|Overall Study|Serious adverse events (SAE)|0|||
130495545|NCT00065182|469783767|FG000|Overall Study|Sponsor Decision|11|||
130495546|NCT00065182|469783768|FG001|Overall Study|Sponsor Decision|7|||
130495547|NCT00065182|469783767|FG000|Overall Study|Withdrawal by Subject|8|||
130495548|NCT00065182|469783768|FG001|Overall Study|Withdrawal by Subject|3|||
130729282|NCT00396565|470630636|FG000|Overall Study|Physician Decision|3|||
130729283|NCT00396565|470630637|FG001|Overall Study|Physician Decision|1|||
130729284|NCT00396565|470630638|FG002|Overall Study|Physician Decision|2|||
130729285|NCT00396565|470630636|FG000|Overall Study|Adverse Event|5|||
130729286|NCT00396565|470630637|FG001|Overall Study|Adverse Event|13|||
130729287|NCT00396565|470630638|FG002|Overall Study|Adverse Event|3|||
130729288|NCT00396565|470630636|FG000|Overall Study|Withdrawal by Subject|8|||
130729289|NCT00396565|470630637|FG001|Overall Study|Withdrawal by Subject|13|||
130729290|NCT00396565|470630638|FG002|Overall Study|Withdrawal by Subject|1|||
130729291|NCT00396565|470630636|FG000|Overall Study|Lack of Efficacy|32|||
130729292|NCT00396565|470630637|FG001|Overall Study|Lack of Efficacy|64|||
130729293|NCT00396565|470630638|FG002|Overall Study|Lack of Efficacy|11|||
130729294|NCT04324021|470630640|FG000|Overall Study|Adverse Event|1|||
130729295|NCT04324021|470630641|FG001|Overall Study|Adverse Event|0|||
130729296|NCT04324021|470630642|FG002|Overall Study|Adverse Event|0|||
130729297|NCT04324021|470630640|FG000|Overall Study|Lack of Efficacy|0|||
130495549|NCT00065182|469783767|FG000|Overall Study|No clinical benefit|1|||
130495550|NCT00065182|469783768|FG001|Overall Study|No clinical benefit|0|||
130495551|NCT00065182|469783767|FG000|Overall Study|Death|0|||
130495552|NCT00065182|469783768|FG001|Overall Study|Death|1|||
130495553|NCT00065182|469783767|FG000|Overall Study|Decline in Status|0|||
130495554|NCT00065182|469783768|FG001|Overall Study|Decline in Status|1|||
130495555|NCT00754325|469783769|FG000|Initial Treatment|Continuing Active Treatment|4|||
130495556|NCT00754325|469783770|FG001|Initial Treatment|Continuing Active Treatment|5|||
130495557|NCT00754325|469783769|FG000|Initial Treatment|Adverse Event|7|||
130495558|NCT00754325|469783770|FG001|Initial Treatment|Adverse Event|6|||
130495559|NCT00754325|469783769|FG000|Initial Treatment|Withdrawal by Subject|2|||
130495560|NCT00754325|469783770|FG001|Initial Treatment|Withdrawal by Subject|2|||
130495561|NCT00754325|469783769|FG000|Initial Treatment|Physician Decision|2|||
130495562|NCT00754325|469783770|FG001|Initial Treatment|Physician Decision|0|||
130495563|NCT00754325|469783769|FG000|Initial Treatment|Sponsor Request|0|||
130495564|NCT00754325|469783770|FG001|Initial Treatment|Sponsor Request|1|||
130495565|NCT00754325|469783769|FG000|Initial Treatment|Disease Progression|35|||
130495566|NCT00754325|469783770|FG001|Initial Treatment|Disease Progression|35|||
130495567|NCT03442777|469783773|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
130495568|NCT03442777|469783774|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
130495569|NCT03442777|469783775|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
130495570|NCT04876417|469783776|FG000|Overall Study|Lost to Follow-up|5|||
130495571|NCT04876417|469783777|FG001|Overall Study|Lost to Follow-up|8|||
130495572|NCT04876417|469783778|FG002|Overall Study|Lost to Follow-up|0|||
130495573|NCT04876417|469783779|FG003|Overall Study|Lost to Follow-up|0|||
130495574|NCT03801148|469783780|FG000|Period 1 (2 Days)|Adverse Event|1|||
130495575|NCT03801148|469783781|FG001|Period 1 (2 Days)|Adverse Event|1|||
130495576|NCT03801148|469783782|FG002|Period 1 (2 Days)|Adverse Event|0|||
130495577|NCT03801148|469783783|FG003|Period 1 (2 Days)|Adverse Event|0|||
130495578|NCT03801148|469783780|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130495579|NCT03801148|469783781|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130495580|NCT03801148|469783782|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130495581|NCT03801148|469783783|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
130495582|NCT03801148|469783780|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130495583|NCT03801148|469783781|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130495584|NCT03801148|469783782|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130495585|NCT03801148|469783783|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130495586|NCT03801148|469783780|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
130495587|NCT03801148|469783781|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
130495588|NCT03801148|469783782|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
130495589|NCT03801148|469783783|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
130495590|NCT00439270|469783784|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
130565624|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
130729298|NCT04324021|470630641|FG001|Overall Study|Lack of Efficacy|0|||
130495591|NCT00439270|469783785|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
130495592|NCT00439270|469783786|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
130495593|NCT00439270|469783787|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
130729299|NCT04324021|470630642|FG002|Overall Study|Lack of Efficacy|1|||
130729300|NCT04324021|470630640|FG000|Overall Study|Death|1|||
130729301|NCT04324021|470630641|FG001|Overall Study|Death|1|||
130729302|NCT04324021|470630642|FG002|Overall Study|Death|0|||
130729303|NCT03097991|470630643|FG000|Overall Study|Didn't meet study criteria|8|||
130729304|NCT03097991|470630644|FG001|Overall Study|Didn't meet study criteria|0|||
130495594|NCT00439270|469783788|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
130495595|NCT00439270|469783784|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
130495596|NCT00439270|469783785|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
130495597|NCT00439270|469783786|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
130495598|NCT00439270|469783787|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
130495599|NCT00439270|469783788|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
130495600|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
130495601|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
130729305|NCT03097991|470630643|FG000|Overall Study|Withdrawal by Subject|12|||
130729306|NCT03097991|470630644|FG001|Overall Study|Withdrawal by Subject|6|||
130729307|NCT03097991|470630643|FG000|Overall Study|Death of Baby|3|||
130729308|NCT03097991|470630644|FG001|Overall Study|Death of Baby|1|||
130729309|NCT03097991|470630643|FG000|Overall Study|Lost to Follow-up|24|||
130729310|NCT03097991|470630644|FG001|Overall Study|Lost to Follow-up|38|||
130729311|NCT03097991|470630643|FG000|Overall Study|Adverse Event|3|||
130729312|NCT03097991|470630644|FG001|Overall Study|Adverse Event|5|||
130729313|NCT00246324|470630645|FG000|Overall Study|Withdrawal by Subject|1|||
130729314|NCT02006732|470630646|FG000|Overall Study|Adverse Event|10|||
130729315|NCT02006732|470630647|FG001|Overall Study|Adverse Event|7|||
130495602|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
130495603|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
130495604|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
130495605|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
130495606|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
130495607|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
130495608|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
130495609|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
130729316|NCT02006732|470630648|FG002|Overall Study|Adverse Event|4|||
130729317|NCT02006732|470630649|FG003|Overall Study|Adverse Event|2|||
130729318|NCT02006732|470630646|FG000|Overall Study|Lack of Efficacy|6|||
130729319|NCT02006732|470630647|FG001|Overall Study|Lack of Efficacy|3|||
130729320|NCT02006732|470630648|FG002|Overall Study|Lack of Efficacy|1|||
130729321|NCT02006732|470630649|FG003|Overall Study|Lack of Efficacy|1|||
130729322|NCT02006732|470630646|FG000|Overall Study|Protocol Violation|1|||
130729323|NCT02006732|470630647|FG001|Overall Study|Protocol Violation|1|||
130729324|NCT02006732|470630648|FG002|Overall Study|Protocol Violation|0|||
130729325|NCT02006732|470630649|FG003|Overall Study|Protocol Violation|0|||
130729326|NCT02006732|470630646|FG000|Overall Study|Lost to Follow-up|0|||
130729327|NCT02006732|470630647|FG001|Overall Study|Lost to Follow-up|1|||
130729328|NCT02006732|470630648|FG002|Overall Study|Lost to Follow-up|0|||
130729329|NCT02006732|470630649|FG003|Overall Study|Lost to Follow-up|0|||
130729330|NCT02006732|470630646|FG000|Overall Study|Withdrawal by Subject|3|||
130729331|NCT02006732|470630647|FG001|Overall Study|Withdrawal by Subject|0|||
130729332|NCT02006732|470630648|FG002|Overall Study|Withdrawal by Subject|4|||
130729333|NCT02006732|470630649|FG003|Overall Study|Withdrawal by Subject|1|||
130729334|NCT03052127|470630650|FG000|Overall Study|Withdrawal by Subject|0|||
130729335|NCT03052127|470630651|FG001|Overall Study|Withdrawal by Subject|0|||
130729336|NCT03052127|470630652|FG002|Overall Study|Withdrawal by Subject|0|||
130729337|NCT03052127|470630653|FG003|Overall Study|Withdrawal by Subject|0|||
130729338|NCT03052127|470630654|FG004|Overall Study|Withdrawal by Subject|0|||
130729339|NCT03052127|470630655|FG005|Overall Study|Withdrawal by Subject|0|||
130729340|NCT03052127|470630656|FG006|Overall Study|Withdrawal by Subject|0|||
130729341|NCT03052127|470630657|FG007|Overall Study|Withdrawal by Subject|1|||
130495610|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
130495611|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
130495612|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
130495613|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
130495614|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
130495615|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
130495616|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
130729342|NCT03052127|470630658|FG008|Overall Study|Withdrawal by Subject|1|||
130729343|NCT03052127|470630659|FG009|Overall Study|Withdrawal by Subject|1|||
130729344|NCT03052127|470630660|FG010|Overall Study|Withdrawal by Subject|0|||
130729345|NCT03052127|470630661|FG011|Overall Study|Withdrawal by Subject|0|||
130729346|NCT03052127|470630650|FG000|Overall Study|Discontinuation by Sponsor|0|||
130729347|NCT03052127|470630651|FG001|Overall Study|Discontinuation by Sponsor|0|||
130729348|NCT03052127|470630652|FG002|Overall Study|Discontinuation by Sponsor|0|||
130729349|NCT03052127|470630653|FG003|Overall Study|Discontinuation by Sponsor|0|||
130729350|NCT03052127|470630654|FG004|Overall Study|Discontinuation by Sponsor|0|||
130729351|NCT03052127|470630655|FG005|Overall Study|Discontinuation by Sponsor|0|||
130495617|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
130729352|NCT03052127|470630656|FG006|Overall Study|Discontinuation by Sponsor|0|||
130729353|NCT03052127|470630657|FG007|Overall Study|Discontinuation by Sponsor|0|||
130495618|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
130495619|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
130495620|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130495621|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130495622|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130495623|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
130495624|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130495625|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
130495626|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
130495627|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
130495628|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
130495629|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
130495630|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
130495631|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
130495632|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
130495633|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
130495634|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
130495635|NCT00439270|469783784|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
130495636|NCT00439270|469783785|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
130495637|NCT00439270|469783786|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
130495638|NCT00439270|469783787|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
130495639|NCT00439270|469783788|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
130495640|NCT01750684|469783789|FG000|Overall Study|Death|1|||
130495641|NCT01750684|469783790|FG001|Overall Study|Death|0|||
130495642|NCT01750684|469783789|FG000|Overall Study|Non-compliance with Study Drug|0|||
130495643|NCT01750684|469783790|FG001|Overall Study|Non-compliance with Study Drug|1|||
130495644|NCT01750684|469783789|FG000|Overall Study|Withdrawn by Sponsor|0|||
130495645|NCT01750684|469783790|FG001|Overall Study|Withdrawn by Sponsor|1|||
130495646|NCT01750684|469783789|FG000|Overall Study|Protocol Violation|1|||
130495647|NCT01750684|469783790|FG001|Overall Study|Protocol Violation|0|||
130495648|NCT03478969|469783791|FG000|Overall Study|Withdrawal by Subject|4|||
130495649|NCT03478969|469783792|FG001|Overall Study|Withdrawal by Subject|7|||
130495650|NCT03478969|469783793|FG002|Overall Study|Withdrawal by Subject|6|||
130495651|NCT03478969|469783791|FG000|Overall Study|Adverse Event|2|||
130495652|NCT03478969|469783792|FG001|Overall Study|Adverse Event|0|||
130495653|NCT03478969|469783793|FG002|Overall Study|Adverse Event|1|||
130495654|NCT03478969|469783791|FG000|Overall Study|Pregnancy|1|||
130495655|NCT03478969|469783792|FG001|Overall Study|Pregnancy|0|||
130495656|NCT03478969|469783793|FG002|Overall Study|Pregnancy|0|||
130495657|NCT03478969|469783791|FG000|Overall Study|Personal Reasons|1|||
130495658|NCT03478969|469783792|FG001|Overall Study|Personal Reasons|0|||
130495659|NCT03478969|469783793|FG002|Overall Study|Personal Reasons|1|||
130495660|NCT03478969|469783791|FG000|Overall Study|Covid-19|1|||
130495661|NCT03478969|469783792|FG001|Overall Study|Covid-19|4|||
130495662|NCT03478969|469783793|FG002|Overall Study|Covid-19|3|||
130495663|NCT03478969|469783791|FG000|Overall Study|Multiple Reasons|0|||
130495664|NCT03478969|469783792|FG001|Overall Study|Multiple Reasons|1|||
130495665|NCT03478969|469783793|FG002|Overall Study|Multiple Reasons|1|||
130495666|NCT03478969|469783791|FG000|Overall Study|Eligibility Criteria|0|||
130495667|NCT03478969|469783792|FG001|Overall Study|Eligibility Criteria|0|||
130495668|NCT03478969|469783793|FG002|Overall Study|Eligibility Criteria|5|||
130495669|NCT03478969|469783791|FG000|Overall Study|Lost to Follow-up|0|||
130495670|NCT03478969|469783792|FG001|Overall Study|Lost to Follow-up|0|||
130495671|NCT03478969|469783793|FG002|Overall Study|Lost to Follow-up|1|||
130495672|NCT01185600|469783794|FG000|Overall Study|Adverse Event|1|||
130495673|NCT01185600|469783795|FG001|Overall Study|Adverse Event|1|||
130495674|NCT01185600|469783794|FG000|Overall Study|Death|0|||
130495675|NCT01185600|469783795|FG001|Overall Study|Death|1|||
130495676|NCT01185600|469783794|FG000|Overall Study|Lost to Follow-up|0|||
130495677|NCT01185600|469783795|FG001|Overall Study|Lost to Follow-up|5|||
130495678|NCT01185600|469783794|FG000|Overall Study|Physician Decision|29|||
130495679|NCT01185600|469783795|FG001|Overall Study|Physician Decision|35|||
130495680|NCT01185600|469783794|FG000|Overall Study|Withdrawal by Subject|1|||
130495681|NCT01185600|469783795|FG001|Overall Study|Withdrawal by Subject|1|||
130495682|NCT01185600|469783794|FG000|Overall Study|Hold by DSMB|1|||
130495683|NCT01185600|469783795|FG001|Overall Study|Hold by DSMB|2|||
130495684|NCT05405244|469783796|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
130495685|NCT05405244|469783797|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
130495686|NCT05405244|469783796|FG000|Washout (2 Weeks)|Adverse Event|2|||
130495687|NCT05405244|469783797|FG001|Washout (2 Weeks)|Adverse Event|0|||
130495688|NCT05405244|469783796|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
130495689|NCT05405244|469783797|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
130495690|NCT00918333|469783800|FG000|Overall Study|Drug not taken per protocol|1|||
130495691|NCT00918333|469783801|FG001|Overall Study|Drug not taken per protocol|0|||
130495692|NCT00918333|469783800|FG000|Overall Study|Inadequate amount of drugs provided|1|||
130495693|NCT00918333|469783801|FG001|Overall Study|Inadequate amount of drugs provided|4|||
130495694|NCT00918333|469783800|FG000|Overall Study|Ineligible|1|||
130495695|NCT00918333|469783801|FG001|Overall Study|Ineligible|0|||
130495696|NCT00918333|469783800|FG000|Overall Study|Withdrawal by Subject|0|||
130495697|NCT00918333|469783801|FG001|Overall Study|Withdrawal by Subject|1|||
130495698|NCT02964741|469783802|FG000|Overall Study|Protocol Violation|1|||
130495699|NCT02964741|469783803|FG001|Overall Study|Protocol Violation|0|||
130495700|NCT02964741|469783804|FG002|Overall Study|Protocol Violation|0|||
130495701|NCT02964741|469783802|FG000|Overall Study|Withdrawal by Subject|0|||
130495702|NCT02964741|469783803|FG001|Overall Study|Withdrawal by Subject|1|||
130495703|NCT02964741|469783804|FG002|Overall Study|Withdrawal by Subject|0|||
130495704|NCT02964741|469783802|FG000|Overall Study|claustrophobia|1|||
130495705|NCT02964741|469783803|FG001|Overall Study|claustrophobia|0|||
130495706|NCT02964741|469783804|FG002|Overall Study|claustrophobia|0|||
130495707|NCT00640159|469783805|FG000|Overall Study|Lost to Follow-up|2|||
130495708|NCT01500200|469783806|FG000|Stage 1|Adverse Event|1|||
130495709|NCT01500200|469783807|FG001|Stage 1|Adverse Event|4|||
130495710|NCT01500200|469783808|FG002|Stage 1|Adverse Event|5|||
130495711|NCT01500200|469783809|FG003|Stage 1|Adverse Event|0|||
130495712|NCT01500200|469783810|FG004|Stage 1|Adverse Event|0|||
130495713|NCT01500200|469783811|FG005|Stage 1|Adverse Event|0|||
130495714|NCT01500200|469783806|FG000|Stage 1|Lost to Follow-up|2|||
130495715|NCT01500200|469783807|FG001|Stage 1|Lost to Follow-up|2|||
130495716|NCT01500200|469783808|FG002|Stage 1|Lost to Follow-up|1|||
130495717|NCT01500200|469783809|FG003|Stage 1|Lost to Follow-up|0|||
130495718|NCT01500200|469783810|FG004|Stage 1|Lost to Follow-up|0|||
130495719|NCT01500200|469783811|FG005|Stage 1|Lost to Follow-up|0|||
130495720|NCT01500200|469783806|FG000|Stage 1|Withdrawal by Subject|3|||
130495721|NCT01500200|469783807|FG001|Stage 1|Withdrawal by Subject|0|||
130495722|NCT01500200|469783808|FG002|Stage 1|Withdrawal by Subject|0|||
130495723|NCT01500200|469783809|FG003|Stage 1|Withdrawal by Subject|0|||
130495724|NCT01500200|469783810|FG004|Stage 1|Withdrawal by Subject|0|||
130495725|NCT01500200|469783811|FG005|Stage 1|Withdrawal by Subject|0|||
130495726|NCT01500200|469783806|FG000|Stage 1|Noncompliance with Study Drug|1|||
130495727|NCT01500200|469783807|FG001|Stage 1|Noncompliance with Study Drug|0|||
130495728|NCT01500200|469783808|FG002|Stage 1|Noncompliance with Study Drug|0|||
130495729|NCT01500200|469783809|FG003|Stage 1|Noncompliance with Study Drug|0|||
130495730|NCT01500200|469783810|FG004|Stage 1|Noncompliance with Study Drug|0|||
130495731|NCT01500200|469783811|FG005|Stage 1|Noncompliance with Study Drug|0|||
130495732|NCT01500200|469783806|FG000|Stage 1|Physician Decision|1|||
130495733|NCT01500200|469783807|FG001|Stage 1|Physician Decision|0|||
130495734|NCT01500200|469783808|FG002|Stage 1|Physician Decision|0|||
130495735|NCT01500200|469783809|FG003|Stage 1|Physician Decision|0|||
130495736|NCT01500200|469783810|FG004|Stage 1|Physician Decision|0|||
130495737|NCT01500200|469783811|FG005|Stage 1|Physician Decision|0|||
130495738|NCT01500200|469783806|FG000|Stage 2|Adverse Event|0|||
130495739|NCT01500200|469783807|FG001|Stage 2|Adverse Event|0|||
130495740|NCT01500200|469783808|FG002|Stage 2|Adverse Event|0|||
130495741|NCT01500200|469783809|FG003|Stage 2|Adverse Event|0|||
130495742|NCT01500200|469783810|FG004|Stage 2|Adverse Event|5|||
130495743|NCT01500200|469783811|FG005|Stage 2|Adverse Event|4|||
130495744|NCT01212744|469783824|FG000|Overall Study|Withdrawal by Subject|1|||
130495745|NCT02167451|469783825|FG000|Overall Study|Withdrawal by Subject|1|||
130495746|NCT01218659|469783826|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
130495747|NCT01218659|469783827|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
130495748|NCT01218659|469783828|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
130495749|NCT01218659|469783826|FG000|18-Month Randomized Period|Did not receive study drug|0|||
130495750|NCT01218659|469783827|FG001|18-Month Randomized Period|Did not receive study drug|3|||
130495751|NCT01218659|469783828|FG002|18-Month Randomized Period|Did not receive study drug|0|||
130495752|NCT01218659|469783826|FG000|12-Month OLE|Withdrawal by Subject|0|||
130495753|NCT01218659|469783827|FG001|12-Month OLE|Withdrawal by Subject|0|||
130495754|NCT01218659|469783828|FG002|12-Month OLE|Withdrawal by Subject|2|||
130495755|NCT01218659|469783826|FG000|12-Month OLE|Physician Decision|0|||
130495756|NCT01218659|469783827|FG001|12-Month OLE|Physician Decision|0|||
130495757|NCT01218659|469783828|FG002|12-Month OLE|Physician Decision|1|||
130495758|NCT01218659|469783826|FG000|12-Month OLE|Lost to Follow-up|0|||
130495759|NCT01218659|469783827|FG001|12-Month OLE|Lost to Follow-up|0|||
130495760|NCT01218659|469783828|FG002|12-Month OLE|Lost to Follow-up|1|||
130495761|NCT01218659|469783826|FG000|12-Month OLE|Pregnancy|0|||
130495762|NCT01218659|469783827|FG001|12-Month OLE|Pregnancy|0|||
130495763|NCT01218659|469783828|FG002|12-Month OLE|Pregnancy|1|||
130495764|NCT01218659|469783826|FG000|12-Month OLE|Lack of Efficacy|0|||
130495765|NCT01218659|469783827|FG001|12-Month OLE|Lack of Efficacy|0|||
130495766|NCT01218659|469783828|FG002|12-Month OLE|Lack of Efficacy|1|||
130495767|NCT01218659|469783826|FG000|12-Month OLE|Declined to participate in the OLE|0|||
130495768|NCT01218659|469783827|FG001|12-Month OLE|Declined to participate in the OLE|0|||
130495769|NCT01218659|469783828|FG002|12-Month OLE|Declined to participate in the OLE|4|||
130495770|NCT04191824|469783835|FG000|Overall Study|Death|13|||
130495771|NCT04191824|469783836|FG001|Overall Study|Death|12|||
130495772|NCT04191824|469783835|FG000|Overall Study|Lost to Follow-up|456|||
130495773|NCT04191824|469783836|FG001|Overall Study|Lost to Follow-up|435|||
130495774|NCT04191824|469783835|FG000|Overall Study|Physician Decision|2|||
130495775|NCT04191824|469783836|FG001|Overall Study|Physician Decision|1|||
130495776|NCT04191824|469783835|FG000|Overall Study|Protocol Violation|0|||
130495777|NCT04191824|469783836|FG001|Overall Study|Protocol Violation|2|||
130495778|NCT04191824|469783835|FG000|Overall Study|Withdrawal by Subject|16|||
130495779|NCT04191824|469783836|FG001|Overall Study|Withdrawal by Subject|18|||
130495780|NCT04191824|469783835|FG000|Overall Study|Early site closure|24|||
130495781|NCT04191824|469783836|FG001|Overall Study|Early site closure|22|||
130495782|NCT01437319|469783842|FG000|Phase I|Lost to Follow-up|2|||
130495783|NCT01437319|469783843|FG001|Phase I|Lost to Follow-up|0|||
130495784|NCT01437319|469783844|FG002|Phase I|Lost to Follow-up|0|||
130495785|NCT01437319|469783842|FG000|Phase I|Protocol Violation|1|||
130495786|NCT01437319|469783843|FG001|Phase I|Protocol Violation|0|||
130495787|NCT01437319|469783844|FG002|Phase I|Protocol Violation|0|||
130495788|NCT01437319|469783842|FG000|Phase I|Study related symptoms/complaints|27|||
130495789|NCT01437319|469783843|FG001|Phase I|Study related symptoms/complaints|0|||
130495790|NCT01437319|469783844|FG002|Phase I|Study related symptoms/complaints|0|||
130495791|NCT01437319|469783842|FG000|Phase I|Withdrawal by Subject|25|||
130495792|NCT01437319|469783843|FG001|Phase I|Withdrawal by Subject|0|||
130495793|NCT01437319|469783844|FG002|Phase I|Withdrawal by Subject|0|||
130495794|NCT01437319|469783842|FG000|Phase II|Withdrawal by Subject|0|||
130495795|NCT01437319|469783843|FG001|Phase II|Withdrawal by Subject|8|||
130495796|NCT01437319|469783844|FG002|Phase II|Withdrawal by Subject|16|||
130495797|NCT01437319|469783842|FG000|Phase II|Lost to Follow-up|0|||
130495798|NCT01437319|469783843|FG001|Phase II|Lost to Follow-up|7|||
130495799|NCT01437319|469783844|FG002|Phase II|Lost to Follow-up|2|||
130495800|NCT01437319|469783842|FG000|Phase II|Study related symptoms/complaints|0|||
130495801|NCT01437319|469783843|FG001|Phase II|Study related symptoms/complaints|28|||
130495802|NCT01437319|469783844|FG002|Phase II|Study related symptoms/complaints|19|||
130495803|NCT01437319|469783842|FG000|Phase II|Protocol Violation|0|||
130495804|NCT01437319|469783843|FG001|Phase II|Protocol Violation|1|||
130495805|NCT01437319|469783844|FG002|Phase II|Protocol Violation|0|||
130495806|NCT01499849|469783845|FG000|Overall Study|Adverse Event|28|||
130495807|NCT01499849|469783846|FG001|Overall Study|Adverse Event|32|||
130495808|NCT01499849|469783845|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
130495809|NCT01499849|469783846|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
130495810|NCT01499849|469783845|FG000|Overall Study|Withdrawal by Subject|43|||
130495811|NCT01499849|469783846|FG001|Overall Study|Withdrawal by Subject|43|||
130495812|NCT01499849|469783845|FG000|Overall Study|Death|5|||
130495813|NCT01499849|469783846|FG001|Overall Study|Death|7|||
130495814|NCT01499849|469783845|FG000|Overall Study|Disease Progression|11|||
130495815|NCT01499849|469783846|FG001|Overall Study|Disease Progression|10|||
130495816|NCT01499849|469783845|FG000|Overall Study|Protocol Violation|11|||
130495817|NCT01499849|469783846|FG001|Overall Study|Protocol Violation|11|||
130495818|NCT01499849|469783845|FG000|Overall Study|Physician Decision|20|||
130495819|NCT01499849|469783846|FG001|Overall Study|Physician Decision|19|||
130495820|NCT01499849|469783845|FG000|Overall Study|Lack of Efficacy|3|||
130495821|NCT01499849|469783846|FG001|Overall Study|Lack of Efficacy|4|||
130495822|NCT01499849|469783845|FG000|Overall Study|Lost to Follow-up|6|||
130495823|NCT01499849|469783846|FG001|Overall Study|Lost to Follow-up|3|||
130495824|NCT01499849|469783845|FG000|Overall Study|Other Reasons|27|||
130495825|NCT01499849|469783846|FG001|Overall Study|Other Reasons|30|||
130495826|NCT00174252|469783847|FG000|Overall Study|Protocol Violation|2|||
130495827|NCT03611556|469783850|FG000|Overall Study|Death|7|||
130495828|NCT03611556|469783851|FG001|Overall Study|Death|7|||
130495829|NCT03611556|469783852|FG002|Overall Study|Death|3|||
130495830|NCT03611556|469783853|FG003|Overall Study|Death|8|||
130495831|NCT03611556|469783854|FG004|Overall Study|Death|47|||
130495832|NCT03611556|469783855|FG005|Overall Study|Death|32|||
130495833|NCT03611556|469783856|FG006|Overall Study|Death|53|||
130495834|NCT03611556|469783850|FG000|Overall Study|Withdrawal by Subject|0|||
130565625|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
130565626|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
130495835|NCT03611556|469783851|FG001|Overall Study|Withdrawal by Subject|0|||
130495836|NCT03611556|469783852|FG002|Overall Study|Withdrawal by Subject|0|||
130495837|NCT03611556|469783853|FG003|Overall Study|Withdrawal by Subject|0|||
130495838|NCT03611556|469783854|FG004|Overall Study|Withdrawal by Subject|4|||
130495839|NCT03611556|469783855|FG005|Overall Study|Withdrawal by Subject|2|||
130495840|NCT03611556|469783856|FG006|Overall Study|Withdrawal by Subject|4|||
130495841|NCT03611556|469783850|FG000|Overall Study|Sponsor decision|0|||
130495842|NCT03611556|469783851|FG001|Overall Study|Sponsor decision|0|||
130495843|NCT03611556|469783852|FG002|Overall Study|Sponsor decision|0|||
130495844|NCT03611556|469783853|FG003|Overall Study|Sponsor decision|0|||
130495845|NCT03611556|469783854|FG004|Overall Study|Sponsor decision|9|||
130495846|NCT03611556|469783855|FG005|Overall Study|Sponsor decision|4|||
130495847|NCT03611556|469783856|FG006|Overall Study|Sponsor decision|12|||
130495848|NCT03611556|469783850|FG000|Overall Study|Reasons|0|||
130495849|NCT03611556|469783851|FG001|Overall Study|Reasons|0|||
130495850|NCT03611556|469783852|FG002|Overall Study|Reasons|0|||
130495851|NCT03611556|469783853|FG003|Overall Study|Reasons|0|||
130495852|NCT03611556|469783854|FG004|Overall Study|Reasons|2|||
130495853|NCT03611556|469783855|FG005|Overall Study|Reasons|0|||
130495854|NCT03611556|469783856|FG006|Overall Study|Reasons|1|||
130495855|NCT02397096|469783858|FG000|Day 1 to Week 24|Adverse Event|7|||
130495856|NCT02397096|469783859|FG001|Day 1 to Week 24|Adverse Event|1|||
130495857|NCT02397096|469783858|FG000|Day 1 to Week 24|Death|1|||
130495858|NCT02397096|469783859|FG001|Day 1 to Week 24|Death|0|||
130495859|NCT02397096|469783858|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
130495860|NCT02397096|469783859|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
130495861|NCT02397096|469783858|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
130495862|NCT02397096|469783859|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
130495863|NCT02397096|469783858|FG000|Day 1 to Week 24|Physician Decision|2|||
130495864|NCT02397096|469783859|FG001|Day 1 to Week 24|Physician Decision|3|||
130495865|NCT02397096|469783858|FG000|Day 1 to Week 24|Protocol Violation|1|||
130495866|NCT02397096|469783859|FG001|Day 1 to Week 24|Protocol Violation|4|||
130495867|NCT02397096|469783858|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
130495868|NCT02397096|469783859|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
130495869|NCT02397096|469783858|FG000|Day 1 to Week 24|Randomized, not treated|3|||
130495870|NCT02397096|469783859|FG001|Day 1 to Week 24|Randomized, not treated|0|||
130495871|NCT02397096|469783858|FG000|Week 24 to Week 48|Adverse Event|6|||
130495872|NCT02397096|469783859|FG001|Week 24 to Week 48|Adverse Event|2|||
130495873|NCT02397096|469783858|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
130495874|NCT02397096|469783859|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
130495875|NCT02397096|469783858|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
130495876|NCT02397096|469783859|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
130495877|NCT02397096|469783858|FG000|Week 24 to Week 48|Physician Decision|2|||
130495878|NCT02397096|469783859|FG001|Week 24 to Week 48|Physician Decision|1|||
130495879|NCT02397096|469783858|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
130495880|NCT02397096|469783859|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
130495881|NCT02397096|469783858|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
130495882|NCT02397096|469783859|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
130495883|NCT02397096|469783858|FG000|Study Extension 1|Adverse Event|7|||
130495884|NCT02397096|469783859|FG001|Study Extension 1|Adverse Event|5|||
130495885|NCT02397096|469783858|FG000|Study Extension 1|Death|1|||
130495886|NCT02397096|469783859|FG001|Study Extension 1|Death|0|||
130495887|NCT02397096|469783858|FG000|Study Extension 1|Lack of Efficacy|2|||
130495888|NCT02397096|469783859|FG001|Study Extension 1|Lack of Efficacy|5|||
130495889|NCT02397096|469783858|FG000|Study Extension 1|Lost to Follow-up|2|||
130495890|NCT02397096|469783859|FG001|Study Extension 1|Lost to Follow-up|3|||
130495891|NCT02397096|469783858|FG000|Study Extension 1|Non-compliance with study drug|3|||
130495892|NCT02397096|469783859|FG001|Study Extension 1|Non-compliance with study drug|0|||
130495893|NCT02397096|469783858|FG000|Study Extension 1|Physician Decision|4|||
130495894|NCT02397096|469783859|FG001|Study Extension 1|Physician Decision|2|||
130495895|NCT02397096|469783858|FG000|Study Extension 1|Pregnancy|1|||
130495896|NCT02397096|469783859|FG001|Study Extension 1|Pregnancy|0|||
130495897|NCT02397096|469783858|FG000|Study Extension 1|Protocol Violation|0|||
130495898|NCT02397096|469783859|FG001|Study Extension 1|Protocol Violation|1|||
130495899|NCT02397096|469783858|FG000|Study Extension 1|Withdrawal by Subject|21|||
130495900|NCT02397096|469783859|FG001|Study Extension 1|Withdrawal by Subject|7|||
130495901|NCT02397096|469783858|FG000|Study Extension 2|Adverse Event|3|||
130495902|NCT02397096|469783859|FG001|Study Extension 2|Adverse Event|3|||
130495903|NCT02397096|469783858|FG000|Study Extension 2|Availability of study medication locally|152|||
130495904|NCT02397096|469783859|FG001|Study Extension 2|Availability of study medication locally|64|||
130495905|NCT02397096|469783858|FG000|Study Extension 2|Death|2|||
130495906|NCT02397096|469783859|FG001|Study Extension 2|Death|0|||
130495907|NCT02397096|469783858|FG000|Study Extension 2|Lack of Efficacy|1|||
130495908|NCT02397096|469783859|FG001|Study Extension 2|Lack of Efficacy|0|||
130495909|NCT02397096|469783858|FG000|Study Extension 2|Lost to Follow-up|2|||
130495910|NCT02397096|469783859|FG001|Study Extension 2|Lost to Follow-up|1|||
130495911|NCT02397096|469783858|FG000|Study Extension 2|Non-compliance with study drug|1|||
130495912|NCT02397096|469783859|FG001|Study Extension 2|Non-compliance with study drug|0|||
130495913|NCT02397096|469783858|FG000|Study Extension 2|Physician Decision|2|||
130495914|NCT02397096|469783859|FG001|Study Extension 2|Physician Decision|5|||
130495915|NCT02397096|469783858|FG000|Study Extension 2|Pregnancy|1|||
130495916|NCT02397096|469783859|FG001|Study Extension 2|Pregnancy|0|||
130495917|NCT02397096|469783858|FG000|Study Extension 2|Withdrawal by Subject|10|||
130495918|NCT02397096|469783859|FG001|Study Extension 2|Withdrawal by Subject|3|||
130495919|NCT02397096|469783858|FG000|Study Extension 3|Adverse Event|1|||
130495920|NCT02397096|469783859|FG001|Study Extension 3|Adverse Event|0|||
130495921|NCT02397096|469783858|FG000|Study Extension 3|Availability of study medication locally|11|||
130495922|NCT02397096|469783859|FG001|Study Extension 3|Availability of study medication locally|3|||
130495923|NCT02397096|469783858|FG000|Study Extension 3|Lost to Follow-up|1|||
130495924|NCT02397096|469783859|FG001|Study Extension 3|Lost to Follow-up|0|||
130495925|NCT02397096|469783858|FG000|Study Extension 3|Withdrawal by Subject|2|||
130495926|NCT02397096|469783859|FG001|Study Extension 3|Withdrawal by Subject|1|||
130495927|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
130495928|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
130495929|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
130495930|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
130495931|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
130495932|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
130495933|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
130495934|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
130495935|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
130495936|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
130495937|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
130495938|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
130495939|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130495940|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130495941|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130495942|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130495943|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130495944|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
130495945|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
130495946|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
130495947|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
130495948|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
130495949|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
130495950|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
130495951|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
130495952|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
130495953|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
130495954|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
130495955|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
130495956|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
130495957|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
130495958|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
130495959|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
130495960|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
130495961|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
130495962|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
130495963|NCT02392234|469783860|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
130495964|NCT02392234|469783861|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
130495965|NCT02392234|469783862|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
130495966|NCT02392234|469783863|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
130495967|NCT02392234|469783864|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
130495968|NCT02392234|469783865|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
130495969|NCT02392234|469783860|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
130495970|NCT02392234|469783861|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130495971|NCT02392234|469783862|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130495972|NCT02392234|469783863|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130495973|NCT02392234|469783864|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130495974|NCT02392234|469783865|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130495975|NCT02052440|469783870|FG000|Overall Study|Withdrawal by Subject|0|||
130495976|NCT02052440|469783871|FG001|Overall Study|Withdrawal by Subject|1|||
130495977|NCT02078648|469783872|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
130495978|NCT02078648|469783873|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
130495979|NCT02078648|469783872|FG000|Overall Study|Adverse Event|0|||
130495980|NCT02078648|469783873|FG001|Overall Study|Adverse Event|1|||
130495981|NCT02078648|469783872|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
130495982|NCT02078648|469783873|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
130495983|NCT02078648|469783872|FG000|Overall Study|Withdrawal by Subject|3|||
130495984|NCT02078648|469783873|FG001|Overall Study|Withdrawal by Subject|1|||
130495985|NCT02078648|469783872|FG000|Overall Study|Investigator Decision|5|||
130495986|NCT02078648|469783873|FG001|Overall Study|Investigator Decision|7|||
130495987|NCT02078648|469783872|FG000|Overall Study|Death|1|||
130729354|NCT03052127|470630658|FG008|Overall Study|Discontinuation by Sponsor|4|||
130495988|NCT02078648|469783873|FG001|Overall Study|Death|1|||
130729355|NCT03052127|470630659|FG009|Overall Study|Discontinuation by Sponsor|2|||
130729356|NCT03052127|470630660|FG010|Overall Study|Discontinuation by Sponsor|5|||
130729357|NCT03052127|470630661|FG011|Overall Study|Discontinuation by Sponsor|13|||
130729358|NCT03052127|470630650|FG000|Overall Study|Inability to comply with trial requirements|0|||
130495989|NCT02078648|469783872|FG000|Overall Study|Undefined|0|||
130495990|NCT02078648|469783873|FG001|Overall Study|Undefined|1|||
130495991|NCT04088227|469783874|FG000|Overall Study|Withdrawal by Subject|1|||
130495992|NCT04088227|469783875|FG001|Overall Study|Withdrawal by Subject|0|||
130495993|NCT04088227|469783874|FG000|Overall Study|Surgery postponed >5weeks|1|||
130495994|NCT04088227|469783875|FG001|Overall Study|Surgery postponed >5weeks|0|||
130495995|NCT03516942|469783878|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
130495996|NCT03516942|469783878|FG000|Registration Through Baseline Survey Com|Death|8|||
130495997|NCT03516942|469783878|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
130495998|NCT03516942|469783878|FG000|T0: Baseline|LOST|13|||
130495999|NCT03516942|469783878|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
130496000|NCT03516942|469783878|FG000|T1: 3 Months Survey|Death|10|||
130496001|NCT03516942|469783878|FG000|T1: 3 Months Survey|Lost|163|||
130496002|NCT03516942|469783878|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
130496003|NCT03516942|469783878|FG000|T2: 6 Month Survey|Death|14|||
130496004|NCT03516942|469783878|FG000|T2: 6 Month Survey|Lost|180|||
130496005|NCT03516942|469783878|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
130496006|NCT03516942|469783878|FG000|T3: 12 Month Survey|Death|19|||
130496007|NCT03516942|469783878|FG000|T3: 12 Month Survey|Lost|209|||
130496008|NCT02401815|469783879|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496009|NCT02401815|469783880|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496010|NCT02401815|469783881|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496011|NCT02401815|469783882|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
130496012|NCT02401815|469783883|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496013|NCT02401815|469783884|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496014|NCT02401815|469783885|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496015|NCT02401815|469783886|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496016|NCT02401815|469783887|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496017|NCT02401815|469783888|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
130496018|NCT02401815|469783879|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
130496019|NCT02401815|469783880|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496020|NCT02401815|469783881|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496021|NCT02401815|469783882|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
130496022|NCT02401815|469783883|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496023|NCT02401815|469783884|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496024|NCT02401815|469783885|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496025|NCT02401815|469783886|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496026|NCT02401815|469783887|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496027|NCT02401815|469783888|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
130496028|NCT02401815|469783879|FG000|Dose Escalation (up to 670 Days)|Death|1|||
130496029|NCT02401815|469783880|FG001|Dose Escalation (up to 670 Days)|Death|2|||
130496030|NCT02401815|469783881|FG002|Dose Escalation (up to 670 Days)|Death|3|||
130496031|NCT02401815|469783882|FG003|Dose Escalation (up to 670 Days)|Death|5|||
130496032|NCT02401815|469783883|FG004|Dose Escalation (up to 670 Days)|Death|4|||
130496033|NCT02401815|469783884|FG005|Dose Escalation (up to 670 Days)|Death|0|||
130496034|NCT02401815|469783885|FG006|Dose Escalation (up to 670 Days)|Death|0|||
130496035|NCT02401815|469783886|FG007|Dose Escalation (up to 670 Days)|Death|0|||
130496036|NCT02401815|469783887|FG008|Dose Escalation (up to 670 Days)|Death|0|||
130496037|NCT02401815|469783888|FG009|Dose Escalation (up to 670 Days)|Death|0|||
130496038|NCT02401815|469783879|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496039|NCT02401815|469783880|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
130496040|NCT02401815|469783881|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496041|NCT02401815|469783882|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496042|NCT02401815|469783883|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
130496043|NCT02401815|469783884|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496044|NCT02401815|469783885|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496045|NCT02401815|469783886|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496046|NCT02401815|469783887|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496047|NCT02401815|469783888|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
130496048|NCT02401815|469783879|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
130496049|NCT02401815|469783880|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496050|NCT02401815|469783881|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496051|NCT02401815|469783882|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496052|NCT02401815|469783883|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
130496053|NCT02401815|469783884|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496054|NCT02401815|469783885|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130565627|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
130496055|NCT02401815|469783886|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496056|NCT02401815|469783887|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496057|NCT02401815|469783888|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
130496058|NCT02401815|469783879|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496059|NCT02401815|469783880|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496060|NCT02401815|469783881|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496061|NCT02401815|469783882|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496062|NCT02401815|469783883|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496063|NCT02401815|469783884|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
130496064|NCT02401815|469783885|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496065|NCT02401815|469783886|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496066|NCT02401815|469783887|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496067|NCT02401815|469783888|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
130496068|NCT02401815|469783879|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496069|NCT02401815|469783880|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496070|NCT02401815|469783881|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496071|NCT02401815|469783882|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496072|NCT02401815|469783883|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496073|NCT02401815|469783884|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496074|NCT02401815|469783885|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
130496075|NCT02401815|469783886|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496076|NCT02401815|469783887|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496077|NCT02401815|469783888|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496078|NCT02401815|469783879|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496079|NCT02401815|469783880|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496080|NCT02401815|469783881|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496081|NCT02401815|469783882|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496082|NCT02401815|469783883|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496083|NCT02401815|469783884|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
130496084|NCT02401815|469783885|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
130496085|NCT02401815|469783886|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496086|NCT02401815|469783887|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496087|NCT02401815|469783888|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
130496088|NCT02401815|469783879|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496089|NCT02401815|469783880|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496090|NCT02401815|469783881|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496091|NCT02401815|469783882|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496092|NCT02401815|469783883|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496093|NCT02401815|469783884|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
130496094|NCT02401815|469783885|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496095|NCT02401815|469783886|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496096|NCT02401815|469783887|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496097|NCT02401815|469783888|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130496098|NCT02401815|469783879|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496099|NCT02401815|469783880|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496100|NCT02401815|469783881|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496101|NCT02401815|469783882|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496102|NCT02401815|469783883|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496103|NCT02401815|469783884|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496104|NCT02401815|469783885|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
130496105|NCT02401815|469783886|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
130496106|NCT02401815|469783887|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
130496107|NCT02401815|469783888|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
130496108|NCT02401815|469783879|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496109|NCT02401815|469783880|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496110|NCT02401815|469783881|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496111|NCT02401815|469783882|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496112|NCT02401815|469783883|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496113|NCT02401815|469783884|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496114|NCT02401815|469783885|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496115|NCT02401815|469783886|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
130496116|NCT02401815|469783887|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
130496117|NCT02401815|469783888|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
130496118|NCT02401815|469783879|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496119|NCT02401815|469783880|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496120|NCT02401815|469783881|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496121|NCT02401815|469783882|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496122|NCT02401815|469783883|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496123|NCT02401815|469783884|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496124|NCT02401815|469783885|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496125|NCT02401815|469783886|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496126|NCT02401815|469783887|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
130496127|NCT02401815|469783888|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
130496128|NCT02401815|469783879|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496129|NCT02401815|469783880|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496130|NCT02401815|469783881|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496131|NCT02401815|469783882|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496132|NCT02401815|469783883|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496133|NCT02401815|469783884|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496134|NCT02401815|469783885|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496135|NCT02401815|469783886|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496136|NCT02401815|469783887|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
130496137|NCT02401815|469783888|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130496138|NCT02401815|469783879|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496139|NCT02401815|469783880|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496140|NCT02401815|469783881|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496141|NCT02401815|469783882|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496142|NCT02401815|469783883|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496143|NCT02401815|469783884|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496144|NCT02401815|469783885|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496145|NCT02401815|469783886|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
130496146|NCT02401815|469783887|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130496147|NCT02401815|469783888|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
130496148|NCT05613907|469783889|FG000|Overall Study|Lost to Follow-up|5|||
130496149|NCT05613907|469783889|FG000|Overall Study|Death|3|||
130496150|NCT05613907|469783889|FG000|Overall Study|Withdrawal by Subject|2|||
130496151|NCT02751528|469783890|FG000|Overall Study|Withdrawal by Subject|1|||
130496152|NCT02751528|469783890|FG000|Overall Study|Adverse Event|1|||
130496153|NCT04218357|469783891|FG000|1st Allocation|Withdrawal by Subject|1|||
130496154|NCT04218357|469783892|FG001|1st Allocation|Withdrawal by Subject|0|||
130496155|NCT01958021|469783894|FG000|Treatment|Progressive disease|206|||
130496156|NCT01958021|469783895|FG001|Treatment|Progressive disease|265|||
130496157|NCT01958021|469783894|FG000|Treatment|Adverse Event|38|||
130496158|NCT01958021|469783895|FG001|Treatment|Adverse Event|10|||
130496159|NCT01958021|469783894|FG000|Treatment|Subject/guardian decision|29|||
130496160|NCT01958021|469783895|FG001|Treatment|Subject/guardian decision|25|||
130496161|NCT01958021|469783894|FG000|Treatment|Physician Decision|28|||
130496162|NCT01958021|469783895|FG001|Treatment|Physician Decision|21|||
130496163|NCT01958021|469783894|FG000|Treatment|Death|6|||
130496164|NCT01958021|469783895|FG001|Treatment|Death|1|||
130496165|NCT01958021|469783894|FG000|Treatment|Protocol deviation|3|||
130496166|NCT01958021|469783895|FG001|Treatment|Protocol deviation|1|||
130729359|NCT03052127|470630651|FG001|Overall Study|Inability to comply with trial requirements|0|||
130729360|NCT03052127|470630652|FG002|Overall Study|Inability to comply with trial requirements|1|||
130729361|NCT03052127|470630653|FG003|Overall Study|Inability to comply with trial requirements|0|||
130729362|NCT03052127|470630654|FG004|Overall Study|Inability to comply with trial requirements|0|||
130729363|NCT03052127|470630655|FG005|Overall Study|Inability to comply with trial requirements|0|||
130729364|NCT03052127|470630656|FG006|Overall Study|Inability to comply with trial requirements|0|||
130496167|NCT01958021|469783894|FG000|Treatment|Sponsor decision|24|||
130496168|NCT01958021|469783895|FG001|Treatment|Sponsor decision|11|||
130729365|NCT03052127|470630657|FG007|Overall Study|Inability to comply with trial requirements|0|||
130729366|NCT03052127|470630658|FG008|Overall Study|Inability to comply with trial requirements|0|||
130729367|NCT03052127|470630659|FG009|Overall Study|Inability to comply with trial requirements|0|||
130729368|NCT03052127|470630660|FG010|Overall Study|Inability to comply with trial requirements|0|||
130496169|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130496170|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130496171|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Death|1|||
130496172|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130496173|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
130496174|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130729369|NCT03052127|470630661|FG011|Overall Study|Inability to comply with trial requirements|0|||
130496175|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130496176|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130496177|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
130496178|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130565628|NCT01131676|470036953|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
130496179|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
130496180|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
130496181|NCT01958021|469783894|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
130496182|NCT01958021|469783895|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
130496183|NCT03664804|469783897|FG000|Overall Study|Withdrawal by Subject|7|||
130496184|NCT04701203|469783898|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
130496185|NCT04701203|469783899|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
130496186|NCT04701203|469783900|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
130496187|NCT04701203|469783898|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
130496188|NCT04701203|469783899|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
130496189|NCT04701203|469783900|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
130496190|NCT04701203|469783898|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
130496191|NCT04701203|469783899|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
130496192|NCT04701203|469783900|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
130496193|NCT04701203|469783898|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
130496194|NCT04701203|469783899|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
130496195|NCT04701203|469783900|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
130496196|NCT06140290|469783902|FG000|Period 1|Adverse Event|1|||
130496197|NCT06140290|469783903|FG001|Period 1|Adverse Event|0|||
130496198|NCT06140290|469783902|FG000|Period 2|Assigned but not treated|0|||
130496199|NCT06140290|469783903|FG001|Period 2|Assigned but not treated|1|||
130496200|NCT06140290|469783902|FG000|Period 2|Withdrawal by Subject|0|||
130496201|NCT06140290|469783903|FG001|Period 2|Withdrawal by Subject|1|||
130496202|NCT03352713|469784843|FG000|Overall Study|Lost to Follow-up|8|||
130496203|NCT03352713|469784843|FG000|Overall Study|Withdrawn by investigator|5|||
130496204|NCT03352713|469784843|FG000|Overall Study|Completed 0 EMAs|8|||
130496205|NCT03352713|469784843|FG000|Overall Study|Device incompatible/stolen|5|||
130496206|NCT01812759|469784844|FG000|Overall Study|Physician Decision|0|||
130496207|NCT01812759|469784845|FG001|Overall Study|Physician Decision|0|||
130496208|NCT01812759|469784846|FG002|Overall Study|Physician Decision|1|||
130496209|NCT00536120|469784847|FG000|Overall Study|Lost to Follow-up|1|||
130496210|NCT00536120|469784848|FG001|Overall Study|Lost to Follow-up|0|||
130496211|NCT00536120|469784847|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
130496212|NCT00536120|469784848|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
130496213|NCT00536120|469784847|FG000|Overall Study|Non-compliance|1|||
130496214|NCT00536120|469784848|FG001|Overall Study|Non-compliance|0|||
130496215|NCT00536120|469784847|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
130496216|NCT00536120|469784848|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
130496217|NCT00536120|469784847|FG000|Overall Study|Steroid Use|0|||
130496218|NCT00536120|469784848|FG001|Overall Study|Steroid Use|2|||
130496219|NCT00536120|469784847|FG000|Overall Study|Missed Study Visit|0|||
130496220|NCT00536120|469784848|FG001|Overall Study|Missed Study Visit|1|||
130496221|NCT02722434|469784849|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
130496222|NCT02722434|469784850|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
130496223|NCT02722434|469784849|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
130496224|NCT02722434|469784850|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
130496225|NCT00360269|469784851|FG000|Overall Study|Lost to Follow-up|7|||
130496226|NCT00360269|469784852|FG001|Overall Study|Lost to Follow-up|9|||
130496227|NCT00360269|469784851|FG000|Overall Study|Physician Decision|1|||
130496228|NCT00360269|469784852|FG001|Overall Study|Physician Decision|2|||
130496229|NCT00360269|469784851|FG000|Overall Study|Adverse Event|1|||
130496230|NCT00360269|469784852|FG001|Overall Study|Adverse Event|0|||
130496231|NCT00360269|469784851|FG000|Overall Study|Withdrawal by Subject|1|||
130496232|NCT00360269|469784852|FG001|Overall Study|Withdrawal by Subject|1|||
130496233|NCT04989816|469784853|FG000|Overall Study|Death|77|||
130496234|NCT04989816|469784853|FG000|Overall Study|Lost to Follow-up|3|||
130496235|NCT01641900|469784854|FG000|Overall Study|Withdrawal by Subject|2|||
130496236|NCT01641900|469784855|FG001|Overall Study|Withdrawal by Subject|2|||
130496237|NCT02941549|469784856|FG000|Overall Study|Adverse Event|1|||
130496238|NCT02941549|469784857|FG001|Overall Study|Adverse Event|0|||
130496239|NCT02941549|469784858|FG002|Overall Study|Adverse Event|0|||
130496240|NCT02941549|469784856|FG000|Overall Study|Withdrawal by Subject|2|||
130496241|NCT02941549|469784857|FG001|Overall Study|Withdrawal by Subject|1|||
130496242|NCT02941549|469784858|FG002|Overall Study|Withdrawal by Subject|2|||
130496243|NCT03451422|469784859|FG000|Overall Study|Lost to Follow-up|0|||
130496244|NCT03451422|469784860|FG001|Overall Study|Lost to Follow-up|0|||
130496245|NCT03451422|469784861|FG002|Overall Study|Lost to Follow-up|0|||
130496246|NCT03451422|469784862|FG003|Overall Study|Lost to Follow-up|0|||
130496247|NCT03451422|469784863|FG004|Overall Study|Lost to Follow-up|0|||
130496248|NCT03451422|469784864|FG005|Overall Study|Lost to Follow-up|1|||
130496249|NCT03451422|469784859|FG000|Overall Study|Decision by sponsor|1|||
130496250|NCT03451422|469784860|FG001|Overall Study|Decision by sponsor|0|||
130496251|NCT03451422|469784861|FG002|Overall Study|Decision by sponsor|1|||
130496252|NCT03451422|469784862|FG003|Overall Study|Decision by sponsor|0|||
130496253|NCT03451422|469784863|FG004|Overall Study|Decision by sponsor|0|||
130496254|NCT03451422|469784864|FG005|Overall Study|Decision by sponsor|0|||
130496255|NCT03451422|469784859|FG000|Overall Study|Withdrawal by Subject|0|||
130496256|NCT03451422|469784860|FG001|Overall Study|Withdrawal by Subject|0|||
130496257|NCT03451422|469784861|FG002|Overall Study|Withdrawal by Subject|2|||
130496258|NCT03451422|469784862|FG003|Overall Study|Withdrawal by Subject|3|||
130496259|NCT03451422|469784863|FG004|Overall Study|Withdrawal by Subject|2|||
130496260|NCT03451422|469784864|FG005|Overall Study|Withdrawal by Subject|1|||
130496261|NCT03601715|469784865|FG000|Second Intervention|Lost to Follow-up|1|||
130496262|NCT03601715|469784866|FG001|Second Intervention|Lost to Follow-up|1|||
130496263|NCT03601715|469784867|FG002|Second Intervention|Lost to Follow-up|0|||
130496264|NCT01313884|469784871|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
130496265|NCT00263757|469784872|FG000|Overall Study|Withdrawal by Subject|5|||
130496266|NCT00263757|469784873|FG001|Overall Study|Withdrawal by Subject|4|||
130496267|NCT00263757|469784872|FG000|Overall Study|Screen failure|0|||
130496268|NCT00263757|469784873|FG001|Overall Study|Screen failure|1|||
130496269|NCT00263757|469784872|FG000|Overall Study|Adverse Event|3|||
130496270|NCT00263757|469784873|FG001|Overall Study|Adverse Event|3|||
130496271|NCT02463448|469784874|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
130496272|NCT02463448|469784874|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
130496273|NCT02463448|469784874|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
130496274|NCT02463448|469784874|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
130496275|NCT00857766|469784878|FG000|Overall Study|Adverse Event|13|||
130496276|NCT00857766|469784879|FG001|Overall Study|Adverse Event|12|||
130496277|NCT00857766|469784878|FG000|Overall Study|Protocol Violation|11|||
130496278|NCT00857766|469784879|FG001|Overall Study|Protocol Violation|11|||
130496279|NCT00857766|469784878|FG000|Overall Study|Lost to Follow-up|1|||
130496280|NCT00857766|469784879|FG001|Overall Study|Lost to Follow-up|0|||
130496281|NCT00857766|469784878|FG000|Overall Study|Investigator Discretion|2|||
130496282|NCT00857766|469784879|FG001|Overall Study|Investigator Discretion|3|||
130496283|NCT00857766|469784878|FG000|Overall Study|Participant Withdrew Consent|4|||
130496284|NCT00857766|469784879|FG001|Overall Study|Participant Withdrew Consent|4|||
130496285|NCT03355573|469784880|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
130496286|NCT03355573|469784880|FG000|Overall Study|Sponsor's decision|1|||
130496287|NCT03355573|469784880|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
130496288|NCT03355573|469784880|FG000|Overall Study|PI's decision|2|||
130496289|NCT03355573|469784880|FG000|Overall Study|Withdrawal by Subject|23|||
130496290|NCT03355573|469784880|FG000|Overall Study|Lost to Follow-up|4|||
130496291|NCT03355573|469784880|FG000|Overall Study|Lack of Efficacy|2|||
130496292|NCT03355573|469784880|FG000|Overall Study|Adverse Event, non-fatal|17|||
130496293|NCT03355573|469784880|FG000|Overall Study|Adverse Event, serious fatal|2|||
130496294|NCT01536093|469784883|FG000|Overall Study|Death|1|||
130496295|NCT01536093|469784884|FG001|Overall Study|Death|2|||
130496296|NCT01536093|469784883|FG000|Overall Study|absence of maternal colostrum|2|||
130496297|NCT01536093|469784884|FG001|Overall Study|absence of maternal colostrum|0|||
130496298|NCT01536093|469784883|FG000|Overall Study|Withdrawal by Subject|0|||
130496299|NCT01536093|469784884|FG001|Overall Study|Withdrawal by Subject|1|||
130496300|NCT03631407|469784885|FG000|Overall Study|Withdrawal by Subject|3|||
130496301|NCT03631407|469784886|FG001|Overall Study|Withdrawal by Subject|2|||
130496302|NCT03631407|469784885|FG000|Overall Study|Sponsor Decision|0|||
130496303|NCT03631407|469784886|FG001|Overall Study|Sponsor Decision|2|||
130496304|NCT03631407|469784885|FG000|Overall Study|Death|16|||
130496305|NCT03631407|469784886|FG001|Overall Study|Death|16|||
130496306|NCT03631407|469784885|FG000|Overall Study|Randomized by mistake without study treatment|1|||
130496307|NCT03631407|469784886|FG001|Overall Study|Randomized by mistake without study treatment|0|||
130496308|NCT00942266|469784887|FG000|Overall Study|Withdrawal by Subject|1|||
130496309|NCT00942266|469784888|FG001|Overall Study|Withdrawal by Subject|0|||
130496310|NCT00942266|469784887|FG000|Overall Study|Adverse Event|2|||
130496311|NCT00942266|469784888|FG001|Overall Study|Adverse Event|1|||
130496312|NCT00942266|469784887|FG000|Overall Study|Disease Progression|38|||
130496313|NCT00942266|469784888|FG001|Overall Study|Disease Progression|11|||
130496314|NCT00942266|469784887|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
130496315|NCT00942266|469784888|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
130496316|NCT00942266|469784887|FG000|Overall Study|Intercurrent illness|0|||
130496317|NCT00942266|469784888|FG001|Overall Study|Intercurrent illness|1|||
130496318|NCT00942266|469784887|FG000|Overall Study|Physician Decision|2|||
130496319|NCT00942266|469784888|FG001|Overall Study|Physician Decision|0|||
130496320|NCT00942266|469784887|FG000|Overall Study|medical deterioration (pneumonia)|0|||
130496321|NCT00942266|469784888|FG001|Overall Study|medical deterioration (pneumonia)|1|||
130496322|NCT00756574|469784892|FG000|Overall Study|Withdrawal by Subject|9|||
130496323|NCT00756574|469784893|FG001|Overall Study|Withdrawal by Subject|7|||
130496324|NCT00756574|469784892|FG000|Overall Study|Lost to Follow-up|4|||
130496325|NCT00756574|469784893|FG001|Overall Study|Lost to Follow-up|4|||
130496326|NCT04795167|469784894|FG000|Overall Study|Death|1|||
130496327|NCT04795167|469784895|FG001|Overall Study|Death|18|||
130496328|NCT04795167|469784896|FG002|Overall Study|Death|1|||
130496329|NCT04795167|469784894|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
130496330|NCT04795167|469784895|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
130496331|NCT04795167|469784896|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
130496332|NCT00918203|469784898|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
130496333|NCT00918203|469784899|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
130496334|NCT00918203|469784900|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
130496335|NCT00918203|469784898|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
130496336|NCT00918203|469784899|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
130496337|NCT00918203|469784900|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
130496338|NCT00918203|469784898|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
130496339|NCT00918203|469784899|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
130496340|NCT00918203|469784900|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
130496341|NCT00918203|469784898|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
130496342|NCT00918203|469784899|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
130496343|NCT00918203|469784900|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
130496344|NCT03488719|469784905|FG000|Overall Study|Adverse Event|0|||
130496345|NCT03488719|469784906|FG001|Overall Study|Adverse Event|4|||
130496346|NCT03488719|469784907|FG002|Overall Study|Adverse Event|2|||
130496347|NCT03488719|469784905|FG000|Overall Study|Other|0|||
130496348|NCT03488719|469784906|FG001|Overall Study|Other|0|||
130496349|NCT03488719|469784907|FG002|Overall Study|Other|5|||
130496350|NCT03477175|469784912|FG000|Overall Study|Unable to travel due to COVID-19|0|||
130496351|NCT03477175|469784913|FG001|Overall Study|Unable to travel due to COVID-19|1|||
130496352|NCT03477175|469784912|FG000|Overall Study|Physician Decision|1|||
130496353|NCT03477175|469784913|FG001|Overall Study|Physician Decision|0|||
130496354|NCT03477175|469784912|FG000|Overall Study|Transitioned to commercial drug|6|||
130496355|NCT03477175|469784913|FG001|Overall Study|Transitioned to commercial drug|6|||
130496356|NCT03477175|469784912|FG000|Overall Study|Lost to Follow-up|1|||
130496357|NCT03477175|469784913|FG001|Overall Study|Lost to Follow-up|1|||
130496358|NCT03477175|469784912|FG000|Overall Study|Withdrawal by Subject|3|||
130496359|NCT03477175|469784913|FG001|Overall Study|Withdrawal by Subject|1|||
130496360|NCT03477175|469784912|FG000|Overall Study|Adverse Event|1|||
130496361|NCT03477175|469784913|FG001|Overall Study|Adverse Event|5|||
130496362|NCT03477175|469784912|FG000|Overall Study|Disease Progression|7|||
130496363|NCT03477175|469784913|FG001|Overall Study|Disease Progression|7|||
130496364|NCT01675492|469784914|FG000|Overall Study|study completed early - product approval|42|||
130496365|NCT05025384|469784915|FG000|Overall Study|Physician Decision|5|||
130496366|NCT05025384|469784916|FG001|Overall Study|Physician Decision|6|||
130496367|NCT03610581|469784917|FG000|Overall Study|Study terminated by sponsor|2|||
130496368|NCT03610581|469784918|FG001|Overall Study|Study terminated by sponsor|0|||
130496369|NCT03610581|469784917|FG000|Overall Study|Other|0|||
130496370|NCT03610581|469784918|FG001|Overall Study|Other|1|||
130496371|NCT03610581|469784917|FG000|Overall Study|Withdrawal by Subject|1|||
130496372|NCT03610581|469784918|FG001|Overall Study|Withdrawal by Subject|0|||
130496373|NCT05485805|469784919|FG000|Overall Study|Withdrawal by Subject|1|||
130496374|NCT05485805|469784920|FG001|Overall Study|Withdrawal by Subject|2|||
130496375|NCT05485805|469784921|FG002|Overall Study|Withdrawal by Subject|2|||
130496376|NCT05485805|469784922|FG003|Overall Study|Withdrawal by Subject|0|||
130496377|NCT05485805|469784923|FG004|Overall Study|Withdrawal by Subject|2|||
130496378|NCT05485805|469784919|FG000|Overall Study|Adverse Event|0|||
130496379|NCT05485805|469784920|FG001|Overall Study|Adverse Event|1|||
130496380|NCT05485805|469784921|FG002|Overall Study|Adverse Event|0|||
130496381|NCT05485805|469784922|FG003|Overall Study|Adverse Event|0|||
130496382|NCT05485805|469784923|FG004|Overall Study|Adverse Event|0|||
130496383|NCT05485805|469784919|FG000|Overall Study|Lost to Follow-up|1|||
130496384|NCT05485805|469784920|FG001|Overall Study|Lost to Follow-up|1|||
130496385|NCT05485805|469784921|FG002|Overall Study|Lost to Follow-up|3|||
130496386|NCT05485805|469784922|FG003|Overall Study|Lost to Follow-up|1|||
130496387|NCT05485805|469784923|FG004|Overall Study|Lost to Follow-up|0|||
130496388|NCT02488408|469784925|FG000|Part A|Adverse Event|2|||
130496389|NCT02488408|469784926|FG001|Part A|Adverse Event|0|||
130496390|NCT02488408|469784927|FG002|Part A|Adverse Event|0|||
130496391|NCT02488408|469784928|FG003|Part A|Adverse Event|0|||
130496392|NCT02488408|469784929|FG004|Part A|Adverse Event|0|||
130496393|NCT02488408|469784930|FG005|Part A|Adverse Event|0|||
130496394|NCT02488408|469784931|FG006|Part A|Adverse Event|0|||
130496395|NCT02488408|469784932|FG007|Part A|Adverse Event|0|||
130496396|NCT02488408|469784933|FG008|Part A|Adverse Event|0|||
130496397|NCT02488408|469784934|FG009|Part A|Adverse Event|0|||
130496398|NCT02488408|469784925|FG000|Part A|Death|1|||
130496399|NCT02488408|469784926|FG001|Part A|Death|5|||
130496400|NCT02488408|469784927|FG002|Part A|Death|0|||
130496401|NCT02488408|469784928|FG003|Part A|Death|0|||
130496402|NCT02488408|469784929|FG004|Part A|Death|3|||
130496403|NCT02488408|469784930|FG005|Part A|Death|0|||
130496404|NCT02488408|469784931|FG006|Part A|Death|0|||
130496405|NCT02488408|469784932|FG007|Part A|Death|0|||
130496406|NCT02488408|469784933|FG008|Part A|Death|0|||
130496407|NCT02488408|469784934|FG009|Part A|Death|0|||
130729370|NCT03052127|470630650|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729371|NCT03052127|470630651|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130496408|NCT02488408|469784925|FG000|Part A|Disease Progression|2|||
130496409|NCT02488408|469784926|FG001|Part A|Disease Progression|8|||
130496410|NCT02488408|469784927|FG002|Part A|Disease Progression|2|||
130496411|NCT02488408|469784928|FG003|Part A|Disease Progression|3|||
130496412|NCT02488408|469784929|FG004|Part A|Disease Progression|4|||
130496413|NCT02488408|469784930|FG005|Part A|Disease Progression|0|||
130496414|NCT02488408|469784931|FG006|Part A|Disease Progression|0|||
130496415|NCT02488408|469784932|FG007|Part A|Disease Progression|0|||
130496416|NCT02488408|469784933|FG008|Part A|Disease Progression|0|||
130496417|NCT02488408|469784934|FG009|Part A|Disease Progression|0|||
130496418|NCT02488408|469784925|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
130496419|NCT02488408|469784926|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
130496420|NCT02488408|469784927|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
130496421|NCT02488408|469784928|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
130496422|NCT02488408|469784929|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
130496423|NCT02488408|469784930|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
130496424|NCT02488408|469784931|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
130496425|NCT02488408|469784932|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
130496426|NCT02488408|469784933|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
130496427|NCT02488408|469784934|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
130496428|NCT02488408|469784925|FG000|Part A|Investigator Decision|0|||
130496429|NCT02488408|469784926|FG001|Part A|Investigator Decision|1|||
130496430|NCT02488408|469784927|FG002|Part A|Investigator Decision|1|||
130496431|NCT02488408|469784928|FG003|Part A|Investigator Decision|0|||
130496432|NCT02488408|469784929|FG004|Part A|Investigator Decision|0|||
130496433|NCT02488408|469784930|FG005|Part A|Investigator Decision|0|||
130496434|NCT02488408|469784931|FG006|Part A|Investigator Decision|0|||
130496435|NCT02488408|469784932|FG007|Part A|Investigator Decision|0|||
130496436|NCT02488408|469784933|FG008|Part A|Investigator Decision|0|||
130496437|NCT02488408|469784934|FG009|Part A|Investigator Decision|0|||
130496438|NCT02488408|469784925|FG000|Part A|Withdrawal by Subject|0|||
130496439|NCT02488408|469784926|FG001|Part A|Withdrawal by Subject|0|||
130496440|NCT02488408|469784927|FG002|Part A|Withdrawal by Subject|2|||
130496441|NCT02488408|469784928|FG003|Part A|Withdrawal by Subject|0|||
130496442|NCT02488408|469784929|FG004|Part A|Withdrawal by Subject|0|||
130496443|NCT02488408|469784930|FG005|Part A|Withdrawal by Subject|0|||
130496444|NCT02488408|469784931|FG006|Part A|Withdrawal by Subject|0|||
130496445|NCT02488408|469784932|FG007|Part A|Withdrawal by Subject|0|||
130496446|NCT02488408|469784933|FG008|Part A|Withdrawal by Subject|0|||
130496447|NCT02488408|469784934|FG009|Part A|Withdrawal by Subject|0|||
130496448|NCT02488408|469784925|FG000|Part A|Other|1|||
130496449|NCT02488408|469784926|FG001|Part A|Other|0|||
130496450|NCT02488408|469784927|FG002|Part A|Other|0|||
130496451|NCT02488408|469784928|FG003|Part A|Other|0|||
130496452|NCT02488408|469784929|FG004|Part A|Other|0|||
130496453|NCT02488408|469784930|FG005|Part A|Other|0|||
130496454|NCT02488408|469784931|FG006|Part A|Other|0|||
130496455|NCT02488408|469784932|FG007|Part A|Other|0|||
130496456|NCT02488408|469784933|FG008|Part A|Other|0|||
130496457|NCT02488408|469784934|FG009|Part A|Other|0|||
130496458|NCT02488408|469784925|FG000|Part B|Adverse Event|0|||
130496459|NCT02488408|469784926|FG001|Part B|Adverse Event|0|||
130496460|NCT02488408|469784927|FG002|Part B|Adverse Event|0|||
130496461|NCT02488408|469784928|FG003|Part B|Adverse Event|0|||
130496462|NCT02488408|469784929|FG004|Part B|Adverse Event|0|||
130496463|NCT02488408|469784930|FG005|Part B|Adverse Event|2|||
130496464|NCT02488408|469784931|FG006|Part B|Adverse Event|2|||
130496465|NCT02488408|469784932|FG007|Part B|Adverse Event|7|||
130496466|NCT02488408|469784933|FG008|Part B|Adverse Event|2|||
130496467|NCT02488408|469784934|FG009|Part B|Adverse Event|2|||
130496468|NCT02488408|469784925|FG000|Part B|Death|0|||
130496469|NCT02488408|469784926|FG001|Part B|Death|0|||
130496470|NCT02488408|469784927|FG002|Part B|Death|0|||
130496471|NCT02488408|469784928|FG003|Part B|Death|0|||
130496472|NCT02488408|469784929|FG004|Part B|Death|0|||
130496473|NCT02488408|469784930|FG005|Part B|Death|3|||
130496474|NCT02488408|469784931|FG006|Part B|Death|1|||
130496475|NCT02488408|469784932|FG007|Part B|Death|2|||
130496476|NCT02488408|469784933|FG008|Part B|Death|2|||
130496477|NCT02488408|469784934|FG009|Part B|Death|2|||
130496478|NCT02488408|469784925|FG000|Part B|Death due to Disease Progression|0|||
130496479|NCT02488408|469784926|FG001|Part B|Death due to Disease Progression|0|||
130496480|NCT02488408|469784927|FG002|Part B|Death due to Disease Progression|0|||
130496481|NCT02488408|469784928|FG003|Part B|Death due to Disease Progression|0|||
130496482|NCT02488408|469784929|FG004|Part B|Death due to Disease Progression|0|||
130496483|NCT02488408|469784930|FG005|Part B|Death due to Disease Progression|2|||
130496484|NCT02488408|469784931|FG006|Part B|Death due to Disease Progression|2|||
130496485|NCT02488408|469784932|FG007|Part B|Death due to Disease Progression|1|||
130496486|NCT02488408|469784933|FG008|Part B|Death due to Disease Progression|1|||
130496487|NCT02488408|469784934|FG009|Part B|Death due to Disease Progression|1|||
130496488|NCT02488408|469784925|FG000|Part B|Disease Progression|0|||
130565629|NCT01131676|470036954|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
130565630|NCT01131676|470036955|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
130496489|NCT02488408|469784926|FG001|Part B|Disease Progression|0|||
130496490|NCT02488408|469784927|FG002|Part B|Disease Progression|0|||
130496491|NCT02488408|469784928|FG003|Part B|Disease Progression|0|||
130496492|NCT02488408|469784929|FG004|Part B|Disease Progression|0|||
130496493|NCT02488408|469784930|FG005|Part B|Disease Progression|6|||
130496494|NCT02488408|469784931|FG006|Part B|Disease Progression|9|||
130496495|NCT02488408|469784932|FG007|Part B|Disease Progression|7|||
130496496|NCT02488408|469784933|FG008|Part B|Disease Progression|9|||
130496497|NCT02488408|469784934|FG009|Part B|Disease Progression|11|||
130496498|NCT02488408|469784925|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
130496499|NCT02488408|469784926|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
130496500|NCT02488408|469784927|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
130496501|NCT02488408|469784928|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
130496502|NCT02488408|469784929|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
130496503|NCT02488408|469784930|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
130496504|NCT02488408|469784931|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
130496505|NCT02488408|469784932|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
130496506|NCT02488408|469784933|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
130496507|NCT02488408|469784934|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
130496508|NCT02488408|469784925|FG000|Part B|Investigator Decision|0|||
130496509|NCT02488408|469784926|FG001|Part B|Investigator Decision|0|||
130496510|NCT02488408|469784927|FG002|Part B|Investigator Decision|0|||
130496511|NCT02488408|469784928|FG003|Part B|Investigator Decision|0|||
130496512|NCT02488408|469784929|FG004|Part B|Investigator Decision|0|||
130496513|NCT02488408|469784930|FG005|Part B|Investigator Decision|0|||
130496514|NCT02488408|469784931|FG006|Part B|Investigator Decision|1|||
130496515|NCT02488408|469784932|FG007|Part B|Investigator Decision|0|||
130496516|NCT02488408|469784933|FG008|Part B|Investigator Decision|2|||
130496517|NCT02488408|469784934|FG009|Part B|Investigator Decision|1|||
130496518|NCT05886777|469784937|FG000|Overall Study|Lost to Follow-up|1|||
130496519|NCT05886777|469784938|FG001|Overall Study|Lost to Follow-up|0|||
130496520|NCT05886777|469784939|FG002|Overall Study|Lost to Follow-up|2|||
130496521|NCT05886777|469784940|FG003|Overall Study|Lost to Follow-up|1|||
130496522|NCT05886777|469784941|FG004|Overall Study|Lost to Follow-up|0|||
130496523|NCT05886777|469784942|FG005|Overall Study|Lost to Follow-up|2|||
130496524|NCT05886777|469784943|FG006|Overall Study|Lost to Follow-up|0|||
130496525|NCT05886777|469784937|FG000|Overall Study|Other|0|||
130496526|NCT05886777|469784938|FG001|Overall Study|Other|2|||
130496527|NCT05886777|469784939|FG002|Overall Study|Other|1|||
130496528|NCT05886777|469784940|FG003|Overall Study|Other|0|||
130496529|NCT05886777|469784941|FG004|Overall Study|Other|0|||
130496530|NCT05886777|469784942|FG005|Overall Study|Other|0|||
130496531|NCT05886777|469784943|FG006|Overall Study|Other|0|||
130496532|NCT05886777|469784937|FG000|Overall Study|Withdrawal by Subject|1|||
130496533|NCT05886777|469784938|FG001|Overall Study|Withdrawal by Subject|0|||
130496534|NCT05886777|469784939|FG002|Overall Study|Withdrawal by Subject|1|||
130496535|NCT05886777|469784940|FG003|Overall Study|Withdrawal by Subject|4|||
130496536|NCT05886777|469784941|FG004|Overall Study|Withdrawal by Subject|3|||
130496537|NCT05886777|469784942|FG005|Overall Study|Withdrawal by Subject|1|||
130496538|NCT05886777|469784943|FG006|Overall Study|Withdrawal by Subject|1|||
130496539|NCT05886777|469784937|FG000|Overall Study|Protocol Violation|0|||
130496540|NCT05886777|469784938|FG001|Overall Study|Protocol Violation|0|||
130496541|NCT05886777|469784939|FG002|Overall Study|Protocol Violation|1|||
130496542|NCT05886777|469784940|FG003|Overall Study|Protocol Violation|0|||
130496543|NCT05886777|469784941|FG004|Overall Study|Protocol Violation|0|||
130496544|NCT05886777|469784942|FG005|Overall Study|Protocol Violation|0|||
130496545|NCT05886777|469784943|FG006|Overall Study|Protocol Violation|0|||
130496546|NCT05886777|469784937|FG000|Overall Study|No longer met eligibility criteria|0|||
130496547|NCT05886777|469784938|FG001|Overall Study|No longer met eligibility criteria|1|||
130496548|NCT05886777|469784939|FG002|Overall Study|No longer met eligibility criteria|0|||
130496549|NCT05886777|469784940|FG003|Overall Study|No longer met eligibility criteria|0|||
130496550|NCT05886777|469784941|FG004|Overall Study|No longer met eligibility criteria|0|||
130496551|NCT05886777|469784942|FG005|Overall Study|No longer met eligibility criteria|0|||
130496552|NCT05886777|469784943|FG006|Overall Study|No longer met eligibility criteria|0|||
130496553|NCT05293717|469784944|FG000|Overall Study|Physician Decision|1|||
130496554|NCT03762850|469786453|FG000|Overall Study|Death|0|||
130496555|NCT03762850|469786454|FG001|Overall Study|Death|1|||
130496556|NCT03762850|469786453|FG000|Overall Study|Lost to Follow-up|0|||
130496557|NCT03762850|469786454|FG001|Overall Study|Lost to Follow-up|1|||
130496558|NCT03762850|469786453|FG000|Overall Study|Physician Decision|0|||
130496559|NCT03762850|469786454|FG001|Overall Study|Physician Decision|1|||
130496560|NCT03762850|469786453|FG000|Overall Study|Withdrawal by Subject|4|||
130496561|NCT03762850|469786454|FG001|Overall Study|Withdrawal by Subject|9|||
130496562|NCT03083366|469786455|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
130729372|NCT03052127|470630652|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729373|NCT03052127|470630653|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729374|NCT03052127|470630654|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729375|NCT03052127|470630655|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729376|NCT03052127|470630656|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729377|NCT03052127|470630657|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729378|NCT03052127|470630658|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729379|NCT03052127|470630659|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729380|NCT03052127|470630660|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130496563|NCT03083366|469786456|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
130496564|NCT03083366|469786455|FG000|Enrollment Period|Lack of Efficacy|1|||
130496565|NCT03083366|469786456|FG001|Enrollment Period|Lack of Efficacy|0|||
130496566|NCT02036970|469786461|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
130496567|NCT02036970|469786462|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
130496568|NCT02036970|469786463|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
130496569|NCT02036970|469786464|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
130496570|NCT02036970|469786465|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
130496571|NCT02036970|469786466|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
130496572|NCT02036970|469786467|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
130496573|NCT02036970|469786468|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
130496574|NCT02036970|469786469|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
130496575|NCT02036970|469786470|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
130496576|NCT02036970|469786461|FG000|Part 1: Day 1 Through Week 16|Death|0|||
130496577|NCT02036970|469786462|FG001|Part 1: Day 1 Through Week 16|Death|0|||
130496578|NCT02036970|469786463|FG002|Part 1: Day 1 Through Week 16|Death|0|||
130496579|NCT02036970|469786464|FG003|Part 1: Day 1 Through Week 16|Death|0|||
130496580|NCT02036970|469786465|FG004|Part 1: Day 1 Through Week 16|Death|0|||
130496581|NCT02036970|469786466|FG005|Part 1: Day 1 Through Week 16|Death|0|||
130496582|NCT02036970|469786467|FG006|Part 1: Day 1 Through Week 16|Death|0|||
130496583|NCT02036970|469786468|FG007|Part 1: Day 1 Through Week 16|Death|0|||
130496584|NCT02036970|469786469|FG008|Part 1: Day 1 Through Week 16|Death|1|||
130496585|NCT02036970|469786470|FG009|Part 1: Day 1 Through Week 16|Death|0|||
130496586|NCT02036970|469786461|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
130496587|NCT02036970|469786462|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496588|NCT02036970|469786463|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
130496589|NCT02036970|469786464|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496590|NCT02036970|469786465|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496591|NCT02036970|469786466|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496592|NCT02036970|469786467|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496593|NCT02036970|469786468|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496594|NCT02036970|469786469|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
130496595|NCT02036970|469786470|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130496596|NCT02036970|469786461|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496597|NCT02036970|469786462|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496598|NCT02036970|469786463|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496599|NCT02036970|469786464|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496600|NCT02036970|469786465|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
130496601|NCT02036970|469786466|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496602|NCT02036970|469786467|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496603|NCT02036970|469786468|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
130496604|NCT02036970|469786469|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
130496605|NCT02036970|469786470|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
130496606|NCT02036970|469786461|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496607|NCT02036970|469786462|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496608|NCT02036970|469786463|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496609|NCT02036970|469786464|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
130496610|NCT02036970|469786465|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496611|NCT02036970|469786466|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496612|NCT02036970|469786467|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496613|NCT02036970|469786468|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496614|NCT02036970|469786469|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496615|NCT02036970|469786470|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
130496616|NCT02036970|469786461|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
130496617|NCT02036970|469786462|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
130496618|NCT02036970|469786463|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
130496619|NCT02036970|469786464|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
130496620|NCT02036970|469786465|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
130565631|NCT01111851|470036958|FG000|Overall Study|All planned PET scans were not obtained.|2|||
130565632|NCT01111851|470036959|FG001|Overall Study|All planned PET scans were not obtained.|0|||
130496621|NCT02036970|469786466|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
130496622|NCT02036970|469786467|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
130496623|NCT02036970|469786468|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
130496624|NCT02036970|469786469|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
130496625|NCT02036970|469786470|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
130496626|NCT02036970|469786461|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496627|NCT02036970|469786462|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496628|NCT02036970|469786463|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496629|NCT02036970|469786464|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496630|NCT02036970|469786465|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496631|NCT02036970|469786466|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496632|NCT02036970|469786467|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496633|NCT02036970|469786468|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
130496634|NCT02036970|469786469|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496635|NCT02036970|469786470|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
130496636|NCT02036970|469786461|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496637|NCT02036970|469786462|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
130496638|NCT02036970|469786463|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
130496639|NCT02036970|469786464|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496640|NCT02036970|469786465|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496641|NCT02036970|469786466|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496642|NCT02036970|469786467|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496643|NCT02036970|469786468|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496644|NCT02036970|469786469|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
130496645|NCT02036970|469786470|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
130496646|NCT02036970|469786461|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496647|NCT02036970|469786462|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
130496648|NCT02036970|469786463|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
130496649|NCT02036970|469786464|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
130496650|NCT02036970|469786465|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496651|NCT02036970|469786466|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496652|NCT02036970|469786467|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496653|NCT02036970|469786468|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496654|NCT02036970|469786469|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
130496655|NCT02036970|469786470|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
130496656|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
130496657|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
130496658|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
130496659|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
130496660|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
130496661|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
130496662|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
130496663|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
130496664|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
130496665|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
130496666|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
130496667|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
130496668|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
130496669|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
130496670|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
130496671|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
130496672|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
130496673|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
130496674|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
130496675|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
130496676|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
130496677|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
130496678|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
130496679|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
130496680|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
130496681|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Other|1|||
130496682|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Other|0|||
130496683|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Other|0|||
130496684|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Other|0|||
130496685|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Other|0|||
130496686|NCT02386098|469786473|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
130496687|NCT02386098|469786474|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
130496688|NCT02386098|469786475|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
130496689|NCT02386098|469786476|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
130496690|NCT02386098|469786477|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
130496691|NCT03002194|469786481|FG000|Overall Study|Lost to Follow-up|6|||
130729381|NCT03052127|470630661|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729382|NCT03694327|470630662|FG000|Overall Study|Lost to Follow-up|13|||
130729383|NCT03694327|470630663|FG001|Overall Study|Lost to Follow-up|23|||
130729384|NCT01464931|470630664|FG000|Overall Study|Withdrawal by Subject|1|||
130729385|NCT01464931|470630665|FG001|Overall Study|Withdrawal by Subject|0|||
130729386|NCT01982812|470630668|FG000|Overall Study|Death|1|||
130496692|NCT03002194|469786481|FG000|Overall Study|Adverse Event|1|||
130496693|NCT03002194|469786481|FG000|Overall Study|Lack of Efficacy|1|||
130496694|NCT03002194|469786481|FG000|Overall Study|Withdrawal by Subject|2|||
130496695|NCT00048932|469786484|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
130496696|NCT00048932|469786485|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
130496697|NCT00048932|469786486|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
130496698|NCT00048932|469786484|FG000|Double Blind Period (DB)|Adverse Event|51|||
130496699|NCT00048932|469786485|FG001|Double Blind Period (DB)|Adverse Event|19|||
130496700|NCT00048932|469786486|FG002|Double Blind Period (DB)|Adverse Event|0|||
130496701|NCT00048932|469786484|FG000|Double Blind Period (DB)|Death|5|||
130496702|NCT00048932|469786485|FG001|Double Blind Period (DB)|Death|3|||
130496703|NCT00048932|469786486|FG002|Double Blind Period (DB)|Death|0|||
130496704|NCT00048932|469786484|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
130496705|NCT00048932|469786485|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
130496706|NCT00048932|469786486|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
130496707|NCT00048932|469786484|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
130496708|NCT00048932|469786485|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
130496709|NCT00048932|469786486|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
130496710|NCT00048932|469786484|FG000|Double Blind Period (DB)|Relocation|1|||
130496711|NCT00048932|469786485|FG001|Double Blind Period (DB)|Relocation|0|||
130496712|NCT00048932|469786486|FG002|Double Blind Period (DB)|Relocation|0|||
130496713|NCT00048932|469786484|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
130496714|NCT00048932|469786485|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
130496715|NCT00048932|469786486|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
130496716|NCT00048932|469786484|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
130496717|NCT00048932|469786485|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
130496718|NCT00048932|469786486|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
130496719|NCT00048932|469786484|FG000|Double Blind Period (DB)|Pregnancy|1|||
130496720|NCT00048932|469786485|FG001|Double Blind Period (DB)|Pregnancy|0|||
130496721|NCT00048932|469786486|FG002|Double Blind Period (DB)|Pregnancy|0|||
130496722|NCT00048932|469786484|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
130496723|NCT00048932|469786485|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
130496724|NCT00048932|469786486|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
130496725|NCT00048932|469786484|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
130496726|NCT00048932|469786485|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
130496727|NCT00048932|469786486|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
130496728|NCT00048932|469786484|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
130496729|NCT00048932|469786485|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
130496730|NCT00048932|469786486|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
130496731|NCT00048932|469786484|FG000|Open Label Period (OL)|Death|0|||
130496732|NCT00048932|469786485|FG001|Open Label Period (OL)|Death|0|||
130496733|NCT00048932|469786486|FG002|Open Label Period (OL)|Death|25|||
130496734|NCT00048932|469786484|FG000|Open Label Period (OL)|Adverse Event|0|||
130496735|NCT00048932|469786485|FG001|Open Label Period (OL)|Adverse Event|0|||
130496736|NCT00048932|469786486|FG002|Open Label Period (OL)|Adverse Event|103|||
130496737|NCT00048932|469786484|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
130496738|NCT00048932|469786485|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
130496739|NCT00048932|469786486|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
130496740|NCT00048932|469786484|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
130496741|NCT00048932|469786485|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
130496742|NCT00048932|469786486|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
130496743|NCT00048932|469786484|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
130496744|NCT00048932|469786485|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
130496745|NCT00048932|469786486|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
130496746|NCT00048932|469786484|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
130496747|NCT00048932|469786485|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
130496748|NCT00048932|469786486|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
130496749|NCT00048932|469786484|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
130496750|NCT00048932|469786485|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
130729387|NCT01982812|470630669|FG001|Overall Study|Death|5|||
130496751|NCT00048932|469786486|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
130496752|NCT00048932|469786484|FG000|Open Label Period (OL)|Pregnancy|0|||
130496753|NCT00048932|469786485|FG001|Open Label Period (OL)|Pregnancy|0|||
130496754|NCT00048932|469786486|FG002|Open Label Period (OL)|Pregnancy|6|||
130496755|NCT00048932|469786484|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
130496756|NCT00048932|469786485|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
130496757|NCT00048932|469786486|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
130496758|NCT00048932|469786484|FG000|Open Label Period (OL)|Investigator Retiring|0|||
130496759|NCT00048932|469786485|FG001|Open Label Period (OL)|Investigator Retiring|0|||
130496760|NCT00048932|469786486|FG002|Open Label Period (OL)|Investigator Retiring|2|||
130496761|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
130496762|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
130496763|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
130496764|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Relocated|0|||
130496765|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Relocated|0|||
130496766|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Relocated|6|||
130496767|NCT00048932|469786484|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
130496768|NCT00048932|469786485|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
130496769|NCT00048932|469786486|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
130496770|NCT00048932|469786484|FG000|Open Label Period (OL)|Site Closure|0|||
130496771|NCT00048932|469786485|FG001|Open Label Period (OL)|Site Closure|0|||
130496772|NCT00048932|469786486|FG002|Open Label Period (OL)|Site Closure|3|||
130496773|NCT00048932|469786484|FG000|Open Label Period (OL)|Trial Terminated|0|||
130496774|NCT00048932|469786485|FG001|Open Label Period (OL)|Trial Terminated|0|||
130496775|NCT00048932|469786486|FG002|Open Label Period (OL)|Trial Terminated|1|||
130496776|NCT00048932|469786484|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
130496777|NCT00048932|469786485|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
130496778|NCT00048932|469786486|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
130496779|NCT00048932|469786484|FG000|Open Label Period (OL)|Patient Decision|0|||
130496780|NCT00048932|469786485|FG001|Open Label Period (OL)|Patient Decision|0|||
130496781|NCT00048932|469786486|FG002|Open Label Period (OL)|Patient Decision|4|||
130496782|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
130496783|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
130496784|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
130496785|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
130496786|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
130496787|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
130496788|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
130496789|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
130496790|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
130496791|NCT00048932|469786484|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
130496792|NCT00048932|469786485|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
130496793|NCT00048932|469786486|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
130496794|NCT00048932|469786484|FG000|Open Label Period (OL)|Investigator Decision|0|||
130496795|NCT00048932|469786485|FG001|Open Label Period (OL)|Investigator Decision|0|||
130496796|NCT00048932|469786486|FG002|Open Label Period (OL)|Investigator Decision|4|||
130496797|NCT00048932|469786484|FG000|Open Label Period (OL)|Site Staff Issues|0|||
130496798|NCT00048932|469786485|FG001|Open Label Period (OL)|Site Staff Issues|0|||
130496799|NCT00048932|469786486|FG002|Open Label Period (OL)|Site Staff Issues|2|||
130496800|NCT00048932|469786484|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
130496801|NCT00048932|469786485|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
130496802|NCT00048932|469786486|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
130496803|NCT00048932|469786484|FG000|Open Label Period (OL)|Participant Surgery|0|||
130496804|NCT00048932|469786485|FG001|Open Label Period (OL)|Participant Surgery|0|||
130496805|NCT00048932|469786486|FG002|Open Label Period (OL)|Participant Surgery|1|||
130496806|NCT02232737|469786487|FG000|Overall Study|Lost to Follow-up|18|||
130496807|NCT02232737|469786488|FG001|Overall Study|Lost to Follow-up|28|||
130496808|NCT02232737|469786489|FG002|Overall Study|Lost to Follow-up|33|||
130496809|NCT02232737|469786487|FG000|Overall Study|Personal reasons|7|||
130496810|NCT02232737|469786488|FG001|Overall Study|Personal reasons|8|||
130496811|NCT02232737|469786489|FG002|Overall Study|Personal reasons|14|||
130496812|NCT02232737|469786487|FG000|Overall Study|Adverse Event|6|||
130496813|NCT02232737|469786488|FG001|Overall Study|Adverse Event|3|||
130496814|NCT02232737|469786489|FG002|Overall Study|Adverse Event|8|||
130496815|NCT02232737|469786487|FG000|Overall Study|Incarcerated|2|||
130496816|NCT02232737|469786488|FG001|Overall Study|Incarcerated|1|||
130496817|NCT02232737|469786489|FG002|Overall Study|Incarcerated|2|||
130496818|NCT02232737|469786487|FG000|Overall Study|Withdrawal by Subject|0|||
130496819|NCT02232737|469786488|FG001|Overall Study|Withdrawal by Subject|1|||
130496820|NCT02232737|469786489|FG002|Overall Study|Withdrawal by Subject|2|||
130496821|NCT02232737|469786487|FG000|Overall Study|Death|0|||
130496822|NCT02232737|469786488|FG001|Overall Study|Death|1|||
130496823|NCT02232737|469786489|FG002|Overall Study|Death|1|||
130496824|NCT02232737|469786487|FG000|Overall Study|Physician Decision|1|||
130496825|NCT02232737|469786488|FG001|Overall Study|Physician Decision|3|||
130496826|NCT02232737|469786489|FG002|Overall Study|Physician Decision|1|||
130496827|NCT02232737|469786487|FG000|Overall Study|Protocol Violation|1|||
130496828|NCT02232737|469786488|FG001|Overall Study|Protocol Violation|0|||
130496829|NCT02232737|469786489|FG002|Overall Study|Protocol Violation|1|||
130496830|NCT02232737|469786487|FG000|Overall Study|Reason unknown|1|||
130496831|NCT02232737|469786488|FG001|Overall Study|Reason unknown|0|||
130496832|NCT02232737|469786489|FG002|Overall Study|Reason unknown|0|||
130496833|NCT04559698|469786490|FG000|Overall Study|Lost to Follow-up|14|||
130496834|NCT04559698|469786491|FG001|Overall Study|Lost to Follow-up|15|||
130496835|NCT04559698|469786490|FG000|Overall Study|Withdrawal by Subject|0|||
130496836|NCT04559698|469786491|FG001|Overall Study|Withdrawal by Subject|1|||
130496837|NCT02200705|469786501|FG000|Overall Study|Excluded|12|||
130496838|NCT02200705|469786501|FG000|Overall Study|Death|21|||
130496839|NCT02200705|469786501|FG000|Overall Study|Withdrawal by Subject|22|||
130496840|NCT02200705|469786501|FG000|Overall Study|Lost to Follow-up|13|||
130496841|NCT02200705|469786501|FG000|Overall Study|Physician Decision|5|||
130496842|NCT02200705|469786501|FG000|Overall Study|Adverse Event|2|||
130496843|NCT03437733|469786502|FG000|Overall Study|Eligibility criteria not met|0|||
130496844|NCT03437733|469786503|FG001|Overall Study|Eligibility criteria not met|3|||
130496845|NCT00786864|469786504|FG000|Overall Study|Lost to Follow-up|0|||
130496846|NCT00786864|469786505|FG001|Overall Study|Lost to Follow-up|1|||
130496847|NCT00786864|469786504|FG000|Overall Study|Sustained serious back injury|1|||
130496848|NCT00786864|469786505|FG001|Overall Study|Sustained serious back injury|0|||
130496849|NCT04162210|469786513|FG000|Overall Study|Lost to Follow-up|4|||
130496850|NCT04162210|469786514|FG001|Overall Study|Lost to Follow-up|1|||
130496851|NCT04162210|469786513|FG000|Overall Study|Withdrawal by Subject|17|||
130496852|NCT04162210|469786514|FG001|Overall Study|Withdrawal by Subject|9|||
130496853|NCT04162210|469786513|FG000|Overall Study|Ongoing|113|||
130496854|NCT04162210|469786514|FG001|Overall Study|Ongoing|59|||
130496855|NCT03220724|469786520|FG000|Overall Study|Lost to Follow-up|2|||
130496856|NCT03220724|469786521|FG001|Overall Study|Lost to Follow-up|2|||
130496857|NCT03220724|469786522|FG002|Overall Study|Lost to Follow-up|0|||
130496858|NCT03220724|469786523|FG003|Overall Study|Lost to Follow-up|3|||
130496859|NCT03220724|469786524|FG004|Overall Study|Lost to Follow-up|1|||
130496860|NCT03220724|469786525|FG005|Overall Study|Lost to Follow-up|0|||
130496861|NCT03220724|469786526|FG006|Overall Study|Lost to Follow-up|2|||
130496862|NCT03220724|469786527|FG007|Overall Study|Lost to Follow-up|1|||
130496863|NCT03220724|469786528|FG008|Overall Study|Lost to Follow-up|0|||
130496864|NCT03220724|469786520|FG000|Overall Study|Withdrawal by Subject|1|||
130496865|NCT03220724|469786521|FG001|Overall Study|Withdrawal by Subject|0|||
130496866|NCT03220724|469786522|FG002|Overall Study|Withdrawal by Subject|1|||
130496867|NCT03220724|469786523|FG003|Overall Study|Withdrawal by Subject|0|||
130496868|NCT03220724|469786524|FG004|Overall Study|Withdrawal by Subject|0|||
130496869|NCT03220724|469786525|FG005|Overall Study|Withdrawal by Subject|0|||
130496870|NCT03220724|469786526|FG006|Overall Study|Withdrawal by Subject|0|||
130496871|NCT03220724|469786527|FG007|Overall Study|Withdrawal by Subject|0|||
130496872|NCT03220724|469786528|FG008|Overall Study|Withdrawal by Subject|0|||
130496873|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
130496874|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
130496875|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
130496876|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
130496877|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
130496878|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
130496879|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
130496880|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
130496881|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
130496882|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
130496883|NCT01767467|469786529|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
130496884|NCT01767467|469786530|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
130496885|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
130496886|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
130496887|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
130496888|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
130496889|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
130565633|NCT01816061|470036960|FG000|Overall Study|Lost to Follow-up|13|||
130496890|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
130496891|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
130496892|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
130496893|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
130496894|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
130496895|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
130496896|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
130565634|NCT01816061|470036961|FG001|Overall Study|Lost to Follow-up|24|||
130565635|NCT01471015|470036963|FG000|Overall Study|Death|0|||
130496897|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
130496898|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
130496899|NCT01767467|469786529|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
130496900|NCT01767467|469786530|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
130496901|NCT01640951|469786531|FG000|Overall Study|Adverse Event|8|||
130496902|NCT01640951|469786532|FG001|Overall Study|Adverse Event|3|||
130496903|NCT01640951|469786533|FG002|Overall Study|Adverse Event|10|||
130496904|NCT01640951|469786534|FG003|Overall Study|Adverse Event|6|||
130496905|NCT01640951|469786535|FG004|Overall Study|Adverse Event|1|||
130496906|NCT01640951|469786536|FG005|Overall Study|Adverse Event|11|||
130496907|NCT01640951|469786537|FG006|Overall Study|Adverse Event|1|||
130496908|NCT01640951|469786538|FG007|Overall Study|Adverse Event|3|||
130496909|NCT01640951|469786531|FG000|Overall Study|Lack of Efficacy|20|||
130496910|NCT01640951|469786532|FG001|Overall Study|Lack of Efficacy|1|||
130496911|NCT01640951|469786533|FG002|Overall Study|Lack of Efficacy|7|||
130496912|NCT01640951|469786534|FG003|Overall Study|Lack of Efficacy|14|||
130496913|NCT01640951|469786535|FG004|Overall Study|Lack of Efficacy|0|||
130496914|NCT01640951|469786536|FG005|Overall Study|Lack of Efficacy|6|||
130496915|NCT01640951|469786537|FG006|Overall Study|Lack of Efficacy|5|||
130496916|NCT01640951|469786538|FG007|Overall Study|Lack of Efficacy|6|||
130496917|NCT01640951|469786531|FG000|Overall Study|Lost to Follow-up|1|||
130496918|NCT01640951|469786532|FG001|Overall Study|Lost to Follow-up|0|||
130496919|NCT01640951|469786533|FG002|Overall Study|Lost to Follow-up|6|||
130496920|NCT01640951|469786534|FG003|Overall Study|Lost to Follow-up|2|||
130496921|NCT01640951|469786535|FG004|Overall Study|Lost to Follow-up|2|||
130496922|NCT01640951|469786536|FG005|Overall Study|Lost to Follow-up|3|||
130496923|NCT01640951|469786537|FG006|Overall Study|Lost to Follow-up|1|||
130496924|NCT01640951|469786538|FG007|Overall Study|Lost to Follow-up|1|||
130496925|NCT01640951|469786531|FG000|Overall Study|Non-compliance with study treatment|0|||
130496926|NCT01640951|469786532|FG001|Overall Study|Non-compliance with study treatment|0|||
130496927|NCT01640951|469786533|FG002|Overall Study|Non-compliance with study treatment|1|||
130496928|NCT01640951|469786534|FG003|Overall Study|Non-compliance with study treatment|1|||
130496929|NCT01640951|469786535|FG004|Overall Study|Non-compliance with study treatment|1|||
130496930|NCT01640951|469786536|FG005|Overall Study|Non-compliance with study treatment|4|||
130496931|NCT01640951|469786537|FG006|Overall Study|Non-compliance with study treatment|1|||
130496932|NCT01640951|469786538|FG007|Overall Study|Non-compliance with study treatment|0|||
130496933|NCT01640951|469786531|FG000|Overall Study|Physician Decision|2|||
130496934|NCT01640951|469786532|FG001|Overall Study|Physician Decision|5|||
130496935|NCT01640951|469786533|FG002|Overall Study|Physician Decision|2|||
130496936|NCT01640951|469786534|FG003|Overall Study|Physician Decision|2|||
130496937|NCT01640951|469786535|FG004|Overall Study|Physician Decision|2|||
130496938|NCT01640951|469786536|FG005|Overall Study|Physician Decision|3|||
130496939|NCT01640951|469786537|FG006|Overall Study|Physician Decision|3|||
130496940|NCT01640951|469786538|FG007|Overall Study|Physician Decision|0|||
130496941|NCT01640951|469786531|FG000|Overall Study|Pregnancy|3|||
130496942|NCT01640951|469786532|FG001|Overall Study|Pregnancy|0|||
130496943|NCT01640951|469786533|FG002|Overall Study|Pregnancy|0|||
130496944|NCT01640951|469786534|FG003|Overall Study|Pregnancy|4|||
130496945|NCT01640951|469786535|FG004|Overall Study|Pregnancy|0|||
130496946|NCT01640951|469786536|FG005|Overall Study|Pregnancy|0|||
130496947|NCT01640951|469786537|FG006|Overall Study|Pregnancy|2|||
130496948|NCT01640951|469786538|FG007|Overall Study|Pregnancy|0|||
130496949|NCT01640951|469786531|FG000|Overall Study|Protocol Deviation|0|||
130496950|NCT01640951|469786532|FG001|Overall Study|Protocol Deviation|1|||
130496951|NCT01640951|469786533|FG002|Overall Study|Protocol Deviation|2|||
130496952|NCT01640951|469786534|FG003|Overall Study|Protocol Deviation|1|||
130496953|NCT01640951|469786535|FG004|Overall Study|Protocol Deviation|0|||
130496954|NCT01640951|469786536|FG005|Overall Study|Protocol Deviation|1|||
130496955|NCT01640951|469786537|FG006|Overall Study|Protocol Deviation|0|||
130496956|NCT01640951|469786538|FG007|Overall Study|Protocol Deviation|0|||
130496957|NCT01640951|469786531|FG000|Overall Study|Subject/Guardian decision|12|||
130496958|NCT01640951|469786532|FG001|Overall Study|Subject/Guardian decision|4|||
130496959|NCT01640951|469786533|FG002|Overall Study|Subject/Guardian decision|13|||
130496960|NCT01640951|469786534|FG003|Overall Study|Subject/Guardian decision|15|||
130496961|NCT01640951|469786535|FG004|Overall Study|Subject/Guardian decision|7|||
130496962|NCT01640951|469786536|FG005|Overall Study|Subject/Guardian decision|19|||
130496963|NCT01640951|469786537|FG006|Overall Study|Subject/Guardian decision|5|||
130496964|NCT01640951|469786538|FG007|Overall Study|Subject/Guardian decision|4|||
130496965|NCT01640951|469786531|FG000|Overall Study|Death|0|||
130496966|NCT01640951|469786532|FG001|Overall Study|Death|1|||
130496967|NCT01640951|469786533|FG002|Overall Study|Death|1|||
130496968|NCT01640951|469786534|FG003|Overall Study|Death|0|||
130496969|NCT01640951|469786535|FG004|Overall Study|Death|0|||
130496970|NCT01640951|469786536|FG005|Overall Study|Death|0|||
130496971|NCT01640951|469786537|FG006|Overall Study|Death|0|||
130496972|NCT01640951|469786538|FG007|Overall Study|Death|2|||
130496973|NCT04971733|469786539|FG000|Overall Study|Adverse Event|1|||
130496974|NCT04971733|469786540|FG001|Overall Study|Adverse Event|1|||
130496975|NCT04971733|469786539|FG000|Overall Study|Subject choice|2|||
130496976|NCT04971733|469786540|FG001|Overall Study|Subject choice|0|||
130496977|NCT04971733|469786539|FG000|Overall Study|Withdrawal by Subject|1|||
130496978|NCT04971733|469786540|FG001|Overall Study|Withdrawal by Subject|0|||
130496979|NCT04971733|469786539|FG000|Overall Study|Other|1|||
130496980|NCT04971733|469786540|FG001|Overall Study|Other|0|||
130496981|NCT02406092|469786541|FG000|Overall Study|Screen failure|10|||
130496982|NCT02406092|469786542|FG001|Overall Study|Screen failure|7|||
130496983|NCT02406092|469786541|FG000|Overall Study|Death|22|||
130496984|NCT02406092|469786542|FG001|Overall Study|Death|5|||
130496985|NCT02406092|469786541|FG000|Overall Study|Lost to Follow-up|4|||
130496986|NCT02406092|469786542|FG001|Overall Study|Lost to Follow-up|1|||
130496987|NCT02406092|469786541|FG000|Overall Study|Adverse Event|1|||
130496988|NCT02406092|469786542|FG001|Overall Study|Adverse Event|0|||
130496989|NCT02406092|469786541|FG000|Overall Study|Withdrawal by Subject|1|||
130496990|NCT02406092|469786542|FG001|Overall Study|Withdrawal by Subject|0|||
130496991|NCT01593020|469786553|FG000|Overall Study|Adverse Event|1|||
130496992|NCT01593020|469786554|FG001|Overall Study|Adverse Event|1|||
130496993|NCT01593020|469786553|FG000|Overall Study|Death|0|||
130496994|NCT01593020|469786554|FG001|Overall Study|Death|1|||
130496995|NCT01593020|469786553|FG000|Overall Study|Ineligible|1|||
130496996|NCT01593020|469786554|FG001|Overall Study|Ineligible|0|||
130496997|NCT03598907|469786562|FG000|Overall Study|Physician Decision|14|||
130496998|NCT03598907|469786563|FG001|Overall Study|Physician Decision|19|||
130496999|NCT05251363|469786564|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
130497000|NCT05251363|469786564|FG000|Overall Study After Implant Period|Death|9|||
130497001|NCT05251363|469786564|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
130497002|NCT05251363|469786564|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
130497003|NCT05251363|469786564|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
130497004|NCT05251363|469786564|FG000|Overall Study After Implant Period|Physician Decision|1|||
130497005|NCT05251363|469786564|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
130497006|NCT03835754|469786565|FG000|Overall Study|Death|4|||
130497007|NCT04686266|469786569|FG000|Overall Study|Withdrawal by Subject|0|||
130497008|NCT04686266|469786570|FG001|Overall Study|Withdrawal by Subject|1|||
130497009|NCT04445831|469786571|FG000|Overall Study|Withdrawal by Subject|2|||
130497010|NCT04445831|469786572|FG001|Overall Study|Withdrawal by Subject|1|||
130497011|NCT04445831|469786573|FG002|Overall Study|Withdrawal by Subject|1|||
130497012|NCT04445831|469786574|FG003|Overall Study|Withdrawal by Subject|0|||
130497013|NCT04445831|469786575|FG004|Overall Study|Withdrawal by Subject|0|||
130497014|NCT04445831|469786576|FG005|Overall Study|Withdrawal by Subject|0|||
130497015|NCT04445831|469786577|FG006|Overall Study|Withdrawal by Subject|0|||
130497016|NCT04445831|469786571|FG000|Overall Study|Subject withdrawal by caregiver|0|||
130497017|NCT04445831|469786572|FG001|Overall Study|Subject withdrawal by caregiver|1|||
130497018|NCT04445831|469786573|FG002|Overall Study|Subject withdrawal by caregiver|0|||
130497019|NCT04445831|469786574|FG003|Overall Study|Subject withdrawal by caregiver|0|||
130497020|NCT04445831|469786575|FG004|Overall Study|Subject withdrawal by caregiver|0|||
130497021|NCT04445831|469786576|FG005|Overall Study|Subject withdrawal by caregiver|0|||
130497022|NCT04445831|469786577|FG006|Overall Study|Subject withdrawal by caregiver|0|||
130497023|NCT04306367|469786582|FG000|Overall Study|Progression of Disease|9|||
130497024|NCT04306367|469786582|FG000|Overall Study|Adverse Event|3|||
130497025|NCT04306367|469786582|FG000|Overall Study|Withdrawal by Subject|1|||
130497026|NCT04912856|469786588|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
130497027|NCT04912856|469786589|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
130497028|NCT04912856|469786588|FG000|Overall Study|Not reported in synoptic CSR.|0|||
130497029|NCT04912856|469786589|FG001|Overall Study|Not reported in synoptic CSR.|1|||
130497030|NCT00748709|469786592|FG000|Overall Study|Progressive disease|15|||
130497031|NCT00748709|469786592|FG000|Overall Study|Drug reducing Toxity|2|||
130497032|NCT00748709|469786592|FG000|Overall Study|Other Adverse Event|1|||
130497033|NCT00748709|469786592|FG000|Overall Study|Withdrawal by Subject|1|||
130497034|NCT00748709|469786592|FG000|Overall Study|Other Reasons|1|||
130497035|NCT05864209|469787932|FG000|Overall Study|Lost to Follow-up|2|||
130497036|NCT05864209|469787933|FG001|Overall Study|Lost to Follow-up|3|||
130497037|NCT00092534|469787936|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
130497038|NCT00092534|469787937|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
130497039|NCT00092534|469787938|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130497040|NCT00092534|469787939|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130497041|NCT00092534|469787940|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130497042|NCT00092534|469787936|FG000|Base Study Vaccination Period|Adverse Event|3|||
130497043|NCT00092534|469787937|FG001|Base Study Vaccination Period|Adverse Event|1|||
130497044|NCT00092534|469787938|FG002|Base Study Vaccination Period|Adverse Event|0|||
130497045|NCT00092534|469787939|FG003|Base Study Vaccination Period|Adverse Event|0|||
130497046|NCT00092534|469787940|FG004|Base Study Vaccination Period|Adverse Event|0|||
130497047|NCT00092534|469787936|FG000|Base Study Vaccination Period|Death|5|||
130497048|NCT00092534|469787937|FG001|Base Study Vaccination Period|Death|4|||
130497049|NCT00092534|469787938|FG002|Base Study Vaccination Period|Death|0|||
130497050|NCT00092534|469787939|FG003|Base Study Vaccination Period|Death|0|||
130729388|NCT01982812|470630668|FG000|Overall Study|Adverse Event|0|||
130729389|NCT01982812|470630669|FG001|Overall Study|Adverse Event|5|||
130729390|NCT00307437|470630670|FG000|Controlled Period|Adverse Event|7|||
130729391|NCT00307437|470630671|FG001|Controlled Period|Adverse Event|2|||
130729392|NCT00307437|470630672|FG002|Controlled Period|Adverse Event|5|||
130729393|NCT00307437|470630673|FG003|Controlled Period|Adverse Event|0|||
130729394|NCT00307437|470630674|FG004|Controlled Period|Adverse Event|0|||
130729395|NCT00307437|470630675|FG005|Controlled Period|Adverse Event|0|||
130729396|NCT00307437|470630676|FG006|Controlled Period|Adverse Event|0|||
130729397|NCT00307437|470630670|FG000|Controlled Period|Death|0|||
130729398|NCT00307437|470630671|FG001|Controlled Period|Death|0|||
130729399|NCT00307437|470630672|FG002|Controlled Period|Death|1|||
130729400|NCT00307437|470630673|FG003|Controlled Period|Death|0|||
130729401|NCT00307437|470630674|FG004|Controlled Period|Death|0|||
130729402|NCT00307437|470630675|FG005|Controlled Period|Death|0|||
130729403|NCT00307437|470630676|FG006|Controlled Period|Death|0|||
130729404|NCT00307437|470630670|FG000|Controlled Period|Lack of Efficacy|2|||
130729405|NCT00307437|470630671|FG001|Controlled Period|Lack of Efficacy|0|||
130729406|NCT00307437|470630672|FG002|Controlled Period|Lack of Efficacy|0|||
130729407|NCT00307437|470630673|FG003|Controlled Period|Lack of Efficacy|0|||
130729408|NCT00307437|470630674|FG004|Controlled Period|Lack of Efficacy|0|||
130729409|NCT00307437|470630675|FG005|Controlled Period|Lack of Efficacy|0|||
130729410|NCT00307437|470630676|FG006|Controlled Period|Lack of Efficacy|0|||
130729411|NCT00307437|470630670|FG000|Controlled Period|Lost to Follow-up|2|||
130729412|NCT00307437|470630671|FG001|Controlled Period|Lost to Follow-up|3|||
130729413|NCT00307437|470630672|FG002|Controlled Period|Lost to Follow-up|0|||
130729414|NCT00307437|470630673|FG003|Controlled Period|Lost to Follow-up|0|||
130729415|NCT00307437|470630674|FG004|Controlled Period|Lost to Follow-up|0|||
130729416|NCT00307437|470630675|FG005|Controlled Period|Lost to Follow-up|0|||
130729417|NCT00307437|470630676|FG006|Controlled Period|Lost to Follow-up|0|||
130729418|NCT00307437|470630670|FG000|Controlled Period|Other|5|||
130729419|NCT00307437|470630671|FG001|Controlled Period|Other|1|||
130729420|NCT00307437|470630672|FG002|Controlled Period|Other|3|||
130729421|NCT00307437|470630673|FG003|Controlled Period|Other|0|||
130729422|NCT00307437|470630674|FG004|Controlled Period|Other|0|||
130729423|NCT00307437|470630675|FG005|Controlled Period|Other|0|||
130729424|NCT00307437|470630676|FG006|Controlled Period|Other|0|||
130729425|NCT00307437|470630670|FG000|After Controlled Period|Adverse Event|0|||
130729426|NCT00307437|470630671|FG001|After Controlled Period|Adverse Event|0|||
130729427|NCT00307437|470630672|FG002|After Controlled Period|Adverse Event|0|||
130729428|NCT00307437|470630673|FG003|After Controlled Period|Adverse Event|18|||
130497051|NCT00092534|469787940|FG004|Base Study Vaccination Period|Death|0|||
130497052|NCT00092534|469787936|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
130497053|NCT00092534|469787937|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
130497054|NCT00092534|469787938|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130497055|NCT00092534|469787939|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130497056|NCT00092534|469787940|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130497057|NCT00092534|469787936|FG000|Base Study Vaccination Period|Physician Decision|1|||
130497058|NCT00092534|469787937|FG001|Base Study Vaccination Period|Physician Decision|0|||
130497059|NCT00092534|469787938|FG002|Base Study Vaccination Period|Physician Decision|0|||
130497060|NCT00092534|469787939|FG003|Base Study Vaccination Period|Physician Decision|0|||
130497061|NCT00092534|469787940|FG004|Base Study Vaccination Period|Physician Decision|0|||
130497062|NCT00092534|469787936|FG000|Base Study Vaccination Period|Pregnancy|9|||
130497063|NCT00092534|469787937|FG001|Base Study Vaccination Period|Pregnancy|7|||
130497064|NCT00092534|469787938|FG002|Base Study Vaccination Period|Pregnancy|0|||
130497065|NCT00092534|469787939|FG003|Base Study Vaccination Period|Pregnancy|0|||
130497066|NCT00092534|469787940|FG004|Base Study Vaccination Period|Pregnancy|0|||
130497067|NCT00092534|469787936|FG000|Base Study Vaccination Period|Protocol Violation|2|||
130497068|NCT00092534|469787937|FG001|Base Study Vaccination Period|Protocol Violation|1|||
130497069|NCT00092534|469787938|FG002|Base Study Vaccination Period|Protocol Violation|0|||
130497070|NCT00092534|469787939|FG003|Base Study Vaccination Period|Protocol Violation|0|||
130497071|NCT00092534|469787940|FG004|Base Study Vaccination Period|Protocol Violation|0|||
130497072|NCT00092534|469787936|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
130497073|NCT00092534|469787937|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
130729429|NCT00307437|470630674|FG004|After Controlled Period|Adverse Event|16|||
130729430|NCT00307437|470630675|FG005|After Controlled Period|Adverse Event|31|||
130729431|NCT00307437|470630676|FG006|After Controlled Period|Adverse Event|40|||
130497074|NCT00092534|469787938|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130497075|NCT00092534|469787939|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130729432|NCT00307437|470630670|FG000|After Controlled Period|Death|0|||
130729433|NCT00307437|470630671|FG001|After Controlled Period|Death|0|||
130729434|NCT00307437|470630672|FG002|After Controlled Period|Death|0|||
130729435|NCT00307437|470630673|FG003|After Controlled Period|Death|3|||
130729436|NCT00307437|470630674|FG004|After Controlled Period|Death|1|||
130729437|NCT00307437|470630675|FG005|After Controlled Period|Death|1|||
130729438|NCT00307437|470630676|FG006|After Controlled Period|Death|3|||
130729439|NCT00307437|470630670|FG000|After Controlled Period|Lack of Efficacy|0|||
130729440|NCT00307437|470630671|FG001|After Controlled Period|Lack of Efficacy|0|||
130729441|NCT00307437|470630672|FG002|After Controlled Period|Lack of Efficacy|0|||
130729442|NCT00307437|470630673|FG003|After Controlled Period|Lack of Efficacy|15|||
130729443|NCT00307437|470630674|FG004|After Controlled Period|Lack of Efficacy|17|||
130729444|NCT00307437|470630675|FG005|After Controlled Period|Lack of Efficacy|37|||
130729445|NCT00307437|470630676|FG006|After Controlled Period|Lack of Efficacy|24|||
130729446|NCT00307437|470630670|FG000|After Controlled Period|Lost to Follow-up|0|||
130729447|NCT00307437|470630671|FG001|After Controlled Period|Lost to Follow-up|0|||
130729448|NCT00307437|470630672|FG002|After Controlled Period|Lost to Follow-up|0|||
130729449|NCT00307437|470630673|FG003|After Controlled Period|Lost to Follow-up|7|||
130729450|NCT00307437|470630674|FG004|After Controlled Period|Lost to Follow-up|12|||
130729451|NCT00307437|470630675|FG005|After Controlled Period|Lost to Follow-up|13|||
130729452|NCT00307437|470630676|FG006|After Controlled Period|Lost to Follow-up|18|||
130729453|NCT00307437|470630670|FG000|After Controlled Period|Other|0|||
130729454|NCT00307437|470630671|FG001|After Controlled Period|Other|0|||
130729455|NCT00307437|470630672|FG002|After Controlled Period|Other|0|||
130729456|NCT00307437|470630673|FG003|After Controlled Period|Other|15|||
130729457|NCT00307437|470630674|FG004|After Controlled Period|Other|9|||
130729458|NCT00307437|470630675|FG005|After Controlled Period|Other|40|||
130729459|NCT00307437|470630676|FG006|After Controlled Period|Other|28|||
130729460|NCT00338728|470630677|FG000|Overall Study|Screen Failure|14|||
130729461|NCT02933255|470630683|FG000|Overall Study|Discontinued due to study closure.|1|||
130729462|NCT02933255|470630684|FG001|Overall Study|Discontinued due to study closure.|0|||
130729463|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
130729464|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
130729465|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
130729466|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
130729467|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
130729468|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
130729469|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
130729470|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
130729471|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
130729472|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
130729473|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
130729474|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
130729475|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
130497076|NCT00092534|469787940|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130497077|NCT00092534|469787936|FG000|Base Study Vaccination Period|Moved|14|||
130497078|NCT00092534|469787937|FG001|Base Study Vaccination Period|Moved|12|||
130497079|NCT00092534|469787938|FG002|Base Study Vaccination Period|Moved|0|||
130497080|NCT00092534|469787939|FG003|Base Study Vaccination Period|Moved|0|||
130497081|NCT00092534|469787940|FG004|Base Study Vaccination Period|Moved|0|||
130497082|NCT00092534|469787936|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
130497083|NCT00092534|469787937|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
130497084|NCT00092534|469787938|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
130497085|NCT00092534|469787939|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
130497086|NCT00092534|469787940|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
130497087|NCT00092534|469787936|FG000|Base Study Vaccination Period|Travel|1|||
130497088|NCT00092534|469787937|FG001|Base Study Vaccination Period|Travel|0|||
130497089|NCT00092534|469787938|FG002|Base Study Vaccination Period|Travel|0|||
130497090|NCT00092534|469787939|FG003|Base Study Vaccination Period|Travel|0|||
130497091|NCT00092534|469787940|FG004|Base Study Vaccination Period|Travel|0|||
130497092|NCT00092534|469787936|FG000|Base Study Vaccination Period|Site Closed|0|||
130497093|NCT00092534|469787937|FG001|Base Study Vaccination Period|Site Closed|1|||
130497094|NCT00092534|469787938|FG002|Base Study Vaccination Period|Site Closed|0|||
130497095|NCT00092534|469787939|FG003|Base Study Vaccination Period|Site Closed|0|||
130497096|NCT00092534|469787940|FG004|Base Study Vaccination Period|Site Closed|0|||
130497097|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Adverse Event|2|||
130497098|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Adverse Event|4|||
130497099|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Adverse Event|0|||
130497100|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Adverse Event|0|||
130497101|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Adverse Event|0|||
130497102|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Death|2|||
130497103|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Death|1|||
130497104|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Death|0|||
130497105|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Death|0|||
130497106|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Death|0|||
130497107|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
130729476|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
130729477|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
130729478|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
130729479|NCT05833139|470633565|FG000|Study Period 2|Adverse Event|1|||
130729480|NCT03922529|470633566|FG000|Overall Study|Withdrawal by Subject|13|||
130497108|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
130497109|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
130497110|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
130497111|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
130497112|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Pregnancy|6|||
130497113|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Pregnancy|10|||
130497114|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Pregnancy|0|||
130497115|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Pregnancy|0|||
130497116|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Pregnancy|0|||
130497117|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
130497118|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
130497119|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
130497120|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
130497121|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
130497122|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
130497123|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
130497124|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
130497125|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
130497126|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
130497127|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Moved|62|||
130497128|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Moved|58|||
130497129|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Moved|0|||
130497130|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Moved|0|||
130497131|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Moved|0|||
130497132|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Travel|10|||
130497133|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Travel|7|||
130497134|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Travel|0|||
130497135|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Travel|0|||
130497136|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Travel|0|||
130497137|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Site Closed|0|||
130497138|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Site Closed|2|||
130497139|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Site Closed|0|||
130497140|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Site Closed|0|||
130497141|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Site Closed|0|||
130497142|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
130497143|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
130497144|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
130497145|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
130497146|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
130497147|NCT00092534|469787936|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
130497148|NCT00092534|469787937|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
130497149|NCT00092534|469787938|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
130497150|NCT00092534|469787939|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
130497151|NCT00092534|469787940|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
130497152|NCT00092534|469787936|FG000|Base Study EXT|Lost to Follow-up|0|||
130497153|NCT00092534|469787937|FG001|Base Study EXT|Lost to Follow-up|0|||
130497154|NCT00092534|469787938|FG002|Base Study EXT|Lost to Follow-up|41|||
130497155|NCT00092534|469787939|FG003|Base Study EXT|Lost to Follow-up|0|||
130565636|NCT01471015|470036964|FG001|Overall Study|Death|1|||
130497156|NCT00092534|469787940|FG004|Base Study EXT|Lost to Follow-up|0|||
130497157|NCT00092534|469787936|FG000|Base Study EXT|Physician Decision|0|||
130497158|NCT00092534|469787937|FG001|Base Study EXT|Physician Decision|0|||
130497159|NCT00092534|469787938|FG002|Base Study EXT|Physician Decision|1|||
130497160|NCT00092534|469787939|FG003|Base Study EXT|Physician Decision|0|||
130497161|NCT00092534|469787940|FG004|Base Study EXT|Physician Decision|0|||
130497162|NCT00092534|469787936|FG000|Base Study EXT|Pregnancy|0|||
130497163|NCT00092534|469787937|FG001|Base Study EXT|Pregnancy|0|||
130497164|NCT00092534|469787938|FG002|Base Study EXT|Pregnancy|12|||
130497165|NCT00092534|469787939|FG003|Base Study EXT|Pregnancy|0|||
130497166|NCT00092534|469787940|FG004|Base Study EXT|Pregnancy|0|||
130497167|NCT00092534|469787936|FG000|Base Study EXT|Withdrawal by Subject|0|||
130497168|NCT00092534|469787937|FG001|Base Study EXT|Withdrawal by Subject|0|||
130497169|NCT00092534|469787938|FG002|Base Study EXT|Withdrawal by Subject|18|||
130497170|NCT00092534|469787939|FG003|Base Study EXT|Withdrawal by Subject|0|||
130497171|NCT00092534|469787940|FG004|Base Study EXT|Withdrawal by Subject|0|||
130497172|NCT00092534|469787936|FG000|Base Study EXT|Participant moved|0|||
130497173|NCT00092534|469787937|FG001|Base Study EXT|Participant moved|0|||
130497174|NCT00092534|469787938|FG002|Base Study EXT|Participant moved|6|||
130497175|NCT00092534|469787939|FG003|Base Study EXT|Participant moved|0|||
130497176|NCT00092534|469787940|FG004|Base Study EXT|Participant moved|0|||
130497177|NCT00092534|469787936|FG000|Base Study EXT|Travel|0|||
130497178|NCT00092534|469787937|FG001|Base Study EXT|Travel|0|||
130497179|NCT00092534|469787938|FG002|Base Study EXT|Travel|2|||
130497180|NCT00092534|469787939|FG003|Base Study EXT|Travel|0|||
130497181|NCT00092534|469787940|FG004|Base Study EXT|Travel|0|||
130497182|NCT00092534|469787936|FG000|Base Study EXT|Site closed|0|||
130565637|NCT01471015|470036965|FG002|Overall Study|Death|1|||
130497183|NCT00092534|469787937|FG001|Base Study EXT|Site closed|0|||
130497184|NCT00092534|469787938|FG002|Base Study EXT|Site closed|21|||
130497185|NCT00092534|469787939|FG003|Base Study EXT|Site closed|0|||
130497186|NCT00092534|469787940|FG004|Base Study EXT|Site closed|0|||
130497187|NCT00092534|469787936|FG000|Base Study EXT|Study ended|0|||
130497188|NCT00092534|469787937|FG001|Base Study EXT|Study ended|0|||
130729481|NCT03922529|470633567|FG001|Overall Study|Withdrawal by Subject|12|||
130729482|NCT03922529|470633566|FG000|Overall Study|Death|7|||
130729483|NCT03922529|470633567|FG001|Overall Study|Death|12|||
130729484|NCT03922529|470633566|FG000|Overall Study|Lost to Follow-up|12|||
130729485|NCT03922529|470633567|FG001|Overall Study|Lost to Follow-up|19|||
130729486|NCT03922529|470633566|FG000|Overall Study|Adverse Event|1|||
130729487|NCT03922529|470633567|FG001|Overall Study|Adverse Event|0|||
130729488|NCT03922529|470633566|FG000|Overall Study|Death after withdrawal|1|||
130729489|NCT03922529|470633567|FG001|Overall Study|Death after withdrawal|0|||
130729490|NCT03922529|470633566|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
130729491|NCT03922529|470633567|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
130729492|NCT03922529|470633566|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
130729493|NCT03922529|470633567|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
130729494|NCT02506153|470633568|FG000|Overall Study|Adverse Event|359|||
130729495|NCT02506153|470633569|FG001|Overall Study|Adverse Event|114|||
130729496|NCT02506153|470633568|FG000|Overall Study|Refused unrelated to adverse event|127|||
130497189|NCT00092534|469787938|FG002|Base Study EXT|Study ended|29|||
130497190|NCT00092534|469787939|FG003|Base Study EXT|Study ended|0|||
130497191|NCT00092534|469787940|FG004|Base Study EXT|Study ended|0|||
130497192|NCT00092534|469787936|FG000|Base Study EXT|Protocol Violation|0|||
130497193|NCT00092534|469787937|FG001|Base Study EXT|Protocol Violation|0|||
130497194|NCT00092534|469787938|FG002|Base Study EXT|Protocol Violation|15|||
130497195|NCT00092534|469787939|FG003|Base Study EXT|Protocol Violation|0|||
130497196|NCT00092534|469787940|FG004|Base Study EXT|Protocol Violation|0|||
130497197|NCT00092534|469787936|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
130497198|NCT00092534|469787937|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
130497199|NCT00092534|469787938|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
130497200|NCT00092534|469787939|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
130497201|NCT00092534|469787940|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
130497202|NCT00371345|469787946|FG000|Overall Study|Disease Progression|21|||
130497203|NCT00371345|469787947|FG001|Overall Study|Disease Progression|35|||
130497204|NCT00371345|469787946|FG000|Overall Study|Study Drug Toxicity|1|||
130497205|NCT00371345|469787947|FG001|Overall Study|Study Drug Toxicity|7|||
130497206|NCT00371345|469787946|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
130497207|NCT00371345|469787947|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
130497208|NCT00371345|469787946|FG000|Overall Study|Participant Request|1|||
130497209|NCT00371345|469787947|FG001|Overall Study|Participant Request|1|||
130497210|NCT00371345|469787946|FG000|Overall Study|Participant Withdrew Consent|0|||
130497211|NCT00371345|469787947|FG001|Overall Study|Participant Withdrew Consent|1|||
130497212|NCT00442104|469787952|FG000|Overall Study|Adverse Event|5|||
130497213|NCT00442104|469787952|FG000|Overall Study|Death|2|||
130497214|NCT00442104|469787952|FG000|Overall Study|Lost to Follow-up|3|||
130497215|NCT00442104|469787952|FG000|Overall Study|Withdrawal by Subject|5|||
130497216|NCT00442104|469787952|FG000|Overall Study|Insufficient Clinical Response|10|||
130497217|NCT00442104|469787952|FG000|Overall Study|Other|21|||
130497218|NCT00442104|469787952|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
130497219|NCT01478594|469787953|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
130497220|NCT01478594|469787954|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
130497221|NCT01478594|469787953|FG000|Overall Study|Death|45|||
130497222|NCT01478594|469787954|FG001|Overall Study|Death|18|||
130497223|NCT01478594|469787953|FG000|Overall Study|Lost to Follow-up|3|||
130497224|NCT01478594|469787954|FG001|Overall Study|Lost to Follow-up|1|||
130497225|NCT01478594|469787953|FG000|Overall Study|Withdrawal by Subject|9|||
130497226|NCT01478594|469787954|FG001|Overall Study|Withdrawal by Subject|3|||
130497227|NCT01478594|469787953|FG000|Overall Study|Study Closed by Sponsor|8|||
130497228|NCT01478594|469787954|FG001|Overall Study|Study Closed by Sponsor|5|||
130497229|NCT00713596|469787955|FG000|Overall Study|Study was terminated|2|||
130497230|NCT00713596|469787956|FG001|Overall Study|Study was terminated|3|||
130497231|NCT00713596|469787957|FG002|Overall Study|Study was terminated|2|||
130497232|NCT04545619|469787958|FG000|Overall Study|due to equipment challenges|1|||
130497233|NCT04885998|469787959|FG000|Overall Study|Withdrawal by Subject|0|||
130497234|NCT04885998|469787960|FG001|Overall Study|Withdrawal by Subject|2|||
130497235|NCT04885998|469787961|FG002|Overall Study|Withdrawal by Subject|0|||
130497236|NCT04885998|469787962|FG003|Overall Study|Withdrawal by Subject|3|||
130497237|NCT04885998|469787959|FG000|Overall Study|Lost to Follow-up|1|||
130497238|NCT04885998|469787960|FG001|Overall Study|Lost to Follow-up|1|||
130497239|NCT04885998|469787961|FG002|Overall Study|Lost to Follow-up|0|||
130497240|NCT04885998|469787962|FG003|Overall Study|Lost to Follow-up|0|||
130729497|NCT02506153|470633569|FG001|Overall Study|Refused unrelated to adverse event|18|||
130497241|NCT04885998|469787959|FG000|Overall Study|Death|2|||
130497242|NCT04885998|469787960|FG001|Overall Study|Death|1|||
130497243|NCT04885998|469787961|FG002|Overall Study|Death|2|||
130497244|NCT04885998|469787962|FG003|Overall Study|Death|2|||
130497245|NCT04885998|469787959|FG000|Overall Study|Decision by sponsor|1|||
130497246|NCT04885998|469787960|FG001|Overall Study|Decision by sponsor|1|||
130497247|NCT04885998|469787961|FG002|Overall Study|Decision by sponsor|0|||
130497248|NCT04885998|469787962|FG003|Overall Study|Decision by sponsor|0|||
130497249|NCT03712371|469787964|FG000|Overall Study|Lack of Efficacy|0|||
130497250|NCT03712371|469787965|FG001|Overall Study|Lack of Efficacy|0|||
130497251|NCT03712371|469787966|FG002|Overall Study|Lack of Efficacy|0|||
130497252|NCT03712371|469787967|FG003|Overall Study|Lack of Efficacy|1|||
130497253|NCT02788981|469787974|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
130497254|NCT02788981|469787975|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
130497255|NCT04250194|469787976|FG000|Overall Study|Declined to schedule biopsy|6|||
130497256|NCT04250194|469787977|FG001|Overall Study|Declined to schedule biopsy|10|||
130497257|NCT04250194|469787976|FG000|Overall Study|Medically Unfit for Biopsy|2|||
130497258|NCT04250194|469787977|FG001|Overall Study|Medically Unfit for Biopsy|1|||
130497259|NCT04250194|469787976|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
130497260|NCT04250194|469787977|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
130497261|NCT04250194|469787976|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
130497262|NCT04250194|469787977|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
130497263|NCT04250194|469787976|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
130497264|NCT04250194|469787977|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
130497265|NCT00463229|469787982|FG000|Overall Study|Lost to Follow-up|5|||
130497266|NCT00463229|469787983|FG001|Overall Study|Lost to Follow-up|7|||
130497267|NCT00463229|469787982|FG000|Overall Study|Death|4|||
130497268|NCT00463229|469787983|FG001|Overall Study|Death|3|||
130497269|NCT01932970|469787984|FG000|Overall Study|Withdrawal by Subject|5|||
130497270|NCT01932970|469787984|FG000|Overall Study|Death|1|||
130497271|NCT01932970|469787984|FG000|Overall Study|Lost to Follow-up|2|||
130497272|NCT01932970|469787984|FG000|Overall Study|Protocol Specified Criteria|10|||
130497273|NCT01359150|469787985|FG000|Overall Study|Lack of Efficacy|1|||
130497274|NCT01359150|469787986|FG001|Overall Study|Lack of Efficacy|1|||
130497275|NCT01359150|469787985|FG000|Overall Study|Withdrawal by Subject|1|||
130497276|NCT01359150|469787986|FG001|Overall Study|Withdrawal by Subject|1|||
130497277|NCT01359150|469787985|FG000|Overall Study|Adverse Event|4|||
130497278|NCT01359150|469787986|FG001|Overall Study|Adverse Event|3|||
130497279|NCT01359150|469787985|FG000|Overall Study|Other|1|||
130497280|NCT01359150|469787986|FG001|Overall Study|Other|0|||
130497281|NCT03113409|469787991|FG000|Overall Study|Withdrawal by Subject|5|||
130497282|NCT03113409|469787992|FG001|Overall Study|Withdrawal by Subject|0|||
130497283|NCT03113409|469787993|FG002|Overall Study|Withdrawal by Subject|0|||
130497284|NCT01787032|469788000|FG000|Overall Study|Protocol Violation|0|||
130497285|NCT01787032|469788001|FG001|Overall Study|Protocol Violation|0|||
130497286|NCT01787032|469788002|FG002|Overall Study|Protocol Violation|0|||
130497287|NCT01787032|469788003|FG003|Overall Study|Protocol Violation|0|||
130497288|NCT01787032|469788004|FG004|Overall Study|Protocol Violation|1|||
130497289|NCT01787032|469788005|FG005|Overall Study|Protocol Violation|1|||
130497290|NCT00776009|469788006|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
130497291|NCT00776009|469788007|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
130497292|NCT00776009|469788008|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
130497293|NCT00776009|469788009|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
130497294|NCT00776009|469788010|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
130497295|NCT00776009|469788011|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
130497296|NCT00776009|469788006|FG000|Period 1: First Intervention|Protocol Violation|0|||
130497297|NCT00776009|469788007|FG001|Period 1: First Intervention|Protocol Violation|1|||
130497298|NCT00776009|469788008|FG002|Period 1: First Intervention|Protocol Violation|0|||
130497299|NCT00776009|469788009|FG003|Period 1: First Intervention|Protocol Violation|0|||
130497300|NCT00776009|469788010|FG004|Period 1: First Intervention|Protocol Violation|1|||
130497301|NCT00776009|469788011|FG005|Period 1: First Intervention|Protocol Violation|0|||
130497302|NCT00776009|469788006|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
130497303|NCT00776009|469788007|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
130497304|NCT00776009|469788008|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
130497305|NCT00776009|469788009|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
130497306|NCT00776009|469788010|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
130497307|NCT00776009|469788011|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
130497308|NCT00776009|469788006|FG000|Period 2: Second Intervention|Protocol Violation|1|||
130497309|NCT00776009|469788007|FG001|Period 2: Second Intervention|Protocol Violation|0|||
130497310|NCT00776009|469788008|FG002|Period 2: Second Intervention|Protocol Violation|1|||
130497311|NCT00776009|469788009|FG003|Period 2: Second Intervention|Protocol Violation|0|||
130497312|NCT00776009|469788010|FG004|Period 2: Second Intervention|Protocol Violation|0|||
130497313|NCT00776009|469788011|FG005|Period 2: Second Intervention|Protocol Violation|0|||
130497314|NCT00776009|469788006|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
130497315|NCT00776009|469788007|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
130497316|NCT00776009|469788008|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
130497317|NCT00776009|469788009|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
130497318|NCT00776009|469788010|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
130497319|NCT00776009|469788011|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
130497320|NCT02040870|469788012|FG000|Overall Study|Completed treatment phase|6|||
130497321|NCT02040870|469788012|FG000|Overall Study|Adverse Event|7|||
130497322|NCT02040870|469788012|FG000|Overall Study|Progressive disease|58|||
130497323|NCT02040870|469788012|FG000|Overall Study|Physician Decision|6|||
130497324|NCT02040870|469788012|FG000|Overall Study|Subject/guardian decision|10|||
130497325|NCT02040870|469788012|FG000|Overall Study|Lost to Follow-up|3|||
130497326|NCT02040870|469788012|FG000|Overall Study|Death|13|||
130497327|NCT02275611|469788015|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
130497328|NCT02275611|469788016|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
130497329|NCT02275611|469788017|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
130497330|NCT02275611|469788018|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
130497331|NCT01759862|469788024|FG000|Overall Study|Physician Decision|3|||
130497332|NCT01759862|469788025|FG001|Overall Study|Physician Decision|1|||
130497333|NCT01759862|469788024|FG000|Overall Study|Adverse Event|0|||
130497334|NCT01759862|469788025|FG001|Overall Study|Adverse Event|1|||
130497335|NCT03890289|469788028|FG000|Overall Study|Adverse Event|1|||
130497336|NCT03890289|469788028|FG000|Overall Study|Physician Decision|1|||
130497337|NCT03890289|469788028|FG000|Overall Study|Lack of Efficacy|2|||
130497338|NCT02816398|469788029|FG000|Overall Study|Death|5|||
130497339|NCT02816398|469788029|FG000|Overall Study|Lack of Efficacy|8|||
130497340|NCT02816398|469788029|FG000|Overall Study|Lost to Follow-up|1|||
130497341|NCT01588951|469788034|FG000|Overall Study|Ineligible in retrospect|0|||
130497342|NCT01588951|469788035|FG001|Overall Study|Ineligible in retrospect|0|||
130497343|NCT01588951|469788036|FG002|Overall Study|Ineligible in retrospect|1|||
130497344|NCT02628626|469788037|FG000|Overall Study|Withdrawal by Subject|2|||
130497345|NCT02628626|469788038|FG001|Overall Study|Withdrawal by Subject|2|||
130497346|NCT02972359|469788044|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
130497347|NCT02972359|469788044|FG000|Overall Study|Lack of Efficacy|1|||
130497348|NCT02972359|469788044|FG000|Overall Study|Adverse Event|4|||
130497349|NCT02972359|469788044|FG000|Overall Study|Death|1|||
130497350|NCT02972359|469788044|FG000|Overall Study|Withdrawal by Subject|30|||
130497351|NCT02972359|469788044|FG000|Overall Study|Protocol Violation|1|||
130497352|NCT02972359|469788044|FG000|Overall Study|Lost to Follow-up|26|||
130497353|NCT02972359|469788044|FG000|Overall Study|Other reasons|5|||
130497354|NCT02972359|469788044|FG000|Overall Study|Missing|1|||
130497355|NCT02063659|469788045|FG000|Double-Blind Treatment Period|Adverse Event|1|||
130497356|NCT02063659|469788046|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130497357|NCT02063659|469788047|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130497358|NCT02063659|469788048|FG003|Double-Blind Treatment Period|Adverse Event|0|||
130497359|NCT02063659|469788045|FG000|Double-Blind Treatment Period|Physician Decision|1|||
130497360|NCT02063659|469788046|FG001|Double-Blind Treatment Period|Physician Decision|0|||
130497361|NCT02063659|469788047|FG002|Double-Blind Treatment Period|Physician Decision|0|||
130497362|NCT02063659|469788048|FG003|Double-Blind Treatment Period|Physician Decision|0|||
130497363|NCT02063659|469788045|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
130497364|NCT02063659|469788046|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
130497365|NCT02063659|469788047|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
130497366|NCT02063659|469788048|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
130497367|NCT02063659|469788045|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
130497368|NCT02063659|469788046|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
130497369|NCT02063659|469788047|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
130497370|NCT02063659|469788048|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
130497371|NCT02063659|469788045|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130565638|NCT02953340|470036966|FG000|Overall Study|Death|0|||
130565639|NCT02953340|470036967|FG001|Overall Study|Death|1|||
130497372|NCT02063659|469788046|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130497373|NCT02063659|469788047|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130497374|NCT02063659|469788048|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
130497375|NCT02063659|469788045|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130497376|NCT02063659|469788046|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130497377|NCT02063659|469788047|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130497378|NCT02063659|469788048|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
130497379|NCT02063659|469788045|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
130497380|NCT02063659|469788046|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
130497381|NCT02063659|469788047|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
130497382|NCT02063659|469788048|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
130497383|NCT02063659|469788045|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130497384|NCT02063659|469788046|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130497385|NCT02063659|469788047|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130497386|NCT02063659|469788048|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
130497387|NCT01532999|469788049|FG000|Overall Study|Lost to Follow-up|14|||
130497388|NCT01532999|469788050|FG001|Overall Study|Lost to Follow-up|8|||
130497389|NCT01532999|469788049|FG000|Overall Study|Physician Decision|1|||
130497390|NCT01532999|469788050|FG001|Overall Study|Physician Decision|2|||
130497391|NCT01532999|469788049|FG000|Overall Study|Withdrawal by Subject|5|||
130497392|NCT01532999|469788050|FG001|Overall Study|Withdrawal by Subject|0|||
130497393|NCT01532999|469788049|FG000|Overall Study|Relocated|2|||
130497394|NCT01532999|469788050|FG001|Overall Study|Relocated|0|||
130497395|NCT01532999|469788049|FG000|Overall Study|should not have been randomized|1|||
130497396|NCT01532999|469788050|FG001|Overall Study|should not have been randomized|0|||
130497397|NCT01532999|469788049|FG000|Overall Study|substantial noncompliance|2|||
130497398|NCT01532999|469788050|FG001|Overall Study|substantial noncompliance|0|||
130497399|NCT01532999|469788049|FG000|Overall Study|no show for week 9 assessments|6|||
130497400|NCT01532999|469788050|FG001|Overall Study|no show for week 9 assessments|4|||
130497401|NCT01532999|469788049|FG000|Overall Study|Adverse Event|0|||
130497402|NCT01532999|469788050|FG001|Overall Study|Adverse Event|1|||
130497403|NCT01532999|469788049|FG000|Overall Study|incarcerated|0|||
130497404|NCT01532999|469788050|FG001|Overall Study|incarcerated|1|||
130497405|NCT01532999|469788049|FG000|Overall Study|New job|0|||
130497406|NCT01532999|469788050|FG001|Overall Study|New job|2|||
130497407|NCT02830204|469788053|FG000|Overall Study|Death|9|||
130497408|NCT02830204|469788053|FG000|Overall Study|Withdrawal by Subject|1|||
130497409|NCT05470114|469788065|FG000|Overall Study|Withdrawal by Subject|1|||
130497410|NCT05470114|469788066|FG001|Overall Study|Withdrawal by Subject|0|||
130497411|NCT05470114|469788065|FG000|Overall Study|Lost to Follow-up|1|||
130497412|NCT05470114|469788066|FG001|Overall Study|Lost to Follow-up|0|||
130497413|NCT04649047|469788067|FG000|Overall Study|Withdrawal by Subject|3|||
130497414|NCT00719888|469788068|FG000|Overall Study|Death|24|||
130497415|NCT00719888|469788069|FG001|Overall Study|Death|9|||
130497416|NCT00719888|469788068|FG000|Overall Study|Relapse|8|||
130497417|NCT00719888|469788069|FG001|Overall Study|Relapse|3|||
130497418|NCT00719888|469788068|FG000|Overall Study|Physician Decision|1|||
130497419|NCT00719888|469788069|FG001|Overall Study|Physician Decision|0|||
130497420|NCT00719888|469788068|FG000|Overall Study|Withdrawal by Subject|1|||
130497421|NCT00719888|469788069|FG001|Overall Study|Withdrawal by Subject|0|||
130497422|NCT05037513|469788070|FG000|Intervention Period|Lost to Follow-up|1|||
130497423|NCT05037513|469788071|FG001|Intervention Period|Lost to Follow-up|2|||
130497424|NCT05037513|469788070|FG000|Follow Up Period|Lost to Follow-up|16|||
130497425|NCT05037513|469788071|FG001|Follow Up Period|Lost to Follow-up|21|||
130497426|NCT05037513|469788070|FG000|Follow Up Period|Death|0|||
130497427|NCT05037513|469788071|FG001|Follow Up Period|Death|1|||
130497428|NCT05037513|469788070|FG000|Follow Up Period|Incarcerated|4|||
130497429|NCT05037513|469788071|FG001|Follow Up Period|Incarcerated|2|||
130497430|NCT03773107|469788072|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
130497431|NCT03773107|469788073|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
130497432|NCT03773107|469788074|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
130497433|NCT03773107|469788075|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
130497434|NCT01563185|469788079|FG000|Overall Study|Withdrawal by Subject|1|||
130497435|NCT01563185|469788079|FG000|Overall Study|Non-Compliance with study drug|1|||
130497436|NCT06056310|469789581|FG000|Overall Study|Other Reasons|2|||
130497437|NCT06056310|469789581|FG000|Overall Study|Sponsor Request|16|||
130497438|NCT05029284|469789584|FG000|Overall Study|Lost to Follow-up|1|||
130497439|NCT04001829|469789585|FG000|Overall Study|Never start protocol therapy|5|||
130497440|NCT04001829|469789586|FG001|Overall Study|Never start protocol therapy|5|||
130497441|NCT04001829|469789585|FG000|Overall Study|Adverse Event|11|||
130729498|NCT02506153|470633568|FG000|Overall Study|Progression/relapse|91|||
130497442|NCT04001829|469789586|FG001|Overall Study|Adverse Event|7|||
130497443|NCT04001829|469789585|FG000|Overall Study|Alternative therapy|1|||
130497444|NCT04001829|469789586|FG001|Overall Study|Alternative therapy|2|||
130497445|NCT04001829|469789585|FG000|Overall Study|Disease progression/relapse|2|||
130497446|NCT04001829|469789586|FG001|Overall Study|Disease progression/relapse|1|||
130497447|NCT04001829|469789585|FG000|Overall Study|Other complicating disease|1|||
130497448|NCT04001829|469789586|FG001|Overall Study|Other complicating disease|0|||
130497449|NCT04001829|469789585|FG000|Overall Study|Withdrawal by Subject|1|||
130497450|NCT04001829|469789586|FG001|Overall Study|Withdrawal by Subject|4|||
130497451|NCT04001829|469789585|FG000|Overall Study|Ineligible|2|||
130497452|NCT04001829|469789586|FG001|Overall Study|Ineligible|2|||
130497453|NCT04001829|469789585|FG000|Overall Study|Reason missing due to delinquent data|1|||
130497454|NCT04001829|469789586|FG001|Overall Study|Reason missing due to delinquent data|0|||
130497455|NCT00985088|469789587|FG000|Overall Study|Serious Adverse Event|1|||
130497456|NCT00985088|469789588|FG001|Overall Study|Serious Adverse Event|1|||
130497457|NCT00985088|469789589|FG002|Overall Study|Serious Adverse Event|0|||
130497458|NCT00985088|469789590|FG003|Overall Study|Serious Adverse Event|0|||
130497459|NCT00985088|469789591|FG004|Overall Study|Serious Adverse Event|0|||
130497460|NCT00985088|469789592|FG005|Overall Study|Serious Adverse Event|0|||
130497461|NCT00985088|469789593|FG006|Overall Study|Serious Adverse Event|0|||
130497462|NCT00985088|469789594|FG007|Overall Study|Serious Adverse Event|1|||
130497463|NCT00985088|469789587|FG000|Overall Study|Adverse Event|0|||
130497464|NCT00985088|469789588|FG001|Overall Study|Adverse Event|0|||
130497465|NCT00985088|469789589|FG002|Overall Study|Adverse Event|1|||
130497466|NCT00985088|469789590|FG003|Overall Study|Adverse Event|0|||
130497467|NCT00985088|469789591|FG004|Overall Study|Adverse Event|0|||
130497468|NCT00985088|469789592|FG005|Overall Study|Adverse Event|0|||
130497469|NCT00985088|469789593|FG006|Overall Study|Adverse Event|0|||
130497470|NCT00985088|469789594|FG007|Overall Study|Adverse Event|0|||
130497471|NCT00985088|469789587|FG000|Overall Study|Withdrawal by Subject|4|||
130497472|NCT00985088|469789588|FG001|Overall Study|Withdrawal by Subject|0|||
130497473|NCT00985088|469789589|FG002|Overall Study|Withdrawal by Subject|0|||
130497474|NCT00985088|469789590|FG003|Overall Study|Withdrawal by Subject|1|||
130497475|NCT00985088|469789591|FG004|Overall Study|Withdrawal by Subject|3|||
130497476|NCT00985088|469789592|FG005|Overall Study|Withdrawal by Subject|2|||
130497477|NCT00985088|469789593|FG006|Overall Study|Withdrawal by Subject|1|||
130497478|NCT00985088|469789594|FG007|Overall Study|Withdrawal by Subject|2|||
130497479|NCT00985088|469789587|FG000|Overall Study|Migrated/moved from study area|0|||
130497480|NCT00985088|469789588|FG001|Overall Study|Migrated/moved from study area|0|||
130497481|NCT00985088|469789589|FG002|Overall Study|Migrated/moved from study area|1|||
130497482|NCT00985088|469789590|FG003|Overall Study|Migrated/moved from study area|0|||
130497483|NCT00985088|469789591|FG004|Overall Study|Migrated/moved from study area|0|||
130497484|NCT00985088|469789592|FG005|Overall Study|Migrated/moved from study area|0|||
130497485|NCT00985088|469789593|FG006|Overall Study|Migrated/moved from study area|0|||
130497486|NCT00985088|469789594|FG007|Overall Study|Migrated/moved from study area|1|||
130497487|NCT00985088|469789587|FG000|Overall Study|Lost to Follow-up|6|||
130497488|NCT00985088|469789588|FG001|Overall Study|Lost to Follow-up|1|||
130497489|NCT00985088|469789589|FG002|Overall Study|Lost to Follow-up|2|||
130497490|NCT00985088|469789590|FG003|Overall Study|Lost to Follow-up|6|||
130497491|NCT00985088|469789591|FG004|Overall Study|Lost to Follow-up|6|||
130497492|NCT00985088|469789592|FG005|Overall Study|Lost to Follow-up|5|||
130497493|NCT00985088|469789593|FG006|Overall Study|Lost to Follow-up|3|||
130497494|NCT00985088|469789594|FG007|Overall Study|Lost to Follow-up|2|||
130497495|NCT01737398|469789595|FG000|Overall Study|Adverse event or SAE|16|||
130497496|NCT01737398|469789596|FG001|Overall Study|Adverse event or SAE|1|||
130497497|NCT01737398|469789595|FG000|Overall Study|Stopping rule met|2|||
130497498|NCT01737398|469789596|FG001|Overall Study|Stopping rule met|1|||
130497499|NCT01737398|469789595|FG000|Overall Study|Voluntary withdrawal|2|||
130497500|NCT01737398|469789596|FG001|Overall Study|Voluntary withdrawal|3|||
130497501|NCT01737398|469789595|FG000|Overall Study|Ineligibility|1|||
130497502|NCT01737398|469789596|FG001|Overall Study|Ineligibility|0|||
130497503|NCT01737398|469789595|FG000|Overall Study|Liver transplant|1|||
130497504|NCT01737398|469789596|FG001|Overall Study|Liver transplant|0|||
130497505|NCT01737398|469789595|FG000|Overall Study|Disease progression|2|||
130497506|NCT01737398|469789596|FG001|Overall Study|Disease progression|3|||
130497507|NCT01737398|469789595|FG000|Overall Study|Sponsor's decision|2|||
130497508|NCT01737398|469789596|FG001|Overall Study|Sponsor's decision|0|||
130497509|NCT05250115|469789597|FG000|Overall Study|Premature study end|40|||
130497510|NCT05250115|469789597|FG000|Overall Study|Adverse Event|8|||
130497511|NCT05250115|469789597|FG000|Overall Study|Lost to Follow-up|7|||
130497512|NCT05250115|469789597|FG000|Overall Study|Withdrawal by Subject|6|||
130497513|NCT05250115|469789597|FG000|Overall Study|Withdrawal of informed consent|1|||
130497514|NCT05250115|469789597|FG000|Overall Study|Other|7|||
130497515|NCT00790569|469789602|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
130497516|NCT00790569|469789603|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
130497517|NCT00790569|469789604|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
130565640|NCT02953340|470036966|FG000|Overall Study|Investigator Decision|3|||
130497518|NCT00790569|469789602|FG000|End of Treatment (6 Month Interview)|Death|0|||
130497519|NCT00790569|469789603|FG001|End of Treatment (6 Month Interview)|Death|2|||
130497520|NCT00790569|469789604|FG002|End of Treatment (6 Month Interview)|Death|1|||
130497521|NCT00790569|469789602|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
130497522|NCT00790569|469789603|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
130497523|NCT00790569|469789604|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
130497524|NCT00790569|469789602|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
130497525|NCT00790569|469789603|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
130497526|NCT00790569|469789604|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
130497527|NCT00790569|469789602|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
130497528|NCT00790569|469789603|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
130497529|NCT00790569|469789604|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
130497530|NCT00790569|469789602|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
130497531|NCT00790569|469789603|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
130497532|NCT00790569|469789604|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
130497533|NCT03244800|469789606|FG000|Overall Study|Adverse Event|0|||
130497534|NCT03244800|469789607|FG001|Overall Study|Adverse Event|1|||
130497535|NCT03244800|469789608|FG002|Overall Study|Adverse Event|0|||
130497536|NCT03244800|469789609|FG003|Overall Study|Adverse Event|1|||
130497537|NCT03244800|469789606|FG000|Overall Study|Withdrew treatment|0|||
130497538|NCT03244800|469789607|FG001|Overall Study|Withdrew treatment|0|||
130497539|NCT03244800|469789608|FG002|Overall Study|Withdrew treatment|0|||
130497540|NCT03244800|469789609|FG003|Overall Study|Withdrew treatment|1|||
130497541|NCT02362035|469789610|FG000|Overall Study|Death|67|||
130497542|NCT02362035|469789610|FG000|Overall Study|Lost to Follow-up|3|||
130497543|NCT02362035|469789610|FG000|Overall Study|Adverse Event|1|||
130497544|NCT02362035|469789610|FG000|Overall Study|Physician Decision|1|||
130497545|NCT02362035|469789610|FG000|Overall Study|Subject started another cancer therapy|10|||
130497546|NCT02362035|469789610|FG000|Overall Study|Study terminated by sponsor|45|||
130497547|NCT02362035|469789610|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
130497548|NCT02362035|469789610|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
130497549|NCT02362035|469789610|FG000|Overall Study|Disease progression|11|||
130497550|NCT02362035|469789610|FG000|Overall Study|Withdrawal by Subject|20|||
130497551|NCT00229658|469789613|FG000|Overall Study|Administrative|2|||
130497552|NCT00229658|469789614|FG001|Overall Study|Administrative|1|||
130497553|NCT00229658|469789613|FG000|Overall Study|Investigator decision|13|||
130497554|NCT00229658|469789614|FG001|Overall Study|Investigator decision|10|||
130497555|NCT00229658|469789613|FG000|Overall Study|Other|80|||
130497556|NCT00229658|469789614|FG001|Overall Study|Other|60|||
130497557|NCT00229658|469789613|FG000|Overall Study|Lost to Follow-up|82|||
130497558|NCT00229658|469789614|FG001|Overall Study|Lost to Follow-up|55|||
130497559|NCT00229658|469789613|FG000|Overall Study|Serious Adverse Event|2|||
130497560|NCT00229658|469789614|FG001|Overall Study|Serious Adverse Event|2|||
130497561|NCT00229658|469789613|FG000|Overall Study|Withdrawal of consent|46|||
130497562|NCT00229658|469789614|FG001|Overall Study|Withdrawal of consent|39|||
130497563|NCT00249769|469789615|FG000|Overall Study|Withdrawal by Subject|1|||
130497564|NCT00249769|469789616|FG001|Overall Study|Withdrawal by Subject|10|||
130497565|NCT00249769|469789617|FG002|Overall Study|Withdrawal by Subject|6|||
130497566|NCT00249769|469789615|FG000|Overall Study|Migration from Study Area|1|||
130497567|NCT00249769|469789616|FG001|Overall Study|Migration from Study Area|3|||
130497568|NCT00249769|469789617|FG002|Overall Study|Migration from Study Area|14|||
130497569|NCT00249769|469789615|FG000|Overall Study|Miscellaneous|0|||
130497570|NCT00249769|469789616|FG001|Overall Study|Miscellaneous|2|||
130497571|NCT00249769|469789617|FG002|Overall Study|Miscellaneous|2|||
130497572|NCT00249769|469789615|FG000|Overall Study|Adverse Event|0|||
130497573|NCT00249769|469789616|FG001|Overall Study|Adverse Event|0|||
130497574|NCT00249769|469789617|FG002|Overall Study|Adverse Event|1|||
130497575|NCT00249769|469789615|FG000|Overall Study|Physician Decision|0|||
130497576|NCT00249769|469789616|FG001|Overall Study|Physician Decision|0|||
130497577|NCT00249769|469789617|FG002|Overall Study|Physician Decision|2|||
130497578|NCT00249769|469789615|FG000|Overall Study|Lost to Follow-up|0|||
130497579|NCT00249769|469789616|FG001|Overall Study|Lost to Follow-up|0|||
130497580|NCT00249769|469789617|FG002|Overall Study|Lost to Follow-up|3|||
130497581|NCT01953224|469789618|FG000|Overall Study|Lost to Follow-up|1|||
130497582|NCT01953224|469789619|FG001|Overall Study|Lost to Follow-up|1|||
130497583|NCT01953224|469789618|FG000|Overall Study|Withdrawal by Subject|1|||
130565641|NCT02953340|470036967|FG001|Overall Study|Investigator Decision|3|||
130565642|NCT02953340|470036966|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
130497584|NCT01953224|469789619|FG001|Overall Study|Withdrawal by Subject|2|||
130497585|NCT03041233|469789620|FG000|Overall Study|Death|5|||
130497586|NCT03041233|469789620|FG000|Overall Study|Physician Decision|1|||
130497587|NCT03041233|469789620|FG000|Overall Study|Lost to Follow-up|16|||
130497588|NCT03041233|469789620|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
130497589|NCT03041233|469789620|FG000|Overall Study|Sponsor Request|1|||
130497590|NCT03041233|469789620|FG000|Overall Study|Duplicate subject|1|||
130497591|NCT03041233|469789620|FG000|Overall Study|Re-ablation|1|||
130497592|NCT03229408|469789621|FG000|Overall Study|Withdrawal by Subject|4|||
130497593|NCT03229408|469789622|FG001|Overall Study|Withdrawal by Subject|1|||
130497594|NCT03229408|469789621|FG000|Overall Study|Adverse Event|2|||
130497595|NCT03229408|469789622|FG001|Overall Study|Adverse Event|0|||
130497596|NCT03229408|469789621|FG000|Overall Study|Pregnancy|0|||
130497597|NCT03229408|469789622|FG001|Overall Study|Pregnancy|1|||
130497598|NCT03229408|469789621|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
130497599|NCT03229408|469789622|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
130497600|NCT03516812|469789625|FG000|Overall Study|Adverse Event|4|||
130497601|NCT03516812|469789625|FG000|Overall Study|Lack of Efficacy|2|||
130497602|NCT03389802|469789628|FG000|Overall Study|Lack of Efficacy|3|||
130497603|NCT03389802|469789629|FG001|Overall Study|Lack of Efficacy|3|||
130497604|NCT03389802|469789630|FG002|Overall Study|Lack of Efficacy|13|||
130497605|NCT03389802|469789631|FG003|Overall Study|Lack of Efficacy|6|||
130497606|NCT03389802|469789632|FG004|Overall Study|Lack of Efficacy|1|||
130497607|NCT03389802|469789628|FG000|Overall Study|Adverse Event|0|||
130497608|NCT03389802|469789629|FG001|Overall Study|Adverse Event|0|||
130497609|NCT03389802|469789630|FG002|Overall Study|Adverse Event|1|||
130497610|NCT03389802|469789631|FG003|Overall Study|Adverse Event|0|||
130497611|NCT03389802|469789632|FG004|Overall Study|Adverse Event|4|||
130497612|NCT03389802|469789628|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
130497613|NCT03389802|469789629|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
130497614|NCT03389802|469789630|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
130497615|NCT03389802|469789631|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
130497616|NCT03389802|469789632|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
130497617|NCT00274261|469789633|FG000|Overall Study|Adverse Event|19|||
130497618|NCT00274261|469789634|FG001|Overall Study|Adverse Event|11|||
130497619|NCT00274261|469789633|FG000|Overall Study|Pregnancy|114|||
130497620|NCT00274261|469789634|FG001|Overall Study|Pregnancy|83|||
130497621|NCT00274261|469789633|FG000|Overall Study|Withdrawal by Subject|179|||
130497622|NCT00274261|469789634|FG001|Overall Study|Withdrawal by Subject|126|||
130497623|NCT00274261|469789633|FG000|Overall Study|Protocol Violation|71|||
130497624|NCT00274261|469789634|FG001|Overall Study|Protocol Violation|42|||
130497625|NCT00274261|469789633|FG000|Overall Study|Lost to Follow-up|106|||
130497626|NCT00274261|469789634|FG001|Overall Study|Lost to Follow-up|75|||
130497627|NCT02426138|469789635|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130497628|NCT02426138|469789636|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130497629|NCT03362190|469789645|FG000|Overall Study|Adverse Event|0|||
130497630|NCT03362190|469789646|FG001|Overall Study|Adverse Event|0|||
130497631|NCT03362190|469789647|FG002|Overall Study|Adverse Event|0|||
130497632|NCT03362190|469789648|FG003|Overall Study|Adverse Event|1|||
130497633|NCT03362190|469789645|FG000|Overall Study|Withdrawal by Subject|0|||
130497634|NCT03362190|469789646|FG001|Overall Study|Withdrawal by Subject|0|||
130497635|NCT03362190|469789647|FG002|Overall Study|Withdrawal by Subject|0|||
130497636|NCT03362190|469789648|FG003|Overall Study|Withdrawal by Subject|1|||
130497637|NCT00687219|469789649|FG000|Overall Study|Adverse Event|8|||
130497638|NCT00687219|469789649|FG000|Overall Study|Discontinuance criteria met|7|||
130497639|NCT00687219|469789649|FG000|Overall Study|HCV-RNA positive conversion|34|||
130497640|NCT00687219|469789649|FG000|Overall Study|Withdrawal by Subject|1|||
130497641|NCT00687219|469789649|FG000|Overall Study|Lack of Efficacy|1|||
130497642|NCT02350634|469789652|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
130497643|NCT01400958|469789663|FG000|Overall Study|Physician Decision|0|||
130497644|NCT01400958|469789664|FG001|Overall Study|Physician Decision|1|||
130497645|NCT01400958|469789663|FG000|Overall Study|Withdrawal by Subject|0|||
130497646|NCT01400958|469789664|FG001|Overall Study|Withdrawal by Subject|1|||
130497647|NCT01400958|469789663|FG000|Overall Study|Adverse Event|1|||
130497648|NCT01400958|469789664|FG001|Overall Study|Adverse Event|0|||
130497649|NCT00914966|469789665|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
130497650|NCT00914966|469789665|FG000|Step 1: 1500 Units|Physician Decision|1|||
130497651|NCT00914966|469789665|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
130497652|NCT04827732|469789666|FG000|Overall Study|Did not start treatment|0|||
130497653|NCT04827732|469789667|FG001|Overall Study|Did not start treatment|1|||
130497654|NCT04827732|469789668|FG002|Overall Study|Did not start treatment|0|||
130497655|NCT04827732|469789669|FG003|Overall Study|Did not start treatment|1|||
130497656|NCT03414684|469789671|FG000|First-course Treatment|Complete response|0|||
130497657|NCT03414684|469789672|FG001|First-course Treatment|Complete response|1|||
130565643|NCT02953340|470036967|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
130497658|NCT03414684|469789671|FG000|First-course Treatment|Intercurrent illness|1|||
130497659|NCT03414684|469789672|FG001|First-course Treatment|Intercurrent illness|0|||
130497660|NCT03414684|469789671|FG000|First-course Treatment|Progressive Disease|31|||
130497661|NCT03414684|469789672|FG001|First-course Treatment|Progressive Disease|32|||
130497662|NCT03414684|469789671|FG000|First-course Treatment|Adverse Event|1|||
130497663|NCT03414684|469789672|FG001|First-course Treatment|Adverse Event|2|||
130497664|NCT03414684|469789671|FG000|First-course Treatment|Physician Decision|0|||
130497665|NCT03414684|469789672|FG001|First-course Treatment|Physician Decision|1|||
130497666|NCT03414684|469789671|FG000|First-course Treatment|Withdrawal by Subject|0|||
130497667|NCT03414684|469789672|FG001|First-course Treatment|Withdrawal by Subject|1|||
130497668|NCT03414684|469789671|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
130497669|NCT03414684|469789672|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
130497670|NCT03414684|469789671|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
130497671|NCT03414684|469789672|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
130497672|NCT03414684|469789671|FG000|First-course Treatment|Still on treatment|3|||
130497673|NCT03414684|469789672|FG001|First-course Treatment|Still on treatment|0|||
130497674|NCT03414684|469789671|FG000|First-course Treatment|Never started protocol therapy|2|||
130497675|NCT03414684|469789672|FG001|First-course Treatment|Never started protocol therapy|1|||
130497676|NCT03414684|469789671|FG000|Crossover Treatment|Progressive disease|0|||
130497677|NCT03414684|469789672|FG001|Crossover Treatment|Progressive disease|12|||
130497678|NCT03414684|469789671|FG000|Crossover Treatment|Adverse Event|0|||
130497679|NCT03414684|469789672|FG001|Crossover Treatment|Adverse Event|3|||
130497680|NCT03414684|469789671|FG000|Crossover Treatment|Physician Decision|0|||
130497681|NCT03414684|469789672|FG001|Crossover Treatment|Physician Decision|1|||
130497682|NCT03414684|469789671|FG000|Crossover Treatment|Still on treatment|0|||
130497683|NCT03414684|469789672|FG001|Crossover Treatment|Still on treatment|2|||
130497684|NCT04038580|469789673|FG000|Washout 1|Death|0|||
130497685|NCT04038580|469789674|FG001|Washout 1|Death|0|||
130497686|NCT04038580|469789675|FG002|Washout 1|Death|0|||
130497687|NCT04038580|469789676|FG003|Washout 1|Death|1|||
130497688|NCT04038580|469789677|FG004|Washout 1|Death|0|||
130497689|NCT04038580|469789678|FG005|Washout 1|Death|0|||
130497690|NCT04038580|469789673|FG000|Washout 1|Withdrawal by Subject|0|||
130497691|NCT04038580|469789674|FG001|Washout 1|Withdrawal by Subject|0|||
130497692|NCT04038580|469789675|FG002|Washout 1|Withdrawal by Subject|0|||
130497693|NCT04038580|469789676|FG003|Washout 1|Withdrawal by Subject|0|||
130497694|NCT04038580|469789677|FG004|Washout 1|Withdrawal by Subject|1|||
130497695|NCT04038580|469789678|FG005|Washout 1|Withdrawal by Subject|0|||
130497696|NCT04038580|469789673|FG000|Wash-out 2|Withdrawal by Subject|1|||
130497697|NCT04038580|469789674|FG001|Wash-out 2|Withdrawal by Subject|0|||
130497698|NCT04038580|469789675|FG002|Wash-out 2|Withdrawal by Subject|0|||
130497699|NCT04038580|469789676|FG003|Wash-out 2|Withdrawal by Subject|2|||
130497700|NCT04038580|469789677|FG004|Wash-out 2|Withdrawal by Subject|0|||
130497701|NCT04038580|469789678|FG005|Wash-out 2|Withdrawal by Subject|1|||
130497702|NCT04038580|469789673|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
130497703|NCT04038580|469789674|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
130497704|NCT04038580|469789675|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
130497705|NCT04038580|469789676|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
130497706|NCT04038580|469789677|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
130497707|NCT04038580|469789678|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
130497708|NCT04038580|469789673|FG000|Wash-out 3|Withdrawal by Subject|1|||
130497709|NCT04038580|469789674|FG001|Wash-out 3|Withdrawal by Subject|0|||
130497710|NCT04038580|469789675|FG002|Wash-out 3|Withdrawal by Subject|2|||
130497711|NCT04038580|469789676|FG003|Wash-out 3|Withdrawal by Subject|0|||
130497712|NCT04038580|469789677|FG004|Wash-out 3|Withdrawal by Subject|0|||
130497713|NCT04038580|469789678|FG005|Wash-out 3|Withdrawal by Subject|0|||
130497714|NCT04021862|469789681|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
130497715|NCT04021862|469789682|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
130497716|NCT04021862|469789683|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
130497717|NCT04021862|469789684|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
130497718|NCT04021862|469789685|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
130497719|NCT04021862|469789686|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
130497720|NCT04021862|469789681|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
130497721|NCT04021862|469789682|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
130497722|NCT04021862|469789683|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
130497723|NCT04021862|469789684|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
130497724|NCT04021862|469789685|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
130497725|NCT04021862|469789686|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
130497726|NCT04021862|469789681|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
130497727|NCT04021862|469789682|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
130497728|NCT04021862|469789683|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
130497729|NCT04021862|469789684|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
130497730|NCT04021862|469789685|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
130729499|NCT02506153|470633569|FG001|Overall Study|Progression/relapse|136|||
130729500|NCT02506153|470633568|FG000|Overall Study|Death|2|||
130729501|NCT02506153|470633569|FG001|Overall Study|Death|1|||
130729502|NCT02506153|470633568|FG000|Overall Study|Other - not protocol specified|23|||
130729503|NCT02506153|470633569|FG001|Overall Study|Other - not protocol specified|12|||
130497731|NCT04021862|469789686|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
130497732|NCT04021862|469789681|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
130497733|NCT04021862|469789682|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
130497734|NCT04021862|469789683|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
130497735|NCT04021862|469789684|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
130497736|NCT04021862|469789685|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
130497737|NCT04021862|469789686|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
130497738|NCT04021862|469789681|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
130497739|NCT04021862|469789682|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
130497740|NCT04021862|469789683|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
130497741|NCT04021862|469789684|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
130497742|NCT04021862|469789685|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
130497743|NCT04021862|469789686|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
130497744|NCT01690624|469789687|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
130497745|NCT01690624|469789688|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
130497746|NCT01690624|469789689|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
130497747|NCT01690624|469789690|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
130497748|NCT01690624|469789687|FG000|Overall Study|Adverse event (other than DLT)|3|||
130497749|NCT01690624|469789688|FG001|Overall Study|Adverse event (other than DLT)|1|||
130497750|NCT01690624|469789689|FG002|Overall Study|Adverse event (other than DLT)|1|||
130497751|NCT01690624|469789690|FG003|Overall Study|Adverse event (other than DLT)|1|||
130497752|NCT01690624|469789687|FG000|Overall Study|Withdrawal by Subject|0|||
130497753|NCT01690624|469789688|FG001|Overall Study|Withdrawal by Subject|0|||
130497754|NCT01690624|469789689|FG002|Overall Study|Withdrawal by Subject|1|||
130497755|NCT01690624|469789690|FG003|Overall Study|Withdrawal by Subject|0|||
130497756|NCT01690624|469789687|FG000|Overall Study|Sponsor is ending trial|0|||
130497757|NCT01690624|469789688|FG001|Overall Study|Sponsor is ending trial|0|||
130497758|NCT01690624|469789689|FG002|Overall Study|Sponsor is ending trial|0|||
130497759|NCT01690624|469789690|FG003|Overall Study|Sponsor is ending trial|1|||
130497760|NCT01690624|469789687|FG000|Overall Study|Physician Decision|0|||
130497761|NCT01690624|469789688|FG001|Overall Study|Physician Decision|0|||
130497762|NCT01690624|469789689|FG002|Overall Study|Physician Decision|0|||
130497763|NCT01690624|469789690|FG003|Overall Study|Physician Decision|1|||
130497764|NCT01690624|469789687|FG000|Overall Study|Withdrawal by Subject|0|||
130497765|NCT01690624|469789688|FG001|Overall Study|Withdrawal by Subject|1|||
130497766|NCT01690624|469789689|FG002|Overall Study|Withdrawal by Subject|0|||
130497767|NCT01690624|469789690|FG003|Overall Study|Withdrawal by Subject|0|||
130497768|NCT01690624|469789687|FG000|Overall Study|Lack of Efficacy|1|||
130497769|NCT01690624|469789688|FG001|Overall Study|Lack of Efficacy|1|||
130497770|NCT01690624|469789689|FG002|Overall Study|Lack of Efficacy|3|||
130497771|NCT01690624|469789690|FG003|Overall Study|Lack of Efficacy|0|||
130497772|NCT02517268|469789692|FG000|Overall Study|Withdrawal by Subject|1|||
130497773|NCT02517268|469789693|FG001|Overall Study|Withdrawal by Subject|0|||
130497774|NCT04577651|469789702|FG000|Overall Study|Screen Failure|7|||
130497775|NCT04577651|469789702|FG000|Overall Study|Adverse Event|1|||
130497776|NCT04577651|469789702|FG000|Overall Study|Death|1|||
130497777|NCT04577651|469789702|FG000|Overall Study|Physician Decision|1|||
130497778|NCT04577651|469789702|FG000|Overall Study|Withdrawal by Subject|3|||
130497779|NCT02328014|469790821|FG000|Overall Study|Adverse Event|1|||
130497780|NCT02328014|469790822|FG001|Overall Study|Adverse Event|0|||
130497781|NCT02328014|469790823|FG002|Overall Study|Adverse Event|0|||
130497782|NCT02328014|469790824|FG003|Overall Study|Adverse Event|1|||
130497783|NCT02328014|469790821|FG000|Overall Study|Death|0|||
130497784|NCT02328014|469790822|FG001|Overall Study|Death|0|||
130497785|NCT02328014|469790823|FG002|Overall Study|Death|0|||
130497786|NCT02328014|469790824|FG003|Overall Study|Death|4|||
130497787|NCT02328014|469790821|FG000|Overall Study|Physician Decision|0|||
130497788|NCT02328014|469790822|FG001|Overall Study|Physician Decision|0|||
130497789|NCT02328014|469790823|FG002|Overall Study|Physician Decision|0|||
130497790|NCT02328014|469790824|FG003|Overall Study|Physician Decision|1|||
130497791|NCT02328014|469790821|FG000|Overall Study|Disease Progression|1|||
130497792|NCT02328014|469790822|FG001|Overall Study|Disease Progression|0|||
130497793|NCT02328014|469790823|FG002|Overall Study|Disease Progression|1|||
130497794|NCT02328014|469790824|FG003|Overall Study|Disease Progression|3|||
130497795|NCT02328014|469790821|FG000|Overall Study|Study Terminated by Sponsor|4|||
130729504|NCT02017015|470633570|FG000|Overall Study|Adverse Event|9|||
130497796|NCT02328014|469790822|FG001|Overall Study|Study Terminated by Sponsor|1|||
130497797|NCT02328014|469790823|FG002|Overall Study|Study Terminated by Sponsor|1|||
130497798|NCT02328014|469790824|FG003|Overall Study|Study Terminated by Sponsor|0|||
130497799|NCT02328014|469790821|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
130497800|NCT02328014|469790822|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
130497801|NCT02328014|469790823|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
130565644|NCT02953340|470036966|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
130497802|NCT02328014|469790824|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
130497803|NCT02328014|469790821|FG000|Overall Study|Withdrawal by Subject|0|||
130497804|NCT02328014|469790822|FG001|Overall Study|Withdrawal by Subject|0|||
130497805|NCT02328014|469790823|FG002|Overall Study|Withdrawal by Subject|0|||
130497806|NCT02328014|469790824|FG003|Overall Study|Withdrawal by Subject|1|||
130497807|NCT01274338|469790825|FG000|Overall Study|Lack of Efficacy|72|||
130497808|NCT01274338|469790826|FG001|Overall Study|Lack of Efficacy|108|||
130497809|NCT01274338|469790827|FG002|Overall Study|Lack of Efficacy|116|||
130497810|NCT01274338|469790828|FG003|Overall Study|Lack of Efficacy|0|||
130497811|NCT01274338|469790829|FG004|Overall Study|Lack of Efficacy|0|||
130497812|NCT01274338|469790830|FG005|Overall Study|Lack of Efficacy|0|||
130497813|NCT01274338|469790825|FG000|Overall Study|Adverse Event|272|||
130497814|NCT01274338|469790826|FG001|Overall Study|Adverse Event|105|||
130497815|NCT01274338|469790827|FG002|Overall Study|Adverse Event|180|||
130497816|NCT01274338|469790828|FG003|Overall Study|Adverse Event|1|||
130497817|NCT01274338|469790829|FG004|Overall Study|Adverse Event|0|||
130497818|NCT01274338|469790830|FG005|Overall Study|Adverse Event|0|||
130497819|NCT01274338|469790825|FG000|Overall Study|Death|8|||
130497820|NCT01274338|469790826|FG001|Overall Study|Death|1|||
130497821|NCT01274338|469790827|FG002|Overall Study|Death|0|||
130497822|NCT01274338|469790828|FG003|Overall Study|Death|0|||
130497823|NCT01274338|469790829|FG004|Overall Study|Death|0|||
130497824|NCT01274338|469790830|FG005|Overall Study|Death|0|||
130497825|NCT01274338|469790825|FG000|Overall Study|Withdrawal by Subject|27|||
130497826|NCT01274338|469790826|FG001|Overall Study|Withdrawal by Subject|99|||
130497827|NCT01274338|469790827|FG002|Overall Study|Withdrawal by Subject|17|||
130497828|NCT01274338|469790828|FG003|Overall Study|Withdrawal by Subject|0|||
130497829|NCT01274338|469790829|FG004|Overall Study|Withdrawal by Subject|0|||
130497830|NCT01274338|469790830|FG005|Overall Study|Withdrawal by Subject|0|||
130497831|NCT01274338|469790825|FG000|Overall Study|Did not start treatment|8|||
130497832|NCT01274338|469790826|FG001|Overall Study|Did not start treatment|116|||
130497833|NCT01274338|469790827|FG002|Overall Study|Did not start treatment|7|||
130497834|NCT01274338|469790828|FG003|Overall Study|Did not start treatment|0|||
130497835|NCT01274338|469790829|FG004|Overall Study|Did not start treatment|0|||
130497836|NCT01274338|469790830|FG005|Overall Study|Did not start treatment|0|||
130497837|NCT01274338|469790825|FG000|Overall Study|Alternative therapy|0|||
130497838|NCT01274338|469790826|FG001|Overall Study|Alternative therapy|1|||
130497839|NCT01274338|469790827|FG002|Overall Study|Alternative therapy|0|||
130497840|NCT01274338|469790828|FG003|Overall Study|Alternative therapy|0|||
130497841|NCT01274338|469790829|FG004|Overall Study|Alternative therapy|0|||
130497842|NCT01274338|469790830|FG005|Overall Study|Alternative therapy|0|||
130497843|NCT01274338|469790825|FG000|Overall Study|Other complicating diseases|0|||
130497844|NCT01274338|469790826|FG001|Overall Study|Other complicating diseases|3|||
130497845|NCT01274338|469790827|FG002|Overall Study|Other complicating diseases|1|||
130497846|NCT01274338|469790828|FG003|Overall Study|Other complicating diseases|0|||
130497847|NCT01274338|469790829|FG004|Overall Study|Other complicating diseases|0|||
130497848|NCT01274338|469790830|FG005|Overall Study|Other complicating diseases|0|||
130497849|NCT01274338|469790825|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
130497850|NCT01274338|469790826|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
130497851|NCT01274338|469790827|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
130497852|NCT01274338|469790828|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
130497853|NCT01274338|469790829|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
130497854|NCT01274338|469790830|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
130497855|NCT01274338|469790825|FG000|Overall Study|Pregnancy|0|||
130497856|NCT01274338|469790826|FG001|Overall Study|Pregnancy|0|||
130497857|NCT01274338|469790827|FG002|Overall Study|Pregnancy|1|||
130497858|NCT01274338|469790828|FG003|Overall Study|Pregnancy|0|||
130497859|NCT01274338|469790829|FG004|Overall Study|Pregnancy|0|||
130497860|NCT01274338|469790830|FG005|Overall Study|Pregnancy|0|||
130497861|NCT01274338|469790825|FG000|Overall Study|Reason not reported|12|||
130497862|NCT01274338|469790826|FG001|Overall Study|Reason not reported|21|||
130565645|NCT02953340|470036967|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
130729505|NCT02017015|470633570|FG000|Overall Study|Withdrawal by Subject|21|||
130729506|NCT02017015|470633570|FG000|Overall Study|Death|4|||
130729507|NCT02017015|470633570|FG000|Overall Study|Progressive Disease|31|||
130729508|NCT02017015|470633570|FG000|Overall Study|Non-compliance with study drug|2|||
130729509|NCT02017015|470633570|FG000|Overall Study|Physician Decision|2|||
130729510|NCT04158245|470633571|FG000|Overall Study|Lost to Follow-up|1|||
130729511|NCT02567435|470633574|FG000|Overall Study|Death|1|||
130729512|NCT02567435|470633575|FG001|Overall Study|Death|1|||
130729513|NCT02567435|470633576|FG002|Overall Study|Death|0|||
130729514|NCT02567435|470633577|FG003|Overall Study|Death|0|||
130729515|NCT02567435|470633574|FG000|Overall Study|Ineligible|1|||
130729516|NCT02567435|470633575|FG001|Overall Study|Ineligible|3|||
130497863|NCT01274338|469790827|FG002|Overall Study|Reason not reported|3|||
130497864|NCT01274338|469790828|FG003|Overall Study|Reason not reported|0|||
130497865|NCT01274338|469790829|FG004|Overall Study|Reason not reported|1|||
130497866|NCT01274338|469790830|FG005|Overall Study|Reason not reported|0|||
130729517|NCT02567435|470633576|FG002|Overall Study|Ineligible|0|||
130497867|NCT05422339|469790831|FG000|Overall Study|Withdrawal by Subject|17|||
130497868|NCT05422339|469790832|FG001|Overall Study|Withdrawal by Subject|15|||
130497869|NCT03678688|469790839|FG000|Overall Study|Reason not Specified|0|||
130497870|NCT03678688|469790840|FG001|Overall Study|Reason not Specified|0|||
130497871|NCT03678688|469790841|FG002|Overall Study|Reason not Specified|3|||
130497872|NCT03678688|469790842|FG003|Overall Study|Reason not Specified|0|||
130497873|NCT03678688|469790843|FG004|Overall Study|Reason not Specified|1|||
130497874|NCT03678688|469790844|FG005|Overall Study|Reason not Specified|0|||
130497875|NCT03678688|469790845|FG006|Overall Study|Reason not Specified|0|||
130497876|NCT03678688|469790846|FG007|Overall Study|Reason not Specified|0|||
130497877|NCT03678688|469790847|FG008|Overall Study|Reason not Specified|0|||
130497878|NCT03678688|469790839|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
130497879|NCT03678688|469790840|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
130497880|NCT03678688|469790841|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
130497881|NCT03678688|469790842|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
130497882|NCT03678688|469790843|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
130497883|NCT03678688|469790844|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
130497884|NCT03678688|469790845|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
130497885|NCT03678688|469790846|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
130497886|NCT03678688|469790847|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
130497887|NCT03678688|469790839|FG000|Overall Study|Covid Related Adverse Event|0|||
130497888|NCT03678688|469790840|FG001|Overall Study|Covid Related Adverse Event|0|||
130497889|NCT03678688|469790841|FG002|Overall Study|Covid Related Adverse Event|0|||
130497890|NCT03678688|469790842|FG003|Overall Study|Covid Related Adverse Event|0|||
130497891|NCT03678688|469790843|FG004|Overall Study|Covid Related Adverse Event|0|||
130497892|NCT03678688|469790844|FG005|Overall Study|Covid Related Adverse Event|3|||
130497893|NCT03678688|469790845|FG006|Overall Study|Covid Related Adverse Event|1|||
130497894|NCT03678688|469790846|FG007|Overall Study|Covid Related Adverse Event|1|||
130497895|NCT03678688|469790847|FG008|Overall Study|Covid Related Adverse Event|0|||
130497896|NCT03678688|469790839|FG000|Overall Study|Physician Decision|0|||
130497897|NCT03678688|469790840|FG001|Overall Study|Physician Decision|0|||
130497898|NCT03678688|469790841|FG002|Overall Study|Physician Decision|0|||
130497899|NCT03678688|469790842|FG003|Overall Study|Physician Decision|0|||
130497900|NCT03678688|469790843|FG004|Overall Study|Physician Decision|0|||
130497901|NCT03678688|469790844|FG005|Overall Study|Physician Decision|1|||
130497902|NCT03678688|469790845|FG006|Overall Study|Physician Decision|0|||
130497903|NCT03678688|469790846|FG007|Overall Study|Physician Decision|0|||
130497904|NCT03678688|469790847|FG008|Overall Study|Physician Decision|0|||
130497905|NCT03678688|469790839|FG000|Overall Study|Withdrawal by Subject|0|||
130497906|NCT03678688|469790840|FG001|Overall Study|Withdrawal by Subject|0|||
130497907|NCT03678688|469790841|FG002|Overall Study|Withdrawal by Subject|0|||
130497908|NCT03678688|469790842|FG003|Overall Study|Withdrawal by Subject|0|||
130497909|NCT03678688|469790843|FG004|Overall Study|Withdrawal by Subject|0|||
130497910|NCT03678688|469790844|FG005|Overall Study|Withdrawal by Subject|0|||
130497911|NCT03678688|469790845|FG006|Overall Study|Withdrawal by Subject|2|||
130497912|NCT03678688|469790846|FG007|Overall Study|Withdrawal by Subject|1|||
130497913|NCT03678688|469790847|FG008|Overall Study|Withdrawal by Subject|0|||
130497914|NCT01278030|469790854|FG000|Overall Study|Withdrawal by Subject|8|||
130497915|NCT01278030|469790855|FG001|Overall Study|Withdrawal by Subject|4|||
130497916|NCT00458783|469790857|FG000|Overall Study|Protocol Violation|1228|||
130497917|NCT00458783|469790858|FG001|Overall Study|Protocol Violation|1220|||
130497918|NCT04401267|469790860|FG000|Overall Study|Death|0|||
130497919|NCT04401267|469790861|FG001|Overall Study|Death|1|||
130497920|NCT04401267|469790860|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
130497921|NCT04401267|469790861|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
130497922|NCT04401267|469790860|FG000|Overall Study|Found to be Ineligible|1|||
130497923|NCT04401267|469790861|FG001|Overall Study|Found to be Ineligible|0|||
130497924|NCT03214081|469790862|FG000|Overall Study|Case Report Forms Uncollected|9|||
130497925|NCT03214081|469790862|FG000|Overall Study|Protocol Deviation|54|||
130497926|NCT02962284|469790863|FG000|Overall Study|Death|2|||
130497927|NCT02962284|469790864|FG001|Overall Study|Death|0|||
130497928|NCT02962284|469790863|FG000|Overall Study|Progressive disease|2|||
130497929|NCT02962284|469790864|FG001|Overall Study|Progressive disease|3|||
130497930|NCT02962284|469790863|FG000|Overall Study|Withdrawal by Subject|1|||
130497931|NCT02962284|469790864|FG001|Overall Study|Withdrawal by Subject|0|||
130497932|NCT05815342|469790865|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
130497933|NCT05815342|469790865|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
130497934|NCT05815342|469790865|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
130497935|NCT05815342|469790865|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
130565646|NCT02953340|470036966|FG000|Overall Study|Withdrawal by Subject|9|||
130565647|NCT02953340|470036967|FG001|Overall Study|Withdrawal by Subject|9|||
130565648|NCT02953340|470036966|FG000|Overall Study|Sponsor decision|0|||
130497936|NCT05815342|469790865|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
130497937|NCT00345046|469790868|FG000|Overall Study|Protocol Violation|1|||
130497938|NCT00345046|469790869|FG001|Overall Study|Protocol Violation|1|||
130497939|NCT00345046|469790870|FG002|Overall Study|Protocol Violation|2|||
130497940|NCT01613417|469790871|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
130497941|NCT01613417|469790872|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
130497942|NCT00512252|469790873|FG000|Overall Study|Lost to Follow-up|0|||
130497943|NCT00512252|469790874|FG001|Overall Study|Lost to Follow-up|0|||
130497944|NCT00512252|469790875|FG002|Overall Study|Lost to Follow-up|1|||
130497945|NCT00512252|469790873|FG000|Overall Study|Protocol Violation|0|||
130497946|NCT00512252|469790874|FG001|Overall Study|Protocol Violation|0|||
130497947|NCT00512252|469790875|FG002|Overall Study|Protocol Violation|1|||
130497948|NCT00512252|469790873|FG000|Overall Study|Death|0|||
130497949|NCT00512252|469790874|FG001|Overall Study|Death|0|||
130497950|NCT00512252|469790875|FG002|Overall Study|Death|1|||
130497951|NCT02357966|469790876|FG000|Overall Study|Death|0|||
130497952|NCT02357966|469790877|FG001|Overall Study|Death|0|||
130497953|NCT02357966|469790878|FG002|Overall Study|Death|1|||
130497954|NCT02357966|469790879|FG003|Overall Study|Death|0|||
130497955|NCT02357966|469790880|FG004|Overall Study|Death|2|||
130497956|NCT02357966|469790881|FG005|Overall Study|Death|0|||
130497957|NCT02357966|469790876|FG000|Overall Study|Physician Decision|1|||
130497958|NCT02357966|469790877|FG001|Overall Study|Physician Decision|0|||
130497959|NCT02357966|469790878|FG002|Overall Study|Physician Decision|0|||
130497960|NCT02357966|469790879|FG003|Overall Study|Physician Decision|0|||
130497961|NCT02357966|469790880|FG004|Overall Study|Physician Decision|1|||
130497962|NCT02357966|469790881|FG005|Overall Study|Physician Decision|0|||
130497963|NCT00705406|469790882|FG000|Overall Study|Lost to Follow-up|3|||
130497964|NCT00705406|469790883|FG001|Overall Study|Lost to Follow-up|3|||
130497965|NCT00705406|469790882|FG000|Overall Study|Did not receive study drug|1|||
130497966|NCT00705406|469790883|FG001|Overall Study|Did not receive study drug|2|||
130497967|NCT04652726|469790890|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
130497968|NCT04652726|469790891|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
130497969|NCT04652726|469790892|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
130497970|NCT04652726|469790890|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
130497971|NCT04652726|469790891|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
130497972|NCT04652726|469790892|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
130497973|NCT02157116|469790893|FG000|Overall Study|Withdrawal by Subject|4|||
130497974|NCT02157116|469790893|FG000|Overall Study|Physician Decision|3|||
130497975|NCT02157116|469790893|FG000|Overall Study|Failed Screening|2|||
130497976|NCT00093496|469790894|FG000|Overall Study|Protocol Violation|1|||
130497977|NCT00093496|469790895|FG001|Overall Study|Protocol Violation|3|||
130497990|NCT02101775|469790902|FG000|Overall Study|Adverse Event|4|||
130497991|NCT02101775|469790903|FG001|Overall Study|Adverse Event|0|||
130497992|NCT02101775|469790904|FG002|Overall Study|Adverse Event|0|||
130497993|NCT02101775|469790902|FG000|Overall Study|Admission to Hospital|0|||
130497994|NCT02101775|469790903|FG001|Overall Study|Admission to Hospital|1|||
130497995|NCT02101775|469790904|FG002|Overall Study|Admission to Hospital|0|||
130497996|NCT04200664|469790907|FG000|Overall Study|Withdrawal by Subject|1|||
130497997|NCT04200664|469790908|FG001|Overall Study|Withdrawal by Subject|0|||
130497998|NCT04200664|469790909|FG002|Overall Study|Withdrawal by Subject|0|||
130497999|NCT04541589|469790910|FG000|Treatment Period|Adverse Event|8|||
130498000|NCT04541589|469790911|FG001|Treatment Period|Adverse Event|2|||
130498001|NCT04541589|469790910|FG000|Treatment Period|Physician Decision|3|||
130498002|NCT04541589|469790911|FG001|Treatment Period|Physician Decision|1|||
130498003|NCT04541589|469790910|FG000|Treatment Period|Subject decision|7|||
130498004|NCT04541589|469790911|FG001|Treatment Period|Subject decision|4|||
130498005|NCT04541589|469790910|FG000|Treatment Period|Withdrawal by Subject|1|||
130498006|NCT04541589|469790911|FG001|Treatment Period|Withdrawal by Subject|0|||
130498007|NCT04541589|469790910|FG000|Safety Follow-up Period|Adverse Event|2|||
130498008|NCT04541589|469790911|FG001|Safety Follow-up Period|Adverse Event|1|||
130498009|NCT04541589|469790910|FG000|Safety Follow-up Period|Physician Decision|1|||
130498010|NCT04541589|469790911|FG001|Safety Follow-up Period|Physician Decision|0|||
130498011|NCT04541589|469790910|FG000|Safety Follow-up Period|Subject decision|5|||
130498012|NCT04541589|469790911|FG001|Safety Follow-up Period|Subject decision|3|||
130498013|NCT04541589|469790910|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
130498014|NCT04541589|469790911|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
130498015|NCT03745313|469790912|FG000|At 30 Days Follow-up|Death|2|||
130498016|NCT03745313|469790912|FG000|At 6 Months Follow-up|Death|1|||
130498017|NCT03745313|469790912|FG000|At 6 Months Follow-up|Missed Visit|1|||
130498018|NCT03745313|469790912|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
130498019|NCT03745313|469790912|FG000|At 1 Year Follow-up|Death|2|||
130498020|NCT03745313|469790912|FG000|At 1 Year Follow-up|Missed Visit|2|||
130498021|NCT03745313|469790912|FG000|At 2 Year Follow-up|Missed Visit|1|||
130498022|NCT01367236|469790913|FG000|Overall Study|Withdrawal by Subject|3|||
130498023|NCT01367236|469790914|FG001|Overall Study|Withdrawal by Subject|1|||
130498024|NCT02278796|469792117|FG000|Overall Study|Death|2|||
130498025|NCT02278796|469792118|FG001|Overall Study|Death|3|||
130729518|NCT02567435|470633577|FG003|Overall Study|Ineligible|0|||
130729519|NCT02567435|470633574|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
130729520|NCT02567435|470633575|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
130729521|NCT02567435|470633576|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
130729522|NCT02567435|470633577|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
130498026|NCT00357994|469792119|FG000|Overall Study|Adverse Event|1|||
130498027|NCT00357994|469792120|FG001|Overall Study|Adverse Event|2|||
130498028|NCT00357994|469792119|FG000|Overall Study|Lack of Efficacy|0|||
130498029|NCT00357994|469792120|FG001|Overall Study|Lack of Efficacy|1|||
130498030|NCT00357994|469792119|FG000|Overall Study|Protocol Violation|1|||
130498031|NCT00357994|469792120|FG001|Overall Study|Protocol Violation|0|||
130498032|NCT01079806|469792123|FG000|Day 1 to Week 96|Adverse Event|0|||
130498033|NCT01079806|469792124|FG001|Day 1 to Week 96|Adverse Event|3|||
130498034|NCT01079806|469792123|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
130498035|NCT01079806|469792124|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
130498036|NCT01079806|469792123|FG000|Day 1 to Week 96|Pregnancy|0|||
130498037|NCT01079806|469792124|FG001|Day 1 to Week 96|Pregnancy|1|||
130498038|NCT01079806|469792123|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
130498039|NCT01079806|469792124|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
130498040|NCT01079806|469792123|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
130498041|NCT01079806|469792124|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
130498042|NCT01079806|469792123|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
130498043|NCT01079806|469792124|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
130498044|NCT01079806|469792123|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
130498045|NCT01079806|469792124|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
130498046|NCT01079806|469792123|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
130498047|NCT01079806|469792124|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
130498048|NCT01079806|469792123|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
130498049|NCT01079806|469792124|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
130498050|NCT01079806|469792123|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
130498051|NCT01079806|469792124|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
130498052|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
130498053|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
130498054|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
130498055|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
130498056|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
130498057|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
130498058|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
130498059|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
130498060|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130498061|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
130498062|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
130498063|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
130498064|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130498065|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130498066|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
130498067|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
130498068|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
130498069|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
130498070|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
130498071|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
130498072|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
130498073|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
130498074|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
130498075|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
130498076|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
130498077|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
130498078|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
130498079|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
130498080|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
130498081|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
130498082|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
130498083|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
130498084|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
130498085|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
130498086|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
130498087|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
130498088|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
130498089|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
130498090|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
130498091|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130498092|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130498093|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
130498094|NCT03732807|469792125|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498095|NCT03732807|469792126|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498096|NCT03732807|469792127|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498097|NCT03732807|469792128|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498098|NCT03732807|469792129|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498099|NCT03732807|469792130|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
130498100|NCT03732807|469792131|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130498101|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
130498102|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
130498103|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
130498104|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
130498105|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
130498106|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
130498107|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
130498108|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
130498109|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
130498110|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
130498111|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
130498112|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
130498113|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
130498114|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
130498115|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
130498116|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
130498117|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
130498118|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
130498119|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
130498120|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
130498121|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
130498122|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498123|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
130498124|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498125|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498126|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498127|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498128|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
130498129|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
130498130|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
130498131|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
130498132|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
130498133|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
130498134|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
130498135|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
130498136|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
130498137|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
130498138|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
130498139|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
130498140|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
130498141|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
130498142|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
130498143|NCT03732807|469792125|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
130498144|NCT03732807|469792126|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
130498145|NCT03732807|469792127|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
130498146|NCT03732807|469792128|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
130498147|NCT03732807|469792129|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
130498148|NCT03732807|469792130|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
130498149|NCT03732807|469792131|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
130498150|NCT01779700|469792132|FG000|Overall Study|Adverse Event|4|||
130498151|NCT01779700|469792133|FG001|Overall Study|Adverse Event|3|||
130498152|NCT01779700|469792132|FG000|Overall Study|Withdrawal by Subject|0|||
130498153|NCT01779700|469792133|FG001|Overall Study|Withdrawal by Subject|2|||
130498154|NCT00019604|469792134|FG000|Overall Study|Death|1|||
130498155|NCT00019604|469792134|FG000|Overall Study|Progressive disease|23|||
130498156|NCT00019604|469792134|FG000|Overall Study|Refused treatment|1|||
130498157|NCT00019604|469792134|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
130498158|NCT00019604|469792134|FG000|Overall Study|Going to have liver transplant|1|||
130498159|NCT00019604|469792134|FG000|Overall Study|Move to a different study|1|||
130498160|NCT00019604|469792134|FG000|Overall Study|Non compliant on systemic CH|1|||
130498161|NCT00019604|469792134|FG000|Overall Study|Non compliant|1|||
130498162|NCT00019604|469792134|FG000|Overall Study|Resectable disease|1|||
130498163|NCT00019604|469792134|FG000|Overall Study|Started new chemo regimen|1|||
130498164|NCT00019604|469792134|FG000|Overall Study|Pt going to immunotherapy study|1|||
130498165|NCT00019604|469792134|FG000|Overall Study|Too much disease|1|||
130498166|NCT00019604|469792134|FG000|Overall Study|Unable to evaluate|1|||
130498167|NCT00019604|469792134|FG000|Overall Study|Details for other not available|4|||
130498168|NCT00734578|469792137|FG000|Overall Study|Adverse Event|4|||
130498169|NCT00734578|469792138|FG001|Overall Study|Adverse Event|6|||
130498170|NCT00734578|469792139|FG002|Overall Study|Adverse Event|1|||
130498171|NCT00734578|469792137|FG000|Overall Study|Protocol Violation|8|||
130498172|NCT00734578|469792138|FG001|Overall Study|Protocol Violation|6|||
130498173|NCT00734578|469792139|FG002|Overall Study|Protocol Violation|3|||
130498174|NCT00734578|469792137|FG000|Overall Study|Withdrawal by Subject|7|||
130498175|NCT00734578|469792138|FG001|Overall Study|Withdrawal by Subject|8|||
130498176|NCT00734578|469792139|FG002|Overall Study|Withdrawal by Subject|11|||
130498177|NCT00734578|469792137|FG000|Overall Study|Lost to Follow-up|9|||
130498178|NCT00734578|469792138|FG001|Overall Study|Lost to Follow-up|3|||
130498179|NCT00734578|469792139|FG002|Overall Study|Lost to Follow-up|5|||
130498180|NCT00734578|469792137|FG000|Overall Study|Lack of Efficacy|3|||
130498181|NCT00734578|469792138|FG001|Overall Study|Lack of Efficacy|2|||
130498182|NCT00734578|469792139|FG002|Overall Study|Lack of Efficacy|5|||
130498183|NCT00734578|469792137|FG000|Overall Study|Randomized in error|1|||
130498184|NCT00734578|469792138|FG001|Overall Study|Randomized in error|0|||
130498185|NCT00734578|469792139|FG002|Overall Study|Randomized in error|0|||
130498186|NCT00734578|469792137|FG000|Overall Study|Exclusion criteria|1|||
130498187|NCT00734578|469792138|FG001|Overall Study|Exclusion criteria|0|||
130498188|NCT00734578|469792139|FG002|Overall Study|Exclusion criteria|0|||
130498189|NCT02085941|469792140|FG000|Overall Study|Lack of Efficacy|1|||
130498190|NCT02085941|469792141|FG001|Overall Study|Lack of Efficacy|0|||
130498191|NCT02085941|469792140|FG000|Overall Study|Death|6|||
130498192|NCT02085941|469792141|FG001|Overall Study|Death|1|||
130498193|NCT02085941|469792140|FG000|Overall Study|Lost to Follow-up|1|||
130498194|NCT02085941|469792141|FG001|Overall Study|Lost to Follow-up|0|||
130498195|NCT02085941|469792140|FG000|Overall Study|Physician Decision|0|||
130498196|NCT02085941|469792141|FG001|Overall Study|Physician Decision|2|||
130498197|NCT03274076|469792143|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
130498198|NCT03274076|469792144|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
130498199|NCT03274076|469792145|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
130498200|NCT03274076|469792146|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
130498201|NCT03274076|469792143|FG000|24 Weeks Open Label|Adverse Event|0|||
130498202|NCT03274076|469792144|FG001|24 Weeks Open Label|Adverse Event|0|||
130498203|NCT03274076|469792145|FG002|24 Weeks Open Label|Adverse Event|2|||
130498204|NCT03274076|469792146|FG003|24 Weeks Open Label|Adverse Event|0|||
130498205|NCT03274076|469792143|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
130498206|NCT03274076|469792144|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
130498207|NCT03274076|469792145|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
130498208|NCT03274076|469792146|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
130498209|NCT00975585|469792147|FG000|Overall Study|Adverse Event|0|||
130498210|NCT00975585|469792148|FG001|Overall Study|Adverse Event|4|||
130498211|NCT00975585|469792147|FG000|Overall Study|Lost to Follow-up|3|||
130498212|NCT00975585|469792148|FG001|Overall Study|Lost to Follow-up|5|||
130498213|NCT00975585|469792147|FG000|Overall Study|Withdrawal by Subject|2|||
130498214|NCT00975585|469792148|FG001|Overall Study|Withdrawal by Subject|1|||
130498215|NCT00975585|469792147|FG000|Overall Study|Lens issue|2|||
130498216|NCT00975585|469792148|FG001|Overall Study|Lens issue|2|||
130498217|NCT00683800|469792149|FG000|Overall Study|Adverse Event|195|||
130498218|NCT00683800|469792150|FG001|Overall Study|Adverse Event|102|||
130729523|NCT03765788|470633578|FG000|Overall Study|Subject decision|2|||
130498219|NCT00683800|469792149|FG000|Overall Study|Death|0|||
130498220|NCT00683800|469792150|FG001|Overall Study|Death|1|||
130498221|NCT00683800|469792149|FG000|Overall Study|Lost to Follow-up|57|||
130498222|NCT00683800|469792150|FG001|Overall Study|Lost to Follow-up|44|||
130498223|NCT00683800|469792149|FG000|Overall Study|Other|5|||
130729524|NCT03765788|470633579|FG001|Overall Study|Subject decision|3|||
130729525|NCT03765788|470633578|FG000|Overall Study|Physician Decision|2|||
130498224|NCT00683800|469792150|FG001|Overall Study|Other|2|||
130498225|NCT00683800|469792149|FG000|Overall Study|Protocol Violation|13|||
130498226|NCT00683800|469792150|FG001|Overall Study|Protocol Violation|16|||
130498227|NCT00683800|469792149|FG000|Overall Study|Withdrawal by Subject|66|||
130498228|NCT00683800|469792150|FG001|Overall Study|Withdrawal by Subject|64|||
130498229|NCT00683800|469792149|FG000|Overall Study|Lack of Efficacy|61|||
130498230|NCT00683800|469792150|FG001|Overall Study|Lack of Efficacy|104|||
130498231|NCT00683800|469792149|FG000|Overall Study|Randomized, not treated|35|||
130498232|NCT00683800|469792150|FG001|Overall Study|Randomized, not treated|33|||
130498233|NCT01953692|469792155|FG000|Overall Study|Adverse Event|5|||
130498234|NCT01953692|469792156|FG001|Overall Study|Adverse Event|2|||
130498235|NCT01953692|469792157|FG002|Overall Study|Adverse Event|4|||
130498236|NCT01953692|469792158|FG003|Overall Study|Adverse Event|2|||
130498237|NCT01953692|469792159|FG004|Overall Study|Adverse Event|1|||
130498238|NCT01953692|469792160|FG005|Overall Study|Adverse Event|2|||
130498239|NCT01953692|469792161|FG006|Overall Study|Adverse Event|0|||
130498240|NCT01953692|469792162|FG007|Overall Study|Adverse Event|0|||
130498241|NCT01953692|469792163|FG008|Overall Study|Adverse Event|0|||
130498242|NCT01953692|469792155|FG000|Overall Study|Clinical Progression|0|||
130498243|NCT01953692|469792156|FG001|Overall Study|Clinical Progression|15|||
130498244|NCT01953692|469792157|FG002|Overall Study|Clinical Progression|7|||
130498245|NCT01953692|469792158|FG003|Overall Study|Clinical Progression|5|||
130498246|NCT01953692|469792159|FG004|Overall Study|Clinical Progression|0|||
130498247|NCT01953692|469792160|FG005|Overall Study|Clinical Progression|7|||
130498248|NCT01953692|469792161|FG006|Overall Study|Clinical Progression|20|||
130498249|NCT01953692|469792162|FG007|Overall Study|Clinical Progression|3|||
130498250|NCT01953692|469792163|FG008|Overall Study|Clinical Progression|3|||
130498251|NCT01953692|469792155|FG000|Overall Study|Death|5|||
130498252|NCT01953692|469792156|FG001|Overall Study|Death|0|||
130498253|NCT01953692|469792157|FG002|Overall Study|Death|2|||
130498254|NCT01953692|469792158|FG003|Overall Study|Death|2|||
130498255|NCT01953692|469792159|FG004|Overall Study|Death|1|||
130498256|NCT01953692|469792160|FG005|Overall Study|Death|3|||
130498257|NCT01953692|469792161|FG006|Overall Study|Death|6|||
130498258|NCT01953692|469792162|FG007|Overall Study|Death|2|||
130498259|NCT01953692|469792163|FG008|Overall Study|Death|1|||
130498260|NCT01953692|469792155|FG000|Overall Study|Excluded Medication|1|||
130498261|NCT01953692|469792156|FG001|Overall Study|Excluded Medication|0|||
130498262|NCT01953692|469792157|FG002|Overall Study|Excluded Medication|0|||
130498263|NCT01953692|469792158|FG003|Overall Study|Excluded Medication|0|||
130498264|NCT01953692|469792159|FG004|Overall Study|Excluded Medication|0|||
130498265|NCT01953692|469792160|FG005|Overall Study|Excluded Medication|0|||
130498266|NCT01953692|469792161|FG006|Overall Study|Excluded Medication|0|||
130498267|NCT01953692|469792162|FG007|Overall Study|Excluded Medication|0|||
130498268|NCT01953692|469792163|FG008|Overall Study|Excluded Medication|0|||
130498269|NCT01953692|469792155|FG000|Overall Study|Lost to Follow-up|1|||
130498270|NCT01953692|469792156|FG001|Overall Study|Lost to Follow-up|0|||
130498271|NCT01953692|469792157|FG002|Overall Study|Lost to Follow-up|3|||
130498272|NCT01953692|469792158|FG003|Overall Study|Lost to Follow-up|1|||
130498273|NCT01953692|469792159|FG004|Overall Study|Lost to Follow-up|0|||
130498274|NCT01953692|469792160|FG005|Overall Study|Lost to Follow-up|1|||
130498275|NCT01953692|469792161|FG006|Overall Study|Lost to Follow-up|0|||
130498276|NCT01953692|469792162|FG007|Overall Study|Lost to Follow-up|0|||
130498277|NCT01953692|469792163|FG008|Overall Study|Lost to Follow-up|0|||
130498278|NCT01953692|469792155|FG000|Overall Study|Physician Decision|11|||
130498279|NCT01953692|469792156|FG001|Overall Study|Physician Decision|4|||
130498280|NCT01953692|469792157|FG002|Overall Study|Physician Decision|2|||
130498281|NCT01953692|469792158|FG003|Overall Study|Physician Decision|2|||
130498282|NCT01953692|469792159|FG004|Overall Study|Physician Decision|1|||
130498283|NCT01953692|469792160|FG005|Overall Study|Physician Decision|2|||
130498284|NCT01953692|469792161|FG006|Overall Study|Physician Decision|4|||
130498285|NCT01953692|469792162|FG007|Overall Study|Physician Decision|1|||
130565649|NCT02953340|470036967|FG001|Overall Study|Sponsor decision|2|||
130498286|NCT01953692|469792163|FG008|Overall Study|Physician Decision|0|||
130498287|NCT01953692|469792155|FG000|Overall Study|Protocol Violation|0|||
130498288|NCT01953692|469792156|FG001|Overall Study|Protocol Violation|2|||
130729526|NCT03765788|470633579|FG001|Overall Study|Physician Decision|4|||
130729527|NCT03765788|470633578|FG000|Overall Study|Death|0|||
130498289|NCT01953692|469792157|FG002|Overall Study|Protocol Violation|1|||
130498290|NCT01953692|469792158|FG003|Overall Study|Protocol Violation|0|||
130498291|NCT01953692|469792159|FG004|Overall Study|Protocol Violation|0|||
130498292|NCT01953692|469792160|FG005|Overall Study|Protocol Violation|0|||
130498293|NCT01953692|469792161|FG006|Overall Study|Protocol Violation|0|||
130498294|NCT01953692|469792162|FG007|Overall Study|Protocol Violation|1|||
130498295|NCT01953692|469792163|FG008|Overall Study|Protocol Violation|0|||
130498296|NCT01953692|469792155|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498297|NCT01953692|469792156|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498298|NCT01953692|469792157|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498299|NCT01953692|469792158|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498300|NCT01953692|469792159|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498301|NCT01953692|469792160|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498302|NCT01953692|469792161|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498303|NCT01953692|469792162|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
130498304|NCT01953692|469792163|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
130498305|NCT01953692|469792155|FG000|Overall Study|Withdrawal by Subject|4|||
130498306|NCT01953692|469792156|FG001|Overall Study|Withdrawal by Subject|2|||
130498307|NCT01953692|469792157|FG002|Overall Study|Withdrawal by Subject|1|||
130498308|NCT01953692|469792158|FG003|Overall Study|Withdrawal by Subject|2|||
130498309|NCT01953692|469792159|FG004|Overall Study|Withdrawal by Subject|0|||
130498310|NCT01953692|469792160|FG005|Overall Study|Withdrawal by Subject|3|||
130498311|NCT01953692|469792161|FG006|Overall Study|Withdrawal by Subject|2|||
130498312|NCT01953692|469792162|FG007|Overall Study|Withdrawal by Subject|1|||
130498313|NCT01953692|469792163|FG008|Overall Study|Withdrawal by Subject|1|||
130498314|NCT01328496|469792171|FG000|Overall Study|Significant Change in Health Status|1|||
130498315|NCT01328496|469792172|FG001|Overall Study|Significant Change in Health Status|0|||
130498316|NCT01886872|469792173|FG000|Overall Study|Ineligible|7|||
130498317|NCT01886872|469792174|FG001|Overall Study|Ineligible|4|||
130498318|NCT01886872|469792175|FG002|Overall Study|Ineligible|12|||
130498319|NCT04941482|469792176|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
130498320|NCT04941482|469792177|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
130498321|NCT05966155|469792178|FG000|Overall Study|Death|1|||
130498322|NCT05966155|469792179|FG001|Overall Study|Death|2|||
130498323|NCT05966155|469792178|FG000|Overall Study|Lost to Follow-up|63|||
130498324|NCT05966155|469792179|FG001|Overall Study|Lost to Follow-up|67|||
130498325|NCT05966155|469792178|FG000|Overall Study|Protocol Violation|1|||
130498326|NCT05966155|469792179|FG001|Overall Study|Protocol Violation|0|||
130498327|NCT05966155|469792178|FG000|Overall Study|Withdrawal by Subject|8|||
130498328|NCT05966155|469792179|FG001|Overall Study|Withdrawal by Subject|9|||
130498329|NCT05966155|469792178|FG000|Overall Study|Enrolled Erroneously|0|||
130498330|NCT05966155|469792179|FG001|Overall Study|Enrolled Erroneously|1|||
130498331|NCT05966155|469792178|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
130498332|NCT05966155|469792179|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
130498333|NCT02743819|469792180|FG000|Overall Study|Lack of Efficacy|5|||
130498334|NCT02743819|469792180|FG000|Overall Study|Death|2|||
130498335|NCT02743819|469792180|FG000|Overall Study|Adverse Event|1|||
130498336|NCT03582475|469792191|FG000|Treatment Period|Withdrawal by Subject|0|||
130498337|NCT03582475|469792192|FG001|Treatment Period|Withdrawal by Subject|1|||
130498338|NCT03582475|469792191|FG000|Follow-up Period|Withdrawal by Subject|0|||
130498339|NCT03582475|469792192|FG001|Follow-up Period|Withdrawal by Subject|1|||
130498340|NCT01706159|469792193|FG000|Overall Study|Withdrawal Criteria|2|||
130498341|NCT01706159|469792194|FG001|Overall Study|Withdrawal Criteria|1|||
130498342|NCT01706159|469792193|FG000|Overall Study|Unclassified|6|||
130498343|NCT01706159|469792194|FG001|Overall Study|Unclassified|1|||
130498344|NCT00553332|469792199|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
130498345|NCT03775486|469792200|FG000|Initial Therapy Phase|Other reason provided|0|||
130498346|NCT03775486|469792201|FG001|Initial Therapy Phase|Other reason provided|15|||
130498347|NCT03775486|469792200|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
130498348|NCT03775486|469792201|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
130498349|NCT03775486|469792200|FG000|Initial Therapy Phase|Protocol Violation|0|||
130498350|NCT03775486|469792201|FG001|Initial Therapy Phase|Protocol Violation|2|||
130498351|NCT03775486|469792200|FG000|Initial Therapy Phase|Adverse Event|0|||
130498352|NCT03775486|469792201|FG001|Initial Therapy Phase|Adverse Event|34|||
130498353|NCT03775486|469792200|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
130498354|NCT03775486|469792201|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
130498355|NCT03775486|469792200|FG000|Maintenance Phase|Withdrawal by Subject|13|||
130498356|NCT03775486|469792201|FG001|Maintenance Phase|Withdrawal by Subject|12|||
130498357|NCT03775486|469792200|FG000|Maintenance Phase|Death|44|||
130498358|NCT03775486|469792201|FG001|Maintenance Phase|Death|45|||
130498359|NCT02235298|469792203|FG000|Overall Study|Lost to Follow-up|6|||
130498360|NCT02235298|469792204|FG001|Overall Study|Lost to Follow-up|5|||
130498361|NCT02235298|469792203|FG000|Overall Study|Adverse Event|2|||
130498362|NCT02235298|469792204|FG001|Overall Study|Adverse Event|2|||
130498363|NCT02235298|469792203|FG000|Overall Study|Withdrawal by Subject|0|||
130498364|NCT02235298|469792204|FG001|Overall Study|Withdrawal by Subject|1|||
130498365|NCT02744066|469792205|FG000|Overall Study|Withdrawal by parent|0|||
130498366|NCT02744066|469792206|FG001|Overall Study|Withdrawal by parent|1|||
130498367|NCT02744066|469792205|FG000|Overall Study|Discharged from NICU prior to completion|0|||
130498368|NCT02744066|469792206|FG001|Overall Study|Discharged from NICU prior to completion|4|||
130498369|NCT02454959|469792207|FG000|Overall Study|Protocol-Specified Criteria|3|||
130498370|NCT02454959|469792207|FG000|Overall Study|Physician Decision|1|||
130498371|NCT02454959|469792207|FG000|Overall Study|Withdrawal by Subject|3|||
130498372|NCT02454959|469792207|FG000|Overall Study|Adverse Event|2|||
130498373|NCT04745676|469792208|FG000|Overall Study|Death|1|||
130498374|NCT04745676|469792209|FG001|Overall Study|Death|0|||
130498375|NCT04745676|469792210|FG002|Overall Study|Death|0|||
130498376|NCT03102034|469792213|FG000|Overall Study|Withdrawal by Subject|1|||
130498377|NCT03102034|469792214|FG001|Overall Study|Withdrawal by Subject|0|||
130498378|NCT05810285|469792226|FG000|Overall Study|Death|4|||
130498379|NCT05810285|469792227|FG001|Overall Study|Death|21|||
130498380|NCT05810285|469792226|FG000|Overall Study|Adverse Event|18|||
130498381|NCT05810285|469792227|FG001|Overall Study|Adverse Event|16|||
130498382|NCT03147287|469792228|FG000|Overall Study|Randomized Not Treated|2|||
130498383|NCT03147287|469792229|FG001|Overall Study|Randomized Not Treated|1|||
130498384|NCT03147287|469792230|FG002|Overall Study|Randomized Not Treated|1|||
130498385|NCT03147287|469792228|FG000|Overall Study|Progressive Disease RECIST|31|||
130498386|NCT03147287|469792229|FG001|Overall Study|Progressive Disease RECIST|72|||
130498387|NCT03147287|469792230|FG002|Overall Study|Progressive Disease RECIST|32|||
130498388|NCT03147287|469792228|FG000|Overall Study|Progressive Disease not RECIST|13|||
130498389|NCT03147287|469792229|FG001|Overall Study|Progressive Disease not RECIST|21|||
130498390|NCT03147287|469792230|FG002|Overall Study|Progressive Disease not RECIST|13|||
130498391|NCT03147287|469792228|FG000|Overall Study|Physician Decision|1|||
130498392|NCT03147287|469792229|FG001|Overall Study|Physician Decision|2|||
130498393|NCT03147287|469792230|FG002|Overall Study|Physician Decision|1|||
130498394|NCT03147287|469792228|FG000|Overall Study|Intercurrent illness|0|||
130498395|NCT03147287|469792229|FG001|Overall Study|Intercurrent illness|1|||
130498396|NCT03147287|469792230|FG002|Overall Study|Intercurrent illness|0|||
130498397|NCT03147287|469792228|FG000|Overall Study|Withdrawal by Subject|2|||
130498398|NCT03147287|469792229|FG001|Overall Study|Withdrawal by Subject|3|||
130498399|NCT03147287|469792230|FG002|Overall Study|Withdrawal by Subject|2|||
130498400|NCT03147287|469792228|FG000|Overall Study|Patient Non-Compliance|0|||
130498401|NCT03147287|469792229|FG001|Overall Study|Patient Non-Compliance|2|||
130498402|NCT03147287|469792230|FG002|Overall Study|Patient Non-Compliance|0|||
130498403|NCT03147287|469792228|FG000|Overall Study|Patient moved|0|||
130498404|NCT03147287|469792229|FG001|Overall Study|Patient moved|1|||
130498405|NCT03147287|469792230|FG002|Overall Study|Patient moved|0|||
130498406|NCT03147287|469792228|FG000|Overall Study|Arm A crossover without PD|1|||
130498407|NCT03147287|469792229|FG001|Overall Study|Arm A crossover without PD|0|||
130498408|NCT03147287|469792230|FG002|Overall Study|Arm A crossover without PD|0|||
130498409|NCT03147287|469792228|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
130498410|NCT03147287|469792229|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
130498411|NCT03147287|469792230|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
130498412|NCT03945773|469793298|FG000|Overall Study|Consent Withdrawn|1|||
130498413|NCT03945773|469793299|FG001|Overall Study|Consent Withdrawn|1|||
130498414|NCT03945773|469793298|FG000|Overall Study|Lost to Follow-up|1|||
130498415|NCT03945773|469793299|FG001|Overall Study|Lost to Follow-up|0|||
130498416|NCT03945773|469793298|FG000|Overall Study|Death|46|||
130498417|NCT03945773|469793299|FG001|Overall Study|Death|22|||
130498418|NCT03945773|469793298|FG000|Overall Study|Physician Decision|1|||
130498419|NCT03945773|469793299|FG001|Overall Study|Physician Decision|0|||
130498420|NCT03945773|469793298|FG000|Overall Study|Other|1|||
130498421|NCT03945773|469793299|FG001|Overall Study|Other|0|||
130498422|NCT03945773|469793298|FG000|Overall Study|Ongoing at the time of DCO|4|||
130498423|NCT03945773|469793299|FG001|Overall Study|Ongoing at the time of DCO|3|||
130498424|NCT01970878|469793301|FG000|Overall Study|Withdrawal by Subject|11|||
130498425|NCT01970878|469793302|FG001|Overall Study|Withdrawal by Subject|10|||
130498426|NCT01970878|469793303|FG002|Overall Study|Withdrawal by Subject|14|||
130498427|NCT01970878|469793304|FG003|Overall Study|Withdrawal by Subject|7|||
130498428|NCT01970878|469793301|FG000|Overall Study|Lost to Follow-up|1|||
130498429|NCT01970878|469793302|FG001|Overall Study|Lost to Follow-up|3|||
130498430|NCT01970878|469793303|FG002|Overall Study|Lost to Follow-up|2|||
130498431|NCT01970878|469793304|FG003|Overall Study|Lost to Follow-up|4|||
130498432|NCT01970878|469793301|FG000|Overall Study|Administrative Reasons|1|||
130498433|NCT01970878|469793302|FG001|Overall Study|Administrative Reasons|0|||
130498434|NCT01970878|469793303|FG002|Overall Study|Administrative Reasons|0|||
130498435|NCT01970878|469793304|FG003|Overall Study|Administrative Reasons|4|||
130565650|NCT02953340|470036966|FG000|Overall Study|Lost to Follow-up|3|||
130729528|NCT03765788|470633579|FG001|Overall Study|Death|1|||
130498436|NCT01970878|469793301|FG000|Overall Study|Lack of Efficacy|2|||
130498437|NCT01970878|469793302|FG001|Overall Study|Lack of Efficacy|1|||
130498438|NCT01970878|469793303|FG002|Overall Study|Lack of Efficacy|2|||
130498439|NCT01970878|469793304|FG003|Overall Study|Lack of Efficacy|0|||
130498440|NCT01970878|469793301|FG000|Overall Study|Adverse Event|12|||
130498441|NCT01970878|469793302|FG001|Overall Study|Adverse Event|7|||
130498442|NCT01970878|469793303|FG002|Overall Study|Adverse Event|4|||
130498443|NCT01970878|469793304|FG003|Overall Study|Adverse Event|3|||
130498444|NCT01970878|469793301|FG000|Overall Study|Protocol Specified Criteria|10|||
130498445|NCT01970878|469793302|FG001|Overall Study|Protocol Specified Criteria|4|||
130565651|NCT02953340|470036967|FG001|Overall Study|Lost to Follow-up|2|||
130565652|NCT02953340|470036966|FG000|Overall Study|Reason not specified|2|||
130565653|NCT02953340|470036967|FG001|Overall Study|Reason not specified|2|||
130498446|NCT01970878|469793303|FG002|Overall Study|Protocol Specified Criteria|3|||
130498447|NCT01970878|469793304|FG003|Overall Study|Protocol Specified Criteria|6|||
130498448|NCT01970878|469793301|FG000|Overall Study|Physician Decision|0|||
130498449|NCT01970878|469793302|FG001|Overall Study|Physician Decision|1|||
130498450|NCT01970878|469793303|FG002|Overall Study|Physician Decision|1|||
130498451|NCT01970878|469793304|FG003|Overall Study|Physician Decision|0|||
130498452|NCT01970878|469793301|FG000|Overall Study|No Completion Status|0|||
130498453|NCT01970878|469793302|FG001|Overall Study|No Completion Status|1|||
130498454|NCT01970878|469793303|FG002|Overall Study|No Completion Status|0|||
130498455|NCT01970878|469793304|FG003|Overall Study|No Completion Status|0|||
130498456|NCT04926857|469793305|FG000|Overall Study|Withdrawal by Subject|40|||
130498457|NCT04926857|469793305|FG000|Overall Study|Death|9|||
130498458|NCT04926857|469793305|FG000|Overall Study|Study product no longer in use|44|||
130498459|NCT04926857|469793305|FG000|Overall Study|Inadequate data to address primary objective|16|||
130498460|NCT00089609|469793308|FG000|Overall Study|Withdrawal by Subject|3|||
130498461|NCT00089609|469793309|FG001|Overall Study|Withdrawal by Subject|1|||
130498462|NCT00747006|469793311|FG000|Overall Study|Adverse Event|1|||
130498463|NCT00747006|469793312|FG001|Overall Study|Adverse Event|0|||
130498464|NCT00747006|469793313|FG002|Overall Study|Adverse Event|0|||
130498465|NCT00747006|469793311|FG000|Overall Study|Lost to Follow-up|0|||
130498466|NCT00747006|469793312|FG001|Overall Study|Lost to Follow-up|1|||
130498467|NCT00747006|469793313|FG002|Overall Study|Lost to Follow-up|0|||
130498468|NCT00747006|469793311|FG000|Overall Study|Physician Decision|2|||
130498469|NCT00747006|469793312|FG001|Overall Study|Physician Decision|0|||
130498470|NCT00747006|469793313|FG002|Overall Study|Physician Decision|1|||
130498471|NCT01372085|469793318|FG000|Washout Period 2|Physician Decision|0|||
130498472|NCT01372085|469793319|FG001|Washout Period 2|Physician Decision|0|||
130498473|NCT01372085|469793320|FG002|Washout Period 2|Physician Decision|0|||
130498474|NCT01372085|469793321|FG003|Washout Period 2|Physician Decision|0|||
130498475|NCT01372085|469793322|FG004|Washout Period 2|Physician Decision|1|||
130498476|NCT01372085|469793323|FG005|Washout Period 2|Physician Decision|0|||
130498477|NCT01372085|469793324|FG006|Washout Period 2|Physician Decision|0|||
130498478|NCT01372085|469793325|FG007|Washout Period 2|Physician Decision|0|||
130498479|NCT01372085|469793326|FG008|Washout Period 2|Physician Decision|0|||
130498480|NCT01372085|469793327|FG009|Washout Period 2|Physician Decision|0|||
130498481|NCT01372085|469793318|FG000|Washout Period 3|Withdrawal by Subject|0|||
130498482|NCT01372085|469793319|FG001|Washout Period 3|Withdrawal by Subject|0|||
130498483|NCT01372085|469793320|FG002|Washout Period 3|Withdrawal by Subject|0|||
130498484|NCT01372085|469793321|FG003|Washout Period 3|Withdrawal by Subject|0|||
130498485|NCT01372085|469793322|FG004|Washout Period 3|Withdrawal by Subject|0|||
130498486|NCT01372085|469793323|FG005|Washout Period 3|Withdrawal by Subject|2|||
130498487|NCT01372085|469793324|FG006|Washout Period 3|Withdrawal by Subject|0|||
130498488|NCT01372085|469793325|FG007|Washout Period 3|Withdrawal by Subject|0|||
130498489|NCT01372085|469793326|FG008|Washout Period 3|Withdrawal by Subject|0|||
130498490|NCT01372085|469793327|FG009|Washout Period 3|Withdrawal by Subject|0|||
130498491|NCT02824198|469793328|FG000|Overall Study|Non-compliance with the protocol|5|||
130498492|NCT02824198|469793329|FG001|Overall Study|Non-compliance with the protocol|1|||
130498493|NCT02824198|469793328|FG000|Overall Study|Lost to Follow-up|5|||
130498494|NCT02824198|469793329|FG001|Overall Study|Lost to Follow-up|2|||
130498495|NCT02824198|469793328|FG000|Overall Study|Withdrawal by Subject|5|||
130498496|NCT02824198|469793329|FG001|Overall Study|Withdrawal by Subject|0|||
130498497|NCT03689946|469793330|FG000|Overall Study|Withdrawal by Subject|3|||
130498498|NCT03689946|469793330|FG000|Overall Study|Lost to Follow-up|3|||
130498499|NCT03689946|469793330|FG000|Overall Study|Data corruption|2|||
130498500|NCT04608409|469793335|FG000|Overall Study|Physician Decision|1|||
130498501|NCT04608409|469793336|FG001|Overall Study|Physician Decision|1|||
130498502|NCT04608409|469793337|FG002|Overall Study|Physician Decision|2|||
130498503|NCT00599196|469793338|FG000|Overall Study|Lack of Efficacy|22|||
130498504|NCT00599196|469793338|FG000|Overall Study|Adverse Event|93|||
130498505|NCT00599196|469793338|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
130498506|NCT00599196|469793338|FG000|Overall Study|Subject withdrew consent|43|||
130498507|NCT00599196|469793338|FG000|Overall Study|Study ended per sponsor|197|||
130498508|NCT00599196|469793338|FG000|Overall Study|Lost to Follow-up|17|||
130498509|NCT00599196|469793338|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
130498510|NCT00599196|469793338|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
130498511|NCT00599196|469793338|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
130498512|NCT00599196|469793338|FG000|Overall Study|Other: Pt Moved To Australia|1|||
130498513|NCT00599196|469793338|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
130498514|NCT00599196|469793338|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
130498525|NCT00795184|469793349|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
130498526|NCT00795184|469793350|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
130498527|NCT00205179|469793352|FG000|Overall Study|Death|0|||
130498528|NCT00205179|469793353|FG001|Overall Study|Death|2|||
130498529|NCT00205179|469793352|FG000|Overall Study|Physician Decision|1|||
130498530|NCT00205179|469793353|FG001|Overall Study|Physician Decision|1|||
130498531|NCT00205179|469793352|FG000|Overall Study|Adverse Event|1|||
130498532|NCT00205179|469793353|FG001|Overall Study|Adverse Event|1|||
130498533|NCT00586313|469793354|FG000|Overall Study|Lack of Efficacy|2|||
130498534|NCT02079649|469793355|FG000|Overall Study|Lost to Follow-up|0|||
130498535|NCT02079649|469793356|FG001|Overall Study|Lost to Follow-up|0|||
130498536|NCT02079649|469793357|FG002|Overall Study|Lost to Follow-up|0|||
130498537|NCT02079649|469793358|FG003|Overall Study|Lost to Follow-up|1|||
130498538|NCT02079649|469793355|FG000|Overall Study|Withdrawal by Subject|0|||
130498539|NCT02079649|469793356|FG001|Overall Study|Withdrawal by Subject|0|||
130498540|NCT02079649|469793357|FG002|Overall Study|Withdrawal by Subject|0|||
130498541|NCT02079649|469793358|FG003|Overall Study|Withdrawal by Subject|1|||
130498542|NCT02079649|469793355|FG000|Overall Study|Randomization error (prior to treatment)|1|||
130498543|NCT02079649|469793356|FG001|Overall Study|Randomization error (prior to treatment)|0|||
130498544|NCT02079649|469793357|FG002|Overall Study|Randomization error (prior to treatment)|1|||
130498545|NCT02079649|469793358|FG003|Overall Study|Randomization error (prior to treatment)|0|||
130498546|NCT00388726|469793361|FG000|Overall Study|Adverse Event|50|||
130498547|NCT00388726|469793362|FG001|Overall Study|Adverse Event|24|||
130498548|NCT00388726|469793361|FG000|Overall Study|Progressive Disease|336|||
130498549|NCT00388726|469793362|FG001|Overall Study|Progressive Disease|153|||
130498550|NCT00388726|469793361|FG000|Overall Study|Clinical Progression|61|||
130498551|NCT00388726|469793362|FG001|Overall Study|Clinical Progression|36|||
130498552|NCT00388726|469793361|FG000|Overall Study|Withdrawal by Subject|10|||
130498553|NCT00388726|469793362|FG001|Overall Study|Withdrawal by Subject|7|||
130498554|NCT00388726|469793361|FG000|Overall Study|Administrative|6|||
130498555|NCT00388726|469793362|FG001|Overall Study|Administrative|9|||
130498556|NCT00388726|469793361|FG000|Overall Study|Physician Decision|18|||
130498557|NCT00388726|469793362|FG001|Overall Study|Physician Decision|13|||
130498558|NCT00388726|469793361|FG000|Overall Study|Death|3|||
130498559|NCT00388726|469793362|FG001|Overall Study|Death|2|||
130498560|NCT00983294|469793364|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
130498561|NCT00983294|469793364|FG000|Colchicine With Azithromycin|Adverse Event|1|||
130498562|NCT00853593|469793365|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
130498563|NCT00853593|469793365|FG000|Overall Study|Model 4396 lead not attempted|29|||
130498564|NCT00853593|469793365|FG000|Overall Study|Implant not attempted|4|||
130498565|NCT00600353|469793370|FG000|Overall Study|history of malignancy within 5 years|1|||
130498566|NCT00600353|469793371|FG001|Overall Study|history of malignancy within 5 years|0|||
130498567|NCT00600353|469793370|FG000|Overall Study|History of prepartive regimen|0|||
130498568|NCT00600353|469793371|FG001|Overall Study|History of prepartive regimen|1|||
130498569|NCT03683576|469793372|FG000|Overall Study|Withdrawal by Subject|2|||
130498570|NCT03683576|469793373|FG001|Overall Study|Withdrawal by Subject|0|||
130498571|NCT03683576|469793374|FG002|Overall Study|Withdrawal by Subject|8|||
130498572|NCT03683576|469793375|FG003|Overall Study|Withdrawal by Subject|3|||
130498573|NCT03683576|469793372|FG000|Overall Study|Adverse Event|3|||
130498574|NCT03683576|469793373|FG001|Overall Study|Adverse Event|0|||
130498575|NCT03683576|469793374|FG002|Overall Study|Adverse Event|0|||
130498576|NCT03683576|469793375|FG003|Overall Study|Adverse Event|4|||
130498577|NCT03683576|469793372|FG000|Overall Study|Lack of Efficacy|1|||
130498578|NCT03683576|469793373|FG001|Overall Study|Lack of Efficacy|0|||
130498579|NCT03683576|469793374|FG002|Overall Study|Lack of Efficacy|1|||
130498580|NCT03683576|469793375|FG003|Overall Study|Lack of Efficacy|1|||
130498581|NCT03683576|469793372|FG000|Overall Study|Lost to Follow-up|0|||
130498582|NCT03683576|469793373|FG001|Overall Study|Lost to Follow-up|1|||
130498583|NCT03683576|469793374|FG002|Overall Study|Lost to Follow-up|2|||
130498584|NCT03683576|469793375|FG003|Overall Study|Lost to Follow-up|0|||
130498585|NCT03683576|469793372|FG000|Overall Study|Other, Not Specified|0|||
130498586|NCT03683576|469793373|FG001|Overall Study|Other, Not Specified|2|||
130498587|NCT03683576|469793374|FG002|Overall Study|Other, Not Specified|0|||
130498588|NCT03683576|469793375|FG003|Overall Study|Other, Not Specified|0|||
130498589|NCT03683576|469793372|FG000|Overall Study|Protocol Violation|0|||
130498590|NCT03683576|469793373|FG001|Overall Study|Protocol Violation|1|||
130498591|NCT03683576|469793374|FG002|Overall Study|Protocol Violation|1|||
130498592|NCT03683576|469793375|FG003|Overall Study|Protocol Violation|0|||
130498593|NCT03611075|469793377|FG000|Overall Study|Physician Decision|0|||
130498594|NCT03611075|469793378|FG001|Overall Study|Physician Decision|1|||
130498595|NCT03611075|469793379|FG002|Overall Study|Physician Decision|1|||
130498596|NCT03611075|469793380|FG003|Overall Study|Physician Decision|0|||
130498597|NCT03611075|469793381|FG004|Overall Study|Physician Decision|0|||
130498598|NCT03611075|469793382|FG005|Overall Study|Physician Decision|0|||
130498599|NCT03611075|469793383|FG006|Overall Study|Physician Decision|0|||
130498600|NCT03611075|469793384|FG007|Overall Study|Physician Decision|0|||
130498601|NCT03611075|469793385|FG008|Overall Study|Physician Decision|0|||
130498602|NCT03611075|469793377|FG000|Overall Study|Lost to Follow-up|1|||
130498603|NCT03611075|469793378|FG001|Overall Study|Lost to Follow-up|0|||
130498604|NCT03611075|469793379|FG002|Overall Study|Lost to Follow-up|0|||
130498605|NCT03611075|469793380|FG003|Overall Study|Lost to Follow-up|2|||
130498606|NCT03611075|469793381|FG004|Overall Study|Lost to Follow-up|0|||
130498607|NCT03611075|469793382|FG005|Overall Study|Lost to Follow-up|0|||
130498608|NCT03611075|469793383|FG006|Overall Study|Lost to Follow-up|0|||
130498609|NCT03611075|469793384|FG007|Overall Study|Lost to Follow-up|0|||
130498610|NCT03611075|469793385|FG008|Overall Study|Lost to Follow-up|0|||
130498611|NCT03611075|469793377|FG000|Overall Study|Withdrawal by Subject|0|||
130498612|NCT03611075|469793378|FG001|Overall Study|Withdrawal by Subject|1|||
130498613|NCT03611075|469793379|FG002|Overall Study|Withdrawal by Subject|1|||
130498614|NCT03611075|469793380|FG003|Overall Study|Withdrawal by Subject|1|||
130498615|NCT03611075|469793381|FG004|Overall Study|Withdrawal by Subject|0|||
130498616|NCT03611075|469793382|FG005|Overall Study|Withdrawal by Subject|0|||
130498617|NCT03611075|469793383|FG006|Overall Study|Withdrawal by Subject|1|||
130498618|NCT03611075|469793384|FG007|Overall Study|Withdrawal by Subject|0|||
130498619|NCT03611075|469793385|FG008|Overall Study|Withdrawal by Subject|0|||
130498620|NCT03611075|469793377|FG000|Overall Study|Reason unknown|0|||
130498621|NCT03611075|469793378|FG001|Overall Study|Reason unknown|0|||
130498622|NCT03611075|469793379|FG002|Overall Study|Reason unknown|0|||
130498623|NCT03611075|469793380|FG003|Overall Study|Reason unknown|1|||
130498624|NCT03611075|469793381|FG004|Overall Study|Reason unknown|0|||
130498625|NCT03611075|469793382|FG005|Overall Study|Reason unknown|0|||
130498626|NCT03611075|469793383|FG006|Overall Study|Reason unknown|1|||
130498627|NCT03611075|469793384|FG007|Overall Study|Reason unknown|0|||
130498628|NCT03611075|469793385|FG008|Overall Study|Reason unknown|0|||
130498629|NCT00676091|469793386|FG000|Infant Series|Parent or legal guardian request|10|||
130498630|NCT00676091|469793387|FG001|Infant Series|Parent or legal guardian request|8|||
130498631|NCT00676091|469793386|FG000|Infant Series|Protocol Violation|6|||
130498632|NCT00676091|469793387|FG001|Infant Series|Protocol Violation|3|||
130498633|NCT00676091|469793386|FG000|Infant Series|Adverse Event|2|||
130498634|NCT00676091|469793387|FG001|Infant Series|Adverse Event|3|||
130498635|NCT00676091|469793386|FG000|Infant Series|Failed to return|1|||
130498636|NCT00676091|469793387|FG001|Infant Series|Failed to return|3|||
130498637|NCT00676091|469793386|FG000|Infant Series|Lost to Follow-up|1|||
130498638|NCT00676091|469793387|FG001|Infant Series|Lost to Follow-up|0|||
130498639|NCT00676091|469793386|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
130498640|NCT00676091|469793387|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
130498641|NCT00676091|469793386|FG000|After Infant Series|Adverse Event|0|||
130498642|NCT00676091|469793387|FG001|After Infant Series|Adverse Event|1|||
130498643|NCT00676091|469793386|FG000|After Infant Series|Protocol Violation|0|||
130498644|NCT00676091|469793387|FG001|After Infant Series|Protocol Violation|1|||
130498645|NCT00676091|469793386|FG000|After Infant Series|Failed to return|1|||
130498646|NCT00676091|469793387|FG001|After Infant Series|Failed to return|1|||
130498647|NCT00676091|469793386|FG000|Toddler Dose|Failed to return|2|||
130498648|NCT00676091|469793387|FG001|Toddler Dose|Failed to return|0|||
130498649|NCT00676091|469793386|FG000|Toddler Dose|Parent or legal guardian request|1|||
130498650|NCT00676091|469793387|FG001|Toddler Dose|Parent or legal guardian request|0|||
130498651|NCT01701401|469793391|FG000|Overall Study|Randomized But Not Treated|3|||
130498652|NCT01701401|469793392|FG001|Overall Study|Randomized But Not Treated|1|||
130498653|NCT01701401|469793393|FG002|Overall Study|Randomized But Not Treated|0|||
130498654|NCT01701401|469793394|FG003|Overall Study|Randomized But Not Treated|1|||
130498655|NCT01701401|469793391|FG000|Overall Study|Lost to Follow-up|5|||
130498656|NCT01701401|469793392|FG001|Overall Study|Lost to Follow-up|5|||
130498657|NCT01701401|469793393|FG002|Overall Study|Lost to Follow-up|1|||
130498658|NCT01701401|469793394|FG003|Overall Study|Lost to Follow-up|3|||
130498659|NCT01701401|469793391|FG000|Overall Study|Withdrew Consent|0|||
130498660|NCT01701401|469793392|FG001|Overall Study|Withdrew Consent|3|||
130498661|NCT01701401|469793393|FG002|Overall Study|Withdrew Consent|1|||
130498662|NCT01701401|469793394|FG003|Overall Study|Withdrew Consent|2|||
130498663|NCT01701401|469793391|FG000|Overall Study|Lack of Efficacy|1|||
130498664|NCT01701401|469793392|FG001|Overall Study|Lack of Efficacy|0|||
130498665|NCT01701401|469793393|FG002|Overall Study|Lack of Efficacy|2|||
130498666|NCT01701401|469793394|FG003|Overall Study|Lack of Efficacy|0|||
130498667|NCT01701401|469793391|FG000|Overall Study|Adverse Event|1|||
130498668|NCT01701401|469793392|FG001|Overall Study|Adverse Event|0|||
130498669|NCT01701401|469793393|FG002|Overall Study|Adverse Event|0|||
130498670|NCT01701401|469793394|FG003|Overall Study|Adverse Event|0|||
130498671|NCT01701401|469793391|FG000|Overall Study|Protocol Violation|0|||
130498672|NCT01701401|469793392|FG001|Overall Study|Protocol Violation|0|||
130498673|NCT01701401|469793393|FG002|Overall Study|Protocol Violation|1|||
130498674|NCT01701401|469793394|FG003|Overall Study|Protocol Violation|0|||
130498675|NCT05366751|469793395|FG000|Overall Study|Adverse Event|25|||
130498676|NCT05366751|469793395|FG000|Overall Study|Physician Decision|3|||
130498677|NCT05366751|469793395|FG000|Overall Study|Lost to Follow-up|2|||
130498678|NCT05366751|469793395|FG000|Overall Study|Withdrawal by Subject|14|||
130498679|NCT05366751|469793395|FG000|Overall Study|Study Terminated by Sponsor|50|||
130498680|NCT05366751|469793395|FG000|Overall Study|Site Terminated by Sponsor|3|||
130498681|NCT05325294|469793398|FG000|Overall Study|Adverse Event|3|||
130498682|NCT05325294|469793399|FG001|Overall Study|Adverse Event|3|||
130498683|NCT05325294|469793398|FG000|Overall Study|Physician Decision|0|||
130498684|NCT05325294|469793399|FG001|Overall Study|Physician Decision|1|||
130498685|NCT05325294|469793398|FG000|Overall Study|Withdrawal by Subject|0|||
130498686|NCT05325294|469793399|FG001|Overall Study|Withdrawal by Subject|3|||
130498687|NCT05325294|469793398|FG000|Overall Study|Lost to Follow-up|1|||
130498688|NCT05325294|469793399|FG001|Overall Study|Lost to Follow-up|0|||
130498689|NCT05325294|469793398|FG000|Overall Study|Sponsor Request|0|||
130498690|NCT05325294|469793399|FG001|Overall Study|Sponsor Request|2|||
130498691|NCT00647387|469793400|FG000|Overall Study|Lost to Follow-up|6|||
130498692|NCT00647387|469793400|FG000|Overall Study|Unsuccessful implant|5|||
130498693|NCT00647387|469793400|FG000|Overall Study|Device explanted|3|||
130498694|NCT00647387|469793400|FG000|Overall Study|Other Reason|3|||
130498695|NCT00647387|469793400|FG000|Overall Study|Death|2|||
130498696|NCT02969356|469793401|FG000|Overall Study|Adverse Event|7|||
130498697|NCT02969356|469793401|FG000|Overall Study|Consent withdrawn|2|||
130498698|NCT02969356|469793401|FG000|Overall Study|Lost to Follow-up|3|||
130498699|NCT02969356|469793401|FG000|Overall Study|Did not need to be reinjected|6|||
130498700|NCT02969356|469793401|FG000|Overall Study|Personal reasons|5|||
130498701|NCT02972034|469794757|FG000|Overall Study|Death|11|||
130498702|NCT02972034|469794758|FG001|Overall Study|Death|1|||
130498703|NCT02972034|469794759|FG002|Overall Study|Death|3|||
130498704|NCT02972034|469794760|FG003|Overall Study|Death|3|||
130498705|NCT02972034|469794761|FG004|Overall Study|Death|2|||
130498706|NCT02972034|469794762|FG005|Overall Study|Death|2|||
130498707|NCT02972034|469794763|FG006|Overall Study|Death|3|||
130498708|NCT02972034|469794764|FG007|Overall Study|Death|4|||
130498709|NCT02972034|469794765|FG008|Overall Study|Death|8|||
130498710|NCT02972034|469794766|FG009|Overall Study|Death|11|||
130498711|NCT02972034|469794767|FG010|Overall Study|Death|3|||
130498712|NCT02972034|469794768|FG011|Overall Study|Death|2|||
130498713|NCT02972034|469794769|FG012|Overall Study|Death|11|||
130498714|NCT02972034|469794770|FG013|Overall Study|Death|10|||
130498715|NCT02972034|469794771|FG014|Overall Study|Death|9|||
130498716|NCT02972034|469794757|FG000|Overall Study|Lost to Follow-up|0|||
130498717|NCT02972034|469794758|FG001|Overall Study|Lost to Follow-up|0|||
130498718|NCT02972034|469794759|FG002|Overall Study|Lost to Follow-up|0|||
130498719|NCT02972034|469794760|FG003|Overall Study|Lost to Follow-up|0|||
130498720|NCT02972034|469794761|FG004|Overall Study|Lost to Follow-up|1|||
130498721|NCT02972034|469794762|FG005|Overall Study|Lost to Follow-up|0|||
130498722|NCT02972034|469794763|FG006|Overall Study|Lost to Follow-up|0|||
130498723|NCT02972034|469794764|FG007|Overall Study|Lost to Follow-up|1|||
130498724|NCT02972034|469794765|FG008|Overall Study|Lost to Follow-up|0|||
130498725|NCT02972034|469794766|FG009|Overall Study|Lost to Follow-up|0|||
130498726|NCT02972034|469794767|FG010|Overall Study|Lost to Follow-up|0|||
130498727|NCT02972034|469794768|FG011|Overall Study|Lost to Follow-up|0|||
130498728|NCT02972034|469794769|FG012|Overall Study|Lost to Follow-up|0|||
130498729|NCT02972034|469794770|FG013|Overall Study|Lost to Follow-up|0|||
130498730|NCT02972034|469794771|FG014|Overall Study|Lost to Follow-up|1|||
130498731|NCT02972034|469794757|FG000|Overall Study|Physician Decision|0|||
130498732|NCT02972034|469794758|FG001|Overall Study|Physician Decision|0|||
130498733|NCT02972034|469794759|FG002|Overall Study|Physician Decision|0|||
130498734|NCT02972034|469794760|FG003|Overall Study|Physician Decision|0|||
130498735|NCT02972034|469794761|FG004|Overall Study|Physician Decision|0|||
130498736|NCT02972034|469794762|FG005|Overall Study|Physician Decision|0|||
130498737|NCT02972034|469794763|FG006|Overall Study|Physician Decision|0|||
130498738|NCT02972034|469794764|FG007|Overall Study|Physician Decision|1|||
130498739|NCT02972034|469794765|FG008|Overall Study|Physician Decision|0|||
130498740|NCT02972034|469794766|FG009|Overall Study|Physician Decision|0|||
130498741|NCT02972034|469794767|FG010|Overall Study|Physician Decision|1|||
130498742|NCT02972034|469794768|FG011|Overall Study|Physician Decision|0|||
130498743|NCT02972034|469794769|FG012|Overall Study|Physician Decision|0|||
130498744|NCT02972034|469794770|FG013|Overall Study|Physician Decision|0|||
130498745|NCT02972034|469794771|FG014|Overall Study|Physician Decision|0|||
130498746|NCT02972034|469794757|FG000|Overall Study|Sponsor Decision|0|||
130498747|NCT02972034|469794758|FG001|Overall Study|Sponsor Decision|0|||
130498748|NCT02972034|469794759|FG002|Overall Study|Sponsor Decision|0|||
130498749|NCT02972034|469794760|FG003|Overall Study|Sponsor Decision|1|||
130498750|NCT02972034|469794761|FG004|Overall Study|Sponsor Decision|0|||
130498751|NCT02972034|469794762|FG005|Overall Study|Sponsor Decision|0|||
130498752|NCT02972034|469794763|FG006|Overall Study|Sponsor Decision|1|||
130498753|NCT02972034|469794764|FG007|Overall Study|Sponsor Decision|1|||
130498754|NCT02972034|469794765|FG008|Overall Study|Sponsor Decision|1|||
130498755|NCT02972034|469794766|FG009|Overall Study|Sponsor Decision|2|||
130498756|NCT02972034|469794767|FG010|Overall Study|Sponsor Decision|2|||
130498757|NCT02972034|469794768|FG011|Overall Study|Sponsor Decision|0|||
130498758|NCT02972034|469794769|FG012|Overall Study|Sponsor Decision|1|||
130498759|NCT02972034|469794770|FG013|Overall Study|Sponsor Decision|0|||
130498760|NCT02972034|469794771|FG014|Overall Study|Sponsor Decision|1|||
130498761|NCT02972034|469794757|FG000|Overall Study|Withdrawal by Subject|3|||
130498762|NCT02972034|469794758|FG001|Overall Study|Withdrawal by Subject|0|||
130498763|NCT02972034|469794759|FG002|Overall Study|Withdrawal by Subject|0|||
130498764|NCT02972034|469794760|FG003|Overall Study|Withdrawal by Subject|0|||
130498765|NCT02972034|469794761|FG004|Overall Study|Withdrawal by Subject|1|||
130498766|NCT02972034|469794762|FG005|Overall Study|Withdrawal by Subject|1|||
130498767|NCT02972034|469794763|FG006|Overall Study|Withdrawal by Subject|0|||
130498768|NCT02972034|469794764|FG007|Overall Study|Withdrawal by Subject|0|||
130498769|NCT02972034|469794765|FG008|Overall Study|Withdrawal by Subject|1|||
130498770|NCT02972034|469794766|FG009|Overall Study|Withdrawal by Subject|1|||
130498771|NCT02972034|469794767|FG010|Overall Study|Withdrawal by Subject|2|||
130498772|NCT02972034|469794768|FG011|Overall Study|Withdrawal by Subject|1|||
130498773|NCT02972034|469794769|FG012|Overall Study|Withdrawal by Subject|1|||
130498774|NCT02972034|469794770|FG013|Overall Study|Withdrawal by Subject|1|||
130498775|NCT02972034|469794771|FG014|Overall Study|Withdrawal by Subject|0|||
130498776|NCT02972034|469794757|FG000|Overall Study|Screen Failure|0|||
130498777|NCT02972034|469794758|FG001|Overall Study|Screen Failure|0|||
130498778|NCT02972034|469794759|FG002|Overall Study|Screen Failure|0|||
130498779|NCT02972034|469794760|FG003|Overall Study|Screen Failure|0|||
130498780|NCT02972034|469794761|FG004|Overall Study|Screen Failure|0|||
130498781|NCT02972034|469794762|FG005|Overall Study|Screen Failure|0|||
130498782|NCT02972034|469794763|FG006|Overall Study|Screen Failure|0|||
130498783|NCT02972034|469794764|FG007|Overall Study|Screen Failure|0|||
130498784|NCT02972034|469794765|FG008|Overall Study|Screen Failure|0|||
130498785|NCT02972034|469794766|FG009|Overall Study|Screen Failure|0|||
130498786|NCT02972034|469794767|FG010|Overall Study|Screen Failure|0|||
130498787|NCT02972034|469794768|FG011|Overall Study|Screen Failure|0|||
130498788|NCT02972034|469794769|FG012|Overall Study|Screen Failure|1|||
130498789|NCT02972034|469794770|FG013|Overall Study|Screen Failure|0|||
130498790|NCT02972034|469794771|FG014|Overall Study|Screen Failure|0|||
130498791|NCT00378898|469794772|FG000|Overall Study|Withdrawal by Subject|10|||
130498792|NCT00378898|469794773|FG001|Overall Study|Withdrawal by Subject|5|||
130498793|NCT00378898|469794772|FG000|Overall Study|Protocol Violation|1|||
130498794|NCT00378898|469794773|FG001|Overall Study|Protocol Violation|1|||
130498795|NCT03136159|469794774|FG000|Overall Study|chorioamnionitis|2|||
130498796|NCT03136159|469794775|FG001|Overall Study|chorioamnionitis|0|||
130498797|NCT03136159|469794774|FG000|Overall Study|vertical skin incision|1|||
130498798|NCT03136159|469794775|FG001|Overall Study|vertical skin incision|0|||
130498799|NCT03136159|469794774|FG000|Overall Study|additional dressing|1|||
130498800|NCT03136159|469794775|FG001|Overall Study|additional dressing|0|||
130498801|NCT03136159|469794774|FG000|Overall Study|never got dressing placed|1|||
130498802|NCT03136159|469794775|FG001|Overall Study|never got dressing placed|0|||
130498803|NCT00745875|469794776|FG000|Overall Study|Continuing study treatment|4|||
130498804|NCT00745875|469794777|FG001|Overall Study|Continuing study treatment|4|||
130498805|NCT01256359|469794778|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
130498806|NCT01256359|469794779|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
130498807|NCT01256359|469794778|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
130498808|NCT01256359|469794779|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
130498809|NCT04497415|469794795|FG000|Overall Study|Lost to Follow-up|43|||
130498810|NCT04497415|469794796|FG001|Overall Study|Lost to Follow-up|27|||
130498811|NCT04693637|469794797|FG000|Overall Study|Death|4|||
130498812|NCT04693637|469794797|FG000|Overall Study|Withdrawal by Subject|3|||
130498813|NCT04693637|469794797|FG000|Overall Study|Physician Decision|2|||
130498814|NCT04693637|469794797|FG000|Overall Study|Lost to Follow-up|1|||
130498815|NCT00853580|469794822|FG000|Overall Study|Lost to Follow-up|3|||
130498816|NCT00853580|469794823|FG001|Overall Study|Lost to Follow-up|5|||
130498817|NCT00853580|469794822|FG000|Overall Study|Protocol Violation|2|||
130498818|NCT00853580|469794823|FG001|Overall Study|Protocol Violation|1|||
130498819|NCT00853580|469794822|FG000|Overall Study|Withdrawal by Subject|2|||
130498820|NCT00853580|469794823|FG001|Overall Study|Withdrawal by Subject|8|||
130498821|NCT00853580|469794822|FG000|Overall Study|Commenced contraindicated therapy|0|||
130498822|NCT00853580|469794823|FG001|Overall Study|Commenced contraindicated therapy|2|||
130498823|NCT01700205|469794824|FG000|Overall Study|Withdrawal by Subject|13|||
130498824|NCT01700205|469794825|FG001|Overall Study|Withdrawal by Subject|13|||
130498825|NCT01700205|469794824|FG000|Overall Study|Protocol Violation|2|||
130498826|NCT01700205|469794825|FG001|Overall Study|Protocol Violation|2|||
130498827|NCT01728324|469794826|FG000|Termination of DBV|Adverse Event|14|||
130498828|NCT01728324|469794827|FG001|Termination of DBV|Adverse Event|13|||
130498829|NCT01728324|469794828|FG002|Termination of DBV|Adverse Event|4|||
130565654|NCT01376778|470036968|FG000|Overall Study|Lost to Follow-up|3|||
130498830|NCT01728324|469794826|FG000|Termination of DBV|Lack of Efficacy|14|||
130498831|NCT01728324|469794827|FG001|Termination of DBV|Lack of Efficacy|12|||
130498832|NCT01728324|469794828|FG002|Termination of DBV|Lack of Efficacy|8|||
130498833|NCT01728324|469794826|FG000|Termination of DBV|Withdrawal by Subject|9|||
130498834|NCT01728324|469794827|FG001|Termination of DBV|Withdrawal by Subject|6|||
130498835|NCT01728324|469794828|FG002|Termination of DBV|Withdrawal by Subject|2|||
130498836|NCT01728324|469794826|FG000|Termination of DBV|Other than stated|1|||
130498837|NCT01728324|469794827|FG001|Termination of DBV|Other than stated|3|||
130498838|NCT01728324|469794828|FG002|Termination of DBV|Other than stated|0|||
130498839|NCT01728324|469794826|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
130498840|NCT01728324|469794827|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
130498841|NCT01728324|469794828|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
130498842|NCT01728324|469794826|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
130498843|NCT01728324|469794827|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
130498844|NCT01728324|469794828|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
130498845|NCT01728324|469794826|FG000|Termination of FDV|Adverse Event|14|||
130498846|NCT01728324|469794827|FG001|Termination of FDV|Adverse Event|13|||
130498847|NCT01728324|469794828|FG002|Termination of FDV|Adverse Event|4|||
130498848|NCT01728324|469794826|FG000|Termination of FDV|Lack of Efficacy|14|||
130498849|NCT01728324|469794827|FG001|Termination of FDV|Lack of Efficacy|12|||
130498850|NCT01728324|469794828|FG002|Termination of FDV|Lack of Efficacy|8|||
130498851|NCT01728324|469794826|FG000|Termination of FDV|Withdrawal by Subject|9|||
130498852|NCT01728324|469794827|FG001|Termination of FDV|Withdrawal by Subject|6|||
130498853|NCT01728324|469794828|FG002|Termination of FDV|Withdrawal by Subject|2|||
130498854|NCT01728324|469794826|FG000|Termination of FDV|Other than stated|1|||
130498855|NCT01728324|469794827|FG001|Termination of FDV|Other than stated|3|||
130498856|NCT01728324|469794828|FG002|Termination of FDV|Other than stated|0|||
130498857|NCT01728324|469794826|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
130498858|NCT01728324|469794827|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
130498859|NCT01728324|469794828|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
130498860|NCT01728324|469794826|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
130498861|NCT01728324|469794827|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
130498862|NCT01728324|469794828|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
130498863|NCT01728324|469794826|FG000|Termination of RBV|Adverse Event|15|||
130498864|NCT01728324|469794827|FG001|Termination of RBV|Adverse Event|16|||
130498865|NCT01728324|469794828|FG002|Termination of RBV|Adverse Event|5|||
130498866|NCT01728324|469794826|FG000|Termination of RBV|Lack of Efficacy|14|||
130498867|NCT01728324|469794827|FG001|Termination of RBV|Lack of Efficacy|11|||
130498868|NCT01728324|469794828|FG002|Termination of RBV|Lack of Efficacy|7|||
130498869|NCT01728324|469794826|FG000|Termination of RBV|Withdrawal by Subject|9|||
130498870|NCT01728324|469794827|FG001|Termination of RBV|Withdrawal by Subject|5|||
130498871|NCT01728324|469794828|FG002|Termination of RBV|Withdrawal by Subject|2|||
130498872|NCT01728324|469794826|FG000|Termination of RBV|Other than stated|1|||
130498873|NCT01728324|469794827|FG001|Termination of RBV|Other than stated|3|||
130498874|NCT01728324|469794828|FG002|Termination of RBV|Other than stated|1|||
130498875|NCT01728324|469794826|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
130498876|NCT01728324|469794827|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
130498877|NCT01728324|469794828|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
130498878|NCT01728324|469794826|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
130498879|NCT01728324|469794827|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
130498880|NCT01728324|469794828|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
130498881|NCT01170208|469794831|FG000|Overall Study|Withdrawal by Subject|5|||
130498882|NCT01170208|469794832|FG001|Overall Study|Withdrawal by Subject|0|||
130498883|NCT01170208|469794833|FG002|Overall Study|Withdrawal by Subject|1|||
130498884|NCT01170208|469794831|FG000|Overall Study|Protocol Violation|1|||
130498885|NCT01170208|469794832|FG001|Overall Study|Protocol Violation|0|||
130498886|NCT01170208|469794833|FG002|Overall Study|Protocol Violation|1|||
130498887|NCT03335488|469794840|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
130498888|NCT03335488|469794841|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
130498889|NCT03335488|469794840|FG000|Safety Extension Period|Adverse Event|1|||
130498890|NCT03335488|469794841|FG001|Safety Extension Period|Adverse Event|0|||
130498891|NCT03335488|469794840|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
130498892|NCT03335488|469794841|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
130498893|NCT02022670|469794842|FG000|Overall Study|Adverse Event|1|||
130498894|NCT02022670|469794843|FG001|Overall Study|Adverse Event|0|||
130498895|NCT02022670|469794844|FG002|Overall Study|Adverse Event|1|||
130498896|NCT02113449|469794845|FG000|Overall Study|Adverse Event|4|||
130498897|NCT04638816|469794846|FG000|Overall Study|Withdrawal by Subject|0|||
130498898|NCT04638816|469794847|FG001|Overall Study|Withdrawal by Subject|1|||
130498899|NCT04638816|469794846|FG000|Overall Study|Lost to Follow-up|0|||
130498900|NCT04638816|469794847|FG001|Overall Study|Lost to Follow-up|1|||
130498901|NCT02251652|469794848|FG000|Overall Study|Withdrawal by Subject|1|||
130498902|NCT01160354|469794851|FG000|Overall Study|Death|0|||
130498903|NCT01160354|469794852|FG001|Overall Study|Death|1|||
130498904|NCT01160354|469794853|FG002|Overall Study|Death|1|||
130498905|NCT01822756|469794854|FG000|Overall Study|Adverse Event|0|||
130498906|NCT01822756|469794855|FG001|Overall Study|Adverse Event|0|||
130498907|NCT01822756|469794856|FG002|Overall Study|Adverse Event|0|||
130498908|NCT01822756|469794857|FG003|Overall Study|Adverse Event|2|||
130498909|NCT01822756|469794858|FG004|Overall Study|Adverse Event|0|||
130498910|NCT01822756|469794854|FG000|Overall Study|Disease progression|11|||
130498911|NCT01822756|469794855|FG001|Overall Study|Disease progression|1|||
130498912|NCT01822756|469794856|FG002|Overall Study|Disease progression|7|||
130498913|NCT01822756|469794857|FG003|Overall Study|Disease progression|2|||
130498914|NCT01822756|469794858|FG004|Overall Study|Disease progression|6|||
130498915|NCT01822756|469794854|FG000|Overall Study|Death|2|||
130498916|NCT01822756|469794855|FG001|Overall Study|Death|2|||
130498917|NCT01822756|469794856|FG002|Overall Study|Death|1|||
130498918|NCT01822756|469794857|FG003|Overall Study|Death|0|||
130498919|NCT01822756|469794858|FG004|Overall Study|Death|0|||
130498920|NCT01822756|469794854|FG000|Overall Study|Lost to Follow-up|1|||
130498921|NCT01822756|469794855|FG001|Overall Study|Lost to Follow-up|0|||
130498922|NCT01822756|469794856|FG002|Overall Study|Lost to Follow-up|1|||
130498923|NCT01822756|469794857|FG003|Overall Study|Lost to Follow-up|0|||
130498924|NCT01822756|469794858|FG004|Overall Study|Lost to Follow-up|1|||
130498925|NCT01822756|469794854|FG000|Overall Study|Physician Decision|0|||
130498926|NCT01822756|469794855|FG001|Overall Study|Physician Decision|1|||
130498927|NCT01822756|469794856|FG002|Overall Study|Physician Decision|0|||
130498928|NCT01822756|469794857|FG003|Overall Study|Physician Decision|0|||
130498929|NCT01822756|469794858|FG004|Overall Study|Physician Decision|0|||
130498930|NCT01822756|469794854|FG000|Overall Study|disease progression & patient preference|2|||
130498931|NCT01822756|469794855|FG001|Overall Study|disease progression & patient preference|0|||
130498932|NCT01822756|469794856|FG002|Overall Study|disease progression & patient preference|1|||
130498933|NCT01822756|469794857|FG003|Overall Study|disease progression & patient preference|0|||
130498934|NCT01822756|469794858|FG004|Overall Study|disease progression & patient preference|0|||
130498935|NCT01827839|469794871|FG000|Overall Study|Adverse Event|1|||
130498936|NCT01827839|469794871|FG000|Overall Study|Consent Withdrawal|2|||
130498937|NCT00933270|469794878|FG000|Overall Study|Withdrawal by Subject|26|||
130498938|NCT00933270|469794878|FG000|Overall Study|Insufficient Follow-up|10|||
130498939|NCT00933270|469794878|FG000|Overall Study|Lost to Follow-up|14|||
130498940|NCT00933270|469794878|FG000|Overall Study|Adverse Event|1|||
130498941|NCT00933270|469794878|FG000|Overall Study|Missed Visit|2|||
130498942|NCT00933270|469794878|FG000|Overall Study|Death|24|||
130498943|NCT00933270|469794878|FG000|Overall Study|Moved or would not return|10|||
130498944|NCT03476798|469794881|FG000|Overall Study|Death|1|||
130498945|NCT03476798|469794881|FG000|Overall Study|Withdrawal by Subject|2|||
130498946|NCT03476798|469794881|FG000|Overall Study|Protocol Violation|2|||
130498947|NCT05824559|469794882|FG000|Overall Study|Adverse Event|2|||
130498948|NCT05824559|469794882|FG000|Overall Study|Physician Decision|2|||
130498949|NCT05824559|469794882|FG000|Overall Study|Progressive Disease|16|||
130498950|NCT05824559|469794882|FG000|Overall Study|Study Terminated by Sponsor|1|||
130498951|NCT05824559|469794882|FG000|Overall Study|Withdrawal by Subject|2|||
130498952|NCT02409680|469794887|FG000|Overall Study|Lost to Follow-up|15|||
130498953|NCT02409680|469794888|FG001|Overall Study|Lost to Follow-up|30|||
130498954|NCT00491894|469794892|FG000|Overall Study|Adverse Event|14|||
130498955|NCT00491894|469794892|FG000|Overall Study|Withdrawal by Subject|5|||
130498956|NCT00491894|469794892|FG000|Overall Study|Death|3|||
130498957|NCT00491894|469794892|FG000|Overall Study|Lost to Follow-up|3|||
130498958|NCT00491894|469794892|FG000|Overall Study|Lack of Efficacy|2|||
130498959|NCT00491894|469794892|FG000|Overall Study|Other-Failed to meet any criteria|2|||
130498960|NCT00491894|469794892|FG000|Overall Study|Physician Decision|2|||
130498961|NCT00491894|469794892|FG000|Overall Study|Protocol Violation|2|||
130498962|NCT00491894|469794892|FG000|Overall Study|Other-Intake of prohibited medication|1|||
130498963|NCT00302211|469794898|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
130498964|NCT00302211|469794899|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
130498965|NCT00302211|469794900|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
130498966|NCT00302211|469794901|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
130498967|NCT00302211|469794902|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
130498968|NCT00302211|469794898|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
130498969|NCT00302211|469794899|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
130498970|NCT00302211|469794900|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
130498971|NCT00302211|469794901|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
130498972|NCT00302211|469794902|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
130498973|NCT00302211|469794898|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
130498974|NCT00302211|469794899|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
130498975|NCT00302211|469794900|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
130498976|NCT00302211|469794901|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
130498977|NCT00302211|469794902|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
130498978|NCT00302211|469794898|FG000|Double Blind Period (New Patients)|Disease progression|0|||
130498979|NCT00302211|469794899|FG001|Double Blind Period (New Patients)|Disease progression|1|||
130498980|NCT00302211|469794900|FG002|Double Blind Period (New Patients)|Disease progression|1|||
130498981|NCT00302211|469794901|FG003|Double Blind Period (New Patients)|Disease progression|0|||
130498982|NCT00302211|469794902|FG004|Double Blind Period (New Patients)|Disease progression|0|||
130498983|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
130498984|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
130498985|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
130498986|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
130498987|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
130498988|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
130498989|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
130498990|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
130498991|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
130498992|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
130498993|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
130498994|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
130498995|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
130498996|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
130498997|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
130498998|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
130498999|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
130499000|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
130499001|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
130499002|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
130499003|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Death|0|||
130499004|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Death|0|||
130499005|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Death|0|||
130499006|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Death|1|||
130499007|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Death|1|||
130499008|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
130499009|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
130499010|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
130499011|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
130499012|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
130499013|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
130499014|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
130499015|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
130499016|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
130499017|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
130499018|NCT00302211|469794898|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
130499019|NCT00302211|469794899|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
130499020|NCT00302211|469794900|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
130499021|NCT00302211|469794901|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
130499022|NCT00302211|469794902|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
130499023|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
130499024|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
130499025|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
130499026|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
130499027|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
130499028|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
130499029|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
130499030|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
130499031|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
130499032|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
130499033|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
130499034|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
130499035|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
130499036|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
130499037|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
130499038|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
130499039|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
130499040|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
130499041|NCT02294461|469794908|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
130499042|NCT02294461|469794909|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
130499043|NCT02294461|469794910|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
130499044|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
130499045|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
130499046|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
130499047|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
130499048|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
130499049|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
130499050|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
130499051|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
130499052|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
130499053|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
130729529|NCT03765788|470633578|FG000|Overall Study|Lost to Follow-up|1|||
130499054|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
130499055|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
130499056|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
130499057|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
130499058|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
130499059|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
130499060|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
130499061|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
130499062|NCT02294461|469794908|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
130499063|NCT02294461|469794909|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
130499064|NCT02294461|469794910|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
130499065|NCT05432986|469794911|FG000|Overall Study|Withdrawal by Subject|2|||
130499066|NCT05432986|469794911|FG000|Overall Study|incomplete measurement|7|||
130499067|NCT04172675|469796475|FG000|Overall Study|Withdrawal by Subject|7|||
130499068|NCT04172675|469796476|FG001|Overall Study|Withdrawal by Subject|5|||
130499069|NCT04172675|469796477|FG002|Overall Study|Withdrawal by Subject|1|||
130499070|NCT04172675|469796478|FG003|Overall Study|Withdrawal by Subject|4|||
130499071|NCT05349721|469796479|FG000|Part A (24 Weeks)|Adverse Event|9|||
130499072|NCT05349721|469796480|FG001|Part A (24 Weeks)|Adverse Event|2|||
130499073|NCT05349721|469796479|FG000|Part A (24 Weeks)|Death|8|||
130499074|NCT05349721|469796480|FG001|Part A (24 Weeks)|Death|3|||
130499075|NCT05349721|469796479|FG000|Part A (24 Weeks)|Disease Progression|1|||
130499076|NCT05349721|469796480|FG001|Part A (24 Weeks)|Disease Progression|1|||
130499077|NCT05349721|469796479|FG000|Part A (24 Weeks)|Screen Failure|2|||
130499078|NCT05349721|469796480|FG001|Part A (24 Weeks)|Screen Failure|0|||
130499079|NCT05349721|469796479|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
130499080|NCT05349721|469796480|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
130499081|NCT05349721|469796479|FG000|Part A (24 Weeks)|Other Than Specified|5|||
130499082|NCT05349721|469796480|FG001|Part A (24 Weeks)|Other Than Specified|1|||
130499083|NCT05349721|469796479|FG000|Part B (28 Weeks)|Adverse Event|3|||
130499084|NCT05349721|469796480|FG001|Part B (28 Weeks)|Adverse Event|0|||
130499085|NCT05349721|469796479|FG000|Part B (28 Weeks)|Death|21|||
130729530|NCT03765788|470633579|FG001|Overall Study|Lost to Follow-up|0|||
130729531|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
130729532|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
130729533|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
130729534|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
130729535|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
130729536|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
130729537|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130729538|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
130729539|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130729540|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130729541|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130729542|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
130729543|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130729544|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130729545|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
130729546|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729547|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130729548|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130499086|NCT05349721|469796480|FG001|Part B (28 Weeks)|Death|11|||
130499087|NCT05349721|469796479|FG000|Part B (28 Weeks)|Disease Progression|2|||
130499088|NCT05349721|469796480|FG001|Part B (28 Weeks)|Disease Progression|1|||
130499089|NCT05349721|469796479|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
130499090|NCT05349721|469796480|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
130499091|NCT05349721|469796479|FG000|Part B (28 Weeks)|Physician Decision|1|||
130499092|NCT05349721|469796480|FG001|Part B (28 Weeks)|Physician Decision|0|||
130499093|NCT05349721|469796479|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
130499094|NCT05349721|469796480|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
130499095|NCT05349721|469796479|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
130499096|NCT05349721|469796480|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
130499097|NCT05349721|469796479|FG000|Part B (28 Weeks)|Other Than Specified|4|||
130499098|NCT05349721|469796480|FG001|Part B (28 Weeks)|Other Than Specified|2|||
130499099|NCT05349721|469796479|FG000|Part C (108 Weeks)|Death|0|||
130499100|NCT05349721|469796480|FG001|Part C (108 Weeks)|Death|1|||
130499101|NCT05349721|469796479|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
130499102|NCT05349721|469796480|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
130499103|NCT05349721|469796479|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
130499104|NCT05349721|469796480|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
130499105|NCT05349721|469796479|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
130499106|NCT05349721|469796480|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
130499107|NCT03070392|469796481|FG000|Overall Study|Not Treated|7|||
130499108|NCT03070392|469796482|FG001|Overall Study|Not Treated|0|||
130499109|NCT03070392|469796483|FG002|Overall Study|Not Treated|3|||
130499110|NCT03070392|469796484|FG003|Overall Study|Not Treated|12|||
130499111|NCT03070392|469796481|FG000|Overall Study|Death|3|||
130499112|NCT03070392|469796482|FG001|Overall Study|Death|0|||
130499113|NCT03070392|469796483|FG002|Overall Study|Death|0|||
130499114|NCT03070392|469796484|FG003|Overall Study|Death|1|||
130499115|NCT03070392|469796481|FG000|Overall Study|Withdrawal by Subject|7|||
130499116|NCT03070392|469796482|FG001|Overall Study|Withdrawal by Subject|0|||
130499117|NCT03070392|469796483|FG002|Overall Study|Withdrawal by Subject|0|||
130499118|NCT03070392|469796484|FG003|Overall Study|Withdrawal by Subject|3|||
130499119|NCT03070392|469796481|FG000|Overall Study|Physician Decision|1|||
130499120|NCT03070392|469796482|FG001|Overall Study|Physician Decision|0|||
130499121|NCT03070392|469796483|FG002|Overall Study|Physician Decision|0|||
130499122|NCT03070392|469796484|FG003|Overall Study|Physician Decision|2|||
130499123|NCT03070392|469796481|FG000|Overall Study|Progressive Disease|154|||
130499124|NCT03070392|469796482|FG001|Overall Study|Progressive Disease|6|||
130499125|NCT03070392|469796483|FG002|Overall Study|Progressive Disease|2|||
130499126|NCT03070392|469796484|FG003|Overall Study|Progressive Disease|70|||
130499127|NCT03070392|469796481|FG000|Overall Study|Adverse Event|6|||
130499128|NCT03070392|469796482|FG001|Overall Study|Adverse Event|1|||
130499129|NCT03070392|469796483|FG002|Overall Study|Adverse Event|1|||
130499130|NCT03070392|469796484|FG003|Overall Study|Adverse Event|3|||
130499131|NCT03070392|469796481|FG000|Overall Study|Alternate anticancer treatment|1|||
130499132|NCT03070392|469796482|FG001|Overall Study|Alternate anticancer treatment|0|||
130499133|NCT03070392|469796483|FG002|Overall Study|Alternate anticancer treatment|0|||
130499134|NCT03070392|469796484|FG003|Overall Study|Alternate anticancer treatment|1|||
130499135|NCT03070392|469796481|FG000|Overall Study|Ongoing|73|||
130499136|NCT03070392|469796482|FG001|Overall Study|Ongoing|0|||
130499137|NCT03070392|469796483|FG002|Overall Study|Ongoing|0|||
130499138|NCT03070392|469796484|FG003|Overall Study|Ongoing|11|||
130499139|NCT03861052|469796486|FG000|Overall Study|Adverse Event|1|||
130499140|NCT03861052|469796487|FG001|Overall Study|Adverse Event|1|||
130499141|NCT03861052|469796488|FG002|Overall Study|Adverse Event|2|||
130499142|NCT03861052|469796489|FG003|Overall Study|Adverse Event|4|||
130499143|NCT03861052|469796486|FG000|Overall Study|Lost to Follow-up|0|||
130499144|NCT03861052|469796487|FG001|Overall Study|Lost to Follow-up|0|||
130499145|NCT03861052|469796488|FG002|Overall Study|Lost to Follow-up|0|||
130499146|NCT03861052|469796489|FG003|Overall Study|Lost to Follow-up|1|||
130499147|NCT03861052|469796486|FG000|Overall Study|Physician Decision|0|||
130729549|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
130729550|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
130729551|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
130729552|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
130729553|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
130729554|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
130499148|NCT03861052|469796487|FG001|Overall Study|Physician Decision|1|||
130499149|NCT03861052|469796488|FG002|Overall Study|Physician Decision|0|||
130499150|NCT03861052|469796489|FG003|Overall Study|Physician Decision|0|||
130499151|NCT03861052|469796486|FG000|Overall Study|Withdrawal by Subject|2|||
130499152|NCT03861052|469796487|FG001|Overall Study|Withdrawal by Subject|5|||
130499153|NCT03861052|469796488|FG002|Overall Study|Withdrawal by Subject|3|||
130499154|NCT03861052|469796489|FG003|Overall Study|Withdrawal by Subject|0|||
130499155|NCT03861052|469796486|FG000|Overall Study|Relocation to other city|1|||
130729555|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
130499156|NCT03861052|469796487|FG001|Overall Study|Relocation to other city|0|||
130499157|NCT03861052|469796488|FG002|Overall Study|Relocation to other city|0|||
130499158|NCT03861052|469796489|FG003|Overall Study|Relocation to other city|0|||
130499159|NCT03009344|469796490|FG000|Overall Study|Lack of Efficacy|5|||
130499160|NCT03009344|469796490|FG000|Overall Study|Withdrawal by Subject|1|||
130499161|NCT03009344|469796490|FG000|Overall Study|Adverse Event|1|||
130499162|NCT02534233|469796493|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
130499163|NCT03823703|469796494|FG000|Overall Study|Sponsor request|0|||
130499164|NCT03823703|469796495|FG001|Overall Study|Sponsor request|3|||
130499165|NCT03823703|469796496|FG002|Overall Study|Sponsor request|4|||
130499166|NCT03823703|469796494|FG000|Overall Study|Adverse Event|3|||
130499167|NCT03823703|469796495|FG001|Overall Study|Adverse Event|1|||
130499168|NCT03823703|469796496|FG002|Overall Study|Adverse Event|0|||
130499169|NCT03823703|469796494|FG000|Overall Study|Withdrawal by Subject|0|||
130499170|NCT03823703|469796495|FG001|Overall Study|Withdrawal by Subject|1|||
130499171|NCT03823703|469796496|FG002|Overall Study|Withdrawal by Subject|0|||
130499172|NCT03137459|469796497|FG000|2-month Assessment|Withdrawal by Subject|13|||
130499173|NCT03137459|469796498|FG001|2-month Assessment|Withdrawal by Subject|3|||
130499174|NCT03137459|469796497|FG000|2-month Assessment|Unable to reach|42|||
130499175|NCT03137459|469796498|FG001|2-month Assessment|Unable to reach|32|||
130499176|NCT03137459|469796497|FG000|2-month Assessment|Refused assessment|7|||
130499177|NCT03137459|469796498|FG001|2-month Assessment|Refused assessment|5|||
130499178|NCT03137459|469796497|FG000|2-month Assessment|Acutely ill|6|||
130499179|NCT03137459|469796498|FG001|2-month Assessment|Acutely ill|2|||
130499180|NCT03137459|469796497|FG000|4-month Assessment|Death|4|||
130499181|NCT03137459|469796498|FG001|4-month Assessment|Death|2|||
130499182|NCT03137459|469796497|FG000|4-month Assessment|Withdrawal by Subject|4|||
130499183|NCT03137459|469796498|FG001|4-month Assessment|Withdrawal by Subject|2|||
130499184|NCT03137459|469796497|FG000|4-month Assessment|Unable to reach|44|||
130499185|NCT03137459|469796498|FG001|4-month Assessment|Unable to reach|29|||
130499186|NCT03137459|469796497|FG000|4-month Assessment|Refused assessment|24|||
130499187|NCT03137459|469796498|FG001|4-month Assessment|Refused assessment|10|||
130499188|NCT03137459|469796497|FG000|4-month Assessment|Acutely ill|2|||
130499189|NCT03137459|469796498|FG001|4-month Assessment|Acutely ill|3|||
130499190|NCT03137459|469796497|FG000|6-months|Lost to Follow-up|14|||
130499191|NCT03137459|469796498|FG001|6-months|Lost to Follow-up|11|||
130499192|NCT03137459|469796497|FG000|6-months|Death|0|||
130499193|NCT03137459|469796498|FG001|6-months|Death|2|||
130499194|NCT03137459|469796497|FG000|6-months|Refused assessment|6|||
130499195|NCT03137459|469796498|FG001|6-months|Refused assessment|3|||
130499196|NCT03137459|469796497|FG000|6-months|Acutely ill|1|||
130499197|NCT03137459|469796498|FG001|6-months|Acutely ill|1|||
130499198|NCT01732757|469796499|FG000|Overall Study|Lost to Follow-up|1|||
130499199|NCT01732757|469796500|FG001|Overall Study|Lost to Follow-up|0|||
130499200|NCT01732757|469796501|FG002|Overall Study|Lost to Follow-up|0|||
130499201|NCT00925548|469796502|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
130499202|NCT00925548|469796503|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
130499203|NCT04921358|469796504|FG000|Overall Study|Withdrawal by Subject|6|||
130499204|NCT04921358|469796505|FG001|Overall Study|Withdrawal by Subject|13|||
130499205|NCT04921358|469796504|FG000|Overall Study|Lost to Follow-up|3|||
130499206|NCT04921358|469796505|FG001|Overall Study|Lost to Follow-up|6|||
130499207|NCT04921358|469796504|FG000|Overall Study|Study Terminated by Sponsor|86|||
130499208|NCT04921358|469796505|FG001|Overall Study|Study Terminated by Sponsor|89|||
130499209|NCT04921358|469796504|FG000|Overall Study|Death|92|||
130499210|NCT04921358|469796505|FG001|Overall Study|Death|82|||
130499211|NCT02372799|469796506|FG000|Treatment Period|Adverse Event|3|||
130499212|NCT02372799|469796507|FG001|Treatment Period|Adverse Event|10|||
130499213|NCT02372799|469796508|FG002|Treatment Period|Adverse Event|6|||
130499214|NCT02372799|469796506|FG000|Treatment Period|Insufficient therapeutic response|2|||
130499215|NCT02372799|469796507|FG001|Treatment Period|Insufficient therapeutic response|2|||
130499216|NCT02372799|469796508|FG002|Treatment Period|Insufficient therapeutic response|0|||
130499217|NCT02372799|469796506|FG000|Treatment Period|Withdrawal by Subject|10|||
130499218|NCT02372799|469796507|FG001|Treatment Period|Withdrawal by Subject|10|||
130499219|NCT02372799|469796508|FG002|Treatment Period|Withdrawal by Subject|2|||
130499220|NCT02372799|469796506|FG000|Treatment Period|Lost to Follow-up|11|||
130499221|NCT02372799|469796507|FG001|Treatment Period|Lost to Follow-up|5|||
130499222|NCT02372799|469796508|FG002|Treatment Period|Lost to Follow-up|3|||
130499223|NCT02372799|469796506|FG000|Treatment Period|Protocol Violation|3|||
130499224|NCT02372799|469796507|FG001|Treatment Period|Protocol Violation|0|||
130499225|NCT02372799|469796508|FG002|Treatment Period|Protocol Violation|0|||
130499226|NCT02372799|469796506|FG000|Treatment Period|Non-compliance with study drug|4|||
130499227|NCT02372799|469796507|FG001|Treatment Period|Non-compliance with study drug|4|||
130499228|NCT02372799|469796508|FG002|Treatment Period|Non-compliance with study drug|4|||
130499229|NCT02372799|469796506|FG000|Treatment Period|Miscellaneous Reasons|1|||
130499230|NCT02372799|469796507|FG001|Treatment Period|Miscellaneous Reasons|1|||
130499231|NCT02372799|469796508|FG002|Treatment Period|Miscellaneous Reasons|0|||
130499232|NCT02372799|469796506|FG000|Down-taper Period|Lost to Follow-up|1|||
130499233|NCT02372799|469796507|FG001|Down-taper Period|Lost to Follow-up|2|||
130499234|NCT02372799|469796508|FG002|Down-taper Period|Lost to Follow-up|2|||
130499235|NCT03116464|469796509|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
130499236|NCT00491400|469796510|FG000|Overall Study|Withdrawal by Subject|5|||
130499237|NCT00491400|469796511|FG001|Overall Study|Withdrawal by Subject|4|||
130499238|NCT00597376|469796512|FG000|Overall Study|Withdrawal by Subject|4|||
130499239|NCT00597376|469796513|FG001|Overall Study|Withdrawal by Subject|3|||
130499240|NCT00597376|469796512|FG000|Overall Study|Adverse Event|4|||
130499241|NCT00597376|469796513|FG001|Overall Study|Adverse Event|1|||
130499242|NCT01532648|469796516|FG000|Overall Study|Lost to Follow-up|3|||
130499243|NCT01532648|469796517|FG001|Overall Study|Lost to Follow-up|4|||
130499244|NCT01532648|469796516|FG000|Overall Study|Lack of Efficacy|4|||
130499245|NCT01532648|469796517|FG001|Overall Study|Lack of Efficacy|1|||
130499246|NCT01532648|469796516|FG000|Overall Study|Protocol Violation|1|||
130499247|NCT01532648|469796517|FG001|Overall Study|Protocol Violation|1|||
130499248|NCT01532648|469796516|FG000|Overall Study|Adverse Event|12|||
130499249|NCT01532648|469796517|FG001|Overall Study|Adverse Event|9|||
130499250|NCT01532648|469796516|FG000|Overall Study|Withdrawal by Subject|16|||
130499251|NCT01532648|469796517|FG001|Overall Study|Withdrawal by Subject|2|||
130499252|NCT01583166|469796518|FG000|Overall Study|Withdrawal by Subject|4|||
130499253|NCT01583166|469796519|FG001|Overall Study|Withdrawal by Subject|6|||
130499254|NCT04652869|469796524|FG000|Overall Study|Withdrawal by Subject|0|||
130499255|NCT04652869|469796525|FG001|Overall Study|Withdrawal by Subject|2|||
130499256|NCT04652869|469796526|FG002|Overall Study|Withdrawal by Subject|0|||
130499257|NCT01833455|469796527|FG000|Overall Study|Withdrawal by Subject|1|||
130499258|NCT01833455|469796528|FG001|Overall Study|Withdrawal by Subject|0|||
130499259|NCT00562094|469796529|FG000|Overall Study|Lost to Follow-up|62|||
130499260|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
130499261|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
130499262|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
130499263|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
130499264|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
130499265|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
130499266|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
130499267|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
130499268|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
130499269|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
130499270|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
130499271|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
130499272|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Other|1|||
130499273|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Other|0|||
130499274|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Other|0|||
130499275|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
130499276|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
130499277|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
130499278|NCT00887224|469796530|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
130499279|NCT00887224|469796531|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
130499280|NCT00887224|469796532|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
130499281|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
130499282|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
130499283|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
130499284|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
130499285|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
130499286|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
130499287|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
130499288|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
130499289|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
130499290|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
130499291|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
130499292|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
130499293|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Other|1|||
130499294|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Other|0|||
130499295|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Other|0|||
130499296|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
130499297|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
130499298|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
130499299|NCT00887224|469796530|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
130499300|NCT00887224|469796531|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
130499301|NCT00887224|469796532|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
130499302|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
130499303|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
130499304|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
130499305|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
130499306|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
130499307|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
130499308|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
130499309|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
130499310|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
130499311|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
130499312|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
130499313|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
130499314|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Other|30|||
130499315|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Other|0|||
130499316|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Other|0|||
130499317|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
130499318|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
130499319|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
130499320|NCT00887224|469796530|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
130499321|NCT00887224|469796531|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
130499322|NCT00887224|469796532|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
130499323|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Adverse Event|0|||
130499324|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Adverse Event|7|||
130499325|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Adverse Event|2|||
130499326|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Failed to return|0|||
130499327|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Failed to return|2|||
130499328|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Failed to return|2|||
130499329|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
130499330|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
130499331|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
130499332|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
130499333|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
130499334|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
130499335|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Other|0|||
130499336|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Other|2|||
130499337|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Other|0|||
130499338|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
130499339|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
130499340|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
130499341|NCT00887224|469796530|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
130499342|NCT00887224|469796531|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
130499343|NCT00887224|469796532|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
130499344|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
130499345|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
130499346|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
130499347|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
130499348|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
130499349|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
130499350|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
130499351|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
130499352|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
130499353|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
130499354|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
130499355|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
130499356|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
130499357|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
130499358|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
130499359|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
130499360|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
130499361|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
130499362|NCT00887224|469796530|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
130499363|NCT00887224|469796531|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
130499364|NCT00887224|469796532|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
130499365|NCT01555138|469796535|FG000|Overall Study|Death|0|||
130499366|NCT01555138|469796536|FG001|Overall Study|Death|1|||
130499367|NCT01555138|469796535|FG000|Overall Study|Lost to Follow-up|1|||
130499368|NCT01555138|469796536|FG001|Overall Study|Lost to Follow-up|0|||
130499369|NCT01555138|469796535|FG000|Overall Study|Abnormal Lab reults|1|||
130565655|NCT01376778|470036969|FG001|Overall Study|Lost to Follow-up|2|||
130565656|NCT02700412|470036970|FG000|Overall Study|Adverse Event|6|||
130499370|NCT01555138|469796536|FG001|Overall Study|Abnormal Lab reults|3|||
130499371|NCT01555138|469796535|FG000|Overall Study|Lack of Efficacy|2|||
130499372|NCT01555138|469796536|FG001|Overall Study|Lack of Efficacy|2|||
130499373|NCT01555138|469796535|FG000|Overall Study|Protocol Violation|5|||
130499374|NCT01555138|469796536|FG001|Overall Study|Protocol Violation|3|||
130499375|NCT01555138|469796535|FG000|Overall Study|Administrative problems|8|||
130499376|NCT01555138|469796536|FG001|Overall Study|Administrative problems|0|||
130499377|NCT01555138|469796535|FG000|Overall Study|Withdrawal by Subject|16|||
130499378|NCT01555138|469796536|FG001|Overall Study|Withdrawal by Subject|15|||
130499379|NCT01555138|469796535|FG000|Overall Study|Adverse Event|14|||
130499380|NCT01555138|469796536|FG001|Overall Study|Adverse Event|14|||
130499381|NCT03883828|469796537|FG000|Overall Study|Did not start radiotherapy|1|||
130499382|NCT03883828|469796538|FG001|Overall Study|Did not start radiotherapy|2|||
130499383|NCT02000752|469796539|FG000|Overall Study|Dystocic delivery|19|||
130499384|NCT02000752|469796540|FG001|Overall Study|Dystocic delivery|8|||
130499385|NCT02000752|469796539|FG000|Overall Study|Shift Changes|12|||
130499386|NCT02000752|469796540|FG001|Overall Study|Shift Changes|5|||
130499387|NCT04938453|469796544|FG000|Washout Period 1|Adverse Event|1|||
130499388|NCT04938453|469796545|FG001|Washout Period 1|Adverse Event|0|||
130499389|NCT04938453|469796544|FG000|Washout Period 1|Physician Decision|0|||
130499390|NCT04938453|469796545|FG001|Washout Period 1|Physician Decision|1|||
130499391|NCT02095145|469796550|FG000|Overall Study|Withdrawal by Subject|1|||
130499392|NCT02095145|469796551|FG001|Overall Study|Withdrawal by Subject|0|||
130499393|NCT04237792|469796555|FG000|Treatment (Day 1)|Adverse Event|1|||
130499394|NCT04237792|469796556|FG001|Treatment (Day 1)|Adverse Event|0|||
130499395|NCT04237792|469796557|FG002|Treatment (Day 1)|Adverse Event|0|||
130499396|NCT04237792|469796558|FG003|Treatment (Day 1)|Adverse Event|0|||
130499397|NCT04237792|469796559|FG004|Treatment (Day 1)|Adverse Event|1|||
130499398|NCT04237792|469796560|FG005|Treatment (Day 1)|Adverse Event|1|||
130499399|NCT04237792|469796555|FG000|Treatment (Day 1)|Other|0|||
130499400|NCT04237792|469796556|FG001|Treatment (Day 1)|Other|0|||
130499401|NCT04237792|469796557|FG002|Treatment (Day 1)|Other|1|||
130499402|NCT04237792|469796558|FG003|Treatment (Day 1)|Other|0|||
130499403|NCT04237792|469796559|FG004|Treatment (Day 1)|Other|0|||
130499404|NCT04237792|469796560|FG005|Treatment (Day 1)|Other|1|||
130499405|NCT04237792|469796555|FG000|Treatment (Day 1)|Not treated|1|||
130499406|NCT04237792|469796556|FG001|Treatment (Day 1)|Not treated|1|||
130499407|NCT04237792|469796557|FG002|Treatment (Day 1)|Not treated|2|||
130499408|NCT04237792|469796558|FG003|Treatment (Day 1)|Not treated|1|||
130499409|NCT04237792|469796559|FG004|Treatment (Day 1)|Not treated|0|||
130499410|NCT04237792|469796560|FG005|Treatment (Day 1)|Not treated|1|||
130499411|NCT05553366|469796562|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
130499412|NCT05553366|469796563|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
130499413|NCT05553366|469796564|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
130499414|NCT05553366|469796562|FG000|Overall Study|Lost to Follow-up|3|||
130499415|NCT05553366|469796563|FG001|Overall Study|Lost to Follow-up|3|||
130499416|NCT05553366|469796564|FG002|Overall Study|Lost to Follow-up|3|||
130499417|NCT05553366|469796562|FG000|Overall Study|Other non-compliance|1|||
130499418|NCT05553366|469796563|FG001|Overall Study|Other non-compliance|1|||
130499419|NCT05553366|469796564|FG002|Overall Study|Other non-compliance|0|||
130499420|NCT05553366|469796562|FG000|Overall Study|Randomized but not dosed|0|||
130499421|NCT05553366|469796563|FG001|Overall Study|Randomized but not dosed|0|||
130499422|NCT05553366|469796564|FG002|Overall Study|Randomized but not dosed|2|||
130499423|NCT02022657|469796568|FG000|Overall Study|Withdrawal by Subject|2|||
130499424|NCT02022657|469796569|FG001|Overall Study|Withdrawal by Subject|0|||
130499425|NCT02022657|469796570|FG002|Overall Study|Withdrawal by Subject|1|||
130499426|NCT02022657|469796571|FG003|Overall Study|Withdrawal by Subject|0|||
130499427|NCT02022657|469796572|FG004|Overall Study|Withdrawal by Subject|0|||
130499428|NCT02022657|469796573|FG005|Overall Study|Withdrawal by Subject|0|||
130499429|NCT02022657|469796568|FG000|Overall Study|Physician Decision|0|||
130499430|NCT02022657|469796569|FG001|Overall Study|Physician Decision|0|||
130499431|NCT02022657|469796570|FG002|Overall Study|Physician Decision|0|||
130499432|NCT02022657|469796571|FG003|Overall Study|Physician Decision|0|||
130499433|NCT02022657|469796572|FG004|Overall Study|Physician Decision|0|||
130499434|NCT02022657|469796573|FG005|Overall Study|Physician Decision|1|||
130499435|NCT03739866|469796575|FG000|Overall Study|Lost to Follow-up|0|||
130499436|NCT03739866|469796576|FG001|Overall Study|Lost to Follow-up|0|||
130499437|NCT03739866|469796577|FG002|Overall Study|Lost to Follow-up|0|||
130499438|NCT03739866|469796578|FG003|Overall Study|Lost to Follow-up|1|||
130499439|NCT03739866|469796579|FG004|Overall Study|Lost to Follow-up|0|||
130499440|NCT03739866|469796580|FG005|Overall Study|Lost to Follow-up|0|||
130499441|NCT03739866|469796581|FG006|Overall Study|Lost to Follow-up|0|||
130499442|NCT03739866|469796582|FG007|Overall Study|Lost to Follow-up|0|||
130499443|NCT03739866|469796575|FG000|Overall Study|Enrolled but not treated|0|||
130499444|NCT03739866|469796576|FG001|Overall Study|Enrolled but not treated|0|||
130499445|NCT03739866|469796577|FG002|Overall Study|Enrolled but not treated|1|||
130499446|NCT03739866|469796578|FG003|Overall Study|Enrolled but not treated|0|||
130565657|NCT02700412|470036970|FG000|Overall Study|Death|1|||
130499447|NCT03739866|469796579|FG004|Overall Study|Enrolled but not treated|1|||
130499448|NCT03739866|469796580|FG005|Overall Study|Enrolled but not treated|0|||
130499449|NCT03739866|469796581|FG006|Overall Study|Enrolled but not treated|0|||
130499450|NCT03739866|469796582|FG007|Overall Study|Enrolled but not treated|0|||
130499451|NCT01034306|469796583|FG000|Overall Study|Adverse Event|1|||
130499452|NCT01034306|469796584|FG001|Overall Study|Adverse Event|0|||
130499453|NCT01034306|469796583|FG000|Overall Study|Lost to Follow-up|0|||
130499454|NCT01034306|469796584|FG001|Overall Study|Lost to Follow-up|1|||
130499455|NCT01034306|469796583|FG000|Overall Study|Withdrawal by Subject|2|||
130499456|NCT01034306|469796584|FG001|Overall Study|Withdrawal by Subject|2|||
130499457|NCT01034306|469796583|FG000|Overall Study|hospitalized and decided to stop|1|||
130499458|NCT01034306|469796584|FG001|Overall Study|hospitalized and decided to stop|0|||
130499459|NCT01034306|469796583|FG000|Overall Study|Noncomplience|1|||
130499460|NCT01034306|469796584|FG001|Overall Study|Noncomplience|0|||
130499461|NCT01619059|469796585|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
130499462|NCT01619059|469796586|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
130499463|NCT01619059|469796585|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
130499464|NCT01619059|469796586|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
130499465|NCT01619059|469796585|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
130499466|NCT01619059|469796586|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
130499467|NCT01619059|469796585|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
130499468|NCT01619059|469796586|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
130499469|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
130499470|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
130499471|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
130499472|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
130499473|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
130499474|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
130499475|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Death|1|||
130499476|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Death|0|||
130499477|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
130499478|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
130499479|NCT01619059|469796585|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
130499480|NCT01619059|469796586|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
130499481|NCT03057600|469796589|FG000|Overall Study|Adverse Event|0|||
130499482|NCT03057600|469796590|FG001|Overall Study|Adverse Event|0|||
130499483|NCT03057600|469796591|FG002|Overall Study|Adverse Event|4|||
130499484|NCT03057600|469796592|FG003|Overall Study|Adverse Event|0|||
130499485|NCT03057600|469796589|FG000|Overall Study|Radiologic Disease Progression|8|||
130499486|NCT03057600|469796590|FG001|Overall Study|Radiologic Disease Progression|7|||
130499487|NCT03057600|469796591|FG002|Overall Study|Radiologic Disease Progression|13|||
130499488|NCT03057600|469796592|FG003|Overall Study|Radiologic Disease Progression|10|||
130499489|NCT03057600|469796589|FG000|Overall Study|Symptomatic Deterioration|0|||
130499490|NCT03057600|469796590|FG001|Overall Study|Symptomatic Deterioration|1|||
130499491|NCT03057600|469796591|FG002|Overall Study|Symptomatic Deterioration|1|||
130499492|NCT03057600|469796592|FG003|Overall Study|Symptomatic Deterioration|0|||
130499493|NCT03057600|469796589|FG000|Overall Study|Investigator Decision|0|||
130499494|NCT03057600|469796590|FG001|Overall Study|Investigator Decision|0|||
130499495|NCT03057600|469796591|FG002|Overall Study|Investigator Decision|1|||
130499496|NCT03057600|469796592|FG003|Overall Study|Investigator Decision|0|||
130499497|NCT03057600|469796589|FG000|Overall Study|Study Termination by Sponsor|0|||
130499498|NCT03057600|469796590|FG001|Overall Study|Study Termination by Sponsor|0|||
130499499|NCT03057600|469796591|FG002|Overall Study|Study Termination by Sponsor|0|||
130499500|NCT03057600|469796592|FG003|Overall Study|Study Termination by Sponsor|2|||
130499501|NCT03057600|469796589|FG000|Overall Study|Withdrawal by Subject|0|||
130499502|NCT03057600|469796590|FG001|Overall Study|Withdrawal by Subject|1|||
130499503|NCT03057600|469796591|FG002|Overall Study|Withdrawal by Subject|0|||
130499504|NCT03057600|469796592|FG003|Overall Study|Withdrawal by Subject|0|||
130499505|NCT03057600|469796589|FG000|Overall Study|Other, Not Specified|1|||
130499506|NCT03057600|469796590|FG001|Overall Study|Other, Not Specified|1|||
130499507|NCT03057600|469796591|FG002|Overall Study|Other, Not Specified|1|||
130499508|NCT03057600|469796592|FG003|Overall Study|Other, Not Specified|1|||
130499509|NCT03489369|469796595|FG000|Overall Study|Documented Progressive Disease|3|||
130499510|NCT03489369|469796596|FG001|Overall Study|Documented Progressive Disease|2|||
130499511|NCT03489369|469796597|FG002|Overall Study|Documented Progressive Disease|3|||
130499512|NCT03489369|469796598|FG003|Overall Study|Documented Progressive Disease|6|||
130499513|NCT03489369|469796595|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
130499514|NCT03489369|469796596|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
130499515|NCT03489369|469796597|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
130499516|NCT03489369|469796598|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
130499517|NCT01968967|469796599|FG000|Treatment Period|Other|22|||
130499518|NCT01968967|469796600|FG001|Treatment Period|Other|22|||
130499519|NCT01968967|469796601|FG002|Treatment Period|Other|0|||
130499520|NCT01968967|469796602|FG003|Treatment Period|Other|0|||
130499521|NCT01968967|469796603|FG004|Treatment Period|Other|0|||
130499522|NCT01968967|469796599|FG000|Treatment Period|Withdrawal by Subject|71|||
130499523|NCT01968967|469796600|FG001|Treatment Period|Withdrawal by Subject|61|||
130499524|NCT01968967|469796601|FG002|Treatment Period|Withdrawal by Subject|0|||
130499525|NCT01968967|469796602|FG003|Treatment Period|Withdrawal by Subject|0|||
130499526|NCT01968967|469796603|FG004|Treatment Period|Withdrawal by Subject|0|||
130499527|NCT01968967|469796599|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
130499528|NCT01968967|469796600|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
130499529|NCT01968967|469796601|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
130499530|NCT01968967|469796602|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
130499531|NCT01968967|469796603|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
130499532|NCT01968967|469796599|FG000|Treatment Period|Lost to Follow-up|26|||
130499533|NCT01968967|469796600|FG001|Treatment Period|Lost to Follow-up|31|||
130499534|NCT01968967|469796601|FG002|Treatment Period|Lost to Follow-up|0|||
130499535|NCT01968967|469796602|FG003|Treatment Period|Lost to Follow-up|0|||
130499536|NCT01968967|469796603|FG004|Treatment Period|Lost to Follow-up|0|||
130499537|NCT01968967|469796599|FG000|Treatment Period|Protocol Violation|1|||
130499538|NCT01968967|469796600|FG001|Treatment Period|Protocol Violation|2|||
130499539|NCT01968967|469796601|FG002|Treatment Period|Protocol Violation|0|||
130499540|NCT01968967|469796602|FG003|Treatment Period|Protocol Violation|0|||
130499541|NCT01968967|469796603|FG004|Treatment Period|Protocol Violation|0|||
130499542|NCT01968967|469796599|FG000|Treatment Period|Adverse Event|9|||
130499543|NCT01968967|469796600|FG001|Treatment Period|Adverse Event|8|||
130499544|NCT01968967|469796601|FG002|Treatment Period|Adverse Event|0|||
130499545|NCT01968967|469796602|FG003|Treatment Period|Adverse Event|0|||
130499546|NCT01968967|469796603|FG004|Treatment Period|Adverse Event|0|||
130499547|NCT01968967|469796599|FG000|Treatment Period|Death|9|||
130499548|NCT01968967|469796600|FG001|Treatment Period|Death|2|||
130499549|NCT01968967|469796601|FG002|Treatment Period|Death|0|||
130499550|NCT01968967|469796602|FG003|Treatment Period|Death|0|||
130499551|NCT01968967|469796603|FG004|Treatment Period|Death|0|||
130499552|NCT01968967|469796599|FG000|Treatment Period|Randomized Not Treated|6|||
130499553|NCT01968967|469796600|FG001|Treatment Period|Randomized Not Treated|5|||
130499554|NCT01968967|469796601|FG002|Treatment Period|Randomized Not Treated|0|||
130499555|NCT01968967|469796602|FG003|Treatment Period|Randomized Not Treated|0|||
130499556|NCT01968967|469796603|FG004|Treatment Period|Randomized Not Treated|0|||
130499557|NCT01968967|469796599|FG000|Extension Period|Withdrew Consent|0|||
130499558|NCT01968967|469796600|FG001|Extension Period|Withdrew Consent|0|||
130499559|NCT01968967|469796601|FG002|Extension Period|Withdrew Consent|2|||
130499560|NCT01968967|469796602|FG003|Extension Period|Withdrew Consent|0|||
130499561|NCT01968967|469796603|FG004|Extension Period|Withdrew Consent|5|||
130499562|NCT00614614|469796606|FG000|Primary Vaccination Phase|Adverse Event|6|||
130499563|NCT00614614|469796607|FG001|Primary Vaccination Phase|Adverse Event|0|||
130499564|NCT00614614|469796608|FG002|Primary Vaccination Phase|Adverse Event|0|||
130499565|NCT00614614|469796609|FG003|Primary Vaccination Phase|Adverse Event|0|||
130499566|NCT00614614|469796610|FG004|Primary Vaccination Phase|Adverse Event|0|||
130499567|NCT00614614|469796606|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
130499568|NCT00614614|469796607|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
130499569|NCT00614614|469796608|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
130499570|NCT00614614|469796609|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
130499571|NCT00614614|469796610|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
130499572|NCT00614614|469796606|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
130499573|NCT00614614|469796607|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
130499574|NCT00614614|469796608|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
130499575|NCT00614614|469796609|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
130499576|NCT00614614|469796610|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
130499577|NCT00614614|469796606|FG000|Primary Vaccination Phase|Protocol Violation|9|||
130499578|NCT00614614|469796607|FG001|Primary Vaccination Phase|Protocol Violation|3|||
130499579|NCT00614614|469796608|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130499580|NCT00614614|469796609|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130499581|NCT00614614|469796610|FG004|Primary Vaccination Phase|Protocol Violation|0|||
130499582|NCT00614614|469796606|FG000|Primary Vaccination Phase|Other|4|||
130499583|NCT00614614|469796607|FG001|Primary Vaccination Phase|Other|0|||
130499584|NCT00614614|469796608|FG002|Primary Vaccination Phase|Other|0|||
130499585|NCT00614614|469796609|FG003|Primary Vaccination Phase|Other|0|||
130499586|NCT00614614|469796610|FG004|Primary Vaccination Phase|Other|0|||
130499587|NCT00614614|469796606|FG000|Booster Vaccination Phase|Adverse Event|0|||
130499588|NCT00614614|469796607|FG001|Booster Vaccination Phase|Adverse Event|0|||
130499589|NCT00614614|469796608|FG002|Booster Vaccination Phase|Adverse Event|1|||
130499590|NCT00614614|469796609|FG003|Booster Vaccination Phase|Adverse Event|1|||
130499591|NCT00614614|469796610|FG004|Booster Vaccination Phase|Adverse Event|0|||
130499592|NCT00614614|469796606|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
130499593|NCT00614614|469796607|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130499594|NCT00614614|469796608|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
130499595|NCT00614614|469796609|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
130499596|NCT00614614|469796610|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
130499597|NCT00614614|469796606|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
130499598|NCT00614614|469796607|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
130729556|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
130729557|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
130729558|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
130729559|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
130729560|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
130729561|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130729562|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729563|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729564|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130729565|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130729566|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
130729567|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Other than specified|0|||
130729568|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Other than specified|0|||
130729569|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Other than specified|1|||
130729570|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130729571|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130729572|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130729573|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130729574|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130729575|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
130729576|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130729577|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130729578|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
130729579|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130729580|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130729581|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
130729582|NCT00678210|470633583|FG000|Overall Study|Adverse Event|1|||
130729583|NCT00678210|470633584|FG001|Overall Study|Adverse Event|2|||
130729584|NCT00678210|470633585|FG002|Overall Study|Adverse Event|3|||
130729585|NCT00678210|470633586|FG003|Overall Study|Adverse Event|3|||
130729586|NCT00678210|470633583|FG000|Overall Study|Lack of Efficacy|2|||
130729587|NCT00678210|470633584|FG001|Overall Study|Lack of Efficacy|3|||
130499599|NCT00614614|469796608|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
130499600|NCT00614614|469796609|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
130499601|NCT00614614|469796610|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
130499602|NCT00614614|469796606|FG000|Booster Vaccination Phase|Protocol Violation|0|||
130499603|NCT00614614|469796607|FG001|Booster Vaccination Phase|Protocol Violation|0|||
130499604|NCT00614614|469796608|FG002|Booster Vaccination Phase|Protocol Violation|2|||
130499605|NCT00614614|469796609|FG003|Booster Vaccination Phase|Protocol Violation|3|||
130499606|NCT00614614|469796610|FG004|Booster Vaccination Phase|Protocol Violation|0|||
130499607|NCT00614614|469796606|FG000|Booster Vaccination Phase|Other|0|||
130499608|NCT00614614|469796607|FG001|Booster Vaccination Phase|Other|1|||
130499609|NCT00614614|469796608|FG002|Booster Vaccination Phase|Other|3|||
130499610|NCT00614614|469796609|FG003|Booster Vaccination Phase|Other|2|||
130499611|NCT00614614|469796610|FG004|Booster Vaccination Phase|Other|1|||
130499612|NCT00989196|469796611|FG000|Treatment Period|Lost to Follow-up|1|||
130499613|NCT00989196|469796612|FG001|Treatment Period|Lost to Follow-up|0|||
130499614|NCT01000805|469796613|FG000|Overall Study|Adverse Event|21|||
130499615|NCT01000805|469796614|FG001|Overall Study|Adverse Event|9|||
130499616|NCT01000805|469796613|FG000|Overall Study|Lack of Efficacy|5|||
130499617|NCT01000805|469796614|FG001|Overall Study|Lack of Efficacy|16|||
130499618|NCT01000805|469796613|FG000|Overall Study|Lost to Follow-up|16|||
130499619|NCT01000805|469796614|FG001|Overall Study|Lost to Follow-up|21|||
130499620|NCT01000805|469796613|FG000|Overall Study|Physician Decision|0|||
130729588|NCT00678210|470633585|FG002|Overall Study|Lack of Efficacy|1|||
130729589|NCT00678210|470633586|FG003|Overall Study|Lack of Efficacy|9|||
130729590|NCT00678210|470633583|FG000|Overall Study|Lost to Follow-up|4|||
130499621|NCT01000805|469796614|FG001|Overall Study|Physician Decision|1|||
130499622|NCT01000805|469796613|FG000|Overall Study|Protocol Violation|12|||
130499623|NCT01000805|469796614|FG001|Overall Study|Protocol Violation|8|||
130499624|NCT01000805|469796613|FG000|Overall Study|Withdrawal by Subject|16|||
130729591|NCT00678210|470633584|FG001|Overall Study|Lost to Follow-up|2|||
130729592|NCT00678210|470633585|FG002|Overall Study|Lost to Follow-up|0|||
130499625|NCT01000805|469796614|FG001|Overall Study|Withdrawal by Subject|6|||
130499626|NCT01000805|469796613|FG000|Overall Study|Sponsor Decision|0|||
130499627|NCT01000805|469796614|FG001|Overall Study|Sponsor Decision|1|||
130499628|NCT03343704|469796620|FG000|Overall Study|Refused to complete follow up|0|||
130729593|NCT00678210|470633586|FG003|Overall Study|Lost to Follow-up|1|||
130499629|NCT03343704|469796621|FG001|Overall Study|Refused to complete follow up|1|||
130499630|NCT03343704|469796620|FG000|Overall Study|Death|0|||
130499631|NCT03343704|469796621|FG001|Overall Study|Death|1|||
130499632|NCT03343704|469796620|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
130499633|NCT03343704|469796621|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
130499634|NCT03789656|469796622|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
130499635|NCT03789656|469796623|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
130499636|NCT03789656|469796624|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
130499637|NCT03789656|469796625|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
130499638|NCT03789656|469796626|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
130499639|NCT03789656|469796622|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
130499640|NCT03789656|469796623|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
130499641|NCT03789656|469796624|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
130499642|NCT03789656|469796625|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
130499643|NCT03789656|469796626|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
130499644|NCT03789656|469796622|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
130499645|NCT03789656|469796623|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
130499646|NCT03789656|469796624|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
130499647|NCT03789656|469796625|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
130499648|NCT03789656|469796626|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
130499649|NCT03789656|469796622|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
130499650|NCT03789656|469796623|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
130499651|NCT03789656|469796624|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
130499652|NCT03789656|469796625|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
130499653|NCT03789656|469796626|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
130499654|NCT02434328|469796634|FG000|Overall Study|Adverse Event|9|||
130499655|NCT02434328|469796635|FG001|Overall Study|Adverse Event|4|||
130499656|NCT02434328|469796634|FG000|Overall Study|Lack of Efficacy|0|||
130499657|NCT02434328|469796635|FG001|Overall Study|Lack of Efficacy|2|||
130499658|NCT02434328|469796634|FG000|Overall Study|Physician Decision|0|||
130499659|NCT02434328|469796635|FG001|Overall Study|Physician Decision|1|||
130499660|NCT02434328|469796634|FG000|Overall Study|Withdrawal by Subject|12|||
130499661|NCT02434328|469796635|FG001|Overall Study|Withdrawal by Subject|21|||
130499662|NCT02434328|469796634|FG000|Overall Study|Death|4|||
130499663|NCT02434328|469796635|FG001|Overall Study|Death|7|||
130499664|NCT02434328|469796634|FG000|Overall Study|Lost to Follow-up|1|||
130499665|NCT02434328|469796635|FG001|Overall Study|Lost to Follow-up|6|||
130499666|NCT02434328|469796634|FG000|Overall Study|Other|4|||
130499667|NCT02434328|469796635|FG001|Overall Study|Other|1|||
130499668|NCT02310581|469798038|FG000|Overall Study|Adverse Event|1|||
130499669|NCT02310581|469798039|FG001|Overall Study|Adverse Event|1|||
130499670|NCT02310581|469798040|FG002|Overall Study|Adverse Event|1|||
130499671|NCT02310581|469798041|FG003|Overall Study|Adverse Event|0|||
130499672|NCT02310581|469798038|FG000|Overall Study|Withdrawal by Subject|2|||
130499673|NCT02310581|469798039|FG001|Overall Study|Withdrawal by Subject|1|||
130499674|NCT02310581|469798040|FG002|Overall Study|Withdrawal by Subject|0|||
130499675|NCT02310581|469798041|FG003|Overall Study|Withdrawal by Subject|1|||
130499676|NCT04658784|469798042|FG000|6-month Follow-up|Lost to Follow-up|2|||
130499677|NCT04658784|469798043|FG001|6-month Follow-up|Lost to Follow-up|5|||
130499678|NCT00454194|469798045|FG000|Overall Study|Adverse Event|7|||
130499679|NCT00454194|469798046|FG001|Overall Study|Adverse Event|2|||
130499680|NCT00454194|469798045|FG000|Overall Study|Withdrawal by Subject|12|||
130499681|NCT00454194|469798046|FG001|Overall Study|Withdrawal by Subject|8|||
130499682|NCT00454194|469798045|FG000|Overall Study|Other Medical Problems|1|||
130499683|NCT00454194|469798046|FG001|Overall Study|Other Medical Problems|2|||
130499684|NCT00454194|469798045|FG000|Overall Study|Other Unspecified Reason|2|||
130499685|NCT00454194|469798046|FG001|Overall Study|Other Unspecified Reason|2|||
130499686|NCT02827201|469798047|FG000|Overall Study|Death|1|||
130499687|NCT02827201|469798048|FG001|Overall Study|Death|2|||
130499688|NCT02827201|469798047|FG000|Overall Study|Patients not treated|1|||
130499689|NCT02827201|469798048|FG001|Overall Study|Patients not treated|1|||
130499690|NCT00620854|469798049|FG000|Washout 1|Withdrawal by Subject|0|||
130499691|NCT00620854|469798050|FG001|Washout 1|Withdrawal by Subject|0|||
130499692|NCT00620854|469798051|FG002|Washout 1|Withdrawal by Subject|1|||
130499693|NCT00620854|469798052|FG003|Washout 1|Withdrawal by Subject|1|||
130499694|NCT00620854|469798053|FG004|Washout 1|Withdrawal by Subject|0|||
130499695|NCT00620854|469798054|FG005|Washout 1|Withdrawal by Subject|0|||
130499696|NCT01124045|469798059|FG000|Overall Study|Lost to Follow-up|0|||
130499697|NCT01124045|469798060|FG001|Overall Study|Lost to Follow-up|1|||
130499698|NCT01124045|469798059|FG000|Overall Study|Physician Decision|0|||
130499699|NCT01124045|469798060|FG001|Overall Study|Physician Decision|2|||
130499700|NCT03205566|469798064|FG000|Phase 1|Protocol Violation|1|||
130499701|NCT03205566|469798065|FG001|Phase 1|Protocol Violation|1|||
130499702|NCT00836498|469798066|FG000|Overall Study|Adverse Event|1|||
130499703|NCT00836498|469798067|FG001|Overall Study|Adverse Event|0|||
130499704|NCT00836498|469798066|FG000|Overall Study|Lost to Follow-up|1|||
130499705|NCT00836498|469798067|FG001|Overall Study|Lost to Follow-up|0|||
130499706|NCT00836498|469798066|FG000|Overall Study|Withdrawal by Subject|2|||
130499707|NCT00836498|469798067|FG001|Overall Study|Withdrawal by Subject|1|||
130499708|NCT03418545|469798068|FG000|Overall Study|Withdrawal by Participant|2|||
130499709|NCT03418545|469798069|FG001|Overall Study|Withdrawal by Participant|4|||
130499710|NCT03418545|469798068|FG000|Overall Study|Lost to Follow-up|3|||
130499711|NCT03418545|469798069|FG001|Overall Study|Lost to Follow-up|5|||
130499712|NCT03418545|469798068|FG000|Overall Study|Reason Not Specified|0|||
130499713|NCT03418545|469798069|FG001|Overall Study|Reason Not Specified|1|||
130499714|NCT03418545|469798068|FG000|Overall Study|Missing Completion Status|0|||
130499715|NCT03418545|469798069|FG001|Overall Study|Missing Completion Status|1|||
130499716|NCT02384382|469798075|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
130499717|NCT02384382|469798075|FG000|Overall Study|Death|1|||
130499718|NCT02384382|469798075|FG000|Overall Study|Adverse Event|1|||
130499719|NCT02384382|469798075|FG000|Overall Study|Disease progression|16|||
130499720|NCT03567616|469798082|FG000|Overall Study|Disease progression|4|||
130499721|NCT03567616|469798082|FG000|Overall Study|Withdrawal by Subject|1|||
130499722|NCT03567616|469798082|FG000|Overall Study|Physician Decision|1|||
130499723|NCT03567616|469798082|FG000|Overall Study|Death|1|||
130499724|NCT03567616|469798082|FG000|Overall Study|Adverse Event|1|||
130499725|NCT00109031|469798083|FG000|Overall Study|Adverse Event|0|||
130499726|NCT00109031|469798084|FG001|Overall Study|Adverse Event|0|||
130499727|NCT00109031|469798085|FG002|Overall Study|Adverse Event|1|||
130499728|NCT00109031|469798086|FG003|Overall Study|Adverse Event|0|||
130499729|NCT00109031|469798083|FG000|Overall Study|Withdrawal by Subject|0|||
130499730|NCT00109031|469798084|FG001|Overall Study|Withdrawal by Subject|1|||
130499731|NCT00109031|469798085|FG002|Overall Study|Withdrawal by Subject|0|||
130499732|NCT00109031|469798086|FG003|Overall Study|Withdrawal by Subject|0|||
130499733|NCT00109031|469798083|FG000|Overall Study|Physician Decision|0|||
130499734|NCT00109031|469798084|FG001|Overall Study|Physician Decision|1|||
130499735|NCT00109031|469798085|FG002|Overall Study|Physician Decision|0|||
130499736|NCT00109031|469798086|FG003|Overall Study|Physician Decision|0|||
130499737|NCT00109031|469798083|FG000|Overall Study|Protocol Violation|0|||
130499738|NCT00109031|469798084|FG001|Overall Study|Protocol Violation|0|||
130499739|NCT00109031|469798085|FG002|Overall Study|Protocol Violation|1|||
130499740|NCT00109031|469798086|FG003|Overall Study|Protocol Violation|0|||
130499741|NCT01957163|469798092|FG000|Overall Study|Adverse Event|5|||
130499742|NCT01957163|469798093|FG001|Overall Study|Adverse Event|2|||
130499743|NCT01957163|469798094|FG002|Overall Study|Adverse Event|4|||
130499744|NCT01957163|469798092|FG000|Overall Study|Lack of Efficacy|5|||
130499745|NCT01957163|469798093|FG001|Overall Study|Lack of Efficacy|4|||
130499746|NCT01957163|469798094|FG002|Overall Study|Lack of Efficacy|9|||
130499747|NCT01957163|469798092|FG000|Overall Study|Protocol Violation|1|||
130499748|NCT01957163|469798093|FG001|Overall Study|Protocol Violation|2|||
130499749|NCT01957163|469798094|FG002|Overall Study|Protocol Violation|0|||
130499750|NCT01957163|469798092|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
130499751|NCT01957163|469798093|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
130499752|NCT01957163|469798094|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
130499753|NCT01957163|469798092|FG000|Overall Study|Lost to Follow-up|0|||
130499754|NCT01957163|469798093|FG001|Overall Study|Lost to Follow-up|1|||
130499755|NCT01957163|469798094|FG002|Overall Study|Lost to Follow-up|0|||
130499756|NCT01957163|469798092|FG000|Overall Study|Withdrawal by Subject|4|||
130499757|NCT01957163|469798093|FG001|Overall Study|Withdrawal by Subject|2|||
130499758|NCT01957163|469798094|FG002|Overall Study|Withdrawal by Subject|4|||
130499759|NCT01065779|469798095|FG000|Overall Study|Duplicate Investigation|1|||
130499760|NCT01065779|469798095|FG000|Overall Study|Investigation Before Contract Date|37|||
130499761|NCT01065779|469798095|FG000|Overall Study|Non-enrollment Period Administration|10|||
130499762|NCT01065779|469798095|FG000|Overall Study|Not Administered With Study Drug|17|||
130499763|NCT01065779|469798095|FG000|Overall Study|Failed to Follow-up|10|||
130499764|NCT01065779|469798095|FG000|Overall Study|Inclusion Criteria Violation|7|||
130499765|NCT02630966|469798096|FG000|Overall Study|Adverse Event|1|||
130499766|NCT02630966|469798097|FG001|Overall Study|Adverse Event|3|||
130499767|NCT02630966|469798096|FG000|Overall Study|Significant Protocol Deviation|0|||
130499768|NCT02630966|469798097|FG001|Overall Study|Significant Protocol Deviation|2|||
130499769|NCT02630966|469798096|FG000|Overall Study|Voluntary Withdrawal|1|||
130499770|NCT02630966|469798097|FG001|Overall Study|Voluntary Withdrawal|1|||
130499771|NCT02630966|469798096|FG000|Overall Study|Lack of Efficacy|0|||
130499772|NCT02630966|469798097|FG001|Overall Study|Lack of Efficacy|2|||
130499773|NCT00641537|469798098|FG000|96-week Period|Adverse Event|0|||
130499774|NCT00641537|469798099|FG001|96-week Period|Adverse Event|1|||
130565658|NCT02700412|470036970|FG000|Overall Study|Lack of Efficacy|19|||
130565659|NCT02700412|470036970|FG000|Overall Study|Protocol Violation|5|||
130499775|NCT00641537|469798100|FG002|96-week Period|Adverse Event|3|||
130499776|NCT00641537|469798101|FG003|96-week Period|Adverse Event|0|||
130499777|NCT00641537|469798102|FG004|96-week Period|Adverse Event|2|||
130499778|NCT00641537|469798103|FG005|96-week Period|Adverse Event|0|||
130499779|NCT00641537|469798104|FG006|96-week Period|Adverse Event|0|||
130565660|NCT02700412|470036970|FG000|Overall Study|Withdrawal by Subject|2|||
130499780|NCT00641537|469798105|FG007|96-week Period|Adverse Event|0|||
130499781|NCT00641537|469798098|FG000|96-week Period|Lost to Follow-up|3|||
130499782|NCT00641537|469798099|FG001|96-week Period|Lost to Follow-up|1|||
130499783|NCT00641537|469798100|FG002|96-week Period|Lost to Follow-up|2|||
130499784|NCT00641537|469798101|FG003|96-week Period|Lost to Follow-up|2|||
130499785|NCT00641537|469798102|FG004|96-week Period|Lost to Follow-up|4|||
130499786|NCT00641537|469798103|FG005|96-week Period|Lost to Follow-up|0|||
130499787|NCT00641537|469798104|FG006|96-week Period|Lost to Follow-up|1|||
130499788|NCT00641537|469798105|FG007|96-week Period|Lost to Follow-up|0|||
130499789|NCT00641537|469798098|FG000|96-week Period|Protocol Violation|0|||
130499790|NCT00641537|469798099|FG001|96-week Period|Protocol Violation|1|||
130499791|NCT00641537|469798100|FG002|96-week Period|Protocol Violation|0|||
130499792|NCT00641537|469798101|FG003|96-week Period|Protocol Violation|1|||
130499793|NCT00641537|469798102|FG004|96-week Period|Protocol Violation|0|||
130499794|NCT00641537|469798103|FG005|96-week Period|Protocol Violation|1|||
130729594|NCT00678210|470633583|FG000|Overall Study|Withdrawal by Subject|3|||
130729595|NCT00678210|470633584|FG001|Overall Study|Withdrawal by Subject|4|||
130729596|NCT00678210|470633585|FG002|Overall Study|Withdrawal by Subject|1|||
130729597|NCT00678210|470633586|FG003|Overall Study|Withdrawal by Subject|7|||
130729598|NCT00678210|470633583|FG000|Overall Study|Other|1|||
130729599|NCT00678210|470633584|FG001|Overall Study|Other|0|||
130729600|NCT00678210|470633585|FG002|Overall Study|Other|1|||
130729601|NCT00678210|470633586|FG003|Overall Study|Other|0|||
130729602|NCT04825912|470633587|FG000|Overall Study|Death|3|||
130729603|NCT04825912|470633587|FG000|Overall Study|Withdrawal by Subject|1|||
130729604|NCT00974922|470633588|FG000|Overall Study|study terminated|24|||
130729605|NCT03965689|470633591|FG000|Overall Study|Too sick to get study intervention|2|||
130729606|NCT03022084|470633592|FG000|Overall Study|Lost to Follow-up|2|||
130729607|NCT03022084|470633593|FG001|Overall Study|Lost to Follow-up|3|||
130729608|NCT01173120|470633594|FG000|Overall Study|Lack of Efficacy|2|||
130729609|NCT01173120|470633594|FG000|Overall Study|Lost to Follow-up|1|||
130729610|NCT01173120|470633594|FG000|Overall Study|Participant Decision|2|||
130729611|NCT01173120|470633594|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
130729612|NCT01173120|470633594|FG000|Overall Study|Switch-Participant Decision|12|||
130729613|NCT01173120|470633594|FG000|Overall Study|Switch-Difficulty With Device|12|||
130729614|NCT00113763|470633595|FG000|Overall Study|Adverse Event|5|||
130729615|NCT00113763|470633596|FG001|Overall Study|Adverse Event|2|||
130729616|NCT00113763|470633595|FG000|Overall Study|Disease Progression|28|||
130729617|NCT00113763|470633596|FG001|Overall Study|Disease Progression|14|||
130729618|NCT00113763|470633595|FG000|Overall Study|Lost to Follow-up|10|||
130729619|NCT00113763|470633596|FG001|Overall Study|Lost to Follow-up|0|||
130729620|NCT00113763|470633595|FG000|Overall Study|Withdrawal by Subject|1|||
130729621|NCT00113763|470633596|FG001|Overall Study|Withdrawal by Subject|4|||
130729622|NCT00113763|470633595|FG000|Overall Study|Other|27|||
130729623|NCT00113763|470633596|FG001|Overall Study|Other|6|||
130729624|NCT00113763|470633595|FG000|Overall Study|Non-compliance|1|||
130729625|NCT00113763|470633596|FG001|Overall Study|Non-compliance|0|||
130729626|NCT00113763|470633595|FG000|Overall Study|Ongoing|1|||
130729627|NCT00113763|470633596|FG001|Overall Study|Ongoing|0|||
130729628|NCT01207583|470633597|FG000|Overall Study|Withdrawal by Subject|0|||
130729629|NCT01207583|470633598|FG001|Overall Study|Withdrawal by Subject|3|||
130499795|NCT00641537|469798104|FG006|96-week Period|Protocol Violation|0|||
130499796|NCT00641537|469798105|FG007|96-week Period|Protocol Violation|0|||
130499797|NCT00641537|469798098|FG000|96-week Period|Death|2|||
130499798|NCT00641537|469798099|FG001|96-week Period|Death|0|||
130499799|NCT00641537|469798100|FG002|96-week Period|Death|1|||
130499800|NCT00641537|469798101|FG003|96-week Period|Death|0|||
130499801|NCT00641537|469798102|FG004|96-week Period|Death|0|||
130499802|NCT00641537|469798103|FG005|96-week Period|Death|0|||
130499803|NCT00641537|469798104|FG006|96-week Period|Death|0|||
130499804|NCT00641537|469798105|FG007|96-week Period|Death|0|||
130499805|NCT00641537|469798098|FG000|96-week Period|Other|4|||
130729630|NCT01207583|470633599|FG002|Overall Study|Withdrawal by Subject|1|||
130729631|NCT01207583|470633597|FG000|Overall Study|Participant failed to return|1|||
130729632|NCT01207583|470633598|FG001|Overall Study|Participant failed to return|0|||
130499806|NCT00641537|469798099|FG001|96-week Period|Other|7|||
130729633|NCT01207583|470633599|FG002|Overall Study|Participant failed to return|0|||
130729634|NCT01207583|470633597|FG000|Overall Study|Lost to Follow-up|0|||
130729635|NCT01207583|470633598|FG001|Overall Study|Lost to Follow-up|2|||
130729636|NCT01207583|470633599|FG002|Overall Study|Lost to Follow-up|0|||
130499807|NCT00641537|469798100|FG002|96-week Period|Other|14|||
130499808|NCT00641537|469798101|FG003|96-week Period|Other|9|||
130499809|NCT00641537|469798102|FG004|96-week Period|Other|11|||
130565661|NCT00928889|470036971|FG000|Overall Study|Lost to Follow-up|3|||
130499810|NCT00641537|469798103|FG005|96-week Period|Other|6|||
130499811|NCT00641537|469798104|FG006|96-week Period|Other|4|||
130729637|NCT01383707|470633600|FG000|Overall Study|Consent withdrawal|6|||
130729638|NCT01383707|470633600|FG000|Overall Study|Death|19|||
130729639|NCT01383707|470633600|FG000|Overall Study|Other|8|||
130729640|NCT01383707|470633600|FG000|Overall Study|Sponsor's decision|2|||
130729641|NCT01383707|470633600|FG000|Overall Study|Adverse Event|14|||
130729642|NCT01383707|470633600|FG000|Overall Study|Progressive disease|23|||
130729643|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
130499812|NCT00641537|469798105|FG007|96-week Period|Other|6|||
130499813|NCT00641537|469798098|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
130499814|NCT00641537|469798099|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
130499815|NCT00641537|469798100|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
130499816|NCT00641537|469798101|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
130499817|NCT00641537|469798102|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
130499818|NCT00641537|469798103|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
130499819|NCT00641537|469798104|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
130499820|NCT00641537|469798105|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
130499821|NCT00641537|469798098|FG000|24-Week Supplemental Follow-up Period|Other|0|||
130499822|NCT00641537|469798099|FG001|24-Week Supplemental Follow-up Period|Other|2|||
130499823|NCT00641537|469798100|FG002|24-Week Supplemental Follow-up Period|Other|2|||
130499824|NCT00641537|469798101|FG003|24-Week Supplemental Follow-up Period|Other|1|||
130499825|NCT00641537|469798102|FG004|24-Week Supplemental Follow-up Period|Other|3|||
130499826|NCT00641537|469798103|FG005|24-Week Supplemental Follow-up Period|Other|0|||
130499827|NCT00641537|469798104|FG006|24-Week Supplemental Follow-up Period|Other|1|||
130499828|NCT00641537|469798105|FG007|24-Week Supplemental Follow-up Period|Other|1|||
130499829|NCT01801007|469798106|FG000|Overall Study|Adverse Event|2|||
130499830|NCT01801007|469798106|FG000|Overall Study|Lost to Follow-up|4|||
130499831|NCT01801007|469798106|FG000|Overall Study|Withdrawal by Subject|5|||
130499832|NCT00665392|469798107|FG000|Overall Study|not treated|1|||
130499833|NCT01321073|469798113|FG000|Overall Study|Did not attempt implant|4|||
130499834|NCT01321073|469798113|FG000|Overall Study|Death|3|||
130499835|NCT05352230|469798122|FG000|First Intervention (3 Months)|study terminated|2|||
130499836|NCT05352230|469798123|FG001|First Intervention (3 Months)|study terminated|2|||
130499837|NCT03697603|469798124|FG000|Overall Study|Adverse Event|3|||
130499838|NCT03697603|469798125|FG001|Overall Study|Adverse Event|18|||
130499839|NCT03697603|469798126|FG002|Overall Study|Adverse Event|3|||
130499840|NCT03697603|469798124|FG000|Overall Study|Physician Decision|1|||
130499841|NCT03697603|469798125|FG001|Overall Study|Physician Decision|0|||
130499842|NCT03697603|469798126|FG002|Overall Study|Physician Decision|2|||
130499843|NCT03697603|469798124|FG000|Overall Study|Protocol Violation|3|||
130499844|NCT03697603|469798125|FG001|Overall Study|Protocol Violation|8|||
130499845|NCT03697603|469798126|FG002|Overall Study|Protocol Violation|5|||
130499846|NCT03697603|469798124|FG000|Overall Study|Withdrawal by Subject|5|||
130499847|NCT03697603|469798125|FG001|Overall Study|Withdrawal by Subject|1|||
130499848|NCT03697603|469798126|FG002|Overall Study|Withdrawal by Subject|1|||
130499849|NCT03697603|469798124|FG000|Overall Study|Protocol Violation|0|||
130499850|NCT03697603|469798125|FG001|Overall Study|Protocol Violation|0|||
130499851|NCT03697603|469798126|FG002|Overall Study|Protocol Violation|1|||
130499852|NCT02686658|469798127|FG000|Overall Study|Adverse Event|0|||
130499853|NCT02686658|469798128|FG001|Overall Study|Adverse Event|0|||
130499854|NCT02686658|469798129|FG002|Overall Study|Adverse Event|1|||
130499855|NCT02686658|469798130|FG003|Overall Study|Adverse Event|1|||
130499856|NCT02686658|469798131|FG004|Overall Study|Adverse Event|2|||
130499857|NCT02686658|469798132|FG005|Overall Study|Adverse Event|1|||
130499858|NCT02686658|469798127|FG000|Overall Study|Investigator decision|0|||
130499859|NCT02686658|469798128|FG001|Overall Study|Investigator decision|0|||
130499860|NCT02686658|469798129|FG002|Overall Study|Investigator decision|0|||
130499861|NCT02686658|469798130|FG003|Overall Study|Investigator decision|1|||
130499862|NCT02686658|469798131|FG004|Overall Study|Investigator decision|2|||
130499863|NCT02686658|469798132|FG005|Overall Study|Investigator decision|1|||
130499864|NCT02686658|469798127|FG000|Overall Study|Sponsor decision|1|||
130499865|NCT02686658|469798128|FG001|Overall Study|Sponsor decision|2|||
130499866|NCT02686658|469798129|FG002|Overall Study|Sponsor decision|1|||
130499867|NCT02686658|469798130|FG003|Overall Study|Sponsor decision|5|||
130499868|NCT02686658|469798131|FG004|Overall Study|Sponsor decision|13|||
130499869|NCT02686658|469798132|FG005|Overall Study|Sponsor decision|2|||
130499870|NCT02686658|469798127|FG000|Overall Study|Lost to Follow-up|0|||
130499871|NCT02686658|469798128|FG001|Overall Study|Lost to Follow-up|0|||
130499872|NCT02686658|469798129|FG002|Overall Study|Lost to Follow-up|2|||
130499873|NCT02686658|469798130|FG003|Overall Study|Lost to Follow-up|0|||
130499874|NCT02686658|469798131|FG004|Overall Study|Lost to Follow-up|0|||
130499875|NCT02686658|469798132|FG005|Overall Study|Lost to Follow-up|1|||
130499876|NCT02686658|469798127|FG000|Overall Study|Death|1|||
130499877|NCT02686658|469798128|FG001|Overall Study|Death|0|||
130499878|NCT02686658|469798129|FG002|Overall Study|Death|0|||
130499879|NCT02686658|469798130|FG003|Overall Study|Death|1|||
130499880|NCT02686658|469798131|FG004|Overall Study|Death|1|||
130499881|NCT02686658|469798132|FG005|Overall Study|Death|1|||
130499882|NCT02686658|469798127|FG000|Overall Study|Withdrawal by Subject|2|||
130499883|NCT02686658|469798128|FG001|Overall Study|Withdrawal by Subject|5|||
130499884|NCT02686658|469798129|FG002|Overall Study|Withdrawal by Subject|4|||
130499885|NCT02686658|469798130|FG003|Overall Study|Withdrawal by Subject|4|||
130499886|NCT02686658|469798131|FG004|Overall Study|Withdrawal by Subject|17|||
130499887|NCT02686658|469798132|FG005|Overall Study|Withdrawal by Subject|8|||
130499888|NCT02686658|469798127|FG000|Overall Study|Placed in hospice care|0|||
130499889|NCT02686658|469798128|FG001|Overall Study|Placed in hospice care|0|||
130499890|NCT02686658|469798129|FG002|Overall Study|Placed in hospice care|1|||
130499891|NCT02686658|469798130|FG003|Overall Study|Placed in hospice care|0|||
130499892|NCT02686658|469798131|FG004|Overall Study|Placed in hospice care|0|||
130499893|NCT02686658|469798132|FG005|Overall Study|Placed in hospice care|0|||
130499894|NCT02686658|469798127|FG000|Overall Study|Participant non-compliance|0|||
130499895|NCT02686658|469798128|FG001|Overall Study|Participant non-compliance|0|||
130499896|NCT02686658|469798129|FG002|Overall Study|Participant non-compliance|0|||
130499897|NCT02686658|469798130|FG003|Overall Study|Participant non-compliance|0|||
130499898|NCT02686658|469798131|FG004|Overall Study|Participant non-compliance|0|||
130499899|NCT02686658|469798132|FG005|Overall Study|Participant non-compliance|1|||
130499900|NCT02686658|469798127|FG000|Overall Study|Concern over coronavirus disease care|0|||
130499901|NCT02686658|469798128|FG001|Overall Study|Concern over coronavirus disease care|0|||
130499902|NCT02686658|469798129|FG002|Overall Study|Concern over coronavirus disease care|0|||
130499903|NCT02686658|469798130|FG003|Overall Study|Concern over coronavirus disease care|0|||
130499904|NCT02686658|469798131|FG004|Overall Study|Concern over coronavirus disease care|2|||
130499905|NCT02686658|469798132|FG005|Overall Study|Concern over coronavirus disease care|1|||
130499906|NCT02309294|469798135|FG000|Overall Study|Withdrawal by Subject|2|||
130499907|NCT03520036|469798136|FG000|Overall Study|Adverse Event|1|||
130499908|NCT03520036|469798137|FG001|Overall Study|Adverse Event|2|||
130499909|NCT03520036|469798138|FG002|Overall Study|Adverse Event|0|||
130499910|NCT03520036|469798136|FG000|Overall Study|Protocol Violation|1|||
130499911|NCT03520036|469798137|FG001|Overall Study|Protocol Violation|0|||
130499912|NCT03520036|469798138|FG002|Overall Study|Protocol Violation|0|||
130499913|NCT03520036|469798136|FG000|Overall Study|Withdrawal by Subject|0|||
130499914|NCT03520036|469798137|FG001|Overall Study|Withdrawal by Subject|1|||
130499915|NCT03520036|469798138|FG002|Overall Study|Withdrawal by Subject|4|||
130499916|NCT03520036|469798136|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
130499917|NCT03520036|469798137|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
130499918|NCT03520036|469798138|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
130499919|NCT00467272|469798141|FG000|Overall Study|Pneumonia|2|||
130499920|NCT00467272|469798141|FG000|Overall Study|Thrombophlebitis|1|||
130499921|NCT00570505|469798142|FG000|Overall Study|Adverse Event|7|||
130499922|NCT00570505|469798142|FG000|Overall Study|Withdrawal by Subject|7|||
130499923|NCT00570505|469798142|FG000|Overall Study|Lost to Follow-up|23|||
130499924|NCT00570505|469798142|FG000|Overall Study|Other loss to follow-up|4|||
130499925|NCT05426109|469798143|FG000|Overall Study|Withdrawal by Subject|0|||
130499926|NCT05426109|469798144|FG001|Overall Study|Withdrawal by Subject|1|||
130499927|NCT05212285|469798145|FG000|Overall Study|Lack of Efficacy|12|||
130499928|NCT05212285|469798146|FG001|Overall Study|Lack of Efficacy|8|||
130499929|NCT05212285|469798145|FG000|Overall Study|Withdrawal by Subject|8|||
130499930|NCT05212285|469798146|FG001|Overall Study|Withdrawal by Subject|1|||
130499931|NCT05212285|469798145|FG000|Overall Study|Lost to Follow-up|13|||
130499932|NCT05212285|469798146|FG001|Overall Study|Lost to Follow-up|1|||
130499933|NCT05212285|469798145|FG000|Overall Study|miss data|21|||
130499934|NCT05212285|469798146|FG001|Overall Study|miss data|2|||
130499935|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
130499936|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
130499937|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
130499938|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
130499939|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
130499940|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
130499941|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
130499942|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
130499943|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
130499944|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
130499945|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
130499946|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
130499947|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
130499948|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
130499949|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
130499950|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
130499951|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
130499952|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
130499953|NCT02222493|469798147|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
130499954|NCT02222493|469798148|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
130499955|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
130499956|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
130499957|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
130499958|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
130565662|NCT00928889|470036972|FG001|Overall Study|Lost to Follow-up|1|||
130499959|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
130499960|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
130499961|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
130499962|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
130499963|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
130499964|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
130499965|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
130499966|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
130499967|NCT02222493|469798147|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
130499968|NCT02222493|469798148|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
130499969|NCT02222493|469798147|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
130499970|NCT02222493|469798148|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
130499971|NCT02222493|469798147|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
130499972|NCT02222493|469798148|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
130499973|NCT02222493|469798147|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
130499974|NCT02222493|469798148|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
130499975|NCT02222493|469798147|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
130499976|NCT02222493|469798148|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
130499977|NCT02222493|469798147|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
130499978|NCT02222493|469798148|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
130499979|NCT03924869|469798152|FG000|Overall Study|Death|66|||
130499980|NCT03924869|469798153|FG001|Overall Study|Death|53|||
130499981|NCT03924869|469798152|FG000|Overall Study|Lost to Follow-up|2|||
130499982|NCT03924869|469798153|FG001|Overall Study|Lost to Follow-up|0|||
130499983|NCT03924869|469798152|FG000|Overall Study|Physician Decision|0|||
130499984|NCT03924869|469798153|FG001|Overall Study|Physician Decision|3|||
130499985|NCT03924869|469798152|FG000|Overall Study|Withdrawal by Subject|5|||
130499986|NCT03924869|469798153|FG001|Overall Study|Withdrawal by Subject|1|||
130499987|NCT03924869|469798152|FG000|Overall Study|Participants Ongoing|154|||
130499988|NCT03924869|469798153|FG001|Overall Study|Participants Ongoing|164|||
130565663|NCT00928889|470036971|FG000|Overall Study|Protocol Violation|0|||
130565664|NCT00928889|470036972|FG001|Overall Study|Protocol Violation|1|||
130499989|NCT02542943|469798154|FG000|Overall Study|Lost to Follow-up|1|||
130499990|NCT02542943|469798155|FG001|Overall Study|Lost to Follow-up|0|||
130499991|NCT02542943|469798156|FG002|Overall Study|Lost to Follow-up|0|||
130499992|NCT02542943|469798154|FG000|Overall Study|Withdrawal by Subject|0|||
130499993|NCT02542943|469798155|FG001|Overall Study|Withdrawal by Subject|1|||
130499994|NCT02542943|469798156|FG002|Overall Study|Withdrawal by Subject|0|||
130499995|NCT05865392|469798165|FG000|Overall Study|Withdrawal by Subject|4|||
130499996|NCT05865392|469798166|FG001|Overall Study|Withdrawal by Subject|0|||
130499997|NCT05865392|469798165|FG000|Overall Study|Didn't meet inclusion criteria|4|||
130499998|NCT05865392|469798166|FG001|Overall Study|Didn't meet inclusion criteria|0|||
130499999|NCT02637063|469799270|FG000|Overall Study|Lost to Follow-up|3|||
130500000|NCT02637063|469799271|FG001|Overall Study|Lost to Follow-up|2|||
130500001|NCT02637063|469799272|FG002|Overall Study|Lost to Follow-up|3|||
130500002|NCT02637063|469799270|FG000|Overall Study|Withdrawal by Subject|2|||
130500003|NCT02637063|469799271|FG001|Overall Study|Withdrawal by Subject|2|||
130500004|NCT02637063|469799272|FG002|Overall Study|Withdrawal by Subject|3|||
130729644|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
130729645|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
130729646|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
130729647|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
130729648|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729649|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
130500005|NCT02634307|469799277|FG000|Overall Study|Adverse Event|50|||
130500006|NCT02634307|469799278|FG001|Overall Study|Adverse Event|24|||
130500007|NCT02634307|469799279|FG002|Overall Study|Adverse Event|14|||
130500008|NCT02634307|469799277|FG000|Overall Study|Lost to Follow-up|21|||
130500009|NCT02634307|469799278|FG001|Overall Study|Lost to Follow-up|5|||
130500010|NCT02634307|469799279|FG002|Overall Study|Lost to Follow-up|6|||
130565665|NCT00928889|470036971|FG000|Overall Study|Adverse Event|1|||
130565666|NCT00928889|470036972|FG001|Overall Study|Adverse Event|0|||
130729650|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729651|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729652|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
130500011|NCT02634307|469799277|FG000|Overall Study|Pregnancy|5|||
130500012|NCT02634307|469799278|FG001|Overall Study|Pregnancy|1|||
130500013|NCT02634307|469799279|FG002|Overall Study|Pregnancy|3|||
130500014|NCT02634307|469799277|FG000|Overall Study|Withdrawal by Subject|38|||
130500015|NCT02634307|469799278|FG001|Overall Study|Withdrawal by Subject|24|||
130500016|NCT02634307|469799279|FG002|Overall Study|Withdrawal by Subject|18|||
130500017|NCT02634307|469799277|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130500018|NCT02634307|469799278|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130500019|NCT02634307|469799279|FG002|Overall Study|Non-Compliance with Study Drug|2|||
130500020|NCT02634307|469799277|FG000|Overall Study|Lack of Efficacy|1|||
130500021|NCT02634307|469799278|FG001|Overall Study|Lack of Efficacy|5|||
130500022|NCT02634307|469799279|FG002|Overall Study|Lack of Efficacy|3|||
130500023|NCT02634307|469799277|FG000|Overall Study|Physician Decision|7|||
130500024|NCT02634307|469799278|FG001|Overall Study|Physician Decision|5|||
130500025|NCT02634307|469799279|FG002|Overall Study|Physician Decision|5|||
130500026|NCT02634307|469799277|FG000|Overall Study|Reason not Specified|3|||
130500027|NCT02634307|469799278|FG001|Overall Study|Reason not Specified|5|||
130729653|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
130729654|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
130500028|NCT02634307|469799279|FG002|Overall Study|Reason not Specified|10|||
130500029|NCT02698475|469799280|FG000|Main Study Period|Lack of Efficacy|1|||
130500030|NCT02698475|469799280|FG000|Main Study Period|Protocol Violation|2|||
130500031|NCT02698475|469799280|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
130500032|NCT02698475|469799280|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
130500033|NCT02698475|469799280|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
130500034|NCT02698475|469799280|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
130500035|NCT02698475|469799280|FG000|Long-Term Extension Period|Other|1|||
130500036|NCT02132949|469799281|FG000|Overall Study|Death|7|||
130500037|NCT02132949|469799282|FG001|Overall Study|Death|13|||
130500038|NCT02132949|469799281|FG000|Overall Study|Lost to Follow-up|14|||
130500039|NCT02132949|469799282|FG001|Overall Study|Lost to Follow-up|4|||
130500040|NCT02132949|469799281|FG000|Overall Study|Withdrawal by Subject|6|||
130500041|NCT02132949|469799282|FG001|Overall Study|Withdrawal by Subject|5|||
130500042|NCT02132949|469799281|FG000|Overall Study|Noncompliance|5|||
130500043|NCT02132949|469799282|FG001|Overall Study|Noncompliance|1|||
130500044|NCT02132949|469799281|FG000|Overall Study|Physician Decision|3|||
130500045|NCT02132949|469799282|FG001|Overall Study|Physician Decision|1|||
130500046|NCT02132949|469799281|FG000|Overall Study|Disease Progression|3|||
130500047|NCT02132949|469799282|FG001|Overall Study|Disease Progression|0|||
130500048|NCT02132949|469799281|FG000|Overall Study|Adverse Event|2|||
130500049|NCT02132949|469799282|FG001|Overall Study|Adverse Event|1|||
130500050|NCT02132949|469799281|FG000|Overall Study|Withdrew Prior to Treatment|1|||
130500051|NCT02132949|469799282|FG001|Overall Study|Withdrew Prior to Treatment|2|||
130500052|NCT02132949|469799281|FG000|Overall Study|Reason Unspecified|0|||
130500053|NCT02132949|469799282|FG001|Overall Study|Reason Unspecified|1|||
130500054|NCT01673594|469799288|FG000|Overall Study|Adverse Event|3|||
130500055|NCT01673594|469799289|FG001|Overall Study|Adverse Event|1|||
130500056|NCT01673594|469799288|FG000|Overall Study|Lost to Follow-up|1|||
130500057|NCT01673594|469799289|FG001|Overall Study|Lost to Follow-up|0|||
130500058|NCT01673594|469799288|FG000|Overall Study|Physician Decision|2|||
130500059|NCT01673594|469799289|FG001|Overall Study|Physician Decision|4|||
130500060|NCT01673594|469799288|FG000|Overall Study|Withdrawal by Subject|0|||
130500061|NCT01673594|469799289|FG001|Overall Study|Withdrawal by Subject|1|||
130500062|NCT03392194|469799292|FG000|Overall Study|Withdrawal by Subject|1|||
130500063|NCT03392194|469799293|FG001|Overall Study|Withdrawal by Subject|2|||
130500064|NCT03392194|469799292|FG000|Overall Study|Conflicts with personal schedule|1|||
130500065|NCT03392194|469799293|FG001|Overall Study|Conflicts with personal schedule|0|||
130500066|NCT03865732|469799294|FG000|Overall Study|Adverse Event|0|||
130500067|NCT03865732|469799295|FG001|Overall Study|Adverse Event|1|||
130500068|NCT03345979|469799300|FG000|Overall Study|Withdrawal by Subject|20|||
130500069|NCT03345979|469799301|FG001|Overall Study|Withdrawal by Subject|31|||
130500070|NCT03345979|469799300|FG000|Overall Study|Adverse Event|10|||
130500071|NCT03345979|469799301|FG001|Overall Study|Adverse Event|11|||
130500072|NCT03345979|469799300|FG000|Overall Study|Lost to Follow-up|8|||
130500073|NCT03345979|469799301|FG001|Overall Study|Lost to Follow-up|9|||
130500074|NCT03345979|469799300|FG000|Overall Study|Lack of Efficacy|4|||
130500075|NCT03345979|469799301|FG001|Overall Study|Lack of Efficacy|2|||
130500076|NCT03345979|469799300|FG000|Overall Study|Protocol Violation|1|||
130500077|NCT03345979|469799301|FG001|Overall Study|Protocol Violation|3|||
130500078|NCT03345979|469799300|FG000|Overall Study|Physician Decision|0|||
130500079|NCT03345979|469799301|FG001|Overall Study|Physician Decision|2|||
130500080|NCT00487240|469799302|FG000|Overall Study|Withdrawal by Subject|12|||
130500081|NCT00487240|469799303|FG001|Overall Study|Withdrawal by Subject|6|||
130500082|NCT00487240|469799302|FG000|Overall Study|Lost to Follow-up|7|||
130500083|NCT00487240|469799303|FG001|Overall Study|Lost to Follow-up|6|||
130500084|NCT00487240|469799302|FG000|Overall Study|Adverse Event|0|||
130729655|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
130500085|NCT00487240|469799303|FG001|Overall Study|Adverse Event|4|||
130500086|NCT00487240|469799302|FG000|Overall Study|Protocol Violation|5|||
130500087|NCT00487240|469799303|FG001|Overall Study|Protocol Violation|5|||
130500088|NCT00487240|469799302|FG000|Overall Study|Entry Criteria Not Met|3|||
130500089|NCT00487240|469799303|FG001|Overall Study|Entry Criteria Not Met|4|||
130500090|NCT00487240|469799302|FG000|Overall Study|Sponsor Decision|2|||
130500091|NCT00487240|469799303|FG001|Overall Study|Sponsor Decision|1|||
130500092|NCT00487240|469799302|FG000|Overall Study|Physician Decision|2|||
130500093|NCT00487240|469799303|FG001|Overall Study|Physician Decision|0|||
130500094|NCT00999596|469799306|FG000|Overall Study|Statistical population not required|101|||
130500095|NCT01698918|469799307|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
130500096|NCT01698918|469799307|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
130500097|NCT01698918|469799307|FG000|First Line Treatment (Core+Extension)|Death|2|||
130500098|NCT01698918|469799307|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
130500099|NCT01698918|469799307|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
130500100|NCT01698918|469799307|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
130500101|NCT01698918|469799307|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
130500102|NCT01698918|469799307|FG000|Second Line Treatment (Core+Extension)|Death|1|||
130500103|NCT01698918|469799307|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
130500104|NCT01698918|469799307|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
130500105|NCT02630186|469799308|FG000|Overall Study|Withdrawal by Subject|1|||
130500106|NCT01019135|469799309|FG000|Overall Study|Did not receive allocated intervention|12|||
130500107|NCT01019135|469799310|FG001|Overall Study|Did not receive allocated intervention|6|||
130500108|NCT01019135|469799311|FG002|Overall Study|Did not receive allocated intervention|25|||
130500109|NCT01019135|469799309|FG000|Overall Study|Did not attend CR|8|||
130500110|NCT01019135|469799310|FG001|Overall Study|Did not attend CR|13|||
130500111|NCT01019135|469799311|FG002|Overall Study|Did not attend CR|6|||
130500112|NCT00439218|469799314|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
130500113|NCT03176407|469799315|FG000|Overall Study|Protocol Violation|1|||
130500114|NCT03176407|469799315|FG000|Overall Study|human failure|1|||
130500115|NCT03176407|469799315|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
130500116|NCT01428583|469799317|FG000|Overall Study|Adverse Event|75|||
130500117|NCT01428583|469799317|FG000|Overall Study|Withdrawal by Subject|51|||
130500118|NCT01428583|469799317|FG000|Overall Study|Lack of Efficacy|37|||
130500119|NCT01428583|469799317|FG000|Overall Study|Lost to Follow-up|17|||
130500120|NCT01428583|469799317|FG000|Overall Study|Death|1|||
130500121|NCT01428583|469799317|FG000|Overall Study|Pregnancy|1|||
130500122|NCT01428583|469799317|FG000|Overall Study|Protocol Violation|1|||
130500123|NCT01428583|469799317|FG000|Overall Study|Physician Decision|12|||
130500124|NCT01428583|469799317|FG000|Overall Study|Non-compliant|25|||
130500125|NCT01428583|469799317|FG000|Overall Study|Confirmed positive urine drug test|8|||
130500126|NCT01428583|469799317|FG000|Overall Study|Sponsor's request|3|||
130500127|NCT01428583|469799317|FG000|Overall Study|Other|6|||
130500128|NCT00670488|469799318|FG000|Overall Study|Adverse Event|0|||
130500129|NCT00670488|469799319|FG001|Overall Study|Adverse Event|7|||
130500130|NCT00670488|469799320|FG002|Overall Study|Adverse Event|0|||
130500131|NCT00670488|469799321|FG003|Overall Study|Adverse Event|3|||
130500132|NCT00670488|469799322|FG004|Overall Study|Adverse Event|1|||
130500133|NCT00670488|469799323|FG005|Overall Study|Adverse Event|1|||
130500134|NCT00670488|469799324|FG006|Overall Study|Adverse Event|5|||
130500135|NCT00670488|469799325|FG007|Overall Study|Adverse Event|1|||
130500136|NCT00670488|469799326|FG008|Overall Study|Adverse Event|0|||
130500137|NCT00670488|469799327|FG009|Overall Study|Adverse Event|1|||
130500138|NCT00670488|469799318|FG000|Overall Study|Physician Decision|1|||
130500139|NCT00670488|469799319|FG001|Overall Study|Physician Decision|9|||
130500140|NCT00670488|469799320|FG002|Overall Study|Physician Decision|0|||
130500141|NCT00670488|469799321|FG003|Overall Study|Physician Decision|1|||
130500142|NCT00670488|469799322|FG004|Overall Study|Physician Decision|0|||
130500143|NCT00670488|469799323|FG005|Overall Study|Physician Decision|0|||
130500144|NCT00670488|469799324|FG006|Overall Study|Physician Decision|0|||
130500145|NCT00670488|469799325|FG007|Overall Study|Physician Decision|0|||
130565667|NCT00928889|470036971|FG000|Overall Study|Other|1|||
130565668|NCT00928889|470036972|FG001|Overall Study|Other|0|||
130565669|NCT04712110|470036973|FG000|Overall Study|Lost to Follow-up|0|||
130565670|NCT04712110|470036974|FG001|Overall Study|Lost to Follow-up|1|||
130565671|NCT04712110|470036973|FG000|Overall Study|Withdrawal by Subject|0|||
130500146|NCT00670488|469799326|FG008|Overall Study|Physician Decision|0|||
130500147|NCT00670488|469799327|FG009|Overall Study|Physician Decision|0|||
130500148|NCT00670488|469799318|FG000|Overall Study|Progressive Disease|2|||
130500149|NCT00670488|469799319|FG001|Overall Study|Progressive Disease|41|||
130565672|NCT04712110|470036974|FG001|Overall Study|Withdrawal by Subject|4|||
130565673|NCT04712110|470036973|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
130565674|NCT04712110|470036974|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
130565675|NCT01197521|470036977|FG000|Overall Study|Not reported|24|||
130565676|NCT01197521|470036978|FG001|Overall Study|Not reported|25|||
130565677|NCT01197521|470036979|FG002|Overall Study|Not reported|21|||
130565678|NCT01197521|470036977|FG000|Overall Study|Enrolment in long term extension|42|||
130565679|NCT01197521|470036978|FG001|Overall Study|Enrolment in long term extension|36|||
130500150|NCT00670488|469799320|FG002|Overall Study|Progressive Disease|3|||
130500151|NCT00670488|469799321|FG003|Overall Study|Progressive Disease|2|||
130500152|NCT00670488|469799322|FG004|Overall Study|Progressive Disease|2|||
130500153|NCT00670488|469799323|FG005|Overall Study|Progressive Disease|4|||
130500154|NCT00670488|469799324|FG006|Overall Study|Progressive Disease|11|||
130500155|NCT00670488|469799325|FG007|Overall Study|Progressive Disease|2|||
130729656|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130729657|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130729658|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729659|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729660|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729661|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729662|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729663|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130729664|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
130729665|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130729666|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
130729667|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
130729668|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729669|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729670|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729671|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729672|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729673|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
130729674|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
130729675|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
130729676|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
130729677|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
130729678|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729679|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729680|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729681|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729682|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729683|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729684|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729685|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729686|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
130729687|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729688|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729689|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729690|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729691|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729692|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729693|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
130729694|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
130500156|NCT00670488|469799326|FG008|Overall Study|Progressive Disease|2|||
130500157|NCT00670488|469799327|FG009|Overall Study|Progressive Disease|1|||
130500158|NCT00670488|469799318|FG000|Overall Study|Withdrawal by Subject|0|||
130500159|NCT00670488|469799319|FG001|Overall Study|Withdrawal by Subject|1|||
130500160|NCT00670488|469799320|FG002|Overall Study|Withdrawal by Subject|0|||
130500161|NCT00670488|469799321|FG003|Overall Study|Withdrawal by Subject|1|||
130500162|NCT00670488|469799322|FG004|Overall Study|Withdrawal by Subject|0|||
130500163|NCT00670488|469799323|FG005|Overall Study|Withdrawal by Subject|0|||
130500164|NCT00670488|469799324|FG006|Overall Study|Withdrawal by Subject|1|||
130500165|NCT00670488|469799325|FG007|Overall Study|Withdrawal by Subject|0|||
130500166|NCT00670488|469799326|FG008|Overall Study|Withdrawal by Subject|1|||
130500167|NCT00670488|469799327|FG009|Overall Study|Withdrawal by Subject|0|||
130500168|NCT01074242|469799332|FG000|Overall Study|Case report before date of contract|40|||
130500169|NCT01074242|469799332|FG000|Overall Study|Lost to Follow-up|1|||
130500170|NCT01074242|469799332|FG000|Overall Study|Case report unclear|6|||
130500171|NCT01074242|469799332|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
130500172|NCT01074242|469799332|FG000|Overall Study|Duplicate Case Report Form|5|||
130500173|NCT01683409|469799337|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
130500174|NCT01683409|469799338|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
130500175|NCT01683409|469799339|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
130500176|NCT01683409|469799340|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
130500177|NCT01683409|469799341|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
130500178|NCT01683409|469799337|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
130500179|NCT01683409|469799338|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
130500180|NCT01683409|469799339|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
130500181|NCT01683409|469799340|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
130729695|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
130729696|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
130729697|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
130500182|NCT01683409|469799341|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
130500183|NCT01683409|469799337|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
130500184|NCT01683409|469799338|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
130729698|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729699|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729700|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729701|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729702|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729703|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729704|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729705|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729706|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
130729707|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729708|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729709|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729710|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729711|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729712|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729713|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
130729714|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
130729715|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
130729716|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
130729717|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
130729718|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
130729719|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
130729720|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
130500185|NCT01683409|469799339|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
130500186|NCT01683409|469799340|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
130500187|NCT01683409|469799341|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
130500188|NCT01683409|469799337|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
130500189|NCT01683409|469799338|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
130500190|NCT01683409|469799339|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
130500191|NCT01683409|469799340|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
130500192|NCT01683409|469799341|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
130500193|NCT01683409|469799337|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
130500194|NCT01683409|469799338|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
130500195|NCT01683409|469799339|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
130500196|NCT01683409|469799340|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
130500197|NCT01683409|469799341|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
130500198|NCT01683409|469799337|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
130500199|NCT01683409|469799338|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
130500200|NCT01683409|469799339|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
130500201|NCT01683409|469799340|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
130500202|NCT01683409|469799341|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
130500203|NCT01683409|469799337|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
130500204|NCT01683409|469799338|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
130500205|NCT01683409|469799339|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
130500206|NCT01683409|469799340|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
130500207|NCT01683409|469799341|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
130500208|NCT01683409|469799337|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
130500209|NCT01683409|469799338|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
130500210|NCT01683409|469799339|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
130500211|NCT01683409|469799340|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
130500212|NCT01683409|469799341|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
130500213|NCT01683409|469799337|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
130500214|NCT01683409|469799338|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
130500215|NCT01683409|469799339|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
130500216|NCT01683409|469799340|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
130500217|NCT01683409|469799341|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
130500218|NCT01683409|469799337|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
130500219|NCT01683409|469799338|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
130500220|NCT01683409|469799339|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
130729721|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
130729722|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
130729723|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729724|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729725|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729726|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729727|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130500221|NCT01683409|469799340|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
130500222|NCT01683409|469799341|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
130500223|NCT01683409|469799337|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
130500224|NCT01683409|469799338|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
130500225|NCT01683409|469799339|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
130500226|NCT01683409|469799340|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
130500227|NCT01683409|469799341|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
130500228|NCT04218864|469799342|FG000|Overall Study|Lost to Follow-up|8|||
130500229|NCT04218864|469799343|FG001|Overall Study|Lost to Follow-up|4|||
130500230|NCT04218864|469799342|FG000|Overall Study|Withdrawal by Subject|1|||
130500231|NCT04218864|469799343|FG001|Overall Study|Withdrawal by Subject|3|||
130500232|NCT01227421|469799345|FG000|Overall Study|Lost to Follow-up|6|||
130500233|NCT01227421|469799346|FG001|Overall Study|Lost to Follow-up|7|||
130500234|NCT01227421|469799347|FG002|Overall Study|Lost to Follow-up|5|||
130500235|NCT01227421|469799345|FG000|Overall Study|Adverse Event|2|||
130500236|NCT01227421|469799346|FG001|Overall Study|Adverse Event|7|||
130500237|NCT01227421|469799347|FG002|Overall Study|Adverse Event|2|||
130500238|NCT01227421|469799345|FG000|Overall Study|Withdrawal by Subject|1|||
130500239|NCT01227421|469799346|FG001|Overall Study|Withdrawal by Subject|2|||
130500240|NCT01227421|469799347|FG002|Overall Study|Withdrawal by Subject|1|||
130500241|NCT01227421|469799345|FG000|Overall Study|Protocol Violation|1|||
130500242|NCT01227421|469799346|FG001|Overall Study|Protocol Violation|1|||
130500243|NCT01227421|469799347|FG002|Overall Study|Protocol Violation|2|||
130500244|NCT01227421|469799345|FG000|Overall Study|Randomized in error|1|||
130500245|NCT01227421|469799346|FG001|Overall Study|Randomized in error|1|||
130500246|NCT01227421|469799347|FG002|Overall Study|Randomized in error|0|||
130500247|NCT00145470|469799348|FG000|Overall Study|Adverse Event|19|||
130500248|NCT00145470|469799349|FG001|Overall Study|Adverse Event|25|||
130500249|NCT00145470|469799348|FG000|Overall Study|Lack of Efficacy|27|||
130500250|NCT00145470|469799349|FG001|Overall Study|Lack of Efficacy|13|||
130500251|NCT00145470|469799348|FG000|Overall Study|Withdrawal by Subject|36|||
130500252|NCT00145470|469799349|FG001|Overall Study|Withdrawal by Subject|34|||
130500253|NCT00145470|469799348|FG000|Overall Study|Lost to Follow-up|21|||
130500254|NCT00145470|469799349|FG001|Overall Study|Lost to Follow-up|17|||
130500255|NCT00145470|469799348|FG000|Overall Study|Reason Not Reported|9|||
130500256|NCT00145470|469799349|FG001|Overall Study|Reason Not Reported|9|||
130500257|NCT04224272|469799351|FG000|Part 1 - Dose Finding|Death|4|||
130500258|NCT04224272|469799351|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
130500259|NCT04224272|469799351|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
130500260|NCT04224272|469799351|FG000|Part 2 - Dose Expansion|Death|10|||
130500261|NCT04224272|469799351|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
130500262|NCT02609048|469799352|FG000|Overall Study|Adverse Event|3|||
130500263|NCT02609048|469799353|FG001|Overall Study|Adverse Event|0|||
130500264|NCT02609048|469799354|FG002|Overall Study|Adverse Event|0|||
130500265|NCT02609048|469799352|FG000|Overall Study|Randomized but never treated|1|||
130500266|NCT02609048|469799353|FG001|Overall Study|Randomized but never treated|1|||
130500267|NCT02609048|469799354|FG002|Overall Study|Randomized but never treated|1|||
130500268|NCT02609048|469799352|FG000|Overall Study|Withdrawal of informed consent|1|||
130500269|NCT02609048|469799353|FG001|Overall Study|Withdrawal of informed consent|0|||
130500270|NCT02609048|469799354|FG002|Overall Study|Withdrawal of informed consent|0|||
130500271|NCT02609048|469799352|FG000|Overall Study|Reason not specified|6|||
130500272|NCT02609048|469799353|FG001|Overall Study|Reason not specified|9|||
130500273|NCT02609048|469799354|FG002|Overall Study|Reason not specified|9|||
130500274|NCT02485925|469799355|FG000|Overall Study|Withdrawal by Subject|3|||
130500275|NCT02485925|469799355|FG000|Overall Study|Death|1|||
130500276|NCT02485925|469799355|FG000|Overall Study|Lost to Follow-up|11|||
130500277|NCT05995977|469799356|FG000|Overall Study|Withdrawal by Subject|1|||
130500278|NCT05995977|469799357|FG001|Overall Study|Withdrawal by Subject|4|||
130500279|NCT05995977|469799356|FG000|Overall Study|Lost to Follow-up|2|||
130500280|NCT05995977|469799357|FG001|Overall Study|Lost to Follow-up|0|||
130500281|NCT04181788|469799358|FG000|TREATMENT|Adverse Event|0|||
130500282|NCT04181788|469799359|FG001|TREATMENT|Adverse Event|2|||
130500283|NCT04181788|469799360|FG002|TREATMENT|Adverse Event|1|||
130500284|NCT04181788|469799361|FG003|TREATMENT|Adverse Event|0|||
130500285|NCT04181788|469799362|FG004|TREATMENT|Adverse Event|1|||
130500286|NCT04181788|469799363|FG005|TREATMENT|Adverse Event|3|||
130500287|NCT04181788|469799358|FG000|TREATMENT|Death|0|||
130500288|NCT04181788|469799359|FG001|TREATMENT|Death|0|||
130500289|NCT04181788|469799360|FG002|TREATMENT|Death|0|||
130500290|NCT04181788|469799361|FG003|TREATMENT|Death|0|||
130500291|NCT04181788|469799362|FG004|TREATMENT|Death|8|||
130500292|NCT04181788|469799363|FG005|TREATMENT|Death|8|||
130500293|NCT04181788|469799358|FG000|TREATMENT|Physician Decision|0|||
130500294|NCT04181788|469799359|FG001|TREATMENT|Physician Decision|0|||
130500295|NCT04181788|469799360|FG002|TREATMENT|Physician Decision|0|||
130500296|NCT04181788|469799361|FG003|TREATMENT|Physician Decision|0|||
130500297|NCT04181788|469799362|FG004|TREATMENT|Physician Decision|0|||
130500298|NCT04181788|469799363|FG005|TREATMENT|Physician Decision|1|||
130500299|NCT04181788|469799358|FG000|TREATMENT|Progressive disease|3|||
130500300|NCT04181788|469799359|FG001|TREATMENT|Progressive disease|3|||
130500301|NCT04181788|469799360|FG002|TREATMENT|Progressive disease|5|||
130500302|NCT04181788|469799361|FG003|TREATMENT|Progressive disease|7|||
130500303|NCT04181788|469799362|FG004|TREATMENT|Progressive disease|20|||
130500304|NCT04181788|469799363|FG005|TREATMENT|Progressive disease|38|||
130500305|NCT04181788|469799358|FG000|TREATMENT|Global deterioration of health status|0|||
130500306|NCT04181788|469799359|FG001|TREATMENT|Global deterioration of health status|2|||
130500307|NCT04181788|469799360|FG002|TREATMENT|Global deterioration of health status|0|||
130500308|NCT04181788|469799361|FG003|TREATMENT|Global deterioration of health status|0|||
130500309|NCT04181788|469799362|FG004|TREATMENT|Global deterioration of health status|2|||
130500310|NCT04181788|469799363|FG005|TREATMENT|Global deterioration of health status|8|||
130500311|NCT04181788|469799358|FG000|TREATMENT|Withdrawal by Subject|1|||
130565680|NCT01197521|470036979|FG002|Overall Study|Enrolment in long term extension|87|||
130565681|NCT01197521|470036977|FG000|Overall Study|Severe non-compliance to protocol|1|||
130565682|NCT01197521|470036978|FG001|Overall Study|Severe non-compliance to protocol|3|||
130729728|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
130500312|NCT04181788|469799359|FG001|TREATMENT|Withdrawal by Subject|2|||
130500313|NCT04181788|469799360|FG002|TREATMENT|Withdrawal by Subject|0|||
130500314|NCT04181788|469799361|FG003|TREATMENT|Withdrawal by Subject|0|||
130500315|NCT04181788|469799362|FG004|TREATMENT|Withdrawal by Subject|3|||
130500316|NCT04181788|469799363|FG005|TREATMENT|Withdrawal by Subject|5|||
130500317|NCT04181788|469799358|FG000|TREATMENT|Other unspecified|0|||
130500318|NCT04181788|469799359|FG001|TREATMENT|Other unspecified|0|||
130500319|NCT04181788|469799360|FG002|TREATMENT|Other unspecified|0|||
130500320|NCT04181788|469799361|FG003|TREATMENT|Other unspecified|0|||
130500321|NCT04181788|469799362|FG004|TREATMENT|Other unspecified|0|||
130500322|NCT04181788|469799363|FG005|TREATMENT|Other unspecified|2|||
130500323|NCT04181788|469799358|FG000|TREATMENT|Ongoing|0|||
130500324|NCT04181788|469799359|FG001|TREATMENT|Ongoing|3|||
130500325|NCT04181788|469799360|FG002|TREATMENT|Ongoing|0|||
130500326|NCT04181788|469799361|FG003|TREATMENT|Ongoing|5|||
130500327|NCT04181788|469799362|FG004|TREATMENT|Ongoing|7|||
130500328|NCT04181788|469799363|FG005|TREATMENT|Ongoing|15|||
130500329|NCT04181788|469799358|FG000|FOLLOW-UP|Death|0|||
130500330|NCT04181788|469799359|FG001|FOLLOW-UP|Death|0|||
130500331|NCT04181788|469799360|FG002|FOLLOW-UP|Death|1|||
130500332|NCT04181788|469799361|FG003|FOLLOW-UP|Death|2|||
130500333|NCT04181788|469799362|FG004|FOLLOW-UP|Death|8|||
130500334|NCT04181788|469799363|FG005|FOLLOW-UP|Death|20|||
130500335|NCT04181788|469799358|FG000|FOLLOW-UP|Lost to Follow-up|0|||
130500336|NCT04181788|469799359|FG001|FOLLOW-UP|Lost to Follow-up|0|||
130500337|NCT04181788|469799360|FG002|FOLLOW-UP|Lost to Follow-up|0|||
130500338|NCT04181788|469799361|FG003|FOLLOW-UP|Lost to Follow-up|0|||
130500339|NCT04181788|469799362|FG004|FOLLOW-UP|Lost to Follow-up|0|||
130500340|NCT04181788|469799363|FG005|FOLLOW-UP|Lost to Follow-up|2|||
130500341|NCT04181788|469799358|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
130500342|NCT04181788|469799359|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
130500343|NCT04181788|469799360|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
130500344|NCT04181788|469799361|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
130500345|NCT04181788|469799362|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
130500346|NCT04181788|469799363|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
130500347|NCT04181788|469799358|FG000|FOLLOW-UP|Other unspecified|0|||
130500348|NCT04181788|469799359|FG001|FOLLOW-UP|Other unspecified|1|||
130729729|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
130729730|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
130729731|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
130729732|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
130729733|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729734|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729735|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729736|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130500349|NCT04181788|469799360|FG002|FOLLOW-UP|Other unspecified|0|||
130500350|NCT04181788|469799361|FG003|FOLLOW-UP|Other unspecified|0|||
130500351|NCT04181788|469799362|FG004|FOLLOW-UP|Other unspecified|0|||
130500352|NCT04181788|469799363|FG005|FOLLOW-UP|Other unspecified|3|||
130500353|NCT04181788|469799358|FG000|FOLLOW-UP|Ongoing|0|||
130500354|NCT04181788|469799359|FG001|FOLLOW-UP|Ongoing|0|||
130500355|NCT04181788|469799360|FG002|FOLLOW-UP|Ongoing|1|||
130500356|NCT04181788|469799361|FG003|FOLLOW-UP|Ongoing|3|||
130500357|NCT04181788|469799362|FG004|FOLLOW-UP|Ongoing|2|||
130500358|NCT04181788|469799363|FG005|FOLLOW-UP|Ongoing|2|||
130500359|NCT04937504|469799364|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
130500360|NCT04937504|469799365|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
130500361|NCT04937504|469799364|FG000|9 Months Assessment|Lost to Follow-up|3|||
130500362|NCT04937504|469799365|FG001|9 Months Assessment|Lost to Follow-up|2|||
130500363|NCT04186247|469799366|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
130500364|NCT04186247|469799367|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
130500365|NCT04186247|469799368|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
130500366|NCT04186247|469799369|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
130500367|NCT04186247|469799370|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
130500368|NCT03662659|469799371|FG000|Pre-treatment|Participant no longer met study criteria|1|||
130500369|NCT03662659|469799372|FG001|Pre-treatment|Participant no longer met study criteria|1|||
130500370|NCT03662659|469799371|FG000|Pre-treatment|Other reasons|1|||
130500371|NCT03662659|469799372|FG001|Pre-treatment|Other reasons|0|||
130500372|NCT03662659|469799371|FG000|Treatment|Completed Treatment|0|||
130500373|NCT03662659|469799372|FG001|Treatment|Completed Treatment|2|||
130500374|NCT03662659|469799371|FG000|Treatment|Disease Progression|85|||
130500375|NCT03662659|469799372|FG001|Treatment|Disease Progression|97|||
130500376|NCT03662659|469799371|FG000|Treatment|Study Drug Toxicity|19|||
130500377|NCT03662659|469799372|FG001|Treatment|Study Drug Toxicity|9|||
130500378|NCT03662659|469799371|FG000|Treatment|Death|11|||
130500379|NCT03662659|469799372|FG001|Treatment|Death|9|||
130500380|NCT03662659|469799371|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
130500381|NCT03662659|469799372|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
130500382|NCT03662659|469799371|FG000|Treatment|Withdrawal by Subject|1|||
130500383|NCT03662659|469799372|FG001|Treatment|Withdrawal by Subject|1|||
130500384|NCT03662659|469799371|FG000|Treatment|Poor/Non-compliance|1|||
130500385|NCT03662659|469799372|FG001|Treatment|Poor/Non-compliance|0|||
130500386|NCT03662659|469799371|FG000|Treatment|Participant no longer meets study criteria|1|||
130500387|NCT03662659|469799372|FG001|Treatment|Participant no longer meets study criteria|0|||
130500388|NCT03662659|469799371|FG000|Treatment|Other reasons|10|||
130500389|NCT03662659|469799372|FG001|Treatment|Other reasons|8|||
130500390|NCT03662659|469799371|FG000|Treatment|Administrative reasons by sponsor|1|||
130500391|NCT03662659|469799372|FG001|Treatment|Administrative reasons by sponsor|0|||
130500392|NCT03662659|469799371|FG000|Treatment|maximum clinical benefit|0|||
130500393|NCT03662659|469799372|FG001|Treatment|maximum clinical benefit|2|||
130500394|NCT02556918|469801417|FG000|Overall Study|Protocol Violation|5|||
130500395|NCT02556918|469801418|FG001|Overall Study|Protocol Violation|6|||
130500396|NCT02556918|469801417|FG000|Overall Study|Withdrawal by Subject|4|||
130500397|NCT02556918|469801418|FG001|Overall Study|Withdrawal by Subject|4|||
130500398|NCT00551421|469801429|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
130500399|NCT04323800|469801432|FG000|Overall Study|Withdrawal by Subject|4|||
130500400|NCT04323800|469801433|FG001|Overall Study|Withdrawal by Subject|4|||
130500401|NCT04323800|469801432|FG000|Overall Study|Incomplete transfusion|1|||
130500402|NCT04323800|469801433|FG001|Overall Study|Incomplete transfusion|0|||
130500403|NCT04323800|469801432|FG000|Overall Study|Other|0|||
130500404|NCT04323800|469801433|FG001|Overall Study|Other|1|||
130500405|NCT04323800|469801432|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
130500406|NCT04323800|469801433|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
130500407|NCT00489554|469801434|FG000|Overall Study|Adverse Event|2|||
130500408|NCT00489554|469801434|FG000|Overall Study|Withdrawal by Subject|1|||
130500409|NCT00489554|469801434|FG000|Overall Study|Lost to Follow-up|1|||
130500410|NCT06571695|469801435|FG000|Overall Study|Lost to Follow-up|1|||
130500411|NCT06571695|469801436|FG001|Overall Study|Lost to Follow-up|6|||
130500412|NCT01380145|469801440|FG000|Overall Study|Progressive disease|4|||
130729737|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729738|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
130500413|NCT02038049|469801445|FG000|Overall Study|Lost to Follow-up|1|||
130500414|NCT02038049|469801446|FG001|Overall Study|Lost to Follow-up|0|||
130500415|NCT02771366|469801447|FG000|Period 1|Withdrawal by Subject|0|||
130500416|NCT02771366|469801448|FG001|Period 1|Withdrawal by Subject|2|||
130500417|NCT02771366|469801447|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
130500418|NCT02771366|469801448|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
130500419|NCT01808534|469801449|FG000|Overall Study|Disease progression|3|||
130729739|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
130500420|NCT01808534|469801449|FG000|Overall Study|Physician Decision|1|||
130729740|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
130500421|NCT02148705|469801455|FG000|Overall Study|Death|2|||
130500422|NCT02148705|469801456|FG001|Overall Study|Death|0|||
130500423|NCT02148705|469801457|FG002|Overall Study|Death|0|||
130500424|NCT02148705|469801455|FG000|Overall Study|Lost to Follow-up|13|||
130500425|NCT02148705|469801456|FG001|Overall Study|Lost to Follow-up|4|||
130500426|NCT02148705|469801457|FG002|Overall Study|Lost to Follow-up|10|||
130500427|NCT02148705|469801455|FG000|Overall Study|Withdrawal by Subject|3|||
130500428|NCT02148705|469801456|FG001|Overall Study|Withdrawal by Subject|0|||
130500429|NCT02148705|469801457|FG002|Overall Study|Withdrawal by Subject|2|||
130729741|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
130500430|NCT02148705|469801455|FG000|Overall Study|Not Treated|0|||
130500431|NCT02148705|469801456|FG001|Overall Study|Not Treated|1|||
130500432|NCT02148705|469801457|FG002|Overall Study|Not Treated|5|||
130500433|NCT01737021|469801458|FG000|Overall Study|Lost to Follow-up|5|||
130500434|NCT01737021|469801459|FG001|Overall Study|Lost to Follow-up|3|||
130500435|NCT02575365|469801466|FG000|Overall Study|Lost to Follow-up|4|||
130500436|NCT01009645|469801473|FG000|Overall Study|Lost to Follow-up|2|||
130500437|NCT01009645|469801474|FG001|Overall Study|Lost to Follow-up|8|||
130500438|NCT01009645|469801475|FG002|Overall Study|Lost to Follow-up|4|||
130500439|NCT01009645|469801476|FG003|Overall Study|Lost to Follow-up|5|||
130500440|NCT05124210|469801477|FG000|Overall Study|Lost to Follow-up|1|||
130500441|NCT05124210|469801478|FG001|Overall Study|Lost to Follow-up|0|||
130500442|NCT05124210|469801477|FG000|Overall Study|Withdrawal by Subject|1|||
130500443|NCT05124210|469801478|FG001|Overall Study|Withdrawal by Subject|0|||
130500444|NCT00768755|469801481|FG000|Phase 1|Death|6|||
130500445|NCT00768755|469801482|FG001|Phase 1|Death|0|||
130500446|NCT00768755|469801483|FG002|Phase 1|Death|0|||
130500447|NCT00768755|469801484|FG003|Phase 1|Death|0|||
130500448|NCT00768755|469801481|FG000|Phase 1|Other|4|||
130500449|NCT00768755|469801482|FG001|Phase 1|Other|0|||
130500450|NCT00768755|469801483|FG002|Phase 1|Other|0|||
130500451|NCT00768755|469801484|FG003|Phase 1|Other|0|||
130500452|NCT00768755|469801481|FG000|Phase 2|Death|0|||
130500453|NCT00768755|469801482|FG001|Phase 2|Death|37|||
130500454|NCT00768755|469801483|FG002|Phase 2|Death|48|||
130500455|NCT00768755|469801484|FG003|Phase 2|Death|31|||
130500456|NCT00768755|469801481|FG000|Phase 2|Protocol Violation|0|||
130500457|NCT00768755|469801482|FG001|Phase 2|Protocol Violation|2|||
130500458|NCT00768755|469801483|FG002|Phase 2|Protocol Violation|0|||
130500459|NCT00768755|469801484|FG003|Phase 2|Protocol Violation|1|||
130500460|NCT00768755|469801481|FG000|Phase 2|Lost to Follow-up|0|||
130500461|NCT00768755|469801482|FG001|Phase 2|Lost to Follow-up|1|||
130500462|NCT00768755|469801483|FG002|Phase 2|Lost to Follow-up|1|||
130500463|NCT00768755|469801484|FG003|Phase 2|Lost to Follow-up|4|||
130500464|NCT00768755|469801481|FG000|Phase 2|Withdrawal by Subject|0|||
130500465|NCT00768755|469801482|FG001|Phase 2|Withdrawal by Subject|1|||
130500466|NCT00768755|469801483|FG002|Phase 2|Withdrawal by Subject|0|||
130500467|NCT00768755|469801484|FG003|Phase 2|Withdrawal by Subject|1|||
130500468|NCT00768755|469801481|FG000|Phase 2|Other|0|||
130500469|NCT00768755|469801482|FG001|Phase 2|Other|1|||
130500470|NCT00768755|469801483|FG002|Phase 2|Other|2|||
130500471|NCT00768755|469801484|FG003|Phase 2|Other|4|||
130500472|NCT00768755|469801481|FG000|Phase 2|Study Terminated by Sponsor|0|||
130500473|NCT00768755|469801482|FG001|Phase 2|Study Terminated by Sponsor|13|||
130500474|NCT00768755|469801483|FG002|Phase 2|Study Terminated by Sponsor|7|||
130500475|NCT00768755|469801484|FG003|Phase 2|Study Terminated by Sponsor|14|||
130500476|NCT00768755|469801481|FG000|Phase 2|Randomized but not treated|0|||
130500477|NCT00768755|469801482|FG001|Phase 2|Randomized but not treated|0|||
130500478|NCT00768755|469801483|FG002|Phase 2|Randomized but not treated|0|||
130500479|NCT00768755|469801484|FG003|Phase 2|Randomized but not treated|2|||
130500480|NCT00310037|469801485|FG000|Overall Study|Adverse Event|7|||
130500481|NCT00310037|469801486|FG001|Overall Study|Adverse Event|14|||
130500482|NCT00310037|469801485|FG000|Overall Study|Withdrawal by Subject|4|||
130500483|NCT00310037|469801486|FG001|Overall Study|Withdrawal by Subject|3|||
130500484|NCT00310037|469801485|FG000|Overall Study|Progression|6|||
130500485|NCT00310037|469801486|FG001|Overall Study|Progression|0|||
130500486|NCT00310037|469801485|FG000|Overall Study|Non-protocol treatment|1|||
130500487|NCT00310037|469801486|FG001|Overall Study|Non-protocol treatment|0|||
130500488|NCT03052517|469801487|FG000|Overall Study|Study Terminated By Sponsor|928|||
130500489|NCT03052517|469801488|FG001|Overall Study|Study Terminated By Sponsor|938|||
130500490|NCT03052517|469801489|FG002|Overall Study|Study Terminated By Sponsor|296|||
130500491|NCT03052517|469801487|FG000|Overall Study|Subject/Guardian Decision|50|||
130729742|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
130500492|NCT03052517|469801488|FG001|Overall Study|Subject/Guardian Decision|45|||
130500493|NCT03052517|469801489|FG002|Overall Study|Subject/Guardian Decision|22|||
130500494|NCT03052517|469801487|FG000|Overall Study|Lack of Efficacy|23|||
130500495|NCT03052517|469801488|FG001|Overall Study|Lack of Efficacy|14|||
130500496|NCT03052517|469801489|FG002|Overall Study|Lack of Efficacy|7|||
130500497|NCT03052517|469801487|FG000|Overall Study|Adverse Event|6|||
130500498|NCT03052517|469801488|FG001|Overall Study|Adverse Event|5|||
130500499|NCT03052517|469801489|FG002|Overall Study|Adverse Event|0|||
130500500|NCT03052517|469801487|FG000|Overall Study|Physician Decision|4|||
130500501|NCT03052517|469801488|FG001|Overall Study|Physician Decision|5|||
130500502|NCT03052517|469801489|FG002|Overall Study|Physician Decision|1|||
130500503|NCT03052517|469801487|FG000|Overall Study|Death|3|||
130500504|NCT03052517|469801488|FG001|Overall Study|Death|0|||
130500505|NCT03052517|469801489|FG002|Overall Study|Death|1|||
130500506|NCT03052517|469801487|FG000|Overall Study|Lost to Follow-up|2|||
130500507|NCT03052517|469801488|FG001|Overall Study|Lost to Follow-up|4|||
130500508|NCT03052517|469801489|FG002|Overall Study|Lost to Follow-up|0|||
130500509|NCT03052517|469801487|FG000|Overall Study|Pregnancy|1|||
130500510|NCT03052517|469801488|FG001|Overall Study|Pregnancy|0|||
130500511|NCT03052517|469801489|FG002|Overall Study|Pregnancy|1|||
130500512|NCT03052517|469801487|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
130500513|NCT03052517|469801488|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
130500514|NCT03052517|469801489|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
130500515|NCT03052517|469801487|FG000|Overall Study|Technical Problems|0|||
130500516|NCT03052517|469801488|FG001|Overall Study|Technical Problems|1|||
130500517|NCT03052517|469801489|FG002|Overall Study|Technical Problems|0|||
130500518|NCT03298087|469801492|FG000|Overall Study|Withdrawal by Subject|4|||
130500519|NCT01530334|469801498|FG000|Overall Study|Adverse Event|3|||
130500520|NCT01530334|469801498|FG000|Overall Study|unknown reason|1|||
130500521|NCT01530334|469801498|FG000|Overall Study|Progressive disease|47|||
130500522|NCT03781375|469801499|FG000|Double-blind Phase|Adverse Event|0|||
130500523|NCT03781375|469801500|FG001|Double-blind Phase|Adverse Event|1|||
130500524|NCT03781375|469801499|FG000|Double-blind Phase|Lack of Response|6|||
130500525|NCT03781375|469801500|FG001|Double-blind Phase|Lack of Response|2|||
130500526|NCT03781375|469801499|FG000|Double-blind Phase|Other|1|||
130500527|NCT03781375|469801500|FG001|Double-blind Phase|Other|3|||
130500528|NCT03781375|469801499|FG000|Open-label Phase|Protocol Issues|0|||
130500529|NCT03781375|469801500|FG001|Open-label Phase|Protocol Issues|1|||
130500530|NCT03781375|469801499|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
130500531|NCT03781375|469801500|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
130500532|NCT03781375|469801499|FG000|Open-label Phase|Other|2|||
130729743|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130500533|NCT03781375|469801500|FG001|Open-label Phase|Other|2|||
130729744|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729745|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729746|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729747|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729748|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130729749|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130729750|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
130729751|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
130729752|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
130729753|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729754|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729755|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729756|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130500534|NCT01485887|469801501|FG000|Overall Study|Withdrawal by Subject|2|||
130500535|NCT01485887|469801501|FG000|Overall Study|Adverse Event|8|||
130500536|NCT01485887|469801501|FG000|Overall Study|Deterioration of primary disease|1|||
130500537|NCT01485887|469801501|FG000|Overall Study|Primary disease markedly improved|1|||
130729757|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729758|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729759|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
130500538|NCT03184987|469801505|FG000|Overall Study|Withdrawal by Subject|0|||
130500539|NCT03184987|469801506|FG001|Overall Study|Withdrawal by Subject|1|||
130500540|NCT03184987|469801507|FG002|Overall Study|Withdrawal by Subject|2|||
130500541|NCT03184987|469801505|FG000|Overall Study|Physician Decision|0|||
130500542|NCT03184987|469801506|FG001|Overall Study|Physician Decision|0|||
130500543|NCT03184987|469801507|FG002|Overall Study|Physician Decision|1|||
130500544|NCT03184987|469801505|FG000|Overall Study|Adverse Event|1|||
130500545|NCT03184987|469801506|FG001|Overall Study|Adverse Event|0|||
130500546|NCT03184987|469801507|FG002|Overall Study|Adverse Event|1|||
130500547|NCT02203799|469801508|FG000|Overall Study|Withdrawal by Subject|3|||
130500548|NCT02106884|469801509|FG000|Overall Study|Change of diagnosis/exclusion|0|||
130500549|NCT02106884|469801510|FG001|Overall Study|Change of diagnosis/exclusion|1|||
130500550|NCT00659373|469801511|FG000|Overall Study|Withdrawal by Subject|3|||
130500551|NCT00659373|469801512|FG001|Overall Study|Withdrawal by Subject|5|||
130729760|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130500552|NCT00659373|469801511|FG000|Overall Study|Assessment Missed|2|||
130500553|NCT00659373|469801512|FG001|Overall Study|Assessment Missed|2|||
130500554|NCT02382640|469801513|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
130500555|NCT02382640|469801514|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
130729761|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
130729762|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
130729763|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729764|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130500556|NCT02382640|469801515|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
130500557|NCT02382640|469801516|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
130500558|NCT01560429|469801519|FG000|Overall Study|Protocol Violation|3|||
130500559|NCT01560429|469801520|FG001|Overall Study|Protocol Violation|6|||
130500560|NCT03162614|469801521|FG000|Overall Study|Lost to Follow-up|2|||
130500561|NCT03162614|469801522|FG001|Overall Study|Lost to Follow-up|1|||
130500562|NCT03162614|469801523|FG002|Overall Study|Lost to Follow-up|1|||
130500563|NCT03162614|469801524|FG003|Overall Study|Lost to Follow-up|1|||
130729765|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130500564|NCT03162614|469801525|FG004|Overall Study|Lost to Follow-up|2|||
130500565|NCT03162614|469801526|FG005|Overall Study|Lost to Follow-up|0|||
130500566|NCT03162614|469801521|FG000|Overall Study|Protocol Violation|0|||
130500567|NCT03162614|469801522|FG001|Overall Study|Protocol Violation|1|||
130500568|NCT03162614|469801523|FG002|Overall Study|Protocol Violation|0|||
130500569|NCT03162614|469801524|FG003|Overall Study|Protocol Violation|1|||
130729766|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729767|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729768|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729769|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729770|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
130729771|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
130500570|NCT03162614|469801525|FG004|Overall Study|Protocol Violation|0|||
130500571|NCT03162614|469801526|FG005|Overall Study|Protocol Violation|0|||
130500572|NCT03162614|469801521|FG000|Overall Study|Withdrawal by Subject|2|||
130500573|NCT03162614|469801522|FG001|Overall Study|Withdrawal by Subject|1|||
130500574|NCT03162614|469801523|FG002|Overall Study|Withdrawal by Subject|1|||
130500575|NCT03162614|469801524|FG003|Overall Study|Withdrawal by Subject|1|||
130500576|NCT03162614|469801525|FG004|Overall Study|Withdrawal by Subject|0|||
130500577|NCT03162614|469801526|FG005|Overall Study|Withdrawal by Subject|0|||
130500578|NCT03162614|469801521|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
130500579|NCT03162614|469801522|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
130500580|NCT03162614|469801523|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
130500581|NCT03162614|469801524|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
130500582|NCT03162614|469801525|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
130500583|NCT03162614|469801526|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
130500584|NCT00391170|469801535|FG000|Overall Study|Withdrawal by Subject|1|||
130500585|NCT00391170|469801536|FG001|Overall Study|Withdrawal by Subject|0|||
130500586|NCT00391170|469801535|FG000|Overall Study|Adverse Event|3|||
130500587|NCT00391170|469801536|FG001|Overall Study|Adverse Event|2|||
130500588|NCT00391170|469801535|FG000|Overall Study|Physician Decision|2|||
130500589|NCT00391170|469801536|FG001|Overall Study|Physician Decision|2|||
130500590|NCT05270460|469801541|FG000|Overall Study|Adverse Event|0|||
130500591|NCT05270460|469801542|FG001|Overall Study|Adverse Event|1|||
130500592|NCT05270460|469801543|FG002|Overall Study|Adverse Event|0|||
130500593|NCT05270460|469801541|FG000|Overall Study|Early Termination|0|||
130500594|NCT05270460|469801542|FG001|Overall Study|Early Termination|1|||
130500595|NCT05270460|469801543|FG002|Overall Study|Early Termination|0|||
130500596|NCT00380250|469801544|FG000|Overall Study|Withdrawal by Subject|39|||
130500597|NCT00380250|469801545|FG001|Overall Study|Withdrawal by Subject|28|||
130500598|NCT00380250|469801544|FG000|Overall Study|Adverse Event|20|||
130500599|NCT00380250|469801545|FG001|Overall Study|Adverse Event|9|||
130500600|NCT00380250|469801544|FG000|Overall Study|Lack of Efficacy|10|||
130500601|NCT00380250|469801545|FG001|Overall Study|Lack of Efficacy|8|||
130500602|NCT00380250|469801544|FG000|Overall Study|Protocol Violation|15|||
130500603|NCT00380250|469801545|FG001|Overall Study|Protocol Violation|5|||
130500604|NCT00380250|469801544|FG000|Overall Study|Lost to Follow-up|14|||
130500605|NCT00380250|469801545|FG001|Overall Study|Lost to Follow-up|5|||
130500606|NCT00380250|469801544|FG000|Overall Study|Physician Decision|1|||
130500607|NCT00380250|469801545|FG001|Overall Study|Physician Decision|0|||
130500608|NCT04029090|469801546|FG000|Overall Study|Protocol Violation|1|||
130500609|NCT04029090|469801547|FG001|Overall Study|Protocol Violation|0|||
130500610|NCT04029090|469801548|FG002|Overall Study|Protocol Violation|0|||
130500611|NCT04029090|469801546|FG000|Overall Study|Withdrawal by Subject|0|||
130500612|NCT04029090|469801547|FG001|Overall Study|Withdrawal by Subject|1|||
130500613|NCT04029090|469801548|FG002|Overall Study|Withdrawal by Subject|0|||
130500614|NCT02157948|469801549|FG000|Overall Study|Withdrawal by Subject|4|||
130500615|NCT02157948|469801550|FG001|Overall Study|Withdrawal by Subject|5|||
130500616|NCT02157948|469801549|FG000|Overall Study|Lost to Follow-up|3|||
130500617|NCT02157948|469801550|FG001|Overall Study|Lost to Follow-up|2|||
130500618|NCT02157948|469801549|FG000|Overall Study|Protocol Specified Criteria|2|||
130500619|NCT02157948|469801550|FG001|Overall Study|Protocol Specified Criteria|1|||
130500620|NCT02157948|469801549|FG000|Overall Study|Decision by Sponsor|0|||
130500621|NCT02157948|469801550|FG001|Overall Study|Decision by Sponsor|1|||
130500622|NCT01604824|469801551|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
130500623|NCT01604824|469801552|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
130500624|NCT01604824|469801553|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
130500625|NCT01604824|469801554|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
130500626|NCT01604824|469801555|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
130500627|NCT01604824|469801556|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
130500628|NCT01604824|469801551|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
130500629|NCT01604824|469801552|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
130500630|NCT01604824|469801553|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
130729772|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130500631|NCT01604824|469801554|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
130500632|NCT01604824|469801555|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
130500633|NCT01604824|469801556|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
130500634|NCT00243867|469801561|FG000|Overall Study|Adverse Event|24|||
130500635|NCT00243867|469801562|FG001|Overall Study|Adverse Event|34|||
130500636|NCT00243867|469801561|FG000|Overall Study|Lack of Efficacy|115|||
130500637|NCT00243867|469801562|FG001|Overall Study|Lack of Efficacy|78|||
130500638|NCT00243867|469801561|FG000|Overall Study|Withdrawal by Subject|11|||
130500639|NCT00243867|469801562|FG001|Overall Study|Withdrawal by Subject|23|||
130500640|NCT00243867|469801561|FG000|Overall Study|Lost to Follow-up|2|||
130500641|NCT00243867|469801562|FG001|Overall Study|Lost to Follow-up|1|||
130500642|NCT00243867|469801561|FG000|Overall Study|Physician Decision|2|||
130500643|NCT00243867|469801562|FG001|Overall Study|Physician Decision|7|||
130500644|NCT00243867|469801561|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
130500645|NCT00243867|469801562|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
130500646|NCT01638000|469801569|FG000|Overall Study|Randomized but Never Received Drug|7|||
130500647|NCT01638000|469801570|FG001|Overall Study|Randomized but Never Received Drug|10|||
130500648|NCT01638000|469801569|FG000|Overall Study|Adverse Event|14|||
130500649|NCT01638000|469801570|FG001|Overall Study|Adverse Event|16|||
130500650|NCT01638000|469801569|FG000|Overall Study|Lack of Efficacy|5|||
130500651|NCT01638000|469801570|FG001|Overall Study|Lack of Efficacy|6|||
130500652|NCT01638000|469801569|FG000|Overall Study|Protocol Violation|11|||
130500653|NCT01638000|469801570|FG001|Overall Study|Protocol Violation|13|||
130500654|NCT01638000|469801569|FG000|Overall Study|Withdrawal by Subject|21|||
130500655|NCT01638000|469801570|FG001|Overall Study|Withdrawal by Subject|24|||
130500656|NCT01638000|469801569|FG000|Overall Study|Miscellaneous|2|||
130500657|NCT01638000|469801570|FG001|Overall Study|Miscellaneous|2|||
130500658|NCT02499328|469801573|FG000|Overall Study|Withdrawal by Subject|1|||
130500659|NCT02499328|469801574|FG001|Overall Study|Withdrawal by Subject|1|||
130500660|NCT02499328|469801575|FG002|Overall Study|Withdrawal by Subject|5|||
130500661|NCT02499328|469801576|FG003|Overall Study|Withdrawal by Subject|3|||
130500662|NCT02499328|469801577|FG004|Overall Study|Withdrawal by Subject|5|||
130500663|NCT02499328|469801578|FG005|Overall Study|Withdrawal by Subject|0|||
130500664|NCT02499328|469801579|FG006|Overall Study|Withdrawal by Subject|0|||
130500665|NCT02499328|469801580|FG007|Overall Study|Withdrawal by Subject|0|||
130500666|NCT02499328|469801581|FG008|Overall Study|Withdrawal by Subject|2|||
130500667|NCT02499328|469801582|FG009|Overall Study|Withdrawal by Subject|2|||
130500668|NCT02499328|469801583|FG010|Overall Study|Withdrawal by Subject|0|||
130500669|NCT02499328|469801584|FG011|Overall Study|Withdrawal by Subject|3|||
130500670|NCT02499328|469801585|FG012|Overall Study|Withdrawal by Subject|7|||
130500671|NCT02499328|469801586|FG013|Overall Study|Withdrawal by Subject|3|||
130500672|NCT02499328|469801587|FG014|Overall Study|Withdrawal by Subject|1|||
130500673|NCT02499328|469801588|FG015|Overall Study|Withdrawal by Subject|0|||
130500674|NCT02499328|469801589|FG016|Overall Study|Withdrawal by Subject|0|||
130500675|NCT02499328|469801590|FG017|Overall Study|Withdrawal by Subject|3|||
130500676|NCT02499328|469801591|FG018|Overall Study|Withdrawal by Subject|0|||
130500677|NCT02499328|469801573|FG000|Overall Study|Lost to Follow-up|0|||
130500678|NCT02499328|469801574|FG001|Overall Study|Lost to Follow-up|1|||
130500679|NCT02499328|469801575|FG002|Overall Study|Lost to Follow-up|1|||
130500680|NCT02499328|469801576|FG003|Overall Study|Lost to Follow-up|2|||
130500681|NCT02499328|469801577|FG004|Overall Study|Lost to Follow-up|0|||
130500682|NCT02499328|469801578|FG005|Overall Study|Lost to Follow-up|0|||
130500683|NCT02499328|469801579|FG006|Overall Study|Lost to Follow-up|0|||
130500684|NCT02499328|469801580|FG007|Overall Study|Lost to Follow-up|2|||
130500685|NCT02499328|469801581|FG008|Overall Study|Lost to Follow-up|3|||
130500686|NCT02499328|469801582|FG009|Overall Study|Lost to Follow-up|0|||
130500687|NCT02499328|469801583|FG010|Overall Study|Lost to Follow-up|0|||
130500688|NCT02499328|469801584|FG011|Overall Study|Lost to Follow-up|0|||
130500689|NCT02499328|469801585|FG012|Overall Study|Lost to Follow-up|0|||
130500690|NCT02499328|469801586|FG013|Overall Study|Lost to Follow-up|0|||
130500691|NCT02499328|469801587|FG014|Overall Study|Lost to Follow-up|0|||
130500692|NCT02499328|469801588|FG015|Overall Study|Lost to Follow-up|0|||
130500693|NCT02499328|469801589|FG016|Overall Study|Lost to Follow-up|0|||
130500694|NCT02499328|469801590|FG017|Overall Study|Lost to Follow-up|0|||
130500695|NCT02499328|469801591|FG018|Overall Study|Lost to Follow-up|1|||
130500696|NCT02499328|469801573|FG000|Overall Study|Death|0|||
130500697|NCT02499328|469801574|FG001|Overall Study|Death|3|||
130500698|NCT02499328|469801575|FG002|Overall Study|Death|3|||
130500699|NCT02499328|469801576|FG003|Overall Study|Death|2|||
130500700|NCT02499328|469801577|FG004|Overall Study|Death|4|||
130500701|NCT02499328|469801578|FG005|Overall Study|Death|7|||
130500702|NCT02499328|469801579|FG006|Overall Study|Death|3|||
130500703|NCT02499328|469801580|FG007|Overall Study|Death|0|||
130500704|NCT02499328|469801581|FG008|Overall Study|Death|2|||
130500705|NCT02499328|469801582|FG009|Overall Study|Death|6|||
130500706|NCT02499328|469801583|FG010|Overall Study|Death|6|||
130500707|NCT02499328|469801584|FG011|Overall Study|Death|20|||
130729773|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
130729774|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
130729775|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
130500708|NCT02499328|469801585|FG012|Overall Study|Death|9|||
130500709|NCT02499328|469801586|FG013|Overall Study|Death|7|||
130500710|NCT02499328|469801587|FG014|Overall Study|Death|3|||
130500711|NCT02499328|469801588|FG015|Overall Study|Death|1|||
130500712|NCT02499328|469801589|FG016|Overall Study|Death|1|||
130500713|NCT02499328|469801590|FG017|Overall Study|Death|16|||
130500714|NCT02499328|469801591|FG018|Overall Study|Death|5|||
130500715|NCT02499328|469801573|FG000|Overall Study|"Other"|2|||
130500716|NCT02499328|469801574|FG001|Overall Study|"Other"|2|||
130500717|NCT02499328|469801575|FG002|Overall Study|"Other"|1|||
130500718|NCT02499328|469801576|FG003|Overall Study|"Other"|3|||
130500719|NCT02499328|469801577|FG004|Overall Study|"Other"|6|||
130500720|NCT02499328|469801578|FG005|Overall Study|"Other"|2|||
130500721|NCT02499328|469801579|FG006|Overall Study|"Other"|3|||
130500722|NCT02499328|469801580|FG007|Overall Study|"Other"|4|||
130500723|NCT02499328|469801581|FG008|Overall Study|"Other"|6|||
130500724|NCT02499328|469801582|FG009|Overall Study|"Other"|16|||
130500725|NCT02499328|469801583|FG010|Overall Study|"Other"|13|||
130500726|NCT02499328|469801584|FG011|Overall Study|"Other"|31|||
130500727|NCT02499328|469801585|FG012|Overall Study|"Other"|8|||
130500728|NCT02499328|469801586|FG013|Overall Study|"Other"|7|||
130500729|NCT02499328|469801587|FG014|Overall Study|"Other"|6|||
130500730|NCT02499328|469801588|FG015|Overall Study|"Other"|0|||
130500731|NCT02499328|469801589|FG016|Overall Study|"Other"|0|||
130500732|NCT02499328|469801590|FG017|Overall Study|"Other"|34|||
130500733|NCT02499328|469801591|FG018|Overall Study|"Other"|43|||
130500734|NCT02499328|469801573|FG000|Overall Study|Disease Progression|0|||
130500735|NCT02499328|469801574|FG001|Overall Study|Disease Progression|0|||
130500736|NCT02499328|469801575|FG002|Overall Study|Disease Progression|0|||
130500737|NCT02499328|469801576|FG003|Overall Study|Disease Progression|0|||
130500738|NCT02499328|469801577|FG004|Overall Study|Disease Progression|0|||
130500739|NCT02499328|469801578|FG005|Overall Study|Disease Progression|0|||
130500740|NCT02499328|469801579|FG006|Overall Study|Disease Progression|1|||
130500741|NCT02499328|469801580|FG007|Overall Study|Disease Progression|0|||
130500742|NCT02499328|469801581|FG008|Overall Study|Disease Progression|1|||
130500743|NCT02499328|469801582|FG009|Overall Study|Disease Progression|0|||
130500744|NCT02499328|469801583|FG010|Overall Study|Disease Progression|1|||
130500745|NCT02499328|469801584|FG011|Overall Study|Disease Progression|0|||
130500746|NCT02499328|469801585|FG012|Overall Study|Disease Progression|0|||
130500747|NCT02499328|469801586|FG013|Overall Study|Disease Progression|0|||
130500748|NCT02499328|469801587|FG014|Overall Study|Disease Progression|0|||
130500749|NCT02499328|469801588|FG015|Overall Study|Disease Progression|0|||
130500750|NCT02499328|469801589|FG016|Overall Study|Disease Progression|0|||
130500751|NCT02499328|469801590|FG017|Overall Study|Disease Progression|2|||
130500752|NCT02499328|469801591|FG018|Overall Study|Disease Progression|0|||
130500753|NCT02499328|469801573|FG000|Overall Study|Adverse Event|1|||
130500754|NCT02499328|469801574|FG001|Overall Study|Adverse Event|0|||
130500755|NCT02499328|469801575|FG002|Overall Study|Adverse Event|0|||
130500756|NCT02499328|469801576|FG003|Overall Study|Adverse Event|1|||
130500757|NCT02499328|469801577|FG004|Overall Study|Adverse Event|0|||
130500758|NCT02499328|469801578|FG005|Overall Study|Adverse Event|0|||
130500759|NCT02499328|469801579|FG006|Overall Study|Adverse Event|0|||
130500760|NCT02499328|469801580|FG007|Overall Study|Adverse Event|0|||
130500761|NCT02499328|469801581|FG008|Overall Study|Adverse Event|0|||
130500762|NCT02499328|469801582|FG009|Overall Study|Adverse Event|0|||
130500763|NCT02499328|469801583|FG010|Overall Study|Adverse Event|0|||
130500764|NCT02499328|469801584|FG011|Overall Study|Adverse Event|0|||
130500765|NCT02499328|469801585|FG012|Overall Study|Adverse Event|1|||
130500766|NCT02499328|469801586|FG013|Overall Study|Adverse Event|0|||
130500767|NCT02499328|469801587|FG014|Overall Study|Adverse Event|0|||
130500768|NCT02499328|469801588|FG015|Overall Study|Adverse Event|0|||
130500769|NCT02499328|469801589|FG016|Overall Study|Adverse Event|0|||
130500770|NCT02499328|469801590|FG017|Overall Study|Adverse Event|0|||
130500771|NCT02499328|469801591|FG018|Overall Study|Adverse Event|0|||
130500772|NCT04602728|469801592|FG000|Overall Study|Lost to Follow-up|4|||
130500773|NCT04602728|469801593|FG001|Overall Study|Lost to Follow-up|4|||
130500774|NCT04447027|469801596|FG000|Dose Escalation|Withdrawal by Subject|1|||
130500775|NCT04447027|469801597|FG001|Dose Escalation|Withdrawal by Subject|4|||
130500776|NCT04447027|469801598|FG002|Dose Escalation|Withdrawal by Subject|3|||
130500777|NCT04447027|469801599|FG003|Dose Escalation|Withdrawal by Subject|3|||
130500778|NCT04447027|469801600|FG004|Dose Escalation|Withdrawal by Subject|1|||
130500779|NCT04447027|469801601|FG005|Dose Escalation|Withdrawal by Subject|0|||
130500780|NCT04447027|469801602|FG006|Dose Escalation|Withdrawal by Subject|0|||
130500781|NCT04447027|469801603|FG007|Dose Escalation|Withdrawal by Subject|0|||
130500782|NCT04447027|469801604|FG008|Dose Escalation|Withdrawal by Subject|0|||
130500783|NCT04447027|469801596|FG000|Dose Escalation|Refused further treatment|0|||
130500784|NCT04447027|469801597|FG001|Dose Escalation|Refused further treatment|1|||
130500785|NCT04447027|469801598|FG002|Dose Escalation|Refused further treatment|1|||
130729776|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
130500786|NCT04447027|469801599|FG003|Dose Escalation|Refused further treatment|0|||
130500787|NCT04447027|469801600|FG004|Dose Escalation|Refused further treatment|0|||
130500788|NCT04447027|469801601|FG005|Dose Escalation|Refused further treatment|0|||
130500789|NCT04447027|469801602|FG006|Dose Escalation|Refused further treatment|0|||
130500790|NCT04447027|469801603|FG007|Dose Escalation|Refused further treatment|0|||
130500791|NCT04447027|469801604|FG008|Dose Escalation|Refused further treatment|0|||
130500792|NCT04447027|469801596|FG000|Dose Expansion|Withdrawal by Subject|0|||
130500793|NCT04447027|469801597|FG001|Dose Expansion|Withdrawal by Subject|0|||
130500794|NCT04447027|469801598|FG002|Dose Expansion|Withdrawal by Subject|0|||
130500795|NCT04447027|469801599|FG003|Dose Expansion|Withdrawal by Subject|0|||
130500796|NCT04447027|469801600|FG004|Dose Expansion|Withdrawal by Subject|0|||
130500797|NCT04447027|469801601|FG005|Dose Expansion|Withdrawal by Subject|2|||
130500798|NCT04447027|469801602|FG006|Dose Expansion|Withdrawal by Subject|0|||
130500799|NCT04447027|469801603|FG007|Dose Expansion|Withdrawal by Subject|2|||
130500800|NCT04447027|469801604|FG008|Dose Expansion|Withdrawal by Subject|0|||
130500801|NCT02831049|469801605|FG000|Overall Study|Lost to Follow-up|0|||
130500802|NCT02831049|469801606|FG001|Overall Study|Lost to Follow-up|0|||
130500803|NCT02831049|469801607|FG002|Overall Study|Lost to Follow-up|1|||
130500804|NCT02831049|469801605|FG000|Overall Study|Withdrawal by Subject|0|||
130500805|NCT02831049|469801606|FG001|Overall Study|Withdrawal by Subject|1|||
130500806|NCT02831049|469801607|FG002|Overall Study|Withdrawal by Subject|1|||
130500807|NCT02831049|469801605|FG000|Overall Study|Pandemic shutdown|1|||
130500808|NCT02831049|469801606|FG001|Overall Study|Pandemic shutdown|0|||
130500809|NCT02831049|469801607|FG002|Overall Study|Pandemic shutdown|0|||
130500810|NCT04118894|469801608|FG000|Overall Study|Lost to Follow-up|21|||
130500811|NCT04118894|469801608|FG000|Overall Study|Withdrawal by Subject|10|||
130500812|NCT04118894|469801608|FG000|Overall Study|Adverse Event|4|||
130500813|NCT02713594|469802765|FG000|Overall Study|Withdrawal by Subject|32|||
130500814|NCT02713594|469802766|FG001|Overall Study|Withdrawal by Subject|22|||
130500815|NCT02713594|469802765|FG000|Overall Study|Lost to Follow-up|358|||
130500816|NCT02713594|469802766|FG001|Overall Study|Lost to Follow-up|374|||
130500817|NCT01214200|469802769|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
130500818|NCT01214200|469802769|FG000|Overall Study|Withdrawal by Subject|2|||
130500819|NCT01823224|469802770|FG000|Overall Study|Lost to Follow-up|5|||
130500820|NCT01823224|469802771|FG001|Overall Study|Lost to Follow-up|6|||
130500821|NCT01823224|469802770|FG000|Overall Study|didn't qualify|1|||
130500822|NCT01823224|469802771|FG001|Overall Study|didn't qualify|2|||
130500823|NCT01823224|469802770|FG000|Overall Study|pharmacy error|0|||
130500824|NCT01823224|469802771|FG001|Overall Study|pharmacy error|1|||
130500825|NCT01823224|469802770|FG000|Overall Study|missed med dose|0|||
130500826|NCT01823224|469802771|FG001|Overall Study|missed med dose|1|||
130500827|NCT01823224|469802770|FG000|Overall Study|Withdrawal by Subject|0|||
130500828|NCT01823224|469802771|FG001|Overall Study|Withdrawal by Subject|1|||
130500829|NCT03292406|469802774|FG000|Overall Study|Progressive Disease|6|||
130500830|NCT03292406|469802775|FG001|Overall Study|Progressive Disease|3|||
130500831|NCT03292406|469802776|FG002|Overall Study|Progressive Disease|4|||
130500832|NCT03292406|469802774|FG000|Overall Study|Adverse Event|7|||
130500833|NCT03292406|469802775|FG001|Overall Study|Adverse Event|1|||
130500834|NCT03292406|469802776|FG002|Overall Study|Adverse Event|4|||
130500835|NCT03292406|469802774|FG000|Overall Study|Withdrawal by Subject|0|||
130500836|NCT03292406|469802775|FG001|Overall Study|Withdrawal by Subject|7|||
130500837|NCT03292406|469802776|FG002|Overall Study|Withdrawal by Subject|2|||
130500838|NCT03292406|469802774|FG000|Overall Study|Protocol Violation|0|||
130500839|NCT03292406|469802775|FG001|Overall Study|Protocol Violation|1|||
130500840|NCT03292406|469802776|FG002|Overall Study|Protocol Violation|1|||
130500841|NCT03292406|469802774|FG000|Overall Study|Other|0|||
130500842|NCT03292406|469802775|FG001|Overall Study|Other|1|||
130500843|NCT03292406|469802776|FG002|Overall Study|Other|2|||
130500844|NCT03737110|469802777|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
130500845|NCT03737110|469802778|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
130500846|NCT03737110|469802779|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
130500847|NCT03737110|469802780|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
130500848|NCT03737110|469802781|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
130500849|NCT03737110|469802782|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
130500850|NCT03737110|469802777|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
130500851|NCT03737110|469802778|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
130500852|NCT03737110|469802779|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
130500853|NCT03737110|469802780|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
130500854|NCT03737110|469802781|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
130500855|NCT03737110|469802782|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
130500856|NCT03737110|469802777|FG000|Run-in (RI) Period|Adverse Event|4|||
130500857|NCT03737110|469802778|FG001|Run-in (RI) Period|Adverse Event|0|||
130500858|NCT03737110|469802779|FG002|Run-in (RI) Period|Adverse Event|0|||
130500859|NCT03737110|469802780|FG003|Run-in (RI) Period|Adverse Event|0|||
130500860|NCT03737110|469802781|FG004|Run-in (RI) Period|Adverse Event|0|||
130500861|NCT03737110|469802782|FG005|Run-in (RI) Period|Adverse Event|0|||
130500862|NCT03737110|469802777|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
130500863|NCT03737110|469802778|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
130500864|NCT03737110|469802779|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
130500865|NCT03737110|469802780|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
130500866|NCT03737110|469802781|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
130500867|NCT03737110|469802782|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
130500868|NCT03737110|469802777|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130500869|NCT03737110|469802778|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130500870|NCT03737110|469802779|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
130500871|NCT03737110|469802780|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130500872|NCT03737110|469802781|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130500873|NCT03737110|469802782|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130500874|NCT03737110|469802777|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130500875|NCT03737110|469802778|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130500876|NCT03737110|469802779|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130500877|NCT03737110|469802780|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
130500878|NCT03737110|469802781|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130500879|NCT03737110|469802782|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130500880|NCT03737110|469802777|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
130500881|NCT03737110|469802778|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
130500882|NCT03737110|469802779|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
130500883|NCT03737110|469802780|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
130500884|NCT03737110|469802781|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
130500885|NCT03737110|469802782|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
130500886|NCT03737110|469802777|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
130500887|NCT03737110|469802778|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
130500888|NCT03737110|469802779|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
130500889|NCT03737110|469802780|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
130500890|NCT03737110|469802781|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
130500891|NCT03737110|469802782|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
130500892|NCT00047385|469802789|FG000|Overall Study|Death before any screening|2|||
130500893|NCT00047385|469802790|FG001|Overall Study|Death before any screening|5|||
130500894|NCT00047385|469802789|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
130500895|NCT00047385|469802790|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
130500896|NCT00047385|469802789|FG000|Overall Study|Eligible for screening but had no screen|260|||
130500897|NCT00047385|469802790|FG001|Overall Study|Eligible for screening but had no screen|492|||
130500898|NCT00273052|469802795|FG000|Overall Study|Withdrawal by Subject|16|||
130500899|NCT00273052|469802796|FG001|Overall Study|Withdrawal by Subject|19|||
130500900|NCT00273052|469802795|FG000|Overall Study|Adverse Event|21|||
130500901|NCT00273052|469802796|FG001|Overall Study|Adverse Event|19|||
130500902|NCT00273052|469802795|FG000|Overall Study|Protocol Violation|14|||
130500903|NCT00273052|469802796|FG001|Overall Study|Protocol Violation|18|||
130500904|NCT00273052|469802795|FG000|Overall Study|Lost to Follow-up|7|||
130500905|NCT00273052|469802796|FG001|Overall Study|Lost to Follow-up|25|||
130500906|NCT00273052|469802795|FG000|Overall Study|Lack of Efficacy|6|||
130500907|NCT00273052|469802796|FG001|Overall Study|Lack of Efficacy|4|||
130500908|NCT00273052|469802795|FG000|Overall Study|Non-Compliance|3|||
130500909|NCT00273052|469802796|FG001|Overall Study|Non-Compliance|1|||
130500910|NCT00273052|469802795|FG000|Overall Study|Other|2|||
130500911|NCT00273052|469802796|FG001|Overall Study|Other|0|||
130500912|NCT00273052|469802795|FG000|Overall Study|Worsening serum lipid levels|0|||
130500913|NCT00273052|469802796|FG001|Overall Study|Worsening serum lipid levels|2|||
130500914|NCT01951703|469802799|FG000|First Intervention|Withdrawal by Subject|1|||
130500915|NCT01951703|469802800|FG001|First Intervention|Withdrawal by Subject|0|||
130500916|NCT01951703|469802799|FG000|First Intervention|Subject was not compliant|1|||
130500917|NCT01951703|469802800|FG001|First Intervention|Subject was not compliant|1|||
130500918|NCT01951703|469802799|FG000|First Intervention|Physician Decision|1|||
130500919|NCT01951703|469802800|FG001|First Intervention|Physician Decision|0|||
130500920|NCT01951703|469802799|FG000|Second Intervention|Protocol Violation|0|||
130500921|NCT01951703|469802800|FG001|Second Intervention|Protocol Violation|1|||
130500922|NCT01951703|469802799|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
130500923|NCT01951703|469802800|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
130500924|NCT02708498|469802801|FG000|Overall Study|Death|20|||
130500925|NCT02708498|469802802|FG001|Overall Study|Death|19|||
130500926|NCT02708498|469802803|FG002|Overall Study|Death|0|||
130500927|NCT02708498|469802804|FG003|Overall Study|Death|0|||
130500928|NCT02708498|469802805|FG004|Overall Study|Death|1|||
130500929|NCT02708498|469802806|FG005|Overall Study|Death|0|||
130500930|NCT02708498|469802807|FG006|Overall Study|Death|0|||
130500931|NCT02708498|469802808|FG007|Overall Study|Death|0|||
130500932|NCT02708498|469802801|FG000|Overall Study|Unknown reason, missing data|0|||
130500933|NCT02708498|469802802|FG001|Overall Study|Unknown reason, missing data|0|||
130500934|NCT02708498|469802803|FG002|Overall Study|Unknown reason, missing data|62|||
130500935|NCT02708498|469802804|FG003|Overall Study|Unknown reason, missing data|51|||
130500936|NCT02708498|469802805|FG004|Overall Study|Unknown reason, missing data|195|||
130500937|NCT02708498|469802806|FG005|Overall Study|Unknown reason, missing data|132|||
130500938|NCT02708498|469802807|FG006|Overall Study|Unknown reason, missing data|0|||
130500939|NCT02708498|469802808|FG007|Overall Study|Unknown reason, missing data|0|||
130500940|NCT04803734|469802811|FG000|Overall Study|Withdrawal by Subject|0|||
130500941|NCT04803734|469802812|FG001|Overall Study|Withdrawal by Subject|1|||
130500942|NCT04803734|469802811|FG000|Overall Study|Protocol Violation|0|||
130500943|NCT04803734|469802812|FG001|Overall Study|Protocol Violation|1|||
130500944|NCT01640288|469802813|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
130500945|NCT01640288|469802814|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
130500946|NCT01640288|469802813|FG000|Overall Study|Screen Failure|20|||
130500947|NCT01640288|469802814|FG001|Overall Study|Screen Failure|18|||
130500948|NCT01640288|469802813|FG000|Overall Study|Withdrawn by PI|5|||
130500949|NCT01640288|469802814|FG001|Overall Study|Withdrawn by PI|0|||
130500950|NCT01640288|469802813|FG000|Overall Study|Withdrawal by Subject|1|||
130500951|NCT01640288|469802814|FG001|Overall Study|Withdrawal by Subject|0|||
130500952|NCT00195819|469802817|FG000|Double-Blind|Withdrawal by Subject|1|||
130500953|NCT00195819|469802818|FG001|Double-Blind|Withdrawal by Subject|0|||
130500954|NCT00195819|469802817|FG000|Double-Blind|Moved|1|||
130500955|NCT00195819|469802818|FG001|Double-Blind|Moved|0|||
130500956|NCT00195819|469802817|FG000|Open-label|Adverse Event|0|||
130500957|NCT00195819|469802818|FG001|Open-label|Adverse Event|9|||
130500958|NCT00195819|469802817|FG000|Open-label|Lack of Efficacy|0|||
130500959|NCT00195819|469802818|FG001|Open-label|Lack of Efficacy|2|||
130500960|NCT00195819|469802817|FG000|Open-label|Pregnancy|0|||
130500961|NCT00195819|469802818|FG001|Open-label|Pregnancy|1|||
130500962|NCT00195819|469802817|FG000|Open-label|Protocol Violation|0|||
130500963|NCT00195819|469802818|FG001|Open-label|Protocol Violation|2|||
130500964|NCT00195819|469802817|FG000|Open-label|Moved|0|||
130500965|NCT00195819|469802818|FG001|Open-label|Moved|1|||
130500966|NCT00195819|469802817|FG000|Open-label|Withdrawal by Subject|0|||
130500967|NCT00195819|469802818|FG001|Open-label|Withdrawal by Subject|5|||
130500968|NCT01629589|469802819|FG000|Overall Study|Protocol Violation|4|||
130500969|NCT01629589|469802820|FG001|Overall Study|Protocol Violation|2|||
130500970|NCT01629589|469802819|FG000|Overall Study|Lost to Follow-up|2|||
130500971|NCT01629589|469802820|FG001|Overall Study|Lost to Follow-up|1|||
130500972|NCT01629589|469802819|FG000|Overall Study|Withdrawal by Subject|2|||
130500973|NCT01629589|469802820|FG001|Overall Study|Withdrawal by Subject|3|||
130500974|NCT01629589|469802819|FG000|Overall Study|Did not receive study vaccine|0|||
130500975|NCT01629589|469802820|FG001|Overall Study|Did not receive study vaccine|1|||
130500976|NCT01303510|469802821|FG000|Overall Study|Lost to Follow-up|1|||
130500977|NCT01303510|469802822|FG001|Overall Study|Lost to Follow-up|0|||
130500978|NCT00822900|469802823|FG000|Overall Study|Withdrawal by Subject|14|||
130500979|NCT00822900|469802824|FG001|Overall Study|Withdrawal by Subject|14|||
130500980|NCT00822900|469802823|FG000|Overall Study|Lost to Follow-up|9|||
130500981|NCT00822900|469802824|FG001|Overall Study|Lost to Follow-up|9|||
130500982|NCT00822900|469802823|FG000|Overall Study|Death|83|||
130500983|NCT00822900|469802824|FG001|Overall Study|Death|69|||
130500984|NCT00822900|469802823|FG000|Overall Study|Became a ward of the state|2|||
130500985|NCT00822900|469802824|FG001|Overall Study|Became a ward of the state|1|||
130500986|NCT00681109|469802825|FG000|Overall Study|Lost to Follow-up|2|||
130500987|NCT00681109|469802826|FG001|Overall Study|Lost to Follow-up|6|||
130500988|NCT00681109|469802827|FG002|Overall Study|Lost to Follow-up|0|||
130729777|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
130729778|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
130729779|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
130500989|NCT04660799|469802828|FG000|Overall Study|Progressive Disease|1|||
130500990|NCT04660799|469802829|FG001|Overall Study|Progressive Disease|1|||
130500991|NCT04660799|469802828|FG000|Overall Study|Death|2|||
130500992|NCT04660799|469802829|FG001|Overall Study|Death|1|||
130500993|NCT04660799|469802828|FG000|Overall Study|Adverse Event|2|||
130500994|NCT04660799|469802829|FG001|Overall Study|Adverse Event|1|||
130500995|NCT04660799|469802828|FG000|Overall Study|Withdrawal by Subject|2|||
130500996|NCT04660799|469802829|FG001|Overall Study|Withdrawal by Subject|5|||
130500997|NCT02161458|469802830|FG000|Overall Study|Withdrawal by Subject|0|||
130500998|NCT02161458|469802831|FG001|Overall Study|Withdrawal by Subject|4|||
130500999|NCT02161458|469802832|FG002|Overall Study|Withdrawal by Subject|4|||
130501000|NCT02161458|469802833|FG003|Overall Study|Withdrawal by Subject|0|||
130501001|NCT02161458|469802830|FG000|Overall Study|Lost to Follow-up|0|||
130501002|NCT02161458|469802831|FG001|Overall Study|Lost to Follow-up|2|||
130501003|NCT02161458|469802832|FG002|Overall Study|Lost to Follow-up|1|||
130501004|NCT02161458|469802833|FG003|Overall Study|Lost to Follow-up|0|||
130501005|NCT00705159|469802839|FG000|Overall Study|Withdrawal by Subject|0|||
130501006|NCT00705159|469802840|FG001|Overall Study|Withdrawal by Subject|1|||
130501007|NCT00705159|469802841|FG002|Overall Study|Withdrawal by Subject|1|||
130501008|NCT00705159|469802842|FG003|Overall Study|Withdrawal by Subject|1|||
130501009|NCT00705159|469802839|FG000|Overall Study|Protocol Violation|0|||
130501010|NCT00705159|469802840|FG001|Overall Study|Protocol Violation|1|||
130501011|NCT00705159|469802841|FG002|Overall Study|Protocol Violation|0|||
130501012|NCT00705159|469802842|FG003|Overall Study|Protocol Violation|0|||
130501013|NCT00705159|469802839|FG000|Overall Study|Adverse Event|0|||
130501014|NCT00705159|469802840|FG001|Overall Study|Adverse Event|0|||
130501015|NCT00705159|469802841|FG002|Overall Study|Adverse Event|1|||
130501016|NCT00705159|469802842|FG003|Overall Study|Adverse Event|0|||
130501017|NCT00705159|469802839|FG000|Overall Study|Lost to Follow-up|0|||
130501018|NCT00705159|469802840|FG001|Overall Study|Lost to Follow-up|0|||
130501019|NCT00705159|469802841|FG002|Overall Study|Lost to Follow-up|3|||
130501020|NCT00705159|469802842|FG003|Overall Study|Lost to Follow-up|2|||
130501021|NCT00705159|469802839|FG000|Overall Study|Screen Failure|0|||
130501022|NCT00705159|469802840|FG001|Overall Study|Screen Failure|0|||
130501023|NCT00705159|469802841|FG002|Overall Study|Screen Failure|0|||
130501024|NCT00705159|469802842|FG003|Overall Study|Screen Failure|1|||
130501025|NCT03026166|469802843|FG000|Overall Study|Death|22|||
130501026|NCT03026166|469802844|FG001|Overall Study|Death|7|||
130501027|NCT03026166|469802843|FG000|Overall Study|Physician Decision|2|||
130501028|NCT03026166|469802844|FG001|Overall Study|Physician Decision|0|||
130501029|NCT03026166|469802843|FG000|Overall Study|Withdrawal by Subject|1|||
130501030|NCT03026166|469802844|FG001|Overall Study|Withdrawal by Subject|2|||
130501031|NCT03026166|469802843|FG000|Overall Study|Lost to Follow-up|1|||
130501032|NCT03026166|469802844|FG001|Overall Study|Lost to Follow-up|0|||
130501033|NCT03026166|469802843|FG000|Overall Study|Study Terminated by Sponsor|3|||
130501034|NCT03026166|469802844|FG001|Overall Study|Study Terminated by Sponsor|3|||
130501035|NCT03026166|469802843|FG000|Overall Study|Other|1|||
130501036|NCT03026166|469802844|FG001|Overall Study|Other|0|||
130501037|NCT03035942|469802847|FG000|Overall Study|Adverse Event|8|||
130501038|NCT03035942|469802848|FG001|Overall Study|Adverse Event|4|||
130501039|NCT03035942|469802849|FG002|Overall Study|Adverse Event|5|||
130501040|NCT02091752|469802850|FG000|Overall Study|Study terminated by Sponsor|2|||
130501041|NCT02091752|469802850|FG000|Overall Study|Adverse Event|1|||
130501042|NCT01989104|469802851|FG000|Overall Study|Withdrawal by Subject|3|||
130501043|NCT01989104|469802852|FG001|Overall Study|Withdrawal by Subject|0|||
130501044|NCT01989104|469802853|FG002|Overall Study|Withdrawal by Subject|0|||
130501045|NCT01989104|469802854|FG003|Overall Study|Withdrawal by Subject|0|||
130501046|NCT01989104|469802855|FG004|Overall Study|Withdrawal by Subject|0|||
130501047|NCT02833948|469802858|FG000|Overall Study|Death|2|||
130501048|NCT02833948|469802859|FG001|Overall Study|Death|3|||
130501049|NCT02833948|469802858|FG000|Overall Study|were not scanned|8|||
130501050|NCT02833948|469802859|FG001|Overall Study|were not scanned|13|||
130501051|NCT02833948|469802858|FG000|Overall Study|scans could not be evaluated|5|||
130501052|NCT02833948|469802859|FG001|Overall Study|scans could not be evaluated|2|||
130501053|NCT04821271|469802863|FG000|Period 1|Withdrawal by Subject|2|||
130501054|NCT04821271|469802864|FG001|Period 1|Withdrawal by Subject|0|||
130501055|NCT04076059|469802865|FG000|Double Blind Phase|Progressive disease|22|||
130501056|NCT04076059|469802866|FG001|Double Blind Phase|Progressive disease|26|||
130501057|NCT04076059|469802867|FG002|Double Blind Phase|Progressive disease|0|||
130501058|NCT04076059|469802865|FG000|Double Blind Phase|Withdrawal by Subject|4|||
130501059|NCT04076059|469802866|FG001|Double Blind Phase|Withdrawal by Subject|11|||
130501060|NCT04076059|469802867|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130501061|NCT04076059|469802865|FG000|Double Blind Phase|Death|1|||
130501062|NCT04076059|469802866|FG001|Double Blind Phase|Death|1|||
130501063|NCT04076059|469802867|FG002|Double Blind Phase|Death|0|||
130501064|NCT04076059|469802865|FG000|Double Blind Phase|Lost to Follow-up|1|||
130501065|NCT04076059|469802866|FG001|Double Blind Phase|Lost to Follow-up|0|||
130501066|NCT04076059|469802867|FG002|Double Blind Phase|Lost to Follow-up|0|||
130729780|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
130729781|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
130729782|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
130501067|NCT04076059|469802865|FG000|Double Blind Phase|Adverse Event|5|||
130501068|NCT04076059|469802866|FG001|Double Blind Phase|Adverse Event|1|||
130501069|NCT04076059|469802867|FG002|Double Blind Phase|Adverse Event|0|||
130501070|NCT04076059|469802865|FG000|Double Blind Phase|Ongoing Participants|82|||
130501071|NCT04076059|469802866|FG001|Double Blind Phase|Ongoing Participants|18|||
130501072|NCT04076059|469802867|FG002|Double Blind Phase|Ongoing Participants|0|||
130501073|NCT04076059|469802865|FG000|Double Blind Phase|Miscellaneous|3|||
130501074|NCT04076059|469802866|FG001|Double Blind Phase|Miscellaneous|1|||
130501075|NCT04076059|469802867|FG002|Double Blind Phase|Miscellaneous|0|||
130501076|NCT04076059|469802865|FG000|Double Blind Phase|Protocol Deviation|1|||
130501077|NCT04076059|469802866|FG001|Double Blind Phase|Protocol Deviation|1|||
130501078|NCT04076059|469802867|FG002|Double Blind Phase|Protocol Deviation|0|||
130501079|NCT04076059|469802865|FG000|Double Blind Phase|Did not take study drug|1|||
130501080|NCT04076059|469802866|FG001|Double Blind Phase|Did not take study drug|1|||
130501081|NCT04076059|469802867|FG002|Double Blind Phase|Did not take study drug|0|||
130501082|NCT04076059|469802865|FG000|Open Label Phase|Progressive disease|0|||
130501083|NCT04076059|469802866|FG001|Open Label Phase|Progressive disease|0|||
130501084|NCT04076059|469802867|FG002|Open Label Phase|Progressive disease|7|||
130501085|NCT04076059|469802865|FG000|Open Label Phase|Withdrawal by Subject|0|||
130501086|NCT04076059|469802866|FG001|Open Label Phase|Withdrawal by Subject|0|||
130501087|NCT04076059|469802867|FG002|Open Label Phase|Withdrawal by Subject|3|||
130501088|NCT04076059|469802865|FG000|Open Label Phase|Death|0|||
130501089|NCT04076059|469802866|FG001|Open Label Phase|Death|0|||
130501090|NCT04076059|469802867|FG002|Open Label Phase|Death|2|||
130501091|NCT04076059|469802865|FG000|Open Label Phase|Ongoing Participants|0|||
130501092|NCT04076059|469802866|FG001|Open Label Phase|Ongoing Participants|0|||
130501093|NCT04076059|469802867|FG002|Open Label Phase|Ongoing Participants|11|||
130501094|NCT06269003|469802872|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
130501095|NCT06269003|469802873|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
130501096|NCT06269003|469802874|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
130501097|NCT06269003|469802875|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
130501098|NCT04535414|469802879|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
130501099|NCT04535414|469802880|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
130501100|NCT04535414|469802879|FG000|Overall Study|Cancelled appointment|1|||
130501101|NCT04535414|469802880|FG001|Overall Study|Cancelled appointment|0|||
130501102|NCT04535414|469802879|FG000|Overall Study|cancelled - food in stomach|2|||
130501103|NCT04535414|469802880|FG001|Overall Study|cancelled - food in stomach|0|||
130501104|NCT04535414|469802879|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
130501105|NCT04535414|469802880|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
130501106|NCT04535414|469802879|FG000|Overall Study|Withdrawal by Subject|0|||
130501107|NCT04535414|469802880|FG001|Overall Study|Withdrawal by Subject|1|||
130501108|NCT00949117|469803987|FG000|Overall Study|Lack of Efficacy|2|||
130501109|NCT00949117|469803988|FG001|Overall Study|Lack of Efficacy|3|||
130501110|NCT00949117|469803987|FG000|Overall Study|Protocol Violation|1|||
130501111|NCT00949117|469803988|FG001|Overall Study|Protocol Violation|1|||
130501112|NCT00949117|469803987|FG000|Overall Study|Adverse Event|0|||
130501113|NCT00949117|469803988|FG001|Overall Study|Adverse Event|1|||
130501114|NCT00799409|469803989|FG000|Overall Study|Withdrawal by Subject|1|||
130501115|NCT00799409|469803990|FG001|Overall Study|Withdrawal by Subject|0|||
130501116|NCT00799409|469803991|FG002|Overall Study|Withdrawal by Subject|0|||
130501117|NCT00799409|469803989|FG000|Overall Study|Lost to Follow-up|1|||
130501118|NCT00799409|469803990|FG001|Overall Study|Lost to Follow-up|0|||
130501119|NCT00799409|469803991|FG002|Overall Study|Lost to Follow-up|0|||
130501120|NCT00799409|469803989|FG000|Overall Study|Optimal Dose Not Achieved|2|||
130501121|NCT00799409|469803990|FG001|Overall Study|Optimal Dose Not Achieved|0|||
130501122|NCT00799409|469803991|FG002|Overall Study|Optimal Dose Not Achieved|0|||
130501123|NCT00799409|469803989|FG000|Overall Study|Failure to follow study protocol)|1|||
130501124|NCT00799409|469803990|FG001|Overall Study|Failure to follow study protocol)|0|||
130501125|NCT00799409|469803991|FG002|Overall Study|Failure to follow study protocol)|0|||
130501126|NCT00799409|469803989|FG000|Overall Study|Did not attend lab school day 1|1|||
130729783|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Other|0|||
130501127|NCT00799409|469803990|FG001|Overall Study|Did not attend lab school day 1|0|||
130501128|NCT00799409|469803991|FG002|Overall Study|Did not attend lab school day 1|0|||
130501129|NCT00799409|469803989|FG000|Overall Study|medication compliance|1|||
130501130|NCT00799409|469803990|FG001|Overall Study|medication compliance|0|||
130501131|NCT00799409|469803991|FG002|Overall Study|medication compliance|0|||
130501132|NCT03964974|469803992|FG000|Overall Study|Lost to Follow-up|3|||
130501133|NCT03964974|469803993|FG001|Overall Study|Lost to Follow-up|2|||
130729784|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Other|0|||
130729785|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Other|0|||
130729786|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Other|0|||
130729787|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Other|0|||
130729788|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Other|0|||
130729789|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Other|0|||
130729790|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Other|0|||
130729791|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Other|1|||
130729792|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Other|1|||
130729793|NCT04948333|470633611|FG000|Overall Study|Adverse Event|6|||
130729794|NCT04948333|470633612|FG001|Overall Study|Adverse Event|4|||
130729795|NCT04948333|470633613|FG002|Overall Study|Adverse Event|0|||
130729796|NCT04948333|470633614|FG003|Overall Study|Adverse Event|2|||
130729797|NCT04948333|470633611|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130729798|NCT04948333|470633612|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130729799|NCT04948333|470633613|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130729800|NCT04948333|470633614|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130729801|NCT04948333|470633611|FG000|Overall Study|Progressive Disease|1|||
130729802|NCT04948333|470633612|FG001|Overall Study|Progressive Disease|5|||
130729803|NCT04948333|470633613|FG002|Overall Study|Progressive Disease|0|||
130729804|NCT04948333|470633614|FG003|Overall Study|Progressive Disease|0|||
130729805|NCT04948333|470633611|FG000|Overall Study|Physician Decision|2|||
130729806|NCT04948333|470633612|FG001|Overall Study|Physician Decision|2|||
130729807|NCT04948333|470633613|FG002|Overall Study|Physician Decision|0|||
130729808|NCT04948333|470633614|FG003|Overall Study|Physician Decision|0|||
130729809|NCT04948333|470633611|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
130729810|NCT04948333|470633612|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
130729811|NCT04948333|470633613|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
130729812|NCT04948333|470633614|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
130729813|NCT04948333|470633611|FG000|Overall Study|Withdrawal by Subject|2|||
130729814|NCT04948333|470633612|FG001|Overall Study|Withdrawal by Subject|0|||
130729815|NCT04948333|470633613|FG002|Overall Study|Withdrawal by Subject|0|||
130729816|NCT04948333|470633614|FG003|Overall Study|Withdrawal by Subject|1|||
130729817|NCT04948333|470633611|FG000|Overall Study|Protocol Violation|0|||
130729818|NCT04948333|470633612|FG001|Overall Study|Protocol Violation|1|||
130729819|NCT04948333|470633613|FG002|Overall Study|Protocol Violation|0|||
130729820|NCT04948333|470633614|FG003|Overall Study|Protocol Violation|0|||
130729821|NCT04948333|470633611|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
130729822|NCT04948333|470633612|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
130729823|NCT04948333|470633613|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
130729824|NCT04948333|470633614|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
130729825|NCT02129608|470633615|FG000|Overall Study|Lost to Follow-up|0|||
130729826|NCT02129608|470633616|FG001|Overall Study|Lost to Follow-up|1|||
130729827|NCT02129608|470633617|FG002|Overall Study|Lost to Follow-up|1|||
130729828|NCT02129608|470633615|FG000|Overall Study|Withdrawal by Subject|0|||
130729829|NCT02129608|470633616|FG001|Overall Study|Withdrawal by Subject|0|||
130729830|NCT02129608|470633617|FG002|Overall Study|Withdrawal by Subject|2|||
130729831|NCT02437903|470633620|FG000|Overall Study|Adverse Event|1|||
130729832|NCT02437903|470633620|FG000|Overall Study|Withdrawal by Subject|1|||
130729833|NCT02437903|470633620|FG000|Overall Study|Lost to Follow-up|3|||
130729834|NCT00616421|470633621|FG000|Overall Study|Withdrawal by Subject|9|||
130729835|NCT00616421|470633622|FG001|Overall Study|Withdrawal by Subject|11|||
130729836|NCT00616421|470633623|FG002|Overall Study|Withdrawal by Subject|8|||
130729837|NCT00616421|470633621|FG000|Overall Study|Lost to Follow-up|12|||
130729838|NCT00616421|470633622|FG001|Overall Study|Lost to Follow-up|26|||
130501134|NCT03964974|469803992|FG000|Overall Study|Withdrawal by Subject|0|||
130729839|NCT00616421|470633623|FG002|Overall Study|Lost to Follow-up|30|||
130501135|NCT03964974|469803993|FG001|Overall Study|Withdrawal by Subject|3|||
130501136|NCT01567852|469803994|FG000|Overall Study|Withdrawal by Subject|3|||
130729840|NCT00616421|470633621|FG000|Overall Study|Inappropriate enrollment|3|||
130729841|NCT00616421|470633622|FG001|Overall Study|Inappropriate enrollment|0|||
130729842|NCT00616421|470633623|FG002|Overall Study|Inappropriate enrollment|1|||
130729843|NCT00616421|470633621|FG000|Overall Study|Administrative reason|1|||
130729844|NCT00616421|470633622|FG001|Overall Study|Administrative reason|0|||
130729845|NCT00616421|470633623|FG002|Overall Study|Administrative reason|0|||
130729846|NCT00616421|470633621|FG000|Overall Study|Protocol Violation|0|||
130729847|NCT00616421|470633622|FG001|Overall Study|Protocol Violation|1|||
130729848|NCT00616421|470633623|FG002|Overall Study|Protocol Violation|2|||
130729849|NCT00616421|470633621|FG000|Overall Study|Unable to classify|1|||
130501137|NCT01567852|469803995|FG001|Overall Study|Withdrawal by Subject|6|||
130501138|NCT01567852|469803994|FG000|Overall Study|ECT discontinued|1|||
130501139|NCT01567852|469803995|FG001|Overall Study|ECT discontinued|1|||
130501140|NCT00670449|469803996|FG000|Overall Study|Adverse Event|6|||
130501141|NCT00670449|469803997|FG001|Overall Study|Adverse Event|2|||
130501142|NCT00670449|469803998|FG002|Overall Study|Adverse Event|8|||
130501143|NCT00670449|469803999|FG003|Overall Study|Adverse Event|5|||
130501144|NCT00670449|469803996|FG000|Overall Study|Protocol Deviation|1|||
130501145|NCT00670449|469803997|FG001|Overall Study|Protocol Deviation|2|||
130501146|NCT00670449|469803998|FG002|Overall Study|Protocol Deviation|0|||
130501147|NCT00670449|469803999|FG003|Overall Study|Protocol Deviation|1|||
130501148|NCT00670449|469803996|FG000|Overall Study|Administrative Problems|0|||
130501149|NCT00670449|469803997|FG001|Overall Study|Administrative Problems|2|||
130501150|NCT00670449|469803998|FG002|Overall Study|Administrative Problems|0|||
130501151|NCT00670449|469803999|FG003|Overall Study|Administrative Problems|1|||
130501152|NCT00670449|469803996|FG000|Overall Study|Subject Withdrew Consent|0|||
130501153|NCT00670449|469803997|FG001|Overall Study|Subject Withdrew Consent|2|||
130501154|NCT00670449|469803998|FG002|Overall Study|Subject Withdrew Consent|0|||
130501155|NCT00670449|469803999|FG003|Overall Study|Subject Withdrew Consent|1|||
130501156|NCT00670449|469803996|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
130501157|NCT00670449|469803997|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130501158|NCT00670449|469803998|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130501159|NCT00670449|469803999|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130501160|NCT00670449|469803996|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
130501161|NCT00670449|469803997|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
130501162|NCT00670449|469803998|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130501163|NCT00670449|469803999|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
130501164|NCT04809623|469804000|FG000|Overall Study|Study Terminated by Sponsor|1|||
130501165|NCT04809623|469804001|FG001|Overall Study|Study Terminated by Sponsor|0|||
130501166|NCT02660086|469804002|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
130501167|NCT02660086|469804003|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
130501168|NCT02660086|469804002|FG000|Overall Study- 12-month|Left full-time employment|12|||
130501169|NCT02660086|469804003|FG001|Overall Study- 12-month|Left full-time employment|20|||
130501170|NCT02660086|469804002|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
130501171|NCT02660086|469804003|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
130501172|NCT02660086|469804002|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
130501173|NCT02660086|469804003|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
130501174|NCT02660086|469804002|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
130501175|NCT02660086|469804003|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
130501176|NCT02660086|469804002|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
130501177|NCT02660086|469804003|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
130501178|NCT00667017|469804007|FG000|Overall Study|Withdrawal by Subject|1|||
130501179|NCT02605174|469804011|FG000|Overall Study|Adverse Event|0|||
130501180|NCT02605174|469804012|FG001|Overall Study|Adverse Event|0|||
130501181|NCT02605174|469804013|FG002|Overall Study|Adverse Event|1|||
130501182|NCT02605174|469804014|FG003|Overall Study|Adverse Event|0|||
130501183|NCT02605174|469804015|FG004|Overall Study|Adverse Event|4|||
130501184|NCT02605174|469804016|FG005|Overall Study|Adverse Event|0|||
130501185|NCT02605174|469804017|FG006|Overall Study|Adverse Event|0|||
130501186|NCT02605174|469804011|FG000|Overall Study|Lost to Follow-up|20|||
130501187|NCT02605174|469804012|FG001|Overall Study|Lost to Follow-up|7|||
130501188|NCT02605174|469804013|FG002|Overall Study|Lost to Follow-up|27|||
130501189|NCT02605174|469804014|FG003|Overall Study|Lost to Follow-up|10|||
130501190|NCT02605174|469804015|FG004|Overall Study|Lost to Follow-up|20|||
130501191|NCT02605174|469804016|FG005|Overall Study|Lost to Follow-up|10|||
130501192|NCT02605174|469804017|FG006|Overall Study|Lost to Follow-up|29|||
130501193|NCT02605174|469804011|FG000|Overall Study|Protocol Violation|10|||
130501194|NCT02605174|469804012|FG001|Overall Study|Protocol Violation|4|||
130501195|NCT02605174|469804013|FG002|Overall Study|Protocol Violation|14|||
130501196|NCT02605174|469804014|FG003|Overall Study|Protocol Violation|6|||
130501197|NCT02605174|469804015|FG004|Overall Study|Protocol Violation|7|||
130501198|NCT02605174|469804016|FG005|Overall Study|Protocol Violation|7|||
130501199|NCT02605174|469804017|FG006|Overall Study|Protocol Violation|12|||
130501200|NCT02605174|469804011|FG000|Overall Study|Pregnancy|1|||
130501201|NCT02605174|469804012|FG001|Overall Study|Pregnancy|0|||
130501202|NCT02605174|469804013|FG002|Overall Study|Pregnancy|0|||
130501203|NCT02605174|469804014|FG003|Overall Study|Pregnancy|2|||
130501204|NCT02605174|469804015|FG004|Overall Study|Pregnancy|0|||
130501205|NCT02605174|469804016|FG005|Overall Study|Pregnancy|0|||
130501206|NCT02605174|469804017|FG006|Overall Study|Pregnancy|0|||
130501207|NCT02605174|469804011|FG000|Overall Study|Withdrawal by Subject|9|||
130501208|NCT02605174|469804012|FG001|Overall Study|Withdrawal by Subject|6|||
130501209|NCT02605174|469804013|FG002|Overall Study|Withdrawal by Subject|14|||
130501210|NCT02605174|469804014|FG003|Overall Study|Withdrawal by Subject|11|||
130501211|NCT02605174|469804015|FG004|Overall Study|Withdrawal by Subject|6|||
130501212|NCT02605174|469804016|FG005|Overall Study|Withdrawal by Subject|4|||
130501213|NCT02605174|469804017|FG006|Overall Study|Withdrawal by Subject|15|||
130501214|NCT02605174|469804011|FG000|Overall Study|Physician Decision|2|||
130501215|NCT02605174|469804012|FG001|Overall Study|Physician Decision|0|||
130501216|NCT02605174|469804013|FG002|Overall Study|Physician Decision|0|||
130501217|NCT02605174|469804014|FG003|Overall Study|Physician Decision|0|||
130501218|NCT02605174|469804015|FG004|Overall Study|Physician Decision|0|||
130501219|NCT02605174|469804016|FG005|Overall Study|Physician Decision|0|||
130501220|NCT02605174|469804017|FG006|Overall Study|Physician Decision|3|||
130501221|NCT02605174|469804011|FG000|Overall Study|Randomization Failure|22|||
130501222|NCT02605174|469804012|FG001|Overall Study|Randomization Failure|6|||
130501223|NCT02605174|469804013|FG002|Overall Study|Randomization Failure|20|||
130501224|NCT02605174|469804014|FG003|Overall Study|Randomization Failure|7|||
130501225|NCT02605174|469804015|FG004|Overall Study|Randomization Failure|16|||
130501226|NCT02605174|469804016|FG005|Overall Study|Randomization Failure|11|||
130501227|NCT02605174|469804017|FG006|Overall Study|Randomization Failure|30|||
130501228|NCT03041090|469804018|FG000|Overall Study|technical error|0|||
130501229|NCT03041090|469804019|FG001|Overall Study|technical error|3|||
130501230|NCT01779050|469804020|FG000|Overall Study|Withdrawal by Subject|1|||
130501231|NCT01779050|469804021|FG001|Overall Study|Withdrawal by Subject|0|||
130501232|NCT02202317|469804022|FG000|Overall Study|Lost to Follow-up|1|||
130501233|NCT01353274|469804023|FG000|Overall Study|No case report form (CRF) collected|28|||
130501234|NCT01409837|469804024|FG000|Overall Study|Withdrawal by Subject|2|||
130501235|NCT01409837|469804025|FG001|Overall Study|Withdrawal by Subject|1|||
130501236|NCT01409837|469804024|FG000|Overall Study|Lost to Follow-up|1|||
130501237|NCT01409837|469804025|FG001|Overall Study|Lost to Follow-up|0|||
130501238|NCT01409837|469804024|FG000|Overall Study|Physician Decision|0|||
130501239|NCT01409837|469804025|FG001|Overall Study|Physician Decision|1|||
130501240|NCT03960645|469804026|FG000|Overall Study|Protocol Violation|1|||
130501241|NCT03960645|469804027|FG001|Overall Study|Protocol Violation|0|||
130501242|NCT00022672|469804029|FG000|Main Phase: 24 Months|Adverse Event|6|||
130501243|NCT00022672|469804030|FG001|Main Phase: 24 Months|Adverse Event|0|||
130501244|NCT00022672|469804029|FG000|Main Phase: 24 Months|Death|0|||
130501245|NCT00022672|469804030|FG001|Main Phase: 24 Months|Death|3|||
130501246|NCT00022672|469804029|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
130501247|NCT00022672|469804030|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
130501248|NCT00022672|469804029|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
130501249|NCT00022672|469804030|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
130501250|NCT00022672|469804029|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
130501251|NCT00022672|469804030|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
130501252|NCT00022672|469804029|FG000|Main Phase: 24 Months|Refused Treatment|3|||
130501253|NCT00022672|469804030|FG001|Main Phase: 24 Months|Refused Treatment|4|||
130501254|NCT00022672|469804029|FG000|Main Phase: 24 Months|Failure to Return|1|||
130501255|NCT00022672|469804030|FG001|Main Phase: 24 Months|Failure to Return|1|||
130501256|NCT00022672|469804029|FG000|Main Phase: 24 Months|Other|1|||
130501257|NCT00022672|469804030|FG001|Main Phase: 24 Months|Other|0|||
130501258|NCT00022672|469804029|FG000|Extension Phase|Adverse Event|1|||
130501259|NCT00022672|469804030|FG001|Extension Phase|Adverse Event|3|||
130501260|NCT00022672|469804029|FG000|Extension Phase|Death|0|||
130501261|NCT00022672|469804030|FG001|Extension Phase|Death|1|||
130501262|NCT00022672|469804029|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
130501263|NCT00022672|469804030|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
130501264|NCT00022672|469804029|FG000|Extension Phase|Refused Treatment|0|||
130501265|NCT00022672|469804030|FG001|Extension Phase|Refused Treatment|2|||
130501266|NCT00022672|469804029|FG000|Extension Phase|Other|1|||
130501267|NCT00022672|469804030|FG001|Extension Phase|Other|1|||
130501268|NCT00403494|469804031|FG000|Overall Study|Adverse Event|10|||
130501269|NCT00403494|469804032|FG001|Overall Study|Adverse Event|8|||
130501270|NCT00403494|469804031|FG000|Overall Study|Withdrew Consent|3|||
130501271|NCT00403494|469804032|FG001|Overall Study|Withdrew Consent|2|||
130501272|NCT00403494|469804031|FG000|Overall Study|Inappropriately enrolled|0|||
130501273|NCT00403494|469804032|FG001|Overall Study|Inappropriately enrolled|1|||
130501274|NCT00403494|469804031|FG000|Overall Study|Lost to Follow-up|0|||
130501275|NCT00403494|469804032|FG001|Overall Study|Lost to Follow-up|2|||
130501276|NCT00403494|469804031|FG000|Overall Study|Protocol noncompliance|0|||
130501277|NCT00403494|469804032|FG001|Overall Study|Protocol noncompliance|1|||
130501278|NCT00403494|469804031|FG000|Overall Study|Death|1|||
130501279|NCT00403494|469804032|FG001|Overall Study|Death|0|||
130501280|NCT00403494|469804031|FG000|Overall Study|Sponsor Request|1|||
130501281|NCT00403494|469804032|FG001|Overall Study|Sponsor Request|0|||
130729850|NCT00616421|470633622|FG001|Overall Study|Unable to classify|0|||
130729851|NCT00616421|470633623|FG002|Overall Study|Unable to classify|0|||
130501282|NCT03490032|469804033|FG000|Overall Study|family issue (child custody)|1|||
130501283|NCT03490032|469804034|FG001|Overall Study|family issue (child custody)|0|||
130501284|NCT03490032|469804035|FG002|Overall Study|family issue (child custody)|0|||
130501285|NCT02224755|469804036|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
130501286|NCT02224755|469804037|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
130729852|NCT02661217|470633624|FG000|Overall Study|Physician Decision|12|||
130501287|NCT02224755|469804036|FG000|Two Year Follow up Post-implant|Death|103|||
130501288|NCT02224755|469804037|FG001|Two Year Follow up Post-implant|Death|98|||
130501289|NCT02224755|469804036|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
130501290|NCT02224755|469804037|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
130501291|NCT02224755|469804036|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
130501292|NCT02224755|469804037|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
130501293|NCT02224755|469804036|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
130501294|NCT02224755|469804037|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
130501295|NCT01852045|469804038|FG000|Overall Study|Adverse Event|1|||
130501296|NCT01852045|469804039|FG001|Overall Study|Adverse Event|0|||
130501297|NCT01852045|469804040|FG002|Overall Study|Adverse Event|0|||
130501298|NCT01852045|469804038|FG000|Overall Study|Lack of Efficacy|3|||
130501299|NCT01852045|469804039|FG001|Overall Study|Lack of Efficacy|0|||
130501300|NCT01852045|469804040|FG002|Overall Study|Lack of Efficacy|0|||
130501301|NCT01852045|469804038|FG000|Overall Study|Lost to Follow-up|0|||
130501302|NCT01852045|469804039|FG001|Overall Study|Lost to Follow-up|1|||
130501303|NCT01852045|469804040|FG002|Overall Study|Lost to Follow-up|1|||
130501304|NCT01852045|469804038|FG000|Overall Study|Withdrawal by Subject|1|||
130501305|NCT01852045|469804039|FG001|Overall Study|Withdrawal by Subject|0|||
130501306|NCT01852045|469804040|FG002|Overall Study|Withdrawal by Subject|1|||
130501307|NCT01852045|469804038|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130501308|NCT01852045|469804039|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130501309|NCT01852045|469804040|FG002|Overall Study|Other Miscellaneous Reasons|2|||
130501310|NCT02736188|469804041|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
130501311|NCT02736188|469804041|FG000|Overall Study|Adverse Event|1|||
130501312|NCT02736188|469804041|FG000|Overall Study|Withdrawal by Subject|1|||
130501313|NCT02736188|469804041|FG000|Overall Study|Other|6|||
130501314|NCT02007070|469804043|FG000|Overall Study|Adverse Event|4|||
130501315|NCT02007070|469804043|FG000|Overall Study|Clinical Progression|4|||
130501316|NCT02007070|469804043|FG000|Overall Study|Death|1|||
130501317|NCT02007070|469804043|FG000|Overall Study|Protocol Violation|2|||
130501318|NCT02007070|469804043|FG000|Overall Study|Physician Decision|1|||
130501319|NCT02007070|469804043|FG000|Overall Study|Progressive Disease|21|||
130501320|NCT05260437|469804044|FG000|Overall Study|Lost to Follow-up|5|||
130501321|NCT05260437|469804045|FG001|Overall Study|Lost to Follow-up|2|||
130501322|NCT05260437|469804046|FG002|Overall Study|Lost to Follow-up|1|||
130501323|NCT05260437|469804047|FG003|Overall Study|Lost to Follow-up|2|||
130501324|NCT05260437|469804048|FG004|Overall Study|Lost to Follow-up|2|||
130501325|NCT05260437|469804044|FG000|Overall Study|Withdrawal by Subject|3|||
130501326|NCT05260437|469804045|FG001|Overall Study|Withdrawal by Subject|0|||
130501327|NCT05260437|469804046|FG002|Overall Study|Withdrawal by Subject|4|||
130501328|NCT05260437|469804047|FG003|Overall Study|Withdrawal by Subject|5|||
130501329|NCT05260437|469804048|FG004|Overall Study|Withdrawal by Subject|0|||
130501330|NCT05260437|469804044|FG000|Overall Study|Vaccine Not Administered|0|||
130501331|NCT05260437|469804045|FG001|Overall Study|Vaccine Not Administered|1|||
130501332|NCT05260437|469804046|FG002|Overall Study|Vaccine Not Administered|0|||
130501333|NCT05260437|469804047|FG003|Overall Study|Vaccine Not Administered|0|||
130501334|NCT05260437|469804048|FG004|Overall Study|Vaccine Not Administered|0|||
130501335|NCT00910962|469804049|FG000|Overall Study|Adverse Event|5|||
130501336|NCT00910962|469804050|FG001|Overall Study|Adverse Event|20|||
130501337|NCT00910962|469804051|FG002|Overall Study|Adverse Event|17|||
130501338|NCT00910962|469804049|FG000|Overall Study|Protocol Violation|1|||
130501339|NCT00910962|469804050|FG001|Overall Study|Protocol Violation|3|||
130501340|NCT00910962|469804051|FG002|Overall Study|Protocol Violation|3|||
130501341|NCT00910962|469804049|FG000|Overall Study|Lost to Follow-up|0|||
130501342|NCT00910962|469804050|FG001|Overall Study|Lost to Follow-up|3|||
130501343|NCT00910962|469804051|FG002|Overall Study|Lost to Follow-up|1|||
130501344|NCT00910962|469804049|FG000|Overall Study|Physician Decision|0|||
130501345|NCT00910962|469804050|FG001|Overall Study|Physician Decision|6|||
130501346|NCT00910962|469804051|FG002|Overall Study|Physician Decision|6|||
130501347|NCT00910962|469804049|FG000|Overall Study|Withdrawal by Subject|25|||
130501348|NCT00910962|469804050|FG001|Overall Study|Withdrawal by Subject|32|||
130501349|NCT00910962|469804051|FG002|Overall Study|Withdrawal by Subject|32|||
130501350|NCT00910962|469804049|FG000|Overall Study|Reached defined stopping criteria|12|||
130501351|NCT00910962|469804050|FG001|Overall Study|Reached defined stopping criteria|14|||
130501352|NCT00910962|469804051|FG002|Overall Study|Reached defined stopping criteria|17|||
130501353|NCT00787176|469804052|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
130501354|NCT00787176|469804053|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
130501355|NCT00787176|469804054|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
130501356|NCT00787176|469804055|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
130501357|NCT02095678|469804059|FG000|Overall Study|Withdrawal by Subject|0|||
130501358|NCT02095678|469804060|FG001|Overall Study|Withdrawal by Subject|1|||
130565683|NCT01197521|470036979|FG002|Overall Study|Severe non-compliance to protocol|3|||
130729853|NCT02661217|470633625|FG001|Overall Study|Physician Decision|15|||
130729854|NCT02661217|470633624|FG000|Overall Study|Lost to Follow-up|1|||
130729855|NCT02661217|470633625|FG001|Overall Study|Lost to Follow-up|4|||
130729856|NCT02661217|470633624|FG000|Overall Study|Protocol Deviation|0|||
130729857|NCT02661217|470633625|FG001|Overall Study|Protocol Deviation|4|||
130501359|NCT02095678|469804059|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
130501360|NCT02095678|469804060|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
130501361|NCT02095678|469804059|FG000|Overall Study|lesion impacted by previous treatment|1|||
130501362|NCT02095678|469804060|FG001|Overall Study|lesion impacted by previous treatment|1|||
130501363|NCT02095678|469804059|FG000|Overall Study|No Confirmed Diagnosis|0|||
130501364|NCT02095678|469804060|FG001|Overall Study|No Confirmed Diagnosis|3|||
130501365|NCT02095678|469804059|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
130501366|NCT02095678|469804060|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
130501367|NCT02095678|469804059|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
130501368|NCT02095678|469804060|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
130501369|NCT00701415|469804061|FG000|Overall Study|Adverse Event|0|||
130501370|NCT00701415|469804062|FG001|Overall Study|Adverse Event|1|||
130501371|NCT00701415|469804061|FG000|Overall Study|Social/family issues and needle phobia|1|||
130501372|NCT00701415|469804062|FG001|Overall Study|Social/family issues and needle phobia|0|||
130501373|NCT02066636|469804065|FG000|Overall Study|Disease progression|51|||
130501374|NCT02066636|469804066|FG001|Overall Study|Disease progression|60|||
130501375|NCT02066636|469804067|FG002|Overall Study|Disease progression|700|||
130501376|NCT02066636|469804065|FG000|Overall Study|Study drug toxicity|13|||
130501377|NCT02066636|469804066|FG001|Overall Study|Study drug toxicity|2|||
130501378|NCT02066636|469804067|FG002|Overall Study|Study drug toxicity|58|||
130501379|NCT02066636|469804065|FG000|Overall Study|Death|4|||
130501380|NCT02066636|469804066|FG001|Overall Study|Death|2|||
130501381|NCT02066636|469804067|FG002|Overall Study|Death|158|||
130501382|NCT02066636|469804065|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130501383|NCT02066636|469804066|FG001|Overall Study|Adverse event unrelated to study drug|4|||
130501384|NCT02066636|469804067|FG002|Overall Study|Adverse event unrelated to study drug|45|||
130501385|NCT02066636|469804065|FG000|Overall Study|Participant request to discontinue treatment|12|||
130501386|NCT02066636|469804066|FG001|Overall Study|Participant request to discontinue treatment|12|||
130501387|NCT02066636|469804067|FG002|Overall Study|Participant request to discontinue treatment|70|||
130501388|NCT02066636|469804065|FG000|Overall Study|Participant withdrew consent|10|||
130501389|NCT02066636|469804066|FG001|Overall Study|Participant withdrew consent|18|||
130501390|NCT02066636|469804067|FG002|Overall Study|Participant withdrew consent|61|||
130501391|NCT02066636|469804065|FG000|Overall Study|Lost to Follow-up|0|||
130501392|NCT02066636|469804066|FG001|Overall Study|Lost to Follow-up|2|||
130501393|NCT02066636|469804067|FG002|Overall Study|Lost to Follow-up|2|||
130501394|NCT02066636|469804065|FG000|Overall Study|Maximum clinical benefit|2|||
130501395|NCT02066636|469804066|FG001|Overall Study|Maximum clinical benefit|2|||
130501396|NCT02066636|469804067|FG002|Overall Study|Maximum clinical benefit|3|||
130501397|NCT02066636|469804065|FG000|Overall Study|Poor/non-compliance|2|||
130501398|NCT02066636|469804066|FG001|Overall Study|Poor/non-compliance|1|||
130501399|NCT02066636|469804067|FG002|Overall Study|Poor/non-compliance|1|||
130501400|NCT02066636|469804065|FG000|Overall Study|Participant no loner meets study criteria|3|||
130501401|NCT02066636|469804066|FG001|Overall Study|Participant no loner meets study criteria|2|||
130501402|NCT02066636|469804067|FG002|Overall Study|Participant no loner meets study criteria|28|||
130501403|NCT02066636|469804065|FG000|Overall Study|Administrative reasons by sponsor|8|||
130501404|NCT02066636|469804066|FG001|Overall Study|Administrative reasons by sponsor|5|||
130501405|NCT02066636|469804067|FG002|Overall Study|Administrative reasons by sponsor|0|||
130501406|NCT02066636|469804065|FG000|Overall Study|Other reasons|16|||
130501407|NCT02066636|469804066|FG001|Overall Study|Other reasons|15|||
130501408|NCT02066636|469804067|FG002|Overall Study|Other reasons|50|||
130501409|NCT03539055|469804068|FG000|Overall Study|Death|4|||
130501410|NCT03539055|469804068|FG000|Overall Study|Lost to Follow-up|1|||
130501411|NCT03539055|469804068|FG000|Overall Study|Withdrawal by Subject|2|||
130501412|NCT03539055|469804068|FG000|Overall Study|Screen Fail|7|||
130501413|NCT03539055|469804068|FG000|Overall Study|Drug Intolerance|2|||
130501414|NCT02521493|469804069|FG000|Overall Study|Death|3|||
130729858|NCT02661217|470633624|FG000|Overall Study|Non-compliance with study treatment|5|||
130501415|NCT02521493|469804070|FG001|Overall Study|Death|4|||
130501416|NCT02521493|469804071|FG002|Overall Study|Death|1|||
130501417|NCT02521493|469804069|FG000|Overall Study|Physician Decision|19|||
130501418|NCT02521493|469804070|FG001|Overall Study|Physician Decision|1|||
130501419|NCT02521493|469804071|FG002|Overall Study|Physician Decision|2|||
130501420|NCT02521493|469804069|FG000|Overall Study|Withdrawal by Subject|3|||
130501421|NCT02521493|469804070|FG001|Overall Study|Withdrawal by Subject|0|||
130501422|NCT02521493|469804071|FG002|Overall Study|Withdrawal by Subject|0|||
130501423|NCT02521493|469804069|FG000|Overall Study|Ineligible|0|||
130501424|NCT02521493|469804070|FG001|Overall Study|Ineligible|1|||
130729859|NCT02661217|470633625|FG001|Overall Study|Non-compliance with study treatment|5|||
130729860|NCT02661217|470633624|FG000|Overall Study|Death|21|||
130729861|NCT02661217|470633625|FG001|Overall Study|Death|15|||
130501425|NCT02521493|469804071|FG002|Overall Study|Ineligible|0|||
130501426|NCT02521493|469804069|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
130501427|NCT02521493|469804070|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
130501428|NCT02521493|469804071|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
130501429|NCT02521493|469804069|FG000|Overall Study|No MRD result|0|||
130501430|NCT02521493|469804070|FG001|Overall Study|No MRD result|0|||
130501431|NCT02521493|469804071|FG002|Overall Study|No MRD result|4|||
130501432|NCT01218594|469804072|FG000|Overall Study|Death|1|||
130501433|NCT01218594|469804072|FG000|Overall Study|Withdrawal by Subject|3|||
130501434|NCT01218594|469804072|FG000|Overall Study|Adverse Event|2|||
130501435|NCT01218594|469804072|FG000|Overall Study|Physician Decision|6|||
130501436|NCT04748341|469804073|FG000|Overall Study|Lost to Follow-up|1|||
130501437|NCT04748341|469804074|FG001|Overall Study|Lost to Follow-up|1|||
130501438|NCT00452114|469804076|FG000|Overall Study|Physician Decision|3|||
130501439|NCT00452114|469804077|FG001|Overall Study|Physician Decision|3|||
130501440|NCT02334215|469804078|FG000|Overall Study|Death|1|||
130501441|NCT02334215|469804079|FG001|Overall Study|Death|1|||
130501442|NCT02334215|469804080|FG002|Overall Study|Death|0|||
130501443|NCT02334215|469804078|FG000|Overall Study|Lost to Follow-up|1|||
130501444|NCT02334215|469804079|FG001|Overall Study|Lost to Follow-up|0|||
130501445|NCT02334215|469804080|FG002|Overall Study|Lost to Follow-up|4|||
130501446|NCT02334215|469804078|FG000|Overall Study|Withdrawal by Subject|2|||
130501447|NCT02334215|469804079|FG001|Overall Study|Withdrawal by Subject|2|||
130501448|NCT02334215|469804080|FG002|Overall Study|Withdrawal by Subject|1|||
130501449|NCT02334215|469804078|FG000|Overall Study|Not released from incarceration on time|3|||
130501450|NCT02334215|469804079|FG001|Overall Study|Not released from incarceration on time|3|||
130501451|NCT02334215|469804080|FG002|Overall Study|Not released from incarceration on time|3|||
130501452|NCT02334215|469804078|FG000|Overall Study|Incarcerated|0|||
130501453|NCT02334215|469804079|FG001|Overall Study|Incarcerated|0|||
130501454|NCT02334215|469804080|FG002|Overall Study|Incarcerated|7|||
130501455|NCT03905642|469804081|FG000|Overall Study|Withdrawal by Subject|3|||
130501456|NCT03905642|469804081|FG000|Overall Study|Pregnancy|1|||
130501457|NCT03905642|469804081|FG000|Overall Study|Adverse Event|1|||
130501458|NCT03905642|469804081|FG000|Overall Study|Lack of Efficacy|1|||
130501459|NCT03905642|469804081|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
130501460|NCT03769090|469805782|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
130501461|NCT03769090|469805783|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
130501462|NCT03769090|469805784|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
130501463|NCT03769090|469805782|FG000|Overall Study|Withdrawal by Subject|52|||
130501464|NCT03769090|469805783|FG001|Overall Study|Withdrawal by Subject|62|||
130501465|NCT03769090|469805784|FG002|Overall Study|Withdrawal by Subject|74|||
130501466|NCT03769090|469805782|FG000|Overall Study|Death|4|||
130501467|NCT03769090|469805783|FG001|Overall Study|Death|2|||
130501468|NCT03769090|469805784|FG002|Overall Study|Death|2|||
130501469|NCT03769090|469805782|FG000|Overall Study|Adverse Event|7|||
130501470|NCT03769090|469805783|FG001|Overall Study|Adverse Event|7|||
130501471|NCT03769090|469805784|FG002|Overall Study|Adverse Event|8|||
130501472|NCT03769090|469805782|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
130501473|NCT03769090|469805783|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
130501474|NCT03769090|469805784|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
130501475|NCT03769090|469805782|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
130501476|NCT03769090|469805783|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
130501477|NCT03769090|469805784|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
130501478|NCT03769090|469805782|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
130501479|NCT03769090|469805783|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
130501480|NCT03769090|469805784|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
130501481|NCT03769090|469805782|FG000|Overall Study|Protocol Violation|5|||
130501482|NCT03769090|469805783|FG001|Overall Study|Protocol Violation|6|||
130501483|NCT03769090|469805784|FG002|Overall Study|Protocol Violation|8|||
130501484|NCT03769090|469805782|FG000|Overall Study|Pregnancy|1|||
130501485|NCT03769090|469805783|FG001|Overall Study|Pregnancy|0|||
130501486|NCT03769090|469805784|FG002|Overall Study|Pregnancy|3|||
130565684|NCT01197521|470036977|FG000|Overall Study|Lack of therapeutic response|2|||
130501487|NCT03769090|469805782|FG000|Overall Study|Lost to Follow-up|19|||
130501488|NCT03769090|469805783|FG001|Overall Study|Lost to Follow-up|25|||
130501489|NCT03769090|469805784|FG002|Overall Study|Lost to Follow-up|21|||
130501490|NCT03769090|469805782|FG000|Overall Study|Condition under investigation worsened|2|||
130501491|NCT03769090|469805783|FG001|Overall Study|Condition under investigation worsened|0|||
130501492|NCT03769090|469805784|FG002|Overall Study|Condition under investigation worsened|1|||
130501493|NCT03769090|469805782|FG000|Overall Study|Lack of Efficacy|1|||
130501494|NCT03769090|469805783|FG001|Overall Study|Lack of Efficacy|2|||
130501495|NCT03769090|469805784|FG002|Overall Study|Lack of Efficacy|2|||
130501496|NCT03769090|469805782|FG000|Overall Study|Other reasons|8|||
130501497|NCT03769090|469805783|FG001|Overall Study|Other reasons|12|||
130729862|NCT02661217|470633624|FG000|Overall Study|Adverse Event|10|||
130729863|NCT02661217|470633625|FG001|Overall Study|Adverse Event|8|||
130729864|NCT02661217|470633624|FG000|Overall Study|Withdrawal by Subject|15|||
130501498|NCT03769090|469805784|FG002|Overall Study|Other reasons|15|||
130501499|NCT02014402|469805788|FG000|Overall Study|Adverse Event|1|||
130501500|NCT02014402|469805789|FG001|Overall Study|Adverse Event|0|||
130501501|NCT02014402|469805790|FG002|Overall Study|Adverse Event|0|||
130501502|NCT02014402|469805791|FG003|Overall Study|Adverse Event|0|||
130501503|NCT02014402|469805788|FG000|Overall Study|Withdrawal by Subject|1|||
130501504|NCT02014402|469805789|FG001|Overall Study|Withdrawal by Subject|2|||
130501505|NCT02014402|469805790|FG002|Overall Study|Withdrawal by Subject|2|||
130501506|NCT02014402|469805791|FG003|Overall Study|Withdrawal by Subject|1|||
130501507|NCT02014402|469805788|FG000|Overall Study|Subject did not have transportation|0|||
130501508|NCT02014402|469805789|FG001|Overall Study|Subject did not have transportation|1|||
130501509|NCT02014402|469805790|FG002|Overall Study|Subject did not have transportation|0|||
130501510|NCT02014402|469805791|FG003|Overall Study|Subject did not have transportation|0|||
130501511|NCT02014402|469805788|FG000|Overall Study|Lost to Follow-up|0|||
130501512|NCT02014402|469805789|FG001|Overall Study|Lost to Follow-up|0|||
130501513|NCT02014402|469805790|FG002|Overall Study|Lost to Follow-up|1|||
130501514|NCT02014402|469805791|FG003|Overall Study|Lost to Follow-up|2|||
130501515|NCT00443820|469805792|FG000|Overall Study|Adverse Event|1|||
130501516|NCT00443820|469805793|FG001|Overall Study|Adverse Event|1|||
130501517|NCT00443820|469805794|FG002|Overall Study|Adverse Event|0|||
130501518|NCT00443820|469805795|FG003|Overall Study|Adverse Event|0|||
130501519|NCT00443820|469805792|FG000|Overall Study|Lack of Efficacy|3|||
130501520|NCT00443820|469805793|FG001|Overall Study|Lack of Efficacy|2|||
130501521|NCT00443820|469805794|FG002|Overall Study|Lack of Efficacy|1|||
130501522|NCT00443820|469805795|FG003|Overall Study|Lack of Efficacy|1|||
130501523|NCT00443820|469805792|FG000|Overall Study|Protocol Violation|2|||
130501524|NCT00443820|469805793|FG001|Overall Study|Protocol Violation|1|||
130501525|NCT00443820|469805794|FG002|Overall Study|Protocol Violation|2|||
130501526|NCT00443820|469805795|FG003|Overall Study|Protocol Violation|1|||
130501527|NCT00443820|469805792|FG000|Overall Study|Withdrawal by Subject|6|||
130501528|NCT00443820|469805793|FG001|Overall Study|Withdrawal by Subject|7|||
130501529|NCT00443820|469805794|FG002|Overall Study|Withdrawal by Subject|8|||
130501530|NCT00443820|469805795|FG003|Overall Study|Withdrawal by Subject|9|||
130501531|NCT00443820|469805792|FG000|Overall Study|Lost to Follow-up|9|||
130501532|NCT00443820|469805793|FG001|Overall Study|Lost to Follow-up|8|||
130501533|NCT00443820|469805794|FG002|Overall Study|Lost to Follow-up|6|||
130501534|NCT00443820|469805795|FG003|Overall Study|Lost to Follow-up|5|||
130501535|NCT00443820|469805792|FG000|Overall Study|Administrative problems|0|||
130501536|NCT00443820|469805793|FG001|Overall Study|Administrative problems|0|||
130501537|NCT00443820|469805794|FG002|Overall Study|Administrative problems|0|||
130501538|NCT00443820|469805795|FG003|Overall Study|Administrative problems|1|||
130501539|NCT00443820|469805792|FG000|Overall Study|Death|0|||
130501540|NCT00443820|469805793|FG001|Overall Study|Death|0|||
130501541|NCT00443820|469805794|FG002|Overall Study|Death|1|||
130501542|NCT00443820|469805795|FG003|Overall Study|Death|0|||
130501543|NCT04633200|469805796|FG000|Overall Study|Lost to Follow-up|3|||
130501544|NCT04633200|469805797|FG001|Overall Study|Lost to Follow-up|5|||
130501545|NCT03493282|469805798|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
130501546|NCT03493282|469805799|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
130501547|NCT03493282|469805800|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
130501548|NCT03493282|469805798|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
130729865|NCT02661217|470633625|FG001|Overall Study|Withdrawal by Subject|19|||
130729866|NCT02661217|470633624|FG000|Overall Study|Did not enter follow-up epoch|7|||
130501549|NCT03493282|469805799|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
130501550|NCT03493282|469805800|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
130501551|NCT01523392|469805801|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130501552|NCT01523392|469805802|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130501553|NCT01523392|469805801|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
130501554|NCT01523392|469805802|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
130501555|NCT01523392|469805801|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
130501556|NCT01523392|469805802|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
130501557|NCT00671853|469805804|FG000|Overall Study|Lack of Efficacy|3|||
130501558|NCT00671853|469805805|FG001|Overall Study|Lack of Efficacy|7|||
130501559|NCT00671853|469805804|FG000|Overall Study|Adverse Event|7|||
130501560|NCT00671853|469805805|FG001|Overall Study|Adverse Event|1|||
130501561|NCT00671853|469805804|FG000|Overall Study|Withdrawal by Subject|1|||
130729867|NCT02661217|470633625|FG001|Overall Study|Did not enter follow-up epoch|10|||
130729868|NCT02661217|470633624|FG000|Overall Study|Death - no study drug received|1|||
130729869|NCT02661217|470633625|FG001|Overall Study|Death - no study drug received|2|||
130729870|NCT02661217|470633624|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
130729871|NCT02661217|470633625|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
130729872|NCT03593395|470633626|FG000|Overall Study|Lost to Follow-up|48|||
130729873|NCT03593395|470633627|FG001|Overall Study|Lost to Follow-up|3|||
130729874|NCT03593395|470633626|FG000|Overall Study|Withdrawal by Subject|5|||
130729875|NCT03593395|470633627|FG001|Overall Study|Withdrawal by Subject|24|||
130729876|NCT03593395|470633626|FG000|Overall Study|Death|2|||
130729877|NCT03593395|470633627|FG001|Overall Study|Death|3|||
130501562|NCT00671853|469805805|FG001|Overall Study|Withdrawal by Subject|5|||
130501563|NCT00671853|469805804|FG000|Overall Study|Lost to Follow-up|8|||
130501564|NCT00671853|469805805|FG001|Overall Study|Lost to Follow-up|8|||
130501565|NCT00671853|469805804|FG000|Overall Study|Physician Decision|0|||
130501566|NCT00671853|469805805|FG001|Overall Study|Physician Decision|2|||
130501567|NCT00671853|469805804|FG000|Overall Study|Non-adherence with study procedures|1|||
130501568|NCT00671853|469805805|FG001|Overall Study|Non-adherence with study procedures|4|||
130729878|NCT03593395|470633626|FG000|Overall Study|Physician Decision|0|||
130501569|NCT01719172|469805806|FG000|Overall Study|Lost to Follow-up|1|||
130501570|NCT01719172|469805806|FG000|Overall Study|Death|1|||
130501571|NCT00587171|469805807|FG000|Overall Study|Lost to Follow-up|1|||
130501572|NCT00587171|469805808|FG001|Overall Study|Lost to Follow-up|1|||
130501573|NCT01848483|469805809|FG000|Overall Study|Death|2|||
130501574|NCT01848483|469805810|FG001|Overall Study|Death|1|||
130501575|NCT01848483|469805809|FG000|Overall Study|Lost to Follow-up|6|||
130501576|NCT01848483|469805810|FG001|Overall Study|Lost to Follow-up|8|||
130501577|NCT01848483|469805809|FG000|Overall Study|Withdrawal by Subject|1|||
130501578|NCT01848483|469805810|FG001|Overall Study|Withdrawal by Subject|0|||
130501579|NCT01848483|469805809|FG000|Overall Study|Incarceration|2|||
130501580|NCT01848483|469805810|FG001|Overall Study|Incarceration|2|||
130501581|NCT01148017|469805811|FG000|Overall Study|Withdrawal by Subject|31|||
130501582|NCT01148017|469805812|FG001|Overall Study|Withdrawal by Subject|14|||
130501583|NCT01148017|469805813|FG002|Overall Study|Withdrawal by Subject|0|||
130501584|NCT01148017|469805814|FG003|Overall Study|Withdrawal by Subject|0|||
130501585|NCT01148017|469805811|FG000|Overall Study|Lost to Follow-up|23|||
130501586|NCT01148017|469805812|FG001|Overall Study|Lost to Follow-up|10|||
130729879|NCT03593395|470633627|FG001|Overall Study|Physician Decision|6|||
130729880|NCT03593395|470633626|FG000|Overall Study|Participant Relocated|19|||
130501587|NCT01148017|469805813|FG002|Overall Study|Lost to Follow-up|0|||
130501588|NCT01148017|469805814|FG003|Overall Study|Lost to Follow-up|0|||
130501589|NCT01148017|469805811|FG000|Overall Study|Inappropriate enrollment|1|||
130501590|NCT01148017|469805812|FG001|Overall Study|Inappropriate enrollment|0|||
130501591|NCT01148017|469805813|FG002|Overall Study|Inappropriate enrollment|0|||
130501592|NCT01148017|469805814|FG003|Overall Study|Inappropriate enrollment|0|||
130501593|NCT01148017|469805811|FG000|Overall Study|Administrative reason|22|||
130501594|NCT01148017|469805812|FG001|Overall Study|Administrative reason|9|||
130501595|NCT01148017|469805813|FG002|Overall Study|Administrative reason|0|||
130501596|NCT01148017|469805814|FG003|Overall Study|Administrative reason|0|||
130501597|NCT01148017|469805811|FG000|Overall Study|Unable to classify|3|||
130501598|NCT01148017|469805812|FG001|Overall Study|Unable to classify|1|||
130501599|NCT01148017|469805813|FG002|Overall Study|Unable to classify|0|||
130501600|NCT01148017|469805814|FG003|Overall Study|Unable to classify|0|||
130501601|NCT04250636|469805817|FG000|Overall Study|Lost to Follow-up|2|||
130501602|NCT01332266|469805820|FG000|Phase 1b|Death|3|||
130501603|NCT01332266|469805821|FG001|Phase 1b|Death|3|||
130501604|NCT01332266|469805822|FG002|Phase 1b|Death|2|||
130501605|NCT01332266|469805823|FG003|Phase 1b|Death|0|||
130501606|NCT01332266|469805824|FG004|Phase 1b|Death|0|||
130501607|NCT01332266|469805820|FG000|Phase 1b|Lost to Follow-up|0|||
130501608|NCT01332266|469805821|FG001|Phase 1b|Lost to Follow-up|1|||
130501609|NCT01332266|469805822|FG002|Phase 1b|Lost to Follow-up|0|||
130501610|NCT01332266|469805823|FG003|Phase 1b|Lost to Follow-up|0|||
130501611|NCT01332266|469805824|FG004|Phase 1b|Lost to Follow-up|0|||
130501612|NCT01332266|469805820|FG000|Phase 1b|Withdrawal by Subject|1|||
130729881|NCT03593395|470633627|FG001|Overall Study|Participant Relocated|3|||
130729882|NCT03593395|470633626|FG000|Overall Study|No Information|1|||
130729883|NCT03593395|470633627|FG001|Overall Study|No Information|7|||
130729884|NCT01524978|470633628|FG000|Overall Study|Other|16|||
130729885|NCT01524978|470633629|FG001|Overall Study|Other|2|||
130729886|NCT01524978|470633630|FG002|Overall Study|Other|1|||
130729887|NCT01524978|470633631|FG003|Overall Study|Other|2|||
130729888|NCT01524978|470633632|FG004|Overall Study|Other|1|||
130729889|NCT01524978|470633633|FG005|Overall Study|Other|3|||
130729890|NCT01524978|470633634|FG006|Overall Study|Other|17|||
130729891|NCT01524978|470633635|FG007|Overall Study|Other|1|||
130729892|NCT01524978|470633636|FG008|Overall Study|Other|2|||
130729893|NCT01524978|470633637|FG009|Overall Study|Other|2|||
130729894|NCT01524978|470633638|FG010|Overall Study|Other|5|||
130729895|NCT01524978|470633628|FG000|Overall Study|Withdrawal by Subject|12|||
130729896|NCT01524978|470633629|FG001|Overall Study|Withdrawal by Subject|0|||
130729897|NCT01524978|470633630|FG002|Overall Study|Withdrawal by Subject|1|||
130729898|NCT01524978|470633631|FG003|Overall Study|Withdrawal by Subject|1|||
130729899|NCT01524978|470633632|FG004|Overall Study|Withdrawal by Subject|3|||
130729900|NCT01524978|470633633|FG005|Overall Study|Withdrawal by Subject|1|||
130729901|NCT01524978|470633634|FG006|Overall Study|Withdrawal by Subject|6|||
130729902|NCT01524978|470633635|FG007|Overall Study|Withdrawal by Subject|2|||
130729903|NCT01524978|470633636|FG008|Overall Study|Withdrawal by Subject|4|||
130729904|NCT01524978|470633637|FG009|Overall Study|Withdrawal by Subject|0|||
130729905|NCT01524978|470633638|FG010|Overall Study|Withdrawal by Subject|5|||
130729906|NCT01524978|470633628|FG000|Overall Study|Lost to Follow-up|0|||
130729907|NCT01524978|470633629|FG001|Overall Study|Lost to Follow-up|0|||
130729908|NCT01524978|470633630|FG002|Overall Study|Lost to Follow-up|3|||
130729909|NCT01524978|470633631|FG003|Overall Study|Lost to Follow-up|0|||
130729910|NCT01524978|470633632|FG004|Overall Study|Lost to Follow-up|1|||
130729911|NCT01524978|470633633|FG005|Overall Study|Lost to Follow-up|1|||
130729912|NCT01524978|470633634|FG006|Overall Study|Lost to Follow-up|2|||
130729913|NCT01524978|470633635|FG007|Overall Study|Lost to Follow-up|0|||
130729914|NCT01524978|470633636|FG008|Overall Study|Lost to Follow-up|1|||
130729915|NCT01524978|470633637|FG009|Overall Study|Lost to Follow-up|1|||
130729916|NCT01524978|470633638|FG010|Overall Study|Lost to Follow-up|1|||
130729917|NCT01524978|470633628|FG000|Overall Study|Death|34|||
130729918|NCT01524978|470633629|FG001|Overall Study|Death|2|||
130729919|NCT01524978|470633630|FG002|Overall Study|Death|5|||
130729920|NCT01524978|470633631|FG003|Overall Study|Death|24|||
130501613|NCT01332266|469805821|FG001|Phase 1b|Withdrawal by Subject|1|||
130501614|NCT01332266|469805822|FG002|Phase 1b|Withdrawal by Subject|1|||
130501615|NCT01332266|469805823|FG003|Phase 1b|Withdrawal by Subject|0|||
130729921|NCT01524978|470633632|FG004|Overall Study|Death|4|||
130729922|NCT01524978|470633633|FG005|Overall Study|Death|4|||
130729923|NCT01524978|470633634|FG006|Overall Study|Death|1|||
130729924|NCT01524978|470633635|FG007|Overall Study|Death|9|||
130729925|NCT01524978|470633636|FG008|Overall Study|Death|5|||
130729926|NCT01524978|470633637|FG009|Overall Study|Death|6|||
130729927|NCT01524978|470633638|FG010|Overall Study|Death|17|||
130729928|NCT00185588|470633641|FG000|Overall Study|Adverse Event|3|||
130729929|NCT00185588|470633642|FG001|Overall Study|Adverse Event|1|||
130729930|NCT00185588|470633643|FG002|Overall Study|Adverse Event|4|||
130501616|NCT01332266|469805824|FG004|Phase 1b|Withdrawal by Subject|0|||
130501617|NCT01332266|469805820|FG000|Phase 2|Death|0|||
130501618|NCT01332266|469805821|FG001|Phase 2|Death|0|||
130501619|NCT01332266|469805822|FG002|Phase 2|Death|0|||
130501620|NCT01332266|469805823|FG003|Phase 2|Death|33|||
130501621|NCT01332266|469805824|FG004|Phase 2|Death|36|||
130729931|NCT00185588|470633644|FG003|Overall Study|Adverse Event|2|||
130729932|NCT00185588|470633641|FG000|Overall Study|Lost to Follow-up|0|||
130729933|NCT00185588|470633642|FG001|Overall Study|Lost to Follow-up|0|||
130501622|NCT01332266|469805820|FG000|Phase 2|Lost to Follow-up|0|||
130501623|NCT01332266|469805821|FG001|Phase 2|Lost to Follow-up|0|||
130501624|NCT01332266|469805822|FG002|Phase 2|Lost to Follow-up|0|||
130501625|NCT01332266|469805823|FG003|Phase 2|Lost to Follow-up|2|||
130501626|NCT01332266|469805824|FG004|Phase 2|Lost to Follow-up|0|||
130501627|NCT01332266|469805820|FG000|Phase 2|Physician Decision|0|||
130501628|NCT01332266|469805821|FG001|Phase 2|Physician Decision|0|||
130501629|NCT01332266|469805822|FG002|Phase 2|Physician Decision|0|||
130501630|NCT01332266|469805823|FG003|Phase 2|Physician Decision|3|||
130501631|NCT01332266|469805824|FG004|Phase 2|Physician Decision|1|||
130501632|NCT01332266|469805820|FG000|Phase 2|Symptomatic deterioration|0|||
130501633|NCT01332266|469805821|FG001|Phase 2|Symptomatic deterioration|0|||
130501634|NCT01332266|469805822|FG002|Phase 2|Symptomatic deterioration|0|||
130501635|NCT01332266|469805823|FG003|Phase 2|Symptomatic deterioration|0|||
130501636|NCT01332266|469805824|FG004|Phase 2|Symptomatic deterioration|1|||
130501637|NCT01332266|469805820|FG000|Phase 2|Progression Disease|0|||
130501638|NCT01332266|469805821|FG001|Phase 2|Progression Disease|0|||
130501639|NCT01332266|469805822|FG002|Phase 2|Progression Disease|0|||
130501640|NCT01332266|469805823|FG003|Phase 2|Progression Disease|2|||
130501641|NCT01332266|469805824|FG004|Phase 2|Progression Disease|1|||
130501642|NCT01332266|469805820|FG000|Phase 2|Withdrawal by Subject|0|||
130501643|NCT01332266|469805821|FG001|Phase 2|Withdrawal by Subject|0|||
130501644|NCT01332266|469805822|FG002|Phase 2|Withdrawal by Subject|0|||
130501645|NCT01332266|469805823|FG003|Phase 2|Withdrawal by Subject|2|||
130501646|NCT01332266|469805824|FG004|Phase 2|Withdrawal by Subject|2|||
130501647|NCT02128269|469805831|FG000|Treatment Period|Adverse Event|1|||
130501648|NCT02128269|469805831|FG000|Treatment Period|Physician Decision|1|||
130501649|NCT00878189|469805832|FG000|Overall Study|Death|0|||
130501650|NCT00878189|469805833|FG001|Overall Study|Death|1|||
130501651|NCT00878189|469805834|FG002|Overall Study|Death|0|||
130501652|NCT00878189|469805835|FG003|Overall Study|Death|1|||
130501653|NCT00878189|469805836|FG004|Overall Study|Death|0|||
130501654|NCT00878189|469805837|FG005|Overall Study|Death|0|||
130501655|NCT00878189|469805838|FG006|Overall Study|Death|0|||
130501656|NCT00878189|469805839|FG007|Overall Study|Death|0|||
130501657|NCT00878189|469805840|FG008|Overall Study|Death|1|||
130501658|NCT00878189|469805832|FG000|Overall Study|Participant Refused to Follow-up|0|||
130501659|NCT00878189|469805833|FG001|Overall Study|Participant Refused to Follow-up|0|||
130501660|NCT00878189|469805834|FG002|Overall Study|Participant Refused to Follow-up|0|||
130501661|NCT00878189|469805835|FG003|Overall Study|Participant Refused to Follow-up|0|||
130501662|NCT00878189|469805836|FG004|Overall Study|Participant Refused to Follow-up|0|||
130501663|NCT00878189|469805837|FG005|Overall Study|Participant Refused to Follow-up|4|||
130501664|NCT00878189|469805838|FG006|Overall Study|Participant Refused to Follow-up|0|||
130501665|NCT00878189|469805839|FG007|Overall Study|Participant Refused to Follow-up|0|||
130501666|NCT00878189|469805840|FG008|Overall Study|Participant Refused to Follow-up|0|||
130501667|NCT00878189|469805832|FG000|Overall Study|Other|3|||
130501668|NCT00878189|469805833|FG001|Overall Study|Other|2|||
130501669|NCT00878189|469805834|FG002|Overall Study|Other|4|||
130501670|NCT00878189|469805835|FG003|Overall Study|Other|7|||
130501671|NCT00878189|469805836|FG004|Overall Study|Other|4|||
130501672|NCT00878189|469805837|FG005|Overall Study|Other|18|||
130501673|NCT00878189|469805838|FG006|Overall Study|Other|15|||
130501674|NCT00878189|469805839|FG007|Overall Study|Other|3|||
130501675|NCT00878189|469805840|FG008|Overall Study|Other|4|||
130501676|NCT00878189|469805832|FG000|Overall Study|Lost to Follow-up|0|||
130501677|NCT00878189|469805833|FG001|Overall Study|Lost to Follow-up|0|||
130501678|NCT00878189|469805834|FG002|Overall Study|Lost to Follow-up|0|||
130501679|NCT00878189|469805835|FG003|Overall Study|Lost to Follow-up|0|||
130501680|NCT00878189|469805836|FG004|Overall Study|Lost to Follow-up|0|||
130501681|NCT00878189|469805837|FG005|Overall Study|Lost to Follow-up|1|||
130501682|NCT00878189|469805838|FG006|Overall Study|Lost to Follow-up|1|||
130501683|NCT00878189|469805839|FG007|Overall Study|Lost to Follow-up|0|||
130501684|NCT00878189|469805840|FG008|Overall Study|Lost to Follow-up|0|||
130501685|NCT00878189|469805832|FG000|Overall Study|Objection Progression or Relapse|0|||
130501686|NCT00878189|469805833|FG001|Overall Study|Objection Progression or Relapse|0|||
130501687|NCT00878189|469805834|FG002|Overall Study|Objection Progression or Relapse|0|||
130501688|NCT00878189|469805835|FG003|Overall Study|Objection Progression or Relapse|0|||
130501689|NCT00878189|469805836|FG004|Overall Study|Objection Progression or Relapse|0|||
130501690|NCT00878189|469805837|FG005|Overall Study|Objection Progression or Relapse|0|||
130501691|NCT00878189|469805838|FG006|Overall Study|Objection Progression or Relapse|0|||
130501692|NCT00878189|469805839|FG007|Overall Study|Objection Progression or Relapse|0|||
130501693|NCT00878189|469805840|FG008|Overall Study|Objection Progression or Relapse|3|||
130501694|NCT00703092|469805841|FG000|Overall Study|Withdrawal by Subject|2|||
130501695|NCT01021748|469805842|FG000|Overall Study|Adverse Event|2|||
130501696|NCT01021748|469805843|FG001|Overall Study|Adverse Event|1|||
130501697|NCT01021748|469805844|FG002|Overall Study|Adverse Event|2|||
130501698|NCT01021748|469805845|FG003|Overall Study|Adverse Event|0|||
130501699|NCT01021748|469805846|FG004|Overall Study|Adverse Event|2|||
130501700|NCT01021748|469805847|FG005|Overall Study|Adverse Event|0|||
130501701|NCT01021748|469805848|FG006|Overall Study|Adverse Event|1|||
130501702|NCT01021748|469805849|FG007|Overall Study|Adverse Event|0|||
130501703|NCT01021748|469805850|FG008|Overall Study|Adverse Event|7|||
130501704|NCT01021748|469805842|FG000|Overall Study|Physician Decision|1|||
130501705|NCT01021748|469805843|FG001|Overall Study|Physician Decision|0|||
130501706|NCT01021748|469805844|FG002|Overall Study|Physician Decision|1|||
130501707|NCT01021748|469805845|FG003|Overall Study|Physician Decision|1|||
130501708|NCT01021748|469805846|FG004|Overall Study|Physician Decision|0|||
130501709|NCT01021748|469805847|FG005|Overall Study|Physician Decision|0|||
130501710|NCT01021748|469805848|FG006|Overall Study|Physician Decision|1|||
130501711|NCT01021748|469805849|FG007|Overall Study|Physician Decision|1|||
130501712|NCT01021748|469805850|FG008|Overall Study|Physician Decision|2|||
130501713|NCT01021748|469805842|FG000|Overall Study|Progressive Disease|3|||
130501714|NCT01021748|469805843|FG001|Overall Study|Progressive Disease|3|||
130501715|NCT01021748|469805844|FG002|Overall Study|Progressive Disease|4|||
130501716|NCT01021748|469805845|FG003|Overall Study|Progressive Disease|6|||
130501717|NCT01021748|469805846|FG004|Overall Study|Progressive Disease|7|||
130501718|NCT01021748|469805847|FG005|Overall Study|Progressive Disease|3|||
130501719|NCT01021748|469805848|FG006|Overall Study|Progressive Disease|0|||
130501720|NCT01021748|469805849|FG007|Overall Study|Progressive Disease|5|||
130501721|NCT01021748|469805850|FG008|Overall Study|Progressive Disease|6|||
130501722|NCT01021748|469805842|FG000|Overall Study|Withdrawal by Subject|0|||
130501723|NCT01021748|469805843|FG001|Overall Study|Withdrawal by Subject|0|||
130501724|NCT01021748|469805844|FG002|Overall Study|Withdrawal by Subject|0|||
130501725|NCT01021748|469805845|FG003|Overall Study|Withdrawal by Subject|0|||
130501726|NCT01021748|469805846|FG004|Overall Study|Withdrawal by Subject|0|||
130501727|NCT01021748|469805847|FG005|Overall Study|Withdrawal by Subject|0|||
130501728|NCT01021748|469805848|FG006|Overall Study|Withdrawal by Subject|1|||
130501729|NCT01021748|469805849|FG007|Overall Study|Withdrawal by Subject|0|||
130501730|NCT01021748|469805850|FG008|Overall Study|Withdrawal by Subject|1|||
130501731|NCT01021748|469805842|FG000|Overall Study|Not Treated|0|||
130501732|NCT01021748|469805843|FG001|Overall Study|Not Treated|1|||
130501733|NCT01021748|469805844|FG002|Overall Study|Not Treated|0|||
130501734|NCT01021748|469805845|FG003|Overall Study|Not Treated|0|||
130501735|NCT01021748|469805846|FG004|Overall Study|Not Treated|0|||
130501736|NCT01021748|469805847|FG005|Overall Study|Not Treated|0|||
130501737|NCT01021748|469805848|FG006|Overall Study|Not Treated|0|||
130501738|NCT01021748|469805849|FG007|Overall Study|Not Treated|0|||
130501739|NCT01021748|469805850|FG008|Overall Study|Not Treated|0|||
130501740|NCT01829711|469805855|FG000|Overall Study|Lost to Follow-up|2|||
130501741|NCT01829711|469805855|FG000|Overall Study|Withdrawal by Subject|3|||
130501742|NCT01829711|469805855|FG000|Overall Study|Death|4|||
130501743|NCT01829711|469805855|FG000|Overall Study|Started new therapies|17|||
130501744|NCT01829711|469805855|FG000|Overall Study|Adverse Event|3|||
130501745|NCT01829711|469805855|FG000|Overall Study|Due to progression of disease|13|||
130501746|NCT01829711|469805855|FG000|Overall Study|Due to lack of response|1|||
130501747|NCT01480258|469805858|FG000|Infant Series|Protocol Violation|2|||
130501748|NCT01480258|469805859|FG001|Infant Series|Protocol Violation|0|||
130501749|NCT01480258|469805858|FG000|Infant Series|Physician Decision|0|||
130501750|NCT01480258|469805859|FG001|Infant Series|Physician Decision|1|||
130501751|NCT01480258|469805858|FG000|Infant Series|Not Vaccinated|3|||
130501752|NCT01480258|469805859|FG001|Infant Series|Not Vaccinated|0|||
130501753|NCT01480258|469805858|FG000|Infant Series|Adverse Event|1|||
130501754|NCT01480258|469805859|FG001|Infant Series|Adverse Event|1|||
130501755|NCT01480258|469805858|FG000|Infant Series|Withdrawal by Subject|1|||
130501756|NCT01480258|469805859|FG001|Infant Series|Withdrawal by Subject|6|||
130501757|NCT01480258|469805858|FG000|Interim Period|Lost to Follow-up|0|||
130501758|NCT01480258|469805859|FG001|Interim Period|Lost to Follow-up|2|||
130501759|NCT01480258|469805858|FG000|Interim Period|Physician Decision|1|||
130501760|NCT01480258|469805859|FG001|Interim Period|Physician Decision|0|||
130501761|NCT01480258|469805858|FG000|Interim Period|Protocol Violation|0|||
130501762|NCT01480258|469805859|FG001|Interim Period|Protocol Violation|1|||
130729934|NCT00185588|470633643|FG002|Overall Study|Lost to Follow-up|1|||
130729935|NCT00185588|470633644|FG003|Overall Study|Lost to Follow-up|2|||
130501763|NCT01480258|469805858|FG000|Interim Period|Withdrawal by Subject|9|||
130501764|NCT01480258|469805859|FG001|Interim Period|Withdrawal by Subject|6|||
130501765|NCT03316170|469805860|FG000|Overall Study|Death|1|||
130501766|NCT03316170|469805861|FG001|Overall Study|Death|0|||
130501767|NCT03316170|469805860|FG000|Overall Study|Lost to Follow-up|6|||
130501768|NCT03316170|469805861|FG001|Overall Study|Lost to Follow-up|7|||
130501769|NCT02169414|469805862|FG000|Overall Study|Withdrawal by Subject|1|||
130501770|NCT02169414|469805863|FG001|Overall Study|Withdrawal by Subject|0|||
130501771|NCT02169414|469805864|FG002|Overall Study|Withdrawal by Subject|0|||
130501772|NCT02169414|469805865|FG003|Overall Study|Withdrawal by Subject|0|||
130501773|NCT02169414|469805862|FG000|Overall Study|Adverse Event|0|||
130501774|NCT02169414|469805863|FG001|Overall Study|Adverse Event|1|||
130501775|NCT02169414|469805864|FG002|Overall Study|Adverse Event|0|||
130501776|NCT02169414|469805865|FG003|Overall Study|Adverse Event|0|||
130501777|NCT03374254|469805866|FG000|Overall Study|Death|5|||
130501778|NCT03374254|469805867|FG001|Overall Study|Death|16|||
130501779|NCT03374254|469805868|FG002|Overall Study|Death|13|||
130501780|NCT03374254|469805869|FG003|Overall Study|Death|11|||
130501781|NCT03374254|469805870|FG004|Overall Study|Death|9|||
130501782|NCT03374254|469805871|FG005|Overall Study|Death|12|||
130501783|NCT03374254|469805872|FG006|Overall Study|Death|11|||
130501784|NCT03374254|469805873|FG007|Overall Study|Death|6|||
130501785|NCT03374254|469805874|FG008|Overall Study|Death|7|||
130501786|NCT03374254|469805866|FG000|Overall Study|Lost to Follow-up|0|||
130501787|NCT03374254|469805867|FG001|Overall Study|Lost to Follow-up|0|||
130501788|NCT03374254|469805868|FG002|Overall Study|Lost to Follow-up|0|||
130501789|NCT03374254|469805869|FG003|Overall Study|Lost to Follow-up|0|||
130501790|NCT03374254|469805870|FG004|Overall Study|Lost to Follow-up|0|||
130501791|NCT03374254|469805871|FG005|Overall Study|Lost to Follow-up|0|||
130501792|NCT03374254|469805872|FG006|Overall Study|Lost to Follow-up|2|||
130501793|NCT03374254|469805873|FG007|Overall Study|Lost to Follow-up|0|||
130501794|NCT03374254|469805874|FG008|Overall Study|Lost to Follow-up|0|||
130501795|NCT03374254|469805866|FG000|Overall Study|Sponsor Decision|1|||
130501796|NCT03374254|469805867|FG001|Overall Study|Sponsor Decision|0|||
130501797|NCT03374254|469805868|FG002|Overall Study|Sponsor Decision|2|||
130501798|NCT03374254|469805869|FG003|Overall Study|Sponsor Decision|3|||
130501799|NCT03374254|469805870|FG004|Overall Study|Sponsor Decision|2|||
130501800|NCT03374254|469805871|FG005|Overall Study|Sponsor Decision|3|||
130501801|NCT03374254|469805872|FG006|Overall Study|Sponsor Decision|3|||
130501802|NCT03374254|469805873|FG007|Overall Study|Sponsor Decision|3|||
130501803|NCT03374254|469805874|FG008|Overall Study|Sponsor Decision|4|||
130501804|NCT03374254|469805866|FG000|Overall Study|Withdrawal by Subject|0|||
130501805|NCT03374254|469805867|FG001|Overall Study|Withdrawal by Subject|0|||
130501806|NCT03374254|469805868|FG002|Overall Study|Withdrawal by Subject|0|||
130501807|NCT03374254|469805869|FG003|Overall Study|Withdrawal by Subject|2|||
130501808|NCT03374254|469805870|FG004|Overall Study|Withdrawal by Subject|0|||
130501809|NCT03374254|469805871|FG005|Overall Study|Withdrawal by Subject|1|||
130501810|NCT03374254|469805872|FG006|Overall Study|Withdrawal by Subject|0|||
130501811|NCT03374254|469805873|FG007|Overall Study|Withdrawal by Subject|0|||
130501812|NCT03374254|469805874|FG008|Overall Study|Withdrawal by Subject|0|||
130501813|NCT02309515|469805875|FG000|Overall Study|Withdrawal by Subject|0|||
130501814|NCT02309515|469805876|FG001|Overall Study|Withdrawal by Subject|1|||
130501815|NCT04070105|469805880|FG000|Overall Study|Lost to Follow-up|0|||
130501816|NCT04070105|469805881|FG001|Overall Study|Lost to Follow-up|0|||
130501817|NCT04070105|469805882|FG002|Overall Study|Lost to Follow-up|0|||
130501818|NCT04070105|469805883|FG003|Overall Study|Lost to Follow-up|0|||
130501819|NCT04070105|469805884|FG004|Overall Study|Lost to Follow-up|0|||
130501820|NCT04070105|469805885|FG005|Overall Study|Lost to Follow-up|1|||
130501821|NCT01858688|469805891|FG000|Overall Study|Withdrawal by Subject|8|||
130501822|NCT01858688|469805891|FG000|Overall Study|Participant began another therapy|3|||
130501823|NCT01858688|469805891|FG000|Overall Study|Physician Decision|2|||
130501824|NCT01858688|469805891|FG000|Overall Study|Progressive Disease|2|||
130501825|NCT01858688|469805891|FG000|Overall Study|Reason not reproted|5|||
130501826|NCT01999335|469805892|FG000|Overall Study|Discontinued before receiving treatment|0|||
130501827|NCT01999335|469805893|FG001|Overall Study|Discontinued before receiving treatment|0|||
130501828|NCT01999335|469805894|FG002|Overall Study|Discontinued before receiving treatment|0|||
130501829|NCT01999335|469805895|FG003|Overall Study|Discontinued before receiving treatment|0|||
130501830|NCT01999335|469805896|FG004|Overall Study|Discontinued before receiving treatment|2|||
130501831|NCT02234141|469805897|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
130501832|NCT02234141|469805898|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
130501833|NCT02234141|469805899|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
130501834|NCT02234141|469805900|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
130501835|NCT02234141|469805901|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
130729936|NCT00185588|470633641|FG000|Overall Study|Withdrawal by Subject|0|||
130729937|NCT00185588|470633642|FG001|Overall Study|Withdrawal by Subject|1|||
130729938|NCT00185588|470633643|FG002|Overall Study|Withdrawal by Subject|0|||
130729939|NCT00185588|470633644|FG003|Overall Study|Withdrawal by Subject|0|||
130729940|NCT00185588|470633641|FG000|Overall Study|Physician Decision|0|||
130501836|NCT02234141|469805902|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
130501837|NCT02234141|469805903|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
130501838|NCT02234141|469805897|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501839|NCT02234141|469805898|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
130501840|NCT02234141|469805899|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501841|NCT02234141|469805900|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501842|NCT02234141|469805901|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501843|NCT02234141|469805902|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501844|NCT02234141|469805903|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
130501845|NCT02234141|469805897|FG000|Treatment Period (24 Weeks)|Death|1|||
130501846|NCT02234141|469805898|FG001|Treatment Period (24 Weeks)|Death|2|||
130565685|NCT01197521|470036978|FG001|Overall Study|Lack of therapeutic response|3|||
130501847|NCT02234141|469805899|FG002|Treatment Period (24 Weeks)|Death|0|||
130501848|NCT02234141|469805900|FG003|Treatment Period (24 Weeks)|Death|1|||
130501849|NCT02234141|469805901|FG004|Treatment Period (24 Weeks)|Death|0|||
130501850|NCT02234141|469805902|FG005|Treatment Period (24 Weeks)|Death|0|||
130501851|NCT02234141|469805903|FG006|Treatment Period (24 Weeks)|Death|0|||
130501852|NCT02234141|469805897|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
130501853|NCT02234141|469805898|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
130501854|NCT02234141|469805899|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
130501855|NCT02234141|469805900|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
130501856|NCT02234141|469805901|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
130501857|NCT02234141|469805902|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
130501858|NCT02234141|469805903|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
130501859|NCT02234141|469805897|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501860|NCT02234141|469805898|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
130501861|NCT02234141|469805899|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501862|NCT02234141|469805900|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501863|NCT02234141|469805901|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501864|NCT02234141|469805902|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501865|NCT02234141|469805903|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
130501866|NCT02234141|469805897|FG000|Long-Term Treatment Period|Death|0|||
130501867|NCT02234141|469805898|FG001|Long-Term Treatment Period|Death|0|||
130501868|NCT02234141|469805899|FG002|Long-Term Treatment Period|Death|0|||
130501869|NCT02234141|469805900|FG003|Long-Term Treatment Period|Death|0|||
130501870|NCT02234141|469805901|FG004|Long-Term Treatment Period|Death|0|||
130501871|NCT02234141|469805902|FG005|Long-Term Treatment Period|Death|1|||
130501872|NCT02234141|469805903|FG006|Long-Term Treatment Period|Death|0|||
130501873|NCT02234141|469805897|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
130501874|NCT02234141|469805898|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
130501875|NCT02234141|469805899|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
130501876|NCT02234141|469805900|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
130501877|NCT02234141|469805901|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
130501878|NCT02234141|469805902|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
130501879|NCT02234141|469805903|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
130501880|NCT02234141|469805897|FG000|Long-Term Treatment Period|Adverse Event|4|||
130501881|NCT02234141|469805898|FG001|Long-Term Treatment Period|Adverse Event|0|||
130501882|NCT02234141|469805899|FG002|Long-Term Treatment Period|Adverse Event|5|||
130501883|NCT02234141|469805900|FG003|Long-Term Treatment Period|Adverse Event|0|||
130501884|NCT02234141|469805901|FG004|Long-Term Treatment Period|Adverse Event|1|||
130501885|NCT02234141|469805902|FG005|Long-Term Treatment Period|Adverse Event|1|||
130501886|NCT02234141|469805903|FG006|Long-Term Treatment Period|Adverse Event|1|||
130501887|NCT02234141|469805897|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
130501888|NCT02234141|469805898|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
130501889|NCT02234141|469805899|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
130501890|NCT02234141|469805900|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
130501891|NCT02234141|469805901|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
130501892|NCT02234141|469805902|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
130501893|NCT02234141|469805903|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
130501894|NCT02234141|469805897|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
130501895|NCT02234141|469805898|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
130501896|NCT02234141|469805899|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
130501897|NCT02234141|469805900|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
130501898|NCT02234141|469805901|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
130501899|NCT02234141|469805902|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
130501900|NCT02234141|469805903|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
130501901|NCT00895245|469805904|FG000|Overall Study|Lack of Efficacy|6|||
130501902|NCT04248868|469805907|FG000|Overall Study|Death|1|||
130501903|NCT04248868|469805907|FG000|Overall Study|Lost to Follow-up|3|||
130501904|NCT04248868|469805907|FG000|Overall Study|Protocol Violation|2|||
130501905|NCT02706483|469805908|FG000|Overall Study|Adverse Event|97|||
130501906|NCT02706483|469805908|FG000|Overall Study|Death|1|||
130501907|NCT02706483|469805908|FG000|Overall Study|Lack of Efficacy|39|||
130501908|NCT02706483|469805908|FG000|Overall Study|Lost to Follow-up|101|||
130501909|NCT02706483|469805908|FG000|Overall Study|Non-compliance with study drug|15|||
130501910|NCT02706483|469805908|FG000|Overall Study|Physician Decision|6|||
130501911|NCT02706483|469805908|FG000|Overall Study|Pregnancy|6|||
130501912|NCT02706483|469805908|FG000|Overall Study|Protocol Violation|18|||
130501913|NCT02706483|469805908|FG000|Overall Study|Withdrawal by Subject|136|||
130501914|NCT02706483|469805908|FG000|Overall Study|Non-compliance with visits|6|||
130501915|NCT02706483|469805908|FG000|Overall Study|Site closure|4|||
130501916|NCT02706483|469805908|FG000|Overall Study|Subject moved|1|||
130501917|NCT03131713|469805909|FG000|Overall Study|Lost to Follow-up|5|||
130501918|NCT03131713|469805910|FG001|Overall Study|Lost to Follow-up|0|||
130501919|NCT02208843|469805913|FG000|Overall Study|Clinical symptoms of progression|2|||
130501920|NCT02208843|469805913|FG000|Overall Study|Progression disease according to RECIST|24|||
130501921|NCT02208843|469805913|FG000|Overall Study|Adverse Event|12|||
130501922|NCT02208843|469805913|FG000|Overall Study|Protocol Violation|1|||
130501923|NCT02208843|469805913|FG000|Overall Study|Withdrawal by Subject|1|||
130501924|NCT02208843|469805913|FG000|Overall Study|Switched to commercial afatinib|20|||
130501925|NCT01976507|469805914|FG000|Overall Study|Adverse Event|6|||
130501926|NCT01976507|469805914|FG000|Overall Study|ablation not done, drug not given|1|||
130501927|NCT00089791|469805920|FG000|Overall Study|Physician Decision|6|||
130501928|NCT00089791|469805921|FG001|Overall Study|Physician Decision|3|||
130501929|NCT00089791|469805920|FG000|Overall Study|Adverse Event|81|||
130501930|NCT00089791|469805921|FG001|Overall Study|Adverse Event|93|||
130501931|NCT00089791|469805920|FG000|Overall Study|Withdrawal by Subject|403|||
130501932|NCT00089791|469805921|FG001|Overall Study|Withdrawal by Subject|344|||
130501933|NCT00089791|469805920|FG000|Overall Study|Death|78|||
130501934|NCT00089791|469805921|FG001|Overall Study|Death|62|||
130501935|NCT00089791|469805920|FG000|Overall Study|Disease progression|7|||
130501936|NCT00089791|469805921|FG001|Overall Study|Disease progression|3|||
130729941|NCT00185588|470633642|FG001|Overall Study|Physician Decision|0|||
130729942|NCT00185588|470633643|FG002|Overall Study|Physician Decision|1|||
130729943|NCT00185588|470633644|FG003|Overall Study|Physician Decision|0|||
130501937|NCT00089791|469805920|FG000|Overall Study|Ineligibility determined|12|||
130501938|NCT00089791|469805921|FG001|Overall Study|Ineligibility determined|9|||
130501939|NCT00089791|469805920|FG000|Overall Study|Lost to Follow-up|57|||
130501940|NCT00089791|469805921|FG001|Overall Study|Lost to Follow-up|57|||
130501941|NCT00089791|469805920|FG000|Overall Study|Noncompliance|17|||
130501942|NCT00089791|469805921|FG001|Overall Study|Noncompliance|13|||
130501943|NCT00089791|469805920|FG000|Overall Study|Other|20|||
130501944|NCT00089791|469805921|FG001|Overall Study|Other|32|||
130501945|NCT00089791|469805920|FG000|Overall Study|Protocol deviation|12|||
130501946|NCT00089791|469805921|FG001|Overall Study|Protocol deviation|10|||
130501947|NCT00089791|469805920|FG000|Overall Study|Requirement for alternative therapy|7|||
130501948|NCT00089791|469805921|FG001|Overall Study|Requirement for alternative therapy|4|||
130729944|NCT02604407|470633645|FG000|Overall Study|Adverse Event|0|||
130501949|NCT00148122|469805922|FG000|Overall Study|Withdrawal by Subject|2|||
130501950|NCT03042767|469805923|FG000|Overall Study|Lost to Follow-up|1|||
130501951|NCT03042767|469805924|FG001|Overall Study|Lost to Follow-up|2|||
130501952|NCT01543204|469805925|FG000|Overall Study|Non-compliance|1|||
130501953|NCT01543204|469805925|FG000|Overall Study|Adverse Event|1|||
130501954|NCT01543204|469805925|FG000|Overall Study|Withdrawal by Subject|4|||
130501955|NCT01543204|469805925|FG000|Overall Study|Requirement for Alternative Therapy|1|||
130501956|NCT01543204|469805925|FG000|Overall Study|Lost to Follow-up|1|||
130501957|NCT01220999|469805926|FG000|Overall Study|Progressive disease|0|||
130501958|NCT01220999|469805927|FG001|Overall Study|Progressive disease|0|||
130501959|NCT01220999|469805928|FG002|Overall Study|Progressive disease|1|||
130501960|NCT01220999|469805929|FG003|Overall Study|Progressive disease|0|||
130501961|NCT01220999|469805930|FG004|Overall Study|Progressive disease|0|||
130501962|NCT02449902|469805934|FG000|Overall Study|Adverse Event|0|||
130501963|NCT02449902|469805935|FG001|Overall Study|Adverse Event|1|||
130501964|NCT02449902|469805934|FG000|Overall Study|Withdrawal by Subject|0|||
130501965|NCT02449902|469805935|FG001|Overall Study|Withdrawal by Subject|1|||
130501966|NCT02362789|469805936|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
130501967|NCT02362789|469805937|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
130501968|NCT02362789|469805938|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
130501969|NCT02362789|469805936|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
130501970|NCT02362789|469805937|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
130501971|NCT02362789|469805938|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
130501972|NCT02362789|469805936|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
130501973|NCT02362789|469805937|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
130501974|NCT02362789|469805938|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
130501975|NCT02362789|469805936|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
130501976|NCT02362789|469805937|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
130501977|NCT02362789|469805938|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
130501978|NCT02362789|469805936|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
130501979|NCT02362789|469805937|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
130501980|NCT02362789|469805938|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
130501981|NCT03326856|469805939|FG000|Overall Study|Lost to Follow-up|1|||
130501982|NCT03326856|469805940|FG001|Overall Study|Lost to Follow-up|1|||
130501983|NCT03326856|469805941|FG002|Overall Study|Lost to Follow-up|0|||
130501984|NCT03326856|469805942|FG003|Overall Study|Lost to Follow-up|0|||
130501985|NCT03326856|469805943|FG004|Overall Study|Lost to Follow-up|0|||
130501986|NCT03861234|469805944|FG000|Overall Study|Not treated|0|||
130501987|NCT03861234|469805945|FG001|Overall Study|Not treated|0|||
130501988|NCT03861234|469805946|FG002|Overall Study|Not treated|0|||
130501989|NCT03861234|469805947|FG003|Overall Study|Not treated|0|||
130501990|NCT03861234|469805948|FG004|Overall Study|Not treated|0|||
130501991|NCT03861234|469805949|FG005|Overall Study|Not treated|1|||
130501992|NCT03861234|469805950|FG006|Overall Study|Not treated|0|||
130501993|NCT03861234|469805951|FG007|Overall Study|Not treated|0|||
130501994|NCT03861234|469805944|FG000|Overall Study|Adverse Event|0|||
130501995|NCT03861234|469805945|FG001|Overall Study|Adverse Event|0|||
130501996|NCT03861234|469805946|FG002|Overall Study|Adverse Event|0|||
130501997|NCT03861234|469805947|FG003|Overall Study|Adverse Event|0|||
130501998|NCT03861234|469805948|FG004|Overall Study|Adverse Event|0|||
130501999|NCT03861234|469805949|FG005|Overall Study|Adverse Event|1|||
130729945|NCT02604407|470633646|FG001|Overall Study|Adverse Event|7|||
130729946|NCT02604407|470633647|FG002|Overall Study|Adverse Event|5|||
130729947|NCT02604407|470633645|FG000|Overall Study|Protocol Violation|2|||
130729948|NCT02604407|470633646|FG001|Overall Study|Protocol Violation|0|||
130729949|NCT02604407|470633647|FG002|Overall Study|Protocol Violation|0|||
130502000|NCT03861234|469805950|FG006|Overall Study|Adverse Event|0|||
130565686|NCT01197521|470036979|FG002|Overall Study|Lack of therapeutic response|4|||
130565687|NCT01197521|470036977|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
130565688|NCT01197521|470036978|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
130565689|NCT01197521|470036979|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130565690|NCT01197521|470036977|FG000|Overall Study|Lost to Follow-up|3|||
130565691|NCT01197521|470036978|FG001|Overall Study|Lost to Follow-up|2|||
130565692|NCT01197521|470036979|FG002|Overall Study|Lost to Follow-up|2|||
130565693|NCT01197521|470036977|FG000|Overall Study|Adverse Event|25|||
130565694|NCT01197521|470036978|FG001|Overall Study|Adverse Event|28|||
130565695|NCT01197521|470036979|FG002|Overall Study|Adverse Event|24|||
130565696|NCT01517893|470036980|FG000|Overall Study|Withdrawal by Subject|3|||
130565697|NCT01517893|470036981|FG001|Overall Study|Withdrawal by Subject|0|||
130729950|NCT02604407|470633645|FG000|Overall Study|Withdrawal by Subject|3|||
130502001|NCT03861234|469805951|FG007|Overall Study|Adverse Event|0|||
130502002|NCT03861234|469805944|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
130502003|NCT03861234|469805945|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
130502004|NCT03861234|469805946|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
130502005|NCT03861234|469805947|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
130502006|NCT03861234|469805948|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
130729951|NCT02604407|470633646|FG001|Overall Study|Withdrawal by Subject|3|||
130729952|NCT02604407|470633647|FG002|Overall Study|Withdrawal by Subject|5|||
130729953|NCT02604407|470633645|FG000|Overall Study|Lost to Follow-up|2|||
130729954|NCT02604407|470633646|FG001|Overall Study|Lost to Follow-up|1|||
130729955|NCT02604407|470633647|FG002|Overall Study|Lost to Follow-up|2|||
130729956|NCT02604407|470633645|FG000|Overall Study|Lack of Efficacy|1|||
130729957|NCT02604407|470633646|FG001|Overall Study|Lack of Efficacy|0|||
130729958|NCT02604407|470633647|FG002|Overall Study|Lack of Efficacy|0|||
130729959|NCT02604407|470633645|FG000|Overall Study|Other|3|||
130729960|NCT02604407|470633646|FG001|Overall Study|Other|1|||
130729961|NCT02604407|470633647|FG002|Overall Study|Other|4|||
130729962|NCT02481869|470633648|FG000|Overall Study|Lost to Follow-up|3|||
130729963|NCT02481869|470633649|FG001|Overall Study|Lost to Follow-up|4|||
130729964|NCT02481869|470633648|FG000|Overall Study|Withdrawal by Subject|2|||
130502007|NCT03861234|469805949|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
130502008|NCT03861234|469805950|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
130502009|NCT03861234|469805951|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
130565698|NCT02285777|470036985|FG000|Overall Study|Withdrawal by Subject|1|||
130565699|NCT02285777|470036986|FG001|Overall Study|Withdrawal by Subject|1|||
130565700|NCT02285777|470036985|FG000|Overall Study|Lost to Follow-up|4|||
130565701|NCT02285777|470036986|FG001|Overall Study|Lost to Follow-up|2|||
130565702|NCT01431274|470036994|FG000|Overall Study|Adverse Event|51|||
130565703|NCT01431274|470036995|FG001|Overall Study|Adverse Event|37|||
130565704|NCT01431274|470036996|FG002|Overall Study|Adverse Event|43|||
130565705|NCT01431274|470036997|FG003|Overall Study|Adverse Event|30|||
130565706|NCT01431274|470036998|FG004|Overall Study|Adverse Event|37|||
130565707|NCT01431274|470036994|FG000|Overall Study|Consent withdrawn not due to AE|29|||
130565708|NCT01431274|470036995|FG001|Overall Study|Consent withdrawn not due to AE|20|||
130565709|NCT01431274|470036996|FG002|Overall Study|Consent withdrawn not due to AE|17|||
130565710|NCT01431274|470036997|FG003|Overall Study|Consent withdrawn not due to AE|20|||
130565711|NCT01431274|470036998|FG004|Overall Study|Consent withdrawn not due to AE|11|||
130565712|NCT01431274|470036994|FG000|Overall Study|Non compliant with protocol|5|||
130565713|NCT01431274|470036995|FG001|Overall Study|Non compliant with protocol|8|||
130565714|NCT01431274|470036996|FG002|Overall Study|Non compliant with protocol|4|||
130565715|NCT01431274|470036997|FG003|Overall Study|Non compliant with protocol|4|||
130565716|NCT01431274|470036998|FG004|Overall Study|Non compliant with protocol|4|||
130565717|NCT01431274|470036994|FG000|Overall Study|Lost to Follow-up|6|||
130565718|NCT01431274|470036995|FG001|Overall Study|Lost to Follow-up|7|||
130565719|NCT01431274|470036996|FG002|Overall Study|Lost to Follow-up|1|||
130565720|NCT01431274|470036997|FG003|Overall Study|Lost to Follow-up|4|||
130565721|NCT01431274|470036998|FG004|Overall Study|Lost to Follow-up|0|||
130565722|NCT01431274|470036994|FG000|Overall Study|Other reason not stated above|6|||
130565723|NCT01431274|470036995|FG001|Overall Study|Other reason not stated above|5|||
130565724|NCT01431274|470036996|FG002|Overall Study|Other reason not stated above|7|||
130565725|NCT01431274|470036997|FG003|Overall Study|Other reason not stated above|2|||
130729965|NCT02481869|470633649|FG001|Overall Study|Withdrawal by Subject|0|||
130502010|NCT03861234|469805944|FG000|Overall Study|As per sponsor decision|0|||
130502011|NCT03861234|469805945|FG001|Overall Study|As per sponsor decision|0|||
130502012|NCT03861234|469805946|FG002|Overall Study|As per sponsor decision|0|||
130502013|NCT03861234|469805947|FG003|Overall Study|As per sponsor decision|0|||
130502014|NCT03861234|469805948|FG004|Overall Study|As per sponsor decision|0|||
130502015|NCT03861234|469805949|FG005|Overall Study|As per sponsor decision|0|||
130502016|NCT03861234|469805950|FG006|Overall Study|As per sponsor decision|1|||
130502017|NCT03861234|469805951|FG007|Overall Study|As per sponsor decision|0|||
130502018|NCT03861234|469805944|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
130502019|NCT03861234|469805945|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
130502020|NCT03861234|469805946|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
130502021|NCT03861234|469805947|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
130502022|NCT03861234|469805948|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
130502023|NCT03861234|469805949|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
130502024|NCT03861234|469805950|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
130502025|NCT03861234|469805951|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
130565726|NCT01431274|470036998|FG004|Overall Study|Other reason not stated above|4|||
130565727|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
130565728|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
130565729|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Death|0|||
130565730|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Death|1|||
130729966|NCT03908437|470633650|FG000|Overall Study|Death|0|||
130729967|NCT03908437|470633651|FG001|Overall Study|Death|1|||
130729968|NCT03908437|470633650|FG000|Overall Study|Lost to Follow-up|31|||
130729969|NCT03908437|470633651|FG001|Overall Study|Lost to Follow-up|24|||
130502026|NCT02852824|469805952|FG000|Overall Study|Withdrawal by Subject|1|||
130729970|NCT00191191|470633652|FG000|Overall Study|Entry Criteria Exclusion|2|||
130502027|NCT02852824|469805953|FG001|Overall Study|Withdrawal by Subject|0|||
130502028|NCT02852824|469805954|FG002|Overall Study|Withdrawal by Subject|0|||
130502029|NCT02852824|469805955|FG003|Overall Study|Withdrawal by Subject|0|||
130502030|NCT02852824|469805956|FG004|Overall Study|Withdrawal by Subject|0|||
130502031|NCT02852824|469805957|FG005|Overall Study|Withdrawal by Subject|0|||
130502032|NCT02852824|469805958|FG006|Overall Study|Withdrawal by Subject|0|||
130502033|NCT02852824|469805952|FG000|Overall Study|Adverse Event|0|||
130502034|NCT02852824|469805953|FG001|Overall Study|Adverse Event|0|||
130502035|NCT02852824|469805954|FG002|Overall Study|Adverse Event|0|||
130502036|NCT02852824|469805955|FG003|Overall Study|Adverse Event|0|||
130502037|NCT02852824|469805956|FG004|Overall Study|Adverse Event|2|||
130502038|NCT02852824|469805957|FG005|Overall Study|Adverse Event|0|||
130502039|NCT02852824|469805958|FG006|Overall Study|Adverse Event|0|||
130502040|NCT03775213|469805959|FG000|Overall Study|Withdrawal by Subject|51|||
130502041|NCT03775213|469805960|FG001|Overall Study|Withdrawal by Subject|53|||
130502042|NCT03775213|469805959|FG000|Overall Study|Incomplete Survey|7|||
130502043|NCT03775213|469805960|FG001|Overall Study|Incomplete Survey|7|||
130502044|NCT00786188|469805961|FG000|Overall Study|Adverse Event|3|||
130502045|NCT00786188|469805962|FG001|Overall Study|Adverse Event|1|||
130502046|NCT00786188|469805961|FG000|Overall Study|Withdrawal by Subject|2|||
130502047|NCT00786188|469805962|FG001|Overall Study|Withdrawal by Subject|0|||
130502048|NCT03928743|469808170|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
130502049|NCT03928743|469808171|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
130502050|NCT03928743|469808172|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
130502051|NCT03928743|469808170|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
130502052|NCT03928743|469808171|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
130502053|NCT03928743|469808172|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
130502054|NCT03928743|469808170|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
130502055|NCT03928743|469808171|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
130502056|NCT03928743|469808172|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
130502057|NCT03928743|469808170|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
130502058|NCT03928743|469808171|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
130502059|NCT03928743|469808172|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
130502060|NCT03928743|469808170|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
130502061|NCT03928743|469808171|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
130502062|NCT03928743|469808172|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
130502063|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
130502064|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
130502065|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
130502066|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
130502067|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
130502068|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
130502069|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
130502070|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
130502071|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
130502072|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
130502073|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
130502074|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
130502075|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
130502076|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
130502077|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
130502078|NCT03928743|469808170|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
130502079|NCT03928743|469808171|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
130502080|NCT03928743|469808172|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
130502081|NCT02236611|469808174|FG000|Overall Study|Adverse Event|10|||
130502082|NCT02236611|469808175|FG001|Overall Study|Adverse Event|16|||
130502083|NCT02236611|469808174|FG000|Overall Study|Lack of Efficacy|4|||
130502084|NCT02236611|469808175|FG001|Overall Study|Lack of Efficacy|7|||
130502085|NCT02236611|469808174|FG000|Overall Study|Lost to Follow-up|0|||
130502086|NCT02236611|469808175|FG001|Overall Study|Lost to Follow-up|2|||
130502087|NCT02236611|469808174|FG000|Overall Study|Protocol deviation|3|||
130502088|NCT02236611|469808175|FG001|Overall Study|Protocol deviation|5|||
130502089|NCT02236611|469808174|FG000|Overall Study|Withdrew consent|9|||
130502090|NCT02236611|469808175|FG001|Overall Study|Withdrew consent|4|||
130729971|NCT00191191|470633653|FG001|Overall Study|Entry Criteria Exclusion|0|||
130729972|NCT00191191|470633652|FG000|Overall Study|Treated with Another Systemic Agent|1|||
130729973|NCT00191191|470633653|FG001|Overall Study|Treated with Another Systemic Agent|1|||
130729974|NCT00191191|470633652|FG000|Overall Study|Adverse Event|11|||
130502091|NCT01450007|469808176|FG000|Overall Study|Late exclusion before treatment|2|||
130729975|NCT00191191|470633653|FG001|Overall Study|Adverse Event|21|||
130502092|NCT01450007|469808177|FG001|Overall Study|Late exclusion before treatment|3|||
130502093|NCT01450007|469808178|FG002|Overall Study|Late exclusion before treatment|2|||
130502094|NCT01450007|469808176|FG000|Overall Study|Protocol Violation|0|||
130502095|NCT01450007|469808177|FG001|Overall Study|Protocol Violation|1|||
130502096|NCT01450007|469808178|FG002|Overall Study|Protocol Violation|1|||
130502097|NCT01450007|469808176|FG000|Overall Study|Adverse Event|0|||
130502098|NCT01450007|469808177|FG001|Overall Study|Adverse Event|1|||
130502099|NCT01450007|469808178|FG002|Overall Study|Adverse Event|0|||
130502100|NCT03851094|469808180|FG000|Overall Study|Withdrawal by Subject|0|||
130502101|NCT03851094|469808181|FG001|Overall Study|Withdrawal by Subject|1|||
130502102|NCT03851094|469808180|FG000|Overall Study|Participant lost device|0|||
130502103|NCT03851094|469808181|FG001|Overall Study|Participant lost device|1|||
130502104|NCT03851094|469808180|FG000|Overall Study|Participant returned device|0|||
130502105|NCT03851094|469808181|FG001|Overall Study|Participant returned device|2|||
130502106|NCT01536704|469808182|FG000|Washout Period 1|Withdrawal by Subject|1|||
130502107|NCT01536704|469808183|FG001|Washout Period 1|Withdrawal by Subject|2|||
130502108|NCT01536704|469808184|FG002|Washout Period 1|Withdrawal by Subject|0|||
130502109|NCT01536704|469808185|FG003|Washout Period 1|Withdrawal by Subject|0|||
130502110|NCT01536704|469808182|FG000|Washout Period 2|Adverse Event|1|||
130502111|NCT01536704|469808183|FG001|Washout Period 2|Adverse Event|0|||
130502112|NCT01536704|469808184|FG002|Washout Period 2|Adverse Event|0|||
130502113|NCT01536704|469808185|FG003|Washout Period 2|Adverse Event|0|||
130502114|NCT01536704|469808182|FG000|Washout Period 2|Withdrawal by Subject|0|||
130502115|NCT01536704|469808183|FG001|Washout Period 2|Withdrawal by Subject|0|||
130502116|NCT01536704|469808184|FG002|Washout Period 2|Withdrawal by Subject|0|||
130502117|NCT01536704|469808185|FG003|Washout Period 2|Withdrawal by Subject|1|||
130502118|NCT01536704|469808182|FG000|Period 3|Adverse Event|0|||
130502119|NCT01536704|469808183|FG001|Period 3|Adverse Event|0|||
130502120|NCT01536704|469808184|FG002|Period 3|Adverse Event|0|||
130502121|NCT01536704|469808185|FG003|Period 3|Adverse Event|1|||
130502122|NCT01536704|469808182|FG000|Washout Period 3|Adverse Event|0|||
130502123|NCT01536704|469808183|FG001|Washout Period 3|Adverse Event|0|||
130502124|NCT01536704|469808184|FG002|Washout Period 3|Adverse Event|1|||
130502125|NCT01536704|469808185|FG003|Washout Period 3|Adverse Event|0|||
130502126|NCT02392507|469808186|FG000|Induction Regimen|Death|3|||
130502127|NCT02392507|469808186|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
130502128|NCT02392507|469808186|FG000|Induction Regimen|Physician Decision|1|||
130502129|NCT02392507|469808186|FG000|Induction Regimen|Withdrawal by Subject|2|||
130502130|NCT02392507|469808186|FG000|Maintenance Regimen|Death|1|||
130502131|NCT02392507|469808186|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
130502132|NCT00240994|469808187|FG000|Overall Study|Lost to Follow-up|1|||
130502133|NCT00240994|469808187|FG000|Overall Study|Protocol Violation|1|||
130502134|NCT00240994|469808187|FG000|Overall Study|Graft failure|1|||
130502135|NCT00749944|469808190|FG000|Overall Study|Lost to Follow-up|2|||
130502136|NCT00749944|469808191|FG001|Overall Study|Lost to Follow-up|1|||
130502137|NCT00749944|469808190|FG000|Overall Study|Other|1|||
130502138|NCT00749944|469808191|FG001|Overall Study|Other|0|||
130502139|NCT00749944|469808190|FG000|Overall Study|Withdrawal by Subject|2|||
130502140|NCT00749944|469808191|FG001|Overall Study|Withdrawal by Subject|0|||
130502141|NCT00624377|469808194|FG000|Overall Study|Lost to Follow-up|355|||
130502142|NCT00624377|469808194|FG000|Overall Study|Withdrawal by Subject|100|||
130502143|NCT00624377|469808194|FG000|Overall Study|Adverse Event|14|||
130502144|NCT00624377|469808194|FG000|Overall Study|Other|91|||
130502145|NCT00624377|469808194|FG000|Overall Study|Non-evaluable population|84|||
130502146|NCT00923078|469808198|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
130502147|NCT00923078|469808199|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
130502148|NCT00923078|469808200|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
130502149|NCT00923078|469808198|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
130502150|NCT00923078|469808199|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
130502151|NCT00923078|469808200|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
130502152|NCT02404441|469808214|FG000|Phase 1 Part|Adverse Event|1|||
130502153|NCT02404441|469808215|FG001|Phase 1 Part|Adverse Event|0|||
130502154|NCT02404441|469808216|FG002|Phase 1 Part|Adverse Event|0|||
130502155|NCT02404441|469808217|FG003|Phase 1 Part|Adverse Event|0|||
130502156|NCT02404441|469808218|FG004|Phase 1 Part|Adverse Event|0|||
130502157|NCT02404441|469808219|FG005|Phase 1 Part|Adverse Event|0|||
130502158|NCT02404441|469808220|FG006|Phase 1 Part|Adverse Event|0|||
130729976|NCT00191191|470633652|FG000|Overall Study|Progressive Disease|84|||
130729977|NCT00191191|470633653|FG001|Overall Study|Progressive Disease|72|||
130502159|NCT02404441|469808221|FG007|Phase 1 Part|Adverse Event|0|||
130502160|NCT02404441|469808222|FG008|Phase 1 Part|Adverse Event|0|||
130502161|NCT02404441|469808223|FG009|Phase 1 Part|Adverse Event|0|||
130502162|NCT02404441|469808214|FG000|Phase 1 Part|Physician Decision|0|||
130502163|NCT02404441|469808215|FG001|Phase 1 Part|Physician Decision|1|||
130502164|NCT02404441|469808216|FG002|Phase 1 Part|Physician Decision|0|||
130502165|NCT02404441|469808217|FG003|Phase 1 Part|Physician Decision|0|||
130502166|NCT02404441|469808218|FG004|Phase 1 Part|Physician Decision|0|||
130502167|NCT02404441|469808219|FG005|Phase 1 Part|Physician Decision|0|||
130502168|NCT02404441|469808220|FG006|Phase 1 Part|Physician Decision|0|||
130502169|NCT02404441|469808221|FG007|Phase 1 Part|Physician Decision|0|||
130502170|NCT02404441|469808222|FG008|Phase 1 Part|Physician Decision|0|||
130502171|NCT02404441|469808223|FG009|Phase 1 Part|Physician Decision|0|||
130502172|NCT02404441|469808214|FG000|Phase 1 Part|Progressive Disease|14|||
130502173|NCT02404441|469808215|FG001|Phase 1 Part|Progressive Disease|11|||
130502174|NCT02404441|469808216|FG002|Phase 1 Part|Progressive Disease|7|||
130502175|NCT02404441|469808217|FG003|Phase 1 Part|Progressive Disease|6|||
130502176|NCT02404441|469808218|FG004|Phase 1 Part|Progressive Disease|9|||
130502177|NCT02404441|469808219|FG005|Phase 1 Part|Progressive Disease|0|||
130502178|NCT02404441|469808220|FG006|Phase 1 Part|Progressive Disease|0|||
130502179|NCT02404441|469808221|FG007|Phase 1 Part|Progressive Disease|0|||
130502180|NCT02404441|469808222|FG008|Phase 1 Part|Progressive Disease|0|||
130502181|NCT02404441|469808223|FG009|Phase 1 Part|Progressive Disease|0|||
130502182|NCT02404441|469808214|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
130502183|NCT02404441|469808215|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
130502184|NCT02404441|469808216|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
130502185|NCT02404441|469808217|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
130502186|NCT02404441|469808218|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
130502187|NCT02404441|469808219|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
130502188|NCT02404441|469808220|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
130502189|NCT02404441|469808221|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
130502190|NCT02404441|469808222|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
130502191|NCT02404441|469808223|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
130502192|NCT02404441|469808214|FG000|Phase 1 Part|Death|1|||
130502193|NCT02404441|469808215|FG001|Phase 1 Part|Death|1|||
130502194|NCT02404441|469808216|FG002|Phase 1 Part|Death|1|||
130502195|NCT02404441|469808217|FG003|Phase 1 Part|Death|0|||
130502196|NCT02404441|469808218|FG004|Phase 1 Part|Death|1|||
130502197|NCT02404441|469808219|FG005|Phase 1 Part|Death|0|||
130502198|NCT02404441|469808220|FG006|Phase 1 Part|Death|0|||
130502199|NCT02404441|469808221|FG007|Phase 1 Part|Death|0|||
130502200|NCT02404441|469808222|FG008|Phase 1 Part|Death|0|||
130502201|NCT02404441|469808223|FG009|Phase 1 Part|Death|0|||
130502202|NCT02404441|469808214|FG000|Phase 2 Part|Adverse Event|0|||
130502203|NCT02404441|469808215|FG001|Phase 2 Part|Adverse Event|0|||
130502204|NCT02404441|469808216|FG002|Phase 2 Part|Adverse Event|0|||
130502205|NCT02404441|469808217|FG003|Phase 2 Part|Adverse Event|0|||
130502206|NCT02404441|469808218|FG004|Phase 2 Part|Adverse Event|0|||
130502207|NCT02404441|469808219|FG005|Phase 2 Part|Adverse Event|2|||
130502208|NCT02404441|469808220|FG006|Phase 2 Part|Adverse Event|3|||
130502209|NCT02404441|469808221|FG007|Phase 2 Part|Adverse Event|3|||
130502210|NCT02404441|469808222|FG008|Phase 2 Part|Adverse Event|6|||
130502211|NCT02404441|469808223|FG009|Phase 2 Part|Adverse Event|1|||
130502212|NCT02404441|469808214|FG000|Phase 2 Part|Physician Decision|0|||
130502213|NCT02404441|469808215|FG001|Phase 2 Part|Physician Decision|0|||
130502214|NCT02404441|469808216|FG002|Phase 2 Part|Physician Decision|0|||
130502215|NCT02404441|469808217|FG003|Phase 2 Part|Physician Decision|0|||
130502216|NCT02404441|469808218|FG004|Phase 2 Part|Physician Decision|0|||
130502217|NCT02404441|469808219|FG005|Phase 2 Part|Physician Decision|7|||
130502218|NCT02404441|469808220|FG006|Phase 2 Part|Physician Decision|9|||
130502219|NCT02404441|469808221|FG007|Phase 2 Part|Physician Decision|2|||
130502220|NCT02404441|469808222|FG008|Phase 2 Part|Physician Decision|1|||
130502221|NCT02404441|469808223|FG009|Phase 2 Part|Physician Decision|3|||
130502222|NCT02404441|469808214|FG000|Phase 2 Part|Progressive disease|0|||
130502223|NCT02404441|469808215|FG001|Phase 2 Part|Progressive disease|0|||
130502224|NCT02404441|469808216|FG002|Phase 2 Part|Progressive disease|0|||
130565731|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
130565732|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
130502225|NCT02404441|469808217|FG003|Phase 2 Part|Progressive disease|0|||
130502226|NCT02404441|469808218|FG004|Phase 2 Part|Progressive disease|0|||
130502227|NCT02404441|469808219|FG005|Phase 2 Part|Progressive disease|43|||
130502228|NCT02404441|469808220|FG006|Phase 2 Part|Progressive disease|32|||
130502229|NCT02404441|469808221|FG007|Phase 2 Part|Progressive disease|31|||
130502230|NCT02404441|469808222|FG008|Phase 2 Part|Progressive disease|39|||
130502231|NCT02404441|469808223|FG009|Phase 2 Part|Progressive disease|27|||
130502232|NCT02404441|469808214|FG000|Phase 2 Part|Subject/guardian decision|0|||
130502233|NCT02404441|469808215|FG001|Phase 2 Part|Subject/guardian decision|0|||
130502234|NCT02404441|469808216|FG002|Phase 2 Part|Subject/guardian decision|0|||
130502235|NCT02404441|469808217|FG003|Phase 2 Part|Subject/guardian decision|0|||
130502236|NCT02404441|469808218|FG004|Phase 2 Part|Subject/guardian decision|0|||
130502237|NCT02404441|469808219|FG005|Phase 2 Part|Subject/guardian decision|3|||
130502238|NCT02404441|469808220|FG006|Phase 2 Part|Subject/guardian decision|9|||
130502239|NCT02404441|469808221|FG007|Phase 2 Part|Subject/guardian decision|0|||
130502240|NCT02404441|469808222|FG008|Phase 2 Part|Subject/guardian decision|3|||
130502241|NCT02404441|469808223|FG009|Phase 2 Part|Subject/guardian decision|2|||
130502242|NCT02404441|469808214|FG000|Phase 2 Part|Death|0|||
130502243|NCT02404441|469808215|FG001|Phase 2 Part|Death|0|||
130502244|NCT02404441|469808216|FG002|Phase 2 Part|Death|0|||
130565733|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
130565734|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
130565735|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
130565736|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
130565737|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
130565738|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
130565739|NCT00843518|470036999|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
130565740|NCT00843518|470037000|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
130565741|NCT00827606|470037001|FG000|Overall Study|Protocol Violation|4|||
130502245|NCT02404441|469808217|FG003|Phase 2 Part|Death|0|||
130502246|NCT02404441|469808218|FG004|Phase 2 Part|Death|0|||
130502247|NCT02404441|469808219|FG005|Phase 2 Part|Death|4|||
130502248|NCT02404441|469808220|FG006|Phase 2 Part|Death|8|||
130502249|NCT02404441|469808221|FG007|Phase 2 Part|Death|4|||
130502250|NCT02404441|469808222|FG008|Phase 2 Part|Death|10|||
130502251|NCT02404441|469808223|FG009|Phase 2 Part|Death|9|||
130502252|NCT01972776|469808232|FG000|Part 1|Withdrawal by Subject|0|||
130502253|NCT01972776|469808233|FG001|Part 1|Withdrawal by Subject|0|||
130502254|NCT01972776|469808234|FG002|Part 1|Withdrawal by Subject|1|||
130502255|NCT01972776|469808235|FG003|Part 1|Withdrawal by Subject|0|||
130502256|NCT01972776|469808236|FG004|Part 1|Withdrawal by Subject|0|||
130502257|NCT01972776|469808237|FG005|Part 1|Withdrawal by Subject|0|||
130502258|NCT01972776|469808232|FG000|Part 1|Adverse Event|0|||
130502259|NCT01972776|469808233|FG001|Part 1|Adverse Event|0|||
130502260|NCT01972776|469808234|FG002|Part 1|Adverse Event|1|||
130502261|NCT01972776|469808235|FG003|Part 1|Adverse Event|1|||
130502262|NCT01972776|469808236|FG004|Part 1|Adverse Event|0|||
130502263|NCT01972776|469808237|FG005|Part 1|Adverse Event|0|||
130502264|NCT01972776|469808232|FG000|Part 2|Adverse Event|0|||
130502265|NCT01972776|469808233|FG001|Part 2|Adverse Event|0|||
130502266|NCT01972776|469808234|FG002|Part 2|Adverse Event|0|||
130502267|NCT01972776|469808235|FG003|Part 2|Adverse Event|0|||
130502268|NCT01972776|469808236|FG004|Part 2|Adverse Event|3|||
130502269|NCT01972776|469808237|FG005|Part 2|Adverse Event|0|||
130502270|NCT01972776|469808232|FG000|Part 2|Administrative problems|0|||
130502271|NCT01972776|469808233|FG001|Part 2|Administrative problems|0|||
130502272|NCT01972776|469808234|FG002|Part 2|Administrative problems|0|||
130502273|NCT01972776|469808235|FG003|Part 2|Administrative problems|0|||
130502274|NCT01972776|469808236|FG004|Part 2|Administrative problems|10|||
130502275|NCT01972776|469808237|FG005|Part 2|Administrative problems|7|||
130502276|NCT02037568|469808238|FG000|Overall Study|Withdrawal by Subject|17|||
130502277|NCT02037568|469808239|FG001|Overall Study|Withdrawal by Subject|24|||
130502278|NCT02037568|469808238|FG000|Overall Study|Lost to Follow-up|16|||
130502279|NCT02037568|469808239|FG001|Overall Study|Lost to Follow-up|13|||
130502280|NCT02037568|469808238|FG000|Overall Study|Screen Failure|3|||
130502281|NCT02037568|469808239|FG001|Overall Study|Screen Failure|1|||
130502282|NCT02037568|469808238|FG000|Overall Study|Patient did not receive transplant|0|||
130502283|NCT02037568|469808239|FG001|Overall Study|Patient did not receive transplant|1|||
130502284|NCT00721734|469808243|FG000|Overall Study|Progressive Disease|3|||
130502285|NCT00721734|469808244|FG001|Overall Study|Progressive Disease|10|||
130502286|NCT00721734|469808245|FG002|Overall Study|Progressive Disease|4|||
130502287|NCT00721734|469808246|FG003|Overall Study|Progressive Disease|5|||
130502288|NCT00721734|469808247|FG004|Overall Study|Progressive Disease|2|||
130502289|NCT00721734|469808243|FG000|Overall Study|Adverse Event|3|||
130502290|NCT00721734|469808244|FG001|Overall Study|Adverse Event|1|||
130502291|NCT00721734|469808245|FG002|Overall Study|Adverse Event|4|||
130502292|NCT00721734|469808246|FG003|Overall Study|Adverse Event|0|||
130502293|NCT00721734|469808247|FG004|Overall Study|Adverse Event|3|||
130502294|NCT00721734|469808243|FG000|Overall Study|Withdrawal by Subject|2|||
130502295|NCT00721734|469808244|FG001|Overall Study|Withdrawal by Subject|1|||
130502296|NCT00721734|469808245|FG002|Overall Study|Withdrawal by Subject|0|||
130502297|NCT00721734|469808246|FG003|Overall Study|Withdrawal by Subject|0|||
130502298|NCT00721734|469808247|FG004|Overall Study|Withdrawal by Subject|1|||
130502299|NCT00721734|469808243|FG000|Overall Study|Other|0|||
130502300|NCT00721734|469808244|FG001|Overall Study|Other|0|||
130502301|NCT00721734|469808245|FG002|Overall Study|Other|0|||
130502302|NCT00721734|469808246|FG003|Overall Study|Other|1|||
130502303|NCT00721734|469808247|FG004|Overall Study|Other|0|||
130502304|NCT00621842|469808248|FG000|Overall Study|Adverse Event|6|||
130502305|NCT00621842|469808248|FG000|Overall Study|Withdrawal by Subject|7|||
130502306|NCT00621842|469808248|FG000|Overall Study|Protocol Violation|4|||
130502307|NCT00621842|469808248|FG000|Overall Study|Lack of Efficacy|2|||
130502308|NCT01989689|469808250|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
130502309|NCT01989689|469808251|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
130502310|NCT01989689|469808250|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
130565742|NCT00827606|470037002|FG001|Overall Study|Protocol Violation|3|||
130565743|NCT00827606|470037001|FG000|Overall Study|Lost to Follow-up|3|||
130502311|NCT01989689|469808251|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
130502312|NCT00526994|469808252|FG000|Overall Study|Lost to Follow-up|98|||
130502313|NCT00526994|469808253|FG001|Overall Study|Lost to Follow-up|108|||
130502314|NCT00526994|469808254|FG002|Overall Study|Lost to Follow-up|96|||
130502315|NCT00526994|469808252|FG000|Overall Study|Death|4|||
130502316|NCT00526994|469808253|FG001|Overall Study|Death|3|||
130502317|NCT00526994|469808254|FG002|Overall Study|Death|3|||
130502318|NCT00526994|469808252|FG000|Overall Study|Withdrawal by Subject|2|||
130502319|NCT00526994|469808253|FG001|Overall Study|Withdrawal by Subject|7|||
130502320|NCT00526994|469808254|FG002|Overall Study|Withdrawal by Subject|5|||
130502321|NCT00526994|469808252|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
130502322|NCT00526994|469808253|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
130502323|NCT00526994|469808254|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
130502324|NCT03938272|469808255|FG000|Overall Study|Withdrawal by Subject|1|||
130502325|NCT03938272|469808256|FG001|Overall Study|Withdrawal by Subject|0|||
130502326|NCT03938272|469808255|FG000|Overall Study|Physician Decision|0|||
130502327|NCT03938272|469808256|FG001|Overall Study|Physician Decision|2|||
130502328|NCT03938272|469808255|FG000|Overall Study|Study termination by sponsor|10|||
130502329|NCT03938272|469808256|FG001|Overall Study|Study termination by sponsor|8|||
130502330|NCT01419184|469808260|FG000|Overall Study|Site data not available|3|||
130502331|NCT01419184|469808261|FG001|Overall Study|Site data not available|2|||
130502332|NCT01419184|469808260|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
130502333|NCT01419184|469808261|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
130502334|NCT01419184|469808260|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
130502335|NCT01419184|469808261|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
130502336|NCT01419184|469808260|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
130502337|NCT01419184|469808261|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
130502338|NCT01419184|469808260|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
130502339|NCT01419184|469808261|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
130502340|NCT01419184|469808260|FG000|Overall Study|Participant randomized, not treated|1|||
130502341|NCT01419184|469808261|FG001|Overall Study|Participant randomized, not treated|0|||
130502342|NCT03692871|469808264|FG000|Overall Study|Death|1|||
130502343|NCT03692871|469808265|FG001|Overall Study|Death|1|||
130502344|NCT03692871|469808264|FG000|Overall Study|Lost to Follow-up|24|||
130502345|NCT03692871|469808265|FG001|Overall Study|Lost to Follow-up|9|||
130502346|NCT03692871|469808264|FG000|Overall Study|Physician Decision|22|||
130502347|NCT03692871|469808265|FG001|Overall Study|Physician Decision|7|||
130502348|NCT03692871|469808264|FG000|Overall Study|Protocol Deviation|1|||
130502349|NCT03692871|469808265|FG001|Overall Study|Protocol Deviation|0|||
130502350|NCT03692871|469808264|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
130502351|NCT03692871|469808265|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
130502352|NCT03989232|469808268|FG000|Overall Study|Lost to Follow-up|3|||
130502353|NCT03989232|469808269|FG001|Overall Study|Lost to Follow-up|10|||
130502354|NCT03989232|469808268|FG000|Overall Study|Withdrawal by Subject|6|||
130502355|NCT03989232|469808269|FG001|Overall Study|Withdrawal by Subject|6|||
130502356|NCT03989232|469808268|FG000|Overall Study|Death|1|||
130502357|NCT03989232|469808269|FG001|Overall Study|Death|2|||
130502358|NCT02644122|469808271|FG000|Overall Study|Withdrawal by Subject|1|||
130502359|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
130502360|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
130502361|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
130502362|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
130502363|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
130502364|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
130502365|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
130502366|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
130502367|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
130502368|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
130502369|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
130502370|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
130502371|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
130502372|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
130502373|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
130502374|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
130502375|NCT03182244|469808272|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
130565744|NCT00827606|470037002|FG001|Overall Study|Lost to Follow-up|1|||
130729978|NCT00191191|470633652|FG000|Overall Study|Toxicity After Dose Reduction|7|||
130502376|NCT03182244|469808273|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
130502377|NCT03182244|469808272|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
130502378|NCT03182244|469808273|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
130502379|NCT03182244|469808272|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
130565745|NCT00827606|470037001|FG000|Overall Study|Withdrawal by Subject|7|||
130729979|NCT00191191|470633653|FG001|Overall Study|Toxicity After Dose Reduction|8|||
130502380|NCT03182244|469808273|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
130502381|NCT03182244|469808272|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
130502382|NCT03182244|469808273|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
130502383|NCT03182244|469808272|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
130502384|NCT03182244|469808273|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
130502385|NCT00680771|469808281|FG000|Overall Study|Withdrawal by Subject|1|||
130502386|NCT00680771|469808282|FG001|Overall Study|Withdrawal by Subject|0|||
130502387|NCT00680771|469808281|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
130502388|NCT00680771|469808282|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
130502389|NCT00680771|469808281|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
130502390|NCT00680771|469808282|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
130502391|NCT01316913|469808283|FG000|Overall Study|Adverse Event|17|||
130502392|NCT01316913|469808284|FG001|Overall Study|Adverse Event|20|||
130502393|NCT01316913|469808285|FG002|Overall Study|Adverse Event|15|||
130502394|NCT01316913|469808286|FG003|Overall Study|Adverse Event|11|||
130502395|NCT01316913|469808283|FG000|Overall Study|Lack of Efficacy|22|||
130502396|NCT01316913|469808284|FG001|Overall Study|Lack of Efficacy|12|||
130502397|NCT01316913|469808285|FG002|Overall Study|Lack of Efficacy|9|||
130502398|NCT01316913|469808286|FG003|Overall Study|Lack of Efficacy|13|||
130565746|NCT00827606|470037002|FG001|Overall Study|Withdrawal by Subject|6|||
130502399|NCT01316913|469808283|FG000|Overall Study|Protocol Violation|1|||
130502400|NCT01316913|469808284|FG001|Overall Study|Protocol Violation|4|||
130502401|NCT01316913|469808285|FG002|Overall Study|Protocol Violation|4|||
130502402|NCT01316913|469808286|FG003|Overall Study|Protocol Violation|1|||
130502403|NCT01316913|469808283|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
130502404|NCT01316913|469808284|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
130502405|NCT01316913|469808285|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
130502406|NCT01316913|469808286|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
130502407|NCT01316913|469808283|FG000|Overall Study|Lost to Follow-up|0|||
130502408|NCT01316913|469808284|FG001|Overall Study|Lost to Follow-up|1|||
130502409|NCT01316913|469808285|FG002|Overall Study|Lost to Follow-up|0|||
130502410|NCT01316913|469808286|FG003|Overall Study|Lost to Follow-up|2|||
130502411|NCT01316913|469808283|FG000|Overall Study|Withdrawal by Subject|10|||
130502412|NCT01316913|469808284|FG001|Overall Study|Withdrawal by Subject|9|||
130502413|NCT01316913|469808285|FG002|Overall Study|Withdrawal by Subject|10|||
130502414|NCT01316913|469808286|FG003|Overall Study|Withdrawal by Subject|6|||
130502415|NCT02691702|469808287|FG000|Overall Study|Adverse Event|1|||
130502416|NCT02691702|469808288|FG001|Overall Study|Adverse Event|0|||
130502417|NCT02691702|469808289|FG002|Overall Study|Adverse Event|0|||
130502418|NCT02691702|469808290|FG003|Overall Study|Adverse Event|0|||
130502419|NCT02691702|469808291|FG004|Overall Study|Adverse Event|0|||
130502420|NCT02691702|469808292|FG005|Overall Study|Adverse Event|0|||
130502421|NCT02691702|469808293|FG006|Overall Study|Adverse Event|0|||
130502422|NCT02691702|469808294|FG007|Overall Study|Adverse Event|0|||
130502423|NCT02691702|469808295|FG008|Overall Study|Adverse Event|1|||
130502424|NCT02691702|469808296|FG009|Overall Study|Adverse Event|0|||
130502425|NCT02691702|469808297|FG010|Overall Study|Adverse Event|1|||
130502426|NCT02691702|469808287|FG000|Overall Study|Lost to Follow-up|0|||
130502427|NCT02691702|469808288|FG001|Overall Study|Lost to Follow-up|0|||
130502428|NCT02691702|469808289|FG002|Overall Study|Lost to Follow-up|1|||
130502429|NCT02691702|469808290|FG003|Overall Study|Lost to Follow-up|0|||
130502430|NCT02691702|469808291|FG004|Overall Study|Lost to Follow-up|0|||
130502431|NCT02691702|469808292|FG005|Overall Study|Lost to Follow-up|2|||
130502432|NCT02691702|469808293|FG006|Overall Study|Lost to Follow-up|0|||
130502433|NCT02691702|469808294|FG007|Overall Study|Lost to Follow-up|0|||
130502434|NCT02691702|469808295|FG008|Overall Study|Lost to Follow-up|0|||
130502435|NCT02691702|469808296|FG009|Overall Study|Lost to Follow-up|0|||
130502436|NCT02691702|469808297|FG010|Overall Study|Lost to Follow-up|1|||
130502437|NCT02691702|469808287|FG000|Overall Study|Withdrawal by Subject|1|||
130502438|NCT02691702|469808288|FG001|Overall Study|Withdrawal by Subject|1|||
130502439|NCT02691702|469808289|FG002|Overall Study|Withdrawal by Subject|0|||
130502440|NCT02691702|469808290|FG003|Overall Study|Withdrawal by Subject|0|||
130502441|NCT02691702|469808291|FG004|Overall Study|Withdrawal by Subject|0|||
130502442|NCT02691702|469808292|FG005|Overall Study|Withdrawal by Subject|1|||
130502443|NCT02691702|469808293|FG006|Overall Study|Withdrawal by Subject|2|||
130502444|NCT02691702|469808294|FG007|Overall Study|Withdrawal by Subject|0|||
130502445|NCT02691702|469808295|FG008|Overall Study|Withdrawal by Subject|0|||
130565747|NCT00827606|470037001|FG000|Overall Study|Pregnancy|0|||
130565748|NCT00827606|470037002|FG001|Overall Study|Pregnancy|1|||
130565749|NCT00827606|470037001|FG000|Overall Study|Other|5|||
130565750|NCT00827606|470037002|FG001|Overall Study|Other|13|||
130565751|NCT00827606|470037001|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
130565752|NCT00827606|470037002|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
130565753|NCT00827606|470037001|FG000|Overall Study|Adverse Event|4|||
130502446|NCT02691702|469808296|FG009|Overall Study|Withdrawal by Subject|0|||
130502447|NCT02691702|469808297|FG010|Overall Study|Withdrawal by Subject|0|||
130502448|NCT02691702|469808287|FG000|Overall Study|Other|0|||
130502449|NCT02691702|469808288|FG001|Overall Study|Other|0|||
130502450|NCT02691702|469808289|FG002|Overall Study|Other|0|||
130502451|NCT02691702|469808290|FG003|Overall Study|Other|0|||
130502452|NCT02691702|469808291|FG004|Overall Study|Other|0|||
130502453|NCT02691702|469808292|FG005|Overall Study|Other|0|||
130502454|NCT02691702|469808293|FG006|Overall Study|Other|1|||
130565754|NCT00827606|470037002|FG001|Overall Study|Adverse Event|2|||
130502455|NCT02691702|469808294|FG007|Overall Study|Other|0|||
130729980|NCT00191191|470633652|FG000|Overall Study|Family/Caregiver Decision|5|||
130502456|NCT02691702|469808295|FG008|Overall Study|Other|1|||
130502457|NCT02691702|469808296|FG009|Overall Study|Other|0|||
130502458|NCT02691702|469808297|FG010|Overall Study|Other|0|||
130502459|NCT02691702|469808287|FG000|Overall Study|Protocol Violation|0|||
130502460|NCT02691702|469808288|FG001|Overall Study|Protocol Violation|0|||
130502461|NCT02691702|469808289|FG002|Overall Study|Protocol Violation|0|||
130729981|NCT00191191|470633653|FG001|Overall Study|Family/Caregiver Decision|7|||
130502462|NCT02691702|469808290|FG003|Overall Study|Protocol Violation|0|||
130502463|NCT02691702|469808291|FG004|Overall Study|Protocol Violation|0|||
130502464|NCT02691702|469808292|FG005|Overall Study|Protocol Violation|0|||
130502465|NCT02691702|469808293|FG006|Overall Study|Protocol Violation|0|||
130502466|NCT02691702|469808294|FG007|Overall Study|Protocol Violation|0|||
130565755|NCT04037748|470037005|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130565756|NCT04037748|470037006|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130502467|NCT02691702|469808295|FG008|Overall Study|Protocol Violation|0|||
130502468|NCT02691702|469808296|FG009|Overall Study|Protocol Violation|2|||
130502469|NCT02691702|469808297|FG010|Overall Study|Protocol Violation|0|||
130502470|NCT05169684|469808298|FG000|Overall Study|Adverse Event|1|||
130502471|NCT05169684|469808299|FG001|Overall Study|Adverse Event|3|||
130502472|NCT05169684|469808298|FG000|Overall Study|Physician Decision|0|||
130502473|NCT05169684|469808299|FG001|Overall Study|Physician Decision|1|||
130502474|NCT05169684|469808298|FG000|Overall Study|Progressive Disease|1|||
130502475|NCT05169684|469808299|FG001|Overall Study|Progressive Disease|1|||
130502476|NCT05169684|469808298|FG000|Overall Study|Participant request to discontinue treatment|0|||
130502477|NCT05169684|469808299|FG001|Overall Study|Participant request to discontinue treatment|1|||
130502478|NCT05169684|469808298|FG000|Overall Study|Other Reason|0|||
130502479|NCT05169684|469808299|FG001|Overall Study|Other Reason|1|||
130502480|NCT01668719|469808300|FG000|Phase I|On treatment|1|||
130502481|NCT01668719|469808301|FG001|Phase I|On treatment|0|||
130502482|NCT01668719|469808302|FG002|Phase I|On treatment|0|||
130502483|NCT01668719|469808300|FG000|Phase I|Adverse Event|2|||
130502484|NCT01668719|469808301|FG001|Phase I|Adverse Event|0|||
130502485|NCT01668719|469808302|FG002|Phase I|Adverse Event|0|||
130502486|NCT01668719|469808300|FG000|Phase I|Progression/relapse|1|||
130502487|NCT01668719|469808301|FG001|Phase I|Progression/relapse|0|||
130502488|NCT01668719|469808302|FG002|Phase I|Progression/relapse|0|||
130502489|NCT01668719|469808300|FG000|Phase I|not protocol specified|2|||
130502490|NCT01668719|469808301|FG001|Phase I|not protocol specified|0|||
130502491|NCT01668719|469808302|FG002|Phase I|not protocol specified|0|||
130502492|NCT01668719|469808300|FG000|Phase II|On treatment|0|||
130502493|NCT01668719|469808301|FG001|Phase II|On treatment|4|||
130502494|NCT01668719|469808302|FG002|Phase II|On treatment|3|||
130502495|NCT01668719|469808300|FG000|Phase II|Adverse Event|0|||
130502496|NCT01668719|469808301|FG001|Phase II|Adverse Event|18|||
130502497|NCT01668719|469808302|FG002|Phase II|Adverse Event|18|||
130502498|NCT01668719|469808300|FG000|Phase II|Refusal unrelated to adverse event|0|||
130502499|NCT01668719|469808301|FG001|Phase II|Refusal unrelated to adverse event|4|||
130502500|NCT01668719|469808302|FG002|Phase II|Refusal unrelated to adverse event|1|||
130502501|NCT01668719|469808300|FG000|Phase II|Progression/relapse|0|||
130502502|NCT01668719|469808301|FG001|Phase II|Progression/relapse|13|||
130502503|NCT01668719|469808302|FG002|Phase II|Progression/relapse|17|||
130502504|NCT01668719|469808300|FG000|Phase II|Death|0|||
130502505|NCT01668719|469808301|FG001|Phase II|Death|0|||
130502506|NCT01668719|469808302|FG002|Phase II|Death|2|||
130502507|NCT01668719|469808300|FG000|Phase II|not protocol specified|0|||
130502508|NCT01668719|469808301|FG001|Phase II|not protocol specified|13|||
130502509|NCT01668719|469808302|FG002|Phase II|not protocol specified|7|||
130502510|NCT02060487|469808303|FG000|Overall Study|Other|1|||
130502511|NCT02060487|469808304|FG001|Overall Study|Other|2|||
130502512|NCT02060487|469808305|FG002|Overall Study|Other|1|||
130502513|NCT02060487|469808303|FG000|Overall Study|Lack of Efficacy|0|||
130502514|NCT02060487|469808304|FG001|Overall Study|Lack of Efficacy|1|||
130502515|NCT02060487|469808305|FG002|Overall Study|Lack of Efficacy|0|||
130502516|NCT02060487|469808303|FG000|Overall Study|Withdrawal by Subject|3|||
130502517|NCT02060487|469808304|FG001|Overall Study|Withdrawal by Subject|10|||
130502518|NCT02060487|469808305|FG002|Overall Study|Withdrawal by Subject|4|||
130502519|NCT02060487|469808303|FG000|Overall Study|Study Terminated By Sponsor|87|||
130502520|NCT02060487|469808304|FG001|Overall Study|Study Terminated By Sponsor|89|||
130502521|NCT02060487|469808305|FG002|Overall Study|Study Terminated By Sponsor|100|||
130502522|NCT02060487|469808303|FG000|Overall Study|Randomized in error|1|||
130502523|NCT02060487|469808304|FG001|Overall Study|Randomized in error|0|||
130502524|NCT02060487|469808305|FG002|Overall Study|Randomized in error|0|||
130502525|NCT02060487|469808303|FG000|Overall Study|Protocol Violation|0|||
130502526|NCT02060487|469808304|FG001|Overall Study|Protocol Violation|1|||
130502527|NCT02060487|469808305|FG002|Overall Study|Protocol Violation|1|||
130502528|NCT02060487|469808303|FG000|Overall Study|Lost to Follow-up|3|||
130502529|NCT02060487|469808304|FG001|Overall Study|Lost to Follow-up|0|||
130502530|NCT02060487|469808305|FG002|Overall Study|Lost to Follow-up|2|||
130502531|NCT02060487|469808303|FG000|Overall Study|Death|34|||
130502532|NCT02060487|469808304|FG001|Overall Study|Death|25|||
130502533|NCT02060487|469808305|FG002|Overall Study|Death|19|||
130502534|NCT02060487|469808303|FG000|Overall Study|Adverse Event|0|||
130502535|NCT02060487|469808304|FG001|Overall Study|Adverse Event|0|||
130502536|NCT02060487|469808305|FG002|Overall Study|Adverse Event|1|||
130502537|NCT05484661|469808306|FG000|Overall Study|Withdrawal by Subject|1|||
130502538|NCT05484661|469808307|FG001|Overall Study|Withdrawal by Subject|0|||
130502539|NCT00875706|469808313|FG000|Overall Study|Withdrawal by Subject|1|||
130502540|NCT00875706|469808314|FG001|Overall Study|Withdrawal by Subject|0|||
130502541|NCT00875706|469808315|FG002|Overall Study|Withdrawal by Subject|0|||
130502542|NCT02970318|469808316|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
130502543|NCT02970318|469808317|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
130502544|NCT02970318|469808318|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
130502545|NCT02970318|469808319|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
130502546|NCT02970318|469808316|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
130502547|NCT02970318|469808317|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
130502548|NCT02970318|469808318|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
130502549|NCT02970318|469808319|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
130502550|NCT02970318|469808316|FG000|Overall for Arm A & Main for Arm B|Death|41|||
130502551|NCT02970318|469808317|FG001|Overall for Arm A & Main for Arm B|Death|33|||
130502552|NCT02970318|469808318|FG002|Overall for Arm A & Main for Arm B|Death|0|||
130502553|NCT02970318|469808319|FG003|Overall for Arm A & Main for Arm B|Death|0|||
130502554|NCT02970318|469808316|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
130502555|NCT02970318|469808317|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
130502556|NCT02970318|469808318|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
130502557|NCT02970318|469808319|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
130502558|NCT02970318|469808316|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
130502559|NCT02970318|469808317|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
130502560|NCT02970318|469808318|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
130502561|NCT02970318|469808319|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
130502562|NCT02970318|469808316|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
130502563|NCT02970318|469808317|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
130502564|NCT02970318|469808318|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
130502565|NCT02970318|469808319|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
130502566|NCT02970318|469808316|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
130502567|NCT02970318|469808317|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
130502568|NCT02970318|469808318|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
130502569|NCT02970318|469808319|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
130502570|NCT00824408|469808320|FG000|Run-in Phase|Progressive disease|4|||
130502571|NCT00824408|469808321|FG001|Run-in Phase|Progressive disease|4|||
130502572|NCT00824408|469808322|FG002|Run-in Phase|Progressive disease|0|||
130502573|NCT00824408|469808323|FG003|Run-in Phase|Progressive disease|0|||
130502574|NCT00824408|469808324|FG004|Run-in Phase|Progressive disease|0|||
130502575|NCT00824408|469808320|FG000|Run-in Phase|Adverse Event|1|||
130502576|NCT00824408|469808321|FG001|Run-in Phase|Adverse Event|1|||
130502577|NCT00824408|469808322|FG002|Run-in Phase|Adverse Event|0|||
130729982|NCT00191191|470633652|FG000|Overall Study|Lost to Follow-up|1|||
130502578|NCT00824408|469808323|FG003|Run-in Phase|Adverse Event|0|||
130502579|NCT00824408|469808324|FG004|Run-in Phase|Adverse Event|0|||
130502580|NCT00824408|469808320|FG000|Run-in Phase|Refused to continue medication|1|||
130502581|NCT00824408|469808321|FG001|Run-in Phase|Refused to continue medication|0|||
130502582|NCT00824408|469808322|FG002|Run-in Phase|Refused to continue medication|0|||
130502583|NCT00824408|469808323|FG003|Run-in Phase|Refused to continue medication|0|||
130502584|NCT00824408|469808324|FG004|Run-in Phase|Refused to continue medication|0|||
130502585|NCT00824408|469808320|FG000|Run-in Phase|Other reason not defined above|0|||
130502586|NCT00824408|469808321|FG001|Run-in Phase|Other reason not defined above|1|||
130502587|NCT00824408|469808322|FG002|Run-in Phase|Other reason not defined above|0|||
130502588|NCT00824408|469808323|FG003|Run-in Phase|Other reason not defined above|0|||
130502589|NCT00824408|469808324|FG004|Run-in Phase|Other reason not defined above|0|||
130502590|NCT00824408|469808320|FG000|Randomized Phase|Not treated|0|||
130502591|NCT00824408|469808321|FG001|Randomized Phase|Not treated|0|||
130502592|NCT00824408|469808322|FG002|Randomized Phase|Not treated|1|||
130502593|NCT00824408|469808323|FG003|Randomized Phase|Not treated|1|||
130502594|NCT00824408|469808324|FG004|Randomized Phase|Not treated|1|||
130502595|NCT00824408|469808320|FG000|Randomized Phase|Progressive disease|0|||
130502596|NCT00824408|469808321|FG001|Randomized Phase|Progressive disease|0|||
130502597|NCT00824408|469808322|FG002|Randomized Phase|Progressive disease|25|||
130502598|NCT00824408|469808323|FG003|Randomized Phase|Progressive disease|36|||
130502599|NCT00824408|469808324|FG004|Randomized Phase|Progressive disease|34|||
130502600|NCT00824408|469808320|FG000|Randomized Phase|Adverse Event|0|||
130502601|NCT00824408|469808321|FG001|Randomized Phase|Adverse Event|0|||
130502602|NCT00824408|469808322|FG002|Randomized Phase|Adverse Event|4|||
130502603|NCT00824408|469808323|FG003|Randomized Phase|Adverse Event|5|||
130502604|NCT00824408|469808324|FG004|Randomized Phase|Adverse Event|5|||
130502605|NCT00824408|469808320|FG000|Randomized Phase|Refused to continue medication|0|||
130502606|NCT00824408|469808321|FG001|Randomized Phase|Refused to continue medication|0|||
130502607|NCT00824408|469808322|FG002|Randomized Phase|Refused to continue medication|2|||
130502608|NCT00824408|469808323|FG003|Randomized Phase|Refused to continue medication|2|||
130502609|NCT00824408|469808324|FG004|Randomized Phase|Refused to continue medication|2|||
130502610|NCT00824408|469808320|FG000|Randomized Phase|Other reason not defined above|0|||
130502611|NCT00824408|469808321|FG001|Randomized Phase|Other reason not defined above|0|||
130502612|NCT00824408|469808322|FG002|Randomized Phase|Other reason not defined above|4|||
130502613|NCT00824408|469808323|FG003|Randomized Phase|Other reason not defined above|2|||
130502614|NCT00824408|469808324|FG004|Randomized Phase|Other reason not defined above|4|||
130502615|NCT01263496|469808333|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
130502616|NCT01263496|469808334|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502617|NCT01263496|469808335|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502618|NCT01263496|469808336|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502619|NCT01263496|469808337|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130565757|NCT04037748|470037005|FG000|Treatment Period 1|Adverse Event|1|||
130565758|NCT04037748|470037006|FG001|Treatment Period 1|Adverse Event|1|||
130565759|NCT04037748|470037005|FG000|Treatment Period 1|Protocol Violation|4|||
130565760|NCT04037748|470037006|FG001|Treatment Period 1|Protocol Violation|5|||
130565761|NCT04037748|470037005|FG000|Treatment Period 2|Adverse Event|0|||
130565762|NCT04037748|470037006|FG001|Treatment Period 2|Adverse Event|1|||
130565763|NCT04037748|470037005|FG000|Treatment Period 2|Protocol Violation|2|||
130565764|NCT04037748|470037006|FG001|Treatment Period 2|Protocol Violation|0|||
130565765|NCT04544475|470037011|FG000|Overall Study|Withdrawal by Subject|1|||
130565766|NCT04544475|470037012|FG001|Overall Study|Withdrawal by Subject|3|||
130565767|NCT01378858|470037013|FG000|Overall Study|Withdrawal by Subject|4|||
130565768|NCT01378858|470037014|FG001|Overall Study|Withdrawal by Subject|4|||
130565769|NCT00501007|470037015|FG000|Overall Study|Inclusion criteria not met.|29|||
130565770|NCT00501007|470037016|FG001|Overall Study|Inclusion criteria not met.|25|||
130502620|NCT01263496|469808338|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502621|NCT01263496|469808339|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502622|NCT01263496|469808340|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502623|NCT01263496|469808341|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
130502624|NCT01263496|469808333|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502625|NCT01263496|469808334|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502626|NCT01263496|469808335|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502627|NCT01263496|469808336|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130565771|NCT02973087|470037019|FG000|Overall Study|Withdrawal by Subject|2|||
130565772|NCT02973087|470037020|FG001|Overall Study|Withdrawal by Subject|1|||
130565773|NCT02973087|470037019|FG000|Overall Study|Adverse Event|1|||
130565774|NCT02973087|470037020|FG001|Overall Study|Adverse Event|0|||
130502628|NCT01263496|469808337|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
130502629|NCT01263496|469808338|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502630|NCT01263496|469808339|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502631|NCT01263496|469808340|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502632|NCT01263496|469808341|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130502633|NCT01263496|469808333|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
130502634|NCT01263496|469808334|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
130502635|NCT01263496|469808335|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
130502636|NCT01263496|469808336|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
130502637|NCT01263496|469808337|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
130502638|NCT01263496|469808338|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
130502639|NCT01263496|469808339|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
130502640|NCT01263496|469808340|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
130502641|NCT01263496|469808341|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
130502642|NCT01263496|469808333|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502643|NCT01263496|469808334|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
130502644|NCT01263496|469808335|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502645|NCT01263496|469808336|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502646|NCT01263496|469808337|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502647|NCT01263496|469808338|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502648|NCT01263496|469808339|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502649|NCT01263496|469808340|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502650|NCT01263496|469808341|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130502651|NCT01263496|469808333|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130502652|NCT01263496|469808334|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130502653|NCT01263496|469808335|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130502654|NCT01263496|469808336|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130502655|NCT01263496|469808337|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
130502656|NCT01263496|469808338|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130502657|NCT01263496|469808339|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130502658|NCT01263496|469808340|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130502659|NCT01263496|469808341|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130502660|NCT01263496|469808333|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
130502661|NCT01263496|469808334|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
130502662|NCT01263496|469808335|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
130502663|NCT01263496|469808336|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130502664|NCT01263496|469808337|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
130502665|NCT01263496|469808338|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130502666|NCT01263496|469808339|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130502667|NCT01263496|469808340|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130502668|NCT01263496|469808341|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130502669|NCT01263496|469808333|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502670|NCT01263496|469808334|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502671|NCT01263496|469808335|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502672|NCT01263496|469808336|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502673|NCT01263496|469808337|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502674|NCT01263496|469808338|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502675|NCT01263496|469808339|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502676|NCT01263496|469808340|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
130502677|NCT01263496|469808341|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130502678|NCT02950961|469808343|FG000|Overall Study|Study had to stop due to COVID.|7|||
130502679|NCT02241785|469808344|FG000|Overall Study|Sponsor Termination|43|||
130502680|NCT02241785|469808344|FG000|Overall Study|Withdrawal by Subject|1|||
130502681|NCT02241785|469808344|FG000|Overall Study|Lost to Follow-up|2|||
130502682|NCT02241785|469808344|FG000|Overall Study|Adverse Event|1|||
130502683|NCT03055988|469808347|FG000|Period 1|Adverse Event|0|||
130502684|NCT03055988|469808348|FG001|Period 1|Adverse Event|1|||
130502685|NCT03055988|469808347|FG000|Period 1|Lost to Follow-up|1|||
130502686|NCT03055988|469808348|FG001|Period 1|Lost to Follow-up|0|||
130502687|NCT03055988|469808347|FG000|Period 1|Withdrawal by Subject|0|||
130502688|NCT03055988|469808348|FG001|Period 1|Withdrawal by Subject|4|||
130502689|NCT03055988|469808347|FG000|Period 2|Adverse Event|0|||
130502690|NCT03055988|469808348|FG001|Period 2|Adverse Event|1|||
130502691|NCT03055988|469808347|FG000|Period 2|Other than listed|1|||
130502692|NCT03055988|469808348|FG001|Period 2|Other than listed|1|||
130502693|NCT00845520|469808349|FG000|Overall Study|Death|1|||
130502694|NCT00845520|469808350|FG001|Overall Study|Death|2|||
130502695|NCT00845520|469808351|FG002|Overall Study|Death|0|||
130565775|NCT02973087|470037019|FG000|Overall Study|other|1|||
130565776|NCT02973087|470037020|FG001|Overall Study|other|1|||
130502696|NCT00845520|469808349|FG000|Overall Study|Lost to Follow-up|1|||
130502697|NCT00845520|469808350|FG001|Overall Study|Lost to Follow-up|0|||
130502698|NCT00845520|469808351|FG002|Overall Study|Lost to Follow-up|0|||
130502699|NCT00845520|469808349|FG000|Overall Study|Adverse Event|0|||
130502700|NCT00845520|469808350|FG001|Overall Study|Adverse Event|0|||
130502701|NCT00845520|469808351|FG002|Overall Study|Adverse Event|1|||
130502702|NCT01736475|469808352|FG000|Overall Study|Adverse Event|4|||
130502703|NCT01736475|469808353|FG001|Overall Study|Adverse Event|0|||
130502704|NCT01736475|469808352|FG000|Overall Study|Withdrawal by Subject|2|||
130502705|NCT01736475|469808353|FG001|Overall Study|Withdrawal by Subject|0|||
130502706|NCT01736475|469808352|FG000|Overall Study|Protocol Violation|4|||
130502707|NCT01736475|469808353|FG001|Overall Study|Protocol Violation|0|||
130502708|NCT01736475|469808352|FG000|Overall Study|Other - Screen failure|1|||
130502709|NCT01736475|469808353|FG001|Overall Study|Other - Screen failure|0|||
130502710|NCT01736475|469808352|FG000|Overall Study|Other - Surgical procedure|1|||
130502711|NCT01736475|469808353|FG001|Overall Study|Other - Surgical procedure|0|||
130502712|NCT02807857|469808354|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
130502713|NCT02807857|469808354|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
130502714|NCT02807857|469808354|FG000|Follow-Up Set|Withdrawal by Subject|8|||
130502715|NCT02807857|469808354|FG000|Follow-Up Set|Lost to Follow-up|7|||
130502716|NCT02807857|469808354|FG000|Follow-Up Set|Physician Decision|6|||
130502717|NCT02807857|469808354|FG000|Follow-Up Set|Adverse Event|3|||
130502718|NCT02807857|469808354|FG000|Follow-Up Set|Death|27|||
130502719|NCT02807857|469808354|FG000|Follow-Up Set|Relocation|2|||
130502720|NCT01075152|469808358|FG000|Overall Study|Withdrawal by Subject|1|||
130502721|NCT01075152|469808359|FG001|Overall Study|Withdrawal by Subject|0|||
130502722|NCT01668355|469809948|FG000|Overall Study|Death|3|||
130502723|NCT01668355|469809949|FG001|Overall Study|Death|1|||
130502724|NCT01668355|469809948|FG000|Overall Study|Withdrawal by Subject|6|||
130502725|NCT01668355|469809949|FG001|Overall Study|Withdrawal by Subject|1|||
130502726|NCT00535626|469809950|FG000|Overall Study|Death|15|||
130502727|NCT00535626|469809950|FG000|Overall Study|Lost to Follow-up|29|||
130502728|NCT00535626|469809950|FG000|Overall Study|Withdrawal by Subject|20|||
130502729|NCT00535626|469809950|FG000|Overall Study|Removal/revision of study component|8|||
130502730|NCT00535626|469809950|FG000|Overall Study|Subject terminated|31|||
130502731|NCT00535626|469809950|FG000|Overall Study|Unable to return|2|||
130502732|NCT01277302|469809951|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
130502733|NCT01277302|469809952|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
130502734|NCT01277302|469809953|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
130502735|NCT01277302|469809951|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
130502736|NCT01277302|469809952|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
130502737|NCT01277302|469809953|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
130502738|NCT01277302|469809951|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
130502739|NCT01277302|469809952|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
130502740|NCT01277302|469809953|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
130502741|NCT01277302|469809951|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
130502742|NCT01277302|469809952|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
130502743|NCT01277302|469809953|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
130502744|NCT01277302|469809951|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
130502745|NCT01277302|469809952|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
130502746|NCT01277302|469809953|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
130502747|NCT01277302|469809951|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
130502748|NCT01277302|469809952|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
130502749|NCT01277302|469809953|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
130502750|NCT01277302|469809951|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
130502751|NCT01277302|469809952|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
130502752|NCT01277302|469809953|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
130502753|NCT01277302|469809951|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
130502754|NCT01277302|469809952|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
130502755|NCT01277302|469809953|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
130502756|NCT01277302|469809951|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
130502757|NCT01277302|469809952|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
130502758|NCT01277302|469809953|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
130502759|NCT02710669|469809954|FG000|Overall Study|Physician Decision|2|||
130502760|NCT02710669|469809955|FG001|Overall Study|Physician Decision|1|||
130502761|NCT02710669|469809956|FG002|Overall Study|Physician Decision|0|||
130502762|NCT02710669|469809954|FG000|Overall Study|Institutional delays (including COVID)|2|||
130502763|NCT02710669|469809955|FG001|Overall Study|Institutional delays (including COVID)|2|||
130502764|NCT02710669|469809956|FG002|Overall Study|Institutional delays (including COVID)|0|||
130502765|NCT02710669|469809954|FG000|Overall Study|arrived in afib/aflutter|10|||
130502766|NCT02710669|469809955|FG001|Overall Study|arrived in afib/aflutter|8|||
130502767|NCT02710669|469809956|FG002|Overall Study|arrived in afib/aflutter|2|||
130502768|NCT01190124|469809959|FG000|Overall Study|Death|3|||
130502769|NCT01190124|469809960|FG001|Overall Study|Death|0|||
130502770|NCT01190124|469809961|FG002|Overall Study|Death|0|||
130502771|NCT01190124|469809959|FG000|Overall Study|Therapeutic Failure|12|||
130502772|NCT01190124|469809960|FG001|Overall Study|Therapeutic Failure|0|||
130502773|NCT01190124|469809961|FG002|Overall Study|Therapeutic Failure|1|||
130502774|NCT01190124|469809959|FG000|Overall Study|Lost to Follow-up|2|||
130502775|NCT01190124|469809960|FG001|Overall Study|Lost to Follow-up|0|||
130502776|NCT01190124|469809961|FG002|Overall Study|Lost to Follow-up|0|||
130502777|NCT00070707|469809962|FG000|Overall Study|Adverse Event|1|||
130502778|NCT00070707|469809963|FG001|Overall Study|Adverse Event|2|||
130502779|NCT00070707|469809962|FG000|Overall Study|Lack of Efficacy|4|||
130502780|NCT00070707|469809963|FG001|Overall Study|Lack of Efficacy|1|||
130502781|NCT00070707|469809962|FG000|Overall Study|Protocol Violation|8|||
130502782|NCT00070707|469809963|FG001|Overall Study|Protocol Violation|4|||
130502783|NCT00070707|469809962|FG000|Overall Study|Unrelated to Study Medication|1|||
130502784|NCT00070707|469809963|FG001|Overall Study|Unrelated to Study Medication|0|||
130502785|NCT02002689|469809968|FG000|Overall Study|Disease Progression|7|||
130502786|NCT02002689|469809968|FG000|Overall Study|Adverse Event|3|||
130502787|NCT00087516|469809969|FG000|Overall Study|Adverse Event|10|||
130502788|NCT00087516|469809970|FG001|Overall Study|Adverse Event|10|||
130502789|NCT00087516|469809971|FG002|Overall Study|Adverse Event|3|||
130502790|NCT00087516|469809972|FG003|Overall Study|Adverse Event|6|||
130502791|NCT00087516|469809969|FG000|Overall Study|Lack of Efficacy|82|||
130502792|NCT00087516|469809970|FG001|Overall Study|Lack of Efficacy|80|||
130502793|NCT00087516|469809971|FG002|Overall Study|Lack of Efficacy|39|||
130502794|NCT00087516|469809972|FG003|Overall Study|Lack of Efficacy|29|||
130502795|NCT00087516|469809969|FG000|Overall Study|Lost to Follow-up|8|||
130502796|NCT00087516|469809970|FG001|Overall Study|Lost to Follow-up|6|||
130502797|NCT00087516|469809971|FG002|Overall Study|Lost to Follow-up|5|||
130502798|NCT00087516|469809972|FG003|Overall Study|Lost to Follow-up|5|||
130502799|NCT00087516|469809969|FG000|Overall Study|Protocol Violation|4|||
130502800|NCT00087516|469809970|FG001|Overall Study|Protocol Violation|8|||
130502801|NCT00087516|469809971|FG002|Overall Study|Protocol Violation|3|||
130502802|NCT00087516|469809972|FG003|Overall Study|Protocol Violation|6|||
130502803|NCT00087516|469809969|FG000|Overall Study|Withdrawal by Subject|16|||
130502804|NCT00087516|469809970|FG001|Overall Study|Withdrawal by Subject|27|||
130502805|NCT00087516|469809971|FG002|Overall Study|Withdrawal by Subject|11|||
130502806|NCT00087516|469809972|FG003|Overall Study|Withdrawal by Subject|12|||
130502807|NCT00087516|469809969|FG000|Overall Study|Site terminated|0|||
130502808|NCT00087516|469809970|FG001|Overall Study|Site terminated|2|||
130502809|NCT00087516|469809971|FG002|Overall Study|Site terminated|1|||
130502810|NCT00087516|469809972|FG003|Overall Study|Site terminated|0|||
130502811|NCT00087516|469809969|FG000|Overall Study|Protocol specified discontinuation|35|||
130502812|NCT00087516|469809970|FG001|Overall Study|Protocol specified discontinuation|33|||
130502813|NCT00087516|469809971|FG002|Overall Study|Protocol specified discontinuation|33|||
130502814|NCT00087516|469809972|FG003|Overall Study|Protocol specified discontinuation|26|||
130502815|NCT00087516|469809969|FG000|Overall Study|Patient moved|3|||
130502816|NCT00087516|469809970|FG001|Overall Study|Patient moved|2|||
130502817|NCT00087516|469809971|FG002|Overall Study|Patient moved|1|||
130502818|NCT00087516|469809972|FG003|Overall Study|Patient moved|0|||
130502819|NCT00087516|469809969|FG000|Overall Study|Patient was non-compliant|3|||
130502820|NCT00087516|469809970|FG001|Overall Study|Patient was non-compliant|1|||
130502821|NCT00087516|469809971|FG002|Overall Study|Patient was non-compliant|0|||
130502822|NCT00087516|469809972|FG003|Overall Study|Patient was non-compliant|0|||
130502823|NCT00087516|469809969|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
130502824|NCT00087516|469809970|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
130502825|NCT00087516|469809971|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
130502826|NCT00087516|469809972|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
130502827|NCT00087516|469809969|FG000|Overall Study|Other|0|||
130502828|NCT00087516|469809970|FG001|Overall Study|Other|0|||
130502829|NCT00087516|469809971|FG002|Overall Study|Other|1|||
130502830|NCT00087516|469809972|FG003|Overall Study|Other|0|||
130502831|NCT01128959|469809977|FG000|Lead in Period|Adverse Event|3|||
130502832|NCT01128959|469809977|FG000|Treatment Period|Adverse Event|3|||
130502833|NCT01128959|469809977|FG000|Treatment Period|Withdrawal by Subject|1|||
130502834|NCT02338999|469809978|FG000|First Intervention|Withdrawal by Subject|3|||
130502835|NCT02338999|469809979|FG001|First Intervention|Withdrawal by Subject|1|||
130502836|NCT02338999|469809978|FG000|Washout Period|Withdrawal by Subject|0|||
130502837|NCT02338999|469809979|FG001|Washout Period|Withdrawal by Subject|2|||
130565777|NCT04143009|470037021|FG000|Pilot Trial|Lost to Follow-up|0|||
130729983|NCT00191191|470633653|FG001|Overall Study|Lost to Follow-up|0|||
130502838|NCT02338999|469809978|FG000|Second Intervention|Withdrawal by Subject|0|||
130502839|NCT02338999|469809979|FG001|Second Intervention|Withdrawal by Subject|2|||
130502840|NCT02701296|469809980|FG000|Overall Study|Incomplete Data|0|||
130502841|NCT02701296|469809981|FG001|Overall Study|Incomplete Data|2|||
130502842|NCT00569166|469809982|FG000|Overall Study|Withdrawal by Subject|7|||
130502843|NCT00569166|469809983|FG001|Overall Study|Withdrawal by Subject|5|||
130502844|NCT00569166|469809984|FG002|Overall Study|Withdrawal by Subject|3|||
130502845|NCT00569166|469809982|FG000|Overall Study|Lost to Follow-up|2|||
130502846|NCT00569166|469809983|FG001|Overall Study|Lost to Follow-up|1|||
130502847|NCT00569166|469809984|FG002|Overall Study|Lost to Follow-up|1|||
130502848|NCT05005247|469809985|FG000|Overall Study|Withdrawal by Subject|0|||
130502849|NCT05005247|469809986|FG001|Overall Study|Withdrawal by Subject|1|||
130502850|NCT05005247|469809987|FG002|Overall Study|Withdrawal by Subject|0|||
130502851|NCT03142932|469809988|FG000|Overall Study|Lost to Follow-up|2|||
130502852|NCT03142932|469809989|FG001|Overall Study|Lost to Follow-up|11|||
130502853|NCT00929526|469809990|FG000|Overall Study|Withdrawal by Subject|1|||
130502854|NCT00929526|469809991|FG001|Overall Study|Withdrawal by Subject|11|||
130502855|NCT00929526|469809990|FG000|Overall Study|Lost to Follow-up|8|||
130502856|NCT00929526|469809991|FG001|Overall Study|Lost to Follow-up|12|||
130502857|NCT00929526|469809990|FG000|Overall Study|Other|8|||
130502858|NCT00929526|469809991|FG001|Overall Study|Other|6|||
130502859|NCT02547974|469809992|FG000|Overall Study|Withdrawal by Subject|1|||
130502860|NCT02547974|469809993|FG001|Overall Study|Withdrawal by Subject|0|||
130502861|NCT02547974|469809994|FG002|Overall Study|Withdrawal by Subject|0|||
130502862|NCT02547974|469809995|FG003|Overall Study|Withdrawal by Subject|0|||
130502863|NCT04766996|469809996|FG000|Overall Study|Withdrawal by Subject|1|||
130502864|NCT04766996|469809997|FG001|Overall Study|Withdrawal by Subject|0|||
130502865|NCT04766996|469809998|FG002|Overall Study|Withdrawal by Subject|13|||
130502866|NCT03547154|469810002|FG000|Overall Study|Disease Progression/Recurrence|6|||
130502867|NCT03547154|469810003|FG001|Overall Study|Disease Progression/Recurrence|14|||
130502868|NCT03547154|469810002|FG000|Overall Study|Adverse Event|26|||
130502869|NCT03547154|469810003|FG001|Overall Study|Adverse Event|31|||
130502870|NCT03547154|469810002|FG000|Overall Study|Protocol Violation|6|||
130502871|NCT03547154|469810003|FG001|Overall Study|Protocol Violation|1|||
130502872|NCT03547154|469810002|FG000|Overall Study|Physician Decision|4|||
130502873|NCT03547154|469810003|FG001|Overall Study|Physician Decision|3|||
130502874|NCT03547154|469810002|FG000|Overall Study|Insufficient Therapeutic Response|13|||
130502875|NCT03547154|469810003|FG001|Overall Study|Insufficient Therapeutic Response|10|||
130502876|NCT03547154|469810002|FG000|Overall Study|Withdrawal by Subject|10|||
130502877|NCT03547154|469810003|FG001|Overall Study|Withdrawal by Subject|6|||
130502878|NCT03547154|469810002|FG000|Overall Study|Not Selected|0|||
130502879|NCT03547154|469810003|FG001|Overall Study|Not Selected|1|||
130502880|NCT03547154|469810002|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
130502881|NCT03547154|469810003|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
130502882|NCT02988713|469810004|FG000|Overall Study|Withdrawal by Subject|1|||
130502883|NCT02988713|469810004|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
130502884|NCT01918033|469810005|FG000|Overall Study|Adverse Event|1|||
130502885|NCT01918033|469810006|FG001|Overall Study|Adverse Event|0|||
130502886|NCT01918033|469810007|FG002|Overall Study|Adverse Event|2|||
130502887|NCT01918033|469810005|FG000|Overall Study|Lost to Follow-up|0|||
130502888|NCT01918033|469810006|FG001|Overall Study|Lost to Follow-up|1|||
130502889|NCT01918033|469810007|FG002|Overall Study|Lost to Follow-up|0|||
130502890|NCT01918033|469810005|FG000|Overall Study|Protocol Violation|2|||
130502891|NCT01918033|469810006|FG001|Overall Study|Protocol Violation|0|||
130502892|NCT01918033|469810007|FG002|Overall Study|Protocol Violation|1|||
130502893|NCT01918033|469810005|FG000|Overall Study|Withdrawal by Subject|2|||
130502894|NCT01918033|469810006|FG001|Overall Study|Withdrawal by Subject|1|||
130502895|NCT01918033|469810007|FG002|Overall Study|Withdrawal by Subject|0|||
130502896|NCT04679675|469810008|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
130502897|NCT04679675|469810009|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
130729984|NCT00191191|470633652|FG000|Overall Study|Physician Decision|3|||
130729985|NCT00191191|470633653|FG001|Overall Study|Physician Decision|2|||
130729986|NCT00191191|470633652|FG000|Overall Study|Good Clinical Practice Violation|0|||
130729987|NCT00191191|470633653|FG001|Overall Study|Good Clinical Practice Violation|1|||
130729988|NCT05445492|470633654|FG000|Overall Study|Physician Decision|1|||
130729989|NCT04238650|470633655|FG000|Overall Study|Withdrawal by Subject|0|||
130729990|NCT04238650|470633656|FG001|Overall Study|Withdrawal by Subject|1|||
130502898|NCT04679675|469810010|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
130565778|NCT04143009|470037022|FG001|Pilot Trial|Lost to Follow-up|1|||
130565779|NCT04143009|470037023|FG002|Pilot Trial|Lost to Follow-up|1|||
130565780|NCT05003622|470037024|FG000|Overall Study|Progressive disease|2|||
130565781|NCT05003622|470037024|FG000|Overall Study|Withdrawal by Subject|1|||
130729991|NCT04289363|470633657|FG000|Overall Study|Lost to Follow-up|14|||
130502899|NCT04679675|469810011|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
130502900|NCT04679675|469810008|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
130502901|NCT04679675|469810009|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
130502902|NCT04679675|469810010|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
130502903|NCT04679675|469810011|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
130502904|NCT03259568|469810016|FG000|Overall Study|Participant performance was low|3|||
130502905|NCT01794299|469810018|FG000|Overall Study|ATIR manufacturing not possible|1|||
130502906|NCT01794299|469810018|FG000|Overall Study|Death|14|||
130502907|NCT01794299|469810018|FG000|Overall Study|Graft failure|1|||
130502908|NCT01794299|469810018|FG000|Overall Study|ATIR batch rejected|2|||
130502909|NCT01794299|469810018|FG000|Overall Study|Relapse|2|||
130502910|NCT01794299|469810018|FG000|Overall Study|Discontinued from active follow-up|1|||
130502911|NCT01794299|469810018|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
130502912|NCT01029704|469810019|FG000|Overall Study|Adverse Event|0|||
130502913|NCT01029704|469810020|FG001|Overall Study|Adverse Event|0|||
130502914|NCT01029704|469810021|FG002|Overall Study|Adverse Event|0|||
130502915|NCT01029704|469810022|FG003|Overall Study|Adverse Event|0|||
130502916|NCT01029704|469810023|FG004|Overall Study|Adverse Event|0|||
130502917|NCT01029704|469810024|FG005|Overall Study|Adverse Event|0|||
130502918|NCT01029704|469810025|FG006|Overall Study|Adverse Event|1|||
130502919|NCT01029704|469810026|FG007|Overall Study|Adverse Event|1|||
130502920|NCT01029704|469810027|FG008|Overall Study|Adverse Event|0|||
130502921|NCT01029704|469810019|FG000|Overall Study|Withdrawal by Subject|0|||
130502922|NCT01029704|469810020|FG001|Overall Study|Withdrawal by Subject|0|||
130502923|NCT01029704|469810021|FG002|Overall Study|Withdrawal by Subject|0|||
130502924|NCT01029704|469810022|FG003|Overall Study|Withdrawal by Subject|0|||
130502925|NCT01029704|469810023|FG004|Overall Study|Withdrawal by Subject|2|||
130502926|NCT01029704|469810024|FG005|Overall Study|Withdrawal by Subject|1|||
130502927|NCT01029704|469810025|FG006|Overall Study|Withdrawal by Subject|1|||
130502928|NCT01029704|469810026|FG007|Overall Study|Withdrawal by Subject|1|||
130502929|NCT01029704|469810027|FG008|Overall Study|Withdrawal by Subject|0|||
130502930|NCT01029704|469810019|FG000|Overall Study|Lost to Follow-up|0|||
130502931|NCT01029704|469810020|FG001|Overall Study|Lost to Follow-up|0|||
130502932|NCT01029704|469810021|FG002|Overall Study|Lost to Follow-up|0|||
130502933|NCT01029704|469810022|FG003|Overall Study|Lost to Follow-up|0|||
130502934|NCT01029704|469810023|FG004|Overall Study|Lost to Follow-up|0|||
130502935|NCT01029704|469810024|FG005|Overall Study|Lost to Follow-up|0|||
130502936|NCT01029704|469810025|FG006|Overall Study|Lost to Follow-up|1|||
130502937|NCT01029704|469810026|FG007|Overall Study|Lost to Follow-up|1|||
130502938|NCT01029704|469810027|FG008|Overall Study|Lost to Follow-up|1|||
130502939|NCT01029704|469810019|FG000|Overall Study|Lack of Efficacy|0|||
130502940|NCT01029704|469810020|FG001|Overall Study|Lack of Efficacy|0|||
130502941|NCT01029704|469810021|FG002|Overall Study|Lack of Efficacy|0|||
130502942|NCT01029704|469810022|FG003|Overall Study|Lack of Efficacy|0|||
130502943|NCT01029704|469810023|FG004|Overall Study|Lack of Efficacy|2|||
130565782|NCT01045798|470037030|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
130565783|NCT01045798|470037031|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
130565784|NCT01045798|470037030|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
130565785|NCT01045798|470037031|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
130565786|NCT01045798|470037030|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
130565787|NCT01045798|470037031|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
130565788|NCT01045798|470037030|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
130565789|NCT01045798|470037031|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
130565790|NCT01484977|470037035|FG000|Overall Study|Adverse Event|8|||
130565791|NCT01484977|470037035|FG000|Overall Study|Lack of Efficacy|4|||
130565792|NCT01484977|470037035|FG000|Overall Study|Protocol Violation|6|||
130565793|NCT01484977|470037035|FG000|Overall Study|Lost to Follow-up|1|||
130565794|NCT01484977|470037035|FG000|Overall Study|Withdrawal by Subject|4|||
130502944|NCT01029704|469810024|FG005|Overall Study|Lack of Efficacy|3|||
130502945|NCT01029704|469810025|FG006|Overall Study|Lack of Efficacy|1|||
130502946|NCT01029704|469810026|FG007|Overall Study|Lack of Efficacy|2|||
130502947|NCT01029704|469810027|FG008|Overall Study|Lack of Efficacy|0|||
130502948|NCT01029704|469810019|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
130729992|NCT04289363|470633658|FG001|Overall Study|Lost to Follow-up|0|||
130502949|NCT01029704|469810020|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
130565795|NCT01484977|470037035|FG000|Overall Study|Subject Protocol Non-compliant|1|||
130729993|NCT03348163|470633662|FG000|Overall Study|Withdrawal by Subject|2|||
130502950|NCT01029704|469810021|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
130502951|NCT01029704|469810022|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
130502952|NCT01029704|469810023|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
130502953|NCT01029704|469810024|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
130502954|NCT01029704|469810025|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
130565796|NCT01484977|470037035|FG000|Overall Study|Moving Overseas|1|||
130565797|NCT01484977|470037035|FG000|Overall Study|Low White Blood Cell Count|1|||
130502955|NCT01029704|469810026|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
130502956|NCT01029704|469810027|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
130502957|NCT03006393|469810028|FG000|Overall Study|Withdrawal by Subject|1|||
130502958|NCT03006393|469810029|FG001|Overall Study|Withdrawal by Subject|1|||
130502959|NCT03006393|469810028|FG000|Overall Study|Pregnancy|0|||
130502960|NCT03006393|469810029|FG001|Overall Study|Pregnancy|1|||
130502961|NCT03006393|469810028|FG000|Overall Study|Lost to Follow-up|0|||
130502962|NCT03006393|469810029|FG001|Overall Study|Lost to Follow-up|1|||
130502963|NCT01365546|469810030|FG000|Overall Study|Withdrawal by Subject|1|||
130502964|NCT01365546|469810030|FG000|Overall Study|Screen failure|9|||
130502965|NCT01365546|469810030|FG000|Overall Study|Study termination|1|||
130502966|NCT00472082|469810031|FG000|Overall Study|Study prematurely terminated|5|||
130502967|NCT00761267|469810032|FG000|Overall Study|Death|1|||
130502968|NCT00761267|469810033|FG001|Overall Study|Death|2|||
130502969|NCT00761267|469810034|FG002|Overall Study|Death|5|||
130502970|NCT00761267|469810032|FG000|Overall Study|Lost to Follow-up|0|||
130502971|NCT00761267|469810033|FG001|Overall Study|Lost to Follow-up|0|||
130502972|NCT00761267|469810034|FG002|Overall Study|Lost to Follow-up|1|||
130502973|NCT00761267|469810032|FG000|Overall Study|Randomized but not treated|1|||
130502974|NCT00761267|469810033|FG001|Overall Study|Randomized but not treated|1|||
130502975|NCT00761267|469810034|FG002|Overall Study|Randomized but not treated|0|||
130502976|NCT00761267|469810032|FG000|Overall Study|Withdrawal by Subject|0|||
130502977|NCT00761267|469810033|FG001|Overall Study|Withdrawal by Subject|1|||
130502978|NCT00761267|469810034|FG002|Overall Study|Withdrawal by Subject|0|||
130502979|NCT03200574|469810049|FG000|Overall Study|Death|4|||
130502980|NCT03200574|469810049|FG000|Overall Study|Withdrawal by Subject|8|||
130502981|NCT03200574|469810049|FG000|Overall Study|Long-Term need for anticoagulation|1|||
130729994|NCT03348163|470633663|FG001|Overall Study|Withdrawal by Subject|0|||
130729995|NCT02585778|470633664|FG000|Overall Study|Adverse Event|17|||
130729996|NCT02585778|470633665|FG001|Overall Study|Adverse Event|4|||
130729997|NCT02585778|470633664|FG000|Overall Study|Participant did not wish to continue|9|||
130729998|NCT02585778|470633665|FG001|Overall Study|Participant did not wish to continue|4|||
130729999|NCT02585778|470633664|FG000|Overall Study|Poor compliance to study protocol|0|||
130730000|NCT02585778|470633665|FG001|Overall Study|Poor compliance to study protocol|2|||
130730001|NCT02585778|470633664|FG000|Overall Study|Death|0|||
130730002|NCT02585778|470633665|FG001|Overall Study|Death|1|||
130730003|NCT02585778|470633664|FG000|Overall Study|Randomized but not treated|1|||
130730004|NCT02585778|470633665|FG001|Overall Study|Randomized but not treated|2|||
130730005|NCT02585778|470633664|FG000|Overall Study|Other than specified above|6|||
130730006|NCT02585778|470633665|FG001|Overall Study|Other than specified above|2|||
130730007|NCT02370238|470633667|FG000|Overall Study|Death|42|||
130730008|NCT02370238|470633668|FG001|Overall Study|Death|35|||
130730009|NCT02370238|470633667|FG000|Overall Study|Lost to Follow-up|1|||
130730010|NCT02370238|470633668|FG001|Overall Study|Lost to Follow-up|3|||
130730011|NCT02370238|470633667|FG000|Overall Study|Withdrawal by Subject|2|||
130730012|NCT02370238|470633668|FG001|Overall Study|Withdrawal by Subject|6|||
130730013|NCT02370238|470633667|FG000|Overall Study|Other|2|||
130730014|NCT02370238|470633668|FG001|Overall Study|Other|1|||
130730015|NCT02789137|470633671|FG000|Overall Study|Dropped out/Died|58|||
130730016|NCT01482312|470633674|FG000|Period 1, 90 Minutes of Wear|Other|1|||
130730017|NCT01482312|470633675|FG001|Period 1, 90 Minutes of Wear|Other|0|||
130730018|NCT01482312|470633676|FG002|Period 1, 90 Minutes of Wear|Other|0|||
130730019|NCT01482312|470633674|FG000|Period 2, 90 Minutes of Wear|Other|1|||
130730020|NCT01482312|470633675|FG001|Period 2, 90 Minutes of Wear|Other|0|||
130730021|NCT01482312|470633676|FG002|Period 2, 90 Minutes of Wear|Other|0|||
130730022|NCT03597295|470633678|FG000|Overall Study|Death|70|||
130730023|NCT03597295|470633678|FG000|Overall Study|Lost to Follow-up|7|||
130730024|NCT00428116|470633679|FG000|Overall Study|Death|1|||
130730025|NCT00428116|470633680|FG001|Overall Study|Death|0|||
130730026|NCT00428116|470633679|FG000|Overall Study|Withdrawal by Subject|1|||
130730027|NCT00428116|470633680|FG001|Overall Study|Withdrawal by Subject|0|||
130730028|NCT00428116|470633679|FG000|Overall Study|Lost to Follow-up|1|||
130730029|NCT00428116|470633680|FG001|Overall Study|Lost to Follow-up|0|||
130730030|NCT02125877|470633681|FG000|Overall Study|Physician Decision|1|||
130502982|NCT03200574|469810049|FG000|Overall Study|Relocation|2|||
130502983|NCT03200574|469810049|FG000|Overall Study|Lost to Follow-up|2|||
130502984|NCT04183491|469810050|FG000|Overall Study|Withdrawal by Subject|0|||
130502985|NCT04183491|469810051|FG001|Overall Study|Withdrawal by Subject|0|||
130502986|NCT04183491|469810052|FG002|Overall Study|Withdrawal by Subject|1|||
130730031|NCT02125877|470633682|FG001|Overall Study|Physician Decision|0|||
130730032|NCT02125877|470633681|FG000|Overall Study|Death|0|||
130730033|NCT02125877|470633682|FG001|Overall Study|Death|1|||
130730034|NCT02125877|470633681|FG000|Overall Study|Administrative problems|0|||
130730035|NCT02125877|470633682|FG001|Overall Study|Administrative problems|1|||
130730036|NCT02125877|470633681|FG000|Overall Study|Participant/guardian decision|0|||
130502987|NCT04183491|469810053|FG003|Overall Study|Withdrawal by Subject|0|||
130502988|NCT04183491|469810054|FG004|Overall Study|Withdrawal by Subject|0|||
130730037|NCT02125877|470633682|FG001|Overall Study|Participant/guardian decision|2|||
130565798|NCT01484977|470037035|FG000|Overall Study|Lack of Compliance|1|||
130565799|NCT04857996|470037036|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
130565800|NCT04857996|470037037|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
130565801|NCT04857996|470037036|FG000|Overall Study|Lost to Follow-up|1|||
130565802|NCT04857996|470037037|FG001|Overall Study|Lost to Follow-up|3|||
130565803|NCT04857996|470037036|FG000|Overall Study|Site Closure|1|||
130565804|NCT04857996|470037037|FG001|Overall Study|Site Closure|0|||
130502989|NCT04183491|469810055|FG005|Overall Study|Withdrawal by Subject|1|||
130502990|NCT04183491|469810056|FG006|Overall Study|Withdrawal by Subject|0|||
130502991|NCT00068107|469810059|FG000|Overall Study|end-stage renal disease|6|||
130502992|NCT00068107|469810059|FG000|Overall Study|Death|2|||
130502993|NCT00068107|469810059|FG000|Overall Study|Withdrawal by Subject|1|||
130502994|NCT03205488|469810060|FG000|Overall Study|Adverse Event|1|||
130502995|NCT03205488|469810061|FG001|Overall Study|Adverse Event|2|||
130502996|NCT03205488|469810062|FG002|Overall Study|Adverse Event|4|||
130502997|NCT03205488|469810060|FG000|Overall Study|Protocol Violation|0|||
130502998|NCT03205488|469810061|FG001|Overall Study|Protocol Violation|0|||
130502999|NCT03205488|469810062|FG002|Overall Study|Protocol Violation|1|||
130503000|NCT01856569|469810063|FG000|Overall Study|Other|1|||
130503001|NCT01856569|469810063|FG000|Overall Study|Changed Site/Structure|1|||
130503002|NCT01856569|469810063|FG000|Overall Study|Lost to Follow-up|3|||
130503003|NCT01856569|469810063|FG000|Overall Study|Did not met inclusion criteria|8|||
130503004|NCT03652610|469810064|FG000|Overall Study|Lost to Follow-up|1|||
130503005|NCT03652610|469810065|FG001|Overall Study|Lost to Follow-up|0|||
130503006|NCT03652610|469810064|FG000|Overall Study|Withdrawal by Subject|3|||
130503007|NCT03652610|469810065|FG001|Overall Study|Withdrawal by Subject|5|||
130503008|NCT00326183|469810066|FG000|Overall Study|Lost to Follow-up|104|||
130503009|NCT00326183|469810067|FG001|Overall Study|Lost to Follow-up|56|||
130503010|NCT00326183|469810066|FG000|Overall Study|Protocol Violation|6|||
130503011|NCT00326183|469810067|FG001|Overall Study|Protocol Violation|3|||
130503012|NCT00326183|469810066|FG000|Overall Study|Withdrawal by Subject|35|||
130503013|NCT00326183|469810067|FG001|Overall Study|Withdrawal by Subject|7|||
130503014|NCT00326183|469810066|FG000|Overall Study|Subject Moved|7|||
130503015|NCT00326183|469810067|FG001|Overall Study|Subject Moved|4|||
130503016|NCT00326183|469810066|FG000|Overall Study|Other|47|||
130503017|NCT00326183|469810067|FG001|Overall Study|Other|13|||
130503018|NCT00326183|469810066|FG000|Overall Study|Adverse Event|1|||
130503019|NCT00326183|469810067|FG001|Overall Study|Adverse Event|0|||
130503020|NCT02279732|469810069|FG000|Overall Study|Death|23|||
130503021|NCT02279732|469810070|FG001|Overall Study|Death|20|||
130503022|NCT02279732|469810069|FG000|Overall Study|Disease Progression|13|||
130503023|NCT02279732|469810070|FG001|Overall Study|Disease Progression|3|||
130503024|NCT02279732|469810069|FG000|Overall Study|Withdrawal by Subject|2|||
130503025|NCT02279732|469810070|FG001|Overall Study|Withdrawal by Subject|7|||
130503026|NCT02279732|469810069|FG000|Overall Study|Adverse Event|1|||
130503027|NCT02279732|469810070|FG001|Overall Study|Adverse Event|2|||
130503028|NCT02279732|469810069|FG000|Overall Study|Administrative Reason By Sponsor|0|||
130503029|NCT02279732|469810070|FG001|Overall Study|Administrative Reason By Sponsor|2|||
130503030|NCT02279732|469810069|FG000|Overall Study|Study Drug Toxicity|2|||
130503031|NCT02279732|469810070|FG001|Overall Study|Study Drug Toxicity|0|||
130503032|NCT02279732|469810069|FG000|Overall Study|Lost to Follow-up|0|||
130503033|NCT02279732|469810070|FG001|Overall Study|Lost to Follow-up|1|||
130503034|NCT02279732|469810069|FG000|Overall Study|Maximum Clinical Benefit|1|||
130503035|NCT02279732|469810070|FG001|Overall Study|Maximum Clinical Benefit|0|||
130503036|NCT02279732|469810069|FG000|Overall Study|Subject Requested to Discontinue|0|||
130503037|NCT02279732|469810070|FG001|Overall Study|Subject Requested to Discontinue|1|||
130503038|NCT02279732|469810069|FG000|Overall Study|Other|53|||
130503039|NCT02279732|469810070|FG001|Overall Study|Other|67|||
130503040|NCT02279732|469810069|FG000|Overall Study|Other|3|||
130503041|NCT02279732|469810070|FG001|Overall Study|Other|3|||
130503042|NCT02915783|469810071|FG000|Overall Study|Death|21|||
130503043|NCT02915783|469810071|FG000|Overall Study|Lost to Follow-up|1|||
130503044|NCT02915783|469810071|FG000|Overall Study|Withdrawal by Subject|2|||
130503045|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
130503046|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
130503047|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
130503048|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
130503049|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
130503050|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
130503051|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
130503052|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
130503053|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
130503054|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
130503055|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
130565805|NCT04857996|470037036|FG000|Overall Study|Withdrawal by Subject|1|||
130565806|NCT04857996|470037037|FG001|Overall Study|Withdrawal by Subject|0|||
130503056|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
130503057|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
130503058|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
130503059|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
130503060|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
130503061|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
130503062|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
130503063|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
130503064|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
130503065|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
130503066|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
130503067|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
130503068|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
130503069|NCT02203032|469810072|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
130503070|NCT02203032|469810073|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
130503071|NCT02203032|469810074|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
130503072|NCT02203032|469810075|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
130503073|NCT02203032|469810072|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
130503074|NCT02203032|469810073|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
130503075|NCT02203032|469810074|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
130503076|NCT02203032|469810075|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
130503077|NCT02203032|469810072|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
130503078|NCT02203032|469810073|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
130503079|NCT02203032|469810074|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
130503080|NCT02203032|469810075|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
130503081|NCT02203032|469810072|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
130503082|NCT02203032|469810073|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
130503083|NCT02203032|469810074|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
130503084|NCT02203032|469810075|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
130503085|NCT02203032|469810072|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
130503086|NCT02203032|469810073|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
130503087|NCT02203032|469810074|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
130503088|NCT02203032|469810075|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
130503089|NCT02203032|469810072|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
130503090|NCT02203032|469810073|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
130503091|NCT02203032|469810074|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
130503092|NCT02203032|469810075|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
130503093|NCT01915914|469810076|FG000|Acute Phase|Withdrawal by Subject|4|||
130503094|NCT01915914|469810077|FG001|Acute Phase|Withdrawal by Subject|0|||
130503095|NCT01915914|469810078|FG002|Acute Phase|Withdrawal by Subject|0|||
130503096|NCT01915914|469810079|FG003|Acute Phase|Withdrawal by Subject|0|||
130503097|NCT01915914|469810076|FG000|Acute Phase|Lost to Follow-up|4|||
130503098|NCT01915914|469810077|FG001|Acute Phase|Lost to Follow-up|0|||
130503099|NCT01915914|469810078|FG002|Acute Phase|Lost to Follow-up|0|||
130503100|NCT01915914|469810079|FG003|Acute Phase|Lost to Follow-up|0|||
130503101|NCT01915914|469810076|FG000|Acute Phase|Physician Decision|1|||
130503102|NCT01915914|469810077|FG001|Acute Phase|Physician Decision|0|||
130503103|NCT01915914|469810078|FG002|Acute Phase|Physician Decision|0|||
130503104|NCT01915914|469810079|FG003|Acute Phase|Physician Decision|0|||
130503105|NCT01915914|469810076|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
130503106|NCT01915914|469810077|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
130503107|NCT01915914|469810078|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
130503108|NCT01915914|469810079|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
130503109|NCT01915914|469810076|FG000|Acute Phase|"Not Achieved treatment success"|1|||
130503110|NCT01915914|469810077|FG001|Acute Phase|"Not Achieved treatment success"|0|||
130503111|NCT01915914|469810078|FG002|Acute Phase|"Not Achieved treatment success"|0|||
130503112|NCT01915914|469810079|FG003|Acute Phase|"Not Achieved treatment success"|0|||
130503113|NCT01915914|469810076|FG000|Acute Phase|Missing|1|||
130503114|NCT01915914|469810077|FG001|Acute Phase|Missing|0|||
130503115|NCT01915914|469810078|FG002|Acute Phase|Missing|0|||
130503116|NCT01915914|469810079|FG003|Acute Phase|Missing|0|||
130503117|NCT01915914|469810076|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130503118|NCT01915914|469810077|FG001|Maintenance Phase|Withdrawal by Subject|1|||
130503119|NCT01915914|469810078|FG002|Maintenance Phase|Withdrawal by Subject|1|||
130503120|NCT01915914|469810079|FG003|Maintenance Phase|Withdrawal by Subject|0|||
130503121|NCT01915914|469810076|FG000|Maintenance Phase|Lost to Follow-up|0|||
130503122|NCT01915914|469810077|FG001|Maintenance Phase|Lost to Follow-up|4|||
130503123|NCT01915914|469810078|FG002|Maintenance Phase|Lost to Follow-up|1|||
130503124|NCT01915914|469810079|FG003|Maintenance Phase|Lost to Follow-up|0|||
130503125|NCT01915914|469810076|FG000|Maintenance Phase|Missing|0|||
130503126|NCT01915914|469810077|FG001|Maintenance Phase|Missing|1|||
130503127|NCT01915914|469810078|FG002|Maintenance Phase|Missing|0|||
130503128|NCT01915914|469810079|FG003|Maintenance Phase|Missing|0|||
130503129|NCT01915914|469810076|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130503130|NCT01915914|469810077|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130503131|NCT01915914|469810078|FG002|Follow-up Phase|Withdrawal by Subject|0|||
130503132|NCT01915914|469810079|FG003|Follow-up Phase|Withdrawal by Subject|1|||
130503133|NCT01915914|469810076|FG000|Follow-up Phase|Physician Decision|0|||
130503134|NCT01915914|469810077|FG001|Follow-up Phase|Physician Decision|0|||
130503135|NCT01915914|469810078|FG002|Follow-up Phase|Physician Decision|0|||
130503136|NCT01915914|469810079|FG003|Follow-up Phase|Physician Decision|1|||
130503137|NCT01528605|469810080|FG000|Overall Study|Lost to Follow-up|1|||
130503138|NCT01528605|469810081|FG001|Overall Study|Lost to Follow-up|0|||
130503139|NCT01528605|469810082|FG002|Overall Study|Lost to Follow-up|1|||
130503140|NCT01528605|469810083|FG003|Overall Study|Lost to Follow-up|1|||
130503141|NCT01528605|469810084|FG004|Overall Study|Lost to Follow-up|0|||
130503142|NCT01528605|469810085|FG005|Overall Study|Lost to Follow-up|0|||
130503143|NCT01528605|469810080|FG000|Overall Study|Death|1|||
130503144|NCT01528605|469810081|FG001|Overall Study|Death|0|||
130503145|NCT01528605|469810082|FG002|Overall Study|Death|0|||
130503146|NCT01528605|469810083|FG003|Overall Study|Death|0|||
130503147|NCT01528605|469810084|FG004|Overall Study|Death|0|||
130503148|NCT01528605|469810085|FG005|Overall Study|Death|0|||
130503149|NCT02432274|469810086|FG000|Overall Study|Death|2|||
130503150|NCT02432274|469810087|FG001|Overall Study|Death|6|||
130503151|NCT02432274|469810088|FG002|Overall Study|Death|7|||
130503152|NCT02432274|469810089|FG003|Overall Study|Death|0|||
130503153|NCT02432274|469810090|FG004|Overall Study|Death|27|||
130503154|NCT02432274|469810091|FG005|Overall Study|Death|7|||
130503155|NCT02432274|469810092|FG006|Overall Study|Death|9|||
130503156|NCT02432274|469810093|FG007|Overall Study|Death|14|||
130503157|NCT02432274|469810086|FG000|Overall Study|Withdrawal of Consent|0|||
130503158|NCT02432274|469810087|FG001|Overall Study|Withdrawal of Consent|0|||
130503159|NCT02432274|469810088|FG002|Overall Study|Withdrawal of Consent|0|||
130503160|NCT02432274|469810089|FG003|Overall Study|Withdrawal of Consent|0|||
130503161|NCT02432274|469810090|FG004|Overall Study|Withdrawal of Consent|2|||
130503162|NCT02432274|469810091|FG005|Overall Study|Withdrawal of Consent|0|||
130503163|NCT02432274|469810092|FG006|Overall Study|Withdrawal of Consent|1|||
130503164|NCT02432274|469810093|FG007|Overall Study|Withdrawal of Consent|2|||
130503165|NCT00116649|469810094|FG000|Overall Study|Adverse Event|20|||
130503166|NCT00116649|469810094|FG000|Overall Study|Lack of Efficacy|1|||
130503167|NCT00116649|469810094|FG000|Overall Study|Lost to Follow-up|32|||
130503168|NCT00116649|469810094|FG000|Overall Study|Withdrawal by Subject|68|||
130503169|NCT00116649|469810094|FG000|Overall Study|Local Skin Reaction|9|||
130503170|NCT00116649|469810094|FG000|Overall Study|Various Reasons|18|||
130565807|NCT01538628|470037038|FG000|Overall Study|Withdrawal by Subject|1|||
130503171|NCT00116649|469810094|FG000|Overall Study|Protocol Specified|7|||
130503172|NCT00513071|469810097|FG000|Overall Study|Adverse Event|1|||
130503173|NCT00513071|469810097|FG000|Overall Study|Withdrawal by Subject|1|||
130503174|NCT00513071|469810097|FG000|Overall Study|Physician Decision|3|||
130503175|NCT00667732|469810098|FG000|Run -In (8 Weeks)|Adverse Event|4|||
130503176|NCT00667732|469810099|FG001|Run -In (8 Weeks)|Adverse Event|0|||
130503177|NCT00667732|469810100|FG002|Run -In (8 Weeks)|Adverse Event|0|||
130503178|NCT00667732|469810098|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
130503179|NCT00667732|469810099|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
130503180|NCT00667732|469810100|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
130503181|NCT00667732|469810098|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
130503182|NCT00667732|469810099|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
130503183|NCT00667732|469810100|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
130503184|NCT02659540|469810101|FG000|Overall Study|Adverse Event|3|||
130503185|NCT02659540|469810102|FG001|Overall Study|Adverse Event|2|||
130503186|NCT02659540|469810101|FG000|Overall Study|Death|1|||
130503187|NCT02659540|469810102|FG001|Overall Study|Death|0|||
130503188|NCT02659540|469810101|FG000|Overall Study|Progressive disease|2|||
130503189|NCT02659540|469810102|FG001|Overall Study|Progressive disease|6|||
130503190|NCT01240590|469810105|FG000|Phase I|Refused further treatment|0|||
130503191|NCT01240590|469810106|FG001|Phase I|Refused further treatment|0|||
130503192|NCT01240590|469810107|FG002|Phase I|Refused further treatment|3|||
130503193|NCT01240590|469810108|FG003|Phase I|Refused further treatment|0|||
130503194|NCT01240590|469810109|FG004|Phase I|Refused further treatment|0|||
130503195|NCT01240590|469810105|FG000|Phase II|Refused further treatment|0|||
130503196|NCT01240590|469810106|FG001|Phase II|Refused further treatment|0|||
130503197|NCT01240590|469810107|FG002|Phase II|Refused further treatment|0|||
130503198|NCT01240590|469810108|FG003|Phase II|Refused further treatment|2|||
130503199|NCT01240590|469810109|FG004|Phase II|Refused further treatment|1|||
130503200|NCT02106325|469810112|FG000|Phase 1|Lost to Follow-up|2|||
130503201|NCT02106325|469810113|FG001|Phase 1|Lost to Follow-up|2|||
130503202|NCT02106325|469810112|FG000|Phase 2|Lost to Follow-up|2|||
130503203|NCT02106325|469810113|FG001|Phase 2|Lost to Follow-up|3|||
130503204|NCT02106325|469810112|FG000|Phase 3|Lost to Follow-up|2|||
130503205|NCT02106325|469810113|FG001|Phase 3|Lost to Follow-up|1|||
130503206|NCT03890484|469810114|FG000|Overall Study|Lost to Follow-up|1|||
130503207|NCT03890484|469810115|FG001|Overall Study|Lost to Follow-up|1|||
130503208|NCT00731692|469811823|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
130503209|NCT00731692|469811824|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
130503210|NCT00731692|469811825|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
130503211|NCT00731692|469811823|FG000|Core Study (36 Months)|Physician Decision|1|||
130503212|NCT00731692|469811824|FG001|Core Study (36 Months)|Physician Decision|0|||
130503213|NCT00731692|469811825|FG002|Core Study (36 Months)|Physician Decision|2|||
130503214|NCT00731692|469811823|FG000|Core Study (36 Months)|Death|2|||
130503215|NCT00731692|469811824|FG001|Core Study (36 Months)|Death|1|||
130503216|NCT00731692|469811825|FG002|Core Study (36 Months)|Death|2|||
130503217|NCT00731692|469811823|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
130503218|NCT00731692|469811824|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
130503219|NCT00731692|469811825|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
130503220|NCT00731692|469811823|FG000|Core Study (36 Months)|Administrative|2|||
130503221|NCT00731692|469811824|FG001|Core Study (36 Months)|Administrative|2|||
130503222|NCT00731692|469811825|FG002|Core Study (36 Months)|Administrative|6|||
130503223|NCT00731692|469811823|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
130503224|NCT00731692|469811824|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
130503225|NCT00731692|469811825|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
130503226|NCT00731692|469811823|FG000|Core Study (36 Months)|Protocol Violation|4|||
130503227|NCT00731692|469811824|FG001|Core Study (36 Months)|Protocol Violation|5|||
130503228|NCT00731692|469811825|FG002|Core Study (36 Months)|Protocol Violation|8|||
130503229|NCT00731692|469811823|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
130503230|NCT00731692|469811824|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
130503231|NCT00731692|469811825|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
130503232|NCT00731692|469811823|FG000|Core Study (36 Months)|Adverse Event|25|||
130503233|NCT00731692|469811824|FG001|Core Study (36 Months)|Adverse Event|28|||
130503234|NCT00731692|469811825|FG002|Core Study (36 Months)|Adverse Event|29|||
130503235|NCT00731692|469811823|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
130503236|NCT00731692|469811824|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
130503237|NCT00731692|469811825|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
130503238|NCT00731692|469811823|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
130503239|NCT00731692|469811824|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
130503240|NCT00731692|469811825|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
130503241|NCT00731692|469811823|FG000|Extension Phase|Abnormal test procedure|0|||
130503242|NCT00731692|469811824|FG001|Extension Phase|Abnormal test procedure|0|||
130503243|NCT00731692|469811825|FG002|Extension Phase|Abnormal test procedure|1|||
130503244|NCT00731692|469811823|FG000|Extension Phase|Abnormal lab values|0|||
130503245|NCT00731692|469811824|FG001|Extension Phase|Abnormal lab values|0|||
130503246|NCT00731692|469811825|FG002|Extension Phase|Abnormal lab values|1|||
130503247|NCT00731692|469811823|FG000|Extension Phase|Lost to Follow-up|0|||
130503248|NCT00731692|469811824|FG001|Extension Phase|Lost to Follow-up|1|||
130503249|NCT00731692|469811825|FG002|Extension Phase|Lost to Follow-up|4|||
130565808|NCT01538628|470037039|FG001|Overall Study|Withdrawal by Subject|1|||
130565809|NCT01538628|470037038|FG000|Overall Study|Lost to Follow-up|0|||
130565810|NCT01538628|470037039|FG001|Overall Study|Lost to Follow-up|1|||
130565811|NCT00914927|470038105|FG000|Overall Study|Adverse Event|0|||
130565812|NCT00914927|470038106|FG001|Overall Study|Adverse Event|0|||
130565813|NCT00914927|470038107|FG002|Overall Study|Adverse Event|0|||
130565814|NCT00914927|470038108|FG003|Overall Study|Adverse Event|0|||
130565815|NCT00914927|470038109|FG004|Overall Study|Adverse Event|1|||
130565816|NCT00914927|470038110|FG005|Overall Study|Adverse Event|0|||
130565817|NCT00914927|470038111|FG006|Overall Study|Adverse Event|0|||
130565818|NCT00914927|470038105|FG000|Overall Study|Withdrawal by Subject|0|||
130565819|NCT00914927|470038106|FG001|Overall Study|Withdrawal by Subject|1|||
130565820|NCT00914927|470038107|FG002|Overall Study|Withdrawal by Subject|0|||
130565821|NCT00914927|470038108|FG003|Overall Study|Withdrawal by Subject|1|||
130565822|NCT00914927|470038109|FG004|Overall Study|Withdrawal by Subject|0|||
130565823|NCT00914927|470038110|FG005|Overall Study|Withdrawal by Subject|0|||
130565824|NCT00914927|470038111|FG006|Overall Study|Withdrawal by Subject|0|||
130565825|NCT00914927|470038105|FG000|Overall Study|Lost to Follow-up|0|||
130565826|NCT00914927|470038106|FG001|Overall Study|Lost to Follow-up|0|||
130565827|NCT00914927|470038107|FG002|Overall Study|Lost to Follow-up|0|||
130565828|NCT00914927|470038108|FG003|Overall Study|Lost to Follow-up|1|||
130565829|NCT00914927|470038109|FG004|Overall Study|Lost to Follow-up|0|||
130565830|NCT00914927|470038110|FG005|Overall Study|Lost to Follow-up|0|||
130565831|NCT00914927|470038111|FG006|Overall Study|Lost to Follow-up|0|||
130565832|NCT00914927|470038105|FG000|Overall Study|Administrative/Other|2|||
130565833|NCT00914927|470038106|FG001|Overall Study|Administrative/Other|1|||
130565834|NCT00914927|470038107|FG002|Overall Study|Administrative/Other|0|||
130565835|NCT00914927|470038108|FG003|Overall Study|Administrative/Other|0|||
130565836|NCT00914927|470038109|FG004|Overall Study|Administrative/Other|1|||
130565837|NCT00914927|470038110|FG005|Overall Study|Administrative/Other|0|||
130565838|NCT00914927|470038111|FG006|Overall Study|Administrative/Other|0|||
130565839|NCT01648790|470038112|FG000|Treatment 3|Withdrawal by Subject|0|||
130565840|NCT01648790|470038113|FG001|Treatment 3|Withdrawal by Subject|0|||
130565841|NCT01648790|470038114|FG002|Treatment 3|Withdrawal by Subject|0|||
130565842|NCT01648790|470038115|FG003|Treatment 3|Withdrawal by Subject|1|||
130565843|NCT01648790|470038116|FG004|Treatment 3|Withdrawal by Subject|0|||
130565844|NCT02969187|470038119|FG000|Overall Study|Physician Decision|12|||
130565845|NCT02969187|470038120|FG001|Overall Study|Physician Decision|13|||
130730038|NCT02125877|470633681|FG000|Overall Study|Withdrawal by Subject|2|||
130503250|NCT00731692|469811823|FG000|Extension Phase|Withdrawal by Subject|4|||
130503251|NCT00731692|469811824|FG001|Extension Phase|Withdrawal by Subject|5|||
130503252|NCT00731692|469811825|FG002|Extension Phase|Withdrawal by Subject|3|||
130503253|NCT00731692|469811823|FG000|Extension Phase|Adverse Event|1|||
130503254|NCT00731692|469811824|FG001|Extension Phase|Adverse Event|1|||
130503255|NCT00731692|469811825|FG002|Extension Phase|Adverse Event|15|||
130503256|NCT03332589|469811826|FG000|Overall Study|Lack of Efficacy|2|||
130503257|NCT03332589|469811827|FG001|Overall Study|Lack of Efficacy|0|||
130503258|NCT03332589|469811828|FG002|Overall Study|Lack of Efficacy|0|||
130503259|NCT03332589|469811826|FG000|Overall Study|Adverse Event|1|||
130503260|NCT03332589|469811827|FG001|Overall Study|Adverse Event|0|||
130503261|NCT03332589|469811828|FG002|Overall Study|Adverse Event|0|||
130503262|NCT03332589|469811826|FG000|Overall Study|Death|1|||
130503263|NCT03332589|469811827|FG001|Overall Study|Death|0|||
130503264|NCT03332589|469811828|FG002|Overall Study|Death|0|||
130730039|NCT02125877|470633682|FG001|Overall Study|Withdrawal by Subject|1|||
130730040|NCT02125877|470633681|FG000|Overall Study|Protocol deviation|4|||
130730041|NCT02125877|470633682|FG001|Overall Study|Protocol deviation|1|||
130730042|NCT02125877|470633681|FG000|Overall Study|Adverse Event|6|||
130503265|NCT00108355|469811833|FG000|Overall Study|Peritonitis at index paracentesis|1|||
130730043|NCT02125877|470633682|FG001|Overall Study|Adverse Event|4|||
130730044|NCT01685840|470633683|FG000|Overall Study|Death|77|||
130730045|NCT01685840|470633684|FG001|Overall Study|Death|66|||
130730046|NCT01685840|470633683|FG000|Overall Study|Lost to Follow-up|27|||
130730047|NCT01685840|470633684|FG001|Overall Study|Lost to Follow-up|25|||
130730048|NCT01685840|470633683|FG000|Overall Study|Physician Decision|3|||
130730049|NCT01685840|470633684|FG001|Overall Study|Physician Decision|7|||
130503266|NCT00108355|469811834|FG001|Overall Study|Peritonitis at index paracentesis|1|||
130503267|NCT00108355|469811833|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
130565846|NCT01486927|470038121|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
130565847|NCT01486927|470038121|FG000|Overall Study|Physician Decision|1|||
130503268|NCT00108355|469811834|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
130503269|NCT02958553|469811835|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
130565848|NCT01486927|470038121|FG000|Overall Study|50 Exposure days not reached|2|||
130565849|NCT01486927|470038121|FG000|Overall Study|Withdrawal by Subject|8|||
130565850|NCT01486927|470038121|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
130730050|NCT01685840|470633683|FG000|Overall Study|Withdrawal by Subject|14|||
130730051|NCT01685840|470633684|FG001|Overall Study|Withdrawal by Subject|17|||
130730052|NCT01685840|470633683|FG000|Overall Study|Futility|197|||
130730053|NCT01685840|470633684|FG001|Overall Study|Futility|200|||
130730054|NCT01685840|470633683|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
130730055|NCT01685840|470633684|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
130730056|NCT01128543|470633685|FG000|Overall Study|Withdrawal by Subject|3|||
130730057|NCT01128543|470633685|FG000|Overall Study|Protocol Violation|1|||
130730058|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
130730059|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
130730060|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
130730061|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Death|1|||
130730062|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Death|3|||
130730063|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Death|1|||
130730064|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
130730065|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130730066|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130730067|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130730068|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
130730069|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130730070|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130730071|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130730072|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
130730073|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
130730074|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
130730075|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
130730076|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130730077|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
130730078|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130730079|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
130730080|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130730081|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130730082|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130730083|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
130730084|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130730085|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
130730086|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
130730087|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
130730088|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130730089|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130730090|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
130730091|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
130730092|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
130730093|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
130730094|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130730095|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
130730096|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130730097|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130730098|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130730099|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
130730100|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130730101|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
130730102|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130730103|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
130730104|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130730105|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130730106|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
130730107|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
130730108|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
130730109|NCT01198132|470633692|FG000|Overall Study|Withdrawal by Subject|4|||
130730110|NCT01198132|470633693|FG001|Overall Study|Withdrawal by Subject|5|||
130730111|NCT01198132|470633692|FG000|Overall Study|Physician Decision|5|||
130730112|NCT01198132|470633693|FG001|Overall Study|Physician Decision|4|||
130730113|NCT01198132|470633692|FG000|Overall Study|Other Unspecified|3|||
130730114|NCT01198132|470633693|FG001|Overall Study|Other Unspecified|6|||
130730115|NCT01198132|470633692|FG000|Overall Study|Lack of Efficacy|2|||
130730116|NCT01198132|470633693|FG001|Overall Study|Lack of Efficacy|3|||
130730117|NCT01198132|470633692|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
130730118|NCT01198132|470633693|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
130730119|NCT01198132|470633692|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
130503270|NCT02958553|469811835|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
130503271|NCT03340961|469811836|FG000|Overall Study|Adverse Event|1|||
130503272|NCT03340961|469811837|FG001|Overall Study|Adverse Event|3|||
130503273|NCT03340961|469811838|FG002|Overall Study|Adverse Event|2|||
130503274|NCT03340961|469811839|FG003|Overall Study|Adverse Event|4|||
130503275|NCT03340961|469811836|FG000|Overall Study|Lost to Follow-up|0|||
130503276|NCT03340961|469811837|FG001|Overall Study|Lost to Follow-up|1|||
130503277|NCT03340961|469811838|FG002|Overall Study|Lost to Follow-up|0|||
130503278|NCT03340961|469811839|FG003|Overall Study|Lost to Follow-up|1|||
130503279|NCT03340961|469811836|FG000|Overall Study|Withdrawal by Subject|3|||
130503280|NCT03340961|469811837|FG001|Overall Study|Withdrawal by Subject|2|||
130730120|NCT01198132|470633693|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
130730121|NCT01198132|470633692|FG000|Overall Study|Adverse Event|0|||
130730122|NCT01198132|470633693|FG001|Overall Study|Adverse Event|1|||
130730123|NCT01198132|470633692|FG000|Overall Study|Protocol Violation|1|||
130730124|NCT01198132|470633693|FG001|Overall Study|Protocol Violation|0|||
130730125|NCT03516513|470633696|FG000|Overall Study|Withdrawal by Subject|2|||
130730126|NCT03516513|470633697|FG001|Overall Study|Withdrawal by Subject|2|||
130730127|NCT03516513|470633698|FG002|Overall Study|Withdrawal by Subject|0|||
130730128|NCT03516513|470633699|FG003|Overall Study|Withdrawal by Subject|0|||
130730129|NCT03071276|470633701|FG000|Overall Study|Adverse Event|1|||
130730130|NCT03071276|470633701|FG000|Overall Study|Lack of Efficacy|14|||
130730131|NCT03390426|470633702|FG000|Overall Study|Protocol Violation|0|||
130730132|NCT03390426|470633703|FG001|Overall Study|Protocol Violation|1|||
130730133|NCT00548093|470633708|FG000|Overall Study|Death|33|||
130730134|NCT00548093|470633709|FG001|Overall Study|Death|13|||
130730135|NCT00548093|470633708|FG000|Overall Study|Lost to Follow-up|3|||
130730136|NCT00548093|470633709|FG001|Overall Study|Lost to Follow-up|1|||
130730137|NCT00548093|470633708|FG000|Overall Study|Objective progression or relapse|1|||
130730138|NCT00548093|470633709|FG001|Overall Study|Objective progression or relapse|1|||
130730139|NCT00548093|470633708|FG000|Overall Study|Other|11|||
130730140|NCT00548093|470633709|FG001|Overall Study|Other|1|||
130730141|NCT00548093|470633708|FG000|Overall Study|Withdrawal by Subject|1|||
130730142|NCT00548093|470633709|FG001|Overall Study|Withdrawal by Subject|0|||
130730143|NCT00548093|470633708|FG000|Overall Study|Completed post-treatment follow-up|1|||
130730144|NCT00548093|470633709|FG001|Overall Study|Completed post-treatment follow-up|0|||
130730145|NCT02516553|470633710|FG000|Overall Study|Progressive disease|2|||
130730146|NCT02516553|470633711|FG001|Overall Study|Progressive disease|2|||
130730147|NCT02516553|470633712|FG002|Overall Study|Progressive disease|3|||
130730148|NCT02516553|470633713|FG003|Overall Study|Progressive disease|5|||
130730149|NCT02516553|470633714|FG004|Overall Study|Progressive disease|3|||
130503281|NCT03340961|469811838|FG002|Overall Study|Withdrawal by Subject|4|||
130503282|NCT03340961|469811839|FG003|Overall Study|Withdrawal by Subject|7|||
130503283|NCT03340961|469811836|FG000|Overall Study|Use of prohibited treatment|0|||
130730150|NCT02516553|470633715|FG005|Overall Study|Progressive disease|0|||
130730151|NCT02516553|470633716|FG006|Overall Study|Progressive disease|5|||
130730152|NCT02516553|470633717|FG007|Overall Study|Progressive disease|5|||
130730153|NCT02516553|470633718|FG008|Overall Study|Progressive disease|11|||
130730154|NCT02516553|470633719|FG009|Overall Study|Progressive disease|3|||
130730155|NCT02516553|470633720|FG010|Overall Study|Progressive disease|10|||
130730156|NCT02516553|470633721|FG011|Overall Study|Progressive disease|8|||
130730157|NCT02516553|470633722|FG012|Overall Study|Progressive disease|8|||
130503284|NCT03340961|469811837|FG001|Overall Study|Use of prohibited treatment|3|||
130503285|NCT03340961|469811838|FG002|Overall Study|Use of prohibited treatment|2|||
130503286|NCT03340961|469811839|FG003|Overall Study|Use of prohibited treatment|4|||
130565851|NCT01476475|470038123|FG000|Overall Study|Adverse Event|6|||
130565852|NCT01476475|470038124|FG001|Overall Study|Adverse Event|0|||
130565853|NCT01476475|470038123|FG000|Overall Study|Poor compliance to protocol|1|||
130565854|NCT01476475|470038124|FG001|Overall Study|Poor compliance to protocol|1|||
130565855|NCT01476475|470038123|FG000|Overall Study|Other reasons|4|||
130565856|NCT01476475|470038124|FG001|Overall Study|Other reasons|2|||
130565857|NCT01278745|470038125|FG000|Overall Study|Death|2|||
130565858|NCT01278745|470038126|FG001|Overall Study|Death|5|||
130565859|NCT01278745|470038127|FG002|Overall Study|Death|7|||
130565860|NCT01278745|470038128|FG003|Overall Study|Death|0|||
130565861|NCT01278745|470038125|FG000|Overall Study|Physician Decision|1|||
130565862|NCT01278745|470038126|FG001|Overall Study|Physician Decision|0|||
130565863|NCT01278745|470038127|FG002|Overall Study|Physician Decision|0|||
130565864|NCT01278745|470038128|FG003|Overall Study|Physician Decision|9|||
130565865|NCT01278745|470038125|FG000|Overall Study|Withdrawal by Subject|1|||
130565866|NCT01278745|470038126|FG001|Overall Study|Withdrawal by Subject|1|||
130565867|NCT01278745|470038127|FG002|Overall Study|Withdrawal by Subject|5|||
130565868|NCT01278745|470038128|FG003|Overall Study|Withdrawal by Subject|1|||
130565869|NCT01278745|470038125|FG000|Overall Study|Sponsor Decision|1|||
130565870|NCT01278745|470038126|FG001|Overall Study|Sponsor Decision|0|||
130565871|NCT01278745|470038127|FG002|Overall Study|Sponsor Decision|62|||
130565872|NCT01278745|470038128|FG003|Overall Study|Sponsor Decision|6|||
130565873|NCT01278745|470038125|FG000|Overall Study|Ineligible|0|||
130565874|NCT01278745|470038126|FG001|Overall Study|Ineligible|0|||
130565875|NCT01278745|470038127|FG002|Overall Study|Ineligible|42|||
130565876|NCT01278745|470038128|FG003|Overall Study|Ineligible|61|||
130565877|NCT01278745|470038125|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
130565878|NCT01278745|470038126|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
130565879|NCT01278745|470038127|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
130565880|NCT01278745|470038128|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
130565881|NCT01843842|470038129|FG000|Overall Study|Do not meet inclusion criteria|1|||
130565882|NCT01843842|470038130|FG001|Overall Study|Do not meet inclusion criteria|1|||
130565883|NCT03374189|470038133|FG000|Overall Study|Lost to Follow-up|1|||
130565884|NCT03374189|470038134|FG001|Overall Study|Lost to Follow-up|0|||
130565885|NCT02375724|470038135|FG000|Overall Study|Lack of Efficacy|1|||
130565886|NCT02375724|470038136|FG001|Overall Study|Lack of Efficacy|1|||
130565887|NCT02375724|470038135|FG000|Overall Study|Withdrawal by Subject|1|||
130565888|NCT02375724|470038136|FG001|Overall Study|Withdrawal by Subject|1|||
130565889|NCT02375724|470038135|FG000|Overall Study|Lost to Follow-up|1|||
130565890|NCT02375724|470038136|FG001|Overall Study|Lost to Follow-up|0|||
130565891|NCT02375724|470038135|FG000|Overall Study|Protocol Violation|1|||
130565892|NCT02375724|470038136|FG001|Overall Study|Protocol Violation|0|||
130565893|NCT02375724|470038135|FG000|Overall Study|Adverse Event|2|||
130565894|NCT02375724|470038136|FG001|Overall Study|Adverse Event|4|||
130565895|NCT01309659|470038137|FG000|Overall Study|Protocol Violation|0|||
130565896|NCT01309659|470038138|FG001|Overall Study|Protocol Violation|1|||
130565897|NCT03462576|470038139|FG000|Overall Study|Protocol Violation|5|||
130565898|NCT03462576|470038140|FG001|Overall Study|Protocol Violation|11|||
130565899|NCT03462576|470038141|FG002|Overall Study|Protocol Violation|7|||
130503287|NCT03340961|469811836|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
130503288|NCT03340961|469811837|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
130503289|NCT03340961|469811838|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
130503290|NCT03340961|469811839|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
130503291|NCT03340961|469811836|FG000|Overall Study|Subject developed an exclusion criterion|0|||
130503292|NCT03340961|469811837|FG001|Overall Study|Subject developed an exclusion criterion|1|||
130503293|NCT03340961|469811838|FG002|Overall Study|Subject developed an exclusion criterion|0|||
130503294|NCT03340961|469811839|FG003|Overall Study|Subject developed an exclusion criterion|0|||
130503295|NCT03340961|469811836|FG000|Overall Study|Protocol Violation|1|||
130503296|NCT03340961|469811837|FG001|Overall Study|Protocol Violation|0|||
130503297|NCT03340961|469811838|FG002|Overall Study|Protocol Violation|1|||
130503298|NCT03340961|469811839|FG003|Overall Study|Protocol Violation|0|||
130503299|NCT03340961|469811836|FG000|Overall Study|Adverse Event|1|||
130503300|NCT03340961|469811837|FG001|Overall Study|Adverse Event|1|||
130503301|NCT03340961|469811838|FG002|Overall Study|Adverse Event|0|||
130503302|NCT03340961|469811839|FG003|Overall Study|Adverse Event|0|||
130503303|NCT03340961|469811836|FG000|Overall Study|Lack of Efficacy|0|||
130503304|NCT03340961|469811837|FG001|Overall Study|Lack of Efficacy|0|||
130503305|NCT03340961|469811838|FG002|Overall Study|Lack of Efficacy|0|||
130503306|NCT03340961|469811839|FG003|Overall Study|Lack of Efficacy|1|||
130503307|NCT00308308|469811840|FG000|Overall Study|Adverse Event|17|||
130565900|NCT03462576|470038139|FG000|Overall Study|Device Malfunction|0|||
130565901|NCT03462576|470038140|FG001|Overall Study|Device Malfunction|0|||
130503308|NCT00308308|469811841|FG001|Overall Study|Adverse Event|2|||
130503309|NCT00308308|469811840|FG000|Overall Study|Lost to Follow-up|5|||
130503310|NCT00308308|469811841|FG001|Overall Study|Lost to Follow-up|5|||
130565902|NCT03462576|470038141|FG002|Overall Study|Device Malfunction|1|||
130565903|NCT03962101|470038143|FG000|Overall Study|Adverse Event|1|||
130565904|NCT03962101|470038143|FG000|Overall Study|Physician Decision|2|||
130565905|NCT03962101|470038143|FG000|Overall Study|Not related to medical events|1|||
130730158|NCT02516553|470633723|FG013|Overall Study|Progressive disease|2|||
130730159|NCT02516553|470633724|FG014|Overall Study|Progressive disease|2|||
130730160|NCT02516553|470633725|FG015|Overall Study|Progressive disease|2|||
130730161|NCT02516553|470633726|FG016|Overall Study|Progressive disease|1|||
130730162|NCT02516553|470633727|FG017|Overall Study|Progressive disease|9|||
130730163|NCT02516553|470633728|FG018|Overall Study|Progressive disease|12|||
130730164|NCT02516553|470633729|FG019|Overall Study|Progressive disease|7|||
130730165|NCT02516553|470633730|FG020|Overall Study|Progressive disease|16|||
130730166|NCT02516553|470633731|FG021|Overall Study|Progressive disease|18|||
130730167|NCT02516553|470633710|FG000|Overall Study|Dose limiting toxicity|0|||
130503311|NCT00308308|469811840|FG000|Overall Study|Physician Decision|15|||
130503312|NCT00308308|469811841|FG001|Overall Study|Physician Decision|7|||
130503313|NCT00308308|469811840|FG000|Overall Study|Protocol Violation|3|||
130503314|NCT00308308|469811841|FG001|Overall Study|Protocol Violation|14|||
130503315|NCT00308308|469811840|FG000|Overall Study|Withdrawal by Subject|47|||
130503316|NCT00308308|469811841|FG001|Overall Study|Withdrawal by Subject|19|||
130503317|NCT00308308|469811840|FG000|Overall Study|Various|7|||
130503318|NCT00308308|469811841|FG001|Overall Study|Various|5|||
130503319|NCT00308308|469811840|FG000|Overall Study|Randomized but not dosed|8|||
130503320|NCT00308308|469811841|FG001|Overall Study|Randomized but not dosed|16|||
130503321|NCT00308308|469811840|FG000|Overall Study|Other|1|||
130503322|NCT00308308|469811841|FG001|Overall Study|Other|0|||
130503323|NCT01686152|469811842|FG000|Overall Study|Withdrawal by Subject|11|||
130503324|NCT01686152|469811843|FG001|Overall Study|Withdrawal by Subject|11|||
130503325|NCT01686152|469811844|FG002|Overall Study|Withdrawal by Subject|3|||
130503326|NCT01686152|469811842|FG000|Overall Study|Drug Code Unblinded|0|||
130503327|NCT01686152|469811843|FG001|Overall Study|Drug Code Unblinded|1|||
130503328|NCT01686152|469811844|FG002|Overall Study|Drug Code Unblinded|0|||
130503329|NCT01686152|469811842|FG000|Overall Study|Protocol Violation|6|||
130503330|NCT01686152|469811843|FG001|Overall Study|Protocol Violation|1|||
130503331|NCT01686152|469811844|FG002|Overall Study|Protocol Violation|0|||
130503332|NCT01686152|469811842|FG000|Overall Study|Adverse Event|12|||
130503333|NCT01686152|469811843|FG001|Overall Study|Adverse Event|11|||
130565906|NCT00271596|470038146|FG000|Overall Study|Protocol Violation|1|||
130565907|NCT00271596|470038147|FG001|Overall Study|Protocol Violation|0|||
130565908|NCT00271596|470038146|FG000|Overall Study|Withdrawal by Subject|0|||
130565909|NCT00271596|470038147|FG001|Overall Study|Withdrawal by Subject|1|||
130565910|NCT04707157|470038148|FG000|Overall Study|Adverse Event|12|||
130565911|NCT04707157|470038149|FG001|Overall Study|Adverse Event|3|||
130565912|NCT04707157|470038148|FG000|Overall Study|Lost to Follow-up|2|||
130565913|NCT04707157|470038149|FG001|Overall Study|Lost to Follow-up|0|||
130565914|NCT04707157|470038148|FG000|Overall Study|Sponsor's decision|1|||
130565915|NCT04707157|470038149|FG001|Overall Study|Sponsor's decision|0|||
130565916|NCT04707157|470038148|FG000|Overall Study|Physician Decision|8|||
130565917|NCT04707157|470038149|FG001|Overall Study|Physician Decision|5|||
130565918|NCT04707157|470038148|FG000|Overall Study|Protocol Deviation|1|||
130565919|NCT04707157|470038149|FG001|Overall Study|Protocol Deviation|0|||
130565920|NCT04707157|470038148|FG000|Overall Study|Withdrawal by Subject|1|||
130565921|NCT04707157|470038149|FG001|Overall Study|Withdrawal by Subject|1|||
130565922|NCT01069172|470038151|FG000|Overall Study|Withdrawal by Subject|1|||
130565923|NCT01069172|470038152|FG001|Overall Study|Withdrawal by Subject|0|||
130565924|NCT04206605|470038153|FG000|Overall Study|Adverse Event|0|||
130565925|NCT04206605|470038154|FG001|Overall Study|Adverse Event|1|||
130565926|NCT04206605|470038153|FG000|Overall Study|Withdrawal by Subject|1|||
130565927|NCT04206605|470038154|FG001|Overall Study|Withdrawal by Subject|0|||
130565928|NCT03901079|470038157|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
130565929|NCT04995055|470038158|FG000|Period 1|COVID-19 Related|1|||
130565930|NCT04995055|470038159|FG001|Period 1|COVID-19 Related|0|||
130565931|NCT04995055|470038158|FG000|Period 1|Withdrawal by Subject|0|||
130565932|NCT04995055|470038159|FG001|Period 1|Withdrawal by Subject|1|||
130565933|NCT04995055|470038158|FG000|Period 1|Subject discontinued due to timing|4|||
130730168|NCT02516553|470633711|FG001|Overall Study|Dose limiting toxicity|0|||
130730169|NCT02516553|470633712|FG002|Overall Study|Dose limiting toxicity|0|||
130503334|NCT01686152|469811844|FG002|Overall Study|Adverse Event|0|||
130503335|NCT01686152|469811842|FG000|Overall Study|Lack of Efficacy|0|||
130503336|NCT01686152|469811843|FG001|Overall Study|Lack of Efficacy|0|||
130565934|NCT04995055|470038159|FG001|Period 1|Subject discontinued due to timing|4|||
130565935|NCT01066585|470038162|FG000|Overall Study|Protocol Violation|1|||
130565936|NCT01066585|470038163|FG001|Overall Study|Protocol Violation|0|||
130565937|NCT01066585|470038162|FG000|Overall Study|Withdrawal by Subject|0|||
130565938|NCT01066585|470038163|FG001|Overall Study|Withdrawal by Subject|3|||
130565939|NCT00884273|470038164|FG000|Overall Study|Adverse Event|0|||
130565940|NCT00884273|470038165|FG001|Overall Study|Adverse Event|2|||
130565941|NCT00884273|470038164|FG000|Overall Study|Protocol Violation|1|||
130565942|NCT00884273|470038165|FG001|Overall Study|Protocol Violation|3|||
130730170|NCT02516553|470633713|FG003|Overall Study|Dose limiting toxicity|0|||
130730171|NCT02516553|470633714|FG004|Overall Study|Dose limiting toxicity|3|||
130503337|NCT01686152|469811844|FG002|Overall Study|Lack of Efficacy|1|||
130565943|NCT00884273|470038164|FG000|Overall Study|Practical reasons|1|||
130503338|NCT01686152|469811842|FG000|Overall Study|IP Non-compliance|5|||
130503339|NCT01686152|469811843|FG001|Overall Study|IP Non-compliance|5|||
130503340|NCT01686152|469811844|FG002|Overall Study|IP Non-compliance|0|||
130503341|NCT01686152|469811842|FG000|Overall Study|Lost to Follow-up|7|||
130503342|NCT01686152|469811843|FG001|Overall Study|Lost to Follow-up|6|||
130503343|NCT01686152|469811844|FG002|Overall Study|Lost to Follow-up|5|||
130503344|NCT01853384|469811845|FG000|Randomized|Adverse Event|5|||
130503345|NCT01853384|469811846|FG001|Randomized|Adverse Event|3|||
130503346|NCT01853384|469811845|FG000|Randomized|Death|1|||
130503347|NCT01853384|469811846|FG001|Randomized|Death|2|||
130503348|NCT01853384|469811845|FG000|Randomized|Lost to Follow-up|1|||
130503349|NCT01853384|469811846|FG001|Randomized|Lost to Follow-up|1|||
130503350|NCT01853384|469811845|FG000|Randomized|Withdrawal by Subject|5|||
130730172|NCT02516553|470633715|FG005|Overall Study|Dose limiting toxicity|1|||
130730173|NCT02516553|470633716|FG006|Overall Study|Dose limiting toxicity|1|||
130730174|NCT02516553|470633717|FG007|Overall Study|Dose limiting toxicity|0|||
130503351|NCT01853384|469811846|FG001|Randomized|Withdrawal by Subject|3|||
130503352|NCT01853384|469811845|FG000|Randomized|Sponsor Decision|47|||
130503353|NCT01853384|469811846|FG001|Randomized|Sponsor Decision|34|||
130503354|NCT01853384|469811845|FG000|Randomized|Other|3|||
130503355|NCT01853384|469811846|FG001|Randomized|Other|3|||
130503356|NCT01853384|469811845|FG000|Completed Follow up Visit 1|Early Termination|13|||
130503357|NCT01853384|469811846|FG001|Completed Follow up Visit 1|Early Termination|9|||
130503358|NCT01853384|469811845|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
130503359|NCT01853384|469811846|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
130503360|NCT01853384|469811845|FG000|Completed Follow up Visit 2|Adverse Event|1|||
130503361|NCT01853384|469811846|FG001|Completed Follow up Visit 2|Adverse Event|0|||
130503362|NCT01853384|469811845|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
130503363|NCT01853384|469811846|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
130503364|NCT01853384|469811845|FG000|Completed Follow up Visit 2|Death|1|||
130503365|NCT01853384|469811846|FG001|Completed Follow up Visit 2|Death|0|||
130503366|NCT01853384|469811845|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
130503367|NCT01853384|469811846|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
130503368|NCT01802333|469811847|FG000|Overall Study|Ineligible|2|||
130503369|NCT01802333|469811848|FG001|Overall Study|Ineligible|6|||
130503370|NCT01802333|469811849|FG002|Overall Study|Ineligible|8|||
130503371|NCT01802333|469811847|FG000|Overall Study|Adverse Event|1|||
130503372|NCT01802333|469811848|FG001|Overall Study|Adverse Event|8|||
130503373|NCT01802333|469811849|FG002|Overall Study|Adverse Event|8|||
130503374|NCT01802333|469811847|FG000|Overall Study|Withdrawal by Subject|6|||
130503375|NCT01802333|469811848|FG001|Overall Study|Withdrawal by Subject|6|||
130503376|NCT01802333|469811849|FG002|Overall Study|Withdrawal by Subject|5|||
130503377|NCT01802333|469811847|FG000|Overall Study|Progression/relapse|1|||
130503378|NCT01802333|469811848|FG001|Overall Study|Progression/relapse|3|||
130503379|NCT01802333|469811849|FG002|Overall Study|Progression/relapse|0|||
130503380|NCT01802333|469811847|FG000|Overall Study|Death|7|||
130503381|NCT01802333|469811848|FG001|Overall Study|Death|14|||
130503382|NCT01802333|469811849|FG002|Overall Study|Death|13|||
130503383|NCT01802333|469811847|FG000|Overall Study|Other - not protocol specified|32|||
130503384|NCT01802333|469811848|FG001|Overall Study|Other - not protocol specified|22|||
130503385|NCT01802333|469811849|FG002|Overall Study|Other - not protocol specified|24|||
130503386|NCT01802333|469811847|FG000|Overall Study|Did not start treatment|0|||
130503387|NCT01802333|469811848|FG001|Overall Study|Did not start treatment|2|||
130503388|NCT01802333|469811849|FG002|Overall Study|Did not start treatment|5|||
130503389|NCT01947491|469811850|FG000|Overall Study|Lost to Follow-up|5|||
130503390|NCT01947491|469811851|FG001|Overall Study|Lost to Follow-up|3|||
130503391|NCT01947491|469811852|FG002|Overall Study|Lost to Follow-up|1|||
130503392|NCT01947491|469811853|FG003|Overall Study|Lost to Follow-up|2|||
130503393|NCT01947491|469811850|FG000|Overall Study|Lack of Efficacy|1|||
130503394|NCT01947491|469811851|FG001|Overall Study|Lack of Efficacy|0|||
130503395|NCT01947491|469811852|FG002|Overall Study|Lack of Efficacy|0|||
130503396|NCT01947491|469811853|FG003|Overall Study|Lack of Efficacy|1|||
130503397|NCT01947491|469811850|FG000|Overall Study|Protocol Violation|1|||
130503398|NCT01947491|469811851|FG001|Overall Study|Protocol Violation|0|||
130503399|NCT01947491|469811852|FG002|Overall Study|Protocol Violation|0|||
130503400|NCT01947491|469811853|FG003|Overall Study|Protocol Violation|0|||
130503401|NCT01947491|469811850|FG000|Overall Study|Withdrawal by Subject|1|||
130503402|NCT01947491|469811851|FG001|Overall Study|Withdrawal by Subject|1|||
130503403|NCT01947491|469811852|FG002|Overall Study|Withdrawal by Subject|1|||
130503404|NCT01947491|469811853|FG003|Overall Study|Withdrawal by Subject|0|||
130503405|NCT01947491|469811850|FG000|Overall Study|Worsening of condition|0|||
130503406|NCT01947491|469811851|FG001|Overall Study|Worsening of condition|1|||
130503407|NCT01947491|469811852|FG002|Overall Study|Worsening of condition|0|||
130503408|NCT01947491|469811853|FG003|Overall Study|Worsening of condition|0|||
130503409|NCT01947491|469811850|FG000|Overall Study|Adverse Event|0|||
130503410|NCT01947491|469811851|FG001|Overall Study|Adverse Event|1|||
130503411|NCT01947491|469811852|FG002|Overall Study|Adverse Event|0|||
130503412|NCT01947491|469811853|FG003|Overall Study|Adverse Event|2|||
130503413|NCT02067663|469811855|FG000|Overall Study|Lost to Follow-up|13|||
130503414|NCT02067663|469811856|FG001|Overall Study|Lost to Follow-up|14|||
130503415|NCT03137784|469811857|FG000|Overall Study|Adverse Event|1|||
130730175|NCT02516553|470633718|FG008|Overall Study|Dose limiting toxicity|1|||
130503416|NCT03137784|469811858|FG001|Overall Study|Adverse Event|1|||
130730176|NCT02516553|470633719|FG009|Overall Study|Dose limiting toxicity|0|||
130503417|NCT03137784|469811859|FG002|Overall Study|Adverse Event|0|||
130503418|NCT03137784|469811860|FG003|Overall Study|Adverse Event|0|||
130503419|NCT03137784|469811861|FG004|Overall Study|Adverse Event|0|||
130503420|NCT03137784|469811862|FG005|Overall Study|Adverse Event|0|||
130503421|NCT03137784|469811857|FG000|Overall Study|Subject/guardian decision|1|||
130503422|NCT03137784|469811858|FG001|Overall Study|Subject/guardian decision|0|||
130503423|NCT03137784|469811859|FG002|Overall Study|Subject/guardian decision|0|||
130503424|NCT03137784|469811860|FG003|Overall Study|Subject/guardian decision|0|||
130503425|NCT03137784|469811861|FG004|Overall Study|Subject/guardian decision|0|||
130503426|NCT03137784|469811862|FG005|Overall Study|Subject/guardian decision|0|||
130503427|NCT03137784|469811857|FG000|Overall Study|Non-compliance with study treatment|0|||
130503428|NCT03137784|469811858|FG001|Overall Study|Non-compliance with study treatment|0|||
130503429|NCT03137784|469811859|FG002|Overall Study|Non-compliance with study treatment|0|||
130503430|NCT03137784|469811860|FG003|Overall Study|Non-compliance with study treatment|0|||
130503431|NCT03137784|469811861|FG004|Overall Study|Non-compliance with study treatment|1|||
130503432|NCT03137784|469811862|FG005|Overall Study|Non-compliance with study treatment|0|||
130503433|NCT01437540|469811863|FG000|Overall Study|Not listed below|7|||
130503434|NCT01437540|469811864|FG001|Overall Study|Not listed below|6|||
130503435|NCT01437540|469811863|FG000|Overall Study|COPD exacerbation|13|||
130503436|NCT01437540|469811864|FG001|Overall Study|COPD exacerbation|3|||
130503437|NCT01437540|469811863|FG000|Overall Study|Lost to Follow-up|3|||
130503438|NCT01437540|469811864|FG001|Overall Study|Lost to Follow-up|5|||
130503439|NCT01437540|469811863|FG000|Overall Study|Lack of Efficacy|23|||
130503440|NCT01437540|469811864|FG001|Overall Study|Lack of Efficacy|11|||
130503441|NCT01437540|469811863|FG000|Overall Study|Protocol Violation|24|||
130503442|NCT01437540|469811864|FG001|Overall Study|Protocol Violation|12|||
130503443|NCT01437540|469811863|FG000|Overall Study|Adverse Event|26|||
130503444|NCT01437540|469811864|FG001|Overall Study|Adverse Event|13|||
130503445|NCT01437540|469811863|FG000|Overall Study|Withdrawal by Subject|31|||
130503446|NCT01437540|469811864|FG001|Overall Study|Withdrawal by Subject|15|||
130503447|NCT01205126|469811866|FG000|Titration Phase|Adverse Event|5|||
130503448|NCT01205126|469811867|FG001|Titration Phase|Adverse Event|3|||
130503449|NCT01205126|469811866|FG000|Titration Phase|Withdrawal by Subject|5|||
130503450|NCT01205126|469811867|FG001|Titration Phase|Withdrawal by Subject|5|||
130503451|NCT01205126|469811866|FG000|Titration Phase|Lost to Follow-up|2|||
130503452|NCT01205126|469811867|FG001|Titration Phase|Lost to Follow-up|2|||
130503453|NCT01205126|469811866|FG000|Titration Phase|No stable titration dose|1|||
130503454|NCT01205126|469811867|FG001|Titration Phase|No stable titration dose|0|||
130503455|NCT01205126|469811866|FG000|Titration Phase|More than maximum dosage required|2|||
130503456|NCT01205126|469811867|FG001|Titration Phase|More than maximum dosage required|3|||
130503457|NCT01205126|469811866|FG000|Titration Phase|Other|8|||
130503458|NCT01205126|469811867|FG001|Titration Phase|Other|6|||
130503459|NCT01205126|469811866|FG000|Between Titration & Maintenance Phase|Other|0|||
130503460|NCT01205126|469811867|FG001|Between Titration & Maintenance Phase|Other|4|||
130503461|NCT01205126|469811866|FG000|Maintenance Phase|Adverse Event|3|||
130503462|NCT01205126|469811867|FG001|Maintenance Phase|Adverse Event|7|||
130503463|NCT01205126|469811866|FG000|Maintenance Phase|Death|4|||
130503464|NCT01205126|469811867|FG001|Maintenance Phase|Death|4|||
130503465|NCT01205126|469811866|FG000|Maintenance Phase|More than the maximum dosage required|5|||
130503466|NCT01205126|469811867|FG001|Maintenance Phase|More than the maximum dosage required|5|||
130503467|NCT01205126|469811866|FG000|Maintenance Phase|Prohibited drugs used|1|||
130503468|NCT01205126|469811867|FG001|Maintenance Phase|Prohibited drugs used|0|||
130503469|NCT01205126|469811866|FG000|Maintenance Phase|Other|11|||
130503470|NCT01205126|469811867|FG001|Maintenance Phase|Other|8|||
130503471|NCT01205126|469811866|FG000|Maintenance Phase|Lost to Follow-up|5|||
130503472|NCT01205126|469811867|FG001|Maintenance Phase|Lost to Follow-up|5|||
130503473|NCT01205126|469811866|FG000|Maintenance Phase|Withdrawal by Subject|8|||
130503474|NCT01205126|469811867|FG001|Maintenance Phase|Withdrawal by Subject|11|||
130503475|NCT00486954|469811868|FG000|Pilot Part|Adverse Event|4|||
130503476|NCT00486954|469811869|FG001|Pilot Part|Adverse Event|0|||
130503477|NCT00486954|469811870|FG002|Pilot Part|Adverse Event|5|||
130503478|NCT00486954|469811871|FG003|Pilot Part|Adverse Event|0|||
130503479|NCT00486954|469811872|FG004|Pilot Part|Adverse Event|0|||
130503480|NCT00486954|469811868|FG000|Pilot Part|Disease Progression|2|||
130503481|NCT00486954|469811869|FG001|Pilot Part|Disease Progression|0|||
130503482|NCT00486954|469811870|FG002|Pilot Part|Disease Progression|1|||
130503483|NCT00486954|469811871|FG003|Pilot Part|Disease Progression|0|||
130503484|NCT00486954|469811872|FG004|Pilot Part|Disease Progression|0|||
130503485|NCT00486954|469811868|FG000|Randomized Part|Lost to Follow-up|0|||
130503486|NCT00486954|469811869|FG001|Randomized Part|Lost to Follow-up|0|||
130503487|NCT00486954|469811870|FG002|Randomized Part|Lost to Follow-up|0|||
130503488|NCT00486954|469811871|FG003|Randomized Part|Lost to Follow-up|0|||
130503489|NCT00486954|469811872|FG004|Randomized Part|Lost to Follow-up|1|||
130503490|NCT00486954|469811868|FG000|Randomized Part|Withdrawal by Subject|0|||
130503491|NCT00486954|469811869|FG001|Randomized Part|Withdrawal by Subject|0|||
130503492|NCT00486954|469811870|FG002|Randomized Part|Withdrawal by Subject|0|||
130503493|NCT00486954|469811871|FG003|Randomized Part|Withdrawal by Subject|1|||
130503494|NCT00486954|469811872|FG004|Randomized Part|Withdrawal by Subject|0|||
130503495|NCT00486954|469811868|FG000|Randomized Part|Sponsor Terminated Study|0|||
130730177|NCT02516553|470633720|FG010|Overall Study|Dose limiting toxicity|0|||
130503496|NCT00486954|469811869|FG001|Randomized Part|Sponsor Terminated Study|0|||
130503497|NCT00486954|469811870|FG002|Randomized Part|Sponsor Terminated Study|0|||
130503498|NCT00486954|469811871|FG003|Randomized Part|Sponsor Terminated Study|19|||
130503499|NCT00486954|469811872|FG004|Randomized Part|Sponsor Terminated Study|13|||
130503500|NCT01836523|469811873|FG000|Overall Study|Adverse Event|15|||
130730178|NCT02516553|470633721|FG011|Overall Study|Dose limiting toxicity|1|||
130503501|NCT01836523|469811874|FG001|Overall Study|Adverse Event|41|||
130503502|NCT01836523|469811875|FG002|Overall Study|Adverse Event|49|||
130503503|NCT01836523|469811876|FG003|Overall Study|Adverse Event|14|||
130503504|NCT01836523|469811873|FG000|Overall Study|Protocol Violation|6|||
130503505|NCT01836523|469811874|FG001|Overall Study|Protocol Violation|3|||
130503506|NCT01836523|469811875|FG002|Overall Study|Protocol Violation|2|||
130503507|NCT01836523|469811876|FG003|Overall Study|Protocol Violation|4|||
130503508|NCT01836523|469811873|FG000|Overall Study|Met Withdrawal Criteria|13|||
130503509|NCT01836523|469811874|FG001|Overall Study|Met Withdrawal Criteria|13|||
130503510|NCT01836523|469811875|FG002|Overall Study|Met Withdrawal Criteria|21|||
130503511|NCT01836523|469811876|FG003|Overall Study|Met Withdrawal Criteria|27|||
130503512|NCT01836523|469811873|FG000|Overall Study|Unclassified|17|||
130503513|NCT01836523|469811874|FG001|Overall Study|Unclassified|28|||
130503514|NCT01836523|469811875|FG002|Overall Study|Unclassified|19|||
130503515|NCT01836523|469811876|FG003|Overall Study|Unclassified|29|||
130503516|NCT01393600|469811882|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
130503517|NCT01393600|469811883|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
130503518|NCT01393600|469811884|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
130503519|NCT01393600|469811885|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
130503520|NCT01393600|469811882|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
130503521|NCT01393600|469811883|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
130503522|NCT01393600|469811884|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
130503523|NCT01393600|469811885|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
130503524|NCT01393600|469811882|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
130503525|NCT01393600|469811883|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
130503526|NCT01393600|469811884|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
130503527|NCT01393600|469811885|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
130503528|NCT01393600|469811882|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
130503529|NCT01393600|469811883|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
130503530|NCT01393600|469811884|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
130503531|NCT01393600|469811885|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
130503532|NCT01393600|469811882|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
130503533|NCT01393600|469811883|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
130503534|NCT01393600|469811884|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
130503535|NCT01393600|469811885|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
130503536|NCT01393600|469811882|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
130503537|NCT01393600|469811883|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
130503538|NCT01393600|469811884|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
130503539|NCT01393600|469811885|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
130503540|NCT01393600|469811882|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
130503541|NCT01393600|469811883|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
130503542|NCT01393600|469811884|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
130503543|NCT01393600|469811885|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
130503544|NCT00603798|469811886|FG000|Overall Study|Adverse Event|4|||
130503545|NCT00603798|469811887|FG001|Overall Study|Adverse Event|2|||
130503546|NCT00603798|469811888|FG002|Overall Study|Adverse Event|1|||
130503547|NCT00603798|469811886|FG000|Overall Study|Withdrawal by Subject|4|||
130503548|NCT00603798|469811887|FG001|Overall Study|Withdrawal by Subject|3|||
130503549|NCT00603798|469811888|FG002|Overall Study|Withdrawal by Subject|4|||
130503550|NCT00603798|469811886|FG000|Overall Study|Lost to Follow-up|1|||
130503551|NCT00603798|469811887|FG001|Overall Study|Lost to Follow-up|0|||
130503552|NCT00603798|469811888|FG002|Overall Study|Lost to Follow-up|1|||
130503553|NCT00603798|469811886|FG000|Overall Study|Non-compliance with study procedures|0|||
130503554|NCT00603798|469811887|FG001|Overall Study|Non-compliance with study procedures|1|||
130503555|NCT00603798|469811888|FG002|Overall Study|Non-compliance with study procedures|0|||
130503556|NCT00603798|469811886|FG000|Overall Study|Not due to AE|1|||
130503557|NCT00603798|469811887|FG001|Overall Study|Not due to AE|1|||
130503558|NCT00603798|469811888|FG002|Overall Study|Not due to AE|4|||
130503559|NCT02245620|469811889|FG000|Overall Study|Physician Decision|1|||
130503560|NCT02245620|469811890|FG001|Overall Study|Physician Decision|1|||
130503561|NCT01102426|469811891|FG000|Overall Study|Randomized but not treated|4|||
130503562|NCT01102426|469811892|FG001|Overall Study|Randomized but not treated|1|||
130503563|NCT01102426|469811891|FG000|Overall Study|Adverse Events (treatment-related)|15|||
130503564|NCT01102426|469811892|FG001|Overall Study|Adverse Events (treatment-related)|8|||
130503565|NCT01102426|469811891|FG000|Overall Study|Physician Decision|9|||
130503566|NCT01102426|469811892|FG001|Overall Study|Physician Decision|6|||
130503567|NCT01102426|469811891|FG000|Overall Study|Progressive Disease|85|||
130503568|NCT01102426|469811892|FG001|Overall Study|Progressive Disease|44|||
130503569|NCT01102426|469811891|FG000|Overall Study|Adverse Events (unrelated to|9|||
130565944|NCT00884273|470038165|FG001|Overall Study|Practical reasons|0|||
130565945|NCT00578136|470038168|FG000|Overall Study|Not given intervention|1|||
130730179|NCT02516553|470633722|FG012|Overall Study|Dose limiting toxicity|0|||
130503570|NCT01102426|469811892|FG001|Overall Study|Adverse Events (unrelated to|1|||
130503571|NCT01102426|469811891|FG000|Overall Study|Patient Refusal|24|||
130503572|NCT01102426|469811892|FG001|Overall Study|Patient Refusal|12|||
130503573|NCT01102426|469811891|FG000|Overall Study|Death (due to adverse events|0|||
130503574|NCT01102426|469811892|FG001|Overall Study|Death (due to adverse events|1|||
130503575|NCT01102426|469811891|FG000|Overall Study|Death (non-related to the study|19|||
130730180|NCT02516553|470633723|FG013|Overall Study|Dose limiting toxicity|1|||
130730181|NCT02516553|470633724|FG014|Overall Study|Dose limiting toxicity|0|||
130730182|NCT02516553|470633725|FG015|Overall Study|Dose limiting toxicity|0|||
130730183|NCT02516553|470633726|FG016|Overall Study|Dose limiting toxicity|1|||
130503576|NCT01102426|469811892|FG001|Overall Study|Death (non-related to the study|8|||
130503577|NCT03136861|469811897|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
130503578|NCT03136861|469811898|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
130503579|NCT03136861|469811899|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
130730184|NCT02516553|470633727|FG017|Overall Study|Dose limiting toxicity|1|||
130730185|NCT02516553|470633728|FG018|Overall Study|Dose limiting toxicity|0|||
130730186|NCT02516553|470633729|FG019|Overall Study|Dose limiting toxicity|2|||
130730187|NCT02516553|470633730|FG020|Overall Study|Dose limiting toxicity|0|||
130730188|NCT02516553|470633731|FG021|Overall Study|Dose limiting toxicity|0|||
130730189|NCT02516553|470633710|FG000|Overall Study|Other Adverse Events|0|||
130730190|NCT02516553|470633711|FG001|Overall Study|Other Adverse Events|0|||
130730191|NCT02516553|470633712|FG002|Overall Study|Other Adverse Events|0|||
130730192|NCT02516553|470633713|FG003|Overall Study|Other Adverse Events|1|||
130730193|NCT02516553|470633714|FG004|Overall Study|Other Adverse Events|0|||
130730194|NCT02516553|470633715|FG005|Overall Study|Other Adverse Events|1|||
130730195|NCT02516553|470633716|FG006|Overall Study|Other Adverse Events|0|||
130730196|NCT02516553|470633717|FG007|Overall Study|Other Adverse Events|0|||
130730197|NCT02516553|470633718|FG008|Overall Study|Other Adverse Events|0|||
130730198|NCT02516553|470633719|FG009|Overall Study|Other Adverse Events|1|||
130730199|NCT02516553|470633720|FG010|Overall Study|Other Adverse Events|3|||
130730200|NCT02516553|470633721|FG011|Overall Study|Other Adverse Events|2|||
130730201|NCT02516553|470633722|FG012|Overall Study|Other Adverse Events|0|||
130730202|NCT02516553|470633723|FG013|Overall Study|Other Adverse Events|1|||
130730203|NCT02516553|470633724|FG014|Overall Study|Other Adverse Events|0|||
130730204|NCT02516553|470633725|FG015|Overall Study|Other Adverse Events|0|||
130730205|NCT02516553|470633726|FG016|Overall Study|Other Adverse Events|0|||
130730206|NCT02516553|470633727|FG017|Overall Study|Other Adverse Events|2|||
130730207|NCT02516553|470633728|FG018|Overall Study|Other Adverse Events|1|||
130730208|NCT02516553|470633729|FG019|Overall Study|Other Adverse Events|2|||
130730209|NCT02516553|470633730|FG020|Overall Study|Other Adverse Events|2|||
130730210|NCT02516553|470633731|FG021|Overall Study|Other Adverse Events|1|||
130503580|NCT03136861|469811900|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
130503581|NCT03136861|469811901|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
130503582|NCT03136861|469811902|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
130503583|NCT03136861|469811903|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
130503584|NCT03136861|469811897|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
130503585|NCT03136861|469811898|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
130503586|NCT03136861|469811899|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
130503587|NCT03136861|469811900|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
130503588|NCT03136861|469811901|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
130503589|NCT03136861|469811902|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
130503590|NCT03136861|469811903|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
130503591|NCT03136861|469811897|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
130503592|NCT03136861|469811898|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
130503593|NCT03136861|469811899|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
130503594|NCT03136861|469811900|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
130503595|NCT03136861|469811901|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
130503596|NCT03136861|469811902|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
130503597|NCT03136861|469811903|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
130503598|NCT03136861|469811897|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130503599|NCT03136861|469811898|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
130503600|NCT03136861|469811899|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130503601|NCT03136861|469811900|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130730211|NCT02516553|470633710|FG000|Overall Study|Refused to continue trial medication|0|||
130730212|NCT02516553|470633711|FG001|Overall Study|Refused to continue trial medication|0|||
130730213|NCT02516553|470633712|FG002|Overall Study|Refused to continue trial medication|0|||
130730214|NCT02516553|470633713|FG003|Overall Study|Refused to continue trial medication|0|||
130730215|NCT02516553|470633714|FG004|Overall Study|Refused to continue trial medication|0|||
130730216|NCT02516553|470633715|FG005|Overall Study|Refused to continue trial medication|0|||
130503602|NCT03136861|469811901|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130503603|NCT03136861|469811902|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130503604|NCT03136861|469811903|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
130503605|NCT03136861|469811897|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
130503606|NCT03136861|469811898|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
130503607|NCT03136861|469811899|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
130503608|NCT03136861|469811900|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
130503609|NCT03136861|469811901|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
130503610|NCT03136861|469811902|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
130503611|NCT03136861|469811903|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
130503612|NCT03136861|469811897|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
130503613|NCT03136861|469811898|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
130503614|NCT03136861|469811899|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
130503615|NCT03136861|469811900|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
130503616|NCT03136861|469811901|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
130503617|NCT03136861|469811902|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
130503618|NCT03136861|469811903|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
130503619|NCT03136861|469811897|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503620|NCT03136861|469811898|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503621|NCT03136861|469811899|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
130503622|NCT03136861|469811900|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503623|NCT03136861|469811901|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503624|NCT03136861|469811902|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503625|NCT03136861|469811903|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
130503626|NCT03136861|469811897|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503627|NCT03136861|469811898|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503628|NCT03136861|469811899|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
130503629|NCT03136861|469811900|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503630|NCT03136861|469811901|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503631|NCT03136861|469811902|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503632|NCT03136861|469811903|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
130503633|NCT05376397|469811908|FG000|Overall Study|Lost to Follow-up|1|||
130503634|NCT01328756|469811909|FG000|Overall Study|Protocol Violation|4|||
130503635|NCT01328756|469811909|FG000|Overall Study|Adverse Event|39|||
130503636|NCT01328756|469811909|FG000|Overall Study|Lack of Efficacy|5|||
130503637|NCT01328756|469811909|FG000|Overall Study|Withdrawal by Subject|41|||
130503638|NCT01328756|469811909|FG000|Overall Study|Lost to Follow-up|5|||
130503639|NCT01328756|469811909|FG000|Overall Study|Other|29|||
130503640|NCT04492475|469811913|FG000|Overall Study|Enrolled but not treated|8|||
130503641|NCT04492475|469811914|FG001|Overall Study|Enrolled but not treated|8|||
130503642|NCT04492475|469811913|FG000|Overall Study|Withdrawal by Subject|4|||
130503643|NCT04492475|469811914|FG001|Overall Study|Withdrawal by Subject|0|||
130503644|NCT04492475|469811913|FG000|Overall Study|Became ineligible after enrollment|2|||
130503645|NCT04492475|469811914|FG001|Overall Study|Became ineligible after enrollment|0|||
130503646|NCT02538094|469811916|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
130503647|NCT02538094|469811917|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
130503648|NCT02538094|469811916|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
130503649|NCT02538094|469811917|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
130503650|NCT03288506|469811918|FG000|Overall Study|Withdrawal by Subject|52|||
130503651|NCT01860079|469811921|FG000|Overall Study|Physician Decision|14|||
130503652|NCT01860079|469811922|FG001|Overall Study|Physician Decision|22|||
130503653|NCT05445557|469811923|FG000|Double Blind Part|Lost to Follow-up|1|||
130503654|NCT01323790|469811924|FG000|Overall Study|Other|3|||
130503655|NCT01323790|469811925|FG001|Overall Study|Other|2|||
130503656|NCT01323790|469811926|FG002|Overall Study|Other|1|||
130503657|NCT01323790|469811924|FG000|Overall Study|Lost to Follow-up|11|||
130503658|NCT01323790|469811925|FG001|Overall Study|Lost to Follow-up|9|||
130503659|NCT01323790|469811926|FG002|Overall Study|Lost to Follow-up|9|||
130503660|NCT01323790|469811924|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
130503661|NCT01323790|469811925|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
130503662|NCT01323790|469811926|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
130503663|NCT01323790|469811924|FG000|Overall Study|Lack of Efficacy|3|||
130503664|NCT01323790|469811925|FG001|Overall Study|Lack of Efficacy|0|||
130503665|NCT01323790|469811926|FG002|Overall Study|Lack of Efficacy|3|||
130503666|NCT01323790|469811924|FG000|Overall Study|Adverse Event|11|||
130503667|NCT01323790|469811925|FG001|Overall Study|Adverse Event|24|||
130565946|NCT00578136|470038169|FG001|Overall Study|Not given intervention|1|||
130503668|NCT01323790|469811926|FG002|Overall Study|Adverse Event|12|||
130565947|NCT02047253|470038170|FG000|Overall Study|Lost to Follow-up|8|||
130503669|NCT01323790|469811924|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130503670|NCT01323790|469811925|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130503671|NCT01323790|469811926|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
130503672|NCT01323790|469811924|FG000|Overall Study|Withdrawal by Subject|23|||
130503673|NCT01323790|469811925|FG001|Overall Study|Withdrawal by Subject|20|||
130503674|NCT01323790|469811926|FG002|Overall Study|Withdrawal by Subject|13|||
130503675|NCT01323790|469811924|FG000|Overall Study|Did Not Receive Treatment|2|||
130503676|NCT01323790|469811925|FG001|Overall Study|Did Not Receive Treatment|0|||
130503677|NCT01323790|469811926|FG002|Overall Study|Did Not Receive Treatment|1|||
130503678|NCT01323790|469811924|FG000|Overall Study|Severe non-compliance with protocol|2|||
130503679|NCT01323790|469811925|FG001|Overall Study|Severe non-compliance with protocol|2|||
130503680|NCT01323790|469811926|FG002|Overall Study|Severe non-compliance with protocol|2|||
130503681|NCT01880736|469811927|FG000|Overall Study|Adverse Event|0|||
130503682|NCT01880736|469811928|FG001|Overall Study|Adverse Event|0|||
130503683|NCT01880736|469811929|FG002|Overall Study|Adverse Event|0|||
130503684|NCT01880736|469811930|FG003|Overall Study|Adverse Event|1|||
130503685|NCT01880736|469811927|FG000|Overall Study|Withdrawal Criteria|1|||
130503686|NCT01880736|469811928|FG001|Overall Study|Withdrawal Criteria|2|||
130503687|NCT01880736|469811929|FG002|Overall Study|Withdrawal Criteria|1|||
130503688|NCT01880736|469811930|FG003|Overall Study|Withdrawal Criteria|5|||
130503689|NCT00266656|469811940|FG000|Overall Study|Death|1|||
130503690|NCT00266656|469811941|FG001|Overall Study|Death|0|||
130503691|NCT00266656|469811940|FG000|Overall Study|Lost to Follow-up|4|||
130503692|NCT00266656|469811941|FG001|Overall Study|Lost to Follow-up|1|||
130503693|NCT00266656|469811940|FG000|Overall Study|Withdrawal by Subject|4|||
130503694|NCT00266656|469811941|FG001|Overall Study|Withdrawal by Subject|2|||
130503695|NCT00266656|469811940|FG000|Overall Study|Did Not Reach Final Height|4|||
130503696|NCT00266656|469811941|FG001|Overall Study|Did Not Reach Final Height|8|||
130503697|NCT00266656|469811940|FG000|Overall Study|Parent/Caregiver Decision|1|||
130503698|NCT00266656|469811941|FG001|Overall Study|Parent/Caregiver Decision|2|||
130503699|NCT00428714|469811945|FG000|Overall Study|Progressive Disease|28|||
130503700|NCT00428714|469811946|FG001|Overall Study|Progressive Disease|36|||
130503701|NCT00428714|469811945|FG000|Overall Study|Withdrawal by Subject|0|||
130503702|NCT00428714|469811946|FG001|Overall Study|Withdrawal by Subject|3|||
130503703|NCT00428714|469811945|FG000|Overall Study|Adverse Event|0|||
130503704|NCT00428714|469811946|FG001|Overall Study|Adverse Event|2|||
130503705|NCT00428714|469811945|FG000|Overall Study|Physician Decision|1|||
130503706|NCT00428714|469811946|FG001|Overall Study|Physician Decision|1|||
130503707|NCT00428714|469811945|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
130503708|NCT00428714|469811946|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
130503709|NCT00428714|469811945|FG000|Overall Study|Death due to other then PD|1|||
130503710|NCT00428714|469811946|FG001|Overall Study|Death due to other then PD|0|||
130503711|NCT02326220|469811960|FG000|Double-blind Treatment Period|Adverse Event|1|||
130503712|NCT02326220|469811961|FG001|Double-blind Treatment Period|Adverse Event|2|||
130503713|NCT02326220|469811962|FG002|Double-blind Treatment Period|Adverse Event|0|||
130565948|NCT01987960|470038172|FG000|Period 1|Adverse Event|24|||
130565949|NCT01987960|470038173|FG001|Period 1|Adverse Event|0|||
130565950|NCT01987960|470038174|FG002|Period 1|Adverse Event|0|||
130565951|NCT01987960|470038175|FG003|Period 1|Adverse Event|0|||
130565952|NCT01987960|470038172|FG000|Period 1|Lack of Efficacy|4|||
130565953|NCT01987960|470038173|FG001|Period 1|Lack of Efficacy|0|||
130565954|NCT01987960|470038174|FG002|Period 1|Lack of Efficacy|0|||
130565955|NCT01987960|470038175|FG003|Period 1|Lack of Efficacy|0|||
130565956|NCT01987960|470038172|FG000|Period 1|Non-compliance with IMP|6|||
130565957|NCT01987960|470038173|FG001|Period 1|Non-compliance with IMP|0|||
130565958|NCT01987960|470038174|FG002|Period 1|Non-compliance with IMP|0|||
130565959|NCT01987960|470038175|FG003|Period 1|Non-compliance with IMP|0|||
130565960|NCT01987960|470038172|FG000|Period 1|Protocol Violation|12|||
130565961|NCT01987960|470038173|FG001|Period 1|Protocol Violation|0|||
130503714|NCT02326220|469811960|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130565962|NCT01987960|470038174|FG002|Period 1|Protocol Violation|0|||
130565963|NCT01987960|470038175|FG003|Period 1|Protocol Violation|0|||
130565964|NCT01987960|470038172|FG000|Period 1|Withdrawal by Subject|21|||
130565965|NCT01987960|470038173|FG001|Period 1|Withdrawal by Subject|0|||
130503715|NCT02326220|469811961|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130503716|NCT02326220|469811962|FG002|Double-blind Treatment Period|Protocol Violation|0|||
130503717|NCT02326220|469811960|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130503718|NCT02326220|469811961|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130503719|NCT02326220|469811962|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130503720|NCT02326220|469811960|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130565966|NCT01987960|470038174|FG002|Period 1|Withdrawal by Subject|0|||
130565967|NCT01987960|470038175|FG003|Period 1|Withdrawal by Subject|0|||
130503721|NCT02326220|469811961|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130503722|NCT02326220|469811962|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
130503723|NCT02326220|469811960|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130503724|NCT02326220|469811961|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130503725|NCT02326220|469811962|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
130730217|NCT02516553|470633716|FG006|Overall Study|Refused to continue trial medication|0|||
130730218|NCT02516553|470633717|FG007|Overall Study|Refused to continue trial medication|0|||
130730219|NCT02516553|470633718|FG008|Overall Study|Refused to continue trial medication|0|||
130730220|NCT02516553|470633719|FG009|Overall Study|Refused to continue trial medication|0|||
130730221|NCT02516553|470633720|FG010|Overall Study|Refused to continue trial medication|1|||
130730222|NCT02516553|470633721|FG011|Overall Study|Refused to continue trial medication|0|||
130730223|NCT02516553|470633722|FG012|Overall Study|Refused to continue trial medication|0|||
130730224|NCT02516553|470633723|FG013|Overall Study|Refused to continue trial medication|0|||
130730225|NCT02516553|470633724|FG014|Overall Study|Refused to continue trial medication|0|||
130730226|NCT02516553|470633725|FG015|Overall Study|Refused to continue trial medication|0|||
130730227|NCT02516553|470633726|FG016|Overall Study|Refused to continue trial medication|0|||
130730228|NCT02516553|470633727|FG017|Overall Study|Refused to continue trial medication|0|||
130730229|NCT02516553|470633728|FG018|Overall Study|Refused to continue trial medication|1|||
130730230|NCT02516553|470633729|FG019|Overall Study|Refused to continue trial medication|0|||
130730231|NCT02516553|470633730|FG020|Overall Study|Refused to continue trial medication|0|||
130730232|NCT02516553|470633731|FG021|Overall Study|Refused to continue trial medication|1|||
130730233|NCT02516553|470633710|FG000|Overall Study|other reasons than listed|0|||
130730234|NCT02516553|470633711|FG001|Overall Study|other reasons than listed|0|||
130730235|NCT02516553|470633712|FG002|Overall Study|other reasons than listed|0|||
130730236|NCT02516553|470633713|FG003|Overall Study|other reasons than listed|0|||
130730237|NCT02516553|470633714|FG004|Overall Study|other reasons than listed|0|||
130730238|NCT02516553|470633715|FG005|Overall Study|other reasons than listed|0|||
130730239|NCT02516553|470633716|FG006|Overall Study|other reasons than listed|0|||
130730240|NCT02516553|470633717|FG007|Overall Study|other reasons than listed|1|||
130730241|NCT02516553|470633718|FG008|Overall Study|other reasons than listed|1|||
130730242|NCT02516553|470633719|FG009|Overall Study|other reasons than listed|0|||
130730243|NCT02516553|470633720|FG010|Overall Study|other reasons than listed|1|||
130730244|NCT02516553|470633721|FG011|Overall Study|other reasons than listed|1|||
130730245|NCT02516553|470633722|FG012|Overall Study|other reasons than listed|0|||
130730246|NCT02516553|470633723|FG013|Overall Study|other reasons than listed|0|||
130730247|NCT02516553|470633724|FG014|Overall Study|other reasons than listed|0|||
130730248|NCT02516553|470633725|FG015|Overall Study|other reasons than listed|0|||
130730249|NCT02516553|470633726|FG016|Overall Study|other reasons than listed|0|||
130730250|NCT02516553|470633727|FG017|Overall Study|other reasons than listed|0|||
130730251|NCT02516553|470633728|FG018|Overall Study|other reasons than listed|0|||
130730252|NCT02516553|470633729|FG019|Overall Study|other reasons than listed|0|||
130730253|NCT02516553|470633730|FG020|Overall Study|other reasons than listed|2|||
130730254|NCT02516553|470633731|FG021|Overall Study|other reasons than listed|2|||
130730255|NCT02924727|470633736|FG000|Overall Study|Withdrawal by Subject|2|||
130730256|NCT02924727|470633737|FG001|Overall Study|Withdrawal by Subject|4|||
130730257|NCT02924727|470633736|FG000|Overall Study|Lost to Follow-up|2|||
130730258|NCT02924727|470633737|FG001|Overall Study|Lost to Follow-up|5|||
130730259|NCT02924727|470633736|FG000|Overall Study|Death|221|||
130730260|NCT02924727|470633737|FG001|Overall Study|Death|247|||
130730261|NCT02924727|470633736|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
130730262|NCT02924727|470633737|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
130730263|NCT00509795|470633740|FG000|Overall Study|Adverse Event|4|||
130730264|NCT00509795|470633741|FG001|Overall Study|Adverse Event|3|||
130730265|NCT00509795|470633742|FG002|Overall Study|Adverse Event|5|||
130730266|NCT00509795|470633743|FG003|Overall Study|Adverse Event|4|||
130730267|NCT00509795|470633740|FG000|Overall Study|Death|3|||
130730268|NCT00509795|470633741|FG001|Overall Study|Death|1|||
130730269|NCT00509795|470633742|FG002|Overall Study|Death|2|||
130730270|NCT00509795|470633743|FG003|Overall Study|Death|7|||
130730271|NCT00509795|470633740|FG000|Overall Study|Lack of Efficacy|0|||
130730272|NCT00509795|470633741|FG001|Overall Study|Lack of Efficacy|0|||
130730273|NCT00509795|470633742|FG002|Overall Study|Lack of Efficacy|2|||
130503726|NCT02114515|469811963|FG000|Overall Study|Lost to Follow-up|52|||
130503727|NCT02114515|469811964|FG001|Overall Study|Lost to Follow-up|55|||
130503728|NCT02114515|469811963|FG000|Overall Study|Death|12|||
130503729|NCT02114515|469811964|FG001|Overall Study|Death|12|||
130730274|NCT00509795|470633743|FG003|Overall Study|Lack of Efficacy|2|||
130730275|NCT00509795|470633740|FG000|Overall Study|Lost to Follow-up|1|||
130730276|NCT00509795|470633741|FG001|Overall Study|Lost to Follow-up|2|||
130730277|NCT00509795|470633742|FG002|Overall Study|Lost to Follow-up|4|||
130730278|NCT00509795|470633743|FG003|Overall Study|Lost to Follow-up|4|||
130730279|NCT00509795|470633740|FG000|Overall Study|OTHER|1|||
130503730|NCT02114515|469811963|FG000|Overall Study|Withdrawal by Subject|4|||
130503731|NCT02114515|469811964|FG001|Overall Study|Withdrawal by Subject|22|||
130503732|NCT02114515|469811963|FG000|Overall Study|Other|65|||
130503733|NCT02114515|469811964|FG001|Overall Study|Other|61|||
130503734|NCT02699099|469811966|FG000|Overall Study|Adverse Event|1|||
130503735|NCT02699099|469811967|FG001|Overall Study|Adverse Event|0|||
130503736|NCT02699099|469811968|FG002|Overall Study|Adverse Event|2|||
130503737|NCT02699099|469811966|FG000|Overall Study|Lost to Follow-up|0|||
130503738|NCT02699099|469811967|FG001|Overall Study|Lost to Follow-up|1|||
130503739|NCT02699099|469811968|FG002|Overall Study|Lost to Follow-up|0|||
130503740|NCT02699099|469811966|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
130503741|NCT02699099|469811967|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130503742|NCT02699099|469811968|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
130503743|NCT00824850|469811970|FG000|Overall Study|Withdrawal by Subject|0|||
130503744|NCT00824850|469811971|FG001|Overall Study|Withdrawal by Subject|1|||
130503745|NCT04820491|469811972|FG000|Overall Study|Withdrawal by Subject|1|||
130503746|NCT04820491|469811973|FG001|Overall Study|Withdrawal by Subject|0|||
130503747|NCT02144285|469811976|FG000|Overall Study|Withdrawal by Subject|0|||
130503748|NCT02144285|469811977|FG001|Overall Study|Withdrawal by Subject|0|||
130503749|NCT02144285|469811978|FG002|Overall Study|Withdrawal by Subject|0|||
130503750|NCT02144285|469811979|FG003|Overall Study|Withdrawal by Subject|0|||
130503751|NCT02144285|469811980|FG004|Overall Study|Withdrawal by Subject|1|||
130503752|NCT02144285|469811981|FG005|Overall Study|Withdrawal by Subject|0|||
130503753|NCT02144285|469811982|FG006|Overall Study|Withdrawal by Subject|0|||
130503754|NCT02144285|469811983|FG007|Overall Study|Withdrawal by Subject|0|||
130503755|NCT02144285|469811984|FG008|Overall Study|Withdrawal by Subject|0|||
130503756|NCT02144285|469811985|FG009|Overall Study|Withdrawal by Subject|0|||
130503757|NCT03659136|469811987|FG000|Overall Study|Not treated|2|||
130503758|NCT03659136|469811988|FG001|Overall Study|Not treated|0|||
130503759|NCT03659136|469811987|FG000|Overall Study|Covid-19 related|1|||
130503760|NCT03659136|469811988|FG001|Overall Study|Covid-19 related|1|||
130503761|NCT03659136|469811987|FG000|Overall Study|Withdrawal by Subject|1|||
130503762|NCT03659136|469811988|FG001|Overall Study|Withdrawal by Subject|6|||
130503763|NCT03659136|469811987|FG000|Overall Study|Adverse Event|4|||
130503764|NCT03659136|469811988|FG001|Overall Study|Adverse Event|6|||
130503765|NCT03659136|469811987|FG000|Overall Study|Progressive disease|37|||
130503766|NCT03659136|469811988|FG001|Overall Study|Progressive disease|31|||
130503767|NCT03659136|469811987|FG000|Overall Study|Study closure|2|||
130503768|NCT03659136|469811988|FG001|Overall Study|Study closure|2|||
130503769|NCT03659136|469811987|FG000|Overall Study|Sponsor decision/recommendation|3|||
130503770|NCT03659136|469811988|FG001|Overall Study|Sponsor decision/recommendation|2|||
130503771|NCT03659136|469811987|FG000|Overall Study|Switched to other drug/therapy|2|||
130503772|NCT03659136|469811988|FG001|Overall Study|Switched to other drug/therapy|2|||
130503773|NCT03659136|469811987|FG000|Overall Study|Lack of clinical benefit|0|||
130503774|NCT03659136|469811988|FG001|Overall Study|Lack of clinical benefit|1|||
130503775|NCT03786471|469811989|FG000|Overall Study|Death|254|||
130503776|NCT03786471|469811990|FG001|Overall Study|Death|223|||
130503777|NCT03786471|469811991|FG002|Overall Study|Death|37|||
130503778|NCT03786471|469811989|FG000|Overall Study|Lost to Follow-up|63|||
130503779|NCT03786471|469811990|FG001|Overall Study|Lost to Follow-up|50|||
130503780|NCT03786471|469811991|FG002|Overall Study|Lost to Follow-up|15|||
130503781|NCT03786471|469811989|FG000|Overall Study|Withdrawal by Subject|99|||
130503782|NCT03786471|469811990|FG001|Overall Study|Withdrawal by Subject|81|||
130503783|NCT03786471|469811991|FG002|Overall Study|Withdrawal by Subject|11|||
130503784|NCT01276509|469813647|FG000|Overall Study|Adverse Event|9|||
130503785|NCT01276509|469813648|FG001|Overall Study|Adverse Event|8|||
130503786|NCT01276509|469813649|FG002|Overall Study|Adverse Event|4|||
130503787|NCT01276509|469813650|FG003|Overall Study|Adverse Event|3|||
130503788|NCT01276509|469813647|FG000|Overall Study|Lack of Efficacy|2|||
130503789|NCT01276509|469813648|FG001|Overall Study|Lack of Efficacy|1|||
130503790|NCT01276509|469813649|FG002|Overall Study|Lack of Efficacy|1|||
130503791|NCT01276509|469813650|FG003|Overall Study|Lack of Efficacy|2|||
130503792|NCT01276509|469813647|FG000|Overall Study|Pregnancy|1|||
130503793|NCT01276509|469813648|FG001|Overall Study|Pregnancy|0|||
130503794|NCT01276509|469813649|FG002|Overall Study|Pregnancy|0|||
130503795|NCT01276509|469813650|FG003|Overall Study|Pregnancy|0|||
130503796|NCT01276509|469813647|FG000|Overall Study|Withdrawal by Subject|1|||
130503797|NCT01276509|469813648|FG001|Overall Study|Withdrawal by Subject|2|||
130503798|NCT01276509|469813649|FG002|Overall Study|Withdrawal by Subject|0|||
130503799|NCT01276509|469813650|FG003|Overall Study|Withdrawal by Subject|0|||
130503800|NCT01276509|469813647|FG000|Overall Study|Other|0|||
130503801|NCT01276509|469813648|FG001|Overall Study|Other|1|||
130503802|NCT01276509|469813649|FG002|Overall Study|Other|0|||
130503803|NCT01276509|469813650|FG003|Overall Study|Other|0|||
130503804|NCT00647699|469813652|FG000|Overall Study|Lost to Follow-up|5|||
130503805|NCT00647699|469813653|FG001|Overall Study|Lost to Follow-up|4|||
130503806|NCT00647699|469813652|FG000|Overall Study|Withdrawal by Subject|3|||
130503807|NCT00647699|469813653|FG001|Overall Study|Withdrawal by Subject|8|||
130503808|NCT00413283|469813654|FG000|Overall Study|Withdrawal by Subject|1|||
130503809|NCT00413283|469813655|FG001|Overall Study|Withdrawal by Subject|0|||
130503810|NCT00413283|469813656|FG002|Overall Study|Withdrawal by Subject|0|||
130503811|NCT00413283|469813657|FG003|Overall Study|Withdrawal by Subject|1|||
130503812|NCT00413283|469813654|FG000|Overall Study|Death|0|||
130503813|NCT00413283|469813655|FG001|Overall Study|Death|0|||
130503814|NCT00413283|469813656|FG002|Overall Study|Death|1|||
130503815|NCT00413283|469813657|FG003|Overall Study|Death|1|||
130503816|NCT00413283|469813654|FG000|Overall Study|Adverse Event|0|||
130730280|NCT00509795|470633741|FG001|Overall Study|OTHER|0|||
130730281|NCT00509795|470633742|FG002|Overall Study|OTHER|4|||
130730282|NCT00509795|470633743|FG003|Overall Study|OTHER|1|||
130730283|NCT00509795|470633740|FG000|Overall Study|Protocol Violation|3|||
130730284|NCT00509795|470633741|FG001|Overall Study|Protocol Violation|0|||
130730285|NCT00509795|470633742|FG002|Overall Study|Protocol Violation|3|||
130730286|NCT00509795|470633743|FG003|Overall Study|Protocol Violation|1|||
130730287|NCT00509795|470633740|FG000|Overall Study|Withdrawal by Subject|10|||
130730288|NCT00509795|470633741|FG001|Overall Study|Withdrawal by Subject|5|||
130730289|NCT00509795|470633742|FG002|Overall Study|Withdrawal by Subject|7|||
130730290|NCT00509795|470633743|FG003|Overall Study|Withdrawal by Subject|8|||
130730291|NCT02759692|470633747|FG000|Period 1|Test article no longer available|1|||
130730292|NCT02759692|470633748|FG001|Period 1|Test article no longer available|1|||
130730293|NCT02759692|470633747|FG000|Period 1|No longer meets eligibility criteria.|1|||
130730294|NCT02759692|470633748|FG001|Period 1|No longer meets eligibility criteria.|0|||
130730295|NCT02759692|470633747|FG000|Period 1|Miss-Randomized|1|||
130730296|NCT02759692|470633748|FG001|Period 1|Miss-Randomized|1|||
130730297|NCT02759692|470633747|FG000|Period 2|Lost to Follow-up|1|||
130730298|NCT02759692|470633748|FG001|Period 2|Lost to Follow-up|0|||
130730299|NCT02759692|470633747|FG000|Period 2|Test article no longer available|0|||
130730300|NCT02759692|470633748|FG001|Period 2|Test article no longer available|1|||
130730301|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
130730302|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
130730303|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
130730304|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
130730305|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
130730306|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
130730307|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
130730308|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
130730309|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
130730310|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
130730311|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
130730312|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
130730313|NCT00451178|470633749|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
130730314|NCT00451178|470633750|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
130730315|NCT00451178|470633749|FG000|Prior to Maintenance Therapy|PD|2|||
130730316|NCT00451178|470633750|FG001|Prior to Maintenance Therapy|PD|0|||
130503817|NCT00413283|469813655|FG001|Overall Study|Adverse Event|0|||
130503818|NCT00413283|469813656|FG002|Overall Study|Adverse Event|0|||
130730317|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
130503819|NCT00413283|469813657|FG003|Overall Study|Adverse Event|1|||
130503820|NCT00413283|469813654|FG000|Overall Study|Ineligibility determined|0|||
130503821|NCT00413283|469813655|FG001|Overall Study|Ineligibility determined|0|||
130730318|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
130730319|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
130730320|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
130503822|NCT00413283|469813656|FG002|Overall Study|Ineligibility determined|0|||
130503823|NCT00413283|469813657|FG003|Overall Study|Ineligibility determined|1|||
130503824|NCT00413283|469813654|FG000|Overall Study|Protocol deviation|0|||
130503825|NCT00413283|469813655|FG001|Overall Study|Protocol deviation|1|||
130503826|NCT00413283|469813656|FG002|Overall Study|Protocol deviation|0|||
130503827|NCT00413283|469813657|FG003|Overall Study|Protocol deviation|0|||
130503828|NCT00413283|469813654|FG000|Overall Study|Requirement for alternative therapy|0|||
130503829|NCT00413283|469813655|FG001|Overall Study|Requirement for alternative therapy|2|||
130503830|NCT00413283|469813656|FG002|Overall Study|Requirement for alternative therapy|0|||
130503831|NCT00413283|469813657|FG003|Overall Study|Requirement for alternative therapy|0|||
130503832|NCT00413283|469813654|FG000|Overall Study|Other|0|||
130730321|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
130730322|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
130730323|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
130730324|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
130730325|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
130730326|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
130730327|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
130730328|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
130730329|NCT00451178|470633749|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
130730330|NCT00451178|470633750|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
130730331|NCT03207867|470633753|FG000|Overall Study|Adverse Event|1|||
130730332|NCT03207867|470633754|FG001|Overall Study|Adverse Event|0|||
130730333|NCT03207867|470633755|FG002|Overall Study|Adverse Event|1|||
130730334|NCT03207867|470633756|FG003|Overall Study|Adverse Event|0|||
130730335|NCT03207867|470633757|FG004|Overall Study|Adverse Event|0|||
130730336|NCT03207867|470633758|FG005|Overall Study|Adverse Event|2|||
130730337|NCT03207867|470633759|FG006|Overall Study|Adverse Event|1|||
130730338|NCT03207867|470633760|FG007|Overall Study|Adverse Event|1|||
130730339|NCT03207867|470633761|FG008|Overall Study|Adverse Event|2|||
130730340|NCT03207867|470633762|FG009|Overall Study|Adverse Event|2|||
130730341|NCT03207867|470633763|FG010|Overall Study|Adverse Event|0|||
130730342|NCT03207867|470633764|FG011|Overall Study|Adverse Event|0|||
130730343|NCT03207867|470633765|FG012|Overall Study|Adverse Event|0|||
130730344|NCT03207867|470633766|FG013|Overall Study|Adverse Event|0|||
130730345|NCT03207867|470633767|FG014|Overall Study|Adverse Event|0|||
130730346|NCT03207867|470633768|FG015|Overall Study|Adverse Event|0|||
130730347|NCT03207867|470633769|FG016|Overall Study|Adverse Event|3|||
130730348|NCT03207867|470633770|FG017|Overall Study|Adverse Event|1|||
130730349|NCT03207867|470633771|FG018|Overall Study|Adverse Event|2|||
130730350|NCT03207867|470633772|FG019|Overall Study|Adverse Event|1|||
130730351|NCT03207867|470633773|FG020|Overall Study|Adverse Event|0|||
130730352|NCT03207867|470633774|FG021|Overall Study|Adverse Event|0|||
130730353|NCT03207867|470633775|FG022|Overall Study|Adverse Event|0|||
130730354|NCT03207867|470633776|FG023|Overall Study|Adverse Event|0|||
130730355|NCT03207867|470633753|FG000|Overall Study|Death|0|||
130730356|NCT03207867|470633754|FG001|Overall Study|Death|0|||
130730357|NCT03207867|470633755|FG002|Overall Study|Death|0|||
130730358|NCT03207867|470633756|FG003|Overall Study|Death|0|||
130730359|NCT03207867|470633757|FG004|Overall Study|Death|0|||
130730360|NCT03207867|470633758|FG005|Overall Study|Death|1|||
130730361|NCT03207867|470633759|FG006|Overall Study|Death|0|||
130730362|NCT03207867|470633760|FG007|Overall Study|Death|3|||
130730363|NCT03207867|470633761|FG008|Overall Study|Death|1|||
130730364|NCT03207867|470633762|FG009|Overall Study|Death|2|||
130730365|NCT03207867|470633763|FG010|Overall Study|Death|0|||
130730366|NCT03207867|470633764|FG011|Overall Study|Death|1|||
130730367|NCT03207867|470633765|FG012|Overall Study|Death|0|||
130503833|NCT00413283|469813655|FG001|Overall Study|Other|0|||
130503834|NCT00413283|469813656|FG002|Overall Study|Other|1|||
130503835|NCT00413283|469813657|FG003|Overall Study|Other|0|||
130503836|NCT02354417|469813658|FG000|Overall Study|Physician Decision|1|||
130503837|NCT01377844|469813659|FG000|Overall Study|Withdrawal by Subject|25|||
130503838|NCT01377844|469813660|FG001|Overall Study|Withdrawal by Subject|28|||
130503839|NCT01377844|469813659|FG000|Overall Study|Protocol Violation|2|||
130503840|NCT01377844|469813660|FG001|Overall Study|Protocol Violation|3|||
130503841|NCT01377844|469813659|FG000|Overall Study|Adverse Event|3|||
130503842|NCT01377844|469813660|FG001|Overall Study|Adverse Event|0|||
130730368|NCT03207867|470633766|FG013|Overall Study|Death|1|||
130503843|NCT01377844|469813659|FG000|Overall Study|Physician Decision|6|||
130730369|NCT03207867|470633767|FG014|Overall Study|Death|0|||
130730370|NCT03207867|470633768|FG015|Overall Study|Death|0|||
130730371|NCT03207867|470633769|FG016|Overall Study|Death|0|||
130730372|NCT03207867|470633770|FG017|Overall Study|Death|2|||
130730373|NCT03207867|470633771|FG018|Overall Study|Death|0|||
130503844|NCT01377844|469813660|FG001|Overall Study|Physician Decision|3|||
130503845|NCT01377844|469813659|FG000|Overall Study|Study terminated by Sponsor|0|||
130730374|NCT03207867|470633772|FG019|Overall Study|Death|1|||
130730375|NCT03207867|470633773|FG020|Overall Study|Death|0|||
130730376|NCT03207867|470633774|FG021|Overall Study|Death|0|||
130503846|NCT01377844|469813660|FG001|Overall Study|Study terminated by Sponsor|1|||
130503847|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
130503848|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130503849|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130503850|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130503851|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
130503852|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130503853|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130503854|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130503855|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
130503856|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130730377|NCT03207867|470633775|FG022|Overall Study|Death|0|||
130730378|NCT03207867|470633776|FG023|Overall Study|Death|0|||
130730379|NCT03207867|470633753|FG000|Overall Study|Physician Decision|3|||
130730380|NCT03207867|470633754|FG001|Overall Study|Physician Decision|5|||
130730381|NCT03207867|470633755|FG002|Overall Study|Physician Decision|0|||
130730382|NCT03207867|470633756|FG003|Overall Study|Physician Decision|3|||
130730383|NCT03207867|470633757|FG004|Overall Study|Physician Decision|2|||
130730384|NCT03207867|470633758|FG005|Overall Study|Physician Decision|0|||
130730385|NCT03207867|470633759|FG006|Overall Study|Physician Decision|0|||
130730386|NCT03207867|470633760|FG007|Overall Study|Physician Decision|0|||
130730387|NCT03207867|470633761|FG008|Overall Study|Physician Decision|4|||
130730388|NCT03207867|470633762|FG009|Overall Study|Physician Decision|2|||
130730389|NCT03207867|470633763|FG010|Overall Study|Physician Decision|0|||
130730390|NCT03207867|470633764|FG011|Overall Study|Physician Decision|4|||
130730391|NCT03207867|470633765|FG012|Overall Study|Physician Decision|0|||
130730392|NCT03207867|470633766|FG013|Overall Study|Physician Decision|0|||
130503857|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130503858|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130503859|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
130503860|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130503861|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130503862|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130503863|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
130503864|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130503865|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130503866|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130503867|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
130503868|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130503869|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130503870|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130503871|NCT01185340|469813663|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
130503872|NCT01185340|469813664|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130503873|NCT01185340|469813665|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130503874|NCT01185340|469813666|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130503875|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130503876|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
130503877|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
130503878|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
130503879|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130503880|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
130503881|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
130503882|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
130503883|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130503884|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
130503885|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
130503886|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
130503887|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130730393|NCT03207867|470633767|FG014|Overall Study|Physician Decision|2|||
130730394|NCT03207867|470633768|FG015|Overall Study|Physician Decision|1|||
130730395|NCT03207867|470633769|FG016|Overall Study|Physician Decision|1|||
130730396|NCT03207867|470633770|FG017|Overall Study|Physician Decision|2|||
130503888|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
130503889|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130503890|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
130503891|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
130503892|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130503893|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
130503894|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130503895|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
130503896|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
130503897|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
130503898|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
130503899|NCT01185340|469813663|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130503900|NCT01185340|469813664|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130503901|NCT01185340|469813665|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
130503902|NCT01185340|469813666|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
130503903|NCT02065895|469813667|FG000|Overall Study|Protocol Violation|1|||
130503904|NCT02065895|469813668|FG001|Overall Study|Protocol Violation|0|||
130503905|NCT02065895|469813669|FG002|Overall Study|Protocol Violation|0|||
130503906|NCT02065895|469813670|FG003|Overall Study|Protocol Violation|1|||
130503907|NCT02065895|469813671|FG004|Overall Study|Protocol Violation|0|||
130503908|NCT02065895|469813672|FG005|Overall Study|Protocol Violation|0|||
130503909|NCT02065895|469813667|FG000|Overall Study|Scheduling conflicts|0|||
130503910|NCT02065895|469813668|FG001|Overall Study|Scheduling conflicts|1|||
130503911|NCT02065895|469813669|FG002|Overall Study|Scheduling conflicts|0|||
130503912|NCT02065895|469813670|FG003|Overall Study|Scheduling conflicts|0|||
130565968|NCT01987960|470038172|FG000|Period 1|Lost to Follow-up|40|||
130565969|NCT01987960|470038173|FG001|Period 1|Lost to Follow-up|0|||
130730397|NCT03207867|470633771|FG018|Overall Study|Physician Decision|1|||
130730398|NCT03207867|470633772|FG019|Overall Study|Physician Decision|3|||
130730399|NCT03207867|470633773|FG020|Overall Study|Physician Decision|0|||
130730400|NCT03207867|470633774|FG021|Overall Study|Physician Decision|0|||
130730401|NCT03207867|470633775|FG022|Overall Study|Physician Decision|0|||
130730402|NCT03207867|470633776|FG023|Overall Study|Physician Decision|0|||
130730403|NCT03207867|470633753|FG000|Overall Study|Progressive Disease|7|||
130730404|NCT03207867|470633754|FG001|Overall Study|Progressive Disease|7|||
130730405|NCT03207867|470633755|FG002|Overall Study|Progressive Disease|9|||
130730406|NCT03207867|470633756|FG003|Overall Study|Progressive Disease|10|||
130730407|NCT03207867|470633757|FG004|Overall Study|Progressive Disease|11|||
130730408|NCT03207867|470633758|FG005|Overall Study|Progressive Disease|10|||
130730409|NCT03207867|470633759|FG006|Overall Study|Progressive Disease|9|||
130730410|NCT03207867|470633760|FG007|Overall Study|Progressive Disease|8|||
130730411|NCT03207867|470633761|FG008|Overall Study|Progressive Disease|19|||
130730412|NCT03207867|470633762|FG009|Overall Study|Progressive Disease|23|||
130730413|NCT03207867|470633763|FG010|Overall Study|Progressive Disease|2|||
130730414|NCT03207867|470633764|FG011|Overall Study|Progressive Disease|24|||
130730415|NCT03207867|470633765|FG012|Overall Study|Progressive Disease|3|||
130730416|NCT03207867|470633766|FG013|Overall Study|Progressive Disease|11|||
130730417|NCT03207867|470633767|FG014|Overall Study|Progressive Disease|9|||
130730418|NCT03207867|470633768|FG015|Overall Study|Progressive Disease|5|||
130730419|NCT03207867|470633769|FG016|Overall Study|Progressive Disease|10|||
130730420|NCT03207867|470633770|FG017|Overall Study|Progressive Disease|14|||
130730421|NCT03207867|470633771|FG018|Overall Study|Progressive Disease|13|||
130730422|NCT03207867|470633772|FG019|Overall Study|Progressive Disease|14|||
130730423|NCT03207867|470633773|FG020|Overall Study|Progressive Disease|6|||
130730424|NCT03207867|470633774|FG021|Overall Study|Progressive Disease|3|||
130730425|NCT03207867|470633775|FG022|Overall Study|Progressive Disease|3|||
130730426|NCT03207867|470633776|FG023|Overall Study|Progressive Disease|3|||
130730427|NCT03207867|470633753|FG000|Overall Study|Patient/guardian Decision|0|||
130730428|NCT03207867|470633754|FG001|Overall Study|Patient/guardian Decision|0|||
130730429|NCT03207867|470633755|FG002|Overall Study|Patient/guardian Decision|1|||
130730430|NCT03207867|470633756|FG003|Overall Study|Patient/guardian Decision|1|||
130730431|NCT03207867|470633757|FG004|Overall Study|Patient/guardian Decision|1|||
130730432|NCT03207867|470633758|FG005|Overall Study|Patient/guardian Decision|2|||
130730433|NCT03207867|470633759|FG006|Overall Study|Patient/guardian Decision|1|||
130730434|NCT03207867|470633760|FG007|Overall Study|Patient/guardian Decision|0|||
130730435|NCT03207867|470633761|FG008|Overall Study|Patient/guardian Decision|1|||
130730436|NCT03207867|470633762|FG009|Overall Study|Patient/guardian Decision|0|||
130730437|NCT03207867|470633763|FG010|Overall Study|Patient/guardian Decision|0|||
130730438|NCT03207867|470633764|FG011|Overall Study|Patient/guardian Decision|1|||
130730439|NCT03207867|470633765|FG012|Overall Study|Patient/guardian Decision|0|||
130730440|NCT03207867|470633766|FG013|Overall Study|Patient/guardian Decision|1|||
130730441|NCT03207867|470633767|FG014|Overall Study|Patient/guardian Decision|2|||
130730442|NCT03207867|470633768|FG015|Overall Study|Patient/guardian Decision|0|||
130730443|NCT03207867|470633769|FG016|Overall Study|Patient/guardian Decision|1|||
130730444|NCT03207867|470633770|FG017|Overall Study|Patient/guardian Decision|3|||
130730445|NCT03207867|470633771|FG018|Overall Study|Patient/guardian Decision|4|||
130730446|NCT03207867|470633772|FG019|Overall Study|Patient/guardian Decision|1|||
130730447|NCT03207867|470633773|FG020|Overall Study|Patient/guardian Decision|0|||
130730448|NCT03207867|470633774|FG021|Overall Study|Patient/guardian Decision|0|||
130730449|NCT03207867|470633775|FG022|Overall Study|Patient/guardian Decision|0|||
130730450|NCT03207867|470633776|FG023|Overall Study|Patient/guardian Decision|0|||
130730451|NCT02447744|470633777|FG000|Overall Study|Withdrawal by Subject|3|||
130730452|NCT02447744|470633778|FG001|Overall Study|Withdrawal by Subject|1|||
130730453|NCT02447744|470633777|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
130730454|NCT02447744|470633778|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
130730455|NCT00912912|470633779|FG000|Overall Study|Withdrawal by Subject|1|||
130730456|NCT00912912|470633779|FG000|Overall Study|Disease Progression|3|||
130730457|NCT00306995|470633780|FG000|Study Part I|Withdrawal by Subject|0|||
130730458|NCT00306995|470633781|FG001|Study Part I|Withdrawal by Subject|0|||
130730459|NCT00306995|470633782|FG002|Study Part I|Withdrawal by Subject|0|||
130730460|NCT00306995|470633783|FG003|Study Part I|Withdrawal by Subject|0|||
130730461|NCT00306995|470633784|FG004|Study Part I|Withdrawal by Subject|0|||
130730462|NCT00306995|470633785|FG005|Study Part I|Withdrawal by Subject|0|||
130730463|NCT00306995|470633786|FG006|Study Part I|Withdrawal by Subject|1|||
130730464|NCT00306995|470633780|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
130730465|NCT00306995|470633781|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
130730466|NCT00306995|470633782|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
130730467|NCT00306995|470633783|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
130730468|NCT00306995|470633784|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
130730469|NCT00306995|470633785|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
130730470|NCT00306995|470633786|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
130565970|NCT01987960|470038174|FG002|Period 1|Lost to Follow-up|0|||
130565971|NCT01987960|470038175|FG003|Period 1|Lost to Follow-up|0|||
130503913|NCT02065895|469813671|FG004|Overall Study|Scheduling conflicts|0|||
130503914|NCT02065895|469813672|FG005|Overall Study|Scheduling conflicts|0|||
130503915|NCT03469258|469813673|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
130503916|NCT03403036|469813680|FG000|Overall Study|Lack of Efficacy|5|||
130503917|NCT00484198|469813683|FG000|Overall Study|Participant Withdrew Consent|12|||
130503918|NCT00484198|469813684|FG001|Overall Study|Participant Withdrew Consent|21|||
130503919|NCT00484198|469813685|FG002|Overall Study|Participant Withdrew Consent|47|||
130503920|NCT00484198|469813686|FG003|Overall Study|Participant Withdrew Consent|59|||
130503921|NCT00484198|469813683|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
130503922|NCT00484198|469813684|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
130503923|NCT00484198|469813685|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
130503924|NCT00484198|469813686|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
130503925|NCT00484198|469813683|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
130503926|NCT00484198|469813684|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
130503927|NCT00484198|469813685|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
130503928|NCT00484198|469813686|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
130503929|NCT00484198|469813683|FG000|Overall Study|Adverse Event|3|||
130503930|NCT00484198|469813684|FG001|Overall Study|Adverse Event|11|||
130503931|NCT00484198|469813685|FG002|Overall Study|Adverse Event|32|||
130503932|NCT00484198|469813686|FG003|Overall Study|Adverse Event|31|||
130503933|NCT00484198|469813683|FG000|Overall Study|Protocol Violation|0|||
130503934|NCT00484198|469813684|FG001|Overall Study|Protocol Violation|5|||
130503935|NCT00484198|469813685|FG002|Overall Study|Protocol Violation|6|||
130503936|NCT00484198|469813686|FG003|Overall Study|Protocol Violation|8|||
130503937|NCT00484198|469813683|FG000|Overall Study|Other|7|||
130503938|NCT00484198|469813684|FG001|Overall Study|Other|10|||
130503939|NCT00484198|469813685|FG002|Overall Study|Other|31|||
130503940|NCT00484198|469813686|FG003|Overall Study|Other|28|||
130503941|NCT00704340|469813687|FG000|Overall Study|Lost to Follow-up|2|||
130503942|NCT00704340|469813688|FG001|Overall Study|Lost to Follow-up|1|||
130503943|NCT00704340|469813687|FG000|Overall Study|Death|0|||
130503944|NCT00704340|469813688|FG001|Overall Study|Death|1|||
130503945|NCT04311983|469813689|FG000|Overall Study|Lost to Follow-up|421|||
130503946|NCT04311983|469813690|FG001|Overall Study|Lost to Follow-up|456|||
130503947|NCT04311983|469813689|FG000|Overall Study|Incomplete survey|7|||
130503948|NCT04311983|469813690|FG001|Overall Study|Incomplete survey|9|||
130503949|NCT04311983|469813689|FG000|Overall Study|Death|1|||
130503950|NCT04311983|469813690|FG001|Overall Study|Death|0|||
130503951|NCT00638456|469813693|FG000|Overall Study|Withdrawal by Subject|6|||
130503952|NCT00638456|469813694|FG001|Overall Study|Withdrawal by Subject|2|||
130503953|NCT03236779|469813695|FG000|Overall Study|Lost to Follow-up|13|||
130503954|NCT03236779|469813696|FG001|Overall Study|Lost to Follow-up|21|||
130503955|NCT02935673|469813697|FG000|Overall Study|Adverse Event|0|||
130503956|NCT02935673|469813698|FG001|Overall Study|Adverse Event|1|||
130503957|NCT02935673|469813699|FG002|Overall Study|Adverse Event|0|||
130503958|NCT02935673|469813697|FG000|Overall Study|Withdrawal by Subject|1|||
130503959|NCT02935673|469813698|FG001|Overall Study|Withdrawal by Subject|2|||
130503960|NCT02935673|469813699|FG002|Overall Study|Withdrawal by Subject|0|||
130503961|NCT00813709|469813700|FG000|Double Blind Period|Adverse Event|4|||
130503962|NCT00813709|469813701|FG001|Double Blind Period|Adverse Event|1|||
130503963|NCT00813709|469813702|FG002|Double Blind Period|Adverse Event|4|||
130503964|NCT00813709|469813703|FG003|Double Blind Period|Adverse Event|0|||
130503965|NCT00813709|469813704|FG004|Double Blind Period|Adverse Event|0|||
130503966|NCT00813709|469813705|FG005|Double Blind Period|Adverse Event|0|||
130503967|NCT00813709|469813700|FG000|Double Blind Period|Lost to Follow-up|3|||
130503968|NCT00813709|469813701|FG001|Double Blind Period|Lost to Follow-up|2|||
130503969|NCT00813709|469813702|FG002|Double Blind Period|Lost to Follow-up|2|||
130503970|NCT00813709|469813703|FG003|Double Blind Period|Lost to Follow-up|0|||
130503971|NCT00813709|469813704|FG004|Double Blind Period|Lost to Follow-up|0|||
130503972|NCT00813709|469813705|FG005|Double Blind Period|Lost to Follow-up|0|||
130503973|NCT00813709|469813700|FG000|Double Blind Period|Switched to open label phase|9|||
130503974|NCT00813709|469813701|FG001|Double Blind Period|Switched to open label phase|26|||
130503975|NCT00813709|469813702|FG002|Double Blind Period|Switched to open label phase|18|||
130503976|NCT00813709|469813703|FG003|Double Blind Period|Switched to open label phase|0|||
130565972|NCT01987960|470038172|FG000|Period 1|administrative or other reason|75|||
130503977|NCT00813709|469813704|FG004|Double Blind Period|Switched to open label phase|0|||
130503978|NCT00813709|469813705|FG005|Double Blind Period|Switched to open label phase|0|||
130503979|NCT00813709|469813700|FG000|Double Blind Period|Randomized but not treated|1|||
130503980|NCT00813709|469813701|FG001|Double Blind Period|Randomized but not treated|3|||
130503981|NCT00813709|469813702|FG002|Double Blind Period|Randomized but not treated|1|||
130565973|NCT01987960|470038173|FG001|Period 1|administrative or other reason|0|||
130565974|NCT01987960|470038174|FG002|Period 1|administrative or other reason|0|||
130503982|NCT00813709|469813703|FG003|Double Blind Period|Randomized but not treated|0|||
130503983|NCT00813709|469813704|FG004|Double Blind Period|Randomized but not treated|0|||
130503984|NCT00813709|469813705|FG005|Double Blind Period|Randomized but not treated|0|||
130503985|NCT00813709|469813700|FG000|Double Blind Period|Other|14|||
130503986|NCT00813709|469813701|FG001|Double Blind Period|Other|9|||
130503987|NCT00813709|469813702|FG002|Double Blind Period|Other|6|||
130503988|NCT00813709|469813703|FG003|Double Blind Period|Other|0|||
130503989|NCT00813709|469813704|FG004|Double Blind Period|Other|0|||
130503990|NCT00813709|469813705|FG005|Double Blind Period|Other|0|||
130503991|NCT00813709|469813700|FG000|Open Label Period|Adverse Event|0|||
130503992|NCT00813709|469813701|FG001|Open Label Period|Adverse Event|0|||
130503993|NCT00813709|469813702|FG002|Open Label Period|Adverse Event|0|||
130503994|NCT00813709|469813703|FG003|Open Label Period|Adverse Event|5|||
130503995|NCT00813709|469813704|FG004|Open Label Period|Adverse Event|4|||
130503996|NCT00813709|469813705|FG005|Open Label Period|Adverse Event|3|||
130503997|NCT00813709|469813700|FG000|Open Label Period|Lack of Efficacy|0|||
130503998|NCT00813709|469813701|FG001|Open Label Period|Lack of Efficacy|0|||
130503999|NCT00813709|469813702|FG002|Open Label Period|Lack of Efficacy|0|||
130504000|NCT00813709|469813703|FG003|Open Label Period|Lack of Efficacy|3|||
130504001|NCT00813709|469813704|FG004|Open Label Period|Lack of Efficacy|1|||
130504002|NCT00813709|469813705|FG005|Open Label Period|Lack of Efficacy|1|||
130504003|NCT00813709|469813700|FG000|Open Label Period|Randomized but not treated|0|||
130504004|NCT00813709|469813701|FG001|Open Label Period|Randomized but not treated|0|||
130504005|NCT00813709|469813702|FG002|Open Label Period|Randomized but not treated|0|||
130504006|NCT00813709|469813703|FG003|Open Label Period|Randomized but not treated|1|||
130504007|NCT00813709|469813704|FG004|Open Label Period|Randomized but not treated|0|||
130504008|NCT00813709|469813705|FG005|Open Label Period|Randomized but not treated|1|||
130504009|NCT00813709|469813700|FG000|Open Label Period|Other|0|||
130504010|NCT00813709|469813701|FG001|Open Label Period|Other|0|||
130504011|NCT00813709|469813702|FG002|Open Label Period|Other|0|||
130504012|NCT00813709|469813703|FG003|Open Label Period|Other|11|||
130504013|NCT00813709|469813704|FG004|Open Label Period|Other|5|||
130504014|NCT00813709|469813705|FG005|Open Label Period|Other|6|||
130504015|NCT02152384|469813706|FG000|Period 1|Withdrawal by Subject|0|||
130504016|NCT02152384|469813707|FG001|Period 1|Withdrawal by Subject|1|||
130504017|NCT02152384|469813706|FG000|Period 1|Adverse Event|1|||
130504018|NCT02152384|469813707|FG001|Period 1|Adverse Event|1|||
130504019|NCT00889863|469813708|FG000|Part I: Open Label|Death|1|||
130504020|NCT00889863|469813709|FG001|Part I: Open Label|Death|0|||
130504021|NCT00889863|469813708|FG000|Part I: Open Label|Adverse Event|4|||
130504022|NCT00889863|469813709|FG001|Part I: Open Label|Adverse Event|0|||
130504023|NCT00889863|469813708|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
130504024|NCT00889863|469813709|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
130504025|NCT00889863|469813708|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
130504026|NCT00889863|469813709|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
130504027|NCT00889863|469813708|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
130504028|NCT00889863|469813709|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
130730471|NCT05422625|470633787|FG000|Overall Study|Withdrawal by Subject|1|||
130730472|NCT05422625|470633788|FG001|Overall Study|Withdrawal by Subject|0|||
130730473|NCT04324073|470635538|FG000|Overall Study|withdrew consent|0|||
130730474|NCT04324073|470635539|FG001|Overall Study|withdrew consent|4|||
130730475|NCT04324073|470635540|FG002|Overall Study|withdrew consent|2|||
130730476|NCT04324073|470635541|FG003|Overall Study|withdrew consent|8|||
130730477|NCT06400238|470635546|FG000|Overall Study|Started Protocol Therapy|2|||
130730478|NCT06400238|470635546|FG000|Overall Study|Adverse Event|1|||
130730479|NCT06400238|470635546|FG000|Overall Study|Death|1|||
130730480|NCT06400238|470635546|FG000|Overall Study|Disease Progression|27|||
130730481|NCT06400238|470635546|FG000|Overall Study|Withdrawal by Subject|2|||
130730482|NCT06400238|470635546|FG000|Overall Study|Physician Decision|2|||
130730483|NCT01277601|470635549|FG000|Overall Study|Adverse Event|5|||
130504029|NCT00889863|469813708|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
130504030|NCT00889863|469813709|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
130504031|NCT00889863|469813708|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
130504032|NCT00889863|469813709|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
130504033|NCT04361617|469813710|FG000|Overall Study|Withdrawal by Subject|0|||
130504034|NCT04361617|469813711|FG001|Overall Study|Withdrawal by Subject|1|||
130504035|NCT01393964|469813712|FG000|Overall Study|Disease Progression|4|||
130504036|NCT01393964|469813713|FG001|Overall Study|Disease Progression|3|||
130504037|NCT01393964|469813714|FG002|Overall Study|Disease Progression|5|||
130504038|NCT01393964|469813712|FG000|Overall Study|Study drug toxicity|1|||
130504039|NCT01393964|469813713|FG001|Overall Study|Study drug toxicity|0|||
130504040|NCT01393964|469813714|FG002|Overall Study|Study drug toxicity|0|||
130504041|NCT01393964|469813712|FG000|Overall Study|Withdrawal by Subject|0|||
130504042|NCT01393964|469813713|FG001|Overall Study|Withdrawal by Subject|0|||
130504043|NCT01393964|469813714|FG002|Overall Study|Withdrawal by Subject|1|||
130504044|NCT01393964|469813712|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130504045|NCT01393964|469813713|FG001|Overall Study|Adverse event unrelated to study drug|3|||
130504046|NCT01393964|469813714|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130504047|NCT01393964|469813712|FG000|Overall Study|Subject request stop study treatment|0|||
130504048|NCT01393964|469813713|FG001|Overall Study|Subject request stop study treatment|1|||
130504049|NCT01393964|469813714|FG002|Overall Study|Subject request stop study treatment|0|||
130504050|NCT01393964|469813712|FG000|Overall Study|Subject decided to move to transplant|1|||
130504051|NCT01393964|469813713|FG001|Overall Study|Subject decided to move to transplant|0|||
130504052|NCT01393964|469813714|FG002|Overall Study|Subject decided to move to transplant|0|||
130504053|NCT01393964|469813712|FG000|Overall Study|Subject switched to commercial supply|1|||
130504054|NCT01393964|469813713|FG001|Overall Study|Subject switched to commercial supply|0|||
130504055|NCT01393964|469813714|FG002|Overall Study|Subject switched to commercial supply|2|||
130504056|NCT01393964|469813712|FG000|Overall Study|Subject plateaued in terms of effect|1|||
130504057|NCT01393964|469813713|FG001|Overall Study|Subject plateaued in terms of effect|0|||
130504058|NCT01393964|469813714|FG002|Overall Study|Subject plateaued in terms of effect|0|||
130504059|NCT01393964|469813712|FG000|Overall Study|Investigator removed subject from study|0|||
130504060|NCT01393964|469813713|FG001|Overall Study|Investigator removed subject from study|1|||
130504061|NCT01393964|469813714|FG002|Overall Study|Investigator removed subject from study|0|||
130504062|NCT01393964|469813712|FG000|Overall Study|Subject converted to roll-over study|0|||
130504063|NCT01393964|469813713|FG001|Overall Study|Subject converted to roll-over study|1|||
130504064|NCT01393964|469813714|FG002|Overall Study|Subject converted to roll-over study|0|||
130504065|NCT01393964|469813712|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
130504066|NCT01393964|469813713|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
130504067|NCT01393964|469813714|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
130504068|NCT00687297|469813717|FG000|Randomization|Withdrawal by Subject|2|||
130504069|NCT00687297|469813718|FG001|Randomization|Withdrawal by Subject|0|||
130504070|NCT00687297|469813717|FG000|Randomization|Withdrew before treatment, ineligible|1|||
130504071|NCT00687297|469813718|FG001|Randomization|Withdrew before treatment, ineligible|1|||
130504072|NCT00687297|469813717|FG000|Induction|Withdrawal by Subject|4|||
130504073|NCT00687297|469813718|FG001|Induction|Withdrawal by Subject|4|||
130504074|NCT00687297|469813717|FG000|Induction|Adverse Event|16|||
130504075|NCT00687297|469813718|FG001|Induction|Adverse Event|15|||
130504076|NCT00687297|469813717|FG000|Induction|Death|7|||
130565975|NCT01987960|470038175|FG003|Period 1|administrative or other reason|0|||
130565976|NCT01987960|470038172|FG000|Period 1|Withdrawal of consent before treatment|4|||
130565977|NCT01987960|470038173|FG001|Period 1|Withdrawal of consent before treatment|0|||
130730484|NCT01277601|470635550|FG001|Overall Study|Adverse Event|3|||
130730485|NCT01277601|470635551|FG002|Overall Study|Adverse Event|0|||
130730486|NCT01277601|470635552|FG003|Overall Study|Adverse Event|7|||
130730487|NCT01277601|470635549|FG000|Overall Study|Withdrawal by Subject|18|||
130730488|NCT01277601|470635550|FG001|Overall Study|Withdrawal by Subject|21|||
130565978|NCT01987960|470038174|FG002|Period 1|Withdrawal of consent before treatment|0|||
130730489|NCT01277601|470635551|FG002|Overall Study|Withdrawal by Subject|8|||
130504077|NCT00687297|469813718|FG001|Induction|Death|11|||
130504078|NCT00687297|469813717|FG000|Induction|Lack of Efficacy|17|||
130504079|NCT00687297|469813718|FG001|Induction|Lack of Efficacy|21|||
130504080|NCT00687297|469813717|FG000|Induction|Ineligible|0|||
130504081|NCT00687297|469813718|FG001|Induction|Ineligible|1|||
130504082|NCT00687297|469813717|FG000|Induction|Patient Noncompliance|1|||
130504083|NCT00687297|469813718|FG001|Induction|Patient Noncompliance|0|||
130504084|NCT00687297|469813717|FG000|Induction|Physician Decision|0|||
130504085|NCT00687297|469813718|FG001|Induction|Physician Decision|2|||
130504086|NCT00687297|469813717|FG000|Induction|Other|0|||
130565979|NCT01987960|470038175|FG003|Period 1|Withdrawal of consent before treatment|0|||
130504087|NCT00687297|469813718|FG001|Induction|Other|1|||
130504088|NCT01228734|469813719|FG000|Overall Study|Randomized, but not treated|0|||
130504089|NCT01228734|469813720|FG001|Overall Study|Randomized, but not treated|4|||
130504090|NCT03128099|469813721|FG000|Overall Study|High dose task was too long|0|||
130504091|NCT03128099|469813722|FG001|Overall Study|High dose task was too long|4|||
130504092|NCT03128099|469813723|FG002|Overall Study|High dose task was too long|0|||
130504093|NCT03128099|469813721|FG000|Overall Study|Participant got a full time job.|1|||
130504094|NCT03128099|469813722|FG001|Overall Study|Participant got a full time job.|0|||
130504095|NCT03128099|469813723|FG002|Overall Study|Participant got a full time job.|0|||
130504096|NCT03128099|469813721|FG000|Overall Study|Became homeless and lost contact|1|||
130504097|NCT03128099|469813722|FG001|Overall Study|Became homeless and lost contact|0|||
130504098|NCT03128099|469813723|FG002|Overall Study|Became homeless and lost contact|0|||
130504099|NCT03128099|469813721|FG000|Overall Study|Did not complete all the assessments|0|||
130504100|NCT03128099|469813722|FG001|Overall Study|Did not complete all the assessments|0|||
130504101|NCT03128099|469813723|FG002|Overall Study|Did not complete all the assessments|1|||
130504102|NCT03390166|469813727|FG000|Overall Study|Death|0|||
130504103|NCT03390166|469813728|FG001|Overall Study|Death|1|||
130504104|NCT03390166|469813727|FG000|Overall Study|Lost to Follow-up|6|||
130504105|NCT03390166|469813728|FG001|Overall Study|Lost to Follow-up|4|||
130504106|NCT03390166|469813727|FG000|Overall Study|Physician Decision|2|||
130504107|NCT03390166|469813728|FG001|Overall Study|Physician Decision|1|||
130504108|NCT03390166|469813727|FG000|Overall Study|Move from study area|3|||
130504109|NCT03390166|469813728|FG001|Overall Study|Move from study area|2|||
130504110|NCT03390166|469813727|FG000|Overall Study|To militarycamp for conscript|1|||
130504111|NCT03390166|469813728|FG001|Overall Study|To militarycamp for conscript|0|||
130504112|NCT03390166|469813727|FG000|Overall Study|To drug therapy course|0|||
130504113|NCT03390166|469813728|FG001|Overall Study|To drug therapy course|1|||
130504114|NCT03390166|469813727|FG000|Overall Study|Move to work oversea|0|||
130504115|NCT03390166|469813728|FG001|Overall Study|Move to work oversea|1|||
130504116|NCT01584648|469813729|FG000|Overall Study|Death|136|||
130504117|NCT01584648|469813730|FG001|Overall Study|Death|146|||
130504118|NCT01584648|469813729|FG000|Overall Study|Lost to Follow-up|9|||
130504119|NCT01584648|469813730|FG001|Overall Study|Lost to Follow-up|9|||
130504120|NCT01584648|469813729|FG000|Overall Study|Investigator discretion|3|||
130504121|NCT01584648|469813730|FG001|Overall Study|Investigator discretion|2|||
130504122|NCT01584648|469813729|FG000|Overall Study|Withdrew consent|13|||
130504123|NCT01584648|469813730|FG001|Overall Study|Withdrew consent|4|||
130504124|NCT01584648|469813729|FG000|Overall Study|Study closed/terminated|50|||
130504125|NCT01584648|469813730|FG001|Overall Study|Study closed/terminated|23|||
130504126|NCT01584648|469813729|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
130504127|NCT01584648|469813730|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
130504128|NCT01137682|469813731|FG000|Overall Study|Adverse Event-CORE|2|||
130504129|NCT01137682|469813732|FG001|Overall Study|Adverse Event-CORE|4|||
130504130|NCT01137682|469813733|FG002|Overall Study|Adverse Event-CORE|0|||
130504131|NCT01137682|469813731|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
130504132|NCT01137682|469813732|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
130504133|NCT01137682|469813733|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
130504134|NCT01137682|469813731|FG000|Overall Study|Administrative problems-CORE|2|||
130504135|NCT01137682|469813732|FG001|Overall Study|Administrative problems-CORE|1|||
130504136|NCT01137682|469813733|FG002|Overall Study|Administrative problems-CORE|0|||
130504137|NCT01137682|469813731|FG000|Overall Study|Protocol Violation-CORE|0|||
130504138|NCT01137682|469813732|FG001|Overall Study|Protocol Violation-CORE|1|||
130504139|NCT01137682|469813733|FG002|Overall Study|Protocol Violation-CORE|1|||
130730490|NCT01277601|470635552|FG003|Overall Study|Withdrawal by Subject|17|||
130730491|NCT01277601|470635549|FG000|Overall Study|Lost to Follow-up|7|||
130730492|NCT01277601|470635550|FG001|Overall Study|Lost to Follow-up|9|||
130730493|NCT01277601|470635551|FG002|Overall Study|Lost to Follow-up|4|||
130730494|NCT01277601|470635552|FG003|Overall Study|Lost to Follow-up|2|||
130730495|NCT01277601|470635549|FG000|Overall Study|Physician Decision|3|||
130730496|NCT01277601|470635550|FG001|Overall Study|Physician Decision|5|||
130730497|NCT01277601|470635551|FG002|Overall Study|Physician Decision|1|||
130730498|NCT01277601|470635552|FG003|Overall Study|Physician Decision|6|||
130730499|NCT01277601|470635549|FG000|Overall Study|Pregnancy|2|||
130730500|NCT01277601|470635550|FG001|Overall Study|Pregnancy|2|||
130730501|NCT01277601|470635551|FG002|Overall Study|Pregnancy|4|||
130730502|NCT01277601|470635552|FG003|Overall Study|Pregnancy|1|||
130730503|NCT01277601|470635549|FG000|Overall Study|Noncompliance with Study Drug|1|||
130730504|NCT01277601|470635550|FG001|Overall Study|Noncompliance with Study Drug|3|||
130730505|NCT01277601|470635551|FG002|Overall Study|Noncompliance with Study Drug|2|||
130730506|NCT01277601|470635552|FG003|Overall Study|Noncompliance with Study Drug|0|||
130730507|NCT01277601|470635549|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
130730508|NCT01277601|470635550|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
130730509|NCT01277601|470635551|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
130730510|NCT01277601|470635552|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
130730511|NCT01277601|470635549|FG000|Overall Study|Protocol Violation|0|||
130730512|NCT01277601|470635550|FG001|Overall Study|Protocol Violation|2|||
130730513|NCT01277601|470635551|FG002|Overall Study|Protocol Violation|5|||
130730514|NCT01277601|470635552|FG003|Overall Study|Protocol Violation|0|||
130730515|NCT01277601|470635549|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
130504140|NCT01137682|469813731|FG000|Overall Study|Adverse Event-Extension|4|||
130504141|NCT01137682|469813732|FG001|Overall Study|Adverse Event-Extension|8|||
130504142|NCT01137682|469813733|FG002|Overall Study|Adverse Event-Extension|7|||
130504143|NCT01137682|469813731|FG000|Overall Study|Lack of Efficacy-Extension|15|||
130504144|NCT01137682|469813732|FG001|Overall Study|Lack of Efficacy-Extension|9|||
130504145|NCT01137682|469813733|FG002|Overall Study|Lack of Efficacy-Extension|13|||
130504146|NCT01137682|469813731|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
130504147|NCT01137682|469813732|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
130504148|NCT01137682|469813733|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
130504149|NCT01137682|469813731|FG000|Overall Study|Lost to Follow Up-Extension|0|||
130504150|NCT01137682|469813732|FG001|Overall Study|Lost to Follow Up-Extension|1|||
130565980|NCT01987960|470038172|FG000|Period 2|Adverse Event|0|||
130565981|NCT01987960|470038173|FG001|Period 2|Adverse Event|0|||
130565982|NCT01987960|470038174|FG002|Period 2|Adverse Event|1|||
130730516|NCT01277601|470635550|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
130730517|NCT01277601|470635551|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
130730518|NCT01277601|470635552|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
130730519|NCT04034927|470635553|FG000|Overall Study|Adverse Event|4|||
130730520|NCT04034927|470635554|FG001|Overall Study|Adverse Event|9|||
130730521|NCT04034927|470635553|FG000|Overall Study|Death|0|||
130730522|NCT04034927|470635554|FG001|Overall Study|Death|1|||
130730523|NCT04034927|470635553|FG000|Overall Study|Withdrawal by Subject|0|||
130730524|NCT04034927|470635554|FG001|Overall Study|Withdrawal by Subject|3|||
130730525|NCT04034927|470635553|FG000|Overall Study|Still on Treatment|2|||
130730526|NCT04034927|470635554|FG001|Overall Study|Still on Treatment|1|||
130730527|NCT04034927|470635553|FG000|Overall Study|Other|1|||
130730528|NCT04034927|470635554|FG001|Overall Study|Other|1|||
130730529|NCT03996447|470635555|FG000|First MRI Examination|Adverse Event|2|||
130730530|NCT03996447|470635556|FG001|First MRI Examination|Adverse Event|0|||
130730531|NCT03996447|470635555|FG000|First MRI Examination|Withdrawal by Subject|1|||
130730532|NCT03996447|470635556|FG001|First MRI Examination|Withdrawal by Subject|2|||
130730533|NCT03996447|470635555|FG000|First MRI Examination|Protocol Violation|0|||
130730534|NCT03996447|470635556|FG001|First MRI Examination|Protocol Violation|1|||
130730535|NCT03996447|470635555|FG000|Washout|Adverse Event|2|||
130730536|NCT03996447|470635556|FG001|Washout|Adverse Event|0|||
130730537|NCT03996447|470635555|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
130730538|NCT03996447|470635556|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
130730539|NCT03996447|470635555|FG000|Washout|Withdrawal by Subject|0|||
130730540|NCT03996447|470635556|FG001|Washout|Withdrawal by Subject|1|||
130730541|NCT03996447|470635555|FG000|Washout|Other reason|1|||
130730542|NCT03996447|470635556|FG001|Washout|Other reason|1|||
130730543|NCT02291510|470635557|FG000|Overall Study|Adverse Event|0|||
130730544|NCT02291510|470635558|FG001|Overall Study|Adverse Event|0|||
130730545|NCT02291510|470635559|FG002|Overall Study|Adverse Event|0|||
130730546|NCT02291510|470635560|FG003|Overall Study|Adverse Event|1|||
130730547|NCT06390839|470635561|FG000|Overall Study|Ineligible|2|||
130730548|NCT06390839|470635561|FG000|Overall Study|Never start protocol therapy|3|||
130730549|NCT06390839|470635561|FG000|Overall Study|Adverse Event|1|||
130730550|NCT06390839|470635561|FG000|Overall Study|Alternative therapy|2|||
130730551|NCT06390839|470635561|FG000|Overall Study|Death|3|||
130730552|NCT06390839|470635561|FG000|Overall Study|Disease progression|28|||
130730553|NCT06390839|470635561|FG000|Overall Study|Withdrawal by Subject|2|||
130730554|NCT06390839|470635561|FG000|Overall Study|Complicating disease|1|||
130730555|NCT06390839|470635561|FG000|Overall Study|Noncompliance|1|||
130730556|NCT04458922|470635562|FG000|Overall Study|Withdrawal by Subject|1|||
130730557|NCT04458922|470635563|FG001|Overall Study|Withdrawal by Subject|0|||
130730558|NCT04458922|470635564|FG002|Overall Study|Withdrawal by Subject|2|||
130730559|NCT04458922|470635562|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
130730560|NCT04458922|470635563|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
130730561|NCT04458922|470635564|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
130730562|NCT04458922|470635562|FG000|Overall Study|Adverse Event|1|||
130730563|NCT04458922|470635563|FG001|Overall Study|Adverse Event|0|||
130730564|NCT04458922|470635564|FG002|Overall Study|Adverse Event|0|||
130730565|NCT04458922|470635562|FG000|Overall Study|Started new study|0|||
130730566|NCT04458922|470635563|FG001|Overall Study|Started new study|0|||
130565983|NCT01987960|470038175|FG003|Period 2|Adverse Event|0|||
130730567|NCT04458922|470635564|FG002|Overall Study|Started new study|1|||
130730568|NCT04458922|470635562|FG000|Overall Study|Progressive disease|6|||
130730569|NCT04458922|470635563|FG001|Overall Study|Progressive disease|8|||
130730570|NCT04458922|470635564|FG002|Overall Study|Progressive disease|2|||
130565984|NCT01987960|470038172|FG000|Period 2|Withdrawal by Subject|0|||
130565985|NCT01987960|470038173|FG001|Period 2|Withdrawal by Subject|0|||
130565986|NCT01987960|470038174|FG002|Period 2|Withdrawal by Subject|1|||
130565987|NCT01987960|470038175|FG003|Period 2|Withdrawal by Subject|0|||
130565988|NCT01987960|470038172|FG000|Period 2|Administrative or other reason|0|||
130565989|NCT01987960|470038173|FG001|Period 2|Administrative or other reason|5|||
130565990|NCT01987960|470038174|FG002|Period 2|Administrative or other reason|7|||
130565991|NCT01987960|470038175|FG003|Period 2|Administrative or other reason|0|||
130565992|NCT01987960|470038172|FG000|Period 3|Adverse Event|0|||
130565993|NCT01987960|470038173|FG001|Period 3|Adverse Event|0|||
130565994|NCT01987960|470038174|FG002|Period 3|Adverse Event|0|||
130565995|NCT01987960|470038175|FG003|Period 3|Adverse Event|7|||
130565996|NCT01987960|470038172|FG000|Period 3|Non-compliance with IMP|0|||
130565997|NCT01987960|470038173|FG001|Period 3|Non-compliance with IMP|0|||
130565998|NCT01987960|470038174|FG002|Period 3|Non-compliance with IMP|0|||
130565999|NCT01987960|470038175|FG003|Period 3|Non-compliance with IMP|1|||
130566000|NCT01987960|470038172|FG000|Period 3|Protocol Violation|0|||
130566001|NCT01987960|470038173|FG001|Period 3|Protocol Violation|0|||
130566002|NCT01987960|470038174|FG002|Period 3|Protocol Violation|0|||
130566003|NCT01987960|470038175|FG003|Period 3|Protocol Violation|6|||
130566004|NCT01987960|470038172|FG000|Period 3|Withdrawal by Subject|0|||
130566005|NCT01987960|470038173|FG001|Period 3|Withdrawal by Subject|0|||
130566006|NCT01987960|470038174|FG002|Period 3|Withdrawal by Subject|0|||
130566007|NCT01987960|470038175|FG003|Period 3|Withdrawal by Subject|9|||
130566008|NCT01987960|470038172|FG000|Period 3|Lost to Follow-up|0|||
130566009|NCT01987960|470038173|FG001|Period 3|Lost to Follow-up|0|||
130566010|NCT01987960|470038174|FG002|Period 3|Lost to Follow-up|0|||
130566011|NCT01987960|470038175|FG003|Period 3|Lost to Follow-up|5|||
130566012|NCT01987960|470038172|FG000|Period 3|Administrative or other reason|0|||
130566013|NCT01987960|470038173|FG001|Period 3|Administrative or other reason|0|||
130566014|NCT01987960|470038174|FG002|Period 3|Administrative or other reason|0|||
130566015|NCT01987960|470038175|FG003|Period 3|Administrative or other reason|43|||
130566016|NCT00932360|470038176|FG000|Washout (One Week)|Withdrawal by Subject|0|||
130566017|NCT00932360|470038177|FG001|Washout (One Week)|Withdrawal by Subject|0|||
130566018|NCT00932360|470038178|FG002|Washout (One Week)|Withdrawal by Subject|0|||
130566019|NCT00932360|470038179|FG003|Washout (One Week)|Withdrawal by Subject|0|||
130566020|NCT00932360|470038180|FG004|Washout (One Week)|Withdrawal by Subject|2|||
130566021|NCT00932360|470038181|FG005|Washout (One Week)|Withdrawal by Subject|0|||
130566022|NCT02536313|470038184|FG000|Overall Study|Lack of Efficacy|0|||
130566023|NCT02536313|470038185|FG001|Overall Study|Lack of Efficacy|1|||
130566024|NCT00993265|470038196|FG000|Overall Study|Adverse Event|1|||
130566025|NCT00993265|470038197|FG001|Overall Study|Adverse Event|0|||
130566026|NCT00993265|470038196|FG000|Overall Study|Changed dose of concomitant drug|2|||
130566027|NCT00993265|470038197|FG001|Overall Study|Changed dose of concomitant drug|0|||
130566028|NCT00993265|470038196|FG000|Overall Study|Non-compliant with study medication|1|||
130566029|NCT00993265|470038197|FG001|Overall Study|Non-compliant with study medication|0|||
130566030|NCT02321930|470038202|FG000|Overall Study|Lost to Follow-up|1|||
130566031|NCT05321069|470038203|FG000|Overall Study|Adverse Event|52|||
130566032|NCT05321069|470038204|FG001|Overall Study|Adverse Event|52|||
130566033|NCT05321069|470038205|FG002|Overall Study|Adverse Event|64|||
130566034|NCT05321069|470038203|FG000|Overall Study|Protocol Violation|1|||
130566035|NCT05321069|470038204|FG001|Overall Study|Protocol Violation|1|||
130566036|NCT05321069|470038205|FG002|Overall Study|Protocol Violation|0|||
130730571|NCT04458922|470635562|FG000|Overall Study|Death|1|||
130730572|NCT04458922|470635563|FG001|Overall Study|Death|0|||
130730573|NCT04458922|470635564|FG002|Overall Study|Death|2|||
130730574|NCT04458922|470635562|FG000|Overall Study|Participant started chemotherapy|0|||
130730575|NCT04458922|470635563|FG001|Overall Study|Participant started chemotherapy|1|||
130730576|NCT04458922|470635564|FG002|Overall Study|Participant started chemotherapy|0|||
130730577|NCT06351371|470635566|FG000|Overall Study|Mutation Status Not Confirmed|9|||
130730578|NCT06351371|470635566|FG000|Overall Study|Ineligible|1|||
130730579|NCT06351371|470635566|FG000|Overall Study|Adverse Event|4|||
130730580|NCT06351371|470635566|FG000|Overall Study|Death|1|||
130730581|NCT06351371|470635566|FG000|Overall Study|Disease progression|14|||
130730582|NCT06351371|470635566|FG000|Overall Study|Withdrawal by Subject|3|||
130566037|NCT05321069|470038203|FG000|Overall Study|Withdrawal by Subject|23|||
130566038|NCT05321069|470038204|FG001|Overall Study|Withdrawal by Subject|18|||
130566039|NCT05321069|470038205|FG002|Overall Study|Withdrawal by Subject|12|||
130566040|NCT05321069|470038203|FG000|Overall Study|Lost to Follow-up|1|||
130566041|NCT05321069|470038204|FG001|Overall Study|Lost to Follow-up|0|||
130566042|NCT05321069|470038205|FG002|Overall Study|Lost to Follow-up|1|||
130566043|NCT05321069|470038203|FG000|Overall Study|No reason stated by the participants|23|||
130566044|NCT05321069|470038204|FG001|Overall Study|No reason stated by the participants|22|||
130566045|NCT05321069|470038205|FG002|Overall Study|No reason stated by the participants|16|||
130730583|NCT06351371|470635566|FG000|Overall Study|Physician Decision|3|||
130730584|NCT03203850|470635567|FG000|Overall Study|Subject/guardian decision|4|||
130730585|NCT03203850|470635568|FG001|Overall Study|Subject/guardian decision|3|||
130566046|NCT05321069|470038203|FG000|Overall Study|Lack of Efficacy|1|||
130504151|NCT01137682|469813733|FG002|Overall Study|Lost to Follow Up-Extension|0|||
130504152|NCT01137682|469813731|FG000|Overall Study|Administrative problems-Extension|0|||
130504153|NCT01137682|469813732|FG001|Overall Study|Administrative problems-Extension|2|||
130504154|NCT01137682|469813733|FG002|Overall Study|Administrative problems-Extension|0|||
130504155|NCT01137682|469813731|FG000|Overall Study|Death-Extension|2|||
130504156|NCT01137682|469813732|FG001|Overall Study|Death-Extension|0|||
130504157|NCT01137682|469813733|FG002|Overall Study|Death-Extension|0|||
130504158|NCT01137682|469813731|FG000|Overall Study|Protocol Violation-Extension|2|||
130504159|NCT01137682|469813732|FG001|Overall Study|Protocol Violation-Extension|1|||
130504160|NCT01137682|469813733|FG002|Overall Study|Protocol Violation-Extension|0|||
130504161|NCT01137682|469813731|FG000|Overall Study|Did not enter extension|2|||
130504162|NCT01137682|469813732|FG001|Overall Study|Did not enter extension|3|||
130504163|NCT01137682|469813733|FG002|Overall Study|Did not enter extension|2|||
130504164|NCT01137682|469813731|FG000|Overall Study|Did not receive treatment in extension|0|||
130504165|NCT01137682|469813732|FG001|Overall Study|Did not receive treatment in extension|0|||
130504166|NCT01137682|469813733|FG002|Overall Study|Did not receive treatment in extension|1|||
130504167|NCT04421456|469813735|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
130504168|NCT04421456|469813736|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
130504169|NCT04421456|469813737|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
130504170|NCT04421456|469813735|FG000|Randomized Treatment Period|Adverse Event|0|||
130504171|NCT04421456|469813736|FG001|Randomized Treatment Period|Adverse Event|1|||
130504172|NCT04421456|469813737|FG002|Randomized Treatment Period|Adverse Event|0|||
130504173|NCT04421456|469813735|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
130504174|NCT04421456|469813736|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
130504175|NCT04421456|469813737|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
130504176|NCT04421456|469813735|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
130504177|NCT04421456|469813736|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
130504178|NCT04421456|469813737|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
130504179|NCT04421456|469813735|FG000|Randomized Treatment Period|Participant non-compliance|1|||
130504180|NCT04421456|469813736|FG001|Randomized Treatment Period|Participant non-compliance|1|||
130504181|NCT04421456|469813737|FG002|Randomized Treatment Period|Participant non-compliance|2|||
130504182|NCT04421456|469813735|FG000|Randomized Treatment Period|Other|0|||
130504183|NCT04421456|469813736|FG001|Randomized Treatment Period|Other|1|||
130504184|NCT04421456|469813737|FG002|Randomized Treatment Period|Other|3|||
130504185|NCT00274287|469813738|FG000|Overall Study|Withdrawal by Subject|1|||
130504186|NCT00274287|469813738|FG000|Overall Study|subject non-compliance|1|||
130504187|NCT04617847|469813739|FG000|Overall Study|Withdrawal by Subject|1|||
130504188|NCT04617847|469813740|FG001|Overall Study|Withdrawal by Subject|0|||
130504189|NCT04617847|469813739|FG000|Overall Study|Adverse Event|0|||
130504190|NCT04617847|469813740|FG001|Overall Study|Adverse Event|2|||
130504191|NCT04617847|469813739|FG000|Overall Study|Death|0|||
130504192|NCT04617847|469813740|FG001|Overall Study|Death|1|||
130504193|NCT04617847|469813739|FG000|Overall Study|Termination of Study by Sponsor|2|||
130504194|NCT04617847|469813740|FG001|Overall Study|Termination of Study by Sponsor|21|||
130504195|NCT00244751|469813741|FG000|Overall Study|Adverse Event|7|||
130504196|NCT00244751|469813742|FG001|Overall Study|Adverse Event|7|||
130504197|NCT00244751|469813743|FG002|Overall Study|Adverse Event|5|||
130504198|NCT00244751|469813741|FG000|Overall Study|Lost to Follow-up|0|||
130504199|NCT00244751|469813742|FG001|Overall Study|Lost to Follow-up|1|||
130504200|NCT00244751|469813743|FG002|Overall Study|Lost to Follow-up|0|||
130504201|NCT00244751|469813741|FG000|Overall Study|Protocol Violation|1|||
130504202|NCT00244751|469813742|FG001|Overall Study|Protocol Violation|0|||
130504203|NCT00244751|469813743|FG002|Overall Study|Protocol Violation|1|||
130730586|NCT03203850|470635567|FG000|Overall Study|Adverse Event|3|||
130730587|NCT03203850|470635568|FG001|Overall Study|Adverse Event|0|||
130730588|NCT03203850|470635567|FG000|Overall Study|Death|1|||
130730589|NCT03203850|470635568|FG001|Overall Study|Death|0|||
130730590|NCT01009814|470635570|FG000|Overall Study|No longer met study criteria|1|||
130730591|NCT01009814|470635571|FG001|Overall Study|No longer met study criteria|1|||
130730592|NCT01009814|470635572|FG002|Overall Study|No longer met study criteria|0|||
130730593|NCT01009814|470635573|FG003|Overall Study|No longer met study criteria|0|||
130730594|NCT01009814|470635574|FG004|Overall Study|No longer met study criteria|0|||
130566047|NCT05321069|470038204|FG001|Overall Study|Lack of Efficacy|1|||
130730595|NCT00618371|470635575|FG000|Overall Study|Withdrawal by Subject|2|||
130504204|NCT00244751|469813741|FG000|Overall Study|Withdrawal by Subject|7|||
130504205|NCT00244751|469813742|FG001|Overall Study|Withdrawal by Subject|5|||
130504206|NCT00244751|469813743|FG002|Overall Study|Withdrawal by Subject|3|||
130504207|NCT00244751|469813741|FG000|Overall Study|Elevated liver enzymes|1|||
130504208|NCT00244751|469813742|FG001|Overall Study|Elevated liver enzymes|0|||
130504209|NCT00244751|469813743|FG002|Overall Study|Elevated liver enzymes|0|||
130504210|NCT00244751|469813741|FG000|Overall Study|Lack of compliance with protocol|0|||
130504211|NCT00244751|469813742|FG001|Overall Study|Lack of compliance with protocol|1|||
130504212|NCT00244751|469813743|FG002|Overall Study|Lack of compliance with protocol|0|||
130504213|NCT00244751|469813741|FG000|Overall Study|Safety reasons|0|||
130504214|NCT00244751|469813742|FG001|Overall Study|Safety reasons|1|||
130730596|NCT03348631|470635578|FG000|Overall Study|Not Eligible, No treatment|0|||
130730597|NCT03348631|470635579|FG001|Overall Study|Not Eligible, No treatment|1|||
130730598|NCT03348631|470635578|FG000|Overall Study|Not Eligible, Treated|2|||
130730599|NCT03348631|470635579|FG001|Overall Study|Not Eligible, Treated|0|||
130730600|NCT03348631|470635578|FG000|Overall Study|Eligible, No Treatment|1|||
130730601|NCT03348631|470635579|FG001|Overall Study|Eligible, No Treatment|0|||
130730602|NCT00451204|470635580|FG000|Overall Study|Adverse Event|4|||
130730603|NCT00451204|470635581|FG001|Overall Study|Adverse Event|6|||
130730604|NCT00451204|470635580|FG000|Overall Study|Lack of Efficacy|4|||
130730605|NCT00451204|470635581|FG001|Overall Study|Lack of Efficacy|4|||
130730606|NCT00451204|470635580|FG000|Overall Study|Lost to Follow-up|4|||
130730607|NCT00451204|470635581|FG001|Overall Study|Lost to Follow-up|4|||
130730608|NCT00451204|470635580|FG000|Overall Study|Protocol Violation|1|||
130730609|NCT00451204|470635581|FG001|Overall Study|Protocol Violation|0|||
130730610|NCT00451204|470635580|FG000|Overall Study|Patient refusal|8|||
130730611|NCT00451204|470635581|FG001|Overall Study|Patient refusal|4|||
130730612|NCT00451204|470635580|FG000|Overall Study|Other|1|||
130730613|NCT00451204|470635581|FG001|Overall Study|Other|2|||
130730614|NCT03055624|470635582|FG000|Overall Study|Study closed|9|||
130730615|NCT01582152|470635583|FG000|Overall Study|Disease Progression|4|||
130730616|NCT01582152|470635584|FG001|Overall Study|Disease Progression|5|||
130730617|NCT01582152|470635583|FG000|Overall Study|Adverse Event|2|||
130730618|NCT01582152|470635584|FG001|Overall Study|Adverse Event|1|||
130730619|NCT02794870|470635590|FG000|Overall Study|Withdrawal by Subject|2|||
130730620|NCT02794870|470635591|FG001|Overall Study|Withdrawal by Subject|0|||
130730621|NCT04172597|470635595|FG000|Overall Study|Disease Progression|0|||
130730622|NCT04172597|470635596|FG001|Overall Study|Disease Progression|0|||
130730623|NCT04172597|470635597|FG002|Overall Study|Disease Progression|0|||
130730624|NCT04172597|470635598|FG003|Overall Study|Disease Progression|0|||
130730625|NCT04172597|470635599|FG004|Overall Study|Disease Progression|1|||
130730626|NCT00794339|470635600|FG000|Overall Study|Withdrawal by Subject|3|||
130730627|NCT00794339|470635600|FG000|Overall Study|Ineligible|4|||
130730628|NCT00794339|470635600|FG000|Overall Study|Tx prior to ATSM|3|||
130730629|NCT00794339|470635600|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
130730630|NCT00794339|470635600|FG000|Overall Study|Tx not per protocol|1|||
130730631|NCT01611857|470635601|FG000|Overall Study|Withdrawal by Subject|0|||
130730632|NCT01611857|470635602|FG001|Overall Study|Withdrawal by Subject|2|||
130730633|NCT00362336|470635619|FG000|Overall Study|Serious Adverse Event|1|||
130730634|NCT00362336|470635620|FG001|Overall Study|Serious Adverse Event|0|||
130730635|NCT00362336|470635621|FG002|Overall Study|Serious Adverse Event|1|||
130730636|NCT00362336|470635619|FG000|Overall Study|Protocol Violation|0|||
130730637|NCT00362336|470635620|FG001|Overall Study|Protocol Violation|0|||
130730638|NCT00362336|470635621|FG002|Overall Study|Protocol Violation|1|||
130730639|NCT00362336|470635619|FG000|Overall Study|Lost to Follow-up|6|||
130730640|NCT00362336|470635620|FG001|Overall Study|Lost to Follow-up|4|||
130730641|NCT00362336|470635621|FG002|Overall Study|Lost to Follow-up|0|||
130730642|NCT00362336|470635619|FG000|Overall Study|Withdrawal by Subject|3|||
130730643|NCT00362336|470635620|FG001|Overall Study|Withdrawal by Subject|3|||
130730644|NCT00362336|470635621|FG002|Overall Study|Withdrawal by Subject|1|||
130730645|NCT04414618|470635622|FG000|Overall Study|Death|3|||
130730646|NCT04414618|470635623|FG001|Overall Study|Death|3|||
130730647|NCT04414618|470635622|FG000|Overall Study|Withdrawal by Subject|2|||
130730648|NCT04414618|470635623|FG001|Overall Study|Withdrawal by Subject|1|||
130730649|NCT04414618|470635622|FG000|Overall Study|Lost to Follow-up|2|||
130730650|NCT04414618|470635623|FG001|Overall Study|Lost to Follow-up|3|||
130730651|NCT04414618|470635622|FG000|Overall Study|Physician Decision|1|||
130730652|NCT04414618|470635623|FG001|Overall Study|Physician Decision|0|||
130730653|NCT00658879|470635624|FG000|Overall Study|Protocol Violation|1|||
130730654|NCT01121562|470635625|FG000|Overall Study|Objective progression or relapse|8|||
130730655|NCT01121562|470635625|FG000|Overall Study|Withdrawal by Subject|1|||
130730656|NCT01121562|470635625|FG000|Overall Study|Adverse Event|1|||
130730657|NCT01121562|470635625|FG000|Overall Study|Sponsor Decision|1|||
130730658|NCT01121562|470635625|FG000|Overall Study|Met study discontinuation criteria|1|||
130730659|NCT02075515|470635626|FG000|Overall Study|Serious Adverse Event|1|||
130730660|NCT02075515|470635627|FG001|Overall Study|Serious Adverse Event|1|||
130730661|NCT02075515|470635628|FG002|Overall Study|Serious Adverse Event|1|||
130730662|NCT02075515|470635626|FG000|Overall Study|Non-Serious Adverse Event|0|||
130730663|NCT02075515|470635627|FG001|Overall Study|Non-Serious Adverse Event|1|||
130730664|NCT02075515|470635628|FG002|Overall Study|Non-Serious Adverse Event|0|||
130730665|NCT02075515|470635626|FG000|Overall Study|Withdrawal by Subject|2|||
130504215|NCT00244751|469813743|FG002|Overall Study|Safety reasons|0|||
130730666|NCT02075515|470635627|FG001|Overall Study|Withdrawal by Subject|0|||
130730667|NCT02075515|470635628|FG002|Overall Study|Withdrawal by Subject|1|||
130730668|NCT02075515|470635626|FG000|Overall Study|Lost to Follow-up|1|||
130730669|NCT02075515|470635627|FG001|Overall Study|Lost to Follow-up|3|||
130730670|NCT02075515|470635628|FG002|Overall Study|Lost to Follow-up|6|||
130730671|NCT00378573|470635631|FG000|Treatment Period|Adverse Event|9|||
130504216|NCT00244751|469813741|FG000|Overall Study|Participant randomized by mistake|0|||
130504217|NCT00244751|469813742|FG001|Overall Study|Participant randomized by mistake|0|||
130504218|NCT00244751|469813743|FG002|Overall Study|Participant randomized by mistake|1|||
130504219|NCT02206607|469813746|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
130504220|NCT02206607|469813747|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
130504221|NCT02206607|469813748|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
130504222|NCT02206607|469813749|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
130504223|NCT02206607|469813750|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
130504224|NCT02206607|469813746|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
130504225|NCT02206607|469813747|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
130504226|NCT02206607|469813748|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
130504227|NCT02206607|469813749|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
130504228|NCT02206607|469813750|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
130504229|NCT01262456|469813751|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
130504230|NCT01262456|469813752|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
130504231|NCT01262456|469813753|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
130504232|NCT01262456|469813751|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
130504233|NCT01262456|469813752|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
130504234|NCT01262456|469813753|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
130504235|NCT01262456|469813751|FG000|3-Month Double-Blind Period|Adverse Event|6|||
130504236|NCT01262456|469813752|FG001|3-Month Double-Blind Period|Adverse Event|4|||
130504237|NCT01262456|469813753|FG002|3-Month Double-Blind Period|Adverse Event|8|||
130504238|NCT01262456|469813751|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
130504239|NCT01262456|469813752|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
130504240|NCT01262456|469813753|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
130504241|NCT01262456|469813751|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
130504242|NCT01262456|469813752|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
130730672|NCT00378573|470635631|FG000|Treatment Period|Physician Decision|1|||
130730673|NCT00378573|470635631|FG000|Treatment Period|Withdrawal by Subject|2|||
130730674|NCT00378573|470635631|FG000|Treatment Period|Disease Progression|4|||
130730675|NCT00378573|470635631|FG000|Treatment Period|Sponsor decision to close study|1|||
130730676|NCT00378573|470635631|FG000|Follow-up|Death|12|||
130730677|NCT00378573|470635631|FG000|Follow-up|Lost to Follow-up|1|||
130730678|NCT00378573|470635631|FG000|Follow-up|Withdrawal by Subject|1|||
130730679|NCT01372748|470635632|FG000|Overall Study|Lost to Follow-up|16|||
130730680|NCT01372748|470635633|FG001|Overall Study|Lost to Follow-up|34|||
130730681|NCT01372748|470635632|FG000|Overall Study|Withdrawal by Subject|7|||
130730682|NCT01372748|470635633|FG001|Overall Study|Withdrawal by Subject|5|||
130730683|NCT00134901|470635634|FG000|Overall Study|Lost to Follow-up|5|||
130730684|NCT00134901|470635635|FG001|Overall Study|Lost to Follow-up|5|||
130730685|NCT00134901|470635634|FG000|Overall Study|discontinued intervention|12|||
130730686|NCT00134901|470635635|FG001|Overall Study|discontinued intervention|10|||
130730687|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
130730688|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
130730689|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
130730690|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
130730691|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730692|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730693|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
130730694|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730695|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
130730696|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
130730697|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130730698|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130730699|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130730700|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
130730701|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
130730702|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130730703|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730704|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730705|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730706|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
130730707|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730708|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730709|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730710|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
130504243|NCT01262456|469813753|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
130730711|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
130504244|NCT01262456|469813751|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
130566048|NCT05321069|470038205|FG002|Overall Study|Lack of Efficacy|0|||
130566049|NCT00853749|470038206|FG000|Overall Study|Lost to Follow-up|0|||
130566050|NCT00853749|470038207|FG001|Overall Study|Lost to Follow-up|1|||
130566051|NCT02269787|470038210|FG000|Overall Study|Lost to Follow-up|20|||
130566052|NCT02269787|470038211|FG001|Overall Study|Lost to Follow-up|6|||
130566053|NCT02269787|470038210|FG000|Overall Study|Death|2|||
130566054|NCT02269787|470038211|FG001|Overall Study|Death|3|||
130566055|NCT02269787|470038210|FG000|Overall Study|Incapacitated|0|||
130566056|NCT02269787|470038211|FG001|Overall Study|Incapacitated|1|||
130566057|NCT00798135|470038212|FG000|Overall Study|Disease progression, relapse|11|||
130566058|NCT00798135|470038212|FG000|Overall Study|Disease progression, refractory|1|||
130566059|NCT00798135|470038212|FG000|Overall Study|Physician Decision|1|||
130566060|NCT00687440|470038213|FG000|Overall Study|Adverse Event|3|||
130566061|NCT00687440|470038213|FG000|Overall Study|Lost to Follow-up|3|||
130566062|NCT00687440|470038213|FG000|Overall Study|Lack of Efficacy|2|||
130566063|NCT00687440|470038213|FG000|Overall Study|Death|2|||
130566064|NCT00687440|470038213|FG000|Overall Study|Other|1|||
130566065|NCT00687440|470038213|FG000|Overall Study|Missing|1|||
130566066|NCT02228720|470038214|FG000|Open Label - Day 30|Lost to Follow-up|1|||
130566067|NCT01392677|470038217|FG000|Overall Study|Adverse Event|3|||
130566068|NCT01392677|470038218|FG001|Overall Study|Adverse Event|1|||
130566069|NCT01392677|470038217|FG000|Overall Study|Withdrawal by Subject|0|||
130730712|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
130730713|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
130730714|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
130730715|NCT01699815|470635642|FG000|Overall Study|Protocol Violation|4|||
130730716|NCT01699815|470635643|FG001|Overall Study|Protocol Violation|7|||
130730717|NCT01699815|470635642|FG000|Overall Study|record could not be located|1|||
130730718|NCT01699815|470635643|FG001|Overall Study|record could not be located|0|||
130730719|NCT01699815|470635642|FG000|Overall Study|Adverse Event|0|||
130730720|NCT01699815|470635643|FG001|Overall Study|Adverse Event|1|||
130730721|NCT00356525|470635644|FG000|Overall Study|Progressive Disease|8|||
130730722|NCT00356525|470635645|FG001|Overall Study|Progressive Disease|5|||
130730723|NCT00356525|470635646|FG002|Overall Study|Progressive Disease|4|||
130730724|NCT00356525|470635647|FG003|Overall Study|Progressive Disease|2|||
130730725|NCT00356525|470635644|FG000|Overall Study|Adverse Event|1|||
130730726|NCT00356525|470635645|FG001|Overall Study|Adverse Event|3|||
130730727|NCT00356525|470635646|FG002|Overall Study|Adverse Event|1|||
130730728|NCT00356525|470635647|FG003|Overall Study|Adverse Event|1|||
130730729|NCT00356525|470635644|FG000|Overall Study|Lost to Follow-up|1|||
130730730|NCT00356525|470635645|FG001|Overall Study|Lost to Follow-up|0|||
130730731|NCT00356525|470635646|FG002|Overall Study|Lost to Follow-up|0|||
130730732|NCT00356525|470635647|FG003|Overall Study|Lost to Follow-up|0|||
130730733|NCT00356525|470635644|FG000|Overall Study|Physician Decision|2|||
130730734|NCT00356525|470635645|FG001|Overall Study|Physician Decision|2|||
130566070|NCT01392677|470038218|FG001|Overall Study|Withdrawal by Subject|2|||
130566071|NCT01392677|470038217|FG000|Overall Study|Incorrect enrollment|2|||
130566072|NCT01392677|470038218|FG001|Overall Study|Incorrect enrollment|3|||
130730735|NCT00356525|470635646|FG002|Overall Study|Physician Decision|2|||
130566073|NCT01392677|470038217|FG000|Overall Study|Other reason|3|||
130730736|NCT00356525|470635647|FG003|Overall Study|Physician Decision|1|||
130730737|NCT00356525|470635644|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130730738|NCT00356525|470635645|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
130730739|NCT00356525|470635646|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
130730740|NCT00356525|470635647|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
130730741|NCT00356525|470635644|FG000|Overall Study|Withdrawal by Subject|1|||
130730742|NCT00356525|470635645|FG001|Overall Study|Withdrawal by Subject|1|||
130730743|NCT00356525|470635646|FG002|Overall Study|Withdrawal by Subject|0|||
130730744|NCT00356525|470635647|FG003|Overall Study|Withdrawal by Subject|3|||
130730745|NCT00356525|470635644|FG000|Overall Study|Death|0|||
130730746|NCT00356525|470635645|FG001|Overall Study|Death|0|||
130730747|NCT00356525|470635646|FG002|Overall Study|Death|0|||
130730748|NCT00356525|470635647|FG003|Overall Study|Death|1|||
130730749|NCT00356525|470635644|FG000|Overall Study|Sponsor Decision|0|||
130730750|NCT00356525|470635645|FG001|Overall Study|Sponsor Decision|0|||
130730751|NCT00356525|470635646|FG002|Overall Study|Sponsor Decision|0|||
130730752|NCT00356525|470635647|FG003|Overall Study|Sponsor Decision|1|||
130730753|NCT04487067|470635670|FG000|Overall Study|Adverse Event|3|||
130730754|NCT04487067|470635670|FG000|Overall Study|Death Other Than Progressive Disease|60|||
130730755|NCT04487067|470635670|FG000|Overall Study|Death Due To Progressive Disease|40|||
130730756|NCT04487067|470635670|FG000|Overall Study|Lost to Follow-up|3|||
130730757|NCT04487067|470635670|FG000|Overall Study|Progressive Disease|1|||
130730758|NCT04487067|470635670|FG000|Overall Study|Protocol Violation|3|||
130730759|NCT04487067|470635670|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
130730760|NCT04487067|470635670|FG000|Overall Study|Withdrawal by Subject|15|||
130730761|NCT02211417|470635671|FG000|Overall Study|Withdrawal by Subject|11|||
130730762|NCT02211417|470635672|FG001|Overall Study|Withdrawal by Subject|8|||
130730763|NCT02211417|470635671|FG000|Overall Study|Protocol Violation|1|||
130730764|NCT02211417|470635672|FG001|Overall Study|Protocol Violation|0|||
130730765|NCT02211417|470635671|FG000|Overall Study|Pregnancy|0|||
130730766|NCT02211417|470635672|FG001|Overall Study|Pregnancy|1|||
130730767|NCT02211417|470635671|FG000|Overall Study|Lost to Follow-up|2|||
130730768|NCT02211417|470635672|FG001|Overall Study|Lost to Follow-up|3|||
130730769|NCT02211417|470635671|FG000|Overall Study|Adverse Event|1|||
130730770|NCT02211417|470635672|FG001|Overall Study|Adverse Event|4|||
130730771|NCT01755091|470635673|FG000|Overall Study|Withdrawal by Subject|6|||
130730772|NCT01755091|470635674|FG001|Overall Study|Withdrawal by Subject|1|||
130730773|NCT01755091|470635675|FG002|Overall Study|Withdrawal by Subject|3|||
130730774|NCT01755091|470635673|FG000|Overall Study|Adverse Event|1|||
130730775|NCT01755091|470635674|FG001|Overall Study|Adverse Event|1|||
130730776|NCT01755091|470635675|FG002|Overall Study|Adverse Event|1|||
130730777|NCT01755091|470635673|FG000|Overall Study|Lost to Follow-up|1|||
130730778|NCT01755091|470635674|FG001|Overall Study|Lost to Follow-up|0|||
130730779|NCT01755091|470635675|FG002|Overall Study|Lost to Follow-up|1|||
130730780|NCT01755091|470635673|FG000|Overall Study|Physician Decision|1|||
130730781|NCT01755091|470635674|FG001|Overall Study|Physician Decision|1|||
130730782|NCT01755091|470635675|FG002|Overall Study|Physician Decision|2|||
130730783|NCT00490841|470635676|FG000|Overall Study|Death|5|||
130730784|NCT00490841|470635676|FG000|Overall Study|Withdrawal by Subject|4|||
130730785|NCT00490841|470635676|FG000|Overall Study|Lost to Follow-up|1|||
130730786|NCT00490841|470635676|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
130730787|NCT06385483|470635677|FG000|Overall Study|Withdrawal by Subject|2|||
130730788|NCT06385483|470635677|FG000|Overall Study|Never start protocol therapy|2|||
130730789|NCT06385483|470635677|FG000|Overall Study|Disease progression|15|||
130730790|NCT01098487|470635678|FG000|Overall Study|Adverse Event|22|||
130730791|NCT01098487|470635678|FG000|Overall Study|Lack of Efficacy|11|||
130730792|NCT01098487|470635678|FG000|Overall Study|Withdrawal by Subject|7|||
130730793|NCT01098487|470635678|FG000|Overall Study|Lost to Follow-up|3|||
130730794|NCT01098487|470635678|FG000|Overall Study|Physician Decision|1|||
130730795|NCT00345631|470635679|FG000|Overall Study|Withdrawal by Subject|1|||
130730796|NCT00345631|470635680|FG001|Overall Study|Withdrawal by Subject|0|||
130730797|NCT00345631|470635681|FG002|Overall Study|Withdrawal by Subject|1|||
130730798|NCT00345631|470635679|FG000|Overall Study|Adverse Event|0|||
130730799|NCT00345631|470635680|FG001|Overall Study|Adverse Event|1|||
130730800|NCT00345631|470635681|FG002|Overall Study|Adverse Event|0|||
130730801|NCT00345631|470635679|FG000|Overall Study|Lost to Follow-up|3|||
130730802|NCT00345631|470635680|FG001|Overall Study|Lost to Follow-up|7|||
130730803|NCT00345631|470635681|FG002|Overall Study|Lost to Follow-up|4|||
130730804|NCT00345631|470635679|FG000|Overall Study|Other reasons|0|||
130730805|NCT00345631|470635680|FG001|Overall Study|Other reasons|0|||
130730806|NCT00345631|470635681|FG002|Overall Study|Other reasons|1|||
130730807|NCT01301729|470635682|FG000|Overall Study|Withdrawal by Subject|2|||
130730808|NCT01301729|470635682|FG000|Overall Study|Participant did not Return for Treatment|1|||
130730809|NCT01301729|470635682|FG000|Overall Study|Violated Selection Criteria|1|||
130730810|NCT01885195|470635683|FG000|Overall Study|Adverse Event|29|||
130730811|NCT01885195|470635683|FG000|Overall Study|Death|1|||
130730812|NCT01885195|470635683|FG000|Overall Study|Disease Progression|67|||
130566074|NCT01392677|470038218|FG001|Overall Study|Other reason|2|||
130566075|NCT03996876|470038219|FG000|Overall Study|Incomplete Data|2|||
130566076|NCT03996876|470038220|FG001|Overall Study|Incomplete Data|4|||
130566077|NCT05264740|470038225|FG000|Baseline|Withdrawal by Subject|0|||
130566078|NCT05264740|470038226|FG001|Baseline|Withdrawal by Subject|1|||
130566079|NCT05264740|470038225|FG000|Follow Up 1|Lost to Follow-up|1|||
130566080|NCT05264740|470038226|FG001|Follow Up 1|Lost to Follow-up|1|||
130566081|NCT05264740|470038225|FG000|Follow Up 1|Withdrawal by Subject|0|||
130566082|NCT05264740|470038226|FG001|Follow Up 1|Withdrawal by Subject|1|||
130566083|NCT05264740|470038225|FG000|Follow Up 2|Lost to Follow-up|1|||
130566084|NCT05264740|470038226|FG001|Follow Up 2|Lost to Follow-up|4|||
130566085|NCT05264740|470038225|FG000|Follow Up 3|Lost to Follow-up|7|||
130566086|NCT05264740|470038226|FG001|Follow Up 3|Lost to Follow-up|4|||
130566087|NCT00597753|470038229|FG000|Overall Study|Adverse Event|6|||
130566088|NCT00597753|470038230|FG001|Overall Study|Adverse Event|2|||
130566089|NCT00597753|470038229|FG000|Overall Study|Death|55|||
130566090|NCT00597753|470038230|FG001|Overall Study|Death|29|||
130566091|NCT00597753|470038229|FG000|Overall Study|Lack of Efficacy|2|||
130566092|NCT00597753|470038230|FG001|Overall Study|Lack of Efficacy|0|||
130566093|NCT00597753|470038229|FG000|Overall Study|Lost to Follow-up|10|||
130566094|NCT00597753|470038230|FG001|Overall Study|Lost to Follow-up|3|||
130566095|NCT00597753|470038229|FG000|Overall Study|Physician Decision|5|||
130566096|NCT00597753|470038230|FG001|Overall Study|Physician Decision|1|||
130566097|NCT00597753|470038229|FG000|Overall Study|Pregnancy|1|||
130566098|NCT00597753|470038230|FG001|Overall Study|Pregnancy|0|||
130566099|NCT00597753|470038229|FG000|Overall Study|Withdrawal by Subject|35|||
130566100|NCT00597753|470038230|FG001|Overall Study|Withdrawal by Subject|12|||
130566101|NCT00597753|470038229|FG000|Overall Study|Discontinued Dialysis|0|||
130566102|NCT00597753|470038230|FG001|Overall Study|Discontinued Dialysis|1|||
130730813|NCT01885195|470635683|FG000|Overall Study|Protocol Deviation|2|||
130730814|NCT01885195|470635683|FG000|Overall Study|Physician Decision|3|||
130730815|NCT01885195|470635683|FG000|Overall Study|Patient/guardian decision|8|||
130730816|NCT04700137|470635684|FG000|Overall Study|Lost to Follow-up|1|||
130730817|NCT04700137|470635685|FG001|Overall Study|Lost to Follow-up|6|||
130730818|NCT04700137|470635686|FG002|Overall Study|Lost to Follow-up|1|||
130730819|NCT04700137|470635687|FG003|Overall Study|Lost to Follow-up|1|||
130730820|NCT04700137|470635684|FG000|Overall Study|Withdrawal by Subject|0|||
130730821|NCT04700137|470635685|FG001|Overall Study|Withdrawal by Subject|0|||
130730822|NCT04700137|470635686|FG002|Overall Study|Withdrawal by Subject|1|||
130730823|NCT04700137|470635687|FG003|Overall Study|Withdrawal by Subject|0|||
130730824|NCT04700137|470635684|FG000|Overall Study|Death|0|||
130730825|NCT04700137|470635685|FG001|Overall Study|Death|0|||
130730826|NCT04700137|470635686|FG002|Overall Study|Death|1|||
130730827|NCT04700137|470635687|FG003|Overall Study|Death|0|||
130730828|NCT01320150|470635689|FG000|Overall Study|Protocol Violation|15|||
130730829|NCT01320150|470635689|FG000|Overall Study|Withdrawal by Subject|5|||
130730830|NCT01320150|470635689|FG000|Overall Study|Death|2|||
130730831|NCT01320150|470635689|FG000|Overall Study|Lost to Follow-up|44|||
130730832|NCT00919854|470635692|FG000|Overall Study|Adverse Event|1|||
130730833|NCT00985491|470635693|FG000|Overall Study|Adverse Event|8|||
130730834|NCT00985491|470635693|FG000|Overall Study|device migration|7|||
130730835|NCT00985491|470635693|FG000|Overall Study|Withdrawal by Subject|1|||
130730836|NCT00985491|470635693|FG000|Overall Study|implant failure|3|||
130730837|NCT04386616|470635700|FG000|Overall Study|Death|22|||
130730838|NCT04386616|470635701|FG001|Overall Study|Death|22|||
130730839|NCT04386616|470635702|FG002|Overall Study|Death|21|||
130730840|NCT04386616|470635700|FG000|Overall Study|Lost to Follow-up|5|||
130730841|NCT04386616|470635701|FG001|Overall Study|Lost to Follow-up|8|||
130730842|NCT04386616|470635702|FG002|Overall Study|Lost to Follow-up|6|||
130730843|NCT04386616|470635700|FG000|Overall Study|Withdrawal by Subject|2|||
130730844|NCT04386616|470635701|FG001|Overall Study|Withdrawal by Subject|4|||
130730845|NCT04386616|470635702|FG002|Overall Study|Withdrawal by Subject|1|||
130730846|NCT04386616|470635700|FG000|Overall Study|Adverse Event|1|||
130730847|NCT04386616|470635701|FG001|Overall Study|Adverse Event|1|||
130730848|NCT04386616|470635702|FG002|Overall Study|Adverse Event|0|||
130730849|NCT01862484|470635703|FG000|Overall Study|Lack of Efficacy|1|||
130730850|NCT01862484|470635704|FG001|Overall Study|Lack of Efficacy|1|||
130730851|NCT01862484|470635703|FG000|Overall Study|Lost to Follow-up|1|||
130566103|NCT00597753|470038229|FG000|Overall Study|Never dosed|2|||
130566104|NCT00597753|470038230|FG001|Overall Study|Never dosed|0|||
130566105|NCT00597753|470038229|FG000|Overall Study|Noncompliance|2|||
130566106|NCT00597753|470038230|FG001|Overall Study|Noncompliance|1|||
130566107|NCT00597753|470038229|FG000|Overall Study|Relocation|17|||
130566108|NCT00597753|470038230|FG001|Overall Study|Relocation|6|||
130566109|NCT00597753|470038229|FG000|Overall Study|Renal transplant|10|||
130730852|NCT01862484|470635704|FG001|Overall Study|Lost to Follow-up|2|||
130730853|NCT01862484|470635703|FG000|Overall Study|Protocol Violation|0|||
130730854|NCT01862484|470635704|FG001|Overall Study|Protocol Violation|2|||
130504245|NCT01262456|469813752|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
130504246|NCT01262456|469813753|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
130730855|NCT01862484|470635703|FG000|Overall Study|Withdrawal by Subject|0|||
130730856|NCT01862484|470635704|FG001|Overall Study|Withdrawal by Subject|3|||
130730857|NCT01632280|470635705|FG000|Overall Study|Withdrawal by Subject|1|||
130730858|NCT01632280|470635706|FG001|Overall Study|Withdrawal by Subject|0|||
130730859|NCT00993421|470635707|FG000|Overall Study|Adverse Event|2|||
130730860|NCT00993421|470635708|FG001|Overall Study|Adverse Event|7|||
130730861|NCT00993421|470635709|FG002|Overall Study|Adverse Event|6|||
130504247|NCT01262456|469813751|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
130730862|NCT00993421|470635710|FG003|Overall Study|Adverse Event|9|||
130730863|NCT00993421|470635711|FG004|Overall Study|Adverse Event|5|||
130730864|NCT00993421|470635712|FG005|Overall Study|Adverse Event|7|||
130730865|NCT00993421|470635713|FG006|Overall Study|Adverse Event|1|||
130730866|NCT00993421|470635707|FG000|Overall Study|Sponsor Decision|36|||
130730867|NCT00993421|470635708|FG001|Overall Study|Sponsor Decision|31|||
130730868|NCT00993421|470635709|FG002|Overall Study|Sponsor Decision|28|||
130730869|NCT00993421|470635710|FG003|Overall Study|Sponsor Decision|30|||
130730870|NCT00993421|470635711|FG004|Overall Study|Sponsor Decision|38|||
130730871|NCT00993421|470635712|FG005|Overall Study|Sponsor Decision|30|||
130730872|NCT00993421|470635713|FG006|Overall Study|Sponsor Decision|29|||
130730873|NCT00993421|470635707|FG000|Overall Study|Lost to Follow-up|3|||
130730874|NCT00993421|470635708|FG001|Overall Study|Lost to Follow-up|5|||
130730875|NCT00993421|470635709|FG002|Overall Study|Lost to Follow-up|5|||
130730876|NCT00993421|470635710|FG003|Overall Study|Lost to Follow-up|0|||
130730877|NCT00993421|470635711|FG004|Overall Study|Lost to Follow-up|0|||
130730878|NCT00993421|470635712|FG005|Overall Study|Lost to Follow-up|0|||
130730879|NCT00993421|470635713|FG006|Overall Study|Lost to Follow-up|6|||
130730880|NCT00993421|470635707|FG000|Overall Study|Withdrawal by Subject|3|||
130730881|NCT00993421|470635708|FG001|Overall Study|Withdrawal by Subject|2|||
130730882|NCT00993421|470635709|FG002|Overall Study|Withdrawal by Subject|3|||
130730883|NCT00993421|470635710|FG003|Overall Study|Withdrawal by Subject|3|||
130730884|NCT00993421|470635711|FG004|Overall Study|Withdrawal by Subject|3|||
130730885|NCT00993421|470635712|FG005|Overall Study|Withdrawal by Subject|5|||
130730886|NCT00993421|470635713|FG006|Overall Study|Withdrawal by Subject|3|||
130730887|NCT00993421|470635707|FG000|Overall Study|Death|0|||
130730888|NCT00993421|470635708|FG001|Overall Study|Death|0|||
130730889|NCT00993421|470635709|FG002|Overall Study|Death|0|||
130730890|NCT00993421|470635710|FG003|Overall Study|Death|0|||
130730891|NCT00993421|470635711|FG004|Overall Study|Death|0|||
130730892|NCT00993421|470635712|FG005|Overall Study|Death|0|||
130730893|NCT00993421|470635713|FG006|Overall Study|Death|1|||
130730894|NCT00993421|470635707|FG000|Overall Study|Entry Criteria Exclusion|0|||
130730895|NCT00993421|470635708|FG001|Overall Study|Entry Criteria Exclusion|0|||
130730896|NCT00993421|470635709|FG002|Overall Study|Entry Criteria Exclusion|1|||
130730897|NCT00993421|470635710|FG003|Overall Study|Entry Criteria Exclusion|3|||
130730898|NCT00993421|470635711|FG004|Overall Study|Entry Criteria Exclusion|0|||
130730899|NCT00993421|470635712|FG005|Overall Study|Entry Criteria Exclusion|1|||
130730900|NCT00993421|470635713|FG006|Overall Study|Entry Criteria Exclusion|0|||
130730901|NCT00993421|470635707|FG000|Overall Study|Physician Decision|0|||
130730902|NCT00993421|470635708|FG001|Overall Study|Physician Decision|0|||
130730903|NCT00993421|470635709|FG002|Overall Study|Physician Decision|0|||
130730904|NCT00993421|470635710|FG003|Overall Study|Physician Decision|0|||
130730905|NCT00993421|470635711|FG004|Overall Study|Physician Decision|0|||
130730906|NCT00993421|470635712|FG005|Overall Study|Physician Decision|1|||
130730907|NCT00993421|470635713|FG006|Overall Study|Physician Decision|1|||
130504248|NCT01262456|469813752|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
130504249|NCT01262456|469813753|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
130504250|NCT01262456|469813751|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
130504251|NCT01262456|469813752|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
130730908|NCT00993421|470635707|FG000|Overall Study|Protocol Violation|0|||
130730909|NCT00993421|470635708|FG001|Overall Study|Protocol Violation|0|||
130730910|NCT00993421|470635709|FG002|Overall Study|Protocol Violation|0|||
130730911|NCT00993421|470635710|FG003|Overall Study|Protocol Violation|0|||
130730912|NCT00993421|470635711|FG004|Overall Study|Protocol Violation|0|||
130730913|NCT00993421|470635712|FG005|Overall Study|Protocol Violation|2|||
130730914|NCT00993421|470635713|FG006|Overall Study|Protocol Violation|1|||
130504252|NCT01262456|469813753|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
130730915|NCT02215967|470635714|FG000|Overall Study|Patient became ineligible for treatment|0|||
130730916|NCT02215967|470635715|FG001|Overall Study|Patient became ineligible for treatment|0|||
130730917|NCT02215967|470635716|FG002|Overall Study|Patient became ineligible for treatment|0|||
130730918|NCT02215967|470635717|FG003|Overall Study|Patient became ineligible for treatment|3|||
130730919|NCT02215967|470635714|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
130730920|NCT02215967|470635715|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
130730921|NCT02215967|470635716|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
130730922|NCT02215967|470635717|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
130730923|NCT00352417|470635721|FG000|Overall Study|Adverse Event|1|||
130730924|NCT00352417|470635722|FG001|Overall Study|Adverse Event|0|||
130730925|NCT00352417|470635721|FG000|Overall Study|Protocol Violation|0|||
130730926|NCT00352417|470635722|FG001|Overall Study|Protocol Violation|2|||
130730927|NCT00352417|470635721|FG000|Overall Study|Withdrawal by Subject|1|||
130730928|NCT00352417|470635722|FG001|Overall Study|Withdrawal by Subject|2|||
130730929|NCT00352417|470635721|FG000|Overall Study|Lost to Follow-up|1|||
130730930|NCT00352417|470635722|FG001|Overall Study|Lost to Follow-up|0|||
130730931|NCT00352417|470635721|FG000|Overall Study|Schedule Change|2|||
130730932|NCT00352417|470635722|FG001|Overall Study|Schedule Change|1|||
130730933|NCT05292183|470637285|FG000|Overall Study|Adverse Event|1|||
130730934|NCT00371033|470637288|FG000|Overall Study|Lost to Follow-up|3|||
130730935|NCT00371033|470637289|FG001|Overall Study|Lost to Follow-up|2|||
130730936|NCT00371033|470637288|FG000|Overall Study|No longer interested|2|||
130730937|NCT00371033|470637289|FG001|Overall Study|No longer interested|0|||
130730938|NCT00371033|470637288|FG000|Overall Study|Uknown|3|||
130730939|NCT00371033|470637289|FG001|Overall Study|Uknown|1|||
130730940|NCT03631199|470637290|FG000|Overall Study|Progressive disease|9|||
130730941|NCT03631199|470637291|FG001|Overall Study|Progressive disease|5|||
130730942|NCT03631199|470637292|FG002|Overall Study|Progressive disease|5|||
130730943|NCT03631199|470637293|FG003|Overall Study|Progressive disease|149|||
130730944|NCT03631199|470637294|FG004|Overall Study|Progressive disease|148|||
130730945|NCT03631199|470637290|FG000|Overall Study|Physician Decision|0|||
130730946|NCT03631199|470637291|FG001|Overall Study|Physician Decision|2|||
130730947|NCT03631199|470637292|FG002|Overall Study|Physician Decision|3|||
130730948|NCT03631199|470637293|FG003|Overall Study|Physician Decision|19|||
130730949|NCT03631199|470637294|FG004|Overall Study|Physician Decision|13|||
130730950|NCT03631199|470637290|FG000|Overall Study|Adverse Event|1|||
130730951|NCT03631199|470637291|FG001|Overall Study|Adverse Event|1|||
130730952|NCT03631199|470637292|FG002|Overall Study|Adverse Event|0|||
130730953|NCT03631199|470637293|FG003|Overall Study|Adverse Event|28|||
130730954|NCT03631199|470637294|FG004|Overall Study|Adverse Event|29|||
130730955|NCT03631199|470637290|FG000|Overall Study|Death|0|||
130730956|NCT03631199|470637291|FG001|Overall Study|Death|1|||
130730957|NCT03631199|470637292|FG002|Overall Study|Death|0|||
130730958|NCT03631199|470637293|FG003|Overall Study|Death|35|||
130730959|NCT03631199|470637294|FG004|Overall Study|Death|48|||
130730960|NCT03631199|470637290|FG000|Overall Study|Subject decision|0|||
130730961|NCT03631199|470637291|FG001|Overall Study|Subject decision|1|||
130730962|NCT03631199|470637292|FG002|Overall Study|Subject decision|0|||
130730963|NCT03631199|470637293|FG003|Overall Study|Subject decision|12|||
130730964|NCT03631199|470637294|FG004|Overall Study|Subject decision|12|||
130730965|NCT03631199|470637290|FG000|Overall Study|No treated|0|||
130730966|NCT03631199|470637291|FG001|Overall Study|No treated|0|||
130730967|NCT03631199|470637292|FG002|Overall Study|No treated|0|||
130730968|NCT03631199|470637293|FG003|Overall Study|No treated|0|||
130730969|NCT03631199|470637294|FG004|Overall Study|No treated|1|||
130730970|NCT03631199|470637290|FG000|Overall Study|Treatment ongoing|0|||
130730971|NCT03631199|470637291|FG001|Overall Study|Treatment ongoing|1|||
130730972|NCT03631199|470637292|FG002|Overall Study|Treatment ongoing|1|||
130730973|NCT03631199|470637293|FG003|Overall Study|Treatment ongoing|76|||
130730974|NCT03631199|470637294|FG004|Overall Study|Treatment ongoing|71|||
130730975|NCT03631199|470637290|FG000|Overall Study|Guardian decision|0|||
130730976|NCT03631199|470637291|FG001|Overall Study|Guardian decision|0|||
130730977|NCT03631199|470637292|FG002|Overall Study|Guardian decision|0|||
130730978|NCT03631199|470637293|FG003|Overall Study|Guardian decision|1|||
130730979|NCT03631199|470637294|FG004|Overall Study|Guardian decision|1|||
130730980|NCT01272037|470637297|FG000|Overall Study|Death|25|||
130730981|NCT01272037|470637298|FG001|Overall Study|Death|28|||
130504253|NCT01262456|469813751|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
130504254|NCT01262456|469813752|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
130504255|NCT01262456|469813753|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
130504256|NCT03541369|469813754|FG000|Overall Study|Death|0|||
130504257|NCT03541369|469813755|FG001|Overall Study|Death|0|||
130730982|NCT01272037|470637297|FG000|Overall Study|Adverse Event|12|||
130730983|NCT01272037|470637298|FG001|Overall Study|Adverse Event|7|||
130504258|NCT03541369|469813756|FG002|Overall Study|Death|0|||
130504259|NCT03541369|469813757|FG003|Overall Study|Death|0|||
130730984|NCT01272037|470637297|FG000|Overall Study|Withdrawal by Subject|175|||
130730985|NCT01272037|470637298|FG001|Overall Study|Withdrawal by Subject|93|||
130730986|NCT01272037|470637297|FG000|Overall Study|Disease progression|70|||
130730987|NCT01272037|470637298|FG001|Overall Study|Disease progression|111|||
130730988|NCT01272037|470637297|FG000|Overall Study|Other reason|42|||
130504260|NCT03541369|469813758|FG004|Overall Study|Death|1|||
130730989|NCT01272037|470637298|FG001|Overall Study|Other reason|41|||
130730990|NCT01272037|470637297|FG000|Overall Study|Delinquent data|24|||
130504261|NCT03541369|469813759|FG005|Overall Study|Death|1|||
130504262|NCT03541369|469813760|FG006|Overall Study|Death|0|||
130504263|NCT03541369|469813761|FG007|Overall Study|Death|2|||
130504264|NCT03541369|469813762|FG008|Overall Study|Death|1|||
130504265|NCT03541369|469813763|FG009|Overall Study|Death|2|||
130730991|NCT01272037|470637298|FG001|Overall Study|Delinquent data|19|||
130730992|NCT01272037|470637297|FG000|Overall Study|Reason under review|33|||
130730993|NCT01272037|470637298|FG001|Overall Study|Reason under review|29|||
130730994|NCT01272037|470637297|FG000|Overall Study|On treatment|626|||
130730995|NCT01272037|470637298|FG001|Overall Study|On treatment|632|||
130730996|NCT02847260|470637299|FG000|Overall Study|Adverse Event|3|||
130730997|NCT02847260|470637299|FG000|Overall Study|Withdrawal by Subject|2|||
130730998|NCT02847260|470637299|FG000|Overall Study|Clinical Deterioration|1|||
130730999|NCT02847260|470637299|FG000|Overall Study|Physician Decision|1|||
130731000|NCT03698019|470637300|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
130731001|NCT03698019|470637301|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
130731002|NCT03698019|470637300|FG000|Step 1: Registration|Withdrawal by Subject|7|||
130731003|NCT03698019|470637301|FG001|Step 1: Registration|Withdrawal by Subject|2|||
130731004|NCT03698019|470637300|FG000|Step 1: Registration|Toxicity|0|||
130731005|NCT03698019|470637301|FG001|Step 1: Registration|Toxicity|1|||
130731006|NCT03698019|470637300|FG000|Step 1: Registration|Disease Progression|0|||
130731007|NCT03698019|470637301|FG001|Step 1: Registration|Disease Progression|12|||
130731008|NCT03698019|470637300|FG000|Step 1: Registration|Co-morbidities|0|||
130731009|NCT03698019|470637301|FG001|Step 1: Registration|Co-morbidities|1|||
130731010|NCT03698019|470637300|FG000|Step 1: Registration|Scheduling Issues|1|||
130731011|NCT03698019|470637301|FG001|Step 1: Registration|Scheduling Issues|0|||
130731012|NCT03698019|470637300|FG000|Step 1: Registration|Participant Refusal|0|||
130731013|NCT03698019|470637301|FG001|Step 1: Registration|Participant Refusal|1|||
130731014|NCT03698019|470637300|FG000|Step 2: Surgery|Participant Refusal|2|||
130731015|NCT03698019|470637301|FG001|Step 2: Surgery|Participant Refusal|1|||
130731016|NCT03698019|470637300|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
130731017|NCT03698019|470637301|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
130731018|NCT03698019|470637300|FG000|Step 2: Surgery|Metastatic Disease|16|||
130731019|NCT03698019|470637301|FG001|Step 2: Surgery|Metastatic Disease|9|||
130731020|NCT03698019|470637300|FG000|Step 2: Surgery|Residual Disease|2|||
130731021|NCT03698019|470637301|FG001|Step 2: Surgery|Residual Disease|1|||
130731022|NCT03698019|470637300|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
130731023|NCT03698019|470637301|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
130731024|NCT03698019|470637300|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
130731025|NCT03698019|470637301|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
130731026|NCT03698019|470637300|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
130731027|NCT03698019|470637301|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
130731028|NCT03698019|470637300|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
130731029|NCT03698019|470637301|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
130731030|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
130504266|NCT03541369|469813764|FG010|Overall Study|Death|1|||
130504267|NCT03541369|469813765|FG011|Overall Study|Death|0|||
130504268|NCT03541369|469813766|FG012|Overall Study|Death|2|||
130504269|NCT03541369|469813767|FG013|Overall Study|Death|1|||
130504270|NCT03541369|469813768|FG014|Overall Study|Death|1|||
130504271|NCT03541369|469813769|FG015|Overall Study|Death|1|||
130504272|NCT03541369|469813770|FG016|Overall Study|Death|0|||
130504273|NCT03541369|469813771|FG017|Overall Study|Death|1|||
130504274|NCT03541369|469813754|FG000|Overall Study|Decision by sponsor|0|||
130504275|NCT03541369|469813755|FG001|Overall Study|Decision by sponsor|0|||
130504276|NCT03541369|469813756|FG002|Overall Study|Decision by sponsor|0|||
130504277|NCT03541369|469813757|FG003|Overall Study|Decision by sponsor|1|||
130504278|NCT03541369|469813758|FG004|Overall Study|Decision by sponsor|0|||
130504279|NCT03541369|469813759|FG005|Overall Study|Decision by sponsor|2|||
130504280|NCT03541369|469813760|FG006|Overall Study|Decision by sponsor|0|||
130504281|NCT03541369|469813761|FG007|Overall Study|Decision by sponsor|1|||
130504282|NCT03541369|469813762|FG008|Overall Study|Decision by sponsor|2|||
130504283|NCT03541369|469813763|FG009|Overall Study|Decision by sponsor|0|||
130504284|NCT03541369|469813764|FG010|Overall Study|Decision by sponsor|0|||
130504285|NCT03541369|469813765|FG011|Overall Study|Decision by sponsor|0|||
130504286|NCT03541369|469813766|FG012|Overall Study|Decision by sponsor|2|||
130731031|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
130504287|NCT03541369|469813767|FG013|Overall Study|Decision by sponsor|2|||
130504288|NCT03541369|469813768|FG014|Overall Study|Decision by sponsor|0|||
130731032|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
130504289|NCT03541369|469813769|FG015|Overall Study|Decision by sponsor|1|||
130504290|NCT03541369|469813770|FG016|Overall Study|Decision by sponsor|1|||
130504291|NCT03541369|469813771|FG017|Overall Study|Decision by sponsor|1|||
130504292|NCT03541369|469813754|FG000|Overall Study|Withdrawal by Subject|0|||
130504293|NCT03541369|469813755|FG001|Overall Study|Withdrawal by Subject|0|||
130566110|NCT00597753|470038230|FG001|Overall Study|Renal transplant|3|||
130731033|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
130731034|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
130731035|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
130731036|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
130731037|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
130731038|NCT00588770|470637302|FG000|Overall Study|Disease progression|85|||
130731039|NCT00588770|470637303|FG001|Overall Study|Disease progression|68|||
130731040|NCT00588770|470637302|FG000|Overall Study|Adverse Event|29|||
130731041|NCT00588770|470637303|FG001|Overall Study|Adverse Event|58|||
130731042|NCT00588770|470637302|FG000|Overall Study|Death|13|||
130731043|NCT00588770|470637303|FG001|Overall Study|Death|22|||
130731044|NCT00588770|470637302|FG000|Overall Study|Withdrawal by Subject|15|||
130731045|NCT00588770|470637303|FG001|Overall Study|Withdrawal by Subject|25|||
130731046|NCT00588770|470637302|FG000|Overall Study|Alternative therapy|2|||
130731047|NCT00588770|470637303|FG001|Overall Study|Alternative therapy|4|||
130731048|NCT00588770|470637302|FG000|Overall Study|Other complicating disease|3|||
130731049|NCT00588770|470637303|FG001|Overall Study|Other complicating disease|2|||
130731050|NCT00588770|470637302|FG000|Overall Study|Not start protocol therapy|0|||
130731051|NCT00588770|470637303|FG001|Overall Study|Not start protocol therapy|9|||
130731052|NCT00588770|470637302|FG000|Overall Study|Lack of Efficacy|8|||
130731053|NCT00588770|470637303|FG001|Overall Study|Lack of Efficacy|10|||
130731054|NCT00588770|470637302|FG000|Overall Study|Physician discretion|2|||
130731055|NCT00588770|470637303|FG001|Overall Study|Physician discretion|0|||
130731056|NCT00588770|470637302|FG000|Overall Study|Patient non-compliance|2|||
130731057|NCT00588770|470637303|FG001|Overall Study|Patient non-compliance|2|||
130731058|NCT01856192|470637304|FG000|Overall Study|Adverse Event|12|||
130731059|NCT01856192|470637305|FG001|Overall Study|Adverse Event|4|||
130731060|NCT01856192|470637304|FG000|Overall Study|Alternative therapy|0|||
130731061|NCT01856192|470637305|FG001|Overall Study|Alternative therapy|3|||
130731062|NCT01856192|470637304|FG000|Overall Study|Death|3|||
130731063|NCT01856192|470637305|FG001|Overall Study|Death|5|||
130504294|NCT03541369|469813756|FG002|Overall Study|Withdrawal by Subject|0|||
130504295|NCT03541369|469813757|FG003|Overall Study|Withdrawal by Subject|0|||
130504296|NCT03541369|469813758|FG004|Overall Study|Withdrawal by Subject|0|||
130504297|NCT03541369|469813759|FG005|Overall Study|Withdrawal by Subject|0|||
130504298|NCT03541369|469813760|FG006|Overall Study|Withdrawal by Subject|1|||
130504299|NCT03541369|469813761|FG007|Overall Study|Withdrawal by Subject|0|||
130504300|NCT03541369|469813762|FG008|Overall Study|Withdrawal by Subject|0|||
130504301|NCT03541369|469813763|FG009|Overall Study|Withdrawal by Subject|0|||
130504302|NCT03541369|469813764|FG010|Overall Study|Withdrawal by Subject|0|||
130504303|NCT03541369|469813765|FG011|Overall Study|Withdrawal by Subject|1|||
130504304|NCT03541369|469813766|FG012|Overall Study|Withdrawal by Subject|0|||
130504305|NCT03541369|469813767|FG013|Overall Study|Withdrawal by Subject|0|||
130504306|NCT03541369|469813768|FG014|Overall Study|Withdrawal by Subject|3|||
130504307|NCT03541369|469813769|FG015|Overall Study|Withdrawal by Subject|0|||
130504308|NCT03541369|469813770|FG016|Overall Study|Withdrawal by Subject|4|||
130504309|NCT03541369|469813771|FG017|Overall Study|Withdrawal by Subject|2|||
130504310|NCT03541369|469813754|FG000|Overall Study|Lost to Follow-up|0|||
130504311|NCT03541369|469813755|FG001|Overall Study|Lost to Follow-up|0|||
130504312|NCT03541369|469813756|FG002|Overall Study|Lost to Follow-up|0|||
130504313|NCT03541369|469813757|FG003|Overall Study|Lost to Follow-up|0|||
130504314|NCT03541369|469813758|FG004|Overall Study|Lost to Follow-up|1|||
130504315|NCT03541369|469813759|FG005|Overall Study|Lost to Follow-up|0|||
130504316|NCT03541369|469813760|FG006|Overall Study|Lost to Follow-up|0|||
130504317|NCT03541369|469813761|FG007|Overall Study|Lost to Follow-up|0|||
130504318|NCT03541369|469813762|FG008|Overall Study|Lost to Follow-up|1|||
130504319|NCT03541369|469813763|FG009|Overall Study|Lost to Follow-up|0|||
130504320|NCT03541369|469813764|FG010|Overall Study|Lost to Follow-up|0|||
130504321|NCT03541369|469813765|FG011|Overall Study|Lost to Follow-up|0|||
130504322|NCT03541369|469813766|FG012|Overall Study|Lost to Follow-up|1|||
130504323|NCT03541369|469813767|FG013|Overall Study|Lost to Follow-up|0|||
130504324|NCT03541369|469813768|FG014|Overall Study|Lost to Follow-up|0|||
130504325|NCT03541369|469813769|FG015|Overall Study|Lost to Follow-up|0|||
130504326|NCT03541369|469813770|FG016|Overall Study|Lost to Follow-up|0|||
130504327|NCT03541369|469813771|FG017|Overall Study|Lost to Follow-up|0|||
130504328|NCT04867382|469813774|FG000|Overall Study|Did not complete the survey|2|||
130504329|NCT04867382|469813775|FG001|Overall Study|Did not complete the survey|1|||
130731064|NCT01856192|470637304|FG000|Overall Study|Lack of Efficacy|0|||
130731065|NCT01856192|470637305|FG001|Overall Study|Lack of Efficacy|5|||
130731066|NCT01856192|470637304|FG000|Overall Study|Withdrawal by Subject|1|||
130731067|NCT01856192|470637305|FG001|Overall Study|Withdrawal by Subject|1|||
130731068|NCT01856192|470637304|FG000|Overall Study|Other diseases|1|||
130731069|NCT01856192|470637305|FG001|Overall Study|Other diseases|0|||
130504330|NCT01681511|469813779|FG000|Overall Study|No Treatment Received|1|||
130731070|NCT01856192|470637304|FG000|Overall Study|Never started treatment|7|||
130566111|NCT00597753|470038229|FG000|Overall Study|Site closed by sponsor|19|||
130566112|NCT00597753|470038230|FG001|Overall Study|Site closed by sponsor|7|||
130566113|NCT00597753|470038229|FG000|Overall Study|Site elected to close|2|||
130566114|NCT00597753|470038230|FG001|Overall Study|Site elected to close|4|||
130566115|NCT03080883|470038231|FG000|Overall Study|Withdrawal by Subject|11|||
130566116|NCT03080883|470038232|FG001|Overall Study|Withdrawal by Subject|15|||
130566117|NCT03080883|470038231|FG000|Overall Study|Adverse Event|22|||
130566118|NCT03080883|470038232|FG001|Overall Study|Adverse Event|22|||
130566119|NCT03080883|470038231|FG000|Overall Study|Alternative Therapy|0|||
130566120|NCT03080883|470038232|FG001|Overall Study|Alternative Therapy|3|||
130566121|NCT03080883|470038231|FG000|Overall Study|Other Complicating Disease|9|||
130566122|NCT03080883|470038232|FG001|Overall Study|Other Complicating Disease|5|||
130566123|NCT03080883|470038231|FG000|Overall Study|Death|21|||
130566124|NCT03080883|470038232|FG001|Overall Study|Death|16|||
130566125|NCT03080883|470038231|FG000|Overall Study|Physician Decision|2|||
130566126|NCT03080883|470038232|FG001|Overall Study|Physician Decision|2|||
130566127|NCT03080883|470038231|FG000|Overall Study|Disease Progression|2|||
130566128|NCT03080883|470038232|FG001|Overall Study|Disease Progression|8|||
130566129|NCT03080883|470038231|FG000|Overall Study|Lost to Follow-up|1|||
130566130|NCT03080883|470038232|FG001|Overall Study|Lost to Follow-up|1|||
130566131|NCT03451851|470038233|FG000|PCP: Week 0 -16|Adverse Event|1|||
130566132|NCT03451851|470038234|FG001|PCP: Week 0 -16|Adverse Event|0|||
130566133|NCT03451851|470038235|FG002|PCP: Week 0 -16|Adverse Event|0|||
130566134|NCT03451851|470038236|FG003|PCP: Week 0 -16|Adverse Event|0|||
130566135|NCT03451851|470038237|FG004|PCP: Week 0 -16|Adverse Event|0|||
130566136|NCT03451851|470038238|FG005|PCP: Week 0 -16|Adverse Event|0|||
130566137|NCT03451851|470038239|FG006|PCP: Week 0 -16|Adverse Event|1|||
130566138|NCT03451851|470038240|FG007|PCP: Week 0 -16|Adverse Event|0|||
130566139|NCT03451851|470038233|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566140|NCT03451851|470038234|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566141|NCT03451851|470038235|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
130566142|NCT03451851|470038236|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566143|NCT03451851|470038237|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566144|NCT03451851|470038238|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566145|NCT03451851|470038239|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566146|NCT03451851|470038240|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
130566147|NCT03451851|470038233|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566148|NCT03451851|470038234|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566149|NCT03451851|470038235|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
130566150|NCT03451851|470038236|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566151|NCT03451851|470038237|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566152|NCT03451851|470038238|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566153|NCT03451851|470038239|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566154|NCT03451851|470038240|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130566155|NCT03451851|470038233|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130566156|NCT03451851|470038234|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130566157|NCT03451851|470038235|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130566158|NCT03451851|470038236|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130566159|NCT03451851|470038237|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
130566160|NCT03451851|470038238|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
130566161|NCT03451851|470038239|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130731071|NCT01856192|470637305|FG001|Overall Study|Never started treatment|5|||
130731072|NCT01856192|470637304|FG000|Overall Study|Path ineligible|20|||
130731073|NCT01856192|470637305|FG001|Overall Study|Path ineligible|34|||
130731074|NCT01856192|470637304|FG000|Overall Study|Non-path ineligible|2|||
130731075|NCT01856192|470637305|FG001|Overall Study|Non-path ineligible|2|||
130731076|NCT01856192|470637304|FG000|Overall Study|Physician Decision|1|||
130731077|NCT01856192|470637305|FG001|Overall Study|Physician Decision|1|||
130731078|NCT01856192|470637304|FG000|Overall Study|Suspicion of progressive disease|1|||
130731079|NCT01856192|470637305|FG001|Overall Study|Suspicion of progressive disease|0|||
130731080|NCT01856192|470637304|FG000|Overall Study|Non-compliance|1|||
130731081|NCT01856192|470637305|FG001|Overall Study|Non-compliance|0|||
130731082|NCT02642042|470637306|FG000|Overall Study|Adverse Event|22|||
130731083|NCT02642042|470637306|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130566162|NCT03451851|470038240|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130566163|NCT03451851|470038233|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566164|NCT03451851|470038234|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566165|NCT03451851|470038235|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566166|NCT03451851|470038236|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566167|NCT03451851|470038237|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
130566168|NCT03451851|470038238|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566169|NCT03451851|470038239|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130731084|NCT02642042|470637306|FG000|Overall Study|Progression/Relapse|28|||
130504331|NCT01681511|469813780|FG001|Overall Study|No Treatment Received|3|||
130504332|NCT01681511|469813779|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
130504333|NCT01681511|469813780|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
130504334|NCT01681511|469813779|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
130504335|NCT01681511|469813780|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
130504336|NCT01681511|469813779|FG000|Overall Study|No Daily Urine Sample Collected|0|||
130504337|NCT01681511|469813780|FG001|Overall Study|No Daily Urine Sample Collected|1|||
130504338|NCT01681511|469813779|FG000|Overall Study|No post-catheter sample collected|11|||
130504339|NCT01681511|469813780|FG001|Overall Study|No post-catheter sample collected|4|||
130504340|NCT01156675|469813781|FG000|Overall Study|Death|5|||
130504341|NCT01156675|469813782|FG001|Overall Study|Death|3|||
130504342|NCT01156675|469813783|FG002|Overall Study|Death|0|||
130504343|NCT01156675|469813781|FG000|Overall Study|No data|29|||
130504344|NCT01156675|469813782|FG001|Overall Study|No data|22|||
130504345|NCT01156675|469813783|FG002|Overall Study|No data|2|||
130504346|NCT01079949|469813784|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
130504347|NCT01079949|469813785|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
130504348|NCT01079949|469813784|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
130504349|NCT01079949|469813785|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
130504350|NCT01079949|469813784|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
130504351|NCT01079949|469813785|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
130504352|NCT01079949|469813784|FG000|Overall Study|Randomized but not treated|1|||
130504353|NCT01079949|469813785|FG001|Overall Study|Randomized but not treated|0|||
130504354|NCT01529632|469813786|FG000|Overall Study|Administrative problem|2|||
130504355|NCT01529632|469813787|FG001|Overall Study|Administrative problem|1|||
130504356|NCT01529632|469813786|FG000|Overall Study|Protocol Violation|0|||
130504357|NCT01529632|469813787|FG001|Overall Study|Protocol Violation|1|||
130504358|NCT01529632|469813786|FG000|Overall Study|Adverse Event|1|||
130504359|NCT01529632|469813787|FG001|Overall Study|Adverse Event|1|||
130504360|NCT05184062|469813788|FG000|Overall Study|Lost to Follow-up|5|||
130504361|NCT05184062|469813789|FG001|Overall Study|Lost to Follow-up|1|||
130504362|NCT05184062|469813788|FG000|Overall Study|Withdrawal by Subject|1|||
130504363|NCT05184062|469813789|FG001|Overall Study|Withdrawal by Subject|0|||
130504364|NCT00747149|469815019|FG000|Overall Study|Adverse Event|0|||
130504365|NCT00747149|469815020|FG001|Overall Study|Adverse Event|15|||
130504366|NCT00747149|469815019|FG000|Overall Study|Lost to Follow-up|0|||
130504367|NCT00747149|469815020|FG001|Overall Study|Lost to Follow-up|10|||
130504368|NCT00747149|469815019|FG000|Overall Study|Withdrawal by Subject|0|||
130504369|NCT00747149|469815020|FG001|Overall Study|Withdrawal by Subject|6|||
130504370|NCT00747149|469815019|FG000|Overall Study|Did not receive treatment|0|||
130504371|NCT00747149|469815020|FG001|Overall Study|Did not receive treatment|1|||
130504372|NCT00747149|469815019|FG000|Overall Study|Incorrect enrollment|0|||
130504373|NCT00747149|469815020|FG001|Overall Study|Incorrect enrollment|6|||
130504374|NCT00747149|469815019|FG000|Overall Study|Severe non-compliance to protocol|0|||
130504375|NCT00747149|469815020|FG001|Overall Study|Severe non-compliance to protocol|1|||
130504376|NCT00747149|469815019|FG000|Overall Study|Not reported|1|||
130504377|NCT00747149|469815020|FG001|Overall Study|Not reported|4|||
130504378|NCT02196259|469815023|FG000|Overall Study|Researcher choice|0|||
130504379|NCT02196259|469815024|FG001|Overall Study|Researcher choice|0|||
130504380|NCT02196259|469815025|FG002|Overall Study|Researcher choice|1|||
130504381|NCT02196259|469815023|FG000|Overall Study|Partial data analysis|0|||
130504382|NCT02196259|469815024|FG001|Overall Study|Partial data analysis|3|||
130504383|NCT02196259|469815025|FG002|Overall Study|Partial data analysis|0|||
130504384|NCT02830893|469815026|FG000|Overall Study|Relocation to out of the country|1|||
130504385|NCT02830893|469815027|FG001|Overall Study|Relocation to out of the country|0|||
130504386|NCT02830893|469815026|FG000|Overall Study|Lost to Follow-up|0|||
130504387|NCT02830893|469815027|FG001|Overall Study|Lost to Follow-up|2|||
130504388|NCT02830893|469815026|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
130504389|NCT02830893|469815027|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
130504390|NCT00215943|469815028|FG000|Overall Study|Disease Progression|3|||
130504391|NCT00215943|469815029|FG001|Overall Study|Disease Progression|5|||
130504392|NCT00215943|469815028|FG000|Overall Study|Alternate therapy|0|||
130504393|NCT00215943|469815029|FG001|Overall Study|Alternate therapy|1|||
130504394|NCT00215943|469815028|FG000|Overall Study|Adverse Event|3|||
130504395|NCT00215943|469815029|FG001|Overall Study|Adverse Event|6|||
130504396|NCT00215943|469815028|FG000|Overall Study|Other disease|0|||
130504397|NCT00215943|469815029|FG001|Overall Study|Other disease|1|||
130504398|NCT00215943|469815028|FG000|Overall Study|Other complications|3|||
130504399|NCT00215943|469815029|FG001|Overall Study|Other complications|1|||
130504400|NCT00246129|469815031|FG000|Overall Study|Lost to Follow-up|1|||
130504401|NCT00246129|469815032|FG001|Overall Study|Lost to Follow-up|0|||
130504402|NCT00246129|469815031|FG000|Overall Study|Death|2|||
130731085|NCT02642042|470637306|FG000|Overall Study|Death|1|||
130731086|NCT02642042|470637306|FG000|Overall Study|Not Protocol Specified|2|||
130731087|NCT04976621|470637307|FG000|Overall Study|Lost to Follow-up|2|||
130731088|NCT04976621|470637308|FG001|Overall Study|Lost to Follow-up|1|||
130731089|NCT04976621|470637307|FG000|Overall Study|Withdrawal by Subject|1|||
130731090|NCT04976621|470637308|FG001|Overall Study|Withdrawal by Subject|0|||
130731091|NCT01495702|470637314|FG000|Randomized Phase|Randomized But Not Treated|1|||
130731092|NCT01495702|470637315|FG001|Randomized Phase|Randomized But Not Treated|4|||
130731093|NCT01495702|470637314|FG000|Randomized Phase|Adverse Event|2|||
130731094|NCT01495702|470637315|FG001|Randomized Phase|Adverse Event|2|||
130731095|NCT01495702|470637314|FG000|Randomized Phase|Death|1|||
130731096|NCT01495702|470637315|FG001|Randomized Phase|Death|0|||
130731097|NCT01495702|470637314|FG000|Randomized Phase|Lack of Efficacy|2|||
130731098|NCT01495702|470637315|FG001|Randomized Phase|Lack of Efficacy|0|||
130731099|NCT01495702|470637314|FG000|Randomized Phase|Investigators Discretion|2|||
130731100|NCT01495702|470637315|FG001|Randomized Phase|Investigators Discretion|0|||
130731101|NCT01495702|470637314|FG000|Randomized Phase|Withdrew Consent|10|||
130731102|NCT01495702|470637315|FG001|Randomized Phase|Withdrew Consent|18|||
130731103|NCT01495702|470637314|FG000|Randomized Phase|Lost to Follow-up|4|||
130731104|NCT01495702|470637315|FG001|Randomized Phase|Lost to Follow-up|3|||
130731105|NCT01495702|470637314|FG000|Randomized Phase|Participant Noncompliance|1|||
130731106|NCT01495702|470637315|FG001|Randomized Phase|Participant Noncompliance|0|||
130731107|NCT01495702|470637314|FG000|Randomized Phase|Protocol Violation|3|||
130731108|NCT01495702|470637315|FG001|Randomized Phase|Protocol Violation|1|||
130731109|NCT04152863|470637316|FG000|Overall Study|Death|13|||
130731110|NCT04152863|470637317|FG001|Overall Study|Death|12|||
130731111|NCT04152863|470637318|FG002|Overall Study|Death|7|||
130731112|NCT04152863|470637316|FG000|Overall Study|Physician Decision|1|||
130731113|NCT04152863|470637317|FG001|Overall Study|Physician Decision|1|||
130731114|NCT04152863|470637318|FG002|Overall Study|Physician Decision|1|||
130731115|NCT04152863|470637316|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
130731116|NCT04152863|470637317|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
130731117|NCT04152863|470637318|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
130731118|NCT04152863|470637316|FG000|Overall Study|Withdrawal by Subject|2|||
130731119|NCT04152863|470637317|FG001|Overall Study|Withdrawal by Subject|1|||
130731120|NCT04152863|470637318|FG002|Overall Study|Withdrawal by Subject|3|||
130731121|NCT00196326|470637319|FG000|Overall Study|Did not meet protocol requirements|64|||
130731122|NCT00196326|470637319|FG000|Overall Study|Non-compliance with the protocol|81|||
130731123|NCT00196326|470637319|FG000|Overall Study|Physician Decision|3|||
130731124|NCT00196326|470637319|FG000|Overall Study|Withdrawal by Subject|225|||
130731125|NCT00196326|470637319|FG000|Overall Study|Adverse Event|253|||
130731126|NCT00196326|470637319|FG000|Overall Study|Pregnancy|34|||
130731127|NCT00196326|470637319|FG000|Overall Study|Lost to Follow-up|304|||
130731128|NCT00196326|470637319|FG000|Overall Study|Other|22|||
130731129|NCT02797171|470637320|FG000|Overall Study|Lost to Follow-up|2|||
130731130|NCT02797171|470637321|FG001|Overall Study|Lost to Follow-up|0|||
130731131|NCT02797171|470637322|FG002|Overall Study|Lost to Follow-up|2|||
130731132|NCT02797171|470637323|FG003|Overall Study|Lost to Follow-up|1|||
130731133|NCT02797171|470637324|FG004|Overall Study|Lost to Follow-up|2|||
130731134|NCT02797171|470637325|FG005|Overall Study|Lost to Follow-up|0|||
130731135|NCT02797171|470637320|FG000|Overall Study|Withdrawal by Subject|1|||
130731136|NCT02797171|470637321|FG001|Overall Study|Withdrawal by Subject|1|||
130731137|NCT02797171|470637322|FG002|Overall Study|Withdrawal by Subject|0|||
130731138|NCT02797171|470637323|FG003|Overall Study|Withdrawal by Subject|0|||
130731139|NCT02797171|470637324|FG004|Overall Study|Withdrawal by Subject|0|||
130731140|NCT02797171|470637325|FG005|Overall Study|Withdrawal by Subject|0|||
130731141|NCT02797171|470637320|FG000|Overall Study|Protocol Violation|1|||
130731142|NCT02797171|470637321|FG001|Overall Study|Protocol Violation|0|||
130731143|NCT02797171|470637322|FG002|Overall Study|Protocol Violation|0|||
130731144|NCT02797171|470637323|FG003|Overall Study|Protocol Violation|0|||
130731145|NCT02797171|470637324|FG004|Overall Study|Protocol Violation|0|||
130731146|NCT02797171|470637325|FG005|Overall Study|Protocol Violation|0|||
130731147|NCT02797171|470637320|FG000|Overall Study|Participant unable to adhere|0|||
130731148|NCT02797171|470637321|FG001|Overall Study|Participant unable to adhere|1|||
130731149|NCT02797171|470637322|FG002|Overall Study|Participant unable to adhere|0|||
130731150|NCT02797171|470637323|FG003|Overall Study|Participant unable to adhere|0|||
130731151|NCT02797171|470637324|FG004|Overall Study|Participant unable to adhere|0|||
130731152|NCT02797171|470637325|FG005|Overall Study|Participant unable to adhere|0|||
130731153|NCT02797171|470637320|FG000|Overall Study|Not Randomized|0|||
130731154|NCT02797171|470637321|FG001|Overall Study|Not Randomized|0|||
130731155|NCT02797171|470637322|FG002|Overall Study|Not Randomized|0|||
130731156|NCT02797171|470637323|FG003|Overall Study|Not Randomized|0|||
130731157|NCT02797171|470637324|FG004|Overall Study|Not Randomized|0|||
130731158|NCT02797171|470637325|FG005|Overall Study|Not Randomized|1|||
130731159|NCT02540083|470637326|FG000|Overall Study|Withdrawal by Subject|16|||
130504403|NCT00246129|469815032|FG001|Overall Study|Death|1|||
130504404|NCT00246129|469815031|FG000|Overall Study|suffered primary non-function|1|||
130504405|NCT00246129|469815032|FG001|Overall Study|suffered primary non-function|0|||
130504406|NCT00246129|469815031|FG000|Overall Study|grafts failed|3|||
130504407|NCT00246129|469815032|FG001|Overall Study|grafts failed|1|||
130504408|NCT01286311|469815033|FG000|Overall Study|Physician did not want outreach sent|14|||
130504409|NCT01286311|469815034|FG001|Overall Study|Physician did not want outreach sent|0|||
130504410|NCT00403845|469815042|FG000|Treatment Period 1|Subject withdrew consent|1|||
130504411|NCT00403845|469815043|FG001|Treatment Period 1|Subject withdrew consent|0|||
130504412|NCT00403845|469815044|FG002|Treatment Period 1|Subject withdrew consent|0|||
130504413|NCT00403845|469815045|FG003|Treatment Period 1|Subject withdrew consent|0|||
130504414|NCT00403845|469815042|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
130504415|NCT00403845|469815043|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
130504416|NCT00403845|469815044|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
130504417|NCT00403845|469815045|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
130504418|NCT00403845|469815042|FG000|Treatment Period 2|Subject withdrew consent|1|||
130504419|NCT00403845|469815043|FG001|Treatment Period 2|Subject withdrew consent|0|||
130504420|NCT00403845|469815044|FG002|Treatment Period 2|Subject withdrew consent|0|||
130504421|NCT00403845|469815045|FG003|Treatment Period 2|Subject withdrew consent|0|||
130504422|NCT00403845|469815042|FG000|Treatment Period 3|Subject withdrew consent|0|||
130504423|NCT00403845|469815043|FG001|Treatment Period 3|Subject withdrew consent|0|||
130504424|NCT00403845|469815044|FG002|Treatment Period 3|Subject withdrew consent|0|||
130504425|NCT00403845|469815045|FG003|Treatment Period 3|Subject withdrew consent|1|||
130504426|NCT00403845|469815042|FG000|Treatment Period 3|Adverse Event|0|||
130504427|NCT00403845|469815043|FG001|Treatment Period 3|Adverse Event|0|||
130504428|NCT00403845|469815044|FG002|Treatment Period 3|Adverse Event|0|||
130504429|NCT00403845|469815045|FG003|Treatment Period 3|Adverse Event|1|||
130504430|NCT00805792|469815046|FG000|Overall Study|Death|3|||
130504431|NCT00805792|469815046|FG000|Overall Study|Lost to Follow-up|2|||
130504432|NCT00578344|469815047|FG000|Overall Study|Insurance problems|1|||
130504433|NCT00578344|469815047|FG000|Overall Study|Graft failure|1|||
130504434|NCT04328467|469815049|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
130504435|NCT04328467|469815050|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
130504436|NCT04328467|469815051|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
130504437|NCT02753075|469815054|FG000|Overall Study|Adverse Event|2|||
130504438|NCT02753075|469815055|FG001|Overall Study|Adverse Event|1|||
130504439|NCT02753075|469815056|FG002|Overall Study|Adverse Event|0|||
130504440|NCT02753075|469815054|FG000|Overall Study|Lost to Follow-up|2|||
130504441|NCT02753075|469815055|FG001|Overall Study|Lost to Follow-up|0|||
130504442|NCT02753075|469815056|FG002|Overall Study|Lost to Follow-up|0|||
130504443|NCT02753075|469815054|FG000|Overall Study|Withdrawal of Consent|1|||
130504444|NCT02753075|469815055|FG001|Overall Study|Withdrawal of Consent|1|||
130504445|NCT02753075|469815056|FG002|Overall Study|Withdrawal of Consent|3|||
130504446|NCT02753075|469815054|FG000|Overall Study|Physician Decision|3|||
130504447|NCT02753075|469815055|FG001|Overall Study|Physician Decision|1|||
130504448|NCT02753075|469815056|FG002|Overall Study|Physician Decision|0|||
130504449|NCT00930644|469815061|FG000|Overall Study|Withdrawal by Subject|4|||
130731160|NCT01427608|470637327|FG000|Overall Study|Death|1|||
130731161|NCT01427608|470637328|FG001|Overall Study|Death|0|||
130731162|NCT01427608|470637327|FG000|Overall Study|Withdrawal by Subject|7|||
130731163|NCT01427608|470637328|FG001|Overall Study|Withdrawal by Subject|3|||
130731164|NCT01427608|470637327|FG000|Overall Study|Relapsed-all cause|13|||
130731165|NCT01427608|470637328|FG001|Overall Study|Relapsed-all cause|34|||
130731166|NCT01427608|470637327|FG000|Overall Study|Events not attributed to study meds|0|||
130731167|NCT01427608|470637328|FG001|Overall Study|Events not attributed to study meds|1|||
130731168|NCT03993379|470637329|FG000|Overall Study|The study was terminated early due to business decision.|0|||
130731169|NCT03993379|470637330|FG001|Overall Study|The study was terminated early due to business decision.|2|||
130504450|NCT00930644|469815061|FG000|Overall Study|Physician Decision|2|||
130504451|NCT00930644|469815061|FG000|Overall Study|Death|1|||
130504452|NCT00930644|469815061|FG000|Overall Study|Adverse Event|16|||
130504453|NCT03265132|469815068|FG000|Overall Study|Adverse Event|0|||
130504454|NCT03265132|469815069|FG001|Overall Study|Adverse Event|1|||
130504455|NCT03265132|469815068|FG000|Overall Study|Lack of Efficacy|0|||
130504456|NCT03265132|469815069|FG001|Overall Study|Lack of Efficacy|2|||
130504457|NCT03265132|469815068|FG000|Overall Study|Progressive disease|0|||
130504458|NCT03265132|469815069|FG001|Overall Study|Progressive disease|2|||
130504459|NCT03265132|469815068|FG000|Overall Study|Withdrawal by Subject|0|||
130504460|NCT03265132|469815069|FG001|Overall Study|Withdrawal by Subject|1|||
130731170|NCT03993379|470637331|FG002|Overall Study|The study was terminated early due to business decision.|0|||
130731171|NCT03993379|470637332|FG003|Overall Study|The study was terminated early due to business decision.|0|||
130731172|NCT03993379|470637329|FG000|Overall Study|Withdrawal by Subject|0|||
130731173|NCT03993379|470637330|FG001|Overall Study|Withdrawal by Subject|1|||
130731174|NCT03993379|470637331|FG002|Overall Study|Withdrawal by Subject|0|||
130731175|NCT03993379|470637332|FG003|Overall Study|Withdrawal by Subject|0|||
130731176|NCT03790657|470637333|FG000|Overall Study|Adverse Event|1|||
130731177|NCT03790657|470637334|FG001|Overall Study|Adverse Event|1|||
130731178|NCT03790657|470637333|FG000|Overall Study|Withdrawal by Subject|1|||
130731179|NCT03790657|470637334|FG001|Overall Study|Withdrawal by Subject|1|||
130731180|NCT01807065|470637335|FG000|Overall Study|Receive no sip-T due to IV access|1|||
130731181|NCT01807065|470637336|FG001|Overall Study|Receive no sip-T due to IV access|1|||
130731182|NCT05246670|470637341|FG000|Overall Study|Withdrawal by Subject|2|||
130731183|NCT05246670|470637342|FG001|Overall Study|Withdrawal by Subject|3|||
130731184|NCT05246670|470637343|FG002|Overall Study|Withdrawal by Subject|0|||
130731185|NCT05246670|470637344|FG003|Overall Study|Withdrawal by Subject|1|||
130731186|NCT05246670|470637341|FG000|Overall Study|Adverse Event|0|||
130731187|NCT05246670|470637342|FG001|Overall Study|Adverse Event|0|||
130731188|NCT05246670|470637343|FG002|Overall Study|Adverse Event|1|||
130731189|NCT05246670|470637344|FG003|Overall Study|Adverse Event|0|||
130731190|NCT05246670|470637341|FG000|Overall Study|Physician Decision|1|||
130731191|NCT05246670|470637342|FG001|Overall Study|Physician Decision|0|||
130731192|NCT05246670|470637343|FG002|Overall Study|Physician Decision|0|||
130731193|NCT05246670|470637344|FG003|Overall Study|Physician Decision|0|||
130731194|NCT05246670|470637341|FG000|Overall Study|Protocol Violation|1|||
130731195|NCT05246670|470637342|FG001|Overall Study|Protocol Violation|0|||
130731196|NCT05246670|470637343|FG002|Overall Study|Protocol Violation|0|||
130731197|NCT05246670|470637344|FG003|Overall Study|Protocol Violation|0|||
130731198|NCT00799058|470637345|FG000|Overall Study|Withdrawal by Subject|2|||
130731199|NCT00799058|470637346|FG001|Overall Study|Withdrawal by Subject|2|||
130731200|NCT00799058|470637347|FG002|Overall Study|Withdrawal by Subject|2|||
130731201|NCT00799058|470637345|FG000|Overall Study|Lost to Follow-up|1|||
130731202|NCT00799058|470637346|FG001|Overall Study|Lost to Follow-up|2|||
130731203|NCT00799058|470637347|FG002|Overall Study|Lost to Follow-up|1|||
130731204|NCT00799058|470637345|FG000|Overall Study|Adverse Event|0|||
130731205|NCT00799058|470637346|FG001|Overall Study|Adverse Event|2|||
130731206|NCT00799058|470637347|FG002|Overall Study|Adverse Event|0|||
130731207|NCT00799058|470637345|FG000|Overall Study|Pregnancy|1|||
130731208|NCT00799058|470637346|FG001|Overall Study|Pregnancy|0|||
130731209|NCT00799058|470637347|FG002|Overall Study|Pregnancy|0|||
130731210|NCT00799058|470637345|FG000|Overall Study|Not adherent|3|||
130731211|NCT00799058|470637346|FG001|Overall Study|Not adherent|2|||
130731212|NCT00799058|470637347|FG002|Overall Study|Not adherent|1|||
130731213|NCT00799058|470637345|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130731214|NCT00799058|470637346|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130731215|NCT00799058|470637347|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
130731216|NCT00799058|470637345|FG000|Overall Study|IP dispensing error|1|||
130731217|NCT00799058|470637346|FG001|Overall Study|IP dispensing error|0|||
130731218|NCT00799058|470637347|FG002|Overall Study|IP dispensing error|0|||
130731219|NCT00799058|470637345|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130731220|NCT00799058|470637346|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
130731221|NCT00799058|470637347|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130731222|NCT00799058|470637345|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
130731223|NCT00799058|470637346|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
130731224|NCT00799058|470637347|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
130731225|NCT00799058|470637345|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130731226|NCT00799058|470637346|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130731227|NCT00799058|470637347|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
130731228|NCT00799058|470637345|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
130731229|NCT00799058|470637346|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130731230|NCT00799058|470637347|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130731231|NCT03639779|470637348|FG000|Overall Study|Lost to Follow-up|1|||
130731232|NCT02088697|470637349|FG000|Period I|Physician Decision|1|||
130504461|NCT03909100|469815070|FG000|Overall Study|Protocol Deviation|2|||
130504462|NCT03909100|469815070|FG000|Overall Study|Technical Problems|4|||
130731233|NCT02088697|470637350|FG001|Period I|Physician Decision|4|||
130731234|NCT02088697|470637349|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
130731235|NCT02088697|470637350|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
130731236|NCT00462904|470637351|FG000|Overall Study|Lost to Follow-up|1|||
130731237|NCT05219448|470637352|FG000|Overall Study|Lost to Follow-up|9|||
130731238|NCT05219448|470637353|FG001|Overall Study|Lost to Follow-up|0|||
130731239|NCT00911300|470637357|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
130731240|NCT00911300|470637358|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
130731241|NCT00911300|470637357|FG000|Overall Study|Death|1|||
130731242|NCT00911300|470637358|FG001|Overall Study|Death|0|||
130731243|NCT00911300|470637357|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
130731244|NCT00911300|470637358|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
130731245|NCT00911300|470637357|FG000|Overall Study|Adverse Event|14|||
130731246|NCT00911300|470637358|FG001|Overall Study|Adverse Event|6|||
130731247|NCT00911300|470637357|FG000|Overall Study|Protocol Violation|3|||
130731248|NCT00911300|470637358|FG001|Overall Study|Protocol Violation|2|||
130731249|NCT00911300|470637357|FG000|Overall Study|Consent Withdrawn|4|||
130731250|NCT00911300|470637358|FG001|Overall Study|Consent Withdrawn|12|||
130731251|NCT00911300|470637357|FG000|Overall Study|Coronary Angiography Performed|1|||
130731252|NCT00911300|470637358|FG001|Overall Study|Coronary Angiography Performed|0|||
130731253|NCT00911300|470637357|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130731254|NCT00911300|470637358|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130731255|NCT00911300|470637357|FG000|Overall Study|Received Commercial Treatment|1|||
130731256|NCT00911300|470637358|FG001|Overall Study|Received Commercial Treatment|0|||
130731257|NCT00911300|470637357|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
130731258|NCT00911300|470637358|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
130731259|NCT00911300|470637357|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130731260|NCT00911300|470637358|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130731261|NCT00911300|470637357|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
130731262|NCT00911300|470637358|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
130731263|NCT00911300|470637357|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
130731264|NCT00911300|470637358|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
130731265|NCT00911300|470637357|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
130731266|NCT00911300|470637358|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
130731267|NCT00911300|470637357|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
130731268|NCT00911300|470637358|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
130731269|NCT00911300|470637357|FG000|Overall Study|International Normalized Ratio Too High|0|||
130731270|NCT00911300|470637358|FG001|Overall Study|International Normalized Ratio Too High|1|||
130731271|NCT00911300|470637357|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
130731272|NCT00911300|470637358|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
130731273|NCT00911300|470637357|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
130731274|NCT00911300|470637358|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
130731275|NCT00911300|470637357|FG000|Overall Study|Physician Decision|0|||
130731276|NCT00911300|470637358|FG001|Overall Study|Physician Decision|1|||
130731277|NCT00911300|470637357|FG000|Overall Study|Treatment Stopped by Mistake|0|||
130731278|NCT00911300|470637358|FG001|Overall Study|Treatment Stopped by Mistake|1|||
130731279|NCT00911300|470637357|FG000|Overall Study|Randomized; No Study Medication Received|0|||
130731280|NCT00911300|470637358|FG001|Overall Study|Randomized; No Study Medication Received|2|||
130731281|NCT02287922|470637359|FG000|Overall Study|Adverse Event|1|||
130731282|NCT02287922|470637360|FG001|Overall Study|Adverse Event|1|||
130731283|NCT02287922|470637361|FG002|Overall Study|Adverse Event|3|||
130731284|NCT02287922|470637362|FG003|Overall Study|Adverse Event|4|||
130731285|NCT02287922|470637359|FG000|Overall Study|Withdrawal by Subject|1|||
130731286|NCT02287922|470637360|FG001|Overall Study|Withdrawal by Subject|1|||
130731287|NCT02287922|470637361|FG002|Overall Study|Withdrawal by Subject|1|||
130731288|NCT02287922|470637362|FG003|Overall Study|Withdrawal by Subject|2|||
130731289|NCT02287922|470637359|FG000|Overall Study|Lost to Follow-up|0|||
130731290|NCT02287922|470637360|FG001|Overall Study|Lost to Follow-up|0|||
130731291|NCT02287922|470637361|FG002|Overall Study|Lost to Follow-up|1|||
130731292|NCT02287922|470637362|FG003|Overall Study|Lost to Follow-up|0|||
130731293|NCT02287922|470637359|FG000|Overall Study|Sponsor's decision|0|||
130731294|NCT02287922|470637360|FG001|Overall Study|Sponsor's decision|0|||
130731295|NCT02287922|470637361|FG002|Overall Study|Sponsor's decision|0|||
130731296|NCT02287922|470637362|FG003|Overall Study|Sponsor's decision|1|||
130731297|NCT02287922|470637359|FG000|Overall Study|Other|1|||
130731298|NCT02287922|470637360|FG001|Overall Study|Other|0|||
130731299|NCT02287922|470637361|FG002|Overall Study|Other|2|||
130731300|NCT02287922|470637362|FG003|Overall Study|Other|0|||
130731301|NCT04152291|470637363|FG000|Overall Study|Covid-19 restrictions|27|||
130731302|NCT04152291|470637363|FG000|Overall Study|Withdrawal by Subject|3|||
130731303|NCT05124691|470637364|FG000|Phase II|Eligibility criteria|0|||
130731304|NCT05124691|470637365|FG001|Phase II|Eligibility criteria|1|||
130731305|NCT05124691|470637366|FG002|Phase II|Eligibility criteria|0|||
130731306|NCT05124691|470637364|FG000|Phase II|Withdrawal by Subject|6|||
130731307|NCT05124691|470637365|FG001|Phase II|Withdrawal by Subject|2|||
130731308|NCT05124691|470637366|FG002|Phase II|Withdrawal by Subject|3|||
130731309|NCT05124691|470637364|FG000|Phase III|Withdrawal by Subject|6|||
130731310|NCT05124691|470637365|FG001|Phase III|Withdrawal by Subject|4|||
130731311|NCT05124691|470637366|FG002|Phase III|Withdrawal by Subject|4|||
130731312|NCT05124691|470637364|FG000|Phase III|Lost to Follow-up|1|||
130731313|NCT05124691|470637365|FG001|Phase III|Lost to Follow-up|0|||
130731314|NCT05124691|470637366|FG002|Phase III|Lost to Follow-up|0|||
130731315|NCT04223752|470637369|FG000|Overall Study|Participant enrolled in error|0|||
130731316|NCT04223752|470637370|FG001|Overall Study|Participant enrolled in error|0|||
130731317|NCT04223752|470637371|FG002|Overall Study|Participant enrolled in error|0|||
130731318|NCT04223752|470637372|FG003|Overall Study|Participant enrolled in error|0|||
130731319|NCT04223752|470637373|FG004|Overall Study|Participant enrolled in error|1|||
130731320|NCT04223752|470637369|FG000|Overall Study|Death|0|||
130731321|NCT04223752|470637370|FG001|Overall Study|Death|0|||
130731322|NCT04223752|470637371|FG002|Overall Study|Death|0|||
130731323|NCT04223752|470637372|FG003|Overall Study|Death|2|||
130731324|NCT04223752|470637373|FG004|Overall Study|Death|1|||
130731325|NCT04739800|470637374|FG000|Overall Study|Adverse Event|2|||
130731326|NCT04739800|470637375|FG001|Overall Study|Adverse Event|1|||
130731327|NCT04739800|470637376|FG002|Overall Study|Adverse Event|4|||
130731328|NCT04739800|470637377|FG003|Overall Study|Adverse Event|5|||
130731329|NCT04739800|470637374|FG000|Overall Study|Never Treated|2|||
130731330|NCT04739800|470637375|FG001|Overall Study|Never Treated|0|||
130731331|NCT04739800|470637376|FG002|Overall Study|Never Treated|1|||
130731332|NCT04739800|470637377|FG003|Overall Study|Never Treated|1|||
130731333|NCT04739800|470637374|FG000|Overall Study|On Treatment|5|||
130731334|NCT04739800|470637375|FG001|Overall Study|On Treatment|9|||
130731335|NCT04739800|470637376|FG002|Overall Study|On Treatment|9|||
130731336|NCT04739800|470637377|FG003|Overall Study|On Treatment|9|||
130731337|NCT04739800|470637374|FG000|Overall Study|Symptomatic Deterioration|1|||
130731338|NCT04739800|470637375|FG001|Overall Study|Symptomatic Deterioration|1|||
130731339|NCT04739800|470637376|FG002|Overall Study|Symptomatic Deterioration|3|||
130731340|NCT04739800|470637377|FG003|Overall Study|Symptomatic Deterioration|0|||
130731341|NCT04739800|470637374|FG000|Overall Study|Withdrawal by Subject|1|||
130731342|NCT04739800|470637375|FG001|Overall Study|Withdrawal by Subject|2|||
130731343|NCT04739800|470637376|FG002|Overall Study|Withdrawal by Subject|1|||
130731344|NCT04739800|470637377|FG003|Overall Study|Withdrawal by Subject|3|||
130731345|NCT04739800|470637374|FG000|Overall Study|Other Reason|1|||
130731346|NCT04739800|470637375|FG001|Overall Study|Other Reason|3|||
130731347|NCT04739800|470637376|FG002|Overall Study|Other Reason|5|||
130731348|NCT04739800|470637377|FG003|Overall Study|Other Reason|4|||
130731349|NCT02779855|470637378|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
130731350|NCT02779855|470637379|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
130731351|NCT02779855|470637380|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
130731352|NCT00447993|470637381|FG000|Overall Study|Lost to Follow-up|0|||
130731353|NCT00447993|470637382|FG001|Overall Study|Lost to Follow-up|0|||
130731354|NCT00447993|470637383|FG002|Overall Study|Lost to Follow-up|2|||
130731355|NCT00447993|470637384|FG003|Overall Study|Lost to Follow-up|2|||
130731356|NCT00447993|470637381|FG000|Overall Study|Withdrawal by Subject|0|||
130731357|NCT00447993|470637382|FG001|Overall Study|Withdrawal by Subject|0|||
130731358|NCT00447993|470637383|FG002|Overall Study|Withdrawal by Subject|2|||
130731359|NCT00447993|470637384|FG003|Overall Study|Withdrawal by Subject|2|||
130731360|NCT02503787|470637389|FG000|Enrollment|Withdrawal by Subject|6|||
130731361|NCT02503787|470637389|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
130731362|NCT02503787|470637389|FG000|Enrollment|Physician Decision|2|||
130731363|NCT02503787|470637389|FG000|Enrollment|Insurance issue|2|||
130731364|NCT02503787|470637389|FG000|Enrollment|Lost to Follow-up|1|||
130731365|NCT02503787|470637389|FG000|Enrollment|Study closure|1|||
130731366|NCT02503787|470637389|FG000|Enrollment|Adverse Event|1|||
130731367|NCT02503787|470637389|FG000|Enrollment|Protocol Violation|1|||
130731368|NCT02503787|470637389|FG000|Enrollment|Inability to implant system|1|||
130731369|NCT02503787|470637389|FG000|Enrollment|Unable to be programmed|1|||
130731370|NCT02503787|470637389|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
130731371|NCT02503787|470637389|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
130731372|NCT02503787|470637389|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
130731373|NCT02503787|470637389|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
130731374|NCT02503787|470637389|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
130731375|NCT02503787|470637389|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
130731376|NCT04787627|470637390|FG000|Overall Study|Withdrawal by Subject|3|||
130731377|NCT04787627|470637391|FG001|Overall Study|Withdrawal by Subject|0|||
130731378|NCT04787627|470637390|FG000|Overall Study|Physician Decision|2|||
130731379|NCT04787627|470637391|FG001|Overall Study|Physician Decision|0|||
130731380|NCT04787627|470637390|FG000|Overall Study|Excluded|0|||
130731381|NCT04787627|470637391|FG001|Overall Study|Excluded|1|||
130731382|NCT00174954|470637393|FG000|Overall Study|Adverse Event|2|||
130731383|NCT00174954|470637393|FG000|Overall Study|No tophi found in MRI|1|||
130731384|NCT00174954|470637393|FG000|Overall Study|Physician Decision|1|||
130731385|NCT00839254|470637394|FG000|Overall Study|Protocol Violation|0|||
130731386|NCT00839254|470637395|FG001|Overall Study|Protocol Violation|1|||
130731387|NCT00839254|470637396|FG002|Overall Study|Protocol Violation|1|||
130731388|NCT00839254|470637397|FG003|Overall Study|Protocol Violation|1|||
130731389|NCT00839254|470637398|FG004|Overall Study|Protocol Violation|0|||
130504463|NCT03909100|469815070|FG000|Overall Study|Withdrawal by Subject|4|||
130504464|NCT03909100|469815070|FG000|Overall Study|Lost to Follow-up|1|||
130504465|NCT03909100|469815070|FG000|Overall Study|Reason not Specified|4|||
130504466|NCT00088166|469815071|FG000|Overall Study|Adverse Event|11|||
130504467|NCT00088166|469815072|FG001|Overall Study|Adverse Event|9|||
130504468|NCT00088166|469815071|FG000|Overall Study|Death|3|||
130504469|NCT00088166|469815072|FG001|Overall Study|Death|1|||
130504470|NCT00088166|469815071|FG000|Overall Study|Lost to Follow-up|0|||
130504471|NCT00088166|469815072|FG001|Overall Study|Lost to Follow-up|1|||
130504472|NCT00088166|469815071|FG000|Overall Study|Physician Decision|4|||
130504473|NCT00088166|469815072|FG001|Overall Study|Physician Decision|1|||
130504474|NCT00088166|469815071|FG000|Overall Study|Protocol Violation|1|||
130504475|NCT00088166|469815072|FG001|Overall Study|Protocol Violation|5|||
130504476|NCT00088166|469815071|FG000|Overall Study|Patient deterioration|29|||
130504477|NCT00088166|469815072|FG001|Overall Study|Patient deterioration|39|||
130504478|NCT00088166|469815071|FG000|Overall Study|Withdrawal by Subject|5|||
130504479|NCT00088166|469815072|FG001|Overall Study|Withdrawal by Subject|5|||
130504480|NCT02671266|469815073|FG000|Overall Study|Withdrawal by Subject|1|||
130504481|NCT02671266|469815074|FG001|Overall Study|Withdrawal by Subject|1|||
130504482|NCT00666705|469815075|FG000|Overall Study|Withdrawal by Subject|1|||
130504483|NCT01109979|469815076|FG000|Overall Study|Physician Decision|2|||
130504484|NCT01109979|469815077|FG001|Overall Study|Physician Decision|0|||
130504485|NCT01109979|469815076|FG000|Overall Study|Withdrawal by Subject|0|||
130504486|NCT01109979|469815077|FG001|Overall Study|Withdrawal by Subject|1|||
130504487|NCT00807599|469815078|FG000|Overall Study|Not treated on protocol study|0|||
130504488|NCT00807599|469815079|FG001|Overall Study|Not treated on protocol study|0|||
130504489|NCT00807599|469815080|FG002|Overall Study|Not treated on protocol study|2|||
130504490|NCT00807599|469815078|FG000|Overall Study|Adverse Event|0|||
130504491|NCT00807599|469815079|FG001|Overall Study|Adverse Event|0|||
130504492|NCT00807599|469815080|FG002|Overall Study|Adverse Event|5|||
130504493|NCT00807599|469815078|FG000|Overall Study|Inadequate response to induction|0|||
130504494|NCT00807599|469815079|FG001|Overall Study|Inadequate response to induction|0|||
130504495|NCT00807599|469815080|FG002|Overall Study|Inadequate response to induction|9|||
130504496|NCT00807599|469815078|FG000|Overall Study|Withdrawal by Subject|0|||
130504497|NCT00807599|469815079|FG001|Overall Study|Withdrawal by Subject|0|||
130504498|NCT00807599|469815080|FG002|Overall Study|Withdrawal by Subject|1|||
130504499|NCT03456856|469815083|FG000|Overall Study|Lost to Follow-up|2|||
130504500|NCT03456856|469815083|FG000|Overall Study|Withdrawal by Subject|1|||
130504501|NCT02542696|469815086|FG000|Overall Study|Adverse Event|167|||
130504502|NCT02542696|469815086|FG000|Overall Study|Lack of Efficacy|26|||
130504503|NCT02542696|469815086|FG000|Overall Study|Lost to Follow-up|6|||
130566170|NCT03451851|470038240|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130566171|NCT03451851|470038233|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566172|NCT03451851|470038234|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566173|NCT03451851|470038235|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566174|NCT03451851|470038236|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566175|NCT03451851|470038237|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
130566176|NCT03451851|470038238|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566177|NCT03451851|470038239|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566178|NCT03451851|470038240|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130566179|NCT05885737|470038241|FG000|DB Period|Adverse Event|4|||
130566180|NCT05885737|470038242|FG001|DB Period|Adverse Event|4|||
130566181|NCT05885737|470038241|FG000|DB Period|Lost to Follow-up|0|||
130566182|NCT05885737|470038242|FG001|DB Period|Lost to Follow-up|1|||
130566183|NCT05885737|470038241|FG000|DB Period|Physician Decision|2|||
130566184|NCT05885737|470038242|FG001|DB Period|Physician Decision|0|||
130566185|NCT05885737|470038241|FG000|DB Period|Withdrawal by Subject|12|||
130566186|NCT05885737|470038242|FG001|DB Period|Withdrawal by Subject|6|||
130566187|NCT05885737|470038241|FG000|DB Period|Other: Unspecified|2|||
130566188|NCT05885737|470038242|FG001|DB Period|Other: Unspecified|2|||
130566189|NCT05885737|470038241|FG000|OLE Period|Adverse Event|3|||
130566190|NCT05885737|470038242|FG001|OLE Period|Adverse Event|2|||
130566191|NCT05885737|470038241|FG000|OLE Period|Physician Decision|1|||
130566192|NCT05885737|470038242|FG001|OLE Period|Physician Decision|0|||
130566193|NCT05885737|470038241|FG000|OLE Period|Withdrawal by Subject|5|||
130566194|NCT05885737|470038242|FG001|OLE Period|Withdrawal by Subject|5|||
130566195|NCT05885737|470038241|FG000|OLE Period|Other: Unspecified|2|||
130566196|NCT05885737|470038242|FG001|OLE Period|Other: Unspecified|1|||
130566197|NCT04360551|470039487|FG000|Overall Study|Withdrawal by Subject|1|||
130566198|NCT04360551|470039488|FG001|Overall Study|Withdrawal by Subject|0|||
130566199|NCT00388973|470039493|FG000|Overall Study|Adverse Event|16|||
130566200|NCT00388973|470039494|FG001|Overall Study|Adverse Event|6|||
130566201|NCT00388973|470039493|FG000|Overall Study|Lack of Efficacy|1|||
130566202|NCT00388973|470039494|FG001|Overall Study|Lack of Efficacy|12|||
130566203|NCT00388973|470039493|FG000|Overall Study|Protocol Violation|3|||
130566204|NCT00388973|470039494|FG001|Overall Study|Protocol Violation|0|||
130566205|NCT00388973|470039493|FG000|Overall Study|Withdrawal by Subject|14|||
130566206|NCT00388973|470039494|FG001|Overall Study|Withdrawal by Subject|17|||
130566207|NCT00388973|470039493|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
130566208|NCT00388973|470039494|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
130566209|NCT00388973|470039493|FG000|Overall Study|Did not complete 61 days of treatment|5|||
130566210|NCT00388973|470039494|FG001|Overall Study|Did not complete 61 days of treatment|4|||
130566211|NCT00388973|470039493|FG000|Overall Study|Left region|0|||
130566212|NCT00388973|470039494|FG001|Overall Study|Left region|1|||
130566213|NCT00388973|470039493|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
130566214|NCT00388973|470039494|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
130566215|NCT00346073|470039509|FG000|Overall Study|Serious Adverse Event|2|||
130566216|NCT00346073|470039510|FG001|Overall Study|Serious Adverse Event|0|||
130566217|NCT00346073|470039509|FG000|Overall Study|Lost to Follow-up|39|||
130566218|NCT00346073|470039510|FG001|Overall Study|Lost to Follow-up|24|||
130566219|NCT03703882|470039515|FG000|Overall Study|Adverse Event|1|||
130566220|NCT03703882|470039516|FG001|Overall Study|Adverse Event|0|||
130566221|NCT03703882|470039515|FG000|Overall Study|Lost to Follow-up|0|||
130566222|NCT03703882|470039516|FG001|Overall Study|Lost to Follow-up|2|||
130566223|NCT03703882|470039515|FG000|Overall Study|Non-compliance with study drug|0|||
130566224|NCT03703882|470039516|FG001|Overall Study|Non-compliance with study drug|1|||
130566225|NCT03703882|470039515|FG000|Overall Study|Physician Decision|0|||
130566226|NCT03703882|470039516|FG001|Overall Study|Physician Decision|1|||
130566227|NCT03703882|470039515|FG000|Overall Study|Progressive disease|1|||
130566228|NCT03703882|470039516|FG001|Overall Study|Progressive disease|0|||
130566229|NCT03703882|470039515|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130566230|NCT03703882|470039516|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130566231|NCT03703882|470039515|FG000|Overall Study|Starting another treatment|0|||
130731390|NCT00839254|470637399|FG005|Overall Study|Protocol Violation|0|||
130731391|NCT00839254|470637400|FG006|Overall Study|Protocol Violation|1|||
130731392|NCT00839254|470637401|FG007|Overall Study|Protocol Violation|2|||
130731393|NCT00839254|470637394|FG000|Overall Study|Physician Decision|0|||
130731394|NCT00839254|470637395|FG001|Overall Study|Physician Decision|1|||
130731395|NCT00839254|470637396|FG002|Overall Study|Physician Decision|0|||
130731396|NCT00839254|470637397|FG003|Overall Study|Physician Decision|0|||
130731397|NCT00839254|470637398|FG004|Overall Study|Physician Decision|0|||
130731398|NCT00839254|470637399|FG005|Overall Study|Physician Decision|0|||
130731399|NCT00839254|470637400|FG006|Overall Study|Physician Decision|0|||
130731400|NCT00839254|470637401|FG007|Overall Study|Physician Decision|1|||
130731401|NCT00839254|470637394|FG000|Overall Study|Wrong treatment number allocation|0|||
130731402|NCT00839254|470637395|FG001|Overall Study|Wrong treatment number allocation|1|||
130566232|NCT03703882|470039516|FG001|Overall Study|Starting another treatment|1|||
130566233|NCT03703882|470039515|FG000|Overall Study|noncompliance with study procedures|0|||
130566234|NCT03703882|470039516|FG001|Overall Study|noncompliance with study procedures|1|||
130566235|NCT01617460|470039517|FG000|Overall Study|Adverse Event|10|||
130566236|NCT01617460|470039517|FG000|Overall Study|Physician Decision|16|||
130566237|NCT01617460|470039517|FG000|Overall Study|Protocol Violation|5|||
130566238|NCT01617460|470039517|FG000|Overall Study|Withdrawal by Subject|9|||
130566239|NCT00075023|470039524|FG000|Pilot Study|Physician Decision|1|||
130731403|NCT00839254|470637396|FG002|Overall Study|Wrong treatment number allocation|0|||
130504504|NCT02542696|469815086|FG000|Overall Study|Withdrawal by Subject|104|||
130504505|NCT02542696|469815086|FG000|Overall Study|Protocol Violation|5|||
130504506|NCT02542696|469815086|FG000|Overall Study|Death|8|||
130504507|NCT02542696|469815086|FG000|Overall Study|DECREASED OFF TIME|1|||
130504508|NCT02542696|469815086|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
130504509|NCT02542696|469815086|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
130504510|NCT02542696|469815086|FG000|Overall Study|MEDICAL HISTORY|1|||
130504511|NCT02542696|469815086|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
130504512|NCT02542696|469815086|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
130504513|NCT02542696|469815086|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
130504514|NCT02542696|469815086|FG000|Overall Study|SPONSOR DECISION|3|||
130504515|NCT02542696|469815086|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
130504516|NCT02542696|469815086|FG000|Overall Study|SUBJECT DECISION|2|||
130504517|NCT02137785|469815087|FG000|Overall Study|Lost to Follow-up|1|||
130504518|NCT02137785|469815088|FG001|Overall Study|Lost to Follow-up|0|||
130504519|NCT02137785|469815087|FG000|Overall Study|Withdrawal by Subject|1|||
130504520|NCT02137785|469815088|FG001|Overall Study|Withdrawal by Subject|4|||
130504521|NCT02137785|469815087|FG000|Overall Study|subject moved out of state|1|||
130504522|NCT02137785|469815088|FG001|Overall Study|subject moved out of state|0|||
130504523|NCT02825550|469815090|FG000|Overall Study|Physician Decision|1|||
130504524|NCT04085614|469815095|FG000|Overall Study|Protocol Violation|9|||
130504525|NCT04085614|469815096|FG001|Overall Study|Protocol Violation|6|||
130504526|NCT02399449|469815097|FG000|Overall Study|Withdrawal by Subject|3|||
130566240|NCT00075023|470039525|FG001|Pilot Study|Physician Decision|2|||
130566241|NCT00075023|470039524|FG000|Pilot Study|Withdrawal by Subject|1|||
130566242|NCT00075023|470039525|FG001|Pilot Study|Withdrawal by Subject|0|||
130566243|NCT04342871|470039526|FG000|Overall Study|Death|4|||
130731404|NCT00839254|470637397|FG003|Overall Study|Wrong treatment number allocation|0|||
130731405|NCT00839254|470637398|FG004|Overall Study|Wrong treatment number allocation|0|||
130731406|NCT00839254|470637399|FG005|Overall Study|Wrong treatment number allocation|1|||
130731407|NCT00839254|470637400|FG006|Overall Study|Wrong treatment number allocation|0|||
130731408|NCT00839254|470637401|FG007|Overall Study|Wrong treatment number allocation|0|||
130731409|NCT00839254|470637394|FG000|Overall Study|Adverse Event|12|||
130731410|NCT00839254|470637395|FG001|Overall Study|Adverse Event|6|||
130731411|NCT00839254|470637396|FG002|Overall Study|Adverse Event|3|||
130731412|NCT00839254|470637397|FG003|Overall Study|Adverse Event|5|||
130731413|NCT00839254|470637398|FG004|Overall Study|Adverse Event|2|||
130731414|NCT00839254|470637399|FG005|Overall Study|Adverse Event|1|||
130731415|NCT00839254|470637400|FG006|Overall Study|Adverse Event|0|||
130731416|NCT00839254|470637401|FG007|Overall Study|Adverse Event|1|||
130731417|NCT00839254|470637394|FG000|Overall Study|Withdrawal by Subject|87|||
130731418|NCT00839254|470637395|FG001|Overall Study|Withdrawal by Subject|53|||
130504527|NCT02399449|469815098|FG001|Overall Study|Withdrawal by Subject|9|||
130504528|NCT02399449|469815097|FG000|Overall Study|Physician Decision|0|||
130504529|NCT02399449|469815098|FG001|Overall Study|Physician Decision|1|||
130504530|NCT02516202|469815099|FG000|Overall Study|Withdrawal by Subject|1|||
130504531|NCT02516202|469815100|FG001|Overall Study|Withdrawal by Subject|0|||
130504532|NCT02516202|469815101|FG002|Overall Study|Withdrawal by Subject|1|||
130731419|NCT00839254|470637396|FG002|Overall Study|Withdrawal by Subject|54|||
130731420|NCT00839254|470637397|FG003|Overall Study|Withdrawal by Subject|32|||
130731421|NCT00839254|470637398|FG004|Overall Study|Withdrawal by Subject|27|||
130731422|NCT00839254|470637399|FG005|Overall Study|Withdrawal by Subject|15|||
130731423|NCT00839254|470637400|FG006|Overall Study|Withdrawal by Subject|22|||
130731424|NCT00839254|470637401|FG007|Overall Study|Withdrawal by Subject|9|||
130731425|NCT00839254|470637394|FG000|Overall Study|Wrong group allocation|0|||
130731426|NCT00839254|470637395|FG001|Overall Study|Wrong group allocation|0|||
130731427|NCT00839254|470637396|FG002|Overall Study|Wrong group allocation|0|||
130731428|NCT00839254|470637397|FG003|Overall Study|Wrong group allocation|0|||
130731429|NCT00839254|470637398|FG004|Overall Study|Wrong group allocation|0|||
130731430|NCT00839254|470637399|FG005|Overall Study|Wrong group allocation|0|||
130731431|NCT00839254|470637400|FG006|Overall Study|Wrong group allocation|1|||
130731432|NCT00839254|470637401|FG007|Overall Study|Wrong group allocation|0|||
130731433|NCT00839254|470637394|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
130731434|NCT00839254|470637395|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731435|NCT00839254|470637396|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731436|NCT00839254|470637397|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731437|NCT00839254|470637398|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731438|NCT00839254|470637399|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
130504533|NCT02516202|469815099|FG000|Overall Study|Lost to Follow-up|1|||
130504534|NCT02516202|469815100|FG001|Overall Study|Lost to Follow-up|1|||
130504535|NCT02516202|469815101|FG002|Overall Study|Lost to Follow-up|1|||
130504536|NCT02516202|469815099|FG000|Overall Study|Stopped Follow-up|0|||
130504537|NCT02516202|469815100|FG001|Overall Study|Stopped Follow-up|0|||
130504538|NCT02516202|469815101|FG002|Overall Study|Stopped Follow-up|1|||
130504539|NCT00337610|469815102|FG000|Overall Study|Adverse Event|2|||
130504540|NCT00337610|469815103|FG001|Overall Study|Adverse Event|2|||
130504541|NCT00337610|469815102|FG000|Overall Study|Death|0|||
130504542|NCT00337610|469815103|FG001|Overall Study|Death|1|||
130504543|NCT00337610|469815102|FG000|Overall Study|Lack of Efficacy|6|||
130504544|NCT00337610|469815103|FG001|Overall Study|Lack of Efficacy|3|||
130504545|NCT00337610|469815102|FG000|Overall Study|Lost to Follow-up|3|||
130504546|NCT00337610|469815103|FG001|Overall Study|Lost to Follow-up|3|||
130504547|NCT00337610|469815102|FG000|Overall Study|Withdrawal by Subject|6|||
130504548|NCT00337610|469815103|FG001|Overall Study|Withdrawal by Subject|5|||
130504549|NCT03979040|469815104|FG000|Overall Study|Withdrawal by Subject|24|||
130504550|NCT03979040|469815105|FG001|Overall Study|Withdrawal by Subject|32|||
130504551|NCT03979040|469815104|FG000|Overall Study|randomized but never started treatment|32|||
130504552|NCT03979040|469815105|FG001|Overall Study|randomized but never started treatment|39|||
130504553|NCT03979040|469815104|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
130504554|NCT03979040|469815105|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
130504555|NCT02102724|469815116|FG000|Overall Study|Lost to Follow-up|1|||
130504556|NCT02102724|469815117|FG001|Overall Study|Lost to Follow-up|0|||
130504557|NCT02102724|469815116|FG000|Overall Study|surgery for brain aneurysm|1|||
130504558|NCT02102724|469815117|FG001|Overall Study|surgery for brain aneurysm|1|||
130504559|NCT02203513|469815118|FG000|Overall Study|Refused further treatment|2|||
130504560|NCT02203513|469815119|FG001|Overall Study|Refused further treatment|0|||
130504561|NCT02203513|469815120|FG002|Overall Study|Refused further treatment|1|||
130504562|NCT02203513|469815121|FG003|Overall Study|Refused further treatment|0|||
130504563|NCT02203513|469815122|FG004|Overall Study|Refused further treatment|0|||
130504564|NCT02203513|469815118|FG000|Overall Study|Switched to alternative treatment|3|||
130504565|NCT02203513|469815119|FG001|Overall Study|Switched to alternative treatment|4|||
130504566|NCT02203513|469815120|FG002|Overall Study|Switched to alternative treatment|0|||
130504567|NCT02203513|469815121|FG003|Overall Study|Switched to alternative treatment|0|||
130504568|NCT02203513|469815122|FG004|Overall Study|Switched to alternative treatment|4|||
130504569|NCT02203513|469815118|FG000|Overall Study|Did not receive investigational product (IP)|0|||
130504570|NCT02203513|469815119|FG001|Overall Study|Did not receive investigational product (IP)|1|||
130504571|NCT02203513|469815120|FG002|Overall Study|Did not receive investigational product (IP)|0|||
130504572|NCT02203513|469815121|FG003|Overall Study|Did not receive investigational product (IP)|0|||
130504573|NCT02203513|469815122|FG004|Overall Study|Did not receive investigational product (IP)|0|||
130504574|NCT02203513|469815118|FG000|Overall Study|Death (unrelated to study therapy)|1|||
130504575|NCT02203513|469815119|FG001|Overall Study|Death (unrelated to study therapy)|3|||
130504576|NCT02203513|469815120|FG002|Overall Study|Death (unrelated to study therapy)|1|||
130504577|NCT02203513|469815121|FG003|Overall Study|Death (unrelated to study therapy)|0|||
130504578|NCT02203513|469815122|FG004|Overall Study|Death (unrelated to study therapy)|2|||
130504579|NCT02203513|469815118|FG000|Overall Study|Lost to Follow-up|0|||
130504580|NCT02203513|469815119|FG001|Overall Study|Lost to Follow-up|0|||
130504581|NCT02203513|469815120|FG002|Overall Study|Lost to Follow-up|1|||
130504582|NCT02203513|469815121|FG003|Overall Study|Lost to Follow-up|1|||
130504583|NCT02203513|469815122|FG004|Overall Study|Lost to Follow-up|0|||
130504584|NCT02008916|469815123|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
130504585|NCT02008916|469815124|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
130504586|NCT02008916|469815125|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
130504587|NCT02008916|469815123|FG000|Week 16 - 156|Adverse Event|4|||
130504588|NCT02008916|469815124|FG001|Week 16 - 156|Adverse Event|2|||
130504589|NCT02008916|469815125|FG002|Week 16 - 156|Adverse Event|3|||
130504590|NCT02008916|469815123|FG000|Week 16 - 156|Withdrawal by Subject|7|||
130566244|NCT04342871|470039526|FG000|Overall Study|Clinical deterioration/illness progression|2|||
130566245|NCT04342871|470039526|FG000|Overall Study|Did not complete baseline assessments|5|||
130566246|NCT04342871|470039526|FG000|Overall Study|Lost to Follow-up|13|||
130566247|NCT03670953|470039527|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
130566248|NCT03670953|470039528|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130566249|NCT03670953|470039529|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130566250|NCT03670953|470039530|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130566251|NCT03670953|470039527|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
130566252|NCT03670953|470039528|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130566253|NCT03670953|470039529|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130566254|NCT03670953|470039530|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130566255|NCT03670953|470039527|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
130566256|NCT03670953|470039528|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130566257|NCT03670953|470039529|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130566258|NCT03670953|470039530|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130566259|NCT03670953|470039527|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
130566260|NCT03670953|470039528|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130566261|NCT03670953|470039529|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130566262|NCT03670953|470039530|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130566263|NCT03670953|470039527|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
130566264|NCT03670953|470039528|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130566265|NCT03670953|470039529|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130566266|NCT03670953|470039530|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130566267|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130566268|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
130566269|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130566270|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130566271|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130566272|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
130566273|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130566274|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130566275|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130566276|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
130566277|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130566278|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130566279|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130566280|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
130566281|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130566282|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130566283|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130566284|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
130566285|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130566286|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130566287|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130566288|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
130566289|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130566290|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130731439|NCT00839254|470637400|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731440|NCT00839254|470637401|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731441|NCT00839254|470637394|FG000|Overall Study|Withdrawn due to non-compliance|2|||
130731442|NCT00839254|470637395|FG001|Overall Study|Withdrawn due to non-compliance|0|||
130731443|NCT00839254|470637396|FG002|Overall Study|Withdrawn due to non-compliance|0|||
130731444|NCT00839254|470637397|FG003|Overall Study|Withdrawn due to non-compliance|0|||
130731445|NCT00839254|470637398|FG004|Overall Study|Withdrawn due to non-compliance|0|||
130731446|NCT00839254|470637399|FG005|Overall Study|Withdrawn due to non-compliance|0|||
130731447|NCT00839254|470637400|FG006|Overall Study|Withdrawn due to non-compliance|0|||
130731448|NCT00839254|470637401|FG007|Overall Study|Withdrawn due to non-compliance|0|||
130731449|NCT00839254|470637394|FG000|Overall Study|Lost to Follow-up|51|||
130731450|NCT00839254|470637395|FG001|Overall Study|Lost to Follow-up|30|||
130731451|NCT00839254|470637396|FG002|Overall Study|Lost to Follow-up|32|||
130731452|NCT00839254|470637397|FG003|Overall Study|Lost to Follow-up|24|||
130731453|NCT00839254|470637398|FG004|Overall Study|Lost to Follow-up|8|||
130731454|NCT00839254|470637399|FG005|Overall Study|Lost to Follow-up|8|||
130731455|NCT00839254|470637400|FG006|Overall Study|Lost to Follow-up|4|||
130731456|NCT00839254|470637401|FG007|Overall Study|Lost to Follow-up|2|||
130731457|NCT00489827|470637404|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130731458|NCT00489827|470637405|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130731459|NCT00489827|470637404|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130731460|NCT00489827|470637405|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130731461|NCT02296931|470637406|FG000|Overall Study|Protocol Violation|0|||
130731462|NCT02296931|470637407|FG001|Overall Study|Protocol Violation|2|||
130504591|NCT02008916|469815124|FG001|Week 16 - 156|Withdrawal by Subject|3|||
130504592|NCT02008916|469815125|FG002|Week 16 - 156|Withdrawal by Subject|5|||
130504593|NCT02008916|469815123|FG000|Week 16 - 156|No longer requires treatment|0|||
130504594|NCT02008916|469815124|FG001|Week 16 - 156|No longer requires treatment|1|||
130566291|NCT03670953|470039527|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130566292|NCT03670953|470039528|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
130566293|NCT03670953|470039529|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130566294|NCT03670953|470039530|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130566295|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
130566296|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
130566297|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
130566298|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
130566299|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
130566300|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
130566301|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
130566302|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
130566303|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
130566304|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
130566305|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
130566306|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
130566307|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130566308|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130566309|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
130566310|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130566311|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
130566312|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
130566313|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
130566314|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
130566315|NCT03670953|470039527|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130566316|NCT03670953|470039528|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130566317|NCT03670953|470039529|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
130566318|NCT03670953|470039530|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130566319|NCT04179734|470039531|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
130566320|NCT04179734|470039532|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
130566321|NCT04179734|470039531|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
130566322|NCT04179734|470039532|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
130566323|NCT00666458|470039534|FG000|Overall Study|Adverse Event|8|||
130566324|NCT00666458|470039535|FG001|Overall Study|Adverse Event|7|||
130566325|NCT00666458|470039534|FG000|Overall Study|Withdrawal by Subject|5|||
130566326|NCT00666458|470039535|FG001|Overall Study|Withdrawal by Subject|4|||
130566327|NCT00666458|470039534|FG000|Overall Study|Lost to Follow-up|0|||
130566328|NCT00666458|470039535|FG001|Overall Study|Lost to Follow-up|3|||
130566329|NCT00666458|470039534|FG000|Overall Study|Administrative reason by sponsor|1|||
130566330|NCT00666458|470039535|FG001|Overall Study|Administrative reason by sponsor|1|||
130566331|NCT00666458|470039534|FG000|Overall Study|Incorrect enrollment|7|||
130566332|NCT00666458|470039535|FG001|Overall Study|Incorrect enrollment|1|||
130566333|NCT00666458|470039534|FG000|Overall Study|Study specific discontinuation criteria|14|||
130566334|NCT00666458|470039535|FG001|Overall Study|Study specific discontinuation criteria|7|||
130566335|NCT00666458|470039534|FG000|Overall Study|Severe non-compliance to the protocol|1|||
130566336|NCT00666458|470039535|FG001|Overall Study|Severe non-compliance to the protocol|1|||
130566337|NCT00666458|470039534|FG000|Overall Study|Safety reasons|1|||
130566338|NCT00666458|470039535|FG001|Overall Study|Safety reasons|0|||
130566339|NCT00666458|470039534|FG000|Overall Study|Medical history of anemia|1|||
130566340|NCT00666458|470039535|FG001|Overall Study|Medical history of anemia|0|||
130566341|NCT02222207|470039537|FG000|Overall Study|Death|1|||
130566342|NCT02222207|470039537|FG000|Overall Study|Other reasons|2|||
130566343|NCT02222207|470039537|FG000|Overall Study|Adverse Event|1|||
130566344|NCT02982954|470039538|FG000|Overall Study|Death|55|||
130566345|NCT02982954|470039539|FG001|Overall Study|Death|29|||
130566346|NCT02982954|470039540|FG002|Overall Study|Death|15|||
130566347|NCT02982954|470039541|FG003|Overall Study|Death|20|||
130566348|NCT02982954|470039538|FG000|Overall Study|Lost to Follow-up|2|||
130566349|NCT02982954|470039539|FG001|Overall Study|Lost to Follow-up|1|||
130566350|NCT02982954|470039540|FG002|Overall Study|Lost to Follow-up|0|||
130566351|NCT02982954|470039541|FG003|Overall Study|Lost to Follow-up|0|||
130566352|NCT02982954|470039538|FG000|Overall Study|Participant withdrew consent|7|||
130566353|NCT02982954|470039539|FG001|Overall Study|Participant withdrew consent|5|||
130566354|NCT02982954|470039540|FG002|Overall Study|Participant withdrew consent|1|||
130566355|NCT02982954|470039541|FG003|Overall Study|Participant withdrew consent|1|||
130566356|NCT02982954|470039538|FG000|Overall Study|Other reasons|42|||
130566357|NCT02982954|470039539|FG001|Overall Study|Other reasons|17|||
130566358|NCT02982954|470039540|FG002|Overall Study|Other reasons|12|||
130566359|NCT02982954|470039541|FG003|Overall Study|Other reasons|3|||
130566360|NCT02982954|470039538|FG000|Overall Study|Premature site closure|0|||
130504595|NCT02008916|469815125|FG002|Week 16 - 156|No longer requires treatment|0|||
130504596|NCT02008916|469815123|FG000|Week 16 - 156|Lost to Follow-up|5|||
130504597|NCT02008916|469815124|FG001|Week 16 - 156|Lost to Follow-up|0|||
130504598|NCT02008916|469815125|FG002|Week 16 - 156|Lost to Follow-up|0|||
130504599|NCT02008916|469815123|FG000|Week 16 - 156|Lack of Efficacy|3|||
130504600|NCT02008916|469815124|FG001|Week 16 - 156|Lack of Efficacy|5|||
130504601|NCT02008916|469815125|FG002|Week 16 - 156|Lack of Efficacy|2|||
130504602|NCT02008916|469815123|FG000|Week 16 - 156|Pregnancy|0|||
130504603|NCT02008916|469815124|FG001|Week 16 - 156|Pregnancy|1|||
130504604|NCT02008916|469815125|FG002|Week 16 - 156|Pregnancy|0|||
130504605|NCT02008916|469815123|FG000|Week 16 - 156|Physician Decision|0|||
130504606|NCT02008916|469815124|FG001|Week 16 - 156|Physician Decision|1|||
130504607|NCT02008916|469815125|FG002|Week 16 - 156|Physician Decision|0|||
130504608|NCT03803475|469815126|FG000|Overall Study|Physician Decision|1|||
130504609|NCT02513667|469815127|FG000|Overall Study|Withdrawal by Subject|0|||
130504610|NCT02513667|469815128|FG001|Overall Study|Withdrawal by Subject|1|||
130504611|NCT03347396|469815129|FG000|Part A (26 Weeks)|Adverse Event|1|||
130504612|NCT03347396|469815130|FG001|Part A (26 Weeks)|Adverse Event|0|||
130504613|NCT03347396|469815129|FG000|Part A (26 Weeks)|Death|0|||
130504614|NCT03347396|469815130|FG001|Part A (26 Weeks)|Death|1|||
130504615|NCT03347396|469815129|FG000|Part B (149 Weeks)|Adverse Event|1|||
130504616|NCT03347396|469815130|FG001|Part B (149 Weeks)|Adverse Event|1|||
130504617|NCT03347396|469815129|FG000|Part B (149 Weeks)|Death|1|||
130504618|NCT03347396|469815130|FG001|Part B (149 Weeks)|Death|0|||
130504619|NCT00392197|469815132|FG000|Overall Study|Adverse Event|4|||
130504620|NCT00392197|469815133|FG001|Overall Study|Adverse Event|12|||
130504621|NCT00392197|469815132|FG000|Overall Study|Lack of Efficacy|3|||
130504622|NCT00392197|469815133|FG001|Overall Study|Lack of Efficacy|4|||
130504623|NCT00392197|469815132|FG000|Overall Study|Lost to Follow-up|0|||
130504624|NCT00392197|469815133|FG001|Overall Study|Lost to Follow-up|1|||
130504625|NCT00392197|469815132|FG000|Overall Study|Physician Decision|3|||
130504626|NCT00392197|469815133|FG001|Overall Study|Physician Decision|2|||
130504627|NCT00392197|469815132|FG000|Overall Study|Protocol Violation|7|||
130504628|NCT00392197|469815133|FG001|Overall Study|Protocol Violation|5|||
130504629|NCT00392197|469815132|FG000|Overall Study|Withdrawal by Subject|4|||
130504630|NCT00392197|469815133|FG001|Overall Study|Withdrawal by Subject|6|||
130504631|NCT03060525|469815134|FG000|Overall Study|moved out of state|1|||
130504632|NCT03060525|469815135|FG001|Overall Study|moved out of state|1|||
130504633|NCT03060525|469815136|FG002|Overall Study|moved out of state|1|||
130504634|NCT03060525|469815137|FG003|Overall Study|moved out of state|1|||
130504635|NCT03060525|469815134|FG000|Overall Study|unable to meet time commitment required of study|2|||
130504636|NCT03060525|469815135|FG001|Overall Study|unable to meet time commitment required of study|3|||
130504637|NCT03060525|469815136|FG002|Overall Study|unable to meet time commitment required of study|3|||
130504638|NCT03060525|469815137|FG003|Overall Study|unable to meet time commitment required of study|1|||
130504639|NCT03060525|469815134|FG000|Overall Study|no longer interested in doing intervention|0|||
130504640|NCT03060525|469815135|FG001|Overall Study|no longer interested in doing intervention|0|||
130504641|NCT03060525|469815136|FG002|Overall Study|no longer interested in doing intervention|0|||
130504642|NCT03060525|469815137|FG003|Overall Study|no longer interested in doing intervention|1|||
130504643|NCT00912964|469815138|FG000|Overall Study|Eligibility criterion not met|1|||
130504644|NCT00912964|469815139|FG001|Overall Study|Eligibility criterion not met|1|||
130504645|NCT00912964|469815140|FG002|Overall Study|Eligibility criterion not met|0|||
130504646|NCT00912964|469815138|FG000|Overall Study|Adverse Event|15|||
130504647|NCT00912964|469815139|FG001|Overall Study|Adverse Event|18|||
130504648|NCT00912964|469815140|FG002|Overall Study|Adverse Event|12|||
130504649|NCT00912964|469815138|FG000|Overall Study|Lack of Efficacy|11|||
130504650|NCT00912964|469815139|FG001|Overall Study|Lack of Efficacy|4|||
130504651|NCT00912964|469815140|FG002|Overall Study|Lack of Efficacy|3|||
130504652|NCT00912964|469815138|FG000|Overall Study|Withdrawal by Subject|20|||
130504653|NCT00912964|469815139|FG001|Overall Study|Withdrawal by Subject|12|||
130504654|NCT00912964|469815140|FG002|Overall Study|Withdrawal by Subject|18|||
130504655|NCT00912964|469815138|FG000|Overall Study|Lost to Follow-up|4|||
130504656|NCT00912964|469815139|FG001|Overall Study|Lost to Follow-up|3|||
130504657|NCT00912964|469815140|FG002|Overall Study|Lost to Follow-up|3|||
130504658|NCT00912964|469815138|FG000|Overall Study|Protocol Violation|5|||
130504659|NCT00912964|469815139|FG001|Overall Study|Protocol Violation|3|||
130504660|NCT00912964|469815140|FG002|Overall Study|Protocol Violation|8|||
130504661|NCT00912964|469815138|FG000|Overall Study|Taking exclusionary medications|7|||
130504662|NCT00912964|469815139|FG001|Overall Study|Taking exclusionary medications|4|||
130504663|NCT00912964|469815140|FG002|Overall Study|Taking exclusionary medications|8|||
130504664|NCT00912964|469815138|FG000|Overall Study|Medical History|1|||
130504665|NCT00912964|469815139|FG001|Overall Study|Medical History|0|||
130504666|NCT00912964|469815140|FG002|Overall Study|Medical History|0|||
130504667|NCT00912964|469815138|FG000|Overall Study|Non-compliance with study procedures|2|||
130504668|NCT00912964|469815139|FG001|Overall Study|Non-compliance with study procedures|0|||
130504669|NCT00912964|469815140|FG002|Overall Study|Non-compliance with study procedures|0|||
130504670|NCT00912964|469815138|FG000|Overall Study|Violation of exclusion criterion|0|||
130504671|NCT00912964|469815139|FG001|Overall Study|Violation of exclusion criterion|0|||
130504672|NCT00912964|469815140|FG002|Overall Study|Violation of exclusion criterion|2|||
130504673|NCT00912964|469815138|FG000|Overall Study|Randomized but never received study drug|0|||
130504674|NCT00912964|469815139|FG001|Overall Study|Randomized but never received study drug|1|||
130504675|NCT00912964|469815140|FG002|Overall Study|Randomized but never received study drug|0|||
130504676|NCT04919499|469815144|FG000|Overall Study|Adverse Event|0|||
130504677|NCT04919499|469815145|FG001|Overall Study|Adverse Event|0|||
130504678|NCT04919499|469815146|FG002|Overall Study|Adverse Event|0|||
130504679|NCT04919499|469815147|FG003|Overall Study|Adverse Event|0|||
130504680|NCT04919499|469815148|FG004|Overall Study|Adverse Event|2|||
130504681|NCT04919499|469815144|FG000|Overall Study|Not treated|0|||
130504682|NCT04919499|469815145|FG001|Overall Study|Not treated|0|||
130504683|NCT04919499|469815146|FG002|Overall Study|Not treated|0|||
130504684|NCT04919499|469815147|FG003|Overall Study|Not treated|1|||
130504685|NCT04919499|469815148|FG004|Overall Study|Not treated|0|||
130504686|NCT04369664|469816834|FG000|Overall Study|Physician Decision|1|||
130504687|NCT04369664|469816835|FG001|Overall Study|Physician Decision|0|||
130504688|NCT03840200|469816838|FG000|Overall Study|Death|6|||
130504689|NCT03840200|469816839|FG001|Overall Study|Death|3|||
130504690|NCT03840200|469816840|FG002|Overall Study|Death|6|||
130504691|NCT03840200|469816841|FG003|Overall Study|Death|10|||
130504692|NCT03840200|469816838|FG000|Overall Study|Reason Not Specified|2|||
130504693|NCT03840200|469816839|FG001|Overall Study|Reason Not Specified|2|||
130504694|NCT03840200|469816840|FG002|Overall Study|Reason Not Specified|1|||
130504695|NCT03840200|469816841|FG003|Overall Study|Reason Not Specified|15|||
130504696|NCT03840200|469816838|FG000|Overall Study|Physician Decision|0|||
130504697|NCT03840200|469816839|FG001|Overall Study|Physician Decision|0|||
130504698|NCT03840200|469816840|FG002|Overall Study|Physician Decision|0|||
130504699|NCT03840200|469816841|FG003|Overall Study|Physician Decision|2|||
130504700|NCT03840200|469816838|FG000|Overall Study|Progressive Disease|0|||
130504701|NCT03840200|469816839|FG001|Overall Study|Progressive Disease|0|||
130504702|NCT03840200|469816840|FG002|Overall Study|Progressive Disease|0|||
130504703|NCT03840200|469816841|FG003|Overall Study|Progressive Disease|1|||
130504704|NCT03840200|469816838|FG000|Overall Study|Withdrawal by Subject|0|||
130504705|NCT03840200|469816839|FG001|Overall Study|Withdrawal by Subject|1|||
130504706|NCT03840200|469816840|FG002|Overall Study|Withdrawal by Subject|0|||
130504707|NCT03840200|469816841|FG003|Overall Study|Withdrawal by Subject|2|||
130504708|NCT05522777|469816842|FG000|Overall Study|Lack of Efficacy|1|||
130504709|NCT05522777|469816842|FG000|Overall Study|Withdrawal by Subject|1|||
130504710|NCT05487300|469816845|FG000|Overall Study|Withdrawal by Subject|1|||
130504711|NCT05487300|469816846|FG001|Overall Study|Withdrawal by Subject|0|||
130504712|NCT05006703|469816847|FG000|Overall Study|Withdrawal by Subject|1|||
130504713|NCT05006703|469816848|FG001|Overall Study|Withdrawal by Subject|0|||
130504714|NCT05006703|469816847|FG000|Overall Study|Lost to Follow-up|13|||
130504715|NCT05006703|469816848|FG001|Overall Study|Lost to Follow-up|5|||
130504716|NCT04620733|469816849|FG000|Overall Study|Adverse Event|4|||
130504717|NCT04620733|469816850|FG001|Overall Study|Adverse Event|3|||
130504718|NCT04620733|469816849|FG000|Overall Study|Withdrawal by Subject|2|||
130504719|NCT04620733|469816850|FG001|Overall Study|Withdrawal by Subject|5|||
130504720|NCT04620733|469816849|FG000|Overall Study|Lost to Follow-up|1|||
130504721|NCT04620733|469816850|FG001|Overall Study|Lost to Follow-up|1|||
130504722|NCT04620733|469816849|FG000|Overall Study|Protocol Deviation|1|||
130504723|NCT04620733|469816850|FG001|Overall Study|Protocol Deviation|1|||
130504724|NCT04620733|469816849|FG000|Overall Study|Reason Not Specified|0|||
130504725|NCT04620733|469816850|FG001|Overall Study|Reason Not Specified|1|||
130504726|NCT02507297|469816853|FG000|Overall Study|Withdrawal by Subject|1|||
130504727|NCT02507297|469816854|FG001|Overall Study|Withdrawal by Subject|0|||
130504728|NCT02507297|469816853|FG000|Overall Study|Lost to Follow-up|0|||
130504729|NCT02507297|469816854|FG001|Overall Study|Lost to Follow-up|1|||
130504730|NCT02489799|469816855|FG000|Overall Study|Lost to Follow-up|4|||
130504731|NCT02489799|469816856|FG001|Overall Study|Lost to Follow-up|1|||
130504732|NCT02489799|469816855|FG000|Overall Study|Failure to Maintain Eligibility|4|||
130504733|NCT02489799|469816856|FG001|Overall Study|Failure to Maintain Eligibility|6|||
130504734|NCT02489799|469816855|FG000|Overall Study|Withdrawal by Subject|1|||
130504735|NCT02489799|469816856|FG001|Overall Study|Withdrawal by Subject|1|||
130504736|NCT02489799|469816855|FG000|Overall Study|Death|0|||
130504737|NCT02489799|469816856|FG001|Overall Study|Death|1|||
130504738|NCT04909593|469816857|FG000|Overall Study|Withdrawal by Subject|1|||
130504739|NCT01018992|469816858|FG000|Overall Study|Adverse Event|8|||
130504740|NCT01018992|469816859|FG001|Overall Study|Adverse Event|3|||
130504741|NCT01018992|469816858|FG000|Overall Study|Withdrawal by Subject|3|||
130504742|NCT01018992|469816859|FG001|Overall Study|Withdrawal by Subject|8|||
130504743|NCT01018992|469816858|FG000|Overall Study|Protocol Violation|0|||
130504744|NCT01018992|469816859|FG001|Overall Study|Protocol Violation|4|||
130504745|NCT01018992|469816858|FG000|Overall Study|Lost to Follow-up|5|||
130504746|NCT01018992|469816859|FG001|Overall Study|Lost to Follow-up|1|||
130504747|NCT03029585|469816860|FG000|Overall Study|Death|1|||
130504748|NCT03029585|469816861|FG001|Overall Study|Death|1|||
130504749|NCT03029585|469816860|FG000|Overall Study|Withdrawal by Subject|1|||
130504750|NCT03029585|469816861|FG001|Overall Study|Withdrawal by Subject|0|||
130504751|NCT02092285|469816862|FG000|Induction Phase|Adverse Event|7|||
130504752|NCT02092285|469816862|FG000|Induction Phase|Physician Decision|4|||
130504753|NCT02092285|469816862|FG000|Induction Phase|Pregnancy|1|||
130504754|NCT02092285|469816862|FG000|Induction Phase|Relapse/Recurrence|7|||
130504755|NCT02092285|469816862|FG000|Induction Phase|Withdrawal by Subject|2|||
130504756|NCT02092285|469816862|FG000|Induction Phase|Lack of Efficacy|14|||
130504757|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
130504758|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
130504759|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
130504760|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
130504761|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
130504762|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
130504763|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
130504764|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
130504765|NCT02092285|469816862|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
130504766|NCT01825785|469816863|FG000|Overall Study|Adverse Event|0|||
130504767|NCT01825785|469816864|FG001|Overall Study|Adverse Event|0|||
130504768|NCT01825785|469816865|FG002|Overall Study|Adverse Event|0|||
130504769|NCT01825785|469816866|FG003|Overall Study|Adverse Event|0|||
130504770|NCT01825785|469816867|FG004|Overall Study|Adverse Event|1|||
130504771|NCT01825785|469816868|FG005|Overall Study|Adverse Event|0|||
130504772|NCT01825785|469816869|FG006|Overall Study|Adverse Event|0|||
130504773|NCT01825785|469816863|FG000|Overall Study|Withdrawal by Subject|0|||
130504774|NCT01825785|469816864|FG001|Overall Study|Withdrawal by Subject|0|||
130504775|NCT01825785|469816865|FG002|Overall Study|Withdrawal by Subject|0|||
130504776|NCT01825785|469816866|FG003|Overall Study|Withdrawal by Subject|0|||
130504777|NCT01825785|469816867|FG004|Overall Study|Withdrawal by Subject|1|||
130504778|NCT01825785|469816868|FG005|Overall Study|Withdrawal by Subject|1|||
130504779|NCT01825785|469816869|FG006|Overall Study|Withdrawal by Subject|0|||
130504780|NCT01304940|469816871|FG000|Overall Study|not meet symptom severity requirement|3|||
130504781|NCT01304940|469816872|FG001|Overall Study|not meet symptom severity requirement|0|||
130504782|NCT00278395|469816875|FG000|Overall Study|Adverse Event|2|||
130504783|NCT00278395|469816875|FG000|Overall Study|Nonevaluable|1|||
130504784|NCT00990184|469816879|FG000|Overall Study|Physician Decision|1|||
130504785|NCT01655498|469816880|FG000|Overall Study|Unrelated health issue|2|||
130504786|NCT01655498|469816880|FG000|Overall Study|Protocol Violation|2|||
130504787|NCT01655498|469816880|FG000|Overall Study|Withdrawal by Subject|1|||
130504788|NCT02784834|469816881|FG000|Overall Study|Lack of Efficacy|1|||
130504789|NCT01090739|469816882|FG000|Enrollment|Withdrawal by Subject|24|||
130504790|NCT01090739|469816882|FG000|Enrollment|Protocol Violation|14|||
130504791|NCT01090739|469816882|FG000|Enrollment|Lost to Follow-up|5|||
130504792|NCT01090739|469816882|FG000|Enrollment|Physician Decision|5|||
130504793|NCT01090739|469816882|FG000|Enrollment|Sponsor termination of site|4|||
130504794|NCT01090739|469816882|FG000|Enrollment|Study implant limit reached|2|||
130504795|NCT01090739|469816882|FG000|Enrollment|Adverse Event|1|||
130504796|NCT01090739|469816882|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
130504797|NCT01090739|469816882|FG000|12 Month Follow-up|Lost to Follow-up|1|||
130504798|NCT01090739|469816882|FG000|12 Month Follow-up|Physician Decision|1|||
130504799|NCT01090739|469816882|FG000|12 Month Follow-up|Death|1|||
130504800|NCT01090739|469816882|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
130504801|NCT01090739|469816882|FG000|24 Month Follow-up|Lost to Follow-up|1|||
130504802|NCT01090739|469816882|FG000|24 Month Follow-up|Death|1|||
130504803|NCT01090739|469816882|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
130504804|NCT01090739|469816882|FG000|36 Month Follow-up|Visit still pending|17|||
130504805|NCT00441168|469816883|FG000|Treatment Period|Death|3|||
130504806|NCT00441168|469816884|FG001|Treatment Period|Death|0|||
130504807|NCT00441168|469816883|FG000|Treatment Period|Adverse Event|1|||
130504808|NCT00441168|469816884|FG001|Treatment Period|Adverse Event|2|||
130504809|NCT00441168|469816883|FG000|Treatment Period|Progressive Disease|0|||
130504810|NCT00441168|469816884|FG001|Treatment Period|Progressive Disease|2|||
130504811|NCT00441168|469816883|FG000|Treatment Period|Protocol Violation|0|||
130504812|NCT00441168|469816884|FG001|Treatment Period|Protocol Violation|1|||
130504813|NCT00441168|469816883|FG000|Treatment Period|Lost to Follow-up|0|||
130504814|NCT00441168|469816884|FG001|Treatment Period|Lost to Follow-up|1|||
130504815|NCT00441168|469816883|FG000|Treatment Period|Withdrawal by Subject|3|||
130504816|NCT00441168|469816884|FG001|Treatment Period|Withdrawal by Subject|0|||
130504817|NCT00441168|469816883|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
130504818|NCT00441168|469816884|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
130504819|NCT00441168|469816883|FG000|Treatment Period|refractory disease|1|||
130504820|NCT00441168|469816884|FG001|Treatment Period|refractory disease|0|||
130504821|NCT00441168|469816883|FG000|Follow-up Period|Death|3|||
130504822|NCT00441168|469816884|FG001|Follow-up Period|Death|0|||
130504823|NCT00441168|469816883|FG000|Follow-up Period|Lost to Follow-up|5|||
130504824|NCT00441168|469816884|FG001|Follow-up Period|Lost to Follow-up|6|||
130504825|NCT00441168|469816883|FG000|Follow-up Period|Withdrawal by Subject|3|||
130504826|NCT00441168|469816884|FG001|Follow-up Period|Withdrawal by Subject|0|||
130504827|NCT00441168|469816883|FG000|Follow-up Period|Other|1|||
130504828|NCT00441168|469816884|FG001|Follow-up Period|Other|3|||
130504829|NCT01670877|469816886|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
130504830|NCT01670877|469816887|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
130504831|NCT01670877|469816888|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
130504832|NCT01670877|469816889|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
130504833|NCT01670877|469816890|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
130504834|NCT01670877|469816891|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
130504835|NCT01670877|469816886|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
130504836|NCT01670877|469816887|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
130504837|NCT01670877|469816888|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
130504838|NCT01670877|469816889|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
130504839|NCT01670877|469816890|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
130504840|NCT01670877|469816891|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
130504841|NCT01670877|469816886|FG000|Part I and Part 2|Grade 2 vomiting|0|||
130504842|NCT01670877|469816887|FG001|Part I and Part 2|Grade 2 vomiting|0|||
130504843|NCT01670877|469816888|FG002|Part I and Part 2|Grade 2 vomiting|0|||
130504844|NCT01670877|469816889|FG003|Part I and Part 2|Grade 2 vomiting|1|||
130504845|NCT01670877|469816890|FG004|Part I and Part 2|Grade 2 vomiting|0|||
130504846|NCT01670877|469816891|FG005|Part I and Part 2|Grade 2 vomiting|0|||
130504847|NCT01670877|469816886|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130504848|NCT01670877|469816887|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130504849|NCT01670877|469816888|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130504850|NCT01670877|469816889|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
130504851|NCT01670877|469816890|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130504852|NCT01670877|469816891|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130504853|NCT01670877|469816886|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
130504854|NCT01670877|469816887|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
130504855|NCT01670877|469816888|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
130504856|NCT01670877|469816889|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
130504857|NCT01670877|469816890|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
130504858|NCT01670877|469816891|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
130504859|NCT03693989|469816892|FG000|Overall Study|Protocol Violation|3|||
130504860|NCT03693989|469816893|FG001|Overall Study|Protocol Violation|4|||
130504861|NCT03146845|469816894|FG000|Overall Study|Reference ulcer healed|1|||
130504862|NCT03146845|469816895|FG001|Overall Study|Reference ulcer healed|0|||
130504863|NCT03146845|469816894|FG000|Overall Study|Physician Decision|1|||
130504864|NCT03146845|469816895|FG001|Overall Study|Physician Decision|0|||
130504865|NCT03146845|469816894|FG000|Overall Study|Adverse Event|1|||
130504866|NCT03146845|469816895|FG001|Overall Study|Adverse Event|0|||
130504867|NCT03146845|469816894|FG000|Overall Study|Withdrawal by Subject|2|||
130504868|NCT03146845|469816895|FG001|Overall Study|Withdrawal by Subject|0|||
130504869|NCT03146845|469816894|FG000|Overall Study|Noncompliance|0|||
130504870|NCT03146845|469816895|FG001|Overall Study|Noncompliance|1|||
130504871|NCT03146845|469816894|FG000|Overall Study|Protocol Violation|0|||
130504872|NCT03146845|469816895|FG001|Overall Study|Protocol Violation|2|||
130504873|NCT03146845|469816894|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
130504874|NCT03146845|469816895|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
130504875|NCT00113529|469816898|FG000|Overall Study|Adverse Event|4|||
130504876|NCT00113529|469816898|FG000|Overall Study|Lack of Efficacy|20|||
130504877|NCT00113529|469816898|FG000|Overall Study|Decision of sponsor|6|||
130566361|NCT02982954|470039539|FG001|Overall Study|Premature site closure|0|||
130504878|NCT00113529|469816898|FG000|Overall Study|Withdrawal by Subject|4|||
130504879|NCT01535261|469816899|FG000|Overall Study|Physician Decision|8|||
130504880|NCT01535261|469816899|FG000|Overall Study|Protocol Violation|3|||
130504881|NCT01535261|469816899|FG000|Overall Study|Death|5|||
130504882|NCT01535261|469816899|FG000|Overall Study|Lost to Follow-up|8|||
130504883|NCT01535261|469816899|FG000|Overall Study|Withdrawal by Subject|14|||
130504884|NCT01535261|469816899|FG000|Overall Study|Adverse Event|12|||
130504885|NCT01757288|469816902|FG000|Overall Study|Consent withdrawal|0|||
130504886|NCT01757288|469816903|FG001|Overall Study|Consent withdrawal|4|||
130504887|NCT01757288|469816904|FG002|Overall Study|Consent withdrawal|4|||
130504888|NCT01757288|469816902|FG000|Overall Study|Patient off study, IRB hold.|0|||
130504889|NCT01757288|469816903|FG001|Overall Study|Patient off study, IRB hold.|0|||
130504890|NCT01757288|469816904|FG002|Overall Study|Patient off study, IRB hold.|1|||
130504891|NCT01757288|469816902|FG000|Overall Study|Patient death prior to starting treatment|0|||
130504892|NCT01757288|469816903|FG001|Overall Study|Patient death prior to starting treatment|0|||
130504893|NCT01757288|469816904|FG002|Overall Study|Patient death prior to starting treatment|1|||
130504894|NCT01757288|469816902|FG000|Overall Study|Wrong medication administered|0|||
130504895|NCT01757288|469816903|FG001|Overall Study|Wrong medication administered|1|||
130504896|NCT01757288|469816904|FG002|Overall Study|Wrong medication administered|0|||
130504897|NCT01757288|469816902|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
130504898|NCT01757288|469816903|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
130504899|NCT01757288|469816904|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
130504900|NCT01757288|469816902|FG000|Overall Study|Not meeting protocol constraints|0|||
130504901|NCT01757288|469816903|FG001|Overall Study|Not meeting protocol constraints|1|||
130504902|NCT01757288|469816904|FG002|Overall Study|Not meeting protocol constraints|1|||
130504903|NCT01757288|469816902|FG000|Overall Study|Multiple missed appointments|0|||
130504904|NCT01757288|469816903|FG001|Overall Study|Multiple missed appointments|1|||
130504905|NCT01757288|469816904|FG002|Overall Study|Multiple missed appointments|0|||
130504906|NCT01757288|469816902|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
130504907|NCT01757288|469816903|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
130504908|NCT01757288|469816904|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
130504909|NCT01757288|469816902|FG000|Overall Study|>2 weeks treatment break|0|||
130504910|NCT01757288|469816903|FG001|Overall Study|>2 weeks treatment break|0|||
130504911|NCT01757288|469816904|FG002|Overall Study|>2 weeks treatment break|1|||
130504912|NCT00042939|469816908|FG000|Overall Study|Adverse Event|6|||
130504913|NCT00042939|469816909|FG001|Overall Study|Adverse Event|7|||
130504914|NCT00042939|469816908|FG000|Overall Study|Death|3|||
130504915|NCT00042939|469816909|FG001|Overall Study|Death|2|||
130504916|NCT00042939|469816908|FG000|Overall Study|Withdrawal by Subject|3|||
130504917|NCT00042939|469816909|FG001|Overall Study|Withdrawal by Subject|4|||
130504918|NCT00042939|469816908|FG000|Overall Study|Other disease|1|||
130504919|NCT00042939|469816909|FG001|Overall Study|Other disease|0|||
130504920|NCT00042939|469816908|FG000|Overall Study|Ineligible|2|||
130504921|NCT00042939|469816909|FG001|Overall Study|Ineligible|2|||
130504922|NCT00042939|469816908|FG000|Overall Study|Deterioration of health|3|||
130504923|NCT00042939|469816909|FG001|Overall Study|Deterioration of health|4|||
130504924|NCT00042939|469816908|FG000|Overall Study|QOL diminished|1|||
130504925|NCT00042939|469816909|FG001|Overall Study|QOL diminished|0|||
130504926|NCT00042939|469816908|FG000|Overall Study|Rising ca 19-9|1|||
130504927|NCT00042939|469816909|FG001|Overall Study|Rising ca 19-9|0|||
130731463|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|3|||
130731464|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|2|||
130731465|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|1|||
130731466|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|1|||
130731467|NCT01377012|470637409|FG000|Core Study|Study terminated by Sponsor|47|||
130731468|NCT01377012|470637410|FG001|Core Study|Study terminated by Sponsor|54|||
130731469|NCT01377012|470637411|FG002|Core Study|Study terminated by Sponsor|46|||
130731470|NCT01377012|470637409|FG000|Core Study|Technical problems|1|||
130731471|NCT01377012|470637410|FG001|Core Study|Technical problems|0|||
130731472|NCT01377012|470637411|FG002|Core Study|Technical problems|0|||
130731473|NCT01377012|470637409|FG000|Core Study|Withdrawal by Subject|15|||
130504928|NCT00042939|469816908|FG000|Overall Study|Patient non-compliance|1|||
130504929|NCT00042939|469816909|FG001|Overall Study|Patient non-compliance|0|||
130504930|NCT00042939|469816908|FG000|Overall Study|Still on treatment|1|||
130504931|NCT00042939|469816909|FG001|Overall Study|Still on treatment|0|||
130504932|NCT00042939|469816908|FG000|Overall Study|Treatment break > 4 weeks|0|||
130504933|NCT00042939|469816909|FG001|Overall Study|Treatment break > 4 weeks|1|||
130504934|NCT00042939|469816908|FG000|Overall Study|Did not start treatment|2|||
130504935|NCT00042939|469816909|FG001|Overall Study|Did not start treatment|1|||
130504936|NCT03349476|469816910|FG000|Overall Study|Physician Decision|3|||
130731474|NCT01377012|470637410|FG001|Core Study|Withdrawal by Subject|23|||
130504937|NCT00795639|469816911|FG000|Overall Study|Death|1|||
130504938|NCT00795639|469816912|FG001|Overall Study|Death|6|||
130731475|NCT01377012|470637411|FG002|Core Study|Withdrawal by Subject|18|||
130504939|NCT00795639|469816911|FG000|Overall Study|Withdrawal by Subject|1|||
130504940|NCT00795639|469816912|FG001|Overall Study|Withdrawal by Subject|3|||
130504941|NCT00795639|469816911|FG000|Overall Study|Pregnancy|1|||
130504942|NCT00795639|469816912|FG001|Overall Study|Pregnancy|0|||
130504943|NCT00795639|469816911|FG000|Overall Study|Adverse Event|5|||
130504944|NCT00795639|469816912|FG001|Overall Study|Adverse Event|2|||
130504945|NCT00795639|469816911|FG000|Overall Study|Other|0|||
130504946|NCT00795639|469816912|FG001|Overall Study|Other|2|||
130504947|NCT00795639|469816911|FG000|Overall Study|Terminated by sponsor|13|||
130504948|NCT00795639|469816912|FG001|Overall Study|Terminated by sponsor|12|||
130566362|NCT02982954|470039540|FG002|Overall Study|Premature site closure|0|||
130504949|NCT00795639|469816911|FG000|Overall Study|Randomized and not treated|0|||
130504950|NCT00795639|469816912|FG001|Overall Study|Randomized and not treated|1|||
130504951|NCT02525744|469816913|FG000|Period 1|Physician Decision|0|||
130566363|NCT02982954|470039541|FG003|Overall Study|Premature site closure|1|||
130566364|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
130566365|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
130566366|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
130566367|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130566368|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130566369|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130566370|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Death|2|||
130566371|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Death|0|||
130566372|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
130566373|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
130566374|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
130566375|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130566376|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
130566377|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130566378|NCT02603120|470039542|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
130566379|NCT02603120|470039543|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
130566380|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
130566381|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
130566382|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
130566383|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
130566384|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
130566385|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
130566386|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
130566387|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
130566388|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
130566389|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
130566390|NCT02603120|470039542|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
130566391|NCT02603120|470039543|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
130566392|NCT00176605|470039546|FG000|Overall Study|Withdrawal by Subject|2|||
130566393|NCT01321710|470039547|FG000|Overall Study|Lost to Follow-up|4|||
130566394|NCT01321710|470039548|FG001|Overall Study|Lost to Follow-up|5|||
130566395|NCT01321710|470039549|FG002|Overall Study|Lost to Follow-up|0|||
130566396|NCT01227187|470039550|FG000|Overall Study|Physician Decision|0|||
130566397|NCT01227187|470039551|FG001|Overall Study|Physician Decision|0|||
130566398|NCT01227187|470039552|FG002|Overall Study|Physician Decision|0|||
130566399|NCT01227187|470039553|FG003|Overall Study|Physician Decision|1|||
130566400|NCT01761292|470039554|FG000|Part 1|Adverse Event|1|||
130566401|NCT01761292|470039554|FG000|Part 1|not receiving treatment in Part 1|1|||
130566402|NCT01761292|470039554|FG000|Extension 1|Withdrawal by Subject|1|||
130566403|NCT00840086|470039555|FG000|Overall Study|Adverse Event|1|||
130566404|NCT00840086|470039555|FG000|Overall Study|Protocol Violation|2|||
130566405|NCT00840086|470039555|FG000|Overall Study|Lost to Follow-up|1|||
130566406|NCT03332498|470039556|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
130566407|NCT03332498|470039557|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
130566408|NCT03332498|470039558|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
130566409|NCT04036708|470039559|FG000|Overall Study|Lost to Follow-up|14|||
130566410|NCT04036708|470039560|FG001|Overall Study|Lost to Follow-up|4|||
130566411|NCT04036708|470039561|FG002|Overall Study|Lost to Follow-up|14|||
130566412|NCT04036708|470039562|FG003|Overall Study|Lost to Follow-up|4|||
130566413|NCT01444742|470039564|FG000|Overall Study|Death|1|||
130566414|NCT02535715|470039565|FG000|Overall Study|Withdrawal by Subject|0|||
130566415|NCT02535715|470039566|FG001|Overall Study|Withdrawal by Subject|0|||
130566416|NCT02535715|470039567|FG002|Overall Study|Withdrawal by Subject|1|||
130566417|NCT00909181|470039568|FG000|Overall Study|Lost to Follow-up|39|||
130566418|NCT00909181|470039569|FG001|Overall Study|Lost to Follow-up|18|||
130566419|NCT00909181|470039570|FG002|Overall Study|Lost to Follow-up|33|||
130566420|NCT02349048|470039572|FG000|Overall Study|Withdrawal by Subject|4|||
130504952|NCT02525744|469816914|FG001|Period 1|Physician Decision|0|||
130504953|NCT02525744|469816915|FG002|Period 1|Physician Decision|1|||
130504954|NCT02525744|469816916|FG003|Period 1|Physician Decision|0|||
130504955|NCT02525744|469816913|FG000|Period 3|Adverse Event|0|||
130504956|NCT02525744|469816914|FG001|Period 3|Adverse Event|1|||
130504957|NCT02525744|469816915|FG002|Period 3|Adverse Event|0|||
130504958|NCT02525744|469816916|FG003|Period 3|Adverse Event|0|||
130504959|NCT02525744|469816913|FG000|Period 4|Withdrawal by Subject|1|||
130504960|NCT02525744|469816914|FG001|Period 4|Withdrawal by Subject|0|||
130504961|NCT02525744|469816915|FG002|Period 4|Withdrawal by Subject|0|||
130504962|NCT02525744|469816916|FG003|Period 4|Withdrawal by Subject|0|||
130504963|NCT02525744|469816913|FG000|Period 5|Physician Decision|1|||
130504964|NCT02525744|469816914|FG001|Period 5|Physician Decision|0|||
130504965|NCT02525744|469816915|FG002|Period 5|Physician Decision|0|||
130504966|NCT02525744|469816916|FG003|Period 5|Physician Decision|0|||
130504967|NCT00879710|469816919|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
130504968|NCT00879710|469816920|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
130504969|NCT00879710|469816921|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
130504970|NCT00879710|469816922|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
130504971|NCT00879710|469816919|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
130504972|NCT00879710|469816920|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
130504973|NCT00879710|469816921|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
130504974|NCT00879710|469816922|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
130504975|NCT01777932|469816923|FG000|Overall Study|Disease progression|136|||
130504976|NCT01777932|469816923|FG000|Overall Study|Death|3|||
130504977|NCT01777932|469816923|FG000|Overall Study|Adverse Event|34|||
130504978|NCT01777932|469816923|FG000|Overall Study|Lost to Follow-up|3|||
130504979|NCT01777932|469816923|FG000|Overall Study|Investigator decision|10|||
130504980|NCT01777932|469816923|FG000|Overall Study|Reimbursement limit|9|||
130504981|NCT01777932|469816923|FG000|Overall Study|Patient refused further treatment|10|||
130504982|NCT01930188|469816927|FG000|Overall Study|unclassified|4|||
130504983|NCT01930188|469816928|FG001|Overall Study|unclassified|5|||
130504984|NCT01930188|469816929|FG002|Overall Study|unclassified|3|||
130504985|NCT01930188|469816927|FG000|Overall Study|Missing follow-up information|2|||
130504986|NCT01930188|469816928|FG001|Overall Study|Missing follow-up information|2|||
130504987|NCT01930188|469816929|FG002|Overall Study|Missing follow-up information|3|||
130504988|NCT01930188|469816927|FG000|Overall Study|Lost to Follow-up|5|||
130504989|NCT01930188|469816928|FG001|Overall Study|Lost to Follow-up|2|||
130504990|NCT01930188|469816929|FG002|Overall Study|Lost to Follow-up|2|||
130504991|NCT01930188|469816927|FG000|Overall Study|Death|2|||
130504992|NCT01930188|469816928|FG001|Overall Study|Death|1|||
130504993|NCT01930188|469816929|FG002|Overall Study|Death|3|||
130504994|NCT01930188|469816927|FG000|Overall Study|Withdrawal by Subject|9|||
130504995|NCT01930188|469816928|FG001|Overall Study|Withdrawal by Subject|11|||
130504996|NCT01930188|469816929|FG002|Overall Study|Withdrawal by Subject|8|||
130504997|NCT02514824|469816930|FG000|Overall Study|Withdrawal by Subject|1|||
130731476|NCT01377012|470637409|FG000|Core Study|Protocol Violation|7|||
130731477|NCT01377012|470637410|FG001|Core Study|Protocol Violation|3|||
130731478|NCT01377012|470637411|FG002|Core Study|Protocol Violation|2|||
130731479|NCT01377012|470637409|FG000|Core Study|Pregnancy|0|||
130731480|NCT01377012|470637410|FG001|Core Study|Pregnancy|0|||
130731481|NCT01377012|470637411|FG002|Core Study|Pregnancy|1|||
130731482|NCT01377012|470637409|FG000|Core Study|Physician Decision|5|||
130731483|NCT01377012|470637410|FG001|Core Study|Physician Decision|4|||
130731484|NCT01377012|470637411|FG002|Core Study|Physician Decision|10|||
130731485|NCT01377012|470637409|FG000|Core Study|Non-Compliant with study treatment|0|||
130731486|NCT01377012|470637410|FG001|Core Study|Non-Compliant with study treatment|0|||
130731487|NCT01377012|470637411|FG002|Core Study|Non-Compliant with study treatment|1|||
130731488|NCT01377012|470637409|FG000|Core Study|No Longer require treatment|0|||
130731489|NCT01377012|470637410|FG001|Core Study|No Longer require treatment|0|||
130731490|NCT01377012|470637411|FG002|Core Study|No Longer require treatment|1|||
130731491|NCT01377012|470637409|FG000|Core Study|Lost to Follow-up|7|||
130731492|NCT01377012|470637410|FG001|Core Study|Lost to Follow-up|5|||
130731493|NCT01377012|470637411|FG002|Core Study|Lost to Follow-up|4|||
130731494|NCT01377012|470637409|FG000|Core Study|Lack of Efficacy|41|||
130731495|NCT01377012|470637410|FG001|Core Study|Lack of Efficacy|28|||
130504998|NCT02514824|469816931|FG001|Overall Study|Withdrawal by Subject|0|||
130504999|NCT02514824|469816932|FG002|Overall Study|Withdrawal by Subject|0|||
130505000|NCT02514824|469816933|FG003|Overall Study|Withdrawal by Subject|0|||
130505001|NCT02514824|469816930|FG000|Overall Study|Dose-Limiting Toxicity|0|||
130505002|NCT02514824|469816931|FG001|Overall Study|Dose-Limiting Toxicity|1|||
130505003|NCT02514824|469816932|FG002|Overall Study|Dose-Limiting Toxicity|0|||
130505004|NCT02514824|469816933|FG003|Overall Study|Dose-Limiting Toxicity|0|||
130505005|NCT00696241|469816934|FG000|Overall Study|Adverse Event|11|||
130731496|NCT01377012|470637411|FG002|Core Study|Lack of Efficacy|37|||
130731497|NCT01377012|470637409|FG000|Core Study|Death|1|||
130731498|NCT01377012|470637410|FG001|Core Study|Death|1|||
130505006|NCT00696241|469816935|FG001|Overall Study|Adverse Event|3|||
130505007|NCT00696241|469816936|FG002|Overall Study|Adverse Event|6|||
130505008|NCT00696241|469816937|FG003|Overall Study|Adverse Event|4|||
130505009|NCT00696241|469816938|FG004|Overall Study|Adverse Event|5|||
130731499|NCT01377012|470637411|FG002|Core Study|Death|1|||
130505010|NCT00696241|469816934|FG000|Overall Study|Protocol Violation|1|||
130505011|NCT00696241|469816935|FG001|Overall Study|Protocol Violation|1|||
130505012|NCT00696241|469816936|FG002|Overall Study|Protocol Violation|2|||
130505013|NCT00696241|469816937|FG003|Overall Study|Protocol Violation|0|||
130505014|NCT00696241|469816938|FG004|Overall Study|Protocol Violation|3|||
130505015|NCT00696241|469816934|FG000|Overall Study|Lost to Follow-up|1|||
130505016|NCT00696241|469816935|FG001|Overall Study|Lost to Follow-up|4|||
130505017|NCT00696241|469816936|FG002|Overall Study|Lost to Follow-up|1|||
130505018|NCT00696241|469816937|FG003|Overall Study|Lost to Follow-up|2|||
130505019|NCT00696241|469816938|FG004|Overall Study|Lost to Follow-up|0|||
130505020|NCT00696241|469816934|FG000|Overall Study|Withdrawal by Subject|4|||
130505021|NCT00696241|469816935|FG001|Overall Study|Withdrawal by Subject|8|||
130505022|NCT00696241|469816936|FG002|Overall Study|Withdrawal by Subject|6|||
130505023|NCT00696241|469816937|FG003|Overall Study|Withdrawal by Subject|1|||
130505024|NCT00696241|469816938|FG004|Overall Study|Withdrawal by Subject|0|||
130505025|NCT00696241|469816934|FG000|Overall Study|Lack of Efficacy|1|||
130505026|NCT00696241|469816935|FG001|Overall Study|Lack of Efficacy|5|||
130505027|NCT00696241|469816936|FG002|Overall Study|Lack of Efficacy|4|||
130505028|NCT00696241|469816937|FG003|Overall Study|Lack of Efficacy|5|||
130505029|NCT00696241|469816938|FG004|Overall Study|Lack of Efficacy|3|||
130505030|NCT00696241|469816934|FG000|Overall Study|Other|6|||
130505031|NCT00696241|469816935|FG001|Overall Study|Other|1|||
130505032|NCT00696241|469816936|FG002|Overall Study|Other|5|||
130505033|NCT00696241|469816937|FG003|Overall Study|Other|2|||
130505034|NCT00696241|469816938|FG004|Overall Study|Other|1|||
130505035|NCT00090519|469816946|FG000|Overall Study|Adverse Event|5|||
130505036|NCT00090519|469816947|FG001|Overall Study|Adverse Event|4|||
130505037|NCT00090519|469816946|FG000|Overall Study|Death|9|||
130505038|NCT00090519|469816947|FG001|Overall Study|Death|9|||
130505039|NCT00090519|469816946|FG000|Overall Study|Lost to Follow-up|26|||
130505040|NCT00090519|469816947|FG001|Overall Study|Lost to Follow-up|29|||
130505041|NCT00090519|469816946|FG000|Overall Study|Withdrawal by Subject|28|||
130505042|NCT00090519|469816947|FG001|Overall Study|Withdrawal by Subject|29|||
130505043|NCT00090519|469816946|FG000|Overall Study|Physician Decision|2|||
130505044|NCT00090519|469816947|FG001|Overall Study|Physician Decision|3|||
130505045|NCT00090519|469816946|FG000|Overall Study|Sponsor Decision|3|||
130505046|NCT00090519|469816947|FG001|Overall Study|Sponsor Decision|1|||
130505047|NCT02161146|469816950|FG000|Overall Study|Adverse Event|1|||
130505048|NCT02161146|469816951|FG001|Overall Study|Adverse Event|1|||
130505049|NCT02161146|469816952|FG002|Overall Study|Adverse Event|0|||
130505050|NCT02161146|469816953|FG003|Overall Study|Adverse Event|1|||
130505051|NCT02161146|469816954|FG004|Overall Study|Adverse Event|0|||
130505052|NCT02161146|469816950|FG000|Overall Study|Lost to Follow-up|0|||
130505053|NCT02161146|469816951|FG001|Overall Study|Lost to Follow-up|1|||
130505054|NCT02161146|469816952|FG002|Overall Study|Lost to Follow-up|0|||
130505055|NCT02161146|469816953|FG003|Overall Study|Lost to Follow-up|0|||
130505056|NCT02161146|469816954|FG004|Overall Study|Lost to Follow-up|0|||
130505057|NCT02161146|469816950|FG000|Overall Study|Personal Reasons|0|||
130505058|NCT02161146|469816951|FG001|Overall Study|Personal Reasons|1|||
130505059|NCT02161146|469816952|FG002|Overall Study|Personal Reasons|0|||
130505060|NCT02161146|469816953|FG003|Overall Study|Personal Reasons|2|||
130505061|NCT02161146|469816954|FG004|Overall Study|Personal Reasons|1|||
130505062|NCT02161146|469816950|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130505063|NCT02161146|469816951|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130505064|NCT02161146|469816952|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130505065|NCT02161146|469816953|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130505066|NCT02161146|469816954|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130505067|NCT02613403|469816957|FG000|Overall Study|Lost to Follow-up|0|||
130505068|NCT02613403|469816958|FG001|Overall Study|Lost to Follow-up|1|||
130505069|NCT02613403|469816959|FG002|Overall Study|Lost to Follow-up|0|||
130505070|NCT02613403|469816960|FG003|Overall Study|Lost to Follow-up|0|||
130505071|NCT02613403|469816961|FG004|Overall Study|Lost to Follow-up|0|||
130505072|NCT02613403|469816957|FG000|Overall Study|Withdrawal by Subject|2|||
130505073|NCT02613403|469816958|FG001|Overall Study|Withdrawal by Subject|0|||
130505074|NCT02613403|469816959|FG002|Overall Study|Withdrawal by Subject|0|||
130505075|NCT02613403|469816960|FG003|Overall Study|Withdrawal by Subject|0|||
130505076|NCT02613403|469816961|FG004|Overall Study|Withdrawal by Subject|0|||
130505077|NCT02189759|469816962|FG000|Overall Study|Lost to Follow-up|0|||
130505078|NCT02189759|469816963|FG001|Overall Study|Lost to Follow-up|0|||
130505079|NCT02189759|469816964|FG002|Overall Study|Lost to Follow-up|2|||
130505080|NCT02189759|469816965|FG003|Overall Study|Lost to Follow-up|5|||
130505081|NCT01147471|469816966|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
130505082|NCT01147471|469816967|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
130505083|NCT01147471|469816966|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
130505084|NCT01147471|469816967|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
130505085|NCT01147471|469816966|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
130505086|NCT01147471|469816967|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
130505087|NCT01147471|469816966|FG000|3 Month Follow Up|Lost to Follow-up|1|||
130505088|NCT01147471|469816967|FG001|3 Month Follow Up|Lost to Follow-up|1|||
130505089|NCT01147471|469816966|FG000|3 Month Follow Up|Physician Decision|0|||
130505090|NCT01147471|469816967|FG001|3 Month Follow Up|Physician Decision|1|||
130505091|NCT01147471|469816966|FG000|6 Month Follow Up|Lost to Follow-up|4|||
130505092|NCT01147471|469816967|FG001|6 Month Follow Up|Lost to Follow-up|2|||
130505093|NCT00800176|469816972|FG000|Overall Study|Adverse Event|2|||
130505094|NCT00800176|469816973|FG001|Overall Study|Adverse Event|1|||
130505095|NCT00800176|469816974|FG002|Overall Study|Adverse Event|0|||
130505096|NCT00800176|469816975|FG003|Overall Study|Adverse Event|2|||
130505097|NCT00800176|469816976|FG004|Overall Study|Adverse Event|1|||
130505098|NCT00800176|469816977|FG005|Overall Study|Adverse Event|1|||
130505099|NCT00800176|469816972|FG000|Overall Study|Refused treatment|3|||
130505100|NCT00800176|469816973|FG001|Overall Study|Refused treatment|2|||
130505101|NCT00800176|469816974|FG002|Overall Study|Refused treatment|0|||
130505102|NCT00800176|469816975|FG003|Overall Study|Refused treatment|0|||
130505103|NCT00800176|469816976|FG004|Overall Study|Refused treatment|1|||
130505104|NCT00800176|469816977|FG005|Overall Study|Refused treatment|4|||
130505105|NCT00800176|469816972|FG000|Overall Study|Failure to return|3|||
130505106|NCT00800176|469816973|FG001|Overall Study|Failure to return|3|||
130505107|NCT00800176|469816974|FG002|Overall Study|Failure to return|0|||
130505108|NCT00800176|469816975|FG003|Overall Study|Failure to return|2|||
130505109|NCT00800176|469816976|FG004|Overall Study|Failure to return|0|||
130505110|NCT00800176|469816977|FG005|Overall Study|Failure to return|0|||
130505111|NCT00800176|469816972|FG000|Overall Study|Other|1|||
130505112|NCT00800176|469816973|FG001|Overall Study|Other|0|||
130505113|NCT00800176|469816974|FG002|Overall Study|Other|0|||
130505114|NCT00800176|469816975|FG003|Overall Study|Other|0|||
130505115|NCT00800176|469816976|FG004|Overall Study|Other|2|||
130505116|NCT00800176|469816977|FG005|Overall Study|Other|0|||
130505117|NCT01294644|469816985|FG000|Overall Study|Adverse Event|2|||
130505118|NCT01294644|469816986|FG001|Overall Study|Adverse Event|0|||
130505119|NCT01294644|469816987|FG002|Overall Study|Adverse Event|1|||
130505120|NCT01294644|469816985|FG000|Overall Study|Withdrawal by Subject|3|||
130505121|NCT01294644|469816986|FG001|Overall Study|Withdrawal by Subject|7|||
130505122|NCT01294644|469816987|FG002|Overall Study|Withdrawal by Subject|4|||
130505123|NCT01294644|469816985|FG000|Overall Study|Lost to Follow-up|3|||
130505124|NCT01294644|469816986|FG001|Overall Study|Lost to Follow-up|2|||
130505125|NCT01294644|469816987|FG002|Overall Study|Lost to Follow-up|5|||
130505126|NCT01294644|469816985|FG000|Overall Study|Miscellaneous Reason|2|||
130505127|NCT01294644|469816986|FG001|Overall Study|Miscellaneous Reason|1|||
130505128|NCT01294644|469816987|FG002|Overall Study|Miscellaneous Reason|4|||
130505129|NCT02188459|469816988|FG000|Overall Study|Lost to Follow-up|3|||
130505130|NCT02188459|469816989|FG001|Overall Study|Lost to Follow-up|4|||
130505131|NCT02188459|469816988|FG000|Overall Study|Early Termination|0|||
130505132|NCT02188459|469816989|FG001|Overall Study|Early Termination|3|||
130505133|NCT02548585|469816990|FG000|Overall Study|Withdrawal by Subject|0|||
130505134|NCT02548585|469816991|FG001|Overall Study|Withdrawal by Subject|0|||
130505135|NCT02548585|469816992|FG002|Overall Study|Withdrawal by Subject|0|||
130505136|NCT02548585|469816993|FG003|Overall Study|Withdrawal by Subject|0|||
130505137|NCT02548585|469816994|FG004|Overall Study|Withdrawal by Subject|0|||
130505138|NCT02548585|469816995|FG005|Overall Study|Withdrawal by Subject|1|||
130505139|NCT02548585|469816996|FG006|Overall Study|Withdrawal by Subject|0|||
130505140|NCT02548585|469816990|FG000|Overall Study|Lost to Follow-up|1|||
130505141|NCT02548585|469816991|FG001|Overall Study|Lost to Follow-up|0|||
130505142|NCT02548585|469816992|FG002|Overall Study|Lost to Follow-up|0|||
130505143|NCT02548585|469816993|FG003|Overall Study|Lost to Follow-up|0|||
130505144|NCT02548585|469816994|FG004|Overall Study|Lost to Follow-up|0|||
130505145|NCT02548585|469816995|FG005|Overall Study|Lost to Follow-up|0|||
130505146|NCT02548585|469816996|FG006|Overall Study|Lost to Follow-up|0|||
130566421|NCT02349048|470039573|FG001|Overall Study|Withdrawal by Subject|0|||
130566422|NCT02349048|470039572|FG000|Overall Study|Lost to Follow-up|1|||
130731500|NCT01377012|470637409|FG000|Core Study|Adverse Event|10|||
130731501|NCT01377012|470637410|FG001|Core Study|Adverse Event|14|||
130731502|NCT01377012|470637411|FG002|Core Study|Adverse Event|13|||
130731503|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
130731504|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130731505|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130731506|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
130731507|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
130731508|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
130731509|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
130731510|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
130731511|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
130505147|NCT02548585|469816990|FG000|Overall Study|Other|1|||
130505148|NCT02548585|469816991|FG001|Overall Study|Other|0|||
130505149|NCT02548585|469816992|FG002|Overall Study|Other|0|||
130505150|NCT02548585|469816993|FG003|Overall Study|Other|2|||
130505151|NCT02548585|469816994|FG004|Overall Study|Other|3|||
130505152|NCT02548585|469816995|FG005|Overall Study|Other|0|||
130731512|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
130566423|NCT02349048|470039573|FG001|Overall Study|Lost to Follow-up|0|||
130566424|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
130566425|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
130566426|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
130566427|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
130566428|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
130566429|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
130566430|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
130566431|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
130566432|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
130566433|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
130566434|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
130566435|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
130566436|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
130566437|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
130566438|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
130566439|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
130566440|NCT00094770|470039576|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
130566441|NCT00094770|470039577|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
130566442|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
130566443|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
130566444|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
130566445|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
130566446|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
130731513|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
130731514|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
130505153|NCT02548585|469816996|FG006|Overall Study|Other|1|||
130505154|NCT02548585|469816990|FG000|Overall Study|Randomized but not treated|0|||
130505155|NCT02548585|469816991|FG001|Overall Study|Randomized but not treated|0|||
130505156|NCT02548585|469816992|FG002|Overall Study|Randomized but not treated|0|||
130505157|NCT02548585|469816993|FG003|Overall Study|Randomized but not treated|0|||
130505158|NCT02548585|469816994|FG004|Overall Study|Randomized but not treated|0|||
130505159|NCT02548585|469816995|FG005|Overall Study|Randomized but not treated|1|||
130505160|NCT02548585|469816996|FG006|Overall Study|Randomized but not treated|0|||
130505161|NCT01986348|469816997|FG000|Overall Study|Death|8|||
130505162|NCT01986348|469816998|FG001|Overall Study|Death|22|||
130505163|NCT01986348|469816999|FG002|Overall Study|Death|10|||
130505164|NCT01986348|469817000|FG003|Overall Study|Death|21|||
130505165|NCT01986348|469816997|FG000|Overall Study|Lost to Follow-up|0|||
130505166|NCT01986348|469816998|FG001|Overall Study|Lost to Follow-up|0|||
130505167|NCT01986348|469816999|FG002|Overall Study|Lost to Follow-up|0|||
130505168|NCT01986348|469817000|FG003|Overall Study|Lost to Follow-up|2|||
130505169|NCT01986348|469816997|FG000|Overall Study|Physician Decision|0|||
130505170|NCT01986348|469816998|FG001|Overall Study|Physician Decision|0|||
130505171|NCT01986348|469816999|FG002|Overall Study|Physician Decision|0|||
130505172|NCT01986348|469817000|FG003|Overall Study|Physician Decision|1|||
130505173|NCT01986348|469816997|FG000|Overall Study|Progressive Disease|0|||
130505174|NCT01986348|469816998|FG001|Overall Study|Progressive Disease|0|||
130505175|NCT01986348|469816999|FG002|Overall Study|Progressive Disease|2|||
130505176|NCT01986348|469817000|FG003|Overall Study|Progressive Disease|0|||
130505177|NCT01986348|469816997|FG000|Overall Study|Withdrawal by Participant|0|||
130505178|NCT01986348|469816998|FG001|Overall Study|Withdrawal by Participant|1|||
130505179|NCT01986348|469816999|FG002|Overall Study|Withdrawal by Participant|2|||
130505180|NCT01986348|469817000|FG003|Overall Study|Withdrawal by Participant|1|||
130505181|NCT01986348|469816997|FG000|Overall Study|Study Terminated by Sponsor|0|||
130505182|NCT01986348|469816998|FG001|Overall Study|Study Terminated by Sponsor|0|||
130505183|NCT01986348|469816999|FG002|Overall Study|Study Terminated by Sponsor|0|||
130505184|NCT01986348|469817000|FG003|Overall Study|Study Terminated by Sponsor|3|||
130505185|NCT01986348|469816997|FG000|Overall Study|Other-unspecified|0|||
130505186|NCT01986348|469816998|FG001|Overall Study|Other-unspecified|1|||
130505187|NCT01986348|469816999|FG002|Overall Study|Other-unspecified|0|||
130505188|NCT01986348|469817000|FG003|Overall Study|Other-unspecified|2|||
130505189|NCT02612285|469817001|FG000|Overall Study|Withdrawal by Subject|1|||
130505190|NCT00805441|469817002|FG000|Overall Study|Adverse Event|5|||
130505191|NCT00805441|469817003|FG001|Overall Study|Adverse Event|2|||
130505192|NCT00805441|469817002|FG000|Overall Study|Lack of Efficacy|0|||
130505193|NCT00805441|469817003|FG001|Overall Study|Lack of Efficacy|2|||
130505194|NCT00805441|469817002|FG000|Overall Study|Protocol Violation|4|||
130566447|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
130566448|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
130566449|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
130566450|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
130505195|NCT00805441|469817003|FG001|Overall Study|Protocol Violation|8|||
130505196|NCT00805441|469817002|FG000|Overall Study|Lost to Follow-up|10|||
130505197|NCT00805441|469817003|FG001|Overall Study|Lost to Follow-up|13|||
130505198|NCT00805441|469817002|FG000|Overall Study|Withdrawal by Subject|15|||
130505199|NCT00805441|469817003|FG001|Overall Study|Withdrawal by Subject|9|||
130505200|NCT00805441|469817002|FG000|Overall Study|Physician Decision|0|||
130505201|NCT00805441|469817003|FG001|Overall Study|Physician Decision|1|||
130505202|NCT00805441|469817002|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
130505203|NCT00805441|469817003|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
130505204|NCT02935894|469817005|FG000|Overall Study|Subject dismissed|1|||
130505205|NCT03242863|469817008|FG000|Study Week 1|Withdrawal by Subject|0|||
130505206|NCT03242863|469817009|FG001|Study Week 1|Withdrawal by Subject|1|||
130505207|NCT03242863|469817010|FG002|Study Week 1|Withdrawal by Subject|0|||
130505208|NCT03242863|469817011|FG003|Study Week 1|Withdrawal by Subject|0|||
130505209|NCT03242863|469817012|FG004|Study Week 1|Withdrawal by Subject|3|||
130505210|NCT03242863|469817013|FG005|Study Week 1|Withdrawal by Subject|0|||
130505211|NCT01898299|469817015|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
130505212|NCT01898299|469817016|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
130505213|NCT00264576|469818662|FG000|Overall Study|Lost to Follow-up|1|||
130505214|NCT00264576|469818663|FG001|Overall Study|Lost to Follow-up|1|||
130505215|NCT02659059|469818666|FG000|Overall Study|Other reasons|6|||
130505216|NCT02659059|469818667|FG001|Overall Study|Other reasons|1|||
130505217|NCT02659059|469818666|FG000|Overall Study|Disease Progression|143|||
130505218|NCT02659059|469818667|FG001|Overall Study|Disease Progression|16|||
130505219|NCT02659059|469818666|FG000|Overall Study|Study Drug toxicity|56|||
130505220|NCT02659059|469818667|FG001|Overall Study|Study Drug toxicity|9|||
130505221|NCT02659059|469818666|FG000|Overall Study|Death|3|||
130505222|NCT02659059|469818667|FG001|Overall Study|Death|1|||
130505223|NCT02659059|469818666|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
130505224|NCT02659059|469818667|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
130505225|NCT02659059|469818666|FG000|Overall Study|Participant request to discontinue study treatment|5|||
130505226|NCT02659059|469818667|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130505227|NCT02659059|469818666|FG000|Overall Study|Participant withdrew consent|6|||
130505228|NCT02659059|469818667|FG001|Overall Study|Participant withdrew consent|1|||
130731515|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
130505229|NCT03976102|469818670|FG000|Overall Study|Withdrawal by Subject|4|||
130505230|NCT03976102|469818671|FG001|Overall Study|Withdrawal by Subject|4|||
130505231|NCT03976102|469818670|FG000|Overall Study|Adverse Event|2|||
130505232|NCT03976102|469818671|FG001|Overall Study|Adverse Event|4|||
130505233|NCT03976102|469818670|FG000|Overall Study|Not related to Covid-19|9|||
130505234|NCT03976102|469818671|FG001|Overall Study|Not related to Covid-19|13|||
130505235|NCT03976102|469818670|FG000|Overall Study|Lost to Follow-up|0|||
130505236|NCT03976102|469818671|FG001|Overall Study|Lost to Follow-up|2|||
130505237|NCT03976102|469818670|FG000|Overall Study|Death|3|||
130505238|NCT03976102|469818671|FG001|Overall Study|Death|2|||
130505239|NCT03976102|469818670|FG000|Overall Study|Physician Decision|1|||
130505240|NCT03976102|469818671|FG001|Overall Study|Physician Decision|1|||
130505241|NCT00092456|469818672|FG000|Overall Study|Adverse Event|0|||
130505242|NCT00092456|469818673|FG001|Overall Study|Adverse Event|0|||
130505243|NCT00092456|469818674|FG002|Overall Study|Adverse Event|1|||
130505244|NCT00092456|469818675|FG003|Overall Study|Adverse Event|1|||
130505245|NCT00092456|469818672|FG000|Overall Study|Lost to Follow-up|2|||
130505246|NCT00092456|469818673|FG001|Overall Study|Lost to Follow-up|2|||
130505247|NCT00092456|469818674|FG002|Overall Study|Lost to Follow-up|1|||
130505248|NCT00092456|469818675|FG003|Overall Study|Lost to Follow-up|2|||
130505249|NCT00092456|469818672|FG000|Overall Study|Protocol Violation|5|||
130505250|NCT00092456|469818673|FG001|Overall Study|Protocol Violation|7|||
130505251|NCT00092456|469818674|FG002|Overall Study|Protocol Violation|8|||
130505252|NCT00092456|469818675|FG003|Overall Study|Protocol Violation|6|||
130505253|NCT00092456|469818672|FG000|Overall Study|Withdrawal by Subject|13|||
130505254|NCT00092456|469818673|FG001|Overall Study|Withdrawal by Subject|5|||
130505255|NCT00092456|469818674|FG002|Overall Study|Withdrawal by Subject|16|||
130505256|NCT00092456|469818675|FG003|Overall Study|Withdrawal by Subject|6|||
130505257|NCT00092456|469818672|FG000|Overall Study|Moved|1|||
130731516|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
130731517|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
130731518|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
130505258|NCT00092456|469818673|FG001|Overall Study|Moved|1|||
130505259|NCT00092456|469818674|FG002|Overall Study|Moved|0|||
130505260|NCT00092456|469818675|FG003|Overall Study|Moved|1|||
130505261|NCT00092456|469818672|FG000|Overall Study|Other|4|||
130505262|NCT00092456|469818673|FG001|Overall Study|Other|2|||
130505263|NCT00092456|469818674|FG002|Overall Study|Other|3|||
130505264|NCT00092456|469818675|FG003|Overall Study|Other|0|||
130505265|NCT04783389|469818678|FG000|Overall Study|Withdrawal by Subject|2|||
130505266|NCT04783389|469818679|FG001|Overall Study|Withdrawal by Subject|0|||
130505267|NCT04783389|469818680|FG002|Overall Study|Withdrawal by Subject|0|||
130505268|NCT04783389|469818678|FG000|Overall Study|Termination of Study by Sponsor|10|||
130505269|NCT04783389|469818679|FG001|Overall Study|Termination of Study by Sponsor|12|||
130505270|NCT04783389|469818680|FG002|Overall Study|Termination of Study by Sponsor|14|||
130505271|NCT02121808|469818681|FG000|Overall Study|Technical problem|3|||
130731519|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
130731520|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
130505272|NCT05066230|469818682|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
130505273|NCT05066230|469818683|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
130505274|NCT05066230|469818682|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
130505275|NCT05066230|469818683|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
130505276|NCT05066230|469818682|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
130505277|NCT05066230|469818683|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
130505278|NCT05066230|469818682|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
130505279|NCT05066230|469818683|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
130505280|NCT05066230|469818682|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
130505281|NCT05066230|469818683|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
130505282|NCT05066230|469818682|FG000|After Week 48|Adverse Event|1|||
130505283|NCT05066230|469818683|FG001|After Week 48|Adverse Event|0|||
130505284|NCT05066230|469818682|FG000|After Week 48|Non-compliance with study schedule|1|||
130505285|NCT05066230|469818683|FG001|After Week 48|Non-compliance with study schedule|0|||
130505286|NCT05066230|469818682|FG000|After Week 48|Withdrawal by Subject|0|||
130505287|NCT05066230|469818683|FG001|After Week 48|Withdrawal by Subject|1|||
130505288|NCT05066230|469818682|FG000|After Week 48|Lost to Follow-up|3|||
130505289|NCT05066230|469818683|FG001|After Week 48|Lost to Follow-up|3|||
130505290|NCT05066230|469818682|FG000|After Week 48|Sponsor Request|115|||
130505291|NCT05066230|469818683|FG001|After Week 48|Sponsor Request|111|||
130505292|NCT02164578|469818684|FG000|Treatment Period|Withdrawal by Subject|3|||
130505293|NCT02164578|469818685|FG001|Treatment Period|Withdrawal by Subject|3|||
130505294|NCT02164578|469818684|FG000|Treatment Period|Adverse Event|13|||
130505295|NCT02164578|469818685|FG001|Treatment Period|Adverse Event|6|||
130505296|NCT02164578|469818684|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
130505297|NCT02164578|469818685|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
130505298|NCT02164578|469818684|FG000|Treatment Period|Protocol Violation|0|||
130505299|NCT02164578|469818685|FG001|Treatment Period|Protocol Violation|2|||
130505300|NCT02164578|469818684|FG000|Extension Period|Withdrawal by Subject|2|||
130505301|NCT02164578|469818685|FG001|Extension Period|Withdrawal by Subject|0|||
130505302|NCT02164578|469818684|FG000|Extension Period|Adverse Event|4|||
130505303|NCT02164578|469818685|FG001|Extension Period|Adverse Event|0|||
130505304|NCT02164578|469818684|FG000|Extension Period|Expiry of study medication|1|||
130505305|NCT02164578|469818685|FG001|Extension Period|Expiry of study medication|0|||
130505306|NCT02164578|469818684|FG000|Extension Period|Protocol Violation|0|||
130505307|NCT02164578|469818685|FG001|Extension Period|Protocol Violation|1|||
130505308|NCT03924193|469818686|FG000|Overall Study|Adverse Event|10|||
130505309|NCT03924193|469818687|FG001|Overall Study|Adverse Event|0|||
130505310|NCT03924193|469818688|FG002|Overall Study|Adverse Event|10|||
130505311|NCT03924193|469818686|FG000|Overall Study|Withdrawal by Subject|5|||
130505312|NCT03924193|469818687|FG001|Overall Study|Withdrawal by Subject|10|||
130505313|NCT03924193|469818688|FG002|Overall Study|Withdrawal by Subject|2|||
130505314|NCT01241448|469818689|FG000|Overall Study|Adverse Event|1|||
130505315|NCT01241448|469818690|FG001|Overall Study|Adverse Event|0|||
130505316|NCT01241448|469818691|FG002|Overall Study|Adverse Event|2|||
130505317|NCT01241448|469818692|FG003|Overall Study|Adverse Event|2|||
130505318|NCT01241448|469818689|FG000|Overall Study|Lost to Follow-up|2|||
130505319|NCT01241448|469818690|FG001|Overall Study|Lost to Follow-up|1|||
130505320|NCT01241448|469818691|FG002|Overall Study|Lost to Follow-up|1|||
130505321|NCT01241448|469818692|FG003|Overall Study|Lost to Follow-up|1|||
130505322|NCT01241448|469818689|FG000|Overall Study|Physician Decision|0|||
130505323|NCT01241448|469818690|FG001|Overall Study|Physician Decision|2|||
130505324|NCT01241448|469818691|FG002|Overall Study|Physician Decision|0|||
130505325|NCT01241448|469818692|FG003|Overall Study|Physician Decision|0|||
130505326|NCT01241448|469818689|FG000|Overall Study|Protocol Violation|10|||
130505327|NCT01241448|469818690|FG001|Overall Study|Protocol Violation|5|||
130505328|NCT01241448|469818691|FG002|Overall Study|Protocol Violation|3|||
130505329|NCT01241448|469818692|FG003|Overall Study|Protocol Violation|6|||
130505330|NCT01241448|469818689|FG000|Overall Study|Sponsor Decision|17|||
130505331|NCT01241448|469818690|FG001|Overall Study|Sponsor Decision|14|||
130505332|NCT01241448|469818691|FG002|Overall Study|Sponsor Decision|12|||
130505333|NCT01241448|469818692|FG003|Overall Study|Sponsor Decision|6|||
130505334|NCT01241448|469818689|FG000|Overall Study|Withdrawal by Subject|4|||
130505335|NCT01241448|469818690|FG001|Overall Study|Withdrawal by Subject|5|||
130505336|NCT01241448|469818691|FG002|Overall Study|Withdrawal by Subject|3|||
130505337|NCT01241448|469818692|FG003|Overall Study|Withdrawal by Subject|6|||
130505338|NCT01241448|469818689|FG000|Overall Study|Excluded due to data integrity issues|3|||
130505339|NCT01241448|469818690|FG001|Overall Study|Excluded due to data integrity issues|2|||
130505340|NCT01241448|469818691|FG002|Overall Study|Excluded due to data integrity issues|2|||
130505341|NCT01241448|469818692|FG003|Overall Study|Excluded due to data integrity issues|2|||
130505342|NCT03740737|469818693|FG000|Overall Study|Protocol deviation|13|||
130505343|NCT03740737|469818694|FG001|Overall Study|Protocol deviation|0|||
130731521|NCT00805961|470637414|FG000|Modality Therapy|Withdrawal by Subject|1|||
130505344|NCT03740737|469818693|FG000|Overall Study|Adverse Event|2|||
130505345|NCT03740737|469818694|FG001|Overall Study|Adverse Event|0|||
130505346|NCT03740737|469818693|FG000|Overall Study|Lost to Follow-up|1|||
130505347|NCT03740737|469818694|FG001|Overall Study|Lost to Follow-up|0|||
130505348|NCT03740737|469818693|FG000|Overall Study|Randomization failure|1|||
130505349|NCT03740737|469818694|FG001|Overall Study|Randomization failure|0|||
130505350|NCT03740737|469818693|FG000|Overall Study|Participant withdrew consent|1|||
130505351|NCT03740737|469818694|FG001|Overall Study|Participant withdrew consent|0|||
130505352|NCT03740737|469818693|FG000|Overall Study|Participant withdrew from trial|2|||
130505353|NCT03740737|469818694|FG001|Overall Study|Participant withdrew from trial|1|||
130505354|NCT01381549|469818701|FG000|Overall Study|Ineligible: No organisms isolated|0|||
130505355|NCT01381549|469818702|FG001|Overall Study|Ineligible: No organisms isolated|0|||
130505356|NCT01381549|469818703|FG002|Overall Study|Ineligible: No organisms isolated|1|||
130505357|NCT02981953|469818704|FG000|Overall Study|Death|9|||
130505358|NCT02981953|469818704|FG000|Overall Study|Withdrawal by Subject|1|||
130505359|NCT02981953|469818704|FG000|Overall Study|Withdrawal to non-compliance|1|||
130505360|NCT02889900|469818707|FG000|Overall Study|Adverse Event|11|||
130505361|NCT02889900|469818707|FG000|Overall Study|Condition under investigation worsened|32|||
130505362|NCT02889900|469818707|FG000|Overall Study|Other|5|||
130505363|NCT02889900|469818707|FG000|Overall Study|Withdrawal by Subject|7|||
130505364|NCT02889900|469818707|FG000|Overall Study|Not treated|2|||
130505365|NCT01416285|469818709|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
130505366|NCT01416285|469818710|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
130505367|NCT01322386|469818718|FG000|Overall Study|Protocol Violation|0|||
130505368|NCT01322386|469818719|FG001|Overall Study|Protocol Violation|1|||
130505369|NCT01322386|469818718|FG000|Overall Study|Physician Decision|0|||
130505370|NCT01322386|469818719|FG001|Overall Study|Physician Decision|1|||
130505371|NCT02291861|469818720|FG000|Overall Study|Adverse Event|2|||
130505372|NCT02291861|469818721|FG001|Overall Study|Adverse Event|4|||
130505373|NCT02291861|469818722|FG002|Overall Study|Adverse Event|1|||
130505374|NCT02291861|469818723|FG003|Overall Study|Adverse Event|2|||
130505375|NCT02291861|469818720|FG000|Overall Study|Death|0|||
130505376|NCT02291861|469818721|FG001|Overall Study|Death|0|||
130505377|NCT02291861|469818722|FG002|Overall Study|Death|1|||
130505378|NCT02291861|469818723|FG003|Overall Study|Death|1|||
130505379|NCT02291861|469818720|FG000|Overall Study|Protocol Violation|1|||
130505380|NCT02291861|469818721|FG001|Overall Study|Protocol Violation|0|||
130505381|NCT02291861|469818722|FG002|Overall Study|Protocol Violation|0|||
130505382|NCT02291861|469818723|FG003|Overall Study|Protocol Violation|1|||
130505383|NCT02291861|469818720|FG000|Overall Study|Withdrawal by Subject|1|||
130505384|NCT02291861|469818721|FG001|Overall Study|Withdrawal by Subject|2|||
130505385|NCT02291861|469818722|FG002|Overall Study|Withdrawal by Subject|1|||
130505386|NCT02291861|469818723|FG003|Overall Study|Withdrawal by Subject|4|||
130505387|NCT02291861|469818720|FG000|Overall Study|Noncompliance|1|||
130505388|NCT02291861|469818721|FG001|Overall Study|Noncompliance|1|||
130505389|NCT02291861|469818722|FG002|Overall Study|Noncompliance|2|||
130505390|NCT02291861|469818723|FG003|Overall Study|Noncompliance|1|||
130505391|NCT02291861|469818720|FG000|Overall Study|Lost to Follow-up|2|||
130505392|NCT02291861|469818721|FG001|Overall Study|Lost to Follow-up|1|||
130505393|NCT02291861|469818722|FG002|Overall Study|Lost to Follow-up|4|||
130505394|NCT02291861|469818723|FG003|Overall Study|Lost to Follow-up|0|||
130505395|NCT02291861|469818720|FG000|Overall Study|Other|0|||
130505396|NCT02291861|469818721|FG001|Overall Study|Other|0|||
130505397|NCT02291861|469818722|FG002|Overall Study|Other|0|||
130505398|NCT02291861|469818723|FG003|Overall Study|Other|1|||
130505399|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
130505400|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
130505401|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
130505402|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
130731522|NCT00805961|470637414|FG000|Modality Therapy|Adverse Event|1|||
130731523|NCT00805961|470637414|FG000|Modality Therapy|Disease Progression|2|||
130505403|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Death|0|||
130505404|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Death|0|||
130505405|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Death|1|||
130505406|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Death|0|||
130505407|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
130505408|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
130505409|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
130505410|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
130505411|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
130505412|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
130505413|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130505414|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
130505415|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
130505416|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
130566451|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
130566452|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
130566453|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
130566454|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
130566455|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
130566456|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
130566457|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
130566458|NCT00094770|470039576|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
130566459|NCT00094770|470039577|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
130566460|NCT04773106|470039581|FG000|Overall Study|Withdrawal by Subject|3|||
130566461|NCT04773106|470039581|FG000|Overall Study|Death|1|||
130566462|NCT01265615|470039584|FG000|Overall Study|Protocol Violation|2|||
130566463|NCT01265615|470039585|FG001|Overall Study|Protocol Violation|2|||
130566464|NCT01265615|470039586|FG002|Overall Study|Protocol Violation|4|||
130731524|NCT00805961|470637414|FG000|Treatment-Free Interval|Adverse Event|3|||
130731525|NCT00805961|470637414|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
130731526|NCT00805961|470637414|FG000|Treatment-Free Interval|Physician Decision|1|||
130731527|NCT00805961|470637414|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
130731528|NCT00805961|470637414|FG000|Maintenance Treatment|Lack of Efficacy|13|||
130731529|NCT00805961|470637414|FG000|Maintenance Treatment|Intercurrent Illness|7|||
130731530|NCT00805961|470637414|FG000|Maintenance Treatment|Adverse Event|6|||
130731531|NCT00805961|470637414|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
130731532|NCT00805961|470637414|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
130731533|NCT00805961|470637414|FG000|Maintenance Treatment|Withdrawn Consent|1|||
130731534|NCT04380961|470637415|FG000|Overall Study|Lost to Follow-up|17|||
130731535|NCT04380961|470637416|FG001|Overall Study|Lost to Follow-up|11|||
130731536|NCT04380961|470637415|FG000|Overall Study|Withdrawal by Subject|3|||
130731537|NCT04380961|470637416|FG001|Overall Study|Withdrawal by Subject|0|||
130731538|NCT04380961|470637415|FG000|Overall Study|Death|22|||
130731539|NCT04380961|470637416|FG001|Overall Study|Death|16|||
130731540|NCT04380961|470637415|FG000|Overall Study|Other|1|||
130731541|NCT04380961|470637416|FG001|Overall Study|Other|0|||
130731542|NCT04380961|470637415|FG000|Overall Study|Randomized but Not Treated|1|||
130731543|NCT04380961|470637416|FG001|Overall Study|Randomized but Not Treated|2|||
130731544|NCT03736031|470637417|FG000|Overall Study|Death|2|||
130731545|NCT03736031|470637418|FG001|Overall Study|Death|4|||
130731546|NCT03736031|470637417|FG000|Overall Study|Lost to Follow-up|21|||
130731547|NCT03736031|470637418|FG001|Overall Study|Lost to Follow-up|2|||
130731548|NCT03736031|470637417|FG000|Overall Study|Withdrawal by Subject|9|||
130731549|NCT03736031|470637418|FG001|Overall Study|Withdrawal by Subject|0|||
130731550|NCT03514017|470637419|FG000|Overall Study|Death|1|||
130731551|NCT03514017|470637419|FG000|Overall Study|Adverse Event|1|||
130731552|NCT03939689|470640932|FG000|Overall Study|Radiographic progression|14|||
130731553|NCT03939689|470640933|FG001|Overall Study|Radiographic progression|17|||
130731554|NCT03939689|470640932|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
130566465|NCT01265615|470039587|FG003|Overall Study|Protocol Violation|3|||
130566466|NCT00632099|470039590|FG000|Overall Study|Lost to Follow-up|3|||
130566467|NCT00632099|470039591|FG001|Overall Study|Lost to Follow-up|3|||
130566468|NCT01923285|470039597|FG000|Overall Study|Withdrawal by Subject|7|||
130566469|NCT01923285|470039598|FG001|Overall Study|Withdrawal by Subject|6|||
130566470|NCT02437864|470039600|FG000|Overall Study|Protocol Violation|4|||
130566471|NCT02437864|470039601|FG001|Overall Study|Protocol Violation|0|||
130566472|NCT00807742|470039604|FG000|Overall Study|Death|9|||
130566473|NCT00807742|470039605|FG001|Overall Study|Death|2|||
130566474|NCT00807742|470039604|FG000|Overall Study|Withdrawal by Subject|2|||
130566475|NCT00807742|470039605|FG001|Overall Study|Withdrawal by Subject|1|||
130566476|NCT00807742|470039604|FG000|Overall Study|Lost to Follow-up|35|||
130566477|NCT00807742|470039605|FG001|Overall Study|Lost to Follow-up|51|||
130566478|NCT00492752|470039606|FG000|Double Blind Treatment|Death|13|||
130566479|NCT00492752|470039607|FG001|Double Blind Treatment|Death|0|||
130566480|NCT00492752|470039608|FG002|Double Blind Treatment|Death|2|||
130566481|NCT00492752|470039609|FG003|Double Blind Treatment|Death|0|||
130566482|NCT00492752|470039606|FG000|Double Blind Treatment|Adverse Event|1|||
130566483|NCT00492752|470039607|FG001|Double Blind Treatment|Adverse Event|0|||
130566484|NCT00492752|470039608|FG002|Double Blind Treatment|Adverse Event|0|||
130566485|NCT00492752|470039609|FG003|Double Blind Treatment|Adverse Event|0|||
130566486|NCT00492752|470039606|FG000|Double Blind Treatment|Protocol Violation|0|||
130566487|NCT00492752|470039607|FG001|Double Blind Treatment|Protocol Violation|0|||
130566488|NCT00492752|470039608|FG002|Double Blind Treatment|Protocol Violation|1|||
130566489|NCT00492752|470039609|FG003|Double Blind Treatment|Protocol Violation|0|||
130566490|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
130566491|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
130566492|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
130731555|NCT03939689|470640933|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
130731556|NCT03939689|470640932|FG000|Overall Study|Adverse Event|1|||
130731557|NCT03939689|470640933|FG001|Overall Study|Adverse Event|8|||
130731558|NCT03939689|470640932|FG000|Overall Study|Unequivocal clinical progression|2|||
130731559|NCT03939689|470640933|FG001|Overall Study|Unequivocal clinical progression|5|||
130505417|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
130505418|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
130505419|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
130505420|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
130505421|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
130505422|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
130505423|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
130505424|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
130505425|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
130505426|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
130505427|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Other|2|||
130505428|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Other|0|||
130505429|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Other|0|||
130505430|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Other|0|||
130505431|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
130505432|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
130505433|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
130505434|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
130505435|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
130505436|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
130505437|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
130505438|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
130505439|NCT03845517|469818732|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
130505440|NCT03845517|469818733|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
130505441|NCT03845517|469818734|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
130505442|NCT03845517|469818735|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
130505443|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
130505444|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
130505445|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
130505446|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
130505447|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Death|0|||
130505448|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Death|0|||
130505449|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Death|1|||
130505450|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Death|1|||
130505451|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
130505452|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
130505453|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
130505454|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
130505455|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
130505456|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
130505457|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
130505458|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
130505459|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
130505460|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
130505461|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
130505462|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
130505463|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Other|1|||
130505464|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Other|0|||
130505465|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Other|1|||
130505466|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Other|0|||
130566493|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
130505467|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
130505468|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
130505469|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
130505470|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
130505471|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
130566494|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
130505472|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
130505473|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
130505474|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
130505475|NCT03845517|469818732|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
130505476|NCT03845517|469818733|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
130505477|NCT03845517|469818734|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
130505478|NCT03845517|469818735|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
130505479|NCT02410278|469818738|FG000|Run-in Period|Adverse Event|5|||
130505480|NCT02410278|469818739|FG001|Run-in Period|Adverse Event|0|||
130505481|NCT02410278|469818740|FG002|Run-in Period|Adverse Event|0|||
130505482|NCT02410278|469818738|FG000|Run-in Period|GSRS Threshold Not Met|30|||
130566495|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
130566496|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
130566497|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
130566498|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
130566499|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
130566500|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
130566501|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
130566502|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
130566503|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
130566504|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
130566505|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
130566506|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
130566507|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
130566508|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
130566509|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
130566510|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130566511|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130505483|NCT02410278|469818739|FG001|Run-in Period|GSRS Threshold Not Met|0|||
130505484|NCT02410278|469818740|FG002|Run-in Period|GSRS Threshold Not Met|0|||
130505485|NCT02410278|469818738|FG000|Run-in Period|Lost to Follow-up|1|||
130505486|NCT02410278|469818739|FG001|Run-in Period|Lost to Follow-up|0|||
130505487|NCT02410278|469818740|FG002|Run-in Period|Lost to Follow-up|0|||
130505488|NCT02410278|469818738|FG000|Run-in Period|Withdrawal by Subject|1|||
130505489|NCT02410278|469818739|FG001|Run-in Period|Withdrawal by Subject|0|||
130505490|NCT02410278|469818740|FG002|Run-in Period|Withdrawal by Subject|0|||
130505491|NCT02410278|469818738|FG000|Run-in Period|Pregnancy|1|||
130505492|NCT02410278|469818739|FG001|Run-in Period|Pregnancy|0|||
130505493|NCT02410278|469818740|FG002|Run-in Period|Pregnancy|0|||
130505494|NCT02410278|469818738|FG000|Study Treatment Period|Adverse Event|0|||
130505495|NCT02410278|469818739|FG001|Study Treatment Period|Adverse Event|6|||
130505496|NCT02410278|469818740|FG002|Study Treatment Period|Adverse Event|3|||
130505497|NCT02410278|469818738|FG000|Study Treatment Period|Physician Decision|0|||
130505498|NCT02410278|469818739|FG001|Study Treatment Period|Physician Decision|0|||
130505499|NCT02410278|469818740|FG002|Study Treatment Period|Physician Decision|1|||
130566512|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130566513|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
130731560|NCT03939689|470640932|FG000|Overall Study|Other|1|||
130731561|NCT03939689|470640933|FG001|Overall Study|Other|4|||
130731562|NCT03939689|470640932|FG000|Overall Study|Death|0|||
130731563|NCT03939689|470640933|FG001|Overall Study|Death|3|||
130731564|NCT03939689|470640932|FG000|Overall Study|Participant decision|0|||
130731565|NCT03939689|470640933|FG001|Overall Study|Participant decision|3|||
130731566|NCT03939689|470640932|FG000|Overall Study|Withdrawal of consent|2|||
130731567|NCT03939689|470640933|FG001|Overall Study|Withdrawal of consent|1|||
130731568|NCT03939689|470640932|FG000|Overall Study|Investigator decision|1|||
130731569|NCT03939689|470640933|FG001|Overall Study|Investigator decision|0|||
130731570|NCT05665595|470640934|FG000|Overall Study|Ongoing|692|||
130731571|NCT05665595|470640935|FG001|Overall Study|Ongoing|698|||
130731572|NCT05665595|470640934|FG000|Overall Study|Withdrawal by Subject|2|||
130731573|NCT05665595|470640935|FG001|Overall Study|Withdrawal by Subject|2|||
130731574|NCT05665595|470640934|FG000|Overall Study|Lost to Follow-up|1|||
130731575|NCT05665595|470640935|FG001|Overall Study|Lost to Follow-up|0|||
130731576|NCT05665595|470640934|FG000|Overall Study|Death|6|||
130731577|NCT05665595|470640935|FG001|Overall Study|Death|1|||
130731578|NCT05771428|470640936|FG000|Overall Study|Adverse Event|0|||
130731579|NCT05771428|470640937|FG001|Overall Study|Adverse Event|1|||
130731580|NCT05771428|470640938|FG002|Overall Study|Adverse Event|1|||
130731581|NCT05771428|470640939|FG003|Overall Study|Adverse Event|1|||
130731582|NCT05771428|470640936|FG000|Overall Study|Withdrawal by Subject|3|||
130731583|NCT05771428|470640937|FG001|Overall Study|Withdrawal by Subject|2|||
130731584|NCT05771428|470640938|FG002|Overall Study|Withdrawal by Subject|1|||
130731585|NCT05771428|470640939|FG003|Overall Study|Withdrawal by Subject|4|||
130731586|NCT05771428|470640936|FG000|Overall Study|Other|0|||
130731587|NCT05771428|470640937|FG001|Overall Study|Other|1|||
130731588|NCT05771428|470640938|FG002|Overall Study|Other|2|||
130731589|NCT05771428|470640939|FG003|Overall Study|Other|1|||
130731590|NCT05771428|470640936|FG000|Overall Study|Randomized but Not Treated|0|||
130731591|NCT05771428|470640937|FG001|Overall Study|Randomized but Not Treated|0|||
130505500|NCT02410278|469818738|FG000|Study Treatment Period|Withdrawal by Subject|0|||
130505501|NCT02410278|469818739|FG001|Study Treatment Period|Withdrawal by Subject|1|||
130505502|NCT02410278|469818740|FG002|Study Treatment Period|Withdrawal by Subject|0|||
130731592|NCT05771428|470640938|FG002|Overall Study|Randomized but Not Treated|1|||
130505503|NCT02410278|469818738|FG000|Study Treatment Period|Other|0|||
130505504|NCT02410278|469818739|FG001|Study Treatment Period|Other|3|||
130731593|NCT05771428|470640939|FG003|Overall Study|Randomized but Not Treated|0|||
130731594|NCT04025229|470640940|FG000|Overall Study|Adverse Event|1|||
130731595|NCT04025229|470640941|FG001|Overall Study|Adverse Event|0|||
130731596|NCT04025229|470640940|FG000|Overall Study|Withdrawal by Subject|0|||
130505505|NCT02410278|469818740|FG002|Study Treatment Period|Other|0|||
130505506|NCT02410278|469818738|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
130731597|NCT04025229|470640941|FG001|Overall Study|Withdrawal by Subject|2|||
130731598|NCT04025229|470640940|FG000|Overall Study|Death|0|||
130731599|NCT04025229|470640941|FG001|Overall Study|Death|1|||
130731600|NCT04025229|470640940|FG000|Overall Study|Physician Decision|0|||
130731601|NCT04025229|470640941|FG001|Overall Study|Physician Decision|1|||
130731602|NCT02964013|470640945|FG000|Overall Study|Death|58|||
130731603|NCT02964013|470640946|FG001|Overall Study|Death|239|||
130731604|NCT02964013|470640947|FG002|Overall Study|Death|38|||
130731605|NCT02964013|470640948|FG003|Overall Study|Death|10|||
130731606|NCT02964013|470640949|FG004|Overall Study|Death|33|||
130731607|NCT02964013|470640945|FG000|Overall Study|Lost to Follow-up|1|||
130731608|NCT02964013|470640946|FG001|Overall Study|Lost to Follow-up|4|||
130731609|NCT02964013|470640947|FG002|Overall Study|Lost to Follow-up|2|||
130731610|NCT02964013|470640948|FG003|Overall Study|Lost to Follow-up|0|||
130731611|NCT02964013|470640949|FG004|Overall Study|Lost to Follow-up|0|||
130731612|NCT02964013|470640945|FG000|Overall Study|Physician Decision|0|||
130731613|NCT02964013|470640946|FG001|Overall Study|Physician Decision|1|||
130731614|NCT02964013|470640947|FG002|Overall Study|Physician Decision|0|||
130731615|NCT02964013|470640948|FG003|Overall Study|Physician Decision|0|||
130731616|NCT02964013|470640949|FG004|Overall Study|Physician Decision|0|||
130731617|NCT02964013|470640945|FG000|Overall Study|Sponsor Decision|3|||
130731618|NCT02964013|470640946|FG001|Overall Study|Sponsor Decision|22|||
130731619|NCT02964013|470640947|FG002|Overall Study|Sponsor Decision|11|||
130731620|NCT02964013|470640948|FG003|Overall Study|Sponsor Decision|0|||
130731621|NCT02964013|470640949|FG004|Overall Study|Sponsor Decision|7|||
130731622|NCT02964013|470640945|FG000|Overall Study|Withdrawal by Subject|6|||
130731623|NCT02964013|470640946|FG001|Overall Study|Withdrawal by Subject|27|||
130731624|NCT02964013|470640947|FG002|Overall Study|Withdrawal by Subject|9|||
130731625|NCT02964013|470640948|FG003|Overall Study|Withdrawal by Subject|0|||
130731626|NCT02964013|470640949|FG004|Overall Study|Withdrawal by Subject|0|||
130731627|NCT02964013|470640945|FG000|Overall Study|Not Treated|0|||
130731628|NCT02964013|470640946|FG001|Overall Study|Not Treated|2|||
130731629|NCT02964013|470640947|FG002|Overall Study|Not Treated|0|||
130731630|NCT02964013|470640948|FG003|Overall Study|Not Treated|1|||
130731631|NCT02964013|470640949|FG004|Overall Study|Not Treated|0|||
130731632|NCT02180711|470640951|FG000|Overall Study|Death|0|||
130731633|NCT02180711|470640952|FG001|Overall Study|Death|1|||
130731634|NCT02180711|470640953|FG002|Overall Study|Death|0|||
130731635|NCT02180711|470640954|FG003|Overall Study|Death|0|||
130731636|NCT02180711|470640955|FG004|Overall Study|Death|7|||
130731637|NCT02180711|470640956|FG005|Overall Study|Death|0|||
130731638|NCT02180711|470640957|FG006|Overall Study|Death|1|||
130731639|NCT02180711|470640958|FG007|Overall Study|Death|3|||
130731640|NCT02180711|470640951|FG000|Overall Study|Lost to Follow-up|0|||
130731641|NCT02180711|470640952|FG001|Overall Study|Lost to Follow-up|1|||
130731642|NCT02180711|470640953|FG002|Overall Study|Lost to Follow-up|0|||
130731643|NCT02180711|470640954|FG003|Overall Study|Lost to Follow-up|0|||
130731644|NCT02180711|470640955|FG004|Overall Study|Lost to Follow-up|1|||
130731645|NCT02180711|470640956|FG005|Overall Study|Lost to Follow-up|1|||
130731646|NCT02180711|470640957|FG006|Overall Study|Lost to Follow-up|0|||
130731647|NCT02180711|470640958|FG007|Overall Study|Lost to Follow-up|3|||
130731648|NCT02180711|470640951|FG000|Overall Study|Withdrawal by Subject|2|||
130731649|NCT02180711|470640952|FG001|Overall Study|Withdrawal by Subject|1|||
130731650|NCT02180711|470640953|FG002|Overall Study|Withdrawal by Subject|0|||
130731651|NCT02180711|470640954|FG003|Overall Study|Withdrawal by Subject|4|||
130731652|NCT02180711|470640955|FG004|Overall Study|Withdrawal by Subject|3|||
130731653|NCT02180711|470640956|FG005|Overall Study|Withdrawal by Subject|0|||
130731654|NCT02180711|470640957|FG006|Overall Study|Withdrawal by Subject|3|||
130731655|NCT02180711|470640958|FG007|Overall Study|Withdrawal by Subject|2|||
130731656|NCT02180711|470640951|FG000|Overall Study|- Disease Progression|0|||
130731657|NCT02180711|470640952|FG001|Overall Study|- Disease Progression|1|||
130731658|NCT02180711|470640953|FG002|Overall Study|- Disease Progression|0|||
130731659|NCT02180711|470640954|FG003|Overall Study|- Disease Progression|0|||
130731660|NCT02180711|470640955|FG004|Overall Study|- Disease Progression|0|||
130731661|NCT02180711|470640956|FG005|Overall Study|- Disease Progression|0|||
130731662|NCT02180711|470640957|FG006|Overall Study|- Disease Progression|0|||
130731663|NCT02180711|470640958|FG007|Overall Study|- Disease Progression|0|||
130731664|NCT02180711|470640951|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
130731665|NCT02180711|470640952|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
130731666|NCT02180711|470640953|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
130731667|NCT02180711|470640954|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
130731668|NCT02180711|470640955|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
130731669|NCT02180711|470640956|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
130731670|NCT02180711|470640957|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
130731671|NCT02180711|470640958|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
130731672|NCT02180711|470640951|FG000|Overall Study|- Study Terminated by Sponsor|2|||
130505507|NCT02410278|469818739|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
130505508|NCT02410278|469818740|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
130505509|NCT03695185|469818741|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
130505510|NCT03695185|469818741|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
130505511|NCT03695185|469818741|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
130505512|NCT03695185|469818741|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
130505513|NCT03695185|469818741|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
130505514|NCT03695185|469818741|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
130505515|NCT02584257|469818742|FG000|Period 1|Withdrawal by Subject|0|||
130505516|NCT02584257|469818743|FG001|Period 1|Withdrawal by Subject|0|||
130505517|NCT02584257|469818744|FG002|Period 1|Withdrawal by Subject|0|||
130505518|NCT02584257|469818745|FG003|Period 1|Withdrawal by Subject|0|||
130505519|NCT02584257|469818746|FG004|Period 1|Withdrawal by Subject|0|||
130505520|NCT02584257|469818747|FG005|Period 1|Withdrawal by Subject|0|||
130505521|NCT02584257|469818748|FG006|Period 1|Withdrawal by Subject|1|||
130505522|NCT02584257|469818749|FG007|Period 1|Withdrawal by Subject|0|||
130505523|NCT02584257|469818750|FG008|Period 1|Withdrawal by Subject|0|||
130505524|NCT02584257|469818742|FG000|Period 2|Physician Decision|1|||
130505525|NCT02584257|469818743|FG001|Period 2|Physician Decision|0|||
130505526|NCT02584257|469818744|FG002|Period 2|Physician Decision|0|||
130505527|NCT02584257|469818745|FG003|Period 2|Physician Decision|0|||
130505528|NCT02584257|469818746|FG004|Period 2|Physician Decision|0|||
130505529|NCT02584257|469818747|FG005|Period 2|Physician Decision|0|||
130505530|NCT02584257|469818748|FG006|Period 2|Physician Decision|0|||
130505531|NCT02584257|469818749|FG007|Period 2|Physician Decision|0|||
130505532|NCT02584257|469818750|FG008|Period 2|Physician Decision|0|||
130505533|NCT02584257|469818742|FG000|Period 2|Adverse Event|0|||
130505534|NCT02584257|469818743|FG001|Period 2|Adverse Event|1|||
130505535|NCT02584257|469818744|FG002|Period 2|Adverse Event|0|||
130505536|NCT02584257|469818745|FG003|Period 2|Adverse Event|0|||
130505537|NCT02584257|469818746|FG004|Period 2|Adverse Event|0|||
130505538|NCT02584257|469818747|FG005|Period 2|Adverse Event|0|||
130505539|NCT02584257|469818748|FG006|Period 2|Adverse Event|0|||
130505540|NCT02584257|469818749|FG007|Period 2|Adverse Event|0|||
130505541|NCT02584257|469818750|FG008|Period 2|Adverse Event|0|||
130505542|NCT03150589|469818760|FG000|Overall Study|Withdrawal by Subject|16|||
130505543|NCT03150589|469818761|FG001|Overall Study|Withdrawal by Subject|9|||
130505544|NCT03150589|469818760|FG000|Overall Study|Adverse Event|7|||
130505545|NCT03150589|469818761|FG001|Overall Study|Adverse Event|6|||
130505546|NCT03150589|469818760|FG000|Overall Study|Protocol Violation|4|||
130505547|NCT03150589|469818761|FG001|Overall Study|Protocol Violation|3|||
130505548|NCT03150589|469818760|FG000|Overall Study|Lost to Follow-up|3|||
130505549|NCT03150589|469818761|FG001|Overall Study|Lost to Follow-up|3|||
130505550|NCT03150589|469818760|FG000|Overall Study|Death|2|||
130505551|NCT03150589|469818761|FG001|Overall Study|Death|3|||
130505552|NCT03150589|469818760|FG000|Overall Study|IP non-compliance and other reasons|12|||
130505553|NCT03150589|469818761|FG001|Overall Study|IP non-compliance and other reasons|3|||
130505554|NCT01020435|469818764|FG000|Overall Study|Lost to Follow-up|0|||
130505555|NCT01020435|469818765|FG001|Overall Study|Lost to Follow-up|1|||
130505556|NCT01000649|469818766|FG000|Overall Study|Adverse Event|5|||
130505557|NCT01000649|469818767|FG001|Overall Study|Adverse Event|1|||
130505558|NCT01000649|469818768|FG002|Overall Study|Adverse Event|2|||
130505559|NCT01000649|469818769|FG003|Overall Study|Adverse Event|4|||
130505560|NCT01000649|469818766|FG000|Overall Study|Lost to Follow-up|0|||
130505561|NCT01000649|469818767|FG001|Overall Study|Lost to Follow-up|2|||
130505562|NCT01000649|469818768|FG002|Overall Study|Lost to Follow-up|0|||
130505563|NCT01000649|469818769|FG003|Overall Study|Lost to Follow-up|2|||
130505564|NCT00346398|469818770|FG000|Overall Study|Lost to Follow-up|3|||
130505565|NCT00346398|469818771|FG001|Overall Study|Lost to Follow-up|0|||
130505566|NCT00346398|469818770|FG000|Overall Study|Withdrawal by Subject|0|||
130505567|NCT00346398|469818771|FG001|Overall Study|Withdrawal by Subject|2|||
130505568|NCT02607956|469818772|FG000|Double-Blinded Phase|Withdrew Consent|17|||
130505569|NCT02607956|469818773|FG001|Double-Blinded Phase|Withdrew Consent|19|||
130505570|NCT02607956|469818774|FG002|Double-Blinded Phase|Withdrew Consent|0|||
130505571|NCT02607956|469818775|FG003|Double-Blinded Phase|Withdrew Consent|0|||
130505572|NCT02607956|469818772|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
130505573|NCT02607956|469818773|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
130505574|NCT02607956|469818774|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
130505575|NCT02607956|469818775|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
130505576|NCT02607956|469818772|FG000|Double-Blinded Phase|Randomized but never treated|7|||
130505577|NCT02607956|469818773|FG001|Double-Blinded Phase|Randomized but never treated|5|||
130505578|NCT02607956|469818774|FG002|Double-Blinded Phase|Randomized but never treated|0|||
130505579|NCT02607956|469818775|FG003|Double-Blinded Phase|Randomized but never treated|0|||
130505580|NCT02607956|469818772|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
130505581|NCT02607956|469818773|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
130505582|NCT02607956|469818774|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
130505583|NCT02607956|469818775|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
130505584|NCT02607956|469818772|FG000|Double-Blinded Phase|Death|4|||
130505585|NCT02607956|469818773|FG001|Double-Blinded Phase|Death|4|||
130505586|NCT02607956|469818774|FG002|Double-Blinded Phase|Death|0|||
130505587|NCT02607956|469818775|FG003|Double-Blinded Phase|Death|0|||
130505588|NCT02607956|469818772|FG000|Double-Blinded Phase|Adverse Event|4|||
130505589|NCT02607956|469818773|FG001|Double-Blinded Phase|Adverse Event|3|||
130505590|NCT02607956|469818774|FG002|Double-Blinded Phase|Adverse Event|0|||
130505591|NCT02607956|469818775|FG003|Double-Blinded Phase|Adverse Event|0|||
130505592|NCT02607956|469818772|FG000|Double-Blinded Phase|Protocol Violation|3|||
130505593|NCT02607956|469818773|FG001|Double-Blinded Phase|Protocol Violation|1|||
130505594|NCT02607956|469818774|FG002|Double-Blinded Phase|Protocol Violation|0|||
130505595|NCT02607956|469818775|FG003|Double-Blinded Phase|Protocol Violation|0|||
130505596|NCT02607956|469818772|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
130505597|NCT02607956|469818773|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
130505598|NCT02607956|469818774|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
130505599|NCT02607956|469818775|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
130505600|NCT02607956|469818772|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
130505601|NCT02607956|469818773|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
130505602|NCT02607956|469818774|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
130505603|NCT02607956|469818775|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
130505604|NCT02607956|469818772|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130505605|NCT02607956|469818773|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130505606|NCT02607956|469818774|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
130505607|NCT02607956|469818775|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
130505608|NCT02607956|469818772|FG000|Open-Label Extension Phase|Death|0|||
130505609|NCT02607956|469818773|FG001|Open-Label Extension Phase|Death|0|||
130505610|NCT02607956|469818774|FG002|Open-Label Extension Phase|Death|1|||
130505611|NCT02607956|469818775|FG003|Open-Label Extension Phase|Death|3|||
130505612|NCT02607956|469818772|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
130505613|NCT02607956|469818773|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
130505614|NCT02607956|469818774|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
130505615|NCT02607956|469818775|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
130505616|NCT02607956|469818772|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
130505617|NCT02607956|469818773|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
130505618|NCT02607956|469818774|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
130505619|NCT02607956|469818775|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
130505620|NCT02607956|469818772|FG000|Open-Label Extension Phase|Protocol Violation|0|||
130505621|NCT02607956|469818773|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130505622|NCT02607956|469818774|FG002|Open-Label Extension Phase|Protocol Violation|0|||
130505623|NCT02607956|469818775|FG003|Open-Label Extension Phase|Protocol Violation|2|||
130505624|NCT02607956|469818772|FG000|Open-Label Extension Phase|Pregnancy|0|||
130505625|NCT02607956|469818773|FG001|Open-Label Extension Phase|Pregnancy|0|||
130505626|NCT02607956|469818774|FG002|Open-Label Extension Phase|Pregnancy|0|||
130505627|NCT02607956|469818775|FG003|Open-Label Extension Phase|Pregnancy|1|||
130505628|NCT00103857|469818776|FG000|54-Week Base Study|Adverse Event|12|||
130505629|NCT00103857|469818777|FG001|54-Week Base Study|Adverse Event|9|||
130505630|NCT00103857|469818778|FG002|54-Week Base Study|Adverse Event|11|||
130505631|NCT00103857|469818779|FG003|54-Week Base Study|Adverse Event|6|||
130505632|NCT00103857|469818780|FG004|54-Week Base Study|Adverse Event|5|||
130505633|NCT00103857|469818781|FG005|54-Week Base Study|Adverse Event|11|||
130505634|NCT00103857|469818782|FG006|54-Week Base Study|Adverse Event|3|||
130505635|NCT00103857|469818776|FG000|54-Week Base Study|Death|0|||
130731673|NCT02180711|470640952|FG001|Overall Study|- Study Terminated by Sponsor|3|||
130731674|NCT02180711|470640953|FG002|Overall Study|- Study Terminated by Sponsor|0|||
130731675|NCT02180711|470640954|FG003|Overall Study|- Study Terminated by Sponsor|5|||
130731676|NCT02180711|470640955|FG004|Overall Study|- Study Terminated by Sponsor|32|||
130731677|NCT02180711|470640956|FG005|Overall Study|- Study Terminated by Sponsor|0|||
130731678|NCT02180711|470640957|FG006|Overall Study|- Study Terminated by Sponsor|4|||
130731679|NCT02180711|470640958|FG007|Overall Study|- Study Terminated by Sponsor|13|||
130731680|NCT02180711|470640951|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
130731681|NCT02180711|470640952|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
130731682|NCT02180711|470640953|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
130731683|NCT02180711|470640954|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
130731684|NCT02180711|470640955|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
130731685|NCT02180711|470640956|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
130731686|NCT02180711|470640957|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
130731687|NCT02180711|470640958|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
130731688|NCT02180711|470640951|FG000|Overall Study|- Other|1|||
130731689|NCT02180711|470640952|FG001|Overall Study|- Other|0|||
130731690|NCT02180711|470640953|FG002|Overall Study|- Other|0|||
130731691|NCT02180711|470640954|FG003|Overall Study|- Other|1|||
130731692|NCT02180711|470640955|FG004|Overall Study|- Other|0|||
130731693|NCT02180711|470640956|FG005|Overall Study|- Other|0|||
130731694|NCT02180711|470640957|FG006|Overall Study|- Other|0|||
130731695|NCT02180711|470640958|FG007|Overall Study|- Other|0|||
130731696|NCT01374919|470640959|FG000|Overall Study|Withdrawal by Subject|2|||
130731697|NCT04079868|470640962|FG000|Overall Study|Lost to Follow-up|100|||
130731698|NCT04079868|470640963|FG001|Overall Study|Lost to Follow-up|200|||
130731699|NCT04079868|470640962|FG000|Overall Study|Physician Decision|100|||
130731700|NCT04079868|470640963|FG001|Overall Study|Physician Decision|0|||
130731701|NCT05620108|470640968|FG000|Overall Study|Physician Decision|1|||
130731702|NCT05620108|470640969|FG001|Overall Study|Physician Decision|2|||
130731703|NCT03569293|470640974|FG000|Overall Study|Adverse Event|4|||
130731704|NCT03569293|470640975|FG001|Overall Study|Adverse Event|1|||
130731705|NCT03569293|470640976|FG002|Overall Study|Adverse Event|5|||
130731706|NCT03569293|470640977|FG003|Overall Study|Adverse Event|1|||
130731707|NCT03569293|470640978|FG004|Overall Study|Adverse Event|0|||
130731708|NCT03569293|470640979|FG005|Overall Study|Adverse Event|0|||
130731709|NCT03569293|470640974|FG000|Overall Study|Withdrawal by Subject|16|||
130731710|NCT03569293|470640975|FG001|Overall Study|Withdrawal by Subject|2|||
130731711|NCT03569293|470640976|FG002|Overall Study|Withdrawal by Subject|4|||
130731712|NCT03569293|470640977|FG003|Overall Study|Withdrawal by Subject|1|||
130731713|NCT03569293|470640978|FG004|Overall Study|Withdrawal by Subject|0|||
130731714|NCT03569293|470640979|FG005|Overall Study|Withdrawal by Subject|0|||
130731715|NCT03569293|470640974|FG000|Overall Study|Lost to Follow-up|1|||
130731716|NCT03569293|470640975|FG001|Overall Study|Lost to Follow-up|3|||
130731717|NCT03569293|470640976|FG002|Overall Study|Lost to Follow-up|1|||
130731718|NCT03569293|470640977|FG003|Overall Study|Lost to Follow-up|1|||
130731719|NCT03569293|470640978|FG004|Overall Study|Lost to Follow-up|0|||
130731720|NCT03569293|470640979|FG005|Overall Study|Lost to Follow-up|0|||
130731721|NCT03569293|470640974|FG000|Overall Study|Other|8|||
130731722|NCT03569293|470640975|FG001|Overall Study|Other|2|||
130731723|NCT03569293|470640976|FG002|Overall Study|Other|1|||
130731724|NCT03569293|470640977|FG003|Overall Study|Other|1|||
130731725|NCT03569293|470640978|FG004|Overall Study|Other|0|||
130731726|NCT03569293|470640979|FG005|Overall Study|Other|0|||
130731727|NCT03569293|470640974|FG000|Overall Study|Ongoing at Time of Analysis|8|||
130731728|NCT03569293|470640975|FG001|Overall Study|Ongoing at Time of Analysis|1|||
130731729|NCT03569293|470640976|FG002|Overall Study|Ongoing at Time of Analysis|3|||
130505636|NCT00103857|469818777|FG001|54-Week Base Study|Death|0|||
130505637|NCT00103857|469818778|FG002|54-Week Base Study|Death|0|||
130505638|NCT00103857|469818779|FG003|54-Week Base Study|Death|0|||
130505639|NCT00103857|469818780|FG004|54-Week Base Study|Death|1|||
130505640|NCT00103857|469818781|FG005|54-Week Base Study|Death|1|||
130505641|NCT00103857|469818782|FG006|54-Week Base Study|Death|0|||
130505642|NCT00103857|469818776|FG000|54-Week Base Study|Lack of Efficacy|11|||
130731730|NCT03569293|470640977|FG003|Overall Study|Ongoing at Time of Analysis|0|||
130731731|NCT03569293|470640978|FG004|Overall Study|Ongoing at Time of Analysis|0|||
130731732|NCT03569293|470640979|FG005|Overall Study|Ongoing at Time of Analysis|0|||
130731733|NCT01171898|470640980|FG000|Overall Study|Death|0|||
130731734|NCT01171898|470640981|FG001|Overall Study|Death|0|||
130731735|NCT01171898|470640982|FG002|Overall Study|Death|2|||
130731736|NCT01171898|470640983|FG003|Overall Study|Death|0|||
130731737|NCT01171898|470640980|FG000|Overall Study|Lost to Follow-up|0|||
130731738|NCT01171898|470640981|FG001|Overall Study|Lost to Follow-up|1|||
130731739|NCT01171898|470640982|FG002|Overall Study|Lost to Follow-up|1|||
130731740|NCT01171898|470640983|FG003|Overall Study|Lost to Follow-up|1|||
130731741|NCT01171898|470640980|FG000|Overall Study|Withdrawal by Subject|1|||
130505643|NCT00103857|469818777|FG001|54-Week Base Study|Lack of Efficacy|14|||
130505644|NCT00103857|469818778|FG002|54-Week Base Study|Lack of Efficacy|8|||
130505645|NCT00103857|469818779|FG003|54-Week Base Study|Lack of Efficacy|4|||
130505646|NCT00103857|469818780|FG004|54-Week Base Study|Lack of Efficacy|3|||
130505647|NCT00103857|469818781|FG005|54-Week Base Study|Lack of Efficacy|14|||
130505648|NCT00103857|469818782|FG006|54-Week Base Study|Lack of Efficacy|19|||
130505649|NCT00103857|469818776|FG000|54-Week Base Study|Lost to Follow-up|5|||
130505650|NCT00103857|469818777|FG001|54-Week Base Study|Lost to Follow-up|4|||
130505651|NCT00103857|469818778|FG002|54-Week Base Study|Lost to Follow-up|7|||
130505652|NCT00103857|469818779|FG003|54-Week Base Study|Lost to Follow-up|5|||
130505653|NCT00103857|469818780|FG004|54-Week Base Study|Lost to Follow-up|10|||
130505654|NCT00103857|469818781|FG005|54-Week Base Study|Lost to Follow-up|9|||
130505655|NCT00103857|469818782|FG006|54-Week Base Study|Lost to Follow-up|3|||
130505656|NCT00103857|469818776|FG000|54-Week Base Study|Physician Decision|1|||
130505657|NCT00103857|469818777|FG001|54-Week Base Study|Physician Decision|1|||
130505658|NCT00103857|469818778|FG002|54-Week Base Study|Physician Decision|0|||
130505659|NCT00103857|469818779|FG003|54-Week Base Study|Physician Decision|0|||
130505660|NCT00103857|469818780|FG004|54-Week Base Study|Physician Decision|1|||
130505661|NCT00103857|469818781|FG005|54-Week Base Study|Physician Decision|0|||
130505662|NCT00103857|469818782|FG006|54-Week Base Study|Physician Decision|0|||
130505663|NCT00103857|469818776|FG000|54-Week Base Study|Pregnancy|1|||
130505664|NCT00103857|469818777|FG001|54-Week Base Study|Pregnancy|0|||
130505665|NCT00103857|469818778|FG002|54-Week Base Study|Pregnancy|0|||
130505666|NCT00103857|469818779|FG003|54-Week Base Study|Pregnancy|0|||
130505667|NCT00103857|469818780|FG004|54-Week Base Study|Pregnancy|1|||
130505668|NCT00103857|469818781|FG005|54-Week Base Study|Pregnancy|0|||
130505669|NCT00103857|469818782|FG006|54-Week Base Study|Pregnancy|1|||
130505670|NCT00103857|469818776|FG000|54-Week Base Study|Protocol Violation|6|||
130505671|NCT00103857|469818777|FG001|54-Week Base Study|Protocol Violation|4|||
130505672|NCT00103857|469818778|FG002|54-Week Base Study|Protocol Violation|2|||
130505673|NCT00103857|469818779|FG003|54-Week Base Study|Protocol Violation|4|||
130505674|NCT00103857|469818780|FG004|54-Week Base Study|Protocol Violation|0|||
130505675|NCT00103857|469818781|FG005|54-Week Base Study|Protocol Violation|3|||
130505676|NCT00103857|469818782|FG006|54-Week Base Study|Protocol Violation|3|||
130505677|NCT00103857|469818776|FG000|54-Week Base Study|Withdrawal by Subject|17|||
130505678|NCT00103857|469818777|FG001|54-Week Base Study|Withdrawal by Subject|16|||
130505679|NCT00103857|469818778|FG002|54-Week Base Study|Withdrawal by Subject|16|||
130505680|NCT00103857|469818779|FG003|54-Week Base Study|Withdrawal by Subject|15|||
130505681|NCT00103857|469818780|FG004|54-Week Base Study|Withdrawal by Subject|10|||
130505682|NCT00103857|469818781|FG005|54-Week Base Study|Withdrawal by Subject|15|||
130505683|NCT00103857|469818782|FG006|54-Week Base Study|Withdrawal by Subject|4|||
130505684|NCT00103857|469818776|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
130505685|NCT00103857|469818777|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
130505686|NCT00103857|469818778|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
130505687|NCT00103857|469818779|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
130505688|NCT00103857|469818780|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
130505689|NCT00103857|469818781|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
130505690|NCT00103857|469818782|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
130505691|NCT00103857|469818776|FG000|54-Week Base Study|patient moved|0|||
130505692|NCT00103857|469818777|FG001|54-Week Base Study|patient moved|1|||
130505693|NCT00103857|469818778|FG002|54-Week Base Study|patient moved|1|||
130505694|NCT00103857|469818779|FG003|54-Week Base Study|patient moved|2|||
130505695|NCT00103857|469818780|FG004|54-Week Base Study|patient moved|3|||
130505696|NCT00103857|469818781|FG005|54-Week Base Study|patient moved|1|||
130505697|NCT00103857|469818782|FG006|54-Week Base Study|patient moved|0|||
130505698|NCT00103857|469818776|FG000|54-Week Base Study|non-compliance with study procedures|1|||
130505699|NCT00103857|469818777|FG001|54-Week Base Study|non-compliance with study procedures|2|||
130505700|NCT00103857|469818778|FG002|54-Week Base Study|non-compliance with study procedures|0|||
130505701|NCT00103857|469818779|FG003|54-Week Base Study|non-compliance with study procedures|0|||
130505702|NCT00103857|469818780|FG004|54-Week Base Study|non-compliance with study procedures|0|||
130505703|NCT00103857|469818781|FG005|54-Week Base Study|non-compliance with study procedures|2|||
130505704|NCT00103857|469818782|FG006|54-Week Base Study|non-compliance with study procedures|0|||
130505705|NCT00103857|469818776|FG000|54-Week Base Study|patient incarcerated|0|||
130505706|NCT00103857|469818777|FG001|54-Week Base Study|patient incarcerated|0|||
130505707|NCT00103857|469818778|FG002|54-Week Base Study|patient incarcerated|0|||
130505708|NCT00103857|469818779|FG003|54-Week Base Study|patient incarcerated|0|||
130505709|NCT00103857|469818780|FG004|54-Week Base Study|patient incarcerated|1|||
130505710|NCT00103857|469818781|FG005|54-Week Base Study|patient incarcerated|1|||
130505711|NCT00103857|469818782|FG006|54-Week Base Study|patient incarcerated|0|||
130505712|NCT00103857|469818776|FG000|54-Week Base Study|laboratory reporting error|0|||
130505713|NCT00103857|469818777|FG001|54-Week Base Study|laboratory reporting error|0|||
130505714|NCT00103857|469818778|FG002|54-Week Base Study|laboratory reporting error|0|||
130505715|NCT00103857|469818779|FG003|54-Week Base Study|laboratory reporting error|0|||
130505716|NCT00103857|469818780|FG004|54-Week Base Study|laboratory reporting error|1|||
130566514|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130505717|NCT00103857|469818781|FG005|54-Week Base Study|laboratory reporting error|0|||
130505718|NCT00103857|469818782|FG006|54-Week Base Study|laboratory reporting error|0|||
130505719|NCT00103857|469818776|FG000|54-Week Base Study|site error|0|||
130505720|NCT00103857|469818777|FG001|54-Week Base Study|site error|0|||
130505721|NCT00103857|469818778|FG002|54-Week Base Study|site error|0|||
130505722|NCT00103857|469818779|FG003|54-Week Base Study|site error|0|||
130505723|NCT00103857|469818780|FG004|54-Week Base Study|site error|0|||
130505724|NCT00103857|469818781|FG005|54-Week Base Study|site error|1|||
130505725|NCT00103857|469818782|FG006|54-Week Base Study|site error|0|||
130505726|NCT00103857|469818776|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
130505727|NCT00103857|469818777|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505728|NCT00103857|469818778|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505729|NCT00103857|469818779|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505730|NCT00103857|469818780|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505731|NCT00103857|469818781|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505732|NCT00103857|469818782|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
130505733|NCT00103857|469818776|FG000|50-Week Extension Study|Adverse Event|2|||
130505734|NCT00103857|469818777|FG001|50-Week Extension Study|Adverse Event|3|||
130505735|NCT00103857|469818778|FG002|50-Week Extension Study|Adverse Event|2|||
130505736|NCT00103857|469818779|FG003|50-Week Extension Study|Adverse Event|0|||
130505737|NCT00103857|469818780|FG004|50-Week Extension Study|Adverse Event|1|||
130505738|NCT00103857|469818781|FG005|50-Week Extension Study|Adverse Event|1|||
130505739|NCT00103857|469818782|FG006|50-Week Extension Study|Adverse Event|0|||
130505740|NCT00103857|469818776|FG000|50-Week Extension Study|Death|0|||
130505741|NCT00103857|469818777|FG001|50-Week Extension Study|Death|0|||
130505742|NCT00103857|469818778|FG002|50-Week Extension Study|Death|0|||
130505743|NCT00103857|469818779|FG003|50-Week Extension Study|Death|1|||
130505744|NCT00103857|469818780|FG004|50-Week Extension Study|Death|0|||
130505745|NCT00103857|469818781|FG005|50-Week Extension Study|Death|1|||
130505746|NCT00103857|469818782|FG006|50-Week Extension Study|Death|0|||
130505747|NCT00103857|469818776|FG000|50-Week Extension Study|Lack of Efficacy|26|||
130505748|NCT00103857|469818777|FG001|50-Week Extension Study|Lack of Efficacy|15|||
130505749|NCT00103857|469818778|FG002|50-Week Extension Study|Lack of Efficacy|13|||
130505750|NCT00103857|469818779|FG003|50-Week Extension Study|Lack of Efficacy|16|||
130505751|NCT00103857|469818780|FG004|50-Week Extension Study|Lack of Efficacy|8|||
130505752|NCT00103857|469818781|FG005|50-Week Extension Study|Lack of Efficacy|8|||
130505753|NCT00103857|469818782|FG006|50-Week Extension Study|Lack of Efficacy|0|||
130505754|NCT00103857|469818776|FG000|50-Week Extension Study|Lost to Follow-up|4|||
130505755|NCT00103857|469818777|FG001|50-Week Extension Study|Lost to Follow-up|0|||
130505756|NCT00103857|469818778|FG002|50-Week Extension Study|Lost to Follow-up|1|||
130505757|NCT00103857|469818779|FG003|50-Week Extension Study|Lost to Follow-up|4|||
130505758|NCT00103857|469818780|FG004|50-Week Extension Study|Lost to Follow-up|3|||
130505759|NCT00103857|469818781|FG005|50-Week Extension Study|Lost to Follow-up|3|||
130505760|NCT00103857|469818782|FG006|50-Week Extension Study|Lost to Follow-up|0|||
130505761|NCT00103857|469818776|FG000|50-Week Extension Study|Physician Decision|0|||
130505762|NCT00103857|469818777|FG001|50-Week Extension Study|Physician Decision|1|||
130505763|NCT00103857|469818778|FG002|50-Week Extension Study|Physician Decision|1|||
130505764|NCT00103857|469818779|FG003|50-Week Extension Study|Physician Decision|0|||
130505765|NCT00103857|469818780|FG004|50-Week Extension Study|Physician Decision|0|||
130505766|NCT00103857|469818781|FG005|50-Week Extension Study|Physician Decision|0|||
130505767|NCT00103857|469818782|FG006|50-Week Extension Study|Physician Decision|0|||
130505768|NCT00103857|469818776|FG000|50-Week Extension Study|Pregnancy|0|||
130505769|NCT00103857|469818777|FG001|50-Week Extension Study|Pregnancy|0|||
130505770|NCT00103857|469818778|FG002|50-Week Extension Study|Pregnancy|1|||
130505771|NCT00103857|469818779|FG003|50-Week Extension Study|Pregnancy|0|||
130505772|NCT00103857|469818780|FG004|50-Week Extension Study|Pregnancy|1|||
130505773|NCT00103857|469818781|FG005|50-Week Extension Study|Pregnancy|0|||
130505774|NCT00103857|469818782|FG006|50-Week Extension Study|Pregnancy|0|||
130505775|NCT00103857|469818776|FG000|50-Week Extension Study|Protocol Violation|1|||
130505776|NCT00103857|469818777|FG001|50-Week Extension Study|Protocol Violation|1|||
130505777|NCT00103857|469818778|FG002|50-Week Extension Study|Protocol Violation|1|||
130505778|NCT00103857|469818779|FG003|50-Week Extension Study|Protocol Violation|2|||
130505779|NCT00103857|469818780|FG004|50-Week Extension Study|Protocol Violation|0|||
130566515|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
130505780|NCT00103857|469818781|FG005|50-Week Extension Study|Protocol Violation|1|||
130505781|NCT00103857|469818782|FG006|50-Week Extension Study|Protocol Violation|0|||
130505782|NCT00103857|469818776|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
130505783|NCT00103857|469818777|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
130505784|NCT00103857|469818778|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
130505785|NCT00103857|469818779|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
130505786|NCT00103857|469818780|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
130505787|NCT00103857|469818781|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
130505788|NCT00103857|469818782|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
130505789|NCT00103857|469818776|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
130505790|NCT00103857|469818777|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
130505791|NCT00103857|469818778|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
130505792|NCT00103857|469818779|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
130505793|NCT00103857|469818780|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
130505794|NCT00103857|469818781|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
130505795|NCT00103857|469818782|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
130505796|NCT00103857|469818776|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
130505797|NCT00103857|469818777|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
130505798|NCT00103857|469818778|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
130505799|NCT00103857|469818779|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
130566516|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130566517|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130566518|NCT00492752|470039606|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
130566519|NCT00492752|470039607|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130566520|NCT00492752|470039608|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130566521|NCT00492752|470039609|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130566522|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
130566523|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
130566524|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
130566525|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
130566526|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
130566527|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
130566528|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
130566529|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
130566530|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
130566531|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
130566532|NCT00219284|470039610|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
130566533|NCT00219284|470039611|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
130566534|NCT00219284|470039610|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
130566535|NCT00219284|470039611|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
130566536|NCT00219284|470039610|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
130566537|NCT00219284|470039611|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
130566538|NCT00219284|470039610|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
130566539|NCT00219284|470039611|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
130566540|NCT01357655|470039612|FG000|Overall Study|Administrative Reason by Sponsor|45|||
130566541|NCT01357655|470039613|FG001|Overall Study|Administrative Reason by Sponsor|0|||
130566542|NCT01357655|470039612|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130566543|NCT01357655|470039613|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130566544|NCT01357655|470039612|FG000|Overall Study|Disease Progression|1|||
130566545|NCT01357655|470039613|FG001|Overall Study|Disease Progression|0|||
130566546|NCT01357655|470039612|FG000|Overall Study|Lost to Follow-up|2|||
130566547|NCT01357655|470039613|FG001|Overall Study|Lost to Follow-up|0|||
130566548|NCT01357655|470039612|FG000|Overall Study|Maximum Clinical Benefit|2|||
130566549|NCT01357655|470039613|FG001|Overall Study|Maximum Clinical Benefit|0|||
130566550|NCT01357655|470039612|FG000|Overall Study|Reason Unspecified|1|||
130566551|NCT01357655|470039613|FG001|Overall Study|Reason Unspecified|0|||
130566552|NCT01357655|470039612|FG000|Overall Study|Study Drug Toxicity|11|||
130566553|NCT01357655|470039613|FG001|Overall Study|Study Drug Toxicity|0|||
130566554|NCT01357655|470039612|FG000|Overall Study|Subject Withdrew Consent|1|||
130566555|NCT01357655|470039613|FG001|Overall Study|Subject Withdrew Consent|0|||
130566556|NCT00609986|470039614|FG000|Overall Study|Did not receive transplant or treatment|8|||
130566557|NCT00609986|470039615|FG001|Overall Study|Did not receive transplant or treatment|3|||
130566558|NCT04722042|470039617|FG000|Overall Study|Withdrawal by Subject|2|||
130566559|NCT04722042|470039618|FG001|Overall Study|Withdrawal by Subject|1|||
130566560|NCT04722042|470039619|FG002|Overall Study|Withdrawal by Subject|0|||
130731742|NCT01171898|470640981|FG001|Overall Study|Withdrawal by Subject|4|||
130731743|NCT01171898|470640982|FG002|Overall Study|Withdrawal by Subject|6|||
130731744|NCT01171898|470640983|FG003|Overall Study|Withdrawal by Subject|3|||
130566561|NCT02090413|470039622|FG000|Overall Study|Adverse Event|11|||
130505800|NCT00103857|469818780|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
130505801|NCT00103857|469818781|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
130505802|NCT00103857|469818782|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
130505803|NCT00103857|469818776|FG000|50-Week Extension Study|patient moved|0|||
130505804|NCT00103857|469818777|FG001|50-Week Extension Study|patient moved|0|||
130505805|NCT00103857|469818778|FG002|50-Week Extension Study|patient moved|1|||
130505806|NCT00103857|469818779|FG003|50-Week Extension Study|patient moved|2|||
130505807|NCT00103857|469818780|FG004|50-Week Extension Study|patient moved|0|||
130505808|NCT00103857|469818781|FG005|50-Week Extension Study|patient moved|0|||
130505809|NCT00103857|469818782|FG006|50-Week Extension Study|patient moved|0|||
130505810|NCT00103857|469818776|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505811|NCT00103857|469818777|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505812|NCT00103857|469818778|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
130505813|NCT00103857|469818779|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505814|NCT00103857|469818780|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505815|NCT00103857|469818781|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505816|NCT00103857|469818782|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
130505817|NCT00103857|469818776|FG000|50-Week Extension Study|reason unspecified|0|||
130505818|NCT00103857|469818777|FG001|50-Week Extension Study|reason unspecified|0|||
130505819|NCT00103857|469818778|FG002|50-Week Extension Study|reason unspecified|0|||
130505820|NCT00103857|469818779|FG003|50-Week Extension Study|reason unspecified|0|||
130505821|NCT00103857|469818780|FG004|50-Week Extension Study|reason unspecified|1|||
130505822|NCT00103857|469818781|FG005|50-Week Extension Study|reason unspecified|0|||
130505823|NCT00103857|469818782|FG006|50-Week Extension Study|reason unspecified|0|||
130505824|NCT01005914|469818783|FG000|Overall Study|Adverse Event|4|||
130505825|NCT01005914|469818783|FG000|Overall Study|Death|4|||
130505826|NCT01005914|469818783|FG000|Overall Study|Lack of Efficacy|1|||
130505827|NCT01005914|469818783|FG000|Overall Study|Withdrawal by Subject|1|||
130505828|NCT01240785|469818785|FG000|Overall Study|Lost to Follow-up|1|||
130505829|NCT01240785|469818786|FG001|Overall Study|Lost to Follow-up|0|||
130505830|NCT01240785|469818785|FG000|Overall Study|Protocol Violation|0|||
130505831|NCT01240785|469818786|FG001|Overall Study|Protocol Violation|3|||
130505832|NCT02132195|469818789|FG000|Initial Assignment|Relapsed|14|||
130505833|NCT02132195|469818790|FG001|Initial Assignment|Relapsed|0|||
130505834|NCT02132195|469818791|FG002|Initial Assignment|Relapsed|0|||
130505835|NCT02132195|469818789|FG000|Rescue Therapy|Relapsed|0|||
130505836|NCT02132195|469818790|FG001|Rescue Therapy|Relapsed|0|||
130505837|NCT02132195|469818791|FG002|Rescue Therapy|Relapsed|7|||
130505838|NCT02132195|469818789|FG000|Rescue Therapy|Physician Decision|0|||
130505839|NCT02132195|469818790|FG001|Rescue Therapy|Physician Decision|0|||
130505840|NCT02132195|469818791|FG002|Rescue Therapy|Physician Decision|1|||
130505841|NCT02132195|469818789|FG000|Rescue Therapy|Withdrawal by Subject|0|||
130505842|NCT02132195|469818790|FG001|Rescue Therapy|Withdrawal by Subject|0|||
130505843|NCT02132195|469818791|FG002|Rescue Therapy|Withdrawal by Subject|1|||
130505844|NCT02132195|469818789|FG000|Rescue Therapy|Adverse Event|0|||
130505845|NCT02132195|469818790|FG001|Rescue Therapy|Adverse Event|0|||
130505846|NCT02132195|469818791|FG002|Rescue Therapy|Adverse Event|2|||
130566562|NCT02090413|470039623|FG001|Overall Study|Adverse Event|15|||
130731745|NCT01171898|470640980|FG000|Overall Study|Terminated by Sponsor|1|||
130731746|NCT01171898|470640981|FG001|Overall Study|Terminated by Sponsor|0|||
130731747|NCT01171898|470640982|FG002|Overall Study|Terminated by Sponsor|0|||
130731748|NCT01171898|470640983|FG003|Overall Study|Terminated by Sponsor|0|||
130731749|NCT01171898|470640980|FG000|Overall Study|Ongoing|1|||
130731750|NCT01171898|470640981|FG001|Overall Study|Ongoing|9|||
130731751|NCT01171898|470640982|FG002|Overall Study|Ongoing|3|||
130731752|NCT01171898|470640983|FG003|Overall Study|Ongoing|0|||
130731753|NCT01171898|470640980|FG000|Overall Study|Other|1|||
130731754|NCT01171898|470640981|FG001|Overall Study|Other|5|||
130731755|NCT01171898|470640982|FG002|Overall Study|Other|0|||
130731756|NCT01171898|470640983|FG003|Overall Study|Other|2|||
130731757|NCT05037097|470640984|FG000|Overall Study|Withdrawal by Subject|0|||
130731758|NCT05037097|470640985|FG001|Overall Study|Withdrawal by Subject|1|||
130731759|NCT05037097|470640986|FG002|Overall Study|Withdrawal by Subject|0|||
130731760|NCT05037097|470640987|FG003|Overall Study|Withdrawal by Subject|1|||
130731761|NCT05037097|470640988|FG004|Overall Study|Withdrawal by Subject|0|||
130731762|NCT05037097|470640989|FG005|Overall Study|Withdrawal by Subject|2|||
130731763|NCT05037097|470640990|FG006|Overall Study|Withdrawal by Subject|0|||
130731764|NCT05037097|470640991|FG007|Overall Study|Withdrawal by Subject|0|||
130731765|NCT05037097|470640984|FG000|Overall Study|Lost to Follow-up|0|||
130731766|NCT05037097|470640985|FG001|Overall Study|Lost to Follow-up|1|||
130731767|NCT05037097|470640986|FG002|Overall Study|Lost to Follow-up|0|||
130731768|NCT05037097|470640987|FG003|Overall Study|Lost to Follow-up|0|||
130731769|NCT05037097|470640988|FG004|Overall Study|Lost to Follow-up|1|||
130731770|NCT05037097|470640989|FG005|Overall Study|Lost to Follow-up|1|||
130731771|NCT05037097|470640990|FG006|Overall Study|Lost to Follow-up|0|||
130731772|NCT05037097|470640991|FG007|Overall Study|Lost to Follow-up|0|||
130731773|NCT04201288|470640994|FG000|Overall Study|Death|1|||
130731774|NCT04201288|470640995|FG001|Overall Study|Death|1|||
130566563|NCT02090413|470039624|FG002|Overall Study|Adverse Event|20|||
130731775|NCT04201288|470640994|FG000|Overall Study|Lost to Follow-up|5|||
130731776|NCT04201288|470640995|FG001|Overall Study|Lost to Follow-up|3|||
130731777|NCT04201288|470640994|FG000|Overall Study|Withdrawal by Subject|1|||
130731778|NCT04201288|470640995|FG001|Overall Study|Withdrawal by Subject|0|||
130731779|NCT02038842|470640996|FG000|Overall Study|Withdrawal by Subject|2|||
130731780|NCT02038842|470640997|FG001|Overall Study|Withdrawal by Subject|2|||
130731781|NCT02038842|470640998|FG002|Overall Study|Withdrawal by Subject|0|||
130731782|NCT02038842|470640999|FG003|Overall Study|Withdrawal by Subject|0|||
130731783|NCT02038842|470640996|FG000|Overall Study|Participant decision|0|||
130731784|NCT02038842|470640997|FG001|Overall Study|Participant decision|0|||
130731785|NCT02038842|470640998|FG002|Overall Study|Participant decision|2|||
130731786|NCT02038842|470640999|FG003|Overall Study|Participant decision|1|||
130731787|NCT02038842|470640996|FG000|Overall Study|Adverse Event|0|||
130731788|NCT02038842|470640997|FG001|Overall Study|Adverse Event|0|||
130731789|NCT02038842|470640998|FG002|Overall Study|Adverse Event|3|||
130731790|NCT02038842|470640999|FG003|Overall Study|Adverse Event|1|||
130566564|NCT02090413|470039622|FG000|Overall Study|Flushing event|2|||
130566565|NCT02090413|470039623|FG001|Overall Study|Flushing event|0|||
130566566|NCT02090413|470039624|FG002|Overall Study|Flushing event|1|||
130566567|NCT02090413|470039622|FG000|Overall Study|Withdrawal by Subject|2|||
130566568|NCT02090413|470039623|FG001|Overall Study|Withdrawal by Subject|2|||
130566569|NCT02090413|470039624|FG002|Overall Study|Withdrawal by Subject|2|||
130566570|NCT02090413|470039622|FG000|Overall Study|Investigator Decision|1|||
130566571|NCT02090413|470039623|FG001|Overall Study|Investigator Decision|1|||
130566572|NCT02090413|470039624|FG002|Overall Study|Investigator Decision|0|||
130566573|NCT02090413|470039622|FG000|Overall Study|Other|2|||
130566574|NCT02090413|470039623|FG001|Overall Study|Other|1|||
130566575|NCT02090413|470039624|FG002|Overall Study|Other|0|||
130566576|NCT02090413|470039622|FG000|Overall Study|Lost to Follow-up|1|||
130566577|NCT02090413|470039623|FG001|Overall Study|Lost to Follow-up|1|||
130566578|NCT02090413|470039624|FG002|Overall Study|Lost to Follow-up|0|||
130566579|NCT01293968|470039625|FG000|Overall Study|non-cooperation|3|||
130566580|NCT01293968|470039626|FG001|Overall Study|non-cooperation|3|||
130566581|NCT03577730|470041467|FG000|Overall Study|Physician Decision|3|||
130566582|NCT03577730|470041468|FG001|Overall Study|Physician Decision|1|||
130566583|NCT03577730|470041467|FG000|Overall Study|Did not receive allocated intervention|1|||
130566584|NCT03577730|470041468|FG001|Overall Study|Did not receive allocated intervention|0|||
130566585|NCT01911442|470041470|FG000|Overall Study|Adverse Event|2|||
130566586|NCT01911442|470041471|FG001|Overall Study|Adverse Event|2|||
130566587|NCT01911442|470041472|FG002|Overall Study|Adverse Event|4|||
130566588|NCT01911442|470041470|FG000|Overall Study|Lack of Efficacy|1|||
130566589|NCT01911442|470041471|FG001|Overall Study|Lack of Efficacy|1|||
130566590|NCT01911442|470041472|FG002|Overall Study|Lack of Efficacy|1|||
130566591|NCT01911442|470041470|FG000|Overall Study|Lost to Follow-up|2|||
130566592|NCT01911442|470041471|FG001|Overall Study|Lost to Follow-up|0|||
130566593|NCT01911442|470041472|FG002|Overall Study|Lost to Follow-up|1|||
130566594|NCT01911442|470041470|FG000|Overall Study|Withdrawal by Subject|1|||
130566595|NCT01911442|470041471|FG001|Overall Study|Withdrawal by Subject|0|||
130566596|NCT01911442|470041472|FG002|Overall Study|Withdrawal by Subject|6|||
130566597|NCT01911442|470041470|FG000|Overall Study|Mother's Work Schedule|0|||
130566598|NCT01911442|470041471|FG001|Overall Study|Mother's Work Schedule|1|||
130566599|NCT01911442|470041472|FG002|Overall Study|Mother's Work Schedule|0|||
130566600|NCT00122681|470041473|FG000|Overall Study|Adverse Event|20|||
130566601|NCT00122681|470041474|FG001|Overall Study|Adverse Event|16|||
130566602|NCT00122681|470041473|FG000|Overall Study|Lost to Follow-up|1080|||
130566603|NCT00122681|470041474|FG001|Overall Study|Lost to Follow-up|1097|||
130505847|NCT03065400|469818792|FG000|Overall Study|Adverse Event|1|||
130505848|NCT03065400|469818792|FG000|Overall Study|Physician Decision|3|||
130505849|NCT03065400|469818792|FG000|Overall Study|Withdrawal by Subject|1|||
130505850|NCT03065400|469818792|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
130505851|NCT03072862|469818793|FG000|Overall Study|Withdrawal by Subject|4|||
130505852|NCT03072862|469818793|FG000|Overall Study|Lost to Follow-up|6|||
130505853|NCT03072862|469818793|FG000|Overall Study|Protocol Violation|4|||
130505854|NCT03072862|469818793|FG000|Overall Study|Physician Decision|2|||
130505855|NCT03072862|469818793|FG000|Overall Study|Death|1|||
130505856|NCT03072862|469818793|FG000|Overall Study|Adverse Event|1|||
130505857|NCT00853957|469818794|FG000|Overall Study|Adverse Event|9|||
130505858|NCT00853957|469818795|FG001|Overall Study|Adverse Event|3|||
130505859|NCT00853957|469818794|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130505860|NCT00853957|469818795|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130505861|NCT00853957|469818794|FG000|Overall Study|Subject withdrew consent|4|||
130505862|NCT00853957|469818795|FG001|Overall Study|Subject withdrew consent|5|||
130505863|NCT00853957|469818794|FG000|Overall Study|Lost to Follow-up|1|||
130505864|NCT00853957|469818795|FG001|Overall Study|Lost to Follow-up|6|||
130566604|NCT00122681|470041473|FG000|Overall Study|Protocol Violation|7|||
130566605|NCT00122681|470041474|FG001|Overall Study|Protocol Violation|10|||
130566606|NCT00122681|470041473|FG000|Overall Study|Withdrawal by Subject|257|||
130566607|NCT00122681|470041474|FG001|Overall Study|Withdrawal by Subject|251|||
130566608|NCT00122681|470041473|FG000|Overall Study|Personal reasons|150|||
130566609|NCT00122681|470041474|FG001|Overall Study|Personal reasons|147|||
130566610|NCT01349465|470041475|FG000|Overall Study|Adverse Event|1|||
130566611|NCT01349465|470041476|FG001|Overall Study|Adverse Event|0|||
130505865|NCT00853957|469818794|FG000|Overall Study|Protocol deviation|0|||
130566612|NCT01349465|470041475|FG000|Overall Study|Death|3|||
130566613|NCT01349465|470041476|FG001|Overall Study|Death|0|||
130566614|NCT01349465|470041475|FG000|Overall Study|Lost to Follow-up|10|||
130566615|NCT01349465|470041476|FG001|Overall Study|Lost to Follow-up|1|||
130505866|NCT00853957|469818795|FG001|Overall Study|Protocol deviation|3|||
130505867|NCT02158806|469818796|FG000|Overall Study|Death|2|||
130505868|NCT02158806|469818797|FG001|Overall Study|Death|0|||
130505869|NCT02158806|469818796|FG000|Overall Study|Withdrawal by Subject|2|||
130566616|NCT01349465|470041475|FG000|Overall Study|Withdrawal by Subject|4|||
130566617|NCT01349465|470041476|FG001|Overall Study|Withdrawal by Subject|2|||
130566618|NCT01349465|470041475|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
130731791|NCT02038842|470640996|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
130731792|NCT02038842|470640997|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
130731793|NCT02038842|470640998|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
130731794|NCT02038842|470640999|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
130731795|NCT03412773|470641000|FG000|Overall Study|Lost to Follow-up|0|||
130731796|NCT03412773|470641001|FG001|Overall Study|Lost to Follow-up|7|||
130505870|NCT02158806|469818797|FG001|Overall Study|Withdrawal by Subject|0|||
130505871|NCT02158806|469818796|FG000|Overall Study|Lost to Follow-up|0|||
130505872|NCT02158806|469818797|FG001|Overall Study|Lost to Follow-up|3|||
130505873|NCT02158806|469818796|FG000|Overall Study|Moved out of area|0|||
130505874|NCT02158806|469818797|FG001|Overall Study|Moved out of area|1|||
130505875|NCT02158806|469818796|FG000|Overall Study|Transferred to palliative care|0|||
130505876|NCT02158806|469818797|FG001|Overall Study|Transferred to palliative care|1|||
130505877|NCT02340806|469818798|FG000|Overall Study|Protocol Violation|2|||
130505878|NCT02340806|469818799|FG001|Overall Study|Protocol Violation|0|||
130505879|NCT02340806|469818798|FG000|Overall Study|epidural catheter replaced|2|||
130505880|NCT02340806|469818799|FG001|Overall Study|epidural catheter replaced|1|||
130505881|NCT02340806|469818798|FG000|Overall Study|history of chronic pain medication|1|||
130505882|NCT02340806|469818799|FG001|Overall Study|history of chronic pain medication|0|||
130505883|NCT02340806|469818798|FG000|Overall Study|re-dose < 90 min of CSE|1|||
130505884|NCT02340806|469818799|FG001|Overall Study|re-dose < 90 min of CSE|3|||
130505885|NCT00452452|469818800|FG000|Overall Study|Protocol Violation|0|||
130505886|NCT00452452|469818801|FG001|Overall Study|Protocol Violation|0|||
130505887|NCT00452452|469818802|FG002|Overall Study|Protocol Violation|1|||
130505888|NCT00452452|469818800|FG000|Overall Study|Withdrawal by Subject|1|||
130505889|NCT00452452|469818801|FG001|Overall Study|Withdrawal by Subject|0|||
130505890|NCT00452452|469818802|FG002|Overall Study|Withdrawal by Subject|0|||
130505891|NCT00452452|469818800|FG000|Overall Study|Lost to Follow-up|1|||
130505892|NCT00452452|469818801|FG001|Overall Study|Lost to Follow-up|0|||
130505893|NCT00452452|469818802|FG002|Overall Study|Lost to Follow-up|0|||
130505894|NCT03070301|469818804|FG000|Overall Study|Progression of disease|16|||
130505895|NCT03070301|469818804|FG000|Overall Study|Physician Decision|3|||
130505896|NCT03070301|469818804|FG000|Overall Study|Withdrawal by Subject|1|||
130505897|NCT04520256|469818808|FG000|Overall Study|Lost to Follow-up|6|||
130505898|NCT04520256|469818809|FG001|Overall Study|Lost to Follow-up|4|||
130505899|NCT04520256|469818810|FG002|Overall Study|Lost to Follow-up|2|||
130505900|NCT04520256|469818811|FG003|Overall Study|Lost to Follow-up|3|||
130505901|NCT04520256|469818812|FG004|Overall Study|Lost to Follow-up|6|||
130505902|NCT04520256|469818813|FG005|Overall Study|Lost to Follow-up|6|||
130505903|NCT04520256|469818814|FG006|Overall Study|Lost to Follow-up|4|||
130505904|NCT04520256|469818815|FG007|Overall Study|Lost to Follow-up|6|||
130505905|NCT04520256|469818816|FG008|Overall Study|Lost to Follow-up|1|||
130505906|NCT04520256|469818817|FG009|Overall Study|Lost to Follow-up|3|||
130505907|NCT04520256|469818818|FG010|Overall Study|Lost to Follow-up|3|||
130505908|NCT04520256|469818819|FG011|Overall Study|Lost to Follow-up|2|||
130505909|NCT04520256|469818820|FG012|Overall Study|Lost to Follow-up|5|||
130505910|NCT04520256|469818821|FG013|Overall Study|Lost to Follow-up|3|||
130505911|NCT04520256|469818822|FG014|Overall Study|Lost to Follow-up|3|||
130505912|NCT04520256|469818823|FG015|Overall Study|Lost to Follow-up|6|||
130505913|NCT04520256|469818824|FG016|Overall Study|Lost to Follow-up|6|||
130505914|NCT04520256|469818825|FG017|Overall Study|Lost to Follow-up|4|||
130505915|NCT04520256|469818826|FG018|Overall Study|Lost to Follow-up|3|||
130505916|NCT04520256|469818827|FG019|Overall Study|Lost to Follow-up|3|||
130505917|NCT04520256|469818828|FG020|Overall Study|Lost to Follow-up|7|||
130505918|NCT04520256|469818829|FG021|Overall Study|Lost to Follow-up|3|||
130505919|NCT04520256|469818830|FG022|Overall Study|Lost to Follow-up|3|||
130505920|NCT04520256|469818831|FG023|Overall Study|Lost to Follow-up|8|||
130505921|NCT04520256|469818832|FG024|Overall Study|Lost to Follow-up|5|||
130505922|NCT04520256|469818833|FG025|Overall Study|Lost to Follow-up|4|||
130505923|NCT04520256|469818834|FG026|Overall Study|Lost to Follow-up|3|||
130505924|NCT04520256|469818835|FG027|Overall Study|Lost to Follow-up|4|||
130731797|NCT03412773|470641002|FG002|Overall Study|Lost to Follow-up|6|||
130731798|NCT03412773|470641000|FG000|Overall Study|Withdrawal by Subject|0|||
130731799|NCT03412773|470641001|FG001|Overall Study|Withdrawal by Subject|15|||
130731800|NCT03412773|470641002|FG002|Overall Study|Withdrawal by Subject|19|||
130731801|NCT03412773|470641000|FG000|Overall Study|Study Closed By Sponsor|3|||
130505925|NCT04520256|469818836|FG028|Overall Study|Lost to Follow-up|3|||
130505926|NCT04520256|469818837|FG029|Overall Study|Lost to Follow-up|4|||
130505927|NCT04520256|469818838|FG030|Overall Study|Lost to Follow-up|4|||
130505928|NCT04520256|469818839|FG031|Overall Study|Lost to Follow-up|4|||
130505929|NCT01072149|469820718|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505930|NCT01072149|469820719|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505931|NCT01072149|469820720|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130505932|NCT01072149|469820721|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505933|NCT01072149|469820722|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505934|NCT01072149|469820723|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505935|NCT01072149|469820724|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505936|NCT01072149|469820725|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505937|NCT01072149|469820726|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505938|NCT01072149|469820727|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505939|NCT01072149|469820728|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505940|NCT01072149|469820729|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505941|NCT01072149|469820730|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505942|NCT01072149|469820731|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505943|NCT01072149|469820732|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505944|NCT01072149|469820733|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505945|NCT01072149|469820734|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505946|NCT01072149|469820735|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130505947|NCT01072149|469820718|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505948|NCT01072149|469820719|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505949|NCT01072149|469820720|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505950|NCT01072149|469820721|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505951|NCT01072149|469820722|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505952|NCT01072149|469820723|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505953|NCT01072149|469820724|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505954|NCT01072149|469820725|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505955|NCT01072149|469820726|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505956|NCT01072149|469820727|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505957|NCT01072149|469820728|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505958|NCT01072149|469820729|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505959|NCT01072149|469820730|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505960|NCT01072149|469820731|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505961|NCT01072149|469820732|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505962|NCT01072149|469820733|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505963|NCT01072149|469820734|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
130505964|NCT01072149|469820735|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
130505965|NCT01072149|469820718|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505966|NCT01072149|469820719|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505967|NCT01072149|469820720|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505968|NCT01072149|469820721|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505969|NCT01072149|469820722|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505970|NCT01072149|469820723|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505971|NCT01072149|469820724|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505972|NCT01072149|469820725|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505973|NCT01072149|469820726|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505974|NCT01072149|469820727|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505975|NCT01072149|469820728|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
130505976|NCT01072149|469820729|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505977|NCT01072149|469820730|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505978|NCT01072149|469820731|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505979|NCT01072149|469820732|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505980|NCT01072149|469820733|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505981|NCT01072149|469820734|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130731802|NCT03412773|470641001|FG001|Overall Study|Study Closed By Sponsor|46|||
130731803|NCT03412773|470641002|FG002|Overall Study|Study Closed By Sponsor|33|||
130731804|NCT03412773|470641000|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
130731805|NCT03412773|470641001|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
130731806|NCT03412773|470641002|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
130731807|NCT03412773|470641000|FG000|Overall Study|Death|7|||
130731808|NCT03412773|470641001|FG001|Overall Study|Death|259|||
130731809|NCT03412773|470641002|FG002|Overall Study|Death|273|||
130731810|NCT03412773|470641000|FG000|Overall Study|Physician Decision|0|||
130731811|NCT03412773|470641001|FG001|Overall Study|Physician Decision|0|||
130731812|NCT03412773|470641002|FG002|Overall Study|Physician Decision|1|||
130731813|NCT04510857|470641003|FG000|Overall Study|Withdrawal by Subject|1|||
130731814|NCT04510857|470641004|FG001|Overall Study|Withdrawal by Subject|2|||
130731815|NCT02819362|470641005|FG000|Overall Study|On-site MRI could not be performed|70|||
130731816|NCT05301751|470641010|FG000|Overall Study|Withdrawal by Subject|0|||
130731817|NCT05301751|470641011|FG001|Overall Study|Withdrawal by Subject|0|||
130731818|NCT05301751|470641012|FG002|Overall Study|Withdrawal by Subject|1|||
130731819|NCT05301751|470641013|FG003|Overall Study|Withdrawal by Subject|0|||
130731820|NCT05332912|470641016|FG000|Overall Study|Withdrawal by Subject|0|||
130731821|NCT05332912|470641017|FG001|Overall Study|Withdrawal by Subject|1|||
130731822|NCT05332912|470641018|FG002|Overall Study|Withdrawal by Subject|2|||
130731823|NCT05332912|470641019|FG003|Overall Study|Withdrawal by Subject|0|||
130731824|NCT05332912|470641016|FG000|Overall Study|Lost to Follow-up|0|||
130731825|NCT05332912|470641017|FG001|Overall Study|Lost to Follow-up|0|||
130505982|NCT01072149|469820735|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130505983|NCT01072149|469820718|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505984|NCT01072149|469820719|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
130505985|NCT01072149|469820720|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505986|NCT01072149|469820721|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505987|NCT01072149|469820722|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505988|NCT01072149|469820723|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505989|NCT01072149|469820724|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505990|NCT01072149|469820725|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505991|NCT01072149|469820726|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505992|NCT01072149|469820727|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505993|NCT01072149|469820728|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505994|NCT01072149|469820729|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505995|NCT01072149|469820730|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505996|NCT01072149|469820731|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505997|NCT01072149|469820732|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505998|NCT01072149|469820733|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130505999|NCT01072149|469820734|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130506000|NCT01072149|469820735|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130506001|NCT01072149|469820718|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506002|NCT01072149|469820719|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506003|NCT01072149|469820720|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
130506004|NCT01072149|469820721|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506005|NCT01072149|469820722|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506006|NCT01072149|469820723|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506007|NCT01072149|469820724|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506008|NCT01072149|469820725|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506009|NCT01072149|469820726|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506010|NCT01072149|469820727|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506011|NCT01072149|469820728|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506012|NCT01072149|469820729|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506013|NCT01072149|469820730|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506014|NCT01072149|469820731|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506015|NCT01072149|469820732|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506016|NCT01072149|469820733|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506017|NCT01072149|469820734|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506018|NCT01072149|469820735|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
130506019|NCT01072149|469820718|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506020|NCT01072149|469820719|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506021|NCT01072149|469820720|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506022|NCT01072149|469820721|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506023|NCT01072149|469820722|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506024|NCT01072149|469820723|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
130731826|NCT05332912|470641018|FG002|Overall Study|Lost to Follow-up|1|||
130731827|NCT05332912|470641019|FG003|Overall Study|Lost to Follow-up|0|||
130731828|NCT01546987|470641022|FG000|Overall Study|Protocol Violation|3|||
130731829|NCT01546987|470641023|FG001|Overall Study|Protocol Violation|4|||
130731830|NCT02710123|470641024|FG000|Overall Study|Lost to Follow-up|3|||
130731831|NCT02710123|470641025|FG001|Overall Study|Lost to Follow-up|4|||
130731832|NCT02710123|470641024|FG000|Overall Study|Withdrawal by Subject|1|||
130731833|NCT02710123|470641025|FG001|Overall Study|Withdrawal by Subject|1|||
130731834|NCT02710123|470641024|FG000|Overall Study|Illness unrelated to study intervention|1|||
130731835|NCT02710123|470641025|FG001|Overall Study|Illness unrelated to study intervention|0|||
130731836|NCT05381948|470641026|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
130731837|NCT05381948|470641027|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
130731838|NCT05381948|470641028|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
130731839|NCT05381948|470641026|FG000|Overall Study|Adverse Event: Non-ocular|0|||
130731840|NCT05381948|470641027|FG001|Overall Study|Adverse Event: Non-ocular|1|||
130731841|NCT05381948|470641028|FG002|Overall Study|Adverse Event: Non-ocular|0|||
130731842|NCT05381948|470641026|FG000|Overall Study|Lost to Follow-up|1|||
130731843|NCT05381948|470641027|FG001|Overall Study|Lost to Follow-up|0|||
130731844|NCT05381948|470641028|FG002|Overall Study|Lost to Follow-up|0|||
130731845|NCT05381948|470641026|FG000|Overall Study|Protocol Deviation|0|||
130731846|NCT05381948|470641027|FG001|Overall Study|Protocol Deviation|2|||
130731847|NCT05381948|470641028|FG002|Overall Study|Protocol Deviation|0|||
130731848|NCT05381948|470641026|FG000|Overall Study|Withdrawal by Subject|1|||
130731849|NCT05381948|470641027|FG001|Overall Study|Withdrawal by Subject|0|||
130731850|NCT05381948|470641028|FG002|Overall Study|Withdrawal by Subject|1|||
130731851|NCT05381948|470641026|FG000|Overall Study|Death|0|||
130731852|NCT05381948|470641027|FG001|Overall Study|Death|2|||
130506025|NCT01072149|469820724|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506026|NCT01072149|469820725|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
130506027|NCT01072149|469820726|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506028|NCT01072149|469820727|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506029|NCT01072149|469820728|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506030|NCT01072149|469820729|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506031|NCT01072149|469820730|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506032|NCT01072149|469820731|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506033|NCT01072149|469820732|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506034|NCT01072149|469820733|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506035|NCT01072149|469820734|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506036|NCT01072149|469820735|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
130506037|NCT01072149|469820718|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
130506038|NCT01072149|469820719|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
130506039|NCT01072149|469820720|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
130506040|NCT01072149|469820721|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
130506041|NCT01072149|469820722|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
130506042|NCT01072149|469820723|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
130506043|NCT01072149|469820724|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
130506044|NCT01072149|469820725|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
130506045|NCT01072149|469820726|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
130506046|NCT01072149|469820727|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
130506047|NCT01072149|469820728|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
130506048|NCT01072149|469820729|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
130506049|NCT01072149|469820730|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
130506050|NCT01072149|469820731|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
130506051|NCT01072149|469820732|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
130506052|NCT01072149|469820733|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
130506053|NCT01072149|469820734|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
130506054|NCT01072149|469820735|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
130506055|NCT01072149|469820718|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506056|NCT01072149|469820719|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506057|NCT01072149|469820720|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506058|NCT01072149|469820721|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506059|NCT01072149|469820722|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506060|NCT01072149|469820723|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506061|NCT01072149|469820724|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506062|NCT01072149|469820725|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506063|NCT01072149|469820726|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506064|NCT01072149|469820727|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506065|NCT01072149|469820728|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506066|NCT01072149|469820729|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506067|NCT01072149|469820730|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506068|NCT01072149|469820731|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506069|NCT01072149|469820732|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506070|NCT01072149|469820733|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
130506071|NCT01072149|469820734|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506072|NCT01072149|469820735|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130506073|NCT01072149|469820718|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
130506074|NCT01072149|469820719|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
130506075|NCT01072149|469820720|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
130506076|NCT01072149|469820721|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
130506077|NCT01072149|469820722|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
130506078|NCT01072149|469820723|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
130506079|NCT01072149|469820724|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
130506080|NCT01072149|469820725|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
130506081|NCT01072149|469820726|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
130506082|NCT01072149|469820727|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
130506083|NCT01072149|469820728|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
130506084|NCT01072149|469820729|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
130506085|NCT01072149|469820730|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
130506086|NCT01072149|469820731|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
130506087|NCT01072149|469820732|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
130506088|NCT01072149|469820733|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
130506089|NCT01072149|469820734|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
130506090|NCT01072149|469820735|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
130506091|NCT01072149|469820718|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506092|NCT01072149|469820719|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506093|NCT01072149|469820720|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506094|NCT01072149|469820721|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506095|NCT01072149|469820722|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506096|NCT01072149|469820723|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506097|NCT01072149|469820724|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506098|NCT01072149|469820725|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506099|NCT01072149|469820726|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506100|NCT01072149|469820727|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506101|NCT01072149|469820728|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506102|NCT01072149|469820729|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506103|NCT01072149|469820730|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
130506104|NCT01072149|469820731|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506105|NCT01072149|469820732|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506106|NCT01072149|469820733|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506107|NCT01072149|469820734|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506108|NCT01072149|469820735|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
130506109|NCT01072149|469820718|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506110|NCT01072149|469820719|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506111|NCT01072149|469820720|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
130506112|NCT01072149|469820721|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506113|NCT01072149|469820722|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506114|NCT01072149|469820723|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506115|NCT01072149|469820724|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506116|NCT01072149|469820725|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130731853|NCT05381948|470641028|FG002|Overall Study|Death|0|||
130731854|NCT05381948|470641026|FG000|Overall Study|Discontinued study without receiving study drug|0|||
130731855|NCT05381948|470641027|FG001|Overall Study|Discontinued study without receiving study drug|0|||
130731856|NCT05381948|470641028|FG002|Overall Study|Discontinued study without receiving study drug|1|||
130731857|NCT02942004|470641033|FG000|Overall Study|Withdrawal by Subject|0|||
130731858|NCT02942004|470641034|FG001|Overall Study|Withdrawal by Subject|2|||
130731859|NCT02942004|470641035|FG002|Overall Study|Withdrawal by Subject|3|||
130731860|NCT02942004|470641033|FG000|Overall Study|Lost to Follow-up|1|||
130731861|NCT02942004|470641034|FG001|Overall Study|Lost to Follow-up|1|||
130731862|NCT02942004|470641035|FG002|Overall Study|Lost to Follow-up|2|||
130731863|NCT02942004|470641033|FG000|Overall Study|Randomized but not dosed|3|||
130731864|NCT02942004|470641034|FG001|Overall Study|Randomized but not dosed|9|||
130731865|NCT02942004|470641035|FG002|Overall Study|Randomized but not dosed|4|||
130731866|NCT04517669|470641036|FG000|Overall Study|Lost to Follow-up|2|||
130731867|NCT04517669|470641036|FG000|Overall Study|Withdrawal by Subject|3|||
130731868|NCT04517669|470641036|FG000|Overall Study|Drug withdrawn|44|||
130731869|NCT04517669|470641036|FG000|Overall Study|Other|1|||
130731870|NCT04517669|470641036|FG000|Overall Study|Eligibility criteria not met|4|||
130731871|NCT04517669|470641036|FG000|Overall Study|Did not receive treatment|3|||
130731872|NCT02446132|470641037|FG000|Overall Study|Adverse Event|10|||
130731873|NCT02446132|470641038|FG001|Overall Study|Adverse Event|27|||
130731874|NCT02446132|470641039|FG002|Overall Study|Adverse Event|27|||
130731875|NCT02446132|470641037|FG000|Overall Study|Death|2|||
130731876|NCT02446132|470641038|FG001|Overall Study|Death|13|||
130731877|NCT02446132|470641039|FG002|Overall Study|Death|10|||
130731878|NCT02446132|470641037|FG000|Overall Study|Lack of Efficacy|1|||
130731879|NCT02446132|470641038|FG001|Overall Study|Lack of Efficacy|10|||
130731880|NCT02446132|470641039|FG002|Overall Study|Lack of Efficacy|6|||
130731881|NCT02446132|470641037|FG000|Overall Study|Lost to Follow-up|2|||
130731882|NCT02446132|470641038|FG001|Overall Study|Lost to Follow-up|4|||
130731883|NCT02446132|470641039|FG002|Overall Study|Lost to Follow-up|5|||
130506117|NCT01072149|469820726|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130731884|NCT02446132|470641037|FG000|Overall Study|Non-compliance With Study Drug|2|||
130731885|NCT02446132|470641038|FG001|Overall Study|Non-compliance With Study Drug|2|||
130731886|NCT02446132|470641039|FG002|Overall Study|Non-compliance With Study Drug|3|||
130731887|NCT02446132|470641037|FG000|Overall Study|Physician Decision|1|||
130731888|NCT02446132|470641038|FG001|Overall Study|Physician Decision|8|||
130731889|NCT02446132|470641039|FG002|Overall Study|Physician Decision|13|||
130731890|NCT02446132|470641037|FG000|Overall Study|Protocol Deviation|0|||
130731891|NCT02446132|470641038|FG001|Overall Study|Protocol Deviation|0|||
130506118|NCT01072149|469820727|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506119|NCT01072149|469820728|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506120|NCT01072149|469820729|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130566619|NCT01349465|470041476|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
130506121|NCT01072149|469820730|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506122|NCT01072149|469820731|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
130506123|NCT01072149|469820732|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506124|NCT01072149|469820733|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506125|NCT01072149|469820734|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506126|NCT01072149|469820735|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
130506127|NCT01912599|469820737|FG000|Overall Study|Withdrawal by Subject|0|||
130506128|NCT01912599|469820738|FG001|Overall Study|Withdrawal by Subject|1|||
130506129|NCT03386344|469820740|FG000|Overall Study|Adverse Event|6|||
130506130|NCT03386344|469820741|FG001|Overall Study|Adverse Event|3|||
130506131|NCT03386344|469820742|FG002|Overall Study|Adverse Event|1|||
130506132|NCT03386344|469820740|FG000|Overall Study|Poor Compliance to Protocol|0|||
130506133|NCT03386344|469820741|FG001|Overall Study|Poor Compliance to Protocol|1|||
130506134|NCT03386344|469820742|FG002|Overall Study|Poor Compliance to Protocol|0|||
130506135|NCT03386344|469820740|FG000|Overall Study|Study Terminated by Sponsor|101|||
130506136|NCT03386344|469820741|FG001|Overall Study|Study Terminated by Sponsor|102|||
130506137|NCT03386344|469820742|FG002|Overall Study|Study Terminated by Sponsor|106|||
130506138|NCT03386344|469820740|FG000|Overall Study|Lost to Follow-up|3|||
130506139|NCT03386344|469820741|FG001|Overall Study|Lost to Follow-up|2|||
130506140|NCT03386344|469820742|FG002|Overall Study|Lost to Follow-up|1|||
130506141|NCT03386344|469820740|FG000|Overall Study|At the Participant's own Request|7|||
130506142|NCT03386344|469820741|FG001|Overall Study|At the Participant's own Request|7|||
130506143|NCT03386344|469820742|FG002|Overall Study|At the Participant's own Request|8|||
130506144|NCT03386344|469820740|FG000|Overall Study|Reason not Specified|0|||
130506145|NCT03386344|469820741|FG001|Overall Study|Reason not Specified|1|||
130506146|NCT03386344|469820742|FG002|Overall Study|Reason not Specified|0|||
130506147|NCT01280721|469820745|FG000|Overall Study|Adverse Event|4|||
130506148|NCT01280721|469820745|FG000|Overall Study|Physician Decision|3|||
130506149|NCT01280721|469820745|FG000|Overall Study|Withdrawal by Subject|6|||
130506150|NCT01280721|469820745|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
130506151|NCT01280721|469820745|FG000|Overall Study|No tolerability for the lowest dose|2|||
130506152|NCT01180400|469820746|FG000|Overall Study|Withdrawal by Subject|5|||
130506153|NCT01180400|469820747|FG001|Overall Study|Withdrawal by Subject|6|||
130506154|NCT01180400|469820746|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130506155|NCT01180400|469820747|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130506156|NCT01180400|469820746|FG000|Overall Study|Adverse Event|12|||
130506157|NCT01180400|469820747|FG001|Overall Study|Adverse Event|10|||
130506158|NCT01180400|469820746|FG000|Overall Study|Severe non-compliance to protocol|1|||
130506159|NCT01180400|469820747|FG001|Overall Study|Severe non-compliance to protocol|2|||
130506160|NCT01180400|469820746|FG000|Overall Study|Condition under investigation worsened|2|||
130506161|NCT01180400|469820747|FG001|Overall Study|Condition under investigation worsened|1|||
130506162|NCT01180400|469820746|FG000|Overall Study|Lack of Efficacy|2|||
130506163|NCT01180400|469820747|FG001|Overall Study|Lack of Efficacy|0|||
130506164|NCT01180400|469820746|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130506165|NCT01180400|469820747|FG001|Overall Study|Study-specific withdrawal criteria|2|||
130506166|NCT01180400|469820746|FG000|Overall Study|Lost to Follow-up|2|||
130506167|NCT01180400|469820747|FG001|Overall Study|Lost to Follow-up|3|||
130506168|NCT01180400|469820746|FG000|Overall Study|Other|0|||
130506169|NCT01180400|469820747|FG001|Overall Study|Other|1|||
130506170|NCT00963924|469820748|FG000|Overall Study|Adverse Event|1|||
130506171|NCT00963924|469820749|FG001|Overall Study|Adverse Event|0|||
130506172|NCT00963924|469820748|FG000|Overall Study|Withdrawal by Subject|0|||
130506173|NCT00963924|469820749|FG001|Overall Study|Withdrawal by Subject|1|||
130506174|NCT00963924|469820748|FG000|Overall Study|Changed antipsychotic|0|||
130506175|NCT00963924|469820749|FG001|Overall Study|Changed antipsychotic|1|||
130506176|NCT00963924|469820748|FG000|Overall Study|Lost to Follow-up|0|||
130506177|NCT00963924|469820749|FG001|Overall Study|Lost to Follow-up|1|||
130506178|NCT03031782|469820754|FG000|Treatment Period 1|Lack of Efficacy|3|||
130506179|NCT03031782|469820755|FG001|Treatment Period 1|Lack of Efficacy|0|||
130506180|NCT03031782|469820756|FG002|Treatment Period 1|Lack of Efficacy|0|||
130506181|NCT03031782|469820757|FG003|Treatment Period 1|Lack of Efficacy|0|||
130506182|NCT03031782|469820758|FG004|Treatment Period 1|Lack of Efficacy|0|||
130506183|NCT03031782|469820754|FG000|Treatment Period 2|Physician Decision|0|||
130506184|NCT03031782|469820755|FG001|Treatment Period 2|Physician Decision|1|||
130506185|NCT03031782|469820756|FG002|Treatment Period 2|Physician Decision|0|||
130506186|NCT03031782|469820757|FG003|Treatment Period 2|Physician Decision|0|||
130506187|NCT03031782|469820758|FG004|Treatment Period 2|Physician Decision|3|||
130506188|NCT03031782|469820754|FG000|Treatment Period 2|Lack of Efficacy|0|||
130506189|NCT03031782|469820755|FG001|Treatment Period 2|Lack of Efficacy|1|||
130506190|NCT03031782|469820756|FG002|Treatment Period 2|Lack of Efficacy|0|||
130506191|NCT03031782|469820757|FG003|Treatment Period 2|Lack of Efficacy|0|||
130506192|NCT03031782|469820758|FG004|Treatment Period 2|Lack of Efficacy|1|||
130506193|NCT03031782|469820754|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130506194|NCT03031782|469820755|FG001|Treatment Period 2|Withdrawal by Subject|3|||
130506195|NCT03031782|469820756|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130506196|NCT03031782|469820757|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130506197|NCT03031782|469820758|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130506198|NCT03031782|469820754|FG000|Treatment Period 2|Adverse Event|0|||
130506199|NCT03031782|469820755|FG001|Treatment Period 2|Adverse Event|1|||
130506200|NCT03031782|469820756|FG002|Treatment Period 2|Adverse Event|2|||
130506201|NCT03031782|469820757|FG003|Treatment Period 2|Adverse Event|0|||
130506202|NCT03031782|469820758|FG004|Treatment Period 2|Adverse Event|0|||
130506203|NCT03031782|469820754|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130506204|NCT03031782|469820755|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130506205|NCT03031782|469820756|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130506206|NCT03031782|469820757|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130506207|NCT03031782|469820758|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130506208|NCT02170207|469820761|FG000|Overall Study|Case report forms unavailable|5|||
130506209|NCT00886834|469820762|FG000|Overall Study|Protocol Violation|0|||
130506210|NCT00886834|469820763|FG001|Overall Study|Protocol Violation|3|||
130506211|NCT03122860|469820764|FG000|Overall Study|Discontinued Before Treatment|1|||
130506212|NCT03122860|469820765|FG001|Overall Study|Discontinued Before Treatment|1|||
130506213|NCT03122860|469820766|FG002|Overall Study|Discontinued Before Treatment|2|||
130506214|NCT03122860|469820767|FG003|Overall Study|Discontinued Before Treatment|0|||
130506215|NCT03122860|469820768|FG004|Overall Study|Discontinued Before Treatment|1|||
130506216|NCT03122860|469820769|FG005|Overall Study|Discontinued Before Treatment|0|||
130506217|NCT03122860|469820764|FG000|Overall Study|Adverse Event|1|||
130506218|NCT03122860|469820765|FG001|Overall Study|Adverse Event|0|||
130506219|NCT03122860|469820766|FG002|Overall Study|Adverse Event|1|||
130506220|NCT03122860|469820767|FG003|Overall Study|Adverse Event|1|||
130506221|NCT03122860|469820768|FG004|Overall Study|Adverse Event|0|||
130506222|NCT03122860|469820769|FG005|Overall Study|Adverse Event|0|||
130506223|NCT03122860|469820764|FG000|Overall Study|Lost to Follow-up|5|||
130506224|NCT03122860|469820765|FG001|Overall Study|Lost to Follow-up|2|||
130731892|NCT02446132|470641039|FG002|Overall Study|Protocol Deviation|1|||
130731893|NCT02446132|470641037|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
130731894|NCT02446132|470641038|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
130731895|NCT02446132|470641039|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
130731896|NCT02446132|470641037|FG000|Overall Study|Study Terminated by Sponsor|4|||
130731897|NCT02446132|470641038|FG001|Overall Study|Study Terminated by Sponsor|35|||
130731898|NCT02446132|470641039|FG002|Overall Study|Study Terminated by Sponsor|58|||
130731899|NCT02446132|470641037|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
130731900|NCT02446132|470641038|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
130731901|NCT02446132|470641039|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
130731902|NCT02446132|470641037|FG000|Overall Study|Withdrawal by Subject|11|||
130731903|NCT02446132|470641038|FG001|Overall Study|Withdrawal by Subject|29|||
130731904|NCT02446132|470641039|FG002|Overall Study|Withdrawal by Subject|25|||
130731905|NCT02446132|470641037|FG000|Overall Study|Reason not Specified|4|||
130731906|NCT02446132|470641038|FG001|Overall Study|Reason not Specified|16|||
130731907|NCT02446132|470641039|FG002|Overall Study|Reason not Specified|10|||
130731908|NCT02446132|470641037|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
130731909|NCT02446132|470641038|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
130731910|NCT02446132|470641039|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
130731911|NCT05526248|470641040|FG000|Overall Study|Lost to Follow-up|1|||
130731912|NCT05526248|470641040|FG000|Overall Study|Adverse Event|2|||
130731913|NCT05526248|470641040|FG000|Overall Study|Withdrawal by Subject|1|||
130731914|NCT06133348|470641041|FG000|Overall Study|Death|3|||
130731915|NCT06133348|470641041|FG000|Overall Study|Lost to Follow-up|1|||
130731916|NCT06133348|470641041|FG000|Overall Study|Physician Decision|1|||
130731917|NCT06133348|470641041|FG000|Overall Study|Withdrawal by Subject|5|||
130731918|NCT04557124|470641042|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
130731919|NCT04557124|470641043|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
130731920|NCT04557124|470641042|FG000|Mid-point (1 Month)|Missed testing|5|||
130731921|NCT04557124|470641043|FG001|Mid-point (1 Month)|Missed testing|4|||
130731922|NCT04557124|470641042|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
130731923|NCT04557124|470641043|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
130506225|NCT03122860|469820766|FG002|Overall Study|Lost to Follow-up|3|||
130506226|NCT03122860|469820767|FG003|Overall Study|Lost to Follow-up|3|||
130506227|NCT03122860|469820768|FG004|Overall Study|Lost to Follow-up|5|||
130731924|NCT04557124|470641042|FG000|Post-testing (2 Months)|Missed testing|1|||
130731925|NCT04557124|470641043|FG001|Post-testing (2 Months)|Missed testing|5|||
130731926|NCT04557124|470641042|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
130731927|NCT04557124|470641043|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
130731928|NCT04557124|470641042|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
130506228|NCT03122860|469820769|FG005|Overall Study|Lost to Follow-up|4|||
130506229|NCT03122860|469820764|FG000|Overall Study|Subject Non-Compliance|0|||
130506230|NCT03122860|469820765|FG001|Overall Study|Subject Non-Compliance|0|||
130506231|NCT03122860|469820766|FG002|Overall Study|Subject Non-Compliance|1|||
130506232|NCT03122860|469820767|FG003|Overall Study|Subject Non-Compliance|0|||
130506233|NCT03122860|469820768|FG004|Overall Study|Subject Non-Compliance|0|||
130506234|NCT03122860|469820769|FG005|Overall Study|Subject Non-Compliance|0|||
130506235|NCT03122860|469820764|FG000|Overall Study|Withdrawal by Subject|3|||
130506236|NCT03122860|469820765|FG001|Overall Study|Withdrawal by Subject|2|||
130506237|NCT03122860|469820766|FG002|Overall Study|Withdrawal by Subject|5|||
130506238|NCT03122860|469820767|FG003|Overall Study|Withdrawal by Subject|7|||
130506239|NCT03122860|469820768|FG004|Overall Study|Withdrawal by Subject|9|||
130506240|NCT03122860|469820769|FG005|Overall Study|Withdrawal by Subject|8|||
130506241|NCT01138657|469820770|FG000|Overall Study|Adverse Event|3|||
130506242|NCT01138657|469820771|FG001|Overall Study|Adverse Event|10|||
130506243|NCT01138657|469820770|FG000|Overall Study|Lack of Efficacy|2|||
130506244|NCT01138657|469820771|FG001|Overall Study|Lack of Efficacy|1|||
130506245|NCT01138657|469820770|FG000|Overall Study|Lost to Follow-up|0|||
130506246|NCT01138657|469820771|FG001|Overall Study|Lost to Follow-up|3|||
130506247|NCT01138657|469820770|FG000|Overall Study|Miscellaneous Reasons|3|||
130506248|NCT01138657|469820771|FG001|Overall Study|Miscellaneous Reasons|4|||
130506249|NCT03875729|469820772|FG000|Overall Study|Adverse Event|0|||
130506250|NCT03875729|469820773|FG001|Overall Study|Adverse Event|5|||
130506251|NCT03875729|469820772|FG000|Overall Study|Withdrawal by Subject|8|||
130506252|NCT03875729|469820773|FG001|Overall Study|Withdrawal by Subject|11|||
130506253|NCT03875729|469820772|FG000|Overall Study|Pregnancy|0|||
130506254|NCT03875729|469820773|FG001|Overall Study|Pregnancy|1|||
130506255|NCT03875729|469820772|FG000|Overall Study|Lost to Follow-up|0|||
130506256|NCT03875729|469820773|FG001|Overall Study|Lost to Follow-up|5|||
130506257|NCT03875729|469820772|FG000|Overall Study|Personal reasons|2|||
130506258|NCT03875729|469820773|FG001|Overall Study|Personal reasons|0|||
130506259|NCT01405508|469820776|FG000|Overall Study|AE, non-serious non-fatal|1|||
130506260|NCT01405508|469820777|FG001|Overall Study|AE, non-serious non-fatal|1|||
130506261|NCT01405508|469820778|FG002|Overall Study|AE, non-serious non-fatal|0|||
130506262|NCT01405508|469820779|FG003|Overall Study|AE, non-serious non-fatal|0|||
130506263|NCT00476957|469820784|FG000|Overall Study|Lost to Follow-up|176|||
130506264|NCT00476957|469820785|FG001|Overall Study|Lost to Follow-up|193|||
130506265|NCT02159352|469820786|FG000|Overall Study|Adverse Event|3|||
130506266|NCT02159352|469820787|FG001|Overall Study|Adverse Event|1|||
130506267|NCT02159352|469820786|FG000|Overall Study|Withdrawal by Subject|0|||
130506268|NCT02159352|469820787|FG001|Overall Study|Withdrawal by Subject|1|||
130506269|NCT00529529|469820788|FG000|Overall Study|Adverse Event|12|||
130506270|NCT00529529|469820789|FG001|Overall Study|Adverse Event|17|||
130506271|NCT00529529|469820790|FG002|Overall Study|Adverse Event|8|||
130506272|NCT00529529|469820788|FG000|Overall Study|Subject withdrew consent|12|||
130506273|NCT00529529|469820789|FG001|Overall Study|Subject withdrew consent|9|||
130506274|NCT00529529|469820790|FG002|Overall Study|Subject withdrew consent|12|||
130506275|NCT00529529|469820788|FG000|Overall Study|Protocol deviation|8|||
130506276|NCT00529529|469820789|FG001|Overall Study|Protocol deviation|12|||
130506277|NCT00529529|469820790|FG002|Overall Study|Protocol deviation|5|||
130506278|NCT00529529|469820788|FG000|Overall Study|Lost to Follow-up|5|||
130506279|NCT00529529|469820789|FG001|Overall Study|Lost to Follow-up|3|||
130506280|NCT00529529|469820790|FG002|Overall Study|Lost to Follow-up|1|||
130506281|NCT00529529|469820788|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130506282|NCT00529529|469820789|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130506283|NCT00529529|469820790|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130506284|NCT00529529|469820788|FG000|Overall Study|Death|2|||
130506285|NCT00529529|469820789|FG001|Overall Study|Death|0|||
130506286|NCT00529529|469820790|FG002|Overall Study|Death|0|||
130506287|NCT00529529|469820788|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130506288|NCT00529529|469820789|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130506289|NCT00529529|469820790|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130506290|NCT00529529|469820788|FG000|Overall Study|Administrative problems|1|||
130506291|NCT00529529|469820789|FG001|Overall Study|Administrative problems|0|||
130506292|NCT00529529|469820790|FG002|Overall Study|Administrative problems|3|||
130506293|NCT01916109|469820795|FG000|Overall Study|Withdrawal by Subject|1|||
130506294|NCT00636168|469820798|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
130506295|NCT00636168|469820799|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
130506296|NCT00636168|469820798|FG000|Randomized to Study Drug|Adverse Event|1|||
130506297|NCT00636168|469820799|FG001|Randomized to Study Drug|Adverse Event|0|||
130506298|NCT00636168|469820798|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
130506299|NCT00636168|469820799|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
130506300|NCT00636168|469820798|FG000|Treated With Study Drug|Recurrence of disease|135|||
130506301|NCT00636168|469820799|FG001|Treated With Study Drug|Recurrence of disease|282|||
130506302|NCT00636168|469820798|FG000|Treated With Study Drug|Adverse Event|250|||
130506303|NCT00636168|469820799|FG001|Treated With Study Drug|Adverse Event|22|||
130506304|NCT00636168|469820798|FG000|Treated With Study Drug|Participant withdrew consent|16|||
130506305|NCT00636168|469820799|FG001|Treated With Study Drug|Participant withdrew consent|21|||
130506306|NCT00636168|469820798|FG000|Treated With Study Drug|Poor/non-compliance|1|||
130506307|NCT00636168|469820799|FG001|Treated With Study Drug|Poor/non-compliance|3|||
130506308|NCT00636168|469820798|FG000|Treated With Study Drug|Death|3|||
130506309|NCT00636168|469820799|FG001|Treated With Study Drug|Death|0|||
130506310|NCT00636168|469820798|FG000|Treated With Study Drug|Pregnancy|1|||
130506311|NCT00636168|469820799|FG001|Treated With Study Drug|Pregnancy|0|||
130506312|NCT00636168|469820798|FG000|Treated With Study Drug|No longer meets study criteria|1|||
130506313|NCT00636168|469820799|FG001|Treated With Study Drug|No longer meets study criteria|0|||
130506314|NCT00636168|469820798|FG000|Treated With Study Drug|Other reason|1|||
130506315|NCT00636168|469820799|FG001|Treated With Study Drug|Other reason|3|||
130506316|NCT00636168|469820798|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
130506317|NCT00636168|469820799|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
130506318|NCT00636168|469820798|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
130506319|NCT00636168|469820799|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
130506320|NCT00636168|469820798|FG000|Long Term Follow-Up|Death|8|||
130506321|NCT00636168|469820799|FG001|Long Term Follow-Up|Death|9|||
130506322|NCT02707952|469820800|FG000|Overall Study|Adverse Event|1|||
130506323|NCT02707952|469820801|FG001|Overall Study|Adverse Event|0|||
130506324|NCT02707952|469820802|FG002|Overall Study|Adverse Event|0|||
130506325|NCT02707952|469820803|FG003|Overall Study|Adverse Event|0|||
130506326|NCT02707952|469820800|FG000|Overall Study|Lost to Follow-up|1|||
130506327|NCT02707952|469820801|FG001|Overall Study|Lost to Follow-up|0|||
130506328|NCT02707952|469820802|FG002|Overall Study|Lost to Follow-up|0|||
130506329|NCT02707952|469820803|FG003|Overall Study|Lost to Follow-up|0|||
130506330|NCT02707952|469820800|FG000|Overall Study|Withdrawal by Subject|0|||
130506331|NCT02707952|469820801|FG001|Overall Study|Withdrawal by Subject|1|||
130506332|NCT02707952|469820802|FG002|Overall Study|Withdrawal by Subject|2|||
130506333|NCT02707952|469820803|FG003|Overall Study|Withdrawal by Subject|0|||
130506334|NCT00237809|469820804|FG000|Overall Study|Lost to Follow-up|11|||
130506335|NCT00237809|469820805|FG001|Overall Study|Lost to Follow-up|10|||
130506336|NCT00237809|469820806|FG002|Overall Study|Lost to Follow-up|9|||
130506337|NCT00237809|469820807|FG003|Overall Study|Lost to Follow-up|9|||
130506338|NCT02006641|469820808|FG000|Overall Study|Withdrawal before treatment|2|||
130506339|NCT02006641|469820809|FG001|Overall Study|Withdrawal before treatment|5|||
130731929|NCT04557124|470641043|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
130731930|NCT04424407|470641047|FG000|Overall Study|Withdrawal by Subject|2|||
130731931|NCT04424407|470641047|FG000|Overall Study|Lost to Follow-up|1|||
130731932|NCT03803943|470641050|FG000|Overall Study|Withdrawal by Subject|2|||
130731933|NCT03803943|470641051|FG001|Overall Study|Withdrawal by Subject|2|||
130731934|NCT03803943|470641052|FG002|Overall Study|Withdrawal by Subject|2|||
130731935|NCT03803943|470641053|FG003|Overall Study|Withdrawal by Subject|2|||
130731936|NCT03499964|470641056|FG000|Overall Study|Lack of Efficacy|6|||
130731937|NCT03499964|470641057|FG001|Overall Study|Lack of Efficacy|26|||
130731938|NCT03499964|470641056|FG000|Overall Study|Adverse Event|1|||
130731939|NCT03499964|470641057|FG001|Overall Study|Adverse Event|0|||
130731940|NCT03499964|470641056|FG000|Overall Study|Death|1|||
130731941|NCT03499964|470641057|FG001|Overall Study|Death|0|||
130731942|NCT03499964|470641056|FG000|Overall Study|Withdrawal by Subject|2|||
130731943|NCT03499964|470641057|FG001|Overall Study|Withdrawal by Subject|1|||
130731944|NCT03499964|470641056|FG000|Overall Study|Lost to Follow-up|1|||
130731945|NCT03499964|470641057|FG001|Overall Study|Lost to Follow-up|0|||
130731946|NCT04638660|470641058|FG000|Overall Study|Withdrawal by Subject|2|||
130731947|NCT04638660|470641059|FG001|Overall Study|Withdrawal by Subject|0|||
130731948|NCT04638660|470641058|FG000|Overall Study|Lost to Follow-up|1|||
130731949|NCT04638660|470641059|FG001|Overall Study|Lost to Follow-up|0|||
130731950|NCT04481373|470641060|FG000|Overall Study|Protocol Violation|1|||
130731951|NCT04481373|470641061|FG001|Overall Study|Protocol Violation|0|||
130731952|NCT04481373|470641060|FG000|Overall Study|Viral load in hospital not over 1000|2|||
130731953|NCT04481373|470641061|FG001|Overall Study|Viral load in hospital not over 1000|1|||
130731954|NCT04481373|470641060|FG000|Overall Study|Death before hospital discharge|1|||
130731955|NCT04481373|470641061|FG001|Overall Study|Death before hospital discharge|0|||
130731956|NCT03199469|470641063|FG000|Overall Study|Randomized, not treated|0|||
130731957|NCT03199469|470641064|FG001|Overall Study|Randomized, not treated|3|||
130731958|NCT03199469|470641063|FG000|Overall Study|Withdrawal by Subject|1|||
130731959|NCT03199469|470641064|FG001|Overall Study|Withdrawal by Subject|0|||
130731960|NCT03199469|470641063|FG000|Overall Study|Death|1|||
130506340|NCT02006641|469820810|FG002|Overall Study|Withdrawal before treatment|3|||
130506341|NCT02006641|469820808|FG000|Overall Study|Adverse Event|15|||
130506342|NCT02006641|469820809|FG001|Overall Study|Adverse Event|11|||
130506343|NCT02006641|469820810|FG002|Overall Study|Adverse Event|15|||
130506344|NCT02006641|469820808|FG000|Overall Study|Protocol Violation|0|||
130506345|NCT02006641|469820809|FG001|Overall Study|Protocol Violation|2|||
130506346|NCT02006641|469820810|FG002|Overall Study|Protocol Violation|2|||
130506347|NCT02006641|469820808|FG000|Overall Study|Lost to Follow-up|0|||
130506348|NCT02006641|469820809|FG001|Overall Study|Lost to Follow-up|1|||
130506349|NCT02006641|469820810|FG002|Overall Study|Lost to Follow-up|0|||
130506350|NCT02006641|469820808|FG000|Overall Study|Withdrawal by Subject|7|||
130506351|NCT02006641|469820809|FG001|Overall Study|Withdrawal by Subject|12|||
130506352|NCT02006641|469820810|FG002|Overall Study|Withdrawal by Subject|11|||
130506353|NCT02006641|469820808|FG000|Overall Study|Other reason: patient didn't show up|1|||
130506354|NCT02006641|469820809|FG001|Overall Study|Other reason: patient didn't show up|0|||
130506355|NCT02006641|469820810|FG002|Overall Study|Other reason: patient didn't show up|0|||
130506356|NCT02006641|469820808|FG000|Overall Study|Other reason:patient didn't want to come|0|||
130506357|NCT02006641|469820809|FG001|Overall Study|Other reason:patient didn't want to come|0|||
130506358|NCT02006641|469820810|FG002|Overall Study|Other reason:patient didn't want to come|1|||
130506359|NCT02006641|469820808|FG000|Overall Study|Other reason: patient has moved|1|||
130506360|NCT02006641|469820809|FG001|Overall Study|Other reason: patient has moved|0|||
130506361|NCT02006641|469820810|FG002|Overall Study|Other reason: patient has moved|1|||
130506362|NCT02006641|469820808|FG000|Overall Study|Other reason: caregiver in hospital|0|||
130506363|NCT02006641|469820809|FG001|Overall Study|Other reason: caregiver in hospital|1|||
130506364|NCT02006641|469820810|FG002|Overall Study|Other reason: caregiver in hospital|0|||
130506365|NCT02006641|469820808|FG000|Overall Study|Other reason: patient's wife has died|0|||
130506366|NCT02006641|469820809|FG001|Overall Study|Other reason: patient's wife has died|0|||
130506367|NCT02006641|469820810|FG002|Overall Study|Other reason: patient's wife has died|1|||
130506368|NCT02006641|469820808|FG000|Overall Study|Other reason: hospitalisation|0|||
130506369|NCT02006641|469820809|FG001|Overall Study|Other reason: hospitalisation|1|||
130506370|NCT02006641|469820810|FG002|Overall Study|Other reason: hospitalisation|0|||
130506371|NCT02006641|469820808|FG000|Overall Study|Other reason: caregiver impossibility|0|||
130506372|NCT02006641|469820809|FG001|Overall Study|Other reason: caregiver impossibility|0|||
130506373|NCT02006641|469820810|FG002|Overall Study|Other reason: caregiver impossibility|1|||
130506374|NCT02006641|469820808|FG000|Overall Study|Other reason: protocol non-compliance|0|||
130506375|NCT02006641|469820809|FG001|Overall Study|Other reason: protocol non-compliance|0|||
130506376|NCT02006641|469820810|FG002|Overall Study|Other reason: protocol non-compliance|1|||
130506377|NCT01287832|469820811|FG000|Overall Study|Adverse Event|1|||
130506378|NCT01287832|469820812|FG001|Overall Study|Adverse Event|0|||
130506379|NCT01287832|469820811|FG000|Overall Study|Death|0|||
130506380|NCT01287832|469820812|FG001|Overall Study|Death|1|||
130506381|NCT04749797|469820814|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
130506382|NCT04749797|469820815|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
130506383|NCT04749797|469820816|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
130506384|NCT01441596|469820817|FG000|Overall Study|Other reason not defined below|0|||
130506385|NCT01441596|469820818|FG001|Overall Study|Other reason not defined below|2|||
130506386|NCT01441596|469820819|FG002|Overall Study|Other reason not defined below|1|||
130506387|NCT01441596|469820817|FG000|Overall Study|Withdrawal by Subject|4|||
130506388|NCT01441596|469820818|FG001|Overall Study|Withdrawal by Subject|0|||
130506389|NCT01441596|469820819|FG002|Overall Study|Withdrawal by Subject|2|||
130506390|NCT01441596|469820817|FG000|Overall Study|Not treated|0|||
130506391|NCT01441596|469820818|FG001|Overall Study|Not treated|1|||
130506392|NCT01441596|469820819|FG002|Overall Study|Not treated|1|||
130506393|NCT00871715|469820824|FG000|Overall Study|Withdrawal by Subject|6|||
130506394|NCT00871715|469820825|FG001|Overall Study|Withdrawal by Subject|10|||
130506395|NCT00871715|469820826|FG002|Overall Study|Withdrawal by Subject|15|||
130506396|NCT00871715|469820824|FG000|Overall Study|Physician Decision|6|||
130506397|NCT00871715|469820825|FG001|Overall Study|Physician Decision|0|||
130506398|NCT00871715|469820826|FG002|Overall Study|Physician Decision|2|||
130506399|NCT00871715|469820824|FG000|Overall Study|Lost to Follow-up|3|||
130506400|NCT00871715|469820825|FG001|Overall Study|Lost to Follow-up|6|||
130506401|NCT00871715|469820826|FG002|Overall Study|Lost to Follow-up|9|||
130506402|NCT03015220|469820829|FG000|Overall Study|Withdrawal by Subject|3|||
130506403|NCT03015220|469820830|FG001|Overall Study|Withdrawal by Subject|2|||
130506404|NCT03015220|469820831|FG002|Overall Study|Withdrawal by Subject|2|||
130506405|NCT03015220|469820832|FG003|Overall Study|Withdrawal by Subject|2|||
130506406|NCT03015220|469820829|FG000|Overall Study|Lost to Follow-up|0|||
130506407|NCT03015220|469820830|FG001|Overall Study|Lost to Follow-up|0|||
130506408|NCT03015220|469820831|FG002|Overall Study|Lost to Follow-up|1|||
130506409|NCT03015220|469820832|FG003|Overall Study|Lost to Follow-up|0|||
130506410|NCT01670526|469820834|FG000|Overall Study|Withdrawal by Subject|3|||
130506411|NCT01670526|469820835|FG001|Overall Study|Withdrawal by Subject|1|||
130506412|NCT01670526|469820834|FG000|Overall Study|Lost to Follow-up|9|||
130506413|NCT01670526|469820835|FG001|Overall Study|Lost to Follow-up|5|||
130506414|NCT02291549|469820836|FG000|Overall Study|Lost to Follow-up|1|||
130506415|NCT02291549|469820837|FG001|Overall Study|Lost to Follow-up|0|||
130506416|NCT02291549|469820836|FG000|Overall Study|Withdrawal by Subject|0|||
130506417|NCT02291549|469820837|FG001|Overall Study|Withdrawal by Subject|1|||
130506418|NCT01794689|469820838|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
130506419|NCT01794689|469820839|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
130506420|NCT01794689|469820840|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
130731961|NCT03199469|470641064|FG001|Overall Study|Death|3|||
130731962|NCT03199469|470641063|FG000|Overall Study|Ongoing|5|||
130731963|NCT03199469|470641064|FG001|Overall Study|Ongoing|14|||
130731964|NCT03842228|470641065|FG000|Overall Study|Adverse Event|1|||
130731965|NCT03842228|470641066|FG001|Overall Study|Adverse Event|1|||
130731966|NCT03842228|470641067|FG002|Overall Study|Adverse Event|1|||
130731967|NCT03842228|470641068|FG003|Overall Study|Adverse Event|0|||
130731968|NCT03842228|470641069|FG004|Overall Study|Adverse Event|0|||
130731969|NCT03842228|470641070|FG005|Overall Study|Adverse Event|0|||
130731970|NCT03842228|470641071|FG006|Overall Study|Adverse Event|0|||
130731971|NCT03842228|470641065|FG000|Overall Study|Death|0|||
130731972|NCT03842228|470641066|FG001|Overall Study|Death|1|||
130731973|NCT03842228|470641067|FG002|Overall Study|Death|0|||
130731974|NCT03842228|470641068|FG003|Overall Study|Death|0|||
130731975|NCT03842228|470641069|FG004|Overall Study|Death|0|||
130731976|NCT03842228|470641070|FG005|Overall Study|Death|0|||
130731977|NCT03842228|470641071|FG006|Overall Study|Death|0|||
130731978|NCT03842228|470641065|FG000|Overall Study|Withdrawal by Subject|0|||
130731979|NCT03842228|470641066|FG001|Overall Study|Withdrawal by Subject|0|||
130731980|NCT03842228|470641067|FG002|Overall Study|Withdrawal by Subject|2|||
130731981|NCT03842228|470641068|FG003|Overall Study|Withdrawal by Subject|1|||
130731982|NCT03842228|470641069|FG004|Overall Study|Withdrawal by Subject|0|||
130731983|NCT03842228|470641070|FG005|Overall Study|Withdrawal by Subject|0|||
130731984|NCT03842228|470641071|FG006|Overall Study|Withdrawal by Subject|2|||
130731985|NCT03842228|470641065|FG000|Overall Study|Progression|8|||
130731986|NCT03842228|470641066|FG001|Overall Study|Progression|1|||
130731987|NCT03842228|470641067|FG002|Overall Study|Progression|7|||
130731988|NCT03842228|470641068|FG003|Overall Study|Progression|5|||
130731989|NCT03842228|470641069|FG004|Overall Study|Progression|4|||
130731990|NCT03842228|470641070|FG005|Overall Study|Progression|2|||
130731991|NCT03842228|470641071|FG006|Overall Study|Progression|3|||
130731992|NCT05014412|470641072|FG000|Overall Study|Death|11|||
130731993|NCT05014412|470641073|FG001|Overall Study|Death|7|||
130731994|NCT05014412|470641074|FG002|Overall Study|Death|4|||
130731995|NCT05014412|470641075|FG003|Overall Study|Death|7|||
130731996|NCT05014412|470641072|FG000|Overall Study|Withdrawal by Subject|1|||
130731997|NCT05014412|470641073|FG001|Overall Study|Withdrawal by Subject|1|||
130731998|NCT05014412|470641074|FG002|Overall Study|Withdrawal by Subject|1|||
130731999|NCT05014412|470641075|FG003|Overall Study|Withdrawal by Subject|2|||
130732000|NCT05014412|470641072|FG000|Overall Study|Ongoing|21|||
130732001|NCT05014412|470641073|FG001|Overall Study|Ongoing|4|||
130732002|NCT05014412|470641074|FG002|Overall Study|Ongoing|6|||
130732003|NCT05014412|470641075|FG003|Overall Study|Ongoing|20|||
130732004|NCT04868539|470641080|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
130732005|NCT04868539|470641081|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
130732006|NCT03651700|470641085|FG000|Overall Study|Withdrawal by Subject|1|||
130732007|NCT03651700|470641086|FG001|Overall Study|Withdrawal by Subject|0|||
130732008|NCT04916730|470641089|FG000|Overall Study|Withdrawal by Subject|4|||
130732009|NCT04916730|470641090|FG001|Overall Study|Withdrawal by Subject|2|||
130732010|NCT04916730|470641089|FG000|Overall Study|Lost to Follow-up|0|||
130732011|NCT04916730|470641090|FG001|Overall Study|Lost to Follow-up|2|||
130732012|NCT04916730|470641089|FG000|Overall Study|Physician Decision|1|||
130732013|NCT04916730|470641090|FG001|Overall Study|Physician Decision|0|||
130732014|NCT05479734|470641093|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
130732015|NCT05479734|470641094|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130732016|NCT05479734|470641093|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130732017|NCT05479734|470641094|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
130732018|NCT05479734|470641093|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130732019|NCT05479734|470641094|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
130732020|NCT05479734|470641093|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
130732021|NCT05479734|470641094|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
130732022|NCT03945825|470641095|FG000|Overall Study|Enrolled but treatment not administered|0|||
130732023|NCT03945825|470641096|FG001|Overall Study|Enrolled but treatment not administered|0|||
130732024|NCT03945825|470641097|FG002|Overall Study|Enrolled but treatment not administered|0|||
130732025|NCT03945825|470641098|FG003|Overall Study|Enrolled but treatment not administered|0|||
130732026|NCT03945825|470641099|FG004|Overall Study|Enrolled but treatment not administered|1|||
130732027|NCT03945825|470641100|FG005|Overall Study|Enrolled but treatment not administered|0|||
130732028|NCT03945825|470641095|FG000|Overall Study|Lost to Follow-up|1|||
130732029|NCT03945825|470641096|FG001|Overall Study|Lost to Follow-up|5|||
130732030|NCT03945825|470641097|FG002|Overall Study|Lost to Follow-up|0|||
130732031|NCT03945825|470641098|FG003|Overall Study|Lost to Follow-up|1|||
130732032|NCT03945825|470641099|FG004|Overall Study|Lost to Follow-up|2|||
130732033|NCT03945825|470641100|FG005|Overall Study|Lost to Follow-up|2|||
130732034|NCT03945825|470641095|FG000|Overall Study|Withdrawal by Subject|1|||
130732035|NCT03945825|470641096|FG001|Overall Study|Withdrawal by Subject|0|||
130732036|NCT03945825|470641097|FG002|Overall Study|Withdrawal by Subject|1|||
130506421|NCT01794689|469820841|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
130506422|NCT01794689|469820838|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
130506423|NCT01794689|469820839|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
130506424|NCT01794689|469820840|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
130506425|NCT01794689|469820841|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
130506426|NCT01794689|469820838|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
130506427|NCT01794689|469820839|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
130506428|NCT01794689|469820840|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
130732037|NCT03945825|470641098|FG003|Overall Study|Withdrawal by Subject|1|||
130732038|NCT03945825|470641099|FG004|Overall Study|Withdrawal by Subject|0|||
130732039|NCT03945825|470641100|FG005|Overall Study|Withdrawal by Subject|1|||
130732040|NCT03083665|470641102|FG000|Double-Blind Period|Adverse Event|5|||
130732041|NCT03083665|470641103|FG001|Double-Blind Period|Adverse Event|4|||
130732042|NCT03083665|470641104|FG002|Double-Blind Period|Adverse Event|5|||
130732043|NCT03083665|470641105|FG003|Double-Blind Period|Adverse Event|0|||
130732044|NCT03083665|470641106|FG004|Double-Blind Period|Adverse Event|0|||
130732045|NCT03083665|470641107|FG005|Double-Blind Period|Adverse Event|0|||
130732046|NCT03083665|470641102|FG000|Double-Blind Period|Lack of Efficacy|0|||
130732047|NCT03083665|470641103|FG001|Double-Blind Period|Lack of Efficacy|0|||
130732048|NCT03083665|470641104|FG002|Double-Blind Period|Lack of Efficacy|1|||
130732049|NCT03083665|470641105|FG003|Double-Blind Period|Lack of Efficacy|0|||
130732050|NCT03083665|470641106|FG004|Double-Blind Period|Lack of Efficacy|0|||
130732051|NCT03083665|470641107|FG005|Double-Blind Period|Lack of Efficacy|0|||
130732052|NCT03083665|470641102|FG000|Double-Blind Period|Protocol Violation|1|||
130732053|NCT03083665|470641103|FG001|Double-Blind Period|Protocol Violation|0|||
130732054|NCT03083665|470641104|FG002|Double-Blind Period|Protocol Violation|1|||
130506429|NCT01794689|469820841|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
130506430|NCT01794689|469820838|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
130506431|NCT01794689|469820839|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
130506432|NCT01794689|469820840|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
130506433|NCT01794689|469820841|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
130506434|NCT01697956|469820842|FG000|Overall Study|Protocol Violation|1|||
130506435|NCT01697956|469820843|FG001|Overall Study|Protocol Violation|1|||
130506436|NCT04447287|469820845|FG000|Period 1: Run-in Period|Adverse Event|3|||
130506437|NCT04447287|469820846|FG001|Period 1: Run-in Period|Adverse Event|0|||
130506438|NCT04447287|469820847|FG002|Period 1: Run-in Period|Adverse Event|0|||
130506439|NCT04447287|469820845|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
130506440|NCT04447287|469820846|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
130506441|NCT04447287|469820847|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
130506442|NCT04447287|469820845|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
130506443|NCT04447287|469820846|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
130506444|NCT04447287|469820847|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
130506445|NCT03246724|469820850|FG000|Overall Study|Withdrawal by Subject|5|||
130566620|NCT03370120|470041480|FG000|Overall Study|Adverse event, non-fatal|24|||
130566621|NCT03370120|470041480|FG000|Overall Study|Withdrawal by Subject|6|||
130566622|NCT03370120|470041480|FG000|Overall Study|Lost to Follow-up|1|||
130566623|NCT03370120|470041480|FG000|Overall Study|Lack of Efficacy|37|||
130566624|NCT03370120|470041480|FG000|Overall Study|Per sponsor's instructions|1|||
130566625|NCT03370120|470041480|FG000|Overall Study|Study was terminated by parent company UCB|2|||
130566626|NCT03370120|470041480|FG000|Overall Study|The study was ended by the promoter|3|||
130566627|NCT03370120|470041480|FG000|Overall Study|Discontinuation of drug development|3|||
130566628|NCT03370120|470041480|FG000|Overall Study|End of project|2|||
130566629|NCT03370120|470041480|FG000|Overall Study|Premature study closure|2|||
130506446|NCT03246724|469820851|FG001|Overall Study|Withdrawal by Subject|2|||
130506447|NCT03246724|469820852|FG002|Overall Study|Withdrawal by Subject|4|||
130506448|NCT03246724|469820853|FG003|Overall Study|Withdrawal by Subject|2|||
130506449|NCT03246724|469820850|FG000|Overall Study|Ineligible on day of surgery|7|||
130566630|NCT03370120|470041480|FG000|Overall Study|Premature program termination|1|||
130566631|NCT03370120|470041480|FG000|Overall Study|Premature study termination|7|||
130506450|NCT03246724|469820851|FG001|Overall Study|Ineligible on day of surgery|2|||
130506451|NCT03246724|469820852|FG002|Overall Study|Ineligible on day of surgery|0|||
130506452|NCT03246724|469820853|FG003|Overall Study|Ineligible on day of surgery|3|||
130506453|NCT03246724|469820850|FG000|Overall Study|Study completed before surgical date|2|||
130506454|NCT03246724|469820851|FG001|Overall Study|Study completed before surgical date|1|||
130506455|NCT03246724|469820852|FG002|Overall Study|Study completed before surgical date|8|||
130506456|NCT03246724|469820853|FG003|Overall Study|Study completed before surgical date|1|||
130506457|NCT03246724|469820850|FG000|Overall Study|Transferred to other arm|0|||
130506458|NCT03246724|469820851|FG001|Overall Study|Transferred to other arm|0|||
130506459|NCT03246724|469820852|FG002|Overall Study|Transferred to other arm|1|||
130506460|NCT03246724|469820853|FG003|Overall Study|Transferred to other arm|0|||
130506461|NCT03246724|469820850|FG000|Overall Study|Unable to obtain medication timely|0|||
130506462|NCT03246724|469820851|FG001|Overall Study|Unable to obtain medication timely|2|||
130506463|NCT03246724|469820852|FG002|Overall Study|Unable to obtain medication timely|2|||
130506464|NCT03246724|469820853|FG003|Overall Study|Unable to obtain medication timely|1|||
130506465|NCT03246724|469820850|FG000|Overall Study|Re-consented to participate|0|||
130506466|NCT03246724|469820851|FG001|Overall Study|Re-consented to participate|0|||
130506467|NCT03246724|469820852|FG002|Overall Study|Re-consented to participate|0|||
130506468|NCT03246724|469820853|FG003|Overall Study|Re-consented to participate|1|||
130506469|NCT02978716|469820854|FG000|Overall Study|Death|25|||
130506470|NCT02978716|469820855|FG001|Overall Study|Death|13|||
130506471|NCT02978716|469820856|FG002|Overall Study|Death|20|||
130566632|NCT03370120|470041480|FG000|Overall Study|Trial terminated by sponsor|2|||
130566633|NCT03370120|470041480|FG000|Overall Study|Trial discontinued by sponsor|2|||
130566634|NCT03370120|470041480|FG000|Overall Study|Study ended|15|||
130566635|NCT03370120|470041480|FG000|Overall Study|Clinical trial has been cancelled|1|||
130566636|NCT03370120|470041480|FG000|Overall Study|End of study per sponsor decision|2|||
130566637|NCT03370120|470041480|FG000|Overall Study|Promoter's decision|2|||
130566638|NCT03370120|470041480|FG000|Overall Study|The trial has been suspended|3|||
130506472|NCT02978716|469820854|FG000|Overall Study|Lost to Follow-up|0|||
130566639|NCT03370120|470041480|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
130506473|NCT02978716|469820855|FG001|Overall Study|Lost to Follow-up|0|||
130566640|NCT03370120|470041480|FG000|Overall Study|Early termination by order of sponsor|2|||
130566641|NCT03370120|470041480|FG000|Overall Study|Discontinuation of the study|5|||
130506474|NCT02978716|469820856|FG002|Overall Study|Lost to Follow-up|1|||
130506475|NCT02978716|469820854|FG000|Overall Study|Withdrawal by Subject|6|||
130566642|NCT03370120|470041480|FG000|Overall Study|End of clinical trial discontinuation|1|||
130566643|NCT03370120|470041480|FG000|Overall Study|Because the clinical trial ended halfway|4|||
130566644|NCT03370120|470041480|FG000|Overall Study|Development discontinued|5|||
130506476|NCT02978716|469820855|FG001|Overall Study|Withdrawal by Subject|4|||
130506477|NCT02978716|469820856|FG002|Overall Study|Withdrawal by Subject|5|||
130506478|NCT02978716|469820854|FG000|Overall Study|Sponsor terminated|2|||
130506479|NCT02978716|469820855|FG001|Overall Study|Sponsor terminated|13|||
130506480|NCT02978716|469820856|FG002|Overall Study|Sponsor terminated|9|||
130506481|NCT02978716|469820854|FG000|Overall Study|Other|1|||
130506482|NCT02978716|469820855|FG001|Overall Study|Other|3|||
130506483|NCT02978716|469820856|FG002|Overall Study|Other|0|||
130566645|NCT03370120|470041480|FG000|Overall Study|Padsenovil program closed|3|||
130566646|NCT03370120|470041480|FG000|Overall Study|End of project|2|||
130506484|NCT00960206|469820857|FG000|Overall Study|Death|7|||
130506485|NCT00960206|469820858|FG001|Overall Study|Death|4|||
130506486|NCT00960206|469820859|FG002|Overall Study|Death|1|||
130506487|NCT00960206|469820857|FG000|Overall Study|Unwilling/Unable to return|1|||
130506488|NCT00960206|469820858|FG001|Overall Study|Unwilling/Unable to return|2|||
130506489|NCT00960206|469820859|FG002|Overall Study|Unwilling/Unable to return|0|||
130506490|NCT00960206|469820857|FG000|Overall Study|Lost to Follow-up|8|||
130506491|NCT00960206|469820858|FG001|Overall Study|Lost to Follow-up|14|||
130506492|NCT00960206|469820859|FG002|Overall Study|Lost to Follow-up|8|||
130506493|NCT00960206|469820857|FG000|Overall Study|Withdrawal by Subject|2|||
130506494|NCT00960206|469820858|FG001|Overall Study|Withdrawal by Subject|4|||
130506495|NCT00960206|469820859|FG002|Overall Study|Withdrawal by Subject|0|||
130506496|NCT00960206|469820857|FG000|Overall Study|Revision of study component|2|||
130506497|NCT00960206|469820858|FG001|Overall Study|Revision of study component|2|||
130506498|NCT00960206|469820859|FG002|Overall Study|Revision of study component|2|||
130506499|NCT00960206|469820857|FG000|Overall Study|Missing 10 year data|20|||
130506500|NCT00960206|469820858|FG001|Overall Study|Missing 10 year data|1|||
130506501|NCT00960206|469820859|FG002|Overall Study|Missing 10 year data|1|||
130506502|NCT02470806|469820862|FG000|Overall Study|Lost to Follow-up|1|||
130506503|NCT02470806|469820863|FG001|Overall Study|Lost to Follow-up|1|||
130506504|NCT02470806|469820862|FG000|Overall Study|Adverse Event|5|||
130506505|NCT02470806|469820863|FG001|Overall Study|Adverse Event|2|||
130506506|NCT02470806|469820862|FG000|Overall Study|Protocol Violation|4|||
130506507|NCT02470806|469820863|FG001|Overall Study|Protocol Violation|11|||
130506508|NCT02470806|469820862|FG000|Overall Study|Physician Decision|0|||
130506509|NCT02470806|469820863|FG001|Overall Study|Physician Decision|3|||
130506510|NCT02470806|469820862|FG000|Overall Study|Withdrawal by Subject|3|||
130506511|NCT02470806|469820863|FG001|Overall Study|Withdrawal by Subject|10|||
130506512|NCT02470806|469820862|FG000|Overall Study|Lack of Efficacy|5|||
130506513|NCT02470806|469820863|FG001|Overall Study|Lack of Efficacy|15|||
130506514|NCT01662505|469820864|FG000|Overall Study|Progressive disease|6|||
130506515|NCT01662505|469820865|FG001|Overall Study|Progressive disease|1|||
130506516|NCT01662505|469820866|FG002|Overall Study|Progressive disease|5|||
130506517|NCT01662505|469820864|FG000|Overall Study|Refused cont. medication|0|||
130506518|NCT01662505|469820865|FG001|Overall Study|Refused cont. medication|0|||
130506519|NCT01662505|469820866|FG002|Overall Study|Refused cont. medication|1|||
130506520|NCT01662505|469820864|FG000|Overall Study|Not specified above|1|||
130506521|NCT01662505|469820865|FG001|Overall Study|Not specified above|3|||
130506522|NCT01662505|469820866|FG002|Overall Study|Not specified above|2|||
130506523|NCT03075878|469820870|FG000|Overall Study|Physician Decision|1|||
130506524|NCT02010684|469820871|FG000|Overall Study|Lost to Follow-up|8|||
130506525|NCT02010684|469820872|FG001|Overall Study|Lost to Follow-up|18|||
130506526|NCT02010684|469820871|FG000|Overall Study|Withdrawal by Subject|4|||
130506527|NCT02010684|469820872|FG001|Overall Study|Withdrawal by Subject|5|||
130506528|NCT00091572|469820881|FG000|Overall Study|Lost to Follow-up|1|||
130506529|NCT00091572|469820882|FG001|Overall Study|Lost to Follow-up|1|||
130506530|NCT00091572|469820881|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
130506531|NCT00091572|469820882|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
130506532|NCT00091572|469820881|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
130506533|NCT00091572|469820882|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
130506534|NCT00091572|469820881|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
130506535|NCT00091572|469820882|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
130506536|NCT00091572|469820881|FG000|Overall Study|Other Reason|6|||
130506537|NCT00091572|469820882|FG001|Overall Study|Other Reason|13|||
130506538|NCT00091572|469820881|FG000|Overall Study|Ongoing (still on treatment)|8|||
130506539|NCT00091572|469820882|FG001|Overall Study|Ongoing (still on treatment)|12|||
130506540|NCT00091572|469820881|FG000|Overall Study|Major Protocol Violation|2|||
130506541|NCT00091572|469820882|FG001|Overall Study|Major Protocol Violation|0|||
130506542|NCT00091572|469820881|FG000|Overall Study|Toxicity (Related AE)|53|||
130506543|NCT00091572|469820882|FG001|Overall Study|Toxicity (Related AE)|9|||
130506544|NCT02942771|469820884|FG000|Overall Study|Adverse Event|1|||
130506545|NCT02942771|469820885|FG001|Overall Study|Adverse Event|0|||
130506546|NCT02942771|469820886|FG002|Overall Study|Adverse Event|0|||
130506547|NCT02942771|469820887|FG003|Overall Study|Adverse Event|0|||
130506548|NCT02942771|469820888|FG004|Overall Study|Adverse Event|2|||
130506549|NCT02942771|469820884|FG000|Overall Study|Lost to Follow-up|1|||
130506550|NCT02942771|469820885|FG001|Overall Study|Lost to Follow-up|0|||
130506551|NCT02942771|469820886|FG002|Overall Study|Lost to Follow-up|0|||
130506552|NCT02942771|469820887|FG003|Overall Study|Lost to Follow-up|0|||
130506553|NCT02942771|469820888|FG004|Overall Study|Lost to Follow-up|0|||
130506554|NCT02942771|469820884|FG000|Overall Study|Withdrawal by Subject|1|||
130506555|NCT02942771|469820885|FG001|Overall Study|Withdrawal by Subject|0|||
130506556|NCT02942771|469820886|FG002|Overall Study|Withdrawal by Subject|0|||
130506557|NCT02942771|469820887|FG003|Overall Study|Withdrawal by Subject|0|||
130506558|NCT02942771|469820888|FG004|Overall Study|Withdrawal by Subject|2|||
130506559|NCT01186809|469820892|FG000|Overall Study|Death|30|||
130506560|NCT04895085|469820893|FG000|Overall Study|Death|1|||
130506561|NCT04895085|469820893|FG000|Overall Study|Withdrawal by Subject|1|||
130506562|NCT04895085|469820893|FG000|Overall Study|No longer eligible: Moved from area|1|||
130506563|NCT01159600|469820898|FG000|Overall Study|Not treated|0|||
130506564|NCT01159600|469820899|FG001|Overall Study|Not treated|0|||
130506565|NCT01159600|469820900|FG002|Overall Study|Not treated|1|||
130506566|NCT01159600|469820901|FG003|Overall Study|Not treated|0|||
130506567|NCT01159600|469820902|FG004|Overall Study|Not treated|0|||
130506568|NCT01159600|469820903|FG005|Overall Study|Not treated|1|||
130506569|NCT01159600|469820904|FG006|Overall Study|Not treated|2|||
130506570|NCT01159600|469820905|FG007|Overall Study|Not treated|2|||
130506571|NCT01159600|469820898|FG000|Overall Study|Adverse Event|7|||
130506572|NCT01159600|469820899|FG001|Overall Study|Adverse Event|2|||
130506573|NCT01159600|469820900|FG002|Overall Study|Adverse Event|5|||
130506574|NCT01159600|469820901|FG003|Overall Study|Adverse Event|1|||
130506575|NCT01159600|469820902|FG004|Overall Study|Adverse Event|8|||
130506576|NCT01159600|469820903|FG005|Overall Study|Adverse Event|6|||
130506577|NCT01159600|469820904|FG006|Overall Study|Adverse Event|7|||
130506578|NCT01159600|469820905|FG007|Overall Study|Adverse Event|5|||
130506579|NCT01159600|469820898|FG000|Overall Study|Lack of Efficacy|0|||
130506580|NCT01159600|469820899|FG001|Overall Study|Lack of Efficacy|0|||
130506581|NCT01159600|469820900|FG002|Overall Study|Lack of Efficacy|0|||
130506582|NCT01159600|469820901|FG003|Overall Study|Lack of Efficacy|0|||
130506583|NCT01159600|469820902|FG004|Overall Study|Lack of Efficacy|2|||
130506584|NCT01159600|469820903|FG005|Overall Study|Lack of Efficacy|0|||
130506585|NCT01159600|469820904|FG006|Overall Study|Lack of Efficacy|0|||
130506586|NCT01159600|469820905|FG007|Overall Study|Lack of Efficacy|1|||
130506587|NCT01159600|469820898|FG000|Overall Study|Non compliant with protocol|2|||
130506588|NCT01159600|469820899|FG001|Overall Study|Non compliant with protocol|1|||
130506589|NCT01159600|469820900|FG002|Overall Study|Non compliant with protocol|0|||
130506590|NCT01159600|469820901|FG003|Overall Study|Non compliant with protocol|0|||
130506591|NCT01159600|469820902|FG004|Overall Study|Non compliant with protocol|2|||
130506592|NCT01159600|469820903|FG005|Overall Study|Non compliant with protocol|0|||
130506593|NCT01159600|469820904|FG006|Overall Study|Non compliant with protocol|2|||
130506594|NCT01159600|469820905|FG007|Overall Study|Non compliant with protocol|0|||
130506595|NCT01159600|469820898|FG000|Overall Study|Lost to Follow-up|2|||
130506596|NCT01159600|469820899|FG001|Overall Study|Lost to Follow-up|3|||
130506597|NCT01159600|469820900|FG002|Overall Study|Lost to Follow-up|4|||
130506598|NCT01159600|469820901|FG003|Overall Study|Lost to Follow-up|3|||
130506599|NCT01159600|469820902|FG004|Overall Study|Lost to Follow-up|3|||
130506600|NCT01159600|469820903|FG005|Overall Study|Lost to Follow-up|0|||
130506601|NCT01159600|469820904|FG006|Overall Study|Lost to Follow-up|3|||
130506602|NCT01159600|469820905|FG007|Overall Study|Lost to Follow-up|2|||
130506603|NCT01159600|469820898|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
130506604|NCT01159600|469820899|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
130506605|NCT01159600|469820900|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
130506606|NCT01159600|469820901|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
130506607|NCT01159600|469820902|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
130506608|NCT01159600|469820903|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
130506609|NCT01159600|469820904|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
130506610|NCT01159600|469820905|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
130506611|NCT01159600|469820898|FG000|Overall Study|Other reason not defined above|3|||
130506612|NCT01159600|469820899|FG001|Overall Study|Other reason not defined above|0|||
130506613|NCT01159600|469820900|FG002|Overall Study|Other reason not defined above|4|||
130506614|NCT01159600|469820901|FG003|Overall Study|Other reason not defined above|2|||
130506615|NCT01159600|469820902|FG004|Overall Study|Other reason not defined above|5|||
130506616|NCT01159600|469820903|FG005|Overall Study|Other reason not defined above|7|||
130506617|NCT01159600|469820904|FG006|Overall Study|Other reason not defined above|3|||
130506618|NCT01159600|469820905|FG007|Overall Study|Other reason not defined above|3|||
130506619|NCT04433091|469820906|FG000|Overall Study|Lost to Follow-up|1|||
130506620|NCT04433091|469820907|FG001|Overall Study|Lost to Follow-up|0|||
130506621|NCT04433091|469820906|FG000|Overall Study|Withdrawn .|2|||
130506622|NCT04433091|469820907|FG001|Overall Study|Withdrawn .|4|||
130506623|NCT04097535|469820908|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
130506624|NCT02880293|469822479|FG000|Overall Study|Inevaluable|5|||
130506625|NCT00451906|469822485|FG000|Overall Study|Adverse Event|515|||
130506626|NCT00451906|469822485|FG000|Overall Study|Lost to Follow-up|31|||
130506627|NCT00451906|469822485|FG000|Overall Study|Withdrawal by Subject|111|||
130506628|NCT00451906|469822485|FG000|Overall Study|Protocol Violation|21|||
130506629|NCT00451906|469822485|FG000|Overall Study|Progressive disease|1328|||
130506630|NCT00451906|469822485|FG000|Overall Study|Termination of the study|108|||
130506631|NCT00451906|469822485|FG000|Overall Study|Other Reasons|121|||
130506632|NCT00451906|469822485|FG000|Overall Study|Did not complete final visit|4|||
130506633|NCT03072238|469822490|FG000|Overall Study|Withdrawal by Subject|44|||
130506634|NCT03072238|469822491|FG001|Overall Study|Withdrawal by Subject|64|||
130506635|NCT03072238|469822490|FG000|Overall Study|Lost to Follow-up|14|||
130506636|NCT03072238|469822491|FG001|Overall Study|Lost to Follow-up|5|||
130506637|NCT03072238|469822490|FG000|Overall Study|Physician Decision|4|||
130506638|NCT03072238|469822491|FG001|Overall Study|Physician Decision|6|||
130506639|NCT03072238|469822490|FG000|Overall Study|Death|351|||
130506640|NCT03072238|469822491|FG001|Overall Study|Death|318|||
130506641|NCT03072238|469822490|FG000|Overall Study|Progressive Disease|3|||
130506642|NCT03072238|469822491|FG001|Overall Study|Progressive Disease|4|||
130506643|NCT03072238|469822490|FG000|Overall Study|Reason Not Specified|138|||
130506644|NCT03072238|469822491|FG001|Overall Study|Reason Not Specified|150|||
130506645|NCT01863368|469822497|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
130506646|NCT01863368|469822498|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
130506647|NCT01863368|469822497|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
130506648|NCT01863368|469822498|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
130506649|NCT01863368|469822497|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
130506650|NCT01863368|469822498|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
130506651|NCT01863368|469822497|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
130506652|NCT01863368|469822498|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
130506653|NCT01863368|469822497|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
130506654|NCT01863368|469822498|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
130506655|NCT01863368|469822497|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
130506656|NCT01863368|469822498|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
130506657|NCT00307489|469822499|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
130506658|NCT00307489|469822500|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
130506659|NCT00307489|469822499|FG000|Baseline Through Week 48|Physician Decision|1|||
130506660|NCT00307489|469822500|FG001|Baseline Through Week 48|Physician Decision|0|||
130506661|NCT00307489|469822499|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
130506662|NCT00307489|469822500|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
130506663|NCT00307489|469822499|FG000|Week 48 Through Week 168|Adverse Event|1|||
130506664|NCT00307489|469822500|FG001|Week 48 Through Week 168|Adverse Event|0|||
130506665|NCT00307489|469822499|FG000|Week 48 Through Week 168|Physician Decision|1|||
130506666|NCT00307489|469822500|FG001|Week 48 Through Week 168|Physician Decision|0|||
130506667|NCT00307489|469822499|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
130566647|NCT03370120|470041480|FG000|Overall Study|Termination of project|1|||
130566648|NCT03370120|470041480|FG000|Overall Study|The study was interrupted by sponsor|4|||
130566649|NCT03370120|470041480|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
130566650|NCT03370120|470041480|FG000|Overall Study|End of sponsor decision|1|||
130566651|NCT03370120|470041480|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
130566652|NCT03370120|470041480|FG000|Overall Study|Early termination of studies|5|||
130566653|NCT03370120|470041480|FG000|Overall Study|This study is ended early|1|||
130566654|NCT03370120|470041480|FG000|Overall Study|End of padsevonil program|2|||
130566655|NCT03370120|470041480|FG000|Overall Study|Decision of sponsor|6|||
130566656|NCT03370120|470041480|FG000|Overall Study|Asked by the sponsor|3|||
130566657|NCT03370120|470041480|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
130566658|NCT03370120|470041480|FG000|Overall Study|PI decision poor compliance from participant|1|||
130566659|NCT03370120|470041480|FG000|Overall Study|Promoter ended the study|3|||
130566660|NCT03370120|470041480|FG000|Overall Study|Premature study close by sponsor's decision|4|||
130566661|NCT03370120|470041480|FG000|Overall Study|Study terminated by sponsor|33|||
130566662|NCT03370120|470041480|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
130566663|NCT03370120|470041480|FG000|Overall Study|Sponsor decision to terminate study|63|||
130566664|NCT03370120|470041480|FG000|Overall Study|Program closure|3|||
130566665|NCT03370120|470041480|FG000|Overall Study|Study ended prematurely|1|||
130566666|NCT03370120|470041480|FG000|Overall Study|Study stopped by sponsor|2|||
130566667|NCT03370120|470041480|FG000|Overall Study|Program termination|55|||
130566668|NCT03370120|470041480|FG000|Overall Study|Sponsor decision|62|||
130566669|NCT03370120|470041480|FG000|Overall Study|Sponsor study closure|10|||
130566670|NCT00454857|470041481|FG000|Overall Study|Withdrawal by Subject|15|||
130566671|NCT00454857|470041481|FG000|Overall Study|Lost to Follow-up|16|||
130566672|NCT00454857|470041481|FG000|Overall Study|Noncompliance|6|||
130566673|NCT00454857|470041481|FG000|Overall Study|Death|5|||
130566674|NCT00454857|470041481|FG000|Overall Study|Other|11|||
130566675|NCT00454857|470041481|FG000|Overall Study|Reason unknown|1|||
130566676|NCT04206020|470041482|FG000|Overall Study|Adverse Event|1|||
130566677|NCT04206020|470041483|FG001|Overall Study|Adverse Event|4|||
130566678|NCT04206020|470041482|FG000|Overall Study|Protocol Violation|2|||
130566679|NCT04206020|470041483|FG001|Overall Study|Protocol Violation|0|||
130566680|NCT04206020|470041482|FG000|Overall Study|Withdrawal by Subject|2|||
130566681|NCT04206020|470041483|FG001|Overall Study|Withdrawal by Subject|0|||
130506668|NCT00307489|469822500|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
130506669|NCT00307489|469822499|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
130566682|NCT04206020|470041482|FG000|Overall Study|Lost to Follow-up|2|||
130506670|NCT00307489|469822500|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
130506671|NCT00307489|469822499|FG000|Week 48 Through Week 168|Death|0|||
130506672|NCT00307489|469822500|FG001|Week 48 Through Week 168|Death|1|||
130506673|NCT00307489|469822499|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
130506674|NCT00307489|469822500|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
130506675|NCT00307489|469822499|FG000|Week 48 Through Week 168|Seroconversion|1|||
130506676|NCT00307489|469822500|FG001|Week 48 Through Week 168|Seroconversion|0|||
130506677|NCT04025762|469822502|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
130566683|NCT04206020|470041483|FG001|Overall Study|Lost to Follow-up|0|||
130566684|NCT04206020|470041482|FG000|Overall Study|Pregnancy|0|||
130566685|NCT04206020|470041483|FG001|Overall Study|Pregnancy|1|||
130566686|NCT04206020|470041482|FG000|Overall Study|Unable to attend visits|1|||
130506678|NCT04025762|469822503|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
130506679|NCT02165202|469822510|FG000|Oral Phase|Refused further participation|5|||
130506680|NCT02165202|469822511|FG001|Oral Phase|Refused further participation|1|||
130506681|NCT02165202|469822510|FG000|Oral Phase|Study product Related Toxicity|1|||
130506682|NCT02165202|469822511|FG001|Oral Phase|Study product Related Toxicity|0|||
130506683|NCT02165202|469822510|FG000|Oral Phase|Unable to contact Participant|1|||
130506684|NCT02165202|469822511|FG001|Oral Phase|Unable to contact Participant|1|||
130506685|NCT02165202|469822510|FG000|Oral Phase|Clinical reasons|1|||
130506686|NCT02165202|469822511|FG001|Oral Phase|Clinical reasons|0|||
130506687|NCT02165202|469822510|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
130506688|NCT02165202|469822511|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
130506689|NCT02165202|469822510|FG000|Oral Phase|CMC advised termination|1|||
130506690|NCT02165202|469822511|FG001|Oral Phase|CMC advised termination|0|||
130506691|NCT02165202|469822510|FG000|Oral Phase|Relocated, no follow-up planned|1|||
130506692|NCT02165202|469822511|FG001|Oral Phase|Relocated, no follow-up planned|0|||
130506693|NCT02165202|469822510|FG000|Oral Phase|Abnormal EKG|0|||
130506694|NCT02165202|469822511|FG001|Oral Phase|Abnormal EKG|1|||
130506695|NCT02165202|469822510|FG000|Injection Phase|Abnormal Lab Value|5|||
130506696|NCT02165202|469822511|FG001|Injection Phase|Abnormal Lab Value|1|||
130506697|NCT02165202|469822510|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
130506698|NCT02165202|469822511|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
130506699|NCT02165202|469822510|FG000|Injection Phase|Unable to attend within Visit Window|1|||
130506700|NCT02165202|469822511|FG001|Injection Phase|Unable to attend within Visit Window|0|||
130506701|NCT02165202|469822510|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
130506702|NCT02165202|469822511|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
130506703|NCT02165202|469822510|FG000|Injection Phase|End of Study|2|||
130506704|NCT02165202|469822511|FG001|Injection Phase|End of Study|1|||
130506705|NCT02165202|469822510|FG000|Injection Phase|Study Product related Toxicity|1|||
130506706|NCT02165202|469822511|FG001|Injection Phase|Study Product related Toxicity|0|||
130506707|NCT02165202|469822510|FG000|Injection Phase|No longer interested|0|||
130506708|NCT02165202|469822511|FG001|Injection Phase|No longer interested|1|||
130506709|NCT02165202|469822510|FG000|Injection Phase|Participant unwilling to comply|1|||
130506710|NCT02165202|469822511|FG001|Injection Phase|Participant unwilling to comply|0|||
130506711|NCT01975701|469822518|FG000|Overall Study|Lost to Follow-up|1|||
130506712|NCT01975701|469822518|FG000|Overall Study|Death|23|||
130506713|NCT01975701|469822518|FG000|Overall Study|Physician Decision|1|||
130506714|NCT02446015|469822521|FG000|Overall Study|Adverse Event|0|||
130506715|NCT02446015|469822522|FG001|Overall Study|Adverse Event|1|||
130566687|NCT04206020|470041483|FG001|Overall Study|Unable to attend visits|2|||
130566688|NCT04416555|470041484|FG000|Overall Study|Withdrawal by Subject|0|||
130566689|NCT04416555|470041485|FG001|Overall Study|Withdrawal by Subject|3|||
130566690|NCT02004262|470041496|FG000|Overall Study|Death|67|||
130566691|NCT02004262|470041497|FG001|Overall Study|Death|64|||
130566692|NCT02004262|470041498|FG002|Overall Study|Death|66|||
130566693|NCT02004262|470041499|FG003|Overall Study|Death|28|||
130566694|NCT02004262|470041500|FG004|Overall Study|Death|29|||
130566695|NCT02004262|470041501|FG005|Overall Study|Death|22|||
130566696|NCT02004262|470041496|FG000|Overall Study|Withdrawal by Subject|1|||
130566697|NCT02004262|470041497|FG001|Overall Study|Withdrawal by Subject|0|||
130566698|NCT02004262|470041498|FG002|Overall Study|Withdrawal by Subject|4|||
130566699|NCT02004262|470041499|FG003|Overall Study|Withdrawal by Subject|0|||
130506716|NCT02446015|469822521|FG000|Overall Study|Withdrawal by Subject|1|||
130506717|NCT02446015|469822522|FG001|Overall Study|Withdrawal by Subject|0|||
130506718|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
130506719|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
130506720|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
130506721|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
130566700|NCT02004262|470041500|FG004|Overall Study|Withdrawal by Subject|1|||
130566701|NCT02004262|470041501|FG005|Overall Study|Withdrawal by Subject|3|||
130566702|NCT02004262|470041496|FG000|Overall Study|Lost to Follow-up|1|||
130566703|NCT02004262|470041497|FG001|Overall Study|Lost to Follow-up|1|||
130732055|NCT03083665|470641105|FG003|Double-Blind Period|Protocol Violation|0|||
130732056|NCT03083665|470641106|FG004|Double-Blind Period|Protocol Violation|0|||
130732057|NCT03083665|470641107|FG005|Double-Blind Period|Protocol Violation|0|||
130732058|NCT03083665|470641102|FG000|Double-Blind Period|Lost to Follow-up|1|||
130732059|NCT03083665|470641103|FG001|Double-Blind Period|Lost to Follow-up|0|||
130732060|NCT03083665|470641104|FG002|Double-Blind Period|Lost to Follow-up|1|||
130732061|NCT03083665|470641105|FG003|Double-Blind Period|Lost to Follow-up|0|||
130732062|NCT03083665|470641106|FG004|Double-Blind Period|Lost to Follow-up|0|||
130732063|NCT03083665|470641107|FG005|Double-Blind Period|Lost to Follow-up|0|||
130732064|NCT03083665|470641102|FG000|Double-Blind Period|Withdrawal by Subject|3|||
130732065|NCT03083665|470641103|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130732066|NCT03083665|470641104|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130732067|NCT03083665|470641105|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130732068|NCT03083665|470641106|FG004|Double-Blind Period|Withdrawal by Subject|0|||
130732069|NCT03083665|470641107|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130732070|NCT03083665|470641102|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
130732071|NCT03083665|470641103|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130732072|NCT03083665|470641104|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130732073|NCT03083665|470641105|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130506722|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Adverse Event|7|||
130506723|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Adverse Event|8|||
130506724|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Adverse Event|8|||
130506725|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Adverse Event|9|||
130506726|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
130506727|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
130506728|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
130506729|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
130506730|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
130506731|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
130506732|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
130506733|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
130506734|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Pregnancy|0|||
130506735|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Pregnancy|2|||
130506736|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Pregnancy|2|||
130506737|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Pregnancy|0|||
130506738|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Non-compliance|1|||
130506739|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Non-compliance|0|||
130506740|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Non-compliance|0|||
130506741|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Non-compliance|3|||
130506742|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Other|3|||
130506743|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Other|0|||
130506744|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Other|3|||
130506745|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Other|2|||
130506746|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
130506747|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
130506748|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
130506749|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
130506750|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
130506751|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
130506752|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
130506753|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
130506754|NCT02143713|469822525|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
130506755|NCT02143713|469822526|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
130506756|NCT02143713|469822527|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
130506757|NCT02143713|469822528|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
130506758|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
130506759|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
130506760|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
130506761|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
130506762|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
130506763|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
130506764|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
130506765|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
130506766|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
130506767|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
130506768|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
130506769|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
130506770|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
130506771|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
130506772|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
130506773|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
130506774|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
130506775|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
130506776|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
130506777|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
130506778|NCT02143713|469822525|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
130506779|NCT02143713|469822526|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
130506780|NCT02143713|469822527|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
130506781|NCT02143713|469822528|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
130506782|NCT01768572|469822531|FG000|Overall Study|Adverse Event|7|||
130506783|NCT01768572|469822532|FG001|Overall Study|Adverse Event|8|||
130506784|NCT01768572|469822533|FG002|Overall Study|Adverse Event|4|||
130506785|NCT01768572|469822531|FG000|Overall Study|Lack of Efficacy|1|||
130506786|NCT01768572|469822532|FG001|Overall Study|Lack of Efficacy|3|||
130506787|NCT01768572|469822533|FG002|Overall Study|Lack of Efficacy|1|||
130506788|NCT01768572|469822531|FG000|Overall Study|Other, Not due to an adverse event|1|||
130506789|NCT01768572|469822532|FG001|Overall Study|Other, Not due to an adverse event|1|||
130506790|NCT01768572|469822533|FG002|Overall Study|Other, Not due to an adverse event|1|||
130506791|NCT00080119|469822534|FG000|Overall Study|Discontinued because of study closure|0|||
130506792|NCT00080119|469822535|FG001|Overall Study|Discontinued because of study closure|0|||
130506793|NCT00080119|469822536|FG002|Overall Study|Discontinued because of study closure|130|||
130506794|NCT00080119|469822537|FG003|Overall Study|Discontinued because of study closure|141|||
130506795|NCT00080119|469822534|FG000|Overall Study|Unable to get to clinic|24|||
130506796|NCT00080119|469822535|FG001|Overall Study|Unable to get to clinic|24|||
130506797|NCT00080119|469822536|FG002|Overall Study|Unable to get to clinic|7|||
130506798|NCT00080119|469822537|FG003|Overall Study|Unable to get to clinic|1|||
130506799|NCT00080119|469822534|FG000|Overall Study|Consent withdrawn|13|||
130506800|NCT00080119|469822535|FG001|Overall Study|Consent withdrawn|17|||
130506801|NCT00080119|469822536|FG002|Overall Study|Consent withdrawn|4|||
130506802|NCT00080119|469822537|FG003|Overall Study|Consent withdrawn|6|||
130506803|NCT00080119|469822534|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
130506804|NCT00080119|469822535|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
130506805|NCT00080119|469822536|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
130506806|NCT00080119|469822537|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
130506807|NCT00080119|469822534|FG000|Overall Study|Lost to Follow-up|16|||
130506808|NCT00080119|469822535|FG001|Overall Study|Lost to Follow-up|19|||
130506809|NCT00080119|469822536|FG002|Overall Study|Lost to Follow-up|19|||
130506810|NCT00080119|469822537|FG003|Overall Study|Lost to Follow-up|14|||
130506811|NCT01919489|469822538|FG000|Overall Study|Rejected the need of injections|4|||
130506812|NCT01919489|469822539|FG001|Overall Study|Rejected the need of injections|7|||
130506813|NCT01919489|469822538|FG000|Overall Study|Adverse Event|10|||
130506814|NCT01919489|469822539|FG001|Overall Study|Adverse Event|0|||
130506815|NCT01919489|469822538|FG000|Overall Study|Hospital readmission|2|||
130506816|NCT01919489|469822539|FG001|Overall Study|Hospital readmission|9|||
130506817|NCT01919489|469822538|FG000|Overall Study|Death|2|||
130506818|NCT01919489|469822539|FG001|Overall Study|Death|1|||
130506819|NCT01919489|469822538|FG000|Overall Study|Lost to Follow-up|38|||
130506820|NCT01919489|469822539|FG001|Overall Study|Lost to Follow-up|27|||
130506821|NCT00871494|469822542|FG000|Overall Study|Protocol Violation|5|||
130506822|NCT00871494|469822542|FG000|Overall Study|Lack of Efficacy|4|||
130506823|NCT00871494|469822542|FG000|Overall Study|Adverse Event|4|||
130506824|NCT00871494|469822542|FG000|Overall Study|Lost to Follow-up|1|||
130506825|NCT01190436|469822547|FG000|Overall Study|Lost to Follow-up|35|||
130506826|NCT01190436|469822547|FG000|Overall Study|Other|4|||
130506827|NCT02721147|469822548|FG000|Overall Study|Lost to Follow-up|2|||
130506828|NCT02721147|469822549|FG001|Overall Study|Lost to Follow-up|0|||
130506829|NCT02721147|469822550|FG002|Overall Study|Lost to Follow-up|0|||
130506830|NCT01722097|469822552|FG000|Overall Study|Patient sheets not returned|6|||
130506831|NCT01722097|469822553|FG001|Overall Study|Patient sheets not returned|5|||
130506832|NCT02009332|469822554|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
130506833|NCT02009332|469822555|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
130506834|NCT02009332|469822556|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
130506835|NCT02009332|469822557|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
130506836|NCT02009332|469822558|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
130506837|NCT02009332|469822559|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
130506838|NCT02009332|469822554|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
130506839|NCT02009332|469822555|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
130506840|NCT02009332|469822556|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
130506841|NCT02009332|469822557|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
130506842|NCT02009332|469822558|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
130506843|NCT02009332|469822559|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
130506844|NCT02009332|469822554|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
130506845|NCT02009332|469822555|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
130506846|NCT02009332|469822556|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
130506847|NCT02009332|469822557|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
130506848|NCT02009332|469822558|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
130506849|NCT02009332|469822559|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
130506850|NCT00248794|469822561|FG000|Overall Study|Lost to Follow-up|6|||
130506851|NCT00248794|469822562|FG001|Overall Study|Lost to Follow-up|8|||
130506852|NCT00248794|469822563|FG002|Overall Study|Lost to Follow-up|3|||
130506853|NCT02632747|469822564|FG000|Wash-out Period|Adverse Event|1|||
130506854|NCT02632747|469822565|FG001|Wash-out Period|Adverse Event|0|||
130506855|NCT03449979|469822566|FG000|Overall Study|Technical difficulty|0|||
130506856|NCT03449979|469822567|FG001|Overall Study|Technical difficulty|0|||
130506857|NCT03449979|469822568|FG002|Overall Study|Technical difficulty|0|||
130506858|NCT03449979|469822569|FG003|Overall Study|Technical difficulty|1|||
130506859|NCT02069379|469822570|FG000|Baseline Measurements|Lost to Follow-up|1|||
130506860|NCT02069379|469822571|FG001|Baseline Measurements|Lost to Follow-up|0|||
130506861|NCT02069379|469822572|FG002|Baseline Measurements|Lost to Follow-up|0|||
130506862|NCT02069379|469822573|FG003|Baseline Measurements|Lost to Follow-up|0|||
130506863|NCT02069379|469822570|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
130506864|NCT02069379|469822571|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
130506865|NCT02069379|469822572|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
130506866|NCT02069379|469822573|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
130506867|NCT02069379|469822570|FG000|First Treatment Arm|Lost to Follow-up|0|||
130506868|NCT02069379|469822571|FG001|First Treatment Arm|Lost to Follow-up|1|||
130506869|NCT02069379|469822572|FG002|First Treatment Arm|Lost to Follow-up|1|||
130506870|NCT02069379|469822573|FG003|First Treatment Arm|Lost to Follow-up|0|||
130506871|NCT02069379|469822570|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
130506872|NCT02069379|469822571|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
130506873|NCT02069379|469822572|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
130506874|NCT02069379|469822573|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
130506875|NCT02069379|469822570|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
130506876|NCT02069379|469822571|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
130506877|NCT02069379|469822572|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
130506878|NCT02069379|469822573|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
130506879|NCT02069379|469822570|FG000|Second Treatment Arm|Lost to Follow-up|0|||
130506880|NCT02069379|469822571|FG001|Second Treatment Arm|Lost to Follow-up|0|||
130506881|NCT02069379|469822572|FG002|Second Treatment Arm|Lost to Follow-up|1|||
130506882|NCT02069379|469822573|FG003|Second Treatment Arm|Lost to Follow-up|0|||
130506883|NCT00700999|469822576|FG000|Overall Study|Lost to Follow-up|7|||
130506884|NCT00700999|469822577|FG001|Overall Study|Lost to Follow-up|7|||
130506885|NCT00700999|469822576|FG000|Overall Study|Excluded - did not meet study criteria|0|||
130506886|NCT00700999|469822577|FG001|Overall Study|Excluded - did not meet study criteria|1|||
130506887|NCT00700999|469822576|FG000|Overall Study|Withdrawal by Subject|8|||
130506888|NCT00700999|469822577|FG001|Overall Study|Withdrawal by Subject|1|||
130506889|NCT03481725|469822578|FG000|Overall Study|Withdrawal by Subject|1|||
130506890|NCT03481725|469822579|FG001|Overall Study|Withdrawal by Subject|0|||
130506891|NCT03651271|469822580|FG000|Overall Study|Death|4|||
130506892|NCT03651271|469822581|FG001|Overall Study|Death|37|||
130506893|NCT03651271|469822582|FG002|Overall Study|Death|0|||
130506894|NCT03651271|469822583|FG003|Overall Study|Death|2|||
130506895|NCT03651271|469822584|FG004|Overall Study|Death|6|||
130506896|NCT03651271|469822580|FG000|Overall Study|Lost to Follow-up|1|||
130506897|NCT03651271|469822581|FG001|Overall Study|Lost to Follow-up|5|||
130506898|NCT03651271|469822582|FG002|Overall Study|Lost to Follow-up|0|||
130506899|NCT03651271|469822583|FG003|Overall Study|Lost to Follow-up|1|||
130506900|NCT03651271|469822584|FG004|Overall Study|Lost to Follow-up|0|||
130506901|NCT03651271|469822580|FG000|Overall Study|Physician Decision|0|||
130506902|NCT03651271|469822581|FG001|Overall Study|Physician Decision|2|||
130506903|NCT03651271|469822582|FG002|Overall Study|Physician Decision|0|||
130506904|NCT03651271|469822583|FG003|Overall Study|Physician Decision|0|||
130506905|NCT03651271|469822584|FG004|Overall Study|Physician Decision|0|||
130506906|NCT03651271|469822580|FG000|Overall Study|Withdrawal by Subject|1|||
130506907|NCT03651271|469822581|FG001|Overall Study|Withdrawal by Subject|15|||
130506908|NCT03651271|469822582|FG002|Overall Study|Withdrawal by Subject|0|||
130506909|NCT03651271|469822583|FG003|Overall Study|Withdrawal by Subject|0|||
130506910|NCT03651271|469822584|FG004|Overall Study|Withdrawal by Subject|1|||
130506911|NCT03651271|469822580|FG000|Overall Study|Patient medically unable to continue|0|||
130506912|NCT03651271|469822581|FG001|Overall Study|Patient medically unable to continue|0|||
130506913|NCT03651271|469822582|FG002|Overall Study|Patient medically unable to continue|0|||
130506914|NCT03651271|469822583|FG003|Overall Study|Patient medically unable to continue|1|||
130506915|NCT03651271|469822584|FG004|Overall Study|Patient medically unable to continue|0|||
130506916|NCT03444155|469822587|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
130506917|NCT03444155|469822588|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
130506918|NCT01133678|469822593|FG000|Overall Study|Death|1|||
130506919|NCT01133678|469822594|FG001|Overall Study|Death|1|||
130506920|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
130506921|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
130506922|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
130506923|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
130506924|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
130506925|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Adverse Event|0|||
130506926|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Adverse Event|1|||
130506927|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Adverse Event|1|||
130506928|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Adverse Event|0|||
130506929|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Adverse Event|0|||
130506930|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
130506931|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
130506932|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
130506933|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
130506934|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
130506935|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Physician Decision|1|||
130506936|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Physician Decision|0|||
130506937|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Physician Decision|0|||
130506938|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Physician Decision|0|||
130506939|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Physician Decision|0|||
130506940|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
130506941|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
130506942|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
130506943|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
130506944|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
130506945|NCT00446095|469822595|FG000|Phase II (8 Weeks)|Ongoing|0|||
130506946|NCT00446095|469822596|FG001|Phase II (8 Weeks)|Ongoing|0|||
130506947|NCT00446095|469822597|FG002|Phase II (8 Weeks)|Ongoing|1|||
130506948|NCT00446095|469822598|FG003|Phase II (8 Weeks)|Ongoing|0|||
130506949|NCT00446095|469822599|FG004|Phase II (8 Weeks)|Ongoing|0|||
130506950|NCT00446095|469822595|FG000|Phase I (28 Days)|Adverse Event|0|||
130506951|NCT00446095|469822596|FG001|Phase I (28 Days)|Adverse Event|0|||
130506952|NCT00446095|469822597|FG002|Phase I (28 Days)|Adverse Event|0|||
130506953|NCT00446095|469822598|FG003|Phase I (28 Days)|Adverse Event|1|||
130506954|NCT00446095|469822599|FG004|Phase I (28 Days)|Adverse Event|0|||
130506955|NCT00446095|469822595|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
130506956|NCT00446095|469822596|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
130506957|NCT00446095|469822597|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
130506958|NCT00446095|469822598|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
130506959|NCT00446095|469822599|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
130506960|NCT02574286|469822600|FG000|Overall Study|Adverse Event|3|||
130506961|NCT02574286|469822600|FG000|Overall Study|Withdrawal by Subject|2|||
130506962|NCT02764320|469822601|FG000|Overall Study|Withdrawal by Subject|35|||
130506963|NCT02764320|469822602|FG001|Overall Study|Withdrawal by Subject|38|||
130506964|NCT02764320|469822601|FG000|Overall Study|Protocol Violation|11|||
130506965|NCT02764320|469822602|FG001|Overall Study|Protocol Violation|6|||
130506966|NCT02764320|469822601|FG000|Overall Study|Adverse Event|2|||
130506967|NCT02764320|469822602|FG001|Overall Study|Adverse Event|0|||
130506968|NCT02764320|469822601|FG000|Overall Study|Health Issues unable to continue|2|||
130506969|NCT02764320|469822602|FG001|Overall Study|Health Issues unable to continue|0|||
130506970|NCT02764320|469822601|FG000|Overall Study|Did not meet inclusion criteria|1|||
130732074|NCT03083665|470641106|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130506971|NCT02764320|469822602|FG001|Overall Study|Did not meet inclusion criteria|0|||
130506972|NCT02764320|469822601|FG000|Overall Study|Subject moved|0|||
130506973|NCT02764320|469822602|FG001|Overall Study|Subject moved|2|||
130506974|NCT02764320|469822601|FG000|Overall Study|Overused medication unavailable|0|||
130506975|NCT02764320|469822602|FG001|Overall Study|Overused medication unavailable|1|||
130506976|NCT02764320|469822601|FG000|Overall Study|Seeking care outside site|0|||
130506977|NCT02764320|469822602|FG001|Overall Study|Seeking care outside site|1|||
130506978|NCT02764320|469822601|FG000|Overall Study|Technology barriers|0|||
130506979|NCT02764320|469822602|FG001|Overall Study|Technology barriers|1|||
130506980|NCT01280656|469822603|FG000|Overall Study|Adverse Event|1|||
130506981|NCT01280656|469822604|FG001|Overall Study|Adverse Event|14|||
130506982|NCT01280656|469822605|FG002|Overall Study|Adverse Event|13|||
130506983|NCT01280656|469822603|FG000|Overall Study|Lack of Efficacy|1|||
130506984|NCT01280656|469822604|FG001|Overall Study|Lack of Efficacy|22|||
130506985|NCT01280656|469822605|FG002|Overall Study|Lack of Efficacy|38|||
130506986|NCT01280656|469822603|FG000|Overall Study|Treatment shortening (RGT)|0|||
130506987|NCT01280656|469822604|FG001|Overall Study|Treatment shortening (RGT)|4|||
130506988|NCT01280656|469822605|FG002|Overall Study|Treatment shortening (RGT)|5|||
130506989|NCT01280656|469822603|FG000|Overall Study|Other|1|||
130506990|NCT01280656|469822604|FG001|Overall Study|Other|7|||
130506991|NCT01280656|469822605|FG002|Overall Study|Other|7|||
130506992|NCT01970527|469822608|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
130506993|NCT01970527|469822609|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
130506994|NCT01970527|469822608|FG000|Treatment|Disease progression|0|||
130506995|NCT01970527|469822609|FG001|Treatment|Disease progression|1|||
130506996|NCT01970527|469822608|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
130506997|NCT01970527|469822609|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
130506998|NCT01970527|469822608|FG000|Treatment|Death|0|||
130506999|NCT01970527|469822609|FG001|Treatment|Death|1|||
130507000|NCT01970527|469822608|FG000|Follow-up Clinic Visit|Disease progression|1|||
130507001|NCT01970527|469822609|FG001|Follow-up Clinic Visit|Disease progression|1|||
130507002|NCT01970527|469822608|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
130507003|NCT01970527|469822609|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
130507004|NCT01970527|469822608|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
130507005|NCT01970527|469822609|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
130507006|NCT01964547|469822610|FG000|Overall Study|Adverse Event|8|||
130507007|NCT01964547|469822611|FG001|Overall Study|Adverse Event|2|||
130507008|NCT01964547|469822610|FG000|Overall Study|Withdrawal by Subject|4|||
130507009|NCT01964547|469822611|FG001|Overall Study|Withdrawal by Subject|7|||
130507010|NCT01964547|469822610|FG000|Overall Study|Lost to Follow-up|0|||
130507011|NCT01964547|469822611|FG001|Overall Study|Lost to Follow-up|1|||
130507012|NCT01964547|469822610|FG000|Overall Study|Withdrawal by Investigator|0|||
130507013|NCT01964547|469822611|FG001|Overall Study|Withdrawal by Investigator|1|||
130507014|NCT01115309|469822612|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
130507015|NCT01115309|469822612|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
130507016|NCT01115309|469822612|FG000|Long-term Follow-up|Lost to Follow-up|6|||
130507017|NCT02147093|469822613|FG000|Period 1|Lost to Follow-up|0|||
130507018|NCT02147093|469822614|FG001|Period 1|Lost to Follow-up|1|||
130507019|NCT02147093|469822613|FG000|Period 2|Protocol Violation|2|||
130507020|NCT02147093|469822614|FG001|Period 2|Protocol Violation|0|||
130507021|NCT00655824|469822615|FG000|Overall Study|Adverse Event|3|||
130507022|NCT00655824|469822615|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
130507023|NCT00655824|469822615|FG000|Overall Study|Protocol Violation|1|||
130507024|NCT00655824|469822615|FG000|Overall Study|Withdrawal by Subject|4|||
130507025|NCT00655824|469822615|FG000|Overall Study|Deterioration of Trial Disease|2|||
130507026|NCT00736502|469822619|FG000|Overall Study|Adverse Event|22|||
130507027|NCT00736502|469822619|FG000|Overall Study|Lack of Efficacy|16|||
130732075|NCT03083665|470641107|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130732076|NCT03083665|470641102|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
130732077|NCT03083665|470641103|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
130732078|NCT03083665|470641104|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
130732079|NCT03083665|470641105|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
130732080|NCT03083665|470641106|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
130732081|NCT03083665|470641107|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
130732082|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130732083|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130732084|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130732085|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
130732086|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130507028|NCT00736502|469822619|FG000|Overall Study|Lost to Follow-up|27|||
130507029|NCT03032198|469822620|FG000|Overall Study|Screen Fail|1|||
130507030|NCT03100370|469822622|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130507031|NCT03100370|469822623|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130507032|NCT03100370|469822624|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130507033|NCT03100370|469822625|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130507034|NCT03100370|469822626|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130507035|NCT03100370|469822627|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130507036|NCT01307800|469822628|FG000|Overall Study|Adverse Event|9|||
130507037|NCT01307800|469822629|FG001|Overall Study|Adverse Event|8|||
130566704|NCT02004262|470041498|FG002|Overall Study|Lost to Follow-up|0|||
130507038|NCT01307800|469822630|FG002|Overall Study|Adverse Event|10|||
130507039|NCT01307800|469822631|FG003|Overall Study|Adverse Event|14|||
130507040|NCT01307800|469822628|FG000|Overall Study|Entry Criteria Not Met|0|||
130507041|NCT01307800|469822629|FG001|Overall Study|Entry Criteria Not Met|0|||
130507042|NCT01307800|469822630|FG002|Overall Study|Entry Criteria Not Met|0|||
130507043|NCT01307800|469822631|FG003|Overall Study|Entry Criteria Not Met|2|||
130507044|NCT01307800|469822628|FG000|Overall Study|Lost to Follow-up|5|||
130507045|NCT01307800|469822629|FG001|Overall Study|Lost to Follow-up|6|||
130507046|NCT01307800|469822630|FG002|Overall Study|Lost to Follow-up|2|||
130507047|NCT01307800|469822631|FG003|Overall Study|Lost to Follow-up|8|||
130507048|NCT01307800|469822628|FG000|Overall Study|Perceived Lack of Efficacy|24|||
130507049|NCT01307800|469822629|FG001|Overall Study|Perceived Lack of Efficacy|23|||
130507050|NCT01307800|469822630|FG002|Overall Study|Perceived Lack of Efficacy|20|||
130507051|NCT01307800|469822631|FG003|Overall Study|Perceived Lack of Efficacy|33|||
130507052|NCT01307800|469822628|FG000|Overall Study|Protocol Violation|0|||
130507053|NCT01307800|469822629|FG001|Overall Study|Protocol Violation|3|||
130507054|NCT01307800|469822630|FG002|Overall Study|Protocol Violation|4|||
130507055|NCT01307800|469822631|FG003|Overall Study|Protocol Violation|5|||
130507056|NCT01307800|469822628|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
130507057|NCT01307800|469822629|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
130507058|NCT01307800|469822630|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
130507059|NCT01307800|469822631|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
130507060|NCT01307800|469822628|FG000|Overall Study|Sponsor Decision|6|||
130507061|NCT01307800|469822629|FG001|Overall Study|Sponsor Decision|9|||
130507062|NCT01307800|469822630|FG002|Overall Study|Sponsor Decision|12|||
130507063|NCT01307800|469822631|FG003|Overall Study|Sponsor Decision|28|||
130507064|NCT01307800|469822628|FG000|Overall Study|Withdrawal by Subject|10|||
130507065|NCT01307800|469822629|FG001|Overall Study|Withdrawal by Subject|11|||
130507066|NCT01307800|469822630|FG002|Overall Study|Withdrawal by Subject|8|||
130507067|NCT01307800|469822631|FG003|Overall Study|Withdrawal by Subject|15|||
130507068|NCT01307800|469822628|FG000|Overall Study|Participant Moved|0|||
130507069|NCT01307800|469822629|FG001|Overall Study|Participant Moved|2|||
130507070|NCT01307800|469822630|FG002|Overall Study|Participant Moved|1|||
130507071|NCT01307800|469822631|FG003|Overall Study|Participant Moved|3|||
130507072|NCT00689351|469822632|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
130507073|NCT00689351|469822633|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
130507074|NCT00689351|469822632|FG000|Infant Series of Dosing|Adverse Event|1|||
130507075|NCT00689351|469822633|FG001|Infant Series of Dosing|Adverse Event|0|||
130507076|NCT00689351|469822632|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
130507077|NCT00689351|469822633|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
130507078|NCT00689351|469822632|FG000|After Infant Series|Parent/legal guardian request|1|||
130507079|NCT00689351|469822633|FG001|After Infant Series|Parent/legal guardian request|0|||
130507080|NCT01766206|469822634|FG000|Overall Study|Withdrawal by Subject|22|||
130507081|NCT01766206|469822634|FG000|Overall Study|Lost to Follow-up|10|||
130507082|NCT01766206|469822634|FG000|Overall Study|Inappropriate enrollment|18|||
130507083|NCT01766206|469822634|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
130507084|NCT02255474|469822635|FG000|Overall Study|Lost to Follow-up|1|||
130507085|NCT02255474|469822636|FG001|Overall Study|Lost to Follow-up|1|||
130507086|NCT02255474|469822637|FG002|Overall Study|Lost to Follow-up|3|||
130507087|NCT02255474|469822635|FG000|Overall Study|Withdrawal by Subject|1|||
130507088|NCT02255474|469822636|FG001|Overall Study|Withdrawal by Subject|1|||
130507089|NCT02255474|469822637|FG002|Overall Study|Withdrawal by Subject|0|||
130507090|NCT01229176|469822638|FG000|Overall Study|Withdrawal by Subject|0|||
130507091|NCT01229176|469822639|FG001|Overall Study|Withdrawal by Subject|0|||
130507092|NCT01229176|469822640|FG002|Overall Study|Withdrawal by Subject|0|||
130507093|NCT01229176|469822641|FG003|Overall Study|Withdrawal by Subject|1|||
130507094|NCT01229176|469822642|FG004|Overall Study|Withdrawal by Subject|1|||
130507095|NCT01229176|469822643|FG005|Overall Study|Withdrawal by Subject|1|||
130507096|NCT01229176|469822644|FG006|Overall Study|Withdrawal by Subject|0|||
130507097|NCT01229176|469822645|FG007|Overall Study|Withdrawal by Subject|1|||
130507098|NCT01229176|469822638|FG000|Overall Study|Lost to Follow-up|0|||
130507099|NCT01229176|469822639|FG001|Overall Study|Lost to Follow-up|3|||
130507100|NCT01229176|469822640|FG002|Overall Study|Lost to Follow-up|0|||
130507101|NCT01229176|469822641|FG003|Overall Study|Lost to Follow-up|0|||
130507102|NCT01229176|469822642|FG004|Overall Study|Lost to Follow-up|1|||
130507103|NCT01229176|469822643|FG005|Overall Study|Lost to Follow-up|1|||
130507104|NCT01229176|469822644|FG006|Overall Study|Lost to Follow-up|0|||
130507105|NCT01229176|469822645|FG007|Overall Study|Lost to Follow-up|2|||
130507106|NCT00882050|469822653|FG000|Overall Study|Physician Decision|1|||
130507107|NCT00882050|469822654|FG001|Overall Study|Physician Decision|0|||
130507108|NCT00882050|469822655|FG002|Overall Study|Physician Decision|0|||
130507109|NCT02367794|469822656|FG000|Overall Study|Death|252|||
130507110|NCT02367794|469822657|FG001|Overall Study|Death|245|||
130507111|NCT02367794|469822658|FG002|Overall Study|Death|243|||
130507112|NCT02367794|469822656|FG000|Overall Study|Lost to Follow-up|1|||
130507113|NCT02367794|469822657|FG001|Overall Study|Lost to Follow-up|2|||
130507114|NCT02367794|469822658|FG002|Overall Study|Lost to Follow-up|2|||
130507115|NCT02367794|469822656|FG000|Overall Study|Physician Decision|0|||
130507116|NCT02367794|469822657|FG001|Overall Study|Physician Decision|5|||
130566705|NCT02004262|470041499|FG003|Overall Study|Lost to Follow-up|0|||
130732087|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130732088|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130732089|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130732090|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130732091|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130732092|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130732093|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
130732094|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130732095|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130732096|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130732097|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130732098|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130732099|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130732100|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130732101|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130732102|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130732103|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130732104|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130732105|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
130732106|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130732107|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130732108|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130732109|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
130732110|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130732111|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130732112|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130732113|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130732114|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130732115|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130732116|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130732117|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
130732118|NCT03083665|470641102|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130732119|NCT03083665|470641103|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130732120|NCT03083665|470641104|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130732121|NCT03083665|470641105|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130732122|NCT03083665|470641106|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130732123|NCT03083665|470641107|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
130732124|NCT04981912|470641108|FG000|Overall Study|Physician Decision|2|||
130732125|NCT00980954|470641111|FG000|Overall Study|Protocol Violation|9|||
130732126|NCT00980954|470641112|FG001|Overall Study|Protocol Violation|15|||
130732127|NCT02519348|470641113|FG000|Overall Study|Death|31|||
130732128|NCT02519348|470641114|FG001|Overall Study|Death|74|||
130507117|NCT02367794|469822658|FG002|Overall Study|Physician Decision|3|||
130507118|NCT02367794|469822656|FG000|Overall Study|Protocol Violation|1|||
130507119|NCT02367794|469822657|FG001|Overall Study|Protocol Violation|0|||
130507120|NCT02367794|469822658|FG002|Overall Study|Protocol Violation|1|||
130507121|NCT02367794|469822656|FG000|Overall Study|Withdrawal by Subject|25|||
130507122|NCT02367794|469822657|FG001|Overall Study|Withdrawal by Subject|12|||
130507123|NCT02367794|469822658|FG002|Overall Study|Withdrawal by Subject|20|||
130507124|NCT02367794|469822656|FG000|Overall Study|Brain metastasis|1|||
130507125|NCT02367794|469822657|FG001|Overall Study|Brain metastasis|0|||
130507126|NCT02367794|469822658|FG002|Overall Study|Brain metastasis|0|||
130507127|NCT02367794|469822656|FG000|Overall Study|Randomized in error|0|||
130507128|NCT02367794|469822657|FG001|Overall Study|Randomized in error|0|||
130507129|NCT02367794|469822658|FG002|Overall Study|Randomized in error|1|||
130507130|NCT02367794|469822656|FG000|Overall Study|Patient unable to receive carboplatin|0|||
130507131|NCT02367794|469822657|FG001|Overall Study|Patient unable to receive carboplatin|0|||
130507132|NCT02367794|469822658|FG002|Overall Study|Patient unable to receive carboplatin|1|||
130507133|NCT02367794|469822656|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
130507134|NCT02367794|469822657|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
130507135|NCT02367794|469822658|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
130507136|NCT02367794|469822656|FG000|Overall Study|Adverse Event|0|||
130566706|NCT02004262|470041500|FG004|Overall Study|Lost to Follow-up|0|||
130507137|NCT02367794|469822657|FG001|Overall Study|Adverse Event|0|||
130566707|NCT02004262|470041501|FG005|Overall Study|Lost to Follow-up|0|||
130507138|NCT02367794|469822658|FG002|Overall Study|Adverse Event|2|||
130507139|NCT02367794|469822656|FG000|Overall Study|Study Terminated By Sponsor|0|||
130507140|NCT02367794|469822657|FG001|Overall Study|Study Terminated By Sponsor|1|||
130507141|NCT02367794|469822658|FG002|Overall Study|Study Terminated By Sponsor|1|||
130507142|NCT02367794|469822656|FG000|Overall Study|Moved to Roll-Over Study|0|||
130507143|NCT02367794|469822657|FG001|Overall Study|Moved to Roll-Over Study|15|||
130507144|NCT02367794|469822658|FG002|Overall Study|Moved to Roll-Over Study|13|||
130507145|NCT02367794|469822656|FG000|Overall Study|Sponsor Request|60|||
130507146|NCT02367794|469822657|FG001|Overall Study|Sponsor Request|57|||
130507147|NCT02367794|469822658|FG002|Overall Study|Sponsor Request|45|||
130507148|NCT02367794|469822656|FG000|Overall Study|Moved into PTAP Study|0|||
130507149|NCT02367794|469822657|FG001|Overall Study|Moved into PTAP Study|2|||
130507150|NCT02367794|469822658|FG002|Overall Study|Moved into PTAP Study|3|||
130507151|NCT02367794|469822656|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
130507152|NCT02367794|469822657|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
130507153|NCT02367794|469822658|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
130507154|NCT02367794|469822656|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
130507155|NCT02367794|469822657|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
130507156|NCT02367794|469822658|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
130507157|NCT02367794|469822656|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
130507158|NCT02367794|469822657|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
130507159|NCT02367794|469822658|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
130507160|NCT02367794|469822656|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
130507161|NCT02367794|469822657|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
130507162|NCT02367794|469822658|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
130507163|NCT01884571|469822659|FG000|Overall Study|Adverse Event|1|||
130507164|NCT01884571|469822659|FG000|Overall Study|Death|2|||
130507165|NCT01884571|469822659|FG000|Overall Study|Withdrawal by Subject|2|||
130507166|NCT01884571|469822659|FG000|Overall Study|Disease progression|3|||
130507167|NCT04820023|469823923|FG000|Overall Study|Death|0|||
130507168|NCT04820023|469823924|FG001|Overall Study|Death|0|||
130507169|NCT04820023|469823925|FG002|Overall Study|Death|0|||
130507170|NCT04820023|469823926|FG003|Overall Study|Death|0|||
130507171|NCT04820023|469823927|FG004|Overall Study|Death|0|||
130507172|NCT04820023|469823928|FG005|Overall Study|Death|0|||
130507173|NCT04820023|469823929|FG006|Overall Study|Death|1|||
130507174|NCT04820023|469823930|FG007|Overall Study|Death|0|||
130507175|NCT04820023|469823931|FG008|Overall Study|Death|1|||
130507176|NCT04820023|469823923|FG000|Overall Study|Withdrawal by Subject|1|||
130507177|NCT04820023|469823924|FG001|Overall Study|Withdrawal by Subject|2|||
130507178|NCT04820023|469823925|FG002|Overall Study|Withdrawal by Subject|2|||
130507179|NCT04820023|469823926|FG003|Overall Study|Withdrawal by Subject|1|||
130507180|NCT04820023|469823927|FG004|Overall Study|Withdrawal by Subject|4|||
130507181|NCT04820023|469823928|FG005|Overall Study|Withdrawal by Subject|3|||
130507182|NCT04820023|469823929|FG006|Overall Study|Withdrawal by Subject|3|||
130507183|NCT04820023|469823930|FG007|Overall Study|Withdrawal by Subject|6|||
130507184|NCT04820023|469823931|FG008|Overall Study|Withdrawal by Subject|5|||
130507185|NCT04820023|469823923|FG000|Overall Study|Progressive Disease|3|||
130507186|NCT04820023|469823924|FG001|Overall Study|Progressive Disease|0|||
130507187|NCT04820023|469823925|FG002|Overall Study|Progressive Disease|2|||
130507188|NCT04820023|469823926|FG003|Overall Study|Progressive Disease|2|||
130566708|NCT02004262|470041496|FG000|Overall Study|Study Terminated by Sponsor|4|||
130566709|NCT02004262|470041497|FG001|Overall Study|Study Terminated by Sponsor|3|||
130566710|NCT02004262|470041498|FG002|Overall Study|Study Terminated by Sponsor|2|||
130566711|NCT02004262|470041499|FG003|Overall Study|Study Terminated by Sponsor|1|||
130566712|NCT02004262|470041500|FG004|Overall Study|Study Terminated by Sponsor|1|||
130566713|NCT02004262|470041501|FG005|Overall Study|Study Terminated by Sponsor|5|||
130566714|NCT03200366|470041505|FG000|Patient Navigation Intervention Given|Death|0|||
130566715|NCT03200366|470041506|FG001|Patient Navigation Intervention Given|Death|2|||
130732129|NCT02519348|470641115|FG002|Overall Study|Death|47|||
130732130|NCT02519348|470641116|FG003|Overall Study|Death|54|||
130732131|NCT02519348|470641117|FG004|Overall Study|Death|63|||
130507189|NCT04820023|469823927|FG004|Overall Study|Progressive Disease|2|||
130507190|NCT04820023|469823928|FG005|Overall Study|Progressive Disease|0|||
130732132|NCT02519348|470641118|FG005|Overall Study|Death|18|||
130732133|NCT02519348|470641119|FG006|Overall Study|Death|2|||
130507191|NCT04820023|469823929|FG006|Overall Study|Progressive Disease|1|||
130507192|NCT04820023|469823930|FG007|Overall Study|Progressive Disease|1|||
130507193|NCT04820023|469823931|FG008|Overall Study|Progressive Disease|0|||
130507194|NCT04820023|469823923|FG000|Overall Study|New anti-cancer therapy|0|||
130507195|NCT04820023|469823924|FG001|Overall Study|New anti-cancer therapy|0|||
130507196|NCT04820023|469823925|FG002|Overall Study|New anti-cancer therapy|0|||
130507197|NCT04820023|469823926|FG003|Overall Study|New anti-cancer therapy|0|||
130507198|NCT04820023|469823927|FG004|Overall Study|New anti-cancer therapy|2|||
130507199|NCT04820023|469823928|FG005|Overall Study|New anti-cancer therapy|0|||
130732134|NCT02519348|470641120|FG007|Overall Study|Death|5|||
130732135|NCT02519348|470641121|FG008|Overall Study|Death|5|||
130732136|NCT02519348|470641113|FG000|Overall Study|Withdrawal by Subject|4|||
130732137|NCT02519348|470641114|FG001|Overall Study|Withdrawal by Subject|7|||
130732138|NCT02519348|470641115|FG002|Overall Study|Withdrawal by Subject|4|||
130732139|NCT02519348|470641116|FG003|Overall Study|Withdrawal by Subject|3|||
130732140|NCT02519348|470641117|FG004|Overall Study|Withdrawal by Subject|3|||
130732141|NCT02519348|470641118|FG005|Overall Study|Withdrawal by Subject|2|||
130732142|NCT02519348|470641119|FG006|Overall Study|Withdrawal by Subject|0|||
130732143|NCT02519348|470641120|FG007|Overall Study|Withdrawal by Subject|0|||
130732144|NCT02519348|470641121|FG008|Overall Study|Withdrawal by Subject|1|||
130732145|NCT02519348|470641113|FG000|Overall Study|Lost to Follow-up|0|||
130732146|NCT02519348|470641114|FG001|Overall Study|Lost to Follow-up|0|||
130732147|NCT02519348|470641115|FG002|Overall Study|Lost to Follow-up|1|||
130732148|NCT02519348|470641116|FG003|Overall Study|Lost to Follow-up|0|||
130732149|NCT02519348|470641117|FG004|Overall Study|Lost to Follow-up|2|||
130732150|NCT02519348|470641118|FG005|Overall Study|Lost to Follow-up|1|||
130732151|NCT02519348|470641119|FG006|Overall Study|Lost to Follow-up|1|||
130732152|NCT02519348|470641120|FG007|Overall Study|Lost to Follow-up|0|||
130732153|NCT02519348|470641121|FG008|Overall Study|Lost to Follow-up|0|||
130732154|NCT02519348|470641113|FG000|Overall Study|Other|0|||
130732155|NCT02519348|470641114|FG001|Overall Study|Other|3|||
130732156|NCT02519348|470641115|FG002|Overall Study|Other|0|||
130732157|NCT02519348|470641116|FG003|Overall Study|Other|0|||
130732158|NCT02519348|470641117|FG004|Overall Study|Other|1|||
130732159|NCT02519348|470641118|FG005|Overall Study|Other|0|||
130732160|NCT02519348|470641119|FG006|Overall Study|Other|0|||
130732161|NCT02519348|470641120|FG007|Overall Study|Other|0|||
130732162|NCT02519348|470641121|FG008|Overall Study|Other|0|||
130732163|NCT02519348|470641113|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
130732164|NCT02519348|470641114|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
130732165|NCT02519348|470641115|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
130732166|NCT02519348|470641116|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
130732167|NCT02519348|470641117|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
130732168|NCT02519348|470641118|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
130732169|NCT02519348|470641119|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
130732170|NCT02519348|470641120|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
130732171|NCT02519348|470641121|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
130732172|NCT05630547|470641122|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
130732173|NCT05630547|470641123|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
130732174|NCT05630547|470641124|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
130732175|NCT05630547|470641125|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
130732176|NCT05630547|470641122|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
130732177|NCT05630547|470641123|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
130732178|NCT05630547|470641124|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
130732179|NCT05630547|470641125|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
130732180|NCT05630547|470641122|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
130732181|NCT05630547|470641123|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
130732182|NCT05630547|470641124|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
130732183|NCT05630547|470641125|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
130732184|NCT05630547|470641122|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
130732185|NCT05630547|470641123|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
130732186|NCT05630547|470641124|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
130732187|NCT05630547|470641125|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
130732188|NCT05630547|470641122|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
130732189|NCT05630547|470641123|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
130732190|NCT05630547|470641124|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
130732191|NCT05630547|470641125|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
130732192|NCT05630547|470641122|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
130732193|NCT05630547|470641123|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
130732194|NCT05630547|470641124|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
130732195|NCT05630547|470641125|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
130732196|NCT05630547|470641122|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
130732197|NCT05630547|470641123|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
130732198|NCT05630547|470641124|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
130732199|NCT05630547|470641125|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
130732200|NCT05630547|470641122|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
130732201|NCT05630547|470641123|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
130732202|NCT05630547|470641124|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
130732203|NCT05630547|470641125|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
130732204|NCT05630547|470641122|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
130566716|NCT03200366|470041507|FG002|Patient Navigation Intervention Given|Death|0|||
130566717|NCT03200366|470041505|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
130566718|NCT03200366|470041506|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
130566719|NCT03200366|470041507|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
130566720|NCT03200366|470041505|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
130566721|NCT03200366|470041506|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
130566722|NCT03200366|470041507|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
130566723|NCT03200366|470041505|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
130566724|NCT03200366|470041506|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
130566725|NCT03200366|470041507|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
130566726|NCT03200366|470041505|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
130566727|NCT03200366|470041506|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
130566728|NCT03200366|470041507|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
130566729|NCT03200366|470041505|FG000|6 Month Post-Baseline Interview|Death|1|||
130566730|NCT03200366|470041506|FG001|6 Month Post-Baseline Interview|Death|1|||
130566731|NCT03200366|470041507|FG002|6 Month Post-Baseline Interview|Death|1|||
130566732|NCT03200366|470041505|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
130566733|NCT03200366|470041506|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
130566734|NCT03200366|470041507|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
130566735|NCT03200366|470041505|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
130566736|NCT03200366|470041506|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
130566737|NCT03200366|470041507|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
130566738|NCT03200366|470041505|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
130566739|NCT03200366|470041506|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
130566740|NCT03200366|470041507|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
130566741|NCT03200366|470041505|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
130566742|NCT03200366|470041506|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
130566743|NCT03200366|470041507|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
130566744|NCT03200366|470041505|FG000|9 Month Post-Baseline Interview|Death|1|||
130566745|NCT03200366|470041506|FG001|9 Month Post-Baseline Interview|Death|1|||
130566746|NCT03200366|470041507|FG002|9 Month Post-Baseline Interview|Death|1|||
130566747|NCT03200366|470041505|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
130566748|NCT03200366|470041506|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
130566749|NCT03200366|470041507|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
130566750|NCT03200366|470041505|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
130566751|NCT03200366|470041506|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
130566752|NCT03200366|470041507|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
130566753|NCT03200366|470041505|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
130566754|NCT03200366|470041506|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
130566755|NCT03200366|470041507|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
130566756|NCT00552175|470041508|FG000|Overall Study|Lack of Efficacy|2|||
130566757|NCT00552175|470041509|FG001|Overall Study|Lack of Efficacy|0|||
130507200|NCT04820023|469823929|FG006|Overall Study|New anti-cancer therapy|0|||
130507201|NCT04820023|469823930|FG007|Overall Study|New anti-cancer therapy|0|||
130507202|NCT04820023|469823931|FG008|Overall Study|New anti-cancer therapy|0|||
130507203|NCT04820023|469823923|FG000|Overall Study|Other|0|||
130507204|NCT04820023|469823924|FG001|Overall Study|Other|1|||
130507205|NCT04820023|469823925|FG002|Overall Study|Other|0|||
130507206|NCT04820023|469823926|FG003|Overall Study|Other|0|||
130507207|NCT04820023|469823927|FG004|Overall Study|Other|0|||
130507208|NCT04820023|469823928|FG005|Overall Study|Other|0|||
130507209|NCT04820023|469823929|FG006|Overall Study|Other|0|||
130507210|NCT04820023|469823930|FG007|Overall Study|Other|2|||
130507211|NCT04820023|469823931|FG008|Overall Study|Other|0|||
130507212|NCT00515112|469823933|FG000|Overall Study|Death|0|||
130507213|NCT00515112|469823934|FG001|Overall Study|Death|1|||
130507214|NCT00515112|469823933|FG000|Overall Study|The study was terminated|3|||
130507215|NCT00515112|469823934|FG001|Overall Study|The study was terminated|2|||
130507216|NCT01020487|469823935|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
130507217|NCT01020487|469823936|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
130507218|NCT01020487|469823937|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
130507219|NCT01020487|469823935|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
130507220|NCT01020487|469823936|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
130566758|NCT00552175|470041510|FG002|Overall Study|Lack of Efficacy|1|||
130507221|NCT01020487|469823937|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
130507222|NCT01020487|469823935|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
130732205|NCT05630547|470641123|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
130732206|NCT05630547|470641124|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
130732207|NCT05630547|470641125|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
130732208|NCT05630547|470641122|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
130732209|NCT05630547|470641123|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
130732210|NCT05630547|470641124|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
130732211|NCT05630547|470641125|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
130732212|NCT05956665|470641126|FG000|Overall Study|Death|1|||
130732213|NCT05956665|470641126|FG000|Overall Study|Withdrawal by Subject|1|||
130732214|NCT06285240|470641127|FG000|Overall Study|Withdrawal by Subject|2|||
130732215|NCT06285240|470641128|FG001|Overall Study|Withdrawal by Subject|0|||
130732216|NCT06285240|470641129|FG002|Overall Study|Withdrawal by Subject|0|||
130732217|NCT06285240|470641130|FG003|Overall Study|Withdrawal by Subject|0|||
130732218|NCT06285240|470641127|FG000|Overall Study|Serious Adverse Event|0|||
130732219|NCT06285240|470641128|FG001|Overall Study|Serious Adverse Event|0|||
130732220|NCT06285240|470641129|FG002|Overall Study|Serious Adverse Event|1|||
130732221|NCT06285240|470641130|FG003|Overall Study|Serious Adverse Event|0|||
130732222|NCT04428151|470641131|FG000|Overall Study|Death|100|||
130732223|NCT04428151|470641132|FG001|Overall Study|Death|86|||
130732224|NCT04428151|470641133|FG002|Overall Study|Death|57|||
130507223|NCT01020487|469823936|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
130507224|NCT01020487|469823937|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
130507225|NCT01020487|469823935|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
130507226|NCT01020487|469823936|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
130507227|NCT01020487|469823937|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
130507228|NCT01020487|469823935|FG000|Part 2 Open-label Period|Adverse Event|0|||
130507229|NCT01020487|469823936|FG001|Part 2 Open-label Period|Adverse Event|4|||
130507230|NCT01020487|469823937|FG002|Part 2 Open-label Period|Adverse Event|1|||
130566759|NCT00552175|470041508|FG000|Overall Study|Adverse Event|9|||
130566760|NCT00552175|470041509|FG001|Overall Study|Adverse Event|9|||
130566761|NCT00552175|470041510|FG002|Overall Study|Adverse Event|10|||
130566762|NCT00552175|470041508|FG000|Overall Study|Withdrawal by Subject|2|||
130566763|NCT00552175|470041509|FG001|Overall Study|Withdrawal by Subject|2|||
130566764|NCT00552175|470041510|FG002|Overall Study|Withdrawal by Subject|1|||
130566765|NCT00552175|470041508|FG000|Overall Study|Lost to Follow-up|0|||
130566766|NCT00552175|470041509|FG001|Overall Study|Lost to Follow-up|0|||
130566767|NCT00552175|470041510|FG002|Overall Study|Lost to Follow-up|1|||
130566768|NCT00552175|470041508|FG000|Overall Study|Entry Criteria Not Met|1|||
130566769|NCT00552175|470041509|FG001|Overall Study|Entry Criteria Not Met|1|||
130566770|NCT00552175|470041510|FG002|Overall Study|Entry Criteria Not Met|0|||
130566771|NCT00552175|470041508|FG000|Overall Study|Reason Not Specified|3|||
130566772|NCT00552175|470041509|FG001|Overall Study|Reason Not Specified|1|||
130566773|NCT00552175|470041510|FG002|Overall Study|Reason Not Specified|1|||
130566774|NCT01543828|470041513|FG000|Treatment 2|Lost to Follow-up|1|||
130566775|NCT01543828|470041514|FG001|Treatment 2|Lost to Follow-up|0|||
130566776|NCT00804570|470041516|FG000|Overall Study|Adverse Event|14|||
130566777|NCT00804570|470041517|FG001|Overall Study|Adverse Event|7|||
130566778|NCT00804570|470041516|FG000|Overall Study|Lack of Efficacy|0|||
130566779|NCT00804570|470041517|FG001|Overall Study|Lack of Efficacy|1|||
130566780|NCT00804570|470041516|FG000|Overall Study|Lost to Follow-up|18|||
130566781|NCT00804570|470041517|FG001|Overall Study|Lost to Follow-up|21|||
130566782|NCT00804570|470041516|FG000|Overall Study|Entry criteria not met|5|||
130566783|NCT00804570|470041517|FG001|Overall Study|Entry criteria not met|5|||
130566784|NCT00804570|470041516|FG000|Overall Study|Protocol Violation|12|||
130566785|NCT00804570|470041517|FG001|Overall Study|Protocol Violation|16|||
130566786|NCT00804570|470041516|FG000|Overall Study|Physician Decision|1|||
130566787|NCT00804570|470041517|FG001|Overall Study|Physician Decision|2|||
130566788|NCT00804570|470041516|FG000|Overall Study|Sponsor decision|1|||
130566789|NCT00804570|470041517|FG001|Overall Study|Sponsor decision|4|||
130566790|NCT00804570|470041516|FG000|Overall Study|Withdrawal by Subject|21|||
130566791|NCT00804570|470041517|FG001|Overall Study|Withdrawal by Subject|38|||
130566792|NCT00290342|470041518|FG000|Overall Study|Other|0|||
130566793|NCT00290342|470041519|FG001|Overall Study|Other|1|||
130566794|NCT00290342|470041518|FG000|Overall Study|Withdrawal by Subject|6|||
130566795|NCT00290342|470041519|FG001|Overall Study|Withdrawal by Subject|4|||
130566796|NCT00290342|470041518|FG000|Overall Study|Lost to Follow-up|1|||
130566797|NCT00290342|470041519|FG001|Overall Study|Lost to Follow-up|0|||
130566798|NCT01056510|470041522|FG000|Overall Study|Dropout Before Start of Treatment|1|||
130566799|NCT01056510|470041523|FG001|Overall Study|Dropout Before Start of Treatment|1|||
130566800|NCT01056510|470041522|FG000|Overall Study|Withdrawal by Subject|4|||
130566801|NCT01056510|470041523|FG001|Overall Study|Withdrawal by Subject|2|||
130566802|NCT01056510|470041522|FG000|Overall Study|Death|29|||
130566803|NCT01056510|470041523|FG001|Overall Study|Death|34|||
130566804|NCT01056510|470041522|FG000|Overall Study|Noncompliance|1|||
130566805|NCT01056510|470041523|FG001|Overall Study|Noncompliance|3|||
130566806|NCT01056510|470041522|FG000|Overall Study|Physician Decision|4|||
130566807|NCT01056510|470041523|FG001|Overall Study|Physician Decision|5|||
130566808|NCT01056510|470041522|FG000|Overall Study|Lost to Follow-up|5|||
130566809|NCT01056510|470041523|FG001|Overall Study|Lost to Follow-up|6|||
130566810|NCT01056510|470041522|FG000|Overall Study|Other|10|||
130566811|NCT01056510|470041523|FG001|Overall Study|Other|12|||
130566812|NCT01056510|470041522|FG000|Overall Study|Missing|0|||
130566813|NCT01056510|470041523|FG001|Overall Study|Missing|1|||
130732225|NCT04428151|470641131|FG000|Overall Study|Lost to Follow-up|1|||
130732226|NCT04428151|470641132|FG001|Overall Study|Lost to Follow-up|1|||
130566814|NCT00243386|470041524|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
130566815|NCT00243386|470041525|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
130732227|NCT04428151|470641133|FG002|Overall Study|Lost to Follow-up|0|||
130732228|NCT04428151|470641131|FG000|Overall Study|Withdrawal by Subject|2|||
130732229|NCT04428151|470641132|FG001|Overall Study|Withdrawal by Subject|2|||
130507231|NCT02400749|469823940|FG000|Week 0 -16|Withdrawal by Subject|5|||
130566816|NCT00243386|470041526|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
130566817|NCT00243386|470041524|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
130566818|NCT00243386|470041525|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
130566819|NCT00243386|470041526|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
130566820|NCT00243386|470041524|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
130566821|NCT00243386|470041525|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
130507232|NCT02400749|469823941|FG001|Week 0 -16|Withdrawal by Subject|5|||
130566822|NCT00243386|470041526|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
130566823|NCT00243386|470041524|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
130566824|NCT00243386|470041525|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
130566825|NCT00243386|470041526|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
130566826|NCT00243386|470041524|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
130566827|NCT00243386|470041525|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
130566828|NCT00243386|470041526|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
130566829|NCT00243386|470041524|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
130507233|NCT02400749|469823940|FG000|Week 0 -16|Adverse Event|3|||
130507234|NCT02400749|469823941|FG001|Week 0 -16|Adverse Event|1|||
130507235|NCT02400749|469823940|FG000|Week 0 -16|Lost to Follow-up|2|||
130507236|NCT02400749|469823941|FG001|Week 0 -16|Lost to Follow-up|0|||
130507237|NCT02400749|469823940|FG000|Week 0 -16|Protocol Violation|1|||
130507238|NCT02400749|469823941|FG001|Week 0 -16|Protocol Violation|0|||
130507239|NCT02400749|469823940|FG000|Week 17 - 32|Withdrawal by Subject|3|||
130507240|NCT02400749|469823941|FG001|Week 17 - 32|Withdrawal by Subject|2|||
130507241|NCT02400749|469823940|FG000|Week 17 - 32|Adverse Event|2|||
130507242|NCT02400749|469823941|FG001|Week 17 - 32|Adverse Event|1|||
130507243|NCT04425252|469823944|FG000|Overall Study|Withdrawal by Subject|2|||
130507244|NCT04425252|469823945|FG001|Overall Study|Withdrawal by Subject|1|||
130507245|NCT04425252|469823944|FG000|Overall Study|Lost to Follow-up|1|||
130566830|NCT00243386|470041525|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
130566831|NCT00243386|470041526|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
130507246|NCT04425252|469823945|FG001|Overall Study|Lost to Follow-up|0|||
130507247|NCT04425252|469823944|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
130566832|NCT00243386|470041524|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
130566833|NCT00243386|470041525|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
130566834|NCT00243386|470041526|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
130507248|NCT04425252|469823945|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
130507249|NCT01279447|469823949|FG000|Overall Study|Lost to Follow-up|3|||
130507250|NCT01279447|469823950|FG001|Overall Study|Lost to Follow-up|1|||
130507251|NCT01215253|469823951|FG000|Overall Study|Withdrawal by Subject|57|||
130507252|NCT01215253|469823952|FG001|Overall Study|Withdrawal by Subject|35|||
130507253|NCT01215253|469823951|FG000|Overall Study|Physician Decision|9|||
130507254|NCT01215253|469823952|FG001|Overall Study|Physician Decision|12|||
130507255|NCT01215253|469823951|FG000|Overall Study|Lost to Follow-up|6|||
130507256|NCT01215253|469823952|FG001|Overall Study|Lost to Follow-up|4|||
130507257|NCT01215253|469823951|FG000|Overall Study|Other|14|||
130507258|NCT01215253|469823952|FG001|Overall Study|Other|12|||
130507259|NCT01131325|469823957|FG000|Overall Study|Adverse Event|1|||
130507260|NCT01131325|469823957|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
130507261|NCT03761849|469823958|FG000|Overall Study|transferred to OpenLabelExtension|35|||
130507262|NCT03761849|469823959|FG001|Overall Study|transferred to OpenLabelExtension|34|||
130507263|NCT03761849|469823960|FG002|Overall Study|transferred to OpenLabelExtension|36|||
130507264|NCT03761849|469823961|FG003|Overall Study|transferred to OpenLabelExtension|0|||
130507265|NCT03761849|469823962|FG004|Overall Study|transferred to OpenLabelExtension|0|||
130507266|NCT03761849|469823963|FG005|Overall Study|transferred to OpenLabelExtension|0|||
130507267|NCT03761849|469823958|FG000|Overall Study|Adverse Event|1|||
130507268|NCT03761849|469823959|FG001|Overall Study|Adverse Event|0|||
130507269|NCT03761849|469823960|FG002|Overall Study|Adverse Event|0|||
130507270|NCT03761849|469823961|FG003|Overall Study|Adverse Event|0|||
130566835|NCT00243386|470041524|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
130507271|NCT03761849|469823962|FG004|Overall Study|Adverse Event|2|||
130507272|NCT03761849|469823963|FG005|Overall Study|Adverse Event|3|||
130507273|NCT03761849|469823958|FG000|Overall Study|Withdrawal by Subject|0|||
130507274|NCT03761849|469823959|FG001|Overall Study|Withdrawal by Subject|0|||
130507275|NCT03761849|469823960|FG002|Overall Study|Withdrawal by Subject|0|||
130507276|NCT03761849|469823961|FG003|Overall Study|Withdrawal by Subject|41|||
130507277|NCT03761849|469823962|FG004|Overall Study|Withdrawal by Subject|43|||
130507278|NCT03761849|469823963|FG005|Overall Study|Withdrawal by Subject|35|||
130507279|NCT03761849|469823958|FG000|Overall Study|Lost to Follow-up|0|||
130507280|NCT03761849|469823959|FG001|Overall Study|Lost to Follow-up|1|||
130507281|NCT03761849|469823960|FG002|Overall Study|Lost to Follow-up|0|||
130507282|NCT03761849|469823961|FG003|Overall Study|Lost to Follow-up|2|||
130507283|NCT03761849|469823962|FG004|Overall Study|Lost to Follow-up|4|||
130507284|NCT03761849|469823963|FG005|Overall Study|Lost to Follow-up|5|||
130507285|NCT03761849|469823958|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
130507286|NCT03761849|469823959|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
130507287|NCT03761849|469823960|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
130507288|NCT03761849|469823961|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
130507289|NCT03761849|469823962|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
130507290|NCT03761849|469823963|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
130507291|NCT03761849|469823958|FG000|Overall Study|Physician Decision|0|||
130507292|NCT03761849|469823959|FG001|Overall Study|Physician Decision|0|||
130507293|NCT03761849|469823960|FG002|Overall Study|Physician Decision|0|||
130507294|NCT03761849|469823961|FG003|Overall Study|Physician Decision|1|||
130507295|NCT03761849|469823962|FG004|Overall Study|Physician Decision|4|||
130507296|NCT03761849|469823963|FG005|Overall Study|Physician Decision|4|||
130507297|NCT03761849|469823958|FG000|Overall Study|Death|0|||
130507298|NCT03761849|469823959|FG001|Overall Study|Death|0|||
130507299|NCT03761849|469823960|FG002|Overall Study|Death|0|||
130507300|NCT03761849|469823961|FG003|Overall Study|Death|1|||
130507301|NCT03761849|469823962|FG004|Overall Study|Death|1|||
130507302|NCT03761849|469823963|FG005|Overall Study|Death|3|||
130507303|NCT03761849|469823958|FG000|Overall Study|Protocol Violation|0|||
130507304|NCT03761849|469823959|FG001|Overall Study|Protocol Violation|0|||
130507305|NCT03761849|469823960|FG002|Overall Study|Protocol Violation|0|||
130507306|NCT03761849|469823961|FG003|Overall Study|Protocol Violation|2|||
130507307|NCT03761849|469823962|FG004|Overall Study|Protocol Violation|2|||
130507308|NCT03761849|469823963|FG005|Overall Study|Protocol Violation|1|||
130507309|NCT03761849|469823958|FG000|Overall Study|Participant could not come to site|0|||
130507310|NCT03761849|469823959|FG001|Overall Study|Participant could not come to site|0|||
130507311|NCT03761849|469823960|FG002|Overall Study|Participant could not come to site|0|||
130507312|NCT03761849|469823961|FG003|Overall Study|Participant could not come to site|0|||
130507313|NCT03761849|469823962|FG004|Overall Study|Participant could not come to site|1|||
130507314|NCT03761849|469823963|FG005|Overall Study|Participant could not come to site|0|||
130507315|NCT03761849|469823958|FG000|Overall Study|SF- safety Finding|0|||
130507316|NCT03761849|469823959|FG001|Overall Study|SF- safety Finding|0|||
130507317|NCT03761849|469823960|FG002|Overall Study|SF- safety Finding|0|||
130507318|NCT03761849|469823961|FG003|Overall Study|SF- safety Finding|0|||
130507319|NCT03761849|469823962|FG004|Overall Study|SF- safety Finding|0|||
130507320|NCT03761849|469823963|FG005|Overall Study|SF- safety Finding|1|||
130507321|NCT03761849|469823958|FG000|Overall Study|Patient did not attend visit|0|||
130507322|NCT03761849|469823959|FG001|Overall Study|Patient did not attend visit|0|||
130507323|NCT03761849|469823960|FG002|Overall Study|Patient did not attend visit|0|||
130507324|NCT03761849|469823961|FG003|Overall Study|Patient did not attend visit|0|||
130507325|NCT03761849|469823962|FG004|Overall Study|Patient did not attend visit|0|||
130507326|NCT03761849|469823963|FG005|Overall Study|Patient did not attend visit|1|||
130732230|NCT04428151|470641133|FG002|Overall Study|Withdrawal by Subject|3|||
130732231|NCT04428151|470641131|FG000|Overall Study|Participant Ongoing in Study|41|||
130732232|NCT04428151|470641132|FG001|Overall Study|Participant Ongoing in Study|53|||
130732233|NCT04428151|470641133|FG002|Overall Study|Participant Ongoing in Study|28|||
130732234|NCT00977470|470641134|FG000|Overall Study|Lack of Efficacy|32|||
130732235|NCT00977470|470641135|FG001|Overall Study|Lack of Efficacy|30|||
130732236|NCT00977470|470641134|FG000|Overall Study|Physician Decision|2|||
130732237|NCT00977470|470641135|FG001|Overall Study|Physician Decision|0|||
130732238|NCT00977470|470641134|FG000|Overall Study|Adverse Event|1|||
130732239|NCT00977470|470641135|FG001|Overall Study|Adverse Event|2|||
130732240|NCT00977470|470641134|FG000|Overall Study|Protocol Violation|1|||
130732241|NCT00977470|470641135|FG001|Overall Study|Protocol Violation|0|||
130732242|NCT00977470|470641134|FG000|Overall Study|Withdrawal by Subject|0|||
130732243|NCT00977470|470641135|FG001|Overall Study|Withdrawal by Subject|2|||
130732244|NCT00977470|470641134|FG000|Overall Study|Death|0|||
130732245|NCT00977470|470641135|FG001|Overall Study|Death|2|||
130732246|NCT00977470|470641134|FG000|Overall Study|clinical decline|0|||
130732247|NCT00977470|470641135|FG001|Overall Study|clinical decline|1|||
130732248|NCT00977470|470641134|FG000|Overall Study|prolonged recovery post-surgery|0|||
130732249|NCT00977470|470641135|FG001|Overall Study|prolonged recovery post-surgery|1|||
130732250|NCT00977470|470641134|FG000|Overall Study|Still on-study|2|||
130732251|NCT00977470|470641135|FG001|Overall Study|Still on-study|0|||
130732252|NCT04844879|470641136|FG000|Overall Study|Death|1|||
130732253|NCT04844879|470641136|FG000|Overall Study|Withdrawal by Subject|1|||
130732254|NCT04844879|470641136|FG000|Overall Study|Adverse Event|1|||
130732255|NCT06152224|470641139|FG000|Overall Study|Withdrawal by Subject|1|||
130732256|NCT06152224|470641140|FG001|Overall Study|Withdrawal by Subject|0|||
130732257|NCT06152224|470641139|FG000|Overall Study|Lost to Follow-up|0|||
130732258|NCT06152224|470641140|FG001|Overall Study|Lost to Follow-up|1|||
130732259|NCT06152224|470641139|FG000|Overall Study|On Follow Up|18|||
130732260|NCT06152224|470641140|FG001|Overall Study|On Follow Up|18|||
130732261|NCT02364557|470641144|FG000|Overall Study|Protocol Violation|3|||
130732262|NCT02364557|470641145|FG001|Overall Study|Protocol Violation|1|||
130732263|NCT03978624|470641150|FG000|Overall Study|Protocol Violation|1|||
130732264|NCT03978624|470641151|FG001|Overall Study|Protocol Violation|0|||
130732265|NCT04347239|470641152|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
130732266|NCT04347239|470641153|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
130732267|NCT04347239|470641154|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
130732268|NCT04347239|470641152|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
130732269|NCT04347239|470641153|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
130732270|NCT04347239|470641154|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
130732271|NCT04201262|470641155|FG000|Primary Treatment Period|Adverse Event|1|||
130732272|NCT04201262|470641156|FG001|Primary Treatment Period|Adverse Event|2|||
130732273|NCT04201262|470641155|FG000|Primary Treatment Period|Physician Decision|1|||
130732274|NCT04201262|470641156|FG001|Primary Treatment Period|Physician Decision|1|||
130732275|NCT04201262|470641155|FG000|Long-term Extension Period|Death|1|||
130732276|NCT04201262|470641156|FG001|Long-term Extension Period|Death|0|||
130732277|NCT03307785|470641158|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
130732278|NCT03307785|470641159|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
130732279|NCT03307785|470641160|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
130732280|NCT03307785|470641161|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
130732281|NCT03307785|470641162|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
130732282|NCT03307785|470641163|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
130732283|NCT03307785|470641164|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
130732284|NCT03307785|470641165|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
130732285|NCT03307785|470641166|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
130732286|NCT03307785|470641167|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
130507327|NCT03840993|469823964|FG000|Overall Study|Adverse Event|1|||
130732287|NCT03307785|470641168|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
130732288|NCT03307785|470641158|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
130732289|NCT03307785|470641159|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
130732290|NCT03307785|470641160|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732291|NCT03307785|470641161|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732292|NCT03307785|470641162|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130507328|NCT03840993|469823965|FG001|Overall Study|Adverse Event|0|||
130507329|NCT03840993|469823964|FG000|Overall Study|Lost to Follow-up|4|||
130507330|NCT03840993|469823965|FG001|Overall Study|Lost to Follow-up|0|||
130507331|NCT03840993|469823964|FG000|Overall Study|Physician Decision|0|||
130507332|NCT03840993|469823965|FG001|Overall Study|Physician Decision|1|||
130507333|NCT03840993|469823964|FG000|Overall Study|Pregnancy|0|||
130507334|NCT03840993|469823965|FG001|Overall Study|Pregnancy|1|||
130507335|NCT03840993|469823964|FG000|Overall Study|Withdrawal by Subject|1|||
130507336|NCT03840993|469823965|FG001|Overall Study|Withdrawal by Subject|3|||
130507337|NCT03840993|469823964|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
130507338|NCT03840993|469823965|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
130507339|NCT02213094|469823966|FG000|Overall Study|Adverse Event|1|||
130507340|NCT02213094|469823967|FG001|Overall Study|Adverse Event|0|||
130507341|NCT00988429|469823968|FG000|Overall Study|Adverse Event|9|||
130507342|NCT00988429|469823969|FG001|Overall Study|Adverse Event|21|||
130507343|NCT00988429|469823970|FG002|Overall Study|Adverse Event|45|||
130507344|NCT00988429|469823968|FG000|Overall Study|Lack of Efficacy|0|||
130507345|NCT00988429|469823969|FG001|Overall Study|Lack of Efficacy|0|||
130507346|NCT00988429|469823970|FG002|Overall Study|Lack of Efficacy|1|||
130507347|NCT00988429|469823968|FG000|Overall Study|Non-Compliance with Study Drug|5|||
130507348|NCT00988429|469823969|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130507349|NCT00988429|469823970|FG002|Overall Study|Non-Compliance with Study Drug|3|||
130507350|NCT00988429|469823968|FG000|Overall Study|Physician Decision|1|||
130507351|NCT00988429|469823969|FG001|Overall Study|Physician Decision|0|||
130507352|NCT00988429|469823970|FG002|Overall Study|Physician Decision|3|||
130507353|NCT00988429|469823968|FG000|Overall Study|Pregnancy|2|||
130507354|NCT00988429|469823969|FG001|Overall Study|Pregnancy|1|||
130507355|NCT00988429|469823970|FG002|Overall Study|Pregnancy|0|||
130507356|NCT00988429|469823968|FG000|Overall Study|Protocol Violation|4|||
130732293|NCT03307785|470641163|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732294|NCT03307785|470641164|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732295|NCT03307785|470641165|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732296|NCT03307785|470641166|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732297|NCT03307785|470641167|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732298|NCT03307785|470641168|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130732299|NCT03307785|470641158|FG000|Part A: Up to 28.5 Months|Death|4|||
130732300|NCT03307785|470641159|FG001|Part A: Up to 28.5 Months|Death|4|||
130732301|NCT03307785|470641160|FG002|Part A: Up to 28.5 Months|Death|0|||
130732302|NCT03307785|470641161|FG003|Part A: Up to 28.5 Months|Death|0|||
130732303|NCT03307785|470641162|FG004|Part A: Up to 28.5 Months|Death|0|||
130732304|NCT03307785|470641163|FG005|Part A: Up to 28.5 Months|Death|0|||
130732305|NCT03307785|470641164|FG006|Part A: Up to 28.5 Months|Death|0|||
130732306|NCT03307785|470641165|FG007|Part A: Up to 28.5 Months|Death|0|||
130732307|NCT03307785|470641166|FG008|Part A: Up to 28.5 Months|Death|0|||
130732308|NCT03307785|470641167|FG009|Part A: Up to 28.5 Months|Death|0|||
130732309|NCT03307785|470641168|FG010|Part A: Up to 28.5 Months|Death|0|||
130732310|NCT03307785|470641158|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
130732311|NCT03307785|470641159|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
130732312|NCT03307785|470641160|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
130732313|NCT03307785|470641161|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
130732314|NCT03307785|470641162|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
130732315|NCT03307785|470641163|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
130732316|NCT03307785|470641164|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
130732317|NCT03307785|470641165|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
130732318|NCT03307785|470641166|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
130732319|NCT03307785|470641167|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
130732320|NCT03307785|470641168|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
130732321|NCT03307785|470641158|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732322|NCT03307785|470641159|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732323|NCT03307785|470641160|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
130732324|NCT03307785|470641161|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732325|NCT03307785|470641162|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732326|NCT03307785|470641163|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732327|NCT03307785|470641164|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732328|NCT03307785|470641165|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732329|NCT03307785|470641166|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732330|NCT03307785|470641167|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732331|NCT03307785|470641168|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
130732332|NCT03307785|470641158|FG000|Part B: Up to Approx. 66 Months|Death|0|||
130732333|NCT03307785|470641159|FG001|Part B: Up to Approx. 66 Months|Death|0|||
130732334|NCT03307785|470641160|FG002|Part B: Up to Approx. 66 Months|Death|7|||
130507357|NCT00988429|469823969|FG001|Overall Study|Protocol Violation|3|||
130507358|NCT00988429|469823970|FG002|Overall Study|Protocol Violation|3|||
130507359|NCT00988429|469823968|FG000|Overall Study|Withdrawal by Subject|7|||
130507360|NCT00988429|469823969|FG001|Overall Study|Withdrawal by Subject|7|||
130566836|NCT00243386|470041525|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
130566837|NCT00243386|470041526|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
130566838|NCT02285998|470041527|FG000|Overall Study|Adverse Event|9|||
130566839|NCT02285998|470041528|FG001|Overall Study|Adverse Event|8|||
130566840|NCT02285998|470041527|FG000|Overall Study|Physician Decision|1|||
130566841|NCT02285998|470041528|FG001|Overall Study|Physician Decision|2|||
130566842|NCT02285998|470041527|FG000|Overall Study|Lost to Follow-up|176|||
130566843|NCT02285998|470041528|FG001|Overall Study|Lost to Follow-up|172|||
130566844|NCT02285998|470041527|FG000|Overall Study|Withdrawal by Subject|53|||
130566845|NCT02285998|470041528|FG001|Overall Study|Withdrawal by Subject|61|||
130566846|NCT02285998|470041527|FG000|Overall Study|Other Reasons|7|||
130566847|NCT02285998|470041528|FG001|Overall Study|Other Reasons|10|||
130507361|NCT00988429|469823970|FG002|Overall Study|Withdrawal by Subject|12|||
130507362|NCT00988429|469823968|FG000|Overall Study|Administrative Reasons|1|||
130507363|NCT00988429|469823969|FG001|Overall Study|Administrative Reasons|2|||
130507364|NCT00988429|469823970|FG002|Overall Study|Administrative Reasons|1|||
130507365|NCT00988429|469823968|FG000|Overall Study|other reasons|8|||
130507366|NCT00988429|469823969|FG001|Overall Study|other reasons|8|||
130507367|NCT00988429|469823970|FG002|Overall Study|other reasons|1|||
130507368|NCT01074229|469823971|FG000|Overall Study|Lost to Follow-up|1|||
130507369|NCT01074229|469823972|FG001|Overall Study|Lost to Follow-up|0|||
130507370|NCT01074229|469823973|FG002|Overall Study|Lost to Follow-up|0|||
130507371|NCT01074229|469823971|FG000|Overall Study|Change to open surgical procedure|1|||
130507372|NCT01074229|469823972|FG001|Overall Study|Change to open surgical procedure|3|||
130507373|NCT01074229|469823973|FG002|Overall Study|Change to open surgical procedure|4|||
130566848|NCT00133991|470041529|FG000|Overall Study|Death|4|||
130566849|NCT03002155|470041530|FG000|Overall Study|Lost to Follow-up|1|||
130507374|NCT02964234|469823974|FG000|Overall Study|Lost to Follow-up|22|||
130507375|NCT02964234|469823975|FG001|Overall Study|Lost to Follow-up|13|||
130507376|NCT02163499|469823978|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
130507377|NCT02163499|469823978|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
130507378|NCT02163499|469823978|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
130507379|NCT02163499|469823978|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
130507380|NCT02163499|469823978|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
130507381|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
130507382|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
130507383|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
130507384|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
130507385|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
130507386|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
130507387|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
130507388|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
130507389|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
130507390|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Death|8|||
130507391|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
130507392|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
130507393|NCT02163499|469823978|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
130507394|NCT01540474|469823979|FG000|Vaccination Period|Lost to Follow-up|0|||
130732335|NCT03307785|470641161|FG003|Part B: Up to Approx. 66 Months|Death|0|||
130732336|NCT03307785|470641162|FG004|Part B: Up to Approx. 66 Months|Death|0|||
130732337|NCT03307785|470641163|FG005|Part B: Up to Approx. 66 Months|Death|0|||
130732338|NCT03307785|470641164|FG006|Part B: Up to Approx. 66 Months|Death|0|||
130732339|NCT03307785|470641165|FG007|Part B: Up to Approx. 66 Months|Death|0|||
130732340|NCT03307785|470641166|FG008|Part B: Up to Approx. 66 Months|Death|0|||
130732341|NCT03307785|470641167|FG009|Part B: Up to Approx. 66 Months|Death|0|||
130732342|NCT03307785|470641168|FG010|Part B: Up to Approx. 66 Months|Death|0|||
130732343|NCT03307785|470641158|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732344|NCT03307785|470641159|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732345|NCT03307785|470641160|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
130732346|NCT03307785|470641161|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732347|NCT03307785|470641162|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732348|NCT03307785|470641163|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732349|NCT03307785|470641164|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732350|NCT03307785|470641165|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732351|NCT03307785|470641166|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732352|NCT03307785|470641167|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732353|NCT03307785|470641168|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130732354|NCT03307785|470641158|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732355|NCT03307785|470641159|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732356|NCT03307785|470641160|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
130732357|NCT03307785|470641161|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732358|NCT03307785|470641162|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732359|NCT03307785|470641163|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732360|NCT03307785|470641164|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732361|NCT03307785|470641165|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732362|NCT03307785|470641166|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732363|NCT03307785|470641167|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732364|NCT03307785|470641168|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130732365|NCT03307785|470641158|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732366|NCT03307785|470641159|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732367|NCT03307785|470641160|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
130732368|NCT03307785|470641161|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732369|NCT03307785|470641162|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732370|NCT03307785|470641163|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732371|NCT03307785|470641164|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732372|NCT03307785|470641165|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732373|NCT03307785|470641166|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732374|NCT03307785|470641167|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732375|NCT03307785|470641168|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130732376|NCT03307785|470641158|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732377|NCT03307785|470641159|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732378|NCT03307785|470641160|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732379|NCT03307785|470641161|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
130507395|NCT01540474|469823980|FG001|Vaccination Period|Lost to Follow-up|1|||
130507396|NCT01540474|469823981|FG002|Vaccination Period|Lost to Follow-up|0|||
130732380|NCT03307785|470641162|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
130732381|NCT03307785|470641163|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732382|NCT03307785|470641164|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732383|NCT03307785|470641165|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732384|NCT03307785|470641166|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732385|NCT03307785|470641167|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732386|NCT03307785|470641168|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130732387|NCT03307785|470641158|FG000|Part C: Up to Approx. 60 Months|Death|0|||
130732388|NCT03307785|470641159|FG001|Part C: Up to Approx. 60 Months|Death|0|||
130732389|NCT03307785|470641160|FG002|Part C: Up to Approx. 60 Months|Death|0|||
130732390|NCT03307785|470641161|FG003|Part C: Up to Approx. 60 Months|Death|2|||
130732391|NCT03307785|470641162|FG004|Part C: Up to Approx. 60 Months|Death|5|||
130732392|NCT03307785|470641163|FG005|Part C: Up to Approx. 60 Months|Death|0|||
130732393|NCT03307785|470641164|FG006|Part C: Up to Approx. 60 Months|Death|0|||
130732394|NCT03307785|470641165|FG007|Part C: Up to Approx. 60 Months|Death|0|||
130732395|NCT03307785|470641166|FG008|Part C: Up to Approx. 60 Months|Death|0|||
130732396|NCT03307785|470641167|FG009|Part C: Up to Approx. 60 Months|Death|0|||
130732397|NCT03307785|470641168|FG010|Part C: Up to Approx. 60 Months|Death|0|||
130732398|NCT03307785|470641158|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732399|NCT03307785|470641159|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732400|NCT03307785|470641160|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732401|NCT03307785|470641161|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
130732402|NCT03307785|470641162|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732403|NCT03307785|470641163|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732404|NCT03307785|470641164|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732405|NCT03307785|470641165|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732406|NCT03307785|470641166|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732407|NCT03307785|470641167|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732408|NCT03307785|470641168|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130732409|NCT03307785|470641158|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732410|NCT03307785|470641159|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732411|NCT03307785|470641160|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732412|NCT03307785|470641161|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732413|NCT03307785|470641162|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
130732414|NCT03307785|470641163|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732415|NCT03307785|470641164|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732416|NCT03307785|470641165|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732417|NCT03307785|470641166|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732418|NCT03307785|470641167|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732419|NCT03307785|470641168|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130732420|NCT03307785|470641158|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732421|NCT03307785|470641159|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732422|NCT03307785|470641160|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732423|NCT03307785|470641161|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732424|NCT03307785|470641162|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732425|NCT03307785|470641163|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
130732426|NCT03307785|470641164|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732427|NCT03307785|470641165|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732428|NCT03307785|470641166|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732429|NCT03307785|470641167|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732430|NCT03307785|470641168|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130732431|NCT03307785|470641158|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
130732432|NCT03307785|470641159|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
130732433|NCT03307785|470641160|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
130732434|NCT03307785|470641161|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
130732435|NCT03307785|470641162|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
130732436|NCT03307785|470641163|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
130732437|NCT03307785|470641164|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
130732438|NCT03307785|470641165|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
130507397|NCT01540474|469823982|FG003|Vaccination Period|Lost to Follow-up|0|||
130507398|NCT00857311|469823983|FG000|Overall Study|Lost to Follow-up|1|||
130507399|NCT00857311|469823984|FG001|Overall Study|Lost to Follow-up|0|||
130507400|NCT00857311|469823985|FG002|Overall Study|Lost to Follow-up|0|||
130732439|NCT03307785|470641166|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
130732440|NCT03307785|470641167|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
130732441|NCT03307785|470641168|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
130732442|NCT03307785|470641158|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130507401|NCT00857311|469823986|FG003|Overall Study|Lost to Follow-up|0|||
130566850|NCT03002155|470041531|FG001|Overall Study|Lost to Follow-up|2|||
130566851|NCT03002155|470041530|FG000|Overall Study|Withdrawal by Subject|1|||
130566852|NCT03002155|470041531|FG001|Overall Study|Withdrawal by Subject|0|||
130566853|NCT03002155|470041530|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
130566854|NCT03002155|470041531|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
130566855|NCT00545298|470041532|FG000|Overall Study|Issues with Standard of Care|2|||
130566856|NCT00545298|470041533|FG001|Overall Study|Issues with Standard of Care|0|||
130566857|NCT00545298|470041534|FG002|Overall Study|Issues with Standard of Care|1|||
130566858|NCT00978029|470041535|FG000|Overall Study|Adverse Event|1|||
130566859|NCT00978029|470041536|FG001|Overall Study|Adverse Event|2|||
130566860|NCT00978029|470041537|FG002|Overall Study|Adverse Event|5|||
130566861|NCT00978029|470041535|FG000|Overall Study|Withdrawal by Subject|0|||
130566862|NCT00978029|470041536|FG001|Overall Study|Withdrawal by Subject|0|||
130566863|NCT00978029|470041537|FG002|Overall Study|Withdrawal by Subject|1|||
130566864|NCT00978029|470041535|FG000|Overall Study|Protocol Violation|0|||
130566865|NCT00978029|470041536|FG001|Overall Study|Protocol Violation|1|||
130566866|NCT00978029|470041537|FG002|Overall Study|Protocol Violation|0|||
130566867|NCT01793142|470041543|FG000|Overall Study|Randomized not treated|7|||
130566868|NCT01820364|470041544|FG000|Part I: LGX818|Death|1|||
130566869|NCT01820364|470041545|FG001|Part I: LGX818|Death|0|||
130566870|NCT01820364|470041544|FG000|Part I: LGX818|Administrative Problems|3|||
130566871|NCT01820364|470041545|FG001|Part I: LGX818|Administrative Problems|0|||
130566872|NCT01820364|470041544|FG000|Part I: LGX818|Adverse Event|6|||
130566873|NCT01820364|470041545|FG001|Part I: LGX818|Adverse Event|0|||
130566874|NCT01820364|470041544|FG000|Part I: LGX818|Disease Progression|4|||
130566875|NCT01820364|470041545|FG001|Part I: LGX818|Disease Progression|0|||
130566876|NCT01820364|470041544|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
130566877|NCT01820364|470041545|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
130566878|NCT03451084|470041548|FG000|Overall Study|Withdrawal by Subject|2|||
130566879|NCT03451084|470041549|FG001|Overall Study|Withdrawal by Subject|1|||
130566880|NCT03451084|470041550|FG002|Overall Study|Withdrawal by Subject|2|||
130566881|NCT03451084|470041551|FG003|Overall Study|Withdrawal by Subject|1|||
130566882|NCT03451084|470041548|FG000|Overall Study|Disease recurrence|0|||
130566883|NCT03451084|470041549|FG001|Overall Study|Disease recurrence|2|||
130566884|NCT03451084|470041550|FG002|Overall Study|Disease recurrence|0|||
130566885|NCT03451084|470041551|FG003|Overall Study|Disease recurrence|0|||
130566886|NCT03451084|470041548|FG000|Overall Study|Lack of Efficacy|0|||
130566887|NCT03451084|470041549|FG001|Overall Study|Lack of Efficacy|3|||
130566888|NCT03451084|470041550|FG002|Overall Study|Lack of Efficacy|0|||
130566889|NCT03451084|470041551|FG003|Overall Study|Lack of Efficacy|1|||
130507402|NCT01799993|469823988|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
130507403|NCT01799993|469823989|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
130507404|NCT01799993|469823988|FG000|Overall Study|Death|61|||
130507405|NCT01799993|469823989|FG001|Overall Study|Death|45|||
130507406|NCT01799993|469823988|FG000|Overall Study|Withdrawal by Subject|23|||
130507407|NCT01799993|469823989|FG001|Overall Study|Withdrawal by Subject|24|||
130507408|NCT01799993|469823988|FG000|Overall Study|Lost to Follow-up|5|||
130507409|NCT01799993|469823989|FG001|Overall Study|Lost to Follow-up|8|||
130507410|NCT01799993|469823988|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
130507411|NCT01799993|469823989|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
130507412|NCT01799993|469823988|FG000|Overall Study|Protocol driven decision point|0|||
130507413|NCT01799993|469823989|FG001|Overall Study|Protocol driven decision point|3|||
130507414|NCT01799993|469823988|FG000|Overall Study|Protocol Violation|1|||
130507415|NCT01799993|469823989|FG001|Overall Study|Protocol Violation|1|||
130507416|NCT01799993|469823988|FG000|Overall Study|Deterioration of general conditions|2|||
130507417|NCT01799993|469823989|FG001|Overall Study|Deterioration of general conditions|0|||
130507418|NCT01799993|469823988|FG000|Overall Study|Screen failure|0|||
130507419|NCT01799993|469823989|FG001|Overall Study|Screen failure|1|||
130507420|NCT01799993|469823988|FG000|Overall Study|Adverse Event|1|||
130507421|NCT01799993|469823989|FG001|Overall Study|Adverse Event|0|||
130507422|NCT01799993|469823988|FG000|Overall Study|Lack of Efficacy|1|||
130507423|NCT01799993|469823989|FG001|Overall Study|Lack of Efficacy|0|||
130507424|NCT01799993|469823988|FG000|Overall Study|Recovery|0|||
130507425|NCT01799993|469823989|FG001|Overall Study|Recovery|1|||
130566890|NCT03451084|470041548|FG000|Overall Study|Death|1|||
130566891|NCT03451084|470041549|FG001|Overall Study|Death|0|||
130566892|NCT03451084|470041550|FG002|Overall Study|Death|2|||
130566893|NCT03451084|470041551|FG003|Overall Study|Death|0|||
130566894|NCT03451084|470041548|FG000|Overall Study|Physician Decision|0|||
130566895|NCT03451084|470041549|FG001|Overall Study|Physician Decision|0|||
130566896|NCT03451084|470041550|FG002|Overall Study|Physician Decision|2|||
130566897|NCT03451084|470041551|FG003|Overall Study|Physician Decision|2|||
130507426|NCT01799993|469823988|FG000|Overall Study|Logistical difficulties|1|||
130507427|NCT01799993|469823989|FG001|Overall Study|Logistical difficulties|0|||
130507428|NCT01799993|469823988|FG000|Overall Study|Protocol deviation|1|||
130507429|NCT01799993|469823989|FG001|Overall Study|Protocol deviation|0|||
130507430|NCT01799993|469823988|FG000|Overall Study|Non-compliance with medical device|1|||
130507431|NCT01799993|469823989|FG001|Overall Study|Non-compliance with medical device|0|||
130507432|NCT01799993|469823988|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130507433|NCT01799993|469823989|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130507434|NCT01799993|469823988|FG000|Overall Study|Other|1|||
130507435|NCT01799993|469823989|FG001|Overall Study|Other|0|||
130507436|NCT01799993|469823988|FG000|Overall Study|Subject didn't return for follow-up|0|||
130507437|NCT01799993|469823989|FG001|Overall Study|Subject didn't return for follow-up|1|||
130507438|NCT04271254|469823990|FG000|Overall Study|Withdrawal by Subject|3|||
130507439|NCT04410445|469823991|FG000|Overall Study|Lost to Follow-up|3|||
130507440|NCT04410445|469823992|FG001|Overall Study|Lost to Follow-up|9|||
130507441|NCT04410445|469823991|FG000|Overall Study|Withdrawal by Subject|27|||
130507442|NCT04410445|469823992|FG001|Overall Study|Withdrawal by Subject|15|||
130507443|NCT01320683|469823993|FG000|Overall Study|Positive antibody response|1|||
130507444|NCT01123356|469823994|FG000|Overall Study|Adverse Event|2|||
130507445|NCT01123356|469823994|FG000|Overall Study|Lack of Efficacy|4|||
130507446|NCT01123356|469823994|FG000|Overall Study|Withdrawal by Subject|1|||
130507447|NCT00759681|469823995|FG000|Overall Study|Death|2|||
130507448|NCT00759681|469823996|FG001|Overall Study|Death|5|||
130507449|NCT00759681|469823995|FG000|Overall Study|Lost to Follow-up|8|||
130507450|NCT00759681|469823996|FG001|Overall Study|Lost to Follow-up|5|||
130507451|NCT02005484|469823999|FG000|Overall Study|Death|1|||
130507452|NCT02005484|469823999|FG000|Overall Study|Disease progression|1|||
130507453|NCT02005484|469823999|FG000|Overall Study|Changed to a Different Study|1|||
130507454|NCT02005484|469823999|FG000|Overall Study|Sponsor decision|1|||
130507455|NCT01129011|469824000|FG000|Overall Study|Adverse Event|20|||
130507456|NCT01129011|469824001|FG001|Overall Study|Adverse Event|30|||
130507457|NCT01129011|469824000|FG000|Overall Study|Withdrawal by Subject|24|||
130507458|NCT01129011|469824001|FG001|Overall Study|Withdrawal by Subject|8|||
130507459|NCT01129011|469824000|FG000|Overall Study|Lost to Follow-up|6|||
130507460|NCT01129011|469824001|FG001|Overall Study|Lost to Follow-up|7|||
130507461|NCT01129011|469824000|FG000|Overall Study|Duodenal Ulcer|2|||
130507462|NCT01129011|469824001|FG001|Overall Study|Duodenal Ulcer|8|||
130507463|NCT01129011|469824000|FG000|Overall Study|misc|7|||
130507464|NCT01129011|469824001|FG001|Overall Study|misc|4|||
130507465|NCT02823574|469824005|FG000|Randomization|Disease Progression|0|||
130507466|NCT02823574|469824006|FG001|Randomization|Disease Progression|0|||
130507467|NCT02823574|469824007|FG002|Randomization|Disease Progression|1|||
130507468|NCT02823574|469824008|FG003|Randomization|Disease Progression|0|||
130732443|NCT03307785|470641159|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732444|NCT03307785|470641160|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732445|NCT03307785|470641161|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732446|NCT03307785|470641162|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732447|NCT03307785|470641163|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
130732448|NCT03307785|470641164|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732449|NCT03307785|470641165|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732450|NCT03307785|470641166|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732451|NCT03307785|470641167|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732452|NCT03307785|470641168|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130732453|NCT03307785|470641158|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732454|NCT03307785|470641159|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130507469|NCT02823574|469824005|FG000|Randomization|AE unrelated to Study Drug|1|||
130507470|NCT02823574|469824006|FG001|Randomization|AE unrelated to Study Drug|0|||
130507471|NCT02823574|469824007|FG002|Randomization|AE unrelated to Study Drug|0|||
130507472|NCT02823574|469824008|FG003|Randomization|AE unrelated to Study Drug|0|||
130507473|NCT02823574|469824005|FG000|Treatment Period|Poor/Non Compliance|1|||
130507474|NCT02823574|469824006|FG001|Treatment Period|Poor/Non Compliance|0|||
130507475|NCT02823574|469824007|FG002|Treatment Period|Poor/Non Compliance|0|||
130507476|NCT02823574|469824008|FG003|Treatment Period|Poor/Non Compliance|1|||
130507477|NCT02823574|469824005|FG000|Treatment Period|Maximum Clinical Benefit|8|||
130507478|NCT02823574|469824006|FG001|Treatment Period|Maximum Clinical Benefit|4|||
130507479|NCT02823574|469824007|FG002|Treatment Period|Maximum Clinical Benefit|7|||
130507480|NCT02823574|469824008|FG003|Treatment Period|Maximum Clinical Benefit|1|||
130507481|NCT02823574|469824005|FG000|Treatment Period|Lost to Follow-up|1|||
130507482|NCT02823574|469824006|FG001|Treatment Period|Lost to Follow-up|1|||
130566898|NCT03451084|470041548|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
130732455|NCT03307785|470641160|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732456|NCT03307785|470641161|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732457|NCT03307785|470641162|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732458|NCT03307785|470641163|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
130732459|NCT03307785|470641164|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130507483|NCT02823574|469824007|FG002|Treatment Period|Lost to Follow-up|0|||
130507484|NCT02823574|469824008|FG003|Treatment Period|Lost to Follow-up|0|||
130507485|NCT02823574|469824005|FG000|Treatment Period|Participant withdrew consent|4|||
130566899|NCT03451084|470041549|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
130566900|NCT03451084|470041550|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
130566901|NCT03451084|470041551|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
130566902|NCT03418129|470041557|FG000|Overall Study|Lost to Follow-up|11|||
130566903|NCT03418129|470041558|FG001|Overall Study|Lost to Follow-up|20|||
130566904|NCT03418129|470041559|FG002|Overall Study|Lost to Follow-up|15|||
130566905|NCT03418129|470041557|FG000|Overall Study|Withdrawal by Subject|3|||
130566906|NCT03418129|470041558|FG001|Overall Study|Withdrawal by Subject|6|||
130566907|NCT03418129|470041559|FG002|Overall Study|Withdrawal by Subject|4|||
130566908|NCT01553188|470041562|FG000|Overall Study|Patient choice|1|||
130566909|NCT01553188|470041563|FG001|Overall Study|Patient choice|0|||
130566910|NCT01553188|470041564|FG002|Overall Study|Patient choice|0|||
130566911|NCT01553188|470041565|FG003|Overall Study|Patient choice|0|||
130566912|NCT01553188|470041562|FG000|Overall Study|Intercurrent illness and adverse event|0|||
130566913|NCT01553188|470041563|FG001|Overall Study|Intercurrent illness and adverse event|1|||
130566914|NCT01553188|470041564|FG002|Overall Study|Intercurrent illness and adverse event|2|||
130566915|NCT01553188|470041565|FG003|Overall Study|Intercurrent illness and adverse event|0|||
130566916|NCT04744207|470041569|FG000|Treatment|Withdrawal by Subject|2|||
130566917|NCT04744207|470041570|FG001|Treatment|Withdrawal by Subject|0|||
130566918|NCT04744207|470041569|FG000|Treatment|Adverse Event|1|||
130507486|NCT02823574|469824006|FG001|Treatment Period|Participant withdrew consent|0|||
130507487|NCT02823574|469824007|FG002|Treatment Period|Participant withdrew consent|0|||
130507488|NCT02823574|469824008|FG003|Treatment Period|Participant withdrew consent|1|||
130507489|NCT02823574|469824005|FG000|Treatment Period|Participant request to discontinue|5|||
130507490|NCT02823574|469824006|FG001|Treatment Period|Participant request to discontinue|0|||
130507491|NCT02823574|469824007|FG002|Treatment Period|Participant request to discontinue|3|||
130507492|NCT02823574|469824008|FG003|Treatment Period|Participant request to discontinue|2|||
130507493|NCT02823574|469824005|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
130507494|NCT02823574|469824006|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
130507495|NCT02823574|469824007|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
130507496|NCT02823574|469824008|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
130507497|NCT02823574|469824005|FG000|Treatment Period|Study Drug Toxicity|11|||
130507498|NCT02823574|469824006|FG001|Treatment Period|Study Drug Toxicity|2|||
130507499|NCT02823574|469824007|FG002|Treatment Period|Study Drug Toxicity|14|||
130507500|NCT02823574|469824008|FG003|Treatment Period|Study Drug Toxicity|4|||
130507501|NCT02823574|469824005|FG000|Treatment Period|Disease Progression|113|||
130507502|NCT02823574|469824006|FG001|Treatment Period|Disease Progression|64|||
130507503|NCT02823574|469824007|FG002|Treatment Period|Disease Progression|82|||
130507504|NCT02823574|469824008|FG003|Treatment Period|Disease Progression|43|||
130507505|NCT02823574|469824005|FG000|Treatment Period|Other reasons|5|||
130507506|NCT02823574|469824006|FG001|Treatment Period|Other reasons|9|||
130507507|NCT02823574|469824007|FG002|Treatment Period|Other reasons|3|||
130507508|NCT02823574|469824008|FG003|Treatment Period|Other reasons|6|||
130507509|NCT02823574|469824005|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130507510|NCT02823574|469824006|FG001|Treatment Period|Participant no longer meets study criteria|0|||
130507511|NCT02823574|469824007|FG002|Treatment Period|Participant no longer meets study criteria|1|||
130507512|NCT02823574|469824008|FG003|Treatment Period|Participant no longer meets study criteria|0|||
130507513|NCT02823574|469824005|FG000|Treatment Period|Death|0|||
130507514|NCT02823574|469824006|FG001|Treatment Period|Death|0|||
130507515|NCT02823574|469824007|FG002|Treatment Period|Death|3|||
130507516|NCT02823574|469824008|FG003|Treatment Period|Death|1|||
130507517|NCT00590759|469824009|FG000|Overall Study|Death|52|||
130507518|NCT00590759|469824009|FG000|Overall Study|Lost to Follow-up|28|||
130507519|NCT00417885|469824010|FG000|Overall Study|Adverse Event|1|||
130507520|NCT00417885|469824010|FG000|Overall Study|Objective Progression or Relapse|3|||
130507521|NCT00417885|469824010|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
130507522|NCT00096278|469824011|FG000|Overall Study|No follow-up data|15|||
130507523|NCT00096278|469824012|FG001|Overall Study|No follow-up data|18|||
130507524|NCT00096278|469824011|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
130507525|NCT00096278|469824012|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
130507526|NCT01894620|469824015|FG000|Overall Study|Withdrawal by Subject|0|||
130507527|NCT01894620|469824016|FG001|Overall Study|Withdrawal by Subject|1|||
130507528|NCT02877680|469824017|FG000|Overall Study|Lost to Follow-up|1|||
130507529|NCT02877680|469824018|FG001|Overall Study|Lost to Follow-up|1|||
130507530|NCT05104242|469824025|FG000|Overall Study|Withdrawal by Subject|1|||
130507531|NCT05104242|469824026|FG001|Overall Study|Withdrawal by Subject|5|||
130507532|NCT05104242|469824025|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
130566919|NCT04744207|470041570|FG001|Treatment|Adverse Event|2|||
130507533|NCT05104242|469824026|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
130507534|NCT01864200|469824027|FG000|Overall Study|Lost to Follow-up|1|||
130507535|NCT01864200|469824028|FG001|Overall Study|Lost to Follow-up|3|||
130507536|NCT01864200|469824027|FG000|Overall Study|Protocol Violation|1|||
130566920|NCT01617070|470041576|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
130507537|NCT01864200|469824028|FG001|Overall Study|Protocol Violation|0|||
130507538|NCT02991118|469824029|FG000|Overall Study|Death|3|||
130507539|NCT02991118|469824030|FG001|Overall Study|Death|8|||
130507540|NCT02991118|469824029|FG000|Overall Study|Protocol Violation|0|||
130507541|NCT02991118|469824030|FG001|Overall Study|Protocol Violation|3|||
130507542|NCT02991118|469824029|FG000|Overall Study|Physician Decision|0|||
130507543|NCT02991118|469824030|FG001|Overall Study|Physician Decision|1|||
130507544|NCT02991118|469824029|FG000|Overall Study|Moved out of the country|0|||
130507545|NCT02991118|469824030|FG001|Overall Study|Moved out of the country|1|||
130507546|NCT02991118|469824029|FG000|Overall Study|Adverse Event|2|||
130507547|NCT02991118|469824030|FG001|Overall Study|Adverse Event|2|||
130507548|NCT02991118|469824029|FG000|Overall Study|Withdrawal by Subject|1|||
130507549|NCT02991118|469824030|FG001|Overall Study|Withdrawal by Subject|7|||
130507550|NCT02991118|469824029|FG000|Overall Study|Could not attend study visits|0|||
130507551|NCT02991118|469824030|FG001|Overall Study|Could not attend study visits|1|||
130507552|NCT02991118|469824029|FG000|Overall Study|Lost to Follow-up|1|||
130507553|NCT02991118|469824030|FG001|Overall Study|Lost to Follow-up|9|||
130507554|NCT00595959|469824031|FG000|Overall Study|Withdrawal by Subject|1|||
130507555|NCT00595959|469824031|FG000|Overall Study|Lost to Follow-up|1|||
130507556|NCT02077374|469824035|FG000|Overall Study|Withdrawal by Subject|0|||
130507557|NCT02077374|469824036|FG001|Overall Study|Withdrawal by Subject|1|||
130507558|NCT02077374|469824035|FG000|Overall Study|Protocol Violation|0|||
130507559|NCT02077374|469824036|FG001|Overall Study|Protocol Violation|1|||
130507560|NCT00424476|469824038|FG000|Overall Study|Withdrawal by Subject|7|||
130507561|NCT00424476|469824039|FG001|Overall Study|Withdrawal by Subject|6|||
130507562|NCT00424476|469824040|FG002|Overall Study|Withdrawal by Subject|3|||
130507563|NCT00424476|469824038|FG000|Overall Study|Adverse Event|19|||
130507564|NCT00424476|469824039|FG001|Overall Study|Adverse Event|16|||
130507565|NCT00424476|469824040|FG002|Overall Study|Adverse Event|15|||
130507566|NCT00424476|469824038|FG000|Overall Study|Lack of Efficacy|16|||
130566921|NCT05376215|470041577|FG000|Overall Study|Withdrawal by Subject|2|||
130566922|NCT05376215|470041578|FG001|Overall Study|Withdrawal by Subject|1|||
130732460|NCT03307785|470641165|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732461|NCT03307785|470641166|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732462|NCT03307785|470641167|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732463|NCT03307785|470641168|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130732464|NCT03307785|470641158|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732465|NCT03307785|470641159|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732466|NCT03307785|470641160|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732467|NCT03307785|470641161|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732468|NCT03307785|470641162|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732469|NCT03307785|470641163|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
130732470|NCT03307785|470641164|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732471|NCT03307785|470641165|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732472|NCT03307785|470641166|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732473|NCT03307785|470641167|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130732474|NCT03307785|470641168|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130507567|NCT00424476|469824039|FG001|Overall Study|Lack of Efficacy|12|||
130507568|NCT00424476|469824040|FG002|Overall Study|Lack of Efficacy|12|||
130507569|NCT00424476|469824038|FG000|Overall Study|Lack of Compliance|1|||
130507570|NCT00424476|469824039|FG001|Overall Study|Lack of Compliance|1|||
130732475|NCT03307785|470641158|FG000|Part E: Up to 4.4 Months|Death|0|||
130732476|NCT03307785|470641159|FG001|Part E: Up to 4.4 Months|Death|0|||
130732477|NCT03307785|470641160|FG002|Part E: Up to 4.4 Months|Death|0|||
130732478|NCT03307785|470641161|FG003|Part E: Up to 4.4 Months|Death|0|||
130732479|NCT03307785|470641162|FG004|Part E: Up to 4.4 Months|Death|0|||
130732480|NCT03307785|470641163|FG005|Part E: Up to 4.4 Months|Death|0|||
130732481|NCT03307785|470641164|FG006|Part E: Up to 4.4 Months|Death|1|||
130732482|NCT03307785|470641165|FG007|Part E: Up to 4.4 Months|Death|0|||
130732483|NCT03307785|470641166|FG008|Part E: Up to 4.4 Months|Death|0|||
130732484|NCT03307785|470641167|FG009|Part E: Up to 4.4 Months|Death|0|||
130732485|NCT03307785|470641168|FG010|Part E: Up to 4.4 Months|Death|0|||
130732486|NCT03307785|470641158|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
130732487|NCT03307785|470641159|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
130732488|NCT03307785|470641160|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
130732489|NCT03307785|470641161|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
130732490|NCT03307785|470641162|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
130732491|NCT03307785|470641163|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
130732492|NCT03307785|470641164|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
130732493|NCT03307785|470641165|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
130732494|NCT03307785|470641166|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
130732495|NCT03307785|470641167|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
130732496|NCT03307785|470641168|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
130732497|NCT03307785|470641158|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
130732498|NCT03307785|470641159|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
130732499|NCT03307785|470641160|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
130732500|NCT03307785|470641161|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
130732501|NCT03307785|470641162|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
130732502|NCT03307785|470641163|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
130507571|NCT00424476|469824040|FG002|Overall Study|Lack of Compliance|1|||
130507572|NCT00424476|469824038|FG000|Overall Study|Lost to Follow-up|4|||
130507573|NCT00424476|469824039|FG001|Overall Study|Lost to Follow-up|6|||
130732503|NCT03307785|470641164|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
130732504|NCT03307785|470641165|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
130732505|NCT03307785|470641166|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
130732506|NCT03307785|470641167|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
130732507|NCT03307785|470641168|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
130507574|NCT00424476|469824040|FG002|Overall Study|Lost to Follow-up|3|||
130507575|NCT00424476|469824038|FG000|Overall Study|Protocol Violation|7|||
130507576|NCT00424476|469824039|FG001|Overall Study|Protocol Violation|2|||
130507577|NCT00424476|469824040|FG002|Overall Study|Protocol Violation|3|||
130507578|NCT00424476|469824038|FG000|Overall Study|Physician Decision|3|||
130507579|NCT00424476|469824039|FG001|Overall Study|Physician Decision|2|||
130507580|NCT00424476|469824040|FG002|Overall Study|Physician Decision|3|||
130507581|NCT00424476|469824038|FG000|Overall Study|Other|4|||
130507582|NCT00424476|469824039|FG001|Overall Study|Other|3|||
130507583|NCT00424476|469824040|FG002|Overall Study|Other|9|||
130507584|NCT00657709|469824041|FG000|Overall Study|AE or Death|7|||
130507585|NCT00657709|469824042|FG001|Overall Study|AE or Death|7|||
130507586|NCT00657709|469824043|FG002|Overall Study|AE or Death|6|||
130507587|NCT00657709|469824044|FG003|Overall Study|AE or Death|7|||
130507588|NCT00657709|469824045|FG004|Overall Study|AE or Death|1|||
130507589|NCT00657709|469824041|FG000|Overall Study|Withdrawal by Subject|7|||
130507590|NCT00657709|469824042|FG001|Overall Study|Withdrawal by Subject|15|||
130507591|NCT00657709|469824043|FG002|Overall Study|Withdrawal by Subject|15|||
130507592|NCT00657709|469824044|FG003|Overall Study|Withdrawal by Subject|5|||
130507593|NCT00657709|469824045|FG004|Overall Study|Withdrawal by Subject|9|||
130507594|NCT00657709|469824041|FG000|Overall Study|Lost to Follow-up|9|||
130507595|NCT00657709|469824042|FG001|Overall Study|Lost to Follow-up|9|||
130507596|NCT00657709|469824043|FG002|Overall Study|Lost to Follow-up|7|||
130507597|NCT00657709|469824044|FG003|Overall Study|Lost to Follow-up|1|||
130507598|NCT00657709|469824045|FG004|Overall Study|Lost to Follow-up|21|||
130507599|NCT00657709|469824041|FG000|Overall Study|Protocol Violation|0|||
130507600|NCT00657709|469824042|FG001|Overall Study|Protocol Violation|2|||
130507601|NCT00657709|469824043|FG002|Overall Study|Protocol Violation|0|||
130507602|NCT00657709|469824044|FG003|Overall Study|Protocol Violation|1|||
130507603|NCT00657709|469824045|FG004|Overall Study|Protocol Violation|2|||
130507604|NCT00632736|469824049|FG000|Overall Study|Adverse Event|104|||
130507605|NCT00632736|469824049|FG000|Overall Study|Lost to Follow-up|15|||
130507606|NCT00632736|469824049|FG000|Overall Study|Protocol Violation|14|||
130566923|NCT05376215|470041577|FG000|Overall Study|Lost to Follow-up|0|||
130566924|NCT05376215|470041578|FG001|Overall Study|Lost to Follow-up|1|||
130566925|NCT00078325|470041586|FG000|Overall Study|Adverse Event|15|||
130566926|NCT00078325|470041587|FG001|Overall Study|Adverse Event|10|||
130566927|NCT00078325|470041588|FG002|Overall Study|Adverse Event|5|||
130566928|NCT00078325|470041586|FG000|Overall Study|Protocol Violation|2|||
130566929|NCT00078325|470041587|FG001|Overall Study|Protocol Violation|2|||
130507607|NCT00632736|469824049|FG000|Overall Study|Withdrawal by Subject|99|||
130507608|NCT00632736|469824049|FG000|Overall Study|Lack of Efficacy|5|||
130507609|NCT00632736|469824049|FG000|Overall Study|Sponsor terminated study|5|||
130507610|NCT00632736|469824049|FG000|Overall Study|Non-compliance|10|||
130507611|NCT00632736|469824049|FG000|Overall Study|Other|16|||
130507612|NCT05700851|469824050|FG000|Overall Study|Received a kidney transplant|1|||
130507613|NCT05700851|469824050|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
130507614|NCT05700851|469824050|FG000|Overall Study|Withdrawal by Subject|1|||
130566930|NCT00078325|470041588|FG002|Overall Study|Protocol Violation|0|||
130507615|NCT00589628|469824051|FG000|Overall Study|Lost to Follow-up|0|||
130507616|NCT00589628|469824052|FG001|Overall Study|Lost to Follow-up|1|||
130507617|NCT00946998|469825845|FG000|Overall Study|Exited prior to first outcome assessment|5|||
130507618|NCT00946998|469825846|FG001|Overall Study|Exited prior to first outcome assessment|3|||
130507619|NCT03978130|469825851|FG000|Overall Study|Lost to Follow-up|13|||
130507620|NCT03978130|469825852|FG001|Overall Study|Lost to Follow-up|14|||
130507621|NCT03978130|469825851|FG000|Overall Study|Withdrawal by Subject|12|||
130507622|NCT03978130|469825852|FG001|Overall Study|Withdrawal by Subject|2|||
130507623|NCT03978130|469825851|FG000|Overall Study|Adverse Event|2|||
130507624|NCT03978130|469825852|FG001|Overall Study|Adverse Event|1|||
130507625|NCT01562275|469825853|FG000|Stage 1|Adverse Event|0|||
130566931|NCT00078325|470041586|FG000|Overall Study|Withdrawal by Subject|1|||
130566932|NCT00078325|470041587|FG001|Overall Study|Withdrawal by Subject|5|||
130566933|NCT00078325|470041588|FG002|Overall Study|Withdrawal by Subject|3|||
130732508|NCT03217747|470641169|FG000|Overall Study|Adverse Event|0|||
130732509|NCT03217747|470641170|FG001|Overall Study|Adverse Event|1|||
130732510|NCT03217747|470641171|FG002|Overall Study|Adverse Event|0|||
130732511|NCT03217747|470641172|FG003|Overall Study|Adverse Event|0|||
130732512|NCT03217747|470641173|FG004|Overall Study|Adverse Event|0|||
130732513|NCT03217747|470641174|FG005|Overall Study|Adverse Event|0|||
130732514|NCT03217747|470641175|FG006|Overall Study|Adverse Event|0|||
130732515|NCT03217747|470641176|FG007|Overall Study|Adverse Event|0|||
130732516|NCT03217747|470641177|FG008|Overall Study|Adverse Event|0|||
130732517|NCT03217747|470641178|FG009|Overall Study|Adverse Event|0|||
130732518|NCT03217747|470641179|FG010|Overall Study|Adverse Event|0|||
130732519|NCT03217747|470641180|FG011|Overall Study|Adverse Event|0|||
130732520|NCT03217747|470641181|FG012|Overall Study|Adverse Event|1|||
130732521|NCT03217747|470641182|FG013|Overall Study|Adverse Event|1|||
130732522|NCT03217747|470641169|FG000|Overall Study|Death|0|||
130732523|NCT03217747|470641170|FG001|Overall Study|Death|0|||
130732524|NCT03217747|470641171|FG002|Overall Study|Death|0|||
130732525|NCT03217747|470641172|FG003|Overall Study|Death|0|||
130732526|NCT03217747|470641173|FG004|Overall Study|Death|0|||
130732527|NCT03217747|470641174|FG005|Overall Study|Death|0|||
130732528|NCT03217747|470641175|FG006|Overall Study|Death|0|||
130732529|NCT03217747|470641176|FG007|Overall Study|Death|0|||
130732530|NCT03217747|470641177|FG008|Overall Study|Death|1|||
130732531|NCT03217747|470641178|FG009|Overall Study|Death|0|||
130732532|NCT03217747|470641179|FG010|Overall Study|Death|0|||
130732533|NCT03217747|470641180|FG011|Overall Study|Death|0|||
130507626|NCT01562275|469825854|FG001|Stage 1|Adverse Event|0|||
130507627|NCT01562275|469825855|FG002|Stage 1|Adverse Event|0|||
130507628|NCT01562275|469825856|FG003|Stage 1|Adverse Event|1|||
130507629|NCT01562275|469825857|FG004|Stage 1|Adverse Event|1|||
130507630|NCT01562275|469825858|FG005|Stage 1|Adverse Event|0|||
130507631|NCT01562275|469825859|FG006|Stage 1|Adverse Event|0|||
130507632|NCT01562275|469825860|FG007|Stage 1|Adverse Event|0|||
130507633|NCT01562275|469825861|FG008|Stage 1|Adverse Event|0|||
130507634|NCT01562275|469825862|FG009|Stage 1|Adverse Event|1|||
130507635|NCT01562275|469825863|FG010|Stage 1|Adverse Event|0|||
130507636|NCT01562275|469825864|FG011|Stage 1|Adverse Event|0|||
130507637|NCT01562275|469825865|FG012|Stage 1|Adverse Event|0|||
130507638|NCT01562275|469825853|FG000|Stage 1|Death|1|||
130507639|NCT01562275|469825854|FG001|Stage 1|Death|0|||
130507640|NCT01562275|469825855|FG002|Stage 1|Death|0|||
130507641|NCT01562275|469825856|FG003|Stage 1|Death|0|||
130507642|NCT01562275|469825857|FG004|Stage 1|Death|0|||
130507643|NCT01562275|469825858|FG005|Stage 1|Death|0|||
130507644|NCT01562275|469825859|FG006|Stage 1|Death|0|||
130507645|NCT01562275|469825860|FG007|Stage 1|Death|0|||
130507646|NCT01562275|469825861|FG008|Stage 1|Death|0|||
130507647|NCT01562275|469825862|FG009|Stage 1|Death|0|||
130507648|NCT01562275|469825863|FG010|Stage 1|Death|0|||
130507649|NCT01562275|469825864|FG011|Stage 1|Death|0|||
130507650|NCT01562275|469825865|FG012|Stage 1|Death|0|||
130507651|NCT01562275|469825853|FG000|Stage 1|Non Compliance|0|||
130507652|NCT01562275|469825854|FG001|Stage 1|Non Compliance|0|||
130507653|NCT01562275|469825855|FG002|Stage 1|Non Compliance|1|||
130507654|NCT01562275|469825856|FG003|Stage 1|Non Compliance|0|||
130507655|NCT01562275|469825857|FG004|Stage 1|Non Compliance|0|||
130732534|NCT03217747|470641181|FG012|Overall Study|Death|0|||
130732535|NCT03217747|470641182|FG013|Overall Study|Death|0|||
130732536|NCT03217747|470641169|FG000|Overall Study|Lack of Efficacy|12|||
130507656|NCT01562275|469825858|FG005|Stage 1|Non Compliance|0|||
130507657|NCT01562275|469825859|FG006|Stage 1|Non Compliance|0|||
130507658|NCT01562275|469825860|FG007|Stage 1|Non Compliance|0|||
130507659|NCT01562275|469825861|FG008|Stage 1|Non Compliance|0|||
130507660|NCT01562275|469825862|FG009|Stage 1|Non Compliance|0|||
130507661|NCT01562275|469825863|FG010|Stage 1|Non Compliance|0|||
130507662|NCT01562275|469825864|FG011|Stage 1|Non Compliance|0|||
130507663|NCT01562275|469825865|FG012|Stage 1|Non Compliance|0|||
130507664|NCT01562275|469825853|FG000|Stage 1|Physician Decision|0|||
130507665|NCT01562275|469825854|FG001|Stage 1|Physician Decision|0|||
130732537|NCT03217747|470641170|FG001|Overall Study|Lack of Efficacy|6|||
130732538|NCT03217747|470641171|FG002|Overall Study|Lack of Efficacy|15|||
130732539|NCT03217747|470641172|FG003|Overall Study|Lack of Efficacy|11|||
130507666|NCT01562275|469825855|FG002|Stage 1|Physician Decision|0|||
130507667|NCT01562275|469825856|FG003|Stage 1|Physician Decision|0|||
130507668|NCT01562275|469825857|FG004|Stage 1|Physician Decision|1|||
130507669|NCT01562275|469825858|FG005|Stage 1|Physician Decision|0|||
130507670|NCT01562275|469825859|FG006|Stage 1|Physician Decision|1|||
130507671|NCT01562275|469825860|FG007|Stage 1|Physician Decision|0|||
130507672|NCT01562275|469825861|FG008|Stage 1|Physician Decision|1|||
130507673|NCT01562275|469825862|FG009|Stage 1|Physician Decision|0|||
130507674|NCT01562275|469825863|FG010|Stage 1|Physician Decision|0|||
130507675|NCT01562275|469825864|FG011|Stage 1|Physician Decision|0|||
130507676|NCT01562275|469825865|FG012|Stage 1|Physician Decision|0|||
130507677|NCT01562275|469825853|FG000|Stage 1|Progression of Disease|2|||
130507678|NCT01562275|469825854|FG001|Stage 1|Progression of Disease|6|||
130507679|NCT01562275|469825855|FG002|Stage 1|Progression of Disease|2|||
130507680|NCT01562275|469825856|FG003|Stage 1|Progression of Disease|1|||
130507681|NCT01562275|469825857|FG004|Stage 1|Progression of Disease|2|||
130507682|NCT01562275|469825858|FG005|Stage 1|Progression of Disease|4|||
130507683|NCT01562275|469825859|FG006|Stage 1|Progression of Disease|1|||
130507684|NCT01562275|469825860|FG007|Stage 1|Progression of Disease|7|||
130507685|NCT01562275|469825861|FG008|Stage 1|Progression of Disease|2|||
130507686|NCT01562275|469825862|FG009|Stage 1|Progression of Disease|5|||
130507687|NCT01562275|469825863|FG010|Stage 1|Progression of Disease|3|||
130507688|NCT01562275|469825864|FG011|Stage 1|Progression of Disease|0|||
130507689|NCT01562275|469825865|FG012|Stage 1|Progression of Disease|0|||
130507690|NCT01562275|469825853|FG000|Stage 1|Withdrawal by Subject|0|||
130507691|NCT01562275|469825854|FG001|Stage 1|Withdrawal by Subject|1|||
130507692|NCT01562275|469825855|FG002|Stage 1|Withdrawal by Subject|0|||
130507693|NCT01562275|469825856|FG003|Stage 1|Withdrawal by Subject|2|||
130507694|NCT01562275|469825857|FG004|Stage 1|Withdrawal by Subject|0|||
130507695|NCT01562275|469825858|FG005|Stage 1|Withdrawal by Subject|0|||
130507696|NCT01562275|469825859|FG006|Stage 1|Withdrawal by Subject|1|||
130507697|NCT01562275|469825860|FG007|Stage 1|Withdrawal by Subject|0|||
130507698|NCT01562275|469825861|FG008|Stage 1|Withdrawal by Subject|0|||
130507699|NCT01562275|469825862|FG009|Stage 1|Withdrawal by Subject|1|||
130507700|NCT01562275|469825863|FG010|Stage 1|Withdrawal by Subject|0|||
130507701|NCT01562275|469825864|FG011|Stage 1|Withdrawal by Subject|0|||
130507702|NCT01562275|469825865|FG012|Stage 1|Withdrawal by Subject|0|||
130507703|NCT01562275|469825853|FG000|Stage 2|Death|0|||
130507704|NCT01562275|469825854|FG001|Stage 2|Death|0|||
130507705|NCT01562275|469825855|FG002|Stage 2|Death|0|||
130507706|NCT01562275|469825856|FG003|Stage 2|Death|0|||
130507707|NCT01562275|469825857|FG004|Stage 2|Death|0|||
130507708|NCT01562275|469825858|FG005|Stage 2|Death|0|||
130507709|NCT01562275|469825859|FG006|Stage 2|Death|0|||
130507710|NCT01562275|469825860|FG007|Stage 2|Death|0|||
130507711|NCT01562275|469825861|FG008|Stage 2|Death|0|||
130507712|NCT01562275|469825862|FG009|Stage 2|Death|0|||
130507713|NCT01562275|469825863|FG010|Stage 2|Death|0|||
130507714|NCT01562275|469825864|FG011|Stage 2|Death|2|||
130507715|NCT01562275|469825865|FG012|Stage 2|Death|1|||
130507716|NCT01562275|469825853|FG000|Stage 2|Progression of Disease|0|||
130507717|NCT01562275|469825854|FG001|Stage 2|Progression of Disease|0|||
130507718|NCT01562275|469825855|FG002|Stage 2|Progression of Disease|0|||
130507719|NCT01562275|469825856|FG003|Stage 2|Progression of Disease|0|||
130507720|NCT01562275|469825857|FG004|Stage 2|Progression of Disease|0|||
130507721|NCT01562275|469825858|FG005|Stage 2|Progression of Disease|0|||
130507722|NCT01562275|469825859|FG006|Stage 2|Progression of Disease|0|||
130507723|NCT01562275|469825860|FG007|Stage 2|Progression of Disease|0|||
130507724|NCT01562275|469825861|FG008|Stage 2|Progression of Disease|0|||
130507725|NCT01562275|469825862|FG009|Stage 2|Progression of Disease|0|||
130507726|NCT01562275|469825863|FG010|Stage 2|Progression of Disease|0|||
130507727|NCT01562275|469825864|FG011|Stage 2|Progression of Disease|12|||
130507728|NCT01562275|469825865|FG012|Stage 2|Progression of Disease|4|||
130507729|NCT04049578|469825866|FG000|Overall Study|Physician Decision|1|||
130507730|NCT00304278|469825870|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
130507731|NCT00304278|469825870|FG000|Overall Study|PT had medical condition preventing TX|1|||
130507732|NCT01945593|469825871|FG000|Overall Study|Adverse Event|0|||
130507733|NCT01945593|469825872|FG001|Overall Study|Adverse Event|0|||
130507734|NCT01945593|469825873|FG002|Overall Study|Adverse Event|0|||
130507735|NCT01945593|469825874|FG003|Overall Study|Adverse Event|5|||
130507736|NCT01945593|469825871|FG000|Overall Study|Physician Decision|0|||
130507737|NCT01945593|469825872|FG001|Overall Study|Physician Decision|0|||
130507738|NCT01945593|469825873|FG002|Overall Study|Physician Decision|1|||
130507739|NCT01945593|469825874|FG003|Overall Study|Physician Decision|1|||
130507740|NCT01945593|469825871|FG000|Overall Study|Withdrawal by Subject|0|||
130507741|NCT01945593|469825872|FG001|Overall Study|Withdrawal by Subject|2|||
130507742|NCT01945593|469825873|FG002|Overall Study|Withdrawal by Subject|0|||
130507743|NCT01945593|469825874|FG003|Overall Study|Withdrawal by Subject|4|||
130507744|NCT01945593|469825871|FG000|Overall Study|Protocol Violation|0|||
130507745|NCT01945593|469825872|FG001|Overall Study|Protocol Violation|2|||
130507746|NCT01945593|469825873|FG002|Overall Study|Protocol Violation|1|||
130507747|NCT01945593|469825874|FG003|Overall Study|Protocol Violation|3|||
130507748|NCT01945593|469825871|FG000|Overall Study|Death|0|||
130507749|NCT01945593|469825872|FG001|Overall Study|Death|0|||
130507750|NCT01945593|469825873|FG002|Overall Study|Death|1|||
130507751|NCT01945593|469825874|FG003|Overall Study|Death|0|||
130507752|NCT01945593|469825871|FG000|Overall Study|Other: Terminated|0|||
130507753|NCT01945593|469825872|FG001|Overall Study|Other: Terminated|0|||
130507754|NCT01945593|469825873|FG002|Overall Study|Other: Terminated|0|||
130507755|NCT01945593|469825874|FG003|Overall Study|Other: Terminated|1|||
130507756|NCT01945593|469825871|FG000|Overall Study|Other: Surgical Procedure|0|||
130507757|NCT01945593|469825872|FG001|Overall Study|Other: Surgical Procedure|2|||
130507758|NCT01945593|469825873|FG002|Overall Study|Other: Surgical Procedure|0|||
130507759|NCT01945593|469825874|FG003|Overall Study|Other: Surgical Procedure|6|||
130507760|NCT01945593|469825871|FG000|Overall Study|Other: Screen Failure|0|||
130507761|NCT01945593|469825872|FG001|Overall Study|Other: Screen Failure|2|||
130507762|NCT01945593|469825873|FG002|Overall Study|Other: Screen Failure|0|||
130507763|NCT01945593|469825874|FG003|Overall Study|Other: Screen Failure|0|||
130507764|NCT00507429|469825875|FG000|Treatment Phase|Disease Progression|12|||
130507765|NCT00507429|469825876|FG001|Treatment Phase|Disease Progression|5|||
130507766|NCT00507429|469825875|FG000|Treatment Phase|Adverse Event|12|||
130507767|NCT00507429|469825876|FG001|Treatment Phase|Adverse Event|5|||
130507768|NCT00507429|469825875|FG000|Treatment Phase|Withdrawal by Subject|3|||
130507769|NCT00507429|469825876|FG001|Treatment Phase|Withdrawal by Subject|3|||
130507770|NCT00507429|469825875|FG000|Treatment Phase|Physician Decision|4|||
130507771|NCT00507429|469825876|FG001|Treatment Phase|Physician Decision|2|||
130507772|NCT00507429|469825875|FG000|Treatment Phase|Other|6|||
130507773|NCT00507429|469825876|FG001|Treatment Phase|Other|3|||
130507774|NCT00507429|469825875|FG000|Maintenance Phase|Progressive Disease|14|||
130507775|NCT00507429|469825876|FG001|Maintenance Phase|Progressive Disease|0|||
130507776|NCT01587703|469825877|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
130507777|NCT01587703|469825878|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507778|NCT01587703|469825879|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507779|NCT01587703|469825880|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507780|NCT01587703|469825881|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507781|NCT01587703|469825882|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507782|NCT01587703|469825883|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507783|NCT01587703|469825884|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507784|NCT01587703|469825885|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507785|NCT01587703|469825886|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507786|NCT01587703|469825887|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507787|NCT01587703|469825888|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507788|NCT01587703|469825889|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507789|NCT01587703|469825890|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507790|NCT01587703|469825891|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507791|NCT01587703|469825892|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507792|NCT01587703|469825893|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507793|NCT01587703|469825894|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507794|NCT01587703|469825895|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
130507795|NCT01587703|469825877|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507796|NCT01587703|469825878|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507797|NCT01587703|469825879|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507798|NCT01587703|469825880|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507799|NCT01587703|469825881|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507800|NCT01587703|469825882|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
130507801|NCT01587703|469825883|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507802|NCT01587703|469825884|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
130507803|NCT01587703|469825885|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507804|NCT01587703|469825886|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507805|NCT01587703|469825887|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507806|NCT01587703|469825888|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507807|NCT01587703|469825889|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130566934|NCT00078325|470041586|FG000|Overall Study|Lost to Follow-up|0|||
130566935|NCT00078325|470041587|FG001|Overall Study|Lost to Follow-up|1|||
130507808|NCT01587703|469825890|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507809|NCT01587703|469825891|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507810|NCT01587703|469825892|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507811|NCT01587703|469825893|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130566936|NCT00078325|470041588|FG002|Overall Study|Lost to Follow-up|1|||
130507812|NCT01587703|469825894|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507813|NCT01587703|469825895|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130507814|NCT01587703|469825877|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507815|NCT01587703|469825878|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507816|NCT01587703|469825879|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507817|NCT01587703|469825880|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507818|NCT01587703|469825881|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507819|NCT01587703|469825882|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507820|NCT01587703|469825883|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
130507821|NCT01587703|469825884|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507822|NCT01587703|469825885|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507823|NCT01587703|469825886|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507824|NCT01587703|469825887|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507825|NCT01587703|469825888|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507826|NCT01587703|469825889|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507827|NCT01587703|469825890|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507828|NCT01587703|469825891|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507829|NCT01587703|469825892|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507830|NCT01587703|469825893|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507831|NCT01587703|469825894|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507832|NCT01587703|469825895|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
130507833|NCT01587703|469825877|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
130507834|NCT01587703|469825878|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
130507835|NCT01587703|469825879|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
130507836|NCT01587703|469825880|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
130507837|NCT01587703|469825881|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
130566937|NCT00078325|470041586|FG000|Overall Study|Physician Decision|2|||
130566938|NCT00078325|470041587|FG001|Overall Study|Physician Decision|0|||
130566939|NCT00078325|470041588|FG002|Overall Study|Physician Decision|1|||
130566940|NCT00078325|470041586|FG000|Overall Study|Miscellaneous|1|||
130566941|NCT00078325|470041587|FG001|Overall Study|Miscellaneous|1|||
130566942|NCT00078325|470041588|FG002|Overall Study|Miscellaneous|1|||
130566943|NCT04126083|470041589|FG000|Overall Study|Withdrawal by Subject|1|||
130566944|NCT03710486|470041593|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
130566945|NCT03710486|470041594|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
130566946|NCT03710486|470041593|FG000|Overall Study|Missing|0|||
130566947|NCT03710486|470041594|FG001|Overall Study|Missing|2|||
130566948|NCT01279850|470041599|FG000|Overall Study|Protocol Violation|50|||
130566949|NCT01279850|470041599|FG000|Overall Study|No Drug Administration Information|7|||
130566950|NCT01279850|470041599|FG000|Overall Study|No Visit After Treatment|34|||
130566951|NCT01131520|470041600|FG000|Overall Study|Computer problem|1|||
130566952|NCT01131520|470041601|FG001|Overall Study|Computer problem|0|||
130566953|NCT01131520|470041600|FG000|Overall Study|Counselor not available|0|||
130566954|NCT01131520|470041601|FG001|Overall Study|Counselor not available|3|||
130566955|NCT01131520|470041600|FG000|Overall Study|Subject changed history after enrollment|0|||
130566956|NCT01131520|470041601|FG001|Overall Study|Subject changed history after enrollment|1|||
130566957|NCT01147744|470041602|FG000|Overall Study|Protocol Violation|1|||
130566958|NCT01147744|470041603|FG001|Overall Study|Protocol Violation|0|||
130566959|NCT01147744|470041604|FG002|Overall Study|Protocol Violation|1|||
130566960|NCT01147744|470041605|FG003|Overall Study|Protocol Violation|0|||
130566961|NCT01147744|470041606|FG004|Overall Study|Protocol Violation|1|||
130566962|NCT01147744|470041607|FG005|Overall Study|Protocol Violation|3|||
130566963|NCT01147744|470041608|FG006|Overall Study|Protocol Violation|1|||
130566964|NCT01147744|470041602|FG000|Overall Study|Physician Decision|0|||
130566965|NCT01147744|470041603|FG001|Overall Study|Physician Decision|1|||
130566966|NCT01147744|470041604|FG002|Overall Study|Physician Decision|1|||
130566967|NCT01147744|470041605|FG003|Overall Study|Physician Decision|0|||
130566968|NCT01147744|470041606|FG004|Overall Study|Physician Decision|0|||
130566969|NCT01147744|470041607|FG005|Overall Study|Physician Decision|0|||
130566970|NCT01147744|470041608|FG006|Overall Study|Physician Decision|1|||
130507838|NCT01587703|469825882|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
130507839|NCT01587703|469825883|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
130507840|NCT01587703|469825884|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
130507841|NCT01587703|469825885|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507842|NCT01587703|469825886|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507843|NCT01587703|469825887|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507844|NCT01587703|469825888|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507845|NCT01587703|469825889|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130566971|NCT01147744|470041602|FG000|Overall Study|Lack of Efficacy|11|||
130566972|NCT01147744|470041603|FG001|Overall Study|Lack of Efficacy|11|||
130566973|NCT01147744|470041604|FG002|Overall Study|Lack of Efficacy|9|||
130507846|NCT01587703|469825890|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507847|NCT01587703|469825891|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507848|NCT01587703|469825892|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507849|NCT01587703|469825893|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507850|NCT01587703|469825894|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507851|NCT01587703|469825895|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
130507852|NCT01587703|469825877|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507853|NCT01587703|469825878|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507854|NCT01587703|469825879|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507855|NCT01587703|469825880|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507856|NCT01587703|469825881|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130566974|NCT01147744|470041605|FG003|Overall Study|Lack of Efficacy|11|||
130566975|NCT01147744|470041606|FG004|Overall Study|Lack of Efficacy|13|||
130566976|NCT01147744|470041607|FG005|Overall Study|Lack of Efficacy|8|||
130507857|NCT01587703|469825882|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507858|NCT01587703|469825883|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130566977|NCT01147744|470041608|FG006|Overall Study|Lack of Efficacy|7|||
130566978|NCT01147744|470041602|FG000|Overall Study|Adverse Event|1|||
130507859|NCT01587703|469825884|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507860|NCT01587703|469825885|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
130566979|NCT01147744|470041603|FG001|Overall Study|Adverse Event|2|||
130566980|NCT01147744|470041604|FG002|Overall Study|Adverse Event|3|||
130566981|NCT01147744|470041605|FG003|Overall Study|Adverse Event|0|||
130566982|NCT01147744|470041606|FG004|Overall Study|Adverse Event|2|||
130566983|NCT01147744|470041607|FG005|Overall Study|Adverse Event|1|||
130566984|NCT01147744|470041608|FG006|Overall Study|Adverse Event|2|||
130566985|NCT01147744|470041602|FG000|Overall Study|Withdrawal by Subject|8|||
130566986|NCT01147744|470041603|FG001|Overall Study|Withdrawal by Subject|4|||
130507861|NCT01587703|469825886|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
130507862|NCT01587703|469825887|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
130507863|NCT01587703|469825888|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507864|NCT01587703|469825889|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507865|NCT01587703|469825890|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507866|NCT01587703|469825891|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507867|NCT01587703|469825892|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507868|NCT01587703|469825893|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507869|NCT01587703|469825894|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507870|NCT01587703|469825895|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130507871|NCT01587703|469825877|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507872|NCT01587703|469825878|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507873|NCT01587703|469825879|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507874|NCT01587703|469825880|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507875|NCT01587703|469825881|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507876|NCT01587703|469825882|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507877|NCT01587703|469825883|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507878|NCT01587703|469825884|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507879|NCT01587703|469825885|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
130507880|NCT01587703|469825886|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507881|NCT01587703|469825887|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
130507882|NCT01587703|469825888|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507883|NCT01587703|469825889|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507884|NCT01587703|469825890|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507885|NCT01587703|469825891|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507886|NCT01587703|469825892|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507887|NCT01587703|469825893|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507888|NCT01587703|469825894|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507889|NCT01587703|469825895|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
130507890|NCT01587703|469825877|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507891|NCT01587703|469825878|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507892|NCT01587703|469825879|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507893|NCT01587703|469825880|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507894|NCT01587703|469825881|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507895|NCT01587703|469825882|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507896|NCT01587703|469825883|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507897|NCT01587703|469825884|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130732540|NCT03217747|470641173|FG004|Overall Study|Lack of Efficacy|3|||
130732541|NCT03217747|470641174|FG005|Overall Study|Lack of Efficacy|14|||
130732542|NCT03217747|470641175|FG006|Overall Study|Lack of Efficacy|10|||
130732543|NCT03217747|470641176|FG007|Overall Study|Lack of Efficacy|4|||
130732544|NCT03217747|470641177|FG008|Overall Study|Lack of Efficacy|2|||
130732545|NCT03217747|470641178|FG009|Overall Study|Lack of Efficacy|7|||
130732546|NCT03217747|470641179|FG010|Overall Study|Lack of Efficacy|3|||
130732547|NCT03217747|470641180|FG011|Overall Study|Lack of Efficacy|1|||
130732548|NCT03217747|470641181|FG012|Overall Study|Lack of Efficacy|3|||
130732549|NCT03217747|470641182|FG013|Overall Study|Lack of Efficacy|1|||
130732550|NCT03217747|470641169|FG000|Overall Study|Withdrawal by Subject|2|||
130732551|NCT03217747|470641170|FG001|Overall Study|Withdrawal by Subject|1|||
130732552|NCT03217747|470641171|FG002|Overall Study|Withdrawal by Subject|1|||
130732553|NCT03217747|470641172|FG003|Overall Study|Withdrawal by Subject|1|||
130732554|NCT03217747|470641173|FG004|Overall Study|Withdrawal by Subject|1|||
130732555|NCT03217747|470641174|FG005|Overall Study|Withdrawal by Subject|2|||
130732556|NCT03217747|470641175|FG006|Overall Study|Withdrawal by Subject|1|||
130732557|NCT03217747|470641176|FG007|Overall Study|Withdrawal by Subject|0|||
130732558|NCT03217747|470641177|FG008|Overall Study|Withdrawal by Subject|0|||
130732559|NCT03217747|470641178|FG009|Overall Study|Withdrawal by Subject|0|||
130732560|NCT03217747|470641179|FG010|Overall Study|Withdrawal by Subject|0|||
130732561|NCT03217747|470641180|FG011|Overall Study|Withdrawal by Subject|1|||
130732562|NCT03217747|470641181|FG012|Overall Study|Withdrawal by Subject|0|||
130732563|NCT03217747|470641182|FG013|Overall Study|Withdrawal by Subject|1|||
130732564|NCT03217747|470641169|FG000|Overall Study|Toxicity and progression|1|||
130732565|NCT03217747|470641170|FG001|Overall Study|Toxicity and progression|0|||
130732566|NCT03217747|470641171|FG002|Overall Study|Toxicity and progression|0|||
130732567|NCT03217747|470641172|FG003|Overall Study|Toxicity and progression|0|||
130732568|NCT03217747|470641173|FG004|Overall Study|Toxicity and progression|0|||
130732569|NCT03217747|470641174|FG005|Overall Study|Toxicity and progression|0|||
130732570|NCT03217747|470641175|FG006|Overall Study|Toxicity and progression|0|||
130732571|NCT03217747|470641176|FG007|Overall Study|Toxicity and progression|0|||
130732572|NCT03217747|470641177|FG008|Overall Study|Toxicity and progression|0|||
130507898|NCT01587703|469825885|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507899|NCT01587703|469825886|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
130507900|NCT01587703|469825887|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
130507901|NCT01587703|469825888|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507902|NCT01587703|469825889|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507903|NCT01587703|469825890|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507904|NCT01587703|469825891|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507905|NCT01587703|469825892|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130566987|NCT01147744|470041604|FG002|Overall Study|Withdrawal by Subject|2|||
130566988|NCT01147744|470041605|FG003|Overall Study|Withdrawal by Subject|2|||
130566989|NCT01147744|470041606|FG004|Overall Study|Withdrawal by Subject|2|||
130566990|NCT01147744|470041607|FG005|Overall Study|Withdrawal by Subject|5|||
130566991|NCT01147744|470041608|FG006|Overall Study|Withdrawal by Subject|2|||
130566992|NCT01147744|470041602|FG000|Overall Study|Lost to Follow-up|0|||
130566993|NCT01147744|470041603|FG001|Overall Study|Lost to Follow-up|1|||
130566994|NCT01147744|470041604|FG002|Overall Study|Lost to Follow-up|0|||
130566995|NCT01147744|470041605|FG003|Overall Study|Lost to Follow-up|0|||
130566996|NCT01147744|470041606|FG004|Overall Study|Lost to Follow-up|0|||
130566997|NCT01147744|470041607|FG005|Overall Study|Lost to Follow-up|0|||
130566998|NCT01147744|470041608|FG006|Overall Study|Lost to Follow-up|0|||
130507906|NCT01587703|469825893|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507907|NCT01587703|469825894|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507908|NCT01587703|469825895|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130507909|NCT01587703|469825877|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507910|NCT01587703|469825878|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507911|NCT01587703|469825879|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507912|NCT01587703|469825880|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507913|NCT01587703|469825881|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507914|NCT01587703|469825882|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507915|NCT01587703|469825883|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507916|NCT01587703|469825884|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507917|NCT01587703|469825885|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
130507918|NCT01587703|469825886|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507919|NCT01587703|469825887|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507920|NCT01587703|469825888|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507921|NCT01587703|469825889|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507922|NCT01587703|469825890|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507923|NCT01587703|469825891|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507924|NCT01587703|469825892|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507925|NCT01587703|469825893|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507926|NCT01587703|469825894|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507927|NCT01587703|469825895|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
130507928|NCT01587703|469825877|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507929|NCT01587703|469825878|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507930|NCT01587703|469825879|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507931|NCT01587703|469825880|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507932|NCT01587703|469825881|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507933|NCT01587703|469825882|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507934|NCT01587703|469825883|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507935|NCT01587703|469825884|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507936|NCT01587703|469825885|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507937|NCT01587703|469825886|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507938|NCT01587703|469825887|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507939|NCT01587703|469825888|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507940|NCT01587703|469825889|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507941|NCT01587703|469825890|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507942|NCT01587703|469825891|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507943|NCT01587703|469825892|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507944|NCT01587703|469825893|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507945|NCT01587703|469825894|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130507946|NCT01587703|469825895|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
130566999|NCT01147744|470041602|FG000|Overall Study|Sponsor decision to amend protocol|7|||
130567000|NCT01147744|470041603|FG001|Overall Study|Sponsor decision to amend protocol|4|||
130567001|NCT01147744|470041604|FG002|Overall Study|Sponsor decision to amend protocol|2|||
130507947|NCT01587703|469825877|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507948|NCT01587703|469825878|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507949|NCT01587703|469825879|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507950|NCT01587703|469825880|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507951|NCT01587703|469825881|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507952|NCT01587703|469825882|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507953|NCT01587703|469825883|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507954|NCT01587703|469825884|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507955|NCT01587703|469825885|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507956|NCT01587703|469825886|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507957|NCT01587703|469825887|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507958|NCT01587703|469825888|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507959|NCT01587703|469825889|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507960|NCT01587703|469825890|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507961|NCT01587703|469825891|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507962|NCT01587703|469825892|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507963|NCT01587703|469825893|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
130507964|NCT01587703|469825894|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
130507965|NCT01587703|469825895|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
130507966|NCT01587703|469825877|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507967|NCT01587703|469825878|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507968|NCT01587703|469825879|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507969|NCT01587703|469825880|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507970|NCT01587703|469825881|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507971|NCT01587703|469825882|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507972|NCT01587703|469825883|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507973|NCT01587703|469825884|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507974|NCT01587703|469825885|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507975|NCT01587703|469825886|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507976|NCT01587703|469825887|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507977|NCT01587703|469825888|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507978|NCT01587703|469825889|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507979|NCT01587703|469825890|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507980|NCT01587703|469825891|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507981|NCT01587703|469825892|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
130507982|NCT01587703|469825893|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507983|NCT01587703|469825894|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507984|NCT01587703|469825895|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130507985|NCT01587703|469825877|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507986|NCT01587703|469825878|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507987|NCT01587703|469825879|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507988|NCT01587703|469825880|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507989|NCT01587703|469825881|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130567002|NCT01147744|470041605|FG003|Overall Study|Sponsor decision to amend protocol|5|||
130567003|NCT01147744|470041606|FG004|Overall Study|Sponsor decision to amend protocol|7|||
130507990|NCT01587703|469825882|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507991|NCT01587703|469825883|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507992|NCT01587703|469825884|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130567004|NCT01147744|470041607|FG005|Overall Study|Sponsor decision to amend protocol|2|||
130567005|NCT01147744|470041608|FG006|Overall Study|Sponsor decision to amend protocol|6|||
130567006|NCT01147744|470041602|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130507993|NCT01587703|469825885|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507994|NCT01587703|469825886|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507995|NCT01587703|469825887|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507996|NCT01587703|469825888|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
130507997|NCT01587703|469825889|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507998|NCT01587703|469825890|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130507999|NCT01587703|469825891|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
130508000|NCT01587703|469825892|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130508001|NCT01587703|469825893|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130508002|NCT01587703|469825894|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130508003|NCT01587703|469825895|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
130508004|NCT01587703|469825877|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130567007|NCT01147744|470041603|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130567008|NCT01147744|470041604|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130567009|NCT01147744|470041605|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130567010|NCT01147744|470041606|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130567011|NCT01147744|470041607|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130567012|NCT01147744|470041608|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130567013|NCT01342484|470041611|FG000|Overall Study|Other Reasons|1|||
130567014|NCT01342484|470041612|FG001|Overall Study|Other Reasons|0|||
130567015|NCT01342484|470041613|FG002|Overall Study|Other Reasons|0|||
130567016|NCT01342484|470041611|FG000|Overall Study|Protocol Violation|0|||
130567017|NCT01342484|470041612|FG001|Overall Study|Protocol Violation|0|||
130567018|NCT01342484|470041613|FG002|Overall Study|Protocol Violation|1|||
130508005|NCT01587703|469825878|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508006|NCT01587703|469825879|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508007|NCT01587703|469825880|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508008|NCT01587703|469825881|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508009|NCT01587703|469825882|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508010|NCT01587703|469825883|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508011|NCT01587703|469825884|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508012|NCT01587703|469825885|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508013|NCT01587703|469825886|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508014|NCT01587703|469825887|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508015|NCT01587703|469825888|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
130508016|NCT01587703|469825889|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
130508017|NCT01587703|469825890|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
130508018|NCT01587703|469825891|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
130508019|NCT01587703|469825892|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
130508020|NCT01587703|469825893|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
130508021|NCT01587703|469825894|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508022|NCT01587703|469825895|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
130508023|NCT01587703|469825877|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508024|NCT01587703|469825878|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508025|NCT01587703|469825879|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508026|NCT01587703|469825880|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508027|NCT01587703|469825881|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508028|NCT01587703|469825882|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508029|NCT01587703|469825883|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508030|NCT01587703|469825884|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508031|NCT01587703|469825885|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508032|NCT01587703|469825886|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508033|NCT01587703|469825887|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508034|NCT01587703|469825888|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
130508035|NCT01587703|469825889|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
130508036|NCT01587703|469825890|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
130508037|NCT01587703|469825891|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
130508038|NCT01587703|469825892|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
130508039|NCT01587703|469825893|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
130508040|NCT01587703|469825894|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508041|NCT01587703|469825895|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
130508042|NCT01587703|469825877|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130567019|NCT01342484|470041611|FG000|Overall Study|Withdrawal by Subject|1|||
130508043|NCT01587703|469825878|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130567020|NCT01342484|470041612|FG001|Overall Study|Withdrawal by Subject|0|||
130508044|NCT01587703|469825879|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508045|NCT01587703|469825880|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508046|NCT01587703|469825881|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508047|NCT01587703|469825882|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508048|NCT01587703|469825883|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508049|NCT01587703|469825884|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508050|NCT01587703|469825885|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508051|NCT01587703|469825886|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508052|NCT01587703|469825887|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508053|NCT01587703|469825888|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
130508054|NCT01587703|469825889|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508055|NCT01587703|469825890|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508056|NCT01587703|469825891|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508057|NCT01587703|469825892|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508058|NCT01587703|469825893|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508059|NCT01587703|469825894|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508060|NCT01587703|469825895|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
130508061|NCT00476151|469825899|FG000|Overall Study|Adverse Event|0|||
130567021|NCT01342484|470041613|FG002|Overall Study|Withdrawal by Subject|0|||
130508062|NCT00476151|469825900|FG001|Overall Study|Adverse Event|2|||
130508063|NCT00476151|469825899|FG000|Overall Study|Protocol Violation|1|||
130508064|NCT00476151|469825900|FG001|Overall Study|Protocol Violation|3|||
130508065|NCT00476151|469825899|FG000|Overall Study|Withdrawal by Subject|2|||
130508066|NCT00476151|469825900|FG001|Overall Study|Withdrawal by Subject|0|||
130508067|NCT00476151|469825899|FG000|Overall Study|Physician Decision|0|||
130508068|NCT00476151|469825900|FG001|Overall Study|Physician Decision|2|||
130508069|NCT01767376|469825911|FG000|Overall Study|Lost to Follow-up|3|||
130508070|NCT01767376|469825912|FG001|Overall Study|Lost to Follow-up|2|||
130508071|NCT01767376|469825913|FG002|Overall Study|Lost to Follow-up|0|||
130508072|NCT01767376|469825911|FG000|Overall Study|Withdrawal by Subject|1|||
130508073|NCT01767376|469825912|FG001|Overall Study|Withdrawal by Subject|1|||
130508074|NCT01767376|469825913|FG002|Overall Study|Withdrawal by Subject|0|||
130508075|NCT01113541|469825917|FG000|Overall Study|Withdrawal by Subject|1|||
130508076|NCT01113541|469825917|FG000|Overall Study|Protocol Violation|1|||
130508077|NCT01113541|469825917|FG000|Overall Study|Study Terminated by Sponsor|7|||
130508078|NCT01113541|469825917|FG000|Overall Study|Adverse Event|4|||
130508079|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
130508080|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
130508081|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130508082|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130508083|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130508084|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130508085|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130508086|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
130508087|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
130508088|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
130508089|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130508090|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130508091|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130508092|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130508093|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
130508094|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130508095|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130508096|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130508097|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130508098|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130508099|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130508100|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508101|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
130508102|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508103|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508104|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508105|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508106|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130508107|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
130508108|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
130508109|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
130508110|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130508111|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130508112|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130508113|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130508114|NCT03745651|469825918|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
130508115|NCT03745651|469825919|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
130508116|NCT03745651|469825920|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
130508117|NCT03745651|469825921|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
130508118|NCT03745651|469825922|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
130508119|NCT03745651|469825923|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
130508120|NCT03745651|469825924|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
130508121|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508122|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508123|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508124|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508125|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508126|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
130508127|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130508128|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130508129|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130508130|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130567022|NCT01840579|470041614|FG000|Overall Study|Status not recorded|0|||
130567023|NCT01840579|470041615|FG001|Overall Study|Status not recorded|0|||
130567024|NCT01840579|470041616|FG002|Overall Study|Status not recorded|2|||
130567025|NCT01840579|470041617|FG003|Overall Study|Status not recorded|3|||
130567026|NCT01840579|470041618|FG004|Overall Study|Status not recorded|4|||
130567027|NCT01840579|470041619|FG005|Overall Study|Status not recorded|3|||
130567028|NCT01840579|470041620|FG006|Overall Study|Status not recorded|0|||
130567029|NCT01840579|470041621|FG007|Overall Study|Status not recorded|3|||
130567030|NCT01840579|470041622|FG008|Overall Study|Status not recorded|3|||
130567031|NCT01840579|470041623|FG009|Overall Study|Status not recorded|3|||
130567032|NCT01840579|470041614|FG000|Overall Study|Progressive disease|3|||
130567033|NCT01840579|470041615|FG001|Overall Study|Progressive disease|5|||
130567034|NCT01840579|470041616|FG002|Overall Study|Progressive disease|0|||
130567035|NCT01840579|470041617|FG003|Overall Study|Progressive disease|0|||
130567036|NCT01840579|470041618|FG004|Overall Study|Progressive disease|0|||
130567037|NCT01840579|470041619|FG005|Overall Study|Progressive disease|0|||
130567038|NCT01840579|470041620|FG006|Overall Study|Progressive disease|0|||
130567039|NCT01840579|470041621|FG007|Overall Study|Progressive disease|0|||
130567040|NCT01840579|470041622|FG008|Overall Study|Progressive disease|0|||
130567041|NCT01840579|470041623|FG009|Overall Study|Progressive disease|0|||
130567042|NCT01840579|470041614|FG000|Overall Study|Ongoing in study|0|||
130567043|NCT01840579|470041615|FG001|Overall Study|Ongoing in study|1|||
130567044|NCT01840579|470041616|FG002|Overall Study|Ongoing in study|0|||
130567045|NCT01840579|470041617|FG003|Overall Study|Ongoing in study|0|||
130567046|NCT01840579|470041618|FG004|Overall Study|Ongoing in study|0|||
130567047|NCT01840579|470041619|FG005|Overall Study|Ongoing in study|0|||
130567048|NCT01840579|470041620|FG006|Overall Study|Ongoing in study|0|||
130567049|NCT01840579|470041621|FG007|Overall Study|Ongoing in study|0|||
130567050|NCT01840579|470041622|FG008|Overall Study|Ongoing in study|0|||
130567051|NCT01840579|470041623|FG009|Overall Study|Ongoing in study|0|||
130567052|NCT01840579|470041614|FG000|Overall Study|Death|0|||
130567053|NCT01840579|470041615|FG001|Overall Study|Death|0|||
130567054|NCT01840579|470041616|FG002|Overall Study|Death|0|||
130567055|NCT01840579|470041617|FG003|Overall Study|Death|0|||
130567056|NCT01840579|470041618|FG004|Overall Study|Death|0|||
130567057|NCT01840579|470041619|FG005|Overall Study|Death|1|||
130567058|NCT01840579|470041620|FG006|Overall Study|Death|0|||
130567059|NCT01840579|470041621|FG007|Overall Study|Death|0|||
130567060|NCT01840579|470041622|FG008|Overall Study|Death|0|||
130567061|NCT01840579|470041623|FG009|Overall Study|Death|0|||
130567062|NCT01840579|470041614|FG000|Overall Study|Adverse Event|0|||
130567063|NCT01840579|470041615|FG001|Overall Study|Adverse Event|1|||
130567064|NCT01840579|470041616|FG002|Overall Study|Adverse Event|0|||
130567065|NCT01840579|470041617|FG003|Overall Study|Adverse Event|0|||
130567066|NCT01840579|470041618|FG004|Overall Study|Adverse Event|0|||
130567067|NCT01840579|470041619|FG005|Overall Study|Adverse Event|0|||
130567068|NCT01840579|470041620|FG006|Overall Study|Adverse Event|0|||
130567069|NCT01840579|470041621|FG007|Overall Study|Adverse Event|0|||
130567070|NCT01840579|470041622|FG008|Overall Study|Adverse Event|0|||
130567071|NCT01840579|470041623|FG009|Overall Study|Adverse Event|0|||
130567072|NCT01840579|470041614|FG000|Overall Study|Follow-up ended by Sponsor|0|||
130567073|NCT01840579|470041615|FG001|Overall Study|Follow-up ended by Sponsor|0|||
130567074|NCT01840579|470041616|FG002|Overall Study|Follow-up ended by Sponsor|0|||
130567075|NCT01840579|470041617|FG003|Overall Study|Follow-up ended by Sponsor|0|||
130567076|NCT01840579|470041618|FG004|Overall Study|Follow-up ended by Sponsor|0|||
130567077|NCT01840579|470041619|FG005|Overall Study|Follow-up ended by Sponsor|0|||
130567078|NCT01840579|470041620|FG006|Overall Study|Follow-up ended by Sponsor|2|||
130567079|NCT01840579|470041621|FG007|Overall Study|Follow-up ended by Sponsor|0|||
130567080|NCT01840579|470041622|FG008|Overall Study|Follow-up ended by Sponsor|0|||
130567081|NCT01840579|470041623|FG009|Overall Study|Follow-up ended by Sponsor|0|||
130567082|NCT01892163|470041624|FG000|Overall Study|Death|1|||
130567083|NCT01892163|470041625|FG001|Overall Study|Death|1|||
130567084|NCT01892163|470041624|FG000|Overall Study|Lost to Follow-up|1|||
130567085|NCT01892163|470041625|FG001|Overall Study|Lost to Follow-up|0|||
130567086|NCT03302975|470041626|FG000|Overall Study|Lost to Follow-up|4|||
130567087|NCT01924182|470041627|FG000|Overall Study|Withdrawal by Subject|1|||
130567088|NCT01924182|470041628|FG001|Overall Study|Withdrawal by Subject|0|||
130567089|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
130567090|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
130567091|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
130567092|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
130567093|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
130567094|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
130567095|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
130567096|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
130567097|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to death|4|||
130567098|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to death|3|||
130567099|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
130567100|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
130567101|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
130567102|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
130567103|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
130567104|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
130567105|NCT02258451|470041629|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
130567106|NCT02258451|470041630|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
130567107|NCT02258451|470041629|FG000|Overall Study|Other reason|1|||
130567108|NCT02258451|470041630|FG001|Overall Study|Other reason|1|||
130567109|NCT02258451|470041629|FG000|Overall Study|Never treated|2|||
130567110|NCT02258451|470041630|FG001|Overall Study|Never treated|3|||
130567111|NCT05419128|470041635|FG000|Overall Study|Withdrawal by Subject|1|||
130567112|NCT05419128|470041636|FG001|Overall Study|Withdrawal by Subject|1|||
130567113|NCT05419128|470041637|FG002|Overall Study|Withdrawal by Subject|0|||
130567114|NCT05419128|470041638|FG003|Overall Study|Withdrawal by Subject|1|||
130567115|NCT05419128|470041639|FG004|Overall Study|Withdrawal by Subject|1|||
130567116|NCT05419128|470041640|FG005|Overall Study|Withdrawal by Subject|0|||
130567117|NCT05419128|470041635|FG000|Overall Study|Lost to Follow-up|0|||
130567118|NCT05419128|470041636|FG001|Overall Study|Lost to Follow-up|0|||
130567119|NCT05419128|470041637|FG002|Overall Study|Lost to Follow-up|1|||
130567120|NCT05419128|470041638|FG003|Overall Study|Lost to Follow-up|0|||
130567121|NCT05419128|470041639|FG004|Overall Study|Lost to Follow-up|0|||
130567122|NCT05419128|470041640|FG005|Overall Study|Lost to Follow-up|1|||
130567123|NCT03834519|470041641|FG000|Overall Study|Lost to Follow-up|2|||
130567124|NCT03834519|470041642|FG001|Overall Study|Lost to Follow-up|1|||
130567125|NCT03834519|470041641|FG000|Overall Study|Withdrawal by Subject|5|||
130567126|NCT03834519|470041642|FG001|Overall Study|Withdrawal by Subject|8|||
130567127|NCT03834519|470041641|FG000|Overall Study|Death|368|||
130567128|NCT03834519|470041642|FG001|Overall Study|Death|174|||
130567129|NCT03834519|470041641|FG000|Overall Study|Physician Decision|5|||
130567130|NCT03834519|470041642|FG001|Overall Study|Physician Decision|1|||
130567131|NCT03834519|470041641|FG000|Overall Study|Sponsor decision|149|||
130567132|NCT03834519|470041642|FG001|Overall Study|Sponsor decision|80|||
130567133|NCT04506086|470041643|FG000|Overall Study|Withdrawal by Subject|2|||
130567134|NCT00517751|470041644|FG000|Overall Study|Death|3|||
130567135|NCT00517751|470041644|FG000|Overall Study|Withdrawal by Subject|37|||
130567136|NCT00517751|470041644|FG000|Overall Study|Lost to Follow-up|4|||
130567137|NCT00517751|470041644|FG000|Overall Study|patient not over due|6|||
130567138|NCT00517751|470041644|FG000|Overall Study|Patient not due for visit|76|||
130567139|NCT00517751|470041644|FG000|Overall Study|Missing|3|||
130567140|NCT00980200|470043434|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
130567141|NCT00980200|470043435|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
130567142|NCT00980200|470043436|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
130567143|NCT00980200|470043437|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
130567144|NCT00980200|470043438|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
130567145|NCT00980200|470043434|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
130567146|NCT00980200|470043435|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
130567147|NCT00980200|470043436|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
130508131|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130508132|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130508133|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
130508134|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
130508135|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130508136|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130508137|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130508138|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
130508139|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
130508140|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
130508141|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
130508142|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130508143|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130732573|NCT03217747|470641178|FG009|Overall Study|Toxicity and progression|0|||
130567148|NCT00980200|470043437|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
130567149|NCT00980200|470043438|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
130567150|NCT00457015|470043439|FG000|Overall Study|Left study site against medical advice|0|||
130567151|NCT00457015|470043440|FG001|Overall Study|Left study site against medical advice|1|||
130567152|NCT01429584|470043444|FG000|Overall Study|Withdrawal by Subject|1|||
130567153|NCT01429584|470043445|FG001|Overall Study|Withdrawal by Subject|0|||
130567154|NCT01429584|470043444|FG000|Overall Study|Protocol Violation|0|||
130567155|NCT01429584|470043445|FG001|Overall Study|Protocol Violation|1|||
130567156|NCT00747643|470043446|FG000|Overall Study|Withdrawal by Subject|36|||
130732574|NCT03217747|470641179|FG010|Overall Study|Toxicity and progression|0|||
130508144|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130508145|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
130508146|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130508147|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
130508148|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
130508149|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
130508150|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
130508151|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
130508152|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
130508153|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
130508154|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
130508155|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
130508156|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508157|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508158|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508159|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508160|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508161|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
130508162|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130508163|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130508164|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130508165|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130508166|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
130508167|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
130508168|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
130508169|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
130508170|NCT03745651|469825918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
130508171|NCT03745651|469825919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
130508172|NCT03745651|469825920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
130508173|NCT03745651|469825921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
130508174|NCT03745651|469825922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
130508175|NCT03745651|469825923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
130508176|NCT03745651|469825924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
130508177|NCT04175834|469825925|FG000|Overall Study|Withdrawal by Subject|1|||
130508178|NCT04175834|469825926|FG001|Overall Study|Withdrawal by Subject|0|||
130508179|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
130508180|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
130508181|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
130508182|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
130508183|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
130508184|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
130508185|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
130508186|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
130508187|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
130508188|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
130508189|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
130508190|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
130508191|NCT01494467|469825931|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
130508192|NCT01494467|469825932|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
130508193|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
130508194|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
130508195|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
130508196|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
130508197|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
130508198|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
130508199|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
130508200|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
130508201|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
130508202|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
130508203|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
130508204|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
130508205|NCT01494467|469825931|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
130508206|NCT01494467|469825932|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
130508207|NCT02309892|469825933|FG000|Overall Study|Physician Decision|1|||
130508208|NCT02309892|469825934|FG001|Overall Study|Physician Decision|0|||
130508209|NCT02309892|469825935|FG002|Overall Study|Physician Decision|0|||
130508210|NCT02309892|469825936|FG003|Overall Study|Physician Decision|0|||
130508211|NCT02309892|469825937|FG004|Overall Study|Physician Decision|0|||
130508212|NCT02309892|469825938|FG005|Overall Study|Physician Decision|0|||
130508213|NCT02309892|469825939|FG006|Overall Study|Physician Decision|0|||
130508214|NCT02309892|469825933|FG000|Overall Study|Adverse Event|1|||
130508215|NCT02309892|469825934|FG001|Overall Study|Adverse Event|0|||
130508216|NCT02309892|469825935|FG002|Overall Study|Adverse Event|1|||
130508217|NCT02309892|469825936|FG003|Overall Study|Adverse Event|0|||
130508218|NCT02309892|469825937|FG004|Overall Study|Adverse Event|0|||
130508219|NCT02309892|469825938|FG005|Overall Study|Adverse Event|0|||
130508220|NCT02309892|469825939|FG006|Overall Study|Adverse Event|0|||
130508221|NCT02309892|469825933|FG000|Overall Study|Progressive Disease|0|||
130508222|NCT02309892|469825934|FG001|Overall Study|Progressive Disease|1|||
130508223|NCT02309892|469825935|FG002|Overall Study|Progressive Disease|0|||
130508224|NCT02309892|469825936|FG003|Overall Study|Progressive Disease|0|||
130508225|NCT02309892|469825937|FG004|Overall Study|Progressive Disease|1|||
130508226|NCT02309892|469825938|FG005|Overall Study|Progressive Disease|0|||
130508227|NCT02309892|469825939|FG006|Overall Study|Progressive Disease|0|||
130508228|NCT02309892|469825933|FG000|Overall Study|Death|0|||
130508229|NCT02309892|469825934|FG001|Overall Study|Death|0|||
130508230|NCT02309892|469825935|FG002|Overall Study|Death|0|||
130508231|NCT02309892|469825936|FG003|Overall Study|Death|0|||
130508232|NCT02309892|469825937|FG004|Overall Study|Death|0|||
130508233|NCT02309892|469825938|FG005|Overall Study|Death|1|||
130508234|NCT02309892|469825939|FG006|Overall Study|Death|0|||
130508235|NCT03262389|469825940|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
130508236|NCT03262389|469825940|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
130508237|NCT03262389|469825940|FG000|Overall Study|opted out of PET/MR|1|||
130508238|NCT01052272|469825941|FG000|Overall Study|Death|0|||
130508239|NCT01052272|469825942|FG001|Overall Study|Death|0|||
130508240|NCT01052272|469825943|FG002|Overall Study|Death|1|||
130508241|NCT01052272|469825944|FG003|Overall Study|Death|1|||
130508242|NCT01052272|469825941|FG000|Overall Study|Physician Decision|0|||
130508243|NCT01052272|469825942|FG001|Overall Study|Physician Decision|1|||
130508244|NCT01052272|469825943|FG002|Overall Study|Physician Decision|0|||
130508245|NCT01052272|469825944|FG003|Overall Study|Physician Decision|0|||
130508246|NCT01052272|469825941|FG000|Overall Study|patient refuses follow-up|5|||
130508247|NCT01052272|469825942|FG001|Overall Study|patient refuses follow-up|4|||
130508248|NCT01052272|469825943|FG002|Overall Study|patient refuses follow-up|2|||
130508249|NCT01052272|469825944|FG003|Overall Study|patient refuses follow-up|4|||
130508250|NCT01052272|469825941|FG000|Overall Study|Withdrawal by Subject|0|||
130508251|NCT01052272|469825942|FG001|Overall Study|Withdrawal by Subject|2|||
130508252|NCT01052272|469825943|FG002|Overall Study|Withdrawal by Subject|3|||
130508253|NCT01052272|469825944|FG003|Overall Study|Withdrawal by Subject|2|||
130508254|NCT01052272|469825941|FG000|Overall Study|placed in long-term care|0|||
130508255|NCT01052272|469825942|FG001|Overall Study|placed in long-term care|0|||
130508256|NCT01052272|469825943|FG002|Overall Study|placed in long-term care|1|||
130508257|NCT01052272|469825944|FG003|Overall Study|placed in long-term care|0|||
130508258|NCT01052272|469825941|FG000|Overall Study|decline in health|0|||
130508259|NCT01052272|469825942|FG001|Overall Study|decline in health|0|||
130508260|NCT01052272|469825943|FG002|Overall Study|decline in health|1|||
130508261|NCT01052272|469825944|FG003|Overall Study|decline in health|0|||
130508262|NCT04739306|469825945|FG000|Main Study Period|Adverse Event|6|||
130508263|NCT04739306|469825946|FG001|Main Study Period|Adverse Event|7|||
130508264|NCT04739306|469825945|FG000|Main Study Period|Lost to Follow-up|4|||
130508265|NCT04739306|469825946|FG001|Main Study Period|Lost to Follow-up|6|||
130508266|NCT04739306|469825945|FG000|Main Study Period|Physician Decision|1|||
130508267|NCT04739306|469825946|FG001|Main Study Period|Physician Decision|1|||
130508268|NCT04739306|469825945|FG000|Main Study Period|Withdrawal by Subject|8|||
130508269|NCT04739306|469825946|FG001|Main Study Period|Withdrawal by Subject|6|||
130508270|NCT04739306|469825945|FG000|Main Study Period|Protocol Violation|0|||
130508271|NCT04739306|469825946|FG001|Main Study Period|Protocol Violation|1|||
130508272|NCT04739306|469825945|FG000|Main Study Period|War in Ukraine|1|||
130508273|NCT04739306|469825946|FG001|Main Study Period|War in Ukraine|1|||
130508274|NCT01077284|469825947|FG000|Overall Study|Adverse Event|2|||
130508275|NCT01077284|469825948|FG001|Overall Study|Adverse Event|0|||
130508276|NCT01077284|469825949|FG002|Overall Study|Adverse Event|1|||
130508277|NCT01077284|469825947|FG000|Overall Study|Lost to Follow-up|1|||
130508278|NCT01077284|469825948|FG001|Overall Study|Lost to Follow-up|2|||
130508279|NCT01077284|469825949|FG002|Overall Study|Lost to Follow-up|0|||
130508280|NCT01077284|469825947|FG000|Overall Study|Withdrawal by Subject|2|||
130508281|NCT01077284|469825948|FG001|Overall Study|Withdrawal by Subject|3|||
130508282|NCT01077284|469825949|FG002|Overall Study|Withdrawal by Subject|1|||
130508283|NCT01077284|469825947|FG000|Overall Study|Other|0|||
130508284|NCT01077284|469825948|FG001|Overall Study|Other|0|||
130508285|NCT01077284|469825949|FG002|Overall Study|Other|1|||
130508286|NCT03209492|469825950|FG000|Overall Study|Case Report Forms Uncollected|5|||
130508287|NCT01762345|469825951|FG000|Overall Study|Adverse Event|5|||
130508288|NCT01762345|469825951|FG000|Overall Study|Protocol Violation|2|||
130508289|NCT02379078|469825952|FG000|Overall Study|Lost to Follow-up|33|||
130508290|NCT02379078|469825953|FG001|Overall Study|Lost to Follow-up|30|||
130508291|NCT02379078|469825952|FG000|Overall Study|Withdrawal by Subject|6|||
130508292|NCT02379078|469825953|FG001|Overall Study|Withdrawal by Subject|5|||
130508293|NCT04908488|469825954|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130508294|NCT04908488|469825955|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130508295|NCT04908488|469825954|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
130508296|NCT04908488|469825955|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
130508297|NCT02959866|469825960|FG000|Overall Study|Withdrawal by Subject|1|||
130508298|NCT00952523|469825961|FG000|Overall Study|Withdrawal by Subject|7|||
130508299|NCT05265247|469825962|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
130508300|NCT05265247|469825963|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
130508301|NCT05265247|469825962|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
130508302|NCT05265247|469825963|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
130508303|NCT05265247|469825962|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
130508304|NCT05265247|469825963|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
130508305|NCT01029925|469825964|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
130508306|NCT01029925|469825964|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
130508307|NCT01029925|469825964|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
130508308|NCT00409747|469825967|FG000|Overall Study|Withdrawal by Subject|1|||
130508309|NCT01721109|469825970|FG000|Overall Study|Lack of Efficacy|1|||
130508310|NCT01721109|469825970|FG000|Overall Study|Non- Compliance with Study Drug|3|||
130508311|NCT01721109|469825970|FG000|Overall Study|Withdrew Consent|1|||
130508312|NCT01721109|469825970|FG000|Overall Study|Lost to Follow-up|2|||
130508313|NCT00134056|469825971|FG000|Randomization|Not eligible for assigned treatment|22|||
130508314|NCT00134056|469825972|FG001|Randomization|Not eligible for assigned treatment|20|||
130508315|NCT00134056|469825971|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
130508316|NCT00134056|469825972|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
130508317|NCT00134056|469825971|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
130508318|NCT00134056|469825972|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
130732575|NCT03217747|470641180|FG011|Overall Study|Toxicity and progression|0|||
130508319|NCT00134056|469825971|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
130732576|NCT03217747|470641181|FG012|Overall Study|Toxicity and progression|0|||
130732577|NCT03217747|470641182|FG013|Overall Study|Toxicity and progression|0|||
130508320|NCT00134056|469825972|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
130732578|NCT03217747|470641169|FG000|Overall Study|Removal of sole target lesion|1|||
130508321|NCT00134056|469825971|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
130508322|NCT00134056|469825972|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
130508323|NCT02555397|469825977|FG000|Overall Study|Withdrawal by Subject|1|||
130508324|NCT02555397|469825978|FG001|Overall Study|Withdrawal by Subject|0|||
130508325|NCT02555397|469825979|FG002|Overall Study|Withdrawal by Subject|0|||
130508326|NCT02555397|469825980|FG003|Overall Study|Withdrawal by Subject|0|||
130732579|NCT03217747|470641170|FG001|Overall Study|Removal of sole target lesion|0|||
130732580|NCT03217747|470641171|FG002|Overall Study|Removal of sole target lesion|0|||
130732581|NCT03217747|470641172|FG003|Overall Study|Removal of sole target lesion|0|||
130732582|NCT03217747|470641173|FG004|Overall Study|Removal of sole target lesion|0|||
130732583|NCT03217747|470641174|FG005|Overall Study|Removal of sole target lesion|0|||
130732584|NCT03217747|470641175|FG006|Overall Study|Removal of sole target lesion|0|||
130732585|NCT03217747|470641176|FG007|Overall Study|Removal of sole target lesion|0|||
130732586|NCT03217747|470641177|FG008|Overall Study|Removal of sole target lesion|0|||
130732587|NCT03217747|470641178|FG009|Overall Study|Removal of sole target lesion|0|||
130732588|NCT03217747|470641179|FG010|Overall Study|Removal of sole target lesion|0|||
130732589|NCT03217747|470641180|FG011|Overall Study|Removal of sole target lesion|0|||
130732590|NCT03217747|470641181|FG012|Overall Study|Removal of sole target lesion|0|||
130732591|NCT03217747|470641182|FG013|Overall Study|Removal of sole target lesion|0|||
130732592|NCT03217747|470641169|FG000|Overall Study|Stroke|0|||
130732593|NCT03217747|470641170|FG001|Overall Study|Stroke|0|||
130732594|NCT03217747|470641171|FG002|Overall Study|Stroke|0|||
130732595|NCT03217747|470641172|FG003|Overall Study|Stroke|0|||
130732596|NCT03217747|470641173|FG004|Overall Study|Stroke|0|||
130732597|NCT03217747|470641174|FG005|Overall Study|Stroke|1|||
130732598|NCT03217747|470641175|FG006|Overall Study|Stroke|0|||
130732599|NCT03217747|470641176|FG007|Overall Study|Stroke|0|||
130732600|NCT03217747|470641177|FG008|Overall Study|Stroke|0|||
130732601|NCT03217747|470641178|FG009|Overall Study|Stroke|0|||
130732602|NCT03217747|470641179|FG010|Overall Study|Stroke|0|||
130732603|NCT03217747|470641180|FG011|Overall Study|Stroke|1|||
130732604|NCT03217747|470641181|FG012|Overall Study|Stroke|0|||
130732605|NCT03217747|470641182|FG013|Overall Study|Stroke|0|||
130732606|NCT04103892|470641183|FG000|Overall Study|Adverse Event|0|||
130732607|NCT04103892|470641184|FG001|Overall Study|Adverse Event|0|||
130732608|NCT04103892|470641185|FG002|Overall Study|Adverse Event|0|||
130732609|NCT04103892|470641186|FG003|Overall Study|Adverse Event|3|||
130732610|NCT04103892|470641183|FG000|Overall Study|Lost to Follow-up|0|||
130732611|NCT04103892|470641184|FG001|Overall Study|Lost to Follow-up|0|||
130732612|NCT04103892|470641185|FG002|Overall Study|Lost to Follow-up|2|||
130732613|NCT04103892|470641186|FG003|Overall Study|Lost to Follow-up|0|||
130732614|NCT04103892|470641183|FG000|Overall Study|Protocol Violation|0|||
130732615|NCT04103892|470641184|FG001|Overall Study|Protocol Violation|0|||
130732616|NCT04103892|470641185|FG002|Overall Study|Protocol Violation|1|||
130732617|NCT04103892|470641186|FG003|Overall Study|Protocol Violation|1|||
130732618|NCT04103892|470641183|FG000|Overall Study|Withdrawal by Subject|1|||
130732619|NCT04103892|470641184|FG001|Overall Study|Withdrawal by Subject|0|||
130732620|NCT04103892|470641185|FG002|Overall Study|Withdrawal by Subject|2|||
130732621|NCT04103892|470641186|FG003|Overall Study|Withdrawal by Subject|5|||
130732622|NCT04103892|470641183|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
130732623|NCT04103892|470641184|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
130508327|NCT02555397|469825981|FG004|Overall Study|Withdrawal by Subject|0|||
130732624|NCT04103892|470641185|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
130732625|NCT04103892|470641186|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
130732626|NCT05097989|470641187|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130567157|NCT00747643|470043447|FG001|Overall Study|Withdrawal by Subject|27|||
130567158|NCT00750698|470043448|FG000|Overall Study|Withdrawal by Subject|1|||
130567159|NCT00750698|470043449|FG001|Overall Study|Withdrawal by Subject|0|||
130567160|NCT00750698|470043448|FG000|Overall Study|Progressive disease|5|||
130567161|NCT00750698|470043449|FG001|Overall Study|Progressive disease|2|||
130567162|NCT02263079|470043450|FG000|Overall Study|Physician Decision|1|||
130567163|NCT02263079|470043451|FG001|Overall Study|Physician Decision|0|||
130567164|NCT02263079|470043452|FG002|Overall Study|Physician Decision|0|||
130567165|NCT02263079|470043450|FG000|Overall Study|Withdrawal by Subject|2|||
130567166|NCT02263079|470043451|FG001|Overall Study|Withdrawal by Subject|8|||
130567167|NCT02263079|470043452|FG002|Overall Study|Withdrawal by Subject|0|||
130567168|NCT03557281|470043453|FG000|Overall Study|Investigator discretion|0|||
130567169|NCT03557281|470043454|FG001|Overall Study|Investigator discretion|0|||
130567170|NCT03557281|470043455|FG002|Overall Study|Investigator discretion|1|||
130567171|NCT03557281|470043456|FG003|Overall Study|Investigator discretion|0|||
130567172|NCT03557281|470043457|FG004|Overall Study|Investigator discretion|0|||
130567173|NCT03557281|470043453|FG000|Overall Study|Withdrawal by Subject|0|||
130567174|NCT03557281|470043454|FG001|Overall Study|Withdrawal by Subject|1|||
130567175|NCT03557281|470043455|FG002|Overall Study|Withdrawal by Subject|1|||
130567176|NCT03557281|470043456|FG003|Overall Study|Withdrawal by Subject|1|||
130567177|NCT03557281|470043457|FG004|Overall Study|Withdrawal by Subject|2|||
130567178|NCT03557281|470043453|FG000|Overall Study|Randomized, but did not receive treatment|0|||
130567179|NCT03557281|470043454|FG001|Overall Study|Randomized, but did not receive treatment|0|||
130567180|NCT03557281|470043455|FG002|Overall Study|Randomized, but did not receive treatment|0|||
130567181|NCT03557281|470043456|FG003|Overall Study|Randomized, but did not receive treatment|0|||
130567182|NCT03557281|470043457|FG004|Overall Study|Randomized, but did not receive treatment|1|||
130567183|NCT00402649|470043458|FG000|Overall Study|Lost to Follow-up|1|||
130508328|NCT00321555|469825982|FG000|Overall Study|Developed antibodies|1|||
130508329|NCT00321555|469825982|FG000|Overall Study|Switched to alternative treatment|3|||
130508330|NCT00321555|469825982|FG000|Overall Study|Physician Decision|1|||
130508331|NCT00321555|469825982|FG000|Overall Study|Disease progression on study|1|||
130508332|NCT00537914|469825983|FG000|Overall Study|Death|1|||
130508333|NCT00537914|469825983|FG000|Overall Study|Adverse Event|7|||
130508334|NCT00537914|469825983|FG000|Overall Study|Treatment failure|10|||
130508335|NCT00537914|469825983|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
130508336|NCT00537914|469825983|FG000|Overall Study|Lost to Follow-up|19|||
130508337|NCT00537914|469825983|FG000|Overall Study|Withdrawal of informed consent|59|||
130508338|NCT02312258|469825984|FG000|Overall Study|Lost to Follow-up|8|||
130508339|NCT02312258|469825985|FG001|Overall Study|Lost to Follow-up|8|||
130508340|NCT02312258|469825984|FG000|Overall Study|Withdrawal by Patient|49|||
130508341|NCT02312258|469825985|FG001|Overall Study|Withdrawal by Patient|76|||
130508342|NCT02312258|469825984|FG000|Overall Study|Reason not Specified|107|||
130508343|NCT02312258|469825985|FG001|Overall Study|Reason not Specified|159|||
130508344|NCT02312258|469825984|FG000|Overall Study|Missing|2|||
130508345|NCT02312258|469825985|FG001|Overall Study|Missing|1|||
130508346|NCT02312258|469825984|FG000|Overall Study|Death|115|||
130508347|NCT02312258|469825985|FG001|Overall Study|Death|181|||
130508348|NCT01468597|469825987|FG000|Overall Study|Found ineligible|17|||
130508349|NCT01468597|469825987|FG000|Overall Study|concomitant valves|12|||
130508350|NCT01468597|469825987|FG000|Overall Study|off-pump CABG|1|||
130508351|NCT01468597|469825987|FG000|Overall Study|no platelet function data|5|||
130508352|NCT02892019|469825993|FG000|Overall Study|randomized but not treated|0|||
130508353|NCT02892019|469825994|FG001|Overall Study|randomized but not treated|1|||
130508354|NCT02892019|469825993|FG000|Overall Study|Withdrawal by Subject|0|||
130508355|NCT02892019|469825994|FG001|Overall Study|Withdrawal by Subject|1|||
130508356|NCT02892019|469825993|FG000|Overall Study|Adverse Event|1|||
130508357|NCT02892019|469825994|FG001|Overall Study|Adverse Event|1|||
130508358|NCT01313663|469825995|FG000|Overall Study|Study Closed/Terminated|2|||
130508359|NCT01313663|469825996|FG001|Overall Study|Study Closed/Terminated|4|||
130508360|NCT01313663|469825995|FG000|Overall Study|Lost to Follow-up|0|||
130508361|NCT01313663|469825996|FG001|Overall Study|Lost to Follow-up|1|||
130508362|NCT01313663|469825995|FG000|Overall Study|Physician Decision|0|||
130508363|NCT01313663|469825996|FG001|Overall Study|Physician Decision|2|||
130508364|NCT01313663|469825995|FG000|Overall Study|Withdrawal by Subject|2|||
130508365|NCT01313663|469825996|FG001|Overall Study|Withdrawal by Subject|1|||
130567184|NCT00402649|470043458|FG000|Overall Study|Withdrawal by Subject|1|||
130567185|NCT01199042|470043461|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
130567186|NCT01199042|470043461|FG000|At Home (3 Months)|Lost to Follow-up|1|||
130567187|NCT01999465|470043462|FG000|Overall Study|Lost to Follow-up|0|||
130508366|NCT01199302|469825997|FG000|Overall Study|Adverse Event|1|||
130508367|NCT01199302|469825998|FG001|Overall Study|Adverse Event|1|||
130508368|NCT01199302|469825999|FG002|Overall Study|Adverse Event|2|||
130508369|NCT01199302|469826000|FG003|Overall Study|Adverse Event|0|||
130508370|NCT01199302|469825997|FG000|Overall Study|Withdrawal by Subject|2|||
130508371|NCT01199302|469825998|FG001|Overall Study|Withdrawal by Subject|2|||
130508372|NCT01199302|469825999|FG002|Overall Study|Withdrawal by Subject|3|||
130508373|NCT01199302|469826000|FG003|Overall Study|Withdrawal by Subject|0|||
130508374|NCT01199302|469825997|FG000|Overall Study|Disease Progression|3|||
130508375|NCT01199302|469825998|FG001|Overall Study|Disease Progression|4|||
130508376|NCT01199302|469825999|FG002|Overall Study|Disease Progression|4|||
130508377|NCT01199302|469826000|FG003|Overall Study|Disease Progression|2|||
130508378|NCT01199302|469825997|FG000|Overall Study|Study Termination|13|||
130508379|NCT01199302|469825998|FG001|Overall Study|Study Termination|8|||
130508380|NCT01199302|469825999|FG002|Overall Study|Study Termination|11|||
130508381|NCT01199302|469826000|FG003|Overall Study|Study Termination|9|||
130508382|NCT01199302|469825997|FG000|Overall Study|Lost to Follow-up|0|||
130508383|NCT01199302|469825998|FG001|Overall Study|Lost to Follow-up|1|||
130508384|NCT01199302|469825999|FG002|Overall Study|Lost to Follow-up|0|||
130508385|NCT01199302|469826000|FG003|Overall Study|Lost to Follow-up|0|||
130508386|NCT01199302|469825997|FG000|Overall Study|Other|1|||
130508387|NCT01199302|469825998|FG001|Overall Study|Other|0|||
130508388|NCT01199302|469825999|FG002|Overall Study|Other|0|||
130508389|NCT01199302|469826000|FG003|Overall Study|Other|0|||
130508390|NCT01634165|469826003|FG000|Period 2|Adverse Event|0|||
130508391|NCT01634165|469826004|FG001|Period 2|Adverse Event|1|||
130508392|NCT01634165|469826005|FG002|Period 2|Adverse Event|0|||
130508393|NCT01634165|469826006|FG003|Period 2|Adverse Event|0|||
130508394|NCT03820024|469826007|FG000|Overall Study|Physician Decision|1|||
130508395|NCT03820024|469826008|FG001|Overall Study|Physician Decision|2|||
130508396|NCT04914897|469828221|FG000|Overall Study|Withdrawal by Subject|3|||
130508397|NCT04914897|469828222|FG001|Overall Study|Withdrawal by Subject|1|||
130508398|NCT04914897|469828223|FG002|Overall Study|Withdrawal by Subject|1|||
130508399|NCT04914897|469828224|FG003|Overall Study|Withdrawal by Subject|1|||
130508400|NCT04914897|469828221|FG000|Overall Study|Poor compliance to protocol|0|||
130508401|NCT04914897|469828222|FG001|Overall Study|Poor compliance to protocol|0|||
130508402|NCT04914897|469828223|FG002|Overall Study|Poor compliance to protocol|1|||
130508403|NCT04914897|469828224|FG003|Overall Study|Poor compliance to protocol|0|||
130508404|NCT04914897|469828221|FG000|Overall Study|Progressive disease|5|||
130508405|NCT04914897|469828222|FG001|Overall Study|Progressive disease|14|||
130508406|NCT04914897|469828223|FG002|Overall Study|Progressive disease|30|||
130508407|NCT04914897|469828224|FG003|Overall Study|Progressive disease|21|||
130508408|NCT04914897|469828221|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130508409|NCT04914897|469828222|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
130508410|NCT04914897|469828223|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
130508411|NCT04914897|469828224|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
130508412|NCT04914897|469828221|FG000|Overall Study|Other|1|||
130508413|NCT04914897|469828222|FG001|Overall Study|Other|0|||
130508414|NCT04914897|469828223|FG002|Overall Study|Other|0|||
130508415|NCT04914897|469828224|FG003|Overall Study|Other|1|||
130508416|NCT03020914|469828225|FG000|Overall Study|Surgery Cancelled|1|||
130508417|NCT03020914|469828226|FG001|Overall Study|Surgery Cancelled|0|||
130508418|NCT00409006|469828229|FG000|Overall Study|Death|15|||
130508419|NCT00409006|469828230|FG001|Overall Study|Death|6|||
130508420|NCT00409006|469828229|FG000|Overall Study|Lost to Follow-up|1|||
130508421|NCT00409006|469828230|FG001|Overall Study|Lost to Follow-up|2|||
130508422|NCT00409006|469828229|FG000|Overall Study|Withdrawal by Subject|3|||
130508423|NCT00409006|469828230|FG001|Overall Study|Withdrawal by Subject|2|||
130732627|NCT05097989|470641188|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732628|NCT05097989|470641189|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732629|NCT05097989|470641190|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732630|NCT05097989|470641191|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732631|NCT05097989|470641192|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
130732632|NCT05097989|470641193|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732633|NCT05097989|470641194|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732634|NCT05097989|470641195|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
130732635|NCT05097989|470641187|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
130732636|NCT05097989|470641188|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
130732637|NCT05097989|470641189|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
130732638|NCT05097989|470641190|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
130732639|NCT05097989|470641191|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
130732640|NCT05097989|470641192|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
130732641|NCT05097989|470641193|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
130508424|NCT00409006|469828229|FG000|Overall Study|Physician Decision|1|||
130508425|NCT00409006|469828230|FG001|Overall Study|Physician Decision|2|||
130508426|NCT00608959|469828231|FG000|Part 1|Did not meet eligibility criteria|1|||
130508427|NCT01005602|469828232|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
130508428|NCT01005602|469828233|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
130567188|NCT01999465|470043463|FG001|Overall Study|Lost to Follow-up|2|||
130508429|NCT01248715|469828234|FG000|Overall Study|Not influenza positive|501|||
130508430|NCT01248715|469828235|FG001|Overall Study|Not influenza positive|510|||
130508431|NCT03409276|469828244|FG000|Overall Study|Withdrawal by Subject|0|||
130508432|NCT03409276|469828245|FG001|Overall Study|Withdrawal by Subject|0|||
130508433|NCT03409276|469828246|FG002|Overall Study|Withdrawal by Subject|0|||
130508434|NCT03409276|469828247|FG003|Overall Study|Withdrawal by Subject|0|||
130508435|NCT03409276|469828248|FG004|Overall Study|Withdrawal by Subject|1|||
130508436|NCT03409276|469828244|FG000|Overall Study|Lost to Follow-up|0|||
130508437|NCT03409276|469828245|FG001|Overall Study|Lost to Follow-up|0|||
130508438|NCT03409276|469828246|FG002|Overall Study|Lost to Follow-up|0|||
130508439|NCT03409276|469828247|FG003|Overall Study|Lost to Follow-up|2|||
130508440|NCT03409276|469828248|FG004|Overall Study|Lost to Follow-up|2|||
130508441|NCT03605745|469828250|FG000|Overall Study|Study was terminated for business reasons|47|||
130508442|NCT03344458|469828254|FG000|Overall Study|Physician Decision|1|||
130508443|NCT03344458|469828254|FG000|Overall Study|Withdrawal by Subject|16|||
130508444|NCT03344458|469828254|FG000|Overall Study|Other reasons|10|||
130508445|NCT03344458|469828254|FG000|Overall Study|Lost to Follow-up|9|||
130508446|NCT03344458|469828254|FG000|Overall Study|Protocol Violation|3|||
130508447|NCT03884478|469828255|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
130508448|NCT03884478|469828256|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
130508449|NCT03884478|469828257|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
130508450|NCT03884478|469828255|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
130508451|NCT03884478|469828256|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
130732642|NCT05097989|470641194|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
130732643|NCT05097989|470641195|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
130732644|NCT05097989|470641187|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130732645|NCT05097989|470641188|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130732646|NCT05097989|470641189|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130732647|NCT05097989|470641190|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130508452|NCT03884478|469828257|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
130508453|NCT03884478|469828255|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
130508454|NCT03884478|469828256|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
130508455|NCT03884478|469828257|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
130508456|NCT03884478|469828255|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
130508457|NCT03884478|469828256|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
130508458|NCT03884478|469828257|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
130508459|NCT01807234|469828260|FG000|Overall Study|Lost to Follow-up|2|||
130508460|NCT01807234|469828261|FG001|Overall Study|Lost to Follow-up|5|||
130508461|NCT01807234|469828262|FG002|Overall Study|Lost to Follow-up|1|||
130508462|NCT01807234|469828263|FG003|Overall Study|Lost to Follow-up|1|||
130508463|NCT01807234|469828264|FG004|Overall Study|Lost to Follow-up|1|||
130508464|NCT01807234|469828265|FG005|Overall Study|Lost to Follow-up|2|||
130508465|NCT01807234|469828260|FG000|Overall Study|Withdrawal by Subject|3|||
130508466|NCT01807234|469828261|FG001|Overall Study|Withdrawal by Subject|1|||
130508467|NCT01807234|469828262|FG002|Overall Study|Withdrawal by Subject|1|||
130508468|NCT01807234|469828263|FG003|Overall Study|Withdrawal by Subject|1|||
130508469|NCT01807234|469828264|FG004|Overall Study|Withdrawal by Subject|2|||
130508470|NCT01807234|469828265|FG005|Overall Study|Withdrawal by Subject|1|||
130508471|NCT01807234|469828260|FG000|Overall Study|Lack of Efficacy|0|||
130508472|NCT01807234|469828261|FG001|Overall Study|Lack of Efficacy|0|||
130508473|NCT01807234|469828262|FG002|Overall Study|Lack of Efficacy|0|||
130508474|NCT01807234|469828263|FG003|Overall Study|Lack of Efficacy|0|||
130508475|NCT01807234|469828264|FG004|Overall Study|Lack of Efficacy|1|||
130508476|NCT01807234|469828265|FG005|Overall Study|Lack of Efficacy|1|||
130508477|NCT00538629|469828266|FG000|Overall Study|At subject's request|1|||
130508478|NCT00538629|469828266|FG000|Overall Study|Adverse Event|2|||
130508479|NCT00538629|469828266|FG000|Overall Study|Lack of Efficacy|12|||
130508480|NCT00538629|469828266|FG000|Overall Study|Lost to Follow-up|6|||
130508481|NCT00538629|469828266|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
130508482|NCT04454125|469828267|FG000|Overall Study|Lost to Follow-up|0|||
130508483|NCT04454125|469828268|FG001|Overall Study|Lost to Follow-up|1|||
130508484|NCT00555620|469828274|FG000|Overall Study|Death|0|||
130508485|NCT00555620|469828275|FG001|Overall Study|Death|1|||
130508486|NCT00555620|469828276|FG002|Overall Study|Death|0|||
130508487|NCT00555620|469828277|FG003|Overall Study|Death|0|||
130508488|NCT00555620|469828278|FG004|Overall Study|Death|0|||
130508489|NCT00555620|469828279|FG005|Overall Study|Death|1|||
130508490|NCT00555620|469828274|FG000|Overall Study|Study terminated by sponsor|0|||
130508491|NCT00555620|469828275|FG001|Overall Study|Study terminated by sponsor|0|||
130732648|NCT05097989|470641191|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130732649|NCT05097989|470641192|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
130508492|NCT00555620|469828276|FG002|Overall Study|Study terminated by sponsor|1|||
130508493|NCT00555620|469828277|FG003|Overall Study|Study terminated by sponsor|0|||
130508494|NCT00555620|469828278|FG004|Overall Study|Study terminated by sponsor|0|||
130508495|NCT00555620|469828279|FG005|Overall Study|Study terminated by sponsor|0|||
130508496|NCT00555620|469828274|FG000|Overall Study|Adverse Event|0|||
130732650|NCT05097989|470641193|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
130732651|NCT05097989|470641194|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
130732652|NCT05097989|470641195|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
130732653|NCT05097989|470641187|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732654|NCT05097989|470641188|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732655|NCT05097989|470641189|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
130732656|NCT05097989|470641190|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732657|NCT05097989|470641191|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732658|NCT05097989|470641192|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
130732659|NCT05097989|470641193|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732660|NCT05097989|470641194|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
130732661|NCT05097989|470641195|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
130732662|NCT05097989|470641187|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732663|NCT05097989|470641188|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732664|NCT05097989|470641189|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
130508497|NCT00555620|469828275|FG001|Overall Study|Adverse Event|0|||
130508498|NCT00555620|469828276|FG002|Overall Study|Adverse Event|1|||
130508499|NCT00555620|469828277|FG003|Overall Study|Adverse Event|5|||
130508500|NCT00555620|469828278|FG004|Overall Study|Adverse Event|0|||
130508501|NCT00555620|469828279|FG005|Overall Study|Adverse Event|1|||
130508502|NCT00555620|469828274|FG000|Overall Study|Objective progression or relapse|6|||
130508503|NCT00555620|469828275|FG001|Overall Study|Objective progression or relapse|5|||
130508504|NCT00555620|469828276|FG002|Overall Study|Objective progression or relapse|12|||
130508505|NCT00555620|469828277|FG003|Overall Study|Objective progression or relapse|17|||
130508506|NCT00555620|469828278|FG004|Overall Study|Objective progression or relapse|3|||
130508507|NCT00555620|469828279|FG005|Overall Study|Objective progression or relapse|16|||
130508508|NCT00555620|469828274|FG000|Overall Study|Participant refused treatment|0|||
130508509|NCT00555620|469828275|FG001|Overall Study|Participant refused treatment|1|||
130508510|NCT00555620|469828276|FG002|Overall Study|Participant refused treatment|1|||
130508511|NCT00555620|469828277|FG003|Overall Study|Participant refused treatment|0|||
130508512|NCT00555620|469828278|FG004|Overall Study|Participant refused treatment|0|||
130508513|NCT00555620|469828279|FG005|Overall Study|Participant refused treatment|1|||
130508514|NCT00555620|469828274|FG000|Overall Study|Other|0|||
130508515|NCT00555620|469828275|FG001|Overall Study|Other|0|||
130508516|NCT00555620|469828276|FG002|Overall Study|Other|0|||
130508517|NCT00555620|469828277|FG003|Overall Study|Other|1|||
130508518|NCT00555620|469828278|FG004|Overall Study|Other|0|||
130508519|NCT00555620|469828279|FG005|Overall Study|Other|3|||
130508520|NCT00828139|469828280|FG000|Overall Study|Adverse Event|8|||
130508521|NCT00828139|469828281|FG001|Overall Study|Adverse Event|1|||
130508522|NCT00828139|469828282|FG002|Overall Study|Adverse Event|10|||
130508523|NCT00828139|469828283|FG003|Overall Study|Adverse Event|5|||
130508524|NCT00828139|469828280|FG000|Overall Study|Death|2|||
130508525|NCT00828139|469828281|FG001|Overall Study|Death|1|||
130508526|NCT00828139|469828282|FG002|Overall Study|Death|0|||
130508527|NCT00828139|469828283|FG003|Overall Study|Death|2|||
130508528|NCT00828139|469828280|FG000|Overall Study|Refusal unrelated to toxicity|3|||
130508529|NCT00828139|469828281|FG001|Overall Study|Refusal unrelated to toxicity|4|||
130508530|NCT00828139|469828282|FG002|Overall Study|Refusal unrelated to toxicity|5|||
130508531|NCT00828139|469828283|FG003|Overall Study|Refusal unrelated to toxicity|3|||
130508532|NCT00828139|469828280|FG000|Overall Study|Disease Progression|24|||
130508533|NCT00828139|469828281|FG001|Overall Study|Disease Progression|33|||
130508534|NCT00828139|469828282|FG002|Overall Study|Disease Progression|35|||
130508535|NCT00828139|469828283|FG003|Overall Study|Disease Progression|39|||
130508536|NCT00828139|469828280|FG000|Overall Study|Other|4|||
130508537|NCT00828139|469828281|FG001|Overall Study|Other|2|||
130508538|NCT00828139|469828282|FG002|Overall Study|Other|5|||
130508539|NCT00828139|469828283|FG003|Overall Study|Other|2|||
130508540|NCT01714947|469828284|FG000|Part B|Progressive Disease|3|||
130508541|NCT01922102|469828285|FG000|Overall Study|Withdrawal by Subject|7|||
130508542|NCT01922102|469828286|FG001|Overall Study|Withdrawal by Subject|3|||
130732665|NCT05097989|470641190|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732666|NCT05097989|470641191|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130508543|NCT01922102|469828287|FG002|Overall Study|Withdrawal by Subject|7|||
130508544|NCT01922102|469828285|FG000|Overall Study|Physician Decision|0|||
130508545|NCT01922102|469828286|FG001|Overall Study|Physician Decision|2|||
130508546|NCT01922102|469828287|FG002|Overall Study|Physician Decision|1|||
130508547|NCT01922102|469828285|FG000|Overall Study|Adverse Event|1|||
130508548|NCT01922102|469828286|FG001|Overall Study|Adverse Event|2|||
130508549|NCT01922102|469828287|FG002|Overall Study|Adverse Event|0|||
130508550|NCT01922102|469828285|FG000|Overall Study|Lost to Follow-up|1|||
130508551|NCT01922102|469828286|FG001|Overall Study|Lost to Follow-up|0|||
130508552|NCT01922102|469828287|FG002|Overall Study|Lost to Follow-up|0|||
130508553|NCT01922102|469828285|FG000|Overall Study|Administrative problems|0|||
130508554|NCT01922102|469828286|FG001|Overall Study|Administrative problems|2|||
130508555|NCT01922102|469828287|FG002|Overall Study|Administrative problems|0|||
130508556|NCT05203822|469828288|FG000|Overall Study|Adverse Event|1|||
130508557|NCT05203822|469828288|FG000|Overall Study|Withdrawal by Subject|1|||
130508558|NCT03696342|469828289|FG000|Overall Study|Lost to Follow-up|1|||
130508559|NCT03696342|469828290|FG001|Overall Study|Lost to Follow-up|0|||
130508560|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
130508561|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
130508562|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
130508563|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
130508564|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
130508565|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
130508566|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
130508567|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130508568|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
130508569|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
130508570|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
130508571|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
130508572|NCT01345253|469828291|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
130508573|NCT01345253|469828292|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
130508574|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
130508575|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
130508576|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
130508577|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
130508578|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
130508579|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
130508580|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
130508581|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
130508582|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
130508583|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
130508584|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
130508585|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
130508586|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
130508587|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
130508588|NCT01345253|469828291|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
130508589|NCT01345253|469828292|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
130508590|NCT01877720|469828298|FG000|Overall Study|Adverse Event|1|||
130508591|NCT01877720|469828299|FG001|Overall Study|Adverse Event|0|||
130508592|NCT00447499|469828300|FG000|Overall Study|Adverse Event|1|||
130508593|NCT00447499|469828300|FG000|Overall Study|Patient Decision|4|||
130508594|NCT00447499|469828300|FG000|Overall Study|Sponsor Decision|1|||
130508595|NCT00447499|469828300|FG000|Overall Study|Physician Decision|1|||
130508596|NCT02068352|469828301|FG000|Overall Study|Lost to Follow-up|0|||
130508597|NCT02068352|469828302|FG001|Overall Study|Lost to Follow-up|2|||
130508598|NCT02068352|469828303|FG002|Overall Study|Lost to Follow-up|0|||
130508599|NCT02068352|469828301|FG000|Overall Study|Adverse Event|4|||
130508600|NCT02068352|469828302|FG001|Overall Study|Adverse Event|2|||
130508601|NCT02068352|469828303|FG002|Overall Study|Adverse Event|7|||
130508602|NCT02068352|469828301|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
130508603|NCT02068352|469828302|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
130508604|NCT02068352|469828303|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
130508605|NCT02068352|469828301|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
130508606|NCT02068352|469828302|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
130508607|NCT02068352|469828303|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
130508608|NCT02068352|469828301|FG000|Overall Study|Protocol Deviation|0|||
130508609|NCT02068352|469828302|FG001|Overall Study|Protocol Deviation|0|||
130508610|NCT02068352|469828303|FG002|Overall Study|Protocol Deviation|1|||
130508611|NCT01322347|469828304|FG000|Overall Study|Adverse Event|7|||
130508612|NCT01322347|469828305|FG001|Overall Study|Adverse Event|2|||
130508613|NCT01322347|469828304|FG000|Overall Study|Death|5|||
130508614|NCT01322347|469828305|FG001|Overall Study|Death|3|||
130508615|NCT01322347|469828304|FG000|Overall Study|Physician Decision|2|||
130567189|NCT01999465|470043462|FG000|Overall Study|Protocol Violation|0|||
130567190|NCT01999465|470043463|FG001|Overall Study|Protocol Violation|1|||
130567191|NCT02554019|470043469|FG000|Overall Study|Withdrawal by Subject|1|||
130567192|NCT02554019|470043470|FG001|Overall Study|Withdrawal by Subject|0|||
130567193|NCT02554019|470043471|FG002|Overall Study|Withdrawal by Subject|2|||
130567194|NCT02554019|470043469|FG000|Overall Study|Adverse Event|1|||
130567195|NCT02554019|470043470|FG001|Overall Study|Adverse Event|0|||
130567196|NCT02554019|470043471|FG002|Overall Study|Adverse Event|0|||
130567197|NCT02463409|470043472|FG000|Overall Study|Withdrawal by Subject|1|||
130567198|NCT02463409|470043472|FG000|Overall Study|Screen failure|1|||
130567199|NCT01308008|470043473|FG000|4 Weeks|Illness, disinterest, time|9|||
130567200|NCT01308008|470043474|FG001|4 Weeks|Illness, disinterest, time|2|||
130567201|NCT03357731|470043475|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
130567202|NCT03357731|470043476|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
130567203|NCT03357731|470043477|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
130567204|NCT03357731|470043478|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
130567205|NCT03357731|470043479|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
130567206|NCT03357731|470043480|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
130567207|NCT03357731|470043475|FG000|Overall Study|Acute bradycardia and hypotension|0|||
130567208|NCT03357731|470043476|FG001|Overall Study|Acute bradycardia and hypotension|0|||
130567209|NCT03357731|470043477|FG002|Overall Study|Acute bradycardia and hypotension|0|||
130567210|NCT03357731|470043478|FG003|Overall Study|Acute bradycardia and hypotension|1|||
130567211|NCT03357731|470043479|FG004|Overall Study|Acute bradycardia and hypotension|0|||
130567212|NCT03357731|470043480|FG005|Overall Study|Acute bradycardia and hypotension|0|||
130567213|NCT03357731|470043475|FG000|Overall Study|Adverse Event|0|||
130567214|NCT03357731|470043476|FG001|Overall Study|Adverse Event|0|||
130567215|NCT03357731|470043477|FG002|Overall Study|Adverse Event|0|||
130567216|NCT03357731|470043478|FG003|Overall Study|Adverse Event|0|||
130567217|NCT03357731|470043479|FG004|Overall Study|Adverse Event|0|||
130567218|NCT03357731|470043480|FG005|Overall Study|Adverse Event|1|||
130567219|NCT03357731|470043475|FG000|Overall Study|Hypotension|0|||
130567220|NCT03357731|470043476|FG001|Overall Study|Hypotension|0|||
130567221|NCT03357731|470043477|FG002|Overall Study|Hypotension|1|||
130567222|NCT03357731|470043478|FG003|Overall Study|Hypotension|1|||
130567223|NCT03357731|470043479|FG004|Overall Study|Hypotension|0|||
130567224|NCT03357731|470043480|FG005|Overall Study|Hypotension|0|||
130567225|NCT03357731|470043475|FG000|Overall Study|Lost to Follow-up|0|||
130567226|NCT03357731|470043476|FG001|Overall Study|Lost to Follow-up|0|||
130567227|NCT03357731|470043477|FG002|Overall Study|Lost to Follow-up|0|||
130567228|NCT03357731|470043478|FG003|Overall Study|Lost to Follow-up|1|||
130567229|NCT03357731|470043479|FG004|Overall Study|Lost to Follow-up|0|||
130567230|NCT03357731|470043480|FG005|Overall Study|Lost to Follow-up|0|||
130567231|NCT01417195|470043481|FG000|Overall Study|Stimulation failure|1|||
130567232|NCT01417195|470043482|FG001|Overall Study|Stimulation failure|0|||
130567233|NCT01417195|470043481|FG000|Overall Study|No embryos for transfer|0|||
130567234|NCT01417195|470043482|FG001|Overall Study|No embryos for transfer|1|||
130567235|NCT01417195|470043481|FG000|Overall Study|No transfer due to risk of OHSS|1|||
130567236|NCT01417195|470043482|FG001|Overall Study|No transfer due to risk of OHSS|0|||
130567237|NCT01417195|470043481|FG000|Overall Study|No transfer due to elevated progesterone|1|||
130567238|NCT01417195|470043482|FG001|Overall Study|No transfer due to elevated progesterone|0|||
130567239|NCT00772954|470043483|FG000|Overall Study|Adverse Event|0|||
130567240|NCT00772954|470043484|FG001|Overall Study|Adverse Event|0|||
130567241|NCT00772954|470043485|FG002|Overall Study|Adverse Event|1|||
130567242|NCT04640272|470043488|FG000|Overall Study|Subject moved out of area|1|||
130567243|NCT02819635|470043492|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
130567244|NCT02819635|470043493|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
130567245|NCT02819635|470043494|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
130567246|NCT02819635|470043495|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
130567247|NCT02819635|470043496|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
130567248|NCT02819635|470043497|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
130567249|NCT02819635|470043498|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
130567250|NCT02819635|470043499|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130567251|NCT02819635|470043500|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130567252|NCT02819635|470043501|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130567253|NCT02819635|470043502|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130567254|NCT02819635|470043503|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130567255|NCT02819635|470043492|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567256|NCT02819635|470043493|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567257|NCT02819635|470043494|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567258|NCT02819635|470043495|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130508616|NCT01322347|469828305|FG001|Overall Study|Physician Decision|1|||
130508617|NCT01322347|469828304|FG000|Overall Study|Protocol Violation|5|||
130508618|NCT01322347|469828305|FG001|Overall Study|Protocol Violation|2|||
130508619|NCT01322347|469828304|FG000|Overall Study|Withdrawal by Subject|1|||
130508620|NCT01322347|469828305|FG001|Overall Study|Withdrawal by Subject|4|||
130508621|NCT01322347|469828304|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
130508622|NCT01322347|469828305|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
130508623|NCT01322347|469828304|FG000|Overall Study|blood transfusion|5|||
130508624|NCT01322347|469828305|FG001|Overall Study|blood transfusion|5|||
130508625|NCT01322347|469828304|FG000|Overall Study|sponsor decision|1|||
130508626|NCT01322347|469828305|FG001|Overall Study|sponsor decision|3|||
130508627|NCT01322347|469828304|FG000|Overall Study|ineligible|6|||
130508628|NCT01322347|469828305|FG001|Overall Study|ineligible|3|||
130508629|NCT01322347|469828304|FG000|Overall Study|kidney transplant|3|||
130508630|NCT01322347|469828305|FG001|Overall Study|kidney transplant|1|||
130508631|NCT01322347|469828304|FG000|Overall Study|study drug withheld > 12 wks|0|||
130508632|NCT01322347|469828305|FG001|Overall Study|study drug withheld > 12 wks|1|||
130508633|NCT01322347|469828304|FG000|Overall Study|moved/changed dialysis|2|||
130508634|NCT01322347|469828305|FG001|Overall Study|moved/changed dialysis|4|||
130508635|NCT01369147|469828307|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
130508636|NCT01369147|469828308|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
130508637|NCT01369147|469828309|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
130508638|NCT00648895|469828315|FG000|Overall Study|Lack of Efficacy|0|||
130508639|NCT00648895|469828316|FG001|Overall Study|Lack of Efficacy|1|||
130508640|NCT02865083|469828317|FG000|Overall Study|Early Termination|3|||
130508641|NCT02865083|469828318|FG001|Overall Study|Early Termination|1|||
130508642|NCT04626128|469828319|FG000|Overall Study|Withdrawal by Subject|0|||
130508643|NCT04626128|469828320|FG001|Overall Study|Withdrawal by Subject|1|||
130508644|NCT04626128|469828321|FG002|Overall Study|Withdrawal by Subject|0|||
130508645|NCT04626128|469828322|FG003|Overall Study|Withdrawal by Subject|0|||
130508646|NCT01182285|469828323|FG000|First Intervention Week 1-10|Disease progression|1|||
130508647|NCT01182285|469828324|FG001|First Intervention Week 1-10|Disease progression|0|||
130508648|NCT01182285|469828325|FG002|First Intervention Week 1-10|Disease progression|0|||
130508649|NCT01182285|469828323|FG000|First Intervention Week 1-10|Adverse Event|1|||
130508650|NCT01182285|469828324|FG001|First Intervention Week 1-10|Adverse Event|0|||
130508651|NCT01182285|469828325|FG002|First Intervention Week 1-10|Adverse Event|0|||
130508652|NCT01182285|469828323|FG000|First Intervention Week 1-10|Non-compliance|1|||
130508653|NCT01182285|469828324|FG001|First Intervention Week 1-10|Non-compliance|0|||
130508654|NCT01182285|469828325|FG002|First Intervention Week 1-10|Non-compliance|0|||
130508655|NCT01182285|469828323|FG000|Third Intervention Week 11-52|Disease Progression|0|||
130508656|NCT01182285|469828324|FG001|Third Intervention Week 11-52|Disease Progression|0|||
130508657|NCT01182285|469828325|FG002|Third Intervention Week 11-52|Disease Progression|6|||
130508658|NCT01182285|469828323|FG000|Third Intervention Week 11-52|Other|0|||
130508659|NCT01182285|469828324|FG001|Third Intervention Week 11-52|Other|0|||
130508660|NCT01182285|469828325|FG002|Third Intervention Week 11-52|Other|2|||
130732667|NCT05097989|470641192|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732668|NCT05097989|470641193|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732669|NCT05097989|470641194|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732670|NCT05097989|470641195|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
130732671|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732672|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
130732673|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732674|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732675|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732676|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732677|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732678|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732679|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
130732680|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732681|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732682|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732683|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732684|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130732685|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732686|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732687|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732688|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130732689|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732690|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732691|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732692|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130508661|NCT00841321|469828326|FG000|Overall Study|Lost to Follow-up|1|||
130508662|NCT00841321|469828327|FG001|Overall Study|Lost to Follow-up|1|||
130508663|NCT00841321|469828326|FG000|Overall Study|Adverse Event|0|||
130508664|NCT00841321|469828327|FG001|Overall Study|Adverse Event|2|||
130508665|NCT00379210|469828330|FG000|Overall Study|Withdrawal by Subject|10|||
130508666|NCT00379210|469828331|FG001|Overall Study|Withdrawal by Subject|7|||
130508667|NCT01358175|469828332|FG000|Overall Study|Death|1|||
130508668|NCT01358175|469828333|FG001|Overall Study|Death|0|||
130508669|NCT01358175|469828334|FG002|Overall Study|Death|1|||
130508670|NCT01358175|469828332|FG000|Overall Study|Withdrawal by Subject|9|||
130508671|NCT01358175|469828333|FG001|Overall Study|Withdrawal by Subject|5|||
130508672|NCT01358175|469828334|FG002|Overall Study|Withdrawal by Subject|10|||
130508673|NCT01358175|469828332|FG000|Overall Study|Technical issues|0|||
130508674|NCT01358175|469828333|FG001|Overall Study|Technical issues|1|||
130508675|NCT01358175|469828334|FG002|Overall Study|Technical issues|0|||
130508676|NCT01358175|469828332|FG000|Overall Study|Pregnancy|0|||
130508677|NCT01358175|469828333|FG001|Overall Study|Pregnancy|1|||
130508678|NCT01358175|469828334|FG002|Overall Study|Pregnancy|0|||
130508679|NCT01358175|469828332|FG000|Overall Study|Physician Decision|1|||
130508680|NCT01358175|469828333|FG001|Overall Study|Physician Decision|0|||
130508681|NCT01358175|469828334|FG002|Overall Study|Physician Decision|0|||
130508682|NCT01358175|469828332|FG000|Overall Study|Non Compliance with Study Treatment|0|||
130508683|NCT01358175|469828333|FG001|Overall Study|Non Compliance with Study Treatment|1|||
130508684|NCT01358175|469828334|FG002|Overall Study|Non Compliance with Study Treatment|1|||
130508685|NCT01358175|469828332|FG000|Overall Study|Lost to Follow-up|1|||
130508686|NCT01358175|469828333|FG001|Overall Study|Lost to Follow-up|1|||
130508687|NCT01358175|469828334|FG002|Overall Study|Lost to Follow-up|3|||
130508688|NCT01358175|469828332|FG000|Overall Study|Lack of Efficacy|3|||
130508689|NCT01358175|469828333|FG001|Overall Study|Lack of Efficacy|8|||
130508690|NCT01358175|469828334|FG002|Overall Study|Lack of Efficacy|6|||
130508691|NCT01358175|469828332|FG000|Overall Study|Adverse Event|6|||
130508692|NCT01358175|469828333|FG001|Overall Study|Adverse Event|11|||
130508693|NCT01358175|469828334|FG002|Overall Study|Adverse Event|11|||
130508694|NCT01525875|469828335|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
130508695|NCT01525875|469828336|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
130508696|NCT01525875|469828335|FG000|Open-label Period|Lost to Follow-up|0|||
130508697|NCT01525875|469828336|FG001|Open-label Period|Lost to Follow-up|2|||
130508698|NCT00821093|469828337|FG000|Overall Study|Adverse Event|20|||
130508699|NCT00821093|469828338|FG001|Overall Study|Adverse Event|12|||
130508700|NCT00821093|469828337|FG000|Overall Study|Withdrawal by Subject|9|||
130508701|NCT00821093|469828338|FG001|Overall Study|Withdrawal by Subject|13|||
130508702|NCT00821093|469828337|FG000|Overall Study|Lost to Follow-up|9|||
130508703|NCT00821093|469828338|FG001|Overall Study|Lost to Follow-up|3|||
130508704|NCT00821093|469828337|FG000|Overall Study|Protocol deviation|3|||
130508705|NCT00821093|469828338|FG001|Overall Study|Protocol deviation|6|||
130508706|NCT00821093|469828337|FG000|Overall Study|Abnormal laboratory value(s)|2|||
130508707|NCT00821093|469828338|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130508708|NCT00821093|469828337|FG000|Overall Study|Lack of Efficacy|2|||
130508709|NCT00821093|469828338|FG001|Overall Study|Lack of Efficacy|2|||
130508710|NCT00821093|469828337|FG000|Overall Study|Death|2|||
130508711|NCT00821093|469828338|FG001|Overall Study|Death|1|||
130508712|NCT00821093|469828337|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130508713|NCT00821093|469828338|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130508714|NCT00821093|469828337|FG000|Overall Study|Administrative problems|1|||
130508715|NCT00821093|469828338|FG001|Overall Study|Administrative problems|2|||
130508716|NCT01107912|469828339|FG000|Period 1|Adverse Event|0|||
130508717|NCT01107912|469828340|FG001|Period 1|Adverse Event|0|||
130508718|NCT01107912|469828341|FG002|Period 1|Adverse Event|0|||
130508719|NCT01107912|469828342|FG003|Period 1|Adverse Event|0|||
130508720|NCT01107912|469828343|FG004|Period 1|Adverse Event|2|||
130508721|NCT01107912|469828344|FG005|Period 1|Adverse Event|0|||
130508722|NCT01107912|469828339|FG000|Period 1|Physician Decision|0|||
130508723|NCT01107912|469828340|FG001|Period 1|Physician Decision|0|||
130508724|NCT01107912|469828341|FG002|Period 1|Physician Decision|0|||
130508725|NCT01107912|469828342|FG003|Period 1|Physician Decision|0|||
130508726|NCT01107912|469828343|FG004|Period 1|Physician Decision|1|||
130508727|NCT01107912|469828344|FG005|Period 1|Physician Decision|0|||
130732693|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
130508728|NCT01107912|469828339|FG000|Period 1|Withdrawal by Subject|1|||
130508729|NCT01107912|469828340|FG001|Period 1|Withdrawal by Subject|0|||
130508730|NCT01107912|469828341|FG002|Period 1|Withdrawal by Subject|0|||
130508731|NCT01107912|469828342|FG003|Period 1|Withdrawal by Subject|0|||
130508732|NCT01107912|469828343|FG004|Period 1|Withdrawal by Subject|0|||
130508733|NCT01107912|469828344|FG005|Period 1|Withdrawal by Subject|0|||
130508734|NCT01107912|469828339|FG000|Period 2|Physician Decision|0|||
130508735|NCT01107912|469828340|FG001|Period 2|Physician Decision|0|||
130508736|NCT01107912|469828341|FG002|Period 2|Physician Decision|1|||
130508737|NCT01107912|469828342|FG003|Period 2|Physician Decision|0|||
130508738|NCT01107912|469828343|FG004|Period 2|Physician Decision|0|||
130567259|NCT02819635|470043496|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
130567260|NCT02819635|470043497|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
130567261|NCT02819635|470043498|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
130732694|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130508739|NCT01107912|469828344|FG005|Period 2|Physician Decision|0|||
130508740|NCT01107912|469828339|FG000|Period 3|Adverse Event|0|||
130508741|NCT01107912|469828340|FG001|Period 3|Adverse Event|1|||
130508742|NCT01107912|469828341|FG002|Period 3|Adverse Event|1|||
130508743|NCT01107912|469828342|FG003|Period 3|Adverse Event|0|||
130508744|NCT01107912|469828343|FG004|Period 3|Adverse Event|0|||
130508745|NCT01107912|469828344|FG005|Period 3|Adverse Event|0|||
130508746|NCT01107912|469828339|FG000|Period 3|Withdrawal by Subject|0|||
130508747|NCT01107912|469828340|FG001|Period 3|Withdrawal by Subject|0|||
130508748|NCT01107912|469828341|FG002|Period 3|Withdrawal by Subject|0|||
130508749|NCT01107912|469828342|FG003|Period 3|Withdrawal by Subject|1|||
130508750|NCT01107912|469828343|FG004|Period 3|Withdrawal by Subject|0|||
130508751|NCT01107912|469828344|FG005|Period 3|Withdrawal by Subject|0|||
130508752|NCT02924051|469828349|FG000|Overall Study|Withdrawal by Subject|1|||
130508753|NCT02924051|469828350|FG001|Overall Study|Withdrawal by Subject|9|||
130508754|NCT02260154|469828351|FG000|Overall Study|Screening failure|2|||
130508755|NCT02561195|469828353|FG000|Vaccination 1 to 3|Adverse Event|4|||
130508756|NCT02561195|469828354|FG001|Vaccination 1 to 3|Adverse Event|5|||
130508757|NCT02561195|469828355|FG002|Vaccination 1 to 3|Adverse Event|0|||
130508758|NCT02561195|469828356|FG003|Vaccination 1 to 3|Adverse Event|3|||
130508759|NCT02561195|469828357|FG004|Vaccination 1 to 3|Adverse Event|4|||
130508760|NCT02561195|469828358|FG005|Vaccination 1 to 3|Adverse Event|0|||
130508761|NCT02561195|469828359|FG006|Vaccination 1 to 3|Adverse Event|0|||
130508762|NCT02561195|469828360|FG007|Vaccination 1 to 3|Adverse Event|0|||
130508763|NCT02561195|469828361|FG008|Vaccination 1 to 3|Adverse Event|0|||
130508764|NCT02561195|469828362|FG009|Vaccination 1 to 3|Adverse Event|0|||
130508765|NCT02561195|469828363|FG010|Vaccination 1 to 3|Adverse Event|0|||
130508766|NCT02561195|469828364|FG011|Vaccination 1 to 3|Adverse Event|0|||
130508767|NCT02561195|469828365|FG012|Vaccination 1 to 3|Adverse Event|0|||
130508768|NCT02561195|469828366|FG013|Vaccination 1 to 3|Adverse Event|0|||
130508769|NCT02561195|469828353|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
130508770|NCT02561195|469828354|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
130508771|NCT02561195|469828355|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
130508772|NCT02561195|469828356|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
130508773|NCT02561195|469828357|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
130508774|NCT02561195|469828358|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
130508775|NCT02561195|469828359|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
130508776|NCT02561195|469828360|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
130508777|NCT02561195|469828361|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
130508778|NCT02561195|469828362|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
130508779|NCT02561195|469828363|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
130508780|NCT02561195|469828364|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
130508781|NCT02561195|469828365|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
130508782|NCT02561195|469828366|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
130508783|NCT02561195|469828353|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508784|NCT02561195|469828354|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
130508785|NCT02561195|469828355|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508786|NCT02561195|469828356|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
130508787|NCT02561195|469828357|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
130508788|NCT02561195|469828358|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
130508789|NCT02561195|469828359|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508790|NCT02561195|469828360|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508791|NCT02561195|469828361|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508792|NCT02561195|469828362|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508793|NCT02561195|469828363|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508794|NCT02561195|469828364|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508795|NCT02561195|469828365|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508796|NCT02561195|469828366|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130508797|NCT02561195|469828353|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
130508798|NCT02561195|469828354|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
130508799|NCT02561195|469828355|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
130508800|NCT02561195|469828356|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
130508801|NCT02561195|469828357|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
130508802|NCT02561195|469828358|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
130508803|NCT02561195|469828359|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
130508804|NCT02561195|469828360|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
130508805|NCT02561195|469828361|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
130508806|NCT02561195|469828362|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
130567262|NCT02819635|470043499|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130508807|NCT02561195|469828363|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
130508808|NCT02561195|469828364|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
130508809|NCT02561195|469828365|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
130508810|NCT02561195|469828366|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
130508811|NCT02561195|469828353|FG000|Vaccination 1 to 3|Other|7|||
130508812|NCT02561195|469828354|FG001|Vaccination 1 to 3|Other|3|||
130508813|NCT02561195|469828355|FG002|Vaccination 1 to 3|Other|1|||
130508814|NCT02561195|469828356|FG003|Vaccination 1 to 3|Other|7|||
130508815|NCT02561195|469828357|FG004|Vaccination 1 to 3|Other|5|||
130508816|NCT02561195|469828358|FG005|Vaccination 1 to 3|Other|1|||
130508817|NCT02561195|469828359|FG006|Vaccination 1 to 3|Other|0|||
130508818|NCT02561195|469828360|FG007|Vaccination 1 to 3|Other|0|||
130508819|NCT02561195|469828361|FG008|Vaccination 1 to 3|Other|0|||
130508820|NCT02561195|469828362|FG009|Vaccination 1 to 3|Other|0|||
130508821|NCT02561195|469828363|FG010|Vaccination 1 to 3|Other|0|||
130508822|NCT02561195|469828364|FG011|Vaccination 1 to 3|Other|0|||
130508823|NCT02561195|469828365|FG012|Vaccination 1 to 3|Other|0|||
130508824|NCT02561195|469828366|FG013|Vaccination 1 to 3|Other|0|||
130508825|NCT02561195|469828353|FG000|Vaccination 1 to 3|Protocol Violation|1|||
130508826|NCT02561195|469828354|FG001|Vaccination 1 to 3|Protocol Violation|0|||
130508827|NCT02561195|469828355|FG002|Vaccination 1 to 3|Protocol Violation|1|||
130508828|NCT02561195|469828356|FG003|Vaccination 1 to 3|Protocol Violation|2|||
130508829|NCT02561195|469828357|FG004|Vaccination 1 to 3|Protocol Violation|5|||
130508830|NCT02561195|469828358|FG005|Vaccination 1 to 3|Protocol Violation|2|||
130508831|NCT02561195|469828359|FG006|Vaccination 1 to 3|Protocol Violation|0|||
130508832|NCT02561195|469828360|FG007|Vaccination 1 to 3|Protocol Violation|0|||
130508833|NCT02561195|469828361|FG008|Vaccination 1 to 3|Protocol Violation|0|||
130508834|NCT02561195|469828362|FG009|Vaccination 1 to 3|Protocol Violation|0|||
130508835|NCT02561195|469828363|FG010|Vaccination 1 to 3|Protocol Violation|0|||
130508836|NCT02561195|469828364|FG011|Vaccination 1 to 3|Protocol Violation|0|||
130508837|NCT02561195|469828365|FG012|Vaccination 1 to 3|Protocol Violation|0|||
130508838|NCT02561195|469828366|FG013|Vaccination 1 to 3|Protocol Violation|0|||
130508839|NCT02561195|469828353|FG000|Vaccination 1 to 3|Death|2|||
130508840|NCT02561195|469828354|FG001|Vaccination 1 to 3|Death|1|||
130508841|NCT02561195|469828355|FG002|Vaccination 1 to 3|Death|0|||
130508842|NCT02561195|469828356|FG003|Vaccination 1 to 3|Death|2|||
130508843|NCT02561195|469828357|FG004|Vaccination 1 to 3|Death|0|||
130508844|NCT02561195|469828358|FG005|Vaccination 1 to 3|Death|0|||
130508845|NCT02561195|469828359|FG006|Vaccination 1 to 3|Death|0|||
130508846|NCT02561195|469828360|FG007|Vaccination 1 to 3|Death|0|||
130508847|NCT02561195|469828361|FG008|Vaccination 1 to 3|Death|0|||
130508848|NCT02561195|469828362|FG009|Vaccination 1 to 3|Death|0|||
130508849|NCT02561195|469828363|FG010|Vaccination 1 to 3|Death|0|||
130508850|NCT02561195|469828364|FG011|Vaccination 1 to 3|Death|0|||
130508851|NCT02561195|469828365|FG012|Vaccination 1 to 3|Death|0|||
130508852|NCT02561195|469828366|FG013|Vaccination 1 to 3|Death|0|||
130508853|NCT02561195|469828353|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
130508854|NCT02561195|469828354|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
130508855|NCT02561195|469828355|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
130508856|NCT02561195|469828356|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
130508857|NCT02561195|469828357|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
130508858|NCT02561195|469828358|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508859|NCT02561195|469828359|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508860|NCT02561195|469828360|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508861|NCT02561195|469828361|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508862|NCT02561195|469828362|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508863|NCT02561195|469828363|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508864|NCT02561195|469828364|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508865|NCT02561195|469828365|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508866|NCT02561195|469828366|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
130508867|NCT02561195|469828353|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
130508868|NCT02561195|469828354|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
130508869|NCT02561195|469828355|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
130508870|NCT02561195|469828356|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
130508871|NCT02561195|469828357|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
130508872|NCT02561195|469828358|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
130508873|NCT02561195|469828359|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
130508874|NCT02561195|469828360|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
130508875|NCT02561195|469828361|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
130508876|NCT02561195|469828362|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
130508877|NCT02561195|469828363|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
130508878|NCT02561195|469828364|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
130508879|NCT02561195|469828365|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
130508880|NCT02561195|469828366|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
130508881|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508882|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508883|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508884|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508885|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508886|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508887|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508888|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508889|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
130508890|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
130732695|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732696|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732697|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
130732698|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732699|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130732700|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732701|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130732702|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732703|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732704|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732705|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732706|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130732707|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
130732708|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
130732709|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
130732710|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
130732711|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
130732712|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
130732713|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
130732714|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
130732715|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
130732716|NCT05097989|470641187|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
130732717|NCT05097989|470641188|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
130732718|NCT05097989|470641189|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
130732719|NCT05097989|470641190|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
130732720|NCT05097989|470641191|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
130732721|NCT05097989|470641192|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
130732722|NCT05097989|470641193|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
130732723|NCT05097989|470641194|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
130732724|NCT05097989|470641195|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
130732725|NCT05097989|470641187|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732726|NCT05097989|470641188|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732727|NCT05097989|470641189|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732728|NCT05097989|470641190|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732729|NCT05097989|470641191|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
130732730|NCT05097989|470641192|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732731|NCT05097989|470641193|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732732|NCT05097989|470641194|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732733|NCT05097989|470641195|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
130732734|NCT05097989|470641187|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
130732735|NCT05097989|470641188|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
130732736|NCT05097989|470641189|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732737|NCT05097989|470641190|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732738|NCT05097989|470641191|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732739|NCT05097989|470641192|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732740|NCT05097989|470641193|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732741|NCT05097989|470641194|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732742|NCT05097989|470641195|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
130732743|NCT05097989|470641187|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
130732744|NCT05097989|470641188|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
130732745|NCT05097989|470641189|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
130732746|NCT05097989|470641190|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
130732747|NCT05097989|470641191|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
130732748|NCT05097989|470641192|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
130732749|NCT05097989|470641193|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
130732750|NCT05097989|470641194|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
130508891|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
130508892|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
130508893|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
130508894|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
130508895|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508896|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508897|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508898|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508899|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508900|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508901|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508902|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508903|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508904|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508905|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508906|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508907|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
130508908|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
130508909|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Death|0|||
130508910|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Death|0|||
130508911|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Death|0|||
130508912|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Death|0|||
130508913|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Death|0|||
130508914|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Death|0|||
130508915|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Death|0|||
130508916|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Death|0|||
130508917|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Death|0|||
130508918|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Death|1|||
130508919|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Death|0|||
130508920|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Death|0|||
130508921|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Death|0|||
130508922|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Death|0|||
130508923|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508924|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508925|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508926|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508927|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508928|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508929|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
130508930|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
130567263|NCT02819635|470043500|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567264|NCT02819635|470043501|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567265|NCT02819635|470043502|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567266|NCT02819635|470043503|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130567267|NCT02819635|470043492|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567268|NCT02819635|470043493|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567269|NCT02819635|470043494|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567270|NCT02819635|470043495|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567271|NCT02819635|470043496|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567272|NCT02819635|470043497|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
130567273|NCT02819635|470043498|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
130567274|NCT02819635|470043499|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567275|NCT02819635|470043500|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567276|NCT02819635|470043501|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567277|NCT02819635|470043502|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567278|NCT02819635|470043503|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130567279|NCT02819635|470043492|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567280|NCT02819635|470043493|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567281|NCT02819635|470043494|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567282|NCT02819635|470043495|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567283|NCT02819635|470043496|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567284|NCT02819635|470043497|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567285|NCT02819635|470043498|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
130567286|NCT02819635|470043499|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567287|NCT02819635|470043500|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567288|NCT02819635|470043501|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567289|NCT02819635|470043502|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567290|NCT02819635|470043503|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130567291|NCT02819635|470043492|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
130567292|NCT02819635|470043493|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
130567293|NCT02819635|470043494|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
130567294|NCT02819635|470043495|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
130567295|NCT02819635|470043496|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
130567296|NCT02819635|470043497|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
130567297|NCT02819635|470043498|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
130567298|NCT02819635|470043499|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130567299|NCT02819635|470043500|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130567300|NCT02819635|470043501|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130567301|NCT02819635|470043502|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130567302|NCT02819635|470043503|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130567303|NCT02819635|470043492|FG000|Substudy 2, Part 2|Adverse Event|0|||
130567304|NCT02819635|470043493|FG001|Substudy 2, Part 2|Adverse Event|0|||
130567305|NCT02819635|470043494|FG002|Substudy 2, Part 2|Adverse Event|0|||
130567306|NCT02819635|470043495|FG003|Substudy 2, Part 2|Adverse Event|0|||
130567307|NCT02819635|470043496|FG004|Substudy 2, Part 2|Adverse Event|0|||
130567308|NCT02819635|470043497|FG005|Substudy 2, Part 2|Adverse Event|4|||
130567309|NCT02819635|470043498|FG006|Substudy 2, Part 2|Adverse Event|0|||
130567310|NCT02819635|470043499|FG007|Substudy 2, Part 2|Adverse Event|0|||
130567311|NCT02819635|470043500|FG008|Substudy 2, Part 2|Adverse Event|0|||
130567312|NCT02819635|470043501|FG009|Substudy 2, Part 2|Adverse Event|0|||
130567313|NCT02819635|470043502|FG010|Substudy 2, Part 2|Adverse Event|0|||
130567314|NCT02819635|470043503|FG011|Substudy 2, Part 2|Adverse Event|0|||
130567315|NCT02819635|470043492|FG000|Substudy 2, Part 2|Withdrew consent|0|||
130567316|NCT02819635|470043493|FG001|Substudy 2, Part 2|Withdrew consent|0|||
130567317|NCT02819635|470043494|FG002|Substudy 2, Part 2|Withdrew consent|0|||
130567318|NCT02819635|470043495|FG003|Substudy 2, Part 2|Withdrew consent|0|||
130567319|NCT02819635|470043496|FG004|Substudy 2, Part 2|Withdrew consent|0|||
130567320|NCT02819635|470043497|FG005|Substudy 2, Part 2|Withdrew consent|3|||
130567321|NCT02819635|470043498|FG006|Substudy 2, Part 2|Withdrew consent|1|||
130567322|NCT02819635|470043499|FG007|Substudy 2, Part 2|Withdrew consent|0|||
130567323|NCT02819635|470043500|FG008|Substudy 2, Part 2|Withdrew consent|0|||
130567324|NCT02819635|470043501|FG009|Substudy 2, Part 2|Withdrew consent|0|||
130567325|NCT02819635|470043502|FG010|Substudy 2, Part 2|Withdrew consent|0|||
130567326|NCT02819635|470043503|FG011|Substudy 2, Part 2|Withdrew consent|0|||
130567327|NCT02819635|470043492|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
130567328|NCT02819635|470043493|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
130567329|NCT02819635|470043494|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
130567330|NCT02819635|470043495|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
130508931|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508932|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
130508933|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
130508934|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
130508935|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
130508936|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
130508937|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508938|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508939|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508940|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508941|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508942|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508943|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508944|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508945|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508946|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508947|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
130508948|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
130508949|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
130508950|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
130508951|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Other|0|||
130508952|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Other|0|||
130508953|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Other|0|||
130508954|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Other|0|||
130508955|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Other|0|||
130508956|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Other|0|||
130508957|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Other|0|||
130508958|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Other|0|||
130508959|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Other|0|||
130508960|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Other|0|||
130508961|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Other|2|||
130508962|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Other|2|||
130508963|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Other|1|||
130508964|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Other|0|||
130508965|NCT02561195|469828353|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508966|NCT02561195|469828354|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508967|NCT02561195|469828355|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508968|NCT02561195|469828356|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508969|NCT02561195|469828357|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508970|NCT02561195|469828358|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508971|NCT02561195|469828359|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
130508972|NCT02561195|469828360|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508973|NCT02561195|469828361|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508974|NCT02561195|469828362|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508975|NCT02561195|469828363|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
130508976|NCT02561195|469828364|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
130508977|NCT02561195|469828365|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130508978|NCT02561195|469828366|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
130508979|NCT03905512|469828367|FG000|Overall Study|Withdrawal by Subject|9|||
130508980|NCT03905512|469828368|FG001|Overall Study|Withdrawal by Subject|8|||
130508981|NCT03905512|469828367|FG000|Overall Study|Adverse Event|1|||
130508982|NCT03905512|469828368|FG001|Overall Study|Adverse Event|2|||
130508983|NCT03905512|469828367|FG000|Overall Study|Lost to Follow-up|4|||
130508984|NCT03905512|469828368|FG001|Overall Study|Lost to Follow-up|3|||
130508985|NCT03905512|469828367|FG000|Overall Study|Other than Specified|7|||
130508986|NCT03905512|469828368|FG001|Overall Study|Other than Specified|4|||
130508987|NCT03547167|469828371|FG000|Overall Study|Withdrawal by Subject|34|||
130508988|NCT03547167|469828372|FG001|Overall Study|Withdrawal by Subject|12|||
130508989|NCT03547167|469828371|FG000|Overall Study|Screen Failure|0|||
130508990|NCT03547167|469828372|FG001|Overall Study|Screen Failure|1|||
130508991|NCT03547167|469828371|FG000|Overall Study|Lost to Follow-up|59|||
130508992|NCT03547167|469828372|FG001|Overall Study|Lost to Follow-up|15|||
130508993|NCT03547167|469828371|FG000|Overall Study|Death|4|||
130508994|NCT03547167|469828372|FG001|Overall Study|Death|2|||
130508995|NCT00866619|469828373|FG000|Overall Study|Adverse Event|112|||
130508996|NCT00866619|469828374|FG001|Overall Study|Adverse Event|106|||
130508997|NCT00866619|469828375|FG002|Overall Study|Adverse Event|47|||
130508998|NCT00866619|469828376|FG003|Overall Study|Adverse Event|44|||
130508999|NCT00866619|469828373|FG000|Overall Study|Protocol Violation|2|||
130509000|NCT00866619|469828374|FG001|Overall Study|Protocol Violation|39|||
130509001|NCT00866619|469828375|FG002|Overall Study|Protocol Violation|2|||
130509002|NCT00866619|469828376|FG003|Overall Study|Protocol Violation|17|||
130509003|NCT00866619|469828373|FG000|Overall Study|Withdrawal by Subject|587|||
130509004|NCT00866619|469828374|FG001|Overall Study|Withdrawal by Subject|295|||
130509005|NCT00866619|469828375|FG002|Overall Study|Withdrawal by Subject|272|||
130509006|NCT00866619|469828376|FG003|Overall Study|Withdrawal by Subject|144|||
130509007|NCT00866619|469828373|FG000|Overall Study|Lost to Follow-up|1145|||
130509008|NCT00866619|469828374|FG001|Overall Study|Lost to Follow-up|830|||
130509009|NCT00866619|469828375|FG002|Overall Study|Lost to Follow-up|568|||
130509010|NCT00866619|469828376|FG003|Overall Study|Lost to Follow-up|425|||
130509011|NCT00645411|469828377|FG000|Overall Study|Adverse Event|0|||
130509012|NCT00645411|469828378|FG001|Overall Study|Adverse Event|0|||
130509013|NCT00645411|469828379|FG002|Overall Study|Adverse Event|0|||
130509014|NCT00645411|469828380|FG003|Overall Study|Adverse Event|2|||
130509015|NCT00645411|469828377|FG000|Overall Study|Withdrawal by Subject|2|||
130509016|NCT00645411|469828378|FG001|Overall Study|Withdrawal by Subject|1|||
130509017|NCT00645411|469828379|FG002|Overall Study|Withdrawal by Subject|19|||
130732751|NCT05097989|470641195|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
130732752|NCT06176768|470641198|FG000|Overall Study|Adverse Event|1|||
130732753|NCT06176768|470641199|FG001|Overall Study|Adverse Event|0|||
130732754|NCT06176768|470641198|FG000|Overall Study|Assigned treatment by mistake|1|||
130732755|NCT06176768|470641199|FG001|Overall Study|Assigned treatment by mistake|0|||
130732756|NCT06176768|470641198|FG000|Overall Study|Lost to Follow-up|0|||
130732757|NCT06176768|470641199|FG001|Overall Study|Lost to Follow-up|3|||
130732758|NCT06176768|470641198|FG000|Overall Study|Physician Decision|1|||
130732759|NCT06176768|470641199|FG001|Overall Study|Physician Decision|0|||
130732760|NCT06176768|470641198|FG000|Overall Study|Protocol deviation|3|||
130732761|NCT06176768|470641199|FG001|Overall Study|Protocol deviation|1|||
130732762|NCT06176768|470641198|FG000|Overall Study|Other|1|||
130732763|NCT06176768|470641199|FG001|Overall Study|Other|0|||
130732764|NCT06176768|470641198|FG000|Overall Study|Withdrawal by Subject|6|||
130732765|NCT06176768|470641199|FG001|Overall Study|Withdrawal by Subject|9|||
130732766|NCT05217641|470641202|FG000|Overall Study|Lost to Follow-up|1|||
130732767|NCT05217641|470641203|FG001|Overall Study|Lost to Follow-up|1|||
130732768|NCT05217641|470641204|FG002|Overall Study|Lost to Follow-up|0|||
130732769|NCT05217641|470641205|FG003|Overall Study|Lost to Follow-up|1|||
130732770|NCT05217641|470641206|FG004|Overall Study|Lost to Follow-up|1|||
130732771|NCT05217641|470641207|FG005|Overall Study|Lost to Follow-up|0|||
130732772|NCT05217641|470641202|FG000|Overall Study|Withdrawal by Subject|0|||
130732773|NCT05217641|470641203|FG001|Overall Study|Withdrawal by Subject|0|||
130732774|NCT05217641|470641204|FG002|Overall Study|Withdrawal by Subject|0|||
130732775|NCT05217641|470641205|FG003|Overall Study|Withdrawal by Subject|3|||
130732776|NCT05217641|470641206|FG004|Overall Study|Withdrawal by Subject|1|||
130732777|NCT05217641|470641207|FG005|Overall Study|Withdrawal by Subject|0|||
130732778|NCT05217641|470641202|FG000|Overall Study|Other: participant did not specify reason|0|||
130732779|NCT05217641|470641203|FG001|Overall Study|Other: participant did not specify reason|0|||
130732780|NCT05217641|470641204|FG002|Overall Study|Other: participant did not specify reason|0|||
130732781|NCT05217641|470641205|FG003|Overall Study|Other: participant did not specify reason|0|||
130732782|NCT05217641|470641206|FG004|Overall Study|Other: participant did not specify reason|1|||
130732783|NCT05217641|470641207|FG005|Overall Study|Other: participant did not specify reason|0|||
130732784|NCT05217641|470641202|FG000|Overall Study|Extended Follow up|1|||
130732785|NCT05217641|470641203|FG001|Overall Study|Extended Follow up|1|||
130732786|NCT05217641|470641204|FG002|Overall Study|Extended Follow up|0|||
130732787|NCT05217641|470641205|FG003|Overall Study|Extended Follow up|0|||
130732788|NCT05217641|470641206|FG004|Overall Study|Extended Follow up|1|||
130732789|NCT05217641|470641207|FG005|Overall Study|Extended Follow up|0|||
130732790|NCT04028843|470641208|FG000|Overall Study|Lost to Follow-up|32|||
130732791|NCT04028843|470641209|FG001|Overall Study|Lost to Follow-up|39|||
130732792|NCT04028843|470641208|FG000|Overall Study|Adverse Event|1|||
130732793|NCT04028843|470641209|FG001|Overall Study|Adverse Event|0|||
130732794|NCT04028843|470641208|FG000|Overall Study|Non-viable Pregnancy|0|||
130732795|NCT04028843|470641209|FG001|Overall Study|Non-viable Pregnancy|1|||
130732796|NCT04028843|470641208|FG000|Overall Study|Withdrawal by Subject|4|||
130732797|NCT04028843|470641209|FG001|Overall Study|Withdrawal by Subject|2|||
130732798|NCT03298451|470641210|FG000|Overall Study|Death|275|||
130732799|NCT03298451|470641211|FG001|Overall Study|Death|260|||
130732800|NCT03298451|470641212|FG002|Overall Study|Death|122|||
130732801|NCT03298451|470641213|FG003|Overall Study|Death|280|||
130732802|NCT03298451|470641210|FG000|Overall Study|Lost to Follow-up|1|||
130732803|NCT03298451|470641211|FG001|Overall Study|Lost to Follow-up|1|||
130732804|NCT03298451|470641212|FG002|Overall Study|Lost to Follow-up|0|||
130732805|NCT03298451|470641213|FG003|Overall Study|Lost to Follow-up|7|||
130732806|NCT03298451|470641210|FG000|Overall Study|Withdrawal by Subject|9|||
130732807|NCT03298451|470641211|FG001|Overall Study|Withdrawal by Subject|7|||
130732808|NCT03298451|470641212|FG002|Overall Study|Withdrawal by Subject|1|||
130732809|NCT03298451|470641213|FG003|Overall Study|Withdrawal by Subject|20|||
130509018|NCT00645411|469828380|FG003|Overall Study|Withdrawal by Subject|21|||
130509019|NCT00645411|469828377|FG000|Overall Study|Lost to Follow-up|10|||
130509020|NCT00645411|469828378|FG001|Overall Study|Lost to Follow-up|5|||
130509021|NCT00645411|469828379|FG002|Overall Study|Lost to Follow-up|124|||
130509022|NCT00645411|469828380|FG003|Overall Study|Lost to Follow-up|75|||
130509023|NCT00645411|469828377|FG000|Overall Study|Protocol Violation|1|||
130509024|NCT00645411|469828378|FG001|Overall Study|Protocol Violation|0|||
130509025|NCT00645411|469828379|FG002|Overall Study|Protocol Violation|1|||
130509026|NCT00645411|469828380|FG003|Overall Study|Protocol Violation|0|||
130509027|NCT00645411|469828377|FG000|Overall Study|Inappropriate enrollment|0|||
130509028|NCT00645411|469828378|FG001|Overall Study|Inappropriate enrollment|0|||
130509029|NCT00645411|469828379|FG002|Overall Study|Inappropriate enrollment|4|||
130509030|NCT00645411|469828380|FG003|Overall Study|Inappropriate enrollment|1|||
130509031|NCT00645411|469828377|FG000|Overall Study|Unable to classify|0|||
130509032|NCT00645411|469828378|FG001|Overall Study|Unable to classify|0|||
130509033|NCT00645411|469828379|FG002|Overall Study|Unable to classify|3|||
130509034|NCT00645411|469828380|FG003|Overall Study|Unable to classify|4|||
130509035|NCT03560206|469828381|FG000|Overall Study|Lost to Follow-up|19|||
130509036|NCT03560206|469828382|FG001|Overall Study|Lost to Follow-up|11|||
130509037|NCT03560206|469828381|FG000|Overall Study|Withdrawal by Subject|2|||
130509038|NCT03560206|469828382|FG001|Overall Study|Withdrawal by Subject|4|||
130509039|NCT03560206|469828381|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
130509040|NCT03560206|469828382|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
130509041|NCT03560206|469828381|FG000|Overall Study|Busy schedule|14|||
130509042|NCT03560206|469828382|FG001|Overall Study|Busy schedule|2|||
130509043|NCT03560206|469828381|FG000|Overall Study|patients' new health condition such as cancer|10|||
130509044|NCT03560206|469828382|FG001|Overall Study|patients' new health condition such as cancer|1|||
130509045|NCT03987074|469828383|FG000|Overall Study|Withdrew Consent|1|||
130509046|NCT03987074|469828384|FG001|Overall Study|Withdrew Consent|1|||
130509047|NCT03987074|469828385|FG002|Overall Study|Withdrew Consent|0|||
130509048|NCT03987074|469828386|FG003|Overall Study|Withdrew Consent|2|||
130509049|NCT03987074|469828387|FG004|Overall Study|Withdrew Consent|1|||
130509050|NCT03987074|469828383|FG000|Overall Study|Adverse Event|2|||
130509051|NCT03987074|469828384|FG001|Overall Study|Adverse Event|1|||
130509052|NCT03987074|469828385|FG002|Overall Study|Adverse Event|0|||
130509053|NCT03987074|469828386|FG003|Overall Study|Adverse Event|0|||
130509054|NCT03987074|469828387|FG004|Overall Study|Adverse Event|1|||
130509055|NCT03987074|469828383|FG000|Overall Study|Lost to Follow-up|0|||
130509056|NCT03987074|469828384|FG001|Overall Study|Lost to Follow-up|0|||
130509057|NCT03987074|469828385|FG002|Overall Study|Lost to Follow-up|1|||
130509058|NCT03987074|469828386|FG003|Overall Study|Lost to Follow-up|1|||
130509059|NCT03987074|469828387|FG004|Overall Study|Lost to Follow-up|0|||
130509060|NCT03987074|469828383|FG000|Overall Study|Investigator's Discretion|0|||
130509061|NCT03987074|469828384|FG001|Overall Study|Investigator's Discretion|0|||
130509062|NCT03987074|469828385|FG002|Overall Study|Investigator's Discretion|0|||
130509063|NCT03987074|469828386|FG003|Overall Study|Investigator's Discretion|1|||
130509064|NCT03987074|469828387|FG004|Overall Study|Investigator's Discretion|0|||
130509065|NCT01334606|469828390|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
130509066|NCT02674399|469828391|FG000|Overall Study|Lost to Follow-up|2|||
130509067|NCT02674399|469828392|FG001|Overall Study|Lost to Follow-up|0|||
130509068|NCT02138838|469828393|FG000|Overall Study|Study Closure|7|||
130509069|NCT02138838|469828394|FG001|Overall Study|Study Closure|6|||
130509070|NCT02138838|469828393|FG000|Overall Study|Withdrawal by Subject|1|||
130509071|NCT02138838|469828394|FG001|Overall Study|Withdrawal by Subject|5|||
130509072|NCT01867307|469828395|FG000|Overall Study|Protocol Violation|2|||
130509073|NCT01867307|469828396|FG001|Overall Study|Protocol Violation|0|||
130509074|NCT01867307|469828395|FG000|Overall Study|Other Adverse Event|1|||
130509075|NCT01867307|469828396|FG001|Overall Study|Other Adverse Event|3|||
130509076|NCT00518206|469828397|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
130509077|NCT00518206|469828398|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
130509078|NCT00518206|469828397|FG000|Overall Study|Withdrawal by Subject|2|||
130509079|NCT00518206|469828398|FG001|Overall Study|Withdrawal by Subject|0|||
130509080|NCT00518206|469828397|FG000|Overall Study|Drug Supply Issue|1|||
130509081|NCT00518206|469828398|FG001|Overall Study|Drug Supply Issue|0|||
130509082|NCT00518206|469828397|FG000|Overall Study|Reason Unknown|1|||
130509083|NCT00518206|469828398|FG001|Overall Study|Reason Unknown|0|||
130509084|NCT00518206|469828397|FG000|Overall Study|Completion Status Unknown|1|||
130509085|NCT00518206|469828398|FG001|Overall Study|Completion Status Unknown|0|||
130509086|NCT00760877|469829611|FG000|Overall Study|Protocol Violation|1|||
130509087|NCT00760877|469829612|FG001|Overall Study|Protocol Violation|0|||
130509088|NCT00760877|469829611|FG000|Overall Study|Non-compliance with protocol treatment|2|||
130509089|NCT00760877|469829612|FG001|Overall Study|Non-compliance with protocol treatment|1|||
130509090|NCT00760877|469829611|FG000|Overall Study|Pregnancy|1|||
130509091|NCT00760877|469829612|FG001|Overall Study|Pregnancy|4|||
130509092|NCT00760877|469829611|FG000|Overall Study|Death|2|||
130509093|NCT00760877|469829612|FG001|Overall Study|Death|1|||
130509094|NCT00760877|469829611|FG000|Overall Study|Withdrawal by Subject|7|||
130509095|NCT00760877|469829612|FG001|Overall Study|Withdrawal by Subject|3|||
130509096|NCT00760877|469829611|FG000|Overall Study|Adverse Event|19|||
130509097|NCT00760877|469829612|FG001|Overall Study|Adverse Event|12|||
130509098|NCT00760877|469829611|FG000|Overall Study|Participant diagnosed with AML|0|||
130509099|NCT00760877|469829612|FG001|Overall Study|Participant diagnosed with AML|1|||
130509100|NCT00760877|469829611|FG000|Overall Study|Participant not eligible to cross-over|0|||
130509101|NCT00760877|469829612|FG001|Overall Study|Participant not eligible to cross-over|1|||
130509102|NCT00760877|469829611|FG000|Overall Study|Physician Decision|1|||
130509103|NCT00760877|469829612|FG001|Overall Study|Physician Decision|2|||
130509104|NCT00760877|469829611|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
130509105|NCT00760877|469829612|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
130509106|NCT00760877|469829611|FG000|Overall Study|Treatment failure|1|||
130509107|NCT00760877|469829612|FG001|Overall Study|Treatment failure|0|||
130509108|NCT00711555|469829613|FG000|Overall Study|Adverse Event|3|||
130509109|NCT05379400|469829617|FG000|Overall Study|Lost to Follow-up|1|||
130509110|NCT05379400|469829618|FG001|Overall Study|Lost to Follow-up|1|||
130732810|NCT05480943|470641214|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
130732811|NCT05480943|470641214|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
130732812|NCT05480943|470641214|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
130732813|NCT05480943|470641214|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
130732814|NCT03633721|470641215|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
130732815|NCT03633721|470641216|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
130732816|NCT03633721|470641217|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
130732817|NCT03633721|470641218|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
130732818|NCT02457832|470641219|FG000|Training|Lost to Follow-up|10|||
130732819|NCT02457832|470641220|FG001|Training|Lost to Follow-up|6|||
130732820|NCT02457832|470641221|FG002|Training|Lost to Follow-up|3|||
130732821|NCT02457832|470641219|FG000|One Month Washout|Lost to Follow-up|0|||
130732822|NCT02457832|470641220|FG001|One Month Washout|Lost to Follow-up|1|||
130732823|NCT02457832|470641221|FG002|One Month Washout|Lost to Follow-up|1|||
130732824|NCT02367040|470641222|FG000|Overall Study|Lost to Follow-up|1|||
130732825|NCT02367040|470641223|FG001|Overall Study|Lost to Follow-up|1|||
130732826|NCT02367040|470641222|FG000|Overall Study|Lack of Efficacy|1|||
130732827|NCT02367040|470641223|FG001|Overall Study|Lack of Efficacy|0|||
130732828|NCT02367040|470641222|FG000|Overall Study|Additional primary malignancy|1|||
130732829|NCT02367040|470641223|FG001|Overall Study|Additional primary malignancy|1|||
130732830|NCT02367040|470641222|FG000|Overall Study|AE not associated with clinical disease progression|117|||
130509111|NCT05356130|469829620|FG000|Overall Study|Withdrawal by Subject|0|||
130509112|NCT05356130|469829621|FG001|Overall Study|Withdrawal by Subject|0|||
130732831|NCT02367040|470641223|FG001|Overall Study|AE not associated with clinical disease progression|12|||
130732832|NCT02367040|470641222|FG000|Overall Study|AE associated with clinical disease progression|1|||
130509113|NCT05356130|469829622|FG002|Overall Study|Withdrawal by Subject|3|||
130509114|NCT03141177|469829623|FG000|Overall Study|Death|62|||
130732833|NCT02367040|470641223|FG001|Overall Study|AE associated with clinical disease progression|4|||
130732834|NCT02367040|470641222|FG000|Overall Study|Physician Decision|2|||
130732835|NCT02367040|470641223|FG001|Overall Study|Physician Decision|8|||
130732836|NCT02367040|470641222|FG000|Overall Study|Non-compliance to study drug|1|||
130732837|NCT02367040|470641223|FG001|Overall Study|Non-compliance to study drug|0|||
130732838|NCT02367040|470641222|FG000|Overall Study|Failure to meet continuation criteria|1|||
130732839|NCT02367040|470641223|FG001|Overall Study|Failure to meet continuation criteria|0|||
130732840|NCT02367040|470641222|FG000|Overall Study|Switching to other therapy|2|||
130732841|NCT02367040|470641223|FG001|Overall Study|Switching to other therapy|0|||
130732842|NCT02367040|470641222|FG000|Overall Study|Withdrawal by Subject|51|||
130732843|NCT02367040|470641223|FG001|Overall Study|Withdrawal by Subject|16|||
130509115|NCT03141177|469829624|FG001|Overall Study|Death|13|||
130509116|NCT03141177|469829625|FG002|Overall Study|Death|84|||
130509117|NCT03141177|469829623|FG000|Overall Study|Participant withdrew consent|9|||
130509118|NCT03141177|469829624|FG001|Overall Study|Participant withdrew consent|2|||
130509119|NCT03141177|469829625|FG002|Overall Study|Participant withdrew consent|13|||
130509120|NCT03141177|469829623|FG000|Overall Study|Not reported|1|||
130509121|NCT03141177|469829624|FG001|Overall Study|Not reported|0|||
130732844|NCT02367040|470641222|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
130732845|NCT02367040|470641223|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130732846|NCT02367040|470641222|FG000|Overall Study|Patient decision|40|||
130732847|NCT02367040|470641223|FG001|Overall Study|Patient decision|14|||
130732848|NCT02367040|470641222|FG000|Overall Study|Required procedure failed|1|||
130732849|NCT02367040|470641223|FG001|Overall Study|Required procedure failed|0|||
130732850|NCT02367040|470641222|FG000|Overall Study|Randomized by mistake with study treatment|1|||
130732851|NCT02367040|470641223|FG001|Overall Study|Randomized by mistake with study treatment|0|||
130732852|NCT02367040|470641222|FG000|Overall Study|Protocol Violation|1|||
130732853|NCT02367040|470641223|FG001|Overall Study|Protocol Violation|0|||
130732854|NCT02367040|470641222|FG000|Overall Study|Progressive disease - radiological progression|54|||
130732855|NCT02367040|470641223|FG001|Overall Study|Progressive disease - radiological progression|80|||
130732856|NCT02367040|470641222|FG000|Overall Study|Progressive disease - clinical progression|6|||
130732857|NCT02367040|470641223|FG001|Overall Study|Progressive disease - clinical progression|6|||
130732858|NCT02367040|470641222|FG000|Overall Study|Drug not administered|3|||
130732859|NCT02367040|470641223|FG001|Overall Study|Drug not administered|2|||
130509122|NCT03141177|469829625|FG002|Overall Study|Not reported|1|||
130509123|NCT03141177|469829623|FG000|Overall Study|Lost to Follow-up|2|||
130509124|NCT03141177|469829624|FG001|Overall Study|Lost to Follow-up|1|||
130509125|NCT03141177|469829625|FG002|Overall Study|Lost to Follow-up|1|||
130509126|NCT03141177|469829623|FG000|Overall Study|Other reasons|4|||
130509127|NCT03141177|469829624|FG001|Overall Study|Other reasons|0|||
130509128|NCT03141177|469829625|FG002|Overall Study|Other reasons|11|||
130509129|NCT03141177|469829623|FG000|Overall Study|Participants did not start treatment period|3|||
130732860|NCT02367040|470641222|FG000|Overall Study|Progressive disease|0|||
130732861|NCT02367040|470641223|FG001|Overall Study|Progressive disease|1|||
130509130|NCT03141177|469829624|FG001|Overall Study|Participants did not start treatment period|0|||
130509131|NCT03141177|469829625|FG002|Overall Study|Participants did not start treatment period|8|||
130732862|NCT02367040|470641222|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
130732863|NCT02367040|470641223|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
130732864|NCT02367040|470641222|FG000|Overall Study|Death|2|||
130732865|NCT02367040|470641223|FG001|Overall Study|Death|0|||
130567331|NCT02819635|470043496|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
130567332|NCT02819635|470043497|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
130567333|NCT02819635|470043498|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
130567334|NCT02819635|470043499|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
130509132|NCT00228813|469829630|FG000|Overall Study|Death|4|||
130509133|NCT05361304|469829636|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
130509134|NCT05361304|469829637|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
130509135|NCT05361304|469829636|FG000|Overall Study|COVID-19 Related|1|||
130509136|NCT05361304|469829637|FG001|Overall Study|COVID-19 Related|2|||
130509137|NCT05361304|469829636|FG000|Overall Study|Withdrawal by Subject|1|||
130509138|NCT05361304|469829637|FG001|Overall Study|Withdrawal by Subject|0|||
130509139|NCT01816165|469829638|FG000|Overall Study|Adverse Event|1|||
130509140|NCT01816165|469829639|FG001|Overall Study|Adverse Event|0|||
130509141|NCT01816165|469829640|FG002|Overall Study|Adverse Event|0|||
130509142|NCT01816165|469829641|FG003|Overall Study|Adverse Event|0|||
130509143|NCT00946088|469829642|FG000|Overall Study|Withdrawal by Subject|0|||
130509144|NCT00946088|469829643|FG001|Overall Study|Withdrawal by Subject|1|||
130509145|NCT04883541|469829644|FG000|Overall Study|Not attending regular yoga class|16|||
130509146|NCT04883541|469829645|FG001|Overall Study|Not attending regular yoga class|0|||
130509147|NCT04883541|469829644|FG000|Overall Study|Not attending the pregnancy school|0|||
130509148|NCT04883541|469829645|FG001|Overall Study|Not attending the pregnancy school|9|||
130509149|NCT04239911|469829646|FG000|Overall Study|Lost to Follow-up|2|||
130509150|NCT04239911|469829647|FG001|Overall Study|Lost to Follow-up|1|||
130509151|NCT02092909|469829655|FG000|Overall Study|Adverse Event|0|||
130509152|NCT02092909|469829656|FG001|Overall Study|Adverse Event|0|||
130509153|NCT02092909|469829657|FG002|Overall Study|Adverse Event|4|||
130509154|NCT02092909|469829658|FG003|Overall Study|Adverse Event|2|||
130509155|NCT02092909|469829655|FG000|Overall Study|Lack of Efficacy|0|||
130509156|NCT02092909|469829656|FG001|Overall Study|Lack of Efficacy|2|||
130509157|NCT02092909|469829657|FG002|Overall Study|Lack of Efficacy|1|||
130509158|NCT02092909|469829658|FG003|Overall Study|Lack of Efficacy|0|||
130509159|NCT02092909|469829655|FG000|Overall Study|Withdrawal by Subject|0|||
130509160|NCT02092909|469829656|FG001|Overall Study|Withdrawal by Subject|0|||
130509161|NCT02092909|469829657|FG002|Overall Study|Withdrawal by Subject|2|||
130509162|NCT02092909|469829658|FG003|Overall Study|Withdrawal by Subject|1|||
130509163|NCT02092909|469829655|FG000|Overall Study|Study terminated by Sponsor|0|||
130509164|NCT02092909|469829656|FG001|Overall Study|Study terminated by Sponsor|0|||
130509165|NCT02092909|469829657|FG002|Overall Study|Study terminated by Sponsor|0|||
130509166|NCT02092909|469829658|FG003|Overall Study|Study terminated by Sponsor|2|||
130509167|NCT02092909|469829655|FG000|Overall Study|Miscellaneous|1|||
130509168|NCT02092909|469829656|FG001|Overall Study|Miscellaneous|1|||
130509169|NCT02092909|469829657|FG002|Overall Study|Miscellaneous|2|||
130509170|NCT02092909|469829658|FG003|Overall Study|Miscellaneous|1|||
130509171|NCT05072795|469829659|FG000|Overall Study|Lost to Follow-up|5|||
130509172|NCT01901302|469829665|FG000|Overall Study|Adverse Event|2|||
130509173|NCT01901302|469829666|FG001|Overall Study|Adverse Event|1|||
130509174|NCT01901302|469829665|FG000|Overall Study|Lack of Efficacy|0|||
130509175|NCT01901302|469829666|FG001|Overall Study|Lack of Efficacy|2|||
130509176|NCT01901302|469829665|FG000|Overall Study|Study Terminated by Sponsor|23|||
130509177|NCT01901302|469829666|FG001|Overall Study|Study Terminated by Sponsor|20|||
130509178|NCT01901302|469829665|FG000|Overall Study|Withdrawal by Subject|2|||
130509179|NCT01901302|469829666|FG001|Overall Study|Withdrawal by Subject|0|||
130509180|NCT01124916|469829667|FG000|Overall Study|Lost to Follow-up|3|||
130509181|NCT01124916|469829668|FG001|Overall Study|Lost to Follow-up|2|||
130509182|NCT00901459|469829677|FG000|Overall Study|Withdrawal by Subject|6|||
130509183|NCT04765046|469829678|FG000|Overall Study|Screen Failure|2|||
130509184|NCT04765046|469829678|FG000|Overall Study|Withdrawal by Subject|4|||
130509185|NCT04765046|469829678|FG000|Overall Study|Physician Decision|4|||
130509186|NCT04765046|469829678|FG000|Overall Study|Surgery Cancelled|8|||
130509187|NCT00753896|469829683|FG000|Overall Study|Adverse Event|4|||
130509188|NCT00753896|469829683|FG000|Overall Study|Death|1|||
130567335|NCT02819635|470043500|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
130509189|NCT00753896|469829683|FG000|Overall Study|Lost to Follow-up|2|||
130509190|NCT00753896|469829683|FG000|Overall Study|Protocol Violation|1|||
130509191|NCT00753896|469829683|FG000|Overall Study|Withdrawal by Subject|4|||
130509192|NCT00753896|469829683|FG000|Overall Study|Entry Criteria Not Met|4|||
130509193|NCT00848198|469829685|FG000|Overall Study|Incomplete Case Report Forms|15|||
130509194|NCT03708744|469829689|FG000|Overall Study|Withdrawal by Subject|0|||
130732866|NCT02367040|470641222|FG000|Overall Study|Study terminated by sponsor|19|||
130732867|NCT02367040|470641223|FG001|Overall Study|Study terminated by sponsor|2|||
130732868|NCT03069937|470641224|FG000|Overall Study|Second primary malignancy noted|1|||
130732869|NCT03589326|470641226|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
130732870|NCT03589326|470641227|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
130732871|NCT03589326|470641226|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
130732872|NCT03589326|470641227|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
130732873|NCT03589326|470641226|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
130732874|NCT03589326|470641227|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
130732875|NCT03589326|470641226|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
130732876|NCT03589326|470641227|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
130732877|NCT03589326|470641226|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
130732878|NCT03589326|470641227|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
130732879|NCT04484142|470641228|FG000|Overall Study|Adverse Event|13|||
130732880|NCT04484142|470641228|FG000|Overall Study|Progressive Disease|87|||
130732881|NCT04484142|470641228|FG000|Overall Study|Clinical Progression|10|||
130732882|NCT04484142|470641228|FG000|Overall Study|Withdrawal by Subject|6|||
130732883|NCT04484142|470641228|FG000|Overall Study|Physician Decision|1|||
130732884|NCT02477618|470641229|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
130732885|NCT02477618|470641230|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
130732886|NCT02477618|470641229|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
130732887|NCT02477618|470641230|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
130732888|NCT02477618|470641229|FG000|Overall Study|Adverse Event|1|||
130732889|NCT02477618|470641230|FG001|Overall Study|Adverse Event|1|||
130732890|NCT02477618|470641229|FG000|Overall Study|Transferred Away from Study Site|1|||
130732891|NCT02477618|470641230|FG001|Overall Study|Transferred Away from Study Site|0|||
130732892|NCT02477618|470641229|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
130732893|NCT02477618|470641230|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
130732894|NCT01892722|470641231|FG000|Overall Study|Protocol deviation|0|||
130732895|NCT01892722|470641232|FG001|Overall Study|Protocol deviation|1|||
130732896|NCT01892722|470641231|FG000|Overall Study|Administrative problems|0|||
130732897|NCT01892722|470641232|FG001|Overall Study|Administrative problems|1|||
130732898|NCT01892722|470641231|FG000|Overall Study|Patient/guardian decision|0|||
130732899|NCT01892722|470641232|FG001|Overall Study|Patient/guardian decision|2|||
130732900|NCT01892722|470641231|FG000|Overall Study|Physician Decision|1|||
130732901|NCT01892722|470641232|FG001|Overall Study|Physician Decision|2|||
130732902|NCT01892722|470641231|FG000|Overall Study|Adverse Event|3|||
130732903|NCT01892722|470641232|FG001|Overall Study|Adverse Event|2|||
130732904|NCT01892722|470641231|FG000|Overall Study|Lack of Efficacy|0|||
130732905|NCT01892722|470641232|FG001|Overall Study|Lack of Efficacy|7|||
130732906|NCT01892722|470641231|FG000|Overall Study|Withdrawal by Subject|3|||
130732907|NCT01892722|470641232|FG001|Overall Study|Withdrawal by Subject|5|||
130732908|NCT03007420|470641234|FG000|Overall Study|Withdrawal by Subject|0|||
130732909|NCT03007420|470641235|FG001|Overall Study|Withdrawal by Subject|2|||
130732910|NCT03007420|470641234|FG000|Overall Study|Physician Decision|0|||
130732911|NCT03007420|470641235|FG001|Overall Study|Physician Decision|1|||
130732912|NCT02101853|470641238|FG000|Block 1 Induction|Adverse Event|11|||
130732913|NCT02101853|470641239|FG001|Block 1 Induction|Adverse Event|0|||
130732914|NCT02101853|470641240|FG002|Block 1 Induction|Adverse Event|0|||
130732915|NCT02101853|470641241|FG003|Block 1 Induction|Adverse Event|0|||
130732916|NCT02101853|470641242|FG004|Block 1 Induction|Adverse Event|0|||
130732917|NCT02101853|470641243|FG005|Block 1 Induction|Adverse Event|0|||
130732918|NCT02101853|470641238|FG000|Block 1 Induction|Death|20|||
130732919|NCT02101853|470641239|FG001|Block 1 Induction|Death|0|||
130732920|NCT02101853|470641240|FG002|Block 1 Induction|Death|0|||
130732921|NCT02101853|470641241|FG003|Block 1 Induction|Death|0|||
130732922|NCT02101853|470641242|FG004|Block 1 Induction|Death|0|||
130732923|NCT02101853|470641243|FG005|Block 1 Induction|Death|0|||
130732924|NCT02101853|470641238|FG000|Block 1 Induction|Lack of Efficacy|6|||
130732925|NCT02101853|470641239|FG001|Block 1 Induction|Lack of Efficacy|0|||
130732926|NCT02101853|470641240|FG002|Block 1 Induction|Lack of Efficacy|0|||
130509195|NCT03708744|469829690|FG001|Overall Study|Withdrawal by Subject|0|||
130732927|NCT02101853|470641241|FG003|Block 1 Induction|Lack of Efficacy|0|||
130732928|NCT02101853|470641242|FG004|Block 1 Induction|Lack of Efficacy|0|||
130732929|NCT02101853|470641243|FG005|Block 1 Induction|Lack of Efficacy|0|||
130732930|NCT02101853|470641238|FG000|Block 1 Induction|Physician Decision|61|||
130732931|NCT02101853|470641239|FG001|Block 1 Induction|Physician Decision|0|||
130732932|NCT02101853|470641240|FG002|Block 1 Induction|Physician Decision|0|||
130732933|NCT02101853|470641241|FG003|Block 1 Induction|Physician Decision|0|||
130732934|NCT02101853|470641242|FG004|Block 1 Induction|Physician Decision|0|||
130732935|NCT02101853|470641243|FG005|Block 1 Induction|Physician Decision|0|||
130732936|NCT02101853|470641238|FG000|Block 1 Induction|Protocol Violation|2|||
130732937|NCT02101853|470641239|FG001|Block 1 Induction|Protocol Violation|0|||
130732938|NCT02101853|470641240|FG002|Block 1 Induction|Protocol Violation|0|||
130567336|NCT02819635|470043501|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
130567337|NCT02819635|470043502|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
130567338|NCT02819635|470043503|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
130567339|NCT02819635|470043492|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567340|NCT02819635|470043493|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567341|NCT02819635|470043494|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567342|NCT02819635|470043495|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567343|NCT02819635|470043496|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567344|NCT02819635|470043497|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567345|NCT02819635|470043498|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
130567346|NCT02819635|470043499|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567347|NCT02819635|470043500|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567348|NCT02819635|470043501|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567349|NCT02819635|470043502|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567350|NCT02819635|470043503|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130567351|NCT02819635|470043492|FG000|Substudy 2, Part 2|Other, not specified|0|||
130567352|NCT02819635|470043493|FG001|Substudy 2, Part 2|Other, not specified|0|||
130567353|NCT02819635|470043494|FG002|Substudy 2, Part 2|Other, not specified|0|||
130567354|NCT02819635|470043495|FG003|Substudy 2, Part 2|Other, not specified|0|||
130567355|NCT02819635|470043496|FG004|Substudy 2, Part 2|Other, not specified|0|||
130567356|NCT02819635|470043497|FG005|Substudy 2, Part 2|Other, not specified|4|||
130509196|NCT03708744|469829691|FG002|Overall Study|Withdrawal by Subject|1|||
130509197|NCT03708744|469829692|FG003|Overall Study|Withdrawal by Subject|0|||
130509198|NCT04930263|469829693|FG000|Overall Study|Withdrawal by Subject|3|||
130509199|NCT04930263|469829694|FG001|Overall Study|Withdrawal by Subject|5|||
130509200|NCT03529942|469829695|FG000|Overall Study|Withdrawal by Subject|13|||
130509201|NCT03529942|469829695|FG000|Overall Study|Physician Decision|1|||
130509202|NCT03529942|469829695|FG000|Overall Study|Lost to Follow-up|7|||
130509203|NCT03529942|469829695|FG000|Overall Study|Needle inserted but no drug administered|1|||
130509204|NCT03529942|469829695|FG000|Overall Study|Personal reasons|1|||
130509205|NCT01536795|469829704|FG000|Overall Study|Lost to Follow-up|0|||
130509206|NCT01536795|469829705|FG001|Overall Study|Lost to Follow-up|2|||
130509207|NCT01536795|469829704|FG000|Overall Study|Lack of Efficacy|1|||
130509208|NCT01536795|469829705|FG001|Overall Study|Lack of Efficacy|0|||
130509209|NCT01699178|469829706|FG000|Overall Study|Adverse Event|1|||
130509210|NCT01699178|469829707|FG001|Overall Study|Adverse Event|5|||
130509211|NCT01699178|469829706|FG000|Overall Study|Lost to Follow-up|1|||
130509212|NCT01699178|469829707|FG001|Overall Study|Lost to Follow-up|6|||
130509213|NCT01699178|469829706|FG000|Overall Study|Non-compliance with Study Drug|3|||
130509214|NCT01699178|469829707|FG001|Overall Study|Non-compliance with Study Drug|1|||
130509215|NCT01699178|469829706|FG000|Overall Study|Physician Decision|1|||
130509216|NCT01699178|469829707|FG001|Overall Study|Physician Decision|0|||
130509217|NCT01699178|469829706|FG000|Overall Study|Withdrawal by Subject|4|||
130509218|NCT01699178|469829707|FG001|Overall Study|Withdrawal by Subject|12|||
130509219|NCT01699178|469829706|FG000|Overall Study|Hematocrit >54%|1|||
130509220|NCT01699178|469829707|FG001|Overall Study|Hematocrit >54%|1|||
130509221|NCT01699178|469829706|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
130509222|NCT01699178|469829707|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
130509223|NCT01699178|469829706|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
130509224|NCT01699178|469829707|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
130509225|NCT02066389|469829710|FG000|Overall Study|Adverse Event|1|||
130509226|NCT02066389|469829711|FG001|Overall Study|Adverse Event|1|||
130509227|NCT02066389|469829712|FG002|Overall Study|Adverse Event|1|||
130509228|NCT02066389|469829713|FG003|Overall Study|Adverse Event|1|||
130509229|NCT02066389|469829714|FG004|Overall Study|Adverse Event|5|||
130509230|NCT02066389|469829715|FG005|Overall Study|Adverse Event|1|||
130509231|NCT02066389|469829710|FG000|Overall Study|Withdrawal by Subject|4|||
130509232|NCT02066389|469829711|FG001|Overall Study|Withdrawal by Subject|0|||
130509233|NCT02066389|469829712|FG002|Overall Study|Withdrawal by Subject|5|||
130509234|NCT02066389|469829713|FG003|Overall Study|Withdrawal by Subject|1|||
130509235|NCT02066389|469829714|FG004|Overall Study|Withdrawal by Subject|1|||
130567357|NCT02819635|470043498|FG006|Substudy 2, Part 2|Other, not specified|8|||
130509236|NCT02066389|469829715|FG005|Overall Study|Withdrawal by Subject|2|||
130509237|NCT02066389|469829710|FG000|Overall Study|Lost to Follow-up|0|||
130509238|NCT02066389|469829711|FG001|Overall Study|Lost to Follow-up|0|||
130509239|NCT02066389|469829712|FG002|Overall Study|Lost to Follow-up|0|||
130509240|NCT02066389|469829713|FG003|Overall Study|Lost to Follow-up|1|||
130509241|NCT02066389|469829714|FG004|Overall Study|Lost to Follow-up|1|||
130509242|NCT02066389|469829715|FG005|Overall Study|Lost to Follow-up|1|||
130509243|NCT02066389|469829710|FG000|Overall Study|Randomized in Error|0|||
130567358|NCT02819635|470043499|FG007|Substudy 2, Part 2|Other, not specified|0|||
130509244|NCT02066389|469829711|FG001|Overall Study|Randomized in Error|0|||
130509245|NCT02066389|469829712|FG002|Overall Study|Randomized in Error|0|||
130509246|NCT02066389|469829713|FG003|Overall Study|Randomized in Error|0|||
130567359|NCT02819635|470043500|FG008|Substudy 2, Part 2|Other, not specified|0|||
130567360|NCT02819635|470043501|FG009|Substudy 2, Part 2|Other, not specified|0|||
130509247|NCT02066389|469829714|FG004|Overall Study|Randomized in Error|0|||
130509248|NCT02066389|469829715|FG005|Overall Study|Randomized in Error|1|||
130509249|NCT01755598|469829718|FG000|Overall Study|Other|109|||
130509250|NCT01755598|469829719|FG001|Overall Study|Other|109|||
130509251|NCT01755598|469829718|FG000|Overall Study|Lost to Follow-up|32|||
130509252|NCT01755598|469829719|FG001|Overall Study|Lost to Follow-up|43|||
130509253|NCT01755598|469829718|FG000|Overall Study|Migrated/moved from study area|76|||
130509254|NCT01755598|469829719|FG001|Overall Study|Migrated/moved from study area|65|||
130509255|NCT01755598|469829718|FG000|Overall Study|Withdrawal by Subject|22|||
130509256|NCT01755598|469829719|FG001|Overall Study|Withdrawal by Subject|31|||
130509257|NCT01755598|469829718|FG000|Overall Study|Protocol Violation|7|||
130509258|NCT01755598|469829719|FG001|Overall Study|Protocol Violation|7|||
130509259|NCT01755598|469829718|FG000|Overall Study|Adverse Event|19|||
130509260|NCT01755598|469829719|FG001|Overall Study|Adverse Event|28|||
130509261|NCT02993926|469829731|FG000|Enantone Treatment Phase|Adverse Event|1|||
130509262|NCT02993926|469829732|FG001|Enantone Treatment Phase|Adverse Event|0|||
130509263|NCT02993926|469829733|FG002|Enantone Treatment Phase|Adverse Event|0|||
130509264|NCT02993926|469829731|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
130509265|NCT02993926|469829732|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
130509266|NCT02993926|469829733|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
130509267|NCT02993926|469829731|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
130509268|NCT02993926|469829732|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
130509269|NCT02993926|469829733|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
130509270|NCT02993926|469829731|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
130509271|NCT02993926|469829732|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
130509272|NCT02993926|469829733|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
130509273|NCT01084772|469829735|FG000|Baseline|Withdrawal by Subject|7|||
130509274|NCT01084772|469829736|FG001|Baseline|Withdrawal by Subject|6|||
130509275|NCT01084772|469829735|FG000|3 Months|Death|1|||
130509276|NCT01084772|469829736|FG001|3 Months|Death|0|||
130509277|NCT01084772|469829735|FG000|3 Months|Study Termination|2|||
130509278|NCT01084772|469829736|FG001|3 Months|Study Termination|2|||
130509279|NCT01084772|469829735|FG000|1 Year|Withdrawal by Subject|0|||
130509280|NCT01084772|469829736|FG001|1 Year|Withdrawal by Subject|1|||
130509281|NCT01084772|469829735|FG000|1 Year|Lost to Follow-up|3|||
130509282|NCT01084772|469829736|FG001|1 Year|Lost to Follow-up|0|||
130509283|NCT01084772|469829735|FG000|1 Year|Study Termination|0|||
130509284|NCT01084772|469829736|FG001|1 Year|Study Termination|7|||
130509285|NCT01084772|469829735|FG000|2 Years|Withdrawal by Subject|1|||
130509286|NCT01084772|469829736|FG001|2 Years|Withdrawal by Subject|0|||
130509287|NCT01084772|469829735|FG000|2 Years|Lost to Follow-up|5|||
130509288|NCT01084772|469829736|FG001|2 Years|Lost to Follow-up|2|||
130509289|NCT01084772|469829735|FG000|2 Years|Study Termination|3|||
130509290|NCT01084772|469829736|FG001|2 Years|Study Termination|2|||
130509291|NCT02332889|469829740|FG000|Overall Study|Physician Decision|1|||
130509292|NCT04198428|469830842|FG000|Overall Study|Withdrawal by Subject|150|||
130509293|NCT04198428|469830843|FG001|Overall Study|Withdrawal by Subject|156|||
130509294|NCT00668746|469830844|FG000|Overall Study|Lost to Follow-up|2|||
130509295|NCT00668746|469830845|FG001|Overall Study|Lost to Follow-up|1|||
130509296|NCT02109172|469830846|FG000|Overall Study|Withdrawal by Subject|1|||
130509297|NCT02109172|469830847|FG001|Overall Study|Withdrawal by Subject|0|||
130509298|NCT02109172|469830848|FG002|Overall Study|Withdrawal by Subject|0|||
130509299|NCT02109172|469830849|FG003|Overall Study|Withdrawal by Subject|1|||
130509300|NCT02109172|469830850|FG004|Overall Study|Withdrawal by Subject|0|||
130509301|NCT02109172|469830851|FG005|Overall Study|Withdrawal by Subject|0|||
130509302|NCT02109172|469830846|FG000|Overall Study|Adverse Event|0|||
130509303|NCT02109172|469830847|FG001|Overall Study|Adverse Event|0|||
130509304|NCT02109172|469830848|FG002|Overall Study|Adverse Event|1|||
130509305|NCT02109172|469830849|FG003|Overall Study|Adverse Event|0|||
130509306|NCT02109172|469830850|FG004|Overall Study|Adverse Event|0|||
130567361|NCT02819635|470043502|FG010|Substudy 2, Part 2|Other, not specified|0|||
130509307|NCT02109172|469830851|FG005|Overall Study|Adverse Event|1|||
130509308|NCT02109172|469830846|FG000|Overall Study|Death|0|||
130509309|NCT02109172|469830847|FG001|Overall Study|Death|0|||
130509310|NCT02109172|469830848|FG002|Overall Study|Death|0|||
130509311|NCT02109172|469830849|FG003|Overall Study|Death|0|||
130509312|NCT02109172|469830850|FG004|Overall Study|Death|1|||
130509313|NCT02109172|469830851|FG005|Overall Study|Death|0|||
130509314|NCT02409732|469830854|FG000|Overall Study|Withdrawal by Subject|4|||
130509315|NCT02409732|469830854|FG000|Overall Study|Lost to Follow-up|2|||
130509316|NCT03960437|469830856|FG000|Overall Study|Removed by PI|4|||
130509317|NCT03960437|469830856|FG000|Overall Study|Lost to Follow-up|2|||
130509318|NCT03960437|469830856|FG000|Overall Study|Withdrawal by Subject|1|||
130509319|NCT03960437|469830856|FG000|Overall Study|Death|2|||
130509320|NCT00473512|469830859|FG000|Period 1 (Phase 1)|Adverse Event|0|||
130732939|NCT02101853|470641241|FG003|Block 1 Induction|Protocol Violation|0|||
130732940|NCT02101853|470641242|FG004|Block 1 Induction|Protocol Violation|0|||
130732941|NCT02101853|470641243|FG005|Block 1 Induction|Protocol Violation|0|||
130732942|NCT02101853|470641238|FG000|Block 1 Induction|Withdrawal by Subject|65|||
130732943|NCT02101853|470641239|FG001|Block 1 Induction|Withdrawal by Subject|0|||
130732944|NCT02101853|470641240|FG002|Block 1 Induction|Withdrawal by Subject|0|||
130732945|NCT02101853|470641241|FG003|Block 1 Induction|Withdrawal by Subject|0|||
130732946|NCT02101853|470641242|FG004|Block 1 Induction|Withdrawal by Subject|0|||
130732947|NCT02101853|470641243|FG005|Block 1 Induction|Withdrawal by Subject|0|||
130732948|NCT02101853|470641238|FG000|Block 1 Induction|Ineligible|8|||
130732949|NCT02101853|470641239|FG001|Block 1 Induction|Ineligible|0|||
130732950|NCT02101853|470641240|FG002|Block 1 Induction|Ineligible|0|||
130732951|NCT02101853|470641241|FG003|Block 1 Induction|Ineligible|0|||
130732952|NCT02101853|470641242|FG004|Block 1 Induction|Ineligible|0|||
130732953|NCT02101853|470641243|FG005|Block 1 Induction|Ineligible|0|||
130732954|NCT02101853|470641238|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
130732955|NCT02101853|470641239|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130732956|NCT02101853|470641240|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130732957|NCT02101853|470641241|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130732958|NCT02101853|470641242|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130732959|NCT02101853|470641243|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130732960|NCT02101853|470641238|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
130732961|NCT02101853|470641239|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130732962|NCT02101853|470641240|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130732963|NCT02101853|470641241|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130732964|NCT02101853|470641242|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130732965|NCT02101853|470641243|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130732966|NCT02101853|470641238|FG000|Post Induction Randomization|Adverse Event|0|||
130732967|NCT02101853|470641239|FG001|Post Induction Randomization|Adverse Event|3|||
130732968|NCT02101853|470641240|FG002|Post Induction Randomization|Adverse Event|8|||
130732969|NCT02101853|470641241|FG003|Post Induction Randomization|Adverse Event|4|||
130732970|NCT02101853|470641242|FG004|Post Induction Randomization|Adverse Event|4|||
130732971|NCT02101853|470641243|FG005|Post Induction Randomization|Adverse Event|0|||
130732972|NCT02101853|470641238|FG000|Post Induction Randomization|Death|0|||
130732973|NCT02101853|470641239|FG001|Post Induction Randomization|Death|9|||
130732974|NCT02101853|470641240|FG002|Post Induction Randomization|Death|2|||
130732975|NCT02101853|470641241|FG003|Post Induction Randomization|Death|2|||
130732976|NCT02101853|470641242|FG004|Post Induction Randomization|Death|0|||
130732977|NCT02101853|470641243|FG005|Post Induction Randomization|Death|0|||
130732978|NCT02101853|470641238|FG000|Post Induction Randomization|Lack of Efficacy|0|||
130732979|NCT02101853|470641239|FG001|Post Induction Randomization|Lack of Efficacy|14|||
130732980|NCT02101853|470641240|FG002|Post Induction Randomization|Lack of Efficacy|23|||
130732981|NCT02101853|470641241|FG003|Post Induction Randomization|Lack of Efficacy|18|||
130732982|NCT02101853|470641242|FG004|Post Induction Randomization|Lack of Efficacy|21|||
130732983|NCT02101853|470641243|FG005|Post Induction Randomization|Lack of Efficacy|0|||
130732984|NCT02101853|470641238|FG000|Post Induction Randomization|Physician Decision|0|||
130732985|NCT02101853|470641239|FG001|Post Induction Randomization|Physician Decision|43|||
130732986|NCT02101853|470641240|FG002|Post Induction Randomization|Physician Decision|23|||
130732987|NCT02101853|470641241|FG003|Post Induction Randomization|Physician Decision|14|||
130732988|NCT02101853|470641242|FG004|Post Induction Randomization|Physician Decision|14|||
130732989|NCT02101853|470641243|FG005|Post Induction Randomization|Physician Decision|0|||
130732990|NCT02101853|470641238|FG000|Post Induction Randomization|Protocol Violation|0|||
130732991|NCT02101853|470641239|FG001|Post Induction Randomization|Protocol Violation|3|||
130732992|NCT02101853|470641240|FG002|Post Induction Randomization|Protocol Violation|0|||
130732993|NCT02101853|470641241|FG003|Post Induction Randomization|Protocol Violation|0|||
130732994|NCT02101853|470641242|FG004|Post Induction Randomization|Protocol Violation|0|||
130732995|NCT02101853|470641243|FG005|Post Induction Randomization|Protocol Violation|0|||
130509321|NCT00473512|469830860|FG001|Period 1 (Phase 1)|Adverse Event|0|||
130509322|NCT00473512|469830861|FG002|Period 1 (Phase 1)|Adverse Event|0|||
130509323|NCT00473512|469830862|FG003|Period 1 (Phase 1)|Adverse Event|5|||
130732996|NCT02101853|470641238|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
130509324|NCT00473512|469830863|FG004|Period 1 (Phase 1)|Adverse Event|0|||
130509325|NCT00473512|469830859|FG000|Period 1 (Phase 1)|Death|0|||
130732997|NCT02101853|470641239|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
130732998|NCT02101853|470641240|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
130509326|NCT00473512|469830860|FG001|Period 1 (Phase 1)|Death|0|||
130732999|NCT02101853|470641241|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
130733000|NCT02101853|470641242|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
130733001|NCT02101853|470641243|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
130733002|NCT02101853|470641238|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130733003|NCT02101853|470641239|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130509327|NCT00473512|469830861|FG002|Period 1 (Phase 1)|Death|0|||
130509328|NCT00473512|469830862|FG003|Period 1 (Phase 1)|Death|1|||
130509329|NCT00473512|469830863|FG004|Period 1 (Phase 1)|Death|0|||
130509330|NCT00473512|469830859|FG000|Period 1 (Phase 1)|Disease Progression|1|||
130509331|NCT00473512|469830860|FG001|Period 1 (Phase 1)|Disease Progression|1|||
130509332|NCT00473512|469830861|FG002|Period 1 (Phase 1)|Disease Progression|0|||
130509333|NCT00473512|469830862|FG003|Period 1 (Phase 1)|Disease Progression|10|||
130509334|NCT00473512|469830863|FG004|Period 1 (Phase 1)|Disease Progression|1|||
130509335|NCT00473512|469830859|FG000|Period 1 (Phase 1)|Other|0|||
130509336|NCT00473512|469830860|FG001|Period 1 (Phase 1)|Other|0|||
130509337|NCT00473512|469830861|FG002|Period 1 (Phase 1)|Other|0|||
130509338|NCT00473512|469830862|FG003|Period 1 (Phase 1)|Other|1|||
130509339|NCT00473512|469830863|FG004|Period 1 (Phase 1)|Other|0|||
130509340|NCT00473512|469830859|FG000|Period 2 (Phase 2)|Adverse Event|0|||
130509341|NCT00473512|469830860|FG001|Period 2 (Phase 2)|Adverse Event|0|||
130509342|NCT00473512|469830861|FG002|Period 2 (Phase 2)|Adverse Event|0|||
130509343|NCT00473512|469830862|FG003|Period 2 (Phase 2)|Adverse Event|1|||
130509344|NCT00473512|469830863|FG004|Period 2 (Phase 2)|Adverse Event|0|||
130509345|NCT00473512|469830859|FG000|Period 2 (Phase 2)|Death|0|||
130509346|NCT00473512|469830860|FG001|Period 2 (Phase 2)|Death|0|||
130509347|NCT00473512|469830861|FG002|Period 2 (Phase 2)|Death|0|||
130509348|NCT00473512|469830862|FG003|Period 2 (Phase 2)|Death|1|||
130509349|NCT00473512|469830863|FG004|Period 2 (Phase 2)|Death|1|||
130509350|NCT00473512|469830859|FG000|Period 2 (Phase 2)|Disease Progression|0|||
130509351|NCT00473512|469830860|FG001|Period 2 (Phase 2)|Disease Progression|2|||
130509352|NCT00473512|469830861|FG002|Period 2 (Phase 2)|Disease Progression|2|||
130509353|NCT00473512|469830862|FG003|Period 2 (Phase 2)|Disease Progression|17|||
130509354|NCT00473512|469830863|FG004|Period 2 (Phase 2)|Disease Progression|1|||
130509355|NCT00473512|469830859|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
130509356|NCT00473512|469830860|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
130509357|NCT00473512|469830861|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
130509358|NCT00473512|469830862|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
130509359|NCT00473512|469830863|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
130509360|NCT00473512|469830859|FG000|Period 2 (Phase 2)|Other|1|||
130509361|NCT00473512|469830860|FG001|Period 2 (Phase 2)|Other|0|||
130509362|NCT00473512|469830861|FG002|Period 2 (Phase 2)|Other|0|||
130509363|NCT00473512|469830862|FG003|Period 2 (Phase 2)|Other|3|||
130509364|NCT00473512|469830863|FG004|Period 2 (Phase 2)|Other|0|||
130509365|NCT00267956|469830864|FG000|Controlled Period|Adverse Event|4|||
130509366|NCT00267956|469830865|FG001|Controlled Period|Adverse Event|1|||
130509367|NCT00267956|469830866|FG002|Controlled Period|Adverse Event|0|||
130509368|NCT00267956|469830867|FG003|Controlled Period|Adverse Event|0|||
130509369|NCT00267956|469830864|FG000|Controlled Period|Lack of Efficacy|4|||
130509370|NCT00267956|469830865|FG001|Controlled Period|Lack of Efficacy|2|||
130509371|NCT00267956|469830866|FG002|Controlled Period|Lack of Efficacy|0|||
130509372|NCT00267956|469830867|FG003|Controlled Period|Lack of Efficacy|0|||
130509373|NCT00267956|469830864|FG000|Controlled Period|Lost to Follow-up|2|||
130509374|NCT00267956|469830865|FG001|Controlled Period|Lost to Follow-up|0|||
130509375|NCT00267956|469830866|FG002|Controlled Period|Lost to Follow-up|0|||
130509376|NCT00267956|469830867|FG003|Controlled Period|Lost to Follow-up|0|||
130509377|NCT00267956|469830864|FG000|Controlled Period|Withdrew consent|3|||
130509378|NCT00267956|469830865|FG001|Controlled Period|Withdrew consent|1|||
130509379|NCT00267956|469830866|FG002|Controlled Period|Withdrew consent|0|||
130509380|NCT00267956|469830867|FG003|Controlled Period|Withdrew consent|0|||
130509381|NCT00267956|469830864|FG000|After Controlled Period|Adverse Event|0|||
130509382|NCT00267956|469830865|FG001|After Controlled Period|Adverse Event|0|||
130509383|NCT00267956|469830866|FG002|After Controlled Period|Adverse Event|2|||
130509384|NCT00267956|469830867|FG003|After Controlled Period|Adverse Event|1|||
130733004|NCT02101853|470641240|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130509385|NCT00267956|469830864|FG000|After Controlled Period|Lack of Efficacy|0|||
130509386|NCT00267956|469830865|FG001|After Controlled Period|Lack of Efficacy|0|||
130509387|NCT00267956|469830866|FG002|After Controlled Period|Lack of Efficacy|1|||
130509388|NCT00267956|469830867|FG003|After Controlled Period|Lack of Efficacy|1|||
130509389|NCT00267956|469830864|FG000|After Controlled Period|Lost to Follow-up|0|||
130509390|NCT00267956|469830865|FG001|After Controlled Period|Lost to Follow-up|0|||
130509391|NCT00267956|469830866|FG002|After Controlled Period|Lost to Follow-up|1|||
130509392|NCT00267956|469830867|FG003|After Controlled Period|Lost to Follow-up|0|||
130509393|NCT00267956|469830864|FG000|After Controlled Period|Withdrew consent|0|||
130509394|NCT00267956|469830865|FG001|After Controlled Period|Withdrew consent|0|||
130509395|NCT00267956|469830866|FG002|After Controlled Period|Withdrew consent|1|||
130733005|NCT02101853|470641241|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
130733006|NCT02101853|470641242|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130733007|NCT02101853|470641243|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130733008|NCT02101853|470641238|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130733009|NCT02101853|470641239|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
130733010|NCT02101853|470641240|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
130733011|NCT02101853|470641241|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130733012|NCT02101853|470641242|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130733013|NCT02101853|470641243|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130733014|NCT02101853|470641238|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733015|NCT02101853|470641239|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
130733016|NCT02101853|470641240|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733017|NCT02101853|470641241|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733018|NCT02101853|470641242|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733019|NCT02101853|470641243|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733020|NCT02101853|470641238|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130733021|NCT02101853|470641239|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130733022|NCT02101853|470641240|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130733023|NCT02101853|470641241|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
130733024|NCT02101853|470641242|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
130733025|NCT02101853|470641243|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130733026|NCT02101853|470641238|FG000|Blinatumomab Salvage Therapy|Death|0|||
130733027|NCT02101853|470641239|FG001|Blinatumomab Salvage Therapy|Death|0|||
130733028|NCT02101853|470641240|FG002|Blinatumomab Salvage Therapy|Death|0|||
130733029|NCT02101853|470641241|FG003|Blinatumomab Salvage Therapy|Death|0|||
130733030|NCT02101853|470641242|FG004|Blinatumomab Salvage Therapy|Death|0|||
130733031|NCT02101853|470641243|FG005|Blinatumomab Salvage Therapy|Death|2|||
130733032|NCT02101853|470641238|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130733033|NCT02101853|470641239|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130509396|NCT00267956|469830867|FG003|After Controlled Period|Withdrew consent|0|||
130733034|NCT02101853|470641240|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130509397|NCT01263223|469830868|FG000|Period 2|Withdrawal by Subject|0|||
130509398|NCT01263223|469830869|FG001|Period 2|Withdrawal by Subject|1|||
130509399|NCT01263223|469830868|FG000|7-day Follow-up|Withdrawal by Subject|0|||
130509400|NCT01263223|469830869|FG001|7-day Follow-up|Withdrawal by Subject|1|||
130509401|NCT01263223|469830868|FG000|7-day Follow-up|Lost to Follow-up|1|||
130509402|NCT01263223|469830869|FG001|7-day Follow-up|Lost to Follow-up|0|||
130509403|NCT02246647|469830870|FG000|Overall Study|Withdrawal by Subject|1|||
130509404|NCT02246647|469830871|FG001|Overall Study|Withdrawal by Subject|1|||
130509405|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
130509406|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
130509407|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
130509408|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
130509409|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
130509410|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
130509411|NCT03557307|469830872|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
130509412|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
130509413|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Death|3|||
130509414|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
130509415|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
130509416|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
130733035|NCT02101853|470641241|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130733036|NCT02101853|470641242|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130733037|NCT02101853|470641243|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
130733038|NCT02101853|470641238|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
130733039|NCT02101853|470641239|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
130733040|NCT02101853|470641240|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
130733041|NCT02101853|470641241|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
130733042|NCT02101853|470641242|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
130733043|NCT02101853|470641243|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
130733044|NCT02101853|470641238|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130733045|NCT02101853|470641239|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130733046|NCT02101853|470641240|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130733047|NCT02101853|470641241|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130509417|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
130509418|NCT03557307|469830872|FG000|Period 2: Maintenance Phase|other|3|||
130567362|NCT02819635|470043503|FG011|Substudy 2, Part 2|Other, not specified|0|||
130567363|NCT02819635|470043492|FG000|Substudy 3|Adverse Event|0|||
130567364|NCT02819635|470043493|FG001|Substudy 3|Adverse Event|0|||
130567365|NCT02819635|470043494|FG002|Substudy 3|Adverse Event|0|||
130567366|NCT02819635|470043495|FG003|Substudy 3|Adverse Event|0|||
130567367|NCT02819635|470043496|FG004|Substudy 3|Adverse Event|0|||
130567368|NCT02819635|470043497|FG005|Substudy 3|Adverse Event|0|||
130567369|NCT02819635|470043498|FG006|Substudy 3|Adverse Event|0|||
130567370|NCT02819635|470043499|FG007|Substudy 3|Adverse Event|0|||
130567371|NCT02819635|470043500|FG008|Substudy 3|Adverse Event|32|||
130567372|NCT02819635|470043501|FG009|Substudy 3|Adverse Event|3|||
130567373|NCT02819635|470043502|FG010|Substudy 3|Adverse Event|12|||
130567374|NCT02819635|470043503|FG011|Substudy 3|Adverse Event|18|||
130567375|NCT02819635|470043492|FG000|Substudy 3|Withdrew consent|0|||
130567376|NCT02819635|470043493|FG001|Substudy 3|Withdrew consent|0|||
130567377|NCT02819635|470043494|FG002|Substudy 3|Withdrew consent|0|||
130567378|NCT02819635|470043495|FG003|Substudy 3|Withdrew consent|0|||
130567379|NCT02819635|470043496|FG004|Substudy 3|Withdrew consent|0|||
130567380|NCT02819635|470043497|FG005|Substudy 3|Withdrew consent|0|||
130567381|NCT02819635|470043498|FG006|Substudy 3|Withdrew consent|0|||
130567382|NCT02819635|470043499|FG007|Substudy 3|Withdrew consent|0|||
130567383|NCT02819635|470043500|FG008|Substudy 3|Withdrew consent|11|||
130567384|NCT02819635|470043501|FG009|Substudy 3|Withdrew consent|1|||
130567385|NCT02819635|470043502|FG010|Substudy 3|Withdrew consent|4|||
130567386|NCT02819635|470043503|FG011|Substudy 3|Withdrew consent|9|||
130567387|NCT02819635|470043492|FG000|Substudy 3|Lost to Follow-up|0|||
130567388|NCT02819635|470043493|FG001|Substudy 3|Lost to Follow-up|0|||
130567389|NCT02819635|470043494|FG002|Substudy 3|Lost to Follow-up|0|||
130567390|NCT02819635|470043495|FG003|Substudy 3|Lost to Follow-up|0|||
130567391|NCT02819635|470043496|FG004|Substudy 3|Lost to Follow-up|0|||
130567392|NCT02819635|470043497|FG005|Substudy 3|Lost to Follow-up|0|||
130567393|NCT02819635|470043498|FG006|Substudy 3|Lost to Follow-up|0|||
130567394|NCT02819635|470043499|FG007|Substudy 3|Lost to Follow-up|0|||
130567395|NCT02819635|470043500|FG008|Substudy 3|Lost to Follow-up|1|||
130567396|NCT02819635|470043501|FG009|Substudy 3|Lost to Follow-up|0|||
130567397|NCT02819635|470043502|FG010|Substudy 3|Lost to Follow-up|1|||
130567398|NCT02819635|470043503|FG011|Substudy 3|Lost to Follow-up|1|||
130567399|NCT02819635|470043492|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567400|NCT02819635|470043493|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567401|NCT02819635|470043494|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567402|NCT02819635|470043495|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567403|NCT02819635|470043496|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567404|NCT02819635|470043497|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567405|NCT02819635|470043498|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567406|NCT02819635|470043499|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567407|NCT02819635|470043500|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567408|NCT02819635|470043501|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567409|NCT02819635|470043502|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
130567410|NCT02819635|470043503|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
130567411|NCT02819635|470043492|FG000|Substudy 3|Other, not specified|0|||
130567412|NCT02819635|470043493|FG001|Substudy 3|Other, not specified|0|||
130567413|NCT02819635|470043494|FG002|Substudy 3|Other, not specified|0|||
130567414|NCT02819635|470043495|FG003|Substudy 3|Other, not specified|0|||
130567415|NCT02819635|470043496|FG004|Substudy 3|Other, not specified|0|||
130567416|NCT02819635|470043497|FG005|Substudy 3|Other, not specified|0|||
130567417|NCT02819635|470043498|FG006|Substudy 3|Other, not specified|0|||
130567418|NCT02819635|470043499|FG007|Substudy 3|Other, not specified|0|||
130567419|NCT02819635|470043500|FG008|Substudy 3|Other, not specified|202|||
130567420|NCT02819635|470043501|FG009|Substudy 3|Other, not specified|5|||
130567421|NCT02819635|470043502|FG010|Substudy 3|Other, not specified|89|||
130567422|NCT02819635|470043503|FG011|Substudy 3|Other, not specified|39|||
130567423|NCT03179891|470043507|FG000|First Intervention|Withdrawal by Subject|1|||
130567424|NCT03179891|470043508|FG001|First Intervention|Withdrawal by Subject|1|||
130567425|NCT03179891|470043507|FG000|First Intervention|Unspecified reason|1|||
130567426|NCT03179891|470043508|FG001|First Intervention|Unspecified reason|0|||
130567427|NCT03179891|470043507|FG000|First Intervention|Protocol Violation|0|||
130567428|NCT03179891|470043508|FG001|First Intervention|Protocol Violation|1|||
130567429|NCT01438489|470043510|FG000|Overall Study|Lost to Follow-up|4|||
130567430|NCT01438489|470043511|FG001|Overall Study|Lost to Follow-up|2|||
130567431|NCT01438489|470043512|FG002|Overall Study|Lost to Follow-up|2|||
130567432|NCT01438489|470043510|FG000|Overall Study|Withdrawal by Subject|11|||
130567433|NCT01438489|470043511|FG001|Overall Study|Withdrawal by Subject|3|||
130567434|NCT01438489|470043512|FG002|Overall Study|Withdrawal by Subject|8|||
130567435|NCT01438489|470043510|FG000|Overall Study|Death|0|||
130567436|NCT01438489|470043511|FG001|Overall Study|Death|0|||
130733048|NCT02101853|470641242|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130733049|NCT02101853|470641243|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
130733050|NCT01638546|470641244|FG000|Overall Study|Adverse Event|1|||
130567437|NCT01438489|470043512|FG002|Overall Study|Death|1|||
130567438|NCT01438489|470043510|FG000|Overall Study|Sponsor decision|4|||
130567439|NCT01438489|470043511|FG001|Overall Study|Sponsor decision|1|||
130567440|NCT01438489|470043512|FG002|Overall Study|Sponsor decision|4|||
130567441|NCT01438489|470043510|FG000|Overall Study|Subject choice/Subject moved|2|||
130567442|NCT01438489|470043511|FG001|Overall Study|Subject choice/Subject moved|1|||
130567443|NCT01438489|470043512|FG002|Overall Study|Subject choice/Subject moved|1|||
130567444|NCT01438489|470043510|FG000|Overall Study|Investigator decision|0|||
130567445|NCT01438489|470043511|FG001|Overall Study|Investigator decision|1|||
130567446|NCT01438489|470043512|FG002|Overall Study|Investigator decision|0|||
130567447|NCT01438489|470043510|FG000|Overall Study|AE/SAEs|2|||
130567448|NCT01438489|470043511|FG001|Overall Study|AE/SAEs|1|||
130733051|NCT01638546|470641245|FG001|Overall Study|Adverse Event|3|||
130567449|NCT01438489|470043512|FG002|Overall Study|AE/SAEs|1|||
130567450|NCT01438489|470043510|FG000|Overall Study|Received prohibited medication|1|||
130567451|NCT01438489|470043511|FG001|Overall Study|Received prohibited medication|0|||
130567452|NCT01438489|470043512|FG002|Overall Study|Received prohibited medication|0|||
130567453|NCT01438489|470043510|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
130567454|NCT01438489|470043511|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
130567455|NCT01438489|470043512|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
130567456|NCT01438489|470043510|FG000|Overall Study|Inadequate venous access|0|||
130567457|NCT01438489|470043511|FG001|Overall Study|Inadequate venous access|2|||
130567458|NCT01438489|470043512|FG002|Overall Study|Inadequate venous access|0|||
130567459|NCT00751400|470043513|FG000|Overall Study|Lost to Follow-up|10|||
130567460|NCT00573430|470043514|FG000|Overall Study|Incorrect enrollment of randomization|0|||
130567461|NCT00573430|470043515|FG001|Overall Study|Incorrect enrollment of randomization|4|||
130567462|NCT00573430|470043516|FG002|Overall Study|Incorrect enrollment of randomization|3|||
130567463|NCT00573430|470043514|FG000|Overall Study|Adverse Event|0|||
130567464|NCT00573430|470043515|FG001|Overall Study|Adverse Event|0|||
130567465|NCT00573430|470043516|FG002|Overall Study|Adverse Event|2|||
130567466|NCT00573430|470043514|FG000|Overall Study|Withdrawal by Subject|1|||
130567467|NCT00573430|470043515|FG001|Overall Study|Withdrawal by Subject|0|||
130567468|NCT00573430|470043516|FG002|Overall Study|Withdrawal by Subject|1|||
130567469|NCT00573430|470043514|FG000|Overall Study|Protocol Violation|0|||
130567470|NCT00573430|470043515|FG001|Overall Study|Protocol Violation|1|||
130567471|NCT00573430|470043516|FG002|Overall Study|Protocol Violation|1|||
130567472|NCT00573430|470043514|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130567473|NCT00573430|470043515|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130567474|NCT00573430|470043516|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
130567475|NCT01148537|470043522|FG000|Overall Study|Withdrawal by Subject|1|||
130567476|NCT01148537|470043523|FG001|Overall Study|Withdrawal by Subject|0|||
130567477|NCT01148537|470043524|FG002|Overall Study|Withdrawal by Subject|2|||
130567478|NCT01148537|470043522|FG000|Overall Study|Adverse Event|2|||
130567479|NCT01148537|470043523|FG001|Overall Study|Adverse Event|0|||
130567480|NCT01148537|470043524|FG002|Overall Study|Adverse Event|1|||
130567481|NCT01324232|470043525|FG000|Overall Study|Protocol Violation|0|||
130567482|NCT01324232|470043526|FG001|Overall Study|Protocol Violation|0|||
130567483|NCT01324232|470043527|FG002|Overall Study|Protocol Violation|0|||
130567484|NCT01324232|470043528|FG003|Overall Study|Protocol Violation|2|||
130567485|NCT01324232|470043525|FG000|Overall Study|Missing|0|||
130567486|NCT01324232|470043526|FG001|Overall Study|Missing|0|||
130567487|NCT01324232|470043527|FG002|Overall Study|Missing|1|||
130567488|NCT01324232|470043528|FG003|Overall Study|Missing|0|||
130567489|NCT01324232|470043525|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
130567490|NCT01324232|470043526|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
130567491|NCT01324232|470043527|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
130567492|NCT01324232|470043528|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
130567493|NCT01324232|470043525|FG000|Overall Study|Lack of Efficacy|2|||
130567494|NCT01324232|470043526|FG001|Overall Study|Lack of Efficacy|1|||
130567495|NCT01324232|470043527|FG002|Overall Study|Lack of Efficacy|2|||
130567496|NCT01324232|470043528|FG003|Overall Study|Lack of Efficacy|2|||
130567497|NCT01324232|470043525|FG000|Overall Study|Participant Refused Medication|0|||
130567498|NCT01324232|470043526|FG001|Overall Study|Participant Refused Medication|1|||
130567499|NCT01324232|470043527|FG002|Overall Study|Participant Refused Medication|0|||
130567500|NCT01324232|470043528|FG003|Overall Study|Participant Refused Medication|0|||
130567501|NCT01324232|470043525|FG000|Overall Study|Intercurrent illness|0|||
130567502|NCT01324232|470043526|FG001|Overall Study|Intercurrent illness|0|||
130567503|NCT01324232|470043527|FG002|Overall Study|Intercurrent illness|0|||
130567504|NCT01324232|470043528|FG003|Overall Study|Intercurrent illness|1|||
130567505|NCT01324232|470043525|FG000|Overall Study|Adverse Event|2|||
130567506|NCT01324232|470043526|FG001|Overall Study|Adverse Event|5|||
130567507|NCT01324232|470043527|FG002|Overall Study|Adverse Event|6|||
130567508|NCT01324232|470043528|FG003|Overall Study|Adverse Event|6|||
130567509|NCT01324232|470043525|FG000|Overall Study|Withdrawal by Subject|0|||
130567510|NCT01324232|470043526|FG001|Overall Study|Withdrawal by Subject|3|||
130567511|NCT01324232|470043527|FG002|Overall Study|Withdrawal by Subject|4|||
130567512|NCT01324232|470043528|FG003|Overall Study|Withdrawal by Subject|0|||
130567513|NCT01324232|470043525|FG000|Overall Study|Lost to Follow-up|1|||
130567514|NCT01324232|470043526|FG001|Overall Study|Lost to Follow-up|0|||
130567515|NCT01324232|470043527|FG002|Overall Study|Lost to Follow-up|0|||
130567516|NCT01324232|470043528|FG003|Overall Study|Lost to Follow-up|0|||
130567517|NCT00661531|470043529|FG000|Overall Study|Withdrawal by Subject|3|||
130567518|NCT03134599|470043531|FG000|Week 1|Lost to Follow-up|0|||
130567519|NCT03134599|470043532|FG001|Week 1|Lost to Follow-up|0|||
130567520|NCT03134599|470043533|FG002|Week 1|Lost to Follow-up|0|||
130567521|NCT03134599|470043534|FG003|Week 1|Lost to Follow-up|0|||
130567522|NCT03134599|470043535|FG004|Week 1|Lost to Follow-up|1|||
130567523|NCT03134599|470043536|FG005|Week 1|Lost to Follow-up|0|||
130567524|NCT03134599|470043531|FG000|Week 2|Lost to Follow-up|1|||
130567525|NCT03134599|470043532|FG001|Week 2|Lost to Follow-up|0|||
130567526|NCT03134599|470043533|FG002|Week 2|Lost to Follow-up|0|||
130567527|NCT03134599|470043534|FG003|Week 2|Lost to Follow-up|1|||
130567528|NCT03134599|470043535|FG004|Week 2|Lost to Follow-up|1|||
130567529|NCT03134599|470043536|FG005|Week 2|Lost to Follow-up|0|||
130567530|NCT03134599|470043531|FG000|Week 3|Lost to Follow-up|0|||
130567531|NCT03134599|470043532|FG001|Week 3|Lost to Follow-up|0|||
130567532|NCT03134599|470043533|FG002|Week 3|Lost to Follow-up|0|||
130567533|NCT03134599|470043534|FG003|Week 3|Lost to Follow-up|1|||
130567534|NCT03134599|470043535|FG004|Week 3|Lost to Follow-up|0|||
130567535|NCT03134599|470043536|FG005|Week 3|Lost to Follow-up|1|||
130567536|NCT01356407|470043539|FG000|Overall Study|Lost to Follow-up|2|||
130567537|NCT01356407|470043540|FG001|Overall Study|Lost to Follow-up|0|||
130567538|NCT01356407|470043539|FG000|Overall Study|Patient Withdrew Consent|2|||
130567539|NCT01356407|470043540|FG001|Overall Study|Patient Withdrew Consent|1|||
130567540|NCT01356407|470043539|FG000|Overall Study|Could not afford IMP administration|0|||
130567541|NCT01356407|470043540|FG001|Overall Study|Could not afford IMP administration|1|||
130567542|NCT01356407|470043539|FG000|Overall Study|Not complete Endoscopy|2|||
130567543|NCT01356407|470043540|FG001|Overall Study|Not complete Endoscopy|2|||
130567544|NCT02018822|470043541|FG000|Overall Study|filling replaced by crown|0|||
130567545|NCT02018822|470043542|FG001|Overall Study|filling replaced by crown|1|||
130567546|NCT02018822|470043543|FG002|Overall Study|filling replaced by crown|0|||
130567547|NCT02018822|470043541|FG000|Overall Study|Physician Decision|0|||
130567548|NCT02018822|470043542|FG001|Overall Study|Physician Decision|1|||
130567549|NCT02018822|470043543|FG002|Overall Study|Physician Decision|1|||
130567550|NCT02018822|470043541|FG000|Overall Study|Lost to Follow-up|6|||
130567551|NCT02018822|470043542|FG001|Overall Study|Lost to Follow-up|6|||
130567552|NCT02018822|470043543|FG002|Overall Study|Lost to Follow-up|5|||
130567553|NCT03201458|470043544|FG000|Overall Study|No longer eligible|2|||
130567554|NCT03201458|470043545|FG001|Overall Study|No longer eligible|5|||
130567555|NCT03201458|470043544|FG000|Overall Study|Health event before starting|1|||
130567556|NCT03201458|470043545|FG001|Overall Study|Health event before starting|0|||
130567557|NCT03201458|470043544|FG000|Overall Study|Physician Decision|1|||
130567558|NCT03201458|470043545|FG001|Overall Study|Physician Decision|0|||
130567559|NCT00715026|470043548|FG000|Overall Study|Withdrawal by Subject|5|||
130567560|NCT00715026|470043548|FG000|Overall Study|Lost to Follow-up|3|||
130567561|NCT00715026|470043548|FG000|Overall Study|Protocol Violation|1|||
130567562|NCT00715026|470043548|FG000|Overall Study|Surgery done on non-study consented hip|1|||
130567563|NCT00750737|470043549|FG000|Overall Study|Withdrawal by Subject|3|||
130567564|NCT00750737|470043550|FG001|Overall Study|Withdrawal by Subject|3|||
130567565|NCT02614859|470043551|FG000|Overall Study|Physician Decision|0|||
130567566|NCT02614859|470043552|FG001|Overall Study|Physician Decision|1|||
130567567|NCT01389752|470043554|FG000|Study Period 1|Sponsor decision|0|||
130567568|NCT01389752|470043555|FG001|Study Period 1|Sponsor decision|2|||
130567569|NCT01389752|470043554|FG000|Study Period 2|Sponsor decision|1|||
130567570|NCT01389752|470043555|FG001|Study Period 2|Sponsor decision|0|||
130567571|NCT03975920|470043570|FG000|Overall Study|Lost to Follow-up|1|||
130567572|NCT03975920|470043571|FG001|Overall Study|Lost to Follow-up|2|||
130567573|NCT03975920|470043570|FG000|Overall Study|Protocol Violation|1|||
130567574|NCT03975920|470043571|FG001|Overall Study|Protocol Violation|1|||
130567575|NCT03975920|470043570|FG000|Overall Study|Did not complete survey|2|||
130567576|NCT03975920|470043571|FG001|Overall Study|Did not complete survey|1|||
130567577|NCT04251910|470043574|FG000|Overall Study|Covid 19 lockdown|0|||
130567578|NCT04251910|470043575|FG001|Overall Study|Covid 19 lockdown|5|||
130567579|NCT04251910|470043576|FG002|Overall Study|Covid 19 lockdown|0|||
130567580|NCT04251910|470043577|FG003|Overall Study|Covid 19 lockdown|4|||
130567581|NCT04251910|470043578|FG004|Overall Study|Covid 19 lockdown|0|||
130567582|NCT04251910|470043579|FG005|Overall Study|Covid 19 lockdown|0|||
130567583|NCT04251910|470043574|FG000|Overall Study|Assisted living facility was closed|0|||
130567584|NCT04251910|470043575|FG001|Overall Study|Assisted living facility was closed|0|||
130567585|NCT04251910|470043576|FG002|Overall Study|Assisted living facility was closed|0|||
130567586|NCT04251910|470043577|FG003|Overall Study|Assisted living facility was closed|0|||
130567587|NCT04251910|470043578|FG004|Overall Study|Assisted living facility was closed|1|||
130567588|NCT04251910|470043579|FG005|Overall Study|Assisted living facility was closed|0|||
130567589|NCT00808236|470043583|FG000|Overall Study|Was not resuscitated|50|||
130567590|NCT00808236|470043584|FG001|Overall Study|Was not resuscitated|56|||
130567591|NCT00808236|470043583|FG000|Overall Study|Pre-defined exclusion|13|||
130567592|NCT00808236|470043584|FG001|Overall Study|Pre-defined exclusion|3|||
130733052|NCT02994069|470641246|FG000|Overall Study|Death|7|||
130567593|NCT00808236|470043583|FG000|Overall Study|Lost to Follow-up|1|||
130733053|NCT02994069|470641247|FG001|Overall Study|Death|13|||
130567594|NCT00808236|470043584|FG001|Overall Study|Lost to Follow-up|1|||
130567595|NCT00808236|470043583|FG000|Overall Study|Physician Decision|0|||
130567596|NCT00808236|470043584|FG001|Overall Study|Physician Decision|1|||
130567597|NCT00808236|470043583|FG000|Overall Study|Death|18|||
130567598|NCT00808236|470043584|FG001|Overall Study|Death|30|||
130567599|NCT02230384|470043585|FG000|Phase 1|Lost to Follow-up|1|||
130733054|NCT02994069|470641246|FG000|Overall Study|Adverse Event|1|||
130567600|NCT02230384|470043586|FG001|Phase 1|Lost to Follow-up|0|||
130567601|NCT02230384|470043585|FG000|Phase 1|Physician Decision|0|||
130567602|NCT02230384|470043586|FG001|Phase 1|Physician Decision|1|||
130567603|NCT02230384|470043585|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
130567604|NCT02230384|470043586|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
130567605|NCT02230384|470043585|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
130567606|NCT02230384|470043586|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
130567607|NCT02230384|470043585|FG000|Phase 2 - Switch|Adverse Event|2|||
130567608|NCT02230384|470043586|FG001|Phase 2 - Switch|Adverse Event|0|||
130567609|NCT00777101|470043587|FG000|Overall Study|Death|48|||
130567610|NCT00777101|470043588|FG001|Overall Study|Death|43|||
130567611|NCT00777101|470043587|FG000|Overall Study|Withdrawal by Subject|11|||
130567612|NCT00777101|470043588|FG001|Overall Study|Withdrawal by Subject|6|||
130567613|NCT00777101|470043587|FG000|Overall Study|Lost to Follow-up|2|||
130567614|NCT00777101|470043588|FG001|Overall Study|Lost to Follow-up|1|||
130567615|NCT00777101|470043587|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130567616|NCT00777101|470043588|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130567617|NCT00777101|470043587|FG000|Overall Study|Failed to Return|0|||
130567618|NCT00777101|470043588|FG001|Overall Study|Failed to Return|1|||
130567619|NCT00961220|470043589|FG000|Overall Study|Adverse Event|3|||
130567620|NCT00961220|470043589|FG000|Overall Study|Lack of Efficacy|1|||
130567621|NCT00961220|470043589|FG000|Overall Study|No IV access for O6BG|1|||
130567622|NCT00961220|470043589|FG000|Overall Study|O6BG no longer supplied|1|||
130567623|NCT00961220|470043589|FG000|Overall Study|Complete Response prior to 12 courses|1|||
130567624|NCT01301950|470043594|FG000|Overall Study|Surgery was cancelled by patient|0|||
130567625|NCT01301950|470043595|FG001|Overall Study|Surgery was cancelled by patient|1|||
130567626|NCT00825162|470043600|FG000|Overall Study|Withdrawal by Subject|11|||
130567627|NCT00825162|470043601|FG001|Overall Study|Withdrawal by Subject|13|||
130567628|NCT00825162|470043602|FG002|Overall Study|Withdrawal by Subject|3|||
130567629|NCT00825162|470043600|FG000|Overall Study|Lost to Follow-up|9|||
130567630|NCT00825162|470043601|FG001|Overall Study|Lost to Follow-up|6|||
130567631|NCT00825162|470043602|FG002|Overall Study|Lost to Follow-up|3|||
130567632|NCT00825162|470043600|FG000|Overall Study|Physician Decision|2|||
130567633|NCT00825162|470043601|FG001|Overall Study|Physician Decision|0|||
130567634|NCT00825162|470043602|FG002|Overall Study|Physician Decision|0|||
130567635|NCT00825162|470043600|FG000|Overall Study|Move away from the study area|1|||
130567636|NCT00825162|470043601|FG001|Overall Study|Move away from the study area|0|||
130567637|NCT00825162|470043602|FG002|Overall Study|Move away from the study area|0|||
130567638|NCT00825162|470043600|FG000|Overall Study|Unable to attend the study visit|5|||
130567639|NCT00825162|470043601|FG001|Overall Study|Unable to attend the study visit|2|||
130567640|NCT00825162|470043602|FG002|Overall Study|Unable to attend the study visit|0|||
130567641|NCT00964743|470043603|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
130567642|NCT00781911|470043607|FG000|Overall Study|Adverse Event|4|||
130567643|NCT00781911|470043608|FG001|Overall Study|Adverse Event|4|||
130567644|NCT00781911|470043607|FG000|Overall Study|Withdrawal by Subject|1|||
130567645|NCT00781911|470043608|FG001|Overall Study|Withdrawal by Subject|2|||
130567646|NCT00781911|470043607|FG000|Overall Study|Physician Decision|0|||
130567647|NCT00781911|470043608|FG001|Overall Study|Physician Decision|2|||
130567648|NCT00781911|470043607|FG000|Overall Study|Sponsor Decision|1|||
130567649|NCT00781911|470043608|FG001|Overall Study|Sponsor Decision|0|||
130567650|NCT03317795|470043611|FG000|Overall Study|IUD Expulsion|1|||
130567651|NCT03317795|470043612|FG001|Overall Study|IUD Expulsion|0|||
130567652|NCT03317795|470043611|FG000|Overall Study|Lost to Follow-up|1|||
130567653|NCT03317795|470043612|FG001|Overall Study|Lost to Follow-up|3|||
130567654|NCT03317795|470043611|FG000|Overall Study|Treatment change|0|||
130567655|NCT03317795|470043612|FG001|Overall Study|Treatment change|3|||
130567656|NCT03317795|470043611|FG000|Overall Study|Intolerance of medication|0|||
130567657|NCT03317795|470043612|FG001|Overall Study|Intolerance of medication|1|||
130567658|NCT01549002|470043613|FG000|Overall Study|Excessive pain|0|||
130567659|NCT01549002|470043614|FG001|Overall Study|Excessive pain|2|||
130567660|NCT01549002|470043613|FG000|Overall Study|Moderate sedation required|0|||
130567661|NCT01549002|470043614|FG001|Overall Study|Moderate sedation required|2|||
130567662|NCT04066491|470043615|FG000|Overall Study|Randomized, not treated|0|||
130733055|NCT02994069|470641247|FG001|Overall Study|Adverse Event|0|||
130733056|NCT02994069|470641246|FG000|Overall Study|Other|2|||
130733057|NCT02994069|470641247|FG001|Overall Study|Other|0|||
130733058|NCT02994069|470641246|FG000|Overall Study|still on follow up/treatment|5|||
130733059|NCT02994069|470641247|FG001|Overall Study|still on follow up/treatment|6|||
130733060|NCT05212168|470641248|FG000|Overall Study|Lost to Follow-up|0|||
130567663|NCT04066491|470043616|FG001|Overall Study|Randomized, not treated|0|||
130567664|NCT04066491|470043617|FG002|Overall Study|Randomized, not treated|2|||
130567665|NCT00495820|470043618|FG000|Overall Study|Adverse Event|1|||
130567666|NCT00495820|470043619|FG001|Overall Study|Adverse Event|1|||
130567667|NCT00820950|470043620|FG000|Overall Study|Scheduling Conflict|0|||
130567668|NCT00820950|470043621|FG001|Overall Study|Scheduling Conflict|0|||
130733061|NCT05212168|470641249|FG001|Overall Study|Lost to Follow-up|3|||
130733062|NCT05212168|470641248|FG000|Overall Study|Study terminated by sponsor|30|||
130567669|NCT00820950|470043622|FG002|Overall Study|Scheduling Conflict|0|||
130567670|NCT00820950|470043623|FG003|Overall Study|Scheduling Conflict|0|||
130567671|NCT00820950|470043624|FG004|Overall Study|Scheduling Conflict|0|||
130567672|NCT00820950|470043625|FG005|Overall Study|Scheduling Conflict|0|||
130567673|NCT00820950|470043626|FG006|Overall Study|Scheduling Conflict|1|||
130567674|NCT00820950|470043627|FG007|Overall Study|Scheduling Conflict|1|||
130567675|NCT00820950|470043628|FG008|Overall Study|Scheduling Conflict|0|||
130567676|NCT00820950|470043629|FG009|Overall Study|Scheduling Conflict|0|||
130567677|NCT00820950|470043620|FG000|Overall Study|Protocol Violation|1|||
130567678|NCT00820950|470043621|FG001|Overall Study|Protocol Violation|1|||
130567679|NCT00820950|470043622|FG002|Overall Study|Protocol Violation|0|||
130567680|NCT00820950|470043623|FG003|Overall Study|Protocol Violation|0|||
130567681|NCT00820950|470043624|FG004|Overall Study|Protocol Violation|0|||
130567682|NCT00820950|470043625|FG005|Overall Study|Protocol Violation|0|||
130567683|NCT00820950|470043626|FG006|Overall Study|Protocol Violation|0|||
130567684|NCT00820950|470043627|FG007|Overall Study|Protocol Violation|0|||
130567685|NCT00820950|470043628|FG008|Overall Study|Protocol Violation|0|||
130567686|NCT00820950|470043629|FG009|Overall Study|Protocol Violation|0|||
130567687|NCT01423851|470043631|FG000|Whole Study|Disease progression|2|||
130567688|NCT01423851|470043632|FG001|Whole Study|Disease progression|1|||
130567689|NCT01423851|470043633|FG002|Whole Study|Disease progression|1|||
130567690|NCT01423851|470043634|FG003|Whole Study|Disease progression|4|||
130567691|NCT01423851|470043635|FG004|Whole Study|Disease progression|1|||
130567692|NCT01423851|470043636|FG005|Whole Study|Disease progression|3|||
130567693|NCT01423851|470043637|FG006|Whole Study|Disease progression|1|||
130567694|NCT01423851|470043638|FG007|Whole Study|Disease progression|4|||
130567695|NCT01423851|470043639|FG008|Whole Study|Disease progression|0|||
130567696|NCT01423851|470043640|FG009|Whole Study|Disease progression|2|||
130567697|NCT01423851|470043641|FG010|Whole Study|Disease progression|10|||
130567698|NCT01423851|470043631|FG000|Whole Study|Physician Decision|0|||
130567699|NCT01423851|470043632|FG001|Whole Study|Physician Decision|1|||
130567700|NCT01423851|470043633|FG002|Whole Study|Physician Decision|2|||
130567701|NCT01423851|470043634|FG003|Whole Study|Physician Decision|0|||
130567702|NCT01423851|470043635|FG004|Whole Study|Physician Decision|2|||
130567703|NCT01423851|470043636|FG005|Whole Study|Physician Decision|0|||
130567704|NCT01423851|470043637|FG006|Whole Study|Physician Decision|2|||
130567705|NCT01423851|470043638|FG007|Whole Study|Physician Decision|1|||
130567706|NCT01423851|470043639|FG008|Whole Study|Physician Decision|3|||
130567707|NCT01423851|470043640|FG009|Whole Study|Physician Decision|4|||
130567708|NCT01423851|470043641|FG010|Whole Study|Physician Decision|12|||
130567709|NCT01423851|470043631|FG000|Whole Study|Withdrawal by Subject|1|||
130567710|NCT01423851|470043632|FG001|Whole Study|Withdrawal by Subject|1|||
130567711|NCT01423851|470043633|FG002|Whole Study|Withdrawal by Subject|0|||
130567712|NCT01423851|470043634|FG003|Whole Study|Withdrawal by Subject|0|||
130567713|NCT01423851|470043635|FG004|Whole Study|Withdrawal by Subject|0|||
130567714|NCT01423851|470043636|FG005|Whole Study|Withdrawal by Subject|0|||
130567715|NCT01423851|470043637|FG006|Whole Study|Withdrawal by Subject|0|||
130567716|NCT01423851|470043638|FG007|Whole Study|Withdrawal by Subject|0|||
130567717|NCT01423851|470043639|FG008|Whole Study|Withdrawal by Subject|2|||
130567718|NCT01423851|470043640|FG009|Whole Study|Withdrawal by Subject|0|||
130567719|NCT01423851|470043641|FG010|Whole Study|Withdrawal by Subject|4|||
130567720|NCT01423851|470043631|FG000|Whole Study|Adverse Event|0|||
130567721|NCT01423851|470043632|FG001|Whole Study|Adverse Event|0|||
130567722|NCT01423851|470043633|FG002|Whole Study|Adverse Event|0|||
130567723|NCT01423851|470043634|FG003|Whole Study|Adverse Event|2|||
130567724|NCT01423851|470043635|FG004|Whole Study|Adverse Event|0|||
130567725|NCT01423851|470043636|FG005|Whole Study|Adverse Event|0|||
130567726|NCT01423851|470043637|FG006|Whole Study|Adverse Event|0|||
130567727|NCT01423851|470043638|FG007|Whole Study|Adverse Event|3|||
130567728|NCT01423851|470043639|FG008|Whole Study|Adverse Event|3|||
130567729|NCT01423851|470043640|FG009|Whole Study|Adverse Event|2|||
130567730|NCT01423851|470043641|FG010|Whole Study|Adverse Event|3|||
130567731|NCT03416153|470043642|FG000|Overall Study|Physician Decision|1|||
130567732|NCT03416153|470043643|FG001|Overall Study|Physician Decision|1|||
130567733|NCT03416153|470043642|FG000|Overall Study|Withdrawal by Subject|1|||
130567734|NCT03416153|470043643|FG001|Overall Study|Withdrawal by Subject|0|||
130567735|NCT00916357|470045616|FG000|Period 1|Withdrawal by Subject|1|||
130567736|NCT00916357|470045617|FG001|Period 1|Withdrawal by Subject|0|||
130567737|NCT00916357|470045618|FG002|Period 1|Withdrawal by Subject|0|||
130567738|NCT00916357|470045619|FG003|Period 1|Withdrawal by Subject|0|||
130567739|NCT00916357|470045620|FG004|Period 1|Withdrawal by Subject|0|||
130733063|NCT05212168|470641249|FG001|Overall Study|Study terminated by sponsor|27|||
130733064|NCT05212168|470641248|FG000|Overall Study|Other|4|||
130733065|NCT05212168|470641249|FG001|Overall Study|Other|7|||
130733066|NCT00936390|470641250|FG000|Overall Study|Protocol Violation|21|||
130567740|NCT00916357|470045621|FG005|Period 1|Withdrawal by Subject|0|||
130567741|NCT00916357|470045616|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
130567742|NCT00916357|470045617|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
130733067|NCT00936390|470641251|FG001|Overall Study|Protocol Violation|25|||
130567743|NCT00916357|470045618|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
130567744|NCT00916357|470045619|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
130567745|NCT00916357|470045620|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
130567746|NCT00916357|470045621|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
130733068|NCT05905783|470641252|FG000|Overall Study|Lost to Follow-up|12|||
130509419|NCT03184519|469830873|FG000|Overall Study|Lost to Follow-up|6|||
130509420|NCT03184519|469830873|FG000|Overall Study|Physician Decision|21|||
130509421|NCT00584909|469830874|FG000|Overall Study|Adverse Event|4|||
130567747|NCT01773109|470045622|FG000|Overall Study|Symptomatic Progression|2|||
130567748|NCT01773109|470045622|FG000|Overall Study|Death|1|||
130567749|NCT01239342|470045623|FG000|Overall Study|Adverse Event|1|||
130567750|NCT01239342|470045624|FG001|Overall Study|Adverse Event|0|||
130567751|NCT01239342|470045623|FG000|Overall Study|Withdrawal by Subject|1|||
130567752|NCT01239342|470045624|FG001|Overall Study|Withdrawal by Subject|5|||
130567753|NCT01239342|470045623|FG000|Overall Study|Reason Unknown|1|||
130567754|NCT01239342|470045624|FG001|Overall Study|Reason Unknown|1|||
130567755|NCT02495844|470045625|FG000|Overall Study|Lack of Efficacy|1|||
130567756|NCT02495844|470045626|FG001|Overall Study|Lack of Efficacy|2|||
130567757|NCT02495844|470045625|FG000|Overall Study|AE, non-fatal|0|||
130567758|NCT02495844|470045626|FG001|Overall Study|AE, non-fatal|1|||
130567759|NCT02495844|470045625|FG000|Overall Study|Hepatitis Positivity|0|||
130567760|NCT02495844|470045626|FG001|Overall Study|Hepatitis Positivity|1|||
130567761|NCT02325219|470045629|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
130567762|NCT02325219|470045630|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
130567763|NCT02325219|470045631|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130567764|NCT02325219|470045632|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130567765|NCT02325219|470045633|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130567766|NCT02325219|470045629|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
130567767|NCT02325219|470045630|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
130567768|NCT02325219|470045631|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130567769|NCT02325219|470045632|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130567770|NCT02325219|470045633|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130567771|NCT02325219|470045629|FG000|Controlled Period (Week 0 - 16)|Other|0|||
130567772|NCT02325219|470045630|FG001|Controlled Period (Week 0 - 16)|Other|0|||
130567773|NCT02325219|470045631|FG002|Controlled Period (Week 0 - 16)|Other|1|||
130567774|NCT02325219|470045632|FG003|Controlled Period (Week 0 - 16)|Other|0|||
130567775|NCT02325219|470045633|FG004|Controlled Period (Week 0 - 16)|Other|0|||
130567776|NCT02325219|470045629|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130567777|NCT02325219|470045630|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130567778|NCT02325219|470045631|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130567779|NCT02325219|470045632|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130567780|NCT02325219|470045633|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
130567781|NCT02325219|470045629|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130567782|NCT02325219|470045630|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
130567783|NCT02325219|470045631|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130567784|NCT02325219|470045632|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130567785|NCT02325219|470045633|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130567786|NCT02325219|470045629|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130567787|NCT02325219|470045630|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
130567788|NCT02325219|470045631|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130567789|NCT02325219|470045632|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130567790|NCT02325219|470045633|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130567791|NCT02918864|470045634|FG000|Overall Study|Withdrawal by Subject|1|||
130567792|NCT02918864|470045635|FG001|Overall Study|Withdrawal by Subject|1|||
130567793|NCT02918864|470045634|FG000|Overall Study|Lost to Follow-up|3|||
130567794|NCT02918864|470045635|FG001|Overall Study|Lost to Follow-up|2|||
130567795|NCT04766021|470045636|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
130567796|NCT04766021|470045636|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
130567797|NCT02257372|470045640|FG000|Overall Study|Adverse Event|3|||
130567798|NCT02257372|470045641|FG001|Overall Study|Adverse Event|7|||
130567799|NCT02257372|470045640|FG000|Overall Study|Lack of Efficacy|2|||
130567800|NCT02257372|470045641|FG001|Overall Study|Lack of Efficacy|1|||
130567801|NCT02257372|470045640|FG000|Overall Study|Protocol Violation|1|||
130567802|NCT02257372|470045641|FG001|Overall Study|Protocol Violation|1|||
130567803|NCT02257372|470045640|FG000|Overall Study|Lost to Follow-up|0|||
130567804|NCT02257372|470045641|FG001|Overall Study|Lost to Follow-up|1|||
130567805|NCT02257372|470045640|FG000|Overall Study|Withdrew consent|1|||
130567806|NCT02257372|470045641|FG001|Overall Study|Withdrew consent|0|||
130567807|NCT00789529|470045642|FG000|Overall Study|Withdrawal by Subject|0|||
130567808|NCT00789529|470045643|FG001|Overall Study|Withdrawal by Subject|1|||
130567809|NCT00789529|470045642|FG000|Overall Study|Other Reason|1|||
130567810|NCT00789529|470045643|FG001|Overall Study|Other Reason|0|||
130567811|NCT02634151|470045644|FG000|Overall Study|Withdrawal by Subject|1|||
130567812|NCT02634151|470045645|FG001|Overall Study|Withdrawal by Subject|0|||
130567813|NCT02634151|470045644|FG000|Overall Study|Non-Compliance|0|||
130567814|NCT02634151|470045645|FG001|Overall Study|Non-Compliance|1|||
130567815|NCT02634151|470045644|FG000|Overall Study|Other|0|||
130733069|NCT05905783|470641253|FG001|Overall Study|Lost to Follow-up|18|||
130567816|NCT02634151|470045645|FG001|Overall Study|Other|1|||
130567817|NCT02347098|470045646|FG000|Overall Study|Death|1|||
130567818|NCT02347098|470045647|FG001|Overall Study|Death|0|||
130733070|NCT05905783|470641252|FG000|Overall Study|Withdrawal by Subject|29|||
130509422|NCT03345407|469830875|FG000|Overall Study|Withdrawal by Subject|11|||
130509423|NCT03345407|469830876|FG001|Overall Study|Withdrawal by Subject|1|||
130509424|NCT03345407|469830877|FG002|Overall Study|Withdrawal by Subject|5|||
130509425|NCT03345407|469830878|FG003|Overall Study|Withdrawal by Subject|6|||
130509426|NCT03345407|469830879|FG004|Overall Study|Withdrawal by Subject|3|||
130509427|NCT03345407|469830880|FG005|Overall Study|Withdrawal by Subject|6|||
130509428|NCT03345407|469830881|FG006|Overall Study|Withdrawal by Subject|16|||
130509429|NCT03345407|469830875|FG000|Overall Study|Physician Decision|3|||
130509430|NCT03345407|469830876|FG001|Overall Study|Physician Decision|1|||
130509431|NCT03345407|469830877|FG002|Overall Study|Physician Decision|0|||
130509432|NCT03345407|469830878|FG003|Overall Study|Physician Decision|0|||
130509433|NCT03345407|469830879|FG004|Overall Study|Physician Decision|1|||
130509434|NCT03345407|469830880|FG005|Overall Study|Physician Decision|2|||
130509435|NCT03345407|469830881|FG006|Overall Study|Physician Decision|3|||
130509436|NCT03345407|469830875|FG000|Overall Study|Lost to Follow-up|2|||
130509437|NCT03345407|469830876|FG001|Overall Study|Lost to Follow-up|0|||
130509438|NCT03345407|469830877|FG002|Overall Study|Lost to Follow-up|1|||
130509439|NCT03345407|469830878|FG003|Overall Study|Lost to Follow-up|0|||
130509440|NCT03345407|469830879|FG004|Overall Study|Lost to Follow-up|1|||
130509441|NCT03345407|469830880|FG005|Overall Study|Lost to Follow-up|2|||
130509442|NCT03345407|469830881|FG006|Overall Study|Lost to Follow-up|3|||
130509443|NCT03345407|469830875|FG000|Overall Study|Protocol-defined stopping criteria|9|||
130509444|NCT03345407|469830876|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130509445|NCT03345407|469830877|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130509446|NCT03345407|469830878|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130509447|NCT03345407|469830879|FG004|Overall Study|Protocol-defined stopping criteria|2|||
130509448|NCT03345407|469830880|FG005|Overall Study|Protocol-defined stopping criteria|1|||
130509449|NCT03345407|469830881|FG006|Overall Study|Protocol-defined stopping criteria|1|||
130509450|NCT03345407|469830875|FG000|Overall Study|Protocol Violation|2|||
130509451|NCT03345407|469830876|FG001|Overall Study|Protocol Violation|0|||
130509452|NCT03345407|469830877|FG002|Overall Study|Protocol Violation|0|||
130509453|NCT03345407|469830878|FG003|Overall Study|Protocol Violation|0|||
130509454|NCT03345407|469830879|FG004|Overall Study|Protocol Violation|1|||
130509455|NCT03345407|469830880|FG005|Overall Study|Protocol Violation|0|||
130509456|NCT03345407|469830881|FG006|Overall Study|Protocol Violation|3|||
130509457|NCT03345407|469830875|FG000|Overall Study|Lack of Efficacy|1|||
130509458|NCT03345407|469830876|FG001|Overall Study|Lack of Efficacy|1|||
130509459|NCT03345407|469830877|FG002|Overall Study|Lack of Efficacy|1|||
130509460|NCT03345407|469830878|FG003|Overall Study|Lack of Efficacy|1|||
130509461|NCT03345407|469830879|FG004|Overall Study|Lack of Efficacy|1|||
130509462|NCT03345407|469830880|FG005|Overall Study|Lack of Efficacy|0|||
130509463|NCT03345407|469830881|FG006|Overall Study|Lack of Efficacy|3|||
130509464|NCT03345407|469830875|FG000|Overall Study|Adverse Event|4|||
130509465|NCT03345407|469830876|FG001|Overall Study|Adverse Event|0|||
130509466|NCT03345407|469830877|FG002|Overall Study|Adverse Event|5|||
130509467|NCT03345407|469830878|FG003|Overall Study|Adverse Event|4|||
130509468|NCT03345407|469830879|FG004|Overall Study|Adverse Event|6|||
130509469|NCT03345407|469830880|FG005|Overall Study|Adverse Event|5|||
130509470|NCT03345407|469830881|FG006|Overall Study|Adverse Event|16|||
130509471|NCT01989156|469830894|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
130509472|NCT01989156|469830895|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130509473|NCT01989156|469830896|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
130509474|NCT01989156|469830894|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
130509475|NCT01989156|469830895|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
130509476|NCT01989156|469830896|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
130509477|NCT01989156|469830894|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
130509478|NCT01989156|469830895|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
130509479|NCT01989156|469830896|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
130509480|NCT01989156|469830894|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
130509481|NCT01989156|469830895|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
130509482|NCT01989156|469830896|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
130509483|NCT01989156|469830894|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
130509484|NCT01989156|469830895|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
130509485|NCT01989156|469830896|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
130509486|NCT01989156|469830894|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
130567819|NCT02347098|470045646|FG000|Overall Study|Withdrawal by Subject|1|||
130509487|NCT01989156|469830895|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
130509488|NCT01989156|469830896|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
130509489|NCT01989156|469830894|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
130509490|NCT01989156|469830895|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
130509491|NCT01989156|469830896|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
130509492|NCT01989156|469830894|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
130567820|NCT02347098|470045647|FG001|Overall Study|Withdrawal by Subject|0|||
130567821|NCT02347098|470045646|FG000|Overall Study|Lost to Follow-up|2|||
130567822|NCT02347098|470045647|FG001|Overall Study|Lost to Follow-up|2|||
130567823|NCT02347098|470045646|FG000|Overall Study|Refuse Follow-up Visit|1|||
130567824|NCT02347098|470045647|FG001|Overall Study|Refuse Follow-up Visit|5|||
130567825|NCT02347098|470045646|FG000|Overall Study|no visit due to illness|2|||
130567826|NCT02347098|470045647|FG001|Overall Study|no visit due to illness|1|||
130567827|NCT02187172|470045648|FG000|Overall Study|Lost to Follow-up|1|||
130567828|NCT02187172|470045649|FG001|Overall Study|Lost to Follow-up|2|||
130567829|NCT02187172|470045648|FG000|Overall Study|Lack of Efficacy|1|||
130567830|NCT02187172|470045649|FG001|Overall Study|Lack of Efficacy|2|||
130567831|NCT02187172|470045648|FG000|Overall Study|Adverse Event|0|||
130567832|NCT02187172|470045649|FG001|Overall Study|Adverse Event|1|||
130567833|NCT02187172|470045648|FG000|Overall Study|Physician Decision|1|||
130567834|NCT02187172|470045649|FG001|Overall Study|Physician Decision|1|||
130567835|NCT00880399|470045650|FG000|Overall Study|Adverse Event|4|||
130567836|NCT00880399|470045651|FG001|Overall Study|Adverse Event|6|||
130567837|NCT00880399|470045652|FG002|Overall Study|Adverse Event|5|||
130567838|NCT00880399|470045650|FG000|Overall Study|Lack of Efficacy|1|||
130567839|NCT00880399|470045651|FG001|Overall Study|Lack of Efficacy|4|||
130567840|NCT00880399|470045652|FG002|Overall Study|Lack of Efficacy|2|||
130567841|NCT00880399|470045650|FG000|Overall Study|Protocol Violation|4|||
130567842|NCT00880399|470045651|FG001|Overall Study|Protocol Violation|4|||
130567843|NCT00880399|470045652|FG002|Overall Study|Protocol Violation|6|||
130567844|NCT00880399|470045650|FG000|Overall Study|Study closed/terminated|3|||
130567845|NCT00880399|470045651|FG001|Overall Study|Study closed/terminated|7|||
130567846|NCT00880399|470045652|FG002|Overall Study|Study closed/terminated|4|||
130567847|NCT00880399|470045650|FG000|Overall Study|Lost to Follow-up|8|||
130567848|NCT00880399|470045651|FG001|Overall Study|Lost to Follow-up|5|||
130567849|NCT00880399|470045652|FG002|Overall Study|Lost to Follow-up|3|||
130567850|NCT00880399|470045650|FG000|Overall Study|Physician Decision|5|||
130567851|NCT00880399|470045651|FG001|Overall Study|Physician Decision|0|||
130567852|NCT00880399|470045652|FG002|Overall Study|Physician Decision|3|||
130567853|NCT00880399|470045650|FG000|Overall Study|Withdrawal by Subject|6|||
130567854|NCT00880399|470045651|FG001|Overall Study|Withdrawal by Subject|3|||
130567855|NCT00880399|470045652|FG002|Overall Study|Withdrawal by Subject|3|||
130567856|NCT04353284|470045657|FG000|Overall Study|Adverse Event|1|||
130567857|NCT04353284|470045658|FG001|Overall Study|Adverse Event|1|||
130567858|NCT04353284|470045657|FG000|Overall Study|Lost to Follow-up|1|||
130567859|NCT04353284|470045658|FG001|Overall Study|Lost to Follow-up|0|||
130567860|NCT00766532|470045667|FG000|Overall Study|Protocol Violation|2|||
130567861|NCT02424253|470045670|FG000|Overall Study|Other, unspecified|1|||
130567862|NCT02424253|470045671|FG001|Overall Study|Other, unspecified|0|||
130567863|NCT02424253|470045670|FG000|Overall Study|Compliance problems|1|||
130567864|NCT02424253|470045671|FG001|Overall Study|Compliance problems|0|||
130567865|NCT02424253|470045670|FG000|Overall Study|Physician Decision|2|||
130567866|NCT02424253|470045671|FG001|Overall Study|Physician Decision|0|||
130567867|NCT02424253|470045670|FG000|Overall Study|Lack of Efficacy|0|||
130567868|NCT02424253|470045671|FG001|Overall Study|Lack of Efficacy|7|||
130567869|NCT02424253|470045670|FG000|Overall Study|Adverse Event|2|||
130567870|NCT02424253|470045671|FG001|Overall Study|Adverse Event|0|||
130567871|NCT02424253|470045670|FG000|Overall Study|Consent withdrawn by subject|4|||
130567872|NCT02424253|470045671|FG001|Overall Study|Consent withdrawn by subject|1|||
130567873|NCT02424253|470045670|FG000|Overall Study|Lost to Follow-up|1|||
130567874|NCT02424253|470045671|FG001|Overall Study|Lost to Follow-up|1|||
130567875|NCT02370615|470045674|FG000|Overall Study|Adverse Event|1|||
130567876|NCT02370615|470045675|FG001|Overall Study|Adverse Event|0|||
130567877|NCT02290873|470045676|FG000|Overall Study|Withdrawal by Subject|0|||
130567878|NCT02290873|470045677|FG001|Overall Study|Withdrawal by Subject|1|||
130567879|NCT02290873|470045678|FG002|Overall Study|Withdrawal by Subject|1|||
130567880|NCT02290873|470045676|FG000|Overall Study|Nellcor device error|1|||
130567881|NCT02290873|470045677|FG001|Overall Study|Nellcor device error|0|||
130733071|NCT05905783|470641253|FG001|Overall Study|Withdrawal by Subject|37|||
130733072|NCT05905783|470641252|FG000|Overall Study|Decision by sponsor|69|||
130733073|NCT05905783|470641253|FG001|Overall Study|Decision by sponsor|65|||
130733074|NCT03907488|470641983|FG000|Overall Study|Adverse Event|20|||
130733075|NCT03907488|470641984|FG001|Overall Study|Adverse Event|20|||
130567882|NCT02290873|470045678|FG002|Overall Study|Nellcor device error|0|||
130567883|NCT02290873|470045676|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
130567884|NCT02290873|470045677|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
130567885|NCT02290873|470045678|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
130567886|NCT02290873|470045676|FG000|Overall Study|Protocol Violation|0|||
130567887|NCT02290873|470045677|FG001|Overall Study|Protocol Violation|0|||
130567888|NCT02290873|470045678|FG002|Overall Study|Protocol Violation|1|||
130733076|NCT03907488|470641983|FG000|Overall Study|Withdrawal by Subject|9|||
130567889|NCT01378104|470045679|FG000|Overall Study|Adverse Event|8|||
130567890|NCT01378104|470045680|FG001|Overall Study|Adverse Event|8|||
130567891|NCT01378104|470045679|FG000|Overall Study|Lack of Efficacy|7|||
130567892|NCT01378104|470045680|FG001|Overall Study|Lack of Efficacy|5|||
130567893|NCT01378104|470045679|FG000|Overall Study|Withdrawal by Subject|12|||
130567894|NCT01378104|470045680|FG001|Overall Study|Withdrawal by Subject|13|||
130567895|NCT02700997|470045681|FG000|Overall Study|Did not undergo CT imaging|1|||
130567896|NCT02700997|470045681|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
130567897|NCT01519765|470045682|FG000|Overall Study|Adverse Event|0|||
130567898|NCT01519765|470045683|FG001|Overall Study|Adverse Event|1|||
130567899|NCT01519765|470045682|FG000|Overall Study|Lack of Efficacy|2|||
130567900|NCT01519765|470045683|FG001|Overall Study|Lack of Efficacy|0|||
130567901|NCT01519765|470045682|FG000|Overall Study|Protocol Violation|1|||
130567902|NCT01519765|470045683|FG001|Overall Study|Protocol Violation|0|||
130567903|NCT01519765|470045682|FG000|Overall Study|Withdrawal by Subject|0|||
130567904|NCT01519765|470045683|FG001|Overall Study|Withdrawal by Subject|1|||
130567905|NCT01473563|470045684|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
130567906|NCT03610724|470045685|FG000|Overall Study|Death|17|||
130567907|NCT03610724|470045685|FG000|Overall Study|Lost to Follow-up|1|||
130567908|NCT03610724|470045685|FG000|Overall Study|Physician Decision|1|||
130567909|NCT03610724|470045685|FG000|Overall Study|Died prior to infusion|1|||
130567910|NCT02354222|470045686|FG000|Overall Study|Adverse Event|0|||
130567911|NCT02354222|470045687|FG001|Overall Study|Adverse Event|3|||
130567912|NCT02354222|470045686|FG000|Overall Study|Physician Decision|1|||
130567913|NCT02354222|470045687|FG001|Overall Study|Physician Decision|1|||
130567914|NCT02354222|470045686|FG000|Overall Study|Pregnancy|1|||
130567915|NCT02354222|470045687|FG001|Overall Study|Pregnancy|0|||
130567916|NCT02354222|470045686|FG000|Overall Study|Withdrawal by Subject|2|||
130567917|NCT02354222|470045687|FG001|Overall Study|Withdrawal by Subject|3|||
130567918|NCT02354222|470045686|FG000|Overall Study|Conflict with the stopping criteria|0|||
130567919|NCT02354222|470045687|FG001|Overall Study|Conflict with the stopping criteria|4|||
130567920|NCT00786565|470045688|FG000|Enrollment Prior to Surgery|Site Closed|3|||
130567921|NCT00786565|470045688|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
130567922|NCT00786565|470045688|FG000|Post Surgery|Abnormal macular pucker|1|||
130567923|NCT00786565|470045688|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
130567924|NCT00432042|470045698|FG000|Overall Study|Protocol Violation|2|||
130567925|NCT00432042|470045699|FG001|Overall Study|Protocol Violation|0|||
130567926|NCT00432042|470045700|FG002|Overall Study|Protocol Violation|0|||
130567927|NCT00432042|470045698|FG000|Overall Study|Withdrawal by Subject|0|||
130567928|NCT00432042|470045699|FG001|Overall Study|Withdrawal by Subject|0|||
130567929|NCT00432042|470045700|FG002|Overall Study|Withdrawal by Subject|2|||
130567930|NCT00432042|470045698|FG000|Overall Study|Lost to Follow-up|5|||
130567931|NCT00432042|470045699|FG001|Overall Study|Lost to Follow-up|1|||
130567932|NCT00432042|470045700|FG002|Overall Study|Lost to Follow-up|0|||
130567933|NCT01585272|470045702|FG000|Overall Study|Adverse Event|22|||
130567934|NCT01585272|470045702|FG000|Overall Study|Protocol Violation|7|||
130567935|NCT01585272|470045702|FG000|Overall Study|Withdrawal by Subject|10|||
130567936|NCT03765138|470045707|FG000|Overall Study|Lost to Follow-up|1|||
130567937|NCT03803059|470045709|FG000|Overall Study|Protocol Violation|2|||
130567938|NCT03803059|470045709|FG000|Overall Study|Lost to Follow-up|1|||
130567939|NCT04013529|470045712|FG000|Overall Study|Withdrawal by Subject|1|||
130567940|NCT04013529|470045713|FG001|Overall Study|Withdrawal by Subject|1|||
130567941|NCT03116698|470045714|FG000|Overall Study|Adverse Event|1|||
130567942|NCT03116698|470045715|FG001|Overall Study|Adverse Event|1|||
130567943|NCT03116698|470045716|FG002|Overall Study|Adverse Event|1|||
130567944|NCT03116698|470045717|FG003|Overall Study|Adverse Event|0|||
130567945|NCT03116698|470045714|FG000|Overall Study|Withdrawal by Subject|1|||
130567946|NCT03116698|470045715|FG001|Overall Study|Withdrawal by Subject|4|||
130567947|NCT03116698|470045716|FG002|Overall Study|Withdrawal by Subject|5|||
130567948|NCT03116698|470045717|FG003|Overall Study|Withdrawal by Subject|2|||
130567949|NCT03116698|470045714|FG000|Overall Study|Lost to Follow-up|2|||
130567950|NCT03116698|470045715|FG001|Overall Study|Lost to Follow-up|0|||
130567951|NCT03116698|470045716|FG002|Overall Study|Lost to Follow-up|0|||
130567952|NCT03116698|470045717|FG003|Overall Study|Lost to Follow-up|0|||
130567953|NCT03116698|470045714|FG000|Overall Study|Physician Decision|1|||
130567954|NCT03116698|470045715|FG001|Overall Study|Physician Decision|1|||
130567955|NCT03116698|470045716|FG002|Overall Study|Physician Decision|0|||
130567956|NCT03116698|470045717|FG003|Overall Study|Physician Decision|0|||
130567957|NCT03116698|470045714|FG000|Overall Study|Protocol Violation|1|||
130567958|NCT03116698|470045715|FG001|Overall Study|Protocol Violation|0|||
130567959|NCT03116698|470045716|FG002|Overall Study|Protocol Violation|0|||
130567960|NCT03116698|470045717|FG003|Overall Study|Protocol Violation|0|||
130567961|NCT03116698|470045714|FG000|Overall Study|Death|0|||
130567962|NCT03116698|470045715|FG001|Overall Study|Death|0|||
130567963|NCT03116698|470045716|FG002|Overall Study|Death|2|||
130567964|NCT03116698|470045717|FG003|Overall Study|Death|0|||
130567965|NCT00788372|470045718|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
130567966|NCT00788372|470045718|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
130567967|NCT00788372|470045718|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
130567968|NCT00788372|470045718|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
130567969|NCT00788372|470045718|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
130567970|NCT00788372|470045718|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
130567971|NCT00788372|470045718|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
130567972|NCT03099187|470045725|FG000|Double-blind Treatment|Adverse Event|19|||
130567973|NCT03099187|470045726|FG001|Double-blind Treatment|Adverse Event|1|||
130567974|NCT03099187|470045727|FG002|Double-blind Treatment|Adverse Event|0|||
130567975|NCT03099187|470045728|FG003|Double-blind Treatment|Adverse Event|0|||
130567976|NCT03099187|470045725|FG000|Double-blind Treatment|Death|1|||
130567977|NCT03099187|470045726|FG001|Double-blind Treatment|Death|3|||
130567978|NCT03099187|470045727|FG002|Double-blind Treatment|Death|0|||
130567979|NCT03099187|470045728|FG003|Double-blind Treatment|Death|0|||
130567980|NCT03099187|470045725|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130567981|NCT03099187|470045726|FG001|Double-blind Treatment|Lack of Efficacy|0|||
130567982|NCT03099187|470045727|FG002|Double-blind Treatment|Lack of Efficacy|0|||
130567983|NCT03099187|470045728|FG003|Double-blind Treatment|Lack of Efficacy|0|||
130567984|NCT03099187|470045725|FG000|Double-blind Treatment|Physician Decision|2|||
130567985|NCT03099187|470045726|FG001|Double-blind Treatment|Physician Decision|1|||
130567986|NCT03099187|470045727|FG002|Double-blind Treatment|Physician Decision|0|||
130567987|NCT03099187|470045728|FG003|Double-blind Treatment|Physician Decision|0|||
130567988|NCT03099187|470045725|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
130567989|NCT03099187|470045726|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
130567990|NCT03099187|470045727|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
130567991|NCT03099187|470045728|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
130567992|NCT03099187|470045725|FG000|Double-blind Treatment|Lung transplantation|0|||
130567993|NCT03099187|470045726|FG001|Double-blind Treatment|Lung transplantation|1|||
130567994|NCT03099187|470045727|FG002|Double-blind Treatment|Lung transplantation|0|||
130567995|NCT03099187|470045728|FG003|Double-blind Treatment|Lung transplantation|0|||
130567996|NCT03099187|470045725|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
130567997|NCT03099187|470045726|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
130567998|NCT03099187|470045727|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
130567999|NCT03099187|470045728|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
130568000|NCT03099187|470045725|FG000|Double-blind Treatment|Disease progression|0|||
130568001|NCT03099187|470045726|FG001|Double-blind Treatment|Disease progression|1|||
130568002|NCT03099187|470045727|FG002|Double-blind Treatment|Disease progression|0|||
130568003|NCT03099187|470045728|FG003|Double-blind Treatment|Disease progression|0|||
130568004|NCT03099187|470045725|FG000|Double-blind Treatment|Randomization error|0|||
130568005|NCT03099187|470045726|FG001|Double-blind Treatment|Randomization error|2|||
130568006|NCT03099187|470045727|FG002|Double-blind Treatment|Randomization error|0|||
130568007|NCT03099187|470045728|FG003|Double-blind Treatment|Randomization error|0|||
130568008|NCT03099187|470045725|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
130568009|NCT03099187|470045726|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
130568010|NCT03099187|470045727|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
130568011|NCT03099187|470045728|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
130568012|NCT03099187|470045725|FG000|12-month Safety Follow-up|Adverse Event|0|||
130568013|NCT03099187|470045726|FG001|12-month Safety Follow-up|Adverse Event|0|||
130568014|NCT03099187|470045727|FG002|12-month Safety Follow-up|Adverse Event|5|||
130568015|NCT03099187|470045728|FG003|12-month Safety Follow-up|Adverse Event|12|||
130568016|NCT03099187|470045725|FG000|12-month Safety Follow-up|Death|0|||
130568017|NCT03099187|470045726|FG001|12-month Safety Follow-up|Death|0|||
130568018|NCT03099187|470045727|FG002|12-month Safety Follow-up|Death|7|||
130568019|NCT03099187|470045728|FG003|12-month Safety Follow-up|Death|9|||
130568020|NCT03099187|470045725|FG000|12-month Safety Follow-up|Lung transplantation|0|||
130568021|NCT03099187|470045726|FG001|12-month Safety Follow-up|Lung transplantation|0|||
130568022|NCT03099187|470045727|FG002|12-month Safety Follow-up|Lung transplantation|2|||
130568023|NCT03099187|470045728|FG003|12-month Safety Follow-up|Lung transplantation|1|||
130568024|NCT03099187|470045725|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
130568025|NCT03099187|470045726|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
130568026|NCT03099187|470045727|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
130568027|NCT03099187|470045728|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
130568028|NCT03099187|470045725|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
130568029|NCT03099187|470045726|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
130568030|NCT03099187|470045727|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
130568031|NCT03099187|470045728|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
130568032|NCT03099187|470045725|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
130568033|NCT03099187|470045726|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
130568034|NCT03099187|470045727|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
130733077|NCT03907488|470641984|FG001|Overall Study|Withdrawal by Subject|13|||
130568035|NCT03099187|470045728|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
130568036|NCT03099187|470045725|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
130568037|NCT03099187|470045726|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
130568038|NCT03099187|470045727|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
130733078|NCT03907488|470641983|FG000|Overall Study|Lack of Efficacy|0|||
130568039|NCT03099187|470045728|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
130568040|NCT05248295|470045729|FG000|Overall Study|found ineligible|4|||
130733079|NCT03907488|470641984|FG001|Overall Study|Lack of Efficacy|9|||
130509493|NCT01989156|469830895|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
130509494|NCT01989156|469830896|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
130509495|NCT00850993|469830899|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
130509496|NCT00850993|469830900|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
130509497|NCT00850993|469830901|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
130509498|NCT00850993|469830902|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
130509499|NCT03839355|469830903|FG000|Overall Study|Withdrawal by Subject|1|||
130509500|NCT03839355|469830904|FG001|Overall Study|Withdrawal by Subject|0|||
130509501|NCT04362176|469830905|FG000|Overall Study|Lost to Follow-up|5|||
130509502|NCT04362176|469830906|FG001|Overall Study|Lost to Follow-up|8|||
130509503|NCT04362176|469830905|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
130509504|NCT04362176|469830906|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
130509505|NCT00742560|469830907|FG000|Overall Study|Adverse Event|0|||
130509506|NCT00742560|469830908|FG001|Overall Study|Adverse Event|0|||
130509507|NCT00742560|469830909|FG002|Overall Study|Adverse Event|1|||
130509508|NCT00742560|469830910|FG003|Overall Study|Adverse Event|1|||
130509509|NCT00742560|469830911|FG004|Overall Study|Adverse Event|1|||
130509510|NCT00742560|469830907|FG000|Overall Study|Death|0|||
130509511|NCT00742560|469830908|FG001|Overall Study|Death|2|||
130509512|NCT00742560|469830909|FG002|Overall Study|Death|0|||
130509513|NCT00742560|469830910|FG003|Overall Study|Death|2|||
130509514|NCT00742560|469830911|FG004|Overall Study|Death|3|||
130509515|NCT00742560|469830907|FG000|Overall Study|Subject's Decision|1|||
130509516|NCT00742560|469830908|FG001|Overall Study|Subject's Decision|0|||
130509517|NCT00742560|469830909|FG002|Overall Study|Subject's Decision|2|||
130509518|NCT00742560|469830910|FG003|Overall Study|Subject's Decision|3|||
130509519|NCT00742560|469830911|FG004|Overall Study|Subject's Decision|3|||
130509520|NCT00742560|469830907|FG000|Overall Study|Investigator's Decision|0|||
130509521|NCT00742560|469830908|FG001|Overall Study|Investigator's Decision|0|||
130509522|NCT00742560|469830909|FG002|Overall Study|Investigator's Decision|4|||
130509523|NCT00742560|469830910|FG003|Overall Study|Investigator's Decision|1|||
130509524|NCT00742560|469830911|FG004|Overall Study|Investigator's Decision|0|||
130509525|NCT00742560|469830907|FG000|Overall Study|Disease Progression|1|||
130509526|NCT00742560|469830908|FG001|Overall Study|Disease Progression|0|||
130509527|NCT00742560|469830909|FG002|Overall Study|Disease Progression|5|||
130509528|NCT00742560|469830910|FG003|Overall Study|Disease Progression|17|||
130509529|NCT00742560|469830911|FG004|Overall Study|Disease Progression|16|||
130509530|NCT00742560|469830907|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
130509531|NCT00742560|469830908|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
130509532|NCT00742560|469830909|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
130509533|NCT00742560|469830910|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
130509534|NCT00742560|469830911|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
130509535|NCT00742560|469830907|FG000|Overall Study|Other|0|||
130509536|NCT00742560|469830908|FG001|Overall Study|Other|1|||
130509537|NCT00742560|469830909|FG002|Overall Study|Other|8|||
130509538|NCT00742560|469830910|FG003|Overall Study|Other|9|||
130509539|NCT00742560|469830911|FG004|Overall Study|Other|9|||
130509540|NCT00742560|469830907|FG000|Overall Study|MIssing|0|||
130509541|NCT00742560|469830908|FG001|Overall Study|MIssing|0|||
130509542|NCT00742560|469830909|FG002|Overall Study|MIssing|0|||
130509543|NCT00742560|469830910|FG003|Overall Study|MIssing|0|||
130509544|NCT00742560|469830911|FG004|Overall Study|MIssing|1|||
130509545|NCT01426217|469830912|FG000|Overall Study|lost sample|8|||
130509546|NCT01426217|469830913|FG001|Overall Study|lost sample|14|||
130509547|NCT01812837|469830914|FG000|Overall Study|Lost to Follow-up|1|||
130509548|NCT01812837|469830915|FG001|Overall Study|Lost to Follow-up|1|||
130509549|NCT01812837|469830916|FG002|Overall Study|Lost to Follow-up|0|||
130509550|NCT01812837|469830914|FG000|Overall Study|Protocol Violation|1|||
130509551|NCT01812837|469830915|FG001|Overall Study|Protocol Violation|0|||
130509552|NCT01812837|469830916|FG002|Overall Study|Protocol Violation|0|||
130509553|NCT04501614|469830917|FG000|Overall Study|Study Terminated by Sponsor|6|||
130509554|NCT04501614|469830918|FG001|Overall Study|Study Terminated by Sponsor|3|||
130509555|NCT04501614|469830917|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
130509556|NCT04501614|469830918|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
130509557|NCT04529941|469830919|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
130509558|NCT04529941|469830920|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
130509559|NCT02991456|469830923|FG000|Overall Study|Adverse Event|2|||
130509560|NCT02991456|469830924|FG001|Overall Study|Adverse Event|0|||
130509561|NCT02991456|469830923|FG000|Overall Study|Lost to Follow-up|0|||
130509562|NCT02991456|469830924|FG001|Overall Study|Lost to Follow-up|2|||
130509563|NCT02991456|469830923|FG000|Overall Study|Withdrawal by Subject|1|||
130509564|NCT02991456|469830924|FG001|Overall Study|Withdrawal by Subject|0|||
130509565|NCT04016415|469830925|FG000|Overall Study|Adverse Event|2|||
130509566|NCT04016415|469830926|FG001|Overall Study|Adverse Event|1|||
130509567|NCT04016415|469830925|FG000|Overall Study|Lost to Follow-up|6|||
130509568|NCT04016415|469830926|FG001|Overall Study|Lost to Follow-up|2|||
130509569|NCT04016415|469830925|FG000|Overall Study|Physician Decision|5|||
130509570|NCT04016415|469830926|FG001|Overall Study|Physician Decision|1|||
130509571|NCT04016415|469830925|FG000|Overall Study|Pregnancy|0|||
130509572|NCT04016415|469830926|FG001|Overall Study|Pregnancy|1|||
130509573|NCT04016415|469830925|FG000|Overall Study|Withdrawal by Subject|24|||
130509574|NCT04016415|469830926|FG001|Overall Study|Withdrawal by Subject|27|||
130509575|NCT04016415|469830925|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
130509576|NCT04016415|469830926|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
130509577|NCT05615870|469830927|FG000|Overall Study|Lost to Follow-up|10|||
130509578|NCT05615870|469830928|FG001|Overall Study|Lost to Follow-up|13|||
130509579|NCT05615870|469830927|FG000|Overall Study|Physician Decision|2|||
130509580|NCT05615870|469830928|FG001|Overall Study|Physician Decision|0|||
130509581|NCT05615870|469830927|FG000|Overall Study|Withdrawal by Subject|0|||
130509582|NCT05615870|469830928|FG001|Overall Study|Withdrawal by Subject|2|||
130509583|NCT05615870|469830927|FG000|Overall Study|Protocol Violation|0|||
130733080|NCT03907488|470641983|FG000|Overall Study|Death|3|||
130733081|NCT03907488|470641984|FG001|Overall Study|Death|8|||
130733082|NCT03907488|470641983|FG000|Overall Study|not protocol specified|5|||
130733083|NCT03907488|470641984|FG001|Overall Study|not protocol specified|8|||
130733084|NCT03907488|470641983|FG000|Overall Study|Ineligible|9|||
130733085|NCT03907488|470641984|FG001|Overall Study|Ineligible|15|||
130733086|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
130733087|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
130733088|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
130733089|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130733090|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130733091|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130733092|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
130733093|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
130733094|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
130733095|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130733096|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130733097|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130733098|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130733099|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
130733100|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130733101|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130733102|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130733103|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130733104|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130733105|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
130733106|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130733107|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130733108|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130733109|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130733110|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130733111|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130733112|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
130733113|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130733114|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130733115|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130733116|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130733117|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
130733118|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
130733119|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130733120|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130733121|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130733122|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
130733123|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
130733124|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
130733125|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130733126|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130733127|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130733128|NCT03524092|470641990|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
130733129|NCT03524092|470641991|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
130733130|NCT03524092|470641992|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
130733131|NCT03524092|470641993|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130509584|NCT05615870|469830928|FG001|Overall Study|Protocol Violation|3|||
130509585|NCT05615870|469830927|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
130568041|NCT05248295|470045730|FG001|Overall Study|found ineligible|1|||
130568042|NCT05248295|470045729|FG000|Overall Study|Withdrawal by Subject|0|||
130568043|NCT05248295|470045730|FG001|Overall Study|Withdrawal by Subject|1|||
130568044|NCT05248295|470045729|FG000|Overall Study|Data loss: audio recording error|1|||
130568045|NCT05248295|470045730|FG001|Overall Study|Data loss: audio recording error|1|||
130568046|NCT03021499|470045733|FG000|Overall Study|Adverse Event|1|||
130568047|NCT03021499|470045734|FG001|Overall Study|Adverse Event|0|||
130568048|NCT03021499|470045733|FG000|Overall Study|Death|1|||
130568049|NCT03021499|470045734|FG001|Overall Study|Death|5|||
130568050|NCT03021499|470045733|FG000|Overall Study|Lack of Efficacy|0|||
130568051|NCT03021499|470045734|FG001|Overall Study|Lack of Efficacy|1|||
130568052|NCT03021499|470045733|FG000|Overall Study|Lost to Follow-up|1|||
130568053|NCT03021499|470045734|FG001|Overall Study|Lost to Follow-up|3|||
130568054|NCT03021499|470045733|FG000|Overall Study|Physician Decision|2|||
130568055|NCT03021499|470045734|FG001|Overall Study|Physician Decision|3|||
130568056|NCT03021499|470045733|FG000|Overall Study|Pregnancy|1|||
130568057|NCT03021499|470045734|FG001|Overall Study|Pregnancy|0|||
130568058|NCT03021499|470045733|FG000|Overall Study|Withdrawal by Subject|7|||
130568059|NCT03021499|470045734|FG001|Overall Study|Withdrawal by Subject|14|||
130568060|NCT03021499|470045733|FG000|Overall Study|Prohibited medication required|1|||
130568061|NCT03021499|470045734|FG001|Overall Study|Prohibited medication required|0|||
130568062|NCT03021499|470045733|FG000|Overall Study|Protocol non-compliance|1|||
130568063|NCT03021499|470045734|FG001|Overall Study|Protocol non-compliance|1|||
130568064|NCT03021499|470045733|FG000|Overall Study|None of the above|0|||
130568065|NCT03021499|470045734|FG001|Overall Study|None of the above|4|||
130568066|NCT03021499|470045733|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
130568067|NCT03021499|470045734|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
130568068|NCT01210690|470045735|FG000|Overall Study|Adverse Event|7|||
130568069|NCT01210690|470045735|FG000|Overall Study|Lack of Efficacy|12|||
130568070|NCT01210690|470045735|FG000|Overall Study|Lost to Follow-up|3|||
130568071|NCT01210690|470045735|FG000|Overall Study|Disease Remission|1|||
130568072|NCT01210690|470045735|FG000|Overall Study|Withdrawal by Subject|1|||
130568073|NCT01210690|470045735|FG000|Overall Study|Patient refused to swallow|1|||
130568074|NCT01210690|470045735|FG000|Overall Study|Patient could not take glucose|1|||
130568075|NCT00470054|470045736|FG000|Overall Study|Ineligible|1|||
130568076|NCT04869345|470045743|FG000|Overall Study|Lost to Follow-up|8|||
130568077|NCT04869345|470045744|FG001|Overall Study|Lost to Follow-up|3|||
130568078|NCT00528021|470045748|FG000|Overall Study|Lack of Efficacy|17|||
130568079|NCT00528021|470045749|FG001|Overall Study|Lack of Efficacy|13|||
130568080|NCT00528021|470045750|FG002|Overall Study|Lack of Efficacy|7|||
130568081|NCT00528021|470045751|FG003|Overall Study|Lack of Efficacy|9|||
130568082|NCT04050982|470045752|FG000|Overall Study|Did not meet eligibility criteria|0|||
130568083|NCT04050982|470045753|FG001|Overall Study|Did not meet eligibility criteria|1|||
130568084|NCT04050982|470045754|FG002|Overall Study|Did not meet eligibility criteria|0|||
130568085|NCT04050982|470045752|FG000|Overall Study|Withdrawal by Subject|1|||
130568086|NCT04050982|470045753|FG001|Overall Study|Withdrawal by Subject|0|||
130568087|NCT04050982|470045754|FG002|Overall Study|Withdrawal by Subject|0|||
130568088|NCT04050982|470045752|FG000|Overall Study|Unable to enroll on platform|1|||
130568089|NCT04050982|470045753|FG001|Overall Study|Unable to enroll on platform|0|||
130568090|NCT04050982|470045754|FG002|Overall Study|Unable to enroll on platform|0|||
130568091|NCT01246583|470045755|FG000|Overall Study|Lost to Follow-up|0|||
130568092|NCT01246583|470045756|FG001|Overall Study|Lost to Follow-up|0|||
130568093|NCT01246583|470045757|FG002|Overall Study|Lost to Follow-up|0|||
130568094|NCT01246583|470045758|FG003|Overall Study|Lost to Follow-up|1|||
130568095|NCT01246583|470045755|FG000|Overall Study|Protocol Violation|0|||
130568096|NCT01246583|470045756|FG001|Overall Study|Protocol Violation|0|||
130568097|NCT01246583|470045757|FG002|Overall Study|Protocol Violation|1|||
130568098|NCT01246583|470045758|FG003|Overall Study|Protocol Violation|0|||
130568099|NCT01246583|470045755|FG000|Overall Study|Withdrawal by Subject|1|||
130568100|NCT01246583|470045756|FG001|Overall Study|Withdrawal by Subject|0|||
130568101|NCT01246583|470045757|FG002|Overall Study|Withdrawal by Subject|0|||
130568102|NCT01246583|470045758|FG003|Overall Study|Withdrawal by Subject|0|||
130568103|NCT05054114|470045759|FG000|Overall Study|Protocol Violation|13|||
130568104|NCT05054114|470045760|FG001|Overall Study|Protocol Violation|1|||
130568105|NCT05054114|470045759|FG000|Overall Study|Pregnancy|0|||
130568106|NCT05054114|470045760|FG001|Overall Study|Pregnancy|1|||
130568107|NCT02116777|470045763|FG000|Overall Study|Adverse Event|0|||
130568108|NCT02116777|470045764|FG001|Overall Study|Adverse Event|0|||
130568109|NCT02116777|470045765|FG002|Overall Study|Adverse Event|0|||
130568110|NCT02116777|470045766|FG003|Overall Study|Adverse Event|0|||
130568111|NCT02116777|470045767|FG004|Overall Study|Adverse Event|2|||
130568112|NCT02116777|470045768|FG005|Overall Study|Adverse Event|2|||
130568113|NCT02116777|470045769|FG006|Overall Study|Adverse Event|0|||
130568114|NCT02116777|470045763|FG000|Overall Study|Death|0|||
130568115|NCT02116777|470045764|FG001|Overall Study|Death|0|||
130568116|NCT02116777|470045765|FG002|Overall Study|Death|0|||
130568117|NCT02116777|470045766|FG003|Overall Study|Death|1|||
130568118|NCT02116777|470045767|FG004|Overall Study|Death|0|||
130568119|NCT02116777|470045768|FG005|Overall Study|Death|0|||
130509586|NCT05615870|469830928|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
130509587|NCT05615870|469830927|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
130509588|NCT05615870|469830928|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
130733132|NCT03524092|470641994|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130733133|NCT03524092|470641995|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130733134|NCT03524092|470641990|FG000|Loss of Response Rescue Period|Adverse Event|0|||
130509589|NCT05615870|469830927|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
130509590|NCT05615870|469830928|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
130509591|NCT00070317|469830929|FG000|Overall Study|Inevaluable (Never Treated)|1|||
130509592|NCT00070317|469830929|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
130509593|NCT00070317|469830929|FG000|Overall Study|Ineligible required test not done|1|||
130509594|NCT00070317|469830929|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
130509595|NCT00070317|469830929|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
130509596|NCT00508144|469830933|FG000|Overall Study|Not eligible|6|||
130509597|NCT00508144|469830933|FG000|Overall Study|Death|5|||
130509598|NCT01661972|469830934|FG000|Overall Study|Adverse Event|1|||
130733135|NCT03524092|470641991|FG001|Loss of Response Rescue Period|Adverse Event|0|||
130733136|NCT03524092|470641992|FG002|Loss of Response Rescue Period|Adverse Event|0|||
130733137|NCT03524092|470641993|FG003|Loss of Response Rescue Period|Adverse Event|2|||
130733138|NCT03524092|470641994|FG004|Loss of Response Rescue Period|Adverse Event|0|||
130733139|NCT03524092|470641995|FG005|Loss of Response Rescue Period|Adverse Event|0|||
130733140|NCT03524092|470641990|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
130733141|NCT03524092|470641991|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
130733142|NCT03524092|470641992|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
130733143|NCT03524092|470641993|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
130733144|NCT03524092|470641994|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
130733145|NCT03524092|470641995|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
130733146|NCT03524092|470641990|FG000|Loss of Response Rescue Period|Pregnancy|0|||
130733147|NCT03524092|470641991|FG001|Loss of Response Rescue Period|Pregnancy|0|||
130733148|NCT03524092|470641992|FG002|Loss of Response Rescue Period|Pregnancy|0|||
130733149|NCT03524092|470641993|FG003|Loss of Response Rescue Period|Pregnancy|1|||
130733150|NCT03524092|470641994|FG004|Loss of Response Rescue Period|Pregnancy|0|||
130733151|NCT03524092|470641995|FG005|Loss of Response Rescue Period|Pregnancy|0|||
130733152|NCT03524092|470641990|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130733153|NCT03524092|470641991|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130733154|NCT03524092|470641992|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130733155|NCT03524092|470641993|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
130733156|NCT03524092|470641994|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130733157|NCT03524092|470641995|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130733158|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130733159|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130733160|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130733161|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130733162|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
130733163|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130733164|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130733165|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130733166|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130733167|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130733168|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
130733169|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130733170|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130733171|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130733172|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130733173|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130733174|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
130733175|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130733176|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130733177|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130733178|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130733179|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130733180|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
130733181|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130733182|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130733183|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130509599|NCT01661972|469830935|FG001|Overall Study|Adverse Event|2|||
130509600|NCT01661972|469830934|FG000|Overall Study|Death during Treatment period|1|||
130509601|NCT01661972|469830935|FG001|Overall Study|Death during Treatment period|1|||
130509602|NCT01661972|469830934|FG000|Overall Study|Withdrawal by Subject|0|||
130509603|NCT01661972|469830935|FG001|Overall Study|Withdrawal by Subject|1|||
130509604|NCT02009865|469830939|FG000|Overall Study|Adverse Event|0|||
130509605|NCT02009865|469830940|FG001|Overall Study|Adverse Event|2|||
130509606|NCT02009865|469830939|FG000|Overall Study|Protocol Violation|0|||
130509607|NCT02009865|469830940|FG001|Overall Study|Protocol Violation|2|||
130509608|NCT02009865|469830939|FG000|Overall Study|Withdrawal by Subject|1|||
130509609|NCT02009865|469830940|FG001|Overall Study|Withdrawal by Subject|1|||
130509610|NCT01760876|469830941|FG000|Overall Study|Non-cardiac death (head injury)|1|||
130509611|NCT01760876|469830941|FG000|Overall Study|Carcinoma of prostate|1|||
130509612|NCT01760876|469830941|FG000|Overall Study|Impaired renal function|1|||
130509613|NCT01760876|469830941|FG000|Overall Study|Major depression|1|||
130509614|NCT01760876|469830941|FG000|Overall Study|Very poor baseline OCT quality|2|||
130509615|NCT01517282|469830944|FG000|Overall Study|Consent withdrawn|0|||
130509616|NCT01517282|469830945|FG001|Overall Study|Consent withdrawn|1|||
130509617|NCT01517282|469830946|FG002|Overall Study|Consent withdrawn|1|||
130509618|NCT01517282|469830947|FG003|Overall Study|Consent withdrawn|1|||
130509619|NCT01517282|469830944|FG000|Overall Study|Physician Decision|1|||
130509620|NCT01517282|469830945|FG001|Overall Study|Physician Decision|0|||
130509621|NCT01517282|469830946|FG002|Overall Study|Physician Decision|0|||
130509622|NCT01517282|469830947|FG003|Overall Study|Physician Decision|0|||
130509623|NCT00525915|469830948|FG000|Overall Study|Non-Compliance|0|||
130509624|NCT00525915|469830949|FG001|Overall Study|Non-Compliance|1|||
130509625|NCT00525915|469830948|FG000|Overall Study|Disease Progression|5|||
130509626|NCT00525915|469830949|FG001|Overall Study|Disease Progression|6|||
130509627|NCT00525915|469830948|FG000|Overall Study|Withdrawal by Subject|1|||
130509628|NCT00525915|469830949|FG001|Overall Study|Withdrawal by Subject|0|||
130509629|NCT00525915|469830948|FG000|Overall Study|Refused Surgery|1|||
130509630|NCT00525915|469830949|FG001|Overall Study|Refused Surgery|2|||
130509631|NCT00525915|469830948|FG000|Overall Study|Unrelated illness|1|||
130509632|NCT00525915|469830949|FG001|Overall Study|Unrelated illness|0|||
130509633|NCT05927753|469831745|FG000|Overall Study|Withdrawal by Subject|0|||
130509634|NCT05927753|469831746|FG001|Overall Study|Withdrawal by Subject|2|||
130509635|NCT05927753|469831745|FG000|Overall Study|Physician Decision|0|||
130509636|NCT05927753|469831746|FG001|Overall Study|Physician Decision|1|||
130509658|NCT04649359|469831752|FG000|Overall Study|Withdrawal by Subject|7|||
130509659|NCT04649359|469831753|FG001|Overall Study|Withdrawal by Subject|7|||
130509660|NCT04649359|469831752|FG000|Overall Study|Death|41|||
130509661|NCT04649359|469831753|FG001|Overall Study|Death|26|||
130509662|NCT04649359|469831752|FG000|Overall Study|Ongoing in the study|75|||
130509663|NCT04649359|469831753|FG001|Overall Study|Ongoing in the study|31|||
130509664|NCT02011568|469831754|FG000|Overall Study|Withdrawal by Subject|8|||
130509665|NCT02011568|469831755|FG001|Overall Study|Withdrawal by Subject|10|||
130509666|NCT02011568|469831754|FG000|Overall Study|Physician Decision|1|||
130509667|NCT02011568|469831755|FG001|Overall Study|Physician Decision|3|||
130509668|NCT04751929|469831757|FG000|Overall Study|Withdrawal by Subject|2|||
130509669|NCT04751929|469831758|FG001|Overall Study|Withdrawal by Subject|0|||
130509670|NCT04751929|469831759|FG002|Overall Study|Withdrawal by Subject|0|||
130509671|NCT04751929|469831760|FG003|Overall Study|Withdrawal by Subject|0|||
130568120|NCT02116777|470045769|FG006|Overall Study|Death|0|||
130509672|NCT04751929|469831757|FG000|Overall Study|Rising PSA|0|||
130509673|NCT04751929|469831758|FG001|Overall Study|Rising PSA|1|||
130509674|NCT04751929|469831759|FG002|Overall Study|Rising PSA|0|||
130568121|NCT02116777|470045763|FG000|Overall Study|Lack of Efficacy|3|||
130568122|NCT02116777|470045764|FG001|Overall Study|Lack of Efficacy|3|||
130568123|NCT02116777|470045765|FG002|Overall Study|Lack of Efficacy|3|||
130568124|NCT02116777|470045766|FG003|Overall Study|Lack of Efficacy|8|||
130568125|NCT02116777|470045767|FG004|Overall Study|Lack of Efficacy|4|||
130568126|NCT02116777|470045768|FG005|Overall Study|Lack of Efficacy|1|||
130568127|NCT02116777|470045769|FG006|Overall Study|Lack of Efficacy|9|||
130568128|NCT02116777|470045763|FG000|Overall Study|Physician Decision|0|||
130568129|NCT02116777|470045764|FG001|Overall Study|Physician Decision|0|||
130568130|NCT02116777|470045765|FG002|Overall Study|Physician Decision|0|||
130568131|NCT02116777|470045766|FG003|Overall Study|Physician Decision|2|||
130568132|NCT02116777|470045767|FG004|Overall Study|Physician Decision|0|||
130568133|NCT02116777|470045768|FG005|Overall Study|Physician Decision|0|||
130568134|NCT02116777|470045769|FG006|Overall Study|Physician Decision|0|||
130568135|NCT02116777|470045763|FG000|Overall Study|Protocol Violation|0|||
130568136|NCT02116777|470045764|FG001|Overall Study|Protocol Violation|0|||
130568137|NCT02116777|470045765|FG002|Overall Study|Protocol Violation|0|||
130568138|NCT02116777|470045766|FG003|Overall Study|Protocol Violation|1|||
130568139|NCT02116777|470045767|FG004|Overall Study|Protocol Violation|0|||
130568140|NCT02116777|470045768|FG005|Overall Study|Protocol Violation|0|||
130568141|NCT02116777|470045769|FG006|Overall Study|Protocol Violation|0|||
130568142|NCT02116777|470045763|FG000|Overall Study|Withdrawal by Subject|0|||
130568143|NCT02116777|470045764|FG001|Overall Study|Withdrawal by Subject|0|||
130568144|NCT02116777|470045765|FG002|Overall Study|Withdrawal by Subject|0|||
130568145|NCT02116777|470045766|FG003|Overall Study|Withdrawal by Subject|1|||
130568146|NCT02116777|470045767|FG004|Overall Study|Withdrawal by Subject|0|||
130568147|NCT02116777|470045768|FG005|Overall Study|Withdrawal by Subject|0|||
130568148|NCT02116777|470045769|FG006|Overall Study|Withdrawal by Subject|0|||
130568149|NCT00733954|470045770|FG000|Overall Study|Lost to Follow-up|5|||
130568150|NCT00733954|470045771|FG001|Overall Study|Lost to Follow-up|2|||
130568151|NCT00733954|470045770|FG000|Overall Study|Protocol Violation|1|||
130568152|NCT00733954|470045771|FG001|Overall Study|Protocol Violation|0|||
130568153|NCT00733954|470045770|FG000|Overall Study|Withdrawal by Subject|2|||
130568154|NCT00733954|470045771|FG001|Overall Study|Withdrawal by Subject|0|||
130568155|NCT02663453|470045772|FG000|Overall Study|Death|4|||
130568156|NCT02663453|470045773|FG001|Overall Study|Death|4|||
130568157|NCT02663453|470045772|FG000|Overall Study|Withdrawal by Subject|1|||
130568158|NCT02663453|470045773|FG001|Overall Study|Withdrawal by Subject|0|||
130568159|NCT01849874|470047199|FG000|Overall Study|Death|89|||
130568160|NCT01849874|470047200|FG001|Overall Study|Death|42|||
130568161|NCT01849874|470047199|FG000|Overall Study|Withdrawal by Subject|17|||
130568162|NCT01849874|470047200|FG001|Overall Study|Withdrawal by Subject|16|||
130568163|NCT01849874|470047199|FG000|Overall Study|Lost to Follow-up|3|||
130568164|NCT01849874|470047200|FG001|Overall Study|Lost to Follow-up|2|||
130568165|NCT01849874|470047199|FG000|Overall Study|Study Termination By Sponsor|93|||
130568166|NCT01849874|470047200|FG001|Overall Study|Study Termination By Sponsor|48|||
130568167|NCT01849874|470047199|FG000|Overall Study|Completed as per protocol amendment 6|3|||
130568168|NCT01849874|470047200|FG001|Overall Study|Completed as per protocol amendment 6|0|||
130568169|NCT01849874|470047199|FG000|Overall Study|Physician Decision|7|||
130568170|NCT01849874|470047200|FG001|Overall Study|Physician Decision|1|||
130568171|NCT01849874|470047199|FG000|Overall Study|Other|16|||
130733184|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130733185|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130733186|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
130733187|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130733188|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130733189|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130733190|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130733191|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130509675|NCT04751929|469831760|FG003|Overall Study|Rising PSA|0|||
130509676|NCT04751929|469831757|FG000|Overall Study|Adverse Event|1|||
130509677|NCT04751929|469831758|FG001|Overall Study|Adverse Event|2|||
130509678|NCT04751929|469831759|FG002|Overall Study|Adverse Event|0|||
130509679|NCT04751929|469831760|FG003|Overall Study|Adverse Event|0|||
130509680|NCT04751929|469831757|FG000|Overall Study|Progressive Disease|3|||
130509681|NCT04751929|469831758|FG001|Overall Study|Progressive Disease|4|||
130509682|NCT04751929|469831759|FG002|Overall Study|Progressive Disease|4|||
130509683|NCT04751929|469831760|FG003|Overall Study|Progressive Disease|0|||
130509684|NCT04751929|469831757|FG000|Overall Study|Death|1|||
130509685|NCT04751929|469831758|FG001|Overall Study|Death|1|||
130509686|NCT04751929|469831759|FG002|Overall Study|Death|0|||
130568172|NCT01849874|470047200|FG001|Overall Study|Other|4|||
130568173|NCT02830880|470047205|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
130568174|NCT02830880|470047205|FG000|Overall Study|Death|1|||
130568175|NCT02830880|470047205|FG000|Overall Study|Physician Decision|1|||
130568176|NCT03551509|470047214|FG000|Overall Study|Lost to Follow-up|0|||
130509687|NCT04751929|469831760|FG003|Overall Study|Death|0|||
130568177|NCT03551509|470047215|FG001|Overall Study|Lost to Follow-up|1|||
130509688|NCT00376259|469831761|FG000|Overall Study|Sponsor request - study termination|21|||
130509689|NCT00376259|469831762|FG001|Overall Study|Sponsor request - study termination|21|||
130509690|NCT00376259|469831761|FG000|Overall Study|Patient request|1|||
130509691|NCT00376259|469831762|FG001|Overall Study|Patient request|0|||
130509692|NCT01012999|469831764|FG000|Overall Study|Protocol Violation|1|||
130509693|NCT02069366|469831765|FG000|Overall Study|Lost to Follow-up|0|||
130509694|NCT02069366|469831766|FG001|Overall Study|Lost to Follow-up|0|||
130509695|NCT02069366|469831767|FG002|Overall Study|Lost to Follow-up|1|||
130509696|NCT02069366|469831768|FG003|Overall Study|Lost to Follow-up|0|||
130509697|NCT02069366|469831769|FG004|Overall Study|Lost to Follow-up|0|||
130509698|NCT02069366|469831770|FG005|Overall Study|Lost to Follow-up|2|||
130509699|NCT02069366|469831765|FG000|Overall Study|Protocol Violation|0|||
130509700|NCT02069366|469831766|FG001|Overall Study|Protocol Violation|0|||
130509701|NCT02069366|469831767|FG002|Overall Study|Protocol Violation|1|||
130509702|NCT02069366|469831768|FG003|Overall Study|Protocol Violation|0|||
130509703|NCT02069366|469831769|FG004|Overall Study|Protocol Violation|0|||
130509704|NCT02069366|469831770|FG005|Overall Study|Protocol Violation|0|||
130509705|NCT02069366|469831765|FG000|Overall Study|Withdrawal by Subject|1|||
130509706|NCT02069366|469831766|FG001|Overall Study|Withdrawal by Subject|0|||
130509707|NCT02069366|469831767|FG002|Overall Study|Withdrawal by Subject|1|||
130509708|NCT02069366|469831768|FG003|Overall Study|Withdrawal by Subject|2|||
130509709|NCT02069366|469831769|FG004|Overall Study|Withdrawal by Subject|0|||
130509710|NCT02069366|469831770|FG005|Overall Study|Withdrawal by Subject|0|||
130509711|NCT02256553|469831771|FG000|Period I|Adverse Event|5|||
130509712|NCT02256553|469831771|FG000|Period I|Protocol Violation|1|||
130509713|NCT02256553|469831771|FG000|Period II|Adverse Event|1|||
130509714|NCT02256553|469831771|FG000|Period II|Subject Moved|1|||
130509715|NCT02256553|469831771|FG000|Period III|Adverse Event|3|||
130509716|NCT03436797|469831772|FG000|Main Study|Withdrawal by Subject|2|||
130509717|NCT03436797|469831772|FG000|Main Study|Adverse Event|4|||
130509718|NCT03436797|469831772|FG000|Main Study|Lost to Follow-up|1|||
130509719|NCT03436797|469831772|FG000|Main Study|Death|1|||
130509720|NCT03436797|469831772|FG000|Main Study|Non-Specific|2|||
130509721|NCT03436797|469831772|FG000|Extended Dosing|Patient decision|1|||
130509722|NCT01951105|469831777|FG000|Overall Study|Adverse Event|0|||
130509723|NCT01951105|469831778|FG001|Overall Study|Adverse Event|5|||
130509724|NCT01951105|469831779|FG002|Overall Study|Adverse Event|0|||
130509725|NCT01951105|469831777|FG000|Overall Study|Lost to Follow-up|0|||
130509726|NCT01951105|469831778|FG001|Overall Study|Lost to Follow-up|1|||
130509727|NCT01951105|469831779|FG002|Overall Study|Lost to Follow-up|0|||
130509728|NCT01951105|469831777|FG000|Overall Study|Protocol Violation|1|||
130509729|NCT01951105|469831778|FG001|Overall Study|Protocol Violation|1|||
130509730|NCT01951105|469831779|FG002|Overall Study|Protocol Violation|1|||
130509731|NCT01951105|469831777|FG000|Overall Study|Withdrawal by Subject|0|||
130509732|NCT01951105|469831778|FG001|Overall Study|Withdrawal by Subject|3|||
130509733|NCT01951105|469831779|FG002|Overall Study|Withdrawal by Subject|1|||
130509734|NCT04175392|469831780|FG000|Overall Study|Withdrawal by Subject|3|||
130509735|NCT04175392|469831781|FG001|Overall Study|Withdrawal by Subject|2|||
130509736|NCT02727998|469831782|FG000|Overall Study|Lost to Follow-up|3|||
130509737|NCT02727998|469831783|FG001|Overall Study|Lost to Follow-up|3|||
130509738|NCT02727998|469831782|FG000|Overall Study|Withdrawal by Subject|0|||
130509739|NCT02727998|469831783|FG001|Overall Study|Withdrawal by Subject|1|||
130509740|NCT02105688|469831784|FG000|Part A: Double-Blind|Adverse Event|1|||
130509741|NCT02105688|469831785|FG001|Part A: Double-Blind|Adverse Event|0|||
130509742|NCT02105688|469831784|FG000|Part A: Double-Blind|Death|0|||
130509743|NCT02105688|469831785|FG001|Part A: Double-Blind|Death|1|||
130509744|NCT02105688|469831784|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
130509745|NCT02105688|469831785|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
130509746|NCT02105688|469831784|FG000|Part A: Double-Blind|Physician Decision|0|||
130509747|NCT02105688|469831785|FG001|Part A: Double-Blind|Physician Decision|1|||
130509748|NCT02105688|469831784|FG000|Part A: Double-Blind|Status Unknown|0|||
130509749|NCT02105688|469831785|FG001|Part A: Double-Blind|Status Unknown|2|||
130509750|NCT02105688|469831784|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
130509751|NCT02105688|469831785|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
130509752|NCT02105688|469831784|FG000|Part B: Observational Follow-up|Death|2|||
130509753|NCT02105688|469831785|FG001|Part B: Observational Follow-up|Death|1|||
130509754|NCT02105688|469831784|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
130509755|NCT02105688|469831785|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
130509756|NCT02105688|469831784|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
130509757|NCT02105688|469831785|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
130509758|NCT02105688|469831784|FG000|Part B: Observational Follow-up|Physician Decision|3|||
130509759|NCT02105688|469831785|FG001|Part B: Observational Follow-up|Physician Decision|1|||
130509760|NCT01601821|469831787|FG000|Overall Study|Death|2|||
130509761|NCT01601821|469831788|FG001|Overall Study|Death|5|||
130509762|NCT01601821|469831787|FG000|Overall Study|Protocol Violation|2|||
130509763|NCT01601821|469831788|FG001|Overall Study|Protocol Violation|2|||
130509764|NCT01601821|469831787|FG000|Overall Study|Lost to Follow-up|6|||
130509765|NCT01601821|469831788|FG001|Overall Study|Lost to Follow-up|14|||
130568178|NCT03551509|470047216|FG002|Overall Study|Lost to Follow-up|0|||
130568179|NCT01040351|470047217|FG000|Overall Study|poor ovarian response|1|||
130568180|NCT01040351|470047218|FG001|Overall Study|poor ovarian response|2|||
130568181|NCT01230307|470047219|FG000|Overall Study|LVAD Placement|0|||
130568182|NCT01230307|470047220|FG001|Overall Study|LVAD Placement|2|||
130568183|NCT00530894|470047224|FG000|Overall Study|Death|84|||
130568184|NCT00530894|470047225|FG001|Overall Study|Death|89|||
130568185|NCT00530894|470047226|FG002|Overall Study|Death|55|||
130568186|NCT00530894|470047227|FG003|Overall Study|Death|89|||
130568187|NCT00530894|470047224|FG000|Overall Study|Lost to Follow-up|1|||
130568188|NCT00530894|470047225|FG001|Overall Study|Lost to Follow-up|3|||
130568189|NCT00530894|470047226|FG002|Overall Study|Lost to Follow-up|0|||
130568190|NCT00530894|470047227|FG003|Overall Study|Lost to Follow-up|0|||
130568191|NCT00530894|470047224|FG000|Overall Study|Withdrawal by Subject|1|||
130568192|NCT00530894|470047225|FG001|Overall Study|Withdrawal by Subject|23|||
130568193|NCT00530894|470047226|FG002|Overall Study|Withdrawal by Subject|0|||
130568194|NCT00530894|470047227|FG003|Overall Study|Withdrawal by Subject|5|||
130568195|NCT00530894|470047224|FG000|Overall Study|Alive and censored prior to 1 year|2|||
130568196|NCT00530894|470047225|FG001|Overall Study|Alive and censored prior to 1 year|0|||
130568197|NCT00530894|470047226|FG002|Overall Study|Alive and censored prior to 1 year|0|||
130568198|NCT00530894|470047227|FG003|Overall Study|Alive and censored prior to 1 year|0|||
130568199|NCT01230242|470047228|FG000|Overall Study|Physician Decision|2|||
130568200|NCT01230242|470047228|FG000|Overall Study|Withdrawal by Subject|1|||
130568201|NCT02256540|470047229|FG000|Overall Study|Withdrawal by Subject|0|||
130568202|NCT02256540|470047230|FG001|Overall Study|Withdrawal by Subject|1|||
130568203|NCT02256540|470047231|FG002|Overall Study|Withdrawal by Subject|1|||
130568204|NCT02256540|470047229|FG000|Overall Study|Back pain preventing exercise|0|||
130568205|NCT02256540|470047230|FG001|Overall Study|Back pain preventing exercise|0|||
130568206|NCT02256540|470047231|FG002|Overall Study|Back pain preventing exercise|1|||
130568207|NCT04329702|470047238|FG000|Overall Study|illness|3|||
130568208|NCT04329702|470047239|FG001|Overall Study|illness|4|||
130568209|NCT04329702|470047240|FG002|Overall Study|illness|0|||
130568210|NCT04329702|470047238|FG000|Overall Study|Lost to Follow-up|0|||
130568211|NCT04329702|470047239|FG001|Overall Study|Lost to Follow-up|0|||
130568212|NCT04329702|470047240|FG002|Overall Study|Lost to Follow-up|2|||
130568213|NCT04329702|470047238|FG000|Overall Study|Death|0|||
130568214|NCT04329702|470047239|FG001|Overall Study|Death|2|||
130568215|NCT04329702|470047240|FG002|Overall Study|Death|0|||
130568216|NCT03719690|470047248|FG000|Overall Study|Withdrawal by Subject|5|||
130568217|NCT03719690|470047249|FG001|Overall Study|Withdrawal by Subject|10|||
130568218|NCT03719690|470047248|FG000|Overall Study|Death|40|||
130568219|NCT03719690|470047249|FG001|Overall Study|Death|149|||
130568220|NCT03719690|470047248|FG000|Overall Study|Miscellaneous|12|||
130568221|NCT03719690|470047249|FG001|Overall Study|Miscellaneous|56|||
130568222|NCT03719690|470047248|FG000|Overall Study|Lost to Follow-up|2|||
130568223|NCT03719690|470047249|FG001|Overall Study|Lost to Follow-up|18|||
130568224|NCT03719690|470047248|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
130568225|NCT03719690|470047249|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
130568226|NCT01918007|470047250|FG000|Overall Study|Baseline oximetry not acceptable|11|||
130568227|NCT01918007|470047251|FG001|Overall Study|Baseline oximetry not acceptable|7|||
130568228|NCT01918007|470047250|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
130568229|NCT01918007|470047251|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
130568230|NCT01918007|470047250|FG000|Overall Study|Lost to Follow-up|4|||
130568231|NCT01918007|470047251|FG001|Overall Study|Lost to Follow-up|7|||
130568232|NCT02037295|470047253|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
130568233|NCT02037295|470047254|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
130568234|NCT02037295|470047255|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
130568235|NCT02037295|470047256|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
130568236|NCT01140451|470047257|FG000|Overall Study|Withdrawal by Subject|26|||
130568237|NCT01140451|470047258|FG001|Overall Study|Withdrawal by Subject|33|||
130568238|NCT01140451|470047257|FG000|Overall Study|Adverse Event|2|||
130568239|NCT01140451|470047258|FG001|Overall Study|Adverse Event|6|||
130568240|NCT01140451|470047257|FG000|Overall Study|Physician Decision|5|||
130568241|NCT01140451|470047258|FG001|Overall Study|Physician Decision|3|||
130568242|NCT01140451|470047257|FG000|Overall Study|Lost to Follow-up|2|||
130568243|NCT01140451|470047258|FG001|Overall Study|Lost to Follow-up|0|||
130568244|NCT01140451|470047257|FG000|Overall Study|Participants Planning Pregnancy|3|||
130568245|NCT01140451|470047258|FG001|Overall Study|Participants Planning Pregnancy|0|||
130509766|NCT01601821|469831787|FG000|Overall Study|Withdrawal by Subject|1|||
130509767|NCT01601821|469831788|FG001|Overall Study|Withdrawal by Subject|0|||
130509768|NCT01601821|469831787|FG000|Overall Study|Graft Loss|6|||
130509769|NCT01601821|469831788|FG001|Overall Study|Graft Loss|6|||
130509770|NCT01601821|469831787|FG000|Overall Study|Study Events|7|||
130509771|NCT01601821|469831788|FG001|Overall Study|Study Events|1|||
130509772|NCT01601821|469831787|FG000|Overall Study|Other|5|||
130509773|NCT01601821|469831788|FG001|Overall Study|Other|1|||
130509774|NCT02469155|469831789|FG000|Overall Study|Adverse Event|6|||
130509775|NCT02469155|469831790|FG001|Overall Study|Adverse Event|0|||
130509776|NCT02469155|469831791|FG002|Overall Study|Adverse Event|1|||
130509777|NCT02469155|469831792|FG003|Overall Study|Adverse Event|10|||
130509778|NCT02469155|469831789|FG000|Overall Study|Lack of Efficacy|13|||
130509779|NCT02469155|469831790|FG001|Overall Study|Lack of Efficacy|10|||
130509780|NCT02469155|469831791|FG002|Overall Study|Lack of Efficacy|10|||
130509781|NCT02469155|469831792|FG003|Overall Study|Lack of Efficacy|8|||
130509782|NCT02469155|469831789|FG000|Overall Study|Death|0|||
130509783|NCT02469155|469831790|FG001|Overall Study|Death|0|||
130509784|NCT02469155|469831791|FG002|Overall Study|Death|0|||
130509785|NCT02469155|469831792|FG003|Overall Study|Death|1|||
130509786|NCT02469155|469831789|FG000|Overall Study|Lost to Follow-up|5|||
130509787|NCT02469155|469831790|FG001|Overall Study|Lost to Follow-up|2|||
130509788|NCT02469155|469831791|FG002|Overall Study|Lost to Follow-up|7|||
130509789|NCT02469155|469831792|FG003|Overall Study|Lost to Follow-up|2|||
130509790|NCT02469155|469831789|FG000|Overall Study|Physician Decision|0|||
130509791|NCT02469155|469831790|FG001|Overall Study|Physician Decision|0|||
130509792|NCT02469155|469831791|FG002|Overall Study|Physician Decision|1|||
130509793|NCT02469155|469831792|FG003|Overall Study|Physician Decision|0|||
130733192|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
130733193|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130733194|NCT03524092|470641990|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130733195|NCT03524092|470641991|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130733196|NCT03524092|470641992|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130733197|NCT03524092|470641993|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130733198|NCT03524092|470641994|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
130733199|NCT03524092|470641995|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130733200|NCT03524092|470641990|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130733201|NCT03524092|470641991|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130733202|NCT03524092|470641992|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130733203|NCT03524092|470641993|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130733204|NCT03524092|470641994|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130733205|NCT03524092|470641995|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
130733206|NCT03524092|470641990|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130733207|NCT03524092|470641991|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130733208|NCT03524092|470641992|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130733209|NCT03524092|470641993|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130733210|NCT03524092|470641994|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130733211|NCT03524092|470641995|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
130733212|NCT03524092|470641990|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130733213|NCT03524092|470641991|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130733214|NCT03524092|470641992|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130733215|NCT03524092|470641993|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130733216|NCT03524092|470641994|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130733217|NCT03524092|470641995|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
130733218|NCT03524092|470641990|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130733219|NCT03524092|470641991|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130733220|NCT03524092|470641992|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130733221|NCT03524092|470641993|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130733222|NCT03524092|470641994|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130733223|NCT03524092|470641995|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
130733224|NCT04303780|470641996|FG000|Overall Study|Death|104|||
130733225|NCT04303780|470641997|FG001|Overall Study|Death|85|||
130733226|NCT04303780|470641996|FG000|Overall Study|Lost to Follow-up|5|||
130733227|NCT04303780|470641997|FG001|Overall Study|Lost to Follow-up|2|||
130733228|NCT04303780|470641996|FG000|Overall Study|Withdrawal by Subject|12|||
130733229|NCT04303780|470641997|FG001|Overall Study|Withdrawal by Subject|39|||
130509794|NCT02469155|469831789|FG000|Overall Study|Withdrawal by Subject|34|||
130509795|NCT02469155|469831790|FG001|Overall Study|Withdrawal by Subject|30|||
130509796|NCT02469155|469831791|FG002|Overall Study|Withdrawal by Subject|20|||
130568246|NCT00441974|470047259|FG000|Overall Study|Adverse Event|6|||
130568247|NCT00441974|470047259|FG000|Overall Study|Consent Withdrawn|35|||
130568248|NCT00441974|470047259|FG000|Overall Study|Lost to Follow-up|80|||
130568249|NCT00441974|470047259|FG000|Overall Study|Protocol Violation|7|||
130568250|NCT02770547|470047260|FG000|Overall Study|Patient non-compliant|1|||
130568251|NCT02770547|470047261|FG001|Overall Study|Patient non-compliant|0|||
130568252|NCT02770547|470047260|FG000|Overall Study|Adverse Event|0|||
130568253|NCT02770547|470047261|FG001|Overall Study|Adverse Event|1|||
130568254|NCT00393887|470047262|FG000|Overall Study|Physician Decision|5|||
130568255|NCT00393887|470047263|FG001|Overall Study|Physician Decision|0|||
130568256|NCT00393887|470047262|FG000|Overall Study|Lost to Follow-up|11|||
130568257|NCT00393887|470047263|FG001|Overall Study|Lost to Follow-up|9|||
130568258|NCT04962022|470047266|FG000|Period 1|Withdrawal by Subject|1|||
130568259|NCT04962022|470047267|FG001|Period 1|Withdrawal by Subject|0|||
130568260|NCT01146873|470047271|FG000|Overall Study|Transfer out|0|||
130568261|NCT01146873|470047272|FG001|Overall Study|Transfer out|6|||
130568262|NCT01967628|470047273|FG000|Overall Study|Withdrawal by Subject|2|||
130568263|NCT01967628|470047274|FG001|Overall Study|Withdrawal by Subject|0|||
130568264|NCT01967628|470047273|FG000|Overall Study|Unable to complete bronchoscopy|4|||
130568265|NCT01967628|470047274|FG001|Overall Study|Unable to complete bronchoscopy|6|||
130733230|NCT04303780|470641996|FG000|Overall Study|Ongoing in study|50|||
130733231|NCT04303780|470641997|FG001|Overall Study|Ongoing in study|45|||
130733232|NCT03968224|470642002|FG000|Overall Study|Lost to Follow-up|11|||
130733233|NCT03968224|470642003|FG001|Overall Study|Lost to Follow-up|18|||
130733234|NCT00336024|470642005|FG000|Overall Study|Death|2|||
130733235|NCT00336024|470642006|FG001|Overall Study|Death|1|||
130733236|NCT00336024|470642005|FG000|Overall Study|Physician Decision|4|||
130733237|NCT00336024|470642006|FG001|Overall Study|Physician Decision|1|||
130733238|NCT00336024|470642005|FG000|Overall Study|Protocol Violation|1|||
130733239|NCT00336024|470642006|FG001|Overall Study|Protocol Violation|0|||
130733240|NCT00336024|470642005|FG000|Overall Study|Withdrawal by Subject|1|||
130733241|NCT00336024|470642006|FG001|Overall Study|Withdrawal by Subject|2|||
130733242|NCT00336024|470642005|FG000|Overall Study|Failure to fulfill consolidation|1|||
130733243|NCT00336024|470642006|FG001|Overall Study|Failure to fulfill consolidation|1|||
130733244|NCT00336024|470642005|FG000|Overall Study|Progressive Disease|4|||
130733245|NCT00336024|470642006|FG001|Overall Study|Progressive Disease|7|||
130733246|NCT00336024|470642005|FG000|Overall Study|Ineligible|7|||
130733247|NCT00336024|470642006|FG001|Overall Study|Ineligible|7|||
130733248|NCT05809596|470642007|FG000|Overall Study|Death|16|||
130733249|NCT05809596|470642007|FG000|Overall Study|Withdrawal by Subject|4|||
130733250|NCT05809596|470642007|FG000|Overall Study|Physician Decision|1|||
130733251|NCT05809596|470642007|FG000|Overall Study|Missed Visit|2|||
130733252|NCT05809596|470642007|FG000|Overall Study|Other|3|||
130733253|NCT05125952|470642008|FG000|Overall Study|Physician Decision|1|||
130733254|NCT03946449|470642009|FG000|Treatment Extension II|Rolled over to another study|0|||
130733255|NCT03946449|470642010|FG001|Treatment Extension II|Rolled over to another study|0|||
130733256|NCT03946449|470642011|FG002|Treatment Extension II|Rolled over to another study|2|||
130733257|NCT03946449|470642009|FG000|Treatment Extension II|Withdrawal by Subject|0|||
130733258|NCT03946449|470642010|FG001|Treatment Extension II|Withdrawal by Subject|0|||
130733259|NCT03946449|470642011|FG002|Treatment Extension II|Withdrawal by Subject|1|||
130733260|NCT07149155|470642014|FG000|Overall Study|Lost to Follow-up|10|||
130733261|NCT03345576|470642015|FG000|Overall Study|Withdrawal by Subject|2|||
130733262|NCT03345576|470642016|FG001|Overall Study|Withdrawal by Subject|2|||
130733263|NCT03345576|470642015|FG000|Overall Study|Adverse Event|1|||
130733264|NCT03345576|470642016|FG001|Overall Study|Adverse Event|0|||
130733265|NCT05067504|470642017|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
130733266|NCT05067504|470642018|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
130733267|NCT05067504|470642017|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
130733268|NCT05067504|470642018|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
130733269|NCT05067504|470642017|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
130733270|NCT05067504|470642018|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
130568266|NCT01967628|470047273|FG000|Overall Study|Lost to Follow-up|1|||
130568267|NCT01967628|470047274|FG001|Overall Study|Lost to Follow-up|0|||
130568268|NCT01967628|470047273|FG000|Overall Study|Low protein concentration in sample|20|||
130509797|NCT02469155|469831792|FG003|Overall Study|Withdrawal by Subject|37|||
130509798|NCT02469155|469831789|FG000|Overall Study|Other|3|||
130509799|NCT02469155|469831790|FG001|Overall Study|Other|3|||
130509800|NCT02469155|469831791|FG002|Overall Study|Other|2|||
130509801|NCT02469155|469831792|FG003|Overall Study|Other|10|||
130509802|NCT02469155|469831789|FG000|Overall Study|Protocol Violation|0|||
130509803|NCT02469155|469831790|FG001|Overall Study|Protocol Violation|1|||
130509804|NCT02469155|469831791|FG002|Overall Study|Protocol Violation|0|||
130509805|NCT02469155|469831792|FG003|Overall Study|Protocol Violation|1|||
130509806|NCT00442559|469831793|FG000|Overall Study|Lost to Follow-up|32|||
130509807|NCT00442559|469831794|FG001|Overall Study|Lost to Follow-up|34|||
130509808|NCT00442559|469831793|FG000|Overall Study|Protocol Violation|1|||
130509809|NCT00442559|469831794|FG001|Overall Study|Protocol Violation|1|||
130509810|NCT00442559|469831793|FG000|Overall Study|Withdrawal by Subject|1|||
130509811|NCT00442559|469831794|FG001|Overall Study|Withdrawal by Subject|0|||
130509812|NCT02604199|469831798|FG000|Overall Study|Pregnancy|0|||
130568269|NCT01967628|470047274|FG001|Overall Study|Low protein concentration in sample|25|||
130568270|NCT02055820|470047277|FG000|Phase I: Dose-Finding|Death|1|||
130568271|NCT02055820|470047278|FG001|Phase I: Dose-Finding|Death|0|||
130568272|NCT02055820|470047279|FG002|Phase I: Dose-Finding|Death|1|||
130509813|NCT02604199|469831799|FG001|Overall Study|Pregnancy|0|||
130509814|NCT02604199|469831800|FG002|Overall Study|Pregnancy|0|||
130509815|NCT02604199|469831801|FG003|Overall Study|Pregnancy|1|||
130509816|NCT02604199|469831798|FG000|Overall Study|Study terminated by sponsor|0|||
130509817|NCT02604199|469831799|FG001|Overall Study|Study terminated by sponsor|2|||
130509818|NCT02604199|469831800|FG002|Overall Study|Study terminated by sponsor|0|||
130509819|NCT02604199|469831801|FG003|Overall Study|Study terminated by sponsor|2|||
130509820|NCT02604199|469831798|FG000|Overall Study|Withdrawal by Subject|0|||
130509821|NCT02604199|469831799|FG001|Overall Study|Withdrawal by Subject|1|||
130509822|NCT02604199|469831800|FG002|Overall Study|Withdrawal by Subject|0|||
130509823|NCT02604199|469831801|FG003|Overall Study|Withdrawal by Subject|0|||
130509824|NCT02812706|469831802|FG000|Phase 1|Adverse Event|0|||
130568273|NCT02055820|470047280|FG003|Phase I: Dose-Finding|Death|2|||
130568274|NCT02055820|470047281|FG004|Phase I: Dose-Finding|Death|0|||
130568275|NCT02055820|470047282|FG005|Phase I: Dose-Finding|Death|1|||
130568276|NCT02055820|470047283|FG006|Phase I: Dose-Finding|Death|1|||
130568277|NCT02055820|470047284|FG007|Phase I: Dose-Finding|Death|0|||
130568278|NCT02055820|470047285|FG008|Phase I: Dose-Finding|Death|0|||
130568279|NCT02055820|470047286|FG009|Phase I: Dose-Finding|Death|0|||
130568280|NCT02055820|470047277|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568281|NCT02055820|470047278|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568282|NCT02055820|470047279|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568283|NCT02055820|470047280|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568284|NCT02055820|470047281|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568285|NCT02055820|470047282|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
130568286|NCT02055820|470047283|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568287|NCT02055820|470047284|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568288|NCT02055820|470047285|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568289|NCT02055820|470047286|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130568290|NCT02055820|470047277|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568291|NCT02055820|470047278|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568292|NCT02055820|470047279|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568293|NCT02055820|470047280|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
130568294|NCT02055820|470047281|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568295|NCT02055820|470047282|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568296|NCT02055820|470047283|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
130568297|NCT02055820|470047284|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568298|NCT02055820|470047285|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568299|NCT02055820|470047286|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
130568300|NCT02055820|470047277|FG000|Phase II: Expansion|Death|0|||
130568301|NCT02055820|470047278|FG001|Phase II: Expansion|Death|0|||
130568302|NCT02055820|470047279|FG002|Phase II: Expansion|Death|0|||
130568303|NCT02055820|470047280|FG003|Phase II: Expansion|Death|0|||
130568304|NCT02055820|470047281|FG004|Phase II: Expansion|Death|33|||
130568305|NCT02055820|470047282|FG005|Phase II: Expansion|Death|0|||
130568306|NCT02055820|470047283|FG006|Phase II: Expansion|Death|0|||
130568307|NCT02055820|470047284|FG007|Phase II: Expansion|Death|0|||
130568308|NCT02055820|470047285|FG008|Phase II: Expansion|Death|0|||
130568309|NCT02055820|470047286|FG009|Phase II: Expansion|Death|0|||
130509825|NCT02812706|469831803|FG001|Phase 1|Adverse Event|2|||
130509826|NCT02812706|469831804|FG002|Phase 1|Adverse Event|0|||
130509827|NCT02812706|469831802|FG000|Phase 1|Progressive disease|3|||
130509828|NCT02812706|469831803|FG001|Phase 1|Progressive disease|3|||
130509829|NCT02812706|469831804|FG002|Phase 1|Progressive disease|0|||
130509830|NCT02812706|469831802|FG000|Phase 2|Adverse Event|0|||
130509831|NCT02812706|469831803|FG001|Phase 2|Adverse Event|0|||
130509832|NCT02812706|469831804|FG002|Phase 2|Adverse Event|2|||
130509833|NCT02812706|469831802|FG000|Phase 2|Progressive disease|0|||
130509834|NCT02812706|469831803|FG001|Phase 2|Progressive disease|0|||
130509835|NCT02812706|469831804|FG002|Phase 2|Progressive disease|22|||
130509836|NCT02812706|469831802|FG000|Phase 2|Other-Unspecified|0|||
130509837|NCT02812706|469831803|FG001|Phase 2|Other-Unspecified|0|||
130509838|NCT02812706|469831804|FG002|Phase 2|Other-Unspecified|4|||
130509839|NCT03166215|469831806|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
130509840|NCT03166215|469831807|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
130509841|NCT03166215|469831808|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
130509842|NCT03166215|469831806|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
130509843|NCT03166215|469831807|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
130568310|NCT02055820|470047277|FG000|Phase II: Expansion|Lost to Follow-up|0|||
130568311|NCT02055820|470047278|FG001|Phase II: Expansion|Lost to Follow-up|0|||
130568312|NCT02055820|470047279|FG002|Phase II: Expansion|Lost to Follow-up|0|||
130568313|NCT02055820|470047280|FG003|Phase II: Expansion|Lost to Follow-up|0|||
130568314|NCT02055820|470047281|FG004|Phase II: Expansion|Lost to Follow-up|4|||
130568315|NCT02055820|470047282|FG005|Phase II: Expansion|Lost to Follow-up|0|||
130568316|NCT02055820|470047283|FG006|Phase II: Expansion|Lost to Follow-up|0|||
130509844|NCT03166215|469831808|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
130509845|NCT05234632|469831810|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
130509846|NCT05234632|469831811|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
130509847|NCT05234632|469831810|FG000|Overall Study|Withdrawal by Subject|2|||
130509848|NCT05234632|469831811|FG001|Overall Study|Withdrawal by Subject|0|||
130509849|NCT05234632|469831810|FG000|Overall Study|Adverse Event|0|||
130509850|NCT05234632|469831811|FG001|Overall Study|Adverse Event|4|||
130509851|NCT05234632|469831810|FG000|Overall Study|Physician Decision|1|||
130509852|NCT05234632|469831811|FG001|Overall Study|Physician Decision|1|||
130509853|NCT05234632|469831810|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
130509854|NCT05234632|469831811|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
130509855|NCT05234632|469831810|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
130509856|NCT05234632|469831811|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
130509857|NCT00658632|469831812|FG000|Overall Study|Adverse Event|13|||
130509858|NCT00658632|469831813|FG001|Overall Study|Adverse Event|11|||
130509859|NCT00658632|469831812|FG000|Overall Study|Lost to Follow-up|25|||
130509860|NCT00658632|469831813|FG001|Overall Study|Lost to Follow-up|23|||
130509861|NCT00658632|469831812|FG000|Overall Study|Withdrawal by Subject|10|||
130509862|NCT00658632|469831813|FG001|Overall Study|Withdrawal by Subject|7|||
130509863|NCT00658632|469831812|FG000|Overall Study|Lack of Efficacy|0|||
130509864|NCT00658632|469831813|FG001|Overall Study|Lack of Efficacy|1|||
130509865|NCT00658632|469831812|FG000|Overall Study|Withdrawal of consent|8|||
130509866|NCT00658632|469831813|FG001|Overall Study|Withdrawal of consent|14|||
130509867|NCT00658632|469831812|FG000|Overall Study|Pregnancy|1|||
130509868|NCT00658632|469831813|FG001|Overall Study|Pregnancy|1|||
130509869|NCT00658632|469831812|FG000|Overall Study|Other|7|||
130509870|NCT00658632|469831813|FG001|Overall Study|Other|8|||
130509871|NCT02632045|469831814|FG000|Overall Study|Withdrawal by Subject|1|||
130509872|NCT02632045|469831815|FG001|Overall Study|Withdrawal by Subject|2|||
130509873|NCT05263492|469831816|FG000|Overall Study|Adverse Event|1|||
130509874|NCT05263492|469831816|FG000|Overall Study|Disease progression during active treatment|3|||
130509875|NCT01885559|469831817|FG000|Overall Study|Lost to Follow-up|15|||
130509876|NCT01885559|469831818|FG001|Overall Study|Lost to Follow-up|16|||
130509877|NCT01885559|469831817|FG000|Overall Study|Less than full participation|9|||
130509878|NCT01885559|469831818|FG001|Overall Study|Less than full participation|19|||
130509879|NCT01885559|469831817|FG000|Overall Study|Protocol Violation|0|||
130509880|NCT01885559|469831818|FG001|Overall Study|Protocol Violation|1|||
130509881|NCT00738400|469831821|FG000|Overall Study|Adverse Event|3|||
130509882|NCT00738400|469831822|FG001|Overall Study|Adverse Event|1|||
130509883|NCT00738400|469831821|FG000|Overall Study|Withdrawal by Subject|0|||
130509884|NCT00738400|469831822|FG001|Overall Study|Withdrawal by Subject|1|||
130509885|NCT00738400|469831821|FG000|Overall Study|Lack of Efficacy|0|||
130509886|NCT00738400|469831822|FG001|Overall Study|Lack of Efficacy|1|||
130509887|NCT00738400|469831821|FG000|Overall Study|Lost to Follow-up|0|||
130509888|NCT00738400|469831822|FG001|Overall Study|Lost to Follow-up|3|||
130509889|NCT00738400|469831821|FG000|Overall Study|Protocol Violation|1|||
130509890|NCT00738400|469831822|FG001|Overall Study|Protocol Violation|0|||
130509891|NCT00738400|469831821|FG000|Overall Study|Non-compliant with study medication|0|||
130509892|NCT00738400|469831822|FG001|Overall Study|Non-compliant with study medication|1|||
130509893|NCT03138499|469831823|FG000|Overall Study|Lost to Follow-up|1|||
130509894|NCT03138499|469831824|FG001|Overall Study|Lost to Follow-up|0|||
130509895|NCT03138499|469831823|FG000|Overall Study|Participants withdrew consent|1|||
130509896|NCT03138499|469831824|FG001|Overall Study|Participants withdrew consent|0|||
130509897|NCT03138499|469831823|FG000|Overall Study|Participant discontinued study before treatment|0|||
130509898|NCT03138499|469831824|FG001|Overall Study|Participant discontinued study before treatment|1|||
130509899|NCT03138499|469831823|FG000|Overall Study|Disease Progression|2|||
130509900|NCT03138499|469831824|FG001|Overall Study|Disease Progression|6|||
130509901|NCT03138499|469831823|FG000|Overall Study|Study drug toxicity|2|||
130509902|NCT03138499|469831824|FG001|Overall Study|Study drug toxicity|2|||
130509903|NCT03138499|469831823|FG000|Overall Study|Participant request to discontinue study treatment|1|||
130509904|NCT03138499|469831824|FG001|Overall Study|Participant request to discontinue study treatment|1|||
130509905|NCT03138499|469831823|FG000|Overall Study|Other reasons|2|||
130509906|NCT03138499|469831824|FG001|Overall Study|Other reasons|0|||
130509907|NCT02312245|469831825|FG000|Overall Study|Death|0|||
130509908|NCT02312245|469831826|FG001|Overall Study|Death|0|||
130509909|NCT02312245|469831827|FG002|Overall Study|Death|0|||
130509910|NCT02312245|469831828|FG003|Overall Study|Death|1|||
130509911|NCT02312245|469831825|FG000|Overall Study|Withdrawal by Subject|1|||
130509912|NCT02312245|469831826|FG001|Overall Study|Withdrawal by Subject|1|||
130509913|NCT02312245|469831827|FG002|Overall Study|Withdrawal by Subject|0|||
130509914|NCT02312245|469831828|FG003|Overall Study|Withdrawal by Subject|2|||
130509915|NCT02312245|469831825|FG000|Overall Study|Alternative Therapy|1|||
130509916|NCT02312245|469831826|FG001|Overall Study|Alternative Therapy|0|||
130509917|NCT02312245|469831827|FG002|Overall Study|Alternative Therapy|0|||
130509918|NCT02312245|469831828|FG003|Overall Study|Alternative Therapy|0|||
130509919|NCT02312245|469831825|FG000|Overall Study|Progression|0|||
130509920|NCT02312245|469831826|FG001|Overall Study|Progression|0|||
130509921|NCT02312245|469831827|FG002|Overall Study|Progression|0|||
130509922|NCT02312245|469831828|FG003|Overall Study|Progression|5|||
130509923|NCT02312245|469831825|FG000|Overall Study|Patient went to hospice|0|||
130509924|NCT02312245|469831826|FG001|Overall Study|Patient went to hospice|0|||
130509925|NCT02312245|469831827|FG002|Overall Study|Patient went to hospice|0|||
130509926|NCT02312245|469831828|FG003|Overall Study|Patient went to hospice|1|||
130509927|NCT02312245|469831825|FG000|Overall Study|Ineligible|1|||
130568317|NCT02055820|470047284|FG007|Phase II: Expansion|Lost to Follow-up|0|||
130568318|NCT02055820|470047285|FG008|Phase II: Expansion|Lost to Follow-up|0|||
130568319|NCT02055820|470047286|FG009|Phase II: Expansion|Lost to Follow-up|0|||
130568320|NCT02055820|470047277|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
130568321|NCT02055820|470047278|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
130568322|NCT02055820|470047279|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
130568323|NCT02055820|470047280|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
130568324|NCT02055820|470047281|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
130568325|NCT02055820|470047282|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
130568326|NCT02055820|470047283|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
130568327|NCT02055820|470047284|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
130568328|NCT02055820|470047285|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
130568329|NCT02055820|470047286|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
130568330|NCT01399788|470047288|FG000|First Intervention Period|Adverse Event|1|||
130568331|NCT01399788|470047289|FG001|First Intervention Period|Adverse Event|0|||
130568332|NCT02919436|470047290|FG000|Overall Study|Did not undergo surgery|16|||
130568333|NCT02919436|470047291|FG001|Overall Study|Did not undergo surgery|20|||
130568334|NCT02919436|470047290|FG000|Overall Study|Enrolled before trial registration|44|||
130568335|NCT02919436|470047291|FG001|Overall Study|Enrolled before trial registration|33|||
130568336|NCT03699007|470047292|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
130568337|NCT03699007|470047293|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
130568338|NCT03699007|470047292|FG000|6-month Follow Up|Lost to Follow-up|2|||
130568339|NCT03699007|470047293|FG001|6-month Follow Up|Lost to Follow-up|3|||
130568340|NCT04718974|470047294|FG000|Overall Study|Death|0|||
130568341|NCT04718974|470047295|FG001|Overall Study|Death|2|||
130568342|NCT04718974|470047294|FG000|Overall Study|Lost to Follow-up|10|||
130568343|NCT04718974|470047295|FG001|Overall Study|Lost to Follow-up|20|||
130568344|NCT04718974|470047294|FG000|Overall Study|Transferred out|2|||
130568345|NCT04718974|470047295|FG001|Overall Study|Transferred out|4|||
130568346|NCT01157364|470047296|FG000|Overall Study|Other Reasons|1|||
130568347|NCT01157364|470047297|FG001|Overall Study|Other Reasons|1|||
130568348|NCT01157364|470047298|FG002|Overall Study|Other Reasons|2|||
130568349|NCT01157364|470047299|FG003|Overall Study|Other Reasons|1|||
130568350|NCT01157364|470047300|FG004|Overall Study|Other Reasons|0|||
130568351|NCT01157364|470047301|FG005|Overall Study|Other Reasons|0|||
130568352|NCT01157364|470047296|FG000|Overall Study|Personal Reasons|0|||
130568353|NCT01157364|470047297|FG001|Overall Study|Personal Reasons|2|||
130568354|NCT01157364|470047298|FG002|Overall Study|Personal Reasons|0|||
130568355|NCT01157364|470047299|FG003|Overall Study|Personal Reasons|0|||
130568356|NCT01157364|470047300|FG004|Overall Study|Personal Reasons|1|||
130568357|NCT01157364|470047301|FG005|Overall Study|Personal Reasons|1|||
130568358|NCT01157364|470047296|FG000|Overall Study|Lost to Follow-up|1|||
130568359|NCT01157364|470047297|FG001|Overall Study|Lost to Follow-up|0|||
130568360|NCT01157364|470047298|FG002|Overall Study|Lost to Follow-up|1|||
130568361|NCT01157364|470047299|FG003|Overall Study|Lost to Follow-up|0|||
130568362|NCT01157364|470047300|FG004|Overall Study|Lost to Follow-up|0|||
130568363|NCT01157364|470047301|FG005|Overall Study|Lost to Follow-up|0|||
130568364|NCT01157364|470047296|FG000|Overall Study|Lack of Efficacy|0|||
130568365|NCT01157364|470047297|FG001|Overall Study|Lack of Efficacy|0|||
130568366|NCT01157364|470047298|FG002|Overall Study|Lack of Efficacy|0|||
130568367|NCT01157364|470047299|FG003|Overall Study|Lack of Efficacy|1|||
130568368|NCT01157364|470047300|FG004|Overall Study|Lack of Efficacy|0|||
130568369|NCT01157364|470047301|FG005|Overall Study|Lack of Efficacy|0|||
130568370|NCT01157364|470047296|FG000|Overall Study|Adverse Event|0|||
130568371|NCT01157364|470047297|FG001|Overall Study|Adverse Event|1|||
130568372|NCT01157364|470047298|FG002|Overall Study|Adverse Event|1|||
130568373|NCT01157364|470047299|FG003|Overall Study|Adverse Event|0|||
130568374|NCT01157364|470047300|FG004|Overall Study|Adverse Event|1|||
130568375|NCT01157364|470047301|FG005|Overall Study|Adverse Event|0|||
130568376|NCT03259074|470047302|FG000|Overall Study|Adverse Event|9|||
130568377|NCT03259074|470047303|FG001|Overall Study|Adverse Event|12|||
130568378|NCT03259074|470047304|FG002|Overall Study|Adverse Event|8|||
130568379|NCT03259074|470047302|FG000|Overall Study|Death|1|||
130568380|NCT03259074|470047303|FG001|Overall Study|Death|1|||
130568381|NCT03259074|470047304|FG002|Overall Study|Death|3|||
130509928|NCT02312245|469831826|FG001|Overall Study|Ineligible|0|||
130509929|NCT02312245|469831827|FG002|Overall Study|Ineligible|0|||
130509930|NCT02312245|469831828|FG003|Overall Study|Ineligible|0|||
130509931|NCT01123200|469831829|FG000|Overall Study|Withdrawal by Subject|1|||
130568382|NCT03259074|470047302|FG000|Overall Study|Lost to Follow-up|2|||
130568383|NCT03259074|470047303|FG001|Overall Study|Lost to Follow-up|4|||
130568384|NCT03259074|470047304|FG002|Overall Study|Lost to Follow-up|3|||
130568385|NCT03259074|470047302|FG000|Overall Study|New Therapy For Study Indication|1|||
130568386|NCT03259074|470047303|FG001|Overall Study|New Therapy For Study Indication|2|||
130568387|NCT03259074|470047304|FG002|Overall Study|New Therapy For Study Indication|2|||
130568388|NCT03259074|470047302|FG000|Overall Study|Physician Decision|4|||
130568389|NCT03259074|470047303|FG001|Overall Study|Physician Decision|12|||
130568390|NCT03259074|470047304|FG002|Overall Study|Physician Decision|10|||
130568391|NCT03259074|470047302|FG000|Overall Study|Pregnancy|1|||
130568392|NCT03259074|470047303|FG001|Overall Study|Pregnancy|1|||
130568393|NCT03259074|470047304|FG002|Overall Study|Pregnancy|0|||
130568394|NCT03259074|470047302|FG000|Overall Study|Progressive Disease|1|||
130568395|NCT03259074|470047303|FG001|Overall Study|Progressive Disease|0|||
130568396|NCT03259074|470047304|FG002|Overall Study|Progressive Disease|0|||
130568397|NCT03259074|470047302|FG000|Overall Study|Protocol Deviation|1|||
130568398|NCT03259074|470047303|FG001|Overall Study|Protocol Deviation|1|||
130568399|NCT03259074|470047304|FG002|Overall Study|Protocol Deviation|3|||
130568400|NCT03259074|470047302|FG000|Overall Study|Subject/Guardian Decision|13|||
130568401|NCT03259074|470047303|FG001|Overall Study|Subject/Guardian Decision|16|||
130568402|NCT03259074|470047304|FG002|Overall Study|Subject/Guardian Decision|14|||
130568403|NCT01780662|470047305|FG000|Overall Study|Adverse Event|1|||
130568404|NCT01780662|470047306|FG001|Overall Study|Adverse Event|0|||
130568405|NCT01780662|470047307|FG002|Overall Study|Adverse Event|2|||
130568406|NCT01780662|470047305|FG000|Overall Study|Physician Decision|0|||
130568407|NCT01780662|470047306|FG001|Overall Study|Physician Decision|5|||
130568408|NCT01780662|470047307|FG002|Overall Study|Physician Decision|7|||
130568409|NCT01780662|470047305|FG000|Overall Study|Protocol Violation|0|||
130568410|NCT01780662|470047306|FG001|Overall Study|Protocol Violation|1|||
130568411|NCT01780662|470047307|FG002|Overall Study|Protocol Violation|0|||
130568412|NCT01780662|470047305|FG000|Overall Study|Ineligible|0|||
130568413|NCT01780662|470047306|FG001|Overall Study|Ineligible|0|||
130568414|NCT01780662|470047307|FG002|Overall Study|Ineligible|1|||
130568415|NCT00053417|470047308|FG000|Overall Study|Adverse Event|1|||
130568416|NCT00053417|470047309|FG001|Overall Study|Adverse Event|0|||
130568417|NCT00053417|470047310|FG002|Overall Study|Adverse Event|1|||
130568418|NCT00053417|470047311|FG003|Overall Study|Adverse Event|5|||
130568419|NCT00053417|470047308|FG000|Overall Study|Non-Compliance|0|||
130568420|NCT00053417|470047309|FG001|Overall Study|Non-Compliance|0|||
130568421|NCT00053417|470047310|FG002|Overall Study|Non-Compliance|0|||
130568422|NCT00053417|470047311|FG003|Overall Study|Non-Compliance|1|||
130568423|NCT00053417|470047308|FG000|Overall Study|Withdrawal by Subject|0|||
130568424|NCT00053417|470047309|FG001|Overall Study|Withdrawal by Subject|1|||
130568425|NCT00053417|470047310|FG002|Overall Study|Withdrawal by Subject|0|||
130568426|NCT00053417|470047311|FG003|Overall Study|Withdrawal by Subject|0|||
130568427|NCT00053417|470047308|FG000|Overall Study|Lost to Follow-up|1|||
130568428|NCT00053417|470047309|FG001|Overall Study|Lost to Follow-up|1|||
130568429|NCT00053417|470047310|FG002|Overall Study|Lost to Follow-up|0|||
130568430|NCT00053417|470047311|FG003|Overall Study|Lost to Follow-up|0|||
130568431|NCT04081363|470047314|FG000|Overall Study|Withdrawal by Subject|1|||
130568432|NCT04081363|470047315|FG001|Overall Study|Withdrawal by Subject|0|||
130568433|NCT00841568|470047317|FG000|Overall Study|Adverse Event|1|||
130568434|NCT00841568|470047317|FG000|Overall Study|Death|1|||
130568435|NCT00841568|470047317|FG000|Overall Study|Withdrawal by Subject|2|||
130568436|NCT00841568|470047317|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
130568437|NCT01087775|470047318|FG000|Overall Study|failed inclusion criteria|2|||
130568438|NCT05289570|470047323|FG000|Overall Study|Physician Decision|1|||
130568439|NCT00645593|470047326|FG000|Overall Study|Later found to be ineligible|1|||
130568440|NCT00645593|470047327|FG001|Overall Study|Later found to be ineligible|0|||
130568441|NCT04218201|470048370|FG000|Overall Study|Death|0|||
130568442|NCT04218201|470048371|FG001|Overall Study|Death|0|||
130568443|NCT04218201|470048372|FG002|Overall Study|Death|2|||
130568444|NCT04218201|470048373|FG003|Overall Study|Death|0|||
130568445|NCT04218201|470048370|FG000|Overall Study|Unable to contact participant|4|||
130568446|NCT04218201|470048371|FG001|Overall Study|Unable to contact participant|0|||
130568447|NCT04218201|470048372|FG002|Overall Study|Unable to contact participant|3|||
130568448|NCT04218201|470048373|FG003|Overall Study|Unable to contact participant|0|||
130568449|NCT04218201|470048370|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
130568450|NCT04218201|470048371|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130509932|NCT02819141|469831830|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
130509933|NCT02819141|469831831|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
130509934|NCT03556891|469831832|FG000|Initial Pivotal Study|Adverse Event|4|||
130509935|NCT03556891|469831832|FG000|Initial Pivotal Study|MRI Need|3|||
130509936|NCT03556891|469831832|FG000|Initial Pivotal Study|Device Failure|1|||
130509937|NCT03556891|469831832|FG000|Initial Pivotal Study|Death|1|||
130509938|NCT03556891|469831832|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
130509939|NCT03556891|469831832|FG000|Initial Pivotal Study|Missing at random|1|||
130509940|NCT03556891|469831832|FG000|Initial Pivotal Study|Missing due to COVID|1|||
130509941|NCT03556891|469831832|FG000|Initial Pivotal Study|Protocol Violation|1|||
130509942|NCT02062827|469832416|FG000|Overall Study|Death|1|||
130509943|NCT02062827|469832417|FG001|Overall Study|Death|0|||
130509944|NCT02062827|469832418|FG002|Overall Study|Death|0|||
130509945|NCT02062827|469832419|FG003|Overall Study|Death|0|||
130509946|NCT02062827|469832420|FG004|Overall Study|Death|0|||
130509947|NCT02062827|469832421|FG005|Overall Study|Death|0|||
130509948|NCT02062827|469832422|FG006|Overall Study|Death|0|||
130509949|NCT02062827|469832423|FG007|Overall Study|Death|0|||
130509950|NCT02062827|469832416|FG000|Overall Study|Withdrawal by Subject|3|||
130509951|NCT02062827|469832417|FG001|Overall Study|Withdrawal by Subject|1|||
130509952|NCT02062827|469832418|FG002|Overall Study|Withdrawal by Subject|1|||
130509953|NCT02062827|469832419|FG003|Overall Study|Withdrawal by Subject|2|||
130509954|NCT02062827|469832420|FG004|Overall Study|Withdrawal by Subject|6|||
130509955|NCT02062827|469832421|FG005|Overall Study|Withdrawal by Subject|0|||
130509956|NCT02062827|469832422|FG006|Overall Study|Withdrawal by Subject|5|||
130509957|NCT02062827|469832423|FG007|Overall Study|Withdrawal by Subject|0|||
130509958|NCT02062827|469832416|FG000|Overall Study|Screen Fail|0|||
130509959|NCT02062827|469832417|FG001|Overall Study|Screen Fail|0|||
130509960|NCT02062827|469832418|FG002|Overall Study|Screen Fail|0|||
130509961|NCT02062827|469832419|FG003|Overall Study|Screen Fail|0|||
130509962|NCT02062827|469832420|FG004|Overall Study|Screen Fail|0|||
130509963|NCT02062827|469832421|FG005|Overall Study|Screen Fail|0|||
130509964|NCT02062827|469832422|FG006|Overall Study|Screen Fail|0|||
130509965|NCT02062827|469832423|FG007|Overall Study|Screen Fail|8|||
130509966|NCT00288353|469832424|FG000|Overall Study|Lack of Efficacy|2|||
130509967|NCT00288353|469832425|FG001|Overall Study|Lack of Efficacy|2|||
130509968|NCT00288353|469832424|FG000|Overall Study|Withdrawal by Subject|5|||
130509969|NCT00288353|469832425|FG001|Overall Study|Withdrawal by Subject|5|||
130509970|NCT05008224|469832426|FG000|Overall Study|Death|3|||
130509971|NCT05008224|469832426|FG000|Overall Study|Lost to Follow-up|2|||
130509972|NCT05008224|469832426|FG000|Overall Study|Did Not Continue on Extension Study|39|||
130509973|NCT05008224|469832426|FG000|Overall Study|Transferred to Extension Study|100|||
130509974|NCT05008224|469832426|FG000|Overall Study|Withdrawal by Subject|2|||
130509975|NCT04985604|469832427|FG000|Overall Study|Death|4|||
130509976|NCT04985604|469832428|FG001|Overall Study|Death|6|||
130509977|NCT04985604|469832427|FG000|Overall Study|Withdrawal by Subject|0|||
130509978|NCT04985604|469832428|FG001|Overall Study|Withdrawal by Subject|1|||
130509979|NCT02282761|469832429|FG000|Overall Study|Death|0|||
130509980|NCT02282761|469832430|FG001|Overall Study|Death|0|||
130509981|NCT02282761|469832431|FG002|Overall Study|Death|1|||
130509982|NCT02282761|469832429|FG000|Overall Study|Adverse Event|6|||
130509983|NCT02282761|469832430|FG001|Overall Study|Adverse Event|2|||
130509984|NCT02282761|469832431|FG002|Overall Study|Adverse Event|0|||
130509985|NCT02282761|469832429|FG000|Overall Study|Lack of Efficacy|11|||
130509986|NCT02282761|469832430|FG001|Overall Study|Lack of Efficacy|6|||
130509987|NCT02282761|469832431|FG002|Overall Study|Lack of Efficacy|17|||
130509988|NCT02282761|469832429|FG000|Overall Study|Lost to Follow-up|2|||
130509989|NCT02282761|469832430|FG001|Overall Study|Lost to Follow-up|2|||
130509990|NCT02282761|469832431|FG002|Overall Study|Lost to Follow-up|1|||
130509991|NCT02282761|469832429|FG000|Overall Study|Physician Decision|0|||
130509992|NCT02282761|469832430|FG001|Overall Study|Physician Decision|0|||
130509993|NCT02282761|469832431|FG002|Overall Study|Physician Decision|2|||
130509994|NCT02282761|469832429|FG000|Overall Study|Withdrawal by Subject|8|||
130509995|NCT02282761|469832430|FG001|Overall Study|Withdrawal by Subject|10|||
130509996|NCT02282761|469832431|FG002|Overall Study|Withdrawal by Subject|16|||
130509997|NCT02282761|469832429|FG000|Overall Study|Other|3|||
130509998|NCT02282761|469832430|FG001|Overall Study|Other|2|||
130509999|NCT02282761|469832431|FG002|Overall Study|Other|1|||
130510000|NCT05878522|469832432|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510001|NCT05878522|469832433|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510002|NCT05878522|469832434|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510003|NCT05878522|469832435|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510004|NCT05878522|469832436|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510005|NCT05878522|469832437|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510006|NCT05878522|469832438|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130568451|NCT04218201|470048372|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130568452|NCT04218201|470048373|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130568453|NCT04218201|470048370|FG000|Overall Study|Withdrawal by Subject|2|||
130568454|NCT04218201|470048371|FG001|Overall Study|Withdrawal by Subject|0|||
130568455|NCT04218201|470048372|FG002|Overall Study|Withdrawal by Subject|0|||
130568456|NCT04218201|470048373|FG003|Overall Study|Withdrawal by Subject|0|||
130568457|NCT04218201|470048370|FG000|Overall Study|PCP plans to leave practice|0|||
130568458|NCT04218201|470048371|FG001|Overall Study|PCP plans to leave practice|8|||
130568459|NCT04218201|470048372|FG002|Overall Study|PCP plans to leave practice|0|||
130568460|NCT04218201|470048373|FG003|Overall Study|PCP plans to leave practice|5|||
130568461|NCT04218201|470048370|FG000|Overall Study|Reduced panel|0|||
130568462|NCT04218201|470048371|FG001|Overall Study|Reduced panel|0|||
130568463|NCT04218201|470048372|FG002|Overall Study|Reduced panel|0|||
130568464|NCT04218201|470048373|FG003|Overall Study|Reduced panel|1|||
130568465|NCT04218201|470048370|FG000|Overall Study|No longer interested in participating|0|||
130568466|NCT04218201|470048371|FG001|Overall Study|No longer interested in participating|1|||
130568467|NCT04218201|470048372|FG002|Overall Study|No longer interested in participating|0|||
130568468|NCT04218201|470048373|FG003|Overall Study|No longer interested in participating|0|||
130568469|NCT03723707|470048374|FG000|Overall Study|Death|32|||
130568470|NCT03723707|470048375|FG001|Overall Study|Death|32|||
130568471|NCT03723707|470048374|FG000|Overall Study|Admitted to long term care|12|||
130568472|NCT03723707|470048375|FG001|Overall Study|Admitted to long term care|12|||
130568473|NCT03723707|470048374|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
130568474|NCT03723707|470048375|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
130568475|NCT03723707|470048374|FG000|Overall Study|Lost to Follow-up|40|||
130568476|NCT03723707|470048375|FG001|Overall Study|Lost to Follow-up|22|||
130568477|NCT03723707|470048374|FG000|Overall Study|Discontinued after study closure|24|||
130568478|NCT03723707|470048375|FG001|Overall Study|Discontinued after study closure|12|||
130568479|NCT01611974|470048376|FG000|Overall Study|Death|10|||
130568480|NCT01611974|470048377|FG001|Overall Study|Death|12|||
130568481|NCT01611974|470048378|FG002|Overall Study|Death|10|||
130568482|NCT01611974|470048376|FG000|Overall Study|Lost to Follow-up|0|||
130568483|NCT01611974|470048377|FG001|Overall Study|Lost to Follow-up|1|||
130568484|NCT01611974|470048378|FG002|Overall Study|Lost to Follow-up|0|||
130568485|NCT01611974|470048376|FG000|Overall Study|Physician Decision|5|||
130568486|NCT01611974|470048377|FG001|Overall Study|Physician Decision|1|||
130568487|NCT01611974|470048378|FG002|Overall Study|Physician Decision|2|||
130568488|NCT01611974|470048376|FG000|Overall Study|Withdrawal by Subject|0|||
130568489|NCT01611974|470048377|FG001|Overall Study|Withdrawal by Subject|1|||
130568490|NCT01611974|470048378|FG002|Overall Study|Withdrawal by Subject|4|||
130510007|NCT05878522|469832439|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510008|NCT05878522|469832440|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
130510009|NCT05878522|469832441|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510010|NCT05878522|469832442|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510011|NCT05878522|469832443|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
130510012|NCT05878522|469832432|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
130510013|NCT05878522|469832433|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510014|NCT05878522|469832434|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510015|NCT05878522|469832435|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510016|NCT05878522|469832436|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510017|NCT05878522|469832437|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510018|NCT05878522|469832438|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510019|NCT05878522|469832439|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510020|NCT05878522|469832440|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510021|NCT05878522|469832441|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
130510022|NCT05878522|469832442|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510023|NCT05878522|469832443|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130510024|NCT05878522|469832432|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510025|NCT05878522|469832433|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
130510026|NCT05878522|469832434|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510027|NCT05878522|469832435|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
130510028|NCT05878522|469832436|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510029|NCT05878522|469832437|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510030|NCT05878522|469832438|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510031|NCT05878522|469832439|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130568491|NCT00530270|470048386|FG000|Overall Study|Protocol Violation|1|||
130568492|NCT00530270|470048387|FG001|Overall Study|Protocol Violation|0|||
130568493|NCT00838331|470048391|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
130568494|NCT03972969|470048393|FG000|3-month Follow-up|Death|1|||
130568495|NCT03972969|470048394|FG001|3-month Follow-up|Death|1|||
130568496|NCT03972969|470048395|FG002|3-month Follow-up|Death|0|||
130568497|NCT03972969|470048393|FG000|6-month Follow-up|Death|1|||
130568498|NCT03972969|470048394|FG001|6-month Follow-up|Death|1|||
130510032|NCT05878522|469832440|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510033|NCT05878522|469832441|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510034|NCT05878522|469832442|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510035|NCT05878522|469832443|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130510036|NCT05878522|469832432|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510037|NCT05878522|469832433|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510038|NCT05878522|469832434|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510039|NCT05878522|469832435|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510040|NCT05878522|469832436|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
130510041|NCT05878522|469832437|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510042|NCT05878522|469832438|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510043|NCT05878522|469832439|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510044|NCT05878522|469832440|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510045|NCT05878522|469832441|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510046|NCT05878522|469832442|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510047|NCT05878522|469832443|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130510048|NCT03345420|469832446|FG000|Overall Study|Withdrawal by Subject|1|||
130510049|NCT02252172|469832447|FG000|Overall Study|Lost to Follow-up|3|||
130510050|NCT02252172|469832448|FG001|Overall Study|Lost to Follow-up|1|||
130568499|NCT03972969|470048395|FG002|6-month Follow-up|Death|1|||
130510051|NCT02252172|469832447|FG000|Overall Study|Ongoing|276|||
130510052|NCT02252172|469832448|FG001|Overall Study|Ongoing|298|||
130510053|NCT05216835|469832449|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
130510054|NCT05216835|469832450|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
130510055|NCT05216835|469832451|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
130568500|NCT03972969|470048393|FG000|6-month Follow-up|Lost to Follow-up|2|||
130568501|NCT03972969|470048394|FG001|6-month Follow-up|Lost to Follow-up|2|||
130568502|NCT03972969|470048395|FG002|6-month Follow-up|Lost to Follow-up|2|||
130510056|NCT05216835|469832452|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
130510057|NCT05216835|469832453|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
130510058|NCT05216835|469832454|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
130510059|NCT05216835|469832455|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
130510060|NCT05216835|469832456|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
130568503|NCT00732303|470048396|FG000|Overall Study|Study Terminated|2|||
130510061|NCT05216835|469832449|FG000|Overall Study|Death|0|||
130510062|NCT05216835|469832450|FG001|Overall Study|Death|0|||
130510063|NCT05216835|469832451|FG002|Overall Study|Death|0|||
130510064|NCT05216835|469832452|FG003|Overall Study|Death|1|||
130510065|NCT05216835|469832453|FG004|Overall Study|Death|1|||
130510066|NCT05216835|469832454|FG005|Overall Study|Death|1|||
130510067|NCT05216835|469832455|FG006|Overall Study|Death|1|||
130510068|NCT05216835|469832456|FG007|Overall Study|Death|1|||
130510069|NCT05216835|469832449|FG000|Overall Study|Physician Decision|0|||
130510070|NCT05216835|469832450|FG001|Overall Study|Physician Decision|0|||
130510071|NCT05216835|469832451|FG002|Overall Study|Physician Decision|0|||
130510072|NCT05216835|469832452|FG003|Overall Study|Physician Decision|0|||
130510073|NCT05216835|469832453|FG004|Overall Study|Physician Decision|0|||
130510074|NCT05216835|469832454|FG005|Overall Study|Physician Decision|1|||
130510075|NCT05216835|469832455|FG006|Overall Study|Physician Decision|1|||
130510076|NCT05216835|469832456|FG007|Overall Study|Physician Decision|0|||
130510077|NCT05216835|469832449|FG000|Overall Study|Study terminated by Sponsor|0|||
130510078|NCT05216835|469832450|FG001|Overall Study|Study terminated by Sponsor|0|||
130510079|NCT05216835|469832451|FG002|Overall Study|Study terminated by Sponsor|0|||
130510080|NCT05216835|469832452|FG003|Overall Study|Study terminated by Sponsor|0|||
130510081|NCT05216835|469832453|FG004|Overall Study|Study terminated by Sponsor|0|||
130510082|NCT05216835|469832454|FG005|Overall Study|Study terminated by Sponsor|0|||
130510083|NCT05216835|469832455|FG006|Overall Study|Study terminated by Sponsor|0|||
130510084|NCT05216835|469832456|FG007|Overall Study|Study terminated by Sponsor|1|||
130510085|NCT05216835|469832449|FG000|Overall Study|Withdrawal by Subject|1|||
130510086|NCT05216835|469832450|FG001|Overall Study|Withdrawal by Subject|0|||
130510087|NCT05216835|469832451|FG002|Overall Study|Withdrawal by Subject|1|||
130510088|NCT05216835|469832452|FG003|Overall Study|Withdrawal by Subject|0|||
130510089|NCT05216835|469832453|FG004|Overall Study|Withdrawal by Subject|1|||
130510090|NCT05216835|469832454|FG005|Overall Study|Withdrawal by Subject|0|||
130510091|NCT05216835|469832455|FG006|Overall Study|Withdrawal by Subject|0|||
130510092|NCT05216835|469832456|FG007|Overall Study|Withdrawal by Subject|1|||
130510093|NCT05216835|469832449|FG000|Overall Study|Other|0|||
130510094|NCT05216835|469832450|FG001|Overall Study|Other|1|||
130510095|NCT05216835|469832451|FG002|Overall Study|Other|0|||
130510096|NCT05216835|469832452|FG003|Overall Study|Other|0|||
130510097|NCT05216835|469832453|FG004|Overall Study|Other|0|||
130510098|NCT05216835|469832454|FG005|Overall Study|Other|0|||
130510099|NCT05216835|469832455|FG006|Overall Study|Other|0|||
130510100|NCT05216835|469832456|FG007|Overall Study|Other|0|||
130510101|NCT05179603|469832457|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130510102|NCT05179603|469832457|FG000|Overall Study|Withdrawal by Subject|1|||
130510103|NCT05179603|469832457|FG000|Overall Study|Progressive disease|4|||
130510104|NCT05179603|469832457|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
130510105|NCT04551053|469832460|FG000|Overall Study|Death|10|||
130510106|NCT04551053|469832461|FG001|Overall Study|Death|9|||
130510107|NCT04551053|469832460|FG000|Overall Study|Lost to Follow-up|0|||
130510108|NCT04551053|469832461|FG001|Overall Study|Lost to Follow-up|2|||
130510109|NCT04551053|469832460|FG000|Overall Study|Study Terminated by Sponsor|57|||
130510110|NCT04551053|469832461|FG001|Overall Study|Study Terminated by Sponsor|65|||
130510111|NCT04551053|469832460|FG000|Overall Study|Withdrawal by Subject|12|||
130510112|NCT04551053|469832461|FG001|Overall Study|Withdrawal by Subject|5|||
130510113|NCT04551053|469832460|FG000|Overall Study|Adverse Event|2|||
130510114|NCT04551053|469832461|FG001|Overall Study|Adverse Event|0|||
130510115|NCT04551053|469832460|FG000|Overall Study|Lack of Efficacy|2|||
130510116|NCT04551053|469832461|FG001|Overall Study|Lack of Efficacy|1|||
130510117|NCT04551053|469832460|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
130510118|NCT04551053|469832461|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
130510119|NCT04551053|469832460|FG000|Overall Study|Splenapendectomi|1|||
130510120|NCT04551053|469832461|FG001|Overall Study|Splenapendectomi|0|||
130510121|NCT04551053|469832460|FG000|Overall Study|Medical Decision|1|||
130510122|NCT04551053|469832461|FG001|Overall Study|Medical Decision|1|||
130510123|NCT05740371|469832462|FG000|Overall Study|Death|1|||
130510124|NCT03019289|469832463|FG000|Overall Study|Adverse Event|1|||
130510125|NCT03019289|469832464|FG001|Overall Study|Adverse Event|0|||
130510126|NCT03019289|469832465|FG002|Overall Study|Adverse Event|0|||
130510127|NCT03019289|469832466|FG003|Overall Study|Adverse Event|0|||
130510128|NCT03019289|469832467|FG004|Overall Study|Adverse Event|0|||
130510129|NCT03019289|469832468|FG005|Overall Study|Adverse Event|0|||
130510130|NCT03019289|469832469|FG006|Overall Study|Adverse Event|0|||
130510131|NCT03019289|469832470|FG007|Overall Study|Adverse Event|0|||
130510132|NCT03019289|469832471|FG008|Overall Study|Adverse Event|1|||
130510133|NCT03019289|469832463|FG000|Overall Study|Other|1|||
130510134|NCT03019289|469832464|FG001|Overall Study|Other|0|||
130510135|NCT03019289|469832465|FG002|Overall Study|Other|0|||
130510136|NCT03019289|469832466|FG003|Overall Study|Other|0|||
130510137|NCT03019289|469832467|FG004|Overall Study|Other|0|||
130510138|NCT03019289|469832468|FG005|Overall Study|Other|0|||
130510139|NCT03019289|469832469|FG006|Overall Study|Other|0|||
130510140|NCT03019289|469832470|FG007|Overall Study|Other|0|||
130510141|NCT03019289|469832471|FG008|Overall Study|Other|0|||
130510142|NCT02389894|469832472|FG000|Overall Study|Death|4|||
130510143|NCT02389894|469832473|FG001|Overall Study|Death|5|||
130510144|NCT02389894|469832474|FG002|Overall Study|Death|3|||
130510145|NCT02389894|469832472|FG000|Overall Study|Withdrawal by Subject|2|||
130510146|NCT02389894|469832473|FG001|Overall Study|Withdrawal by Subject|4|||
130568504|NCT01074190|470048397|FG000|Overall Study|Emergency Cesarean Delivery|1|||
130568505|NCT01074190|470048398|FG001|Overall Study|Emergency Cesarean Delivery|2|||
130568506|NCT01074190|470048399|FG002|Overall Study|Emergency Cesarean Delivery|1|||
130568507|NCT01074190|470048397|FG000|Overall Study|Protocol Violation|2|||
130568508|NCT01074190|470048398|FG001|Overall Study|Protocol Violation|1|||
130568509|NCT01074190|470048399|FG002|Overall Study|Protocol Violation|0|||
130568510|NCT01074190|470048397|FG000|Overall Study|Delivered in under 90 minutes|0|||
130568511|NCT01074190|470048398|FG001|Overall Study|Delivered in under 90 minutes|2|||
130568512|NCT01074190|470048399|FG002|Overall Study|Delivered in under 90 minutes|1|||
130568513|NCT01074190|470048397|FG000|Overall Study|Subject withdrew consent|1|||
130568514|NCT01074190|470048398|FG001|Overall Study|Subject withdrew consent|1|||
130568515|NCT01074190|470048399|FG002|Overall Study|Subject withdrew consent|1|||
130568516|NCT00264875|470048400|FG000|Overall Study|Adverse Event|6|||
130568517|NCT00264875|470048400|FG000|Overall Study|Lost to Follow-up|6|||
130568518|NCT00264875|470048400|FG000|Overall Study|Protocol Violation|11|||
130568519|NCT00264875|470048400|FG000|Overall Study|Withdrawal by Subject|7|||
130568520|NCT02409290|470048404|FG000|Overall Study|Protocol Violation|3|||
130568521|NCT02409290|470048405|FG001|Overall Study|Protocol Violation|6|||
130568522|NCT02409290|470048406|FG002|Overall Study|Protocol Violation|9|||
130568523|NCT02409290|470048407|FG003|Overall Study|Protocol Violation|4|||
130568524|NCT02409290|470048404|FG000|Overall Study|No positive culture/no baseline sample|3|||
130568525|NCT02409290|470048405|FG001|Overall Study|No positive culture/no baseline sample|9|||
130568526|NCT02409290|470048406|FG002|Overall Study|No positive culture/no baseline sample|6|||
130568527|NCT02409290|470048407|FG003|Overall Study|No positive culture/no baseline sample|5|||
130568528|NCT02409290|470048404|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
130568529|NCT02409290|470048405|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130648310|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130510147|NCT02389894|469832474|FG002|Overall Study|Withdrawal by Subject|5|||
130510148|NCT02389894|469832472|FG000|Overall Study|Lost to Follow-up|2|||
130510149|NCT02389894|469832473|FG001|Overall Study|Lost to Follow-up|1|||
130510150|NCT02389894|469832474|FG002|Overall Study|Lost to Follow-up|1|||
130510151|NCT01549951|469832475|FG000|Overall Study|Adverse Event|15|||
130510152|NCT01549951|469832475|FG000|Overall Study|Withdrawal by Subject|2|||
130510153|NCT01549951|469832475|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
130510154|NCT01549951|469832475|FG000|Overall Study|Progressive disease|29|||
130510155|NCT01549951|469832475|FG000|Overall Study|Symptomatic deterioration|1|||
130510156|NCT01549951|469832475|FG000|Overall Study|Other|2|||
130510157|NCT01730118|469833924|FG000|Dose Escalation|Death on study|5|||
130510158|NCT01730118|469833925|FG001|Dose Escalation|Death on study|7|||
130510159|NCT01730118|469833926|FG002|Dose Escalation|Death on study|2|||
130510160|NCT01730118|469833927|FG003|Dose Escalation|Death on study|6|||
130510161|NCT01730118|469833928|FG004|Dose Escalation|Death on study|0|||
130510162|NCT01730118|469833929|FG005|Dose Escalation|Death on study|0|||
130510163|NCT01730118|469833930|FG006|Dose Escalation|Death on study|0|||
130510164|NCT01730118|469833924|FG000|Dose Escalation|Died before treatment|0|||
130510165|NCT01730118|469833925|FG001|Dose Escalation|Died before treatment|0|||
130510166|NCT01730118|469833926|FG002|Dose Escalation|Died before treatment|0|||
130510167|NCT01730118|469833927|FG003|Dose Escalation|Died before treatment|0|||
130510168|NCT01730118|469833928|FG004|Dose Escalation|Died before treatment|0|||
130510169|NCT01730118|469833929|FG005|Dose Escalation|Died before treatment|0|||
130510170|NCT01730118|469833930|FG006|Dose Escalation|Died before treatment|1|||
130510171|NCT01730118|469833924|FG000|Dose Escalation|Chose to start a different treatment|1|||
130510172|NCT01730118|469833925|FG001|Dose Escalation|Chose to start a different treatment|0|||
130510173|NCT01730118|469833926|FG002|Dose Escalation|Chose to start a different treatment|0|||
130510174|NCT01730118|469833927|FG003|Dose Escalation|Chose to start a different treatment|0|||
130510175|NCT01730118|469833928|FG004|Dose Escalation|Chose to start a different treatment|0|||
130510176|NCT01730118|469833929|FG005|Dose Escalation|Chose to start a different treatment|0|||
130510177|NCT01730118|469833930|FG006|Dose Escalation|Chose to start a different treatment|0|||
130510178|NCT01730118|469833924|FG000|Dose Escalation|Withdrawal by Subject|0|||
130510179|NCT01730118|469833925|FG001|Dose Escalation|Withdrawal by Subject|0|||
130510180|NCT01730118|469833926|FG002|Dose Escalation|Withdrawal by Subject|1|||
130510181|NCT01730118|469833927|FG003|Dose Escalation|Withdrawal by Subject|0|||
130510182|NCT01730118|469833928|FG004|Dose Escalation|Withdrawal by Subject|0|||
130510183|NCT01730118|469833929|FG005|Dose Escalation|Withdrawal by Subject|0|||
130510184|NCT01730118|469833930|FG006|Dose Escalation|Withdrawal by Subject|0|||
130510185|NCT01730118|469833924|FG000|Dose Escalation|Disease progression prior to treatment|0|||
130510186|NCT01730118|469833925|FG001|Dose Escalation|Disease progression prior to treatment|0|||
130510187|NCT01730118|469833926|FG002|Dose Escalation|Disease progression prior to treatment|0|||
130510188|NCT01730118|469833927|FG003|Dose Escalation|Disease progression prior to treatment|0|||
130510189|NCT01730118|469833928|FG004|Dose Escalation|Disease progression prior to treatment|0|||
130510190|NCT01730118|469833929|FG005|Dose Escalation|Disease progression prior to treatment|0|||
130510191|NCT01730118|469833930|FG006|Dose Escalation|Disease progression prior to treatment|1|||
130510192|NCT01730118|469833924|FG000|Dose Expansion|Death|0|||
130510193|NCT01730118|469833925|FG001|Dose Expansion|Death|0|||
130510194|NCT01730118|469833926|FG002|Dose Expansion|Death|0|||
130510195|NCT01730118|469833927|FG003|Dose Expansion|Death|0|||
130510196|NCT01730118|469833928|FG004|Dose Expansion|Death|1|||
130510197|NCT01730118|469833929|FG005|Dose Expansion|Death|0|||
130510198|NCT01730118|469833930|FG006|Dose Expansion|Death|0|||
130510199|NCT01730118|469833924|FG000|Dose Expansion|Other medical condition|0|||
130510200|NCT01730118|469833925|FG001|Dose Expansion|Other medical condition|0|||
130510201|NCT01730118|469833926|FG002|Dose Expansion|Other medical condition|0|||
130510202|NCT01730118|469833927|FG003|Dose Expansion|Other medical condition|0|||
130510203|NCT01730118|469833928|FG004|Dose Expansion|Other medical condition|1|||
130510204|NCT01730118|469833929|FG005|Dose Expansion|Other medical condition|0|||
130510205|NCT01730118|469833930|FG006|Dose Expansion|Other medical condition|0|||
130510206|NCT01730118|469833924|FG000|Dose Expansion|Withdrawal by Subject|0|||
130510207|NCT01730118|469833925|FG001|Dose Expansion|Withdrawal by Subject|0|||
130510208|NCT01730118|469833926|FG002|Dose Expansion|Withdrawal by Subject|0|||
130510209|NCT01730118|469833927|FG003|Dose Expansion|Withdrawal by Subject|0|||
130510210|NCT01730118|469833928|FG004|Dose Expansion|Withdrawal by Subject|1|||
130510211|NCT01730118|469833929|FG005|Dose Expansion|Withdrawal by Subject|0|||
130510212|NCT01730118|469833930|FG006|Dose Expansion|Withdrawal by Subject|0|||
130510213|NCT01730118|469833924|FG000|Dose Expansion|Disease progression|0|||
130510214|NCT01730118|469833925|FG001|Dose Expansion|Disease progression|0|||
130510215|NCT01730118|469833926|FG002|Dose Expansion|Disease progression|0|||
130510216|NCT01730118|469833927|FG003|Dose Expansion|Disease progression|0|||
130510217|NCT01730118|469833928|FG004|Dose Expansion|Disease progression|0|||
130510218|NCT01730118|469833929|FG005|Dose Expansion|Disease progression|1|||
130510219|NCT01730118|469833930|FG006|Dose Expansion|Disease progression|0|||
130510220|NCT01730118|469833924|FG000|Dose Expansion|Inability to return|0|||
130510221|NCT01730118|469833925|FG001|Dose Expansion|Inability to return|0|||
130510222|NCT01730118|469833926|FG002|Dose Expansion|Inability to return|0|||
130510223|NCT01730118|469833927|FG003|Dose Expansion|Inability to return|0|||
130510224|NCT01730118|469833928|FG004|Dose Expansion|Inability to return|0|||
130510225|NCT01730118|469833929|FG005|Dose Expansion|Inability to return|1|||
130510226|NCT01730118|469833930|FG006|Dose Expansion|Inability to return|0|||
130510227|NCT01730118|469833924|FG000|Dose Expansion|Physician Decision|0|||
130510228|NCT01730118|469833925|FG001|Dose Expansion|Physician Decision|0|||
130510229|NCT01730118|469833926|FG002|Dose Expansion|Physician Decision|0|||
130510230|NCT01730118|469833927|FG003|Dose Expansion|Physician Decision|0|||
130510231|NCT01730118|469833928|FG004|Dose Expansion|Physician Decision|0|||
130510232|NCT01730118|469833929|FG005|Dose Expansion|Physician Decision|1|||
130510233|NCT01730118|469833930|FG006|Dose Expansion|Physician Decision|0|||
130510234|NCT00489489|469833932|FG000|Overall Study|Not treated due to protocol violation|0|||
130510235|NCT00489489|469833933|FG001|Overall Study|Not treated due to protocol violation|1|||
130510236|NCT00489489|469833934|FG002|Overall Study|Not treated due to protocol violation|1|||
130510237|NCT00489489|469833932|FG000|Overall Study|Adverse Event|1|||
130510238|NCT00489489|469833933|FG001|Overall Study|Adverse Event|1|||
130510239|NCT00489489|469833934|FG002|Overall Study|Adverse Event|1|||
130510240|NCT00489489|469833932|FG000|Overall Study|Protocol Violation|1|||
130510241|NCT00489489|469833933|FG001|Overall Study|Protocol Violation|0|||
130510242|NCT00489489|469833934|FG002|Overall Study|Protocol Violation|1|||
130510243|NCT00489489|469833932|FG000|Overall Study|Progressive disease|0|||
130510244|NCT00489489|469833933|FG001|Overall Study|Progressive disease|1|||
130510245|NCT00489489|469833934|FG002|Overall Study|Progressive disease|0|||
130510246|NCT00489489|469833932|FG000|Overall Study|Participant did not wish to continue|1|||
130510247|NCT00489489|469833933|FG001|Overall Study|Participant did not wish to continue|1|||
130510248|NCT00489489|469833934|FG002|Overall Study|Participant did not wish to continue|0|||
130510249|NCT00489489|469833932|FG000|Overall Study|Other than above|0|||
130510250|NCT00489489|469833933|FG001|Overall Study|Other than above|1|||
130510251|NCT00489489|469833934|FG002|Overall Study|Other than above|0|||
130510252|NCT02101554|469833940|FG000|Overall Study|Protocol Violation|0|||
130510253|NCT02101554|469833941|FG001|Overall Study|Protocol Violation|1|||
130510254|NCT02101554|469833942|FG002|Overall Study|Protocol Violation|0|||
130510255|NCT02101554|469833940|FG000|Overall Study|Insufficient Clinical Response|0|||
130510256|NCT02101554|469833941|FG001|Overall Study|Insufficient Clinical Response|2|||
130510257|NCT02101554|469833942|FG002|Overall Study|Insufficient Clinical Response|0|||
130510258|NCT02101554|469833940|FG000|Overall Study|Adverse Event|2|||
130510259|NCT02101554|469833941|FG001|Overall Study|Adverse Event|1|||
130510260|NCT02101554|469833942|FG002|Overall Study|Adverse Event|1|||
130510261|NCT02101554|469833940|FG000|Overall Study|Lost to Follow-up|0|||
130510262|NCT02101554|469833941|FG001|Overall Study|Lost to Follow-up|1|||
130510263|NCT02101554|469833942|FG002|Overall Study|Lost to Follow-up|0|||
130510264|NCT02101554|469833940|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
130510265|NCT02101554|469833941|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
130510266|NCT02101554|469833942|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
130510267|NCT01350102|469833943|FG000|Overall Study|Adverse Event|0|||
130510268|NCT01350102|469833944|FG001|Overall Study|Adverse Event|0|||
130510269|NCT01350102|469833945|FG002|Overall Study|Adverse Event|1|||
130510270|NCT01350102|469833946|FG003|Overall Study|Adverse Event|0|||
130510271|NCT04523571|469833948|FG000|Received 2 Doses|Withdrawal by Subject|0|||
130510272|NCT04523571|469833949|FG001|Received 2 Doses|Withdrawal by Subject|0|||
130510273|NCT04523571|469833950|FG002|Received 2 Doses|Withdrawal by Subject|0|||
130510274|NCT04523571|469833951|FG003|Received 2 Doses|Withdrawal by Subject|1|||
130510275|NCT04523571|469833952|FG004|Received 2 Doses|Withdrawal by Subject|1|||
130510276|NCT04523571|469833953|FG005|Received 2 Doses|Withdrawal by Subject|0|||
130510277|NCT04523571|469833948|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
130510278|NCT04523571|469833949|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
130510279|NCT04523571|469833950|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
130510280|NCT04523571|469833951|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
130510281|NCT04523571|469833952|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
130510282|NCT04523571|469833953|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
130510283|NCT04523571|469833948|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130510284|NCT04523571|469833949|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130510285|NCT04523571|469833950|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130510286|NCT04523571|469833951|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130510287|NCT04523571|469833952|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130510288|NCT04523571|469833953|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
130510289|NCT04523571|469833948|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130510290|NCT04523571|469833949|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130510291|NCT04523571|469833950|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130510292|NCT04523571|469833951|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
130510293|NCT04523571|469833952|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
130510294|NCT04523571|469833953|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130510295|NCT04385849|469833955|FG000|Overall Study|Lost to Follow-up|1|||
130510296|NCT04385849|469833956|FG001|Overall Study|Lost to Follow-up|0|||
130510297|NCT01375777|469833957|FG000|Overall Study|Withdrawal by Subject|0|||
130510298|NCT01375777|469833958|FG001|Overall Study|Withdrawal by Subject|2|||
130510299|NCT01375777|469833959|FG002|Overall Study|Withdrawal by Subject|1|||
130510300|NCT01375777|469833960|FG003|Overall Study|Withdrawal by Subject|0|||
130510301|NCT01375777|469833961|FG004|Overall Study|Withdrawal by Subject|1|||
130510302|NCT01375777|469833962|FG005|Overall Study|Withdrawal by Subject|1|||
130510303|NCT01375777|469833963|FG006|Overall Study|Withdrawal by Subject|1|||
130510304|NCT01375777|469833964|FG007|Overall Study|Withdrawal by Subject|2|||
130510305|NCT01375777|469833965|FG008|Overall Study|Withdrawal by Subject|1|||
130510306|NCT01375777|469833957|FG000|Overall Study|Lost to Follow-up|1|||
130510307|NCT01375777|469833958|FG001|Overall Study|Lost to Follow-up|0|||
130510308|NCT01375777|469833959|FG002|Overall Study|Lost to Follow-up|0|||
130510309|NCT01375777|469833960|FG003|Overall Study|Lost to Follow-up|0|||
130510310|NCT01375777|469833961|FG004|Overall Study|Lost to Follow-up|0|||
130510311|NCT01375777|469833962|FG005|Overall Study|Lost to Follow-up|0|||
130510312|NCT01375777|469833963|FG006|Overall Study|Lost to Follow-up|1|||
130510313|NCT01375777|469833964|FG007|Overall Study|Lost to Follow-up|0|||
130510314|NCT01375777|469833965|FG008|Overall Study|Lost to Follow-up|0|||
130510315|NCT01375777|469833957|FG000|Overall Study|Other|1|||
130510316|NCT01375777|469833958|FG001|Overall Study|Other|1|||
130510317|NCT01375777|469833959|FG002|Overall Study|Other|0|||
130510318|NCT01375777|469833960|FG003|Overall Study|Other|0|||
130510319|NCT01375777|469833961|FG004|Overall Study|Other|0|||
130510320|NCT01375777|469833962|FG005|Overall Study|Other|0|||
130510321|NCT01375777|469833963|FG006|Overall Study|Other|0|||
130510322|NCT01375777|469833964|FG007|Overall Study|Other|0|||
130510323|NCT01375777|469833965|FG008|Overall Study|Other|1|||
130510324|NCT05878990|469833966|FG000|Overall Study|Lost to Follow-up|7|||
130510325|NCT05878990|469833966|FG000|Overall Study|Withdrawal by Subject|1|||
130510326|NCT01136733|469833969|FG000|Phase 1b|Adverse Event|0|||
130510327|NCT01136733|469833970|FG001|Phase 1b|Adverse Event|3|||
130510328|NCT01136733|469833971|FG002|Phase 1b|Adverse Event|1|||
130510329|NCT01136733|469833972|FG003|Phase 1b|Adverse Event|0|||
130510330|NCT01136733|469833973|FG004|Phase 1b|Adverse Event|0|||
130510331|NCT01136733|469833974|FG005|Phase 1b|Adverse Event|0|||
130510332|NCT01136733|469833975|FG006|Phase 1b|Adverse Event|0|||
130510333|NCT01136733|469833969|FG000|Phase 1b|Participant Choice|0|||
130510334|NCT01136733|469833970|FG001|Phase 1b|Participant Choice|0|||
130510335|NCT01136733|469833971|FG002|Phase 1b|Participant Choice|1|||
130510336|NCT01136733|469833972|FG003|Phase 1b|Participant Choice|0|||
130510337|NCT01136733|469833973|FG004|Phase 1b|Participant Choice|0|||
130510338|NCT01136733|469833974|FG005|Phase 1b|Participant Choice|0|||
130510339|NCT01136733|469833975|FG006|Phase 1b|Participant Choice|0|||
130510340|NCT01136733|469833969|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
130510341|NCT01136733|469833970|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
130510342|NCT01136733|469833971|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
130510343|NCT01136733|469833972|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
130510344|NCT01136733|469833973|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
130510345|NCT01136733|469833974|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
130510346|NCT01136733|469833975|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
130510347|NCT01136733|469833969|FG000|Phase 1b|Clinical Progression|1|||
130510348|NCT01136733|469833970|FG001|Phase 1b|Clinical Progression|1|||
130510349|NCT01136733|469833971|FG002|Phase 1b|Clinical Progression|0|||
130510350|NCT01136733|469833972|FG003|Phase 1b|Clinical Progression|0|||
130510351|NCT01136733|469833973|FG004|Phase 1b|Clinical Progression|0|||
130510352|NCT01136733|469833974|FG005|Phase 1b|Clinical Progression|0|||
130510353|NCT01136733|469833975|FG006|Phase 1b|Clinical Progression|0|||
130510354|NCT01136733|469833969|FG000|Phase 2|Disease Progression|0|||
130510355|NCT01136733|469833970|FG001|Phase 2|Disease Progression|0|||
130510356|NCT01136733|469833971|FG002|Phase 2|Disease Progression|0|||
130510357|NCT01136733|469833972|FG003|Phase 2|Disease Progression|0|||
130510358|NCT01136733|469833973|FG004|Phase 2|Disease Progression|30|||
130510359|NCT01136733|469833974|FG005|Phase 2|Disease Progression|32|||
130510360|NCT01136733|469833975|FG006|Phase 2|Disease Progression|38|||
130510361|NCT01136733|469833969|FG000|Phase 2|Adverse Event|0|||
130510362|NCT01136733|469833970|FG001|Phase 2|Adverse Event|0|||
130510363|NCT01136733|469833971|FG002|Phase 2|Adverse Event|0|||
130510364|NCT01136733|469833972|FG003|Phase 2|Adverse Event|0|||
130510365|NCT01136733|469833973|FG004|Phase 2|Adverse Event|11|||
130510366|NCT01136733|469833974|FG005|Phase 2|Adverse Event|13|||
130510367|NCT01136733|469833975|FG006|Phase 2|Adverse Event|5|||
130510368|NCT01136733|469833969|FG000|Phase 2|Participant Choice|0|||
130510369|NCT01136733|469833970|FG001|Phase 2|Participant Choice|0|||
130510370|NCT01136733|469833971|FG002|Phase 2|Participant Choice|0|||
130510371|NCT01136733|469833972|FG003|Phase 2|Participant Choice|0|||
130510372|NCT01136733|469833973|FG004|Phase 2|Participant Choice|3|||
130510373|NCT01136733|469833974|FG005|Phase 2|Participant Choice|0|||
130510374|NCT01136733|469833975|FG006|Phase 2|Participant Choice|1|||
130568530|NCT02409290|470048406|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130568531|NCT02409290|470048407|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130568532|NCT00708500|470048408|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
130568533|NCT00708500|470048409|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
130568534|NCT00708500|470048410|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
130568535|NCT00708500|470048408|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
130568536|NCT00708500|470048409|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
130568537|NCT00708500|470048410|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
130568538|NCT00708500|470048408|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
130568539|NCT00708500|470048409|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
130568540|NCT00708500|470048410|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
130568541|NCT00708500|470048408|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
130568542|NCT00708500|470048409|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
130568543|NCT00708500|470048410|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
130568544|NCT00708500|470048408|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
130568545|NCT00708500|470048409|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
130568546|NCT00708500|470048410|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
130568547|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
130568548|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
130568549|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
130568550|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
130568551|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
130568552|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
130568553|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
130568554|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
130568555|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
130568556|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
130568557|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
130568558|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
130568559|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
130568560|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
130568561|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
130568562|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
130568563|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
130568564|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
130568565|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
130568566|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
130568567|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
130568568|NCT00708500|470048408|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
130568569|NCT00708500|470048409|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
130568570|NCT00708500|470048410|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
130568571|NCT00708500|470048408|FG000|FOLLOWUP|Adverse Event|0|||
130568572|NCT00708500|470048409|FG001|FOLLOWUP|Adverse Event|1|||
130568573|NCT00708500|470048410|FG002|FOLLOWUP|Adverse Event|0|||
130568574|NCT00708500|470048408|FG000|FOLLOWUP|Lost to Follow-up|1|||
130568575|NCT00708500|470048409|FG001|FOLLOWUP|Lost to Follow-up|6|||
130568576|NCT00708500|470048410|FG002|FOLLOWUP|Lost to Follow-up|4|||
130568577|NCT00708500|470048408|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
130568578|NCT00708500|470048409|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
130568579|NCT00708500|470048410|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
130568580|NCT00708500|470048408|FG000|FOLLOWUP|Subject withdrew consent|31|||
130568581|NCT00708500|470048409|FG001|FOLLOWUP|Subject withdrew consent|4|||
130568582|NCT00708500|470048410|FG002|FOLLOWUP|Subject withdrew consent|5|||
130568583|NCT00708500|470048408|FG000|FOLLOWUP|Non-compliance with protocol|5|||
130568584|NCT00708500|470048409|FG001|FOLLOWUP|Non-compliance with protocol|0|||
130568585|NCT00708500|470048410|FG002|FOLLOWUP|Non-compliance with protocol|1|||
130568586|NCT00705783|470048417|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
130568587|NCT00705783|470048418|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
130568588|NCT00705783|470048419|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
130568589|NCT00705783|470048417|FG000|Conversion Phase|Lost to Follow-up|13|||
130568590|NCT00705783|470048418|FG001|Conversion Phase|Lost to Follow-up|0|||
130568591|NCT00705783|470048419|FG002|Conversion Phase|Lost to Follow-up|0|||
130568592|NCT00705783|470048417|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
130568593|NCT00705783|470048418|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
130568594|NCT00705783|470048419|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
130568595|NCT00705783|470048417|FG000|Conversion Phase|Withdrawn by Investigator|4|||
130510375|NCT01136733|469833969|FG000|Phase 2|Administrative-Withdrew Consent|0|||
130510376|NCT01136733|469833970|FG001|Phase 2|Administrative-Withdrew Consent|0|||
130510377|NCT01136733|469833971|FG002|Phase 2|Administrative-Withdrew Consent|0|||
130510378|NCT01136733|469833972|FG003|Phase 2|Administrative-Withdrew Consent|0|||
130510379|NCT01136733|469833973|FG004|Phase 2|Administrative-Withdrew Consent|1|||
130510380|NCT01136733|469833974|FG005|Phase 2|Administrative-Withdrew Consent|0|||
130510381|NCT01136733|469833975|FG006|Phase 2|Administrative-Withdrew Consent|0|||
130510382|NCT01136733|469833969|FG000|Phase 2|Other|0|||
130510383|NCT01136733|469833970|FG001|Phase 2|Other|0|||
130510384|NCT01136733|469833971|FG002|Phase 2|Other|0|||
130510385|NCT01136733|469833972|FG003|Phase 2|Other|0|||
130510386|NCT01136733|469833973|FG004|Phase 2|Other|6|||
130510387|NCT01136733|469833974|FG005|Phase 2|Other|7|||
130510388|NCT01136733|469833975|FG006|Phase 2|Other|6|||
130510389|NCT03314233|469833982|FG000|Overall Study|No longer eligible at time of delivery|1|||
130510390|NCT00168805|469833984|FG000|Overall Study|Adverse Event|7|||
130510391|NCT00168805|469833985|FG001|Overall Study|Adverse Event|11|||
130510392|NCT00168805|469833986|FG002|Overall Study|Adverse Event|16|||
130510393|NCT00168805|469833984|FG000|Overall Study|Protocol Violation|12|||
130510394|NCT00168805|469833985|FG001|Overall Study|Protocol Violation|11|||
130510395|NCT00168805|469833986|FG002|Overall Study|Protocol Violation|8|||
130510396|NCT00168805|469833984|FG000|Overall Study|Lost to Follow-up|12|||
130510397|NCT00168805|469833985|FG001|Overall Study|Lost to Follow-up|17|||
130510398|NCT00168805|469833986|FG002|Overall Study|Lost to Follow-up|11|||
130510399|NCT00168805|469833984|FG000|Overall Study|Withdrawal by Subject|16|||
130510400|NCT00168805|469833985|FG001|Overall Study|Withdrawal by Subject|18|||
130510401|NCT00168805|469833986|FG002|Overall Study|Withdrawal by Subject|21|||
130510402|NCT00168805|469833984|FG000|Overall Study|Other|24|||
130510403|NCT00168805|469833985|FG001|Overall Study|Other|21|||
130510404|NCT00168805|469833986|FG002|Overall Study|Other|22|||
130510405|NCT00168805|469833984|FG000|Treatment|Adverse Event|25|||
130510406|NCT00168805|469833985|FG001|Treatment|Adverse Event|26|||
130510407|NCT00168805|469833986|FG002|Treatment|Adverse Event|32|||
130510408|NCT00168805|469833984|FG000|Treatment|Protocol Violation|3|||
130510409|NCT00168805|469833985|FG001|Treatment|Protocol Violation|5|||
130510410|NCT00168805|469833986|FG002|Treatment|Protocol Violation|5|||
130510411|NCT00168805|469833984|FG000|Treatment|Withdrawal by Subject|3|||
130510412|NCT00168805|469833985|FG001|Treatment|Withdrawal by Subject|7|||
130510413|NCT00168805|469833986|FG002|Treatment|Withdrawal by Subject|8|||
130510414|NCT00168805|469833984|FG000|Treatment|Other|18|||
130510415|NCT00168805|469833985|FG001|Treatment|Other|18|||
130510416|NCT00168805|469833986|FG002|Treatment|Other|17|||
130510417|NCT01114217|469833987|FG000|Overall Study|Adverse Event|5|||
130510418|NCT01114217|469833988|FG001|Overall Study|Adverse Event|3|||
130510419|NCT01114217|469833987|FG000|Overall Study|Lost to Follow-up|17|||
130510420|NCT01114217|469833988|FG001|Overall Study|Lost to Follow-up|33|||
130510421|NCT01114217|469833987|FG000|Overall Study|Withdrawal by Subject|21|||
130510422|NCT01114217|469833988|FG001|Overall Study|Withdrawal by Subject|28|||
130510423|NCT01114217|469833987|FG000|Overall Study|Other-Clerical Error|3|||
130510424|NCT01114217|469833988|FG001|Overall Study|Other-Clerical Error|0|||
130510425|NCT01114217|469833987|FG000|Overall Study|Other-Early termination|6|||
130510426|NCT01114217|469833988|FG001|Overall Study|Other-Early termination|10|||
130510427|NCT01114217|469833987|FG000|Overall Study|Other-Procedure|1|||
130510428|NCT01114217|469833988|FG001|Overall Study|Other-Procedure|1|||
130510429|NCT01114217|469833987|FG000|Overall Study|Other-Pregnancy|2|||
130510430|NCT01114217|469833988|FG001|Overall Study|Other-Pregnancy|4|||
130510431|NCT01114217|469833987|FG000|Overall Study|Other-Protocol Violation|1|||
130510432|NCT01114217|469833988|FG001|Overall Study|Other-Protocol Violation|3|||
130510433|NCT01114217|469833987|FG000|Overall Study|Other-Lack of Efficacy|1|||
130510434|NCT01114217|469833988|FG001|Overall Study|Other-Lack of Efficacy|0|||
130510435|NCT01114217|469833987|FG000|Overall Study|Other-Non Compliance|2|||
130510436|NCT01114217|469833988|FG001|Overall Study|Other-Non Compliance|0|||
130510437|NCT01114217|469833987|FG000|Overall Study|Other-Physician Decision|1|||
130510438|NCT01114217|469833988|FG001|Overall Study|Other-Physician Decision|1|||
130510439|NCT01114217|469833987|FG000|Overall Study|Other-Sponsor Decision|10|||
130510440|NCT01114217|469833988|FG001|Overall Study|Other-Sponsor Decision|12|||
130510441|NCT01114217|469833987|FG000|Overall Study|Other-Study Termination|0|||
130510442|NCT01114217|469833988|FG001|Overall Study|Other-Study Termination|1|||
130510443|NCT01114217|469833987|FG000|Overall Study|Other-Study Withdrawn|1|||
130510444|NCT01114217|469833988|FG001|Overall Study|Other-Study Withdrawn|1|||
130510445|NCT01114217|469833987|FG000|Overall Study|Other-Site Stopped Communicating|2|||
130510446|NCT01114217|469833988|FG001|Overall Study|Other-Site Stopped Communicating|0|||
130510447|NCT01114217|469833987|FG000|Overall Study|Other-Lost to Follow-up|1|||
130510448|NCT01114217|469833988|FG001|Overall Study|Other-Lost to Follow-up|0|||
130510449|NCT01114217|469833987|FG000|Overall Study|Other-Withdrawal by Subject|1|||
130510450|NCT01114217|469833988|FG001|Overall Study|Other-Withdrawal by Subject|1|||
130510451|NCT01183013|469833991|FG000|Overall Study|Adverse Event|6|||
130510452|NCT01183013|469833992|FG001|Overall Study|Adverse Event|8|||
130510453|NCT01183013|469833993|FG002|Overall Study|Adverse Event|5|||
130510454|NCT01183013|469833994|FG003|Overall Study|Adverse Event|5|||
130510455|NCT01183013|469833995|FG004|Overall Study|Adverse Event|10|||
130510456|NCT01183013|469833996|FG005|Overall Study|Adverse Event|10|||
130510457|NCT01183013|469833997|FG006|Overall Study|Adverse Event|6|||
130510458|NCT01183013|469833991|FG000|Overall Study|Lack of Efficacy|3|||
130510459|NCT01183013|469833992|FG001|Overall Study|Lack of Efficacy|2|||
130510460|NCT01183013|469833993|FG002|Overall Study|Lack of Efficacy|1|||
130510461|NCT01183013|469833994|FG003|Overall Study|Lack of Efficacy|2|||
130510462|NCT01183013|469833995|FG004|Overall Study|Lack of Efficacy|1|||
130510463|NCT01183013|469833996|FG005|Overall Study|Lack of Efficacy|2|||
130510464|NCT01183013|469833997|FG006|Overall Study|Lack of Efficacy|0|||
130510465|NCT01183013|469833991|FG000|Overall Study|Protocol Violation|5|||
130510466|NCT01183013|469833992|FG001|Overall Study|Protocol Violation|2|||
130510467|NCT01183013|469833993|FG002|Overall Study|Protocol Violation|4|||
130510468|NCT01183013|469833994|FG003|Overall Study|Protocol Violation|0|||
130510469|NCT01183013|469833995|FG004|Overall Study|Protocol Violation|4|||
130510470|NCT01183013|469833996|FG005|Overall Study|Protocol Violation|3|||
130510471|NCT01183013|469833997|FG006|Overall Study|Protocol Violation|3|||
130510472|NCT01183013|469833991|FG000|Overall Study|Lost to Follow-up|7|||
130510473|NCT01183013|469833992|FG001|Overall Study|Lost to Follow-up|3|||
130510474|NCT01183013|469833993|FG002|Overall Study|Lost to Follow-up|4|||
130510475|NCT01183013|469833994|FG003|Overall Study|Lost to Follow-up|3|||
130510476|NCT01183013|469833995|FG004|Overall Study|Lost to Follow-up|2|||
130510477|NCT01183013|469833996|FG005|Overall Study|Lost to Follow-up|6|||
130510478|NCT01183013|469833997|FG006|Overall Study|Lost to Follow-up|5|||
130510479|NCT01183013|469833991|FG000|Overall Study|Withdrawal by Subject|9|||
130510480|NCT01183013|469833992|FG001|Overall Study|Withdrawal by Subject|13|||
130510481|NCT01183013|469833993|FG002|Overall Study|Withdrawal by Subject|10|||
130510482|NCT01183013|469833994|FG003|Overall Study|Withdrawal by Subject|8|||
130510483|NCT01183013|469833995|FG004|Overall Study|Withdrawal by Subject|7|||
130510484|NCT01183013|469833996|FG005|Overall Study|Withdrawal by Subject|9|||
130510485|NCT01183013|469833997|FG006|Overall Study|Withdrawal by Subject|10|||
130510486|NCT01183013|469833991|FG000|Overall Study|Reasons other than stated above|15|||
130510487|NCT01183013|469833992|FG001|Overall Study|Reasons other than stated above|11|||
130510488|NCT01183013|469833993|FG002|Overall Study|Reasons other than stated above|17|||
130510489|NCT01183013|469833994|FG003|Overall Study|Reasons other than stated above|12|||
130510490|NCT01183013|469833995|FG004|Overall Study|Reasons other than stated above|12|||
130568596|NCT00705783|470048418|FG001|Conversion Phase|Withdrawn by Investigator|0|||
130568597|NCT00705783|470048419|FG002|Conversion Phase|Withdrawn by Investigator|0|||
130568598|NCT00705783|470048417|FG000|Conversion Phase|Withdrew Consent|24|||
130568599|NCT00705783|470048418|FG001|Conversion Phase|Withdrew Consent|0|||
130568600|NCT00705783|470048419|FG002|Conversion Phase|Withdrew Consent|0|||
130510491|NCT01183013|469833996|FG005|Overall Study|Reasons other than stated above|15|||
130510492|NCT01183013|469833997|FG006|Overall Study|Reasons other than stated above|13|||
130510493|NCT03785210|469834001|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
130510494|NCT03785210|469834002|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
130510495|NCT00472199|469834003|FG000|Overall Study|Adverse Event|19|||
130510496|NCT00472199|469834004|FG001|Overall Study|Adverse Event|23|||
130510497|NCT00472199|469834003|FG000|Overall Study|Lack of Efficacy|4|||
130510498|NCT00472199|469834004|FG001|Overall Study|Lack of Efficacy|25|||
130510499|NCT00472199|469834003|FG000|Overall Study|Lost to Follow-up|2|||
130510500|NCT00472199|469834004|FG001|Overall Study|Lost to Follow-up|4|||
130568601|NCT00705783|470048417|FG000|Conversion Phase|Protocol Deviation|2|||
130510501|NCT00472199|469834003|FG000|Overall Study|Protocol Violation|3|||
130510502|NCT00472199|469834004|FG001|Overall Study|Protocol Violation|2|||
130510503|NCT00472199|469834003|FG000|Overall Study|Withdrawal by Subject|6|||
130510504|NCT00472199|469834004|FG001|Overall Study|Withdrawal by Subject|5|||
130510505|NCT00472199|469834003|FG000|Overall Study|personal reason|0|||
130510506|NCT00472199|469834004|FG001|Overall Study|personal reason|1|||
130510507|NCT00472199|469834003|FG000|Overall Study|patient was asymptomatic|1|||
130510508|NCT00472199|469834004|FG001|Overall Study|patient was asymptomatic|0|||
130510509|NCT01757171|469834005|FG000|Overall Study|Adverse Event|5|||
130510510|NCT01757171|469834006|FG001|Overall Study|Adverse Event|1|||
130510511|NCT01757171|469834005|FG000|Overall Study|Disease Progression|1|||
130510512|NCT01757171|469834006|FG001|Overall Study|Disease Progression|0|||
130510513|NCT01757171|469834005|FG000|Overall Study|Hospitalization|1|||
130510514|NCT01757171|469834006|FG001|Overall Study|Hospitalization|0|||
130510515|NCT01757171|469834005|FG000|Overall Study|ECOG decline|1|||
130510516|NCT01757171|469834006|FG001|Overall Study|ECOG decline|0|||
130510517|NCT01014013|469834010|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
130510518|NCT01014013|469834011|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
130510519|NCT01014013|469834010|FG000|Overall Study|Clinical adverse experience|4|||
130510520|NCT01014013|469834011|FG001|Overall Study|Clinical adverse experience|2|||
130510521|NCT01014013|469834010|FG000|Overall Study|Laboratory adverse experience|1|||
130510522|NCT01014013|469834011|FG001|Overall Study|Laboratory adverse experience|1|||
130510523|NCT01014013|469834010|FG000|Overall Study|Protocol Violation|1|||
130510524|NCT01014013|469834011|FG001|Overall Study|Protocol Violation|3|||
130510525|NCT01014013|469834010|FG000|Overall Study|Withdrawal by Subject|7|||
130510526|NCT01014013|469834011|FG001|Overall Study|Withdrawal by Subject|4|||
130510527|NCT01014013|469834010|FG000|Overall Study|Clinical/microbiologic failure|1|||
130510528|NCT01014013|469834011|FG001|Overall Study|Clinical/microbiologic failure|2|||
130510529|NCT01014013|469834010|FG000|Overall Study|Pathogen culture = no growth|26|||
130510530|NCT01014013|469834011|FG001|Overall Study|Pathogen culture = no growth|34|||
130510531|NCT01014013|469834010|FG000|Overall Study|Negative urine culture|2|||
130510532|NCT01014013|469834011|FG001|Overall Study|Negative urine culture|0|||
130510533|NCT01014013|469834010|FG000|Overall Study|Pathogen resistant|7|||
130510534|NCT01014013|469834011|FG001|Overall Study|Pathogen resistant|4|||
130510535|NCT01014013|469834010|FG000|Overall Study|Physician Decision|0|||
130510536|NCT01014013|469834011|FG001|Overall Study|Physician Decision|1|||
130510537|NCT01014013|469834010|FG000|Overall Study|Another antibiotic therapy required|0|||
130510538|NCT01014013|469834011|FG001|Overall Study|Another antibiotic therapy required|1|||
130510539|NCT01014013|469834010|FG000|Overall Study|Appendectomy|1|||
130510540|NCT01014013|469834011|FG001|Overall Study|Appendectomy|0|||
130510541|NCT01014013|469834010|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
130510542|NCT01014013|469834011|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
130510543|NCT00316121|469834012|FG000|Overall Study|Death|1|||
130510544|NCT00316121|469834013|FG001|Overall Study|Death|0|||
130510545|NCT00316121|469834012|FG000|Overall Study|Lost to Follow-up|14|||
130510546|NCT00316121|469834013|FG001|Overall Study|Lost to Follow-up|8|||
130510547|NCT00316121|469834012|FG000|Overall Study|Withdrawal by Subject|2|||
130510548|NCT00316121|469834013|FG001|Overall Study|Withdrawal by Subject|0|||
130510549|NCT00316121|469834012|FG000|Overall Study|Reason is missing|1|||
130510550|NCT00316121|469834013|FG001|Overall Study|Reason is missing|0|||
130510551|NCT00316121|469834012|FG000|Overall Study|Subject relocated|1|||
130510552|NCT00316121|469834013|FG001|Overall Study|Subject relocated|1|||
130510553|NCT00316121|469834012|FG000|Overall Study|Subject refused to return|1|||
130510554|NCT00316121|469834013|FG001|Overall Study|Subject refused to return|0|||
130510555|NCT00316121|469834012|FG000|Overall Study|Subject no show for visit x 3|1|||
130510556|NCT00316121|469834013|FG001|Overall Study|Subject no show for visit x 3|0|||
130510557|NCT00316121|469834012|FG000|Overall Study|Subject did not have 24 month visit|1|||
130510558|NCT00316121|469834013|FG001|Overall Study|Subject did not have 24 month visit|0|||
130510559|NCT05274906|469834014|FG000|Overall Study|Withdrawal by Subject|2|||
130510560|NCT05274906|469834015|FG001|Overall Study|Withdrawal by Subject|1|||
130510561|NCT02213458|469834018|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
130510562|NCT02213458|469834019|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
130510563|NCT02213458|469834018|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
130510564|NCT02213458|469834019|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
130510565|NCT02213458|469834018|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
130510566|NCT02213458|469834019|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
130510567|NCT02213458|469834018|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
130510568|NCT02213458|469834019|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
130510569|NCT02213458|469834018|FG000|Overall Study|Refused re-consent|6|||
130510570|NCT02213458|469834019|FG001|Overall Study|Refused re-consent|0|||
130510571|NCT02213458|469834018|FG000|Overall Study|Lost to Follow-up|2|||
130510572|NCT02213458|469834019|FG001|Overall Study|Lost to Follow-up|2|||
130510573|NCT02213458|469834018|FG000|Overall Study|Withdrawal by Subject|26|||
130510574|NCT02213458|469834019|FG001|Overall Study|Withdrawal by Subject|8|||
130510575|NCT00910871|469834020|FG000|Overall Study|Adverse Event|5|||
130510576|NCT00910871|469834020|FG000|Overall Study|Death|12|||
130510577|NCT00910871|469834020|FG000|Overall Study|Lost to Follow-up|8|||
130510578|NCT00910871|469834020|FG000|Overall Study|Protocol Violation|11|||
130510579|NCT00910871|469834020|FG000|Overall Study|Withdrawal by Subject|12|||
130510580|NCT00910871|469834020|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
130510581|NCT00910871|469834020|FG000|Overall Study|Undefined|1|||
130510582|NCT01075815|469834021|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
130510583|NCT01075815|469834022|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
130510584|NCT01075815|469834021|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
130510585|NCT01075815|469834022|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
130510586|NCT01075815|469834021|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
130510587|NCT01075815|469834022|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
130510588|NCT03503188|469834023|FG000|Overall Study|Non eligible in the sub study|0|||
130510589|NCT03503188|469834024|FG001|Overall Study|Non eligible in the sub study|1|||
130510590|NCT03747575|469834031|FG000|Overall Study|Withdrawal by Subject|6|||
130510591|NCT03747575|469834032|FG001|Overall Study|Withdrawal by Subject|3|||
130510592|NCT03747575|469834031|FG000|Overall Study|Lost to Follow-up|3|||
130510593|NCT03747575|469834032|FG001|Overall Study|Lost to Follow-up|3|||
130510594|NCT03747575|469834031|FG000|Overall Study|Adverse Event|0|||
130510595|NCT03747575|469834032|FG001|Overall Study|Adverse Event|1|||
130510596|NCT03005106|469834033|FG000|Overall Study|Lost to Follow-up|16|||
130510597|NCT03005106|469834033|FG000|Overall Study|Adverse Event|1|||
130510598|NCT03005106|469834033|FG000|Overall Study|Physician Decision|1|||
130510599|NCT03005106|469834033|FG000|Overall Study|Death|2|||
130510600|NCT00936065|469834036|FG000|Overall Study|Adverse Event|1|||
130510601|NCT00936065|469834037|FG001|Overall Study|Adverse Event|0|||
130510602|NCT00936065|469834038|FG002|Overall Study|Adverse Event|1|||
130510603|NCT00936065|469834036|FG000|Overall Study|Lack of Efficacy|1|||
130510604|NCT00936065|469834037|FG001|Overall Study|Lack of Efficacy|0|||
130510605|NCT00936065|469834038|FG002|Overall Study|Lack of Efficacy|1|||
130510606|NCT00936065|469834036|FG000|Overall Study|Lost to Follow-up|1|||
130510607|NCT00936065|469834037|FG001|Overall Study|Lost to Follow-up|0|||
130510608|NCT00936065|469834038|FG002|Overall Study|Lost to Follow-up|0|||
130510609|NCT00936065|469834036|FG000|Overall Study|Protocol Violation|1|||
130510610|NCT00936065|469834037|FG001|Overall Study|Protocol Violation|2|||
130510611|NCT00936065|469834038|FG002|Overall Study|Protocol Violation|1|||
130510612|NCT00936065|469834036|FG000|Overall Study|Withdrawal by Subject|0|||
130510613|NCT00936065|469834037|FG001|Overall Study|Withdrawal by Subject|2|||
130510614|NCT00936065|469834038|FG002|Overall Study|Withdrawal by Subject|4|||
130510615|NCT00145496|469834039|FG000|Overall Study|Adverse Event|42|||
130510616|NCT00145496|469834040|FG001|Overall Study|Adverse Event|30|||
130510617|NCT00145496|469834039|FG000|Overall Study|Lack of Efficacy|12|||
130510618|NCT00145496|469834040|FG001|Overall Study|Lack of Efficacy|7|||
130510619|NCT00145496|469834039|FG000|Overall Study|Withdrawal by Subject|32|||
130510620|NCT00145496|469834040|FG001|Overall Study|Withdrawal by Subject|26|||
130510621|NCT00145496|469834039|FG000|Overall Study|Lost to Follow-up|12|||
130510622|NCT00145496|469834040|FG001|Overall Study|Lost to Follow-up|5|||
130510623|NCT00145496|469834039|FG000|Overall Study|Other|25|||
130510624|NCT00145496|469834040|FG001|Overall Study|Other|13|||
130510625|NCT01429285|469834041|FG000|Overall Study|Protocol Violation|9|||
130510626|NCT01429285|469834042|FG001|Overall Study|Protocol Violation|4|||
130510627|NCT01429285|469834041|FG000|Overall Study|Missing Data|5|||
130510628|NCT01429285|469834042|FG001|Overall Study|Missing Data|3|||
130510629|NCT01429285|469834041|FG000|Overall Study|Erroneously Enrolled Twice|8|||
130510630|NCT01429285|469834042|FG001|Overall Study|Erroneously Enrolled Twice|2|||
130510631|NCT01052714|469834046|FG000|Overall Study|Adverse Event|6|||
130510632|NCT01052714|469834047|FG001|Overall Study|Adverse Event|3|||
130510633|NCT01052714|469834048|FG002|Overall Study|Adverse Event|0|||
130510634|NCT01052714|469834046|FG000|Overall Study|Death|1|||
130510635|NCT01052714|469834047|FG001|Overall Study|Death|2|||
130510636|NCT01052714|469834048|FG002|Overall Study|Death|0|||
130510637|NCT01052714|469834046|FG000|Overall Study|Lost to Follow-up|2|||
130510638|NCT01052714|469834047|FG001|Overall Study|Lost to Follow-up|3|||
130510639|NCT01052714|469834048|FG002|Overall Study|Lost to Follow-up|0|||
130510640|NCT01052714|469834046|FG000|Overall Study|Physician Decision|9|||
130510641|NCT01052714|469834047|FG001|Overall Study|Physician Decision|9|||
130510642|NCT01052714|469834048|FG002|Overall Study|Physician Decision|1|||
130510643|NCT01052714|469834046|FG000|Overall Study|Withdrawal by Subject|7|||
130510644|NCT01052714|469834047|FG001|Overall Study|Withdrawal by Subject|12|||
130510645|NCT01052714|469834048|FG002|Overall Study|Withdrawal by Subject|1|||
130510646|NCT03689452|469834051|FG000|Overall Study|Lost to Follow-up|1|||
130510647|NCT03689452|469834052|FG001|Overall Study|Lost to Follow-up|1|||
130510648|NCT02676778|469834054|FG000|Overall Study|Disease Progression|7|||
130510649|NCT02676778|469834055|FG001|Overall Study|Disease Progression|3|||
130510650|NCT02676778|469834056|FG002|Overall Study|Disease Progression|1|||
130510651|NCT02676778|469834054|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
130510652|NCT02676778|469834055|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
130510653|NCT02676778|469834056|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
130510654|NCT02676778|469834054|FG000|Overall Study|Withdrawal by Subject|3|||
130510655|NCT02676778|469834055|FG001|Overall Study|Withdrawal by Subject|2|||
130510656|NCT02676778|469834056|FG002|Overall Study|Withdrawal by Subject|0|||
130510657|NCT02676778|469834054|FG000|Overall Study|Other|4|||
130510658|NCT02676778|469834055|FG001|Overall Study|Other|3|||
130510659|NCT02676778|469834056|FG002|Overall Study|Other|0|||
130568602|NCT00705783|470048418|FG001|Conversion Phase|Protocol Deviation|0|||
130568603|NCT00705783|470048419|FG002|Conversion Phase|Protocol Deviation|0|||
130568604|NCT00705783|470048417|FG000|Conversion Phase|Adverse Event|11|||
130568605|NCT00705783|470048418|FG001|Conversion Phase|Adverse Event|0|||
130568606|NCT00705783|470048419|FG002|Conversion Phase|Adverse Event|0|||
130568607|NCT00705783|470048417|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
130568608|NCT00705783|470048418|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130568609|NCT00705783|470048419|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130568610|NCT00705783|470048417|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
130568611|NCT00705783|470048418|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130568612|NCT00705783|470048419|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130568613|NCT00705783|470048417|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
130568614|NCT00705783|470048418|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
130568615|NCT00705783|470048419|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
130568616|NCT00705783|470048417|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
130568617|NCT00705783|470048418|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
130568618|NCT00705783|470048419|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
130510660|NCT02676778|469834054|FG000|Overall Study|Adverse Event|2|||
130510661|NCT02676778|469834055|FG001|Overall Study|Adverse Event|3|||
130510662|NCT02676778|469834056|FG002|Overall Study|Adverse Event|0|||
130510663|NCT00732498|469834057|FG000|Overall Study|Ineligible|1|||
130510664|NCT00732498|469834057|FG000|Overall Study|Adverse Event|2|||
130510665|NCT00732498|469834057|FG000|Overall Study|Physician Decision|3|||
130510666|NCT03394508|469834065|FG000|Overall Study|Protocol Violation|0|||
130510667|NCT03394508|469834066|FG001|Overall Study|Protocol Violation|3|||
130510668|NCT03394508|469834065|FG000|Overall Study|Lost to Follow-up|1|||
130510669|NCT03394508|469834066|FG001|Overall Study|Lost to Follow-up|0|||
130510670|NCT03214198|469834069|FG000|Overall Study|Case Report Forms Uncollected|18|||
130510671|NCT03214198|469834069|FG000|Overall Study|Protocol Deviation|18|||
130510672|NCT04295499|469834070|FG000|Overall Study|moving out of state|1|||
130510673|NCT04295499|469834071|FG001|Overall Study|moving out of state|0|||
130510674|NCT04295499|469834070|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
130510675|NCT04295499|469834071|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
130510676|NCT03122548|469834072|FG000|Overall Study|Death|2|||
130510677|NCT03122548|469834072|FG000|Overall Study|Progression - subject went into hospice|1|||
130510678|NCT03122548|469834072|FG000|Overall Study|Study Terminated by Sponsor|2|||
130510679|NCT02135445|469834073|FG000|Overall Study|Lost to Follow-up|1|||
130510680|NCT02135445|469834074|FG001|Overall Study|Lost to Follow-up|0|||
130510681|NCT02135445|469834073|FG000|Overall Study|Withdrawal by Subject|1|||
130510682|NCT02135445|469834074|FG001|Overall Study|Withdrawal by Subject|0|||
130510683|NCT04448561|469834080|FG000|Overall Study|Noncompliance|1|||
130510684|NCT04448561|469834081|FG001|Overall Study|Noncompliance|0|||
130510685|NCT04851587|469835453|FG000|Overall Study|Lost to Follow-up|18|||
130510686|NCT02136797|469835454|FG000|Overall Study|Not Treated|8|||
130510687|NCT03694210|469835455|FG000|Overall Study|Death|1|||
130510688|NCT03694210|469835455|FG000|Overall Study|Screen Failure|7|||
130510689|NCT02706834|469835456|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130510690|NCT02706834|469835457|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130510691|NCT02706834|469835458|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130510692|NCT02706834|469835459|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
130510693|NCT02706834|469835460|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130510694|NCT02706834|469835461|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
130510695|NCT02706834|469835462|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
130510696|NCT02706834|469835463|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
130510697|NCT02706834|469835464|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
130510698|NCT02706834|469835465|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
130510699|NCT02706834|469835466|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
130510700|NCT02706834|469835456|FG000|Overall Study|Lost to Follow-up|0|||
130510701|NCT02706834|469835457|FG001|Overall Study|Lost to Follow-up|0|||
130510702|NCT02706834|469835458|FG002|Overall Study|Lost to Follow-up|1|||
130510703|NCT02706834|469835459|FG003|Overall Study|Lost to Follow-up|0|||
130510704|NCT02706834|469835460|FG004|Overall Study|Lost to Follow-up|0|||
130510705|NCT02706834|469835461|FG005|Overall Study|Lost to Follow-up|0|||
130510706|NCT02706834|469835462|FG006|Overall Study|Lost to Follow-up|0|||
130510707|NCT02706834|469835463|FG007|Overall Study|Lost to Follow-up|0|||
130510708|NCT02706834|469835464|FG008|Overall Study|Lost to Follow-up|0|||
130568619|NCT00705783|470048417|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
130568620|NCT00705783|470048418|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130568621|NCT00705783|470048419|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130568622|NCT00705783|470048417|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
130510709|NCT02706834|469835465|FG009|Overall Study|Lost to Follow-up|0|||
130510710|NCT02706834|469835466|FG010|Overall Study|Lost to Follow-up|0|||
130510711|NCT02706834|469835456|FG000|Overall Study|Voluntary Withdrawal|1|||
130510712|NCT02706834|469835457|FG001|Overall Study|Voluntary Withdrawal|0|||
130510713|NCT02706834|469835458|FG002|Overall Study|Voluntary Withdrawal|0|||
130510714|NCT02706834|469835459|FG003|Overall Study|Voluntary Withdrawal|0|||
130510715|NCT02706834|469835460|FG004|Overall Study|Voluntary Withdrawal|0|||
130510716|NCT02706834|469835461|FG005|Overall Study|Voluntary Withdrawal|0|||
130510717|NCT02706834|469835462|FG006|Overall Study|Voluntary Withdrawal|0|||
130510718|NCT02706834|469835463|FG007|Overall Study|Voluntary Withdrawal|0|||
130510719|NCT02706834|469835464|FG008|Overall Study|Voluntary Withdrawal|0|||
130510720|NCT02706834|469835465|FG009|Overall Study|Voluntary Withdrawal|1|||
130510721|NCT02706834|469835466|FG010|Overall Study|Voluntary Withdrawal|0|||
130510722|NCT02706834|469835456|FG000|Overall Study|Other Reason Not Specified|1|||
130510723|NCT02706834|469835457|FG001|Overall Study|Other Reason Not Specified|0|||
130510724|NCT02706834|469835458|FG002|Overall Study|Other Reason Not Specified|0|||
130510725|NCT02706834|469835459|FG003|Overall Study|Other Reason Not Specified|0|||
130510726|NCT02706834|469835460|FG004|Overall Study|Other Reason Not Specified|1|||
130510727|NCT02706834|469835461|FG005|Overall Study|Other Reason Not Specified|0|||
130510728|NCT02706834|469835462|FG006|Overall Study|Other Reason Not Specified|0|||
130510729|NCT02706834|469835463|FG007|Overall Study|Other Reason Not Specified|0|||
130510730|NCT02706834|469835464|FG008|Overall Study|Other Reason Not Specified|0|||
130510731|NCT02706834|469835465|FG009|Overall Study|Other Reason Not Specified|0|||
130510732|NCT02706834|469835466|FG010|Overall Study|Other Reason Not Specified|0|||
130510733|NCT00627523|469835467|FG000|Overall Study|Lack of Efficacy|1|||
130510734|NCT00627523|469835468|FG001|Overall Study|Lack of Efficacy|0|||
130510735|NCT00627523|469835467|FG000|Overall Study|Withdrawal by Subject|0|||
130510736|NCT00627523|469835468|FG001|Overall Study|Withdrawal by Subject|2|||
130510737|NCT00627523|469835467|FG000|Overall Study|Other|1|||
130510738|NCT00627523|469835468|FG001|Overall Study|Other|0|||
130510739|NCT02543294|469835471|FG000|Overall Study|Lost to Follow-up|3|||
130510740|NCT02543294|469835471|FG000|Overall Study|Physician Decision|2|||
130510741|NCT02543294|469835471|FG000|Overall Study|Withdrawal by Subject|7|||
130510742|NCT01038128|469835473|FG000|Overall Study|Lack of Efficacy|1|||
130510743|NCT01038128|469835473|FG000|Overall Study|Lost to Follow-up|1|||
130510744|NCT01038128|469835473|FG000|Overall Study|Withdrawal by Subject|2|||
130510745|NCT03672188|469835480|FG000|Overall Study|Withdrawal by Subject|0|||
130510746|NCT03672188|469835481|FG001|Overall Study|Withdrawal by Subject|0|||
130510747|NCT03672188|469835482|FG002|Overall Study|Withdrawal by Subject|0|||
130510748|NCT03672188|469835483|FG003|Overall Study|Withdrawal by Subject|3|||
130510749|NCT03672188|469835484|FG004|Overall Study|Withdrawal by Subject|0|||
130510750|NCT03672188|469835485|FG005|Overall Study|Withdrawal by Subject|0|||
130510751|NCT03672188|469835486|FG006|Overall Study|Withdrawal by Subject|0|||
130510752|NCT03672188|469835487|FG007|Overall Study|Withdrawal by Subject|0|||
130510753|NCT03672188|469835488|FG008|Overall Study|Withdrawal by Subject|0|||
130510754|NCT03672188|469835489|FG009|Overall Study|Withdrawal by Subject|0|||
130510755|NCT03672188|469835490|FG010|Overall Study|Withdrawal by Subject|0|||
130510756|NCT03672188|469835491|FG011|Overall Study|Withdrawal by Subject|0|||
130510757|NCT03672188|469835492|FG012|Overall Study|Withdrawal by Subject|0|||
130510758|NCT03672188|469835493|FG013|Overall Study|Withdrawal by Subject|0|||
130510759|NCT03672188|469835494|FG014|Overall Study|Withdrawal by Subject|0|||
130510760|NCT03672188|469835480|FG000|Overall Study|Death|0|||
130510761|NCT03672188|469835481|FG001|Overall Study|Death|0|||
130510762|NCT03672188|469835482|FG002|Overall Study|Death|0|||
130510763|NCT03672188|469835483|FG003|Overall Study|Death|0|||
130510764|NCT03672188|469835484|FG004|Overall Study|Death|0|||
130510765|NCT03672188|469835485|FG005|Overall Study|Death|0|||
130510766|NCT03672188|469835486|FG006|Overall Study|Death|0|||
130510767|NCT03672188|469835487|FG007|Overall Study|Death|0|||
130510768|NCT03672188|469835488|FG008|Overall Study|Death|0|||
130510769|NCT03672188|469835489|FG009|Overall Study|Death|0|||
130510770|NCT03672188|469835490|FG010|Overall Study|Death|0|||
130510771|NCT03672188|469835491|FG011|Overall Study|Death|0|||
130510772|NCT03672188|469835492|FG012|Overall Study|Death|1|||
130510773|NCT03672188|469835493|FG013|Overall Study|Death|0|||
130510774|NCT03672188|469835494|FG014|Overall Study|Death|0|||
130510775|NCT03672188|469835480|FG000|Overall Study|Lost to Follow-up|0|||
130510776|NCT03672188|469835481|FG001|Overall Study|Lost to Follow-up|0|||
130510777|NCT03672188|469835482|FG002|Overall Study|Lost to Follow-up|1|||
130510778|NCT03672188|469835483|FG003|Overall Study|Lost to Follow-up|0|||
130568623|NCT00705783|470048418|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130510779|NCT03672188|469835484|FG004|Overall Study|Lost to Follow-up|0|||
130510780|NCT03672188|469835485|FG005|Overall Study|Lost to Follow-up|0|||
130510781|NCT03672188|469835486|FG006|Overall Study|Lost to Follow-up|0|||
130510782|NCT03672188|469835487|FG007|Overall Study|Lost to Follow-up|0|||
130510783|NCT03672188|469835488|FG008|Overall Study|Lost to Follow-up|0|||
130510784|NCT03672188|469835489|FG009|Overall Study|Lost to Follow-up|0|||
130510785|NCT03672188|469835490|FG010|Overall Study|Lost to Follow-up|0|||
130510786|NCT03672188|469835491|FG011|Overall Study|Lost to Follow-up|0|||
130510787|NCT03672188|469835492|FG012|Overall Study|Lost to Follow-up|0|||
130510788|NCT03672188|469835493|FG013|Overall Study|Lost to Follow-up|0|||
130510789|NCT03672188|469835494|FG014|Overall Study|Lost to Follow-up|0|||
130510790|NCT03320941|469835504|FG000|Overall Study|subject/guardian decision|0|||
130568624|NCT00705783|470048419|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130568625|NCT00705783|470048417|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
130568626|NCT00705783|470048418|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
130568627|NCT00705783|470048419|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
130568628|NCT00705783|470048417|FG000|Oral Stabilization Phase|Adverse Event|14|||
130568629|NCT00705783|470048418|FG001|Oral Stabilization Phase|Adverse Event|0|||
130568630|NCT00705783|470048419|FG002|Oral Stabilization Phase|Adverse Event|0|||
130568631|NCT00705783|470048417|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
130568632|NCT00705783|470048418|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130568633|NCT00705783|470048419|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130568634|NCT00705783|470048417|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
130568635|NCT00705783|470048418|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130568636|NCT00705783|470048419|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130568637|NCT00705783|470048417|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
130568638|NCT00705783|470048418|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
130568639|NCT00705783|470048419|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
130568640|NCT00705783|470048417|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
130568641|NCT00705783|470048418|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
130568642|NCT00705783|470048419|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
130568643|NCT00705783|470048417|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
130568644|NCT00705783|470048418|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
130568645|NCT00705783|470048419|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
130568646|NCT00705783|470048417|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
130568647|NCT00705783|470048418|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
130568648|NCT00705783|470048419|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
130568649|NCT00705783|470048417|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
130568650|NCT00705783|470048418|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
130568651|NCT00705783|470048419|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
130568652|NCT00705783|470048417|FG000|Depot Stabilization Phase|Adverse Event|17|||
130568653|NCT00705783|470048418|FG001|Depot Stabilization Phase|Adverse Event|0|||
130568654|NCT00705783|470048419|FG002|Depot Stabilization Phase|Adverse Event|0|||
130510791|NCT03320941|469835505|FG001|Overall Study|subject/guardian decision|0|||
130510792|NCT03320941|469835506|FG002|Overall Study|subject/guardian decision|0|||
130510793|NCT03320941|469835507|FG003|Overall Study|subject/guardian decision|1|||
130510794|NCT03320941|469835508|FG004|Overall Study|subject/guardian decision|0|||
130510795|NCT01838499|469835509|FG000|Overall Study|Protocol Violation|0|||
130510796|NCT01838499|469835510|FG001|Overall Study|Protocol Violation|1|||
130510797|NCT01838499|469835509|FG000|Overall Study|Lost to Follow-up|2|||
130510798|NCT01838499|469835510|FG001|Overall Study|Lost to Follow-up|4|||
130510799|NCT01838499|469835509|FG000|Overall Study|Lack of Efficacy|1|||
130510800|NCT01838499|469835510|FG001|Overall Study|Lack of Efficacy|2|||
130510801|NCT01838499|469835509|FG000|Overall Study|Adverse Event|2|||
130510802|NCT01838499|469835510|FG001|Overall Study|Adverse Event|1|||
130510803|NCT01838499|469835509|FG000|Overall Study|Withdrawal by Subject|19|||
130510804|NCT01838499|469835510|FG001|Overall Study|Withdrawal by Subject|9|||
130510805|NCT03614923|469835511|FG000|Overall Study|Withdrawal by Subject|2|||
130510806|NCT03614923|469835512|FG001|Overall Study|Withdrawal by Subject|1|||
130510807|NCT03614923|469835513|FG002|Overall Study|Withdrawal by Subject|1|||
130568655|NCT00705783|470048417|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
130568656|NCT00705783|470048418|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130510808|NCT03614923|469835511|FG000|Overall Study|Adverse Event|0|||
130568657|NCT00705783|470048419|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130510809|NCT03614923|469835512|FG001|Overall Study|Adverse Event|2|||
130510810|NCT03614923|469835513|FG002|Overall Study|Adverse Event|1|||
130510811|NCT03614923|469835511|FG000|Overall Study|Lost to Follow-up|1|||
130510812|NCT03614923|469835512|FG001|Overall Study|Lost to Follow-up|0|||
130510813|NCT03614923|469835513|FG002|Overall Study|Lost to Follow-up|1|||
130510814|NCT03614923|469835511|FG000|Overall Study|Lack of Efficacy|2|||
130568658|NCT00705783|470048417|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
130568659|NCT00705783|470048418|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130568660|NCT00705783|470048419|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130568661|NCT00705783|470048417|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
130568662|NCT00705783|470048418|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
130568663|NCT00705783|470048419|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
130568664|NCT00705783|470048417|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
130568665|NCT00705783|470048418|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
130568666|NCT00705783|470048419|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
130568667|NCT00705783|470048417|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
130568668|NCT00705783|470048418|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
130568669|NCT00705783|470048419|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
130568670|NCT00705783|470048417|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
130568671|NCT00705783|470048418|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
130568672|NCT00705783|470048419|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
130568673|NCT00705783|470048417|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
130568674|NCT00705783|470048418|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
130568675|NCT00705783|470048419|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
130568676|NCT00705783|470048417|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
130568677|NCT00705783|470048418|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
130568678|NCT00705783|470048419|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
130568679|NCT00705783|470048417|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
130568680|NCT00705783|470048418|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
130568681|NCT00705783|470048419|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
130568682|NCT00705783|470048417|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
130568683|NCT00705783|470048418|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
130568684|NCT00705783|470048419|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
130568685|NCT00705783|470048417|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
130568686|NCT00705783|470048418|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
130568687|NCT00705783|470048419|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
130568688|NCT02182687|470048420|FG000|Overall Study|Withdrawal by Subject|4|||
130568689|NCT02182687|470048421|FG001|Overall Study|Withdrawal by Subject|0|||
130568690|NCT02182687|470048420|FG000|Overall Study|Adverse Event|1|||
130568691|NCT02182687|470048421|FG001|Overall Study|Adverse Event|0|||
130568692|NCT02182687|470048420|FG000|Overall Study|Lost to Follow-up|0|||
130568693|NCT02182687|470048421|FG001|Overall Study|Lost to Follow-up|1|||
130568694|NCT02184195|470048424|FG000|Overall Study|Patient decision|5|||
130568695|NCT02184195|470048425|FG001|Overall Study|Patient decision|2|||
130568696|NCT02184195|470048424|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130568697|NCT02184195|470048425|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130568698|NCT02184195|470048424|FG000|Overall Study|Death|67|||
130568699|NCT02184195|470048425|FG001|Overall Study|Death|44|||
130568700|NCT02184195|470048424|FG000|Overall Study|Lost to Follow-up|1|||
130568701|NCT02184195|470048425|FG001|Overall Study|Lost to Follow-up|5|||
130568702|NCT02184195|470048424|FG000|Overall Study|Other|0|||
130568703|NCT02184195|470048425|FG001|Overall Study|Other|3|||
130568704|NCT00939783|470048428|FG000|Overall Study|Death|6|||
130568705|NCT00939783|470048428|FG000|Overall Study|Adverse Event|39|||
130568706|NCT00939783|470048428|FG000|Overall Study|Study Terminated by Sponsor|498|||
130568707|NCT00939783|470048428|FG000|Overall Study|Withdrawal by Subject|78|||
130568708|NCT00939783|470048428|FG000|Overall Study|Other|16|||
130568709|NCT00939783|470048428|FG000|Overall Study|Lost to Follow-up|8|||
130568710|NCT00939783|470048428|FG000|Overall Study|Protocol Violation|3|||
130568711|NCT00939783|470048428|FG000|Overall Study|Enrolled but not treated|1|||
130568712|NCT02255409|470048437|FG000|Overall Study|Administrative Reason|3|||
130568713|NCT02255409|470048438|FG001|Overall Study|Administrative Reason|7|||
130568714|NCT02255409|470048437|FG000|Overall Study|Withdrawal by Subject|1|||
130568715|NCT02255409|470048438|FG001|Overall Study|Withdrawal by Subject|5|||
130568716|NCT02255409|470048437|FG000|Overall Study|Lost to Follow-up|10|||
130568717|NCT02255409|470048438|FG001|Overall Study|Lost to Follow-up|19|||
130568718|NCT01251367|470048439|FG000|Overall Study|Protocol Violation|1|||
130568719|NCT01251367|470048439|FG000|Overall Study|Lack of Efficacy|2|||
130568720|NCT01251367|470048439|FG000|Overall Study|Adverse Event|19|||
130568721|NCT01251367|470048439|FG000|Overall Study|Withdrawal by Subject|36|||
130568722|NCT01251367|470048439|FG000|Overall Study|Lost to Follow-up|5|||
130568723|NCT01251367|470048439|FG000|Overall Study|Subject Required Alternative Treatment|7|||
130568724|NCT01251367|470048439|FG000|Overall Study|No Study Drug Available|1|||
130568725|NCT01251367|470048439|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
130568726|NCT01251367|470048439|FG000|Overall Study|End of Study Visit Performed in Error|1|||
130568727|NCT03775421|470048443|FG000|Overall Study|Lost to Follow-up|2|||
130568728|NCT03775421|470048443|FG000|Overall Study|Withdrawal by Subject|10|||
130568729|NCT03775421|470048443|FG000|Overall Study|Physician Decision|3|||
130568730|NCT03775421|470048443|FG000|Overall Study|Death|1|||
130568731|NCT03775421|470048443|FG000|Overall Study|Study Terminated by Sponsor|94|||
130568732|NCT03917823|470048444|FG000|Overall Study|Lost to Follow-up|1|||
130568733|NCT03917823|470048445|FG001|Overall Study|Lost to Follow-up|1|||
130568734|NCT03917823|470048444|FG000|Overall Study|Withdrawal by Subject|0|||
130568735|NCT03917823|470048445|FG001|Overall Study|Withdrawal by Subject|1|||
130568736|NCT00135668|470048446|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
130568737|NCT00135668|470048447|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
130568738|NCT00135668|470048448|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
130568739|NCT00135668|470048449|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
130568740|NCT02016820|470048450|FG000|Overall Study|Lost to Follow-up|2|||
130568741|NCT02016820|470048451|FG001|Overall Study|Lost to Follow-up|4|||
130568742|NCT01227044|470048454|FG000|Overall Study|Lost to Follow-up|5|||
130510815|NCT03614923|469835512|FG001|Overall Study|Lack of Efficacy|0|||
130510816|NCT03614923|469835513|FG002|Overall Study|Lack of Efficacy|1|||
130510817|NCT03614923|469835511|FG000|Overall Study|Non-compliance|0|||
130510818|NCT03614923|469835512|FG001|Overall Study|Non-compliance|1|||
130510819|NCT03614923|469835513|FG002|Overall Study|Non-compliance|0|||
130510820|NCT03614923|469835511|FG000|Overall Study|Other|0|||
130510821|NCT03614923|469835512|FG001|Overall Study|Other|1|||
130510822|NCT03614923|469835513|FG002|Overall Study|Other|1|||
130510823|NCT01107353|469835514|FG000|Overall Study|Positive Drug Screen|1|||
130510824|NCT01107353|469835515|FG001|Overall Study|Positive Drug Screen|0|||
130510825|NCT03360071|469835516|FG000|Overall Study|Lost to Follow-up|1|||
130510826|NCT03360071|469835517|FG001|Overall Study|Lost to Follow-up|0|||
130510827|NCT01745380|469835518|FG000|Overall Study|Lost to Follow-up|1|||
130510828|NCT01745380|469835519|FG001|Overall Study|Lost to Follow-up|0|||
130510829|NCT01745380|469835518|FG000|Overall Study|Lack of Efficacy|0|||
130510830|NCT01745380|469835519|FG001|Overall Study|Lack of Efficacy|1|||
130510831|NCT01882088|469835520|FG000|Overall Study|Intolerance of esophageal manometry|1|||
130510832|NCT01882088|469835520|FG000|Overall Study|no possibility to place the catheter|1|||
130510833|NCT01882088|469835520|FG000|Overall Study|Protocol Violation|1|||
130510834|NCT01882088|469835520|FG000|Overall Study|inadequate pH-impedance tracings|2|||
130510835|NCT01193283|469835524|FG000|Overall Study|Death|1|||
130510836|NCT02368691|469835525|FG000|Overall Study|Death|13|||
130510837|NCT02368691|469835525|FG000|Overall Study|Lack of Efficacy|15|||
130510838|NCT02368691|469835525|FG000|Overall Study|Physician Decision|4|||
130510839|NCT02720198|469835526|FG000|Overall Study|Withdrawal by Subject|0|||
130510840|NCT02720198|469835527|FG001|Overall Study|Withdrawal by Subject|1|||
130510841|NCT01268488|469835553|FG000|Overall Study|Adverse Event|3|||
130510842|NCT01268488|469835553|FG000|Overall Study|Physician Decision|2|||
130510843|NCT00460577|469835556|FG000|Overall Study|Protocol Violation|2|||
130510844|NCT00460577|469835557|FG001|Overall Study|Protocol Violation|6|||
130510845|NCT01047306|469835558|FG000|Overall Study|Withdrawal by Subject|2|||
130510846|NCT01047306|469835559|FG001|Overall Study|Withdrawal by Subject|0|||
130510847|NCT01047306|469835558|FG000|Overall Study|Lost to Follow-up|1|||
130510848|NCT01047306|469835559|FG001|Overall Study|Lost to Follow-up|0|||
130510849|NCT01878253|469835560|FG000|Overall Study|Death|1|||
130510850|NCT01878253|469835560|FG000|Overall Study|SIdus System Removal|3|||
130510851|NCT01878253|469835560|FG000|Overall Study|Withdrawal by Subject|1|||
130510852|NCT01878253|469835560|FG000|Overall Study|Lost to Follow-up|2|||
130510853|NCT01878253|469835560|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
130510854|NCT04043806|469835561|FG000|Overall Study|Commercial drug is available for participants|13|||
130510855|NCT04043806|469835561|FG000|Overall Study|Physician Decision|2|||
130510856|NCT04043806|469835561|FG000|Overall Study|Other|12|||
130510857|NCT04043806|469835561|FG000|Overall Study|Adverse Event|2|||
130510858|NCT04043806|469835561|FG000|Overall Study|Lost to Follow-up|6|||
130510859|NCT04043806|469835561|FG000|Overall Study|Other non-compliance|2|||
130510860|NCT04043806|469835561|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
130510861|NCT04043806|469835561|FG000|Overall Study|Never Dosed|1|||
130510862|NCT04799587|469835563|FG000|Overall Study|Withdrawal by Subject|0|||
130510863|NCT04799587|469835564|FG001|Overall Study|Withdrawal by Subject|1|||
130510864|NCT01613599|469835567|FG000|Overall Study|Death|9|||
130510865|NCT01613599|469835567|FG000|Overall Study|Lost to Follow-up|5|||
130510866|NCT01613599|469835567|FG000|Overall Study|Withdrawal by Subject|8|||
130510867|NCT01613599|469835567|FG000|Overall Study|Reason not specified|3|||
130510868|NCT00617708|469835569|FG000|Overall Study|Adverse Event|0|||
130510869|NCT00617708|469835570|FG001|Overall Study|Adverse Event|6|||
130510870|NCT00617708|469835571|FG002|Overall Study|Adverse Event|9|||
130510871|NCT00617708|469835569|FG000|Overall Study|Withdrawal by Subject|1|||
130510872|NCT00617708|469835570|FG001|Overall Study|Withdrawal by Subject|1|||
130510873|NCT00617708|469835571|FG002|Overall Study|Withdrawal by Subject|7|||
130510874|NCT00617708|469835569|FG000|Overall Study|Death|0|||
130510875|NCT00617708|469835570|FG001|Overall Study|Death|6|||
130510876|NCT00617708|469835571|FG002|Overall Study|Death|5|||
130510877|NCT00617708|469835569|FG000|Overall Study|Progression/Relapse|7|||
130510878|NCT00617708|469835570|FG001|Overall Study|Progression/Relapse|40|||
130510879|NCT00617708|469835571|FG002|Overall Study|Progression/Relapse|36|||
130510880|NCT00617708|469835569|FG000|Overall Study|Not protocol specified|1|||
130510881|NCT00617708|469835570|FG001|Overall Study|Not protocol specified|4|||
130510882|NCT00617708|469835571|FG002|Overall Study|Not protocol specified|2|||
130510883|NCT00617708|469835569|FG000|Overall Study|Not eligible|1|||
130510884|NCT00617708|469835570|FG001|Overall Study|Not eligible|3|||
130510885|NCT00617708|469835571|FG002|Overall Study|Not eligible|5|||
130510886|NCT02058992|469835574|FG000|Overall Study|Lost to Follow-up|4|||
130510887|NCT02058992|469835574|FG000|Overall Study|Protocol Violation|92|||
130510888|NCT02058992|469835574|FG000|Overall Study|CRF Uncollected|20|||
130510889|NCT02130401|469835577|FG000|Overall Study|Poor enrollment|6|||
130510890|NCT00321672|469835578|FG000|Overall Study|Withdrawal by Subject|5|||
130510891|NCT00321672|469835579|FG001|Overall Study|Withdrawal by Subject|1|||
130510892|NCT00321672|469835580|FG002|Overall Study|Withdrawal by Subject|2|||
130510893|NCT00321672|469835581|FG003|Overall Study|Withdrawal by Subject|0|||
130510894|NCT00321672|469835578|FG000|Overall Study|Noncompliance|1|||
130510895|NCT00321672|469835579|FG001|Overall Study|Noncompliance|2|||
130510896|NCT00321672|469835580|FG002|Overall Study|Noncompliance|1|||
130510897|NCT00321672|469835581|FG003|Overall Study|Noncompliance|0|||
130510898|NCT00321672|469835578|FG000|Overall Study|Adverse Event|1|||
130510899|NCT00321672|469835579|FG001|Overall Study|Adverse Event|1|||
130510900|NCT00321672|469835580|FG002|Overall Study|Adverse Event|0|||
130510901|NCT00321672|469835581|FG003|Overall Study|Adverse Event|0|||
130510902|NCT00321672|469835578|FG000|Overall Study|Lack of Efficacy|1|||
130510903|NCT00321672|469835579|FG001|Overall Study|Lack of Efficacy|1|||
130510904|NCT00321672|469835580|FG002|Overall Study|Lack of Efficacy|0|||
130510905|NCT00321672|469835581|FG003|Overall Study|Lack of Efficacy|0|||
130510906|NCT00321672|469835578|FG000|Overall Study|Lost to Follow-up|2|||
130510907|NCT00321672|469835579|FG001|Overall Study|Lost to Follow-up|0|||
130510908|NCT00321672|469835580|FG002|Overall Study|Lost to Follow-up|4|||
130510909|NCT00321672|469835581|FG003|Overall Study|Lost to Follow-up|2|||
130510910|NCT00321672|469835578|FG000|Overall Study|Death|1|||
130510911|NCT00321672|469835579|FG001|Overall Study|Death|0|||
130510912|NCT00321672|469835580|FG002|Overall Study|Death|0|||
130510913|NCT00321672|469835581|FG003|Overall Study|Death|0|||
130510914|NCT00321672|469835578|FG000|Overall Study|Too far to travel for visits|1|||
130510915|NCT00321672|469835579|FG001|Overall Study|Too far to travel for visits|0|||
130510916|NCT00321672|469835580|FG002|Overall Study|Too far to travel for visits|0|||
130510917|NCT00321672|469835581|FG003|Overall Study|Too far to travel for visits|0|||
130510918|NCT00321672|469835578|FG000|Overall Study|Incarcerated|0|||
130510919|NCT00321672|469835579|FG001|Overall Study|Incarcerated|0|||
130510920|NCT00321672|469835580|FG002|Overall Study|Incarcerated|2|||
130510921|NCT00321672|469835581|FG003|Overall Study|Incarcerated|0|||
130510922|NCT00321672|469835578|FG000|Overall Study|Moved out of state|0|||
130510923|NCT00321672|469835579|FG001|Overall Study|Moved out of state|1|||
130510924|NCT00321672|469835580|FG002|Overall Study|Moved out of state|1|||
130510925|NCT00321672|469835581|FG003|Overall Study|Moved out of state|0|||
130510926|NCT00321672|469835578|FG000|Overall Study|Protocol Violation|0|||
130510927|NCT00321672|469835579|FG001|Overall Study|Protocol Violation|0|||
130510928|NCT00321672|469835580|FG002|Overall Study|Protocol Violation|1|||
130510929|NCT00321672|469835581|FG003|Overall Study|Protocol Violation|0|||
130510930|NCT00321672|469835578|FG000|Overall Study|Diagnosis of testicular cancer|0|||
130510931|NCT00321672|469835579|FG001|Overall Study|Diagnosis of testicular cancer|1|||
130510932|NCT00321672|469835580|FG002|Overall Study|Diagnosis of testicular cancer|0|||
130510933|NCT00321672|469835581|FG003|Overall Study|Diagnosis of testicular cancer|0|||
130510934|NCT00321672|469835578|FG000|Overall Study|Extensive travel required for new job|0|||
130510935|NCT00321672|469835579|FG001|Overall Study|Extensive travel required for new job|1|||
130510936|NCT00321672|469835580|FG002|Overall Study|Extensive travel required for new job|0|||
130510937|NCT00321672|469835581|FG003|Overall Study|Extensive travel required for new job|0|||
130510938|NCT00512902|469835582|FG000|Overall Study|Adverse Event|7|||
130510939|NCT00512902|469835582|FG000|Overall Study|Lost to Follow-up|1|||
130510940|NCT00448344|469835583|FG000|Overall Study|Lost to Follow-up|20|||
130510941|NCT00448344|469835584|FG001|Overall Study|Lost to Follow-up|22|||
130510942|NCT00448344|469835583|FG000|Overall Study|Withdrawal by Subject|6|||
130510943|NCT00448344|469835584|FG001|Overall Study|Withdrawal by Subject|8|||
130510944|NCT00448344|469835583|FG000|Overall Study|Death|3|||
130510945|NCT00448344|469835584|FG001|Overall Study|Death|4|||
130510946|NCT00448344|469835583|FG000|Overall Study|Physician Decision|1|||
130510947|NCT00448344|469835584|FG001|Overall Study|Physician Decision|2|||
130510948|NCT01288729|469835589|FG000|Overall Study|Withdrawal by Subject|1|||
130510949|NCT01288729|469835590|FG001|Overall Study|Withdrawal by Subject|0|||
130510950|NCT00267865|469835591|FG000|Induction Treatment|Died before completing.|2|||
130510951|NCT00267865|469835591|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
130510952|NCT03686176|469835592|FG000|Overall Study|Procedure cancelled|1|||
130510953|NCT03686176|469835593|FG001|Overall Study|Procedure cancelled|0|||
130510954|NCT03686176|469835594|FG002|Overall Study|Procedure cancelled|0|||
130510955|NCT03686176|469835592|FG000|Overall Study|VR Malfunction|1|||
130510956|NCT03686176|469835593|FG001|Overall Study|VR Malfunction|0|||
130510957|NCT03686176|469835594|FG002|Overall Study|VR Malfunction|0|||
130510958|NCT03050372|469837085|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
130510959|NCT03050372|469837086|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
130510960|NCT03050372|469837085|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
130510961|NCT03050372|469837086|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
130510962|NCT00396409|469837087|FG000|Period 1 - 2007|Adverse Event|0|||
130510963|NCT00396409|469837088|FG001|Period 1 - 2007|Adverse Event|1|||
130568743|NCT01227044|470048455|FG001|Overall Study|Lost to Follow-up|7|||
130568744|NCT01227044|470048454|FG000|Overall Study|Discontinued Intervention|1|||
130568745|NCT01227044|470048455|FG001|Overall Study|Discontinued Intervention|2|||
130568746|NCT00583362|470048456|FG000|Overall Study|Adverse Event|44|||
130568747|NCT00583362|470048456|FG000|Overall Study|Lack of Efficacy|22|||
130568748|NCT00583362|470048456|FG000|Overall Study|Lost to Follow-up|4|||
130568749|NCT00583362|470048456|FG000|Overall Study|Non-compliance with study drug|28|||
130568750|NCT00583362|470048456|FG000|Overall Study|Pregnancy|7|||
130568751|NCT00583362|470048456|FG000|Overall Study|Miscommunication of visit window|5|||
130568752|NCT00583362|470048456|FG000|Overall Study|Current site closed|7|||
130568753|NCT00583362|470048456|FG000|Overall Study|Subject not dosed in LBSL99|1|||
130568754|NCT00583362|470048456|FG000|Overall Study|Subject moved out of the country/state|2|||
130568755|NCT00583362|470048456|FG000|Overall Study|Missed visits due to staff changes|1|||
130568756|NCT00583362|470048456|FG000|Overall Study|Misunderstanding of protocol|1|||
130568757|NCT00583362|470048456|FG000|Overall Study|Behavioral problems and non-compliance|1|||
130568758|NCT00583362|470048456|FG000|Overall Study|Sponsor request due to missed doses|1|||
130568759|NCT00583362|470048456|FG000|Overall Study|Physician Decision|19|||
130568760|NCT00583362|470048456|FG000|Overall Study|Protocol Violation|2|||
130568761|NCT00583362|470048456|FG000|Overall Study|Withdrawal by Subject|57|||
130568762|NCT00473343|470048457|FG000|Overall Study|Adverse Event|9|||
130568763|NCT00473343|470048457|FG000|Overall Study|Lost to Follow-up|8|||
130568764|NCT00473343|470048457|FG000|Overall Study|Treatment failure|27|||
130568765|NCT00473343|470048457|FG000|Overall Study|Withdrew consent|3|||
130568766|NCT00473343|470048457|FG000|Overall Study|Other un-specified reason|3|||
130568767|NCT04247061|470048460|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
130568768|NCT04247061|470048460|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
130568769|NCT04247061|470048460|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
130568770|NCT01136655|470048465|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
130568771|NCT01136655|470048465|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
130568772|NCT01136655|470048465|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
130568773|NCT01136655|470048465|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
130568774|NCT02287623|470048471|FG000|Overall Study|Protocol Violation|0|||
130568775|NCT02287623|470048472|FG001|Overall Study|Protocol Violation|1|||
130568776|NCT00455013|470048474|FG000|Short Term Period|Adverse Event|2|||
130568777|NCT00455013|470048475|FG001|Short Term Period|Adverse Event|5|||
130568778|NCT00455013|470048476|FG002|Short Term Period|Adverse Event|0|||
130568779|NCT00455013|470048474|FG000|Short Term Period|Withdrawal by Subject|0|||
130568780|NCT00455013|470048475|FG001|Short Term Period|Withdrawal by Subject|0|||
130568781|NCT00455013|470048476|FG002|Short Term Period|Withdrawal by Subject|1|||
130568782|NCT00455013|470048474|FG000|Short Term Period|Lack of Efficacy|4|||
130568783|NCT00455013|470048475|FG001|Short Term Period|Lack of Efficacy|0|||
130568784|NCT00455013|470048476|FG002|Short Term Period|Lack of Efficacy|0|||
130568785|NCT00455013|470048474|FG000|Short Term Period|Other|0|||
130568786|NCT00455013|470048475|FG001|Short Term Period|Other|0|||
130568787|NCT00455013|470048476|FG002|Short Term Period|Other|1|||
130568788|NCT00455013|470048474|FG000|Long Term Extension (LTE)|Adverse Event|0|||
130568789|NCT00455013|470048475|FG001|Long Term Extension (LTE)|Adverse Event|1|||
130568790|NCT00455013|470048476|FG002|Long Term Extension (LTE)|Adverse Event|1|||
130568791|NCT00455013|470048474|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
130568792|NCT00455013|470048475|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
130568793|NCT00455013|470048476|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
130568794|NCT00455013|470048474|FG000|Long Term Extension (LTE)|Death|1|||
130510964|NCT00396409|469837087|FG000|Period 1 - 2007|Lack of Efficacy|0|||
130510965|NCT00396409|469837088|FG001|Period 1 - 2007|Lack of Efficacy|1|||
130510966|NCT00396409|469837087|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
130510967|NCT00396409|469837088|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
130510968|NCT00396409|469837087|FG000|Period 1 - 2007|Lost to Follow-up|2|||
130510969|NCT00396409|469837088|FG001|Period 1 - 2007|Lost to Follow-up|3|||
130510970|NCT00396409|469837087|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
130510971|NCT00396409|469837088|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
130510972|NCT00396409|469837087|FG000|Period 2 - 2008|Protocol Violation|1|||
130510973|NCT00396409|469837088|FG001|Period 2 - 2008|Protocol Violation|0|||
130510974|NCT00396409|469837087|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
130568795|NCT00455013|470048475|FG001|Long Term Extension (LTE)|Death|1|||
130510975|NCT00396409|469837088|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
130510976|NCT00396409|469837087|FG000|Period 2 - 2008|Lost to Follow-up|3|||
130510977|NCT00396409|469837088|FG001|Period 2 - 2008|Lost to Follow-up|1|||
130568796|NCT00455013|470048476|FG002|Long Term Extension (LTE)|Death|0|||
130568797|NCT00455013|470048474|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
130568798|NCT00455013|470048475|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
130568799|NCT00455013|470048476|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
130568800|NCT00455013|470048474|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
130568801|NCT00455013|470048475|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
130510978|NCT00331799|469837089|FG000|Overall Study|Withdrawal by Subject|2|||
130568802|NCT00455013|470048476|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
130568803|NCT00455013|470048474|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
130568804|NCT00455013|470048475|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
130568805|NCT00455013|470048476|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
130568806|NCT00455013|470048474|FG000|Long Term Extension (LTE)|non-specified|0|||
130568807|NCT00455013|470048475|FG001|Long Term Extension (LTE)|non-specified|0|||
130568808|NCT00455013|470048476|FG002|Long Term Extension (LTE)|non-specified|1|||
130568809|NCT02739620|470048479|FG000|Overall Study|Lost to Follow-up|3|||
130568810|NCT02739620|470048480|FG001|Overall Study|Lost to Follow-up|1|||
130568811|NCT02739620|470048479|FG000|Overall Study|Adverse Event|0|||
130568812|NCT02739620|470048480|FG001|Overall Study|Adverse Event|1|||
130568813|NCT02577146|470048481|FG000|Overall Study|Lost to Follow-up|8|||
130568814|NCT02577146|470048481|FG000|Overall Study|Physician Decision|3|||
130568815|NCT02577146|470048481|FG000|Overall Study|Screen Failure|17|||
130568816|NCT01970501|470048482|FG000|Overall Study|Discontinuation of study by sponsor|16|||
130568817|NCT01970501|470048483|FG001|Overall Study|Discontinuation of study by sponsor|14|||
130568818|NCT01970501|470048482|FG000|Overall Study|Withdrawal by Subject|6|||
130568819|NCT01970501|470048483|FG001|Overall Study|Withdrawal by Subject|7|||
130568820|NCT01970501|470048482|FG000|Overall Study|Adverse Event|2|||
130568821|NCT01970501|470048483|FG001|Overall Study|Adverse Event|4|||
130568822|NCT01970501|470048482|FG000|Overall Study|Death|1|||
130568823|NCT01970501|470048483|FG001|Overall Study|Death|3|||
130568824|NCT01970501|470048482|FG000|Overall Study|Physician Decision|2|||
130568825|NCT01970501|470048483|FG001|Overall Study|Physician Decision|0|||
130568826|NCT01439555|470048485|FG000|Overall Study|Protocol Violation|1|||
130568827|NCT00102960|470048488|FG000|Overall Study|Death|23|||
130568828|NCT00102960|470048489|FG001|Overall Study|Death|11|||
130510979|NCT00331799|469837089|FG000|Overall Study|Sedation|1|||
130510980|NCT04203199|469837092|FG000|First Intervention Period|Lost to Follow-up|0|||
130510981|NCT04203199|469837093|FG001|First Intervention Period|Lost to Follow-up|1|||
130510982|NCT04203199|469837092|FG000|Second Intervention Period|Medication change|1|||
130510983|NCT04203199|469837093|FG001|Second Intervention Period|Medication change|0|||
130510984|NCT01870999|469837097|FG000|Overall Study|Adverse Event|0|||
130510985|NCT01870999|469837098|FG001|Overall Study|Adverse Event|4|||
130510986|NCT01870999|469837099|FG002|Overall Study|Adverse Event|1|||
130510987|NCT01870999|469837097|FG000|Overall Study|Subject met withdrawal criteria|3|||
130510988|NCT01870999|469837098|FG001|Overall Study|Subject met withdrawal criteria|2|||
130510989|NCT01870999|469837099|FG002|Overall Study|Subject met withdrawal criteria|0|||
130510990|NCT01870999|469837097|FG000|Overall Study|Subject withdrawn by Investigator|1|||
130510991|NCT01870999|469837098|FG001|Overall Study|Subject withdrawn by Investigator|0|||
130510992|NCT01870999|469837099|FG002|Overall Study|Subject withdrawn by Investigator|0|||
130510993|NCT01870999|469837097|FG000|Overall Study|Withdrawal by Subject|0|||
130510994|NCT01870999|469837098|FG001|Overall Study|Withdrawal by Subject|2|||
130510995|NCT01870999|469837099|FG002|Overall Study|Withdrawal by Subject|5|||
130510996|NCT01870999|469837097|FG000|Overall Study|Protocol Violation|0|||
130510997|NCT01870999|469837098|FG001|Overall Study|Protocol Violation|0|||
130510998|NCT01870999|469837099|FG002|Overall Study|Protocol Violation|1|||
130510999|NCT03034772|469837100|FG000|Overall Study|Adverse Event|0|||
130511000|NCT03034772|469837101|FG001|Overall Study|Adverse Event|1|||
130511001|NCT03034772|469837100|FG000|Overall Study|Withdrawal by Subject|0|||
130511002|NCT03034772|469837101|FG001|Overall Study|Withdrawal by Subject|1|||
130568829|NCT00102960|470048490|FG002|Overall Study|Death|11|||
130568830|NCT00102960|470048488|FG000|Overall Study|Lost to Follow-up|6|||
130568831|NCT00102960|470048489|FG001|Overall Study|Lost to Follow-up|12|||
130568832|NCT00102960|470048490|FG002|Overall Study|Lost to Follow-up|16|||
130568833|NCT00102960|470048488|FG000|Overall Study|Withdrawal by Subject|1|||
130568834|NCT00102960|470048489|FG001|Overall Study|Withdrawal by Subject|0|||
130568835|NCT00102960|470048490|FG002|Overall Study|Withdrawal by Subject|1|||
130568836|NCT05121480|470050099|FG000|Overall Study|Lack of Efficacy|2|||
130568837|NCT05121480|470050100|FG001|Overall Study|Lack of Efficacy|2|||
130568838|NCT05121480|470050101|FG002|Overall Study|Lack of Efficacy|1|||
130511003|NCT02660034|469837102|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
130511004|NCT02660034|469837103|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
130568839|NCT05121480|470050102|FG003|Overall Study|Lack of Efficacy|4|||
130568840|NCT05121480|470050103|FG004|Overall Study|Lack of Efficacy|0|||
130511005|NCT02660034|469837104|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
130511006|NCT02660034|469837105|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
130511007|NCT02660034|469837106|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
130511008|NCT02660034|469837107|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
130511009|NCT02660034|469837108|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
130511010|NCT02660034|469837109|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
130511011|NCT02660034|469837110|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
130511012|NCT02660034|469837111|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
130511013|NCT02660034|469837112|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
130511014|NCT02660034|469837113|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
130511015|NCT02660034|469837114|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
130511016|NCT02660034|469837115|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
130511017|NCT02660034|469837102|FG000|Overall Study|Progressive Disease (Clinical)|7|||
130511018|NCT02660034|469837103|FG001|Overall Study|Progressive Disease (Clinical)|8|||
130511019|NCT02660034|469837104|FG002|Overall Study|Progressive Disease (Clinical)|3|||
130511020|NCT02660034|469837105|FG003|Overall Study|Progressive Disease (Clinical)|9|||
130511021|NCT02660034|469837106|FG004|Overall Study|Progressive Disease (Clinical)|3|||
130511022|NCT02660034|469837107|FG005|Overall Study|Progressive Disease (Clinical)|0|||
130511023|NCT02660034|469837108|FG006|Overall Study|Progressive Disease (Clinical)|0|||
130511024|NCT02660034|469837109|FG007|Overall Study|Progressive Disease (Clinical)|0|||
130511025|NCT02660034|469837110|FG008|Overall Study|Progressive Disease (Clinical)|0|||
130511026|NCT02660034|469837111|FG009|Overall Study|Progressive Disease (Clinical)|0|||
130511027|NCT02660034|469837112|FG010|Overall Study|Progressive Disease (Clinical)|0|||
130511028|NCT02660034|469837113|FG011|Overall Study|Progressive Disease (Clinical)|0|||
130511029|NCT02660034|469837114|FG012|Overall Study|Progressive Disease (Clinical)|0|||
130511030|NCT02660034|469837115|FG013|Overall Study|Progressive Disease (Clinical)|0|||
130511031|NCT02660034|469837102|FG000|Overall Study|Lost to Follow-up|0|||
130511032|NCT02660034|469837103|FG001|Overall Study|Lost to Follow-up|0|||
130511033|NCT02660034|469837104|FG002|Overall Study|Lost to Follow-up|1|||
130511034|NCT02660034|469837105|FG003|Overall Study|Lost to Follow-up|1|||
130511035|NCT02660034|469837106|FG004|Overall Study|Lost to Follow-up|0|||
130511036|NCT02660034|469837107|FG005|Overall Study|Lost to Follow-up|0|||
130511037|NCT02660034|469837108|FG006|Overall Study|Lost to Follow-up|0|||
130511038|NCT02660034|469837109|FG007|Overall Study|Lost to Follow-up|0|||
130511039|NCT02660034|469837110|FG008|Overall Study|Lost to Follow-up|0|||
130511040|NCT02660034|469837111|FG009|Overall Study|Lost to Follow-up|1|||
130511041|NCT02660034|469837112|FG010|Overall Study|Lost to Follow-up|1|||
130511042|NCT02660034|469837113|FG011|Overall Study|Lost to Follow-up|1|||
130568841|NCT05121480|470050104|FG005|Overall Study|Lack of Efficacy|1|||
130568842|NCT05121480|470050105|FG006|Overall Study|Lack of Efficacy|0|||
130568843|NCT05121480|470050106|FG007|Overall Study|Lack of Efficacy|2|||
130568844|NCT05121480|470050099|FG000|Overall Study|Treatment Failure|0|||
130568845|NCT05121480|470050100|FG001|Overall Study|Treatment Failure|2|||
130568846|NCT05121480|470050101|FG002|Overall Study|Treatment Failure|0|||
130568847|NCT05121480|470050102|FG003|Overall Study|Treatment Failure|1|||
130568848|NCT05121480|470050103|FG004|Overall Study|Treatment Failure|0|||
130568849|NCT05121480|470050104|FG005|Overall Study|Treatment Failure|0|||
130568850|NCT05121480|470050105|FG006|Overall Study|Treatment Failure|0|||
130568851|NCT05121480|470050106|FG007|Overall Study|Treatment Failure|0|||
130568852|NCT05121480|470050099|FG000|Overall Study|Adverse Event|0|||
130568853|NCT05121480|470050100|FG001|Overall Study|Adverse Event|1|||
130568854|NCT05121480|470050101|FG002|Overall Study|Adverse Event|0|||
130568855|NCT05121480|470050102|FG003|Overall Study|Adverse Event|5|||
130568856|NCT05121480|470050103|FG004|Overall Study|Adverse Event|3|||
130568857|NCT05121480|470050104|FG005|Overall Study|Adverse Event|2|||
130568858|NCT05121480|470050105|FG006|Overall Study|Adverse Event|0|||
130568859|NCT05121480|470050106|FG007|Overall Study|Adverse Event|4|||
130568860|NCT05121480|470050099|FG000|Overall Study|Withdrawal by Subject|4|||
130568861|NCT05121480|470050100|FG001|Overall Study|Withdrawal by Subject|9|||
130568862|NCT05121480|470050101|FG002|Overall Study|Withdrawal by Subject|1|||
130511043|NCT02660034|469837114|FG012|Overall Study|Lost to Follow-up|0|||
130511044|NCT02660034|469837115|FG013|Overall Study|Lost to Follow-up|0|||
130511045|NCT02660034|469837102|FG000|Overall Study|Participant moved into special access scheme|1|||
130511046|NCT02660034|469837103|FG001|Overall Study|Participant moved into special access scheme|2|||
130511047|NCT02660034|469837104|FG002|Overall Study|Participant moved into special access scheme|0|||
130511048|NCT02660034|469837105|FG003|Overall Study|Participant moved into special access scheme|0|||
130511049|NCT02660034|469837106|FG004|Overall Study|Participant moved into special access scheme|0|||
130511050|NCT02660034|469837107|FG005|Overall Study|Participant moved into special access scheme|0|||
130511051|NCT02660034|469837108|FG006|Overall Study|Participant moved into special access scheme|0|||
130511052|NCT02660034|469837109|FG007|Overall Study|Participant moved into special access scheme|0|||
130511053|NCT02660034|469837110|FG008|Overall Study|Participant moved into special access scheme|0|||
130511054|NCT02660034|469837111|FG009|Overall Study|Participant moved into special access scheme|0|||
130511055|NCT02660034|469837112|FG010|Overall Study|Participant moved into special access scheme|0|||
130511056|NCT02660034|469837113|FG011|Overall Study|Participant moved into special access scheme|0|||
130511057|NCT02660034|469837114|FG012|Overall Study|Participant moved into special access scheme|0|||
130511058|NCT02660034|469837115|FG013|Overall Study|Participant moved into special access scheme|0|||
130511059|NCT02660034|469837102|FG000|Overall Study|Adverse Event|1|||
130511060|NCT02660034|469837103|FG001|Overall Study|Adverse Event|0|||
130511061|NCT02660034|469837104|FG002|Overall Study|Adverse Event|0|||
130511062|NCT02660034|469837105|FG003|Overall Study|Adverse Event|0|||
130511063|NCT02660034|469837106|FG004|Overall Study|Adverse Event|0|||
130511064|NCT02660034|469837107|FG005|Overall Study|Adverse Event|0|||
130511065|NCT02660034|469837108|FG006|Overall Study|Adverse Event|0|||
130511066|NCT02660034|469837109|FG007|Overall Study|Adverse Event|0|||
130568863|NCT05121480|470050102|FG003|Overall Study|Withdrawal by Subject|8|||
130511067|NCT02660034|469837110|FG008|Overall Study|Adverse Event|0|||
130511068|NCT02660034|469837111|FG009|Overall Study|Adverse Event|0|||
130511069|NCT02660034|469837112|FG010|Overall Study|Adverse Event|0|||
130511070|NCT02660034|469837113|FG011|Overall Study|Adverse Event|0|||
130511071|NCT02660034|469837114|FG012|Overall Study|Adverse Event|0|||
130511072|NCT02660034|469837115|FG013|Overall Study|Adverse Event|0|||
130511073|NCT02660034|469837102|FG000|Overall Study|Sponsor Decision|0|||
130511074|NCT02660034|469837103|FG001|Overall Study|Sponsor Decision|1|||
130511075|NCT02660034|469837104|FG002|Overall Study|Sponsor Decision|2|||
130511076|NCT02660034|469837105|FG003|Overall Study|Sponsor Decision|2|||
130511077|NCT02660034|469837106|FG004|Overall Study|Sponsor Decision|3|||
130568864|NCT05121480|470050103|FG004|Overall Study|Withdrawal by Subject|0|||
130511078|NCT02660034|469837107|FG005|Overall Study|Sponsor Decision|0|||
130511079|NCT02660034|469837108|FG006|Overall Study|Sponsor Decision|0|||
130568865|NCT05121480|470050104|FG005|Overall Study|Withdrawal by Subject|9|||
130568866|NCT05121480|470050105|FG006|Overall Study|Withdrawal by Subject|0|||
130568867|NCT05121480|470050106|FG007|Overall Study|Withdrawal by Subject|4|||
130511080|NCT02660034|469837109|FG007|Overall Study|Sponsor Decision|0|||
130568868|NCT05121480|470050099|FG000|Overall Study|Non-compliance with the protocol|0|||
130568869|NCT05121480|470050100|FG001|Overall Study|Non-compliance with the protocol|0|||
130511081|NCT02660034|469837110|FG008|Overall Study|Sponsor Decision|0|||
130511082|NCT02660034|469837111|FG009|Overall Study|Sponsor Decision|0|||
130511083|NCT02660034|469837112|FG010|Overall Study|Sponsor Decision|0|||
130568870|NCT05121480|470050101|FG002|Overall Study|Non-compliance with the protocol|0|||
130568871|NCT05121480|470050102|FG003|Overall Study|Non-compliance with the protocol|0|||
130568872|NCT05121480|470050103|FG004|Overall Study|Non-compliance with the protocol|1|||
130511084|NCT02660034|469837113|FG011|Overall Study|Sponsor Decision|0|||
130511085|NCT02660034|469837114|FG012|Overall Study|Sponsor Decision|0|||
130511086|NCT02660034|469837115|FG013|Overall Study|Sponsor Decision|1|||
130511087|NCT02660034|469837102|FG000|Overall Study|Withdrawal by Subject|0|||
130511088|NCT02660034|469837103|FG001|Overall Study|Withdrawal by Subject|0|||
130568873|NCT05121480|470050104|FG005|Overall Study|Non-compliance with the protocol|6|||
130568874|NCT05121480|470050105|FG006|Overall Study|Non-compliance with the protocol|0|||
130568875|NCT05121480|470050106|FG007|Overall Study|Non-compliance with the protocol|1|||
130568876|NCT05121480|470050099|FG000|Overall Study|Lost to Follow-up|0|||
130511089|NCT02660034|469837104|FG002|Overall Study|Withdrawal by Subject|0|||
130511090|NCT02660034|469837105|FG003|Overall Study|Withdrawal by Subject|0|||
130511091|NCT02660034|469837106|FG004|Overall Study|Withdrawal by Subject|0|||
130511092|NCT02660034|469837107|FG005|Overall Study|Withdrawal by Subject|0|||
130511093|NCT02660034|469837108|FG006|Overall Study|Withdrawal by Subject|1|||
130511094|NCT02660034|469837109|FG007|Overall Study|Withdrawal by Subject|1|||
130511095|NCT02660034|469837110|FG008|Overall Study|Withdrawal by Subject|1|||
130568877|NCT05121480|470050100|FG001|Overall Study|Lost to Follow-up|4|||
130568878|NCT05121480|470050101|FG002|Overall Study|Lost to Follow-up|1|||
130568879|NCT05121480|470050102|FG003|Overall Study|Lost to Follow-up|3|||
130568880|NCT05121480|470050103|FG004|Overall Study|Lost to Follow-up|1|||
130568881|NCT05121480|470050104|FG005|Overall Study|Lost to Follow-up|1|||
130568882|NCT05121480|470050105|FG006|Overall Study|Lost to Follow-up|1|||
130568883|NCT05121480|470050106|FG007|Overall Study|Lost to Follow-up|4|||
130568884|NCT05121480|470050099|FG000|Overall Study|Physician Decision|0|||
130568885|NCT05121480|470050100|FG001|Overall Study|Physician Decision|0|||
130568886|NCT05121480|470050101|FG002|Overall Study|Physician Decision|0|||
130568887|NCT05121480|470050102|FG003|Overall Study|Physician Decision|0|||
130568888|NCT05121480|470050103|FG004|Overall Study|Physician Decision|0|||
130568889|NCT05121480|470050104|FG005|Overall Study|Physician Decision|1|||
130568890|NCT05121480|470050105|FG006|Overall Study|Physician Decision|0|||
130568891|NCT05121480|470050106|FG007|Overall Study|Physician Decision|1|||
130568892|NCT05121480|470050099|FG000|Overall Study|Other Reason|0|||
130568893|NCT05121480|470050100|FG001|Overall Study|Other Reason|0|||
130568894|NCT05121480|470050101|FG002|Overall Study|Other Reason|0|||
130511096|NCT02660034|469837111|FG009|Overall Study|Withdrawal by Subject|0|||
130511097|NCT02660034|469837112|FG010|Overall Study|Withdrawal by Subject|0|||
130511098|NCT02660034|469837113|FG011|Overall Study|Withdrawal by Subject|1|||
130511099|NCT02660034|469837114|FG012|Overall Study|Withdrawal by Subject|2|||
130511100|NCT02660034|469837115|FG013|Overall Study|Withdrawal by Subject|0|||
130511101|NCT02660034|469837102|FG000|Overall Study|Death|0|||
130511102|NCT02660034|469837103|FG001|Overall Study|Death|0|||
130511103|NCT02660034|469837104|FG002|Overall Study|Death|0|||
130511104|NCT02660034|469837105|FG003|Overall Study|Death|0|||
130511105|NCT02660034|469837106|FG004|Overall Study|Death|0|||
130511106|NCT02660034|469837107|FG005|Overall Study|Death|13|||
130568895|NCT05121480|470050102|FG003|Overall Study|Other Reason|0|||
130568896|NCT05121480|470050103|FG004|Overall Study|Other Reason|0|||
130568897|NCT05121480|470050104|FG005|Overall Study|Other Reason|1|||
130568898|NCT05121480|470050105|FG006|Overall Study|Other Reason|1|||
130568899|NCT05121480|470050106|FG007|Overall Study|Other Reason|1|||
130568900|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
130511107|NCT02660034|469837108|FG006|Overall Study|Death|14|||
130511108|NCT02660034|469837109|FG007|Overall Study|Death|10|||
130568901|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
130568902|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130568903|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130511109|NCT02660034|469837110|FG008|Overall Study|Death|9|||
130568904|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130568905|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
130511110|NCT02660034|469837111|FG009|Overall Study|Death|21|||
130511111|NCT02660034|469837112|FG010|Overall Study|Death|17|||
130511112|NCT02660034|469837113|FG011|Overall Study|Death|15|||
130511113|NCT02660034|469837114|FG012|Overall Study|Death|18|||
130511114|NCT02660034|469837115|FG013|Overall Study|Death|7|||
130511115|NCT02660034|469837102|FG000|Overall Study|Physician Decision|0|||
130511116|NCT02660034|469837103|FG001|Overall Study|Physician Decision|0|||
130511117|NCT02660034|469837104|FG002|Overall Study|Physician Decision|0|||
130511118|NCT02660034|469837105|FG003|Overall Study|Physician Decision|0|||
130511119|NCT02660034|469837106|FG004|Overall Study|Physician Decision|0|||
130511120|NCT02660034|469837107|FG005|Overall Study|Physician Decision|0|||
130511121|NCT02660034|469837108|FG006|Overall Study|Physician Decision|0|||
130511122|NCT02660034|469837109|FG007|Overall Study|Physician Decision|0|||
130511123|NCT02660034|469837110|FG008|Overall Study|Physician Decision|0|||
130511124|NCT02660034|469837111|FG009|Overall Study|Physician Decision|0|||
130511125|NCT02660034|469837112|FG010|Overall Study|Physician Decision|0|||
130511126|NCT02660034|469837113|FG011|Overall Study|Physician Decision|0|||
130511127|NCT02660034|469837114|FG012|Overall Study|Physician Decision|0|||
130511128|NCT02660034|469837115|FG013|Overall Study|Physician Decision|1|||
130511129|NCT02660034|469837102|FG000|Overall Study|Participants transferred to LTE|0|||
130511130|NCT02660034|469837103|FG001|Overall Study|Participants transferred to LTE|0|||
130511131|NCT02660034|469837104|FG002|Overall Study|Participants transferred to LTE|0|||
130511132|NCT02660034|469837105|FG003|Overall Study|Participants transferred to LTE|0|||
130511133|NCT02660034|469837106|FG004|Overall Study|Participants transferred to LTE|0|||
130511134|NCT02660034|469837107|FG005|Overall Study|Participants transferred to LTE|10|||
130511135|NCT02660034|469837108|FG006|Overall Study|Participants transferred to LTE|8|||
130511136|NCT02660034|469837109|FG007|Overall Study|Participants transferred to LTE|8|||
130511137|NCT02660034|469837110|FG008|Overall Study|Participants transferred to LTE|10|||
130511138|NCT02660034|469837111|FG009|Overall Study|Participants transferred to LTE|1|||
130511139|NCT02660034|469837112|FG010|Overall Study|Participants transferred to LTE|2|||
130511140|NCT02660034|469837113|FG011|Overall Study|Participants transferred to LTE|4|||
130511141|NCT02660034|469837114|FG012|Overall Study|Participants transferred to LTE|1|||
130511142|NCT02660034|469837115|FG013|Overall Study|Participants transferred to LTE|1|||
130511143|NCT01533181|469837118|FG000|Overall Study|Disease progression pre-active treatment|0|||
130511144|NCT01533181|469837119|FG001|Overall Study|Disease progression pre-active treatment|1|||
130511145|NCT01533181|469837118|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
130511146|NCT01533181|469837119|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
130511147|NCT01837719|469837122|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
130511148|NCT01837719|469837122|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
130511149|NCT01703988|469837123|FG000|Overall Study|Investigator Judgment|0|||
130511150|NCT01703988|469837124|FG001|Overall Study|Investigator Judgment|0|||
130511151|NCT01703988|469837125|FG002|Overall Study|Investigator Judgment|0|||
130511152|NCT01703988|469837126|FG003|Overall Study|Investigator Judgment|1|||
130511153|NCT06247488|469837127|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
130511154|NCT06247488|469837128|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
130511155|NCT06247488|469837129|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
130511156|NCT06247488|469837130|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
130511157|NCT06247488|469837131|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
130511158|NCT06247488|469837132|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
130511159|NCT06247488|469837127|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
130511160|NCT06247488|469837128|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
130511161|NCT06247488|469837129|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
130511162|NCT06247488|469837130|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
130511163|NCT06247488|469837131|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
130511164|NCT06247488|469837132|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
130511165|NCT06247488|469837127|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
130511166|NCT06247488|469837128|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
130511167|NCT06247488|469837129|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
130511168|NCT06247488|469837130|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
130511169|NCT06247488|469837131|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
130511170|NCT06247488|469837132|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
130511171|NCT06247488|469837127|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
130511172|NCT06247488|469837128|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
130511173|NCT06247488|469837129|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
130511174|NCT06247488|469837130|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
130511175|NCT06247488|469837131|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
130511176|NCT06247488|469837132|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
130511177|NCT06247488|469837127|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
130511178|NCT06247488|469837128|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
130511179|NCT06247488|469837129|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
130511180|NCT06247488|469837130|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
130511181|NCT06247488|469837131|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
130511182|NCT06247488|469837132|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
130511183|NCT06247488|469837127|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
130511184|NCT06247488|469837128|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
130511185|NCT06247488|469837129|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
130511186|NCT06247488|469837130|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
130511187|NCT06247488|469837131|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
130511188|NCT06247488|469837132|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
130511189|NCT06247488|469837127|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
130511190|NCT06247488|469837128|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
130511191|NCT06247488|469837129|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
130511192|NCT06247488|469837130|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
130511193|NCT06247488|469837131|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
130511194|NCT06247488|469837132|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
130511195|NCT02995733|469837133|FG000|Overall Study|Study site closed|9|||
130511196|NCT02995733|469837134|FG001|Overall Study|Study site closed|10|||
130511197|NCT02995733|469837133|FG000|Overall Study|Death|3|||
130511198|NCT02995733|469837134|FG001|Overall Study|Death|4|||
130511199|NCT02995733|469837133|FG000|Overall Study|Withdrawal by Subject|6|||
130511200|NCT02995733|469837134|FG001|Overall Study|Withdrawal by Subject|2|||
130511201|NCT02995733|469837133|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
130511202|NCT02995733|469837134|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
130511203|NCT02995733|469837133|FG000|Overall Study|Lost to Follow-up|48|||
130511204|NCT02995733|469837134|FG001|Overall Study|Lost to Follow-up|37|||
130511205|NCT02995733|469837133|FG000|Overall Study|Other|0|||
130511206|NCT02995733|469837134|FG001|Overall Study|Other|1|||
130511207|NCT04879823|469837135|FG000|Overall Study|Physician Decision|3|||
130511208|NCT04879823|469837136|FG001|Overall Study|Physician Decision|1|||
130511209|NCT04879823|469837135|FG000|Overall Study|Protocol Violation|2|||
130511210|NCT04879823|469837136|FG001|Overall Study|Protocol Violation|3|||
130511211|NCT04879823|469837135|FG000|Overall Study|Lost to Follow-up|43|||
130511212|NCT04879823|469837136|FG001|Overall Study|Lost to Follow-up|35|||
130511213|NCT04468633|469837137|FG000|Overall Study|Withdrawal by Subject|4|||
130511214|NCT04468633|469837138|FG001|Overall Study|Withdrawal by Subject|0|||
130511215|NCT00460434|469837141|FG000|Overall Study|Lost to Follow-up|3|||
130511216|NCT00460434|469837142|FG001|Overall Study|Lost to Follow-up|7|||
130511217|NCT02722278|469837145|FG000|Overall Study|Withdrawal by Subject|5|||
130511218|NCT02722278|469837146|FG001|Overall Study|Withdrawal by Subject|3|||
130511219|NCT02722278|469837145|FG000|Overall Study|Adverse Event|4|||
130511220|NCT02722278|469837146|FG001|Overall Study|Adverse Event|1|||
130511221|NCT02722278|469837145|FG000|Overall Study|Lost to Follow-up|2|||
130511222|NCT02722278|469837146|FG001|Overall Study|Lost to Follow-up|0|||
130511223|NCT02722278|469837145|FG000|Overall Study|Protocol Violation|1|||
130511224|NCT02722278|469837146|FG001|Overall Study|Protocol Violation|0|||
130511225|NCT02722278|469837145|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
130511226|NCT02722278|469837146|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
130511227|NCT02722278|469837145|FG000|Overall Study|Subject declined after tx assignment|0|||
130511228|NCT02722278|469837146|FG001|Overall Study|Subject declined after tx assignment|1|||
130511229|NCT02722278|469837145|FG000|Overall Study|Site closure not study related|0|||
130511230|NCT02722278|469837146|FG001|Overall Study|Site closure not study related|1|||
130511231|NCT02465866|469837147|FG000|Period 3|Withdrawal by Subject|0|||
130511232|NCT02465866|469837148|FG001|Period 3|Withdrawal by Subject|1|||
130511233|NCT02465866|469837149|FG002|Period 3|Withdrawal by Subject|0|||
130511234|NCT02465866|469837150|FG003|Period 3|Withdrawal by Subject|0|||
130511235|NCT00203502|469837151|FG000|Overall Study|Death|1|||
130511236|NCT02023099|469837152|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
130511237|NCT02023099|469837153|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
130511238|NCT02023099|469837154|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
130511239|NCT02023099|469837152|FG000|Overall Study|Withdrawn Consent|3|||
130511240|NCT02023099|469837153|FG001|Overall Study|Withdrawn Consent|0|||
130511241|NCT02023099|469837154|FG002|Overall Study|Withdrawn Consent|1|||
130511242|NCT02023099|469837152|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
130511243|NCT02023099|469837153|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
130511244|NCT02023099|469837154|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
130511245|NCT01469819|469837155|FG000|Overall Study|Withdrawal by Subject|1|||
130511246|NCT01469819|469837155|FG000|Overall Study|Did not meet inclusionary criteria|2|||
130511247|NCT01469819|469837155|FG000|Overall Study|Could not swallow SmartPill|2|||
130511248|NCT01469819|469837155|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
130511249|NCT04057937|469837156|FG000|Placebo-controlled Phase|Adverse Event|3|||
130511250|NCT04057937|469837157|FG001|Placebo-controlled Phase|Adverse Event|0|||
130511251|NCT04057937|469837156|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
130511252|NCT04057937|469837157|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
130511253|NCT04057937|469837156|FG000|Active-treatment Phase|Pregnancy|0|||
130511254|NCT04057937|469837157|FG001|Active-treatment Phase|Pregnancy|1|||
130511255|NCT04057937|469837156|FG000|Active-treatment Phase|Physician Decision|0|||
130511256|NCT04057937|469837157|FG001|Active-treatment Phase|Physician Decision|1|||
130511257|NCT02446912|469837158|FG000|Overall Study|Adverse Event|3|||
130511258|NCT02446912|469837159|FG001|Overall Study|Adverse Event|13|||
130511259|NCT02446912|469837160|FG002|Overall Study|Adverse Event|5|||
130511260|NCT02446912|469837158|FG000|Overall Study|Condition under investigation worsened|0|||
130511261|NCT02446912|469837159|FG001|Overall Study|Condition under investigation worsened|1|||
130511262|NCT02446912|469837160|FG002|Overall Study|Condition under investigation worsened|1|||
130511263|NCT02446912|469837158|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130511264|NCT02446912|469837159|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130511265|NCT02446912|469837160|FG002|Overall Study|Study-specific withdrawal criteria|0|||
130511266|NCT02446912|469837158|FG000|Overall Study|Lack of Efficacy|1|||
130511267|NCT02446912|469837159|FG001|Overall Study|Lack of Efficacy|4|||
130511268|NCT02446912|469837160|FG002|Overall Study|Lack of Efficacy|7|||
130511269|NCT02446912|469837158|FG000|Overall Study|Lost to Follow-up|0|||
130511270|NCT02446912|469837159|FG001|Overall Study|Lost to Follow-up|0|||
130511271|NCT02446912|469837160|FG002|Overall Study|Lost to Follow-up|2|||
130511272|NCT02446912|469837158|FG000|Overall Study|Severe non-compliance to protocol|1|||
130511273|NCT02446912|469837159|FG001|Overall Study|Severe non-compliance to protocol|0|||
130511274|NCT02446912|469837160|FG002|Overall Study|Severe non-compliance to protocol|1|||
130511275|NCT02446912|469837158|FG000|Overall Study|Withdrawal by Subject|10|||
130511276|NCT02446912|469837159|FG001|Overall Study|Withdrawal by Subject|15|||
130511277|NCT02446912|469837160|FG002|Overall Study|Withdrawal by Subject|15|||
130511278|NCT02446912|469837158|FG000|Overall Study|Miscellaneous|2|||
130511279|NCT02446912|469837159|FG001|Overall Study|Miscellaneous|2|||
130511280|NCT02446912|469837160|FG002|Overall Study|Miscellaneous|4|||
130511281|NCT00147745|469837161|FG000|Overall Study|Withdrawal by Subject|1|||
130511282|NCT00147745|469837162|FG001|Overall Study|Withdrawal by Subject|0|||
130511283|NCT00147745|469837163|FG002|Overall Study|Withdrawal by Subject|0|||
130511284|NCT00510783|469837172|FG000|Overall Study|Lost to Follow-up|29|||
130511285|NCT00510783|469837173|FG001|Overall Study|Lost to Follow-up|25|||
130511286|NCT00510783|469837172|FG000|Overall Study|Withdrawal by Subject|2|||
130511287|NCT00510783|469837173|FG001|Overall Study|Withdrawal by Subject|3|||
130511288|NCT00510783|469837172|FG000|Overall Study|Protocol Violation|0|||
130511289|NCT00510783|469837173|FG001|Overall Study|Protocol Violation|1|||
130511290|NCT02305797|469837174|FG000|Overall Study|Adverse Event|11|||
130511291|NCT02305797|469837175|FG001|Overall Study|Adverse Event|2|||
130511292|NCT02305797|469837174|FG000|Overall Study|Withdrawal by Subject|9|||
130511293|NCT02305797|469837175|FG001|Overall Study|Withdrawal by Subject|10|||
130511294|NCT02305797|469837174|FG000|Overall Study|Lack of Efficacy|6|||
130511295|NCT02305797|469837175|FG001|Overall Study|Lack of Efficacy|0|||
130511296|NCT02305797|469837174|FG000|Overall Study|Lost to Follow-up|5|||
130511297|NCT02305797|469837175|FG001|Overall Study|Lost to Follow-up|11|||
130511298|NCT02305797|469837174|FG000|Overall Study|Pregnancy|0|||
130511299|NCT02305797|469837175|FG001|Overall Study|Pregnancy|2|||
130511300|NCT02305797|469837174|FG000|Overall Study|Noncompliance|14|||
130511301|NCT02305797|469837175|FG001|Overall Study|Noncompliance|12|||
130511302|NCT02305797|469837174|FG000|Overall Study|Reason not collected|0|||
130511303|NCT02305797|469837175|FG001|Overall Study|Reason not collected|1|||
130511304|NCT00422162|469837176|FG000|Overall Study|Adverse Event|11|||
130511305|NCT00422162|469837177|FG001|Overall Study|Adverse Event|9|||
130511306|NCT00422162|469837176|FG000|Overall Study|Lack of Efficacy|4|||
130511307|NCT00422162|469837177|FG001|Overall Study|Lack of Efficacy|10|||
130511308|NCT00422162|469837176|FG000|Overall Study|Withdrawal by Subject|7|||
130511309|NCT00422162|469837177|FG001|Overall Study|Withdrawal by Subject|6|||
130511310|NCT00422162|469837176|FG000|Overall Study|Lost to Follow-up|1|||
130511311|NCT00422162|469837177|FG001|Overall Study|Lost to Follow-up|2|||
130511312|NCT00422162|469837176|FG000|Overall Study|Non-Compliant with Protocol|1|||
130511313|NCT00422162|469837177|FG001|Overall Study|Non-Compliant with Protocol|1|||
130511314|NCT00422162|469837176|FG000|Overall Study|Other|0|||
130511315|NCT00422162|469837177|FG001|Overall Study|Other|1|||
130511316|NCT00422162|469837176|FG000|Overall Study|Didn't Receive Treatment|0|||
130511317|NCT00422162|469837177|FG001|Overall Study|Didn't Receive Treatment|1|||
130511318|NCT02522299|469837178|FG000|Overall Study|Adverse Event|2|||
130511319|NCT02522299|469837179|FG001|Overall Study|Adverse Event|0|||
130511320|NCT02522299|469837178|FG000|Overall Study|Physician Decision|0|||
130511321|NCT02522299|469837179|FG001|Overall Study|Physician Decision|1|||
130511322|NCT02522299|469837178|FG000|Overall Study|Withdrawal by Subject|2|||
130511323|NCT02522299|469837179|FG001|Overall Study|Withdrawal by Subject|0|||
130511324|NCT01622088|469837180|FG000|Overall Study|Adverse Event|20|||
130511325|NCT01622088|469837180|FG000|Overall Study|Lost to Follow-up|1|||
130511326|NCT01622088|469837180|FG000|Overall Study|Withdrawal by Subject|20|||
130511327|NCT01622088|469837180|FG000|Overall Study|Investigator Decision|1|||
130511328|NCT01622088|469837180|FG000|Overall Study|Death|53|||
130511329|NCT01622088|469837180|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
130511330|NCT00274846|469837183|FG000|Overall Study|Did not receive adequate NK cells|1|||
130511331|NCT03045302|469837184|FG000|Overall Study|Pre-treatment adverse event|1|||
130511332|NCT05287178|469837187|FG000|Overall Study|Lost to Follow-up|2|||
130511333|NCT01648699|469837188|FG000|Overall Study|Death|1|||
130511334|NCT01648699|469837188|FG000|Overall Study|Lost to Follow-up|2|||
130511335|NCT01648699|469837188|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
130511336|NCT02267746|469837189|FG000|Overall Study|Adverse Event|0|||
130511337|NCT02267746|469837190|FG001|Overall Study|Adverse Event|2|||
130511338|NCT02267746|469837191|FG002|Overall Study|Adverse Event|1|||
130511339|NCT02267746|469837189|FG000|Overall Study|Protocol Violation|8|||
130511340|NCT02267746|469837190|FG001|Overall Study|Protocol Violation|7|||
130511341|NCT02267746|469837191|FG002|Overall Study|Protocol Violation|3|||
130511342|NCT02267746|469837189|FG000|Overall Study|Lack of Efficacy|11|||
130511343|NCT02267746|469837190|FG001|Overall Study|Lack of Efficacy|11|||
130511344|NCT02267746|469837191|FG002|Overall Study|Lack of Efficacy|15|||
130511345|NCT02267746|469837189|FG000|Overall Study|Protocol Violation|1|||
130511346|NCT02267746|469837190|FG001|Overall Study|Protocol Violation|2|||
130511347|NCT02267746|469837191|FG002|Overall Study|Protocol Violation|1|||
130511348|NCT02267746|469837189|FG000|Overall Study|Miscellaneous|1|||
130511349|NCT02267746|469837190|FG001|Overall Study|Miscellaneous|0|||
130511350|NCT02267746|469837191|FG002|Overall Study|Miscellaneous|1|||
130511351|NCT00990314|469837203|FG000|Overall Study|Death|2|||
130511352|NCT00990314|469837203|FG000|Overall Study|Adverse Event|2|||
130511353|NCT00990314|469837203|FG000|Overall Study|Withdrawal by Subject|3|||
130511354|NCT00990314|469837203|FG000|Overall Study|Non-Compliance|1|||
130511355|NCT00990314|469837203|FG000|Overall Study|Physician Decision|3|||
130511356|NCT00990314|469837203|FG000|Overall Study|Lack of Efficacy|1|||
130511357|NCT01636778|469837208|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
130511358|NCT01636778|469837209|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
130511359|NCT01636778|469837210|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
130511360|NCT01636778|469837208|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
130511361|NCT01636778|469837209|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
130511362|NCT01636778|469837210|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
130511363|NCT01636778|469837208|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
130511364|NCT01636778|469837209|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
130511365|NCT01636778|469837210|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
130511366|NCT01636778|469837208|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
130511367|NCT01636778|469837209|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
130511368|NCT01636778|469837210|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
130511369|NCT01636778|469837208|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
130511370|NCT01636778|469837209|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
130511371|NCT01636778|469837210|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
130511372|NCT01636778|469837208|FG000|Follow-up Period After Part 2|Other|0|||
130511373|NCT01636778|469837209|FG001|Follow-up Period After Part 2|Other|0|||
130511374|NCT01636778|469837210|FG002|Follow-up Period After Part 2|Other|1|||
130511375|NCT01636778|469837208|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
130511376|NCT01636778|469837209|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
130511377|NCT01636778|469837210|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
130511378|NCT01636778|469837208|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
130511379|NCT01636778|469837209|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
130511380|NCT01636778|469837210|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
130511381|NCT03530345|469837212|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130511382|NCT03530345|469837213|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
130511383|NCT03530345|469837212|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
130511384|NCT03530345|469837213|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
130511385|NCT03530345|469837212|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
130511386|NCT03530345|469837213|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
130511387|NCT03530345|469837212|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
130511388|NCT03530345|469837213|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
130511389|NCT04853394|469837218|FG000|Follow-up Interviews|Lost to Follow-up|22|||
130511390|NCT04853394|469837219|FG001|Follow-up Interviews|Lost to Follow-up|15|||
130511391|NCT04212299|469837223|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
130511392|NCT04413149|469839003|FG000|Overall Study|Death|10|||
130511393|NCT04413149|469839004|FG001|Overall Study|Death|5|||
130511394|NCT04413149|469839003|FG000|Overall Study|Lung transplantation|1|||
130511395|NCT04413149|469839004|FG001|Overall Study|Lung transplantation|0|||
130511396|NCT00705614|469839005|FG000|Initial Intervention|Adverse Event|40|||
130511397|NCT00705614|469839006|FG001|Initial Intervention|Adverse Event|21|||
130511398|NCT00705614|469839005|FG000|Initial Intervention|Lost to Follow-up|310|||
130511399|NCT00705614|469839006|FG001|Initial Intervention|Lost to Follow-up|191|||
130511400|NCT00705614|469839005|FG000|Initial Intervention|Withdrawal by Subject|114|||
130511401|NCT00705614|469839006|FG001|Initial Intervention|Withdrawal by Subject|71|||
130568906|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
130568907|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130568908|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130568909|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130568910|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
130568911|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
130568912|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130568913|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130568914|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130568915|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
130511402|NCT00705614|469839005|FG000|Initial Intervention|Administrative Reason|51|||
130511403|NCT00705614|469839006|FG001|Initial Intervention|Administrative Reason|38|||
130511404|NCT00705614|469839005|FG000|Initial Intervention|Status completion unknown|3|||
130511405|NCT00705614|469839006|FG001|Initial Intervention|Status completion unknown|0|||
130511406|NCT00705614|469839005|FG000|Switch to Remicade|Adverse Event|0|||
130511407|NCT00705614|469839006|FG001|Switch to Remicade|Adverse Event|5|||
130511408|NCT00705614|469839005|FG000|Switch to Remicade|Lost to Follow-up|0|||
130511409|NCT00705614|469839006|FG001|Switch to Remicade|Lost to Follow-up|23|||
130511410|NCT00705614|469839005|FG000|Switch to Remicade|Withdrawal by Subject|0|||
130511411|NCT00705614|469839006|FG001|Switch to Remicade|Withdrawal by Subject|12|||
130511412|NCT00705614|469839005|FG000|Switch to Remicade|Administrative Reason|0|||
130511413|NCT00705614|469839006|FG001|Switch to Remicade|Administrative Reason|9|||
130511414|NCT00676195|469839009|FG000|Overall Study|Lost to Follow-up|1|||
130511415|NCT00676195|469839009|FG000|Overall Study|Adverse Event|1|||
130511416|NCT00676195|469839009|FG000|Overall Study|Physician Decision|1|||
130511417|NCT02661490|469839010|FG000|Overall Study|Lost to Follow-up|0|||
130511418|NCT02661490|469839011|FG001|Overall Study|Lost to Follow-up|1|||
130511419|NCT02661490|469839012|FG002|Overall Study|Lost to Follow-up|0|||
130511420|NCT02661490|469839013|FG003|Overall Study|Lost to Follow-up|0|||
130511421|NCT02661490|469839014|FG004|Overall Study|Lost to Follow-up|2|||
130511422|NCT02661490|469839010|FG000|Overall Study|Withdrawal by Subject|2|||
130511423|NCT02661490|469839011|FG001|Overall Study|Withdrawal by Subject|0|||
130511424|NCT02661490|469839012|FG002|Overall Study|Withdrawal by Subject|2|||
130511425|NCT02661490|469839013|FG003|Overall Study|Withdrawal by Subject|0|||
130511426|NCT02661490|469839014|FG004|Overall Study|Withdrawal by Subject|0|||
130511427|NCT02661490|469839010|FG000|Overall Study|Death|1|||
130511428|NCT02661490|469839011|FG001|Overall Study|Death|1|||
130511429|NCT02661490|469839012|FG002|Overall Study|Death|0|||
130511430|NCT02661490|469839013|FG003|Overall Study|Death|1|||
130511431|NCT02661490|469839014|FG004|Overall Study|Death|0|||
130511432|NCT02661490|469839010|FG000|Overall Study|Reason not Specified|0|||
130511433|NCT02661490|469839011|FG001|Overall Study|Reason not Specified|0|||
130511434|NCT02661490|469839012|FG002|Overall Study|Reason not Specified|0|||
130511435|NCT02661490|469839013|FG003|Overall Study|Reason not Specified|0|||
130511436|NCT02661490|469839014|FG004|Overall Study|Reason not Specified|1|||
130511437|NCT00814632|469839015|FG000|Overall Study|Lack of Efficacy|2|||
130511438|NCT05335005|469839016|FG000|Overall Study|Lost to Follow-up|1|||
130511439|NCT04050722|469839017|FG000|Overall Study|Withdrawal by Subject|1|||
130511440|NCT04050722|469839018|FG001|Overall Study|Withdrawal by Subject|0|||
130511441|NCT00644332|469839019|FG000|Overall Study|Adverse Event|11|||
130511442|NCT00644332|469839019|FG000|Overall Study|Withdrawal by Subject|6|||
130511443|NCT00644332|469839019|FG000|Overall Study|Completion Status Unknown|2|||
130511444|NCT00644332|469839019|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
130511445|NCT00644332|469839019|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
130511446|NCT00355784|469839021|FG000|Overall Study|Withdrawal by Subject|0|||
130511447|NCT00355784|469839022|FG001|Overall Study|Withdrawal by Subject|0|||
130511448|NCT00355784|469839023|FG002|Overall Study|Withdrawal by Subject|2|||
130511449|NCT03602053|469839026|FG000|Overall Study|Withdrawal by Subject|7|||
130511450|NCT03602053|469839027|FG001|Overall Study|Withdrawal by Subject|9|||
130511451|NCT03602053|469839028|FG002|Overall Study|Withdrawal by Subject|7|||
130511452|NCT03602053|469839026|FG000|Overall Study|Lost to Follow-up|5|||
130511453|NCT03602053|469839027|FG001|Overall Study|Lost to Follow-up|6|||
130511454|NCT03602053|469839028|FG002|Overall Study|Lost to Follow-up|0|||
130511455|NCT03602053|469839026|FG000|Overall Study|Protocol Violation|3|||
130511456|NCT03602053|469839027|FG001|Overall Study|Protocol Violation|0|||
130511457|NCT03602053|469839028|FG002|Overall Study|Protocol Violation|4|||
130511458|NCT03602053|469839026|FG000|Overall Study|Physician Decision|1|||
130511459|NCT03602053|469839027|FG001|Overall Study|Physician Decision|0|||
130511460|NCT03602053|469839028|FG002|Overall Study|Physician Decision|0|||
130511461|NCT03602053|469839026|FG000|Overall Study|migration|2|||
130511462|NCT03602053|469839027|FG001|Overall Study|migration|3|||
130511463|NCT03602053|469839028|FG002|Overall Study|migration|0|||
130511464|NCT03602053|469839026|FG000|Overall Study|Other|1|||
130511465|NCT03602053|469839027|FG001|Overall Study|Other|0|||
130511466|NCT03602053|469839028|FG002|Overall Study|Other|0|||
130511467|NCT01572493|469839029|FG000|Overall Study|Physician Decision|1|||
130511468|NCT01572493|469839030|FG001|Overall Study|Physician Decision|0|||
130511469|NCT01572493|469839031|FG002|Overall Study|Physician Decision|0|||
130511470|NCT01572493|469839032|FG003|Overall Study|Physician Decision|0|||
130511471|NCT01572493|469839033|FG004|Overall Study|Physician Decision|0|||
130511472|NCT01572493|469839034|FG005|Overall Study|Physician Decision|0|||
130511473|NCT01572493|469839035|FG006|Overall Study|Physician Decision|0|||
130511474|NCT01572493|469839036|FG007|Overall Study|Physician Decision|0|||
130511475|NCT01572493|469839037|FG008|Overall Study|Physician Decision|0|||
130511476|NCT01572493|469839029|FG000|Overall Study|Switched to alternative treatment|0|||
130511477|NCT01572493|469839030|FG001|Overall Study|Switched to alternative treatment|1|||
130511478|NCT01572493|469839031|FG002|Overall Study|Switched to alternative treatment|2|||
130511479|NCT01572493|469839032|FG003|Overall Study|Switched to alternative treatment|1|||
130568916|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
130568917|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130568918|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130568919|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130568920|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
130568921|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
130568922|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130568923|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130568924|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130568925|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
130568926|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
130568927|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130568928|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130568929|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130568930|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
130568931|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
130568932|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130568933|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130568934|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130568935|NCT02831673|470050109|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
130568936|NCT02831673|470050110|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
130568937|NCT02831673|470050111|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130568938|NCT02831673|470050112|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130568939|NCT02831673|470050113|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130568940|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130568941|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130568942|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
130568943|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
130568944|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130568945|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130568946|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130568947|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
130568948|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130568949|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130568950|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130568951|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130568952|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130568953|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
130568954|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130568955|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130568956|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130568957|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
130568958|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
130568959|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130568960|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130568961|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130568962|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
130568963|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
130568964|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130568965|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130568966|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130568967|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
130568968|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
130568969|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130568970|NCT02831673|470050109|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130568971|NCT02831673|470050110|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130568972|NCT02831673|470050111|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
130568973|NCT02831673|470050112|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
130568974|NCT02831673|470050113|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130568975|NCT02831673|470050109|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130568976|NCT02831673|470050110|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130568977|NCT02831673|470050111|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130568978|NCT02831673|470050112|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130568979|NCT02831673|470050113|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
130568980|NCT02831673|470050109|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130568981|NCT02831673|470050110|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130568982|NCT02831673|470050111|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130568983|NCT02831673|470050112|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130568984|NCT02831673|470050113|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
130568985|NCT02831673|470050109|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130568986|NCT02831673|470050110|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130568987|NCT02831673|470050111|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130568988|NCT02831673|470050112|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130568989|NCT02831673|470050113|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
130568990|NCT02831673|470050109|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130568991|NCT02831673|470050110|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130568992|NCT02831673|470050111|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130568993|NCT02831673|470050112|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130568994|NCT02831673|470050113|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
130568995|NCT02831673|470050109|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130568996|NCT02831673|470050110|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130568997|NCT02831673|470050111|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130568998|NCT02831673|470050112|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130568999|NCT02831673|470050113|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
130569000|NCT02356562|470050115|FG000|Overall Study|Withdrawal by Subject|0|||
130569001|NCT02356562|470050116|FG001|Overall Study|Withdrawal by Subject|1|||
130569002|NCT02356562|470050115|FG000|Overall Study|Re-entered treatment in a previous study|1|||
130569003|NCT02356562|470050116|FG001|Overall Study|Re-entered treatment in a previous study|0|||
130569004|NCT02356562|470050115|FG000|Overall Study|site closure|1|||
130569005|NCT02356562|470050116|FG001|Overall Study|site closure|0|||
130569006|NCT00412750|470050117|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130569007|NCT00412750|470050118|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130569008|NCT00412750|470050119|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130569009|NCT00412750|470050117|FG000|Overall Study|Administrative problems|21|||
130569010|NCT00412750|470050118|FG001|Overall Study|Administrative problems|17|||
130569011|NCT00412750|470050119|FG002|Overall Study|Administrative problems|14|||
130569012|NCT00412750|470050117|FG000|Overall Study|Adverse Event|8|||
130569013|NCT00412750|470050118|FG001|Overall Study|Adverse Event|3|||
130569014|NCT00412750|470050119|FG002|Overall Study|Adverse Event|3|||
130569015|NCT00412750|470050117|FG000|Overall Study|Lost to Follow-up|1|||
130569016|NCT00412750|470050118|FG001|Overall Study|Lost to Follow-up|0|||
130569017|NCT00412750|470050119|FG002|Overall Study|Lost to Follow-up|1|||
130569018|NCT00412750|470050117|FG000|Overall Study|Withdrawal by Subject|0|||
130569019|NCT00412750|470050118|FG001|Overall Study|Withdrawal by Subject|1|||
130569020|NCT00412750|470050119|FG002|Overall Study|Withdrawal by Subject|2|||
130569021|NCT00412750|470050117|FG000|Overall Study|Lack of Efficacy|0|||
130569022|NCT00412750|470050118|FG001|Overall Study|Lack of Efficacy|0|||
130569023|NCT00412750|470050119|FG002|Overall Study|Lack of Efficacy|3|||
130569024|NCT02104583|470050127|FG000|Overall Study|New ICD or CRT-D implanted|2|||
130569025|NCT02104583|470050128|FG001|Overall Study|New ICD or CRT-D implanted|0|||
130569026|NCT02104583|470050129|FG002|Overall Study|New ICD or CRT-D implanted|1|||
130569027|NCT02104583|470050130|FG003|Overall Study|New ICD or CRT-D implanted|0|||
130569028|NCT02104583|470050131|FG004|Overall Study|New ICD or CRT-D implanted|0|||
130569029|NCT02104583|470050127|FG000|Overall Study|Death|2|||
130569030|NCT02104583|470050128|FG001|Overall Study|Death|1|||
130569031|NCT02104583|470050129|FG002|Overall Study|Death|3|||
130569032|NCT02104583|470050130|FG003|Overall Study|Death|3|||
130569033|NCT02104583|470050131|FG004|Overall Study|Death|5|||
130569034|NCT02104583|470050127|FG000|Overall Study|Subject required cardiac ablation|6|||
130569035|NCT02104583|470050128|FG001|Overall Study|Subject required cardiac ablation|4|||
130569036|NCT02104583|470050129|FG002|Overall Study|Subject required cardiac ablation|4|||
130569037|NCT02104583|470050130|FG003|Overall Study|Subject required cardiac ablation|5|||
130569038|NCT02104583|470050131|FG004|Overall Study|Subject required cardiac ablation|4|||
130569039|NCT02104583|470050127|FG000|Overall Study|Subject required prohibited medication|0|||
130569040|NCT02104583|470050128|FG001|Overall Study|Subject required prohibited medication|1|||
130569041|NCT02104583|470050129|FG002|Overall Study|Subject required prohibited medication|1|||
130569042|NCT02104583|470050130|FG003|Overall Study|Subject required prohibited medication|0|||
130511480|NCT01572493|469839033|FG004|Overall Study|Switched to alternative treatment|2|||
130511481|NCT01572493|469839034|FG005|Overall Study|Switched to alternative treatment|0|||
130511482|NCT01572493|469839035|FG006|Overall Study|Switched to alternative treatment|2|||
130511483|NCT01572493|469839036|FG007|Overall Study|Switched to alternative treatment|0|||
130511484|NCT01572493|469839037|FG008|Overall Study|Switched to alternative treatment|2|||
130511485|NCT01572493|469839029|FG000|Overall Study|Death|0|||
130511486|NCT01572493|469839030|FG001|Overall Study|Death|0|||
130511487|NCT01572493|469839031|FG002|Overall Study|Death|0|||
130511488|NCT01572493|469839032|FG003|Overall Study|Death|1|||
130511489|NCT01572493|469839033|FG004|Overall Study|Death|0|||
130511490|NCT01572493|469839034|FG005|Overall Study|Death|1|||
130511491|NCT01572493|469839035|FG006|Overall Study|Death|0|||
130511492|NCT01572493|469839036|FG007|Overall Study|Death|0|||
130511493|NCT01572493|469839037|FG008|Overall Study|Death|0|||
130511494|NCT01572493|469839029|FG000|Overall Study|Adverse Event|0|||
130511495|NCT01572493|469839030|FG001|Overall Study|Adverse Event|0|||
130511496|NCT01572493|469839031|FG002|Overall Study|Adverse Event|0|||
130511497|NCT01572493|469839032|FG003|Overall Study|Adverse Event|0|||
130511498|NCT01572493|469839033|FG004|Overall Study|Adverse Event|0|||
130511499|NCT01572493|469839034|FG005|Overall Study|Adverse Event|0|||
130511500|NCT01572493|469839035|FG006|Overall Study|Adverse Event|1|||
130511501|NCT01572493|469839036|FG007|Overall Study|Adverse Event|0|||
130511502|NCT01572493|469839037|FG008|Overall Study|Adverse Event|0|||
130511503|NCT00609245|469839038|FG000|Overall Study|Adverse Event|1|||
130511504|NCT01234675|469839039|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
130511505|NCT01234675|469839040|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130511506|NCT01234675|469839039|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130511507|NCT01234675|469839040|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
130511508|NCT02889809|469839041|FG000|Overall Study|Withdrawal by Subject|30|||
130511509|NCT02889809|469839042|FG001|Overall Study|Withdrawal by Subject|21|||
130511510|NCT02889809|469839041|FG000|Overall Study|Lost to Follow-up|1|||
130511511|NCT02889809|469839042|FG001|Overall Study|Lost to Follow-up|1|||
130511512|NCT02889809|469839041|FG000|Overall Study|Site Closed|12|||
130511513|NCT02889809|469839042|FG001|Overall Study|Site Closed|11|||
130511514|NCT02798861|469839051|FG000|Overall Study|Lost to Follow-up|22|||
130511515|NCT02798861|469839051|FG000|Overall Study|Withdrawal by Subject|1|||
130511516|NCT02186015|469839052|FG000|Overall Study|Physician Decision|1|||
130511517|NCT02186015|469839053|FG001|Overall Study|Physician Decision|0|||
130511518|NCT01797705|469839054|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
130511519|NCT01797705|469839054|FG000|Overall Study|Withdrawal by Subject|1|||
130511520|NCT01838447|469839055|FG000|Overall Study|Change in surgical plan|1|||
130511521|NCT01838447|469839056|FG001|Overall Study|Change in surgical plan|2|||
130511522|NCT01838447|469839055|FG000|Overall Study|Withdrawal by Subject|1|||
130511523|NCT01838447|469839056|FG001|Overall Study|Withdrawal by Subject|1|||
130511524|NCT02030847|469839057|FG000|Overall Study|Death|10|||
130511525|NCT02030847|469839057|FG000|Overall Study|Disease Progression|15|||
130511526|NCT02030847|469839057|FG000|Overall Study|New Cancer Therapy|8|||
130511527|NCT02030847|469839057|FG000|Overall Study|Physician Decision|3|||
130511528|NCT02030847|469839057|FG000|Overall Study|Withdrawal by Subject|1|||
130511529|NCT01103141|469839058|FG000|Overall Study|Death|0|||
130511530|NCT01103141|469839059|FG001|Overall Study|Death|1|||
130511531|NCT01103141|469839058|FG000|Overall Study|Lost to Follow-up|2|||
130511532|NCT01103141|469839059|FG001|Overall Study|Lost to Follow-up|1|||
130511533|NCT01403805|469839062|FG000|Overall Study|Withdrawal by Subject|0|||
130511534|NCT01403805|469839063|FG001|Overall Study|Withdrawal by Subject|4|||
130511535|NCT01403805|469839062|FG000|Overall Study|Lost to Follow-up|0|||
130511536|NCT01403805|469839063|FG001|Overall Study|Lost to Follow-up|2|||
130511537|NCT01403805|469839062|FG000|Overall Study|Death|0|||
130511538|NCT01403805|469839063|FG001|Overall Study|Death|1|||
130511539|NCT01695993|469839064|FG000|Overall Study|Lost to Follow-up|2|||
130511540|NCT01695993|469839065|FG001|Overall Study|Lost to Follow-up|1|||
130511541|NCT01695993|469839066|FG002|Overall Study|Lost to Follow-up|3|||
130511542|NCT01695993|469839064|FG000|Overall Study|Withdrawal by Subject|2|||
130511543|NCT01695993|469839065|FG001|Overall Study|Withdrawal by Subject|2|||
130511544|NCT01695993|469839066|FG002|Overall Study|Withdrawal by Subject|2|||
130511545|NCT01695993|469839064|FG000|Overall Study|To ill to continue|1|||
130511546|NCT01695993|469839065|FG001|Overall Study|To ill to continue|2|||
130511547|NCT01695993|469839066|FG002|Overall Study|To ill to continue|0|||
130511548|NCT01695993|469839064|FG000|Overall Study|Changed Medical Facility|0|||
130569043|NCT02104583|470050131|FG004|Overall Study|Subject required prohibited medication|1|||
130511549|NCT01695993|469839065|FG001|Overall Study|Changed Medical Facility|0|||
130569044|NCT02104583|470050127|FG000|Overall Study|Withdrew Consent|3|||
130511550|NCT01695993|469839066|FG002|Overall Study|Changed Medical Facility|1|||
130511551|NCT02029521|469839067|FG000|Overall Study|Protocol Violation|1|||
130511552|NCT02029521|469839068|FG001|Overall Study|Protocol Violation|0|||
130511553|NCT02029521|469839067|FG000|Overall Study|Withdrawal by Subject|1|||
130511554|NCT02029521|469839068|FG001|Overall Study|Withdrawal by Subject|1|||
130511555|NCT01072396|469839070|FG000|Period One|Adverse Event|1|||
130569045|NCT02104583|470050128|FG001|Overall Study|Withdrew Consent|2|||
130569046|NCT02104583|470050129|FG002|Overall Study|Withdrew Consent|0|||
130569047|NCT02104583|470050130|FG003|Overall Study|Withdrew Consent|2|||
130569048|NCT02104583|470050131|FG004|Overall Study|Withdrew Consent|1|||
130569049|NCT02104583|470050127|FG000|Overall Study|Investigator's Discretion|1|||
130569050|NCT02104583|470050128|FG001|Overall Study|Investigator's Discretion|0|||
130569051|NCT02104583|470050129|FG002|Overall Study|Investigator's Discretion|0|||
130569052|NCT02104583|470050130|FG003|Overall Study|Investigator's Discretion|0|||
130569053|NCT02104583|470050131|FG004|Overall Study|Investigator's Discretion|0|||
130569054|NCT02104583|470050127|FG000|Overall Study|Protocol Violation|0|||
130569055|NCT02104583|470050128|FG001|Overall Study|Protocol Violation|0|||
130569056|NCT02104583|470050129|FG002|Overall Study|Protocol Violation|1|||
130569057|NCT02104583|470050130|FG003|Overall Study|Protocol Violation|0|||
130569058|NCT02104583|470050131|FG004|Overall Study|Protocol Violation|0|||
130569059|NCT02104583|470050127|FG000|Overall Study|Adverse Event|3|||
130569060|NCT02104583|470050128|FG001|Overall Study|Adverse Event|3|||
130569061|NCT02104583|470050129|FG002|Overall Study|Adverse Event|6|||
130569062|NCT02104583|470050130|FG003|Overall Study|Adverse Event|6|||
130569063|NCT02104583|470050131|FG004|Overall Study|Adverse Event|1|||
130569064|NCT02104583|470050127|FG000|Overall Study|Lost to Follow-up|1|||
130569065|NCT02104583|470050128|FG001|Overall Study|Lost to Follow-up|0|||
130569066|NCT02104583|470050129|FG002|Overall Study|Lost to Follow-up|0|||
130569067|NCT02104583|470050130|FG003|Overall Study|Lost to Follow-up|0|||
130569068|NCT02104583|470050131|FG004|Overall Study|Lost to Follow-up|0|||
130569069|NCT02104583|470050127|FG000|Overall Study|Randomized but Never Treated|0|||
130569070|NCT02104583|470050128|FG001|Overall Study|Randomized but Never Treated|0|||
130569071|NCT02104583|470050129|FG002|Overall Study|Randomized but Never Treated|0|||
130569072|NCT02104583|470050130|FG003|Overall Study|Randomized but Never Treated|1|||
130569073|NCT02104583|470050131|FG004|Overall Study|Randomized but Never Treated|0|||
130569074|NCT01351389|470050132|FG000|Overall Study|Withdrawal by Subject|7|||
130569075|NCT01351389|470050133|FG001|Overall Study|Withdrawal by Subject|0|||
130569076|NCT01351389|470050132|FG000|Overall Study|did not complete intervention|23|||
130569077|NCT01351389|470050133|FG001|Overall Study|did not complete intervention|15|||
130569078|NCT02646982|470050134|FG000|Overall Study|Adverse Event|1|||
130569079|NCT02646982|470050135|FG001|Overall Study|Adverse Event|1|||
130569080|NCT02646982|470050134|FG000|Overall Study|Withdrawal by Subject|2|||
130569081|NCT02646982|470050135|FG001|Overall Study|Withdrawal by Subject|1|||
130569082|NCT00713700|470050136|FG000|Overall Study|Lost to Follow-up|3|||
130569083|NCT00713700|470050136|FG000|Overall Study|Withdrawal by Subject|1|||
130569084|NCT03923426|470050138|FG000|Overall Study|Other|19|||
130569085|NCT03923426|470050138|FG000|Overall Study|Lost to Follow-up|16|||
130569086|NCT03923426|470050138|FG000|Overall Study|Death|107|||
130569087|NCT03923426|470050138|FG000|Overall Study|Incomplete response to question|13|||
130569088|NCT00769002|470050139|FG000|Overall Study|Study was not completed, no data|9|||
130569089|NCT00769002|470050140|FG001|Overall Study|Study was not completed, no data|9|||
130569090|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
130569091|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
130569092|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
130569093|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
130569094|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
130569095|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
130569096|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
130569097|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
130569098|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
130569099|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
130569100|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
130569101|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
130569102|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
130569103|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
130511556|NCT01072396|469839071|FG001|Period One|Adverse Event|1|||
130511557|NCT01072396|469839070|FG000|Period One|Protocol Violation|2|||
130511558|NCT01072396|469839071|FG001|Period One|Protocol Violation|1|||
130511559|NCT01072396|469839070|FG000|Period One|Withdrawal by Subject|2|||
130511560|NCT01072396|469839071|FG001|Period One|Withdrawal by Subject|0|||
130511561|NCT01072396|469839070|FG000|Washout Period|Missing termination information|0|||
130511562|NCT01072396|469839071|FG001|Washout Period|Missing termination information|1|||
130511563|NCT01072396|469839070|FG000|Period Two|Adverse Event|0|||
130569104|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
130569105|NCT00960661|470050144|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
130511564|NCT01072396|469839071|FG001|Period Two|Adverse Event|3|||
130569106|NCT00960661|470050145|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
130569107|NCT00960661|470050146|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
130569108|NCT00960661|470050144|FG000|Interventional Phase|Adverse Event|0|||
130511565|NCT01072396|469839070|FG000|Period Two|Lost to Follow-up|1|||
130511566|NCT01072396|469839071|FG001|Period Two|Lost to Follow-up|0|||
130511567|NCT02504502|469839074|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
130511568|NCT02504502|469839075|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
130511569|NCT02504502|469839074|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
130511570|NCT02504502|469839075|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
130511571|NCT00105521|469839076|FG000|Overall Study|Other|1|||
130511572|NCT00105521|469839077|FG001|Overall Study|Other|1|||
130511573|NCT00105521|469839078|FG002|Overall Study|Other|2|||
130511574|NCT00105521|469839079|FG003|Overall Study|Other|0|||
130511575|NCT00105521|469839076|FG000|Overall Study|Adverse Event|10|||
130511576|NCT00105521|469839077|FG001|Overall Study|Adverse Event|4|||
130511577|NCT00105521|469839078|FG002|Overall Study|Adverse Event|10|||
130511578|NCT00105521|469839079|FG003|Overall Study|Adverse Event|8|||
130511579|NCT00105521|469839076|FG000|Overall Study|Withdrawal by Subject|1|||
130511580|NCT00105521|469839077|FG001|Overall Study|Withdrawal by Subject|0|||
130511581|NCT00105521|469839078|FG002|Overall Study|Withdrawal by Subject|1|||
130511582|NCT00105521|469839079|FG003|Overall Study|Withdrawal by Subject|4|||
130511583|NCT00105521|469839076|FG000|Overall Study|Lack of Efficacy|0|||
130511584|NCT00105521|469839077|FG001|Overall Study|Lack of Efficacy|0|||
130511585|NCT00105521|469839078|FG002|Overall Study|Lack of Efficacy|0|||
130511586|NCT00105521|469839079|FG003|Overall Study|Lack of Efficacy|1|||
130511587|NCT00105521|469839076|FG000|Overall Study|Protocol Violation|3|||
130511588|NCT00105521|469839077|FG001|Overall Study|Protocol Violation|5|||
130511589|NCT00105521|469839078|FG002|Overall Study|Protocol Violation|4|||
130511590|NCT00105521|469839079|FG003|Overall Study|Protocol Violation|4|||
130511591|NCT00105521|469839076|FG000|Overall Study|Lost to Follow-up|0|||
130511592|NCT00105521|469839077|FG001|Overall Study|Lost to Follow-up|1|||
130511593|NCT00105521|469839078|FG002|Overall Study|Lost to Follow-up|0|||
130511594|NCT00105521|469839079|FG003|Overall Study|Lost to Follow-up|0|||
130511595|NCT02744898|469839081|FG000|Overall Study|Progressive Disease|2|||
130511596|NCT02744898|469839081|FG000|Overall Study|Physician Decision|1|||
130511597|NCT02744898|469839081|FG000|Overall Study|Toxicity|1|||
130511598|NCT03508830|469839088|FG000|Overall Study|Withdrawal by Subject|3|||
130511599|NCT03508830|469839089|FG001|Overall Study|Withdrawal by Subject|4|||
130511600|NCT03508830|469839088|FG000|Overall Study|Physician Decision|2|||
130511601|NCT03508830|469839089|FG001|Overall Study|Physician Decision|2|||
130511602|NCT04908800|469839094|FG000|Overall Study|Adverse Event|0|||
130511603|NCT04908800|469839095|FG001|Overall Study|Adverse Event|0|||
130511604|NCT04908800|469839096|FG002|Overall Study|Adverse Event|0|||
130511605|NCT04908800|469839097|FG003|Overall Study|Adverse Event|0|||
130511606|NCT04908800|469839098|FG004|Overall Study|Adverse Event|0|||
130511607|NCT04908800|469839099|FG005|Overall Study|Adverse Event|0|||
130511608|NCT04908800|469839100|FG006|Overall Study|Adverse Event|0|||
130511609|NCT04908800|469839101|FG007|Overall Study|Adverse Event|0|||
130511610|NCT04908800|469839102|FG008|Overall Study|Adverse Event|0|||
130511611|NCT04908800|469839103|FG009|Overall Study|Adverse Event|0|||
130511612|NCT04908800|469839104|FG010|Overall Study|Adverse Event|1|||
130511613|NCT04908800|469839105|FG011|Overall Study|Adverse Event|0|||
130511614|NCT04908800|469839106|FG012|Overall Study|Adverse Event|0|||
130511615|NCT04598776|469839115|FG000|Overall Study|Protocol Violation|5|||
130511616|NCT04598776|469839115|FG000|Overall Study|Physician Decision|4|||
130511617|NCT00728884|469839116|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
130511618|NCT00728884|469839116|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
130511619|NCT00348283|469839117|FG000|Induction|Adverse Event|0|||
130511620|NCT00348283|469839118|FG001|Induction|Adverse Event|2|||
130511621|NCT00348283|469839117|FG000|Induction|Protocol Violation|0|||
130511622|NCT00348283|469839118|FG001|Induction|Protocol Violation|4|||
130511623|NCT00348283|469839117|FG000|Double Blind|Adverse Event|2|||
130511624|NCT00348283|469839118|FG001|Double Blind|Adverse Event|5|||
130511625|NCT00348283|469839117|FG000|Double Blind|Withdrawal by Subject|1|||
130511626|NCT00348283|469839118|FG001|Double Blind|Withdrawal by Subject|1|||
130511627|NCT00348283|469839117|FG000|Double Blind|Protocol Violation|0|||
130511628|NCT00348283|469839118|FG001|Double Blind|Protocol Violation|1|||
130511629|NCT00348283|469839117|FG000|Double Blind|Lack of Efficacy|2|||
130511630|NCT00348283|469839118|FG001|Double Blind|Lack of Efficacy|2|||
130511631|NCT00348283|469839117|FG000|Double Blind|Pregnancy|0|||
130511632|NCT00348283|469839118|FG001|Double Blind|Pregnancy|1|||
130511633|NCT00348283|469839117|FG000|Open Label|Adverse Event|0|||
130511634|NCT00348283|469839118|FG001|Open Label|Adverse Event|8|||
130511635|NCT00348283|469839117|FG000|Open Label|Withdrawal by Subject|0|||
130511636|NCT00348283|469839118|FG001|Open Label|Withdrawal by Subject|4|||
130511637|NCT00348283|469839117|FG000|Open Label|Lost to Follow-up|0|||
130511638|NCT00348283|469839118|FG001|Open Label|Lost to Follow-up|1|||
130511639|NCT00348283|469839117|FG000|Open Label|Lack of Efficacy|0|||
130511640|NCT00348283|469839118|FG001|Open Label|Lack of Efficacy|13|||
130511641|NCT00348283|469839117|FG000|Open Label|Administrative reasons|0|||
130511642|NCT00348283|469839118|FG001|Open Label|Administrative reasons|5|||
130511643|NCT00348283|469839117|FG000|Open Label|Subject moved to the United States|0|||
130511644|NCT00348283|469839118|FG001|Open Label|Subject moved to the United States|1|||
130511645|NCT00348283|469839117|FG000|Open Label|Pregnancy|0|||
130569109|NCT00960661|470050145|FG001|Interventional Phase|Adverse Event|17|||
130511646|NCT00348283|469839118|FG001|Open Label|Pregnancy|1|||
130511647|NCT00348283|469839117|FG000|Open Label|Sponsor decision|0|||
130511648|NCT00348283|469839118|FG001|Open Label|Sponsor decision|1|||
130511649|NCT06312566|469839123|FG000|Overall Study|Protocol Violation|0|||
130511650|NCT06312566|469839124|FG001|Overall Study|Protocol Violation|1|||
130511651|NCT04736472|469839125|FG000|Overall Study|Lost to Follow-up|1|||
130511652|NCT04736472|469839126|FG001|Overall Study|Lost to Follow-up|0|||
130511653|NCT04736472|469839127|FG002|Overall Study|Lost to Follow-up|0|||
130511654|NCT04736472|469839125|FG000|Overall Study|Withdrawal by Subject|2|||
130511655|NCT04736472|469839126|FG001|Overall Study|Withdrawal by Subject|0|||
130511656|NCT04736472|469839127|FG002|Overall Study|Withdrawal by Subject|0|||
130511657|NCT04736472|469839125|FG000|Overall Study|Protocol Violation|48|||
130511658|NCT04736472|469839126|FG001|Overall Study|Protocol Violation|0|||
130511659|NCT04736472|469839127|FG002|Overall Study|Protocol Violation|6|||
130511660|NCT03861078|469839128|FG000|Overall Study|COVID-19 shut down|4|||
130511661|NCT03861078|469839128|FG000|Overall Study|Lost to Follow-up|1|||
130511662|NCT03861078|469839128|FG000|Overall Study|Protocol Violation|2|||
130511663|NCT03861078|469839128|FG000|Overall Study|lack of venous access|1|||
130511664|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
130511665|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
130511666|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
130511667|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
130511668|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
130511669|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
130511670|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
130511671|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
130511672|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
130511673|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
130511674|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
130511675|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
130569110|NCT00960661|470050146|FG002|Interventional Phase|Adverse Event|8|||
130569111|NCT00960661|470050144|FG000|Interventional Phase|Death|0|||
130511676|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
130511677|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
130511678|NCT02971683|469839129|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
130511679|NCT02971683|469839130|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
130511680|NCT02971683|469839129|FG000|Open-Label|Lost to Follow-up|1|||
130511681|NCT02971683|469839130|FG001|Open-Label|Lost to Follow-up|0|||
130511682|NCT02971683|469839129|FG000|Open-Label|Participants withdrew consent|0|||
130511683|NCT02971683|469839130|FG001|Open-Label|Participants withdrew consent|2|||
130511684|NCT02971683|469839129|FG000|Open-Label|Participant request to discontinue study treatment|1|||
130511685|NCT02971683|469839130|FG001|Open-Label|Participant request to discontinue study treatment|0|||
130511686|NCT02971683|469839129|FG000|Open-Label|Lack of Efficacy|2|||
130511687|NCT02971683|469839130|FG001|Open-Label|Lack of Efficacy|0|||
130511688|NCT02971683|469839129|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
130511689|NCT02971683|469839130|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
130511690|NCT02971683|469839129|FG000|Long-Term Open Label|Participant withdrew consent|1|||
130511691|NCT02971683|469839130|FG001|Long-Term Open Label|Participant withdrew consent|0|||
130511692|NCT02971683|469839129|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
130511693|NCT02971683|469839130|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
130511694|NCT02971683|469839129|FG000|Long-Term Open Label|Adverse Event|1|||
130511695|NCT02971683|469839130|FG001|Long-Term Open Label|Adverse Event|2|||
130511696|NCT02971683|469839129|FG000|Long-Term Open Label|Lack of Efficacy|1|||
130511697|NCT02971683|469839130|FG001|Long-Term Open Label|Lack of Efficacy|1|||
130511698|NCT02268526|469839133|FG000|Overall Study|Adverse Event|0|||
130511699|NCT02268526|469839134|FG001|Overall Study|Adverse Event|2|||
130511700|NCT02268526|469839135|FG002|Overall Study|Adverse Event|1|||
130511701|NCT02268526|469839133|FG000|Overall Study|Death|1|||
130511702|NCT02268526|469839134|FG001|Overall Study|Death|11|||
130511703|NCT02268526|469839135|FG002|Overall Study|Death|0|||
130511704|NCT02268526|469839133|FG000|Overall Study|protocol deviation|0|||
130511705|NCT02268526|469839134|FG001|Overall Study|protocol deviation|1|||
130511706|NCT02268526|469839135|FG002|Overall Study|protocol deviation|0|||
130511707|NCT02268526|469839133|FG000|Overall Study|Physician Decision|0|||
130511708|NCT02268526|469839134|FG001|Overall Study|Physician Decision|0|||
130511709|NCT02268526|469839135|FG002|Overall Study|Physician Decision|1|||
130511710|NCT02268526|469839133|FG000|Overall Study|Subject/guardian decision|0|||
130511711|NCT02268526|469839134|FG001|Overall Study|Subject/guardian decision|7|||
130511712|NCT02268526|469839135|FG002|Overall Study|Subject/guardian decision|3|||
130511713|NCT00596960|469839136|FG000|Overall Study|Death|1|||
130511714|NCT00596960|469839137|FG001|Overall Study|Death|2|||
130511715|NCT00596960|469839136|FG000|Overall Study|Lost to Follow-up|6|||
130511716|NCT00596960|469839137|FG001|Overall Study|Lost to Follow-up|5|||
130511717|NCT00596960|469839136|FG000|Overall Study|Withdrawal by Subject|1|||
130511718|NCT00596960|469839137|FG001|Overall Study|Withdrawal by Subject|0|||
130511719|NCT00596960|469839136|FG000|Overall Study|Incarcerated|2|||
130511720|NCT00596960|469839137|FG001|Overall Study|Incarcerated|0|||
130511721|NCT00596960|469839136|FG000|Overall Study|Physician Decision|1|||
130511722|NCT00596960|469839137|FG001|Overall Study|Physician Decision|0|||
130511723|NCT00596960|469839136|FG000|Overall Study|Protocol Violation|0|||
130511724|NCT00596960|469839137|FG001|Overall Study|Protocol Violation|1|||
130511725|NCT00596960|469839136|FG000|Overall Study|No alcohol use data|0|||
130511726|NCT00596960|469839137|FG001|Overall Study|No alcohol use data|1|||
130511727|NCT02374476|469839140|FG000|VT Induced Ablation|Screening Failures|36|||
130511728|NCT02374476|469839141|FG001|VT Induced Ablation|Screening Failures|0|||
130511729|NCT02374476|469839142|FG002|VT Induced Ablation|Screening Failures|0|||
130511730|NCT02374476|469839140|FG000|Arm Assignment|Withdrawal by Subject|0|||
130511731|NCT02374476|469839141|FG001|Arm Assignment|Withdrawal by Subject|0|||
130511732|NCT02374476|469839142|FG002|Arm Assignment|Withdrawal by Subject|1|||
130511733|NCT03305458|469839143|FG000|Overall Study|Withdrawal by Subject|50|||
130511734|NCT03305458|469839144|FG001|Overall Study|Withdrawal by Subject|46|||
130511735|NCT03305458|469839145|FG002|Overall Study|Withdrawal by Subject|93|||
130511736|NCT03305458|469839143|FG000|Overall Study|Lost to Follow-up|85|||
130511737|NCT03305458|469839144|FG001|Overall Study|Lost to Follow-up|85|||
130511738|NCT03305458|469839145|FG002|Overall Study|Lost to Follow-up|35|||
130511739|NCT05431543|469839148|FG000|Overall Study|Medical History|1|||
130511740|NCT05431543|469839149|FG001|Overall Study|Medical History|0|||
130511741|NCT05431543|469839150|FG002|Overall Study|Medical History|0|||
130511742|NCT00440037|469839151|FG000|Overall Study|Withdrawal by Subject|6|||
130511743|NCT00440037|469839151|FG000|Overall Study|Administrative decision|3|||
130511744|NCT00141271|469839155|FG000|Overall Study|Adverse Event|31|||
130511745|NCT00141271|469839156|FG001|Overall Study|Adverse Event|19|||
130511746|NCT00141271|469839157|FG002|Overall Study|Adverse Event|17|||
130511747|NCT00141271|469839155|FG000|Overall Study|Laboratory Abnormality|2|||
130511748|NCT00141271|469839156|FG001|Overall Study|Laboratory Abnormality|1|||
130511749|NCT00141271|469839157|FG002|Overall Study|Laboratory Abnormality|1|||
130511750|NCT00141271|469839155|FG000|Overall Study|Lack of Efficacy|7|||
130511751|NCT00141271|469839156|FG001|Overall Study|Lack of Efficacy|7|||
130511752|NCT00141271|469839157|FG002|Overall Study|Lack of Efficacy|3|||
130511753|NCT00141271|469839155|FG000|Overall Study|Lost to Follow-up|15|||
130511754|NCT00141271|469839156|FG001|Overall Study|Lost to Follow-up|15|||
130511755|NCT00141271|469839157|FG002|Overall Study|Lost to Follow-up|21|||
130511756|NCT00141271|469839155|FG000|Overall Study|Withdrawal by Subject|14|||
130511757|NCT00141271|469839156|FG001|Overall Study|Withdrawal by Subject|9|||
130511758|NCT00141271|469839157|FG002|Overall Study|Withdrawal by Subject|10|||
130511759|NCT00141271|469839155|FG000|Overall Study|Other|11|||
130511760|NCT00141271|469839156|FG001|Overall Study|Other|12|||
130511761|NCT00141271|469839157|FG002|Overall Study|Other|5|||
130511762|NCT02442622|469839163|FG000|Overall Study|Withdrawal by Subject|3|||
130511763|NCT02442622|469839164|FG001|Overall Study|Withdrawal by Subject|1|||
130511764|NCT02878590|469840694|FG000|Overall Study|Withdrawal by Subject|2|||
130511765|NCT03322514|469840695|FG000|Overall Study|Withdrawal by Subject|1|||
130511766|NCT03322514|469840696|FG001|Overall Study|Withdrawal by Subject|1|||
130511767|NCT01904019|469840697|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
130511768|NCT01904019|469840697|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
130511769|NCT01904019|469840697|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
130511770|NCT01904019|469840697|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
130511771|NCT01904019|469840697|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
130511772|NCT01904019|469840697|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
130511773|NCT02388932|469840699|FG000|Overall Study|Death|1|||
130511774|NCT03087851|469840703|FG000|Overall Study|Withdraw on medical grounds|0|||
130511775|NCT03087851|469840704|FG001|Overall Study|Withdraw on medical grounds|1|||
130511776|NCT03087851|469840705|FG002|Overall Study|Withdraw on medical grounds|2|||
130511777|NCT00678899|469840711|FG000|Overall Study|Adverse Event|1|||
130511778|NCT03451292|469840712|FG000|Overall Study|Death|44|||
130511779|NCT03451292|469840713|FG001|Overall Study|Death|59|||
130511780|NCT03451292|469840712|FG000|Overall Study|Withdrawal by Subject|18|||
130511781|NCT03451292|469840713|FG001|Overall Study|Withdrawal by Subject|13|||
130511782|NCT03451292|469840712|FG000|Overall Study|Transplantation|18|||
130511783|NCT03451292|469840713|FG001|Overall Study|Transplantation|12|||
130511784|NCT03451292|469840712|FG000|Overall Study|Lost to Follow-up|4|||
130511785|NCT03451292|469840713|FG001|Overall Study|Lost to Follow-up|12|||
130511786|NCT03451292|469840712|FG000|Overall Study|Physician Decision|4|||
130511787|NCT03451292|469840713|FG001|Overall Study|Physician Decision|3|||
130511788|NCT03451292|469840712|FG000|Overall Study|Adverse Event|3|||
130511789|NCT03451292|469840713|FG001|Overall Study|Adverse Event|3|||
130511790|NCT03451292|469840712|FG000|Overall Study|Non-compliance with Study Drug|2|||
130511791|NCT03451292|469840713|FG001|Overall Study|Non-compliance with Study Drug|0|||
130511792|NCT01090076|469840721|FG000|Overall Study|Death|1|||
130511793|NCT01090076|469840722|FG001|Overall Study|Death|1|||
130511794|NCT01090076|469840721|FG000|Overall Study|Withdrawal by Subject|0|||
130511795|NCT01090076|469840722|FG001|Overall Study|Withdrawal by Subject|1|||
130511796|NCT01636258|469840723|FG000|Overall Study|Lost to Follow-up|1|||
130511797|NCT01636258|469840724|FG001|Overall Study|Lost to Follow-up|0|||
130511798|NCT00116584|469840727|FG000|Overall Study|Withdrawal by Subject|1|||
130511799|NCT00116584|469840728|FG001|Overall Study|Withdrawal by Subject|0|||
130511800|NCT00116584|469840727|FG000|Overall Study|Protocol Violation|1|||
130511801|NCT00116584|469840728|FG001|Overall Study|Protocol Violation|1|||
130511802|NCT00907517|469840729|FG000|Overall Study|Progressive Disease|3|||
130511803|NCT00907517|469840730|FG001|Overall Study|Progressive Disease|3|||
130511804|NCT00907517|469840731|FG002|Overall Study|Progressive Disease|4|||
130511805|NCT00907517|469840732|FG003|Overall Study|Progressive Disease|4|||
130511806|NCT00907517|469840733|FG004|Overall Study|Progressive Disease|4|||
130511807|NCT00907517|469840729|FG000|Overall Study|Symptomatic Deterioration|0|||
130511808|NCT00907517|469840730|FG001|Overall Study|Symptomatic Deterioration|0|||
130511809|NCT00907517|469840731|FG002|Overall Study|Symptomatic Deterioration|0|||
130511810|NCT00907517|469840732|FG003|Overall Study|Symptomatic Deterioration|0|||
130511811|NCT00907517|469840733|FG004|Overall Study|Symptomatic Deterioration|1|||
130511812|NCT01498445|469840737|FG000|Overall Study|Lack of Efficacy|0|||
130511813|NCT01498445|469840738|FG001|Overall Study|Lack of Efficacy|0|||
130511814|NCT01498445|469840739|FG002|Overall Study|Lack of Efficacy|1|||
130511815|NCT01498445|469840740|FG003|Overall Study|Lack of Efficacy|2|||
130511816|NCT01498445|469840741|FG004|Overall Study|Lack of Efficacy|0|||
130569112|NCT00960661|470050145|FG001|Interventional Phase|Death|1|||
130511817|NCT01498445|469840742|FG005|Overall Study|Lack of Efficacy|0|||
130511818|NCT01498445|469840737|FG000|Overall Study|Screen Failure|0|||
130511819|NCT01498445|469840738|FG001|Overall Study|Screen Failure|0|||
130511820|NCT01498445|469840739|FG002|Overall Study|Screen Failure|0|||
130511821|NCT01498445|469840740|FG003|Overall Study|Screen Failure|0|||
130511822|NCT01498445|469840741|FG004|Overall Study|Screen Failure|1|||
130511823|NCT01498445|469840742|FG005|Overall Study|Screen Failure|1|||
130511824|NCT02592434|469840743|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
130511825|NCT02592434|469840744|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
130511826|NCT02592434|469840745|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
130511827|NCT02592434|469840743|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
130511828|NCT02592434|469840744|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
130511829|NCT02592434|469840745|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
130511830|NCT02592434|469840743|FG000|Open-Label Phase (18 Weeks)|Other|3|||
130511831|NCT02592434|469840744|FG001|Open-Label Phase (18 Weeks)|Other|0|||
130511832|NCT02592434|469840745|FG002|Open-Label Phase (18 Weeks)|Other|0|||
130511833|NCT02592434|469840743|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
130511834|NCT02592434|469840744|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
130511835|NCT02592434|469840745|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
130511836|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
130511837|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
130511838|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
130511839|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
130511840|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
130511841|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
130511842|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Other|0|||
130511843|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Other|1|||
130511844|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Other|0|||
130569113|NCT00960661|470050146|FG002|Interventional Phase|Death|0|||
130511845|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
130511846|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
130569114|NCT00960661|470050144|FG000|Interventional Phase|Lost to Follow-up|0|||
130569115|NCT00960661|470050145|FG001|Interventional Phase|Lost to Follow-up|0|||
130569116|NCT00960661|470050146|FG002|Interventional Phase|Lost to Follow-up|2|||
130569117|NCT00960661|470050144|FG000|Interventional Phase|entry criteria not met|0|||
130569118|NCT00960661|470050145|FG001|Interventional Phase|entry criteria not met|3|||
130569119|NCT00960661|470050146|FG002|Interventional Phase|entry criteria not met|0|||
130569120|NCT00960661|470050144|FG000|Interventional Phase|Protocol Violation|0|||
130569121|NCT00960661|470050145|FG001|Interventional Phase|Protocol Violation|7|||
130569122|NCT00960661|470050146|FG002|Interventional Phase|Protocol Violation|2|||
130569123|NCT00960661|470050144|FG000|Interventional Phase|Withdrawal by Subject|0|||
130569124|NCT00960661|470050145|FG001|Interventional Phase|Withdrawal by Subject|18|||
130569125|NCT00960661|470050146|FG002|Interventional Phase|Withdrawal by Subject|29|||
130569126|NCT00960661|470050144|FG000|Interventional Phase|Physician Decision|0|||
130569127|NCT00960661|470050145|FG001|Interventional Phase|Physician Decision|3|||
130569128|NCT00960661|470050146|FG002|Interventional Phase|Physician Decision|5|||
130569129|NCT00960661|470050144|FG000|Interventional Phase|sponsor decision|0|||
130569130|NCT00960661|470050145|FG001|Interventional Phase|sponsor decision|1|||
130569131|NCT00960661|470050146|FG002|Interventional Phase|sponsor decision|0|||
130569132|NCT00960661|470050144|FG000|Interventional Phase|Lack of Efficacy|0|||
130569133|NCT00960661|470050145|FG001|Interventional Phase|Lack of Efficacy|2|||
130569134|NCT00960661|470050146|FG002|Interventional Phase|Lack of Efficacy|0|||
130569135|NCT02699892|470050149|FG000|Overall Study|Other|36|||
130569136|NCT00847912|470050159|FG000|Overall Study|Protocol Violation|6|||
130569137|NCT00847912|470050160|FG001|Overall Study|Protocol Violation|7|||
130569138|NCT00847912|470050159|FG000|Overall Study|Withdrawal by Subject|3|||
130569139|NCT00847912|470050160|FG001|Overall Study|Withdrawal by Subject|6|||
130569140|NCT01732796|470050167|FG000|Overall Study|Adverse Event|16|||
130569141|NCT01732796|470050168|FG001|Overall Study|Adverse Event|16|||
130569142|NCT01732796|470050169|FG002|Overall Study|Adverse Event|4|||
130569143|NCT01732796|470050167|FG000|Overall Study|Lack of Efficacy|21|||
130569144|NCT01732796|470050168|FG001|Overall Study|Lack of Efficacy|18|||
130569145|NCT01732796|470050169|FG002|Overall Study|Lack of Efficacy|5|||
130569146|NCT01732796|470050167|FG000|Overall Study|Lost to Follow-up|2|||
130569147|NCT01732796|470050168|FG001|Overall Study|Lost to Follow-up|0|||
130569148|NCT01732796|470050169|FG002|Overall Study|Lost to Follow-up|0|||
130569149|NCT01732796|470050167|FG000|Overall Study|Withdrawal by Subject|6|||
130569150|NCT01732796|470050168|FG001|Overall Study|Withdrawal by Subject|8|||
130569151|NCT01732796|470050169|FG002|Overall Study|Withdrawal by Subject|2|||
130569152|NCT01732796|470050167|FG000|Overall Study|Other reason not defined above|1|||
130569153|NCT01732796|470050168|FG001|Overall Study|Other reason not defined above|0|||
130569154|NCT01732796|470050169|FG002|Overall Study|Other reason not defined above|2|||
130569155|NCT00930761|470050172|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
130569156|NCT00930761|470050173|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
130569157|NCT00930761|470050172|FG000|Overall Study|less than 3 music therapy sessions|0|||
130569158|NCT00930761|470050173|FG001|Overall Study|less than 3 music therapy sessions|3|||
130569159|NCT01500278|470050180|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
130569160|NCT01500278|470050181|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
130569161|NCT01500278|470050180|FG000|Week 0 - Week 12|Protocol Violation|10|||
130569162|NCT01500278|470050181|FG001|Week 0 - Week 12|Protocol Violation|16|||
130569163|NCT01500278|470050180|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
130569164|NCT01500278|470050181|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
130569165|NCT01500278|470050180|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
130569166|NCT01500278|470050181|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
130569167|NCT01500278|470050180|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
130569168|NCT01500278|470050181|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
130569169|NCT01500278|470050180|FG000|Week 0 - Week 12|Patient decision|1|||
130569170|NCT01500278|470050181|FG001|Week 0 - Week 12|Patient decision|0|||
130569171|NCT01500278|470050180|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
130569172|NCT01500278|470050181|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
130569173|NCT01500278|470050180|FG000|Week 0 - Week 12|Investigator decision|1|||
130569174|NCT01500278|470050181|FG001|Week 0 - Week 12|Investigator decision|0|||
130569175|NCT01500278|470050180|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
130569176|NCT01500278|470050181|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
130569177|NCT01500278|470050180|FG000|Week 0 - Week 12|Sponsor decision|1|||
130569178|NCT01500278|470050181|FG001|Week 0 - Week 12|Sponsor decision|0|||
130569179|NCT01500278|470050180|FG000|Week 0 - Week 12|Personal reason|0|||
130569180|NCT01500278|470050181|FG001|Week 0 - Week 12|Personal reason|1|||
130569181|NCT01500278|470050180|FG000|Week 0 - Week 12|Other serious disease|0|||
130569182|NCT01500278|470050181|FG001|Week 0 - Week 12|Other serious disease|1|||
130569183|NCT01500278|470050180|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
130569184|NCT01500278|470050181|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
130569185|NCT01500278|470050180|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
130569186|NCT01500278|470050181|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
130569187|NCT01500278|470050180|FG000|Week 13 - Week 104|Protocol Violation|6|||
130569188|NCT01500278|470050181|FG001|Week 13 - Week 104|Protocol Violation|6|||
130569189|NCT01500278|470050180|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
130569190|NCT01500278|470050181|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
130569191|NCT01500278|470050180|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
130569192|NCT01500278|470050181|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
130569193|NCT01500278|470050180|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
130569194|NCT01500278|470050181|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
130569195|NCT01500278|470050180|FG000|Week 13 - Week 104|Non/bad compliance|7|||
130569196|NCT01500278|470050181|FG001|Week 13 - Week 104|Non/bad compliance|5|||
130569197|NCT01500278|470050180|FG000|Week 13 - Week 104|Recurrent infections|1|||
130569198|NCT01500278|470050181|FG001|Week 13 - Week 104|Recurrent infections|0|||
130569199|NCT01500278|470050180|FG000|Week 13 - Week 104|False positive test|1|||
130569200|NCT01500278|470050181|FG001|Week 13 - Week 104|False positive test|2|||
130569201|NCT01500278|470050180|FG000|Week 13 - Week 104|Sponsor request|4|||
130569202|NCT01500278|470050181|FG001|Week 13 - Week 104|Sponsor request|0|||
130569203|NCT01500278|470050180|FG000|Week 13 - Week 104|Withdrawn in error|1|||
130569204|NCT01500278|470050181|FG001|Week 13 - Week 104|Withdrawn in error|0|||
130569205|NCT01500278|470050180|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
130569206|NCT01500278|470050181|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
130569207|NCT01500278|470050180|FG000|Week 13 - Week 104|Protocol deviation|1|||
130569208|NCT01500278|470050181|FG001|Week 13 - Week 104|Protocol deviation|0|||
130569209|NCT01500278|470050180|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
130569210|NCT01500278|470050181|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
130569211|NCT01500278|470050180|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
130569212|NCT01500278|470050181|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
130569213|NCT01500278|470050180|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
130569214|NCT01500278|470050181|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
130569215|NCT01500278|470050180|FG000|Week 13 - Week 104|Relocation|0|||
130569216|NCT01500278|470050181|FG001|Week 13 - Week 104|Relocation|1|||
130569217|NCT01500278|470050180|FG000|Week 13 - Week 104|Sponsor decision|0|||
130511847|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
130511848|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
130511849|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
130511850|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
130511851|NCT02592434|469840743|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
130511852|NCT02592434|469840744|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
130511853|NCT02592434|469840745|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
130511854|NCT00561678|469840746|FG000|Overall Study|Withdrawal by Subject|4|||
130511855|NCT00561678|469840747|FG001|Overall Study|Withdrawal by Subject|3|||
130511856|NCT00561678|469840746|FG000|Overall Study|surgery cancelled|1|||
130511857|NCT00561678|469840747|FG001|Overall Study|surgery cancelled|1|||
130511858|NCT00561678|469840746|FG000|Overall Study|surgery rescheduled to different site|2|||
130511859|NCT00561678|469840747|FG001|Overall Study|surgery rescheduled to different site|2|||
130511860|NCT00561678|469840746|FG000|Overall Study|anesthesia provider refusal|1|||
130511861|NCT00561678|469840747|FG001|Overall Study|anesthesia provider refusal|0|||
130511862|NCT04748445|469840748|FG000|Overall Study|No longer met eligibility criteria|12|||
130511863|NCT04748445|469840748|FG000|Overall Study|Other|36|||
130511864|NCT04748445|469840748|FG000|Overall Study|Withdrawal by Subject|553|||
130511865|NCT04748445|469840748|FG000|Overall Study|Lost to Follow-up|30|||
130511866|NCT01106586|469840749|FG000|Overall Study|Adverse Event|9|||
130511867|NCT01106586|469840750|FG001|Overall Study|Adverse Event|15|||
130511868|NCT01106586|469840749|FG000|Overall Study|Death|1|||
130511869|NCT01106586|469840750|FG001|Overall Study|Death|3|||
130511870|NCT01106586|469840749|FG000|Overall Study|Pregnancy|2|||
130511871|NCT01106586|469840750|FG001|Overall Study|Pregnancy|2|||
130569218|NCT01500278|470050181|FG001|Week 13 - Week 104|Sponsor decision|2|||
130569219|NCT01500278|470050180|FG000|Week 13 - Week 104|Medical monitor decision|0|||
130569220|NCT01500278|470050181|FG001|Week 13 - Week 104|Medical monitor decision|2|||
130569221|NCT01500278|470050180|FG000|Week 13 - Week 104|Personal reason|0|||
130511872|NCT01106586|469840749|FG000|Overall Study|Lack of Efficacy|1|||
130511873|NCT01106586|469840750|FG001|Overall Study|Lack of Efficacy|0|||
130511874|NCT01106586|469840749|FG000|Overall Study|Investigator's Discretion|5|||
130511875|NCT01106586|469840750|FG001|Overall Study|Investigator's Discretion|8|||
130511876|NCT01106586|469840749|FG000|Overall Study|Withdrew Consent|18|||
130511877|NCT01106586|469840750|FG001|Overall Study|Withdrew Consent|30|||
130511878|NCT01106586|469840749|FG000|Overall Study|Lost to Follow-up|24|||
130511879|NCT01106586|469840750|FG001|Overall Study|Lost to Follow-up|20|||
130511880|NCT01106586|469840749|FG000|Overall Study|Participant Noncompliance|12|||
130511881|NCT01106586|469840750|FG001|Overall Study|Participant Noncompliance|10|||
130511882|NCT01106586|469840749|FG000|Overall Study|Protocol Violation|1|||
130511883|NCT01106586|469840750|FG001|Overall Study|Protocol Violation|0|||
130511884|NCT01106586|469840749|FG000|Overall Study|Participant Transferred to Another Study|212|||
130511885|NCT01106586|469840750|FG001|Overall Study|Participant Transferred to Another Study|197|||
130511886|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Adverse Event|3|||
130511887|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Adverse Event|0|||
130511888|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
130511889|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
130511890|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Disease Progression|23|||
130511891|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Disease Progression|22|||
130511892|NCT01379521|469840751|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
130511893|NCT01379521|469840752|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
130511894|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
130511895|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
130511896|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
130511897|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
130511898|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
130511899|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
130511900|NCT01379521|469840751|FG000|Overall Study -Treatment Period|Death|2|||
130511901|NCT01379521|469840752|FG001|Overall Study -Treatment Period|Death|1|||
130511902|NCT01379521|469840751|FG000|Post-Treatment Evaluations|Disease Progression|22|||
130511903|NCT01379521|469840752|FG001|Post-Treatment Evaluations|Disease Progression|20|||
130511904|NCT01379521|469840751|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
130511905|NCT01379521|469840752|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
130511906|NCT01379521|469840751|FG000|Post-Treatment Evaluations|Death|1|||
130511907|NCT01379521|469840752|FG001|Post-Treatment Evaluations|Death|0|||
130511908|NCT00938041|469840753|FG000|Overall Study|Lost to Follow-up|6|||
130511909|NCT00938041|469840753|FG000|Overall Study|Received Alternative Therapy|1|||
130511910|NCT00938041|469840753|FG000|Overall Study|Progressive Disease|5|||
130511911|NCT00938041|469840753|FG000|Overall Study|Death|12|||
130511912|NCT00938041|469840753|FG000|Overall Study|Adrenal Insufficiency|3|||
130511913|NCT01026103|469840754|FG000|Overall Study|Physician Decision|1|||
130511914|NCT01026103|469840754|FG000|Overall Study|did not receive study device bc of error|1|||
130511915|NCT00428441|469840755|FG000|Overall Study|Lost to Follow-up|1|||
130511916|NCT02475733|469840756|FG000|Overall Study|Withdrawal by Subject|1|||
130511917|NCT02475733|469840757|FG001|Overall Study|Withdrawal by Subject|0|||
130511918|NCT02475733|469840756|FG000|Overall Study|Physician Decision|1|||
130569222|NCT01500278|470050181|FG001|Week 13 - Week 104|Personal reason|1|||
130511919|NCT02475733|469840757|FG001|Overall Study|Physician Decision|0|||
130511920|NCT00404547|469840758|FG000|Overall Study|Adverse Event|39|||
130511921|NCT00404547|469840759|FG001|Overall Study|Adverse Event|6|||
130511922|NCT00404547|469840758|FG000|Overall Study|Withdrawal by Subject|19|||
130511923|NCT00404547|469840759|FG001|Overall Study|Withdrawal by Subject|2|||
130511924|NCT00404547|469840758|FG000|Overall Study|Protocol Violation|0|||
130511925|NCT00404547|469840759|FG001|Overall Study|Protocol Violation|1|||
130511926|NCT00404547|469840758|FG000|Overall Study|Lost to Follow-up|20|||
130511927|NCT00404547|469840759|FG001|Overall Study|Lost to Follow-up|9|||
130511928|NCT00404547|469840758|FG000|Overall Study|Lack of compliance|5|||
130511929|NCT00404547|469840759|FG001|Overall Study|Lack of compliance|1|||
130511930|NCT00404547|469840758|FG000|Overall Study|Other|4|||
130511931|NCT00404547|469840759|FG001|Overall Study|Other|0|||
130511932|NCT00404547|469840758|FG000|Overall Study|Reason not stated|3|||
130511933|NCT00404547|469840759|FG001|Overall Study|Reason not stated|6|||
130511934|NCT03906240|469840762|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
130511935|NCT03906240|469840763|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
130511936|NCT03906240|469840762|FG000|Overall Study|Lost to Follow-up|1|||
130511937|NCT03906240|469840763|FG001|Overall Study|Lost to Follow-up|0|||
130511938|NCT03906240|469840762|FG000|Overall Study|Withdrawal by Subject|0|||
130511939|NCT03906240|469840763|FG001|Overall Study|Withdrawal by Subject|1|||
130511940|NCT03751280|469840768|FG000|Overall Study|Adverse Event|0|||
130511941|NCT03751280|469840769|FG001|Overall Study|Adverse Event|1|||
130511942|NCT03751280|469840768|FG000|Overall Study|Lost to Follow-up|3|||
130569223|NCT01500278|470050180|FG000|Week 13 - Week 104|Not completed|0|||
130511943|NCT03751280|469840769|FG001|Overall Study|Lost to Follow-up|5|||
130511944|NCT03751280|469840768|FG000|Overall Study|Physician Decision|0|||
130511945|NCT03751280|469840769|FG001|Overall Study|Physician Decision|2|||
130511946|NCT03751280|469840768|FG000|Overall Study|Protocol Violation|0|||
130511947|NCT03751280|469840769|FG001|Overall Study|Protocol Violation|2|||
130511948|NCT03751280|469840768|FG000|Overall Study|Withdrawal by Subject|5|||
130511949|NCT03751280|469840769|FG001|Overall Study|Withdrawal by Subject|2|||
130511950|NCT00296504|469840771|FG000|Interim Analysis|Withdrawal by Subject|8|||
130511951|NCT00296504|469840772|FG001|Interim Analysis|Withdrawal by Subject|0|||
130511952|NCT00296504|469840773|FG002|Interim Analysis|Withdrawal by Subject|12|||
130511953|NCT00296504|469840774|FG003|Interim Analysis|Withdrawal by Subject|0|||
130511954|NCT00296504|469840775|FG004|Interim Analysis|Withdrawal by Subject|5|||
130511955|NCT00296504|469840776|FG005|Interim Analysis|Withdrawal by Subject|5|||
130511956|NCT00296504|469840777|FG006|Interim Analysis|Withdrawal by Subject|9|||
130511957|NCT00296504|469840778|FG007|Interim Analysis|Withdrawal by Subject|3|||
130511958|NCT00296504|469840779|FG008|Interim Analysis|Withdrawal by Subject|0|||
130511959|NCT00296504|469840771|FG000|Interim Analysis|Lost to Follow-up|13|||
130511960|NCT00296504|469840772|FG001|Interim Analysis|Lost to Follow-up|3|||
130511961|NCT00296504|469840773|FG002|Interim Analysis|Lost to Follow-up|26|||
130511962|NCT00296504|469840774|FG003|Interim Analysis|Lost to Follow-up|8|||
130511963|NCT00296504|469840775|FG004|Interim Analysis|Lost to Follow-up|14|||
130511964|NCT00296504|469840776|FG005|Interim Analysis|Lost to Follow-up|4|||
130511965|NCT00296504|469840777|FG006|Interim Analysis|Lost to Follow-up|11|||
130511966|NCT00296504|469840778|FG007|Interim Analysis|Lost to Follow-up|4|||
130511967|NCT00296504|469840779|FG008|Interim Analysis|Lost to Follow-up|0|||
130511968|NCT00296504|469840771|FG000|Interim Analysis|Clinical Progression|1|||
130511969|NCT00296504|469840772|FG001|Interim Analysis|Clinical Progression|0|||
130511970|NCT00296504|469840773|FG002|Interim Analysis|Clinical Progression|1|||
130511971|NCT00296504|469840774|FG003|Interim Analysis|Clinical Progression|1|||
130511972|NCT00296504|469840775|FG004|Interim Analysis|Clinical Progression|0|||
130511973|NCT00296504|469840776|FG005|Interim Analysis|Clinical Progression|2|||
130511974|NCT00296504|469840777|FG006|Interim Analysis|Clinical Progression|1|||
130511975|NCT00296504|469840778|FG007|Interim Analysis|Clinical Progression|2|||
130511976|NCT00296504|469840779|FG008|Interim Analysis|Clinical Progression|0|||
130511977|NCT00296504|469840771|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
130511978|NCT00296504|469840772|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
130511979|NCT00296504|469840773|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
130511980|NCT00296504|469840774|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
130511981|NCT00296504|469840775|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
130511982|NCT00296504|469840776|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
130511983|NCT00296504|469840777|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
130511984|NCT00296504|469840778|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
130511985|NCT00296504|469840779|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
130511986|NCT00296504|469840771|FG000|Interim Analysis|Adverse Event|0|||
130511987|NCT00296504|469840772|FG001|Interim Analysis|Adverse Event|0|||
130511988|NCT00296504|469840773|FG002|Interim Analysis|Adverse Event|13|||
130511989|NCT00296504|469840774|FG003|Interim Analysis|Adverse Event|4|||
130511990|NCT00296504|469840775|FG004|Interim Analysis|Adverse Event|6|||
130511991|NCT00296504|469840776|FG005|Interim Analysis|Adverse Event|3|||
130511992|NCT00296504|469840777|FG006|Interim Analysis|Adverse Event|4|||
130511993|NCT00296504|469840778|FG007|Interim Analysis|Adverse Event|5|||
130511994|NCT00296504|469840779|FG008|Interim Analysis|Adverse Event|0|||
130511995|NCT00296504|469840771|FG000|Interim Analysis|Protocol Violation|0|||
130511996|NCT00296504|469840772|FG001|Interim Analysis|Protocol Violation|0|||
130511997|NCT00296504|469840773|FG002|Interim Analysis|Protocol Violation|2|||
130511998|NCT00296504|469840774|FG003|Interim Analysis|Protocol Violation|0|||
130511999|NCT00296504|469840775|FG004|Interim Analysis|Protocol Violation|1|||
130512000|NCT00296504|469840776|FG005|Interim Analysis|Protocol Violation|0|||
130512001|NCT00296504|469840777|FG006|Interim Analysis|Protocol Violation|0|||
130512002|NCT00296504|469840778|FG007|Interim Analysis|Protocol Violation|1|||
130512003|NCT00296504|469840779|FG008|Interim Analysis|Protocol Violation|0|||
130512004|NCT00296504|469840771|FG000|Interim Analysis|Insufficient CD4 Response|0|||
130512005|NCT00296504|469840772|FG001|Interim Analysis|Insufficient CD4 Response|0|||
130512006|NCT00296504|469840773|FG002|Interim Analysis|Insufficient CD4 Response|0|||
130512007|NCT00296504|469840774|FG003|Interim Analysis|Insufficient CD4 Response|0|||
130512008|NCT00296504|469840775|FG004|Interim Analysis|Insufficient CD4 Response|1|||
130512009|NCT00296504|469840776|FG005|Interim Analysis|Insufficient CD4 Response|1|||
130512010|NCT00296504|469840777|FG006|Interim Analysis|Insufficient CD4 Response|0|||
130512011|NCT00296504|469840778|FG007|Interim Analysis|Insufficient CD4 Response|0|||
130512012|NCT00296504|469840779|FG008|Interim Analysis|Insufficient CD4 Response|0|||
130512013|NCT00296504|469840771|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
130512014|NCT00296504|469840772|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
130512015|NCT00296504|469840773|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
130512016|NCT00296504|469840774|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
130512017|NCT00296504|469840775|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
130512018|NCT00296504|469840776|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
130512019|NCT00296504|469840777|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
130512020|NCT00296504|469840778|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
130512021|NCT00296504|469840779|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
130512022|NCT00296504|469840771|FG000|Interim Analysis|Pregnancy|4|||
130512023|NCT00296504|469840772|FG001|Interim Analysis|Pregnancy|1|||
130512024|NCT00296504|469840773|FG002|Interim Analysis|Pregnancy|4|||
130512025|NCT00296504|469840774|FG003|Interim Analysis|Pregnancy|2|||
130512026|NCT00296504|469840775|FG004|Interim Analysis|Pregnancy|0|||
130569224|NCT01500278|470050181|FG001|Week 13 - Week 104|Not completed|1|||
130569225|NCT01500278|470050180|FG000|Week 13 - Week 104|Death|2|||
130569226|NCT01500278|470050181|FG001|Week 13 - Week 104|Death|4|||
130569227|NCT01500278|470050180|FG000|Week 13 - Week 104|Adverse Event|54|||
130569228|NCT01500278|470050181|FG001|Week 13 - Week 104|Adverse Event|54|||
130569229|NCT00283595|470050182|FG000|Overall Study|Withdrawal by Subject|1|||
130512027|NCT00296504|469840776|FG005|Interim Analysis|Pregnancy|1|||
130512028|NCT00296504|469840777|FG006|Interim Analysis|Pregnancy|1|||
130512029|NCT00296504|469840778|FG007|Interim Analysis|Pregnancy|1|||
130512030|NCT00296504|469840779|FG008|Interim Analysis|Pregnancy|0|||
130569230|NCT00283595|470050183|FG001|Overall Study|Withdrawal by Subject|2|||
130512031|NCT00296504|469840771|FG000|Interim Analysis|Death|1|||
130512032|NCT00296504|469840772|FG001|Interim Analysis|Death|0|||
130512033|NCT00296504|469840773|FG002|Interim Analysis|Death|3|||
130512034|NCT00296504|469840774|FG003|Interim Analysis|Death|0|||
130512035|NCT00296504|469840775|FG004|Interim Analysis|Death|0|||
130512036|NCT00296504|469840776|FG005|Interim Analysis|Death|0|||
130512037|NCT00296504|469840777|FG006|Interim Analysis|Death|0|||
130512038|NCT00296504|469840778|FG007|Interim Analysis|Death|0|||
130512039|NCT00296504|469840779|FG008|Interim Analysis|Death|0|||
130512040|NCT00296504|469840771|FG000|Interim Analysis|Participant Non-compliant|0|||
130512041|NCT00296504|469840772|FG001|Interim Analysis|Participant Non-compliant|1|||
130512042|NCT00296504|469840773|FG002|Interim Analysis|Participant Non-compliant|2|||
130512043|NCT00296504|469840774|FG003|Interim Analysis|Participant Non-compliant|1|||
130512044|NCT00296504|469840775|FG004|Interim Analysis|Participant Non-compliant|1|||
130512045|NCT00296504|469840776|FG005|Interim Analysis|Participant Non-compliant|3|||
130512046|NCT00296504|469840777|FG006|Interim Analysis|Participant Non-compliant|6|||
130512047|NCT00296504|469840778|FG007|Interim Analysis|Participant Non-compliant|2|||
130512048|NCT00296504|469840779|FG008|Interim Analysis|Participant Non-compliant|0|||
130512049|NCT00296504|469840771|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512050|NCT00296504|469840772|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512051|NCT00296504|469840773|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
130512052|NCT00296504|469840774|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512053|NCT00296504|469840775|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512054|NCT00296504|469840776|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
130512055|NCT00296504|469840777|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512056|NCT00296504|469840778|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512057|NCT00296504|469840779|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
130512058|NCT00296504|469840771|FG000|Interim Analysis|To Simplify Treatment|0|||
130512059|NCT00296504|469840772|FG001|Interim Analysis|To Simplify Treatment|0|||
130512060|NCT00296504|469840773|FG002|Interim Analysis|To Simplify Treatment|1|||
130512061|NCT00296504|469840774|FG003|Interim Analysis|To Simplify Treatment|0|||
130512062|NCT00296504|469840775|FG004|Interim Analysis|To Simplify Treatment|0|||
130512063|NCT00296504|469840776|FG005|Interim Analysis|To Simplify Treatment|0|||
130512064|NCT00296504|469840777|FG006|Interim Analysis|To Simplify Treatment|2|||
130512065|NCT00296504|469840778|FG007|Interim Analysis|To Simplify Treatment|0|||
130512066|NCT00296504|469840779|FG008|Interim Analysis|To Simplify Treatment|0|||
130512067|NCT00296504|469840771|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512068|NCT00296504|469840772|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512069|NCT00296504|469840773|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
130512070|NCT00296504|469840774|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512071|NCT00296504|469840775|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512072|NCT00296504|469840776|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512073|NCT00296504|469840777|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512074|NCT00296504|469840778|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512075|NCT00296504|469840779|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
130512076|NCT00296504|469840771|FG000|Interim Analysis|Participant Moved|1|||
130512077|NCT00296504|469840772|FG001|Interim Analysis|Participant Moved|0|||
130512078|NCT00296504|469840773|FG002|Interim Analysis|Participant Moved|1|||
130512079|NCT00296504|469840774|FG003|Interim Analysis|Participant Moved|0|||
130512080|NCT00296504|469840775|FG004|Interim Analysis|Participant Moved|0|||
130512081|NCT00296504|469840776|FG005|Interim Analysis|Participant Moved|1|||
130512082|NCT00296504|469840777|FG006|Interim Analysis|Participant Moved|1|||
130512083|NCT00296504|469840778|FG007|Interim Analysis|Participant Moved|0|||
130512084|NCT00296504|469840779|FG008|Interim Analysis|Participant Moved|0|||
130512085|NCT00296504|469840771|FG000|Interim Analysis|Participant Was Incarcerated|2|||
130512086|NCT00296504|469840772|FG001|Interim Analysis|Participant Was Incarcerated|0|||
130512087|NCT00296504|469840773|FG002|Interim Analysis|Participant Was Incarcerated|1|||
130512088|NCT00296504|469840774|FG003|Interim Analysis|Participant Was Incarcerated|0|||
130512089|NCT00296504|469840775|FG004|Interim Analysis|Participant Was Incarcerated|0|||
130512090|NCT00296504|469840776|FG005|Interim Analysis|Participant Was Incarcerated|0|||
130512091|NCT00296504|469840777|FG006|Interim Analysis|Participant Was Incarcerated|0|||
130512092|NCT00296504|469840778|FG007|Interim Analysis|Participant Was Incarcerated|0|||
130512093|NCT00296504|469840779|FG008|Interim Analysis|Participant Was Incarcerated|0|||
130512094|NCT00296504|469840771|FG000|Interim Analysis|Resistance to FPV|0|||
130512095|NCT00296504|469840772|FG001|Interim Analysis|Resistance to FPV|0|||
130512096|NCT00296504|469840773|FG002|Interim Analysis|Resistance to FPV|1|||
130512097|NCT00296504|469840774|FG003|Interim Analysis|Resistance to FPV|0|||
130512098|NCT00296504|469840775|FG004|Interim Analysis|Resistance to FPV|0|||
130512099|NCT00296504|469840776|FG005|Interim Analysis|Resistance to FPV|0|||
130512100|NCT00296504|469840777|FG006|Interim Analysis|Resistance to FPV|0|||
130512101|NCT00296504|469840778|FG007|Interim Analysis|Resistance to FPV|0|||
130512102|NCT00296504|469840779|FG008|Interim Analysis|Resistance to FPV|0|||
130512103|NCT00296504|469840771|FG000|Interim Analysis|Physician Decision|0|||
130512104|NCT00296504|469840772|FG001|Interim Analysis|Physician Decision|0|||
130512105|NCT00296504|469840773|FG002|Interim Analysis|Physician Decision|1|||
130512106|NCT00296504|469840774|FG003|Interim Analysis|Physician Decision|0|||
130512107|NCT00296504|469840775|FG004|Interim Analysis|Physician Decision|0|||
130569231|NCT01709435|470050187|FG000|Overall Study|Adverse Event|1|||
130569232|NCT01709435|470050188|FG001|Overall Study|Adverse Event|1|||
130512108|NCT00296504|469840776|FG005|Interim Analysis|Physician Decision|0|||
130512109|NCT00296504|469840777|FG006|Interim Analysis|Physician Decision|0|||
130512110|NCT00296504|469840778|FG007|Interim Analysis|Physician Decision|0|||
130512111|NCT00296504|469840779|FG008|Interim Analysis|Physician Decision|0|||
130512112|NCT00296504|469840771|FG000|Interim Analysis|Principle Investigator Discretion|2|||
130512113|NCT00296504|469840772|FG001|Interim Analysis|Principle Investigator Discretion|0|||
130512114|NCT00296504|469840773|FG002|Interim Analysis|Principle Investigator Discretion|1|||
130512115|NCT00296504|469840774|FG003|Interim Analysis|Principle Investigator Discretion|1|||
130512116|NCT00296504|469840775|FG004|Interim Analysis|Principle Investigator Discretion|0|||
130512117|NCT00296504|469840776|FG005|Interim Analysis|Principle Investigator Discretion|0|||
130512118|NCT00296504|469840777|FG006|Interim Analysis|Principle Investigator Discretion|0|||
130512119|NCT00296504|469840778|FG007|Interim Analysis|Principle Investigator Discretion|0|||
130512120|NCT00296504|469840779|FG008|Interim Analysis|Principle Investigator Discretion|0|||
130512121|NCT00296504|469840771|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
130512122|NCT00296504|469840772|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
130512123|NCT00296504|469840773|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
130512124|NCT00296504|469840774|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
130512125|NCT00296504|469840775|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
130512126|NCT00296504|469840776|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
130512127|NCT00296504|469840777|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
130512128|NCT00296504|469840778|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
130512129|NCT00296504|469840779|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
130512130|NCT00296504|469840771|FG000|Interim Analysis|Non-adherence|2|||
130512131|NCT00296504|469840772|FG001|Interim Analysis|Non-adherence|0|||
130512132|NCT00296504|469840773|FG002|Interim Analysis|Non-adherence|0|||
130512133|NCT00296504|469840774|FG003|Interim Analysis|Non-adherence|0|||
130512134|NCT00296504|469840775|FG004|Interim Analysis|Non-adherence|1|||
130512135|NCT00296504|469840776|FG005|Interim Analysis|Non-adherence|0|||
130512136|NCT00296504|469840777|FG006|Interim Analysis|Non-adherence|0|||
130512137|NCT00296504|469840778|FG007|Interim Analysis|Non-adherence|1|||
130512138|NCT00296504|469840779|FG008|Interim Analysis|Non-adherence|0|||
130512139|NCT00296504|469840771|FG000|Interim Analysis|Site Closing|1|||
130512140|NCT00296504|469840772|FG001|Interim Analysis|Site Closing|0|||
130512141|NCT00296504|469840773|FG002|Interim Analysis|Site Closing|0|||
130512142|NCT00296504|469840774|FG003|Interim Analysis|Site Closing|0|||
130512143|NCT00296504|469840775|FG004|Interim Analysis|Site Closing|0|||
130512144|NCT00296504|469840776|FG005|Interim Analysis|Site Closing|1|||
130512145|NCT00296504|469840777|FG006|Interim Analysis|Site Closing|2|||
130512146|NCT00296504|469840778|FG007|Interim Analysis|Site Closing|0|||
130512147|NCT00296504|469840779|FG008|Interim Analysis|Site Closing|0|||
130512148|NCT00296504|469840771|FG000|Interim Analysis|Lack of Personnel at Site|1|||
130512149|NCT00296504|469840772|FG001|Interim Analysis|Lack of Personnel at Site|0|||
130512150|NCT00296504|469840773|FG002|Interim Analysis|Lack of Personnel at Site|0|||
130512151|NCT00296504|469840774|FG003|Interim Analysis|Lack of Personnel at Site|0|||
130512152|NCT00296504|469840775|FG004|Interim Analysis|Lack of Personnel at Site|0|||
130512153|NCT00296504|469840776|FG005|Interim Analysis|Lack of Personnel at Site|0|||
130512154|NCT00296504|469840777|FG006|Interim Analysis|Lack of Personnel at Site|0|||
130512155|NCT00296504|469840778|FG007|Interim Analysis|Lack of Personnel at Site|0|||
130512156|NCT00296504|469840779|FG008|Interim Analysis|Lack of Personnel at Site|0|||
130512157|NCT00296504|469840771|FG000|Interim Analysis|Missed Schedule Date|1|||
130512158|NCT00296504|469840772|FG001|Interim Analysis|Missed Schedule Date|0|||
130512159|NCT00296504|469840773|FG002|Interim Analysis|Missed Schedule Date|0|||
130512160|NCT00296504|469840774|FG003|Interim Analysis|Missed Schedule Date|0|||
130512161|NCT00296504|469840775|FG004|Interim Analysis|Missed Schedule Date|0|||
130512162|NCT00296504|469840776|FG005|Interim Analysis|Missed Schedule Date|0|||
130512163|NCT00296504|469840777|FG006|Interim Analysis|Missed Schedule Date|0|||
130512164|NCT00296504|469840778|FG007|Interim Analysis|Missed Schedule Date|0|||
130569233|NCT01709435|470050189|FG002|Overall Study|Adverse Event|1|||
130569234|NCT01709435|470050190|FG003|Overall Study|Adverse Event|0|||
130512165|NCT00296504|469840779|FG008|Interim Analysis|Missed Schedule Date|0|||
130569235|NCT01709435|470050191|FG004|Overall Study|Adverse Event|0|||
130569236|NCT01709435|470050192|FG005|Overall Study|Adverse Event|1|||
130512166|NCT00296504|469840771|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
130512167|NCT00296504|469840772|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
130512168|NCT00296504|469840773|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
130512169|NCT00296504|469840774|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
130512170|NCT00296504|469840775|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
130512171|NCT00296504|469840776|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
130512172|NCT00296504|469840777|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
130512173|NCT00296504|469840778|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
130569237|NCT01709435|470050187|FG000|Overall Study|Lack of Efficacy|5|||
130512174|NCT00296504|469840779|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
130512175|NCT00296504|469840771|FG000|Interim Analysis|Participant Stopped|0|||
130512176|NCT00296504|469840772|FG001|Interim Analysis|Participant Stopped|0|||
130512177|NCT00296504|469840773|FG002|Interim Analysis|Participant Stopped|0|||
130512178|NCT00296504|469840774|FG003|Interim Analysis|Participant Stopped|0|||
130512179|NCT00296504|469840775|FG004|Interim Analysis|Participant Stopped|1|||
130512180|NCT00296504|469840776|FG005|Interim Analysis|Participant Stopped|0|||
130512181|NCT00296504|469840777|FG006|Interim Analysis|Participant Stopped|0|||
130512182|NCT00296504|469840778|FG007|Interim Analysis|Participant Stopped|0|||
130512183|NCT00296504|469840779|FG008|Interim Analysis|Participant Stopped|0|||
130512184|NCT00296504|469840771|FG000|Interim Analysis|Physician and Participant Decision|0|||
130512185|NCT00296504|469840772|FG001|Interim Analysis|Physician and Participant Decision|0|||
130512186|NCT00296504|469840773|FG002|Interim Analysis|Physician and Participant Decision|0|||
130512187|NCT00296504|469840774|FG003|Interim Analysis|Physician and Participant Decision|0|||
130512188|NCT00296504|469840775|FG004|Interim Analysis|Physician and Participant Decision|0|||
130512189|NCT00296504|469840776|FG005|Interim Analysis|Physician and Participant Decision|1|||
130512190|NCT00296504|469840777|FG006|Interim Analysis|Physician and Participant Decision|0|||
130512191|NCT00296504|469840778|FG007|Interim Analysis|Physician and Participant Decision|0|||
130512192|NCT00296504|469840779|FG008|Interim Analysis|Physician and Participant Decision|0|||
130512193|NCT00296504|469840771|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
130512194|NCT00296504|469840772|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
130512195|NCT00296504|469840773|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
130512196|NCT00296504|469840774|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
130512197|NCT00296504|469840775|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
130512198|NCT00296504|469840776|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
130512199|NCT00296504|469840777|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
130512200|NCT00296504|469840778|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
130512201|NCT00296504|469840779|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
130512202|NCT00296504|469840771|FG000|Interim Analysis|Study Ended|0|||
130512203|NCT00296504|469840772|FG001|Interim Analysis|Study Ended|0|||
130512204|NCT00296504|469840773|FG002|Interim Analysis|Study Ended|0|||
130512205|NCT00296504|469840774|FG003|Interim Analysis|Study Ended|0|||
130512206|NCT00296504|469840775|FG004|Interim Analysis|Study Ended|0|||
130512207|NCT00296504|469840776|FG005|Interim Analysis|Study Ended|0|||
130512208|NCT00296504|469840777|FG006|Interim Analysis|Study Ended|1|||
130512209|NCT00296504|469840778|FG007|Interim Analysis|Study Ended|0|||
130512210|NCT00296504|469840779|FG008|Interim Analysis|Study Ended|0|||
130512211|NCT00296504|469840771|FG000|Interim Analysis|Participant Needed Interferon|0|||
130512212|NCT00296504|469840772|FG001|Interim Analysis|Participant Needed Interferon|0|||
130512213|NCT00296504|469840773|FG002|Interim Analysis|Participant Needed Interferon|0|||
130512214|NCT00296504|469840774|FG003|Interim Analysis|Participant Needed Interferon|0|||
130512215|NCT00296504|469840775|FG004|Interim Analysis|Participant Needed Interferon|0|||
130512216|NCT00296504|469840776|FG005|Interim Analysis|Participant Needed Interferon|0|||
130512217|NCT00296504|469840777|FG006|Interim Analysis|Participant Needed Interferon|0|||
130512218|NCT00296504|469840778|FG007|Interim Analysis|Participant Needed Interferon|1|||
130512219|NCT00296504|469840779|FG008|Interim Analysis|Participant Needed Interferon|0|||
130512220|NCT00296504|469840771|FG000|Interim Analysis|Ongoing|32|||
130512221|NCT00296504|469840772|FG001|Interim Analysis|Ongoing|12|||
130512222|NCT00296504|469840773|FG002|Interim Analysis|Ongoing|16|||
130512223|NCT00296504|469840774|FG003|Interim Analysis|Ongoing|22|||
130512224|NCT00296504|469840775|FG004|Interim Analysis|Ongoing|0|||
130569238|NCT01709435|470050188|FG001|Overall Study|Lack of Efficacy|7|||
130512225|NCT00296504|469840776|FG005|Interim Analysis|Ongoing|0|||
130512226|NCT00296504|469840777|FG006|Interim Analysis|Ongoing|30|||
130512227|NCT00296504|469840778|FG007|Interim Analysis|Ongoing|1|||
130512228|NCT00296504|469840779|FG008|Interim Analysis|Ongoing|0|||
130512229|NCT00296504|469840771|FG000|Final Analysis|Withdrawal by Subject|0|||
130512230|NCT00296504|469840772|FG001|Final Analysis|Withdrawal by Subject|0|||
130512231|NCT00296504|469840773|FG002|Final Analysis|Withdrawal by Subject|0|||
130569239|NCT01709435|470050189|FG002|Overall Study|Lack of Efficacy|2|||
130512232|NCT00296504|469840774|FG003|Final Analysis|Withdrawal by Subject|0|||
130512233|NCT00296504|469840775|FG004|Final Analysis|Withdrawal by Subject|0|||
130512234|NCT00296504|469840776|FG005|Final Analysis|Withdrawal by Subject|0|||
130512235|NCT00296504|469840777|FG006|Final Analysis|Withdrawal by Subject|0|||
130512236|NCT00296504|469840778|FG007|Final Analysis|Withdrawal by Subject|0|||
130512237|NCT00296504|469840779|FG008|Final Analysis|Withdrawal by Subject|1|||
130512238|NCT00296504|469840771|FG000|Final Analysis|Lost to Follow-up|0|||
130512239|NCT00296504|469840772|FG001|Final Analysis|Lost to Follow-up|0|||
130512240|NCT00296504|469840773|FG002|Final Analysis|Lost to Follow-up|0|||
130512241|NCT00296504|469840774|FG003|Final Analysis|Lost to Follow-up|0|||
130512242|NCT00296504|469840775|FG004|Final Analysis|Lost to Follow-up|0|||
130512243|NCT00296504|469840776|FG005|Final Analysis|Lost to Follow-up|0|||
130512244|NCT00296504|469840777|FG006|Final Analysis|Lost to Follow-up|0|||
130512245|NCT00296504|469840778|FG007|Final Analysis|Lost to Follow-up|0|||
130512246|NCT00296504|469840779|FG008|Final Analysis|Lost to Follow-up|5|||
130512247|NCT00296504|469840771|FG000|Final Analysis|Insufficient Viral Load Response|0|||
130512248|NCT00296504|469840772|FG001|Final Analysis|Insufficient Viral Load Response|0|||
130512249|NCT00296504|469840773|FG002|Final Analysis|Insufficient Viral Load Response|0|||
130512250|NCT00296504|469840774|FG003|Final Analysis|Insufficient Viral Load Response|0|||
130512251|NCT00296504|469840775|FG004|Final Analysis|Insufficient Viral Load Response|0|||
130512252|NCT00296504|469840776|FG005|Final Analysis|Insufficient Viral Load Response|0|||
130512253|NCT00296504|469840777|FG006|Final Analysis|Insufficient Viral Load Response|0|||
130512254|NCT00296504|469840778|FG007|Final Analysis|Insufficient Viral Load Response|0|||
130512255|NCT00296504|469840779|FG008|Final Analysis|Insufficient Viral Load Response|6|||
130512256|NCT00296504|469840771|FG000|Final Analysis|Adverse Event|0|||
130512257|NCT00296504|469840772|FG001|Final Analysis|Adverse Event|0|||
130512258|NCT00296504|469840773|FG002|Final Analysis|Adverse Event|0|||
130512259|NCT00296504|469840774|FG003|Final Analysis|Adverse Event|0|||
130512260|NCT00296504|469840775|FG004|Final Analysis|Adverse Event|0|||
130512261|NCT00296504|469840776|FG005|Final Analysis|Adverse Event|0|||
130512262|NCT00296504|469840777|FG006|Final Analysis|Adverse Event|0|||
130512263|NCT00296504|469840778|FG007|Final Analysis|Adverse Event|0|||
130512264|NCT00296504|469840779|FG008|Final Analysis|Adverse Event|2|||
130512265|NCT00296504|469840771|FG000|Final Analysis|Pregnancy|0|||
130512266|NCT00296504|469840772|FG001|Final Analysis|Pregnancy|0|||
130512267|NCT00296504|469840773|FG002|Final Analysis|Pregnancy|0|||
130512268|NCT00296504|469840774|FG003|Final Analysis|Pregnancy|0|||
130512269|NCT00296504|469840775|FG004|Final Analysis|Pregnancy|0|||
130512270|NCT00296504|469840776|FG005|Final Analysis|Pregnancy|0|||
130512271|NCT00296504|469840777|FG006|Final Analysis|Pregnancy|0|||
130512272|NCT00296504|469840778|FG007|Final Analysis|Pregnancy|0|||
130512273|NCT00296504|469840779|FG008|Final Analysis|Pregnancy|4|||
130512274|NCT00296504|469840771|FG000|Final Analysis|Tuberculosis|0|||
130512275|NCT00296504|469840772|FG001|Final Analysis|Tuberculosis|0|||
130512276|NCT00296504|469840773|FG002|Final Analysis|Tuberculosis|0|||
130512277|NCT00296504|469840774|FG003|Final Analysis|Tuberculosis|0|||
130512278|NCT00296504|469840775|FG004|Final Analysis|Tuberculosis|0|||
130512279|NCT00296504|469840776|FG005|Final Analysis|Tuberculosis|0|||
130512280|NCT00296504|469840777|FG006|Final Analysis|Tuberculosis|0|||
130512281|NCT00296504|469840778|FG007|Final Analysis|Tuberculosis|0|||
130512282|NCT00296504|469840779|FG008|Final Analysis|Tuberculosis|1|||
130512283|NCT00296504|469840771|FG000|Final Analysis|Participant Moved to Another Country|0|||
130512284|NCT00296504|469840772|FG001|Final Analysis|Participant Moved to Another Country|0|||
130512285|NCT00296504|469840773|FG002|Final Analysis|Participant Moved to Another Country|0|||
130512286|NCT00296504|469840774|FG003|Final Analysis|Participant Moved to Another Country|0|||
130512287|NCT00296504|469840775|FG004|Final Analysis|Participant Moved to Another Country|0|||
130512288|NCT00296504|469840776|FG005|Final Analysis|Participant Moved to Another Country|0|||
130512289|NCT00296504|469840777|FG006|Final Analysis|Participant Moved to Another Country|0|||
130512290|NCT00296504|469840778|FG007|Final Analysis|Participant Moved to Another Country|0|||
130512291|NCT00296504|469840779|FG008|Final Analysis|Participant Moved to Another Country|1|||
130569240|NCT01709435|470050190|FG003|Overall Study|Lack of Efficacy|2|||
130512292|NCT00296504|469840771|FG000|Final Analysis|Poor Adherence|0|||
130512293|NCT00296504|469840772|FG001|Final Analysis|Poor Adherence|0|||
130512294|NCT00296504|469840773|FG002|Final Analysis|Poor Adherence|0|||
130512295|NCT00296504|469840774|FG003|Final Analysis|Poor Adherence|0|||
130512296|NCT00296504|469840775|FG004|Final Analysis|Poor Adherence|0|||
130512297|NCT00296504|469840776|FG005|Final Analysis|Poor Adherence|0|||
130512298|NCT00296504|469840777|FG006|Final Analysis|Poor Adherence|0|||
130512299|NCT00296504|469840778|FG007|Final Analysis|Poor Adherence|0|||
130512300|NCT00296504|469840779|FG008|Final Analysis|Poor Adherence|1|||
130512301|NCT02162771|469840780|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
130512302|NCT02162771|469840781|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
130512303|NCT02162771|469840780|FG000|Core Study Period (Part 2)|Adverse Event|4|||
130512304|NCT02162771|469840781|FG001|Core Study Period (Part 2)|Adverse Event|1|||
130512305|NCT02162771|469840780|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
130512306|NCT02162771|469840781|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
130512307|NCT02162771|469840780|FG000|Core Study Period (Part 2)|Physician Decision|0|||
130512308|NCT02162771|469840781|FG001|Core Study Period (Part 2)|Physician Decision|2|||
130512309|NCT02162771|469840780|FG000|Core Study Period (Part 2)|Death|1|||
130512310|NCT02162771|469840781|FG001|Core Study Period (Part 2)|Death|0|||
130512311|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
130512312|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
130512313|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
130569241|NCT01709435|470050191|FG004|Overall Study|Lack of Efficacy|6|||
130569242|NCT01709435|470050192|FG005|Overall Study|Lack of Efficacy|3|||
130569243|NCT01709435|470050187|FG000|Overall Study|Physician Decision|0|||
130569244|NCT01709435|470050188|FG001|Overall Study|Physician Decision|1|||
130569245|NCT01709435|470050189|FG002|Overall Study|Physician Decision|0|||
130569246|NCT01709435|470050190|FG003|Overall Study|Physician Decision|1|||
130569247|NCT01709435|470050191|FG004|Overall Study|Physician Decision|2|||
130569248|NCT01709435|470050192|FG005|Overall Study|Physician Decision|0|||
130569249|NCT01709435|470050187|FG000|Overall Study|Withdrawal by Subject|0|||
130569250|NCT01709435|470050188|FG001|Overall Study|Withdrawal by Subject|0|||
130569251|NCT01709435|470050189|FG002|Overall Study|Withdrawal by Subject|3|||
130569252|NCT01709435|470050190|FG003|Overall Study|Withdrawal by Subject|0|||
130569253|NCT01709435|470050191|FG004|Overall Study|Withdrawal by Subject|2|||
130569254|NCT01709435|470050192|FG005|Overall Study|Withdrawal by Subject|2|||
130512314|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
130512315|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Death|2|||
130512316|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Death|1|||
130512317|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
130512318|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
130512319|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
130512320|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
130512321|NCT02162771|469840780|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
130512322|NCT02162771|469840781|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
130512323|NCT01348763|469840785|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
130512324|NCT01348763|469840785|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
130512325|NCT01078571|469840786|FG000|Overall Study|Adverse Event|36|||
130512326|NCT01078571|469840786|FG000|Overall Study|Lack of effectiveness|36|||
130512327|NCT01078571|469840786|FG000|Overall Study|Reason not reported|21|||
130512328|NCT01078571|469840786|FG000|Overall Study|Withdrawal by Subject|12|||
130512329|NCT01078571|469840786|FG000|Overall Study|Lost to Follow-up|8|||
130512330|NCT01078571|469840786|FG000|Overall Study|Protocol Violation|2|||
130512331|NCT03647709|469840791|FG000|Overall Study|Lost to Follow-up|5|||
130512332|NCT03647709|469840791|FG000|Overall Study|Physician Decision|6|||
130512333|NCT03647709|469840791|FG000|Overall Study|Withdrawal by Subject|3|||
130512334|NCT00449033|469840794|FG000|Treatment Period|Adverse Event|117|||
130512335|NCT00449033|469840795|FG001|Treatment Period|Adverse Event|83|||
130512336|NCT00449033|469840794|FG000|Treatment Period|Death|21|||
130512337|NCT00449033|469840795|FG001|Treatment Period|Death|12|||
130512338|NCT00449033|469840794|FG000|Treatment Period|Lost to Follow-up|0|||
130512339|NCT00449033|469840795|FG001|Treatment Period|Lost to Follow-up|2|||
130512340|NCT00449033|469840794|FG000|Treatment Period|Physician Decision|4|||
130512341|NCT00449033|469840795|FG001|Treatment Period|Physician Decision|5|||
130512342|NCT00449033|469840794|FG000|Treatment Period|Protocol Violation|8|||
130512343|NCT00449033|469840795|FG001|Treatment Period|Protocol Violation|7|||
130512344|NCT00449033|469840794|FG000|Treatment Period|Disease Progression|231|||
130512345|NCT00449033|469840795|FG001|Treatment Period|Disease Progression|288|||
130512346|NCT00449033|469840794|FG000|Treatment Period|Consent Withdrawn|36|||
130512347|NCT00449033|469840795|FG001|Treatment Period|Consent Withdrawn|20|||
130512348|NCT00449033|469840794|FG000|Treatment Period|Amended Protocol Criteria|22|||
130512349|NCT00449033|469840795|FG001|Treatment Period|Amended Protocol Criteria|18|||
130512350|NCT00449033|469840794|FG000|Treatment Period|Non-compliance|7|||
130512351|NCT00449033|469840795|FG001|Treatment Period|Non-compliance|8|||
130512352|NCT00449033|469840794|FG000|Treatment Period|Second Malignancy|0|||
130512353|NCT00449033|469840795|FG001|Treatment Period|Second Malignancy|1|||
130512354|NCT00449033|469840794|FG000|Treatment Period|Reason Missing|0|||
130512355|NCT00449033|469840795|FG001|Treatment Period|Reason Missing|4|||
130512356|NCT00449033|469840794|FG000|Treatment Period|Treatment Ongoing|6|||
130512357|NCT00449033|469840795|FG001|Treatment Period|Treatment Ongoing|4|||
130512358|NCT00449033|469840794|FG000|Follow-up Period|Death|299|||
130569255|NCT00183274|470050193|FG000|Phase 1: Open-Label|Adverse Event|31|||
130569256|NCT00183274|470050194|FG001|Phase 1: Open-Label|Adverse Event|0|||
130569257|NCT00183274|470050195|FG002|Phase 1: Open-Label|Adverse Event|0|||
130569258|NCT00183274|470050196|FG003|Phase 1: Open-Label|Adverse Event|0|||
130569259|NCT00183274|470050197|FG004|Phase 1: Open-Label|Adverse Event|0|||
130569260|NCT00183274|470050198|FG005|Phase 1: Open-Label|Adverse Event|0|||
130512359|NCT00449033|469840795|FG001|Follow-up Period|Death|311|||
130512360|NCT00449033|469840794|FG000|Follow-up Period|Lost to Follow-up|6|||
130512361|NCT00449033|469840795|FG001|Follow-up Period|Lost to Follow-up|10|||
130512362|NCT00449033|469840794|FG000|Follow-up Period|Reason Missing|120|||
130512363|NCT00449033|469840795|FG001|Follow-up Period|Reason Missing|113|||
130512364|NCT01257698|469840796|FG000|Overall Study|Protocol Violation|4|||
130512365|NCT01257698|469840797|FG001|Overall Study|Protocol Violation|0|||
130512366|NCT04393779|469840798|FG000|Overall Study|Death|1|||
130512367|NCT04393779|469840798|FG000|Overall Study|Device reintervention or explant|4|||
130512368|NCT01190228|469840799|FG000|Overall Study|Protocol Violation|4|||
130512369|NCT01190228|469840800|FG001|Overall Study|Protocol Violation|0|||
130512370|NCT01190228|469840801|FG002|Overall Study|Protocol Violation|0|||
130569261|NCT00183274|470050193|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
130569262|NCT00183274|470050194|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
130569263|NCT00183274|470050195|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
130569264|NCT00183274|470050196|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
130569265|NCT00183274|470050197|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
130512371|NCT01190228|469840799|FG000|Overall Study|Withdrawal by Subject|1|||
130512372|NCT01190228|469840800|FG001|Overall Study|Withdrawal by Subject|0|||
130512373|NCT01190228|469840801|FG002|Overall Study|Withdrawal by Subject|0|||
130512374|NCT02038803|469840807|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
130569266|NCT00183274|470050198|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
130569267|NCT00183274|470050193|FG000|Phase 1: Open-Label|Protocol Violation|11|||
130569268|NCT00183274|470050194|FG001|Phase 1: Open-Label|Protocol Violation|0|||
130569269|NCT00183274|470050195|FG002|Phase 1: Open-Label|Protocol Violation|0|||
130569270|NCT00183274|470050196|FG003|Phase 1: Open-Label|Protocol Violation|0|||
130569271|NCT00183274|470050197|FG004|Phase 1: Open-Label|Protocol Violation|0|||
130569272|NCT00183274|470050198|FG005|Phase 1: Open-Label|Protocol Violation|0|||
130569273|NCT00183274|470050193|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
130569274|NCT00183274|470050194|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
130569275|NCT00183274|470050195|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
130569276|NCT00183274|470050196|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
130569277|NCT00183274|470050197|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
130569278|NCT00183274|470050198|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
130569279|NCT00183274|470050193|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
130569280|NCT00183274|470050194|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
130569281|NCT00183274|470050195|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
130569282|NCT00183274|470050196|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
130569283|NCT00183274|470050197|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
130569284|NCT00183274|470050198|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
130569285|NCT00183274|470050193|FG000|Phase 1: Open-Label|Other|9|||
130569286|NCT00183274|470050194|FG001|Phase 1: Open-Label|Other|0|||
130569287|NCT00183274|470050195|FG002|Phase 1: Open-Label|Other|0|||
130569288|NCT00183274|470050196|FG003|Phase 1: Open-Label|Other|0|||
130569289|NCT00183274|470050197|FG004|Phase 1: Open-Label|Other|0|||
130569290|NCT00183274|470050198|FG005|Phase 1: Open-Label|Other|0|||
130569291|NCT00183274|470050193|FG000|Phase 2: Double-Blind|Relapsed|0|||
130569292|NCT00183274|470050194|FG001|Phase 2: Double-Blind|Relapsed|8|||
130569293|NCT00183274|470050195|FG002|Phase 2: Double-Blind|Relapsed|29|||
130569294|NCT00183274|470050196|FG003|Phase 2: Double-Blind|Relapsed|0|||
130569295|NCT00183274|470050197|FG004|Phase 2: Double-Blind|Relapsed|0|||
130569296|NCT00183274|470050198|FG005|Phase 2: Double-Blind|Relapsed|0|||
130569297|NCT00183274|470050193|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130512375|NCT02038803|469840807|FG000|Overall Study|Lost to Follow-up|1|||
130512376|NCT04372186|469840808|FG000|Overall Study|Death|24|||
130512377|NCT04372186|469840809|FG001|Overall Study|Death|11|||
130512378|NCT04372186|469840808|FG000|Overall Study|Transferred to a different facility for care|0|||
130512379|NCT04372186|469840809|FG001|Overall Study|Transferred to a different facility for care|2|||
130512380|NCT02116582|469840810|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
130512381|NCT02116582|469840810|FG000|Overall Study|Adverse Event|22|||
130512382|NCT02116582|469840810|FG000|Overall Study|Death|9|||
130512383|NCT02116582|469840810|FG000|Overall Study|Progressive Disease|148|||
130512384|NCT02116582|469840810|FG000|Overall Study|Protocol Violation|3|||
130512385|NCT02116582|469840810|FG000|Overall Study|Withdrawal by Subject|8|||
130512386|NCT02116582|469840810|FG000|Overall Study|Other: Miscellaneous|11|||
130512387|NCT02116582|469840810|FG000|Overall Study|Lost to Follow-up|1|||
130569298|NCT00183274|470050194|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
130569299|NCT00183274|470050195|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
130569300|NCT00183274|470050196|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130569301|NCT00183274|470050197|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130569302|NCT00183274|470050198|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130569303|NCT00183274|470050193|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130569304|NCT00183274|470050194|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130569305|NCT00183274|470050195|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130569306|NCT00183274|470050196|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
130569307|NCT00183274|470050197|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
130569308|NCT00183274|470050198|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
130512388|NCT02116582|469840810|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
130512389|NCT03219216|469840811|FG000|Overall Study|Lost to Follow-up|0|||
130512390|NCT03219216|469840812|FG001|Overall Study|Lost to Follow-up|1|||
130512391|NCT02332824|469840813|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
130512392|NCT02332824|469840814|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130512393|NCT02332824|469840815|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130569309|NCT00183274|470050193|FG000|Phase 3: Double-Blind|Relapsed|0|||
130569310|NCT00183274|470050194|FG001|Phase 3: Double-Blind|Relapsed|0|||
130569311|NCT00183274|470050195|FG002|Phase 3: Double-Blind|Relapsed|0|||
130569312|NCT00183274|470050196|FG003|Phase 3: Double-Blind|Relapsed|1|||
130569313|NCT00183274|470050197|FG004|Phase 3: Double-Blind|Relapsed|11|||
130569314|NCT00183274|470050198|FG005|Phase 3: Double-Blind|Relapsed|2|||
130569315|NCT00618410|470050201|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
130569316|NCT00618410|470050202|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
130569317|NCT01297270|470050209|FG000|Overall Study|Adverse Event|19|||
130569318|NCT01297270|470050210|FG001|Overall Study|Adverse Event|32|||
130569319|NCT01297270|470050211|FG002|Overall Study|Adverse Event|5|||
130569320|NCT01297270|470050209|FG000|Overall Study|Lack of Efficacy|15|||
130569321|NCT01297270|470050210|FG001|Overall Study|Lack of Efficacy|17|||
130569322|NCT01297270|470050211|FG002|Overall Study|Lack of Efficacy|15|||
130569323|NCT01297270|470050209|FG000|Overall Study|Lost to Follow-up|1|||
130569324|NCT01297270|470050210|FG001|Overall Study|Lost to Follow-up|2|||
130569325|NCT01297270|470050211|FG002|Overall Study|Lost to Follow-up|1|||
130569326|NCT01297270|470050209|FG000|Overall Study|Protocol Violation|0|||
130569327|NCT01297270|470050210|FG001|Overall Study|Protocol Violation|2|||
130569328|NCT01297270|470050211|FG002|Overall Study|Protocol Violation|0|||
130569329|NCT01297270|470050209|FG000|Overall Study|Withdrawal by Subject|7|||
130512394|NCT02332824|469840816|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130512395|NCT02332824|469840817|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
130512396|NCT02332824|469840818|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
130512397|NCT02332824|469840813|FG000|Overall Study|Voluntary Withdrawal|1|||
130512398|NCT02332824|469840814|FG001|Overall Study|Voluntary Withdrawal|0|||
130512399|NCT02332824|469840815|FG002|Overall Study|Voluntary Withdrawal|0|||
130512400|NCT02332824|469840816|FG003|Overall Study|Voluntary Withdrawal|0|||
130512401|NCT02332824|469840817|FG004|Overall Study|Voluntary Withdrawal|0|||
130512402|NCT02332824|469840818|FG005|Overall Study|Voluntary Withdrawal|0|||
130512403|NCT02332824|469840813|FG000|Overall Study|Inconvenient schedule|1|||
130512404|NCT02332824|469840814|FG001|Overall Study|Inconvenient schedule|1|||
130512405|NCT02332824|469840815|FG002|Overall Study|Inconvenient schedule|0|||
130512406|NCT02332824|469840816|FG003|Overall Study|Inconvenient schedule|0|||
130512407|NCT02332824|469840817|FG004|Overall Study|Inconvenient schedule|0|||
130512408|NCT02332824|469840818|FG005|Overall Study|Inconvenient schedule|0|||
130512409|NCT02332824|469840813|FG000|Overall Study|Transfer|0|||
130512410|NCT02332824|469840814|FG001|Overall Study|Transfer|0|||
130512411|NCT02332824|469840815|FG002|Overall Study|Transfer|1|||
130512412|NCT02332824|469840816|FG003|Overall Study|Transfer|1|||
130512413|NCT02332824|469840817|FG004|Overall Study|Transfer|0|||
130512414|NCT02332824|469840818|FG005|Overall Study|Transfer|0|||
130512415|NCT00498797|469840819|FG000|Overall Study|Withdrawal by Subject|4|||
130512416|NCT00498797|469840820|FG001|Overall Study|Withdrawal by Subject|2|||
130512417|NCT00498797|469840819|FG000|Overall Study|Adverse Event|12|||
130512418|NCT00498797|469840820|FG001|Overall Study|Adverse Event|5|||
130512419|NCT00498797|469840819|FG000|Overall Study|Condition under investigation worsened|19|||
130512420|NCT00498797|469840820|FG001|Overall Study|Condition under investigation worsened|21|||
130512421|NCT00498797|469840819|FG000|Overall Study|Other|3|||
130512422|NCT00498797|469840820|FG001|Overall Study|Other|1|||
130512423|NCT00914732|469840821|FG000|Overall Study|Lost to Follow-up|6|||
130512424|NCT00914732|469840822|FG001|Overall Study|Lost to Follow-up|7|||
130512425|NCT00914732|469840823|FG002|Overall Study|Lost to Follow-up|9|||
130512426|NCT00914732|469840821|FG000|Overall Study|Withdrawal by Subject|3|||
130512427|NCT00914732|469840822|FG001|Overall Study|Withdrawal by Subject|0|||
130512428|NCT00914732|469840823|FG002|Overall Study|Withdrawal by Subject|2|||
130512429|NCT00914732|469840821|FG000|Overall Study|Adverse Event|1|||
130512430|NCT00914732|469840822|FG001|Overall Study|Adverse Event|0|||
130512431|NCT00914732|469840823|FG002|Overall Study|Adverse Event|0|||
130512432|NCT01855399|469840824|FG000|6 Month|Lost to Follow-up|12|||
130512433|NCT01855399|469840825|FG001|6 Month|Lost to Follow-up|9|||
130512434|NCT01855399|469840824|FG000|6 Month|Withdrawal by Subject|8|||
130512435|NCT01855399|469840825|FG001|6 Month|Withdrawal by Subject|6|||
130569330|NCT01297270|470050210|FG001|Overall Study|Withdrawal by Subject|15|||
130569331|NCT01297270|470050211|FG002|Overall Study|Withdrawal by Subject|7|||
130569332|NCT01297270|470050209|FG000|Overall Study|Other reason not defined above|3|||
130569333|NCT01297270|470050210|FG001|Overall Study|Other reason not defined above|3|||
130569334|NCT01297270|470050211|FG002|Overall Study|Other reason not defined above|1|||
130512436|NCT01855399|469840824|FG000|12 Month|Lost to Follow-up|7|||
130512437|NCT01855399|469840825|FG001|12 Month|Lost to Follow-up|11|||
130512438|NCT03953079|469840826|FG000|Core Study|Withdrawal by Subject|1|||
130512439|NCT03953079|469840827|FG001|Core Study|Withdrawal by Subject|2|||
130512440|NCT03953079|469840828|FG002|Core Study|Withdrawal by Subject|1|||
130512441|NCT03953079|469840826|FG000|Core Study|COVID-19|0|||
130512442|NCT03953079|469840827|FG001|Core Study|COVID-19|1|||
130512443|NCT03953079|469840828|FG002|Core Study|COVID-19|0|||
130512444|NCT03953079|469840826|FG000|Core Study|Difficulties leaving the house|0|||
130512445|NCT03953079|469840827|FG001|Core Study|Difficulties leaving the house|1|||
130512446|NCT03953079|469840828|FG002|Core Study|Difficulties leaving the house|0|||
130512447|NCT03953079|469840826|FG000|Extension Study|Withdrawal by Subject|1|||
130512448|NCT03953079|469840827|FG001|Extension Study|Withdrawal by Subject|0|||
130512449|NCT03953079|469840828|FG002|Extension Study|Withdrawal by Subject|0|||
130512450|NCT03953079|469840826|FG000|Extension Study|Received Rescue Treatment|5|||
130569335|NCT01297270|470050209|FG000|Overall Study|Not treated|0|||
130512451|NCT03953079|469840827|FG001|Extension Study|Received Rescue Treatment|6|||
130512452|NCT03953079|469840828|FG002|Extension Study|Received Rescue Treatment|5|||
130512453|NCT04394624|469840829|FG000|Overall Study|Adverse Event|6|||
130512454|NCT04394624|469840830|FG001|Overall Study|Adverse Event|0|||
130512455|NCT04394624|469840829|FG000|Overall Study|Progressive disease|24|||
130512456|NCT04394624|469840830|FG001|Overall Study|Progressive disease|0|||
130512457|NCT04394624|469840829|FG000|Overall Study|Not related to COVID-19|1|||
130512458|NCT04394624|469840830|FG001|Overall Study|Not related to COVID-19|0|||
130512459|NCT00990821|469840836|FG000|Overall Study|Withdrawal by Subject|0|||
130512460|NCT00990821|469840837|FG001|Overall Study|Withdrawal by Subject|2|||
130512461|NCT00990821|469840838|FG002|Overall Study|Withdrawal by Subject|0|||
130512462|NCT00990821|469840839|FG003|Overall Study|Withdrawal by Subject|0|||
130512463|NCT00990821|469840840|FG004|Overall Study|Withdrawal by Subject|3|||
130512464|NCT00990821|469840841|FG005|Overall Study|Withdrawal by Subject|3|||
130512465|NCT00990821|469840842|FG006|Overall Study|Withdrawal by Subject|1|||
130512466|NCT00990821|469840843|FG007|Overall Study|Withdrawal by Subject|0|||
130512467|NCT00990821|469840844|FG008|Overall Study|Withdrawal by Subject|0|||
130512468|NCT00990821|469840845|FG009|Overall Study|Withdrawal by Subject|1|||
130512469|NCT00990821|469840846|FG010|Overall Study|Withdrawal by Subject|3|||
130512470|NCT00990821|469840847|FG011|Overall Study|Withdrawal by Subject|5|||
130512471|NCT00990821|469840848|FG012|Overall Study|Withdrawal by Subject|2|||
130512472|NCT00990821|469840849|FG013|Overall Study|Withdrawal by Subject|1|||
130512473|NCT04150250|469840850|FG000|Overall Study|Lost to Follow-up|0|||
130512474|NCT04150250|469840851|FG001|Overall Study|Lost to Follow-up|2|||
130512475|NCT01786551|469840852|FG000|Overall Study|Participant withdrew consent|2|||
130512476|NCT00308113|469840854|FG000|Overall Study|Protocol closure|0|||
130512477|NCT00308113|469840855|FG001|Overall Study|Protocol closure|0|||
130512478|NCT00308113|469840856|FG002|Overall Study|Protocol closure|0|||
130512479|NCT00308113|469840857|FG003|Overall Study|Protocol closure|1|||
130512480|NCT01123642|469840860|FG000|Overall Study|Lost to Follow-up|23|||
130512481|NCT01123642|469840860|FG000|Overall Study|Withdrawal by Subject|9|||
130512482|NCT01123642|469840860|FG000|Overall Study|ineligible at baseline assessment|36|||
130512483|NCT01184859|469842628|FG000|Period 1: Single Dose|Insufficient urine production|0|||
130512484|NCT01184859|469842629|FG001|Period 1: Single Dose|Insufficient urine production|1|||
130512485|NCT01184859|469842630|FG002|Period 1: Single Dose|Insufficient urine production|0|||
130512486|NCT01184859|469842631|FG003|Period 1: Single Dose|Insufficient urine production|0|||
130512487|NCT01184859|469842632|FG004|Period 1: Single Dose|Insufficient urine production|0|||
130512488|NCT01184859|469842628|FG000|Period 1: Single Dose|Protocol Violation|0|||
130512489|NCT01184859|469842629|FG001|Period 1: Single Dose|Protocol Violation|1|||
130512490|NCT01184859|469842630|FG002|Period 1: Single Dose|Protocol Violation|0|||
130512491|NCT01184859|469842631|FG003|Period 1: Single Dose|Protocol Violation|0|||
130512492|NCT01184859|469842632|FG004|Period 1: Single Dose|Protocol Violation|0|||
130512493|NCT01184859|469842628|FG000|Period 1: Single Dose|Adverse Event|0|||
130512494|NCT01184859|469842629|FG001|Period 1: Single Dose|Adverse Event|0|||
130512495|NCT01184859|469842630|FG002|Period 1: Single Dose|Adverse Event|0|||
130512496|NCT01184859|469842631|FG003|Period 1: Single Dose|Adverse Event|0|||
130512497|NCT01184859|469842632|FG004|Period 1: Single Dose|Adverse Event|1|||
130512498|NCT01184859|469842628|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
130512499|NCT01184859|469842629|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
130512500|NCT01184859|469842630|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
130512501|NCT01184859|469842631|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
130512502|NCT01184859|469842632|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
130512503|NCT01184859|469842628|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
130512504|NCT01184859|469842629|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
130512505|NCT01184859|469842630|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
130512506|NCT01184859|469842631|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
130512507|NCT01184859|469842632|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
130512508|NCT00961298|469842633|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
130512509|NCT00961298|469842633|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
130512510|NCT00961298|469842633|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
130512511|NCT01232569|469842634|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
130512512|NCT01232569|469842635|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130512513|NCT01232569|469842636|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130512514|NCT01232569|469842637|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
130512515|NCT01232569|469842634|FG000|Double-blind Treatment Period|Escape|2|||
130512516|NCT01232569|469842635|FG001|Double-blind Treatment Period|Escape|2|||
130512517|NCT01232569|469842636|FG002|Double-blind Treatment Period|Escape|0|||
130512518|NCT01232569|469842637|FG003|Double-blind Treatment Period|Escape|0|||
130512519|NCT01232569|469842634|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
130512520|NCT01232569|469842635|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130512521|NCT01232569|469842636|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130512522|NCT01232569|469842637|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130512523|NCT01232569|469842634|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
130512524|NCT01232569|469842635|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
130512525|NCT01232569|469842636|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130512526|NCT01232569|469842637|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
130512527|NCT01232569|469842634|FG000|Double-blind Treatment Period|Physician Decision|1|||
130512528|NCT01232569|469842635|FG001|Double-blind Treatment Period|Physician Decision|0|||
130512529|NCT01232569|469842636|FG002|Double-blind Treatment Period|Physician Decision|0|||
130512530|NCT01232569|469842637|FG003|Double-blind Treatment Period|Physician Decision|0|||
130512531|NCT01232569|469842634|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
130512532|NCT01232569|469842635|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
130512533|NCT01232569|469842636|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
130512534|NCT01232569|469842637|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
130512535|NCT01232569|469842634|FG000|Double-blind Treatment Period|Death|2|||
130512536|NCT01232569|469842635|FG001|Double-blind Treatment Period|Death|0|||
130512537|NCT01232569|469842636|FG002|Double-blind Treatment Period|Death|0|||
130512538|NCT01232569|469842637|FG003|Double-blind Treatment Period|Death|0|||
130512539|NCT04044352|469842638|FG000|Overall Study|Lost to Follow-up|9|||
130512540|NCT04044352|469842638|FG000|Overall Study|Withdrawal by Subject|2|||
130512541|NCT00651937|469842639|FG000|Overall Study|Withdrawal by Subject|4|||
130512542|NCT00651937|469842640|FG001|Overall Study|Withdrawal by Subject|1|||
130512543|NCT01503515|469842645|FG000|Overall Study|Adverse Event|4|||
130512544|NCT01503515|469842646|FG001|Overall Study|Adverse Event|5|||
130512545|NCT01503515|469842645|FG000|Overall Study|Death|0|||
130512546|NCT01503515|469842646|FG001|Overall Study|Death|1|||
130512547|NCT01503515|469842645|FG000|Overall Study|Physician Decision|14|||
130512548|NCT01503515|469842646|FG001|Overall Study|Physician Decision|23|||
130512549|NCT01503515|469842645|FG000|Overall Study|Withdrawal by Subject|0|||
130512550|NCT01503515|469842646|FG001|Overall Study|Withdrawal by Subject|1|||
130512551|NCT01503515|469842645|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
130512552|NCT01503515|469842646|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
130512553|NCT01503515|469842645|FG000|Overall Study|Ineligible|1|||
130512554|NCT01503515|469842646|FG001|Overall Study|Ineligible|1|||
130512555|NCT02123797|469842650|FG000|Baseline Intervention|Death|9|||
130512556|NCT02123797|469842651|FG001|Baseline Intervention|Death|16|||
130512557|NCT02123797|469842652|FG002|Baseline Intervention|Death|0|||
130512558|NCT02123797|469842653|FG003|Baseline Intervention|Death|0|||
130512559|NCT02123797|469842654|FG004|Baseline Intervention|Death|0|||
130512560|NCT02123797|469842650|FG000|Baseline Intervention|Withdrawal by Subject|2|||
130512561|NCT02123797|469842651|FG001|Baseline Intervention|Withdrawal by Subject|8|||
130512562|NCT02123797|469842652|FG002|Baseline Intervention|Withdrawal by Subject|0|||
130512563|NCT02123797|469842653|FG003|Baseline Intervention|Withdrawal by Subject|0|||
130512564|NCT02123797|469842654|FG004|Baseline Intervention|Withdrawal by Subject|0|||
130512565|NCT02123797|469842650|FG000|Baseline Intervention|Relocation|2|||
130512566|NCT02123797|469842651|FG001|Baseline Intervention|Relocation|0|||
130512567|NCT02123797|469842652|FG002|Baseline Intervention|Relocation|0|||
130512568|NCT02123797|469842653|FG003|Baseline Intervention|Relocation|0|||
130512569|NCT02123797|469842654|FG004|Baseline Intervention|Relocation|0|||
130512570|NCT02123797|469842650|FG000|Baseline Intervention|Out of window for initial survey|6|||
130512571|NCT02123797|469842651|FG001|Baseline Intervention|Out of window for initial survey|13|||
130512572|NCT02123797|469842652|FG002|Baseline Intervention|Out of window for initial survey|0|||
130512573|NCT02123797|469842653|FG003|Baseline Intervention|Out of window for initial survey|0|||
130512574|NCT02123797|469842654|FG004|Baseline Intervention|Out of window for initial survey|0|||
130512575|NCT02123797|469842650|FG000|Baseline Intervention|Lost to Follow-up|0|||
130512576|NCT02123797|469842651|FG001|Baseline Intervention|Lost to Follow-up|5|||
130512577|NCT02123797|469842652|FG002|Baseline Intervention|Lost to Follow-up|0|||
130512578|NCT02123797|469842653|FG003|Baseline Intervention|Lost to Follow-up|0|||
130512579|NCT02123797|469842654|FG004|Baseline Intervention|Lost to Follow-up|0|||
130512580|NCT02123797|469842650|FG000|Baseline Intervention|Other Disease|3|||
130512581|NCT02123797|469842651|FG001|Baseline Intervention|Other Disease|0|||
130512582|NCT02123797|469842652|FG002|Baseline Intervention|Other Disease|0|||
130512583|NCT02123797|469842653|FG003|Baseline Intervention|Other Disease|0|||
130512584|NCT02123797|469842654|FG004|Baseline Intervention|Other Disease|0|||
130512585|NCT02123797|469842650|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
130512586|NCT02123797|469842651|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
130512587|NCT02123797|469842652|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
130512588|NCT02123797|469842653|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
130512589|NCT02123797|469842654|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
130512590|NCT02123797|469842650|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
130512591|NCT02123797|469842651|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
130512592|NCT02123797|469842652|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
130512593|NCT02123797|469842653|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
130512594|NCT02123797|469842654|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
130512595|NCT02123797|469842650|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
130569336|NCT01297270|470050210|FG001|Overall Study|Not treated|1|||
130512596|NCT02123797|469842651|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
130512597|NCT02123797|469842652|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512598|NCT02123797|469842653|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512599|NCT02123797|469842654|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512600|NCT02123797|469842650|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
130512601|NCT02123797|469842651|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
130512602|NCT02123797|469842652|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
130512603|NCT02123797|469842653|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
130512604|NCT02123797|469842654|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
130512605|NCT02123797|469842650|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
130512606|NCT02123797|469842651|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
130512607|NCT02123797|469842652|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
130512608|NCT02123797|469842653|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
130512609|NCT02123797|469842654|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
130512610|NCT02123797|469842650|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
130512611|NCT02123797|469842651|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
130512612|NCT02123797|469842652|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
130512613|NCT02123797|469842653|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
130512614|NCT02123797|469842654|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
130512615|NCT02123797|469842650|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
130512616|NCT02123797|469842651|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
130512617|NCT02123797|469842652|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
130512618|NCT02123797|469842653|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
130512619|NCT02123797|469842654|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
130512620|NCT02123797|469842650|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
130512621|NCT02123797|469842651|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
130512622|NCT02123797|469842652|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512623|NCT02123797|469842653|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512624|NCT02123797|469842654|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
130512625|NCT02123797|469842650|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
130512626|NCT02123797|469842651|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
130512627|NCT02123797|469842652|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
130512628|NCT02123797|469842653|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
130512629|NCT02123797|469842654|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
130512630|NCT00443755|469842655|FG000|Overall Study|Withdrawal by Subject|2|||
130512631|NCT00443755|469842656|FG001|Overall Study|Withdrawal by Subject|1|||
130512632|NCT02339506|469842666|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
130512633|NCT02339506|469842667|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
130512634|NCT02339506|469842666|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
130512635|NCT02339506|469842667|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
130512636|NCT03997409|469842668|FG000|Overall Study|Protocol Violation|1|||
130512637|NCT03997409|469842669|FG001|Overall Study|Protocol Violation|1|||
130512638|NCT03997409|469842670|FG002|Overall Study|Protocol Violation|0|||
130512639|NCT03997409|469842668|FG000|Overall Study|Withdrawal by Subject|3|||
130512640|NCT03997409|469842669|FG001|Overall Study|Withdrawal by Subject|0|||
130512641|NCT03997409|469842670|FG002|Overall Study|Withdrawal by Subject|0|||
130512642|NCT03997409|469842668|FG000|Overall Study|Lost to Follow-up|0|||
130512643|NCT03997409|469842669|FG001|Overall Study|Lost to Follow-up|0|||
130512644|NCT03997409|469842670|FG002|Overall Study|Lost to Follow-up|1|||
130512645|NCT01753323|469842671|FG000|Overall Study|Lack of Efficacy|0|||
130512646|NCT01753323|469842672|FG001|Overall Study|Lack of Efficacy|0|||
130512647|NCT01753323|469842673|FG002|Overall Study|Lack of Efficacy|8|||
130512648|NCT01753323|469842671|FG000|Overall Study|Protocol deviation|1|||
130512649|NCT01753323|469842672|FG001|Overall Study|Protocol deviation|0|||
130512650|NCT01753323|469842673|FG002|Overall Study|Protocol deviation|0|||
130512651|NCT01753323|469842671|FG000|Overall Study|Adverse Event|0|||
130512652|NCT01753323|469842672|FG001|Overall Study|Adverse Event|0|||
130512653|NCT01753323|469842673|FG002|Overall Study|Adverse Event|1|||
130512654|NCT01116440|469842675|FG000|Treatment|Withdrawal by Subject|2|||
130512655|NCT01116440|469842676|FG001|Treatment|Withdrawal by Subject|2|||
130512656|NCT01116440|469842675|FG000|Treatment|Lost to Follow-up|1|||
130512657|NCT01116440|469842676|FG001|Treatment|Lost to Follow-up|1|||
130512658|NCT01116440|469842675|FG000|Treatment|Protocol Violation|0|||
130512659|NCT01116440|469842676|FG001|Treatment|Protocol Violation|2|||
130512660|NCT01116440|469842675|FG000|Treatment|Lack of Efficacy|0|||
130512661|NCT01116440|469842676|FG001|Treatment|Lack of Efficacy|1|||
130512662|NCT01116440|469842675|FG000|Treatment|Adverse Event|0|||
130512663|NCT01116440|469842676|FG001|Treatment|Adverse Event|1|||
130512664|NCT01116440|469842675|FG000|Withdrawal|Withdrawal by Subject|0|||
130512665|NCT01116440|469842676|FG001|Withdrawal|Withdrawal by Subject|1|||
130512666|NCT01116440|469842675|FG000|Withdrawal|Lost to Follow-up|0|||
130512667|NCT01116440|469842676|FG001|Withdrawal|Lost to Follow-up|1|||
130512668|NCT01116440|469842675|FG000|Follow-up|Lost to Follow-up|0|||
130512669|NCT01116440|469842676|FG001|Follow-up|Lost to Follow-up|1|||
130512670|NCT01116440|469842675|FG000|Follow-up|Withdrawal by Subject|0|||
130512671|NCT01116440|469842676|FG001|Follow-up|Withdrawal by Subject|1|||
130512672|NCT01446042|469842691|FG000|Overall Study|Withdrawal by Subject|12|||
130512673|NCT01446042|469842692|FG001|Overall Study|Withdrawal by Subject|2|||
130512674|NCT01446042|469842693|FG002|Overall Study|Withdrawal by Subject|4|||
130512675|NCT01446042|469842691|FG000|Overall Study|Adverse Event|1|||
130512676|NCT01446042|469842692|FG001|Overall Study|Adverse Event|0|||
130512677|NCT01446042|469842693|FG002|Overall Study|Adverse Event|4|||
130512678|NCT01446042|469842691|FG000|Overall Study|Lost to Follow-up|5|||
130512679|NCT01446042|469842692|FG001|Overall Study|Lost to Follow-up|0|||
130512680|NCT01446042|469842693|FG002|Overall Study|Lost to Follow-up|0|||
130512681|NCT01446042|469842691|FG000|Overall Study|Other reasons|2|||
130512682|NCT01446042|469842692|FG001|Overall Study|Other reasons|1|||
130512683|NCT01446042|469842693|FG002|Overall Study|Other reasons|1|||
130512684|NCT03575572|469842695|FG000|Overall Study|Withdrawal by Subject|2|||
130512685|NCT03575572|469842695|FG000|Overall Study|Physician Decision|2|||
130512686|NCT00157209|469842696|FG000|Overall Study|Ongoing at data cut-off|10|||
130512687|NCT00157209|469842697|FG001|Overall Study|Ongoing at data cut-off|0|||
130512688|NCT03802513|469842698|FG000|Overall Study|Lost to Follow-up|1|||
130512689|NCT02588027|469842712|FG000|Overall Study|Withdrawal by Subject|1|||
130512690|NCT02588027|469842713|FG001|Overall Study|Withdrawal by Subject|3|||
130512691|NCT02588027|469842712|FG000|Overall Study|Protocol Violation|4|||
130512692|NCT02588027|469842713|FG001|Overall Study|Protocol Violation|1|||
130512693|NCT01770509|469842714|FG000|Overall Study|Injury|0|||
130512694|NCT01770509|469842715|FG001|Overall Study|Injury|1|||
130512695|NCT01770509|469842714|FG000|Overall Study|Lost to Follow-up|1|||
130512696|NCT01770509|469842715|FG001|Overall Study|Lost to Follow-up|2|||
130512697|NCT03928821|469842716|FG000|Overall Study|Death|0|||
130512698|NCT03928821|469842717|FG001|Overall Study|Death|1|||
130512699|NCT03928821|469842718|FG002|Overall Study|Death|0|||
130512700|NCT03928821|469842719|FG003|Overall Study|Death|0|||
130512701|NCT03928821|469842716|FG000|Overall Study|Lost to Follow-up|0|||
130512702|NCT03928821|469842717|FG001|Overall Study|Lost to Follow-up|2|||
130512703|NCT03928821|469842718|FG002|Overall Study|Lost to Follow-up|3|||
130512704|NCT03928821|469842719|FG003|Overall Study|Lost to Follow-up|0|||
130512705|NCT03928821|469842716|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130512706|NCT03928821|469842717|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130512707|NCT03928821|469842718|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130512708|NCT03928821|469842719|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130512709|NCT03840148|469842726|FG000|Study Drug Disposition|Adverse Event|13|||
130512710|NCT03840148|469842727|FG001|Study Drug Disposition|Adverse Event|2|||
130512711|NCT03840148|469842726|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
130512712|NCT03840148|469842727|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
130512713|NCT03840148|469842726|FG000|Study Drug Disposition|Lack of Efficacy|3|||
130512714|NCT03840148|469842727|FG001|Study Drug Disposition|Lack of Efficacy|0|||
130512715|NCT03840148|469842726|FG000|Study Drug Disposition|Physician Decision|2|||
130512716|NCT03840148|469842727|FG001|Study Drug Disposition|Physician Decision|0|||
130512717|NCT03840148|469842726|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
130512718|NCT03840148|469842727|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
130512719|NCT03840148|469842726|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
130512720|NCT03840148|469842727|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
130512721|NCT03840148|469842726|FG000|Study Completion Disposition|Physician Decision|2|||
130512722|NCT03840148|469842727|FG001|Study Completion Disposition|Physician Decision|0|||
130512723|NCT03840148|469842726|FG000|Study Completion Disposition|Covid-19 related|2|||
130512724|NCT03840148|469842727|FG001|Study Completion Disposition|Covid-19 related|0|||
130512725|NCT03840148|469842726|FG000|Study Completion Disposition|Lost to Follow-up|1|||
130512726|NCT03840148|469842727|FG001|Study Completion Disposition|Lost to Follow-up|1|||
130512727|NCT03840148|469842726|FG000|Study Completion Disposition|Death|1|||
130512728|NCT03840148|469842727|FG001|Study Completion Disposition|Death|0|||
130512729|NCT03840148|469842726|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
130512730|NCT03840148|469842727|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
130512731|NCT03615404|469842728|FG000|Overall Study|Death|1|||
130512732|NCT03615404|469842728|FG000|Overall Study|vaccine did not pass quality assurance|1|||
130512733|NCT01774929|469842729|FG000|Overall Study|Adverse Event|3|||
130512734|NCT00603278|469842731|FG000|Overall Study|Lack of Efficacy|35|||
130512735|NCT00603278|469842732|FG001|Overall Study|Lack of Efficacy|10|||
130512736|NCT00603278|469842733|FG002|Overall Study|Lack of Efficacy|11|||
130512737|NCT00603278|469842734|FG003|Overall Study|Lack of Efficacy|8|||
130512738|NCT00603278|469842735|FG004|Overall Study|Lack of Efficacy|7|||
130512739|NCT00603278|469842736|FG005|Overall Study|Lack of Efficacy|14|||
130512740|NCT00603278|469842731|FG000|Overall Study|Adverse Event|0|||
130512741|NCT00603278|469842732|FG001|Overall Study|Adverse Event|3|||
130512742|NCT00603278|469842733|FG002|Overall Study|Adverse Event|1|||
130512743|NCT00603278|469842734|FG003|Overall Study|Adverse Event|0|||
130512744|NCT00603278|469842735|FG004|Overall Study|Adverse Event|2|||
130512745|NCT00603278|469842736|FG005|Overall Study|Adverse Event|1|||
130512746|NCT00603278|469842731|FG000|Overall Study|Withdrawal by Subject|2|||
130512747|NCT00603278|469842732|FG001|Overall Study|Withdrawal by Subject|3|||
130512748|NCT00603278|469842733|FG002|Overall Study|Withdrawal by Subject|1|||
130512749|NCT00603278|469842734|FG003|Overall Study|Withdrawal by Subject|2|||
130512750|NCT00603278|469842735|FG004|Overall Study|Withdrawal by Subject|1|||
130512751|NCT00603278|469842736|FG005|Overall Study|Withdrawal by Subject|2|||
130512752|NCT00603278|469842731|FG000|Overall Study|Protocol Violation|3|||
130512753|NCT00603278|469842732|FG001|Overall Study|Protocol Violation|0|||
130512754|NCT00603278|469842733|FG002|Overall Study|Protocol Violation|1|||
130512755|NCT00603278|469842734|FG003|Overall Study|Protocol Violation|1|||
130512756|NCT00603278|469842735|FG004|Overall Study|Protocol Violation|0|||
130512757|NCT00603278|469842736|FG005|Overall Study|Protocol Violation|1|||
130512758|NCT00603278|469842731|FG000|Overall Study|Physician Decision|0|||
130512759|NCT00603278|469842732|FG001|Overall Study|Physician Decision|1|||
130512760|NCT00603278|469842733|FG002|Overall Study|Physician Decision|0|||
130512761|NCT00603278|469842734|FG003|Overall Study|Physician Decision|0|||
130512762|NCT00603278|469842735|FG004|Overall Study|Physician Decision|2|||
130512763|NCT00603278|469842736|FG005|Overall Study|Physician Decision|1|||
130512764|NCT00603278|469842731|FG000|Overall Study|Lost to Follow-up|1|||
130512765|NCT00603278|469842732|FG001|Overall Study|Lost to Follow-up|0|||
130512766|NCT00603278|469842733|FG002|Overall Study|Lost to Follow-up|0|||
130512767|NCT00603278|469842734|FG003|Overall Study|Lost to Follow-up|0|||
130512768|NCT00603278|469842735|FG004|Overall Study|Lost to Follow-up|1|||
130512769|NCT00603278|469842736|FG005|Overall Study|Lost to Follow-up|0|||
130512770|NCT04374253|469842740|FG000|Overall Study|Adverse Event|0|||
130512771|NCT04374253|469842741|FG001|Overall Study|Adverse Event|26|||
130512772|NCT04374253|469842742|FG002|Overall Study|Adverse Event|2|||
130512773|NCT04374253|469842743|FG003|Overall Study|Adverse Event|12|||
130512774|NCT04374253|469842740|FG000|Overall Study|Study terminated by sponsor|13|||
130512775|NCT04374253|469842741|FG001|Overall Study|Study terminated by sponsor|593|||
130512776|NCT04374253|469842742|FG002|Overall Study|Study terminated by sponsor|21|||
130512777|NCT04374253|469842743|FG003|Overall Study|Study terminated by sponsor|567|||
130512778|NCT04374253|469842740|FG000|Overall Study|Withdrawal by Subject|0|||
130512779|NCT04374253|469842741|FG001|Overall Study|Withdrawal by Subject|55|||
130512780|NCT04374253|469842742|FG002|Overall Study|Withdrawal by Subject|3|||
130512781|NCT04374253|469842743|FG003|Overall Study|Withdrawal by Subject|40|||
130512782|NCT04374253|469842740|FG000|Overall Study|Physician Decision|1|||
130512783|NCT04374253|469842741|FG001|Overall Study|Physician Decision|10|||
130512784|NCT04374253|469842742|FG002|Overall Study|Physician Decision|1|||
130512785|NCT04374253|469842743|FG003|Overall Study|Physician Decision|10|||
130512786|NCT04374253|469842740|FG000|Overall Study|Protocol Violation|0|||
130512787|NCT04374253|469842741|FG001|Overall Study|Protocol Violation|0|||
130512788|NCT04374253|469842742|FG002|Overall Study|Protocol Violation|0|||
130512789|NCT04374253|469842743|FG003|Overall Study|Protocol Violation|2|||
130512790|NCT04374253|469842740|FG000|Overall Study|Death|0|||
130512791|NCT04374253|469842741|FG001|Overall Study|Death|3|||
130512792|NCT04374253|469842742|FG002|Overall Study|Death|1|||
130512793|NCT04374253|469842743|FG003|Overall Study|Death|1|||
130512794|NCT04374253|469842740|FG000|Overall Study|Lack of Efficacy|0|||
130512795|NCT04374253|469842741|FG001|Overall Study|Lack of Efficacy|0|||
130512796|NCT04374253|469842742|FG002|Overall Study|Lack of Efficacy|0|||
130512797|NCT04374253|469842743|FG003|Overall Study|Lack of Efficacy|1|||
130512798|NCT04374253|469842740|FG000|Overall Study|Lost to Follow-up|1|||
130512799|NCT04374253|469842741|FG001|Overall Study|Lost to Follow-up|1|||
130569337|NCT01297270|470050211|FG002|Overall Study|Not treated|0|||
130569338|NCT03882970|470050214|FG000|Overall Study|Adverse Event|5|||
130569339|NCT03882970|470050215|FG001|Overall Study|Adverse Event|7|||
130512800|NCT04374253|469842742|FG002|Overall Study|Lost to Follow-up|0|||
130512801|NCT04374253|469842743|FG003|Overall Study|Lost to Follow-up|2|||
130512802|NCT04374253|469842740|FG000|Overall Study|Reason Not Specified|0|||
130512803|NCT04374253|469842741|FG001|Overall Study|Reason Not Specified|8|||
130512804|NCT04374253|469842742|FG002|Overall Study|Reason Not Specified|0|||
130512805|NCT04374253|469842743|FG003|Overall Study|Reason Not Specified|8|||
130512806|NCT04382053|469842746|FG000|Overall Study|Death|6|||
130512807|NCT04382053|469842747|FG001|Overall Study|Death|8|||
130512808|NCT04382053|469842746|FG000|Overall Study|Lost to Follow-up|0|||
130512809|NCT04382053|469842747|FG001|Overall Study|Lost to Follow-up|2|||
130512810|NCT04382053|469842746|FG000|Overall Study|Protocol Deviation|1|||
130512811|NCT04382053|469842747|FG001|Overall Study|Protocol Deviation|2|||
130512812|NCT04382053|469842746|FG000|Overall Study|Withdrawal by Subject|2|||
130512813|NCT04382053|469842747|FG001|Overall Study|Withdrawal by Subject|1|||
130512814|NCT01399905|469842751|FG000|Overall Study|Withdrawal by Subject|1|||
130512815|NCT01399905|469842752|FG001|Overall Study|Withdrawal by Subject|1|||
130512816|NCT02577315|469842753|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130512817|NCT02577315|469842754|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
130512818|NCT00417989|469842757|FG000|Overall Study|Withdrawal by Subject|13|||
130512819|NCT00417989|469842758|FG001|Overall Study|Withdrawal by Subject|13|||
130512820|NCT00417989|469842757|FG000|Overall Study|Lost to Follow-up|1|||
130512821|NCT00417989|469842758|FG001|Overall Study|Lost to Follow-up|6|||
130512822|NCT00417989|469842757|FG000|Overall Study|Protocol Violation|1|||
130512823|NCT00417989|469842758|FG001|Overall Study|Protocol Violation|0|||
130512824|NCT00417989|469842757|FG000|Overall Study|Death|0|||
130512825|NCT00417989|469842758|FG001|Overall Study|Death|1|||
130512826|NCT00417989|469842757|FG000|Overall Study|Physician Decision|5|||
130512827|NCT00417989|469842758|FG001|Overall Study|Physician Decision|2|||
130512828|NCT01945086|469842761|FG000|Overall Study|Withdrawal by Subject|1|||
130512829|NCT01945086|469842762|FG001|Overall Study|Withdrawal by Subject|0|||
130512830|NCT01945086|469842763|FG002|Overall Study|Withdrawal by Subject|1|||
130512831|NCT01945086|469842761|FG000|Overall Study|Adverse Event|0|||
130512832|NCT01945086|469842762|FG001|Overall Study|Adverse Event|0|||
130512833|NCT01945086|469842763|FG002|Overall Study|Adverse Event|1|||
130512834|NCT00748098|469842764|FG000|First Treatment Intervention Period|Adverse Event|1|||
130512835|NCT00748098|469842765|FG001|First Treatment Intervention Period|Adverse Event|1|||
130512836|NCT00748098|469842764|FG000|First Treatment Intervention Period|Protocol Violation|1|||
130512837|NCT00748098|469842765|FG001|First Treatment Intervention Period|Protocol Violation|0|||
130512838|NCT00748098|469842764|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
130512839|NCT00748098|469842765|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
130512840|NCT00748098|469842764|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
130512841|NCT00748098|469842765|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
130512842|NCT00748098|469842764|FG000|First Taper Period|Protocol Violation|1|||
130512843|NCT00748098|469842765|FG001|First Taper Period|Protocol Violation|0|||
130512844|NCT00748098|469842764|FG000|First Taper Period|Withdrawal by Subject|2|||
130512845|NCT00748098|469842765|FG001|First Taper Period|Withdrawal by Subject|0|||
130512846|NCT00748098|469842764|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
130512847|NCT00748098|469842765|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
130512848|NCT00748098|469842764|FG000|1-Week Washout Period|Adverse Event|0|||
130512849|NCT00748098|469842765|FG001|1-Week Washout Period|Adverse Event|1|||
130512850|NCT00748098|469842764|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
130512851|NCT00748098|469842765|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
130512852|NCT00748098|469842764|FG000|Second Treatment Intervention Period|Adverse Event|4|||
130512853|NCT00748098|469842765|FG001|Second Treatment Intervention Period|Adverse Event|1|||
130512854|NCT00748098|469842764|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
130512855|NCT00748098|469842765|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
130512856|NCT00748098|469842764|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
130512857|NCT00748098|469842765|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
130512858|NCT01537120|469844295|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
130512859|NCT01537120|469844295|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
130512860|NCT02514577|469844296|FG000|Overall Study|Lost to Follow-up|6|||
130512861|NCT02514577|469844297|FG001|Overall Study|Lost to Follow-up|6|||
130512862|NCT02514577|469844296|FG000|Overall Study|Protocol Violation|1|||
130512863|NCT02514577|469844297|FG001|Overall Study|Protocol Violation|0|||
130512864|NCT02514577|469844296|FG000|Overall Study|Withdrawal by Subject|6|||
130569340|NCT03882970|470050216|FG002|Overall Study|Adverse Event|3|||
130569341|NCT03882970|470050217|FG003|Overall Study|Adverse Event|1|||
130569342|NCT03882970|470050214|FG000|Overall Study|Death|1|||
130569343|NCT03882970|470050215|FG001|Overall Study|Death|2|||
130569344|NCT03882970|470050216|FG002|Overall Study|Death|1|||
130569345|NCT03882970|470050217|FG003|Overall Study|Death|1|||
130569346|NCT03882970|470050214|FG000|Overall Study|Lost to Follow-up|8|||
130512865|NCT02514577|469844297|FG001|Overall Study|Withdrawal by Subject|6|||
130512866|NCT02514577|469844296|FG000|Overall Study|Adverse Event|1|||
130512867|NCT02514577|469844297|FG001|Overall Study|Adverse Event|1|||
130512868|NCT04816708|469844300|FG000|Overall Study|Lost to Follow-up|10|||
130512869|NCT04816708|469844301|FG001|Overall Study|Lost to Follow-up|4|||
130512870|NCT03568708|469844302|FG000|Overall Study|Withdrawal by Subject|1|||
130512871|NCT03568708|469844303|FG001|Overall Study|Withdrawal by Subject|1|||
130512872|NCT03568708|469844302|FG000|Overall Study|Lost to Follow-up|0|||
130569347|NCT03882970|470050215|FG001|Overall Study|Lost to Follow-up|9|||
130569348|NCT03882970|470050216|FG002|Overall Study|Lost to Follow-up|5|||
130569349|NCT03882970|470050217|FG003|Overall Study|Lost to Follow-up|5|||
130512873|NCT03568708|469844303|FG001|Overall Study|Lost to Follow-up|1|||
130512874|NCT00511147|469844304|FG000|Overall Study|Withdrawal by Subject|1|||
130512875|NCT00511147|469844304|FG000|Overall Study|Disease progression|5|||
130512876|NCT00511147|469844304|FG000|Overall Study|Required platelet transfusion|1|||
130512877|NCT00809783|469844305|FG000|Overall Study|Death|1|||
130512878|NCT00809783|469844306|FG001|Overall Study|Death|0|||
130512879|NCT00809783|469844307|FG002|Overall Study|Death|0|||
130512880|NCT00809783|469844305|FG000|Overall Study|Adverse Event|34|||
130512881|NCT00809783|469844306|FG001|Overall Study|Adverse Event|52|||
130512882|NCT00809783|469844307|FG002|Overall Study|Adverse Event|71|||
130512883|NCT00809783|469844305|FG000|Overall Study|Lack of Efficacy|39|||
130512884|NCT00809783|469844306|FG001|Overall Study|Lack of Efficacy|52|||
130569350|NCT03882970|470050214|FG000|Overall Study|Physician Decision|0|||
130569351|NCT03882970|470050215|FG001|Overall Study|Physician Decision|2|||
130569352|NCT03882970|470050216|FG002|Overall Study|Physician Decision|2|||
130569353|NCT03882970|470050217|FG003|Overall Study|Physician Decision|2|||
130569354|NCT03882970|470050214|FG000|Overall Study|Protocol Violation|2|||
130569355|NCT03882970|470050215|FG001|Overall Study|Protocol Violation|0|||
130569356|NCT03882970|470050216|FG002|Overall Study|Protocol Violation|0|||
130569357|NCT03882970|470050217|FG003|Overall Study|Protocol Violation|0|||
130569358|NCT03882970|470050214|FG000|Overall Study|Withdrawal by Subject|8|||
130569359|NCT03882970|470050215|FG001|Overall Study|Withdrawal by Subject|17|||
130569360|NCT03882970|470050216|FG002|Overall Study|Withdrawal by Subject|7|||
130569361|NCT03882970|470050217|FG003|Overall Study|Withdrawal by Subject|22|||
130569362|NCT03882970|470050214|FG000|Overall Study|Personal Reason|2|||
130569363|NCT03882970|470050215|FG001|Overall Study|Personal Reason|3|||
130569364|NCT03882970|470050216|FG002|Overall Study|Personal Reason|1|||
130569365|NCT03882970|470050217|FG003|Overall Study|Personal Reason|3|||
130569366|NCT02863809|470050219|FG000|Overall Study|Adverse Event|8|||
130569367|NCT02863809|470050220|FG001|Overall Study|Adverse Event|8|||
130569368|NCT02863809|470050219|FG000|Overall Study|Withdrawal by Subject|0|||
130569369|NCT02863809|470050220|FG001|Overall Study|Withdrawal by Subject|1|||
130569370|NCT02863809|470050219|FG000|Overall Study|Lost to Follow-up|1|||
130569371|NCT02863809|470050220|FG001|Overall Study|Lost to Follow-up|1|||
130569372|NCT02863809|470050219|FG000|Overall Study|Death|1|||
130569373|NCT02863809|470050220|FG001|Overall Study|Death|0|||
130569374|NCT02830776|470050221|FG000|Overall Study|Lost to Follow-up|1|||
130569375|NCT03029143|470050222|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
130569376|NCT03029143|470050223|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
130569377|NCT03029143|470050224|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
130569378|NCT03029143|470050222|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
130569379|NCT03029143|470050223|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
130569380|NCT03029143|470050224|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
130569381|NCT03029143|470050222|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
130569382|NCT03029143|470050223|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
130569383|NCT03029143|470050224|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
130569384|NCT03029143|470050222|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
130569385|NCT03029143|470050223|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
130512885|NCT00809783|469844307|FG002|Overall Study|Lack of Efficacy|63|||
130512886|NCT00809783|469844305|FG000|Overall Study|Lost to Follow-up|0|||
130512887|NCT00809783|469844306|FG001|Overall Study|Lost to Follow-up|3|||
130512888|NCT00809783|469844307|FG002|Overall Study|Lost to Follow-up|4|||
130512889|NCT00809783|469844305|FG000|Overall Study|Withdrawal by Subject|47|||
130512890|NCT00809783|469844306|FG001|Overall Study|Withdrawal by Subject|72|||
130512891|NCT00809783|469844307|FG002|Overall Study|Withdrawal by Subject|64|||
130512892|NCT00809783|469844305|FG000|Overall Study|Protocol Violation|2|||
130512893|NCT00809783|469844306|FG001|Overall Study|Protocol Violation|6|||
130512894|NCT00809783|469844307|FG002|Overall Study|Protocol Violation|5|||
130512895|NCT00809783|469844305|FG000|Overall Study|Randomized, but not treated|3|||
130512896|NCT00809783|469844306|FG001|Overall Study|Randomized, but not treated|0|||
130512897|NCT00809783|469844307|FG002|Overall Study|Randomized, but not treated|2|||
130512898|NCT00809783|469844305|FG000|Overall Study|Study Terminated by Sponsor|378|||
130512899|NCT00809783|469844306|FG001|Overall Study|Study Terminated by Sponsor|626|||
130512900|NCT00809783|469844307|FG002|Overall Study|Study Terminated by Sponsor|565|||
130512901|NCT00809783|469844305|FG000|Overall Study|Other|21|||
130512902|NCT00809783|469844306|FG001|Overall Study|Other|21|||
130512903|NCT00809783|469844307|FG002|Overall Study|Other|16|||
130512904|NCT00126555|469844308|FG000|Overall Study|Withdrawal by Subject|1|||
130512905|NCT00126555|469844308|FG000|Overall Study|Adverse Event|2|||
130512906|NCT00126555|469844308|FG000|Overall Study|Progressive Disease|3|||
130569386|NCT03029143|470050224|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
130569387|NCT03029143|470050222|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
130569388|NCT03029143|470050223|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
130569389|NCT03029143|470050224|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
130569390|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
130512907|NCT00396097|469844318|FG000|Overall Study|Withdrawal by Subject|17|||
130512908|NCT00396097|469844319|FG001|Overall Study|Withdrawal by Subject|17|||
130512909|NCT00396097|469844318|FG000|Overall Study|Lost to Follow-up|4|||
130512910|NCT00396097|469844319|FG001|Overall Study|Lost to Follow-up|9|||
130512911|NCT00396097|469844318|FG000|Overall Study|Other|3|||
130512912|NCT00396097|469844319|FG001|Overall Study|Other|5|||
130512913|NCT00396097|469844318|FG000|Overall Study|Protocol Violation|0|||
130512914|NCT00396097|469844319|FG001|Overall Study|Protocol Violation|6|||
130512915|NCT00396097|469844318|FG000|Overall Study|Adverse Event|1|||
130512916|NCT00396097|469844319|FG001|Overall Study|Adverse Event|5|||
130512917|NCT00396097|469844318|FG000|Overall Study|Insufficient Clinical Response|1|||
130512918|NCT00396097|469844319|FG001|Overall Study|Insufficient Clinical Response|4|||
130512919|NCT01732588|469844320|FG000|First Intervention (7 Days)|Adverse Event|0|||
130512920|NCT01732588|469844321|FG001|First Intervention (7 Days)|Adverse Event|1|||
130512921|NCT01732588|469844322|FG002|First Intervention (7 Days)|Adverse Event|0|||
130512922|NCT00730925|469844325|FG000|Overall Study|Progressive Disease|21|||
130512923|NCT00730925|469844325|FG000|Overall Study|Dose reducing Event|2|||
130512924|NCT00730925|469844325|FG000|Overall Study|Other Averse Event|7|||
130512925|NCT00730925|469844325|FG000|Overall Study|Protocol Violation|1|||
130512926|NCT00730925|469844325|FG000|Overall Study|Withdrawal by Subject|1|||
130512927|NCT00730925|469844325|FG000|Overall Study|Switch to combination therapy|8|||
130512928|NCT00730925|469844325|FG000|Overall Study|Other|1|||
130512929|NCT00191984|469844332|FG000|Overall Study|Disease Progression|21|||
130512930|NCT00191984|469844332|FG000|Overall Study|Adverse Event|4|||
130512931|NCT00191984|469844332|FG000|Overall Study|Death|2|||
130512932|NCT00191984|469844332|FG000|Overall Study|Entry Criteria Exclusion|1|||
130512933|NCT00191984|469844332|FG000|Overall Study|Withdrawal by Subject|7|||
130512934|NCT00191984|469844332|FG000|Overall Study|Physician Decision|4|||
130512935|NCT01732627|469844333|FG000|Overall Study|Withdrawal by Subject|1|||
130512936|NCT01732627|469844334|FG001|Overall Study|Withdrawal by Subject|0|||
130512937|NCT00005908|469844337|FG000|Overall Study|Withdrawal by Subject|1|||
130512938|NCT00005908|469844338|FG001|Overall Study|Withdrawal by Subject|0|||
130512939|NCT04736602|469844341|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
130512940|NCT04736602|469844341|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
130512941|NCT02131155|469844347|FG000|Overall Study|Adverse Event|1|||
130512942|NCT02131155|469844348|FG001|Overall Study|Adverse Event|0|||
130512943|NCT02131155|469844347|FG000|Overall Study|Treatment completed|1|||
130512944|NCT02131155|469844348|FG001|Overall Study|Treatment completed|0|||
130512945|NCT02131155|469844347|FG000|Overall Study|Primary tumour recurrence|2|||
130512946|NCT02131155|469844348|FG001|Overall Study|Primary tumour recurrence|1|||
130512947|NCT02131155|469844347|FG000|Overall Study|Refused to continue study medication|1|||
130512948|NCT02131155|469844348|FG001|Overall Study|Refused to continue study medication|0|||
130512949|NCT02131155|469844347|FG000|Overall Study|Study early termination|20|||
130512950|NCT02131155|469844348|FG001|Overall Study|Study early termination|10|||
130512951|NCT01887418|469844349|FG000|Overall Study|Travelling difficulties|0|||
130512952|NCT01887418|469844350|FG001|Overall Study|Travelling difficulties|0|||
130512953|NCT01887418|469844351|FG002|Overall Study|Travelling difficulties|1|||
130512954|NCT00475735|469844352|FG000|Treatment Period 1|Adverse Event|2|||
130512955|NCT00475735|469844353|FG001|Treatment Period 1|Adverse Event|0|||
130512956|NCT00475735|469844354|FG002|Treatment Period 1|Adverse Event|0|||
130512957|NCT00475735|469844355|FG003|Treatment Period 1|Adverse Event|0|||
130512958|NCT00475735|469844356|FG004|Treatment Period 1|Adverse Event|0|||
130512959|NCT00475735|469844357|FG005|Treatment Period 1|Adverse Event|0|||
130512960|NCT00475735|469844352|FG000|Treatment Period 1|Lack of Efficacy|1|||
130512961|NCT00475735|469844353|FG001|Treatment Period 1|Lack of Efficacy|0|||
130512962|NCT00475735|469844354|FG002|Treatment Period 1|Lack of Efficacy|0|||
130512963|NCT00475735|469844355|FG003|Treatment Period 1|Lack of Efficacy|0|||
130512964|NCT00475735|469844356|FG004|Treatment Period 1|Lack of Efficacy|0|||
130512965|NCT00475735|469844357|FG005|Treatment Period 1|Lack of Efficacy|0|||
130512966|NCT00475735|469844352|FG000|Treatment Period 1|Lost to Follow-up|0|||
130512967|NCT00475735|469844353|FG001|Treatment Period 1|Lost to Follow-up|0|||
130512968|NCT00475735|469844354|FG002|Treatment Period 1|Lost to Follow-up|0|||
130512969|NCT00475735|469844355|FG003|Treatment Period 1|Lost to Follow-up|0|||
130512970|NCT00475735|469844356|FG004|Treatment Period 1|Lost to Follow-up|0|||
130512971|NCT00475735|469844357|FG005|Treatment Period 1|Lost to Follow-up|1|||
130512972|NCT00475735|469844352|FG000|Treatment Period 1|Protocol Violation|0|||
130512973|NCT00475735|469844353|FG001|Treatment Period 1|Protocol Violation|0|||
130512974|NCT00475735|469844354|FG002|Treatment Period 1|Protocol Violation|0|||
130512975|NCT00475735|469844355|FG003|Treatment Period 1|Protocol Violation|1|||
130512976|NCT00475735|469844356|FG004|Treatment Period 1|Protocol Violation|0|||
130512977|NCT00475735|469844357|FG005|Treatment Period 1|Protocol Violation|0|||
130512978|NCT00475735|469844352|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130512979|NCT00475735|469844353|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130512980|NCT00475735|469844354|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130512981|NCT00475735|469844355|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130512982|NCT00475735|469844356|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130512983|NCT00475735|469844357|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130512984|NCT00475735|469844352|FG000|Treatment Period 1|DC due to AE but continuing|0|||
130512985|NCT00475735|469844353|FG001|Treatment Period 1|DC due to AE but continuing|0|||
130512986|NCT00475735|469844354|FG002|Treatment Period 1|DC due to AE but continuing|0|||
130512987|NCT00475735|469844355|FG003|Treatment Period 1|DC due to AE but continuing|1|||
130512988|NCT00475735|469844356|FG004|Treatment Period 1|DC due to AE but continuing|2|||
130512989|NCT00475735|469844357|FG005|Treatment Period 1|DC due to AE but continuing|2|||
130569391|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
130569392|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
130569393|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
130569394|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
130569395|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
130569396|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130569397|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130569398|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
130569399|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
130569400|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
130569401|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
130569402|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130569403|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
130569404|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
130569405|NCT03029143|470050222|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
130569406|NCT03029143|470050223|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
130569407|NCT03029143|470050224|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
130569408|NCT00607386|470050225|FG000|Overall Study|Physician Decision|1|||
130569409|NCT00974675|470050228|FG000|Overall Study|Adverse Event|2|||
130569410|NCT00974675|470050229|FG001|Overall Study|Adverse Event|1|||
130569411|NCT00974675|470050230|FG002|Overall Study|Adverse Event|1|||
130569412|NCT00974675|470050231|FG003|Overall Study|Adverse Event|1|||
130569413|NCT00974675|470050228|FG000|Overall Study|Physician Decision|0|||
130569414|NCT00974675|470050229|FG001|Overall Study|Physician Decision|0|||
130569415|NCT00974675|470050230|FG002|Overall Study|Physician Decision|1|||
130569416|NCT00974675|470050231|FG003|Overall Study|Physician Decision|0|||
130569417|NCT00974675|470050228|FG000|Overall Study|Participant on holiday; unable to attend|0|||
130569418|NCT00974675|470050229|FG001|Overall Study|Participant on holiday; unable to attend|0|||
130569419|NCT00974675|470050230|FG002|Overall Study|Participant on holiday; unable to attend|0|||
130569420|NCT00974675|470050231|FG003|Overall Study|Participant on holiday; unable to attend|1|||
130569421|NCT02121262|470050232|FG000|Overall Study|Adverse Event|6|||
130569422|NCT02121262|470050233|FG001|Overall Study|Adverse Event|3|||
130569423|NCT02121262|470050232|FG000|Overall Study|Lack of Efficacy|3|||
130569424|NCT02121262|470050233|FG001|Overall Study|Lack of Efficacy|0|||
130569425|NCT02121262|470050232|FG000|Overall Study|Personal Reasons|19|||
130569426|NCT02121262|470050233|FG001|Overall Study|Personal Reasons|5|||
130569427|NCT02121262|470050232|FG000|Overall Study|Protocol Violation|1|||
130569428|NCT02121262|470050233|FG001|Overall Study|Protocol Violation|1|||
130569429|NCT02121262|470050232|FG000|Overall Study|Participant Dropped-out|0|||
130569430|NCT02121262|470050233|FG001|Overall Study|Participant Dropped-out|1|||
130569431|NCT02121262|470050232|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
130569432|NCT02121262|470050233|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
130569433|NCT02121262|470050232|FG000|Overall Study|Consent Withdrawn|1|||
130569434|NCT02121262|470050233|FG001|Overall Study|Consent Withdrawn|0|||
130569435|NCT01765920|470050237|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
130569436|NCT01765920|470050238|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
130569437|NCT01765920|470050237|FG000|Overall Study|Patient code disclosure|0|||
130569438|NCT01765920|470050238|FG001|Overall Study|Patient code disclosure|1|||
130569439|NCT01081249|470050239|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
130569440|NCT01081249|470050240|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
130569441|NCT02411539|470050241|FG000|Overall Study|Lost to Follow-up|2|||
130569442|NCT02411539|470050242|FG001|Overall Study|Lost to Follow-up|0|||
130569443|NCT02411539|470050241|FG000|Overall Study|Confounding medical condition|0|||
130569444|NCT02411539|470050242|FG001|Overall Study|Confounding medical condition|1|||
130569445|NCT00282334|470050243|FG000|Overall Study|Withdrawal by Subject|8|||
130569446|NCT00282334|470050244|FG001|Overall Study|Withdrawal by Subject|5|||
130569447|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
130569448|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
130569449|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
130569450|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
130569451|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
130569452|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
130569453|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
130569454|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
130569455|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
130569456|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
130569457|NCT04041284|470050245|FG000|DB Phase (12 Weeks)|Other than specified|1|||
130569458|NCT04041284|470050246|FG001|DB Phase (12 Weeks)|Other than specified|0|||
130569459|NCT04041284|470050245|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130569460|NCT04041284|470050246|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130569461|NCT04041284|470050245|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
130512990|NCT00475735|469844352|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130512991|NCT00475735|469844353|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
130512992|NCT00475735|469844354|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130512993|NCT00475735|469844355|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130512994|NCT00475735|469844356|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130512995|NCT00475735|469844357|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130512996|NCT00475735|469844352|FG000|Treatment Washout|Lost to Follow-up|0|||
130512997|NCT00475735|469844353|FG001|Treatment Washout|Lost to Follow-up|1|||
130512998|NCT00475735|469844354|FG002|Treatment Washout|Lost to Follow-up|0|||
130512999|NCT00475735|469844355|FG003|Treatment Washout|Lost to Follow-up|0|||
130513000|NCT00475735|469844356|FG004|Treatment Washout|Lost to Follow-up|0|||
130513001|NCT00475735|469844357|FG005|Treatment Washout|Lost to Follow-up|0|||
130513002|NCT00475735|469844352|FG000|Treatment Washout|Protocol Violation|0|||
130513003|NCT00475735|469844353|FG001|Treatment Washout|Protocol Violation|1|||
130513004|NCT00475735|469844354|FG002|Treatment Washout|Protocol Violation|0|||
130513005|NCT00475735|469844355|FG003|Treatment Washout|Protocol Violation|0|||
130513006|NCT00475735|469844356|FG004|Treatment Washout|Protocol Violation|0|||
130513007|NCT00475735|469844357|FG005|Treatment Washout|Protocol Violation|0|||
130569462|NCT04041284|470050246|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
130569463|NCT04041284|470050245|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
130569464|NCT04041284|470050246|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
130569465|NCT04041284|470050245|FG000|OL Phase (12 Weeks)|Other than specified|6|||
130569466|NCT04041284|470050246|FG001|OL Phase (12 Weeks)|Other than specified|2|||
130569467|NCT00886600|470050251|FG000|Double-blind Monotherapy|Adverse Event|1|||
130569468|NCT00886600|470050252|FG001|Double-blind Monotherapy|Adverse Event|1|||
130569469|NCT00886600|470050253|FG002|Double-blind Monotherapy|Adverse Event|1|||
130569470|NCT00886600|470050254|FG003|Double-blind Monotherapy|Adverse Event|1|||
130569471|NCT00886600|470050251|FG000|Double-blind Monotherapy|Protocol Violation|0|||
130569472|NCT00886600|470050252|FG001|Double-blind Monotherapy|Protocol Violation|0|||
130569473|NCT00886600|470050253|FG002|Double-blind Monotherapy|Protocol Violation|0|||
130569474|NCT00886600|470050254|FG003|Double-blind Monotherapy|Protocol Violation|1|||
130569475|NCT00886600|470050251|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
130569476|NCT00886600|470050252|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
130569477|NCT00886600|470050253|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
130569478|NCT00886600|470050254|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
130569479|NCT00886600|470050251|FG000|Combination Therapy Period|Adverse Event|0|||
130569480|NCT00886600|470050252|FG001|Combination Therapy Period|Adverse Event|0|||
130569481|NCT00886600|470050253|FG002|Combination Therapy Period|Adverse Event|1|||
130569482|NCT00886600|470050254|FG003|Combination Therapy Period|Adverse Event|0|||
130569483|NCT00886600|470050251|FG000|Combination Therapy Period|Protocol Violation|0|||
130569484|NCT00886600|470050252|FG001|Combination Therapy Period|Protocol Violation|0|||
130569485|NCT00886600|470050253|FG002|Combination Therapy Period|Protocol Violation|1|||
130569486|NCT00886600|470050254|FG003|Combination Therapy Period|Protocol Violation|0|||
130569487|NCT01439204|470050255|FG000|Overall Study|Withdrawal by Subject|0|||
130569488|NCT01439204|470050256|FG001|Overall Study|Withdrawal by Subject|1|||
130569489|NCT01439204|470050255|FG000|Overall Study|Lost to Follow-up|0|||
130569490|NCT01439204|470050256|FG001|Overall Study|Lost to Follow-up|2|||
130569491|NCT01439204|470050255|FG000|Overall Study|No longer meets study criteria|1|||
130569492|NCT01439204|470050256|FG001|Overall Study|No longer meets study criteria|0|||
130569493|NCT01439204|470050255|FG000|Overall Study|poor/non-compliance|3|||
130569494|NCT01439204|470050256|FG001|Overall Study|poor/non-compliance|0|||
130569495|NCT00754793|470050259|FG000|Overall Study|voluntary withdrawn from study|0|||
130569496|NCT00754793|470050260|FG001|Overall Study|voluntary withdrawn from study|1|||
130648311|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
130648312|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648313|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648314|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648315|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648316|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648317|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130648318|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648319|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130513008|NCT00475735|469844352|FG000|Treatment Period 2|Adverse Event|0|||
130648320|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648321|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648322|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648323|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
130648324|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648325|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648326|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648327|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130569497|NCT01135498|470051776|FG000|Overall Study|Adverse Event|20|||
130513009|NCT00475735|469844353|FG001|Treatment Period 2|Adverse Event|1|||
130513010|NCT00475735|469844354|FG002|Treatment Period 2|Adverse Event|0|||
130513011|NCT00475735|469844355|FG003|Treatment Period 2|Adverse Event|2|||
130513012|NCT00475735|469844356|FG004|Treatment Period 2|Adverse Event|0|||
130513013|NCT00475735|469844357|FG005|Treatment Period 2|Adverse Event|0|||
130513014|NCT00475735|469844352|FG000|Treatment Period 2|Lack of Efficacy|0|||
130513015|NCT00475735|469844353|FG001|Treatment Period 2|Lack of Efficacy|0|||
130513016|NCT00475735|469844354|FG002|Treatment Period 2|Lack of Efficacy|0|||
130513017|NCT00475735|469844355|FG003|Treatment Period 2|Lack of Efficacy|0|||
130513018|NCT00475735|469844356|FG004|Treatment Period 2|Lack of Efficacy|0|||
130513019|NCT00475735|469844357|FG005|Treatment Period 2|Lack of Efficacy|1|||
130513020|NCT00475735|469844352|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130513021|NCT00475735|469844353|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130513022|NCT00475735|469844354|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130513023|NCT00475735|469844355|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130513024|NCT00475735|469844356|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130513025|NCT00475735|469844357|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130513026|NCT03132753|469844358|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
130513027|NCT03132753|469844359|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
130513028|NCT03132753|469844358|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
130513029|NCT03132753|469844359|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
130513030|NCT00125853|469844360|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
130513031|NCT00125853|469844361|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
130513032|NCT02350127|469844365|FG000|4-Month Assessment|Withdrawal by Subject|10|||
130513033|NCT02350127|469844366|FG001|4-Month Assessment|Withdrawal by Subject|9|||
130513034|NCT02350127|469844365|FG000|4-Month Assessment|Death|1|||
130513035|NCT02350127|469844366|FG001|4-Month Assessment|Death|0|||
130513036|NCT02350127|469844365|FG000|8-Month Assessment|Death|1|||
130513037|NCT02350127|469844366|FG001|8-Month Assessment|Death|1|||
130513038|NCT02350127|469844365|FG000|8-Month Assessment|Withdrawal by Subject|5|||
130513039|NCT02350127|469844366|FG001|8-Month Assessment|Withdrawal by Subject|8|||
130513040|NCT02097056|469844367|FG000|Overall Study|Protocol Violation|2|||
130513041|NCT02097056|469844367|FG000|Overall Study|Withdrawal by Subject|15|||
130513042|NCT02097056|469844367|FG000|Overall Study|Lost to Follow-up|2|||
130513043|NCT02097056|469844367|FG000|Overall Study|Adverse Event|37|||
130513044|NCT02097056|469844367|FG000|Overall Study|Other|2|||
130513045|NCT02359552|469844374|FG000|Overall Study|Lost to Follow-up|3|||
130513046|NCT02359552|469844375|FG001|Overall Study|Lost to Follow-up|4|||
130513047|NCT01395914|469844383|FG000|Overall Study|Unrelated to study drug AE|6|||
130513048|NCT01395914|469844384|FG001|Overall Study|Unrelated to study drug AE|1|||
130513049|NCT01395914|469844383|FG000|Overall Study|Death|23|||
130513050|NCT01395914|469844384|FG001|Overall Study|Death|17|||
130513051|NCT01395914|469844383|FG000|Overall Study|Other|9|||
130513052|NCT01395914|469844384|FG001|Overall Study|Other|3|||
130513053|NCT01395914|469844383|FG000|Overall Study|Withdrawal by patient|27|||
130513054|NCT01395914|469844384|FG001|Overall Study|Withdrawal by patient|14|||
130513055|NCT01395914|469844383|FG000|Overall Study|Study drug-related AE|1|||
130513056|NCT01395914|469844384|FG001|Overall Study|Study drug-related AE|0|||
130513057|NCT01395914|469844383|FG000|Overall Study|Lost to Follow-up|6|||
130513058|NCT01395914|469844384|FG001|Overall Study|Lost to Follow-up|2|||
130513059|NCT03023878|469844385|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
130513060|NCT03023878|469844385|FG000|Pre-Study Run-In Period|Death|1|||
130513061|NCT03023878|469844385|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
130513062|NCT03023878|469844385|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
130513063|NCT03023878|469844385|FG000|Treatment Period|Disease Progression|1|||
130513064|NCT03023878|469844385|FG000|Treatment Period|Withdrawal by Subject|1|||
130513065|NCT03023878|469844385|FG000|Treatment Period|Adverse Event|1|||
130513066|NCT03023878|469844385|FG000|Long Term Follow-Up Period|Death|2|||
130569498|NCT01135498|470051776|FG000|Overall Study|Progressive disease|38|||
130569499|NCT01135498|470051776|FG000|Overall Study|Investigator judgement|25|||
130569500|NCT01135498|470051776|FG000|Overall Study|Withdrawal by Subject|4|||
130569501|NCT01135498|470051776|FG000|Overall Study|Death|1|||
130513067|NCT01247922|469844389|FG000|Overall Study|Disease progression|4|||
130513068|NCT01876823|469844392|FG000|Overall Study|Withdrawal by Subject|5|||
130513069|NCT01876823|469844392|FG000|Overall Study|Physician Decision|2|||
130513070|NCT01876823|469844392|FG000|Overall Study|Patients moved|2|||
130513071|NCT02849509|469844393|FG000|Overall Study|Worsening of disease under study|1|||
130513072|NCT02849509|469844394|FG001|Overall Study|Worsening of disease under study|1|||
130513073|NCT02849509|469844395|FG002|Overall Study|Worsening of disease under study|1|||
130513074|NCT02849509|469844393|FG000|Overall Study|Worsening of other pre-existing disease|0|||
130513075|NCT02849509|469844394|FG001|Overall Study|Worsening of other pre-existing disease|1|||
130513076|NCT02849509|469844395|FG002|Overall Study|Worsening of other pre-existing disease|2|||
130513077|NCT02849509|469844393|FG000|Overall Study|Other adverse event|36|||
130513078|NCT02849509|469844394|FG001|Overall Study|Other adverse event|41|||
130513079|NCT02849509|469844395|FG002|Overall Study|Other adverse event|8|||
130569502|NCT01135498|470051776|FG000|Overall Study|Ongoing at time of analysis|2|||
130513080|NCT02849509|469844393|FG000|Overall Study|Withdrawal by Subject|6|||
130513081|NCT02849509|469844394|FG001|Overall Study|Withdrawal by Subject|17|||
130513082|NCT02849509|469844395|FG002|Overall Study|Withdrawal by Subject|12|||
130513083|NCT02849509|469844393|FG000|Overall Study|Lost to Follow-up|27|||
130513084|NCT02849509|469844394|FG001|Overall Study|Lost to Follow-up|67|||
130513085|NCT02849509|469844395|FG002|Overall Study|Lost to Follow-up|36|||
130513086|NCT02849509|469844393|FG000|Overall Study|Other, reason not specified|14|||
130513087|NCT02849509|469844394|FG001|Overall Study|Other, reason not specified|29|||
130513088|NCT02849509|469844395|FG002|Overall Study|Other, reason not specified|25|||
130513089|NCT02849509|469844393|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
130513090|NCT02849509|469844394|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
130513091|NCT02849509|469844395|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
130513092|NCT00985621|469844398|FG000|Overall Study|Adverse Event|2|||
130513093|NCT00985621|469844399|FG001|Overall Study|Adverse Event|3|||
130513094|NCT00985621|469844400|FG002|Overall Study|Adverse Event|4|||
130513095|NCT00985621|469844401|FG003|Overall Study|Adverse Event|16|||
130513096|NCT00985621|469844398|FG000|Overall Study|Lack of Efficacy|10|||
130513097|NCT00985621|469844399|FG001|Overall Study|Lack of Efficacy|6|||
130513098|NCT00985621|469844400|FG002|Overall Study|Lack of Efficacy|5|||
130513099|NCT00985621|469844401|FG003|Overall Study|Lack of Efficacy|12|||
130513100|NCT00985621|469844398|FG000|Overall Study|Lost to Follow-up|2|||
130513101|NCT00985621|469844399|FG001|Overall Study|Lost to Follow-up|3|||
130513102|NCT00985621|469844400|FG002|Overall Study|Lost to Follow-up|4|||
130513103|NCT00985621|469844401|FG003|Overall Study|Lost to Follow-up|4|||
130513104|NCT00985621|469844398|FG000|Overall Study|Study Terminated by Sponsor|89|||
130513105|NCT00985621|469844399|FG001|Overall Study|Study Terminated by Sponsor|108|||
130513106|NCT00985621|469844400|FG002|Overall Study|Study Terminated by Sponsor|99|||
130513107|NCT00985621|469844401|FG003|Overall Study|Study Terminated by Sponsor|92|||
130513108|NCT00985621|469844398|FG000|Overall Study|Protocol Violation|1|||
130513109|NCT00985621|469844399|FG001|Overall Study|Protocol Violation|1|||
130513110|NCT00985621|469844400|FG002|Overall Study|Protocol Violation|1|||
130513111|NCT00985621|469844401|FG003|Overall Study|Protocol Violation|0|||
130513112|NCT00985621|469844398|FG000|Overall Study|Withdrawal by Subject|8|||
130513113|NCT00985621|469844399|FG001|Overall Study|Withdrawal by Subject|10|||
130513114|NCT00985621|469844400|FG002|Overall Study|Withdrawal by Subject|8|||
130513115|NCT00985621|469844401|FG003|Overall Study|Withdrawal by Subject|12|||
130513116|NCT00985621|469844398|FG000|Overall Study|Other|1|||
130513117|NCT00985621|469844399|FG001|Overall Study|Other|0|||
130513118|NCT00985621|469844400|FG002|Overall Study|Other|0|||
130513119|NCT00985621|469844401|FG003|Overall Study|Other|0|||
130513120|NCT00985621|469844398|FG000|Overall Study|Randomized but not Treated|1|||
130513121|NCT00985621|469844399|FG001|Overall Study|Randomized but not Treated|0|||
130513122|NCT00985621|469844400|FG002|Overall Study|Randomized but not Treated|2|||
130513123|NCT00985621|469844401|FG003|Overall Study|Randomized but not Treated|1|||
130513124|NCT01911819|469844402|FG000|Overall Study|Adverse Event|0|||
130513125|NCT01911819|469844403|FG001|Overall Study|Adverse Event|1|||
130513126|NCT01911819|469844404|FG002|Overall Study|Adverse Event|0|||
130513127|NCT01911819|469844402|FG000|Overall Study|Withdrawal by Subject|1|||
130513128|NCT01911819|469844403|FG001|Overall Study|Withdrawal by Subject|1|||
130513129|NCT01911819|469844404|FG002|Overall Study|Withdrawal by Subject|0|||
130513130|NCT00257556|469844405|FG000|Overall Study|Adverse Event|1|||
130513131|NCT00257556|469844406|FG001|Overall Study|Adverse Event|4|||
130513132|NCT00257556|469844405|FG000|Overall Study|Physician Decision|6|||
130513133|NCT00257556|469844406|FG001|Overall Study|Physician Decision|0|||
130513134|NCT00257556|469844405|FG000|Overall Study|Did not meet hCG criterion|3|||
130513135|NCT00257556|469844406|FG001|Overall Study|Did not meet hCG criterion|0|||
130513136|NCT00257556|469844405|FG000|Overall Study|other reason|4|||
130513137|NCT00257556|469844406|FG001|Overall Study|other reason|6|||
130513138|NCT03849300|469844407|FG000|Overall Study|move out to different area|1|||
130513139|NCT03849300|469844408|FG001|Overall Study|move out to different area|3|||
130513140|NCT03849300|469844409|FG002|Overall Study|move out to different area|1|||
130513141|NCT03849300|469844410|FG003|Overall Study|move out to different area|4|||
130513142|NCT03849300|469844407|FG000|Overall Study|scheduling/transportation conflict|4|||
130513143|NCT03849300|469844408|FG001|Overall Study|scheduling/transportation conflict|4|||
130513144|NCT03849300|469844409|FG002|Overall Study|scheduling/transportation conflict|3|||
130513145|NCT03849300|469844410|FG003|Overall Study|scheduling/transportation conflict|2|||
130513146|NCT04839289|469844411|FG000|Overall Study|Withdrawal by Subject|1|||
130513147|NCT04839289|469844412|FG001|Overall Study|Withdrawal by Subject|0|||
130513148|NCT04743999|469844414|FG000|3-month Questionnaire|Death|1|||
130513149|NCT04743999|469844414|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
130513150|NCT04743999|469844414|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
130513151|NCT04743999|469844414|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
130513152|NCT00464737|469844415|FG000|Overall Study|Adverse Event|12|||
130513153|NCT00464737|469844416|FG001|Overall Study|Adverse Event|17|||
130513154|NCT00464737|469844417|FG002|Overall Study|Adverse Event|33|||
130513155|NCT00464737|469844415|FG000|Overall Study|Lack of Efficacy|7|||
130513156|NCT00464737|469844416|FG001|Overall Study|Lack of Efficacy|7|||
130569503|NCT01594853|470051777|FG000|Overall Study|Withdrawal by Subject|1|||
130569504|NCT01594853|470051778|FG001|Overall Study|Withdrawal by Subject|1|||
130569505|NCT01594853|470051777|FG000|Overall Study|Lost to Follow-up|1|||
130569506|NCT01594853|470051778|FG001|Overall Study|Lost to Follow-up|1|||
130569507|NCT01594853|470051777|FG000|Overall Study|noncompliance with exercise|0|||
130569508|NCT01594853|470051778|FG001|Overall Study|noncompliance with exercise|1|||
130569509|NCT03548935|470051779|FG000|Overall Study|Withdrawal by Subject|26|||
130569510|NCT03548935|470051780|FG001|Overall Study|Withdrawal by Subject|17|||
130569511|NCT03548935|470051779|FG000|Overall Study|Lost to Follow-up|39|||
130569512|NCT03548935|470051780|FG001|Overall Study|Lost to Follow-up|28|||
130569513|NCT03548935|470051779|FG000|Overall Study|Death|1|||
130569514|NCT03548935|470051780|FG001|Overall Study|Death|1|||
130569515|NCT03571646|470051781|FG000|Overall Study|Adverse Event|1|||
130569516|NCT03571646|470051782|FG001|Overall Study|Adverse Event|0|||
130569517|NCT03571646|470051781|FG000|Overall Study|Withdrawal by Subject|1|||
130569518|NCT03571646|470051782|FG001|Overall Study|Withdrawal by Subject|1|||
130569519|NCT04677959|470051783|FG000|Overall Study|Adverse Event|1|||
130569520|NCT04677959|470051784|FG001|Overall Study|Adverse Event|9|||
130569521|NCT04677959|470051783|FG000|Overall Study|Withdrawal by Subject|2|||
130569522|NCT04677959|470051784|FG001|Overall Study|Withdrawal by Subject|15|||
130569523|NCT04677959|470051783|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130569524|NCT04677959|470051784|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130569525|NCT04677959|470051783|FG000|Overall Study|Non-compliance with study drug|0|||
130569526|NCT04677959|470051784|FG001|Overall Study|Non-compliance with study drug|2|||
130569527|NCT04677959|470051783|FG000|Overall Study|Protocol deviation|0|||
130569528|NCT04677959|470051784|FG001|Overall Study|Protocol deviation|11|||
130569529|NCT04677959|470051783|FG000|Overall Study|Lost to Follow-up|9|||
130569530|NCT04677959|470051784|FG001|Overall Study|Lost to Follow-up|13|||
130569531|NCT04677959|470051783|FG000|Overall Study|Other than specified|0|||
130569532|NCT04677959|470051784|FG001|Overall Study|Other than specified|8|||
130569533|NCT00763815|470051785|FG000|Overall Study|Adverse Event|14|||
130569534|NCT00763815|470051786|FG001|Overall Study|Adverse Event|29|||
130569535|NCT00763815|470051785|FG000|Overall Study|Lack of Efficacy|10|||
130569536|NCT00763815|470051786|FG001|Overall Study|Lack of Efficacy|11|||
130569537|NCT00763815|470051785|FG000|Overall Study|Poor Compliance to Protocol|6|||
130569538|NCT00763815|470051786|FG001|Overall Study|Poor Compliance to Protocol|6|||
130569539|NCT00763815|470051785|FG000|Overall Study|Lost to Follow-up|2|||
130569540|NCT00763815|470051786|FG001|Overall Study|Lost to Follow-up|4|||
130569541|NCT00763815|470051785|FG000|Overall Study|Early Termination|1|||
130569542|NCT00763815|470051786|FG001|Overall Study|Early Termination|0|||
130569543|NCT00763815|470051785|FG000|Overall Study|Familial and Personal Reasons|9|||
130569544|NCT00763815|470051786|FG001|Overall Study|Familial and Personal Reasons|16|||
130569545|NCT00763815|470051785|FG000|Overall Study|Physician Decision|1|||
130569546|NCT00763815|470051786|FG001|Overall Study|Physician Decision|0|||
130569547|NCT00763815|470051785|FG000|Overall Study|Withdrawal by Subject|7|||
130569548|NCT00763815|470051786|FG001|Overall Study|Withdrawal by Subject|12|||
130569549|NCT00763815|470051785|FG000|Overall Study|Protocol Violation|2|||
130569550|NCT00763815|470051786|FG001|Overall Study|Protocol Violation|5|||
130569551|NCT00763815|470051785|FG000|Overall Study|Sponsor's Decision|0|||
130569552|NCT00763815|470051786|FG001|Overall Study|Sponsor's Decision|1|||
130513157|NCT00464737|469844417|FG002|Overall Study|Lack of Efficacy|4|||
130513158|NCT00464737|469844415|FG000|Overall Study|Withdrawal by Subject|5|||
130513159|NCT00464737|469844416|FG001|Overall Study|Withdrawal by Subject|3|||
130513160|NCT00464737|469844417|FG002|Overall Study|Withdrawal by Subject|5|||
130513161|NCT00464737|469844415|FG000|Overall Study|Protocol Violation|1|||
130513162|NCT00464737|469844416|FG001|Overall Study|Protocol Violation|1|||
130513163|NCT00464737|469844417|FG002|Overall Study|Protocol Violation|5|||
130513164|NCT00464737|469844415|FG000|Overall Study|Non-compliance|0|||
130513165|NCT00464737|469844416|FG001|Overall Study|Non-compliance|1|||
130513166|NCT00464737|469844417|FG002|Overall Study|Non-compliance|1|||
130513167|NCT00464737|469844415|FG000|Overall Study|Lost to Follow-up|5|||
130513168|NCT00464737|469844416|FG001|Overall Study|Lost to Follow-up|2|||
130513169|NCT00464737|469844417|FG002|Overall Study|Lost to Follow-up|5|||
130513170|NCT00464737|469844415|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
130513171|NCT00464737|469844416|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
130513172|NCT00464737|469844417|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
130513173|NCT00464737|469844415|FG000|Overall Study|Other: Subject left town; family illness|1|||
130513174|NCT00464737|469844416|FG001|Overall Study|Other: Subject left town; family illness|0|||
130513175|NCT00464737|469844417|FG002|Overall Study|Other: Subject left town; family illness|0|||
130513176|NCT00464737|469844415|FG000|Overall Study|Other: Study demands too great|0|||
130513177|NCT00464737|469844416|FG001|Overall Study|Other: Study demands too great|1|||
130513178|NCT00464737|469844417|FG002|Overall Study|Other: Study demands too great|0|||
130513179|NCT00464737|469844415|FG000|Overall Study|Other: Personal family reasons|0|||
130513180|NCT00464737|469844416|FG001|Overall Study|Other: Personal family reasons|0|||
130513181|NCT00464737|469844417|FG002|Overall Study|Other: Personal family reasons|1|||
130513182|NCT00464737|469844415|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
130513183|NCT00464737|469844416|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
130513184|NCT00464737|469844417|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
130513185|NCT01207453|469844418|FG000|First Intervention|Adverse Event|2|||
130513186|NCT01207453|469844419|FG001|First Intervention|Adverse Event|1|||
130513187|NCT01207453|469844418|FG000|Washout|Adverse Event|1|||
130513188|NCT01207453|469844419|FG001|Washout|Adverse Event|0|||
130513189|NCT01207453|469844418|FG000|Washout|Lost to Follow-up|1|||
130513190|NCT01207453|469844419|FG001|Washout|Lost to Follow-up|0|||
130513191|NCT01207453|469844418|FG000|2nd Intervention|Adverse Event|1|||
130513192|NCT01207453|469844419|FG001|2nd Intervention|Adverse Event|2|||
130513193|NCT01207453|469844418|FG000|2nd Intervention|Lost to Follow-up|1|||
130513194|NCT01207453|469844419|FG001|2nd Intervention|Lost to Follow-up|0|||
130513195|NCT00676663|469844422|FG000|Overall Study|Death|43|||
130513196|NCT00676663|469844423|FG001|Overall Study|Death|27|||
130513197|NCT00676663|469844422|FG000|Overall Study|Withdrew Consent|1|||
130513198|NCT00676663|469844423|FG001|Overall Study|Withdrew Consent|8|||
130513199|NCT00676663|469844422|FG000|Overall Study|Lost to Follow-up|1|||
130513200|NCT00676663|469844423|FG001|Overall Study|Lost to Follow-up|3|||
130513201|NCT00580047|469844424|FG000|Overall Study|Lost to Follow-up|1|||
130569553|NCT01970995|470051787|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130513202|NCT00580047|469844425|FG001|Overall Study|Lost to Follow-up|1|||
130513203|NCT00580047|469844426|FG002|Overall Study|Lost to Follow-up|0|||
130513204|NCT00580047|469844424|FG000|Overall Study|Withdrawal by Subject|1|||
130513205|NCT00580047|469844425|FG001|Overall Study|Withdrawal by Subject|1|||
130513206|NCT00580047|469844426|FG002|Overall Study|Withdrawal by Subject|2|||
130513207|NCT00580047|469844424|FG000|Overall Study|Withdrawal by Subject|1|||
130513208|NCT00580047|469844425|FG001|Overall Study|Withdrawal by Subject|0|||
130513209|NCT00580047|469844426|FG002|Overall Study|Withdrawal by Subject|0|||
130513210|NCT00170950|469844439|FG000|Overall Study|Death|236|||
130513211|NCT00170950|469844440|FG001|Overall Study|Death|274|||
130513212|NCT00170950|469844439|FG000|Overall Study|Withdrawal by Subject|496|||
130513213|NCT00170950|469844440|FG001|Overall Study|Withdrawal by Subject|498|||
130513214|NCT00170950|469844439|FG000|Overall Study|Lost to Follow-up|134|||
130513215|NCT00170950|469844440|FG001|Overall Study|Lost to Follow-up|115|||
130513216|NCT00170950|469844439|FG000|Overall Study|Missing|2|||
130569554|NCT01970995|470051788|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130569555|NCT01970995|470051789|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130569556|NCT01970995|470051787|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
130569557|NCT01970995|470051788|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
130569558|NCT01970995|470051789|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
130569559|NCT01263639|470051790|FG000|Overall Study|Lost to Follow-up|66|||
130569560|NCT01263639|470051791|FG001|Overall Study|Lost to Follow-up|70|||
130569561|NCT01263639|470051790|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
130569562|NCT01263639|470051791|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
130513217|NCT00170950|469844440|FG001|Overall Study|Missing|1|||
130513218|NCT00170950|469844439|FG000|Overall Study|Termination Data Not Recorded|17|||
130513219|NCT00170950|469844440|FG001|Overall Study|Termination Data Not Recorded|22|||
130513220|NCT00635570|469846113|FG000|Overall Study|Lost to Follow-up|8|||
130513221|NCT00635570|469846114|FG001|Overall Study|Lost to Follow-up|8|||
130513222|NCT00635570|469846113|FG000|Overall Study|Withdrawal by Subject|1|||
130513223|NCT00635570|469846114|FG001|Overall Study|Withdrawal by Subject|1|||
130513224|NCT00635570|469846113|FG000|Overall Study|Adverse Event|2|||
130513225|NCT00635570|469846114|FG001|Overall Study|Adverse Event|0|||
130569563|NCT01576549|470051792|FG000|Overall Study|Sponsor Decision|2|||
130569564|NCT02716987|470051805|FG000|Overall Study|Ligand synthesis failure|0|||
130513226|NCT00635570|469846113|FG000|Overall Study|Physician Decision|1|||
130513227|NCT00635570|469846114|FG001|Overall Study|Physician Decision|0|||
130513228|NCT00635570|469846113|FG000|Overall Study|Did not complete survey|2|||
130513229|NCT00635570|469846114|FG001|Overall Study|Did not complete survey|1|||
130513230|NCT00635570|469846113|FG000|Overall Study|Early termination(No sexual activity)|1|||
130513231|NCT00635570|469846114|FG001|Overall Study|Early termination(No sexual activity)|1|||
130513232|NCT00377312|469846125|FG000|Overall Study|Adverse Event|1|||
130513233|NCT00377312|469846126|FG001|Overall Study|Adverse Event|1|||
130513234|NCT02775214|469846127|FG000|Overall Study|Withdrawal by Subject|2|||
130513235|NCT02775214|469846128|FG001|Overall Study|Withdrawal by Subject|0|||
130513236|NCT00762723|469846129|FG000|Overall Study|Study Terminated slow enrollement|5|||
130513237|NCT00762723|469846130|FG001|Overall Study|Study Terminated slow enrollement|5|||
130513238|NCT00762723|469846131|FG002|Overall Study|Study Terminated slow enrollement|3|||
130513239|NCT01145417|469846132|FG000|Overall Study|Death|1|||
130513240|NCT01145417|469846133|FG001|Overall Study|Death|0|||
130513241|NCT01145417|469846132|FG000|Overall Study|Lost to Follow-up|2|||
130513242|NCT01145417|469846133|FG001|Overall Study|Lost to Follow-up|1|||
130513243|NCT01145417|469846132|FG000|Overall Study|Withdrawal by Subject|1|||
130513244|NCT01145417|469846133|FG001|Overall Study|Withdrawal by Subject|2|||
130513245|NCT01145417|469846132|FG000|Overall Study|Pregnancy|1|||
130513246|NCT01145417|469846133|FG001|Overall Study|Pregnancy|0|||
130513247|NCT01145417|469846132|FG000|Overall Study|Adverse Event|0|||
130513248|NCT01145417|469846133|FG001|Overall Study|Adverse Event|1|||
130513249|NCT01145417|469846132|FG000|Overall Study|Study terminated by sponsor|35|||
130513250|NCT01145417|469846133|FG001|Overall Study|Study terminated by sponsor|43|||
130513251|NCT01145417|469846132|FG000|Overall Study|Other|1|||
130513252|NCT01145417|469846133|FG001|Overall Study|Other|0|||
130513253|NCT01191697|469846134|FG000|Overall Study|Death|1|||
130513254|NCT01191697|469846134|FG000|Overall Study|Physician Decision|2|||
130513255|NCT01191697|469846134|FG000|Overall Study|Pursue chemoradiation|2|||
130513256|NCT01191697|469846134|FG000|Overall Study|Break from chemotherapy|2|||
130513257|NCT01191697|469846134|FG000|Overall Study|Withdrawal by Subject|1|||
130513258|NCT01191697|469846134|FG000|Overall Study|Surveillance|1|||
130513259|NCT01191697|469846134|FG000|Overall Study|Adverse Event|2|||
130513260|NCT01191697|469846134|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
130513261|NCT01191697|469846134|FG000|Overall Study|Not completed but analyzed|25|||
130513262|NCT03461211|469846148|FG000|Overall Study|Adverse Event|1|||
130513263|NCT03461211|469846149|FG001|Overall Study|Adverse Event|1|||
130513264|NCT03461211|469846148|FG000|Overall Study|Lack of Efficacy|0|||
130513265|NCT03461211|469846149|FG001|Overall Study|Lack of Efficacy|1|||
130513266|NCT01284634|469846150|FG000|Overall Study|Adverse Event|1|||
130513267|NCT01284634|469846151|FG001|Overall Study|Adverse Event|0|||
130513268|NCT01284634|469846152|FG002|Overall Study|Adverse Event|2|||
130513269|NCT01284634|469846153|FG003|Overall Study|Adverse Event|1|||
130513270|NCT03772041|469846155|FG000|Overall Study|Adverse Event|8|||
130513271|NCT03772041|469846156|FG001|Overall Study|Adverse Event|3|||
130513272|NCT03772041|469846155|FG000|Overall Study|Withdrawal by Subject|0|||
130513273|NCT03772041|469846156|FG001|Overall Study|Withdrawal by Subject|2|||
130513274|NCT03772041|469846155|FG000|Overall Study|Protocol Violation|4|||
130513275|NCT03772041|469846156|FG001|Overall Study|Protocol Violation|2|||
130513276|NCT03772041|469846155|FG000|Overall Study|Physician Decision|2|||
130513277|NCT03772041|469846156|FG001|Overall Study|Physician Decision|3|||
130513278|NCT01525641|469846157|FG000|Overall Study|Case report form not collected|25|||
130513279|NCT01525641|469846157|FG000|Overall Study|No visit since the first visit|16|||
130513280|NCT01525641|469846157|FG000|Overall Study|Adverse Event|73|||
130513281|NCT01525641|469846157|FG000|Overall Study|Lack of Efficacy|24|||
130513282|NCT01525641|469846157|FG000|Overall Study|Improvement|5|||
130513283|NCT01525641|469846157|FG000|Overall Study|Lost to follow-up (relocation)|1|||
130513284|NCT01525641|469846157|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
130513285|NCT01525641|469846157|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
130513286|NCT01525641|469846157|FG000|Overall Study|Other than stated above|7|||
130513287|NCT05012397|469846167|FG000|Overall Study|Death|10|||
130513288|NCT05012397|469846167|FG000|Overall Study|Physician Decision|9|||
130513289|NCT05012397|469846167|FG000|Overall Study|Withdrawal by Subject|5|||
130513290|NCT05012397|469846167|FG000|Overall Study|Lost to Follow-up|2|||
130513291|NCT03334747|469846168|FG000|Treatment Phase|Technical problems|0|||
130513292|NCT03334747|469846169|FG001|Treatment Phase|Technical problems|0|||
130513293|NCT03334747|469846170|FG002|Treatment Phase|Technical problems|0|||
130513294|NCT03334747|469846171|FG003|Treatment Phase|Technical problems|0|||
130513295|NCT03334747|469846172|FG004|Treatment Phase|Technical problems|1|||
130513296|NCT03334747|469846173|FG005|Treatment Phase|Technical problems|0|||
130513297|NCT03334747|469846174|FG006|Treatment Phase|Technical problems|0|||
130513298|NCT03334747|469846175|FG007|Treatment Phase|Technical problems|0|||
130513299|NCT03334747|469846176|FG008|Treatment Phase|Technical problems|0|||
130513300|NCT03334747|469846168|FG000|Treatment Phase|Subject/guardian decision|1|||
130513301|NCT03334747|469846169|FG001|Treatment Phase|Subject/guardian decision|0|||
130513302|NCT03334747|469846170|FG002|Treatment Phase|Subject/guardian decision|0|||
130513303|NCT03334747|469846171|FG003|Treatment Phase|Subject/guardian decision|0|||
130513304|NCT03334747|469846172|FG004|Treatment Phase|Subject/guardian decision|0|||
130513305|NCT03334747|469846173|FG005|Treatment Phase|Subject/guardian decision|1|||
130513306|NCT03334747|469846174|FG006|Treatment Phase|Subject/guardian decision|0|||
130513307|NCT03334747|469846175|FG007|Treatment Phase|Subject/guardian decision|0|||
130513308|NCT03334747|469846176|FG008|Treatment Phase|Subject/guardian decision|0|||
130513309|NCT03334747|469846168|FG000|Follow-Up Phase|Subject/guardian decision|0|||
130513310|NCT03334747|469846169|FG001|Follow-Up Phase|Subject/guardian decision|0|||
130513311|NCT03334747|469846170|FG002|Follow-Up Phase|Subject/guardian decision|0|||
130513312|NCT03334747|469846171|FG003|Follow-Up Phase|Subject/guardian decision|0|||
130513313|NCT03334747|469846172|FG004|Follow-Up Phase|Subject/guardian decision|0|||
130513314|NCT03334747|469846173|FG005|Follow-Up Phase|Subject/guardian decision|0|||
130513315|NCT03334747|469846174|FG006|Follow-Up Phase|Subject/guardian decision|1|||
130513316|NCT03334747|469846175|FG007|Follow-Up Phase|Subject/guardian decision|0|||
130513317|NCT03334747|469846176|FG008|Follow-Up Phase|Subject/guardian decision|1|||
130513318|NCT02567227|469846177|FG000|9 Weeks|Adverse Event|5|||
130513319|NCT02567227|469846178|FG001|9 Weeks|Adverse Event|5|||
130513320|NCT02567227|469846177|FG000|9 Weeks|Withdrawal by Subject|18|||
130513321|NCT02567227|469846178|FG001|9 Weeks|Withdrawal by Subject|8|||
130513322|NCT02567227|469846177|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
130513323|NCT02567227|469846178|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
130513324|NCT02567227|469846177|FG000|6 Month|Death|2|||
130513325|NCT02567227|469846178|FG001|6 Month|Death|0|||
130513326|NCT02567227|469846177|FG000|6 Month|Lost to Follow-up|43|||
130513327|NCT02567227|469846178|FG001|6 Month|Lost to Follow-up|40|||
130513328|NCT02567227|469846177|FG000|12 Months|Lost to Follow-up|31|||
130513329|NCT02567227|469846178|FG001|12 Months|Lost to Follow-up|32|||
130513330|NCT02567227|469846177|FG000|12 Months|Death|0|||
130513331|NCT02567227|469846178|FG001|12 Months|Death|2|||
130513332|NCT02137239|469846179|FG000|Overall Study|Discontinued Study Treatment|0|||
130513333|NCT02137239|469846180|FG001|Overall Study|Discontinued Study Treatment|3|||
130513334|NCT02137239|469846179|FG000|Overall Study|Withdrew Consent|1|||
130513335|NCT02137239|469846180|FG001|Overall Study|Withdrew Consent|1|||
130513336|NCT02137239|469846179|FG000|Overall Study|Adverse Event|2|||
130513337|NCT02137239|469846180|FG001|Overall Study|Adverse Event|2|||
130513338|NCT02498418|469846184|FG000|Overall Study|Lack of Efficacy|0|||
130513339|NCT02498418|469846185|FG001|Overall Study|Lack of Efficacy|0|||
130513340|NCT02498418|469846186|FG002|Overall Study|Lack of Efficacy|1|||
130513341|NCT02498418|469846184|FG000|Overall Study|Withdrawal by Subject|2|||
130513342|NCT02498418|469846185|FG001|Overall Study|Withdrawal by Subject|0|||
130513343|NCT02498418|469846186|FG002|Overall Study|Withdrawal by Subject|3|||
130513344|NCT02498418|469846184|FG000|Overall Study|Lost to Follow-up|0|||
130513345|NCT02498418|469846185|FG001|Overall Study|Lost to Follow-up|1|||
130513346|NCT02498418|469846186|FG002|Overall Study|Lost to Follow-up|1|||
130513347|NCT02498418|469846184|FG000|Overall Study|Participant taken prohibited medication|0|||
130513348|NCT02498418|469846185|FG001|Overall Study|Participant taken prohibited medication|1|||
130513349|NCT02498418|469846186|FG002|Overall Study|Participant taken prohibited medication|1|||
130513350|NCT00762502|469846187|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
130513351|NCT00762502|469846188|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
130513352|NCT00762502|469846189|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
130513353|NCT00762502|469846187|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
130513354|NCT00762502|469846188|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
130513355|NCT00762502|469846189|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
130513356|NCT00762502|469846187|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
130513357|NCT00762502|469846188|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
130513358|NCT00762502|469846189|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
130513359|NCT03042559|469846190|FG000|Overall Study|drop out|1|||
130513360|NCT03042559|469846191|FG001|Overall Study|drop out|1|||
130513361|NCT00385697|469846195|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
130513362|NCT00385697|469846196|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
130513363|NCT00385697|469846197|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
130513364|NCT00385697|469846198|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
130513365|NCT00385697|469846199|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
130513366|NCT00385697|469846195|FG000|Open-label Segment 1|Lost to Follow-up|1|||
130513367|NCT00385697|469846196|FG001|Open-label Segment 1|Lost to Follow-up|0|||
130513368|NCT00385697|469846197|FG002|Open-label Segment 1|Lost to Follow-up|0|||
130513369|NCT00385697|469846198|FG003|Open-label Segment 1|Lost to Follow-up|0|||
130513370|NCT00385697|469846199|FG004|Open-label Segment 1|Lost to Follow-up|0|||
130513371|NCT00385697|469846195|FG000|Double-blind Segment 2|Adverse Event|0|||
130513372|NCT00385697|469846196|FG001|Double-blind Segment 2|Adverse Event|3|||
130513373|NCT00385697|469846197|FG002|Double-blind Segment 2|Adverse Event|1|||
130513374|NCT00385697|469846198|FG003|Double-blind Segment 2|Adverse Event|0|||
130513375|NCT00385697|469846199|FG004|Double-blind Segment 2|Adverse Event|0|||
130513376|NCT00385697|469846195|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
130513377|NCT00385697|469846196|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
130513378|NCT00385697|469846197|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
130513379|NCT00385697|469846198|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
130513380|NCT00385697|469846199|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
130513381|NCT00385697|469846195|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
130513382|NCT00385697|469846196|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
130513383|NCT00385697|469846197|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
130513384|NCT00385697|469846198|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
130513385|NCT00385697|469846199|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
130513386|NCT00385697|469846195|FG000|Double-blind Segment 2|Other|0|||
130513387|NCT00385697|469846196|FG001|Double-blind Segment 2|Other|2|||
130513388|NCT00385697|469846197|FG002|Double-blind Segment 2|Other|0|||
130513389|NCT00385697|469846198|FG003|Double-blind Segment 2|Other|0|||
130513390|NCT00385697|469846199|FG004|Double-blind Segment 2|Other|0|||
130513391|NCT01485991|469846200|FG000|Overall Study|Adverse Event|0|||
130513392|NCT01485991|469846201|FG001|Overall Study|Adverse Event|4|||
130513393|NCT01485991|469846200|FG000|Overall Study|Lost to Follow-up|13|||
130513394|NCT01485991|469846201|FG001|Overall Study|Lost to Follow-up|10|||
130513395|NCT01485991|469846200|FG000|Overall Study|Withdrawal by Subject|13|||
130513396|NCT01485991|469846201|FG001|Overall Study|Withdrawal by Subject|20|||
130513397|NCT01485991|469846200|FG000|Overall Study|randomized but not treated|6|||
130513398|NCT01485991|469846201|FG001|Overall Study|randomized but not treated|2|||
130513399|NCT02538471|469846203|FG000|Overall Study|Progression of disease|2|||
130513400|NCT01475370|469846204|FG000|Overall Study|Exacerbation of primary disease|2|||
130513401|NCT01475370|469846205|FG001|Overall Study|Exacerbation of primary disease|2|||
130513402|NCT01475370|469846206|FG002|Overall Study|Exacerbation of primary disease|2|||
130513403|NCT01475370|469846204|FG000|Overall Study|Study drug administration difficult|0|||
130513404|NCT01475370|469846205|FG001|Overall Study|Study drug administration difficult|1|||
130569565|NCT02716987|470051806|FG001|Overall Study|Ligand synthesis failure|0|||
130569566|NCT02716987|470051807|FG002|Overall Study|Ligand synthesis failure|1|||
130569567|NCT02716987|470051808|FG003|Overall Study|Ligand synthesis failure|0|||
130569568|NCT02716987|470051809|FG004|Overall Study|Ligand synthesis failure|0|||
130513405|NCT01475370|469846206|FG002|Overall Study|Study drug administration difficult|1|||
130513406|NCT01475370|469846204|FG000|Overall Study|Other than specified|1|||
130513407|NCT01475370|469846205|FG001|Overall Study|Other than specified|0|||
130513408|NCT01475370|469846206|FG002|Overall Study|Other than specified|0|||
130513409|NCT00084747|469846209|FG000|Overall Study|Relapsed|8|||
130513410|NCT00084747|469846209|FG000|Overall Study|Death|3|||
130513411|NCT00084747|469846209|FG000|Overall Study|Withdrawal by Subject|2|||
130513412|NCT02382406|469846214|FG000|Study Treatment|Disease Progression|8|||
130513413|NCT02382406|469846215|FG001|Study Treatment|Disease Progression|0|||
130513414|NCT02382406|469846216|FG002|Study Treatment|Disease Progression|20|||
130513415|NCT02382406|469846214|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
130513416|NCT02382406|469846215|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
130513417|NCT02382406|469846216|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
130513418|NCT02382406|469846214|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
130513419|NCT02382406|469846215|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
130513420|NCT02382406|469846216|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
130513421|NCT02382406|469846214|FG000|Study Treatment|symptomatic deterioration|1|||
130513422|NCT02382406|469846215|FG001|Study Treatment|symptomatic deterioration|0|||
130513423|NCT02382406|469846216|FG002|Study Treatment|symptomatic deterioration|1|||
130513424|NCT02382406|469846214|FG000|Study Treatment|Death|0|||
130513425|NCT02382406|469846215|FG001|Study Treatment|Death|0|||
130513426|NCT02382406|469846216|FG002|Study Treatment|Death|2|||
130513427|NCT02382406|469846214|FG000|Follow up|Death|11|||
130513428|NCT02382406|469846215|FG001|Follow up|Death|0|||
130513429|NCT02382406|469846216|FG002|Follow up|Death|19|||
130513430|NCT02382406|469846214|FG000|Follow up|Symptomatic deterioration|1|||
130513431|NCT02382406|469846215|FG001|Follow up|Symptomatic deterioration|0|||
130513432|NCT02382406|469846216|FG002|Follow up|Symptomatic deterioration|1|||
130513433|NCT02382406|469846214|FG000|Follow up|Patient Refused Follow-up|1|||
130513434|NCT02382406|469846215|FG001|Follow up|Patient Refused Follow-up|0|||
130513435|NCT02382406|469846216|FG002|Follow up|Patient Refused Follow-up|0|||
130513436|NCT02382406|469846214|FG000|Follow up|Study Terminated|1|||
130513437|NCT02382406|469846215|FG001|Follow up|Study Terminated|0|||
130513438|NCT02382406|469846216|FG002|Follow up|Study Terminated|8|||
130513439|NCT02382406|469846214|FG000|Follow up|Withdrawal by Subject|0|||
130513440|NCT02382406|469846215|FG001|Follow up|Withdrawal by Subject|0|||
130513441|NCT02382406|469846216|FG002|Follow up|Withdrawal by Subject|2|||
130513442|NCT04543942|469846219|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
130569569|NCT02716987|470051810|FG005|Overall Study|Ligand synthesis failure|0|||
130569570|NCT02716987|470051805|FG000|Overall Study|Withdrawal by Subject|0|||
130569571|NCT02716987|470051806|FG001|Overall Study|Withdrawal by Subject|0|||
130569572|NCT02716987|470051807|FG002|Overall Study|Withdrawal by Subject|0|||
130569573|NCT02716987|470051808|FG003|Overall Study|Withdrawal by Subject|0|||
130569574|NCT02716987|470051809|FG004|Overall Study|Withdrawal by Subject|1|||
130569575|NCT02716987|470051810|FG005|Overall Study|Withdrawal by Subject|1|||
130569576|NCT02829138|470051811|FG000|Overall Study|Withdrawal by Subject|1|||
130569577|NCT02829138|470051812|FG001|Overall Study|Withdrawal by Subject|0|||
130569578|NCT01394627|470051813|FG000|First Intervention (1 Day)|poor intravenous access|0|||
130513443|NCT04543942|469846220|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
130513444|NCT04543942|469846219|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
130513445|NCT04543942|469846220|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
130513446|NCT01323309|469846221|FG000|Overall Study|Death|9|||
130513447|NCT01323309|469846222|FG001|Overall Study|Death|15|||
130513448|NCT01323309|469846223|FG002|Overall Study|Death|5|||
130513449|NCT01323309|469846221|FG000|Overall Study|Lost to Follow-up|11|||
130513450|NCT01323309|469846222|FG001|Overall Study|Lost to Follow-up|14|||
130513451|NCT01323309|469846223|FG002|Overall Study|Lost to Follow-up|24|||
130513452|NCT01323309|469846221|FG000|Overall Study|Withdrawal by Subject|14|||
130513453|NCT01323309|469846222|FG001|Overall Study|Withdrawal by Subject|14|||
130513454|NCT01323309|469846223|FG002|Overall Study|Withdrawal by Subject|18|||
130513455|NCT01323309|469846221|FG000|Overall Study|Disease progression|5|||
130513456|NCT01323309|469846222|FG001|Overall Study|Disease progression|11|||
130569579|NCT01394627|470051814|FG001|First Intervention (1 Day)|poor intravenous access|1|||
130513457|NCT01323309|469846223|FG002|Overall Study|Disease progression|4|||
130513458|NCT03048058|469846225|FG000|Overall Study|Lost to Follow-up|4|||
130513459|NCT03048058|469846226|FG001|Overall Study|Lost to Follow-up|0|||
130513460|NCT03048058|469846225|FG000|Overall Study|Withdrawal by Subject|0|||
130513461|NCT03048058|469846226|FG001|Overall Study|Withdrawal by Subject|4|||
130513462|NCT00577096|469846245|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
130513463|NCT00577096|469846246|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
130513464|NCT00577096|469846245|FG000|Short Term Participation|Withdrawal by Subject|3|||
130513465|NCT00577096|469846246|FG001|Short Term Participation|Withdrawal by Subject|5|||
130513466|NCT00577096|469846245|FG000|Short Term Participation|Death|1|||
130513467|NCT00577096|469846246|FG001|Short Term Participation|Death|1|||
130513468|NCT00832650|469846247|FG000|Overall Study|Randomized but not treated|0|||
130513469|NCT00832650|469846248|FG001|Overall Study|Randomized but not treated|0|||
130513470|NCT00832650|469846249|FG002|Overall Study|Randomized but not treated|1|||
130513471|NCT00794573|469846255|FG000|Overall Study|Death|3|||
130513472|NCT00794573|469846256|FG001|Overall Study|Death|0|||
130513473|NCT00794573|469846255|FG000|Overall Study|Withdrawal by Subject|9|||
130513474|NCT00794573|469846256|FG001|Overall Study|Withdrawal by Subject|12|||
130513475|NCT00794573|469846255|FG000|Overall Study|Lost to Follow-up|26|||
130513476|NCT00794573|469846256|FG001|Overall Study|Lost to Follow-up|33|||
130513477|NCT02418819|469846262|FG000|Overall Study|Adverse Event|0|||
130513478|NCT02418819|469846263|FG001|Overall Study|Adverse Event|0|||
130513479|NCT02418819|469846264|FG002|Overall Study|Adverse Event|1|||
130513480|NCT02418819|469846265|FG003|Overall Study|Adverse Event|0|||
130513481|NCT02418819|469846262|FG000|Overall Study|Lost to Follow-up|1|||
130513482|NCT02418819|469846263|FG001|Overall Study|Lost to Follow-up|0|||
130513483|NCT02418819|469846264|FG002|Overall Study|Lost to Follow-up|0|||
130513484|NCT02418819|469846265|FG003|Overall Study|Lost to Follow-up|0|||
130513485|NCT02418819|469846262|FG000|Overall Study|No longer meets eligibility criteria|0|||
130513486|NCT02418819|469846263|FG001|Overall Study|No longer meets eligibility criteria|0|||
130513487|NCT02418819|469846264|FG002|Overall Study|No longer meets eligibility criteria|1|||
130513488|NCT02418819|469846265|FG003|Overall Study|No longer meets eligibility criteria|0|||
130513489|NCT02418819|469846262|FG000|Overall Study|No longer willing to participate|0|||
130513490|NCT02418819|469846263|FG001|Overall Study|No longer willing to participate|0|||
130513491|NCT02418819|469846264|FG002|Overall Study|No longer willing to participate|2|||
130513492|NCT02418819|469846265|FG003|Overall Study|No longer willing to participate|1|||
130513493|NCT01721759|469846266|FG000|Treatment Period|Disease Progression|85|||
130513494|NCT01721759|469846266|FG000|Treatment Period|Study drug toxicity|14|||
130513495|NCT01721759|469846266|FG000|Treatment Period|Death|1|||
130513496|NCT01721759|469846266|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
130513497|NCT01721759|469846266|FG000|Treatment Period|Participant request to withdraw|3|||
130513498|NCT01721759|469846266|FG000|Treatment Period|Other Reasons|3|||
130513499|NCT01721759|469846266|FG000|End of Study Period|Participant Withdrew Consent|5|||
130513500|NCT01721759|469846266|FG000|End of Study Period|Death|101|||
130513501|NCT01721759|469846266|FG000|End of Study Period|Lost to Follow-up|1|||
130513502|NCT01721759|469846266|FG000|End of Study Period|Other Reasons|10|||
130513503|NCT00390806|469846267|FG000|Overall Study|Lost to Follow-up|7|||
130513504|NCT00390806|469846268|FG001|Overall Study|Lost to Follow-up|6|||
130513505|NCT00390806|469846267|FG000|Overall Study|Protocol Violation|2|||
130513506|NCT00390806|469846268|FG001|Overall Study|Protocol Violation|2|||
130513507|NCT00390806|469846267|FG000|Overall Study|Withdrawal by Subject|12|||
130513508|NCT00390806|469846268|FG001|Overall Study|Withdrawal by Subject|15|||
130513509|NCT00390806|469846267|FG000|Overall Study|Investigator Decision|4|||
130513510|NCT00390806|469846268|FG001|Overall Study|Investigator Decision|6|||
130513511|NCT00390806|469846267|FG000|Overall Study|Death|1|||
130513512|NCT00390806|469846268|FG001|Overall Study|Death|0|||
130513513|NCT00390806|469846267|FG000|Overall Study|Physician Decision|0|||
130513514|NCT00390806|469846268|FG001|Overall Study|Physician Decision|1|||
130513515|NCT00390806|469846267|FG000|Overall Study|Ongoing|4|||
130513516|NCT00390806|469846268|FG001|Overall Study|Ongoing|2|||
130513517|NCT00714688|469846269|FG000|Overall Study|Lack of Efficacy|14|||
130513518|NCT00714688|469846270|FG001|Overall Study|Lack of Efficacy|1|||
130513519|NCT00714688|469846271|FG002|Overall Study|Lack of Efficacy|4|||
130513520|NCT00714688|469846269|FG000|Overall Study|Withdrawal by Subject|4|||
130513521|NCT00714688|469846270|FG001|Overall Study|Withdrawal by Subject|3|||
130513522|NCT00714688|469846271|FG002|Overall Study|Withdrawal by Subject|3|||
130513523|NCT00714688|469846269|FG000|Overall Study|Lost to Follow-up|5|||
130513524|NCT00714688|469846270|FG001|Overall Study|Lost to Follow-up|2|||
130513525|NCT00714688|469846271|FG002|Overall Study|Lost to Follow-up|0|||
130513526|NCT00714688|469846269|FG000|Overall Study|Adverse Event|2|||
130513527|NCT00714688|469846270|FG001|Overall Study|Adverse Event|15|||
130513528|NCT00714688|469846271|FG002|Overall Study|Adverse Event|19|||
130513529|NCT00714688|469846269|FG000|Overall Study|Subject Non-compliant|3|||
130513530|NCT00714688|469846270|FG001|Overall Study|Subject Non-compliant|5|||
130513531|NCT00714688|469846271|FG002|Overall Study|Subject Non-compliant|5|||
130513532|NCT00714688|469846269|FG000|Overall Study|Ineligible to Continue the Study|0|||
130513533|NCT00714688|469846270|FG001|Overall Study|Ineligible to Continue the Study|1|||
130569580|NCT01394627|470051813|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
130569581|NCT01394627|470051814|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
130569582|NCT03223428|470051817|FG000|Overall Study|No longer taking Xermelo|27|||
130569583|NCT03223428|470051817|FG000|Overall Study|Declined Consent|1|||
130569584|NCT03223428|470051817|FG000|Overall Study|Non-responders|56|||
130569585|NCT03223428|470051817|FG000|Overall Study|Withdrawal by Subject|14|||
130569586|NCT02025907|470051818|FG000|Overall Study|Lack of Efficacy|1|||
130569587|NCT02025907|470051819|FG001|Overall Study|Lack of Efficacy|0|||
130569588|NCT02025907|470051818|FG000|Overall Study|Withdrawal by Subject|15|||
130569589|NCT02025907|470051819|FG001|Overall Study|Withdrawal by Subject|8|||
130569590|NCT02025907|470051818|FG000|Overall Study|Protocol Violation|2|||
130569591|NCT02025907|470051819|FG001|Overall Study|Protocol Violation|0|||
130569592|NCT02025907|470051818|FG000|Overall Study|Physician Decision|2|||
130569593|NCT02025907|470051819|FG001|Overall Study|Physician Decision|0|||
130569594|NCT02025907|470051818|FG000|Overall Study|Lost to Follow-up|2|||
130569595|NCT02025907|470051819|FG001|Overall Study|Lost to Follow-up|2|||
130569596|NCT02025907|470051818|FG000|Overall Study|Adverse Event|3|||
130569597|NCT02025907|470051819|FG001|Overall Study|Adverse Event|1|||
130569598|NCT02025907|470051818|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
130569599|NCT02025907|470051819|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
130569600|NCT03681119|470051820|FG000|Overall Study|No specific reason|4|||
130569601|NCT03681119|470051821|FG001|Overall Study|No specific reason|0|||
130569602|NCT03681119|470051820|FG000|Overall Study|Sickness|2|||
130569603|NCT03681119|470051821|FG001|Overall Study|Sickness|0|||
130569604|NCT00563186|470051825|FG000|Overall Study|LOS<48 hours|97|||
130569605|NCT00563186|470051826|FG001|Overall Study|LOS<48 hours|74|||
130569606|NCT00563186|470051825|FG000|Overall Study|Incomplete data|1|||
130569607|NCT00563186|470051826|FG001|Overall Study|Incomplete data|1|||
130569608|NCT00879645|470051827|FG000|Overall Study|Adverse Event|1|||
130569609|NCT00879645|470051828|FG001|Overall Study|Adverse Event|0|||
130569610|NCT00879645|470051829|FG002|Overall Study|Adverse Event|0|||
130569611|NCT00879645|470051830|FG003|Overall Study|Adverse Event|0|||
130569612|NCT03631732|470051831|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
130569613|NCT03631732|470051832|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
130569614|NCT03631732|470051831|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
130569615|NCT03631732|470051832|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
130569616|NCT03631732|470051831|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
130569617|NCT03631732|470051832|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
130569618|NCT03631732|470051831|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
130569619|NCT03631732|470051832|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
130569620|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
130569621|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
130569622|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
130569623|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
130569624|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
130569625|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
130569626|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
130569627|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
130569628|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
130569629|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
130569630|NCT03631732|470051831|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
130569631|NCT03631732|470051832|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
130569632|NCT04288154|470051833|FG000|Overall Study|Withdrawal by Subject|9|||
130569633|NCT04288154|470051834|FG001|Overall Study|Withdrawal by Subject|9|||
130569634|NCT02873936|470051835|FG000|Overall Study|Withdrew Consent|4|||
130569635|NCT02873936|470051836|FG001|Overall Study|Withdrew Consent|11|||
130569636|NCT02873936|470051837|FG002|Overall Study|Withdrew Consent|20|||
130569637|NCT02873936|470051835|FG000|Overall Study|Investigator's Discretion|3|||
130569638|NCT02873936|470051836|FG001|Overall Study|Investigator's Discretion|5|||
130569639|NCT02873936|470051837|FG002|Overall Study|Investigator's Discretion|4|||
130569640|NCT02873936|470051835|FG000|Overall Study|Adverse Event|3|||
130569641|NCT02873936|470051836|FG001|Overall Study|Adverse Event|5|||
130569642|NCT02873936|470051837|FG002|Overall Study|Adverse Event|3|||
130569643|NCT02873936|470051835|FG000|Overall Study|Protocol Violation|0|||
130569644|NCT02873936|470051836|FG001|Overall Study|Protocol Violation|1|||
130569645|NCT02873936|470051837|FG002|Overall Study|Protocol Violation|3|||
130569646|NCT02873936|470051835|FG000|Overall Study|Lost to Follow-up|1|||
130569647|NCT02873936|470051836|FG001|Overall Study|Lost to Follow-up|1|||
130569648|NCT02873936|470051837|FG002|Overall Study|Lost to Follow-up|1|||
130569649|NCT02873936|470051835|FG000|Overall Study|Non-compliance With Study Drug|1|||
130569650|NCT02873936|470051836|FG001|Overall Study|Non-compliance With Study Drug|0|||
130569651|NCT02873936|470051837|FG002|Overall Study|Non-compliance With Study Drug|1|||
130569652|NCT02873936|470051835|FG000|Overall Study|Randomized but not Dosed|1|||
130569653|NCT02873936|470051836|FG001|Overall Study|Randomized but not Dosed|0|||
130569654|NCT02873936|470051837|FG002|Overall Study|Randomized but not Dosed|0|||
130569655|NCT02943564|470051838|FG000|Overall Study|Miscellaneous Reasons|0|||
130569656|NCT02943564|470051839|FG001|Overall Study|Miscellaneous Reasons|0|||
130569657|NCT02943564|470051840|FG002|Overall Study|Miscellaneous Reasons|3|||
130569658|NCT02943564|470051838|FG000|Overall Study|Site terminated by sponsor|0|||
130569659|NCT02943564|470051839|FG001|Overall Study|Site terminated by sponsor|1|||
130569660|NCT02943564|470051840|FG002|Overall Study|Site terminated by sponsor|0|||
130569661|NCT02943564|470051838|FG000|Overall Study|Non-compliance with study drug|0|||
130569662|NCT02943564|470051839|FG001|Overall Study|Non-compliance with study drug|1|||
130569663|NCT02943564|470051840|FG002|Overall Study|Non-compliance with study drug|0|||
130569664|NCT02943564|470051838|FG000|Overall Study|Pregnancy|0|||
130569665|NCT02943564|470051839|FG001|Overall Study|Pregnancy|1|||
130569666|NCT02943564|470051840|FG002|Overall Study|Pregnancy|1|||
130569667|NCT02943564|470051838|FG000|Overall Study|Protocol Violation|2|||
130569668|NCT02943564|470051839|FG001|Overall Study|Protocol Violation|2|||
130569669|NCT02943564|470051840|FG002|Overall Study|Protocol Violation|2|||
130569670|NCT02943564|470051838|FG000|Overall Study|Lost to Follow-up|1|||
130569671|NCT02943564|470051839|FG001|Overall Study|Lost to Follow-up|0|||
130569672|NCT02943564|470051840|FG002|Overall Study|Lost to Follow-up|0|||
130569673|NCT02943564|470051838|FG000|Overall Study|Withdrawal by Subject|6|||
130569674|NCT02943564|470051839|FG001|Overall Study|Withdrawal by Subject|5|||
130569675|NCT02943564|470051840|FG002|Overall Study|Withdrawal by Subject|2|||
130569676|NCT02943564|470051838|FG000|Overall Study|Adverse Event|1|||
130569677|NCT02943564|470051839|FG001|Overall Study|Adverse Event|2|||
130569678|NCT02943564|470051840|FG002|Overall Study|Adverse Event|1|||
130569679|NCT02943564|470051838|FG000|Overall Study|Lack of Efficacy|0|||
130569680|NCT02943564|470051839|FG001|Overall Study|Lack of Efficacy|1|||
130569681|NCT02943564|470051840|FG002|Overall Study|Lack of Efficacy|0|||
130569682|NCT01073267|470051844|FG000|Overall Study|Disease Progression|3|||
130569683|NCT01225731|470051845|FG000|Part 1|Did not meet eligibility criteria|1|||
130569684|NCT01225731|470051846|FG001|Part 1|Did not meet eligibility criteria|0|||
130569685|NCT01225731|470051847|FG002|Part 1|Did not meet eligibility criteria|0|||
130569686|NCT01225731|470051848|FG003|Part 1|Did not meet eligibility criteria|0|||
130569687|NCT01225731|470051849|FG004|Part 1|Did not meet eligibility criteria|1|||
130569688|NCT01225731|470051850|FG005|Part 1|Did not meet eligibility criteria|0|||
130569689|NCT01225731|470051851|FG006|Part 1|Did not meet eligibility criteria|0|||
130569690|NCT01225731|470051852|FG007|Part 1|Did not meet eligibility criteria|0|||
130569691|NCT01225731|470051853|FG008|Part 1|Did not meet eligibility criteria|0|||
130569692|NCT01225731|470051854|FG009|Part 1|Did not meet eligibility criteria|0|||
130569693|NCT01225731|470051855|FG010|Part 1|Did not meet eligibility criteria|0|||
130569694|NCT01225731|470051856|FG011|Part 1|Did not meet eligibility criteria|0|||
130569695|NCT01225731|470051857|FG012|Part 1|Did not meet eligibility criteria|0|||
130569696|NCT01225731|470051845|FG000|Part 1|Adverse Event|1|||
130569697|NCT01225731|470051846|FG001|Part 1|Adverse Event|2|||
130569698|NCT01225731|470051847|FG002|Part 1|Adverse Event|1|||
130569699|NCT01225731|470051848|FG003|Part 1|Adverse Event|1|||
130569700|NCT01225731|470051849|FG004|Part 1|Adverse Event|1|||
130569701|NCT01225731|470051850|FG005|Part 1|Adverse Event|0|||
130569702|NCT01225731|470051851|FG006|Part 1|Adverse Event|0|||
130569703|NCT01225731|470051852|FG007|Part 1|Adverse Event|0|||
130569704|NCT01225731|470051853|FG008|Part 1|Adverse Event|0|||
130569705|NCT01225731|470051854|FG009|Part 1|Adverse Event|0|||
130569706|NCT01225731|470051855|FG010|Part 1|Adverse Event|0|||
130569707|NCT01225731|470051856|FG011|Part 1|Adverse Event|0|||
130569708|NCT01225731|470051857|FG012|Part 1|Adverse Event|0|||
130569709|NCT01225731|470051845|FG000|Part 1|Withdrawal by Subject|0|||
130569710|NCT01225731|470051846|FG001|Part 1|Withdrawal by Subject|3|||
130569711|NCT01225731|470051847|FG002|Part 1|Withdrawal by Subject|0|||
130569712|NCT01225731|470051848|FG003|Part 1|Withdrawal by Subject|0|||
130569713|NCT01225731|470051849|FG004|Part 1|Withdrawal by Subject|4|||
130569714|NCT01225731|470051850|FG005|Part 1|Withdrawal by Subject|0|||
130569715|NCT01225731|470051851|FG006|Part 1|Withdrawal by Subject|0|||
130569716|NCT01225731|470051852|FG007|Part 1|Withdrawal by Subject|0|||
130569717|NCT01225731|470051853|FG008|Part 1|Withdrawal by Subject|0|||
130569718|NCT01225731|470051854|FG009|Part 1|Withdrawal by Subject|0|||
130569719|NCT01225731|470051855|FG010|Part 1|Withdrawal by Subject|0|||
130569720|NCT01225731|470051856|FG011|Part 1|Withdrawal by Subject|0|||
130569721|NCT01225731|470051857|FG012|Part 1|Withdrawal by Subject|0|||
130569722|NCT01225731|470051845|FG000|Part 1|Protocol Violation|0|||
130569723|NCT01225731|470051846|FG001|Part 1|Protocol Violation|0|||
130569724|NCT01225731|470051847|FG002|Part 1|Protocol Violation|0|||
130569725|NCT01225731|470051848|FG003|Part 1|Protocol Violation|1|||
130569726|NCT01225731|470051849|FG004|Part 1|Protocol Violation|0|||
130569727|NCT01225731|470051850|FG005|Part 1|Protocol Violation|0|||
130569728|NCT01225731|470051851|FG006|Part 1|Protocol Violation|0|||
130569729|NCT01225731|470051852|FG007|Part 1|Protocol Violation|0|||
130569730|NCT01225731|470051853|FG008|Part 1|Protocol Violation|0|||
130569731|NCT01225731|470051854|FG009|Part 1|Protocol Violation|0|||
130569732|NCT01225731|470051855|FG010|Part 1|Protocol Violation|0|||
130569733|NCT01225731|470051856|FG011|Part 1|Protocol Violation|0|||
130569734|NCT01225731|470051857|FG012|Part 1|Protocol Violation|0|||
130569735|NCT01225731|470051845|FG000|Part 2|Protocol Violation|0|||
130569736|NCT01225731|470051846|FG001|Part 2|Protocol Violation|0|||
130569737|NCT01225731|470051847|FG002|Part 2|Protocol Violation|0|||
130569738|NCT01225731|470051848|FG003|Part 2|Protocol Violation|0|||
130569739|NCT01225731|470051849|FG004|Part 2|Protocol Violation|0|||
130569740|NCT01225731|470051850|FG005|Part 2|Protocol Violation|1|||
130569741|NCT01225731|470051851|FG006|Part 2|Protocol Violation|0|||
130569742|NCT01225731|470051852|FG007|Part 2|Protocol Violation|0|||
130569743|NCT01225731|470051853|FG008|Part 2|Protocol Violation|1|||
130569744|NCT01225731|470051854|FG009|Part 2|Protocol Violation|0|||
130569745|NCT01225731|470051855|FG010|Part 2|Protocol Violation|0|||
130569746|NCT01225731|470051856|FG011|Part 2|Protocol Violation|0|||
130569747|NCT01225731|470051857|FG012|Part 2|Protocol Violation|0|||
130569748|NCT01225731|470051845|FG000|Part 2|Adverse Event|0|||
130569749|NCT01225731|470051846|FG001|Part 2|Adverse Event|0|||
130569750|NCT01225731|470051847|FG002|Part 2|Adverse Event|0|||
130569751|NCT01225731|470051848|FG003|Part 2|Adverse Event|0|||
130569752|NCT01225731|470051849|FG004|Part 2|Adverse Event|0|||
130569753|NCT01225731|470051850|FG005|Part 2|Adverse Event|0|||
130569754|NCT01225731|470051851|FG006|Part 2|Adverse Event|4|||
130569755|NCT01225731|470051852|FG007|Part 2|Adverse Event|4|||
130569756|NCT01225731|470051853|FG008|Part 2|Adverse Event|2|||
130569757|NCT01225731|470051854|FG009|Part 2|Adverse Event|0|||
130569758|NCT01225731|470051855|FG010|Part 2|Adverse Event|0|||
130569759|NCT01225731|470051856|FG011|Part 2|Adverse Event|0|||
130569760|NCT01225731|470051857|FG012|Part 2|Adverse Event|0|||
130569761|NCT01225731|470051845|FG000|Part 2|Lack of Efficacy|0|||
130569762|NCT01225731|470051846|FG001|Part 2|Lack of Efficacy|0|||
130569763|NCT01225731|470051847|FG002|Part 2|Lack of Efficacy|0|||
130569764|NCT01225731|470051848|FG003|Part 2|Lack of Efficacy|0|||
130569765|NCT01225731|470051849|FG004|Part 2|Lack of Efficacy|0|||
130569766|NCT01225731|470051850|FG005|Part 2|Lack of Efficacy|1|||
130569767|NCT01225731|470051851|FG006|Part 2|Lack of Efficacy|0|||
130569768|NCT01225731|470051852|FG007|Part 2|Lack of Efficacy|12|||
130569769|NCT01225731|470051853|FG008|Part 2|Lack of Efficacy|3|||
130569770|NCT01225731|470051854|FG009|Part 2|Lack of Efficacy|0|||
130569771|NCT01225731|470051855|FG010|Part 2|Lack of Efficacy|0|||
130569772|NCT01225731|470051856|FG011|Part 2|Lack of Efficacy|0|||
130569773|NCT01225731|470051857|FG012|Part 2|Lack of Efficacy|0|||
130569774|NCT01225731|470051845|FG000|Part 2|Pregnancy|0|||
130569775|NCT01225731|470051846|FG001|Part 2|Pregnancy|0|||
130569776|NCT01225731|470051847|FG002|Part 2|Pregnancy|0|||
130569777|NCT01225731|470051848|FG003|Part 2|Pregnancy|0|||
130569778|NCT01225731|470051849|FG004|Part 2|Pregnancy|0|||
130569779|NCT01225731|470051850|FG005|Part 2|Pregnancy|0|||
130569780|NCT01225731|470051851|FG006|Part 2|Pregnancy|1|||
130569781|NCT01225731|470051852|FG007|Part 2|Pregnancy|0|||
130569782|NCT01225731|470051853|FG008|Part 2|Pregnancy|1|||
130569783|NCT01225731|470051854|FG009|Part 2|Pregnancy|0|||
130569784|NCT01225731|470051855|FG010|Part 2|Pregnancy|0|||
130569785|NCT01225731|470051856|FG011|Part 2|Pregnancy|0|||
130569786|NCT01225731|470051857|FG012|Part 2|Pregnancy|0|||
130569787|NCT01225731|470051845|FG000|Part 2|Lost to Follow-up|0|||
130569788|NCT01225731|470051846|FG001|Part 2|Lost to Follow-up|0|||
130569789|NCT01225731|470051847|FG002|Part 2|Lost to Follow-up|0|||
130569790|NCT01225731|470051848|FG003|Part 2|Lost to Follow-up|0|||
130569791|NCT01225731|470051849|FG004|Part 2|Lost to Follow-up|0|||
130569792|NCT01225731|470051850|FG005|Part 2|Lost to Follow-up|0|||
130569793|NCT01225731|470051851|FG006|Part 2|Lost to Follow-up|0|||
130569794|NCT01225731|470051852|FG007|Part 2|Lost to Follow-up|3|||
130569795|NCT01225731|470051853|FG008|Part 2|Lost to Follow-up|1|||
130569796|NCT01225731|470051854|FG009|Part 2|Lost to Follow-up|0|||
130569797|NCT01225731|470051855|FG010|Part 2|Lost to Follow-up|0|||
130569798|NCT01225731|470051856|FG011|Part 2|Lost to Follow-up|0|||
130569799|NCT01225731|470051857|FG012|Part 2|Lost to Follow-up|0|||
130569800|NCT01225731|470051845|FG000|Part 2|Physician Decision|0|||
130569801|NCT01225731|470051846|FG001|Part 2|Physician Decision|0|||
130569802|NCT01225731|470051847|FG002|Part 2|Physician Decision|0|||
130569803|NCT01225731|470051848|FG003|Part 2|Physician Decision|0|||
130569804|NCT01225731|470051849|FG004|Part 2|Physician Decision|0|||
130569805|NCT01225731|470051850|FG005|Part 2|Physician Decision|0|||
130569806|NCT01225731|470051851|FG006|Part 2|Physician Decision|0|||
130569807|NCT01225731|470051852|FG007|Part 2|Physician Decision|2|||
130569808|NCT01225731|470051853|FG008|Part 2|Physician Decision|2|||
130569809|NCT01225731|470051854|FG009|Part 2|Physician Decision|0|||
130569810|NCT01225731|470051855|FG010|Part 2|Physician Decision|0|||
130569811|NCT01225731|470051856|FG011|Part 2|Physician Decision|0|||
130569812|NCT01225731|470051857|FG012|Part 2|Physician Decision|0|||
130569813|NCT01225731|470051845|FG000|Part 2|Withdrawal by Subject|0|||
130569814|NCT01225731|470051846|FG001|Part 2|Withdrawal by Subject|0|||
130569815|NCT01225731|470051847|FG002|Part 2|Withdrawal by Subject|0|||
130569816|NCT01225731|470051848|FG003|Part 2|Withdrawal by Subject|0|||
130569817|NCT01225731|470051849|FG004|Part 2|Withdrawal by Subject|0|||
130569818|NCT01225731|470051850|FG005|Part 2|Withdrawal by Subject|1|||
130569819|NCT01225731|470051851|FG006|Part 2|Withdrawal by Subject|3|||
130569820|NCT01225731|470051852|FG007|Part 2|Withdrawal by Subject|4|||
130513534|NCT00714688|469846271|FG002|Overall Study|Ineligible to Continue the Study|1|||
130513535|NCT00714688|469846269|FG000|Overall Study|Sponsor's Decision|0|||
130513536|NCT00714688|469846270|FG001|Overall Study|Sponsor's Decision|2|||
130513537|NCT00714688|469846271|FG002|Overall Study|Sponsor's Decision|0|||
130513538|NCT00714688|469846269|FG000|Overall Study|Other|1|||
130513539|NCT00714688|469846270|FG001|Overall Study|Other|6|||
130513540|NCT00714688|469846271|FG002|Overall Study|Other|5|||
130513541|NCT01808144|469846273|FG000|Overall Study|Death|1|||
130513542|NCT01808144|469846274|FG001|Overall Study|Death|0|||
130513543|NCT01808144|469846273|FG000|Overall Study|Withdrawal by Subject|16|||
130513544|NCT01808144|469846274|FG001|Overall Study|Withdrawal by Subject|23|||
130513545|NCT01808144|469846273|FG000|Overall Study|Lost to Follow-up|6|||
130513546|NCT01808144|469846274|FG001|Overall Study|Lost to Follow-up|3|||
130513547|NCT01808144|469846273|FG000|Overall Study|Protocol Violation|6|||
130513548|NCT01808144|469846274|FG001|Overall Study|Protocol Violation|6|||
130513549|NCT01808144|469846273|FG000|Overall Study|Gout flare|0|||
130513550|NCT01808144|469846274|FG001|Overall Study|Gout flare|1|||
130513551|NCT01808144|469846273|FG000|Overall Study|Adverse Event|11|||
130513552|NCT01808144|469846274|FG001|Overall Study|Adverse Event|15|||
130513553|NCT00383500|469846275|FG000|Overall Study|Withdrawal by Subject|8|||
130513554|NCT00383500|469846276|FG001|Overall Study|Withdrawal by Subject|3|||
130513555|NCT00383500|469846277|FG002|Overall Study|Withdrawal by Subject|0|||
130513556|NCT00383500|469846275|FG000|Overall Study|Lost to Follow-up|0|||
130513557|NCT00383500|469846276|FG001|Overall Study|Lost to Follow-up|0|||
130513558|NCT00383500|469846277|FG002|Overall Study|Lost to Follow-up|2|||
130569821|NCT01225731|470051853|FG008|Part 2|Withdrawal by Subject|1|||
130569822|NCT01225731|470051854|FG009|Part 2|Withdrawal by Subject|0|||
130569823|NCT01225731|470051855|FG010|Part 2|Withdrawal by Subject|0|||
130569824|NCT01225731|470051856|FG011|Part 2|Withdrawal by Subject|0|||
130569825|NCT01225731|470051857|FG012|Part 2|Withdrawal by Subject|0|||
130569826|NCT01225731|470051845|FG000|Part 3|Adverse Event|0|||
130569827|NCT01225731|470051846|FG001|Part 3|Adverse Event|0|||
130569828|NCT01225731|470051847|FG002|Part 3|Adverse Event|0|||
130569829|NCT01225731|470051848|FG003|Part 3|Adverse Event|0|||
130569830|NCT01225731|470051849|FG004|Part 3|Adverse Event|0|||
130569831|NCT01225731|470051850|FG005|Part 3|Adverse Event|0|||
130569832|NCT01225731|470051851|FG006|Part 3|Adverse Event|0|||
130569833|NCT01225731|470051852|FG007|Part 3|Adverse Event|0|||
130569834|NCT01225731|470051853|FG008|Part 3|Adverse Event|0|||
130569835|NCT01225731|470051854|FG009|Part 3|Adverse Event|0|||
130569836|NCT01225731|470051855|FG010|Part 3|Adverse Event|1|||
130569837|NCT01225731|470051856|FG011|Part 3|Adverse Event|1|||
130569838|NCT01225731|470051857|FG012|Part 3|Adverse Event|0|||
130569839|NCT01225731|470051845|FG000|Part 3|Lost to Follow-up|0|||
130569840|NCT01225731|470051846|FG001|Part 3|Lost to Follow-up|0|||
130569841|NCT01225731|470051847|FG002|Part 3|Lost to Follow-up|0|||
130569842|NCT01225731|470051848|FG003|Part 3|Lost to Follow-up|0|||
130569843|NCT01225731|470051849|FG004|Part 3|Lost to Follow-up|0|||
130569844|NCT01225731|470051850|FG005|Part 3|Lost to Follow-up|0|||
130569845|NCT01225731|470051851|FG006|Part 3|Lost to Follow-up|0|||
130569846|NCT01225731|470051852|FG007|Part 3|Lost to Follow-up|0|||
130569847|NCT01225731|470051853|FG008|Part 3|Lost to Follow-up|0|||
130569848|NCT01225731|470051854|FG009|Part 3|Lost to Follow-up|0|||
130569849|NCT01225731|470051855|FG010|Part 3|Lost to Follow-up|1|||
130569850|NCT01225731|470051856|FG011|Part 3|Lost to Follow-up|2|||
130569851|NCT01225731|470051857|FG012|Part 3|Lost to Follow-up|1|||
130569852|NCT01225731|470051845|FG000|Part 3|Physician Decision|0|||
130569853|NCT01225731|470051846|FG001|Part 3|Physician Decision|0|||
130569854|NCT01225731|470051847|FG002|Part 3|Physician Decision|0|||
130569855|NCT01225731|470051848|FG003|Part 3|Physician Decision|0|||
130569856|NCT01225731|470051849|FG004|Part 3|Physician Decision|0|||
130569857|NCT01225731|470051850|FG005|Part 3|Physician Decision|0|||
130569858|NCT01225731|470051851|FG006|Part 3|Physician Decision|0|||
130569859|NCT01225731|470051852|FG007|Part 3|Physician Decision|0|||
130569860|NCT01225731|470051853|FG008|Part 3|Physician Decision|0|||
130569861|NCT01225731|470051854|FG009|Part 3|Physician Decision|0|||
130569862|NCT01225731|470051855|FG010|Part 3|Physician Decision|0|||
130569863|NCT01225731|470051856|FG011|Part 3|Physician Decision|1|||
130569864|NCT01225731|470051857|FG012|Part 3|Physician Decision|2|||
130569865|NCT01225731|470051845|FG000|Part 3|Withdrawal by Subject|0|||
130569866|NCT01225731|470051846|FG001|Part 3|Withdrawal by Subject|0|||
130569867|NCT01225731|470051847|FG002|Part 3|Withdrawal by Subject|0|||
130569868|NCT01225731|470051848|FG003|Part 3|Withdrawal by Subject|0|||
130569869|NCT01225731|470051849|FG004|Part 3|Withdrawal by Subject|0|||
130569870|NCT01225731|470051850|FG005|Part 3|Withdrawal by Subject|0|||
130569871|NCT01225731|470051851|FG006|Part 3|Withdrawal by Subject|0|||
130569872|NCT01225731|470051852|FG007|Part 3|Withdrawal by Subject|0|||
130569873|NCT01225731|470051853|FG008|Part 3|Withdrawal by Subject|0|||
130569874|NCT01225731|470051854|FG009|Part 3|Withdrawal by Subject|0|||
130569875|NCT01225731|470051855|FG010|Part 3|Withdrawal by Subject|4|||
130569876|NCT01225731|470051856|FG011|Part 3|Withdrawal by Subject|6|||
130569877|NCT01225731|470051857|FG012|Part 3|Withdrawal by Subject|4|||
130569878|NCT00577642|470051858|FG000|Overall Study|Clinical Disease Progression|1|||
130569879|NCT00917150|470051863|FG000|Overall Study|Adverse Event|12|||
130569880|NCT00917150|470051864|FG001|Overall Study|Adverse Event|7|||
130569881|NCT00917150|470051865|FG002|Overall Study|Adverse Event|12|||
130569882|NCT00917150|470051866|FG003|Overall Study|Adverse Event|11|||
130569883|NCT00917150|470051863|FG000|Overall Study|Death|1|||
130569884|NCT00917150|470051864|FG001|Overall Study|Death|4|||
130569885|NCT00917150|470051865|FG002|Overall Study|Death|3|||
130569886|NCT00917150|470051866|FG003|Overall Study|Death|2|||
130569887|NCT00917150|470051863|FG000|Overall Study|Lost to Follow-up|1|||
130569888|NCT00917150|470051864|FG001|Overall Study|Lost to Follow-up|0|||
130569889|NCT00917150|470051865|FG002|Overall Study|Lost to Follow-up|4|||
130569890|NCT00917150|470051866|FG003|Overall Study|Lost to Follow-up|2|||
130569891|NCT00917150|470051863|FG000|Overall Study|Physician Decision|0|||
130569892|NCT00917150|470051864|FG001|Overall Study|Physician Decision|2|||
130569893|NCT00917150|470051865|FG002|Overall Study|Physician Decision|0|||
130569894|NCT00917150|470051866|FG003|Overall Study|Physician Decision|1|||
130569895|NCT00917150|470051863|FG000|Overall Study|Protocol Violation|5|||
130569896|NCT00917150|470051864|FG001|Overall Study|Protocol Violation|5|||
130569897|NCT00917150|470051865|FG002|Overall Study|Protocol Violation|3|||
130569898|NCT00917150|470051866|FG003|Overall Study|Protocol Violation|5|||
130569899|NCT00917150|470051863|FG000|Overall Study|Withdrawal by Subject|15|||
130569900|NCT00917150|470051864|FG001|Overall Study|Withdrawal by Subject|16|||
130569901|NCT00917150|470051865|FG002|Overall Study|Withdrawal by Subject|18|||
130569902|NCT00917150|470051866|FG003|Overall Study|Withdrawal by Subject|11|||
130569903|NCT00917150|470051863|FG000|Overall Study|Other than specified|3|||
130569904|NCT00917150|470051864|FG001|Overall Study|Other than specified|3|||
130569905|NCT00917150|470051865|FG002|Overall Study|Other than specified|2|||
130569906|NCT00917150|470051866|FG003|Overall Study|Other than specified|2|||
130569907|NCT03891264|470051867|FG000|Overall Study|Adverse Event|1|||
130569908|NCT03891264|470051867|FG000|Overall Study|Withdrawal by Subject|2|||
130569909|NCT03891264|470051867|FG000|Overall Study|Physician Decision|2|||
130569910|NCT01505634|470051872|FG000|Overall Study|Withdrawal by Subject|2|||
130569911|NCT01505634|470051873|FG001|Overall Study|Withdrawal by Subject|5|||
130569912|NCT01505634|470051874|FG002|Overall Study|Withdrawal by Subject|1|||
130569913|NCT01505634|470051872|FG000|Overall Study|Physician Decision|1|||
130569914|NCT01505634|470051873|FG001|Overall Study|Physician Decision|1|||
130569915|NCT01505634|470051874|FG002|Overall Study|Physician Decision|0|||
130569916|NCT01505634|470051872|FG000|Overall Study|Adverse Event|1|||
130569917|NCT01505634|470051873|FG001|Overall Study|Adverse Event|0|||
130569918|NCT01505634|470051874|FG002|Overall Study|Adverse Event|0|||
130569919|NCT01505634|470051872|FG000|Overall Study|Insufficient supply of drug at site|1|||
130569920|NCT01505634|470051873|FG001|Overall Study|Insufficient supply of drug at site|0|||
130569921|NCT01505634|470051874|FG002|Overall Study|Insufficient supply of drug at site|0|||
130569922|NCT01505634|470051872|FG000|Overall Study|Protocol Violation|2|||
130569923|NCT01505634|470051873|FG001|Overall Study|Protocol Violation|0|||
130569924|NCT01505634|470051874|FG002|Overall Study|Protocol Violation|0|||
130569925|NCT01505634|470051872|FG000|Overall Study|Lost to Follow-up|1|||
130569926|NCT01505634|470051873|FG001|Overall Study|Lost to Follow-up|4|||
130569927|NCT01505634|470051874|FG002|Overall Study|Lost to Follow-up|4|||
130569928|NCT01505634|470051872|FG000|Overall Study|Death|1|||
130569929|NCT01505634|470051873|FG001|Overall Study|Death|0|||
130569930|NCT01505634|470051874|FG002|Overall Study|Death|0|||
130569931|NCT01505634|470051872|FG000|Overall Study|In a conflict zone|0|||
130569932|NCT01505634|470051873|FG001|Overall Study|In a conflict zone|0|||
130569933|NCT01505634|470051874|FG002|Overall Study|In a conflict zone|1|||
130569934|NCT02054897|470051875|FG000|Overall Study|Withdrawal by Subject|2|||
130569935|NCT02054897|470051876|FG001|Overall Study|Withdrawal by Subject|0|||
130569936|NCT02054897|470051877|FG002|Overall Study|Withdrawal by Subject|2|||
130569937|NCT02054897|470051875|FG000|Overall Study|Missing follow-up information|3|||
130569938|NCT02054897|470051876|FG001|Overall Study|Missing follow-up information|5|||
130569939|NCT02054897|470051877|FG002|Overall Study|Missing follow-up information|3|||
130569940|NCT02054897|470051875|FG000|Overall Study|Lost to Follow-up|4|||
130569941|NCT02054897|470051876|FG001|Overall Study|Lost to Follow-up|2|||
130569942|NCT02054897|470051877|FG002|Overall Study|Lost to Follow-up|7|||
130569943|NCT02054897|470051875|FG000|Overall Study|Randomized but not exposed|1|||
130569944|NCT02054897|470051876|FG001|Overall Study|Randomized but not exposed|0|||
130569945|NCT02054897|470051877|FG002|Overall Study|Randomized but not exposed|0|||
130569946|NCT00794157|470051878|FG000|Overall Study|Adverse Event|4|||
130569947|NCT00794157|470051879|FG001|Overall Study|Adverse Event|1|||
130569948|NCT00794157|470051880|FG002|Overall Study|Adverse Event|8|||
130569949|NCT00794157|470051878|FG000|Overall Study|Subject withdrew consent|2|||
130569950|NCT00794157|470051879|FG001|Overall Study|Subject withdrew consent|0|||
130569951|NCT00794157|470051880|FG002|Overall Study|Subject withdrew consent|3|||
130569952|NCT00794157|470051878|FG000|Overall Study|Lost to Follow-up|2|||
130569953|NCT00794157|470051879|FG001|Overall Study|Lost to Follow-up|0|||
130569954|NCT00794157|470051880|FG002|Overall Study|Lost to Follow-up|1|||
130569955|NCT00794157|470051878|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130569956|NCT00794157|470051879|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130569957|NCT00794157|470051880|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130569958|NCT00794157|470051878|FG000|Overall Study|Administrative problems|1|||
130569959|NCT00794157|470051879|FG001|Overall Study|Administrative problems|7|||
130569960|NCT00794157|470051880|FG002|Overall Study|Administrative problems|4|||
130569961|NCT00794157|470051878|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130569962|NCT00794157|470051879|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130569963|NCT00794157|470051880|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130569964|NCT00794157|470051878|FG000|Overall Study|Protocol deviation|0|||
130569965|NCT00794157|470051879|FG001|Overall Study|Protocol deviation|1|||
130569966|NCT00794157|470051880|FG002|Overall Study|Protocol deviation|1|||
130569967|NCT01692275|470051881|FG000|Overall Study|Lost to Follow-up|57|||
130569968|NCT01692275|470051882|FG001|Overall Study|Lost to Follow-up|48|||
130569969|NCT01692275|470051881|FG000|Overall Study|Withdrawal by Subject|9|||
130569970|NCT01692275|470051882|FG001|Overall Study|Withdrawal by Subject|11|||
130569971|NCT01624662|470051885|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
130569972|NCT01624662|470051886|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130569973|NCT01624662|470051887|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130569974|NCT01624662|470051888|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
130569975|NCT01624662|470051885|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
130569976|NCT01624662|470051886|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
130569977|NCT01624662|470051887|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130569978|NCT01624662|470051888|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130569979|NCT01624662|470051885|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130569980|NCT01624662|470051886|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
130569981|NCT01624662|470051887|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130569982|NCT01624662|470051888|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130569983|NCT01624662|470051885|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
130513559|NCT00925288|469847868|FG000|Overall Study|Lost to Follow-up|9|||
130513560|NCT00925288|469847869|FG001|Overall Study|Lost to Follow-up|7|||
130513561|NCT02176356|469847870|FG000|Overall Study|Screen Failure|14|||
130513562|NCT02176356|469847870|FG000|Overall Study|Lost to Follow-up|4|||
130513563|NCT02176356|469847870|FG000|Overall Study|Personal Reasons|3|||
130513564|NCT02176356|469847870|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130513565|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
130513566|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
130513567|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
130513568|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
130513569|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
130513570|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
130513571|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
130513572|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
130513573|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
130513574|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
130513575|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
130513576|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
130513577|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
130513578|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
130513579|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
130513580|NCT00332488|469847871|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
130513581|NCT00332488|469847872|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
130513582|NCT00332488|469847873|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
130513583|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
130513584|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
130513585|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
130513586|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
130513587|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
130513588|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
130513589|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
130513590|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
130513591|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
130513592|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
130513593|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
130513594|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
130513595|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
130513596|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
130513597|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
130513598|NCT00332488|469847871|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
130513599|NCT00332488|469847872|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
130569984|NCT01624662|470051886|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130569985|NCT01624662|470051887|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
130569986|NCT01624662|470051888|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130569987|NCT01624662|470051885|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130569988|NCT01624662|470051886|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130569989|NCT01624662|470051887|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130569990|NCT01624662|470051888|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130569991|NCT01624662|470051885|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130569992|NCT01624662|470051886|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
130569993|NCT01624662|470051887|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130569994|NCT01624662|470051888|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130569995|NCT01624662|470051885|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130569996|NCT01624662|470051886|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130513600|NCT00332488|469847873|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
130513601|NCT00371462|469847874|FG000|Overall Study|Withdrawal by Subject|1|||
130513602|NCT00371462|469847875|FG001|Overall Study|Withdrawal by Subject|0|||
130513603|NCT00371462|469847874|FG000|Overall Study|Other|7|||
130513604|NCT00371462|469847875|FG001|Overall Study|Other|8|||
130513605|NCT02507687|469847876|FG000|Overall Study|Adverse Event|3|||
130513606|NCT02507687|469847877|FG001|Overall Study|Adverse Event|2|||
130513607|NCT02507687|469847878|FG002|Overall Study|Adverse Event|2|||
130513608|NCT02507687|469847879|FG003|Overall Study|Adverse Event|2|||
130513609|NCT02507687|469847876|FG000|Overall Study|Withdrawal by Subject|1|||
130513610|NCT02507687|469847877|FG001|Overall Study|Withdrawal by Subject|4|||
130513611|NCT02507687|469847878|FG002|Overall Study|Withdrawal by Subject|6|||
130513612|NCT02507687|469847879|FG003|Overall Study|Withdrawal by Subject|6|||
130513613|NCT02507687|469847876|FG000|Overall Study|Protocol Violation|1|||
130513614|NCT02507687|469847877|FG001|Overall Study|Protocol Violation|0|||
130513615|NCT02507687|469847878|FG002|Overall Study|Protocol Violation|2|||
130513616|NCT02507687|469847879|FG003|Overall Study|Protocol Violation|0|||
130513617|NCT02507687|469847876|FG000|Overall Study|Lost to Follow-up|0|||
130513618|NCT02507687|469847877|FG001|Overall Study|Lost to Follow-up|0|||
130513619|NCT02507687|469847878|FG002|Overall Study|Lost to Follow-up|2|||
130513620|NCT02507687|469847879|FG003|Overall Study|Lost to Follow-up|1|||
130513621|NCT02507687|469847876|FG000|Overall Study|Screen Failure|0|||
130513622|NCT02507687|469847877|FG001|Overall Study|Screen Failure|0|||
130569997|NCT01624662|470051887|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130569998|NCT01624662|470051888|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130569999|NCT00361270|470051889|FG000|Overall Study|Death|0|||
130570000|NCT00361270|470051890|FG001|Overall Study|Death|0|||
130570001|NCT00361270|470051891|FG002|Overall Study|Death|0|||
130570002|NCT00361270|470051892|FG003|Overall Study|Death|2|||
130570003|NCT00361270|470051889|FG000|Overall Study|Lost to Follow-up|4|||
130570004|NCT00361270|470051890|FG001|Overall Study|Lost to Follow-up|1|||
130570005|NCT00361270|470051891|FG002|Overall Study|Lost to Follow-up|0|||
130570006|NCT00361270|470051892|FG003|Overall Study|Lost to Follow-up|0|||
130570007|NCT00361270|470051889|FG000|Overall Study|Physician Decision|0|||
130570008|NCT00361270|470051890|FG001|Overall Study|Physician Decision|0|||
130570009|NCT00361270|470051891|FG002|Overall Study|Physician Decision|1|||
130570010|NCT00361270|470051892|FG003|Overall Study|Physician Decision|0|||
130570011|NCT00361270|470051889|FG000|Overall Study|Protocol Violation|9|||
130570012|NCT00361270|470051890|FG001|Overall Study|Protocol Violation|4|||
130570013|NCT00361270|470051891|FG002|Overall Study|Protocol Violation|5|||
130570014|NCT00361270|470051892|FG003|Overall Study|Protocol Violation|4|||
130570015|NCT00361270|470051889|FG000|Overall Study|Withdrawal by Subject|6|||
130570016|NCT00361270|470051890|FG001|Overall Study|Withdrawal by Subject|6|||
130570017|NCT00361270|470051891|FG002|Overall Study|Withdrawal by Subject|3|||
130570018|NCT00361270|470051892|FG003|Overall Study|Withdrawal by Subject|7|||
130570019|NCT00361270|470051889|FG000|Overall Study|Afraid of Hypnosis|1|||
130570020|NCT00361270|470051890|FG001|Overall Study|Afraid of Hypnosis|2|||
130570021|NCT00361270|470051891|FG002|Overall Study|Afraid of Hypnosis|0|||
130570022|NCT00361270|470051892|FG003|Overall Study|Afraid of Hypnosis|0|||
130570023|NCT00361270|470051889|FG000|Overall Study|Problems with Transportation|4|||
130570024|NCT00361270|470051890|FG001|Overall Study|Problems with Transportation|0|||
130570025|NCT00361270|470051891|FG002|Overall Study|Problems with Transportation|0|||
130570026|NCT00361270|470051892|FG003|Overall Study|Problems with Transportation|0|||
130570027|NCT00361270|470051889|FG000|Overall Study|Adverse Event|0|||
130570028|NCT00361270|470051890|FG001|Overall Study|Adverse Event|1|||
130570029|NCT00361270|470051891|FG002|Overall Study|Adverse Event|1|||
130570030|NCT00361270|470051892|FG003|Overall Study|Adverse Event|0|||
130570031|NCT01100437|470051896|FG000|Titration/Stabilization|Adverse Event|0|||
130570032|NCT01100437|470051897|FG001|Titration/Stabilization|Adverse Event|0|||
130570033|NCT01100437|470051898|FG002|Titration/Stabilization|Adverse Event|4|||
130513623|NCT02507687|469847878|FG002|Overall Study|Screen Failure|1|||
130513624|NCT02507687|469847879|FG003|Overall Study|Screen Failure|0|||
130570034|NCT01100437|470051896|FG000|Titration/Stabilization|Non-compliance|0|||
130570035|NCT01100437|470051897|FG001|Titration/Stabilization|Non-compliance|0|||
130570036|NCT01100437|470051898|FG002|Titration/Stabilization|Non-compliance|1|||
130570037|NCT01100437|470051896|FG000|Titration/Stabilization|Sponsor canceled study|0|||
130570038|NCT01100437|470051897|FG001|Titration/Stabilization|Sponsor canceled study|0|||
130570039|NCT01100437|470051898|FG002|Titration/Stabilization|Sponsor canceled study|1|||
130570040|NCT01100437|470051896|FG000|Maintenance|Withdrawal by Subject|0|||
130570041|NCT01100437|470051897|FG001|Maintenance|Withdrawal by Subject|0|||
130570042|NCT01100437|470051898|FG002|Maintenance|Withdrawal by Subject|1|||
130570043|NCT01100437|470051896|FG000|Maintenance|Sponsor termination of study|0|||
130570044|NCT01100437|470051897|FG001|Maintenance|Sponsor termination of study|0|||
130570045|NCT01100437|470051898|FG002|Maintenance|Sponsor termination of study|1|||
130570046|NCT02581202|470051911|FG000|Overall Study|Lack of Efficacy|2|||
130570047|NCT02581202|470051911|FG000|Overall Study|Withdrawal by Subject|4|||
130570048|NCT02581202|470051911|FG000|Overall Study|Lost to Follow-up|5|||
130570049|NCT02581202|470051911|FG000|Overall Study|Pregnancy|3|||
130570050|NCT01806779|470051914|FG000|Overall Study|Physician Decision|2|||
130570051|NCT01806779|470051915|FG001|Overall Study|Physician Decision|0|||
130570052|NCT01806779|470051916|FG002|Overall Study|Physician Decision|1|||
130570053|NCT01806779|470051914|FG000|Overall Study|Lack of Efficacy|1|||
130570054|NCT01806779|470051915|FG001|Overall Study|Lack of Efficacy|1|||
130570055|NCT01806779|470051916|FG002|Overall Study|Lack of Efficacy|0|||
130570056|NCT01806779|470051914|FG000|Overall Study|Lost to Follow-up|19|||
130570057|NCT01806779|470051915|FG001|Overall Study|Lost to Follow-up|20|||
130570058|NCT01806779|470051916|FG002|Overall Study|Lost to Follow-up|0|||
130570059|NCT01806779|470051914|FG000|Overall Study|Withdrawal by Subject|20|||
130570060|NCT01806779|470051915|FG001|Overall Study|Withdrawal by Subject|23|||
130570061|NCT01806779|470051916|FG002|Overall Study|Withdrawal by Subject|22|||
130570062|NCT02595450|470051919|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
130570063|NCT02595450|470051919|FG000|Overall Study|Enrolled, but not treated|8|||
130570064|NCT04294901|470051921|FG000|Overall Study|Death|86|||
130570065|NCT04294901|470051922|FG001|Overall Study|Death|110|||
130570066|NCT04294901|470051921|FG000|Overall Study|Provider did not have historical control patients|581|||
130570067|NCT04294901|470051922|FG001|Overall Study|Provider did not have historical control patients|0|||
130570068|NCT04294901|470051921|FG000|Overall Study|Provider did not have intervention patients|0|||
130570069|NCT04294901|470051922|FG001|Overall Study|Provider did not have intervention patients|98|||
130570070|NCT01934556|470051923|FG000|Overall Study|Withdrawal by Subject|0|||
130570071|NCT01934556|470051924|FG001|Overall Study|Withdrawal by Subject|1|||
130570072|NCT01934556|470051925|FG002|Overall Study|Withdrawal by Subject|1|||
130570073|NCT01934556|470051923|FG000|Overall Study|Lost to Follow-up|4|||
130570074|NCT01934556|470051924|FG001|Overall Study|Lost to Follow-up|10|||
130570075|NCT01934556|470051925|FG002|Overall Study|Lost to Follow-up|7|||
130570076|NCT01934556|470051923|FG000|Overall Study|Death|1|||
130570077|NCT01934556|470051924|FG001|Overall Study|Death|5|||
130570078|NCT01934556|470051925|FG002|Overall Study|Death|2|||
130570079|NCT05038020|470051931|FG000|Overall Study|Early Termination|3|||
130570080|NCT05038020|470051932|FG001|Overall Study|Early Termination|0|||
130570081|NCT03770260|470053811|FG000|Overall Study|Disease progression|0|||
130570082|NCT03770260|470053812|FG001|Overall Study|Disease progression|1|||
130570083|NCT03770260|470053813|FG002|Overall Study|Disease progression|0|||
130570084|NCT03770260|470053814|FG003|Overall Study|Disease progression|0|||
130570085|NCT02484911|470053815|FG000|Overall Study|Withdrawal by Subject|2|||
130570086|NCT02484911|470053816|FG001|Overall Study|Withdrawal by Subject|1|||
130570087|NCT02484911|470053815|FG000|Overall Study|Protocol Violation|2|||
130570088|NCT02484911|470053816|FG001|Overall Study|Protocol Violation|1|||
130570089|NCT01652885|470053821|FG000|Overall Study|Adverse Event|1|||
130570090|NCT00075400|470053822|FG000|Overall Study|Ineligible: wrong primary|1|||
130570091|NCT00075400|470053822|FG000|Overall Study|Never treated|2|||
130570092|NCT00490568|470053823|FG000|Overall Study|Adverse Event|116|||
130570093|NCT00490568|470053823|FG000|Overall Study|Lost to Follow-up|13|||
130570094|NCT00490568|470053823|FG000|Overall Study|Protocol Violation|45|||
130570095|NCT00490568|470053823|FG000|Overall Study|Withdrawal by Subject|135|||
130570096|NCT00490568|470053823|FG000|Overall Study|Still in the study at termination|974|||
130570097|NCT00490568|470053823|FG000|Overall Study|Other|1|||
130570098|NCT00490568|470053823|FG000|Overall Study|Exclusion criteria met|1|||
130570099|NCT00490568|470053823|FG000|Overall Study|Caregiver related|20|||
130570100|NCT00490568|470053823|FG000|Overall Study|Abnormal ECG|25|||
130570101|NCT00490568|470053823|FG000|Overall Study|Participant refused follow-up|9|||
130570102|NCT00490568|470053823|FG000|Overall Study|Legal representative withdrew consent|1|||
130570103|NCT00490568|470053823|FG000|Overall Study|Disease progression|4|||
130570104|NCT00490568|470053823|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
130570105|NCT00490568|470053823|FG000|Overall Study|Investigator decision|3|||
130570106|NCT00490568|470053823|FG000|Overall Study|Non-Compliance|7|||
130570107|NCT00490568|470053823|FG000|Overall Study|Efficacy related|3|||
130570108|NCT00490568|470053823|FG000|Overall Study|Participant died|1|||
130570109|NCT00490568|470053823|FG000|Overall Study|Participant withdrawal due to surgery|1|||
130570110|NCT01395394|470053824|FG000|Baseline Study Visit|Protocol Violation|1|||
130570111|NCT01395394|470053825|FG001|Baseline Study Visit|Protocol Violation|0|||
130570112|NCT01395394|470053826|FG002|Baseline Study Visit|Protocol Violation|0|||
130570113|NCT03451773|470053829|FG000|Overall Study|Death on study|1|||
130570114|NCT03451773|470053830|FG001|Overall Study|Death on study|5|||
130570115|NCT03451773|470053829|FG000|Overall Study|Death during follow-up period|0|||
130513625|NCT02507687|469847876|FG000|Overall Study|Other, Not Specified|0|||
130513626|NCT02507687|469847877|FG001|Overall Study|Other, Not Specified|0|||
130513627|NCT02507687|469847878|FG002|Overall Study|Other, Not Specified|2|||
130513628|NCT02507687|469847879|FG003|Overall Study|Other, Not Specified|4|||
130513629|NCT05372913|469847884|FG000|Overall Study|Withdrawal by Subject|0|||
130513630|NCT05372913|469847885|FG001|Overall Study|Withdrawal by Subject|2|||
130513631|NCT05372913|469847884|FG000|Overall Study|Protocol Violation|2|||
130513632|NCT05372913|469847885|FG001|Overall Study|Protocol Violation|2|||
130513633|NCT05372913|469847884|FG000|Overall Study|Adverse Event|0|||
130513634|NCT05372913|469847885|FG001|Overall Study|Adverse Event|1|||
130513635|NCT03275402|469847886|FG000|Overall Study|Death|17|||
130513636|NCT03275402|469847886|FG000|Overall Study|Study terminated by sponsor|21|||
130513637|NCT03275402|469847886|FG000|Overall Study|Withdrawal by Subject|1|||
130513638|NCT05135156|469847887|FG000|Overall Study|Lost to Follow-up|0|||
130513639|NCT05135156|469847888|FG001|Overall Study|Lost to Follow-up|0|||
130513640|NCT05135156|469847889|FG002|Overall Study|Lost to Follow-up|2|||
130513641|NCT02986659|469847890|FG000|First Intervention Period|Adverse Event|3|||
130513642|NCT02986659|469847891|FG001|First Intervention Period|Adverse Event|1|||
130513643|NCT02986659|469847890|FG000|First Intervention Period|Lost to Follow-up|1|||
130513644|NCT02986659|469847891|FG001|First Intervention Period|Lost to Follow-up|0|||
130513645|NCT02986659|469847890|FG000|First Intervention Period|Withdrawal by Subject|0|||
130513646|NCT02986659|469847891|FG001|First Intervention Period|Withdrawal by Subject|1|||
130513647|NCT02986659|469847890|FG000|Second Intervention Period|Adverse Event|0|||
130513648|NCT02986659|469847891|FG001|Second Intervention Period|Adverse Event|6|||
130513649|NCT01059526|469847895|FG000|Overall Study|Patient enrolled but not treated|20|||
130513650|NCT01059526|469847896|FG001|Overall Study|Patient enrolled but not treated|17|||
130513651|NCT01059526|469847895|FG000|Overall Study|Adverse Event|2|||
130513652|NCT01059526|469847896|FG001|Overall Study|Adverse Event|2|||
130513653|NCT01059526|469847895|FG000|Overall Study|Protocol Violation|0|||
130513654|NCT01059526|469847896|FG001|Overall Study|Protocol Violation|1|||
130513655|NCT01059526|469847895|FG000|Overall Study|Withdrawal by Subject|3|||
130513656|NCT01059526|469847896|FG001|Overall Study|Withdrawal by Subject|1|||
130513657|NCT01059526|469847895|FG000|Overall Study|Lost to Follow-up|4|||
130513658|NCT01059526|469847896|FG001|Overall Study|Lost to Follow-up|1|||
130513659|NCT01059526|469847895|FG000|Overall Study|Patient found to be dermatographic|1|||
130513660|NCT01059526|469847896|FG001|Overall Study|Patient found to be dermatographic|0|||
130513661|NCT02720081|469847897|FG000|Overall Study|Adverse Event|0|||
130513662|NCT02720081|469847898|FG001|Overall Study|Adverse Event|3|||
130513663|NCT02720081|469847897|FG000|Overall Study|Protocol Violation|4|||
130513664|NCT02720081|469847898|FG001|Overall Study|Protocol Violation|1|||
130513665|NCT02005029|469847900|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
130513666|NCT02005029|469847901|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
130513667|NCT01370018|469847902|FG000|Overall Study|Did not meet criteria for analysis|1|||
130513668|NCT01536535|469847906|FG000|Overall Study|Withdrawal by Subject|10|||
130513669|NCT01536535|469847907|FG001|Overall Study|Withdrawal by Subject|5|||
130513670|NCT01536535|469847906|FG000|Overall Study|Lost to Follow-up|4|||
130513671|NCT01536535|469847907|FG001|Overall Study|Lost to Follow-up|6|||
130513672|NCT01536535|469847906|FG000|Overall Study|Physician Decision|1|||
130513673|NCT01536535|469847907|FG001|Overall Study|Physician Decision|1|||
130513674|NCT01536535|469847906|FG000|Overall Study|Participant moved|0|||
130513675|NCT01536535|469847907|FG001|Overall Study|Participant moved|1|||
130513676|NCT03794609|469847909|FG000|Overall Study|Other|10|||
130513677|NCT03794609|469847909|FG000|Overall Study|Withdrawal by Subject|66|||
130513678|NCT03794609|469847909|FG000|Overall Study|The child is enrolled in an interventional study|70|||
130513679|NCT03794609|469847909|FG000|Overall Study|Inclusion/exclusion criteria|8|||
130513680|NCT03794609|469847909|FG000|Overall Study|At sponsor's request|151|||
130513681|NCT03794609|469847909|FG000|Overall Study|Physician Decision|1|||
130513682|NCT03794609|469847909|FG000|Overall Study|Lost to Follow-up|5|||
130570116|NCT03451773|470053830|FG001|Overall Study|Death during follow-up period|1|||
130570117|NCT03468855|470053831|FG000|Overall Study|Adverse Event|2|||
130570118|NCT03468855|470053831|FG000|Overall Study|Lost to Follow-up|5|||
130570119|NCT03468855|470053831|FG000|Overall Study|Withdrawal by Subject|3|||
130570120|NCT03468855|470053831|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
130513683|NCT04474691|469847916|FG000|Overall Study|Withdrawal by Subject|9|||
130570121|NCT00390546|470053832|FG000|Overall Study|Renal impairment|1|||
130570122|NCT00390546|470053833|FG001|Overall Study|Renal impairment|0|||
130570123|NCT00390546|470053832|FG000|Overall Study|Physician Decision|5|||
130570124|NCT00390546|470053833|FG001|Overall Study|Physician Decision|5|||
130513684|NCT00139659|469847917|FG000|Overall Study|Adverse Event|12|||
130513685|NCT00139659|469847918|FG001|Overall Study|Adverse Event|1|||
130513686|NCT00139659|469847917|FG000|Overall Study|Lack of Efficacy|1|||
130513687|NCT00139659|469847918|FG001|Overall Study|Lack of Efficacy|1|||
130513688|NCT00139659|469847917|FG000|Overall Study|Lost to Follow-up|7|||
130513689|NCT00139659|469847918|FG001|Overall Study|Lost to Follow-up|3|||
130513690|NCT00139659|469847917|FG000|Overall Study|Reason not Specified|6|||
130513691|NCT00139659|469847918|FG001|Overall Study|Reason not Specified|3|||
130513692|NCT00139659|469847917|FG000|Overall Study|Withdrawal by Subject|14|||
130513693|NCT00139659|469847918|FG001|Overall Study|Withdrawal by Subject|10|||
130513694|NCT02625922|469847920|FG000|Overall Study|Non-availability of IMP|1|||
130513695|NCT02625922|469847921|FG001|Overall Study|Non-availability of IMP|1|||
130513696|NCT02625922|469847920|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
130513697|NCT02625922|469847921|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
130513698|NCT02391116|469847922|FG000|Treatment|Withdrawal by Subject|1|||
130513699|NCT02391116|469847922|FG000|Treatment|Protocol Violation|1|||
130570125|NCT00812214|470053839|FG000|Overall Study|Lost to Follow-up|3|||
130570126|NCT00812214|470053840|FG001|Overall Study|Lost to Follow-up|1|||
130570127|NCT02145741|470053841|FG000|Overall Study|Progressive disease|3|||
130570128|NCT02145741|470053842|FG001|Overall Study|Progressive disease|6|||
130570129|NCT02145741|470053843|FG002|Overall Study|Progressive disease|6|||
130570130|NCT02145741|470053841|FG000|Overall Study|quality issue with the administered drug|3|||
130570131|NCT02145741|470053842|FG001|Overall Study|quality issue with the administered drug|0|||
130570132|NCT02145741|470053843|FG002|Overall Study|quality issue with the administered drug|0|||
130570133|NCT01192022|470053844|FG000|Overall Study|Withdrawal of Consent|3|||
130570134|NCT01192022|470053845|FG001|Overall Study|Withdrawal of Consent|1|||
130570135|NCT01192022|470053846|FG002|Overall Study|Withdrawal of Consent|0|||
130570136|NCT01192022|470053847|FG003|Overall Study|Withdrawal of Consent|0|||
130570137|NCT01192022|470053848|FG004|Overall Study|Withdrawal of Consent|0|||
130570138|NCT01192022|470053844|FG000|Overall Study|Lost to Follow-up|4|||
130570139|NCT01192022|470053845|FG001|Overall Study|Lost to Follow-up|2|||
130570140|NCT01192022|470053846|FG002|Overall Study|Lost to Follow-up|1|||
130570141|NCT01192022|470053847|FG003|Overall Study|Lost to Follow-up|1|||
130570142|NCT01192022|470053848|FG004|Overall Study|Lost to Follow-up|0|||
130570143|NCT01192022|470053844|FG000|Overall Study|Adverse Event|1|||
130570144|NCT01192022|470053845|FG001|Overall Study|Adverse Event|0|||
130570145|NCT01192022|470053846|FG002|Overall Study|Adverse Event|0|||
130570146|NCT01192022|470053847|FG003|Overall Study|Adverse Event|0|||
130570147|NCT01192022|470053848|FG004|Overall Study|Adverse Event|0|||
130570148|NCT01192022|470053844|FG000|Overall Study|Fatal Adverse Event|4|||
130570149|NCT01192022|470053845|FG001|Overall Study|Fatal Adverse Event|6|||
130570150|NCT01192022|470053846|FG002|Overall Study|Fatal Adverse Event|0|||
130570151|NCT01192022|470053847|FG003|Overall Study|Fatal Adverse Event|0|||
130570152|NCT01192022|470053848|FG004|Overall Study|Fatal Adverse Event|1|||
130570153|NCT01192022|470053844|FG000|Overall Study|Physician withdrew-patient hardship|1|||
130570154|NCT01192022|470053845|FG001|Overall Study|Physician withdrew-patient hardship|0|||
130570155|NCT01192022|470053846|FG002|Overall Study|Physician withdrew-patient hardship|0|||
130570156|NCT01192022|470053847|FG003|Overall Study|Physician withdrew-patient hardship|0|||
130570157|NCT01192022|470053848|FG004|Overall Study|Physician withdrew-patient hardship|0|||
130570158|NCT01192022|470053844|FG000|Overall Study|Patient too sick from chemotherapy|0|||
130570159|NCT01192022|470053845|FG001|Overall Study|Patient too sick from chemotherapy|1|||
130570160|NCT01192022|470053846|FG002|Overall Study|Patient too sick from chemotherapy|0|||
130570161|NCT01192022|470053847|FG003|Overall Study|Patient too sick from chemotherapy|0|||
130570162|NCT01192022|470053848|FG004|Overall Study|Patient too sick from chemotherapy|0|||
130570163|NCT01192022|470053844|FG000|Overall Study|Patient needed surgery|0|||
130570164|NCT01192022|470053845|FG001|Overall Study|Patient needed surgery|1|||
130570165|NCT01192022|470053846|FG002|Overall Study|Patient needed surgery|0|||
130570166|NCT01192022|470053847|FG003|Overall Study|Patient needed surgery|0|||
130570167|NCT01192022|470053848|FG004|Overall Study|Patient needed surgery|0|||
130570168|NCT01192022|470053844|FG000|Overall Study|Parents did not allow all follow up|0|||
130570169|NCT01192022|470053845|FG001|Overall Study|Parents did not allow all follow up|0|||
130570170|NCT01192022|470053846|FG002|Overall Study|Parents did not allow all follow up|0|||
130570171|NCT01192022|470053847|FG003|Overall Study|Parents did not allow all follow up|1|||
130570172|NCT01192022|470053848|FG004|Overall Study|Parents did not allow all follow up|0|||
130570173|NCT00129766|470053850|FG000|Overall Study|Death|3|||
130570174|NCT00129766|470053851|FG001|Overall Study|Death|8|||
130570175|NCT00129766|470053850|FG000|Overall Study|Withdrawal of consent|31|||
130570176|NCT00129766|470053851|FG001|Overall Study|Withdrawal of consent|30|||
130570177|NCT00129766|470053850|FG000|Overall Study|Lost to Follow-up|26|||
130570178|NCT00129766|470053851|FG001|Overall Study|Lost to Follow-up|21|||
130570179|NCT00781456|470053853|FG000|Overall Study|Adverse Event|3|||
130570180|NCT00781456|470053854|FG001|Overall Study|Adverse Event|3|||
130570181|NCT00781456|470053853|FG000|Overall Study|Withdrawal by Subject|3|||
130570182|NCT00781456|470053854|FG001|Overall Study|Withdrawal by Subject|5|||
130570183|NCT00781456|470053853|FG000|Overall Study|Protocol Violation|4|||
130570184|NCT00781456|470053854|FG001|Overall Study|Protocol Violation|1|||
130570185|NCT00781456|470053853|FG000|Overall Study|Noncompliance With Protocol|1|||
130570186|NCT00781456|470053854|FG001|Overall Study|Noncompliance With Protocol|1|||
130570187|NCT00781456|470053853|FG000|Overall Study|Lost to Follow-up|10|||
130513700|NCT02391116|469847922|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
130513701|NCT02391116|469847922|FG000|Treatment|AE with Clinical PD|3|||
130513702|NCT02391116|469847922|FG000|Safety Follow-up|Adverse Event|1|||
130513703|NCT02391116|469847922|FG000|Safety Follow-up|Withdrawal by Subject|4|||
130513704|NCT02391116|469847922|FG000|Safety Follow-up|Switching to Other Therapy|4|||
130513705|NCT02391116|469847922|FG000|Safety Follow-up|No Follow Up|1|||
130513706|NCT02391116|469847922|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
130513707|NCT02391116|469847922|FG000|Active Follow-up|Withdrawal by Subject|1|||
130513708|NCT02391116|469847922|FG000|Active Follow-up|Switching to Other Therapy|2|||
130513709|NCT02391116|469847922|FG000|Survival Follow-up|Withdrawal by Subject|3|||
130513710|NCT02391116|469847922|FG000|Survival Follow-up|Switching to Other Therapy|1|||
130513711|NCT01747629|469847923|FG000|Overall Study|Adverse Event|1|||
130513712|NCT01747629|469847924|FG001|Overall Study|Adverse Event|2|||
130513713|NCT01747629|469847923|FG000|Overall Study|Withdrawal by Subject|2|||
130513714|NCT01747629|469847924|FG001|Overall Study|Withdrawal by Subject|2|||
130513715|NCT01747629|469847923|FG000|Overall Study|Noncompliance|1|||
130513716|NCT01747629|469847924|FG001|Overall Study|Noncompliance|1|||
130513717|NCT01747629|469847923|FG000|Overall Study|Inclusion criteria not met|1|||
130513718|NCT01747629|469847924|FG001|Overall Study|Inclusion criteria not met|0|||
130513719|NCT01747629|469847923|FG000|Overall Study|Not treated|1|||
130513720|NCT01747629|469847924|FG001|Overall Study|Not treated|0|||
130513721|NCT01747629|469847923|FG000|Overall Study|Other|2|||
130513722|NCT01747629|469847924|FG001|Overall Study|Other|1|||
130513723|NCT04414397|469847925|FG000|Control Period|Withdrawal by Subject|2|||
130513724|NCT04414397|469847926|FG001|Control Period|Withdrawal by Subject|2|||
130513725|NCT04414397|469847925|FG000|Control Period|Lost to Follow-up|0|||
130513726|NCT04414397|469847926|FG001|Control Period|Lost to Follow-up|4|||
130513727|NCT04414397|469847925|FG000|Control Period|Protocol deviation|0|||
130513728|NCT04414397|469847926|FG001|Control Period|Protocol deviation|1|||
130513729|NCT04414397|469847925|FG000|Post-Control Period|Withdrawal by Subject|3|||
130513730|NCT04414397|469847926|FG001|Post-Control Period|Withdrawal by Subject|6|||
130513731|NCT04414397|469847925|FG000|Post-Control Period|Lost to Follow-up|4|||
130513732|NCT04414397|469847926|FG001|Post-Control Period|Lost to Follow-up|9|||
130513733|NCT04414397|469847925|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
130513734|NCT04414397|469847926|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
130513735|NCT04414397|469847925|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
130513736|NCT04414397|469847926|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
130513737|NCT01920178|469847930|FG000|Overall Study|Lost to Follow-up|2|||
130513738|NCT01920178|469847931|FG001|Overall Study|Lost to Follow-up|1|||
130513739|NCT01261793|469847932|FG000|Overall Study|Lack of Efficacy|44|||
130513740|NCT01261793|469847933|FG001|Overall Study|Lack of Efficacy|37|||
130513741|NCT01261793|469847934|FG002|Overall Study|Lack of Efficacy|32|||
130513742|NCT01261793|469847932|FG000|Overall Study|Protocol Violation|3|||
130513743|NCT01261793|469847933|FG001|Overall Study|Protocol Violation|5|||
130513744|NCT01261793|469847934|FG002|Overall Study|Protocol Violation|6|||
130513745|NCT01261793|469847932|FG000|Overall Study|Lost to Follow-up|10|||
130513746|NCT01261793|469847933|FG001|Overall Study|Lost to Follow-up|3|||
130513747|NCT01261793|469847934|FG002|Overall Study|Lost to Follow-up|7|||
130513748|NCT01261793|469847932|FG000|Overall Study|Withdrawal by Subject|12|||
130513749|NCT01261793|469847933|FG001|Overall Study|Withdrawal by Subject|14|||
130513750|NCT01261793|469847934|FG002|Overall Study|Withdrawal by Subject|14|||
130513751|NCT01261793|469847932|FG000|Overall Study|Death|3|||
130513752|NCT01261793|469847933|FG001|Overall Study|Death|1|||
130513753|NCT01261793|469847934|FG002|Overall Study|Death|0|||
130513754|NCT01261793|469847932|FG000|Overall Study|Adverse Event|9|||
130513755|NCT01261793|469847933|FG001|Overall Study|Adverse Event|24|||
130513756|NCT01261793|469847934|FG002|Overall Study|Adverse Event|19|||
130513757|NCT01261793|469847932|FG000|Overall Study|Patient non-availability|1|||
130513758|NCT01261793|469847933|FG001|Overall Study|Patient non-availability|1|||
130513759|NCT01261793|469847934|FG002|Overall Study|Patient non-availability|1|||
130513760|NCT01261793|469847932|FG000|Overall Study|Suspected pregnancy|1|||
130513761|NCT01261793|469847933|FG001|Overall Study|Suspected pregnancy|1|||
130513762|NCT01261793|469847934|FG002|Overall Study|Suspected pregnancy|0|||
130513763|NCT01261793|469847932|FG000|Overall Study|Patient non-compliance|1|||
130513764|NCT01261793|469847933|FG001|Overall Study|Patient non-compliance|0|||
130513765|NCT01261793|469847934|FG002|Overall Study|Patient non-compliance|1|||
130513766|NCT01261793|469847932|FG000|Overall Study|Patient pregnant|1|||
130513767|NCT01261793|469847933|FG001|Overall Study|Patient pregnant|0|||
130513768|NCT01261793|469847934|FG002|Overall Study|Patient pregnant|0|||
130513769|NCT01261793|469847932|FG000|Overall Study|Outside the study area|0|||
130513770|NCT01261793|469847933|FG001|Overall Study|Outside the study area|2|||
130513771|NCT01261793|469847934|FG002|Overall Study|Outside the study area|1|||
130513772|NCT01261793|469847932|FG000|Overall Study|Lack of efficacy & patient not available|0|||
130513773|NCT01261793|469847933|FG001|Overall Study|Lack of efficacy & patient not available|1|||
130513774|NCT01261793|469847934|FG002|Overall Study|Lack of efficacy & patient not available|0|||
130513775|NCT01261793|469847932|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
130513776|NCT01261793|469847933|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
130570188|NCT00781456|470053854|FG001|Overall Study|Lost to Follow-up|5|||
130570189|NCT00781456|470053853|FG000|Overall Study|Other Reason, Unknown|0|||
130570190|NCT00781456|470053854|FG001|Overall Study|Other Reason, Unknown|1|||
130570191|NCT04091087|470053855|FG000|Overall Study|Not treated|1|||
130570192|NCT04091087|470053856|FG001|Overall Study|Not treated|0|||
130570193|NCT04091087|470053855|FG000|Overall Study|Adverse Event|4|||
130570194|NCT04091087|470053856|FG001|Overall Study|Adverse Event|4|||
130570195|NCT04091087|470053855|FG000|Overall Study|Protocol Violation|0|||
130570196|NCT04091087|470053856|FG001|Overall Study|Protocol Violation|1|||
130570197|NCT04091087|470053855|FG000|Overall Study|Withdrawal by Subject|5|||
130570198|NCT04091087|470053856|FG001|Overall Study|Withdrawal by Subject|2|||
130570199|NCT05440539|470053857|FG000|Overall Study|Lost to Follow-up|4|||
130570200|NCT05440539|470053858|FG001|Overall Study|Lost to Follow-up|4|||
130570201|NCT05440539|470053857|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
130570202|NCT05440539|470053858|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
130570203|NCT03808077|470053859|FG000|Overall Study|Physician Decision|2|||
130570204|NCT03808077|470053860|FG001|Overall Study|Physician Decision|3|||
130570205|NCT03808077|470053859|FG000|Overall Study|Withdrawal by Subject|1|||
130570206|NCT03808077|470053860|FG001|Overall Study|Withdrawal by Subject|0|||
130570207|NCT03808077|470053859|FG000|Overall Study|Equipment Issues|2|||
130570208|NCT03808077|470053860|FG001|Overall Study|Equipment Issues|1|||
130570209|NCT04152161|470053861|FG000|Overall Study|Death|0|||
130570210|NCT04152161|470053862|FG001|Overall Study|Death|1|||
130570211|NCT04152161|470053861|FG000|Overall Study|Physician Decision|0|||
130570212|NCT04152161|470053862|FG001|Overall Study|Physician Decision|1|||
130570213|NCT04152161|470053861|FG000|Overall Study|Lost to Follow-up|9|||
130513777|NCT01261793|469847934|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
130513778|NCT01261793|469847932|FG000|Overall Study|Randomization error|0|||
130513779|NCT01261793|469847933|FG001|Overall Study|Randomization error|1|||
130513780|NCT01261793|469847934|FG002|Overall Study|Randomization error|0|||
130513781|NCT01261793|469847932|FG000|Overall Study|Patient unable to start IV line|0|||
130513782|NCT01261793|469847933|FG001|Overall Study|Patient unable to start IV line|0|||
130513783|NCT01261793|469847934|FG002|Overall Study|Patient unable to start IV line|1|||
130513784|NCT03562117|469847935|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
130513785|NCT03562117|469847936|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
130513786|NCT03562117|469847937|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
130513787|NCT01294358|469847938|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
130513788|NCT01294358|469847939|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
130513789|NCT01294358|469847940|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
130513790|NCT01294358|469847941|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
130513791|NCT01294358|469847942|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
130513792|NCT01294358|469847938|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
130513793|NCT01294358|469847939|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
130513794|NCT01294358|469847940|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
130513795|NCT01294358|469847941|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
130513796|NCT01294358|469847942|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
130513797|NCT01294358|469847938|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
130513798|NCT01294358|469847939|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
130513799|NCT01294358|469847940|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
130513800|NCT01294358|469847941|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
130513801|NCT01294358|469847942|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
130513802|NCT01294358|469847938|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
130513803|NCT01294358|469847939|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
130513804|NCT01294358|469847940|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
130513805|NCT01294358|469847941|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
130513806|NCT01294358|469847942|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
130513807|NCT02784535|469847949|FG000|Overall Study|Adverse Event|1|||
130513808|NCT02784535|469847950|FG001|Overall Study|Adverse Event|0|||
130513809|NCT02784535|469847949|FG000|Overall Study|Withdrawal by Subject|0|||
130513810|NCT02784535|469847950|FG001|Overall Study|Withdrawal by Subject|1|||
130513811|NCT02784535|469847949|FG000|Overall Study|Physician Decision|0|||
130513812|NCT02784535|469847950|FG001|Overall Study|Physician Decision|1|||
130570214|NCT04152161|470053862|FG001|Overall Study|Lost to Follow-up|3|||
130570215|NCT04152161|470053861|FG000|Overall Study|Protocol Violation|1|||
130570216|NCT04152161|470053862|FG001|Overall Study|Protocol Violation|0|||
130570217|NCT04152161|470053861|FG000|Overall Study|Withdrawal by Subject|29|||
130570218|NCT04152161|470053862|FG001|Overall Study|Withdrawal by Subject|28|||
130513813|NCT03740919|469847955|FG000|Lead-in Period|Lost to Follow-up|1|||
130513814|NCT03740919|469847956|FG001|Lead-in Period|Lost to Follow-up|0|||
130513815|NCT03740919|469847957|FG002|Lead-in Period|Lost to Follow-up|0|||
130513816|NCT03740919|469847958|FG003|Lead-in Period|Lost to Follow-up|0|||
130570219|NCT04152161|470053861|FG000|Overall Study|Sponsor termination of study|750|||
130570220|NCT04152161|470053862|FG001|Overall Study|Sponsor termination of study|755|||
130570221|NCT04152161|470053861|FG000|Overall Study|Other|20|||
130513817|NCT03740919|469847955|FG000|Lead-in Period|Physician Decision|2|||
130513818|NCT03740919|469847956|FG001|Lead-in Period|Physician Decision|0|||
130513819|NCT03740919|469847957|FG002|Lead-in Period|Physician Decision|0|||
130513820|NCT03740919|469847958|FG003|Lead-in Period|Physician Decision|0|||
130513821|NCT03740919|469847955|FG000|Lead-in Period|Protocol Violation|1|||
130513822|NCT03740919|469847956|FG001|Lead-in Period|Protocol Violation|0|||
130513823|NCT03740919|469847957|FG002|Lead-in Period|Protocol Violation|0|||
130513824|NCT03740919|469847958|FG003|Lead-in Period|Protocol Violation|0|||
130513825|NCT03740919|469847955|FG000|Lead-in Period|Withdrawal by Subject|10|||
130513826|NCT03740919|469847956|FG001|Lead-in Period|Withdrawal by Subject|0|||
130513827|NCT03740919|469847957|FG002|Lead-in Period|Withdrawal by Subject|0|||
130513828|NCT03740919|469847958|FG003|Lead-in Period|Withdrawal by Subject|0|||
130513829|NCT03740919|469847955|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
130513830|NCT03740919|469847956|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
130513831|NCT03740919|469847957|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
130513832|NCT03740919|469847958|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
130513833|NCT03740919|469847955|FG000|Lead-in Period|Study Task Too Burdensome|1|||
130513834|NCT03740919|469847956|FG001|Lead-in Period|Study Task Too Burdensome|0|||
130513835|NCT03740919|469847957|FG002|Lead-in Period|Study Task Too Burdensome|0|||
130513836|NCT03740919|469847958|FG003|Lead-in Period|Study Task Too Burdensome|0|||
130513837|NCT03740919|469847955|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
130513838|NCT03740919|469847956|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
130513839|NCT03740919|469847957|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
130513840|NCT03740919|469847958|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
130513841|NCT03740919|469847955|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
130513842|NCT03740919|469847956|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
130513843|NCT03740919|469847957|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
130513844|NCT03740919|469847958|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
130513845|NCT03740919|469847955|FG000|Treatment Period|Adverse Event|0|||
130513846|NCT03740919|469847956|FG001|Treatment Period|Adverse Event|0|||
130513847|NCT03740919|469847957|FG002|Treatment Period|Adverse Event|2|||
130513848|NCT03740919|469847958|FG003|Treatment Period|Adverse Event|0|||
130513849|NCT03740919|469847955|FG000|Treatment Period|Protocol Violation|0|||
130513850|NCT03740919|469847956|FG001|Treatment Period|Protocol Violation|1|||
130513851|NCT03740919|469847957|FG002|Treatment Period|Protocol Violation|0|||
130513852|NCT03740919|469847958|FG003|Treatment Period|Protocol Violation|0|||
130513853|NCT03740919|469847955|FG000|Treatment Period|Withdrawal by Subject|0|||
130513854|NCT03740919|469847956|FG001|Treatment Period|Withdrawal by Subject|7|||
130513855|NCT03740919|469847957|FG002|Treatment Period|Withdrawal by Subject|6|||
130513856|NCT03740919|469847958|FG003|Treatment Period|Withdrawal by Subject|2|||
130513857|NCT03740919|469847955|FG000|Treatment Period|Terminated by Sponsor|0|||
130513858|NCT03740919|469847956|FG001|Treatment Period|Terminated by Sponsor|1|||
130513859|NCT03740919|469847957|FG002|Treatment Period|Terminated by Sponsor|0|||
130513860|NCT03740919|469847958|FG003|Treatment Period|Terminated by Sponsor|0|||
130513861|NCT03740919|469847955|FG000|Treatment Period|Issue with Insulin Pump|0|||
130513862|NCT03740919|469847956|FG001|Treatment Period|Issue with Insulin Pump|1|||
130513863|NCT03740919|469847957|FG002|Treatment Period|Issue with Insulin Pump|0|||
130513864|NCT03740919|469847958|FG003|Treatment Period|Issue with Insulin Pump|0|||
130513865|NCT03740919|469847955|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
130513866|NCT03740919|469847956|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
130513867|NCT03740919|469847957|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
130513868|NCT03740919|469847958|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
130513869|NCT03740919|469847955|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
130513870|NCT03740919|469847956|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
130513871|NCT03740919|469847957|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
130513872|NCT03740919|469847958|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
130513873|NCT03740919|469847955|FG000|Treatment Period|Not Completing Diary|0|||
130513874|NCT03740919|469847956|FG001|Treatment Period|Not Completing Diary|0|||
130513875|NCT03740919|469847957|FG002|Treatment Period|Not Completing Diary|1|||
130513876|NCT03740919|469847958|FG003|Treatment Period|Not Completing Diary|0|||
130513877|NCT03740919|469847955|FG000|Treatment Period|Insulin Painful to Participant|0|||
130513878|NCT03740919|469847956|FG001|Treatment Period|Insulin Painful to Participant|0|||
130513879|NCT03740919|469847957|FG002|Treatment Period|Insulin Painful to Participant|1|||
130513880|NCT03740919|469847958|FG003|Treatment Period|Insulin Painful to Participant|0|||
130513881|NCT02335242|469847959|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
130513882|NCT02335242|469847960|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
130513883|NCT02335242|469847959|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
130513884|NCT02335242|469847960|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
130570222|NCT04152161|470053862|FG001|Overall Study|Other|18|||
130570223|NCT03246958|470053863|FG000|Overall Study|Withdrawal by Subject|0|||
130513885|NCT02335242|469847959|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
130513886|NCT02335242|469847960|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
130513887|NCT03873038|469847963|FG000|Part 2|Withdrawal by Subject|0|||
130513888|NCT03873038|469847964|FG001|Part 2|Withdrawal by Subject|0|||
130513889|NCT03873038|469847965|FG002|Part 2|Withdrawal by Subject|0|||
130513890|NCT03873038|469847966|FG003|Part 2|Withdrawal by Subject|0|||
130513891|NCT03873038|469847967|FG004|Part 2|Withdrawal by Subject|0|||
130513892|NCT03873038|469847968|FG005|Part 2|Withdrawal by Subject|1|||
130513893|NCT03873038|469847963|FG000|Part 2|Unknon|0|||
130513894|NCT03873038|469847964|FG001|Part 2|Unknon|0|||
130513895|NCT03873038|469847965|FG002|Part 2|Unknon|0|||
130513896|NCT03873038|469847966|FG003|Part 2|Unknon|0|||
130513897|NCT03873038|469847967|FG004|Part 2|Unknon|1|||
130513898|NCT03873038|469847968|FG005|Part 2|Unknon|0|||
130513899|NCT04222088|469847969|FG000|Overall Study|Lost to Follow-up|5|||
130513900|NCT04222088|469847970|FG001|Overall Study|Lost to Follow-up|1|||
130513901|NCT04222088|469847969|FG000|Overall Study|Withdrawal by Subject|4|||
130513902|NCT04222088|469847970|FG001|Overall Study|Withdrawal by Subject|0|||
130513903|NCT00905255|469847971|FG000|Overall Study|Adverse Event|7|||
130513904|NCT00905255|469847972|FG001|Overall Study|Adverse Event|5|||
130513905|NCT00905255|469847971|FG000|Overall Study|Withdrawal by Subject|5|||
130513906|NCT00905255|469847972|FG001|Overall Study|Withdrawal by Subject|4|||
130513907|NCT00905255|469847971|FG000|Overall Study|Familial and Personal Reasons|1|||
130513908|NCT00905255|469847972|FG001|Overall Study|Familial and Personal Reasons|0|||
130513909|NCT02133131|469847975|FG000|Overall Study|Adverse Event|0|||
130513910|NCT02133131|469847976|FG001|Overall Study|Adverse Event|0|||
130513911|NCT02133131|469847977|FG002|Overall Study|Adverse Event|0|||
130513912|NCT02133131|469847978|FG003|Overall Study|Adverse Event|1|||
130513913|NCT02133131|469847979|FG004|Overall Study|Adverse Event|0|||
130513914|NCT02133131|469847980|FG005|Overall Study|Adverse Event|0|||
130513915|NCT02133131|469847981|FG006|Overall Study|Adverse Event|0|||
130513916|NCT02133131|469847975|FG000|Overall Study|Lost to Follow-up|1|||
130513917|NCT02133131|469847976|FG001|Overall Study|Lost to Follow-up|0|||
130513918|NCT02133131|469847977|FG002|Overall Study|Lost to Follow-up|0|||
130513919|NCT02133131|469847978|FG003|Overall Study|Lost to Follow-up|1|||
130513920|NCT02133131|469847979|FG004|Overall Study|Lost to Follow-up|0|||
130513921|NCT02133131|469847980|FG005|Overall Study|Lost to Follow-up|0|||
130513922|NCT02133131|469847981|FG006|Overall Study|Lost to Follow-up|0|||
130513923|NCT02133131|469847975|FG000|Overall Study|Status not recorded|4|||
130513924|NCT02133131|469847976|FG001|Overall Study|Status not recorded|5|||
130513925|NCT02133131|469847977|FG002|Overall Study|Status not recorded|1|||
130513926|NCT02133131|469847978|FG003|Overall Study|Status not recorded|4|||
130513927|NCT02133131|469847979|FG004|Overall Study|Status not recorded|0|||
130513928|NCT02133131|469847980|FG005|Overall Study|Status not recorded|0|||
130513929|NCT02133131|469847981|FG006|Overall Study|Status not recorded|0|||
130513930|NCT02133131|469847975|FG000|Overall Study|Ongoing in study|0|||
130513931|NCT02133131|469847976|FG001|Overall Study|Ongoing in study|0|||
130513932|NCT02133131|469847977|FG002|Overall Study|Ongoing in study|0|||
130513933|NCT02133131|469847978|FG003|Overall Study|Ongoing in study|0|||
130513934|NCT02133131|469847979|FG004|Overall Study|Ongoing in study|15|||
130513935|NCT02133131|469847980|FG005|Overall Study|Ongoing in study|14|||
130513936|NCT02133131|469847981|FG006|Overall Study|Ongoing in study|11|||
130513937|NCT02133131|469847975|FG000|Overall Study|Protocol Violation|0|||
130513938|NCT02133131|469847976|FG001|Overall Study|Protocol Violation|0|||
130513939|NCT02133131|469847977|FG002|Overall Study|Protocol Violation|0|||
130513940|NCT02133131|469847978|FG003|Overall Study|Protocol Violation|0|||
130513941|NCT02133131|469847979|FG004|Overall Study|Protocol Violation|0|||
130513942|NCT02133131|469847980|FG005|Overall Study|Protocol Violation|0|||
130513943|NCT02133131|469847981|FG006|Overall Study|Protocol Violation|1|||
130513944|NCT01544153|469847982|FG000|Overall Study|Under 18|0|||
130570224|NCT03246958|470053864|FG001|Overall Study|Withdrawal by Subject|1|||
130570225|NCT03246958|470053865|FG002|Overall Study|Withdrawal by Subject|0|||
130570226|NCT03246958|470053866|FG003|Overall Study|Withdrawal by Subject|0|||
130570227|NCT03246958|470053867|FG004|Overall Study|Withdrawal by Subject|0|||
130513945|NCT01544153|469847983|FG001|Overall Study|Under 18|1|||
130513946|NCT01544153|469847984|FG002|Overall Study|Under 18|0|||
130513947|NCT01544153|469847985|FG003|Overall Study|Under 18|0|||
130513948|NCT01544153|469847982|FG000|Overall Study|Non-smoker|0|||
130513949|NCT01544153|469847983|FG001|Overall Study|Non-smoker|0|||
130513950|NCT01544153|469847984|FG002|Overall Study|Non-smoker|1|||
130513951|NCT01544153|469847985|FG003|Overall Study|Non-smoker|0|||
130513952|NCT00884793|469847990|FG000|Overall Study|Withdrawal by Subject|1|||
130513953|NCT04783519|469847991|FG000|Overall Study|Withdrawal by Subject|2|||
130513954|NCT04783519|469847992|FG001|Overall Study|Withdrawal by Subject|7|||
130513955|NCT04783519|469847993|FG002|Overall Study|Withdrawal by Subject|3|||
130570228|NCT03246958|470053868|FG005|Overall Study|Withdrawal by Subject|1|||
130570229|NCT03246958|470053869|FG006|Overall Study|Withdrawal by Subject|0|||
130513956|NCT04783519|469847991|FG000|Overall Study|Lost to Follow-up|9|||
130513957|NCT04783519|469847992|FG001|Overall Study|Lost to Follow-up|7|||
130513958|NCT04783519|469847993|FG002|Overall Study|Lost to Follow-up|6|||
130513959|NCT01032200|469847994|FG000|Overall Study|Death|1|||
130513960|NCT01032200|469847995|FG001|Overall Study|Death|1|||
130513961|NCT01032200|469847994|FG000|Overall Study|Withdrawal by Subject|1|||
130513962|NCT01032200|469847995|FG001|Overall Study|Withdrawal by Subject|3|||
130513963|NCT01032200|469847994|FG000|Overall Study|Toxicity|0|||
130513964|NCT01032200|469847995|FG001|Overall Study|Toxicity|2|||
130513965|NCT01032200|469847994|FG000|Overall Study|Progression|1|||
130513966|NCT01032200|469847995|FG001|Overall Study|Progression|0|||
130513967|NCT01032200|469847994|FG000|Overall Study|Multiple|1|||
130513968|NCT01032200|469847995|FG001|Overall Study|Multiple|1|||
130513969|NCT02785900|469847996|FG000|Overall Study|Study Termination by Sponsor|64|||
130513970|NCT02785900|469847997|FG001|Overall Study|Study Termination by Sponsor|81|||
130513971|NCT02785900|469847996|FG000|Overall Study|Death|46|||
130513972|NCT02785900|469847997|FG001|Overall Study|Death|32|||
130513973|NCT02785900|469847996|FG000|Overall Study|Withdrawal by Subject|4|||
130513974|NCT02785900|469847997|FG001|Overall Study|Withdrawal by Subject|8|||
130513975|NCT02785900|469847996|FG000|Overall Study|Physician Decision|3|||
130513976|NCT02785900|469847997|FG001|Overall Study|Physician Decision|2|||
130513977|NCT03993054|469847998|FG000|Overall Study|PI Decision|1|||
130513978|NCT04341584|469848002|FG000|Overall Study|Withdrew consent|0|||
130513979|NCT04341584|469848003|FG001|Overall Study|Withdrew consent|2|||
130513980|NCT04341584|469848004|FG002|Overall Study|Withdrew consent|2|||
130513981|NCT04341584|469848005|FG003|Overall Study|Withdrew consent|1|||
130513982|NCT00497198|469848007|FG000|Overall Study|Adverse Event|4|||
130513983|NCT00497198|469848008|FG001|Overall Study|Adverse Event|2|||
130513984|NCT00497198|469848007|FG000|Overall Study|Physician Decision|1|||
130513985|NCT00497198|469848008|FG001|Overall Study|Physician Decision|2|||
130513986|NCT00497198|469848007|FG000|Overall Study|Withdrawal by Subject|0|||
130513987|NCT00497198|469848008|FG001|Overall Study|Withdrawal by Subject|1|||
130513988|NCT04267393|469848009|FG000|Randomization|Adverse Event|1|||
130513989|NCT04267393|469848010|FG001|Randomization|Adverse Event|0|||
130513990|NCT04267393|469848011|FG002|Randomization|Adverse Event|0|||
130513991|NCT04267393|469848009|FG000|Randomization|Administrative Reasons by Sponsor|0|||
130513992|NCT04267393|469848010|FG001|Randomization|Administrative Reasons by Sponsor|1|||
130513993|NCT04267393|469848011|FG002|Randomization|Administrative Reasons by Sponsor|0|||
130513994|NCT04267393|469848009|FG000|Treatment Period|Adverse Event|0|||
130513995|NCT04267393|469848010|FG001|Treatment Period|Adverse Event|2|||
130513996|NCT04267393|469848011|FG002|Treatment Period|Adverse Event|3|||
130513997|NCT04267393|469848009|FG000|Treatment Period|Participant Withdrew Consent|0|||
130513998|NCT04267393|469848010|FG001|Treatment Period|Participant Withdrew Consent|0|||
130570230|NCT03246958|470053863|FG000|Overall Study|Progression|13|||
130570231|NCT03246958|470053864|FG001|Overall Study|Progression|9|||
130513999|NCT04267393|469848011|FG002|Treatment Period|Participant Withdrew Consent|1|||
130514000|NCT04267393|469848009|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
130514001|NCT04267393|469848010|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
130570232|NCT03246958|470053865|FG002|Overall Study|Progression|3|||
130570233|NCT03246958|470053866|FG003|Overall Study|Progression|2|||
130570234|NCT03246958|470053867|FG004|Overall Study|Progression|1|||
130570235|NCT03246958|470053868|FG005|Overall Study|Progression|2|||
130570236|NCT03246958|470053869|FG006|Overall Study|Progression|1|||
130570237|NCT03246958|470053863|FG000|Overall Study|Adverse Event|2|||
130570238|NCT03246958|470053864|FG001|Overall Study|Adverse Event|2|||
130570239|NCT03246958|470053865|FG002|Overall Study|Adverse Event|0|||
130570240|NCT03246958|470053866|FG003|Overall Study|Adverse Event|1|||
130570241|NCT03246958|470053867|FG004|Overall Study|Adverse Event|1|||
130514002|NCT04267393|469848011|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
130514003|NCT02799745|469848012|FG000|Overall Study|Participant moved out of state|1|||
130514004|NCT02799745|469848013|FG001|Overall Study|Participant moved out of state|0|||
130514005|NCT02799745|469848012|FG000|Overall Study|Discontinued due to planned surgery|1|||
130514006|NCT02799745|469848013|FG001|Overall Study|Discontinued due to planned surgery|0|||
130514007|NCT02799745|469848012|FG000|Overall Study|Withdrawal by Subject|16|||
130514008|NCT02799745|469848013|FG001|Overall Study|Withdrawal by Subject|25|||
130514009|NCT02799745|469848012|FG000|Overall Study|Protocol Deviation|4|||
130514010|NCT02799745|469848013|FG001|Overall Study|Protocol Deviation|5|||
130514011|NCT02799745|469848012|FG000|Overall Study|Progressive Disease|28|||
130514012|NCT02799745|469848013|FG001|Overall Study|Progressive Disease|38|||
130514013|NCT02799745|469848012|FG000|Overall Study|Lost to Follow-up|3|||
130514014|NCT02799745|469848013|FG001|Overall Study|Lost to Follow-up|2|||
130570242|NCT03246958|470053868|FG005|Overall Study|Adverse Event|0|||
130514015|NCT02799745|469848012|FG000|Overall Study|Death|3|||
130514016|NCT02799745|469848013|FG001|Overall Study|Death|0|||
130514017|NCT02799745|469848012|FG000|Overall Study|Adverse Event|0|||
130514018|NCT02799745|469848013|FG001|Overall Study|Adverse Event|1|||
130514019|NCT04853238|469848014|FG000|Overall Study|Death|4|||
130514020|NCT04853238|469848015|FG001|Overall Study|Death|0|||
130570243|NCT03246958|470053869|FG006|Overall Study|Adverse Event|2|||
130514021|NCT04853238|469848016|FG002|Overall Study|Death|2|||
130514022|NCT04853238|469848014|FG000|Overall Study|Lost to Follow-up|16|||
130570244|NCT03246958|470053863|FG000|Overall Study|Death|0|||
130570245|NCT03246958|470053864|FG001|Overall Study|Death|1|||
130570246|NCT03246958|470053865|FG002|Overall Study|Death|0|||
130570247|NCT03246958|470053866|FG003|Overall Study|Death|0|||
130570248|NCT03246958|470053867|FG004|Overall Study|Death|0|||
130570249|NCT03246958|470053868|FG005|Overall Study|Death|0|||
130514023|NCT04853238|469848015|FG001|Overall Study|Lost to Follow-up|2|||
130514024|NCT04853238|469848016|FG002|Overall Study|Lost to Follow-up|37|||
130514025|NCT04853238|469848014|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
130514026|NCT04853238|469848015|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
130514027|NCT04853238|469848016|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
130514028|NCT04853238|469848014|FG000|Overall Study|Withdrawal by Subject|6|||
130514029|NCT04853238|469848015|FG001|Overall Study|Withdrawal by Subject|0|||
130514030|NCT04853238|469848016|FG002|Overall Study|Withdrawal by Subject|21|||
130514031|NCT04853238|469848014|FG000|Overall Study|Physician Decision|0|||
130514032|NCT04853238|469848015|FG001|Overall Study|Physician Decision|0|||
130514033|NCT04853238|469848016|FG002|Overall Study|Physician Decision|2|||
130514034|NCT04853238|469848014|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
130514035|NCT04853238|469848015|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
130514036|NCT04853238|469848016|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
130514037|NCT00434577|469849753|FG000|Months 0-3|Serious Adverse Event|0|||
130514038|NCT00434577|469849754|FG001|Months 0-3|Serious Adverse Event|0|||
130514039|NCT00434577|469849755|FG002|Months 0-3|Serious Adverse Event|1|||
130514040|NCT00434577|469849756|FG003|Months 0-3|Serious Adverse Event|0|||
130514041|NCT00434577|469849757|FG004|Months 0-3|Serious Adverse Event|0|||
130514042|NCT00434577|469849753|FG000|Months 0-3|Adverse Event|0|||
130514043|NCT00434577|469849754|FG001|Months 0-3|Adverse Event|1|||
130514044|NCT00434577|469849755|FG002|Months 0-3|Adverse Event|1|||
130514045|NCT00434577|469849756|FG003|Months 0-3|Adverse Event|0|||
130514046|NCT00434577|469849757|FG004|Months 0-3|Adverse Event|0|||
130514047|NCT00434577|469849753|FG000|Months 0-3|Lost to Follow-up|0|||
130514048|NCT00434577|469849754|FG001|Months 0-3|Lost to Follow-up|0|||
130514049|NCT00434577|469849755|FG002|Months 0-3|Lost to Follow-up|0|||
130514050|NCT00434577|469849756|FG003|Months 0-3|Lost to Follow-up|0|||
130514051|NCT00434577|469849757|FG004|Months 0-3|Lost to Follow-up|2|||
130514052|NCT00434577|469849753|FG000|Months 0-3|Protocol Violation|1|||
130514053|NCT00434577|469849754|FG001|Months 0-3|Protocol Violation|0|||
130514054|NCT00434577|469849755|FG002|Months 0-3|Protocol Violation|1|||
130514055|NCT00434577|469849756|FG003|Months 0-3|Protocol Violation|0|||
130514056|NCT00434577|469849757|FG004|Months 0-3|Protocol Violation|0|||
130514057|NCT00434577|469849753|FG000|Months 0-3|Withdrawal by Subject|2|||
130514058|NCT00434577|469849754|FG001|Months 0-3|Withdrawal by Subject|1|||
130514059|NCT00434577|469849755|FG002|Months 0-3|Withdrawal by Subject|1|||
130514060|NCT00434577|469849756|FG003|Months 0-3|Withdrawal by Subject|1|||
130514061|NCT00434577|469849757|FG004|Months 0-3|Withdrawal by Subject|1|||
130514062|NCT01589523|469849770|FG000|Overall Study|Withdrawal by Subject|1|||
130514063|NCT00961896|469849771|FG000|Overall Study|Abnormal laboratory value|0|||
130514064|NCT00961896|469849772|FG001|Overall Study|Abnormal laboratory value|0|||
130514065|NCT00961896|469849773|FG002|Overall Study|Abnormal laboratory value|1|||
130514066|NCT00506922|469849774|FG000|Overall Study|Physician Decision|0|||
130514067|NCT00506922|469849775|FG001|Overall Study|Physician Decision|0|||
130514068|NCT00506922|469849776|FG002|Overall Study|Physician Decision|0|||
130514069|NCT00506922|469849777|FG003|Overall Study|Physician Decision|2|||
130514070|NCT00506922|469849778|FG004|Overall Study|Physician Decision|0|||
130514071|NCT00506922|469849774|FG000|Overall Study|Withdrawal by Subject|0|||
130514072|NCT00506922|469849775|FG001|Overall Study|Withdrawal by Subject|0|||
130514073|NCT00506922|469849776|FG002|Overall Study|Withdrawal by Subject|0|||
130514074|NCT00506922|469849777|FG003|Overall Study|Withdrawal by Subject|0|||
130514075|NCT00506922|469849778|FG004|Overall Study|Withdrawal by Subject|1|||
130514076|NCT00792259|469849779|FG000|Overall Study|Poor Quality Scans|1|||
130514077|NCT00792259|469849780|FG001|Overall Study|Poor Quality Scans|0|||
130514078|NCT00792259|469849781|FG002|Overall Study|Poor Quality Scans|0|||
130514079|NCT03721978|469849783|FG000|Overall Study|Withdrawal by Subject|6|||
130514080|NCT03721978|469849784|FG001|Overall Study|Withdrawal by Subject|1|||
130514081|NCT03721978|469849783|FG000|Overall Study|Adverse Event|1|||
130514082|NCT03721978|469849784|FG001|Overall Study|Adverse Event|1|||
130514083|NCT03721978|469849783|FG000|Overall Study|Progressive Disease|1|||
130514084|NCT03721978|469849784|FG001|Overall Study|Progressive Disease|0|||
130514085|NCT03721978|469849783|FG000|Overall Study|Lost to Follow-up|5|||
130514086|NCT03721978|469849784|FG001|Overall Study|Lost to Follow-up|1|||
130514087|NCT03721978|469849783|FG000|Overall Study|Reason not Specified|0|||
130514088|NCT03721978|469849784|FG001|Overall Study|Reason not Specified|2|||
130514089|NCT05244226|469849787|FG000|Overall Study|Adverse Event|1|||
130514090|NCT05244226|469849788|FG001|Overall Study|Adverse Event|0|||
130514091|NCT05244226|469849789|FG002|Overall Study|Adverse Event|0|||
130514092|NCT05244226|469849787|FG000|Overall Study|Lost to Follow-up|0|||
130514093|NCT05244226|469849788|FG001|Overall Study|Lost to Follow-up|0|||
130514094|NCT05244226|469849789|FG002|Overall Study|Lost to Follow-up|1|||
130514095|NCT05244226|469849787|FG000|Overall Study|Protocol Violation|0|||
130514096|NCT05244226|469849788|FG001|Overall Study|Protocol Violation|2|||
130514097|NCT05244226|469849789|FG002|Overall Study|Protocol Violation|2|||
130514098|NCT02675998|469849796|FG000|8-Week Treatment Period|Adverse Event|6|||
130514099|NCT02675998|469849797|FG001|8-Week Treatment Period|Adverse Event|5|||
130514100|NCT02675998|469849798|FG002|8-Week Treatment Period|Adverse Event|6|||
130514101|NCT02675998|469849799|FG003|8-Week Treatment Period|Adverse Event|0|||
130570250|NCT03246958|470053869|FG006|Overall Study|Death|0|||
130570251|NCT03246958|470053863|FG000|Overall Study|Physician Decision|0|||
130570252|NCT03246958|470053864|FG001|Overall Study|Physician Decision|0|||
130570253|NCT03246958|470053865|FG002|Overall Study|Physician Decision|0|||
130570254|NCT03246958|470053866|FG003|Overall Study|Physician Decision|1|||
130570255|NCT03246958|470053867|FG004|Overall Study|Physician Decision|0|||
130570256|NCT03246958|470053868|FG005|Overall Study|Physician Decision|0|||
130570257|NCT03246958|470053869|FG006|Overall Study|Physician Decision|0|||
130570258|NCT03246958|470053863|FG000|Overall Study|Never start treatment|1|||
130570259|NCT03246958|470053864|FG001|Overall Study|Never start treatment|0|||
130570260|NCT03246958|470053865|FG002|Overall Study|Never start treatment|0|||
130570261|NCT03246958|470053866|FG003|Overall Study|Never start treatment|0|||
130570262|NCT03246958|470053867|FG004|Overall Study|Never start treatment|0|||
130570263|NCT03246958|470053868|FG005|Overall Study|Never start treatment|0|||
130570264|NCT03246958|470053869|FG006|Overall Study|Never start treatment|0|||
130570265|NCT03246958|470053863|FG000|Overall Study|Over enrollment|0|||
130570266|NCT03246958|470053864|FG001|Overall Study|Over enrollment|2|||
130570267|NCT03246958|470053865|FG002|Overall Study|Over enrollment|0|||
130570268|NCT03246958|470053866|FG003|Overall Study|Over enrollment|0|||
130570269|NCT03246958|470053867|FG004|Overall Study|Over enrollment|0|||
130514102|NCT02675998|469849796|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
130514103|NCT02675998|469849797|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
130514104|NCT02675998|469849798|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
130570270|NCT03246958|470053868|FG005|Overall Study|Over enrollment|0|||
130570271|NCT03246958|470053869|FG006|Overall Study|Over enrollment|0|||
130570272|NCT01379274|470053870|FG000|Overall Study|funding withdrawn|1|||
130570273|NCT03287219|470053871|FG000|Overall Study|Protocol Violation|0|||
130570274|NCT03287219|470053872|FG001|Overall Study|Protocol Violation|2|||
130570275|NCT00631020|470053873|FG000|Overall Study|Lost to Follow-up|7|||
130570276|NCT00631020|470053873|FG000|Overall Study|Incarcerated|1|||
130570277|NCT03221751|470053874|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
130570278|NCT03221751|470053875|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
130570279|NCT00586495|470053876|FG000|Treatment Period|Adverse Event|11|||
130514105|NCT02675998|469849799|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
130514106|NCT02675998|469849796|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
130514107|NCT02675998|469849797|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
130514108|NCT02675998|469849798|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
130514109|NCT02675998|469849799|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
130514110|NCT02675998|469849796|FG000|8-Week Treatment Period|Physician Decision|1|||
130514111|NCT02675998|469849797|FG001|8-Week Treatment Period|Physician Decision|0|||
130514112|NCT02675998|469849798|FG002|8-Week Treatment Period|Physician Decision|2|||
130514113|NCT02675998|469849799|FG003|8-Week Treatment Period|Physician Decision|0|||
130514114|NCT02675998|469849796|FG000|8-Week Treatment Period|GI side Effects|1|||
130514115|NCT02675998|469849797|FG001|8-Week Treatment Period|GI side Effects|4|||
130514116|NCT02675998|469849798|FG002|8-Week Treatment Period|GI side Effects|2|||
130514117|NCT02675998|469849799|FG003|8-Week Treatment Period|GI side Effects|0|||
130514118|NCT02675998|469849796|FG000|8-Week Treatment Period|Protocol Violation|1|||
130514119|NCT02675998|469849797|FG001|8-Week Treatment Period|Protocol Violation|1|||
130514120|NCT02675998|469849798|FG002|8-Week Treatment Period|Protocol Violation|1|||
130514121|NCT02675998|469849799|FG003|8-Week Treatment Period|Protocol Violation|0|||
130514122|NCT02675998|469849796|FG000|8-Week Treatment Period|Other|3|||
130514123|NCT02675998|469849797|FG001|8-Week Treatment Period|Other|1|||
130514124|NCT02675998|469849798|FG002|8-Week Treatment Period|Other|2|||
130514125|NCT02675998|469849799|FG003|8-Week Treatment Period|Other|0|||
130514126|NCT02675998|469849796|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
130514127|NCT02675998|469849797|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
130514128|NCT02675998|469849798|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
130570280|NCT00586495|470053876|FG000|Treatment Period|Death|1|||
130570281|NCT00586495|470053876|FG000|Treatment Period|Protocol Violation|1|||
130570282|NCT00586495|470053876|FG000|Treatment Period|Withdrawal by Subject|1|||
130570283|NCT00586495|470053876|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
130570284|NCT00586495|470053876|FG000|Treatment Period|Switch to commercial drug|10|||
130570285|NCT00586495|470053876|FG000|Follow-up|Death|40|||
130570286|NCT00586495|470053876|FG000|Follow-up|Lost to Follow-up|1|||
130570287|NCT00586495|470053876|FG000|Follow-up|Withdrawal by Subject|4|||
130570288|NCT00586495|470053876|FG000|Follow-up|Protocol driven decision point|37|||
130570289|NCT00586495|470053876|FG000|Follow-up|Switch to commercial drug|10|||
130570290|NCT00440947|470053877|FG000|36-Week Induction Phase|Adverse Event|16|||
130570291|NCT00440947|470053878|FG001|36-Week Induction Phase|Adverse Event|0|||
130514129|NCT02675998|469849799|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
130514130|NCT02675998|469849796|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
130514131|NCT02675998|469849797|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
130514132|NCT02675998|469849798|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
130514133|NCT02675998|469849799|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
130514134|NCT02675998|469849796|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
130514135|NCT02675998|469849797|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
130514136|NCT02675998|469849798|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
130514137|NCT02675998|469849799|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
130514138|NCT02675998|469849796|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
130514139|NCT02675998|469849797|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
130514140|NCT02675998|469849798|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
130514141|NCT02675998|469849799|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
130514142|NCT02675998|469849796|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
130514143|NCT02675998|469849797|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
130514144|NCT02675998|469849798|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
130514145|NCT02675998|469849799|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
130514146|NCT00275301|469849800|FG000|Overall Study|Adverse Event|5|||
130514147|NCT04357964|469849801|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
130514148|NCT04357964|469849802|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
130514149|NCT04357964|469849801|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
130514150|NCT04357964|469849802|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
130514151|NCT04357964|469849801|FG000|Overall Study|Adipose sample was insufficient quality|0|||
130514152|NCT04357964|469849802|FG001|Overall Study|Adipose sample was insufficient quality|1|||
130514153|NCT00733226|469849805|FG000|Overall Study|Withdrawal by Subject|1|||
130514154|NCT00733226|469849806|FG001|Overall Study|Withdrawal by Subject|0|||
130514155|NCT00733226|469849805|FG000|Overall Study|Lost to Follow-up|2|||
130514156|NCT00733226|469849806|FG001|Overall Study|Lost to Follow-up|0|||
130514157|NCT00733226|469849805|FG000|Overall Study|moved to another place|2|||
130514158|NCT00733226|469849806|FG001|Overall Study|moved to another place|0|||
130514159|NCT00848393|469849813|FG000|Overall Study|Protocol Violation|0|||
130514160|NCT00848393|469849814|FG001|Overall Study|Protocol Violation|0|||
130514161|NCT00848393|469849815|FG002|Overall Study|Protocol Violation|1|||
130514162|NCT00848393|469849813|FG000|Overall Study|surgical complications unrelated to stud|0|||
130514163|NCT00848393|469849814|FG001|Overall Study|surgical complications unrelated to stud|0|||
130514164|NCT00848393|469849815|FG002|Overall Study|surgical complications unrelated to stud|2|||
130514165|NCT02561078|469849816|FG000|Overall Study|Adverse Event|5|||
130514166|NCT02561078|469849817|FG001|Overall Study|Adverse Event|2|||
130514167|NCT02561078|469849816|FG000|Overall Study|Death|2|||
130514168|NCT02561078|469849817|FG001|Overall Study|Death|1|||
130514169|NCT02561078|469849816|FG000|Overall Study|Lost to Follow-up|2|||
130514170|NCT02561078|469849817|FG001|Overall Study|Lost to Follow-up|6|||
130514171|NCT02561078|469849816|FG000|Overall Study|Non-Compliance with Study Drug|6|||
130514172|NCT02561078|469849817|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130514173|NCT02561078|469849816|FG000|Overall Study|Physician Decision|2|||
130514174|NCT02561078|469849817|FG001|Overall Study|Physician Decision|3|||
130514175|NCT02561078|469849816|FG000|Overall Study|Withdrawal by Subject|13|||
130514176|NCT02561078|469849817|FG001|Overall Study|Withdrawal by Subject|10|||
130514177|NCT00043186|469849824|FG000|Overall Study|Physician Decision|0|||
130514178|NCT00043186|469849825|FG001|Overall Study|Physician Decision|0|||
130514179|NCT00043186|469849826|FG002|Overall Study|Physician Decision|3|||
130514180|NCT00043186|469849827|FG003|Overall Study|Physician Decision|0|||
130514181|NCT00043186|469849828|FG004|Overall Study|Physician Decision|1|||
130514182|NCT00043186|469849829|FG005|Overall Study|Physician Decision|0|||
130514183|NCT00043186|469849830|FG006|Overall Study|Physician Decision|0|||
130514184|NCT00043186|469849831|FG007|Overall Study|Physician Decision|1|||
130514185|NCT00043186|469849832|FG008|Overall Study|Physician Decision|1|||
130514186|NCT00043186|469849824|FG000|Overall Study|Adverse Event|2|||
130514187|NCT00043186|469849825|FG001|Overall Study|Adverse Event|2|||
130514188|NCT00043186|469849826|FG002|Overall Study|Adverse Event|2|||
130514189|NCT00043186|469849827|FG003|Overall Study|Adverse Event|3|||
130514190|NCT00043186|469849828|FG004|Overall Study|Adverse Event|2|||
130514191|NCT00043186|469849829|FG005|Overall Study|Adverse Event|1|||
130514192|NCT00043186|469849830|FG006|Overall Study|Adverse Event|2|||
130514193|NCT00043186|469849831|FG007|Overall Study|Adverse Event|1|||
130514194|NCT00043186|469849832|FG008|Overall Study|Adverse Event|3|||
130514195|NCT00043186|469849824|FG000|Overall Study|Withdrawal by Subject|11|||
130514196|NCT00043186|469849825|FG001|Overall Study|Withdrawal by Subject|8|||
130514197|NCT00043186|469849826|FG002|Overall Study|Withdrawal by Subject|11|||
130514198|NCT00043186|469849827|FG003|Overall Study|Withdrawal by Subject|13|||
130514199|NCT00043186|469849828|FG004|Overall Study|Withdrawal by Subject|14|||
130514200|NCT00043186|469849829|FG005|Overall Study|Withdrawal by Subject|6|||
130514201|NCT00043186|469849830|FG006|Overall Study|Withdrawal by Subject|12|||
130514202|NCT00043186|469849831|FG007|Overall Study|Withdrawal by Subject|9|||
130514203|NCT00043186|469849832|FG008|Overall Study|Withdrawal by Subject|10|||
130514204|NCT00043186|469849824|FG000|Overall Study|Death|0|||
130514205|NCT00043186|469849825|FG001|Overall Study|Death|0|||
130514206|NCT00043186|469849826|FG002|Overall Study|Death|1|||
130514207|NCT00043186|469849827|FG003|Overall Study|Death|0|||
130514208|NCT00043186|469849828|FG004|Overall Study|Death|0|||
130514209|NCT00043186|469849829|FG005|Overall Study|Death|0|||
130514210|NCT00043186|469849830|FG006|Overall Study|Death|2|||
130514211|NCT00043186|469849831|FG007|Overall Study|Death|0|||
130514212|NCT00043186|469849832|FG008|Overall Study|Death|0|||
130514213|NCT00043186|469849824|FG000|Overall Study|Disease progression|1|||
130514214|NCT00043186|469849825|FG001|Overall Study|Disease progression|0|||
130514215|NCT00043186|469849826|FG002|Overall Study|Disease progression|0|||
130514216|NCT00043186|469849827|FG003|Overall Study|Disease progression|3|||
130514217|NCT00043186|469849828|FG004|Overall Study|Disease progression|0|||
130514218|NCT00043186|469849829|FG005|Overall Study|Disease progression|0|||
130514219|NCT00043186|469849830|FG006|Overall Study|Disease progression|0|||
130514220|NCT00043186|469849831|FG007|Overall Study|Disease progression|4|||
130514221|NCT00043186|469849832|FG008|Overall Study|Disease progression|0|||
130514222|NCT00043186|469849824|FG000|Overall Study|Ineligibility determined|0|||
130570292|NCT00440947|470053879|FG002|36-Week Induction Phase|Adverse Event|0|||
130514223|NCT00043186|469849825|FG001|Overall Study|Ineligibility determined|0|||
130514224|NCT00043186|469849826|FG002|Overall Study|Ineligibility determined|0|||
130514225|NCT00043186|469849827|FG003|Overall Study|Ineligibility determined|0|||
130514226|NCT00043186|469849828|FG004|Overall Study|Ineligibility determined|0|||
130514227|NCT00043186|469849829|FG005|Overall Study|Ineligibility determined|0|||
130514228|NCT00043186|469849830|FG006|Overall Study|Ineligibility determined|0|||
130514229|NCT00043186|469849831|FG007|Overall Study|Ineligibility determined|0|||
130514230|NCT00043186|469849832|FG008|Overall Study|Ineligibility determined|1|||
130514231|NCT00043186|469849824|FG000|Overall Study|Lost to Follow-up|3|||
130514232|NCT00043186|469849825|FG001|Overall Study|Lost to Follow-up|5|||
130514233|NCT00043186|469849826|FG002|Overall Study|Lost to Follow-up|1|||
130514234|NCT00043186|469849827|FG003|Overall Study|Lost to Follow-up|1|||
130514235|NCT00043186|469849828|FG004|Overall Study|Lost to Follow-up|1|||
130514236|NCT00043186|469849829|FG005|Overall Study|Lost to Follow-up|1|||
130514237|NCT00043186|469849830|FG006|Overall Study|Lost to Follow-up|1|||
130514238|NCT00043186|469849831|FG007|Overall Study|Lost to Follow-up|1|||
130514239|NCT00043186|469849832|FG008|Overall Study|Lost to Follow-up|2|||
130514240|NCT00043186|469849824|FG000|Overall Study|Noncompliance|0|||
130514241|NCT00043186|469849825|FG001|Overall Study|Noncompliance|0|||
130514242|NCT00043186|469849826|FG002|Overall Study|Noncompliance|1|||
130514243|NCT00043186|469849827|FG003|Overall Study|Noncompliance|1|||
130570293|NCT00440947|470053880|FG003|36-Week Induction Phase|Adverse Event|0|||
130570294|NCT00440947|470053881|FG004|36-Week Induction Phase|Adverse Event|0|||
130570295|NCT00440947|470053877|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
130570296|NCT00440947|470053878|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130570297|NCT00440947|470053879|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130570298|NCT00440947|470053880|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130570299|NCT00440947|470053881|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130570300|NCT00440947|470053877|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
130570301|NCT00440947|470053878|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130570302|NCT00440947|470053879|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130570303|NCT00440947|470053880|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130570304|NCT00440947|470053881|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130514244|NCT00043186|469849828|FG004|Overall Study|Noncompliance|0|||
130514245|NCT00043186|469849829|FG005|Overall Study|Noncompliance|0|||
130514246|NCT00043186|469849830|FG006|Overall Study|Noncompliance|0|||
130514247|NCT00043186|469849831|FG007|Overall Study|Noncompliance|0|||
130514248|NCT00043186|469849832|FG008|Overall Study|Noncompliance|0|||
130514249|NCT00043186|469849824|FG000|Overall Study|Other|0|||
130570305|NCT00440947|470053877|FG000|36-Week Induction Phase|Non-compliance|10|||
130570306|NCT00440947|470053878|FG001|36-Week Induction Phase|Non-compliance|0|||
130570307|NCT00440947|470053879|FG002|36-Week Induction Phase|Non-compliance|0|||
130570308|NCT00440947|470053880|FG003|36-Week Induction Phase|Non-compliance|0|||
130570309|NCT00440947|470053881|FG004|36-Week Induction Phase|Non-compliance|0|||
130570310|NCT00440947|470053877|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
130570311|NCT00440947|470053878|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
130514250|NCT00043186|469849825|FG001|Overall Study|Other|0|||
130514251|NCT00043186|469849826|FG002|Overall Study|Other|1|||
130514252|NCT00043186|469849827|FG003|Overall Study|Other|1|||
130514253|NCT00043186|469849828|FG004|Overall Study|Other|0|||
130514254|NCT00043186|469849829|FG005|Overall Study|Other|0|||
130514255|NCT00043186|469849830|FG006|Overall Study|Other|0|||
130514256|NCT00043186|469849831|FG007|Overall Study|Other|0|||
130514257|NCT00043186|469849832|FG008|Overall Study|Other|0|||
130514258|NCT03722485|469849833|FG000|Overall Study|Withdrawal by Subject|1|||
130570312|NCT00440947|470053879|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
130570313|NCT00440947|470053880|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
130570314|NCT00440947|470053881|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
130570315|NCT00440947|470053877|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
130570316|NCT00440947|470053878|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
130570317|NCT00440947|470053879|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
130514259|NCT03722485|469849834|FG001|Overall Study|Withdrawal by Subject|0|||
130514260|NCT03722485|469849833|FG000|Overall Study|Adverse Event|0|||
130514261|NCT03722485|469849834|FG001|Overall Study|Adverse Event|2|||
130514262|NCT03722485|469849833|FG000|Overall Study|subject discharged prior to study completion|1|||
130514263|NCT03722485|469849834|FG001|Overall Study|subject discharged prior to study completion|5|||
130514264|NCT03722485|469849833|FG000|Overall Study|eligibility criteria not met|2|||
130514265|NCT03722485|469849834|FG001|Overall Study|eligibility criteria not met|0|||
130514266|NCT00349622|469849835|FG000|Overall Study|Death|168|||
130514267|NCT00349622|469849836|FG001|Overall Study|Death|86|||
130514268|NCT00349622|469849835|FG000|Overall Study|Lost to Follow-up|5|||
130514269|NCT00349622|469849836|FG001|Overall Study|Lost to Follow-up|1|||
130514270|NCT00349622|469849835|FG000|Overall Study|Withdrawal by Subject|5|||
130514271|NCT00349622|469849836|FG001|Overall Study|Withdrawal by Subject|9|||
130514272|NCT01902381|469849837|FG000|Overall Study|Withdrawal by Subject|1|||
130514273|NCT00755716|469849843|FG000|Overall Study|Adverse Event|1|||
130514274|NCT00755716|469849844|FG001|Overall Study|Adverse Event|4|||
130514275|NCT00755716|469849845|FG002|Overall Study|Adverse Event|1|||
130514276|NCT00755716|469849843|FG000|Overall Study|Lack of Efficacy|2|||
130514277|NCT00755716|469849844|FG001|Overall Study|Lack of Efficacy|0|||
130514278|NCT00755716|469849845|FG002|Overall Study|Lack of Efficacy|0|||
130514279|NCT00755716|469849843|FG000|Overall Study|Lost to Follow-up|5|||
130514280|NCT00755716|469849844|FG001|Overall Study|Lost to Follow-up|3|||
130514281|NCT00755716|469849845|FG002|Overall Study|Lost to Follow-up|1|||
130514282|NCT00755716|469849843|FG000|Overall Study|work schedule issues|0|||
130514283|NCT00755716|469849844|FG001|Overall Study|work schedule issues|1|||
130514284|NCT00755716|469849845|FG002|Overall Study|work schedule issues|1|||
130514285|NCT02762500|469849846|FG000|Overall Study|Lack of Efficacy|1|||
130514286|NCT02762500|469849847|FG001|Overall Study|Lack of Efficacy|0|||
130514287|NCT02762500|469849846|FG000|Overall Study|Withdrawal by Subject|1|||
130570318|NCT00440947|470053880|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
130570319|NCT00440947|470053881|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
130570320|NCT00440947|470053877|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
130570321|NCT00440947|470053878|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130570322|NCT00440947|470053879|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130570323|NCT00440947|470053880|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130570324|NCT00440947|470053881|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130570325|NCT00440947|470053877|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
130570326|NCT00440947|470053878|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
130570327|NCT00440947|470053879|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
130570328|NCT00440947|470053880|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
130570329|NCT00440947|470053881|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
130570330|NCT00440947|470053877|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
130570331|NCT00440947|470053878|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130570332|NCT00440947|470053879|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130570333|NCT00440947|470053880|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130570334|NCT00440947|470053881|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130570335|NCT00440947|470053877|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
130570336|NCT00440947|470053878|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130570337|NCT00440947|470053879|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130570338|NCT00440947|470053880|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130570339|NCT00440947|470053881|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130570340|NCT00440947|470053877|FG000|36-Week Induction Phase|Incarceration|3|||
130570341|NCT00440947|470053878|FG001|36-Week Induction Phase|Incarceration|0|||
130570342|NCT00440947|470053879|FG002|36-Week Induction Phase|Incarceration|0|||
130570343|NCT00440947|470053880|FG003|36-Week Induction Phase|Incarceration|0|||
130514288|NCT02762500|469849847|FG001|Overall Study|Withdrawal by Subject|1|||
130514289|NCT02762500|469849846|FG000|Overall Study|Adverse Event|0|||
130514290|NCT02762500|469849847|FG001|Overall Study|Adverse Event|2|||
130514291|NCT02229396|469849848|FG000|Overall Study|Adverse Event|6|||
130514292|NCT02229396|469849849|FG001|Overall Study|Adverse Event|12|||
130570344|NCT00440947|470053881|FG004|36-Week Induction Phase|Incarceration|0|||
130514293|NCT02229396|469849850|FG002|Overall Study|Adverse Event|12|||
130570345|NCT00440947|470053877|FG000|36-Week Induction Phase|Pregnancy|1|||
130514294|NCT02229396|469849848|FG000|Overall Study|Death|2|||
130514295|NCT02229396|469849849|FG001|Overall Study|Death|3|||
130570346|NCT00440947|470053878|FG001|36-Week Induction Phase|Pregnancy|0|||
130570347|NCT00440947|470053879|FG002|36-Week Induction Phase|Pregnancy|0|||
130570348|NCT00440947|470053880|FG003|36-Week Induction Phase|Pregnancy|0|||
130570349|NCT00440947|470053881|FG004|36-Week Induction Phase|Pregnancy|0|||
130570350|NCT00440947|470053877|FG000|48-Week Randomization Phase|Adverse Event|0|||
130514296|NCT02229396|469849850|FG002|Overall Study|Death|1|||
130514297|NCT02229396|469849848|FG000|Overall Study|Lost to Follow-up|14|||
130514298|NCT02229396|469849849|FG001|Overall Study|Lost to Follow-up|14|||
130514299|NCT02229396|469849850|FG002|Overall Study|Lost to Follow-up|21|||
130514300|NCT02229396|469849848|FG000|Overall Study|Protocol Violation|2|||
130514301|NCT02229396|469849849|FG001|Overall Study|Protocol Violation|1|||
130514302|NCT02229396|469849850|FG002|Overall Study|Protocol Violation|0|||
130514303|NCT02229396|469849848|FG000|Overall Study|Patient Incorrectly Randomized|0|||
130514304|NCT02229396|469849849|FG001|Overall Study|Patient Incorrectly Randomized|0|||
130514305|NCT02229396|469849850|FG002|Overall Study|Patient Incorrectly Randomized|1|||
130514306|NCT02229396|469849848|FG000|Overall Study|Other|10|||
130514307|NCT02229396|469849849|FG001|Overall Study|Other|18|||
130514308|NCT02229396|469849850|FG002|Overall Study|Other|15|||
130514309|NCT02229396|469849848|FG000|Overall Study|Withdrawal by Subject|42|||
130514310|NCT02229396|469849849|FG001|Overall Study|Withdrawal by Subject|28|||
130514311|NCT02229396|469849850|FG002|Overall Study|Withdrawal by Subject|41|||
130514312|NCT02229396|469849848|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
130514313|NCT02229396|469849849|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130514314|NCT02229396|469849850|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
130514315|NCT02229396|469849848|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
130514316|NCT02229396|469849849|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
130514317|NCT02229396|469849850|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
130514318|NCT00730847|469849851|FG000|Overall Study|Adverse Event|1|||
130514319|NCT00730847|469849851|FG000|Overall Study|Protocol Violation|2|||
130514320|NCT00730847|469849851|FG000|Overall Study|Withdrawal by Subject|16|||
130514321|NCT00730847|469849851|FG000|Overall Study|Lost to Follow-up|67|||
130514322|NCT00730847|469849851|FG000|Overall Study|Unknown completion status|21|||
130514323|NCT00730847|469849851|FG000|Overall Study|Other|24|||
130570351|NCT00440947|470053878|FG001|48-Week Randomization Phase|Adverse Event|2|||
130570352|NCT00440947|470053879|FG002|48-Week Randomization Phase|Adverse Event|5|||
130570353|NCT00440947|470053880|FG003|48-Week Randomization Phase|Adverse Event|0|||
130570354|NCT00440947|470053881|FG004|48-Week Randomization Phase|Adverse Event|0|||
130570355|NCT00440947|470053877|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130570356|NCT00440947|470053878|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
130570357|NCT00440947|470053879|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
130570358|NCT00440947|470053880|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130570359|NCT00440947|470053881|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130570360|NCT00440947|470053877|FG000|48-Week Randomization Phase|Non-compliance|0|||
130570361|NCT00440947|470053878|FG001|48-Week Randomization Phase|Non-compliance|3|||
130570362|NCT00440947|470053879|FG002|48-Week Randomization Phase|Non-compliance|4|||
130570363|NCT00440947|470053880|FG003|48-Week Randomization Phase|Non-compliance|0|||
130570364|NCT00440947|470053881|FG004|48-Week Randomization Phase|Non-compliance|0|||
130570365|NCT00440947|470053877|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
130570366|NCT00440947|470053878|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
130570367|NCT00440947|470053879|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
130570368|NCT00440947|470053880|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
130570369|NCT00440947|470053881|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
130570370|NCT00440947|470053877|FG000|48-Week Randomization Phase|Protocol Violation|0|||
130570371|NCT00440947|470053878|FG001|48-Week Randomization Phase|Protocol Violation|0|||
130570372|NCT00440947|470053879|FG002|48-Week Randomization Phase|Protocol Violation|1|||
130570373|NCT00440947|470053880|FG003|48-Week Randomization Phase|Protocol Violation|0|||
130570374|NCT00440947|470053881|FG004|48-Week Randomization Phase|Protocol Violation|0|||
130570375|NCT00440947|470053877|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
130570376|NCT00440947|470053878|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
130570377|NCT00440947|470053879|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
130570378|NCT00440947|470053880|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
130570379|NCT00440947|470053881|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
130570380|NCT00440947|470053877|FG000|48-Week Randomization Phase|Pregnancy|0|||
130570381|NCT00440947|470053878|FG001|48-Week Randomization Phase|Pregnancy|0|||
130570382|NCT00440947|470053879|FG002|48-Week Randomization Phase|Pregnancy|1|||
130570383|NCT00440947|470053880|FG003|48-Week Randomization Phase|Pregnancy|0|||
130570384|NCT00440947|470053881|FG004|48-Week Randomization Phase|Pregnancy|0|||
130570385|NCT00440947|470053877|FG000|48-Week Randomization Phase|Incarceration|0|||
130570386|NCT00440947|470053878|FG001|48-Week Randomization Phase|Incarceration|3|||
130570387|NCT00440947|470053879|FG002|48-Week Randomization Phase|Incarceration|0|||
130514324|NCT03022578|469849852|FG000|Overall Study|Adverse Event|1|||
130514325|NCT03022578|469849852|FG000|Overall Study|Lack of Efficacy|2|||
130514326|NCT03022578|469849852|FG000|Overall Study|Withdrawal by Subject|1|||
130514327|NCT03681353|469849858|FG000|Overall Study|Lost to Follow-up|2|||
130570388|NCT00440947|470053880|FG003|48-Week Randomization Phase|Incarceration|0|||
130570389|NCT00440947|470053881|FG004|48-Week Randomization Phase|Incarceration|0|||
130570390|NCT00440947|470053877|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130570391|NCT00440947|470053878|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
130570392|NCT00440947|470053879|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130570393|NCT00440947|470053880|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130570394|NCT00440947|470053881|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130570395|NCT00440947|470053877|FG000|48-Week Randomization Phase|Physician Decision|0|||
130570396|NCT00440947|470053878|FG001|48-Week Randomization Phase|Physician Decision|2|||
130570397|NCT00440947|470053879|FG002|48-Week Randomization Phase|Physician Decision|0|||
130570398|NCT00440947|470053880|FG003|48-Week Randomization Phase|Physician Decision|0|||
130570399|NCT00440947|470053881|FG004|48-Week Randomization Phase|Physician Decision|0|||
130570400|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
130570401|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
130570402|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
130570403|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
130570404|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
130570405|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130570406|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130570407|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130570408|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
130570409|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
130570410|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130570411|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130570412|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130570413|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
130570414|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
130570415|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
130570416|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
130570417|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
130570418|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
130570419|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
130570420|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130570421|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130570422|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130570423|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
130570424|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
130570425|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
130570426|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
130570427|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
130570428|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
130570429|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
130570430|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130570431|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130570432|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130570433|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
130570434|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
130570435|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
130570436|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
130570437|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
130570438|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
130570439|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
130570440|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
130570441|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
130570442|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
130570443|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
130570444|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
130570445|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
130570446|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
130570447|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
130570448|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
130570449|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
130570450|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130570451|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130570452|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130514328|NCT03681353|469849858|FG000|Overall Study|Withdrawal by Subject|3|||
130514329|NCT03681353|469849858|FG000|Overall Study|withdrawn by PI|2|||
130514330|NCT00726388|469849861|FG000|Overall Study|Withdrawal by Subject|5|||
130514331|NCT00726388|469849861|FG000|Overall Study|Adverse Event|3|||
130514332|NCT00726388|469849861|FG000|Overall Study|Lost to Follow-up|10|||
130514333|NCT00726388|469849861|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
130514334|NCT00726388|469849861|FG000|Overall Study|Other|5|||
130514335|NCT00726388|469849861|FG000|Overall Study|Enrolled, Not Treated|79|||
130514336|NCT00111839|469849862|FG000|Overall Study|Disease Progression|30|||
130514337|NCT00111839|469849863|FG001|Overall Study|Disease Progression|33|||
130514338|NCT00111839|469849864|FG002|Overall Study|Disease Progression|33|||
130514339|NCT00111839|469849862|FG000|Overall Study|Adverse Event|5|||
130514340|NCT00111839|469849863|FG001|Overall Study|Adverse Event|3|||
130514341|NCT00111839|469849864|FG002|Overall Study|Adverse Event|1|||
130514342|NCT00111839|469849862|FG000|Overall Study|Protocol Violation|2|||
130514343|NCT00111839|469849863|FG001|Overall Study|Protocol Violation|4|||
130514344|NCT00111839|469849864|FG002|Overall Study|Protocol Violation|2|||
130514345|NCT00111839|469849862|FG000|Overall Study|Death|1|||
130514346|NCT00111839|469849863|FG001|Overall Study|Death|1|||
130514347|NCT00111839|469849864|FG002|Overall Study|Death|6|||
130514348|NCT00111839|469849862|FG000|Overall Study|Withdrawal by Subject|2|||
130514349|NCT00111839|469849863|FG001|Overall Study|Withdrawal by Subject|2|||
130514350|NCT00111839|469849864|FG002|Overall Study|Withdrawal by Subject|2|||
130514351|NCT00111839|469849862|FG000|Overall Study|Lost to Follow-up|1|||
130514352|NCT00111839|469849863|FG001|Overall Study|Lost to Follow-up|0|||
130514353|NCT00111839|469849864|FG002|Overall Study|Lost to Follow-up|0|||
130514354|NCT00111839|469849862|FG000|Overall Study|Logistical Constraint|1|||
130514355|NCT00111839|469849863|FG001|Overall Study|Logistical Constraint|0|||
130514356|NCT00111839|469849864|FG002|Overall Study|Logistical Constraint|0|||
130514357|NCT00111839|469849862|FG000|Overall Study|Other|6|||
130514358|NCT00111839|469849863|FG001|Overall Study|Other|3|||
130514359|NCT00111839|469849864|FG002|Overall Study|Other|3|||
130514360|NCT00111839|469849862|FG000|Overall Study|Randomized but Not Treated|0|||
130514361|NCT00111839|469849863|FG001|Overall Study|Randomized but Not Treated|0|||
130514362|NCT00111839|469849864|FG002|Overall Study|Randomized but Not Treated|2|||
130514363|NCT01011049|469849865|FG000|Overall Study|Protocol Violation|0|||
130514364|NCT01011049|469849866|FG001|Overall Study|Protocol Violation|0|||
130514365|NCT01011049|469849867|FG002|Overall Study|Protocol Violation|2|||
130514366|NCT01011049|469849868|FG003|Overall Study|Protocol Violation|0|||
130514367|NCT01011049|469849865|FG000|Overall Study|Lost to Follow-up|1|||
130570453|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
130570454|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
130570455|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Other|0|||
130570456|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Other|0|||
130570457|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Other|0|||
130570458|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Other|1|||
130570459|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Other|0|||
130570460|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
130570461|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
130570462|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
130570463|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
130570464|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
130570465|NCT00440947|470053877|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130570466|NCT00440947|470053878|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130570467|NCT00440947|470053879|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130570468|NCT00440947|470053880|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130570469|NCT00440947|470053881|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
130570470|NCT01834274|470053885|FG000|Overall Study|Study Termination|41|||
130570471|NCT01834274|470053886|FG001|Overall Study|Study Termination|38|||
130570472|NCT01834274|470053885|FG000|Overall Study|Withdrawal by Subject|1|||
130570473|NCT01834274|470053886|FG001|Overall Study|Withdrawal by Subject|1|||
130570474|NCT01834274|470053885|FG000|Overall Study|Lost to Follow-up|3|||
130570475|NCT01834274|470053886|FG001|Overall Study|Lost to Follow-up|1|||
130570476|NCT01834274|470053885|FG000|Overall Study|Other|2|||
130514368|NCT01011049|469849866|FG001|Overall Study|Lost to Follow-up|2|||
130514369|NCT01011049|469849867|FG002|Overall Study|Lost to Follow-up|1|||
130514370|NCT01011049|469849868|FG003|Overall Study|Lost to Follow-up|0|||
130514371|NCT01011049|469849865|FG000|Overall Study|Withdrawal by Subject|0|||
130514372|NCT01011049|469849866|FG001|Overall Study|Withdrawal by Subject|0|||
130514373|NCT01011049|469849867|FG002|Overall Study|Withdrawal by Subject|1|||
130514374|NCT01011049|469849868|FG003|Overall Study|Withdrawal by Subject|0|||
130514375|NCT00382408|469849869|FG000|Overall Study|Did not meet protocol requirement|3|||
130514376|NCT00382408|469849870|FG001|Overall Study|Did not meet protocol requirement|3|||
130570477|NCT01834274|470053886|FG001|Overall Study|Other|1|||
130570478|NCT01422915|470053895|FG000|Overall Study|Adverse Event|1|||
130570479|NCT02813694|470053896|FG000|Overall Study|Physician Decision|0|||
130570480|NCT02813694|470053897|FG001|Overall Study|Physician Decision|1|||
130570481|NCT02813694|470053896|FG000|Overall Study|Withdrawal by Subject|10|||
130570482|NCT02813694|470053897|FG001|Overall Study|Withdrawal by Subject|9|||
130570483|NCT02813694|470053896|FG000|Overall Study|Lost to Follow-up|1|||
130570484|NCT02813694|470053897|FG001|Overall Study|Lost to Follow-up|1|||
130570485|NCT02813694|470053896|FG000|Overall Study|Death|3|||
130570486|NCT02813694|470053897|FG001|Overall Study|Death|3|||
130570487|NCT02813694|470053896|FG000|Overall Study|Randomized- did not receive study drug|2|||
130570488|NCT02813694|470053897|FG001|Overall Study|Randomized- did not receive study drug|0|||
130570489|NCT02813694|470053896|FG000|Overall Study|Patient hospitalized|1|||
130570490|NCT02813694|470053897|FG001|Overall Study|Patient hospitalized|0|||
130570491|NCT01265797|470053898|FG000|Run-in Month|Withdrawal by Subject|0|||
130570492|NCT01265797|470053899|FG001|Run-in Month|Withdrawal by Subject|4|||
130570493|NCT01265797|470053898|FG000|Run-in Month|1st seizure during run-in month|0|||
130570494|NCT01265797|470053899|FG001|Run-in Month|1st seizure during run-in month|1|||
130570495|NCT01265797|470053898|FG000|Blinded Month|Lack of Efficacy|5|||
130570496|NCT01265797|470053899|FG001|Blinded Month|Lack of Efficacy|0|||
130570497|NCT01265797|470053898|FG000|Blinded Month|Lost to Follow-up|1|||
130570498|NCT01265797|470053899|FG001|Blinded Month|Lost to Follow-up|0|||
130570499|NCT01265797|470053898|FG000|Blinded Month|Protocol Violation|2|||
130570500|NCT01265797|470053899|FG001|Blinded Month|Protocol Violation|1|||
130570501|NCT01265797|470053898|FG000|Blinded Month|Adverse Event|2|||
130570502|NCT01265797|470053899|FG001|Blinded Month|Adverse Event|0|||
130570503|NCT01265797|470053898|FG000|Blinded Month|Diary data incomplete|0|||
130570504|NCT01265797|470053899|FG001|Blinded Month|Diary data incomplete|1|||
130570505|NCT01265797|470053898|FG000|Open Label Month|Lost to Follow-up|0|||
130570506|NCT01265797|470053899|FG001|Open Label Month|Lost to Follow-up|1|||
130570507|NCT02980224|470053902|FG000|Overall Study|Adverse Event|4|||
130570508|NCT02980224|470053903|FG001|Overall Study|Adverse Event|1|||
130570509|NCT02980224|470053902|FG000|Overall Study|Withdrawal by Subject|0|||
130570510|NCT02980224|470053903|FG001|Overall Study|Withdrawal by Subject|2|||
130570511|NCT00606320|470053904|FG000|Overall Study|Adverse Event|3|||
130570512|NCT00606320|470053904|FG000|Overall Study|Lack of Efficacy|5|||
130570513|NCT00606320|470053904|FG000|Overall Study|Physician Decision|7|||
130570514|NCT00606320|470053904|FG000|Overall Study|Protocol Violation|8|||
130570515|NCT00606320|470053904|FG000|Overall Study|Withdrawal by Subject|10|||
130570516|NCT00606320|470053904|FG000|Overall Study|Progression to depressive phase|4|||
130570517|NCT01152021|470053905|FG000|Overall Study|Adverse Event|4|||
130570518|NCT01152021|470053906|FG001|Overall Study|Adverse Event|4|||
130570519|NCT01152021|470053905|FG000|Overall Study|Study drug had expired|1|||
130570520|NCT01152021|470053906|FG001|Overall Study|Study drug had expired|0|||
130570521|NCT01152021|470053905|FG000|Overall Study|Physician Decision|1|||
130570522|NCT01152021|470053906|FG001|Overall Study|Physician Decision|1|||
130570523|NCT01152021|470053905|FG000|Overall Study|No access to study drug in Pharmacy|0|||
130570524|NCT01152021|470053906|FG001|Overall Study|No access to study drug in Pharmacy|1|||
130570525|NCT02595723|470053907|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
130570526|NCT02595723|470053908|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
130570527|NCT02595723|470053909|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
130570528|NCT02595723|470053907|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
130570529|NCT02595723|470053908|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
130570530|NCT02595723|470053909|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
130570531|NCT04839380|470053910|FG000|Overall Study|Withdrawal by Subject|2|||
130570532|NCT04839380|470053910|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
130570533|NCT01087905|470053911|FG000|Overall Study|Lost to Follow-up|24|||
130570534|NCT01087905|470053912|FG001|Overall Study|Lost to Follow-up|28|||
130570535|NCT01087905|470053913|FG002|Overall Study|Lost to Follow-up|18|||
130570536|NCT01087905|470053914|FG003|Overall Study|Lost to Follow-up|31|||
130570537|NCT01087905|470053915|FG004|Overall Study|Lost to Follow-up|27|||
130570538|NCT01087905|470053916|FG005|Overall Study|Lost to Follow-up|25|||
130570539|NCT01087905|470053917|FG006|Overall Study|Lost to Follow-up|20|||
130570540|NCT01087905|470053918|FG007|Overall Study|Lost to Follow-up|24|||
130570541|NCT01087905|470053911|FG000|Overall Study|Withdrawal by Subject|5|||
130570542|NCT01087905|470053912|FG001|Overall Study|Withdrawal by Subject|4|||
130570543|NCT01087905|470053913|FG002|Overall Study|Withdrawal by Subject|4|||
130570544|NCT01087905|470053914|FG003|Overall Study|Withdrawal by Subject|5|||
130570545|NCT01087905|470053915|FG004|Overall Study|Withdrawal by Subject|4|||
130570546|NCT01087905|470053916|FG005|Overall Study|Withdrawal by Subject|3|||
130570547|NCT01087905|470053917|FG006|Overall Study|Withdrawal by Subject|3|||
130570548|NCT01087905|470053918|FG007|Overall Study|Withdrawal by Subject|5|||
130570549|NCT01347554|470053919|FG000|Overall Study|Lack of Efficacy|7|||
130570550|NCT01347554|470053920|FG001|Overall Study|Lack of Efficacy|11|||
130570551|NCT00004259|470053922|FG000|Overall Study|Protocol Violation|1|||
130570552|NCT00004259|470053923|FG001|Overall Study|Protocol Violation|2|||
130570553|NCT00004259|470053924|FG002|Overall Study|Protocol Violation|0|||
130570554|NCT00004259|470053925|FG003|Overall Study|Protocol Violation|0|||
130570555|NCT00004259|470053922|FG000|Overall Study|Withdrawal by Subject|0|||
130570556|NCT00004259|470053923|FG001|Overall Study|Withdrawal by Subject|2|||
130514377|NCT00382408|469849869|FG000|Overall Study|Protocol Violation|2|||
130514378|NCT00382408|469849870|FG001|Overall Study|Protocol Violation|2|||
130514379|NCT00382408|469849869|FG000|Overall Study|Physician Decision|1|||
130514380|NCT00382408|469849870|FG001|Overall Study|Physician Decision|0|||
130514381|NCT00382408|469849869|FG000|Overall Study|Withdrawal by Subject|17|||
130514382|NCT00382408|469849870|FG001|Overall Study|Withdrawal by Subject|6|||
130514383|NCT00382408|469849869|FG000|Overall Study|Pregnancy|2|||
130514384|NCT00382408|469849870|FG001|Overall Study|Pregnancy|0|||
130514385|NCT00382408|469849869|FG000|Overall Study|Lost to Follow-up|19|||
130514386|NCT00382408|469849870|FG001|Overall Study|Lost to Follow-up|8|||
130514387|NCT00382408|469849869|FG000|Overall Study|Other|100|||
130514388|NCT00382408|469849870|FG001|Overall Study|Other|35|||
130514389|NCT00352053|469849873|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
130514390|NCT00352053|469849874|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
130514391|NCT00352053|469849873|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
130514392|NCT00352053|469849874|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
130514393|NCT00352053|469849873|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
130514394|NCT00352053|469849874|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
130514395|NCT00352053|469849873|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
130514396|NCT00352053|469849874|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
130514397|NCT00352053|469849873|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
130514398|NCT00352053|469849874|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
130514399|NCT00352053|469849873|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
130514400|NCT00352053|469849874|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
130514401|NCT00352053|469849873|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
130514402|NCT00352053|469849874|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
130514403|NCT00352053|469849873|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
130514404|NCT00352053|469849874|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
130514405|NCT00352053|469849873|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
130514406|NCT00352053|469849874|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
130514407|NCT00352053|469849873|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
130514408|NCT00352053|469849874|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
130514409|NCT00352053|469849873|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
130514410|NCT00352053|469849874|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
130514411|NCT00352053|469849873|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
130514412|NCT00352053|469849874|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
130514413|NCT00352053|469849873|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
130514414|NCT00352053|469849874|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
130514415|NCT01066897|469849875|FG000|Overall Study|Withdrawal by Subject|1|||
130514416|NCT01066897|469849876|FG001|Overall Study|Withdrawal by Subject|0|||
130514417|NCT01066897|469849875|FG000|Overall Study|stopped study after developing the flu.|1|||
130514418|NCT01066897|469849876|FG001|Overall Study|stopped study after developing the flu.|0|||
130514419|NCT02402465|469849877|FG000|Overall Study|Withdrawal by Subject|0|||
130514420|NCT02402465|469849878|FG001|Overall Study|Withdrawal by Subject|0|||
130514421|NCT02402465|469849879|FG002|Overall Study|Withdrawal by Subject|0|||
130514422|NCT02402465|469849880|FG003|Overall Study|Withdrawal by Subject|0|||
130514423|NCT02402465|469849881|FG004|Overall Study|Withdrawal by Subject|0|||
130514424|NCT02402465|469849882|FG005|Overall Study|Withdrawal by Subject|1|||
130514425|NCT02402465|469849877|FG000|Overall Study|Lost to Follow-up|0|||
130514426|NCT02402465|469849878|FG001|Overall Study|Lost to Follow-up|1|||
130514427|NCT02402465|469849879|FG002|Overall Study|Lost to Follow-up|0|||
130514428|NCT02402465|469849880|FG003|Overall Study|Lost to Follow-up|0|||
130514429|NCT02402465|469849881|FG004|Overall Study|Lost to Follow-up|1|||
130514430|NCT02402465|469849882|FG005|Overall Study|Lost to Follow-up|0|||
130514431|NCT03807700|469849883|FG000|Overall Study|Withdrawal by Subject|2|||
130514432|NCT03807700|469849884|FG001|Overall Study|Withdrawal by Subject|1|||
130514433|NCT01675050|469849885|FG000|Period One Treatment|Withdrawal by Subject|1|||
130514434|NCT01675050|469849886|FG001|Period One Treatment|Withdrawal by Subject|0|||
130514435|NCT02282917|469849888|FG000|Overall Study|Withdrawal by Subject|1|||
130514436|NCT02282917|469849888|FG000|Overall Study|Screen Failure/Not Eligible|1|||
130514437|NCT00655668|469849895|FG000|Overall Study|Adverse Event|6|||
130514438|NCT00655668|469849895|FG000|Overall Study|Death|5|||
130514439|NCT00655668|469849895|FG000|Overall Study|Disease Progression|27|||
130514440|NCT00655668|469849895|FG000|Overall Study|Study Terminated|9|||
130514441|NCT00655668|469849895|FG000|Overall Study|Other|1|||
130514442|NCT00655668|469849895|FG000|Overall Study|New Lymphoma Treatment Started|4|||
130514443|NCT00655668|469849895|FG000|Overall Study|Withdrawal by Subject|2|||
130514444|NCT00595764|469849896|FG000|Overall Study|Protocol Violation|24|||
130514445|NCT00595764|469849897|FG001|Overall Study|Protocol Violation|19|||
130514446|NCT00595764|469849896|FG000|Overall Study|Missed Medication >1 week|10|||
130514447|NCT00595764|469849897|FG001|Overall Study|Missed Medication >1 week|17|||
130514448|NCT00595764|469849896|FG000|Overall Study|Missed 3 PM visits|1|||
130514449|NCT00595764|469849897|FG001|Overall Study|Missed 3 PM visits|7|||
130514450|NCT00595764|469849896|FG000|Overall Study|Withdrawal by Subject|4|||
130514451|NCT00595764|469849897|FG001|Overall Study|Withdrawal by Subject|0|||
130514452|NCT01894256|469849898|FG000|Part A|Adverse Event|0|||
130514453|NCT01894256|469849899|FG001|Part A|Adverse Event|1|||
130514454|NCT01894256|469849900|FG002|Part A|Adverse Event|0|||
130514455|NCT01894256|469849898|FG000|Part B|Death|0|||
130514456|NCT01894256|469849899|FG001|Part B|Death|1|||
130514457|NCT01894256|469849900|FG002|Part B|Death|1|||
130514458|NCT01894256|469849898|FG000|Part B|Withdrawal by Subject|0|||
130514459|NCT01894256|469849899|FG001|Part B|Withdrawal by Subject|1|||
130514460|NCT01894256|469849900|FG002|Part B|Withdrawal by Subject|0|||
130514461|NCT01894256|469849898|FG000|Part B|Lack of Efficacy|15|||
130514462|NCT01894256|469849899|FG001|Part B|Lack of Efficacy|12|||
130514463|NCT01894256|469849900|FG002|Part B|Lack of Efficacy|13|||
130514464|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
130514465|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
130514466|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
130514467|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
130514468|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
130514469|NCT00500539|469849904|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
130514470|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
130514471|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
130514472|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
130514473|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
130514474|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Death|1|||
130514475|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
130514476|NCT00500539|469849904|FG000|Follow-up Period (16 Weeks)|Missing|3|||
130514477|NCT00645099|469849905|FG000|Overall Study|Lack of Efficacy|15|||
130514478|NCT00645099|469849906|FG001|Overall Study|Lack of Efficacy|6|||
130514479|NCT00645099|469849905|FG000|Overall Study|Withdrawal by Subject|30|||
130514480|NCT00645099|469849906|FG001|Overall Study|Withdrawal by Subject|22|||
130514481|NCT00645099|469849905|FG000|Overall Study|Lost to Follow-up|6|||
130514482|NCT00645099|469849906|FG001|Overall Study|Lost to Follow-up|4|||
130514483|NCT00645099|469849905|FG000|Overall Study|Adverse Event|11|||
130514484|NCT00645099|469849906|FG001|Overall Study|Adverse Event|5|||
130514485|NCT00645099|469849905|FG000|Overall Study|Other|9|||
130514486|NCT00645099|469849906|FG001|Overall Study|Other|5|||
130514487|NCT01201915|469849907|FG000|Overall Study|Adverse Event|2|||
130514488|NCT01201915|469849908|FG001|Overall Study|Adverse Event|1|||
130514489|NCT01201915|469849909|FG002|Overall Study|Adverse Event|1|||
130514490|NCT01201915|469849907|FG000|Overall Study|Lost to Follow-up|0|||
130514491|NCT01201915|469849908|FG001|Overall Study|Lost to Follow-up|4|||
130514492|NCT01201915|469849909|FG002|Overall Study|Lost to Follow-up|0|||
130514493|NCT01201915|469849907|FG000|Overall Study|Physician Decision|3|||
130514494|NCT01201915|469849908|FG001|Overall Study|Physician Decision|0|||
130514495|NCT01201915|469849909|FG002|Overall Study|Physician Decision|0|||
130514496|NCT01201915|469849907|FG000|Overall Study|Subject Decision|3|||
130514497|NCT01201915|469849908|FG001|Overall Study|Subject Decision|3|||
130514498|NCT01201915|469849909|FG002|Overall Study|Subject Decision|5|||
130514499|NCT01201915|469849907|FG000|Overall Study|Target Lesion Progression|0|||
130514500|NCT01201915|469849908|FG001|Overall Study|Target Lesion Progression|3|||
130514501|NCT01201915|469849909|FG002|Overall Study|Target Lesion Progression|0|||
130514502|NCT02316171|469849912|FG000|Overall Study|difficulties with urinary catheter|1|||
130514503|NCT02316171|469849913|FG001|Overall Study|difficulties with urinary catheter|0|||
130514504|NCT02316171|469849914|FG002|Overall Study|difficulties with urinary catheter|0|||
130514505|NCT02316171|469849915|FG003|Overall Study|difficulties with urinary catheter|0|||
130514506|NCT01804140|469849917|FG000|Overall Study|No sampling or biopsy procedures done|114|||
130514507|NCT01524887|469849918|FG000|Overall Study|Withdrawal by Subject|6|||
130514508|NCT01524887|469849919|FG001|Overall Study|Withdrawal by Subject|2|||
130514509|NCT01524887|469849920|FG002|Overall Study|Withdrawal by Subject|3|||
130514510|NCT01524887|469849918|FG000|Overall Study|Adverse Event|5|||
130514511|NCT01524887|469849919|FG001|Overall Study|Adverse Event|1|||
130514512|NCT01524887|469849920|FG002|Overall Study|Adverse Event|1|||
130514513|NCT01524887|469849918|FG000|Overall Study|Protocol Violation|0|||
130514514|NCT01524887|469849919|FG001|Overall Study|Protocol Violation|0|||
130514515|NCT01524887|469849920|FG002|Overall Study|Protocol Violation|1|||
130514516|NCT01524887|469849918|FG000|Overall Study|Study termination|73|||
130514517|NCT01524887|469849919|FG001|Overall Study|Study termination|87|||
130514518|NCT01524887|469849920|FG002|Overall Study|Study termination|79|||
130514519|NCT01524887|469849918|FG000|Overall Study|Withdrawal by Caregiver|0|||
130514520|NCT01524887|469849919|FG001|Overall Study|Withdrawal by Caregiver|0|||
130514521|NCT01524887|469849920|FG002|Overall Study|Withdrawal by Caregiver|2|||
130514522|NCT01524887|469849918|FG000|Overall Study|Use of prohibited medication|1|||
130514523|NCT01524887|469849919|FG001|Overall Study|Use of prohibited medication|0|||
130514524|NCT01524887|469849920|FG002|Overall Study|Use of prohibited medication|0|||
130570557|NCT00004259|470053924|FG002|Overall Study|Withdrawal by Subject|0|||
130570558|NCT00004259|470053925|FG003|Overall Study|Withdrawal by Subject|0|||
130570559|NCT00996944|470053926|FG000|Double-blind Treatment Period|Adverse Event|2|||
130570560|NCT00996944|470053927|FG001|Double-blind Treatment Period|Adverse Event|1|||
130570561|NCT00996944|470053926|FG000|Double-blind Treatment Period|Protocol Violation|1|||
130570562|NCT00996944|470053927|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130570563|NCT00996944|470053926|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
130570564|NCT00996944|470053927|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
130570565|NCT00996944|470053926|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130570566|NCT00996944|470053927|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130570567|NCT00996944|470053926|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
130570568|NCT00996944|470053927|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
130570569|NCT00769184|470053928|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
130570570|NCT00769184|470053929|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
130570571|NCT00769184|470053928|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
130570572|NCT00769184|470053929|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
130570573|NCT00769184|470053928|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
130570574|NCT00769184|470053929|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
130570575|NCT00385255|470053930|FG000|Overall Study|Serious Adverse Event|1|||
130570576|NCT00385255|470053931|FG001|Overall Study|Serious Adverse Event|2|||
130570577|NCT00385255|470053930|FG000|Overall Study|Protocol Violation|0|||
130570578|NCT00385255|470053931|FG001|Overall Study|Protocol Violation|4|||
130570579|NCT00385255|470053930|FG000|Overall Study|Withdrawal by Subject|0|||
130570580|NCT00385255|470053931|FG001|Overall Study|Withdrawal by Subject|8|||
130570581|NCT00385255|470053930|FG000|Overall Study|Migrated/moved from study area|0|||
130570582|NCT00385255|470053931|FG001|Overall Study|Migrated/moved from study area|1|||
130570583|NCT00385255|470053930|FG000|Overall Study|Lost to Follow-up|20|||
130570584|NCT00385255|470053931|FG001|Overall Study|Lost to Follow-up|58|||
130570585|NCT02443883|470053932|FG000|Overall Study|Adverse Event|0|||
130570586|NCT02443883|470053933|FG001|Overall Study|Adverse Event|1|||
130570587|NCT02443883|470053934|FG002|Overall Study|Adverse Event|0|||
130570588|NCT02443883|470053935|FG003|Overall Study|Adverse Event|0|||
130570589|NCT02443883|470053932|FG000|Overall Study|Lost to Follow-up|3|||
130570590|NCT02443883|470053933|FG001|Overall Study|Lost to Follow-up|2|||
130570591|NCT02443883|470053934|FG002|Overall Study|Lost to Follow-up|1|||
130570592|NCT02443883|470053935|FG003|Overall Study|Lost to Follow-up|0|||
130570593|NCT02443883|470053932|FG000|Overall Study|Physician Decision|1|||
130570594|NCT02443883|470053933|FG001|Overall Study|Physician Decision|1|||
130570595|NCT02443883|470053934|FG002|Overall Study|Physician Decision|0|||
130570596|NCT02443883|470053935|FG003|Overall Study|Physician Decision|3|||
130570597|NCT02443883|470053932|FG000|Overall Study|Withdrawal by Subject|1|||
130570598|NCT02443883|470053933|FG001|Overall Study|Withdrawal by Subject|0|||
130570599|NCT02443883|470053934|FG002|Overall Study|Withdrawal by Subject|0|||
130570600|NCT02443883|470053935|FG003|Overall Study|Withdrawal by Subject|2|||
130570601|NCT02443883|470053932|FG000|Overall Study|Randomized, but never treated|1|||
130570602|NCT02443883|470053933|FG001|Overall Study|Randomized, but never treated|0|||
130570603|NCT02443883|470053934|FG002|Overall Study|Randomized, but never treated|0|||
130570604|NCT02443883|470053935|FG003|Overall Study|Randomized, but never treated|0|||
130570605|NCT02937818|470053936|FG000|Overall Study|Participants decision|2|||
130570606|NCT02937818|470053937|FG001|Overall Study|Participants decision|1|||
130570607|NCT02937818|470053938|FG002|Overall Study|Participants decision|1|||
130570608|NCT02937818|470053939|FG003|Overall Study|Participants decision|1|||
130570609|NCT02937818|470053936|FG000|Overall Study|Adverse Event|2|||
130570610|NCT02937818|470053937|FG001|Overall Study|Adverse Event|4|||
130570611|NCT02937818|470053938|FG002|Overall Study|Adverse Event|1|||
130570612|NCT02937818|470053939|FG003|Overall Study|Adverse Event|1|||
130570613|NCT02937818|470053936|FG000|Overall Study|Disease progression|17|||
130570614|NCT02937818|470053937|FG001|Overall Study|Disease progression|15|||
130570615|NCT02937818|470053938|FG002|Overall Study|Disease progression|7|||
130570616|NCT02937818|470053939|FG003|Overall Study|Disease progression|19|||
130570617|NCT02937818|470053936|FG000|Overall Study|Condition under investigation worsened|0|||
130570618|NCT02937818|470053937|FG001|Overall Study|Condition under investigation worsened|0|||
130570619|NCT02937818|470053938|FG002|Overall Study|Condition under investigation worsened|1|||
130570620|NCT02937818|470053939|FG003|Overall Study|Condition under investigation worsened|0|||
130570621|NCT00205855|470053950|FG000|Overall Study|Only received temporary implants|16|||
130570622|NCT00205855|470053950|FG000|Overall Study|Withdrawal by Subject|5|||
130570623|NCT00506883|470053953|FG000|Overall Study|Lost to Follow-up|1|||
130570624|NCT00506883|470053954|FG001|Overall Study|Lost to Follow-up|1|||
130570625|NCT00506883|470053955|FG002|Overall Study|Lost to Follow-up|1|||
130570626|NCT00506883|470053953|FG000|Overall Study|Withdrawal by Subject|1|||
130570627|NCT00506883|470053954|FG001|Overall Study|Withdrawal by Subject|0|||
130570628|NCT00506883|470053955|FG002|Overall Study|Withdrawal by Subject|1|||
130570629|NCT00506883|470053953|FG000|Overall Study|Lack of Efficacy|0|||
130570630|NCT00506883|470053954|FG001|Overall Study|Lack of Efficacy|1|||
130570631|NCT00506883|470053955|FG002|Overall Study|Lack of Efficacy|1|||
130570632|NCT00506883|470053953|FG000|Overall Study|Other|5|||
130570633|NCT00506883|470053954|FG001|Overall Study|Other|1|||
130570634|NCT00506883|470053955|FG002|Overall Study|Other|1|||
130570635|NCT01445951|470053956|FG000|Overall Study|Adverse Event|16|||
130570636|NCT01445951|470053957|FG001|Overall Study|Adverse Event|9|||
130570637|NCT01445951|470053958|FG002|Overall Study|Adverse Event|0|||
130570638|NCT01445951|470053956|FG000|Overall Study|Protocol Violation|2|||
130570639|NCT01445951|470053957|FG001|Overall Study|Protocol Violation|2|||
130570640|NCT01445951|470053958|FG002|Overall Study|Protocol Violation|2|||
130570641|NCT01445951|470053956|FG000|Overall Study|Withdrawal by Subject|21|||
130570642|NCT01445951|470053957|FG001|Overall Study|Withdrawal by Subject|16|||
130570643|NCT01445951|470053958|FG002|Overall Study|Withdrawal by Subject|8|||
130570644|NCT01445951|470053956|FG000|Overall Study|Physician Decision|3|||
130570645|NCT01445951|470053957|FG001|Overall Study|Physician Decision|1|||
130570646|NCT01445951|470053958|FG002|Overall Study|Physician Decision|0|||
130570647|NCT01445951|470053956|FG000|Overall Study|Lost to Follow-up|1|||
130570648|NCT01445951|470053957|FG001|Overall Study|Lost to Follow-up|2|||
130570649|NCT01445951|470053958|FG002|Overall Study|Lost to Follow-up|4|||
130570650|NCT01445951|470053956|FG000|Overall Study|Pregnancy|0|||
130570651|NCT01445951|470053957|FG001|Overall Study|Pregnancy|1|||
130570652|NCT01445951|470053958|FG002|Overall Study|Pregnancy|4|||
130570653|NCT01445951|470053956|FG000|Overall Study|Death|0|||
130570654|NCT01445951|470053957|FG001|Overall Study|Death|0|||
130570655|NCT01445951|470053958|FG002|Overall Study|Death|1|||
130570656|NCT01445951|470053956|FG000|Overall Study|Non-compliance with study drug|1|||
130570657|NCT01445951|470053957|FG001|Overall Study|Non-compliance with study drug|2|||
130570658|NCT01445951|470053958|FG002|Overall Study|Non-compliance with study drug|0|||
130570659|NCT01445951|470053956|FG000|Overall Study|Non-compliance with protocol|0|||
130570660|NCT01445951|470053957|FG001|Overall Study|Non-compliance with protocol|1|||
130570661|NCT01445951|470053958|FG002|Overall Study|Non-compliance with protocol|0|||
130570662|NCT01445951|470053956|FG000|Overall Study|Sponsor decision - subject travel|0|||
130570663|NCT01445951|470053957|FG001|Overall Study|Sponsor decision - subject travel|1|||
130570664|NCT01445951|470053958|FG002|Overall Study|Sponsor decision - subject travel|0|||
130570665|NCT01445951|470053956|FG000|Overall Study|Cough|0|||
130570666|NCT01445951|470053957|FG001|Overall Study|Cough|1|||
130570667|NCT01445951|470053958|FG002|Overall Study|Cough|0|||
130570668|NCT05513625|470053959|FG000|Overall Study|Withdrawal by Subject|1|||
130570669|NCT01015768|470053960|FG000|Overall Study|Some subject data unuseable|4|||
130570670|NCT01015768|470053961|FG001|Overall Study|Some subject data unuseable|4|||
130570671|NCT01627860|470053962|FG000|Overall Study|Adverse Event|9|||
130570672|NCT01627860|470053963|FG001|Overall Study|Adverse Event|4|||
130570673|NCT01627860|470053962|FG000|Overall Study|Withdrawal by Subject|2|||
130570674|NCT01627860|470053963|FG001|Overall Study|Withdrawal by Subject|1|||
130570675|NCT01627860|470053962|FG000|Overall Study|Seizure frequency doubled|0|||
130570676|NCT01627860|470053963|FG001|Overall Study|Seizure frequency doubled|1|||
130570677|NCT01627860|470053962|FG000|Overall Study|Protocol Violation|1|||
130570678|NCT01627860|470053963|FG001|Overall Study|Protocol Violation|0|||
130570679|NCT00677014|470053969|FG000|Overall Study|Lost to Follow-up|20|||
130570680|NCT00677014|470053970|FG001|Overall Study|Lost to Follow-up|12|||
130570681|NCT00677014|470053971|FG002|Overall Study|Lost to Follow-up|24|||
130514525|NCT01002547|469851807|FG000|Overall Study|Withdrawal by Subject|4|||
130514526|NCT01002547|469851808|FG001|Overall Study|Withdrawal by Subject|0|||
130514527|NCT01002547|469851809|FG002|Overall Study|Withdrawal by Subject|5|||
130514528|NCT01002547|469851807|FG000|Overall Study|Lost to Follow-up|2|||
130514529|NCT01002547|469851808|FG001|Overall Study|Lost to Follow-up|1|||
130514530|NCT01002547|469851809|FG002|Overall Study|Lost to Follow-up|1|||
130514531|NCT01002547|469851807|FG000|Overall Study|Physician Decision|1|||
130514532|NCT01002547|469851808|FG001|Overall Study|Physician Decision|0|||
130514533|NCT01002547|469851809|FG002|Overall Study|Physician Decision|0|||
130514534|NCT01002547|469851807|FG000|Overall Study|Death|0|||
130514535|NCT01002547|469851808|FG001|Overall Study|Death|2|||
130514536|NCT01002547|469851809|FG002|Overall Study|Death|2|||
130514537|NCT01002547|469851807|FG000|Overall Study|Adverse Event|1|||
130514538|NCT01002547|469851808|FG001|Overall Study|Adverse Event|0|||
130514539|NCT01002547|469851809|FG002|Overall Study|Adverse Event|0|||
130514540|NCT02093897|469851816|FG000|Overall Study|Physician Decision|1|||
130514541|NCT02093897|469851816|FG000|Overall Study|Planned age group closure - no's reached|17|||
130514542|NCT02093897|469851816|FG000|Overall Study|Adverse event, non-fatal|1|||
130570682|NCT00677014|470053969|FG000|Overall Study|Death|6|||
130570683|NCT00677014|470053970|FG001|Overall Study|Death|15|||
130570684|NCT00677014|470053971|FG002|Overall Study|Death|7|||
130570685|NCT00677014|470053969|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
130570686|NCT00677014|470053970|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
130570687|NCT00677014|470053971|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
130570688|NCT00640328|470053972|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130570689|NCT00640328|470053973|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
130570690|NCT00640328|470053974|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130570691|NCT00640328|470053975|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130570692|NCT00640328|470053976|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130570693|NCT00640328|470053977|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130570694|NCT00640328|470053972|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130570695|NCT00640328|470053973|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130570696|NCT00640328|470053974|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130570697|NCT00640328|470053975|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130570698|NCT00640328|470053976|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
130570699|NCT00640328|470053977|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130570700|NCT00640328|470053972|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130570701|NCT00640328|470053973|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130570702|NCT00640328|470053974|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
130570703|NCT00640328|470053975|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130570704|NCT00640328|470053976|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130570705|NCT00640328|470053977|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130570706|NCT00640328|470053972|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130570707|NCT00640328|470053973|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
130570708|NCT00640328|470053974|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130570709|NCT00640328|470053975|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
130570710|NCT00640328|470053976|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130570711|NCT00640328|470053977|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130570712|NCT02374099|470053978|FG000|Overall Study|Adverse Event|1|||
130570713|NCT02374099|470053979|FG001|Overall Study|Adverse Event|0|||
130570714|NCT02374099|470053978|FG000|Overall Study|Progressive Disease|35|||
130570715|NCT02374099|470053979|FG001|Overall Study|Progressive Disease|40|||
130570716|NCT02374099|470053978|FG000|Overall Study|Withdrawal by Subject|5|||
130570717|NCT02374099|470053979|FG001|Overall Study|Withdrawal by Subject|1|||
130570718|NCT02374099|470053978|FG000|Overall Study|Miscellaneous|2|||
130570719|NCT02374099|470053979|FG001|Overall Study|Miscellaneous|3|||
130570720|NCT02374099|470053978|FG000|Overall Study|Randomized, but not treated|2|||
130570721|NCT02374099|470053979|FG001|Overall Study|Randomized, but not treated|1|||
130570722|NCT02374099|470053978|FG000|Overall Study|Study Terminated by Sponsor|3|||
130570723|NCT02374099|470053979|FG001|Overall Study|Study Terminated by Sponsor|4|||
130570724|NCT01033825|470053980|FG000|Overall Study|Withdrawal by Subject|2|||
130570725|NCT01033825|470053981|FG001|Overall Study|Withdrawal by Subject|3|||
130570726|NCT01033825|470053982|FG002|Overall Study|Withdrawal by Subject|2|||
130570727|NCT01033825|470053983|FG003|Overall Study|Withdrawal by Subject|1|||
130570728|NCT01033825|470053984|FG004|Overall Study|Withdrawal by Subject|1|||
130570729|NCT01033825|470053985|FG005|Overall Study|Withdrawal by Subject|0|||
130570730|NCT01033825|470053986|FG006|Overall Study|Withdrawal by Subject|0|||
130570731|NCT01033825|470053980|FG000|Overall Study|Adverse Event|0|||
130570732|NCT01033825|470053981|FG001|Overall Study|Adverse Event|0|||
130570733|NCT01033825|470053982|FG002|Overall Study|Adverse Event|0|||
130514543|NCT00088452|469851817|FG000|Overall Study|Did not receive intervention|1|||
130514544|NCT00088452|469851818|FG001|Overall Study|Did not receive intervention|0|||
130514545|NCT00088452|469851819|FG002|Overall Study|Did not receive intervention|1|||
130514546|NCT02081196|469851821|FG000|Overall Study|Lost to Follow-up|1|||
130514547|NCT03098797|469851824|FG000|Part 2 Open Label Extension|Adverse Event|2|||
130514548|NCT03098797|469851825|FG001|Part 2 Open Label Extension|Adverse Event|0|||
130514549|NCT02329223|469851828|FG000|Overall Study|Withdrawal by Subject|1|||
130514550|NCT02329223|469851829|FG001|Overall Study|Withdrawal by Subject|2|||
130514551|NCT02329223|469851830|FG002|Overall Study|Withdrawal by Subject|5|||
130514552|NCT02329223|469851828|FG000|Overall Study|Physician Decision|0|||
130514553|NCT02329223|469851829|FG001|Overall Study|Physician Decision|0|||
130514554|NCT02329223|469851830|FG002|Overall Study|Physician Decision|1|||
130514555|NCT02329223|469851828|FG000|Overall Study|Adverse Event|0|||
130514556|NCT02329223|469851829|FG001|Overall Study|Adverse Event|1|||
130514557|NCT02329223|469851830|FG002|Overall Study|Adverse Event|0|||
130514558|NCT00381888|469851831|FG000|Overall Study|Death|1|||
130514559|NCT00381888|469851831|FG000|Overall Study|Withdrawal by Subject|1|||
130514560|NCT00381888|469851831|FG000|Overall Study|Physician Decision|1|||
130514561|NCT00381888|469851831|FG000|Overall Study|Protocol Violation|9|||
130514562|NCT00381888|469851831|FG000|Overall Study|Had laparoscopic surgery|2|||
130514563|NCT00381888|469851831|FG000|Overall Study|Surgery was cancelled|2|||
130514564|NCT00381888|469851831|FG000|Overall Study|Adverse Event|1|||
130514565|NCT03449134|469851832|FG000|52-Week Treatment Period|Death|2|||
130514566|NCT03449134|469851833|FG001|52-Week Treatment Period|Death|1|||
130514567|NCT03449134|469851834|FG002|52-Week Treatment Period|Death|0|||
130514568|NCT03449134|469851832|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
130514569|NCT03449134|469851833|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
130514570|NCT03449134|469851834|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
130514571|NCT03449134|469851832|FG000|52-Week Treatment Period|Physician Decision|2|||
130570734|NCT01033825|470053983|FG003|Overall Study|Adverse Event|1|||
130570735|NCT01033825|470053984|FG004|Overall Study|Adverse Event|0|||
130570736|NCT01033825|470053985|FG005|Overall Study|Adverse Event|0|||
130570737|NCT01033825|470053986|FG006|Overall Study|Adverse Event|0|||
130570738|NCT01033825|470053980|FG000|Overall Study|Protocol Violation|1|||
130570739|NCT01033825|470053981|FG001|Overall Study|Protocol Violation|0|||
130570740|NCT01033825|470053982|FG002|Overall Study|Protocol Violation|0|||
130514572|NCT03449134|469851833|FG001|52-Week Treatment Period|Physician Decision|3|||
130514573|NCT03449134|469851834|FG002|52-Week Treatment Period|Physician Decision|3|||
130570741|NCT01033825|470053983|FG003|Overall Study|Protocol Violation|0|||
130570742|NCT01033825|470053984|FG004|Overall Study|Protocol Violation|0|||
130570743|NCT01033825|470053985|FG005|Overall Study|Protocol Violation|0|||
130570744|NCT01033825|470053986|FG006|Overall Study|Protocol Violation|0|||
130570745|NCT01033825|470053980|FG000|Overall Study|Other|0|||
130570746|NCT01033825|470053981|FG001|Overall Study|Other|0|||
130570747|NCT01033825|470053982|FG002|Overall Study|Other|0|||
130570748|NCT01033825|470053983|FG003|Overall Study|Other|0|||
130570749|NCT01033825|470053984|FG004|Overall Study|Other|1|||
130570750|NCT01033825|470053985|FG005|Overall Study|Other|0|||
130570751|NCT01033825|470053986|FG006|Overall Study|Other|0|||
130570752|NCT01326546|470053987|FG000|Overall Study|Lost to Follow-up|8|||
130570753|NCT01326546|470053988|FG001|Overall Study|Lost to Follow-up|7|||
130570754|NCT01326546|470053987|FG000|Overall Study|Protocol Violation|3|||
130570755|NCT01326546|470053988|FG001|Overall Study|Protocol Violation|4|||
130570756|NCT01326546|470053987|FG000|Overall Study|Pregnancy|0|||
130570757|NCT01326546|470053988|FG001|Overall Study|Pregnancy|1|||
130570758|NCT01326546|470053987|FG000|Overall Study|Adverse Event|1|||
130570759|NCT01326546|470053988|FG001|Overall Study|Adverse Event|0|||
130570760|NCT01326546|470053987|FG000|Overall Study|Withdrawal by Subject|5|||
130570761|NCT01326546|470053988|FG001|Overall Study|Withdrawal by Subject|1|||
130570762|NCT04294719|470053989|FG000|Overall Study|Withdrawal by Subject|1|||
130570763|NCT00081159|470053990|FG000|Overall Study|Withdrawal by Subject|0|||
130570764|NCT00081159|470053991|FG001|Overall Study|Withdrawal by Subject|3|||
130570765|NCT00081159|470053990|FG000|Overall Study|Myelosuppression prior to treatment|0|||
130570766|NCT00081159|470053991|FG001|Overall Study|Myelosuppression prior to treatment|1|||
130570767|NCT00081159|470053990|FG000|Overall Study|Lost to Follow-up|2|||
130570768|NCT00081159|470053991|FG001|Overall Study|Lost to Follow-up|1|||
130570769|NCT01714687|470053994|FG000|Overall Study|Withdrawal by Subject|1|||
130570770|NCT01714687|470053995|FG001|Overall Study|Withdrawal by Subject|0|||
130570771|NCT01714687|470053994|FG000|Overall Study|Lost to Follow-up|2|||
130570772|NCT01714687|470053995|FG001|Overall Study|Lost to Follow-up|4|||
130570773|NCT01553136|470053996|FG000|Overall Study|Adverse Event|3|||
130570774|NCT01553136|470053997|FG001|Overall Study|Adverse Event|2|||
130570775|NCT01553136|470053996|FG000|Overall Study|Withdrawal by Subject|2|||
130570776|NCT01553136|470053997|FG001|Overall Study|Withdrawal by Subject|3|||
130570777|NCT01553136|470053996|FG000|Overall Study|Lost to Follow-up|4|||
130570778|NCT01553136|470053997|FG001|Overall Study|Lost to Follow-up|10|||
130570779|NCT01553136|470053996|FG000|Overall Study|Physician Decision|2|||
130570780|NCT01553136|470053997|FG001|Overall Study|Physician Decision|3|||
130570781|NCT01553136|470053996|FG000|Overall Study|Scheduling Difficulties|5|||
130570782|NCT01553136|470053997|FG001|Overall Study|Scheduling Difficulties|4|||
130514574|NCT03449134|469851832|FG000|52-Week Treatment Period|Screen Failure|1|||
130514575|NCT03449134|469851833|FG001|52-Week Treatment Period|Screen Failure|0|||
130514576|NCT03449134|469851834|FG002|52-Week Treatment Period|Screen Failure|1|||
130514577|NCT03449134|469851832|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
130514578|NCT03449134|469851833|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
130514579|NCT03449134|469851834|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
130570783|NCT00894556|470053998|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
130570784|NCT00894556|470053999|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
130570785|NCT00894556|470054000|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
130570786|NCT00894556|470054001|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
130570787|NCT00894556|470053998|FG000|Treatment Phase|Lost to Follow-up|2|||
130570788|NCT00894556|470053999|FG001|Treatment Phase|Lost to Follow-up|3|||
130570789|NCT00894556|470054000|FG002|Treatment Phase|Lost to Follow-up|1|||
130514580|NCT03449134|469851832|FG000|52-Week Treatment Period|Site Closure|1|||
130514581|NCT03449134|469851833|FG001|52-Week Treatment Period|Site Closure|0|||
130570790|NCT00894556|470054001|FG003|Treatment Phase|Lost to Follow-up|0|||
130570791|NCT00894556|470053998|FG000|Treatment Phase|Lack of Qualifying Event|2|||
130570792|NCT00894556|470053999|FG001|Treatment Phase|Lack of Qualifying Event|1|||
130570793|NCT00894556|470054000|FG002|Treatment Phase|Lack of Qualifying Event|0|||
130570794|NCT00894556|470054001|FG003|Treatment Phase|Lack of Qualifying Event|0|||
130570795|NCT03077685|470054004|FG000|Overall Study|Lost to Follow-up|0|||
130570796|NCT03077685|470054005|FG001|Overall Study|Lost to Follow-up|0|||
130570797|NCT03077685|470054006|FG002|Overall Study|Lost to Follow-up|0|||
130514582|NCT03449134|469851834|FG002|52-Week Treatment Period|Site Closure|0|||
130514583|NCT00957996|469851835|FG000|Overall Study|Death|4|||
130514584|NCT00957996|469851836|FG001|Overall Study|Death|10|||
130514585|NCT00957996|469851835|FG000|Overall Study|Lost to Follow-up|4|||
130514586|NCT00957996|469851836|FG001|Overall Study|Lost to Follow-up|7|||
130514587|NCT00957996|469851835|FG000|Overall Study|Withdrawal by Subject|9|||
130514588|NCT00957996|469851836|FG001|Overall Study|Withdrawal by Subject|2|||
130514589|NCT00957996|469851835|FG000|Overall Study|Adverse Event|2|||
130514590|NCT00957996|469851836|FG001|Overall Study|Adverse Event|1|||
130570798|NCT03077685|470054007|FG003|Overall Study|Lost to Follow-up|0|||
130570799|NCT03077685|470054008|FG004|Overall Study|Lost to Follow-up|1|||
130570800|NCT03077685|470054004|FG000|Overall Study|Death|0|||
130570801|NCT03077685|470054005|FG001|Overall Study|Death|0|||
130570802|NCT03077685|470054006|FG002|Overall Study|Death|1|||
130570803|NCT03077685|470054007|FG003|Overall Study|Death|1|||
130570804|NCT03077685|470054008|FG004|Overall Study|Death|3|||
130570805|NCT03077685|470054004|FG000|Overall Study|Withdrawal by Subject|0|||
130570806|NCT03077685|470054005|FG001|Overall Study|Withdrawal by Subject|0|||
130570807|NCT03077685|470054006|FG002|Overall Study|Withdrawal by Subject|0|||
130570808|NCT03077685|470054007|FG003|Overall Study|Withdrawal by Subject|2|||
130570809|NCT03077685|470054008|FG004|Overall Study|Withdrawal by Subject|1|||
130570810|NCT03077685|470054004|FG000|Overall Study|Physician Decision|0|||
130570811|NCT03077685|470054005|FG001|Overall Study|Physician Decision|0|||
130570812|NCT03077685|470054006|FG002|Overall Study|Physician Decision|1|||
130570813|NCT03077685|470054007|FG003|Overall Study|Physician Decision|0|||
130570814|NCT03077685|470054008|FG004|Overall Study|Physician Decision|3|||
130570815|NCT03077685|470054004|FG000|Overall Study|Disease Progression|1|||
130570816|NCT03077685|470054005|FG001|Overall Study|Disease Progression|0|||
130570817|NCT03077685|470054006|FG002|Overall Study|Disease Progression|0|||
130514591|NCT00957996|469851835|FG000|Overall Study|Physician Decision|1|||
130514592|NCT00957996|469851836|FG001|Overall Study|Physician Decision|1|||
130514593|NCT00957996|469851835|FG000|Overall Study|Influenza-related complication|0|||
130514594|NCT00957996|469851836|FG001|Overall Study|Influenza-related complication|1|||
130514595|NCT00957996|469851835|FG000|Overall Study|Missing|1|||
130514596|NCT00957996|469851836|FG001|Overall Study|Missing|0|||
130514597|NCT00957996|469851835|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
130514598|NCT00957996|469851836|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
130514599|NCT01580995|469851841|FG000|Overall Study|Lost to Follow-up|2|||
130514600|NCT01580995|469851842|FG001|Overall Study|Lost to Follow-up|2|||
130514601|NCT02916706|469851843|FG000|Overall Study|Adverse Event|0|||
130514602|NCT02916706|469851844|FG001|Overall Study|Adverse Event|1|||
130514603|NCT02916706|469851843|FG000|Overall Study|Lost to Follow-up|0|||
130514604|NCT02916706|469851844|FG001|Overall Study|Lost to Follow-up|1|||
130514605|NCT02916706|469851843|FG000|Overall Study|Physician Decision|1|||
130514606|NCT02916706|469851844|FG001|Overall Study|Physician Decision|0|||
130514607|NCT02916706|469851843|FG000|Overall Study|Protocol Violation|3|||
130514608|NCT02916706|469851844|FG001|Overall Study|Protocol Violation|1|||
130514609|NCT02916706|469851843|FG000|Overall Study|Withdrawal by Subject|6|||
130514610|NCT02916706|469851844|FG001|Overall Study|Withdrawal by Subject|9|||
130514611|NCT02916706|469851843|FG000|Overall Study|Other|5|||
130514612|NCT02916706|469851844|FG001|Overall Study|Other|19|||
130514613|NCT00598871|469851845|FG000|Overall Study|Adverse Event|0|||
130514614|NCT00598871|469851846|FG001|Overall Study|Adverse Event|1|||
130514615|NCT01194271|469851847|FG000|Overall Study|Withdrawal by Subject|1|||
130514616|NCT01194271|469851847|FG000|Overall Study|Ineligible, Screen Failure|1|||
130514617|NCT01194271|469851847|FG000|Overall Study|Death|1|||
130514618|NCT01983462|469851848|FG000|Overall Study|Adverse Event|1|||
130514619|NCT01983462|469851849|FG001|Overall Study|Adverse Event|0|||
130514620|NCT01983462|469851850|FG002|Overall Study|Adverse Event|0|||
130514621|NCT00381797|469851851|FG000|Overall Study|Withdrawal by Subject|1|||
130514622|NCT00381797|469851852|FG001|Overall Study|Withdrawal by Subject|1|||
130514623|NCT00381797|469851853|FG002|Overall Study|Withdrawal by Subject|0|||
130514624|NCT00381797|469851854|FG003|Overall Study|Withdrawal by Subject|0|||
130514625|NCT00381797|469851855|FG004|Overall Study|Withdrawal by Subject|2|||
130514626|NCT00381797|469851851|FG000|Overall Study|Ineligible|0|||
130514627|NCT00381797|469851852|FG001|Overall Study|Ineligible|0|||
130514628|NCT00381797|469851853|FG002|Overall Study|Ineligible|0|||
130514629|NCT00381797|469851854|FG003|Overall Study|Ineligible|1|||
130514630|NCT00381797|469851855|FG004|Overall Study|Ineligible|0|||
130514631|NCT00443898|469851856|FG000|Overall Study|Adverse Event|0|||
130514632|NCT00443898|469851857|FG001|Overall Study|Adverse Event|0|||
130514633|NCT00443898|469851858|FG002|Overall Study|Adverse Event|1|||
130514634|NCT00443898|469851859|FG003|Overall Study|Adverse Event|1|||
130514635|NCT00443898|469851856|FG000|Overall Study|Lack of Efficacy|2|||
130514636|NCT00443898|469851857|FG001|Overall Study|Lack of Efficacy|3|||
130514637|NCT00443898|469851858|FG002|Overall Study|Lack of Efficacy|3|||
130514638|NCT00443898|469851859|FG003|Overall Study|Lack of Efficacy|1|||
130514639|NCT00443898|469851856|FG000|Overall Study|Protocol Violation|1|||
130570818|NCT03077685|470054007|FG003|Overall Study|Disease Progression|2|||
130570819|NCT03077685|470054008|FG004|Overall Study|Disease Progression|1|||
130514640|NCT00443898|469851857|FG001|Overall Study|Protocol Violation|1|||
130514641|NCT00443898|469851858|FG002|Overall Study|Protocol Violation|1|||
130514642|NCT00443898|469851859|FG003|Overall Study|Protocol Violation|0|||
130514643|NCT00443898|469851856|FG000|Overall Study|Withdrawal by Subject|11|||
130514644|NCT00443898|469851857|FG001|Overall Study|Withdrawal by Subject|10|||
130514645|NCT00443898|469851858|FG002|Overall Study|Withdrawal by Subject|10|||
130514646|NCT00443898|469851859|FG003|Overall Study|Withdrawal by Subject|6|||
130514647|NCT00443898|469851856|FG000|Overall Study|Lost to Follow-up|10|||
130514648|NCT00443898|469851857|FG001|Overall Study|Lost to Follow-up|10|||
130514649|NCT00443898|469851858|FG002|Overall Study|Lost to Follow-up|14|||
130514650|NCT00443898|469851859|FG003|Overall Study|Lost to Follow-up|10|||
130514651|NCT00443898|469851856|FG000|Overall Study|Death|0|||
130514652|NCT00443898|469851857|FG001|Overall Study|Death|1|||
130514653|NCT00443898|469851858|FG002|Overall Study|Death|0|||
130514654|NCT00443898|469851859|FG003|Overall Study|Death|0|||
130514655|NCT00958711|469851860|FG000|Overall Study|Withdrawal by Subject|0|||
130514656|NCT00958711|469851861|FG001|Overall Study|Withdrawal by Subject|4|||
130514657|NCT00958711|469851860|FG000|Overall Study|Physician Decision|5|||
130514658|NCT00958711|469851861|FG001|Overall Study|Physician Decision|7|||
130514659|NCT00958711|469851860|FG000|Overall Study|Lost to Follow-up|4|||
130514660|NCT00958711|469851861|FG001|Overall Study|Lost to Follow-up|1|||
130514661|NCT00958711|469851860|FG000|Overall Study|Other|2|||
130514662|NCT00958711|469851861|FG001|Overall Study|Other|5|||
130514663|NCT00958711|469851860|FG000|Overall Study|Death|1|||
130514664|NCT00958711|469851861|FG001|Overall Study|Death|2|||
130514665|NCT00958711|469851860|FG000|Overall Study|Adverse Event|1|||
130514666|NCT00958711|469851861|FG001|Overall Study|Adverse Event|2|||
130514667|NCT00550771|469851864|FG000|Overall Study|Adverse Event|11|||
130514668|NCT00550771|469851865|FG001|Overall Study|Adverse Event|3|||
130514669|NCT00550771|469851864|FG000|Overall Study|Discontinued for study-related reasons|0|||
130514670|NCT00550771|469851865|FG001|Overall Study|Discontinued for study-related reasons|1|||
130514671|NCT00550771|469851864|FG000|Overall Study|Physician Decision|2|||
130514672|NCT00550771|469851865|FG001|Overall Study|Physician Decision|0|||
130514673|NCT00550771|469851864|FG000|Overall Study|Withdrawal by Subject|0|||
130514674|NCT00550771|469851865|FG001|Overall Study|Withdrawal by Subject|1|||
130514675|NCT00550771|469851864|FG000|Overall Study|Protocol Violation|4|||
130514676|NCT00550771|469851865|FG001|Overall Study|Protocol Violation|5|||
130514677|NCT00839306|469851870|FG000|Overall Study|Adverse Event|3|||
130514678|NCT00839306|469851871|FG001|Overall Study|Adverse Event|5|||
130514679|NCT00839306|469851870|FG000|Overall Study|Lost to Follow-up|6|||
130514680|NCT00839306|469851871|FG001|Overall Study|Lost to Follow-up|9|||
130514681|NCT00839306|469851870|FG000|Overall Study|Withdrawal by Subject|5|||
130514682|NCT00839306|469851871|FG001|Overall Study|Withdrawal by Subject|7|||
130514683|NCT00839306|469851870|FG000|Overall Study|Lack of Efficacy|5|||
130514684|NCT00839306|469851871|FG001|Overall Study|Lack of Efficacy|4|||
130514685|NCT00839306|469851870|FG000|Overall Study|Other|6|||
130514686|NCT00839306|469851871|FG001|Overall Study|Other|18|||
130514687|NCT01697592|469851872|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
130514688|NCT01697592|469851873|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514689|NCT01697592|469851874|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514690|NCT01697592|469851875|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514691|NCT01697592|469851876|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514692|NCT01697592|469851877|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514693|NCT01697592|469851878|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514694|NCT01697592|469851879|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514695|NCT01697592|469851880|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514696|NCT01697592|469851881|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
130514697|NCT01697592|469851872|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514698|NCT01697592|469851873|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514699|NCT01697592|469851874|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514700|NCT01697592|469851875|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514701|NCT01697592|469851876|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514702|NCT01697592|469851877|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
130514703|NCT01697592|469851878|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514704|NCT01697592|469851879|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514705|NCT01697592|469851880|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514706|NCT01697592|469851881|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130514707|NCT01697592|469851872|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
130514708|NCT01697592|469851873|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514709|NCT01697592|469851874|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514710|NCT01697592|469851875|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514711|NCT01697592|469851876|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514712|NCT01697592|469851877|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514713|NCT01697592|469851878|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514714|NCT01697592|469851879|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514715|NCT01697592|469851880|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514716|NCT01697592|469851881|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130514717|NCT01697592|469851872|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130514718|NCT01697592|469851873|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130514719|NCT01697592|469851874|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514720|NCT01697592|469851875|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514721|NCT01697592|469851876|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514722|NCT01697592|469851877|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514723|NCT01697592|469851878|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130514724|NCT01697592|469851879|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514725|NCT01697592|469851880|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130514726|NCT01697592|469851881|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130514727|NCT01697592|469851872|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130514728|NCT01697592|469851873|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
130514729|NCT01697592|469851874|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
130514730|NCT01697592|469851875|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
130514731|NCT01697592|469851876|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130514732|NCT01697592|469851877|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130514733|NCT01697592|469851878|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
130514734|NCT01697592|469851879|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130514735|NCT01697592|469851880|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130514736|NCT01697592|469851881|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
130514737|NCT01697592|469851872|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
130514738|NCT01697592|469851873|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514739|NCT01697592|469851874|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514740|NCT01697592|469851875|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
130514741|NCT01697592|469851876|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514742|NCT01697592|469851877|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514743|NCT01697592|469851878|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514744|NCT01697592|469851879|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514745|NCT01697592|469851880|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514746|NCT01697592|469851881|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130514747|NCT01697592|469851872|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
130514748|NCT01697592|469851873|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514749|NCT01697592|469851874|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514750|NCT01697592|469851875|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514751|NCT01697592|469851876|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514752|NCT01697592|469851877|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
130514753|NCT01697592|469851878|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514754|NCT01697592|469851879|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
130514755|NCT01697592|469851880|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514756|NCT01697592|469851881|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
130514757|NCT01697592|469851872|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
130514758|NCT01697592|469851873|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
130514759|NCT01697592|469851874|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
130514760|NCT01697592|469851875|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
130514761|NCT01697592|469851876|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
130514762|NCT01697592|469851877|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
130514763|NCT01697592|469851878|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
130514764|NCT01697592|469851879|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
130514765|NCT01697592|469851880|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
130514766|NCT01697592|469851881|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
130514767|NCT01126879|469851882|FG000|Overall Study|Progressive Disease|3|||
130514768|NCT01126879|469851883|FG001|Overall Study|Progressive Disease|1|||
130514769|NCT01126879|469851882|FG000|Overall Study|Withdrawal by Subject|1|||
130514770|NCT01126879|469851883|FG001|Overall Study|Withdrawal by Subject|0|||
130514771|NCT01126879|469851882|FG000|Overall Study|Adverse Event|0|||
130514772|NCT01126879|469851883|FG001|Overall Study|Adverse Event|1|||
130514773|NCT01126879|469851882|FG000|Overall Study|Physician Decision|1|||
130514774|NCT01126879|469851883|FG001|Overall Study|Physician Decision|0|||
130514775|NCT00498433|469851884|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
130514776|NCT00498433|469851885|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
130514777|NCT00498433|469851886|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
130514778|NCT00498433|469851884|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
130514779|NCT00498433|469851885|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
130514780|NCT00498433|469851886|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
130514781|NCT00498433|469851884|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
130514782|NCT00498433|469851885|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
130514783|NCT00498433|469851886|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
130514784|NCT00498433|469851884|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
130514785|NCT00498433|469851885|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
130570820|NCT03077685|470054004|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
130570821|NCT03077685|470054005|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
130570822|NCT03077685|470054006|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
130570823|NCT03077685|470054007|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
130570824|NCT03077685|470054008|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
130514786|NCT00498433|469851886|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
130514787|NCT03193216|469851890|FG000|Overall Study|Lost to Follow-up|1|||
130514788|NCT03193216|469851891|FG001|Overall Study|Lost to Follow-up|0|||
130514789|NCT03193216|469851890|FG000|Overall Study|Withdrawal by Subject|5|||
130514790|NCT03193216|469851891|FG001|Overall Study|Withdrawal by Subject|0|||
130514791|NCT03193216|469851890|FG000|Overall Study|Physician Decision|4|||
130514792|NCT03193216|469851891|FG001|Overall Study|Physician Decision|0|||
130514793|NCT01514864|469851892|FG000|Overall Study|Disease progression|7|||
130514794|NCT01514864|469851893|FG001|Overall Study|Disease progression|5|||
130514795|NCT01514864|469851892|FG000|Overall Study|Study drug toxicity|2|||
130514796|NCT01514864|469851893|FG001|Overall Study|Study drug toxicity|0|||
130514797|NCT02253147|469851895|FG000|Overall Study|Protocol Violation|30|||
130514798|NCT02253147|469851895|FG000|Overall Study|Did not consent to study extension|9|||
130514799|NCT02253147|469851895|FG000|Overall Study|Conditional re-treatment at W52|5|||
130514800|NCT02253147|469851895|FG000|Overall Study|Lost to Follow-up|2|||
130514801|NCT02253147|469851895|FG000|Overall Study|Withdrawal by Subject|1|||
130514802|NCT02254681|469851896|FG000|Overall Study|Lack of Efficacy|6|||
130514803|NCT02316847|469851897|FG000|Overall Study|Adverse Event|0|||
130514804|NCT02316847|469851898|FG001|Overall Study|Adverse Event|3|||
130514805|NCT02316847|469851897|FG000|Overall Study|Lost to Follow-up|0|||
130514806|NCT02316847|469851898|FG001|Overall Study|Lost to Follow-up|2|||
130514807|NCT02316847|469851897|FG000|Overall Study|Physician Decision|0|||
130514808|NCT02316847|469851898|FG001|Overall Study|Physician Decision|1|||
130514809|NCT02316847|469851897|FG000|Overall Study|Pregnancy|0|||
130514810|NCT02316847|469851898|FG001|Overall Study|Pregnancy|1|||
130514811|NCT02316847|469851897|FG000|Overall Study|Withdrawal by Subject|2|||
130514812|NCT02316847|469851898|FG001|Overall Study|Withdrawal by Subject|9|||
130514813|NCT02316847|469851897|FG000|Overall Study|Noncompliance with study drug|0|||
130514814|NCT02316847|469851898|FG001|Overall Study|Noncompliance with study drug|3|||
130514815|NCT02316847|469851897|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
130514816|NCT02316847|469851898|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
130514817|NCT02621047|469851899|FG000|Overall Study|Adverse Event|0|||
130514818|NCT02621047|469851900|FG001|Overall Study|Adverse Event|0|||
130514819|NCT02621047|469851901|FG002|Overall Study|Adverse Event|1|||
130514820|NCT02236598|469851907|FG000|Overall Study|Adverse Event|0|||
130514821|NCT02236598|469851908|FG001|Overall Study|Adverse Event|1|||
130514822|NCT02236598|469851907|FG000|Overall Study|Withdrawal by Subject|0|||
130514823|NCT02236598|469851908|FG001|Overall Study|Withdrawal by Subject|1|||
130514824|NCT01264887|469851910|FG000|Overall Study|Adverse Event|5|||
130514825|NCT01264887|469851910|FG000|Overall Study|Death|7|||
130514826|NCT01264887|469851910|FG000|Overall Study|Lack of Efficacy|5|||
130514827|NCT01264887|469851910|FG000|Overall Study|Physician Decision|4|||
130514828|NCT01264887|469851910|FG000|Overall Study|Withdrawal by Subject|6|||
130570825|NCT03077685|470054004|FG000|Overall Study|Subject entered hospice care|0|||
130514829|NCT01264887|469851910|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
130570826|NCT03077685|470054005|FG001|Overall Study|Subject entered hospice care|0|||
130570827|NCT03077685|470054006|FG002|Overall Study|Subject entered hospice care|0|||
130570828|NCT03077685|470054007|FG003|Overall Study|Subject entered hospice care|0|||
130570829|NCT03077685|470054008|FG004|Overall Study|Subject entered hospice care|1|||
130570830|NCT01979536|470054009|FG000|Overall Study|Physician Decision|2|||
130570831|NCT01979536|470054010|FG001|Overall Study|Physician Decision|3|||
130570832|NCT01979536|470054009|FG000|Overall Study|Withdrawal by Subject|0|||
130570833|NCT01979536|470054010|FG001|Overall Study|Withdrawal by Subject|1|||
130570834|NCT01979536|470054009|FG000|Overall Study|Refusal|0|||
130570835|NCT01979536|470054010|FG001|Overall Study|Refusal|1|||
130570836|NCT01979536|470054009|FG000|Overall Study|Relapse|0|||
130570837|NCT01979536|470054010|FG001|Overall Study|Relapse|1|||
130570838|NCT01979536|470054009|FG000|Overall Study|Study terminated by Sponsor|0|||
130570839|NCT01979536|470054010|FG001|Overall Study|Study terminated by Sponsor|1|||
130514830|NCT01264887|469851910|FG000|Overall Study|Other|2|||
130514831|NCT02171130|469851911|FG000|Overall Study|Death|1|||
130514832|NCT02171130|469851911|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
130514833|NCT02171130|469851911|FG000|Overall Study|Discontinued; Site Termination|5|||
130514834|NCT02171130|469851911|FG000|Overall Study|Withdrawal by Subject|3|||
130514835|NCT02171130|469851911|FG000|Overall Study|Physician Decision|1|||
130514836|NCT02171130|469851911|FG000|Overall Study|Lost to Follow-up|1|||
130514837|NCT02171130|469851911|FG000|Overall Study|Met Exclusion Criteria|1|||
130514838|NCT03544229|469851912|FG000|Overall Study|Adverse Event|1|||
130514839|NCT03544229|469851913|FG001|Overall Study|Adverse Event|0|||
130514840|NCT03544229|469851914|FG002|Overall Study|Adverse Event|1|||
130514841|NCT03544229|469851915|FG003|Overall Study|Adverse Event|0|||
130570840|NCT01979536|470054009|FG000|Overall Study|Did not start treatment|0|||
130570841|NCT01979536|470054010|FG001|Overall Study|Did not start treatment|1|||
130570842|NCT04649255|470055639|FG000|Overall Study|Death|9|||
130570843|NCT04649255|470055639|FG000|Overall Study|Withdrawal by Subject|1|||
130570844|NCT04129528|470055640|FG000|Overall Study|Adverse Event|1|||
130570845|NCT04129528|470055641|FG001|Overall Study|Adverse Event|0|||
130570846|NCT04129528|470055640|FG000|Overall Study|Physician Decision|1|||
130570847|NCT04129528|470055641|FG001|Overall Study|Physician Decision|1|||
130570848|NCT04129528|470055640|FG000|Overall Study|Withdrawal by Subject|1|||
130570849|NCT04129528|470055641|FG001|Overall Study|Withdrawal by Subject|1|||
130570850|NCT01964352|470055642|FG000|Overall Study|Adverse Event|13|||
130570851|NCT01964352|470055643|FG001|Overall Study|Adverse Event|3|||
130570852|NCT01964352|470055644|FG002|Overall Study|Adverse Event|4|||
130570853|NCT01964352|470055645|FG003|Overall Study|Adverse Event|3|||
130570854|NCT01964352|470055642|FG000|Overall Study|Lack of Efficacy|6|||
130570855|NCT01964352|470055643|FG001|Overall Study|Lack of Efficacy|0|||
130570856|NCT01964352|470055644|FG002|Overall Study|Lack of Efficacy|0|||
130570857|NCT01964352|470055645|FG003|Overall Study|Lack of Efficacy|0|||
130570858|NCT01964352|470055642|FG000|Overall Study|Protocol Violation|2|||
130570859|NCT01964352|470055643|FG001|Overall Study|Protocol Violation|4|||
130570860|NCT01964352|470055644|FG002|Overall Study|Protocol Violation|0|||
130570861|NCT01964352|470055645|FG003|Overall Study|Protocol Violation|2|||
130570862|NCT01964352|470055642|FG000|Overall Study|Lost to Follow-up|1|||
130570863|NCT01964352|470055643|FG001|Overall Study|Lost to Follow-up|0|||
130570864|NCT01964352|470055644|FG002|Overall Study|Lost to Follow-up|0|||
130570865|NCT01964352|470055645|FG003|Overall Study|Lost to Follow-up|1|||
130570866|NCT01964352|470055642|FG000|Overall Study|Withdrawal by Subject|4|||
130570867|NCT01964352|470055643|FG001|Overall Study|Withdrawal by Subject|2|||
130570868|NCT01964352|470055644|FG002|Overall Study|Withdrawal by Subject|1|||
130570869|NCT01964352|470055645|FG003|Overall Study|Withdrawal by Subject|0|||
130570870|NCT01964352|470055642|FG000|Overall Study|Other than stated above|0|||
130570871|NCT01964352|470055643|FG001|Overall Study|Other than stated above|2|||
130570872|NCT01964352|470055644|FG002|Overall Study|Other than stated above|1|||
130570873|NCT01964352|470055645|FG003|Overall Study|Other than stated above|2|||
130570874|NCT01908101|470055646|FG000|Overall Study|Physician Decision|1|||
130570875|NCT01908101|470055646|FG000|Overall Study|Withdrawal by Subject|1|||
130570876|NCT01908101|470055646|FG000|Overall Study|Incorrect Diagnosis|2|||
130570877|NCT01908101|470055646|FG000|Overall Study|Incorrect Starting Dose|1|||
130514842|NCT03544229|469851912|FG000|Overall Study|Protocol Deviation|0|||
130514843|NCT03544229|469851913|FG001|Overall Study|Protocol Deviation|0|||
130514844|NCT03544229|469851914|FG002|Overall Study|Protocol Deviation|1|||
130514845|NCT03544229|469851915|FG003|Overall Study|Protocol Deviation|0|||
130514846|NCT03544229|469851912|FG000|Overall Study|Lost to Follow-up|3|||
130514847|NCT03544229|469851913|FG001|Overall Study|Lost to Follow-up|0|||
130514848|NCT03544229|469851914|FG002|Overall Study|Lost to Follow-up|0|||
130514849|NCT03544229|469851915|FG003|Overall Study|Lost to Follow-up|2|||
130514850|NCT03544229|469851912|FG000|Overall Study|Voluntary Withdrawal|2|||
130570878|NCT01908101|470055646|FG000|Overall Study|Did not complete the first cycle|4|||
130570879|NCT00477165|470055650|FG000|Overall Study|Adverse Event|7|||
130570880|NCT00477165|470055651|FG001|Overall Study|Adverse Event|2|||
130570881|NCT00105443|470055653|FG000|Double-Blind Treatment|Adverse Event|1|||
130570882|NCT00105443|470055654|FG001|Double-Blind Treatment|Adverse Event|0|||
130570883|NCT00105443|470055655|FG002|Double-Blind Treatment|Adverse Event|0|||
130570884|NCT00105443|470055656|FG003|Double-Blind Treatment|Adverse Event|0|||
130570885|NCT00105443|470055653|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
130570886|NCT00105443|470055654|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
130570887|NCT00105443|470055655|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
130570888|NCT00105443|470055656|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
130570889|NCT00105443|470055653|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
130570890|NCT00105443|470055654|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
130570891|NCT00105443|470055655|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
130570892|NCT00105443|470055656|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
130570893|NCT00105443|470055653|FG000|Double-Blind Treatment|Physician Decision|1|||
130570894|NCT00105443|470055654|FG001|Double-Blind Treatment|Physician Decision|0|||
130570895|NCT00105443|470055655|FG002|Double-Blind Treatment|Physician Decision|2|||
130570896|NCT00105443|470055656|FG003|Double-Blind Treatment|Physician Decision|0|||
130570897|NCT00105443|470055653|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
130570898|NCT00105443|470055654|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
130570899|NCT00105443|470055655|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
130570900|NCT00105443|470055656|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
130570901|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
130570902|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
130570903|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
130570904|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
130514851|NCT03544229|469851913|FG001|Overall Study|Voluntary Withdrawal|1|||
130514852|NCT03544229|469851914|FG002|Overall Study|Voluntary Withdrawal|3|||
130514853|NCT03544229|469851915|FG003|Overall Study|Voluntary Withdrawal|0|||
130514854|NCT03544229|469851912|FG000|Overall Study|Lack of Efficacy|0|||
130514855|NCT03544229|469851913|FG001|Overall Study|Lack of Efficacy|1|||
130514856|NCT03544229|469851914|FG002|Overall Study|Lack of Efficacy|0|||
130514857|NCT03544229|469851915|FG003|Overall Study|Lack of Efficacy|0|||
130514858|NCT03187353|469851917|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
130514859|NCT03187353|469851918|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
130570905|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
130570906|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
130570907|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
130570908|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
130570909|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
130570910|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
130570911|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
130570912|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
130570913|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
130570914|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
130570915|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
130570916|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
130570917|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
130570918|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
130570919|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
130570920|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
130570921|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130570922|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
130570923|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130570924|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130570925|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
130570926|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
130570927|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
130570928|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
130570929|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
130570930|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
130570931|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
130570932|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
130570933|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
130570934|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
130570935|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
130570936|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
130570937|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130570938|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130570939|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
130570940|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130570941|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
130570942|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130570943|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130570944|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130570945|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130570946|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130570947|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130570948|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
130570949|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
130570950|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
130570951|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
130570952|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
130570953|NCT00105443|470055653|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
130570954|NCT00105443|470055654|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
130514860|NCT03187353|469851917|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
130514861|NCT03187353|469851918|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130514862|NCT03187353|469851917|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
130514863|NCT03187353|469851918|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
130514864|NCT03187353|469851917|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130514865|NCT03187353|469851918|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
130514866|NCT03187353|469851917|FG000|Washout (2 Weeks)|Adverse Event|2|||
130570955|NCT00105443|470055655|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
130570956|NCT00105443|470055656|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
130570957|NCT02135692|470055657|FG000|Overall Study|Adverse Event|3|||
130570958|NCT02135692|470055657|FG000|Overall Study|Lack of Efficacy|2|||
130570959|NCT02135692|470055657|FG000|Overall Study|Protocol Violation|2|||
130570960|NCT02135692|470055657|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
130570961|NCT02135692|470055657|FG000|Overall Study|Product commercially available|159|||
130570962|NCT02135692|470055657|FG000|Overall Study|Study closed/terminated|153|||
130570963|NCT02135692|470055657|FG000|Overall Study|Lost to Follow-up|4|||
130570964|NCT02135692|470055657|FG000|Overall Study|Withdrawal by Subject|15|||
130514867|NCT03187353|469851918|FG001|Washout (2 Weeks)|Adverse Event|0|||
130514868|NCT03187353|469851917|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
130514869|NCT03187353|469851918|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
130514870|NCT01061775|469851919|FG000|Overall Study|Physician Decision|2|||
130514871|NCT01061775|469851919|FG000|Overall Study|Lost to Follow-up|1|||
130514872|NCT03303521|469851920|FG000|Overall Study|Withdrawal by Subject|2|||
130514873|NCT03303521|469851921|FG001|Overall Study|Withdrawal by Subject|0|||
130514874|NCT03303521|469851920|FG000|Overall Study|Death|1|||
130514875|NCT03303521|469851921|FG001|Overall Study|Death|0|||
130514876|NCT03303521|469851920|FG000|Overall Study|Kidney transplantation|0|||
130514877|NCT03303521|469851921|FG001|Overall Study|Kidney transplantation|1|||
130514878|NCT03303521|469851920|FG000|Overall Study|Investigational product discontinuation|0|||
130514879|NCT03303521|469851921|FG001|Overall Study|Investigational product discontinuation|1|||
130514880|NCT03303521|469851920|FG000|Overall Study|Transferred to non-study dialysis center|1|||
130514881|NCT03303521|469851921|FG001|Overall Study|Transferred to non-study dialysis center|0|||
130514882|NCT03303521|469851920|FG000|Overall Study|Non-comliance to study protocol|0|||
130514883|NCT03303521|469851921|FG001|Overall Study|Non-comliance to study protocol|1|||
130514884|NCT03303521|469851920|FG000|Overall Study|Adverse Event|1|||
130514885|NCT03303521|469851921|FG001|Overall Study|Adverse Event|0|||
130514886|NCT02642159|469851922|FG000|Overall Study|Randomized but not treated|1|||
130514887|NCT02642159|469851923|FG001|Overall Study|Randomized but not treated|0|||
130514888|NCT02642159|469851922|FG000|Overall Study|Adverse Event|10|||
130514889|NCT02642159|469851923|FG001|Overall Study|Adverse Event|4|||
130514890|NCT02642159|469851922|FG000|Overall Study|Withdrawal by Subject|9|||
130514891|NCT02642159|469851923|FG001|Overall Study|Withdrawal by Subject|1|||
130514892|NCT02642159|469851922|FG000|Overall Study|Poor compliance to study protocol|1|||
130514893|NCT02642159|469851923|FG001|Overall Study|Poor compliance to study protocol|0|||
130514894|NCT02642159|469851922|FG000|Overall Study|Other than specified above|10|||
130514895|NCT02642159|469851923|FG001|Overall Study|Other than specified above|3|||
130514896|NCT02205476|469851924|FG000|Overall Study|Study termination by Sponsor|7|||
130514897|NCT02205476|469851925|FG001|Overall Study|Study termination by Sponsor|3|||
130514898|NCT01313299|469851926|FG000|Overall Study|Adverse Event|3|||
130514899|NCT01313299|469851927|FG001|Overall Study|Adverse Event|1|||
130514900|NCT01313299|469851928|FG002|Overall Study|Adverse Event|1|||
130514901|NCT01313299|469851926|FG000|Overall Study|Lost to Follow-up|1|||
130514902|NCT01313299|469851927|FG001|Overall Study|Lost to Follow-up|0|||
130514903|NCT01313299|469851928|FG002|Overall Study|Lost to Follow-up|0|||
130514904|NCT01313299|469851926|FG000|Overall Study|Protocol Violation|2|||
130514905|NCT01313299|469851927|FG001|Overall Study|Protocol Violation|0|||
130514906|NCT01313299|469851928|FG002|Overall Study|Protocol Violation|0|||
130514907|NCT01313299|469851926|FG000|Overall Study|Withdrawal by Subject|1|||
130514908|NCT01313299|469851927|FG001|Overall Study|Withdrawal by Subject|0|||
130514909|NCT01313299|469851928|FG002|Overall Study|Withdrawal by Subject|2|||
130514910|NCT01313299|469851926|FG000|Overall Study|Family reason and moved out of state|0|||
130514911|NCT01313299|469851927|FG001|Overall Study|Family reason and moved out of state|2|||
130514912|NCT01313299|469851928|FG002|Overall Study|Family reason and moved out of state|0|||
130514913|NCT01313299|469851926|FG000|Overall Study|Lack of subject compliance|0|||
130514914|NCT01313299|469851927|FG001|Overall Study|Lack of subject compliance|0|||
130514915|NCT01313299|469851928|FG002|Overall Study|Lack of subject compliance|1|||
130514916|NCT02391545|469851929|FG000|Overall Study|Death|0|||
130514917|NCT02391545|469851930|FG001|Overall Study|Death|2|||
130514918|NCT02391545|469851929|FG000|Overall Study|Lost to Follow-up|0|||
130514919|NCT02391545|469851930|FG001|Overall Study|Lost to Follow-up|1|||
130514920|NCT02391545|469851929|FG000|Overall Study|Termination of study by sponsor|20|||
130514921|NCT02391545|469851930|FG001|Overall Study|Termination of study by sponsor|20|||
130514922|NCT02391545|469851929|FG000|Overall Study|Withdrawal by Subject|0|||
130514923|NCT02391545|469851930|FG001|Overall Study|Withdrawal by Subject|1|||
130570965|NCT01157078|470055658|FG000|Overall Study|Withdrawal by Subject|12|||
130514924|NCT02391545|469851929|FG000|Overall Study|Other Reasons|6|||
130514925|NCT02391545|469851930|FG001|Overall Study|Other Reasons|4|||
130514926|NCT04754594|469851931|FG000|Blinded Period|Withdrawal by Subject|4|||
130570966|NCT01157078|470055659|FG001|Overall Study|Withdrawal by Subject|14|||
130514927|NCT04754594|469851932|FG001|Blinded Period|Withdrawal by Subject|9|||
130514928|NCT04754594|469851933|FG002|Blinded Period|Withdrawal by Subject|0|||
130570967|NCT01157078|470055658|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130570968|NCT01157078|470055659|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130570969|NCT01157078|470055658|FG000|Overall Study|Adverse Event|6|||
130570970|NCT01157078|470055659|FG001|Overall Study|Adverse Event|6|||
130570971|NCT01157078|470055658|FG000|Overall Study|Severe non-compliance to protocol|2|||
130570972|NCT01157078|470055659|FG001|Overall Study|Severe non-compliance to protocol|4|||
130570973|NCT01157078|470055658|FG000|Overall Study|Condition under investigation worsened|0|||
130570974|NCT01157078|470055659|FG001|Overall Study|Condition under investigation worsened|1|||
130570975|NCT01157078|470055658|FG000|Overall Study|Lack of Efficacy|2|||
130570976|NCT01157078|470055659|FG001|Overall Study|Lack of Efficacy|0|||
130570977|NCT01157078|470055658|FG000|Overall Study|Study-specific withdrawal criteria|2|||
130570978|NCT01157078|470055659|FG001|Overall Study|Study-specific withdrawal criteria|2|||
130570979|NCT01157078|470055658|FG000|Overall Study|Lost to Follow-up|7|||
130570980|NCT01157078|470055659|FG001|Overall Study|Lost to Follow-up|5|||
130570981|NCT01157078|470055658|FG000|Overall Study|Other|2|||
130570982|NCT01157078|470055659|FG001|Overall Study|Other|4|||
130570983|NCT04682405|470055660|FG000|Overall Study|Adverse Event|0|||
130570984|NCT04682405|470055661|FG001|Overall Study|Adverse Event|1|||
130570985|NCT04429061|470055664|FG000|Overall Study|Lost to Follow-up|62|||
130570986|NCT04429061|470055665|FG001|Overall Study|Lost to Follow-up|87|||
130570987|NCT04429061|470055664|FG000|Overall Study|Withdrawal by Subject|3|||
130570988|NCT04429061|470055665|FG001|Overall Study|Withdrawal by Subject|4|||
130570989|NCT00879229|470055672|FG000|Overall Study|Study terminated by Sponsor|13|||
130570990|NCT00879229|470055673|FG001|Overall Study|Study terminated by Sponsor|12|||
130570991|NCT00879229|470055672|FG000|Overall Study|Death|4|||
130570992|NCT00879229|470055673|FG001|Overall Study|Death|2|||
130570993|NCT00879229|470055672|FG000|Overall Study|Adverse Event|2|||
130570994|NCT00879229|470055673|FG001|Overall Study|Adverse Event|0|||
130570995|NCT00879229|470055672|FG000|Overall Study|Withdrawal by Subject|1|||
130570996|NCT00879229|470055673|FG001|Overall Study|Withdrawal by Subject|0|||
130570997|NCT00879229|470055672|FG000|Overall Study|Clinical status did not improve|1|||
130570998|NCT00879229|470055673|FG001|Overall Study|Clinical status did not improve|0|||
130570999|NCT00879229|470055672|FG000|Overall Study|Other|1|||
130571000|NCT00879229|470055673|FG001|Overall Study|Other|0|||
130571001|NCT01097746|470055674|FG000|Overall Study|Adverse Event|4|||
130571002|NCT01097746|470055674|FG000|Overall Study|taken off study before any treatment given|1|||
130571003|NCT00631371|470055681|FG000|Overall Study|Lost to Follow-up|24|||
130571004|NCT00631371|470055682|FG001|Overall Study|Lost to Follow-up|19|||
130571005|NCT00631371|470055681|FG000|Overall Study|Other reason|5|||
130571006|NCT00631371|470055682|FG001|Overall Study|Other reason|12|||
130571007|NCT00631371|470055681|FG000|Overall Study|subject request|38|||
130571008|NCT00631371|470055682|FG001|Overall Study|subject request|45|||
130571009|NCT00631371|470055681|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
130571010|NCT00631371|470055682|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
130571011|NCT00631371|470055681|FG000|Overall Study|Death|263|||
130571012|NCT00631371|470055682|FG001|Overall Study|Death|239|||
130571013|NCT02095535|470055683|FG000|Recruitment|Protocol Violation|2|||
130571014|NCT00623480|470055684|FG000|Overall Study|Lost to Follow-up|0|||
130514929|NCT04754594|469851934|FG003|Blinded Period|Withdrawal by Subject|0|||
130514930|NCT04754594|469851931|FG000|Blinded Period|Protocol Violation|2|||
130514931|NCT04754594|469851932|FG001|Blinded Period|Protocol Violation|2|||
130514932|NCT04754594|469851933|FG002|Blinded Period|Protocol Violation|0|||
130514933|NCT04754594|469851934|FG003|Blinded Period|Protocol Violation|0|||
130514934|NCT04754594|469851931|FG000|Blinded Period|Lost to Follow-up|1|||
130514935|NCT04754594|469851932|FG001|Blinded Period|Lost to Follow-up|1|||
130514936|NCT04754594|469851933|FG002|Blinded Period|Lost to Follow-up|0|||
130514937|NCT04754594|469851934|FG003|Blinded Period|Lost to Follow-up|0|||
130514938|NCT04754594|469851931|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
130514939|NCT04754594|469851932|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
130514940|NCT04754594|469851933|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
130514941|NCT04754594|469851934|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
130514942|NCT04754594|469851931|FG000|Unblinded Period|Withdrawal by Subject|6|||
130514943|NCT04754594|469851932|FG001|Unblinded Period|Withdrawal by Subject|8|||
130514944|NCT04754594|469851933|FG002|Unblinded Period|Withdrawal by Subject|0|||
130514945|NCT04754594|469851934|FG003|Unblinded Period|Withdrawal by Subject|0|||
130514946|NCT04754594|469851931|FG000|Unblinded Period|Lost to Follow-up|5|||
130571015|NCT00623480|470055685|FG001|Overall Study|Lost to Follow-up|1|||
130571016|NCT00623480|470055684|FG000|Overall Study|Withdrawal by Subject|2|||
130571017|NCT00623480|470055685|FG001|Overall Study|Withdrawal by Subject|4|||
130571018|NCT00623480|470055684|FG000|Overall Study|Lack of Efficacy|1|||
130571019|NCT00623480|470055685|FG001|Overall Study|Lack of Efficacy|0|||
130571020|NCT00623480|470055684|FG000|Overall Study|Non-compliant with study medication|4|||
130571021|NCT00623480|470055685|FG001|Overall Study|Non-compliant with study medication|0|||
130571022|NCT00623480|470055684|FG000|Overall Study|Protocol Violation|0|||
130571023|NCT00623480|470055685|FG001|Overall Study|Protocol Violation|1|||
130571024|NCT00623480|470055684|FG000|Overall Study|Site closed by sponsor|0|||
130571025|NCT00623480|470055685|FG001|Overall Study|Site closed by sponsor|1|||
130571026|NCT03709654|470055686|FG000|Overall Study|Lost to Follow-up|1|||
130514947|NCT04754594|469851932|FG001|Unblinded Period|Lost to Follow-up|3|||
130514948|NCT04754594|469851933|FG002|Unblinded Period|Lost to Follow-up|0|||
130514949|NCT04754594|469851934|FG003|Unblinded Period|Lost to Follow-up|0|||
130514950|NCT04754594|469851931|FG000|Unblinded Period|Protocol Violation|2|||
130514951|NCT04754594|469851932|FG001|Unblinded Period|Protocol Violation|4|||
130514952|NCT04754594|469851933|FG002|Unblinded Period|Protocol Violation|0|||
130514953|NCT04754594|469851934|FG003|Unblinded Period|Protocol Violation|0|||
130514954|NCT04754594|469851931|FG000|Unblinded Period|Other|3|||
130514955|NCT04754594|469851932|FG001|Unblinded Period|Other|0|||
130514956|NCT04754594|469851933|FG002|Unblinded Period|Other|0|||
130514957|NCT04754594|469851934|FG003|Unblinded Period|Other|0|||
130514958|NCT04754594|469851931|FG000|Infant Participants|Withdrawal by Subject|0|||
130514959|NCT04754594|469851932|FG001|Infant Participants|Withdrawal by Subject|0|||
130514960|NCT04754594|469851933|FG002|Infant Participants|Withdrawal by Subject|9|||
130514961|NCT04754594|469851934|FG003|Infant Participants|Withdrawal by Subject|17|||
130514962|NCT04754594|469851931|FG000|Infant Participants|Lost to Follow-up|0|||
130514963|NCT04754594|469851932|FG001|Infant Participants|Lost to Follow-up|0|||
130514964|NCT04754594|469851933|FG002|Infant Participants|Lost to Follow-up|4|||
130514965|NCT04754594|469851934|FG003|Infant Participants|Lost to Follow-up|10|||
130514966|NCT04754594|469851931|FG000|Infant Participants|Death|0|||
130514967|NCT04754594|469851932|FG001|Infant Participants|Death|0|||
130514968|NCT04754594|469851933|FG002|Infant Participants|Death|1|||
130514969|NCT04754594|469851934|FG003|Infant Participants|Death|1|||
130514970|NCT04754594|469851931|FG000|Infant Participants|Other|0|||
130514971|NCT04754594|469851932|FG001|Infant Participants|Other|0|||
130514972|NCT04754594|469851933|FG002|Infant Participants|Other|1|||
130514973|NCT04754594|469851934|FG003|Infant Participants|Other|1|||
130514974|NCT03340766|469851937|FG000|Overall Study|Withdrawal by Subject|2|||
130514975|NCT03340766|469851938|FG001|Overall Study|Withdrawal by Subject|1|||
130514976|NCT03340766|469851939|FG002|Overall Study|Withdrawal by Subject|3|||
130514977|NCT03340766|469851937|FG000|Overall Study|Lost to Follow-up|0|||
130514978|NCT03340766|469851938|FG001|Overall Study|Lost to Follow-up|0|||
130514979|NCT03340766|469851939|FG002|Overall Study|Lost to Follow-up|1|||
130514980|NCT03340766|469851937|FG000|Overall Study|Death|6|||
130514981|NCT03340766|469851938|FG001|Overall Study|Death|7|||
130514982|NCT03340766|469851939|FG002|Overall Study|Death|4|||
130514983|NCT00975130|469851945|FG000|Study Part 1|Adverse Event|150|||
130514984|NCT00975130|469851946|FG001|Study Part 1|Adverse Event|0|||
130514985|NCT00975130|469851947|FG002|Study Part 1|Adverse Event|0|||
130514986|NCT00975130|469851945|FG000|Study Part 1|Lost to Follow-up|19|||
130514987|NCT00975130|469851946|FG001|Study Part 1|Lost to Follow-up|0|||
130514988|NCT00975130|469851947|FG002|Study Part 1|Lost to Follow-up|0|||
130514989|NCT00975130|469851945|FG000|Study Part 1|Withdrawal by Subject|61|||
130514990|NCT00975130|469851946|FG001|Study Part 1|Withdrawal by Subject|0|||
130514991|NCT00975130|469851947|FG002|Study Part 1|Withdrawal by Subject|0|||
130514992|NCT00975130|469851945|FG000|Study Part 1|Protocol Violation|13|||
130514993|NCT00975130|469851946|FG001|Study Part 1|Protocol Violation|0|||
130514994|NCT00975130|469851947|FG002|Study Part 1|Protocol Violation|0|||
130514995|NCT00975130|469851945|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
130514996|NCT00975130|469851946|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
130514997|NCT00975130|469851947|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
130514998|NCT00975130|469851945|FG000|Study Part 1|Administrative|4|||
130514999|NCT00975130|469851946|FG001|Study Part 1|Administrative|0|||
130515000|NCT00975130|469851947|FG002|Study Part 1|Administrative|0|||
130515001|NCT00975130|469851945|FG000|Study Part 1|Withdrew Consent|24|||
130515002|NCT00975130|469851946|FG001|Study Part 1|Withdrew Consent|0|||
130515003|NCT00975130|469851947|FG002|Study Part 1|Withdrew Consent|0|||
130515004|NCT00975130|469851945|FG000|Study Part 2|Adverse Event|0|||
130515005|NCT00975130|469851946|FG001|Study Part 2|Adverse Event|14|||
130515006|NCT00975130|469851947|FG002|Study Part 2|Adverse Event|7|||
130515007|NCT00975130|469851945|FG000|Study Part 2|Lost to Follow-up|0|||
130515008|NCT00975130|469851946|FG001|Study Part 2|Lost to Follow-up|0|||
130515009|NCT00975130|469851947|FG002|Study Part 2|Lost to Follow-up|1|||
130515010|NCT00975130|469851945|FG000|Study Part 2|Withdrawal by Subject|0|||
130515011|NCT00975130|469851946|FG001|Study Part 2|Withdrawal by Subject|13|||
130515012|NCT00975130|469851947|FG002|Study Part 2|Withdrawal by Subject|5|||
130515013|NCT00975130|469851945|FG000|Study Part 2|Withdrew Consent|0|||
130515014|NCT00975130|469851946|FG001|Study Part 2|Withdrew Consent|6|||
130515015|NCT00975130|469851947|FG002|Study Part 2|Withdrew Consent|2|||
130515016|NCT00975130|469851945|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
130515017|NCT00975130|469851946|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
130515018|NCT00975130|469851947|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
130515019|NCT00975130|469851945|FG000|Study Part 2|Administrative|0|||
130515020|NCT00975130|469851946|FG001|Study Part 2|Administrative|1|||
130515021|NCT00975130|469851947|FG002|Study Part 2|Administrative|0|||
130515022|NCT00975130|469851945|FG000|Study Part 2|Protocol Violation|0|||
130515023|NCT00975130|469851946|FG001|Study Part 2|Protocol Violation|0|||
130515024|NCT00975130|469851947|FG002|Study Part 2|Protocol Violation|1|||
130515025|NCT00734851|469851948|FG000|Overall Study|Withdrawal by Subject|2|||
130515026|NCT00734851|469851948|FG000|Overall Study|Lost to Follow-up|1|||
130515027|NCT00734851|469851948|FG000|Overall Study|Physician Decision|18|||
130515028|NCT01332318|469851954|FG000|Overall Study|Adverse Event|0|||
130515029|NCT01332318|469851955|FG001|Overall Study|Adverse Event|3|||
130515030|NCT01332318|469851956|FG002|Overall Study|Adverse Event|0|||
130515031|NCT01332318|469851957|FG003|Overall Study|Adverse Event|0|||
130515032|NCT01332318|469851954|FG000|Overall Study|Withdrawal by Subject|1|||
130515033|NCT01332318|469851955|FG001|Overall Study|Withdrawal by Subject|1|||
130515034|NCT01332318|469851956|FG002|Overall Study|Withdrawal by Subject|0|||
130515035|NCT01332318|469851957|FG003|Overall Study|Withdrawal by Subject|1|||
130515036|NCT01332318|469851954|FG000|Overall Study|Protocol Violation|1|||
130515037|NCT01332318|469851955|FG001|Overall Study|Protocol Violation|0|||
130515038|NCT01332318|469851956|FG002|Overall Study|Protocol Violation|1|||
130515039|NCT01332318|469851957|FG003|Overall Study|Protocol Violation|1|||
130515040|NCT02820298|469851958|FG000|Overall Study|Withdrawal by Subject|0|||
130515041|NCT02820298|469851959|FG001|Overall Study|Withdrawal by Subject|1|||
130515042|NCT02820298|469851958|FG000|Overall Study|Physician Decision|1|||
130515043|NCT02820298|469851959|FG001|Overall Study|Physician Decision|0|||
130515044|NCT02820298|469851958|FG000|Overall Study|Protocol Violation|0|||
130515045|NCT02820298|469851959|FG001|Overall Study|Protocol Violation|1|||
130515046|NCT01780584|469851960|FG000|Overall Study|Death|1|||
130515047|NCT01780584|469851961|FG001|Overall Study|Death|0|||
130515048|NCT01780584|469851962|FG002|Overall Study|Death|1|||
130515049|NCT01780584|469851960|FG000|Overall Study|Adverse Event|0|||
130515050|NCT01780584|469851961|FG001|Overall Study|Adverse Event|1|||
130515051|NCT01780584|469851962|FG002|Overall Study|Adverse Event|0|||
130515052|NCT01780584|469851960|FG000|Overall Study|Protocol Violation|0|||
130515053|NCT01780584|469851961|FG001|Overall Study|Protocol Violation|0|||
130515054|NCT01780584|469851962|FG002|Overall Study|Protocol Violation|1|||
130515055|NCT00727259|469851963|FG000|Overall Study|Not all questionnaires completed|1055|||
130515056|NCT01021683|469851964|FG000|Overall Study|Lack of Efficacy|12|||
130515057|NCT01021683|469851964|FG000|Overall Study|Recovery of neutrophil count|51|||
130515058|NCT01021683|469851964|FG000|Overall Study|Other|8|||
130515059|NCT03406507|469851965|FG000|Extension Period|Lack of Efficacy|0|||
130515060|NCT03406507|469851966|FG001|Extension Period|Lack of Efficacy|1|||
130515061|NCT00663923|469851967|FG000|Overall Study|Lost to Follow-up|2|||
130515062|NCT00547300|469851968|FG000|Overall Study|Study was Administratively Terminated|25|||
130515063|NCT00547300|469851969|FG001|Overall Study|Study was Administratively Terminated|24|||
130515064|NCT00547300|469851968|FG000|Overall Study|Did not Meet Entry Criteria|0|||
130515065|NCT00547300|469851969|FG001|Overall Study|Did not Meet Entry Criteria|2|||
130515066|NCT04380688|469851970|FG000|Overall Study|Death|2|||
130515067|NCT04380688|469851971|FG001|Overall Study|Death|2|||
130515068|NCT04380688|469851970|FG000|Overall Study|Lost to Follow-up|2|||
130515069|NCT04380688|469851971|FG001|Overall Study|Lost to Follow-up|4|||
130515070|NCT04380688|469851970|FG000|Overall Study|Withdrawal by Subject|3|||
130515071|NCT04380688|469851971|FG001|Overall Study|Withdrawal by Subject|3|||
130515072|NCT01967719|469853801|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
130515073|NCT01967719|469853802|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
130515074|NCT01967719|469853803|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130515075|NCT01967719|469853804|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
130515076|NCT01967719|469853801|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
130515077|NCT01967719|469853802|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
130515078|NCT01967719|469853803|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
130515079|NCT01967719|469853804|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
130515080|NCT00796614|469853805|FG000|Overall Study|Adverse Event|1|||
130515081|NCT00796614|469853806|FG001|Overall Study|Adverse Event|2|||
130515082|NCT00796614|469853807|FG002|Overall Study|Adverse Event|0|||
130515083|NCT00796614|469853808|FG003|Overall Study|Adverse Event|0|||
130515084|NCT00796614|469853805|FG000|Overall Study|Protocol Violation|0|||
130515085|NCT00796614|469853806|FG001|Overall Study|Protocol Violation|0|||
130515086|NCT00796614|469853807|FG002|Overall Study|Protocol Violation|2|||
130515087|NCT00796614|469853808|FG003|Overall Study|Protocol Violation|0|||
130515088|NCT00796614|469853805|FG000|Overall Study|Lost to Follow-up|2|||
130515089|NCT00796614|469853806|FG001|Overall Study|Lost to Follow-up|2|||
130515090|NCT00796614|469853807|FG002|Overall Study|Lost to Follow-up|1|||
130515091|NCT00796614|469853808|FG003|Overall Study|Lost to Follow-up|0|||
130515092|NCT00796614|469853805|FG000|Overall Study|Withdrawal by Subject|1|||
130515093|NCT00796614|469853806|FG001|Overall Study|Withdrawal by Subject|0|||
130515094|NCT00796614|469853807|FG002|Overall Study|Withdrawal by Subject|0|||
130571027|NCT03709654|470055687|FG001|Overall Study|Lost to Follow-up|1|||
130571028|NCT03709654|470055686|FG000|Overall Study|Withdrawal by Subject|1|||
130515095|NCT00796614|469853808|FG003|Overall Study|Withdrawal by Subject|1|||
130571029|NCT03709654|470055687|FG001|Overall Study|Withdrawal by Subject|1|||
130515096|NCT00796614|469853805|FG000|Overall Study|Other than stated|1|||
130515097|NCT00796614|469853806|FG001|Overall Study|Other than stated|0|||
130515098|NCT00796614|469853807|FG002|Overall Study|Other than stated|0|||
130515099|NCT00796614|469853808|FG003|Overall Study|Other than stated|0|||
130515100|NCT01231464|469853809|FG000|Overall Study|Adverse Event|0|||
130515101|NCT01231464|469853810|FG001|Overall Study|Adverse Event|1|||
130515102|NCT01231464|469853809|FG000|Overall Study|Protocol Violation|1|||
130515103|NCT01231464|469853810|FG001|Overall Study|Protocol Violation|2|||
130515104|NCT01231464|469853809|FG000|Overall Study|Lost to Follow-up|1|||
130515105|NCT01231464|469853810|FG001|Overall Study|Lost to Follow-up|2|||
130515106|NCT01231464|469853809|FG000|Overall Study|Withdrawal by Subject|3|||
130515107|NCT01231464|469853810|FG001|Overall Study|Withdrawal by Subject|2|||
130515108|NCT01960348|469853817|FG000|Overall Study|Adverse event, not serious|2|||
130515109|NCT01960348|469853818|FG001|Overall Study|Adverse event, not serious|2|||
130515110|NCT01960348|469853817|FG000|Overall Study|Adverse event, serious fatal|6|||
130515111|NCT01960348|469853818|FG001|Overall Study|Adverse event, serious fatal|5|||
130515112|NCT01960348|469853817|FG000|Overall Study|Adverse event, serious non-fatal|0|||
130515113|NCT01960348|469853818|FG001|Overall Study|Adverse event, serious non-fatal|3|||
130515114|NCT01960348|469853817|FG000|Overall Study|Withdrawal by Subject|1|||
130571030|NCT03709654|470055686|FG000|Overall Study|Adverse Event|1|||
130571031|NCT03709654|470055687|FG001|Overall Study|Adverse Event|0|||
130571032|NCT01902966|470055688|FG000|Overall Study|Death|1|||
130571033|NCT01902966|470055688|FG000|Overall Study|Physician Decision|1|||
130571034|NCT01902966|470055688|FG000|Overall Study|Withdrawal by Subject|1|||
130571035|NCT02631200|470055689|FG000|First Period|Death|1|||
130571036|NCT02631200|470055690|FG001|First Period|Death|2|||
130571037|NCT02631200|470055689|FG000|First Period|Patient ill-health|2|||
130571038|NCT02631200|470055690|FG001|First Period|Patient ill-health|4|||
130571039|NCT02631200|470055689|FG000|First Period|Withdrawal by Subject|4|||
130571040|NCT02631200|470055690|FG001|First Period|Withdrawal by Subject|1|||
130571041|NCT02631200|470055689|FG000|Deferred Period|Death|0|||
130571042|NCT02631200|470055690|FG001|Deferred Period|Death|1|||
130571043|NCT02631200|470055689|FG000|Deferred Period|Received kidney transplant|0|||
130571044|NCT02631200|470055690|FG001|Deferred Period|Received kidney transplant|1|||
130571045|NCT02631200|470055689|FG000|Deferred Period|Withdrawal by Subject|0|||
130571046|NCT02631200|470055690|FG001|Deferred Period|Withdrawal by Subject|2|||
130571047|NCT02631200|470055689|FG000|Deferred Period|Lost to Follow-up|0|||
130571048|NCT02631200|470055690|FG001|Deferred Period|Lost to Follow-up|1|||
130571049|NCT01081912|470055691|FG000|Conversion/Titration|Adverse Event|47|||
130571050|NCT01081912|470055692|FG001|Conversion/Titration|Adverse Event|0|||
130571051|NCT01081912|470055693|FG002|Conversion/Titration|Adverse Event|0|||
130571052|NCT01081912|470055691|FG000|Conversion/Titration|Lack of Efficacy|17|||
130571053|NCT01081912|470055692|FG001|Conversion/Titration|Lack of Efficacy|0|||
130571054|NCT01081912|470055693|FG002|Conversion/Titration|Lack of Efficacy|0|||
130571055|NCT01081912|470055691|FG000|Conversion/Titration|Lost to Follow-up|5|||
130571056|NCT01081912|470055692|FG001|Conversion/Titration|Lost to Follow-up|0|||
130571057|NCT01081912|470055693|FG002|Conversion/Titration|Lost to Follow-up|0|||
130571058|NCT01081912|470055691|FG000|Conversion/Titration|Physician Decision|2|||
130571059|NCT01081912|470055692|FG001|Conversion/Titration|Physician Decision|0|||
130571060|NCT01081912|470055693|FG002|Conversion/Titration|Physician Decision|0|||
130571061|NCT01081912|470055691|FG000|Conversion/Titration|Protocol Violation|67|||
130571062|NCT01081912|470055692|FG001|Conversion/Titration|Protocol Violation|0|||
130571063|NCT01081912|470055693|FG002|Conversion/Titration|Protocol Violation|0|||
130571064|NCT01081912|470055691|FG000|Conversion/Titration|Withdrawal by Subject|23|||
130571065|NCT01081912|470055692|FG001|Conversion/Titration|Withdrawal by Subject|0|||
130571066|NCT01081912|470055693|FG002|Conversion/Titration|Withdrawal by Subject|0|||
130571067|NCT01081912|470055691|FG000|Conversion/Titration|Non-Compliance|47|||
130571068|NCT01081912|470055692|FG001|Conversion/Titration|Non-Compliance|0|||
130571069|NCT01081912|470055693|FG002|Conversion/Titration|Non-Compliance|0|||
130571070|NCT01081912|470055691|FG000|Maintenance Treatment|Adverse Event|0|||
130571071|NCT01081912|470055692|FG001|Maintenance Treatment|Adverse Event|2|||
130571072|NCT01081912|470055693|FG002|Maintenance Treatment|Adverse Event|12|||
130571073|NCT01081912|470055691|FG000|Maintenance Treatment|Lack of Efficacy|0|||
130571074|NCT01081912|470055692|FG001|Maintenance Treatment|Lack of Efficacy|14|||
130571075|NCT01081912|470055693|FG002|Maintenance Treatment|Lack of Efficacy|64|||
130571076|NCT01081912|470055691|FG000|Maintenance Treatment|Lost to Follow-up|0|||
130515115|NCT01960348|469853818|FG001|Overall Study|Withdrawal by Subject|11|||
130515116|NCT01960348|469853817|FG000|Overall Study|Physician Decision|0|||
130515117|NCT01960348|469853818|FG001|Overall Study|Physician Decision|1|||
130571077|NCT01081912|470055692|FG001|Maintenance Treatment|Lost to Follow-up|1|||
130571078|NCT01081912|470055693|FG002|Maintenance Treatment|Lost to Follow-up|0|||
130571079|NCT01081912|470055691|FG000|Maintenance Treatment|Physician Decision|0|||
130571080|NCT01081912|470055692|FG001|Maintenance Treatment|Physician Decision|0|||
130571081|NCT01081912|470055693|FG002|Maintenance Treatment|Physician Decision|1|||
130571082|NCT01081912|470055691|FG000|Maintenance Treatment|Protocol Violation|0|||
130571083|NCT01081912|470055692|FG001|Maintenance Treatment|Protocol Violation|1|||
130571084|NCT01081912|470055693|FG002|Maintenance Treatment|Protocol Violation|2|||
130571085|NCT01081912|470055691|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
130571086|NCT01081912|470055692|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
130571087|NCT01081912|470055693|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
130515118|NCT01960348|469853817|FG000|Overall Study|Protocol Violation|1|||
130515119|NCT01960348|469853818|FG001|Overall Study|Protocol Violation|0|||
130515120|NCT02151643|469853821|FG000|Overall Study|Adverse Event|2|||
130515121|NCT02151643|469853822|FG001|Overall Study|Adverse Event|0|||
130515122|NCT02151643|469853823|FG002|Overall Study|Adverse Event|1|||
130515123|NCT02151643|469853824|FG003|Overall Study|Adverse Event|4|||
130515124|NCT02151643|469853825|FG004|Overall Study|Adverse Event|0|||
130515125|NCT02151643|469853821|FG000|Overall Study|Withdrawal by Subject|0|||
130515126|NCT02151643|469853822|FG001|Overall Study|Withdrawal by Subject|1|||
130515127|NCT02151643|469853823|FG002|Overall Study|Withdrawal by Subject|1|||
130515128|NCT02151643|469853824|FG003|Overall Study|Withdrawal by Subject|1|||
130515129|NCT02151643|469853825|FG004|Overall Study|Withdrawal by Subject|1|||
130515130|NCT02151643|469853821|FG000|Overall Study|Hyperphosphataemia|1|||
130515131|NCT02151643|469853822|FG001|Overall Study|Hyperphosphataemia|0|||
130515132|NCT02151643|469853823|FG002|Overall Study|Hyperphosphataemia|0|||
130515133|NCT02151643|469853824|FG003|Overall Study|Hyperphosphataemia|0|||
130515134|NCT02151643|469853825|FG004|Overall Study|Hyperphosphataemia|1|||
130515135|NCT02151643|469853821|FG000|Overall Study|High Ferritin levels|3|||
130515136|NCT02151643|469853822|FG001|Overall Study|High Ferritin levels|3|||
130515137|NCT02151643|469853823|FG002|Overall Study|High Ferritin levels|2|||
130515138|NCT02151643|469853824|FG003|Overall Study|High Ferritin levels|2|||
130515139|NCT02151643|469853825|FG004|Overall Study|High Ferritin levels|1|||
130515140|NCT00508274|469853828|FG000|Overall Study|Adverse Event|5|||
130515141|NCT00508274|469853828|FG000|Overall Study|Death|7|||
130515142|NCT00508274|469853828|FG000|Overall Study|Disease progression|32|||
130515143|NCT00508274|469853828|FG000|Overall Study|Withdrawal by Subject|1|||
130515144|NCT00508274|469853828|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
130515145|NCT00508274|469853828|FG000|Overall Study|Missing|3|||
130515146|NCT03296566|469853829|FG000|Overall Study|Lost to Follow-up|19|||
130515147|NCT03296566|469853830|FG001|Overall Study|Lost to Follow-up|46|||
130515148|NCT03296566|469853829|FG000|Overall Study|Withdrawal by Subject|0|||
130515149|NCT03296566|469853830|FG001|Overall Study|Withdrawal by Subject|3|||
130515150|NCT00197106|469853831|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
130515151|NCT00197106|469853832|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
130515152|NCT00197106|469853833|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
130515153|NCT00197106|469853831|FG000|Overall Treatment Period|Lack of Efficacy|0|||
130515154|NCT00197106|469853832|FG001|Overall Treatment Period|Lack of Efficacy|1|||
130515155|NCT00197106|469853833|FG002|Overall Treatment Period|Lack of Efficacy|0|||
130515156|NCT00197106|469853831|FG000|Overall Treatment Period|Lost to Follow-up|0|||
130515157|NCT00197106|469853832|FG001|Overall Treatment Period|Lost to Follow-up|0|||
130515158|NCT00197106|469853833|FG002|Overall Treatment Period|Lost to Follow-up|2|||
130515159|NCT00197106|469853831|FG000|Overall Treatment Period|Protocol Violation|0|||
130515160|NCT00197106|469853832|FG001|Overall Treatment Period|Protocol Violation|0|||
130515161|NCT00197106|469853833|FG002|Overall Treatment Period|Protocol Violation|2|||
130515162|NCT00197106|469853831|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
130515163|NCT00197106|469853832|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
130571088|NCT01081912|470055691|FG000|Maintenance Treatment|Non-Compliance|0|||
130571089|NCT01081912|470055692|FG001|Maintenance Treatment|Non-Compliance|4|||
130571090|NCT01081912|470055693|FG002|Maintenance Treatment|Non-Compliance|7|||
130571091|NCT01081912|470055691|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
130571092|NCT01081912|470055692|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
130571093|NCT01081912|470055693|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
130571094|NCT04677712|470055695|FG000|Overall Study|Lost to Follow-up|0|||
130571095|NCT04677712|470055696|FG001|Overall Study|Lost to Follow-up|1|||
130571096|NCT04677712|470055697|FG002|Overall Study|Lost to Follow-up|0|||
130571097|NCT04677712|470055698|FG003|Overall Study|Lost to Follow-up|0|||
130571098|NCT04677712|470055699|FG004|Overall Study|Lost to Follow-up|0|||
130571099|NCT04677712|470055700|FG005|Overall Study|Lost to Follow-up|0|||
130571100|NCT00711100|470055701|FG000|Overall Study|Lack of Efficacy|5|||
130571101|NCT00711100|470055701|FG000|Overall Study|Withdrawal by Subject|8|||
130571102|NCT00783094|470055702|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
130571103|NCT00783094|470055703|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
130571104|NCT00783094|470055704|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
130571105|NCT00783094|470055702|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
130571106|NCT00783094|470055703|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
130571107|NCT00783094|470055704|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
130571108|NCT00783094|470055702|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
130515164|NCT00197106|469853833|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
130515165|NCT01084239|469853838|FG000|28-Day Follow-up|Lost to Follow-up|4|||
130515166|NCT01084239|469853839|FG001|28-Day Follow-up|Lost to Follow-up|9|||
130515167|NCT02679079|469853840|FG000|Overall Study|Adverse Event|2|||
130571109|NCT00783094|470055703|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
130515168|NCT02679079|469853841|FG001|Overall Study|Adverse Event|0|||
130515169|NCT02679079|469853842|FG002|Overall Study|Adverse Event|2|||
130515170|NCT02679079|469853840|FG000|Overall Study|Protocol Violation|0|||
130515171|NCT02679079|469853841|FG001|Overall Study|Protocol Violation|1|||
130515172|NCT02679079|469853842|FG002|Overall Study|Protocol Violation|0|||
130515173|NCT02679079|469853840|FG000|Overall Study|Withdrawal by Subject|2|||
130515174|NCT02679079|469853841|FG001|Overall Study|Withdrawal by Subject|1|||
130515175|NCT02679079|469853842|FG002|Overall Study|Withdrawal by Subject|0|||
130515176|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
130515177|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
130515178|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
130515179|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
130515180|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
130515181|NCT00520403|469853843|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
130515182|NCT00520403|469853843|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
130515183|NCT00520403|469853843|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
130515184|NCT02435381|469853844|FG000|Overall Study|Lost to Follow-up|2|||
130515185|NCT02435381|469853845|FG001|Overall Study|Lost to Follow-up|1|||
130515186|NCT04150341|469853848|FG000|Overall Study|Physician Decision|0|||
130515187|NCT04150341|469853849|FG001|Overall Study|Physician Decision|0|||
130515188|NCT04150341|469853850|FG002|Overall Study|Physician Decision|1|||
130515189|NCT04150341|469853851|FG003|Overall Study|Physician Decision|0|||
130515190|NCT04150341|469853852|FG004|Overall Study|Physician Decision|0|||
130515191|NCT04150341|469853853|FG005|Overall Study|Physician Decision|0|||
130515192|NCT04150341|469853848|FG000|Overall Study|Adverse Event|0|||
130515193|NCT04150341|469853849|FG001|Overall Study|Adverse Event|0|||
130515194|NCT04150341|469853850|FG002|Overall Study|Adverse Event|0|||
130515195|NCT04150341|469853851|FG003|Overall Study|Adverse Event|0|||
130515196|NCT04150341|469853852|FG004|Overall Study|Adverse Event|1|||
130515197|NCT04150341|469853853|FG005|Overall Study|Adverse Event|0|||
130515198|NCT00405912|469853854|FG000|Overall Study|Withdrawal by Subject|12|||
130515199|NCT00405912|469853855|FG001|Overall Study|Withdrawal by Subject|11|||
130515200|NCT00405912|469853856|FG002|Overall Study|Withdrawal by Subject|12|||
130515201|NCT00405912|469853854|FG000|Overall Study|Lost to Follow-up|4|||
130515202|NCT00405912|469853855|FG001|Overall Study|Lost to Follow-up|8|||
130515203|NCT00405912|469853856|FG002|Overall Study|Lost to Follow-up|4|||
130515204|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
130515205|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
130515206|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
130515207|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
130515208|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
130515209|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
130515210|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
130515211|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
130515212|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Death|6|||
130515213|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Death|2|||
130515214|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Death|2|||
130515215|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Death|9|||
130515216|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
130515217|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
130515218|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
130515219|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
130515220|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
130515221|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
130515222|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
130515223|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
130515224|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
130515225|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
130515226|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
130515227|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
130515228|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
130515229|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
130515230|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
130515231|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
130515232|NCT03730662|469853857|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
130515233|NCT03730662|469853858|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
130571110|NCT00783094|470055704|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
130515234|NCT03730662|469853859|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
130515235|NCT03730662|469853860|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
130515236|NCT03730662|469853857|FG000|Variable Treatment Period|Adverse Event|1|||
130515237|NCT03730662|469853858|FG001|Variable Treatment Period|Adverse Event|2|||
130515238|NCT03730662|469853859|FG002|Variable Treatment Period|Adverse Event|0|||
130515239|NCT03730662|469853860|FG003|Variable Treatment Period|Adverse Event|7|||
130515240|NCT03730662|469853857|FG000|Variable Treatment Period|Death|9|||
130515241|NCT03730662|469853858|FG001|Variable Treatment Period|Death|0|||
130515242|NCT03730662|469853859|FG002|Variable Treatment Period|Death|6|||
130515243|NCT03730662|469853860|FG003|Variable Treatment Period|Death|26|||
130515244|NCT03730662|469853857|FG000|Variable Treatment Period|Lost to Follow-up|2|||
130515245|NCT03730662|469853858|FG001|Variable Treatment Period|Lost to Follow-up|1|||
130515246|NCT03730662|469853859|FG002|Variable Treatment Period|Lost to Follow-up|4|||
130515247|NCT03730662|469853860|FG003|Variable Treatment Period|Lost to Follow-up|11|||
130515248|NCT03730662|469853857|FG000|Variable Treatment Period|Personal Reason|0|||
130515249|NCT03730662|469853858|FG001|Variable Treatment Period|Personal Reason|2|||
130515250|NCT03730662|469853859|FG002|Variable Treatment Period|Personal Reason|1|||
130515251|NCT03730662|469853860|FG003|Variable Treatment Period|Personal Reason|6|||
130515252|NCT03730662|469853857|FG000|Variable Treatment Period|Physician Decision|0|||
130515253|NCT03730662|469853858|FG001|Variable Treatment Period|Physician Decision|0|||
130515254|NCT03730662|469853859|FG002|Variable Treatment Period|Physician Decision|0|||
130515255|NCT03730662|469853860|FG003|Variable Treatment Period|Physician Decision|3|||
130515256|NCT03730662|469853857|FG000|Variable Treatment Period|Protocol Violation|0|||
130515257|NCT03730662|469853858|FG001|Variable Treatment Period|Protocol Violation|1|||
130515258|NCT03730662|469853859|FG002|Variable Treatment Period|Protocol Violation|1|||
130515259|NCT03730662|469853860|FG003|Variable Treatment Period|Protocol Violation|1|||
130515260|NCT03730662|469853857|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
130515261|NCT03730662|469853858|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
130571111|NCT00783094|470055702|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
130515262|NCT03730662|469853859|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
130515263|NCT03730662|469853860|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
130515264|NCT01797562|469853861|FG000|Overall Study|Protocol Violation|5|||
130515265|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
130515266|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
130571112|NCT00783094|470055703|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
130571113|NCT00783094|470055704|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
130571114|NCT00783094|470055702|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
130571115|NCT00783094|470055703|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
130571116|NCT00783094|470055704|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
130571117|NCT00783094|470055702|FG000|Open-Label Extension Period|Adverse Event|12|||
130571118|NCT00783094|470055703|FG001|Open-Label Extension Period|Adverse Event|7|||
130515267|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
130515268|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
130515269|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Death|0|||
130515270|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Death|1|||
130515271|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
130515272|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
130515273|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
130515274|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
130515275|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
130515276|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
130515277|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
130515278|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
130515279|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
130515280|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
130515281|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
130515282|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
130515283|NCT01309243|469853862|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
130515284|NCT01309243|469853863|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
130515285|NCT01309243|469853862|FG000|Extension Phase|Lost to Follow-up|6|||
130515286|NCT01309243|469853863|FG001|Extension Phase|Lost to Follow-up|0|||
130515287|NCT00632931|469853866|FG000|Part 1, Period 1|Protocol Violation|1|||
130515288|NCT00632931|469853867|FG001|Part 1, Period 1|Protocol Violation|0|||
130515289|NCT00632931|469853868|FG002|Part 1, Period 1|Protocol Violation|0|||
130515290|NCT00632931|469853866|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
130515291|NCT00632931|469853867|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
130515292|NCT00632931|469853868|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
130571119|NCT00783094|470055704|FG002|Open-Label Extension Period|Adverse Event|16|||
130515293|NCT00632931|469853866|FG000|Part 2|Adverse Event|0|||
130515294|NCT00632931|469853867|FG001|Part 2|Adverse Event|0|||
130515295|NCT00632931|469853868|FG002|Part 2|Adverse Event|3|||
130571120|NCT00783094|470055702|FG000|Open-Label Extension Period|Death|0|||
130571121|NCT00783094|470055703|FG001|Open-Label Extension Period|Death|0|||
130515296|NCT00632931|469853866|FG000|Part 2|Death|0|||
130515297|NCT00632931|469853867|FG001|Part 2|Death|0|||
130515298|NCT00632931|469853868|FG002|Part 2|Death|1|||
130515299|NCT00632931|469853866|FG000|Part 2|Lack of Efficacy|0|||
130515300|NCT00632931|469853867|FG001|Part 2|Lack of Efficacy|0|||
130571122|NCT00783094|470055704|FG002|Open-Label Extension Period|Death|1|||
130515301|NCT00632931|469853868|FG002|Part 2|Lack of Efficacy|17|||
130515302|NCT00632931|469853866|FG000|Part 2|Withdrawal by Subject|0|||
130515303|NCT00632931|469853867|FG001|Part 2|Withdrawal by Subject|0|||
130515304|NCT00632931|469853868|FG002|Part 2|Withdrawal by Subject|3|||
130515305|NCT01441583|469853871|FG000|Overall Study|Withdrawal by Subject|1|||
130515306|NCT01441583|469853872|FG001|Overall Study|Withdrawal by Subject|1|||
130515307|NCT01441583|469853873|FG002|Overall Study|Withdrawal by Subject|1|||
130515308|NCT01441583|469853871|FG000|Overall Study|Death|1|||
130515309|NCT01441583|469853872|FG001|Overall Study|Death|0|||
130515310|NCT01441583|469853873|FG002|Overall Study|Death|4|||
130571123|NCT00783094|470055702|FG000|Open-Label Extension Period|Protocol Violation|4|||
130571124|NCT00783094|470055703|FG001|Open-Label Extension Period|Protocol Violation|5|||
130571125|NCT00783094|470055704|FG002|Open-Label Extension Period|Protocol Violation|7|||
130571126|NCT00783094|470055702|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
130571127|NCT00783094|470055703|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
130571128|NCT00783094|470055704|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
130571129|NCT00783094|470055702|FG000|Open-Label Extension Period|Physician Decision|4|||
130571130|NCT00783094|470055703|FG001|Open-Label Extension Period|Physician Decision|2|||
130571131|NCT00783094|470055704|FG002|Open-Label Extension Period|Physician Decision|3|||
130571132|NCT00783094|470055702|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
130571133|NCT00783094|470055703|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
130571134|NCT00783094|470055704|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
130571135|NCT02513329|470055705|FG000|Overall Study|Lost to Follow-up|5|||
130571136|NCT02513329|470055706|FG001|Overall Study|Lost to Follow-up|2|||
130571137|NCT01294670|470055707|FG000|Overall Study|Not treated|1|||
130571138|NCT01294670|470055708|FG001|Overall Study|Not treated|0|||
130571139|NCT01294670|470055709|FG002|Overall Study|Not treated|0|||
130571140|NCT01294670|470055710|FG003|Overall Study|Not treated|0|||
130571141|NCT01294670|470055711|FG004|Overall Study|Not treated|0|||
130571142|NCT02083380|470055715|FG000|Overall Study|Lack of Efficacy|68|||
130571143|NCT02083380|470055716|FG001|Overall Study|Lack of Efficacy|79|||
130571144|NCT02083380|470055717|FG002|Overall Study|Lack of Efficacy|64|||
130571145|NCT02083380|470055715|FG000|Overall Study|Withdrawal by Subject|9|||
130571146|NCT02083380|470055716|FG001|Overall Study|Withdrawal by Subject|3|||
130571147|NCT02083380|470055717|FG002|Overall Study|Withdrawal by Subject|7|||
130571148|NCT02083380|470055715|FG000|Overall Study|Physician Decision|1|||
130571149|NCT02083380|470055716|FG001|Overall Study|Physician Decision|6|||
130571150|NCT02083380|470055717|FG002|Overall Study|Physician Decision|3|||
130571151|NCT02083380|470055715|FG000|Overall Study|Adverse Event|0|||
130571152|NCT02083380|470055716|FG001|Overall Study|Adverse Event|0|||
130571153|NCT02083380|470055717|FG002|Overall Study|Adverse Event|1|||
130571154|NCT02083380|470055715|FG000|Overall Study|Lost to Follow-up|5|||
130571155|NCT02083380|470055716|FG001|Overall Study|Lost to Follow-up|3|||
130571156|NCT02083380|470055717|FG002|Overall Study|Lost to Follow-up|3|||
130571157|NCT02083380|470055715|FG000|Overall Study|Other|8|||
130571158|NCT02083380|470055716|FG001|Overall Study|Other|4|||
130571159|NCT02083380|470055717|FG002|Overall Study|Other|6|||
130571160|NCT00001379|470055718|FG000|Initial Treatment|Disease progression|21|||
130571161|NCT00001379|470055719|FG001|Initial Treatment|Disease progression|3|||
130571162|NCT00001379|470055720|FG002|Initial Treatment|Disease progression|0|||
130571163|NCT00001379|470055721|FG003|Initial Treatment|Disease progression|0|||
130571164|NCT00001379|470055718|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
130571165|NCT00001379|470055719|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
130571166|NCT00001379|470055720|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
130571167|NCT00001379|470055721|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
130571168|NCT00001379|470055718|FG000|Initial Treatment|Received alternative treatment|2|||
130571169|NCT00001379|470055719|FG001|Initial Treatment|Received alternative treatment|1|||
130571170|NCT00001379|470055720|FG002|Initial Treatment|Received alternative treatment|0|||
130571171|NCT00001379|470055721|FG003|Initial Treatment|Received alternative treatment|0|||
130571172|NCT00001379|470055718|FG000|Initial Treatment|Refused further treatment|2|||
130571173|NCT00001379|470055719|FG001|Initial Treatment|Refused further treatment|0|||
130571174|NCT00001379|470055720|FG002|Initial Treatment|Refused further treatment|0|||
130571175|NCT00001379|470055721|FG003|Initial Treatment|Refused further treatment|0|||
130571176|NCT00001379|470055718|FG000|Initial Treatment|Did not receive protocol treatment|0|||
130571177|NCT00001379|470055719|FG001|Initial Treatment|Did not receive protocol treatment|0|||
130571178|NCT00001379|470055720|FG002|Initial Treatment|Did not receive protocol treatment|5|||
130571179|NCT00001379|470055721|FG003|Initial Treatment|Did not receive protocol treatment|0|||
130571180|NCT00001379|470055718|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130571181|NCT00001379|470055719|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130571182|NCT00001379|470055720|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130515311|NCT01441583|469853871|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
130571183|NCT00001379|470055721|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
130571184|NCT00001379|470055718|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
130571185|NCT00001379|470055719|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
130515312|NCT01441583|469853872|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
130515313|NCT01441583|469853873|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
130515314|NCT03341312|469853874|FG000|Period 1|Withdrawal by Subject|0|||
130515315|NCT03341312|469853875|FG001|Period 1|Withdrawal by Subject|1|||
130515316|NCT03341312|469853876|FG002|Period 1|Withdrawal by Subject|0|||
130515317|NCT03341312|469853877|FG003|Period 1|Withdrawal by Subject|0|||
130515318|NCT01812707|469853878|FG000|Overall Study|Adverse Event|0|||
130515319|NCT01812707|469853879|FG001|Overall Study|Adverse Event|0|||
130515320|NCT01812707|469853880|FG002|Overall Study|Adverse Event|0|||
130515321|NCT01812707|469853881|FG003|Overall Study|Adverse Event|2|||
130515322|NCT01812707|469853878|FG000|Overall Study|Poor compliance to protocol|1|||
130515323|NCT01812707|469853879|FG001|Overall Study|Poor compliance to protocol|0|||
130515324|NCT01812707|469853880|FG002|Overall Study|Poor compliance to protocol|0|||
130515325|NCT01812707|469853881|FG003|Overall Study|Poor compliance to protocol|0|||
130515326|NCT01812707|469853878|FG000|Overall Study|Consent withdrawn by participant|1|||
130515327|NCT01812707|469853879|FG001|Overall Study|Consent withdrawn by participant|0|||
130515328|NCT01812707|469853880|FG002|Overall Study|Consent withdrawn by participant|0|||
130515329|NCT01812707|469853881|FG003|Overall Study|Consent withdrawn by participant|0|||
130515330|NCT05060237|469853882|FG000|Overall Study|Withdrawal by Subject|4|||
130515331|NCT05060237|469853882|FG000|Overall Study|Screening failure|8|||
130515332|NCT02396758|469853883|FG000|Overall Study|Withdrawal by Subject|2|||
130515333|NCT02396758|469853884|FG001|Overall Study|Withdrawal by Subject|0|||
130515334|NCT02396758|469853885|FG002|Overall Study|Withdrawal by Subject|0|||
130515335|NCT02396758|469853886|FG003|Overall Study|Withdrawal by Subject|1|||
130515336|NCT02396758|469853883|FG000|Overall Study|Lost to Follow-up|8|||
130515337|NCT02396758|469853884|FG001|Overall Study|Lost to Follow-up|5|||
130515338|NCT02396758|469853885|FG002|Overall Study|Lost to Follow-up|3|||
130515339|NCT02396758|469853886|FG003|Overall Study|Lost to Follow-up|3|||
130515340|NCT02396758|469853883|FG000|Overall Study|Death|1|||
130515341|NCT02396758|469853884|FG001|Overall Study|Death|1|||
130515342|NCT02396758|469853885|FG002|Overall Study|Death|0|||
130515343|NCT02396758|469853886|FG003|Overall Study|Death|1|||
130515344|NCT02396758|469853883|FG000|Overall Study|Randomized but not treated|1|||
130515345|NCT02396758|469853884|FG001|Overall Study|Randomized but not treated|0|||
130515346|NCT02396758|469853885|FG002|Overall Study|Randomized but not treated|1|||
130515347|NCT02396758|469853886|FG003|Overall Study|Randomized but not treated|0|||
130515348|NCT00265096|469853887|FG000|Overall Study|Adverse Event|14|||
130515349|NCT00265096|469853888|FG001|Overall Study|Adverse Event|18|||
130515350|NCT00265096|469853889|FG002|Overall Study|Adverse Event|18|||
130515351|NCT00265096|469853887|FG000|Overall Study|Lost to Follow-up|2|||
130515352|NCT00265096|469853888|FG001|Overall Study|Lost to Follow-up|5|||
130515353|NCT00265096|469853889|FG002|Overall Study|Lost to Follow-up|3|||
130515354|NCT00265096|469853887|FG000|Overall Study|Death|0|||
130515355|NCT00265096|469853888|FG001|Overall Study|Death|1|||
130515356|NCT00265096|469853889|FG002|Overall Study|Death|2|||
130515357|NCT00265096|469853887|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
130515358|NCT00265096|469853888|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130515359|NCT00265096|469853889|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
130515360|NCT00265096|469853887|FG000|Overall Study|Other|11|||
130515361|NCT00265096|469853888|FG001|Overall Study|Other|19|||
130515362|NCT00265096|469853889|FG002|Overall Study|Other|10|||
130515363|NCT00774306|469853890|FG000|Overall Study|Adverse Event|3|||
130515364|NCT00774306|469853891|FG001|Overall Study|Adverse Event|0|||
130515365|NCT00774306|469853892|FG002|Overall Study|Adverse Event|0|||
130515366|NCT00774306|469853893|FG003|Overall Study|Adverse Event|0|||
130515367|NCT00774306|469853890|FG000|Overall Study|Protocol Violation|2|||
130515368|NCT00774306|469853891|FG001|Overall Study|Protocol Violation|0|||
130515369|NCT00774306|469853892|FG002|Overall Study|Protocol Violation|3|||
130571186|NCT00001379|470055720|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
130515370|NCT00774306|469853893|FG003|Overall Study|Protocol Violation|0|||
130515371|NCT00774306|469853890|FG000|Overall Study|Withdrawal by Subject|6|||
130515372|NCT00774306|469853891|FG001|Overall Study|Withdrawal by Subject|1|||
130515373|NCT00774306|469853892|FG002|Overall Study|Withdrawal by Subject|1|||
130515374|NCT00774306|469853893|FG003|Overall Study|Withdrawal by Subject|0|||
130515375|NCT00774306|469853890|FG000|Overall Study|Lost to Follow-up|6|||
130515376|NCT00774306|469853891|FG001|Overall Study|Lost to Follow-up|0|||
130515377|NCT00774306|469853892|FG002|Overall Study|Lost to Follow-up|4|||
130515378|NCT00774306|469853893|FG003|Overall Study|Lost to Follow-up|5|||
130515379|NCT00774306|469853890|FG000|Overall Study|Death|1|||
130515380|NCT00774306|469853891|FG001|Overall Study|Death|1|||
130515381|NCT00774306|469853892|FG002|Overall Study|Death|0|||
130515382|NCT00774306|469853893|FG003|Overall Study|Death|0|||
130515383|NCT00666835|469853894|FG000|Overall Study|Withdrawal by Subject|5|||
130515384|NCT00666835|469853895|FG001|Overall Study|Withdrawal by Subject|2|||
130571187|NCT00001379|470055721|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
130571188|NCT00001379|470055718|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
130571189|NCT00001379|470055719|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
130571190|NCT00001379|470055720|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
130571191|NCT00001379|470055721|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
130571192|NCT00001379|470055718|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
130571193|NCT00001379|470055719|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130571194|NCT00001379|470055720|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130571195|NCT00001379|470055721|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130571196|NCT00001379|470055718|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
130571197|NCT00001379|470055719|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
130571198|NCT00001379|470055720|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
130571199|NCT00001379|470055721|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
130571200|NCT03703102|470055727|FG000|Overall Study|Adverse Event|4|||
130571201|NCT03703102|470055728|FG001|Overall Study|Adverse Event|3|||
130515385|NCT00666835|469853894|FG000|Overall Study|Lack of Efficacy|0|||
130571202|NCT03703102|470055729|FG002|Overall Study|Adverse Event|7|||
130571203|NCT03703102|470055730|FG003|Overall Study|Adverse Event|3|||
130571204|NCT03703102|470055731|FG004|Overall Study|Adverse Event|13|||
130571205|NCT03703102|470055727|FG000|Overall Study|Lack of Efficacy|4|||
130571206|NCT03703102|470055728|FG001|Overall Study|Lack of Efficacy|0|||
130571207|NCT03703102|470055729|FG002|Overall Study|Lack of Efficacy|1|||
130571208|NCT03703102|470055730|FG003|Overall Study|Lack of Efficacy|4|||
130571209|NCT03703102|470055731|FG004|Overall Study|Lack of Efficacy|1|||
130515386|NCT00666835|469853895|FG001|Overall Study|Lack of Efficacy|1|||
130515387|NCT00666835|469853894|FG000|Overall Study|Incl./excl. not fulfilled|7|||
130515388|NCT00666835|469853895|FG001|Overall Study|Incl./excl. not fulfilled|2|||
130571210|NCT03703102|470055727|FG000|Overall Study|Lost to Follow-up|0|||
130571211|NCT03703102|470055728|FG001|Overall Study|Lost to Follow-up|0|||
130571212|NCT03703102|470055729|FG002|Overall Study|Lost to Follow-up|1|||
130571213|NCT03703102|470055730|FG003|Overall Study|Lost to Follow-up|2|||
130571214|NCT03703102|470055731|FG004|Overall Study|Lost to Follow-up|2|||
130571215|NCT03703102|470055727|FG000|Overall Study|Physician Decision|2|||
130571216|NCT03703102|470055728|FG001|Overall Study|Physician Decision|2|||
130571217|NCT03703102|470055729|FG002|Overall Study|Physician Decision|2|||
130571218|NCT03703102|470055730|FG003|Overall Study|Physician Decision|2|||
130571219|NCT03703102|470055731|FG004|Overall Study|Physician Decision|4|||
130571220|NCT03703102|470055727|FG000|Overall Study|Withdrawal by Subject|7|||
130571221|NCT03703102|470055728|FG001|Overall Study|Withdrawal by Subject|5|||
130571222|NCT03703102|470055729|FG002|Overall Study|Withdrawal by Subject|5|||
130571223|NCT03703102|470055730|FG003|Overall Study|Withdrawal by Subject|5|||
130571224|NCT03703102|470055731|FG004|Overall Study|Withdrawal by Subject|9|||
130571225|NCT03703102|470055727|FG000|Overall Study|Ineligibility|0|||
130571226|NCT03703102|470055728|FG001|Overall Study|Ineligibility|0|||
130571227|NCT03703102|470055729|FG002|Overall Study|Ineligibility|1|||
130571228|NCT03703102|470055730|FG003|Overall Study|Ineligibility|0|||
130515389|NCT00666835|469853894|FG000|Overall Study|Adverse Event|7|||
130515390|NCT00666835|469853895|FG001|Overall Study|Adverse Event|6|||
130515391|NCT00666835|469853894|FG000|Overall Study|Protocol Violation|2|||
130515392|NCT00666835|469853895|FG001|Overall Study|Protocol Violation|0|||
130515393|NCT00666835|469853894|FG000|Overall Study|Death|15|||
130515394|NCT00666835|469853895|FG001|Overall Study|Death|4|||
130515395|NCT00666835|469853894|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
130515396|NCT00666835|469853895|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
130515397|NCT00666835|469853894|FG000|Overall Study|Hemoglobulin concentration|4|||
130515398|NCT00666835|469853895|FG001|Overall Study|Hemoglobulin concentration|3|||
130515399|NCT00666835|469853894|FG000|Overall Study|Planned operation|2|||
130571229|NCT03703102|470055731|FG004|Overall Study|Ineligibility|0|||
130571230|NCT03703102|470055727|FG000|Overall Study|Protocol Deviation|4|||
130571231|NCT03703102|470055728|FG001|Overall Study|Protocol Deviation|4|||
130571232|NCT03703102|470055729|FG002|Overall Study|Protocol Deviation|3|||
130571233|NCT03703102|470055730|FG003|Overall Study|Protocol Deviation|0|||
130515400|NCT00666835|469853895|FG001|Overall Study|Planned operation|0|||
130571234|NCT03703102|470055731|FG004|Overall Study|Protocol Deviation|0|||
130571235|NCT03703102|470055727|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130571236|NCT03703102|470055728|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130571237|NCT03703102|470055729|FG002|Overall Study|Non-Compliance with Study Drug|2|||
130571238|NCT03703102|470055730|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130571239|NCT03703102|470055731|FG004|Overall Study|Non-Compliance with Study Drug|4|||
130571240|NCT00876187|470055732|FG000|Overall Study|Adverse Event|14|||
130571241|NCT00876187|470055733|FG001|Overall Study|Adverse Event|12|||
130515401|NCT00666835|469853894|FG000|Overall Study|Physician Decision|1|||
130515402|NCT00666835|469853895|FG001|Overall Study|Physician Decision|2|||
130515403|NCT03319719|469853898|FG000|Overall Study|Lost to Follow-up|1|||
130515404|NCT00744796|469853899|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
130515405|NCT04772313|469853900|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
130515406|NCT04772313|469853900|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
130515407|NCT01836198|469853901|FG000|Part A, Period 2|Protocol Violation|0|||
130515408|NCT01836198|469853902|FG001|Part A, Period 2|Protocol Violation|1|||
130515409|NCT01836198|469853903|FG002|Part A, Period 2|Protocol Violation|0|||
130515410|NCT02215954|469853904|FG000|Overall Study|Adverse Event|0|||
130515411|NCT02215954|469853905|FG001|Overall Study|Adverse Event|0|||
130515412|NCT02215954|469853906|FG002|Overall Study|Adverse Event|1|||
130515413|NCT02215954|469853904|FG000|Overall Study|Withdrawal by Subject|0|||
130515414|NCT02215954|469853905|FG001|Overall Study|Withdrawal by Subject|0|||
130515415|NCT02215954|469853906|FG002|Overall Study|Withdrawal by Subject|2|||
130515416|NCT02215954|469853904|FG000|Overall Study|Not exposed|1|||
130515417|NCT02215954|469853905|FG001|Overall Study|Not exposed|1|||
130515418|NCT02215954|469853906|FG002|Overall Study|Not exposed|3|||
130515419|NCT02460562|469853907|FG000|Overall Study|Lost to Follow-up|15|||
130515420|NCT02460562|469853908|FG001|Overall Study|Lost to Follow-up|16|||
130515421|NCT01654289|469853909|FG000|Overall Study|Withdrawal by Subject|10|||
130515422|NCT01654289|469853910|FG001|Overall Study|Withdrawal by Subject|8|||
130515423|NCT01654289|469853911|FG002|Overall Study|Withdrawal by Subject|5|||
130515424|NCT01654289|469853909|FG000|Overall Study|Withdrew from intervention only|17|||
130515425|NCT01654289|469853910|FG001|Overall Study|Withdrew from intervention only|20|||
130515426|NCT01654289|469853911|FG002|Overall Study|Withdrew from intervention only|0|||
130515427|NCT04194541|469853912|FG000|Day 1 Through 13|Lost to Follow-up|3|||
130515428|NCT04194541|469853912|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
130515429|NCT04194541|469853912|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
130515430|NCT03746483|469853913|FG000|Overall Study|Adverse Event|0|||
130515431|NCT03746483|469853914|FG001|Overall Study|Adverse Event|1|||
130515432|NCT03746483|469853913|FG000|Overall Study|Lack of Efficacy|3|||
130515433|NCT03746483|469853914|FG001|Overall Study|Lack of Efficacy|2|||
130515434|NCT03746483|469853913|FG000|Overall Study|Lost to Follow-up|1|||
130515435|NCT03746483|469853914|FG001|Overall Study|Lost to Follow-up|0|||
130515436|NCT03746483|469853913|FG000|Overall Study|Protocol Violation|2|||
130515437|NCT03746483|469853914|FG001|Overall Study|Protocol Violation|0|||
130515438|NCT00187135|469853915|FG000|Visit One|Withdrawal by Subject|1|||
130515439|NCT00187135|469853916|FG001|Visit One|Withdrawal by Subject|0|||
130515440|NCT00187135|469853917|FG002|Visit One|Withdrawal by Subject|0|||
130515441|NCT00187135|469853918|FG003|Visit One|Withdrawal by Subject|0|||
130515442|NCT00187135|469853919|FG004|Visit One|Withdrawal by Subject|0|||
130515443|NCT00187135|469853920|FG005|Visit One|Withdrawal by Subject|1|||
130515444|NCT00187135|469853915|FG000|Visit One|Physician Decision|3|||
130515445|NCT00187135|469853916|FG001|Visit One|Physician Decision|1|||
130515446|NCT00187135|469853917|FG002|Visit One|Physician Decision|0|||
130515447|NCT00187135|469853918|FG003|Visit One|Physician Decision|0|||
130515448|NCT00187135|469853919|FG004|Visit One|Physician Decision|0|||
130571242|NCT00876187|470055734|FG002|Overall Study|Adverse Event|19|||
130571243|NCT00876187|470055735|FG003|Overall Study|Adverse Event|29|||
130571244|NCT00876187|470055736|FG004|Overall Study|Adverse Event|10|||
130571245|NCT00876187|470055732|FG000|Overall Study|Lack of Efficacy|59|||
130571246|NCT00876187|470055733|FG001|Overall Study|Lack of Efficacy|34|||
130571247|NCT00876187|470055734|FG002|Overall Study|Lack of Efficacy|45|||
130571248|NCT00876187|470055735|FG003|Overall Study|Lack of Efficacy|34|||
130571249|NCT00876187|470055736|FG004|Overall Study|Lack of Efficacy|59|||
130571250|NCT00876187|470055732|FG000|Overall Study|Lost to Follow-up|9|||
130571251|NCT00876187|470055733|FG001|Overall Study|Lost to Follow-up|10|||
130571252|NCT00876187|470055734|FG002|Overall Study|Lost to Follow-up|8|||
130571253|NCT00876187|470055735|FG003|Overall Study|Lost to Follow-up|8|||
130571254|NCT00876187|470055736|FG004|Overall Study|Lost to Follow-up|11|||
130571255|NCT00876187|470055732|FG000|Overall Study|Protocol Violation|6|||
130571256|NCT00876187|470055733|FG001|Overall Study|Protocol Violation|7|||
130571257|NCT00876187|470055734|FG002|Overall Study|Protocol Violation|7|||
130571258|NCT00876187|470055735|FG003|Overall Study|Protocol Violation|6|||
130515449|NCT00187135|469853920|FG005|Visit One|Physician Decision|1|||
130515450|NCT00187135|469853915|FG000|Visit Two|Death|0|||
130515451|NCT00187135|469853916|FG001|Visit Two|Death|0|||
130515452|NCT00187135|469853917|FG002|Visit Two|Death|0|||
130515453|NCT00187135|469853918|FG003|Visit Two|Death|1|||
130515454|NCT00187135|469853919|FG004|Visit Two|Death|0|||
130515455|NCT00187135|469853920|FG005|Visit Two|Death|1|||
130515456|NCT00187135|469853915|FG000|Visit Two|Physician Decision|1|||
130515457|NCT00187135|469853916|FG001|Visit Two|Physician Decision|0|||
130515458|NCT00187135|469853917|FG002|Visit Two|Physician Decision|0|||
130571259|NCT00876187|470055736|FG004|Overall Study|Protocol Violation|3|||
130571260|NCT00876187|470055732|FG000|Overall Study|Withdrawal by Subject|16|||
130571261|NCT00876187|470055733|FG001|Overall Study|Withdrawal by Subject|26|||
130571262|NCT00876187|470055734|FG002|Overall Study|Withdrawal by Subject|32|||
130515459|NCT00187135|469853918|FG003|Visit Two|Physician Decision|0|||
130515460|NCT00187135|469853919|FG004|Visit Two|Physician Decision|0|||
130515461|NCT00187135|469853920|FG005|Visit Two|Physician Decision|0|||
130515462|NCT00187135|469853915|FG000|Visit Two|Withdrawal by Subject|1|||
130515463|NCT00187135|469853916|FG001|Visit Two|Withdrawal by Subject|1|||
130515464|NCT00187135|469853917|FG002|Visit Two|Withdrawal by Subject|1|||
130515465|NCT00187135|469853918|FG003|Visit Two|Withdrawal by Subject|0|||
130515466|NCT00187135|469853919|FG004|Visit Two|Withdrawal by Subject|1|||
130515467|NCT00187135|469853920|FG005|Visit Two|Withdrawal by Subject|1|||
130571263|NCT00876187|470055735|FG003|Overall Study|Withdrawal by Subject|38|||
130571264|NCT00876187|470055736|FG004|Overall Study|Withdrawal by Subject|37|||
130571265|NCT00876187|470055732|FG000|Overall Study|Entered extension study|101|||
130571266|NCT00876187|470055733|FG001|Overall Study|Entered extension study|120|||
130571267|NCT00876187|470055734|FG002|Overall Study|Entered extension study|156|||
130571268|NCT00876187|470055735|FG003|Overall Study|Entered extension study|151|||
130571269|NCT00876187|470055736|FG004|Overall Study|Entered extension study|144|||
130571270|NCT00876187|470055732|FG000|Overall Study|Randomized but not treated|3|||
130571271|NCT00876187|470055733|FG001|Overall Study|Randomized but not treated|1|||
130571272|NCT00876187|470055734|FG002|Overall Study|Randomized but not treated|3|||
130571273|NCT00876187|470055735|FG003|Overall Study|Randomized but not treated|2|||
130571274|NCT00876187|470055736|FG004|Overall Study|Randomized but not treated|3|||
130571275|NCT00876187|470055732|FG000|Overall Study|Other|2|||
130571276|NCT00876187|470055733|FG001|Overall Study|Other|5|||
130571277|NCT00876187|470055734|FG002|Overall Study|Other|9|||
130571278|NCT00876187|470055735|FG003|Overall Study|Other|7|||
130571279|NCT00876187|470055736|FG004|Overall Study|Other|4|||
130571280|NCT00405067|470055737|FG000|Overall Study|Adverse Event|4|||
130571281|NCT00405067|470055738|FG001|Overall Study|Adverse Event|9|||
130571282|NCT00405067|470055739|FG002|Overall Study|Adverse Event|4|||
130571283|NCT00405067|470055737|FG000|Overall Study|Lost to Follow-up|0|||
130571284|NCT00405067|470055738|FG001|Overall Study|Lost to Follow-up|0|||
130571285|NCT00405067|470055739|FG002|Overall Study|Lost to Follow-up|1|||
130571286|NCT01650636|470055740|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
130571287|NCT01650636|470055741|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
130571288|NCT01650636|470055740|FG000|Washout up to 5 Months|Physician Decision|2|||
130571289|NCT01650636|470055741|FG001|Washout up to 5 Months|Physician Decision|2|||
130571290|NCT01650636|470055740|FG000|Washout up to 5 Months|Death|1|||
130571291|NCT01650636|470055741|FG001|Washout up to 5 Months|Death|0|||
130571292|NCT01650636|470055740|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
130571293|NCT01650636|470055741|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
130571294|NCT01650636|470055740|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
130571295|NCT01650636|470055741|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
130571296|NCT01650636|470055740|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
130571297|NCT01650636|470055741|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
130571298|NCT01560780|470055743|FG000|Overall Study|Death|2|||
130515468|NCT00187135|469853915|FG000|Visit Two|Study Discontinued|3|||
130515469|NCT00187135|469853916|FG001|Visit Two|Study Discontinued|2|||
130515470|NCT00187135|469853917|FG002|Visit Two|Study Discontinued|1|||
130515471|NCT00187135|469853918|FG003|Visit Two|Study Discontinued|7|||
130515472|NCT00187135|469853919|FG004|Visit Two|Study Discontinued|5|||
130515473|NCT00187135|469853920|FG005|Visit Two|Study Discontinued|6|||
130515474|NCT00187135|469853915|FG000|Visit Three|Death|0|||
130515475|NCT00187135|469853916|FG001|Visit Three|Death|0|||
130515476|NCT00187135|469853917|FG002|Visit Three|Death|1|||
130515477|NCT00187135|469853918|FG003|Visit Three|Death|0|||
130515478|NCT00187135|469853919|FG004|Visit Three|Death|1|||
130515479|NCT00187135|469853920|FG005|Visit Three|Death|0|||
130515480|NCT00187135|469853915|FG000|Visit Three|Withdrawal by Subject|0|||
130515481|NCT00187135|469853916|FG001|Visit Three|Withdrawal by Subject|1|||
130515482|NCT00187135|469853917|FG002|Visit Three|Withdrawal by Subject|1|||
130515483|NCT00187135|469853918|FG003|Visit Three|Withdrawal by Subject|2|||
130515484|NCT00187135|469853919|FG004|Visit Three|Withdrawal by Subject|0|||
130515485|NCT00187135|469853920|FG005|Visit Three|Withdrawal by Subject|0|||
130515486|NCT00187135|469853915|FG000|Visit Three|Study Discontinued|7|||
130515487|NCT00187135|469853916|FG001|Visit Three|Study Discontinued|6|||
130515488|NCT00187135|469853917|FG002|Visit Three|Study Discontinued|7|||
130515489|NCT00187135|469853918|FG003|Visit Three|Study Discontinued|7|||
130515490|NCT00187135|469853919|FG004|Visit Three|Study Discontinued|7|||
130515491|NCT00187135|469853920|FG005|Visit Three|Study Discontinued|6|||
130515492|NCT01951261|469853923|FG000|Overall Study|Death|1|||
130515493|NCT01951261|469853924|FG001|Overall Study|Death|0|||
130515494|NCT01951261|469853923|FG000|Overall Study|Lost to Follow-up|4|||
130515495|NCT01951261|469853924|FG001|Overall Study|Lost to Follow-up|3|||
130571299|NCT01560780|470055744|FG001|Overall Study|Death|1|||
130571300|NCT01560780|470055743|FG000|Overall Study|Patient Preference|11|||
130571301|NCT01560780|470055744|FG001|Overall Study|Patient Preference|11|||
130571302|NCT01032915|470055745|FG000|Overall Study|Adverse Event|2|||
130571303|NCT01032915|470055746|FG001|Overall Study|Adverse Event|2|||
130571304|NCT01032915|470055747|FG002|Overall Study|Adverse Event|1|||
130571305|NCT01032915|470055748|FG003|Overall Study|Adverse Event|1|||
130571306|NCT01032915|470055745|FG000|Overall Study|Abnormal test procedure result|0|||
130515496|NCT01951261|469853923|FG000|Overall Study|Protocol Violation|4|||
130515497|NCT01951261|469853924|FG001|Overall Study|Protocol Violation|3|||
130515498|NCT01924806|469853925|FG000|Overall Study|Physician Decision|2|||
130515499|NCT01924806|469853926|FG001|Overall Study|Physician Decision|1|||
130515500|NCT00297778|469853930|FG000|Overall Study|Adverse Event|16|||
130515501|NCT00297778|469853931|FG001|Overall Study|Adverse Event|10|||
130515502|NCT00297778|469853930|FG000|Overall Study|Withdrawal by Subject|1|||
130515503|NCT00297778|469853931|FG001|Overall Study|Withdrawal by Subject|5|||
130515504|NCT00297778|469853930|FG000|Overall Study|Lack of Efficacy|2|||
130515505|NCT00297778|469853931|FG001|Overall Study|Lack of Efficacy|1|||
130515506|NCT00297778|469853930|FG000|Overall Study|Non-compliant with trial protocol|0|||
130515507|NCT00297778|469853931|FG001|Overall Study|Non-compliant with trial protocol|3|||
130515508|NCT00297778|469853930|FG000|Overall Study|Other|0|||
130515509|NCT00297778|469853931|FG001|Overall Study|Other|1|||
130515510|NCT00679549|469853932|FG000|Overall Study|dropout|2|||
130515511|NCT00679549|469853933|FG001|Overall Study|dropout|4|||
130515512|NCT00679549|469853932|FG000|Overall Study|missing outcome echocardiograms|4|||
130515513|NCT00679549|469853933|FG001|Overall Study|missing outcome echocardiograms|5|||
130515514|NCT03280108|469853934|FG000|Overall Study|Lost to Follow-up|2|||
130515515|NCT03280108|469853935|FG001|Overall Study|Lost to Follow-up|0|||
130515516|NCT02201771|469853936|FG000|Overall Study|Death|3|||
130515517|NCT02201771|469853937|FG001|Overall Study|Death|2|||
130515518|NCT02201771|469853938|FG002|Overall Study|Death|0|||
130515519|NCT02201771|469853936|FG000|Overall Study|Protocol Violation|10|||
130515520|NCT02201771|469853937|FG001|Overall Study|Protocol Violation|8|||
130515521|NCT02201771|469853938|FG002|Overall Study|Protocol Violation|10|||
130515522|NCT01820637|469853939|FG000|Overall Study|Death|2|||
130515523|NCT01820637|469853939|FG000|Overall Study|Withdrawal by Subject|1|||
130515524|NCT00264498|469853940|FG000|Randomized Treatment|Death|0|||
130515525|NCT00264498|469853941|FG001|Randomized Treatment|Death|3|||
130515526|NCT00264498|469853940|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130515527|NCT00264498|469853941|FG001|Randomized Treatment|Withdrawal by Subject|1|||
130515528|NCT00264498|469853940|FG000|Randomized Treatment|Objective disease Progression|13|||
130515529|NCT00264498|469853941|FG001|Randomized Treatment|Objective disease Progression|14|||
130515530|NCT00264498|469853940|FG000|Randomized Treatment|Physician Decision|1|||
130515531|NCT00264498|469853941|FG001|Randomized Treatment|Physician Decision|0|||
130515532|NCT00264498|469853940|FG000|Randomized Treatment|Incorrectly randomized|1|||
130515533|NCT00264498|469853941|FG001|Randomized Treatment|Incorrectly randomized|0|||
130515534|NCT00264498|469853940|FG000|Randomized Treatment|Study Closure|1|||
130515535|NCT00264498|469853941|FG001|Randomized Treatment|Study Closure|0|||
130515536|NCT00264498|469853940|FG000|Randomized Treatment|Protocol Violation|1|||
130515537|NCT00264498|469853941|FG001|Randomized Treatment|Protocol Violation|0|||
130515538|NCT00264498|469853940|FG000|Crossover Treatment|Death|1|||
130515539|NCT00264498|469853941|FG001|Crossover Treatment|Death|3|||
130515540|NCT00264498|469853940|FG000|Crossover Treatment|Objective disease progression|4|||
130515541|NCT00264498|469853941|FG001|Crossover Treatment|Objective disease progression|5|||
130515542|NCT00264498|469853940|FG000|Crossover Treatment|Study closure|0|||
130515543|NCT00264498|469853941|FG001|Crossover Treatment|Study closure|1|||
130515544|NCT00264498|469853940|FG000|Crossover Treatment|Withdrawal by Subject|1|||
130515545|NCT00264498|469853941|FG001|Crossover Treatment|Withdrawal by Subject|0|||
130515546|NCT04089332|469853945|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
130515547|NCT04089332|469853945|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
130515548|NCT04089332|469853945|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
130515549|NCT02256488|469853946|FG000|Overall Study|Lost to Follow-up|6|||
130515550|NCT02256488|469853947|FG001|Overall Study|Lost to Follow-up|6|||
130515551|NCT02256488|469853948|FG002|Overall Study|Lost to Follow-up|9|||
130515552|NCT02256488|469853949|FG003|Overall Study|Lost to Follow-up|3|||
130515553|NCT02256488|469853946|FG000|Overall Study|OTHER|1|||
130515554|NCT02256488|469853947|FG001|Overall Study|OTHER|0|||
130515555|NCT02256488|469853948|FG002|Overall Study|OTHER|1|||
130515556|NCT02256488|469853949|FG003|Overall Study|OTHER|1|||
130515557|NCT02256488|469853946|FG000|Overall Study|Withdrawal by Subject|1|||
130515558|NCT02256488|469853947|FG001|Overall Study|Withdrawal by Subject|0|||
130515559|NCT02256488|469853948|FG002|Overall Study|Withdrawal by Subject|0|||
130515560|NCT02256488|469853949|FG003|Overall Study|Withdrawal by Subject|2|||
130515561|NCT00240097|469853950|FG000|Part I|Adverse Event|1|||
130515562|NCT00240097|469853950|FG000|Part I|Death|1|||
130515563|NCT00240097|469853950|FG000|Part I|histology|1|||
130515564|NCT00240097|469853950|FG000|Part I|unevaluable|1|||
130515565|NCT00240097|469853950|FG000|Part II|did not continue from Part I|23|||
130515566|NCT00818519|469853951|FG000|Overall Study|Adverse Event|2|||
130515567|NCT00818519|469853952|FG001|Overall Study|Adverse Event|2|||
130515568|NCT00818519|469853951|FG000|Overall Study|Lost to Follow-up|4|||
130515569|NCT00818519|469853952|FG001|Overall Study|Lost to Follow-up|6|||
130515570|NCT00818519|469853951|FG000|Overall Study|Protocol Violation|2|||
130515571|NCT00818519|469853952|FG001|Overall Study|Protocol Violation|1|||
130515572|NCT00818519|469853951|FG000|Overall Study|Pregnancy|0|||
130515573|NCT00818519|469853952|FG001|Overall Study|Pregnancy|1|||
130515574|NCT00818519|469853951|FG000|Overall Study|Withdrawal by Subject|4|||
130515575|NCT00818519|469853952|FG001|Overall Study|Withdrawal by Subject|9|||
130515576|NCT00818519|469853951|FG000|Overall Study|participant recovered completely|1|||
130515577|NCT00818519|469853952|FG001|Overall Study|participant recovered completely|0|||
130515578|NCT00818519|469853951|FG000|Overall Study|participant will leave for long tme|1|||
130515579|NCT00818519|469853952|FG001|Overall Study|participant will leave for long tme|0|||
130515580|NCT03356145|469853955|FG000|Overall Study|Withdrawal by Subject|2|||
130515581|NCT03356145|469853956|FG001|Overall Study|Withdrawal by Subject|1|||
130515582|NCT03356145|469853955|FG000|Overall Study|Did not meet inclusion criteria|1|||
130515583|NCT03356145|469853956|FG001|Overall Study|Did not meet inclusion criteria|0|||
130515584|NCT03613454|469853957|FG000|Overall Study|Protocol Violation|1|||
130515585|NCT03613454|469853958|FG001|Overall Study|Protocol Violation|0|||
130515586|NCT03613454|469853957|FG000|Overall Study|Protocol Violation|0|||
130515587|NCT03613454|469853958|FG001|Overall Study|Protocol Violation|1|||
130515588|NCT02963922|469853959|FG000|Overall Study|Adverse Event|15|||
130515589|NCT02963922|469853960|FG001|Overall Study|Adverse Event|6|||
130515590|NCT02963922|469853959|FG000|Overall Study|Protocol deviation|6|||
130515591|NCT02963922|469853960|FG001|Overall Study|Protocol deviation|6|||
130515592|NCT02963922|469853959|FG000|Overall Study|Lack of Efficacy|1|||
130515593|NCT02963922|469853960|FG001|Overall Study|Lack of Efficacy|1|||
130515594|NCT02963922|469853959|FG000|Overall Study|Lost to Follow-up|2|||
130515595|NCT02963922|469853960|FG001|Overall Study|Lost to Follow-up|3|||
130515596|NCT02963922|469853959|FG000|Overall Study|Other|8|||
130515597|NCT02963922|469853960|FG001|Overall Study|Other|14|||
130515598|NCT02040532|469853962|FG000|Overall Study|Lost to Follow-up|1|||
130515599|NCT02040532|469853962|FG000|Overall Study|Physician Decision|4|||
130515600|NCT02040532|469853962|FG000|Overall Study|Adverse Event|4|||
130515601|NCT02040532|469853962|FG000|Overall Study|Withdrawal by Subject|3|||
130515602|NCT03640754|469853967|FG000|Overall Study|Withdrawal by Subject|1|||
130515603|NCT03640754|469853968|FG001|Overall Study|Withdrawal by Subject|0|||
130515604|NCT03640754|469853967|FG000|Overall Study|Lost to Follow-up|0|||
130515605|NCT03640754|469853968|FG001|Overall Study|Lost to Follow-up|1|||
130515606|NCT01679613|469853974|FG000|Overall Study|other than stated above|0|||
130515607|NCT01679613|469853975|FG001|Overall Study|other than stated above|1|||
130515608|NCT01679613|469853976|FG002|Overall Study|other than stated above|2|||
130515609|NCT01679613|469853977|FG003|Overall Study|other than stated above|2|||
130515610|NCT03169530|469853978|FG000|Overall Study|Study ended by NIH|15|||
130515611|NCT03169530|469853979|FG001|Overall Study|Study ended by NIH|17|||
130515612|NCT02965599|469853980|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
130515613|NCT02965599|469853981|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
130515614|NCT02956278|469855481|FG000|Overall Study|Withdrawal by Subject|6|||
130515615|NCT02956278|469855482|FG001|Overall Study|Withdrawal by Subject|2|||
130515616|NCT02956278|469855483|FG002|Overall Study|Withdrawal by Subject|0|||
130515617|NCT00509821|469855493|FG000|Study Period 1 (Induction)|Death|0|||
130515618|NCT00509821|469855494|FG001|Study Period 1 (Induction)|Death|1|||
130515619|NCT00509821|469855493|FG000|Study Period 1 (Induction)|Adverse Event|0|||
130515620|NCT00509821|469855494|FG001|Study Period 1 (Induction)|Adverse Event|2|||
130515621|NCT00509821|469855493|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
130515622|NCT00509821|469855494|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
130515623|NCT02720185|469855496|FG000|Overall Study|Lost to Follow-up|1|||
130515624|NCT03924947|469855497|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
130515625|NCT03924947|469855498|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
130515626|NCT03924947|469855499|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
130515627|NCT03924947|469855500|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
130515628|NCT03924947|469855501|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
130515629|NCT03924947|469855502|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
130515630|NCT00833898|469855508|FG000|Overall Study|Withdrawal by Subject|33|||
130515631|NCT00833898|469855509|FG001|Overall Study|Withdrawal by Subject|27|||
130515632|NCT00833898|469855508|FG000|Overall Study|Lost to Follow-up|7|||
130515633|NCT00833898|469855509|FG001|Overall Study|Lost to Follow-up|7|||
130515634|NCT00833898|469855508|FG000|Overall Study|Patient did not receive transplant|0|||
130515635|NCT00833898|469855509|FG001|Overall Study|Patient did not receive transplant|2|||
130515636|NCT00805285|469855510|FG000|Overall Study|Lack of Efficacy|1|||
130515637|NCT00917462|469855511|FG000|Overall Study|Clinical Deterioration|1|||
130515638|NCT01402063|469855512|FG000|Overall Study|Withdrawal by Subject|3|||
130515639|NCT01402063|469855513|FG001|Overall Study|Withdrawal by Subject|3|||
130515640|NCT01631825|469855517|FG000|Overall Study|Adverse Event|42|||
130515641|NCT01631825|469855517|FG000|Overall Study|Lack of Efficacy|7|||
130515642|NCT01631825|469855517|FG000|Overall Study|Withdrawal by Subject|9|||
130515643|NCT01631825|469855517|FG000|Overall Study|Protocol Violation|4|||
130515644|NCT01631825|469855517|FG000|Overall Study|Discontinuation criteria|1|||
130515645|NCT01631825|469855517|FG000|Overall Study|Physician Decision|2|||
130515646|NCT02110225|469855518|FG000|Overall Study|Lost to Follow-up|0|||
130515647|NCT02110225|469855519|FG001|Overall Study|Lost to Follow-up|1|||
130515648|NCT02110225|469855520|FG002|Overall Study|Lost to Follow-up|0|||
130515649|NCT02176018|469855521|FG000|Overall Study|Adverse Event|0|||
130515650|NCT02176018|469855522|FG001|Overall Study|Adverse Event|2|||
130515651|NCT02176018|469855521|FG000|Overall Study|Lost to Follow-up|3|||
130515652|NCT02176018|469855522|FG001|Overall Study|Lost to Follow-up|1|||
130515653|NCT02176018|469855521|FG000|Overall Study|Protocol Violation|1|||
130515654|NCT02176018|469855522|FG001|Overall Study|Protocol Violation|1|||
130515655|NCT02176018|469855521|FG000|Overall Study|Withdrawal by Subject|1|||
130515656|NCT02176018|469855522|FG001|Overall Study|Withdrawal by Subject|2|||
130515657|NCT03022045|469855523|FG000|Overall Study|Adverse Event|0|||
130515658|NCT03022045|469855524|FG001|Overall Study|Adverse Event|1|||
130515659|NCT03022045|469855523|FG000|Overall Study|Withdrawal by Subject|1|||
130515660|NCT03022045|469855524|FG001|Overall Study|Withdrawal by Subject|1|||
130515661|NCT02499835|469855528|FG000|Overall Study|Withdrawal by Subject|1|||
130515662|NCT02499835|469855529|FG001|Overall Study|Withdrawal by Subject|0|||
130515663|NCT02499835|469855530|FG002|Overall Study|Withdrawal by Subject|0|||
130515664|NCT02499835|469855531|FG003|Overall Study|Withdrawal by Subject|1|||
130515665|NCT02499835|469855528|FG000|Overall Study|Physician Decision|0|||
130515666|NCT02499835|469855529|FG001|Overall Study|Physician Decision|3|||
130515667|NCT02499835|469855530|FG002|Overall Study|Physician Decision|18|||
130515668|NCT02499835|469855531|FG003|Overall Study|Physician Decision|7|||
130515669|NCT02499835|469855528|FG000|Overall Study|Adverse Event|0|||
130515670|NCT02499835|469855529|FG001|Overall Study|Adverse Event|0|||
130571307|NCT01032915|470055746|FG001|Overall Study|Abnormal test procedure result|0|||
130515671|NCT02499835|469855530|FG002|Overall Study|Adverse Event|0|||
130515672|NCT02499835|469855531|FG003|Overall Study|Adverse Event|1|||
130515673|NCT02499835|469855528|FG000|Overall Study|Disease progression|2|||
130515674|NCT02499835|469855529|FG001|Overall Study|Disease progression|1|||
130515675|NCT02499835|469855530|FG002|Overall Study|Disease progression|0|||
130515676|NCT02499835|469855531|FG003|Overall Study|Disease progression|7|||
130515677|NCT05109117|469855532|FG000|Overall Study|Lost to Follow-up|1|||
130515678|NCT05109117|469855532|FG000|Overall Study|Discontinued for non-compliance|1|||
130515679|NCT03972137|469855533|FG000|Overall Study|Lost to Follow-up|2|||
130515680|NCT03972137|469855533|FG000|Overall Study|Withdrawal by Subject|4|||
130515681|NCT00899379|469855537|FG000|Overall Study|Adverse Event|2|||
130515682|NCT00899379|469855538|FG001|Overall Study|Adverse Event|2|||
130515683|NCT00899379|469855539|FG002|Overall Study|Adverse Event|1|||
130515684|NCT00899379|469855540|FG003|Overall Study|Adverse Event|1|||
130515685|NCT00899379|469855541|FG004|Overall Study|Adverse Event|2|||
130515686|NCT00899379|469855537|FG000|Overall Study|Lack of Efficacy|0|||
130515687|NCT00899379|469855538|FG001|Overall Study|Lack of Efficacy|4|||
130515688|NCT00899379|469855539|FG002|Overall Study|Lack of Efficacy|3|||
130515689|NCT00899379|469855540|FG003|Overall Study|Lack of Efficacy|0|||
130515690|NCT00899379|469855541|FG004|Overall Study|Lack of Efficacy|1|||
130515691|NCT00899379|469855537|FG000|Overall Study|Lost to Follow-up|9|||
130515692|NCT00899379|469855538|FG001|Overall Study|Lost to Follow-up|3|||
130515693|NCT00899379|469855539|FG002|Overall Study|Lost to Follow-up|0|||
130515694|NCT00899379|469855540|FG003|Overall Study|Lost to Follow-up|6|||
130515695|NCT00899379|469855541|FG004|Overall Study|Lost to Follow-up|2|||
130515696|NCT00899379|469855537|FG000|Overall Study|Protocol Violation|0|||
130515697|NCT00899379|469855538|FG001|Overall Study|Protocol Violation|0|||
130515698|NCT00899379|469855539|FG002|Overall Study|Protocol Violation|1|||
130515699|NCT00899379|469855540|FG003|Overall Study|Protocol Violation|1|||
130515700|NCT00899379|469855541|FG004|Overall Study|Protocol Violation|0|||
130515701|NCT00899379|469855537|FG000|Overall Study|Withdrawal by Subject|2|||
130515702|NCT00899379|469855538|FG001|Overall Study|Withdrawal by Subject|4|||
130515703|NCT00899379|469855539|FG002|Overall Study|Withdrawal by Subject|2|||
130515704|NCT00899379|469855540|FG003|Overall Study|Withdrawal by Subject|3|||
130515705|NCT00899379|469855541|FG004|Overall Study|Withdrawal by Subject|6|||
130515706|NCT00899379|469855537|FG000|Overall Study|Pregnancy|0|||
130515707|NCT00899379|469855538|FG001|Overall Study|Pregnancy|0|||
130515708|NCT00899379|469855539|FG002|Overall Study|Pregnancy|1|||
130515709|NCT00899379|469855540|FG003|Overall Study|Pregnancy|0|||
130515710|NCT00899379|469855541|FG004|Overall Study|Pregnancy|1|||
130515711|NCT00899379|469855537|FG000|Overall Study|Patient Uncooperative|0|||
130515712|NCT00899379|469855538|FG001|Overall Study|Patient Uncooperative|1|||
130515713|NCT00899379|469855539|FG002|Overall Study|Patient Uncooperative|0|||
130515714|NCT00899379|469855540|FG003|Overall Study|Patient Uncooperative|1|||
130515715|NCT00899379|469855541|FG004|Overall Study|Patient Uncooperative|2|||
130515716|NCT00899379|469855537|FG000|Overall Study|Abnormal Baseline ECG|0|||
130515717|NCT00899379|469855538|FG001|Overall Study|Abnormal Baseline ECG|0|||
130515718|NCT00899379|469855539|FG002|Overall Study|Abnormal Baseline ECG|0|||
130515719|NCT00899379|469855540|FG003|Overall Study|Abnormal Baseline ECG|1|||
130515720|NCT00899379|469855541|FG004|Overall Study|Abnormal Baseline ECG|0|||
130515721|NCT00899379|469855537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130515722|NCT00899379|469855538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130515723|NCT00899379|469855539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130515724|NCT00899379|469855540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130515725|NCT00899379|469855541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130515726|NCT00899379|469855537|FG000|Overall Study|Not Completed/Entered Extn|5|||
130515727|NCT00899379|469855538|FG001|Overall Study|Not Completed/Entered Extn|1|||
130571308|NCT01032915|470055747|FG002|Overall Study|Abnormal test procedure result|1|||
130571309|NCT01032915|470055748|FG003|Overall Study|Abnormal test procedure result|0|||
130571310|NCT01032915|470055745|FG000|Overall Study|Withdrawal by Subject|0|||
130571311|NCT01032915|470055746|FG001|Overall Study|Withdrawal by Subject|3|||
130571312|NCT01032915|470055747|FG002|Overall Study|Withdrawal by Subject|1|||
130515728|NCT00899379|469855539|FG002|Overall Study|Not Completed/Entered Extn|6|||
130515729|NCT00899379|469855540|FG003|Overall Study|Not Completed/Entered Extn|4|||
130515730|NCT00899379|469855541|FG004|Overall Study|Not Completed/Entered Extn|3|||
130515731|NCT00899379|469855537|FG000|Overall Study|Study Terminated|3|||
130515732|NCT00899379|469855538|FG001|Overall Study|Study Terminated|0|||
130515733|NCT00899379|469855539|FG002|Overall Study|Study Terminated|3|||
130515734|NCT00899379|469855540|FG003|Overall Study|Study Terminated|3|||
130515735|NCT00899379|469855541|FG004|Overall Study|Study Terminated|1|||
130515736|NCT00899379|469855537|FG000|Overall Study|Lost to Follow-up|3|||
130515737|NCT00899379|469855538|FG001|Overall Study|Lost to Follow-up|1|||
130515738|NCT00899379|469855539|FG002|Overall Study|Lost to Follow-up|0|||
130515739|NCT00899379|469855540|FG003|Overall Study|Lost to Follow-up|2|||
130515740|NCT00899379|469855541|FG004|Overall Study|Lost to Follow-up|5|||
130515741|NCT00899379|469855537|FG000|Overall Study|Withdrawal by Subject|4|||
130515742|NCT00899379|469855538|FG001|Overall Study|Withdrawal by Subject|7|||
130515743|NCT00899379|469855539|FG002|Overall Study|Withdrawal by Subject|4|||
130515744|NCT00899379|469855540|FG003|Overall Study|Withdrawal by Subject|7|||
130515745|NCT00899379|469855541|FG004|Overall Study|Withdrawal by Subject|2|||
130515746|NCT00899379|469855537|FG000|Overall Study|Pregnancy|1|||
130515747|NCT00899379|469855538|FG001|Overall Study|Pregnancy|0|||
130515748|NCT00899379|469855539|FG002|Overall Study|Pregnancy|0|||
130515749|NCT00899379|469855540|FG003|Overall Study|Pregnancy|0|||
130515750|NCT00899379|469855541|FG004|Overall Study|Pregnancy|0|||
130515751|NCT00899379|469855537|FG000|Overall Study|Patient Uncooperative|0|||
130515752|NCT00899379|469855538|FG001|Overall Study|Patient Uncooperative|0|||
130515753|NCT00899379|469855539|FG002|Overall Study|Patient Uncooperative|0|||
130515754|NCT00899379|469855540|FG003|Overall Study|Patient Uncooperative|1|||
130515755|NCT00899379|469855541|FG004|Overall Study|Patient Uncooperative|0|||
130515756|NCT00899379|469855537|FG000|Overall Study|Abnormal Prestudy Labs|0|||
130515757|NCT00899379|469855538|FG001|Overall Study|Abnormal Prestudy Labs|0|||
130515758|NCT00899379|469855539|FG002|Overall Study|Abnormal Prestudy Labs|0|||
130515759|NCT00899379|469855540|FG003|Overall Study|Abnormal Prestudy Labs|0|||
130515760|NCT00899379|469855541|FG004|Overall Study|Abnormal Prestudy Labs|2|||
130515761|NCT00899379|469855537|FG000|Overall Study|Abnormal Baseline ECG|0|||
130515762|NCT00899379|469855538|FG001|Overall Study|Abnormal Baseline ECG|0|||
130515763|NCT00899379|469855539|FG002|Overall Study|Abnormal Baseline ECG|1|||
130515764|NCT00899379|469855540|FG003|Overall Study|Abnormal Baseline ECG|1|||
130515765|NCT00899379|469855541|FG004|Overall Study|Abnormal Baseline ECG|0|||
130515766|NCT00899379|469855537|FG000|Overall Study|No Attack Pretreatment|3|||
130515767|NCT00899379|469855538|FG001|Overall Study|No Attack Pretreatment|5|||
130515768|NCT00899379|469855539|FG002|Overall Study|No Attack Pretreatment|5|||
130515769|NCT00899379|469855540|FG003|Overall Study|No Attack Pretreatment|6|||
130515770|NCT00899379|469855541|FG004|Overall Study|No Attack Pretreatment|4|||
130515771|NCT00899379|469855537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130515772|NCT00899379|469855538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130515773|NCT00899379|469855539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130515774|NCT00899379|469855540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130515775|NCT00899379|469855541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130571313|NCT01032915|470055748|FG003|Overall Study|Withdrawal by Subject|1|||
130571314|NCT01032915|470055745|FG000|Overall Study|Administrative reasons|5|||
130571315|NCT01032915|470055746|FG001|Overall Study|Administrative reasons|6|||
130571316|NCT01032915|470055747|FG002|Overall Study|Administrative reasons|4|||
130571317|NCT01032915|470055748|FG003|Overall Study|Administrative reasons|4|||
130571318|NCT01032915|470055745|FG000|Overall Study|Protocol Violation|1|||
130571319|NCT01032915|470055746|FG001|Overall Study|Protocol Violation|0|||
130571320|NCT01032915|470055747|FG002|Overall Study|Protocol Violation|0|||
130571321|NCT01032915|470055748|FG003|Overall Study|Protocol Violation|1|||
130515776|NCT00899379|469855537|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
130515777|NCT00899379|469855538|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
130515778|NCT00899379|469855539|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
130515779|NCT00899379|469855540|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
130515780|NCT00899379|469855541|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
130515781|NCT03220776|469855546|FG000|Overall Study|Claustrophobia|0|||
130571322|NCT03363321|470055749|FG000|Overall Study|Withdrawal by Subject|0|||
130571323|NCT03363321|470055750|FG001|Overall Study|Withdrawal by Subject|1|||
130571324|NCT03363321|470055751|FG002|Overall Study|Withdrawal by Subject|0|||
130515782|NCT03220776|469855547|FG001|Overall Study|Claustrophobia|1|||
130515783|NCT03220776|469855548|FG002|Overall Study|Claustrophobia|1|||
130515784|NCT03220776|469855549|FG003|Overall Study|Claustrophobia|0|||
130571325|NCT03363321|470055752|FG003|Overall Study|Withdrawal by Subject|1|||
130515785|NCT03220776|469855550|FG004|Overall Study|Claustrophobia|1|||
130515786|NCT03220776|469855551|FG005|Overall Study|Claustrophobia|0|||
130515787|NCT03220776|469855546|FG000|Overall Study|MRI Equipment Failure|1|||
130515788|NCT03220776|469855547|FG001|Overall Study|MRI Equipment Failure|0|||
130515789|NCT03220776|469855548|FG002|Overall Study|MRI Equipment Failure|0|||
130515790|NCT03220776|469855549|FG003|Overall Study|MRI Equipment Failure|0|||
130515791|NCT03220776|469855550|FG004|Overall Study|MRI Equipment Failure|0|||
130515792|NCT03220776|469855551|FG005|Overall Study|MRI Equipment Failure|0|||
130515793|NCT03220776|469855546|FG000|Overall Study|Inclimate Weather|0|||
130515794|NCT03220776|469855547|FG001|Overall Study|Inclimate Weather|0|||
130515795|NCT03220776|469855548|FG002|Overall Study|Inclimate Weather|0|||
130515796|NCT03220776|469855549|FG003|Overall Study|Inclimate Weather|0|||
130515797|NCT03220776|469855550|FG004|Overall Study|Inclimate Weather|0|||
130515798|NCT03220776|469855551|FG005|Overall Study|Inclimate Weather|1|||
130515799|NCT03220776|469855546|FG000|Overall Study|Physician Decision|0|||
130515800|NCT03220776|469855547|FG001|Overall Study|Physician Decision|0|||
130515801|NCT03220776|469855548|FG002|Overall Study|Physician Decision|0|||
130515802|NCT03220776|469855549|FG003|Overall Study|Physician Decision|1|||
130515803|NCT03220776|469855550|FG004|Overall Study|Physician Decision|0|||
130515804|NCT03220776|469855551|FG005|Overall Study|Physician Decision|0|||
130515805|NCT03220776|469855546|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
130515806|NCT03220776|469855547|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
130515807|NCT03220776|469855548|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
130515808|NCT03220776|469855549|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
130515809|NCT03220776|469855550|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
130515810|NCT03220776|469855551|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
130515811|NCT03220776|469855546|FG000|Overall Study|Protocol Violation|0|||
130515812|NCT03220776|469855547|FG001|Overall Study|Protocol Violation|0|||
130515813|NCT03220776|469855548|FG002|Overall Study|Protocol Violation|0|||
130515814|NCT03220776|469855549|FG003|Overall Study|Protocol Violation|2|||
130515815|NCT03220776|469855550|FG004|Overall Study|Protocol Violation|0|||
130515816|NCT03220776|469855551|FG005|Overall Study|Protocol Violation|1|||
130515817|NCT03220776|469855546|FG000|Overall Study|Withdrawal by Subject|1|||
130515818|NCT03220776|469855547|FG001|Overall Study|Withdrawal by Subject|0|||
130515819|NCT03220776|469855548|FG002|Overall Study|Withdrawal by Subject|0|||
130515820|NCT03220776|469855549|FG003|Overall Study|Withdrawal by Subject|0|||
130515821|NCT03220776|469855550|FG004|Overall Study|Withdrawal by Subject|0|||
130515822|NCT03220776|469855551|FG005|Overall Study|Withdrawal by Subject|0|||
130515823|NCT03226353|469855552|FG000|Overall Study|Withdrawal by Subject|1|||
130515824|NCT03226353|469855552|FG000|Overall Study|Screen Failure|5|||
130515825|NCT03441789|469855554|FG000|Overall Study|Withdrawal by Subject|1|||
130515826|NCT03441789|469855555|FG001|Overall Study|Withdrawal by Subject|1|||
130515827|NCT03441789|469855554|FG000|Overall Study|Adverse Event|0|||
130515828|NCT03441789|469855555|FG001|Overall Study|Adverse Event|1|||
130515829|NCT03441789|469855554|FG000|Overall Study|Protocol Violation|0|||
130515830|NCT03441789|469855555|FG001|Overall Study|Protocol Violation|1|||
130515831|NCT03441789|469855554|FG000|Overall Study|Lost to Follow-up|0|||
130515832|NCT03441789|469855555|FG001|Overall Study|Lost to Follow-up|1|||
130515833|NCT01780545|469855556|FG000|Overall Study|Withdrawal by Subject|3|||
130515834|NCT01780545|469855557|FG001|Overall Study|Withdrawal by Subject|1|||
130515835|NCT01780545|469855556|FG000|Overall Study|Lost to Follow-up|1|||
130515836|NCT01780545|469855557|FG001|Overall Study|Lost to Follow-up|1|||
130515837|NCT02581189|469855563|FG000|Overall Study|Failure to return|36|||
130515838|NCT02581189|469855563|FG000|Overall Study|Withdrew consent|5|||
130515839|NCT02581189|469855563|FG000|Overall Study|Death|3|||
130515840|NCT02581189|469855563|FG000|Overall Study|Insufficient virological response|2|||
130515841|NCT02581189|469855563|FG000|Overall Study|Other, not specified|7|||
130515842|NCT00797511|469855564|FG000|Overall Study|Withdrawal by Subject|1|||
130515843|NCT00843115|469855565|FG000|Overall Study|Death|4|||
130515844|NCT00843115|469855565|FG000|Overall Study|Adverse Event|30|||
130515845|NCT00843115|469855565|FG000|Overall Study|Lost to Follow-up|4|||
130515846|NCT00843115|469855565|FG000|Overall Study|Withdrawal by Subject|17|||
130515847|NCT00843115|469855565|FG000|Overall Study|Family wanted meds stopped|1|||
130515848|NCT00843115|469855565|FG000|Overall Study|Family does not want continuation|1|||
130515849|NCT00843115|469855565|FG000|Overall Study|Patient forgot to take meds|1|||
130515850|NCT00843115|469855565|FG000|Overall Study|Does not meet entrance criteria|1|||
130515851|NCT00843115|469855565|FG000|Overall Study|Physician Decision|1|||
130515852|NCT00843115|469855565|FG000|Overall Study|Family discontinued meds|1|||
130515853|NCT00843115|469855565|FG000|Overall Study|patient took for 2 days then stopped|1|||
130515854|NCT00843115|469855565|FG000|Overall Study|patient never took the medication|1|||
130515855|NCT00843115|469855565|FG000|Overall Study|hospitalized due to deterioration|1|||
130515856|NCT00843115|469855565|FG000|Overall Study|week 12 not done|1|||
130515857|NCT00843115|469855565|FG000|Overall Study|Syndrome De Glissement|1|||
130515858|NCT01037413|469855566|FG000|Part A: Skin Testing|Adverse Event|1|||
130515859|NCT01037413|469855567|FG001|Part A: Skin Testing|Adverse Event|0|||
130515860|NCT01037413|469855566|FG000|Part A: Skin Testing|Protocol Violation|1|||
130515861|NCT01037413|469855567|FG001|Part A: Skin Testing|Protocol Violation|0|||
130515862|NCT01037413|469855566|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
130515863|NCT01037413|469855567|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
130515864|NCT01037413|469855566|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
130515865|NCT01037413|469855567|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
130515866|NCT00619983|469855571|FG000|Test Drug Alone|Withdrawal by Subject|1|||
130515867|NCT00619983|469855572|FG001|Test Drug Alone|Withdrawal by Subject|0|||
130515868|NCT00619983|469855573|FG002|Test Drug Alone|Withdrawal by Subject|0|||
130515869|NCT00619983|469855574|FG003|Test Drug Alone|Withdrawal by Subject|1|||
130515870|NCT00619983|469855571|FG000|Test Drug Alone|Failure of daily diary device|1|||
130515871|NCT00619983|469855572|FG001|Test Drug Alone|Failure of daily diary device|1|||
130515872|NCT00619983|469855573|FG002|Test Drug Alone|Failure of daily diary device|2|||
130515873|NCT00619983|469855574|FG003|Test Drug Alone|Failure of daily diary device|2|||
130515874|NCT03371485|469855578|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
130515875|NCT03371485|469855578|FG000|2-year Follow-up|Death|5|||
130515876|NCT02204319|469855579|FG000|Overall Study|Pregnancy|1|||
130515877|NCT02204319|469855579|FG000|Overall Study|Withdrawal by Subject|2|||
130515878|NCT02853305|469855580|FG000|Overall Study|Death|287|||
130515879|NCT02853305|469855581|FG001|Overall Study|Death|249|||
130515880|NCT02853305|469855582|FG002|Overall Study|Death|300|||
130515881|NCT02853305|469855580|FG000|Overall Study|Withdrawal by Subject|2|||
130515882|NCT02853305|469855581|FG001|Overall Study|Withdrawal by Subject|8|||
130515883|NCT02853305|469855582|FG002|Overall Study|Withdrawal by Subject|3|||
130515884|NCT02853305|469855580|FG000|Overall Study|Transferred to Extension Study|46|||
130515885|NCT02853305|469855581|FG001|Overall Study|Transferred to Extension Study|30|||
130515886|NCT02853305|469855582|FG002|Overall Study|Transferred to Extension Study|25|||
130515887|NCT02853305|469855580|FG000|Overall Study|Did Not Continue on Extension Study|16|||
130515888|NCT02853305|469855581|FG001|Overall Study|Did Not Continue on Extension Study|20|||
130515889|NCT02853305|469855582|FG002|Overall Study|Did Not Continue on Extension Study|24|||
130515890|NCT01287416|469855585|FG000|Pre-post Training|Withdrawal by Subject|17|||
130515891|NCT01287416|469855586|FG001|Pre-post Training|Withdrawal by Subject|24|||
130515892|NCT01287416|469855585|FG000|Pre-post Training|Lost to Follow-up|5|||
130515893|NCT01287416|469855586|FG001|Pre-post Training|Lost to Follow-up|1|||
130515894|NCT01287416|469855585|FG000|6 Month Follow-up|Lost to Follow-up|3|||
130515895|NCT01287416|469855586|FG001|6 Month Follow-up|Lost to Follow-up|2|||
130515896|NCT02506881|469855592|FG000|First Intervention (Day 1)|Protocol Violation|0|||
130515897|NCT02506881|469855593|FG001|First Intervention (Day 1)|Protocol Violation|0|||
130515898|NCT02506881|469855594|FG002|First Intervention (Day 1)|Protocol Violation|1|||
130515899|NCT02506881|469855595|FG003|First Intervention (Day 1)|Protocol Violation|0|||
130515900|NCT02506881|469855592|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130515901|NCT02506881|469855593|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130515902|NCT02506881|469855594|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130515903|NCT02506881|469855595|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
130515904|NCT02506881|469855592|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
130515905|NCT02506881|469855593|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
130515906|NCT02506881|469855594|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
130515907|NCT02506881|469855595|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
130515908|NCT01919398|469855596|FG000|Overall Study|Progressive Disease|0|||
130515909|NCT01919398|469855597|FG001|Overall Study|Progressive Disease|0|||
130515910|NCT01919398|469855598|FG002|Overall Study|Progressive Disease|4|||
130515911|NCT02016690|469855601|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
130515912|NCT02016690|469855601|FG000|Overall Study|Excluded from SAS: Duplication|2|||
130515913|NCT02016690|469855601|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
130515914|NCT02016690|469855601|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
130515915|NCT02016690|469855601|FG000|Overall Study|Did not meet inclusion criteria|13|||
130515916|NCT02016690|469855601|FG000|Overall Study|Hospitalized for RSV at study start|3|||
130515917|NCT00050167|469855602|FG000|Overall Study|not eligible not invasive|1|||
130515918|NCT00050167|469855603|FG001|Overall Study|not eligible not invasive|1|||
130515919|NCT00495612|469855606|FG000|Overall Study|Lost to Follow-up|1|||
130515920|NCT00495612|469855607|FG001|Overall Study|Lost to Follow-up|0|||
130515921|NCT00495612|469855606|FG000|Overall Study|Subject's Decision to Withdraw|3|||
130515922|NCT00495612|469855607|FG001|Overall Study|Subject's Decision to Withdraw|0|||
130515923|NCT06016127|469855610|FG000|Overall Study|Withdrawal by Subject|4|||
130515924|NCT06016127|469855611|FG001|Overall Study|Withdrawal by Subject|3|||
130515925|NCT02864147|469855617|FG000|Overall Study|Withdrawal by Subject|3|||
130515926|NCT02864147|469855618|FG001|Overall Study|Withdrawal by Subject|2|||
130515927|NCT02864147|469855619|FG002|Overall Study|Withdrawal by Subject|1|||
130515928|NCT02864147|469855617|FG000|Overall Study|Lost to Follow-up|0|||
130515929|NCT02864147|469855618|FG001|Overall Study|Lost to Follow-up|4|||
130515930|NCT02864147|469855619|FG002|Overall Study|Lost to Follow-up|0|||
130515931|NCT02864147|469855617|FG000|Overall Study|Adverse Event|0|||
130515932|NCT02864147|469855618|FG001|Overall Study|Adverse Event|1|||
130515933|NCT02864147|469855619|FG002|Overall Study|Adverse Event|0|||
130515934|NCT02864147|469855617|FG000|Overall Study|Pregnancy|4|||
130515935|NCT02864147|469855618|FG001|Overall Study|Pregnancy|0|||
130515936|NCT02864147|469855619|FG002|Overall Study|Pregnancy|0|||
130515937|NCT02864147|469855617|FG000|Overall Study|Physician Decision|0|||
130515938|NCT02864147|469855618|FG001|Overall Study|Physician Decision|0|||
130515939|NCT02864147|469855619|FG002|Overall Study|Physician Decision|1|||
130515940|NCT02864147|469855617|FG000|Overall Study|Opted for excisional procedures|0|||
130515941|NCT02864147|469855618|FG001|Overall Study|Opted for excisional procedures|0|||
130515942|NCT02864147|469855619|FG002|Overall Study|Opted for excisional procedures|3|||
130515943|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
130515944|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
130515945|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
130515946|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
130515947|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
130515948|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
130515949|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
130515950|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
130515951|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
130515952|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
130515953|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
130515954|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
130515955|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
130515956|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
130515957|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
130515958|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
130515959|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
130515960|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
130515961|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
130515962|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
130515963|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
130515964|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
130515965|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
130515966|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
130515967|NCT02269917|469855620|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
130515968|NCT02269917|469855621|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
130515969|NCT02269917|469855622|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
130515970|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130515971|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130515972|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
130515973|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130515974|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130515975|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
130515976|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130515977|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130515978|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
130515979|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130515980|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130515981|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
130515982|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
130515983|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
130515984|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
130515985|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130515986|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130515987|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
130515988|NCT02269917|469855620|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130515989|NCT02269917|469855621|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130515990|NCT02269917|469855622|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
130515991|NCT02383927|469855623|FG000|Overall Study|Disease Progression|8|||
130515992|NCT02383927|469855624|FG001|Overall Study|Disease Progression|8|||
130515993|NCT02383927|469855625|FG002|Overall Study|Disease Progression|15|||
130515994|NCT02383927|469855626|FG003|Overall Study|Disease Progression|4|||
130515995|NCT02383927|469855623|FG000|Overall Study|Physician Decision|0|||
130515996|NCT02383927|469855624|FG001|Overall Study|Physician Decision|0|||
130515997|NCT02383927|469855625|FG002|Overall Study|Physician Decision|2|||
130515998|NCT02383927|469855626|FG003|Overall Study|Physician Decision|0|||
130515999|NCT02383927|469855623|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
130571326|NCT03363321|470055753|FG004|Overall Study|Withdrawal by Subject|0|||
130516000|NCT02383927|469855624|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
130571327|NCT01577186|470055754|FG000|Overall Study|Adverse Event|23|||
130516001|NCT02383927|469855625|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
130516002|NCT02383927|469855626|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
130516003|NCT02383927|469855623|FG000|Overall Study|Adverse Event|4|||
130516004|NCT02383927|469855624|FG001|Overall Study|Adverse Event|1|||
130516005|NCT02383927|469855625|FG002|Overall Study|Adverse Event|3|||
130516006|NCT02383927|469855626|FG003|Overall Study|Adverse Event|5|||
130516007|NCT02383927|469855623|FG000|Overall Study|Miscellaneous|1|||
130516008|NCT02383927|469855624|FG001|Overall Study|Miscellaneous|0|||
130516009|NCT02383927|469855625|FG002|Overall Study|Miscellaneous|0|||
130516010|NCT02383927|469855626|FG003|Overall Study|Miscellaneous|1|||
130516011|NCT02383927|469855623|FG000|Overall Study|Withdrawal by Subject|0|||
130516012|NCT02383927|469855624|FG001|Overall Study|Withdrawal by Subject|1|||
130516013|NCT02383927|469855625|FG002|Overall Study|Withdrawal by Subject|4|||
130516014|NCT02383927|469855626|FG003|Overall Study|Withdrawal by Subject|0|||
130516015|NCT02865135|469855627|FG000|Overall Study|Death|0|||
130516016|NCT02865135|469855628|FG001|Overall Study|Death|1|||
130516017|NCT02865135|469855629|FG002|Overall Study|Death|0|||
130516018|NCT02865135|469855627|FG000|Overall Study|Progression|6|||
130516019|NCT02865135|469855628|FG001|Overall Study|Progression|2|||
130516020|NCT02865135|469855629|FG002|Overall Study|Progression|2|||
130516021|NCT01071317|469855630|FG000|Overall Study|Lost to Follow-up|2|||
130516022|NCT01071317|469855631|FG001|Overall Study|Lost to Follow-up|2|||
130516023|NCT02154516|469855632|FG000|Overall Study|Withdrawal by Subject|0|||
130516024|NCT02154516|469855633|FG001|Overall Study|Withdrawal by Subject|1|||
130516025|NCT02154516|469855632|FG000|Overall Study|Lost to Follow-up|1|||
130516026|NCT02154516|469855633|FG001|Overall Study|Lost to Follow-up|0|||
130516027|NCT02154516|469855632|FG000|Overall Study|Removal/revision of device|1|||
130516028|NCT02154516|469855633|FG001|Overall Study|Removal/revision of device|0|||
130516029|NCT02154516|469855632|FG000|Overall Study|Death|2|||
130516030|NCT02154516|469855633|FG001|Overall Study|Death|1|||
130516031|NCT00230971|469855634|FG000|Randomization|No study drug administered|3|||
130516032|NCT00230971|469855635|FG001|Randomization|No study drug administered|3|||
130516033|NCT00230971|469855634|FG000|Baseline Participants|Lost to Follow-up|5|||
130516034|NCT00230971|469855635|FG001|Baseline Participants|Lost to Follow-up|12|||
130516035|NCT00230971|469855634|FG000|Baseline Participants|Death|6|||
130516036|NCT00230971|469855635|FG001|Baseline Participants|Death|5|||
130516037|NCT00230971|469855634|FG000|Baseline Participants|Withdrawal by Subject|7|||
130516038|NCT00230971|469855635|FG001|Baseline Participants|Withdrawal by Subject|1|||
130516039|NCT00230971|469855634|FG000|Baseline Participants|Adverse Event|1|||
130516040|NCT00230971|469855635|FG001|Baseline Participants|Adverse Event|0|||
130516041|NCT00230971|469855634|FG000|Baseline Participants|No bacteria observed|1|||
130516042|NCT00230971|469855635|FG001|Baseline Participants|No bacteria observed|0|||
130516043|NCT00230971|469855634|FG000|Baseline Participants|Failure to return|1|||
130516044|NCT00230971|469855635|FG001|Baseline Participants|Failure to return|1|||
130516045|NCT00230971|469855634|FG000|Baseline Participants|Reintervention|1|||
130516046|NCT00230971|469855635|FG001|Baseline Participants|Reintervention|0|||
130516047|NCT01772147|469857548|FG000|Overall Study|Adverse Event|13|||
130571328|NCT01577186|470055754|FG000|Overall Study|Death|1|||
130571329|NCT01577186|470055754|FG000|Overall Study|Lost to Follow-up|28|||
130571330|NCT01577186|470055754|FG000|Overall Study|Withdrawal by Subject|35|||
130571331|NCT01577186|470055754|FG000|Overall Study|Insufficient Response|18|||
130571332|NCT01577186|470055754|FG000|Overall Study|Ineligible to Continue|15|||
130571333|NCT01577186|470055754|FG000|Overall Study|Non-Compliant|8|||
130571334|NCT01577186|470055754|FG000|Overall Study|Other|2|||
130571335|NCT02915523|470055758|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
130571336|NCT02915523|470055759|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
130571337|NCT02915523|470055760|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
130571338|NCT02915523|470055761|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
130571339|NCT02915523|470055758|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
130571340|NCT02915523|470055759|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
130571341|NCT02915523|470055760|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
130571342|NCT02915523|470055761|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
130571343|NCT02915523|470055758|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130516048|NCT01772147|469857549|FG001|Overall Study|Adverse Event|10|||
130516049|NCT01772147|469857550|FG002|Overall Study|Adverse Event|6|||
130571344|NCT02915523|470055759|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
130571345|NCT02915523|470055760|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130571346|NCT02915523|470055761|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130571347|NCT02915523|470055758|FG000|Expansion Phase (Phase 2)|Death|0|||
130571348|NCT02915523|470055759|FG001|Expansion Phase (Phase 2)|Death|0|||
130516050|NCT01772147|469857548|FG000|Overall Study|Withdrew Consent|7|||
130516051|NCT01772147|469857549|FG001|Overall Study|Withdrew Consent|8|||
130516052|NCT01772147|469857550|FG002|Overall Study|Withdrew Consent|4|||
130516053|NCT01772147|469857548|FG000|Overall Study|Lost to Follow-up|1|||
130516054|NCT01772147|469857549|FG001|Overall Study|Lost to Follow-up|0|||
130516055|NCT01772147|469857550|FG002|Overall Study|Lost to Follow-up|1|||
130516056|NCT01772147|469857548|FG000|Overall Study|Protocol Deviation|2|||
130516057|NCT01772147|469857549|FG001|Overall Study|Protocol Deviation|1|||
130516058|NCT01772147|469857550|FG002|Overall Study|Protocol Deviation|1|||
130516059|NCT01772147|469857548|FG000|Overall Study|Lack of Efficacy|8|||
130516060|NCT01772147|469857549|FG001|Overall Study|Lack of Efficacy|6|||
130516061|NCT01772147|469857550|FG002|Overall Study|Lack of Efficacy|6|||
130516062|NCT02972242|469857551|FG000|Overall Study|Withdrawal by Subject|1|||
130516063|NCT02972242|469857552|FG001|Overall Study|Withdrawal by Subject|0|||
130516064|NCT04572997|469857553|FG000|Overall Study|Adverse Event|1|||
130516065|NCT00740597|469857554|FG000|Overall Study|insurance would not cover treatment|1|||
130516066|NCT00552513|469857557|FG000|Overall Study|Lost to Follow-up|5|||
130516067|NCT00552513|469857558|FG001|Overall Study|Lost to Follow-up|1|||
130516068|NCT01816685|469857559|FG000|Overall Study|Lost to Follow-up|7|||
130516069|NCT01816685|469857560|FG001|Overall Study|Lost to Follow-up|9|||
130516070|NCT01816685|469857559|FG000|Overall Study|Surgery Cancelled|3|||
130516071|NCT01816685|469857560|FG001|Overall Study|Surgery Cancelled|2|||
130516072|NCT01157351|469857561|FG000|Overall Study|Adverse Event|5|||
130516073|NCT01157351|469857562|FG001|Overall Study|Adverse Event|4|||
130516074|NCT01157351|469857561|FG000|Overall Study|Death|1|||
130516075|NCT01157351|469857562|FG001|Overall Study|Death|0|||
130516076|NCT01157351|469857561|FG000|Overall Study|Lost to Follow-up|53|||
130516077|NCT01157351|469857562|FG001|Overall Study|Lost to Follow-up|55|||
130516078|NCT01157351|469857561|FG000|Overall Study|Withdrawal by Subject|37|||
130516079|NCT01157351|469857562|FG001|Overall Study|Withdrawal by Subject|27|||
130516080|NCT01157351|469857561|FG000|Overall Study|Physician Decision|5|||
130516081|NCT01157351|469857562|FG001|Overall Study|Physician Decision|4|||
130516082|NCT01157351|469857561|FG000|Overall Study|Protocol Violation|0|||
130516083|NCT01157351|469857562|FG001|Overall Study|Protocol Violation|1|||
130516084|NCT01157351|469857561|FG000|Overall Study|Other|32|||
130516085|NCT01157351|469857562|FG001|Overall Study|Other|36|||
130516086|NCT01157351|469857561|FG000|Overall Study|Noncompliance with Study Drug|0|||
130516087|NCT01157351|469857562|FG001|Overall Study|Noncompliance with Study Drug|3|||
130516088|NCT01157351|469857561|FG000|Overall Study|Randomized but not Treated|4|||
130516089|NCT01157351|469857562|FG001|Overall Study|Randomized but not Treated|2|||
130516090|NCT00746785|469857563|FG000|Overall Study|Lost to Follow-up|29|||
130516091|NCT00746785|469857564|FG001|Overall Study|Lost to Follow-up|25|||
130516092|NCT00746785|469857565|FG002|Overall Study|Lost to Follow-up|27|||
130516093|NCT02517528|469857567|FG000|Overall Study|Withdrawal by Subject|1|||
130516094|NCT00684203|469857568|FG000|Overall Study|Adverse Event|6|||
130516095|NCT00684203|469857569|FG001|Overall Study|Adverse Event|4|||
130516096|NCT00684203|469857570|FG002|Overall Study|Adverse Event|8|||
130516097|NCT00684203|469857571|FG003|Overall Study|Adverse Event|0|||
130516098|NCT00684203|469857572|FG004|Overall Study|Adverse Event|0|||
130516099|NCT00684203|469857573|FG005|Overall Study|Adverse Event|0|||
130516100|NCT00684203|469857568|FG000|Overall Study|Protocol-defined clinical event|3|||
130516101|NCT00684203|469857569|FG001|Overall Study|Protocol-defined clinical event|1|||
130516102|NCT00684203|469857570|FG002|Overall Study|Protocol-defined clinical event|0|||
130516103|NCT00684203|469857571|FG003|Overall Study|Protocol-defined clinical event|0|||
130516104|NCT00684203|469857572|FG004|Overall Study|Protocol-defined clinical event|0|||
130516105|NCT00684203|469857573|FG005|Overall Study|Protocol-defined clinical event|0|||
130516106|NCT00684203|469857568|FG000|Overall Study|Withdrawal by Subject|0|||
130516107|NCT00684203|469857569|FG001|Overall Study|Withdrawal by Subject|2|||
130516108|NCT00684203|469857570|FG002|Overall Study|Withdrawal by Subject|1|||
130516109|NCT00684203|469857571|FG003|Overall Study|Withdrawal by Subject|0|||
130516110|NCT00684203|469857572|FG004|Overall Study|Withdrawal by Subject|0|||
130516111|NCT00684203|469857573|FG005|Overall Study|Withdrawal by Subject|0|||
130516112|NCT00684203|469857568|FG000|Overall Study|Did not meet protocol eligibility|0|||
130516113|NCT00684203|469857569|FG001|Overall Study|Did not meet protocol eligibility|1|||
130516114|NCT00684203|469857570|FG002|Overall Study|Did not meet protocol eligibility|0|||
130516115|NCT00684203|469857571|FG003|Overall Study|Did not meet protocol eligibility|0|||
130516116|NCT00684203|469857572|FG004|Overall Study|Did not meet protocol eligibility|0|||
130516117|NCT00684203|469857573|FG005|Overall Study|Did not meet protocol eligibility|0|||
130516118|NCT03418493|469857576|FG000|Overall Study|Adverse Event|1|||
130516119|NCT03418493|469857577|FG001|Overall Study|Adverse Event|0|||
130516120|NCT03418493|469857578|FG002|Overall Study|Adverse Event|0|||
130516121|NCT03418493|469857579|FG003|Overall Study|Adverse Event|0|||
130516122|NCT03418493|469857580|FG004|Overall Study|Adverse Event|0|||
130516123|NCT03418493|469857581|FG005|Overall Study|Adverse Event|0|||
130516124|NCT03418493|469857582|FG006|Overall Study|Adverse Event|0|||
130516125|NCT03418493|469857583|FG007|Overall Study|Adverse Event|0|||
130516126|NCT03418493|469857584|FG008|Overall Study|Adverse Event|0|||
130516127|NCT03418493|469857585|FG009|Overall Study|Adverse Event|0|||
130516128|NCT03418493|469857586|FG010|Overall Study|Adverse Event|0|||
130516129|NCT03418493|469857576|FG000|Overall Study|Protocol Violation|0|||
130516130|NCT03418493|469857577|FG001|Overall Study|Protocol Violation|0|||
130516131|NCT03418493|469857578|FG002|Overall Study|Protocol Violation|0|||
130516132|NCT03418493|469857579|FG003|Overall Study|Protocol Violation|0|||
130516133|NCT03418493|469857580|FG004|Overall Study|Protocol Violation|0|||
130516134|NCT03418493|469857581|FG005|Overall Study|Protocol Violation|0|||
130516135|NCT03418493|469857582|FG006|Overall Study|Protocol Violation|0|||
130516136|NCT03418493|469857583|FG007|Overall Study|Protocol Violation|0|||
130516137|NCT03418493|469857584|FG008|Overall Study|Protocol Violation|0|||
130516138|NCT03418493|469857585|FG009|Overall Study|Protocol Violation|1|||
130516139|NCT03418493|469857586|FG010|Overall Study|Protocol Violation|0|||
130516140|NCT00719212|469857587|FG000|Overall Study|Death|41|||
130516141|NCT00719212|469857587|FG000|Overall Study|Lost to Follow-up|2|||
130516142|NCT00719212|469857587|FG000|Overall Study|Withdrawal by Subject|1|||
130516143|NCT05446714|469857588|FG000|Overall Study|Lost to Follow-up|1|||
130516144|NCT05446714|469857589|FG001|Overall Study|Lost to Follow-up|3|||
130516145|NCT05446714|469857590|FG002|Overall Study|Lost to Follow-up|2|||
130516146|NCT05446714|469857588|FG000|Overall Study|Protocol Violation|2|||
130516147|NCT05446714|469857589|FG001|Overall Study|Protocol Violation|0|||
130516148|NCT05446714|469857590|FG002|Overall Study|Protocol Violation|0|||
130516149|NCT01990313|469857593|FG000|Overall Study|Lost to Follow-up|1|||
130516150|NCT03511378|469857594|FG000|Overall Study|Withdrawal by Subject|2|||
130516151|NCT03511378|469857595|FG001|Overall Study|Withdrawal by Subject|2|||
130516152|NCT03511378|469857594|FG000|Overall Study|Patient not coming or schedule visit|1|||
130516153|NCT03511378|469857595|FG001|Overall Study|Patient not coming or schedule visit|0|||
130516154|NCT00837096|469857596|FG000|Overall Study|Physician Decision|1|||
130516155|NCT00837096|469857597|FG001|Overall Study|Physician Decision|1|||
130516156|NCT00837096|469857596|FG000|Overall Study|Not reported|9|||
130516157|NCT00837096|469857597|FG001|Overall Study|Not reported|8|||
130516158|NCT00280683|469857598|FG000|Overall Study|Withdrawal by Subject|1|||
130516159|NCT00280683|469857599|FG001|Overall Study|Withdrawal by Subject|2|||
130516160|NCT00280683|469857598|FG000|Overall Study|Adverse Event|1|||
130516161|NCT00280683|469857599|FG001|Overall Study|Adverse Event|1|||
130516162|NCT01243411|469857600|FG000|Overall Study|Withdrawal by Subject|18|||
130516163|NCT01243411|469857600|FG000|Overall Study|Lost to Follow-up|10|||
130516164|NCT01243411|469857600|FG000|Overall Study|Adverse Event|5|||
130516165|NCT01243411|469857600|FG000|Overall Study|Other|8|||
130516166|NCT02396953|469857603|FG000|Overall Study|Withdrawal by Subject|0|||
130516167|NCT02396953|469857604|FG001|Overall Study|Withdrawal by Subject|0|||
130516168|NCT02396953|469857605|FG002|Overall Study|Withdrawal by Subject|1|||
130516169|NCT02396953|469857603|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
130516170|NCT02396953|469857604|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
130516171|NCT02396953|469857605|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
130516172|NCT02396953|469857603|FG000|Overall Study|Personal Reasons|1|||
130516173|NCT02396953|469857604|FG001|Overall Study|Personal Reasons|1|||
130516174|NCT02396953|469857605|FG002|Overall Study|Personal Reasons|0|||
130516175|NCT00510198|469857606|FG000|Overall Study|Withdrawal by Subject|5|||
130516176|NCT00510198|469857607|FG001|Overall Study|Withdrawal by Subject|4|||
130516177|NCT00329550|469857609|FG000|Overall Study|Adverse Event|3|||
130516178|NCT00329550|469857610|FG001|Overall Study|Adverse Event|4|||
130516179|NCT00329550|469857611|FG002|Overall Study|Adverse Event|2|||
130516180|NCT00329550|469857609|FG000|Overall Study|Withdrawal of Consent|1|||
130516181|NCT00329550|469857610|FG001|Overall Study|Withdrawal of Consent|0|||
130516182|NCT00329550|469857611|FG002|Overall Study|Withdrawal of Consent|1|||
130516183|NCT00329550|469857609|FG000|Overall Study|Due to Relocation|0|||
130571349|NCT02915523|470055760|FG002|Expansion Phase (Phase 2)|Death|26|||
130571350|NCT02915523|470055761|FG003|Expansion Phase (Phase 2)|Death|53|||
130571351|NCT02915523|470055758|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
130571352|NCT02915523|470055759|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
130571353|NCT02915523|470055760|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
130571354|NCT02915523|470055761|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
130571355|NCT02915523|470055758|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
130571356|NCT02915523|470055759|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
130571357|NCT02915523|470055760|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
130516184|NCT00329550|469857610|FG001|Overall Study|Due to Relocation|0|||
130516185|NCT00329550|469857611|FG002|Overall Study|Due to Relocation|1|||
130516186|NCT03168425|469857621|FG000|Overall Study|Lost to Follow-up|5|||
130516187|NCT03168425|469857622|FG001|Overall Study|Lost to Follow-up|8|||
130516188|NCT03168425|469857621|FG000|Overall Study|unable to confirm post op opioids|2|||
130516189|NCT03168425|469857622|FG001|Overall Study|unable to confirm post op opioids|3|||
130516190|NCT04491006|469857623|FG000|Overall Study|Adverse Event|0|||
130516191|NCT04491006|469857624|FG001|Overall Study|Adverse Event|3|||
130516192|NCT04491006|469857625|FG002|Overall Study|Adverse Event|5|||
130516193|NCT04491006|469857623|FG000|Overall Study|Withdrawal by Subject|1|||
130516194|NCT04491006|469857624|FG001|Overall Study|Withdrawal by Subject|0|||
130516195|NCT04491006|469857625|FG002|Overall Study|Withdrawal by Subject|2|||
130516196|NCT01960114|469857629|FG000|Overall Study|Adverse Event|1|||
130516197|NCT01960114|469857630|FG001|Overall Study|Adverse Event|0|||
130516198|NCT01960114|469857629|FG000|Overall Study|Could not swallow study medication|0|||
130516199|NCT01960114|469857630|FG001|Overall Study|Could not swallow study medication|1|||
130516200|NCT02469077|469857631|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
130516201|NCT02469077|469857632|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
130516202|NCT02469077|469857631|FG000|Post Randomization/Intervention Period|Relocated|1|||
130516203|NCT02469077|469857632|FG001|Post Randomization/Intervention Period|Relocated|1|||
130516204|NCT02469077|469857631|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
130516205|NCT02469077|469857632|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
130516206|NCT02469077|469857631|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
130516207|NCT02469077|469857632|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
130516208|NCT01040403|469857633|FG000|Overall Study|Adverse Event|10|||
130516209|NCT01040403|469857633|FG000|Overall Study|Protocol Violation|2|||
130516210|NCT01040403|469857633|FG000|Overall Study|Lost to Follow-up|1|||
130516211|NCT01040403|469857633|FG000|Overall Study|Not treated|1|||
130516212|NCT01040403|469857633|FG000|Overall Study|Other reason not defined above|6|||
130516213|NCT01885936|469857634|FG000|Overall Study|Withdrawal by Subject|1|||
130516214|NCT01885936|469857635|FG001|Overall Study|Withdrawal by Subject|0|||
130516215|NCT03036150|469857636|FG000|Overall Study|Withdrawal by Subject|8|||
130516216|NCT03036150|469857637|FG001|Overall Study|Withdrawal by Subject|3|||
130516217|NCT03036150|469857636|FG000|Overall Study|Lost to Follow-up|2|||
130516218|NCT03036150|469857637|FG001|Overall Study|Lost to Follow-up|2|||
130516219|NCT00427778|469857638|FG000|First Intervention (4 Weeks)|no longer interested|1|||
130516220|NCT00427778|469857639|FG001|First Intervention (4 Weeks)|no longer interested|0|||
130516221|NCT00427778|469857638|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
130516222|NCT00427778|469857639|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
130516223|NCT00427778|469857638|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
130516224|NCT00427778|469857639|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
130516225|NCT00427778|469857638|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
130516226|NCT00427778|469857639|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
130516227|NCT00439647|469857640|FG000|Overall Study|Withdrawal by Subject|25|||
130516228|NCT00439647|469857641|FG001|Overall Study|Withdrawal by Subject|22|||
130516229|NCT00439647|469857640|FG000|Overall Study|Death|15|||
130516230|NCT00439647|469857641|FG001|Overall Study|Death|18|||
130516231|NCT00439647|469857640|FG000|Overall Study|Adverse Event|11|||
130516232|NCT00439647|469857641|FG001|Overall Study|Adverse Event|11|||
130516233|NCT00439647|469857640|FG000|Overall Study|Lost to Follow-up|4|||
130516234|NCT00439647|469857641|FG001|Overall Study|Lost to Follow-up|12|||
130516235|NCT00439647|469857640|FG000|Overall Study|Protocol Violation|3|||
130516236|NCT00439647|469857641|FG001|Overall Study|Protocol Violation|4|||
130516237|NCT00439647|469857640|FG000|Overall Study|Lack of Efficacy|0|||
130516238|NCT00439647|469857641|FG001|Overall Study|Lack of Efficacy|4|||
130516239|NCT02845375|469857642|FG000|Overall Study|upper airway obstruction|1|||
130516240|NCT02845375|469857643|FG001|Overall Study|upper airway obstruction|2|||
130516241|NCT02845375|469857644|FG002|Overall Study|upper airway obstruction|1|||
130516242|NCT01177137|469857649|FG000|Overall Study|Withdrawal by Subject|10|||
130516243|NCT01177137|469857650|FG001|Overall Study|Withdrawal by Subject|10|||
130516244|NCT01177137|469857651|FG002|Overall Study|Withdrawal by Subject|2|||
130516245|NCT02959177|469857652|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
130516246|NCT02959177|469857653|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
130516247|NCT02959177|469857654|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130516248|NCT02959177|469857652|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
130516249|NCT02959177|469857653|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
130516250|NCT02959177|469857654|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
130516251|NCT02959177|469857652|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130516252|NCT02959177|469857653|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130516253|NCT02959177|469857654|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130516254|NCT02959177|469857652|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130516255|NCT02959177|469857653|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130516256|NCT02959177|469857654|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130516257|NCT02959177|469857652|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
130516258|NCT02959177|469857653|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
130516259|NCT02959177|469857654|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
130516260|NCT02959177|469857652|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
130516261|NCT02959177|469857653|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
130516262|NCT02959177|469857654|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
130516263|NCT02959177|469857652|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
130516264|NCT02959177|469857653|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
130516265|NCT02959177|469857654|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
130516266|NCT04531813|469857659|FG000|Overall Study|Protocol Violation|1|||
130516267|NCT04531813|469857659|FG000|Overall Study|Withdrawal by Subject|1|||
130516268|NCT02381652|469857664|FG000|Overall Study|Withdrawal by Subject|0|||
130516269|NCT02381652|469857665|FG001|Overall Study|Withdrawal by Subject|0|||
130516270|NCT02381652|469857666|FG002|Overall Study|Withdrawal by Subject|1|||
130516271|NCT01340300|469857667|FG000|Overall Study|Lost to Follow-up|3|||
130516272|NCT01340300|469857668|FG001|Overall Study|Lost to Follow-up|0|||
130516273|NCT01340300|469857669|FG002|Overall Study|Lost to Follow-up|5|||
130516274|NCT01340300|469857670|FG003|Overall Study|Lost to Follow-up|10|||
130571358|NCT02915523|470055761|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
130571359|NCT02915523|470055758|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130571360|NCT02915523|470055759|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130571361|NCT02915523|470055760|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130571362|NCT02915523|470055761|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
130516275|NCT01340300|469857667|FG000|Overall Study|Withdrawal by Subject|5|||
130516276|NCT01340300|469857668|FG001|Overall Study|Withdrawal by Subject|6|||
130516277|NCT01340300|469857669|FG002|Overall Study|Withdrawal by Subject|6|||
130516278|NCT01340300|469857670|FG003|Overall Study|Withdrawal by Subject|3|||
130516279|NCT01340300|469857667|FG000|Overall Study|Adverse Event|1|||
130516280|NCT01340300|469857668|FG001|Overall Study|Adverse Event|0|||
130516281|NCT01340300|469857669|FG002|Overall Study|Adverse Event|4|||
130516282|NCT01340300|469857670|FG003|Overall Study|Adverse Event|0|||
130516283|NCT01340300|469857667|FG000|Overall Study|Physician Decision|0|||
130516284|NCT01340300|469857668|FG001|Overall Study|Physician Decision|1|||
130516285|NCT01340300|469857669|FG002|Overall Study|Physician Decision|0|||
130516286|NCT01340300|469857670|FG003|Overall Study|Physician Decision|0|||
130516287|NCT01340300|469857667|FG000|Overall Study|Unrelated sickness|0|||
130516288|NCT01340300|469857668|FG001|Overall Study|Unrelated sickness|2|||
130516289|NCT01340300|469857669|FG002|Overall Study|Unrelated sickness|0|||
130516290|NCT01340300|469857670|FG003|Overall Study|Unrelated sickness|1|||
130516291|NCT01954771|469857674|FG000|Overall Study|Missing HbA1c of end-point|1|||
130516292|NCT01954771|469857675|FG001|Overall Study|Missing HbA1c of end-point|1|||
130516293|NCT01954771|469857676|FG002|Overall Study|Missing HbA1c of end-point|0|||
130516294|NCT01954771|469857674|FG000|Overall Study|Missing CGMS of end-point|1|||
130516295|NCT01954771|469857675|FG001|Overall Study|Missing CGMS of end-point|1|||
130516296|NCT01954771|469857676|FG002|Overall Study|Missing CGMS of end-point|0|||
130516297|NCT01954771|469857674|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
130516298|NCT01954771|469857675|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
130516299|NCT01954771|469857676|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
130516300|NCT03635775|469857677|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
130516301|NCT03635775|469857678|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
130516302|NCT03635775|469857679|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
130516303|NCT03635775|469857680|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
130516304|NCT02996097|469857686|FG000|Overall Study|Lost to Follow-up|11|||
130516305|NCT02996097|469857687|FG001|Overall Study|Lost to Follow-up|11|||
130516306|NCT00583115|469857688|FG000|Overall Study|Death|1|||
130516307|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
130516308|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
130516309|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
130516310|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
130516311|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
130516312|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
130516313|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
130516314|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
130516315|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
130516316|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
130516317|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
130516318|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
130571363|NCT00915681|470055762|FG000|Overall Study|Screening failures|46|||
130571364|NCT00811135|470055763|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
130571365|NCT00811135|470055763|FG000|Overall Study|Death|3|||
130571366|NCT00811135|470055763|FG000|Overall Study|Protocol Violation|2|||
130571367|NCT00811135|470055763|FG000|Overall Study|Violation of Selection Criteria|1|||
130571368|NCT00811135|470055763|FG000|Overall Study|Refused Treatment|1|||
130571369|NCT00811135|470055763|FG000|Overall Study|Withdrawal by Subject|3|||
130516319|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
130571370|NCT00811135|470055763|FG000|Overall Study|Administrative/Other Unspecified|11|||
130571371|NCT00811135|470055763|FG000|Overall Study|Ongoing|59|||
130571372|NCT00401375|470055771|FG000|Overall Study|Protocol Violation|2|||
130516320|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
130516321|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
130516322|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
130516323|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
130516324|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
130516325|NCT03569475|469857689|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
130516326|NCT03569475|469857690|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
130516327|NCT03569475|469857691|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
130516328|NCT03569475|469857689|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
130516329|NCT03569475|469857690|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
130516330|NCT03569475|469857691|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
130516331|NCT03569475|469857689|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
130516332|NCT03569475|469857690|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
130516333|NCT03569475|469857691|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
130516334|NCT03638258|469857692|FG000|Overall Study|Adverse Event|1|||
130516335|NCT03638258|469857693|FG001|Overall Study|Adverse Event|0|||
130516336|NCT03638258|469857694|FG002|Overall Study|Adverse Event|2|||
130516337|NCT03638258|469857692|FG000|Overall Study|Lost to Follow-up|2|||
130516338|NCT03638258|469857693|FG001|Overall Study|Lost to Follow-up|4|||
130516339|NCT03638258|469857694|FG002|Overall Study|Lost to Follow-up|5|||
130516340|NCT03638258|469857692|FG000|Overall Study|Pregnancy|0|||
130516341|NCT03638258|469857693|FG001|Overall Study|Pregnancy|0|||
130516342|NCT03638258|469857694|FG002|Overall Study|Pregnancy|1|||
130516343|NCT03638258|469857692|FG000|Overall Study|Protocol Violation|0|||
130516344|NCT03638258|469857693|FG001|Overall Study|Protocol Violation|0|||
130516345|NCT03638258|469857694|FG002|Overall Study|Protocol Violation|1|||
130516346|NCT03638258|469857692|FG000|Overall Study|Withdrawal by Subject|4|||
130516347|NCT03638258|469857693|FG001|Overall Study|Withdrawal by Subject|5|||
130516348|NCT03638258|469857694|FG002|Overall Study|Withdrawal by Subject|12|||
130516349|NCT03638258|469857692|FG000|Overall Study|Lack of Efficacy|0|||
130516350|NCT03638258|469857693|FG001|Overall Study|Lack of Efficacy|0|||
130516351|NCT03638258|469857694|FG002|Overall Study|Lack of Efficacy|2|||
130516352|NCT02109107|469857697|FG000|Overall Study|Lost to Follow-up|2|||
130516353|NCT01121185|469857698|FG000|Overall Study|Not infused|0|||
130516354|NCT01121185|469857699|FG001|Overall Study|Not infused|1|||
130516355|NCT01121185|469857698|FG000|Overall Study|Not transplanted|1|||
130516356|NCT01121185|469857699|FG001|Overall Study|Not transplanted|0|||
130516357|NCT00509925|469857702|FG000|Overall Study|Personal reasons|0|||
130516358|NCT00509925|469857703|FG001|Overall Study|Personal reasons|1|||
130516359|NCT03302559|469857704|FG000|Overall Study|Adverse Event|2|||
130516360|NCT03302559|469857704|FG000|Overall Study|Lost to Follow-up|1|||
130516361|NCT03302559|469857704|FG000|Overall Study|Withdrew Consent|3|||
130516362|NCT04130061|469857705|FG000|Overall Study|OR team forgot to request membrane|1|||
130516363|NCT04130061|469857706|FG001|Overall Study|OR team forgot to request membrane|0|||
130516364|NCT03226106|469859183|FG000|Overall Study|Withdrawal by Subject|2|||
130516365|NCT03226106|469859184|FG001|Overall Study|Withdrawal by Subject|0|||
130516366|NCT03226106|469859183|FG000|Overall Study|Adverse Event|1|||
130516367|NCT03226106|469859184|FG001|Overall Study|Adverse Event|0|||
130516368|NCT03226106|469859183|FG000|Overall Study|Lost to Follow-up|2|||
130516369|NCT03226106|469859184|FG001|Overall Study|Lost to Follow-up|0|||
130516370|NCT00721214|469859185|FG000|Overall Study|Chose another center for transplant|1|||
130516371|NCT00721214|469859185|FG000|Overall Study|Death|3|||
130516372|NCT00488319|469859186|FG000|Overall Study|Adverse Event|1|||
130516373|NCT00488319|469859187|FG001|Overall Study|Adverse Event|2|||
130516374|NCT00488319|469859188|FG002|Overall Study|Adverse Event|23|||
130516375|NCT00488319|469859186|FG000|Overall Study|Lack of Efficacy|6|||
130516376|NCT00488319|469859187|FG001|Overall Study|Lack of Efficacy|12|||
130516377|NCT00488319|469859188|FG002|Overall Study|Lack of Efficacy|27|||
130516378|NCT00488319|469859186|FG000|Overall Study|Lost to Follow-up|3|||
130516379|NCT00488319|469859187|FG001|Overall Study|Lost to Follow-up|5|||
130516380|NCT00488319|469859188|FG002|Overall Study|Lost to Follow-up|16|||
130516381|NCT00488319|469859186|FG000|Overall Study|Withdrawal by Subject|5|||
130516382|NCT00488319|469859187|FG001|Overall Study|Withdrawal by Subject|20|||
130516383|NCT00488319|469859188|FG002|Overall Study|Withdrawal by Subject|44|||
130516384|NCT00488319|469859186|FG000|Overall Study|Other reasons for withdrawal|0|||
130516385|NCT00488319|469859187|FG001|Overall Study|Other reasons for withdrawal|4|||
130516386|NCT00488319|469859188|FG002|Overall Study|Other reasons for withdrawal|12|||
130516387|NCT03712449|469859192|FG000|Overall Study|Withdraw Consent|0|||
130516388|NCT03712449|469859193|FG001|Overall Study|Withdraw Consent|1|||
130516389|NCT00666198|469859199|FG000|Overall Study|Protocol Violation|10|||
130516390|NCT00666198|469859199|FG000|Overall Study|No Visit After First Day of Treatment|13|||
130516391|NCT00666198|469859199|FG000|Overall Study|Safety Not Assessable|6|||
130516392|NCT00666198|469859199|FG000|Overall Study|No Drug Administration|4|||
130516393|NCT05153499|469859200|FG000|Overall Study|Withdrawal by Subject|1|||
130516394|NCT05153499|469859201|FG001|Overall Study|Withdrawal by Subject|0|||
130516395|NCT05153499|469859200|FG000|Overall Study|Clinical Hold|1|||
130516396|NCT05153499|469859201|FG001|Overall Study|Clinical Hold|0|||
130516397|NCT05153499|469859200|FG000|Overall Study|Study Termination|6|||
130516398|NCT05153499|469859201|FG001|Overall Study|Study Termination|5|||
130516399|NCT02166047|469859203|FG000|Overall Study|Withdrawal by Participant|0|||
130516400|NCT02166047|469859204|FG001|Overall Study|Withdrawal by Participant|1|||
130516401|NCT02166047|469859205|FG002|Overall Study|Withdrawal by Participant|2|||
130516402|NCT02166047|469859206|FG003|Overall Study|Withdrawal by Participant|0|||
130516403|NCT02166047|469859207|FG004|Overall Study|Withdrawal by Participant|0|||
130516404|NCT02166047|469859208|FG005|Overall Study|Withdrawal by Participant|0|||
130516405|NCT02166047|469859209|FG006|Overall Study|Withdrawal by Participant|1|||
130516406|NCT02166047|469859210|FG007|Overall Study|Withdrawal by Participant|0|||
130516407|NCT02166047|469859211|FG008|Overall Study|Withdrawal by Participant|0|||
130516408|NCT02166047|469859212|FG009|Overall Study|Withdrawal by Participant|0|||
130516409|NCT02166047|469859213|FG010|Overall Study|Withdrawal by Participant|0|||
130516410|NCT02166047|469859214|FG011|Overall Study|Withdrawal by Participant|0|||
130516411|NCT02166047|469859203|FG000|Overall Study|Adverse Event|0|||
130516412|NCT02166047|469859204|FG001|Overall Study|Adverse Event|0|||
130516413|NCT02166047|469859205|FG002|Overall Study|Adverse Event|0|||
130516414|NCT02166047|469859206|FG003|Overall Study|Adverse Event|0|||
130516415|NCT02166047|469859207|FG004|Overall Study|Adverse Event|1|||
130516416|NCT02166047|469859208|FG005|Overall Study|Adverse Event|0|||
130516417|NCT02166047|469859209|FG006|Overall Study|Adverse Event|1|||
130516418|NCT02166047|469859210|FG007|Overall Study|Adverse Event|0|||
130516419|NCT02166047|469859211|FG008|Overall Study|Adverse Event|0|||
130516420|NCT02166047|469859212|FG009|Overall Study|Adverse Event|0|||
130516421|NCT02166047|469859213|FG010|Overall Study|Adverse Event|2|||
130516422|NCT02166047|469859214|FG011|Overall Study|Adverse Event|0|||
130516423|NCT02490878|469859220|FG000|Overall Study|deemed ineligible|0|||
130516424|NCT02490878|469859221|FG001|Overall Study|deemed ineligible|1|||
130516425|NCT02490878|469859220|FG000|Overall Study|progression prior to treatment|0|||
130516426|NCT02490878|469859221|FG001|Overall Study|progression prior to treatment|1|||
130516427|NCT02490878|469859220|FG000|Overall Study|only submitted baseline QOL|0|||
130516428|NCT02490878|469859221|FG001|Overall Study|only submitted baseline QOL|1|||
130516429|NCT00451555|469859223|FG000|Overall Study|Protocol Violation|2|||
130516430|NCT00451555|469859224|FG001|Overall Study|Protocol Violation|2|||
130516431|NCT00451555|469859223|FG000|Overall Study|Adverse Event|3|||
130516432|NCT00451555|469859224|FG001|Overall Study|Adverse Event|1|||
130516433|NCT00451555|469859223|FG000|Overall Study|Withdrawal by Subject|6|||
130516434|NCT00451555|469859224|FG001|Overall Study|Withdrawal by Subject|0|||
130516435|NCT00451555|469859223|FG000|Overall Study|Physician Decision|2|||
130516436|NCT00451555|469859224|FG001|Overall Study|Physician Decision|1|||
130516437|NCT00922441|469859227|FG000|Overall Study|Protocol Violation|0|||
130516438|NCT00922441|469859228|FG001|Overall Study|Protocol Violation|0|||
130516439|NCT00922441|469859229|FG002|Overall Study|Protocol Violation|2|||
130516440|NCT00922441|469859227|FG000|Overall Study|Withdrawal by Subject|0|||
130516441|NCT00922441|469859228|FG001|Overall Study|Withdrawal by Subject|0|||
130516442|NCT00922441|469859229|FG002|Overall Study|Withdrawal by Subject|1|||
130516443|NCT02973477|469859232|FG000|First Intervention|Lost to Follow-up|0|||
130516444|NCT02973477|469859233|FG001|First Intervention|Lost to Follow-up|2|||
130516445|NCT02973477|469859232|FG000|Washout|Withdrawal by Subject|1|||
130516446|NCT02973477|469859233|FG001|Washout|Withdrawal by Subject|0|||
130516447|NCT02973477|469859232|FG000|Second Intervention|Lost to Follow-up|1|||
130516448|NCT02973477|469859233|FG001|Second Intervention|Lost to Follow-up|0|||
130516449|NCT00317603|469859239|FG000|Overall Study|Progressive Disease|3|||
130516450|NCT00523549|469859240|FG000|Overall Study|Adverse Event|6|||
130516451|NCT00523549|469859241|FG001|Overall Study|Adverse Event|3|||
130516452|NCT00523549|469859240|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130516453|NCT00523549|469859241|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130516454|NCT00523549|469859240|FG000|Overall Study|Protocol Deviation|3|||
130516455|NCT00523549|469859241|FG001|Overall Study|Protocol Deviation|1|||
130516456|NCT00523549|469859240|FG000|Overall Study|Patient withdrew consent|7|||
130516457|NCT00523549|469859241|FG001|Overall Study|Patient withdrew consent|6|||
130516458|NCT00523549|469859240|FG000|Overall Study|Lost to Follow-up|3|||
130516459|NCT00523549|469859241|FG001|Overall Study|Lost to Follow-up|5|||
130516460|NCT00053352|469859246|FG000|Overall Study|Lost to Follow-up|0|||
130516461|NCT00053352|469859247|FG001|Overall Study|Lost to Follow-up|1|||
130516462|NCT00053352|469859246|FG000|Overall Study|Physician Decision|11|||
130516463|NCT00053352|469859247|FG001|Overall Study|Physician Decision|1|||
130516464|NCT00053352|469859246|FG000|Overall Study|Withdrawal by Subject|1|||
130516465|NCT00053352|469859247|FG001|Overall Study|Withdrawal by Subject|0|||
130516466|NCT00053352|469859246|FG000|Overall Study|Ineligible|8|||
130516467|NCT00053352|469859247|FG001|Overall Study|Ineligible|8|||
130516468|NCT00053352|469859246|FG000|Overall Study|Disease at new site|1|||
130516469|NCT00053352|469859247|FG001|Overall Study|Disease at new site|0|||
130516470|NCT00931918|469859248|FG000|Overall Study|Adverse Event|4|||
130516471|NCT00931918|469859249|FG001|Overall Study|Adverse Event|6|||
130516472|NCT00931918|469859248|FG000|Overall Study|Progressive Disease|2|||
130516473|NCT00931918|469859249|FG001|Overall Study|Progressive Disease|1|||
130516474|NCT00931918|469859248|FG000|Overall Study|Symptomatic Deterioration|1|||
130516475|NCT00931918|469859249|FG001|Overall Study|Symptomatic Deterioration|0|||
130516476|NCT00931918|469859248|FG000|Overall Study|Withdrawal by Patient|3|||
130516477|NCT00931918|469859249|FG001|Overall Study|Withdrawal by Patient|4|||
130516478|NCT00931918|469859248|FG000|Overall Study|Other Reason not Specified|4|||
130516479|NCT00931918|469859249|FG001|Overall Study|Other Reason not Specified|4|||
130516480|NCT00931918|469859248|FG000|Overall Study|Did not receive study drug|3|||
130516481|NCT00931918|469859249|FG001|Overall Study|Did not receive study drug|2|||
130516482|NCT00570921|469859250|FG000|Overall Study|Protocol Violation|1|||
130516483|NCT00570921|469859250|FG000|Overall Study|Physician Decision|1|||
130516484|NCT00784277|469859252|FG000|IR Treatment|Adverse Event|4|||
130516485|NCT00784277|469859253|FG001|IR Treatment|Adverse Event|8|||
130516486|NCT00784277|469859254|FG002|IR Treatment|Adverse Event|19|||
130516487|NCT00784277|469859255|FG003|IR Treatment|Adverse Event|35|||
130516488|NCT00784277|469859256|FG004|IR Treatment|Adverse Event|0|||
130516489|NCT00784277|469859257|FG005|IR Treatment|Adverse Event|0|||
130516490|NCT00784277|469859258|FG006|IR Treatment|Adverse Event|0|||
130516491|NCT00784277|469859252|FG000|IR Treatment|Lack of Efficacy|4|||
130516492|NCT00784277|469859253|FG001|IR Treatment|Lack of Efficacy|4|||
130516493|NCT00784277|469859254|FG002|IR Treatment|Lack of Efficacy|1|||
130516494|NCT00784277|469859255|FG003|IR Treatment|Lack of Efficacy|0|||
130516495|NCT00784277|469859256|FG004|IR Treatment|Lack of Efficacy|0|||
130516496|NCT00784277|469859257|FG005|IR Treatment|Lack of Efficacy|0|||
130516497|NCT00784277|469859258|FG006|IR Treatment|Lack of Efficacy|0|||
130516498|NCT00784277|469859252|FG000|IR Treatment|Lost to Follow-up|1|||
130516499|NCT00784277|469859253|FG001|IR Treatment|Lost to Follow-up|0|||
130516500|NCT00784277|469859254|FG002|IR Treatment|Lost to Follow-up|1|||
130516501|NCT00784277|469859255|FG003|IR Treatment|Lost to Follow-up|0|||
130516502|NCT00784277|469859256|FG004|IR Treatment|Lost to Follow-up|0|||
130516503|NCT00784277|469859257|FG005|IR Treatment|Lost to Follow-up|0|||
130516504|NCT00784277|469859258|FG006|IR Treatment|Lost to Follow-up|0|||
130516505|NCT00784277|469859252|FG000|IR Treatment|Withdrawal by Subject|5|||
130516506|NCT00784277|469859253|FG001|IR Treatment|Withdrawal by Subject|1|||
130516507|NCT00784277|469859254|FG002|IR Treatment|Withdrawal by Subject|4|||
130516508|NCT00784277|469859255|FG003|IR Treatment|Withdrawal by Subject|6|||
130516509|NCT00784277|469859256|FG004|IR Treatment|Withdrawal by Subject|0|||
130516510|NCT00784277|469859257|FG005|IR Treatment|Withdrawal by Subject|0|||
130516511|NCT00784277|469859258|FG006|IR Treatment|Withdrawal by Subject|0|||
130516512|NCT00784277|469859252|FG000|IR Treatment|Resolution Of Pain|0|||
130516513|NCT00784277|469859253|FG001|IR Treatment|Resolution Of Pain|1|||
130516514|NCT00784277|469859254|FG002|IR Treatment|Resolution Of Pain|0|||
130516515|NCT00784277|469859255|FG003|IR Treatment|Resolution Of Pain|0|||
130516516|NCT00784277|469859256|FG004|IR Treatment|Resolution Of Pain|0|||
130516517|NCT00784277|469859257|FG005|IR Treatment|Resolution Of Pain|0|||
130516518|NCT00784277|469859258|FG006|IR Treatment|Resolution Of Pain|0|||
130516519|NCT00784277|469859252|FG000|IR Treatment|Other|2|||
130571373|NCT00401375|470055772|FG001|Overall Study|Protocol Violation|2|||
130571374|NCT00401375|470055773|FG002|Overall Study|Protocol Violation|1|||
130571375|NCT00401375|470055771|FG000|Overall Study|Adverse Event|6|||
130571376|NCT00401375|470055772|FG001|Overall Study|Adverse Event|11|||
130571377|NCT00401375|470055773|FG002|Overall Study|Adverse Event|10|||
130571378|NCT00401375|470055771|FG000|Overall Study|Withdrawal by Subject|9|||
130571379|NCT00401375|470055772|FG001|Overall Study|Withdrawal by Subject|7|||
130516520|NCT00784277|469859253|FG001|IR Treatment|Other|3|||
130516521|NCT00784277|469859254|FG002|IR Treatment|Other|3|||
130516522|NCT00784277|469859255|FG003|IR Treatment|Other|2|||
130516523|NCT00784277|469859256|FG004|IR Treatment|Other|0|||
130516524|NCT00784277|469859257|FG005|IR Treatment|Other|0|||
130571380|NCT00401375|470055773|FG002|Overall Study|Withdrawal by Subject|7|||
130516525|NCT00784277|469859258|FG006|IR Treatment|Other|0|||
130516526|NCT00784277|469859252|FG000|ER Treatment|Adverse Event|0|||
130516527|NCT00784277|469859253|FG001|ER Treatment|Adverse Event|0|||
130516528|NCT00784277|469859254|FG002|ER Treatment|Adverse Event|0|||
130516529|NCT00784277|469859255|FG003|ER Treatment|Adverse Event|0|||
130516530|NCT00784277|469859256|FG004|ER Treatment|Adverse Event|1|||
130516531|NCT00784277|469859257|FG005|ER Treatment|Adverse Event|7|||
130516532|NCT00784277|469859258|FG006|ER Treatment|Adverse Event|7|||
130516533|NCT00784277|469859252|FG000|ER Treatment|Lack of Efficacy|0|||
130516534|NCT00784277|469859253|FG001|ER Treatment|Lack of Efficacy|0|||
130516535|NCT00784277|469859254|FG002|ER Treatment|Lack of Efficacy|0|||
130516536|NCT00784277|469859255|FG003|ER Treatment|Lack of Efficacy|0|||
130516537|NCT00784277|469859256|FG004|ER Treatment|Lack of Efficacy|3|||
130516538|NCT00784277|469859257|FG005|ER Treatment|Lack of Efficacy|4|||
130516539|NCT00784277|469859258|FG006|ER Treatment|Lack of Efficacy|0|||
130571381|NCT00401375|470055771|FG000|Overall Study|Lost to Follow-up|0|||
130571382|NCT00401375|470055772|FG001|Overall Study|Lost to Follow-up|1|||
130516540|NCT00784277|469859252|FG000|ER Treatment|Lost to Follow-up|0|||
130516541|NCT00784277|469859253|FG001|ER Treatment|Lost to Follow-up|0|||
130516542|NCT00784277|469859254|FG002|ER Treatment|Lost to Follow-up|0|||
130516543|NCT00784277|469859255|FG003|ER Treatment|Lost to Follow-up|0|||
130516544|NCT00784277|469859256|FG004|ER Treatment|Lost to Follow-up|0|||
130516545|NCT00784277|469859257|FG005|ER Treatment|Lost to Follow-up|2|||
130516546|NCT00784277|469859258|FG006|ER Treatment|Lost to Follow-up|0|||
130516547|NCT00784277|469859252|FG000|ER Treatment|Withdrawal by Subject|0|||
130516548|NCT00784277|469859253|FG001|ER Treatment|Withdrawal by Subject|0|||
130516549|NCT00784277|469859254|FG002|ER Treatment|Withdrawal by Subject|0|||
130516550|NCT00784277|469859255|FG003|ER Treatment|Withdrawal by Subject|0|||
130516551|NCT00784277|469859256|FG004|ER Treatment|Withdrawal by Subject|2|||
130516552|NCT00784277|469859257|FG005|ER Treatment|Withdrawal by Subject|5|||
130516553|NCT00784277|469859258|FG006|ER Treatment|Withdrawal by Subject|3|||
130516554|NCT00784277|469859252|FG000|ER Treatment|Study Medication Non-Compliant|0|||
130516555|NCT00784277|469859253|FG001|ER Treatment|Study Medication Non-Compliant|0|||
130516556|NCT00784277|469859254|FG002|ER Treatment|Study Medication Non-Compliant|0|||
130516557|NCT00784277|469859255|FG003|ER Treatment|Study Medication Non-Compliant|0|||
130516558|NCT00784277|469859256|FG004|ER Treatment|Study Medication Non-Compliant|2|||
130516559|NCT00784277|469859257|FG005|ER Treatment|Study Medication Non-Compliant|3|||
130516560|NCT00784277|469859258|FG006|ER Treatment|Study Medication Non-Compliant|3|||
130516561|NCT00784277|469859252|FG000|ER Treatment|Other|0|||
130516562|NCT00784277|469859253|FG001|ER Treatment|Other|0|||
130516563|NCT00784277|469859254|FG002|ER Treatment|Other|0|||
130516564|NCT00784277|469859255|FG003|ER Treatment|Other|0|||
130516565|NCT00784277|469859256|FG004|ER Treatment|Other|1|||
130516566|NCT00784277|469859257|FG005|ER Treatment|Other|3|||
130516567|NCT00784277|469859258|FG006|ER Treatment|Other|2|||
130516568|NCT00588341|469859259|FG000|Overall Study|Withdrawal by Subject|3|||
130516569|NCT00588341|469859259|FG000|Overall Study|Not treated due to metastatic disease|1|||
130516570|NCT00588341|469859259|FG000|Overall Study|Patient ineligible|1|||
130516571|NCT03041701|469859263|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
130516572|NCT03041701|469859264|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
130516573|NCT03041701|469859265|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
130516574|NCT03041701|469859263|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
130516575|NCT03041701|469859264|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
130516576|NCT03041701|469859265|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
130516577|NCT00745121|469859266|FG000|Overall Study|Death|3|||
130516578|NCT00745121|469859267|FG001|Overall Study|Death|0|||
130516579|NCT00745121|469859266|FG000|Overall Study|Adverse Event|1|||
130516580|NCT00745121|469859267|FG001|Overall Study|Adverse Event|0|||
130516581|NCT00745121|469859266|FG000|Overall Study|Lost to Follow-up|1|||
130516582|NCT00745121|469859267|FG001|Overall Study|Lost to Follow-up|0|||
130516583|NCT00745121|469859266|FG000|Overall Study|Withdrawal by Subject|4|||
130516584|NCT00745121|469859267|FG001|Overall Study|Withdrawal by Subject|2|||
130516585|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
130516586|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130516587|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130516588|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130516589|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130516590|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
130516591|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130516592|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130516593|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130516594|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130516595|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
130516596|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130516597|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130516598|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130516599|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130516600|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
130516601|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130516602|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130516603|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130516604|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130516605|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
130516606|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130516607|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130516608|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130516609|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130516610|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
130516611|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130516612|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130516613|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130516614|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130516615|NCT01187407|469859268|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
130516616|NCT01187407|469859269|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130516617|NCT01187407|469859270|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130516618|NCT01187407|469859271|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130516619|NCT01187407|469859272|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130516620|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130516621|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
130516622|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
130516623|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
130516624|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
130516625|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130516626|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
130516627|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
130516628|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
130516629|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
130516630|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130516631|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
130516632|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
130516633|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
130516634|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
130516635|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130516636|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130516637|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130516638|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
130516639|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130516640|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
130516641|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
130516642|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130516643|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
130516644|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
130516645|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
130516646|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130516647|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130516648|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
130516649|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
130516650|NCT01187407|469859268|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130516651|NCT01187407|469859269|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130516652|NCT01187407|469859270|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130516653|NCT01187407|469859271|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130516654|NCT01187407|469859272|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
130516655|NCT02630706|469859280|FG000|Overall Study|Adverse Event|2|||
130516656|NCT02630706|469859281|FG001|Overall Study|Adverse Event|1|||
130516657|NCT02630706|469859282|FG002|Overall Study|Adverse Event|1|||
130516658|NCT02630706|469859280|FG000|Overall Study|Lost to Follow-up|0|||
130516659|NCT02630706|469859281|FG001|Overall Study|Lost to Follow-up|1|||
130516660|NCT02630706|469859282|FG002|Overall Study|Lost to Follow-up|2|||
130516661|NCT02630706|469859280|FG000|Overall Study|Physician Decision|1|||
130516662|NCT02630706|469859281|FG001|Overall Study|Physician Decision|1|||
130516663|NCT02630706|469859282|FG002|Overall Study|Physician Decision|0|||
130516664|NCT02630706|469859280|FG000|Overall Study|Pregnancy|0|||
130516665|NCT02630706|469859281|FG001|Overall Study|Pregnancy|1|||
130516666|NCT02630706|469859282|FG002|Overall Study|Pregnancy|0|||
130516667|NCT02630706|469859280|FG000|Overall Study|Withdrawal by Subject|4|||
130516668|NCT02630706|469859281|FG001|Overall Study|Withdrawal by Subject|5|||
130516669|NCT02630706|469859282|FG002|Overall Study|Withdrawal by Subject|7|||
130516670|NCT00640042|469859283|FG000|Enrollment|Did not receive study drug|83|||
130516671|NCT01527500|469859286|FG000|Part A|Administrative|11|||
130516672|NCT01527500|469859287|FG001|Part A|Administrative|7|||
130516673|NCT01527500|469859286|FG000|Part A|Adverse Event|4|||
130516674|NCT01527500|469859287|FG001|Part A|Adverse Event|2|||
130516675|NCT01527500|469859286|FG000|Part A|Death|4|||
130516676|NCT01527500|469859287|FG001|Part A|Death|1|||
130516677|NCT01527500|469859286|FG000|Part A|Lost to Follow-up|0|||
130516678|NCT01527500|469859287|FG001|Part A|Lost to Follow-up|1|||
130516679|NCT01527500|469859286|FG000|Part A|Protocol Deviation|9|||
130516680|NCT01527500|469859287|FG001|Part A|Protocol Deviation|2|||
130516681|NCT01527500|469859286|FG000|Part A|Withdrawal by Subject|2|||
130516682|NCT01527500|469859287|FG001|Part A|Withdrawal by Subject|0|||
130516683|NCT01527500|469859286|FG000|Part B|Adverse Event|1|||
130516684|NCT01527500|469859287|FG001|Part B|Adverse Event|0|||
130516685|NCT03078751|469859302|FG000|Overall Study|Adverse Event|4|||
130516686|NCT03078751|469859303|FG001|Overall Study|Adverse Event|0|||
130516687|NCT03078751|469859302|FG000|Overall Study|Physician Decision|1|||
130516688|NCT03078751|469859303|FG001|Overall Study|Physician Decision|0|||
130516689|NCT03078751|469859302|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
130516690|NCT03078751|469859303|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
130516691|NCT03078751|469859302|FG000|Overall Study|Subject/guardian decision|8|||
130516692|NCT03078751|469859303|FG001|Overall Study|Subject/guardian decision|1|||
130516693|NCT03078751|469859302|FG000|Overall Study|Untreated|0|||
130516694|NCT03078751|469859303|FG001|Overall Study|Untreated|4|||
130516695|NCT00607789|469859304|FG000|Overall Study|Adverse Event|3|||
130516696|NCT00607789|469859305|FG001|Overall Study|Adverse Event|0|||
130516697|NCT00607789|469859304|FG000|Overall Study|Lack of Efficacy|0|||
130516698|NCT00607789|469859305|FG001|Overall Study|Lack of Efficacy|1|||
130516699|NCT00607789|469859304|FG000|Overall Study|Inadequate adherence|3|||
130516700|NCT00607789|469859305|FG001|Overall Study|Inadequate adherence|0|||
130516701|NCT00607789|469859304|FG000|Overall Study|Lost to Follow-up|0|||
130516702|NCT00607789|469859305|FG001|Overall Study|Lost to Follow-up|5|||
130516703|NCT00607789|469859304|FG000|Overall Study|Withdrawal by Subject|1|||
130516704|NCT00607789|469859305|FG001|Overall Study|Withdrawal by Subject|0|||
130516705|NCT01209286|469859306|FG000|Overall Study|Adverse Event|4|||
130516706|NCT01209286|469859307|FG001|Overall Study|Adverse Event|3|||
130516707|NCT01209286|469859308|FG002|Overall Study|Adverse Event|1|||
130516708|NCT01209286|469859306|FG000|Overall Study|Hematological Relapse After Remission|0|||
130516709|NCT01209286|469859307|FG001|Overall Study|Hematological Relapse After Remission|1|||
130516710|NCT01209286|469859308|FG002|Overall Study|Hematological Relapse After Remission|1|||
130516711|NCT01209286|469859306|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
130516712|NCT01209286|469859307|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
130516713|NCT01209286|469859308|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
130516714|NCT01209286|469859306|FG000|Overall Study|Physician Decision|0|||
130516715|NCT01209286|469859307|FG001|Overall Study|Physician Decision|2|||
130516716|NCT01209286|469859308|FG002|Overall Study|Physician Decision|0|||
130516717|NCT01209286|469859306|FG000|Overall Study|Other|0|||
130516718|NCT01209286|469859307|FG001|Overall Study|Other|1|||
130516719|NCT01209286|469859308|FG002|Overall Study|Other|0|||
130516720|NCT03915951|469859312|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
130516721|NCT03915951|469859313|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
130516722|NCT03915951|469859312|FG000|Overall Study|Adverse Event|12|||
130516723|NCT03915951|469859313|FG001|Overall Study|Adverse Event|6|||
130516724|NCT03915951|469859312|FG000|Overall Study|Disease progression (radiological)|17|||
130516725|NCT03915951|469859313|FG001|Overall Study|Disease progression (radiological)|15|||
130516726|NCT03915951|469859312|FG000|Overall Study|Disease progression (clinical)|4|||
130516727|NCT03915951|469859313|FG001|Overall Study|Disease progression (clinical)|1|||
130516728|NCT03915951|469859312|FG000|Overall Study|Patient decision|0|||
130516729|NCT03915951|469859313|FG001|Overall Study|Patient decision|4|||
130516730|NCT03915951|469859312|FG000|Overall Study|Investigator decision|0|||
130516731|NCT03915951|469859313|FG001|Overall Study|Investigator decision|1|||
130516732|NCT03915951|469859312|FG000|Overall Study|Consent withdrawn|1|||
130516733|NCT03915951|469859313|FG001|Overall Study|Consent withdrawn|1|||
130516734|NCT03915951|469859312|FG000|Overall Study|Death|0|||
130516735|NCT03915951|469859313|FG001|Overall Study|Death|3|||
130516736|NCT01196741|469859317|FG000|Overall Study|Disease progression|34|||
130516737|NCT01196741|469859318|FG001|Overall Study|Disease progression|14|||
130516738|NCT01196741|469859317|FG000|Overall Study|Adverse Event|10|||
130516739|NCT01196741|469859318|FG001|Overall Study|Adverse Event|6|||
130516740|NCT01196741|469859317|FG000|Overall Study|Serious Adverse Event|3|||
130516741|NCT01196741|469859318|FG001|Overall Study|Serious Adverse Event|1|||
130516742|NCT01196741|469859317|FG000|Overall Study|Dose limiting Adverse Event|2|||
130516743|NCT01196741|469859318|FG001|Overall Study|Dose limiting Adverse Event|1|||
130516744|NCT01196741|469859317|FG000|Overall Study|Withdrawal by Subject|3|||
130516745|NCT01196741|469859318|FG001|Overall Study|Withdrawal by Subject|0|||
130516746|NCT01196741|469859317|FG000|Overall Study|Other reason|3|||
130516747|NCT01196741|469859318|FG001|Overall Study|Other reason|3|||
130516748|NCT01196741|469859317|FG000|Overall Study|Other|3|||
130516749|NCT01196741|469859318|FG001|Overall Study|Other|2|||
130516750|NCT01196741|469859317|FG000|Overall Study|Protocol Violation|2|||
130516751|NCT01196741|469859318|FG001|Overall Study|Protocol Violation|1|||
130516752|NCT01064856|469859320|FG000|Double-blind (DB) Period|Adverse Event|1|||
130516753|NCT01064856|469859321|FG001|Double-blind (DB) Period|Adverse Event|0|||
130516754|NCT01064856|469859322|FG002|Double-blind (DB) Period|Adverse Event|0|||
130516755|NCT01064856|469859323|FG003|Double-blind (DB) Period|Adverse Event|0|||
130516756|NCT01064856|469859320|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
130516757|NCT01064856|469859321|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
130516758|NCT01064856|469859322|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
130516759|NCT01064856|469859323|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
130516760|NCT01064856|469859320|FG000|Open-label (OL) Period|Adverse Event|0|||
130516761|NCT01064856|469859321|FG001|Open-label (OL) Period|Adverse Event|0|||
130516762|NCT01064856|469859322|FG002|Open-label (OL) Period|Adverse Event|12|||
130516763|NCT01064856|469859323|FG003|Open-label (OL) Period|Adverse Event|6|||
130516764|NCT01064856|469859320|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
130516765|NCT01064856|469859321|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
130516766|NCT01064856|469859322|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
130516767|NCT01064856|469859323|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
130516768|NCT01064856|469859320|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
130516769|NCT01064856|469859321|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
130516770|NCT01064856|469859322|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
130516771|NCT01064856|469859323|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
130516772|NCT01064856|469859320|FG000|Open-label (OL) Period|Other|0|||
130516773|NCT01064856|469859321|FG001|Open-label (OL) Period|Other|0|||
130516774|NCT01064856|469859322|FG002|Open-label (OL) Period|Other|7|||
130516775|NCT01064856|469859323|FG003|Open-label (OL) Period|Other|7|||
130516776|NCT01204775|469859324|FG000|Overall Study|Poor/non-compliance|0|||
130516777|NCT01204775|469859325|FG001|Overall Study|Poor/non-compliance|1|||
130516778|NCT01204775|469859324|FG000|Overall Study|Withdrawal by Subject|1|||
130516779|NCT01204775|469859325|FG001|Overall Study|Withdrawal by Subject|0|||
130516780|NCT02273180|469859326|FG000|Overall Study|Adverse Event|2|||
130516781|NCT02273180|469859327|FG001|Overall Study|Adverse Event|2|||
130516782|NCT02273180|469859326|FG000|Overall Study|Lack of Efficacy|1|||
130516783|NCT02273180|469859327|FG001|Overall Study|Lack of Efficacy|0|||
130516784|NCT02273180|469859326|FG000|Overall Study|Protocol Violation|1|||
130516785|NCT02273180|469859327|FG001|Overall Study|Protocol Violation|7|||
130516786|NCT02273180|469859326|FG000|Overall Study|Randomized but not treated|1|||
130516787|NCT02273180|469859327|FG001|Overall Study|Randomized but not treated|0|||
130516788|NCT02273180|469859326|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
130516789|NCT02273180|469859327|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
130516790|NCT02273180|469859326|FG000|Overall Study|Other than specified above|21|||
130516791|NCT02273180|469859327|FG001|Overall Study|Other than specified above|10|||
130516792|NCT03749616|469859330|FG000|Overall Study|Lost to Follow-up|4|||
130516793|NCT03749616|469859331|FG001|Overall Study|Lost to Follow-up|7|||
130516794|NCT03749616|469859330|FG000|Overall Study|Screen Failure|1|||
130516795|NCT03749616|469859331|FG001|Overall Study|Screen Failure|1|||
130516796|NCT03749616|469859330|FG000|Overall Study|Withdrawal by Subject|2|||
130516797|NCT03749616|469859331|FG001|Overall Study|Withdrawal by Subject|0|||
130516798|NCT04435522|469859334|FG000|Overall Study|Withdrawal by Subject|2|||
130516799|NCT00951171|469859335|FG000|Overall Study|Adverse Event|2|||
130516800|NCT00951171|469859336|FG001|Overall Study|Adverse Event|0|||
130516801|NCT00919061|469859337|FG000|Overall Study|Adverse Event|1|||
130516802|NCT00919061|469859337|FG000|Overall Study|Withdrawal by Subject|1|||
130516803|NCT05294328|469859346|FG000|Overall Study|Adverse Event|1|||
130516804|NCT05294328|469859347|FG001|Overall Study|Adverse Event|0|||
130516805|NCT05294328|469859348|FG002|Overall Study|Adverse Event|0|||
130516806|NCT05294328|469859346|FG000|Overall Study|Physician Decision|1|||
130516807|NCT05294328|469859347|FG001|Overall Study|Physician Decision|1|||
130516808|NCT05294328|469859348|FG002|Overall Study|Physician Decision|0|||
130516809|NCT05294328|469859346|FG000|Overall Study|Withdrawal by Subject|0|||
130516810|NCT05294328|469859347|FG001|Overall Study|Withdrawal by Subject|2|||
130516811|NCT05294328|469859348|FG002|Overall Study|Withdrawal by Subject|1|||
130516812|NCT05294328|469859346|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
130516813|NCT05294328|469859347|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
130516814|NCT05294328|469859348|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
130516815|NCT02056873|469859349|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
130516816|NCT00113269|469861074|FG000|Overall Study|Not transplanted, donor issues|4|||
130516817|NCT00113269|469861075|FG001|Overall Study|Not transplanted, donor issues|0|||
130516818|NCT00113269|469861076|FG002|Overall Study|Not transplanted, donor issues|2|||
130516819|NCT00113269|469861077|FG003|Overall Study|Not transplanted, donor issues|2|||
130516820|NCT00113269|469861074|FG000|Overall Study|Not transplanted, recipient issues|2|||
130516821|NCT00113269|469861075|FG001|Overall Study|Not transplanted, recipient issues|1|||
130516822|NCT00113269|469861076|FG002|Overall Study|Not transplanted, recipient issues|7|||
130516823|NCT00113269|469861077|FG003|Overall Study|Not transplanted, recipient issues|4|||
130516824|NCT00113269|469861074|FG000|Overall Study|Early graft loss, technical|0|||
130516825|NCT00113269|469861075|FG001|Overall Study|Early graft loss, technical|0|||
130516826|NCT00113269|469861076|FG002|Overall Study|Early graft loss, technical|2|||
130516827|NCT00113269|469861077|FG003|Overall Study|Early graft loss, technical|0|||
130516828|NCT00113269|469861074|FG000|Overall Study|Death in operating room|0|||
130516829|NCT00113269|469861075|FG001|Overall Study|Death in operating room|0|||
130516830|NCT00113269|469861076|FG002|Overall Study|Death in operating room|0|||
130516831|NCT00113269|469861077|FG003|Overall Study|Death in operating room|1|||
130516832|NCT00113269|469861074|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
130571383|NCT00401375|470055773|FG002|Overall Study|Lost to Follow-up|1|||
130516833|NCT00113269|469861075|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
130516834|NCT00113269|469861076|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
130516835|NCT00113269|469861077|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
130516836|NCT00113269|469861074|FG000|Overall Study|Adverse Event|2|||
130516837|NCT00113269|469861075|FG001|Overall Study|Adverse Event|7|||
130516838|NCT00113269|469861076|FG002|Overall Study|Adverse Event|11|||
130516839|NCT00113269|469861077|FG003|Overall Study|Adverse Event|7|||
130516840|NCT00113269|469861074|FG000|Overall Study|Withdrawal by Subject|4|||
130516841|NCT00113269|469861075|FG001|Overall Study|Withdrawal by Subject|3|||
130516842|NCT00113269|469861076|FG002|Overall Study|Withdrawal by Subject|4|||
130516843|NCT00113269|469861077|FG003|Overall Study|Withdrawal by Subject|2|||
130516844|NCT00113269|469861074|FG000|Overall Study|Graft loss|6|||
130516845|NCT00113269|469861075|FG001|Overall Study|Graft loss|6|||
130516846|NCT00113269|469861076|FG002|Overall Study|Graft loss|4|||
130516847|NCT00113269|469861077|FG003|Overall Study|Graft loss|9|||
130516848|NCT00113269|469861074|FG000|Overall Study|Protocol Violation|1|||
130516849|NCT00113269|469861075|FG001|Overall Study|Protocol Violation|0|||
130516850|NCT00113269|469861076|FG002|Overall Study|Protocol Violation|4|||
130516851|NCT00113269|469861077|FG003|Overall Study|Protocol Violation|2|||
130516852|NCT00113269|469861074|FG000|Overall Study|Lost to Follow-up|2|||
130516853|NCT00113269|469861075|FG001|Overall Study|Lost to Follow-up|3|||
130516854|NCT00113269|469861076|FG002|Overall Study|Lost to Follow-up|6|||
130516855|NCT00113269|469861077|FG003|Overall Study|Lost to Follow-up|3|||
130516856|NCT00113269|469861074|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
130516857|NCT00113269|469861075|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
130516858|NCT00113269|469861076|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
130516859|NCT00113269|469861077|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
130516860|NCT00113269|469861074|FG000|Overall Study|Discontinued due to rejection|0|||
130516861|NCT00113269|469861075|FG001|Overall Study|Discontinued due to rejection|0|||
130516862|NCT00113269|469861076|FG002|Overall Study|Discontinued due to rejection|1|||
130516863|NCT00113269|469861077|FG003|Overall Study|Discontinued due to rejection|0|||
130516864|NCT00113269|469861074|FG000|Overall Study|Moved|0|||
130516865|NCT00113269|469861075|FG001|Overall Study|Moved|1|||
130516866|NCT00113269|469861076|FG002|Overall Study|Moved|0|||
130516867|NCT00113269|469861077|FG003|Overall Study|Moved|3|||
130516868|NCT00113269|469861074|FG000|Overall Study|Received pancreas transplant|0|||
130516869|NCT00113269|469861075|FG001|Overall Study|Received pancreas transplant|0|||
130516870|NCT00113269|469861076|FG002|Overall Study|Received pancreas transplant|0|||
130516871|NCT00113269|469861077|FG003|Overall Study|Received pancreas transplant|2|||
130516872|NCT00113269|469861074|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
130516873|NCT00113269|469861075|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
130516874|NCT00113269|469861076|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
130516875|NCT00113269|469861077|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
130516876|NCT00113269|469861074|FG000|Overall Study|Did not meet eligibility criteria|1|||
130516877|NCT00113269|469861075|FG001|Overall Study|Did not meet eligibility criteria|0|||
130516878|NCT00113269|469861076|FG002|Overall Study|Did not meet eligibility criteria|0|||
130516879|NCT00113269|469861077|FG003|Overall Study|Did not meet eligibility criteria|1|||
130516880|NCT00113269|469861074|FG000|Overall Study|Unable to return for follow up|2|||
130516881|NCT00113269|469861075|FG001|Overall Study|Unable to return for follow up|1|||
130516882|NCT00113269|469861076|FG002|Overall Study|Unable to return for follow up|0|||
130516883|NCT00113269|469861077|FG003|Overall Study|Unable to return for follow up|0|||
130516884|NCT01821729|469861078|FG000|Overall Study|Withdrawal by Subject|1|||
130516885|NCT01093599|469861081|FG000|Overall Study|Lost to Follow-up|32|||
130516886|NCT01093599|469861082|FG001|Overall Study|Lost to Follow-up|46|||
130516887|NCT01703845|469861083|FG000|Overall Study|Adverse Event|1|||
130516888|NCT01703845|469861084|FG001|Overall Study|Adverse Event|0|||
130516889|NCT01703845|469861083|FG000|Overall Study|Protocol Violation|1|||
130516890|NCT01703845|469861084|FG001|Overall Study|Protocol Violation|0|||
130516891|NCT01703845|469861083|FG000|Overall Study|other than stated above|1|||
130516892|NCT01703845|469861084|FG001|Overall Study|other than stated above|0|||
130516893|NCT01644188|469861085|FG000|Overall Study|Adverse Event|44|||
130516894|NCT01644188|469861086|FG001|Overall Study|Adverse Event|20|||
130516895|NCT01644188|469861085|FG000|Overall Study|Poor compliance to protocol|26|||
130516896|NCT01644188|469861086|FG001|Overall Study|Poor compliance to protocol|14|||
130516897|NCT01644188|469861085|FG000|Overall Study|Physician Decision|1|||
130516898|NCT01644188|469861086|FG001|Overall Study|Physician Decision|3|||
130516899|NCT01644188|469861085|FG000|Overall Study|Participant moved|7|||
130516900|NCT01644188|469861086|FG001|Overall Study|Participant moved|2|||
130516901|NCT01644188|469861085|FG000|Overall Study|Related to auto-injector administration|2|||
130516902|NCT01644188|469861086|FG001|Overall Study|Related to auto-injector administration|2|||
130516903|NCT01644188|469861085|FG000|Overall Study|Consent withdrawn by participant|14|||
130516904|NCT01644188|469861086|FG001|Overall Study|Consent withdrawn by participant|7|||
130516905|NCT01644188|469861085|FG000|Overall Study|Selection criteria finally not met|2|||
130516906|NCT01644188|469861086|FG001|Overall Study|Selection criteria finally not met|0|||
130516907|NCT01644188|469861085|FG000|Overall Study|Lost to Follow-up|1|||
130516908|NCT01644188|469861086|FG001|Overall Study|Lost to Follow-up|0|||
130516909|NCT01644188|469861085|FG000|Overall Study|Death|4|||
130516910|NCT01644188|469861086|FG001|Overall Study|Death|3|||
130516911|NCT01644188|469861085|FG000|Overall Study|Last visit outside protocol visit window|14|||
130516912|NCT01644188|469861086|FG001|Overall Study|Last visit outside protocol visit window|16|||
130516913|NCT01644188|469861085|FG000|Overall Study|Site closure|1|||
130516914|NCT01644188|469861086|FG001|Overall Study|Site closure|1|||
130516915|NCT01644188|469861085|FG000|Overall Study|Other than specified above|6|||
130516916|NCT01644188|469861086|FG001|Overall Study|Other than specified above|7|||
130516917|NCT00966979|469861090|FG000|Overall Study|Death|1|||
130516918|NCT00966979|469861090|FG000|Overall Study|Lost to Follow-up|6|||
130516919|NCT00966979|469861090|FG000|Overall Study|Withdrawal by Subject|14|||
130516920|NCT00966979|469861090|FG000|Overall Study|Adverse Event|5|||
130516921|NCT00966979|469861090|FG000|Overall Study|Sponsor terminated early|49|||
130516922|NCT00966979|469861090|FG000|Overall Study|Censored because surgery not done|2|||
130516923|NCT00966979|469861090|FG000|Overall Study|Censored because study device was not implanted|14|||
130516924|NCT00966979|469861090|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
130516925|NCT04140266|469861091|FG000|Overall Study|Physician Decision|2|||
130516926|NCT04140266|469861092|FG001|Overall Study|Physician Decision|0|||
130516927|NCT04140266|469861091|FG000|Overall Study|Withdrawal by Subject|4|||
130516928|NCT04140266|469861092|FG001|Overall Study|Withdrawal by Subject|2|||
130516929|NCT03119688|469861096|FG000|Overall Study|Adverse Event|4|||
130516930|NCT01649557|469861097|FG000|Overall Study|Lost to Follow-up|5|||
130516931|NCT01649557|469861098|FG001|Overall Study|Lost to Follow-up|0|||
130516932|NCT01649557|469861099|FG002|Overall Study|Lost to Follow-up|3|||
130516933|NCT01649557|469861097|FG000|Overall Study|Adverse Event|7|||
130516934|NCT01649557|469861098|FG001|Overall Study|Adverse Event|5|||
130516935|NCT01649557|469861099|FG002|Overall Study|Adverse Event|1|||
130516936|NCT01649557|469861097|FG000|Overall Study|Met withdrawal criteria|4|||
130516937|NCT01649557|469861098|FG001|Overall Study|Met withdrawal criteria|0|||
130516938|NCT01649557|469861099|FG002|Overall Study|Met withdrawal criteria|0|||
130516939|NCT01649557|469861097|FG000|Overall Study|Physician Decision|8|||
130516940|NCT01649557|469861098|FG001|Overall Study|Physician Decision|2|||
130516941|NCT01649557|469861099|FG002|Overall Study|Physician Decision|1|||
130516942|NCT01649557|469861097|FG000|Overall Study|Withdrawal by Subject|15|||
130516943|NCT01649557|469861098|FG001|Overall Study|Withdrawal by Subject|5|||
130516944|NCT01649557|469861099|FG002|Overall Study|Withdrawal by Subject|4|||
130516945|NCT01649557|469861097|FG000|Overall Study|Protocol deviation|0|||
130516946|NCT01649557|469861098|FG001|Overall Study|Protocol deviation|2|||
130516947|NCT01649557|469861099|FG002|Overall Study|Protocol deviation|0|||
130516948|NCT01649557|469861097|FG000|Overall Study|Lack of Efficacy|5|||
130516949|NCT01649557|469861098|FG001|Overall Study|Lack of Efficacy|0|||
130516950|NCT01649557|469861099|FG002|Overall Study|Lack of Efficacy|0|||
130516951|NCT03029234|469861102|FG000|Overall Study|Sponsor Decision|1|||
130516952|NCT03029234|469861102|FG000|Overall Study|Withdrawal by Subject|5|||
130516953|NCT03029234|469861102|FG000|Overall Study|Death|91|||
130516954|NCT03029234|469861102|FG000|Overall Study|Lost to Follow-up|2|||
130516955|NCT01649297|469861103|FG000|Overall Study|Adverse Event|5|||
130516956|NCT01649297|469861104|FG001|Overall Study|Adverse Event|5|||
130516957|NCT01649297|469861105|FG002|Overall Study|Adverse Event|4|||
130516958|NCT01649297|469861106|FG003|Overall Study|Adverse Event|13|||
130516959|NCT01649297|469861107|FG004|Overall Study|Adverse Event|1|||
130516960|NCT01649297|469861103|FG000|Overall Study|Lack of Efficacy|0|||
130516961|NCT01649297|469861104|FG001|Overall Study|Lack of Efficacy|0|||
130516962|NCT01649297|469861105|FG002|Overall Study|Lack of Efficacy|0|||
130516963|NCT01649297|469861106|FG003|Overall Study|Lack of Efficacy|0|||
130516964|NCT01649297|469861107|FG004|Overall Study|Lack of Efficacy|1|||
130516965|NCT01649297|469861103|FG000|Overall Study|Non compliant with Protocol|1|||
130516966|NCT01649297|469861104|FG001|Overall Study|Non compliant with Protocol|0|||
130516967|NCT01649297|469861105|FG002|Overall Study|Non compliant with Protocol|3|||
130516968|NCT01649297|469861106|FG003|Overall Study|Non compliant with Protocol|2|||
130516969|NCT01649297|469861107|FG004|Overall Study|Non compliant with Protocol|1|||
130516970|NCT01649297|469861103|FG000|Overall Study|Lost to Follow-up|1|||
130516971|NCT01649297|469861104|FG001|Overall Study|Lost to Follow-up|1|||
130516972|NCT01649297|469861105|FG002|Overall Study|Lost to Follow-up|4|||
130516973|NCT01649297|469861106|FG003|Overall Study|Lost to Follow-up|3|||
130516974|NCT01649297|469861107|FG004|Overall Study|Lost to Follow-up|0|||
130516975|NCT01649297|469861103|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
130516976|NCT01649297|469861104|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
130516977|NCT01649297|469861105|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
130516978|NCT01649297|469861106|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
130516979|NCT01649297|469861107|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
130516980|NCT01649297|469861103|FG000|Overall Study|For other reason|4|||
130516981|NCT01649297|469861104|FG001|Overall Study|For other reason|1|||
130516982|NCT01649297|469861105|FG002|Overall Study|For other reason|2|||
130516983|NCT01649297|469861106|FG003|Overall Study|For other reason|0|||
130516984|NCT01649297|469861107|FG004|Overall Study|For other reason|0|||
130516985|NCT01685047|469861108|FG000|Overall Study|Withdrawal by Subject|20|||
130516986|NCT01685047|469861108|FG000|Overall Study|Death|26|||
130516987|NCT01685047|469861108|FG000|Overall Study|Lost to Follow-up|8|||
130516988|NCT01685047|469861108|FG000|Overall Study|Physician Decision|25|||
130516989|NCT01685047|469861108|FG000|Overall Study|Adverse Event|5|||
130516990|NCT01685047|469861108|FG000|Overall Study|patient withdrawn by sponsor|1|||
130516991|NCT02544113|469861109|FG000|Overall Study|Death|3|||
130516992|NCT02544113|469861110|FG001|Overall Study|Death|4|||
130516993|NCT02847637|469861112|FG000|Overall Study|Withdrawal by Subject|0|||
130516994|NCT02847637|469861113|FG001|Overall Study|Withdrawal by Subject|1|||
130516995|NCT02847637|469861114|FG002|Overall Study|Withdrawal by Subject|1|||
130516996|NCT02847637|469861115|FG003|Overall Study|Withdrawal by Subject|0|||
130516997|NCT02847637|469861112|FG000|Overall Study|Lost to Follow-up|1|||
130516998|NCT02847637|469861113|FG001|Overall Study|Lost to Follow-up|1|||
130516999|NCT02847637|469861114|FG002|Overall Study|Lost to Follow-up|0|||
130517000|NCT02847637|469861115|FG003|Overall Study|Lost to Follow-up|0|||
130517001|NCT01746108|469861118|FG000|Overall Study|Migrated /moved from study area|0|||
130517002|NCT01746108|469861119|FG001|Overall Study|Migrated /moved from study area|1|||
130517003|NCT01746108|469861120|FG002|Overall Study|Migrated /moved from study area|0|||
130517004|NCT01746108|469861118|FG000|Overall Study|Adverse event, non-fatal|0|||
130517005|NCT01746108|469861119|FG001|Overall Study|Adverse event, non-fatal|1|||
130517006|NCT01746108|469861120|FG002|Overall Study|Adverse event, non-fatal|0|||
130517007|NCT01746108|469861118|FG000|Overall Study|Withdrawal by Subject|0|||
130517008|NCT01746108|469861119|FG001|Overall Study|Withdrawal by Subject|1|||
130517009|NCT01746108|469861120|FG002|Overall Study|Withdrawal by Subject|0|||
130517010|NCT01746108|469861118|FG000|Overall Study|Lost to Follow-up|0|||
130517011|NCT01746108|469861119|FG001|Overall Study|Lost to Follow-up|1|||
130517012|NCT01746108|469861120|FG002|Overall Study|Lost to Follow-up|0|||
130517013|NCT01388478|469861126|FG000|Overall Study|Adverse Event|4|||
130517014|NCT01388478|469861126|FG000|Overall Study|Withdrawal by Subject|1|||
130517015|NCT01990664|469861127|FG000|Overall Study|Lost to Follow-up|2|||
130517016|NCT01990664|469861128|FG001|Overall Study|Lost to Follow-up|6|||
130517017|NCT01990664|469861127|FG000|Overall Study|Withdrawal by Subject|2|||
130517018|NCT01990664|469861128|FG001|Overall Study|Withdrawal by Subject|3|||
130517019|NCT01990664|469861127|FG000|Overall Study|Protocol Violation|1|||
130517020|NCT01990664|469861128|FG001|Overall Study|Protocol Violation|0|||
130517021|NCT01990664|469861127|FG000|Overall Study|Lens Discomfort|1|||
130517022|NCT01990664|469861128|FG001|Overall Study|Lens Discomfort|1|||
130517023|NCT01990664|469861127|FG000|Overall Study|Lens Handling Difficulties|1|||
130571384|NCT00401375|470055771|FG000|Overall Study|Other than specified|2|||
130571385|NCT00401375|470055772|FG001|Overall Study|Other than specified|1|||
130571386|NCT00401375|470055773|FG002|Overall Study|Other than specified|3|||
130571387|NCT00401375|470055771|FG000|Overall Study|Randomized but not treated|3|||
130571388|NCT00401375|470055772|FG001|Overall Study|Randomized but not treated|3|||
130571389|NCT00401375|470055773|FG002|Overall Study|Randomized but not treated|3|||
130571390|NCT03152019|470055774|FG000|Overall Study|Adverse Event|0|||
130571391|NCT03152019|470055775|FG001|Overall Study|Adverse Event|1|||
130571392|NCT00254501|470055781|FG000|Overall Study|Lost to Follow-up|1|||
130571393|NCT00254501|470055782|FG001|Overall Study|Lost to Follow-up|1|||
130571394|NCT00923130|470055783|FG000|Overall Study|Stopped treatment due to progression|17|||
130571395|NCT00923130|470055783|FG000|Overall Study|Death|1|||
130517024|NCT01990664|469861128|FG001|Overall Study|Lens Handling Difficulties|0|||
130517025|NCT01990664|469861127|FG000|Overall Study|Unsatisfactory Visual Response|0|||
130517026|NCT01990664|469861128|FG001|Overall Study|Unsatisfactory Visual Response|1|||
130517027|NCT02246218|469861129|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130517028|NCT02246218|469861130|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130517029|NCT02246218|469861129|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
130517030|NCT02246218|469861130|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
130517031|NCT02246218|469861129|FG000|Overall Study|Adverse Event|1|||
130517032|NCT02246218|469861130|FG001|Overall Study|Adverse Event|1|||
130517033|NCT02246218|469861129|FG000|Overall Study|Lost to Follow-up|1|||
130517034|NCT02246218|469861130|FG001|Overall Study|Lost to Follow-up|0|||
130517035|NCT03891641|469861131|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
130517036|NCT03891641|469861132|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
130517037|NCT01713998|469861134|FG000|Overall Study|Lost to Follow-up|2|||
130517038|NCT01713998|469861135|FG001|Overall Study|Lost to Follow-up|0|||
130517039|NCT01713998|469861136|FG002|Overall Study|Lost to Follow-up|2|||
130517040|NCT01713998|469861134|FG000|Overall Study|Withdrawal by Subject|1|||
130517041|NCT01713998|469861135|FG001|Overall Study|Withdrawal by Subject|0|||
130517042|NCT01713998|469861136|FG002|Overall Study|Withdrawal by Subject|0|||
130517043|NCT02101268|469861137|FG000|Randomized Treatment Phase|Subject Decision|8|||
130571396|NCT00923130|470055783|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
130571397|NCT00923130|470055783|FG000|Overall Study|Switched to alternative treatment|2|||
130517044|NCT02101268|469861138|FG001|Randomized Treatment Phase|Subject Decision|4|||
130517045|NCT02101268|469861139|FG002|Randomized Treatment Phase|Subject Decision|0|||
130517046|NCT02101268|469861140|FG003|Randomized Treatment Phase|Subject Decision|0|||
130571398|NCT00923130|470055783|FG000|Overall Study|Refused further treatment|2|||
130517047|NCT02101268|469861137|FG000|Randomized Treatment Phase|Physician Decision|4|||
130517048|NCT02101268|469861138|FG001|Randomized Treatment Phase|Physician Decision|1|||
130517049|NCT02101268|469861139|FG002|Randomized Treatment Phase|Physician Decision|0|||
130517050|NCT02101268|469861140|FG003|Randomized Treatment Phase|Physician Decision|0|||
130517051|NCT02101268|469861137|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
130517052|NCT02101268|469861138|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
130517053|NCT02101268|469861139|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
130517054|NCT02101268|469861140|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
130517055|NCT02101268|469861137|FG000|Randomized Treatment Phase|Adverse Event|6|||
130517056|NCT02101268|469861138|FG001|Randomized Treatment Phase|Adverse Event|0|||
130517057|NCT02101268|469861139|FG002|Randomized Treatment Phase|Adverse Event|0|||
130517058|NCT02101268|469861140|FG003|Randomized Treatment Phase|Adverse Event|0|||
130517059|NCT02101268|469861137|FG000|Randomized Treatment Phase|Death|5|||
130517060|NCT02101268|469861138|FG001|Randomized Treatment Phase|Death|4|||
130517061|NCT02101268|469861139|FG002|Randomized Treatment Phase|Death|0|||
130517062|NCT02101268|469861140|FG003|Randomized Treatment Phase|Death|0|||
130517063|NCT02101268|469861137|FG000|Randomized Treatment Phase|Disease Progression|4|||
130517064|NCT02101268|469861138|FG001|Randomized Treatment Phase|Disease Progression|1|||
130517065|NCT02101268|469861139|FG002|Randomized Treatment Phase|Disease Progression|0|||
130517066|NCT02101268|469861140|FG003|Randomized Treatment Phase|Disease Progression|0|||
130517067|NCT02101268|469861137|FG000|Extended Treatment Phase|Subject Decision|0|||
130517068|NCT02101268|469861138|FG001|Extended Treatment Phase|Subject Decision|0|||
130517069|NCT02101268|469861139|FG002|Extended Treatment Phase|Subject Decision|3|||
130517070|NCT02101268|469861140|FG003|Extended Treatment Phase|Subject Decision|2|||
130517071|NCT02101268|469861137|FG000|Extended Treatment Phase|Physician Decision|0|||
130517072|NCT02101268|469861138|FG001|Extended Treatment Phase|Physician Decision|0|||
130517073|NCT02101268|469861139|FG002|Extended Treatment Phase|Physician Decision|5|||
130517074|NCT02101268|469861140|FG003|Extended Treatment Phase|Physician Decision|2|||
130517075|NCT02101268|469861137|FG000|Extended Treatment Phase|Adverse Event|0|||
130517076|NCT02101268|469861138|FG001|Extended Treatment Phase|Adverse Event|0|||
130517077|NCT02101268|469861139|FG002|Extended Treatment Phase|Adverse Event|14|||
130517078|NCT02101268|469861140|FG003|Extended Treatment Phase|Adverse Event|18|||
130517079|NCT02101268|469861137|FG000|Extended Treatment Phase|Death|0|||
130517080|NCT02101268|469861138|FG001|Extended Treatment Phase|Death|0|||
130517081|NCT02101268|469861139|FG002|Extended Treatment Phase|Death|5|||
130517082|NCT02101268|469861140|FG003|Extended Treatment Phase|Death|1|||
130517083|NCT02101268|469861137|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
130517084|NCT02101268|469861138|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
130517085|NCT02101268|469861139|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
130517086|NCT02101268|469861140|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
130517087|NCT02101268|469861137|FG000|Extended Treatment Phase|Disease Progression|0|||
130517088|NCT02101268|469861138|FG001|Extended Treatment Phase|Disease Progression|0|||
130517089|NCT02101268|469861139|FG002|Extended Treatment Phase|Disease Progression|13|||
130517090|NCT02101268|469861140|FG003|Extended Treatment Phase|Disease Progression|6|||
130517091|NCT02101268|469861137|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
130517092|NCT02101268|469861138|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
130517093|NCT02101268|469861139|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
130517094|NCT02101268|469861140|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
130517095|NCT00740870|469861141|FG000|Overall Study|Not Catheterized|4|||
130517096|NCT00740870|469861141|FG000|Overall Study|Further testing contraindicated implant|17|||
130517097|NCT00607997|469861142|FG000|Overall Study|Lack of Efficacy|6|||
130517098|NCT00607997|469861143|FG001|Overall Study|Lack of Efficacy|20|||
130517099|NCT00607997|469861144|FG002|Overall Study|Lack of Efficacy|14|||
130517100|NCT00607997|469861145|FG003|Overall Study|Lack of Efficacy|10|||
130517101|NCT00607997|469861142|FG000|Overall Study|Death|8|||
130517102|NCT00607997|469861143|FG001|Overall Study|Death|5|||
130517103|NCT00607997|469861144|FG002|Overall Study|Death|2|||
130517104|NCT00607997|469861145|FG003|Overall Study|Death|5|||
130517105|NCT00607997|469861142|FG000|Overall Study|Adverse Event|3|||
130517106|NCT00607997|469861143|FG001|Overall Study|Adverse Event|1|||
130517107|NCT00607997|469861144|FG002|Overall Study|Adverse Event|2|||
130517108|NCT00607997|469861145|FG003|Overall Study|Adverse Event|0|||
130517109|NCT00607997|469861142|FG000|Overall Study|Physician Decision|4|||
130571399|NCT04194528|470055791|FG000|Overall Study|Adverse Event|1|||
130571400|NCT03921424|470055795|FG000|Overall Study|Lost to Follow-up|0|||
130517110|NCT00607997|469861143|FG001|Overall Study|Physician Decision|1|||
130517111|NCT00607997|469861144|FG002|Overall Study|Physician Decision|0|||
130517112|NCT00607997|469861145|FG003|Overall Study|Physician Decision|0|||
130517113|NCT00607997|469861142|FG000|Overall Study|Relapse, recurrent illness|4|||
130517114|NCT00607997|469861143|FG001|Overall Study|Relapse, recurrent illness|0|||
130517115|NCT00607997|469861144|FG002|Overall Study|Relapse, recurrent illness|2|||
130517116|NCT00607997|469861145|FG003|Overall Study|Relapse, recurrent illness|0|||
130517117|NCT00607997|469861142|FG000|Overall Study|Other without explanation|2|||
130571401|NCT03921424|470055796|FG001|Overall Study|Lost to Follow-up|1|||
130571402|NCT03921424|470055795|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130571403|NCT03921424|470055796|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130571404|NCT00522431|470057281|FG000|Overall Study|Adverse Event|5|||
130571405|NCT00522431|470057281|FG000|Overall Study|Protocol Violation|2|||
130571406|NCT00522431|470057281|FG000|Overall Study|Withdrawal by Subject|2|||
130571407|NCT00522431|470057281|FG000|Overall Study|Subject non-compliance|1|||
130571408|NCT00522431|470057281|FG000|Overall Study|Other/unknown|1|||
130571409|NCT00513409|470057287|FG000|Overall Study|Adverse Event|0|||
130571410|NCT00513409|470057288|FG001|Overall Study|Adverse Event|1|||
130571411|NCT00513409|470057287|FG000|Overall Study|Withdrawal by Subject|0|||
130571412|NCT00513409|470057288|FG001|Overall Study|Withdrawal by Subject|2|||
130571413|NCT00513409|470057287|FG000|Overall Study|Lost to Follow-up|0|||
130571414|NCT00513409|470057288|FG001|Overall Study|Lost to Follow-up|1|||
130571415|NCT00513409|470057287|FG000|Overall Study|Physician Decision|1|||
130571416|NCT00513409|470057288|FG001|Overall Study|Physician Decision|0|||
130571417|NCT00513409|470057287|FG000|Overall Study|Visit 3 not done|1|||
130571418|NCT00513409|470057288|FG001|Overall Study|Visit 3 not done|2|||
130571419|NCT01049035|470057289|FG000|Overall Study|Serious adverse event|0|||
130571420|NCT01049035|470057290|FG001|Overall Study|Serious adverse event|1|||
130571421|NCT01049035|470057291|FG002|Overall Study|Serious adverse event|1|||
130571422|NCT01049035|470057292|FG003|Overall Study|Serious adverse event|2|||
130571423|NCT01049035|470057293|FG004|Overall Study|Serious adverse event|0|||
130571424|NCT01049035|470057294|FG005|Overall Study|Serious adverse event|0|||
130571425|NCT01049035|470057295|FG006|Overall Study|Serious adverse event|0|||
130571426|NCT01049035|470057289|FG000|Overall Study|Other adverse event (AE)|0|||
130571427|NCT01049035|470057290|FG001|Overall Study|Other adverse event (AE)|0|||
130571428|NCT01049035|470057291|FG002|Overall Study|Other adverse event (AE)|0|||
130571429|NCT01049035|470057292|FG003|Overall Study|Other adverse event (AE)|1|||
130571430|NCT01049035|470057293|FG004|Overall Study|Other adverse event (AE)|0|||
130571431|NCT01049035|470057294|FG005|Overall Study|Other adverse event (AE)|0|||
130571432|NCT01049035|470057295|FG006|Overall Study|Other adverse event (AE)|0|||
130571433|NCT01049035|470057289|FG000|Overall Study|Non-compliance with the protocol|12|||
130571434|NCT01049035|470057290|FG001|Overall Study|Non-compliance with the protocol|6|||
130571435|NCT01049035|470057291|FG002|Overall Study|Non-compliance with the protocol|14|||
130571436|NCT01049035|470057292|FG003|Overall Study|Non-compliance with the protocol|5|||
130571437|NCT01049035|470057293|FG004|Overall Study|Non-compliance with the protocol|3|||
130571438|NCT01049035|470057294|FG005|Overall Study|Non-compliance with the protocol|4|||
130571439|NCT01049035|470057295|FG006|Overall Study|Non-compliance with the protocol|10|||
130571440|NCT01049035|470057289|FG000|Overall Study|Lost to Follow-up|5|||
130571441|NCT01049035|470057290|FG001|Overall Study|Lost to Follow-up|4|||
130571442|NCT01049035|470057291|FG002|Overall Study|Lost to Follow-up|4|||
130571443|NCT01049035|470057292|FG003|Overall Study|Lost to Follow-up|1|||
130571444|NCT01049035|470057293|FG004|Overall Study|Lost to Follow-up|0|||
130571445|NCT01049035|470057294|FG005|Overall Study|Lost to Follow-up|3|||
130571446|NCT01049035|470057295|FG006|Overall Study|Lost to Follow-up|3|||
130571447|NCT01049035|470057289|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
130571448|NCT01049035|470057290|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
130571449|NCT01049035|470057291|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
130571450|NCT01049035|470057292|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
130571451|NCT01049035|470057293|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
130571452|NCT01049035|470057294|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
130571453|NCT01049035|470057295|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
130571454|NCT03189446|470057297|FG000|Overall Study|Adverse Event|2|||
130571455|NCT03189446|470057297|FG000|Overall Study|Withdrawal by Subject|2|||
130571456|NCT03189446|470057297|FG000|Overall Study|Physician Decision|1|||
130571457|NCT05634577|470057298|FG000|Overall Study|Lost to Follow-up|1|||
130571458|NCT05634577|470057298|FG000|Overall Study|Withdrawal by Subject|1|||
130571459|NCT04839978|470057299|FG000|Overall Study|Lost to Follow-up|135|||
130571460|NCT04839978|470057300|FG001|Overall Study|Lost to Follow-up|147|||
130571461|NCT03865706|470057301|FG000|Overall Study|Death|0|||
130571462|NCT03865706|470057302|FG001|Overall Study|Death|3|||
130571463|NCT03865706|470057303|FG002|Overall Study|Death|1|||
130571464|NCT02412787|470057307|FG000|Overall Study|Withdrawal by Subject|9|||
130571465|NCT02412787|470057307|FG000|Overall Study|Participation Terminated by Investigator|1|||
130571466|NCT02412787|470057307|FG000|Overall Study|Site Terminated by Sponsor|21|||
130571467|NCT02412787|470057307|FG000|Overall Study|Technical Problems|1|||
130571468|NCT02412787|470057307|FG000|Overall Study|Reason Not Specified|1|||
130571469|NCT02311153|470057308|FG000|Overall Study|Lost to Follow-up|5|||
130571470|NCT02311153|470057309|FG001|Overall Study|Lost to Follow-up|7|||
130571471|NCT00957008|470057314|FG000|Overall Study|Withdrawal by Subject|13|||
130571472|NCT00957008|470057315|FG001|Overall Study|Withdrawal by Subject|10|||
130571473|NCT00957008|470057316|FG002|Overall Study|Withdrawal by Subject|12|||
130571474|NCT00957008|470057317|FG003|Overall Study|Withdrawal by Subject|16|||
130571475|NCT00957008|470057314|FG000|Overall Study|Lost to Follow-up|3|||
130571476|NCT00957008|470057315|FG001|Overall Study|Lost to Follow-up|1|||
130571477|NCT00957008|470057316|FG002|Overall Study|Lost to Follow-up|3|||
130571478|NCT00957008|470057317|FG003|Overall Study|Lost to Follow-up|4|||
130571479|NCT00957008|470057314|FG000|Overall Study|Physician Decision|1|||
130571480|NCT00957008|470057315|FG001|Overall Study|Physician Decision|0|||
130571481|NCT00957008|470057316|FG002|Overall Study|Physician Decision|1|||
130571482|NCT00957008|470057317|FG003|Overall Study|Physician Decision|1|||
130571483|NCT00957008|470057314|FG000|Overall Study|Relocated; Family conflict|4|||
130571484|NCT00957008|470057315|FG001|Overall Study|Relocated; Family conflict|1|||
130571485|NCT00957008|470057316|FG002|Overall Study|Relocated; Family conflict|1|||
130571486|NCT00957008|470057317|FG003|Overall Study|Relocated; Family conflict|3|||
130571487|NCT01118351|470057318|FG000|Overall Study|Adverse Event|3|||
130571488|NCT01118351|470057318|FG000|Overall Study|Withdrawal by Subject|1|||
130571489|NCT00414453|470057332|FG000|Overall Study|Abnormal lab work|16|||
130571490|NCT00845728|470057333|FG000|Overall Study|Abnormal laboratory value (s)|2|||
130571491|NCT00845728|470057334|FG001|Overall Study|Abnormal laboratory value (s)|2|||
130571492|NCT00845728|470057333|FG000|Overall Study|Patient's inability to use the device|4|||
130571493|NCT00845728|470057334|FG001|Overall Study|Patient's inability to use the device|6|||
130571494|NCT00845728|470057333|FG000|Overall Study|Abnormal test procedure result (s)|7|||
130571495|NCT00845728|470057334|FG001|Overall Study|Abnormal test procedure result (s)|2|||
130571496|NCT00845728|470057333|FG000|Overall Study|Lost to Follow-up|22|||
130571497|NCT00845728|470057334|FG001|Overall Study|Lost to Follow-up|13|||
130571498|NCT00845728|470057333|FG000|Overall Study|Death|24|||
130571499|NCT00845728|470057334|FG001|Overall Study|Death|26|||
130571500|NCT00845728|470057333|FG000|Overall Study|Administrative Problems|34|||
130571501|NCT00845728|470057334|FG001|Overall Study|Administrative Problems|26|||
130571502|NCT00845728|470057333|FG000|Overall Study|Protocol Violation|36|||
130571503|NCT00845728|470057334|FG001|Overall Study|Protocol Violation|24|||
130571504|NCT00845728|470057333|FG000|Overall Study|Lack of Efficacy|51|||
130571505|NCT00845728|470057334|FG001|Overall Study|Lack of Efficacy|39|||
130517118|NCT00607997|469861143|FG001|Overall Study|Other without explanation|0|||
130517119|NCT00607997|469861144|FG002|Overall Study|Other without explanation|4|||
130517120|NCT00607997|469861145|FG003|Overall Study|Other without explanation|1|||
130517121|NCT00839332|469861146|FG000|Phase 1|Disease Progression|38|||
130517122|NCT00839332|469861147|FG001|Phase 1|Disease Progression|0|||
130517123|NCT00839332|469861148|FG002|Phase 1|Disease Progression|0|||
130517124|NCT00839332|469861146|FG000|Phase 1|Adverse Event|6|||
130517125|NCT00839332|469861147|FG001|Phase 1|Adverse Event|0|||
130517126|NCT00839332|469861148|FG002|Phase 1|Adverse Event|0|||
130517127|NCT00839332|469861146|FG000|Phase 1|Withdrawal by Subject|4|||
130517128|NCT00839332|469861147|FG001|Phase 1|Withdrawal by Subject|0|||
130517129|NCT00839332|469861148|FG002|Phase 1|Withdrawal by Subject|0|||
130517130|NCT00839332|469861146|FG000|Phase 1|Physician Decision|2|||
130517131|NCT00839332|469861147|FG001|Phase 1|Physician Decision|0|||
130517132|NCT00839332|469861148|FG002|Phase 1|Physician Decision|0|||
130517133|NCT00839332|469861146|FG000|Phase 2|Protocol Violation|0|||
130517134|NCT00839332|469861147|FG001|Phase 2|Protocol Violation|1|||
130517135|NCT00839332|469861148|FG002|Phase 2|Protocol Violation|0|||
130517136|NCT00839332|469861146|FG000|Phase 2|Disease Progression|0|||
130517137|NCT00839332|469861147|FG001|Phase 2|Disease Progression|46|||
130517138|NCT00839332|469861148|FG002|Phase 2|Disease Progression|21|||
130517139|NCT00839332|469861146|FG000|Phase 2|Adverse Event|0|||
130517140|NCT00839332|469861147|FG001|Phase 2|Adverse Event|8|||
130517141|NCT00839332|469861148|FG002|Phase 2|Adverse Event|6|||
130517142|NCT00839332|469861146|FG000|Phase 2|Death|0|||
130517143|NCT00839332|469861147|FG001|Phase 2|Death|4|||
130517144|NCT00839332|469861148|FG002|Phase 2|Death|2|||
130517145|NCT00839332|469861146|FG000|Phase 2|Withdrawal by Subject|0|||
130517146|NCT00839332|469861147|FG001|Phase 2|Withdrawal by Subject|5|||
130517147|NCT00839332|469861148|FG002|Phase 2|Withdrawal by Subject|8|||
130517148|NCT00839332|469861146|FG000|Phase 2|Physician Decision|0|||
130517149|NCT00839332|469861147|FG001|Phase 2|Physician Decision|4|||
130517150|NCT00839332|469861148|FG002|Phase 2|Physician Decision|1|||
130517151|NCT00839332|469861146|FG000|Phase 2|Lost to Follow-up|0|||
130571506|NCT00845728|470057333|FG000|Overall Study|Adverse Event|101|||
130571507|NCT00845728|470057334|FG001|Overall Study|Adverse Event|96|||
130571508|NCT00845728|470057333|FG000|Overall Study|Withdrawal by Subject|105|||
130571509|NCT00845728|470057334|FG001|Overall Study|Withdrawal by Subject|108|||
130571510|NCT04951037|470057337|FG000|Overall Study|Lost to Follow-up|16|||
130571511|NCT04951037|470057337|FG000|Overall Study|Withdrawal by Subject|5|||
130571512|NCT04951037|470057337|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
130571513|NCT05630937|470057338|FG000|Overall Study|Study terminated by sponsor|1|||
130571514|NCT05630937|470057339|FG001|Overall Study|Study terminated by sponsor|1|||
130571515|NCT05630937|470057340|FG002|Overall Study|Study terminated by sponsor|8|||
130517152|NCT00839332|469861147|FG001|Phase 2|Lost to Follow-up|0|||
130517153|NCT00839332|469861148|FG002|Phase 2|Lost to Follow-up|1|||
130517154|NCT01200485|469861149|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
130517155|NCT01200485|469861150|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
130517156|NCT01200485|469861151|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
130517157|NCT01200485|469861149|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
130517158|NCT01200485|469861150|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
130517159|NCT01200485|469861151|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
130517160|NCT06080438|469861152|FG000|Overall Study|Lost to Follow-up|2|||
130517161|NCT03589300|469861153|FG000|Overall Study|Adverse Event|2|||
130517162|NCT03589300|469861153|FG000|Overall Study|Death|4|||
130517163|NCT03589300|469861153|FG000|Overall Study|Lost to Follow-up|12|||
130517164|NCT03589300|469861153|FG000|Overall Study|Withdrawal by Subject|5|||
130517165|NCT01678898|469861156|FG000|PB-102-F01|Adverse Event|0|||
130517166|NCT01678898|469861157|FG001|PB-102-F01|Adverse Event|1|||
130517167|NCT01678898|469861158|FG002|PB-102-F01|Adverse Event|0|||
130517168|NCT01678898|469861156|FG000|PB-102-F01|Physician Decision|0|||
130517169|NCT01678898|469861157|FG001|PB-102-F01|Physician Decision|1|||
130517170|NCT01678898|469861158|FG002|PB-102-F01|Physician Decision|0|||
130517171|NCT02864342|469861160|FG000|Overall Study|Eligibility Criteria Deviation|2|||
130517172|NCT02864342|469861161|FG001|Overall Study|Eligibility Criteria Deviation|3|||
130517173|NCT02864342|469861160|FG000|Overall Study|Withdrawal by Subject|4|||
130517174|NCT02864342|469861161|FG001|Overall Study|Withdrawal by Subject|2|||
130517175|NCT02864342|469861160|FG000|Overall Study|Device Technology Issue|6|||
130517176|NCT02864342|469861161|FG001|Overall Study|Device Technology Issue|7|||
130517177|NCT02864342|469861160|FG000|Overall Study|Death|0|||
130517178|NCT02864342|469861161|FG001|Overall Study|Death|1|||
130517179|NCT02864342|469861160|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
130517180|NCT02864342|469861161|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
130517181|NCT02864342|469861160|FG000|Overall Study|Lost to Follow-up|1|||
130517182|NCT02864342|469861161|FG001|Overall Study|Lost to Follow-up|5|||
130517183|NCT02864342|469861160|FG000|Overall Study|Lost Device|1|||
130517184|NCT02864342|469861161|FG001|Overall Study|Lost Device|0|||
130517185|NCT02864342|469861160|FG000|Overall Study|Adverse Event|1|||
130517186|NCT02864342|469861161|FG001|Overall Study|Adverse Event|0|||
130517187|NCT00776984|469861162|FG000|Overall Study|Adverse Event|8|||
130517188|NCT00776984|469861163|FG001|Overall Study|Adverse Event|2|||
130517189|NCT00776984|469861162|FG000|Overall Study|Protocol Violation|4|||
130517190|NCT00776984|469861163|FG001|Overall Study|Protocol Violation|2|||
130517191|NCT00776984|469861162|FG000|Overall Study|Lost to Follow-up|2|||
130517192|NCT00776984|469861163|FG001|Overall Study|Lost to Follow-up|0|||
130517193|NCT00776984|469861162|FG000|Overall Study|Withdrawal by Subject|12|||
130517194|NCT00776984|469861163|FG001|Overall Study|Withdrawal by Subject|7|||
130517195|NCT00776984|469861162|FG000|Overall Study|Lack of Efficacy|0|||
130517196|NCT00776984|469861163|FG001|Overall Study|Lack of Efficacy|1|||
130517197|NCT00776984|469861162|FG000|Overall Study|Other|5|||
130517198|NCT00776984|469861163|FG001|Overall Study|Other|9|||
130517199|NCT02573883|469861166|FG000|Six Month Follow Up|Lost to Follow-up|1|||
130517200|NCT02573883|469861167|FG001|Six Month Follow Up|Lost to Follow-up|0|||
130517201|NCT02573883|469861168|FG002|Six Month Follow Up|Lost to Follow-up|0|||
130517202|NCT02573883|469861169|FG003|Six Month Follow Up|Lost to Follow-up|0|||
130517203|NCT02573883|469861166|FG000|One Year Follow Up|Lost to Follow-up|2|||
130517204|NCT02573883|469861167|FG001|One Year Follow Up|Lost to Follow-up|1|||
130517205|NCT02573883|469861168|FG002|One Year Follow Up|Lost to Follow-up|0|||
130517206|NCT02573883|469861169|FG003|One Year Follow Up|Lost to Follow-up|0|||
130517207|NCT01544309|469861170|FG000|Overall Study|Withdrawal by Subject|12|||
130517208|NCT01544309|469861171|FG001|Overall Study|Withdrawal by Subject|7|||
130517209|NCT01544309|469861170|FG000|Overall Study|Protocol Violation|2|||
130517210|NCT01544309|469861171|FG001|Overall Study|Protocol Violation|1|||
130517211|NCT01544309|469861170|FG000|Overall Study|Physician Decision|4|||
130517212|NCT01544309|469861171|FG001|Overall Study|Physician Decision|1|||
130517213|NCT01544309|469861170|FG000|Overall Study|Not performed pre-dose examination|1|||
130517214|NCT01544309|469861171|FG001|Overall Study|Not performed pre-dose examination|2|||
130517215|NCT01544309|469861170|FG000|Overall Study|Administered prohibit prior medication|1|||
130517216|NCT01544309|469861171|FG001|Overall Study|Administered prohibit prior medication|0|||
130517217|NCT00118703|469861172|FG000|Overall Study|Protocol Violation|1|||
130517218|NCT00118703|469861173|FG001|Overall Study|Protocol Violation|0|||
130517219|NCT00118703|469861172|FG000|Overall Study|Adverse Event|1|||
130517220|NCT00118703|469861173|FG001|Overall Study|Adverse Event|1|||
130517221|NCT00118703|469861172|FG000|Overall Study|Participant took two different treatment|0|||
130517222|NCT00118703|469861173|FG001|Overall Study|Participant took two different treatment|1|||
130517223|NCT00118703|469861172|FG000|Overall Study|Withdrawal by Subject|2|||
130517224|NCT00118703|469861173|FG001|Overall Study|Withdrawal by Subject|5|||
130517225|NCT00118703|469861172|FG000|Overall Study|Lost to Follow-up|1|||
130517226|NCT00118703|469861173|FG001|Overall Study|Lost to Follow-up|2|||
130517227|NCT01560585|469861178|FG000|Overall Study|Physician Decision|3|||
130517228|NCT02725008|469861179|FG000|Overall Study|Lost to Follow-up|7|||
130517229|NCT02725008|469861180|FG001|Overall Study|Lost to Follow-up|9|||
130517230|NCT02725008|469861179|FG000|Overall Study|Withdrawal by Subject|2|||
130517231|NCT02725008|469861180|FG001|Overall Study|Withdrawal by Subject|2|||
130517232|NCT02725008|469861179|FG000|Overall Study|Admitted to hospital|0|||
130517233|NCT02725008|469861180|FG001|Overall Study|Admitted to hospital|1|||
130517234|NCT01363297|469861181|FG000|Overall Study|Other|0|||
130517235|NCT01363297|469861182|FG001|Overall Study|Other|0|||
130517236|NCT01363297|469861183|FG002|Overall Study|Other|0|||
130517237|NCT01363297|469861184|FG003|Overall Study|Other|0|||
130517238|NCT01363297|469861185|FG004|Overall Study|Other|1|||
130517239|NCT01363297|469861181|FG000|Overall Study|Death|3|||
130517240|NCT01363297|469861182|FG001|Overall Study|Death|6|||
130517241|NCT01363297|469861183|FG002|Overall Study|Death|6|||
130517242|NCT01363297|469861184|FG003|Overall Study|Death|10|||
130517243|NCT01363297|469861185|FG004|Overall Study|Death|30|||
130517244|NCT02515097|469861186|FG000|Overall Study|Lost to Follow-up|4|||
130517245|NCT02515097|469861187|FG001|Overall Study|Lost to Follow-up|2|||
130517246|NCT02515097|469861186|FG000|Overall Study|Withdrawal by Subject|1|||
130517247|NCT02515097|469861187|FG001|Overall Study|Withdrawal by Subject|3|||
130517248|NCT02515097|469861186|FG000|Overall Study|Adverse Event|2|||
130517249|NCT02515097|469861187|FG001|Overall Study|Adverse Event|1|||
130517250|NCT01180790|469861193|FG000|Overall Study|Adverse Event|1|||
130517251|NCT01180790|469861194|FG001|Overall Study|Adverse Event|1|||
130517252|NCT01180790|469861195|FG002|Overall Study|Adverse Event|2|||
130517253|NCT01180790|469861196|FG003|Overall Study|Adverse Event|0|||
130517254|NCT01180790|469861197|FG004|Overall Study|Adverse Event|1|||
130517255|NCT01180790|469861198|FG005|Overall Study|Adverse Event|3|||
130517256|NCT01180790|469861199|FG006|Overall Study|Adverse Event|0|||
130517257|NCT01180790|469861193|FG000|Overall Study|Withdrawal by Subject|3|||
130517258|NCT01180790|469861194|FG001|Overall Study|Withdrawal by Subject|0|||
130517259|NCT01180790|469861195|FG002|Overall Study|Withdrawal by Subject|5|||
130517260|NCT01180790|469861196|FG003|Overall Study|Withdrawal by Subject|0|||
130517261|NCT01180790|469861197|FG004|Overall Study|Withdrawal by Subject|2|||
130517262|NCT01180790|469861198|FG005|Overall Study|Withdrawal by Subject|1|||
130517263|NCT01180790|469861199|FG006|Overall Study|Withdrawal by Subject|0|||
130517264|NCT01180790|469861193|FG000|Overall Study|Lost to Follow-up|3|||
130517265|NCT01180790|469861194|FG001|Overall Study|Lost to Follow-up|1|||
130517266|NCT01180790|469861195|FG002|Overall Study|Lost to Follow-up|0|||
130517267|NCT01180790|469861196|FG003|Overall Study|Lost to Follow-up|2|||
130517268|NCT01180790|469861197|FG004|Overall Study|Lost to Follow-up|1|||
130517269|NCT01180790|469861198|FG005|Overall Study|Lost to Follow-up|0|||
130517270|NCT01180790|469861199|FG006|Overall Study|Lost to Follow-up|1|||
130517271|NCT01180790|469861193|FG000|Overall Study|Physician Decision|1|||
130517272|NCT01180790|469861194|FG001|Overall Study|Physician Decision|0|||
130517273|NCT01180790|469861195|FG002|Overall Study|Physician Decision|0|||
130517274|NCT01180790|469861196|FG003|Overall Study|Physician Decision|1|||
130517275|NCT01180790|469861197|FG004|Overall Study|Physician Decision|0|||
130517276|NCT01180790|469861198|FG005|Overall Study|Physician Decision|0|||
130517277|NCT01180790|469861199|FG006|Overall Study|Physician Decision|0|||
130517278|NCT01180790|469861193|FG000|Overall Study|Lack of Efficacy|1|||
130517279|NCT01180790|469861194|FG001|Overall Study|Lack of Efficacy|2|||
130517280|NCT01180790|469861195|FG002|Overall Study|Lack of Efficacy|5|||
130517281|NCT01180790|469861196|FG003|Overall Study|Lack of Efficacy|6|||
130517282|NCT01180790|469861197|FG004|Overall Study|Lack of Efficacy|1|||
130517283|NCT01180790|469861198|FG005|Overall Study|Lack of Efficacy|3|||
130517284|NCT01180790|469861199|FG006|Overall Study|Lack of Efficacy|0|||
130517285|NCT01180790|469861193|FG000|Overall Study|compliance|0|||
130517286|NCT01180790|469861194|FG001|Overall Study|compliance|1|||
130517287|NCT01180790|469861195|FG002|Overall Study|compliance|0|||
130517288|NCT01180790|469861196|FG003|Overall Study|compliance|0|||
130517289|NCT01180790|469861197|FG004|Overall Study|compliance|0|||
130517290|NCT01180790|469861198|FG005|Overall Study|compliance|0|||
130517291|NCT01180790|469861199|FG006|Overall Study|compliance|0|||
130517292|NCT01180790|469861193|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517293|NCT01180790|469861194|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517294|NCT01180790|469861195|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
130517295|NCT01180790|469861196|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517296|NCT01180790|469861197|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517297|NCT01180790|469861198|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517298|NCT01180790|469861199|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
130517299|NCT01568112|469861202|FG000|Overall Study|Randomized But Not Treated|0|||
130517300|NCT01568112|469861203|FG001|Overall Study|Randomized But Not Treated|1|||
130517301|NCT01568112|469861204|FG002|Overall Study|Randomized But Not Treated|0|||
130517302|NCT01568112|469861205|FG003|Overall Study|Randomized But Not Treated|0|||
130517303|NCT01568112|469861202|FG000|Overall Study|Withdrew due to Adverse Event|2|||
130517304|NCT01568112|469861203|FG001|Overall Study|Withdrew due to Adverse Event|4|||
130517305|NCT01568112|469861204|FG002|Overall Study|Withdrew due to Adverse Event|6|||
130517306|NCT01568112|469861205|FG003|Overall Study|Withdrew due to Adverse Event|3|||
130517307|NCT01568112|469861202|FG000|Overall Study|Lost to Follow-up|0|||
130517308|NCT01568112|469861203|FG001|Overall Study|Lost to Follow-up|0|||
130517309|NCT01568112|469861204|FG002|Overall Study|Lost to Follow-up|0|||
130517310|NCT01568112|469861205|FG003|Overall Study|Lost to Follow-up|1|||
130517311|NCT01568112|469861202|FG000|Overall Study|Withdrawal by Subject|2|||
130517312|NCT01568112|469861203|FG001|Overall Study|Withdrawal by Subject|3|||
130517313|NCT01568112|469861204|FG002|Overall Study|Withdrawal by Subject|0|||
130517314|NCT01568112|469861205|FG003|Overall Study|Withdrawal by Subject|7|||
130571516|NCT05630937|470057341|FG003|Overall Study|Study terminated by sponsor|0|||
130517315|NCT01568112|469861202|FG000|Overall Study|Withdrawal by Physician|1|||
130517316|NCT01568112|469861203|FG001|Overall Study|Withdrawal by Physician|0|||
130517317|NCT01568112|469861204|FG002|Overall Study|Withdrawal by Physician|1|||
130517318|NCT01568112|469861205|FG003|Overall Study|Withdrawal by Physician|1|||
130517319|NCT00560313|469863355|FG000|Overall Study|Adverse Events or Death|2|||
130517320|NCT00560313|469863355|FG000|Overall Study|Withdrawal by Subject|2|||
130517321|NCT00560313|469863355|FG000|Overall Study|Lost to Follow-up|1|||
130517322|NCT00560313|469863355|FG000|Overall Study|Protocol Violation|1|||
130517323|NCT00526097|469863359|FG000|Overall Study|Adverse Event|6|||
130517324|NCT00526097|469863360|FG001|Overall Study|Adverse Event|44|||
130517325|NCT00526097|469863359|FG000|Overall Study|Protocol Violation|4|||
130517326|NCT00526097|469863360|FG001|Overall Study|Protocol Violation|10|||
130517327|NCT00526097|469863359|FG000|Overall Study|Withdrawal by Subject|3|||
130517328|NCT00526097|469863360|FG001|Overall Study|Withdrawal by Subject|1|||
130517329|NCT00526097|469863359|FG000|Overall Study|Other|2|||
130517330|NCT00526097|469863360|FG001|Overall Study|Other|1|||
130517331|NCT00943618|469863361|FG000|Overall Study|Lost to Follow-up|38|||
130517332|NCT00943618|469863362|FG001|Overall Study|Lost to Follow-up|48|||
130517333|NCT00943618|469863363|FG002|Overall Study|Lost to Follow-up|20|||
130517334|NCT00943618|469863361|FG000|Overall Study|Discontinued Medication|17|||
130517335|NCT00943618|469863362|FG001|Overall Study|Discontinued Medication|29|||
130517336|NCT00943618|469863363|FG002|Overall Study|Discontinued Medication|11|||
130517337|NCT03713281|469863373|FG000|Overall Study|Lens handling difficuluties|2|||
130517338|NCT03713281|469863373|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
130517339|NCT05006417|469863376|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
130517340|NCT02158247|469863377|FG000|Overall Study|Invisible vocal cords|5|||
130517341|NCT00875615|469863386|FG000|Overall Study|Withdrawal by Subject|1|||
130517342|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
130517343|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
130517344|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
130517345|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
130517346|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
130517347|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
130517348|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
130517349|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
130517350|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
130517351|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
130517352|NCT01772823|469863387|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
130517353|NCT01772823|469863388|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
130517354|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
130517355|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
130517356|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
130517357|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
130517358|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
130517359|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
130517360|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
130517361|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
130517362|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
130517363|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
130517364|NCT01772823|469863387|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
130517365|NCT01772823|469863388|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
130517366|NCT01772823|469863387|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
130517367|NCT01772823|469863388|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
130517368|NCT01772823|469863387|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
130517369|NCT01772823|469863388|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
130517370|NCT01772823|469863387|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
130517371|NCT01772823|469863388|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
130517372|NCT01772823|469863387|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
130517373|NCT01772823|469863388|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
130517374|NCT00468858|469863393|FG000|Overall Study|Adverse Event|0|||
130571517|NCT05630937|470057338|FG000|Overall Study|Lost to Follow-up|0|||
130517375|NCT00468858|469863394|FG001|Overall Study|Adverse Event|1|||
130517376|NCT00468858|469863395|FG002|Overall Study|Adverse Event|0|||
130571518|NCT05630937|470057339|FG001|Overall Study|Lost to Follow-up|0|||
130571519|NCT05630937|470057340|FG002|Overall Study|Lost to Follow-up|1|||
130571520|NCT05630937|470057341|FG003|Overall Study|Lost to Follow-up|0|||
130571521|NCT05630937|470057338|FG000|Overall Study|Enrolled but not treated|0|||
130517377|NCT00468858|469863393|FG000|Overall Study|Withdrawal by Subject|7|||
130571522|NCT05630937|470057339|FG001|Overall Study|Enrolled but not treated|0|||
130571523|NCT05630937|470057340|FG002|Overall Study|Enrolled but not treated|0|||
130571524|NCT05630937|470057341|FG003|Overall Study|Enrolled but not treated|1|||
130571525|NCT01604265|470057348|FG000|Overall Study|Adverse Event|1|||
130571526|NCT01604265|470057349|FG001|Overall Study|Adverse Event|0|||
130571527|NCT01604265|470057348|FG000|Overall Study|Withdrawal by Subject|1|||
130571528|NCT01604265|470057349|FG001|Overall Study|Withdrawal by Subject|0|||
130571529|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
130571530|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
130571531|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
130571532|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
130571533|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
130571534|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
130571535|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
130571536|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
130571537|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
130571538|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130571539|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
130571540|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
130571541|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
130571542|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
130571543|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
130571544|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
130571545|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
130571546|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
130571547|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
130571548|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
130571549|NCT02706873|470057350|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
130571550|NCT02706873|470057351|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
130571551|NCT02706873|470057352|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
130571552|NCT02706873|470057353|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
130571553|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
130571554|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
130571555|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
130517378|NCT00468858|469863394|FG001|Overall Study|Withdrawal by Subject|4|||
130517379|NCT00468858|469863395|FG002|Overall Study|Withdrawal by Subject|5|||
130517380|NCT00468858|469863393|FG000|Overall Study|Relocation|1|||
130517381|NCT00468858|469863394|FG001|Overall Study|Relocation|3|||
130517382|NCT00468858|469863395|FG002|Overall Study|Relocation|3|||
130517383|NCT00468858|469863393|FG000|Overall Study|Lost to Follow-up|1|||
130517384|NCT00468858|469863394|FG001|Overall Study|Lost to Follow-up|2|||
130517385|NCT00468858|469863395|FG002|Overall Study|Lost to Follow-up|5|||
130517386|NCT00468858|469863393|FG000|Overall Study|Other|0|||
130517387|NCT00468858|469863394|FG001|Overall Study|Other|0|||
130517388|NCT00468858|469863395|FG002|Overall Study|Other|1|||
130517389|NCT01093222|469863396|FG000|Overall Study|Ineligible|6|||
130517390|NCT01093222|469863396|FG000|Overall Study|Adverse Event|7|||
130517391|NCT01093222|469863396|FG000|Overall Study|Progression/relapse|24|||
130517392|NCT01093222|469863396|FG000|Overall Study|Death|2|||
130517393|NCT01093222|469863396|FG000|Overall Study|Not protocol specified|1|||
130517394|NCT01670188|469863397|FG000|Overall Study|Death|0|||
130517395|NCT01670188|469863398|FG001|Overall Study|Death|1|||
130517396|NCT02212301|469863399|FG000|Period 1|Lost to Follow-up|0|||
130517397|NCT02212301|469863400|FG001|Period 1|Lost to Follow-up|1|||
130517398|NCT03927222|469863401|FG000|Overall Study|Progression|3|||
130517399|NCT03927222|469863401|FG000|Overall Study|CMV testing results inconclusive|1|||
130517400|NCT03927222|469863401|FG000|Overall Study|Unable to generate enough vaccines|1|||
130517401|NCT03927222|469863401|FG000|Overall Study|Early study termination|1|||
130517402|NCT02025985|469863404|FG000|Overall Study|Consent withdrawn|0|||
130517403|NCT02025985|469863405|FG001|Overall Study|Consent withdrawn|0|||
130517404|NCT02025985|469863406|FG002|Overall Study|Consent withdrawn|1|||
130571556|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
130571557|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
130571558|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
130571559|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
130571560|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
130571561|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
130517405|NCT02025985|469863407|FG003|Overall Study|Consent withdrawn|0|||
130517406|NCT02025985|469863408|FG004|Overall Study|Consent withdrawn|0|||
130517407|NCT02025985|469863404|FG000|Overall Study|Termination of study by Sponsor|4|||
130517408|NCT02025985|469863405|FG001|Overall Study|Termination of study by Sponsor|3|||
130517409|NCT02025985|469863406|FG002|Overall Study|Termination of study by Sponsor|1|||
130517410|NCT02025985|469863407|FG003|Overall Study|Termination of study by Sponsor|1|||
130517411|NCT02025985|469863408|FG004|Overall Study|Termination of study by Sponsor|3|||
130517412|NCT02025985|469863404|FG000|Overall Study|Death|21|||
130571562|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
130571563|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
130571564|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
130571565|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
130571566|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
130571567|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
130571568|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
130571569|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130571570|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130571571|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130571572|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
130571573|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
130571574|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
130571575|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
130571576|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
130571577|NCT02706873|470057350|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
130571578|NCT02706873|470057351|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
130571579|NCT02706873|470057352|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
130571580|NCT02706873|470057353|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
130571581|NCT00464334|470057359|FG000|Overall Study|Adverse Event|0|||
130571582|NCT00464334|470057360|FG001|Overall Study|Adverse Event|0|||
130571583|NCT00464334|470057361|FG002|Overall Study|Adverse Event|0|||
130571584|NCT00464334|470057362|FG003|Overall Study|Adverse Event|1|||
130571585|NCT00464334|470057363|FG004|Overall Study|Adverse Event|1|||
130571586|NCT00464334|470057364|FG005|Overall Study|Adverse Event|1|||
130571587|NCT00464334|470057365|FG006|Overall Study|Adverse Event|0|||
130571588|NCT00464334|470057366|FG007|Overall Study|Adverse Event|0|||
130571589|NCT00464334|470057367|FG008|Overall Study|Adverse Event|2|||
130571590|NCT00464334|470057368|FG009|Overall Study|Adverse Event|1|||
130571591|NCT00464334|470057369|FG010|Overall Study|Adverse Event|2|||
130571592|NCT00464334|470057359|FG000|Overall Study|Lack of Efficacy|0|||
130571593|NCT00464334|470057360|FG001|Overall Study|Lack of Efficacy|1|||
130571594|NCT00464334|470057361|FG002|Overall Study|Lack of Efficacy|0|||
130571595|NCT00464334|470057362|FG003|Overall Study|Lack of Efficacy|0|||
130571596|NCT00464334|470057363|FG004|Overall Study|Lack of Efficacy|0|||
130571597|NCT00464334|470057364|FG005|Overall Study|Lack of Efficacy|0|||
130571598|NCT00464334|470057365|FG006|Overall Study|Lack of Efficacy|0|||
130571599|NCT00464334|470057366|FG007|Overall Study|Lack of Efficacy|0|||
130571600|NCT00464334|470057367|FG008|Overall Study|Lack of Efficacy|0|||
130571601|NCT00464334|470057368|FG009|Overall Study|Lack of Efficacy|0|||
130571602|NCT00464334|470057369|FG010|Overall Study|Lack of Efficacy|0|||
130571603|NCT00464334|470057359|FG000|Overall Study|Lost to Follow-up|0|||
130571604|NCT00464334|470057360|FG001|Overall Study|Lost to Follow-up|0|||
130571605|NCT00464334|470057361|FG002|Overall Study|Lost to Follow-up|1|||
130571606|NCT00464334|470057362|FG003|Overall Study|Lost to Follow-up|0|||
130571607|NCT00464334|470057363|FG004|Overall Study|Lost to Follow-up|1|||
130571608|NCT00464334|470057364|FG005|Overall Study|Lost to Follow-up|0|||
130571609|NCT00464334|470057365|FG006|Overall Study|Lost to Follow-up|1|||
130571610|NCT00464334|470057366|FG007|Overall Study|Lost to Follow-up|0|||
130571611|NCT00464334|470057367|FG008|Overall Study|Lost to Follow-up|0|||
130571612|NCT00464334|470057368|FG009|Overall Study|Lost to Follow-up|0|||
130571613|NCT00464334|470057369|FG010|Overall Study|Lost to Follow-up|2|||
130571614|NCT00464334|470057359|FG000|Overall Study|Progressive Disease|0|||
130571615|NCT00464334|470057360|FG001|Overall Study|Progressive Disease|0|||
130571616|NCT00464334|470057361|FG002|Overall Study|Progressive Disease|0|||
130571617|NCT00464334|470057362|FG003|Overall Study|Progressive Disease|0|||
130571618|NCT00464334|470057363|FG004|Overall Study|Progressive Disease|0|||
130571619|NCT00464334|470057364|FG005|Overall Study|Progressive Disease|1|||
130571620|NCT00464334|470057365|FG006|Overall Study|Progressive Disease|0|||
130571621|NCT00464334|470057366|FG007|Overall Study|Progressive Disease|0|||
130571622|NCT00464334|470057367|FG008|Overall Study|Progressive Disease|1|||
130571623|NCT00464334|470057368|FG009|Overall Study|Progressive Disease|0|||
130571624|NCT00464334|470057369|FG010|Overall Study|Progressive Disease|0|||
130571625|NCT00464334|470057359|FG000|Overall Study|Study Terminated by Sponsor|0|||
130571626|NCT00464334|470057360|FG001|Overall Study|Study Terminated by Sponsor|0|||
130571627|NCT00464334|470057361|FG002|Overall Study|Study Terminated by Sponsor|0|||
130571628|NCT00464334|470057362|FG003|Overall Study|Study Terminated by Sponsor|1|||
130571629|NCT00464334|470057363|FG004|Overall Study|Study Terminated by Sponsor|0|||
130571630|NCT00464334|470057364|FG005|Overall Study|Study Terminated by Sponsor|0|||
130571631|NCT00464334|470057365|FG006|Overall Study|Study Terminated by Sponsor|0|||
130571632|NCT00464334|470057366|FG007|Overall Study|Study Terminated by Sponsor|0|||
130571633|NCT00464334|470057367|FG008|Overall Study|Study Terminated by Sponsor|0|||
130571634|NCT00464334|470057368|FG009|Overall Study|Study Terminated by Sponsor|0|||
130571635|NCT00464334|470057369|FG010|Overall Study|Study Terminated by Sponsor|0|||
130571636|NCT00464334|470057359|FG000|Overall Study|Withdrawal by Subject|1|||
130571637|NCT00464334|470057360|FG001|Overall Study|Withdrawal by Subject|7|||
130517413|NCT02025985|469863405|FG001|Overall Study|Death|20|||
130517414|NCT02025985|469863406|FG002|Overall Study|Death|23|||
130517415|NCT02025985|469863407|FG003|Overall Study|Death|20|||
130517416|NCT02025985|469863408|FG004|Overall Study|Death|17|||
130517417|NCT03723915|469863420|FG000|Screening|Failed to meet screening requirements.|2|||
130517418|NCT03723915|469863420|FG000|On Treatment|Failed to meet treatment requirements|2|||
130517419|NCT01978236|469863421|FG000|Overall Study|Discontinued due to study close|2|||
130517420|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
130517421|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
130517422|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
130517423|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
130517424|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
130517425|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
130517426|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Rejections|0|||
130517427|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Rejections|0|||
130517428|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Rejections|55|||
130517429|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
130517430|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
130517431|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
130517432|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
130517433|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
130517434|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
130517435|NCT00634920|469863423|FG000|Period 1 - Pre-Randomization|Other issues|0|||
130517436|NCT00634920|469863424|FG001|Period 1 - Pre-Randomization|Other issues|0|||
130517437|NCT00634920|469863425|FG002|Period 1 - Pre-Randomization|Other issues|6|||
130517438|NCT00634920|469863423|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
130517439|NCT00634920|469863424|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
130517440|NCT00634920|469863425|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
130517441|NCT00634920|469863423|FG000|Period 2 - Post-Randomization|Rejection|11|||
130517442|NCT00634920|469863424|FG001|Period 2 - Post-Randomization|Rejection|5|||
130517443|NCT00634920|469863425|FG002|Period 2 - Post-Randomization|Rejection|0|||
130517444|NCT00634920|469863423|FG000|Period 2 - Post-Randomization|Death|2|||
130517445|NCT00634920|469863424|FG001|Period 2 - Post-Randomization|Death|5|||
130517446|NCT00634920|469863425|FG002|Period 2 - Post-Randomization|Death|0|||
130517447|NCT00634920|469863423|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
130517448|NCT00634920|469863424|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
130517449|NCT00634920|469863425|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
130517450|NCT00634920|469863423|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
130517451|NCT00634920|469863424|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
130517452|NCT00634920|469863425|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
130517453|NCT00819013|469863426|FG000|Overall Study|Not meeting continuing study eligibility|2|||
130517454|NCT00819013|469863427|FG001|Overall Study|Not meeting continuing study eligibility|1|||
130517455|NCT00819013|469863428|FG002|Overall Study|Not meeting continuing study eligibility|2|||
130517456|NCT00819013|469863429|FG003|Overall Study|Not meeting continuing study eligibility|1|||
130517457|NCT00819013|469863426|FG000|Overall Study|Adverse Event|0|||
130517458|NCT00819013|469863427|FG001|Overall Study|Adverse Event|0|||
130517459|NCT00819013|469863428|FG002|Overall Study|Adverse Event|1|||
130517460|NCT00819013|469863429|FG003|Overall Study|Adverse Event|0|||
130517461|NCT00819013|469863426|FG000|Overall Study|Withdrawal by Subject|1|||
130517462|NCT00819013|469863427|FG001|Overall Study|Withdrawal by Subject|0|||
130517463|NCT00819013|469863428|FG002|Overall Study|Withdrawal by Subject|1|||
130517464|NCT00819013|469863429|FG003|Overall Study|Withdrawal by Subject|0|||
130517465|NCT00819013|469863426|FG000|Overall Study|Lost to Follow-up|0|||
130517466|NCT00819013|469863427|FG001|Overall Study|Lost to Follow-up|0|||
130517467|NCT00819013|469863428|FG002|Overall Study|Lost to Follow-up|1|||
130517468|NCT00819013|469863429|FG003|Overall Study|Lost to Follow-up|2|||
130517469|NCT00819013|469863426|FG000|Overall Study|Death|0|||
130517470|NCT00819013|469863427|FG001|Overall Study|Death|0|||
130517471|NCT00819013|469863428|FG002|Overall Study|Death|0|||
130517472|NCT00819013|469863429|FG003|Overall Study|Death|1|||
130517473|NCT00576823|469863432|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
130517474|NCT00576823|469863433|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
130517475|NCT00576823|469863434|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
130517476|NCT00576823|469863432|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
130517477|NCT00576823|469863433|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
130517478|NCT00576823|469863434|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
130517479|NCT00510146|469863437|FG000|Double-Blind Treatment|Adverse Event|30|||
130517480|NCT00510146|469863438|FG001|Double-Blind Treatment|Adverse Event|13|||
130517481|NCT00510146|469863437|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
130517482|NCT00510146|469863438|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
130517483|NCT00510146|469863437|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
130517484|NCT00510146|469863438|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
130517485|NCT00510146|469863437|FG000|Double-Blind Treatment|Physician Decision|6|||
130517486|NCT00510146|469863438|FG001|Double-Blind Treatment|Physician Decision|0|||
130517487|NCT00510146|469863437|FG000|Double-Blind Treatment|Protocol Violation|1|||
130517488|NCT00510146|469863438|FG001|Double-Blind Treatment|Protocol Violation|2|||
130517489|NCT00510146|469863437|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
130517490|NCT00510146|469863438|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
130517491|NCT00510146|469863437|FG000|Double-Blind Treatment|Clinical Relapse|0|||
130517492|NCT00510146|469863438|FG001|Double-Blind Treatment|Clinical Relapse|1|||
130517493|NCT00510146|469863437|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
130517494|NCT00510146|469863438|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
130517495|NCT00510146|469863437|FG000|Open-Label Treatment|Adverse Event|22|||
130517496|NCT00510146|469863438|FG001|Open-Label Treatment|Adverse Event|8|||
130517497|NCT00510146|469863437|FG000|Open-Label Treatment|Death|1|||
130517498|NCT00510146|469863438|FG001|Open-Label Treatment|Death|1|||
130517499|NCT00510146|469863437|FG000|Open-Label Treatment|Lack of Efficacy|4|||
130517500|NCT00510146|469863438|FG001|Open-Label Treatment|Lack of Efficacy|0|||
130517501|NCT00510146|469863437|FG000|Open-Label Treatment|Lost to Follow-up|10|||
130517502|NCT00510146|469863438|FG001|Open-Label Treatment|Lost to Follow-up|1|||
130517503|NCT00510146|469863437|FG000|Open-Label Treatment|Physician Decision|3|||
130517504|NCT00510146|469863438|FG001|Open-Label Treatment|Physician Decision|1|||
130517505|NCT00510146|469863437|FG000|Open-Label Treatment|Protocol Violation|4|||
130517506|NCT00510146|469863438|FG001|Open-Label Treatment|Protocol Violation|2|||
130517507|NCT00510146|469863437|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
130517508|NCT00510146|469863438|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
130517509|NCT00510146|469863437|FG000|Open-Label Treatment|Clinical Relapse|1|||
130517510|NCT00510146|469863438|FG001|Open-Label Treatment|Clinical Relapse|1|||
130517511|NCT00510146|469863437|FG000|Open-Label Treatment|Sponsor Decision|2|||
130517512|NCT00510146|469863438|FG001|Open-Label Treatment|Sponsor Decision|0|||
130517513|NCT03188536|469863439|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
130517514|NCT03188536|469863439|FG000|Overall Study|Not participated/met inclusion criteria|1|||
130517515|NCT01930214|469863441|FG000|Overall Study|Death|4|||
130517516|NCT01930214|469863442|FG001|Overall Study|Death|4|||
130517517|NCT01930214|469863443|FG002|Overall Study|Death|11|||
130517518|NCT01930214|469863441|FG000|Overall Study|Lost to Follow-up|12|||
130517519|NCT01930214|469863442|FG001|Overall Study|Lost to Follow-up|13|||
130517520|NCT01930214|469863443|FG002|Overall Study|Lost to Follow-up|12|||
130517521|NCT01930214|469863441|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
130517522|NCT01930214|469863442|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
130517523|NCT01930214|469863443|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
130517524|NCT01930214|469863441|FG000|Overall Study|Physician Decision|2|||
130517525|NCT01930214|469863442|FG001|Overall Study|Physician Decision|0|||
130517526|NCT01930214|469863443|FG002|Overall Study|Physician Decision|0|||
130517527|NCT02132117|469863444|FG000|Overall Study|Adverse Event|6|||
130517528|NCT02132117|469863445|FG001|Overall Study|Adverse Event|1|||
130517529|NCT02132117|469863444|FG000|Overall Study|Lost to Follow-up|2|||
130517530|NCT02132117|469863445|FG001|Overall Study|Lost to Follow-up|2|||
130517531|NCT02132117|469863444|FG000|Overall Study|Personal Reasons|1|||
130517532|NCT02132117|469863445|FG001|Overall Study|Personal Reasons|2|||
130517533|NCT02132117|469863444|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130517534|NCT02132117|469863445|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130517535|NCT03796208|469863452|FG000|Overall Study|Withdrawal by Subject|3|||
130517536|NCT03796208|469863453|FG001|Overall Study|Withdrawal by Subject|0|||
130517537|NCT03796208|469863452|FG000|Overall Study|Loss of pregnancy|1|||
130517538|NCT03796208|469863453|FG001|Overall Study|Loss of pregnancy|1|||
130517539|NCT03796208|469863452|FG000|Overall Study|Changed prenatal clinics|0|||
130517540|NCT03796208|469863453|FG001|Overall Study|Changed prenatal clinics|5|||
130517541|NCT03796208|469863452|FG000|Overall Study|Lost to Follow-up|20|||
130517542|NCT03796208|469863453|FG001|Overall Study|Lost to Follow-up|16|||
130517543|NCT00519285|469863454|FG000|Overall Study|Adverse Event|127|||
130517544|NCT00519285|469863455|FG001|Overall Study|Adverse Event|266|||
130517545|NCT00519285|469863454|FG000|Overall Study|Disease progression|334|||
130517546|NCT00519285|469863455|FG001|Overall Study|Disease progression|186|||
130517547|NCT00519285|469863454|FG000|Overall Study|Physician Decision|75|||
130517548|NCT00519285|469863455|FG001|Overall Study|Physician Decision|47|||
130517549|NCT00519285|469863454|FG000|Overall Study|Participant's request|53|||
130517550|NCT00519285|469863455|FG001|Overall Study|Participant's request|84|||
130517551|NCT00519285|469863454|FG000|Overall Study|Consent withdrawn|4|||
130517552|NCT00519285|469863455|FG001|Overall Study|Consent withdrawn|5|||
130517553|NCT00519285|469863454|FG000|Overall Study|Poor compliance to protocol|5|||
130517554|NCT00519285|469863455|FG001|Overall Study|Poor compliance to protocol|7|||
130517555|NCT00519285|469863454|FG000|Overall Study|Reason unspecified|5|||
130517556|NCT00519285|469863455|FG001|Overall Study|Reason unspecified|8|||
130517557|NCT00519285|469863454|FG000|Overall Study|Not treated|8|||
130517558|NCT00519285|469863455|FG001|Overall Study|Not treated|7|||
130517559|NCT00519285|469863454|FG000|Overall Study|Treatment ongoing|1|||
130517560|NCT00519285|469863455|FG001|Overall Study|Treatment ongoing|2|||
130517561|NCT01020747|469863460|FG000|Overall Study|Withdrawal by Subject|1|||
130517562|NCT01222078|469863461|FG000|Overall Study|Early termination of the study|1|||
130571638|NCT00464334|470057361|FG002|Overall Study|Withdrawal by Subject|4|||
130571639|NCT00464334|470057362|FG003|Overall Study|Withdrawal by Subject|2|||
130571640|NCT00464334|470057363|FG004|Overall Study|Withdrawal by Subject|2|||
130571641|NCT00464334|470057364|FG005|Overall Study|Withdrawal by Subject|2|||
130571642|NCT00464334|470057365|FG006|Overall Study|Withdrawal by Subject|2|||
130571643|NCT00464334|470057366|FG007|Overall Study|Withdrawal by Subject|1|||
130571644|NCT00464334|470057367|FG008|Overall Study|Withdrawal by Subject|3|||
130571645|NCT00464334|470057368|FG009|Overall Study|Withdrawal by Subject|0|||
130571646|NCT00464334|470057369|FG010|Overall Study|Withdrawal by Subject|0|||
130571647|NCT00794677|470057377|FG000|First Intervention|Withdrawal by Subject|2|||
130571648|NCT00794677|470057378|FG001|First Intervention|Withdrawal by Subject|0|||
130571649|NCT00796315|470057384|FG000|Overall Study|Protocol Violation|0|||
130571650|NCT00796315|470057385|FG001|Overall Study|Protocol Violation|1|||
130571651|NCT00796315|470057386|FG002|Overall Study|Protocol Violation|0|||
130571652|NCT00689871|470057393|FG000|Overall Study|Lost to Follow-up|123|||
130571653|NCT00689871|470057394|FG001|Overall Study|Lost to Follow-up|13|||
130571654|NCT00689871|470057395|FG002|Overall Study|Lost to Follow-up|37|||
130571655|NCT00689871|470057396|FG003|Overall Study|Lost to Follow-up|1|||
130571656|NCT00689871|470057393|FG000|Overall Study|Explanted of All Study Devices|36|||
130571657|NCT00689871|470057394|FG001|Overall Study|Explanted of All Study Devices|25|||
130571658|NCT00689871|470057395|FG002|Overall Study|Explanted of All Study Devices|29|||
130571659|NCT00689871|470057396|FG003|Overall Study|Explanted of All Study Devices|3|||
130571660|NCT00689871|470057393|FG000|Overall Study|Withdrawal by Subject|13|||
130571661|NCT00689871|470057394|FG001|Overall Study|Withdrawal by Subject|3|||
130571662|NCT00689871|470057395|FG002|Overall Study|Withdrawal by Subject|4|||
130571663|NCT00689871|470057396|FG003|Overall Study|Withdrawal by Subject|1|||
130571664|NCT00689871|470057393|FG000|Overall Study|Death|1|||
130571665|NCT00689871|470057394|FG001|Overall Study|Death|10|||
130571666|NCT00689871|470057395|FG002|Overall Study|Death|2|||
130571667|NCT00689871|470057396|FG003|Overall Study|Death|2|||
130571668|NCT00689871|470057393|FG000|Overall Study|Physician Decision|2|||
130571669|NCT00689871|470057394|FG001|Overall Study|Physician Decision|1|||
130571670|NCT00689871|470057395|FG002|Overall Study|Physician Decision|1|||
130571671|NCT00689871|470057396|FG003|Overall Study|Physician Decision|0|||
130571672|NCT00542269|470057399|FG000|Overall Study|Adverse Event|10|||
130571673|NCT00542269|470057400|FG001|Overall Study|Adverse Event|4|||
130571674|NCT00542269|470057401|FG002|Overall Study|Adverse Event|5|||
130571675|NCT00542269|470057399|FG000|Overall Study|Protocol Violation|1|||
130571676|NCT00542269|470057400|FG001|Overall Study|Protocol Violation|1|||
130571677|NCT00542269|470057401|FG002|Overall Study|Protocol Violation|0|||
130571678|NCT00542269|470057399|FG000|Overall Study|Withdrawal by Subject|1|||
130571679|NCT00542269|470057400|FG001|Overall Study|Withdrawal by Subject|0|||
130571680|NCT00542269|470057401|FG002|Overall Study|Withdrawal by Subject|0|||
130571681|NCT00542269|470057399|FG000|Overall Study|Administrative problems|1|||
130571682|NCT00542269|470057400|FG001|Overall Study|Administrative problems|1|||
130571683|NCT00542269|470057401|FG002|Overall Study|Administrative problems|1|||
130571684|NCT00889265|470057402|FG000|Overall Study|Adverse Event|1|||
130571685|NCT00889265|470057402|FG000|Overall Study|Lost to Follow-up|5|||
130571686|NCT00889265|470057402|FG000|Overall Study|Protocol Violation|1|||
130571687|NCT00814892|470057410|FG000|Overall Study|Disease Progression|1|||
130571688|NCT00814892|470057410|FG000|Overall Study|Study Termination|1|||
130571689|NCT00845650|470057411|FG000|Overall Study|Withdrawal by Subject|0|||
130571690|NCT00845650|470057412|FG001|Overall Study|Withdrawal by Subject|0|||
130571691|NCT00845650|470057413|FG002|Overall Study|Withdrawal by Subject|0|||
130571692|NCT00845650|470057414|FG003|Overall Study|Withdrawal by Subject|0|||
130571693|NCT00845650|470057415|FG004|Overall Study|Withdrawal by Subject|2|||
130571694|NCT00845650|470057416|FG005|Overall Study|Withdrawal by Subject|0|||
130571695|NCT00845650|470057411|FG000|Overall Study|Lost to Follow-up|0|||
130571696|NCT00845650|470057412|FG001|Overall Study|Lost to Follow-up|0|||
130571697|NCT00845650|470057413|FG002|Overall Study|Lost to Follow-up|3|||
130571698|NCT00845650|470057414|FG003|Overall Study|Lost to Follow-up|1|||
130571699|NCT00845650|470057415|FG004|Overall Study|Lost to Follow-up|0|||
130571700|NCT00845650|470057416|FG005|Overall Study|Lost to Follow-up|1|||
130571701|NCT00845650|470057411|FG000|Overall Study|Sponsor hold on dosing|0|||
130571702|NCT00845650|470057412|FG001|Overall Study|Sponsor hold on dosing|0|||
130571703|NCT00845650|470057413|FG002|Overall Study|Sponsor hold on dosing|0|||
130571704|NCT00845650|470057414|FG003|Overall Study|Sponsor hold on dosing|0|||
130571705|NCT00845650|470057415|FG004|Overall Study|Sponsor hold on dosing|1|||
130571706|NCT00845650|470057416|FG005|Overall Study|Sponsor hold on dosing|1|||
130571707|NCT00845650|470057411|FG000|Overall Study|Unable to access IV line|1|||
130571708|NCT00845650|470057412|FG001|Overall Study|Unable to access IV line|0|||
130571709|NCT00845650|470057413|FG002|Overall Study|Unable to access IV line|0|||
130571710|NCT00845650|470057414|FG003|Overall Study|Unable to access IV line|0|||
130571711|NCT00845650|470057415|FG004|Overall Study|Unable to access IV line|0|||
130571712|NCT00845650|470057416|FG005|Overall Study|Unable to access IV line|0|||
130571713|NCT00531752|470057417|FG000|First Double-blind Intervention Period|Adverse Event|2|||
130571714|NCT00531752|470057418|FG001|First Double-blind Intervention Period|Adverse Event|0|||
130571715|NCT00531752|470057419|FG002|First Double-blind Intervention Period|Adverse Event|1|||
130571716|NCT00531752|470057420|FG003|First Double-blind Intervention Period|Adverse Event|1|||
130571717|NCT00531752|470057417|FG000|First Double-blind Intervention Period|Other|1|||
130571718|NCT00531752|470057418|FG001|First Double-blind Intervention Period|Other|4|||
130571719|NCT00531752|470057419|FG002|First Double-blind Intervention Period|Other|4|||
130571720|NCT00531752|470057420|FG003|First Double-blind Intervention Period|Other|0|||
130571721|NCT00531752|470057417|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
130571722|NCT00531752|470057418|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
130571723|NCT00531752|470057419|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
130571724|NCT00531752|470057420|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
130571725|NCT00531752|470057417|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
130571726|NCT00531752|470057418|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
130571727|NCT00531752|470057419|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
130571728|NCT00531752|470057420|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
130571729|NCT00531752|470057417|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
130571730|NCT00531752|470057418|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
130571731|NCT00531752|470057419|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
130571732|NCT00531752|470057420|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
130571733|NCT00531752|470057417|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
130571734|NCT00531752|470057418|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
130571735|NCT00531752|470057419|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
130571736|NCT00531752|470057420|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
130571737|NCT00531752|470057417|FG000|Second Double-blind Intervention Period|Other|1|||
130571738|NCT00531752|470057418|FG001|Second Double-blind Intervention Period|Other|1|||
130571739|NCT00531752|470057419|FG002|Second Double-blind Intervention Period|Other|0|||
130571740|NCT00531752|470057420|FG003|Second Double-blind Intervention Period|Other|0|||
130571741|NCT00531752|470057417|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130571742|NCT00531752|470057418|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130571743|NCT00531752|470057419|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130571744|NCT00531752|470057420|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
130571745|NCT00531752|470057417|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130571746|NCT00531752|470057418|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130571747|NCT00531752|470057419|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130571748|NCT00531752|470057420|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
130571749|NCT00950664|470057421|FG000|First Intervention|Lost to Follow-up|1|||
130571750|NCT00950664|470057422|FG001|First Intervention|Lost to Follow-up|3|||
130571751|NCT00950664|470057421|FG000|First Intervention|Withdrawal by Subject|2|||
130571752|NCT00950664|470057422|FG001|First Intervention|Withdrawal by Subject|2|||
130571753|NCT02821715|470057423|FG000|Overall Study|Protocol Violation|1|||
130571754|NCT02821715|470057424|FG001|Overall Study|Protocol Violation|0|||
130571755|NCT02821715|470057425|FG002|Overall Study|Protocol Violation|0|||
130571756|NCT02821715|470057426|FG003|Overall Study|Protocol Violation|0|||
130571757|NCT02821715|470057427|FG004|Overall Study|Protocol Violation|0|||
130571758|NCT02821715|470057428|FG005|Overall Study|Protocol Violation|0|||
130571759|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Death|3|||
130571760|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Death|0|||
130571761|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Adverse Event|12|||
130571762|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Adverse Event|6|||
130571763|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
130571764|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
130571765|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
130571766|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
130571767|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
130571768|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
130571769|NCT00159861|470057429|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
130571770|NCT00159861|470057430|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
130571771|NCT00159861|470057429|FG000|Extension Study - up to 3 Years|Death|24|||
130517563|NCT02175745|469863462|FG000|Overall Study|Not Eligible|1|||
130517564|NCT00808899|469863464|FG000|Overall Study|Death|1|||
130517565|NCT00808899|469863464|FG000|Overall Study|Physician Decision|3|||
130517566|NCT04688086|469863469|FG000|Overall Study|Lost to Follow-up|164|||
130517567|NCT04688086|469863469|FG000|Overall Study|Imaging error;|64|||
130517568|NCT00988117|469863470|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
130517569|NCT00988117|469863470|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
130517570|NCT00853021|469863475|FG000|Overall Study|Adverse Event|2|||
130517571|NCT00853021|469863475|FG000|Overall Study|Withdrawal by Subject|2|||
130517572|NCT00853021|469863475|FG000|Overall Study|Death|1|||
130517573|NCT01329419|469863476|FG000|Overall Study|Protocol Violation|235|||
130517574|NCT01220856|469863477|FG000|Overall Study|graft loss|3|||
130517575|NCT01220856|469863478|FG001|Overall Study|graft loss|3|||
130517576|NCT01220856|469863477|FG000|Overall Study|Lost to Follow-up|1|||
130517577|NCT01220856|469863478|FG001|Overall Study|Lost to Follow-up|0|||
130517578|NCT04088500|469863479|FG000|Overall Study|Reason unknown|1|||
130517579|NCT04088500|469863479|FG000|Overall Study|Participant withdrew consent|1|||
130517580|NCT04088500|469863479|FG000|Overall Study|Disease progression|3|||
130517581|NCT00981578|469863480|FG000|Overall Study|Death|1|||
130517582|NCT00981578|469863480|FG000|Overall Study|Withdrawal by Subject|2|||
130517583|NCT04206384|469863481|FG000|Overall Study|Withdrawal by Subject|8|||
130517584|NCT04206384|469863481|FG000|Overall Study|Adverse Event|2|||
130517585|NCT02212197|469863482|FG000|Overall Study|Need for radiotherapy|1|||
130517586|NCT02212197|469863483|FG001|Overall Study|Need for radiotherapy|0|||
130517587|NCT02212197|469863484|FG002|Overall Study|Need for radiotherapy|0|||
130517588|NCT01078584|469863485|FG000|Overall Study|Final Status Unknown|1073|||
130517589|NCT01078584|469863485|FG000|Overall Study|Lost to Follow-up|670|||
130517590|NCT01078584|469863485|FG000|Overall Study|Non-serious Adverse Event|577|||
130517591|NCT01078584|469863485|FG000|Overall Study|Withdrawal of Consent|244|||
130517592|NCT01078584|469863485|FG000|Overall Study|Physician Withdrew from Study|90|||
130517593|NCT01078584|469863485|FG000|Overall Study|Non-compliance|67|||
130517594|NCT01078584|469863485|FG000|Overall Study|Blood Pressure Controlled|49|||
130517595|NCT01078584|469863485|FG000|Overall Study|Physician Switched Medication|26|||
130517596|NCT01078584|469863485|FG000|Overall Study|Physician Discontinued Patient|12|||
130517597|NCT01078584|469863485|FG000|Overall Study|Lack of Efficacy|98|||
130517598|NCT01078584|469863485|FG000|Overall Study|Protocol Violation|75|||
130517599|NCT01078584|469863485|FG000|Overall Study|Serious Adverse Event|27|||
130571772|NCT00159861|470057430|FG001|Extension Study - up to 3 Years|Death|28|||
130571773|NCT00159861|470057429|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
130571774|NCT00159861|470057430|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
130571775|NCT00159861|470057429|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
130571776|NCT00159861|470057430|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
130571777|NCT00159861|470057429|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
130571778|NCT00159861|470057430|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
130571779|NCT00159861|470057429|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
130571780|NCT00159861|470057430|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
130571781|NCT04489888|470057431|FG000|Overall Study|Death|75|||
130571782|NCT04489888|470057431|FG000|Overall Study|Sponsor Decision|26|||
130571783|NCT03349099|470057432|FG000|Overall Study|Physician Decision|3|||
130571784|NCT03349099|470057433|FG001|Overall Study|Physician Decision|4|||
130571785|NCT03349099|470057432|FG000|Overall Study|Stone migrated from the kidney|1|||
130517600|NCT01078584|469863485|FG000|Overall Study|Multiple Reasons|2|||
130517601|NCT03015181|469863487|FG000|Overall Study|Enrolled, but product never administered|1|||
130517602|NCT03015181|469863488|FG001|Overall Study|Enrolled, but product never administered|0|||
130517603|NCT03015181|469863489|FG002|Overall Study|Enrolled, but product never administered|0|||
130517604|NCT03015181|469863490|FG003|Overall Study|Enrolled, but product never administered|0|||
130517605|NCT03015181|469863491|FG004|Overall Study|Enrolled, but product never administered|0|||
130517606|NCT03015181|469863492|FG005|Overall Study|Enrolled, but product never administered|0|||
130517607|NCT03015181|469863493|FG006|Overall Study|Enrolled, but product never administered|0|||
130571786|NCT03349099|470057433|FG001|Overall Study|Stone migrated from the kidney|0|||
130571787|NCT00278993|470057434|FG000|Overall Study|Adverse Event|24|||
130517608|NCT03015181|469863487|FG000|Overall Study|Withdrawal by Subject|0|||
130517609|NCT03015181|469863488|FG001|Overall Study|Withdrawal by Subject|0|||
130517610|NCT03015181|469863489|FG002|Overall Study|Withdrawal by Subject|0|||
130517611|NCT03015181|469863490|FG003|Overall Study|Withdrawal by Subject|0|||
130517612|NCT03015181|469863491|FG004|Overall Study|Withdrawal by Subject|0|||
130517613|NCT03015181|469863492|FG005|Overall Study|Withdrawal by Subject|1|||
130517614|NCT03015181|469863493|FG006|Overall Study|Withdrawal by Subject|0|||
130517615|NCT03015181|469863487|FG000|Overall Study|Physician Decision|0|||
130517616|NCT03015181|469863488|FG001|Overall Study|Physician Decision|0|||
130517617|NCT03015181|469863489|FG002|Overall Study|Physician Decision|0|||
130517618|NCT03015181|469863490|FG003|Overall Study|Physician Decision|0|||
130517619|NCT03015181|469863491|FG004|Overall Study|Physician Decision|0|||
130517620|NCT03015181|469863492|FG005|Overall Study|Physician Decision|0|||
130517621|NCT03015181|469863493|FG006|Overall Study|Physician Decision|1|||
130571788|NCT00278993|470057434|FG000|Overall Study|Withdrawal by Subject|5|||
130571789|NCT00278993|470057434|FG000|Overall Study|Progressive Disease|65|||
130571790|NCT00278993|470057434|FG000|Overall Study|Physician Decision|9|||
130517622|NCT02551692|469863494|FG000|Overall Study|Lost to Follow-up|0|||
130517623|NCT02551692|469863495|FG001|Overall Study|Lost to Follow-up|1|||
130517624|NCT02551692|469863496|FG002|Overall Study|Lost to Follow-up|4|||
130517625|NCT02551692|469863494|FG000|Overall Study|Withdrawal by Subject|1|||
130517626|NCT02551692|469863495|FG001|Overall Study|Withdrawal by Subject|0|||
130517627|NCT02551692|469863496|FG002|Overall Study|Withdrawal by Subject|1|||
130517628|NCT01091519|469863497|FG000|Overall Study|Adverse Event|12|||
130517629|NCT01091519|469863498|FG001|Overall Study|Adverse Event|16|||
130517630|NCT01091519|469863497|FG000|Overall Study|Death|1|||
130517631|NCT01091519|469863498|FG001|Overall Study|Death|0|||
130517632|NCT01091519|469863497|FG000|Overall Study|Lack of Efficacy|16|||
130517633|NCT01091519|469863498|FG001|Overall Study|Lack of Efficacy|19|||
130517634|NCT01091519|469863497|FG000|Overall Study|Lost to Follow-up|14|||
130517635|NCT01091519|469863498|FG001|Overall Study|Lost to Follow-up|24|||
130517636|NCT01091519|469863497|FG000|Overall Study|Withdrawal by Subject|2|||
130517637|NCT01091519|469863498|FG001|Overall Study|Withdrawal by Subject|2|||
130571791|NCT00278993|470057434|FG000|Overall Study|Not Otherwise Specified|4|||
130571792|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
130571793|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
130571794|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
130571795|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
130571796|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
130571797|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
130571798|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130571799|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130571800|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130571801|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130571802|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
130571803|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
130571804|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
130571805|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
130571806|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
130571807|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
130571808|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
130571809|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
130571810|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
130571811|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
130571812|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
130571813|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
130571814|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
130571815|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
130571816|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
130571817|NCT03829657|470057437|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
130571818|NCT03829657|470057438|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
130571819|NCT03829657|470057439|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
130571820|NCT03829657|470057440|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
130571821|NCT03829657|470057441|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
130571822|NCT03829657|470057437|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130571823|NCT03829657|470057438|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130571824|NCT03829657|470057439|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130571825|NCT03829657|470057440|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130571826|NCT03829657|470057441|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
130517638|NCT01091519|469863497|FG000|Overall Study|Other|6|||
130517639|NCT01091519|469863498|FG001|Overall Study|Other|8|||
130517640|NCT01091519|469863497|FG000|Overall Study|Randomized not treated|4|||
130517641|NCT01091519|469863498|FG001|Overall Study|Randomized not treated|4|||
130517642|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
130517643|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
130517644|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
130517645|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Other|1|||
130517646|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Other|0|||
130517647|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Other|0|||
130517648|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Physician Decision|3|||
130517649|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Physician Decision|0|||
130517650|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Physician Decision|0|||
130517651|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
130517652|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
130517653|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
130517654|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
130517655|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
130517656|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
130517657|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Adverse Event|18|||
130517658|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Adverse Event|0|||
130517659|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Adverse Event|0|||
130517660|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
130571827|NCT03829657|470057437|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130571828|NCT03829657|470057438|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130571829|NCT03829657|470057439|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130571830|NCT03829657|470057440|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
130571831|NCT03829657|470057441|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
130571832|NCT03829657|470057437|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130571833|NCT03829657|470057438|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130571834|NCT03829657|470057439|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130571835|NCT03829657|470057440|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
130571836|NCT03829657|470057441|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
130571837|NCT03829657|470057437|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130571838|NCT03829657|470057438|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130571839|NCT03829657|470057439|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130571840|NCT03829657|470057440|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130571841|NCT03829657|470057441|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
130571842|NCT01014689|470057442|FG000|Overall Study|Lack of Efficacy|0|||
130571843|NCT01014689|470057443|FG001|Overall Study|Lack of Efficacy|1|||
130571844|NCT01014689|470057442|FG000|Overall Study|Adverse Event|3|||
130571845|NCT01014689|470057443|FG001|Overall Study|Adverse Event|0|||
130571846|NCT01014689|470057442|FG000|Overall Study|Withdrawal by Subject|5|||
130571847|NCT01014689|470057443|FG001|Overall Study|Withdrawal by Subject|4|||
130571848|NCT01014689|470057442|FG000|Overall Study|Protocol Violation|1|||
130571849|NCT01014689|470057443|FG001|Overall Study|Protocol Violation|1|||
130571850|NCT01014689|470057442|FG000|Overall Study|Lost to Follow-up|3|||
130571851|NCT01014689|470057443|FG001|Overall Study|Lost to Follow-up|7|||
130571852|NCT01014689|470057442|FG000|Overall Study|Pregnancy|1|||
130571853|NCT01014689|470057443|FG001|Overall Study|Pregnancy|0|||
130571854|NCT00609791|470058852|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
130571855|NCT01394939|470058857|FG000|Overall Study|Adverse Event|1|||
130571856|NCT01394939|470058858|FG001|Overall Study|Adverse Event|3|||
130571857|NCT01394939|470058859|FG002|Overall Study|Adverse Event|0|||
130571858|NCT01394939|470058860|FG003|Overall Study|Adverse Event|2|||
130571859|NCT01394939|470058857|FG000|Overall Study|Death|0|||
130571860|NCT01394939|470058858|FG001|Overall Study|Death|2|||
130571861|NCT01394939|470058859|FG002|Overall Study|Death|0|||
130571862|NCT01394939|470058860|FG003|Overall Study|Death|0|||
130571863|NCT01394939|470058857|FG000|Overall Study|Physician Decision|0|||
130571864|NCT01394939|470058858|FG001|Overall Study|Physician Decision|1|||
130571865|NCT01394939|470058859|FG002|Overall Study|Physician Decision|0|||
130571866|NCT01394939|470058860|FG003|Overall Study|Physician Decision|0|||
130571867|NCT01394939|470058857|FG000|Overall Study|Withdrawal by Subject|0|||
130571868|NCT01394939|470058858|FG001|Overall Study|Withdrawal by Subject|2|||
130571869|NCT01394939|470058859|FG002|Overall Study|Withdrawal by Subject|0|||
130571870|NCT01394939|470058860|FG003|Overall Study|Withdrawal by Subject|2|||
130571871|NCT01394939|470058857|FG000|Overall Study|Others|0|||
130571872|NCT01394939|470058858|FG001|Overall Study|Others|2|||
130571873|NCT01394939|470058859|FG002|Overall Study|Others|0|||
130571874|NCT01394939|470058860|FG003|Overall Study|Others|3|||
130571875|NCT00150592|470058863|FG000|Overall Study|Adverse Event|4|||
130571876|NCT00150592|470058864|FG001|Overall Study|Adverse Event|1|||
130571877|NCT00150592|470058863|FG000|Overall Study|Protocol Violation|1|||
130571878|NCT00150592|470058864|FG001|Overall Study|Protocol Violation|0|||
130571879|NCT00150592|470058863|FG000|Overall Study|Withdrawal by Subject|1|||
130571880|NCT00150592|470058864|FG001|Overall Study|Withdrawal by Subject|2|||
130571881|NCT00150592|470058863|FG000|Overall Study|Non-compliance|1|||
130571882|NCT00150592|470058864|FG001|Overall Study|Non-compliance|0|||
130571883|NCT00874120|470058869|FG000|First Intervention|Adverse Event|0|||
130571884|NCT00874120|470058870|FG001|First Intervention|Adverse Event|1|||
130571885|NCT00874120|470058869|FG000|First Intervention|Withdrawal by Subject|2|||
130571886|NCT00874120|470058870|FG001|First Intervention|Withdrawal by Subject|0|||
130571887|NCT00874120|470058869|FG000|First Intervention|Lost to Follow-up|0|||
130571888|NCT00874120|470058870|FG001|First Intervention|Lost to Follow-up|1|||
130571889|NCT00874120|470058869|FG000|First Intervention|Protocol Violation|3|||
130571890|NCT00874120|470058870|FG001|First Intervention|Protocol Violation|0|||
130571891|NCT00874120|470058869|FG000|First Intervention|positive drug test|1|||
130571892|NCT00874120|470058870|FG001|First Intervention|positive drug test|0|||
130571893|NCT00874120|470058869|FG000|Second Intervention|Withdrawal by Subject|1|||
130571894|NCT00874120|470058870|FG001|Second Intervention|Withdrawal by Subject|0|||
130571895|NCT00874120|470058869|FG000|Second Intervention|Protocol Violation|1|||
130571896|NCT00874120|470058870|FG001|Second Intervention|Protocol Violation|0|||
130571897|NCT01823679|470058871|FG000|Overall Study|Death|1|||
130571898|NCT03927105|470058872|FG000|Overall Study|Death|1|||
130571899|NCT03927105|470058872|FG000|Overall Study|In observation for potential re-treatment|2|||
130517661|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
130517662|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
130517663|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
130517664|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
130571900|NCT03927105|470058872|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
130571901|NCT00647556|470058876|FG000|Overall Study|Adverse Event|0|||
130571902|NCT00647556|470058877|FG001|Overall Study|Adverse Event|1|||
130571903|NCT00647556|470058876|FG000|Overall Study|Lost to Follow-up|1|||
130571904|NCT00647556|470058877|FG001|Overall Study|Lost to Follow-up|0|||
130571905|NCT00647556|470058876|FG000|Overall Study|Protocol Violation|0|||
130571906|NCT00647556|470058877|FG001|Overall Study|Protocol Violation|1|||
130571907|NCT00647556|470058876|FG000|Overall Study|Withdrawal by Subject|1|||
130571908|NCT00647556|470058877|FG001|Overall Study|Withdrawal by Subject|0|||
130571909|NCT00647556|470058876|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
130571910|NCT00647556|470058877|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
130571911|NCT05594173|470058878|FG000|Overall Study|Adverse Event|1|||
130571912|NCT05594173|470058878|FG000|Overall Study|COVID-19 Pandemic|2|||
130571913|NCT01877187|470058879|FG000|Overall Study|Death|2|||
130571914|NCT01877187|470058879|FG000|Overall Study|Withdrawal by Subject|4|||
130571915|NCT01877187|470058879|FG000|Overall Study|Lost to Follow-up|3|||
130571916|NCT01877187|470058879|FG000|Overall Study|Declining clinical status|11|||
130571917|NCT01877187|470058879|FG000|Overall Study|Liver transplant|2|||
130571918|NCT03776175|470058881|FG000|Treatment Period (42 Days)|Adverse Event|0|||
130571919|NCT03776175|470058882|FG001|Treatment Period (42 Days)|Adverse Event|1|||
130571920|NCT03776175|470058883|FG002|Treatment Period (42 Days)|Adverse Event|1|||
130571921|NCT03776175|470058884|FG003|Treatment Period (42 Days)|Adverse Event|0|||
130571922|NCT03776175|470058881|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
130571923|NCT03776175|470058882|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
130571924|NCT03776175|470058883|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
130571925|NCT03776175|470058884|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
130571926|NCT03776175|470058881|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
130571927|NCT03776175|470058882|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
130571928|NCT03776175|470058883|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
130517665|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
130517666|NCT03030599|469863501|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
130517667|NCT03030599|469863502|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
130517668|NCT03030599|469863503|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
130517669|NCT03030599|469863501|FG000|Stable Dose|Protocol deviation|3|||
130517670|NCT03030599|469863502|FG001|Stable Dose|Protocol deviation|0|||
130517671|NCT03030599|469863503|FG002|Stable Dose|Protocol deviation|0|||
130517672|NCT03030599|469863501|FG000|Stable Dose|Adverse Event|1|||
130517673|NCT03030599|469863502|FG001|Stable Dose|Adverse Event|0|||
130517674|NCT03030599|469863503|FG002|Stable Dose|Adverse Event|0|||
130517675|NCT03030599|469863501|FG000|Stable Dose|Lost to Follow-up|1|||
130517676|NCT03030599|469863502|FG001|Stable Dose|Lost to Follow-up|0|||
130517677|NCT03030599|469863503|FG002|Stable Dose|Lost to Follow-up|0|||
130517678|NCT03030599|469863501|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
130517679|NCT03030599|469863502|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
130517680|NCT03030599|469863503|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
130517681|NCT03030599|469863501|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
130517682|NCT03030599|469863502|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
130517683|NCT03030599|469863503|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
130517684|NCT03030599|469863501|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
130517685|NCT03030599|469863502|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
130517686|NCT03030599|469863503|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
130517687|NCT03030599|469863501|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
130517688|NCT03030599|469863502|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
130517689|NCT03030599|469863503|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
130517690|NCT03030599|469863501|FG000|Open-label Extension|Adverse Event|3|||
130517691|NCT03030599|469863502|FG001|Open-label Extension|Adverse Event|0|||
130571929|NCT03776175|470058884|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
130571930|NCT03776175|470058881|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
130571931|NCT03776175|470058882|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
130571932|NCT03776175|470058883|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
130571933|NCT03776175|470058884|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
130517692|NCT03030599|469863503|FG002|Open-label Extension|Adverse Event|0|||
130517693|NCT03030599|469863501|FG000|Open-label Extension|Lost to Follow-up|2|||
130517694|NCT03030599|469863502|FG001|Open-label Extension|Lost to Follow-up|0|||
130517695|NCT03030599|469863503|FG002|Open-label Extension|Lost to Follow-up|0|||
130517696|NCT03030599|469863501|FG000|Open-label Extension|Lack of Efficacy|1|||
130517697|NCT03030599|469863502|FG001|Open-label Extension|Lack of Efficacy|0|||
130517698|NCT03030599|469863503|FG002|Open-label Extension|Lack of Efficacy|0|||
130517699|NCT03030599|469863501|FG000|Open-label Extension|Other Reason|1|||
130517700|NCT03030599|469863502|FG001|Open-label Extension|Other Reason|0|||
130517701|NCT03030599|469863503|FG002|Open-label Extension|Other Reason|0|||
130517702|NCT01177228|469863504|FG000|Overall Study|Positive tuberculosis test|0|||
130517703|NCT01177228|469863505|FG001|Overall Study|Positive tuberculosis test|1|||
130517704|NCT01177228|469863506|FG002|Overall Study|Positive tuberculosis test|0|||
130517705|NCT01177228|469863507|FG003|Overall Study|Positive tuberculosis test|0|||
130517706|NCT01177228|469863504|FG000|Overall Study|Worsening disease activity|1|||
130517707|NCT01177228|469863505|FG001|Overall Study|Worsening disease activity|0|||
130517708|NCT01177228|469863506|FG002|Overall Study|Worsening disease activity|0|||
130517709|NCT01177228|469863507|FG003|Overall Study|Worsening disease activity|0|||
130517710|NCT01177228|469863504|FG000|Overall Study|Withdrawal by Subject|0|||
130517711|NCT01177228|469863505|FG001|Overall Study|Withdrawal by Subject|1|||
130517712|NCT01177228|469863506|FG002|Overall Study|Withdrawal by Subject|0|||
130517713|NCT01177228|469863507|FG003|Overall Study|Withdrawal by Subject|0|||
130517714|NCT01592383|469863508|FG000|Overall Study|Adverse Event|1|||
130517715|NCT04582864|469863509|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
130517716|NCT04582864|469863509|FG000|Overall Study|Death|1|||
130517717|NCT04167085|469863510|FG000|Baseline|Withdrawal by Subject|2|||
130517718|NCT04167085|469863511|FG001|Baseline|Withdrawal by Subject|1|||
130517719|NCT04167085|469863510|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
130517720|NCT04167085|469863511|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
130517721|NCT00702520|469863515|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
130517722|NCT00702520|469863516|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
130517723|NCT00702520|469863517|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
130517724|NCT00702520|469863518|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
130517725|NCT00702520|469863515|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
130517726|NCT00702520|469863516|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
130517727|NCT00702520|469863517|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
130517728|NCT00702520|469863518|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
130517729|NCT00702520|469863515|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
130517730|NCT00702520|469863516|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
130517731|NCT00702520|469863517|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
130517732|NCT00702520|469863518|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
130517733|NCT02481934|469863519|FG000|Overall Study|Death|2|||
130517734|NCT00942188|469863520|FG000|Overall Study|Adverse Event|0|||
130517735|NCT00942188|469863521|FG001|Overall Study|Adverse Event|3|||
130517736|NCT00942188|469863522|FG002|Overall Study|Adverse Event|2|||
130571934|NCT03776175|470058881|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
130571935|NCT03776175|470058882|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
130571936|NCT03776175|470058883|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
130571937|NCT03776175|470058884|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
130571938|NCT03776175|470058881|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130571939|NCT03776175|470058882|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130571940|NCT03776175|470058883|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130571941|NCT03776175|470058884|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
130571942|NCT02599961|470058885|FG000|Overall Study|Withdrawal by Subject|1|||
130571943|NCT02599961|470058885|FG000|Overall Study|Subject Non-Compliance|2|||
130571944|NCT02599961|470058885|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
130571945|NCT02599961|470058885|FG000|Overall Study|Other, Not Specified|3|||
130571946|NCT00143312|470058886|FG000|Overall Study|Death|11|||
130571947|NCT00143312|470058886|FG000|Overall Study|Adverse Event|2|||
130571948|NCT00143312|470058886|FG000|Overall Study|Lost to Follow-up|1|||
130571949|NCT00143312|470058886|FG000|Overall Study|Other|1|||
130571950|NCT00143312|470058886|FG000|Overall Study|Withdrawal by Subject|1|||
130517737|NCT00942188|469863523|FG003|Overall Study|Adverse Event|0|||
130517738|NCT00942188|469863520|FG000|Overall Study|Lack of Efficacy|0|||
130517739|NCT00942188|469863521|FG001|Overall Study|Lack of Efficacy|0|||
130571951|NCT01029366|470058887|FG000|Overall Study|Withdrawal by Subject|1|||
130571952|NCT01029366|470058888|FG001|Overall Study|Withdrawal by Subject|0|||
130571953|NCT01029366|470058887|FG000|Overall Study|Death|1|||
130571954|NCT01029366|470058888|FG001|Overall Study|Death|1|||
130571955|NCT01029366|470058887|FG000|Overall Study|disease progression|2|||
130571956|NCT01029366|470058888|FG001|Overall Study|disease progression|0|||
130517740|NCT00942188|469863522|FG002|Overall Study|Lack of Efficacy|0|||
130517741|NCT00942188|469863523|FG003|Overall Study|Lack of Efficacy|1|||
130517742|NCT00942188|469863520|FG000|Overall Study|Protocol Violation|1|||
130517743|NCT00942188|469863521|FG001|Overall Study|Protocol Violation|1|||
130517744|NCT00942188|469863522|FG002|Overall Study|Protocol Violation|0|||
130517745|NCT00942188|469863523|FG003|Overall Study|Protocol Violation|0|||
130517746|NCT00942188|469863520|FG000|Overall Study|Lost to Follow-up|2|||
130517747|NCT00942188|469863521|FG001|Overall Study|Lost to Follow-up|1|||
130517748|NCT00942188|469863522|FG002|Overall Study|Lost to Follow-up|2|||
130517749|NCT00942188|469863523|FG003|Overall Study|Lost to Follow-up|0|||
130517750|NCT00942188|469863520|FG000|Overall Study|Withdrawal by Subject|1|||
130517751|NCT00942188|469863521|FG001|Overall Study|Withdrawal by Subject|3|||
130517752|NCT00942188|469863522|FG002|Overall Study|Withdrawal by Subject|4|||
130517753|NCT00942188|469863523|FG003|Overall Study|Withdrawal by Subject|2|||
130517754|NCT00942188|469863520|FG000|Overall Study|Physician Decision|0|||
130517755|NCT00942188|469863521|FG001|Overall Study|Physician Decision|0|||
130517756|NCT00942188|469863522|FG002|Overall Study|Physician Decision|1|||
130517757|NCT00942188|469863523|FG003|Overall Study|Physician Decision|0|||
130517758|NCT00942188|469863520|FG000|Overall Study|Sponsor Decision|0|||
130517759|NCT00942188|469863521|FG001|Overall Study|Sponsor Decision|2|||
130517760|NCT00942188|469863522|FG002|Overall Study|Sponsor Decision|0|||
130517761|NCT00942188|469863523|FG003|Overall Study|Sponsor Decision|1|||
130517762|NCT00276016|469863524|FG000|Intervention 1|Withdrawal by Subject|0|||
130517763|NCT00276016|469863525|FG001|Intervention 1|Withdrawal by Subject|1|||
130517764|NCT00276016|469863526|FG002|Intervention 1|Withdrawal by Subject|0|||
130517765|NCT00276016|469863527|FG003|Intervention 1|Withdrawal by Subject|0|||
130517766|NCT00276016|469863528|FG004|Intervention 1|Withdrawal by Subject|0|||
130517767|NCT00276016|469863529|FG005|Intervention 1|Withdrawal by Subject|0|||
130517768|NCT01374971|469863530|FG000|Overall Study|Withdrawal by Subject|1|||
130517769|NCT01222533|469865534|FG000|Overall Study|Adverse Event|5|||
130517770|NCT01222533|469865534|FG000|Overall Study|Withdrawal by Subject|5|||
130517771|NCT01222533|469865534|FG000|Overall Study|Other|4|||
130517772|NCT01947517|469865535|FG000|Overall Study|Withdrawal by Subject|1|||
130517773|NCT01947517|469865536|FG001|Overall Study|Withdrawal by Subject|1|||
130517774|NCT00460564|469865540|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
130517775|NCT00460564|469865541|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
130517776|NCT00460564|469865542|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517777|NCT00460564|469865543|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517778|NCT00460564|469865544|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517779|NCT00460564|469865545|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517780|NCT00460564|469865546|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517781|NCT00460564|469865547|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130517782|NCT00460564|469865540|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
130517783|NCT00460564|469865541|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517784|NCT00460564|469865542|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517785|NCT00460564|469865543|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517786|NCT00460564|469865544|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517787|NCT00460564|469865545|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517788|NCT00460564|469865546|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517789|NCT00460564|469865547|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130517790|NCT00460564|469865540|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130517791|NCT00460564|469865541|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130517792|NCT00460564|469865542|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130517793|NCT00460564|469865543|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130517794|NCT00460564|469865544|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
130517795|NCT00460564|469865545|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
130517796|NCT00460564|469865546|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
130517797|NCT00460564|469865547|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130517798|NCT00460564|469865540|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517799|NCT00460564|469865541|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517800|NCT00460564|469865542|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517801|NCT00460564|469865543|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517802|NCT00460564|469865544|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
130517803|NCT00460564|469865545|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
130517804|NCT00460564|469865546|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517805|NCT00460564|469865547|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130517806|NCT00460564|469865540|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517807|NCT00460564|469865541|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517808|NCT00460564|469865542|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517809|NCT00460564|469865543|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517810|NCT00460564|469865544|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
130517811|NCT00460564|469865545|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517812|NCT00460564|469865546|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517813|NCT00460564|469865547|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130517814|NCT00320398|469865552|FG000|Overall Study|Adverse Event|1|||
130517815|NCT00320398|469865553|FG001|Overall Study|Adverse Event|4|||
130517816|NCT00320398|469865552|FG000|Overall Study|Other|1|||
130517817|NCT00320398|469865553|FG001|Overall Study|Other|0|||
130517818|NCT00630552|469865554|FG000|Overall Study|Adverse Event|0|||
130517819|NCT00630552|469865555|FG001|Overall Study|Adverse Event|1|||
130517820|NCT00630552|469865556|FG002|Overall Study|Adverse Event|5|||
130517821|NCT00630552|469865557|FG003|Overall Study|Adverse Event|4|||
130517822|NCT00630552|469865558|FG004|Overall Study|Adverse Event|2|||
130517823|NCT00630552|469865554|FG000|Overall Study|Disease progression|5|||
130517824|NCT00630552|469865555|FG001|Overall Study|Disease progression|6|||
130517825|NCT00630552|469865556|FG002|Overall Study|Disease progression|27|||
130517826|NCT00630552|469865557|FG003|Overall Study|Disease progression|22|||
130517827|NCT00630552|469865558|FG004|Overall Study|Disease progression|31|||
130517828|NCT00630552|469865554|FG000|Overall Study|Never received IP|0|||
130517829|NCT00630552|469865555|FG001|Overall Study|Never received IP|0|||
130517830|NCT00630552|469865556|FG002|Overall Study|Never received IP|0|||
130517831|NCT00630552|469865557|FG003|Overall Study|Never received IP|2|||
130517832|NCT00630552|469865558|FG004|Overall Study|Never received IP|2|||
130517833|NCT00630552|469865554|FG000|Overall Study|Ineligibility determined|0|||
130517834|NCT00630552|469865555|FG001|Overall Study|Ineligibility determined|0|||
130517835|NCT00630552|469865556|FG002|Overall Study|Ineligibility determined|0|||
130517836|NCT00630552|469865557|FG003|Overall Study|Ineligibility determined|0|||
130517837|NCT00630552|469865558|FG004|Overall Study|Ineligibility determined|1|||
130517838|NCT00630552|469865554|FG000|Overall Study|Protocol Violation|0|||
130517839|NCT00630552|469865555|FG001|Overall Study|Protocol Violation|0|||
130517840|NCT00630552|469865556|FG002|Overall Study|Protocol Violation|0|||
130517841|NCT00630552|469865557|FG003|Overall Study|Protocol Violation|1|||
130517842|NCT00630552|469865558|FG004|Overall Study|Protocol Violation|0|||
130517843|NCT00630552|469865554|FG000|Overall Study|Physician Decision|0|||
130517844|NCT00630552|469865555|FG001|Overall Study|Physician Decision|0|||
130517845|NCT00630552|469865556|FG002|Overall Study|Physician Decision|0|||
130517846|NCT00630552|469865557|FG003|Overall Study|Physician Decision|0|||
130517847|NCT00630552|469865558|FG004|Overall Study|Physician Decision|1|||
130517848|NCT00630552|469865554|FG000|Overall Study|Death|0|||
130517849|NCT00630552|469865555|FG001|Overall Study|Death|0|||
130517850|NCT00630552|469865556|FG002|Overall Study|Death|1|||
130517851|NCT00630552|469865557|FG003|Overall Study|Death|2|||
130517852|NCT00630552|469865558|FG004|Overall Study|Death|2|||
130517853|NCT00630552|469865554|FG000|Overall Study|Withdrawal by Subject|0|||
130517854|NCT00630552|469865555|FG001|Overall Study|Withdrawal by Subject|0|||
130517855|NCT00630552|469865556|FG002|Overall Study|Withdrawal by Subject|0|||
130517856|NCT00630552|469865557|FG003|Overall Study|Withdrawal by Subject|1|||
130517857|NCT00630552|469865558|FG004|Overall Study|Withdrawal by Subject|0|||
130517858|NCT00630552|469865554|FG000|Overall Study|Other|0|||
130517859|NCT00630552|469865555|FG001|Overall Study|Other|0|||
130517860|NCT00630552|469865556|FG002|Overall Study|Other|4|||
130517861|NCT00630552|469865557|FG003|Overall Study|Other|2|||
130517862|NCT00630552|469865558|FG004|Overall Study|Other|0|||
130517863|NCT04349644|469865559|FG000|Allocation/Pretest|Lost to pretest|0|||
130517864|NCT04349644|469865560|FG001|Allocation/Pretest|Lost to pretest|3|||
130517865|NCT04349644|469865559|FG000|Posttest|Lost to posttest|0|||
130517866|NCT04349644|469865560|FG001|Posttest|Lost to posttest|8|||
130517867|NCT04349644|469865559|FG000|Posttest|Discontinued intervention|6|||
130517868|NCT04349644|469865560|FG001|Posttest|Discontinued intervention|0|||
130517869|NCT04349644|469865559|FG000|Follow-up|Lost to Follow-up|0|||
130517870|NCT04349644|469865560|FG001|Follow-up|Lost to Follow-up|2|||
130517871|NCT00983905|469865562|FG000|Theophylline Alone|Adverse Event|1|||
130517872|NCT00983905|469865562|FG000|Colchicine Alone|Adverse Event|2|||
130517873|NCT02741713|469865566|FG000|Overall Study|Surgery type changed intra-operatively|2|||
130517874|NCT02741713|469865567|FG001|Overall Study|Surgery type changed intra-operatively|1|||
130517875|NCT00809341|469865570|FG000|Overall Study|Physician Decision|0|||
130517876|NCT00809341|469865571|FG001|Overall Study|Physician Decision|1|||
130517877|NCT00225277|469865575|FG000|Overall Study|Adverse Event|30|||
130517878|NCT00225277|469865576|FG001|Overall Study|Adverse Event|34|||
130517879|NCT00225277|469865575|FG000|Overall Study|Lack of Efficacy|4|||
130517880|NCT00225277|469865576|FG001|Overall Study|Lack of Efficacy|1|||
130517881|NCT00225277|469865575|FG000|Overall Study|Lost to Follow-up|4|||
130517882|NCT00225277|469865576|FG001|Overall Study|Lost to Follow-up|6|||
130517883|NCT00225277|469865575|FG000|Overall Study|Physician Decision|6|||
130517884|NCT00225277|469865576|FG001|Overall Study|Physician Decision|8|||
130517885|NCT00225277|469865575|FG000|Overall Study|Protocol Violation|6|||
130517886|NCT00225277|469865576|FG001|Overall Study|Protocol Violation|3|||
130517887|NCT00225277|469865575|FG000|Overall Study|Withdrawal by Subject|40|||
130517888|NCT00225277|469865576|FG001|Overall Study|Withdrawal by Subject|34|||
130517889|NCT00225277|469865575|FG000|Overall Study|Other|7|||
130517890|NCT00225277|469865576|FG001|Overall Study|Other|9|||
130517891|NCT04582669|469865583|FG000|Overall Study|Subject missed appointment(s).|1|||
130517892|NCT04582669|469865584|FG001|Overall Study|Subject missed appointment(s).|0|||
130517893|NCT04582669|469865585|FG002|Overall Study|Subject missed appointment(s).|1|||
130517894|NCT04582669|469865586|FG003|Overall Study|Subject missed appointment(s).|2|||
130517895|NCT04582669|469865583|FG000|Overall Study|Protocol Violation|0|||
130517896|NCT04582669|469865584|FG001|Overall Study|Protocol Violation|1|||
130517897|NCT04582669|469865585|FG002|Overall Study|Protocol Violation|1|||
130517898|NCT04582669|469865586|FG003|Overall Study|Protocol Violation|0|||
130517899|NCT00591409|469865587|FG000|Overall Study|Not Treated|0|||
130517900|NCT00591409|469865588|FG001|Overall Study|Not Treated|0|||
130517901|NCT00591409|469865589|FG002|Overall Study|Not Treated|0|||
130517902|NCT00591409|469865590|FG003|Overall Study|Not Treated|0|||
130517903|NCT00591409|469865591|FG004|Overall Study|Not Treated|1|||
130517904|NCT00591409|469865592|FG005|Overall Study|Not Treated|0|||
130517905|NCT00591409|469865593|FG006|Overall Study|Not Treated|0|||
130517906|NCT00591409|469865594|FG007|Overall Study|Not Treated|0|||
130517907|NCT00591409|469865595|FG008|Overall Study|Not Treated|0|||
130517908|NCT00591409|469865596|FG009|Overall Study|Not Treated|1|||
130517909|NCT00677092|469865597|FG000|Overall Study|Adverse Event|1|||
130517910|NCT00677092|469865597|FG000|Overall Study|Lost to Follow-up|1|||
130517911|NCT00677092|469865597|FG000|Overall Study|Withdrawal by Subject|3|||
130517912|NCT00677092|469865597|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
130517913|NCT02716298|469865598|FG000|First Intervention (1 Month)|Lens discomfort|1|||
130517914|NCT02716298|469865599|FG001|First Intervention (1 Month)|Lens discomfort|1|||
130517915|NCT00550446|469865600|FG000|Up To Week 12|Adverse Event|2|||
130517916|NCT00550446|469865601|FG001|Up To Week 12|Adverse Event|2|||
130517917|NCT00550446|469865602|FG002|Up To Week 12|Adverse Event|0|||
130517918|NCT00550446|469865603|FG003|Up To Week 12|Adverse Event|0|||
130517919|NCT00550446|469865604|FG004|Up To Week 12|Adverse Event|2|||
130517920|NCT00550446|469865605|FG005|Up To Week 12|Adverse Event|2|||
130517921|NCT00550446|469865606|FG006|Up To Week 12|Adverse Event|1|||
130517922|NCT00550446|469865607|FG007|Up To Week 12|Adverse Event|0|||
130517923|NCT00550446|469865608|FG008|Up To Week 12|Adverse Event|0|||
130517924|NCT00550446|469865609|FG009|Up To Week 12|Adverse Event|0|||
130517925|NCT00550446|469865610|FG010|Up To Week 12|Adverse Event|0|||
130517926|NCT00550446|469865600|FG000|Up To Week 12|Lack of Efficacy|3|||
130517927|NCT00550446|469865601|FG001|Up To Week 12|Lack of Efficacy|1|||
130517928|NCT00550446|469865602|FG002|Up To Week 12|Lack of Efficacy|0|||
130517929|NCT00550446|469865603|FG003|Up To Week 12|Lack of Efficacy|1|||
130517930|NCT00550446|469865604|FG004|Up To Week 12|Lack of Efficacy|0|||
130517931|NCT00550446|469865605|FG005|Up To Week 12|Lack of Efficacy|3|||
130517932|NCT00550446|469865606|FG006|Up To Week 12|Lack of Efficacy|3|||
130517933|NCT00550446|469865607|FG007|Up To Week 12|Lack of Efficacy|0|||
130517934|NCT00550446|469865608|FG008|Up To Week 12|Lack of Efficacy|0|||
130517935|NCT00550446|469865609|FG009|Up To Week 12|Lack of Efficacy|0|||
130517936|NCT00550446|469865610|FG010|Up To Week 12|Lack of Efficacy|0|||
130517937|NCT00550446|469865600|FG000|Up To Week 12|Lost to Follow-up|0|||
130517938|NCT00550446|469865601|FG001|Up To Week 12|Lost to Follow-up|1|||
130517939|NCT00550446|469865602|FG002|Up To Week 12|Lost to Follow-up|0|||
130517940|NCT00550446|469865603|FG003|Up To Week 12|Lost to Follow-up|0|||
130517941|NCT00550446|469865604|FG004|Up To Week 12|Lost to Follow-up|1|||
130517942|NCT00550446|469865605|FG005|Up To Week 12|Lost to Follow-up|1|||
130517943|NCT00550446|469865606|FG006|Up To Week 12|Lost to Follow-up|2|||
130517944|NCT00550446|469865607|FG007|Up To Week 12|Lost to Follow-up|0|||
130517945|NCT00550446|469865608|FG008|Up To Week 12|Lost to Follow-up|0|||
130517946|NCT00550446|469865609|FG009|Up To Week 12|Lost to Follow-up|0|||
130517947|NCT00550446|469865610|FG010|Up To Week 12|Lost to Follow-up|0|||
130517948|NCT00550446|469865600|FG000|Up To Week 12|Withdrawal by Subject|2|||
130517949|NCT00550446|469865601|FG001|Up To Week 12|Withdrawal by Subject|0|||
130517950|NCT00550446|469865602|FG002|Up To Week 12|Withdrawal by Subject|3|||
130517951|NCT00550446|469865603|FG003|Up To Week 12|Withdrawal by Subject|2|||
130517952|NCT00550446|469865604|FG004|Up To Week 12|Withdrawal by Subject|0|||
130571957|NCT01029366|470058887|FG000|Overall Study|manufacturing failure|0|||
130571958|NCT01029366|470058888|FG001|Overall Study|manufacturing failure|1|||
130571959|NCT00906087|470058894|FG000|Initial Washout|Withdrawal by Subject|1|||
130571960|NCT00906087|470058894|FG000|Initial Washout|Physician Decision|1|||
130517953|NCT00550446|469865605|FG005|Up To Week 12|Withdrawal by Subject|1|||
130517954|NCT00550446|469865606|FG006|Up To Week 12|Withdrawal by Subject|3|||
130517955|NCT00550446|469865607|FG007|Up To Week 12|Withdrawal by Subject|0|||
130517956|NCT00550446|469865608|FG008|Up To Week 12|Withdrawal by Subject|0|||
130517957|NCT00550446|469865609|FG009|Up To Week 12|Withdrawal by Subject|0|||
130517958|NCT00550446|469865610|FG010|Up To Week 12|Withdrawal by Subject|0|||
130517959|NCT00550446|469865600|FG000|Up To Week 12|Other|3|||
130517960|NCT00550446|469865601|FG001|Up To Week 12|Other|0|||
130517961|NCT00550446|469865602|FG002|Up To Week 12|Other|0|||
130517962|NCT00550446|469865603|FG003|Up To Week 12|Other|0|||
130517963|NCT00550446|469865604|FG004|Up To Week 12|Other|0|||
130517964|NCT00550446|469865605|FG005|Up To Week 12|Other|1|||
130517965|NCT00550446|469865606|FG006|Up To Week 12|Other|4|||
130517966|NCT00550446|469865607|FG007|Up To Week 12|Other|0|||
130517967|NCT00550446|469865608|FG008|Up To Week 12|Other|0|||
130517968|NCT00550446|469865609|FG009|Up To Week 12|Other|0|||
130571961|NCT02898259|470058895|FG000|Overall Study|Adverse Event|0|||
130517969|NCT00550446|469865610|FG010|Up To Week 12|Other|0|||
130517970|NCT00550446|469865600|FG000|Up To Week 12|Randomized not treated|0|||
130517971|NCT00550446|469865601|FG001|Up To Week 12|Randomized not treated|1|||
130517972|NCT00550446|469865602|FG002|Up To Week 12|Randomized not treated|1|||
130517973|NCT00550446|469865603|FG003|Up To Week 12|Randomized not treated|0|||
130517974|NCT00550446|469865604|FG004|Up To Week 12|Randomized not treated|0|||
130517975|NCT00550446|469865605|FG005|Up To Week 12|Randomized not treated|0|||
130517976|NCT00550446|469865606|FG006|Up To Week 12|Randomized not treated|0|||
130517977|NCT00550446|469865607|FG007|Up To Week 12|Randomized not treated|0|||
130517978|NCT00550446|469865608|FG008|Up To Week 12|Randomized not treated|0|||
130517979|NCT00550446|469865609|FG009|Up To Week 12|Randomized not treated|0|||
130517980|NCT00550446|469865610|FG010|Up To Week 12|Randomized not treated|0|||
130517981|NCT00550446|469865600|FG000|Post Week 12|Adverse Event|2|||
130517982|NCT00550446|469865601|FG001|Post Week 12|Adverse Event|1|||
130517983|NCT00550446|469865602|FG002|Post Week 12|Adverse Event|1|||
130517984|NCT00550446|469865603|FG003|Post Week 12|Adverse Event|1|||
130517985|NCT00550446|469865604|FG004|Post Week 12|Adverse Event|1|||
130517986|NCT00550446|469865605|FG005|Post Week 12|Adverse Event|1|||
130517987|NCT00550446|469865606|FG006|Post Week 12|Adverse Event|0|||
130517988|NCT00550446|469865607|FG007|Post Week 12|Adverse Event|0|||
130517989|NCT00550446|469865608|FG008|Post Week 12|Adverse Event|0|||
130517990|NCT00550446|469865609|FG009|Post Week 12|Adverse Event|4|||
130517991|NCT00550446|469865610|FG010|Post Week 12|Adverse Event|0|||
130517992|NCT00550446|469865600|FG000|Post Week 12|Lack of Efficacy|0|||
130517993|NCT00550446|469865601|FG001|Post Week 12|Lack of Efficacy|0|||
130517994|NCT00550446|469865602|FG002|Post Week 12|Lack of Efficacy|1|||
130517995|NCT00550446|469865603|FG003|Post Week 12|Lack of Efficacy|0|||
130517996|NCT00550446|469865604|FG004|Post Week 12|Lack of Efficacy|0|||
130517997|NCT00550446|469865605|FG005|Post Week 12|Lack of Efficacy|0|||
130517998|NCT00550446|469865606|FG006|Post Week 12|Lack of Efficacy|0|||
130517999|NCT00550446|469865607|FG007|Post Week 12|Lack of Efficacy|1|||
130518000|NCT00550446|469865608|FG008|Post Week 12|Lack of Efficacy|1|||
130518001|NCT00550446|469865609|FG009|Post Week 12|Lack of Efficacy|2|||
130518002|NCT00550446|469865610|FG010|Post Week 12|Lack of Efficacy|1|||
130518003|NCT00550446|469865600|FG000|Post Week 12|Lost to Follow-up|0|||
130518004|NCT00550446|469865601|FG001|Post Week 12|Lost to Follow-up|0|||
130518005|NCT00550446|469865602|FG002|Post Week 12|Lost to Follow-up|1|||
130518006|NCT00550446|469865603|FG003|Post Week 12|Lost to Follow-up|1|||
130518007|NCT00550446|469865604|FG004|Post Week 12|Lost to Follow-up|0|||
130518008|NCT00550446|469865605|FG005|Post Week 12|Lost to Follow-up|0|||
130518009|NCT00550446|469865606|FG006|Post Week 12|Lost to Follow-up|1|||
130518010|NCT00550446|469865607|FG007|Post Week 12|Lost to Follow-up|0|||
130518011|NCT00550446|469865608|FG008|Post Week 12|Lost to Follow-up|0|||
130518012|NCT00550446|469865609|FG009|Post Week 12|Lost to Follow-up|0|||
130518013|NCT00550446|469865610|FG010|Post Week 12|Lost to Follow-up|0|||
130518014|NCT00550446|469865600|FG000|Post Week 12|Withdrawal by Subject|0|||
130518015|NCT00550446|469865601|FG001|Post Week 12|Withdrawal by Subject|0|||
130518016|NCT00550446|469865602|FG002|Post Week 12|Withdrawal by Subject|0|||
130518017|NCT00550446|469865603|FG003|Post Week 12|Withdrawal by Subject|0|||
130518018|NCT00550446|469865604|FG004|Post Week 12|Withdrawal by Subject|1|||
130518019|NCT00550446|469865605|FG005|Post Week 12|Withdrawal by Subject|0|||
130518020|NCT00550446|469865606|FG006|Post Week 12|Withdrawal by Subject|0|||
130518021|NCT00550446|469865607|FG007|Post Week 12|Withdrawal by Subject|0|||
130518022|NCT00550446|469865608|FG008|Post Week 12|Withdrawal by Subject|0|||
130518023|NCT00550446|469865609|FG009|Post Week 12|Withdrawal by Subject|0|||
130518024|NCT00550446|469865610|FG010|Post Week 12|Withdrawal by Subject|0|||
130518025|NCT00550446|469865600|FG000|Post Week 12|Other|1|||
130518026|NCT00550446|469865601|FG001|Post Week 12|Other|1|||
130518027|NCT00550446|469865602|FG002|Post Week 12|Other|0|||
130518028|NCT00550446|469865603|FG003|Post Week 12|Other|1|||
130518029|NCT00550446|469865604|FG004|Post Week 12|Other|0|||
130518030|NCT00550446|469865605|FG005|Post Week 12|Other|0|||
130518031|NCT00550446|469865606|FG006|Post Week 12|Other|1|||
130518032|NCT00550446|469865607|FG007|Post Week 12|Other|0|||
130518033|NCT00550446|469865608|FG008|Post Week 12|Other|1|||
130518034|NCT00550446|469865609|FG009|Post Week 12|Other|1|||
130518035|NCT00550446|469865610|FG010|Post Week 12|Other|0|||
130518036|NCT03503162|469865611|FG000|Overall Study|did not meet eligibility|1|||
130518037|NCT04952701|469865612|FG000|Control Lens|Physician Decision|4|||
130518038|NCT04952701|469865612|FG000|Test Lens|Physician Decision|1|||
130518039|NCT00578318|469865619|FG000|Overall Study|Lost to Follow-up|2|||
130518040|NCT00578318|469865620|FG001|Overall Study|Lost to Follow-up|0|||
130518041|NCT00578318|469865619|FG000|Overall Study|Physician Decision|1|||
130518042|NCT00578318|469865620|FG001|Overall Study|Physician Decision|0|||
130518043|NCT00866918|469865621|FG000|Overall Study|Death|1|||
130518044|NCT00866918|469865622|FG001|Overall Study|Death|5|||
130518045|NCT00866918|469865621|FG000|Overall Study|Lack of Efficacy|1|||
130518046|NCT00866918|469865622|FG001|Overall Study|Lack of Efficacy|1|||
130518047|NCT00866918|469865621|FG000|Overall Study|Physician Decision|10|||
130518048|NCT00866918|469865622|FG001|Overall Study|Physician Decision|2|||
130518049|NCT00866918|469865621|FG000|Overall Study|Ineligible|2|||
130518050|NCT00866918|469865622|FG001|Overall Study|Ineligible|4|||
130518051|NCT00866918|469865621|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
130518052|NCT00866918|469865622|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
130518053|NCT00866918|469865621|FG000|Overall Study|Secondary malignancy|1|||
130518054|NCT00866918|469865622|FG001|Overall Study|Secondary malignancy|0|||
130518055|NCT00527514|469865623|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
130518056|NCT00527514|469865623|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
130518057|NCT00527514|469865623|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
130518058|NCT00527514|469865623|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
130518059|NCT00527514|469865623|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
130518060|NCT00527514|469865623|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
130518061|NCT00527514|469865623|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
130518062|NCT00920699|469865631|FG000|Overall Study|Withdrawal by Subject|2|||
130518063|NCT00920699|469865632|FG001|Overall Study|Withdrawal by Subject|0|||
130518064|NCT00920699|469865633|FG002|Overall Study|Withdrawal by Subject|2|||
130518065|NCT00920699|469865631|FG000|Overall Study|no longer met eligibility|0|||
130518066|NCT00920699|469865632|FG001|Overall Study|no longer met eligibility|1|||
130518067|NCT00920699|469865633|FG002|Overall Study|no longer met eligibility|0|||
130518068|NCT00920699|469865631|FG000|Overall Study|Lost to Follow-up|0|||
130518069|NCT00920699|469865632|FG001|Overall Study|Lost to Follow-up|0|||
130518070|NCT00920699|469865633|FG002|Overall Study|Lost to Follow-up|2|||
130518071|NCT00001941|469865637|FG000|Overall Study|not treated- rapidly progressing disease|0|||
130518072|NCT00001941|469865638|FG001|Overall Study|not treated- rapidly progressing disease|0|||
130518073|NCT00001941|469865639|FG002|Overall Study|not treated- rapidly progressing disease|0|||
130518074|NCT00001941|469865640|FG003|Overall Study|not treated- rapidly progressing disease|0|||
130518075|NCT00001941|469865641|FG004|Overall Study|not treated- rapidly progressing disease|1|||
130518076|NCT01281917|469865647|FG000|Overall Study|Withdrawal by Subject|1|||
130518077|NCT00363649|469865649|FG000|Overall Study|Withdrawal by Subject|1|||
130518078|NCT00363649|469865650|FG001|Overall Study|Withdrawal by Subject|1|||
130518079|NCT00363649|469865649|FG000|Overall Study|Adverse Event|6|||
130518080|NCT00363649|469865650|FG001|Overall Study|Adverse Event|0|||
130518081|NCT04947436|469865653|FG000|Overall Study|Lost to Follow-up|3|||
130518082|NCT04947436|469865654|FG001|Overall Study|Lost to Follow-up|7|||
130518083|NCT04947436|469865655|FG002|Overall Study|Lost to Follow-up|5|||
130518084|NCT04947436|469865653|FG000|Overall Study|Death|1|||
130518085|NCT04947436|469865654|FG001|Overall Study|Death|1|||
130518086|NCT04947436|469865655|FG002|Overall Study|Death|1|||
130518087|NCT02161185|469865657|FG000|Treatment Phase|Administrative/Other|7|||
130518088|NCT00372255|469865658|FG000|Overall Study|Withdrawn for other reasons|2|||
130518089|NCT00372255|469865659|FG001|Overall Study|Withdrawn for other reasons|1|||
130518090|NCT02970305|469865665|FG000|Overall Study|Adverse Event|10|||
130518091|NCT02970305|469865666|FG001|Overall Study|Adverse Event|6|||
130518092|NCT02970305|469865665|FG000|Overall Study|Lack of Efficacy|1|||
130518093|NCT02970305|469865666|FG001|Overall Study|Lack of Efficacy|1|||
130518094|NCT02970305|469865665|FG000|Overall Study|Noncompliance with study drug|2|||
130518095|NCT02970305|469865666|FG001|Overall Study|Noncompliance with study drug|4|||
130518096|NCT02970305|469865665|FG000|Overall Study|Protocol Violation|2|||
130518097|NCT02970305|469865666|FG001|Overall Study|Protocol Violation|2|||
130518098|NCT02970305|469865665|FG000|Overall Study|Withdrawal by Subject|12|||
130518099|NCT02970305|469865666|FG001|Overall Study|Withdrawal by Subject|11|||
130518100|NCT02970305|469865665|FG000|Overall Study|Not further specified|1|||
130518101|NCT02970305|469865666|FG001|Overall Study|Not further specified|2|||
130518102|NCT02970305|469865665|FG000|Overall Study|Lost to Follow-up|1|||
130518103|NCT02970305|469865666|FG001|Overall Study|Lost to Follow-up|2|||
130518104|NCT00983892|469865667|FG000|Overall Study|Withdrawal by Subject|10|||
130518105|NCT00983892|469865668|FG001|Overall Study|Withdrawal by Subject|12|||
130518106|NCT03120949|469865669|FG000|Overall Study|randomized in error|1|||
130518107|NCT03120949|469865670|FG001|Overall Study|randomized in error|0|||
130518108|NCT03120949|469865669|FG000|Overall Study|Death|13|||
130518109|NCT03120949|469865670|FG001|Overall Study|Death|13|||
130518110|NCT03120949|469865669|FG000|Overall Study|Lost to Follow-up|23|||
130518111|NCT03120949|469865670|FG001|Overall Study|Lost to Follow-up|13|||
130518112|NCT03120949|469865669|FG000|Overall Study|Withdrawal by Subject|139|||
130518113|NCT03120949|469865670|FG001|Overall Study|Withdrawal by Subject|124|||
130518114|NCT03120949|469865669|FG000|Overall Study|Covid-19|43|||
130518115|NCT03120949|469865670|FG001|Overall Study|Covid-19|34|||
130518116|NCT03120949|469865669|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
130518117|NCT03120949|469865670|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
130518118|NCT03120949|469865669|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
130518119|NCT03120949|469865670|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
130518120|NCT03120949|469865669|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
130518121|NCT03120949|469865670|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
130518122|NCT03120949|469865669|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
130518123|NCT03120949|469865670|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
130518124|NCT03120949|469865669|FG000|Overall Study|Site was closed|2|||
130518125|NCT03120949|469865670|FG001|Overall Study|Site was closed|3|||
130518126|NCT03120949|469865669|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
130518127|NCT03120949|469865670|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
130518128|NCT03120949|469865669|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
130518129|NCT03120949|469865670|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
130518130|NCT03120949|469865669|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
130518131|NCT03120949|469865670|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
130518132|NCT03120949|469865669|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
130518133|NCT03120949|469865670|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
130518134|NCT03120949|469865669|FG000|Overall Study|Other: Adverse Event|0|||
130518135|NCT03120949|469865670|FG001|Overall Study|Other: Adverse Event|1|||
130518136|NCT03120949|469865669|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
130518137|NCT03120949|469865670|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
130518138|NCT03120949|469865669|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
130518139|NCT03120949|469865670|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
130518140|NCT03120949|469865669|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
130518141|NCT03120949|469865670|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
130518142|NCT03120949|469865669|FG000|Overall Study|Personal Reasons|0|||
130518143|NCT03120949|469865670|FG001|Overall Study|Personal Reasons|1|||
130518144|NCT03120949|469865669|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
130518145|NCT03120949|469865670|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
130518146|NCT03120949|469865669|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
130518147|NCT03120949|469865670|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
130518148|NCT03120949|469865669|FG000|Overall Study|Compliance With Medication|0|||
130518149|NCT03120949|469865670|FG001|Overall Study|Compliance With Medication|1|||
130518150|NCT03120949|469865669|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
130518151|NCT03120949|469865670|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
130518152|NCT03120949|469865669|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
130518153|NCT03120949|469865670|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
130518154|NCT03120949|469865669|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
130518155|NCT03120949|469865670|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
130518156|NCT04522778|469865671|FG000|Overall Study|Patient did not want to wear the device|1|||
130518157|NCT04522778|469865672|FG001|Overall Study|Patient did not want to wear the device|0|||
130518158|NCT04522778|469865671|FG000|Overall Study|Lost to Follow-up|0|||
130518159|NCT04522778|469865672|FG001|Overall Study|Lost to Follow-up|1|||
130518160|NCT01225159|469865675|FG000|Overall Study|Change operation|1|||
130518161|NCT01225159|469865676|FG001|Overall Study|Change operation|0|||
130518162|NCT00312845|469865680|FG000|Overall Study|Adverse Event|19|||
130518163|NCT00312845|469865681|FG001|Overall Study|Adverse Event|5|||
130518164|NCT00312845|469865680|FG000|Overall Study|Death|2|||
130518165|NCT00312845|469865681|FG001|Overall Study|Death|2|||
130518166|NCT00312845|469865680|FG000|Overall Study|Withdrawal by Subject|14|||
130518167|NCT00312845|469865681|FG001|Overall Study|Withdrawal by Subject|6|||
130518168|NCT00312845|469865680|FG000|Overall Study|Disease Progression|56|||
130518169|NCT00312845|469865681|FG001|Overall Study|Disease Progression|77|||
130518170|NCT00312845|469865680|FG000|Overall Study|Lost to Follow-up|2|||
130518171|NCT00312845|469865681|FG001|Overall Study|Lost to Follow-up|0|||
130518172|NCT00312845|469865680|FG000|Overall Study|Other|6|||
130518173|NCT00312845|469865681|FG001|Overall Study|Other|5|||
130518174|NCT03512288|469865684|FG000|Overall Study|Adverse Event|1|||
130518175|NCT03512288|469865685|FG001|Overall Study|Adverse Event|0|||
130518176|NCT03512288|469865684|FG000|Overall Study|Lost to Follow-up|12|||
130518177|NCT03512288|469865685|FG001|Overall Study|Lost to Follow-up|15|||
130518178|NCT03512288|469865684|FG000|Overall Study|Physician Decision|0|||
130518179|NCT03512288|469865685|FG001|Overall Study|Physician Decision|2|||
130518180|NCT03512288|469865684|FG000|Overall Study|Protocol Violation|6|||
130518181|NCT03512288|469865685|FG001|Overall Study|Protocol Violation|4|||
130518182|NCT03512288|469865684|FG000|Overall Study|Medication error without associated adverse event|1|||
130518183|NCT03512288|469865685|FG001|Overall Study|Medication error without associated adverse event|0|||
130518184|NCT03512288|469865684|FG000|Overall Study|No longer met eligibility criteria|5|||
130518185|NCT03512288|469865685|FG001|Overall Study|No longer met eligibility criteria|2|||
130518186|NCT03512288|469865684|FG000|Overall Study|Withdrawal by parent/guardian|14|||
130518187|NCT03512288|469865685|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130518188|NCT03512288|469865684|FG000|Overall Study|Other|1|||
130518189|NCT03512288|469865685|FG001|Overall Study|Other|1|||
130518190|NCT03512288|469865684|FG000|Overall Study|Randomized but not treated|1|||
130518191|NCT03512288|469865685|FG001|Overall Study|Randomized but not treated|1|||
130518192|NCT01208870|469865688|FG000|Overall Study|Lost to Follow-up|2|||
130518193|NCT01208870|469865689|FG001|Overall Study|Lost to Follow-up|8|||
130571962|NCT02898259|470058896|FG001|Overall Study|Adverse Event|0|||
130571963|NCT02898259|470058897|FG002|Overall Study|Adverse Event|1|||
130571964|NCT02898259|470058898|FG003|Overall Study|Adverse Event|0|||
130571965|NCT02898259|470058899|FG004|Overall Study|Adverse Event|0|||
130518194|NCT01494298|469865692|FG000|Overall Study|Protocol Violation|2|||
130518195|NCT01494298|469865693|FG001|Overall Study|Protocol Violation|8|||
130518196|NCT00006436|469865695|FG000|Overall Study|Refused further treatment|2|||
130518197|NCT00006436|469865695|FG000|Overall Study|Declined to participate (before treatment started)|1|||
130518198|NCT00316589|469865696|FG000|Overall Study|Withdrawal by Subject|0|||
130518199|NCT00316589|469865697|FG001|Overall Study|Withdrawal by Subject|5|||
130518200|NCT00316589|469865698|FG002|Overall Study|Withdrawal by Subject|0|||
130518201|NCT00316589|469865699|FG003|Overall Study|Withdrawal by Subject|1|||
130518202|NCT00316589|469865696|FG000|Overall Study|Subject unwilling/unable to comply|0|||
130518203|NCT00316589|469865697|FG001|Overall Study|Subject unwilling/unable to comply|6|||
130518204|NCT00316589|469865698|FG002|Overall Study|Subject unwilling/unable to comply|0|||
130518205|NCT00316589|469865699|FG003|Overall Study|Subject unwilling/unable to comply|2|||
130518206|NCT00316589|469865696|FG000|Overall Study|Adverse Event|1|||
130518207|NCT00316589|469865697|FG001|Overall Study|Adverse Event|0|||
130518208|NCT00316589|469865698|FG002|Overall Study|Adverse Event|0|||
130518209|NCT00316589|469865699|FG003|Overall Study|Adverse Event|1|||
130518210|NCT00316589|469865696|FG000|Overall Study|Physician Decision|0|||
130518211|NCT00316589|469865697|FG001|Overall Study|Physician Decision|1|||
130518212|NCT00316589|469865698|FG002|Overall Study|Physician Decision|0|||
130518213|NCT00316589|469865699|FG003|Overall Study|Physician Decision|0|||
130518214|NCT00316589|469865696|FG000|Overall Study|Other reason|0|||
130518215|NCT00316589|469865697|FG001|Overall Study|Other reason|12|||
130518216|NCT00316589|469865698|FG002|Overall Study|Other reason|1|||
130518217|NCT00316589|469865699|FG003|Overall Study|Other reason|1|||
130518218|NCT01482819|469865700|FG000|Overall Study|Lost to Follow-up|2|||
130518219|NCT00562484|469865701|FG000|Overall Study|Adverse Event|6|||
130518220|NCT00562484|469865702|FG001|Overall Study|Adverse Event|1|||
130518221|NCT00562484|469865701|FG000|Overall Study|Protocol Violation|11|||
130518222|NCT00562484|469865702|FG001|Overall Study|Protocol Violation|2|||
130518223|NCT00562484|469865701|FG000|Overall Study|Withdrawal by Subject|12|||
130518224|NCT00562484|469865702|FG001|Overall Study|Withdrawal by Subject|9|||
130518225|NCT00562484|469865701|FG000|Overall Study|Moved away from the study area|20|||
130518226|NCT00562484|469865702|FG001|Overall Study|Moved away from the study area|9|||
130518227|NCT00562484|469865701|FG000|Overall Study|Lost to Follow-up|132|||
130518228|NCT00562484|469865702|FG001|Overall Study|Lost to Follow-up|71|||
130518229|NCT00562484|469865701|FG000|Overall Study|Reason not provided or not specified|25|||
130518230|NCT00562484|469865702|FG001|Overall Study|Reason not provided or not specified|12|||
130518231|NCT05041439|469865703|FG000|Overall Study|Withdrawal by Subject|1|||
130518232|NCT05041439|469865704|FG001|Overall Study|Withdrawal by Subject|1|||
130518233|NCT05041439|469865703|FG000|Overall Study|Death|1|||
130518234|NCT05041439|469865704|FG001|Overall Study|Death|0|||
130518235|NCT01904136|469866857|FG000|Overall Study|Physician Decision|0|||
130518236|NCT01904136|469866858|FG001|Overall Study|Physician Decision|0|||
130518237|NCT01904136|469866859|FG002|Overall Study|Physician Decision|0|||
130518238|NCT01904136|469866860|FG003|Overall Study|Physician Decision|0|||
130518239|NCT01904136|469866861|FG004|Overall Study|Physician Decision|0|||
130518240|NCT01904136|469866862|FG005|Overall Study|Physician Decision|1|||
130518241|NCT01904136|469866863|FG006|Overall Study|Physician Decision|0|||
130518242|NCT01904136|469866864|FG007|Overall Study|Physician Decision|0|||
130571966|NCT02898259|470058895|FG000|Overall Study|Lack of Efficacy|1|||
130571967|NCT02898259|470058896|FG001|Overall Study|Lack of Efficacy|1|||
130518243|NCT01904136|469866865|FG008|Overall Study|Physician Decision|0|||
130518244|NCT01929876|469866874|FG000|Period 2|Non-Compliance|1|||
130518245|NCT01845649|469866877|FG000|Overall Study|Adverse Event|7|||
130518246|NCT01845649|469866878|FG001|Overall Study|Adverse Event|10|||
130518247|NCT01845649|469866877|FG000|Overall Study|Lack of Efficacy|1|||
130518248|NCT01845649|469866878|FG001|Overall Study|Lack of Efficacy|1|||
130518249|NCT01845649|469866877|FG000|Overall Study|Lost to Follow-up|2|||
130518250|NCT01845649|469866878|FG001|Overall Study|Lost to Follow-up|2|||
130571968|NCT02898259|470058897|FG002|Overall Study|Lack of Efficacy|3|||
130518251|NCT01845649|469866877|FG000|Overall Study|Withdrew Consent|12|||
130518252|NCT01845649|469866878|FG001|Overall Study|Withdrew Consent|4|||
130518253|NCT01845649|469866877|FG000|Overall Study|Protocol Deviation|7|||
130518254|NCT01845649|469866878|FG001|Overall Study|Protocol Deviation|4|||
130518255|NCT01845649|469866877|FG000|Overall Study|Reason not Specified|2|||
130518256|NCT01845649|469866878|FG001|Overall Study|Reason not Specified|1|||
130518257|NCT03991988|469866879|FG000|Overall Study|Withdrawal by Subject|2|||
130518258|NCT03991988|469866880|FG001|Overall Study|Withdrawal by Subject|2|||
130518259|NCT02412111|469866881|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
130518260|NCT02412111|469866882|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
130518261|NCT02412111|469866883|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
130518262|NCT02412111|469866881|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
130571969|NCT02898259|470058898|FG003|Overall Study|Lack of Efficacy|0|||
130571970|NCT02898259|470058899|FG004|Overall Study|Lack of Efficacy|0|||
130571971|NCT02898259|470058895|FG000|Overall Study|Lost to Follow-up|0|||
130571972|NCT02898259|470058896|FG001|Overall Study|Lost to Follow-up|0|||
130571973|NCT02898259|470058897|FG002|Overall Study|Lost to Follow-up|1|||
130571974|NCT02898259|470058898|FG003|Overall Study|Lost to Follow-up|0|||
130571975|NCT02898259|470058899|FG004|Overall Study|Lost to Follow-up|0|||
130571976|NCT02898259|470058895|FG000|Overall Study|Transformation before study began|0|||
130571977|NCT02898259|470058896|FG001|Overall Study|Transformation before study began|0|||
130571978|NCT02898259|470058897|FG002|Overall Study|Transformation before study began|0|||
130571979|NCT02898259|470058898|FG003|Overall Study|Transformation before study began|1|||
130571980|NCT02898259|470058899|FG004|Overall Study|Transformation before study began|0|||
130571981|NCT01046877|470058908|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
130571982|NCT01046877|470058908|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
130571983|NCT03016325|470058911|FG000|Treatment Period|Participant withdrew consent|0|||
130571984|NCT03016325|470058912|FG001|Treatment Period|Participant withdrew consent|1|||
130571985|NCT03016325|470058913|FG002|Treatment Period|Participant withdrew consent|0|||
130571986|NCT03016325|470058914|FG003|Treatment Period|Participant withdrew consent|0|||
130571987|NCT03016325|470058915|FG004|Treatment Period|Participant withdrew consent|0|||
130571988|NCT03016325|470058916|FG005|Treatment Period|Participant withdrew consent|0|||
130571989|NCT03016325|470058917|FG006|Treatment Period|Participant withdrew consent|0|||
130571990|NCT03016325|470058918|FG007|Treatment Period|Participant withdrew consent|0|||
130571991|NCT03016325|470058911|FG000|Treatment Period|Death|0|||
130571992|NCT03016325|470058912|FG001|Treatment Period|Death|0|||
130571993|NCT03016325|470058913|FG002|Treatment Period|Death|0|||
130571994|NCT03016325|470058914|FG003|Treatment Period|Death|0|||
130571995|NCT03016325|470058915|FG004|Treatment Period|Death|2|||
130571996|NCT03016325|470058916|FG005|Treatment Period|Death|0|||
130571997|NCT03016325|470058917|FG006|Treatment Period|Death|0|||
130571998|NCT03016325|470058918|FG007|Treatment Period|Death|0|||
130571999|NCT03016325|470058911|FG000|Treatment Period|Participant refuses assessments|0|||
130572000|NCT03016325|470058912|FG001|Treatment Period|Participant refuses assessments|0|||
130572001|NCT03016325|470058913|FG002|Treatment Period|Participant refuses assessments|1|||
130572002|NCT03016325|470058914|FG003|Treatment Period|Participant refuses assessments|0|||
130572003|NCT03016325|470058915|FG004|Treatment Period|Participant refuses assessments|0|||
130572004|NCT03016325|470058916|FG005|Treatment Period|Participant refuses assessments|0|||
130572005|NCT03016325|470058917|FG006|Treatment Period|Participant refuses assessments|0|||
130572006|NCT03016325|470058918|FG007|Treatment Period|Participant refuses assessments|0|||
130572007|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Death|2|||
130572008|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Death|0|||
130572009|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Death|5|||
130572010|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Death|6|||
130572011|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Death|3|||
130572012|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Death|0|||
130572013|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Death|0|||
130572014|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Death|0|||
130572015|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
130572016|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
130572017|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
130572018|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
130572019|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
130572020|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
130572021|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
130572022|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
130572023|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
130572024|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
130572025|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
130572026|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
130572027|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
130572028|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
130572029|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
130572030|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
130572031|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
130572032|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
130572033|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
130572034|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
130572035|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
130572036|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
130572037|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
130572038|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
130572039|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
130572040|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
130572041|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
130572042|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
130518263|NCT02412111|469866882|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
130518264|NCT02412111|469866883|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
130518265|NCT02412111|469866881|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
130518266|NCT02412111|469866882|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
130518267|NCT02412111|469866883|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
130518268|NCT02412111|469866881|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
130518269|NCT02412111|469866882|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
130518270|NCT02412111|469866883|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
130518271|NCT02412111|469866881|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
130518272|NCT02412111|469866882|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
130518273|NCT02412111|469866883|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
130518274|NCT02412111|469866881|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
130518275|NCT02412111|469866882|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
130518276|NCT02412111|469866883|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
130518277|NCT02412111|469866881|FG000|Active Comparator Period (8 Weeks)|Other|0|||
130518278|NCT02412111|469866882|FG001|Active Comparator Period (8 Weeks)|Other|0|||
130518279|NCT02412111|469866883|FG002|Active Comparator Period (8 Weeks)|Other|2|||
130518280|NCT00487552|469866884|FG000|Overall Study|Unsuccessful magnet placements|3|||
130518281|NCT00487552|469866884|FG000|Overall Study|Death due to progressive malignancy|2|||
130518282|NCT00487552|469866884|FG000|Overall Study|Stent not placed|1|||
130518283|NCT01169636|469866885|FG000|Overall Study|Adverse Event|0|||
130518284|NCT01169636|469866886|FG001|Overall Study|Adverse Event|0|||
130518285|NCT01169636|469866887|FG002|Overall Study|Adverse Event|1|||
130518286|NCT01169636|469866888|FG003|Overall Study|Adverse Event|1|||
130518287|NCT01169636|469866889|FG004|Overall Study|Adverse Event|0|||
130518288|NCT01169636|469866885|FG000|Overall Study|Screen failure|0|||
130518289|NCT01169636|469866886|FG001|Overall Study|Screen failure|0|||
130518290|NCT01169636|469866887|FG002|Overall Study|Screen failure|2|||
130518291|NCT01169636|469866888|FG003|Overall Study|Screen failure|0|||
130518292|NCT01169636|469866889|FG004|Overall Study|Screen failure|0|||
130518293|NCT01169636|469866885|FG000|Overall Study|Withdrawal by Subject|0|||
130518294|NCT01169636|469866886|FG001|Overall Study|Withdrawal by Subject|0|||
130518295|NCT01169636|469866887|FG002|Overall Study|Withdrawal by Subject|0|||
130518296|NCT01169636|469866888|FG003|Overall Study|Withdrawal by Subject|0|||
130518297|NCT01169636|469866889|FG004|Overall Study|Withdrawal by Subject|3|||
130518298|NCT02705625|469866890|FG000|Overall Study|Protocol Violation|1|||
130518299|NCT02705625|469866891|FG001|Overall Study|Protocol Violation|0|||
130518300|NCT02705625|469866892|FG002|Overall Study|Protocol Violation|0|||
130518301|NCT02705625|469866890|FG000|Overall Study|Adverse Event|6|||
130518302|NCT02705625|469866891|FG001|Overall Study|Adverse Event|5|||
130518303|NCT02705625|469866892|FG002|Overall Study|Adverse Event|2|||
130518304|NCT02705625|469866890|FG000|Overall Study|Death|0|||
130518305|NCT02705625|469866891|FG001|Overall Study|Death|0|||
130518306|NCT02705625|469866892|FG002|Overall Study|Death|1|||
130518307|NCT02705625|469866890|FG000|Overall Study|Withdrawal by Subject|1|||
130518308|NCT02705625|469866891|FG001|Overall Study|Withdrawal by Subject|4|||
130518309|NCT02705625|469866892|FG002|Overall Study|Withdrawal by Subject|5|||
130518310|NCT02705625|469866890|FG000|Overall Study|Lost to Follow-up|0|||
130518311|NCT02705625|469866891|FG001|Overall Study|Lost to Follow-up|0|||
130518312|NCT02705625|469866892|FG002|Overall Study|Lost to Follow-up|1|||
130518313|NCT02705625|469866890|FG000|Overall Study|Non-compliance|0|||
130518314|NCT02705625|469866891|FG001|Overall Study|Non-compliance|1|||
130518315|NCT02705625|469866892|FG002|Overall Study|Non-compliance|1|||
130518316|NCT02705625|469866890|FG000|Overall Study|Overdosing|0|||
130518317|NCT02705625|469866891|FG001|Overall Study|Overdosing|0|||
130518318|NCT02705625|469866892|FG002|Overall Study|Overdosing|1|||
130518319|NCT00494026|469866893|FG000|Overall Study|Sponsor Decision|4|||
130518320|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
130518321|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
130518322|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
130518323|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
130518324|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
130518325|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
130518326|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
130518327|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
130518328|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
130518329|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
130518330|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
130518331|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
130572043|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
130518332|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
130518333|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
130518334|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
130572044|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
130572045|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
130572046|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
130572047|NCT03016325|470058911|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572048|NCT03016325|470058912|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572049|NCT03016325|470058913|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
130572050|NCT03016325|470058914|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572051|NCT03016325|470058915|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572052|NCT03016325|470058916|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572053|NCT03016325|470058917|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572054|NCT03016325|470058918|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130572055|NCT03016325|470058911|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572056|NCT03016325|470058912|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
130572057|NCT03016325|470058913|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572058|NCT03016325|470058914|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572059|NCT03016325|470058915|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572060|NCT03016325|470058916|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572061|NCT03016325|470058917|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572062|NCT03016325|470058918|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130572063|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Death|3|||
130572064|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Death|3|||
130572065|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Death|11|||
130572066|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Death|12|||
130572067|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Death|9|||
130572068|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Death|0|||
130572069|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Death|0|||
130572070|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Death|1|||
130572071|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
130572072|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572073|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572074|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572075|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572076|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572077|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572078|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130572079|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572080|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572081|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572082|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572083|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
130572084|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572085|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
130572086|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
130572087|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572088|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572089|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572090|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572091|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
130572092|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572093|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572094|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130572095|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572096|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572097|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572098|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572099|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
130572100|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572101|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572102|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
130572103|NCT03016325|470058911|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572104|NCT03016325|470058912|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572105|NCT03016325|470058913|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572106|NCT03016325|470058914|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
130572107|NCT03016325|470058915|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572108|NCT03016325|470058916|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572109|NCT03016325|470058917|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572110|NCT03016325|470058918|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130572111|NCT03016325|470058911|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572112|NCT03016325|470058912|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
130572113|NCT03016325|470058913|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572114|NCT03016325|470058914|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572115|NCT03016325|470058915|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572116|NCT03016325|470058916|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572117|NCT03016325|470058917|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572118|NCT03016325|470058918|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130572119|NCT03016325|470058911|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130572120|NCT03016325|470058912|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130572121|NCT03016325|470058913|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130518335|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
130518336|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
130518337|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
130518338|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
130518339|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
130518340|NCT02637856|469866895|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
130572122|NCT03016325|470058914|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130572123|NCT03016325|470058915|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130572124|NCT03016325|470058916|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
130572125|NCT03016325|470058917|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
130572126|NCT03016325|470058918|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
130572127|NCT02970292|470058919|FG000|Overall Study|Physician Decision|1|||
130572128|NCT02970292|470058920|FG001|Overall Study|Physician Decision|1|||
130572129|NCT02970292|470058919|FG000|Overall Study|Withdrawal by Subject|11|||
130572130|NCT02970292|470058920|FG001|Overall Study|Withdrawal by Subject|5|||
130572131|NCT02970292|470058919|FG000|Overall Study|Noncompliance with study drug|2|||
130572132|NCT02970292|470058920|FG001|Overall Study|Noncompliance with study drug|2|||
130572133|NCT02970292|470058919|FG000|Overall Study|Adverse Event|5|||
130572134|NCT02970292|470058920|FG001|Overall Study|Adverse Event|0|||
130572135|NCT02970292|470058919|FG000|Overall Study|Lack of Efficacy|1|||
130572136|NCT02970292|470058920|FG001|Overall Study|Lack of Efficacy|0|||
130572137|NCT02970292|470058919|FG000|Overall Study|Lost to Follow-up|1|||
130572138|NCT02970292|470058920|FG001|Overall Study|Lost to Follow-up|0|||
130572139|NCT02970292|470058919|FG000|Overall Study|Protocol Violation|2|||
130572140|NCT02970292|470058920|FG001|Overall Study|Protocol Violation|0|||
130572141|NCT02970292|470058919|FG000|Overall Study|Other|1|||
130518341|NCT02637856|469866896|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
130518342|NCT02637856|469866895|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
130518343|NCT02637856|469866896|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
130518344|NCT02637856|469866895|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
130518345|NCT02637856|469866896|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
130518346|NCT04544865|469866898|FG000|Overall Study|Death|0|||
130518347|NCT04544865|469866899|FG001|Overall Study|Death|2|||
130518348|NCT04544865|469866898|FG000|Overall Study|Lost to Follow-up|11|||
130518349|NCT04544865|469866899|FG001|Overall Study|Lost to Follow-up|7|||
130518350|NCT04544865|469866898|FG000|Overall Study|Withdrawal by Subject|0|||
130518351|NCT04544865|469866899|FG001|Overall Study|Withdrawal by Subject|1|||
130518352|NCT04544865|469866898|FG000|Overall Study|Other|0|||
130518353|NCT04544865|469866899|FG001|Overall Study|Other|1|||
130518354|NCT02815735|469866903|FG000|First Intervention (4 Weeks)|Discomfort|1|||
130518355|NCT02815735|469866904|FG001|First Intervention (4 Weeks)|Discomfort|0|||
130518356|NCT02815735|469866903|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
130518357|NCT02815735|469866904|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130518358|NCT02815735|469866903|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
130518359|NCT02815735|469866904|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
130518360|NCT02815735|469866903|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
130518361|NCT02815735|469866904|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
130518362|NCT02973802|469866907|FG000|Overall Study|Lost to Follow-up|1|||
130572142|NCT02970292|470058920|FG001|Overall Study|Other|0|||
130572143|NCT00513500|470058926|FG000|Overall Study|Lost to Follow-up|35|||
130572144|NCT00513500|470058927|FG001|Overall Study|Lost to Follow-up|39|||
130518363|NCT02973802|469866907|FG000|Overall Study|Withdrawal by Subject|1|||
130572145|NCT00513500|470058926|FG000|Overall Study|Death|2|||
130518364|NCT03357471|469866908|FG000|Overall Study|Adverse Event|1|||
130518365|NCT03357471|469866909|FG001|Overall Study|Adverse Event|0|||
130518366|NCT03357471|469866908|FG000|Overall Study|Lost to Follow-up|1|||
130518367|NCT03357471|469866909|FG001|Overall Study|Lost to Follow-up|0|||
130518368|NCT01850823|469866910|FG000|Overall Study|Early Visit Window|0|||
130572146|NCT00513500|470058927|FG001|Overall Study|Death|1|||
130572147|NCT00513500|470058926|FG000|Overall Study|Hospitalized|4|||
130518369|NCT01850823|469866911|FG001|Overall Study|Early Visit Window|1|||
130518370|NCT01850823|469866912|FG002|Overall Study|Early Visit Window|4|||
130518371|NCT01850823|469866910|FG000|Overall Study|Enrolled in Error|0|||
130518372|NCT01850823|469866911|FG001|Overall Study|Enrolled in Error|1|||
130518373|NCT01850823|469866912|FG002|Overall Study|Enrolled in Error|2|||
130518374|NCT01850823|469866910|FG000|Overall Study|Lack of Efficacy|1|||
130518375|NCT01850823|469866911|FG001|Overall Study|Lack of Efficacy|0|||
130518376|NCT01850823|469866912|FG002|Overall Study|Lack of Efficacy|0|||
130518377|NCT01850823|469866910|FG000|Overall Study|Lost to Follow-up|0|||
130518378|NCT01850823|469866911|FG001|Overall Study|Lost to Follow-up|0|||
130518379|NCT01850823|469866912|FG002|Overall Study|Lost to Follow-up|1|||
130518380|NCT01850823|469866910|FG000|Overall Study|Restricted Medication|0|||
130518381|NCT01850823|469866911|FG001|Overall Study|Restricted Medication|0|||
130518382|NCT01850823|469866912|FG002|Overall Study|Restricted Medication|2|||
130518383|NCT01850823|469866910|FG000|Overall Study|Significant worstening of SAR|0|||
130518384|NCT01850823|469866911|FG001|Overall Study|Significant worstening of SAR|1|||
130518385|NCT01850823|469866912|FG002|Overall Study|Significant worstening of SAR|0|||
130518386|NCT01850823|469866910|FG000|Overall Study|Withdrawal by Subject|2|||
130518387|NCT01850823|469866911|FG001|Overall Study|Withdrawal by Subject|0|||
130518388|NCT01850823|469866912|FG002|Overall Study|Withdrawal by Subject|1|||
130518389|NCT01751165|469866913|FG000|Overall Study|Adverse event, serious fatal|1|||
130518390|NCT01751165|469866914|FG001|Overall Study|Adverse event, serious fatal|0|||
130518391|NCT01751165|469866915|FG002|Overall Study|Adverse event, serious fatal|1|||
130518392|NCT01751165|469866913|FG000|Overall Study|Withdrawal by Subject|0|||
130518393|NCT01751165|469866914|FG001|Overall Study|Withdrawal by Subject|0|||
130518394|NCT01751165|469866915|FG002|Overall Study|Withdrawal by Subject|1|||
130518395|NCT01751165|469866913|FG000|Overall Study|Serious adverse event|0|||
130518396|NCT01751165|469866914|FG001|Overall Study|Serious adverse event|2|||
130518397|NCT01751165|469866915|FG002|Overall Study|Serious adverse event|0|||
130518398|NCT01751165|469866913|FG000|Overall Study|Lost to Follow-up|1|||
130518399|NCT01751165|469866914|FG001|Overall Study|Lost to Follow-up|1|||
130518400|NCT01751165|469866915|FG002|Overall Study|Lost to Follow-up|1|||
130518401|NCT02895360|469866916|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
130518402|NCT02895360|469866917|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
130518403|NCT02895360|469866918|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
130518404|NCT02895360|469866919|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
130518405|NCT02895360|469866920|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
130518406|NCT02895360|469866921|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
130518407|NCT02895360|469866916|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
130518408|NCT02895360|469866917|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
130518409|NCT02895360|469866918|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
130518410|NCT02895360|469866919|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
130518411|NCT02895360|469866920|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
130518412|NCT02895360|469866921|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
130518413|NCT02895360|469866916|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
130518414|NCT02895360|469866917|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
130518415|NCT02895360|469866918|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
130518416|NCT02895360|469866919|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
130518417|NCT02895360|469866920|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
130518418|NCT02895360|469866921|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
130518419|NCT02895360|469866916|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
130518420|NCT02895360|469866917|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
130518421|NCT02895360|469866918|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
130518422|NCT02895360|469866919|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
130518423|NCT02895360|469866920|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
130518424|NCT02895360|469866921|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
130518425|NCT02895360|469866916|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
130518426|NCT02895360|469866917|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
130518427|NCT02895360|469866918|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
130518428|NCT02895360|469866919|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
130518429|NCT02895360|469866920|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
130518430|NCT02895360|469866921|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
130518431|NCT02895360|469866916|FG000|Phase 2a|Adverse Event|0|||
130518432|NCT02895360|469866917|FG001|Phase 2a|Adverse Event|0|||
130518433|NCT02895360|469866918|FG002|Phase 2a|Adverse Event|0|||
130518434|NCT02895360|469866919|FG003|Phase 2a|Adverse Event|0|||
130518435|NCT02895360|469866920|FG004|Phase 2a|Adverse Event|0|||
130518436|NCT02895360|469866921|FG005|Phase 2a|Adverse Event|1|||
130572148|NCT00513500|470058927|FG001|Overall Study|Hospitalized|14|||
130518437|NCT02895360|469866916|FG000|Phase 2a|Progressive disease|0|||
130518438|NCT02895360|469866917|FG001|Phase 2a|Progressive disease|0|||
130518439|NCT02895360|469866918|FG002|Phase 2a|Progressive disease|0|||
130518440|NCT02895360|469866919|FG003|Phase 2a|Progressive disease|0|||
130518441|NCT02895360|469866920|FG004|Phase 2a|Progressive disease|11|||
130572149|NCT00749996|470058930|FG000|Overall Study|Lost to Follow-up|7|||
130572150|NCT00749996|470058931|FG001|Overall Study|Lost to Follow-up|4|||
130572151|NCT00749996|470058930|FG000|Overall Study|Withdrawal by Subject|5|||
130572152|NCT00749996|470058931|FG001|Overall Study|Withdrawal by Subject|4|||
130572153|NCT00749996|470058930|FG000|Overall Study|Protocol Violation|2|||
130572154|NCT00749996|470058931|FG001|Overall Study|Protocol Violation|3|||
130572155|NCT00749996|470058930|FG000|Overall Study|Physician Decision|2|||
130572156|NCT00749996|470058931|FG001|Overall Study|Physician Decision|0|||
130572157|NCT00749996|470058930|FG000|Overall Study|Pregnancy|0|||
130572158|NCT00749996|470058931|FG001|Overall Study|Pregnancy|2|||
130572159|NCT00749996|470058930|FG000|Overall Study|Adverse Event|1|||
130572160|NCT00749996|470058931|FG001|Overall Study|Adverse Event|0|||
130572161|NCT00749996|470058930|FG000|Overall Study|Death|1|||
130572162|NCT00749996|470058931|FG001|Overall Study|Death|0|||
130572163|NCT01902290|470058932|FG000|Overall Study|Withdrawal by Subject|19|||
130572164|NCT01902290|470058933|FG001|Overall Study|Withdrawal by Subject|27|||
130572165|NCT01902290|470058932|FG000|Overall Study|Lost to Follow-up|2|||
130572166|NCT01902290|470058933|FG001|Overall Study|Lost to Follow-up|2|||
130572167|NCT01902290|470058932|FG000|Overall Study|Death|1|||
130572168|NCT01902290|470058933|FG001|Overall Study|Death|0|||
130572169|NCT01902290|470058932|FG000|Overall Study|Sponsor Decision|26|||
130572170|NCT01902290|470058933|FG001|Overall Study|Sponsor Decision|24|||
130572171|NCT00517829|470058934|FG000|Overall Study|Adverse Event|22|||
130572172|NCT00517829|470058935|FG001|Overall Study|Adverse Event|34|||
130572173|NCT00517829|470058934|FG000|Overall Study|Disease Progression|39|||
130572174|NCT00517829|470058935|FG001|Overall Study|Disease Progression|32|||
130572175|NCT00517829|470058934|FG000|Overall Study|Patient Request|6|||
130572176|NCT00517829|470058935|FG001|Overall Study|Patient Request|5|||
130572177|NCT00517829|470058934|FG000|Overall Study|Investigator Request|5|||
130572178|NCT00517829|470058935|FG001|Overall Study|Investigator Request|3|||
130572179|NCT00517829|470058934|FG000|Overall Study|Other|3|||
130572180|NCT00517829|470058935|FG001|Overall Study|Other|1|||
130572181|NCT03436862|470058937|FG000|Overall Study|Adverse Event|4|||
130572182|NCT03436862|470058937|FG000|Overall Study|Progressive Disease|2|||
130572183|NCT00606086|470058938|FG000|Overall Study|Adverse Event|1|||
130572184|NCT00606086|470058939|FG001|Overall Study|Adverse Event|1|||
130572185|NCT00606086|470058938|FG000|Overall Study|Lost to Follow-up|4|||
130572186|NCT00606086|470058939|FG001|Overall Study|Lost to Follow-up|8|||
130572187|NCT00606086|470058938|FG000|Overall Study|Protocol Violation|1|||
130572188|NCT00606086|470058939|FG001|Overall Study|Protocol Violation|0|||
130572189|NCT00606086|470058938|FG000|Overall Study|Withdrawal by Subject|5|||
130572190|NCT00606086|470058939|FG001|Overall Study|Withdrawal by Subject|3|||
130572191|NCT00606086|470058938|FG000|Overall Study|Non-compliance|0|||
130572192|NCT00606086|470058939|FG001|Overall Study|Non-compliance|1|||
130572193|NCT00606086|470058938|FG000|Overall Study|Randomized, not treated|1|||
130572194|NCT00606086|470058939|FG001|Overall Study|Randomized, not treated|2|||
130572195|NCT00391222|470058942|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130572196|NCT00391222|470058943|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130572197|NCT00391222|470058944|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130572198|NCT00391222|470058945|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
130572199|NCT00391222|470058942|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130572200|NCT00391222|470058943|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130572201|NCT00391222|470058944|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130572202|NCT00391222|470058945|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
130572203|NCT00391222|470058942|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130572204|NCT00391222|470058943|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130572205|NCT00391222|470058944|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130572206|NCT00391222|470058945|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
130572207|NCT00391222|470058942|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130572208|NCT00391222|470058943|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130572209|NCT00391222|470058944|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130572210|NCT00391222|470058945|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
130572211|NCT00391222|470058942|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
130572212|NCT00391222|470058943|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
130572213|NCT00391222|470058944|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
130572214|NCT00391222|470058945|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
130572215|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
130572216|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
130572217|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
130572218|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
130572219|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
130572220|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
130572221|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
130572222|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
130572223|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
130518442|NCT02895360|469866921|FG005|Phase 2a|Progressive disease|11|||
130518443|NCT00307164|469866924|FG000|Overall Study|Death|1|||
130518444|NCT00307164|469866925|FG001|Overall Study|Death|0|||
130518445|NCT00307164|469866924|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130518446|NCT00307164|469866925|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130518447|NCT00307164|469866924|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
130518448|NCT00307164|469866925|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
130518449|NCT00307164|469866924|FG000|Overall Study|Withdrawal by Subject|1|||
130518450|NCT00307164|469866925|FG001|Overall Study|Withdrawal by Subject|8|||
130518451|NCT00307164|469866924|FG000|Overall Study|Not compliant with requirements|4|||
130518452|NCT00307164|469866925|FG001|Overall Study|Not compliant with requirements|4|||
130518453|NCT00307164|469866924|FG000|Overall Study|Lost to Follow-up|6|||
130518454|NCT00307164|469866925|FG001|Overall Study|Lost to Follow-up|1|||
130518455|NCT01732926|469866927|FG000|Overall Study|Study Terminated by Sponsor|168|||
130518456|NCT01732926|469866928|FG001|Overall Study|Study Terminated by Sponsor|80|||
130518457|NCT01732926|469866927|FG000|Overall Study|Withdrawal by Subject|46|||
130518458|NCT01732926|469866928|FG001|Overall Study|Withdrawal by Subject|8|||
130518459|NCT01732926|469866927|FG000|Overall Study|Physician Decision|24|||
130518460|NCT01732926|469866928|FG001|Overall Study|Physician Decision|11|||
130518461|NCT01732926|469866927|FG000|Overall Study|Other Reason|21|||
130518462|NCT01732926|469866928|FG001|Overall Study|Other Reason|4|||
130518463|NCT01732926|469866927|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
130518464|NCT01732926|469866928|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
130518465|NCT01732926|469866927|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
130518466|NCT01732926|469866928|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
130518467|NCT02262364|469866932|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
130518468|NCT01049984|469866933|FG000|Overall Study|Withdrawal by Subject|1|||
130518469|NCT01049984|469866934|FG001|Overall Study|Withdrawal by Subject|5|||
130518470|NCT01049984|469866933|FG000|Overall Study|Protocol Violation|3|||
130518471|NCT01049984|469866934|FG001|Overall Study|Protocol Violation|4|||
130518472|NCT01049984|469866933|FG000|Overall Study|Lost to Follow-up|2|||
130518473|NCT01049984|469866934|FG001|Overall Study|Lost to Follow-up|1|||
130518474|NCT01049984|469866933|FG000|Overall Study|Adverse Event|13|||
130518475|NCT01049984|469866934|FG001|Overall Study|Adverse Event|7|||
130518476|NCT01049984|469866933|FG000|Overall Study|Treatment failure|0|||
130518477|NCT01049984|469866934|FG001|Overall Study|Treatment failure|2|||
130518478|NCT02560389|469866938|FG000|Overall Study|Lost to Follow-up|1|||
130518479|NCT02560389|469866939|FG001|Overall Study|Lost to Follow-up|2|||
130518480|NCT02560389|469866940|FG002|Overall Study|Lost to Follow-up|2|||
130518481|NCT02560389|469866938|FG000|Overall Study|Tested positive for illicit substance|0|||
130518482|NCT02560389|469866939|FG001|Overall Study|Tested positive for illicit substance|1|||
130518483|NCT02560389|469866940|FG002|Overall Study|Tested positive for illicit substance|0|||
130518484|NCT00827775|469866949|FG000|Overall Study|Withdrawal by Subject|0|||
130518485|NCT00827775|469866950|FG001|Overall Study|Withdrawal by Subject|5|||
130518486|NCT02287883|469866954|FG000|Overall Study|Death|8|||
130518487|NCT02287883|469866955|FG001|Overall Study|Death|7|||
130518488|NCT02287883|469866954|FG000|Overall Study|No longer eligible|222|||
130518489|NCT02287883|469866955|FG001|Overall Study|No longer eligible|182|||
130518490|NCT02287883|469866954|FG000|Overall Study|Non-response to survey|229|||
130518491|NCT02287883|469866955|FG001|Overall Study|Non-response to survey|237|||
130518492|NCT00802438|469866956|FG000|Overall Study|Screen Failure|20|||
130518493|NCT00802438|469866956|FG000|Overall Study|Withdrawal by Subject|7|||
130518494|NCT00802438|469866956|FG000|Overall Study|Physician Decision|1|||
130518495|NCT03175198|469866957|FG000|Overall Study|Adverse Event|480|||
130518496|NCT03175198|469866957|FG000|Overall Study|No actual visit|120|||
130518497|NCT03175198|469866957|FG000|Overall Study|Registration rule not followed|4|||
130518498|NCT03175198|469866957|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
130518499|NCT03175198|469866957|FG000|Overall Study|Other personal reason|509|||
130518500|NCT03175198|469866957|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
130518501|NCT03175198|469866957|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
130518502|NCT03175198|469866957|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
130518503|NCT03175198|469866957|FG000|Overall Study|To conduct invasive treatment of operation|53|||
130518504|NCT03175198|469866957|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
130518505|NCT01260142|469866959|FG000|Treatment Period 1|Study on hold|1|||
130518506|NCT01260142|469866960|FG001|Treatment Period 1|Study on hold|1|||
130518507|NCT01260142|469866961|FG002|Treatment Period 1|Study on hold|0|||
130518508|NCT01260142|469866962|FG003|Treatment Period 1|Study on hold|0|||
130518509|NCT01260142|469866963|FG004|Treatment Period 1|Study on hold|1|||
130518510|NCT01260142|469866964|FG005|Treatment Period 1|Study on hold|2|||
130518511|NCT01260142|469866959|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
130518512|NCT01260142|469866960|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
130518513|NCT01260142|469866961|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
130518514|NCT01260142|469866962|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
130518515|NCT01260142|469866963|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
130572224|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
130572225|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
130572226|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
130572227|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
130572228|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
130572229|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
130572230|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
130572231|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
130572232|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
130572233|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
130572234|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
130572235|NCT00391222|470058942|FG000|Period III (Double-Blind Treatment)|Other|6|||
130572236|NCT00391222|470058943|FG001|Period III (Double-Blind Treatment)|Other|1|||
130572237|NCT00391222|470058944|FG002|Period III (Double-Blind Treatment)|Other|6|||
130572238|NCT00391222|470058945|FG003|Period III (Double-Blind Treatment)|Other|0|||
130572239|NCT03215771|470058946|FG000|Overall Study|Withdrawal by Subject|2|||
130572240|NCT03215771|470058946|FG000|Overall Study|Physician Decision|1|||
130572241|NCT02039375|470058947|FG000|Overall Study|Lost to Follow-up|2|||
130572242|NCT04770389|470058948|FG000|Overall Study|Adverse Event|1|||
130572243|NCT04770389|470058949|FG001|Overall Study|Adverse Event|2|||
130572244|NCT04770389|470058950|FG002|Overall Study|Adverse Event|0|||
130572245|NCT04770389|470058951|FG003|Overall Study|Adverse Event|1|||
130572246|NCT04770389|470058948|FG000|Overall Study|Withdrawal by Subject|0|||
130572247|NCT04770389|470058949|FG001|Overall Study|Withdrawal by Subject|2|||
130572248|NCT04770389|470058950|FG002|Overall Study|Withdrawal by Subject|1|||
130572249|NCT04770389|470058951|FG003|Overall Study|Withdrawal by Subject|0|||
130572250|NCT04770389|470058948|FG000|Overall Study|Failed attempt to draw blood|1|||
130572251|NCT04770389|470058949|FG001|Overall Study|Failed attempt to draw blood|0|||
130572252|NCT04770389|470058950|FG002|Overall Study|Failed attempt to draw blood|0|||
130572253|NCT04770389|470058951|FG003|Overall Study|Failed attempt to draw blood|0|||
130572254|NCT04770389|470058948|FG000|Overall Study|Left the country|0|||
130572255|NCT04770389|470058949|FG001|Overall Study|Left the country|0|||
130572256|NCT04770389|470058950|FG002|Overall Study|Left the country|1|||
130572257|NCT04770389|470058951|FG003|Overall Study|Left the country|2|||
130572258|NCT04770389|470058948|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
130572259|NCT04770389|470058949|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
130572260|NCT04770389|470058950|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
130572261|NCT04770389|470058951|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
130572262|NCT04770389|470058948|FG000|Overall Study|Lost to Follow-up|0|||
130572263|NCT04770389|470058949|FG001|Overall Study|Lost to Follow-up|0|||
130572264|NCT04770389|470058950|FG002|Overall Study|Lost to Follow-up|0|||
130572265|NCT04770389|470058951|FG003|Overall Study|Lost to Follow-up|1|||
130572266|NCT04770389|470058948|FG000|Overall Study|Moved away from study site|0|||
130572267|NCT04770389|470058949|FG001|Overall Study|Moved away from study site|1|||
130572268|NCT04770389|470058950|FG002|Overall Study|Moved away from study site|0|||
130572269|NCT04770389|470058951|FG003|Overall Study|Moved away from study site|0|||
130572270|NCT03693625|470058959|FG000|Overall Study|Adverse Event|2|||
130572271|NCT03693625|470058960|FG001|Overall Study|Adverse Event|0|||
130572272|NCT03693625|470058959|FG000|Overall Study|Study Terminated By Sponsor|20|||
130572273|NCT03693625|470058960|FG001|Overall Study|Study Terminated By Sponsor|7|||
130572274|NCT03693625|470058959|FG000|Overall Study|Withdrawal by Subject|1|||
130572275|NCT03693625|470058960|FG001|Overall Study|Withdrawal by Subject|1|||
130572276|NCT01508702|470058961|FG000|Overall Study|Adverse Event|7|||
130572277|NCT01508702|470058962|FG001|Overall Study|Adverse Event|3|||
130572278|NCT01508702|470058961|FG000|Overall Study|Gout flare|2|||
130572279|NCT01508702|470058962|FG001|Overall Study|Gout flare|0|||
130572280|NCT01508702|470058961|FG000|Overall Study|Protocol Violation|2|||
130572281|NCT01508702|470058962|FG001|Overall Study|Protocol Violation|1|||
130572282|NCT01508702|470058961|FG000|Overall Study|Lost to Follow-up|1|||
130572283|NCT01508702|470058962|FG001|Overall Study|Lost to Follow-up|2|||
130572284|NCT01508702|470058961|FG000|Overall Study|Withdrawal by Subject|11|||
130572285|NCT01508702|470058962|FG001|Overall Study|Withdrawal by Subject|7|||
130572286|NCT00250835|470058964|FG000|Overall Study|Withdrawal by Subject|1|||
130572287|NCT01187953|470058965|FG000|Overall Study|Death|11|||
130572288|NCT01187953|470058966|FG001|Overall Study|Death|13|||
130572289|NCT01187953|470058965|FG000|Overall Study|Adverse Event|1|||
130572290|NCT01187953|470058966|FG001|Overall Study|Adverse Event|2|||
130572291|NCT01187953|470058965|FG000|Overall Study|Lost to Follow-up|0|||
130572292|NCT01187953|470058966|FG001|Overall Study|Lost to Follow-up|3|||
130572293|NCT01187953|470058965|FG000|Overall Study|Withdrawal by Subject|3|||
130572294|NCT01187953|470058966|FG001|Overall Study|Withdrawal by Subject|3|||
130572295|NCT01464307|470058970|FG000|Main Period|Death|0|||
130572296|NCT01464307|470058971|FG001|Main Period|Death|1|||
130572297|NCT01464307|470058970|FG000|Main Period|Adverse Event|6|||
130572298|NCT01464307|470058971|FG001|Main Period|Adverse Event|1|||
130572299|NCT01464307|470058970|FG000|Main Period|Lack of Efficacy|2|||
130572300|NCT01464307|470058971|FG001|Main Period|Lack of Efficacy|0|||
130572301|NCT01464307|470058970|FG000|Main Period|Withdrawal by Subject|5|||
130572302|NCT01464307|470058971|FG001|Main Period|Withdrawal by Subject|2|||
130572303|NCT01464307|470058970|FG000|Main Period|Predefined discontinuation criteria|2|||
130572304|NCT01464307|470058971|FG001|Main Period|Predefined discontinuation criteria|1|||
130572305|NCT01464307|470058970|FG000|Open-Label Extension Period|Adverse Event|15|||
130572306|NCT01464307|470058971|FG001|Open-Label Extension Period|Adverse Event|0|||
130572307|NCT01464307|470058970|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
130572308|NCT01464307|470058971|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
130572309|NCT01464307|470058970|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
130572310|NCT01464307|470058971|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
130572311|NCT01464307|470058970|FG000|Open-Label Extension Period|Death|1|||
130572312|NCT01464307|470058971|FG001|Open-Label Extension Period|Death|0|||
130572313|NCT01464307|470058970|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130572314|NCT01464307|470058971|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
130572315|NCT01464307|470058970|FG000|Open-Label Extension Period|Non-compliance|9|||
130572316|NCT01464307|470058971|FG001|Open-Label Extension Period|Non-compliance|0|||
130572317|NCT01464307|470058970|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
130572318|NCT01464307|470058971|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
130572319|NCT02457637|470058974|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
130572320|NCT04942925|470058977|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130572321|NCT04942925|470058978|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130572322|NCT04942925|470058977|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
130572323|NCT04942925|470058978|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
130572324|NCT01273883|470058979|FG000|First Intervention|Adverse Event|2|||
130572325|NCT01273883|470058980|FG001|First Intervention|Adverse Event|1|||
130572326|NCT01273883|470058979|FG000|Second Intervention|Lost to Follow-up|1|||
130572327|NCT01273883|470058980|FG001|Second Intervention|Lost to Follow-up|1|||
130572328|NCT01273883|470058979|FG000|Second Intervention|Lack of Efficacy|1|||
130572329|NCT01273883|470058980|FG001|Second Intervention|Lack of Efficacy|0|||
130572330|NCT01430455|470058984|FG000|Overall Study|Withdrawal by Subject|1|||
130572331|NCT01430455|470058984|FG000|Overall Study|Switched to follow-up phase|1|||
130572332|NCT00333359|470058986|FG000|Overall Study|Adverse Event|29|||
130572333|NCT00333359|470058987|FG001|Overall Study|Adverse Event|35|||
130572334|NCT00333359|470058986|FG000|Overall Study|Withdrawal by Subject|19|||
130572335|NCT00333359|470058987|FG001|Overall Study|Withdrawal by Subject|37|||
130572336|NCT00333359|470058986|FG000|Overall Study|Physician Decision|2|||
130572337|NCT00333359|470058987|FG001|Overall Study|Physician Decision|2|||
130572338|NCT00333359|470058986|FG000|Overall Study|Protocol Non-compliance|2|||
130572339|NCT00333359|470058987|FG001|Overall Study|Protocol Non-compliance|8|||
130572340|NCT00333359|470058986|FG000|Overall Study|Lost to Follow-up|15|||
130572341|NCT00333359|470058987|FG001|Overall Study|Lost to Follow-up|25|||
130572342|NCT00333359|470058986|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
130572343|NCT00333359|470058987|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
130572344|NCT00333359|470058986|FG000|Overall Study|Treatment Failure|3|||
130572345|NCT00333359|470058987|FG001|Overall Study|Treatment Failure|8|||
130572346|NCT00333359|470058986|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
130572347|NCT00333359|470058987|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
130572348|NCT02867995|470058989|FG000|Overall Study|Withdrawal by Subject|0|||
130572349|NCT02867995|470058990|FG001|Overall Study|Withdrawal by Subject|1|||
130572350|NCT02867995|470058989|FG000|Overall Study|Lost to Follow-up|0|||
130572351|NCT02867995|470058990|FG001|Overall Study|Lost to Follow-up|2|||
130572352|NCT00290433|470060692|FG000|Overall Study|Disease Progression|13|||
130572353|NCT00290433|470060692|FG000|Overall Study|Adverse Event|14|||
130572354|NCT00290433|470060692|FG000|Overall Study|Withdrawal by Subject|1|||
130572355|NCT00290433|470060692|FG000|Overall Study|Non-Compliance|1|||
130572356|NCT00290433|470060692|FG000|Overall Study|Congestive Heart Failure|1|||
130572357|NCT00290433|470060692|FG000|Overall Study|Transplant in CR|5|||
130572358|NCT00290433|470060692|FG000|Overall Study|Unrelated Infection/Death|1|||
130572359|NCT02559687|470060693|FG000|Overall Study|Death|112|||
130572360|NCT02559687|470060693|FG000|Overall Study|Sponsor Decision|5|||
130572361|NCT02559687|470060693|FG000|Overall Study|Withdrawal by Subject|4|||
130572362|NCT01780831|470060698|FG000|Overall Study|Withdrawal by Subject|0|||
130572363|NCT01780831|470060699|FG001|Overall Study|Withdrawal by Subject|0|||
130572364|NCT01780831|470060700|FG002|Overall Study|Withdrawal by Subject|4|||
130572365|NCT01780831|470060701|FG003|Overall Study|Withdrawal by Subject|0|||
130572366|NCT01780831|470060698|FG000|Overall Study|Lost to Follow-up|0|||
130572367|NCT01780831|470060699|FG001|Overall Study|Lost to Follow-up|0|||
130572368|NCT01780831|470060700|FG002|Overall Study|Lost to Follow-up|0|||
130572369|NCT01780831|470060701|FG003|Overall Study|Lost to Follow-up|1|||
130572370|NCT03031301|470060704|FG000|Overall Study|Protocol Violation|4|||
130572371|NCT03031301|470060705|FG001|Overall Study|Protocol Violation|8|||
130572372|NCT03031301|470060704|FG000|Overall Study|Withdrawal by Subject|7|||
130572373|NCT03031301|470060705|FG001|Overall Study|Withdrawal by Subject|4|||
130572374|NCT03031301|470060704|FG000|Overall Study|Lost to Follow-up|4|||
130572375|NCT03031301|470060705|FG001|Overall Study|Lost to Follow-up|12|||
130572376|NCT03031301|470060704|FG000|Overall Study|Noncompliance|1|||
130572377|NCT03031301|470060705|FG001|Overall Study|Noncompliance|3|||
130572378|NCT03031301|470060704|FG000|Overall Study|Technical issue|1|||
130572379|NCT03031301|470060705|FG001|Overall Study|Technical issue|1|||
130572380|NCT03031301|470060704|FG000|Overall Study|Adverse Event|1|||
130572381|NCT03031301|470060705|FG001|Overall Study|Adverse Event|0|||
130572382|NCT02429414|470060706|FG000|Overall Study|Physician Decision|0|||
130572383|NCT02429414|470060707|FG001|Overall Study|Physician Decision|1|||
130572384|NCT03245450|470060708|FG000|Overall Study|Radiological disease progression|3|||
130572385|NCT03245450|470060709|FG001|Overall Study|Radiological disease progression|3|||
130572386|NCT03245450|470060710|FG002|Overall Study|Radiological disease progression|2|||
130572387|NCT03245450|470060711|FG003|Overall Study|Radiological disease progression|2|||
130572388|NCT03245450|470060712|FG004|Overall Study|Radiological disease progression|7|||
130572389|NCT03245450|470060713|FG005|Overall Study|Radiological disease progression|6|||
130572390|NCT03245450|470060714|FG006|Overall Study|Radiological disease progression|6|||
130572391|NCT03245450|470060708|FG000|Overall Study|Clinical disease progression|0|||
130572392|NCT03245450|470060709|FG001|Overall Study|Clinical disease progression|0|||
130572393|NCT03245450|470060710|FG002|Overall Study|Clinical disease progression|1|||
130572394|NCT03245450|470060711|FG003|Overall Study|Clinical disease progression|0|||
130572395|NCT03245450|470060712|FG004|Overall Study|Clinical disease progression|0|||
130572396|NCT03245450|470060713|FG005|Overall Study|Clinical disease progression|2|||
130572397|NCT03245450|470060714|FG006|Overall Study|Clinical disease progression|0|||
130572398|NCT03245450|470060708|FG000|Overall Study|Other|0|||
130572399|NCT03245450|470060709|FG001|Overall Study|Other|0|||
130572400|NCT03245450|470060710|FG002|Overall Study|Other|0|||
130572401|NCT03245450|470060711|FG003|Overall Study|Other|1|||
130572402|NCT03245450|470060712|FG004|Overall Study|Other|1|||
130572403|NCT03245450|470060713|FG005|Overall Study|Other|1|||
130572404|NCT03245450|470060714|FG006|Overall Study|Other|1|||
130572405|NCT03245450|470060708|FG000|Overall Study|Withdrawal by Subject|0|||
130572406|NCT03245450|470060709|FG001|Overall Study|Withdrawal by Subject|1|||
130572407|NCT03245450|470060710|FG002|Overall Study|Withdrawal by Subject|0|||
130572408|NCT03245450|470060711|FG003|Overall Study|Withdrawal by Subject|0|||
130572409|NCT03245450|470060712|FG004|Overall Study|Withdrawal by Subject|0|||
130572410|NCT03245450|470060713|FG005|Overall Study|Withdrawal by Subject|0|||
130572411|NCT03245450|470060714|FG006|Overall Study|Withdrawal by Subject|0|||
130572412|NCT03245450|470060708|FG000|Overall Study|Adverse Event|0|||
130572413|NCT03245450|470060709|FG001|Overall Study|Adverse Event|0|||
130572414|NCT03245450|470060710|FG002|Overall Study|Adverse Event|0|||
130572415|NCT03245450|470060711|FG003|Overall Study|Adverse Event|0|||
130572416|NCT03245450|470060712|FG004|Overall Study|Adverse Event|1|||
130572417|NCT03245450|470060713|FG005|Overall Study|Adverse Event|0|||
130572418|NCT03245450|470060714|FG006|Overall Study|Adverse Event|2|||
130572419|NCT01784861|470060719|FG000|Overall Study|Adverse Event|0|||
130572420|NCT01784861|470060720|FG001|Overall Study|Adverse Event|0|||
130572421|NCT01784861|470060721|FG002|Overall Study|Adverse Event|1|||
130572422|NCT01784861|470060722|FG003|Overall Study|Adverse Event|2|||
130572423|NCT01784861|470060723|FG004|Overall Study|Adverse Event|1|||
130572424|NCT01784861|470060724|FG005|Overall Study|Adverse Event|0|||
130572425|NCT01784861|470060719|FG000|Overall Study|Withdrawal by Subject|0|||
130572426|NCT01784861|470060720|FG001|Overall Study|Withdrawal by Subject|0|||
130518516|NCT01260142|469866964|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
130518517|NCT01260142|469866959|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130518518|NCT01260142|469866960|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130518519|NCT01260142|469866961|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130518520|NCT01260142|469866962|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130518521|NCT01260142|469866963|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130518522|NCT01260142|469866964|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130518523|NCT00496834|469866968|FG000|Overall Study|Withdrawal by Subject|4|||
130518524|NCT00496834|469866969|FG001|Overall Study|Withdrawal by Subject|6|||
130518525|NCT00496834|469866968|FG000|Overall Study|Contraindicated medication administered|0|||
130518526|NCT00496834|469866969|FG001|Overall Study|Contraindicated medication administered|1|||
130518527|NCT00496834|469866968|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
130518528|NCT00496834|469866969|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
130518529|NCT00496834|469866968|FG000|Overall Study|Adverse Event|5|||
130518530|NCT00496834|469866969|FG001|Overall Study|Adverse Event|3|||
130572427|NCT01784861|470060721|FG002|Overall Study|Withdrawal by Subject|0|||
130572428|NCT01784861|470060722|FG003|Overall Study|Withdrawal by Subject|1|||
130518531|NCT00496834|469866968|FG000|Overall Study|IP administration violation|2|||
130518532|NCT00496834|469866969|FG001|Overall Study|IP administration violation|0|||
130518533|NCT00496834|469866968|FG000|Overall Study|Lost to Follow-up|2|||
130572429|NCT01784861|470060723|FG004|Overall Study|Withdrawal by Subject|0|||
130572430|NCT01784861|470060724|FG005|Overall Study|Withdrawal by Subject|0|||
130572431|NCT01784861|470060719|FG000|Overall Study|Physician Decision|0|||
130572432|NCT01784861|470060720|FG001|Overall Study|Physician Decision|0|||
130572433|NCT01784861|470060721|FG002|Overall Study|Physician Decision|0|||
130572434|NCT01784861|470060722|FG003|Overall Study|Physician Decision|2|||
130572435|NCT01784861|470060723|FG004|Overall Study|Physician Decision|0|||
130572436|NCT01784861|470060724|FG005|Overall Study|Physician Decision|1|||
130572437|NCT03948178|470060727|FG000|Overall Study|Protocol Violation|1|||
130572438|NCT03948178|470060727|FG000|Overall Study|Lost to Follow-up|2|||
130518534|NCT00496834|469866969|FG001|Overall Study|Lost to Follow-up|0|||
130518535|NCT00496834|469866968|FG000|Overall Study|Blood Pressure control failure|2|||
130518536|NCT00496834|469866969|FG001|Overall Study|Blood Pressure control failure|1|||
130518537|NCT01227928|469866970|FG000|Overall Study|Lost to Follow-up|4|||
130518538|NCT01227928|469866971|FG001|Overall Study|Lost to Follow-up|2|||
130518539|NCT01227928|469866970|FG000|Overall Study|Withdrawal by Subject|4|||
130518540|NCT01227928|469866971|FG001|Overall Study|Withdrawal by Subject|3|||
130518541|NCT01227928|469866970|FG000|Overall Study|Death|14|||
130518542|NCT01227928|469866971|FG001|Overall Study|Death|12|||
130518543|NCT02930837|469866974|FG000|Overall Study|Adverse Event|6|||
130518544|NCT02930837|469866974|FG000|Overall Study|Lost to Follow-up|5|||
130518545|NCT02930837|469866974|FG000|Overall Study|Withdrawal by Subject|1|||
130518546|NCT01393613|469866975|FG000|Overall Study|Adverse Event|11|||
130518547|NCT01393613|469866976|FG001|Overall Study|Adverse Event|11|||
130518548|NCT01393613|469866977|FG002|Overall Study|Adverse Event|13|||
130518549|NCT01393613|469866978|FG003|Overall Study|Adverse Event|22|||
130518550|NCT01393613|469866975|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
130518551|NCT01393613|469866976|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
130518552|NCT01393613|469866977|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
130518553|NCT01393613|469866978|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130518554|NCT01393613|469866975|FG000|Overall Study|Physician Decision|2|||
130518555|NCT01393613|469866976|FG001|Overall Study|Physician Decision|0|||
130518556|NCT01393613|469866977|FG002|Overall Study|Physician Decision|0|||
130518557|NCT01393613|469866978|FG003|Overall Study|Physician Decision|1|||
130518558|NCT01393613|469866975|FG000|Overall Study|Withdrawal by Subject|15|||
130518559|NCT01393613|469866976|FG001|Overall Study|Withdrawal by Subject|25|||
130518560|NCT01393613|469866977|FG002|Overall Study|Withdrawal by Subject|23|||
130518561|NCT01393613|469866978|FG003|Overall Study|Withdrawal by Subject|21|||
130518562|NCT01393613|469866975|FG000|Overall Study|Protocol Deviation|2|||
130518563|NCT01393613|469866976|FG001|Overall Study|Protocol Deviation|1|||
130518564|NCT01393613|469866977|FG002|Overall Study|Protocol Deviation|0|||
130518565|NCT01393613|469866978|FG003|Overall Study|Protocol Deviation|0|||
130518566|NCT01393613|469866975|FG000|Overall Study|Lack of Efficacy|9|||
130518567|NCT01393613|469866976|FG001|Overall Study|Lack of Efficacy|20|||
130518568|NCT01393613|469866977|FG002|Overall Study|Lack of Efficacy|16|||
130518569|NCT01393613|469866978|FG003|Overall Study|Lack of Efficacy|21|||
130518570|NCT03821064|469866979|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
130518571|NCT01283971|469866984|FG000|Overall Study|Adverse Event|3|||
130518572|NCT01283971|469866985|FG001|Overall Study|Adverse Event|5|||
130518573|NCT01283971|469866984|FG000|Overall Study|Insufficient therapeutic responses|3|||
130518574|NCT01283971|469866985|FG001|Overall Study|Insufficient therapeutic responses|3|||
130518575|NCT01283971|469866984|FG000|Overall Study|Protocol Violation|5|||
130518576|NCT01283971|469866985|FG001|Overall Study|Protocol Violation|1|||
130518577|NCT01283971|469866984|FG000|Overall Study|Refused treatment|3|||
130518578|NCT01283971|469866985|FG001|Overall Study|Refused treatment|1|||
130518579|NCT01283971|469866984|FG000|Overall Study|Failure to return|0|||
130518580|NCT01283971|469866985|FG001|Overall Study|Failure to return|1|||
130518581|NCT01283971|469866984|FG000|Overall Study|Administrative reasons|1|||
130518582|NCT01283971|469866985|FG001|Overall Study|Administrative reasons|1|||
130518583|NCT02598934|469866994|FG000|Overall Study|Adverse Event|11|||
130518584|NCT02598934|469866995|FG001|Overall Study|Adverse Event|13|||
130518585|NCT02598934|469866994|FG000|Overall Study|Failure to Return|3|||
130518586|NCT02598934|469866995|FG001|Overall Study|Failure to Return|3|||
130518587|NCT02598934|469866994|FG000|Overall Study|Withdrawal by Subject|2|||
130518588|NCT02598934|469866995|FG001|Overall Study|Withdrawal by Subject|3|||
130572439|NCT03948178|470060727|FG000|Overall Study|Withdrawal by Subject|2|||
130572440|NCT03948178|470060727|FG000|Overall Study|Reason not known|2|||
130572441|NCT03948178|470060727|FG000|Overall Study|Personal reason|14|||
130518589|NCT02598934|469866994|FG000|Overall Study|Administrative|2|||
130518590|NCT02598934|469866995|FG001|Overall Study|Administrative|1|||
130518591|NCT02598934|469866994|FG000|Overall Study|Protocol Violation|1|||
130518592|NCT02598934|469866995|FG001|Overall Study|Protocol Violation|2|||
130518593|NCT03325608|469866998|FG000|Overall Study|Lost to Follow-up|23|||
130518594|NCT03325608|469866999|FG001|Overall Study|Lost to Follow-up|23|||
130518595|NCT03325608|469867000|FG002|Overall Study|Lost to Follow-up|30|||
130518596|NCT03325608|469867001|FG003|Overall Study|Lost to Follow-up|30|||
130518597|NCT03325608|469866998|FG000|Overall Study|Death of Caregiver|0|||
130518598|NCT03325608|469866999|FG001|Overall Study|Death of Caregiver|0|||
130518599|NCT03325608|469867000|FG002|Overall Study|Death of Caregiver|2|||
130572442|NCT03948178|470060727|FG000|Overall Study|Disease progression|30|||
130572443|NCT03948178|470060727|FG000|Overall Study|Adverse Event|12|||
130572444|NCT03948178|470060727|FG000|Overall Study|Sponsor terminated study|164|||
130572445|NCT02432235|470060728|FG000|Overall Study|Death|1|||
130572446|NCT02432235|470060729|FG001|Overall Study|Death|1|||
130572447|NCT02432235|470060730|FG002|Overall Study|Death|2|||
130572448|NCT02432235|470060731|FG003|Overall Study|Death|2|||
130572449|NCT02432235|470060732|FG004|Overall Study|Death|1|||
130518600|NCT03325608|469867001|FG003|Overall Study|Death of Caregiver|2|||
130518601|NCT03325608|469866998|FG000|Overall Study|Death of Care Recipient|34|||
130518602|NCT03325608|469866999|FG001|Overall Study|Death of Care Recipient|34|||
130518603|NCT03325608|469867000|FG002|Overall Study|Death of Care Recipient|28|||
130518604|NCT03325608|469867001|FG003|Overall Study|Death of Care Recipient|28|||
130518605|NCT03325608|469866998|FG000|Overall Study|Withdrawal by Subject|49|||
130518606|NCT03325608|469866999|FG001|Overall Study|Withdrawal by Subject|49|||
130518607|NCT03325608|469867000|FG002|Overall Study|Withdrawal by Subject|35|||
130518608|NCT03325608|469867001|FG003|Overall Study|Withdrawal by Subject|35|||
130518609|NCT03325608|469866998|FG000|Overall Study|Ineligible|7|||
130518610|NCT03325608|469866999|FG001|Overall Study|Ineligible|7|||
130518611|NCT03325608|469867000|FG002|Overall Study|Ineligible|5|||
130518612|NCT03325608|469867001|FG003|Overall Study|Ineligible|5|||
130518613|NCT02188784|469867002|FG000|Overall Study|Death|3|||
130518614|NCT02188784|469867003|FG001|Overall Study|Death|1|||
130518615|NCT02188784|469867002|FG000|Overall Study|Lost to Follow-up|1|||
130518616|NCT02188784|469867003|FG001|Overall Study|Lost to Follow-up|0|||
130518617|NCT02188784|469867002|FG000|Overall Study|Withdrawal by Subject|3|||
130518618|NCT02188784|469867003|FG001|Overall Study|Withdrawal by Subject|9|||
130518619|NCT02188784|469867002|FG000|Overall Study|Physician Decision|2|||
130518620|NCT02188784|469867003|FG001|Overall Study|Physician Decision|3|||
130518621|NCT04944784|469867004|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
130518622|NCT04944784|469867005|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
130518623|NCT04944784|469867006|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
130518624|NCT04944784|469867007|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
130518625|NCT04944784|469867004|FG000|Double-blind Period|Adverse Event|20|||
130518626|NCT04944784|469867005|FG001|Double-blind Period|Adverse Event|4|||
130518627|NCT04944784|469867006|FG002|Double-blind Period|Adverse Event|0|||
130518628|NCT04944784|469867007|FG003|Double-blind Period|Adverse Event|0|||
130518629|NCT04944784|469867004|FG000|Double-blind Period|Withdrawal by Subject|15|||
130518630|NCT04944784|469867005|FG001|Double-blind Period|Withdrawal by Subject|4|||
130518631|NCT04944784|469867006|FG002|Double-blind Period|Withdrawal by Subject|0|||
130518632|NCT04944784|469867007|FG003|Double-blind Period|Withdrawal by Subject|0|||
130518633|NCT04944784|469867004|FG000|Double-blind Period|Death|7|||
130518634|NCT04944784|469867005|FG001|Double-blind Period|Death|2|||
130518635|NCT04944784|469867006|FG002|Double-blind Period|Death|0|||
130518636|NCT04944784|469867007|FG003|Double-blind Period|Death|0|||
130518637|NCT04944784|469867004|FG000|Double-blind Period|Physician Decision|2|||
130518638|NCT04944784|469867005|FG001|Double-blind Period|Physician Decision|1|||
130518639|NCT04944784|469867006|FG002|Double-blind Period|Physician Decision|0|||
130518640|NCT04944784|469867007|FG003|Double-blind Period|Physician Decision|0|||
130518641|NCT04944784|469867004|FG000|Double-blind Period|Lack of Efficacy|0|||
130518642|NCT04944784|469867005|FG001|Double-blind Period|Lack of Efficacy|1|||
130518643|NCT04944784|469867006|FG002|Double-blind Period|Lack of Efficacy|0|||
130518644|NCT04944784|469867007|FG003|Double-blind Period|Lack of Efficacy|0|||
130518645|NCT04944784|469867004|FG000|Double-blind Period|Sponsor Request|2|||
130518646|NCT04944784|469867005|FG001|Double-blind Period|Sponsor Request|1|||
130518647|NCT04944784|469867006|FG002|Double-blind Period|Sponsor Request|0|||
130518648|NCT04944784|469867007|FG003|Double-blind Period|Sponsor Request|0|||
130518649|NCT04944784|469867004|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
130518650|NCT04944784|469867005|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
130518651|NCT04944784|469867006|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
130518652|NCT04944784|469867007|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
130518653|NCT04944784|469867004|FG000|Double-blind Period|Participant Choice|1|||
130572450|NCT02432235|470060733|FG005|Overall Study|Death|3|||
130572451|NCT02432235|470060734|FG006|Overall Study|Death|11|||
130518654|NCT04944784|469867005|FG001|Double-blind Period|Participant Choice|1|||
130518655|NCT04944784|469867006|FG002|Double-blind Period|Participant Choice|0|||
130518656|NCT04944784|469867007|FG003|Double-blind Period|Participant Choice|0|||
130518657|NCT04944784|469867004|FG000|Double-blind Period|Progressive Disease|2|||
130518658|NCT04944784|469867005|FG001|Double-blind Period|Progressive Disease|2|||
130518659|NCT04944784|469867006|FG002|Double-blind Period|Progressive Disease|0|||
130518660|NCT04944784|469867007|FG003|Double-blind Period|Progressive Disease|0|||
130518661|NCT04944784|469867004|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
130518662|NCT04944784|469867005|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
130518663|NCT04944784|469867006|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
130518664|NCT04944784|469867007|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
130518665|NCT04944784|469867004|FG000|Active Drug Period|Adverse Event|0|||
130572452|NCT02432235|470060735|FG007|Overall Study|Death|15|||
130572453|NCT02432235|470060736|FG008|Overall Study|Death|15|||
130518666|NCT04944784|469867005|FG001|Active Drug Period|Adverse Event|0|||
130572454|NCT02432235|470060737|FG009|Overall Study|Death|3|||
130572455|NCT02432235|470060738|FG010|Overall Study|Death|1|||
130572456|NCT02432235|470060739|FG011|Overall Study|Death|0|||
130572457|NCT02432235|470060728|FG000|Overall Study|Withdrawal by Subject|0|||
130572458|NCT02432235|470060729|FG001|Overall Study|Withdrawal by Subject|1|||
130572459|NCT02432235|470060730|FG002|Overall Study|Withdrawal by Subject|0|||
130572460|NCT02432235|470060731|FG003|Overall Study|Withdrawal by Subject|0|||
130572461|NCT02432235|470060732|FG004|Overall Study|Withdrawal by Subject|0|||
130572462|NCT02432235|470060733|FG005|Overall Study|Withdrawal by Subject|2|||
130572463|NCT02432235|470060734|FG006|Overall Study|Withdrawal by Subject|5|||
130572464|NCT02432235|470060735|FG007|Overall Study|Withdrawal by Subject|3|||
130572465|NCT02432235|470060736|FG008|Overall Study|Withdrawal by Subject|1|||
130572466|NCT02432235|470060737|FG009|Overall Study|Withdrawal by Subject|0|||
130572467|NCT02432235|470060738|FG010|Overall Study|Withdrawal by Subject|0|||
130572468|NCT02432235|470060739|FG011|Overall Study|Withdrawal by Subject|0|||
130572469|NCT02432235|470060728|FG000|Overall Study|Lost to Follow-up|0|||
130572470|NCT02432235|470060729|FG001|Overall Study|Lost to Follow-up|0|||
130572471|NCT02432235|470060730|FG002|Overall Study|Lost to Follow-up|0|||
130572472|NCT02432235|470060731|FG003|Overall Study|Lost to Follow-up|0|||
130572473|NCT02432235|470060732|FG004|Overall Study|Lost to Follow-up|0|||
130572474|NCT02432235|470060733|FG005|Overall Study|Lost to Follow-up|1|||
130572475|NCT02432235|470060734|FG006|Overall Study|Lost to Follow-up|0|||
130572476|NCT02432235|470060735|FG007|Overall Study|Lost to Follow-up|0|||
130572477|NCT02432235|470060736|FG008|Overall Study|Lost to Follow-up|1|||
130572478|NCT02432235|470060737|FG009|Overall Study|Lost to Follow-up|0|||
130572479|NCT02432235|470060738|FG010|Overall Study|Lost to Follow-up|0|||
130572480|NCT02432235|470060739|FG011|Overall Study|Lost to Follow-up|0|||
130572481|NCT02432235|470060728|FG000|Overall Study|Miscellaneous|0|||
130572482|NCT02432235|470060729|FG001|Overall Study|Miscellaneous|0|||
130572483|NCT02432235|470060730|FG002|Overall Study|Miscellaneous|0|||
130572484|NCT02432235|470060731|FG003|Overall Study|Miscellaneous|0|||
130572485|NCT02432235|470060732|FG004|Overall Study|Miscellaneous|1|||
130572486|NCT02432235|470060733|FG005|Overall Study|Miscellaneous|6|||
130572487|NCT02432235|470060734|FG006|Overall Study|Miscellaneous|2|||
130572488|NCT02432235|470060735|FG007|Overall Study|Miscellaneous|2|||
130572489|NCT02432235|470060736|FG008|Overall Study|Miscellaneous|4|||
130572490|NCT02432235|470060737|FG009|Overall Study|Miscellaneous|0|||
130572491|NCT02432235|470060738|FG010|Overall Study|Miscellaneous|0|||
130572492|NCT02432235|470060739|FG011|Overall Study|Miscellaneous|1|||
130572493|NCT00382993|470060740|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
130572494|NCT00382993|470060741|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
130572495|NCT00382993|470060740|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
130572496|NCT00382993|470060741|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
130572497|NCT00382993|470060740|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
130572498|NCT00382993|470060741|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
130572499|NCT00382993|470060740|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
130572500|NCT00382993|470060741|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
130518667|NCT04944784|469867006|FG002|Active Drug Period|Adverse Event|3|||
130518668|NCT04944784|469867007|FG003|Active Drug Period|Adverse Event|6|||
130518669|NCT04944784|469867004|FG000|Active Drug Period|Withdrawal by Subject|0|||
130518670|NCT04944784|469867005|FG001|Active Drug Period|Withdrawal by Subject|0|||
130518671|NCT04944784|469867006|FG002|Active Drug Period|Withdrawal by Subject|4|||
130518672|NCT04944784|469867007|FG003|Active Drug Period|Withdrawal by Subject|7|||
130518673|NCT04944784|469867004|FG000|Active Drug Period|Death|0|||
130518674|NCT04944784|469867005|FG001|Active Drug Period|Death|0|||
130518675|NCT04944784|469867006|FG002|Active Drug Period|Death|3|||
130518676|NCT04944784|469867007|FG003|Active Drug Period|Death|4|||
130518677|NCT04944784|469867004|FG000|Active Drug Period|Lack of Efficacy|0|||
130518678|NCT04944784|469867005|FG001|Active Drug Period|Lack of Efficacy|0|||
130518679|NCT04944784|469867006|FG002|Active Drug Period|Lack of Efficacy|2|||
130518680|NCT04944784|469867007|FG003|Active Drug Period|Lack of Efficacy|2|||
130518681|NCT04944784|469867004|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
130518682|NCT04944784|469867005|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
130518683|NCT04944784|469867006|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
130518684|NCT04944784|469867007|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
130572501|NCT00382993|470060740|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
130572502|NCT00382993|470060741|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
130572503|NCT00382993|470060740|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130572504|NCT00382993|470060741|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
130518685|NCT04944784|469867004|FG000|Active Drug Period|Participant Choice|0|||
130518686|NCT04944784|469867005|FG001|Active Drug Period|Participant Choice|0|||
130518687|NCT04944784|469867006|FG002|Active Drug Period|Participant Choice|0|||
130518688|NCT04944784|469867007|FG003|Active Drug Period|Participant Choice|1|||
130572505|NCT00382993|470060740|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
130572506|NCT00382993|470060741|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
130518689|NCT04944784|469867004|FG000|Active Drug Period|Progressive Disease|0|||
130518690|NCT04944784|469867005|FG001|Active Drug Period|Progressive Disease|0|||
130518691|NCT04944784|469867006|FG002|Active Drug Period|Progressive Disease|4|||
130518692|NCT04944784|469867007|FG003|Active Drug Period|Progressive Disease|4|||
130518693|NCT04944784|469867004|FG000|Active Drug Period|Lost to Follow-up|0|||
130518694|NCT04944784|469867005|FG001|Active Drug Period|Lost to Follow-up|0|||
130518695|NCT04944784|469867006|FG002|Active Drug Period|Lost to Follow-up|0|||
130518696|NCT04944784|469867007|FG003|Active Drug Period|Lost to Follow-up|1|||
130518697|NCT00853372|469868959|FG000|Overall Study|Death|30|||
130518698|NCT00853372|469868960|FG001|Overall Study|Death|26|||
130518699|NCT00853372|469868959|FG000|Overall Study|Lost to Follow-up|1|||
130518700|NCT00853372|469868960|FG001|Overall Study|Lost to Follow-up|2|||
130518701|NCT00853372|469868959|FG000|Overall Study|Full Consent Withdrawn|1|||
130518702|NCT00853372|469868960|FG001|Overall Study|Full Consent Withdrawn|1|||
130518703|NCT01268098|469868961|FG000|Overall Study|Adverse Event|1|||
130518704|NCT01268098|469868962|FG001|Overall Study|Adverse Event|0|||
130518705|NCT02418845|469868965|FG000|Overall Study|Lost to Follow-up|7|||
130518706|NCT02418845|469868966|FG001|Overall Study|Lost to Follow-up|2|||
130518707|NCT02418845|469868965|FG000|Overall Study|Lack of Efficacy|0|||
130518708|NCT02418845|469868966|FG001|Overall Study|Lack of Efficacy|3|||
130518709|NCT02418845|469868965|FG000|Overall Study|Physician Decision|5|||
130518710|NCT02418845|469868966|FG001|Overall Study|Physician Decision|5|||
130518711|NCT02418845|469868965|FG000|Overall Study|Protocol Violation|1|||
130518712|NCT02418845|469868966|FG001|Overall Study|Protocol Violation|0|||
130518713|NCT02418845|469868965|FG000|Overall Study|Withdrawal by Subject|3|||
130518714|NCT02418845|469868966|FG001|Overall Study|Withdrawal by Subject|2|||
130518715|NCT02994784|469868967|FG000|6 Months Follow-up|Lost to Follow-up|3|||
130518716|NCT02466243|469868969|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
130518717|NCT02466243|469868970|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
130518718|NCT02466243|469868969|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
130518719|NCT02466243|469868970|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
130518720|NCT02466243|469868969|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
130518721|NCT02466243|469868970|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
130518722|NCT02466243|469868969|FG000|Part B Open-label Treatment Period|Missing|2|||
130518723|NCT02466243|469868970|FG001|Part B Open-label Treatment Period|Missing|2|||
130518724|NCT00477464|469868971|FG000|Overall Study|Lost to Follow-up|1|||
130518725|NCT00477464|469868971|FG000|Overall Study|Death|36|||
130518726|NCT00477464|469868971|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
130518727|NCT00639769|469868972|FG000|Overall Study|Death|2|||
130518728|NCT00639769|469868972|FG000|Overall Study|Adverse Event|7|||
130518729|NCT00639769|469868972|FG000|Overall Study|Lack of Efficacy|1|||
130518730|NCT00639769|469868972|FG000|Overall Study|Disease progression|26|||
130518731|NCT00639769|469868972|FG000|Overall Study|Withdrawal by Subject|4|||
130518732|NCT00863798|469868973|FG000|Overall Study|Adverse Event|5|||
130518733|NCT00863798|469868974|FG001|Overall Study|Adverse Event|2|||
130518734|NCT00863798|469868975|FG002|Overall Study|Adverse Event|4|||
130518735|NCT00863798|469868973|FG000|Overall Study|Participant failed to return|2|||
130518736|NCT00863798|469868974|FG001|Overall Study|Participant failed to return|1|||
130518737|NCT00863798|469868975|FG002|Overall Study|Participant failed to return|0|||
130518738|NCT00863798|469868973|FG000|Overall Study|Investigator request|1|||
130518739|NCT00863798|469868974|FG001|Overall Study|Investigator request|2|||
130518740|NCT00863798|469868975|FG002|Overall Study|Investigator request|1|||
130518741|NCT00863798|469868973|FG000|Overall Study|Lack of Efficacy|4|||
130518742|NCT00863798|469868974|FG001|Overall Study|Lack of Efficacy|3|||
130518743|NCT00863798|469868975|FG002|Overall Study|Lack of Efficacy|6|||
130518744|NCT00863798|469868973|FG000|Overall Study|Lost to Follow-up|6|||
130518745|NCT00863798|469868974|FG001|Overall Study|Lost to Follow-up|9|||
130518746|NCT00863798|469868975|FG002|Overall Study|Lost to Follow-up|5|||
130518747|NCT00863798|469868973|FG000|Overall Study|Other|2|||
130518748|NCT00863798|469868974|FG001|Overall Study|Other|3|||
130518749|NCT00863798|469868975|FG002|Overall Study|Other|1|||
130518750|NCT00863798|469868973|FG000|Overall Study|Protocol Violation|0|||
130518751|NCT00863798|469868974|FG001|Overall Study|Protocol Violation|1|||
130518752|NCT00863798|469868975|FG002|Overall Study|Protocol Violation|1|||
130518753|NCT00863798|469868973|FG000|Overall Study|Withdrawal by Subject|8|||
130518754|NCT00863798|469868974|FG001|Overall Study|Withdrawal by Subject|7|||
130518755|NCT00863798|469868975|FG002|Overall Study|Withdrawal by Subject|4|||
130518756|NCT00863798|469868973|FG000|Overall Study|Randomized not treated|4|||
130518757|NCT00863798|469868974|FG001|Overall Study|Randomized not treated|2|||
130518758|NCT00863798|469868975|FG002|Overall Study|Randomized not treated|3|||
130518759|NCT04238520|469868976|FG000|Overall Study|Withdrawal by Subject|1|||
130518760|NCT04238520|469868977|FG001|Overall Study|Withdrawal by Subject|1|||
130518761|NCT04238520|469868976|FG000|Overall Study|Lost to Follow-up|1|||
130518762|NCT04238520|469868977|FG001|Overall Study|Lost to Follow-up|2|||
130518763|NCT04238520|469868976|FG000|Overall Study|Death|0|||
130518764|NCT04238520|469868977|FG001|Overall Study|Death|2|||
130518765|NCT04238520|469868976|FG000|Overall Study|Unsafe home environment for research staff|0|||
130518766|NCT04238520|469868977|FG001|Overall Study|Unsafe home environment for research staff|1|||
130518767|NCT01470599|469868978|FG000|Overall Study|Did not meet entrance criteria|1|||
130518768|NCT01470599|469868979|FG001|Overall Study|Did not meet entrance criteria|0|||
130518769|NCT01470599|469868978|FG000|Overall Study|Lost to Follow-up|2|||
130518770|NCT01470599|469868979|FG001|Overall Study|Lost to Follow-up|1|||
130518771|NCT01470599|469868978|FG000|Overall Study|Withdrawal by Subject|3|||
130518772|NCT01470599|469868979|FG001|Overall Study|Withdrawal by Subject|4|||
130518773|NCT01470599|469868978|FG000|Overall Study|Other|1|||
130518774|NCT01470599|469868979|FG001|Overall Study|Other|0|||
130518775|NCT01470599|469868978|FG000|Overall Study|Protocol Violation|3|||
130518776|NCT01470599|469868979|FG001|Overall Study|Protocol Violation|1|||
130518777|NCT01470599|469868978|FG000|Overall Study|Adverse event related to study drug|2|||
130518778|NCT01470599|469868979|FG001|Overall Study|Adverse event related to study drug|5|||
130518779|NCT01470599|469868978|FG000|Overall Study|Insufficient clinical response|6|||
130518780|NCT01470599|469868979|FG001|Overall Study|Insufficient clinical response|27|||
130518781|NCT01470599|469868978|FG000|Overall Study|Adverse event not related to study drug|1|||
130518782|NCT01470599|469868979|FG001|Overall Study|Adverse event not related to study drug|5|||
130518783|NCT00195442|469868980|FG000|Overall Study|Less than expected therapeutic effect|38|||
130518784|NCT00195442|469868980|FG000|Overall Study|Lost to Follow-up|27|||
130518785|NCT00195442|469868980|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
130518786|NCT00195442|469868980|FG000|Overall Study|Intermittent product shortage|21|||
130518787|NCT00195442|469868980|FG000|Overall Study|Death|7|||
130518788|NCT00195442|469868980|FG000|Overall Study|No reason specified|4|||
130518789|NCT00195442|469868980|FG000|Overall Study|Poor cooperation|2|||
130518790|NCT00195442|469868980|FG000|Overall Study|Other|14|||
130518791|NCT00847132|469868981|FG000|Overall Study|Death|1|||
130518792|NCT00847132|469868982|FG001|Overall Study|Death|1|||
130518793|NCT01057251|469868983|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
130518794|NCT01057251|469868984|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
130518795|NCT01057251|469868983|FG000|Overall Study|Adverse Event|4|||
130518796|NCT01057251|469868984|FG001|Overall Study|Adverse Event|2|||
130518797|NCT01057251|469868983|FG000|Overall Study|Lack of Efficacy|2|||
130518798|NCT01057251|469868984|FG001|Overall Study|Lack of Efficacy|11|||
130518799|NCT01057251|469868983|FG000|Overall Study|Protocol Violation|6|||
130518800|NCT01057251|469868984|FG001|Overall Study|Protocol Violation|2|||
130518801|NCT01057251|469868983|FG000|Overall Study|Withdrawal by Subject|4|||
130518802|NCT01057251|469868984|FG001|Overall Study|Withdrawal by Subject|5|||
130518803|NCT01057251|469868983|FG000|Overall Study|Lost to Follow-up|7|||
130518804|NCT01057251|469868984|FG001|Overall Study|Lost to Follow-up|6|||
130518805|NCT01057251|469868983|FG000|Overall Study|Other Reason|1|||
130518806|NCT01057251|469868984|FG001|Overall Study|Other Reason|1|||
130518807|NCT00784147|469868985|FG000|Overall Study|Lost to Follow-up|2|||
130518808|NCT00784147|469868986|FG001|Overall Study|Lost to Follow-up|4|||
130518809|NCT00784147|469868985|FG000|Overall Study|Withdrawal by Subject|1|||
130518810|NCT00784147|469868986|FG001|Overall Study|Withdrawal by Subject|3|||
130518811|NCT00784147|469868985|FG000|Overall Study|Physician Decision|2|||
130518812|NCT00784147|469868986|FG001|Overall Study|Physician Decision|1|||
130518813|NCT00784147|469868985|FG000|Overall Study|Protocol Violation|1|||
130518814|NCT00784147|469868986|FG001|Overall Study|Protocol Violation|1|||
130518815|NCT00784147|469868985|FG000|Overall Study|Death|2|||
130518816|NCT00784147|469868986|FG001|Overall Study|Death|0|||
130518817|NCT03596242|469868987|FG000|Overall Study|Lost to Follow-up|2|||
130518818|NCT03596242|469868988|FG001|Overall Study|Lost to Follow-up|2|||
130518819|NCT02509312|469868989|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
130572507|NCT00382993|470060740|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
130518820|NCT02509312|469868990|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
130518821|NCT02509312|469868989|FG000|Overall Study|Obstetrician refusal|0|||
130518822|NCT02509312|469868990|FG001|Overall Study|Obstetrician refusal|1|||
130518823|NCT02509312|469868989|FG000|Overall Study|Patient elected for TOLAC|1|||
130518824|NCT02509312|469868990|FG001|Overall Study|Patient elected for TOLAC|0|||
130518825|NCT02509312|469868989|FG000|Overall Study|Cesarean deemed stat|1|||
130518826|NCT02509312|469868990|FG001|Overall Study|Cesarean deemed stat|0|||
130518827|NCT02509312|469868989|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
130518828|NCT02509312|469868990|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
130518829|NCT00706914|469868991|FG000|Overall Study|Lack of Efficacy|0|||
130518830|NCT00706914|469868992|FG001|Overall Study|Lack of Efficacy|1|||
130518831|NCT00706914|469868993|FG002|Overall Study|Lack of Efficacy|0|||
130518832|NCT00706914|469868991|FG000|Overall Study|Lost to Follow-up|1|||
130518833|NCT00706914|469868992|FG001|Overall Study|Lost to Follow-up|0|||
130518834|NCT00706914|469868993|FG002|Overall Study|Lost to Follow-up|0|||
130518835|NCT00706914|469868991|FG000|Overall Study|Adverse Event|2|||
130518836|NCT00706914|469868992|FG001|Overall Study|Adverse Event|2|||
130518837|NCT00706914|469868993|FG002|Overall Study|Adverse Event|0|||
130518838|NCT00706914|469868991|FG000|Overall Study|Protocol Violation|3|||
130518839|NCT00706914|469868992|FG001|Overall Study|Protocol Violation|1|||
130518840|NCT00706914|469868993|FG002|Overall Study|Protocol Violation|1|||
130518841|NCT00702650|469868995|FG000|Overall Study|Withdrawal by Subject|9|||
130518842|NCT00702650|469868995|FG000|Overall Study|Non-Compliance of Study Drug|3|||
130518843|NCT00702650|469868995|FG000|Overall Study|Lost to Follow-up|2|||
130518844|NCT00702650|469868995|FG000|Overall Study|Non-Compliance with Site Directives|1|||
130518845|NCT00702650|469868995|FG000|Overall Study|Sponsor Request|1|||
130518846|NCT00702650|469868995|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
130518847|NCT00702650|469868995|FG000|Overall Study|Adverse Event|3|||
130518848|NCT00988533|469869003|FG000|Overall Study|Lost to Follow-up|3|||
130518849|NCT00943722|469869006|FG000|Base Study|Adverse Event|0|||
130518850|NCT00943722|469869007|FG001|Base Study|Adverse Event|0|||
130518851|NCT00943722|469869008|FG002|Base Study|Adverse Event|0|||
130518852|NCT00943722|469869009|FG003|Base Study|Adverse Event|1|||
130518853|NCT00943722|469869010|FG004|Base Study|Adverse Event|0|||
130518854|NCT00943722|469869011|FG005|Base Study|Adverse Event|0|||
130518855|NCT00943722|469869012|FG006|Base Study|Adverse Event|0|||
130518856|NCT00943722|469869006|FG000|Base Study|Lost to Follow-up|12|||
130518857|NCT00943722|469869007|FG001|Base Study|Lost to Follow-up|8|||
130518858|NCT00943722|469869008|FG002|Base Study|Lost to Follow-up|10|||
130518859|NCT00943722|469869009|FG003|Base Study|Lost to Follow-up|8|||
130518860|NCT00943722|469869010|FG004|Base Study|Lost to Follow-up|11|||
130518861|NCT00943722|469869011|FG005|Base Study|Lost to Follow-up|0|||
130518862|NCT00943722|469869012|FG006|Base Study|Lost to Follow-up|0|||
130518863|NCT00943722|469869006|FG000|Base Study|Physician Decision|1|||
130518864|NCT00943722|469869007|FG001|Base Study|Physician Decision|0|||
130518865|NCT00943722|469869008|FG002|Base Study|Physician Decision|0|||
130518866|NCT00943722|469869009|FG003|Base Study|Physician Decision|0|||
130518867|NCT00943722|469869010|FG004|Base Study|Physician Decision|1|||
130518868|NCT00943722|469869011|FG005|Base Study|Physician Decision|0|||
130518869|NCT00943722|469869012|FG006|Base Study|Physician Decision|0|||
130518870|NCT00943722|469869006|FG000|Base Study|Pregnancy|0|||
130518871|NCT00943722|469869007|FG001|Base Study|Pregnancy|0|||
130518872|NCT00943722|469869008|FG002|Base Study|Pregnancy|1|||
130518873|NCT00943722|469869009|FG003|Base Study|Pregnancy|0|||
130518874|NCT00943722|469869010|FG004|Base Study|Pregnancy|2|||
130518875|NCT00943722|469869011|FG005|Base Study|Pregnancy|0|||
130518876|NCT00943722|469869012|FG006|Base Study|Pregnancy|0|||
130518877|NCT00943722|469869006|FG000|Base Study|Protocol Violation|0|||
130518878|NCT00943722|469869007|FG001|Base Study|Protocol Violation|1|||
130518879|NCT00943722|469869008|FG002|Base Study|Protocol Violation|0|||
130518880|NCT00943722|469869009|FG003|Base Study|Protocol Violation|0|||
130518881|NCT00943722|469869010|FG004|Base Study|Protocol Violation|2|||
130518882|NCT00943722|469869011|FG005|Base Study|Protocol Violation|0|||
130518883|NCT00943722|469869012|FG006|Base Study|Protocol Violation|0|||
130518884|NCT00943722|469869006|FG000|Base Study|Withdrawal by Subject|12|||
130518885|NCT00943722|469869007|FG001|Base Study|Withdrawal by Subject|13|||
130518886|NCT00943722|469869008|FG002|Base Study|Withdrawal by Subject|2|||
130518887|NCT00943722|469869009|FG003|Base Study|Withdrawal by Subject|13|||
130518888|NCT00943722|469869010|FG004|Base Study|Withdrawal by Subject|8|||
130518889|NCT00943722|469869011|FG005|Base Study|Withdrawal by Subject|0|||
130518890|NCT00943722|469869012|FG006|Base Study|Withdrawal by Subject|0|||
130518891|NCT00943722|469869006|FG000|Base Study|Month 12 visit not completed|0|||
130518892|NCT00943722|469869007|FG001|Base Study|Month 12 visit not completed|0|||
130518893|NCT00943722|469869008|FG002|Base Study|Month 12 visit not completed|0|||
130518894|NCT00943722|469869009|FG003|Base Study|Month 12 visit not completed|0|||
130572508|NCT00382993|470060741|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
130518895|NCT00943722|469869010|FG004|Base Study|Month 12 visit not completed|2|||
130518896|NCT00943722|469869011|FG005|Base Study|Month 12 visit not completed|0|||
130518897|NCT00943722|469869012|FG006|Base Study|Month 12 visit not completed|0|||
130518898|NCT00943722|469869006|FG000|First Extension Study: EXT 1|Adverse Event|0|||
130518899|NCT00943722|469869007|FG001|First Extension Study: EXT 1|Adverse Event|0|||
130518900|NCT00943722|469869008|FG002|First Extension Study: EXT 1|Adverse Event|0|||
130518901|NCT00943722|469869009|FG003|First Extension Study: EXT 1|Adverse Event|0|||
130518902|NCT00943722|469869010|FG004|First Extension Study: EXT 1|Adverse Event|0|||
130518903|NCT00943722|469869011|FG005|First Extension Study: EXT 1|Adverse Event|1|||
130518904|NCT00943722|469869012|FG006|First Extension Study: EXT 1|Adverse Event|0|||
130518905|NCT00943722|469869006|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
130518906|NCT00943722|469869007|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
130518907|NCT00943722|469869008|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
130518908|NCT00943722|469869009|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
130518909|NCT00943722|469869010|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
130518910|NCT00943722|469869011|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
130518911|NCT00943722|469869012|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
130518912|NCT00943722|469869006|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
130518913|NCT00943722|469869007|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
130518914|NCT00943722|469869008|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
130518915|NCT00943722|469869009|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
130518916|NCT00943722|469869010|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
130518917|NCT00943722|469869011|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
130518918|NCT00943722|469869012|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
130518919|NCT00943722|469869006|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
130518920|NCT00943722|469869007|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
130518921|NCT00943722|469869008|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
130518922|NCT00943722|469869009|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
130518923|NCT00943722|469869010|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
130518924|NCT00943722|469869011|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
130518925|NCT00943722|469869012|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
130518926|NCT00943722|469869006|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
130518927|NCT00943722|469869007|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
130518928|NCT00943722|469869008|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
130518929|NCT00943722|469869009|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
130518930|NCT00943722|469869010|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
130518931|NCT00943722|469869011|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
130518932|NCT00943722|469869012|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
130518933|NCT00943722|469869006|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
130518934|NCT00943722|469869007|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
130518935|NCT00943722|469869008|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
130518936|NCT00943722|469869009|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
130518937|NCT00943722|469869010|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
130518938|NCT00943722|469869011|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
130518939|NCT00943722|469869012|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
130518940|NCT00943722|469869006|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
130518941|NCT00943722|469869007|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
130518942|NCT00943722|469869008|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
130518943|NCT00943722|469869009|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
130518944|NCT00943722|469869010|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
130518945|NCT00943722|469869011|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
130518946|NCT00943722|469869012|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
130518947|NCT00943722|469869006|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
130518948|NCT00943722|469869007|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
130518949|NCT00943722|469869008|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
130518950|NCT00943722|469869009|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
130518951|NCT00943722|469869010|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
130518952|NCT00943722|469869011|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
130518953|NCT00943722|469869012|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
130518954|NCT00943722|469869006|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130518955|NCT00943722|469869007|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130518956|NCT00943722|469869008|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130518957|NCT00943722|469869009|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130518958|NCT00943722|469869010|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130518959|NCT00943722|469869011|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
130518960|NCT00943722|469869012|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
130518961|NCT01036165|469869017|FG000|Overall Study|Adverse Event|6|||
130518962|NCT01036165|469869017|FG000|Overall Study|Lost to Follow-up|2|||
130518963|NCT01036165|469869017|FG000|Overall Study|Withdrawal by Subject|3|||
130518964|NCT01036165|469869017|FG000|Overall Study|Device Related Issues|3|||
130518965|NCT01036165|469869017|FG000|Overall Study|Problems finding proper area to inject|1|||
130518966|NCT00913523|469869024|FG000|Overall Study|Withdrawal by Subject|3|||
130518967|NCT00913523|469869025|FG001|Overall Study|Withdrawal by Subject|2|||
130518968|NCT00913523|469869026|FG002|Overall Study|Withdrawal by Subject|2|||
130518969|NCT00913523|469869024|FG000|Overall Study|Lost to Follow-up|1|||
130518970|NCT00913523|469869025|FG001|Overall Study|Lost to Follow-up|1|||
130518971|NCT00913523|469869026|FG002|Overall Study|Lost to Follow-up|1|||
130518972|NCT00913523|469869024|FG000|Overall Study|Adverse Event|1|||
130518973|NCT00913523|469869025|FG001|Overall Study|Adverse Event|0|||
130518974|NCT00913523|469869026|FG002|Overall Study|Adverse Event|0|||
130518975|NCT00913523|469869024|FG000|Overall Study|Protocol Violation|5|||
130518976|NCT00913523|469869025|FG001|Overall Study|Protocol Violation|8|||
130518977|NCT00913523|469869026|FG002|Overall Study|Protocol Violation|8|||
130518978|NCT00913523|469869024|FG000|Overall Study|Pregnancy|1|||
130518979|NCT00913523|469869025|FG001|Overall Study|Pregnancy|3|||
130518980|NCT00913523|469869026|FG002|Overall Study|Pregnancy|0|||
130518981|NCT00913523|469869024|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
130518982|NCT00913523|469869025|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
130518983|NCT00913523|469869026|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
130518984|NCT01844726|469869027|FG000|Overall Study|Withdrawal by Subject|0|||
130518985|NCT01844726|469869028|FG001|Overall Study|Withdrawal by Subject|1|||
130518986|NCT01844726|469869027|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
130518987|NCT01844726|469869028|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
130518988|NCT00916305|469869029|FG000|Overall Study|Lost to Follow-up|21|||
130518989|NCT00916305|469869030|FG001|Overall Study|Lost to Follow-up|27|||
130518990|NCT00916305|469869029|FG000|Overall Study|Withdrawal by Subject|0|||
130518991|NCT00916305|469869030|FG001|Overall Study|Withdrawal by Subject|1|||
130518992|NCT04191148|469869035|FG000|Overall Study|Withdrawal by Subject|1|||
130518993|NCT04191148|469869036|FG001|Overall Study|Withdrawal by Subject|0|||
130518994|NCT04191148|469869035|FG000|Overall Study|Adverse Event|1|||
130518995|NCT04191148|469869036|FG001|Overall Study|Adverse Event|0|||
130518996|NCT01274559|469869037|FG000|Overall Study|Adverse Event|57|||
130518997|NCT01274559|469869038|FG001|Overall Study|Adverse Event|13|||
130518998|NCT01274559|469869037|FG000|Overall Study|Death|1|||
130518999|NCT01274559|469869038|FG001|Overall Study|Death|1|||
130519000|NCT01274559|469869037|FG000|Overall Study|Lost to Follow-up|3|||
130519001|NCT01274559|469869038|FG001|Overall Study|Lost to Follow-up|3|||
130519002|NCT01274559|469869037|FG000|Overall Study|Non-compliance with Study Drug|2|||
130519003|NCT01274559|469869038|FG001|Overall Study|Non-compliance with Study Drug|4|||
130519004|NCT01274559|469869037|FG000|Overall Study|Physician Decision|2|||
130519005|NCT01274559|469869038|FG001|Overall Study|Physician Decision|1|||
130519006|NCT01274559|469869037|FG000|Overall Study|Protocol Violation|28|||
130519007|NCT01274559|469869038|FG001|Overall Study|Protocol Violation|23|||
130519008|NCT01274559|469869037|FG000|Overall Study|Study Terminated by Sponsor|79|||
130519009|NCT01274559|469869038|FG001|Overall Study|Study Terminated by Sponsor|87|||
130519010|NCT01274559|469869037|FG000|Overall Study|Withdrawal by Subject|25|||
130519011|NCT01274559|469869038|FG001|Overall Study|Withdrawal by Subject|13|||
130519012|NCT03409731|469869050|FG000|Overall Study|Withdrawal by Subject|17|||
130519013|NCT03409731|469869050|FG000|Overall Study|Death|4|||
130519014|NCT04016805|469869051|FG000|Overall Study|Sponsor's Discretion|30|||
130519015|NCT04016805|469869052|FG001|Overall Study|Sponsor's Discretion|6|||
130519016|NCT04016805|469869053|FG002|Overall Study|Sponsor's Discretion|5|||
130519017|NCT00545571|469869054|FG000|Overall Study|Administrative Reasons|1|||
130519018|NCT00545571|469869054|FG000|Overall Study|Adverse Event|2|||
130519019|NCT00545571|469869054|FG000|Overall Study|Death|5|||
130519020|NCT00545571|469869054|FG000|Overall Study|Lack of Efficacy|1|||
130519021|NCT00545571|469869054|FG000|Overall Study|Protocol Violation|2|||
130519022|NCT00545571|469869054|FG000|Overall Study|Refused Treatment|1|||
130519023|NCT00545571|469869054|FG000|Overall Study|Screen Failure|16|||
130519024|NCT00545571|469869054|FG000|Overall Study|Transfusion|12|||
130519025|NCT00545571|469869054|FG000|Overall Study|Early Termination of Study|24|||
130519026|NCT00545571|469869054|FG000|Overall Study|Kidney Transplantation|3|||
130519027|NCT01193218|469869055|FG000|0-12 Weeks|Adverse Event|6|||
130519028|NCT01193218|469869056|FG001|0-12 Weeks|Adverse Event|0|||
130519029|NCT01193218|469869057|FG002|0-12 Weeks|Adverse Event|1|||
130519030|NCT01193218|469869058|FG003|0-12 Weeks|Adverse Event|0|||
130519031|NCT01193218|469869059|FG004|0-12 Weeks|Adverse Event|0|||
130519032|NCT01193218|469869060|FG005|0-12 Weeks|Adverse Event|2|||
130519033|NCT01193218|469869061|FG006|0-12 Weeks|Adverse Event|2|||
130519034|NCT01193218|469869062|FG007|0-12 Weeks|Adverse Event|0|||
130519035|NCT01193218|469869055|FG000|0-12 Weeks|Protocol Violation|0|||
130519036|NCT01193218|469869056|FG001|0-12 Weeks|Protocol Violation|0|||
130519037|NCT01193218|469869057|FG002|0-12 Weeks|Protocol Violation|0|||
130519038|NCT01193218|469869058|FG003|0-12 Weeks|Protocol Violation|0|||
130519039|NCT01193218|469869059|FG004|0-12 Weeks|Protocol Violation|1|||
130519040|NCT01193218|469869060|FG005|0-12 Weeks|Protocol Violation|1|||
130519041|NCT01193218|469869061|FG006|0-12 Weeks|Protocol Violation|0|||
130519042|NCT01193218|469869062|FG007|0-12 Weeks|Protocol Violation|0|||
130519043|NCT01193218|469869055|FG000|0-12 Weeks|Withdrawal by Subject|3|||
130519044|NCT01193218|469869056|FG001|0-12 Weeks|Withdrawal by Subject|0|||
130519045|NCT01193218|469869057|FG002|0-12 Weeks|Withdrawal by Subject|2|||
130519046|NCT01193218|469869058|FG003|0-12 Weeks|Withdrawal by Subject|0|||
130519047|NCT01193218|469869059|FG004|0-12 Weeks|Withdrawal by Subject|0|||
130519048|NCT01193218|469869060|FG005|0-12 Weeks|Withdrawal by Subject|0|||
130519049|NCT01193218|469869061|FG006|0-12 Weeks|Withdrawal by Subject|1|||
130519050|NCT01193218|469869062|FG007|0-12 Weeks|Withdrawal by Subject|0|||
130519051|NCT01193218|469869055|FG000|12-52 Weeks|Adverse Event|1|||
130519052|NCT01193218|469869056|FG001|12-52 Weeks|Adverse Event|0|||
130519053|NCT01193218|469869057|FG002|12-52 Weeks|Adverse Event|1|||
130519054|NCT01193218|469869058|FG003|12-52 Weeks|Adverse Event|2|||
130519055|NCT01193218|469869059|FG004|12-52 Weeks|Adverse Event|3|||
130519056|NCT01193218|469869060|FG005|12-52 Weeks|Adverse Event|3|||
130519057|NCT01193218|469869061|FG006|12-52 Weeks|Adverse Event|1|||
130519058|NCT01193218|469869062|FG007|12-52 Weeks|Adverse Event|2|||
130519059|NCT01193218|469869055|FG000|12-52 Weeks|Lack of Efficacy|0|||
130519060|NCT01193218|469869056|FG001|12-52 Weeks|Lack of Efficacy|0|||
130519061|NCT01193218|469869057|FG002|12-52 Weeks|Lack of Efficacy|0|||
130519062|NCT01193218|469869058|FG003|12-52 Weeks|Lack of Efficacy|0|||
130519063|NCT01193218|469869059|FG004|12-52 Weeks|Lack of Efficacy|0|||
130519064|NCT01193218|469869060|FG005|12-52 Weeks|Lack of Efficacy|0|||
130519065|NCT01193218|469869061|FG006|12-52 Weeks|Lack of Efficacy|1|||
130519066|NCT01193218|469869062|FG007|12-52 Weeks|Lack of Efficacy|0|||
130519067|NCT01193218|469869055|FG000|12-52 Weeks|Withdrawal by Subject|3|||
130519068|NCT01193218|469869056|FG001|12-52 Weeks|Withdrawal by Subject|0|||
130519069|NCT01193218|469869057|FG002|12-52 Weeks|Withdrawal by Subject|3|||
130519070|NCT01193218|469869058|FG003|12-52 Weeks|Withdrawal by Subject|0|||
130519071|NCT01193218|469869059|FG004|12-52 Weeks|Withdrawal by Subject|0|||
130519072|NCT01193218|469869060|FG005|12-52 Weeks|Withdrawal by Subject|2|||
130519073|NCT01193218|469869061|FG006|12-52 Weeks|Withdrawal by Subject|1|||
130519074|NCT01193218|469869062|FG007|12-52 Weeks|Withdrawal by Subject|2|||
130519075|NCT01193218|469869055|FG000|12-52 Weeks|Other reason than above|1|||
130519076|NCT01193218|469869056|FG001|12-52 Weeks|Other reason than above|0|||
130519077|NCT01193218|469869057|FG002|12-52 Weeks|Other reason than above|0|||
130519078|NCT01193218|469869058|FG003|12-52 Weeks|Other reason than above|1|||
130519079|NCT01193218|469869059|FG004|12-52 Weeks|Other reason than above|1|||
130519080|NCT01193218|469869060|FG005|12-52 Weeks|Other reason than above|0|||
130519081|NCT01193218|469869061|FG006|12-52 Weeks|Other reason than above|0|||
130519082|NCT01193218|469869062|FG007|12-52 Weeks|Other reason than above|0|||
130519083|NCT01013740|469869063|FG000|Overall Study|Lost to Follow-up|3|||
130519084|NCT01013740|469869064|FG001|Overall Study|Lost to Follow-up|5|||
130519085|NCT01013740|469869063|FG000|Overall Study|Physician Decision|2|||
130519086|NCT01013740|469869064|FG001|Overall Study|Physician Decision|0|||
130519087|NCT01013740|469869063|FG000|Overall Study|Withdrawal by Subject|2|||
130519088|NCT01013740|469869064|FG001|Overall Study|Withdrawal by Subject|10|||
130519089|NCT01013740|469869063|FG000|Overall Study|study close / terminated : done in error|2|||
130519090|NCT01013740|469869064|FG001|Overall Study|study close / terminated : done in error|1|||
130519091|NCT01013740|469869063|FG000|Overall Study|Missing|2|||
130519092|NCT01013740|469869064|FG001|Overall Study|Missing|1|||
130519093|NCT01013740|469869063|FG000|Overall Study|Ongoing: Study records not completed|0|||
130519094|NCT01013740|469869064|FG001|Overall Study|Ongoing: Study records not completed|2|||
130519095|NCT00338949|469869065|FG000|Subject Screening|Screen failures|11|||
130519096|NCT00338949|469869066|FG001|Subject Screening|Screen failures|11|||
130519097|NCT00338949|469869065|FG000|Randomization|Withdrawal by Subject|1|||
130519098|NCT00338949|469869066|FG001|Randomization|Withdrawal by Subject|0|||
130519099|NCT00338949|469869065|FG000|Randomization|Adverse Event|0|||
130519100|NCT00338949|469869066|FG001|Randomization|Adverse Event|5|||
130519101|NCT03811834|469869067|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
130519102|NCT01242371|469869068|FG000|Overall Study|Withdrawal by Subject|2|||
130519103|NCT01242371|469869069|FG001|Overall Study|Withdrawal by Subject|2|||
130519104|NCT01242371|469869068|FG000|Overall Study|Protocol Violation|0|||
130519105|NCT01242371|469869069|FG001|Overall Study|Protocol Violation|3|||
130519106|NCT00025662|469869070|FG000|Overall Study|Withdrawal by Subject|2|||
130519107|NCT00025662|469869070|FG000|Overall Study|Technical failure of manipulation|1|||
130519108|NCT01349036|469869071|FG000|Overall Study|Disease progression|13|||
130519109|NCT01349036|469869072|FG001|Overall Study|Disease progression|22|||
130519110|NCT01349036|469869071|FG000|Overall Study|Other|1|||
130519111|NCT01349036|469869072|FG001|Overall Study|Other|0|||
130519112|NCT01349036|469869071|FG000|Overall Study|Withdrawal by Subject|0|||
130519113|NCT01349036|469869072|FG001|Overall Study|Withdrawal by Subject|2|||
130519114|NCT01215032|469869075|FG000|Overall Study|Adverse Event|3|||
130519115|NCT01215032|469869075|FG000|Overall Study|Lack of Efficacy|17|||
130519116|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
130519117|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
130519118|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
130519119|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
130519120|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
130519121|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
130519122|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
130519123|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
130519124|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
130519125|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
130519126|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
130519127|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
130519128|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
130519129|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
130519130|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
130519131|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
130519132|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
130519133|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
130519134|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
130519135|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
130519136|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
130519137|NCT01125566|469869076|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
130519138|NCT01125566|469869077|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
130519139|NCT01125566|469869078|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
130519140|NCT01125566|469869076|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
130519141|NCT01125566|469869077|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
130519142|NCT01125566|469869078|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
130519143|NCT01125566|469869076|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
130519144|NCT01125566|469869077|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
130519145|NCT01125566|469869078|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
130519146|NCT01125566|469869076|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
130519147|NCT01125566|469869077|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
130519148|NCT01125566|469869078|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
130519149|NCT01125566|469869076|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
130519150|NCT01125566|469869077|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
130519151|NCT01125566|469869078|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
130519152|NCT03028012|469869079|FG000|Overall Study|Lost to Follow-up|2|||
130519153|NCT03028012|469869080|FG001|Overall Study|Lost to Follow-up|3|||
130519154|NCT03028012|469869081|FG002|Overall Study|Lost to Follow-up|3|||
130519155|NCT02484547|469869088|FG000|Placebo-Controlled Period|Adverse Event|10|||
130519156|NCT02484547|469869089|FG001|Placebo-Controlled Period|Adverse Event|13|||
130519157|NCT02484547|469869090|FG002|Placebo-Controlled Period|Adverse Event|20|||
130519158|NCT02484547|469869091|FG003|Placebo-Controlled Period|Adverse Event|0|||
130519159|NCT02484547|469869092|FG004|Placebo-Controlled Period|Adverse Event|0|||
130519160|NCT02484547|469869093|FG005|Placebo-Controlled Period|Adverse Event|0|||
130519161|NCT02484547|469869094|FG006|Placebo-Controlled Period|Adverse Event|0|||
130519162|NCT02484547|469869088|FG000|Placebo-Controlled Period|Change of Treatment|0|||
130519163|NCT02484547|469869089|FG001|Placebo-Controlled Period|Change of Treatment|0|||
130519164|NCT02484547|469869090|FG002|Placebo-Controlled Period|Change of Treatment|1|||
130519165|NCT02484547|469869091|FG003|Placebo-Controlled Period|Change of Treatment|0|||
130519166|NCT02484547|469869092|FG004|Placebo-Controlled Period|Change of Treatment|0|||
130519167|NCT02484547|469869093|FG005|Placebo-Controlled Period|Change of Treatment|0|||
130519168|NCT02484547|469869094|FG006|Placebo-Controlled Period|Change of Treatment|0|||
130519169|NCT02484547|469869088|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
130519170|NCT02484547|469869089|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
130519171|NCT02484547|469869090|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
130519172|NCT02484547|469869091|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
130519173|NCT02484547|469869092|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
130519174|NCT02484547|469869093|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
130519175|NCT02484547|469869094|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
130519176|NCT02484547|469869088|FG000|Placebo-Controlled Period|Death|5|||
130519177|NCT02484547|469869089|FG001|Placebo-Controlled Period|Death|0|||
130519178|NCT02484547|469869090|FG002|Placebo-Controlled Period|Death|6|||
130519179|NCT02484547|469869091|FG003|Placebo-Controlled Period|Death|0|||
130519180|NCT02484547|469869092|FG004|Placebo-Controlled Period|Death|0|||
130519181|NCT02484547|469869093|FG005|Placebo-Controlled Period|Death|0|||
130519182|NCT02484547|469869094|FG006|Placebo-Controlled Period|Death|0|||
130519183|NCT02484547|469869088|FG000|Placebo-Controlled Period|Disease Progression|2|||
130519184|NCT02484547|469869089|FG001|Placebo-Controlled Period|Disease Progression|0|||
130519185|NCT02484547|469869090|FG002|Placebo-Controlled Period|Disease Progression|1|||
130519186|NCT02484547|469869091|FG003|Placebo-Controlled Period|Disease Progression|0|||
130519187|NCT02484547|469869092|FG004|Placebo-Controlled Period|Disease Progression|0|||
130519188|NCT02484547|469869093|FG005|Placebo-Controlled Period|Disease Progression|0|||
130519189|NCT02484547|469869094|FG006|Placebo-Controlled Period|Disease Progression|0|||
130519190|NCT02484547|469869088|FG000|Placebo-Controlled Period|Investigator Decision|2|||
130519191|NCT02484547|469869089|FG001|Placebo-Controlled Period|Investigator Decision|2|||
130519192|NCT02484547|469869090|FG002|Placebo-Controlled Period|Investigator Decision|5|||
130519193|NCT02484547|469869091|FG003|Placebo-Controlled Period|Investigator Decision|0|||
130519194|NCT02484547|469869092|FG004|Placebo-Controlled Period|Investigator Decision|0|||
130519195|NCT02484547|469869093|FG005|Placebo-Controlled Period|Investigator Decision|0|||
130519196|NCT02484547|469869094|FG006|Placebo-Controlled Period|Investigator Decision|0|||
130519197|NCT02484547|469869088|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
130519198|NCT02484547|469869089|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
130519199|NCT02484547|469869090|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
130519200|NCT02484547|469869091|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
130519201|NCT02484547|469869092|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
130519202|NCT02484547|469869093|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
130519203|NCT02484547|469869094|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
130519204|NCT02484547|469869088|FG000|Placebo-Controlled Period|Relocation|1|||
130519205|NCT02484547|469869089|FG001|Placebo-Controlled Period|Relocation|1|||
130572509|NCT00382993|470060740|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
130572510|NCT00382993|470060741|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
130572511|NCT00382993|470060740|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
130572512|NCT00382993|470060741|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
130572513|NCT01965262|470060754|FG000|Second Intervention (7 Days)|Discontinued|0|||
130572514|NCT01965262|470060755|FG001|Second Intervention (7 Days)|Discontinued|1|||
130572515|NCT01965262|470060754|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
130572516|NCT01965262|470060755|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
130572517|NCT01965262|470060754|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
130572518|NCT01965262|470060755|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
130572519|NCT01827670|470060758|FG000|Overall Study|Withdrawal of Consent|3|||
130572520|NCT01827670|470060759|FG001|Overall Study|Withdrawal of Consent|2|||
130572521|NCT01827670|470060758|FG000|Overall Study|Lost to Follow-up|0|||
130572522|NCT01827670|470060759|FG001|Overall Study|Lost to Follow-up|1|||
130572523|NCT00790907|470060764|FG000|Overall Study|Adverse Event|9|||
130572524|NCT00790907|470060765|FG001|Overall Study|Adverse Event|7|||
130572525|NCT00790907|470060766|FG002|Overall Study|Adverse Event|6|||
130572526|NCT00790907|470060764|FG000|Overall Study|Physician Decision|304|||
130572527|NCT00790907|470060765|FG001|Overall Study|Physician Decision|271|||
130572528|NCT00790907|470060766|FG002|Overall Study|Physician Decision|255|||
130572529|NCT00790907|470060764|FG000|Overall Study|Withdrawal by Subject|1|||
130572530|NCT00790907|470060765|FG001|Overall Study|Withdrawal by Subject|7|||
130572531|NCT00790907|470060766|FG002|Overall Study|Withdrawal by Subject|5|||
130572532|NCT00790907|470060764|FG000|Overall Study|Bleeding Event|11|||
130572533|NCT00790907|470060765|FG001|Overall Study|Bleeding Event|16|||
130572534|NCT00790907|470060766|FG002|Overall Study|Bleeding Event|21|||
130572535|NCT00790907|470060764|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
130572536|NCT00790907|470060765|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
130572537|NCT00790907|470060766|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
130572538|NCT00790907|470060764|FG000|Overall Study|Qualifying Condition Not Present|29|||
130572539|NCT00790907|470060765|FG001|Overall Study|Qualifying Condition Not Present|14|||
130572540|NCT00790907|470060766|FG002|Overall Study|Qualifying Condition Not Present|16|||
130572541|NCT00790907|470060764|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
130572542|NCT00790907|470060765|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
130572543|NCT00790907|470060766|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
130572544|NCT00790907|470060764|FG000|Overall Study|Did Not Receive Study Drug|10|||
130572545|NCT00790907|470060765|FG001|Overall Study|Did Not Receive Study Drug|0|||
130572546|NCT00790907|470060766|FG002|Overall Study|Did Not Receive Study Drug|0|||
130572547|NCT00109707|470060768|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
130572548|NCT00109707|470060769|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
130572549|NCT00109707|470060770|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
130572550|NCT00109707|470060768|FG000|Overall Study|Abnormal laboratory values|1|||
130572551|NCT00109707|470060769|FG001|Overall Study|Abnormal laboratory values|0|||
130572552|NCT00109707|470060770|FG002|Overall Study|Abnormal laboratory values|0|||
130572553|NCT00109707|470060768|FG000|Overall Study|Administrative problems|2|||
130572554|NCT00109707|470060769|FG001|Overall Study|Administrative problems|0|||
130572555|NCT00109707|470060770|FG002|Overall Study|Administrative problems|1|||
130572556|NCT00109707|470060768|FG000|Overall Study|Adverse Event|10|||
130572557|NCT00109707|470060769|FG001|Overall Study|Adverse Event|2|||
130572558|NCT00109707|470060770|FG002|Overall Study|Adverse Event|3|||
130572559|NCT00109707|470060768|FG000|Overall Study|Death|4|||
130572560|NCT00109707|470060769|FG001|Overall Study|Death|0|||
130572561|NCT00109707|470060770|FG002|Overall Study|Death|0|||
130572562|NCT00109707|470060768|FG000|Overall Study|Disease progression|12|||
130572563|NCT00109707|470060769|FG001|Overall Study|Disease progression|4|||
130572564|NCT00109707|470060770|FG002|Overall Study|Disease progression|3|||
130572565|NCT00109707|470060768|FG000|Overall Study|Lost to Follow-up|3|||
130572566|NCT00109707|470060769|FG001|Overall Study|Lost to Follow-up|0|||
130572567|NCT00109707|470060770|FG002|Overall Study|Lost to Follow-up|0|||
130572568|NCT00109707|470060768|FG000|Overall Study|Protocol Violation|1|||
130572569|NCT00109707|470060769|FG001|Overall Study|Protocol Violation|0|||
130572570|NCT00109707|470060770|FG002|Overall Study|Protocol Violation|0|||
130572571|NCT00109707|470060768|FG000|Overall Study|Patient withdrew consent|6|||
130572572|NCT00109707|470060769|FG001|Overall Study|Patient withdrew consent|1|||
130572573|NCT00109707|470060770|FG002|Overall Study|Patient withdrew consent|0|||
130572574|NCT02250274|470060771|FG000|Overall Study|Insufficient blood draw amount|7|||
130572575|NCT02250274|470060772|FG001|Overall Study|Insufficient blood draw amount|6|||
130572576|NCT00446511|470060775|FG000|Overall Study|Adverse Event|7|||
130572577|NCT00446511|470060776|FG001|Overall Study|Adverse Event|2|||
130572578|NCT00446511|470060777|FG002|Overall Study|Adverse Event|3|||
130572579|NCT00446511|470060778|FG003|Overall Study|Adverse Event|1|||
130572580|NCT00446511|470060775|FG000|Overall Study|Protocol Violation|0|||
130572581|NCT00446511|470060776|FG001|Overall Study|Protocol Violation|0|||
130572582|NCT00446511|470060777|FG002|Overall Study|Protocol Violation|0|||
130572583|NCT00446511|470060778|FG003|Overall Study|Protocol Violation|1|||
130519206|NCT02484547|469869090|FG002|Placebo-Controlled Period|Relocation|1|||
130519207|NCT02484547|469869091|FG003|Placebo-Controlled Period|Relocation|0|||
130519208|NCT02484547|469869092|FG004|Placebo-Controlled Period|Relocation|0|||
130519209|NCT02484547|469869093|FG005|Placebo-Controlled Period|Relocation|0|||
130519210|NCT02484547|469869094|FG006|Placebo-Controlled Period|Relocation|0|||
130519211|NCT02484547|469869088|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
130519212|NCT02484547|469869089|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
130519213|NCT02484547|469869090|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
130519214|NCT02484547|469869091|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
130519215|NCT02484547|469869092|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
130519216|NCT02484547|469869093|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
130519217|NCT02484547|469869094|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
130519218|NCT02484547|469869088|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
130519219|NCT02484547|469869089|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
130519220|NCT02484547|469869090|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
130519221|NCT02484547|469869091|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130519222|NCT02484547|469869092|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130519223|NCT02484547|469869093|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130519224|NCT02484547|469869094|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130519225|NCT02484547|469869088|FG000|Placebo-Controlled Period|Reason not Specified|216|||
130519226|NCT02484547|469869089|FG001|Placebo-Controlled Period|Reason not Specified|194|||
130519227|NCT02484547|469869090|FG002|Placebo-Controlled Period|Reason not Specified|183|||
130519228|NCT02484547|469869091|FG003|Placebo-Controlled Period|Reason not Specified|0|||
130519229|NCT02484547|469869092|FG004|Placebo-Controlled Period|Reason not Specified|0|||
130519230|NCT02484547|469869093|FG005|Placebo-Controlled Period|Reason not Specified|0|||
130519231|NCT02484547|469869094|FG006|Placebo-Controlled Period|Reason not Specified|0|||
130519232|NCT02484547|469869088|FG000|Long-Term Extension Period|Adverse Event|0|||
130519233|NCT02484547|469869089|FG001|Long-Term Extension Period|Adverse Event|0|||
130519234|NCT02484547|469869090|FG002|Long-Term Extension Period|Adverse Event|0|||
130519235|NCT02484547|469869091|FG003|Long-Term Extension Period|Adverse Event|0|||
130519236|NCT02484547|469869092|FG004|Long-Term Extension Period|Adverse Event|1|||
130519237|NCT02484547|469869093|FG005|Long-Term Extension Period|Adverse Event|3|||
130519238|NCT02484547|469869094|FG006|Long-Term Extension Period|Adverse Event|2|||
130519239|NCT02484547|469869088|FG000|Long-Term Extension Period|Death|0|||
130519240|NCT02484547|469869089|FG001|Long-Term Extension Period|Death|0|||
130519241|NCT02484547|469869090|FG002|Long-Term Extension Period|Death|0|||
130519242|NCT02484547|469869091|FG003|Long-Term Extension Period|Death|0|||
130519243|NCT02484547|469869092|FG004|Long-Term Extension Period|Death|0|||
130519244|NCT02484547|469869093|FG005|Long-Term Extension Period|Death|3|||
130519245|NCT02484547|469869094|FG006|Long-Term Extension Period|Death|0|||
130519246|NCT02484547|469869088|FG000|Long-Term Extension Period|Disease Progression|0|||
130519247|NCT02484547|469869089|FG001|Long-Term Extension Period|Disease Progression|0|||
130519248|NCT02484547|469869090|FG002|Long-Term Extension Period|Disease Progression|0|||
130519249|NCT02484547|469869091|FG003|Long-Term Extension Period|Disease Progression|0|||
130519250|NCT02484547|469869092|FG004|Long-Term Extension Period|Disease Progression|2|||
130519251|NCT02484547|469869093|FG005|Long-Term Extension Period|Disease Progression|4|||
130519252|NCT02484547|469869094|FG006|Long-Term Extension Period|Disease Progression|0|||
130519253|NCT02484547|469869088|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
130519254|NCT02484547|469869089|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
130519255|NCT02484547|469869090|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
130519256|NCT02484547|469869091|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
130519257|NCT02484547|469869092|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
130519258|NCT02484547|469869093|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
130519259|NCT02484547|469869094|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
130519260|NCT02484547|469869088|FG000|Long-Term Extension Period|Loss of Capacity|0|||
130519261|NCT02484547|469869089|FG001|Long-Term Extension Period|Loss of Capacity|0|||
130519262|NCT02484547|469869090|FG002|Long-Term Extension Period|Loss of Capacity|0|||
130519263|NCT02484547|469869091|FG003|Long-Term Extension Period|Loss of Capacity|0|||
130519264|NCT02484547|469869092|FG004|Long-Term Extension Period|Loss of Capacity|1|||
130519265|NCT02484547|469869093|FG005|Long-Term Extension Period|Loss of Capacity|0|||
130519266|NCT02484547|469869094|FG006|Long-Term Extension Period|Loss of Capacity|0|||
130519267|NCT02484547|469869088|FG000|Long-Term Extension Period|Change of Treatment|0|||
130519268|NCT02484547|469869089|FG001|Long-Term Extension Period|Change of Treatment|0|||
130519269|NCT02484547|469869090|FG002|Long-Term Extension Period|Change of Treatment|0|||
130519270|NCT02484547|469869091|FG003|Long-Term Extension Period|Change of Treatment|0|||
130519271|NCT02484547|469869092|FG004|Long-Term Extension Period|Change of Treatment|0|||
130519272|NCT02484547|469869093|FG005|Long-Term Extension Period|Change of Treatment|0|||
130519273|NCT02484547|469869094|FG006|Long-Term Extension Period|Change of Treatment|1|||
130519274|NCT02484547|469869088|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
130519275|NCT02484547|469869089|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
130519276|NCT02484547|469869090|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
130519277|NCT02484547|469869091|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
130519278|NCT02484547|469869092|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
130519279|NCT02484547|469869093|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
130519280|NCT02484547|469869094|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
130519281|NCT02484547|469869088|FG000|Long-Term Extension Period|Investigator Decision|0|||
130519282|NCT02484547|469869089|FG001|Long-Term Extension Period|Investigator Decision|0|||
130519283|NCT02484547|469869090|FG002|Long-Term Extension Period|Investigator Decision|0|||
130519284|NCT02484547|469869091|FG003|Long-Term Extension Period|Investigator Decision|2|||
130519285|NCT02484547|469869092|FG004|Long-Term Extension Period|Investigator Decision|1|||
130519286|NCT02484547|469869093|FG005|Long-Term Extension Period|Investigator Decision|0|||
130519287|NCT02484547|469869094|FG006|Long-Term Extension Period|Investigator Decision|1|||
130519288|NCT02484547|469869088|FG000|Long-Term Extension Period|Relocation|0|||
130519289|NCT02484547|469869089|FG001|Long-Term Extension Period|Relocation|0|||
130519290|NCT02484547|469869090|FG002|Long-Term Extension Period|Relocation|0|||
130519291|NCT02484547|469869091|FG003|Long-Term Extension Period|Relocation|1|||
130519292|NCT02484547|469869092|FG004|Long-Term Extension Period|Relocation|1|||
130519293|NCT02484547|469869093|FG005|Long-Term Extension Period|Relocation|0|||
130519294|NCT02484547|469869094|FG006|Long-Term Extension Period|Relocation|0|||
130519295|NCT02484547|469869088|FG000|Long-Term Extension Period|Study Visit Burden|0|||
130519296|NCT02484547|469869089|FG001|Long-Term Extension Period|Study Visit Burden|0|||
130519297|NCT02484547|469869090|FG002|Long-Term Extension Period|Study Visit Burden|0|||
130519298|NCT02484547|469869091|FG003|Long-Term Extension Period|Study Visit Burden|2|||
130519299|NCT02484547|469869092|FG004|Long-Term Extension Period|Study Visit Burden|0|||
130519300|NCT02484547|469869093|FG005|Long-Term Extension Period|Study Visit Burden|0|||
130519301|NCT02484547|469869094|FG006|Long-Term Extension Period|Study Visit Burden|3|||
130519302|NCT02484547|469869088|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
130519303|NCT02484547|469869089|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
130519304|NCT02484547|469869090|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
130519305|NCT02484547|469869091|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
130519306|NCT02484547|469869092|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
130519307|NCT02484547|469869093|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
130519308|NCT02484547|469869094|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
130519309|NCT02484547|469869088|FG000|Long-Term Extension Period|Reason not Specified|0|||
130519310|NCT02484547|469869089|FG001|Long-Term Extension Period|Reason not Specified|0|||
130519311|NCT02484547|469869090|FG002|Long-Term Extension Period|Reason not Specified|0|||
130519312|NCT02484547|469869091|FG003|Long-Term Extension Period|Reason not Specified|119|||
130519313|NCT02484547|469869092|FG004|Long-Term Extension Period|Reason not Specified|117|||
130519314|NCT02484547|469869093|FG005|Long-Term Extension Period|Reason not Specified|223|||
130519315|NCT02484547|469869094|FG006|Long-Term Extension Period|Reason not Specified|231|||
130519316|NCT01813305|469869095|FG000|Overall Study|Withdrawal by Subject|12|||
130519317|NCT01813305|469869096|FG001|Overall Study|Withdrawal by Subject|5|||
130519318|NCT01813305|469869095|FG000|Overall Study|Safety Concern|4|||
130519319|NCT01813305|469869096|FG001|Overall Study|Safety Concern|0|||
130519320|NCT01813305|469869095|FG000|Overall Study|Ulcer became worse|4|||
130519321|NCT01813305|469869096|FG001|Overall Study|Ulcer became worse|0|||
130519322|NCT01813305|469869095|FG000|Overall Study|Physician Decision|4|||
130519323|NCT01813305|469869096|FG001|Overall Study|Physician Decision|0|||
130519324|NCT01813305|469869095|FG000|Overall Study|Lost to Follow-up|3|||
130519325|NCT01813305|469869096|FG001|Overall Study|Lost to Follow-up|1|||
130519326|NCT01813305|469869095|FG000|Overall Study|Protocol Violation|1|||
130519327|NCT01813305|469869096|FG001|Overall Study|Protocol Violation|0|||
130519328|NCT01813305|469869095|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
130519329|NCT01813305|469869096|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
130519330|NCT01665599|469869100|FG000|Overall Study|Adverse Event|1|||
130519331|NCT01665599|469869100|FG000|Overall Study|Consent Withdrawn|1|||
130519332|NCT01665599|469869100|FG000|Overall Study|Investigator/Sponsor decision|1|||
130519333|NCT01665599|469869100|FG000|Overall Study|Death|1|||
130519334|NCT01665599|469869100|FG000|Overall Study|Lost to Follow-up|2|||
130519335|NCT01665599|469869100|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
130519336|NCT01665599|469869100|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
130519337|NCT01424189|469869101|FG000|Overall Study|Adverse Event|1|||
130519338|NCT01424189|469869102|FG001|Overall Study|Adverse Event|0|||
130519339|NCT01424189|469869101|FG000|Overall Study|Lost to Follow-up|4|||
130519340|NCT01424189|469869102|FG001|Overall Study|Lost to Follow-up|1|||
130519341|NCT01424189|469869101|FG000|Overall Study|Withdrawal by Subject|4|||
130519342|NCT01424189|469869102|FG001|Overall Study|Withdrawal by Subject|4|||
130519343|NCT01424189|469869101|FG000|Overall Study|Subject moved|1|||
130519344|NCT01424189|469869102|FG001|Overall Study|Subject moved|0|||
130519345|NCT01424189|469869101|FG000|Overall Study|Death|3|||
130519346|NCT01424189|469869102|FG001|Overall Study|Death|1|||
130519347|NCT01705145|469869103|FG000|Part B|Adverse Event|1|||
130572584|NCT00446511|470060775|FG000|Overall Study|Withdrawal by Subject|0|||
130519348|NCT00069277|469869104|FG000|Overall Study|Adverse Event|3|||
130519349|NCT00069277|469869104|FG000|Overall Study|Withdrawal by Subject|1|||
130519350|NCT00069277|469869104|FG000|Overall Study|Progressive Disease|15|||
130519351|NCT00069277|469869104|FG000|Overall Study|Physician Decision|2|||
130519352|NCT00361842|469869105|FG000|Overall Study|Withdrawal by Subject|2|||
130519353|NCT00361842|469869106|FG001|Overall Study|Withdrawal by Subject|3|||
130519354|NCT00361842|469869105|FG000|Overall Study|Death|2|||
130519355|NCT00361842|469869106|FG001|Overall Study|Death|1|||
130519356|NCT00361842|469869105|FG000|Overall Study|Disease progression|19|||
130519357|NCT00361842|469869106|FG001|Overall Study|Disease progression|20|||
130519358|NCT00361842|469869105|FG000|Overall Study|Adverse Event|2|||
130519359|NCT00361842|469869106|FG001|Overall Study|Adverse Event|3|||
130519360|NCT00361842|469869105|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
130519361|NCT00361842|469869106|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
130519362|NCT00361842|469869105|FG000|Overall Study|Other|1|||
130519363|NCT00361842|469869106|FG001|Overall Study|Other|0|||
130519364|NCT00361842|469869105|FG000|Overall Study|Other|0|||
130519365|NCT00361842|469869106|FG001|Overall Study|Other|2|||
130519366|NCT01077622|469869107|FG000|Overall Study|Physician Decision|2|||
130519367|NCT01077622|469869107|FG000|Overall Study|Withdrawal by Subject|1|||
130519368|NCT00424177|469869108|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
130519369|NCT00424177|469869108|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
130519370|NCT00424177|469869108|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
130519371|NCT00424177|469869108|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
130519372|NCT00424177|469869108|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
130519373|NCT00424177|469869108|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
130519374|NCT00424177|469869108|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
130519375|NCT00424177|469869108|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
130519376|NCT00424177|469869108|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
130519377|NCT00424177|469869108|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
130519378|NCT04159805|469869109|FG000|Overall Study|Withdrawal by Subject|0|||
130519379|NCT04159805|469869110|FG001|Overall Study|Withdrawal by Subject|2|||
130519380|NCT04159805|469869111|FG002|Overall Study|Withdrawal by Subject|2|||
130519381|NCT01502371|469869114|FG000|Overall Study|Withdrawal by Subject|1|||
130519382|NCT01502371|469869115|FG001|Overall Study|Withdrawal by Subject|2|||
130519383|NCT01502371|469869116|FG002|Overall Study|Withdrawal by Subject|1|||
130519384|NCT01502371|469869117|FG003|Overall Study|Withdrawal by Subject|1|||
130519385|NCT01502371|469869118|FG004|Overall Study|Withdrawal by Subject|1|||
130519386|NCT01502371|469869114|FG000|Overall Study|Adverse Event|2|||
130519387|NCT01502371|469869115|FG001|Overall Study|Adverse Event|1|||
130519388|NCT01502371|469869116|FG002|Overall Study|Adverse Event|0|||
130519389|NCT01502371|469869117|FG003|Overall Study|Adverse Event|4|||
130519390|NCT01502371|469869118|FG004|Overall Study|Adverse Event|3|||
130519391|NCT01502371|469869114|FG000|Overall Study|Treatment Failure|22|||
130519392|NCT01502371|469869115|FG001|Overall Study|Treatment Failure|20|||
130519393|NCT01502371|469869116|FG002|Overall Study|Treatment Failure|12|||
130519394|NCT01502371|469869117|FG003|Overall Study|Treatment Failure|19|||
130519395|NCT01502371|469869118|FG004|Overall Study|Treatment Failure|30|||
130519396|NCT01502371|469869114|FG000|Overall Study|Lack of Efficacy|3|||
130519397|NCT01502371|469869115|FG001|Overall Study|Lack of Efficacy|3|||
130519398|NCT01502371|469869116|FG002|Overall Study|Lack of Efficacy|2|||
130519399|NCT01502371|469869117|FG003|Overall Study|Lack of Efficacy|2|||
130519400|NCT01502371|469869118|FG004|Overall Study|Lack of Efficacy|4|||
130519401|NCT01502371|469869114|FG000|Overall Study|Physician Decision|3|||
130519402|NCT01502371|469869115|FG001|Overall Study|Physician Decision|0|||
130519403|NCT01502371|469869116|FG002|Overall Study|Physician Decision|0|||
130519404|NCT01502371|469869117|FG003|Overall Study|Physician Decision|0|||
130519405|NCT01502371|469869118|FG004|Overall Study|Physician Decision|1|||
130519406|NCT01502371|469869114|FG000|Overall Study|Noncompliance with Study Drug|0|||
130519407|NCT01502371|469869115|FG001|Overall Study|Noncompliance with Study Drug|0|||
130519408|NCT01502371|469869116|FG002|Overall Study|Noncompliance with Study Drug|1|||
130519409|NCT01502371|469869117|FG003|Overall Study|Noncompliance with Study Drug|2|||
130519410|NCT01502371|469869118|FG004|Overall Study|Noncompliance with Study Drug|1|||
130519411|NCT01502371|469869114|FG000|Overall Study|Technical Problems|1|||
130519412|NCT01502371|469869115|FG001|Overall Study|Technical Problems|0|||
130519413|NCT01502371|469869116|FG002|Overall Study|Technical Problems|2|||
130519414|NCT01502371|469869117|FG003|Overall Study|Technical Problems|4|||
130519415|NCT01502371|469869118|FG004|Overall Study|Technical Problems|1|||
130519416|NCT01502371|469869114|FG000|Overall Study|Protocol Violation|9|||
130519417|NCT01502371|469869115|FG001|Overall Study|Protocol Violation|5|||
130519418|NCT01502371|469869116|FG002|Overall Study|Protocol Violation|6|||
130519419|NCT01502371|469869117|FG003|Overall Study|Protocol Violation|5|||
130519420|NCT01502371|469869118|FG004|Overall Study|Protocol Violation|10|||
130519421|NCT01502371|469869114|FG000|Overall Study|Excluded Medication|0|||
130519422|NCT01502371|469869115|FG001|Overall Study|Excluded Medication|1|||
130519423|NCT01502371|469869116|FG002|Overall Study|Excluded Medication|1|||
130572585|NCT00446511|470060776|FG001|Overall Study|Withdrawal by Subject|0|||
130519424|NCT01502371|469869117|FG003|Overall Study|Excluded Medication|0|||
130519425|NCT01502371|469869118|FG004|Overall Study|Excluded Medication|1|||
130519426|NCT02154347|469869119|FG000|Double-blind Period|Adverse Event|1|||
130519427|NCT02154347|469869120|FG001|Double-blind Period|Adverse Event|2|||
130519428|NCT02154347|469869119|FG000|Double-blind Period|Lack of Efficacy|1|||
130519429|NCT02154347|469869120|FG001|Double-blind Period|Lack of Efficacy|0|||
130519430|NCT02154347|469869119|FG000|Double-blind Period|Physician Decision|0|||
130519431|NCT02154347|469869120|FG001|Double-blind Period|Physician Decision|1|||
130519432|NCT02154347|469869119|FG000|Double-blind Period|Withdrawal by Subject|1|||
130519433|NCT02154347|469869120|FG001|Double-blind Period|Withdrawal by Subject|1|||
130519434|NCT02154347|469869119|FG000|Open-label Period|Adverse Event|3|||
130519435|NCT02154347|469869120|FG001|Open-label Period|Adverse Event|4|||
130519436|NCT02154347|469869119|FG000|Open-label Period|Lack of Efficacy|4|||
130519437|NCT02154347|469869120|FG001|Open-label Period|Lack of Efficacy|19|||
130519438|NCT02154347|469869119|FG000|Open-label Period|Protocol Violation|0|||
130519439|NCT02154347|469869120|FG001|Open-label Period|Protocol Violation|1|||
130519440|NCT02154347|469869119|FG000|Open-label Period|Withdrawal by Subject|0|||
130519441|NCT02154347|469869120|FG001|Open-label Period|Withdrawal by Subject|1|||
130519442|NCT02473913|469869122|FG000|Overall Study|Lost to Follow-up|3|||
130519443|NCT02473913|469869123|FG001|Overall Study|Lost to Follow-up|3|||
130519444|NCT01190449|469869126|FG000|Overall Study|Ineligible|0|||
130519445|NCT01190449|469869127|FG001|Overall Study|Ineligible|4|||
130519446|NCT03282799|469869128|FG000|Overall Study|Pregnancy|1|||
130519447|NCT03282799|469869129|FG001|Overall Study|Pregnancy|0|||
130519448|NCT03282799|469869128|FG000|Overall Study|Physician Decision|1|||
130519449|NCT03282799|469869129|FG001|Overall Study|Physician Decision|0|||
130519450|NCT02210208|469870325|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
130519451|NCT02210208|469870325|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
130519452|NCT02210208|469870325|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
130519453|NCT01171183|469870326|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
130519454|NCT01171183|469870327|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
130519455|NCT01171183|469870326|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
130519456|NCT01171183|469870327|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
130519457|NCT01171183|469870326|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
130519458|NCT01171183|469870327|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
130519459|NCT01171183|469870326|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
130519460|NCT01171183|469870327|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
130519461|NCT01171183|469870326|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
130519462|NCT01171183|469870327|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
130519463|NCT01171183|469870326|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
130519464|NCT01171183|469870327|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
130519465|NCT01066936|469870328|FG000|Overall Study|Death|2|||
130519466|NCT01066936|469870328|FG000|Overall Study|Device revised/removed|1|||
130519467|NCT01066936|469870328|FG000|Overall Study|Lost to Follow-up|3|||
130519468|NCT01066936|469870328|FG000|Overall Study|Withdrawal by Subject|4|||
130519469|NCT01726049|469870329|FG000|Overall Study|Death|1|||
130519470|NCT01726049|469870330|FG001|Overall Study|Death|1|||
130519471|NCT01726049|469870329|FG000|Overall Study|Adverse Event|4|||
130519472|NCT01726049|469870330|FG001|Overall Study|Adverse Event|1|||
130519473|NCT01726049|469870329|FG000|Overall Study|refused second HC|0|||
130519474|NCT01726049|469870330|FG001|Overall Study|refused second HC|2|||
130519475|NCT04156399|469870338|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
130519476|NCT04156399|469870338|FG000|Overall Study|study suspension due to COVID pandemic|3|||
130519477|NCT03440047|469870339|FG000|Overall Study|Withdrawal by Subject|2|||
130519478|NCT01181609|469870340|FG000|Overall Study|Adverse Event|1|||
130519479|NCT01181609|469870340|FG000|Overall Study|Withdrawal by Subject|1|||
130519480|NCT01181609|469870340|FG000|Overall Study|Lost to Follow-up|1|||
130519481|NCT01181609|469870340|FG000|Overall Study|Death|50|||
130519482|NCT01722045|469870341|FG000|Overall Study|Adverse Event|8|||
130519483|NCT01722045|469870341|FG000|Overall Study|Death|3|||
130519484|NCT01722045|469870341|FG000|Overall Study|Withdrawal by Subject|8|||
130519485|NCT01722045|469870341|FG000|Overall Study|Lost to Follow-up|4|||
130519486|NCT01722045|469870341|FG000|Overall Study|Protocol Deviation|1|||
130519487|NCT01722045|469870341|FG000|Overall Study|Physician Decision|3|||
130519488|NCT01722045|469870341|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
130519489|NCT03834623|469870353|FG000|Overall Study|Progression|0|||
130519490|NCT03834623|469870354|FG001|Overall Study|Progression|1|||
130519491|NCT00478647|469870355|FG000|Overall Study|Adverse Event|1|||
130519492|NCT00478647|469870355|FG000|Overall Study|Withdrawal by Subject|1|||
130519493|NCT00511836|469870358|FG000|Double-blind Period|Lost to Follow-up|1|||
130519494|NCT00511836|469870359|FG001|Double-blind Period|Lost to Follow-up|0|||
130519495|NCT01755546|469870363|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
130519496|NCT01755546|469870363|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
130519497|NCT01755546|469870363|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
130572586|NCT00446511|470060777|FG002|Overall Study|Withdrawal by Subject|0|||
130572587|NCT00446511|470060778|FG003|Overall Study|Withdrawal by Subject|3|||
130572588|NCT00446511|470060775|FG000|Overall Study|Administrative Problems|3|||
130572589|NCT00446511|470060776|FG001|Overall Study|Administrative Problems|0|||
130572590|NCT00446511|470060777|FG002|Overall Study|Administrative Problems|4|||
130572591|NCT00446511|470060778|FG003|Overall Study|Administrative Problems|1|||
130572592|NCT01618214|470060779|FG000|Overall Study|Adverse Event|3|||
130572593|NCT01618214|470060780|FG001|Overall Study|Adverse Event|1|||
130572594|NCT01618214|470060779|FG000|Overall Study|Lack of Efficacy|1|||
130572595|NCT01618214|470060780|FG001|Overall Study|Lack of Efficacy|1|||
130572596|NCT01618214|470060779|FG000|Overall Study|Protocol Violation|1|||
130572597|NCT01618214|470060780|FG001|Overall Study|Protocol Violation|4|||
130572598|NCT01618214|470060779|FG000|Overall Study|Withdrawal Criteria|1|||
130572599|NCT01618214|470060780|FG001|Overall Study|Withdrawal Criteria|2|||
130572600|NCT01618214|470060779|FG000|Overall Study|Unclassified|4|||
130572601|NCT01618214|470060780|FG001|Overall Study|Unclassified|5|||
130572602|NCT02228590|470060782|FG000|Overall Study|Withdrawal by Subject|1|||
130572603|NCT03873714|470060783|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
130572604|NCT03028870|470060784|FG000|Overall Study|Adverse Event|7|||
130572605|NCT03028870|470060785|FG001|Overall Study|Adverse Event|4|||
130572606|NCT03028870|470060786|FG002|Overall Study|Adverse Event|3|||
130572607|NCT03028870|470060787|FG003|Overall Study|Adverse Event|3|||
130572608|NCT03028870|470060784|FG000|Overall Study|Withdrawal by Subject|1|||
130572609|NCT03028870|470060785|FG001|Overall Study|Withdrawal by Subject|1|||
130572610|NCT03028870|470060786|FG002|Overall Study|Withdrawal by Subject|1|||
130572611|NCT03028870|470060787|FG003|Overall Study|Withdrawal by Subject|2|||
130572612|NCT03028870|470060784|FG000|Overall Study|Lost to Follow-up|1|||
130572613|NCT03028870|470060785|FG001|Overall Study|Lost to Follow-up|0|||
130572614|NCT03028870|470060786|FG002|Overall Study|Lost to Follow-up|0|||
130572615|NCT03028870|470060787|FG003|Overall Study|Lost to Follow-up|0|||
130572616|NCT03028870|470060784|FG000|Overall Study|Lack of Efficacy|3|||
130572617|NCT03028870|470060785|FG001|Overall Study|Lack of Efficacy|0|||
130572618|NCT03028870|470060786|FG002|Overall Study|Lack of Efficacy|0|||
130572619|NCT03028870|470060787|FG003|Overall Study|Lack of Efficacy|0|||
130572620|NCT03028870|470060784|FG000|Overall Study|Administrative|5|||
130572621|NCT03028870|470060785|FG001|Overall Study|Administrative|5|||
130572622|NCT03028870|470060786|FG002|Overall Study|Administrative|12|||
130572623|NCT03028870|470060787|FG003|Overall Study|Administrative|4|||
130572624|NCT00708123|470060788|FG000|Period 1|Protocol Violation|0|||
130572625|NCT00708123|470060789|FG001|Period 1|Protocol Violation|1|||
130572626|NCT00708123|470060790|FG002|Period 1|Protocol Violation|0|||
130572627|NCT00708123|470060791|FG003|Period 1|Protocol Violation|1|||
130572628|NCT00708123|470060792|FG004|Period 1|Protocol Violation|0|||
130572629|NCT00708123|470060788|FG000|Period 1|Adverse Event|0|||
130572630|NCT00708123|470060789|FG001|Period 1|Adverse Event|0|||
130519498|NCT01755546|469870363|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
130519499|NCT01755546|469870363|FG000|Titration Phase|Adverse Event|11|||
130519500|NCT01755546|469870363|FG000|Titration Phase|Lack of Efficacy|18|||
130519501|NCT01755546|469870363|FG000|Titration Phase|Protocol Violation|9|||
130519502|NCT01755546|469870363|FG000|Titration Phase|Lost to Follow-up|2|||
130519503|NCT01755546|469870363|FG000|Titration Phase|Other and Continuing|22|||
130519504|NCT01755546|469870363|FG000|Titration Phase|Withdrawal by Subject|8|||
130519505|NCT01755546|469870363|FG000|Long Term Treatment|Adverse Event|12|||
130519506|NCT01755546|469870363|FG000|Long Term Treatment|Lack of Efficacy|6|||
130519507|NCT01755546|469870363|FG000|Long Term Treatment|Protocol Violation|10|||
130519508|NCT01755546|469870363|FG000|Long Term Treatment|Withdrawal by Subject|35|||
130519509|NCT01755546|469870363|FG000|Long Term Treatment|Lost to Follow-up|17|||
130572631|NCT00708123|470060790|FG002|Period 1|Adverse Event|1|||
130572632|NCT00708123|470060791|FG003|Period 1|Adverse Event|0|||
130572633|NCT00708123|470060792|FG004|Period 1|Adverse Event|0|||
130572634|NCT00708123|470060788|FG000|Period 2|Protocol Violation|0|||
130572635|NCT00708123|470060789|FG001|Period 2|Protocol Violation|0|||
130572636|NCT00708123|470060790|FG002|Period 2|Protocol Violation|0|||
130572637|NCT00708123|470060791|FG003|Period 2|Protocol Violation|1|||
130572638|NCT00708123|470060792|FG004|Period 2|Protocol Violation|0|||
130572639|NCT00708123|470060788|FG000|Period 2|Other Reason|1|||
130572640|NCT00708123|470060789|FG001|Period 2|Other Reason|0|||
130572641|NCT00708123|470060790|FG002|Period 2|Other Reason|0|||
130572642|NCT00708123|470060791|FG003|Period 2|Other Reason|0|||
130519510|NCT01755546|469870363|FG000|Long Term Treatment|other and ongoing|41|||
130519511|NCT00362375|469870364|FG000|Overall Study|Lost to Follow-up|40|||
130572643|NCT00708123|470060792|FG004|Period 2|Other Reason|0|||
130572644|NCT00708123|470060788|FG000|Period 3|Lost to Follow-up|0|||
130572645|NCT00708123|470060789|FG001|Period 3|Lost to Follow-up|0|||
130572646|NCT00708123|470060790|FG002|Period 3|Lost to Follow-up|1|||
130572647|NCT00708123|470060791|FG003|Period 3|Lost to Follow-up|1|||
130572648|NCT00708123|470060792|FG004|Period 3|Lost to Follow-up|0|||
130572649|NCT00708123|470060788|FG000|Period 4|Protocol Violation|0|||
130572650|NCT00708123|470060789|FG001|Period 4|Protocol Violation|1|||
130572651|NCT00708123|470060790|FG002|Period 4|Protocol Violation|0|||
130572652|NCT00708123|470060791|FG003|Period 4|Protocol Violation|0|||
130572653|NCT00708123|470060792|FG004|Period 4|Protocol Violation|0|||
130572654|NCT04486950|470060793|FG000|Overall Study|Lost to Follow-up|0|||
130572655|NCT04486950|470060794|FG001|Overall Study|Lost to Follow-up|0|||
130572656|NCT04486950|470060795|FG002|Overall Study|Lost to Follow-up|0|||
130572657|NCT04486950|470060796|FG003|Overall Study|Lost to Follow-up|0|||
130572658|NCT04486950|470060797|FG004|Overall Study|Lost to Follow-up|0|||
130572659|NCT04486950|470060798|FG005|Overall Study|Lost to Follow-up|1|||
130572660|NCT04486950|470060799|FG006|Overall Study|Lost to Follow-up|0|||
130572661|NCT00550680|470060800|FG000|Overall Study|Administrative Reasons|1|||
130572662|NCT00550680|470060800|FG000|Overall Study|Adverse Event|5|||
130572663|NCT00550680|470060800|FG000|Overall Study|Death|3|||
130572664|NCT00550680|470060800|FG000|Overall Study|Early Improvement|1|||
130572665|NCT00550680|470060800|FG000|Overall Study|Lost to Follow-up|3|||
130572666|NCT00550680|470060800|FG000|Overall Study|Lack of Efficacy|1|||
130572667|NCT00550680|470060800|FG000|Overall Study|Other|10|||
130572668|NCT00550680|470060800|FG000|Overall Study|Protocol Violation|7|||
130572669|NCT00550680|470060800|FG000|Overall Study|Refused Treatment|19|||
130572670|NCT00550680|470060800|FG000|Overall Study|Screen Failure|6|||
130572671|NCT01119248|470060801|FG000|Overall Study|Physician Decision|5|||
130572672|NCT00562354|470060802|FG000|Overall Study|Physician Decision|0|||
130572673|NCT00562354|470060803|FG001|Overall Study|Physician Decision|1|||
130572674|NCT00562354|470060802|FG000|Overall Study|Lost to Follow-up|0|||
130572675|NCT00562354|470060803|FG001|Overall Study|Lost to Follow-up|1|||
130572676|NCT00317109|470060804|FG000|Overall Study|Withdrawal by Subject|2|||
130572677|NCT00317109|470060805|FG001|Overall Study|Withdrawal by Subject|0|||
130572678|NCT00317109|470060804|FG000|Overall Study|Migated/moved from study area|1|||
130572679|NCT00317109|470060805|FG001|Overall Study|Migated/moved from study area|0|||
130572680|NCT01883635|470060807|FG000|Overall Study|Withdrawal by Subject|4|||
130572681|NCT01883635|470060808|FG001|Overall Study|Withdrawal by Subject|0|||
130572682|NCT00761514|470060809|FG000|Overall Study|Adverse Event|1|||
130572683|NCT00761514|470060809|FG000|Overall Study|Withdrawal by Subject|2|||
130572684|NCT00761514|470060809|FG000|Overall Study|Lost to Follow-up|1|||
130572685|NCT00761514|470060809|FG000|Overall Study|Health insurance didn't cover study drug|1|||
130572686|NCT00761514|470060809|FG000|Overall Study|Problem complying with study visit|1|||
130572687|NCT00761514|470060809|FG000|Overall Study|Unable to pay for medications|1|||
130572688|NCT03885089|470060812|FG000|Overall Study|No informed consent for publication of study results|2|||
130572689|NCT01425008|470060821|FG000|Dose Escalation Phase|Progressive Disease|2|||
130572690|NCT01425008|470060822|FG001|Dose Escalation Phase|Progressive Disease|3|||
130572691|NCT01425008|470060823|FG002|Dose Escalation Phase|Progressive Disease|2|||
130572692|NCT01425008|470060824|FG003|Dose Escalation Phase|Progressive Disease|3|||
130572693|NCT01425008|470060825|FG004|Dose Escalation Phase|Progressive Disease|5|||
130572694|NCT01425008|470060826|FG005|Dose Escalation Phase|Progressive Disease|4|||
130572695|NCT01425008|470060827|FG006|Dose Escalation Phase|Progressive Disease|0|||
130572696|NCT01425008|470060828|FG007|Dose Escalation Phase|Progressive Disease|2|||
130572697|NCT01425008|470060829|FG008|Dose Escalation Phase|Progressive Disease|6|||
130572698|NCT01425008|470060830|FG009|Dose Escalation Phase|Progressive Disease|2|||
130572699|NCT01425008|470060831|FG010|Dose Escalation Phase|Progressive Disease|0|||
130572700|NCT01425008|470060832|FG011|Dose Escalation Phase|Progressive Disease|0|||
130572701|NCT01425008|470060833|FG012|Dose Escalation Phase|Progressive Disease|0|||
130572702|NCT01425008|470060834|FG013|Dose Escalation Phase|Progressive Disease|0|||
130572703|NCT01425008|470060835|FG014|Dose Escalation Phase|Progressive Disease|0|||
130572704|NCT01425008|470060836|FG015|Dose Escalation Phase|Progressive Disease|0|||
130572705|NCT01425008|470060837|FG016|Dose Escalation Phase|Progressive Disease|0|||
130572706|NCT01425008|470060838|FG017|Dose Escalation Phase|Progressive Disease|0|||
130572707|NCT01425008|470060839|FG018|Dose Escalation Phase|Progressive Disease|0|||
130572708|NCT01425008|470060821|FG000|Dose Escalation Phase|Adverse Event|2|||
130572709|NCT01425008|470060822|FG001|Dose Escalation Phase|Adverse Event|0|||
130572710|NCT01425008|470060823|FG002|Dose Escalation Phase|Adverse Event|0|||
130572711|NCT01425008|470060824|FG003|Dose Escalation Phase|Adverse Event|0|||
130572712|NCT01425008|470060825|FG004|Dose Escalation Phase|Adverse Event|0|||
130572713|NCT01425008|470060826|FG005|Dose Escalation Phase|Adverse Event|2|||
130572714|NCT01425008|470060827|FG006|Dose Escalation Phase|Adverse Event|0|||
130572715|NCT01425008|470060828|FG007|Dose Escalation Phase|Adverse Event|0|||
130572716|NCT01425008|470060829|FG008|Dose Escalation Phase|Adverse Event|2|||
130572717|NCT01425008|470060830|FG009|Dose Escalation Phase|Adverse Event|0|||
130572718|NCT01425008|470060831|FG010|Dose Escalation Phase|Adverse Event|0|||
130572719|NCT01425008|470060832|FG011|Dose Escalation Phase|Adverse Event|0|||
130572720|NCT01425008|470060833|FG012|Dose Escalation Phase|Adverse Event|0|||
130572721|NCT01425008|470060834|FG013|Dose Escalation Phase|Adverse Event|0|||
130572722|NCT01425008|470060835|FG014|Dose Escalation Phase|Adverse Event|0|||
130572723|NCT01425008|470060836|FG015|Dose Escalation Phase|Adverse Event|0|||
130572724|NCT01425008|470060837|FG016|Dose Escalation Phase|Adverse Event|0|||
130572725|NCT01425008|470060838|FG017|Dose Escalation Phase|Adverse Event|0|||
130572726|NCT01425008|470060839|FG018|Dose Escalation Phase|Adverse Event|0|||
130572727|NCT01425008|470060821|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572728|NCT01425008|470060822|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572729|NCT01425008|470060823|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572730|NCT01425008|470060824|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572731|NCT01425008|470060825|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130572732|NCT01425008|470060826|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572733|NCT01425008|470060827|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
130572734|NCT01425008|470060828|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130572735|NCT01425008|470060829|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130572736|NCT01425008|470060830|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572737|NCT01425008|470060831|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572738|NCT01425008|470060832|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572739|NCT01425008|470060833|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572740|NCT01425008|470060834|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572741|NCT01425008|470060835|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572742|NCT01425008|470060836|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572743|NCT01425008|470060837|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572744|NCT01425008|470060838|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572745|NCT01425008|470060839|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130572746|NCT01425008|470060821|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130572747|NCT01425008|470060822|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130572748|NCT01425008|470060823|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130572749|NCT01425008|470060824|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130572750|NCT01425008|470060825|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
130572751|NCT01425008|470060826|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
130572752|NCT01425008|470060827|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
130572753|NCT01425008|470060828|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
130572754|NCT01425008|470060829|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
130572755|NCT01425008|470060830|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
130572756|NCT01425008|470060831|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
130572757|NCT01425008|470060832|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
130572758|NCT01425008|470060833|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
130572759|NCT01425008|470060834|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
130572760|NCT01425008|470060835|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
130572761|NCT01425008|470060836|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
130572762|NCT01425008|470060837|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
130572763|NCT01425008|470060838|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
130572764|NCT01425008|470060839|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
130572765|NCT01425008|470060821|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572766|NCT01425008|470060822|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572767|NCT01425008|470060823|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
130572768|NCT01425008|470060824|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572769|NCT01425008|470060825|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572770|NCT01425008|470060826|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572771|NCT01425008|470060827|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572772|NCT01425008|470060828|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572773|NCT01425008|470060829|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
130572774|NCT01425008|470060830|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
130572775|NCT01425008|470060831|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572776|NCT01425008|470060832|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572777|NCT01425008|470060833|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572778|NCT01425008|470060834|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572779|NCT01425008|470060835|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572780|NCT01425008|470060836|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572781|NCT01425008|470060837|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572782|NCT01425008|470060838|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572783|NCT01425008|470060839|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
130572784|NCT01425008|470060821|FG000|Dose Escalation Phase|Other|0|||
130572785|NCT01425008|470060822|FG001|Dose Escalation Phase|Other|0|||
130572786|NCT01425008|470060823|FG002|Dose Escalation Phase|Other|0|||
130572787|NCT01425008|470060824|FG003|Dose Escalation Phase|Other|0|||
130572788|NCT01425008|470060825|FG004|Dose Escalation Phase|Other|0|||
130572789|NCT01425008|470060826|FG005|Dose Escalation Phase|Other|0|||
130572790|NCT01425008|470060827|FG006|Dose Escalation Phase|Other|0|||
130572791|NCT01425008|470060828|FG007|Dose Escalation Phase|Other|0|||
130572792|NCT01425008|470060829|FG008|Dose Escalation Phase|Other|1|||
130572793|NCT01425008|470060830|FG009|Dose Escalation Phase|Other|0|||
130572794|NCT01425008|470060831|FG010|Dose Escalation Phase|Other|0|||
130572795|NCT01425008|470060832|FG011|Dose Escalation Phase|Other|0|||
130572796|NCT01425008|470060833|FG012|Dose Escalation Phase|Other|0|||
130572797|NCT01425008|470060834|FG013|Dose Escalation Phase|Other|0|||
130572798|NCT01425008|470060835|FG014|Dose Escalation Phase|Other|0|||
130572799|NCT01425008|470060836|FG015|Dose Escalation Phase|Other|0|||
130572800|NCT01425008|470060837|FG016|Dose Escalation Phase|Other|0|||
130572801|NCT01425008|470060838|FG017|Dose Escalation Phase|Other|0|||
130572802|NCT01425008|470060839|FG018|Dose Escalation Phase|Other|0|||
130572803|NCT01425008|470060821|FG000|Dose Expansion Phase|Progressive Disease|0|||
130572804|NCT01425008|470060822|FG001|Dose Expansion Phase|Progressive Disease|0|||
130572805|NCT01425008|470060823|FG002|Dose Expansion Phase|Progressive Disease|0|||
130572806|NCT01425008|470060824|FG003|Dose Expansion Phase|Progressive Disease|0|||
130572807|NCT01425008|470060825|FG004|Dose Expansion Phase|Progressive Disease|0|||
130572808|NCT01425008|470060826|FG005|Dose Expansion Phase|Progressive Disease|0|||
130572809|NCT01425008|470060827|FG006|Dose Expansion Phase|Progressive Disease|0|||
130572810|NCT01425008|470060828|FG007|Dose Expansion Phase|Progressive Disease|0|||
130572811|NCT01425008|470060829|FG008|Dose Expansion Phase|Progressive Disease|0|||
130572812|NCT01425008|470060830|FG009|Dose Expansion Phase|Progressive Disease|0|||
130572813|NCT01425008|470060831|FG010|Dose Expansion Phase|Progressive Disease|10|||
130572814|NCT01425008|470060832|FG011|Dose Expansion Phase|Progressive Disease|4|||
130572815|NCT01425008|470060833|FG012|Dose Expansion Phase|Progressive Disease|12|||
130572816|NCT01425008|470060834|FG013|Dose Expansion Phase|Progressive Disease|1|||
130572817|NCT01425008|470060835|FG014|Dose Expansion Phase|Progressive Disease|5|||
130572818|NCT01425008|470060836|FG015|Dose Expansion Phase|Progressive Disease|8|||
130572819|NCT01425008|470060837|FG016|Dose Expansion Phase|Progressive Disease|9|||
130519512|NCT00362375|469870365|FG001|Overall Study|Lost to Follow-up|35|||
130519513|NCT04984239|469870366|FG000|Overall Study|Lost to Follow-up|1|||
130519514|NCT04606199|469870367|FG000|Overall Study|Withdrawal by Subject|2|||
130519515|NCT04190225|469870368|FG000|Overall Study|Lost to Follow-up|2|||
130519516|NCT04190225|469870369|FG001|Overall Study|Lost to Follow-up|3|||
130519517|NCT04190225|469870368|FG000|Overall Study|Withdrawal by Subject|3|||
130519518|NCT04190225|469870369|FG001|Overall Study|Withdrawal by Subject|2|||
130519519|NCT04190225|469870368|FG000|Overall Study|Unrelated health condition|2|||
130519520|NCT04190225|469870369|FG001|Overall Study|Unrelated health condition|0|||
130519521|NCT01114139|469870371|FG000|Overall Study|Adverse Event|3|||
130519522|NCT01114139|469870372|FG001|Overall Study|Adverse Event|2|||
130519523|NCT01114139|469870371|FG000|Overall Study|Lost to Follow-up|15|||
130519524|NCT01114139|469870372|FG001|Overall Study|Lost to Follow-up|3|||
130519525|NCT01114139|469870371|FG000|Overall Study|Withdrawal by Subject|17|||
130519526|NCT01114139|469870372|FG001|Overall Study|Withdrawal by Subject|6|||
130519527|NCT01114139|469870371|FG000|Overall Study|Other-Missed 1 visit|1|||
130519528|NCT01114139|469870372|FG001|Overall Study|Other-Missed 1 visit|0|||
130519529|NCT01114139|469870371|FG000|Overall Study|Other-Protocol Violation|1|||
130519530|NCT01114139|469870372|FG001|Overall Study|Other-Protocol Violation|0|||
130519531|NCT01114139|469870371|FG000|Overall Study|Other-Out of window for study drug dose|1|||
130519532|NCT01114139|469870372|FG001|Overall Study|Other-Out of window for study drug dose|0|||
130519533|NCT01114139|469870371|FG000|Overall Study|Other-Participant falsified records|0|||
130519534|NCT01114139|469870372|FG001|Overall Study|Other-Participant falsified records|1|||
130519535|NCT01114139|469870371|FG000|Overall Study|Other-Participant went on hospice|0|||
130519536|NCT01114139|469870372|FG001|Overall Study|Other-Participant went on hospice|1|||
130519537|NCT01114139|469870371|FG000|Overall Study|Other-Physician changed treatment|1|||
130519538|NCT01114139|469870372|FG001|Overall Study|Other-Physician changed treatment|0|||
130519539|NCT01114139|469870371|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
130519540|NCT01114139|469870372|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
130519541|NCT01917006|469870374|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
130519542|NCT01917006|469870375|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
130519543|NCT01917006|469870376|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
130519544|NCT01917006|469870377|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
130519545|NCT01917006|469870378|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
130519546|NCT01917006|469870379|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
130519547|NCT01917006|469870380|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
130519548|NCT01917006|469870381|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
130519549|NCT01917006|469870374|FG000|Randomized-treatment Period|Personal Reasons|0|||
130519550|NCT01917006|469870375|FG001|Randomized-treatment Period|Personal Reasons|0|||
130519551|NCT01917006|469870376|FG002|Randomized-treatment Period|Personal Reasons|0|||
130519552|NCT01917006|469870377|FG003|Randomized-treatment Period|Personal Reasons|0|||
130572820|NCT01425008|470060838|FG017|Dose Expansion Phase|Progressive Disease|2|||
130572821|NCT01425008|470060839|FG018|Dose Expansion Phase|Progressive Disease|10|||
130572822|NCT01425008|470060821|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
130572823|NCT01425008|470060822|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
130519553|NCT01917006|469870378|FG004|Randomized-treatment Period|Personal Reasons|0|||
130519554|NCT01917006|469870379|FG005|Randomized-treatment Period|Personal Reasons|1|||
130519555|NCT01917006|469870380|FG006|Randomized-treatment Period|Personal Reasons|0|||
130519556|NCT01917006|469870381|FG007|Randomized-treatment Period|Personal Reasons|0|||
130572824|NCT01425008|470060823|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
130572825|NCT01425008|470060824|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
130572826|NCT01425008|470060825|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
130519557|NCT01917006|469870374|FG000|Randomized-treatment Period|Protocol Violation|1|||
130519558|NCT01917006|469870375|FG001|Randomized-treatment Period|Protocol Violation|0|||
130519559|NCT01917006|469870376|FG002|Randomized-treatment Period|Protocol Violation|0|||
130519560|NCT01917006|469870377|FG003|Randomized-treatment Period|Protocol Violation|0|||
130519561|NCT01917006|469870378|FG004|Randomized-treatment Period|Protocol Violation|0|||
130519562|NCT01917006|469870379|FG005|Randomized-treatment Period|Protocol Violation|0|||
130519563|NCT01917006|469870380|FG006|Randomized-treatment Period|Protocol Violation|0|||
130519564|NCT01917006|469870381|FG007|Randomized-treatment Period|Protocol Violation|0|||
130519565|NCT01917006|469870374|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519566|NCT01917006|469870375|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519567|NCT01917006|469870376|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519568|NCT01917006|469870377|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519569|NCT01917006|469870378|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519570|NCT01917006|469870379|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519571|NCT01917006|469870380|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
130519572|NCT01917006|469870381|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
130519573|NCT01917006|469870374|FG000|Open-label Period|Adverse Event|0|||
130519574|NCT01917006|469870375|FG001|Open-label Period|Adverse Event|0|||
130519575|NCT01917006|469870376|FG002|Open-label Period|Adverse Event|0|||
130519576|NCT01917006|469870377|FG003|Open-label Period|Adverse Event|0|||
130519577|NCT01917006|469870378|FG004|Open-label Period|Adverse Event|0|||
130519578|NCT01917006|469870379|FG005|Open-label Period|Adverse Event|0|||
130519579|NCT01917006|469870380|FG006|Open-label Period|Adverse Event|0|||
130519580|NCT01917006|469870381|FG007|Open-label Period|Adverse Event|1|||
130519581|NCT01917006|469870374|FG000|Open-label Period|Lost to Follow-up|0|||
130519582|NCT01917006|469870375|FG001|Open-label Period|Lost to Follow-up|0|||
130519583|NCT01917006|469870376|FG002|Open-label Period|Lost to Follow-up|0|||
130519584|NCT01917006|469870377|FG003|Open-label Period|Lost to Follow-up|0|||
130519585|NCT01917006|469870378|FG004|Open-label Period|Lost to Follow-up|0|||
130519586|NCT01917006|469870379|FG005|Open-label Period|Lost to Follow-up|0|||
130519587|NCT01917006|469870380|FG006|Open-label Period|Lost to Follow-up|0|||
130519588|NCT01917006|469870381|FG007|Open-label Period|Lost to Follow-up|1|||
130519589|NCT01475461|469870386|FG000|Run-in Period|Not meet eligibility criteria|16|||
130519590|NCT01475461|469870387|FG001|Run-in Period|Not meet eligibility criteria|0|||
130519591|NCT01475461|469870388|FG002|Run-in Period|Not meet eligibility criteria|0|||
130519592|NCT01475461|469870389|FG003|Run-in Period|Not meet eligibility criteria|0|||
130519593|NCT01475461|469870390|FG004|Run-in Period|Not meet eligibility criteria|0|||
130519594|NCT01475461|469870391|FG005|Run-in Period|Not meet eligibility criteria|0|||
130519595|NCT01475461|469870392|FG006|Run-in Period|Not meet eligibility criteria|0|||
130519596|NCT01475461|469870386|FG000|Run-in Period|Lost to Follow-up|7|||
130519597|NCT01475461|469870387|FG001|Run-in Period|Lost to Follow-up|0|||
130519598|NCT01475461|469870388|FG002|Run-in Period|Lost to Follow-up|0|||
130572827|NCT01425008|470060826|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
130572828|NCT01425008|470060827|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
130572829|NCT01425008|470060828|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
130519599|NCT01475461|469870389|FG003|Run-in Period|Lost to Follow-up|0|||
130519600|NCT01475461|469870390|FG004|Run-in Period|Lost to Follow-up|0|||
130519601|NCT01475461|469870391|FG005|Run-in Period|Lost to Follow-up|0|||
130519602|NCT01475461|469870392|FG006|Run-in Period|Lost to Follow-up|0|||
130519603|NCT01475461|469870386|FG000|Run-in Period|Withdrawal by Subject|11|||
130519604|NCT01475461|469870387|FG001|Run-in Period|Withdrawal by Subject|0|||
130519605|NCT01475461|469870388|FG002|Run-in Period|Withdrawal by Subject|0|||
130519606|NCT01475461|469870389|FG003|Run-in Period|Withdrawal by Subject|0|||
130519607|NCT01475461|469870390|FG004|Run-in Period|Withdrawal by Subject|0|||
130519608|NCT01475461|469870391|FG005|Run-in Period|Withdrawal by Subject|0|||
130519609|NCT01475461|469870392|FG006|Run-in Period|Withdrawal by Subject|0|||
130519610|NCT01475461|469870386|FG000|Run-in Period|Other|3|||
130519611|NCT01475461|469870387|FG001|Run-in Period|Other|0|||
130519612|NCT01475461|469870388|FG002|Run-in Period|Other|0|||
130519613|NCT01475461|469870389|FG003|Run-in Period|Other|0|||
130519614|NCT01475461|469870390|FG004|Run-in Period|Other|0|||
130519615|NCT01475461|469870391|FG005|Run-in Period|Other|0|||
130519616|NCT01475461|469870392|FG006|Run-in Period|Other|0|||
130519617|NCT01475461|469870386|FG000|Run-in Period|Protocol Violation|4|||
130519618|NCT01475461|469870387|FG001|Run-in Period|Protocol Violation|0|||
130519619|NCT01475461|469870388|FG002|Run-in Period|Protocol Violation|0|||
130519620|NCT01475461|469870389|FG003|Run-in Period|Protocol Violation|0|||
130519621|NCT01475461|469870390|FG004|Run-in Period|Protocol Violation|0|||
130519622|NCT01475461|469870391|FG005|Run-in Period|Protocol Violation|0|||
130519623|NCT01475461|469870392|FG006|Run-in Period|Protocol Violation|0|||
130519624|NCT01475461|469870386|FG000|Treatment Period|Death|0|||
130519625|NCT01475461|469870387|FG001|Treatment Period|Death|0|||
130519626|NCT01475461|469870388|FG002|Treatment Period|Death|0|||
130519627|NCT01475461|469870389|FG003|Treatment Period|Death|1|||
130519628|NCT01475461|469870390|FG004|Treatment Period|Death|0|||
130519629|NCT01475461|469870391|FG005|Treatment Period|Death|0|||
130519630|NCT01475461|469870392|FG006|Treatment Period|Death|0|||
130519631|NCT01475461|469870386|FG000|Treatment Period|Lost to Follow-up|0|||
130519632|NCT01475461|469870387|FG001|Treatment Period|Lost to Follow-up|3|||
130519633|NCT01475461|469870388|FG002|Treatment Period|Lost to Follow-up|2|||
130519634|NCT01475461|469870389|FG003|Treatment Period|Lost to Follow-up|3|||
130519635|NCT01475461|469870390|FG004|Treatment Period|Lost to Follow-up|1|||
130519636|NCT01475461|469870391|FG005|Treatment Period|Lost to Follow-up|2|||
130519637|NCT01475461|469870392|FG006|Treatment Period|Lost to Follow-up|1|||
130519638|NCT01475461|469870386|FG000|Treatment Period|Withdrawal by Subject|0|||
130519639|NCT01475461|469870387|FG001|Treatment Period|Withdrawal by Subject|2|||
130519640|NCT01475461|469870388|FG002|Treatment Period|Withdrawal by Subject|2|||
130519641|NCT01475461|469870389|FG003|Treatment Period|Withdrawal by Subject|0|||
130519642|NCT01475461|469870390|FG004|Treatment Period|Withdrawal by Subject|2|||
130519643|NCT01475461|469870391|FG005|Treatment Period|Withdrawal by Subject|2|||
130519644|NCT01475461|469870392|FG006|Treatment Period|Withdrawal by Subject|0|||
130519645|NCT01475461|469870386|FG000|Treatment Period|Other|0|||
130519646|NCT01475461|469870387|FG001|Treatment Period|Other|1|||
130519647|NCT01475461|469870388|FG002|Treatment Period|Other|0|||
130519648|NCT01475461|469870389|FG003|Treatment Period|Other|0|||
130519649|NCT01475461|469870390|FG004|Treatment Period|Other|0|||
130519650|NCT01475461|469870391|FG005|Treatment Period|Other|0|||
130519651|NCT01475461|469870392|FG006|Treatment Period|Other|0|||
130519652|NCT01475461|469870386|FG000|Treatment Period|Protocol Violation|0|||
130519653|NCT01475461|469870387|FG001|Treatment Period|Protocol Violation|1|||
130519654|NCT01475461|469870388|FG002|Treatment Period|Protocol Violation|0|||
130519655|NCT01475461|469870389|FG003|Treatment Period|Protocol Violation|0|||
130519656|NCT01475461|469870390|FG004|Treatment Period|Protocol Violation|0|||
130519657|NCT01475461|469870391|FG005|Treatment Period|Protocol Violation|0|||
130519658|NCT01475461|469870392|FG006|Treatment Period|Protocol Violation|1|||
130519659|NCT01475461|469870386|FG000|Treatment Period|Lack of Efficacy|0|||
130519660|NCT01475461|469870387|FG001|Treatment Period|Lack of Efficacy|2|||
130519661|NCT01475461|469870388|FG002|Treatment Period|Lack of Efficacy|0|||
130519662|NCT01475461|469870389|FG003|Treatment Period|Lack of Efficacy|2|||
130519663|NCT01475461|469870390|FG004|Treatment Period|Lack of Efficacy|1|||
130519664|NCT01475461|469870391|FG005|Treatment Period|Lack of Efficacy|1|||
130519665|NCT01475461|469870392|FG006|Treatment Period|Lack of Efficacy|0|||
130519666|NCT01475461|469870386|FG000|Treatment Period|Medication Error|0|||
130519667|NCT01475461|469870387|FG001|Treatment Period|Medication Error|0|||
130519668|NCT01475461|469870388|FG002|Treatment Period|Medication Error|0|||
130519669|NCT01475461|469870389|FG003|Treatment Period|Medication Error|1|||
130519670|NCT01475461|469870390|FG004|Treatment Period|Medication Error|0|||
130519671|NCT01475461|469870391|FG005|Treatment Period|Medication Error|0|||
130519672|NCT01475461|469870392|FG006|Treatment Period|Medication Error|0|||
130519673|NCT01475461|469870386|FG000|Treatment Period|Adverse Event|0|||
130519674|NCT01475461|469870387|FG001|Treatment Period|Adverse Event|0|||
130519675|NCT01475461|469870388|FG002|Treatment Period|Adverse Event|0|||
130519676|NCT01475461|469870389|FG003|Treatment Period|Adverse Event|1|||
130519677|NCT01475461|469870390|FG004|Treatment Period|Adverse Event|0|||
130519678|NCT01475461|469870391|FG005|Treatment Period|Adverse Event|0|||
130519679|NCT01475461|469870392|FG006|Treatment Period|Adverse Event|0|||
130519680|NCT02512861|469870400|FG000|Overall Study|Protocol Violation|3|||
130519681|NCT02512861|469870401|FG001|Overall Study|Protocol Violation|7|||
130519682|NCT02512861|469870400|FG000|Overall Study|Physician Decision|3|||
130519683|NCT02512861|469870401|FG001|Overall Study|Physician Decision|1|||
130519684|NCT02512861|469870400|FG000|Overall Study|Withdrawal by Subject|0|||
130572830|NCT01425008|470060829|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
130519685|NCT02512861|469870401|FG001|Overall Study|Withdrawal by Subject|1|||
130519686|NCT03214250|469870404|FG000|Overall Study|Death|5|||
130519687|NCT03214250|469870405|FG001|Overall Study|Death|5|||
130519688|NCT03214250|469870406|FG002|Overall Study|Death|7|||
130519689|NCT03214250|469870407|FG003|Overall Study|Death|4|||
130519690|NCT03214250|469870408|FG004|Overall Study|Death|23|||
130519691|NCT03214250|469870409|FG005|Overall Study|Death|23|||
130519692|NCT03214250|469870410|FG006|Overall Study|Death|24|||
130519693|NCT03214250|469870404|FG000|Overall Study|Lost to Follow-up|0|||
130519694|NCT03214250|469870405|FG001|Overall Study|Lost to Follow-up|0|||
130519695|NCT03214250|469870406|FG002|Overall Study|Lost to Follow-up|0|||
130519696|NCT03214250|469870407|FG003|Overall Study|Lost to Follow-up|1|||
130519697|NCT03214250|469870408|FG004|Overall Study|Lost to Follow-up|1|||
130519698|NCT03214250|469870409|FG005|Overall Study|Lost to Follow-up|2|||
130519699|NCT03214250|469870410|FG006|Overall Study|Lost to Follow-up|0|||
130519700|NCT03214250|469870404|FG000|Overall Study|Other|0|||
130572831|NCT01425008|470060830|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
130572832|NCT01425008|470060831|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
130572833|NCT01425008|470060832|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
130572834|NCT01425008|470060833|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
130572835|NCT01425008|470060834|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
130519701|NCT03214250|469870405|FG001|Overall Study|Other|0|||
130519702|NCT03214250|469870406|FG002|Overall Study|Other|0|||
130519703|NCT03214250|469870407|FG003|Overall Study|Other|0|||
130519704|NCT03214250|469870408|FG004|Overall Study|Other|1|||
130519705|NCT03214250|469870409|FG005|Overall Study|Other|1|||
130519706|NCT03214250|469870410|FG006|Overall Study|Other|2|||
130519707|NCT03214250|469870404|FG000|Overall Study|Remains on Study|2|||
130519708|NCT03214250|469870405|FG001|Overall Study|Remains on Study|2|||
130519709|NCT03214250|469870406|FG002|Overall Study|Remains on Study|0|||
130519710|NCT03214250|469870407|FG003|Overall Study|Remains on Study|1|||
130519711|NCT03214250|469870408|FG004|Overall Study|Remains on Study|7|||
130519712|NCT03214250|469870409|FG005|Overall Study|Remains on Study|5|||
130519713|NCT03214250|469870410|FG006|Overall Study|Remains on Study|3|||
130519714|NCT03214250|469870404|FG000|Overall Study|Withdrawal by Subject|0|||
130519715|NCT03214250|469870405|FG001|Overall Study|Withdrawal by Subject|0|||
130519716|NCT03214250|469870406|FG002|Overall Study|Withdrawal by Subject|1|||
130519717|NCT03214250|469870407|FG003|Overall Study|Withdrawal by Subject|2|||
130519718|NCT03214250|469870408|FG004|Overall Study|Withdrawal by Subject|5|||
130519719|NCT03214250|469870409|FG005|Overall Study|Withdrawal by Subject|0|||
130519720|NCT03214250|469870410|FG006|Overall Study|Withdrawal by Subject|2|||
130519721|NCT00292981|469870414|FG000|Overall Study|Adverse Event|1|||
130519722|NCT00292981|469870414|FG000|Overall Study|Lost to Follow-up|13|||
130519723|NCT00292981|469870414|FG000|Overall Study|Withdrawal by Subject|22|||
130519724|NCT00292981|469870414|FG000|Overall Study|Other|3|||
130519725|NCT00594178|469870415|FG000|Overall Study|Physician Decision|5|||
130519726|NCT02971228|469870418|FG000|Overall Study|Withdrawal by Subject|1|||
130519727|NCT02971228|469870419|FG001|Overall Study|Withdrawal by Subject|1|||
130519728|NCT02971228|469870420|FG002|Overall Study|Withdrawal by Subject|0|||
130519729|NCT02971228|469870421|FG003|Overall Study|Withdrawal by Subject|0|||
130519730|NCT02971228|469870422|FG004|Overall Study|Withdrawal by Subject|0|||
130519731|NCT02971228|469870418|FG000|Overall Study|Logistical challenges|0|||
130519732|NCT02971228|469870419|FG001|Overall Study|Logistical challenges|1|||
130519733|NCT02971228|469870420|FG002|Overall Study|Logistical challenges|0|||
130519734|NCT02971228|469870421|FG003|Overall Study|Logistical challenges|0|||
130519735|NCT02971228|469870422|FG004|Overall Study|Logistical challenges|0|||
130519736|NCT01321723|469870423|FG000|Overall Study|Adverse Event|3|||
130519737|NCT01321723|469870424|FG001|Overall Study|Adverse Event|5|||
130519738|NCT01321723|469870425|FG002|Overall Study|Adverse Event|2|||
130519739|NCT01321723|469870423|FG000|Overall Study|Withdrawal by Subject|2|||
130519740|NCT01321723|469870424|FG001|Overall Study|Withdrawal by Subject|0|||
130519741|NCT01321723|469870425|FG002|Overall Study|Withdrawal by Subject|2|||
130519742|NCT00025506|469870426|FG000|Overall Study|Ineligible: clerical error|1|||
130519743|NCT00025506|469870426|FG000|Overall Study|Ineligible: wrong cell type|5|||
130519744|NCT00025506|469870426|FG000|Overall Study|Ineligible: inadequate pathology|2|||
130519745|NCT00025506|469870426|FG000|Overall Study|Never Treated|2|||
130519746|NCT00713206|469870427|FG000|Overall Study|Lost to Follow-up|4|||
130519747|NCT00713206|469870428|FG001|Overall Study|Lost to Follow-up|4|||
130519748|NCT00713206|469870427|FG000|Overall Study|Death|1|||
130519749|NCT00713206|469870428|FG001|Overall Study|Death|0|||
130519750|NCT02561806|469870429|FG000|Induction Period|Adverse Event|0|||
130519751|NCT02561806|469870430|FG001|Induction Period|Adverse Event|2|||
130519752|NCT02561806|469870429|FG000|Induction Period|Lack of Efficacy|1|||
130519753|NCT02561806|469870430|FG001|Induction Period|Lack of Efficacy|0|||
130519754|NCT02561806|469870429|FG000|Induction Period|Withdrawal by Subject|0|||
130519755|NCT02561806|469870430|FG001|Induction Period|Withdrawal by Subject|2|||
130519756|NCT02561806|469870429|FG000|Induction Period|Site staff became unblinded|1|||
130519757|NCT02561806|469870430|FG001|Induction Period|Site staff became unblinded|0|||
130519758|NCT02561806|469870429|FG000|Induction Period|Randomized but not treated|0|||
130519759|NCT02561806|469870430|FG001|Induction Period|Randomized but not treated|1|||
130519760|NCT02561806|469870429|FG000|Maintenance Period|Adverse Event|2|||
130519761|NCT02561806|469870430|FG001|Maintenance Period|Adverse Event|1|||
130519762|NCT02561806|469870429|FG000|Maintenance Period|Lack of Efficacy|3|||
130519763|NCT02561806|469870430|FG001|Maintenance Period|Lack of Efficacy|1|||
130519764|NCT02561806|469870429|FG000|Maintenance Period|Lost to Follow-up|2|||
130519765|NCT02561806|469870430|FG001|Maintenance Period|Lost to Follow-up|2|||
130519766|NCT02561806|469870429|FG000|Maintenance Period|Protocol Violation|1|||
130519767|NCT02561806|469870430|FG001|Maintenance Period|Protocol Violation|0|||
130519768|NCT02561806|469870429|FG000|Maintenance Period|Withdrawal by Subject|5|||
130519769|NCT02561806|469870430|FG001|Maintenance Period|Withdrawal by Subject|3|||
130519770|NCT02561806|469870429|FG000|Maintenance Period|Site staff became unblinded|0|||
130519771|NCT02561806|469870430|FG001|Maintenance Period|Site staff became unblinded|1|||
130572836|NCT01425008|470060835|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
130572837|NCT01425008|470060836|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
130572838|NCT01425008|470060837|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
130572839|NCT01425008|470060838|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
130572840|NCT01425008|470060839|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
130572841|NCT01425008|470060821|FG000|Dose Expansion Phase|Other|0|||
130572842|NCT01425008|470060822|FG001|Dose Expansion Phase|Other|0|||
130572843|NCT01425008|470060823|FG002|Dose Expansion Phase|Other|0|||
130572844|NCT01425008|470060824|FG003|Dose Expansion Phase|Other|0|||
130572845|NCT01425008|470060825|FG004|Dose Expansion Phase|Other|0|||
130572846|NCT01425008|470060826|FG005|Dose Expansion Phase|Other|0|||
130572847|NCT01425008|470060827|FG006|Dose Expansion Phase|Other|0|||
130572848|NCT01425008|470060828|FG007|Dose Expansion Phase|Other|0|||
130572849|NCT01425008|470060829|FG008|Dose Expansion Phase|Other|0|||
130572850|NCT01425008|470060830|FG009|Dose Expansion Phase|Other|0|||
130572851|NCT01425008|470060831|FG010|Dose Expansion Phase|Other|0|||
130572852|NCT01425008|470060832|FG011|Dose Expansion Phase|Other|0|||
130572853|NCT01425008|470060833|FG012|Dose Expansion Phase|Other|1|||
130572854|NCT01425008|470060834|FG013|Dose Expansion Phase|Other|0|||
130572855|NCT01425008|470060835|FG014|Dose Expansion Phase|Other|0|||
130572856|NCT01425008|470060836|FG015|Dose Expansion Phase|Other|0|||
130572857|NCT01425008|470060837|FG016|Dose Expansion Phase|Other|2|||
130572858|NCT01425008|470060838|FG017|Dose Expansion Phase|Other|0|||
130572859|NCT01425008|470060839|FG018|Dose Expansion Phase|Other|4|||
130572860|NCT01425008|470060821|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572861|NCT01425008|470060822|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572862|NCT01425008|470060823|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572863|NCT01425008|470060824|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572864|NCT01425008|470060825|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572865|NCT01425008|470060826|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572866|NCT01425008|470060827|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572867|NCT01425008|470060828|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572868|NCT01425008|470060829|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572869|NCT01425008|470060830|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572870|NCT01425008|470060831|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
130572871|NCT01425008|470060832|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
130572872|NCT01425008|470060833|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572873|NCT01425008|470060834|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572874|NCT01425008|470060835|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572875|NCT01425008|470060836|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
130572876|NCT01425008|470060837|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
130572877|NCT01425008|470060838|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
130572878|NCT01425008|470060839|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
130572879|NCT01425008|470060821|FG000|Dose Expansion Phase|Adverse Event|0|||
130572880|NCT01425008|470060822|FG001|Dose Expansion Phase|Adverse Event|0|||
130572881|NCT01425008|470060823|FG002|Dose Expansion Phase|Adverse Event|0|||
130572882|NCT01425008|470060824|FG003|Dose Expansion Phase|Adverse Event|0|||
130572883|NCT01425008|470060825|FG004|Dose Expansion Phase|Adverse Event|0|||
130572884|NCT01425008|470060826|FG005|Dose Expansion Phase|Adverse Event|0|||
130572885|NCT01425008|470060827|FG006|Dose Expansion Phase|Adverse Event|0|||
130572886|NCT01425008|470060828|FG007|Dose Expansion Phase|Adverse Event|0|||
130572887|NCT01425008|470060829|FG008|Dose Expansion Phase|Adverse Event|0|||
130572888|NCT01425008|470060830|FG009|Dose Expansion Phase|Adverse Event|0|||
130572889|NCT01425008|470060831|FG010|Dose Expansion Phase|Adverse Event|2|||
130572890|NCT01425008|470060832|FG011|Dose Expansion Phase|Adverse Event|3|||
130572891|NCT01425008|470060833|FG012|Dose Expansion Phase|Adverse Event|3|||
130572892|NCT01425008|470060834|FG013|Dose Expansion Phase|Adverse Event|0|||
130572893|NCT01425008|470060835|FG014|Dose Expansion Phase|Adverse Event|1|||
130572894|NCT01425008|470060836|FG015|Dose Expansion Phase|Adverse Event|1|||
130572895|NCT01425008|470060837|FG016|Dose Expansion Phase|Adverse Event|5|||
130572896|NCT01425008|470060838|FG017|Dose Expansion Phase|Adverse Event|0|||
130572897|NCT01425008|470060839|FG018|Dose Expansion Phase|Adverse Event|3|||
130572898|NCT01425008|470060821|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
130572899|NCT01425008|470060822|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130572900|NCT01425008|470060823|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
130572901|NCT01425008|470060824|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
130572902|NCT01425008|470060825|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
130572903|NCT01425008|470060826|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
130572904|NCT01425008|470060827|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
130572905|NCT01425008|470060828|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
130572906|NCT01425008|470060829|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
130572907|NCT01425008|470060830|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
130572908|NCT01425008|470060831|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
130572909|NCT01425008|470060832|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
130572910|NCT01425008|470060833|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
130572911|NCT01425008|470060834|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
130572912|NCT01425008|470060835|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
130572913|NCT01425008|470060836|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
130572914|NCT01425008|470060837|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
130572915|NCT01425008|470060838|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
130572916|NCT01425008|470060839|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
130572917|NCT01425008|470060821|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572918|NCT01425008|470060822|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572919|NCT01425008|470060823|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572920|NCT01425008|470060824|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572921|NCT01425008|470060825|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572922|NCT01425008|470060826|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572923|NCT01425008|470060827|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572924|NCT01425008|470060828|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572925|NCT01425008|470060829|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572926|NCT01425008|470060830|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572927|NCT01425008|470060831|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572928|NCT01425008|470060832|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572929|NCT01425008|470060833|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572930|NCT01425008|470060834|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572931|NCT01425008|470060835|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572932|NCT01425008|470060836|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572933|NCT01425008|470060837|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572934|NCT01425008|470060838|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130572935|NCT01425008|470060839|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
130572936|NCT00805480|470060842|FG000|Overall Study|Withdrawal by Subject|13|||
130572937|NCT00805480|470060843|FG001|Overall Study|Withdrawal by Subject|5|||
130572938|NCT00805480|470060844|FG002|Overall Study|Withdrawal by Subject|11|||
130572939|NCT00805480|470060845|FG003|Overall Study|Withdrawal by Subject|5|||
130572940|NCT00805480|470060842|FG000|Overall Study|Lost to Follow-up|1|||
130572941|NCT00805480|470060843|FG001|Overall Study|Lost to Follow-up|2|||
130572942|NCT00805480|470060844|FG002|Overall Study|Lost to Follow-up|0|||
130572943|NCT00805480|470060845|FG003|Overall Study|Lost to Follow-up|0|||
130572944|NCT00805480|470060842|FG000|Overall Study|Adverse Event|0|||
130572945|NCT00805480|470060843|FG001|Overall Study|Adverse Event|0|||
130572946|NCT00805480|470060844|FG002|Overall Study|Adverse Event|1|||
130572947|NCT00805480|470060845|FG003|Overall Study|Adverse Event|0|||
130572948|NCT00562588|470060846|FG000|Overall Study|Adverse Event|40|||
130572949|NCT00562588|470060847|FG001|Overall Study|Adverse Event|58|||
130572950|NCT00562588|470060846|FG000|Overall Study|Protocol Violation|30|||
130572951|NCT00562588|470060847|FG001|Overall Study|Protocol Violation|26|||
130572952|NCT00562588|470060846|FG000|Overall Study|Lost to Follow-up|12|||
130572953|NCT00562588|470060847|FG001|Overall Study|Lost to Follow-up|4|||
130572954|NCT00562588|470060846|FG000|Overall Study|Withdrawal by Subject|10|||
130572955|NCT00562588|470060847|FG001|Overall Study|Withdrawal by Subject|9|||
130572956|NCT00562588|470060846|FG000|Overall Study|Other|0|||
130572957|NCT00562588|470060847|FG001|Overall Study|Other|2|||
130572958|NCT03315871|470060851|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
130572959|NCT03315871|470060852|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
130572960|NCT03315871|470060853|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
130572961|NCT03315871|470060851|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130572962|NCT03315871|470060852|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
130572963|NCT03315871|470060853|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130572964|NCT03315871|470060851|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
130572965|NCT03315871|470060852|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
130572966|NCT03315871|470060853|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
130572967|NCT03315871|470060851|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
130572968|NCT03315871|470060852|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
130572969|NCT03315871|470060853|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
130572970|NCT03315871|470060851|FG000|PROSTVAC + CV301|Progressive disease|0|||
130572971|NCT03315871|470060852|FG001|PROSTVAC + CV301|Progressive disease|0|||
130572972|NCT03315871|470060853|FG002|PROSTVAC + CV301|Progressive disease|1|||
130572973|NCT03315871|470060851|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
130572974|NCT03315871|470060852|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
130572975|NCT03315871|470060853|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
130572976|NCT04099251|470064163|FG000|Pre-Treatment|Other reasons|1|||
130572977|NCT04099251|470064164|FG001|Pre-Treatment|Other reasons|0|||
130572978|NCT04099251|470064163|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
130572979|NCT04099251|470064164|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
130572980|NCT04099251|470064163|FG000|Blinded Treatment Phase|Other reasons|16|||
130519772|NCT02561806|469870429|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
130519773|NCT02561806|469870430|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
130519774|NCT02561806|469870429|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
130519775|NCT02561806|469870430|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
130519776|NCT02547441|469870431|FG000|Double-Blind Study Period|Adverse Event|4|||
130519777|NCT02547441|469870432|FG001|Double-Blind Study Period|Adverse Event|9|||
130519778|NCT02547441|469870431|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
130519779|NCT02547441|469870432|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
130519780|NCT02547441|469870431|FG000|Double-Blind Study Period|Physician Decision|1|||
130519781|NCT02547441|469870432|FG001|Double-Blind Study Period|Physician Decision|0|||
130519782|NCT02547441|469870431|FG000|Double-Blind Study Period|Protocol Violation|1|||
130519783|NCT02547441|469870432|FG001|Double-Blind Study Period|Protocol Violation|2|||
130519784|NCT02547441|469870431|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
130519785|NCT02547441|469870432|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
130519786|NCT02547441|469870431|FG000|Double-Blind Study Period|Sponsor Decision|1|||
130519787|NCT02547441|469870432|FG001|Double-Blind Study Period|Sponsor Decision|0|||
130519788|NCT02547441|469870431|FG000|Open-Label Study Period|Adverse Event|10|||
130519789|NCT02547441|469870432|FG001|Open-Label Study Period|Adverse Event|11|||
130519790|NCT02547441|469870431|FG000|Open-Label Study Period|Lack of Efficacy|3|||
130519791|NCT02547441|469870432|FG001|Open-Label Study Period|Lack of Efficacy|2|||
130519792|NCT02547441|469870431|FG000|Open-Label Study Period|Lost to Follow-up|7|||
130519793|NCT02547441|469870432|FG001|Open-Label Study Period|Lost to Follow-up|8|||
130519794|NCT02547441|469870431|FG000|Open-Label Study Period|Physician Decision|1|||
130519795|NCT02547441|469870432|FG001|Open-Label Study Period|Physician Decision|0|||
130519796|NCT02547441|469870431|FG000|Open-Label Study Period|Protocol Violation|2|||
130519797|NCT02547441|469870432|FG001|Open-Label Study Period|Protocol Violation|0|||
130519798|NCT02547441|469870431|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
130519799|NCT02547441|469870432|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
130519800|NCT02547441|469870431|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
130519801|NCT02547441|469870432|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
130519802|NCT01322009|469870434|FG000|Overall Study|Death|0|||
130519803|NCT01322009|469870435|FG001|Overall Study|Death|1|||
130519804|NCT01322009|469870434|FG000|Overall Study|Adverse Event|0|||
130519805|NCT01322009|469870435|FG001|Overall Study|Adverse Event|1|||
130519806|NCT01322009|469870434|FG000|Overall Study|ng tube discontinued|0|||
130519807|NCT01322009|469870435|FG001|Overall Study|ng tube discontinued|1|||
130519808|NCT00905034|469870436|FG000|Overall Study|Withdrawal by Subject|1|||
130519809|NCT00394589|469870437|FG000|Overall Study|Adverse Event|2|||
130519810|NCT00394589|469870438|FG001|Overall Study|Adverse Event|1|||
130519811|NCT00394589|469870439|FG002|Overall Study|Adverse Event|2|||
130519812|NCT00394589|469870437|FG000|Overall Study|Lack of Efficacy|2|||
130519813|NCT00394589|469870438|FG001|Overall Study|Lack of Efficacy|2|||
130519814|NCT00394589|469870439|FG002|Overall Study|Lack of Efficacy|3|||
130519815|NCT00394589|469870437|FG000|Overall Study|Protocol Violation|4|||
130519816|NCT00394589|469870438|FG001|Overall Study|Protocol Violation|0|||
130519817|NCT00394589|469870439|FG002|Overall Study|Protocol Violation|2|||
130519818|NCT04081389|469870440|FG000|Overall Study|Withdrawal by Subject|0|||
130519819|NCT04081389|469870441|FG001|Overall Study|Withdrawal by Subject|0|||
130519820|NCT04081389|469870442|FG002|Overall Study|Withdrawal by Subject|1|||
130519821|NCT04081389|469870443|FG003|Overall Study|Withdrawal by Subject|0|||
130519822|NCT02427958|469870449|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
130519823|NCT02427958|469870449|FG000|Overall Study|Lost to Follow-up|6|||
130519824|NCT02427958|469870449|FG000|Overall Study|Withdrawal by Subject|14|||
130519825|NCT02427958|469870449|FG000|Overall Study|Lack of Efficacy|1|||
130572981|NCT04099251|470064164|FG001|Blinded Treatment Phase|Other reasons|7|||
130572982|NCT04099251|470064163|FG000|Blinded Treatment Phase|Disease recurrence|26|||
130519826|NCT00582114|469870452|FG000|Overall Study|Death|4|||
130519827|NCT00582114|469870453|FG001|Overall Study|Death|4|||
130519828|NCT00582114|469870452|FG000|Overall Study|Kidney Transplant|3|||
130519829|NCT00582114|469870453|FG001|Overall Study|Kidney Transplant|1|||
130519830|NCT00582114|469870452|FG000|Overall Study|Lost to Follow-up|7|||
130519831|NCT00582114|469870453|FG001|Overall Study|Lost to Follow-up|6|||
130519832|NCT00582114|469870452|FG000|Overall Study|Withdrawal by Subject|8|||
130519833|NCT00582114|469870453|FG001|Overall Study|Withdrawal by Subject|16|||
130519834|NCT00582114|469870452|FG000|Overall Study|Adverse Event|1|||
130519835|NCT00582114|469870453|FG001|Overall Study|Adverse Event|1|||
130519836|NCT00582114|469870452|FG000|Overall Study|Physician Decision|0|||
130519837|NCT00582114|469870453|FG001|Overall Study|Physician Decision|6|||
130519838|NCT00582114|469870452|FG000|Overall Study|Stopped by data safety monitoring board|19|||
130519839|NCT00582114|469870453|FG001|Overall Study|Stopped by data safety monitoring board|20|||
130519840|NCT02604342|469870454|FG000|Overall Study|Death|32|||
130519841|NCT02604342|469870455|FG001|Overall Study|Death|16|||
130519842|NCT02604342|469870454|FG000|Overall Study|Progression of disease|1|||
130519843|NCT02604342|469870455|FG001|Overall Study|Progression of disease|0|||
130519844|NCT02604342|469870454|FG000|Overall Study|Withdrawal by Subject|5|||
130572983|NCT04099251|470064164|FG001|Blinded Treatment Phase|Disease recurrence|41|||
130572984|NCT04099251|470064163|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
130572985|NCT04099251|470064164|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
130572986|NCT04099251|470064163|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
130572987|NCT04099251|470064164|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
130572988|NCT04099251|470064163|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
130572989|NCT04099251|470064164|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
130572990|NCT04099251|470064163|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
130572991|NCT04099251|470064164|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
130572992|NCT04099251|470064163|FG000|Blinded Treatment Phase|Death|6|||
130572993|NCT04099251|470064164|FG001|Blinded Treatment Phase|Death|2|||
130572994|NCT04099251|470064163|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
130572995|NCT04099251|470064164|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
130572996|NCT04099251|470064163|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
130572997|NCT04099251|470064164|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
130572998|NCT04099251|470064163|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
130572999|NCT04099251|470064164|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
130573000|NCT04099251|470064163|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
130573001|NCT04099251|470064164|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
130573002|NCT04099251|470064163|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
130573003|NCT04099251|470064164|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
130573004|NCT04099251|470064163|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
130573005|NCT04099251|470064164|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
130573006|NCT04099251|470064163|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
130573007|NCT04099251|470064164|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
130573008|NCT04099251|470064163|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
130573009|NCT04099251|470064164|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
130573010|NCT04099251|470064163|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
130573011|NCT04099251|470064164|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
130573012|NCT05032157|470064165|FG000|Overall Study|Adverse Event|12|||
130573013|NCT05032157|470064166|FG001|Overall Study|Adverse Event|7|||
130573014|NCT05032157|470064165|FG000|Overall Study|Pregnancy|0|||
130573015|NCT05032157|470064166|FG001|Overall Study|Pregnancy|2|||
130573016|NCT05032157|470064165|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130573017|NCT05032157|470064166|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
130573018|NCT05032157|470064165|FG000|Overall Study|Protocol Deviation|8|||
130573019|NCT05032157|470064166|FG001|Overall Study|Protocol Deviation|4|||
130573020|NCT05032157|470064165|FG000|Overall Study|Lost to Follow-up|1|||
130573021|NCT05032157|470064166|FG001|Overall Study|Lost to Follow-up|3|||
130573022|NCT05032157|470064165|FG000|Overall Study|Physician Decision|7|||
130573023|NCT05032157|470064166|FG001|Overall Study|Physician Decision|2|||
130573024|NCT05032157|470064165|FG000|Overall Study|Patient Decision|38|||
130573025|NCT05032157|470064166|FG001|Overall Study|Patient Decision|19|||
130573026|NCT03047980|470064167|FG000|Overall Study|Adverse Event|1|||
130573027|NCT00880893|470064168|FG000|Overall Study|Protocol Violation|13|||
130573028|NCT00880893|470064169|FG001|Overall Study|Protocol Violation|1|||
130573029|NCT00880893|470064168|FG000|Overall Study|Withdrawal by Subject|15|||
130573030|NCT00880893|470064169|FG001|Overall Study|Withdrawal by Subject|11|||
130573031|NCT00880893|470064168|FG000|Overall Study|Lost to Follow-up|76|||
130573032|NCT00880893|470064169|FG001|Overall Study|Lost to Follow-up|33|||
130573033|NCT00880893|470064168|FG000|Overall Study|Serious adverse event|3|||
130573034|NCT00880893|470064169|FG001|Overall Study|Serious adverse event|0|||
130573035|NCT02164981|470064170|FG000|Started|Withdrawal by Subject|2|||
130573036|NCT02164981|470064171|FG001|Started|Withdrawal by Subject|1|||
130573037|NCT02164981|470064172|FG002|Started|Withdrawal by Subject|0|||
130573038|NCT02164981|470064170|FG000|Started|Protocol Violation|2|||
130573039|NCT02164981|470064171|FG001|Started|Protocol Violation|0|||
130573040|NCT02164981|470064172|FG002|Started|Protocol Violation|0|||
130573041|NCT02164981|470064170|FG000|Started|Adverse Event|1|||
130573042|NCT02164981|470064171|FG001|Started|Adverse Event|2|||
130573043|NCT02164981|470064172|FG002|Started|Adverse Event|0|||
130573044|NCT02164981|470064170|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
130573045|NCT02164981|470064171|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
130573046|NCT02164981|470064172|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
130573047|NCT02164981|470064170|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
130573048|NCT02164981|470064171|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
130573049|NCT02164981|470064172|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
130573050|NCT02164981|470064170|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
130573051|NCT02164981|470064171|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
130573052|NCT02164981|470064172|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
130573053|NCT02404103|470064173|FG000|Overall Study|Adverse Event|1|||
130573054|NCT02404103|470064174|FG001|Overall Study|Adverse Event|0|||
130573055|NCT02404103|470064173|FG000|Overall Study|Lost to Follow-up|3|||
130573056|NCT02404103|470064174|FG001|Overall Study|Lost to Follow-up|3|||
130573057|NCT01783678|470064175|FG000|Overall Study|Randomized but Not Treated|0|||
130573058|NCT01783678|470064176|FG001|Overall Study|Randomized but Not Treated|0|||
130573059|NCT01783678|470064177|FG002|Overall Study|Randomized but Not Treated|0|||
130573060|NCT01783678|470064178|FG003|Overall Study|Randomized but Not Treated|1|||
130573061|NCT01783678|470064179|FG004|Overall Study|Randomized but Not Treated|0|||
130573062|NCT01783678|470064180|FG005|Overall Study|Randomized but Not Treated|0|||
130573063|NCT01783678|470064175|FG000|Overall Study|Lack of Efficacy|1|||
130573064|NCT01783678|470064176|FG001|Overall Study|Lack of Efficacy|13|||
130573065|NCT01783678|470064177|FG002|Overall Study|Lack of Efficacy|1|||
130573066|NCT01783678|470064178|FG003|Overall Study|Lack of Efficacy|3|||
130573067|NCT01783678|470064179|FG004|Overall Study|Lack of Efficacy|6|||
130573068|NCT01783678|470064180|FG005|Overall Study|Lack of Efficacy|5|||
130573069|NCT01783678|470064175|FG000|Overall Study|Lost to Follow-up|0|||
130573070|NCT01783678|470064176|FG001|Overall Study|Lost to Follow-up|4|||
130573071|NCT01783678|470064177|FG002|Overall Study|Lost to Follow-up|0|||
130573072|NCT01783678|470064178|FG003|Overall Study|Lost to Follow-up|2|||
130573073|NCT01783678|470064179|FG004|Overall Study|Lost to Follow-up|1|||
130573074|NCT01783678|470064180|FG005|Overall Study|Lost to Follow-up|0|||
130573075|NCT01783678|470064175|FG000|Overall Study|Withdrew Consent|1|||
130573076|NCT01783678|470064176|FG001|Overall Study|Withdrew Consent|1|||
130573077|NCT01783678|470064177|FG002|Overall Study|Withdrew Consent|0|||
130573078|NCT01783678|470064178|FG003|Overall Study|Withdrew Consent|2|||
130573079|NCT01783678|470064179|FG004|Overall Study|Withdrew Consent|0|||
130573080|NCT01783678|470064180|FG005|Overall Study|Withdrew Consent|0|||
130573081|NCT01995071|470064181|FG000|Overall Study|Adverse Event|0|||
130573082|NCT01995071|470064182|FG001|Overall Study|Adverse Event|0|||
130573083|NCT01995071|470064183|FG002|Overall Study|Adverse Event|0|||
130573084|NCT01995071|470064184|FG003|Overall Study|Adverse Event|0|||
130573085|NCT01995071|470064185|FG004|Overall Study|Adverse Event|0|||
130573086|NCT01995071|470064186|FG005|Overall Study|Adverse Event|0|||
130573087|NCT01995071|470064187|FG006|Overall Study|Adverse Event|1|||
130573088|NCT01995071|470064188|FG007|Overall Study|Adverse Event|0|||
130573089|NCT01995071|470064189|FG008|Overall Study|Adverse Event|0|||
130573090|NCT01995071|470064190|FG009|Overall Study|Adverse Event|0|||
130573091|NCT01995071|470064191|FG010|Overall Study|Adverse Event|0|||
130573092|NCT01995071|470064192|FG011|Overall Study|Adverse Event|0|||
130573093|NCT01995071|470064181|FG000|Overall Study|Moved|0|||
130573094|NCT01995071|470064182|FG001|Overall Study|Moved|0|||
130573095|NCT01995071|470064183|FG002|Overall Study|Moved|1|||
130573096|NCT01995071|470064184|FG003|Overall Study|Moved|0|||
130573097|NCT01995071|470064185|FG004|Overall Study|Moved|1|||
130573098|NCT01995071|470064186|FG005|Overall Study|Moved|0|||
130573099|NCT01995071|470064187|FG006|Overall Study|Moved|0|||
130573100|NCT01995071|470064188|FG007|Overall Study|Moved|0|||
130573101|NCT01995071|470064189|FG008|Overall Study|Moved|0|||
130573102|NCT01995071|470064190|FG009|Overall Study|Moved|0|||
130573103|NCT01995071|470064191|FG010|Overall Study|Moved|1|||
130573104|NCT01995071|470064192|FG011|Overall Study|Moved|0|||
130573105|NCT01995071|470064181|FG000|Overall Study|Lost to Follow-up|1|||
130573106|NCT01995071|470064182|FG001|Overall Study|Lost to Follow-up|0|||
130573107|NCT01995071|470064183|FG002|Overall Study|Lost to Follow-up|0|||
130573108|NCT01995071|470064184|FG003|Overall Study|Lost to Follow-up|0|||
130573109|NCT01995071|470064185|FG004|Overall Study|Lost to Follow-up|0|||
130573110|NCT01995071|470064186|FG005|Overall Study|Lost to Follow-up|0|||
130573111|NCT01995071|470064187|FG006|Overall Study|Lost to Follow-up|0|||
130573112|NCT01995071|470064188|FG007|Overall Study|Lost to Follow-up|1|||
130573113|NCT01995071|470064189|FG008|Overall Study|Lost to Follow-up|1|||
130573114|NCT01995071|470064190|FG009|Overall Study|Lost to Follow-up|0|||
130573115|NCT01995071|470064191|FG010|Overall Study|Lost to Follow-up|0|||
130573116|NCT01995071|470064192|FG011|Overall Study|Lost to Follow-up|0|||
130573117|NCT01995071|470064181|FG000|Overall Study|Incarcerated|0|||
130573118|NCT01995071|470064182|FG001|Overall Study|Incarcerated|0|||
130573119|NCT01995071|470064183|FG002|Overall Study|Incarcerated|0|||
130573120|NCT01995071|470064184|FG003|Overall Study|Incarcerated|0|||
130573121|NCT01995071|470064185|FG004|Overall Study|Incarcerated|0|||
130573122|NCT01995071|470064186|FG005|Overall Study|Incarcerated|0|||
130573123|NCT01995071|470064187|FG006|Overall Study|Incarcerated|0|||
130573124|NCT01995071|470064188|FG007|Overall Study|Incarcerated|1|||
130573125|NCT01995071|470064189|FG008|Overall Study|Incarcerated|0|||
130573126|NCT01995071|470064190|FG009|Overall Study|Incarcerated|0|||
130573127|NCT01995071|470064191|FG010|Overall Study|Incarcerated|0|||
130573128|NCT01995071|470064192|FG011|Overall Study|Incarcerated|0|||
130573129|NCT00328627|470064193|FG000|Overall Study|Hyperglycemic Rescue|41|||
130573130|NCT00328627|470064194|FG001|Overall Study|Hyperglycemic Rescue|18|||
130573131|NCT00328627|470064195|FG002|Overall Study|Hyperglycemic Rescue|16|||
130573132|NCT00328627|470064196|FG003|Overall Study|Hyperglycemic Rescue|13|||
130573133|NCT00328627|470064197|FG004|Overall Study|Hyperglycemic Rescue|6|||
130573134|NCT00328627|470064198|FG005|Overall Study|Hyperglycemic Rescue|5|||
130573135|NCT00328627|470064199|FG006|Overall Study|Hyperglycemic Rescue|19|||
130573136|NCT00328627|470064200|FG007|Overall Study|Hyperglycemic Rescue|6|||
130573137|NCT00328627|470064201|FG008|Overall Study|Hyperglycemic Rescue|6|||
130573138|NCT00328627|470064202|FG009|Overall Study|Hyperglycemic Rescue|11|||
130573139|NCT00328627|470064203|FG010|Overall Study|Hyperglycemic Rescue|3|||
130573140|NCT00328627|470064204|FG011|Overall Study|Hyperglycemic Rescue|2|||
130573141|NCT00328627|470064193|FG000|Overall Study|Adverse Event|3|||
130573142|NCT00328627|470064194|FG001|Overall Study|Adverse Event|1|||
130573143|NCT00328627|470064195|FG002|Overall Study|Adverse Event|2|||
130573144|NCT00328627|470064196|FG003|Overall Study|Adverse Event|3|||
130573145|NCT00328627|470064197|FG004|Overall Study|Adverse Event|1|||
130573146|NCT00328627|470064198|FG005|Overall Study|Adverse Event|2|||
130573147|NCT00328627|470064199|FG006|Overall Study|Adverse Event|1|||
130573148|NCT00328627|470064200|FG007|Overall Study|Adverse Event|2|||
130573149|NCT00328627|470064201|FG008|Overall Study|Adverse Event|0|||
130573150|NCT00328627|470064202|FG009|Overall Study|Adverse Event|7|||
130573151|NCT00328627|470064203|FG010|Overall Study|Adverse Event|5|||
130573152|NCT00328627|470064204|FG011|Overall Study|Adverse Event|4|||
130573153|NCT00328627|470064193|FG000|Overall Study|Protocol Violation|2|||
130573154|NCT00328627|470064194|FG001|Overall Study|Protocol Violation|2|||
130573155|NCT00328627|470064195|FG002|Overall Study|Protocol Violation|2|||
130573156|NCT00328627|470064196|FG003|Overall Study|Protocol Violation|8|||
130573157|NCT00328627|470064197|FG004|Overall Study|Protocol Violation|5|||
130573158|NCT00328627|470064198|FG005|Overall Study|Protocol Violation|5|||
130573159|NCT00328627|470064199|FG006|Overall Study|Protocol Violation|6|||
130573160|NCT00328627|470064200|FG007|Overall Study|Protocol Violation|2|||
130573161|NCT00328627|470064201|FG008|Overall Study|Protocol Violation|1|||
130573162|NCT00328627|470064202|FG009|Overall Study|Protocol Violation|4|||
130573163|NCT00328627|470064203|FG010|Overall Study|Protocol Violation|6|||
130573164|NCT00328627|470064204|FG011|Overall Study|Protocol Violation|2|||
130573165|NCT00328627|470064193|FG000|Overall Study|Lost to Follow-up|4|||
130573166|NCT00328627|470064194|FG001|Overall Study|Lost to Follow-up|2|||
130573167|NCT00328627|470064195|FG002|Overall Study|Lost to Follow-up|2|||
130573168|NCT00328627|470064196|FG003|Overall Study|Lost to Follow-up|4|||
130573169|NCT00328627|470064197|FG004|Overall Study|Lost to Follow-up|0|||
130573170|NCT00328627|470064198|FG005|Overall Study|Lost to Follow-up|2|||
130573171|NCT00328627|470064199|FG006|Overall Study|Lost to Follow-up|3|||
130573172|NCT00328627|470064200|FG007|Overall Study|Lost to Follow-up|0|||
130573173|NCT00328627|470064201|FG008|Overall Study|Lost to Follow-up|3|||
130573174|NCT00328627|470064202|FG009|Overall Study|Lost to Follow-up|2|||
130573175|NCT00328627|470064203|FG010|Overall Study|Lost to Follow-up|0|||
130573176|NCT00328627|470064204|FG011|Overall Study|Lost to Follow-up|1|||
130573177|NCT00328627|470064193|FG000|Overall Study|Withdrawal by Subject|5|||
130573178|NCT00328627|470064194|FG001|Overall Study|Withdrawal by Subject|4|||
130573179|NCT00328627|470064195|FG002|Overall Study|Withdrawal by Subject|5|||
130573180|NCT00328627|470064196|FG003|Overall Study|Withdrawal by Subject|6|||
130573181|NCT00328627|470064197|FG004|Overall Study|Withdrawal by Subject|2|||
130573182|NCT00328627|470064198|FG005|Overall Study|Withdrawal by Subject|5|||
130573183|NCT00328627|470064199|FG006|Overall Study|Withdrawal by Subject|4|||
130573184|NCT00328627|470064200|FG007|Overall Study|Withdrawal by Subject|4|||
130573185|NCT00328627|470064201|FG008|Overall Study|Withdrawal by Subject|4|||
130573186|NCT00328627|470064202|FG009|Overall Study|Withdrawal by Subject|5|||
130573187|NCT00328627|470064203|FG010|Overall Study|Withdrawal by Subject|2|||
130573188|NCT00328627|470064204|FG011|Overall Study|Withdrawal by Subject|7|||
130573189|NCT00328627|470064193|FG000|Overall Study|Pregnancy|0|||
130573190|NCT00328627|470064194|FG001|Overall Study|Pregnancy|1|||
130573191|NCT00328627|470064195|FG002|Overall Study|Pregnancy|0|||
130573192|NCT00328627|470064196|FG003|Overall Study|Pregnancy|0|||
130573193|NCT00328627|470064197|FG004|Overall Study|Pregnancy|0|||
130573194|NCT00328627|470064198|FG005|Overall Study|Pregnancy|0|||
130573195|NCT00328627|470064199|FG006|Overall Study|Pregnancy|0|||
130573196|NCT00328627|470064200|FG007|Overall Study|Pregnancy|0|||
130573197|NCT00328627|470064201|FG008|Overall Study|Pregnancy|0|||
130573198|NCT00328627|470064202|FG009|Overall Study|Pregnancy|0|||
130573199|NCT00328627|470064203|FG010|Overall Study|Pregnancy|0|||
130573200|NCT00328627|470064204|FG011|Overall Study|Pregnancy|0|||
130573201|NCT00328627|470064193|FG000|Overall Study|Physician Decision|4|||
130573202|NCT00328627|470064194|FG001|Overall Study|Physician Decision|3|||
130573203|NCT00328627|470064195|FG002|Overall Study|Physician Decision|1|||
130573204|NCT00328627|470064196|FG003|Overall Study|Physician Decision|2|||
130573205|NCT00328627|470064197|FG004|Overall Study|Physician Decision|1|||
130573206|NCT00328627|470064198|FG005|Overall Study|Physician Decision|1|||
130573207|NCT00328627|470064199|FG006|Overall Study|Physician Decision|1|||
130573208|NCT00328627|470064200|FG007|Overall Study|Physician Decision|0|||
130573209|NCT00328627|470064201|FG008|Overall Study|Physician Decision|3|||
130573210|NCT00328627|470064202|FG009|Overall Study|Physician Decision|2|||
130573211|NCT00328627|470064203|FG010|Overall Study|Physician Decision|1|||
130573212|NCT00328627|470064204|FG011|Overall Study|Physician Decision|0|||
130573213|NCT00328627|470064193|FG000|Overall Study|Other|0|||
130573214|NCT00328627|470064194|FG001|Overall Study|Other|0|||
130573215|NCT00328627|470064195|FG002|Overall Study|Other|0|||
130573216|NCT00328627|470064196|FG003|Overall Study|Other|1|||
130573217|NCT00328627|470064197|FG004|Overall Study|Other|0|||
130573218|NCT00328627|470064198|FG005|Overall Study|Other|0|||
130573219|NCT00328627|470064199|FG006|Overall Study|Other|1|||
130573220|NCT00328627|470064200|FG007|Overall Study|Other|0|||
130573221|NCT00328627|470064201|FG008|Overall Study|Other|0|||
130573222|NCT00328627|470064202|FG009|Overall Study|Other|1|||
130573223|NCT00328627|470064203|FG010|Overall Study|Other|1|||
130573224|NCT00328627|470064204|FG011|Overall Study|Other|0|||
130573225|NCT00112905|470064205|FG000|Overall Study|Adverse Event|4|||
130573226|NCT00112905|470064205|FG000|Overall Study|Death|1|||
130573227|NCT00112905|470064205|FG000|Overall Study|Ineligibility|5|||
130573228|NCT00112905|470064205|FG000|Overall Study|Alternative treatment|1|||
130573229|NCT00112905|470064205|FG000|Overall Study|performance status was deteiorating|1|||
130573230|NCT02600507|470064206|FG000|Overall Study|Adverse Event|3|||
130573231|NCT02600507|470064207|FG001|Overall Study|Adverse Event|15|||
130573232|NCT02600507|470064208|FG002|Overall Study|Adverse Event|5|||
130573233|NCT02600507|470064206|FG000|Overall Study|Lack of Efficacy|3|||
130573234|NCT02600507|470064207|FG001|Overall Study|Lack of Efficacy|8|||
130573235|NCT02600507|470064208|FG002|Overall Study|Lack of Efficacy|5|||
130573236|NCT02600507|470064206|FG000|Overall Study|Lost to Follow-up|3|||
130573237|NCT02600507|470064207|FG001|Overall Study|Lost to Follow-up|5|||
130573238|NCT02600507|470064208|FG002|Overall Study|Lost to Follow-up|2|||
130573239|NCT02600507|470064206|FG000|Overall Study|Protocol Violation|12|||
130573240|NCT02600507|470064207|FG001|Overall Study|Protocol Violation|4|||
130573241|NCT02600507|470064208|FG002|Overall Study|Protocol Violation|4|||
130573242|NCT02600507|470064206|FG000|Overall Study|Physician Decision|1|||
130573243|NCT02600507|470064207|FG001|Overall Study|Physician Decision|0|||
130573244|NCT02600507|470064208|FG002|Overall Study|Physician Decision|1|||
130573245|NCT02600507|470064206|FG000|Overall Study|Withdrawal by Subject|7|||
130573246|NCT02600507|470064207|FG001|Overall Study|Withdrawal by Subject|11|||
130573247|NCT02600507|470064208|FG002|Overall Study|Withdrawal by Subject|7|||
130573248|NCT02600507|470064206|FG000|Overall Study|Other|0|||
130573249|NCT02600507|470064207|FG001|Overall Study|Other|1|||
130573250|NCT02600507|470064208|FG002|Overall Study|Other|1|||
130573251|NCT00605085|470064214|FG000|Overall Study|Withdrawal by Subject|8|||
130573252|NCT00605085|470064215|FG001|Overall Study|Withdrawal by Subject|5|||
130573253|NCT00605085|470064214|FG000|Overall Study|Adverse Event|9|||
130573254|NCT00605085|470064215|FG001|Overall Study|Adverse Event|5|||
130573255|NCT00605085|470064214|FG000|Overall Study|Pregnancy|2|||
130573256|NCT00605085|470064215|FG001|Overall Study|Pregnancy|0|||
130573257|NCT00605085|470064214|FG000|Overall Study|Protocol Violation|3|||
130573258|NCT00605085|470064215|FG001|Overall Study|Protocol Violation|2|||
130573259|NCT00605085|470064214|FG000|Overall Study|Lost to Follow-up|10|||
130573260|NCT00605085|470064215|FG001|Overall Study|Lost to Follow-up|5|||
130573261|NCT00605085|470064214|FG000|Overall Study|administrative reasons|18|||
130573262|NCT00605085|470064215|FG001|Overall Study|administrative reasons|8|||
130573263|NCT00621504|470064216|FG000|Overall Study|Adverse Event|1|||
130573264|NCT00621504|470064217|FG001|Overall Study|Adverse Event|3|||
130573265|NCT00621504|470064216|FG000|Overall Study|At the request of sponsor/investigator|1|||
130573266|NCT00621504|470064217|FG001|Overall Study|At the request of sponsor/investigator|0|||
130573267|NCT00621504|470064216|FG000|Overall Study|Withdrew consent|9|||
130573268|NCT00621504|470064217|FG001|Overall Study|Withdrew consent|6|||
130573269|NCT00621504|470064216|FG000|Overall Study|Lost to Follow-up|8|||
130573270|NCT00621504|470064217|FG001|Overall Study|Lost to Follow-up|10|||
130573271|NCT00621504|470064216|FG000|Overall Study|Other|1|||
130573272|NCT00621504|470064217|FG001|Overall Study|Other|0|||
130573273|NCT00621504|470064216|FG000|Overall Study|Death|6|||
130573274|NCT00621504|470064217|FG001|Overall Study|Death|6|||
130573275|NCT03311711|470064222|FG000|Overall Study|Death|1|||
130573276|NCT03311711|470064223|FG001|Overall Study|Death|0|||
130573277|NCT03311711|470064224|FG002|Overall Study|Death|0|||
130573278|NCT03311711|470064225|FG003|Overall Study|Death|0|||
130573279|NCT03311711|470064226|FG004|Overall Study|Death|0|||
130573280|NCT03311711|470064227|FG005|Overall Study|Death|0|||
130573281|NCT03311711|470064228|FG006|Overall Study|Death|1|||
130573282|NCT03311711|470064229|FG007|Overall Study|Death|0|||
130573283|NCT03311711|470064230|FG008|Overall Study|Death|1|||
130573284|NCT03311711|470064231|FG009|Overall Study|Death|0|||
130573285|NCT03311711|470064222|FG000|Overall Study|Death of dyad partner|0|||
130573286|NCT03311711|470064223|FG001|Overall Study|Death of dyad partner|1|||
130573287|NCT03311711|470064224|FG002|Overall Study|Death of dyad partner|0|||
130573288|NCT03311711|470064225|FG003|Overall Study|Death of dyad partner|0|||
130573289|NCT03311711|470064226|FG004|Overall Study|Death of dyad partner|0|||
130573290|NCT03311711|470064227|FG005|Overall Study|Death of dyad partner|0|||
130573291|NCT03311711|470064228|FG006|Overall Study|Death of dyad partner|0|||
130573292|NCT03311711|470064229|FG007|Overall Study|Death of dyad partner|1|||
130573293|NCT03311711|470064230|FG008|Overall Study|Death of dyad partner|0|||
130573294|NCT03311711|470064231|FG009|Overall Study|Death of dyad partner|1|||
130519845|NCT02604342|469870455|FG001|Overall Study|Withdrawal by Subject|6|||
130519846|NCT02604342|469870454|FG000|Overall Study|Other|1|||
130519847|NCT02604342|469870455|FG001|Overall Study|Other|0|||
130519848|NCT02604342|469870454|FG000|Overall Study|Study Termination by Sponsor|1|||
130519849|NCT02604342|469870455|FG001|Overall Study|Study Termination by Sponsor|0|||
130519850|NCT02604342|469870454|FG000|Overall Study|Lost to Follow-up|1|||
130519851|NCT02604342|469870455|FG001|Overall Study|Lost to Follow-up|1|||
130519852|NCT02604342|469870454|FG000|Overall Study|Physician Decision|2|||
130519853|NCT02604342|469870455|FG001|Overall Study|Physician Decision|0|||
130519854|NCT00130728|469870456|FG000|Overall Study|Death|258|||
130519855|NCT00130728|469870457|FG001|Overall Study|Death|258|||
130519856|NCT00130728|469870456|FG000|Overall Study|Lost to Follow-up|4|||
130519857|NCT00130728|469870457|FG001|Overall Study|Lost to Follow-up|0|||
130519858|NCT00130728|469870456|FG000|Overall Study|Withdrawal by Subject|0|||
130519859|NCT00130728|469870457|FG001|Overall Study|Withdrawal by Subject|2|||
130519860|NCT00746356|469870458|FG000|Overall Study|Withdrawal by Subject|2|||
130519861|NCT00746356|469870459|FG001|Overall Study|Withdrawal by Subject|3|||
130519862|NCT00746356|469870458|FG000|Overall Study|Death|7|||
130519863|NCT00746356|469870459|FG001|Overall Study|Death|3|||
130519864|NCT00746356|469870458|FG000|Overall Study|Lost to Follow-up|1|||
130519865|NCT00746356|469870459|FG001|Overall Study|Lost to Follow-up|0|||
130519866|NCT00746356|469870458|FG000|Overall Study|Removal of Device|0|||
130519867|NCT00746356|469870459|FG001|Overall Study|Removal of Device|1|||
130519868|NCT00746356|469870458|FG000|Overall Study|Patient relocated|1|||
130519869|NCT00746356|469870459|FG001|Overall Study|Patient relocated|0|||
130519870|NCT02881047|469870462|FG000|Overall Study|Adverse Event|1|||
130519871|NCT02881047|469870462|FG000|Overall Study|Withdrawal by Subject|1|||
130519872|NCT01203956|469870468|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
130519873|NCT01203956|469870469|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
130519874|NCT02230306|469870470|FG000|Overall Study|Did not receive study treatment|1|||
130519875|NCT01503164|469870474|FG000|Overall Study|Withdrawal by Subject|2|||
130519876|NCT01503164|469870475|FG001|Overall Study|Withdrawal by Subject|1|||
130519877|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
130519878|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
130519879|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
130519880|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
130519881|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
130519882|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
130519883|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
130519884|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
130519885|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
130519886|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
130519887|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
130519888|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
130519889|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
130519890|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
130519891|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
130519892|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
130519893|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
130519894|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
130519895|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
130519896|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
130519897|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
130519898|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
130573295|NCT03311711|470064222|FG000|Overall Study|Lost to Follow-up|2|||
130519899|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
130519900|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
130519901|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
130519902|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
130519903|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
130519904|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
130519905|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
130519906|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
130519907|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
130519908|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
130519909|NCT00092521|469872146|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
130519910|NCT00092521|469872147|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
130519911|NCT00092521|469872148|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
130519912|NCT00092521|469872149|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
130519913|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
130519914|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
130573296|NCT03311711|470064223|FG001|Overall Study|Lost to Follow-up|2|||
130573297|NCT03311711|470064224|FG002|Overall Study|Lost to Follow-up|0|||
130573298|NCT03311711|470064225|FG003|Overall Study|Lost to Follow-up|0|||
130519915|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
130519916|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
130519917|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
130519918|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
130519919|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
130519920|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
130519921|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
130519922|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
130519923|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
130519924|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
130519925|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Death|2|||
130519926|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Death|0|||
130519927|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Death|1|||
130519928|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Death|0|||
130519929|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
130519930|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
130519931|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
130519932|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
130519933|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
130519934|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
130519935|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
130519936|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
130519937|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
130519938|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
130519939|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
130519940|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
130519941|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Moved|32|||
130519942|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Moved|2|||
130519943|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Moved|28|||
130519944|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Moved|0|||
130519945|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
130519946|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
130519947|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
130519948|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
130519949|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Travel|2|||
130519950|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Travel|0|||
130519951|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Travel|0|||
130519952|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Travel|0|||
130519953|NCT00092521|469872146|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
130519954|NCT00092521|469872147|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
130519955|NCT00092521|469872148|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
130519956|NCT00092521|469872149|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
130519957|NCT00092521|469872146|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
130519958|NCT00092521|469872147|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
130519959|NCT00092521|469872148|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
130519960|NCT00092521|469872149|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
130519961|NCT00092521|469872146|FG000|Extension Study (Group 4)|Adverse Event|0|||
130519962|NCT00092521|469872147|FG001|Extension Study (Group 4)|Adverse Event|0|||
130573299|NCT03311711|470064226|FG004|Overall Study|Lost to Follow-up|0|||
130573300|NCT03311711|470064227|FG005|Overall Study|Lost to Follow-up|0|||
130573301|NCT03311711|470064228|FG006|Overall Study|Lost to Follow-up|1|||
130573302|NCT03311711|470064229|FG007|Overall Study|Lost to Follow-up|1|||
130573303|NCT03311711|470064230|FG008|Overall Study|Lost to Follow-up|0|||
130573304|NCT03311711|470064231|FG009|Overall Study|Lost to Follow-up|0|||
130573305|NCT03311711|470064222|FG000|Overall Study|Withdrawal by Subject|1|||
130573306|NCT03311711|470064223|FG001|Overall Study|Withdrawal by Subject|1|||
130573307|NCT03311711|470064224|FG002|Overall Study|Withdrawal by Subject|0|||
130573308|NCT03311711|470064225|FG003|Overall Study|Withdrawal by Subject|0|||
130573309|NCT03311711|470064226|FG004|Overall Study|Withdrawal by Subject|0|||
130573310|NCT03311711|470064227|FG005|Overall Study|Withdrawal by Subject|0|||
130573311|NCT03311711|470064228|FG006|Overall Study|Withdrawal by Subject|3|||
130519963|NCT00092521|469872148|FG002|Extension Study (Group 4)|Adverse Event|0|||
130519964|NCT00092521|469872149|FG003|Extension Study (Group 4)|Adverse Event|2|||
130519965|NCT00092521|469872146|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
130519966|NCT00092521|469872147|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
130519967|NCT00092521|469872148|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
130519968|NCT00092521|469872149|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
130573312|NCT03311711|470064229|FG007|Overall Study|Withdrawal by Subject|3|||
130573313|NCT03311711|470064230|FG008|Overall Study|Withdrawal by Subject|0|||
130519969|NCT00092521|469872146|FG000|Extension Study (Group 4)|Pregnancy|0|||
130519970|NCT00092521|469872147|FG001|Extension Study (Group 4)|Pregnancy|0|||
130519971|NCT00092521|469872148|FG002|Extension Study (Group 4)|Pregnancy|0|||
130519972|NCT00092521|469872149|FG003|Extension Study (Group 4)|Pregnancy|4|||
130519973|NCT00092521|469872146|FG000|Extension Study (Group 4)|Protocol Violation|0|||
130519974|NCT00092521|469872147|FG001|Extension Study (Group 4)|Protocol Violation|0|||
130519975|NCT00092521|469872148|FG002|Extension Study (Group 4)|Protocol Violation|0|||
130519976|NCT00092521|469872149|FG003|Extension Study (Group 4)|Protocol Violation|2|||
130519977|NCT00092521|469872146|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
130519978|NCT00092521|469872147|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
130519979|NCT00092521|469872148|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
130519980|NCT00092521|469872149|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
130519981|NCT00092521|469872146|FG000|Extension Study (Group 4)|Moved|0|||
130519982|NCT00092521|469872147|FG001|Extension Study (Group 4)|Moved|0|||
130519983|NCT00092521|469872148|FG002|Extension Study (Group 4)|Moved|0|||
130519984|NCT00092521|469872149|FG003|Extension Study (Group 4)|Moved|16|||
130519985|NCT00092521|469872146|FG000|Extension Study (Group 4)|Site Terminated|0|||
130519986|NCT00092521|469872147|FG001|Extension Study (Group 4)|Site Terminated|0|||
130519987|NCT00092521|469872148|FG002|Extension Study (Group 4)|Site Terminated|0|||
130519988|NCT00092521|469872149|FG003|Extension Study (Group 4)|Site Terminated|4|||
130519989|NCT00092521|469872146|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
130519990|NCT00092521|469872147|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
130519991|NCT00092521|469872148|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
130519992|NCT00092521|469872149|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
130519993|NCT03464383|469872150|FG000|Overall Study|Lost to Follow-up|1|||
130519994|NCT03464383|469872151|FG001|Overall Study|Lost to Follow-up|0|||
130519995|NCT03464383|469872152|FG002|Overall Study|Lost to Follow-up|0|||
130519996|NCT03464383|469872150|FG000|Overall Study|Withdrawal by Subject|0|||
130519997|NCT03464383|469872151|FG001|Overall Study|Withdrawal by Subject|1|||
130519998|NCT03464383|469872152|FG002|Overall Study|Withdrawal by Subject|0|||
130519999|NCT00605566|469872153|FG000|Overall Study|Adverse Event|1|||
130573314|NCT03311711|470064231|FG009|Overall Study|Withdrawal by Subject|0|||
130573315|NCT01623271|470064236|FG000|Overall Study|Withdrawal by Subject|2|||
130573316|NCT01339559|470064238|FG000|Overall Study|Adverse Event|92|||
130573317|NCT01339559|470064238|FG000|Overall Study|Death|5|||
130573318|NCT01339559|470064238|FG000|Overall Study|Lack of Efficacy|164|||
130573319|NCT01339559|470064238|FG000|Overall Study|Lost to Follow-up|22|||
130573320|NCT01339559|470064238|FG000|Overall Study|Subject choice|89|||
130573321|NCT01339559|470064238|FG000|Overall Study|Protocol Violation|15|||
130573322|NCT01339559|470064238|FG000|Overall Study|Study closure at site|1|||
130573323|NCT01339559|470064238|FG000|Overall Study|Incarcerated|2|||
130573324|NCT01339559|470064238|FG000|Overall Study|Epilepsy surgery|1|||
130573325|NCT01339559|470064238|FG000|Overall Study|Pregnancy planned|2|||
130573326|NCT01339559|470064238|FG000|Overall Study|Left the country|1|||
130573327|NCT01339559|470064238|FG000|Overall Study|Investigator decision|2|||
130573328|NCT01339559|470064238|FG000|Overall Study|Patient didn't wish to continue|1|||
130573329|NCT01339559|470064238|FG000|Overall Study|PI decision|1|||
130573330|NCT01137773|470064241|FG000|Overall Study|Death|3|||
130573331|NCT01137773|470064242|FG001|Overall Study|Death|3|||
130573332|NCT01137773|470064241|FG000|Overall Study|Lost to Follow-up|6|||
130573333|NCT01137773|470064242|FG001|Overall Study|Lost to Follow-up|0|||
130573334|NCT03548051|470064243|FG000|Overall Study|Death|1|||
130573335|NCT03548051|470064244|FG001|Overall Study|Death|1|||
130573336|NCT03548051|470064243|FG000|Overall Study|Withdrawal by Subject|1|||
130573337|NCT03548051|470064244|FG001|Overall Study|Withdrawal by Subject|0|||
130573338|NCT01745146|470064245|FG000|Overall Study|Withdrawal by Subject|1|||
130520000|NCT00605566|469872153|FG000|Overall Study|Clinical deterioration|1|||
130520001|NCT00605566|469872153|FG000|Overall Study|Poor compliance in run-in period|1|||
130573339|NCT01745146|470064246|FG001|Overall Study|Withdrawal by Subject|3|||
130573340|NCT01745146|470064245|FG000|Overall Study|Lost to Follow-up|2|||
130573341|NCT01745146|470064246|FG001|Overall Study|Lost to Follow-up|0|||
130573342|NCT02684981|470064247|FG000|Overall Study|Permanently discontinued the treatment|157|||
130573343|NCT02684981|470064248|FG001|Overall Study|Permanently discontinued the treatment|161|||
130573344|NCT02684981|470064249|FG002|Overall Study|Permanently discontinued the treatment|110|||
130573345|NCT02684981|470064247|FG000|Overall Study|Other|83|||
130573346|NCT02684981|470064248|FG001|Overall Study|Other|49|||
130573347|NCT02684981|470064249|FG002|Overall Study|Other|17|||
130573348|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
130573349|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130573350|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130520002|NCT00695136|469872161|FG000|Overall Study|Withdrawal by Subject|1|||
130520003|NCT00695136|469872161|FG000|Overall Study|unrelated adverse event|1|||
130520004|NCT02826798|469872163|FG000|Overall Study|Withdrawal by Subject|0|||
130520005|NCT02826798|469872164|FG001|Overall Study|Withdrawal by Subject|1|||
130520006|NCT02826798|469872165|FG002|Overall Study|Withdrawal by Subject|0|||
130520007|NCT02826798|469872166|FG003|Overall Study|Withdrawal by Subject|1|||
130573351|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130573352|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
130573353|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130573354|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130573355|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130573356|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
130573357|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130573358|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130573359|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130573360|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
130573361|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130573362|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130573363|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130573364|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
130573365|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
130573366|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
130573367|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
130573368|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
130573369|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130573370|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130573371|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130573372|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
130573373|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130573374|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130573375|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130573376|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
130573377|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130573378|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130573379|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130573380|NCT03605680|470064251|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
130573381|NCT03605680|470064252|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130573382|NCT03605680|470064253|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130573383|NCT03605680|470064254|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130573384|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
130573385|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
130573386|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
130573387|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
130573388|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
130573389|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
130573390|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
130573391|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
130573392|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130573393|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130573394|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130573395|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130573396|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130573397|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130573398|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
130573399|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130573400|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
130573401|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
130573402|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
130573403|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
130573404|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
130573405|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
130573406|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
130573407|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
130573408|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
130573409|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130573410|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130573411|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
130573412|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
130573413|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
130573414|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
130573415|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
130573416|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
130573417|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
130573418|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
130573419|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
130573420|NCT03605680|470064251|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
130573421|NCT03605680|470064252|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
130573422|NCT03605680|470064253|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
130573423|NCT03605680|470064254|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
130573424|NCT00488982|470064256|FG000|Course 1|Physician Decision|0|||
130573425|NCT00488982|470064257|FG001|Course 1|Physician Decision|2|||
130573426|NCT00488982|470064258|FG002|Course 1|Physician Decision|4|||
130573427|NCT00488982|470064256|FG000|Course 1|Withdrawal by Subject|0|||
130573428|NCT00488982|470064257|FG001|Course 1|Withdrawal by Subject|8|||
130573429|NCT00488982|470064258|FG002|Course 1|Withdrawal by Subject|2|||
130573430|NCT00488982|470064256|FG000|Course 1|nonprotocol therapy|0|||
130573431|NCT00488982|470064257|FG001|Course 1|nonprotocol therapy|2|||
130573432|NCT00488982|470064258|FG002|Course 1|nonprotocol therapy|2|||
130573433|NCT00488982|470064256|FG000|Course 1|Adverse Event|0|||
130573434|NCT00488982|470064257|FG001|Course 1|Adverse Event|0|||
130573435|NCT00488982|470064258|FG002|Course 1|Adverse Event|6|||
130573436|NCT03548558|470064259|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
130573437|NCT03548558|470064260|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
130573438|NCT03548558|470064261|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130573439|NCT03548558|470064262|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
130573440|NCT03548558|470064263|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130573441|NCT03548558|470064264|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130573442|NCT03548558|470064265|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130573443|NCT03548558|470064259|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
130573444|NCT03548558|470064260|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
130573445|NCT03548558|470064261|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
130573446|NCT03548558|470064262|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
130573447|NCT03548558|470064263|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
130573448|NCT03548558|470064264|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
130573449|NCT03548558|470064265|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
130573450|NCT03548558|470064259|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
130573451|NCT03548558|470064260|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
130573452|NCT03548558|470064261|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
130573453|NCT03548558|470064262|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
130573454|NCT03548558|470064263|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
130573455|NCT03548558|470064264|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
130573456|NCT03548558|470064265|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
130573457|NCT03548558|470064259|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130573458|NCT03548558|470064260|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130573459|NCT03548558|470064261|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130573460|NCT03548558|470064262|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130573461|NCT03548558|470064263|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
130573462|NCT03548558|470064264|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
130573463|NCT03548558|470064265|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
130573464|NCT03548558|470064259|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130573465|NCT03548558|470064260|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130573466|NCT03548558|470064261|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130573467|NCT03548558|470064262|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130573468|NCT03548558|470064263|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
130573469|NCT03548558|470064264|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
130573470|NCT03548558|470064265|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
130573471|NCT03548558|470064259|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130573472|NCT03548558|470064260|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130573473|NCT03548558|470064261|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130573474|NCT03548558|470064262|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130573475|NCT03548558|470064263|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
130573476|NCT03548558|470064264|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
130573477|NCT03548558|470064265|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
130573478|NCT03273166|470064271|FG000|Overall Study|Withdrawn prior to Completion|31|||
130520008|NCT02826798|469872167|FG004|Overall Study|Withdrawal by Subject|0|||
130520009|NCT02806505|469872168|FG000|Overall Study|Adverse event/intercurrent illness|1|||
130520010|NCT02806505|469872169|FG001|Overall Study|Adverse event/intercurrent illness|3|||
130520011|NCT02806505|469872168|FG000|Overall Study|Death|4|||
130520012|NCT02806505|469872169|FG001|Overall Study|Death|0|||
130520013|NCT02806505|469872168|FG000|Overall Study|Did not cooperate/refused treatment|3|||
130520014|NCT02806505|469872169|FG001|Overall Study|Did not cooperate/refused treatment|3|||
130520015|NCT02806505|469872168|FG000|Overall Study|Failure to return|0|||
130520016|NCT02806505|469872169|FG001|Overall Study|Failure to return|1|||
130520017|NCT02806505|469872168|FG000|Overall Study|Insufficient therapeutic response|2|||
130520018|NCT02806505|469872169|FG001|Overall Study|Insufficient therapeutic response|4|||
130520019|NCT01333111|469872172|FG000|Overall Study|patient undergoing major surgery|0|||
130520020|NCT01333111|469872173|FG001|Overall Study|patient undergoing major surgery|2|||
130520021|NCT01333111|469872174|FG002|Overall Study|patient undergoing major surgery|0|||
130520022|NCT01333111|469872172|FG000|Overall Study|personal reasons|0|||
130520023|NCT01333111|469872173|FG001|Overall Study|personal reasons|0|||
130520024|NCT01333111|469872174|FG002|Overall Study|personal reasons|1|||
130520025|NCT01333111|469872172|FG000|Overall Study|unclassified|1|||
130520026|NCT01333111|469872173|FG001|Overall Study|unclassified|0|||
130520027|NCT01333111|469872174|FG002|Overall Study|unclassified|0|||
130520028|NCT01333111|469872172|FG000|Overall Study|withdrawal criteria|0|||
130520029|NCT01333111|469872173|FG001|Overall Study|withdrawal criteria|1|||
130520030|NCT01333111|469872174|FG002|Overall Study|withdrawal criteria|0|||
130520031|NCT01333111|469872172|FG000|Overall Study|Non-compliance|1|||
130520032|NCT01333111|469872173|FG001|Overall Study|Non-compliance|0|||
130520033|NCT01333111|469872174|FG002|Overall Study|Non-compliance|0|||
130520034|NCT01333111|469872172|FG000|Overall Study|Ineffective therapy|0|||
130520035|NCT01333111|469872173|FG001|Overall Study|Ineffective therapy|0|||
130520036|NCT01333111|469872174|FG002|Overall Study|Ineffective therapy|1|||
130520037|NCT02161406|469872175|FG000|Overall Study|Death|2|||
130520038|NCT02161406|469872176|FG001|Overall Study|Death|1|||
130520039|NCT02161406|469872175|FG000|Overall Study|Lost to Follow-up|2|||
130520040|NCT02161406|469872176|FG001|Overall Study|Lost to Follow-up|1|||
130520041|NCT02161406|469872175|FG000|Overall Study|Withdrawal by Subject|2|||
130520042|NCT02161406|469872176|FG001|Overall Study|Withdrawal by Subject|4|||
130520043|NCT02161406|469872175|FG000|Overall Study|investigator withdrew subject|3|||
130520044|NCT02161406|469872176|FG001|Overall Study|investigator withdrew subject|1|||
130520045|NCT02161406|469872175|FG000|Overall Study|Lack of Efficacy|1|||
130520046|NCT02161406|469872176|FG001|Overall Study|Lack of Efficacy|1|||
130520047|NCT02161406|469872175|FG000|Overall Study|relocation|0|||
130520048|NCT02161406|469872176|FG001|Overall Study|relocation|1|||
130520049|NCT00664105|469872177|FG000|Overall Study|Death|3|||
130520050|NCT00664105|469872177|FG000|Overall Study|Withdrawal by Subject|5|||
130520051|NCT00664105|469872177|FG000|Overall Study|Adverse Event|9|||
130520052|NCT00664105|469872177|FG000|Overall Study|Disease progression|7|||
130520053|NCT04732871|469872178|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
130520054|NCT04732871|469872179|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
130520055|NCT04732871|469872180|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
130520056|NCT04732871|469872178|FG000|Overall Study|Lost to Follow-up|7|||
130520057|NCT04732871|469872179|FG001|Overall Study|Lost to Follow-up|4|||
130520058|NCT04732871|469872180|FG002|Overall Study|Lost to Follow-up|3|||
130520059|NCT04732871|469872178|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
130520060|NCT04732871|469872179|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
130520061|NCT04732871|469872180|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
130520062|NCT04732871|469872178|FG000|Overall Study|Migrated / moved from the study area|5|||
130520063|NCT04732871|469872179|FG001|Overall Study|Migrated / moved from the study area|0|||
130520064|NCT04732871|469872180|FG002|Overall Study|Migrated / moved from the study area|0|||
130520065|NCT04732871|469872178|FG000|Overall Study|Other|1|||
130520066|NCT04732871|469872179|FG001|Overall Study|Other|0|||
130520067|NCT04732871|469872180|FG002|Overall Study|Other|1|||
130520068|NCT04732871|469872178|FG000|Overall Study|Ongoing|6|||
130520069|NCT04732871|469872179|FG001|Overall Study|Ongoing|0|||
130520070|NCT04732871|469872180|FG002|Overall Study|Ongoing|1|||
130520071|NCT04732871|469872178|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
130520072|NCT04732871|469872179|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
130520073|NCT04732871|469872180|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
130520074|NCT02034162|469872183|FG000|Double-blind|Lost to Follow-up|3|||
130520075|NCT02034162|469872184|FG001|Double-blind|Lost to Follow-up|0|||
130520076|NCT02034162|469872185|FG002|Double-blind|Lost to Follow-up|0|||
130520077|NCT02034162|469872183|FG000|Double-blind|Physician Decision|1|||
130520078|NCT02034162|469872184|FG001|Double-blind|Physician Decision|0|||
130520079|NCT02034162|469872185|FG002|Double-blind|Physician Decision|0|||
130520080|NCT02034162|469872183|FG000|Double-blind|Protocol Violation|0|||
130520081|NCT02034162|469872184|FG001|Double-blind|Protocol Violation|1|||
130520082|NCT02034162|469872185|FG002|Double-blind|Protocol Violation|0|||
130520083|NCT02034162|469872183|FG000|Double-blind|Withdrawal by Subject|5|||
130520084|NCT02034162|469872184|FG001|Double-blind|Withdrawal by Subject|7|||
130520085|NCT02034162|469872185|FG002|Double-blind|Withdrawal by Subject|0|||
130520086|NCT03458728|469872187|FG000|Overall Study|Adverse Event|1|||
130520087|NCT03458728|469872188|FG001|Overall Study|Adverse Event|0|||
130520088|NCT03458728|469872187|FG000|Overall Study|Physician Decision|1|||
130520089|NCT03458728|469872188|FG001|Overall Study|Physician Decision|0|||
130520090|NCT03458728|469872187|FG000|Overall Study|Progressive disease - clinical assessment|1|||
130520091|NCT03458728|469872188|FG001|Overall Study|Progressive disease - clinical assessment|0|||
130520092|NCT03458728|469872187|FG000|Overall Study|Progressive disease - radiological progression|21|||
130520093|NCT03458728|469872188|FG001|Overall Study|Progressive disease - radiological progression|6|||
130520094|NCT03458728|469872187|FG000|Overall Study|Withdrawal by Subject|0|||
130520095|NCT03458728|469872188|FG001|Overall Study|Withdrawal by Subject|1|||
130520096|NCT00908349|469872192|FG000|Overall Study|Adverse Event|10|||
130520097|NCT00908349|469872192|FG000|Overall Study|Withdrawal by Subject|9|||
130520098|NCT00908349|469872192|FG000|Overall Study|Physician Decision|5|||
130520099|NCT00908349|469872192|FG000|Overall Study|Lost to Follow-up|5|||
130520100|NCT00908349|469872192|FG000|Overall Study|Various|6|||
130520101|NCT02624869|469872197|FG000|Overall Study|Lost to Follow-up|0|||
130520102|NCT02624869|469872198|FG001|Overall Study|Lost to Follow-up|0|||
130520103|NCT02624869|469872199|FG002|Overall Study|Lost to Follow-up|1|||
130520104|NCT02624869|469872197|FG000|Overall Study|Withdrawal by Subject|1|||
130520105|NCT02624869|469872198|FG001|Overall Study|Withdrawal by Subject|3|||
130520106|NCT02624869|469872199|FG002|Overall Study|Withdrawal by Subject|1|||
130520107|NCT03294941|469872201|FG000|Overall Study|Withdrawal by Subject|0|||
130520108|NCT03294941|469872202|FG001|Overall Study|Withdrawal by Subject|2|||
130520109|NCT03927690|469872203|FG000|Overall Study|Withdrawal by Subject|3|||
130520110|NCT03927690|469872204|FG001|Overall Study|Withdrawal by Subject|1|||
130520111|NCT03927690|469872205|FG002|Overall Study|Withdrawal by Subject|1|||
130520112|NCT03927690|469872203|FG000|Overall Study|Adverse Event|1|||
130520113|NCT03927690|469872204|FG001|Overall Study|Adverse Event|0|||
130520114|NCT03927690|469872205|FG002|Overall Study|Adverse Event|0|||
130520115|NCT03927690|469872203|FG000|Overall Study|Death|1|||
130520116|NCT03927690|469872204|FG001|Overall Study|Death|0|||
130520117|NCT03927690|469872205|FG002|Overall Study|Death|0|||
130520118|NCT03927690|469872203|FG000|Overall Study|Lost to Follow-up|2|||
130520119|NCT03927690|469872204|FG001|Overall Study|Lost to Follow-up|2|||
130520120|NCT03927690|469872205|FG002|Overall Study|Lost to Follow-up|1|||
130520121|NCT04051242|469872209|FG000|Overall Study|Withdrawal by Subject|1|||
130520122|NCT04051242|469872209|FG000|Overall Study|Physician Decision|1|||
130520123|NCT01202409|469872211|FG000|Overall Study|Adverse Event|1|||
130520124|NCT01202409|469872211|FG000|Overall Study|Ineligible - KRAS mutants|7|||
130520125|NCT00337285|469872212|FG000|Overall Study|Withdrawal by Subject|42|||
130520126|NCT00337285|469872212|FG000|Overall Study|Lost to Follow-up|41|||
130520127|NCT00337285|469872212|FG000|Overall Study|Adverse Event|28|||
130520128|NCT00337285|469872212|FG000|Overall Study|Protocol Violation|27|||
130520129|NCT00337285|469872212|FG000|Overall Study|Lack of Efficacy|11|||
130520130|NCT00337285|469872212|FG000|Overall Study|Death|1|||
130520131|NCT00337285|469872212|FG000|Overall Study|Physician Decision|1|||
130520132|NCT00337285|469872212|FG000|Overall Study|Lack of protocol compliance|7|||
130520133|NCT01774019|469872213|FG000|Overall Study|No longer meets protocol criteria|2|||
130520134|NCT01774019|469872214|FG001|Overall Study|No longer meets protocol criteria|0|||
130520135|NCT01774019|469872213|FG000|Overall Study|Withdrawal by Subject|1|||
130520136|NCT01774019|469872214|FG001|Overall Study|Withdrawal by Subject|0|||
130520137|NCT01774019|469872213|FG000|Overall Study|Surgery delayed > 120 days|1|||
130520138|NCT01774019|469872214|FG001|Overall Study|Surgery delayed > 120 days|0|||
130520139|NCT01774019|469872213|FG000|Overall Study|Patient refused surgery|1|||
130520140|NCT01774019|469872214|FG001|Overall Study|Patient refused surgery|1|||
130520141|NCT01774019|469872213|FG000|Overall Study|Unable to implant study device|1|||
130520142|NCT01774019|469872214|FG001|Overall Study|Unable to implant study device|0|||
130520143|NCT01774019|469872213|FG000|Overall Study|Lost to Follow-up|0|||
130520144|NCT01774019|469872214|FG001|Overall Study|Lost to Follow-up|3|||
130573479|NCT02669017|470064272|FG000|Overall Study|Death|1|||
130573480|NCT02669017|470064273|FG001|Overall Study|Death|2|||
130573481|NCT02669017|470064274|FG002|Overall Study|Death|2|||
130520145|NCT00553605|469872215|FG000|Overall Study|Did not meet entrance criteria|1|||
130520146|NCT00553605|469872216|FG001|Overall Study|Did not meet entrance criteria|3|||
130520147|NCT00553605|469872215|FG000|Overall Study|Did not receive full dose|1|||
130520148|NCT00553605|469872216|FG001|Overall Study|Did not receive full dose|0|||
130520149|NCT00553605|469872215|FG000|Overall Study|Randomized but not treated|2|||
130520150|NCT00553605|469872216|FG001|Overall Study|Randomized but not treated|0|||
130520151|NCT01004185|469872217|FG000|Overall Study|Adverse Event|1|||
130520152|NCT01004185|469872218|FG001|Overall Study|Adverse Event|1|||
130520153|NCT01004185|469872217|FG000|Overall Study|Lost to Follow-up|0|||
130520154|NCT01004185|469872218|FG001|Overall Study|Lost to Follow-up|1|||
130520155|NCT01004185|469872217|FG000|Overall Study|Lack of Efficacy|2|||
130520156|NCT01004185|469872218|FG001|Overall Study|Lack of Efficacy|1|||
130520157|NCT01004185|469872217|FG000|Overall Study|Sponsor Terminated Study|4|||
130520158|NCT01004185|469872218|FG001|Overall Study|Sponsor Terminated Study|5|||
130520159|NCT01004185|469872217|FG000|Overall Study|Withdrawal by Subject|2|||
130520160|NCT01004185|469872218|FG001|Overall Study|Withdrawal by Subject|1|||
130520161|NCT03481556|469872223|FG000|Overall Study|Adverse Event|1|||
130520162|NCT03481556|469872224|FG001|Overall Study|Adverse Event|0|||
130520163|NCT03481556|469872225|FG002|Overall Study|Adverse Event|0|||
130520164|NCT03481556|469872226|FG003|Overall Study|Adverse Event|0|||
130520165|NCT03481556|469872223|FG000|Overall Study|Death|4|||
130520166|NCT03481556|469872224|FG001|Overall Study|Death|2|||
130520167|NCT03481556|469872225|FG002|Overall Study|Death|3|||
130520168|NCT03481556|469872226|FG003|Overall Study|Death|16|||
130520169|NCT03481556|469872223|FG000|Overall Study|Study Terminated by Sponsor|10|||
130520170|NCT03481556|469872224|FG001|Overall Study|Study Terminated by Sponsor|5|||
130520171|NCT03481556|469872225|FG002|Overall Study|Study Terminated by Sponsor|2|||
130520172|NCT03481556|469872226|FG003|Overall Study|Study Terminated by Sponsor|9|||
130520173|NCT03463577|469872227|FG000|Overall Study|Lost to Follow-up|238|||
130520174|NCT03463577|469872228|FG001|Overall Study|Lost to Follow-up|435|||
130520175|NCT03463577|469872229|FG002|Overall Study|Lost to Follow-up|0|||
130520176|NCT03463577|469872230|FG003|Overall Study|Lost to Follow-up|0|||
130520177|NCT03463577|469872231|FG004|Overall Study|Lost to Follow-up|0|||
130520178|NCT03463577|469872232|FG005|Overall Study|Lost to Follow-up|0|||
130520179|NCT03463577|469872227|FG000|Overall Study|With unknown pregnancy outcome|0|||
130520180|NCT03463577|469872228|FG001|Overall Study|With unknown pregnancy outcome|5|||
130520181|NCT03463577|469872229|FG002|Overall Study|With unknown pregnancy outcome|0|||
130520182|NCT03463577|469872230|FG003|Overall Study|With unknown pregnancy outcome|0|||
130520183|NCT03463577|469872231|FG004|Overall Study|With unknown pregnancy outcome|0|||
130520184|NCT03463577|469872232|FG005|Overall Study|With unknown pregnancy outcome|0|||
130520185|NCT03463577|469872227|FG000|Overall Study|Maternal death|2|||
130520186|NCT03463577|469872228|FG001|Overall Study|Maternal death|0|||
130520187|NCT03463577|469872229|FG002|Overall Study|Maternal death|0|||
130520188|NCT03463577|469872230|FG003|Overall Study|Maternal death|0|||
130520189|NCT03463577|469872231|FG004|Overall Study|Maternal death|0|||
130520190|NCT03463577|469872232|FG005|Overall Study|Maternal death|0|||
130520191|NCT03463577|469872227|FG000|Overall Study|Neonatal death|0|||
130520192|NCT03463577|469872228|FG001|Overall Study|Neonatal death|0|||
130520193|NCT03463577|469872229|FG002|Overall Study|Neonatal death|0|||
130520194|NCT03463577|469872230|FG003|Overall Study|Neonatal death|15|||
130520195|NCT03463577|469872231|FG004|Overall Study|Neonatal death|17|||
130520196|NCT03463577|469872232|FG005|Overall Study|Neonatal death|0|||
130520197|NCT01085812|469872234|FG000|Open-Label Period|Adverse Event|0|||
130520198|NCT01085812|469872235|FG001|Open-Label Period|Adverse Event|80|||
130520199|NCT01085812|469872234|FG000|Open-Label Period|Lack of Efficacy|0|||
130520200|NCT01085812|469872235|FG001|Open-Label Period|Lack of Efficacy|26|||
130520201|NCT01085812|469872234|FG000|Open-Label Period|Protocol Violation|0|||
130520202|NCT01085812|469872235|FG001|Open-Label Period|Protocol Violation|39|||
130520203|NCT01085812|469872234|FG000|Open-Label Period|Withdrawal by Subject|0|||
130520204|NCT01085812|469872235|FG001|Open-Label Period|Withdrawal by Subject|53|||
130520205|NCT01085812|469872234|FG000|Open-Label Period|Lost to Follow-up|0|||
130520206|NCT01085812|469872235|FG001|Open-Label Period|Lost to Follow-up|42|||
130520207|NCT01085812|469872234|FG000|Double-Blind Period|Adverse Event|3|||
130520208|NCT01085812|469872235|FG001|Double-Blind Period|Adverse Event|8|||
130520209|NCT01085812|469872234|FG000|Double-Blind Period|Protocol Violation|2|||
130520210|NCT01085812|469872235|FG001|Double-Blind Period|Protocol Violation|7|||
130520211|NCT01085812|469872234|FG000|Double-Blind Period|Withdrawal by Subject|11|||
130520212|NCT01085812|469872235|FG001|Double-Blind Period|Withdrawal by Subject|24|||
130520213|NCT01085812|469872234|FG000|Double-Blind Period|Lost to Follow-up|5|||
130520214|NCT01085812|469872235|FG001|Double-Blind Period|Lost to Follow-up|17|||
130520215|NCT01085812|469872234|FG000|Double-Blind Period|Other Reasons|0|||
130520216|NCT01085812|469872235|FG001|Double-Blind Period|Other Reasons|2|||
130520217|NCT01085812|469872234|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
130520218|NCT01085812|469872235|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
130520219|NCT01085812|469872234|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
130520220|NCT01085812|469872235|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
130520221|NCT01085812|469872234|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
130520222|NCT01085812|469872235|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
130520223|NCT01085812|469872234|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
130520224|NCT01085812|469872235|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
130520225|NCT01085812|469872234|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
130520226|NCT01085812|469872235|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
130573482|NCT02669017|470064275|FG003|Overall Study|Death|3|||
130573483|NCT02669017|470064276|FG004|Overall Study|Death|8|||
130573484|NCT02669017|470064277|FG005|Overall Study|Death|18|||
130573485|NCT02669017|470064278|FG006|Overall Study|Death|10|||
130573486|NCT02669017|470064279|FG007|Overall Study|Death|47|||
130573487|NCT02669017|470064280|FG008|Overall Study|Death|20|||
130573488|NCT02669017|470064272|FG000|Overall Study|Withdrawal by Subject|0|||
130573489|NCT02669017|470064273|FG001|Overall Study|Withdrawal by Subject|0|||
130573490|NCT02669017|470064274|FG002|Overall Study|Withdrawal by Subject|0|||
130573491|NCT02669017|470064275|FG003|Overall Study|Withdrawal by Subject|1|||
130573492|NCT02669017|470064276|FG004|Overall Study|Withdrawal by Subject|2|||
130573493|NCT02669017|470064277|FG005|Overall Study|Withdrawal by Subject|0|||
130573494|NCT02669017|470064278|FG006|Overall Study|Withdrawal by Subject|0|||
130573495|NCT02669017|470064279|FG007|Overall Study|Withdrawal by Subject|2|||
130573496|NCT02669017|470064280|FG008|Overall Study|Withdrawal by Subject|2|||
130573497|NCT02669017|470064272|FG000|Overall Study|Lost to Follow-up|0|||
130573498|NCT02669017|470064273|FG001|Overall Study|Lost to Follow-up|0|||
130573499|NCT02669017|470064274|FG002|Overall Study|Lost to Follow-up|0|||
130573500|NCT02669017|470064275|FG003|Overall Study|Lost to Follow-up|0|||
130573501|NCT02669017|470064276|FG004|Overall Study|Lost to Follow-up|0|||
130573502|NCT02669017|470064277|FG005|Overall Study|Lost to Follow-up|0|||
130573503|NCT02669017|470064278|FG006|Overall Study|Lost to Follow-up|0|||
130573504|NCT02669017|470064279|FG007|Overall Study|Lost to Follow-up|0|||
130573505|NCT02669017|470064280|FG008|Overall Study|Lost to Follow-up|1|||
130573506|NCT02669017|470064272|FG000|Overall Study|Miscellaneous|0|||
130573507|NCT02669017|470064273|FG001|Overall Study|Miscellaneous|0|||
130573508|NCT02669017|470064274|FG002|Overall Study|Miscellaneous|0|||
130573509|NCT02669017|470064275|FG003|Overall Study|Miscellaneous|0|||
130573510|NCT02669017|470064276|FG004|Overall Study|Miscellaneous|2|||
130573511|NCT02669017|470064277|FG005|Overall Study|Miscellaneous|1|||
130573512|NCT02669017|470064278|FG006|Overall Study|Miscellaneous|1|||
130573513|NCT02669017|470064279|FG007|Overall Study|Miscellaneous|13|||
130573514|NCT02669017|470064280|FG008|Overall Study|Miscellaneous|2|||
130573515|NCT03509350|470064282|FG000|Overall Study|Withdrawal by Subject|0|||
130573516|NCT03509350|470064283|FG001|Overall Study|Withdrawal by Subject|2|||
130573517|NCT01425203|470064284|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
130573518|NCT01425203|470064285|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
130573519|NCT01425203|470064286|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
130573520|NCT01425203|470064284|FG000|Treatment Phase|Failure at futility timepoint|8|||
130573521|NCT01425203|470064285|FG001|Treatment Phase|Failure at futility timepoint|27|||
130573522|NCT01425203|470064286|FG002|Treatment Phase|Failure at futility timepoint|0|||
130573523|NCT01425203|470064284|FG000|Treatment Phase|Other virologic failure criteria|5|||
130573524|NCT01425203|470064285|FG001|Treatment Phase|Other virologic failure criteria|3|||
130573525|NCT01425203|470064286|FG002|Treatment Phase|Other virologic failure criteria|0|||
130573526|NCT01425203|470064284|FG000|Treatment Phase|Unidentified reasons|11|||
130573527|NCT01425203|470064285|FG001|Treatment Phase|Unidentified reasons|5|||
130573528|NCT01425203|470064286|FG002|Treatment Phase|Unidentified reasons|0|||
130573529|NCT01425203|470064284|FG000|Treatment Phase|Did not receive treatment|0|||
130573530|NCT01425203|470064285|FG001|Treatment Phase|Did not receive treatment|1|||
130573531|NCT01425203|470064286|FG002|Treatment Phase|Did not receive treatment|0|||
130573532|NCT01425203|470064284|FG000|Crossover Phase|Failure at futility timepoint|0|||
130573533|NCT01425203|470064285|FG001|Crossover Phase|Failure at futility timepoint|0|||
130573534|NCT01425203|470064286|FG002|Crossover Phase|Failure at futility timepoint|3|||
130573535|NCT01425203|470064284|FG000|Crossover Phase|Other virologic failure criteria|0|||
130573536|NCT01425203|470064285|FG001|Crossover Phase|Other virologic failure criteria|0|||
130573537|NCT01425203|470064286|FG002|Crossover Phase|Other virologic failure criteria|3|||
130573538|NCT00535132|470064289|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
130573539|NCT00535132|470064290|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
130573540|NCT00535132|470064289|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
130573541|NCT00535132|470064290|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
130573542|NCT00267748|470064293|FG000|Non-randomized Period|Progressive disease|10|||
130573543|NCT00267748|470064294|FG001|Non-randomized Period|Progressive disease|0|||
130573544|NCT00267748|470064295|FG002|Non-randomized Period|Progressive disease|0|||
130573545|NCT00267748|470064293|FG000|Non-randomized Period|Adverse Event|8|||
130573546|NCT00267748|470064294|FG001|Non-randomized Period|Adverse Event|0|||
130573547|NCT00267748|470064295|FG002|Non-randomized Period|Adverse Event|0|||
130573548|NCT00267748|470064293|FG000|Non-randomized Period|Death|1|||
130573549|NCT00267748|470064294|FG001|Non-randomized Period|Death|0|||
130573550|NCT00267748|470064295|FG002|Non-randomized Period|Death|0|||
130573551|NCT00267748|470064293|FG000|Non-randomized Period|Participant not willing to participate|1|||
130573552|NCT00267748|470064294|FG001|Non-randomized Period|Participant not willing to participate|0|||
130573553|NCT00267748|470064295|FG002|Non-randomized Period|Participant not willing to participate|0|||
130573554|NCT00267748|470064293|FG000|Non-randomized Period|Other|3|||
130573555|NCT00267748|470064294|FG001|Non-randomized Period|Other|0|||
130573556|NCT00267748|470064295|FG002|Non-randomized Period|Other|0|||
130573557|NCT00267748|470064293|FG000|Randomized Period|Death|0|||
130573558|NCT00267748|470064294|FG001|Randomized Period|Death|2|||
130573559|NCT00267748|470064295|FG002|Randomized Period|Death|3|||
130573560|NCT00267748|470064293|FG000|Randomized Period|Adverse Event|0|||
130573561|NCT00267748|470064294|FG001|Randomized Period|Adverse Event|23|||
130573562|NCT00267748|470064295|FG002|Randomized Period|Adverse Event|25|||
130573563|NCT00267748|470064293|FG000|Randomized Period|Global deterioration of health status|0|||
130573564|NCT00267748|470064294|FG001|Randomized Period|Global deterioration of health status|6|||
130573565|NCT00267748|470064295|FG002|Randomized Period|Global deterioration of health status|7|||
130573566|NCT00267748|470064293|FG000|Randomized Period|Lost to Follow-up|0|||
130573567|NCT00267748|470064294|FG001|Randomized Period|Lost to Follow-up|1|||
130573568|NCT00267748|470064295|FG002|Randomized Period|Lost to Follow-up|0|||
130573569|NCT00267748|470064293|FG000|Randomized Period|Objective progression or relapse|0|||
130573570|NCT00267748|470064294|FG001|Randomized Period|Objective progression or relapse|77|||
130573571|NCT00267748|470064295|FG002|Randomized Period|Objective progression or relapse|86|||
130573572|NCT00267748|470064293|FG000|Randomized Period|Withdrawal by Subject|0|||
130573573|NCT00267748|470064294|FG001|Randomized Period|Withdrawal by Subject|9|||
130573574|NCT00267748|470064295|FG002|Randomized Period|Withdrawal by Subject|2|||
130573575|NCT00267748|470064293|FG000|Randomized Period|Other|0|||
130573576|NCT00267748|470064294|FG001|Randomized Period|Other|9|||
130573577|NCT00267748|470064295|FG002|Randomized Period|Other|6|||
130573578|NCT00267748|470064293|FG000|Randomized Period|randomized but not treated|0|||
130573579|NCT00267748|470064294|FG001|Randomized Period|randomized but not treated|0|||
130573580|NCT00267748|470064295|FG002|Randomized Period|randomized but not treated|3|||
130573581|NCT01294800|470064296|FG000|Overall Study|Adverse Event|7|||
130573582|NCT01294800|470064297|FG001|Overall Study|Adverse Event|6|||
130573583|NCT01294800|470064298|FG002|Overall Study|Adverse Event|12|||
130573584|NCT01294800|470064299|FG003|Overall Study|Adverse Event|5|||
130573585|NCT01294800|470064296|FG000|Overall Study|Subject Withdrew Consent|2|||
130573586|NCT01294800|470064297|FG001|Overall Study|Subject Withdrew Consent|2|||
130573587|NCT01294800|470064298|FG002|Overall Study|Subject Withdrew Consent|2|||
130520227|NCT01101997|469872236|FG000|Overall Study|Withdrawal by Subject|2|||
130520228|NCT00496626|469872239|FG000|Overall Study|Lost to Follow-up|0|||
130520229|NCT00496626|469872240|FG001|Overall Study|Lost to Follow-up|1|||
130520230|NCT00496626|469872239|FG000|Overall Study|Protocol Violation|1|||
130520231|NCT00496626|469872240|FG001|Overall Study|Protocol Violation|0|||
130520232|NCT00496626|469872239|FG000|Overall Study|Withdrawal by Subject|5|||
130520233|NCT00496626|469872240|FG001|Overall Study|Withdrawal by Subject|4|||
130520234|NCT00496626|469872239|FG000|Overall Study|Relocated|0|||
130520235|NCT00496626|469872240|FG001|Overall Study|Relocated|1|||
130520236|NCT00727415|469872241|FG000|Phase I|Dose Limiting Toxicity|2|||
130520237|NCT00853229|469872243|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
130520238|NCT00853229|469872244|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
130520239|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
130520240|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
130520241|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
130520242|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
130520243|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
130520244|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
130520245|NCT03201900|469872248|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
130520246|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
130520247|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
130520248|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
130520249|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
130520250|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
130520251|NCT03201900|469872248|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
130520252|NCT00776659|469872252|FG000|Overall Study|Lost to Follow-up|15|||
130520253|NCT00776659|469872252|FG000|Overall Study|Withdrawal by Subject|10|||
130520254|NCT00776659|469872252|FG000|Overall Study|Study Terminated by Sponsor|1|||
130520255|NCT01233999|469872255|FG000|Overall Study|Withdrawal by Subject|1|||
130520256|NCT01233999|469872255|FG000|Overall Study|Lost to Follow-up|1|||
130520257|NCT01167192|469872256|FG000|Overall Study|Adverse Event|1|||
130573588|NCT01294800|470064299|FG003|Overall Study|Subject Withdrew Consent|11|||
130573589|NCT01294800|470064296|FG000|Overall Study|Lost to Follow-up|0|||
130573590|NCT01294800|470064297|FG001|Overall Study|Lost to Follow-up|0|||
130573591|NCT01294800|470064298|FG002|Overall Study|Lost to Follow-up|1|||
130520258|NCT01167192|469872256|FG000|Overall Study|Death|1|||
130520259|NCT01167192|469872256|FG000|Overall Study|Withdrawal by Subject|1|||
130520260|NCT01167192|469872256|FG000|Overall Study|Insurance denial|1|||
130520261|NCT00129649|469872259|FG000|Overall Study|Withdrawal by Subject|76|||
130573592|NCT01294800|470064299|FG003|Overall Study|Lost to Follow-up|0|||
130573593|NCT01294800|470064296|FG000|Overall Study|Non-compliance With Protocol|0|||
130573594|NCT01294800|470064297|FG001|Overall Study|Non-compliance With Protocol|1|||
130573595|NCT01294800|470064298|FG002|Overall Study|Non-compliance With Protocol|1|||
130573596|NCT01294800|470064299|FG003|Overall Study|Non-compliance With Protocol|0|||
130573597|NCT01294800|470064296|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
130573598|NCT01294800|470064297|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130573599|NCT01294800|470064298|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
130573600|NCT01294800|470064299|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
130573601|NCT02941627|470064301|FG000|Overall Study|Death|1|||
130573602|NCT02941627|470064301|FG000|Overall Study|Surgical failure|1|||
130573603|NCT02941627|470064301|FG000|Overall Study|cholesteatoma prevented implantation|1|||
130573604|NCT03594227|470064302|FG000|Overall Study|Adverse Event|2|||
130573605|NCT03594227|470064303|FG001|Overall Study|Adverse Event|1|||
130573606|NCT03594227|470064304|FG002|Overall Study|Adverse Event|0|||
130573607|NCT03594227|470064305|FG003|Overall Study|Adverse Event|2|||
130573608|NCT03594227|470064302|FG000|Overall Study|Lost to Follow-up|1|||
130573609|NCT03594227|470064303|FG001|Overall Study|Lost to Follow-up|1|||
130573610|NCT03594227|470064304|FG002|Overall Study|Lost to Follow-up|1|||
130573611|NCT03594227|470064305|FG003|Overall Study|Lost to Follow-up|0|||
130573612|NCT03594227|470064302|FG000|Overall Study|Withdrawal by Subject|1|||
130573613|NCT03594227|470064303|FG001|Overall Study|Withdrawal by Subject|1|||
130573614|NCT03594227|470064304|FG002|Overall Study|Withdrawal by Subject|1|||
130573615|NCT03594227|470064305|FG003|Overall Study|Withdrawal by Subject|1|||
130573616|NCT03594227|470064302|FG000|Overall Study|Pregnancy|0|||
130573617|NCT03594227|470064303|FG001|Overall Study|Pregnancy|1|||
130573618|NCT03594227|470064304|FG002|Overall Study|Pregnancy|0|||
130573619|NCT03594227|470064305|FG003|Overall Study|Pregnancy|0|||
130573620|NCT03594227|470064302|FG000|Overall Study|Sponsor Decision|0|||
130573621|NCT03594227|470064303|FG001|Overall Study|Sponsor Decision|0|||
130573622|NCT03594227|470064304|FG002|Overall Study|Sponsor Decision|0|||
130573623|NCT03594227|470064305|FG003|Overall Study|Sponsor Decision|1|||
130573624|NCT03594227|470064302|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
130573625|NCT03594227|470064303|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
130573626|NCT03594227|470064304|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
130573627|NCT03594227|470064305|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
130573628|NCT01888640|470064306|FG000|Overall Study|Lost to Follow-up|1|||
130573629|NCT01888640|470064307|FG001|Overall Study|Lost to Follow-up|2|||
130573630|NCT01888640|470064308|FG002|Overall Study|Lost to Follow-up|0|||
130573631|NCT01888640|470064306|FG000|Overall Study|Withdrawal by Subject|15|||
130573632|NCT01888640|470064307|FG001|Overall Study|Withdrawal by Subject|11|||
130573633|NCT01888640|470064308|FG002|Overall Study|Withdrawal by Subject|4|||
130573634|NCT01888640|470064306|FG000|Overall Study|Minimum dose not met|10|||
130573635|NCT01888640|470064307|FG001|Overall Study|Minimum dose not met|16|||
130573636|NCT01888640|470064308|FG002|Overall Study|Minimum dose not met|0|||
130573637|NCT01888640|470064306|FG000|Overall Study|Given wrong unit (placebo)|1|||
130573638|NCT01888640|470064307|FG001|Overall Study|Given wrong unit (placebo)|0|||
130573639|NCT01888640|470064308|FG002|Overall Study|Given wrong unit (placebo)|0|||
130573640|NCT01888640|470064306|FG000|Overall Study|Excluded for prior TENS|0|||
130573641|NCT01888640|470064307|FG001|Overall Study|Excluded for prior TENS|1|||
130573642|NCT01888640|470064308|FG002|Overall Study|Excluded for prior TENS|0|||
130573643|NCT01888640|470064306|FG000|Overall Study|Researcher Termination of Participant|0|||
130573644|NCT01888640|470064307|FG001|Overall Study|Researcher Termination of Participant|1|||
130573645|NCT01888640|470064308|FG002|Overall Study|Researcher Termination of Participant|1|||
130520262|NCT00129649|469872260|FG001|Overall Study|Withdrawal by Subject|65|||
130520263|NCT01710800|469872264|FG000|Overall Study|Withdrawal by Subject|21|||
130520264|NCT01710800|469872264|FG000|Overall Study|Protocol Violation|1|||
130520265|NCT00511797|469872265|FG000|Overall Study|Adverse Event|1|||
130520266|NCT00511797|469872266|FG001|Overall Study|Adverse Event|2|||
130520267|NCT00511797|469872267|FG002|Overall Study|Adverse Event|2|||
130520268|NCT00511797|469872268|FG003|Overall Study|Adverse Event|2|||
130520269|NCT00511797|469872265|FG000|Overall Study|Lost to Follow-up|1|||
130520270|NCT00511797|469872266|FG001|Overall Study|Lost to Follow-up|0|||
130520271|NCT00511797|469872267|FG002|Overall Study|Lost to Follow-up|0|||
130520272|NCT00511797|469872268|FG003|Overall Study|Lost to Follow-up|1|||
130573646|NCT02199080|470064315|FG000|Overall Study|Protocol Violation|12|||
130573647|NCT01277549|470064316|FG000|Overall Study|Failed to meet eligibility criteria|13|||
130573648|NCT01277549|470064317|FG001|Overall Study|Failed to meet eligibility criteria|9|||
130573649|NCT01277549|470064316|FG000|Overall Study|Withdrawal by Subject|1|||
130573650|NCT01277549|470064317|FG001|Overall Study|Withdrawal by Subject|3|||
130573651|NCT01277549|470064316|FG000|Overall Study|Protocol Violation|10|||
130573652|NCT01277549|470064317|FG001|Overall Study|Protocol Violation|1|||
130573653|NCT01277549|470064316|FG000|Overall Study|Physician Decision|2|||
130520273|NCT00511797|469872265|FG000|Overall Study|Pregnancy|0|||
130520274|NCT00511797|469872266|FG001|Overall Study|Pregnancy|0|||
130520275|NCT00511797|469872267|FG002|Overall Study|Pregnancy|0|||
130520276|NCT00511797|469872268|FG003|Overall Study|Pregnancy|1|||
130520277|NCT00511797|469872265|FG000|Overall Study|Protocol Violation|0|||
130520278|NCT00511797|469872266|FG001|Overall Study|Protocol Violation|2|||
130520279|NCT00511797|469872267|FG002|Overall Study|Protocol Violation|2|||
130520280|NCT00511797|469872268|FG003|Overall Study|Protocol Violation|3|||
130520281|NCT00511797|469872265|FG000|Overall Study|Withdrawal by Subject|3|||
130520282|NCT00511797|469872266|FG001|Overall Study|Withdrawal by Subject|3|||
130520283|NCT00511797|469872267|FG002|Overall Study|Withdrawal by Subject|4|||
130520284|NCT00511797|469872268|FG003|Overall Study|Withdrawal by Subject|2|||
130520285|NCT00511797|469872265|FG000|Overall Study|Never dispensed|1|||
130520286|NCT00511797|469872266|FG001|Overall Study|Never dispensed|0|||
130520287|NCT00511797|469872267|FG002|Overall Study|Never dispensed|1|||
130520288|NCT00511797|469872268|FG003|Overall Study|Never dispensed|3|||
130520289|NCT00511797|469872265|FG000|Overall Study|Study drug not taken|0|||
130520290|NCT00511797|469872266|FG001|Overall Study|Study drug not taken|1|||
130520291|NCT00511797|469872267|FG002|Overall Study|Study drug not taken|0|||
130520292|NCT00511797|469872268|FG003|Overall Study|Study drug not taken|1|||
130520293|NCT00511797|469872265|FG000|Overall Study|Partially missing diary|0|||
130520294|NCT00511797|469872266|FG001|Overall Study|Partially missing diary|0|||
130520295|NCT00511797|469872267|FG002|Overall Study|Partially missing diary|1|||
130520296|NCT00511797|469872268|FG003|Overall Study|Partially missing diary|0|||
130520297|NCT00511797|469872265|FG000|Overall Study|Other (moving etc)|1|||
130520298|NCT00511797|469872266|FG001|Overall Study|Other (moving etc)|0|||
130520299|NCT00511797|469872267|FG002|Overall Study|Other (moving etc)|1|||
130520300|NCT00511797|469872268|FG003|Overall Study|Other (moving etc)|2|||
130520301|NCT03974100|469872269|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
130520302|NCT03974100|469872270|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
130520303|NCT03974100|469872271|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
130520304|NCT03974100|469872272|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
130520305|NCT03974100|469872273|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
130520306|NCT03974100|469872269|FG000|TP1 - Day 1 to Week 52|Death|1|||
130520307|NCT03974100|469872270|FG001|TP1 - Day 1 to Week 52|Death|0|||
130520308|NCT03974100|469872271|FG002|TP1 - Day 1 to Week 52|Death|0|||
130520309|NCT03974100|469872272|FG003|TP1 - Day 1 to Week 52|Death|0|||
130520310|NCT03974100|469872273|FG004|TP1 - Day 1 to Week 52|Death|0|||
130520311|NCT03974100|469872269|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
130520312|NCT03974100|469872270|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
130520313|NCT03974100|469872271|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
130520314|NCT03974100|469872272|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
130520315|NCT03974100|469872273|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
130520316|NCT03974100|469872269|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
130520317|NCT03974100|469872270|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
130520318|NCT03974100|469872271|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
130520319|NCT03974100|469872272|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
130520320|NCT03974100|469872273|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
130520321|NCT03974100|469872269|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
130520322|NCT03974100|469872270|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
130520323|NCT03974100|469872271|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
130520324|NCT03974100|469872272|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
130520325|NCT03974100|469872273|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
130520326|NCT03974100|469872269|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
130520327|NCT03974100|469872270|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
130520328|NCT03974100|469872271|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
130520329|NCT03974100|469872272|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
130520330|NCT03974100|469872273|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
130520331|NCT03974100|469872269|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
130520332|NCT03974100|469872270|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
130520333|NCT03974100|469872271|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
130520334|NCT03974100|469872272|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
130520335|NCT03974100|469872273|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
130520336|NCT01560871|469872276|FG000|Overall Study|transportation issues|2|||
130520337|NCT01560871|469872277|FG001|Overall Study|transportation issues|1|||
130520338|NCT01560871|469872276|FG000|Overall Study|relocation|1|||
130520339|NCT01560871|469872277|FG001|Overall Study|relocation|0|||
130520340|NCT01560871|469872276|FG000|Overall Study|readmission to a hospital|2|||
130520341|NCT01560871|469872277|FG001|Overall Study|readmission to a hospital|1|||
130520342|NCT01560871|469872276|FG000|Overall Study|Lost to Follow-up|1|||
130520343|NCT01560871|469872277|FG001|Overall Study|Lost to Follow-up|0|||
130520344|NCT02024750|469872278|FG000|Overall Study|Withdrawal by Subject|2|||
130520345|NCT02024750|469872279|FG001|Overall Study|Withdrawal by Subject|1|||
130520346|NCT04814992|469872290|FG000|Overall Study|Withdrawal by Subject|6|||
130520347|NCT04814992|469872291|FG001|Overall Study|Withdrawal by Subject|3|||
130520348|NCT04814992|469872290|FG000|Overall Study|Lost to Follow-up|1|||
130520349|NCT04814992|469872291|FG001|Overall Study|Lost to Follow-up|4|||
130520350|NCT00691678|469872292|FG000|Overall Study|Adverse Event|5|||
130520351|NCT00691678|469872292|FG000|Overall Study|life events, pain|11|||
130520352|NCT01831726|469872293|FG000|Overall Study|Adverse Event|16|||
130520353|NCT01831726|469872293|FG000|Overall Study|Death|7|||
130520354|NCT01831726|469872293|FG000|Overall Study|Disease Progression|49|||
130520355|NCT01831726|469872293|FG000|Overall Study|Physician Decision|1|||
130520356|NCT01831726|469872293|FG000|Overall Study|Subject/guardian decision|7|||
130520357|NCT03049306|469872294|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
130520358|NCT03049306|469872295|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
130520359|NCT03151551|469872296|FG000|Open-Label Treatment Period|Adverse Event|0|||
130520360|NCT03151551|469872297|FG001|Open-Label Treatment Period|Adverse Event|2|||
130520361|NCT03151551|469872296|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
130520362|NCT03151551|469872297|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130520363|NCT03151551|469872296|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
130520364|NCT03151551|469872297|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
130520365|NCT03151551|469872296|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
130520366|NCT03151551|469872297|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
130520367|NCT03151551|469872296|FG000|Open-Label Treatment Period|Physician Decision|3|||
130520368|NCT03151551|469872297|FG001|Open-Label Treatment Period|Physician Decision|0|||
130520369|NCT03151551|469872296|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
130520370|NCT03151551|469872297|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
130520371|NCT03151551|469872296|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
130520372|NCT03151551|469872297|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
130520373|NCT03151551|469872296|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130520374|NCT03151551|469872297|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130520375|NCT03151551|469872296|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
130520376|NCT03151551|469872297|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
130520377|NCT03151551|469872296|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
130520378|NCT03151551|469872297|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
130520379|NCT00514813|469872302|FG000|Overall Study|Study terminated|14|||
130520380|NCT00514813|469872303|FG001|Overall Study|Study terminated|74|||
130520381|NCT00514813|469872304|FG002|Overall Study|Study terminated|40|||
130520382|NCT00514813|469872305|FG003|Overall Study|Study terminated|2|||
130520383|NCT00514813|469872302|FG000|Overall Study|Adverse Event|0|||
130520384|NCT00514813|469872303|FG001|Overall Study|Adverse Event|2|||
130520385|NCT00514813|469872304|FG002|Overall Study|Adverse Event|2|||
130520386|NCT00514813|469872305|FG003|Overall Study|Adverse Event|0|||
130520387|NCT00514813|469872302|FG000|Overall Study|Protocol Violation|1|||
130520388|NCT00514813|469872303|FG001|Overall Study|Protocol Violation|0|||
130520389|NCT00514813|469872304|FG002|Overall Study|Protocol Violation|0|||
130520390|NCT00514813|469872305|FG003|Overall Study|Protocol Violation|0|||
130520391|NCT00514813|469872302|FG000|Overall Study|Withdrawal by Subject|0|||
130520392|NCT00514813|469872303|FG001|Overall Study|Withdrawal by Subject|1|||
130520393|NCT00514813|469872304|FG002|Overall Study|Withdrawal by Subject|0|||
130520394|NCT00514813|469872305|FG003|Overall Study|Withdrawal by Subject|0|||
130520395|NCT00514813|469872302|FG000|Overall Study|Lack of Efficacy|0|||
130520396|NCT00514813|469872303|FG001|Overall Study|Lack of Efficacy|1|||
130520397|NCT00514813|469872304|FG002|Overall Study|Lack of Efficacy|0|||
130520398|NCT00514813|469872305|FG003|Overall Study|Lack of Efficacy|0|||
130520399|NCT00514813|469872302|FG000|Overall Study|Kidney transplant|0|||
130520400|NCT00514813|469872303|FG001|Overall Study|Kidney transplant|6|||
130520401|NCT00514813|469872304|FG002|Overall Study|Kidney transplant|2|||
130520402|NCT00514813|469872305|FG003|Overall Study|Kidney transplant|0|||
130520403|NCT00514813|469872302|FG000|Overall Study|Death|0|||
130520404|NCT00514813|469872303|FG001|Overall Study|Death|2|||
130520405|NCT00514813|469872304|FG002|Overall Study|Death|3|||
130520406|NCT00514813|469872305|FG003|Overall Study|Death|2|||
130520407|NCT02979613|469872306|FG000|Double-Blind Phase|Withdrew Consent|2|||
130520408|NCT02979613|469872307|FG001|Double-Blind Phase|Withdrew Consent|4|||
130520409|NCT02979613|469872306|FG000|Double-Blind Phase|Pregnancy|2|||
130520410|NCT02979613|469872307|FG001|Double-Blind Phase|Pregnancy|2|||
130520411|NCT02979613|469872306|FG000|Double-Blind Phase|Adverse Event|2|||
130520412|NCT02979613|469872307|FG001|Double-Blind Phase|Adverse Event|0|||
130520413|NCT02979613|469872306|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130520414|NCT02979613|469872307|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130520415|NCT02979613|469872306|FG000|Double-Blind Phase|Protocol Violation|1|||
130520416|NCT02979613|469872307|FG001|Double-Blind Phase|Protocol Violation|1|||
130573654|NCT01277549|470064317|FG001|Overall Study|Physician Decision|1|||
130520417|NCT02979613|469872306|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
130520418|NCT02979613|469872307|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
130520419|NCT02979613|469872306|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
130520420|NCT02979613|469872307|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
130520421|NCT02979613|469872306|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
130520422|NCT02979613|469872307|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130520423|NCT02979613|469872306|FG000|Open-Label Extension (OLE) Phase|Death|0|||
130520424|NCT02979613|469872307|FG001|Open-Label Extension (OLE) Phase|Death|1|||
130520425|NCT02979613|469872306|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
130520426|NCT02979613|469872307|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
130520427|NCT00143598|469872310|FG000|Overall Study|Lost to Follow-up|23|||
130520428|NCT00143598|469872311|FG001|Overall Study|Lost to Follow-up|21|||
130520429|NCT00143598|469872310|FG000|Overall Study|Withdrawal by Subject|33|||
130520430|NCT00143598|469872311|FG001|Overall Study|Withdrawal by Subject|37|||
130520431|NCT00143598|469872310|FG000|Overall Study|Death|36|||
130520432|NCT00143598|469872311|FG001|Overall Study|Death|36|||
130520433|NCT01878383|469874151|FG000|Overall Study|Lost to Follow-up|0|||
130520434|NCT01878383|469874152|FG001|Overall Study|Lost to Follow-up|1499|||
130520435|NCT03475056|469874153|FG000|Overall Study|Lost to Follow-up|0|||
130520436|NCT03475056|469874154|FG001|Overall Study|Lost to Follow-up|1|||
130520437|NCT03475056|469874153|FG000|Overall Study|Moved from Area|0|||
130520438|NCT03475056|469874154|FG001|Overall Study|Moved from Area|2|||
130520439|NCT01932762|469874157|FG000|Overall Study|Withdrawal by Subject|1|||
130520440|NCT01932762|469874158|FG001|Overall Study|Withdrawal by Subject|2|||
130520441|NCT01932762|469874159|FG002|Overall Study|Withdrawal by Subject|0|||
130520442|NCT01932762|469874160|FG003|Overall Study|Withdrawal by Subject|0|||
130520443|NCT01932762|469874157|FG000|Overall Study|Lost to Follow-up|4|||
130520444|NCT01932762|469874158|FG001|Overall Study|Lost to Follow-up|0|||
130520445|NCT01932762|469874159|FG002|Overall Study|Lost to Follow-up|0|||
130520446|NCT01932762|469874160|FG003|Overall Study|Lost to Follow-up|1|||
130520447|NCT01932762|469874157|FG000|Overall Study|Physician Decision|1|||
130520448|NCT01932762|469874158|FG001|Overall Study|Physician Decision|0|||
130520449|NCT01932762|469874159|FG002|Overall Study|Physician Decision|0|||
130520450|NCT01932762|469874160|FG003|Overall Study|Physician Decision|0|||
130520451|NCT01172639|469874163|FG000|Overall Study|Death|1|||
130520452|NCT01172639|469874164|FG001|Overall Study|Death|1|||
130520453|NCT01172639|469874165|FG002|Overall Study|Death|0|||
130520454|NCT01172639|469874166|FG003|Overall Study|Death|0|||
130520455|NCT01172639|469874167|FG004|Overall Study|Death|0|||
130520456|NCT01172639|469874163|FG000|Overall Study|Lost to Follow-up|9|||
130520457|NCT01172639|469874164|FG001|Overall Study|Lost to Follow-up|7|||
130520458|NCT01172639|469874165|FG002|Overall Study|Lost to Follow-up|11|||
130520459|NCT01172639|469874166|FG003|Overall Study|Lost to Follow-up|6|||
130520460|NCT01172639|469874167|FG004|Overall Study|Lost to Follow-up|6|||
130520461|NCT01172639|469874163|FG000|Overall Study|Withdrawal by Subject|3|||
130520462|NCT01172639|469874164|FG001|Overall Study|Withdrawal by Subject|3|||
130520463|NCT01172639|469874165|FG002|Overall Study|Withdrawal by Subject|5|||
130520464|NCT01172639|469874166|FG003|Overall Study|Withdrawal by Subject|5|||
130520465|NCT01172639|469874167|FG004|Overall Study|Withdrawal by Subject|0|||
130520466|NCT02172950|469874168|FG000|Overall Study|Physician Decision|3|||
130520467|NCT02172950|469874169|FG001|Overall Study|Physician Decision|3|||
130520468|NCT02172950|469874168|FG000|Overall Study|Lack of Efficacy|1|||
130520469|NCT02172950|469874169|FG001|Overall Study|Lack of Efficacy|0|||
130520470|NCT02172950|469874168|FG000|Overall Study|Adverse Event|4|||
130520471|NCT02172950|469874169|FG001|Overall Study|Adverse Event|1|||
130520472|NCT02172950|469874168|FG000|Overall Study|Withdrawal by Subject|10|||
130520473|NCT02172950|469874169|FG001|Overall Study|Withdrawal by Subject|0|||
130520474|NCT02172950|469874168|FG000|Overall Study|Protocol Violation|1|||
130520475|NCT02172950|469874169|FG001|Overall Study|Protocol Violation|0|||
130520476|NCT02172950|469874168|FG000|Overall Study|Lost to Follow-up|1|||
130520477|NCT02172950|469874169|FG001|Overall Study|Lost to Follow-up|0|||
130520478|NCT02172950|469874168|FG000|Overall Study|Death|1|||
130520479|NCT02172950|469874169|FG001|Overall Study|Death|0|||
130520480|NCT02172950|469874168|FG000|Overall Study|Patient traveling|1|||
130520481|NCT02172950|469874169|FG001|Overall Study|Patient traveling|0|||
130520482|NCT02172950|469874168|FG000|Overall Study|Patient went to other country|1|||
130520483|NCT02172950|469874169|FG001|Overall Study|Patient went to other country|0|||
130520484|NCT02172950|469874168|FG000|Overall Study|Patient relocated overseas|1|||
130520485|NCT02172950|469874169|FG001|Overall Study|Patient relocated overseas|1|||
130520486|NCT02172950|469874168|FG000|Overall Study|Patient moving|1|||
130520487|NCT02172950|469874169|FG001|Overall Study|Patient moving|0|||
130520488|NCT00469456|469874170|FG000|Overall Study|Adverse Event|4|||
130520489|NCT00469456|469874171|FG001|Overall Study|Adverse Event|3|||
130520490|NCT00469456|469874170|FG000|Overall Study|Protocol Violation|1|||
130520491|NCT00469456|469874171|FG001|Overall Study|Protocol Violation|0|||
130520492|NCT00469456|469874170|FG000|Overall Study|Withdrawal by Subject|4|||
130520493|NCT00469456|469874171|FG001|Overall Study|Withdrawal by Subject|1|||
130520494|NCT00611715|469874174|FG000|Overall Study|Disease Progression|24|||
130520495|NCT00611715|469874175|FG001|Overall Study|Disease Progression|4|||
130520496|NCT00611715|469874174|FG000|Overall Study|Withdrawal by Subject|5|||
130520497|NCT00611715|469874175|FG001|Overall Study|Withdrawal by Subject|1|||
130520498|NCT00611715|469874174|FG000|Overall Study|Adverse Event|9|||
130520499|NCT00611715|469874175|FG001|Overall Study|Adverse Event|1|||
130520500|NCT00611715|469874174|FG000|Overall Study|Death|1|||
130520501|NCT00611715|469874175|FG001|Overall Study|Death|0|||
130520502|NCT00611715|469874174|FG000|Overall Study|two patients are still on treatment|2|||
130520503|NCT00611715|469874175|FG001|Overall Study|two patients are still on treatment|0|||
130520504|NCT00107978|469874176|FG000|Overall Study|Adverse Event|1|||
130520505|NCT00107978|469874177|FG001|Overall Study|Adverse Event|5|||
130520506|NCT00107978|469874176|FG000|Overall Study|Death|3|||
130520507|NCT00107978|469874177|FG001|Overall Study|Death|3|||
130573655|NCT01097863|470064320|FG000|Overall Study|Discomfort|1|||
130573656|NCT01097863|470064321|FG001|Overall Study|Discomfort|0|||
130573657|NCT01097863|470064322|FG002|Overall Study|Discomfort|1|||
130573658|NCT01097863|470064320|FG000|Overall Study|Did not return for final visit|0|||
130573659|NCT01097863|470064321|FG001|Overall Study|Did not return for final visit|0|||
130573660|NCT01097863|470064322|FG002|Overall Study|Did not return for final visit|1|||
130573661|NCT00574275|470064323|FG000|Overall Study|Randomized but not treated|2|||
130573662|NCT00574275|470064324|FG001|Overall Study|Randomized but not treated|3|||
130573663|NCT00574275|470064323|FG000|Overall Study|Adverse Event|32|||
130573664|NCT00574275|470064324|FG001|Overall Study|Adverse Event|76|||
130573665|NCT00574275|470064323|FG000|Overall Study|Disease progression|160|||
130573666|NCT00574275|470064324|FG001|Overall Study|Disease progression|146|||
130573667|NCT00574275|470064323|FG000|Overall Study|Lost to Follow-up|2|||
130573668|NCT00574275|470064324|FG001|Overall Study|Lost to Follow-up|1|||
130573669|NCT00574275|470064323|FG000|Overall Study|Study stopped based on DMC decision|62|||
130573670|NCT00574275|470064324|FG001|Overall Study|Study stopped based on DMC decision|23|||
130573671|NCT00574275|470064323|FG000|Overall Study|Withdrawal by Subject|15|||
130573672|NCT00574275|470064324|FG001|Overall Study|Withdrawal by Subject|17|||
130573673|NCT00574275|470064323|FG000|Overall Study|Error calculating tumor measurement|1|||
130520508|NCT00107978|469874176|FG000|Overall Study|Lost to Follow-up|20|||
130520509|NCT00107978|469874177|FG001|Overall Study|Lost to Follow-up|28|||
130520510|NCT00107978|469874176|FG000|Overall Study|Withdrawal by Subject|4|||
130520511|NCT00107978|469874177|FG001|Overall Study|Withdrawal by Subject|9|||
130520512|NCT00107978|469874176|FG000|Overall Study|Protocol Violation|0|||
130520513|NCT00107978|469874177|FG001|Overall Study|Protocol Violation|1|||
130520514|NCT00107978|469874176|FG000|Overall Study|Other|5|||
130520515|NCT00107978|469874177|FG001|Overall Study|Other|4|||
130520516|NCT02669407|469874180|FG000|Overall Study|Physician Decision|3|||
130520517|NCT00704171|469874184|FG000|Overall Study|Withdrawal by Subject|1|||
130520518|NCT00704171|469874185|FG001|Overall Study|Withdrawal by Subject|0|||
130520519|NCT01874665|469874186|FG000|Overall Study|Adverse Event|6|||
130520520|NCT01874665|469874187|FG001|Overall Study|Adverse Event|2|||
130520521|NCT01874665|469874186|FG000|Overall Study|Withdrawal by Subject|4|||
130520522|NCT01874665|469874187|FG001|Overall Study|Withdrawal by Subject|1|||
130520523|NCT01874665|469874186|FG000|Overall Study|Physician Decision|3|||
130520524|NCT01874665|469874187|FG001|Overall Study|Physician Decision|0|||
130520525|NCT01874665|469874186|FG000|Overall Study|Clinical Progressive Disease|4|||
130520526|NCT01874665|469874187|FG001|Overall Study|Clinical Progressive Disease|3|||
130520527|NCT01874665|469874186|FG000|Overall Study|Study Terminated by Sponsor|0|||
130520528|NCT01874665|469874187|FG001|Overall Study|Study Terminated by Sponsor|2|||
130520529|NCT01874665|469874186|FG000|Overall Study|Documented Progressive Disease|11|||
130520530|NCT01874665|469874187|FG001|Overall Study|Documented Progressive Disease|7|||
130520531|NCT01874665|469874186|FG000|Overall Study|Other|2|||
130520532|NCT01874665|469874187|FG001|Overall Study|Other|0|||
130520533|NCT00350298|469874190|FG000|Overall Study|Death|7|||
130520534|NCT00350298|469874191|FG001|Overall Study|Death|8|||
130520535|NCT00350298|469874190|FG000|Overall Study|Lost to Follow-up|1|||
130520536|NCT00350298|469874191|FG001|Overall Study|Lost to Follow-up|2|||
130520537|NCT00350298|469874190|FG000|Overall Study|Withdrawal by Subject|1|||
130520538|NCT00350298|469874191|FG001|Overall Study|Withdrawal by Subject|3|||
130520539|NCT03634839|469874192|FG000|First Intervention (2 Hours)|Adverse Event|0|||
130520540|NCT03634839|469874193|FG001|First Intervention (2 Hours)|Adverse Event|2|||
130520541|NCT02447432|469874194|FG000|Epoch 001|Adverse Event|1|||
130520542|NCT02447432|469874195|FG001|Epoch 001|Adverse Event|1|||
130520543|NCT02447432|469874194|FG000|Epoch 001|Withdrawal by Subject|0|||
130573674|NCT00574275|470064324|FG001|Overall Study|Error calculating tumor measurement|0|||
130573675|NCT00574275|470064323|FG000|Overall Study|Physician Decision|1|||
130573676|NCT00574275|470064324|FG001|Overall Study|Physician Decision|1|||
130573677|NCT00574275|470064323|FG000|Overall Study|Protocol Violation|0|||
130573678|NCT00574275|470064324|FG001|Overall Study|Protocol Violation|1|||
130573679|NCT00574275|470064323|FG000|Overall Study|Patient and Investigator decision|0|||
130573680|NCT00574275|470064324|FG001|Overall Study|Patient and Investigator decision|1|||
130573681|NCT00574275|470064323|FG000|Overall Study|Insurance change|0|||
130520544|NCT02447432|469874195|FG001|Epoch 001|Withdrawal by Subject|4|||
130573682|NCT00574275|470064324|FG001|Overall Study|Insurance change|1|||
130573683|NCT00574275|470064323|FG000|Overall Study|Operation for curative intent|0|||
130573684|NCT00574275|470064324|FG001|Overall Study|Operation for curative intent|1|||
130573685|NCT02703311|470064326|FG000|Overall Study|Death|5|||
130520545|NCT02447432|469874194|FG000|Epoch 001|Migrated/moved from study area|3|||
130520546|NCT02447432|469874195|FG001|Epoch 001|Migrated/moved from study area|5|||
130573686|NCT02703311|470064326|FG000|Overall Study|Withdrawal by Subject|3|||
130573687|NCT00960843|470064327|FG000|Overall Study|Lost to Follow-up|2|||
130573688|NCT00960843|470064328|FG001|Overall Study|Lost to Follow-up|0|||
130573689|NCT00960843|470064327|FG000|Overall Study|Protocol Violation|0|||
130520547|NCT02447432|469874194|FG000|Epoch 001|Lost to Follow-up|1|||
130520548|NCT02447432|469874195|FG001|Epoch 001|Lost to Follow-up|3|||
130520549|NCT02647788|469874196|FG000|Overall Study|Lost to Follow-up|13|||
130520550|NCT02647788|469874197|FG001|Overall Study|Lost to Follow-up|11|||
130520551|NCT02647788|469874196|FG000|Overall Study|Did not want opiate|0|||
130520552|NCT02647788|469874197|FG001|Overall Study|Did not want opiate|1|||
130520553|NCT02647788|469874196|FG000|Overall Study|Withdrawal by Subject|1|||
130520554|NCT02647788|469874197|FG001|Overall Study|Withdrawal by Subject|0|||
130520555|NCT02647788|469874196|FG000|Overall Study|Felt itchy with assigned medication|1|||
130520556|NCT02647788|469874197|FG001|Overall Study|Felt itchy with assigned medication|0|||
130520557|NCT02647788|469874196|FG000|Overall Study|Felt nauseous with assigned medication|1|||
130520558|NCT02647788|469874197|FG001|Overall Study|Felt nauseous with assigned medication|1|||
130520559|NCT00233389|469874200|FG000|Overall Study|Adverse Event|5|||
130520560|NCT00233389|469874201|FG001|Overall Study|Adverse Event|5|||
130520561|NCT00233389|469874200|FG000|Overall Study|Lack of Efficacy|11|||
130520562|NCT00233389|469874201|FG001|Overall Study|Lack of Efficacy|8|||
130520563|NCT00233389|469874200|FG000|Overall Study|Lost to Follow-up|1|||
130520564|NCT00233389|469874201|FG001|Overall Study|Lost to Follow-up|1|||
130520565|NCT00233389|469874200|FG000|Overall Study|Physician Decision|1|||
130520566|NCT00233389|469874201|FG001|Overall Study|Physician Decision|0|||
130520567|NCT00233389|469874200|FG000|Overall Study|Protocol Violation|0|||
130520568|NCT00233389|469874201|FG001|Overall Study|Protocol Violation|1|||
130520569|NCT00233389|469874200|FG000|Overall Study|Withdrawal by Subject|0|||
130520570|NCT00233389|469874201|FG001|Overall Study|Withdrawal by Subject|1|||
130520571|NCT01588366|469874209|FG000|Overall Study|Adverse Event|0|||
130520572|NCT01588366|469874210|FG001|Overall Study|Adverse Event|1|||
130520573|NCT01588366|469874211|FG002|Overall Study|Adverse Event|0|||
130520574|NCT01588366|469874212|FG003|Overall Study|Adverse Event|1|||
130520575|NCT01588366|469874213|FG004|Overall Study|Adverse Event|0|||
130520576|NCT01588366|469874214|FG005|Overall Study|Adverse Event|2|||
130520577|NCT00719043|469874215|FG000|Overall Study|Adverse Event|5|||
130520578|NCT00719043|469874216|FG001|Overall Study|Adverse Event|1|||
130520579|NCT00719043|469874217|FG002|Overall Study|Adverse Event|2|||
130520580|NCT00719043|469874218|FG003|Overall Study|Adverse Event|2|||
130520581|NCT00719043|469874219|FG004|Overall Study|Adverse Event|1|||
130520582|NCT00719043|469874220|FG005|Overall Study|Adverse Event|4|||
130520583|NCT00719043|469874221|FG006|Overall Study|Adverse Event|4|||
130520584|NCT00719043|469874215|FG000|Overall Study|Lost to Follow-up|14|||
130520585|NCT00719043|469874216|FG001|Overall Study|Lost to Follow-up|10|||
130520586|NCT00719043|469874217|FG002|Overall Study|Lost to Follow-up|8|||
130520587|NCT00719043|469874218|FG003|Overall Study|Lost to Follow-up|9|||
130520588|NCT00719043|469874219|FG004|Overall Study|Lost to Follow-up|10|||
130520589|NCT00719043|469874220|FG005|Overall Study|Lost to Follow-up|9|||
130520590|NCT00719043|469874221|FG006|Overall Study|Lost to Follow-up|9|||
130520591|NCT00719043|469874215|FG000|Overall Study|Protocol Violation|0|||
130520592|NCT00719043|469874216|FG001|Overall Study|Protocol Violation|0|||
130520593|NCT00719043|469874217|FG002|Overall Study|Protocol Violation|0|||
130520594|NCT00719043|469874218|FG003|Overall Study|Protocol Violation|0|||
130520595|NCT00719043|469874219|FG004|Overall Study|Protocol Violation|0|||
130520596|NCT00719043|469874220|FG005|Overall Study|Protocol Violation|1|||
130520597|NCT00719043|469874221|FG006|Overall Study|Protocol Violation|0|||
130520598|NCT00719043|469874215|FG000|Overall Study|Other|1|||
130520599|NCT00719043|469874216|FG001|Overall Study|Other|0|||
130520600|NCT00719043|469874217|FG002|Overall Study|Other|1|||
130520601|NCT00719043|469874218|FG003|Overall Study|Other|2|||
130520602|NCT00719043|469874219|FG004|Overall Study|Other|0|||
130520603|NCT00719043|469874220|FG005|Overall Study|Other|2|||
130520604|NCT00719043|469874221|FG006|Overall Study|Other|1|||
130520605|NCT00719043|469874215|FG000|Overall Study|Withdrawal by Subject|12|||
130520606|NCT00719043|469874216|FG001|Overall Study|Withdrawal by Subject|14|||
130520607|NCT00719043|469874217|FG002|Overall Study|Withdrawal by Subject|9|||
130520608|NCT00719043|469874218|FG003|Overall Study|Withdrawal by Subject|10|||
130520609|NCT00719043|469874219|FG004|Overall Study|Withdrawal by Subject|16|||
130520610|NCT00719043|469874220|FG005|Overall Study|Withdrawal by Subject|18|||
130520611|NCT00719043|469874221|FG006|Overall Study|Withdrawal by Subject|14|||
130520612|NCT00302159|469874222|FG000|Overall Study|pt declined before treatment started|1|||
130520613|NCT00302159|469874222|FG000|Overall Study|pt started Avastin|1|||
130520614|NCT03245619|469874223|FG000|Part A (Up to Day 22)|Physician Decision|4|||
130520615|NCT03245619|469874224|FG001|Part A (Up to Day 22)|Physician Decision|6|||
130520616|NCT03245619|469874225|FG002|Part A (Up to Day 22)|Physician Decision|6|||
130520617|NCT03245619|469874226|FG003|Part A (Up to Day 22)|Physician Decision|0|||
130520618|NCT03245619|469874227|FG004|Part A (Up to Day 22)|Physician Decision|0|||
130520619|NCT03245619|469874228|FG005|Part A (Up to Day 22)|Physician Decision|0|||
130520620|NCT03245619|469874229|FG006|Part A (Up to Day 22)|Physician Decision|0|||
130520621|NCT03245619|469874230|FG007|Part A (Up to Day 22)|Physician Decision|0|||
130520622|NCT03245619|469874231|FG008|Part A (Up to Day 22)|Physician Decision|0|||
130520623|NCT03245619|469874232|FG009|Part A (Up to Day 22)|Physician Decision|0|||
130520624|NCT03245619|469874233|FG010|Part A (Up to Day 22)|Physician Decision|0|||
130520625|NCT03245619|469874234|FG011|Part A (Up to Day 22)|Physician Decision|0|||
130520626|NCT03245619|469874235|FG012|Part A (Up to Day 22)|Physician Decision|0|||
130520627|NCT03245619|469874236|FG013|Part A (Up to Day 22)|Physician Decision|0|||
130573690|NCT00960843|470064328|FG001|Overall Study|Protocol Violation|4|||
130520628|NCT03245619|469874237|FG014|Part A (Up to Day 22)|Physician Decision|0|||
130520629|NCT03245619|469874238|FG015|Part A (Up to Day 22)|Physician Decision|0|||
130520630|NCT03245619|469874239|FG016|Part A (Up to Day 22)|Physician Decision|0|||
130520631|NCT04962698|469874242|FG000|Motor Imagery|Technical difficulty|1|||
130520632|NCT04962698|469874243|FG001|Motor Imagery|Technical difficulty|0|||
130520633|NCT04962698|469874242|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
130520634|NCT04962698|469874243|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
130520635|NCT04962698|469874242|FG000|Kinesthetic MI|Technical difficulty|1|||
130520636|NCT04962698|469874243|FG001|Kinesthetic MI|Technical difficulty|0|||
130520637|NCT04962698|469874242|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
130520638|NCT04962698|469874243|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
130520639|NCT04962698|469874242|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
130520640|NCT04962698|469874243|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
130520641|NCT04962698|469874242|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
130520642|NCT04962698|469874243|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
130520643|NCT04962698|469874242|FG000|Virtual-hand Interaction|Technical difficulty|1|||
130520644|NCT04962698|469874243|FG001|Virtual-hand Interaction|Technical difficulty|0|||
130520645|NCT04962698|469874242|FG000|Robotic Action Observation|Technical difficulty|1|||
130520646|NCT04962698|469874243|FG001|Robotic Action Observation|Technical difficulty|0|||
130520647|NCT04962698|469874242|FG000|Rest|Technical difficulty|1|||
130520648|NCT04962698|469874243|FG001|Rest|Technical difficulty|0|||
130520649|NCT04962698|469874242|FG000|Rest|Exclusion criteria met after enrollment|0|||
130520650|NCT04962698|469874243|FG001|Rest|Exclusion criteria met after enrollment|2|||
130520651|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
130520652|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
130520653|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
130520654|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
130520655|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
130520656|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
130520657|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
130520658|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
130520659|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
130520660|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
130520661|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
130520662|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
130520663|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
130520664|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
130520665|NCT01664923|469874259|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
130520666|NCT01664923|469874260|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
130520667|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
130520668|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
130520669|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
130520670|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
130520671|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
130520672|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
130520673|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
130520674|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
130520675|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
130520676|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
130520677|NCT01664923|469874259|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
130520678|NCT01664923|469874260|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
130520679|NCT02835092|469874263|FG000|Overall Study|Withdrawal by Subject|3|||
130520680|NCT02835092|469874264|FG001|Overall Study|Withdrawal by Subject|6|||
130520681|NCT02835092|469874265|FG002|Overall Study|Withdrawal by Subject|3|||
130520682|NCT02835092|469874263|FG000|Overall Study|Lost to Follow-up|0|||
130520683|NCT02835092|469874264|FG001|Overall Study|Lost to Follow-up|2|||
130520684|NCT02835092|469874265|FG002|Overall Study|Lost to Follow-up|0|||
130520685|NCT01657877|469874267|FG000|Overall Study|Withdrawal by Subject|4|||
130520686|NCT01657877|469874267|FG000|Overall Study|Protocol Violation|6|||
130520687|NCT01657877|469874267|FG000|Overall Study|Adverse Event|2|||
130520688|NCT01657877|469874267|FG000|Overall Study|Other Reason|2|||
130520689|NCT01114672|469874269|FG000|Overall Study|Death|0|||
130520690|NCT01114672|469874270|FG001|Overall Study|Death|1|||
130520691|NCT01114672|469874269|FG000|Overall Study|Withdrawal by Subject|2|||
130520692|NCT01114672|469874270|FG001|Overall Study|Withdrawal by Subject|1|||
130520693|NCT01114672|469874269|FG000|Overall Study|Lost to Follow-up|1|||
130520694|NCT01114672|469874270|FG001|Overall Study|Lost to Follow-up|0|||
130520695|NCT01114672|469874269|FG000|Overall Study|transplanted|1|||
130520696|NCT01114672|469874270|FG001|Overall Study|transplanted|0|||
130520697|NCT02586415|469874275|FG000|Overall Study|Death|13|||
130520698|NCT02586415|469874276|FG001|Overall Study|Death|23|||
130573691|NCT00960843|470064327|FG000|Overall Study|Repeated needle dislodgment|0|||
130520699|NCT02586415|469874275|FG000|Overall Study|Lost to Follow-up|1|||
130520700|NCT02586415|469874276|FG001|Overall Study|Lost to Follow-up|2|||
130520701|NCT02872311|469874277|FG000|Overall Study|Death|2|||
130520702|NCT02872311|469874278|FG001|Overall Study|Death|0|||
130520703|NCT02872311|469874279|FG002|Overall Study|Death|0|||
130520704|NCT02872311|469874280|FG003|Overall Study|Death|0|||
130520705|NCT02872311|469874281|FG004|Overall Study|Death|0|||
130520706|NCT02872311|469874277|FG000|Overall Study|Lost to Follow-up|2|||
130520707|NCT02872311|469874278|FG001|Overall Study|Lost to Follow-up|0|||
130520708|NCT02872311|469874279|FG002|Overall Study|Lost to Follow-up|0|||
130520709|NCT02872311|469874280|FG003|Overall Study|Lost to Follow-up|0|||
130520710|NCT02872311|469874281|FG004|Overall Study|Lost to Follow-up|0|||
130520711|NCT02872311|469874277|FG000|Overall Study|Protocol Violation|0|||
130520712|NCT02872311|469874278|FG001|Overall Study|Protocol Violation|2|||
130520713|NCT02872311|469874279|FG002|Overall Study|Protocol Violation|1|||
130520714|NCT02872311|469874280|FG003|Overall Study|Protocol Violation|0|||
130520715|NCT02872311|469874281|FG004|Overall Study|Protocol Violation|0|||
130520716|NCT04545476|469874282|FG000|Overall Study|Lost to Follow-up|1|||
130520717|NCT04545476|469874283|FG001|Overall Study|Lost to Follow-up|1|||
130520718|NCT04545476|469874284|FG002|Overall Study|Lost to Follow-up|0|||
130520719|NCT04545476|469874285|FG003|Overall Study|Lost to Follow-up|0|||
130520720|NCT00690378|469874286|FG000|Overall Study|Adverse Event|1|||
130520721|NCT00690378|469874287|FG001|Overall Study|Adverse Event|0|||
130520722|NCT00690378|469874286|FG000|Overall Study|Withdrawal by Subject|2|||
130520723|NCT00690378|469874287|FG001|Overall Study|Withdrawal by Subject|0|||
130520724|NCT00690378|469874286|FG000|Overall Study|Protocol Violation|1|||
130520725|NCT00690378|469874287|FG001|Overall Study|Protocol Violation|0|||
130520726|NCT00690378|469874286|FG000|Overall Study|Lost to Follow-up|2|||
130520727|NCT00690378|469874287|FG001|Overall Study|Lost to Follow-up|3|||
130520728|NCT00690378|469874286|FG000|Overall Study|Did not meet inc/exc criteria|13|||
130520729|NCT00690378|469874287|FG001|Overall Study|Did not meet inc/exc criteria|11|||
130520730|NCT00690378|469874286|FG000|Overall Study|Social problem|1|||
130520731|NCT00690378|469874287|FG001|Overall Study|Social problem|0|||
130520732|NCT00878553|469874288|FG000|Sleep Study|Withdrawal by Subject|2|||
130520733|NCT00878553|469874289|FG001|Sleep Study|Withdrawal by Subject|0|||
130520734|NCT00878553|469874290|FG002|Sleep Study|Withdrawal by Subject|0|||
130520735|NCT00878553|469874291|FG003|Sleep Study|Withdrawal by Subject|0|||
130520736|NCT00878553|469874292|FG004|Sleep Study|Withdrawal by Subject|0|||
130520737|NCT00878553|469874288|FG000|Sleep Study|Lost to Follow-up|1|||
130520738|NCT00878553|469874289|FG001|Sleep Study|Lost to Follow-up|0|||
130520739|NCT00878553|469874290|FG002|Sleep Study|Lost to Follow-up|0|||
130520740|NCT00878553|469874291|FG003|Sleep Study|Lost to Follow-up|0|||
130520741|NCT00878553|469874292|FG004|Sleep Study|Lost to Follow-up|0|||
130520742|NCT00878553|469874288|FG000|Sleep Study|car accident|1|||
130520743|NCT00878553|469874289|FG001|Sleep Study|car accident|0|||
130520744|NCT00878553|469874290|FG002|Sleep Study|car accident|0|||
130520745|NCT00878553|469874291|FG003|Sleep Study|car accident|0|||
130520746|NCT00878553|469874292|FG004|Sleep Study|car accident|0|||
130520747|NCT00878553|469874288|FG000|Sleep Study|family emergency|1|||
130520748|NCT00878553|469874289|FG001|Sleep Study|family emergency|0|||
130520749|NCT00878553|469874290|FG002|Sleep Study|family emergency|0|||
130520750|NCT00878553|469874291|FG003|Sleep Study|family emergency|0|||
130520751|NCT00878553|469874292|FG004|Sleep Study|family emergency|0|||
130520752|NCT00878553|469874288|FG000|PK Study|Withdrawal by Subject|0|||
130520753|NCT00878553|469874289|FG001|PK Study|Withdrawal by Subject|0|||
130520754|NCT00878553|469874290|FG002|PK Study|Withdrawal by Subject|0|||
130520755|NCT00878553|469874291|FG003|PK Study|Withdrawal by Subject|1|||
130520756|NCT00878553|469874292|FG004|PK Study|Withdrawal by Subject|0|||
130520757|NCT00912223|469874293|FG000|Overall Study|Withdrawal by Subject|1|||
130520758|NCT00912223|469874293|FG000|Overall Study|Not transplanted|1|||
130520759|NCT00912223|469874293|FG000|Overall Study|Transformed disease|1|||
130520760|NCT00461123|469874294|FG000|Overall Study|Adverse Event|1|||
130520761|NCT00461123|469874295|FG001|Overall Study|Adverse Event|0|||
130520762|NCT00461123|469874294|FG000|Overall Study|Lost to Follow-up|1|||
130520763|NCT00461123|469874295|FG001|Overall Study|Lost to Follow-up|1|||
130520764|NCT00461123|469874294|FG000|Overall Study|Protocol Violation|3|||
130520765|NCT00461123|469874295|FG001|Overall Study|Protocol Violation|2|||
130520766|NCT00461123|469874294|FG000|Overall Study|Withdrawal by Subject|1|||
130520767|NCT00461123|469874295|FG001|Overall Study|Withdrawal by Subject|3|||
130520768|NCT00927901|469874296|FG000|Treatment Period 1|Subject withdrew consent|0|||
130520769|NCT00927901|469874297|FG001|Treatment Period 1|Subject withdrew consent|0|||
130520770|NCT00927901|469874298|FG002|Treatment Period 1|Subject withdrew consent|1|||
130520771|NCT00927901|469874299|FG003|Treatment Period 1|Subject withdrew consent|0|||
130520772|NCT00927901|469874296|FG000|Treatment Period 4|Adverse Event|0|||
130520773|NCT00927901|469874297|FG001|Treatment Period 4|Adverse Event|0|||
130573692|NCT00960843|470064328|FG001|Overall Study|Repeated needle dislodgment|1|||
130573693|NCT00652366|470064329|FG000|Overall Study|Adverse Event|8|||
130520774|NCT00927901|469874298|FG002|Treatment Period 4|Adverse Event|0|||
130520775|NCT00927901|469874299|FG003|Treatment Period 4|Adverse Event|1|||
130520776|NCT00927901|469874296|FG000|Treatment Period 4|Subject withdrew consent|0|||
130520777|NCT00927901|469874297|FG001|Treatment Period 4|Subject withdrew consent|0|||
130520778|NCT00927901|469874298|FG002|Treatment Period 4|Subject withdrew consent|1|||
130520779|NCT00927901|469874299|FG003|Treatment Period 4|Subject withdrew consent|0|||
130520780|NCT03029819|469874300|FG000|Overall Study|Lost to Follow-up|3|||
130520781|NCT03029819|469874301|FG001|Overall Study|Lost to Follow-up|5|||
130520782|NCT03029819|469874300|FG000|Overall Study|Removed due to disruptive behavior|0|||
130520783|NCT03029819|469874301|FG001|Overall Study|Removed due to disruptive behavior|1|||
130520784|NCT03605368|469874304|FG000|Overall Study|Lost to Follow-up|2|||
130520785|NCT03605368|469874305|FG001|Overall Study|Lost to Follow-up|1|||
130520786|NCT03605368|469874306|FG002|Overall Study|Lost to Follow-up|3|||
130520787|NCT03605368|469874307|FG003|Overall Study|Lost to Follow-up|2|||
130520788|NCT03605368|469874304|FG000|Overall Study|Withdrawal by Subject|0|||
130520789|NCT03605368|469874305|FG001|Overall Study|Withdrawal by Subject|0|||
130520790|NCT03605368|469874306|FG002|Overall Study|Withdrawal by Subject|4|||
130520791|NCT03605368|469874307|FG003|Overall Study|Withdrawal by Subject|3|||
130520792|NCT02650466|469874309|FG000|Overall Study|Physician Decision|1|||
130520793|NCT02650466|469874309|FG000|Overall Study|Withdrawal by Subject|5|||
130520794|NCT02650466|469874309|FG000|Overall Study|Lost to Follow-up|1|||
130520795|NCT01837797|469874310|FG000|Period 1|Adverse Event|9|||
130520796|NCT01837797|469874311|FG001|Period 1|Adverse Event|0|||
130520797|NCT01837797|469874312|FG002|Period 1|Adverse Event|0|||
130520798|NCT01837797|469874313|FG003|Period 1|Adverse Event|0|||
130520799|NCT01837797|469874314|FG004|Period 1|Adverse Event|0|||
130520800|NCT01837797|469874310|FG000|Period 1|Withdrawal by Subject|6|||
130520801|NCT01837797|469874311|FG001|Period 1|Withdrawal by Subject|0|||
130520802|NCT01837797|469874312|FG002|Period 1|Withdrawal by Subject|0|||
130520803|NCT01837797|469874313|FG003|Period 1|Withdrawal by Subject|0|||
130520804|NCT01837797|469874314|FG004|Period 1|Withdrawal by Subject|0|||
130520805|NCT01837797|469874310|FG000|Period 1|Administrative reasons|76|||
130520806|NCT01837797|469874311|FG001|Period 1|Administrative reasons|0|||
130520807|NCT01837797|469874312|FG002|Period 1|Administrative reasons|0|||
130520808|NCT01837797|469874313|FG003|Period 1|Administrative reasons|0|||
130520809|NCT01837797|469874314|FG004|Period 1|Administrative reasons|0|||
130520810|NCT01837797|469874310|FG000|Period 1|Withdrawal of consent before treatment|1|||
130520811|NCT01837797|469874311|FG001|Period 1|Withdrawal of consent before treatment|0|||
130520812|NCT01837797|469874312|FG002|Period 1|Withdrawal of consent before treatment|0|||
130520813|NCT01837797|469874313|FG003|Period 1|Withdrawal of consent before treatment|0|||
130520814|NCT01837797|469874314|FG004|Period 1|Withdrawal of consent before treatment|0|||
130520815|NCT01837797|469874310|FG000|Period 1|Other|10|||
130520816|NCT01837797|469874311|FG001|Period 1|Other|0|||
130520817|NCT01837797|469874312|FG002|Period 1|Other|0|||
130520818|NCT01837797|469874313|FG003|Period 1|Other|0|||
130520819|NCT01837797|469874314|FG004|Period 1|Other|0|||
130520820|NCT01837797|469874310|FG000|Period 2|Administrative or other reasons|0|||
130520821|NCT01837797|469874311|FG001|Period 2|Administrative or other reasons|5|||
130520822|NCT01837797|469874312|FG002|Period 2|Administrative or other reasons|2|||
130520823|NCT01837797|469874313|FG003|Period 2|Administrative or other reasons|4|||
130520824|NCT01837797|469874314|FG004|Period 2|Administrative or other reasons|0|||
130520825|NCT01837797|469874310|FG000|Period 2|Adverse Event|0|||
130520826|NCT01837797|469874311|FG001|Period 2|Adverse Event|0|||
130520827|NCT01837797|469874312|FG002|Period 2|Adverse Event|0|||
130520828|NCT01837797|469874313|FG003|Period 2|Adverse Event|1|||
130520829|NCT01837797|469874314|FG004|Period 2|Adverse Event|0|||
130520830|NCT01837797|469874310|FG000|Period 3|Adverse Event|0|||
130520831|NCT01837797|469874311|FG001|Period 3|Adverse Event|0|||
130520832|NCT01837797|469874312|FG002|Period 3|Adverse Event|0|||
130520833|NCT01837797|469874313|FG003|Period 3|Adverse Event|0|||
130520834|NCT01837797|469874314|FG004|Period 3|Adverse Event|1|||
130520835|NCT01837797|469874310|FG000|Period 3|Administrative reasons|0|||
130520836|NCT01837797|469874311|FG001|Period 3|Administrative reasons|0|||
130520837|NCT01837797|469874312|FG002|Period 3|Administrative reasons|0|||
130520838|NCT01837797|469874313|FG003|Period 3|Administrative reasons|0|||
130520839|NCT01837797|469874314|FG004|Period 3|Administrative reasons|20|||
130520840|NCT01837797|469874310|FG000|Period 3|Other|0|||
130520841|NCT01837797|469874311|FG001|Period 3|Other|0|||
130520842|NCT01837797|469874312|FG002|Period 3|Other|0|||
130520843|NCT01837797|469874313|FG003|Period 3|Other|0|||
130520844|NCT01837797|469874314|FG004|Period 3|Other|2|||
130520845|NCT03797989|469874315|FG000|VAC069A|Withdrawal by Subject|0|||
130520846|NCT03797989|469874316|FG001|VAC069A|Withdrawal by Subject|0|||
130520847|NCT03797989|469874317|FG002|VAC069A|Withdrawal by Subject|1|||
130520848|NCT03797989|469874318|FG003|VAC069A|Withdrawal by Subject|0|||
130520849|NCT03797989|469874319|FG004|VAC069A|Withdrawal by Subject|0|||
130520850|NCT03797989|469874320|FG005|VAC069A|Withdrawal by Subject|0|||
130520851|NCT03797989|469874321|FG006|VAC069A|Withdrawal by Subject|0|||
130573694|NCT00652366|470064330|FG001|Overall Study|Adverse Event|4|||
130573695|NCT00652366|470064331|FG002|Overall Study|Adverse Event|7|||
130573696|NCT00652366|470064332|FG003|Overall Study|Adverse Event|17|||
130573697|NCT00652366|470064333|FG004|Overall Study|Adverse Event|13|||
130573698|NCT00652366|470064329|FG000|Overall Study|Death|5|||
130573699|NCT00652366|470064330|FG001|Overall Study|Death|4|||
130573700|NCT00652366|470064331|FG002|Overall Study|Death|1|||
130573701|NCT00652366|470064332|FG003|Overall Study|Death|8|||
130573702|NCT00652366|470064333|FG004|Overall Study|Death|5|||
130573703|NCT00652366|470064329|FG000|Overall Study|Lack of Efficacy|84|||
130573704|NCT00652366|470064330|FG001|Overall Study|Lack of Efficacy|58|||
130573705|NCT00652366|470064331|FG002|Overall Study|Lack of Efficacy|53|||
130573706|NCT00652366|470064332|FG003|Overall Study|Lack of Efficacy|133|||
130573707|NCT00652366|470064333|FG004|Overall Study|Lack of Efficacy|13|||
130573708|NCT00652366|470064329|FG000|Overall Study|Violation of Selection Criteria|0|||
130573709|NCT00652366|470064330|FG001|Overall Study|Violation of Selection Criteria|0|||
130573710|NCT00652366|470064331|FG002|Overall Study|Violation of Selection Criteria|1|||
130573711|NCT00652366|470064332|FG003|Overall Study|Violation of Selection Criteria|0|||
130573712|NCT00652366|470064333|FG004|Overall Study|Violation of Selection Criteria|0|||
130573713|NCT00652366|470064329|FG000|Overall Study|Protocol Violation|1|||
130573714|NCT00652366|470064330|FG001|Overall Study|Protocol Violation|0|||
130573715|NCT00652366|470064331|FG002|Overall Study|Protocol Violation|0|||
130573716|NCT00652366|470064332|FG003|Overall Study|Protocol Violation|0|||
130573717|NCT00652366|470064333|FG004|Overall Study|Protocol Violation|0|||
130573718|NCT00652366|470064329|FG000|Overall Study|Refused treatment|3|||
130573719|NCT00652366|470064330|FG001|Overall Study|Refused treatment|7|||
130573720|NCT00652366|470064331|FG002|Overall Study|Refused treatment|6|||
130573721|NCT00652366|470064332|FG003|Overall Study|Refused treatment|17|||
130573722|NCT00652366|470064333|FG004|Overall Study|Refused treatment|5|||
130573723|NCT00652366|470064329|FG000|Overall Study|Other|5|||
130573724|NCT00652366|470064330|FG001|Overall Study|Other|2|||
130573725|NCT00652366|470064331|FG002|Overall Study|Other|3|||
130573726|NCT00652366|470064332|FG003|Overall Study|Other|4|||
130573727|NCT00652366|470064333|FG004|Overall Study|Other|0|||
130573728|NCT02069899|470064338|FG000|Overall Study|Adverse Event|6|||
130573729|NCT02069899|470064339|FG001|Overall Study|Adverse Event|0|||
130573730|NCT02069899|470064340|FG002|Overall Study|Adverse Event|1|||
130520852|NCT03797989|469874322|FG007|VAC069A|Withdrawal by Subject|0|||
130520853|NCT03797989|469874323|FG008|VAC069A|Withdrawal by Subject|0|||
130520854|NCT03797989|469874324|FG009|VAC069A|Withdrawal by Subject|0|||
130520855|NCT03797989|469874325|FG010|VAC069A|Withdrawal by Subject|0|||
130520856|NCT03797989|469874326|FG011|VAC069A|Withdrawal by Subject|0|||
130520857|NCT00604188|469874328|FG000|Overall Study|Adverse Event|1|||
130520858|NCT00604188|469874329|FG001|Overall Study|Adverse Event|4|||
130520859|NCT00604188|469874328|FG000|Overall Study|Lost to Follow-up|17|||
130520860|NCT00604188|469874329|FG001|Overall Study|Lost to Follow-up|15|||
130520861|NCT00604188|469874328|FG000|Overall Study|Withdrawal by Subject|5|||
130520862|NCT00604188|469874329|FG001|Overall Study|Withdrawal by Subject|1|||
130520863|NCT00604188|469874328|FG000|Overall Study|Non-compliance with protocol|4|||
130520864|NCT00604188|469874329|FG001|Overall Study|Non-compliance with protocol|4|||
130520865|NCT00604188|469874328|FG000|Overall Study|Did not receive study drug|0|||
130520866|NCT00604188|469874329|FG001|Overall Study|Did not receive study drug|1|||
130520867|NCT04088136|469874330|FG000|Overall Study|Withdrawal by Subject|5|||
130573731|NCT02069899|470064338|FG000|Overall Study|Withdrawal by Participant|2|||
130573732|NCT02069899|470064339|FG001|Overall Study|Withdrawal by Participant|0|||
130573733|NCT02069899|470064340|FG002|Overall Study|Withdrawal by Participant|0|||
130573734|NCT02069899|470064338|FG000|Overall Study|Lost to Follow-up|1|||
130573735|NCT02069899|470064339|FG001|Overall Study|Lost to Follow-up|0|||
130573736|NCT02069899|470064340|FG002|Overall Study|Lost to Follow-up|1|||
130573737|NCT02069899|470064338|FG000|Overall Study|Other|4|||
130573738|NCT02069899|470064339|FG001|Overall Study|Other|0|||
130573739|NCT02069899|470064340|FG002|Overall Study|Other|0|||
130573740|NCT02069899|470064338|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
130573741|NCT02069899|470064339|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
130573742|NCT02069899|470064340|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
130520868|NCT04088136|469874331|FG001|Overall Study|Withdrawal by Subject|0|||
130520869|NCT04088136|469874330|FG000|Overall Study|Lack of Efficacy|0|||
130520870|NCT04088136|469874331|FG001|Overall Study|Lack of Efficacy|1|||
130520871|NCT00356759|469874332|FG000|Overall Study|Death|5|||
130573743|NCT02069899|470064338|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
130520872|NCT00356759|469874333|FG001|Overall Study|Death|2|||
130520873|NCT00356759|469874332|FG000|Overall Study|Withdrawal by Subject|2|||
130520874|NCT00356759|469874333|FG001|Overall Study|Withdrawal by Subject|2|||
130520875|NCT00356759|469874332|FG000|Overall Study|Adverse Event|1|||
130520876|NCT00356759|469874333|FG001|Overall Study|Adverse Event|3|||
130520877|NCT00356759|469874332|FG000|Overall Study|Lost to Follow-up|1|||
130520878|NCT00356759|469874333|FG001|Overall Study|Lost to Follow-up|1|||
130520879|NCT00356759|469874332|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
130520880|NCT00356759|469874333|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
130520881|NCT00934700|469874334|FG000|Overall Study|missing scan|5|||
130520882|NCT00934700|469874335|FG001|Overall Study|missing scan|9|||
130520883|NCT00934700|469874334|FG000|Overall Study|Death|8|||
130520884|NCT00934700|469874335|FG001|Overall Study|Death|3|||
130520885|NCT01075100|469874338|FG000|Overall Study|Adverse Event|15|||
130520886|NCT01075100|469874339|FG001|Overall Study|Adverse Event|18|||
130520887|NCT01075100|469874338|FG000|Overall Study|Patient Request|4|||
130520888|NCT01075100|469874339|FG001|Overall Study|Patient Request|4|||
130520889|NCT01075100|469874338|FG000|Overall Study|Investigator Request|2|||
130520890|NCT01075100|469874339|FG001|Overall Study|Investigator Request|1|||
130520891|NCT01075100|469874338|FG000|Overall Study|Disease Progression|25|||
130520892|NCT01075100|469874339|FG001|Overall Study|Disease Progression|29|||
130520893|NCT01075100|469874338|FG000|Overall Study|Other|3|||
130520894|NCT01075100|469874339|FG001|Overall Study|Other|1|||
130520895|NCT02250183|469874340|FG000|Overall Study|Withdrawal by Subject|2|||
130520896|NCT02250183|469874340|FG000|Overall Study|Adverse Event|5|||
130520897|NCT02250183|469874340|FG000|Overall Study|Lost to Follow-up|1|||
130520898|NCT05896696|469874341|FG000|Overall Study|Screening Failure|7|||
130520899|NCT05896696|469874341|FG000|Overall Study|Withdrawal by Subject|2|||
130520900|NCT03900715|469874342|FG000|Overall Study|Protocol Deviation|1|||
130520901|NCT03900715|469874342|FG000|Overall Study|Lack of Efficacy|1|||
130520902|NCT03900715|469874342|FG000|Overall Study|Progressive Disease|6|||
130520903|NCT03900715|469874342|FG000|Overall Study|Adverse Event|2|||
130520904|NCT03900715|469874342|FG000|Overall Study|Other reasons|11|||
130520905|NCT02080403|469876137|FG000|Overall Study|Adverse Event|5|||
130520906|NCT02080403|469876138|FG001|Overall Study|Adverse Event|1|||
130520907|NCT02080403|469876137|FG000|Overall Study|Death|0|||
130520908|NCT02080403|469876138|FG001|Overall Study|Death|2|||
130520909|NCT02080403|469876137|FG000|Overall Study|Lost to Follow-up|2|||
130520910|NCT02080403|469876138|FG001|Overall Study|Lost to Follow-up|0|||
130520911|NCT02080403|469876137|FG000|Overall Study|Pregnancy|0|||
130520912|NCT02080403|469876138|FG001|Overall Study|Pregnancy|1|||
130520913|NCT02080403|469876137|FG000|Overall Study|Protocol Violation|3|||
130520914|NCT02080403|469876138|FG001|Overall Study|Protocol Violation|7|||
130520915|NCT02080403|469876137|FG000|Overall Study|Withdrawal by Subject|5|||
130520916|NCT02080403|469876138|FG001|Overall Study|Withdrawal by Subject|1|||
130520917|NCT01101334|469876139|FG000|Overall Study|Adverse Event|9|||
130520918|NCT01101334|469876140|FG001|Overall Study|Adverse Event|4|||
130520919|NCT01101334|469876139|FG000|Overall Study|Death|7|||
130520920|NCT01101334|469876140|FG001|Overall Study|Death|1|||
130520921|NCT01101334|469876139|FG000|Overall Study|Withdrawal by Subject|4|||
130520922|NCT01101334|469876140|FG001|Overall Study|Withdrawal by Subject|3|||
130520923|NCT01101334|469876139|FG000|Overall Study|Withdrawal by Sponsor|1|||
130520924|NCT01101334|469876140|FG001|Overall Study|Withdrawal by Sponsor|1|||
130520925|NCT01101334|469876139|FG000|Overall Study|Progressive Disease|22|||
130520926|NCT01101334|469876140|FG001|Overall Study|Progressive Disease|35|||
130520927|NCT01101334|469876139|FG000|Overall Study|Other|2|||
130520928|NCT01101334|469876140|FG001|Overall Study|Other|1|||
130520929|NCT03864341|469876143|FG000|Overall Study|Withdrawal by Subject|1|||
130520930|NCT02202109|469876145|FG000|Overall Study|Lost to Follow-up|88|||
130520931|NCT02202109|469876146|FG001|Overall Study|Lost to Follow-up|87|||
130520932|NCT02202109|469876145|FG000|Overall Study|Withdrawal by Subject|2|||
130520933|NCT02202109|469876146|FG001|Overall Study|Withdrawal by Subject|0|||
130520934|NCT00612352|469876147|FG000|Overall Study|Adverse Event|1|||
130520935|NCT00612352|469876148|FG001|Overall Study|Adverse Event|0|||
130520936|NCT00612352|469876147|FG000|Overall Study|Withdrawal by Subject|3|||
130520937|NCT00612352|469876148|FG001|Overall Study|Withdrawal by Subject|5|||
130520938|NCT00612352|469876147|FG000|Overall Study|moved out of state|1|||
130520939|NCT00612352|469876148|FG001|Overall Study|moved out of state|0|||
130520940|NCT00612352|469876147|FG000|Overall Study|didn't return calls/show up on test date|4|||
130520941|NCT00612352|469876148|FG001|Overall Study|didn't return calls/show up on test date|1|||
130520942|NCT00263211|469876149|FG000|Overall Study|Death|1|||
130520943|NCT00263211|469876150|FG001|Overall Study|Death|0|||
130520944|NCT00263211|469876149|FG000|Overall Study|Withdrawal by Subject|3|||
130520945|NCT00263211|469876150|FG001|Overall Study|Withdrawal by Subject|0|||
130520946|NCT00263211|469876149|FG000|Overall Study|Protocol Violation|1|||
130520947|NCT00263211|469876150|FG001|Overall Study|Protocol Violation|0|||
130520948|NCT00263211|469876149|FG000|Overall Study|Disease Progression|0|||
130520949|NCT00263211|469876150|FG001|Overall Study|Disease Progression|1|||
130520950|NCT00760513|469876151|FG000|Overall Study|Withdrawal by Subject|5|||
130520951|NCT00760513|469876152|FG001|Overall Study|Withdrawal by Subject|7|||
130520952|NCT01468077|469876158|FG000|Overall Study|Adverse Event|2|||
130520953|NCT01468077|469876159|FG001|Overall Study|Adverse Event|2|||
130520954|NCT01468077|469876158|FG000|Overall Study|Lack of Efficacy|1|||
130520955|NCT01468077|469876159|FG001|Overall Study|Lack of Efficacy|1|||
130520956|NCT01468077|469876158|FG000|Overall Study|Physician Decision|1|||
130520957|NCT01468077|469876159|FG001|Overall Study|Physician Decision|0|||
130520958|NCT04843579|469876160|FG000|Overall Study|Adverse Event|1|||
130520959|NCT04843579|469876160|FG000|Overall Study|Disease Progression|1|||
130520960|NCT00761956|469876161|FG000|Overall Study|Lost to Follow-up|6|||
130520961|NCT00761956|469876162|FG001|Overall Study|Lost to Follow-up|11|||
130520962|NCT00761956|469876161|FG000|Overall Study|Withdrawal by Subject|3|||
130520963|NCT00761956|469876162|FG001|Overall Study|Withdrawal by Subject|8|||
130520964|NCT00761956|469876161|FG000|Overall Study|Death|0|||
130520965|NCT00761956|469876162|FG001|Overall Study|Death|1|||
130520966|NCT00761956|469876161|FG000|Overall Study|Adverse Event|26|||
130520967|NCT00761956|469876162|FG001|Overall Study|Adverse Event|34|||
130520968|NCT03024996|469876164|FG000|Overall Study|Death|57|||
130520969|NCT03024996|469876165|FG001|Overall Study|Death|55|||
130520970|NCT03024996|469876164|FG000|Overall Study|Disease relapse|1|||
130520971|NCT03024996|469876165|FG001|Overall Study|Disease relapse|0|||
130520972|NCT03024996|469876164|FG000|Overall Study|Lost to Follow-up|5|||
130520973|NCT03024996|469876165|FG001|Overall Study|Lost to Follow-up|10|||
130520974|NCT03024996|469876164|FG000|Overall Study|Other|3|||
130520975|NCT03024996|469876165|FG001|Overall Study|Other|3|||
130520976|NCT03024996|469876164|FG000|Overall Study|Physician Decision|0|||
130520977|NCT03024996|469876165|FG001|Overall Study|Physician Decision|1|||
130520978|NCT03024996|469876164|FG000|Overall Study|Study terminated by sponsor|303|||
130520979|NCT03024996|469876165|FG001|Overall Study|Study terminated by sponsor|283|||
130520980|NCT03024996|469876164|FG000|Overall Study|Withdrawal by Subject|21|||
130520981|NCT03024996|469876165|FG001|Overall Study|Withdrawal by Subject|36|||
130520982|NCT01951378|469876169|FG000|Overall Study|Study Terminated-Not completed|23|||
130520983|NCT01951378|469876170|FG001|Overall Study|Study Terminated-Not completed|17|||
130520984|NCT00464945|469876171|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
130520985|NCT00464945|469876172|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
130520986|NCT00464945|469876171|FG000|Infant Series|Protocol Violation|1|||
130520987|NCT00464945|469876172|FG001|Infant Series|Protocol Violation|0|||
130520988|NCT00464945|469876171|FG000|Infant Series|Lost to Follow-up|1|||
130520989|NCT00464945|469876172|FG001|Infant Series|Lost to Follow-up|0|||
130520990|NCT00464945|469876171|FG000|After Infant Series|Withdrawal by Subject|0|||
130520991|NCT00464945|469876172|FG001|After Infant Series|Withdrawal by Subject|2|||
130520992|NCT00464945|469876171|FG000|Toddler Dose|Lost to Follow-up|0|||
130520993|NCT00464945|469876172|FG001|Toddler Dose|Lost to Follow-up|1|||
130520994|NCT03065933|469876175|FG000|Overall Study|study terminated|5|||
130520995|NCT02536742|469876176|FG000|Overall Study|Did not start protocol therapy|1|||
130520996|NCT02536742|469876176|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
130520997|NCT04629443|469876177|FG000|Overall Study|Adverse Event|2|||
130520998|NCT04629443|469876178|FG001|Overall Study|Adverse Event|1|||
130520999|NCT04629443|469876179|FG002|Overall Study|Adverse Event|2|||
130521000|NCT04629443|469876177|FG000|Overall Study|Progressive Disease|2|||
130521001|NCT04629443|469876178|FG001|Overall Study|Progressive Disease|3|||
130521002|NCT04629443|469876179|FG002|Overall Study|Progressive Disease|3|||
130521003|NCT04629443|469876177|FG000|Overall Study|Physician Decision|1|||
130521004|NCT04629443|469876178|FG001|Overall Study|Physician Decision|3|||
130521005|NCT04629443|469876179|FG002|Overall Study|Physician Decision|0|||
130521006|NCT01547117|469876181|FG000|Overall Study|Physician Decision|0|||
130521007|NCT01547117|469876182|FG001|Overall Study|Physician Decision|1|||
130521008|NCT01547117|469876183|FG002|Overall Study|Physician Decision|1|||
130521009|NCT01547117|469876184|FG003|Overall Study|Physician Decision|3|||
130521010|NCT01547117|469876181|FG000|Overall Study|Withdrawal by Subject|1|||
130521011|NCT01547117|469876182|FG001|Overall Study|Withdrawal by Subject|2|||
130521012|NCT01547117|469876183|FG002|Overall Study|Withdrawal by Subject|1|||
130521013|NCT01547117|469876184|FG003|Overall Study|Withdrawal by Subject|2|||
130521014|NCT03491215|469876187|FG000|Overall Study|Death|6|||
130521015|NCT03491215|469876188|FG001|Overall Study|Death|2|||
130521016|NCT03491215|469876189|FG002|Overall Study|Death|1|||
130521017|NCT03491215|469876190|FG003|Overall Study|Death|0|||
130521018|NCT03491215|469876187|FG000|Overall Study|Physician Decision|1|||
130521019|NCT03491215|469876188|FG001|Overall Study|Physician Decision|0|||
130521020|NCT03491215|469876189|FG002|Overall Study|Physician Decision|0|||
130521021|NCT03491215|469876190|FG003|Overall Study|Physician Decision|0|||
130521022|NCT01336205|469876195|FG000|Overall Study|Other|22|||
130521023|NCT01336205|469876196|FG001|Overall Study|Other|9|||
130521024|NCT01336205|469876195|FG000|Overall Study|Lost to Follow-up|40|||
130521025|NCT01336205|469876196|FG001|Overall Study|Lost to Follow-up|20|||
130521026|NCT01336205|469876195|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
130521027|NCT01336205|469876196|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
130521028|NCT01336205|469876195|FG000|Overall Study|Lack of Efficacy|4|||
130521029|NCT01336205|469876196|FG001|Overall Study|Lack of Efficacy|0|||
130573744|NCT02069899|470064339|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
130573745|NCT02069899|470064340|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
130573746|NCT00490451|470064343|FG000|Overall Study|Adverse Event|3|||
130573747|NCT00490451|470064344|FG001|Overall Study|Adverse Event|3|||
130573748|NCT00490451|470064343|FG000|Overall Study|Death|3|||
130573749|NCT00490451|470064344|FG001|Overall Study|Death|1|||
130573750|NCT00490451|470064343|FG000|Overall Study|Withdrawal by Subject|2|||
130573751|NCT00490451|470064344|FG001|Overall Study|Withdrawal by Subject|0|||
130573752|NCT00490451|470064343|FG000|Overall Study|Investigator Decision|1|||
130573753|NCT00490451|470064344|FG001|Overall Study|Investigator Decision|0|||
130573754|NCT00490451|470064343|FG000|Overall Study|Protocol Violation|1|||
130573755|NCT00490451|470064344|FG001|Overall Study|Protocol Violation|0|||
130573756|NCT00490451|470064343|FG000|Overall Study|Progressive Disease|53|||
130573757|NCT00490451|470064344|FG001|Overall Study|Progressive Disease|34|||
130573758|NCT01181011|470064345|FG000|Overall Study|Adverse Event|2|||
130573759|NCT01181011|470064345|FG000|Overall Study|Lost to Follow-up|1|||
130573760|NCT00137111|470064346|FG000|Total Therapy|Death|35|||
130573761|NCT00137111|470064347|FG001|Total Therapy|Death|0|||
130573762|NCT00137111|470064348|FG002|Total Therapy|Death|0|||
130573763|NCT00137111|470064349|FG003|Total Therapy|Death|0|||
130573764|NCT00137111|470064346|FG000|Total Therapy|Non Compliance|5|||
130573765|NCT00137111|470064347|FG001|Total Therapy|Non Compliance|0|||
130573766|NCT00137111|470064348|FG002|Total Therapy|Non Compliance|0|||
130573767|NCT00137111|470064349|FG003|Total Therapy|Non Compliance|0|||
130573768|NCT04703075|470064350|FG000|Overall Study|Adverse Event|11|||
130573769|NCT04703075|470064351|FG001|Overall Study|Adverse Event|7|||
130573770|NCT04703075|470064350|FG000|Overall Study|Lost to Follow-up|6|||
130573771|NCT04703075|470064351|FG001|Overall Study|Lost to Follow-up|12|||
130573772|NCT04703075|470064350|FG000|Overall Study|Physician Decision|3|||
130521030|NCT01336205|469876195|FG000|Overall Study|Severe noncompliance with protocol|9|||
130521031|NCT01336205|469876196|FG001|Overall Study|Severe noncompliance with protocol|2|||
130521032|NCT01336205|469876195|FG000|Overall Study|Adverse Event|56|||
130521033|NCT01336205|469876196|FG001|Overall Study|Adverse Event|6|||
130521034|NCT01336205|469876195|FG000|Overall Study|Death|1|||
130521035|NCT01336205|469876196|FG001|Overall Study|Death|1|||
130521036|NCT01336205|469876195|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
130521037|NCT01336205|469876196|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
130521038|NCT01336205|469876195|FG000|Overall Study|Withdrawal by Subject|72|||
130521039|NCT01336205|469876196|FG001|Overall Study|Withdrawal by Subject|38|||
130521040|NCT01336205|469876195|FG000|Overall Study|Did not receive treatment|4|||
130521041|NCT01336205|469876196|FG001|Overall Study|Did not receive treatment|0|||
130521042|NCT01006616|469876197|FG000|Period 1 (6 Months)|Adverse Event|10|||
130521043|NCT01006616|469876198|FG001|Period 1 (6 Months)|Adverse Event|31|||
130521044|NCT01006616|469876199|FG002|Period 1 (6 Months)|Adverse Event|37|||
130521045|NCT01006616|469876200|FG003|Period 1 (6 Months)|Adverse Event|9|||
130521046|NCT01006616|469876197|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
130521047|NCT01006616|469876198|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
130521048|NCT01006616|469876199|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
130521049|NCT01006616|469876200|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
130521050|NCT01006616|469876197|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
130521051|NCT01006616|469876198|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
130521052|NCT01006616|469876199|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
130521053|NCT01006616|469876200|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
130521054|NCT01006616|469876197|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
130521055|NCT01006616|469876198|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
130521056|NCT01006616|469876199|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
130521057|NCT01006616|469876200|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
130521058|NCT01006616|469876197|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
130521059|NCT01006616|469876198|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
130521060|NCT01006616|469876199|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
130573773|NCT04703075|470064351|FG001|Overall Study|Physician Decision|0|||
130573774|NCT04703075|470064350|FG000|Overall Study|Moved|0|||
130573775|NCT04703075|470064351|FG001|Overall Study|Moved|2|||
130573776|NCT04703075|470064350|FG000|Overall Study|Index INH Resistant|0|||
130573777|NCT04703075|470064351|FG001|Overall Study|Index INH Resistant|1|||
130573778|NCT04703075|470064350|FG000|Overall Study|Lack of Efficacy|6|||
130573779|NCT04703075|470064351|FG001|Overall Study|Lack of Efficacy|18|||
130573780|NCT01967550|470064352|FG000|Overall Study|Withdrawal by Subject|1|||
130573781|NCT01967550|470064353|FG001|Overall Study|Withdrawal by Subject|0|||
130573782|NCT01967550|470064352|FG000|Overall Study|Adverse Event|2|||
130573783|NCT01967550|470064353|FG001|Overall Study|Adverse Event|0|||
130573784|NCT01967550|470064352|FG000|Overall Study|Protocol Violation|2|||
130573785|NCT01967550|470064353|FG001|Overall Study|Protocol Violation|1|||
130573786|NCT01967550|470064352|FG000|Overall Study|Non Compliance|0|||
130521061|NCT01006616|469876200|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
130573787|NCT01967550|470064353|FG001|Overall Study|Non Compliance|1|||
130521062|NCT01006616|469876197|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
130521063|NCT01006616|469876198|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
130521064|NCT01006616|469876199|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
130521065|NCT01006616|469876200|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
130521066|NCT01006616|469876197|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
130521067|NCT01006616|469876198|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
130521068|NCT01006616|469876199|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
130521069|NCT01006616|469876200|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
130521070|NCT01006616|469876197|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
130521071|NCT01006616|469876198|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
130521072|NCT01006616|469876199|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
130521073|NCT01006616|469876200|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
130521074|NCT01006616|469876197|FG000|Period 1 (6 Months)|Not Treated|0|||
130521075|NCT01006616|469876198|FG001|Period 1 (6 Months)|Not Treated|0|||
130521076|NCT01006616|469876199|FG002|Period 1 (6 Months)|Not Treated|1|||
130521077|NCT01006616|469876200|FG003|Period 1 (6 Months)|Not Treated|1|||
130521078|NCT01006616|469876197|FG000|Period 2 (18 Months)|Adverse Event|6|||
130521079|NCT01006616|469876198|FG001|Period 2 (18 Months)|Adverse Event|6|||
130521080|NCT01006616|469876199|FG002|Period 2 (18 Months)|Adverse Event|6|||
130521081|NCT01006616|469876200|FG003|Period 2 (18 Months)|Adverse Event|4|||
130521082|NCT01006616|469876197|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
130521083|NCT01006616|469876198|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
130521084|NCT01006616|469876199|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
130521085|NCT01006616|469876200|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
130521086|NCT01006616|469876197|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
130521087|NCT01006616|469876198|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
130521088|NCT01006616|469876199|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
130521089|NCT01006616|469876200|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
130521090|NCT01006616|469876197|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
130521091|NCT01006616|469876198|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
130521092|NCT01006616|469876199|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
130521093|NCT01006616|469876200|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
130521094|NCT01006616|469876197|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
130521095|NCT01006616|469876198|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
130521096|NCT01006616|469876199|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
130521097|NCT01006616|469876200|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
130521098|NCT01006616|469876197|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
130521099|NCT01006616|469876198|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
130521100|NCT01006616|469876199|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
130521101|NCT01006616|469876200|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
130521102|NCT01006616|469876197|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
130521103|NCT01006616|469876198|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
130521104|NCT01006616|469876199|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
130521105|NCT01006616|469876200|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
130521106|NCT01006616|469876197|FG000|Period 2 (18 Months)|Study Terminated|63|||
130521107|NCT01006616|469876198|FG001|Period 2 (18 Months)|Study Terminated|46|||
130521108|NCT01006616|469876199|FG002|Period 2 (18 Months)|Study Terminated|44|||
130521109|NCT01006616|469876200|FG003|Period 2 (18 Months)|Study Terminated|70|||
130521110|NCT02482935|469876201|FG000|Period 1|Withdrawal by Subject|1|||
130521111|NCT02482935|469876202|FG001|Period 1|Withdrawal by Subject|0|||
130521112|NCT01585298|469876207|FG000|Overall Study|Study completion was not documented.|1|||
130521113|NCT01585298|469876207|FG000|Overall Study|Protocol deviation|1|||
130521114|NCT01585298|469876207|FG000|Overall Study|Administrative problems|4|||
130521115|NCT01585298|469876207|FG000|Overall Study|Lost to Follow-up|2|||
130521116|NCT01585298|469876207|FG000|Overall Study|Withdrawal by Subject|4|||
130521117|NCT01585298|469876207|FG000|Overall Study|Abnormal test procedure results|1|||
130521118|NCT01585298|469876207|FG000|Overall Study|Adverse Event|24|||
130521119|NCT01898442|469876209|FG000|Overall Study|Hemolysis/technical problems|1|||
130521120|NCT01898442|469876210|FG001|Overall Study|Hemolysis/technical problems|2|||
130521121|NCT01898442|469876211|FG002|Overall Study|Hemolysis/technical problems|2|||
130521122|NCT01898442|469876209|FG000|Overall Study|Patient vomited pills|0|||
130521123|NCT01898442|469876210|FG001|Overall Study|Patient vomited pills|0|||
130521124|NCT01898442|469876211|FG002|Overall Study|Patient vomited pills|1|||
130521125|NCT05178979|469876212|FG000|Overall Study|Death|0|||
130521126|NCT05178979|469876213|FG001|Overall Study|Death|5|||
130521127|NCT05178979|469876214|FG002|Overall Study|Death|0|||
130521128|NCT05178979|469876215|FG003|Overall Study|Death|3|||
130521129|NCT05178979|469876212|FG000|Overall Study|Adverse Event|0|||
130521130|NCT05178979|469876213|FG001|Overall Study|Adverse Event|1|||
130521131|NCT05178979|469876214|FG002|Overall Study|Adverse Event|0|||
130521132|NCT05178979|469876215|FG003|Overall Study|Adverse Event|0|||
130521133|NCT05178979|469876212|FG000|Overall Study|Lost to Follow-up|1|||
130521134|NCT05178979|469876213|FG001|Overall Study|Lost to Follow-up|8|||
130521135|NCT05178979|469876214|FG002|Overall Study|Lost to Follow-up|3|||
130521136|NCT05178979|469876215|FG003|Overall Study|Lost to Follow-up|8|||
130521137|NCT01704547|469876217|FG000|Overall Study|Physician Decision|4|||
130521138|NCT01704547|469876217|FG000|Overall Study|Withdrawal by Subject|1|||
130521139|NCT02019641|469876224|FG000|10-Week Follow up|Withdrawal by investigator|2|||
130521140|NCT02019641|469876225|FG001|10-Week Follow up|Withdrawal by investigator|0|||
130521141|NCT02019641|469876226|FG002|10-Week Follow up|Withdrawal by investigator|0|||
130521142|NCT02019641|469876224|FG000|10-Week Follow up|Withdrawal by Subject|1|||
130521143|NCT02019641|469876225|FG001|10-Week Follow up|Withdrawal by Subject|1|||
130521144|NCT02019641|469876226|FG002|10-Week Follow up|Withdrawal by Subject|0|||
130521145|NCT02019641|469876224|FG000|20-Week Follow up|Withdrawal by investigator|0|||
130521146|NCT02019641|469876225|FG001|20-Week Follow up|Withdrawal by investigator|0|||
130521147|NCT02019641|469876226|FG002|20-Week Follow up|Withdrawal by investigator|1|||
130521148|NCT03318783|469876227|FG000|Overall Study|Withdrawal by Subject|0|||
130521149|NCT03318783|469876228|FG001|Overall Study|Withdrawal by Subject|1|||
130521150|NCT03318783|469876227|FG000|Overall Study|Death|0|||
130521151|NCT03318783|469876228|FG001|Overall Study|Death|1|||
130521152|NCT03410108|469876231|FG000|Overall Study|Ongoing|41|||
130521153|NCT03410108|469876231|FG000|Overall Study|Adverse Event|4|||
130521154|NCT03410108|469876231|FG000|Overall Study|Progressive Disease|58|||
130521155|NCT03410108|469876231|FG000|Overall Study|Withdrawal by Subject|1|||
130521156|NCT04035577|469876235|FG000|Overall Study|Lost to Follow-up|1|||
130521157|NCT04035577|469876235|FG000|Overall Study|Withdrawal by Subject|1|||
130521158|NCT03269695|469876236|FG000|Overall Study|Adverse Event|2|||
130521159|NCT03269695|469876237|FG001|Overall Study|Adverse Event|1|||
130521160|NCT03269695|469876236|FG000|Overall Study|Lack of Efficacy|0|||
130521161|NCT03269695|469876237|FG001|Overall Study|Lack of Efficacy|1|||
130521162|NCT03269695|469876236|FG000|Overall Study|Withdrawal by Subject|0|||
130521163|NCT03269695|469876237|FG001|Overall Study|Withdrawal by Subject|1|||
130521164|NCT00104637|469876239|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
130521165|NCT00104637|469876240|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
130521166|NCT01313624|469876241|FG000|Double-Blind Phase|Adverse Event|27|||
130521167|NCT01313624|469876242|FG001|Double-Blind Phase|Adverse Event|4|||
130521168|NCT01313624|469876241|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
130521169|NCT01313624|469876242|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
130521170|NCT01313624|469876241|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130521171|NCT01313624|469876242|FG001|Double-Blind Phase|Lost to Follow-up|2|||
130521172|NCT01313624|469876241|FG000|Double-Blind Phase|Physician Decision|1|||
130521173|NCT01313624|469876242|FG001|Double-Blind Phase|Physician Decision|0|||
130521174|NCT01313624|469876241|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130521175|NCT01313624|469876242|FG001|Double-Blind Phase|Lack of Efficacy|0|||
130521176|NCT01313624|469876241|FG000|Open-Label Phase|Adverse Event|1|||
130521177|NCT01313624|469876242|FG001|Open-Label Phase|Adverse Event|10|||
130521178|NCT01313624|469876241|FG000|Open-Label Phase|Withdrawal by Subject|2|||
130521179|NCT01313624|469876242|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130521180|NCT01313624|469876241|FG000|Open-Label Phase|Lost to Follow-up|1|||
130521181|NCT01313624|469876242|FG001|Open-Label Phase|Lost to Follow-up|1|||
130521182|NCT00505414|469876243|FG000|Titration Phase|Adverse Event|0|||
130521183|NCT00505414|469876244|FG001|Titration Phase|Adverse Event|0|||
130521184|NCT00505414|469876245|FG002|Titration Phase|Adverse Event|0|||
130521185|NCT00505414|469876246|FG003|Titration Phase|Adverse Event|8|||
130521186|NCT00505414|469876247|FG004|Titration Phase|Adverse Event|3|||
130521187|NCT00505414|469876243|FG000|Titration Phase|Death|0|||
130521188|NCT00505414|469876244|FG001|Titration Phase|Death|0|||
130521189|NCT00505414|469876245|FG002|Titration Phase|Death|0|||
130521190|NCT00505414|469876246|FG003|Titration Phase|Death|2|||
130521191|NCT00505414|469876247|FG004|Titration Phase|Death|0|||
130521192|NCT00505414|469876243|FG000|Titration Phase|Lack of Efficacy|0|||
130521193|NCT00505414|469876244|FG001|Titration Phase|Lack of Efficacy|0|||
130521194|NCT00505414|469876245|FG002|Titration Phase|Lack of Efficacy|0|||
130521195|NCT00505414|469876246|FG003|Titration Phase|Lack of Efficacy|10|||
130521196|NCT00505414|469876247|FG004|Titration Phase|Lack of Efficacy|1|||
130521197|NCT00505414|469876243|FG000|Titration Phase|Protocol Violation|0|||
130521198|NCT00505414|469876244|FG001|Titration Phase|Protocol Violation|0|||
130521199|NCT00505414|469876245|FG002|Titration Phase|Protocol Violation|0|||
130521200|NCT00505414|469876246|FG003|Titration Phase|Protocol Violation|0|||
130521201|NCT00505414|469876247|FG004|Titration Phase|Protocol Violation|1|||
130521202|NCT00505414|469876243|FG000|Titration Phase|Withdrawal by Subject|0|||
130521203|NCT00505414|469876244|FG001|Titration Phase|Withdrawal by Subject|0|||
130521204|NCT00505414|469876245|FG002|Titration Phase|Withdrawal by Subject|0|||
130521205|NCT00505414|469876246|FG003|Titration Phase|Withdrawal by Subject|3|||
130521206|NCT00505414|469876247|FG004|Titration Phase|Withdrawal by Subject|4|||
130521207|NCT00505414|469876243|FG000|Titration Phase|Underlying disease and therapy required|0|||
130521208|NCT00505414|469876244|FG001|Titration Phase|Underlying disease and therapy required|0|||
130521209|NCT00505414|469876245|FG002|Titration Phase|Underlying disease and therapy required|0|||
130573788|NCT02425826|470064358|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
130573789|NCT02425826|470064359|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
130573790|NCT02425826|470064360|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
130573791|NCT02425826|470064358|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130573792|NCT02425826|470064359|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
130573793|NCT02425826|470064360|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130573794|NCT02425826|470064358|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
130573795|NCT02425826|470064359|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
130573796|NCT02425826|470064360|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
130573797|NCT02425826|470064358|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
130573798|NCT02425826|470064359|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
130573799|NCT02425826|470064360|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
130573800|NCT02425826|470064358|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
130573801|NCT02425826|470064359|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
130573802|NCT02425826|470064360|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
130573803|NCT02425826|470064358|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
130573804|NCT02425826|470064359|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
130573805|NCT02425826|470064360|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
130573806|NCT02425826|470064358|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
130573807|NCT02425826|470064359|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
130573808|NCT02425826|470064360|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
130573809|NCT02425826|470064358|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
130573810|NCT02425826|470064359|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
130573811|NCT02425826|470064360|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
130573812|NCT02425826|470064358|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
130573813|NCT02425826|470064359|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
130573814|NCT02425826|470064360|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
130573815|NCT02425826|470064358|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
130573816|NCT02425826|470064359|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
130573817|NCT02425826|470064360|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
130573818|NCT02124564|470064366|FG000|Treatment Period|Adverse Event|2|||
130573819|NCT02124564|470064366|FG000|Treatment Period|Lack of Efficacy|3|||
130573820|NCT02124564|470064366|FG000|Treatment Period|Withdrawal by Subject|2|||
130573821|NCT02043548|470064369|FG000|Overall Study|Lack of Efficacy|1|||
130573822|NCT02043548|470064370|FG001|Overall Study|Lack of Efficacy|0|||
130573823|NCT02043548|470064369|FG000|Overall Study|Adverse Event|0|||
130573824|NCT02043548|470064370|FG001|Overall Study|Adverse Event|1|||
130573825|NCT01314716|470064374|FG000|Double-Blind Phase|Randomized but not treated|1|||
130573826|NCT01314716|470064375|FG001|Double-Blind Phase|Randomized but not treated|1|||
130573827|NCT01314716|470064374|FG000|Double-Blind Phase|Adverse Event|10|||
130573828|NCT01314716|470064375|FG001|Double-Blind Phase|Adverse Event|4|||
130573829|NCT01314716|470064374|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
130573830|NCT01314716|470064375|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130573831|NCT01314716|470064374|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130573832|NCT01314716|470064375|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130573833|NCT01314716|470064374|FG000|Double-Blind Phase|Sponsor request|1|||
130573834|NCT01314716|470064375|FG001|Double-Blind Phase|Sponsor request|2|||
130573835|NCT01314716|470064374|FG000|Double-Blind Phase|Physician Decision|0|||
130573836|NCT01314716|470064375|FG001|Double-Blind Phase|Physician Decision|1|||
130573837|NCT01314716|470064374|FG000|Open-Label Phase|Adverse Event|4|||
130573838|NCT01314716|470064375|FG001|Open-Label Phase|Adverse Event|6|||
130573839|NCT01314716|470064374|FG000|Open-Label Phase|Withdrawal by Subject|1|||
130573840|NCT01314716|470064375|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130573841|NCT01314716|470064374|FG000|Open-Label Phase|Physician Decision|5|||
130573842|NCT01314716|470064375|FG001|Open-Label Phase|Physician Decision|4|||
130573843|NCT04311502|470066196|FG000|Overall Study|Death|1|||
130573844|NCT04311502|470066197|FG001|Overall Study|Death|1|||
130573845|NCT04311502|470066198|FG002|Overall Study|Death|1|||
130573846|NCT04311502|470066196|FG000|Overall Study|Lost to Follow-up|2|||
130573847|NCT04311502|470066197|FG001|Overall Study|Lost to Follow-up|3|||
130573848|NCT04311502|470066198|FG002|Overall Study|Lost to Follow-up|0|||
130573849|NCT04311502|470066196|FG000|Overall Study|Participant is in prison|1|||
130573850|NCT04311502|470066197|FG001|Overall Study|Participant is in prison|0|||
130573851|NCT04311502|470066198|FG002|Overall Study|Participant is in prison|0|||
130573852|NCT04311502|470066196|FG000|Overall Study|Participant moved out of country|1|||
130573853|NCT04311502|470066197|FG001|Overall Study|Participant moved out of country|0|||
130573854|NCT04311502|470066198|FG002|Overall Study|Participant moved out of country|0|||
130573855|NCT04311502|470066196|FG000|Overall Study|Withdrawal by Subject|2|||
130573856|NCT04311502|470066197|FG001|Overall Study|Withdrawal by Subject|0|||
130573857|NCT04311502|470066198|FG002|Overall Study|Withdrawal by Subject|0|||
130573858|NCT04311502|470066196|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
130573859|NCT04311502|470066197|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
130573860|NCT04311502|470066198|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
130573861|NCT03040999|470066199|FG000|Overall Study|Lost to Follow-up|2|||
130573862|NCT03040999|470066200|FG001|Overall Study|Lost to Follow-up|2|||
130573863|NCT03040999|470066199|FG000|Overall Study|Withdrawal by Subject|12|||
130573864|NCT03040999|470066200|FG001|Overall Study|Withdrawal by Subject|13|||
130573865|NCT03040999|470066199|FG000|Overall Study|Death|155|||
130573866|NCT03040999|470066200|FG001|Overall Study|Death|171|||
130573867|NCT03040999|470066199|FG000|Overall Study|Physician Decision|0|||
130573868|NCT03040999|470066200|FG001|Overall Study|Physician Decision|3|||
130573869|NCT03657043|470066201|FG000|Overall Study|Withdrawal by Subject|1|||
130573870|NCT03657043|470066202|FG001|Overall Study|Withdrawal by Subject|1|||
130573871|NCT03657043|470066203|FG002|Overall Study|Withdrawal by Subject|0|||
130573872|NCT03657043|470066204|FG003|Overall Study|Withdrawal by Subject|0|||
130573873|NCT03657043|470066205|FG004|Overall Study|Withdrawal by Subject|4|||
130573874|NCT03657043|470066201|FG000|Overall Study|Study closure by Sponsor|0|||
130573875|NCT03657043|470066202|FG001|Overall Study|Study closure by Sponsor|2|||
130573876|NCT03657043|470066203|FG002|Overall Study|Study closure by Sponsor|0|||
130573877|NCT03657043|470066204|FG003|Overall Study|Study closure by Sponsor|0|||
130573878|NCT03657043|470066205|FG004|Overall Study|Study closure by Sponsor|17|||
130573879|NCT03657043|470066201|FG000|Overall Study|Lost to Follow-up|0|||
130573880|NCT03657043|470066202|FG001|Overall Study|Lost to Follow-up|0|||
130573881|NCT03657043|470066203|FG002|Overall Study|Lost to Follow-up|0|||
130573882|NCT03657043|470066204|FG003|Overall Study|Lost to Follow-up|0|||
130573883|NCT03657043|470066205|FG004|Overall Study|Lost to Follow-up|4|||
130573884|NCT03657043|470066201|FG000|Overall Study|Death|6|||
130573885|NCT03657043|470066202|FG001|Overall Study|Death|5|||
130573886|NCT03657043|470066203|FG002|Overall Study|Death|0|||
130573887|NCT03657043|470066204|FG003|Overall Study|Death|0|||
130573888|NCT03657043|470066205|FG004|Overall Study|Death|53|||
130573889|NCT03657043|470066201|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
130573890|NCT03657043|470066202|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
130573891|NCT03657043|470066203|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
130573892|NCT03657043|470066204|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
130573893|NCT03657043|470066205|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
130573894|NCT03657043|470066201|FG000|Overall Study|Adverse Event|0|||
130573895|NCT03657043|470066202|FG001|Overall Study|Adverse Event|0|||
130573896|NCT03657043|470066203|FG002|Overall Study|Adverse Event|0|||
130573897|NCT03657043|470066204|FG003|Overall Study|Adverse Event|0|||
130573898|NCT03657043|470066205|FG004|Overall Study|Adverse Event|2|||
130573899|NCT03657043|470066201|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
130573900|NCT03657043|470066202|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
130573901|NCT03657043|470066203|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
130573902|NCT03657043|470066204|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
130573903|NCT03657043|470066205|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
130573904|NCT03657043|470066201|FG000|Overall Study|Withdrawal - declined follow-up|0|||
130573905|NCT03657043|470066202|FG001|Overall Study|Withdrawal - declined follow-up|0|||
130573906|NCT03657043|470066203|FG002|Overall Study|Withdrawal - declined follow-up|0|||
130573907|NCT03657043|470066204|FG003|Overall Study|Withdrawal - declined follow-up|0|||
130573908|NCT03657043|470066205|FG004|Overall Study|Withdrawal - declined follow-up|1|||
130573909|NCT02627495|470066208|FG000|Overall Study|Withdrawal by Subject|4|||
130573910|NCT03257267|470066209|FG000|Overall Study|Adverse Event|17|||
130573911|NCT03257267|470066210|FG001|Overall Study|Adverse Event|7|||
130573912|NCT03257267|470066209|FG000|Overall Study|Death|96|||
130573913|NCT03257267|470066210|FG001|Overall Study|Death|98|||
130573914|NCT03257267|470066209|FG000|Overall Study|Lost to Follow-up|2|||
130573915|NCT03257267|470066210|FG001|Overall Study|Lost to Follow-up|2|||
130573916|NCT03257267|470066209|FG000|Overall Study|Non-compliance with Study Drug|0|||
130573917|NCT03257267|470066210|FG001|Overall Study|Non-compliance with Study Drug|2|||
130573918|NCT03257267|470066209|FG000|Overall Study|Participant Decision|35|||
130573919|NCT03257267|470066210|FG001|Overall Study|Participant Decision|43|||
130573920|NCT03257267|470066209|FG000|Overall Study|Sponsor Decision|1|||
130573921|NCT03257267|470066210|FG001|Overall Study|Sponsor Decision|0|||
130573922|NCT03257267|470066209|FG000|Overall Study|Physician Decision|1|||
130573923|NCT03257267|470066210|FG001|Overall Study|Physician Decision|3|||
130573924|NCT03257267|470066209|FG000|Overall Study|Disease Progression|109|||
130573925|NCT03257267|470066210|FG001|Overall Study|Disease Progression|121|||
130573926|NCT03257267|470066209|FG000|Overall Study|Withdrawal by Subject|8|||
130573927|NCT03257267|470066210|FG001|Overall Study|Withdrawal by Subject|26|||
130573928|NCT03257267|470066209|FG000|Overall Study|Other|0|||
130573929|NCT03257267|470066210|FG001|Overall Study|Other|2|||
130573930|NCT01979523|470066211|FG000|Overall Study|Withdrawal by Subject|1|||
130573931|NCT01979523|470066212|FG001|Overall Study|Withdrawal by Subject|0|||
130573932|NCT00706134|470066213|FG000|Overall Study|Adverse Event|8|||
130573933|NCT00706134|470066214|FG001|Overall Study|Adverse Event|7|||
130573934|NCT00706134|470066215|FG002|Overall Study|Adverse Event|2|||
130573935|NCT00706134|470066216|FG003|Overall Study|Adverse Event|3|||
130573936|NCT00706134|470066213|FG000|Overall Study|Lost to Follow-up|0|||
130573937|NCT00706134|470066214|FG001|Overall Study|Lost to Follow-up|1|||
130573938|NCT00706134|470066215|FG002|Overall Study|Lost to Follow-up|0|||
130573939|NCT00706134|470066216|FG003|Overall Study|Lost to Follow-up|0|||
130573940|NCT00706134|470066213|FG000|Overall Study|Protocol Violation|0|||
130573941|NCT00706134|470066214|FG001|Overall Study|Protocol Violation|6|||
130573942|NCT00706134|470066215|FG002|Overall Study|Protocol Violation|0|||
130573943|NCT00706134|470066216|FG003|Overall Study|Protocol Violation|3|||
130573944|NCT00706134|470066213|FG000|Overall Study|Withdrawal by Subject|1|||
130573945|NCT00706134|470066214|FG001|Overall Study|Withdrawal by Subject|2|||
130573946|NCT00706134|470066215|FG002|Overall Study|Withdrawal by Subject|1|||
130573947|NCT00706134|470066216|FG003|Overall Study|Withdrawal by Subject|0|||
130573948|NCT00706134|470066213|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
130573949|NCT00706134|470066214|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130573950|NCT00706134|470066215|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130573951|NCT00706134|470066216|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
130573952|NCT00706134|470066213|FG000|Overall Study|Did not meet study criteria|2|||
130573953|NCT00706134|470066214|FG001|Overall Study|Did not meet study criteria|0|||
130573954|NCT00706134|470066215|FG002|Overall Study|Did not meet study criteria|0|||
130573955|NCT00706134|470066216|FG003|Overall Study|Did not meet study criteria|0|||
130573956|NCT01982292|470066217|FG000|Overall Study|Adverse Event|2|||
130573957|NCT01982292|470066218|FG001|Overall Study|Adverse Event|0|||
130573958|NCT01982292|470066217|FG000|Overall Study|Death|1|||
130573959|NCT01982292|470066218|FG001|Overall Study|Death|0|||
130573960|NCT01982292|470066217|FG000|Overall Study|Lost to Follow-up|2|||
130573961|NCT01982292|470066218|FG001|Overall Study|Lost to Follow-up|0|||
130573962|NCT01982292|470066217|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
130573963|NCT01982292|470066218|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
130573964|NCT01982292|470066217|FG000|Overall Study|Protocol Deviation|1|||
130573965|NCT01982292|470066218|FG001|Overall Study|Protocol Deviation|0|||
130573966|NCT01982292|470066217|FG000|Overall Study|Patient/Guardian Decision|3|||
130573967|NCT01982292|470066218|FG001|Overall Study|Patient/Guardian Decision|1|||
130573968|NCT01982292|470066217|FG000|Overall Study|Technical Problems|2|||
130573969|NCT01982292|470066218|FG001|Overall Study|Technical Problems|0|||
130521210|NCT00505414|469876246|FG003|Titration Phase|Underlying disease and therapy required|7|||
130521211|NCT00505414|469876247|FG004|Titration Phase|Underlying disease and therapy required|3|||
130521212|NCT00505414|469876243|FG000|Maintenance Phase|Adverse Event|2|||
130521213|NCT00505414|469876244|FG001|Maintenance Phase|Adverse Event|2|||
130521214|NCT00505414|469876245|FG002|Maintenance Phase|Adverse Event|3|||
130521215|NCT00505414|469876246|FG003|Maintenance Phase|Adverse Event|0|||
130521216|NCT00505414|469876247|FG004|Maintenance Phase|Adverse Event|0|||
130521217|NCT00505414|469876243|FG000|Maintenance Phase|Death|2|||
130521218|NCT00505414|469876244|FG001|Maintenance Phase|Death|0|||
130521219|NCT00505414|469876245|FG002|Maintenance Phase|Death|1|||
130521220|NCT00505414|469876246|FG003|Maintenance Phase|Death|0|||
130521221|NCT00505414|469876247|FG004|Maintenance Phase|Death|0|||
130521222|NCT00505414|469876243|FG000|Maintenance Phase|Lack of Efficacy|2|||
130521223|NCT00505414|469876244|FG001|Maintenance Phase|Lack of Efficacy|1|||
130521224|NCT00505414|469876245|FG002|Maintenance Phase|Lack of Efficacy|1|||
130521225|NCT00505414|469876246|FG003|Maintenance Phase|Lack of Efficacy|0|||
130521226|NCT00505414|469876247|FG004|Maintenance Phase|Lack of Efficacy|0|||
130521227|NCT00505414|469876243|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130521228|NCT00505414|469876244|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130521229|NCT00505414|469876245|FG002|Maintenance Phase|Withdrawal by Subject|1|||
130521230|NCT00505414|469876246|FG003|Maintenance Phase|Withdrawal by Subject|0|||
130521231|NCT00505414|469876247|FG004|Maintenance Phase|Withdrawal by Subject|0|||
130521232|NCT00505414|469876243|FG000|Maintenance Phase|underlying disease and therapy required|0|||
130521233|NCT00505414|469876244|FG001|Maintenance Phase|underlying disease and therapy required|2|||
130521234|NCT00505414|469876245|FG002|Maintenance Phase|underlying disease and therapy required|2|||
130521235|NCT00505414|469876246|FG003|Maintenance Phase|underlying disease and therapy required|0|||
130521236|NCT00505414|469876247|FG004|Maintenance Phase|underlying disease and therapy required|0|||
130573970|NCT00746252|470066219|FG000|Overall Study|weight gain >7.5 %|1|||
130573971|NCT00746252|470066220|FG001|Overall Study|weight gain >7.5 %|2|||
130573972|NCT00082888|470066221|FG000|Overall Study|Ineligible|1|||
130521237|NCT00846768|469876248|FG000|Overall Study|Adverse Event|0|||
130521238|NCT00846768|469876249|FG001|Overall Study|Adverse Event|1|||
130521239|NCT00846768|469876250|FG002|Overall Study|Adverse Event|0|||
130521240|NCT00846768|469876251|FG003|Overall Study|Adverse Event|0|||
130521241|NCT00644878|469876252|FG000|Overall Study|Adverse Event|2|||
130521242|NCT00644878|469876252|FG000|Overall Study|Abnormal laboratory value|3|||
130573973|NCT00082888|470066222|FG001|Overall Study|Ineligible|0|||
130573974|NCT00082888|470066223|FG002|Overall Study|Ineligible|0|||
130573975|NCT01659320|470066225|FG000|Overall Study|Withdrawal by Subject|2|||
130573976|NCT01659320|470066225|FG000|Overall Study|Physician Decision|1|||
130573977|NCT01870401|470066226|FG000|Overall Study|Death|48|||
130573978|NCT01870401|470066227|FG001|Overall Study|Death|24|||
130573979|NCT01870401|470066226|FG000|Overall Study|Withdrawal by Subject|39|||
130573980|NCT01870401|470066227|FG001|Overall Study|Withdrawal by Subject|26|||
130573981|NCT01870401|470066226|FG000|Overall Study|Lost to Follow-up|19|||
130573982|NCT01870401|470066227|FG001|Overall Study|Lost to Follow-up|14|||
130573983|NCT01870401|470066226|FG000|Overall Study|Other|9|||
130573984|NCT01870401|470066227|FG001|Overall Study|Other|7|||
130573985|NCT01870401|470066226|FG000|Overall Study|On-going in the Study|35|||
130573986|NCT01870401|470066227|FG001|Overall Study|On-going in the Study|25|||
130573987|NCT04623242|470066228|FG000|Overall Study|Withdrawal by Subject|7|||
130573988|NCT04623242|470066229|FG001|Overall Study|Withdrawal by Subject|12|||
130573989|NCT04623242|470066230|FG002|Overall Study|Withdrawal by Subject|5|||
130573990|NCT04623242|470066231|FG003|Overall Study|Withdrawal by Subject|7|||
130573991|NCT04623242|470066232|FG004|Overall Study|Withdrawal by Subject|0|||
130573992|NCT04623242|470066228|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
130573993|NCT04623242|470066229|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
130573994|NCT04623242|470066230|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
130573995|NCT04623242|470066231|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
130573996|NCT04623242|470066232|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
130573997|NCT04623242|470066228|FG000|Overall Study|Subject unblinded to mutation status|0|||
130573998|NCT04623242|470066229|FG001|Overall Study|Subject unblinded to mutation status|0|||
130573999|NCT04623242|470066230|FG002|Overall Study|Subject unblinded to mutation status|0|||
130574000|NCT04623242|470066231|FG003|Overall Study|Subject unblinded to mutation status|13|||
130574001|NCT04623242|470066232|FG004|Overall Study|Subject unblinded to mutation status|0|||
130574002|NCT00820898|470066233|FG000|Overall Study|Inelgible - wrong primary site|1|||
130574003|NCT00272038|470066236|FG000|Overall Study|withdrew before they received 2 cycles|7|||
130574004|NCT00493870|470066237|FG000|Overall Study|Lost to Follow-up|12|||
130574005|NCT00493870|470066238|FG001|Overall Study|Lost to Follow-up|15|||
130574006|NCT01289015|470066243|FG000|Overall Study|Protocol Violation|12|||
130574007|NCT01289015|470066244|FG001|Overall Study|Protocol Violation|9|||
130574008|NCT01289015|470066243|FG000|Overall Study|Adverse Event|3|||
130574009|NCT01289015|470066244|FG001|Overall Study|Adverse Event|0|||
130574010|NCT01289015|470066243|FG000|Overall Study|Lost to Follow-up|33|||
130574011|NCT01289015|470066244|FG001|Overall Study|Lost to Follow-up|17|||
130574012|NCT01289015|470066243|FG000|Overall Study|Withdrawal by Subject|17|||
130574013|NCT01289015|470066244|FG001|Overall Study|Withdrawal by Subject|8|||
130574014|NCT01289015|470066243|FG000|Overall Study|Disease progression|1|||
130574015|NCT01289015|470066244|FG001|Overall Study|Disease progression|0|||
130574016|NCT01289015|470066243|FG000|Overall Study|Negative baseline culture and others|33|||
130574017|NCT01289015|470066244|FG001|Overall Study|Negative baseline culture and others|20|||
130574018|NCT01709149|470066248|FG000|Open-label Lead-in Phase|Adverse Event|109|||
130574019|NCT01709149|470066249|FG001|Open-label Lead-in Phase|Adverse Event|0|||
130574020|NCT01709149|470066250|FG002|Open-label Lead-in Phase|Adverse Event|0|||
130574021|NCT01709149|470066248|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
130574022|NCT01709149|470066249|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
130574023|NCT01709149|470066250|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
130574024|NCT01709149|470066248|FG000|Open-label Lead-in Phase|Death|1|||
130574025|NCT01709149|470066249|FG001|Open-label Lead-in Phase|Death|0|||
130574026|NCT01709149|470066250|FG002|Open-label Lead-in Phase|Death|0|||
130574027|NCT01709149|470066248|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
130574028|NCT01709149|470066249|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
130574029|NCT01709149|470066250|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
130574030|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130574031|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
130574032|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
130574033|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130574034|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
130574035|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
130574036|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130574037|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
130574038|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
130574039|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
130574040|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
130574041|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
130574042|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
130574043|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
130574044|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
130574045|NCT01709149|470066248|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130574046|NCT01709149|470066249|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
130574047|NCT01709149|470066250|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130574048|NCT02797808|470066255|FG000|Overall Study|Withdrawal by Subject|1|||
130574049|NCT02797808|470066256|FG001|Overall Study|Withdrawal by Subject|1|||
130574050|NCT02797808|470066255|FG000|Overall Study|Physician Decision|6|||
130574051|NCT02797808|470066256|FG001|Overall Study|Physician Decision|2|||
130574052|NCT02192827|470066257|FG000|Overall Study|Lost to Follow-up|25|||
130574053|NCT02192827|470066258|FG001|Overall Study|Lost to Follow-up|27|||
130574054|NCT02192827|470066257|FG000|Overall Study|Given additional steroids with admission|13|||
130574055|NCT02192827|470066258|FG001|Overall Study|Given additional steroids with admission|11|||
130574056|NCT02590588|470066259|FG000|Overall Study|Adverse Event|1|||
130574057|NCT05098041|470066263|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
130574058|NCT00797732|470066269|FG000|Overall Study|Withdrawal by Subject|3|||
130574059|NCT00797732|470066270|FG001|Overall Study|Withdrawal by Subject|3|||
130574060|NCT00797732|470066271|FG002|Overall Study|Withdrawal by Subject|0|||
130574061|NCT00797732|470066269|FG000|Overall Study|Lost to Follow-up|1|||
130574062|NCT00797732|470066270|FG001|Overall Study|Lost to Follow-up|0|||
130574063|NCT00797732|470066271|FG002|Overall Study|Lost to Follow-up|0|||
130574064|NCT00797732|470066269|FG000|Overall Study|Death|1|||
130574065|NCT00797732|470066270|FG001|Overall Study|Death|0|||
130574066|NCT00797732|470066271|FG002|Overall Study|Death|0|||
130574067|NCT00797732|470066269|FG000|Overall Study|Not meet inclusion criteria|0|||
130574068|NCT00797732|470066270|FG001|Overall Study|Not meet inclusion criteria|0|||
130574069|NCT00797732|470066271|FG002|Overall Study|Not meet inclusion criteria|7|||
130574070|NCT00797732|470066269|FG000|Overall Study|Excluded due to time constraints|0|||
130574071|NCT00797732|470066270|FG001|Overall Study|Excluded due to time constraints|0|||
130574072|NCT00797732|470066271|FG002|Overall Study|Excluded due to time constraints|24|||
130574073|NCT00797732|470066269|FG000|Overall Study|Refused to Participate|0|||
130574074|NCT00797732|470066270|FG001|Overall Study|Refused to Participate|0|||
130574075|NCT00797732|470066271|FG002|Overall Study|Refused to Participate|123|||
130574076|NCT00401752|470066272|FG000|Overall Study|Adverse Event|2|||
130574077|NCT00401752|470066273|FG001|Overall Study|Adverse Event|5|||
130574078|NCT00401752|470066272|FG000|Overall Study|Withdrawal by Subject|2|||
130574079|NCT00401752|470066273|FG001|Overall Study|Withdrawal by Subject|6|||
130574080|NCT00401752|470066272|FG000|Overall Study|Lost to Follow-up|1|||
130574081|NCT00401752|470066273|FG001|Overall Study|Lost to Follow-up|4|||
130574082|NCT00401752|470066272|FG000|Overall Study|Development of any exclusion criteria|4|||
130574083|NCT00401752|470066273|FG001|Overall Study|Development of any exclusion criteria|2|||
130574084|NCT00401752|470066272|FG000|Overall Study|Physician Decision|1|||
130574085|NCT00401752|470066273|FG001|Overall Study|Physician Decision|1|||
130574086|NCT01895322|470066274|FG000|Overall Study|Adverse Event|1|||
130574087|NCT01895322|470066274|FG000|Overall Study|Withdrawal by Subject|2|||
130574088|NCT01895322|470066274|FG000|Overall Study|Protocol Violation|10|||
130574089|NCT02275338|470066275|FG000|Overall Study|Adverse Event|15|||
130574090|NCT02275338|470066275|FG000|Overall Study|Lack of Efficacy|3|||
130574091|NCT02275338|470066275|FG000|Overall Study|Withdrawal by Subject|4|||
130574092|NCT02275338|470066275|FG000|Overall Study|Disease progression (death)|1|||
130574093|NCT02275338|470066275|FG000|Overall Study|Ineligible to start Phase 2|4|||
130574094|NCT02275338|470066275|FG000|Overall Study|Reason not specified|5|||
130574095|NCT02275338|470066275|FG000|Overall Study|Does not meet entry criteria|1|||
130574096|NCT01857869|470066278|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
130521243|NCT00644878|469876252|FG000|Overall Study|Protocol deviation|2|||
130521244|NCT00644878|469876252|FG000|Overall Study|Treatment duration completed as per protocol|11|||
130521245|NCT00591591|469876255|FG000|Overall Study|Withdrawal by Subject|1|||
130521246|NCT00591591|469876256|FG001|Overall Study|Withdrawal by Subject|37|||
130521247|NCT00591591|469876255|FG000|Overall Study|Lack of Efficacy|10|||
130521248|NCT00591591|469876256|FG001|Overall Study|Lack of Efficacy|2|||
130521249|NCT00468130|469876262|FG000|Overall Study|Adverse Event|2|||
130521250|NCT00468130|469876263|FG001|Overall Study|Adverse Event|1|||
130521251|NCT00468130|469876262|FG000|Overall Study|Withdrawal by Subject|0|||
130521252|NCT00468130|469876263|FG001|Overall Study|Withdrawal by Subject|1|||
130521253|NCT00436956|469876264|FG000|Overall Study|Not evaluable|1|||
130521254|NCT00436956|469876265|FG001|Overall Study|Not evaluable|0|||
130521255|NCT01841112|469876267|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
130521256|NCT01841112|469876268|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
130521257|NCT01841112|469876269|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
130521258|NCT01841112|469876270|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
130521259|NCT01841112|469876271|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
130521260|NCT01726517|469876275|FG000|Overall Study|Withdrawal by Subject|0|||
130521261|NCT01726517|469876276|FG001|Overall Study|Withdrawal by Subject|0|||
130574097|NCT01857869|470066279|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
130574098|NCT01857869|470066280|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
130574099|NCT01857869|470066281|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
130574100|NCT01857869|470066282|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
130574101|NCT01857869|470066283|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
130574102|NCT01857869|470066284|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
130521262|NCT01726517|469876277|FG002|Overall Study|Withdrawal by Subject|1|||
130521263|NCT01726517|469876278|FG003|Overall Study|Withdrawal by Subject|0|||
130521264|NCT01726517|469876279|FG004|Overall Study|Withdrawal by Subject|0|||
130521265|NCT03765164|469876280|FG000|Pre-intervention|Withdrawal by Subject|5|||
130521266|NCT03765164|469876281|FG001|Pre-intervention|Withdrawal by Subject|6|||
130521267|NCT03448536|469876283|FG000|Overall Study|Protocol Violation|2|||
130521268|NCT03448536|469876284|FG001|Overall Study|Protocol Violation|0|||
130521269|NCT03448536|469876283|FG000|Overall Study|Pregnancy|1|||
130521270|NCT03448536|469876284|FG001|Overall Study|Pregnancy|0|||
130521271|NCT03448536|469876283|FG000|Overall Study|Withdrawal by Subject|1|||
130521272|NCT03448536|469876284|FG001|Overall Study|Withdrawal by Subject|2|||
130521273|NCT03448536|469876283|FG000|Overall Study|Lost to Follow-up|3|||
130521274|NCT03448536|469876284|FG001|Overall Study|Lost to Follow-up|2|||
130521275|NCT03448536|469876283|FG000|Overall Study|Inadequate pain reporter|1|||
130521276|NCT03448536|469876284|FG001|Overall Study|Inadequate pain reporter|0|||
130521277|NCT03448536|469876283|FG000|Overall Study|Other|3|||
130521278|NCT03448536|469876284|FG001|Overall Study|Other|0|||
130521279|NCT03448536|469876283|FG000|Overall Study|Physician Decision|1|||
130521280|NCT03448536|469876284|FG001|Overall Study|Physician Decision|0|||
130521281|NCT04052997|469876289|FG000|Overall Study|Withdrawal by Subject|17|||
130521282|NCT04052997|469876289|FG000|Overall Study|Physician Decision|50|||
130521283|NCT04052997|469876289|FG000|Overall Study|Death|43|||
130521284|NCT04052997|469876289|FG000|Overall Study|Lost to Follow-up|5|||
130521285|NCT04052997|469876289|FG000|Overall Study|Progression of Disease|1|||
130521286|NCT01024036|469876290|FG000|Blinded Treatment|Adverse Event|1|||
130521287|NCT01024036|469876291|FG001|Blinded Treatment|Adverse Event|1|||
130521288|NCT01024036|469876290|FG000|Blinded Treatment|Lack of Efficacy|16|||
130521289|NCT01024036|469876291|FG001|Blinded Treatment|Lack of Efficacy|14|||
130521290|NCT01024036|469876290|FG000|Blinded Treatment|Physician Decision|1|||
130521291|NCT01024036|469876291|FG001|Blinded Treatment|Physician Decision|0|||
130521292|NCT01024036|469876290|FG000|Blinded Treatment|Death|0|||
130521293|NCT01024036|469876291|FG001|Blinded Treatment|Death|2|||
130521294|NCT01024036|469876290|FG000|Blinded Treatment|Withdrawal by Subject|4|||
130521295|NCT01024036|469876291|FG001|Blinded Treatment|Withdrawal by Subject|3|||
130521296|NCT01024036|469876290|FG000|Unblinded Treatment|Adverse Event|0|||
130521297|NCT01024036|469876291|FG001|Unblinded Treatment|Adverse Event|1|||
130521298|NCT01024036|469876290|FG000|Unblinded Treatment|Lack of Efficacy|0|||
130521299|NCT01024036|469876291|FG001|Unblinded Treatment|Lack of Efficacy|2|||
130521300|NCT01024036|469876290|FG000|Follow-Up Period|Lost to Follow-up|1|||
130521301|NCT01024036|469876291|FG001|Follow-Up Period|Lost to Follow-up|1|||
130521302|NCT01024036|469876290|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130521303|NCT01024036|469876291|FG001|Follow-Up Period|Withdrawal by Subject|1|||
130521304|NCT01024036|469876290|FG000|Follow-Up Period|Adverse Event|4|||
130521305|NCT01024036|469876291|FG001|Follow-Up Period|Adverse Event|1|||
130521306|NCT01999972|469878624|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
130521307|NCT01999972|469878625|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
130521308|NCT01999972|469878626|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
130521309|NCT01999972|469878627|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
130521310|NCT01999972|469878628|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
130521311|NCT01999972|469878629|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
130521312|NCT01999972|469878624|FG000|Dose Escalation Part|Death|0|||
130521313|NCT01999972|469878625|FG001|Dose Escalation Part|Death|1|||
130521314|NCT01999972|469878626|FG002|Dose Escalation Part|Death|0|||
130521315|NCT01999972|469878627|FG003|Dose Escalation Part|Death|0|||
130521316|NCT01999972|469878628|FG004|Dose Escalation Part|Death|0|||
130521317|NCT01999972|469878629|FG005|Dose Escalation Part|Death|0|||
130521318|NCT01999972|469878624|FG000|Dose Escalation Part|Enrolled but not treated|0|||
130521319|NCT01999972|469878625|FG001|Dose Escalation Part|Enrolled but not treated|0|||
130521320|NCT01999972|469878626|FG002|Dose Escalation Part|Enrolled but not treated|1|||
130521321|NCT01999972|469878627|FG003|Dose Escalation Part|Enrolled but not treated|1|||
130521322|NCT01999972|469878628|FG004|Dose Escalation Part|Enrolled but not treated|0|||
130521323|NCT01999972|469878629|FG005|Dose Escalation Part|Enrolled but not treated|0|||
130521324|NCT01999972|469878624|FG000|Dose Escalation Part|Disease progression|3|||
130521325|NCT01999972|469878625|FG001|Dose Escalation Part|Disease progression|2|||
130521326|NCT01999972|469878626|FG002|Dose Escalation Part|Disease progression|3|||
130521327|NCT01999972|469878627|FG003|Dose Escalation Part|Disease progression|6|||
130521328|NCT01999972|469878628|FG004|Dose Escalation Part|Disease progression|0|||
130521329|NCT01999972|469878629|FG005|Dose Escalation Part|Disease progression|0|||
130521330|NCT01999972|469878624|FG000|Dose Escalation Part|Adverse Event|0|||
130521331|NCT01999972|469878625|FG001|Dose Escalation Part|Adverse Event|0|||
130521332|NCT01999972|469878626|FG002|Dose Escalation Part|Adverse Event|0|||
130521333|NCT01999972|469878627|FG003|Dose Escalation Part|Adverse Event|2|||
130521334|NCT01999972|469878628|FG004|Dose Escalation Part|Adverse Event|0|||
130521335|NCT01999972|469878629|FG005|Dose Escalation Part|Adverse Event|0|||
130521336|NCT01999972|469878624|FG000|Dose Escalation Part|Global deterioration of health status|1|||
130521337|NCT01999972|469878625|FG001|Dose Escalation Part|Global deterioration of health status|0|||
130521338|NCT01999972|469878626|FG002|Dose Escalation Part|Global deterioration of health status|0|||
130521339|NCT01999972|469878627|FG003|Dose Escalation Part|Global deterioration of health status|1|||
130521340|NCT01999972|469878628|FG004|Dose Escalation Part|Global deterioration of health status|0|||
130521341|NCT01999972|469878629|FG005|Dose Escalation Part|Global deterioration of health status|0|||
130521342|NCT01999972|469878624|FG000|Dose Expansion Part|Death|0|||
130521343|NCT01999972|469878625|FG001|Dose Expansion Part|Death|0|||
130521344|NCT01999972|469878626|FG002|Dose Expansion Part|Death|0|||
130521345|NCT01999972|469878627|FG003|Dose Expansion Part|Death|0|||
130521346|NCT01999972|469878628|FG004|Dose Expansion Part|Death|2|||
130521347|NCT01999972|469878629|FG005|Dose Expansion Part|Death|1|||
130521348|NCT01999972|469878624|FG000|Dose Expansion Part|Disease progression|0|||
130521349|NCT01999972|469878625|FG001|Dose Expansion Part|Disease progression|0|||
130521350|NCT01999972|469878626|FG002|Dose Expansion Part|Disease progression|0|||
130521351|NCT01999972|469878627|FG003|Dose Expansion Part|Disease progression|0|||
130521352|NCT01999972|469878628|FG004|Dose Expansion Part|Disease progression|9|||
130521353|NCT01999972|469878629|FG005|Dose Expansion Part|Disease progression|3|||
130521354|NCT01999972|469878624|FG000|Dose Expansion Part|Sponsor decision|0|||
130521355|NCT01999972|469878625|FG001|Dose Expansion Part|Sponsor decision|0|||
130521356|NCT01999972|469878626|FG002|Dose Expansion Part|Sponsor decision|0|||
130521357|NCT01999972|469878627|FG003|Dose Expansion Part|Sponsor decision|0|||
130521358|NCT01999972|469878628|FG004|Dose Expansion Part|Sponsor decision|1|||
130521359|NCT01999972|469878629|FG005|Dose Expansion Part|Sponsor decision|0|||
130521360|NCT01999972|469878624|FG000|Dose Expansion Part|Adverse Event|0|||
130521361|NCT01999972|469878625|FG001|Dose Expansion Part|Adverse Event|0|||
130521362|NCT01999972|469878626|FG002|Dose Expansion Part|Adverse Event|0|||
130521363|NCT01999972|469878627|FG003|Dose Expansion Part|Adverse Event|0|||
130521364|NCT01999972|469878628|FG004|Dose Expansion Part|Adverse Event|4|||
130521365|NCT01999972|469878629|FG005|Dose Expansion Part|Adverse Event|2|||
130521366|NCT01999972|469878624|FG000|Dose Expansion Part|Participant's non-compliance|0|||
130521367|NCT01999972|469878625|FG001|Dose Expansion Part|Participant's non-compliance|0|||
130521368|NCT01999972|469878626|FG002|Dose Expansion Part|Participant's non-compliance|0|||
130521369|NCT01999972|469878627|FG003|Dose Expansion Part|Participant's non-compliance|0|||
130521370|NCT01999972|469878628|FG004|Dose Expansion Part|Participant's non-compliance|0|||
130521371|NCT01999972|469878629|FG005|Dose Expansion Part|Participant's non-compliance|1|||
130521372|NCT01999972|469878624|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
130521373|NCT01999972|469878625|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
130521374|NCT01999972|469878626|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
130521375|NCT01999972|469878627|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
130521376|NCT01999972|469878628|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
130521377|NCT01999972|469878629|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
130521378|NCT01999972|469878624|FG000|Dose Expansion Part|Changed to standard of care|0|||
130521379|NCT01999972|469878625|FG001|Dose Expansion Part|Changed to standard of care|0|||
130521380|NCT01999972|469878626|FG002|Dose Expansion Part|Changed to standard of care|0|||
130521381|NCT01999972|469878627|FG003|Dose Expansion Part|Changed to standard of care|0|||
130521382|NCT01999972|469878628|FG004|Dose Expansion Part|Changed to standard of care|1|||
130521383|NCT01999972|469878629|FG005|Dose Expansion Part|Changed to standard of care|0|||
130521384|NCT01986114|469878631|FG000|Overall Study|Adverse Event|59|||
130521385|NCT01986114|469878631|FG000|Overall Study|Lack of Efficacy|23|||
130521386|NCT01986114|469878631|FG000|Overall Study|Withdrawal by Subject|58|||
130521387|NCT01986114|469878631|FG000|Overall Study|Noncompliance|3|||
130521388|NCT01986114|469878631|FG000|Overall Study|Protocol Violation|1|||
130521389|NCT01986114|469878631|FG000|Overall Study|Lost to Follow-up|5|||
130521390|NCT01986114|469878631|FG000|Overall Study|Other reason|7|||
130521391|NCT02808975|469878633|FG000|Overall Study|Adverse Event|3|||
130521392|NCT02808975|469878634|FG001|Overall Study|Adverse Event|4|||
130521393|NCT02808975|469878633|FG000|Overall Study|Withdrew consent|9|||
130521394|NCT02808975|469878634|FG001|Overall Study|Withdrew consent|8|||
130521395|NCT02808975|469878633|FG000|Overall Study|Lost to Follow-up|4|||
130521396|NCT02808975|469878634|FG001|Overall Study|Lost to Follow-up|6|||
130521397|NCT02808975|469878633|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
130521398|NCT02808975|469878634|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
130521399|NCT02808975|469878633|FG000|Overall Study|Other, not specified|5|||
130521400|NCT02808975|469878634|FG001|Overall Study|Other, not specified|1|||
130521401|NCT00030823|469878635|FG000|Overall Study|Withdrawal by Subject|1|||
130521402|NCT04333147|469878637|FG000|Overall Study|Adverse Event|43|||
130521403|NCT04333147|469878638|FG001|Overall Study|Adverse Event|40|||
130521404|NCT04333147|469878637|FG000|Overall Study|Lack of Efficacy|49|||
130521405|NCT04333147|469878638|FG001|Overall Study|Lack of Efficacy|48|||
130521406|NCT04333147|469878637|FG000|Overall Study|Lost to Follow-up|19|||
130521407|NCT04333147|469878638|FG001|Overall Study|Lost to Follow-up|16|||
130521408|NCT04333147|469878637|FG000|Overall Study|Physician Decision|17|||
130521409|NCT04333147|469878638|FG001|Overall Study|Physician Decision|20|||
130521410|NCT04333147|469878637|FG000|Overall Study|Withdrawal by Subject|65|||
130521411|NCT04333147|469878638|FG001|Overall Study|Withdrawal by Subject|68|||
130521412|NCT04333147|469878637|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
130521413|NCT04333147|469878638|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
130574103|NCT01857869|470066285|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
130574104|NCT01857869|470066286|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
130574105|NCT01857869|470066287|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
130574106|NCT01857869|470066278|FG000|Primary/Challenge Phase|Pregnancy|1|||
130574107|NCT01857869|470066279|FG001|Primary/Challenge Phase|Pregnancy|0|||
130574108|NCT01857869|470066280|FG002|Primary/Challenge Phase|Pregnancy|0|||
130574109|NCT01857869|470066281|FG003|Primary/Challenge Phase|Pregnancy|0|||
130574110|NCT01857869|470066282|FG004|Primary/Challenge Phase|Pregnancy|0|||
130574111|NCT01857869|470066283|FG005|Primary/Challenge Phase|Pregnancy|0|||
130574112|NCT01857869|470066284|FG006|Primary/Challenge Phase|Pregnancy|0|||
130574113|NCT01857869|470066285|FG007|Primary/Challenge Phase|Pregnancy|0|||
130574114|NCT01857869|470066286|FG008|Primary/Challenge Phase|Pregnancy|0|||
130574115|NCT01857869|470066287|FG009|Primary/Challenge Phase|Pregnancy|0|||
130574116|NCT01857869|470066278|FG000|Primary/Challenge Phase|Protocol Violation|1|||
130574117|NCT01857869|470066279|FG001|Primary/Challenge Phase|Protocol Violation|0|||
130574118|NCT01857869|470066280|FG002|Primary/Challenge Phase|Protocol Violation|0|||
130574119|NCT01857869|470066281|FG003|Primary/Challenge Phase|Protocol Violation|0|||
130574120|NCT01857869|470066282|FG004|Primary/Challenge Phase|Protocol Violation|0|||
130574121|NCT01857869|470066283|FG005|Primary/Challenge Phase|Protocol Violation|0|||
130574122|NCT01857869|470066284|FG006|Primary/Challenge Phase|Protocol Violation|0|||
130574123|NCT01857869|470066285|FG007|Primary/Challenge Phase|Protocol Violation|0|||
130574124|NCT01857869|470066286|FG008|Primary/Challenge Phase|Protocol Violation|0|||
130574125|NCT01857869|470066287|FG009|Primary/Challenge Phase|Protocol Violation|0|||
130574126|NCT01857869|470066278|FG000|Primary/Challenge Phase|Other|1|||
130574127|NCT01857869|470066279|FG001|Primary/Challenge Phase|Other|1|||
130574128|NCT01857869|470066280|FG002|Primary/Challenge Phase|Other|0|||
130574129|NCT01857869|470066281|FG003|Primary/Challenge Phase|Other|0|||
130574130|NCT01857869|470066282|FG004|Primary/Challenge Phase|Other|0|||
130574131|NCT01857869|470066283|FG005|Primary/Challenge Phase|Other|0|||
130574132|NCT01857869|470066284|FG006|Primary/Challenge Phase|Other|0|||
130574133|NCT01857869|470066285|FG007|Primary/Challenge Phase|Other|0|||
130574134|NCT01857869|470066286|FG008|Primary/Challenge Phase|Other|0|||
130574135|NCT01857869|470066287|FG009|Primary/Challenge Phase|Other|0|||
130574136|NCT01857869|470066278|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574137|NCT01857869|470066279|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574138|NCT01857869|470066280|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574139|NCT01857869|470066281|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
130574140|NCT01857869|470066282|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574141|NCT01857869|470066283|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574142|NCT01857869|470066284|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574143|NCT01857869|470066285|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574144|NCT01857869|470066286|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574145|NCT01857869|470066287|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130574146|NCT01857869|470066278|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574147|NCT01857869|470066279|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574148|NCT01857869|470066280|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574149|NCT01857869|470066281|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
130574150|NCT01857869|470066282|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574151|NCT01857869|470066283|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574152|NCT01857869|470066284|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574153|NCT01857869|470066285|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574154|NCT01857869|470066286|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574155|NCT01857869|470066287|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130574156|NCT03603496|470066297|FG000|Overall Study|Death|19|||
130574157|NCT03603496|470066298|FG001|Overall Study|Death|24|||
130574158|NCT03603496|470066297|FG000|Overall Study|Lost to Follow-up|141|||
130574159|NCT03603496|470066298|FG001|Overall Study|Lost to Follow-up|141|||
130574160|NCT03603496|470066297|FG000|Overall Study|Withdrawal by Subject|26|||
130574161|NCT03603496|470066298|FG001|Overall Study|Withdrawal by Subject|20|||
130574162|NCT00774345|470066299|FG000|Pre-treatment|Other reasons|2|||
130574163|NCT00774345|470066300|FG001|Pre-treatment|Other reasons|0|||
130574164|NCT00774345|470066299|FG000|Treatment|Adverse Event|61|||
130574165|NCT00774345|470066300|FG001|Treatment|Adverse Event|15|||
130574166|NCT00774345|470066299|FG000|Treatment|Progressive Disease without histologic transformation|51|||
130574167|NCT00774345|470066300|FG001|Treatment|Progressive Disease without histologic transformation|111|||
130574168|NCT00774345|470066299|FG000|Treatment|Progressive Disease with histologic transformation|4|||
130574169|NCT00774345|470066300|FG001|Treatment|Progressive Disease with histologic transformation|2|||
130574170|NCT00774345|470066299|FG000|Treatment|Withdrawal by Subject|5|||
130574171|NCT00774345|470066300|FG001|Treatment|Withdrawal by Subject|2|||
130574172|NCT00774345|470066299|FG000|Treatment|Lost to Follow-up|1|||
130574173|NCT00774345|470066300|FG001|Treatment|Lost to Follow-up|1|||
130574174|NCT00774345|470066299|FG000|Treatment|Death|4|||
130574175|NCT00774345|470066300|FG001|Treatment|Death|0|||
130574176|NCT00774345|470066299|FG000|Treatment|Other Reasons|32|||
130574177|NCT00774345|470066300|FG001|Treatment|Other Reasons|26|||
130521414|NCT04333147|469878637|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
130521415|NCT04333147|469878638|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
130521416|NCT04333147|469878637|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
130521417|NCT04333147|469878638|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
130521418|NCT02106195|469878639|FG000|Overall Study|Adverse Event|2|||
130521419|NCT02106195|469878639|FG000|Overall Study|Protocol Violation|1|||
130521420|NCT03062449|469878640|FG000|Overall Study|Withdrawal by Subject|7|||
130521421|NCT03062449|469878641|FG001|Overall Study|Withdrawal by Subject|1|||
130521422|NCT04702893|469878643|FG000|Overall Study|Other reasons than listed|11|||
130521423|NCT04702893|469878643|FG000|Overall Study|Withdrawal by Subject|3|||
130521424|NCT04702893|469878643|FG000|Overall Study|Lost to Follow-up|7|||
130521425|NCT04702893|469878643|FG000|Overall Study|Death|10|||
130521426|NCT04702893|469878643|FG000|Overall Study|Not treated|6|||
130521427|NCT00408928|469878644|FG000|Overall Study|Withdrawal by Subject|1|||
130521428|NCT00408928|469878644|FG000|Overall Study|Death|1|||
130521429|NCT00408928|469878644|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
130521430|NCT04469465|469878645|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
130521431|NCT04469465|469878646|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
130521432|NCT04469465|469878645|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
130521433|NCT04469465|469878646|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
130521434|NCT04469465|469878645|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
130521435|NCT04469465|469878646|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
130521436|NCT04469465|469878645|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
130521437|NCT04469465|469878646|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
130521438|NCT04469465|469878645|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
130521439|NCT04469465|469878646|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
130521440|NCT04469465|469878645|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
130521441|NCT04469465|469878646|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
130521442|NCT04469465|469878645|FG000|Long-Term Extension (LTE)|Death|0|||
130521443|NCT04469465|469878646|FG001|Long-Term Extension (LTE)|Death|1|||
130521444|NCT04469465|469878645|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
130521445|NCT04469465|469878646|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
130521446|NCT03194867|469878647|FG000|Overall Study|Incorrect completion of end of study form|0|||
130521447|NCT03194867|469878648|FG001|Overall Study|Incorrect completion of end of study form|0|||
130521448|NCT03194867|469878649|FG002|Overall Study|Incorrect completion of end of study form|1|||
130521449|NCT03194867|469878650|FG003|Overall Study|Incorrect completion of end of study form|0|||
130521450|NCT03305809|469878651|FG000|Overall Study|Adverse Event|2|||
130521451|NCT03305809|469878652|FG001|Overall Study|Adverse Event|2|||
130521452|NCT03305809|469878653|FG002|Overall Study|Adverse Event|6|||
130521453|NCT03305809|469878654|FG003|Overall Study|Adverse Event|6|||
130521454|NCT03305809|469878651|FG000|Overall Study|Death|0|||
130521455|NCT03305809|469878652|FG001|Overall Study|Death|0|||
130521456|NCT03305809|469878653|FG002|Overall Study|Death|1|||
130521457|NCT03305809|469878654|FG003|Overall Study|Death|1|||
130521458|NCT03305809|469878651|FG000|Overall Study|Lost to Follow-up|1|||
130521459|NCT03305809|469878652|FG001|Overall Study|Lost to Follow-up|2|||
130521460|NCT03305809|469878653|FG002|Overall Study|Lost to Follow-up|0|||
130521461|NCT03305809|469878654|FG003|Overall Study|Lost to Follow-up|0|||
130521462|NCT03305809|469878651|FG000|Overall Study|Sponsor Decision|1|||
130521463|NCT03305809|469878652|FG001|Overall Study|Sponsor Decision|0|||
130521464|NCT03305809|469878653|FG002|Overall Study|Sponsor Decision|1|||
130521465|NCT03305809|469878654|FG003|Overall Study|Sponsor Decision|8|||
130521466|NCT03305809|469878651|FG000|Overall Study|Physician Decision|0|||
130521467|NCT03305809|469878652|FG001|Overall Study|Physician Decision|0|||
130521468|NCT03305809|469878653|FG002|Overall Study|Physician Decision|2|||
130521469|NCT03305809|469878654|FG003|Overall Study|Physician Decision|4|||
130521470|NCT03305809|469878651|FG000|Overall Study|Progressive Disease|0|||
130521471|NCT03305809|469878652|FG001|Overall Study|Progressive Disease|0|||
130521472|NCT03305809|469878653|FG002|Overall Study|Progressive Disease|1|||
130521473|NCT03305809|469878654|FG003|Overall Study|Progressive Disease|0|||
130521474|NCT03305809|469878651|FG000|Overall Study|Protocol Violation|1|||
130521475|NCT03305809|469878652|FG001|Overall Study|Protocol Violation|0|||
130521476|NCT03305809|469878653|FG002|Overall Study|Protocol Violation|2|||
130521477|NCT03305809|469878654|FG003|Overall Study|Protocol Violation|3|||
130521478|NCT03305809|469878651|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
130574178|NCT00835237|470066301|FG000|Overall Study|Lost to Follow-up|4|||
130574179|NCT00835237|470066302|FG001|Overall Study|Lost to Follow-up|0|||
130574180|NCT00835237|470066301|FG000|Overall Study|Withdrawal by Subject|2|||
130574181|NCT00835237|470066302|FG001|Overall Study|Withdrawal by Subject|0|||
130574182|NCT01265550|470066303|FG000|Pre Randomization|Withdrawal by Subject|0|||
130574183|NCT01265550|470066304|FG001|Pre Randomization|Withdrawal by Subject|0|||
130574184|NCT01265550|470066305|FG002|Pre Randomization|Withdrawal by Subject|0|||
130574185|NCT01265550|470066306|FG003|Pre Randomization|Withdrawal by Subject|70|||
130574186|NCT01265550|470066303|FG000|Pre Randomization|Technical Exclusions|0|||
130574187|NCT01265550|470066304|FG001|Pre Randomization|Technical Exclusions|0|||
130574188|NCT01265550|470066305|FG002|Pre Randomization|Technical Exclusions|0|||
130574189|NCT01265550|470066306|FG003|Pre Randomization|Technical Exclusions|54|||
130574190|NCT01265550|470066303|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
130574191|NCT01265550|470066304|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
130574192|NCT01265550|470066305|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
130574193|NCT01265550|470066306|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
130574194|NCT01265550|470066303|FG000|Pre Randomization|Non-GERD organic disorders|0|||
130574195|NCT01265550|470066304|FG001|Pre Randomization|Non-GERD organic disorders|0|||
130574196|NCT01265550|470066305|FG002|Pre Randomization|Non-GERD organic disorders|0|||
130574197|NCT01265550|470066306|FG003|Pre Randomization|Non-GERD organic disorders|23|||
130574198|NCT01265550|470066303|FG000|Pre Randomization|Functional heartburn|0|||
130574199|NCT01265550|470066304|FG001|Pre Randomization|Functional heartburn|0|||
130574200|NCT01265550|470066305|FG002|Pre Randomization|Functional heartburn|0|||
130574201|NCT01265550|470066306|FG003|Pre Randomization|Functional heartburn|99|||
130574202|NCT00623428|470066309|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
130574203|NCT00623428|470066310|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
130574204|NCT00623428|470066309|FG000|Treatment Period|Death|0|||
130574205|NCT00623428|470066310|FG001|Treatment Period|Death|1|||
130574206|NCT00623428|470066309|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
130574207|NCT00623428|470066310|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
130574208|NCT00623428|470066309|FG000|Treatment Period|Insufficient therapeutic response|0|||
130574209|NCT00623428|470066310|FG001|Treatment Period|Insufficient therapeutic response|2|||
130574210|NCT00623428|470066309|FG000|Treatment Period|Other|0|||
130574211|NCT00623428|470066310|FG001|Treatment Period|Other|1|||
130574212|NCT00623428|470066309|FG000|Treatment Period|Withdrawal by Subject|0|||
130574213|NCT00623428|470066310|FG001|Treatment Period|Withdrawal by Subject|1|||
130574214|NCT00623428|470066309|FG000|Follow-up Period|Relapse post-treatment|11|||
130574215|NCT00623428|470066310|FG001|Follow-up Period|Relapse post-treatment|3|||
130574216|NCT00623428|470066309|FG000|Follow-up Period|Failure to return|10|||
130574217|NCT00623428|470066310|FG001|Follow-up Period|Failure to return|2|||
130574218|NCT00623428|470066309|FG000|Follow-up Period|Patient withdrew consent|5|||
130574219|NCT00623428|470066310|FG001|Follow-up Period|Patient withdrew consent|4|||
130574220|NCT00623428|470066309|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
130521479|NCT03305809|469878652|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
130521480|NCT03305809|469878653|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
130521481|NCT03305809|469878654|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
130521482|NCT03305809|469878651|FG000|Overall Study|Withdrawal by Subject|2|||
130521483|NCT03305809|469878652|FG001|Overall Study|Withdrawal by Subject|4|||
130521484|NCT03305809|469878653|FG002|Overall Study|Withdrawal by Subject|5|||
130521485|NCT03305809|469878654|FG003|Overall Study|Withdrawal by Subject|2|||
130521486|NCT03305809|469878651|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
130521487|NCT03305809|469878652|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
130521488|NCT03305809|469878653|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
130521489|NCT03305809|469878654|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
130521490|NCT00816556|469878655|FG000|Overall Study|Adverse Event|1|||
130521491|NCT00816556|469878656|FG001|Overall Study|Adverse Event|1|||
130521492|NCT00816556|469878657|FG002|Overall Study|Adverse Event|1|||
130521493|NCT00816556|469878655|FG000|Overall Study|Withdrawal by Subject|1|||
130521494|NCT00816556|469878656|FG001|Overall Study|Withdrawal by Subject|1|||
130521495|NCT00816556|469878657|FG002|Overall Study|Withdrawal by Subject|1|||
130521496|NCT00816556|469878655|FG000|Overall Study|Lost to Follow-up|0|||
130521497|NCT00816556|469878656|FG001|Overall Study|Lost to Follow-up|0|||
130521498|NCT00816556|469878657|FG002|Overall Study|Lost to Follow-up|1|||
130521499|NCT02438371|469878658|FG000|Overall Study|Lost to Follow-up|3|||
130521500|NCT02438371|469878659|FG001|Overall Study|Lost to Follow-up|2|||
130521501|NCT02438371|469878658|FG000|Overall Study|Withdrawal by Subject|1|||
130521502|NCT02438371|469878659|FG001|Overall Study|Withdrawal by Subject|1|||
130574221|NCT00623428|470066310|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
130574222|NCT00623428|470066309|FG000|Follow-up Period|Did not cooperate|0|||
130574223|NCT00623428|470066310|FG001|Follow-up Period|Did not cooperate|3|||
130574224|NCT00623428|470066309|FG000|Follow-up Period|Reason not specified|1|||
130574225|NCT00623428|470066310|FG001|Follow-up Period|Reason not specified|1|||
130574226|NCT00623428|470066309|FG000|Follow-up Period|Death|0|||
130574227|NCT00623428|470066310|FG001|Follow-up Period|Death|1|||
130574228|NCT01929408|470066313|FG000|Overall Study|received HCT as initial treatment|8|||
130574229|NCT02788747|470066314|FG000|Overall Study|Adverse Event|1|||
130574230|NCT02788747|470066315|FG001|Overall Study|Adverse Event|0|||
130574231|NCT02788747|470066316|FG002|Overall Study|Adverse Event|0|||
130574232|NCT02500121|470066317|FG000|Overall Study|Lost to Follow-up|0|||
130574233|NCT02500121|470066318|FG001|Overall Study|Lost to Follow-up|1|||
130574234|NCT02500121|470066317|FG000|Overall Study|Withdrawal by Subject|1|||
130574235|NCT02500121|470066318|FG001|Overall Study|Withdrawal by Subject|1|||
130574236|NCT02500121|470066317|FG000|Overall Study|Death|26|||
130574237|NCT02500121|470066318|FG001|Overall Study|Death|24|||
130574238|NCT00852995|470066320|FG000|Overall Study|Adverse Event|1|||
130574239|NCT00852995|470066321|FG001|Overall Study|Adverse Event|0|||
130574240|NCT00852995|470066322|FG002|Overall Study|Adverse Event|4|||
130574241|NCT00852995|470066323|FG003|Overall Study|Adverse Event|0|||
130574242|NCT00852995|470066324|FG004|Overall Study|Adverse Event|0|||
130574243|NCT00852995|470066320|FG000|Overall Study|Lost to Follow-up|0|||
130574244|NCT00852995|470066321|FG001|Overall Study|Lost to Follow-up|1|||
130574245|NCT00852995|470066322|FG002|Overall Study|Lost to Follow-up|1|||
130574246|NCT00852995|470066323|FG003|Overall Study|Lost to Follow-up|0|||
130574247|NCT00852995|470066324|FG004|Overall Study|Lost to Follow-up|0|||
130574248|NCT00852995|470066320|FG000|Overall Study|Withdrawal by Subject|4|||
130574249|NCT00852995|470066321|FG001|Overall Study|Withdrawal by Subject|0|||
130574250|NCT00852995|470066322|FG002|Overall Study|Withdrawal by Subject|0|||
130574251|NCT00852995|470066323|FG003|Overall Study|Withdrawal by Subject|1|||
130574252|NCT00852995|470066324|FG004|Overall Study|Withdrawal by Subject|2|||
130574253|NCT00852995|470066320|FG000|Overall Study|Non-Compliance|0|||
130574254|NCT00852995|470066321|FG001|Overall Study|Non-Compliance|0|||
130574255|NCT00852995|470066322|FG002|Overall Study|Non-Compliance|0|||
130574256|NCT00852995|470066323|FG003|Overall Study|Non-Compliance|2|||
130574257|NCT00852995|470066324|FG004|Overall Study|Non-Compliance|0|||
130574258|NCT00852995|470066320|FG000|Overall Study|Progressive Disease|1|||
130574259|NCT00852995|470066321|FG001|Overall Study|Progressive Disease|0|||
130574260|NCT00852995|470066322|FG002|Overall Study|Progressive Disease|0|||
130574261|NCT00852995|470066323|FG003|Overall Study|Progressive Disease|2|||
130574262|NCT00852995|470066324|FG004|Overall Study|Progressive Disease|1|||
130574263|NCT00852995|470066320|FG000|Overall Study|Physician Decision|1|||
130574264|NCT00852995|470066321|FG001|Overall Study|Physician Decision|0|||
130574265|NCT00852995|470066322|FG002|Overall Study|Physician Decision|0|||
130574266|NCT00852995|470066323|FG003|Overall Study|Physician Decision|0|||
130574267|NCT00852995|470066324|FG004|Overall Study|Physician Decision|0|||
130574268|NCT00852995|470066320|FG000|Overall Study|Protocol Violation|0|||
130574269|NCT00852995|470066321|FG001|Overall Study|Protocol Violation|0|||
130574270|NCT00852995|470066322|FG002|Overall Study|Protocol Violation|0|||
130574271|NCT00852995|470066323|FG003|Overall Study|Protocol Violation|0|||
130574272|NCT00852995|470066324|FG004|Overall Study|Protocol Violation|1|||
130574273|NCT00852995|470066320|FG000|Overall Study|Moved Out of Area|1|||
130574274|NCT00852995|470066321|FG001|Overall Study|Moved Out of Area|0|||
130574275|NCT00852995|470066322|FG002|Overall Study|Moved Out of Area|0|||
130574276|NCT00852995|470066323|FG003|Overall Study|Moved Out of Area|0|||
130574277|NCT00852995|470066324|FG004|Overall Study|Moved Out of Area|0|||
130574278|NCT01836783|470066325|FG000|Overall Study|Withdrawal by Subject|0|||
130574279|NCT01836783|470066326|FG001|Overall Study|Withdrawal by Subject|2|||
130574280|NCT04518462|470066327|FG000|Overall Study|Withdrawal by Subject|0|||
130574281|NCT04518462|470066328|FG001|Overall Study|Withdrawal by Subject|0|||
130574282|NCT04518462|470066329|FG002|Overall Study|Withdrawal by Subject|1|||
130574283|NCT04518462|470066327|FG000|Overall Study|Physician Decision|1|||
130574284|NCT04518462|470066328|FG001|Overall Study|Physician Decision|1|||
130574285|NCT04518462|470066329|FG002|Overall Study|Physician Decision|0|||
130574286|NCT04418076|470066333|FG000|Overall Study|Death|1|||
130574287|NCT04418076|470066334|FG001|Overall Study|Death|0|||
130574288|NCT04418076|470066335|FG002|Overall Study|Death|0|||
130574289|NCT04418076|470066336|FG003|Overall Study|Death|0|||
130574290|NCT04418076|470066333|FG000|Overall Study|Lost to Follow-up|2|||
130574291|NCT04418076|470066334|FG001|Overall Study|Lost to Follow-up|5|||
130574292|NCT04418076|470066335|FG002|Overall Study|Lost to Follow-up|1|||
130574293|NCT04418076|470066336|FG003|Overall Study|Lost to Follow-up|2|||
130574294|NCT04418076|470066333|FG000|Overall Study|Withdrawal by Subject|1|||
130574295|NCT04418076|470066334|FG001|Overall Study|Withdrawal by Subject|0|||
130574296|NCT04418076|470066335|FG002|Overall Study|Withdrawal by Subject|1|||
130574297|NCT04418076|470066336|FG003|Overall Study|Withdrawal by Subject|1|||
130574298|NCT04418076|470066333|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
130574299|NCT04418076|470066334|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
130574300|NCT04418076|470066335|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
130574301|NCT04418076|470066336|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
130574302|NCT01471782|470066337|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
130574303|NCT01471782|470066338|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
130574304|NCT01471782|470066339|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
130574305|NCT01471782|470066340|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
130521503|NCT03546816|469878660|FG000|Overall Study|Adverse Event|5|||
130521504|NCT03546816|469878661|FG001|Overall Study|Adverse Event|3|||
130521505|NCT03546816|469878660|FG000|Overall Study|Lack of Efficacy|2|||
130521506|NCT03546816|469878661|FG001|Overall Study|Lack of Efficacy|4|||
130521507|NCT03546816|469878660|FG000|Overall Study|Pregnancy|1|||
130521508|NCT03546816|469878661|FG001|Overall Study|Pregnancy|0|||
130521509|NCT03546816|469878660|FG000|Overall Study|Physician Decision|2|||
130521510|NCT03546816|469878661|FG001|Overall Study|Physician Decision|0|||
130521511|NCT03546816|469878660|FG000|Overall Study|Withdrawal by Subject|8|||
130521512|NCT03546816|469878661|FG001|Overall Study|Withdrawal by Subject|10|||
130521513|NCT03546816|469878660|FG000|Overall Study|Lost to Follow-up|3|||
130521514|NCT03546816|469878661|FG001|Overall Study|Lost to Follow-up|2|||
130521515|NCT01161446|469878662|FG000|Overall Study|Lost to Follow-up|18|||
130521516|NCT01161446|469878663|FG001|Overall Study|Lost to Follow-up|14|||
130521517|NCT01161446|469878662|FG000|Overall Study|Withdrawal by Subject|0|||
130521518|NCT01161446|469878663|FG001|Overall Study|Withdrawal by Subject|1|||
130521519|NCT01660256|469878666|FG000|Overall Study|Adverse Event|4|||
130521520|NCT01660256|469878667|FG001|Overall Study|Adverse Event|0|||
130521521|NCT01660256|469878668|FG002|Overall Study|Adverse Event|2|||
130521522|NCT01660256|469878666|FG000|Overall Study|Withdrawal by Subject|1|||
130521523|NCT01660256|469878667|FG001|Overall Study|Withdrawal by Subject|0|||
130521524|NCT01660256|469878668|FG002|Overall Study|Withdrawal by Subject|2|||
130521525|NCT01162135|469878670|FG000|Overall Study|Withdrawal by Subject|1|||
130521526|NCT01162135|469878670|FG000|Overall Study|Severe back pain|1|||
130521527|NCT01162135|469878670|FG000|Overall Study|Ineligible|1|||
130521528|NCT02088554|469878671|FG000|Overall Study|Exited before procedure|130|||
130521529|NCT02088554|469878671|FG000|Overall Study|Attempted but not implanted|31|||
130521530|NCT02088554|469878671|FG000|Overall Study|Implant not attempted|19|||
130521531|NCT02088554|469878671|FG000|Overall Study|Pending next visit|532|||
130521532|NCT02088554|469878671|FG000|Overall Study|Death|170|||
130521533|NCT02088554|469878671|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
130521534|NCT02088554|469878671|FG000|Overall Study|Lost to Follow-up|23|||
130521535|NCT02088554|469878671|FG000|Overall Study|Explanted|32|||
130521536|NCT02088554|469878671|FG000|Overall Study|Any other reason not covered by previous categories|11|||
130521537|NCT00551135|469878672|FG000|Overall Study|Adverse Event|1|||
130521538|NCT00551135|469878673|FG001|Overall Study|Adverse Event|0|||
130521539|NCT00551135|469878674|FG002|Overall Study|Adverse Event|1|||
130521540|NCT00551135|469878675|FG003|Overall Study|Adverse Event|1|||
130521541|NCT00551135|469878672|FG000|Overall Study|Lost to Follow-up|0|||
130521542|NCT00551135|469878673|FG001|Overall Study|Lost to Follow-up|0|||
130521543|NCT00551135|469878674|FG002|Overall Study|Lost to Follow-up|0|||
130521544|NCT00551135|469878675|FG003|Overall Study|Lost to Follow-up|1|||
130521545|NCT00551135|469878672|FG000|Overall Study|Other|3|||
130521546|NCT00551135|469878673|FG001|Overall Study|Other|2|||
130521547|NCT00551135|469878674|FG002|Overall Study|Other|1|||
130521548|NCT00551135|469878675|FG003|Overall Study|Other|2|||
130521549|NCT00551135|469878672|FG000|Overall Study|Withdrawal by Subject|1|||
130521550|NCT00551135|469878673|FG001|Overall Study|Withdrawal by Subject|0|||
130521551|NCT00551135|469878674|FG002|Overall Study|Withdrawal by Subject|3|||
130521552|NCT00551135|469878675|FG003|Overall Study|Withdrawal by Subject|1|||
130521553|NCT00858247|469878676|FG000|Baseline Assessment|Withdrawal by Subject|1|||
130521554|NCT00858247|469878677|FG001|Baseline Assessment|Withdrawal by Subject|1|||
130521555|NCT00858247|469878676|FG000|Baseline Assessment|Poor IV access|1|||
130521556|NCT00858247|469878677|FG001|Baseline Assessment|Poor IV access|0|||
130521557|NCT00858247|469878676|FG000|Baseline Assessment|Protocol Violation|0|||
130521558|NCT00858247|469878677|FG001|Baseline Assessment|Protocol Violation|1|||
130521559|NCT00858247|469878676|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
130521560|NCT00858247|469878677|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
130521561|NCT03898960|469878680|FG000|Overall Study|Death|10|||
130521562|NCT00548847|469878681|FG000|Overall Study|Disease progression|7|||
130521563|NCT01379703|469878682|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
130521564|NCT01379703|469878683|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
130521565|NCT01379703|469878684|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
130521566|NCT01379703|469878682|FG000|Study Start Through 9 Months|Adverse Event|0|||
130521567|NCT01379703|469878683|FG001|Study Start Through 9 Months|Adverse Event|14|||
130521568|NCT01379703|469878684|FG002|Study Start Through 9 Months|Adverse Event|10|||
130521569|NCT01379703|469878682|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
130521570|NCT01379703|469878683|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
130521571|NCT01379703|469878684|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
130521572|NCT01379703|469878682|FG000|Study Start Through 9 Months|Treatment Failure|0|||
130521573|NCT01379703|469878683|FG001|Study Start Through 9 Months|Treatment Failure|2|||
130574306|NCT01471782|470066341|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
130521574|NCT01379703|469878684|FG002|Study Start Through 9 Months|Treatment Failure|2|||
130521575|NCT01379703|469878682|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
130521576|NCT01379703|469878683|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
130574307|NCT01471782|470066342|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
130574308|NCT01471782|470066337|FG000|Overall Study|Lack of Efficacy|1|||
130574309|NCT01471782|470066338|FG001|Overall Study|Lack of Efficacy|2|||
130574310|NCT01471782|470066339|FG002|Overall Study|Lack of Efficacy|1|||
130574311|NCT01471782|470066340|FG003|Overall Study|Lack of Efficacy|1|||
130574312|NCT01471782|470066341|FG004|Overall Study|Lack of Efficacy|5|||
130574313|NCT01471782|470066342|FG005|Overall Study|Lack of Efficacy|18|||
130574314|NCT01471782|470066337|FG000|Overall Study|Adverse Event|1|||
130574315|NCT01471782|470066338|FG001|Overall Study|Adverse Event|1|||
130574316|NCT01471782|470066339|FG002|Overall Study|Adverse Event|2|||
130574317|NCT01471782|470066340|FG003|Overall Study|Adverse Event|2|||
130574318|NCT01471782|470066341|FG004|Overall Study|Adverse Event|3|||
130574319|NCT01471782|470066342|FG005|Overall Study|Adverse Event|1|||
130574320|NCT01471782|470066337|FG000|Overall Study|Other|0|||
130574321|NCT01471782|470066338|FG001|Overall Study|Other|0|||
130574322|NCT01471782|470066339|FG002|Overall Study|Other|1|||
130574323|NCT01471782|470066340|FG003|Overall Study|Other|1|||
130574324|NCT01471782|470066341|FG004|Overall Study|Other|6|||
130574325|NCT01471782|470066342|FG005|Overall Study|Other|5|||
130574326|NCT01471782|470066337|FG000|Overall Study|Change of Chemotherapy|1|||
130574327|NCT01471782|470066338|FG001|Overall Study|Change of Chemotherapy|1|||
130574328|NCT01471782|470066339|FG002|Overall Study|Change of Chemotherapy|0|||
130574329|NCT01471782|470066340|FG003|Overall Study|Change of Chemotherapy|0|||
130574330|NCT01471782|470066341|FG004|Overall Study|Change of Chemotherapy|1|||
130574331|NCT01471782|470066342|FG005|Overall Study|Change of Chemotherapy|4|||
130574332|NCT01471782|470066337|FG000|Overall Study|Disease Relapse|0|||
130574333|NCT01471782|470066338|FG001|Overall Study|Disease Relapse|0|||
130574334|NCT01471782|470066339|FG002|Overall Study|Disease Relapse|0|||
130574335|NCT01471782|470066340|FG003|Overall Study|Disease Relapse|1|||
130574336|NCT01471782|470066341|FG004|Overall Study|Disease Relapse|2|||
130574337|NCT01471782|470066342|FG005|Overall Study|Disease Relapse|1|||
130574338|NCT01471782|470066337|FG000|Overall Study|Physician Decision|0|||
130574339|NCT01471782|470066338|FG001|Overall Study|Physician Decision|0|||
130574340|NCT01471782|470066339|FG002|Overall Study|Physician Decision|0|||
130574341|NCT01471782|470066340|FG003|Overall Study|Physician Decision|0|||
130574342|NCT01471782|470066341|FG004|Overall Study|Physician Decision|3|||
130574343|NCT01471782|470066342|FG005|Overall Study|Physician Decision|8|||
130574344|NCT01471782|470066337|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130574345|NCT01471782|470066338|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130574346|NCT01471782|470066339|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130574347|NCT01471782|470066340|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130574348|NCT01471782|470066341|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
130574349|NCT01471782|470066342|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130574350|NCT01471782|470066337|FG000|Overall Study|Death|0|||
130574351|NCT01471782|470066338|FG001|Overall Study|Death|0|||
130574352|NCT01471782|470066339|FG002|Overall Study|Death|0|||
130574353|NCT01471782|470066340|FG003|Overall Study|Death|0|||
130574354|NCT01471782|470066341|FG004|Overall Study|Death|0|||
130574355|NCT01471782|470066342|FG005|Overall Study|Death|1|||
130574356|NCT01452152|470066343|FG000|Overall Study|Study termination by sponsor|5|||
130574357|NCT01452152|470066344|FG001|Overall Study|Study termination by sponsor|0|||
130574358|NCT01452152|470066345|FG002|Overall Study|Study termination by sponsor|4|||
130574359|NCT02068547|470067596|FG000|Overall Study|Lost to Follow-up|3|||
130574360|NCT02068547|470067597|FG001|Overall Study|Lost to Follow-up|3|||
130574361|NCT02068547|470067596|FG000|Overall Study|Physician Decision|1|||
130574362|NCT02068547|470067597|FG001|Overall Study|Physician Decision|0|||
130574363|NCT01736579|470067598|FG000|Overall Study|Termination of Study by Sponsor|2|||
130574364|NCT01736579|470067599|FG001|Overall Study|Termination of Study by Sponsor|2|||
130574365|NCT02543528|470067607|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130574366|NCT02543528|470067608|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130574367|NCT02543528|470067609|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130574368|NCT02543528|470067610|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130574369|NCT02543528|470067611|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
130574370|NCT02543528|470067607|FG000|Adaptation Period|Lens Handling Difficultes|0|||
130574371|NCT02543528|470067608|FG001|Adaptation Period|Lens Handling Difficultes|0|||
130574372|NCT02543528|470067609|FG002|Adaptation Period|Lens Handling Difficultes|0|||
130574373|NCT02543528|470067610|FG003|Adaptation Period|Lens Handling Difficultes|0|||
130574374|NCT02543528|470067611|FG004|Adaptation Period|Lens Handling Difficultes|8|||
130574375|NCT02543528|470067607|FG000|Adaptation Period|Lost to Follow-up|0|||
130574376|NCT02543528|470067608|FG001|Adaptation Period|Lost to Follow-up|0|||
130574377|NCT02543528|470067609|FG002|Adaptation Period|Lost to Follow-up|0|||
130574378|NCT02543528|470067610|FG003|Adaptation Period|Lost to Follow-up|0|||
130574379|NCT02543528|470067611|FG004|Adaptation Period|Lost to Follow-up|14|||
130574380|NCT02543528|470067607|FG000|Adaptation Period|Adverse Event|0|||
130574381|NCT02543528|470067608|FG001|Adaptation Period|Adverse Event|0|||
130574382|NCT02543528|470067609|FG002|Adaptation Period|Adverse Event|0|||
130574383|NCT02543528|470067610|FG003|Adaptation Period|Adverse Event|0|||
130574384|NCT02543528|470067611|FG004|Adaptation Period|Adverse Event|2|||
130574385|NCT02543528|470067607|FG000|Extended Wear Period|Adverse Event|17|||
130574386|NCT02543528|470067608|FG001|Extended Wear Period|Adverse Event|11|||
130574387|NCT02543528|470067609|FG002|Extended Wear Period|Adverse Event|16|||
130574388|NCT02543528|470067610|FG003|Extended Wear Period|Adverse Event|3|||
130574389|NCT02543528|470067611|FG004|Extended Wear Period|Adverse Event|0|||
130574390|NCT02543528|470067607|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
130574391|NCT02543528|470067608|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
130574392|NCT02543528|470067609|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
130574393|NCT02543528|470067610|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
130574394|NCT02543528|470067611|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
130574395|NCT02543528|470067607|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
130574396|NCT02543528|470067608|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130574397|NCT02543528|470067609|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130574398|NCT02543528|470067610|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130574399|NCT02543528|470067611|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130574400|NCT02543528|470067607|FG000|Extended Wear Period|Lost to Follow-up|0|||
130574401|NCT02543528|470067608|FG001|Extended Wear Period|Lost to Follow-up|1|||
130574402|NCT02543528|470067609|FG002|Extended Wear Period|Lost to Follow-up|2|||
130574403|NCT02543528|470067610|FG003|Extended Wear Period|Lost to Follow-up|1|||
130574404|NCT02543528|470067611|FG004|Extended Wear Period|Lost to Follow-up|0|||
130574405|NCT02543528|470067607|FG000|Extended Wear Period|Withdrawal by Subject|10|||
130521577|NCT01379703|469878684|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
130521578|NCT01379703|469878682|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
130521579|NCT01379703|469878683|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
130521580|NCT01379703|469878684|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
130521581|NCT01379703|469878682|FG000|Study Start Through 9 Months|Medication not available|0|||
130521582|NCT01379703|469878683|FG001|Study Start Through 9 Months|Medication not available|2|||
130521583|NCT01379703|469878684|FG002|Study Start Through 9 Months|Medication not available|1|||
130521584|NCT01379703|469878682|FG000|Study Start Through 9 Months|Poor general condition|0|||
130521585|NCT01379703|469878683|FG001|Study Start Through 9 Months|Poor general condition|1|||
130521586|NCT01379703|469878684|FG002|Study Start Through 9 Months|Poor general condition|0|||
130521587|NCT01379703|469878682|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
130521588|NCT01379703|469878683|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
130521589|NCT01379703|469878684|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
130521590|NCT01379703|469878682|FG000|Study Start Through 9 Months|Reason unknown|2|||
130521591|NCT01379703|469878683|FG001|Study Start Through 9 Months|Reason unknown|31|||
130521592|NCT01379703|469878684|FG002|Study Start Through 9 Months|Reason unknown|24|||
130521593|NCT01379703|469878682|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
130521594|NCT01379703|469878683|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
130521595|NCT01379703|469878684|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
130521596|NCT01379703|469878682|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
130521597|NCT01379703|469878683|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
130521598|NCT01379703|469878684|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
130521599|NCT01379703|469878682|FG000|9 Months Through 18 Months|Adverse Event|0|||
130521600|NCT01379703|469878683|FG001|9 Months Through 18 Months|Adverse Event|6|||
130521601|NCT01379703|469878684|FG002|9 Months Through 18 Months|Adverse Event|0|||
130521602|NCT01379703|469878682|FG000|9 Months Through 18 Months|Treatment failure|0|||
130521603|NCT01379703|469878683|FG001|9 Months Through 18 Months|Treatment failure|5|||
130521604|NCT01379703|469878684|FG002|9 Months Through 18 Months|Treatment failure|0|||
130521605|NCT01379703|469878682|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
130521606|NCT01379703|469878683|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
130521607|NCT01379703|469878684|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
130521608|NCT01379703|469878682|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
130521609|NCT01379703|469878683|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
130521610|NCT01379703|469878684|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
130521611|NCT01379703|469878682|FG000|9 Months Through 18 Months|Fatigue|0|||
130521612|NCT01379703|469878683|FG001|9 Months Through 18 Months|Fatigue|1|||
130521613|NCT01379703|469878684|FG002|9 Months Through 18 Months|Fatigue|0|||
130521614|NCT01379703|469878682|FG000|9 Months Through 18 Months|Reason Unknown|0|||
130521615|NCT01379703|469878683|FG001|9 Months Through 18 Months|Reason Unknown|23|||
130521616|NCT01379703|469878684|FG002|9 Months Through 18 Months|Reason Unknown|0|||
130521617|NCT01316887|469878685|FG000|Overall Study|Adverse Event|13|||
130521618|NCT01316887|469878686|FG001|Overall Study|Adverse Event|21|||
130521619|NCT01316887|469878687|FG002|Overall Study|Adverse Event|17|||
130574406|NCT02543528|470067608|FG001|Extended Wear Period|Withdrawal by Subject|9|||
130574407|NCT02543528|470067609|FG002|Extended Wear Period|Withdrawal by Subject|4|||
130521620|NCT01316887|469878685|FG000|Overall Study|Lack of Efficacy|9|||
130574408|NCT02543528|470067610|FG003|Extended Wear Period|Withdrawal by Subject|5|||
130574409|NCT02543528|470067611|FG004|Extended Wear Period|Withdrawal by Subject|0|||
130521621|NCT01316887|469878686|FG001|Overall Study|Lack of Efficacy|3|||
130521622|NCT01316887|469878687|FG002|Overall Study|Lack of Efficacy|1|||
130574410|NCT02049944|470067612|FG000|Overall Study|Protocol Violation|2|||
130574411|NCT01408147|470067613|FG000|Overall Study|Withdrawal by Subject|0|||
130521623|NCT01316887|469878685|FG000|Overall Study|Protocol Violation|2|||
130521624|NCT01316887|469878686|FG001|Overall Study|Protocol Violation|6|||
130521625|NCT01316887|469878687|FG002|Overall Study|Protocol Violation|6|||
130521626|NCT01316887|469878685|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
130521627|NCT01316887|469878686|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
130521628|NCT01316887|469878687|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
130521629|NCT01316887|469878685|FG000|Overall Study|Study Closed/Terminated|2|||
130521630|NCT01316887|469878686|FG001|Overall Study|Study Closed/Terminated|4|||
130521631|NCT01316887|469878687|FG002|Overall Study|Study Closed/Terminated|3|||
130574412|NCT01408147|470067614|FG001|Overall Study|Withdrawal by Subject|1|||
130574413|NCT01765673|470067615|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
130574414|NCT01042600|470067616|FG000|Overall Study|Ineligible|1|||
130574415|NCT01042600|470067617|FG001|Overall Study|Ineligible|0|||
130574416|NCT05048719|470067618|FG000|Overall Study|Withdrawal by Subject|2|||
130574417|NCT05048719|470067619|FG001|Overall Study|Withdrawal by Subject|1|||
130574418|NCT05048719|470067620|FG002|Overall Study|Withdrawal by Subject|3|||
130574419|NCT05048719|470067621|FG003|Overall Study|Withdrawal by Subject|1|||
130574420|NCT05048719|470067622|FG004|Overall Study|Withdrawal by Subject|0|||
130574421|NCT05048719|470067623|FG005|Overall Study|Withdrawal by Subject|2|||
130574422|NCT05048719|470067624|FG006|Overall Study|Withdrawal by Subject|1|||
130574423|NCT05048719|470067625|FG007|Overall Study|Withdrawal by Subject|1|||
130574424|NCT05048719|470067626|FG008|Overall Study|Withdrawal by Subject|0|||
130574425|NCT05048719|470067618|FG000|Overall Study|Death|1|||
130574426|NCT05048719|470067619|FG001|Overall Study|Death|0|||
130574427|NCT05048719|470067620|FG002|Overall Study|Death|0|||
130574428|NCT05048719|470067621|FG003|Overall Study|Death|0|||
130574429|NCT05048719|470067622|FG004|Overall Study|Death|0|||
130574430|NCT05048719|470067623|FG005|Overall Study|Death|0|||
130574431|NCT05048719|470067624|FG006|Overall Study|Death|0|||
130574432|NCT05048719|470067625|FG007|Overall Study|Death|0|||
130574433|NCT05048719|470067626|FG008|Overall Study|Death|0|||
130574434|NCT05048719|470067618|FG000|Overall Study|Adverse Event|0|||
130574435|NCT05048719|470067619|FG001|Overall Study|Adverse Event|1|||
130574436|NCT05048719|470067620|FG002|Overall Study|Adverse Event|2|||
130574437|NCT05048719|470067621|FG003|Overall Study|Adverse Event|0|||
130574438|NCT05048719|470067622|FG004|Overall Study|Adverse Event|1|||
130574439|NCT05048719|470067623|FG005|Overall Study|Adverse Event|0|||
130574440|NCT05048719|470067624|FG006|Overall Study|Adverse Event|0|||
130574441|NCT05048719|470067625|FG007|Overall Study|Adverse Event|0|||
130574442|NCT05048719|470067626|FG008|Overall Study|Adverse Event|0|||
130574443|NCT05048719|470067618|FG000|Overall Study|Lost to Follow-up|0|||
130574444|NCT05048719|470067619|FG001|Overall Study|Lost to Follow-up|0|||
130574445|NCT05048719|470067620|FG002|Overall Study|Lost to Follow-up|1|||
130574446|NCT05048719|470067621|FG003|Overall Study|Lost to Follow-up|3|||
130574447|NCT05048719|470067622|FG004|Overall Study|Lost to Follow-up|1|||
130574448|NCT05048719|470067623|FG005|Overall Study|Lost to Follow-up|1|||
130574449|NCT05048719|470067624|FG006|Overall Study|Lost to Follow-up|1|||
130574450|NCT05048719|470067625|FG007|Overall Study|Lost to Follow-up|1|||
130574451|NCT05048719|470067626|FG008|Overall Study|Lost to Follow-up|0|||
130574452|NCT05048719|470067618|FG000|Overall Study|Physician Decision|0|||
130574453|NCT05048719|470067619|FG001|Overall Study|Physician Decision|0|||
130574454|NCT05048719|470067620|FG002|Overall Study|Physician Decision|0|||
130574455|NCT05048719|470067621|FG003|Overall Study|Physician Decision|0|||
130574456|NCT05048719|470067622|FG004|Overall Study|Physician Decision|0|||
130574457|NCT05048719|470067623|FG005|Overall Study|Physician Decision|0|||
130574458|NCT05048719|470067624|FG006|Overall Study|Physician Decision|0|||
130574459|NCT05048719|470067625|FG007|Overall Study|Physician Decision|1|||
130574460|NCT05048719|470067626|FG008|Overall Study|Physician Decision|1|||
130521632|NCT01316887|469878685|FG000|Overall Study|Lost to Follow-up|1|||
130521633|NCT01316887|469878686|FG001|Overall Study|Lost to Follow-up|7|||
130521634|NCT01316887|469878687|FG002|Overall Study|Lost to Follow-up|5|||
130574461|NCT05048719|470067618|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
130521635|NCT01316887|469878685|FG000|Overall Study|Withdrawal by Subject|8|||
130521636|NCT01316887|469878686|FG001|Overall Study|Withdrawal by Subject|16|||
130574462|NCT05048719|470067619|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574463|NCT05048719|470067620|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574464|NCT05048719|470067621|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574465|NCT05048719|470067622|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574466|NCT05048719|470067623|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574467|NCT05048719|470067624|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574468|NCT05048719|470067625|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130574469|NCT05048719|470067626|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130521637|NCT01316887|469878687|FG002|Overall Study|Withdrawal by Subject|15|||
130521638|NCT00813098|469878690|FG000|Overall Study|Adverse Event|2|||
130574470|NCT05048719|470067618|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130521639|NCT00813098|469878691|FG001|Overall Study|Adverse Event|4|||
130521640|NCT00813098|469878692|FG002|Overall Study|Adverse Event|1|||
130521641|NCT00813098|469878690|FG000|Overall Study|Withdrawal by Subject|0|||
130521642|NCT00813098|469878691|FG001|Overall Study|Withdrawal by Subject|1|||
130521643|NCT00813098|469878692|FG002|Overall Study|Withdrawal by Subject|0|||
130521644|NCT00813098|469878690|FG000|Overall Study|Inability to complete study procedures|1|||
130521645|NCT00813098|469878691|FG001|Overall Study|Inability to complete study procedures|0|||
130521646|NCT00813098|469878692|FG002|Overall Study|Inability to complete study procedures|0|||
130521647|NCT00813098|469878690|FG000|Overall Study|Lost to Follow-up|0|||
130521648|NCT00813098|469878691|FG001|Overall Study|Lost to Follow-up|1|||
130521649|NCT00813098|469878692|FG002|Overall Study|Lost to Follow-up|0|||
130521650|NCT00813098|469878690|FG000|Overall Study|Protocol Violation|0|||
130521651|NCT00813098|469878691|FG001|Overall Study|Protocol Violation|0|||
130521652|NCT00813098|469878692|FG002|Overall Study|Protocol Violation|1|||
130521653|NCT00813098|469878690|FG000|Overall Study|Principal Investigator decision|0|||
130521654|NCT00813098|469878691|FG001|Overall Study|Principal Investigator decision|1|||
130521655|NCT00813098|469878692|FG002|Overall Study|Principal Investigator decision|0|||
130521656|NCT00813098|469878690|FG000|Overall Study|Withdrew Consent|0|||
130521657|NCT00813098|469878691|FG001|Overall Study|Withdrew Consent|1|||
130521658|NCT00813098|469878692|FG002|Overall Study|Withdrew Consent|0|||
130521659|NCT03470545|469878695|FG000|Overall Study|Death|0|||
130521660|NCT03470545|469878696|FG001|Overall Study|Death|1|||
130521661|NCT03470545|469878695|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
130521662|NCT03470545|469878696|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
130521663|NCT03470545|469878695|FG000|Overall Study|Adverse Event|2|||
130521664|NCT03470545|469878696|FG001|Overall Study|Adverse Event|0|||
130521665|NCT03470545|469878695|FG000|Overall Study|Withdrawal by Subject|1|||
130521666|NCT03470545|469878696|FG001|Overall Study|Withdrawal by Subject|1|||
130521667|NCT03470545|469878695|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
130521668|NCT03470545|469878696|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
130521669|NCT00585975|469878697|FG000|Overall Study|Withdrawal by Subject|3|||
130521670|NCT00585975|469878698|FG001|Overall Study|Withdrawal by Subject|3|||
130521671|NCT00585975|469878697|FG000|Overall Study|Lost to Follow-up|2|||
130521672|NCT00585975|469878698|FG001|Overall Study|Lost to Follow-up|1|||
130521673|NCT00585975|469878697|FG000|Overall Study|Enrollment met/over-enrolled|10|||
130521674|NCT00585975|469878698|FG001|Overall Study|Enrollment met/over-enrolled|9|||
130521675|NCT03672175|469878699|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
130521676|NCT03672175|469878700|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
130521677|NCT03672175|469878701|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
130521678|NCT03672175|469878699|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
130521679|NCT03672175|469878700|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
130521680|NCT03672175|469878701|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
130521681|NCT03672175|469878699|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
130521682|NCT03672175|469878700|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
130521683|NCT03672175|469878701|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
130521684|NCT03672175|469878699|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
130521685|NCT03672175|469878700|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
130521686|NCT03672175|469878701|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
130521687|NCT03672175|469878699|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
130521688|NCT03672175|469878700|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
130521689|NCT03672175|469878701|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
130521690|NCT03672175|469878699|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
130521691|NCT03672175|469878700|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
130521692|NCT03672175|469878701|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
130574471|NCT05048719|470067619|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
130574472|NCT05048719|470067620|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574473|NCT05048719|470067621|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574474|NCT05048719|470067622|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574475|NCT05048719|470067623|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574476|NCT05048719|470067624|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130648328|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130521693|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
130521694|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
130521695|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
130521696|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
130521697|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
130521698|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
130574477|NCT05048719|470067625|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574478|NCT05048719|470067626|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130574479|NCT05048719|470067618|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574480|NCT05048719|470067619|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
130574481|NCT05048719|470067620|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574482|NCT05048719|470067621|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574483|NCT05048719|470067622|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574484|NCT05048719|470067623|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574485|NCT05048719|470067624|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574486|NCT05048719|470067625|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574487|NCT05048719|470067626|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130574488|NCT05048719|470067618|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574489|NCT05048719|470067619|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574490|NCT05048719|470067620|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574491|NCT05048719|470067621|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
130574492|NCT05048719|470067622|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574493|NCT05048719|470067623|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574494|NCT05048719|470067624|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574495|NCT05048719|470067625|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574496|NCT05048719|470067626|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130574497|NCT05048719|470067618|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574498|NCT05048719|470067619|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574499|NCT05048719|470067620|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574500|NCT05048719|470067621|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574501|NCT05048719|470067622|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574502|NCT05048719|470067623|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
130574503|NCT05048719|470067624|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574504|NCT05048719|470067625|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574505|NCT05048719|470067626|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130574506|NCT04541004|470067627|FG000|Overall Study|Adverse Event|2|||
130574507|NCT00817531|470067629|FG000|Overall Study|Adverse Event|1|||
130574508|NCT00817531|470067629|FG000|Overall Study|Lack of Efficacy|1|||
130574509|NCT02239939|470067630|FG000|Overall Study|Adverse Event|1|||
130574510|NCT02239939|470067631|FG001|Overall Study|Adverse Event|0|||
130574511|NCT02239939|470067630|FG000|Overall Study|Withdrawal by Subject|1|||
130574512|NCT02239939|470067631|FG001|Overall Study|Withdrawal by Subject|1|||
130574513|NCT02239939|470067630|FG000|Overall Study|Lost to Follow-up|0|||
130574514|NCT02239939|470067631|FG001|Overall Study|Lost to Follow-up|1|||
130574515|NCT03325673|470067641|FG000|Overall Study|Adverse Event|4|||
130574516|NCT03325673|470067642|FG001|Overall Study|Adverse Event|0|||
130574517|NCT00590590|470067643|FG000|Overall Study|Lack of Efficacy|1|||
130574518|NCT00590590|470067644|FG001|Overall Study|Lack of Efficacy|2|||
130574519|NCT00590590|470067645|FG002|Overall Study|Lack of Efficacy|0|||
130574520|NCT00590590|470067643|FG000|Overall Study|Adverse Event|1|||
130574521|NCT00590590|470067644|FG001|Overall Study|Adverse Event|0|||
130574522|NCT00590590|470067645|FG002|Overall Study|Adverse Event|0|||
130574523|NCT00590590|470067643|FG000|Overall Study|Protocol Violation|0|||
130574524|NCT00590590|470067644|FG001|Overall Study|Protocol Violation|0|||
130574525|NCT00590590|470067645|FG002|Overall Study|Protocol Violation|2|||
130574526|NCT00590590|470067643|FG000|Overall Study|Lost to Follow-up|4|||
130574527|NCT00590590|470067644|FG001|Overall Study|Lost to Follow-up|1|||
130574528|NCT00590590|470067645|FG002|Overall Study|Lost to Follow-up|2|||
130574529|NCT00590590|470067643|FG000|Overall Study|Withdrawal by Subject|0|||
130574530|NCT00590590|470067644|FG001|Overall Study|Withdrawal by Subject|1|||
130574531|NCT00590590|470067645|FG002|Overall Study|Withdrawal by Subject|1|||
130574532|NCT00590590|470067643|FG000|Overall Study|Did not complete due to study closure|1|||
130574533|NCT00590590|470067644|FG001|Overall Study|Did not complete due to study closure|1|||
130574534|NCT00590590|470067645|FG002|Overall Study|Did not complete due to study closure|1|||
130574535|NCT00590590|470067643|FG000|Overall Study|Did not complete study|0|||
130574536|NCT00590590|470067644|FG001|Overall Study|Did not complete study|1|||
130574537|NCT00590590|470067645|FG002|Overall Study|Did not complete study|0|||
130574538|NCT01514682|470067646|FG000|Overall Study|Withdrawal by Subject|2|||
130574539|NCT01514682|470067647|FG001|Overall Study|Withdrawal by Subject|3|||
130574540|NCT01514682|470067646|FG000|Overall Study|Physician Decision|4|||
130574541|NCT01514682|470067647|FG001|Overall Study|Physician Decision|3|||
130574542|NCT00132132|470067648|FG000|Overall Study|Lost to Follow-up|7|||
130574543|NCT00132132|470067649|FG001|Overall Study|Lost to Follow-up|2|||
130574544|NCT02105454|470067656|FG000|Overall Study|Withdrawal by Subject|1|||
130574545|NCT02721355|470067657|FG000|Overall Study|Lost to Follow-up|6|||
130574546|NCT02721355|470067658|FG001|Overall Study|Lost to Follow-up|1|||
130574547|NCT00356278|470067659|FG000|Overall Study|Withdrawal by Subject|25|||
130574548|NCT00356278|470067660|FG001|Overall Study|Withdrawal by Subject|15|||
130574549|NCT00356278|470067661|FG002|Overall Study|Withdrawal by Subject|19|||
130574550|NCT01652287|470067662|FG000|Overall Study|Withdrawal by Subject|2|||
130574551|NCT01652287|470067663|FG001|Overall Study|Withdrawal by Subject|0|||
130574552|NCT00527605|470067664|FG000|Overall Study|Adverse Event|3|||
130574553|NCT00527605|470067665|FG001|Overall Study|Adverse Event|0|||
130574554|NCT00527605|470067664|FG000|Overall Study|Withdrawal by Subject|3|||
130574555|NCT00527605|470067665|FG001|Overall Study|Withdrawal by Subject|7|||
130574556|NCT00527605|470067664|FG000|Overall Study|Lost to Follow-up|6|||
130574557|NCT00527605|470067665|FG001|Overall Study|Lost to Follow-up|2|||
130574558|NCT00527605|470067664|FG000|Overall Study|Protocol Violation|1|||
130574559|NCT00527605|470067665|FG001|Overall Study|Protocol Violation|2|||
130574560|NCT00763139|470067666|FG000|Overall Study|Adverse Event|4|||
130574561|NCT00763139|470067667|FG001|Overall Study|Adverse Event|2|||
130574562|NCT00763139|470067666|FG000|Overall Study|Withdrawal by Subject|0|||
130574563|NCT00763139|470067667|FG001|Overall Study|Withdrawal by Subject|1|||
130521699|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
130521700|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
130521701|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
130521702|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
130521703|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
130521704|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
130521705|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
130521706|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
130521707|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
130521708|NCT03672175|469878699|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
130521709|NCT03672175|469878700|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
130521710|NCT03672175|469878701|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
130521711|NCT03414047|469878702|FG000|Overall Study|Adverse Event|0|||
130521712|NCT03414047|469878703|FG001|Overall Study|Adverse Event|0|||
130521713|NCT03414047|469878704|FG002|Overall Study|Adverse Event|1|||
130521714|NCT03414047|469878705|FG003|Overall Study|Adverse Event|1|||
130521715|NCT03414047|469878702|FG000|Overall Study|Physician Decision|1|||
130521716|NCT03414047|469878703|FG001|Overall Study|Physician Decision|0|||
130521717|NCT03414047|469878704|FG002|Overall Study|Physician Decision|0|||
130521718|NCT03414047|469878705|FG003|Overall Study|Physician Decision|1|||
130521719|NCT03414047|469878702|FG000|Overall Study|Withdrawal by Subject|1|||
130521720|NCT03414047|469878703|FG001|Overall Study|Withdrawal by Subject|0|||
130521721|NCT03414047|469878704|FG002|Overall Study|Withdrawal by Subject|2|||
130521722|NCT03414047|469878705|FG003|Overall Study|Withdrawal by Subject|0|||
130521723|NCT01772563|469878706|FG000|Cycle 1|Dose limiting toxicity|2|||
130521724|NCT01772563|469878706|FG000|Cycle 1|Progressive disease|2|||
130521725|NCT01772563|469878706|FG000|Cycle 2 and Beyond|Progressive disease|17|||
130521726|NCT01772563|469878706|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
130521727|NCT01772563|469878706|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
130521728|NCT01192776|469878707|FG000|Overall Study|Death|8|||
130521729|NCT01192776|469878708|FG001|Overall Study|Death|15|||
130521730|NCT01192776|469878709|FG002|Overall Study|Death|18|||
130521731|NCT01192776|469878710|FG003|Overall Study|Death|15|||
130521732|NCT01192776|469878707|FG000|Overall Study|Lost to Follow-up|3|||
130521733|NCT01192776|469878708|FG001|Overall Study|Lost to Follow-up|6|||
130521734|NCT01192776|469878709|FG002|Overall Study|Lost to Follow-up|3|||
130521735|NCT01192776|469878710|FG003|Overall Study|Lost to Follow-up|5|||
130521736|NCT01086384|469878713|FG000|2-week Run-in Period|Adverse Event|1|||
130521737|NCT01086384|469878714|FG001|2-week Run-in Period|Adverse Event|0|||
130521738|NCT01086384|469878715|FG002|2-week Run-in Period|Adverse Event|0|||
130521739|NCT01086384|469878713|FG000|2-week Run-in Period|Protocol Violation|1|||
130521740|NCT01086384|469878714|FG001|2-week Run-in Period|Protocol Violation|0|||
130521741|NCT01086384|469878715|FG002|2-week Run-in Period|Protocol Violation|0|||
130521742|NCT01086384|469878713|FG000|2-week Run-in Period|Lost to Follow-up|1|||
130521743|NCT01086384|469878714|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130574564|NCT00763139|470067666|FG000|Overall Study|med change not allowed by protocol|1|||
130574565|NCT00763139|470067667|FG001|Overall Study|med change not allowed by protocol|0|||
130521744|NCT01086384|469878715|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130521745|NCT01086384|469878713|FG000|2-week Run-in Period|Physician Decision|6|||
130521746|NCT01086384|469878714|FG001|2-week Run-in Period|Physician Decision|0|||
130521747|NCT01086384|469878715|FG002|2-week Run-in Period|Physician Decision|0|||
130521748|NCT01086384|469878713|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
130521749|NCT01086384|469878714|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130521750|NCT01086384|469878715|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130521751|NCT01086384|469878713|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
130521752|NCT01086384|469878714|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
130521753|NCT01086384|469878715|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
130521754|NCT01086384|469878713|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
130521755|NCT01086384|469878714|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
130521756|NCT01086384|469878715|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
130521757|NCT01086384|469878713|FG000|2-week Run-in Period|Randomized in Error|1|||
130521758|NCT01086384|469878714|FG001|2-week Run-in Period|Randomized in Error|0|||
130521759|NCT01086384|469878715|FG002|2-week Run-in Period|Randomized in Error|0|||
130521760|NCT01086384|469878713|FG000|Treatment Period|Withdrawal by Subject|0|||
130521761|NCT01086384|469878714|FG001|Treatment Period|Withdrawal by Subject|53|||
130521762|NCT01086384|469878715|FG002|Treatment Period|Withdrawal by Subject|55|||
130521763|NCT01086384|469878713|FG000|Treatment Period|Protocol Violation|0|||
130521764|NCT01086384|469878714|FG001|Treatment Period|Protocol Violation|26|||
130521765|NCT01086384|469878715|FG002|Treatment Period|Protocol Violation|17|||
130521766|NCT01086384|469878713|FG000|Treatment Period|Lack of Efficacy|0|||
130521767|NCT01086384|469878714|FG001|Treatment Period|Lack of Efficacy|22|||
130521768|NCT01086384|469878715|FG002|Treatment Period|Lack of Efficacy|13|||
130521769|NCT01086384|469878713|FG000|Treatment Period|Adverse Event|0|||
130521770|NCT01086384|469878714|FG001|Treatment Period|Adverse Event|19|||
130521771|NCT01086384|469878715|FG002|Treatment Period|Adverse Event|15|||
130521772|NCT01086384|469878713|FG000|Treatment Period|Lost to Follow-up|0|||
130521773|NCT01086384|469878714|FG001|Treatment Period|Lost to Follow-up|11|||
130521774|NCT01086384|469878715|FG002|Treatment Period|Lost to Follow-up|9|||
130521775|NCT01086384|469878713|FG000|Treatment Period|Physician Decision|0|||
130521776|NCT01086384|469878714|FG001|Treatment Period|Physician Decision|9|||
130521777|NCT01086384|469878715|FG002|Treatment Period|Physician Decision|6|||
130521778|NCT01086384|469878713|FG000|Treatment Period|Study Closed/Terminated|0|||
130521779|NCT01086384|469878714|FG001|Treatment Period|Study Closed/Terminated|7|||
130521780|NCT01086384|469878715|FG002|Treatment Period|Study Closed/Terminated|8|||
130521781|NCT01086384|469878713|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
130521782|NCT01086384|469878714|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
130521783|NCT01086384|469878715|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
130521784|NCT01086384|469878713|FG000|Treatment Period|Received Treatment in Error|0|||
130521785|NCT01086384|469878714|FG001|Treatment Period|Received Treatment in Error|1|||
130521786|NCT01086384|469878715|FG002|Treatment Period|Received Treatment in Error|0|||
130521787|NCT02777242|469878716|FG000|Overall Study|Other|2|||
130521788|NCT02777242|469878716|FG000|Overall Study|Lost to Follow-up|1|||
130521789|NCT02777242|469878716|FG000|Overall Study|Multiple|1|||
130521790|NCT02777242|469878716|FG000|Overall Study|Sponsor's request|1|||
130521791|NCT02777242|469878716|FG000|Overall Study|Withdrawal by Subject|1|||
130521792|NCT01721746|469878723|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
130521793|NCT01721746|469878724|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
130521794|NCT01721746|469878723|FG000|Pre-Treatment|Withdrawal by Subject|1|||
130521795|NCT01721746|469878724|FG001|Pre-Treatment|Withdrawal by Subject|16|||
130521796|NCT01721746|469878723|FG000|Pre-Treatment|Poor/Non-compliance|1|||
130521797|NCT01721746|469878724|FG001|Pre-Treatment|Poor/Non-compliance|0|||
130521798|NCT01721746|469878723|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
130521799|NCT01721746|469878724|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
130521800|NCT01721746|469878723|FG000|Treatment|Disease Progression|192|||
130521801|NCT01721746|469878724|FG001|Treatment|Disease Progression|74|||
130521802|NCT01721746|469878723|FG000|Treatment|Study Drug Toxicity|19|||
130521803|NCT01721746|469878724|FG001|Treatment|Study Drug Toxicity|11|||
130521804|NCT01721746|469878723|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
130521805|NCT01721746|469878724|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
130521806|NCT01721746|469878723|FG000|Treatment|Participant request to discontinue Study treatment|26|||
130521807|NCT01721746|469878724|FG001|Treatment|Participant request to discontinue Study treatment|7|||
130521808|NCT01721746|469878723|FG000|Treatment|Participant withdrew consent|4|||
130521809|NCT01721746|469878724|FG001|Treatment|Participant withdrew consent|2|||
130521810|NCT01721746|469878723|FG000|Treatment|Maximum Clinical Benefit|9|||
130521811|NCT01721746|469878724|FG001|Treatment|Maximum Clinical Benefit|3|||
130521812|NCT01721746|469878723|FG000|Treatment|Poor/Non-compliance|2|||
130521813|NCT01721746|469878724|FG001|Treatment|Poor/Non-compliance|0|||
130521814|NCT01721746|469878723|FG000|Treatment|Participant no longer met Study criteria|4|||
130521815|NCT01721746|469878724|FG001|Treatment|Participant no longer met Study criteria|0|||
130521816|NCT01721746|469878723|FG000|Treatment|Other reasons|6|||
130521817|NCT01721746|469878724|FG001|Treatment|Other reasons|2|||
130521818|NCT04358068|469878725|FG000|Overall Study|Did not initiate study treatment|2|||
130521819|NCT04358068|469878726|FG001|Overall Study|Did not initiate study treatment|2|||
130521820|NCT02143063|469878731|FG000|Overall Study|Lost to Follow-up|16|||
130521821|NCT02143063|469878732|FG001|Overall Study|Lost to Follow-up|28|||
130521822|NCT02143063|469878733|FG002|Overall Study|Lost to Follow-up|29|||
130521823|NCT02143063|469878731|FG000|Overall Study|Withdrawal by Subject|0|||
130521824|NCT02143063|469878732|FG001|Overall Study|Withdrawal by Subject|1|||
130574566|NCT01592760|470067668|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
130574567|NCT01592760|470067669|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
130574568|NCT01592760|470067670|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
130574569|NCT04312009|470067671|FG000|Overall Study|Withdrawal by Subject|2|||
130574570|NCT04312009|470067672|FG001|Overall Study|Withdrawal by Subject|1|||
130574571|NCT00179309|470067683|FG000|Treatment|Toxicity|2|||
130574572|NCT00179309|470067684|FG001|Treatment|Toxicity|3|||
130574573|NCT00179309|470067683|FG000|Treatment|Withdrawal by Subject|1|||
130574574|NCT00179309|470067684|FG001|Treatment|Withdrawal by Subject|2|||
130574575|NCT00179309|470067683|FG000|Treatment|Allergy|1|||
130574576|NCT00179309|470067684|FG001|Treatment|Allergy|0|||
130574577|NCT01678144|470067687|FG000|Stage 1: MAR Classic|Adverse Event|1|||
130574578|NCT02363686|470067690|FG000|Overall Study|Withdrawal by Subject|22|||
130574579|NCT02363686|470067690|FG000|Overall Study|incomplete FEES examinations|13|||
130574580|NCT01496885|470067694|FG000|Overall Study|Lost to Follow-up|13|||
130574581|NCT01496885|470067694|FG000|Overall Study|Withdrawal by Subject|7|||
130574582|NCT01496885|470067694|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
130574583|NCT01496885|470067694|FG000|Overall Study|Death|1|||
130574584|NCT04607733|470067703|FG000|Overall Study|Lost to Follow-up|1|||
130574585|NCT04607733|470067704|FG001|Overall Study|Lost to Follow-up|0|||
130574586|NCT04607733|470067705|FG002|Overall Study|Lost to Follow-up|0|||
130574587|NCT04607733|470067706|FG003|Overall Study|Lost to Follow-up|1|||
130574588|NCT04607733|470067707|FG004|Overall Study|Lost to Follow-up|1|||
130574589|NCT04607733|470067708|FG005|Overall Study|Lost to Follow-up|0|||
130574590|NCT04607733|470067703|FG000|Overall Study|Withdrawal by Subject|0|||
130574591|NCT04607733|470067704|FG001|Overall Study|Withdrawal by Subject|0|||
130574592|NCT04607733|470067705|FG002|Overall Study|Withdrawal by Subject|0|||
130574593|NCT04607733|470067706|FG003|Overall Study|Withdrawal by Subject|0|||
130574594|NCT04607733|470067707|FG004|Overall Study|Withdrawal by Subject|1|||
130574595|NCT04607733|470067708|FG005|Overall Study|Withdrawal by Subject|0|||
130574596|NCT00075504|470067741|FG000|Overall Study|Withdrawal by Subject|9|||
130574597|NCT00075504|470067742|FG001|Overall Study|Withdrawal by Subject|7|||
130574598|NCT01692301|470067744|FG000|Overall Study|Adverse Event|15|||
130574599|NCT01692301|470067745|FG001|Overall Study|Adverse Event|12|||
130574600|NCT01692301|470067744|FG000|Overall Study|Death|1|||
130574601|NCT01692301|470067745|FG001|Overall Study|Death|2|||
130574602|NCT01692301|470067744|FG000|Overall Study|Lack of Efficacy|0|||
130574603|NCT01692301|470067745|FG001|Overall Study|Lack of Efficacy|5|||
130574604|NCT01692301|470067744|FG000|Overall Study|Non-compliance with study treatment|1|||
130574605|NCT01692301|470067745|FG001|Overall Study|Non-compliance with study treatment|2|||
130574606|NCT01692301|470067744|FG000|Overall Study|Protocol deviation|9|||
130574607|NCT01692301|470067745|FG001|Overall Study|Protocol deviation|2|||
130574608|NCT01692301|470067744|FG000|Overall Study|Patient/guardian decision|16|||
130574609|NCT01692301|470067745|FG001|Overall Study|Patient/guardian decision|15|||
130574610|NCT01692301|470067744|FG000|Overall Study|Technical problems|0|||
130574611|NCT01692301|470067745|FG001|Overall Study|Technical problems|1|||
130574612|NCT01692301|470067744|FG000|Overall Study|Physician Decision|2|||
130574613|NCT01692301|470067745|FG001|Overall Study|Physician Decision|2|||
130574614|NCT01692301|470067744|FG000|Overall Study|Lost to Follow-up|1|||
130574615|NCT01692301|470067745|FG001|Overall Study|Lost to Follow-up|1|||
130574616|NCT01568593|470067746|FG000|Overall Study|Lack of Efficacy|4|||
130574617|NCT01568593|470067747|FG001|Overall Study|Lack of Efficacy|1|||
130574618|NCT01568593|470067746|FG000|Overall Study|Adverse Event|3|||
130574619|NCT01568593|470067747|FG001|Overall Study|Adverse Event|2|||
130574620|NCT02109484|470067748|FG000|Overall Study|Lost to Follow-up|0|||
130574621|NCT02109484|470067749|FG001|Overall Study|Lost to Follow-up|0|||
130574622|NCT02109484|470067750|FG002|Overall Study|Lost to Follow-up|0|||
130574623|NCT02109484|470067751|FG003|Overall Study|Lost to Follow-up|1|||
130574624|NCT02109484|470067752|FG004|Overall Study|Lost to Follow-up|1|||
130574625|NCT02109484|470067753|FG005|Overall Study|Lost to Follow-up|0|||
130574626|NCT02109484|470067754|FG006|Overall Study|Lost to Follow-up|1|||
130574627|NCT02109484|470067755|FG007|Overall Study|Lost to Follow-up|0|||
130574628|NCT02109484|470067748|FG000|Overall Study|Withdrawal by Subject|0|||
130574629|NCT02109484|470067749|FG001|Overall Study|Withdrawal by Subject|0|||
130574630|NCT02109484|470067750|FG002|Overall Study|Withdrawal by Subject|0|||
130574631|NCT02109484|470067751|FG003|Overall Study|Withdrawal by Subject|0|||
130574632|NCT02109484|470067752|FG004|Overall Study|Withdrawal by Subject|1|||
130574633|NCT02109484|470067753|FG005|Overall Study|Withdrawal by Subject|1|||
130574634|NCT02109484|470067754|FG006|Overall Study|Withdrawal by Subject|1|||
130574635|NCT02109484|470067755|FG007|Overall Study|Withdrawal by Subject|0|||
130574636|NCT02109484|470067748|FG000|Overall Study|Physician Decision|0|||
130574637|NCT02109484|470067749|FG001|Overall Study|Physician Decision|0|||
130574638|NCT02109484|470067750|FG002|Overall Study|Physician Decision|0|||
130574639|NCT02109484|470067751|FG003|Overall Study|Physician Decision|0|||
130574640|NCT02109484|470067752|FG004|Overall Study|Physician Decision|2|||
130574641|NCT02109484|470067753|FG005|Overall Study|Physician Decision|0|||
130574642|NCT02109484|470067754|FG006|Overall Study|Physician Decision|0|||
130574643|NCT02109484|470067755|FG007|Overall Study|Physician Decision|0|||
130574644|NCT02109484|470067748|FG000|Overall Study|Death|0|||
130521825|NCT02143063|469878733|FG002|Overall Study|Withdrawal by Subject|0|||
130521826|NCT02143063|469878731|FG000|Overall Study|Death|0|||
130521827|NCT02143063|469878732|FG001|Overall Study|Death|1|||
130521828|NCT02143063|469878733|FG002|Overall Study|Death|1|||
130521829|NCT01099579|469878736|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
130521830|NCT01099579|469878737|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
130521831|NCT01099579|469878738|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
130521832|NCT01099579|469878736|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
130521833|NCT01099579|469878737|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
130521834|NCT01099579|469878738|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
130521835|NCT01099579|469878736|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
130521836|NCT01099579|469878737|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
130521837|NCT01099579|469878738|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
130521838|NCT01099579|469878736|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
130521839|NCT01099579|469878737|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
130521840|NCT01099579|469878738|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
130521841|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
130521842|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
130521843|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
130521844|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
130521845|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
130521846|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
130521847|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
130521848|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
130521849|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
130521850|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
130521851|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
130521852|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
130521853|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
130521854|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
130521855|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
130521856|NCT01099579|469878736|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
130521857|NCT01099579|469878737|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
130521858|NCT01099579|469878738|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
130521859|NCT00909532|469878739|FG000|Overall Study|Adverse Event|4|||
130521860|NCT00909532|469878740|FG001|Overall Study|Adverse Event|1|||
130521861|NCT00909532|469878739|FG000|Overall Study|Pregnancy|0|||
130521862|NCT00909532|469878740|FG001|Overall Study|Pregnancy|1|||
130521863|NCT00909532|469878739|FG000|Overall Study|Prohibited Medication|2|||
130521864|NCT00909532|469878740|FG001|Overall Study|Prohibited Medication|1|||
130521865|NCT00909532|469878739|FG000|Overall Study|Withdrawal of Consent|1|||
130521866|NCT00909532|469878740|FG001|Overall Study|Withdrawal of Consent|1|||
130521867|NCT00909532|469878739|FG000|Overall Study|Noncompliance with Study Requirements|0|||
130521868|NCT00909532|469878740|FG001|Overall Study|Noncompliance with Study Requirements|2|||
130521869|NCT00909532|469878739|FG000|Overall Study|Physician Decision|1|||
130521870|NCT00909532|469878740|FG001|Overall Study|Physician Decision|0|||
130521871|NCT00909532|469878739|FG000|Overall Study|Wrong Genotype|1|||
130521872|NCT00909532|469878740|FG001|Overall Study|Wrong Genotype|0|||
130521873|NCT00909532|469878739|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
130521874|NCT00909532|469878740|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
130521875|NCT01130168|469878741|FG000|Period 1|Withdrawal by Subject|0|||
130521876|NCT01130168|469878742|FG001|Period 1|Withdrawal by Subject|1|||
130521877|NCT01130168|469878743|FG002|Period 1|Withdrawal by Subject|0|||
130521878|NCT01130168|469878744|FG003|Period 1|Withdrawal by Subject|1|||
130521879|NCT01130168|469878745|FG004|Period 1|Withdrawal by Subject|0|||
130521880|NCT01130168|469878746|FG005|Period 1|Withdrawal by Subject|0|||
130521881|NCT01130168|469878741|FG000|Period 1|Discontinued For Other Reason|0|||
130521882|NCT01130168|469878742|FG001|Period 1|Discontinued For Other Reason|0|||
130521883|NCT01130168|469878743|FG002|Period 1|Discontinued For Other Reason|1|||
130521884|NCT01130168|469878744|FG003|Period 1|Discontinued For Other Reason|1|||
130521885|NCT01130168|469878745|FG004|Period 1|Discontinued For Other Reason|0|||
130521886|NCT01130168|469878746|FG005|Period 1|Discontinued For Other Reason|0|||
130521887|NCT01130168|469878741|FG000|Period 1|Adverse Event|0|||
130521888|NCT01130168|469878742|FG001|Period 1|Adverse Event|0|||
130521889|NCT01130168|469878743|FG002|Period 1|Adverse Event|0|||
130521890|NCT01130168|469878744|FG003|Period 1|Adverse Event|1|||
130521891|NCT01130168|469878745|FG004|Period 1|Adverse Event|0|||
130521892|NCT01130168|469878746|FG005|Period 1|Adverse Event|0|||
130521893|NCT01438840|469878747|FG000|Core Study|Adverse Event|0|||
130521894|NCT01438840|469878748|FG001|Core Study|Adverse Event|3|||
130521895|NCT01438840|469878749|FG002|Core Study|Adverse Event|0|||
130521896|NCT01438840|469878747|FG000|Core Study|Lack of Efficacy|15|||
130521897|NCT01438840|469878748|FG001|Core Study|Lack of Efficacy|7|||
130521898|NCT01438840|469878749|FG002|Core Study|Lack of Efficacy|0|||
130521899|NCT01438840|469878747|FG000|Core Study|Withdrawal of consent|1|||
130521900|NCT01438840|469878748|FG001|Core Study|Withdrawal of consent|0|||
130521901|NCT01438840|469878749|FG002|Core Study|Withdrawal of consent|0|||
130521902|NCT01438840|469878747|FG000|Extension Phase|Adverse Event|0|||
130521903|NCT01438840|469878748|FG001|Extension Phase|Adverse Event|0|||
130521904|NCT01438840|469878749|FG002|Extension Phase|Adverse Event|3|||
130521905|NCT01438840|469878747|FG000|Extension Phase|Lost to Follow-up|0|||
130521906|NCT01438840|469878748|FG001|Extension Phase|Lost to Follow-up|0|||
130521907|NCT01438840|469878749|FG002|Extension Phase|Lost to Follow-up|1|||
130521908|NCT01438840|469878747|FG000|Extension Phase|Withdrawal by Subject|0|||
130521909|NCT01438840|469878748|FG001|Extension Phase|Withdrawal by Subject|0|||
130521910|NCT01438840|469878749|FG002|Extension Phase|Withdrawal by Subject|3|||
130521911|NCT01438840|469878747|FG000|Extension Phase|Lack of Efficacy|0|||
130521912|NCT01438840|469878748|FG001|Extension Phase|Lack of Efficacy|0|||
130521913|NCT01438840|469878749|FG002|Extension Phase|Lack of Efficacy|2|||
130521914|NCT01438840|469878747|FG000|Extension Phase|Other|0|||
130521915|NCT01438840|469878748|FG001|Extension Phase|Other|0|||
130521916|NCT01438840|469878749|FG002|Extension Phase|Other|1|||
130521917|NCT01774305|469878752|FG000|Overall Study|Physician Decision|1|||
130521918|NCT01774305|469878753|FG001|Overall Study|Physician Decision|0|||
130521919|NCT01157377|469878755|FG000|Overall Study|Lost to Follow-up|0|||
130521920|NCT01157377|469878756|FG001|Overall Study|Lost to Follow-up|0|||
130521921|NCT01157377|469878757|FG002|Overall Study|Lost to Follow-up|1|||
130521922|NCT01157377|469878758|FG003|Overall Study|Lost to Follow-up|0|||
130521923|NCT01157377|469878759|FG004|Overall Study|Lost to Follow-up|1|||
130521924|NCT01157377|469878760|FG005|Overall Study|Lost to Follow-up|1|||
130521925|NCT01157377|469878761|FG006|Overall Study|Lost to Follow-up|0|||
130521926|NCT01157377|469878755|FG000|Overall Study|Personal Reasons|2|||
130521927|NCT01157377|469878756|FG001|Overall Study|Personal Reasons|1|||
130521928|NCT01157377|469878757|FG002|Overall Study|Personal Reasons|0|||
130521929|NCT01157377|469878758|FG003|Overall Study|Personal Reasons|1|||
130521930|NCT01157377|469878759|FG004|Overall Study|Personal Reasons|0|||
130521931|NCT01157377|469878760|FG005|Overall Study|Personal Reasons|0|||
130521932|NCT01157377|469878761|FG006|Overall Study|Personal Reasons|0|||
130521933|NCT01157377|469878755|FG000|Overall Study|Protocol Violation|0|||
130521934|NCT01157377|469878756|FG001|Overall Study|Protocol Violation|0|||
130521935|NCT01157377|469878757|FG002|Overall Study|Protocol Violation|0|||
130521936|NCT01157377|469878758|FG003|Overall Study|Protocol Violation|0|||
130521937|NCT01157377|469878759|FG004|Overall Study|Protocol Violation|0|||
130521938|NCT01157377|469878760|FG005|Overall Study|Protocol Violation|1|||
130521939|NCT01157377|469878761|FG006|Overall Study|Protocol Violation|0|||
130521940|NCT01157377|469878755|FG000|Overall Study|Lack of Efficacy|0|||
130521941|NCT01157377|469878756|FG001|Overall Study|Lack of Efficacy|0|||
130521942|NCT01157377|469878757|FG002|Overall Study|Lack of Efficacy|0|||
130521943|NCT01157377|469878758|FG003|Overall Study|Lack of Efficacy|0|||
130521944|NCT01157377|469878759|FG004|Overall Study|Lack of Efficacy|0|||
130521945|NCT01157377|469878760|FG005|Overall Study|Lack of Efficacy|0|||
130521946|NCT01157377|469878761|FG006|Overall Study|Lack of Efficacy|1|||
130521947|NCT01157377|469878755|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130521948|NCT01157377|469878756|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130521949|NCT01157377|469878757|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130521950|NCT01157377|469878758|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130521951|NCT01157377|469878759|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130521952|NCT01157377|469878760|FG005|Overall Study|Other Miscellaneous Reasons|1|||
130521953|NCT01157377|469878761|FG006|Overall Study|Other Miscellaneous Reasons|1|||
130521954|NCT02261285|469878764|FG000|Overall Study|Disease progression|0|||
130521955|NCT02261285|469878765|FG001|Overall Study|Disease progression|0|||
130521956|NCT02261285|469878766|FG002|Overall Study|Disease progression|1|||
130521957|NCT01702519|469878767|FG000|Washout Period|Lost to Follow-up|1|||
130521958|NCT01702519|469878768|FG001|Washout Period|Lost to Follow-up|0|||
130521959|NCT01702519|469878767|FG000|Washout Period|Withdrawal by Subject|0|||
130521960|NCT01702519|469878768|FG001|Washout Period|Withdrawal by Subject|2|||
130521961|NCT03738397|469878769|FG000|Overall Study|Adverse Event|3|||
130521962|NCT03738397|469878770|FG001|Overall Study|Adverse Event|7|||
130521963|NCT03738397|469878769|FG000|Overall Study|Withdrawal by Subject|8|||
130521964|NCT03738397|469878770|FG001|Overall Study|Withdrawal by Subject|11|||
130521965|NCT03738397|469878769|FG000|Overall Study|Lost to Follow-up|7|||
130521966|NCT03738397|469878770|FG001|Overall Study|Lost to Follow-up|5|||
130521967|NCT03738397|469878769|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130521968|NCT03738397|469878770|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130521969|NCT03738397|469878769|FG000|Overall Study|Other|4|||
130521970|NCT03738397|469878770|FG001|Overall Study|Other|6|||
130521971|NCT01263925|469878779|FG000|Overall Study|Protocol Violation|1|||
130521972|NCT01263925|469878780|FG001|Overall Study|Protocol Violation|0|||
130521973|NCT01263925|469878779|FG000|Overall Study|Lack of Efficacy|0|||
130521974|NCT01263925|469878780|FG001|Overall Study|Lack of Efficacy|1|||
130521975|NCT01263925|469878779|FG000|Overall Study|Adverse Event|23|||
130521976|NCT01263925|469878780|FG001|Overall Study|Adverse Event|22|||
130521977|NCT01263925|469878779|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
130521978|NCT01263925|469878780|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
130521979|NCT01263925|469878779|FG000|Overall Study|Withdrawal by Subject|6|||
130521980|NCT01263925|469878780|FG001|Overall Study|Withdrawal by Subject|8|||
130574645|NCT02109484|470067749|FG001|Overall Study|Death|0|||
130574646|NCT02109484|470067750|FG002|Overall Study|Death|0|||
130574647|NCT02109484|470067751|FG003|Overall Study|Death|0|||
130574648|NCT02109484|470067752|FG004|Overall Study|Death|0|||
130574649|NCT02109484|470067753|FG005|Overall Study|Death|0|||
130574650|NCT02109484|470067754|FG006|Overall Study|Death|0|||
130574651|NCT02109484|470067755|FG007|Overall Study|Death|2|||
130574652|NCT02109484|470067748|FG000|Overall Study|Moved away from study area|0|||
130574653|NCT02109484|470067749|FG001|Overall Study|Moved away from study area|0|||
130574654|NCT02109484|470067750|FG002|Overall Study|Moved away from study area|0|||
130574655|NCT02109484|470067751|FG003|Overall Study|Moved away from study area|0|||
130574656|NCT02109484|470067752|FG004|Overall Study|Moved away from study area|0|||
130574657|NCT02109484|470067753|FG005|Overall Study|Moved away from study area|0|||
130574658|NCT02109484|470067754|FG006|Overall Study|Moved away from study area|1|||
130574659|NCT02109484|470067755|FG007|Overall Study|Moved away from study area|1|||
130574660|NCT02111993|470067760|FG000|Overall Study|Physician Decision|5|||
130574661|NCT02111993|470067761|FG001|Overall Study|Physician Decision|4|||
130574662|NCT00293579|470067762|FG000|Overall Study|Withdrawal by Subject|1|||
130574663|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
130574664|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
130574665|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
130574666|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
130574667|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
130574668|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
130574669|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
130574670|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
130574671|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
130574672|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
130574673|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
130574674|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
130574675|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
130574676|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
130574677|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
130574678|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
130574679|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
130574680|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
130574681|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
130574682|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
130574683|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
130574684|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
130574685|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
130574686|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
130574687|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
130574688|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
130574689|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
130574690|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
130574691|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
130574692|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
130574693|NCT00784654|470067769|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
130574694|NCT00784654|470067770|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
130574695|NCT00784654|470067771|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
130574696|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
130574697|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
130574698|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
130574699|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
130574700|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
130574701|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
130574702|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130574703|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130574704|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
130574705|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
130574706|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
130574707|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
130574708|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130574709|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Adverse Event|1|||
130574710|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Adverse Event|1|||
130574711|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
130574712|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
130574713|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
130574714|NCT00784654|470067769|FG000|Randomized Withdrawal Period|Family reasons|0|||
130574715|NCT00784654|470067770|FG001|Randomized Withdrawal Period|Family reasons|0|||
130574716|NCT00784654|470067771|FG002|Randomized Withdrawal Period|Family reasons|1|||
130574717|NCT00262873|470067772|FG000|Overall Study|Adverse Event|3|||
130574718|NCT00262873|470067772|FG000|Overall Study|Withdrawal by Subject|5|||
130574719|NCT00844753|470067773|FG000|Overall Study|Lack of Efficacy|1|||
130574720|NCT00844753|470067774|FG001|Overall Study|Lack of Efficacy|0|||
130574721|NCT00844753|470067775|FG002|Overall Study|Lack of Efficacy|2|||
130574722|NCT00844753|470067776|FG003|Overall Study|Lack of Efficacy|2|||
130574723|NCT00844753|470067773|FG000|Overall Study|Adverse Event|3|||
130574724|NCT00844753|470067774|FG001|Overall Study|Adverse Event|2|||
130574725|NCT00844753|470067775|FG002|Overall Study|Adverse Event|5|||
130574726|NCT00844753|470067776|FG003|Overall Study|Adverse Event|5|||
130574727|NCT00844753|470067773|FG000|Overall Study|Lost to Follow-up|1|||
130574728|NCT00844753|470067774|FG001|Overall Study|Lost to Follow-up|1|||
130574729|NCT00844753|470067775|FG002|Overall Study|Lost to Follow-up|0|||
130574730|NCT00844753|470067776|FG003|Overall Study|Lost to Follow-up|1|||
130574731|NCT00844753|470067773|FG000|Overall Study|could not swallow medication|2|||
130574732|NCT00844753|470067774|FG001|Overall Study|could not swallow medication|0|||
130574733|NCT00844753|470067775|FG002|Overall Study|could not swallow medication|0|||
130574734|NCT00844753|470067776|FG003|Overall Study|could not swallow medication|0|||
130574735|NCT00844753|470067773|FG000|Overall Study|Withdrawal by Subject|1|||
130574736|NCT00844753|470067774|FG001|Overall Study|Withdrawal by Subject|0|||
130574737|NCT00844753|470067775|FG002|Overall Study|Withdrawal by Subject|0|||
130574738|NCT00844753|470067776|FG003|Overall Study|Withdrawal by Subject|3|||
130574739|NCT03368170|470069533|FG000|Overall Study|Adverse Event|2|||
130574740|NCT03368170|470069534|FG001|Overall Study|Adverse Event|1|||
130574741|NCT01662440|470069535|FG000|Overall Study|Adverse Event|1|||
130574742|NCT01662440|470069536|FG001|Overall Study|Adverse Event|0|||
130574743|NCT01662440|470069537|FG002|Overall Study|Adverse Event|0|||
130521981|NCT01263925|469878779|FG000|Overall Study|Other|4|||
130521982|NCT01263925|469878780|FG001|Overall Study|Other|4|||
130521983|NCT01263925|469878779|FG000|Overall Study|Lost to Follow-up|3|||
130521984|NCT01263925|469878780|FG001|Overall Study|Lost to Follow-up|1|||
130521985|NCT01263925|469878779|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
130521986|NCT01263925|469878780|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
130521987|NCT01263925|469878779|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
130521988|NCT01263925|469878780|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
130521989|NCT01263925|469878779|FG000|Overall Study|AE/ Withdrawal|1|||
130521990|NCT01263925|469878780|FG001|Overall Study|AE/ Withdrawal|4|||
130521991|NCT01263925|469878779|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
130521992|NCT01263925|469878780|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
130521993|NCT01263925|469878779|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
130521994|NCT01263925|469878780|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
130521995|NCT01263925|469878779|FG000|Overall Study|Withdrawal/ Not specified|0|||
130521996|NCT01263925|469878780|FG001|Overall Study|Withdrawal/ Not specified|1|||
130521997|NCT00573651|469878787|FG000|Overall Study|Lost to Follow-up|3|||
130521998|NCT00573651|469878787|FG000|Overall Study|Withdrawal by Subject|1|||
130521999|NCT00474383|469878811|FG000|Main Study|Adverse Event|11|||
130522000|NCT00474383|469878812|FG001|Main Study|Adverse Event|0|||
130522001|NCT00474383|469878811|FG000|Main Study|Symptomatic Deterioration|1|||
130522002|NCT00474383|469878812|FG001|Main Study|Symptomatic Deterioration|0|||
130522003|NCT00474383|469878811|FG000|Main Study|Progressive Disease|23|||
130522004|NCT00474383|469878812|FG001|Main Study|Progressive Disease|0|||
130522005|NCT00474383|469878811|FG000|Main Study|Other|1|||
130574744|NCT01662440|470069538|FG003|Overall Study|Adverse Event|1|||
130574745|NCT01662440|470069535|FG000|Overall Study|Death|0|||
130574746|NCT01662440|470069536|FG001|Overall Study|Death|1|||
130574747|NCT01662440|470069537|FG002|Overall Study|Death|0|||
130574748|NCT01662440|470069538|FG003|Overall Study|Death|0|||
130574749|NCT01662440|470069535|FG000|Overall Study|Lost to Follow-up|2|||
130574750|NCT01662440|470069536|FG001|Overall Study|Lost to Follow-up|2|||
130574751|NCT01662440|470069537|FG002|Overall Study|Lost to Follow-up|4|||
130574752|NCT01662440|470069538|FG003|Overall Study|Lost to Follow-up|1|||
130574753|NCT01662440|470069535|FG000|Overall Study|Subject moved to another country.|0|||
130522006|NCT00474383|469878812|FG001|Main Study|Other|0|||
130574754|NCT01662440|470069536|FG001|Overall Study|Subject moved to another country.|1|||
130574755|NCT01662440|470069537|FG002|Overall Study|Subject moved to another country.|0|||
130574756|NCT01662440|470069538|FG003|Overall Study|Subject moved to another country.|0|||
130574757|NCT01662440|470069535|FG000|Overall Study|Protocol Violation|1|||
130574758|NCT01662440|470069536|FG001|Overall Study|Protocol Violation|0|||
130522007|NCT00474383|469878811|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
130522008|NCT00474383|469878812|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
130522009|NCT00474383|469878811|FG000|Extension|Progressive Disease|0|||
130574759|NCT01662440|470069537|FG002|Overall Study|Protocol Violation|0|||
130574760|NCT01662440|470069538|FG003|Overall Study|Protocol Violation|0|||
130574761|NCT01662440|470069535|FG000|Overall Study|Withdrawal by Subject|5|||
130574762|NCT01662440|470069536|FG001|Overall Study|Withdrawal by Subject|2|||
130574763|NCT01662440|470069537|FG002|Overall Study|Withdrawal by Subject|2|||
130574764|NCT01662440|470069538|FG003|Overall Study|Withdrawal by Subject|2|||
130574765|NCT02229552|470069539|FG000|Baseline|Withdrawal by Subject|6|||
130574766|NCT02229552|470069539|FG000|1-year Follow up|Withdrawal by Subject|7|||
130574767|NCT02229552|470069539|FG000|1-year Follow up|Lost to Follow-up|18|||
130574768|NCT02229552|470069539|FG000|2-Year Follow up|Withdrawal by Subject|9|||
130574769|NCT02229552|470069539|FG000|2-Year Follow up|Lost to Follow-up|17|||
130574770|NCT04872101|470069540|FG000|Overall Study|Withdrawal by Subject|10|||
130574771|NCT04872101|470069541|FG001|Overall Study|Withdrawal by Subject|16|||
130574772|NCT04872101|470069540|FG000|Overall Study|Lack of Efficacy|6|||
130574773|NCT04872101|470069541|FG001|Overall Study|Lack of Efficacy|14|||
130574774|NCT04872101|470069540|FG000|Overall Study|Adverse Event|1|||
130574775|NCT04872101|470069541|FG001|Overall Study|Adverse Event|6|||
130574776|NCT04872101|470069540|FG000|Overall Study|Lost to Follow-up|2|||
130574777|NCT04872101|470069541|FG001|Overall Study|Lost to Follow-up|1|||
130574778|NCT04872101|470069540|FG000|Overall Study|Pregnancy|2|||
130574779|NCT04872101|470069541|FG001|Overall Study|Pregnancy|0|||
130574780|NCT04872101|470069540|FG000|Overall Study|Prohibited Medication|1|||
130574781|NCT04872101|470069541|FG001|Overall Study|Prohibited Medication|0|||
130574782|NCT04872101|470069540|FG000|Overall Study|Not dosed|1|||
130574783|NCT04872101|470069541|FG001|Overall Study|Not dosed|0|||
130574784|NCT00971945|470069542|FG000|Overall Study|Progressive Disease|3|||
130574785|NCT00971945|470069542|FG000|Overall Study|Change in treatment policy|1|||
130574786|NCT00971945|470069542|FG000|Overall Study|Other reasons|2|||
130574787|NCT03354663|470069543|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
130574788|NCT03354663|470069543|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
130574789|NCT03354663|470069543|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
130574790|NCT03354663|470069543|FG000|Completed 30-day Visit|Missed Visit|1|||
130574791|NCT03691974|470069544|FG000|Overall Study|Physician Decision|1|||
130574792|NCT03691974|470069545|FG001|Overall Study|Physician Decision|0|||
130574793|NCT03691974|470069544|FG000|Overall Study|Adverse Event|1|||
130574794|NCT03691974|470069545|FG001|Overall Study|Adverse Event|0|||
130574795|NCT03691974|470069544|FG000|Overall Study|Withdrawal by Subject|11|||
130574796|NCT03691974|470069545|FG001|Overall Study|Withdrawal by Subject|9|||
130574797|NCT03691974|470069544|FG000|Overall Study|Protocol Violation|1|||
130574798|NCT03691974|470069545|FG001|Overall Study|Protocol Violation|0|||
130574799|NCT03691974|470069544|FG000|Overall Study|Lost to Follow-up|8|||
130574800|NCT03691974|470069545|FG001|Overall Study|Lost to Follow-up|7|||
130574801|NCT01661140|470069546|FG000|Open-Label Period|Adverse Event|44|||
130574802|NCT01661140|470069547|FG001|Open-Label Period|Adverse Event|0|||
130574803|NCT01661140|470069548|FG002|Open-Label Period|Adverse Event|0|||
130574804|NCT01661140|470069546|FG000|Open-Label Period|Protocol Violation|3|||
130574805|NCT01661140|470069547|FG001|Open-Label Period|Protocol Violation|0|||
130574806|NCT01661140|470069548|FG002|Open-Label Period|Protocol Violation|0|||
130574807|NCT01661140|470069546|FG000|Open-Label Period|Withdrawal by Subject|5|||
130574808|NCT01661140|470069547|FG001|Open-Label Period|Withdrawal by Subject|0|||
130574809|NCT01661140|470069548|FG002|Open-Label Period|Withdrawal by Subject|0|||
130574810|NCT01661140|470069546|FG000|Open-Label Period|Investigator Decision|3|||
130574811|NCT01661140|470069547|FG001|Open-Label Period|Investigator Decision|0|||
130574812|NCT01661140|470069548|FG002|Open-Label Period|Investigator Decision|0|||
130574813|NCT01661140|470069546|FG000|Open-Label Period|Death|1|||
130574814|NCT01661140|470069547|FG001|Open-Label Period|Death|0|||
130574815|NCT01661140|470069548|FG002|Open-Label Period|Death|0|||
130574816|NCT01661140|470069546|FG000|Open-Label Period|Administrative/Other|1|||
130574817|NCT01661140|470069547|FG001|Open-Label Period|Administrative/Other|0|||
130574818|NCT01661140|470069548|FG002|Open-Label Period|Administrative/Other|0|||
130574819|NCT01661140|470069546|FG000|Open-Label Period|Sponsor termination|16|||
130574820|NCT01661140|470069547|FG001|Open-Label Period|Sponsor termination|0|||
130574821|NCT01661140|470069548|FG002|Open-Label Period|Sponsor termination|0|||
130574822|NCT01661140|470069546|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
130574823|NCT01661140|470069547|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
130574824|NCT01661140|470069548|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
130574825|NCT01661140|470069546|FG000|Open-Label Period|Lost to Follow-up|2|||
130574826|NCT01661140|470069547|FG001|Open-Label Period|Lost to Follow-up|0|||
130574827|NCT01661140|470069548|FG002|Open-Label Period|Lost to Follow-up|0|||
130574828|NCT01661140|470069546|FG000|Double-Blind Period|Refused Treatment|0|||
130574829|NCT01661140|470069547|FG001|Double-Blind Period|Refused Treatment|0|||
130574830|NCT01661140|470069548|FG002|Double-Blind Period|Refused Treatment|1|||
130574831|NCT01661140|470069546|FG000|Double-Blind Period|Adverse Event|0|||
130574832|NCT01661140|470069547|FG001|Double-Blind Period|Adverse Event|16|||
130574833|NCT01661140|470069548|FG002|Double-Blind Period|Adverse Event|18|||
130574834|NCT01661140|470069546|FG000|Double-Blind Period|Protocol Violation|0|||
130574835|NCT01661140|470069547|FG001|Double-Blind Period|Protocol Violation|2|||
130574836|NCT01661140|470069548|FG002|Double-Blind Period|Protocol Violation|3|||
130574837|NCT01661140|470069546|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130574838|NCT01661140|470069547|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130574839|NCT01661140|470069548|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130574840|NCT01661140|470069546|FG000|Double-Blind Period|Investigator's Decision|0|||
130574841|NCT01661140|470069547|FG001|Double-Blind Period|Investigator's Decision|1|||
130574842|NCT01661140|470069548|FG002|Double-Blind Period|Investigator's Decision|2|||
130574843|NCT01661140|470069546|FG000|Double-Blind Period|Sponsor Termination|0|||
130574844|NCT01661140|470069547|FG001|Double-Blind Period|Sponsor Termination|14|||
130574845|NCT01661140|470069548|FG002|Double-Blind Period|Sponsor Termination|17|||
130574846|NCT01661140|470069546|FG000|Double-Blind Period|Administrative/Other|0|||
130574847|NCT01661140|470069547|FG001|Double-Blind Period|Administrative/Other|7|||
130574848|NCT01661140|470069548|FG002|Double-Blind Period|Administrative/Other|6|||
130574849|NCT01391000|470069549|FG000|Overall Study|Lost to Follow-up|2|||
130574850|NCT01391000|470069550|FG001|Overall Study|Lost to Follow-up|0|||
130574851|NCT00494091|470069551|FG000|Overall Study|Death|5|||
130574852|NCT00494091|470069552|FG001|Overall Study|Death|54|||
130574853|NCT00494091|470069551|FG000|Overall Study|Lost to Follow-up|0|||
130574854|NCT00494091|470069552|FG001|Overall Study|Lost to Follow-up|4|||
130574855|NCT00494091|470069551|FG000|Overall Study|Other|1|||
130574856|NCT00494091|470069552|FG001|Overall Study|Other|11|||
130574857|NCT00494091|470069551|FG000|Overall Study|Withdrawal by Subject|0|||
130574858|NCT00494091|470069552|FG001|Overall Study|Withdrawal by Subject|7|||
130574859|NCT00883337|470069559|FG000|Core Treatment Period|Adverse Event|9|||
130574860|NCT00883337|470069560|FG001|Core Treatment Period|Adverse Event|12|||
130574861|NCT00883337|470069561|FG002|Core Treatment Period|Adverse Event|22|||
130574862|NCT00883337|470069559|FG000|Core Treatment Period|Lack of Efficacy|7|||
130574863|NCT00883337|470069560|FG001|Core Treatment Period|Lack of Efficacy|4|||
130574864|NCT00883337|470069561|FG002|Core Treatment Period|Lack of Efficacy|2|||
130574865|NCT00883337|470069559|FG000|Core Treatment Period|Lost to Follow-up|1|||
130574866|NCT00883337|470069560|FG001|Core Treatment Period|Lost to Follow-up|1|||
130574867|NCT00883337|470069561|FG002|Core Treatment Period|Lost to Follow-up|0|||
130574868|NCT00883337|470069559|FG000|Core Treatment Period|Withdrawal by Subject|2|||
130574869|NCT00883337|470069560|FG001|Core Treatment Period|Withdrawal by Subject|2|||
130574870|NCT00883337|470069561|FG002|Core Treatment Period|Withdrawal by Subject|6|||
130574871|NCT00883337|470069559|FG000|Core Treatment Period|Wish to be pregnant|1|||
130574872|NCT00883337|470069560|FG001|Core Treatment Period|Wish to be pregnant|2|||
130574873|NCT00883337|470069561|FG002|Core Treatment Period|Wish to be pregnant|1|||
130574874|NCT00883337|470069559|FG000|Core Treatment Period|Poor compliance to protocol|0|||
130574875|NCT00883337|470069560|FG001|Core Treatment Period|Poor compliance to protocol|0|||
130574876|NCT00883337|470069561|FG002|Core Treatment Period|Poor compliance to protocol|1|||
130574877|NCT00883337|470069559|FG000|Core Treatment Period|Other than above|0|||
130574878|NCT00883337|470069560|FG001|Core Treatment Period|Other than above|1|||
130574879|NCT00883337|470069561|FG002|Core Treatment Period|Other than above|1|||
130574880|NCT00883337|470069559|FG000|Extension Treatment Period|Adverse Event|8|||
130574881|NCT00883337|470069560|FG001|Extension Treatment Period|Adverse Event|5|||
130574882|NCT00883337|470069561|FG002|Extension Treatment Period|Adverse Event|5|||
130574883|NCT00883337|470069559|FG000|Extension Treatment Period|Lack of Efficacy|8|||
130574884|NCT00883337|470069560|FG001|Extension Treatment Period|Lack of Efficacy|8|||
130574885|NCT00883337|470069561|FG002|Extension Treatment Period|Lack of Efficacy|8|||
130574886|NCT00883337|470069559|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
130574887|NCT00883337|470069560|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
130574888|NCT00883337|470069561|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
130574889|NCT00883337|470069559|FG000|Extension Treatment Period|Lost to Follow-up|1|||
130574890|NCT00883337|470069560|FG001|Extension Treatment Period|Lost to Follow-up|0|||
130574891|NCT00883337|470069561|FG002|Extension Treatment Period|Lost to Follow-up|0|||
130574892|NCT00883337|470069559|FG000|Extension Treatment Period|Other than above|10|||
130574893|NCT00883337|470069560|FG001|Extension Treatment Period|Other than above|9|||
130574894|NCT00883337|470069561|FG002|Extension Treatment Period|Other than above|5|||
130574895|NCT03468309|470069565|FG000|Overall Study|Lost to Follow-up|4|||
130574896|NCT03468309|470069565|FG000|Overall Study|Withdrawal by Subject|2|||
130574897|NCT05131204|470069569|FG000|Overall Study|Sponsor request|2|||
130574898|NCT05131204|470069570|FG001|Overall Study|Sponsor request|1|||
130574899|NCT03446885|470069571|FG000|Overall Study|Lost to Follow-up|1|||
130574900|NCT03446885|470069572|FG001|Overall Study|Lost to Follow-up|0|||
130574901|NCT03446885|470069571|FG000|Overall Study|Did not complete entire visit|1|||
130574902|NCT03446885|470069572|FG001|Overall Study|Did not complete entire visit|0|||
130574903|NCT01485627|470069575|FG000|Overall Study|Patient withdrew|6|||
130574904|NCT01485627|470069576|FG001|Overall Study|Patient withdrew|5|||
130574905|NCT01485627|470069575|FG000|Overall Study|Patient died|3|||
130574906|NCT01485627|470069576|FG001|Overall Study|Patient died|1|||
130574907|NCT01485627|470069575|FG000|Overall Study|Patient lost to followup|0|||
130574908|NCT01485627|470069576|FG001|Overall Study|Patient lost to followup|1|||
130574909|NCT01485627|470069575|FG000|Overall Study|Caregiver withdrew|3|||
130574910|NCT01485627|470069576|FG001|Overall Study|Caregiver withdrew|3|||
130574911|NCT01485627|470069575|FG000|Overall Study|Caregiver lost to follow up|11|||
130574912|NCT01485627|470069576|FG001|Overall Study|Caregiver lost to follow up|12|||
130574913|NCT01485627|470069575|FG000|Overall Study|Caregiver died|1|||
130574914|NCT01485627|470069576|FG001|Overall Study|Caregiver died|0|||
130574915|NCT01485627|470069575|FG000|Overall Study|caregiver was not bereaved|42|||
130574916|NCT01485627|470069576|FG001|Overall Study|caregiver was not bereaved|35|||
130574917|NCT02264990|470069579|FG000|Overall Study|Death|255|||
130574918|NCT02264990|470069580|FG001|Overall Study|Death|250|||
130574919|NCT02264990|470069579|FG000|Overall Study|Withdrawal by Subject|4|||
130574920|NCT02264990|470069580|FG001|Overall Study|Withdrawal by Subject|5|||
130574921|NCT02264990|470069579|FG000|Overall Study|Lost to Follow-up|1|||
130522010|NCT00474383|469878812|FG001|Extension|Progressive Disease|5|||
130522011|NCT02998918|469878813|FG000|Overall Study|Withdrawal by Subject|1|||
130522012|NCT02998918|469878814|FG001|Overall Study|Withdrawal by Subject|0|||
130522013|NCT00443599|469878820|FG000|Overall Study|Physician Decision|2|||
130522014|NCT00443599|469878821|FG001|Overall Study|Physician Decision|1|||
130522015|NCT00443599|469878820|FG000|Overall Study|Death|1|||
130522016|NCT00443599|469878821|FG001|Overall Study|Death|1|||
130522017|NCT00443599|469878820|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
130522018|NCT00443599|469878821|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
130522019|NCT04811339|469878824|FG000|Overall Study|lack of transportation not wanting to return|4|||
130522020|NCT04811339|469878825|FG001|Overall Study|lack of transportation not wanting to return|8|||
130522021|NCT04811339|469878826|FG002|Overall Study|lack of transportation not wanting to return|0|||
130522022|NCT04811339|469878824|FG000|Overall Study|Adverse Event|3|||
130522023|NCT04811339|469878825|FG001|Overall Study|Adverse Event|0|||
130522024|NCT04811339|469878826|FG002|Overall Study|Adverse Event|0|||
130522025|NCT04811339|469878824|FG000|Overall Study|Lost to Follow-up|1|||
130522026|NCT04811339|469878825|FG001|Overall Study|Lost to Follow-up|0|||
130522027|NCT04811339|469878826|FG002|Overall Study|Lost to Follow-up|0|||
130522028|NCT04811339|469878824|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
130522029|NCT04811339|469878825|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
130522030|NCT04811339|469878826|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
130522031|NCT04811339|469878824|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
130522032|NCT04811339|469878825|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
130522033|NCT04811339|469878826|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
130522034|NCT04811339|469878824|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
130522035|NCT04811339|469878825|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
130522036|NCT04811339|469878826|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
130522037|NCT04811339|469878824|FG000|Overall Study|Withdrawal by Subject|0|||
130522038|NCT04811339|469878825|FG001|Overall Study|Withdrawal by Subject|3|||
130522039|NCT04811339|469878826|FG002|Overall Study|Withdrawal by Subject|0|||
130522040|NCT04811339|469878824|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
130522041|NCT04811339|469878825|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
130522042|NCT04811339|469878826|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
130522043|NCT04811339|469878824|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
130522044|NCT04811339|469878825|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
130522045|NCT04811339|469878826|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
130522046|NCT00497874|469880684|FG000|Overall Study|Withdrawal by Subject|48|||
130522047|NCT00497874|469880685|FG001|Overall Study|Withdrawal by Subject|17|||
130522048|NCT00497874|469880684|FG000|Overall Study|Illness|8|||
130522049|NCT00497874|469880685|FG001|Overall Study|Illness|4|||
130522050|NCT00497874|469880684|FG000|Overall Study|Death|2|||
130522051|NCT00497874|469880685|FG001|Overall Study|Death|4|||
130522052|NCT00497874|469880684|FG000|Overall Study|Unable to contact|52|||
130522053|NCT00497874|469880685|FG001|Overall Study|Unable to contact|67|||
130522054|NCT00497874|469880684|FG000|Overall Study|Unable to schedule|37|||
130522055|NCT00497874|469880685|FG001|Overall Study|Unable to schedule|24|||
130522056|NCT00891046|469880688|FG000|Overall Study|Protocol Violation|1|||
130522057|NCT00891046|469880689|FG001|Overall Study|Protocol Violation|1|||
130522058|NCT00891046|469880690|FG002|Overall Study|Protocol Violation|0|||
130522059|NCT00891046|469880691|FG003|Overall Study|Protocol Violation|0|||
130522060|NCT00891046|469880692|FG004|Overall Study|Protocol Violation|1|||
130522061|NCT00891046|469880688|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130522062|NCT00891046|469880689|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130522063|NCT00891046|469880690|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
130522064|NCT00891046|469880691|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
130574922|NCT02264990|470069580|FG001|Overall Study|Lost to Follow-up|3|||
130574923|NCT02264990|470069579|FG000|Overall Study|Other|0|||
130574924|NCT02264990|470069580|FG001|Overall Study|Other|1|||
130574925|NCT01098071|470069589|FG000|Overall Study|Surgery (adenoidectomy)|2|||
130574926|NCT01098071|470069589|FG000|Overall Study|Lost to Follow-up|13|||
130522065|NCT00891046|469880692|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
130522066|NCT00891046|469880688|FG000|Overall Study|Administrative problems|0|||
130522067|NCT00891046|469880689|FG001|Overall Study|Administrative problems|0|||
130522068|NCT00891046|469880690|FG002|Overall Study|Administrative problems|0|||
130522069|NCT00891046|469880691|FG003|Overall Study|Administrative problems|0|||
130522070|NCT00891046|469880692|FG004|Overall Study|Administrative problems|1|||
130522071|NCT00891046|469880688|FG000|Overall Study|Participant no longer required drug|0|||
130522072|NCT00891046|469880689|FG001|Overall Study|Participant no longer required drug|2|||
130522073|NCT00891046|469880690|FG002|Overall Study|Participant no longer required drug|0|||
130522074|NCT00891046|469880691|FG003|Overall Study|Participant no longer required drug|0|||
130522075|NCT00891046|469880692|FG004|Overall Study|Participant no longer required drug|1|||
130522076|NCT00891046|469880688|FG000|Overall Study|Adverse Event|4|||
130522077|NCT00891046|469880689|FG001|Overall Study|Adverse Event|3|||
130522078|NCT00891046|469880690|FG002|Overall Study|Adverse Event|2|||
130522079|NCT00891046|469880691|FG003|Overall Study|Adverse Event|0|||
130522080|NCT00891046|469880692|FG004|Overall Study|Adverse Event|14|||
130522081|NCT00891046|469880688|FG000|Overall Study|Withdrawal by Subject|2|||
130522082|NCT00891046|469880689|FG001|Overall Study|Withdrawal by Subject|1|||
130522083|NCT00891046|469880690|FG002|Overall Study|Withdrawal by Subject|2|||
130522084|NCT00891046|469880691|FG003|Overall Study|Withdrawal by Subject|1|||
130522085|NCT00891046|469880692|FG004|Overall Study|Withdrawal by Subject|1|||
130522086|NCT00891046|469880688|FG000|Overall Study|Lost to Follow-up|0|||
130522087|NCT00891046|469880689|FG001|Overall Study|Lost to Follow-up|0|||
130522088|NCT00891046|469880690|FG002|Overall Study|Lost to Follow-up|0|||
130522089|NCT00891046|469880691|FG003|Overall Study|Lost to Follow-up|0|||
130522090|NCT00891046|469880692|FG004|Overall Study|Lost to Follow-up|1|||
130522091|NCT03113383|469880695|FG000|Overall Study|Death|4|||
130522092|NCT03113383|469880696|FG001|Overall Study|Death|0|||
130522093|NCT03568812|469880698|FG000|Overall Study|Physician Decision|0|||
130522094|NCT03568812|469880699|FG001|Overall Study|Physician Decision|1|||
130522095|NCT01010204|469880702|FG000|Overall Study|Lost to Follow-up|2|||
130522096|NCT01010204|469880703|FG001|Overall Study|Lost to Follow-up|2|||
130522097|NCT01010204|469880702|FG000|Overall Study|Adverse Event|1|||
130522098|NCT01010204|469880703|FG001|Overall Study|Adverse Event|3|||
130522099|NCT01010204|469880702|FG000|Overall Study|Withdrawal by Subject|2|||
130522100|NCT01010204|469880703|FG001|Overall Study|Withdrawal by Subject|3|||
130522101|NCT01010204|469880702|FG000|Overall Study|psychiatric hospitalization|2|||
130522102|NCT01010204|469880703|FG001|Overall Study|psychiatric hospitalization|1|||
130522103|NCT02330562|469880704|FG000|Overall Study|Adverse Event|0|||
130522104|NCT02330562|469880705|FG001|Overall Study|Adverse Event|0|||
130522105|NCT02330562|469880706|FG002|Overall Study|Adverse Event|3|||
130522106|NCT02330562|469880707|FG003|Overall Study|Adverse Event|0|||
130522107|NCT02330562|469880708|FG004|Overall Study|Adverse Event|3|||
130522108|NCT02330562|469880709|FG005|Overall Study|Adverse Event|1|||
130522109|NCT02330562|469880710|FG006|Overall Study|Adverse Event|0|||
130522110|NCT02330562|469880711|FG007|Overall Study|Adverse Event|0|||
130522111|NCT02330562|469880712|FG008|Overall Study|Adverse Event|0|||
130522112|NCT02330562|469880713|FG009|Overall Study|Adverse Event|1|||
130522113|NCT02330562|469880714|FG010|Overall Study|Adverse Event|1|||
130522114|NCT02330562|469880704|FG000|Overall Study|Participant decision|1|||
130522115|NCT02330562|469880705|FG001|Overall Study|Participant decision|0|||
130522116|NCT02330562|469880706|FG002|Overall Study|Participant decision|4|||
130522117|NCT02330562|469880707|FG003|Overall Study|Participant decision|1|||
130522118|NCT02330562|469880708|FG004|Overall Study|Participant decision|5|||
130522119|NCT02330562|469880709|FG005|Overall Study|Participant decision|2|||
130522120|NCT02330562|469880710|FG006|Overall Study|Participant decision|0|||
130522121|NCT02330562|469880711|FG007|Overall Study|Participant decision|0|||
130522122|NCT02330562|469880712|FG008|Overall Study|Participant decision|0|||
130522123|NCT02330562|469880713|FG009|Overall Study|Participant decision|3|||
130522124|NCT02330562|469880714|FG010|Overall Study|Participant decision|0|||
130522125|NCT02330562|469880704|FG000|Overall Study|Disease progression|5|||
130522126|NCT02330562|469880705|FG001|Overall Study|Disease progression|3|||
130522127|NCT02330562|469880706|FG002|Overall Study|Disease progression|20|||
130522128|NCT02330562|469880707|FG003|Overall Study|Disease progression|28|||
130522129|NCT02330562|469880708|FG004|Overall Study|Disease progression|23|||
130522130|NCT02330562|469880709|FG005|Overall Study|Disease progression|7|||
130522131|NCT02330562|469880710|FG006|Overall Study|Disease progression|1|||
130522132|NCT02330562|469880711|FG007|Overall Study|Disease progression|1|||
130522133|NCT02330562|469880712|FG008|Overall Study|Disease progression|1|||
130522134|NCT02330562|469880713|FG009|Overall Study|Disease progression|0|||
130522135|NCT02330562|469880714|FG010|Overall Study|Disease progression|5|||
130522136|NCT02330562|469880704|FG000|Overall Study|Other reasons|0|||
130522137|NCT02330562|469880705|FG001|Overall Study|Other reasons|0|||
130522138|NCT02330562|469880706|FG002|Overall Study|Other reasons|0|||
130522139|NCT02330562|469880707|FG003|Overall Study|Other reasons|1|||
130522140|NCT02330562|469880708|FG004|Overall Study|Other reasons|0|||
130522141|NCT02330562|469880709|FG005|Overall Study|Other reasons|0|||
130522142|NCT02330562|469880710|FG006|Overall Study|Other reasons|0|||
130574927|NCT01662895|470069591|FG000|Overall Study|Lost to Follow-up|0|||
130574928|NCT01662895|470069592|FG001|Overall Study|Lost to Follow-up|1|||
130574929|NCT01665807|470069598|FG000|Overall Study|Withdrawal by Subject|2|||
130574930|NCT01665807|470069599|FG001|Overall Study|Withdrawal by Subject|0|||
130574931|NCT01665807|470069600|FG002|Overall Study|Withdrawal by Subject|1|||
130574932|NCT01142726|470069601|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
130574933|NCT01142726|470069602|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
130574934|NCT01142726|470069603|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
130574935|NCT01142726|470069601|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
130574936|NCT01142726|470069602|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
130574937|NCT01142726|470069603|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
130574938|NCT01142726|470069601|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
130574939|NCT01142726|470069602|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
130574940|NCT01142726|470069603|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
130574941|NCT01142726|470069601|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
130574942|NCT01142726|470069602|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
130574943|NCT01142726|470069603|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
130574944|NCT01142726|470069601|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
130574945|NCT01142726|470069602|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
130574946|NCT01142726|470069603|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
130574947|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
130574948|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
130574949|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
130574950|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
130574951|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
130574952|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
130574953|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
130574954|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
130574955|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
130574956|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
130574957|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
130574958|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
130574959|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
130574960|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
130574961|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
130574962|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
130574963|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
130574964|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
130574965|NCT01142726|470069601|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
130574966|NCT01142726|470069602|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
130574967|NCT01142726|470069603|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
130574968|NCT01142726|470069601|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
130574969|NCT01142726|470069602|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
130574970|NCT01142726|470069603|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
130574971|NCT01142726|470069601|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130574972|NCT01142726|470069602|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130574973|NCT01142726|470069603|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130574974|NCT01142726|470069601|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
130574975|NCT01142726|470069602|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
130574976|NCT01142726|470069603|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
130574977|NCT01142726|470069601|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
130574978|NCT01142726|470069602|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
130574979|NCT01142726|470069603|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
130574980|NCT00419380|470069604|FG000|Overall Study|Lack of Efficacy|1|||
130574981|NCT00419380|470069605|FG001|Overall Study|Lack of Efficacy|7|||
130574982|NCT00419380|470069604|FG000|Overall Study|Physician Decision|0|||
130574983|NCT00419380|470069605|FG001|Overall Study|Physician Decision|1|||
130574984|NCT00419380|470069604|FG000|Overall Study|Lost to Follow-up|0|||
130574985|NCT00419380|470069605|FG001|Overall Study|Lost to Follow-up|1|||
130574986|NCT00419380|470069604|FG000|Overall Study|Withdrawal by Subject|0|||
130574987|NCT00419380|470069605|FG001|Overall Study|Withdrawal by Subject|1|||
130574988|NCT01026831|470069608|FG000|Overall Study|Adverse Event|4|||
130574989|NCT01026831|470069609|FG001|Overall Study|Adverse Event|3|||
130574990|NCT01026831|470069608|FG000|Overall Study|Lost to Follow-up|2|||
130574991|NCT01026831|470069609|FG001|Overall Study|Lost to Follow-up|0|||
130574992|NCT01026831|470069608|FG000|Overall Study|Physician Decision|1|||
130574993|NCT01026831|470069609|FG001|Overall Study|Physician Decision|1|||
130574994|NCT01026831|470069608|FG000|Overall Study|Protocol Violation|0|||
130522143|NCT02330562|469880711|FG007|Overall Study|Other reasons|0|||
130522144|NCT02330562|469880712|FG008|Overall Study|Other reasons|0|||
130522145|NCT02330562|469880713|FG009|Overall Study|Other reasons|0|||
130522146|NCT02330562|469880714|FG010|Overall Study|Other reasons|0|||
130522147|NCT02330562|469880704|FG000|Overall Study|Withdrawal by Subject|0|||
130522148|NCT02330562|469880705|FG001|Overall Study|Withdrawal by Subject|0|||
130522149|NCT02330562|469880706|FG002|Overall Study|Withdrawal by Subject|0|||
130522150|NCT02330562|469880707|FG003|Overall Study|Withdrawal by Subject|0|||
130522151|NCT02330562|469880708|FG004|Overall Study|Withdrawal by Subject|0|||
130522152|NCT02330562|469880709|FG005|Overall Study|Withdrawal by Subject|0|||
130522153|NCT02330562|469880710|FG006|Overall Study|Withdrawal by Subject|0|||
130522154|NCT02330562|469880711|FG007|Overall Study|Withdrawal by Subject|0|||
130522155|NCT02330562|469880712|FG008|Overall Study|Withdrawal by Subject|0|||
130522156|NCT02330562|469880713|FG009|Overall Study|Withdrawal by Subject|1|||
130522157|NCT02330562|469880714|FG010|Overall Study|Withdrawal by Subject|0|||
130522158|NCT03082612|469880715|FG000|Overall Study|Lost to Follow-up|2|||
130522159|NCT03082612|469880716|FG001|Overall Study|Lost to Follow-up|0|||
130522160|NCT03732820|469880721|FG000|Overall Study|Death|168|||
130522161|NCT03732820|469880722|FG001|Overall Study|Death|203|||
130522162|NCT03732820|469880721|FG000|Overall Study|Other|2|||
130522163|NCT03732820|469880722|FG001|Overall Study|Other|2|||
130522164|NCT03732820|469880721|FG000|Overall Study|Failure to meet randomisation criteria|1|||
130522165|NCT03732820|469880722|FG001|Overall Study|Failure to meet randomisation criteria|1|||
130522166|NCT03732820|469880721|FG000|Overall Study|Patient decision|14|||
130522167|NCT03732820|469880722|FG001|Overall Study|Patient decision|10|||
130522168|NCT03732820|469880721|FG000|Overall Study|Screen failure|0|||
130522169|NCT03732820|469880722|FG001|Overall Study|Screen failure|1|||
130522170|NCT03732820|469880721|FG000|Overall Study|Patients ongoing study at data cut off|210|||
130522171|NCT03732820|469880722|FG001|Overall Study|Patients ongoing study at data cut off|178|||
130522172|NCT03732820|469880721|FG000|Overall Study|Lost to Follow-up|4|||
130522173|NCT03732820|469880722|FG001|Overall Study|Lost to Follow-up|2|||
130522174|NCT00992992|469880723|FG000|Overall Study|Lost to Follow-up|3|||
130522175|NCT00992992|469880723|FG000|Overall Study|Death|16|||
130522176|NCT00992992|469880723|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
130522177|NCT00992992|469880723|FG000|Overall Study|Sponsor Closed the Study|4|||
130522178|NCT00832000|469880725|FG000|Overall Study|Adverse Event|2|||
130522179|NCT00832000|469880726|FG001|Overall Study|Adverse Event|0|||
130522180|NCT00832000|469880725|FG000|Overall Study|Withdrawal by Subject|1|||
130522181|NCT00832000|469880726|FG001|Overall Study|Withdrawal by Subject|0|||
130522182|NCT00832000|469880725|FG000|Overall Study|No calls to IVR in either period|1|||
130522183|NCT00832000|469880726|FG001|Overall Study|No calls to IVR in either period|1|||
130522184|NCT00832000|469880725|FG000|Overall Study|No calls to IVR in period 2|2|||
130522185|NCT00832000|469880726|FG001|Overall Study|No calls to IVR in period 2|0|||
130522186|NCT02725567|469880728|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
130522187|NCT02725567|469880729|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
130522188|NCT02725567|469880728|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
130522189|NCT02725567|469880729|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
130522190|NCT02725567|469880728|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
130522191|NCT02725567|469880729|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
130522192|NCT00255944|469880730|FG000|Overall Study|Lost to Follow-up|797|||
130522193|NCT00255944|469880731|FG001|Overall Study|Lost to Follow-up|834|||
130522194|NCT01129115|469880732|FG000|Overall Study|Adverse Event|1|||
130522195|NCT01129115|469880733|FG001|Overall Study|Adverse Event|2|||
130522196|NCT01129115|469880734|FG002|Overall Study|Adverse Event|3|||
130522197|NCT01129115|469880735|FG003|Overall Study|Adverse Event|3|||
130522198|NCT01129115|469880732|FG000|Overall Study|Withdrawal by Subject|1|||
130522199|NCT01129115|469880733|FG001|Overall Study|Withdrawal by Subject|3|||
130522200|NCT01129115|469880734|FG002|Overall Study|Withdrawal by Subject|1|||
130522201|NCT01129115|469880735|FG003|Overall Study|Withdrawal by Subject|4|||
130522202|NCT01129115|469880732|FG000|Overall Study|Protocol Violation|0|||
130522203|NCT01129115|469880733|FG001|Overall Study|Protocol Violation|2|||
130522204|NCT01129115|469880734|FG002|Overall Study|Protocol Violation|2|||
130522205|NCT01129115|469880735|FG003|Overall Study|Protocol Violation|2|||
130522206|NCT01747837|469880737|FG000|Overall Study|Lost to Follow-up|5|||
130522207|NCT01747837|469880738|FG001|Overall Study|Lost to Follow-up|2|||
130522208|NCT01747837|469880737|FG000|Overall Study|Death|4|||
130522209|NCT01747837|469880738|FG001|Overall Study|Death|4|||
130522210|NCT01435798|469880740|FG000|Overall Study|Withdrawal by Subject|1|||
130522211|NCT01253447|469880741|FG000|Overall Study|Adverse Event|2|||
130522212|NCT00817336|469880742|FG000|Overall Study|Withdrawal by Subject|1|||
130522213|NCT00817336|469880743|FG001|Overall Study|Withdrawal by Subject|1|||
130522214|NCT02299427|469880744|FG000|Overall Study|Withdrawal by Subject|1|||
130522215|NCT02299427|469880745|FG001|Overall Study|Withdrawal by Subject|0|||
130522216|NCT02299427|469880744|FG000|Overall Study|Lost to Follow-up|1|||
130522217|NCT02299427|469880745|FG001|Overall Study|Lost to Follow-up|3|||
130574995|NCT01026831|470069609|FG001|Overall Study|Protocol Violation|2|||
130574996|NCT01026831|470069608|FG000|Overall Study|Withdrawal by Subject|7|||
130574997|NCT01026831|470069609|FG001|Overall Study|Withdrawal by Subject|5|||
130574998|NCT01180660|470069610|FG000|Overall Study|Changed to open surgery|1|||
130574999|NCT01180660|470069611|FG001|Overall Study|Changed to open surgery|0|||
130575000|NCT03861559|470069612|FG000|Overall Study|Adverse Event|0|||
130575001|NCT03861559|470069613|FG001|Overall Study|Adverse Event|2|||
130575002|NCT03861559|470069612|FG000|Overall Study|Treatment failure|0|||
130575003|NCT03861559|470069613|FG001|Overall Study|Treatment failure|2|||
130575004|NCT03861559|470069612|FG000|Overall Study|Noncompliance|1|||
130575005|NCT03861559|470069613|FG001|Overall Study|Noncompliance|1|||
130575006|NCT03861559|470069612|FG000|Overall Study|Did not meet eligibility requirements|1|||
130575007|NCT03861559|470069613|FG001|Overall Study|Did not meet eligibility requirements|0|||
130575008|NCT02751502|470069614|FG000|Overall Study|Lack of funding|4|||
130575009|NCT02678390|470069615|FG000|AE (1 Day)|Withdrawal by Subject|0|||
130575010|NCT02678390|470069616|FG001|AE (1 Day)|Withdrawal by Subject|1|||
130575011|NCT03499028|470069617|FG000|Overall Study|Lost to Follow-up|12|||
130575012|NCT03499028|470069618|FG001|Overall Study|Lost to Follow-up|9|||
130575013|NCT03499028|470069617|FG000|Overall Study|Withdrawal by Subject|5|||
130575014|NCT03499028|470069618|FG001|Overall Study|Withdrawal by Subject|8|||
130575015|NCT03499028|470069617|FG000|Overall Study|Unplanned SNF discharge|5|||
130575016|NCT03499028|470069618|FG001|Overall Study|Unplanned SNF discharge|8|||
130575017|NCT00498173|470069619|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
130575018|NCT00498173|470069620|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
130575019|NCT00498173|470069621|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
130575020|NCT03595553|470069622|FG000|Overall Study|Withdrawal by Subject|20|||
130575021|NCT03595553|470069623|FG001|Overall Study|Withdrawal by Subject|8|||
130575022|NCT03595553|470069622|FG000|Overall Study|Physician Decision|3|||
130575023|NCT03595553|470069623|FG001|Overall Study|Physician Decision|2|||
130575024|NCT03595553|470069622|FG000|Overall Study|Adverse Event|2|||
130575025|NCT03595553|470069623|FG001|Overall Study|Adverse Event|5|||
130575026|NCT03595553|470069622|FG000|Overall Study|Death|24|||
130575027|NCT03595553|470069623|FG001|Overall Study|Death|22|||
130575028|NCT03595553|470069622|FG000|Overall Study|Lost to Follow-up|6|||
130575029|NCT03595553|470069623|FG001|Overall Study|Lost to Follow-up|7|||
130575030|NCT03595553|470069622|FG000|Overall Study|Other as indicated in CSR|3|||
130575031|NCT03595553|470069623|FG001|Overall Study|Other as indicated in CSR|3|||
130575032|NCT03595553|470069622|FG000|Overall Study|Sponsor Decision|0|||
130575033|NCT03595553|470069623|FG001|Overall Study|Sponsor Decision|1|||
130575034|NCT01110200|470069624|FG000|Overall Study|Adverse Event|28|||
130575035|NCT01110200|470069625|FG001|Overall Study|Adverse Event|28|||
130575036|NCT01110200|470069624|FG000|Overall Study|Withdrawal by Subject|25|||
130575037|NCT01110200|470069625|FG001|Overall Study|Withdrawal by Subject|32|||
130575038|NCT01110200|470069624|FG000|Overall Study|Lack of Efficacy|16|||
130575039|NCT01110200|470069625|FG001|Overall Study|Lack of Efficacy|25|||
130575040|NCT01110200|470069624|FG000|Overall Study|Protocol Violation|14|||
130575041|NCT01110200|470069625|FG001|Overall Study|Protocol Violation|12|||
130575042|NCT01110200|470069624|FG000|Overall Study|Physician Decision|13|||
130575043|NCT01110200|470069625|FG001|Overall Study|Physician Decision|17|||
130575044|NCT01110200|470069624|FG000|Overall Study|Lost to Follow-up|10|||
130575045|NCT01110200|470069625|FG001|Overall Study|Lost to Follow-up|7|||
130575046|NCT01437397|470069626|FG000|Overall Study|Lost to Follow-up|9|||
130575047|NCT01437397|470069627|FG001|Overall Study|Lost to Follow-up|4|||
130575048|NCT01437397|470069628|FG002|Overall Study|Lost to Follow-up|2|||
130575049|NCT01437397|470069629|FG003|Overall Study|Lost to Follow-up|4|||
130575050|NCT01437397|470069630|FG004|Overall Study|Lost to Follow-up|5|||
130575051|NCT01437397|470069626|FG000|Overall Study|Withdrawal by Subject|11|||
130575052|NCT01437397|470069627|FG001|Overall Study|Withdrawal by Subject|12|||
130575053|NCT01437397|470069628|FG002|Overall Study|Withdrawal by Subject|24|||
130575054|NCT01437397|470069629|FG003|Overall Study|Withdrawal by Subject|11|||
130575055|NCT01437397|470069630|FG004|Overall Study|Withdrawal by Subject|22|||
130575056|NCT01437397|470069626|FG000|Overall Study|Protocol Violation|10|||
130575057|NCT01437397|470069627|FG001|Overall Study|Protocol Violation|12|||
130575058|NCT01437397|470069628|FG002|Overall Study|Protocol Violation|13|||
130575059|NCT01437397|470069629|FG003|Overall Study|Protocol Violation|21|||
130575060|NCT01437397|470069630|FG004|Overall Study|Protocol Violation|19|||
130575061|NCT01437397|470069626|FG000|Overall Study|Lack of Efficacy|5|||
130575062|NCT01437397|470069627|FG001|Overall Study|Lack of Efficacy|4|||
130575063|NCT01437397|470069628|FG002|Overall Study|Lack of Efficacy|8|||
130575064|NCT01437397|470069629|FG003|Overall Study|Lack of Efficacy|10|||
130575065|NCT01437397|470069630|FG004|Overall Study|Lack of Efficacy|20|||
130575066|NCT01437397|470069626|FG000|Overall Study|Adverse Event|21|||
130575067|NCT01437397|470069627|FG001|Overall Study|Adverse Event|22|||
130575068|NCT01437397|470069628|FG002|Overall Study|Adverse Event|16|||
130575069|NCT01437397|470069629|FG003|Overall Study|Adverse Event|14|||
130522218|NCT02299427|469880744|FG000|Overall Study|not adherent to dog website use|21|||
130522219|NCT02299427|469880745|FG001|Overall Study|not adherent to dog website use|0|||
130522220|NCT02108652|469880746|FG000|Overall Study|Death|253|||
130522221|NCT02108652|469880746|FG000|Overall Study|Lost to Follow-up|2|||
130522222|NCT02108652|469880746|FG000|Overall Study|Withdrawal by Subject|16|||
130522223|NCT02108652|469880746|FG000|Overall Study|Study Terminated By Sponsor|31|||
130522224|NCT02108652|469880746|FG000|Overall Study|Non-Compliance|1|||
130522225|NCT02108652|469880746|FG000|Overall Study|Physician Decision|6|||
130522226|NCT02108652|469880746|FG000|Overall Study|Progression Of Disease|1|||
130522227|NCT01121913|469880749|FG000|First Intervention Period|Adverse Event|0|||
130522228|NCT01121913|469880750|FG001|First Intervention Period|Adverse Event|0|||
130522229|NCT01121913|469880751|FG002|First Intervention Period|Adverse Event|1|||
130522230|NCT01121913|469880752|FG003|First Intervention Period|Adverse Event|0|||
130522231|NCT01121913|469880749|FG000|First Washout Period|Withdrawal by Subject|1|||
130522232|NCT01121913|469880750|FG001|First Washout Period|Withdrawal by Subject|0|||
130522233|NCT01121913|469880751|FG002|First Washout Period|Withdrawal by Subject|0|||
130522234|NCT01121913|469880752|FG003|First Washout Period|Withdrawal by Subject|0|||
130522235|NCT01121913|469880749|FG000|Second Intervention Period|Adverse Event|0|||
130522236|NCT01121913|469880750|FG001|Second Intervention Period|Adverse Event|0|||
130522237|NCT01121913|469880751|FG002|Second Intervention Period|Adverse Event|1|||
130522238|NCT01121913|469880752|FG003|Second Intervention Period|Adverse Event|0|||
130522239|NCT01121913|469880749|FG000|Second Washout Period|Withdrawal by Subject|0|||
130522240|NCT01121913|469880750|FG001|Second Washout Period|Withdrawal by Subject|0|||
130522241|NCT01121913|469880751|FG002|Second Washout Period|Withdrawal by Subject|1|||
130522242|NCT01121913|469880752|FG003|Second Washout Period|Withdrawal by Subject|0|||
130522243|NCT01121913|469880749|FG000|Third Washout Period|Adverse Event|1|||
130522244|NCT01121913|469880750|FG001|Third Washout Period|Adverse Event|0|||
130522245|NCT01121913|469880751|FG002|Third Washout Period|Adverse Event|0|||
130522246|NCT01121913|469880752|FG003|Third Washout Period|Adverse Event|0|||
130522247|NCT02564718|469880755|FG000|Overall Study|Withdrew from treatment|0|||
130522248|NCT02564718|469880756|FG001|Overall Study|Withdrew from treatment|1|||
130522249|NCT00935259|469880757|FG000|Period 1|Administrative (scheduling conflict)|1|||
130522250|NCT00935259|469880758|FG001|Period 1|Administrative (scheduling conflict)|1|||
130522251|NCT00937521|469880759|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522252|NCT00937521|469880760|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522253|NCT00937521|469880761|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
130522254|NCT00937521|469880762|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522255|NCT00937521|469880763|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522256|NCT00937521|469880764|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522257|NCT00937521|469880765|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
130522258|NCT00937521|469880766|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130522259|NCT00937521|469880759|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
130522260|NCT00937521|469880760|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
130522261|NCT00937521|469880761|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
130522262|NCT00937521|469880762|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
130522263|NCT00937521|469880763|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
130522264|NCT00937521|469880764|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
130522265|NCT00937521|469880765|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
130522266|NCT00937521|469880766|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
130522267|NCT00937521|469880759|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522268|NCT00937521|469880760|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522269|NCT00937521|469880761|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
130522270|NCT00937521|469880762|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
130522271|NCT00937521|469880763|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522272|NCT00937521|469880764|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522273|NCT00937521|469880765|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522274|NCT00937521|469880766|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
130522275|NCT00937521|469880759|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
130522276|NCT00937521|469880760|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
130522277|NCT00937521|469880761|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
130522278|NCT00937521|469880762|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
130522279|NCT00937521|469880763|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
130522280|NCT00937521|469880764|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
130522281|NCT00937521|469880765|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
130522282|NCT00937521|469880766|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
130522283|NCT00937521|469880759|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
130522284|NCT00937521|469880760|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130575070|NCT01437397|470069630|FG004|Overall Study|Adverse Event|21|||
130575071|NCT01437397|470069626|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
130575072|NCT01437397|470069627|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
130575073|NCT01437397|470069628|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
130575074|NCT01437397|470069629|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
130575075|NCT01437397|470069630|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
130575076|NCT00903175|470069631|FG000|Period 1 - First Line|Adverse Event|36|||
130575077|NCT00903175|470069632|FG001|Period 1 - First Line|Adverse Event|50|||
130575078|NCT00903175|470069631|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
130575079|NCT00903175|470069632|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
130575080|NCT00903175|470069631|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
130575081|NCT00903175|470069632|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
130575082|NCT00903175|470069631|FG000|Period 1 - First Line|Protocol Violation|3|||
130575083|NCT00903175|470069632|FG001|Period 1 - First Line|Protocol Violation|3|||
130575084|NCT00903175|470069631|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
130575085|NCT00903175|470069632|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
130575086|NCT00903175|470069631|FG000|Period 1 - First Line|Administrative problems|12|||
130575087|NCT00903175|470069632|FG001|Period 1 - First Line|Administrative problems|13|||
130575088|NCT00903175|470069631|FG000|Period 1 - First Line|Death|17|||
130575089|NCT00903175|470069632|FG001|Period 1 - First Line|Death|10|||
130575090|NCT00903175|470069631|FG000|Period 2 - Second Line|Missing|1|||
130575091|NCT00903175|470069632|FG001|Period 2 - Second Line|Missing|0|||
130575092|NCT00903175|470069631|FG000|Period 2 - Second Line|Adverse Event|16|||
130575093|NCT00903175|470069632|FG001|Period 2 - Second Line|Adverse Event|20|||
130575094|NCT00903175|470069631|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
130575095|NCT00903175|470069632|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
130575096|NCT00903175|470069631|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
130575097|NCT00903175|470069632|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
130575098|NCT00903175|470069631|FG000|Period 2 - Second Line|Administrative problems|19|||
130575099|NCT00903175|470069632|FG001|Period 2 - Second Line|Administrative problems|9|||
130522285|NCT00937521|469880761|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130522286|NCT00937521|469880762|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130522287|NCT00937521|469880763|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130522288|NCT00937521|469880764|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130522289|NCT00937521|469880765|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
130522290|NCT00937521|469880766|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
130522291|NCT00937521|469880759|FG000|Booster Phase|Adverse Event|0|||
130522292|NCT00937521|469880760|FG001|Booster Phase|Adverse Event|0|||
130522293|NCT00937521|469880761|FG002|Booster Phase|Adverse Event|0|||
130522294|NCT00937521|469880762|FG003|Booster Phase|Adverse Event|0|||
130522295|NCT00937521|469880763|FG004|Booster Phase|Adverse Event|0|||
130522296|NCT00937521|469880764|FG005|Booster Phase|Adverse Event|0|||
130522297|NCT00937521|469880765|FG006|Booster Phase|Adverse Event|1|||
130522298|NCT00937521|469880766|FG007|Booster Phase|Adverse Event|0|||
130522299|NCT00937521|469880759|FG000|Booster Phase|Withdrawal by Subject|1|||
130522300|NCT00937521|469880760|FG001|Booster Phase|Withdrawal by Subject|0|||
130522301|NCT00937521|469880761|FG002|Booster Phase|Withdrawal by Subject|0|||
130522302|NCT00937521|469880762|FG003|Booster Phase|Withdrawal by Subject|1|||
130522303|NCT00937521|469880763|FG004|Booster Phase|Withdrawal by Subject|0|||
130522304|NCT00937521|469880764|FG005|Booster Phase|Withdrawal by Subject|0|||
130522305|NCT00937521|469880765|FG006|Booster Phase|Withdrawal by Subject|0|||
130522306|NCT00937521|469880766|FG007|Booster Phase|Withdrawal by Subject|2|||
130522307|NCT00937521|469880759|FG000|Booster Phase|Lost to Follow-up|2|||
130522308|NCT00937521|469880760|FG001|Booster Phase|Lost to Follow-up|2|||
130522309|NCT00937521|469880761|FG002|Booster Phase|Lost to Follow-up|4|||
130522310|NCT00937521|469880762|FG003|Booster Phase|Lost to Follow-up|2|||
130522311|NCT00937521|469880763|FG004|Booster Phase|Lost to Follow-up|4|||
130522312|NCT00937521|469880764|FG005|Booster Phase|Lost to Follow-up|4|||
130522313|NCT00937521|469880765|FG006|Booster Phase|Lost to Follow-up|3|||
130522314|NCT00937521|469880766|FG007|Booster Phase|Lost to Follow-up|0|||
130522315|NCT00937521|469880759|FG000|Booster Phase|Administrative Reason|0|||
130522316|NCT00937521|469880760|FG001|Booster Phase|Administrative Reason|0|||
130522317|NCT00937521|469880761|FG002|Booster Phase|Administrative Reason|1|||
130522318|NCT00937521|469880762|FG003|Booster Phase|Administrative Reason|0|||
130522319|NCT00937521|469880763|FG004|Booster Phase|Administrative Reason|1|||
130575100|NCT00903175|470069631|FG000|Period 2 - Second Line|Death|5|||
130575101|NCT00903175|470069632|FG001|Period 2 - Second Line|Death|2|||
130575102|NCT01687712|470069633|FG000|Cycle 1|Not Biochemically Pregnant|386|||
130522320|NCT00937521|469880764|FG005|Booster Phase|Administrative Reason|1|||
130522321|NCT00937521|469880765|FG006|Booster Phase|Administrative Reason|0|||
130522322|NCT00937521|469880766|FG007|Booster Phase|Administrative Reason|0|||
130522323|NCT00937521|469880759|FG000|Booster Phase|Protocol Deviation|0|||
130522324|NCT00937521|469880760|FG001|Booster Phase|Protocol Deviation|0|||
130522325|NCT00937521|469880761|FG002|Booster Phase|Protocol Deviation|0|||
130575103|NCT01687712|470069634|FG001|Cycle 1|Not Biochemically Pregnant|348|||
130522326|NCT00937521|469880762|FG003|Booster Phase|Protocol Deviation|0|||
130522327|NCT00937521|469880763|FG004|Booster Phase|Protocol Deviation|0|||
130522328|NCT00937521|469880764|FG005|Booster Phase|Protocol Deviation|0|||
130522329|NCT00937521|469880765|FG006|Booster Phase|Protocol Deviation|1|||
130522330|NCT00937521|469880766|FG007|Booster Phase|Protocol Deviation|0|||
130522331|NCT00874497|469880770|FG000|Overall Study|Lost to Follow-up|2|||
130522332|NCT00874497|469880771|FG001|Overall Study|Lost to Follow-up|4|||
130522333|NCT00874497|469880770|FG000|Overall Study|Adverse Event|9|||
130522334|NCT00874497|469880771|FG001|Overall Study|Adverse Event|4|||
130522335|NCT00874497|469880770|FG000|Overall Study|Sponsor Discontinued Trial|7|||
130522336|NCT00874497|469880771|FG001|Overall Study|Sponsor Discontinued Trial|3|||
130522337|NCT00874497|469880770|FG000|Overall Study|Met Withdrawal Criteria|4|||
130522338|NCT00874497|469880771|FG001|Overall Study|Met Withdrawal Criteria|2|||
130522339|NCT00874497|469880770|FG000|Overall Study|Physician Decision|1|||
130522340|NCT00874497|469880771|FG001|Overall Study|Physician Decision|1|||
130522341|NCT00874497|469880770|FG000|Overall Study|Withdrawal by Subject|5|||
130522342|NCT00874497|469880771|FG001|Overall Study|Withdrawal by Subject|4|||
130522343|NCT01017263|469880772|FG000|Overall Study|not eligible|12|||
130522344|NCT02980705|469880773|FG000|Overall Study|Adverse Event|0|||
130522345|NCT02980705|469880774|FG001|Overall Study|Adverse Event|1|||
130522346|NCT02980705|469880773|FG000|Overall Study|Withdrawal by Subject|6|||
130522347|NCT02980705|469880774|FG001|Overall Study|Withdrawal by Subject|9|||
130522348|NCT02980705|469880773|FG000|Overall Study|withdrew participation|0|||
130522349|NCT02980705|469880774|FG001|Overall Study|withdrew participation|1|||
130522350|NCT02980705|469880773|FG000|Overall Study|Lost to Follow-up|2|||
130522351|NCT02980705|469880774|FG001|Overall Study|Lost to Follow-up|0|||
130522352|NCT00263575|469880775|FG000|Titration Period|Adverse Event|14|||
130522353|NCT00263575|469880775|FG000|Titration Period|Withdrawal by Subject|10|||
130522354|NCT00263575|469880775|FG000|Titration Period|Protocol Violation|9|||
130522355|NCT00263575|469880775|FG000|Titration Period|Sponsor Decision|2|||
130522356|NCT00263575|469880775|FG000|Titration Period|Other|2|||
130522357|NCT00263575|469880775|FG000|Titration Period|Lack of Efficacy|6|||
130522358|NCT00263575|469880775|FG000|Maintence Period|Adverse Event|23|||
130522359|NCT00263575|469880775|FG000|Maintence Period|Withdrawal by Subject|8|||
130522360|NCT00263575|469880775|FG000|Maintence Period|Protocol Violation|4|||
130522361|NCT00263575|469880775|FG000|Maintence Period|Lack of Efficacy|4|||
130522362|NCT00263575|469880775|FG000|Maintence Period|Physician Decision|6|||
130522363|NCT00263575|469880775|FG000|Maintence Period|Lost to Follow-up|1|||
130522364|NCT00263575|469880775|FG000|Maintence Period|Sponsor Decision|24|||
130522365|NCT00263575|469880775|FG000|Maintence Period|Other|7|||
130522366|NCT04353817|469880776|FG000|Overall Study|Adverse Event|0|||
130522367|NCT04353817|469880777|FG001|Overall Study|Adverse Event|1|||
130522368|NCT00239681|469880778|FG000|Overall Study|Adverse Event|100|||
130522369|NCT00239681|469880779|FG001|Overall Study|Adverse Event|99|||
130522370|NCT00239681|469880778|FG000|Overall Study|Withdrawal by Subject|458|||
130522371|NCT00239681|469880779|FG001|Overall Study|Withdrawal by Subject|489|||
130522372|NCT00239681|469880778|FG000|Overall Study|Lost to Follow-up|28|||
130522373|NCT00239681|469880779|FG001|Overall Study|Lost to Follow-up|22|||
130522374|NCT00239681|469880778|FG000|Overall Study|Protocol Violation|4|||
130522375|NCT00239681|469880779|FG001|Overall Study|Protocol Violation|4|||
130522376|NCT00239681|469880778|FG000|Overall Study|Physician Decision|13|||
130522377|NCT00239681|469880779|FG001|Overall Study|Physician Decision|17|||
130522378|NCT00239681|469880778|FG000|Overall Study|No information chacked on CaseReportForm|90|||
130522379|NCT00239681|469880779|FG001|Overall Study|No information chacked on CaseReportForm|84|||
130522380|NCT02447718|469880780|FG000|Overall Study|Lost to Follow-up|8|||
130522381|NCT02447718|469880781|FG001|Overall Study|Lost to Follow-up|0|||
130522382|NCT02447718|469880780|FG000|Overall Study|Withdrawal by Subject|3|||
130522383|NCT02447718|469880781|FG001|Overall Study|Withdrawal by Subject|0|||
130522384|NCT02447718|469880780|FG000|Overall Study|Screen Failure|1|||
130522385|NCT02447718|469880781|FG001|Overall Study|Screen Failure|0|||
130522386|NCT03599622|469880786|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130522387|NCT03599622|469880787|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
130522388|NCT03599622|469880788|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
130522389|NCT03599622|469880789|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
130522390|NCT03599622|469880786|FG000|Pre-Treatment Period|Other reasons|1|||
130522391|NCT03599622|469880787|FG001|Pre-Treatment Period|Other reasons|1|||
130522392|NCT03599622|469880788|FG002|Pre-Treatment Period|Other reasons|1|||
130522393|NCT03599622|469880789|FG003|Pre-Treatment Period|Other reasons|0|||
130522394|NCT03599622|469880786|FG000|Treatment Period|Adverse Event|11|||
130522395|NCT03599622|469880787|FG001|Treatment Period|Adverse Event|20|||
130522396|NCT03599622|469880788|FG002|Treatment Period|Adverse Event|18|||
130522397|NCT03599622|469880789|FG003|Treatment Period|Adverse Event|2|||
130522398|NCT03599622|469880786|FG000|Treatment Period|Lack of Efficacy|18|||
130522399|NCT03599622|469880787|FG001|Treatment Period|Lack of Efficacy|12|||
130522400|NCT03599622|469880788|FG002|Treatment Period|Lack of Efficacy|13|||
130522401|NCT03599622|469880789|FG003|Treatment Period|Lack of Efficacy|2|||
130522402|NCT03599622|469880786|FG000|Treatment Period|Withdrawal by Subject|5|||
130522403|NCT03599622|469880787|FG001|Treatment Period|Withdrawal by Subject|11|||
130522404|NCT03599622|469880788|FG002|Treatment Period|Withdrawal by Subject|16|||
130522405|NCT03599622|469880789|FG003|Treatment Period|Withdrawal by Subject|1|||
130522406|NCT03599622|469880786|FG000|Treatment Period|Other reasons|4|||
130522407|NCT03599622|469880787|FG001|Treatment Period|Other reasons|6|||
130522408|NCT03599622|469880788|FG002|Treatment Period|Other reasons|7|||
130522409|NCT03599622|469880789|FG003|Treatment Period|Other reasons|0|||
130522410|NCT03599622|469880786|FG000|Treatment Period|Lost to Follow-up|1|||
130522411|NCT03599622|469880787|FG001|Treatment Period|Lost to Follow-up|0|||
130522412|NCT03599622|469880788|FG002|Treatment Period|Lost to Follow-up|0|||
130522413|NCT03599622|469880789|FG003|Treatment Period|Lost to Follow-up|0|||
130522414|NCT03599622|469880786|FG000|Treatment Period|Study terminated by sponsor|7|||
130522415|NCT03599622|469880787|FG001|Treatment Period|Study terminated by sponsor|20|||
130522416|NCT03599622|469880788|FG002|Treatment Period|Study terminated by sponsor|15|||
130522417|NCT03599622|469880789|FG003|Treatment Period|Study terminated by sponsor|0|||
130522418|NCT03599622|469880786|FG000|Treatment Period|Site terminated by sponsor|0|||
130522419|NCT03599622|469880787|FG001|Treatment Period|Site terminated by sponsor|1|||
130522420|NCT03599622|469880788|FG002|Treatment Period|Site terminated by sponsor|0|||
130522421|NCT03599622|469880789|FG003|Treatment Period|Site terminated by sponsor|0|||
130522422|NCT00770588|469880790|FG000|Overall Study|Adverse Event|9|||
130522423|NCT00770588|469880791|FG001|Overall Study|Adverse Event|2|||
130522424|NCT00770588|469880790|FG000|Overall Study|Death caused by progression of disease|70|||
130522425|NCT00770588|469880791|FG001|Overall Study|Death caused by progression of disease|91|||
130522426|NCT00770588|469880790|FG000|Overall Study|Lost to Follow-up|1|||
130522427|NCT00770588|469880791|FG001|Overall Study|Lost to Follow-up|1|||
130522428|NCT00770588|469880790|FG000|Overall Study|Withdrawal by Subject|1|||
130522429|NCT00770588|469880791|FG001|Overall Study|Withdrawal by Subject|1|||
130522430|NCT00665223|469880792|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
130522431|NCT00665223|469880793|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
130522432|NCT00665223|469880794|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
130522433|NCT00665223|469880792|FG000|Randomized Phase (26 Weeks)|Death|0|||
130522434|NCT00665223|469880793|FG001|Randomized Phase (26 Weeks)|Death|0|||
130522435|NCT00665223|469880794|FG002|Randomized Phase (26 Weeks)|Death|1|||
130522436|NCT00665223|469880792|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
130522437|NCT00665223|469880793|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
130522438|NCT00665223|469880794|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
130522439|NCT00665223|469880792|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
130522440|NCT00665223|469880793|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
130522441|NCT00665223|469880794|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
130522442|NCT00665223|469880792|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
130522443|NCT00665223|469880793|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
130522444|NCT00665223|469880794|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
130522445|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
130522446|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
130522447|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
130522448|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Death|0|||
130522449|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Death|1|||
130522450|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Death|0|||
130522451|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
130522452|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
130522453|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
130522454|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
130522455|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
130522456|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
130522457|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
130522458|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
130522459|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
130522460|NCT00665223|469880792|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
130522461|NCT00665223|469880793|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
130522462|NCT00665223|469880794|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
130522463|NCT00002597|469880795|FG000|Overall Study|Protocol Violation|19|||
130522464|NCT00002597|469880796|FG001|Overall Study|Protocol Violation|17|||
130522465|NCT00002597|469880795|FG000|Overall Study|Withdrawal by Subject|7|||
130522466|NCT00002597|469880796|FG001|Overall Study|Withdrawal by Subject|6|||
130522467|NCT01426113|469880797|FG000|Overall Study|Study Discontinued|1|||
130522468|NCT01426113|469880798|FG001|Overall Study|Study Discontinued|1|||
130522469|NCT01426113|469880797|FG000|Overall Study|Adverse Event|0|||
130522470|NCT01426113|469880798|FG001|Overall Study|Adverse Event|1|||
130522471|NCT02485899|469880799|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
130522472|NCT02485899|469880800|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130522473|NCT02485899|469880799|FG000|Overall Study|Withdrawal by Subject|1|||
130575104|NCT01687712|470069633|FG000|Cycle 1|Early Pregnancy Loss|43|||
130575105|NCT01687712|470069634|FG001|Cycle 1|Early Pregnancy Loss|60|||
130575106|NCT01687712|470069633|FG000|Cycle 1|Ectopic Pregnancy|5|||
130575107|NCT01687712|470069634|FG001|Cycle 1|Ectopic Pregnancy|5|||
130575108|NCT01687712|470069633|FG000|Cycle 1|Heterotropic Pregnancy|1|||
130575109|NCT01687712|470069634|FG001|Cycle 1|Heterotropic Pregnancy|0|||
130575110|NCT01687712|470069633|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
130575111|NCT01687712|470069634|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
130575112|NCT01687712|470069633|FG000|Cycle 1|Abortion|3|||
130575113|NCT01687712|470069634|FG001|Cycle 1|Abortion|0|||
130575114|NCT01687712|470069633|FG000|Cycle 1|Intrauterine Fetal Death|0|||
130575115|NCT01687712|470069634|FG001|Cycle 1|Intrauterine Fetal Death|1|||
130575116|NCT01687712|470069633|FG000|Cycle 1|Lost to Follow-up|1|||
130575117|NCT01687712|470069634|FG001|Cycle 1|Lost to Follow-up|1|||
130575118|NCT01687712|470069633|FG000|Cycle 2|Not Biochemically Pregnant|74|||
130575119|NCT01687712|470069634|FG001|Cycle 2|Not Biochemically Pregnant|77|||
130575120|NCT01687712|470069633|FG000|Cycle 2|Early Pregnancy Loss|18|||
130575121|NCT01687712|470069634|FG001|Cycle 2|Early Pregnancy Loss|16|||
130575122|NCT01687712|470069633|FG000|Cycle 2|Ectopic Pregnancy|0|||
130575123|NCT01687712|470069634|FG001|Cycle 2|Ectopic Pregnancy|1|||
130575124|NCT01687712|470069633|FG000|Cycle 2|Still Birth|1|||
130575125|NCT01687712|470069634|FG001|Cycle 2|Still Birth|0|||
130575126|NCT01687712|470069633|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
130575127|NCT01687712|470069634|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
130575128|NCT01687712|470069633|FG000|Cycle 3|Not Biochemically Pregnant|21|||
130575129|NCT01687712|470069634|FG001|Cycle 3|Not Biochemically Pregnant|22|||
130575130|NCT01687712|470069633|FG000|Cycle 3|Early Pregnancy Loss|1|||
130575131|NCT01687712|470069634|FG001|Cycle 3|Early Pregnancy Loss|2|||
130575132|NCT01687712|470069633|FG000|Cycle 3|Ectopic Pregnancy|1|||
130575133|NCT01687712|470069634|FG001|Cycle 3|Ectopic Pregnancy|0|||
130575134|NCT01687712|470069633|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
130575135|NCT01687712|470069634|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
130575136|NCT03074474|470069639|FG000|Overall Study|Lost to Follow-up|10|||
130575137|NCT03074474|470069639|FG000|Overall Study|Withdrawal by Subject|10|||
130575138|NCT03074474|470069639|FG000|Overall Study|Death|4|||
130575139|NCT03074474|470069639|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
130575140|NCT01035905|470069642|FG000|Overall Study|Lack of Efficacy|1|||
130575141|NCT01035905|470069643|FG001|Overall Study|Lack of Efficacy|1|||
130575142|NCT01632566|470069646|FG000|Overall Study|Withdrawal by Subject|0|||
130575143|NCT01632566|470069647|FG001|Overall Study|Withdrawal by Subject|1|||
130575144|NCT01632566|470069648|FG002|Overall Study|Withdrawal by Subject|0|||
130575145|NCT01632566|470069649|FG003|Overall Study|Withdrawal by Subject|0|||
130575146|NCT01632566|470069650|FG004|Overall Study|Withdrawal by Subject|0|||
130575147|NCT01632566|470069646|FG000|Overall Study|Sponsor Decision|0|||
130575148|NCT01632566|470069647|FG001|Overall Study|Sponsor Decision|2|||
130575149|NCT01632566|470069648|FG002|Overall Study|Sponsor Decision|9|||
130575150|NCT01632566|470069649|FG003|Overall Study|Sponsor Decision|2|||
130575151|NCT01632566|470069650|FG004|Overall Study|Sponsor Decision|2|||
130575152|NCT02158091|470069652|FG000|Overall Study|DLT|2|||
130575153|NCT02158091|470069653|FG001|Overall Study|DLT|1|||
130575154|NCT02158091|470069654|FG002|Overall Study|DLT|0|||
130575155|NCT03977467|470069655|FG000|Overall Study|Disease Progression|1|||
130575156|NCT03977467|470069656|FG001|Overall Study|Disease Progression|1|||
130575157|NCT03977467|470069657|FG002|Overall Study|Disease Progression|30|||
130575158|NCT03977467|470069658|FG003|Overall Study|Disease Progression|0|||
130575159|NCT03977467|470069655|FG000|Overall Study|Adverse Event|0|||
130575160|NCT03977467|470069656|FG001|Overall Study|Adverse Event|1|||
130575161|NCT03977467|470069657|FG002|Overall Study|Adverse Event|0|||
130575162|NCT03977467|470069658|FG003|Overall Study|Adverse Event|0|||
130575163|NCT03977467|470069655|FG000|Overall Study|Death|0|||
130575164|NCT03977467|470069656|FG001|Overall Study|Death|0|||
130575165|NCT03977467|470069657|FG002|Overall Study|Death|3|||
130575166|NCT03977467|470069658|FG003|Overall Study|Death|0|||
130575167|NCT03977467|470069655|FG000|Overall Study|Lack of Efficacy|0|||
130575168|NCT03977467|470069656|FG001|Overall Study|Lack of Efficacy|0|||
130575169|NCT03977467|470069657|FG002|Overall Study|Lack of Efficacy|1|||
130575170|NCT03977467|470069658|FG003|Overall Study|Lack of Efficacy|0|||
130575171|NCT03977467|470069655|FG000|Overall Study|Withdrawal by Subject|2|||
130575172|NCT03977467|470069656|FG001|Overall Study|Withdrawal by Subject|1|||
130575173|NCT03977467|470069657|FG002|Overall Study|Withdrawal by Subject|4|||
130575174|NCT03977467|470069658|FG003|Overall Study|Withdrawal by Subject|0|||
130575175|NCT03977467|470069655|FG000|Overall Study|Study Terminated|1|||
130575176|NCT03977467|470069656|FG001|Overall Study|Study Terminated|0|||
130575177|NCT03977467|470069657|FG002|Overall Study|Study Terminated|0|||
130575178|NCT03977467|470069658|FG003|Overall Study|Study Terminated|1|||
130575179|NCT05913232|470069659|FG000|Overall Study|Adverse Event|0|||
130575180|NCT05913232|470069660|FG001|Overall Study|Adverse Event|2|||
130575181|NCT05913232|470069661|FG002|Overall Study|Adverse Event|1|||
130575182|NCT05913232|470069662|FG003|Overall Study|Adverse Event|1|||
130575183|NCT01318109|470069663|FG000|Overall Study|Adverse Event|0|||
130575184|NCT01318109|470069664|FG001|Overall Study|Adverse Event|2|||
130522474|NCT02485899|469880800|FG001|Overall Study|Withdrawal by Subject|0|||
130522475|NCT02485899|469880799|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
130522476|NCT02485899|469880800|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
130522477|NCT01918371|469880801|FG000|Overall Study|Missing Data|1|||
130522478|NCT01918371|469880802|FG001|Overall Study|Missing Data|1|||
130522479|NCT01006889|469880803|FG000|Overall Study|Withdrawal by Subject|3|||
130522480|NCT00623363|469880804|FG000|Overall Study|Adverse Event|2|||
130522481|NCT00623363|469880805|FG001|Overall Study|Adverse Event|2|||
130522482|NCT00823836|469880807|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
130522483|NCT00823836|469880808|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
130522484|NCT00823836|469880807|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
130522485|NCT00823836|469880808|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
130522486|NCT00823836|469880807|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
130522487|NCT00823836|469880808|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
130522488|NCT00823836|469880807|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
130522489|NCT00823836|469880808|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
130522490|NCT00823836|469880807|FG000|Long-term Phase|Adverse Event|3|||
130522491|NCT00823836|469880808|FG001|Long-term Phase|Adverse Event|2|||
130522492|NCT00823836|469880807|FG000|Long-term Phase|Physician Decision|1|||
130522493|NCT00823836|469880808|FG001|Long-term Phase|Physician Decision|2|||
130522494|NCT00823836|469880807|FG000|Long-term Phase|Withdrawal by Subject|1|||
130522495|NCT00823836|469880808|FG001|Long-term Phase|Withdrawal by Subject|1|||
130522496|NCT02725528|469880813|FG000|Overall Study|Lost to Follow-up|1|||
130522497|NCT02725528|469880814|FG001|Overall Study|Lost to Follow-up|4|||
130522498|NCT02725528|469880813|FG000|Overall Study|Withdrawal by Subject|0|||
130522499|NCT02725528|469880814|FG001|Overall Study|Withdrawal by Subject|1|||
130522500|NCT02062645|469880818|FG000|Overall Study|Adverse Event|2|||
130522501|NCT02062645|469880818|FG000|Overall Study|Protocol Violation|8|||
130522502|NCT02062645|469880818|FG000|Overall Study|Lost to Follow-up|5|||
130522503|NCT00798304|469880819|FG000|Overall Study|Adverse Event|0|||
130522504|NCT00798304|469880820|FG001|Overall Study|Adverse Event|1|||
130522505|NCT00798304|469880821|FG002|Overall Study|Adverse Event|1|||
130522506|NCT00798304|469880819|FG000|Overall Study|Discontinuation by Sponsor|14|||
130522507|NCT00798304|469880820|FG001|Overall Study|Discontinuation by Sponsor|21|||
130522508|NCT00798304|469880821|FG002|Overall Study|Discontinuation by Sponsor|9|||
130522509|NCT04211389|469880822|FG000|Overall Study|Adverse Event|1|||
130522510|NCT04211389|469880823|FG001|Overall Study|Adverse Event|2|||
130522511|NCT04211389|469880822|FG000|Overall Study|Lost to Follow-up|15|||
130522512|NCT04211389|469880823|FG001|Overall Study|Lost to Follow-up|7|||
130522513|NCT04211389|469880822|FG000|Overall Study|Protocol Violation|0|||
130522514|NCT04211389|469880823|FG001|Overall Study|Protocol Violation|1|||
130522515|NCT04211389|469880822|FG000|Overall Study|Withdrawal by Subject|10|||
130522516|NCT04211389|469880823|FG001|Overall Study|Withdrawal by Subject|11|||
130522517|NCT01062971|469880832|FG000|Overall Study|Protocol Violation|1|||
130522518|NCT01062971|469880833|FG001|Overall Study|Protocol Violation|3|||
130522519|NCT01062971|469880832|FG000|Overall Study|Lost to Follow-up|3|||
130522520|NCT01062971|469880833|FG001|Overall Study|Lost to Follow-up|4|||
130522521|NCT01530087|469880834|FG000|Overall Study|Physician Decision|2|||
130522522|NCT02760485|469880835|FG000|Phase 1|Death|3|||
130522523|NCT02760485|469880836|FG001|Phase 1|Death|6|||
130522524|NCT02760485|469880837|FG002|Phase 1|Death|0|||
130522525|NCT02760485|469880835|FG000|Phase 1|Withdrawal by Subject|2|||
130522526|NCT02760485|469880836|FG001|Phase 1|Withdrawal by Subject|0|||
130522527|NCT02760485|469880837|FG002|Phase 1|Withdrawal by Subject|0|||
130522528|NCT02760485|469880835|FG000|Phase 1|Progressive Disease|1|||
130522529|NCT02760485|469880836|FG001|Phase 1|Progressive Disease|0|||
130522530|NCT02760485|469880837|FG002|Phase 1|Progressive Disease|0|||
130522531|NCT02760485|469880835|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
130522532|NCT02760485|469880836|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
130522533|NCT02760485|469880837|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
130522534|NCT02760485|469880835|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
130522535|NCT02760485|469880836|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
130522536|NCT02760485|469880837|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
130522537|NCT02760485|469880835|FG000|Phase 2|Death|0|||
130522538|NCT02760485|469880836|FG001|Phase 2|Death|0|||
130522539|NCT02760485|469880837|FG002|Phase 2|Death|12|||
130522540|NCT02760485|469880835|FG000|Phase 2|Withdrawal by Subject|0|||
130522541|NCT02760485|469880836|FG001|Phase 2|Withdrawal by Subject|0|||
130522542|NCT02760485|469880837|FG002|Phase 2|Withdrawal by Subject|3|||
130522543|NCT02760485|469880835|FG000|Phase 2|Progressive Disease|0|||
130522544|NCT02760485|469880836|FG001|Phase 2|Progressive Disease|0|||
130522545|NCT02760485|469880837|FG002|Phase 2|Progressive Disease|1|||
130522546|NCT02760485|469880835|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
130522547|NCT02760485|469880836|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
130522548|NCT02760485|469880837|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
130575185|NCT01318109|470069665|FG002|Overall Study|Adverse Event|0|||
130522549|NCT00904722|469880838|FG000|Overall Study|Physician Decision|1|||
130522550|NCT01087814|469880839|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
130522551|NCT01087814|469880840|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
130522552|NCT01087814|469880839|FG000|Second Intervention (5 Days)|Physician Decision|1|||
130522553|NCT01087814|469880840|FG001|Second Intervention (5 Days)|Physician Decision|0|||
130522554|NCT01891890|469880841|FG000|Overall Study|Lost to Follow-up|0|||
130522555|NCT01891890|469880842|FG001|Overall Study|Lost to Follow-up|0|||
130522556|NCT01891890|469880843|FG002|Overall Study|Lost to Follow-up|1|||
130522557|NCT01891890|469880841|FG000|Overall Study|Study ended before endpoint reached|7|||
130522558|NCT01891890|469880842|FG001|Overall Study|Study ended before endpoint reached|3|||
130522559|NCT01891890|469880843|FG002|Overall Study|Study ended before endpoint reached|6|||
130522560|NCT01161628|469880844|FG000|Overall Study|Death|6|||
130522561|NCT01161628|469880844|FG000|Overall Study|Lack of Efficacy|2|||
130522562|NCT04680637|469880845|FG000|Overall Study|Lost to Follow-up|0|||
130522563|NCT04680637|469880846|FG001|Overall Study|Lost to Follow-up|1|||
130522564|NCT04680637|469880847|FG002|Overall Study|Lost to Follow-up|0|||
130522565|NCT04680637|469880848|FG003|Overall Study|Lost to Follow-up|1|||
130522566|NCT04680637|469880845|FG000|Overall Study|Death|1|||
130522567|NCT04680637|469880846|FG001|Overall Study|Death|0|||
130522568|NCT04680637|469880847|FG002|Overall Study|Death|0|||
130522569|NCT04680637|469880848|FG003|Overall Study|Death|0|||
130522570|NCT04680637|469880845|FG000|Overall Study|Withdrawal by Subject|7|||
130522571|NCT04680637|469880846|FG001|Overall Study|Withdrawal by Subject|10|||
130522572|NCT04680637|469880847|FG002|Overall Study|Withdrawal by Subject|17|||
130522573|NCT04680637|469880848|FG003|Overall Study|Withdrawal by Subject|15|||
130522574|NCT04680637|469880845|FG000|Overall Study|Decision by Sponsor|21|||
130522575|NCT04680637|469880846|FG001|Overall Study|Decision by Sponsor|15|||
130522576|NCT04680637|469880847|FG002|Overall Study|Decision by Sponsor|7|||
130522577|NCT04680637|469880848|FG003|Overall Study|Decision by Sponsor|32|||
130522578|NCT01256671|469882887|FG000|Overall Study|Adverse Event|29|||
130522579|NCT01256671|469882887|FG000|Overall Study|Lost to Follow-up|16|||
130522580|NCT01256671|469882887|FG000|Overall Study|Withdrawal by Subject|31|||
130522581|NCT01256671|469882887|FG000|Overall Study|Physician Decision|3|||
130522582|NCT01256671|469882887|FG000|Overall Study|Lack of Efficacy|4|||
130522583|NCT01256671|469882887|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
130522584|NCT04009629|469882888|FG000|Overall Study|Withdrawal by Subject|2|||
130522585|NCT04009629|469882889|FG001|Overall Study|Withdrawal by Subject|0|||
130522586|NCT04398368|469882890|FG000|Overall Study|Withdrawal by Subject|2|||
130522587|NCT03602586|469882891|FG000|Overall Study|Withdrawal by Subject|3|||
130522588|NCT04523207|469882896|FG000|Overall Study|Adverse Event|5|||
130522589|NCT04523207|469882897|FG001|Overall Study|Adverse Event|1|||
130522590|NCT04523207|469882896|FG000|Overall Study|Lost to Follow-up|2|||
130522591|NCT04523207|469882897|FG001|Overall Study|Lost to Follow-up|0|||
130522592|NCT04523207|469882896|FG000|Overall Study|Withdrawal by Subject|2|||
130522593|NCT04523207|469882897|FG001|Overall Study|Withdrawal by Subject|0|||
130522594|NCT04523207|469882896|FG000|Overall Study|Progressive Disease|2|||
130522595|NCT04523207|469882897|FG001|Overall Study|Progressive Disease|1|||
130522596|NCT04523207|469882896|FG000|Overall Study|Other|7|||
130522597|NCT04523207|469882897|FG001|Overall Study|Other|1|||
130522598|NCT00328562|469882900|FG000|Overall Study|Disease progression|1|||
130522599|NCT04014790|469882901|FG000|Overall Study|Death|4|||
130522600|NCT04014790|469882901|FG000|Overall Study|Adverse Event|1|||
130522601|NCT04014790|469882901|FG000|Overall Study|Withdrawal by Subject|1|||
130522602|NCT01519778|469882902|FG000|Overall Study|Withdrawal by Subject|3|||
130522603|NCT01519778|469882902|FG000|Overall Study|Lost to Follow-up|10|||
130522604|NCT01519778|469882902|FG000|Overall Study|Physician Decision|1|||
130522605|NCT04486313|469882903|FG000|Overall Study|Lost to Follow-up|7|||
130522606|NCT04486313|469882904|FG001|Overall Study|Lost to Follow-up|9|||
130522607|NCT04486313|469882903|FG000|Overall Study|Withdrawal by Subject|8|||
130522608|NCT04486313|469882904|FG001|Overall Study|Withdrawal by Subject|6|||
130522609|NCT04486313|469882903|FG000|Overall Study|Physician Decision|1|||
130522610|NCT04486313|469882904|FG001|Overall Study|Physician Decision|1|||
130522611|NCT04486313|469882903|FG000|Overall Study|Death|2|||
130522612|NCT04486313|469882904|FG001|Overall Study|Death|0|||
130575186|NCT01318109|470069663|FG000|Overall Study|Withdrawal by Subject|1|||
130575187|NCT01318109|470069664|FG001|Overall Study|Withdrawal by Subject|0|||
130522613|NCT04486313|469882903|FG000|Overall Study|Protocol Violation|1|||
130522614|NCT04486313|469882904|FG001|Overall Study|Protocol Violation|1|||
130522615|NCT01657799|469882905|FG000|Overall Study|Adverse Event Related to progression|6|||
130522616|NCT01657799|469882906|FG001|Overall Study|Adverse Event Related to progression|8|||
130522617|NCT01657799|469882907|FG002|Overall Study|Adverse Event Related to progression|12|||
130522618|NCT01657799|469882905|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
130522619|NCT01657799|469882906|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
130522620|NCT01657799|469882907|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
130522621|NCT01657799|469882905|FG000|Overall Study|Withdrawal by Subject|13|||
130522622|NCT01657799|469882906|FG001|Overall Study|Withdrawal by Subject|10|||
130522623|NCT01657799|469882907|FG002|Overall Study|Withdrawal by Subject|10|||
130522624|NCT01657799|469882905|FG000|Overall Study|Lost to Follow-up|1|||
130522625|NCT01657799|469882906|FG001|Overall Study|Lost to Follow-up|0|||
130575188|NCT01318109|470069665|FG002|Overall Study|Withdrawal by Subject|0|||
130575189|NCT01318109|470069663|FG000|Overall Study|Schedule Conflict|0|||
130575190|NCT01318109|470069664|FG001|Overall Study|Schedule Conflict|1|||
130575191|NCT01318109|470069665|FG002|Overall Study|Schedule Conflict|0|||
130575192|NCT01328951|470069666|FG000|Overall Study|Disease Progression|17|||
130575193|NCT01328951|470069667|FG001|Overall Study|Disease Progression|14|||
130575194|NCT01328951|470069666|FG000|Overall Study|Adverse Event|2|||
130575195|NCT01328951|470069667|FG001|Overall Study|Adverse Event|0|||
130575196|NCT01328951|470069666|FG000|Overall Study|Death|243|||
130575197|NCT01328951|470069667|FG001|Overall Study|Death|258|||
130575198|NCT01328951|470069666|FG000|Overall Study|Lost to Follow-up|6|||
130575199|NCT01328951|470069667|FG001|Overall Study|Lost to Follow-up|7|||
130575200|NCT01328951|470069666|FG000|Overall Study|Withdrawal by Subject|6|||
130575201|NCT01328951|470069667|FG001|Overall Study|Withdrawal by Subject|6|||
130575202|NCT01328951|470069666|FG000|Overall Study|Study Closed by the Sponsor|36|||
130575203|NCT01328951|470069667|FG001|Overall Study|Study Closed by the Sponsor|31|||
130575204|NCT01328951|470069666|FG000|Overall Study|Other|11|||
130575205|NCT01328951|470069667|FG001|Overall Study|Other|6|||
130575206|NCT04042103|470069671|FG000|Overall Study|Lost to Follow-up|1|||
130575207|NCT04042103|470069671|FG000|Overall Study|Withdrawal by Subject|1|||
130575208|NCT01003210|470069672|FG000|Overall Study|Lost to Follow-up|1|||
130575209|NCT01003210|470069673|FG001|Overall Study|Lost to Follow-up|3|||
130575210|NCT00271817|470069674|FG000|Part 1|Adverse Event|68|||
130575211|NCT00271817|470069675|FG001|Part 1|Adverse Event|25|||
130575212|NCT00271817|470069676|FG002|Part 1|Adverse Event|156|||
130575213|NCT00271817|470069674|FG000|Part 1|Lost to Follow-up|6|||
130575214|NCT00271817|470069675|FG001|Part 1|Lost to Follow-up|8|||
130575215|NCT00271817|470069676|FG002|Part 1|Lost to Follow-up|24|||
130575216|NCT00271817|470069674|FG000|Part 1|Protocol Violation|5|||
130575217|NCT00271817|470069675|FG001|Part 1|Protocol Violation|4|||
130575218|NCT00271817|470069676|FG002|Part 1|Protocol Violation|7|||
130575219|NCT00271817|470069674|FG000|Part 1|Patient Moved|3|||
130575220|NCT00271817|470069675|FG001|Part 1|Patient Moved|1|||
130575221|NCT00271817|470069676|FG002|Part 1|Patient Moved|5|||
130575222|NCT00271817|470069674|FG000|Part 1|Withdrawal by Subject|23|||
130575223|NCT00271817|470069675|FG001|Part 1|Withdrawal by Subject|17|||
130575224|NCT00271817|470069676|FG002|Part 1|Withdrawal by Subject|45|||
130575225|NCT00271817|470069674|FG000|Part 1|LDL < 50 mg/dL|1|||
130575226|NCT00271817|470069675|FG001|Part 1|LDL < 50 mg/dL|4|||
130575227|NCT00271817|470069676|FG002|Part 1|LDL < 50 mg/dL|48|||
130575228|NCT00271817|470069674|FG000|Part 2|Adverse Event|0|||
130575229|NCT00271817|470069675|FG001|Part 2|Adverse Event|17|||
130575230|NCT00271817|470069676|FG002|Part 2|Adverse Event|33|||
130575231|NCT00271817|470069674|FG000|Part 2|Lack of Efficacy|0|||
130575232|NCT00271817|470069675|FG001|Part 2|Lack of Efficacy|1|||
130575233|NCT00271817|470069676|FG002|Part 2|Lack of Efficacy|6|||
130575234|NCT00271817|470069674|FG000|Part 2|Lost to Follow-up|0|||
130575235|NCT00271817|470069675|FG001|Part 2|Lost to Follow-up|6|||
130575236|NCT00271817|470069676|FG002|Part 2|Lost to Follow-up|18|||
130575237|NCT00271817|470069674|FG000|Part 2|Protocol Violation|0|||
130575238|NCT00271817|470069675|FG001|Part 2|Protocol Violation|3|||
130575239|NCT00271817|470069676|FG002|Part 2|Protocol Violation|5|||
130575240|NCT00271817|470069674|FG000|Part 2|Patient Moved|0|||
130575241|NCT00271817|470069675|FG001|Part 2|Patient Moved|0|||
130575242|NCT00271817|470069676|FG002|Part 2|Patient Moved|5|||
130575243|NCT00271817|470069674|FG000|Part 2|Withdrawal by Subject|0|||
130575244|NCT00271817|470069675|FG001|Part 2|Withdrawal by Subject|2|||
130575245|NCT00271817|470069676|FG002|Part 2|Withdrawal by Subject|13|||
130575246|NCT00271817|470069674|FG000|Part 2|LDL < 50 mg/dL|0|||
130575247|NCT00271817|470069675|FG001|Part 2|LDL < 50 mg/dL|3|||
130575248|NCT00271817|470069676|FG002|Part 2|LDL < 50 mg/dL|4|||
130575249|NCT00861744|470069680|FG000|Overall Study|Adverse Event|0|||
130575250|NCT00861744|470069681|FG001|Overall Study|Adverse Event|0|||
130575251|NCT00861744|470069682|FG002|Overall Study|Adverse Event|0|||
130575252|NCT00861744|470069683|FG003|Overall Study|Adverse Event|1|||
130575253|NCT00861744|470069680|FG000|Overall Study|Lost to Follow-up|7|||
130575254|NCT00861744|470069681|FG001|Overall Study|Lost to Follow-up|19|||
130575255|NCT00861744|470069682|FG002|Overall Study|Lost to Follow-up|17|||
130575256|NCT00861744|470069683|FG003|Overall Study|Lost to Follow-up|12|||
130575257|NCT00861744|470069680|FG000|Overall Study|Withdrawal by Subject|10|||
130575258|NCT00861744|470069681|FG001|Overall Study|Withdrawal by Subject|6|||
130575259|NCT00861744|470069682|FG002|Overall Study|Withdrawal by Subject|6|||
130575260|NCT00861744|470069683|FG003|Overall Study|Withdrawal by Subject|19|||
130575261|NCT00861744|470069680|FG000|Overall Study|Protocol Violation|0|||
130575262|NCT00861744|470069681|FG001|Overall Study|Protocol Violation|1|||
130575263|NCT00861744|470069682|FG002|Overall Study|Protocol Violation|0|||
130575264|NCT00861744|470069683|FG003|Overall Study|Protocol Violation|0|||
130575265|NCT00861744|470069680|FG000|Overall Study|Migration from study area|0|||
130575266|NCT00861744|470069681|FG001|Overall Study|Migration from study area|3|||
130575267|NCT00861744|470069682|FG002|Overall Study|Migration from study area|1|||
130575268|NCT00861744|470069683|FG003|Overall Study|Migration from study area|0|||
130575269|NCT00861744|470069680|FG000|Overall Study|Blood draws|0|||
130575270|NCT00861744|470069681|FG001|Overall Study|Blood draws|0|||
130575271|NCT00861744|470069682|FG002|Overall Study|Blood draws|0|||
130575272|NCT00861744|470069683|FG003|Overall Study|Blood draws|1|||
130575273|NCT05107765|470069684|FG000|Overall Study|Lost to Follow-up|4|||
130575274|NCT05107765|470069685|FG001|Overall Study|Lost to Follow-up|1|||
130575275|NCT05107765|470069684|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
130575276|NCT05107765|470069685|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
130575277|NCT05107765|470069684|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
130575278|NCT05107765|470069685|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
130575279|NCT01411085|470069688|FG000|Overall Study|Physician Decision|1|||
130575280|NCT01411085|470069688|FG000|Overall Study|Protocol Violation|1|||
130575281|NCT01411085|470069688|FG000|Overall Study|Adverse Event|1|||
130575282|NCT03809611|470069689|FG000|Overall Study|Withdrawal by Subject|1|||
130575283|NCT03809611|470069690|FG001|Overall Study|Withdrawal by Subject|1|||
130575284|NCT02193074|470069691|FG000|Overall Study|Withdrawal by Subject|1|||
130575285|NCT02193074|470069692|FG001|Overall Study|Withdrawal by Subject|2|||
130575286|NCT02193074|470069691|FG000|Overall Study|Adverse Event|16|||
130575287|NCT02193074|470069692|FG001|Overall Study|Adverse Event|13|||
130575288|NCT03124563|470069693|FG000|Overall Study|Lost to Follow-up|1|||
130575289|NCT03124563|470069694|FG001|Overall Study|Lost to Follow-up|1|||
130575290|NCT03124563|470069693|FG000|Overall Study|Withdrawal by Subject|1|||
130575291|NCT03124563|470069694|FG001|Overall Study|Withdrawal by Subject|1|||
130575292|NCT01534533|470069695|FG000|Overall Study|Lost to Follow-up|3|||
130575293|NCT01534533|470069696|FG001|Overall Study|Lost to Follow-up|0|||
130575294|NCT01534533|470069697|FG002|Overall Study|Lost to Follow-up|4|||
130575295|NCT01534533|470069698|FG003|Overall Study|Lost to Follow-up|3|||
130575296|NCT01534533|470069695|FG000|Overall Study|Withdrawal by Subject|5|||
130575297|NCT01534533|470069696|FG001|Overall Study|Withdrawal by Subject|3|||
130575298|NCT01534533|470069697|FG002|Overall Study|Withdrawal by Subject|4|||
130575299|NCT01534533|470069698|FG003|Overall Study|Withdrawal by Subject|1|||
130575300|NCT02787850|470071177|FG000|Overall Study|Withdrawal by Subject|0|||
130575301|NCT02787850|470071178|FG001|Overall Study|Withdrawal by Subject|1|||
130575302|NCT02921971|470071179|FG000|Overall Study|Adverse Event|1|||
130575303|NCT02921971|470071180|FG001|Overall Study|Adverse Event|2|||
130575304|NCT02921971|470071179|FG000|Overall Study|Lack of Efficacy|3|||
130575305|NCT02921971|470071180|FG001|Overall Study|Lack of Efficacy|1|||
130575306|NCT02921971|470071179|FG000|Overall Study|Other than specified above|2|||
130575307|NCT02921971|470071180|FG001|Overall Study|Other than specified above|1|||
130575308|NCT00452699|470071181|FG000|Overall Study|Adverse Event|10|||
130575309|NCT00452699|470071182|FG001|Overall Study|Adverse Event|3|||
130575310|NCT00452699|470071181|FG000|Overall Study|Lack of Efficacy|6|||
130575311|NCT00452699|470071182|FG001|Overall Study|Lack of Efficacy|4|||
130575312|NCT00452699|470071181|FG000|Overall Study|Lost to Follow-up|6|||
130575313|NCT00452699|470071182|FG001|Overall Study|Lost to Follow-up|9|||
130575314|NCT00452699|470071181|FG000|Overall Study|Protocol Violation|21|||
130575315|NCT00452699|470071182|FG001|Overall Study|Protocol Violation|25|||
130575316|NCT00452699|470071181|FG000|Overall Study|Withdrawal by Subject|26|||
130575317|NCT00452699|470071182|FG001|Overall Study|Withdrawal by Subject|25|||
130575318|NCT00452699|470071181|FG000|Overall Study|Other|12|||
130575319|NCT00452699|470071182|FG001|Overall Study|Other|7|||
130575320|NCT00326898|470071183|FG000|Overall Study|Disease progression|52|||
130575321|NCT00326898|470071184|FG001|Overall Study|Disease progression|54|||
130575322|NCT00326898|470071185|FG002|Overall Study|Disease progression|102|||
130575323|NCT00326898|470071183|FG000|Overall Study|Adverse Event|124|||
130575324|NCT00326898|470071184|FG001|Overall Study|Adverse Event|128|||
130575325|NCT00326898|470071185|FG002|Overall Study|Adverse Event|33|||
130575326|NCT00326898|470071183|FG000|Overall Study|Death|2|||
130575327|NCT00326898|470071184|FG001|Overall Study|Death|0|||
130575328|NCT00326898|470071185|FG002|Overall Study|Death|0|||
130575329|NCT00326898|470071183|FG000|Overall Study|Withdrawal by Subject|134|||
130575330|NCT00326898|470071184|FG001|Overall Study|Withdrawal by Subject|128|||
130575331|NCT00326898|470071185|FG002|Overall Study|Withdrawal by Subject|32|||
130575332|NCT00326898|470071183|FG000|Overall Study|Alternative therapy|1|||
130575333|NCT00326898|470071184|FG001|Overall Study|Alternative therapy|0|||
130575334|NCT00326898|470071185|FG002|Overall Study|Alternative therapy|0|||
130575335|NCT00326898|470071183|FG000|Overall Study|Other complicating disease|5|||
130575336|NCT00326898|470071184|FG001|Overall Study|Other complicating disease|5|||
130575337|NCT00326898|470071185|FG002|Overall Study|Other complicating disease|4|||
130575338|NCT00326898|470071183|FG000|Overall Study|Other/Missing/Unknown|33|||
130575339|NCT00326898|470071184|FG001|Overall Study|Other/Missing/Unknown|28|||
130575340|NCT00326898|470071185|FG002|Overall Study|Other/Missing/Unknown|32|||
130575341|NCT03847987|470071186|FG000|Overall Study|Lost to Follow-up|1|||
130575342|NCT03847987|470071187|FG001|Overall Study|Lost to Follow-up|0|||
130575343|NCT03847987|470071186|FG000|Overall Study|Adverse Event|2|||
130575344|NCT03847987|470071187|FG001|Overall Study|Adverse Event|0|||
130575345|NCT01637142|470071193|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
130575346|NCT02111564|470071194|FG000|Overall Study|Death|109|||
130575347|NCT02111564|470071195|FG001|Overall Study|Death|120|||
130575348|NCT02111564|470071194|FG000|Overall Study|Lost to Follow-up|2|||
130575349|NCT02111564|470071195|FG001|Overall Study|Lost to Follow-up|3|||
130575350|NCT02111564|470071194|FG000|Overall Study|Withdrawal by Subject|20|||
130575351|NCT02111564|470071195|FG001|Overall Study|Withdrawal by Subject|20|||
130575352|NCT00687362|470071196|FG000|Overall Study|Protocol Violation|2|||
130575353|NCT00687362|470071196|FG000|Overall Study|Withdrawal by Subject|1|||
130575354|NCT04681170|470071201|FG000|Stratified Enrolment & run-in|Death|1|||
130575355|NCT04681170|470071202|FG001|Stratified Enrolment & run-in|Death|0|||
130575356|NCT04681170|470071201|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
130575357|NCT04681170|470071202|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
130575358|NCT04681170|470071201|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
130575359|NCT04681170|470071202|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
130575360|NCT04681170|470071201|FG000|Open Label Efficacy Phase|Adverse Event|0|||
130575361|NCT04681170|470071202|FG001|Open Label Efficacy Phase|Adverse Event|2|||
130575362|NCT04681170|470071201|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
130575363|NCT04681170|470071202|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
130575364|NCT04681170|470071201|FG000|Open Label Safety Phase|AEs and none compliance|0|||
130575365|NCT04681170|470071202|FG001|Open Label Safety Phase|AEs and none compliance|1|||
130575366|NCT04986202|470071203|FG000|Overall Study|Death|10|||
130575367|NCT04986202|470071204|FG001|Overall Study|Death|3|||
130575368|NCT04986202|470071205|FG002|Overall Study|Death|10|||
130575369|NCT04986202|470071203|FG000|Overall Study|Physician Decision|3|||
130575370|NCT04986202|470071204|FG001|Overall Study|Physician Decision|1|||
130575371|NCT04986202|470071205|FG002|Overall Study|Physician Decision|2|||
130575372|NCT04986202|470071203|FG000|Overall Study|Withdrawal by Subject|4|||
130575373|NCT04986202|470071204|FG001|Overall Study|Withdrawal by Subject|2|||
130575374|NCT04986202|470071205|FG002|Overall Study|Withdrawal by Subject|4|||
130575375|NCT02468648|470071206|FG000|Overall Study|Death|1|||
130575376|NCT02118792|470071207|FG000|Overall Study|Withdrawal by Subject|6|||
130575377|NCT02118792|470071208|FG001|Overall Study|Withdrawal by Subject|3|||
130575378|NCT02118792|470071207|FG000|Overall Study|Lost to Follow-up|4|||
130575379|NCT02118792|470071208|FG001|Overall Study|Lost to Follow-up|4|||
130575380|NCT02118792|470071207|FG000|Overall Study|Adverse Event|5|||
130575381|NCT02118792|470071208|FG001|Overall Study|Adverse Event|4|||
130575382|NCT02118792|470071207|FG000|Overall Study|Withdrawal by parent/guardian|14|||
130575383|NCT02118792|470071208|FG001|Overall Study|Withdrawal by parent/guardian|20|||
130575384|NCT02118792|470071207|FG000|Overall Study|Other|1|||
130575385|NCT02118792|470071208|FG001|Overall Study|Other|6|||
130575386|NCT02118792|470071207|FG000|Overall Study|Randomised but not treated|1|||
130575387|NCT02118792|470071208|FG001|Overall Study|Randomised but not treated|0|||
130575388|NCT02787863|470071209|FG000|Overall Study|Death|1|||
130575389|NCT02787863|470071210|FG001|Overall Study|Death|0|||
130575390|NCT02787863|470071211|FG002|Overall Study|Death|1|||
130575391|NCT02787863|470071212|FG003|Overall Study|Death|0|||
130575392|NCT02787863|470071213|FG004|Overall Study|Death|0|||
130575393|NCT02787863|470071214|FG005|Overall Study|Death|0|||
130575394|NCT02787863|470071215|FG006|Overall Study|Death|0|||
130575395|NCT02787863|470071216|FG007|Overall Study|Death|0|||
130522626|NCT01657799|469882907|FG002|Overall Study|Lost to Follow-up|1|||
130522627|NCT01657799|469882905|FG000|Overall Study|Disease Progression|2|||
130522628|NCT01657799|469882906|FG001|Overall Study|Disease Progression|4|||
130522629|NCT01657799|469882907|FG002|Overall Study|Disease Progression|4|||
130522630|NCT01657799|469882905|FG000|Overall Study|Progressive Disease Clinical|7|||
130522631|NCT01657799|469882906|FG001|Overall Study|Progressive Disease Clinical|4|||
130522632|NCT01657799|469882907|FG002|Overall Study|Progressive Disease Clinical|7|||
130522633|NCT01657799|469882905|FG000|Overall Study|Radiographic & Clinical Progression|16|||
130522634|NCT01657799|469882906|FG001|Overall Study|Radiographic & Clinical Progression|11|||
130522635|NCT01657799|469882907|FG002|Overall Study|Radiographic & Clinical Progression|15|||
130522636|NCT01657799|469882905|FG000|Overall Study|Other|52|||
130522637|NCT01657799|469882906|FG001|Overall Study|Other|62|||
130522638|NCT01657799|469882907|FG002|Overall Study|Other|49|||
130522639|NCT03021551|469882908|FG000|Overall Study|Equipment Issues|2|||
130522640|NCT03021551|469882908|FG000|Overall Study|Protocol Violation|1|||
130575396|NCT02787863|470071209|FG000|Overall Study|Withdrawal by Subject|0|||
130575397|NCT02787863|470071210|FG001|Overall Study|Withdrawal by Subject|1|||
130575398|NCT02787863|470071211|FG002|Overall Study|Withdrawal by Subject|1|||
130575399|NCT02787863|470071212|FG003|Overall Study|Withdrawal by Subject|0|||
130575400|NCT02787863|470071213|FG004|Overall Study|Withdrawal by Subject|0|||
130575401|NCT02787863|470071214|FG005|Overall Study|Withdrawal by Subject|0|||
130575402|NCT02787863|470071215|FG006|Overall Study|Withdrawal by Subject|0|||
130522641|NCT00412880|469882909|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
130575403|NCT02787863|470071216|FG007|Overall Study|Withdrawal by Subject|0|||
130575404|NCT01368835|470071217|FG000|Overall Study|Inclusion criteria/photography quality|22|||
130522642|NCT00412880|469882909|FG000|Overall Study|Consent withdrawn|1|||
130522643|NCT00412880|469882909|FG000|Overall Study|Adverse Event|1|||
130522644|NCT00412880|469882909|FG000|Overall Study|Progressive disease|20|||
130522645|NCT01496365|469882910|FG000|Overall Study|Adverse Event|2|||
130522646|NCT01496365|469882911|FG001|Overall Study|Adverse Event|3|||
130522647|NCT01496365|469882912|FG002|Overall Study|Adverse Event|3|||
130522648|NCT01496365|469882913|FG003|Overall Study|Adverse Event|2|||
130522649|NCT01496365|469882914|FG004|Overall Study|Adverse Event|5|||
130522650|NCT01496365|469882915|FG005|Overall Study|Adverse Event|6|||
130522651|NCT01496365|469882916|FG006|Overall Study|Adverse Event|4|||
130522652|NCT01496365|469882910|FG000|Overall Study|Withdrawal by Subject|6|||
130522653|NCT01496365|469882911|FG001|Overall Study|Withdrawal by Subject|6|||
130575405|NCT01368835|470071217|FG000|Overall Study|Lost to Follow-up|11|||
130575406|NCT02754726|470071218|FG000|Overall Study|Progressive Disease by RECIST|13|||
130575407|NCT02754726|470071218|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
130575408|NCT02754726|470071218|FG000|Overall Study|Clinical Disease Progression|5|||
130575409|NCT02754726|470071218|FG000|Overall Study|Adverse Event|3|||
130575410|NCT02754726|470071218|FG000|Overall Study|Withdrawal by Subject|1|||
130575411|NCT02754726|470071218|FG000|Overall Study|Tolerability|1|||
130575412|NCT00252057|470071227|FG000|Overall Study|Withdrawal by Subject|2|||
130575413|NCT00252057|470071228|FG001|Overall Study|Withdrawal by Subject|5|||
130575414|NCT00252057|470071227|FG000|Overall Study|Death|1|||
130575415|NCT00252057|470071228|FG001|Overall Study|Death|2|||
130575416|NCT00252057|470071227|FG000|Overall Study|Participant previously enrolled|0|||
130575417|NCT00252057|470071228|FG001|Overall Study|Participant previously enrolled|1|||
130575418|NCT01903837|470071230|FG000|Part A|Withdrawal by Subject|4|||
130575419|NCT01903837|470071231|FG001|Part A|Withdrawal by Subject|9|||
130575420|NCT01903837|470071232|FG002|Part A|Withdrawal by Subject|8|||
130575421|NCT01903837|470071233|FG003|Part A|Withdrawal by Subject|5|||
130575422|NCT01903837|470071230|FG000|Part A|Adverse Event|3|||
130575423|NCT01903837|470071231|FG001|Part A|Adverse Event|6|||
130575424|NCT01903837|470071232|FG002|Part A|Adverse Event|9|||
130575425|NCT01903837|470071233|FG003|Part A|Adverse Event|6|||
130575426|NCT01903837|470071230|FG000|Part A|Lost to Follow-up|9|||
130575427|NCT01903837|470071231|FG001|Part A|Lost to Follow-up|7|||
130575428|NCT01903837|470071232|FG002|Part A|Lost to Follow-up|7|||
130575429|NCT01903837|470071233|FG003|Part A|Lost to Follow-up|2|||
130575430|NCT01903837|470071230|FG000|Part A|Non-compliance with study drug|1|||
130575431|NCT01903837|470071231|FG001|Part A|Non-compliance with study drug|4|||
130575432|NCT01903837|470071232|FG002|Part A|Non-compliance with study drug|4|||
130575433|NCT01903837|470071233|FG003|Part A|Non-compliance with study drug|0|||
130575434|NCT01903837|470071230|FG000|Part A|Physician Decision|1|||
130575435|NCT01903837|470071231|FG001|Part A|Physician Decision|1|||
130575436|NCT01903837|470071232|FG002|Part A|Physician Decision|0|||
130575437|NCT01903837|470071233|FG003|Part A|Physician Decision|0|||
130575438|NCT01903837|470071230|FG000|Part A|Protocol Violation|1|||
130575439|NCT01903837|470071231|FG001|Part A|Protocol Violation|1|||
130575440|NCT01903837|470071232|FG002|Part A|Protocol Violation|0|||
130575441|NCT01903837|470071233|FG003|Part A|Protocol Violation|0|||
130575442|NCT01903837|470071230|FG000|Part B|Lost to Follow-up|0|||
130575443|NCT01903837|470071231|FG001|Part B|Lost to Follow-up|3|||
130575444|NCT01903837|470071232|FG002|Part B|Lost to Follow-up|3|||
130575445|NCT01903837|470071233|FG003|Part B|Lost to Follow-up|4|||
130575446|NCT01903837|470071230|FG000|Part B|Withdrawal by Subject|1|||
130575447|NCT01903837|470071231|FG001|Part B|Withdrawal by Subject|2|||
130575448|NCT01903837|470071232|FG002|Part B|Withdrawal by Subject|0|||
130575449|NCT01903837|470071233|FG003|Part B|Withdrawal by Subject|3|||
130575450|NCT01903837|470071230|FG000|Part B|Adverse Event|3|||
130575451|NCT01903837|470071231|FG001|Part B|Adverse Event|0|||
130575452|NCT01903837|470071232|FG002|Part B|Adverse Event|2|||
130522654|NCT01496365|469882912|FG002|Overall Study|Withdrawal by Subject|0|||
130522655|NCT01496365|469882913|FG003|Overall Study|Withdrawal by Subject|1|||
130522656|NCT01496365|469882914|FG004|Overall Study|Withdrawal by Subject|3|||
130522657|NCT01496365|469882915|FG005|Overall Study|Withdrawal by Subject|2|||
130522658|NCT01496365|469882916|FG006|Overall Study|Withdrawal by Subject|1|||
130522659|NCT01496365|469882910|FG000|Overall Study|Protocol Violation|2|||
130522660|NCT01496365|469882911|FG001|Overall Study|Protocol Violation|1|||
130522661|NCT01496365|469882912|FG002|Overall Study|Protocol Violation|1|||
130575453|NCT01903837|470071233|FG003|Part B|Adverse Event|0|||
130575454|NCT01903837|470071230|FG000|Part B|Non-compliance with study drug|2|||
130575455|NCT01903837|470071231|FG001|Part B|Non-compliance with study drug|0|||
130575456|NCT01903837|470071232|FG002|Part B|Non-compliance with study drug|0|||
130575457|NCT01903837|470071233|FG003|Part B|Non-compliance with study drug|1|||
130575458|NCT01903837|470071230|FG000|Part B|Incarceration|2|||
130575459|NCT01903837|470071231|FG001|Part B|Incarceration|0|||
130575460|NCT01903837|470071232|FG002|Part B|Incarceration|0|||
130575461|NCT01903837|470071233|FG003|Part B|Incarceration|1|||
130575462|NCT01903837|470071230|FG000|Part B|Physician Decision|1|||
130575463|NCT01903837|470071231|FG001|Part B|Physician Decision|0|||
130575464|NCT01903837|470071232|FG002|Part B|Physician Decision|0|||
130575465|NCT01903837|470071233|FG003|Part B|Physician Decision|2|||
130575466|NCT01903837|470071230|FG000|Part B|Lack of Efficacy|0|||
130575467|NCT01903837|470071231|FG001|Part B|Lack of Efficacy|1|||
130575468|NCT01903837|470071232|FG002|Part B|Lack of Efficacy|0|||
130575469|NCT01903837|470071233|FG003|Part B|Lack of Efficacy|0|||
130575470|NCT00705939|470071235|FG000|Overall Study|Protocol Violation|0|||
130575471|NCT00705939|470071236|FG001|Overall Study|Protocol Violation|0|||
130575472|NCT00705939|470071237|FG002|Overall Study|Protocol Violation|1|||
130575473|NCT00705939|470071235|FG000|Overall Study|Withdrawal by Subject|0|||
130575474|NCT00705939|470071236|FG001|Overall Study|Withdrawal by Subject|1|||
130575475|NCT00705939|470071237|FG002|Overall Study|Withdrawal by Subject|3|||
130575476|NCT00705939|470071235|FG000|Overall Study|Physician Decision|0|||
130575477|NCT00705939|470071236|FG001|Overall Study|Physician Decision|1|||
130575478|NCT00705939|470071237|FG002|Overall Study|Physician Decision|0|||
130575479|NCT05048342|470071238|FG000|Overall Study|Adverse Event|1|||
130575480|NCT05048342|470071238|FG000|Overall Study|Subject decision|2|||
130575481|NCT02728830|470071239|FG000|Overall Study|Exclusionary Surgery|9|||
130575482|NCT02728830|470071239|FG000|Overall Study|Exclusionary Pathology|6|||
130575483|NCT02728830|470071239|FG000|Overall Study|Physician Decision|3|||
130575484|NCT02728830|470071239|FG000|Overall Study|Withdrawal by Subject|2|||
130575485|NCT02728830|470071239|FG000|Overall Study|Lost to Follow-up|1|||
130575486|NCT02728830|470071239|FG000|Overall Study|Exclusionary Lab Values|1|||
130575487|NCT02728830|470071239|FG000|Overall Study|Contraindicated Illness|1|||
130575488|NCT02728830|470071239|FG000|Overall Study|Language Barrier|1|||
130575489|NCT01081795|470071240|FG000|Overall Study|Adverse Event|18|||
130575490|NCT01081795|470071241|FG001|Overall Study|Adverse Event|23|||
130575491|NCT01081795|470071242|FG002|Overall Study|Adverse Event|6|||
130575492|NCT01081795|470071240|FG000|Overall Study|Lack of Efficacy|7|||
130575493|NCT01081795|470071241|FG001|Overall Study|Lack of Efficacy|5|||
130575494|NCT01081795|470071242|FG002|Overall Study|Lack of Efficacy|19|||
130575495|NCT01081795|470071240|FG000|Overall Study|Subject's schedule|1|||
130575496|NCT01081795|470071241|FG001|Overall Study|Subject's schedule|1|||
130575497|NCT01081795|470071242|FG002|Overall Study|Subject's schedule|2|||
130575498|NCT01081795|470071240|FG000|Overall Study|Revocation of informed consent|2|||
130575499|NCT01081795|470071241|FG001|Overall Study|Revocation of informed consent|0|||
130575500|NCT01081795|470071242|FG002|Overall Study|Revocation of informed consent|0|||
130575501|NCT01081795|470071240|FG000|Overall Study|Ineligible for participation|1|||
130575502|NCT01081795|470071241|FG001|Overall Study|Ineligible for participation|0|||
130575503|NCT01081795|470071242|FG002|Overall Study|Ineligible for participation|0|||
130575504|NCT01081795|470071240|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
130575505|NCT01081795|470071241|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
130575506|NCT01081795|470071242|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
130575507|NCT01081795|470071240|FG000|Overall Study|Using drug with restricted days of use|2|||
130575508|NCT01081795|470071241|FG001|Overall Study|Using drug with restricted days of use|3|||
130575509|NCT01081795|470071242|FG002|Overall Study|Using drug with restricted days of use|2|||
130575510|NCT01081795|470071240|FG000|Overall Study|Other|1|||
130575511|NCT01081795|470071241|FG001|Overall Study|Other|2|||
130575512|NCT01081795|470071242|FG002|Overall Study|Other|0|||
130575513|NCT00143455|470071243|FG000|Cohort 1|Adverse Event|8|||
130575514|NCT00143455|470071244|FG001|Cohort 1|Adverse Event|4|||
130575515|NCT00143455|470071245|FG002|Cohort 1|Adverse Event|0|||
130575516|NCT00143455|470071246|FG003|Cohort 1|Adverse Event|0|||
130575517|NCT00143455|470071243|FG000|Cohort 1|Death|5|||
130575518|NCT00143455|470071244|FG001|Cohort 1|Death|2|||
130575519|NCT00143455|470071245|FG002|Cohort 1|Death|0|||
130575520|NCT00143455|470071246|FG003|Cohort 1|Death|0|||
130575521|NCT00143455|470071243|FG000|Cohort 1|Progressive Disease|0|||
130575522|NCT00143455|470071244|FG001|Cohort 1|Progressive Disease|6|||
130575523|NCT00143455|470071245|FG002|Cohort 1|Progressive Disease|0|||
130575524|NCT00143455|470071246|FG003|Cohort 1|Progressive Disease|0|||
130575525|NCT00143455|470071243|FG000|Cohort 1|Withdrawal by Subject|1|||
130575526|NCT00143455|470071244|FG001|Cohort 1|Withdrawal by Subject|4|||
130575527|NCT00143455|470071245|FG002|Cohort 1|Withdrawal by Subject|0|||
130575528|NCT00143455|470071246|FG003|Cohort 1|Withdrawal by Subject|0|||
130575529|NCT00143455|470071243|FG000|Cohort 1|Randomized But Not Treated|0|||
130575530|NCT00143455|470071244|FG001|Cohort 1|Randomized But Not Treated|1|||
130575531|NCT00143455|470071245|FG002|Cohort 1|Randomized But Not Treated|0|||
130575532|NCT00143455|470071246|FG003|Cohort 1|Randomized But Not Treated|0|||
130575533|NCT00143455|470071243|FG000|Cohort 2|Adverse Event|0|||
130575534|NCT00143455|470071244|FG001|Cohort 2|Adverse Event|0|||
130575535|NCT00143455|470071245|FG002|Cohort 2|Adverse Event|42|||
130575536|NCT00143455|470071246|FG003|Cohort 2|Adverse Event|30|||
130575537|NCT00143455|470071243|FG000|Cohort 2|No Longer Required Study Treatment|0|||
130575538|NCT00143455|470071244|FG001|Cohort 2|No Longer Required Study Treatment|0|||
130575539|NCT00143455|470071245|FG002|Cohort 2|No Longer Required Study Treatment|1|||
130575540|NCT00143455|470071246|FG003|Cohort 2|No Longer Required Study Treatment|0|||
130575541|NCT00143455|470071243|FG000|Cohort 2|Protocol Violation|0|||
130575542|NCT00143455|470071244|FG001|Cohort 2|Protocol Violation|0|||
130575543|NCT00143455|470071245|FG002|Cohort 2|Protocol Violation|1|||
130575544|NCT00143455|470071246|FG003|Cohort 2|Protocol Violation|1|||
130575545|NCT00143455|470071243|FG000|Cohort 2|Lost to Follow-up|0|||
130575546|NCT00143455|470071244|FG001|Cohort 2|Lost to Follow-up|0|||
130575547|NCT00143455|470071245|FG002|Cohort 2|Lost to Follow-up|1|||
130575548|NCT00143455|470071246|FG003|Cohort 2|Lost to Follow-up|4|||
130575549|NCT00143455|470071243|FG000|Cohort 2|Death|0|||
130575550|NCT00143455|470071244|FG001|Cohort 2|Death|0|||
130575551|NCT00143455|470071245|FG002|Cohort 2|Death|20|||
130575552|NCT00143455|470071246|FG003|Cohort 2|Death|12|||
130575553|NCT00143455|470071243|FG000|Cohort 2|Progressive Disease|0|||
130522662|NCT01496365|469882913|FG003|Overall Study|Protocol Violation|0|||
130522663|NCT01496365|469882914|FG004|Overall Study|Protocol Violation|0|||
130522664|NCT01496365|469882915|FG005|Overall Study|Protocol Violation|1|||
130522665|NCT01496365|469882916|FG006|Overall Study|Protocol Violation|0|||
130522666|NCT01496365|469882910|FG000|Overall Study|Lack of Efficacy|1|||
130522667|NCT01496365|469882911|FG001|Overall Study|Lack of Efficacy|0|||
130522668|NCT01496365|469882912|FG002|Overall Study|Lack of Efficacy|0|||
130522669|NCT01496365|469882913|FG003|Overall Study|Lack of Efficacy|0|||
130522670|NCT01496365|469882914|FG004|Overall Study|Lack of Efficacy|0|||
130522671|NCT01496365|469882915|FG005|Overall Study|Lack of Efficacy|1|||
130522672|NCT01496365|469882916|FG006|Overall Study|Lack of Efficacy|0|||
130522673|NCT01496365|469882910|FG000|Overall Study|Lost to Follow-up|0|||
130522674|NCT01496365|469882911|FG001|Overall Study|Lost to Follow-up|1|||
130522675|NCT01496365|469882912|FG002|Overall Study|Lost to Follow-up|0|||
130522676|NCT01496365|469882913|FG003|Overall Study|Lost to Follow-up|0|||
130522677|NCT01496365|469882914|FG004|Overall Study|Lost to Follow-up|2|||
130522678|NCT01496365|469882915|FG005|Overall Study|Lost to Follow-up|0|||
130522679|NCT01496365|469882916|FG006|Overall Study|Lost to Follow-up|0|||
130522680|NCT01496365|469882910|FG000|Overall Study|Other|4|||
130522681|NCT01496365|469882911|FG001|Overall Study|Other|4|||
130522682|NCT01496365|469882912|FG002|Overall Study|Other|2|||
130522683|NCT01496365|469882913|FG003|Overall Study|Other|1|||
130522684|NCT01496365|469882914|FG004|Overall Study|Other|3|||
130522685|NCT01496365|469882915|FG005|Overall Study|Other|0|||
130522686|NCT01496365|469882916|FG006|Overall Study|Other|1|||
130522687|NCT01288209|469882917|FG000|Overall Study|Withdrawal by Subject|1|||
130522688|NCT01288209|469882918|FG001|Overall Study|Withdrawal by Subject|3|||
130522689|NCT01288209|469882917|FG000|Overall Study|Other|1|||
130522690|NCT01288209|469882918|FG001|Overall Study|Other|0|||
130522691|NCT01015677|469882920|FG000|Overall Study|Adverse Event|0|||
130522692|NCT01015677|469882921|FG001|Overall Study|Adverse Event|1|||
130522693|NCT01015677|469882922|FG002|Overall Study|Adverse Event|0|||
130522694|NCT01015677|469882920|FG000|Overall Study|Lack of Efficacy|0|||
130522695|NCT01015677|469882921|FG001|Overall Study|Lack of Efficacy|1|||
130522696|NCT01015677|469882922|FG002|Overall Study|Lack of Efficacy|0|||
130522697|NCT01015677|469882920|FG000|Overall Study|Protocol Violation|0|||
130522698|NCT01015677|469882921|FG001|Overall Study|Protocol Violation|1|||
130522699|NCT01015677|469882922|FG002|Overall Study|Protocol Violation|0|||
130522700|NCT01015677|469882920|FG000|Overall Study|Withdrawal by Subject|1|||
130522701|NCT01015677|469882921|FG001|Overall Study|Withdrawal by Subject|1|||
130522702|NCT01015677|469882922|FG002|Overall Study|Withdrawal by Subject|0|||
130522703|NCT01646385|469882926|FG000|Overall Study|Death|202|||
130522704|NCT01646385|469882927|FG001|Overall Study|Death|222|||
130522705|NCT01646385|469882926|FG000|Overall Study|Switched to alternate biologic|636|||
130522706|NCT01646385|469882927|FG001|Overall Study|Switched to alternate biologic|649|||
130522707|NCT01843777|469882928|FG000|Overall Study|Withdrawal by Subject|1|||
130522708|NCT01843777|469882929|FG001|Overall Study|Withdrawal by Subject|0|||
130522709|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
130522710|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
130575554|NCT00143455|470071244|FG001|Cohort 2|Progressive Disease|0|||
130575555|NCT00143455|470071245|FG002|Cohort 2|Progressive Disease|20|||
130575556|NCT00143455|470071246|FG003|Cohort 2|Progressive Disease|27|||
130575557|NCT00143455|470071243|FG000|Cohort 2|Withdrawal by Subject|0|||
130575558|NCT00143455|470071244|FG001|Cohort 2|Withdrawal by Subject|0|||
130522711|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
130522712|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
130522713|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
130522714|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
130522715|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
130522716|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
130522717|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
130522718|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
130575559|NCT00143455|470071245|FG002|Cohort 2|Withdrawal by Subject|13|||
130522719|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
130522720|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
130522721|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
130575560|NCT00143455|470071246|FG003|Cohort 2|Withdrawal by Subject|12|||
130575561|NCT00143455|470071243|FG000|Cohort 2|Other|0|||
130522722|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
130522723|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
130522724|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
130522725|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
130522726|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
130522727|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
130522728|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
130522729|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
130522730|NCT04599855|469882937|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
130522731|NCT04599855|469882938|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
130522732|NCT04599855|469882939|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
130522733|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
130522734|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
130522735|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
130522736|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
130522737|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
130522738|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
130522739|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
130522740|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
130522741|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
130522742|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
130522743|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
130522744|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
130522745|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
130522746|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
130522747|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
130522748|NCT04599855|469882937|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
130522749|NCT04599855|469882938|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
130522750|NCT04599855|469882939|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
130522751|NCT02165397|469882940|FG000|Overall Study|Death|7|||
130522752|NCT02165397|469882941|FG001|Overall Study|Death|10|||
130522753|NCT02165397|469882942|FG002|Overall Study|Death|8|||
130522754|NCT02165397|469882940|FG000|Overall Study|Lost to Follow-up|1|||
130522755|NCT02165397|469882941|FG001|Overall Study|Lost to Follow-up|3|||
130522756|NCT02165397|469882942|FG002|Overall Study|Lost to Follow-up|0|||
130522757|NCT02165397|469882940|FG000|Overall Study|Withdrawal by Subject|6|||
130522758|NCT02165397|469882941|FG001|Overall Study|Withdrawal by Subject|6|||
130522759|NCT02165397|469882942|FG002|Overall Study|Withdrawal by Subject|1|||
130522760|NCT02165397|469882940|FG000|Overall Study|Other, Not Specified|0|||
130522761|NCT02165397|469882941|FG001|Overall Study|Other, Not Specified|0|||
130522762|NCT02165397|469882942|FG002|Overall Study|Other, Not Specified|1|||
130522763|NCT04799418|469882943|FG000|Overall Study|Death|1|||
130522764|NCT04799418|469882944|FG001|Overall Study|Death|1|||
130522765|NCT04799418|469882943|FG000|Overall Study|Lack of Efficacy|14|||
130522766|NCT04799418|469882944|FG001|Overall Study|Lack of Efficacy|14|||
130522767|NCT04799418|469882943|FG000|Overall Study|Withdrawal by Subject|10|||
130522768|NCT04799418|469882944|FG001|Overall Study|Withdrawal by Subject|7|||
130522769|NCT04799418|469882943|FG000|Overall Study|Adverse Event|3|||
130522770|NCT04799418|469882944|FG001|Overall Study|Adverse Event|2|||
130522771|NCT03297398|469882945|FG000|Overall Study|Sponsor's decision|6|||
130522772|NCT03297398|469882946|FG001|Overall Study|Sponsor's decision|9|||
130522773|NCT03297398|469882947|FG002|Overall Study|Sponsor's decision|7|||
130522774|NCT03297398|469882945|FG000|Overall Study|Adverse Event|1|||
130522775|NCT03297398|469882946|FG001|Overall Study|Adverse Event|4|||
130522776|NCT03297398|469882947|FG002|Overall Study|Adverse Event|4|||
130522777|NCT03297398|469882945|FG000|Overall Study|Withdrawal by Subject|1|||
130522778|NCT03297398|469882946|FG001|Overall Study|Withdrawal by Subject|2|||
130522779|NCT03297398|469882947|FG002|Overall Study|Withdrawal by Subject|2|||
130522780|NCT03297398|469882945|FG000|Overall Study|Protocol Violation|0|||
130522781|NCT03297398|469882946|FG001|Overall Study|Protocol Violation|2|||
130522782|NCT03297398|469882947|FG002|Overall Study|Protocol Violation|0|||
130522783|NCT03297398|469882945|FG000|Overall Study|Physician Decision|0|||
130522784|NCT03297398|469882946|FG001|Overall Study|Physician Decision|0|||
130522785|NCT03297398|469882947|FG002|Overall Study|Physician Decision|1|||
130522786|NCT03297398|469882945|FG000|Overall Study|Lost to Follow-up|0|||
130522787|NCT03297398|469882946|FG001|Overall Study|Lost to Follow-up|0|||
130522788|NCT03297398|469882947|FG002|Overall Study|Lost to Follow-up|1|||
130522789|NCT00236184|469882952|FG000|Overall Study|Adverse Event|5|||
130522790|NCT00236184|469882953|FG001|Overall Study|Adverse Event|2|||
130522791|NCT00236184|469882952|FG000|Overall Study|Lack of Efficacy|0|||
130522792|NCT00236184|469882953|FG001|Overall Study|Lack of Efficacy|1|||
130522793|NCT00236184|469882952|FG000|Overall Study|Lost to Follow-up|3|||
130522794|NCT00236184|469882953|FG001|Overall Study|Lost to Follow-up|4|||
130522795|NCT00236184|469882952|FG000|Overall Study|Physician Decision|1|||
130575562|NCT00143455|470071244|FG001|Cohort 2|Other|0|||
130575563|NCT00143455|470071245|FG002|Cohort 2|Other|7|||
130575564|NCT00143455|470071246|FG003|Cohort 2|Other|6|||
130575565|NCT00143455|470071243|FG000|Cohort 2|Randomized But Not Treated|0|||
130575566|NCT00143455|470071244|FG001|Cohort 2|Randomized But Not Treated|0|||
130575567|NCT00143455|470071245|FG002|Cohort 2|Randomized But Not Treated|1|||
130575568|NCT00143455|470071246|FG003|Cohort 2|Randomized But Not Treated|1|||
130575569|NCT03713944|470071247|FG000|Study Treatment|Patient non-compliance|1|||
130575570|NCT03713944|470071247|FG000|Study Treatment|Alternative Cancer Therapy|3|||
130575571|NCT03713944|470071247|FG000|Study Treatment|Disease Progression|18|||
130575572|NCT03713944|470071247|FG000|Study Treatment|AE/Side Effects/Complications|2|||
130575573|NCT03713944|470071247|FG000|Study Treatment|Death|2|||
130575574|NCT03713944|470071247|FG000|Study Treatment|Withdrawal by Subject|1|||
130575575|NCT03713944|470071247|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
130575576|NCT03713944|470071247|FG000|Study Treatment|Symptomatic Deterioration|2|||
130575577|NCT03713944|470071247|FG000|Follow up|Withdrawal by Subject|2|||
130575578|NCT03713944|470071247|FG000|Follow up|Death|11|||
130522796|NCT00236184|469882953|FG001|Overall Study|Physician Decision|1|||
130522797|NCT00236184|469882952|FG000|Overall Study|Withdrawal by Subject|3|||
130522798|NCT00236184|469882953|FG001|Overall Study|Withdrawal by Subject|0|||
130522799|NCT00236184|469882952|FG000|Overall Study|Protocol Violation|3|||
130522800|NCT00236184|469882953|FG001|Overall Study|Protocol Violation|0|||
130522801|NCT00236184|469882952|FG000|Overall Study|non-compliance with study drug|2|||
130522802|NCT00236184|469882953|FG001|Overall Study|non-compliance with study drug|1|||
130522803|NCT00236184|469882952|FG000|Overall Study|other|1|||
130522804|NCT00236184|469882953|FG001|Overall Study|other|2|||
130522805|NCT02312206|469882954|FG000|Overall Study|Adverse Event|3|||
130522806|NCT02312206|469882955|FG001|Overall Study|Adverse Event|6|||
130522807|NCT02312206|469882954|FG000|Overall Study|Withdrawal by Subject|6|||
130522808|NCT02312206|469882955|FG001|Overall Study|Withdrawal by Subject|6|||
130522809|NCT02312206|469882954|FG000|Overall Study|Physician Decision|7|||
130522810|NCT02312206|469882955|FG001|Overall Study|Physician Decision|6|||
130522811|NCT02312206|469882954|FG000|Overall Study|Death|31|||
130522812|NCT02312206|469882955|FG001|Overall Study|Death|36|||
130522813|NCT02312206|469882954|FG000|Overall Study|Study Terminated by Sponsor|81|||
130522814|NCT02312206|469882955|FG001|Overall Study|Study Terminated by Sponsor|74|||
130522815|NCT02312206|469882954|FG000|Overall Study|Patient transferred to hospice|0|||
130522816|NCT02312206|469882955|FG001|Overall Study|Patient transferred to hospice|1|||
130522817|NCT02312206|469882954|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
130522818|NCT02312206|469882955|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
130522819|NCT02312206|469882954|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
130522820|NCT02312206|469882955|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
130522821|NCT02312206|469882954|FG000|Overall Study|Disease Progression|1|||
130522822|NCT02312206|469882955|FG001|Overall Study|Disease Progression|0|||
130522823|NCT02250534|469882966|FG000|Overall Study|Lost to Follow-up|18|||
130522824|NCT02250534|469882967|FG001|Overall Study|Lost to Follow-up|28|||
130522825|NCT02250534|469882968|FG002|Overall Study|Lost to Follow-up|33|||
130522826|NCT02250534|469882966|FG000|Overall Study|Personal reasons|7|||
130522827|NCT02250534|469882967|FG001|Overall Study|Personal reasons|8|||
130522828|NCT02250534|469882968|FG002|Overall Study|Personal reasons|14|||
130522829|NCT02250534|469882966|FG000|Overall Study|Adverse Event|6|||
130522830|NCT02250534|469882967|FG001|Overall Study|Adverse Event|3|||
130522831|NCT02250534|469882968|FG002|Overall Study|Adverse Event|8|||
130522832|NCT02250534|469882966|FG000|Overall Study|incarcerated|2|||
130522833|NCT02250534|469882967|FG001|Overall Study|incarcerated|1|||
130522834|NCT02250534|469882968|FG002|Overall Study|incarcerated|2|||
130522835|NCT02250534|469882966|FG000|Overall Study|Withdrawal by Subject|0|||
130522836|NCT02250534|469882967|FG001|Overall Study|Withdrawal by Subject|1|||
130522837|NCT02250534|469882968|FG002|Overall Study|Withdrawal by Subject|2|||
130522838|NCT02250534|469882966|FG000|Overall Study|Death|0|||
130522839|NCT02250534|469882967|FG001|Overall Study|Death|1|||
130522840|NCT02250534|469882968|FG002|Overall Study|Death|1|||
130522841|NCT02250534|469882966|FG000|Overall Study|Physician Decision|1|||
130522842|NCT02250534|469882967|FG001|Overall Study|Physician Decision|3|||
130522843|NCT02250534|469882968|FG002|Overall Study|Physician Decision|1|||
130522844|NCT02250534|469882966|FG000|Overall Study|Protocol Violation|1|||
130522845|NCT02250534|469882967|FG001|Overall Study|Protocol Violation|0|||
130522846|NCT02250534|469882968|FG002|Overall Study|Protocol Violation|1|||
130522847|NCT02250534|469882966|FG000|Overall Study|Reason unknown|1|||
130522848|NCT02250534|469882967|FG001|Overall Study|Reason unknown|0|||
130522849|NCT02250534|469882968|FG002|Overall Study|Reason unknown|0|||
130522850|NCT00217022|469882969|FG000|Overall Study|Withdrawal by Subject|1|||
130522851|NCT00217022|469882970|FG001|Overall Study|Withdrawal by Subject|1|||
130522852|NCT01182181|469882971|FG000|First Intervention|Adverse Event|1|||
130575579|NCT03713944|470071247|FG000|Follow up|Study Terminated|3|||
130575580|NCT03847610|470071250|FG000|Overall Study|Withdrawal by Subject|1|||
130575581|NCT03099707|470071251|FG000|Overall Study|Withdrawal by Subject|0|||
130522853|NCT01182181|469882972|FG001|First Intervention|Adverse Event|0|||
130575582|NCT03099707|470071252|FG001|Overall Study|Withdrawal by Subject|3|||
130575583|NCT03099707|470071251|FG000|Overall Study|Lost to Follow-up|0|||
130575584|NCT03099707|470071252|FG001|Overall Study|Lost to Follow-up|1|||
130575585|NCT01445769|470071253|FG000|Overall Study|Consent Withdrawn|2|||
130575586|NCT01445769|470071253|FG000|Overall Study|Disease Progression|1|||
130575587|NCT01445769|470071253|FG000|Overall Study|Lost to Follow-up|5|||
130575588|NCT03127384|470071263|FG000|Overall Study|Lost to Follow-up|4|||
130575589|NCT03127384|470071263|FG000|Overall Study|Subject request|2|||
130575590|NCT01967537|470071267|FG000|Overall Study|Withdrawal by Subject|52|||
130575591|NCT01967537|470071267|FG000|Overall Study|Refuse treatment|2|||
130575592|NCT01967537|470071267|FG000|Overall Study|Lost to Follow-up|6|||
130575593|NCT01079182|470071268|FG000|Overall Study|Lost to Follow-up|1634|||
130575594|NCT01079182|470071268|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
130575595|NCT01079182|470071268|FG000|Overall Study|Lack of Efficacy|514|||
130575596|NCT01079182|470071268|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
130575597|NCT01079182|470071268|FG000|Overall Study|Reasons not Evaluated|271|||
130575598|NCT04417894|470071269|FG000|Overall Study|Lost to Follow-up|3|||
130575599|NCT04417894|470071270|FG001|Overall Study|Lost to Follow-up|0|||
130575600|NCT04417894|470071269|FG000|Overall Study|Withdrawal by Subject|7|||
130575601|NCT04417894|470071270|FG001|Overall Study|Withdrawal by Subject|6|||
130575602|NCT04417894|470071269|FG000|Overall Study|Lack of Efficacy|3|||
130575603|NCT04417894|470071270|FG001|Overall Study|Lack of Efficacy|1|||
130575604|NCT05130463|470071271|FG000|Overall Study|Unspecified reasons|2|||
130575605|NCT05130463|470071271|FG000|Overall Study|off-label indication dose|435|||
130575606|NCT03461757|470071272|FG000|Overall Study|Adverse Event|1|||
130575607|NCT03461757|470071273|FG001|Overall Study|Adverse Event|0|||
130575608|NCT03461757|470071272|FG000|Overall Study|Lost to Follow-up|13|||
130575609|NCT03461757|470071273|FG001|Overall Study|Lost to Follow-up|7|||
130575610|NCT03461757|470071272|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
130575611|NCT03461757|470071273|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
130575612|NCT03461757|470071272|FG000|Overall Study|Non-compliance with study treatment|0|||
130575613|NCT03461757|470071273|FG001|Overall Study|Non-compliance with study treatment|1|||
130575614|NCT03461757|470071272|FG000|Overall Study|Pregnancy|2|||
130575615|NCT03461757|470071273|FG001|Overall Study|Pregnancy|0|||
130575616|NCT03461757|470071272|FG000|Overall Study|Protocol Violation|1|||
130575617|NCT03461757|470071273|FG001|Overall Study|Protocol Violation|1|||
130575618|NCT03461757|470071272|FG000|Overall Study|Withdrawal by Subject|7|||
130575619|NCT03461757|470071273|FG001|Overall Study|Withdrawal by Subject|7|||
130575620|NCT03461757|470071272|FG000|Overall Study|Other Reasons|1|||
130575621|NCT03461757|470071273|FG001|Overall Study|Other Reasons|4|||
130575622|NCT03652662|470071279|FG000|Overall Study|Withdrawal by Subject|2|||
130575623|NCT03652662|470071280|FG001|Overall Study|Withdrawal by Subject|1|||
130575624|NCT03652662|470071279|FG000|Overall Study|Lost to Follow-up|1|||
130575625|NCT03652662|470071280|FG001|Overall Study|Lost to Follow-up|0|||
130575626|NCT00487539|470071281|FG000|Overall Study|Adverse Event|3|||
130575627|NCT00487539|470071282|FG001|Overall Study|Adverse Event|2|||
130575628|NCT00487539|470071283|FG002|Overall Study|Adverse Event|1|||
130575629|NCT00487539|470071284|FG003|Overall Study|Adverse Event|1|||
130575630|NCT00487539|470071281|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130575631|NCT00487539|470071282|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130575632|NCT00487539|470071283|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130575633|NCT00487539|470071284|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
130575634|NCT00487539|470071281|FG000|Overall Study|Other|3|||
130575635|NCT00487539|470071282|FG001|Overall Study|Other|1|||
130575636|NCT00487539|470071283|FG002|Overall Study|Other|2|||
130575637|NCT00487539|470071284|FG003|Overall Study|Other|2|||
130575638|NCT03440814|470071285|FG000|Overall Study|Adverse Event|2|||
130575639|NCT03440814|470071286|FG001|Overall Study|Adverse Event|1|||
130575640|NCT03440814|470071285|FG000|Overall Study|Lost to Follow-up|2|||
130575641|NCT03440814|470071286|FG001|Overall Study|Lost to Follow-up|0|||
130575642|NCT03440814|470071285|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
130575643|NCT03440814|470071286|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
130575644|NCT00879697|470071287|FG000|Overall Study|Physician Decision|2|||
130575645|NCT00879697|470071288|FG001|Overall Study|Physician Decision|2|||
130575646|NCT00088374|470071289|FG000|Overall Study|patient did not receive any 17AAG|1|||
130575647|NCT00088374|470071289|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
130575648|NCT00720109|470071290|FG000|Induction Period|Did not meet eligibility criteria|3|||
130575649|NCT00720109|470071291|FG001|Induction Period|Did not meet eligibility criteria|0|||
130575650|NCT00720109|470071292|FG002|Induction Period|Did not meet eligibility criteria|0|||
130575651|NCT00720109|470071290|FG000|Induction Period|Bone Marrow Transplant|2|||
130575652|NCT00720109|470071291|FG001|Induction Period|Bone Marrow Transplant|0|||
130575653|NCT00720109|470071292|FG002|Induction Period|Bone Marrow Transplant|0|||
130575654|NCT00720109|470071290|FG000|Induction Period|Physician Decision|1|||
130575655|NCT00720109|470071291|FG001|Induction Period|Physician Decision|0|||
130575656|NCT00720109|470071292|FG002|Induction Period|Physician Decision|0|||
130575657|NCT00720109|470071290|FG000|Risk Stratification Period|Adverse Event|0|||
130575658|NCT00720109|470071291|FG001|Risk Stratification Period|Adverse Event|1|||
130522854|NCT01182181|469882971|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
130522855|NCT01182181|469882972|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
130522856|NCT03845075|469882973|FG000|Part 1 - DB|Withdrawal by Subject|1|||
130522857|NCT03845075|469882974|FG001|Part 1 - DB|Withdrawal by Subject|1|||
130522858|NCT03845075|469882975|FG002|Part 1 - DB|Withdrawal by Subject|0|||
130522859|NCT03845075|469882976|FG003|Part 1 - DB|Withdrawal by Subject|0|||
130522860|NCT03845075|469882973|FG000|Part 1 - DB|Adverse Event|0|||
130522861|NCT03845075|469882974|FG001|Part 1 - DB|Adverse Event|1|||
130522862|NCT03845075|469882975|FG002|Part 1 - DB|Adverse Event|0|||
130522863|NCT03845075|469882976|FG003|Part 1 - DB|Adverse Event|0|||
130522864|NCT03845075|469882973|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
130522865|NCT03845075|469882974|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
130522866|NCT03845075|469882975|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
130522867|NCT03845075|469882976|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
130522868|NCT03856047|469882977|FG000|Overall Study|Withdrawal by Subject|0|||
130522869|NCT03856047|469882978|FG001|Overall Study|Withdrawal by Subject|1|||
130522870|NCT03856047|469882979|FG002|Overall Study|Withdrawal by Subject|1|||
130522871|NCT03856047|469882980|FG003|Overall Study|Withdrawal by Subject|0|||
130522872|NCT03856047|469882981|FG004|Overall Study|Withdrawal by Subject|3|||
130522873|NCT03856047|469882982|FG005|Overall Study|Withdrawal by Subject|0|||
130522874|NCT03856047|469882983|FG006|Overall Study|Withdrawal by Subject|2|||
130522875|NCT03856047|469882977|FG000|Overall Study|Lost to Follow-up|4|||
130522876|NCT03856047|469882978|FG001|Overall Study|Lost to Follow-up|2|||
130522877|NCT03856047|469882979|FG002|Overall Study|Lost to Follow-up|3|||
130522878|NCT03856047|469882980|FG003|Overall Study|Lost to Follow-up|1|||
130522879|NCT03856047|469882981|FG004|Overall Study|Lost to Follow-up|4|||
130522880|NCT03856047|469882982|FG005|Overall Study|Lost to Follow-up|4|||
130522881|NCT03856047|469882983|FG006|Overall Study|Lost to Follow-up|4|||
130522882|NCT01278615|469882984|FG000|Overall Study|Withdrawal by Subject|2|||
130522883|NCT00905359|469882985|FG000|Overall Study|Lost to Follow-up|17|||
130522884|NCT00905359|469882986|FG001|Overall Study|Lost to Follow-up|10|||
130522885|NCT00905359|469882985|FG000|Overall Study|Death|2|||
130522886|NCT00905359|469882986|FG001|Overall Study|Death|0|||
130522887|NCT00905359|469882985|FG000|Overall Study|Withdrawal consent|5|||
130522888|NCT00905359|469882986|FG001|Overall Study|Withdrawal consent|6|||
130522889|NCT02138253|469882987|FG000|Overall Study|Adverse Event|3|||
130522890|NCT02138253|469882988|FG001|Overall Study|Adverse Event|3|||
130522891|NCT02138253|469882987|FG000|Overall Study|Lost to Follow-up|2|||
130522892|NCT02138253|469882988|FG001|Overall Study|Lost to Follow-up|1|||
130522893|NCT02138253|469882987|FG000|Overall Study|Physician Decision|2|||
130522894|NCT02138253|469882988|FG001|Overall Study|Physician Decision|0|||
130522895|NCT02138253|469882987|FG000|Overall Study|Non compliance|1|||
130522896|NCT02138253|469882988|FG001|Overall Study|Non compliance|0|||
130522897|NCT02138253|469882987|FG000|Overall Study|Withdrawal by Subject|1|||
130522898|NCT02138253|469882988|FG001|Overall Study|Withdrawal by Subject|0|||
130522899|NCT02654132|469882989|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
130522900|NCT02654132|469882990|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
130522901|NCT02654132|469882989|FG000|Treatment Period|Disease progression|43|||
130522902|NCT02654132|469882990|FG001|Treatment Period|Disease progression|38|||
130522903|NCT02654132|469882989|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
130522904|NCT02654132|469882990|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
130522905|NCT02654132|469882989|FG000|Treatment Period|Other reasons|4|||
130522906|NCT02654132|469882990|FG001|Treatment Period|Other reasons|2|||
130522907|NCT02654132|469882989|FG000|Treatment Period|Study drug toxicity|2|||
130522908|NCT02654132|469882990|FG001|Treatment Period|Study drug toxicity|2|||
130522909|NCT02654132|469882989|FG000|Treatment Period|Withdrawal by Subject|2|||
130522910|NCT02654132|469882990|FG001|Treatment Period|Withdrawal by Subject|1|||
130522911|NCT02654132|469882989|FG000|Treatment Period|Maximum Clinical Benefit|0|||
130522912|NCT02654132|469882990|FG001|Treatment Period|Maximum Clinical Benefit|2|||
130522913|NCT02654132|469882989|FG000|Treatment Period|Participant request to discontinue|2|||
130522914|NCT02654132|469882990|FG001|Treatment Period|Participant request to discontinue|0|||
130522915|NCT02654132|469882989|FG000|Treatment Period|Administrative reasons by sponsor|0|||
130522916|NCT02654132|469882990|FG001|Treatment Period|Administrative reasons by sponsor|1|||
130522917|NCT02654132|469882989|FG000|Treatment Period|Death|1|||
130522918|NCT02654132|469882990|FG001|Treatment Period|Death|0|||
130522919|NCT02872012|469882992|FG000|Overall Study|Withdrawal by Subject|1|||
130522920|NCT02872012|469882993|FG001|Overall Study|Withdrawal by Subject|0|||
130522921|NCT02872012|469882994|FG002|Overall Study|Withdrawal by Subject|0|||
130522922|NCT02872012|469882995|FG003|Overall Study|Withdrawal by Subject|0|||
130522923|NCT02872012|469882996|FG004|Overall Study|Withdrawal by Subject|0|||
130522924|NCT01728623|469882997|FG000|Overall Study|Disease progression|26|||
130522925|NCT01728623|469882997|FG000|Overall Study|Adverse Event|1|||
130522926|NCT01728623|469882997|FG000|Overall Study|Withdrawal by Subject|1|||
130522927|NCT00243022|469882998|FG000|Overall Study|Withdrawal by Subject|1|||
130522928|NCT00243022|469882999|FG001|Overall Study|Withdrawal by Subject|0|||
130522929|NCT00243022|469882998|FG000|Overall Study|Death|1|||
130575659|NCT00720109|470071292|FG002|Risk Stratification Period|Adverse Event|0|||
130575660|NCT00720109|470071290|FG000|Risk Stratification Period|Physician Decision|0|||
130575661|NCT00720109|470071291|FG001|Risk Stratification Period|Physician Decision|2|||
130575662|NCT00720109|470071292|FG002|Risk Stratification Period|Physician Decision|1|||
130575663|NCT00720109|470071290|FG000|Risk Stratification Period|Bone marrow transplant|0|||
130575664|NCT00720109|470071291|FG001|Risk Stratification Period|Bone marrow transplant|9|||
130575665|NCT00720109|470071292|FG002|Risk Stratification Period|Bone marrow transplant|7|||
130575666|NCT00720109|470071290|FG000|Risk Stratification Period|Disease progression or relapse|0|||
130575667|NCT00720109|470071291|FG001|Risk Stratification Period|Disease progression or relapse|2|||
130575668|NCT00720109|470071292|FG002|Risk Stratification Period|Disease progression or relapse|0|||
130575669|NCT00720109|470071290|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
130575670|NCT00720109|470071291|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
130575671|NCT00720109|470071292|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
130575672|NCT00371865|470071293|FG000|Overall Study|Lack of Efficacy|0|||
130575673|NCT00371865|470071294|FG001|Overall Study|Lack of Efficacy|2|||
130575674|NCT00371865|470071293|FG000|Overall Study|Protocol Violation|3|||
130575675|NCT00371865|470071294|FG001|Overall Study|Protocol Violation|2|||
130575676|NCT00371865|470071293|FG000|Overall Study|Withdrawal by Subject|12|||
130575677|NCT00371865|470071294|FG001|Overall Study|Withdrawal by Subject|10|||
130575678|NCT02508194|470071295|FG000|Overall Study|Death|5|||
130575679|NCT02508194|470071296|FG001|Overall Study|Death|3|||
130575680|NCT02508194|470071295|FG000|Overall Study|Lost to Follow-up|25|||
130575681|NCT02508194|470071296|FG001|Overall Study|Lost to Follow-up|18|||
130575682|NCT02508194|470071295|FG000|Overall Study|Withdrawal by Subject|20|||
130575683|NCT02508194|470071296|FG001|Overall Study|Withdrawal by Subject|18|||
130575684|NCT02508194|470071295|FG000|Overall Study|Error in Randomization|1|||
130575685|NCT02508194|470071296|FG001|Overall Study|Error in Randomization|3|||
130575686|NCT02508194|470071295|FG000|Overall Study|Principal Investigator Decision|1|||
130575687|NCT02508194|470071296|FG001|Overall Study|Principal Investigator Decision|2|||
130575688|NCT04153188|470071301|FG000|Overall Study|Lost to Follow-up|1|||
130575689|NCT04153188|470071302|FG001|Overall Study|Lost to Follow-up|1|||
130575690|NCT04153188|470071301|FG000|Overall Study|Withdrawal by Subject|2|||
130575691|NCT04153188|470071302|FG001|Overall Study|Withdrawal by Subject|0|||
130575692|NCT04153188|470071301|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
130575693|NCT04153188|470071302|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
130575694|NCT00264238|470071303|FG000|Overall Study|Protocol Violation|1|||
130575695|NCT04899232|470071304|FG000|Screening Period|Physician Decision|1|||
130575696|NCT04899232|470071305|FG001|Screening Period|Physician Decision|0|||
130575697|NCT04899232|470071306|FG002|Screening Period|Physician Decision|0|||
130575698|NCT04899232|470071304|FG000|Screening Period|Withdrawal by Subject|1|||
130575699|NCT04899232|470071305|FG001|Screening Period|Withdrawal by Subject|0|||
130575700|NCT04899232|470071306|FG002|Screening Period|Withdrawal by Subject|0|||
130575701|NCT04899232|470071304|FG000|Screening Period|Participant discharged before receiving intervention|3|||
130575702|NCT04899232|470071305|FG001|Screening Period|Participant discharged before receiving intervention|0|||
130575703|NCT04899232|470071306|FG002|Screening Period|Participant discharged before receiving intervention|0|||
130575704|NCT00700271|470071307|FG000|Overall Study|Adverse Event|4|||
130575705|NCT00700271|470071308|FG001|Overall Study|Adverse Event|6|||
130575706|NCT00700271|470071307|FG000|Overall Study|Protocol Violation|1|||
130575707|NCT00700271|470071308|FG001|Overall Study|Protocol Violation|0|||
130575708|NCT00700271|470071307|FG000|Overall Study|Administrative Reasons|1|||
130575709|NCT00700271|470071308|FG001|Overall Study|Administrative Reasons|0|||
130575710|NCT00700271|470071307|FG000|Overall Study|Withdrawal by Subject|6|||
130575711|NCT00700271|470071308|FG001|Overall Study|Withdrawal by Subject|4|||
130575712|NCT00700271|470071307|FG000|Overall Study|Lost to Follow-up|2|||
130575713|NCT00700271|470071308|FG001|Overall Study|Lost to Follow-up|2|||
130575714|NCT03110224|470071309|FG000|Overall Study|Death|3|||
130575715|NCT03110224|470071309|FG000|Overall Study|Lost to Follow-up|132|||
130575716|NCT03110224|470071309|FG000|Overall Study|Physician Decision|2|||
130575717|NCT03110224|470071309|FG000|Overall Study|Site Closed by Physician|35|||
130575718|NCT03110224|470071309|FG000|Overall Study|Site Closed by Sponsor|202|||
130575719|NCT03110224|470071309|FG000|Overall Study|Withdrawal by Subject|9|||
130575720|NCT01564862|470071310|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130575721|NCT01564862|470071311|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
130575722|NCT01564862|470071312|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130575723|NCT01564862|470071310|FG000|Overall Study|Major Protocol Deviation|3|||
130575724|NCT01564862|470071311|FG001|Overall Study|Major Protocol Deviation|3|||
130575725|NCT01564862|470071312|FG002|Overall Study|Major Protocol Deviation|4|||
130575726|NCT01564862|470071310|FG000|Overall Study|Lost to Follow-up|10|||
130575727|NCT01564862|470071311|FG001|Overall Study|Lost to Follow-up|8|||
130575728|NCT01564862|470071312|FG002|Overall Study|Lost to Follow-up|6|||
130575729|NCT01564862|470071310|FG000|Overall Study|Voluntary Withdrawal|9|||
130575730|NCT01564862|470071311|FG001|Overall Study|Voluntary Withdrawal|6|||
130575731|NCT01564862|470071312|FG002|Overall Study|Voluntary Withdrawal|8|||
130522930|NCT00243022|469882999|FG001|Overall Study|Death|0|||
130522931|NCT00243022|469882998|FG000|Overall Study|Difficult Travel Distance|0|||
130522932|NCT00243022|469882999|FG001|Overall Study|Difficult Travel Distance|1|||
130522933|NCT03517111|469883004|FG000|Enrolled|Withdrawal by Subject|0|||
130522934|NCT03517111|469883005|FG001|Enrolled|Withdrawal by Subject|1|||
130522935|NCT03517111|469883006|FG002|Enrolled|Withdrawal by Subject|0|||
130522936|NCT03517111|469883004|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
130522937|NCT03517111|469883005|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
130522938|NCT03517111|469883006|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
130522939|NCT03517111|469883004|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
130522940|NCT03517111|469883005|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
130522941|NCT03517111|469883006|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
130522942|NCT03517111|469883004|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
130522943|NCT03517111|469883005|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
130522944|NCT03517111|469883006|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
130522945|NCT03517111|469883004|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
130522946|NCT03517111|469883005|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
130522947|NCT03517111|469883006|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
130522948|NCT00621192|469883007|FG000|Overall Study|Withdrawal by Subject|0|||
130522949|NCT00621192|469883008|FG001|Overall Study|Withdrawal by Subject|0|||
130522950|NCT00621192|469883009|FG002|Overall Study|Withdrawal by Subject|2|||
130522951|NCT00621192|469883010|FG003|Overall Study|Withdrawal by Subject|0|||
130522952|NCT00621192|469883007|FG000|Overall Study|Physician Decision|1|||
130522953|NCT00621192|469883008|FG001|Overall Study|Physician Decision|3|||
130522954|NCT00621192|469883009|FG002|Overall Study|Physician Decision|0|||
130522955|NCT00621192|469883010|FG003|Overall Study|Physician Decision|0|||
130522956|NCT00621192|469883007|FG000|Overall Study|Protocol Violation|1|||
130522957|NCT00621192|469883008|FG001|Overall Study|Protocol Violation|0|||
130522958|NCT00621192|469883009|FG002|Overall Study|Protocol Violation|0|||
130522959|NCT00621192|469883010|FG003|Overall Study|Protocol Violation|1|||
130522960|NCT00621192|469883007|FG000|Overall Study|Adverse Event|0|||
130522961|NCT00621192|469883008|FG001|Overall Study|Adverse Event|1|||
130522962|NCT00621192|469883009|FG002|Overall Study|Adverse Event|0|||
130522963|NCT00621192|469883010|FG003|Overall Study|Adverse Event|1|||
130522964|NCT00621192|469883007|FG000|Overall Study|Death|2|||
130522965|NCT00621192|469883008|FG001|Overall Study|Death|5|||
130522966|NCT00621192|469883009|FG002|Overall Study|Death|0|||
130522967|NCT00621192|469883010|FG003|Overall Study|Death|0|||
130522968|NCT00621192|469883007|FG000|Overall Study|Final Assessments not Completed|0|||
130522969|NCT00621192|469883008|FG001|Overall Study|Final Assessments not Completed|0|||
130522970|NCT00621192|469883009|FG002|Overall Study|Final Assessments not Completed|3|||
130522971|NCT00621192|469883010|FG003|Overall Study|Final Assessments not Completed|1|||
130522972|NCT04706793|469883011|FG000|Treatment|Disease worsening|10|||
130522973|NCT04706793|469883012|FG001|Treatment|Disease worsening|10|||
130522974|NCT04706793|469883011|FG000|Follow-up|Lack of Efficacy|1|||
130522975|NCT04706793|469883012|FG001|Follow-up|Lack of Efficacy|0|||
130522976|NCT04706793|469883011|FG000|Follow-up|Disease worsening|8|||
130522977|NCT04706793|469883012|FG001|Follow-up|Disease worsening|10|||
130522978|NCT04706793|469883011|FG000|Follow-up|Adverse Event|1|||
130522979|NCT04706793|469883012|FG001|Follow-up|Adverse Event|0|||
130522980|NCT03713320|469883015|FG000|Randomized Period|Adverse Event|1|||
130522981|NCT03713320|469883016|FG001|Randomized Period|Adverse Event|5|||
130522982|NCT03713320|469883017|FG002|Randomized Period|Adverse Event|0|||
130522983|NCT03713320|469883015|FG000|Randomized Period|Physician Decision|1|||
130522984|NCT03713320|469883016|FG001|Randomized Period|Physician Decision|1|||
130522985|NCT03713320|469883017|FG002|Randomized Period|Physician Decision|0|||
130522986|NCT03713320|469883015|FG000|Randomized Period|Withdrawal by Subject|4|||
130522987|NCT03713320|469883016|FG001|Randomized Period|Withdrawal by Subject|0|||
130522988|NCT03713320|469883017|FG002|Randomized Period|Withdrawal by Subject|0|||
130522989|NCT03713320|469883015|FG000|Randomized Period|Participant decision|3|||
130522990|NCT03713320|469883016|FG001|Randomized Period|Participant decision|1|||
130522991|NCT03713320|469883017|FG002|Randomized Period|Participant decision|0|||
130522992|NCT03713320|469883015|FG000|Randomized Period|Study terminated by sponsor|6|||
130522993|NCT03713320|469883016|FG001|Randomized Period|Study terminated by sponsor|3|||
130522994|NCT03713320|469883017|FG002|Randomized Period|Study terminated by sponsor|0|||
130522995|NCT03713320|469883015|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
130522996|NCT03713320|469883016|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
130522997|NCT03713320|469883017|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
130522998|NCT03713320|469883015|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
130522999|NCT03713320|469883016|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
130575732|NCT01564862|470071310|FG000|Overall Study|Lack of Efficacy|1|||
130575733|NCT01564862|470071311|FG001|Overall Study|Lack of Efficacy|5|||
130575734|NCT01564862|470071312|FG002|Overall Study|Lack of Efficacy|6|||
130575735|NCT01564862|470071310|FG000|Overall Study|Other reason(s)|1|||
130575736|NCT01564862|470071311|FG001|Overall Study|Other reason(s)|0|||
130575737|NCT01564862|470071312|FG002|Overall Study|Other reason(s)|0|||
130575738|NCT02028455|470071313|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575739|NCT02028455|470071314|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575740|NCT02028455|470071315|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575741|NCT02028455|470071316|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575742|NCT02028455|470071317|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575743|NCT02028455|470071318|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130575744|NCT02028455|470071319|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
130575745|NCT02028455|470071320|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
130575746|NCT02028455|470071313|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
130575747|NCT02028455|470071314|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
130575748|NCT02028455|470071315|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
130575749|NCT02028455|470071316|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
130575750|NCT02028455|470071317|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
130575751|NCT02028455|470071318|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
130575752|NCT02028455|470071319|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
130575753|NCT02028455|470071320|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
130575754|NCT02028455|470071313|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575755|NCT02028455|470071314|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575756|NCT02028455|470071315|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575757|NCT02028455|470071316|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575758|NCT02028455|470071317|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575759|NCT02028455|470071318|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
130575760|NCT02028455|470071319|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130575761|NCT02028455|470071320|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
130575762|NCT02028455|470071313|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130575763|NCT02028455|470071314|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130575764|NCT02028455|470071315|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
130575765|NCT02028455|470071316|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
130575766|NCT02028455|470071317|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130575767|NCT02028455|470071318|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130575768|NCT02028455|470071319|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
130575769|NCT02028455|470071320|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
130575770|NCT02396589|470071321|FG000|Intervention|Lost to Follow-up|1|||
130575771|NCT02396589|470071322|FG001|Intervention|Lost to Follow-up|0|||
130575772|NCT02396589|470071321|FG000|6 Month Follow-up|change in health status|0|||
130575773|NCT02396589|470071322|FG001|6 Month Follow-up|change in health status|1|||
130575774|NCT02396589|470071321|FG000|9 Month Follow-up|Death|0|||
130575775|NCT02396589|470071322|FG001|9 Month Follow-up|Death|1|||
130575776|NCT02396589|470071321|FG000|12 Month Follow up|Lost to Follow-up|0|||
130575777|NCT02396589|470071322|FG001|12 Month Follow up|Lost to Follow-up|2|||
130575778|NCT04341948|470071323|FG000|Overall Study|Adverse Event|0|||
130575779|NCT04341948|470071324|FG001|Overall Study|Adverse Event|1|||
130575780|NCT04341948|470071323|FG000|Overall Study|Lost to Follow-up|6|||
130575781|NCT04341948|470071324|FG001|Overall Study|Lost to Follow-up|1|||
130575782|NCT04341948|470071323|FG000|Overall Study|Physician Decision|1|||
130575783|NCT04341948|470071324|FG001|Overall Study|Physician Decision|2|||
130575784|NCT04341948|470071323|FG000|Overall Study|Withdrawal by Participant|6|||
130575785|NCT04341948|470071324|FG001|Overall Study|Withdrawal by Participant|3|||
130575786|NCT04341948|470071323|FG000|Overall Study|Lack of compliance by Participant|1|||
130575787|NCT04341948|470071324|FG001|Overall Study|Lack of compliance by Participant|0|||
130575788|NCT04705051|470072949|FG000|Overall Study|Enrolled but not treated|1|||
130575789|NCT04705051|470072949|FG000|Overall Study|Study terminated by sponsor|23|||
130575790|NCT01761266|470072953|FG000|Overall Study|Death|415|||
130575791|NCT01761266|470072954|FG001|Overall Study|Death|402|||
130575792|NCT01761266|470072953|FG000|Overall Study|Lost to Follow-up|8|||
130575793|NCT01761266|470072954|FG001|Overall Study|Lost to Follow-up|12|||
130575794|NCT01761266|470072953|FG000|Overall Study|Withdrawal by Subject|14|||
130575795|NCT01761266|470072954|FG001|Overall Study|Withdrawal by Subject|10|||
130575796|NCT01761266|470072953|FG000|Overall Study|Sponsor Decision|41|||
130575797|NCT01761266|470072954|FG001|Overall Study|Sponsor Decision|52|||
130575798|NCT01284114|470072955|FG000|Overall Study|viral infection|1|||
130575799|NCT01284114|470072955|FG000|Overall Study|From the results of ALLTITUDE study|1|||
130575800|NCT01284114|470072955|FG000|Overall Study|Symptomatic hypotension|1|||
130575801|NCT01284114|470072955|FG000|Overall Study|dizziness|1|||
130575802|NCT03445000|470072957|FG000|Overall Study|Disease progression|8|||
130575803|NCT03445000|470072957|FG000|Overall Study|Adverse Event|3|||
130575804|NCT03445000|470072957|FG000|Overall Study|Death|2|||
130575805|NCT03445000|470072957|FG000|Overall Study|Physician Decision|1|||
130575806|NCT03409744|470072958|FG000|Overall Study|Death|2|||
130575807|NCT03409744|470072958|FG000|Overall Study|Physician Decision|5|||
130575808|NCT03409744|470072958|FG000|Overall Study|Pregnancy|1|||
130575809|NCT03409744|470072958|FG000|Overall Study|Lost to Follow-up|1|||
130575810|NCT03409744|470072958|FG000|Overall Study|Protocol Violation|1|||
130575811|NCT00264004|470072960|FG000|Overall Study|Adverse Event|2|||
130575812|NCT00264004|470072961|FG001|Overall Study|Adverse Event|3|||
130575813|NCT00264004|470072962|FG002|Overall Study|Adverse Event|6|||
130575814|NCT00264004|470072963|FG003|Overall Study|Adverse Event|4|||
130575815|NCT00264004|470072960|FG000|Overall Study|Withdrawal by Subject|0|||
130575816|NCT00264004|470072961|FG001|Overall Study|Withdrawal by Subject|1|||
130575817|NCT00264004|470072962|FG002|Overall Study|Withdrawal by Subject|2|||
130575818|NCT00264004|470072963|FG003|Overall Study|Withdrawal by Subject|2|||
130575819|NCT00264004|470072960|FG000|Overall Study|Other|2|||
130575820|NCT00264004|470072961|FG001|Overall Study|Other|2|||
130575821|NCT00264004|470072962|FG002|Overall Study|Other|0|||
130575822|NCT00264004|470072963|FG003|Overall Study|Other|3|||
130575823|NCT00264004|470072960|FG000|Overall Study|Development study specific disc. crit.|1|||
130575824|NCT00264004|470072961|FG001|Overall Study|Development study specific disc. crit.|0|||
130575825|NCT00264004|470072962|FG002|Overall Study|Development study specific disc. crit.|1|||
130575826|NCT00264004|470072963|FG003|Overall Study|Development study specific disc. crit.|0|||
130575827|NCT00264004|470072960|FG000|Overall Study|Cond. under inv. worsened|9|||
130575828|NCT00264004|470072961|FG001|Overall Study|Cond. under inv. worsened|5|||
130575829|NCT00264004|470072962|FG002|Overall Study|Cond. under inv. worsened|3|||
130575830|NCT00264004|470072963|FG003|Overall Study|Cond. under inv. worsened|4|||
130575831|NCT00264004|470072960|FG000|Overall Study|Not treated|3|||
130575832|NCT00264004|470072961|FG001|Overall Study|Not treated|0|||
130575833|NCT00264004|470072962|FG002|Overall Study|Not treated|2|||
130575834|NCT00264004|470072963|FG003|Overall Study|Not treated|2|||
130575835|NCT00691483|470072964|FG000|Overall Study|Adverse Event|14|||
130575836|NCT00691483|470072965|FG001|Overall Study|Adverse Event|6|||
130575837|NCT00691483|470072964|FG000|Overall Study|Lost to Follow-up|17|||
130575838|NCT00691483|470072965|FG001|Overall Study|Lost to Follow-up|10|||
130575839|NCT00691483|470072964|FG000|Overall Study|Withdrawal by Subject|24|||
130575840|NCT00691483|470072965|FG001|Overall Study|Withdrawal by Subject|7|||
130575841|NCT00691483|470072964|FG000|Overall Study|Other known cause|6|||
130575842|NCT00691483|470072965|FG001|Overall Study|Other known cause|1|||
130575843|NCT00691483|470072964|FG000|Overall Study|Randomized by not treated|7|||
130575844|NCT00691483|470072965|FG001|Overall Study|Randomized by not treated|1|||
130575845|NCT01535729|470072967|FG000|Overall Study|Withdrawal by Subject|2|||
130575846|NCT01535729|470072967|FG000|Overall Study|Disease progression|230|||
130575847|NCT01535729|470072967|FG000|Overall Study|Discontinued treatment|25|||
130575848|NCT01535729|470072967|FG000|Overall Study|Lost to Follow-up|8|||
130575849|NCT01535729|470072967|FG000|Overall Study|Death|52|||
130575850|NCT01535729|470072967|FG000|Overall Study|Other|19|||
130575851|NCT01535729|470072967|FG000|Overall Study|Did not sign informed consent|1|||
130575852|NCT01535729|470072967|FG000|Overall Study|No previous chemotherapy|33|||
130575853|NCT01535729|470072967|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
130575854|NCT01535729|470072967|FG000|Overall Study|Protocol Violation|11|||
130575855|NCT01535729|470072967|FG000|Overall Study|Screening failure|1|||
130575856|NCT01535729|470072967|FG000|Overall Study|Not treated|9|||
130575857|NCT01535729|470072967|FG000|Overall Study|No participant record available|5|||
130575858|NCT02740478|470072968|FG000|Overall Study|Withdrawal by Subject|1|||
130575859|NCT02615990|470072971|FG000|Overall Study|study terminated|1|||
130575860|NCT02615990|470072972|FG001|Overall Study|study terminated|1|||
130575861|NCT01363986|470072973|FG000|Overall Study|Disease progression|1|||
130575862|NCT00130832|470072974|FG000|Overall Study|Adverse Event|1|||
130575863|NCT00130832|470072975|FG001|Overall Study|Adverse Event|1|||
130575864|NCT00130832|470072974|FG000|Overall Study|Lost to Follow-up|1|||
130575865|NCT00130832|470072975|FG001|Overall Study|Lost to Follow-up|2|||
130575866|NCT00130832|470072974|FG000|Overall Study|Protocol Violation|6|||
130575867|NCT00130832|470072975|FG001|Overall Study|Protocol Violation|8|||
130575868|NCT00130832|470072974|FG000|Overall Study|Withdrawal by Subject|6|||
130575869|NCT00130832|470072975|FG001|Overall Study|Withdrawal by Subject|1|||
130575870|NCT00130832|470072974|FG000|Overall Study|Moved|2|||
130575871|NCT00130832|470072975|FG001|Overall Study|Moved|2|||
130575872|NCT00130832|470072974|FG000|Overall Study|Other|0|||
130575873|NCT00130832|470072975|FG001|Overall Study|Other|3|||
130575874|NCT03905863|470072976|FG000|Overall Study|Adverse Event|2|||
130575875|NCT03905863|470072977|FG001|Overall Study|Adverse Event|4|||
130575876|NCT03905863|470072976|FG000|Overall Study|Withdrawal by Subject|2|||
130575877|NCT03905863|470072977|FG001|Overall Study|Withdrawal by Subject|2|||
130575878|NCT03905863|470072976|FG000|Overall Study|Physician Decision|0|||
130575879|NCT03905863|470072977|FG001|Overall Study|Physician Decision|3|||
130575880|NCT03905863|470072976|FG000|Overall Study|Lost to Follow-up|1|||
130575881|NCT03905863|470072977|FG001|Overall Study|Lost to Follow-up|0|||
130575882|NCT03905863|470072976|FG000|Overall Study|Protocol Violation|0|||
130523000|NCT03713320|469883017|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
130523001|NCT01880437|469883018|FG000|Overall Study|Death|12|||
130575883|NCT03905863|470072977|FG001|Overall Study|Protocol Violation|2|||
130575884|NCT03905863|470072976|FG000|Overall Study|Death|0|||
130575885|NCT03905863|470072977|FG001|Overall Study|Death|1|||
130575886|NCT02354703|470072979|FG000|Overall Study|Withdrawal by Subject|1|||
130575887|NCT02354703|470072980|FG001|Overall Study|Withdrawal by Subject|1|||
130575888|NCT02354703|470072981|FG002|Overall Study|Withdrawal by Subject|1|||
130575889|NCT02354703|470072982|FG003|Overall Study|Withdrawal by Subject|1|||
130575890|NCT02354703|470072979|FG000|Overall Study|Lost to Follow-up|2|||
130575891|NCT02354703|470072980|FG001|Overall Study|Lost to Follow-up|7|||
130575892|NCT02354703|470072981|FG002|Overall Study|Lost to Follow-up|9|||
130575893|NCT02354703|470072982|FG003|Overall Study|Lost to Follow-up|2|||
130575894|NCT02354703|470072979|FG000|Overall Study|Adverse Event|0|||
130575895|NCT02354703|470072980|FG001|Overall Study|Adverse Event|0|||
130575896|NCT02354703|470072981|FG002|Overall Study|Adverse Event|1|||
130575897|NCT02354703|470072982|FG003|Overall Study|Adverse Event|0|||
130575898|NCT02944448|470072983|FG000|Overall Study|Adverse Event|37|||
130575899|NCT02944448|470072984|FG001|Overall Study|Adverse Event|6|||
130575900|NCT02944448|470072983|FG000|Overall Study|Lack of Efficacy|8|||
130575901|NCT02944448|470072984|FG001|Overall Study|Lack of Efficacy|5|||
130575902|NCT02944448|470072983|FG000|Overall Study|Lost to Follow-up|3|||
130575903|NCT02944448|470072984|FG001|Overall Study|Lost to Follow-up|1|||
130575904|NCT02944448|470072983|FG000|Overall Study|Protocol Violation|25|||
130575905|NCT02944448|470072984|FG001|Overall Study|Protocol Violation|7|||
130575906|NCT02944448|470072983|FG000|Overall Study|Withdrawal by Subject|14|||
130575907|NCT02944448|470072984|FG001|Overall Study|Withdrawal by Subject|4|||
130575908|NCT02944448|470072983|FG000|Overall Study|Sponsor did not supply drug in time|0|||
130575909|NCT02944448|470072984|FG001|Overall Study|Sponsor did not supply drug in time|1|||
130575910|NCT02944448|470072983|FG000|Overall Study|Noncompliant with dosing|1|||
130575911|NCT02944448|470072984|FG001|Overall Study|Noncompliant with dosing|0|||
130575912|NCT02944448|470072983|FG000|Overall Study|Abnormal laboratory values|1|||
130575913|NCT02944448|470072984|FG001|Overall Study|Abnormal laboratory values|0|||
130575914|NCT00925015|470072987|FG000|Overall Study|Adverse Event|1|||
130575915|NCT00925015|470072988|FG001|Overall Study|Adverse Event|2|||
130575916|NCT00925015|470072989|FG002|Overall Study|Adverse Event|1|||
130575917|NCT00925015|470072987|FG000|Overall Study|Physician Decision|0|||
130575918|NCT00925015|470072988|FG001|Overall Study|Physician Decision|1|||
130575919|NCT00925015|470072989|FG002|Overall Study|Physician Decision|0|||
130575920|NCT00925015|470072987|FG000|Overall Study|Progressive Disease|7|||
130575921|NCT00925015|470072988|FG001|Overall Study|Progressive Disease|3|||
130575922|NCT00925015|470072989|FG002|Overall Study|Progressive Disease|4|||
130575923|NCT00925015|470072987|FG000|Overall Study|Withdrawal by Subject|0|||
130523002|NCT01880437|469883019|FG001|Overall Study|Death|4|||
130523003|NCT01880437|469883020|FG002|Overall Study|Death|17|||
130523004|NCT01880437|469883018|FG000|Overall Study|Study terminated by Sponsor|3|||
130523005|NCT01880437|469883019|FG001|Overall Study|Study terminated by Sponsor|0|||
130523006|NCT01880437|469883020|FG002|Overall Study|Study terminated by Sponsor|2|||
130523007|NCT02569957|469883022|FG000|Overall Study|Withdrawal by Subject|0|||
130523008|NCT02569957|469883023|FG001|Overall Study|Withdrawal by Subject|1|||
130523009|NCT04354168|469883024|FG000|Overall Study|Lost to Follow-up|22|||
130523010|NCT01781832|469883025|FG000|Overall Study|Withdrawal by Subject|1|||
130523011|NCT02719743|469883026|FG000|Overall Study|Consent withdrawal|0|||
130523012|NCT02719743|469883027|FG001|Overall Study|Consent withdrawal|2|||
130523013|NCT02719743|469883028|FG002|Overall Study|Consent withdrawal|0|||
130523014|NCT02719743|469883029|FG003|Overall Study|Consent withdrawal|1|||
130523015|NCT02719743|469883030|FG004|Overall Study|Consent withdrawal|0|||
130523016|NCT02719743|469883026|FG000|Overall Study|Migrated/moved from study area|0|||
130575924|NCT00925015|470072988|FG001|Overall Study|Withdrawal by Subject|0|||
130575925|NCT00925015|470072989|FG002|Overall Study|Withdrawal by Subject|1|||
130575926|NCT05499559|470072990|FG000|Overall Study|Lost to Follow-up|467|||
130523017|NCT02719743|469883027|FG001|Overall Study|Migrated/moved from study area|0|||
130523018|NCT02719743|469883028|FG002|Overall Study|Migrated/moved from study area|0|||
130575927|NCT03118297|470072991|FG000|Overall Study|Lost to Follow-up|0|||
130575928|NCT03118297|470072992|FG001|Overall Study|Lost to Follow-up|2|||
130575929|NCT01415752|470072998|FG000|Induction (Step 1)|Ineligible|4|||
130575930|NCT01415752|470072999|FG001|Induction (Step 1)|Ineligible|3|||
130575931|NCT01415752|470073000|FG002|Induction (Step 1)|Ineligible|4|||
130575932|NCT01415752|470073001|FG003|Induction (Step 1)|Ineligible|4|||
130575933|NCT01415752|470072998|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
130575934|NCT01415752|470072999|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
130523019|NCT02719743|469883029|FG003|Overall Study|Migrated/moved from study area|0|||
130523020|NCT02719743|469883030|FG004|Overall Study|Migrated/moved from study area|2|||
130523021|NCT02719743|469883026|FG000|Overall Study|Lost to Follow-up|1|||
130523022|NCT02719743|469883027|FG001|Overall Study|Lost to Follow-up|1|||
130575935|NCT01415752|470073000|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
130575936|NCT01415752|470073001|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
130575937|NCT01415752|470072998|FG000|Maintenance (Step 2)|Adverse Event|3|||
130575938|NCT01415752|470072999|FG001|Maintenance (Step 2)|Adverse Event|4|||
130575939|NCT01415752|470073000|FG002|Maintenance (Step 2)|Adverse Event|9|||
130575940|NCT01415752|470073001|FG003|Maintenance (Step 2)|Adverse Event|6|||
130575941|NCT01415752|470072998|FG000|Maintenance (Step 2)|Death|1|||
130575942|NCT01415752|470072999|FG001|Maintenance (Step 2)|Death|1|||
130575943|NCT01415752|470073000|FG002|Maintenance (Step 2)|Death|2|||
130575944|NCT01415752|470073001|FG003|Maintenance (Step 2)|Death|0|||
130575945|NCT01415752|470072998|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
130575946|NCT01415752|470072999|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
130575947|NCT01415752|470073000|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
130575948|NCT01415752|470073001|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
130575949|NCT01415752|470072998|FG000|Maintenance (Step 2)|Alternative therapy|0|||
130575950|NCT01415752|470072999|FG001|Maintenance (Step 2)|Alternative therapy|1|||
130575951|NCT01415752|470073000|FG002|Maintenance (Step 2)|Alternative therapy|0|||
130575952|NCT01415752|470073001|FG003|Maintenance (Step 2)|Alternative therapy|0|||
130575953|NCT01415752|470072998|FG000|Maintenance (Step 2)|Other reasons|3|||
130575954|NCT01415752|470072999|FG001|Maintenance (Step 2)|Other reasons|6|||
130575955|NCT01415752|470073000|FG002|Maintenance (Step 2)|Other reasons|4|||
130575956|NCT01415752|470073001|FG003|Maintenance (Step 2)|Other reasons|6|||
130575957|NCT01415752|470072998|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
130575958|NCT01415752|470072999|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
130575959|NCT01415752|470073000|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
130575960|NCT01415752|470073001|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
130575961|NCT01415752|470072998|FG000|Maintenance (Step 2)|ineligible|1|||
130575962|NCT01415752|470072999|FG001|Maintenance (Step 2)|ineligible|1|||
130575963|NCT01415752|470073000|FG002|Maintenance (Step 2)|ineligible|1|||
130575964|NCT01415752|470073001|FG003|Maintenance (Step 2)|ineligible|0|||
130575965|NCT01415752|470072998|FG000|Maintenance (Step 2)|Missing|4|||
130575966|NCT01415752|470072999|FG001|Maintenance (Step 2)|Missing|1|||
130575967|NCT01415752|470073000|FG002|Maintenance (Step 2)|Missing|4|||
130575968|NCT01415752|470073001|FG003|Maintenance (Step 2)|Missing|3|||
130575969|NCT01441063|470073005|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
130575970|NCT01441063|470073005|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
130575971|NCT01926782|470073006|FG000|Overall Study|Participant moved|2|||
130575972|NCT01926782|470073007|FG001|Overall Study|Participant moved|0|||
130575973|NCT01926782|470073008|FG002|Overall Study|Participant moved|1|||
130575974|NCT01926782|470073009|FG003|Overall Study|Participant moved|1|||
130575975|NCT01926782|470073010|FG004|Overall Study|Participant moved|0|||
130575976|NCT01926782|470073011|FG005|Overall Study|Participant moved|3|||
130575977|NCT01926782|470073006|FG000|Overall Study|Physician Decision|0|||
130575978|NCT01926782|470073007|FG001|Overall Study|Physician Decision|2|||
130575979|NCT01926782|470073008|FG002|Overall Study|Physician Decision|1|||
130575980|NCT01926782|470073009|FG003|Overall Study|Physician Decision|1|||
130575981|NCT01926782|470073010|FG004|Overall Study|Physician Decision|0|||
130575982|NCT01926782|470073011|FG005|Overall Study|Physician Decision|0|||
130575983|NCT01926782|470073006|FG000|Overall Study|Other than specified|2|||
130575984|NCT01926782|470073007|FG001|Overall Study|Other than specified|3|||
130575985|NCT01926782|470073008|FG002|Overall Study|Other than specified|5|||
130575986|NCT01926782|470073009|FG003|Overall Study|Other than specified|12|||
130575987|NCT01926782|470073010|FG004|Overall Study|Other than specified|4|||
130575988|NCT01926782|470073011|FG005|Overall Study|Other than specified|11|||
130575989|NCT01926782|470073006|FG000|Overall Study|Adverse Event|13|||
130575990|NCT01926782|470073007|FG001|Overall Study|Adverse Event|4|||
130575991|NCT01926782|470073008|FG002|Overall Study|Adverse Event|17|||
130575992|NCT01926782|470073009|FG003|Overall Study|Adverse Event|4|||
130575993|NCT01926782|470073010|FG004|Overall Study|Adverse Event|3|||
130575994|NCT01926782|470073011|FG005|Overall Study|Adverse Event|14|||
130575995|NCT01926782|470073006|FG000|Overall Study|Poor compliance to protocol|5|||
130575996|NCT01926782|470073007|FG001|Overall Study|Poor compliance to protocol|3|||
130575997|NCT01926782|470073008|FG002|Overall Study|Poor compliance to protocol|8|||
130575998|NCT01926782|470073009|FG003|Overall Study|Poor compliance to protocol|0|||
130575999|NCT01926782|470073010|FG004|Overall Study|Poor compliance to protocol|1|||
130576000|NCT01926782|470073011|FG005|Overall Study|Poor compliance to protocol|6|||
130576001|NCT01926782|470073006|FG000|Overall Study|Randomized and not treated|0|||
130576002|NCT01926782|470073007|FG001|Overall Study|Randomized and not treated|0|||
130576003|NCT01926782|470073008|FG002|Overall Study|Randomized and not treated|0|||
130523023|NCT02719743|469883028|FG002|Overall Study|Lost to Follow-up|0|||
130523024|NCT02719743|469883029|FG003|Overall Study|Lost to Follow-up|0|||
130523025|NCT02719743|469883030|FG004|Overall Study|Lost to Follow-up|0|||
130523026|NCT01209598|469883031|FG000|Overall Study|Withdrawal by Subject|1|||
130523027|NCT01209598|469883032|FG001|Overall Study|Withdrawal by Subject|0|||
130523028|NCT02601209|469883033|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
130523029|NCT02601209|469883034|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
130523030|NCT02601209|469883035|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
130523031|NCT02601209|469883036|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523032|NCT02601209|469883037|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523033|NCT02601209|469883038|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523034|NCT02601209|469883039|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523035|NCT02601209|469883040|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523036|NCT02601209|469883041|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
130523037|NCT02601209|469883033|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523038|NCT02601209|469883034|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523039|NCT02601209|469883035|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523040|NCT02601209|469883036|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523041|NCT02601209|469883037|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
130523042|NCT02601209|469883038|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
130523043|NCT02601209|469883039|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
130523044|NCT02601209|469883040|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523045|NCT02601209|469883041|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
130523046|NCT02804399|469883044|FG000|Period 2|Adverse Event|0|||
130523047|NCT02804399|469883045|FG001|Period 2|Adverse Event|1|||
130523048|NCT03636373|469883046|FG000|Overall Study|Study closure due to Covid-19|1|||
130523049|NCT03636373|469883047|FG001|Overall Study|Study closure due to Covid-19|0|||
130523050|NCT00572533|469883048|FG000|Overall Study|Death|4|||
130523051|NCT00572533|469883049|FG001|Overall Study|Death|1|||
130523052|NCT00572533|469883048|FG000|Overall Study|Received Kidney Transplant|2|||
130523053|NCT00572533|469883049|FG001|Overall Study|Received Kidney Transplant|1|||
130523054|NCT00572533|469883048|FG000|Overall Study|Social Issues|1|||
130523055|NCT00572533|469883049|FG001|Overall Study|Social Issues|0|||
130523056|NCT00572533|469883048|FG000|Overall Study|Transfer out of Facility|0|||
130523057|NCT00572533|469883049|FG001|Overall Study|Transfer out of Facility|1|||
130523058|NCT05523219|469883050|FG000|Overall Study|Wrong inclusion|1|||
130523059|NCT05523219|469883050|FG000|Overall Study|Lost to Follow-up|7|||
130523060|NCT03772613|469883051|FG000|Overall Study|Lost to Follow-up|0|||
130523061|NCT03772613|469883052|FG001|Overall Study|Lost to Follow-up|1|||
130523062|NCT03772613|469883053|FG002|Overall Study|Lost to Follow-up|1|||
130523063|NCT01182207|469883054|FG000|First Intervention|Positive Hepatitis Results|0|||
130523064|NCT01182207|469883055|FG001|First Intervention|Positive Hepatitis Results|1|||
130523065|NCT01182207|469883054|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
130523066|NCT01182207|469883055|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
130523067|NCT01427738|469883056|FG000|Overall Study|Death|12|||
130523068|NCT01427738|469883057|FG001|Overall Study|Death|9|||
130523069|NCT01427738|469883056|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130523070|NCT01427738|469883057|FG001|Overall Study|Severe debilitation, unable to continue|1|||
130523071|NCT01427738|469883056|FG000|Overall Study|Subject unable to get to clinic|5|||
130523072|NCT01427738|469883057|FG001|Overall Study|Subject unable to get to clinic|2|||
130523073|NCT01427738|469883056|FG000|Overall Study|Withdrawal by Subject|0|||
130523074|NCT01427738|469883057|FG001|Overall Study|Withdrawal by Subject|2|||
130523075|NCT01427738|469883056|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
130523076|NCT01427738|469883057|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
130523077|NCT01427738|469883056|FG000|Overall Study|Lost to Follow-up|1|||
130523078|NCT01427738|469883057|FG001|Overall Study|Lost to Follow-up|5|||
130523079|NCT00661713|469883058|FG000|Overall Study|Death|1|||
130523080|NCT00661713|469883059|FG001|Overall Study|Death|0|||
130523081|NCT00661713|469883060|FG002|Overall Study|Death|0|||
130523082|NCT00661713|469883061|FG003|Overall Study|Death|0|||
130523083|NCT00661713|469883062|FG004|Overall Study|Death|1|||
130523084|NCT00661713|469883063|FG005|Overall Study|Death|0|||
130523085|NCT00661713|469883064|FG006|Overall Study|Death|0|||
130523086|NCT00661713|469883065|FG007|Overall Study|Death|0|||
130523087|NCT00661713|469883058|FG000|Overall Study|Unable to Classify|1|||
130523088|NCT00661713|469883059|FG001|Overall Study|Unable to Classify|0|||
130523089|NCT00661713|469883060|FG002|Overall Study|Unable to Classify|0|||
130523090|NCT00661713|469883061|FG003|Overall Study|Unable to Classify|0|||
130523091|NCT00661713|469883062|FG004|Overall Study|Unable to Classify|0|||
130523092|NCT00661713|469883063|FG005|Overall Study|Unable to Classify|0|||
130523093|NCT00661713|469883064|FG006|Overall Study|Unable to Classify|0|||
130576004|NCT01926782|470073009|FG003|Overall Study|Randomized and not treated|1|||
130576005|NCT01926782|470073010|FG004|Overall Study|Randomized and not treated|0|||
130576006|NCT01926782|470073011|FG005|Overall Study|Randomized and not treated|0|||
130576007|NCT01926782|470073006|FG000|Overall Study|Withdrawal by Subject|6|||
130576008|NCT01926782|470073007|FG001|Overall Study|Withdrawal by Subject|1|||
130576009|NCT01926782|470073008|FG002|Overall Study|Withdrawal by Subject|8|||
130576010|NCT01926782|470073009|FG003|Overall Study|Withdrawal by Subject|1|||
130576011|NCT01926782|470073010|FG004|Overall Study|Withdrawal by Subject|0|||
130576012|NCT01926782|470073011|FG005|Overall Study|Withdrawal by Subject|5|||
130576013|NCT01926782|470073006|FG000|Overall Study|Related to study drug administration|0|||
130576014|NCT01926782|470073007|FG001|Overall Study|Related to study drug administration|0|||
130576015|NCT01926782|470073008|FG002|Overall Study|Related to study drug administration|0|||
130576016|NCT01926782|470073009|FG003|Overall Study|Related to study drug administration|0|||
130576017|NCT01926782|470073010|FG004|Overall Study|Related to study drug administration|0|||
130576018|NCT01926782|470073011|FG005|Overall Study|Related to study drug administration|2|||
130576019|NCT04372927|470073014|FG000|Overall Study|Death|1|||
130576020|NCT00661271|470073015|FG000|Overall Study|Lost to Follow-up|28|||
130576021|NCT00661271|470073016|FG001|Overall Study|Lost to Follow-up|25|||
130576022|NCT00430508|470073018|FG000|Overall Study|Adverse Event|2|||
130576023|NCT00430508|470073019|FG001|Overall Study|Adverse Event|3|||
130576024|NCT00430508|470073020|FG002|Overall Study|Adverse Event|5|||
130576025|NCT00430508|470073021|FG003|Overall Study|Adverse Event|3|||
130576026|NCT00430508|470073018|FG000|Overall Study|Withdrawal by Subject|0|||
130576027|NCT00430508|470073019|FG001|Overall Study|Withdrawal by Subject|1|||
130576028|NCT00430508|470073020|FG002|Overall Study|Withdrawal by Subject|1|||
130576029|NCT00430508|470073021|FG003|Overall Study|Withdrawal by Subject|1|||
130576030|NCT00430508|470073018|FG000|Overall Study|responder at visit 4|0|||
130576031|NCT00430508|470073019|FG001|Overall Study|responder at visit 4|0|||
130576032|NCT00430508|470073020|FG002|Overall Study|responder at visit 4|2|||
130576033|NCT00430508|470073021|FG003|Overall Study|responder at visit 4|0|||
130576034|NCT00430508|470073018|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
130576035|NCT00430508|470073019|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
130576036|NCT00430508|470073020|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
130576037|NCT00430508|470073021|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
130576038|NCT00430508|470073018|FG000|Overall Study|Other|1|||
130576039|NCT00430508|470073019|FG001|Overall Study|Other|1|||
130576040|NCT00430508|470073020|FG002|Overall Study|Other|3|||
130576041|NCT00430508|470073021|FG003|Overall Study|Other|0|||
130576042|NCT01707693|470073026|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
130576043|NCT01707693|470073027|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
130576044|NCT01707693|470073026|FG000|Overall Study Allocation|Protocol Violation|4|||
130576045|NCT01707693|470073027|FG001|Overall Study Allocation|Protocol Violation|3|||
130576046|NCT01707693|470073026|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
130576047|NCT01707693|470073027|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
130576048|NCT01707693|470073026|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
130576049|NCT01707693|470073027|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
130576050|NCT04673786|470073029|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
130576051|NCT04673786|470073030|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
130576052|NCT04673786|470073031|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
130576053|NCT04673786|470073029|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
130576054|NCT04673786|470073030|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
130576055|NCT04673786|470073031|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
130576056|NCT04673786|470073029|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
130576057|NCT04673786|470073030|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
130576058|NCT04673786|470073031|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
130576059|NCT04673786|470073029|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
130576060|NCT04673786|470073030|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
130576061|NCT04673786|470073031|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
130576062|NCT04673786|470073029|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
130576063|NCT04673786|470073030|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
130576064|NCT04673786|470073031|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
130576065|NCT04673786|470073029|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
130576066|NCT04673786|470073030|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
130576067|NCT04673786|470073031|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
130576068|NCT01325428|470073032|FG000|Part A|Progressive disease according to RECIST|9|||
130576069|NCT01325428|470073032|FG000|Part A|Clinical signs, symptoms of progression|2|||
130576070|NCT01325428|470073032|FG000|Part A|Other adverse event|1|||
130576071|NCT01325428|470073032|FG000|Part A|Refused continue taking trial medication|2|||
130576072|NCT01325428|470073032|FG000|Part A|Other reason not defined above|2|||
130576073|NCT01325428|470073032|FG000|Part B|Refused continue taking trial medication|2|||
130576074|NCT01325428|470073032|FG000|Part B|Other reason not defined above|1|||
130576075|NCT00343889|470073046|FG000|Overall Study|Lost to Follow-up|2|||
130576076|NCT00343889|470073047|FG001|Overall Study|Lost to Follow-up|0|||
130576077|NCT00343889|470073046|FG000|Overall Study|Withdrawal by Subject|0|||
130576078|NCT00343889|470073047|FG001|Overall Study|Withdrawal by Subject|1|||
130576079|NCT00343889|470073046|FG000|Overall Study|Protocol Violation|1|||
130576080|NCT00343889|470073047|FG001|Overall Study|Protocol Violation|0|||
130576081|NCT01294579|470073050|FG000|Overall Study|Disease progression|12|||
130576082|NCT01294579|470073050|FG000|Overall Study|Adverse Event|11|||
130576083|NCT01294579|470073050|FG000|Overall Study|Study closed/terminated|3|||
130576084|NCT01294579|470073050|FG000|Overall Study|Lost to Follow-up|1|||
130576085|NCT01294579|470073050|FG000|Overall Study|Physician Decision|3|||
130576086|NCT01294579|470073050|FG000|Overall Study|Withdrawal by Subject|5|||
130576087|NCT02573155|470073051|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
130576088|NCT02573155|470073052|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
130576089|NCT02573155|470073051|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
130576090|NCT02573155|470073052|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
130576091|NCT02573155|470073051|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
130576092|NCT02573155|470073052|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
130576093|NCT02573155|470073051|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
130576094|NCT02573155|470073052|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
130576095|NCT02573155|470073051|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
130576096|NCT02573155|470073052|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
130576097|NCT02573155|470073051|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
130576098|NCT02573155|470073052|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
130576099|NCT02573155|470073051|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
130576100|NCT02573155|470073052|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
130576101|NCT02573155|470073051|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
130576102|NCT02573155|470073052|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
130576103|NCT00903929|470073053|FG000|Overall Study|Withdrawal by Subject|0|||
130576104|NCT00903929|470073054|FG001|Overall Study|Withdrawal by Subject|0|||
130576105|NCT00903929|470073055|FG002|Overall Study|Withdrawal by Subject|1|||
130576106|NCT00903929|470073056|FG003|Overall Study|Withdrawal by Subject|2|||
130576107|NCT00903929|470073053|FG000|Overall Study|Adverse Event|0|||
130576108|NCT00903929|470073054|FG001|Overall Study|Adverse Event|0|||
130576109|NCT00903929|470073055|FG002|Overall Study|Adverse Event|0|||
130576110|NCT00903929|470073056|FG003|Overall Study|Adverse Event|1|||
130576111|NCT00516737|470073062|FG000|Overall Study|Lost to Follow-up|2|||
130576112|NCT00516737|470073063|FG001|Overall Study|Lost to Follow-up|0|||
130576113|NCT00516737|470073062|FG000|Overall Study|Physician Decision|0|||
130523094|NCT00661713|469883065|FG007|Overall Study|Unable to Classify|0|||
130523095|NCT00661713|469883058|FG000|Overall Study|Protocol Violation|1|||
130523096|NCT00661713|469883059|FG001|Overall Study|Protocol Violation|6|||
130523097|NCT00661713|469883060|FG002|Overall Study|Protocol Violation|3|||
130523098|NCT00661713|469883061|FG003|Overall Study|Protocol Violation|3|||
130523099|NCT00661713|469883062|FG004|Overall Study|Protocol Violation|0|||
130523100|NCT00661713|469883063|FG005|Overall Study|Protocol Violation|2|||
130523101|NCT00661713|469883064|FG006|Overall Study|Protocol Violation|2|||
130523102|NCT00661713|469883065|FG007|Overall Study|Protocol Violation|1|||
130523103|NCT00661713|469883058|FG000|Overall Study|Withdrawal by Subject|11|||
130523104|NCT00661713|469883059|FG001|Overall Study|Withdrawal by Subject|25|||
130523105|NCT00661713|469883060|FG002|Overall Study|Withdrawal by Subject|12|||
130523106|NCT00661713|469883061|FG003|Overall Study|Withdrawal by Subject|21|||
130523107|NCT00661713|469883062|FG004|Overall Study|Withdrawal by Subject|12|||
130523108|NCT00661713|469883063|FG005|Overall Study|Withdrawal by Subject|26|||
130523109|NCT00661713|469883064|FG006|Overall Study|Withdrawal by Subject|45|||
130523110|NCT00661713|469883065|FG007|Overall Study|Withdrawal by Subject|9|||
130523111|NCT00661713|469883058|FG000|Overall Study|Lost to Follow-up|2|||
130523112|NCT00661713|469883059|FG001|Overall Study|Lost to Follow-up|7|||
130523113|NCT00661713|469883060|FG002|Overall Study|Lost to Follow-up|2|||
130523114|NCT00661713|469883061|FG003|Overall Study|Lost to Follow-up|2|||
130523115|NCT00661713|469883062|FG004|Overall Study|Lost to Follow-up|5|||
130523116|NCT00661713|469883063|FG005|Overall Study|Lost to Follow-up|7|||
130576114|NCT00516737|470073063|FG001|Overall Study|Physician Decision|1|||
130576115|NCT00516737|470073062|FG000|Overall Study|Withdrawal by Subject|0|||
130576116|NCT00516737|470073063|FG001|Overall Study|Withdrawal by Subject|1|||
130523117|NCT00661713|469883064|FG006|Overall Study|Lost to Follow-up|14|||
130523118|NCT00661713|469883065|FG007|Overall Study|Lost to Follow-up|1|||
130523119|NCT00661713|469883058|FG000|Overall Study|Administrative Reason|0|||
130576117|NCT00516737|470073062|FG000|Overall Study|Lack of Qualifying Event|9|||
130523120|NCT00661713|469883059|FG001|Overall Study|Administrative Reason|1|||
130523121|NCT00661713|469883060|FG002|Overall Study|Administrative Reason|0|||
130523122|NCT00661713|469883061|FG003|Overall Study|Administrative Reason|2|||
130523123|NCT00661713|469883062|FG004|Overall Study|Administrative Reason|2|||
130523124|NCT00661713|469883063|FG005|Overall Study|Administrative Reason|2|||
130523125|NCT00661713|469883064|FG006|Overall Study|Administrative Reason|1|||
130523126|NCT00661713|469883065|FG007|Overall Study|Administrative Reason|0|||
130523127|NCT00661713|469883058|FG000|Overall Study|Adverse Event|0|||
130523128|NCT00661713|469883059|FG001|Overall Study|Adverse Event|0|||
130523129|NCT00661713|469883060|FG002|Overall Study|Adverse Event|0|||
130523130|NCT00661713|469883061|FG003|Overall Study|Adverse Event|0|||
130523131|NCT00661713|469883062|FG004|Overall Study|Adverse Event|0|||
130523132|NCT00661713|469883063|FG005|Overall Study|Adverse Event|0|||
130523133|NCT00661713|469883064|FG006|Overall Study|Adverse Event|1|||
130523134|NCT00661713|469883065|FG007|Overall Study|Adverse Event|0|||
130523135|NCT00661713|469883058|FG000|Overall Study|Inappropriate Enrollment|0|||
130523136|NCT00661713|469883059|FG001|Overall Study|Inappropriate Enrollment|0|||
130523137|NCT00661713|469883060|FG002|Overall Study|Inappropriate Enrollment|0|||
130523138|NCT00661713|469883061|FG003|Overall Study|Inappropriate Enrollment|0|||
130523139|NCT00661713|469883062|FG004|Overall Study|Inappropriate Enrollment|0|||
130523140|NCT00661713|469883063|FG005|Overall Study|Inappropriate Enrollment|0|||
130523141|NCT00661713|469883064|FG006|Overall Study|Inappropriate Enrollment|1|||
130523142|NCT00661713|469883065|FG007|Overall Study|Inappropriate Enrollment|0|||
130523143|NCT02658175|469883066|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
130523144|NCT02658175|469883067|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
130523145|NCT02658175|469883068|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
130523146|NCT02658175|469883066|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
130523147|NCT02658175|469883067|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
130523148|NCT02658175|469883068|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
130523149|NCT02658175|469883066|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
130523150|NCT02658175|469883067|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
130523151|NCT02658175|469883068|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
130523152|NCT02658175|469883066|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
130523153|NCT02658175|469883067|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
130523154|NCT02658175|469883068|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
130523155|NCT02658175|469883066|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
130523156|NCT02658175|469883067|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
130523157|NCT02658175|469883068|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
130523158|NCT02658175|469883066|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
130523159|NCT02658175|469883067|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
130523160|NCT02658175|469883068|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
130523161|NCT02658175|469883066|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
130523162|NCT02658175|469883067|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
130523163|NCT02658175|469883068|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
130523164|NCT02658175|469883066|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
130523165|NCT02658175|469883067|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
130523166|NCT02658175|469883068|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
130523167|NCT02658175|469883066|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
130523168|NCT02658175|469883067|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
130523169|NCT02658175|469883068|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
130523170|NCT02658175|469883066|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
130523171|NCT02658175|469883067|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
130523172|NCT02658175|469883068|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
130523173|NCT02037256|469883074|FG000|Overall Study|Protocol Violation|0|||
130523174|NCT02037256|469883075|FG001|Overall Study|Protocol Violation|1|||
130523175|NCT02037256|469883074|FG000|Overall Study|Withdrawn prior to Velcade|0|||
130523176|NCT02037256|469883075|FG001|Overall Study|Withdrawn prior to Velcade|2|||
130523177|NCT03614676|469884567|FG000|Overall Study|Delivery before planned visit|2|||
130523178|NCT03614676|469884568|FG001|Overall Study|Delivery before planned visit|0|||
130523179|NCT03614676|469884567|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
130523180|NCT03614676|469884568|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
130523181|NCT03614676|469884567|FG000|Overall Study|Migrated / moved from the study area|30|||
130523182|NCT03614676|469884568|FG001|Overall Study|Migrated / moved from the study area|22|||
130523183|NCT03614676|469884567|FG000|Overall Study|Lost to Follow-up|17|||
130523184|NCT03614676|469884568|FG001|Overall Study|Lost to Follow-up|42|||
130523185|NCT03614676|469884567|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
130523186|NCT03614676|469884568|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
130523187|NCT03614676|469884567|FG000|Overall Study|Other|16|||
130576118|NCT00516737|470073063|FG001|Overall Study|Lack of Qualifying Event|6|||
130576119|NCT00512798|470073064|FG000|Overall Study|Death|0|||
130576120|NCT00512798|470073065|FG001|Overall Study|Death|3|||
130576121|NCT00512798|470073064|FG000|Overall Study|Adverse Event|2|||
130576122|NCT00512798|470073065|FG001|Overall Study|Adverse Event|4|||
130576123|NCT00512798|470073064|FG000|Overall Study|Progression of disease|14|||
130576124|NCT00512798|470073065|FG001|Overall Study|Progression of disease|20|||
130576125|NCT00512798|470073064|FG000|Overall Study|Withdrawal by Subject|3|||
130576126|NCT00512798|470073065|FG001|Overall Study|Withdrawal by Subject|0|||
130576127|NCT00454805|470073069|FG000|Overall Study|Withdrawal by Subject|9|||
130576128|NCT00454805|470073070|FG001|Overall Study|Withdrawal by Subject|2|||
130576129|NCT00454805|470073069|FG000|Overall Study|Death|0|||
130576130|NCT00454805|470073070|FG001|Overall Study|Death|2|||
130576131|NCT00454805|470073069|FG000|Overall Study|Disease progression|16|||
130576132|NCT00454805|470073070|FG001|Overall Study|Disease progression|19|||
130576133|NCT00454805|470073069|FG000|Overall Study|In order to begin radiotherapy|1|||
130576134|NCT00454805|470073070|FG001|Overall Study|In order to begin radiotherapy|0|||
130576135|NCT01358864|470073088|FG000|Overall Study|Adverse Event|0|||
130576136|NCT01358864|470073089|FG001|Overall Study|Adverse Event|6|||
130576137|NCT01358864|470073090|FG002|Overall Study|Adverse Event|9|||
130576138|NCT01358864|470073091|FG003|Overall Study|Adverse Event|0|||
130576139|NCT01358864|470073092|FG004|Overall Study|Adverse Event|4|||
130576140|NCT01358864|470073093|FG005|Overall Study|Adverse Event|8|||
130576141|NCT01358864|470073094|FG006|Overall Study|Adverse Event|12|||
130576142|NCT01358864|470073095|FG007|Overall Study|Adverse Event|7|||
130576143|NCT01358864|470073088|FG000|Overall Study|Lack of Efficacy|26|||
130576144|NCT01358864|470073089|FG001|Overall Study|Lack of Efficacy|3|||
130576145|NCT01358864|470073090|FG002|Overall Study|Lack of Efficacy|4|||
130576146|NCT01358864|470073091|FG003|Overall Study|Lack of Efficacy|19|||
130576147|NCT01358864|470073092|FG004|Overall Study|Lack of Efficacy|7|||
130576148|NCT01358864|470073093|FG005|Overall Study|Lack of Efficacy|4|||
130576149|NCT01358864|470073094|FG006|Overall Study|Lack of Efficacy|49|||
130576150|NCT01358864|470073095|FG007|Overall Study|Lack of Efficacy|44|||
130576151|NCT01358864|470073088|FG000|Overall Study|Lost to Follow-up|0|||
130576152|NCT01358864|470073089|FG001|Overall Study|Lost to Follow-up|0|||
130576153|NCT01358864|470073090|FG002|Overall Study|Lost to Follow-up|1|||
130576154|NCT01358864|470073091|FG003|Overall Study|Lost to Follow-up|0|||
130576155|NCT01358864|470073092|FG004|Overall Study|Lost to Follow-up|0|||
130576156|NCT01358864|470073093|FG005|Overall Study|Lost to Follow-up|0|||
130576157|NCT01358864|470073094|FG006|Overall Study|Lost to Follow-up|0|||
130523188|NCT03614676|469884568|FG001|Overall Study|Other|47|||
130523189|NCT03614676|469884567|FG000|Overall Study|Protocol Violation|0|||
130523190|NCT03614676|469884568|FG001|Overall Study|Protocol Violation|2|||
130523191|NCT03614676|469884567|FG000|Overall Study|Neonatal event of interest|0|||
130523192|NCT03614676|469884568|FG001|Overall Study|Neonatal event of interest|6|||
130523193|NCT03614676|469884567|FG000|Overall Study|Death in infant greater than 28 days old|0|||
130523194|NCT03614676|469884568|FG001|Overall Study|Death in infant greater than 28 days old|12|||
130523195|NCT03614676|469884567|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
130523196|NCT03614676|469884568|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
130523197|NCT02166476|469884578|FG000|Overall Study|Withdrawal by Subject|5|||
130523198|NCT02166476|469884579|FG001|Overall Study|Withdrawal by Subject|7|||
130523199|NCT02166476|469884578|FG000|Overall Study|Adverse Event|3|||
130523200|NCT02166476|469884579|FG001|Overall Study|Adverse Event|3|||
130523201|NCT02166476|469884578|FG000|Overall Study|Lost to Follow-up|5|||
130523202|NCT02166476|469884579|FG001|Overall Study|Lost to Follow-up|10|||
130523203|NCT02166476|469884578|FG000|Overall Study|Physician Decision|1|||
130523204|NCT02166476|469884579|FG001|Overall Study|Physician Decision|0|||
130523205|NCT02166476|469884578|FG000|Overall Study|Unable to Come for Visit|0|||
130523206|NCT02166476|469884579|FG001|Overall Study|Unable to Come for Visit|3|||
130523207|NCT02053610|469884584|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
130523208|NCT02053610|469884585|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
130523209|NCT02053610|469884584|FG000|Overall Study|Withdrew Consent|2|||
130523210|NCT02053610|469884585|FG001|Overall Study|Withdrew Consent|9|||
130523211|NCT02053610|469884584|FG000|Overall Study|Death|5|||
130523212|NCT02053610|469884585|FG001|Overall Study|Death|5|||
130523213|NCT02053610|469884584|FG000|Overall Study|Administrative/Other|1|||
130576158|NCT01358864|470073095|FG007|Overall Study|Lost to Follow-up|1|||
130576159|NCT01358864|470073088|FG000|Overall Study|Withdrawal by Subject|3|||
130576160|NCT01358864|470073089|FG001|Overall Study|Withdrawal by Subject|4|||
130576161|NCT01358864|470073090|FG002|Overall Study|Withdrawal by Subject|2|||
130576162|NCT01358864|470073091|FG003|Overall Study|Withdrawal by Subject|0|||
130576163|NCT01358864|470073092|FG004|Overall Study|Withdrawal by Subject|0|||
130576164|NCT01358864|470073093|FG005|Overall Study|Withdrawal by Subject|1|||
130576165|NCT01358864|470073094|FG006|Overall Study|Withdrawal by Subject|1|||
130576166|NCT01358864|470073095|FG007|Overall Study|Withdrawal by Subject|3|||
130523214|NCT02053610|469884585|FG001|Overall Study|Administrative/Other|1|||
130523215|NCT02053610|469884584|FG000|Overall Study|Disease Progression|2|||
130523216|NCT02053610|469884585|FG001|Overall Study|Disease Progression|3|||
130523217|NCT02053610|469884584|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
130523218|NCT02053610|469884585|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
130523219|NCT02053610|469884584|FG000|Overall Study|Did not Receive Treatment|4|||
130523220|NCT02053610|469884585|FG001|Overall Study|Did not Receive Treatment|2|||
130523221|NCT02053610|469884584|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130523222|NCT02053610|469884585|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130523223|NCT02053610|469884584|FG000|Overall Study|Violation of Selection Criteria|1|||
130523224|NCT02053610|469884585|FG001|Overall Study|Violation of Selection Criteria|0|||
130523225|NCT00543062|469884591|FG000|Overall Study|Withdrawal by Subject|1|||
130523226|NCT00543062|469884592|FG001|Overall Study|Withdrawal by Subject|0|||
130523227|NCT00543062|469884593|FG002|Overall Study|Withdrawal by Subject|2|||
130523228|NCT00543062|469884594|FG003|Overall Study|Withdrawal by Subject|0|||
130523229|NCT00543062|469884591|FG000|Overall Study|Adverse Event|0|||
130523230|NCT00543062|469884592|FG001|Overall Study|Adverse Event|1|||
130523231|NCT00543062|469884593|FG002|Overall Study|Adverse Event|1|||
130523232|NCT00543062|469884594|FG003|Overall Study|Adverse Event|1|||
130523233|NCT00543062|469884591|FG000|Overall Study|Protocol Violation|1|||
130523234|NCT00543062|469884592|FG001|Overall Study|Protocol Violation|0|||
130523235|NCT00543062|469884593|FG002|Overall Study|Protocol Violation|0|||
130523236|NCT00543062|469884594|FG003|Overall Study|Protocol Violation|0|||
130523237|NCT01513330|469884595|FG000|SenSura Mio First,|Adverse Event|2|||
130523238|NCT01513330|469884596|FG001|SenSura Mio First,|Adverse Event|0|||
130523239|NCT01513330|469884595|FG000|SenSura Mio First,|Lack of Efficacy|0|||
130523240|NCT01513330|469884596|FG001|SenSura Mio First,|Lack of Efficacy|1|||
130523241|NCT01513330|469884595|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
130523242|NCT01513330|469884596|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
130523243|NCT01513330|469884595|FG000|SenSura Mio First,|Other|1|||
130523244|NCT01513330|469884596|FG001|SenSura Mio First,|Other|0|||
130523245|NCT01513330|469884595|FG000|Standard Care First,|Lack of Efficacy|2|||
130523246|NCT01513330|469884596|FG001|Standard Care First,|Lack of Efficacy|2|||
130523247|NCT01513330|469884595|FG000|Standard Care First,|Withdrawal by Subject|1|||
130523248|NCT01513330|469884596|FG001|Standard Care First,|Withdrawal by Subject|2|||
130523249|NCT01513330|469884595|FG000|Standard Care First,|Other|1|||
130523250|NCT01513330|469884596|FG001|Standard Care First,|Other|0|||
130523251|NCT02232399|469884601|FG000|Overall Study|Adverse Event|1|||
130523252|NCT02232399|469884602|FG001|Overall Study|Adverse Event|0|||
130523253|NCT02232399|469884601|FG000|Overall Study|Withdrawal by Subject|0|||
130523254|NCT02232399|469884602|FG001|Overall Study|Withdrawal by Subject|1|||
130523255|NCT01777334|469884603|FG000|Overall Study|Adverse Event|18|||
130523256|NCT01777334|469884604|FG001|Overall Study|Adverse Event|14|||
130523257|NCT01777334|469884603|FG000|Overall Study|Lack of Efficacy|15|||
130523258|NCT01777334|469884604|FG001|Overall Study|Lack of Efficacy|29|||
130523259|NCT01777334|469884603|FG000|Overall Study|Protocol Violation|3|||
130523260|NCT01777334|469884604|FG001|Overall Study|Protocol Violation|7|||
130523261|NCT01777334|469884603|FG000|Overall Study|Lost to Follow-up|3|||
130523262|NCT01777334|469884604|FG001|Overall Study|Lost to Follow-up|2|||
130523263|NCT01777334|469884603|FG000|Overall Study|Withdrawal by Subject|14|||
130523264|NCT01777334|469884604|FG001|Overall Study|Withdrawal by Subject|11|||
130523265|NCT00763451|469884610|FG000|Overall Study|Adverse Event|4|||
130523266|NCT00763451|469884611|FG001|Overall Study|Adverse Event|6|||
130523267|NCT00763451|469884612|FG002|Overall Study|Adverse Event|19|||
130523268|NCT00763451|469884613|FG003|Overall Study|Adverse Event|14|||
130523269|NCT00763451|469884610|FG000|Overall Study|Lack of Efficacy|1|||
130523270|NCT00763451|469884611|FG001|Overall Study|Lack of Efficacy|4|||
130523271|NCT00763451|469884612|FG002|Overall Study|Lack of Efficacy|3|||
130523272|NCT00763451|469884613|FG003|Overall Study|Lack of Efficacy|2|||
130523273|NCT00763451|469884610|FG000|Overall Study|Withdrawal by Subject|1|||
130523274|NCT00763451|469884611|FG001|Overall Study|Withdrawal by Subject|6|||
130523275|NCT00763451|469884612|FG002|Overall Study|Withdrawal by Subject|9|||
130523276|NCT00763451|469884613|FG003|Overall Study|Withdrawal by Subject|7|||
130523277|NCT00763451|469884610|FG000|Overall Study|Protocol Violation|0|||
130523278|NCT00763451|469884611|FG001|Overall Study|Protocol Violation|0|||
130523279|NCT00763451|469884612|FG002|Overall Study|Protocol Violation|1|||
130576167|NCT01358864|470073088|FG000|Overall Study|Other reason not defined above|2|||
130523280|NCT00763451|469884613|FG003|Overall Study|Protocol Violation|0|||
130523281|NCT00763451|469884610|FG000|Overall Study|Poor Compliance to Protocol|1|||
130576168|NCT01358864|470073089|FG001|Overall Study|Other reason not defined above|0|||
130576169|NCT01358864|470073090|FG002|Overall Study|Other reason not defined above|0|||
130523282|NCT00763451|469884611|FG001|Overall Study|Poor Compliance to Protocol|1|||
130523283|NCT00763451|469884612|FG002|Overall Study|Poor Compliance to Protocol|2|||
130523284|NCT00763451|469884613|FG003|Overall Study|Poor Compliance to Protocol|2|||
130523285|NCT00763451|469884610|FG000|Overall Study|Familial and Personal Reasons|5|||
130523286|NCT00763451|469884611|FG001|Overall Study|Familial and Personal Reasons|3|||
130576170|NCT01358864|470073091|FG003|Overall Study|Other reason not defined above|0|||
130576171|NCT01358864|470073092|FG004|Overall Study|Other reason not defined above|0|||
130576172|NCT01358864|470073093|FG005|Overall Study|Other reason not defined above|0|||
130576173|NCT01358864|470073094|FG006|Overall Study|Other reason not defined above|2|||
130576174|NCT01358864|470073095|FG007|Overall Study|Other reason not defined above|0|||
130576175|NCT01358864|470073088|FG000|Overall Study|Not treated|0|||
130576176|NCT01358864|470073089|FG001|Overall Study|Not treated|0|||
130576177|NCT01358864|470073090|FG002|Overall Study|Not treated|0|||
130576178|NCT01358864|470073091|FG003|Overall Study|Not treated|0|||
130576179|NCT01358864|470073092|FG004|Overall Study|Not treated|0|||
130576180|NCT01358864|470073093|FG005|Overall Study|Not treated|0|||
130576181|NCT01358864|470073094|FG006|Overall Study|Not treated|1|||
130576182|NCT01358864|470073095|FG007|Overall Study|Not treated|0|||
130576183|NCT01489527|470073102|FG000|Overall Study|Pregnancy|9|||
130576184|NCT01489527|470073103|FG001|Overall Study|Pregnancy|14|||
130576185|NCT01489527|470073102|FG000|Overall Study|Participant moved|6|||
130576186|NCT01489527|470073103|FG001|Overall Study|Participant moved|7|||
130576187|NCT01489527|470073102|FG000|Overall Study|Withdrawal by Subject|0|||
130576188|NCT01489527|470073103|FG001|Overall Study|Withdrawal by Subject|4|||
130576189|NCT01489527|470073102|FG000|Overall Study|Lost to Follow-up|5|||
130576190|NCT01489527|470073103|FG001|Overall Study|Lost to Follow-up|1|||
130576191|NCT01489527|470073102|FG000|Overall Study|Procedures|1|||
130576192|NCT01489527|470073103|FG001|Overall Study|Procedures|0|||
130576193|NCT01489527|470073102|FG000|Overall Study|Not compliant|1|||
130576194|NCT01489527|470073103|FG001|Overall Study|Not compliant|0|||
130576195|NCT01984268|470073104|FG000|Overall Study|Study Terminated|15|||
130576196|NCT01344876|470073106|FG000|Overall Study|Adverse Event|0|||
130576197|NCT01344876|470073107|FG001|Overall Study|Adverse Event|0|||
130576198|NCT01344876|470073108|FG002|Overall Study|Adverse Event|0|||
130576199|NCT01344876|470073109|FG003|Overall Study|Adverse Event|0|||
130576200|NCT01344876|470073110|FG004|Overall Study|Adverse Event|1|||
130576201|NCT01344876|470073106|FG000|Overall Study|Withdrawal by Subject|0|||
130576202|NCT01344876|470073107|FG001|Overall Study|Withdrawal by Subject|0|||
130576203|NCT01344876|470073108|FG002|Overall Study|Withdrawal by Subject|1|||
130576204|NCT01344876|470073109|FG003|Overall Study|Withdrawal by Subject|0|||
130576205|NCT01344876|470073110|FG004|Overall Study|Withdrawal by Subject|0|||
130576206|NCT01344876|470073106|FG000|Overall Study|Definite progression of primary disease|1|||
130576207|NCT01344876|470073107|FG001|Overall Study|Definite progression of primary disease|0|||
130576208|NCT01344876|470073108|FG002|Overall Study|Definite progression of primary disease|0|||
130576209|NCT01344876|470073109|FG003|Overall Study|Definite progression of primary disease|3|||
130576210|NCT01344876|470073110|FG004|Overall Study|Definite progression of primary disease|0|||
130576211|NCT02926950|470073111|FG000|Overall Study|Adverse Event|4|||
130576212|NCT02926950|470073112|FG001|Overall Study|Adverse Event|6|||
130576213|NCT02926950|470073111|FG000|Overall Study|At the participant's own request|21|||
130576214|NCT02926950|470073112|FG001|Overall Study|At the participant's own request|25|||
130576215|NCT02926950|470073111|FG000|Overall Study|Reason not Specified|17|||
130576216|NCT02926950|470073112|FG001|Overall Study|Reason not Specified|9|||
130576217|NCT02926950|470073111|FG000|Overall Study|Lost to Follow-up|7|||
130576218|NCT02926950|470073112|FG001|Overall Study|Lost to Follow-up|8|||
130576219|NCT00049673|470074817|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
130576220|NCT00049673|470074818|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
130576221|NCT02475681|470074819|FG000|Overall Study|Death|16|||
130576222|NCT02475681|470074820|FG001|Overall Study|Death|6|||
130576223|NCT02475681|470074821|FG002|Overall Study|Death|9|||
130576224|NCT02475681|470074819|FG000|Overall Study|Physician Decision|0|||
130576225|NCT02475681|470074820|FG001|Overall Study|Physician Decision|3|||
130576226|NCT02475681|470074821|FG002|Overall Study|Physician Decision|1|||
130576227|NCT02475681|470074819|FG000|Overall Study|Withdrawal by Subject|12|||
130576228|NCT02475681|470074820|FG001|Overall Study|Withdrawal by Subject|6|||
130576229|NCT02475681|470074821|FG002|Overall Study|Withdrawal by Subject|9|||
130576230|NCT02475681|470074819|FG000|Overall Study|Lost to Follow-up|2|||
130576231|NCT02475681|470074820|FG001|Overall Study|Lost to Follow-up|1|||
130576232|NCT02475681|470074821|FG002|Overall Study|Lost to Follow-up|3|||
130576233|NCT02475681|470074819|FG000|Overall Study|Ongoing in Study|0|||
130576234|NCT02475681|470074820|FG001|Overall Study|Ongoing in Study|163|||
130576235|NCT02475681|470074821|FG002|Overall Study|Ongoing in Study|157|||
130576236|NCT02475681|470074819|FG000|Overall Study|Reasons other than above listed|2|||
130576237|NCT02475681|470074820|FG001|Overall Study|Reasons other than above listed|0|||
130576238|NCT02475681|470074821|FG002|Overall Study|Reasons other than above listed|0|||
130576239|NCT01262365|470074824|FG000|Overall Study|Lack of Efficacy|35|||
130576240|NCT01262365|470074825|FG001|Overall Study|Lack of Efficacy|30|||
130576241|NCT01262365|470074826|FG002|Overall Study|Lack of Efficacy|47|||
130576242|NCT01262365|470074824|FG000|Overall Study|Protocol Violation|3|||
130576243|NCT01262365|470074825|FG001|Overall Study|Protocol Violation|1|||
130576244|NCT01262365|470074826|FG002|Overall Study|Protocol Violation|1|||
130576245|NCT01262365|470074824|FG000|Overall Study|Lost to Follow-up|3|||
130576246|NCT01262365|470074825|FG001|Overall Study|Lost to Follow-up|7|||
130576247|NCT01262365|470074826|FG002|Overall Study|Lost to Follow-up|6|||
130523287|NCT00763451|469884612|FG002|Overall Study|Familial and Personal Reasons|5|||
130523288|NCT00763451|469884613|FG003|Overall Study|Familial and Personal Reasons|4|||
130523289|NCT00763451|469884610|FG000|Overall Study|Randomized but not Treated|1|||
130523290|NCT00763451|469884611|FG001|Overall Study|Randomized but not Treated|1|||
130523291|NCT00763451|469884612|FG002|Overall Study|Randomized but not Treated|0|||
130523292|NCT00763451|469884613|FG003|Overall Study|Randomized but not Treated|0|||
130523293|NCT00763451|469884610|FG000|Overall Study|Study Site Reason|0|||
130523294|NCT00763451|469884611|FG001|Overall Study|Study Site Reason|1|||
130523295|NCT00763451|469884612|FG002|Overall Study|Study Site Reason|1|||
130523296|NCT00763451|469884613|FG003|Overall Study|Study Site Reason|1|||
130523297|NCT00725543|469884617|FG000|Overall Study|Adverse Event|10|||
130523298|NCT00725543|469884617|FG000|Overall Study|Lack of Efficacy|3|||
130523299|NCT00725543|469884617|FG000|Overall Study|Withdrawal by Subject|10|||
130523300|NCT00725543|469884617|FG000|Overall Study|Physician Decision|5|||
130523301|NCT00725543|469884617|FG000|Overall Study|Lost to Follow-up|4|||
130523302|NCT00725543|469884617|FG000|Overall Study|Non-compliance|2|||
130523303|NCT00725543|469884617|FG000|Overall Study|Other|119|||
130523304|NCT05594589|469884618|FG000|Overall Study|Other|0|||
130523305|NCT05594589|469884619|FG001|Overall Study|Other|1|||
130523306|NCT05594589|469884620|FG002|Overall Study|Other|0|||
130523307|NCT02168478|469884627|FG000|Overall Study|Withdrawal by Subject|1|||
130523308|NCT02168478|469884627|FG000|Overall Study|Did Not Consent to Participation|2|||
130523309|NCT02168478|469884627|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
130523310|NCT00087555|469884628|FG000|Overall Study|Adverse Event|3|||
130523311|NCT00087555|469884629|FG001|Overall Study|Adverse Event|6|||
130523312|NCT00087555|469884630|FG002|Overall Study|Adverse Event|14|||
130523313|NCT00087555|469884628|FG000|Overall Study|Lost to Follow-up|0|||
130523314|NCT00087555|469884629|FG001|Overall Study|Lost to Follow-up|1|||
130523315|NCT00087555|469884630|FG002|Overall Study|Lost to Follow-up|1|||
130523316|NCT00087555|469884628|FG000|Overall Study|Non - Compliance|1|||
130523317|NCT00087555|469884629|FG001|Overall Study|Non - Compliance|0|||
130523318|NCT00087555|469884630|FG002|Overall Study|Non - Compliance|0|||
130523319|NCT00087555|469884628|FG000|Overall Study|Protocol Violation|0|||
130523320|NCT00087555|469884629|FG001|Overall Study|Protocol Violation|0|||
130523321|NCT00087555|469884630|FG002|Overall Study|Protocol Violation|2|||
130523322|NCT00087555|469884628|FG000|Overall Study|Screen Failure|1|||
130523323|NCT00087555|469884629|FG001|Overall Study|Screen Failure|1|||
130523324|NCT00087555|469884630|FG002|Overall Study|Screen Failure|0|||
130523325|NCT00087555|469884628|FG000|Overall Study|Pregnancy|0|||
130523326|NCT00087555|469884629|FG001|Overall Study|Pregnancy|1|||
130523327|NCT00087555|469884630|FG002|Overall Study|Pregnancy|1|||
130523328|NCT00087555|469884628|FG000|Overall Study|Withdrawal by Subject|3|||
130523329|NCT00087555|469884629|FG001|Overall Study|Withdrawal by Subject|2|||
130523330|NCT00087555|469884630|FG002|Overall Study|Withdrawal by Subject|1|||
130523331|NCT00087555|469884628|FG000|Overall Study|Lack of Efficacy|2|||
130523332|NCT00087555|469884629|FG001|Overall Study|Lack of Efficacy|0|||
130523333|NCT00087555|469884630|FG002|Overall Study|Lack of Efficacy|1|||
130523334|NCT00087555|469884628|FG000|Overall Study|Non Compliance|0|||
130523335|NCT00087555|469884629|FG001|Overall Study|Non Compliance|0|||
130523336|NCT00087555|469884630|FG002|Overall Study|Non Compliance|1|||
130523337|NCT00087555|469884628|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
130523338|NCT00087555|469884629|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
130523339|NCT00087555|469884630|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
130523340|NCT00087555|469884628|FG000|Overall Study|Patient wanted to go back on Med|1|||
130523341|NCT00087555|469884629|FG001|Overall Study|Patient wanted to go back on Med|0|||
130523342|NCT00087555|469884630|FG002|Overall Study|Patient wanted to go back on Med|0|||
130523343|NCT02344173|469884639|FG000|Procedure|Ablation Procedure Not Performed|7|||
130523344|NCT02344173|469884639|FG000|12-month Visit|Death|8|||
130523345|NCT02344173|469884639|FG000|12-month Visit|Withdrawal by Subject|30|||
130523346|NCT02344173|469884639|FG000|12-month Visit|Lost to Follow-up|58|||
130523347|NCT03845023|469884640|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
130523348|NCT03845023|469884641|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
130523349|NCT03845023|469884642|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
130523350|NCT03845023|469884643|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
130523351|NCT03845023|469884640|FG000|Follow-Up (14 Days)|Adverse Event|0|||
130523352|NCT03845023|469884641|FG001|Follow-Up (14 Days)|Adverse Event|0|||
130523353|NCT03845023|469884642|FG002|Follow-Up (14 Days)|Adverse Event|1|||
130523354|NCT03845023|469884643|FG003|Follow-Up (14 Days)|Adverse Event|1|||
130523355|NCT05314374|469884644|FG000|Overall Study|Adverse Event|2|||
130523356|NCT05314374|469884645|FG001|Overall Study|Adverse Event|2|||
130523357|NCT02554383|469884646|FG000|Overall Study|Ineligible|3|||
130523358|NCT02554383|469884647|FG001|Overall Study|Ineligible|2|||
130523359|NCT02554383|469884646|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
130523360|NCT02554383|469884647|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
130523361|NCT02554383|469884646|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
130576248|NCT01262365|470074824|FG000|Overall Study|Withdrawal by Subject|17|||
130523362|NCT02554383|469884647|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
130523363|NCT02554383|469884646|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
130523364|NCT02554383|469884647|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
130523365|NCT02918292|469884648|FG000|Study Enrollment Prior to Transplant|Death|1|||
130523366|NCT02918292|469884648|FG000|Study Follow up After Transplant|Death|6|||
130523367|NCT01801982|469884651|FG000|Overall Study|Lost to Follow-up|1|||
130523368|NCT01185171|469884652|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
130523369|NCT01185171|469884652|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
130523370|NCT01185171|469884652|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
130523371|NCT01185171|469884652|FG000|Maintenance|Elevated liver transaminases|3|||
130523372|NCT01185171|469884652|FG000|Maintenance|Rush|2|||
130523373|NCT01185171|469884652|FG000|Maintenance|Diarrhea|1|||
130523374|NCT01185171|469884652|FG000|Maintenance|Xerostomia|1|||
130523375|NCT01185171|469884652|FG000|Maintenance|Nausea|1|||
130523376|NCT01185171|469884652|FG000|Maintenance|Comorbid Illness|2|||
130523377|NCT01185171|469884652|FG000|Maintenance|Withdrawal by Subject|1|||
130523378|NCT01185171|469884652|FG000|Maintenance|Disease Recurrence|1|||
130523379|NCT00727506|469884653|FG000|Overall Study|Adverse Event|0|||
130523380|NCT00727506|469884654|FG001|Overall Study|Adverse Event|0|||
130523381|NCT00727506|469884655|FG002|Overall Study|Adverse Event|4|||
130523382|NCT00727506|469884656|FG003|Overall Study|Adverse Event|4|||
130523383|NCT00727506|469884657|FG004|Overall Study|Adverse Event|1|||
130523384|NCT00727506|469884658|FG005|Overall Study|Adverse Event|8|||
130523385|NCT00727506|469884653|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130523386|NCT00727506|469884654|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130523387|NCT00727506|469884655|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130523388|NCT00727506|469884656|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130523389|NCT00727506|469884657|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130523390|NCT00727506|469884658|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130523391|NCT00727506|469884653|FG000|Overall Study|Progressive disease|4|||
130523392|NCT00727506|469884654|FG001|Overall Study|Progressive disease|7|||
130523393|NCT00727506|469884655|FG002|Overall Study|Progressive disease|9|||
130523394|NCT00727506|469884656|FG003|Overall Study|Progressive disease|28|||
130523395|NCT00727506|469884657|FG004|Overall Study|Progressive disease|38|||
130523396|NCT00727506|469884658|FG005|Overall Study|Progressive disease|28|||
130523397|NCT00727506|469884653|FG000|Overall Study|Refused to continue medication|0|||
130523398|NCT00727506|469884654|FG001|Overall Study|Refused to continue medication|1|||
130523399|NCT00727506|469884655|FG002|Overall Study|Refused to continue medication|2|||
130523400|NCT00727506|469884656|FG003|Overall Study|Refused to continue medication|3|||
130523401|NCT00727506|469884657|FG004|Overall Study|Refused to continue medication|1|||
130523402|NCT00727506|469884658|FG005|Overall Study|Refused to continue medication|2|||
130523403|NCT00727506|469884653|FG000|Overall Study|Other reason not described above|0|||
130523404|NCT00727506|469884654|FG001|Overall Study|Other reason not described above|0|||
130523405|NCT00727506|469884655|FG002|Overall Study|Other reason not described above|1|||
130523406|NCT00727506|469884656|FG003|Overall Study|Other reason not described above|4|||
130523407|NCT00727506|469884657|FG004|Overall Study|Other reason not described above|1|||
130523408|NCT00727506|469884658|FG005|Overall Study|Other reason not described above|1|||
130523409|NCT00715117|469884659|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
130523410|NCT00715117|469884660|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
130523411|NCT01482429|469884661|FG000|Care Usual|Protocol Violation|0|||
130523412|NCT01482429|469884662|FG001|Care Usual|Protocol Violation|172|||
130523413|NCT01482429|469884661|FG000|Care Usual|Lost to Follow-up|0|||
130523414|NCT01482429|469884662|FG001|Care Usual|Lost to Follow-up|1|||
130523415|NCT01482429|469884661|FG000|Protocol|Protocol Violation|275|||
130523416|NCT01482429|469884662|FG001|Protocol|Protocol Violation|0|||
130523417|NCT01214421|469884663|FG000|Overall Study|Lost to Follow-up|7|||
130523418|NCT01214421|469884664|FG001|Overall Study|Lost to Follow-up|3|||
130523419|NCT01214421|469884665|FG002|Overall Study|Lost to Follow-up|7|||
130523420|NCT01214421|469884666|FG003|Overall Study|Lost to Follow-up|3|||
130523421|NCT01214421|469884663|FG000|Overall Study|Adverse Event|16|||
130523422|NCT01214421|469884664|FG001|Overall Study|Adverse Event|35|||
130523423|NCT01214421|469884665|FG002|Overall Study|Adverse Event|14|||
130523424|NCT01214421|469884666|FG003|Overall Study|Adverse Event|3|||
130523425|NCT01214421|469884663|FG000|Overall Study|Sponsor Discontinued Site|1|||
130523426|NCT01214421|469884664|FG001|Overall Study|Sponsor Discontinued Site|2|||
130523427|NCT01214421|469884665|FG002|Overall Study|Sponsor Discontinued Site|0|||
130523428|NCT01214421|469884666|FG003|Overall Study|Sponsor Discontinued Site|0|||
130523429|NCT01214421|469884663|FG000|Overall Study|Withdrawal Criteria Met|3|||
130523430|NCT01214421|469884664|FG001|Overall Study|Withdrawal Criteria Met|0|||
130523431|NCT01214421|469884665|FG002|Overall Study|Withdrawal Criteria Met|2|||
130523432|NCT01214421|469884666|FG003|Overall Study|Withdrawal Criteria Met|1|||
130523433|NCT01214421|469884663|FG000|Overall Study|Physician Decision|2|||
130523434|NCT01214421|469884664|FG001|Overall Study|Physician Decision|0|||
130523435|NCT01214421|469884665|FG002|Overall Study|Physician Decision|4|||
130523436|NCT01214421|469884666|FG003|Overall Study|Physician Decision|0|||
130523437|NCT01214421|469884663|FG000|Overall Study|Withdrawal by Subject|21|||
130576249|NCT01262365|470074825|FG001|Overall Study|Withdrawal by Subject|22|||
130576250|NCT01262365|470074826|FG002|Overall Study|Withdrawal by Subject|22|||
130576251|NCT01262365|470074824|FG000|Overall Study|Death|1|||
130576252|NCT01262365|470074825|FG001|Overall Study|Death|2|||
130576253|NCT01262365|470074826|FG002|Overall Study|Death|1|||
130576254|NCT01262365|470074824|FG000|Overall Study|Adverse Event|26|||
130576255|NCT01262365|470074825|FG001|Overall Study|Adverse Event|16|||
130576256|NCT01262365|470074826|FG002|Overall Study|Adverse Event|11|||
130576257|NCT01262365|470074824|FG000|Overall Study|sponsor decision|1|||
130576258|NCT01262365|470074825|FG001|Overall Study|sponsor decision|1|||
130576259|NCT01262365|470074826|FG002|Overall Study|sponsor decision|0|||
130576260|NCT01262365|470074824|FG000|Overall Study|Randomization error|1|||
130576261|NCT01262365|470074825|FG001|Overall Study|Randomization error|0|||
130576262|NCT01262365|470074826|FG002|Overall Study|Randomization error|2|||
130576263|NCT01262365|470074824|FG000|Overall Study|Non-compliance|1|||
130576264|NCT01262365|470074825|FG001|Overall Study|Non-compliance|0|||
130576265|NCT01262365|470074826|FG002|Overall Study|Non-compliance|2|||
130576266|NCT01262365|470074824|FG000|Overall Study|Suspected pregnancy|1|||
130576267|NCT01262365|470074825|FG001|Overall Study|Suspected pregnancy|0|||
130576268|NCT01262365|470074826|FG002|Overall Study|Suspected pregnancy|0|||
130576269|NCT01262365|470074824|FG000|Overall Study|Patient pregnant|1|||
130576270|NCT01262365|470074825|FG001|Overall Study|Patient pregnant|0|||
130576271|NCT01262365|470074826|FG002|Overall Study|Patient pregnant|1|||
130576272|NCT01262365|470074824|FG000|Overall Study|Toxicity related to study drug|0|||
130576273|NCT01262365|470074825|FG001|Overall Study|Toxicity related to study drug|1|||
130576274|NCT01262365|470074826|FG002|Overall Study|Toxicity related to study drug|0|||
130576275|NCT01262365|470074824|FG000|Overall Study|Cannot tolerate the protocol|0|||
130576276|NCT01262365|470074825|FG001|Overall Study|Cannot tolerate the protocol|1|||
130576277|NCT01262365|470074826|FG002|Overall Study|Cannot tolerate the protocol|0|||
130576278|NCT01262365|470074824|FG000|Overall Study|Patient unavailable|0|||
130576279|NCT01262365|470074825|FG001|Overall Study|Patient unavailable|0|||
130576280|NCT01262365|470074826|FG002|Overall Study|Patient unavailable|1|||
130576281|NCT02322710|470074828|FG000|Overall Study|No efficacy assessment post-baseline|0|||
130576282|NCT02322710|470074829|FG001|Overall Study|No efficacy assessment post-baseline|1|||
130576283|NCT02322710|470074828|FG000|Overall Study|Protocol Violation|20|||
130576284|NCT02322710|470074829|FG001|Overall Study|Protocol Violation|25|||
130576285|NCT04161131|470074830|FG000|Overall Study|Ineligible|2|||
130576286|NCT04161131|470074830|FG000|Overall Study|Lost to Follow-up|4|||
130576287|NCT03733392|470074831|FG000|Overall Study|Withdrawal by Subject|11|||
130576288|NCT03733392|470074832|FG001|Overall Study|Withdrawal by Subject|1|||
130576289|NCT03733392|470074831|FG000|Overall Study|Death|1|||
130576290|NCT03733392|470074832|FG001|Overall Study|Death|0|||
130576291|NCT03733392|470074831|FG000|Overall Study|Lost to Follow-up|5|||
130576292|NCT03733392|470074832|FG001|Overall Study|Lost to Follow-up|0|||
130576293|NCT03733392|470074831|FG000|Overall Study|Protocol Violation|0|||
130576294|NCT03733392|470074832|FG001|Overall Study|Protocol Violation|1|||
130576295|NCT03733392|470074831|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
130576296|NCT03733392|470074832|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
130576297|NCT03733392|470074831|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
130576298|NCT03733392|470074832|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
130576299|NCT03733392|470074831|FG000|Overall Study|Patient Non-Compliance|2|||
130576300|NCT03733392|470074832|FG001|Overall Study|Patient Non-Compliance|1|||
130576301|NCT03733392|470074831|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
130576302|NCT03733392|470074832|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
130576303|NCT03733392|470074831|FG000|Overall Study|Withdrawal prior to procedure|5|||
130576304|NCT03733392|470074832|FG001|Overall Study|Withdrawal prior to procedure|2|||
130576305|NCT04316585|470074833|FG000|Overall Study|Adverse Event|2|||
130576306|NCT04316585|470074834|FG001|Overall Study|Adverse Event|1|||
130576307|NCT04316585|470074833|FG000|Overall Study|Lost to Follow-up|1|||
130576308|NCT04316585|470074834|FG001|Overall Study|Lost to Follow-up|0|||
130576309|NCT04316585|470074833|FG000|Overall Study|Withdrawal by Subject|2|||
130576310|NCT04316585|470074834|FG001|Overall Study|Withdrawal by Subject|3|||
130576311|NCT04316585|470074833|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130576312|NCT04316585|470074834|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
130576313|NCT04316585|470074833|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
130576314|NCT04316585|470074834|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
130576315|NCT01407926|470074842|FG000|Overall Study|Lost to Follow-up|55|||
130576316|NCT02814565|470074843|FG000|Overall Study|Lack of Efficacy|0|||
130576317|NCT02814565|470074844|FG001|Overall Study|Lack of Efficacy|1|||
130576318|NCT02814565|470074843|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
130576319|NCT02814565|470074844|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
130576320|NCT04656652|470074845|FG000|Overall Study|Lost to Follow-up|2|||
130576321|NCT04656652|470074846|FG001|Overall Study|Lost to Follow-up|2|||
130576322|NCT04656652|470074845|FG000|Overall Study|Death|213|||
130576323|NCT04656652|470074846|FG001|Overall Study|Death|212|||
130576324|NCT04656652|470074845|FG000|Overall Study|Other|1|||
130523438|NCT01214421|469884664|FG001|Overall Study|Withdrawal by Subject|18|||
130523439|NCT01214421|469884665|FG002|Overall Study|Withdrawal by Subject|11|||
130523440|NCT01214421|469884666|FG003|Overall Study|Withdrawal by Subject|2|||
130523441|NCT03561597|469884667|FG000|Overall Study|Lost to Follow-up|20|||
130523442|NCT03783689|469884669|FG000|Overall Study|Adverse Event|2|||
130523443|NCT03783689|469884670|FG001|Overall Study|Adverse Event|0|||
130523444|NCT03783689|469884669|FG000|Overall Study|Lost to Follow-up|2|||
130523445|NCT03783689|469884670|FG001|Overall Study|Lost to Follow-up|1|||
130523446|NCT03783689|469884669|FG000|Overall Study|Physician Decision|2|||
130523447|NCT03783689|469884670|FG001|Overall Study|Physician Decision|1|||
130523448|NCT03783689|469884669|FG000|Overall Study|Withdrawal by Subject|3|||
130523449|NCT03783689|469884670|FG001|Overall Study|Withdrawal by Subject|3|||
130523450|NCT02581059|469884671|FG000|Study Treatment|Disease Progression|1|||
130523451|NCT02581059|469884672|FG001|Study Treatment|Disease Progression|1|||
130523452|NCT02581059|469884671|FG000|Study Treatment|Adverse Event|2|||
130523453|NCT02581059|469884672|FG001|Study Treatment|Adverse Event|1|||
130523454|NCT02581059|469884671|FG000|Study Treatment|Death|1|||
130523455|NCT02581059|469884672|FG001|Study Treatment|Death|1|||
130523456|NCT02581059|469884671|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130523457|NCT02581059|469884672|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130523458|NCT02581059|469884671|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
130523459|NCT02581059|469884672|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
130523460|NCT02581059|469884671|FG000|Follow up|Death|1|||
130523461|NCT02581059|469884672|FG001|Follow up|Death|3|||
130523462|NCT02581059|469884671|FG000|Follow up|study terminated|1|||
130523463|NCT02581059|469884672|FG001|Follow up|study terminated|1|||
130523464|NCT02581059|469884671|FG000|Follow up|screen failure|0|||
130523465|NCT02581059|469884672|FG001|Follow up|screen failure|1|||
130523466|NCT02581059|469884671|FG000|Follow up|Patient started new clinical trial|1|||
130523467|NCT02581059|469884672|FG001|Follow up|Patient started new clinical trial|0|||
130523468|NCT02392104|469884675|FG000|Overall Study|discontinuation of warfarin|3|||
130523469|NCT02392104|469884675|FG000|Overall Study|bleeding event|1|||
130523470|NCT02392104|469884675|FG000|Overall Study|transferred care to another doctor|2|||
130523471|NCT02392104|469884675|FG000|Overall Study|INR goal range changed|1|||
130523472|NCT02392104|469884675|FG000|Overall Study|admitted to skilled nursing facility|3|||
130523473|NCT02392104|469884675|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
130523474|NCT04887506|469884676|FG000|Overall Study|Death|1|||
130523475|NCT04887506|469884677|FG001|Overall Study|Death|1|||
130523476|NCT04887506|469884676|FG000|Overall Study|Withdrawal by Subject|0|||
130523477|NCT04887506|469884677|FG001|Overall Study|Withdrawal by Subject|3|||
130523478|NCT04887506|469884676|FG000|Overall Study|Adverse Event|4|||
130523479|NCT04887506|469884677|FG001|Overall Study|Adverse Event|3|||
130523480|NCT04887506|469884676|FG000|Overall Study|Other - Not Reported|1|||
130523481|NCT04887506|469884677|FG001|Overall Study|Other - Not Reported|1|||
130523482|NCT02394665|469884680|FG000|Overall Study|Physician Decision|1|||
130523483|NCT02394665|469884681|FG001|Overall Study|Physician Decision|0|||
130523484|NCT02394665|469884682|FG002|Overall Study|Physician Decision|0|||
130523485|NCT02636608|469884683|FG000|Overall Study|Failure to Return|4|||
130523486|NCT02636608|469884683|FG000|Overall Study|Insufficient Virological Response|1|||
130523487|NCT02636608|469884683|FG000|Overall Study|Death|3|||
130523488|NCT02636608|469884683|FG000|Overall Study|Other|2|||
130523489|NCT02636608|469884683|FG000|Overall Study|Did Not Receive Treatment|1|||
130523490|NCT01255761|469884684|FG000|Overall Study|Adverse Event|29|||
130523491|NCT01255761|469884685|FG001|Overall Study|Adverse Event|43|||
130523492|NCT01255761|469884684|FG000|Overall Study|Lack of Efficacy|86|||
130523493|NCT01255761|469884685|FG001|Overall Study|Lack of Efficacy|74|||
130523494|NCT01255761|469884684|FG000|Overall Study|Protocol Violation|9|||
130523495|NCT01255761|469884685|FG001|Overall Study|Protocol Violation|5|||
130523496|NCT01255761|469884684|FG000|Overall Study|Lost to Follow-up|10|||
130576325|NCT04656652|470074846|FG001|Overall Study|Other|0|||
130576326|NCT04656652|470074845|FG000|Overall Study|Withdrawal by Subject|15|||
130523497|NCT01255761|469884685|FG001|Overall Study|Lost to Follow-up|8|||
130576327|NCT04656652|470074846|FG001|Overall Study|Withdrawal by Subject|29|||
130523498|NCT01255761|469884684|FG000|Overall Study|Withdrawal by Subject|11|||
130523499|NCT01255761|469884685|FG001|Overall Study|Withdrawal by Subject|27|||
130523500|NCT01255761|469884684|FG000|Overall Study|Other Reasons|37|||
130523501|NCT01255761|469884685|FG001|Overall Study|Other Reasons|18|||
130523502|NCT05613088|469884688|FG000|Treatment|Ongoing Study Treatment|9|||
130523503|NCT05613088|469884689|FG001|Treatment|Ongoing Study Treatment|2|||
130523504|NCT05613088|469884688|FG000|Treatment|Adverse Event|3|||
130523505|NCT05613088|469884689|FG001|Treatment|Adverse Event|1|||
130523506|NCT05613088|469884688|FG000|Treatment|Other Reasons|0|||
130523507|NCT05613088|469884689|FG001|Treatment|Other Reasons|1|||
130523508|NCT05613088|469884688|FG000|Treatment|Progressive Disease|58|||
130523509|NCT05613088|469884689|FG001|Treatment|Progressive Disease|26|||
130576328|NCT01885000|470074849|FG000|Overall Study|Adverse Event|1|||
130576329|NCT01885000|470074850|FG001|Overall Study|Adverse Event|0|||
130576330|NCT01885000|470074849|FG000|Overall Study|Withdrawal by Subject|1|||
130523510|NCT05613088|469884688|FG000|Treatment|Withdrawal by Subject|0|||
130523511|NCT05613088|469884689|FG001|Treatment|Withdrawal by Subject|4|||
130523512|NCT03912532|469884691|FG000|Overall Study|Adverse Event|3|||
130523513|NCT03912532|469884692|FG001|Overall Study|Adverse Event|3|||
130523514|NCT03912532|469884693|FG002|Overall Study|Adverse Event|2|||
130523515|NCT03912532|469884694|FG003|Overall Study|Adverse Event|2|||
130523516|NCT03912532|469884691|FG000|Overall Study|Lost to Follow-up|3|||
130523517|NCT03912532|469884692|FG001|Overall Study|Lost to Follow-up|2|||
130523518|NCT03912532|469884693|FG002|Overall Study|Lost to Follow-up|1|||
130523519|NCT03912532|469884694|FG003|Overall Study|Lost to Follow-up|2|||
130523520|NCT03912532|469884691|FG000|Overall Study|Withdrawal by Subject|1|||
130523521|NCT03912532|469884692|FG001|Overall Study|Withdrawal by Subject|1|||
130523522|NCT03912532|469884693|FG002|Overall Study|Withdrawal by Subject|2|||
130523523|NCT03912532|469884694|FG003|Overall Study|Withdrawal by Subject|0|||
130523524|NCT03912532|469884691|FG000|Overall Study|Physician Decision|1|||
130523525|NCT03912532|469884692|FG001|Overall Study|Physician Decision|0|||
130523526|NCT03912532|469884693|FG002|Overall Study|Physician Decision|0|||
130523527|NCT03912532|469884694|FG003|Overall Study|Physician Decision|3|||
130523528|NCT03912532|469884691|FG000|Overall Study|Other|0|||
130523529|NCT03912532|469884692|FG001|Overall Study|Other|1|||
130523530|NCT03912532|469884693|FG002|Overall Study|Other|1|||
130523531|NCT03912532|469884694|FG003|Overall Study|Other|0|||
130523532|NCT03783871|469884699|FG000|Overall Study|Withdrawal by Subject|15|||
130523533|NCT03783871|469884699|FG000|Overall Study|Death|13|||
130523534|NCT03783871|469884699|FG000|Overall Study|Lost to Follow-up|2|||
130523535|NCT03569891|469884701|FG000|Lead-in|Ineligible during lead-in|8|||
130523536|NCT03569891|469884701|FG000|Lead-in|Withdrawal by Subject|3|||
130523537|NCT03569891|469884701|FG000|Lead-in|Risks related to COVID-19|2|||
130523538|NCT03569891|469884701|FG000|AMT-061|Adverse Event|1|||
130523539|NCT04594733|469884702|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130523540|NCT04594733|469884703|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130523541|NCT04594733|469884702|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
130523542|NCT04594733|469884703|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
130523543|NCT04594733|469884702|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
130523544|NCT04594733|469884703|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130523545|NCT02647645|469884706|FG000|Overall Study|Lost to Follow-up|2|||
130523546|NCT02647645|469884707|FG001|Overall Study|Lost to Follow-up|1|||
130523547|NCT00356811|469884708|FG000|Overall Study|Death|35|||
130523548|NCT00356811|469884708|FG000|Overall Study|Lost to Follow-up|2|||
130523549|NCT00356811|469884708|FG000|Overall Study|Withdrawal by Subject|6|||
130523550|NCT00356811|469884708|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
130523551|NCT00356811|469884708|FG000|Overall Study|Study Is Terminating|3|||
130523552|NCT00356811|469884708|FG000|Overall Study|Site Closed during Follow-up|2|||
130523553|NCT02386839|469884709|FG000|Overall Study|Death|1|||
130523554|NCT02386839|469884710|FG001|Overall Study|Death|0|||
130523555|NCT02386839|469884709|FG000|Overall Study|Withdrawal by Subject|9|||
130523556|NCT02386839|469884710|FG001|Overall Study|Withdrawal by Subject|10|||
130523557|NCT02386839|469884709|FG000|Overall Study|Lost to Follow-up|4|||
130523558|NCT02386839|469884710|FG001|Overall Study|Lost to Follow-up|4|||
130523559|NCT02386839|469884709|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
130523560|NCT02386839|469884710|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
130523561|NCT02386839|469884709|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
130523562|NCT02386839|469884710|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
130523563|NCT02386839|469884709|FG000|Overall Study|Other (unspecified)|1|||
130523564|NCT02386839|469884710|FG001|Overall Study|Other (unspecified)|0|||
130523565|NCT02101983|469884711|FG000|Overall Study|Physician Decision|1|||
130523566|NCT02101983|469884712|FG001|Overall Study|Physician Decision|0|||
130523567|NCT00826228|469886593|FG000|Overall Study|Withdrawal by Subject|1|||
130576331|NCT01885000|470074850|FG001|Overall Study|Withdrawal by Subject|1|||
130576332|NCT01885000|470074849|FG000|Overall Study|Protocol Violation|0|||
130576333|NCT01885000|470074850|FG001|Overall Study|Protocol Violation|1|||
130576334|NCT03124784|470074851|FG000|Overall Study|Adverse Event|1|||
130576335|NCT03124784|470074851|FG000|Overall Study|Computer/Equip Malfunction|1|||
130576336|NCT01777152|470074855|FG000|Overall Study|Withdrawal by Subject|22|||
130576337|NCT01777152|470074856|FG001|Overall Study|Withdrawal by Subject|16|||
130576338|NCT01777152|470074855|FG000|Overall Study|Lost to Follow-up|3|||
130576339|NCT01777152|470074856|FG001|Overall Study|Lost to Follow-up|5|||
130576340|NCT01777152|470074855|FG000|Overall Study|Death|68|||
130576341|NCT01777152|470074856|FG001|Overall Study|Death|89|||
130576342|NCT01777152|470074855|FG000|Overall Study|Not eligible, no study drug received|1|||
130576343|NCT01777152|470074856|FG001|Overall Study|Not eligible, no study drug received|0|||
130576344|NCT01777152|470074855|FG000|Overall Study|Change of diagnosis|1|||
130576345|NCT01777152|470074856|FG001|Overall Study|Change of diagnosis|0|||
130576346|NCT02469090|470074859|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
130576347|NCT02469090|470074860|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
130576348|NCT02469090|470074861|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
130576349|NCT02469090|470074859|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
130576350|NCT02469090|470074860|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
130576351|NCT02469090|470074861|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
130576352|NCT02469090|470074859|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
130576353|NCT02469090|470074860|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
130576354|NCT02469090|470074861|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
130576355|NCT02469090|470074859|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
130576356|NCT02469090|470074860|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
130576357|NCT02469090|470074861|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
130576358|NCT02469090|470074859|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
130576359|NCT02469090|470074860|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
130576360|NCT02469090|470074861|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
130576361|NCT02469090|470074859|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
130576362|NCT02469090|470074860|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
130576363|NCT02469090|470074861|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
130576364|NCT02469090|470074859|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
130576365|NCT02469090|470074860|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
130576366|NCT02469090|470074861|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
130576367|NCT02469090|470074859|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
130576368|NCT02469090|470074860|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
130576369|NCT02469090|470074861|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
130576370|NCT01391507|470074863|FG000|Overall Study|Death|0|||
130576371|NCT01391507|470074864|FG001|Overall Study|Death|0|||
130576372|NCT01391507|470074865|FG002|Overall Study|Death|0|||
130576373|NCT01391507|470074866|FG003|Overall Study|Death|1|||
130576374|NCT01391507|470074863|FG000|Overall Study|Adverse Event|1|||
130576375|NCT01391507|470074864|FG001|Overall Study|Adverse Event|1|||
130576376|NCT01391507|470074865|FG002|Overall Study|Adverse Event|2|||
130576377|NCT01391507|470074866|FG003|Overall Study|Adverse Event|2|||
130576378|NCT01391507|470074863|FG000|Overall Study|Withdrawal by Subject|1|||
130576379|NCT01391507|470074864|FG001|Overall Study|Withdrawal by Subject|2|||
130576380|NCT01391507|470074865|FG002|Overall Study|Withdrawal by Subject|1|||
130576381|NCT01391507|470074866|FG003|Overall Study|Withdrawal by Subject|1|||
130576382|NCT01391507|470074863|FG000|Overall Study|Lack of Efficacy|0|||
130576383|NCT01391507|470074864|FG001|Overall Study|Lack of Efficacy|0|||
130576384|NCT01391507|470074865|FG002|Overall Study|Lack of Efficacy|0|||
130576385|NCT01391507|470074866|FG003|Overall Study|Lack of Efficacy|1|||
130576386|NCT01391507|470074863|FG000|Overall Study|Protocol Violation|2|||
130576387|NCT01391507|470074864|FG001|Overall Study|Protocol Violation|1|||
130576388|NCT01391507|470074865|FG002|Overall Study|Protocol Violation|1|||
130576389|NCT01391507|470074866|FG003|Overall Study|Protocol Violation|2|||
130576390|NCT02926209|470074867|FG000|Study Cohort|Poor Bowel Preparation|1|||
130576391|NCT02926209|470074868|FG001|Study Cohort|Poor Bowel Preparation|0|||
130576392|NCT00577993|470074871|FG000|Overall Study|Adverse Event|1|||
130576393|NCT00577993|470074872|FG001|Overall Study|Adverse Event|0|||
130576394|NCT00577993|470074873|FG002|Overall Study|Adverse Event|0|||
130576395|NCT00577993|470074871|FG000|Overall Study|Death|0|||
130576396|NCT00577993|470074872|FG001|Overall Study|Death|1|||
130576397|NCT00577993|470074873|FG002|Overall Study|Death|1|||
130576398|NCT00577993|470074871|FG000|Overall Study|Lack of Efficacy|0|||
130576399|NCT00577993|470074872|FG001|Overall Study|Lack of Efficacy|1|||
130576400|NCT00577993|470074873|FG002|Overall Study|Lack of Efficacy|0|||
130523568|NCT00903760|469886594|FG000|Overall Study|Disease Progression/Death|8|||
130523569|NCT00903760|469886595|FG001|Overall Study|Disease Progression/Death|6|||
130523570|NCT00903760|469886594|FG000|Overall Study|Stem Cell Transplant|8|||
130523571|NCT00903760|469886595|FG001|Overall Study|Stem Cell Transplant|4|||
130523572|NCT00903760|469886594|FG000|Overall Study|Physician Decision|1|||
130523573|NCT00903760|469886595|FG001|Overall Study|Physician Decision|2|||
130523574|NCT00903760|469886594|FG000|Overall Study|Death|0|||
130523575|NCT00903760|469886595|FG001|Overall Study|Death|1|||
130523576|NCT00903760|469886594|FG000|Overall Study|Lost to Follow-up|1|||
130523577|NCT00903760|469886595|FG001|Overall Study|Lost to Follow-up|0|||
130523578|NCT00903760|469886594|FG000|Overall Study|Withdrawal by Subject|1|||
130523579|NCT00903760|469886595|FG001|Overall Study|Withdrawal by Subject|2|||
130523580|NCT00903760|469886594|FG000|Overall Study|Off treatment for long period|0|||
130523581|NCT00903760|469886595|FG001|Overall Study|Off treatment for long period|1|||
130523582|NCT02388347|469886596|FG000|Overall Study|Withdrawal by Subject|0|||
130523583|NCT02388347|469886597|FG001|Overall Study|Withdrawal by Subject|0|||
130523584|NCT02388347|469886598|FG002|Overall Study|Withdrawal by Subject|1|||
130523585|NCT02388347|469886599|FG003|Overall Study|Withdrawal by Subject|0|||
130523586|NCT02388347|469886600|FG004|Overall Study|Withdrawal by Subject|0|||
130523587|NCT02825251|469886602|FG000|Overall Study|Adverse Event|0|||
130523588|NCT02825251|469886603|FG001|Overall Study|Adverse Event|1|||
130523589|NCT02825251|469886602|FG000|Overall Study|Lost to Follow-up|0|||
130523590|NCT02825251|469886603|FG001|Overall Study|Lost to Follow-up|1|||
130523591|NCT02825251|469886602|FG000|Overall Study|Withdrawal by Subject|1|||
130523592|NCT02825251|469886603|FG001|Overall Study|Withdrawal by Subject|4|||
130523593|NCT02825251|469886602|FG000|Overall Study|Unclassified|2|||
130523594|NCT02825251|469886603|FG001|Overall Study|Unclassified|0|||
130523595|NCT01845805|469886604|FG000|Overall Study|Withdrawal by Subject|1|||
130523596|NCT01845805|469886605|FG001|Overall Study|Withdrawal by Subject|2|||
130523597|NCT01845805|469886604|FG000|Overall Study|Disease Progression|13|||
130523598|NCT01845805|469886605|FG001|Overall Study|Disease Progression|14|||
130523599|NCT01845805|469886604|FG000|Overall Study|Drug-related Toxicity|4|||
130523600|NCT01845805|469886605|FG001|Overall Study|Drug-related Toxicity|0|||
130523601|NCT02820597|469886607|FG000|Overall Study|Lost to Follow-up|12|||
130523602|NCT00575042|469886608|FG000|Overall Study|Adverse Event|2|||
130523603|NCT00575042|469886608|FG000|Overall Study|Lost to Follow-up|1|||
130523604|NCT04795336|469886609|FG000|Overall Study|Withdrawal by Subject|3|||
130523605|NCT04795336|469886610|FG001|Overall Study|Withdrawal by Subject|4|||
130523606|NCT04795336|469886611|FG002|Overall Study|Withdrawal by Subject|3|||
130523607|NCT04795336|469886612|FG003|Overall Study|Withdrawal by Subject|12|||
130523608|NCT04795336|469886609|FG000|Overall Study|Lost study logs|0|||
130523609|NCT04795336|469886610|FG001|Overall Study|Lost study logs|1|||
130523610|NCT04795336|469886611|FG002|Overall Study|Lost study logs|0|||
130523611|NCT04795336|469886612|FG003|Overall Study|Lost study logs|2|||
130523612|NCT04795336|469886609|FG000|Overall Study|Did not take study medication|2|||
130523613|NCT04795336|469886610|FG001|Overall Study|Did not take study medication|0|||
130523614|NCT04795336|469886611|FG002|Overall Study|Did not take study medication|0|||
130523615|NCT04795336|469886612|FG003|Overall Study|Did not take study medication|0|||
130523616|NCT03898700|469886613|FG000|Overall Study|Withdrawal by Subject|2|||
130523617|NCT02666664|469886614|FG000|Overall Study|Physician Decision|0|||
130523618|NCT02666664|469886615|FG001|Overall Study|Physician Decision|1|||
130523619|NCT02666664|469886614|FG000|Overall Study|Protocol Violation|0|||
130523620|NCT02666664|469886615|FG001|Overall Study|Protocol Violation|2|||
130523621|NCT02666664|469886614|FG000|Overall Study|Other|0|||
130523622|NCT02666664|469886615|FG001|Overall Study|Other|1|||
130523623|NCT02666664|469886614|FG000|Overall Study|Adverse Event|12|||
130523624|NCT02666664|469886615|FG001|Overall Study|Adverse Event|37|||
130523625|NCT02666664|469886614|FG000|Overall Study|Withdrawal by participant|23|||
130523626|NCT02666664|469886615|FG001|Overall Study|Withdrawal by participant|40|||
130523627|NCT02666664|469886614|FG000|Overall Study|Sponsor decision|0|||
130523628|NCT02666664|469886615|FG001|Overall Study|Sponsor decision|1|||
130523629|NCT02666664|469886614|FG000|Overall Study|Lost to Follow-up|1|||
130523630|NCT02666664|469886615|FG001|Overall Study|Lost to Follow-up|2|||
130523631|NCT03616964|469886616|FG000|Overall Study|Adverse Event|15|||
130523632|NCT03616964|469886617|FG001|Overall Study|Adverse Event|10|||
130523633|NCT03616964|469886618|FG002|Overall Study|Adverse Event|16|||
130523634|NCT03616964|469886616|FG000|Overall Study|Death|3|||
130523635|NCT03616964|469886617|FG001|Overall Study|Death|0|||
130523636|NCT03616964|469886618|FG002|Overall Study|Death|4|||
130523637|NCT03616964|469886616|FG000|Overall Study|Lack of Efficacy|4|||
130523638|NCT03616964|469886617|FG001|Overall Study|Lack of Efficacy|8|||
130523639|NCT03616964|469886618|FG002|Overall Study|Lack of Efficacy|8|||
130523640|NCT03616964|469886616|FG000|Overall Study|Lost to Follow-up|2|||
130523641|NCT03616964|469886617|FG001|Overall Study|Lost to Follow-up|1|||
130523642|NCT03616964|469886618|FG002|Overall Study|Lost to Follow-up|3|||
130576401|NCT00577993|470074871|FG000|Overall Study|Protocol Violation|2|||
130576402|NCT00577993|470074872|FG001|Overall Study|Protocol Violation|3|||
130576403|NCT00577993|470074873|FG002|Overall Study|Protocol Violation|0|||
130576404|NCT00577993|470074871|FG000|Overall Study|Withdrawal by Subject|1|||
130576405|NCT00577993|470074872|FG001|Overall Study|Withdrawal by Subject|0|||
130576406|NCT00577993|470074873|FG002|Overall Study|Withdrawal by Subject|2|||
130576407|NCT00577993|470074871|FG000|Overall Study|Conversion|2|||
130576408|NCT00577993|470074872|FG001|Overall Study|Conversion|5|||
130576409|NCT00577993|470074873|FG002|Overall Study|Conversion|0|||
130576410|NCT00577993|470074871|FG000|Overall Study|Uninsured|1|||
130576411|NCT00577993|470074872|FG001|Overall Study|Uninsured|0|||
130576412|NCT00577993|470074873|FG002|Overall Study|Uninsured|0|||
130576413|NCT01847885|470074874|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
130576414|NCT01847885|470074875|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
130576415|NCT01847885|470074876|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
130576416|NCT01847885|470074874|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
130576417|NCT01847885|470074875|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
130576418|NCT01847885|470074876|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
130576419|NCT01847885|470074874|FG000|Initial Enrollment (Consented)|Screen failure|39|||
130576420|NCT01847885|470074875|FG001|Initial Enrollment (Consented)|Screen failure|0|||
130576421|NCT01847885|470074876|FG002|Initial Enrollment (Consented)|Screen failure|0|||
130576422|NCT01847885|470074874|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
130576423|NCT01847885|470074875|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
130576424|NCT01847885|470074876|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
130576425|NCT01847885|470074874|FG000|Randomization|Protocol Violation|0|||
130576426|NCT01847885|470074875|FG001|Randomization|Protocol Violation|1|||
130576427|NCT01847885|470074876|FG002|Randomization|Protocol Violation|0|||
130576428|NCT01847885|470074874|FG000|Randomization|Withdrawal by Subject|0|||
130576429|NCT01847885|470074875|FG001|Randomization|Withdrawal by Subject|0|||
130576430|NCT01847885|470074876|FG002|Randomization|Withdrawal by Subject|2|||
130576431|NCT01847885|470074874|FG000|Randomization|Screen Failure|0|||
130576432|NCT01847885|470074875|FG001|Randomization|Screen Failure|3|||
130576433|NCT01847885|470074876|FG002|Randomization|Screen Failure|0|||
130576434|NCT04029519|470074878|FG000|Overall Study|Protocol Violation|1|||
130576435|NCT04029519|470074878|FG000|Overall Study|Withdrawal by Subject|3|||
130576436|NCT04029519|470074878|FG000|Overall Study|Lost to Follow-up|1|||
130576437|NCT00070941|470074881|FG000|Overall Study|Adverse Event|10|||
130576438|NCT00070941|470074882|FG001|Overall Study|Adverse Event|8|||
130576439|NCT00070941|470074883|FG002|Overall Study|Adverse Event|4|||
130576440|NCT00094055|470074884|FG000|Overall Study|Adverse Event|11|||
130576441|NCT00094055|470074884|FG000|Overall Study|Death|4|||
130576442|NCT00094055|470074884|FG000|Overall Study|Lack of Efficacy|17|||
130576443|NCT00094055|470074884|FG000|Overall Study|Lost to Follow-up|2|||
130576444|NCT00094055|470074884|FG000|Overall Study|progressive disease|2|||
130576445|NCT00094055|470074884|FG000|Overall Study|clinical progression|1|||
130576446|NCT00094055|470074884|FG000|Overall Study|roll-over to another study|14|||
130576447|NCT00094055|470074884|FG000|Overall Study|Withdrawal by Subject|9|||
130576448|NCT00411554|470074886|FG000|Overall Study|Adverse Event|2|||
130576449|NCT00411554|470074887|FG001|Overall Study|Adverse Event|4|||
130576450|NCT00411554|470074886|FG000|Overall Study|Lack of Efficacy|2|||
130576451|NCT00411554|470074887|FG001|Overall Study|Lack of Efficacy|5|||
130576452|NCT00411554|470074886|FG000|Overall Study|Withdrawal by Subject|3|||
130576453|NCT00411554|470074887|FG001|Overall Study|Withdrawal by Subject|0|||
130576454|NCT00411554|470074886|FG000|Overall Study|Patient Moved|1|||
130576455|NCT00411554|470074887|FG001|Overall Study|Patient Moved|0|||
130576456|NCT02462473|470074888|FG000|Overall Study|Death|1|||
130576457|NCT02462473|470074888|FG000|Overall Study|Other|3|||
130576458|NCT03728309|470074889|FG000|Overall Study|Randomized but not Treated|0|||
130576459|NCT03728309|470074890|FG001|Overall Study|Randomized but not Treated|1|||
130576460|NCT03728309|470074889|FG000|Overall Study|Adverse Event|0|||
130576461|NCT03728309|470074890|FG001|Overall Study|Adverse Event|1|||
130576462|NCT03728309|470074889|FG000|Overall Study|Withdrawal by Subject|2|||
130576463|NCT03728309|470074890|FG001|Overall Study|Withdrawal by Subject|8|||
130576464|NCT03728309|470074889|FG000|Overall Study|Lost to Follow-up|9|||
130576465|NCT03728309|470074890|FG001|Overall Study|Lost to Follow-up|10|||
130576466|NCT03728309|470074889|FG000|Overall Study|Protocol Deviation|0|||
130576467|NCT03728309|470074890|FG001|Overall Study|Protocol Deviation|1|||
130576468|NCT03728309|470074889|FG000|Overall Study|Due to COVID|1|||
130576469|NCT03728309|470074890|FG001|Overall Study|Due to COVID|3|||
130576470|NCT00953758|470074893|FG000|Overall Study|Death|2|||
130576471|NCT00953758|470074894|FG001|Overall Study|Death|0|||
130576472|NCT00953758|470074895|FG002|Overall Study|Death|1|||
130576473|NCT00953758|470074896|FG003|Overall Study|Death|1|||
130576474|NCT00953758|470074897|FG004|Overall Study|Death|1|||
130576475|NCT00953758|470074898|FG005|Overall Study|Death|1|||
130576476|NCT00953758|470074899|FG006|Overall Study|Death|1|||
130576477|NCT00953758|470074900|FG007|Overall Study|Death|3|||
130576478|NCT00953758|470074901|FG008|Overall Study|Death|1|||
130576479|NCT00953758|470074902|FG009|Overall Study|Death|0|||
130523643|NCT03616964|469886616|FG000|Overall Study|Withdrawal by Subject|18|||
130523644|NCT03616964|469886617|FG001|Overall Study|Withdrawal by Subject|14|||
130523645|NCT03616964|469886618|FG002|Overall Study|Withdrawal by Subject|21|||
130523646|NCT03616964|469886616|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
130523647|NCT03616964|469886617|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
130523648|NCT03616964|469886618|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
130523649|NCT03616964|469886616|FG000|Overall Study|Sponsor's Decision|1|||
130523650|NCT03616964|469886617|FG001|Overall Study|Sponsor's Decision|0|||
130523651|NCT03616964|469886618|FG002|Overall Study|Sponsor's Decision|0|||
130523652|NCT03616964|469886616|FG000|Overall Study|Physician Decision|0|||
130523653|NCT03616964|469886617|FG001|Overall Study|Physician Decision|2|||
130523654|NCT03616964|469886618|FG002|Overall Study|Physician Decision|0|||
130523655|NCT03616964|469886616|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
130523656|NCT03616964|469886617|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
130523657|NCT03616964|469886618|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
130523658|NCT03616964|469886616|FG000|Overall Study|Protocol Violation|0|||
130523659|NCT03616964|469886617|FG001|Overall Study|Protocol Violation|1|||
130523660|NCT03616964|469886618|FG002|Overall Study|Protocol Violation|0|||
130523661|NCT03616964|469886616|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
130523662|NCT03616964|469886617|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
130523663|NCT03616964|469886618|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
130523664|NCT03616964|469886616|FG000|Overall Study|Randomized but Never Treated|1|||
130523665|NCT03616964|469886617|FG001|Overall Study|Randomized but Never Treated|1|||
130523666|NCT03616964|469886618|FG002|Overall Study|Randomized but Never Treated|1|||
130523667|NCT00971997|469886619|FG000|Overall Study|Adverse Event|2|||
130523668|NCT00971997|469886619|FG000|Overall Study|Death|1|||
130523669|NCT00971997|469886619|FG000|Overall Study|Protocol Violation|4|||
130523670|NCT00971997|469886619|FG000|Overall Study|Withdrawal by Subject|5|||
130523671|NCT00971997|469886619|FG000|Overall Study|Physician Decision|7|||
130523672|NCT01266018|469886622|FG000|Overall Study|Physician Decision|1|||
130523673|NCT01266018|469886623|FG001|Overall Study|Physician Decision|0|||
130523674|NCT01266018|469886622|FG000|Overall Study|Progressive disease|0|||
130523675|NCT01266018|469886623|FG001|Overall Study|Progressive disease|1|||
130523676|NCT03167151|469886624|FG000|Overall Study|Withdrawal by Subject|1|||
130523677|NCT03167151|469886625|FG001|Overall Study|Withdrawal by Subject|0|||
130523678|NCT03167151|469886626|FG002|Overall Study|Withdrawal by Subject|0|||
130523679|NCT03167151|469886624|FG000|Overall Study|No evidence of tumour at surgery|0|||
130523680|NCT03167151|469886625|FG001|Overall Study|No evidence of tumour at surgery|1|||
130523681|NCT03167151|469886626|FG002|Overall Study|No evidence of tumour at surgery|1|||
130523682|NCT01458522|469886627|FG000|Overall Study|Withdrawal by Subject|2|||
130523683|NCT01458522|469886628|FG001|Overall Study|Withdrawal by Subject|2|||
130523684|NCT01458522|469886627|FG000|Overall Study|Physician Decision|1|||
130523685|NCT01458522|469886628|FG001|Overall Study|Physician Decision|9|||
130523686|NCT02684123|469886629|FG000|Phase 1|Lack of Efficacy|5|||
130523687|NCT02684123|469886630|FG001|Phase 1|Lack of Efficacy|0|||
130523688|NCT02684123|469886629|FG000|Phase 1|Adverse Event|3|||
130523689|NCT02684123|469886630|FG001|Phase 1|Adverse Event|0|||
130523690|NCT02684123|469886629|FG000|Phase 1|Lost to Follow-up|0|||
130523691|NCT02684123|469886630|FG001|Phase 1|Lost to Follow-up|1|||
130523692|NCT02684123|469886629|FG000|Phase 2|Lack of Efficacy|1|||
130523693|NCT02684123|469886630|FG001|Phase 2|Lack of Efficacy|8|||
130523694|NCT00516139|469886631|FG000|Overall Study|Adverse Event|27|||
130523695|NCT00516139|469886631|FG000|Overall Study|Lost to Follow-up|1|||
130523696|NCT00516139|469886631|FG000|Overall Study|Protocol Violation|1|||
130523697|NCT00516139|469886631|FG000|Overall Study|Withdrawal by Subject|8|||
130523698|NCT00516139|469886631|FG000|Overall Study|Lack of Efficacy|1|||
130523699|NCT00416598|469886634|FG000|Induction & Intensification|Adverse Event|38|||
130523700|NCT00416598|469886634|FG000|Induction & Intensification|Death|32|||
130523701|NCT00416598|469886634|FG000|Induction & Intensification|Withdrawal by Subject|46|||
130523702|NCT00416598|469886634|FG000|Induction & Intensification|Alternative Treatment|135|||
130523703|NCT00416598|469886634|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
130523704|NCT00416598|469886634|FG000|Induction & Intensification|Relapse/progression|29|||
130523705|NCT00416598|469886634|FG000|Induction & Intensification|Failed induction|87|||
130523706|NCT00416598|469886634|FG000|Decitabine Maintenance|Adverse Event|5|||
130523707|NCT00416598|469886634|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
130523708|NCT00416598|469886634|FG000|Decitabine Maintenance|Progression/relapse|38|||
130523709|NCT00416598|469886634|FG000|Decitabine Maintenance|Alternative treatment|2|||
130523710|NCT00416598|469886634|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
130523711|NCT04367480|469886635|FG000|Overall Study|Adverse Event|1|||
130523712|NCT04367480|469886636|FG001|Overall Study|Adverse Event|1|||
130523713|NCT04367480|469886635|FG000|Overall Study|Death|1|||
130523714|NCT04367480|469886636|FG001|Overall Study|Death|0|||
130523715|NCT04367480|469886635|FG000|Overall Study|Lost to Follow-up|1|||
130523716|NCT04367480|469886636|FG001|Overall Study|Lost to Follow-up|1|||
130523717|NCT04367480|469886635|FG000|Overall Study|Withdrawal by Subject|0|||
130523718|NCT04367480|469886636|FG001|Overall Study|Withdrawal by Subject|3|||
130523719|NCT04367480|469886635|FG000|Overall Study|App glitch during the study|1|||
130523720|NCT04367480|469886636|FG001|Overall Study|App glitch during the study|0|||
130523721|NCT04367480|469886635|FG000|Overall Study|Device Distribution Error|0|||
130523722|NCT04367480|469886636|FG001|Overall Study|Device Distribution Error|2|||
130523723|NCT04367480|469886635|FG000|Overall Study|Ineligible after Randomization|0|||
130523724|NCT04367480|469886636|FG001|Overall Study|Ineligible after Randomization|1|||
130523725|NCT04367480|469886635|FG000|Overall Study|Other Medical Reasons|0|||
130523726|NCT04367480|469886636|FG001|Overall Study|Other Medical Reasons|2|||
130523727|NCT04120376|469886637|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
130523728|NCT04120376|469886638|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
130523729|NCT02641587|469886639|FG000|Confinement Period|Adverse Event|1|||
130523730|NCT02641587|469886640|FG001|Confinement Period|Adverse Event|0|||
130523731|NCT02641587|469886639|FG000|Confinement Period|Withdrawal by Subject|2|||
130523732|NCT02641587|469886640|FG001|Confinement Period|Withdrawal by Subject|1|||
130523733|NCT02641587|469886639|FG000|Ambulatory Period|Withdrawal by Subject|1|||
130523734|NCT02641587|469886640|FG001|Ambulatory Period|Withdrawal by Subject|0|||
130523735|NCT01165177|469886641|FG000|Overall Study|Serious Adverse Event|227|||
130523736|NCT01165177|469886642|FG001|Overall Study|Serious Adverse Event|235|||
130523737|NCT01165177|469886641|FG000|Overall Study|Withdrawal by Subject|368|||
130523738|NCT01165177|469886642|FG001|Overall Study|Withdrawal by Subject|354|||
130523739|NCT01165177|469886641|FG000|Overall Study|Protocol Violation|19|||
130523740|NCT01165177|469886642|FG001|Overall Study|Protocol Violation|21|||
130523741|NCT01165177|469886641|FG000|Overall Study|Non-serious adverse event|30|||
130523742|NCT01165177|469886642|FG001|Overall Study|Non-serious adverse event|18|||
130523743|NCT01165177|469886641|FG000|Overall Study|Other unspecified reasons|47|||
130523744|NCT01165177|469886642|FG001|Overall Study|Other unspecified reasons|35|||
130523745|NCT01165177|469886641|FG000|Overall Study|Suspected HZ episode|0|||
130523746|NCT01165177|469886642|FG001|Overall Study|Suspected HZ episode|2|||
130523747|NCT01165177|469886641|FG000|Overall Study|Lost to Follow-up|183|||
130523748|NCT01165177|469886642|FG001|Overall Study|Lost to Follow-up|194|||
130523749|NCT01165177|469886641|FG000|Overall Study|Migrated/ moved from study area|48|||
130523750|NCT01165177|469886642|FG001|Overall Study|Migrated/ moved from study area|43|||
130523751|NCT00634842|469886643|FG000|Overall Study|Adverse Event|2|||
130523752|NCT00634842|469886644|FG001|Overall Study|Adverse Event|3|||
130523753|NCT00634842|469886643|FG000|Overall Study|Protocol Violation|8|||
130523754|NCT00634842|469886644|FG001|Overall Study|Protocol Violation|4|||
130523755|NCT00634842|469886643|FG000|Overall Study|Move to another state|1|||
130523756|NCT00634842|469886644|FG001|Overall Study|Move to another state|0|||
130523757|NCT00634842|469886643|FG000|Overall Study|Inclusion criteria were not met|1|||
130523758|NCT00634842|469886644|FG001|Overall Study|Inclusion criteria were not met|0|||
130523759|NCT00634842|469886643|FG000|Overall Study|Lost to Follow-up|1|||
130523760|NCT00634842|469886644|FG001|Overall Study|Lost to Follow-up|2|||
130523761|NCT00634842|469886643|FG000|Overall Study|Physician Decision|1|||
130523762|NCT00634842|469886644|FG001|Overall Study|Physician Decision|0|||
130523763|NCT00634842|469886643|FG000|Overall Study|Withdrawal by Subject|1|||
130523764|NCT00634842|469886644|FG001|Overall Study|Withdrawal by Subject|3|||
130523765|NCT00634842|469886643|FG000|Overall Study|Lack of time and intolerance to drug|0|||
130523766|NCT00634842|469886644|FG001|Overall Study|Lack of time and intolerance to drug|1|||
130523767|NCT00634842|469886643|FG000|Overall Study|Discontinued due to injection|0|||
130523768|NCT00634842|469886644|FG001|Overall Study|Discontinued due to injection|2|||
130523769|NCT00634842|469886643|FG000|Overall Study|No need of study drug to treat diabetes|0|||
130523770|NCT00634842|469886644|FG001|Overall Study|No need of study drug to treat diabetes|1|||
130523771|NCT00634842|469886643|FG000|Overall Study|No wish to keep taking Avandia|0|||
130523772|NCT00634842|469886644|FG001|Overall Study|No wish to keep taking Avandia|1|||
130523773|NCT00634842|469886643|FG000|Overall Study|Subject off study drug for too long|0|||
130523774|NCT00634842|469886644|FG001|Overall Study|Subject off study drug for too long|1|||
130523775|NCT00810342|469886647|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
130523776|NCT00810342|469886648|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
130523777|NCT00810342|469886647|FG000|Month 1 Follow-up|Pregnancy|1|||
130523778|NCT00810342|469886648|FG001|Month 1 Follow-up|Pregnancy|0|||
130523779|NCT00810342|469886647|FG000|6-month Follow-up|Lost to Follow-up|18|||
130523780|NCT00810342|469886648|FG001|6-month Follow-up|Lost to Follow-up|6|||
130523781|NCT00810342|469886647|FG000|6-month Follow-up|Pregnancy|6|||
130523782|NCT00810342|469886648|FG001|6-month Follow-up|Pregnancy|2|||
130523783|NCT00810342|469886647|FG000|12-month Followup|Pregnancy|9|||
130523784|NCT00810342|469886648|FG001|12-month Followup|Pregnancy|10|||
130523785|NCT00810342|469886647|FG000|12-month Followup|Lost to Follow-up|3|||
130523786|NCT00810342|469886648|FG001|12-month Followup|Lost to Follow-up|1|||
130523787|NCT04504630|469886650|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
130523788|NCT04504630|469886651|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
130523789|NCT04504630|469886650|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
130523790|NCT04504630|469886651|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
130523791|NCT00943787|469886672|FG000|Overall Study|Physician Decision|4|||
130523792|NCT00943787|469886672|FG000|Overall Study|Withdrawal by Subject|3|||
130523793|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
130523794|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
130523795|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
130523796|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
130523797|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
130523798|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
130523799|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
130523800|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
130523801|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
130523802|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
130523803|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
130523804|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
130523805|NCT01216072|469886673|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
130523806|NCT01216072|469886674|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
130523807|NCT01216072|469886673|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
130523808|NCT01216072|469886674|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
130523809|NCT01216072|469886673|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
130523810|NCT01216072|469886674|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
130523811|NCT01216072|469886673|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
130523812|NCT01216072|469886674|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
130523813|NCT04294667|469886675|FG000|Overall Study|Lack of Efficacy|4|||
130523814|NCT04294667|469886676|FG001|Overall Study|Lack of Efficacy|4|||
130523815|NCT04294667|469886675|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
130523816|NCT04294667|469886676|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
130523817|NCT04294667|469886675|FG000|Overall Study|Patient has a Renal Flare|1|||
130523818|NCT04294667|469886676|FG001|Overall Study|Patient has a Renal Flare|0|||
130523819|NCT04294667|469886675|FG000|Overall Study|SLE Worsening|0|||
130523820|NCT04294667|469886676|FG001|Overall Study|SLE Worsening|1|||
130523821|NCT04294667|469886675|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
130523822|NCT04294667|469886676|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
130523823|NCT04294667|469886675|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
130523824|NCT04294667|469886676|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
130523825|NCT04294667|469886675|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
130523826|NCT04294667|469886676|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
130523827|NCT04294667|469886675|FG000|Overall Study|Subject Moved to Another State|0|||
130523828|NCT04294667|469886676|FG001|Overall Study|Subject Moved to Another State|1|||
130523829|NCT04294667|469886675|FG000|Overall Study|Adverse event, serious fatal|0|||
130523830|NCT04294667|469886676|FG001|Overall Study|Adverse event, serious fatal|1|||
130523831|NCT04294667|469886675|FG000|Overall Study|Adverse event, non-fatal|3|||
130523832|NCT04294667|469886676|FG001|Overall Study|Adverse event, non-fatal|4|||
130523833|NCT00756457|469886677|FG000|Overall Study|Lost to Follow-up|1|||
130523834|NCT00756457|469886678|FG001|Overall Study|Lost to Follow-up|2|||
130523835|NCT01777490|469886681|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
130523836|NCT01777490|469886682|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
130523837|NCT01777490|469886683|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
130523838|NCT01777490|469886684|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
130523839|NCT02818998|469886687|FG000|Overall Study|Adverse Event|3|||
130523840|NCT02818998|469886688|FG001|Overall Study|Adverse Event|2|||
130523841|NCT02818998|469886689|FG002|Overall Study|Adverse Event|1|||
130523842|NCT02818998|469886687|FG000|Overall Study|Lost to Follow-up|4|||
130523843|NCT02818998|469886688|FG001|Overall Study|Lost to Follow-up|1|||
130523844|NCT02818998|469886689|FG002|Overall Study|Lost to Follow-up|2|||
130523845|NCT02818998|469886687|FG000|Overall Study|Withdrawal by sponsor|0|||
130523846|NCT02818998|469886688|FG001|Overall Study|Withdrawal by sponsor|1|||
130523847|NCT02818998|469886689|FG002|Overall Study|Withdrawal by sponsor|1|||
130523848|NCT02818998|469886687|FG000|Overall Study|Death|3|||
130523849|NCT02818998|469886688|FG001|Overall Study|Death|6|||
130523850|NCT02818998|469886689|FG002|Overall Study|Death|8|||
130523851|NCT02818998|469886687|FG000|Overall Study|Withdrawal by Subject|7|||
130523852|NCT02818998|469886688|FG001|Overall Study|Withdrawal by Subject|6|||
130523853|NCT02818998|469886689|FG002|Overall Study|Withdrawal by Subject|6|||
130576480|NCT00953758|470074893|FG000|Overall Study|Participant refused further follow-up|0|||
130576481|NCT00953758|470074894|FG001|Overall Study|Participant refused further follow-up|0|||
130576482|NCT00953758|470074895|FG002|Overall Study|Participant refused further follow-up|1|||
130576483|NCT00953758|470074896|FG003|Overall Study|Participant refused further follow-up|0|||
130576484|NCT00953758|470074897|FG004|Overall Study|Participant refused further follow-up|3|||
130576485|NCT00953758|470074898|FG005|Overall Study|Participant refused further follow-up|0|||
130576486|NCT00953758|470074899|FG006|Overall Study|Participant refused further follow-up|0|||
130576487|NCT00953758|470074900|FG007|Overall Study|Participant refused further follow-up|0|||
130576488|NCT00953758|470074901|FG008|Overall Study|Participant refused further follow-up|1|||
130576489|NCT00953758|470074902|FG009|Overall Study|Participant refused further follow-up|0|||
130576490|NCT00953758|470074893|FG000|Overall Study|Lost to Follow-up|0|||
130576491|NCT00953758|470074894|FG001|Overall Study|Lost to Follow-up|0|||
130576492|NCT00953758|470074895|FG002|Overall Study|Lost to Follow-up|0|||
130576493|NCT00953758|470074896|FG003|Overall Study|Lost to Follow-up|1|||
130576494|NCT00953758|470074897|FG004|Overall Study|Lost to Follow-up|0|||
130576495|NCT00953758|470074898|FG005|Overall Study|Lost to Follow-up|0|||
130576496|NCT00953758|470074899|FG006|Overall Study|Lost to Follow-up|0|||
130576497|NCT00953758|470074900|FG007|Overall Study|Lost to Follow-up|1|||
130576498|NCT00953758|470074901|FG008|Overall Study|Lost to Follow-up|0|||
130576499|NCT00953758|470074902|FG009|Overall Study|Lost to Follow-up|1|||
130576500|NCT00953758|470074893|FG000|Overall Study|Physician Decision|0|||
130576501|NCT00953758|470074894|FG001|Overall Study|Physician Decision|0|||
130576502|NCT00953758|470074895|FG002|Overall Study|Physician Decision|0|||
130576503|NCT00953758|470074896|FG003|Overall Study|Physician Decision|0|||
130576504|NCT00953758|470074897|FG004|Overall Study|Physician Decision|1|||
130576505|NCT00953758|470074898|FG005|Overall Study|Physician Decision|0|||
130576506|NCT00953758|470074899|FG006|Overall Study|Physician Decision|0|||
130576507|NCT00953758|470074900|FG007|Overall Study|Physician Decision|0|||
130576508|NCT00953758|470074901|FG008|Overall Study|Physician Decision|0|||
130576509|NCT00953758|470074902|FG009|Overall Study|Physician Decision|0|||
130576510|NCT00953758|470074893|FG000|Overall Study|Disease progression|0|||
130576511|NCT00953758|470074894|FG001|Overall Study|Disease progression|0|||
130576512|NCT00953758|470074895|FG002|Overall Study|Disease progression|0|||
130576513|NCT00953758|470074896|FG003|Overall Study|Disease progression|0|||
130576514|NCT00953758|470074897|FG004|Overall Study|Disease progression|1|||
130576515|NCT00953758|470074898|FG005|Overall Study|Disease progression|0|||
130576516|NCT00953758|470074899|FG006|Overall Study|Disease progression|0|||
130576517|NCT00953758|470074900|FG007|Overall Study|Disease progression|0|||
130576518|NCT00953758|470074901|FG008|Overall Study|Disease progression|0|||
130576519|NCT00953758|470074902|FG009|Overall Study|Disease progression|0|||
130576520|NCT00953758|470074893|FG000|Overall Study|Participant went for transplant|0|||
130576521|NCT00953758|470074894|FG001|Overall Study|Participant went for transplant|0|||
130576522|NCT00953758|470074895|FG002|Overall Study|Participant went for transplant|0|||
130576523|NCT00953758|470074896|FG003|Overall Study|Participant went for transplant|0|||
130576524|NCT00953758|470074897|FG004|Overall Study|Participant went for transplant|0|||
130576525|NCT00953758|470074898|FG005|Overall Study|Participant went for transplant|0|||
130576526|NCT00953758|470074899|FG006|Overall Study|Participant went for transplant|0|||
130576527|NCT00953758|470074900|FG007|Overall Study|Participant went for transplant|0|||
130576528|NCT00953758|470074901|FG008|Overall Study|Participant went for transplant|1|||
130576529|NCT00953758|470074902|FG009|Overall Study|Participant went for transplant|0|||
130576530|NCT02682901|470074903|FG000|Overall Study|Adverse Event|10|||
130576531|NCT02682901|470074904|FG001|Overall Study|Adverse Event|3|||
130576532|NCT02682901|470074903|FG000|Overall Study|Lack of Efficacy|0|||
130576533|NCT02682901|470074904|FG001|Overall Study|Lack of Efficacy|1|||
130576534|NCT03298022|470074905|FG000|Overall Study|Lack of Efficacy|4|||
130576535|NCT03298022|470074905|FG000|Overall Study|Withdrawal by Subject|7|||
130576536|NCT03298022|470074905|FG000|Overall Study|Adverse Event|1|||
130576537|NCT03298022|470074905|FG000|Overall Study|disease relapse|1|||
130576538|NCT01422239|470074908|FG000|Overall Study|Lost to Follow-up|4|||
130576539|NCT01422239|470074909|FG001|Overall Study|Lost to Follow-up|3|||
130576540|NCT03167073|470074910|FG000|Overall Study|Stillbirth|1|||
130576541|NCT03167073|470074911|FG001|Overall Study|Stillbirth|0|||
130576542|NCT01276236|470074912|FG000|Overall Study|Lack of Efficacy|2|||
130576543|NCT01276236|470074912|FG000|Overall Study|Withdrawal by Subject|4|||
130576544|NCT01400451|470074913|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
130523854|NCT02818998|469886687|FG000|Overall Study|Physician Decision|1|||
130523855|NCT02818998|469886688|FG001|Overall Study|Physician Decision|0|||
130523856|NCT02818998|469886689|FG002|Overall Study|Physician Decision|0|||
130523857|NCT00632021|469886693|FG000|Overall Study|Withdrawal/death|4|||
130523858|NCT00632021|469886694|FG001|Overall Study|Withdrawal/death|7|||
130523859|NCT00952848|469886697|FG000|Overall Study|Withdrawal by Subject|4|||
130523860|NCT00458393|469886698|FG000|Overall Study|Withdrawal by Subject|67|||
130523861|NCT00458393|469886699|FG001|Overall Study|Withdrawal by Subject|80|||
130523862|NCT00458393|469886698|FG000|Overall Study|Physician Decision|31|||
130523863|NCT00458393|469886699|FG001|Overall Study|Physician Decision|22|||
130523864|NCT00458393|469886698|FG000|Overall Study|Relocated|77|||
130523865|NCT00458393|469886699|FG001|Overall Study|Relocated|81|||
130523866|NCT00458393|469886698|FG000|Overall Study|Lost to Follow-up|115|||
130523867|NCT00458393|469886699|FG001|Overall Study|Lost to Follow-up|92|||
130523868|NCT00458393|469886698|FG000|Overall Study|Sites marked other on the form.|19|||
130523869|NCT00458393|469886699|FG001|Overall Study|Sites marked other on the form.|20|||
130523870|NCT00857233|469886702|FG000|Overall Study|Adverse Event|24|||
130523871|NCT00857233|469886702|FG000|Overall Study|Lack of Efficacy|1|||
130523872|NCT00857233|469886702|FG000|Overall Study|Non-compliance|1|||
130523873|NCT00857233|469886702|FG000|Overall Study|Withdrawal of Consent|9|||
130523874|NCT00857233|469886702|FG000|Overall Study|Lost to Follow-up|4|||
130523875|NCT00857233|469886702|FG000|Overall Study|Nursing Home Placement|14|||
130523876|NCT00857233|469886702|FG000|Overall Study|Other Reasons|2|||
130523877|NCT05043883|469886703|FG000|Overall Study|Minimum required measurements could not be taken|4|||
130523878|NCT01587118|469886704|FG000|Overall Study|Adverse Event|3|||
130523879|NCT01587118|469886704|FG000|Overall Study|Lost to Follow-up|2|||
130523880|NCT01587118|469886704|FG000|Overall Study|Relocation|1|||
130523881|NCT01587118|469886704|FG000|Overall Study|nonresponse|1|||
130523882|NCT00537329|469886705|FG000|Overall Study|Death|10|||
130523883|NCT00537329|469886705|FG000|Overall Study|Adverse Event|3|||
130523884|NCT00537329|469886705|FG000|Overall Study|Lack of Efficacy|2|||
130523885|NCT00537329|469886705|FG000|Overall Study|Lost to Follow-up|6|||
130523886|NCT00537329|469886705|FG000|Overall Study|Withdrawal by Subject|4|||
130523887|NCT00537329|469886705|FG000|Overall Study|Other|1|||
130523888|NCT02287233|469886706|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
130523889|NCT02287233|469886707|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
130523890|NCT02287233|469886708|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
130523891|NCT02287233|469886706|FG000|Overall Study|Adverse Event Related to Progression|0|||
130523892|NCT02287233|469886707|FG001|Overall Study|Adverse Event Related to Progression|2|||
130523893|NCT02287233|469886708|FG002|Overall Study|Adverse Event Related to Progression|8|||
130523894|NCT02287233|469886706|FG000|Overall Study|Physician Decision|1|||
130523895|NCT02287233|469886707|FG001|Overall Study|Physician Decision|2|||
130523896|NCT02287233|469886708|FG002|Overall Study|Physician Decision|4|||
130523897|NCT02287233|469886706|FG000|Overall Study|Progressive Disease with Death|0|||
130523898|NCT02287233|469886707|FG001|Overall Study|Progressive Disease with Death|0|||
130523899|NCT02287233|469886708|FG002|Overall Study|Progressive Disease with Death|10|||
130523900|NCT02287233|469886706|FG000|Overall Study|Progressive Disease Without Death|2|||
130523901|NCT02287233|469886707|FG001|Overall Study|Progressive Disease Without Death|3|||
130523902|NCT02287233|469886708|FG002|Overall Study|Progressive Disease Without Death|20|||
130523903|NCT02287233|469886706|FG000|Overall Study|Withdrawal by Subject|1|||
130523904|NCT02287233|469886707|FG001|Overall Study|Withdrawal by Subject|1|||
130523905|NCT02287233|469886708|FG002|Overall Study|Withdrawal by Subject|7|||
130523906|NCT02287233|469886706|FG000|Overall Study|Other|3|||
130523907|NCT02287233|469886707|FG001|Overall Study|Other|0|||
130523908|NCT02287233|469886708|FG002|Overall Study|Other|15|||
130523909|NCT02287233|469886706|FG000|Overall Study|Did Not Receive Treatment|0|||
130523910|NCT02287233|469886707|FG001|Overall Study|Did Not Receive Treatment|0|||
130523911|NCT02287233|469886708|FG002|Overall Study|Did Not Receive Treatment|2|||
130523912|NCT00085566|469886709|FG000|Overall Study|Adverse Event|0|||
130523913|NCT00085566|469886710|FG001|Overall Study|Adverse Event|0|||
130523914|NCT00085566|469886711|FG002|Overall Study|Adverse Event|10|||
130523915|NCT00085566|469886709|FG000|Overall Study|Patient Not treated|0|||
130523916|NCT00085566|469886710|FG001|Overall Study|Patient Not treated|0|||
130523917|NCT00085566|469886711|FG002|Overall Study|Patient Not treated|3|||
130523918|NCT00085566|469886709|FG000|Overall Study|Clinical progression|0|||
130523919|NCT00085566|469886710|FG001|Overall Study|Clinical progression|0|||
130523920|NCT00085566|469886711|FG002|Overall Study|Clinical progression|1|||
130523921|NCT03174782|469886712|FG000|Overall Study|Protocol Violation|1|||
130523922|NCT03174782|469886713|FG001|Overall Study|Protocol Violation|0|||
130523923|NCT03174782|469886712|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
130523924|NCT03174782|469886713|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
130523925|NCT03178045|469886714|FG000|Overall Study|Withdrawal by Subject|5|||
130523926|NCT03178045|469886715|FG001|Overall Study|Withdrawal by Subject|7|||
130523927|NCT03178045|469886714|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
130523928|NCT03178045|469886715|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
130523929|NCT03178045|469886714|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
130576545|NCT01400451|470074914|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
130576546|NCT01400451|470074915|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
130576547|NCT01400451|470074913|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
130576548|NCT01400451|470074914|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
130576549|NCT01400451|470074915|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
130576550|NCT01400451|470074913|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
130576551|NCT01400451|470074914|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
130576552|NCT01400451|470074915|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
130576553|NCT01400451|470074913|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
130576554|NCT01400451|470074914|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
130576555|NCT01400451|470074915|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
130576556|NCT01400451|470074913|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
130576557|NCT01400451|470074914|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
130576558|NCT01400451|470074915|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
130576559|NCT00044512|470074916|FG000|Follow Up|Lost to Follow-up|2|||
130576560|NCT02799069|470074918|FG000|Overall Study|Adverse Event|0|||
130576561|NCT02799069|470074919|FG001|Overall Study|Adverse Event|2|||
130576562|NCT02799069|470074920|FG002|Overall Study|Adverse Event|2|||
130576563|NCT02799069|470074918|FG000|Overall Study|Lack of Efficacy|2|||
130576564|NCT02799069|470074919|FG001|Overall Study|Lack of Efficacy|0|||
130576565|NCT02799069|470074920|FG002|Overall Study|Lack of Efficacy|0|||
130576566|NCT02799069|470074918|FG000|Overall Study|Lost to Follow-up|1|||
130576567|NCT02799069|470074919|FG001|Overall Study|Lost to Follow-up|1|||
130576568|NCT02799069|470074920|FG002|Overall Study|Lost to Follow-up|0|||
130576569|NCT02799069|470074918|FG000|Overall Study|Withdrawal by Subject|4|||
130576570|NCT02799069|470074919|FG001|Overall Study|Withdrawal by Subject|4|||
130576571|NCT02799069|470074920|FG002|Overall Study|Withdrawal by Subject|3|||
130576572|NCT02799069|470074918|FG000|Overall Study|Protocol Violation|1|||
130576573|NCT02799069|470074919|FG001|Overall Study|Protocol Violation|0|||
130576574|NCT02799069|470074920|FG002|Overall Study|Protocol Violation|2|||
130576575|NCT02695628|470074925|FG000|Overall Study|Withdrawal by Subject|1|||
130523930|NCT03178045|469886715|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
130523931|NCT03432390|469886718|FG000|Apnea Period|Protocol Violation|2|||
130523932|NCT03432390|469886719|FG001|Apnea Period|Protocol Violation|2|||
130523933|NCT02058836|469886721|FG000|Overall Study|Withdrawal by Subject|1|||
130523934|NCT02058836|469886722|FG001|Overall Study|Withdrawal by Subject|1|||
130523935|NCT00267098|469886723|FG000|Overall Study|Death|0|||
130523936|NCT00267098|469886724|FG001|Overall Study|Death|0|||
130523937|NCT00267098|469886725|FG002|Overall Study|Death|57|||
130523938|NCT00267098|469886726|FG003|Overall Study|Death|66|||
130523939|NCT00267098|469886727|FG004|Overall Study|Death|14|||
130523940|NCT00267098|469886728|FG005|Overall Study|Death|23|||
130523941|NCT00267098|469886729|FG006|Overall Study|Death|28|||
130523942|NCT00267098|469886730|FG007|Overall Study|Death|9|||
130523943|NCT00267098|469886723|FG000|Overall Study|Lost to Follow-up|0|||
130523944|NCT00267098|469886724|FG001|Overall Study|Lost to Follow-up|0|||
130523945|NCT00267098|469886725|FG002|Overall Study|Lost to Follow-up|6|||
130523946|NCT00267098|469886726|FG003|Overall Study|Lost to Follow-up|5|||
130523947|NCT00267098|469886727|FG004|Overall Study|Lost to Follow-up|2|||
130523948|NCT00267098|469886728|FG005|Overall Study|Lost to Follow-up|3|||
130523949|NCT00267098|469886729|FG006|Overall Study|Lost to Follow-up|1|||
130576576|NCT01681433|470074926|FG000|Overall Study|Lack of Efficacy|23|||
130576577|NCT01681433|470074927|FG001|Overall Study|Lack of Efficacy|23|||
130576578|NCT01681433|470074926|FG000|Overall Study|Withdrawal by Subject|5|||
130523950|NCT00267098|469886730|FG007|Overall Study|Lost to Follow-up|1|||
130523951|NCT00267098|469886723|FG000|Overall Study|Withdrawal by Subject|8|||
130576579|NCT01681433|470074927|FG001|Overall Study|Withdrawal by Subject|5|||
130576580|NCT01681433|470074926|FG000|Overall Study|Protocol Violation|2|||
130523952|NCT00267098|469886724|FG001|Overall Study|Withdrawal by Subject|0|||
130523953|NCT00267098|469886725|FG002|Overall Study|Withdrawal by Subject|24|||
130523954|NCT00267098|469886726|FG003|Overall Study|Withdrawal by Subject|21|||
130523955|NCT00267098|469886727|FG004|Overall Study|Withdrawal by Subject|12|||
130576581|NCT01681433|470074927|FG001|Overall Study|Protocol Violation|0|||
130576582|NCT01681433|470074926|FG000|Overall Study|Adverse Event|2|||
130576583|NCT01681433|470074927|FG001|Overall Study|Adverse Event|4|||
130576584|NCT01681433|470074926|FG000|Overall Study|Lost to Follow-up|0|||
130576585|NCT01681433|470074927|FG001|Overall Study|Lost to Follow-up|1|||
130576586|NCT01844895|470074928|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
130576587|NCT01844895|470074928|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
130576588|NCT01844895|470074928|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
130576589|NCT01844895|470074928|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
130576590|NCT01844895|470074928|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
130576591|NCT01844895|470074928|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
130576592|NCT01844895|470074928|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
130576593|NCT00511355|470074932|FG000|Overall Study|Adverse Event|4|||
130576594|NCT00511355|470074933|FG001|Overall Study|Adverse Event|4|||
130576595|NCT00511355|470074932|FG000|Overall Study|Pregnancy Wish|1|||
130576596|NCT00511355|470074933|FG001|Overall Study|Pregnancy Wish|0|||
130576597|NCT00511355|470074932|FG000|Overall Study|Lost to Follow-up|2|||
130576598|NCT00511355|470074933|FG001|Overall Study|Lost to Follow-up|1|||
130523956|NCT00267098|469886728|FG005|Overall Study|Withdrawal by Subject|9|||
130523957|NCT00267098|469886729|FG006|Overall Study|Withdrawal by Subject|12|||
130523958|NCT00267098|469886730|FG007|Overall Study|Withdrawal by Subject|5|||
130523959|NCT00267098|469886723|FG000|Overall Study|Physician Decision|5|||
130523960|NCT00267098|469886724|FG001|Overall Study|Physician Decision|0|||
130523961|NCT00267098|469886725|FG002|Overall Study|Physician Decision|7|||
130523962|NCT00267098|469886726|FG003|Overall Study|Physician Decision|11|||
130523963|NCT00267098|469886727|FG004|Overall Study|Physician Decision|5|||
130523964|NCT00267098|469886728|FG005|Overall Study|Physician Decision|4|||
130523965|NCT00267098|469886729|FG006|Overall Study|Physician Decision|3|||
130523966|NCT00267098|469886730|FG007|Overall Study|Physician Decision|0|||
130523967|NCT00267098|469886723|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
130523968|NCT00267098|469886724|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523969|NCT00267098|469886725|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523970|NCT00267098|469886726|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523971|NCT00267098|469886727|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130523972|NCT00267098|469886728|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523973|NCT00267098|469886729|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523974|NCT00267098|469886730|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130523975|NCT00267098|469886723|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523976|NCT00267098|469886724|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
130523977|NCT00267098|469886725|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523978|NCT00267098|469886726|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523979|NCT00267098|469886727|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523980|NCT00267098|469886728|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523981|NCT00267098|469886729|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523982|NCT00267098|469886730|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
130523983|NCT00267098|469886723|FG000|Overall Study|Site closure|0|||
130523984|NCT00267098|469886724|FG001|Overall Study|Site closure|0|||
130523985|NCT00267098|469886725|FG002|Overall Study|Site closure|0|||
130523986|NCT00267098|469886726|FG003|Overall Study|Site closure|1|||
130523987|NCT00267098|469886727|FG004|Overall Study|Site closure|0|||
130523988|NCT00267098|469886728|FG005|Overall Study|Site closure|1|||
130523989|NCT00267098|469886729|FG006|Overall Study|Site closure|1|||
130523990|NCT00267098|469886730|FG007|Overall Study|Site closure|0|||
130523991|NCT00267098|469886723|FG000|Overall Study|Explanted Medtronic device|0|||
130523992|NCT00267098|469886724|FG001|Overall Study|Explanted Medtronic device|0|||
130523993|NCT00267098|469886725|FG002|Overall Study|Explanted Medtronic device|0|||
130523994|NCT00267098|469886726|FG003|Overall Study|Explanted Medtronic device|1|||
130523995|NCT00267098|469886727|FG004|Overall Study|Explanted Medtronic device|0|||
130523996|NCT00267098|469886728|FG005|Overall Study|Explanted Medtronic device|0|||
130523997|NCT00267098|469886729|FG006|Overall Study|Explanted Medtronic device|0|||
130523998|NCT00267098|469886730|FG007|Overall Study|Explanted Medtronic device|0|||
130523999|NCT00267098|469886723|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524000|NCT00267098|469886724|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524001|NCT00267098|469886725|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130576599|NCT00511355|470074932|FG000|Overall Study|Other Reason|0|||
130576600|NCT00511355|470074933|FG001|Overall Study|Other Reason|1|||
130524002|NCT00267098|469886726|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524003|NCT00267098|469886727|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
130524004|NCT00267098|469886728|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524005|NCT00267098|469886729|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524006|NCT00267098|469886730|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130524007|NCT00267098|469886723|FG000|Overall Study|Subject listed for heart transplant|0|||
130524008|NCT00267098|469886724|FG001|Overall Study|Subject listed for heart transplant|0|||
130524009|NCT00267098|469886725|FG002|Overall Study|Subject listed for heart transplant|0|||
130576601|NCT00511355|470074932|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
130576602|NCT00511355|470074933|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
130524010|NCT00267098|469886726|FG003|Overall Study|Subject listed for heart transplant|0|||
130524011|NCT00267098|469886727|FG004|Overall Study|Subject listed for heart transplant|0|||
130524012|NCT00267098|469886728|FG005|Overall Study|Subject listed for heart transplant|0|||
130524013|NCT00267098|469886729|FG006|Overall Study|Subject listed for heart transplant|1|||
130524014|NCT00267098|469886730|FG007|Overall Study|Subject listed for heart transplant|0|||
130524015|NCT00267098|469886723|FG000|Overall Study|Sponsor withdrew subject|0|||
130524016|NCT00267098|469886724|FG001|Overall Study|Sponsor withdrew subject|0|||
130524017|NCT00267098|469886725|FG002|Overall Study|Sponsor withdrew subject|0|||
130524018|NCT00267098|469886726|FG003|Overall Study|Sponsor withdrew subject|1|||
130524019|NCT00267098|469886727|FG004|Overall Study|Sponsor withdrew subject|0|||
130524020|NCT00267098|469886728|FG005|Overall Study|Sponsor withdrew subject|0|||
130524021|NCT00267098|469886729|FG006|Overall Study|Sponsor withdrew subject|0|||
130524022|NCT00267098|469886730|FG007|Overall Study|Sponsor withdrew subject|0|||
130524023|NCT00547534|469886736|FG000|Overall Study|Adverse Event|7|||
130524024|NCT00547534|469886736|FG000|Overall Study|Disease Progression|4|||
130524025|NCT02689453|469886740|FG000|Overall Study|Progressive disease|0|||
130524026|NCT02689453|469886741|FG001|Overall Study|Progressive disease|1|||
130524027|NCT02689453|469886742|FG002|Overall Study|Progressive disease|1|||
130524028|NCT02688530|469886743|FG000|Overall Study|Withdrawal by Subject|0|||
130524029|NCT02688530|469886744|FG001|Overall Study|Withdrawal by Subject|1|||
130524030|NCT02688530|469886745|FG002|Overall Study|Withdrawal by Subject|0|||
130524031|NCT02688530|469886746|FG003|Overall Study|Withdrawal by Subject|0|||
130524032|NCT02688530|469886743|FG000|Overall Study|Lost to Follow-up|0|||
130524033|NCT02688530|469886744|FG001|Overall Study|Lost to Follow-up|0|||
130524034|NCT02688530|469886745|FG002|Overall Study|Lost to Follow-up|2|||
130524035|NCT02688530|469886746|FG003|Overall Study|Lost to Follow-up|0|||
130524036|NCT01658020|469886747|FG000|Overall Study|Adverse Event|3|||
130524037|NCT01658020|469886748|FG001|Overall Study|Adverse Event|3|||
130524038|NCT01658020|469886747|FG000|Overall Study|Lost to Follow-up|1|||
130524039|NCT01658020|469886748|FG001|Overall Study|Lost to Follow-up|0|||
130524040|NCT01658020|469886747|FG000|Overall Study|Withdrawal by Subject|4|||
130524041|NCT01658020|469886748|FG001|Overall Study|Withdrawal by Subject|5|||
130524042|NCT01658020|469886747|FG000|Overall Study|Protocol Violation|0|||
130524043|NCT01658020|469886748|FG001|Overall Study|Protocol Violation|1|||
130524044|NCT04206085|469886749|FG000|Overall Study|Lost to Follow-up|0|||
130524045|NCT04206085|469886750|FG001|Overall Study|Lost to Follow-up|1|||
130524046|NCT04206085|469886751|FG002|Overall Study|Lost to Follow-up|0|||
130524047|NCT04206085|469886749|FG000|Overall Study|Lost to Follow-up|0|||
130524048|NCT04206085|469886750|FG001|Overall Study|Lost to Follow-up|0|||
130524049|NCT04206085|469886751|FG002|Overall Study|Lost to Follow-up|1|||
130524050|NCT00815919|469886754|FG000|Overall Study|Unrelated Fungal Infection|1|||
130524051|NCT00815919|469886754|FG000|Overall Study|AML Relapse|1|||
130524052|NCT00815919|469886754|FG000|Overall Study|Lack of Efficacy|2|||
130524053|NCT01466790|469886757|FG000|Overall Study|Adverse Event|1|||
130524054|NCT01466790|469886758|FG001|Overall Study|Adverse Event|0|||
130524055|NCT01466790|469886759|FG002|Overall Study|Adverse Event|0|||
130524056|NCT01466790|469886760|FG003|Overall Study|Adverse Event|0|||
130524057|NCT01466790|469886761|FG004|Overall Study|Adverse Event|2|||
130524058|NCT01466790|469886762|FG005|Overall Study|Adverse Event|0|||
130524059|NCT01466790|469886763|FG006|Overall Study|Adverse Event|0|||
130524060|NCT01466790|469886764|FG007|Overall Study|Adverse Event|0|||
130524061|NCT01466790|469886757|FG000|Overall Study|Lost to Follow-up|2|||
130524062|NCT01466790|469886758|FG001|Overall Study|Lost to Follow-up|0|||
130524063|NCT01466790|469886759|FG002|Overall Study|Lost to Follow-up|0|||
130524064|NCT01466790|469886760|FG003|Overall Study|Lost to Follow-up|0|||
130524065|NCT01466790|469886761|FG004|Overall Study|Lost to Follow-up|0|||
130524066|NCT01466790|469886762|FG005|Overall Study|Lost to Follow-up|0|||
130524067|NCT01466790|469886763|FG006|Overall Study|Lost to Follow-up|0|||
130524068|NCT01466790|469886764|FG007|Overall Study|Lost to Follow-up|0|||
130524069|NCT01466790|469886757|FG000|Overall Study|Withdrawal by Subject|1|||
130524070|NCT01466790|469886758|FG001|Overall Study|Withdrawal by Subject|1|||
130524071|NCT01466790|469886759|FG002|Overall Study|Withdrawal by Subject|0|||
130524072|NCT01466790|469886760|FG003|Overall Study|Withdrawal by Subject|0|||
130524073|NCT01466790|469886761|FG004|Overall Study|Withdrawal by Subject|1|||
130524074|NCT01466790|469886762|FG005|Overall Study|Withdrawal by Subject|0|||
130524075|NCT01466790|469886763|FG006|Overall Study|Withdrawal by Subject|1|||
130524076|NCT01466790|469886764|FG007|Overall Study|Withdrawal by Subject|1|||
130524077|NCT00307047|469888511|FG000|Overall Study|Lost to Follow-up|35|||
130524078|NCT00307047|469888512|FG001|Overall Study|Lost to Follow-up|24|||
130524079|NCT00307047|469888511|FG000|Overall Study|Withdrawal by Subject|6|||
130524080|NCT00307047|469888512|FG001|Overall Study|Withdrawal by Subject|6|||
130524081|NCT00307047|469888511|FG000|Overall Study|Physician Decision|1|||
130524082|NCT00307047|469888512|FG001|Overall Study|Physician Decision|2|||
130524083|NCT00307047|469888511|FG000|Overall Study|Lost to follow-up for other reasons|0|||
130524084|NCT00307047|469888512|FG001|Overall Study|Lost to follow-up for other reasons|1|||
130524085|NCT00307047|469888511|FG000|Overall Study|All death, all MI, all Revascularization|27|||
130524086|NCT00307047|469888512|FG001|Overall Study|All death, all MI, all Revascularization|16|||
130524087|NCT00487825|469888513|FG000|Overall Study|Adverse Event|2|||
130524088|NCT00487825|469888514|FG001|Overall Study|Adverse Event|2|||
130524089|NCT00487825|469888513|FG000|Overall Study|Lack of Efficacy|1|||
130524090|NCT00487825|469888514|FG001|Overall Study|Lack of Efficacy|1|||
130524091|NCT00487825|469888513|FG000|Overall Study|Other|3|||
130524092|NCT00487825|469888514|FG001|Overall Study|Other|2|||
130524093|NCT02104505|469888515|FG000|First Intervention (14 Days)|Adverse Event|2|||
130524094|NCT02104505|469888516|FG001|First Intervention (14 Days)|Adverse Event|0|||
130524095|NCT02104505|469888515|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
130524096|NCT02104505|469888516|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
130524097|NCT02104505|469888515|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
130524098|NCT02104505|469888516|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
130524099|NCT02104505|469888515|FG000|First Intervention (14 Days)|exclusionary condition|0|||
130524100|NCT02104505|469888516|FG001|First Intervention (14 Days)|exclusionary condition|1|||
130524101|NCT02104505|469888515|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130524102|NCT02104505|469888516|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130524103|NCT02104505|469888515|FG000|Second Intervention (14 Days)|Adverse Event|2|||
130524104|NCT02104505|469888516|FG001|Second Intervention (14 Days)|Adverse Event|0|||
130524105|NCT01639742|469888517|FG000|Overall Study|Study Ongoing|17|||
130524106|NCT01639742|469888517|FG000|Overall Study|Lost to Follow-up|1|||
130524107|NCT01190644|469888518|FG000|Overall Study|Death|2|||
130524108|NCT01190644|469888518|FG000|Overall Study|Disease progression|1|||
130524109|NCT02366143|469888519|FG000|Overall Study|Death|307|||
130524110|NCT02366143|469888520|FG001|Overall Study|Death|278|||
130524111|NCT02366143|469888521|FG002|Overall Study|Death|280|||
130524112|NCT02366143|469888519|FG000|Overall Study|Lost to Follow-up|2|||
130524113|NCT02366143|469888520|FG001|Overall Study|Lost to Follow-up|4|||
130524114|NCT02366143|469888521|FG002|Overall Study|Lost to Follow-up|2|||
130524115|NCT02366143|469888519|FG000|Overall Study|Physician Decision|1|||
130524116|NCT02366143|469888520|FG001|Overall Study|Physician Decision|2|||
130524117|NCT02366143|469888521|FG002|Overall Study|Physician Decision|1|||
130524118|NCT02366143|469888519|FG000|Overall Study|Protocol Violation|0|||
130524119|NCT02366143|469888520|FG001|Overall Study|Protocol Violation|0|||
130524120|NCT02366143|469888521|FG002|Overall Study|Protocol Violation|2|||
130524121|NCT02366143|469888519|FG000|Overall Study|Withdrawal by Subject|16|||
130524122|NCT02366143|469888520|FG001|Overall Study|Withdrawal by Subject|17|||
130524123|NCT02366143|469888521|FG002|Overall Study|Withdrawal by Subject|22|||
130524124|NCT02366143|469888519|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
130524125|NCT02366143|469888520|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
130524126|NCT02366143|469888521|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
130524127|NCT02366143|469888519|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
130524128|NCT02366143|469888520|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
130524129|NCT02366143|469888521|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
130524130|NCT02366143|469888519|FG000|Overall Study|Randomization Error|1|||
130524131|NCT02366143|469888520|FG001|Overall Study|Randomization Error|0|||
130524132|NCT02366143|469888521|FG002|Overall Study|Randomization Error|0|||
130524133|NCT02366143|469888519|FG000|Overall Study|PI Move and Site Closure|1|||
130524134|NCT02366143|469888520|FG001|Overall Study|PI Move and Site Closure|0|||
130524135|NCT02366143|469888521|FG002|Overall Study|PI Move and Site Closure|1|||
130524136|NCT02366143|469888519|FG000|Overall Study|Study Terminated By Sponsor|0|||
130524137|NCT02366143|469888520|FG001|Overall Study|Study Terminated By Sponsor|0|||
130524138|NCT02366143|469888521|FG002|Overall Study|Study Terminated By Sponsor|2|||
130524139|NCT02366143|469888519|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
130524140|NCT02366143|469888520|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
130524141|NCT02366143|469888521|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
130524142|NCT02366143|469888519|FG000|Overall Study|Patient moved to roll-over study|1|||
130524143|NCT02366143|469888520|FG001|Overall Study|Patient moved to roll-over study|19|||
130524144|NCT02366143|469888521|FG002|Overall Study|Patient moved to roll-over study|28|||
130524145|NCT02366143|469888519|FG000|Overall Study|Patient moved to commercial stock|0|||
130524146|NCT02366143|469888520|FG001|Overall Study|Patient moved to commercial stock|0|||
130524147|NCT02366143|469888521|FG002|Overall Study|Patient moved to commercial stock|1|||
130524148|NCT02366143|469888519|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
130524149|NCT02366143|469888520|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
130524150|NCT02366143|469888521|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
130524151|NCT02366143|469888519|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
130524152|NCT02366143|469888520|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
130524153|NCT02366143|469888521|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
130524154|NCT02366143|469888519|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
130524155|NCT02366143|469888520|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
130524156|NCT02366143|469888521|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
130576603|NCT00511355|470074932|FG000|Overall Study|Withdrawal of informed consent|0|||
130576604|NCT00511355|470074933|FG001|Overall Study|Withdrawal of informed consent|1|||
130576605|NCT00511355|470074932|FG000|Overall Study|Other reason pre-treatment|0|||
130576606|NCT00511355|470074933|FG001|Overall Study|Other reason pre-treatment|1|||
130576607|NCT01627899|470074936|FG000|Overall Study|Study terminated early by sponsor.|5|||
130524157|NCT02366143|469888519|FG000|Overall Study|Requester's instructions|1|||
130524158|NCT02366143|469888520|FG001|Overall Study|Requester's instructions|1|||
130524159|NCT02366143|469888521|FG002|Overall Study|Requester's instructions|1|||
130576608|NCT04770779|470074937|FG000|Overall Study|Randomized, never treated|0|||
130576609|NCT04770779|470074938|FG001|Overall Study|Randomized, never treated|1|||
130576610|NCT04770779|470074937|FG000|Overall Study|Adverse Event|9|||
130576611|NCT04770779|470074938|FG001|Overall Study|Adverse Event|1|||
130576612|NCT04770779|470074937|FG000|Overall Study|Withdrawal by Subject|7|||
130576613|NCT04770779|470074938|FG001|Overall Study|Withdrawal by Subject|1|||
130576614|NCT04770779|470074937|FG000|Overall Study|Pregnancy|0|||
130576615|NCT04770779|470074938|FG001|Overall Study|Pregnancy|1|||
130576616|NCT03692052|470074939|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
130576617|NCT03692052|470074939|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
130576618|NCT03692052|470074939|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
130576619|NCT03692052|470074939|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
130576620|NCT05600309|470074940|FG000|Overall Study|Death|41|||
130576621|NCT05600309|470074941|FG001|Overall Study|Death|38|||
130576622|NCT05600309|470074940|FG000|Overall Study|Sponsor Decision|9|||
130576623|NCT05600309|470074941|FG001|Overall Study|Sponsor Decision|6|||
130576624|NCT04158648|470074942|FG000|Overall Study|Ongoing in the Study|69|||
130576625|NCT04158648|470074942|FG000|Overall Study|Withdrawal by Subject|4|||
130576626|NCT04209855|470074943|FG000|Overall Study|Death|161|||
130576627|NCT04209855|470074944|FG001|Overall Study|Death|177|||
130576628|NCT04209855|470074943|FG000|Overall Study|PI Discretion|1|||
130576629|NCT04209855|470074944|FG001|Overall Study|PI Discretion|1|||
130576630|NCT04209855|470074943|FG000|Overall Study|Lost to Follow-up|5|||
130576631|NCT04209855|470074944|FG001|Overall Study|Lost to Follow-up|2|||
130576632|NCT04209855|470074943|FG000|Overall Study|Withdrew consent|10|||
130576633|NCT04209855|470074944|FG001|Overall Study|Withdrew consent|24|||
130576634|NCT04209855|470074943|FG000|Overall Study|Sponsor decision|44|||
130576635|NCT04209855|470074944|FG001|Overall Study|Sponsor decision|18|||
130576636|NCT04209855|470074943|FG000|Overall Study|Other than specified|6|||
130576637|NCT04209855|470074944|FG001|Overall Study|Other than specified|4|||
130576638|NCT02289950|470074945|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
130576639|NCT02289950|470074946|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
130576640|NCT02289950|470074945|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
130576641|NCT02289950|470074946|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
130576642|NCT02289950|470074945|FG000|Overall Study|Lost to Follow-up|1|||
130576643|NCT02289950|470074946|FG001|Overall Study|Lost to Follow-up|0|||
130576644|NCT02289950|470074945|FG000|Overall Study|Physician Decision|9|||
130576645|NCT02289950|470074946|FG001|Overall Study|Physician Decision|3|||
130576646|NCT02289950|470074945|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
130576647|NCT02289950|470074946|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
130576648|NCT02289950|470074945|FG000|Overall Study|Withdrawal by Subject|1|||
130576649|NCT02289950|470074946|FG001|Overall Study|Withdrawal by Subject|3|||
130576650|NCT02289950|470074945|FG000|Overall Study|Test article held for greater than 28 days|0|||
130576651|NCT02289950|470074946|FG001|Overall Study|Test article held for greater than 28 days|1|||
130576652|NCT02289950|470074945|FG000|Overall Study|Adverse Event|11|||
130576653|NCT02289950|470074946|FG001|Overall Study|Adverse Event|3|||
130524160|NCT02366143|469888519|FG000|Overall Study|Uneligible|0|||
130524161|NCT02366143|469888520|FG001|Overall Study|Uneligible|1|||
130524162|NCT02366143|469888521|FG002|Overall Study|Uneligible|0|||
130524163|NCT02366143|469888519|FG000|Overall Study|Post Trial Migration|0|||
130524164|NCT02366143|469888520|FG001|Overall Study|Post Trial Migration|1|||
130524165|NCT02366143|469888521|FG002|Overall Study|Post Trial Migration|0|||
130524166|NCT02366143|469888519|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
130524167|NCT02366143|469888520|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
130524168|NCT02366143|469888521|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
130524169|NCT02366143|469888519|FG000|Overall Study|Patient switched to PTAP|0|||
130576654|NCT02289950|470074945|FG000|Overall Study|Death|1|||
130576655|NCT02289950|470074946|FG001|Overall Study|Death|1|||
130576656|NCT02289950|470074945|FG000|Overall Study|Other|5|||
130576657|NCT02289950|470074946|FG001|Overall Study|Other|2|||
130576658|NCT02289950|470074945|FG000|Overall Study|Not Treated|2|||
130576659|NCT02289950|470074946|FG001|Overall Study|Not Treated|1|||
130576660|NCT01250379|470074949|FG000|Overall Study|Death|141|||
130576661|NCT01250379|470074950|FG001|Overall Study|Death|148|||
130576662|NCT01250379|470074949|FG000|Overall Study|Withdrawal by Subject|32|||
130576663|NCT01250379|470074950|FG001|Overall Study|Withdrawal by Subject|20|||
130576664|NCT01250379|470074949|FG000|Overall Study|Physician Decision|11|||
130524170|NCT02366143|469888520|FG001|Overall Study|Patient switched to PTAP|1|||
130524171|NCT02366143|469888521|FG002|Overall Study|Patient switched to PTAP|0|||
130524172|NCT02366143|469888519|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
130524173|NCT02366143|469888520|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
130524174|NCT02366143|469888521|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
130524175|NCT04411186|469888522|FG000|Overall Study|Withdrawn due to protocol violation|0|||
130524176|NCT04411186|469888523|FG001|Overall Study|Withdrawn due to protocol violation|1|||
130524177|NCT01053247|469888524|FG000|Overall Study|Withdrawal by Subject|9|||
130524178|NCT01053247|469888525|FG001|Overall Study|Withdrawal by Subject|4|||
130524179|NCT01053247|469888526|FG002|Overall Study|Withdrawal by Subject|15|||
130524180|NCT01053247|469888524|FG000|Overall Study|Lack of Efficacy|1|||
130524181|NCT01053247|469888525|FG001|Overall Study|Lack of Efficacy|0|||
130524182|NCT01053247|469888526|FG002|Overall Study|Lack of Efficacy|1|||
130524183|NCT01053247|469888524|FG000|Overall Study|Protocol Violation|2|||
130524184|NCT01053247|469888525|FG001|Overall Study|Protocol Violation|1|||
130524185|NCT01053247|469888526|FG002|Overall Study|Protocol Violation|2|||
130524186|NCT01053247|469888524|FG000|Overall Study|Lost to Follow-up|8|||
130524187|NCT01053247|469888525|FG001|Overall Study|Lost to Follow-up|5|||
130524188|NCT01053247|469888526|FG002|Overall Study|Lost to Follow-up|7|||
130524189|NCT01053247|469888524|FG000|Overall Study|Adverse Event|0|||
130524190|NCT01053247|469888525|FG001|Overall Study|Adverse Event|9|||
130524191|NCT01053247|469888526|FG002|Overall Study|Adverse Event|3|||
130524192|NCT00701909|469888527|FG000|Overall Study|Withdrawal by Subject|0|||
130524193|NCT00701909|469888528|FG001|Overall Study|Withdrawal by Subject|1|||
130524194|NCT01385748|469888529|FG000|Overall Study|Withdrawal by Subject|7|||
130524195|NCT01385748|469888530|FG001|Overall Study|Withdrawal by Subject|4|||
130524196|NCT01385748|469888531|FG002|Overall Study|Withdrawal by Subject|5|||
130524197|NCT01385748|469888529|FG000|Overall Study|Noncompliance|3|||
130524198|NCT01385748|469888530|FG001|Overall Study|Noncompliance|1|||
130524199|NCT01385748|469888531|FG002|Overall Study|Noncompliance|6|||
130524200|NCT01385748|469888529|FG000|Overall Study|Other|1|||
130524201|NCT01385748|469888530|FG001|Overall Study|Other|7|||
130524202|NCT01385748|469888531|FG002|Overall Study|Other|1|||
130524203|NCT01385748|469888529|FG000|Overall Study|Adverse Event|4|||
130524204|NCT01385748|469888530|FG001|Overall Study|Adverse Event|2|||
130524205|NCT01385748|469888531|FG002|Overall Study|Adverse Event|1|||
130524206|NCT00174447|469888535|FG000|Overall Study|Adverse Event|19|||
130524207|NCT00174447|469888535|FG000|Overall Study|Withdrawal by Subject|15|||
130524208|NCT00174447|469888535|FG000|Overall Study|Protocol Violation|1|||
130524209|NCT00174447|469888535|FG000|Overall Study|Lack of Efficacy|1|||
130524210|NCT00174447|469888535|FG000|Overall Study|Administrative reason/Other|2|||
130524211|NCT01437423|469888538|FG000|Overall Study|Lost to Follow-up|12|||
130524212|NCT01437423|469888538|FG000|Overall Study|Off label usage|3|||
130524213|NCT00633945|469888539|FG000|Overall Study|Physician Decision|2|||
130524214|NCT03865953|469888540|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
130524215|NCT03865953|469888541|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130524216|NCT03865953|469888540|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
130524217|NCT03865953|469888541|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
130524218|NCT03865953|469888540|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
130524219|NCT03865953|469888541|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
130524220|NCT01271504|469888542|FG000|Overall Study|Death|7|||
130524221|NCT01271504|469888543|FG001|Overall Study|Death|6|||
130524222|NCT01271504|469888544|FG002|Overall Study|Death|32|||
130524223|NCT01271504|469888545|FG003|Overall Study|Death|32|||
130524224|NCT01271504|469888542|FG000|Overall Study|Lost to Follow-up|0|||
130524225|NCT01271504|469888543|FG001|Overall Study|Lost to Follow-up|1|||
130524226|NCT01271504|469888544|FG002|Overall Study|Lost to Follow-up|3|||
130524227|NCT01271504|469888545|FG003|Overall Study|Lost to Follow-up|1|||
130524228|NCT01271504|469888542|FG000|Overall Study|Protocol Violation|0|||
130524229|NCT01271504|469888543|FG001|Overall Study|Protocol Violation|0|||
130524230|NCT01271504|469888544|FG002|Overall Study|Protocol Violation|0|||
130524231|NCT01271504|469888545|FG003|Overall Study|Protocol Violation|2|||
130524232|NCT01271504|469888542|FG000|Overall Study|Administrative Reasons|0|||
130524233|NCT01271504|469888543|FG001|Overall Study|Administrative Reasons|0|||
130524234|NCT01271504|469888544|FG002|Overall Study|Administrative Reasons|6|||
130524235|NCT01271504|469888545|FG003|Overall Study|Administrative Reasons|5|||
130524236|NCT01271504|469888542|FG000|Overall Study|Withdrawal by Subject|0|||
130576665|NCT01250379|470074950|FG001|Overall Study|Physician Decision|3|||
130576666|NCT01250379|470074949|FG000|Overall Study|Protocol Violation|2|||
130524237|NCT01271504|469888543|FG001|Overall Study|Withdrawal by Subject|0|||
130524238|NCT01271504|469888544|FG002|Overall Study|Withdrawal by Subject|1|||
130524239|NCT01271504|469888545|FG003|Overall Study|Withdrawal by Subject|3|||
130524240|NCT01271504|469888542|FG000|Overall Study|Other|0|||
130524241|NCT01271504|469888543|FG001|Overall Study|Other|1|||
130524242|NCT01271504|469888544|FG002|Overall Study|Other|2|||
130524243|NCT01271504|469888545|FG003|Overall Study|Other|0|||
130524244|NCT02229578|469888546|FG000|Overall Study|Withdrawal by Subject|1|||
130524245|NCT02229578|469888547|FG001|Overall Study|Withdrawal by Subject|3|||
130524246|NCT02229578|469888546|FG000|Overall Study|Protocol Violation|2|||
130524247|NCT02229578|469888547|FG001|Overall Study|Protocol Violation|0|||
130524248|NCT02706951|469888549|FG000|Period 1|Adverse Event|1|||
130524249|NCT02706951|469888550|FG001|Period 1|Adverse Event|5|||
130524250|NCT02706951|469888551|FG002|Period 1|Adverse Event|3|||
130524251|NCT02706951|469888552|FG003|Period 1|Adverse Event|0|||
130524252|NCT02706951|469888553|FG004|Period 1|Adverse Event|0|||
130524253|NCT02706951|469888549|FG000|Period 1|Withdrawal by Subject|10|||
130524254|NCT02706951|469888550|FG001|Period 1|Withdrawal by Subject|6|||
130524255|NCT02706951|469888551|FG002|Period 1|Withdrawal by Subject|6|||
130524256|NCT02706951|469888552|FG003|Period 1|Withdrawal by Subject|0|||
130524257|NCT02706951|469888553|FG004|Period 1|Withdrawal by Subject|0|||
130524258|NCT02706951|469888549|FG000|Period 1|Lost to Follow-up|0|||
130524259|NCT02706951|469888550|FG001|Period 1|Lost to Follow-up|4|||
130524260|NCT02706951|469888551|FG002|Period 1|Lost to Follow-up|1|||
130524261|NCT02706951|469888552|FG003|Period 1|Lost to Follow-up|0|||
130524262|NCT02706951|469888553|FG004|Period 1|Lost to Follow-up|0|||
130524263|NCT02706951|469888549|FG000|Period 1|Other|2|||
130524264|NCT02706951|469888550|FG001|Period 1|Other|1|||
130524265|NCT02706951|469888551|FG002|Period 1|Other|0|||
130524266|NCT02706951|469888552|FG003|Period 1|Other|0|||
130524267|NCT02706951|469888553|FG004|Period 1|Other|0|||
130524268|NCT02706951|469888549|FG000|Period 2|Adverse Event|0|||
130524269|NCT02706951|469888550|FG001|Period 2|Adverse Event|0|||
130524270|NCT02706951|469888551|FG002|Period 2|Adverse Event|0|||
130524271|NCT02706951|469888552|FG003|Period 2|Adverse Event|25|||
130524272|NCT02706951|469888553|FG004|Period 2|Adverse Event|34|||
130524273|NCT02706951|469888549|FG000|Period 2|Withdrawal by Subject|0|||
130524274|NCT02706951|469888550|FG001|Period 2|Withdrawal by Subject|0|||
130524275|NCT02706951|469888551|FG002|Period 2|Withdrawal by Subject|0|||
130524276|NCT02706951|469888552|FG003|Period 2|Withdrawal by Subject|38|||
130524277|NCT02706951|469888553|FG004|Period 2|Withdrawal by Subject|44|||
130524278|NCT02706951|469888549|FG000|Period 2|Lost to Follow-up|0|||
130524279|NCT02706951|469888550|FG001|Period 2|Lost to Follow-up|0|||
130524280|NCT02706951|469888551|FG002|Period 2|Lost to Follow-up|0|||
130524281|NCT02706951|469888552|FG003|Period 2|Lost to Follow-up|17|||
130524282|NCT02706951|469888553|FG004|Period 2|Lost to Follow-up|9|||
130524283|NCT02706951|469888549|FG000|Period 2|COVID-19 Related|0|||
130524284|NCT02706951|469888550|FG001|Period 2|COVID-19 Related|0|||
130524285|NCT02706951|469888551|FG002|Period 2|COVID-19 Related|0|||
130524286|NCT02706951|469888552|FG003|Period 2|COVID-19 Related|1|||
130524287|NCT02706951|469888553|FG004|Period 2|COVID-19 Related|2|||
130524288|NCT02706951|469888549|FG000|Period 2|Other|0|||
130524289|NCT02706951|469888550|FG001|Period 2|Other|0|||
130524290|NCT02706951|469888551|FG002|Period 2|Other|0|||
130524291|NCT02706951|469888552|FG003|Period 2|Other|37|||
130524292|NCT02706951|469888553|FG004|Period 2|Other|31|||
130524293|NCT02599688|469888557|FG000|Overall Study|Lack of Efficacy|1|||
130524294|NCT02599688|469888557|FG000|Overall Study|Withdrawal by Subject|1|||
130524295|NCT02599688|469888557|FG000|Overall Study|Termination by Sponsor|2|||
130524296|NCT01841697|469888558|FG000|Overall Study|Death|0|||
130524297|NCT01841697|469888559|FG001|Overall Study|Death|1|||
130524298|NCT01841697|469888558|FG000|Overall Study|Lost to Follow-up|4|||
130524299|NCT01841697|469888559|FG001|Overall Study|Lost to Follow-up|1|||
130524300|NCT01841697|469888558|FG000|Overall Study|Withdrawal by Subject|16|||
130524301|NCT01841697|469888559|FG001|Overall Study|Withdrawal by Subject|16|||
130524302|NCT00822770|469888560|FG000|Overall Study|Not treated|1|||
130524303|NCT00822770|469888561|FG001|Overall Study|Not treated|0|||
130524304|NCT00822770|469888560|FG000|Overall Study|Complication/Incomplete treatment|1|||
130524305|NCT00822770|469888561|FG001|Overall Study|Complication/Incomplete treatment|0|||
130524306|NCT00822770|469888560|FG000|Overall Study|Death|1|||
130524307|NCT00822770|469888561|FG001|Overall Study|Death|1|||
130524308|NCT01101061|469888562|FG000|Overall Study|Adverse Event|0|||
130524309|NCT01101061|469888563|FG001|Overall Study|Adverse Event|0|||
130524310|NCT01101061|469888564|FG002|Overall Study|Adverse Event|1|||
130524311|NCT01101061|469888565|FG003|Overall Study|Adverse Event|0|||
130524312|NCT01101061|469888566|FG004|Overall Study|Adverse Event|0|||
130524313|NCT01101061|469888567|FG005|Overall Study|Adverse Event|0|||
130524314|NCT02049515|469888568|FG000|Overall Study|Adverse Event|46|||
130524315|NCT02049515|469888569|FG001|Overall Study|Adverse Event|2|||
130524316|NCT02049515|469888568|FG000|Overall Study|Protocol-specified Disease Progression|23|||
130524317|NCT02049515|469888569|FG001|Overall Study|Protocol-specified Disease Progression|2|||
130576667|NCT01250379|470074950|FG001|Overall Study|Protocol Violation|8|||
130576668|NCT01250379|470074949|FG000|Overall Study|Lost to Follow-up|9|||
130524318|NCT02049515|469888568|FG000|Overall Study|Death|6|||
130524319|NCT02049515|469888569|FG001|Overall Study|Death|0|||
130524320|NCT02049515|469888568|FG000|Overall Study|Physician Decision|5|||
130524321|NCT02049515|469888569|FG001|Overall Study|Physician Decision|1|||
130524322|NCT02049515|469888568|FG000|Overall Study|Withdrawal by Subject|3|||
130524323|NCT02049515|469888569|FG001|Overall Study|Withdrawal by Subject|0|||
130524324|NCT02049515|469888568|FG000|Overall Study|Termination of the Study by Sponsor|2|||
130524325|NCT02049515|469888569|FG001|Overall Study|Termination of the Study by Sponsor|0|||
130524326|NCT02049515|469888568|FG000|Overall Study|Protocol Violation|1|||
130576669|NCT01250379|470074950|FG001|Overall Study|Lost to Follow-up|6|||
130576670|NCT01250379|470074949|FG000|Overall Study|Adverse Event|5|||
130576671|NCT01250379|470074950|FG001|Overall Study|Adverse Event|4|||
130576672|NCT01250379|470074949|FG000|Overall Study|Other|0|||
130576673|NCT01250379|470074950|FG001|Overall Study|Other|4|||
130576674|NCT01250379|470074949|FG000|Overall Study|Participant noncompliance|2|||
130524327|NCT02049515|469888569|FG001|Overall Study|Protocol Violation|1|||
130524328|NCT02049515|469888568|FG000|Overall Study|Clinical Deterioration|1|||
130524329|NCT02049515|469888569|FG001|Overall Study|Clinical Deterioration|0|||
130524330|NCT02049515|469888568|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
130524331|NCT02049515|469888569|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
130524332|NCT02049515|469888568|FG000|Overall Study|Treatment Interruption >42 Days|1|||
130524333|NCT02049515|469888569|FG001|Overall Study|Treatment Interruption >42 Days|0|||
130524334|NCT02049515|469888568|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
130524335|NCT02049515|469888569|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
130524336|NCT00224029|469888571|FG000|Overall Study|Lost to Follow-up|1|||
130524337|NCT00224029|469888571|FG000|Overall Study|Withdrawal by Subject|4|||
130524338|NCT00224029|469888571|FG000|Overall Study|Other|1|||
130524339|NCT01390441|469888572|FG000|Treatment Period|Protocol Violation|0|||
130524340|NCT01390441|469888573|FG001|Treatment Period|Protocol Violation|1|||
130524341|NCT01390441|469888574|FG002|Treatment Period|Protocol Violation|0|||
130524342|NCT01390441|469888575|FG003|Treatment Period|Protocol Violation|0|||
130524343|NCT01390441|469888576|FG004|Treatment Period|Protocol Violation|0|||
130524344|NCT01390441|469888572|FG000|Treatment Period|Physician Decision|0|||
130524345|NCT01390441|469888573|FG001|Treatment Period|Physician Decision|0|||
130524346|NCT01390441|469888574|FG002|Treatment Period|Physician Decision|0|||
130524347|NCT01390441|469888575|FG003|Treatment Period|Physician Decision|1|||
130524348|NCT01390441|469888576|FG004|Treatment Period|Physician Decision|0|||
130524349|NCT01390441|469888572|FG000|Treatment Period|Lack of Efficacy|0|||
130524350|NCT01390441|469888573|FG001|Treatment Period|Lack of Efficacy|0|||
130524351|NCT01390441|469888574|FG002|Treatment Period|Lack of Efficacy|0|||
130524352|NCT01390441|469888575|FG003|Treatment Period|Lack of Efficacy|0|||
130524353|NCT01390441|469888576|FG004|Treatment Period|Lack of Efficacy|1|||
130524354|NCT01390441|469888572|FG000|Treatment Period|Unknown due to early stopping of study|0|||
130524355|NCT01390441|469888573|FG001|Treatment Period|Unknown due to early stopping of study|0|||
130524356|NCT01390441|469888574|FG002|Treatment Period|Unknown due to early stopping of study|8|||
130524357|NCT01390441|469888575|FG003|Treatment Period|Unknown due to early stopping of study|11|||
130524358|NCT01390441|469888576|FG004|Treatment Period|Unknown due to early stopping of study|7|||
130524359|NCT01390441|469888572|FG000|Treatment Period|Adverse Event|0|||
130524360|NCT01390441|469888573|FG001|Treatment Period|Adverse Event|0|||
130524361|NCT01390441|469888574|FG002|Treatment Period|Adverse Event|1|||
130524362|NCT01390441|469888575|FG003|Treatment Period|Adverse Event|1|||
130524363|NCT01390441|469888576|FG004|Treatment Period|Adverse Event|2|||
130524364|NCT01390441|469888572|FG000|Treatment Period|Withdrawal by Subject|0|||
130524365|NCT01390441|469888573|FG001|Treatment Period|Withdrawal by Subject|0|||
130524366|NCT01390441|469888574|FG002|Treatment Period|Withdrawal by Subject|1|||
130524367|NCT01390441|469888575|FG003|Treatment Period|Withdrawal by Subject|0|||
130524368|NCT01390441|469888576|FG004|Treatment Period|Withdrawal by Subject|1|||
130524369|NCT01390441|469888572|FG000|Treatment Period|Lost to Follow-up|1|||
130524370|NCT01390441|469888573|FG001|Treatment Period|Lost to Follow-up|0|||
130524371|NCT01390441|469888574|FG002|Treatment Period|Lost to Follow-up|0|||
130524372|NCT01390441|469888575|FG003|Treatment Period|Lost to Follow-up|0|||
130524373|NCT01390441|469888576|FG004|Treatment Period|Lost to Follow-up|0|||
130524374|NCT01390441|469888572|FG000|Extension Period|Protocol Violation|3|||
130524375|NCT01390441|469888573|FG001|Extension Period|Protocol Violation|1|||
130524376|NCT01390441|469888574|FG002|Extension Period|Protocol Violation|0|||
130524377|NCT01390441|469888575|FG003|Extension Period|Protocol Violation|1|||
130524378|NCT01390441|469888576|FG004|Extension Period|Protocol Violation|0|||
130524379|NCT01407276|469888577|FG000|Overall Study|Withdrawal by Subject|0|||
130524380|NCT01407276|469888578|FG001|Overall Study|Withdrawal by Subject|0|||
130524381|NCT01407276|469888579|FG002|Overall Study|Withdrawal by Subject|0|||
130524382|NCT01407276|469888580|FG003|Overall Study|Withdrawal by Subject|0|||
130524383|NCT01407276|469888581|FG004|Overall Study|Withdrawal by Subject|0|||
130524384|NCT01407276|469888582|FG005|Overall Study|Withdrawal by Subject|0|||
130524385|NCT01407276|469888583|FG006|Overall Study|Withdrawal by Subject|0|||
130524386|NCT01407276|469888584|FG007|Overall Study|Withdrawal by Subject|1|||
130524387|NCT02635386|469888585|FG000|Overall Study|Pregnancy|2|||
130524388|NCT02635386|469888586|FG001|Overall Study|Pregnancy|0|||
130524389|NCT02635386|469888587|FG002|Overall Study|Pregnancy|0|||
130524390|NCT02635386|469888588|FG003|Overall Study|Pregnancy|0|||
130524391|NCT02635386|469888589|FG004|Overall Study|Pregnancy|2|||
130576675|NCT01250379|470074950|FG001|Overall Study|Participant noncompliance|0|||
130524392|NCT02635386|469888585|FG000|Overall Study|Withdrawal by Subject|1|||
130524393|NCT02635386|469888586|FG001|Overall Study|Withdrawal by Subject|1|||
130524394|NCT02635386|469888587|FG002|Overall Study|Withdrawal by Subject|0|||
130524395|NCT02635386|469888588|FG003|Overall Study|Withdrawal by Subject|1|||
130524396|NCT02635386|469888589|FG004|Overall Study|Withdrawal by Subject|0|||
130524397|NCT02635386|469888585|FG000|Overall Study|Physician Decision|0|||
130524398|NCT02635386|469888586|FG001|Overall Study|Physician Decision|1|||
130524399|NCT02635386|469888587|FG002|Overall Study|Physician Decision|0|||
130524400|NCT02635386|469888588|FG003|Overall Study|Physician Decision|0|||
130524401|NCT02635386|469888589|FG004|Overall Study|Physician Decision|0|||
130524402|NCT02635386|469888585|FG000|Overall Study|Moved Out of State|0|||
130524403|NCT02635386|469888586|FG001|Overall Study|Moved Out of State|1|||
130524404|NCT02635386|469888587|FG002|Overall Study|Moved Out of State|0|||
130524405|NCT02635386|469888588|FG003|Overall Study|Moved Out of State|0|||
130524406|NCT02635386|469888589|FG004|Overall Study|Moved Out of State|0|||
130524407|NCT02635386|469888585|FG000|Overall Study|Noncompliant|0|||
130524408|NCT02635386|469888586|FG001|Overall Study|Noncompliant|2|||
130524409|NCT02635386|469888587|FG002|Overall Study|Noncompliant|1|||
130524410|NCT02635386|469888588|FG003|Overall Study|Noncompliant|1|||
130524411|NCT02635386|469888589|FG004|Overall Study|Noncompliant|1|||
130524412|NCT02635386|469888585|FG000|Overall Study|side effects|0|||
130524413|NCT02635386|469888586|FG001|Overall Study|side effects|0|||
130524414|NCT02635386|469888587|FG002|Overall Study|side effects|1|||
130524415|NCT02635386|469888588|FG003|Overall Study|side effects|4|||
130524416|NCT02635386|469888589|FG004|Overall Study|side effects|6|||
130524417|NCT02635386|469888585|FG000|Overall Study|needed other major surgery|0|||
130524418|NCT02635386|469888586|FG001|Overall Study|needed other major surgery|1|||
130524419|NCT02635386|469888587|FG002|Overall Study|needed other major surgery|0|||
130524420|NCT02635386|469888588|FG003|Overall Study|needed other major surgery|0|||
130524421|NCT02635386|469888589|FG004|Overall Study|needed other major surgery|0|||
130524422|NCT02635386|469888585|FG000|Overall Study|Other medical problems not drug related|0|||
130524423|NCT02635386|469888586|FG001|Overall Study|Other medical problems not drug related|0|||
130524424|NCT02635386|469888587|FG002|Overall Study|Other medical problems not drug related|0|||
130524425|NCT02635386|469888588|FG003|Overall Study|Other medical problems not drug related|1|||
130524426|NCT02635386|469888589|FG004|Overall Study|Other medical problems not drug related|0|||
130524427|NCT00778921|469888593|FG000|Overall Study|Adverse Event|9|||
130524428|NCT00778921|469888594|FG001|Overall Study|Adverse Event|10|||
130524429|NCT00778921|469888595|FG002|Overall Study|Adverse Event|14|||
130524430|NCT00778921|469888593|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130524431|NCT00778921|469888594|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
130524432|NCT00778921|469888595|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130524433|NCT00778921|469888593|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
130524434|NCT00778921|469888594|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130524435|NCT00778921|469888595|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
130524436|NCT00778921|469888593|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
130524437|NCT00778921|469888594|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
130524438|NCT00778921|469888595|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
130524439|NCT00778921|469888593|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
130524440|NCT00778921|469888594|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
130524441|NCT00778921|469888595|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
130524442|NCT00778921|469888593|FG000|Overall Study|Patient withdrew request|3|||
130524443|NCT00778921|469888594|FG001|Overall Study|Patient withdrew request|1|||
130524444|NCT00778921|469888595|FG002|Overall Study|Patient withdrew request|6|||
130524445|NCT00778921|469888593|FG000|Overall Study|Lost to Follow-up|0|||
130524446|NCT00778921|469888594|FG001|Overall Study|Lost to Follow-up|2|||
130524447|NCT00778921|469888595|FG002|Overall Study|Lost to Follow-up|1|||
130524448|NCT00778921|469888593|FG000|Overall Study|Administrative Problems|1|||
130524449|NCT00778921|469888594|FG001|Overall Study|Administrative Problems|2|||
130524450|NCT00778921|469888595|FG002|Overall Study|Administrative Problems|0|||
130524451|NCT00778921|469888593|FG000|Overall Study|Protocol Violation|3|||
130524452|NCT00778921|469888594|FG001|Overall Study|Protocol Violation|0|||
130524453|NCT00778921|469888595|FG002|Overall Study|Protocol Violation|2|||
130524454|NCT00778921|469888593|FG000|Overall Study|Not treated|0|||
130524455|NCT00778921|469888594|FG001|Overall Study|Not treated|2|||
130524456|NCT00778921|469888595|FG002|Overall Study|Not treated|2|||
130524457|NCT04805073|469888596|FG000|Overall Study|study personnel not available|2|||
130524458|NCT04805073|469888597|FG001|Overall Study|study personnel not available|0|||
130524459|NCT04805073|469888596|FG000|Overall Study|spinal anesthesia failure|0|||
130524460|NCT04805073|469888597|FG001|Overall Study|spinal anesthesia failure|1|||
130524461|NCT04805073|469888596|FG000|Overall Study|Lost to Follow-up|0|||
130524462|NCT04805073|469888597|FG001|Overall Study|Lost to Follow-up|2|||
130524463|NCT01163474|469888598|FG000|Overall Study|Withdrawal by Subject|1|||
130524464|NCT01163474|469888598|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
130524465|NCT01163474|469888598|FG000|Overall Study|Lost to Follow-up|3|||
130524466|NCT01078922|469888606|FG000|Overall Study|Adverse Event|1|||
130524467|NCT02706847|469888609|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
130524468|NCT02706847|469888610|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
130524469|NCT02706847|469888611|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
130524470|NCT02706847|469888612|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
130524471|NCT02706847|469888609|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
130524472|NCT02706847|469888610|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
130524473|NCT02706847|469888611|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
130524474|NCT02706847|469888612|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
130524475|NCT02706847|469888609|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
130524476|NCT02706847|469888610|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
130524477|NCT02706847|469888611|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
130524478|NCT02706847|469888612|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
130524479|NCT02706847|469888609|FG000|Period 1: Day 1 to Week 12|Other|4|||
130524480|NCT02706847|469888610|FG001|Period 1: Day 1 to Week 12|Other|4|||
130524481|NCT02706847|469888611|FG002|Period 1: Day 1 to Week 12|Other|2|||
130524482|NCT02706847|469888612|FG003|Period 1: Day 1 to Week 12|Other|2|||
130524483|NCT02706847|469888609|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
130524484|NCT02706847|469888610|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
130524485|NCT02706847|469888611|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
130524486|NCT02706847|469888612|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
130524487|NCT02706847|469888609|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
130524488|NCT02706847|469888610|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
130524489|NCT02706847|469888611|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
130524490|NCT02706847|469888612|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
130524491|NCT02706847|469888609|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
130524492|NCT02706847|469888610|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
130524493|NCT02706847|469888611|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
130524494|NCT02706847|469888612|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
130524495|NCT02706847|469888609|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
130524496|NCT02706847|469888610|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
130524497|NCT02706847|469888611|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
130524498|NCT02706847|469888612|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
130524499|NCT02706847|469888609|FG000|Period 1: Week 12 to Week 24|Other|1|||
130524500|NCT02706847|469888610|FG001|Period 1: Week 12 to Week 24|Other|0|||
130524501|NCT02706847|469888611|FG002|Period 1: Week 12 to Week 24|Other|1|||
130524502|NCT02706847|469888612|FG003|Period 1: Week 12 to Week 24|Other|4|||
130524503|NCT02706847|469888609|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
130524504|NCT02706847|469888610|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
130524505|NCT02706847|469888611|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
130524506|NCT02706847|469888612|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
130524507|NCT02706847|469888609|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
130524508|NCT02706847|469888610|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
130524509|NCT02706847|469888611|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
130524510|NCT02706847|469888612|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
130524511|NCT02706847|469888609|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
130524512|NCT02706847|469888610|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
130524513|NCT02706847|469888611|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
130524514|NCT02706847|469888612|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
130524515|NCT02706847|469888609|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
130524516|NCT02706847|469888610|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
130524517|NCT02706847|469888611|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
130524518|NCT02706847|469888612|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
130524519|NCT02706847|469888609|FG000|Period 2: Week 24 to Week 260|Other|8|||
130524520|NCT02706847|469888610|FG001|Period 2: Week 24 to Week 260|Other|5|||
130524521|NCT02706847|469888611|FG002|Period 2: Week 24 to Week 260|Other|15|||
130524522|NCT02706847|469888612|FG003|Period 2: Week 24 to Week 260|Other|15|||
130576676|NCT05902364|470074951|FG000|Overall Study|Adverse Event|1|||
130576677|NCT05902364|470074952|FG001|Overall Study|Adverse Event|0|||
130576678|NCT00644787|470074953|FG000|Period 1: Titration Phase|Adverse Event|11|||
130576679|NCT00644787|470074954|FG001|Period 1: Titration Phase|Adverse Event|0|||
130576680|NCT00644787|470074955|FG002|Period 1: Titration Phase|Adverse Event|0|||
130576681|NCT00644787|470074953|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
130576682|NCT00644787|470074954|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
130576683|NCT00644787|470074955|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
130524523|NCT01174264|469888613|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
130524524|NCT01174264|469888614|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
130524525|NCT01174264|469888615|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
130524526|NCT01174264|469888613|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
130524527|NCT01174264|469888614|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
130524528|NCT01174264|469888615|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
130524529|NCT01174264|469888613|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
130524530|NCT01174264|469888614|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
130524531|NCT01174264|469888615|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
130524532|NCT02353871|469888618|FG000|Overall Study|Protocol deviation|0|||
130524533|NCT02353871|469888619|FG001|Overall Study|Protocol deviation|1|||
130524534|NCT02353871|469888618|FG000|Overall Study|Consent withdrawn|1|||
130524535|NCT02353871|469888619|FG001|Overall Study|Consent withdrawn|8|||
130524536|NCT02353871|469888618|FG000|Overall Study|Lost to Follow-up|2|||
130524537|NCT02353871|469888619|FG001|Overall Study|Lost to Follow-up|0|||
130524538|NCT00115336|469888620|FG000|Overall Study|Hospital discharge before study drug|0|||
130524539|NCT00115336|469888621|FG001|Overall Study|Hospital discharge before study drug|1|||
130524540|NCT01191008|469888635|FG000|Overall Study|Protocol Violation|7|||
130524541|NCT01191008|469888635|FG000|Overall Study|Lost to Follow-up|8|||
130524542|NCT04905849|469888638|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
130524543|NCT04905849|469888639|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
130524544|NCT04913948|469888647|FG000|Overall Study|Withdrawal by Subject|2|||
130524545|NCT04913948|469888647|FG000|Overall Study|Sample processing issues|1|||
130524546|NCT04913948|469888647|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
130524547|NCT04199052|469888648|FG000|Overall Study|Lost to Follow-up|11|||
130524548|NCT04199052|469888649|FG001|Overall Study|Lost to Follow-up|18|||
130524549|NCT00699842|469888650|FG000|Overall Study|Death|0|||
130524550|NCT00699842|469888651|FG001|Overall Study|Death|1|||
130524551|NCT00699842|469888652|FG002|Overall Study|Death|0|||
130524552|NCT03522389|469888653|FG000|Overall Study|Lost to Follow-up|1|||
130524553|NCT03522389|469888654|FG001|Overall Study|Lost to Follow-up|1|||
130524554|NCT03522389|469888655|FG002|Overall Study|Lost to Follow-up|2|||
130524555|NCT03522389|469888653|FG000|Overall Study|had herniated nucleus pulposus|0|||
130524556|NCT03522389|469888654|FG001|Overall Study|had herniated nucleus pulposus|1|||
130524557|NCT03522389|469888655|FG002|Overall Study|had herniated nucleus pulposus|0|||
130524558|NCT03522389|469888653|FG000|Overall Study|go to work in other province|1|||
130524559|NCT03522389|469888654|FG001|Overall Study|go to work in other province|0|||
130524560|NCT03522389|469888655|FG002|Overall Study|go to work in other province|0|||
130524561|NCT04750577|469888656|FG000|Overall Study|Adverse Event|2|||
130524562|NCT04750577|469888657|FG001|Overall Study|Adverse Event|10|||
130524563|NCT04750577|469888658|FG002|Overall Study|Adverse Event|8|||
130524564|NCT04750577|469888659|FG003|Overall Study|Adverse Event|1|||
130524565|NCT04750577|469888656|FG000|Overall Study|Change of residence|0|||
130524566|NCT04750577|469888657|FG001|Overall Study|Change of residence|0|||
130524567|NCT04750577|469888658|FG002|Overall Study|Change of residence|1|||
130524568|NCT04750577|469888659|FG003|Overall Study|Change of residence|0|||
130524569|NCT04750577|469888656|FG000|Overall Study|Burden of study procedures|0|||
130524570|NCT04750577|469888657|FG001|Overall Study|Burden of study procedures|2|||
130524571|NCT04750577|469888658|FG002|Overall Study|Burden of study procedures|2|||
130524572|NCT04750577|469888659|FG003|Overall Study|Burden of study procedures|0|||
130524573|NCT04750577|469888656|FG000|Overall Study|Prematurely discontinued|0|||
130524574|NCT04750577|469888657|FG001|Overall Study|Prematurely discontinued|0|||
130524575|NCT04750577|469888658|FG002|Overall Study|Prematurely discontinued|0|||
130524576|NCT04750577|469888659|FG003|Overall Study|Prematurely discontinued|2|||
130524577|NCT04750577|469888656|FG000|Overall Study|Protocol deviation|1|||
130524578|NCT04750577|469888657|FG001|Overall Study|Protocol deviation|1|||
130524579|NCT04750577|469888658|FG002|Overall Study|Protocol deviation|1|||
130524580|NCT04750577|469888659|FG003|Overall Study|Protocol deviation|1|||
130524581|NCT04750577|469888656|FG000|Overall Study|Other than listed|3|||
130576684|NCT00644787|470074953|FG000|Period 1: Titration Phase|Physician Decision|1|||
130524582|NCT04750577|469888657|FG001|Overall Study|Other than listed|2|||
130524583|NCT04750577|469888658|FG002|Overall Study|Other than listed|2|||
130524584|NCT04750577|469888659|FG003|Overall Study|Other than listed|1|||
130524585|NCT04750577|469888656|FG000|Overall Study|Not treated|0|||
130524586|NCT04750577|469888657|FG001|Overall Study|Not treated|0|||
130524587|NCT04750577|469888658|FG002|Overall Study|Not treated|0|||
130524588|NCT04750577|469888659|FG003|Overall Study|Not treated|2|||
130524589|NCT04599907|469888662|FG000|Overall Study|Withdrawal by Subject|1|||
130524590|NCT04599907|469888663|FG001|Overall Study|Withdrawal by Subject|7|||
130524591|NCT04599907|469888664|FG002|Overall Study|Withdrawal by Subject|6|||
130524592|NCT04599907|469888662|FG000|Overall Study|Lost to Follow-up|0|||
130524593|NCT04599907|469888663|FG001|Overall Study|Lost to Follow-up|1|||
130524594|NCT04599907|469888664|FG002|Overall Study|Lost to Follow-up|0|||
130524595|NCT01251887|469888666|FG000|Overall Study|Scheduling conflict|1|||
130524596|NCT01251887|469888667|FG001|Overall Study|Scheduling conflict|2|||
130524597|NCT01251887|469888668|FG002|Overall Study|Scheduling conflict|2|||
130524598|NCT01251887|469888666|FG000|Overall Study|Physician Decision|0|||
130524599|NCT01251887|469888667|FG001|Overall Study|Physician Decision|1|||
130524600|NCT01251887|469888668|FG002|Overall Study|Physician Decision|0|||
130524601|NCT03668223|469888669|FG000|Overall Study|Death|10|||
130524602|NCT03668223|469888670|FG001|Overall Study|Death|5|||
130524603|NCT03668223|469888669|FG000|Overall Study|Lost to Follow-up|12|||
130524604|NCT03668223|469888670|FG001|Overall Study|Lost to Follow-up|12|||
130524605|NCT03668223|469888669|FG000|Overall Study|Withdrawal by Subject|8|||
130524606|NCT03668223|469888670|FG001|Overall Study|Withdrawal by Subject|3|||
130524607|NCT01103232|469888671|FG000|Overall Study|Withdrawal by Subject|1|||
130524608|NCT01103232|469888672|FG001|Overall Study|Withdrawal by Subject|1|||
130524609|NCT01103232|469888671|FG000|Overall Study|Protocol Violation|0|||
130524610|NCT01103232|469888672|FG001|Overall Study|Protocol Violation|1|||
130524611|NCT05347485|469888673|FG000|Overall Study|Death|14|||
130524612|NCT05347485|469888673|FG000|Overall Study|Lost to Follow-up|2|||
130524613|NCT05347485|469888673|FG000|Overall Study|Withdrawal by Subject|13|||
130524614|NCT05347485|469888673|FG000|Overall Study|Progressive Disease|1|||
130524615|NCT05347485|469888673|FG000|Overall Study|Study Terminated by Sponsor|49|||
130524616|NCT05347485|469888673|FG000|Overall Study|Other|1|||
130524617|NCT05347485|469888673|FG000|Overall Study|Enrolled (consented) but not treated|4|||
130524618|NCT05347485|469888673|FG000|Overall Study|Disease Relapse|2|||
130524619|NCT03733899|469888674|FG000|Period 1|Protocol Violation|0|||
130524620|NCT03733899|469888675|FG001|Period 1|Protocol Violation|0|||
130524621|NCT03733899|469888676|FG002|Period 1|Protocol Violation|0|||
130524622|NCT03733899|469888677|FG003|Period 1|Protocol Violation|0|||
130524623|NCT03733899|469888678|FG004|Period 1|Protocol Violation|0|||
130524624|NCT03733899|469888679|FG005|Period 1|Protocol Violation|1|||
130524625|NCT03733899|469888674|FG000|Period 2|Unscuccessful Treatment|0|||
130524626|NCT03733899|469888675|FG001|Period 2|Unscuccessful Treatment|1|||
130524627|NCT03733899|469888676|FG002|Period 2|Unscuccessful Treatment|0|||
130524628|NCT03733899|469888677|FG003|Period 2|Unscuccessful Treatment|0|||
130524629|NCT03733899|469888678|FG004|Period 2|Unscuccessful Treatment|0|||
130524630|NCT03733899|469888679|FG005|Period 2|Unscuccessful Treatment|0|||
130524631|NCT03733899|469888674|FG000|Period 3|Withdrawal by Subject|1|||
130524632|NCT03733899|469888675|FG001|Period 3|Withdrawal by Subject|0|||
130524633|NCT03733899|469888676|FG002|Period 3|Withdrawal by Subject|0|||
130524634|NCT03733899|469888677|FG003|Period 3|Withdrawal by Subject|0|||
130524635|NCT03733899|469888678|FG004|Period 3|Withdrawal by Subject|0|||
130524636|NCT03733899|469888679|FG005|Period 3|Withdrawal by Subject|0|||
130524637|NCT04650698|469890191|FG000|Overall Study|Protocol Violation|2|||
130524638|NCT04650698|469890192|FG001|Overall Study|Protocol Violation|1|||
130524639|NCT04650698|469890191|FG000|Overall Study|Withdrawal by Subject|0|||
130524640|NCT04650698|469890192|FG001|Overall Study|Withdrawal by Subject|1|||
130524641|NCT03778294|469890193|FG000|Overall Study|Death|1|||
130524642|NCT03778294|469890193|FG000|Overall Study|Issues with insurance|1|||
130524643|NCT03778294|469890193|FG000|Overall Study|disease progression before treatment|2|||
130524644|NCT03023722|469890205|FG000|Overall Study|No follow-up assessment|4|||
130524645|NCT00589303|469890210|FG000|Overall Study|Withdrawal by Subject|2|||
130524646|NCT00589303|469890211|FG001|Overall Study|Withdrawal by Subject|1|||
130524647|NCT04836559|469890214|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
130524648|NCT04836559|469890215|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
130524649|NCT04836559|469890216|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
130524650|NCT04836559|469890217|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
130524651|NCT04836559|469890218|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
130524652|NCT04836559|469890219|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
130524653|NCT04836559|469890220|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
130524654|NCT04836559|469890221|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
130524655|NCT04836559|469890214|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130524656|NCT04836559|469890215|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
130524657|NCT04836559|469890216|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
130524658|NCT04836559|469890217|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
130524659|NCT04836559|469890218|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130524660|NCT04836559|469890219|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130524661|NCT04836559|469890220|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130524662|NCT04836559|469890221|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130524663|NCT04836559|469890214|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
130524664|NCT04836559|469890215|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524665|NCT04836559|469890216|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524666|NCT04836559|469890217|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524667|NCT04836559|469890218|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524668|NCT04836559|469890219|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524669|NCT04836559|469890220|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524670|NCT04836559|469890221|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
130524671|NCT04836559|469890214|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
130524672|NCT04836559|469890215|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524673|NCT04836559|469890216|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524674|NCT04836559|469890217|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524675|NCT04836559|469890218|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524676|NCT04836559|469890219|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524677|NCT04836559|469890220|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524678|NCT04836559|469890221|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
130524679|NCT04836559|469890214|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524680|NCT04836559|469890215|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524681|NCT04836559|469890216|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524682|NCT04836559|469890217|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
130524683|NCT04836559|469890218|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524684|NCT04836559|469890219|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524685|NCT04836559|469890220|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524686|NCT04836559|469890221|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
130524687|NCT04836559|469890214|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
130524688|NCT04836559|469890215|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
130524689|NCT04836559|469890216|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
130524690|NCT04836559|469890217|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
130524691|NCT04836559|469890218|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
130524692|NCT04836559|469890219|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
130524693|NCT04836559|469890220|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
130524694|NCT04836559|469890221|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
130524695|NCT04836559|469890214|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
130524696|NCT04836559|469890215|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
130524697|NCT04836559|469890216|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
130524698|NCT04836559|469890217|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
130524699|NCT04836559|469890218|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
130524700|NCT04836559|469890219|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
130524701|NCT04836559|469890220|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
130524702|NCT04836559|469890221|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
130524703|NCT04836559|469890214|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
130524704|NCT04836559|469890215|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
130524705|NCT04836559|469890216|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
130524706|NCT04836559|469890217|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
130524707|NCT04836559|469890218|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
130524708|NCT04836559|469890219|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
130524709|NCT04836559|469890220|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
130524710|NCT04836559|469890221|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
130524711|NCT04836559|469890214|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524712|NCT04836559|469890215|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524713|NCT04836559|469890216|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524714|NCT04836559|469890217|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524715|NCT04836559|469890218|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524716|NCT04836559|469890219|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524717|NCT04836559|469890220|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
130524718|NCT04836559|469890221|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
130524719|NCT00730015|469890222|FG000|Overall Study|Adverse Event|11|||
130524720|NCT00730015|469890223|FG001|Overall Study|Adverse Event|10|||
130524721|NCT00730015|469890224|FG002|Overall Study|Adverse Event|8|||
130576685|NCT00644787|470074954|FG001|Period 1: Titration Phase|Physician Decision|0|||
130576686|NCT00644787|470074955|FG002|Period 1: Titration Phase|Physician Decision|0|||
130576687|NCT00644787|470074953|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
130576688|NCT00644787|470074954|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
130576689|NCT00644787|470074955|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
130576690|NCT00644787|470074953|FG000|Period 1: Titration Phase|Worsening of complications|1|||
130576691|NCT00644787|470074954|FG001|Period 1: Titration Phase|Worsening of complications|0|||
130576692|NCT00644787|470074955|FG002|Period 1: Titration Phase|Worsening of complications|0|||
130524722|NCT00730015|469890222|FG000|Overall Study|Protocol Violation|2|||
130524723|NCT00730015|469890223|FG001|Overall Study|Protocol Violation|6|||
130524724|NCT00730015|469890224|FG002|Overall Study|Protocol Violation|4|||
130524725|NCT00730015|469890222|FG000|Overall Study|Withdrawal by Subject|12|||
130524726|NCT00730015|469890223|FG001|Overall Study|Withdrawal by Subject|12|||
130524727|NCT00730015|469890224|FG002|Overall Study|Withdrawal by Subject|8|||
130524728|NCT00730015|469890222|FG000|Overall Study|Lost to Follow-up|4|||
130524729|NCT00730015|469890223|FG001|Overall Study|Lost to Follow-up|10|||
130524730|NCT00730015|469890224|FG002|Overall Study|Lost to Follow-up|3|||
130524731|NCT00730015|469890222|FG000|Overall Study|Lack of Efficacy|1|||
130524732|NCT00730015|469890223|FG001|Overall Study|Lack of Efficacy|2|||
130524733|NCT00730015|469890224|FG002|Overall Study|Lack of Efficacy|8|||
130524734|NCT00730015|469890222|FG000|Overall Study|Other Reason|1|||
130524735|NCT00730015|469890223|FG001|Overall Study|Other Reason|0|||
130524736|NCT00730015|469890224|FG002|Overall Study|Other Reason|1|||
130524737|NCT02370251|469890225|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
130524738|NCT02370251|469890225|FG000|Overall Study|Death|4|||
130524739|NCT00013611|469890226|FG000|Overall Study|Lost to Follow-up|91|||
130524740|NCT00013611|469890227|FG001|Overall Study|Lost to Follow-up|100|||
130524741|NCT01150045|469890228|FG000|Overall Study|Protocol Violation|0|||
130524742|NCT01150045|469890229|FG001|Overall Study|Protocol Violation|1|||
130524743|NCT01150045|469890230|FG002|Overall Study|Protocol Violation|0|||
130524744|NCT01150045|469890231|FG003|Overall Study|Protocol Violation|1|||
130524745|NCT01663506|469890233|FG000|Overall Study|Lack of Efficacy|3|||
130524746|NCT01663506|469890233|FG000|Overall Study|Consent Withdrawal by Subject|1|||
130524747|NCT01663506|469890233|FG000|Overall Study|Lost to Follow-up|1|||
130524748|NCT01663506|469890233|FG000|Overall Study|Adverse Event|1|||
130524749|NCT01663506|469890233|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
130524750|NCT02094898|469890239|FG000|Overall Study|Clinical Worsening|2|||
130524751|NCT02094898|469890239|FG000|Overall Study|Adverse Event|2|||
130524752|NCT02094898|469890239|FG000|Overall Study|Lack of Efficacy|1|||
130524753|NCT05382039|469890240|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
130524754|NCT05382039|469890241|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
130524755|NCT05382039|469890242|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
130524756|NCT05382039|469890240|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
130524757|NCT05382039|469890241|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
130524758|NCT05382039|469890242|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
130524759|NCT05382039|469890240|FG000|Overall Study|waiting for confirmation|0|||
130524760|NCT05382039|469890241|FG001|Overall Study|waiting for confirmation|0|||
130524761|NCT05382039|469890242|FG002|Overall Study|waiting for confirmation|1|||
130524762|NCT01432626|469890243|FG000|Overall Study|LV function recovered|2|||
130524763|NCT01432626|469890243|FG000|Overall Study|Withdrawal by Subject|2|||
130524764|NCT01432626|469890243|FG000|Overall Study|Only 1 image competed|2|||
130524765|NCT01432626|469890243|FG000|Overall Study|Imaging agent not available|1|||
130524766|NCT01234883|469890244|FG000|Overall Study|Early treatment release|8|||
130524767|NCT01234883|469890245|FG001|Overall Study|Early treatment release|10|||
130524768|NCT01234883|469890244|FG000|Overall Study|Parent/guardian withdrew consent|1|||
130524769|NCT01234883|469890245|FG001|Overall Study|Parent/guardian withdrew consent|2|||
130524770|NCT01234883|469890244|FG000|Overall Study|Technical difficulties with IV infusion|0|||
130524771|NCT01234883|469890245|FG001|Overall Study|Technical difficulties with IV infusion|1|||
130524772|NCT01234883|469890244|FG000|Overall Study|Inclusion/exclusion failure|1|||
130524773|NCT01234883|469890245|FG001|Overall Study|Inclusion/exclusion failure|0|||
130524774|NCT03210519|469890246|FG000|Overall Study|Adverse Event|2|||
130524775|NCT03210519|469890247|FG001|Overall Study|Adverse Event|0|||
130524776|NCT04351269|469890248|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
130524777|NCT04351269|469890249|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
130524778|NCT04351269|469890250|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
130524779|NCT04351269|469890248|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
130524780|NCT04351269|469890249|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
130524781|NCT04351269|469890250|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
130524782|NCT04351269|469890248|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
130576693|NCT00644787|470074953|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
130576694|NCT00644787|470074954|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
130576695|NCT00644787|470074955|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
130576696|NCT00644787|470074953|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
130576697|NCT00644787|470074954|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
130576698|NCT00644787|470074955|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
130576699|NCT00644787|470074953|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
130576700|NCT00644787|470074954|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
130576701|NCT00644787|470074955|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
130576702|NCT00644787|470074953|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
130576703|NCT00644787|470074954|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
130576704|NCT00644787|470074955|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
130576705|NCT00644787|470074953|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
130576706|NCT00644787|470074954|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
130576707|NCT00644787|470074955|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
130576708|NCT00644787|470074953|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
130576709|NCT00644787|470074954|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
130576710|NCT00644787|470074955|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
130576711|NCT00644787|470074953|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
130576712|NCT00644787|470074954|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
130576713|NCT00644787|470074955|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
130576714|NCT00936208|470074956|FG000|Overall Study|Protocol Violation|37|||
130576715|NCT00936208|470074957|FG001|Overall Study|Protocol Violation|22|||
130576716|NCT04428424|470074960|FG000|Overall Study|Does not meet entrance criteria|132|||
130576717|NCT04428424|470074960|FG000|Overall Study|Lost to Follow-up|115|||
130576718|NCT04818593|470074961|FG000|Overall Study|Low Oocyte Yield|8|||
130576719|NCT04818593|470074962|FG001|Overall Study|Low Oocyte Yield|8|||
130576720|NCT04818593|470074961|FG000|Overall Study|Not ICSI Insemination|7|||
130576721|NCT04818593|470074962|FG001|Overall Study|Not ICSI Insemination|7|||
130576722|NCT04818593|470074961|FG000|Overall Study|Poor Sperm Quality|2|||
130576723|NCT04818593|470074962|FG001|Overall Study|Poor Sperm Quality|2|||
130576724|NCT04818593|470074961|FG000|Overall Study|Withdrawal by Subject|2|||
130576725|NCT04818593|470074962|FG001|Overall Study|Withdrawal by Subject|2|||
130576726|NCT04818593|470074961|FG000|Overall Study|Conversion to IUI due to low response|1|||
130576727|NCT04818593|470074962|FG001|Overall Study|Conversion to IUI due to low response|1|||
130576728|NCT05036083|470074963|FG000|Overall Study|Physician Decision|1|||
130576729|NCT05036083|470074963|FG000|Overall Study|Withdrawal by Subject|1|||
130576730|NCT05036083|470074963|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
130576731|NCT05036083|470074963|FG000|Overall Study|IV not sustainable|1|||
130576732|NCT02968810|470076514|FG000|Overall Study|Lost to Follow-up|1|||
130576733|NCT02968810|470076515|FG001|Overall Study|Lost to Follow-up|0|||
130576734|NCT02968810|470076514|FG000|Overall Study|Physician Decision|1|||
130576735|NCT02968810|470076515|FG001|Overall Study|Physician Decision|0|||
130576736|NCT02968810|470076514|FG000|Overall Study|Withdrawal by Subject|1|||
130576737|NCT02968810|470076515|FG001|Overall Study|Withdrawal by Subject|3|||
130576738|NCT02968810|470076514|FG000|Overall Study|Disease Progression|0|||
130576739|NCT02968810|470076515|FG001|Overall Study|Disease Progression|1|||
130576740|NCT01790503|470076516|FG000|Overall Study|Adverse Event|1|||
130576741|NCT01790503|470076517|FG001|Overall Study|Adverse Event|0|||
130576742|NCT01790503|470076518|FG002|Overall Study|Adverse Event|0|||
130576743|NCT01790503|470076519|FG003|Overall Study|Adverse Event|0|||
130576744|NCT01790503|470076520|FG004|Overall Study|Adverse Event|0|||
130576745|NCT01790503|470076521|FG005|Overall Study|Adverse Event|2|||
130576746|NCT01790503|470076522|FG006|Overall Study|Adverse Event|0|||
130576747|NCT01790503|470076523|FG007|Overall Study|Adverse Event|0|||
130576748|NCT01790503|470076524|FG008|Overall Study|Adverse Event|2|||
130576749|NCT01790503|470076525|FG009|Overall Study|Adverse Event|4|||
130576750|NCT01790503|470076526|FG010|Overall Study|Adverse Event|7|||
130576751|NCT01790503|470076516|FG000|Overall Study|Withdrawal by Subject|0|||
130576752|NCT01790503|470076517|FG001|Overall Study|Withdrawal by Subject|0|||
130576753|NCT01790503|470076518|FG002|Overall Study|Withdrawal by Subject|1|||
130576754|NCT01790503|470076519|FG003|Overall Study|Withdrawal by Subject|1|||
130576755|NCT01790503|470076520|FG004|Overall Study|Withdrawal by Subject|1|||
130576756|NCT01790503|470076521|FG005|Overall Study|Withdrawal by Subject|2|||
130576757|NCT01790503|470076522|FG006|Overall Study|Withdrawal by Subject|1|||
130576758|NCT01790503|470076523|FG007|Overall Study|Withdrawal by Subject|0|||
130576759|NCT01790503|470076524|FG008|Overall Study|Withdrawal by Subject|0|||
130576760|NCT01790503|470076525|FG009|Overall Study|Withdrawal by Subject|0|||
130576761|NCT01790503|470076526|FG010|Overall Study|Withdrawal by Subject|1|||
130576762|NCT01790503|470076516|FG000|Overall Study|Disease progression|2|||
130576763|NCT01790503|470076517|FG001|Overall Study|Disease progression|1|||
130576764|NCT01790503|470076518|FG002|Overall Study|Disease progression|0|||
130576765|NCT01790503|470076519|FG003|Overall Study|Disease progression|1|||
130576766|NCT01790503|470076520|FG004|Overall Study|Disease progression|2|||
130576767|NCT01790503|470076521|FG005|Overall Study|Disease progression|1|||
130576768|NCT01790503|470076522|FG006|Overall Study|Disease progression|0|||
130576769|NCT01790503|470076523|FG007|Overall Study|Disease progression|1|||
130576770|NCT01790503|470076524|FG008|Overall Study|Disease progression|0|||
130576771|NCT01790503|470076525|FG009|Overall Study|Disease progression|17|||
130576772|NCT01790503|470076526|FG010|Overall Study|Disease progression|7|||
130576773|NCT01790503|470076516|FG000|Overall Study|Protocol Violation|0|||
130576774|NCT01790503|470076517|FG001|Overall Study|Protocol Violation|0|||
130576775|NCT01790503|470076518|FG002|Overall Study|Protocol Violation|0|||
130576776|NCT01790503|470076519|FG003|Overall Study|Protocol Violation|0|||
130576777|NCT01790503|470076520|FG004|Overall Study|Protocol Violation|0|||
130576778|NCT01790503|470076521|FG005|Overall Study|Protocol Violation|0|||
130576779|NCT01790503|470076522|FG006|Overall Study|Protocol Violation|0|||
130576780|NCT01790503|470076523|FG007|Overall Study|Protocol Violation|0|||
130576781|NCT01790503|470076524|FG008|Overall Study|Protocol Violation|0|||
130576782|NCT01790503|470076525|FG009|Overall Study|Protocol Violation|1|||
130576783|NCT01790503|470076526|FG010|Overall Study|Protocol Violation|0|||
130576784|NCT01790503|470076516|FG000|Overall Study|Physician Decision|0|||
130576785|NCT01790503|470076517|FG001|Overall Study|Physician Decision|0|||
130576786|NCT01790503|470076518|FG002|Overall Study|Physician Decision|0|||
130576787|NCT01790503|470076519|FG003|Overall Study|Physician Decision|0|||
130576788|NCT01790503|470076520|FG004|Overall Study|Physician Decision|0|||
130576789|NCT01790503|470076521|FG005|Overall Study|Physician Decision|0|||
130576790|NCT01790503|470076522|FG006|Overall Study|Physician Decision|0|||
130576791|NCT01790503|470076523|FG007|Overall Study|Physician Decision|0|||
130576792|NCT01790503|470076524|FG008|Overall Study|Physician Decision|0|||
130576793|NCT01790503|470076525|FG009|Overall Study|Physician Decision|1|||
130576794|NCT01790503|470076526|FG010|Overall Study|Physician Decision|1|||
130576795|NCT01790503|470076516|FG000|Overall Study|Death|0|||
130576796|NCT01790503|470076517|FG001|Overall Study|Death|0|||
130576797|NCT01790503|470076518|FG002|Overall Study|Death|0|||
130576798|NCT01790503|470076519|FG003|Overall Study|Death|0|||
130576799|NCT01790503|470076520|FG004|Overall Study|Death|0|||
130576800|NCT01790503|470076521|FG005|Overall Study|Death|0|||
130576801|NCT01790503|470076522|FG006|Overall Study|Death|0|||
130576802|NCT01790503|470076523|FG007|Overall Study|Death|0|||
130576803|NCT01790503|470076524|FG008|Overall Study|Death|0|||
130576804|NCT01790503|470076525|FG009|Overall Study|Death|1|||
130576805|NCT01790503|470076526|FG010|Overall Study|Death|0|||
130576806|NCT01790503|470076516|FG000|Overall Study|Non Compliance|0|||
130576807|NCT01790503|470076517|FG001|Overall Study|Non Compliance|0|||
130576808|NCT01790503|470076518|FG002|Overall Study|Non Compliance|0|||
130576809|NCT01790503|470076519|FG003|Overall Study|Non Compliance|0|||
130576810|NCT01790503|470076520|FG004|Overall Study|Non Compliance|1|||
130576811|NCT01790503|470076521|FG005|Overall Study|Non Compliance|0|||
130576812|NCT01790503|470076522|FG006|Overall Study|Non Compliance|0|||
130576813|NCT01790503|470076523|FG007|Overall Study|Non Compliance|0|||
130576814|NCT01790503|470076524|FG008|Overall Study|Non Compliance|0|||
130576815|NCT01790503|470076525|FG009|Overall Study|Non Compliance|0|||
130576816|NCT01790503|470076526|FG010|Overall Study|Non Compliance|0|||
130576817|NCT01790503|470076516|FG000|Overall Study|Other|0|||
130576818|NCT01790503|470076517|FG001|Overall Study|Other|0|||
130576819|NCT01790503|470076518|FG002|Overall Study|Other|0|||
130576820|NCT01790503|470076519|FG003|Overall Study|Other|0|||
130576821|NCT01790503|470076520|FG004|Overall Study|Other|1|||
130576822|NCT01790503|470076521|FG005|Overall Study|Other|0|||
130576823|NCT01790503|470076522|FG006|Overall Study|Other|0|||
130576824|NCT01790503|470076523|FG007|Overall Study|Other|0|||
130576825|NCT01790503|470076524|FG008|Overall Study|Other|1|||
130576826|NCT01790503|470076525|FG009|Overall Study|Other|2|||
130576827|NCT01790503|470076526|FG010|Overall Study|Other|0|||
130576828|NCT02605642|470076527|FG000|Overall Study|Other|11|||
130576829|NCT02605642|470076528|FG001|Overall Study|Other|1|||
130576830|NCT02605642|470076527|FG000|Overall Study|Participant non-compliance|2|||
130576831|NCT02605642|470076528|FG001|Overall Study|Participant non-compliance|4|||
130576832|NCT02605642|470076527|FG000|Overall Study|Physician Decision|10|||
130576833|NCT02605642|470076528|FG001|Overall Study|Physician Decision|0|||
130576834|NCT02605642|470076527|FG000|Overall Study|Lost to Follow-up|12|||
130576835|NCT02605642|470076528|FG001|Overall Study|Lost to Follow-up|1|||
130576836|NCT02605642|470076527|FG000|Overall Study|Adverse Event|14|||
130576837|NCT02605642|470076528|FG001|Overall Study|Adverse Event|2|||
130576838|NCT02605642|470076527|FG000|Overall Study|Withdrawal by Subject|23|||
130576839|NCT02605642|470076528|FG001|Overall Study|Withdrawal by Subject|2|||
130576840|NCT02605642|470076527|FG000|Overall Study|Lack of response|24|||
130576841|NCT02605642|470076528|FG001|Overall Study|Lack of response|11|||
130576842|NCT00984204|470076537|FG000|Overall Study|Death|1|||
130576843|NCT00984204|470076537|FG000|Overall Study|Lost to Follow-up|4|||
130576844|NCT00984204|470076537|FG000|Overall Study|Lack of Efficacy|10|||
130576845|NCT00699348|470076538|FG000|Overall Study|Death|6|||
130576846|NCT00699348|470076538|FG000|Overall Study|Adverse Event|15|||
130576847|NCT00699348|470076538|FG000|Overall Study|Withdrawal by Subject|11|||
130576848|NCT00699348|470076538|FG000|Overall Study|Protocol Violation|10|||
130524783|NCT04351269|469890249|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
130524784|NCT04351269|469890250|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
130524785|NCT04351269|469890248|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
130524786|NCT04351269|469890249|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
130524787|NCT04351269|469890250|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
130524788|NCT04351269|469890248|FG000|Overall Study|Lost to Follow-up|1|||
130524789|NCT04351269|469890249|FG001|Overall Study|Lost to Follow-up|3|||
130524790|NCT04351269|469890250|FG002|Overall Study|Lost to Follow-up|0|||
130524791|NCT02270671|469890253|FG000|Overall Study|Withdrawal by Subject|1|||
130524792|NCT02270671|469890254|FG001|Overall Study|Withdrawal by Subject|1|||
130524793|NCT02270671|469890253|FG000|Overall Study|Protocol Violation|0|||
130524794|NCT02270671|469890254|FG001|Overall Study|Protocol Violation|1|||
130524795|NCT02270671|469890253|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
130524796|NCT02270671|469890254|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
130524797|NCT02270671|469890253|FG000|Overall Study|Lost to Follow-up|2|||
130524798|NCT02270671|469890254|FG001|Overall Study|Lost to Follow-up|1|||
130524799|NCT05878873|469890266|FG000|Overall Study|Lost to Follow-up|2|||
130524800|NCT05878873|469890267|FG001|Overall Study|Lost to Follow-up|0|||
130524801|NCT00882115|469890269|FG000|Overall Study|Withdrawal by Subject|3|||
130524802|NCT00882115|469890269|FG000|Overall Study|did not respond to DEP challe|6|||
130524803|NCT02552147|469890270|FG000|First Intervention (7 Days)|Protocol Violation|1|||
130524804|NCT02552147|469890271|FG001|First Intervention (7 Days)|Protocol Violation|0|||
130524805|NCT02552147|469890270|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
130524806|NCT02552147|469890271|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
130524807|NCT01547598|469890272|FG000|Overall Study|Withdrew consent|1|||
130524808|NCT01547598|469890273|FG001|Overall Study|Withdrew consent|1|||
130524809|NCT01547598|469890272|FG000|Overall Study|Lost to Follow-up|1|||
130524810|NCT01547598|469890273|FG001|Overall Study|Lost to Follow-up|1|||
130524811|NCT01547598|469890272|FG000|Overall Study|Adverse Event|1|||
130524812|NCT01547598|469890273|FG001|Overall Study|Adverse Event|1|||
130524813|NCT01547598|469890272|FG000|Overall Study|Protocol Violation|1|||
130524814|NCT01547598|469890273|FG001|Overall Study|Protocol Violation|1|||
130524815|NCT01547598|469890272|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130524816|NCT01547598|469890273|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130524817|NCT02229227|469890274|FG000|Overall Study|Adverse Event|14|||
130524818|NCT02229227|469890275|FG001|Overall Study|Adverse Event|9|||
130524819|NCT02229227|469890274|FG000|Overall Study|Lack of Efficacy|3|||
130524820|NCT02229227|469890275|FG001|Overall Study|Lack of Efficacy|3|||
130524821|NCT02229227|469890274|FG000|Overall Study|Protocol Violation|6|||
130524822|NCT02229227|469890275|FG001|Overall Study|Protocol Violation|8|||
130524823|NCT02229227|469890274|FG000|Overall Study|Protocol defined stopping criteria|1|||
130524824|NCT02229227|469890275|FG001|Overall Study|Protocol defined stopping criteria|3|||
130524825|NCT02229227|469890274|FG000|Overall Study|Lost to Follow-up|3|||
130524826|NCT02229227|469890275|FG001|Overall Study|Lost to Follow-up|3|||
130524827|NCT02229227|469890274|FG000|Overall Study|Study terminated by sponsor|11|||
130524828|NCT02229227|469890275|FG001|Overall Study|Study terminated by sponsor|11|||
130524829|NCT02229227|469890274|FG000|Overall Study|Withdrawal by Subject|8|||
130524830|NCT02229227|469890275|FG001|Overall Study|Withdrawal by Subject|12|||
130524831|NCT02229227|469890274|FG000|Overall Study|Other|0|||
130524832|NCT02229227|469890275|FG001|Overall Study|Other|1|||
130524833|NCT02229227|469890274|FG000|Overall Study|Physician Decision|5|||
130524834|NCT02229227|469890275|FG001|Overall Study|Physician Decision|12|||
130524835|NCT04071301|469890276|FG000|Overall Study|Withdrawal by Subject|6|||
130524836|NCT04071301|469890276|FG000|Overall Study|Death|1|||
130524837|NCT02125279|469890277|FG000|Overall Study|Lack of Efficacy|2|||
130524838|NCT02125279|469890277|FG000|Overall Study|Withdrawal by Subject|6|||
130524839|NCT02125279|469890277|FG000|Overall Study|Protocol Violation|1|||
130524840|NCT02125279|469890277|FG000|Overall Study|Lost to Follow-up|4|||
130524841|NCT01850589|469890283|FG000|Overall Study|Withdrawal by Subject|8|||
130524842|NCT01850589|469890284|FG001|Overall Study|Withdrawal by Subject|0|||
130524843|NCT04468230|469890289|FG000|Overall Study|Adverse Event|2|||
130524844|NCT03721705|469890292|FG000|Overall Study|Adverse Event|2|||
130524845|NCT03721705|469890293|FG001|Overall Study|Adverse Event|0|||
130524846|NCT03721705|469890292|FG000|Overall Study|Withdrawal by Subject|4|||
130524847|NCT03721705|469890293|FG001|Overall Study|Withdrawal by Subject|10|||
130524848|NCT03721705|469890292|FG000|Overall Study|No Suitable Study Partner|1|||
130524849|NCT03721705|469890293|FG001|Overall Study|No Suitable Study Partner|0|||
130524850|NCT03721705|469890292|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
130524851|NCT03721705|469890293|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
130524852|NCT03721705|469890292|FG000|Overall Study|Death|0|||
130524853|NCT03721705|469890293|FG001|Overall Study|Death|1|||
130524854|NCT01790295|469890294|FG000|Overall Study|Adverse Event|1|||
130524855|NCT01790295|469890294|FG000|Overall Study|Death|4|||
130524856|NCT01790295|469890294|FG000|Overall Study|Lack of Efficacy|2|||
130524857|NCT01790295|469890294|FG000|Overall Study|Study closure|4|||
130524858|NCT03721172|469890297|FG000|Placebo-controlled Phase|Adverse Event|7|||
130524859|NCT03721172|469890298|FG001|Placebo-controlled Phase|Adverse Event|7|||
130524860|NCT03721172|469890299|FG002|Placebo-controlled Phase|Adverse Event|0|||
130524861|NCT03721172|469890297|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
130524862|NCT03721172|469890298|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
130524863|NCT03721172|469890299|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
130524864|NCT03721172|469890297|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
130524865|NCT03721172|469890298|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
130524866|NCT03721172|469890299|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
130524867|NCT03721172|469890297|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
130524868|NCT03721172|469890298|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
130524869|NCT03721172|469890299|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
130524870|NCT03721172|469890297|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
130524871|NCT03721172|469890298|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
130524872|NCT03721172|469890299|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
130524873|NCT03721172|469890297|FG000|Placebo-controlled Phase|Other|3|||
130524874|NCT03721172|469890298|FG001|Placebo-controlled Phase|Other|0|||
130524875|NCT03721172|469890299|FG002|Placebo-controlled Phase|Other|0|||
130524876|NCT03721172|469890297|FG000|Apremilast Extension Phase|Adverse Event|0|||
130524877|NCT03721172|469890298|FG001|Apremilast Extension Phase|Adverse Event|0|||
130524878|NCT03721172|469890299|FG002|Apremilast Extension Phase|Adverse Event|10|||
130524879|NCT03721172|469890297|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
130524880|NCT03721172|469890298|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
130524881|NCT03721172|469890299|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
130524882|NCT03721172|469890297|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
130524883|NCT03721172|469890298|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
130524884|NCT03721172|469890299|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
130524885|NCT03721172|469890297|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
130524886|NCT03721172|469890298|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
130524887|NCT03721172|469890299|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
130524888|NCT03721172|469890297|FG000|Apremilast Extension Phase|Protocol Violation|0|||
130524889|NCT03721172|469890298|FG001|Apremilast Extension Phase|Protocol Violation|0|||
130524890|NCT03721172|469890299|FG002|Apremilast Extension Phase|Protocol Violation|1|||
130524891|NCT03721172|469890297|FG000|Apremilast Extension Phase|Physician Decision|0|||
130524892|NCT03721172|469890298|FG001|Apremilast Extension Phase|Physician Decision|0|||
130524893|NCT03721172|469890299|FG002|Apremilast Extension Phase|Physician Decision|1|||
130524894|NCT03721172|469890297|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
130524895|NCT03721172|469890298|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
130524896|NCT03721172|469890299|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
130524897|NCT03721172|469890297|FG000|Apremilast Extension Phase|Other|0|||
130524898|NCT03721172|469890298|FG001|Apremilast Extension Phase|Other|0|||
130524899|NCT03721172|469890299|FG002|Apremilast Extension Phase|Other|3|||
130524900|NCT03721172|469890297|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
130524901|NCT03721172|469890298|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
130524902|NCT03721172|469890299|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
130524903|NCT00420784|469890300|FG000|Overall Study|Adverse Event|11|||
130524904|NCT00420784|469890301|FG001|Overall Study|Adverse Event|29|||
130524905|NCT00420784|469890302|FG002|Overall Study|Adverse Event|10|||
130524906|NCT00420784|469890303|FG003|Overall Study|Adverse Event|5|||
130524907|NCT00420784|469890300|FG000|Overall Study|Withdrawal by Subject|0|||
130524908|NCT00420784|469890301|FG001|Overall Study|Withdrawal by Subject|1|||
130524909|NCT00420784|469890302|FG002|Overall Study|Withdrawal by Subject|0|||
130524910|NCT00420784|469890303|FG003|Overall Study|Withdrawal by Subject|0|||
130524911|NCT00420784|469890300|FG000|Overall Study|Lost to Follow-up|0|||
130524912|NCT00420784|469890301|FG001|Overall Study|Lost to Follow-up|0|||
130524913|NCT00420784|469890302|FG002|Overall Study|Lost to Follow-up|2|||
130524914|NCT00420784|469890303|FG003|Overall Study|Lost to Follow-up|1|||
130524915|NCT00420784|469890300|FG000|Overall Study|Virologic Stopping Rule|17|||
130524916|NCT00420784|469890301|FG001|Overall Study|Virologic Stopping Rule|26|||
130524917|NCT00420784|469890302|FG002|Overall Study|Virologic Stopping Rule|41|||
130524918|NCT00420784|469890303|FG003|Overall Study|Virologic Stopping Rule|67|||
130524919|NCT00420784|469890300|FG000|Overall Study|Other|1|||
130524920|NCT00420784|469890301|FG001|Overall Study|Other|2|||
130524921|NCT00420784|469890302|FG002|Overall Study|Other|0|||
130524922|NCT00420784|469890303|FG003|Overall Study|Other|5|||
130524923|NCT02402322|469890306|FG000|Pretreatment|Withdrawal by Subject|3|||
130524924|NCT02402322|469890307|FG001|Pretreatment|Withdrawal by Subject|1|||
130524925|NCT02402322|469890308|FG002|Pretreatment|Withdrawal by Subject|1|||
130524926|NCT02402322|469890306|FG000|Follow-up|Withdrawal by Subject|6|||
130524927|NCT02402322|469890307|FG001|Follow-up|Withdrawal by Subject|3|||
130524928|NCT02402322|469890308|FG002|Follow-up|Withdrawal by Subject|24|||
130524929|NCT04593823|469890309|FG000|Overall Study|Withdrawal by Subject|1|||
130524930|NCT04593823|469890310|FG001|Overall Study|Withdrawal by Subject|1|||
130524931|NCT04593823|469890309|FG000|Overall Study|Lost to Follow-up|0|||
130576849|NCT00699348|470076538|FG000|Overall Study|Lack of Efficacy|8|||
130576850|NCT00699348|470076538|FG000|Overall Study|Failure to return|1|||
130576851|NCT00699348|470076538|FG000|Overall Study|Blood transfusion|24|||
130576852|NCT00699348|470076538|FG000|Overall Study|Renal transplantation|10|||
130576853|NCT00699348|470076538|FG000|Overall Study|Other|5|||
130576854|NCT03269344|470076539|FG000|Overall Study|Protocol Violation|4|||
130576855|NCT03269344|470076540|FG001|Overall Study|Protocol Violation|3|||
130576856|NCT02597855|470076543|FG000|Overall Study|Lost to Follow-up|2|||
130576857|NCT02597855|470076544|FG001|Overall Study|Lost to Follow-up|1|||
130576858|NCT03704194|470076550|FG000|Overall Study|Withdrawal by Subject|0|||
130576859|NCT03704194|470076551|FG001|Overall Study|Withdrawal by Subject|1|||
130576860|NCT02889796|470076554|FG000|Overall Study|Withdrew Consent|18|||
130576861|NCT02889796|470076555|FG001|Overall Study|Withdrew Consent|29|||
130576862|NCT02889796|470076556|FG002|Overall Study|Withdrew Consent|20|||
130576863|NCT02889796|470076557|FG003|Overall Study|Withdrew Consent|1|||
130576864|NCT02889796|470076558|FG004|Overall Study|Withdrew Consent|2|||
130576865|NCT02889796|470076559|FG005|Overall Study|Withdrew Consent|35|||
130576866|NCT02889796|470076554|FG000|Overall Study|Investigator's Discretion|10|||
130576867|NCT02889796|470076555|FG001|Overall Study|Investigator's Discretion|9|||
130576868|NCT02889796|470076556|FG002|Overall Study|Investigator's Discretion|10|||
130576869|NCT02889796|470076557|FG003|Overall Study|Investigator's Discretion|3|||
130576870|NCT02889796|470076558|FG004|Overall Study|Investigator's Discretion|0|||
130576871|NCT02889796|470076559|FG005|Overall Study|Investigator's Discretion|15|||
130576872|NCT02889796|470076554|FG000|Overall Study|Adverse Event|17|||
130576873|NCT02889796|470076555|FG001|Overall Study|Adverse Event|8|||
130576874|NCT02889796|470076556|FG002|Overall Study|Adverse Event|8|||
130576875|NCT02889796|470076557|FG003|Overall Study|Adverse Event|4|||
130576876|NCT02889796|470076558|FG004|Overall Study|Adverse Event|1|||
130576877|NCT02889796|470076559|FG005|Overall Study|Adverse Event|7|||
130576878|NCT02889796|470076554|FG000|Overall Study|Lost to Follow-up|5|||
130576879|NCT02889796|470076555|FG001|Overall Study|Lost to Follow-up|7|||
130576880|NCT02889796|470076556|FG002|Overall Study|Lost to Follow-up|2|||
130576881|NCT02889796|470076557|FG003|Overall Study|Lost to Follow-up|0|||
130576882|NCT02889796|470076558|FG004|Overall Study|Lost to Follow-up|2|||
130576883|NCT02889796|470076559|FG005|Overall Study|Lost to Follow-up|6|||
130576884|NCT02889796|470076554|FG000|Overall Study|Protocol Violation|0|||
130576885|NCT02889796|470076555|FG001|Overall Study|Protocol Violation|1|||
130576886|NCT02889796|470076556|FG002|Overall Study|Protocol Violation|3|||
130576887|NCT02889796|470076557|FG003|Overall Study|Protocol Violation|0|||
130576888|NCT02889796|470076558|FG004|Overall Study|Protocol Violation|0|||
130576889|NCT02889796|470076559|FG005|Overall Study|Protocol Violation|4|||
130576890|NCT02889796|470076554|FG000|Overall Study|Non-compliance With Study Drug|0|||
130576891|NCT02889796|470076555|FG001|Overall Study|Non-compliance With Study Drug|2|||
130576892|NCT02889796|470076556|FG002|Overall Study|Non-compliance With Study Drug|0|||
130576893|NCT02889796|470076557|FG003|Overall Study|Non-compliance With Study Drug|0|||
130576894|NCT02889796|470076558|FG004|Overall Study|Non-compliance With Study Drug|1|||
130576895|NCT02889796|470076559|FG005|Overall Study|Non-compliance With Study Drug|2|||
130576896|NCT02889796|470076554|FG000|Overall Study|Death|1|||
130576897|NCT02889796|470076555|FG001|Overall Study|Death|1|||
130576898|NCT02889796|470076556|FG002|Overall Study|Death|0|||
130576899|NCT02889796|470076557|FG003|Overall Study|Death|1|||
130576900|NCT02889796|470076558|FG004|Overall Study|Death|0|||
130576901|NCT02889796|470076559|FG005|Overall Study|Death|1|||
130576902|NCT02889796|470076554|FG000|Overall Study|Pregnancy|0|||
130576903|NCT02889796|470076555|FG001|Overall Study|Pregnancy|1|||
130576904|NCT02889796|470076556|FG002|Overall Study|Pregnancy|1|||
130576905|NCT02889796|470076557|FG003|Overall Study|Pregnancy|0|||
130576906|NCT02889796|470076558|FG004|Overall Study|Pregnancy|0|||
130576907|NCT02889796|470076559|FG005|Overall Study|Pregnancy|0|||
130576908|NCT02889796|470076554|FG000|Overall Study|Randomized but not Dosed|2|||
130576909|NCT02889796|470076555|FG001|Overall Study|Randomized but not Dosed|0|||
130576910|NCT02889796|470076556|FG002|Overall Study|Randomized but not Dosed|0|||
130576911|NCT02889796|470076557|FG003|Overall Study|Randomized but not Dosed|0|||
130576912|NCT02889796|470076558|FG004|Overall Study|Randomized but not Dosed|0|||
130576913|NCT02889796|470076559|FG005|Overall Study|Randomized but not Dosed|2|||
130576914|NCT02479802|470076561|FG000|Overall Study|Lost to Follow-up|1|||
130576915|NCT02479802|470076561|FG000|Overall Study|Adverse Event|1|||
130576916|NCT01882907|470076562|FG000|Overall Study|Adverse Event|3|||
130576917|NCT01882907|470076563|FG001|Overall Study|Adverse Event|1|||
130576918|NCT01882907|470076562|FG000|Overall Study|Lack of Efficacy|0|||
130576919|NCT01882907|470076563|FG001|Overall Study|Lack of Efficacy|3|||
130576920|NCT01882907|470076562|FG000|Overall Study|Lost to Follow-up|1|||
130576921|NCT01882907|470076563|FG001|Overall Study|Lost to Follow-up|4|||
130576922|NCT01882907|470076562|FG000|Overall Study|Protocol Violation|10|||
130576923|NCT01882907|470076563|FG001|Overall Study|Protocol Violation|14|||
130576924|NCT01882907|470076562|FG000|Overall Study|Withdrawal by Subject|0|||
130576925|NCT01882907|470076563|FG001|Overall Study|Withdrawal by Subject|6|||
130576926|NCT01978093|470076564|FG000|Overall Study|Death|1|||
130576927|NCT01978093|470076565|FG001|Overall Study|Death|0|||
130576928|NCT01978093|470076564|FG000|Overall Study|Adverse Event|0|||
130524932|NCT04593823|469890310|FG001|Overall Study|Lost to Follow-up|1|||
130524933|NCT02472145|469890311|FG000|Overall Study|Death|10|||
130524934|NCT02472145|469890312|FG001|Overall Study|Death|101|||
130524935|NCT02472145|469890313|FG002|Overall Study|Death|99|||
130524936|NCT02472145|469890311|FG000|Overall Study|Lost to Follow-up|0|||
130524937|NCT02472145|469890312|FG001|Overall Study|Lost to Follow-up|1|||
130524938|NCT02472145|469890313|FG002|Overall Study|Lost to Follow-up|0|||
130524939|NCT02472145|469890311|FG000|Overall Study|Withdrawal by Subject|0|||
130524940|NCT02472145|469890312|FG001|Overall Study|Withdrawal by Subject|9|||
130524941|NCT02472145|469890313|FG002|Overall Study|Withdrawal by Subject|13|||
130524942|NCT02472145|469890311|FG000|Overall Study|Sponsor decision|0|||
130524943|NCT02472145|469890312|FG001|Overall Study|Sponsor decision|3|||
130524944|NCT02472145|469890313|FG002|Overall Study|Sponsor decision|2|||
130524945|NCT02472145|469890311|FG000|Overall Study|Other|0|||
130524946|NCT02472145|469890312|FG001|Overall Study|Other|45|||
130524947|NCT02472145|469890313|FG002|Overall Study|Other|43|||
130524948|NCT01296555|469890314|FG000|Overall Study|Adverse Event|0|||
130524949|NCT01296555|469890315|FG001|Overall Study|Adverse Event|0|||
130524950|NCT01296555|469890316|FG002|Overall Study|Adverse Event|1|||
130524951|NCT01296555|469890317|FG003|Overall Study|Adverse Event|1|||
130524952|NCT01296555|469890318|FG004|Overall Study|Adverse Event|2|||
130524953|NCT01296555|469890319|FG005|Overall Study|Adverse Event|4|||
130524954|NCT01296555|469890320|FG006|Overall Study|Adverse Event|1|||
130524955|NCT01296555|469890321|FG007|Overall Study|Adverse Event|4|||
130524956|NCT01296555|469890322|FG008|Overall Study|Adverse Event|3|||
130524957|NCT01296555|469890323|FG009|Overall Study|Adverse Event|1|||
130524958|NCT01296555|469890324|FG010|Overall Study|Adverse Event|0|||
130524959|NCT01296555|469890325|FG011|Overall Study|Adverse Event|4|||
130524960|NCT01296555|469890326|FG012|Overall Study|Adverse Event|1|||
130524961|NCT01296555|469890327|FG013|Overall Study|Adverse Event|4|||
130524962|NCT01296555|469890328|FG014|Overall Study|Adverse Event|0|||
130524963|NCT01296555|469890329|FG015|Overall Study|Adverse Event|0|||
130524964|NCT01296555|469890330|FG016|Overall Study|Adverse Event|0|||
130524965|NCT01296555|469890331|FG017|Overall Study|Adverse Event|0|||
130524966|NCT01296555|469890332|FG018|Overall Study|Adverse Event|0|||
130524967|NCT01296555|469890333|FG019|Overall Study|Adverse Event|1|||
130524968|NCT01296555|469890334|FG020|Overall Study|Adverse Event|0|||
130524969|NCT01296555|469890335|FG021|Overall Study|Adverse Event|0|||
130524970|NCT01296555|469890336|FG022|Overall Study|Adverse Event|0|||
130524971|NCT01296555|469890337|FG023|Overall Study|Adverse Event|0|||
130524972|NCT01296555|469890338|FG024|Overall Study|Adverse Event|0|||
130524973|NCT01296555|469890339|FG025|Overall Study|Adverse Event|0|||
130524974|NCT01296555|469890340|FG026|Overall Study|Adverse Event|0|||
130524975|NCT01296555|469890341|FG027|Overall Study|Adverse Event|0|||
130524976|NCT01296555|469890342|FG028|Overall Study|Adverse Event|0|||
130524977|NCT01296555|469890314|FG000|Overall Study|Reason Not Specified|0|||
130524978|NCT01296555|469890315|FG001|Overall Study|Reason Not Specified|0|||
130524979|NCT01296555|469890316|FG002|Overall Study|Reason Not Specified|0|||
130524980|NCT01296555|469890317|FG003|Overall Study|Reason Not Specified|0|||
130524981|NCT01296555|469890318|FG004|Overall Study|Reason Not Specified|0|||
130524982|NCT01296555|469890319|FG005|Overall Study|Reason Not Specified|0|||
130524983|NCT01296555|469890320|FG006|Overall Study|Reason Not Specified|0|||
130524984|NCT01296555|469890321|FG007|Overall Study|Reason Not Specified|0|||
130524985|NCT01296555|469890322|FG008|Overall Study|Reason Not Specified|0|||
130524986|NCT01296555|469890323|FG009|Overall Study|Reason Not Specified|0|||
130524987|NCT01296555|469890324|FG010|Overall Study|Reason Not Specified|0|||
130524988|NCT01296555|469890325|FG011|Overall Study|Reason Not Specified|0|||
130524989|NCT01296555|469890326|FG012|Overall Study|Reason Not Specified|0|||
130524990|NCT01296555|469890327|FG013|Overall Study|Reason Not Specified|1|||
130524991|NCT01296555|469890328|FG014|Overall Study|Reason Not Specified|2|||
130524992|NCT01296555|469890329|FG015|Overall Study|Reason Not Specified|3|||
130524993|NCT01296555|469890330|FG016|Overall Study|Reason Not Specified|7|||
130524994|NCT01296555|469890331|FG017|Overall Study|Reason Not Specified|4|||
130524995|NCT01296555|469890332|FG018|Overall Study|Reason Not Specified|3|||
130524996|NCT01296555|469890333|FG019|Overall Study|Reason Not Specified|7|||
130524997|NCT01296555|469890334|FG020|Overall Study|Reason Not Specified|11|||
130524998|NCT01296555|469890335|FG021|Overall Study|Reason Not Specified|5|||
130524999|NCT01296555|469890336|FG022|Overall Study|Reason Not Specified|5|||
130525000|NCT01296555|469890337|FG023|Overall Study|Reason Not Specified|7|||
130525001|NCT01296555|469890338|FG024|Overall Study|Reason Not Specified|2|||
130525002|NCT01296555|469890339|FG025|Overall Study|Reason Not Specified|2|||
130525003|NCT01296555|469890340|FG026|Overall Study|Reason Not Specified|19|||
130525004|NCT01296555|469890341|FG027|Overall Study|Reason Not Specified|11|||
130525005|NCT01296555|469890342|FG028|Overall Study|Reason Not Specified|9|||
130525006|NCT01296555|469890314|FG000|Overall Study|Physician Decision|0|||
130576929|NCT01978093|470076565|FG001|Overall Study|Adverse Event|5|||
130576930|NCT01978093|470076564|FG000|Overall Study|Protocol Violation|8|||
130576931|NCT01978093|470076565|FG001|Overall Study|Protocol Violation|2|||
130576932|NCT01978093|470076564|FG000|Overall Study|Withdrawal by Subject|29|||
130576933|NCT01978093|470076565|FG001|Overall Study|Withdrawal by Subject|25|||
130576934|NCT01978093|470076564|FG000|Overall Study|Lost to Follow-up|11|||
130576935|NCT01978093|470076565|FG001|Overall Study|Lost to Follow-up|15|||
130576936|NCT01978093|470076564|FG000|Overall Study|Migrated/moved from study area|11|||
130576937|NCT01978093|470076565|FG001|Overall Study|Migrated/moved from study area|13|||
130576938|NCT01978093|470076564|FG000|Overall Study|Loss of kaiser coverage|4|||
130576939|NCT01978093|470076565|FG001|Overall Study|Loss of kaiser coverage|10|||
130576940|NCT01978093|470076564|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
130576941|NCT01978093|470076565|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
130576942|NCT01978093|470076564|FG000|Overall Study|Mother lost custody of child|0|||
130576943|NCT01978093|470076565|FG001|Overall Study|Mother lost custody of child|1|||
130576944|NCT01978093|470076564|FG000|Overall Study|Child was in care of grandmother|0|||
130576945|NCT01978093|470076565|FG001|Overall Study|Child was in care of grandmother|1|||
130576946|NCT01978093|470076564|FG000|Overall Study|N/A for vaccine administration|0|||
130576947|NCT01978093|470076565|FG001|Overall Study|N/A for vaccine administration|1|||
130576948|NCT05702515|470076566|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
130576949|NCT02792842|470076568|FG000|Overall Study|Adverse Event|4|||
130576950|NCT02792842|470076569|FG001|Overall Study|Adverse Event|2|||
130576951|NCT02792842|470076570|FG002|Overall Study|Adverse Event|3|||
130576952|NCT02792842|470076568|FG000|Overall Study|Withdrawal by Subject|0|||
130576953|NCT02792842|470076569|FG001|Overall Study|Withdrawal by Subject|1|||
130576954|NCT02792842|470076570|FG002|Overall Study|Withdrawal by Subject|2|||
130576955|NCT02792842|470076568|FG000|Overall Study|Lost to Follow-up|0|||
130576956|NCT02792842|470076569|FG001|Overall Study|Lost to Follow-up|0|||
130576957|NCT02792842|470076570|FG002|Overall Study|Lost to Follow-up|1|||
130576958|NCT02792842|470076568|FG000|Overall Study|Schedule delay|0|||
130576959|NCT02792842|470076569|FG001|Overall Study|Schedule delay|1|||
130576960|NCT02792842|470076570|FG002|Overall Study|Schedule delay|1|||
130576961|NCT01491178|470076573|FG000|Overall Study|Adverse Event|1016|||
130576962|NCT01491178|470076573|FG000|Overall Study|Improvement of NVAF|210|||
130576963|NCT01491178|470076573|FG000|Overall Study|To conduct invasive treatment|59|||
130576964|NCT01491178|470076573|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
130576965|NCT01491178|470076573|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
130576966|NCT01491178|470076573|FG000|Overall Study|To take a contraindication|20|||
130576967|NCT01491178|470076573|FG000|Overall Study|Other than specified above|657|||
130576968|NCT01604512|470076574|FG000|Overall Study|Withdrawal by Subject|3|||
130576969|NCT01604512|470076574|FG000|Overall Study|Not treated|4|||
130576970|NCT03132636|470076575|FG000|Overall Study|Adverse Event|1|||
130525007|NCT01296555|469890315|FG001|Overall Study|Physician Decision|0|||
130525008|NCT01296555|469890316|FG002|Overall Study|Physician Decision|0|||
130525009|NCT01296555|469890317|FG003|Overall Study|Physician Decision|0|||
130525010|NCT01296555|469890318|FG004|Overall Study|Physician Decision|1|||
130525011|NCT01296555|469890319|FG005|Overall Study|Physician Decision|0|||
130525012|NCT01296555|469890320|FG006|Overall Study|Physician Decision|0|||
130525013|NCT01296555|469890321|FG007|Overall Study|Physician Decision|0|||
130525014|NCT01296555|469890322|FG008|Overall Study|Physician Decision|0|||
130525015|NCT01296555|469890323|FG009|Overall Study|Physician Decision|0|||
130525016|NCT01296555|469890324|FG010|Overall Study|Physician Decision|0|||
130525017|NCT01296555|469890325|FG011|Overall Study|Physician Decision|0|||
130525018|NCT01296555|469890326|FG012|Overall Study|Physician Decision|0|||
130525019|NCT01296555|469890327|FG013|Overall Study|Physician Decision|1|||
130525020|NCT01296555|469890328|FG014|Overall Study|Physician Decision|0|||
130525021|NCT01296555|469890329|FG015|Overall Study|Physician Decision|0|||
130525022|NCT01296555|469890330|FG016|Overall Study|Physician Decision|0|||
130525023|NCT01296555|469890331|FG017|Overall Study|Physician Decision|0|||
130525024|NCT01296555|469890332|FG018|Overall Study|Physician Decision|0|||
130525025|NCT01296555|469890333|FG019|Overall Study|Physician Decision|1|||
130525026|NCT01296555|469890334|FG020|Overall Study|Physician Decision|0|||
130525027|NCT01296555|469890335|FG021|Overall Study|Physician Decision|0|||
130525028|NCT01296555|469890336|FG022|Overall Study|Physician Decision|0|||
130525029|NCT01296555|469890337|FG023|Overall Study|Physician Decision|0|||
130525030|NCT01296555|469890338|FG024|Overall Study|Physician Decision|0|||
130525031|NCT01296555|469890339|FG025|Overall Study|Physician Decision|0|||
130525032|NCT01296555|469890340|FG026|Overall Study|Physician Decision|0|||
130525033|NCT01296555|469890341|FG027|Overall Study|Physician Decision|0|||
130525034|NCT01296555|469890342|FG028|Overall Study|Physician Decision|0|||
130525035|NCT01296555|469890314|FG000|Overall Study|Progressive Disease|6|||
130576971|NCT03132636|470076576|FG001|Overall Study|Adverse Event|2|||
130576972|NCT03132636|470076575|FG000|Overall Study|Death|4|||
130576973|NCT03132636|470076576|FG001|Overall Study|Death|7|||
130576974|NCT03132636|470076575|FG000|Overall Study|Lost to Follow-up|3|||
130576975|NCT03132636|470076576|FG001|Overall Study|Lost to Follow-up|2|||
130576976|NCT03132636|470076575|FG000|Overall Study|Non compliance with protocol by participant|1|||
130525036|NCT01296555|469890315|FG001|Overall Study|Progressive Disease|3|||
130525037|NCT01296555|469890316|FG002|Overall Study|Progressive Disease|3|||
130525038|NCT01296555|469890317|FG003|Overall Study|Progressive Disease|7|||
130525039|NCT01296555|469890318|FG004|Overall Study|Progressive Disease|6|||
130525040|NCT01296555|469890319|FG005|Overall Study|Progressive Disease|16|||
130525041|NCT01296555|469890320|FG006|Overall Study|Progressive Disease|16|||
130525042|NCT01296555|469890321|FG007|Overall Study|Progressive Disease|8|||
130525043|NCT01296555|469890322|FG008|Overall Study|Progressive Disease|7|||
130525044|NCT01296555|469890323|FG009|Overall Study|Progressive Disease|18|||
130525045|NCT01296555|469890324|FG010|Overall Study|Progressive Disease|7|||
130525046|NCT01296555|469890325|FG011|Overall Study|Progressive Disease|14|||
130525047|NCT01296555|469890326|FG012|Overall Study|Progressive Disease|5|||
130525048|NCT01296555|469890327|FG013|Overall Study|Progressive Disease|12|||
130525049|NCT01296555|469890328|FG014|Overall Study|Progressive Disease|1|||
130525050|NCT01296555|469890329|FG015|Overall Study|Progressive Disease|1|||
130525051|NCT01296555|469890330|FG016|Overall Study|Progressive Disease|0|||
130525052|NCT01296555|469890331|FG017|Overall Study|Progressive Disease|0|||
130525053|NCT01296555|469890332|FG018|Overall Study|Progressive Disease|0|||
130525054|NCT01296555|469890333|FG019|Overall Study|Progressive Disease|1|||
130525055|NCT01296555|469890334|FG020|Overall Study|Progressive Disease|0|||
130525056|NCT01296555|469890335|FG021|Overall Study|Progressive Disease|0|||
130525057|NCT01296555|469890336|FG022|Overall Study|Progressive Disease|0|||
130525058|NCT01296555|469890337|FG023|Overall Study|Progressive Disease|0|||
130525059|NCT01296555|469890338|FG024|Overall Study|Progressive Disease|1|||
130525060|NCT01296555|469890339|FG025|Overall Study|Progressive Disease|0|||
130525061|NCT01296555|469890340|FG026|Overall Study|Progressive Disease|5|||
130525062|NCT01296555|469890341|FG027|Overall Study|Progressive Disease|1|||
130525063|NCT01296555|469890342|FG028|Overall Study|Progressive Disease|0|||
130525064|NCT01296555|469890314|FG000|Overall Study|Protocol Violation|0|||
130525065|NCT01296555|469890315|FG001|Overall Study|Protocol Violation|0|||
130525066|NCT01296555|469890316|FG002|Overall Study|Protocol Violation|0|||
130525067|NCT01296555|469890317|FG003|Overall Study|Protocol Violation|0|||
130525068|NCT01296555|469890318|FG004|Overall Study|Protocol Violation|0|||
130525069|NCT01296555|469890319|FG005|Overall Study|Protocol Violation|0|||
130525070|NCT01296555|469890320|FG006|Overall Study|Protocol Violation|0|||
130525071|NCT01296555|469890321|FG007|Overall Study|Protocol Violation|0|||
130525072|NCT01296555|469890322|FG008|Overall Study|Protocol Violation|0|||
130525073|NCT01296555|469890323|FG009|Overall Study|Protocol Violation|0|||
130525074|NCT01296555|469890324|FG010|Overall Study|Protocol Violation|0|||
130525075|NCT01296555|469890325|FG011|Overall Study|Protocol Violation|0|||
130525076|NCT01296555|469890326|FG012|Overall Study|Protocol Violation|0|||
130525077|NCT01296555|469890327|FG013|Overall Study|Protocol Violation|1|||
130525078|NCT01296555|469890328|FG014|Overall Study|Protocol Violation|0|||
130525079|NCT01296555|469890329|FG015|Overall Study|Protocol Violation|0|||
130525080|NCT01296555|469890330|FG016|Overall Study|Protocol Violation|0|||
130525081|NCT01296555|469890331|FG017|Overall Study|Protocol Violation|0|||
130525082|NCT01296555|469890332|FG018|Overall Study|Protocol Violation|0|||
130525083|NCT01296555|469890333|FG019|Overall Study|Protocol Violation|0|||
130525084|NCT01296555|469890334|FG020|Overall Study|Protocol Violation|0|||
130525085|NCT01296555|469890335|FG021|Overall Study|Protocol Violation|0|||
130525086|NCT01296555|469890336|FG022|Overall Study|Protocol Violation|0|||
130525087|NCT01296555|469890337|FG023|Overall Study|Protocol Violation|0|||
130525088|NCT01296555|469890338|FG024|Overall Study|Protocol Violation|0|||
130525089|NCT01296555|469890339|FG025|Overall Study|Protocol Violation|0|||
130525090|NCT01296555|469890340|FG026|Overall Study|Protocol Violation|0|||
130525091|NCT01296555|469890341|FG027|Overall Study|Protocol Violation|0|||
130525092|NCT01296555|469890342|FG028|Overall Study|Protocol Violation|0|||
130525093|NCT01296555|469890314|FG000|Overall Study|Study Terminated By Sponsor|0|||
130525094|NCT01296555|469890315|FG001|Overall Study|Study Terminated By Sponsor|0|||
130525095|NCT01296555|469890316|FG002|Overall Study|Study Terminated By Sponsor|0|||
130525096|NCT01296555|469890317|FG003|Overall Study|Study Terminated By Sponsor|0|||
130525097|NCT01296555|469890318|FG004|Overall Study|Study Terminated By Sponsor|0|||
130525098|NCT01296555|469890319|FG005|Overall Study|Study Terminated By Sponsor|0|||
130525099|NCT01296555|469890320|FG006|Overall Study|Study Terminated By Sponsor|0|||
130525100|NCT01296555|469890321|FG007|Overall Study|Study Terminated By Sponsor|0|||
130525101|NCT01296555|469890322|FG008|Overall Study|Study Terminated By Sponsor|0|||
130525102|NCT01296555|469890323|FG009|Overall Study|Study Terminated By Sponsor|0|||
130525103|NCT01296555|469890324|FG010|Overall Study|Study Terminated By Sponsor|0|||
130525104|NCT01296555|469890325|FG011|Overall Study|Study Terminated By Sponsor|0|||
130525105|NCT01296555|469890326|FG012|Overall Study|Study Terminated By Sponsor|0|||
130525106|NCT01296555|469890327|FG013|Overall Study|Study Terminated By Sponsor|0|||
130525107|NCT01296555|469890328|FG014|Overall Study|Study Terminated By Sponsor|0|||
130525108|NCT01296555|469890329|FG015|Overall Study|Study Terminated By Sponsor|0|||
130525109|NCT01296555|469890330|FG016|Overall Study|Study Terminated By Sponsor|0|||
130525110|NCT01296555|469890331|FG017|Overall Study|Study Terminated By Sponsor|0|||
130525111|NCT01296555|469890332|FG018|Overall Study|Study Terminated By Sponsor|0|||
130525112|NCT01296555|469890333|FG019|Overall Study|Study Terminated By Sponsor|0|||
130525113|NCT01296555|469890334|FG020|Overall Study|Study Terminated By Sponsor|0|||
130525114|NCT01296555|469890335|FG021|Overall Study|Study Terminated By Sponsor|0|||
130576977|NCT03132636|470076576|FG001|Overall Study|Non compliance with protocol by participant|1|||
130576978|NCT03132636|470076575|FG000|Overall Study|Subject decision|1|||
130525115|NCT01296555|469890336|FG022|Overall Study|Study Terminated By Sponsor|0|||
130525116|NCT01296555|469890337|FG023|Overall Study|Study Terminated By Sponsor|0|||
130525117|NCT01296555|469890338|FG024|Overall Study|Study Terminated By Sponsor|0|||
130525118|NCT01296555|469890339|FG025|Overall Study|Study Terminated By Sponsor|1|||
130525119|NCT01296555|469890340|FG026|Overall Study|Study Terminated By Sponsor|0|||
130525120|NCT01296555|469890341|FG027|Overall Study|Study Terminated By Sponsor|0|||
130525121|NCT01296555|469890342|FG028|Overall Study|Study Terminated By Sponsor|0|||
130525122|NCT01296555|469890314|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525123|NCT01296555|469890315|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525124|NCT01296555|469890316|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525125|NCT01296555|469890317|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525126|NCT01296555|469890318|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525127|NCT01296555|469890319|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525128|NCT01296555|469890320|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525129|NCT01296555|469890321|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525130|NCT01296555|469890322|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525131|NCT01296555|469890323|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525132|NCT01296555|469890324|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525133|NCT01296555|469890325|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525134|NCT01296555|469890326|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525135|NCT01296555|469890327|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525136|NCT01296555|469890328|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525137|NCT01296555|469890329|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525138|NCT01296555|469890330|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525139|NCT01296555|469890331|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525140|NCT01296555|469890332|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525141|NCT01296555|469890333|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
130525142|NCT01296555|469890334|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525143|NCT01296555|469890335|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525144|NCT01296555|469890336|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525145|NCT01296555|469890337|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525146|NCT01296555|469890338|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525147|NCT01296555|469890339|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525148|NCT01296555|469890340|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525149|NCT01296555|469890341|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525150|NCT01296555|469890342|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130525151|NCT01296555|469890314|FG000|Overall Study|Death|0|||
130525152|NCT01296555|469890315|FG001|Overall Study|Death|0|||
130525153|NCT01296555|469890316|FG002|Overall Study|Death|0|||
130525154|NCT01296555|469890317|FG003|Overall Study|Death|2|||
130525155|NCT01296555|469890318|FG004|Overall Study|Death|1|||
130525156|NCT01296555|469890319|FG005|Overall Study|Death|0|||
130525157|NCT01296555|469890320|FG006|Overall Study|Death|2|||
130525158|NCT01296555|469890321|FG007|Overall Study|Death|0|||
130525159|NCT01296555|469890322|FG008|Overall Study|Death|0|||
130525160|NCT01296555|469890323|FG009|Overall Study|Death|1|||
130525161|NCT01296555|469890324|FG010|Overall Study|Death|0|||
130525162|NCT01296555|469890325|FG011|Overall Study|Death|1|||
130525163|NCT01296555|469890326|FG012|Overall Study|Death|0|||
130525164|NCT01296555|469890327|FG013|Overall Study|Death|2|||
130525165|NCT01296555|469890328|FG014|Overall Study|Death|27|||
130525166|NCT01296555|469890329|FG015|Overall Study|Death|15|||
130576979|NCT03132636|470076576|FG001|Overall Study|Subject decision|9|||
130525167|NCT01296555|469890330|FG016|Overall Study|Death|11|||
130525168|NCT01296555|469890331|FG017|Overall Study|Death|11|||
130525169|NCT01296555|469890332|FG018|Overall Study|Death|17|||
130525170|NCT01296555|469890333|FG019|Overall Study|Death|12|||
130525171|NCT01296555|469890334|FG020|Overall Study|Death|13|||
130525172|NCT01296555|469890335|FG021|Overall Study|Death|12|||
130525173|NCT01296555|469890336|FG022|Overall Study|Death|12|||
130525174|NCT01296555|469890337|FG023|Overall Study|Death|13|||
130525175|NCT01296555|469890338|FG024|Overall Study|Death|7|||
130525176|NCT01296555|469890339|FG025|Overall Study|Death|7|||
130525177|NCT01296555|469890340|FG026|Overall Study|Death|35|||
130525178|NCT01296555|469890341|FG027|Overall Study|Death|92|||
130525179|NCT01296555|469890342|FG028|Overall Study|Death|44|||
130525180|NCT01296555|469890314|FG000|Overall Study|Lost to Follow-up|0|||
130525181|NCT01296555|469890315|FG001|Overall Study|Lost to Follow-up|0|||
130525182|NCT01296555|469890316|FG002|Overall Study|Lost to Follow-up|0|||
130525183|NCT01296555|469890317|FG003|Overall Study|Lost to Follow-up|0|||
130525184|NCT01296555|469890318|FG004|Overall Study|Lost to Follow-up|0|||
130525185|NCT01296555|469890319|FG005|Overall Study|Lost to Follow-up|0|||
130525186|NCT01296555|469890320|FG006|Overall Study|Lost to Follow-up|0|||
130525187|NCT01296555|469890321|FG007|Overall Study|Lost to Follow-up|0|||
130525188|NCT01296555|469890322|FG008|Overall Study|Lost to Follow-up|0|||
130525189|NCT01296555|469890323|FG009|Overall Study|Lost to Follow-up|0|||
130525190|NCT01296555|469890324|FG010|Overall Study|Lost to Follow-up|0|||
130525191|NCT01296555|469890325|FG011|Overall Study|Lost to Follow-up|0|||
130525192|NCT01296555|469890326|FG012|Overall Study|Lost to Follow-up|0|||
130525193|NCT01296555|469890327|FG013|Overall Study|Lost to Follow-up|0|||
130525194|NCT01296555|469890328|FG014|Overall Study|Lost to Follow-up|2|||
130525195|NCT01296555|469890329|FG015|Overall Study|Lost to Follow-up|1|||
130525196|NCT01296555|469890330|FG016|Overall Study|Lost to Follow-up|0|||
130525197|NCT01296555|469890331|FG017|Overall Study|Lost to Follow-up|2|||
130525198|NCT01296555|469890332|FG018|Overall Study|Lost to Follow-up|0|||
130525199|NCT01296555|469890333|FG019|Overall Study|Lost to Follow-up|2|||
130525200|NCT01296555|469890334|FG020|Overall Study|Lost to Follow-up|3|||
130525201|NCT01296555|469890335|FG021|Overall Study|Lost to Follow-up|2|||
130525202|NCT01296555|469890336|FG022|Overall Study|Lost to Follow-up|0|||
130525203|NCT01296555|469890337|FG023|Overall Study|Lost to Follow-up|0|||
130525204|NCT01296555|469890338|FG024|Overall Study|Lost to Follow-up|0|||
130525205|NCT01296555|469890339|FG025|Overall Study|Lost to Follow-up|0|||
130525206|NCT01296555|469890340|FG026|Overall Study|Lost to Follow-up|3|||
130525207|NCT01296555|469890341|FG027|Overall Study|Lost to Follow-up|13|||
130525208|NCT01296555|469890342|FG028|Overall Study|Lost to Follow-up|5|||
130525209|NCT01296555|469890314|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130525210|NCT01296555|469890315|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130525211|NCT01296555|469890316|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130525212|NCT01296555|469890317|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130525213|NCT01296555|469890318|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130525214|NCT01296555|469890319|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130525215|NCT01296555|469890320|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130525216|NCT01296555|469890321|FG007|Overall Study|Non-Compliance With Study Drug|1|||
130525217|NCT01296555|469890322|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130525218|NCT01296555|469890323|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130525219|NCT01296555|469890324|FG010|Overall Study|Non-Compliance With Study Drug|0|||
130525220|NCT01296555|469890325|FG011|Overall Study|Non-Compliance With Study Drug|0|||
130525221|NCT01296555|469890326|FG012|Overall Study|Non-Compliance With Study Drug|0|||
130525222|NCT01296555|469890327|FG013|Overall Study|Non-Compliance With Study Drug|0|||
130525223|NCT01296555|469890328|FG014|Overall Study|Non-Compliance With Study Drug|0|||
130525224|NCT01296555|469890329|FG015|Overall Study|Non-Compliance With Study Drug|0|||
130525225|NCT01296555|469890330|FG016|Overall Study|Non-Compliance With Study Drug|0|||
130525226|NCT01296555|469890331|FG017|Overall Study|Non-Compliance With Study Drug|0|||
130525227|NCT01296555|469890332|FG018|Overall Study|Non-Compliance With Study Drug|0|||
130525228|NCT01296555|469890333|FG019|Overall Study|Non-Compliance With Study Drug|0|||
130525229|NCT01296555|469890334|FG020|Overall Study|Non-Compliance With Study Drug|0|||
130525230|NCT01296555|469890335|FG021|Overall Study|Non-Compliance With Study Drug|0|||
130525231|NCT01296555|469890336|FG022|Overall Study|Non-Compliance With Study Drug|0|||
130525232|NCT01296555|469890337|FG023|Overall Study|Non-Compliance With Study Drug|0|||
130525233|NCT01296555|469890338|FG024|Overall Study|Non-Compliance With Study Drug|0|||
130525234|NCT01296555|469890339|FG025|Overall Study|Non-Compliance With Study Drug|0|||
130525235|NCT01296555|469890340|FG026|Overall Study|Non-Compliance With Study Drug|0|||
130525236|NCT01296555|469890341|FG027|Overall Study|Non-Compliance With Study Drug|0|||
130525237|NCT01296555|469890342|FG028|Overall Study|Non-Compliance With Study Drug|0|||
130525238|NCT01296555|469890314|FG000|Overall Study|Withdrawal by Subject|0|||
130525239|NCT01296555|469890315|FG001|Overall Study|Withdrawal by Subject|0|||
130525240|NCT01296555|469890316|FG002|Overall Study|Withdrawal by Subject|0|||
130525241|NCT01296555|469890317|FG003|Overall Study|Withdrawal by Subject|0|||
130525242|NCT01296555|469890318|FG004|Overall Study|Withdrawal by Subject|1|||
130525243|NCT01296555|469890319|FG005|Overall Study|Withdrawal by Subject|0|||
130525244|NCT01296555|469890320|FG006|Overall Study|Withdrawal by Subject|1|||
130525245|NCT01296555|469890321|FG007|Overall Study|Withdrawal by Subject|0|||
130525246|NCT01296555|469890322|FG008|Overall Study|Withdrawal by Subject|0|||
130525247|NCT01296555|469890323|FG009|Overall Study|Withdrawal by Subject|0|||
130525248|NCT01296555|469890324|FG010|Overall Study|Withdrawal by Subject|1|||
130525249|NCT01296555|469890325|FG011|Overall Study|Withdrawal by Subject|1|||
130525250|NCT01296555|469890326|FG012|Overall Study|Withdrawal by Subject|0|||
130525251|NCT01296555|469890327|FG013|Overall Study|Withdrawal by Subject|0|||
130525252|NCT01296555|469890328|FG014|Overall Study|Withdrawal by Subject|3|||
130525253|NCT01296555|469890329|FG015|Overall Study|Withdrawal by Subject|0|||
130525254|NCT01296555|469890330|FG016|Overall Study|Withdrawal by Subject|2|||
130525255|NCT01296555|469890331|FG017|Overall Study|Withdrawal by Subject|1|||
130525256|NCT01296555|469890332|FG018|Overall Study|Withdrawal by Subject|0|||
130525257|NCT01296555|469890333|FG019|Overall Study|Withdrawal by Subject|1|||
130525258|NCT01296555|469890334|FG020|Overall Study|Withdrawal by Subject|1|||
130525259|NCT01296555|469890335|FG021|Overall Study|Withdrawal by Subject|1|||
130525260|NCT01296555|469890336|FG022|Overall Study|Withdrawal by Subject|3|||
130576980|NCT03132636|470076575|FG000|Overall Study|Sponsor decision|0|||
130576981|NCT03132636|470076576|FG001|Overall Study|Sponsor decision|1|||
130576982|NCT03132636|470076575|FG000|Overall Study|Physician Decision|1|||
130576983|NCT03132636|470076576|FG001|Overall Study|Physician Decision|0|||
130576984|NCT03132636|470076575|FG000|Overall Study|Progressive disease|33|||
130576985|NCT03132636|470076576|FG001|Overall Study|Progressive disease|36|||
130576986|NCT03132636|470076575|FG000|Overall Study|Withdrawal of consent|2|||
130576987|NCT03132636|470076576|FG001|Overall Study|Withdrawal of consent|5|||
130576988|NCT03132636|470076575|FG000|Overall Study|Did not re-consent|1|||
130576989|NCT03132636|470076576|FG001|Overall Study|Did not re-consent|0|||
130576990|NCT03132636|470076575|FG000|Overall Study|Lost insurance coverage|1|||
130576991|NCT03132636|470076576|FG001|Overall Study|Lost insurance coverage|0|||
130576992|NCT03132636|470076575|FG000|Overall Study|Related to radiological outcomes|0|||
130576993|NCT03132636|470076576|FG001|Overall Study|Related to radiological outcomes|1|||
130576994|NCT03132636|470076575|FG000|Overall Study|Unable to come to site for continued visits|0|||
130576995|NCT03132636|470076576|FG001|Overall Study|Unable to come to site for continued visits|1|||
130576996|NCT00493038|470076586|FG000|Treatment|Adverse Event|8|||
130576997|NCT00493038|470076587|FG001|Treatment|Adverse Event|4|||
130576998|NCT00493038|470076586|FG000|Treatment|Lost to Follow-up|5|||
130576999|NCT00493038|470076587|FG001|Treatment|Lost to Follow-up|3|||
130577000|NCT00493038|470076586|FG000|Treatment|Withdrawal by Subject|11|||
130577001|NCT00493038|470076587|FG001|Treatment|Withdrawal by Subject|12|||
130577002|NCT00493038|470076586|FG000|Treatment|Other|0|||
130577003|NCT00493038|470076587|FG001|Treatment|Other|1|||
130577004|NCT00493038|470076586|FG000|Follow-up|Lost to Follow-up|1|||
130577005|NCT00493038|470076587|FG001|Follow-up|Lost to Follow-up|0|||
130577006|NCT03345472|470076588|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
130577007|NCT03345472|470076588|FG000|Implant to 3 Months|Physician Decision|1|||
130577008|NCT03345472|470076588|FG000|Implant to 3 Months|Adverse Event|1|||
130577009|NCT03345472|470076588|FG000|3 Months to 12 Months|Physician Decision|3|||
130577010|NCT03345472|470076588|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
130577011|NCT03345472|470076588|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
130577012|NCT03345472|470076588|FG000|3 Months to 12 Months|Adverse Event|1|||
130577013|NCT03345472|470076588|FG000|3 Months to 12 Months|Death|1|||
130577014|NCT01100944|470076589|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
130577015|NCT01100944|470076590|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
130577016|NCT01100944|470076591|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
130577017|NCT01100944|470076589|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
130577018|NCT01100944|470076590|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
130577019|NCT01100944|470076591|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
130577020|NCT01100944|470076589|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
130577021|NCT01100944|470076590|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
130577022|NCT01100944|470076591|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
130577023|NCT01100944|470076589|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
130577024|NCT01100944|470076590|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
130577025|NCT01100944|470076591|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
130577026|NCT00699907|470076594|FG000|Overall Study|Withdrawal by Subject|2|||
130577027|NCT00699907|470076595|FG001|Overall Study|Withdrawal by Subject|1|||
130525261|NCT01296555|469890337|FG023|Overall Study|Withdrawal by Subject|0|||
130525262|NCT01296555|469890338|FG024|Overall Study|Withdrawal by Subject|0|||
130525263|NCT01296555|469890339|FG025|Overall Study|Withdrawal by Subject|0|||
130525264|NCT01296555|469890340|FG026|Overall Study|Withdrawal by Subject|8|||
130525265|NCT01296555|469890341|FG027|Overall Study|Withdrawal by Subject|4|||
130525266|NCT01296555|469890342|FG028|Overall Study|Withdrawal by Subject|2|||
130525267|NCT03000348|469890347|FG000|Overall Study|Adverse Event|1|||
130525268|NCT03000348|469890348|FG001|Overall Study|Adverse Event|1|||
130577028|NCT00699907|470076596|FG002|Overall Study|Withdrawal by Subject|0|||
130577029|NCT00699907|470076594|FG000|Overall Study|No usable sample|0|||
130577030|NCT00699907|470076595|FG001|Overall Study|No usable sample|9|||
130577031|NCT00699907|470076596|FG002|Overall Study|No usable sample|8|||
130577032|NCT02161211|470076597|FG000|Overall Study|Lost to Follow-up|21|||
130577033|NCT02161211|470076598|FG001|Overall Study|Lost to Follow-up|27|||
130577034|NCT02161211|470076599|FG002|Overall Study|Lost to Follow-up|21|||
130577035|NCT02161211|470076597|FG000|Overall Study|Dropped|12|||
130525269|NCT03000348|469890349|FG002|Overall Study|Adverse Event|1|||
130525270|NCT03000348|469890350|FG003|Overall Study|Adverse Event|1|||
130525271|NCT03000348|469890351|FG004|Overall Study|Adverse Event|1|||
130525272|NCT03000348|469890352|FG005|Overall Study|Adverse Event|1|||
130577036|NCT02161211|470076598|FG001|Overall Study|Dropped|5|||
130577037|NCT02161211|470076599|FG002|Overall Study|Dropped|9|||
130577038|NCT01536860|470076600|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
130525273|NCT03000348|469890347|FG000|Overall Study|Lost to Follow-up|0|||
130525274|NCT03000348|469890348|FG001|Overall Study|Lost to Follow-up|0|||
130577039|NCT01536860|470076601|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
130577040|NCT01536860|470076602|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
130577041|NCT01164722|470076603|FG000|Overall Study|Adverse Event|0|||
130577042|NCT01164722|470076604|FG001|Overall Study|Adverse Event|1|||
130577043|NCT01164722|470076603|FG000|Overall Study|Withdrawal by Subject|3|||
130577044|NCT01164722|470076604|FG001|Overall Study|Withdrawal by Subject|4|||
130577045|NCT01164722|470076603|FG000|Overall Study|Lost to Follow-up|3|||
130577046|NCT01164722|470076604|FG001|Overall Study|Lost to Follow-up|6|||
130577047|NCT01164722|470076603|FG000|Overall Study|met protocol criteria for non-treatment|11|||
130577048|NCT01164722|470076604|FG001|Overall Study|met protocol criteria for non-treatment|1|||
130577049|NCT01164722|470076603|FG000|Overall Study|enrolled on other study, concomitant med|1|||
130577050|NCT01164722|470076604|FG001|Overall Study|enrolled on other study, concomitant med|3|||
130577051|NCT01543087|470076608|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
130577052|NCT01543087|470076609|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
130577053|NCT01543087|470076610|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
130577054|NCT01543087|470076611|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
130577055|NCT01543087|470076612|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
130577056|NCT01543087|470076613|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
130577057|NCT01543087|470076608|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
130577058|NCT01543087|470076609|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130577059|NCT01543087|470076610|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
130577060|NCT01543087|470076611|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
130577061|NCT01543087|470076612|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130577062|NCT01543087|470076613|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130577063|NCT01543087|470076608|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
130577064|NCT01543087|470076609|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
130577065|NCT01543087|470076610|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
130577066|NCT01543087|470076611|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
130577067|NCT01543087|470076612|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
130577068|NCT01543087|470076613|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
130577069|NCT01543087|470076608|FG000|Stage 1 (48 Months)|Other than specified|5|||
130577070|NCT01543087|470076609|FG001|Stage 1 (48 Months)|Other than specified|0|||
130577071|NCT01543087|470076610|FG002|Stage 1 (48 Months)|Other than specified|9|||
130577072|NCT01543087|470076611|FG003|Stage 1 (48 Months)|Other than specified|0|||
130577073|NCT01543087|470076612|FG004|Stage 1 (48 Months)|Other than specified|0|||
130577074|NCT01543087|470076613|FG005|Stage 1 (48 Months)|Other than specified|0|||
130577075|NCT01543087|470076608|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
130577076|NCT01543087|470076609|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
130577077|NCT01543087|470076610|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
130577078|NCT01543087|470076611|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
130577079|NCT01543087|470076612|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
130577080|NCT01543087|470076613|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
130577081|NCT01543087|470076608|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130577082|NCT01543087|470076609|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
130577083|NCT01543087|470076610|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130577084|NCT01543087|470076611|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130577085|NCT01543087|470076612|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
130577086|NCT01543087|470076613|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130577087|NCT01543087|470076608|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
130577088|NCT01543087|470076609|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
130577089|NCT01543087|470076610|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
130577090|NCT01543087|470076611|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
130577091|NCT01543087|470076612|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
130577092|NCT01543087|470076613|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
130577093|NCT00706030|470076615|FG000|Overall Study|Disease Progression|4|||
130577094|NCT00706030|470076616|FG001|Overall Study|Disease Progression|6|||
130577095|NCT00706030|470076617|FG002|Overall Study|Disease Progression|46|||
130577096|NCT00706030|470076618|FG003|Overall Study|Disease Progression|12|||
130577097|NCT00706030|470076615|FG000|Overall Study|Adverse Event|1|||
130577098|NCT00706030|470076616|FG001|Overall Study|Adverse Event|0|||
130577099|NCT00706030|470076617|FG002|Overall Study|Adverse Event|4|||
130577100|NCT00706030|470076618|FG003|Overall Study|Adverse Event|2|||
130577101|NCT00706030|470076615|FG000|Overall Study|Withdrawal by Subject|1|||
130577102|NCT00706030|470076616|FG001|Overall Study|Withdrawal by Subject|0|||
130577103|NCT00706030|470076617|FG002|Overall Study|Withdrawal by Subject|2|||
130577104|NCT00706030|470076618|FG003|Overall Study|Withdrawal by Subject|0|||
130577105|NCT00706030|470076615|FG000|Overall Study|Physician Decision|0|||
130577106|NCT00706030|470076616|FG001|Overall Study|Physician Decision|0|||
130577107|NCT00706030|470076617|FG002|Overall Study|Physician Decision|2|||
130577108|NCT00706030|470076618|FG003|Overall Study|Physician Decision|0|||
130577109|NCT00706030|470076615|FG000|Overall Study|Not recorded|0|||
130577110|NCT00706030|470076616|FG001|Overall Study|Not recorded|0|||
130577111|NCT00706030|470076617|FG002|Overall Study|Not recorded|2|||
130525275|NCT03000348|469890349|FG002|Overall Study|Lost to Follow-up|1|||
130525276|NCT03000348|469890350|FG003|Overall Study|Lost to Follow-up|0|||
130525277|NCT03000348|469890351|FG004|Overall Study|Lost to Follow-up|0|||
130525278|NCT03000348|469890352|FG005|Overall Study|Lost to Follow-up|0|||
130525279|NCT03000348|469890347|FG000|Overall Study|Withdrawal by Subject|0|||
130525280|NCT03000348|469890348|FG001|Overall Study|Withdrawal by Subject|1|||
130525281|NCT03000348|469890349|FG002|Overall Study|Withdrawal by Subject|0|||
130525282|NCT03000348|469890350|FG003|Overall Study|Withdrawal by Subject|0|||
130525283|NCT03000348|469890351|FG004|Overall Study|Withdrawal by Subject|0|||
130525284|NCT03000348|469890352|FG005|Overall Study|Withdrawal by Subject|0|||
130525285|NCT03000348|469890347|FG000|Overall Study|Consent|0|||
130525286|NCT03000348|469890348|FG001|Overall Study|Consent|0|||
130525287|NCT03000348|469890349|FG002|Overall Study|Consent|0|||
130525288|NCT03000348|469890350|FG003|Overall Study|Consent|0|||
130525289|NCT03000348|469890351|FG004|Overall Study|Consent|1|||
130525290|NCT03000348|469890352|FG005|Overall Study|Consent|0|||
130525291|NCT03000348|469890347|FG000|Overall Study|Failure to expectorate sputum|1|||
130525292|NCT03000348|469890348|FG001|Overall Study|Failure to expectorate sputum|0|||
130525293|NCT03000348|469890349|FG002|Overall Study|Failure to expectorate sputum|1|||
130525294|NCT03000348|469890350|FG003|Overall Study|Failure to expectorate sputum|0|||
130525295|NCT03000348|469890351|FG004|Overall Study|Failure to expectorate sputum|1|||
130525296|NCT03000348|469890352|FG005|Overall Study|Failure to expectorate sputum|0|||
130525297|NCT03000348|469890347|FG000|Overall Study|No gram negative|1|||
130525298|NCT03000348|469890348|FG001|Overall Study|No gram negative|2|||
130525299|NCT03000348|469890349|FG002|Overall Study|No gram negative|1|||
130525300|NCT03000348|469890350|FG003|Overall Study|No gram negative|1|||
130525301|NCT03000348|469890351|FG004|Overall Study|No gram negative|1|||
130525302|NCT03000348|469890352|FG005|Overall Study|No gram negative|1|||
130525303|NCT03000348|469890347|FG000|Overall Study|Patient had no transport|0|||
130525304|NCT03000348|469890348|FG001|Overall Study|Patient had no transport|0|||
130525305|NCT03000348|469890349|FG002|Overall Study|Patient had no transport|0|||
130525306|NCT03000348|469890350|FG003|Overall Study|Patient had no transport|1|||
130525307|NCT03000348|469890351|FG004|Overall Study|Patient had no transport|0|||
130525308|NCT03000348|469890352|FG005|Overall Study|Patient had no transport|0|||
130525309|NCT03000348|469890347|FG000|Overall Study|Dosing|0|||
130525310|NCT03000348|469890348|FG001|Overall Study|Dosing|0|||
130525311|NCT03000348|469890349|FG002|Overall Study|Dosing|0|||
130525312|NCT03000348|469890350|FG003|Overall Study|Dosing|0|||
130525313|NCT03000348|469890351|FG004|Overall Study|Dosing|1|||
130525314|NCT03000348|469890352|FG005|Overall Study|Dosing|0|||
130525315|NCT04042077|469890353|FG000|Overall Study|Adverse Event|0|||
130525316|NCT04042077|469890354|FG001|Overall Study|Adverse Event|1|||
130525317|NCT04042077|469890353|FG000|Overall Study|Death|2|||
130525318|NCT04042077|469890354|FG001|Overall Study|Death|1|||
130525319|NCT04042077|469890353|FG000|Overall Study|Physician Decision|2|||
130525320|NCT04042077|469890354|FG001|Overall Study|Physician Decision|0|||
130525321|NCT04042077|469890353|FG000|Overall Study|Withdrawal by Subject|3|||
130525322|NCT04042077|469890354|FG001|Overall Study|Withdrawal by Subject|2|||
130525323|NCT04042077|469890353|FG000|Overall Study|Lack of Efficacy|0|||
130525324|NCT04042077|469890354|FG001|Overall Study|Lack of Efficacy|1|||
130525325|NCT00745498|469890356|FG000|Overall Study|Lost to Follow-up|1|||
130525326|NCT00745498|469890357|FG001|Overall Study|Lost to Follow-up|1|||
130525327|NCT00745498|469890358|FG002|Overall Study|Lost to Follow-up|3|||
130525328|NCT00745498|469890356|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
130525329|NCT00745498|469890357|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
130525330|NCT00745498|469890358|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
130525331|NCT00745498|469890356|FG000|Overall Study|Non-PDR related VH|0|||
130525332|NCT00745498|469890357|FG001|Overall Study|Non-PDR related VH|1|||
130525333|NCT00745498|469890358|FG002|Overall Study|Non-PDR related VH|1|||
130525334|NCT00745498|469890356|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
130525335|NCT00745498|469890357|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
130525336|NCT00745498|469890358|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
130525337|NCT02031536|469890362|FG000|Overall Study|ineligible|1|||
130525338|NCT02031536|469890363|FG001|Overall Study|ineligible|0|||
130525339|NCT00838929|469890365|FG000|Overall Study|Protocol Violation|0|||
130525340|NCT00838929|469890366|FG001|Overall Study|Protocol Violation|1|||
130525341|NCT00838929|469890367|FG002|Overall Study|Protocol Violation|0|||
130525342|NCT00838929|469890365|FG000|Overall Study|Disease progression|0|||
130525343|NCT00838929|469890366|FG001|Overall Study|Disease progression|2|||
130525344|NCT00838929|469890367|FG002|Overall Study|Disease progression|1|||
130525345|NCT01068210|469890374|FG000|Overall Study|Lost to Follow-up|1|||
130525346|NCT01068210|469890375|FG001|Overall Study|Lost to Follow-up|2|||
130525347|NCT01068210|469890376|FG002|Overall Study|Lost to Follow-up|2|||
130525348|NCT01068210|469890377|FG003|Overall Study|Lost to Follow-up|1|||
130525349|NCT01068210|469890374|FG000|Overall Study|Second cancer|0|||
130525350|NCT01068210|469890375|FG001|Overall Study|Second cancer|1|||
130525351|NCT01068210|469890376|FG002|Overall Study|Second cancer|0|||
130525352|NCT01068210|469890377|FG003|Overall Study|Second cancer|0|||
130525353|NCT01068210|469890374|FG000|Overall Study|Disease progression|0|||
130577112|NCT00706030|470076618|FG003|Overall Study|Not recorded|0|||
130577113|NCT00706030|470076615|FG000|Overall Study|Protocol Violation|0|||
130577114|NCT00706030|470076616|FG001|Overall Study|Protocol Violation|0|||
130577115|NCT00706030|470076617|FG002|Overall Study|Protocol Violation|1|||
130577116|NCT00706030|470076618|FG003|Overall Study|Protocol Violation|1|||
130577117|NCT00706030|470076615|FG000|Overall Study|Failed to return|0|||
130577118|NCT00706030|470076616|FG001|Overall Study|Failed to return|0|||
130577119|NCT00706030|470076617|FG002|Overall Study|Failed to return|1|||
130577120|NCT00706030|470076618|FG003|Overall Study|Failed to return|0|||
130577121|NCT00706030|470076615|FG000|Overall Study|Symptomatic Deterioration|0|||
130577122|NCT00706030|470076616|FG001|Overall Study|Symptomatic Deterioration|0|||
130577123|NCT00706030|470076617|FG002|Overall Study|Symptomatic Deterioration|1|||
130577124|NCT00706030|470076618|FG003|Overall Study|Symptomatic Deterioration|0|||
130577125|NCT00706030|470076615|FG000|Overall Study|No treatment received|0|||
130577126|NCT00706030|470076616|FG001|Overall Study|No treatment received|0|||
130577127|NCT00706030|470076617|FG002|Overall Study|No treatment received|0|||
130577128|NCT00706030|470076618|FG003|Overall Study|No treatment received|1|||
130577129|NCT00706030|470076615|FG000|Overall Study|Death|0|||
130577130|NCT00706030|470076616|FG001|Overall Study|Death|0|||
130577131|NCT00706030|470076617|FG002|Overall Study|Death|1|||
130577132|NCT00706030|470076618|FG003|Overall Study|Death|0|||
130577133|NCT05779072|470076619|FG000|Overall Study|Lost to Follow-up|0|||
130577134|NCT05779072|470076620|FG001|Overall Study|Lost to Follow-up|1|||
130577135|NCT05779072|470076619|FG000|Overall Study|Withdrawal by Subject|1|||
130577136|NCT05779072|470076620|FG001|Overall Study|Withdrawal by Subject|5|||
130577137|NCT00357500|470076635|FG000|Overall Study|Adverse Event|3|||
130577138|NCT00357500|470076635|FG000|Overall Study|Withdrawal by Subject|5|||
130577139|NCT00357500|470076635|FG000|Overall Study|Progressive Disease|65|||
130577140|NCT00357500|470076635|FG000|Overall Study|Not Started Protocol Therapy|4|||
130577141|NCT02301403|470076636|FG000|Overall Study|Withdrawal by Subject|28|||
130577142|NCT02301403|470076637|FG001|Overall Study|Withdrawal by Subject|41|||
130577143|NCT00730639|470076638|FG000|Overall Study|Adverse Event|3|||
130577144|NCT00730639|470076639|FG001|Overall Study|Adverse Event|0|||
130577145|NCT00730639|470076640|FG002|Overall Study|Adverse Event|9|||
130577146|NCT00730639|470076641|FG003|Overall Study|Adverse Event|8|||
130577147|NCT00730639|470076642|FG004|Overall Study|Adverse Event|23|||
130577148|NCT00730639|470076638|FG000|Overall Study|Complete Response|0|||
130577149|NCT00730639|470076639|FG001|Overall Study|Complete Response|0|||
130577150|NCT00730639|470076640|FG002|Overall Study|Complete Response|2|||
130577151|NCT00730639|470076641|FG003|Overall Study|Complete Response|2|||
130577152|NCT00730639|470076642|FG004|Overall Study|Complete Response|1|||
130577153|NCT00730639|470076638|FG000|Overall Study|Completed Maximum Cycles|0|||
130577154|NCT00730639|470076639|FG001|Overall Study|Completed Maximum Cycles|0|||
130577155|NCT00730639|470076640|FG002|Overall Study|Completed Maximum Cycles|11|||
130577156|NCT00730639|470076641|FG003|Overall Study|Completed Maximum Cycles|3|||
130577157|NCT00730639|470076642|FG004|Overall Study|Completed Maximum Cycles|6|||
130577158|NCT00730639|470076638|FG000|Overall Study|Death|0|||
130577159|NCT00730639|470076639|FG001|Overall Study|Death|0|||
130577160|NCT00730639|470076640|FG002|Overall Study|Death|0|||
130577161|NCT00730639|470076641|FG003|Overall Study|Death|0|||
130577162|NCT00730639|470076642|FG004|Overall Study|Death|2|||
130525354|NCT01068210|469890375|FG001|Overall Study|Disease progression|0|||
130525355|NCT01068210|469890376|FG002|Overall Study|Disease progression|0|||
130525356|NCT01068210|469890377|FG003|Overall Study|Disease progression|2|||
130525357|NCT04886518|469890382|FG000|Overall Study|Noncompliance with study drug|1|||
130525358|NCT04886518|469890383|FG001|Overall Study|Noncompliance with study drug|0|||
130525359|NCT04886518|469890384|FG002|Overall Study|Noncompliance with study drug|0|||
130525360|NCT04886518|469890382|FG000|Overall Study|Adverse Event|0|||
130577163|NCT00730639|470076638|FG000|Overall Study|Disease Progression|12|||
130577164|NCT00730639|470076639|FG001|Overall Study|Disease Progression|13|||
130577165|NCT00730639|470076640|FG002|Overall Study|Disease Progression|48|||
130577166|NCT00730639|470076641|FG003|Overall Study|Disease Progression|32|||
130525361|NCT04886518|469890383|FG001|Overall Study|Adverse Event|1|||
130577167|NCT00730639|470076642|FG004|Overall Study|Disease Progression|88|||
130525362|NCT04886518|469890384|FG002|Overall Study|Adverse Event|0|||
130577168|NCT00730639|470076638|FG000|Overall Study|non-specified|0|||
130525363|NCT04886518|469890382|FG000|Overall Study|Withdrawal by Subject|1|||
130577169|NCT00730639|470076639|FG001|Overall Study|non-specified|0|||
130577170|NCT00730639|470076640|FG002|Overall Study|non-specified|4|||
130577171|NCT00730639|470076641|FG003|Overall Study|non-specified|2|||
130577172|NCT00730639|470076642|FG004|Overall Study|non-specified|3|||
130577173|NCT00730639|470076638|FG000|Overall Study|Protocol Violation|0|||
130577174|NCT00730639|470076639|FG001|Overall Study|Protocol Violation|0|||
130577175|NCT00730639|470076640|FG002|Overall Study|Protocol Violation|1|||
130577176|NCT00730639|470076641|FG003|Overall Study|Protocol Violation|0|||
130577177|NCT00730639|470076642|FG004|Overall Study|Protocol Violation|0|||
130577178|NCT00730639|470076638|FG000|Overall Study|Withdrawal by Subject|0|||
130577179|NCT00730639|470076639|FG001|Overall Study|Withdrawal by Subject|0|||
130577180|NCT00730639|470076640|FG002|Overall Study|Withdrawal by Subject|6|||
130577181|NCT00730639|470076641|FG003|Overall Study|Withdrawal by Subject|3|||
130577182|NCT00730639|470076642|FG004|Overall Study|Withdrawal by Subject|4|||
130577183|NCT00730639|470076638|FG000|Overall Study|Treatment on-going|2|||
130577184|NCT00730639|470076639|FG001|Overall Study|Treatment on-going|5|||
130577185|NCT00730639|470076640|FG002|Overall Study|Treatment on-going|5|||
130577186|NCT00730639|470076641|FG003|Overall Study|Treatment on-going|4|||
130577187|NCT00730639|470076642|FG004|Overall Study|Treatment on-going|4|||
130577188|NCT02665286|470076643|FG000|Overall Study|Lost to Follow-up|3|||
130577189|NCT02665286|470076644|FG001|Overall Study|Lost to Follow-up|2|||
130577190|NCT02665286|470076645|FG002|Overall Study|Lost to Follow-up|1|||
130577191|NCT03064841|470076646|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
130577192|NCT03064841|470076646|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
130577193|NCT03064841|470076646|FG000|Overall Study|Screen failure|2|||
130577194|NCT00217087|470076647|FG000|Overall Study|decided to have esophagectomy|1|||
130577195|NCT00217087|470076648|FG001|Overall Study|decided to have esophagectomy|2|||
130577196|NCT00217087|470076647|FG000|Overall Study|completed less than 12 months return|10|||
130577197|NCT00217087|470076648|FG001|Overall Study|completed less than 12 months return|18|||
130577198|NCT03208231|470076649|FG000|Overall Study|Death|1|||
130577199|NCT03208231|470076650|FG001|Overall Study|Death|2|||
130577200|NCT03208231|470076649|FG000|Overall Study|Moved and unable to get to clinic|1|||
130577201|NCT03208231|470076650|FG001|Overall Study|Moved and unable to get to clinic|0|||
130577202|NCT03208231|470076649|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
130577203|NCT03208231|470076650|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
130577210|NCT04622046|470076671|FG000|Intervention Period|Adverse Event|1|||
130577211|NCT04622046|470076671|FG000|Intervention Period|Withdrawal by Subject|2|||
130577212|NCT04622046|470076671|FG000|Extension Period|Ongoing in the Extension Period|21|||
130577213|NCT01844986|470076672|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
130577214|NCT01844986|470076673|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
130577215|NCT01844986|470076672|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
130577216|NCT01844986|470076673|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
130577217|NCT01844986|470076672|FG000|Overall Study (Global Cohort)|Death|55|||
130577218|NCT01844986|470076673|FG001|Overall Study (Global Cohort)|Death|26|||
130577219|NCT01844986|470076672|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
130577220|NCT01844986|470076673|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
130577221|NCT01844986|470076672|FG000|Overall Study (China Cohort)|Death|10|||
130577222|NCT01844986|470076673|FG001|Overall Study (China Cohort)|Death|6|||
130577223|NCT03266016|470078459|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
130577224|NCT03266016|470078460|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130577225|NCT03266016|470078461|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130577226|NCT03266016|470078462|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130577227|NCT03266016|470078459|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
130577228|NCT03266016|470078460|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
130577229|NCT03266016|470078461|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
130577230|NCT03266016|470078462|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
130577231|NCT04183335|470078463|FG000|Overall Study|Adverse Event|1|||
130577232|NCT04183335|470078464|FG001|Overall Study|Adverse Event|0|||
130577233|NCT04183335|470078463|FG000|Overall Study|Withdrawal by Subject|12|||
130577234|NCT04183335|470078464|FG001|Overall Study|Withdrawal by Subject|3|||
130577235|NCT01268293|470078469|FG000|Overall Study|Disease progression|7|||
130577236|NCT01268293|470078469|FG000|Overall Study|Adverse Event|1|||
130577237|NCT01268293|470078469|FG000|Overall Study|Subject choice|1|||
130577238|NCT01449708|470078470|FG000|Overall Study|Protocol Violation|0|||
130577239|NCT01449708|470078471|FG001|Overall Study|Protocol Violation|1|||
130577240|NCT01449708|470078470|FG000|Overall Study|surgical complication|1|||
130577241|NCT01449708|470078471|FG001|Overall Study|surgical complication|2|||
130577242|NCT01449708|470078470|FG000|Overall Study|respiratory failure|1|||
130577243|NCT01449708|470078471|FG001|Overall Study|respiratory failure|0|||
130577244|NCT00223496|470078474|FG000|Overall Study|screen failure|9|||
130577245|NCT00223496|470078474|FG000|Overall Study|Lost to Follow-up|4|||
130577246|NCT00223496|470078474|FG000|Overall Study|Lack of Efficacy|6|||
130577247|NCT00223496|470078474|FG000|Overall Study|Withdrawal by Subject|1|||
130577248|NCT00223496|470078474|FG000|Overall Study|Physician Decision|2|||
130577249|NCT00559507|470078475|FG000|Overall Study|Not treated, patient ineligible|3|||
130577250|NCT01414257|470078476|FG000|Overall Study|No Visit After First Day of Treatment|12|||
130577251|NCT01414257|470078476|FG000|Overall Study|Protocol Violation|10|||
130577252|NCT01784965|470078479|FG000|Overall Study|Withdrawal by Subject|6|||
130577253|NCT01784965|470078480|FG001|Overall Study|Withdrawal by Subject|3|||
130577254|NCT01784965|470078479|FG000|Overall Study|Adverse Event|0|||
130577255|NCT01784965|470078480|FG001|Overall Study|Adverse Event|8|||
130577256|NCT03757988|470078481|FG000|Overall Study|Withdrawal by Subject|1|||
130577257|NCT03823391|470078482|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
130577258|NCT03823391|470078483|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
130577259|NCT03823391|470078482|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
130577260|NCT03823391|470078483|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
130577261|NCT05689047|470078484|FG000|Overall Study|Lost to Follow-up|0|||
130577262|NCT05689047|470078485|FG001|Overall Study|Lost to Follow-up|1|||
130577263|NCT05689047|470078484|FG000|Overall Study|Protocol Deviation|1|||
130525364|NCT04886518|469890383|FG001|Overall Study|Withdrawal by Subject|0|||
130577264|NCT05689047|470078485|FG001|Overall Study|Protocol Deviation|0|||
130577265|NCT01562548|470078491|FG000|Overall Study|Lost to Follow-up|0|||
130577266|NCT01562548|470078492|FG001|Overall Study|Lost to Follow-up|0|||
130577267|NCT01562548|470078493|FG002|Overall Study|Lost to Follow-up|1|||
130577268|NCT01562548|470078494|FG003|Overall Study|Lost to Follow-up|0|||
130577269|NCT01496066|470078495|FG000|Overall Study|Lost to Follow-up|8|||
130577270|NCT01496066|470078496|FG001|Overall Study|Lost to Follow-up|5|||
130577271|NCT01496066|470078495|FG000|Overall Study|Explant|3|||
130577272|NCT01496066|470078496|FG001|Overall Study|Explant|0|||
130577273|NCT01496066|470078495|FG000|Overall Study|Death|1|||
130577274|NCT01496066|470078496|FG001|Overall Study|Death|4|||
130525365|NCT04886518|469890384|FG002|Overall Study|Withdrawal by Subject|0|||
130525366|NCT02035696|469892400|FG000|Overall Study|Lost to Follow-up|0|||
130525367|NCT02035696|469892401|FG001|Overall Study|Lost to Follow-up|3|||
130525368|NCT02035696|469892402|FG002|Overall Study|Lost to Follow-up|1|||
130525369|NCT02035696|469892403|FG003|Overall Study|Lost to Follow-up|2|||
130525370|NCT02035696|469892400|FG000|Overall Study|Withdrawal by Subject|3|||
130525371|NCT02035696|469892401|FG001|Overall Study|Withdrawal by Subject|0|||
130525372|NCT02035696|469892402|FG002|Overall Study|Withdrawal by Subject|2|||
130525373|NCT02035696|469892403|FG003|Overall Study|Withdrawal by Subject|1|||
130525374|NCT01090011|469892404|FG000|Overall Study|Progressive disease|128|||
130525375|NCT01090011|469892404|FG000|Overall Study|Adverse Event|32|||
130525376|NCT01090011|469892404|FG000|Overall Study|Protocol Violation|1|||
130525377|NCT01090011|469892404|FG000|Overall Study|Refusal to start/continue medication|5|||
130525378|NCT01090011|469892404|FG000|Overall Study|Other reason not defined above|5|||
130525379|NCT00379769|469892405|FG000|Main Study|Death|57|||
130525380|NCT00379769|469892406|FG001|Main Study|Death|67|||
130525381|NCT00379769|469892407|FG002|Main Study|Death|54|||
130525382|NCT00379769|469892408|FG003|Main Study|Death|72|||
130525383|NCT00379769|469892409|FG004|Main Study|Death|0|||
130525384|NCT00379769|469892410|FG005|Main Study|Death|0|||
130525385|NCT00379769|469892405|FG000|Main Study|Adverse Event|5|||
130525386|NCT00379769|469892406|FG001|Main Study|Adverse Event|8|||
130525387|NCT00379769|469892407|FG002|Main Study|Adverse Event|10|||
130525388|NCT00379769|469892408|FG003|Main Study|Adverse Event|11|||
130525389|NCT00379769|469892409|FG004|Main Study|Adverse Event|0|||
130525390|NCT00379769|469892410|FG005|Main Study|Adverse Event|0|||
130525391|NCT00379769|469892405|FG000|Main Study|Lost to Follow-up|29|||
130525392|NCT00379769|469892406|FG001|Main Study|Lost to Follow-up|29|||
130525393|NCT00379769|469892407|FG002|Main Study|Lost to Follow-up|25|||
130577275|NCT03237065|470078497|FG000|Overall Study|Adverse Event|0|||
130577276|NCT03237065|470078498|FG001|Overall Study|Adverse Event|2|||
130577277|NCT03237065|470078497|FG000|Overall Study|Protocol Violation|0|||
130525394|NCT00379769|469892408|FG003|Main Study|Lost to Follow-up|26|||
130525395|NCT00379769|469892409|FG004|Main Study|Lost to Follow-up|0|||
130525396|NCT00379769|469892410|FG005|Main Study|Lost to Follow-up|0|||
130525397|NCT00379769|469892405|FG000|Main Study|Withdrawal by Subject|46|||
130525398|NCT00379769|469892406|FG001|Main Study|Withdrawal by Subject|56|||
130525399|NCT00379769|469892407|FG002|Main Study|Withdrawal by Subject|72|||
130525400|NCT00379769|469892408|FG003|Main Study|Withdrawal by Subject|70|||
130577278|NCT03237065|470078498|FG001|Overall Study|Protocol Violation|1|||
130577279|NCT03237065|470078497|FG000|Overall Study|Withdrawal by Subject|3|||
130577280|NCT03237065|470078498|FG001|Overall Study|Withdrawal by Subject|0|||
130577281|NCT03237065|470078497|FG000|Overall Study|Lost to Follow-up|1|||
130577282|NCT03237065|470078498|FG001|Overall Study|Lost to Follow-up|0|||
130577283|NCT03237065|470078497|FG000|Overall Study|Unable to obtain venous access|0|||
130525401|NCT00379769|469892409|FG004|Main Study|Withdrawal by Subject|0|||
130525402|NCT00379769|469892410|FG005|Main Study|Withdrawal by Subject|0|||
130577284|NCT03237065|470078498|FG001|Overall Study|Unable to obtain venous access|1|||
130525403|NCT00379769|469892405|FG000|Main Study|Moved to survival status follow-up only|27|||
130525404|NCT00379769|469892406|FG001|Main Study|Moved to survival status follow-up only|25|||
130525405|NCT00379769|469892407|FG002|Main Study|Moved to survival status follow-up only|32|||
130525406|NCT00379769|469892408|FG003|Main Study|Moved to survival status follow-up only|36|||
130525407|NCT00379769|469892409|FG004|Main Study|Moved to survival status follow-up only|0|||
130525408|NCT00379769|469892410|FG005|Main Study|Moved to survival status follow-up only|0|||
130525409|NCT00379769|469892405|FG000|Main Study|Participant moved|3|||
130525410|NCT00379769|469892406|FG001|Main Study|Participant moved|2|||
130525411|NCT00379769|469892407|FG002|Main Study|Participant moved|3|||
130525412|NCT00379769|469892408|FG003|Main Study|Participant moved|3|||
130525413|NCT00379769|469892409|FG004|Main Study|Participant moved|0|||
130525414|NCT00379769|469892410|FG005|Main Study|Participant moved|0|||
130525415|NCT00379769|469892405|FG000|Main Study|Poor compliance|3|||
130525416|NCT00379769|469892406|FG001|Main Study|Poor compliance|2|||
130525417|NCT00379769|469892407|FG002|Main Study|Poor compliance|2|||
130525418|NCT00379769|469892408|FG003|Main Study|Poor compliance|1|||
130525419|NCT00379769|469892409|FG004|Main Study|Poor compliance|0|||
130525420|NCT00379769|469892410|FG005|Main Study|Poor compliance|0|||
130525421|NCT00379769|469892405|FG000|Main Study|Prohibited glucose lowering medication|0|||
130525422|NCT00379769|469892406|FG001|Main Study|Prohibited glucose lowering medication|3|||
130525423|NCT00379769|469892407|FG002|Main Study|Prohibited glucose lowering medication|0|||
130525424|NCT00379769|469892408|FG003|Main Study|Prohibited glucose lowering medication|1|||
130525425|NCT00379769|469892409|FG004|Main Study|Prohibited glucose lowering medication|0|||
130525426|NCT00379769|469892410|FG005|Main Study|Prohibited glucose lowering medication|0|||
130525427|NCT00379769|469892405|FG000|Main Study|Site closed|4|||
130525428|NCT00379769|469892406|FG001|Main Study|Site closed|4|||
130525429|NCT00379769|469892407|FG002|Main Study|Site closed|4|||
130525430|NCT00379769|469892408|FG003|Main Study|Site closed|8|||
130525431|NCT00379769|469892409|FG004|Main Study|Site closed|0|||
130525432|NCT00379769|469892410|FG005|Main Study|Site closed|0|||
130525433|NCT00379769|469892405|FG000|Main Study|Entry criteria violation|0|||
130525434|NCT00379769|469892406|FG001|Main Study|Entry criteria violation|0|||
130525435|NCT00379769|469892407|FG002|Main Study|Entry criteria violation|1|||
130525436|NCT00379769|469892408|FG003|Main Study|Entry criteria violation|1|||
130525437|NCT00379769|469892409|FG004|Main Study|Entry criteria violation|0|||
130525438|NCT00379769|469892410|FG005|Main Study|Entry criteria violation|0|||
130525439|NCT00379769|469892405|FG000|Main Study|Participant did not take study drug|0|||
130525440|NCT00379769|469892406|FG001|Main Study|Participant did not take study drug|0|||
130525441|NCT00379769|469892407|FG002|Main Study|Participant did not take study drug|1|||
130525442|NCT00379769|469892408|FG003|Main Study|Participant did not take study drug|0|||
130525443|NCT00379769|469892409|FG004|Main Study|Participant did not take study drug|0|||
130525444|NCT00379769|469892410|FG005|Main Study|Participant did not take study drug|0|||
130525445|NCT00379769|469892405|FG000|Main Study|Physician Decision|2|||
130525446|NCT00379769|469892406|FG001|Main Study|Physician Decision|2|||
130525447|NCT00379769|469892407|FG002|Main Study|Physician Decision|1|||
130525448|NCT00379769|469892408|FG003|Main Study|Physician Decision|1|||
130525449|NCT00379769|469892409|FG004|Main Study|Physician Decision|0|||
130525450|NCT00379769|469892410|FG005|Main Study|Physician Decision|0|||
130525451|NCT00379769|469892405|FG000|Main Study|Participant completed study at visit 27|1|||
130525452|NCT00379769|469892406|FG001|Main Study|Participant completed study at visit 27|0|||
130525453|NCT00379769|469892407|FG002|Main Study|Participant completed study at visit 27|0|||
130525454|NCT00379769|469892408|FG003|Main Study|Participant completed study at visit 27|0|||
130525455|NCT00379769|469892409|FG004|Main Study|Participant completed study at visit 27|0|||
130525456|NCT00379769|469892410|FG005|Main Study|Participant completed study at visit 27|0|||
130525457|NCT00379769|469892405|FG000|Main Study|Personal reasons|1|||
130525458|NCT00379769|469892406|FG001|Main Study|Personal reasons|0|||
130525459|NCT00379769|469892407|FG002|Main Study|Personal reasons|0|||
130525460|NCT00379769|469892408|FG003|Main Study|Personal reasons|0|||
130525461|NCT00379769|469892409|FG004|Main Study|Personal reasons|0|||
130525462|NCT00379769|469892410|FG005|Main Study|Personal reasons|0|||
130525463|NCT00379769|469892405|FG000|Main Study|Risk of heart failure|0|||
130525464|NCT00379769|469892406|FG001|Main Study|Risk of heart failure|1|||
130525465|NCT00379769|469892407|FG002|Main Study|Risk of heart failure|0|||
130525466|NCT00379769|469892408|FG003|Main Study|Risk of heart failure|0|||
130525467|NCT00379769|469892409|FG004|Main Study|Risk of heart failure|0|||
130525468|NCT00379769|469892410|FG005|Main Study|Risk of heart failure|0|||
130525469|NCT00379769|469892405|FG000|Main Study|Investigator refused to log temperature|0|||
130525470|NCT00379769|469892406|FG001|Main Study|Investigator refused to log temperature|0|||
130525471|NCT00379769|469892407|FG002|Main Study|Investigator refused to log temperature|1|||
130525472|NCT00379769|469892408|FG003|Main Study|Investigator refused to log temperature|0|||
130525473|NCT00379769|469892409|FG004|Main Study|Investigator refused to log temperature|0|||
130525474|NCT00379769|469892410|FG005|Main Study|Investigator refused to log temperature|0|||
130525475|NCT00379769|469892405|FG000|Main Study|Reason unspecified|0|||
130525476|NCT00379769|469892406|FG001|Main Study|Reason unspecified|0|||
130525477|NCT00379769|469892407|FG002|Main Study|Reason unspecified|1|||
130525478|NCT00379769|469892408|FG003|Main Study|Reason unspecified|0|||
130525479|NCT00379769|469892409|FG004|Main Study|Reason unspecified|0|||
130525480|NCT00379769|469892410|FG005|Main Study|Reason unspecified|0|||
130525481|NCT00379769|469892405|FG000|Observational Follow-up|Death|0|||
130525482|NCT00379769|469892406|FG001|Observational Follow-up|Death|0|||
130525483|NCT00379769|469892407|FG002|Observational Follow-up|Death|0|||
130525484|NCT00379769|469892408|FG003|Observational Follow-up|Death|0|||
130525485|NCT00379769|469892409|FG004|Observational Follow-up|Death|78|||
130525486|NCT00379769|469892410|FG005|Observational Follow-up|Death|70|||
130525487|NCT00379769|469892405|FG000|Observational Follow-up|Adverse Event|0|||
130525488|NCT00379769|469892406|FG001|Observational Follow-up|Adverse Event|0|||
130525489|NCT00379769|469892407|FG002|Observational Follow-up|Adverse Event|0|||
130525490|NCT00379769|469892408|FG003|Observational Follow-up|Adverse Event|0|||
130525491|NCT00379769|469892409|FG004|Observational Follow-up|Adverse Event|1|||
130525492|NCT00379769|469892410|FG005|Observational Follow-up|Adverse Event|0|||
130525493|NCT00379769|469892405|FG000|Observational Follow-up|Lost to Follow-up|0|||
130525494|NCT00379769|469892406|FG001|Observational Follow-up|Lost to Follow-up|0|||
130525495|NCT00379769|469892407|FG002|Observational Follow-up|Lost to Follow-up|0|||
130525496|NCT00379769|469892408|FG003|Observational Follow-up|Lost to Follow-up|0|||
130525497|NCT00379769|469892409|FG004|Observational Follow-up|Lost to Follow-up|25|||
130525498|NCT00379769|469892410|FG005|Observational Follow-up|Lost to Follow-up|27|||
130525499|NCT00379769|469892405|FG000|Observational Follow-up|Withdrawal by Subject|0|||
130525500|NCT00379769|469892406|FG001|Observational Follow-up|Withdrawal by Subject|0|||
130525501|NCT00379769|469892407|FG002|Observational Follow-up|Withdrawal by Subject|0|||
130525502|NCT00379769|469892408|FG003|Observational Follow-up|Withdrawal by Subject|0|||
130525503|NCT00379769|469892409|FG004|Observational Follow-up|Withdrawal by Subject|12|||
130525504|NCT00379769|469892410|FG005|Observational Follow-up|Withdrawal by Subject|12|||
130525505|NCT00379769|469892405|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
130525506|NCT00379769|469892406|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
130525507|NCT00379769|469892407|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
130525508|NCT00379769|469892408|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
130525509|NCT00379769|469892409|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
130525510|NCT00379769|469892410|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
130525511|NCT00379769|469892405|FG000|Observational Follow-up|Physician Decision|0|||
130525512|NCT00379769|469892406|FG001|Observational Follow-up|Physician Decision|0|||
130525513|NCT00379769|469892407|FG002|Observational Follow-up|Physician Decision|0|||
130525514|NCT00379769|469892408|FG003|Observational Follow-up|Physician Decision|0|||
130525515|NCT00379769|469892409|FG004|Observational Follow-up|Physician Decision|8|||
130525516|NCT00379769|469892410|FG005|Observational Follow-up|Physician Decision|8|||
130525517|NCT00379769|469892405|FG000|Observational Follow-up|Site Closed Early|0|||
130525518|NCT00379769|469892406|FG001|Observational Follow-up|Site Closed Early|0|||
130525519|NCT00379769|469892407|FG002|Observational Follow-up|Site Closed Early|0|||
130525520|NCT00379769|469892408|FG003|Observational Follow-up|Site Closed Early|0|||
130525521|NCT00379769|469892409|FG004|Observational Follow-up|Site Closed Early|6|||
130525522|NCT00379769|469892410|FG005|Observational Follow-up|Site Closed Early|7|||
130525523|NCT00379769|469892405|FG000|Observational Follow-up|Participant Moved|0|||
130525524|NCT00379769|469892406|FG001|Observational Follow-up|Participant Moved|0|||
130525525|NCT00379769|469892407|FG002|Observational Follow-up|Participant Moved|0|||
130525526|NCT00379769|469892408|FG003|Observational Follow-up|Participant Moved|0|||
130525527|NCT00379769|469892409|FG004|Observational Follow-up|Participant Moved|0|||
130525528|NCT00379769|469892410|FG005|Observational Follow-up|Participant Moved|1|||
130525529|NCT00379769|469892405|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
130525530|NCT00379769|469892406|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
130525531|NCT00379769|469892407|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
130525532|NCT00379769|469892408|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
130525533|NCT00379769|469892409|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
130525534|NCT00379769|469892410|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
130525535|NCT01689363|469892415|FG000|Overall Study|Protocol Violation|0|||
130525536|NCT01689363|469892416|FG001|Overall Study|Protocol Violation|1|||
130525537|NCT01689363|469892417|FG002|Overall Study|Protocol Violation|0|||
130525538|NCT01689363|469892418|FG003|Overall Study|Protocol Violation|0|||
130525539|NCT01689363|469892419|FG004|Overall Study|Protocol Violation|0|||
130525540|NCT01689363|469892420|FG005|Overall Study|Protocol Violation|0|||
130525541|NCT01689363|469892421|FG006|Overall Study|Protocol Violation|0|||
130525542|NCT01689363|469892422|FG007|Overall Study|Protocol Violation|0|||
130525543|NCT02859064|469892423|FG000|Overall Study|Progressive Disease|3|||
130525544|NCT02859064|469892423|FG000|Overall Study|Physician Decision|1|||
130525545|NCT02859064|469892423|FG000|Overall Study|Withdrawal by Subject|1|||
130525546|NCT02859064|469892423|FG000|Overall Study|Death|1|||
130525547|NCT00321685|469892424|FG000|Overall Study|Adverse Event|18|||
130525548|NCT00321685|469892424|FG000|Overall Study|Death|2|||
130525549|NCT00321685|469892424|FG000|Overall Study|Withdrawal by Subject|8|||
130525550|NCT00321685|469892424|FG000|Overall Study|Alternative therapy|1|||
130525551|NCT00321685|469892424|FG000|Overall Study|Complicating disese|1|||
130577285|NCT00209339|470078499|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
130577286|NCT00209339|470078499|FG000|At 12 Months Follow-up|Death|1|||
130577287|NCT00209339|470078499|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
130577288|NCT00209339|470078499|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
130577289|NCT00209339|470078499|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
130577290|NCT00209339|470078499|FG000|At 24 Months Follow-up|Death|1|||
130577291|NCT00209339|470078499|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
130577292|NCT00209339|470078499|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
130577293|NCT00209339|470078499|FG000|At 4 Years Follow-up|Death|1|||
130577294|NCT00209339|470078499|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
130577295|NCT00209339|470078499|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
130577296|NCT00209339|470078499|FG000|At 5 Years Follow-up|Death|1|||
130577297|NCT01587079|470078500|FG000|Overall Study|Protocol-specified criteria|9|||
130577298|NCT01587079|470078500|FG000|Overall Study|Protocol Violation|5|||
130577299|NCT01587079|470078500|FG000|Overall Study|Lost to Follow-up|2|||
130577300|NCT01587079|470078500|FG000|Overall Study|Physician Decision|2|||
130577301|NCT01587079|470078500|FG000|Overall Study|Withdrawal by Subject|7|||
130577302|NCT01587079|470078500|FG000|Overall Study|Adverse Event|14|||
130577303|NCT01764633|470078501|FG000|Overall Study|Withdrawal by Subject|105|||
130577304|NCT01764633|470078502|FG001|Overall Study|Withdrawal by Subject|88|||
130577305|NCT01764633|470078501|FG000|Overall Study|Lost to Follow-up|13|||
130577306|NCT01764633|470078502|FG001|Overall Study|Lost to Follow-up|5|||
130577307|NCT02268058|470078503|FG000|Overall Study|Protocol Violation|1|||
130577308|NCT02268058|470078504|FG001|Overall Study|Protocol Violation|0|||
130577309|NCT02268058|470078505|FG002|Overall Study|Protocol Violation|0|||
130577310|NCT02268058|470078506|FG003|Overall Study|Protocol Violation|0|||
130525552|NCT00321685|469892424|FG000|Overall Study|Other|5|||
130525553|NCT00321685|469892424|FG000|Overall Study|Not start protocol therapy|2|||
130525554|NCT00321685|469892424|FG000|Overall Study|Ineligible|2|||
130525555|NCT00127842|469892425|FG000|Overall Study|Adverse Event|15|||
130525556|NCT00127842|469892425|FG000|Overall Study|Withdrawal by Subject|3|||
130525557|NCT00127842|469892425|FG000|Overall Study|Lost to Follow-up|1|||
130525558|NCT00127842|469892425|FG000|Overall Study|Lack of Efficacy|12|||
130525559|NCT00127842|469892425|FG000|Overall Study|Noncompliance|2|||
130525560|NCT00127842|469892425|FG000|Overall Study|Protocol Violation|1|||
130525561|NCT00127842|469892425|FG000|Overall Study|Other|5|||
130525562|NCT01638390|469892428|FG000|Overall Study|screening failures|21|||
130525563|NCT01536587|469892429|FG000|Overall Study|Adverse Event|2|||
130525564|NCT02354651|469892430|FG000|Overall Study|Withdrawal by Subject|2|||
130525565|NCT02354651|469892430|FG000|Overall Study|Physician Decision|1|||
130525566|NCT01377389|469892431|FG000|Overall Study|Withdrawal by Subject|1|||
130525567|NCT01377389|469892431|FG000|Overall Study|Screen failure|2|||
130525568|NCT03382561|469892432|FG000|Overall Study|Disease progression|47|||
130525569|NCT03382561|469892433|FG001|Overall Study|Disease progression|6|||
130525570|NCT03382561|469892432|FG000|Overall Study|Adverse Event|10|||
130525571|NCT03382561|469892433|FG001|Overall Study|Adverse Event|2|||
130525572|NCT03382561|469892432|FG000|Overall Study|Death|8|||
130525573|NCT03382561|469892433|FG001|Overall Study|Death|3|||
130525574|NCT03382561|469892432|FG000|Overall Study|Withdrawal by Subject|6|||
130525575|NCT03382561|469892433|FG001|Overall Study|Withdrawal by Subject|5|||
130525576|NCT03382561|469892432|FG000|Overall Study|Alternative therapy|2|||
130525577|NCT03382561|469892433|FG001|Overall Study|Alternative therapy|8|||
130525578|NCT03382561|469892432|FG000|Overall Study|Never started treatment|3|||
130525579|NCT03382561|469892433|FG001|Overall Study|Never started treatment|6|||
130525580|NCT03382561|469892432|FG000|Overall Study|Lack of Efficacy|0|||
130525581|NCT03382561|469892433|FG001|Overall Study|Lack of Efficacy|1|||
130577311|NCT00704964|470078512|FG000|Overall Study|Not completed on time|328|||
130577312|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
130577313|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
130577314|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
130577315|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
130525582|NCT03382561|469892432|FG000|Overall Study|Physician Decision|0|||
130525583|NCT03382561|469892433|FG001|Overall Study|Physician Decision|1|||
130525584|NCT03382561|469892432|FG000|Overall Study|Other complicating disease|0|||
130525585|NCT03382561|469892433|FG001|Overall Study|Other complicating disease|1|||
130525586|NCT01131104|469892434|FG000|Overall Study|Withdrawal by Subject|3|||
130525587|NCT01131104|469892434|FG000|Overall Study|Physician Decision|4|||
130525588|NCT01131104|469892434|FG000|Overall Study|Information Not Available|5|||
130525589|NCT01131104|469892434|FG000|Overall Study|No Information on Index Date of Onset|1|||
130577316|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
130525590|NCT01245140|469892435|FG000|Overall Study|Adverse Event|1|||
130577317|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
130577318|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
130577319|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
130577320|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
130525591|NCT01245140|469892436|FG001|Overall Study|Adverse Event|3|||
130525592|NCT01245140|469892435|FG000|Overall Study|Lack of Efficacy|2|||
130525593|NCT01245140|469892436|FG001|Overall Study|Lack of Efficacy|4|||
130525594|NCT01245140|469892435|FG000|Overall Study|Protocol Violation|0|||
130525595|NCT01245140|469892436|FG001|Overall Study|Protocol Violation|1|||
130525596|NCT01245140|469892435|FG000|Overall Study|Withdrawal by Subject|0|||
130525597|NCT01245140|469892436|FG001|Overall Study|Withdrawal by Subject|1|||
130525598|NCT01245140|469892435|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
130525599|NCT01245140|469892436|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
130525600|NCT00334542|469892437|FG000|Overall Study|Adverse Event|3|||
130525601|NCT00334542|469892437|FG000|Overall Study|Withdrawal by Subject|1|||
130525602|NCT00334542|469892437|FG000|Overall Study|New cancer diagnosis|1|||
130525603|NCT01080326|469892438|FG000|Overall Study|Patient deterioration prior to procedure|3|||
130525604|NCT01080326|469892438|FG000|Overall Study|Surgeon decision|1|||
130525605|NCT01318876|469892439|FG000|Day 8 Survey|email address invalid|96|||
130525606|NCT01318876|469892439|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
130525607|NCT01318876|469892439|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
130525608|NCT00723125|469892441|FG000|Overall Study|Met Dx|1|||
130525609|NCT00723125|469892442|FG001|Overall Study|Met Dx|0|||
130525610|NCT00723125|469892441|FG000|Overall Study|Withdrawal by Subject|15|||
130525611|NCT00723125|469892442|FG001|Overall Study|Withdrawal by Subject|6|||
130525612|NCT00723125|469892441|FG000|Overall Study|Adverse Event|2|||
130525613|NCT00723125|469892442|FG001|Overall Study|Adverse Event|0|||
130525614|NCT02196077|469892443|FG000|Overall Study|Adverse Event|4|||
130525615|NCT02196077|469892443|FG000|Overall Study|Lack of Efficacy|1|||
130525616|NCT02196077|469892443|FG000|Overall Study|Withdrawal by Subject|14|||
130525617|NCT02196077|469892443|FG000|Overall Study|Physician Decision|1|||
130525618|NCT02196077|469892443|FG000|Overall Study|Lost to Follow-up|3|||
130525619|NCT02196077|469892443|FG000|Overall Study|Protocol Violation|24|||
130525620|NCT00003477|469892458|FG000|Overall Study|Not evalauable|4|||
130525621|NCT01236352|469892459|FG000|Overall Study|Death|0|||
130525622|NCT01236352|469892460|FG001|Overall Study|Death|0|||
130525623|NCT01236352|469892461|FG002|Overall Study|Death|0|||
130525624|NCT01236352|469892462|FG003|Overall Study|Death|0|||
130525625|NCT01236352|469892463|FG004|Overall Study|Death|0|||
130525626|NCT01236352|469892464|FG005|Overall Study|Death|0|||
130525627|NCT01236352|469892465|FG006|Overall Study|Death|0|||
130525628|NCT01236352|469892466|FG007|Overall Study|Death|1|||
130525629|NCT01236352|469892467|FG008|Overall Study|Death|0|||
130525630|NCT01236352|469892468|FG009|Overall Study|Death|0|||
130525631|NCT01236352|469892469|FG010|Overall Study|Death|0|||
130525632|NCT01236352|469892459|FG000|Overall Study|Withdrawal by Subject|0|||
130525633|NCT01236352|469892460|FG001|Overall Study|Withdrawal by Subject|0|||
130525634|NCT01236352|469892461|FG002|Overall Study|Withdrawal by Subject|0|||
130525635|NCT01236352|469892462|FG003|Overall Study|Withdrawal by Subject|0|||
130525636|NCT01236352|469892463|FG004|Overall Study|Withdrawal by Subject|0|||
130525637|NCT01236352|469892464|FG005|Overall Study|Withdrawal by Subject|0|||
130525638|NCT01236352|469892465|FG006|Overall Study|Withdrawal by Subject|0|||
130525639|NCT01236352|469892466|FG007|Overall Study|Withdrawal by Subject|0|||
130525640|NCT01236352|469892467|FG008|Overall Study|Withdrawal by Subject|0|||
130525641|NCT01236352|469892468|FG009|Overall Study|Withdrawal by Subject|2|||
130525642|NCT01236352|469892469|FG010|Overall Study|Withdrawal by Subject|1|||
130525643|NCT01236352|469892459|FG000|Overall Study|Adverse Event|0|||
130525644|NCT01236352|469892460|FG001|Overall Study|Adverse Event|0|||
130525645|NCT01236352|469892461|FG002|Overall Study|Adverse Event|0|||
130525646|NCT01236352|469892462|FG003|Overall Study|Adverse Event|0|||
130525647|NCT01236352|469892463|FG004|Overall Study|Adverse Event|0|||
130525648|NCT01236352|469892464|FG005|Overall Study|Adverse Event|0|||
130525649|NCT01236352|469892465|FG006|Overall Study|Adverse Event|2|||
130525650|NCT01236352|469892466|FG007|Overall Study|Adverse Event|0|||
130525651|NCT01236352|469892467|FG008|Overall Study|Adverse Event|0|||
130525652|NCT01236352|469892468|FG009|Overall Study|Adverse Event|4|||
130525653|NCT01236352|469892469|FG010|Overall Study|Adverse Event|1|||
130525654|NCT01236352|469892459|FG000|Overall Study|Study drug toxicity|0|||
130525655|NCT01236352|469892460|FG001|Overall Study|Study drug toxicity|0|||
130525656|NCT01236352|469892461|FG002|Overall Study|Study drug toxicity|0|||
130525657|NCT01236352|469892462|FG003|Overall Study|Study drug toxicity|0|||
130525658|NCT01236352|469892463|FG004|Overall Study|Study drug toxicity|0|||
130525659|NCT01236352|469892464|FG005|Overall Study|Study drug toxicity|1|||
130525660|NCT01236352|469892465|FG006|Overall Study|Study drug toxicity|1|||
130525661|NCT01236352|469892466|FG007|Overall Study|Study drug toxicity|0|||
130525662|NCT01236352|469892467|FG008|Overall Study|Study drug toxicity|0|||
130525663|NCT01236352|469892468|FG009|Overall Study|Study drug toxicity|2|||
130525664|NCT01236352|469892469|FG010|Overall Study|Study drug toxicity|2|||
130525665|NCT01236352|469892459|FG000|Overall Study|Disease progression|1|||
130525666|NCT01236352|469892460|FG001|Overall Study|Disease progression|2|||
130525667|NCT01236352|469892461|FG002|Overall Study|Disease progression|1|||
130525668|NCT01236352|469892462|FG003|Overall Study|Disease progression|2|||
130525669|NCT01236352|469892463|FG004|Overall Study|Disease progression|2|||
130525670|NCT01236352|469892464|FG005|Overall Study|Disease progression|2|||
130525671|NCT01236352|469892465|FG006|Overall Study|Disease progression|1|||
130525672|NCT01236352|469892466|FG007|Overall Study|Disease progression|3|||
130525673|NCT01236352|469892467|FG008|Overall Study|Disease progression|2|||
130525674|NCT01236352|469892468|FG009|Overall Study|Disease progression|2|||
130525675|NCT01236352|469892469|FG010|Overall Study|Disease progression|2|||
130525676|NCT01236352|469892459|FG000|Overall Study|Poor/Non-compliance|1|||
130525677|NCT01236352|469892460|FG001|Overall Study|Poor/Non-compliance|0|||
130525678|NCT01236352|469892461|FG002|Overall Study|Poor/Non-compliance|0|||
130525679|NCT01236352|469892462|FG003|Overall Study|Poor/Non-compliance|0|||
130525680|NCT01236352|469892463|FG004|Overall Study|Poor/Non-compliance|0|||
130525681|NCT01236352|469892464|FG005|Overall Study|Poor/Non-compliance|0|||
130525682|NCT01236352|469892465|FG006|Overall Study|Poor/Non-compliance|0|||
130525683|NCT01236352|469892466|FG007|Overall Study|Poor/Non-compliance|0|||
130525684|NCT01236352|469892467|FG008|Overall Study|Poor/Non-compliance|0|||
130525685|NCT01236352|469892468|FG009|Overall Study|Poor/Non-compliance|0|||
130525686|NCT01236352|469892469|FG010|Overall Study|Poor/Non-compliance|0|||
130525687|NCT01236352|469892459|FG000|Overall Study|Maximum clinical benefit|1|||
130525688|NCT01236352|469892460|FG001|Overall Study|Maximum clinical benefit|1|||
130525689|NCT01236352|469892461|FG002|Overall Study|Maximum clinical benefit|1|||
130525690|NCT01236352|469892462|FG003|Overall Study|Maximum clinical benefit|0|||
130525691|NCT01236352|469892463|FG004|Overall Study|Maximum clinical benefit|2|||
130525692|NCT01236352|469892464|FG005|Overall Study|Maximum clinical benefit|0|||
130525693|NCT01236352|469892465|FG006|Overall Study|Maximum clinical benefit|3|||
130525694|NCT01236352|469892466|FG007|Overall Study|Maximum clinical benefit|1|||
130525695|NCT01236352|469892467|FG008|Overall Study|Maximum clinical benefit|1|||
130525696|NCT01236352|469892468|FG009|Overall Study|Maximum clinical benefit|4|||
130525697|NCT01236352|469892469|FG010|Overall Study|Maximum clinical benefit|2|||
130525698|NCT01236352|469892459|FG000|Overall Study|Subject request to discontinue treatment|0|||
130525699|NCT01236352|469892460|FG001|Overall Study|Subject request to discontinue treatment|0|||
130525700|NCT01236352|469892461|FG002|Overall Study|Subject request to discontinue treatment|1|||
130525701|NCT01236352|469892462|FG003|Overall Study|Subject request to discontinue treatment|1|||
130525702|NCT01236352|469892463|FG004|Overall Study|Subject request to discontinue treatment|0|||
130525703|NCT01236352|469892464|FG005|Overall Study|Subject request to discontinue treatment|1|||
130525704|NCT01236352|469892465|FG006|Overall Study|Subject request to discontinue treatment|0|||
130525705|NCT01236352|469892466|FG007|Overall Study|Subject request to discontinue treatment|0|||
130525706|NCT01236352|469892467|FG008|Overall Study|Subject request to discontinue treatment|0|||
130525707|NCT01236352|469892468|FG009|Overall Study|Subject request to discontinue treatment|1|||
130525708|NCT01236352|469892469|FG010|Overall Study|Subject request to discontinue treatment|4|||
130525709|NCT01236352|469892459|FG000|Overall Study|Subject to receive drug via EAP|1|||
130525710|NCT01236352|469892460|FG001|Overall Study|Subject to receive drug via EAP|1|||
130525711|NCT01236352|469892461|FG002|Overall Study|Subject to receive drug via EAP|1|||
130525712|NCT01236352|469892462|FG003|Overall Study|Subject to receive drug via EAP|0|||
130525713|NCT01236352|469892463|FG004|Overall Study|Subject to receive drug via EAP|0|||
130525714|NCT01236352|469892464|FG005|Overall Study|Subject to receive drug via EAP|0|||
130525715|NCT01236352|469892465|FG006|Overall Study|Subject to receive drug via EAP|0|||
130525716|NCT01236352|469892466|FG007|Overall Study|Subject to receive drug via EAP|2|||
130525717|NCT01236352|469892467|FG008|Overall Study|Subject to receive drug via EAP|0|||
130525718|NCT01236352|469892468|FG009|Overall Study|Subject to receive drug via EAP|4|||
130525719|NCT01236352|469892469|FG010|Overall Study|Subject to receive drug via EAP|0|||
130525720|NCT01236352|469892459|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
130525721|NCT01236352|469892460|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
130525722|NCT01236352|469892461|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
130525723|NCT01236352|469892462|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
130525724|NCT01236352|469892463|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
130525725|NCT01236352|469892464|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
130525726|NCT01236352|469892465|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
130525727|NCT01236352|469892466|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
130525728|NCT01236352|469892467|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
130525729|NCT01236352|469892468|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
130525730|NCT01236352|469892469|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
130525731|NCT01236352|469892459|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525732|NCT01236352|469892460|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525733|NCT01236352|469892461|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525734|NCT01236352|469892462|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525735|NCT01236352|469892463|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525736|NCT01236352|469892464|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525737|NCT01236352|469892465|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525738|NCT01236352|469892466|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525739|NCT01236352|469892467|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525740|NCT01236352|469892468|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130525741|NCT01236352|469892469|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
130577321|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
130577322|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
130577323|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
130577324|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
130577325|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
130577326|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
130577327|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
130577328|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
130525742|NCT01236352|469892459|FG000|Overall Study|Lack of response to drug|0|||
130525743|NCT01236352|469892460|FG001|Overall Study|Lack of response to drug|0|||
130525744|NCT01236352|469892461|FG002|Overall Study|Lack of response to drug|0|||
130525745|NCT01236352|469892462|FG003|Overall Study|Lack of response to drug|0|||
130525746|NCT01236352|469892463|FG004|Overall Study|Lack of response to drug|0|||
130525747|NCT01236352|469892464|FG005|Overall Study|Lack of response to drug|0|||
130525748|NCT01236352|469892465|FG006|Overall Study|Lack of response to drug|0|||
130525749|NCT01236352|469892466|FG007|Overall Study|Lack of response to drug|0|||
130525750|NCT01236352|469892467|FG008|Overall Study|Lack of response to drug|0|||
130525751|NCT01236352|469892468|FG009|Overall Study|Lack of response to drug|1|||
130525752|NCT01236352|469892469|FG010|Overall Study|Lack of response to drug|1|||
130525753|NCT01236352|469892459|FG000|Overall Study|Patient transferred to IST|0|||
130525754|NCT01236352|469892460|FG001|Overall Study|Patient transferred to IST|0|||
130525755|NCT01236352|469892461|FG002|Overall Study|Patient transferred to IST|0|||
130525756|NCT01236352|469892462|FG003|Overall Study|Patient transferred to IST|0|||
130525757|NCT01236352|469892463|FG004|Overall Study|Patient transferred to IST|0|||
130525758|NCT01236352|469892464|FG005|Overall Study|Patient transferred to IST|0|||
130525759|NCT01236352|469892465|FG006|Overall Study|Patient transferred to IST|0|||
130525760|NCT01236352|469892466|FG007|Overall Study|Patient transferred to IST|0|||
130525761|NCT01236352|469892467|FG008|Overall Study|Patient transferred to IST|0|||
130525762|NCT01236352|469892468|FG009|Overall Study|Patient transferred to IST|2|||
130525763|NCT01236352|469892469|FG010|Overall Study|Patient transferred to IST|6|||
130525764|NCT01575873|469892470|FG000|Overall Study|Withdrawal by Subject|15|||
130525765|NCT01575873|469892471|FG001|Overall Study|Withdrawal by Subject|20|||
130525766|NCT01575873|469892472|FG002|Overall Study|Withdrawal by Subject|34|||
130525767|NCT01575873|469892473|FG003|Overall Study|Withdrawal by Subject|34|||
130525768|NCT01575873|469892470|FG000|Overall Study|Adverse Event|7|||
130525769|NCT01575873|469892471|FG001|Overall Study|Adverse Event|7|||
130525770|NCT01575873|469892472|FG002|Overall Study|Adverse Event|9|||
130525771|NCT01575873|469892473|FG003|Overall Study|Adverse Event|12|||
130525772|NCT01575873|469892470|FG000|Overall Study|Lost to Follow-up|1|||
130525773|NCT01575873|469892471|FG001|Overall Study|Lost to Follow-up|3|||
130525774|NCT01575873|469892472|FG002|Overall Study|Lost to Follow-up|13|||
130525775|NCT01575873|469892473|FG003|Overall Study|Lost to Follow-up|5|||
130525776|NCT01575873|469892470|FG000|Overall Study|Death|3|||
130525777|NCT01575873|469892471|FG001|Overall Study|Death|2|||
130525778|NCT01575873|469892472|FG002|Overall Study|Death|8|||
130525779|NCT01575873|469892473|FG003|Overall Study|Death|9|||
130525780|NCT01575873|469892470|FG000|Overall Study|Noncompliance|1|||
130525781|NCT01575873|469892471|FG001|Overall Study|Noncompliance|2|||
130525782|NCT01575873|469892472|FG002|Overall Study|Noncompliance|4|||
130525783|NCT01575873|469892473|FG003|Overall Study|Noncompliance|3|||
130525784|NCT01575873|469892470|FG000|Overall Study|Administrative decision|1|||
130525785|NCT01575873|469892471|FG001|Overall Study|Administrative decision|1|||
130525786|NCT01575873|469892472|FG002|Overall Study|Administrative decision|1|||
130525787|NCT01575873|469892473|FG003|Overall Study|Administrative decision|0|||
130525788|NCT01575873|469892470|FG000|Overall Study|Protocol deviation|0|||
130525789|NCT01575873|469892471|FG001|Overall Study|Protocol deviation|1|||
130525790|NCT01575873|469892472|FG002|Overall Study|Protocol deviation|0|||
130525791|NCT01575873|469892473|FG003|Overall Study|Protocol deviation|1|||
130577329|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
130525792|NCT01575873|469892470|FG000|Overall Study|Requirement for Alternative Therapy|0|||
130525793|NCT01575873|469892471|FG001|Overall Study|Requirement for Alternative Therapy|0|||
130525794|NCT01575873|469892472|FG002|Overall Study|Requirement for Alternative Therapy|1|||
130525795|NCT01575873|469892473|FG003|Overall Study|Requirement for Alternative Therapy|1|||
130577330|NCT04418765|470078513|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
130525796|NCT01575873|469892470|FG000|Overall Study|Other|0|||
130525797|NCT01575873|469892471|FG001|Overall Study|Other|0|||
130525798|NCT01575873|469892472|FG002|Overall Study|Other|4|||
130525799|NCT01575873|469892473|FG003|Overall Study|Other|2|||
130525800|NCT00965497|469892475|FG000|Overall Study|Physician Decision|1|||
130525801|NCT00246090|469892479|FG000|Overall Study|Adverse Event|25|||
130525802|NCT00246090|469892479|FG000|Overall Study|Withdrawal by Subject|7|||
130525803|NCT00246090|469892479|FG000|Overall Study|Progressive Disease|212|||
130525804|NCT00246090|469892479|FG000|Overall Study|Clinical Progression|30|||
130525805|NCT00246090|469892479|FG000|Overall Study|Physician Decision|11|||
130525806|NCT00246090|469892479|FG000|Overall Study|Not Otherwise Specified|10|||
130525807|NCT01827046|469892483|FG000|Overall Study|Lost to Follow-up|1|||
130525808|NCT01827046|469892484|FG001|Overall Study|Lost to Follow-up|5|||
130525809|NCT01827046|469892483|FG000|Overall Study|Withdrawal by Subject|0|||
130525810|NCT01827046|469892484|FG001|Overall Study|Withdrawal by Subject|4|||
130525811|NCT02734004|469892485|FG000|Overall Study|Death|36|||
130525812|NCT02734004|469892486|FG001|Overall Study|Death|24|||
130525813|NCT02734004|469892487|FG002|Overall Study|Death|26|||
130525814|NCT02734004|469892488|FG003|Overall Study|Death|35|||
130525815|NCT02734004|469892489|FG004|Overall Study|Death|13|||
130525816|NCT02734004|469892490|FG005|Overall Study|Death|17|||
130525817|NCT02734004|469892491|FG006|Overall Study|Death|20|||
130525818|NCT02734004|469892485|FG000|Overall Study|Lost to Follow-up|1|||
130525819|NCT02734004|469892486|FG001|Overall Study|Lost to Follow-up|1|||
130525820|NCT02734004|469892487|FG002|Overall Study|Lost to Follow-up|0|||
130525821|NCT02734004|469892488|FG003|Overall Study|Lost to Follow-up|0|||
130525822|NCT02734004|469892489|FG004|Overall Study|Lost to Follow-up|1|||
130525823|NCT02734004|469892490|FG005|Overall Study|Lost to Follow-up|0|||
130525824|NCT02734004|469892491|FG006|Overall Study|Lost to Follow-up|0|||
130525825|NCT02734004|469892485|FG000|Overall Study|Withdrawal by Subject|3|||
130525826|NCT02734004|469892486|FG001|Overall Study|Withdrawal by Subject|1|||
130525827|NCT02734004|469892487|FG002|Overall Study|Withdrawal by Subject|1|||
130525828|NCT02734004|469892488|FG003|Overall Study|Withdrawal by Subject|1|||
130525829|NCT02734004|469892489|FG004|Overall Study|Withdrawal by Subject|3|||
130525830|NCT02734004|469892490|FG005|Overall Study|Withdrawal by Subject|0|||
130525831|NCT02734004|469892491|FG006|Overall Study|Withdrawal by Subject|2|||
130525832|NCT02734004|469892485|FG000|Overall Study|Other|0|||
130525833|NCT02734004|469892486|FG001|Overall Study|Other|8|||
130525834|NCT02734004|469892487|FG002|Overall Study|Other|7|||
130525835|NCT02734004|469892488|FG003|Overall Study|Other|4|||
130525836|NCT02734004|469892489|FG004|Overall Study|Other|34|||
130525837|NCT02734004|469892490|FG005|Overall Study|Other|14|||
130525838|NCT02734004|469892491|FG006|Overall Study|Other|10|||
130525839|NCT01294436|469892492|FG000|Overall Study|Adverse Event|10|||
130525840|NCT01294436|469892493|FG001|Overall Study|Adverse Event|17|||
130525841|NCT01294436|469892492|FG000|Overall Study|Withdrawal by Subject|11|||
130525842|NCT01294436|469892493|FG001|Overall Study|Withdrawal by Subject|28|||
130525843|NCT01294436|469892492|FG000|Overall Study|subject no longer meets study criteria|5|||
130525844|NCT01294436|469892493|FG001|Overall Study|subject no longer meets study criteria|20|||
130525845|NCT01294436|469892492|FG000|Overall Study|poor/non-compliance|2|||
130525846|NCT01294436|469892493|FG001|Overall Study|poor/non-compliance|5|||
130525847|NCT01018732|469892496|FG000|Overall Study|Lost to Follow-up|0|||
130525848|NCT01018732|469892497|FG001|Overall Study|Lost to Follow-up|0|||
130525849|NCT01018732|469892498|FG002|Overall Study|Lost to Follow-up|3|||
130525850|NCT01018732|469892496|FG000|Overall Study|Protocol Violation|1|||
130525851|NCT01018732|469892497|FG001|Overall Study|Protocol Violation|1|||
130525852|NCT01018732|469892498|FG002|Overall Study|Protocol Violation|0|||
130525853|NCT01018732|469892496|FG000|Overall Study|Inappropriate Enrollment|0|||
130525854|NCT01018732|469892497|FG001|Overall Study|Inappropriate Enrollment|1|||
130525855|NCT01018732|469892498|FG002|Overall Study|Inappropriate Enrollment|0|||
130525856|NCT01018732|469892496|FG000|Overall Study|Unable to Classify|0|||
130525857|NCT01018732|469892497|FG001|Overall Study|Unable to Classify|0|||
130525858|NCT01018732|469892498|FG002|Overall Study|Unable to Classify|1|||
130525859|NCT01536171|469892499|FG000|Overall Study|Withdrawal by Subject|1|||
130525860|NCT00585078|469892500|FG000|Overall Study|Withdrawal by Subject|4|||
130525861|NCT00585078|469892500|FG000|Overall Study|Poor performance status|1|||
130525862|NCT00585078|469892500|FG000|Overall Study|Disease Progression|24|||
130525863|NCT00585078|469892500|FG000|Overall Study|Adverse Event|10|||
130525864|NCT00585078|469892500|FG000|Overall Study|Death|1|||
130525865|NCT02781311|469892503|FG000|Overall Study|Adverse Event|2|||
130525866|NCT02781311|469892504|FG001|Overall Study|Adverse Event|6|||
130525867|NCT02781311|469892505|FG002|Overall Study|Adverse Event|1|||
130525868|NCT02781311|469892503|FG000|Overall Study|Withdrawal of Consent|11|||
130525869|NCT02781311|469892504|FG001|Overall Study|Withdrawal of Consent|12|||
130525870|NCT02781311|469892505|FG002|Overall Study|Withdrawal of Consent|2|||
130525871|NCT02781311|469892503|FG000|Overall Study|Lost to Follow-up|11|||
130525872|NCT02781311|469892504|FG001|Overall Study|Lost to Follow-up|8|||
130525873|NCT02781311|469892505|FG002|Overall Study|Lost to Follow-up|1|||
130525874|NCT02781311|469892503|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130525875|NCT02781311|469892504|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130525876|NCT02781311|469892505|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130525877|NCT01056263|469892508|FG000|Overall Study|Adverse Event|12|||
130525878|NCT01056263|469892508|FG000|Overall Study|Death|1|||
130525879|NCT01056263|469892508|FG000|Overall Study|Withdrawal by Subject|1|||
130525880|NCT01056263|469892508|FG000|Overall Study|Lack of Efficacy|29|||
130525881|NCT01056263|469892508|FG000|Overall Study|Progressive disease|2|||
130525882|NCT01056263|469892508|FG000|Overall Study|Neoplasm progression|1|||
130525883|NCT01056263|469892508|FG000|Overall Study|Objective progression or relapse|1|||
130525884|NCT01056263|469892508|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
130525885|NCT05990387|469892509|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
130525886|NCT05990387|469892510|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
130577331|NCT04418765|470078514|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
130577332|NCT04418765|470078515|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
130577333|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
130577334|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
130577335|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
130577336|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
130577337|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
130577338|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
130577339|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
130577340|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
130577341|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
130577342|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
130577343|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
130577344|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
130577345|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
130577346|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
130577347|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
130577348|NCT04418765|470078513|FG000|Extension Period (48 Weeks)|Other than specified|0|||
130577349|NCT04418765|470078514|FG001|Extension Period (48 Weeks)|Other than specified|5|||
130577350|NCT04418765|470078515|FG002|Extension Period (48 Weeks)|Other than specified|2|||
130577351|NCT02217566|470078517|FG000|Overall Study|Lost to Follow-up|2|||
130577352|NCT02217566|470078517|FG000|Overall Study|Death|3|||
130577353|NCT02217566|470078517|FG000|Overall Study|Early study termination|6|||
130577354|NCT01999582|470078525|FG000|Overall Study|Withdrawal by Subject|0|||
130577355|NCT01999582|470078526|FG001|Overall Study|Withdrawal by Subject|0|||
130577356|NCT01999582|470078527|FG002|Overall Study|Withdrawal by Subject|0|||
130577357|NCT01999582|470078528|FG003|Overall Study|Withdrawal by Subject|1|||
130577358|NCT01999582|470078529|FG004|Overall Study|Withdrawal by Subject|0|||
130577359|NCT01999582|470078530|FG005|Overall Study|Withdrawal by Subject|0|||
130577360|NCT01999582|470078525|FG000|Overall Study|Adverse Event|0|||
130577361|NCT01999582|470078526|FG001|Overall Study|Adverse Event|0|||
130577362|NCT01999582|470078527|FG002|Overall Study|Adverse Event|3|||
130525887|NCT02257918|469892511|FG000|Overall Study|Lost to Follow-up|4|||
130525888|NCT02257918|469892512|FG001|Overall Study|Lost to Follow-up|1|||
130525889|NCT02257918|469892513|FG002|Overall Study|Lost to Follow-up|0|||
130525890|NCT02257918|469892511|FG000|Overall Study|Withdrawal by Subject|0|||
130525891|NCT02257918|469892512|FG001|Overall Study|Withdrawal by Subject|0|||
130525892|NCT02257918|469892513|FG002|Overall Study|Withdrawal by Subject|1|||
130525893|NCT02257918|469892511|FG000|Overall Study|Pregnancy|0|||
130525894|NCT02257918|469892512|FG001|Overall Study|Pregnancy|0|||
130525895|NCT02257918|469892513|FG002|Overall Study|Pregnancy|1|||
130525896|NCT01806389|469892515|FG000|Overall Study|Withdrawal by Subject|4|||
130525897|NCT03371823|469892520|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
130525898|NCT03371823|469892521|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
130525899|NCT01263054|469892525|FG000|Overall Study|Death|1|||
130525900|NCT01263054|469892526|FG001|Overall Study|Death|0|||
130525901|NCT01263054|469892525|FG000|Overall Study|Lost to Follow-up|2|||
130525902|NCT01263054|469892526|FG001|Overall Study|Lost to Follow-up|2|||
130525903|NCT01263054|469892525|FG000|Overall Study|Withdrawal by Subject|1|||
130525904|NCT01263054|469892526|FG001|Overall Study|Withdrawal by Subject|3|||
130525905|NCT01263054|469892525|FG000|Overall Study|Qualification Violation|1|||
130525906|NCT01263054|469892526|FG001|Overall Study|Qualification Violation|0|||
130525907|NCT01263054|469892525|FG000|Overall Study|Other|0|||
130525908|NCT01263054|469892526|FG001|Overall Study|Other|1|||
130525909|NCT01310699|469892527|FG000|Overall Study|Patients did not complete tandem.|4|||
130525910|NCT01310699|469892528|FG001|Overall Study|Patients did not complete tandem.|6|||
130525911|NCT00936598|469892529|FG000|Overall Study|Withdrawal by Subject|1|||
130525912|NCT00936598|469892530|FG001|Overall Study|Withdrawal by Subject|0|||
130525913|NCT00936598|469892529|FG000|Overall Study|Ineligible after consent|1|||
130525914|NCT00936598|469892530|FG001|Overall Study|Ineligible after consent|0|||
130525915|NCT00926575|469892531|FG000|Overall Study|Adverse Event|1|||
130525916|NCT00926575|469892532|FG001|Overall Study|Adverse Event|1|||
130525917|NCT00926575|469892531|FG000|Overall Study|Death|4|||
130525918|NCT00926575|469892532|FG001|Overall Study|Death|4|||
130525919|NCT00926575|469892531|FG000|Overall Study|Lost to Follow-up|1|||
130525920|NCT00926575|469892532|FG001|Overall Study|Lost to Follow-up|1|||
130525921|NCT00926575|469892531|FG000|Overall Study|Physician Decision|1|||
130525922|NCT00926575|469892532|FG001|Overall Study|Physician Decision|2|||
130525923|NCT00926575|469892531|FG000|Overall Study|Protocol Violation|1|||
130525924|NCT00926575|469892532|FG001|Overall Study|Protocol Violation|0|||
130525925|NCT00926575|469892531|FG000|Overall Study|Withdrawal by Subject|8|||
130577363|NCT01999582|470078528|FG003|Overall Study|Adverse Event|0|||
130577364|NCT01999582|470078529|FG004|Overall Study|Adverse Event|1|||
130577365|NCT01999582|470078530|FG005|Overall Study|Adverse Event|0|||
130577366|NCT01999582|470078525|FG000|Overall Study|Other Reasons|1|||
130577367|NCT01999582|470078526|FG001|Overall Study|Other Reasons|0|||
130525926|NCT00926575|469892532|FG001|Overall Study|Withdrawal by Subject|9|||
130525927|NCT02201901|469892535|FG000|Overall Study|Randomized but never treated|0|||
130577368|NCT01999582|470078527|FG002|Overall Study|Other Reasons|3|||
130577369|NCT01999582|470078528|FG003|Overall Study|Other Reasons|1|||
130577370|NCT01999582|470078529|FG004|Overall Study|Other Reasons|1|||
130577371|NCT01999582|470078530|FG005|Overall Study|Other Reasons|2|||
130577372|NCT01999582|470078525|FG000|Overall Study|Protocol Violation|1|||
130577373|NCT01999582|470078526|FG001|Overall Study|Protocol Violation|0|||
130577374|NCT01999582|470078527|FG002|Overall Study|Protocol Violation|0|||
130577375|NCT01999582|470078528|FG003|Overall Study|Protocol Violation|0|||
130577376|NCT01999582|470078529|FG004|Overall Study|Protocol Violation|0|||
130577377|NCT01999582|470078530|FG005|Overall Study|Protocol Violation|1|||
130577378|NCT01999582|470078525|FG000|Overall Study|Lack of Efficacy|1|||
130577379|NCT01999582|470078526|FG001|Overall Study|Lack of Efficacy|3|||
130577380|NCT01999582|470078527|FG002|Overall Study|Lack of Efficacy|0|||
130577381|NCT01999582|470078528|FG003|Overall Study|Lack of Efficacy|1|||
130577382|NCT01999582|470078529|FG004|Overall Study|Lack of Efficacy|0|||
130577383|NCT01999582|470078530|FG005|Overall Study|Lack of Efficacy|0|||
130577384|NCT00999908|470078537|FG000|Treatment Period 1|Subject withdrew consent|2|||
130577385|NCT00999908|470078538|FG001|Treatment Period 1|Subject withdrew consent|0|||
130577386|NCT00999908|470078539|FG002|Treatment Period 1|Subject withdrew consent|0|||
130577387|NCT00999908|470078537|FG000|Treatment Period 2|Protocol Violation|1|||
130577388|NCT00999908|470078538|FG001|Treatment Period 2|Protocol Violation|0|||
130525928|NCT02201901|469892536|FG001|Overall Study|Randomized but never treated|1|||
130525929|NCT02201901|469892537|FG002|Overall Study|Randomized but never treated|0|||
130525930|NCT02201901|469892535|FG000|Overall Study|Lack of Efficacy|7|||
130525931|NCT02201901|469892536|FG001|Overall Study|Lack of Efficacy|1|||
130525932|NCT02201901|469892537|FG002|Overall Study|Lack of Efficacy|6|||
130525933|NCT02201901|469892535|FG000|Overall Study|Death|3|||
130525934|NCT02201901|469892536|FG001|Overall Study|Death|3|||
130525935|NCT02201901|469892537|FG002|Overall Study|Death|3|||
130525936|NCT02201901|469892535|FG000|Overall Study|Lost to Follow-up|2|||
130525937|NCT02201901|469892536|FG001|Overall Study|Lost to Follow-up|3|||
130525938|NCT02201901|469892537|FG002|Overall Study|Lost to Follow-up|2|||
130525939|NCT02201901|469892535|FG000|Overall Study|Withdrew Consent|2|||
130525940|NCT02201901|469892536|FG001|Overall Study|Withdrew Consent|0|||
130525941|NCT02201901|469892537|FG002|Overall Study|Withdrew Consent|2|||
130525942|NCT02201901|469892535|FG000|Overall Study|Adverse Event|1|||
130525943|NCT02201901|469892536|FG001|Overall Study|Adverse Event|1|||
130525944|NCT02201901|469892537|FG002|Overall Study|Adverse Event|0|||
130525945|NCT02242643|469892538|FG000|Overall Study|Protocol Violation|1|||
130525946|NCT02242643|469892539|FG001|Overall Study|Protocol Violation|2|||
130525947|NCT02242643|469892538|FG000|Overall Study|Withdrawal by Subject|15|||
130525948|NCT02242643|469892539|FG001|Overall Study|Withdrawal by Subject|10|||
130525949|NCT02242643|469892538|FG000|Overall Study|Migrated/moved from study area|1|||
130525950|NCT02242643|469892539|FG001|Overall Study|Migrated/moved from study area|3|||
130525951|NCT02242643|469892538|FG000|Overall Study|Lost to Follow-up|54|||
130525952|NCT02242643|469892539|FG001|Overall Study|Lost to Follow-up|61|||
130525953|NCT02242643|469892538|FG000|Overall Study|Child placed in foster care by family|0|||
130525954|NCT02242643|469892539|FG001|Overall Study|Child placed in foster care by family|1|||
130525955|NCT02242643|469892538|FG000|Overall Study|Non-compliance|1|||
130577389|NCT00999908|470078539|FG002|Treatment Period 2|Protocol Violation|0|||
130577390|NCT03889639|470078542|FG000|Overall Study|Withdrawal by Subject|0|||
130577391|NCT03889639|470078543|FG001|Overall Study|Withdrawal by Subject|0|||
130525956|NCT02242643|469892539|FG001|Overall Study|Non-compliance|0|||
130525957|NCT02242643|469892538|FG000|Overall Study|Consent withdrawal by parent|1|||
130525958|NCT02242643|469892539|FG001|Overall Study|Consent withdrawal by parent|0|||
130525959|NCT02242643|469892538|FG000|Overall Study|Protocol requirements not followed|1|||
130525960|NCT02242643|469892539|FG001|Overall Study|Protocol requirements not followed|0|||
130525961|NCT02242643|469892538|FG000|Overall Study|Language barrier|1|||
130525962|NCT02242643|469892539|FG001|Overall Study|Language barrier|0|||
130525963|NCT02242643|469892538|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
130525964|NCT02242643|469892539|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
130525965|NCT02633397|469892547|FG000|Overall Study|Adverse Event|8|||
130525966|NCT02633397|469892548|FG001|Overall Study|Adverse Event|8|||
130525967|NCT02633397|469892547|FG000|Overall Study|Study Burden|4|||
130525968|NCT02633397|469892548|FG001|Overall Study|Study Burden|1|||
130525969|NCT02633397|469892547|FG000|Overall Study|Treatment interruption|2|||
130577392|NCT03889639|470078544|FG002|Overall Study|Withdrawal by Subject|0|||
130577393|NCT03889639|470078545|FG003|Overall Study|Withdrawal by Subject|0|||
130577394|NCT03889639|470078546|FG004|Overall Study|Withdrawal by Subject|0|||
130577395|NCT03889639|470078547|FG005|Overall Study|Withdrawal by Subject|0|||
130577396|NCT03889639|470078548|FG006|Overall Study|Withdrawal by Subject|0|||
130577397|NCT03889639|470078549|FG007|Overall Study|Withdrawal by Subject|1|||
130577398|NCT01703858|470078550|FG000|Overall Study|Withdrawal by Subject|0|||
130577399|NCT01703858|470078551|FG001|Overall Study|Withdrawal by Subject|1|||
130577400|NCT01703858|470078552|FG002|Overall Study|Withdrawal by Subject|0|||
130577401|NCT00993031|470078554|FG000|Overall Study|Death|0|||
130577402|NCT00993031|470078555|FG001|Overall Study|Death|1|||
130577403|NCT00993031|470078554|FG000|Overall Study|Physician Decision|0|||
130577404|NCT00993031|470078555|FG001|Overall Study|Physician Decision|2|||
130577405|NCT00993031|470078554|FG000|Overall Study|Withdrawal by Subject|3|||
130577406|NCT00993031|470078555|FG001|Overall Study|Withdrawal by Subject|3|||
130577407|NCT00993031|470078554|FG000|Overall Study|Lost to Follow-up|19|||
130577408|NCT00993031|470078555|FG001|Overall Study|Lost to Follow-up|13|||
130577409|NCT03115151|470078556|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
130525970|NCT02633397|469892548|FG001|Overall Study|Treatment interruption|5|||
130525971|NCT02633397|469892547|FG000|Overall Study|Death|2|||
130525972|NCT02633397|469892548|FG001|Overall Study|Death|2|||
130525973|NCT02633397|469892547|FG000|Overall Study|Physician Decision|0|||
130525974|NCT02633397|469892548|FG001|Overall Study|Physician Decision|1|||
130525975|NCT03595878|469892549|FG000|Overall Study|Death|2|||
130525976|NCT03595878|469892550|FG001|Overall Study|Death|1|||
130525977|NCT03595878|469892551|FG002|Overall Study|Death|0|||
130525978|NCT03595878|469892549|FG000|Overall Study|Disease progression|2|||
130525979|NCT03595878|469892550|FG001|Overall Study|Disease progression|1|||
130525980|NCT03595878|469892551|FG002|Overall Study|Disease progression|2|||
130525981|NCT03494985|469892552|FG000|Overall Study|Adverse Event|3|||
130525982|NCT03494985|469892553|FG001|Overall Study|Adverse Event|2|||
130525983|NCT03494985|469892554|FG002|Overall Study|Adverse Event|3|||
130525984|NCT03494985|469892555|FG003|Overall Study|Adverse Event|0|||
130525985|NCT03494985|469892552|FG000|Overall Study|Other (Withdrawal of consent)|2|||
130525986|NCT03494985|469892553|FG001|Overall Study|Other (Withdrawal of consent)|3|||
130525987|NCT03494985|469892554|FG002|Overall Study|Other (Withdrawal of consent)|2|||
130525988|NCT03494985|469892555|FG003|Overall Study|Other (Withdrawal of consent)|5|||
130525989|NCT03494985|469892552|FG000|Overall Study|Other (Not specified)|0|||
130525990|NCT03494985|469892553|FG001|Overall Study|Other (Not specified)|1|||
130525991|NCT03494985|469892554|FG002|Overall Study|Other (Not specified)|1|||
130525992|NCT03494985|469892555|FG003|Overall Study|Other (Not specified)|0|||
130525993|NCT03036124|469892556|FG000|Overall Study|Lost to Follow-up|0|||
130525994|NCT03036124|469892557|FG001|Overall Study|Lost to Follow-up|2|||
130525995|NCT03036124|469892556|FG000|Overall Study|Withdrawal by Subject|5|||
130525996|NCT03036124|469892557|FG001|Overall Study|Withdrawal by Subject|4|||
130525997|NCT02282059|469892558|FG000|Overall Study|Other|15|||
130525998|NCT02282059|469892559|FG001|Overall Study|Other|3|||
130525999|NCT02282059|469892558|FG000|Overall Study|Participant refused further follow-up|8|||
130526000|NCT02282059|469892559|FG001|Overall Study|Participant refused further follow-up|4|||
130526001|NCT02282059|469892558|FG000|Overall Study|Lost to Follow-up|19|||
130526002|NCT02282059|469892559|FG001|Overall Study|Lost to Follow-up|3|||
130526003|NCT02282059|469892558|FG000|Overall Study|Death|40|||
130526004|NCT02282059|469892559|FG001|Overall Study|Death|8|||
130526005|NCT05093504|469892560|FG000|Overall Study|Death|0|||
130526006|NCT05093504|469892561|FG001|Overall Study|Death|1|||
130526007|NCT02394925|469892562|FG000|Overall Study|Adverse Event|1|||
130526008|NCT02394925|469892562|FG000|Overall Study|Lens Discomfort|3|||
130526009|NCT02394925|469892562|FG000|Overall Study|Lens handling difficulities|5|||
130526010|NCT02394925|469892562|FG000|Overall Study|Lost to Follow-up|9|||
130526011|NCT02394925|469892562|FG000|Overall Study|Protocol Violation|5|||
130577410|NCT03115151|470078557|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
130526012|NCT02394925|469892562|FG000|Overall Study|No longer meet eligibility criteria|1|||
130526013|NCT02394925|469892562|FG000|Overall Study|Unsatisfactory Visual Response|5|||
130526014|NCT00966264|469894409|FG000|Overall Study|Lost to Follow-up|4|||
130526015|NCT00966264|469894410|FG001|Overall Study|Lost to Follow-up|3|||
130526016|NCT01867047|469894411|FG000|Overall Study|Lost to Follow-up|3|||
130526017|NCT01867047|469894412|FG001|Overall Study|Lost to Follow-up|3|||
130526018|NCT01867047|469894411|FG000|Overall Study|Withdrawal by Subject|2|||
130526019|NCT01867047|469894412|FG001|Overall Study|Withdrawal by Subject|0|||
130526020|NCT01867047|469894411|FG000|Overall Study|Physician Decision|2|||
130526021|NCT01867047|469894412|FG001|Overall Study|Physician Decision|0|||
130526022|NCT01867047|469894411|FG000|Overall Study|surgery not indicated in protocol|1|||
130526023|NCT01867047|469894412|FG001|Overall Study|surgery not indicated in protocol|2|||
130526024|NCT04596995|469894413|FG000|Overall Study|Lack of Efficacy|8|||
130526025|NCT04596995|469894413|FG000|Overall Study|Lost to Follow-up|3|||
130526026|NCT04596995|469894413|FG000|Overall Study|Withdrawal by Subject|12|||
130526027|NCT04596995|469894413|FG000|Overall Study|Sponsor decision|3|||
130577411|NCT03115151|470078556|FG000|Overall Study|Epidural catheter removal|1|||
130577412|NCT03115151|470078557|FG001|Overall Study|Epidural catheter removal|0|||
130526028|NCT04596995|469894413|FG000|Overall Study|Enrolled in managed access program|3|||
130526029|NCT00590564|469894415|FG000|Overall Study|Withdrawal by Subject|4|||
130526030|NCT00590564|469894415|FG000|Overall Study|Lost to Follow-up|6|||
130577413|NCT03115151|470078556|FG000|Overall Study|Withdrawal by Subject|0|||
130577414|NCT03115151|470078557|FG001|Overall Study|Withdrawal by Subject|1|||
130577415|NCT03115151|470078556|FG000|Overall Study|Intervention not received according to the protocol.|1|||
130577416|NCT03115151|470078557|FG001|Overall Study|Intervention not received according to the protocol.|1|||
130577417|NCT03115151|470078556|FG000|Overall Study|Physician Decision|1|||
130577418|NCT03115151|470078557|FG001|Overall Study|Physician Decision|0|||
130577419|NCT03115151|470078556|FG000|Overall Study|Randomization not applied|1|||
130577420|NCT03115151|470078557|FG001|Overall Study|Randomization not applied|1|||
130577421|NCT03870555|470078563|FG000|Period 3 (2 Days)|Adverse Event|1|||
130577422|NCT03870555|470078564|FG001|Period 3 (2 Days)|Adverse Event|0|||
130577423|NCT03870555|470078565|FG002|Period 3 (2 Days)|Adverse Event|0|||
130577424|NCT03694925|470078567|FG000|Overall Study|Inadequate laboratory testing|0|||
130577425|NCT03694925|470078568|FG001|Overall Study|Inadequate laboratory testing|3|||
130577426|NCT03694925|470078569|FG002|Overall Study|Inadequate laboratory testing|0|||
130577427|NCT03434977|470078579|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
130577428|NCT03434977|470078580|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
130577429|NCT03920670|470078581|FG000|Overall Study|Protocol Violation|2|||
130577430|NCT03920670|470078582|FG001|Overall Study|Protocol Violation|2|||
130577431|NCT03920670|470078581|FG000|Overall Study|Adverse Event|1|||
130577432|NCT03920670|470078582|FG001|Overall Study|Adverse Event|0|||
130577433|NCT04820309|470078588|FG000|Overall Study|Adverse Event|96|||
130577434|NCT04820309|470078588|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
130577435|NCT04820309|470078588|FG000|Overall Study|Consent Withdrawn|93|||
130577436|NCT04820309|470078588|FG000|Overall Study|failure to adhere to protocol|32|||
130577437|NCT04820309|470078588|FG000|Overall Study|alcohol or drug use|6|||
130577438|NCT04820309|470078588|FG000|Overall Study|Lost to Follow-up|46|||
130577439|NCT04820309|470078588|FG000|Overall Study|Death|2|||
130577440|NCT04820309|470078588|FG000|Overall Study|Pregnancy|1|||
130577441|NCT04820309|470078588|FG000|Overall Study|Other reasons|12|||
130577442|NCT02270242|470078593|FG000|Overall Study|Withdrawal by Subject|18|||
130577443|NCT02270242|470078594|FG001|Overall Study|Withdrawal by Subject|25|||
130577444|NCT02270242|470078593|FG000|Overall Study|Lost to Follow-up|41|||
130577445|NCT02270242|470078594|FG001|Overall Study|Lost to Follow-up|27|||
130577446|NCT02270242|470078593|FG000|Overall Study|Physician Decision|0|||
130577447|NCT02270242|470078594|FG001|Overall Study|Physician Decision|1|||
130577448|NCT02321436|470078595|FG000|Overall Study|Withdrawal by Subject|1|||
130577449|NCT02321436|470078596|FG001|Overall Study|Withdrawal by Subject|0|||
130577450|NCT02321436|470078595|FG000|Overall Study|Lost to Follow-up|0|||
130577451|NCT02321436|470078596|FG001|Overall Study|Lost to Follow-up|1|||
130577452|NCT03355300|470078597|FG000|Overall Study|Physician Decision|0|||
130577453|NCT03355300|470078598|FG001|Overall Study|Physician Decision|1|||
130577454|NCT03355300|470078597|FG000|Overall Study|Lack of Efficacy|2|||
130577455|NCT03355300|470078598|FG001|Overall Study|Lack of Efficacy|1|||
130577456|NCT03355300|470078597|FG000|Overall Study|Other reason|1|||
130577457|NCT03355300|470078598|FG001|Overall Study|Other reason|0|||
130577458|NCT03048422|470078599|FG000|Overall Study|Death|1|||
130577459|NCT03048422|470078600|FG001|Overall Study|Death|0|||
130577460|NCT03048422|470078601|FG002|Overall Study|Death|0|||
130577461|NCT03048422|470078599|FG000|Overall Study|Lost to Follow-up|5|||
130577462|NCT03048422|470078600|FG001|Overall Study|Lost to Follow-up|0|||
130577463|NCT03048422|470078601|FG002|Overall Study|Lost to Follow-up|1|||
130577464|NCT03048422|470078599|FG000|Overall Study|Withdrawal by Subject|5|||
130577465|NCT03048422|470078600|FG001|Overall Study|Withdrawal by Subject|7|||
130577466|NCT03048422|470078601|FG002|Overall Study|Withdrawal by Subject|4|||
130577467|NCT03048422|470078599|FG000|Overall Study|Moved|3|||
130577468|NCT03048422|470078600|FG001|Overall Study|Moved|2|||
130577469|NCT03048422|470078601|FG002|Overall Study|Moved|2|||
130577470|NCT03048422|470078599|FG000|Overall Study|Noncompliant with Study Requirements|2|||
130577471|NCT03048422|470078600|FG001|Overall Study|Noncompliant with Study Requirements|1|||
130577472|NCT03048422|470078601|FG002|Overall Study|Noncompliant with Study Requirements|2|||
130577473|NCT03048422|470078599|FG000|Overall Study|Not Able to Get to Clinic|1|||
130577474|NCT03048422|470078600|FG001|Overall Study|Not Able to Get to Clinic|0|||
130577475|NCT03048422|470078601|FG002|Overall Study|Not Able to Get to Clinic|0|||
130577476|NCT03505021|470078602|FG000|Overall Study|Protocol Violation|1|||
130577477|NCT03505021|470078603|FG001|Overall Study|Protocol Violation|0|||
130577478|NCT03505021|470078602|FG000|Overall Study|Death|9|||
130577479|NCT03505021|470078603|FG001|Overall Study|Death|8|||
130577480|NCT03505021|470078602|FG000|Overall Study|Consent withdrawn by subject|6|||
130577481|NCT03505021|470078603|FG001|Overall Study|Consent withdrawn by subject|1|||
130577482|NCT03505021|470078602|FG000|Overall Study|Lost to Follow-up|5|||
130577483|NCT03505021|470078603|FG001|Overall Study|Lost to Follow-up|3|||
130577484|NCT03505021|470078602|FG000|Overall Study|Adverse Event|26|||
130577485|NCT03505021|470078603|FG001|Overall Study|Adverse Event|9|||
130577486|NCT03505021|470078602|FG000|Overall Study|Disease progression|33|||
130577487|NCT03505021|470078603|FG001|Overall Study|Disease progression|17|||
130577488|NCT03505021|470078602|FG000|Overall Study|Other|11|||
130577489|NCT03505021|470078603|FG001|Overall Study|Other|5|||
130577490|NCT03505021|470078602|FG000|Overall Study|Personal reason|21|||
130577491|NCT03505021|470078603|FG001|Overall Study|Personal reason|12|||
130577492|NCT03406897|470080327|FG000|Overall Study|Lost to Follow-up|1|||
130577493|NCT03406897|470080328|FG001|Overall Study|Lost to Follow-up|2|||
130577494|NCT03406897|470080327|FG000|Overall Study|Withdrawal by Subject|4|||
130577495|NCT03406897|470080328|FG001|Overall Study|Withdrawal by Subject|4|||
130577496|NCT03406897|470080327|FG000|Overall Study|Physician Decision|0|||
130577497|NCT03406897|470080328|FG001|Overall Study|Physician Decision|1|||
130577498|NCT02392429|470080329|FG000|Screening|Screen failure|15|||
130577499|NCT02392429|470080329|FG000|Enrolled Participants|Ineligible due to disease|3|||
130577500|NCT02392429|470080329|FG000|Enrolled Participants|Withdrawal by Subject|4|||
130577501|NCT02392429|470080329|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
130577502|NCT02392429|470080329|FG000|Evaluable|Death|5|||
130577503|NCT02392429|470080329|FG000|Evaluable|Withdrawal by Subject|1|||
130577504|NCT02392429|470080329|FG000|Evaluable|Adverse Event|1|||
130577505|NCT02392429|470080329|FG000|Evaluable|remission bone marrow biopsy|3|||
130577506|NCT00482014|470080330|FG000|Overall Study|Withdrawal by Subject|1|||
130577507|NCT00482014|470080331|FG001|Overall Study|Withdrawal by Subject|2|||
130577508|NCT00482014|470080332|FG002|Overall Study|Withdrawal by Subject|3|||
130577509|NCT00482014|470080333|FG003|Overall Study|Withdrawal by Subject|4|||
130577510|NCT00482014|470080330|FG000|Overall Study|Adverse Event|3|||
130577511|NCT00482014|470080331|FG001|Overall Study|Adverse Event|0|||
130577512|NCT00482014|470080332|FG002|Overall Study|Adverse Event|2|||
130577513|NCT00482014|470080333|FG003|Overall Study|Adverse Event|8|||
130577514|NCT00482014|470080330|FG000|Overall Study|Death|1|||
130577515|NCT00482014|470080331|FG001|Overall Study|Death|2|||
130577516|NCT00482014|470080332|FG002|Overall Study|Death|1|||
130577517|NCT00482014|470080333|FG003|Overall Study|Death|4|||
130577518|NCT00482014|470080330|FG000|Overall Study|Lack of Efficacy|1|||
130577519|NCT00482014|470080331|FG001|Overall Study|Lack of Efficacy|0|||
130526031|NCT00590564|469894415|FG000|Overall Study|Protocol Violation|1|||
130526032|NCT00590564|469894415|FG000|Overall Study|Patient Found to be Ineligible|1|||
130526033|NCT00590564|469894415|FG000|Overall Study|Patient Non-compliance|6|||
130526034|NCT01434680|469894416|FG000|Overall Study|Withdrawal by Subject|1|||
130526035|NCT01434680|469894417|FG001|Overall Study|Withdrawal by Subject|0|||
130526036|NCT01434680|469894418|FG002|Overall Study|Withdrawal by Subject|2|||
130526037|NCT01434680|469894419|FG003|Overall Study|Withdrawal by Subject|0|||
130526038|NCT01434680|469894416|FG000|Overall Study|Lost to Follow-up|1|||
130526039|NCT01434680|469894417|FG001|Overall Study|Lost to Follow-up|1|||
130526040|NCT01434680|469894418|FG002|Overall Study|Lost to Follow-up|0|||
130526041|NCT01434680|469894419|FG003|Overall Study|Lost to Follow-up|0|||
130526042|NCT01434680|469894416|FG000|Overall Study|Protocol Violation|1|||
130526043|NCT01434680|469894417|FG001|Overall Study|Protocol Violation|1|||
130526044|NCT01434680|469894418|FG002|Overall Study|Protocol Violation|0|||
130526045|NCT01434680|469894419|FG003|Overall Study|Protocol Violation|0|||
130526046|NCT03020069|469894423|FG000|Overall Study|Lost to Follow-up|0|||
130526047|NCT03020069|469894424|FG001|Overall Study|Lost to Follow-up|1|||
130526048|NCT05765435|469894430|FG000|Overall Study|Lost to Follow-up|0|||
130526049|NCT05765435|469894431|FG001|Overall Study|Lost to Follow-up|1|||
130526050|NCT05765435|469894432|FG002|Overall Study|Lost to Follow-up|0|||
130526051|NCT05765435|469894430|FG000|Overall Study|Withdrawal by Subject|0|||
130526052|NCT05765435|469894431|FG001|Overall Study|Withdrawal by Subject|0|||
130526053|NCT05765435|469894432|FG002|Overall Study|Withdrawal by Subject|1|||
130526054|NCT00781937|469894441|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
130526055|NCT00781937|469894442|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
130526056|NCT00781937|469894441|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
130526057|NCT00781937|469894442|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
130526058|NCT00781937|469894441|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
130526059|NCT00781937|469894442|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
130526060|NCT00781937|469894441|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
130526061|NCT00781937|469894442|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
130526062|NCT00781937|469894441|FG000|Main Trial Period Through Week 56|Unclassified|10|||
130526063|NCT00781937|469894442|FG001|Main Trial Period Through Week 56|Unclassified|15|||
130526064|NCT00781937|469894441|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
130526065|NCT00781937|469894442|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
130526066|NCT00781937|469894441|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
130526067|NCT00781937|469894442|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
130577520|NCT00482014|470080332|FG002|Overall Study|Lack of Efficacy|4|||
130577521|NCT00482014|470080333|FG003|Overall Study|Lack of Efficacy|6|||
130577522|NCT00482014|470080330|FG000|Overall Study|Sponsor Decision|1|||
130577523|NCT00482014|470080331|FG001|Overall Study|Sponsor Decision|2|||
130526068|NCT04698915|469894443|FG000|Overall Study|Adverse Event|2|||
130526069|NCT04698915|469894444|FG001|Overall Study|Adverse Event|0|||
130526070|NCT04698915|469894443|FG000|Overall Study|Death|23|||
130526071|NCT04698915|469894444|FG001|Overall Study|Death|20|||
130577524|NCT00482014|470080332|FG002|Overall Study|Sponsor Decision|1|||
130577525|NCT00482014|470080333|FG003|Overall Study|Sponsor Decision|1|||
130577526|NCT01178138|470080334|FG000|Overall Study|Lost to Follow-up|8|||
130526072|NCT04698915|469894443|FG000|Overall Study|Physician Decision|1|||
130526073|NCT04698915|469894444|FG001|Overall Study|Physician Decision|1|||
130526074|NCT04698915|469894443|FG000|Overall Study|Lost to Follow-up|1|||
130526075|NCT04698915|469894444|FG001|Overall Study|Lost to Follow-up|0|||
130526076|NCT04698915|469894443|FG000|Overall Study|Study Terminated by Sponsor|55|||
130526077|NCT04698915|469894444|FG001|Overall Study|Study Terminated by Sponsor|60|||
130526078|NCT04698915|469894443|FG000|Overall Study|Withdrawal by Subject|2|||
130526079|NCT04698915|469894444|FG001|Overall Study|Withdrawal by Subject|3|||
130526080|NCT01907906|469894445|FG000|Overall Study|Withdrawal by Subject|1|||
130526081|NCT01907906|469894446|FG001|Overall Study|Withdrawal by Subject|0|||
130526082|NCT01907906|469894445|FG000|Overall Study|Physician Decision|3|||
130526083|NCT01907906|469894446|FG001|Overall Study|Physician Decision|1|||
130526084|NCT03520075|469894447|FG000|Phase 1 (Dose Escalation)|Death|2|||
130526085|NCT03520075|469894448|FG001|Phase 1 (Dose Escalation)|Death|2|||
130526086|NCT03520075|469894449|FG002|Phase 1 (Dose Escalation)|Death|3|||
130526087|NCT03520075|469894450|FG003|Phase 1 (Dose Escalation)|Death|2|||
130526088|NCT03520075|469894451|FG004|Phase 1 (Dose Escalation)|Death|6|||
130526089|NCT03520075|469894452|FG005|Phase 1 (Dose Escalation)|Death|5|||
130526090|NCT03520075|469894453|FG006|Phase 1 (Dose Escalation)|Death|3|||
130526091|NCT03520075|469894454|FG007|Phase 1 (Dose Escalation)|Death|2|||
130526092|NCT03520075|469894455|FG008|Phase 1 (Dose Escalation)|Death|3|||
130526093|NCT03520075|469894456|FG009|Phase 1 (Dose Escalation)|Death|1|||
130526094|NCT03520075|469894457|FG010|Phase 1 (Dose Escalation)|Death|5|||
130526095|NCT03520075|469894458|FG011|Phase 1 (Dose Escalation)|Death|7|||
130526096|NCT03520075|469894459|FG012|Phase 1 (Dose Escalation)|Death|11|||
130526097|NCT03520075|469894460|FG013|Phase 1 (Dose Escalation)|Death|0|||
130526098|NCT03520075|469894461|FG014|Phase 1 (Dose Escalation)|Death|0|||
130526099|NCT03520075|469894462|FG015|Phase 1 (Dose Escalation)|Death|0|||
130526100|NCT03520075|469894463|FG016|Phase 1 (Dose Escalation)|Death|0|||
130526101|NCT03520075|469894464|FG017|Phase 1 (Dose Escalation)|Death|0|||
130526102|NCT03520075|469894465|FG018|Phase 1 (Dose Escalation)|Death|0|||
130526103|NCT03520075|469894447|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
130526104|NCT03520075|469894448|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526105|NCT03520075|469894449|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526106|NCT03520075|469894450|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
130526107|NCT03520075|469894451|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
130526108|NCT03520075|469894452|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
130526109|NCT03520075|469894453|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526110|NCT03520075|469894454|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
130526111|NCT03520075|469894455|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526112|NCT03520075|469894456|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
130526113|NCT03520075|469894457|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526114|NCT03520075|469894458|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526115|NCT03520075|469894459|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
130526116|NCT03520075|469894460|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526117|NCT03520075|469894461|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526118|NCT03520075|469894462|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526119|NCT03520075|469894463|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526120|NCT03520075|469894464|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526121|NCT03520075|469894465|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130526122|NCT03520075|469894447|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526123|NCT03520075|469894448|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
130526124|NCT03520075|469894449|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526125|NCT03520075|469894450|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
130526126|NCT03520075|469894451|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
130526127|NCT03520075|469894452|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526128|NCT03520075|469894453|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526129|NCT03520075|469894454|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526130|NCT03520075|469894455|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526131|NCT03520075|469894456|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526132|NCT03520075|469894457|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
130526133|NCT03520075|469894458|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526134|NCT03520075|469894459|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
130526135|NCT03520075|469894460|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526136|NCT03520075|469894461|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526137|NCT03520075|469894462|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526138|NCT03520075|469894463|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526139|NCT03520075|469894464|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526140|NCT03520075|469894465|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130526141|NCT03520075|469894447|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526142|NCT03520075|469894448|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130577527|NCT01178138|470080334|FG000|Overall Study|Withdrawal by Subject|7|||
130577528|NCT01178138|470080334|FG000|Overall Study|Physician Decision|8|||
130577529|NCT01241708|470080335|FG000|Overall Study|Withdrawal by Subject|6|||
130577530|NCT01241708|470080335|FG000|Overall Study|Screen Failure|6|||
130577531|NCT01241708|470080335|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
130577532|NCT01241708|470080335|FG000|Overall Study|Lost to Follow-up|5|||
130577533|NCT04137887|470080338|FG000|Overall Study|Death|102|||
130577534|NCT04137887|470080339|FG001|Overall Study|Death|92|||
130577535|NCT04137887|470080338|FG000|Overall Study|Withdrawal by Subject|2|||
130577536|NCT04137887|470080339|FG001|Overall Study|Withdrawal by Subject|3|||
130577537|NCT04137887|470080338|FG000|Overall Study|Randomized but not treated|0|||
130577538|NCT04137887|470080339|FG001|Overall Study|Randomized but not treated|1|||
130577539|NCT01396005|470080346|FG000|Overall Study|Withdrawal by Subject|0|||
130577540|NCT01396005|470080347|FG001|Overall Study|Withdrawal by Subject|1|||
130577541|NCT01396005|470080346|FG000|Overall Study|Non-compliance with protocol|0|||
130577542|NCT01396005|470080347|FG001|Overall Study|Non-compliance with protocol|1|||
130577543|NCT00424827|470080348|FG000|Overall Study|Adverse Event|1|||
130577544|NCT03806127|470080351|FG000|Overall Study|Withdrawal by Subject|4|||
130577545|NCT03806127|470080352|FG001|Overall Study|Withdrawal by Subject|5|||
130577546|NCT03806127|470080351|FG000|Overall Study|Protocol Violation|3|||
130577547|NCT03806127|470080352|FG001|Overall Study|Protocol Violation|1|||
130577548|NCT03806127|470080351|FG000|Overall Study|Adverse Event|3|||
130577549|NCT03806127|470080352|FG001|Overall Study|Adverse Event|0|||
130577550|NCT03806127|470080351|FG000|Overall Study|Unable to Complete Procedures|0|||
130577551|NCT03806127|470080352|FG001|Overall Study|Unable to Complete Procedures|1|||
130577552|NCT03806127|470080351|FG000|Overall Study|Pregnancy|0|||
130577553|NCT03806127|470080352|FG001|Overall Study|Pregnancy|1|||
130577554|NCT03806127|470080351|FG000|Overall Study|Lost to Follow-up|5|||
130577555|NCT03806127|470080352|FG001|Overall Study|Lost to Follow-up|1|||
130577556|NCT03806127|470080351|FG000|Overall Study|Physician Decision|1|||
130577557|NCT03806127|470080352|FG001|Overall Study|Physician Decision|1|||
130577558|NCT03806127|470080351|FG000|Overall Study|Could Not Come Due to Covid|1|||
130577559|NCT03806127|470080352|FG001|Overall Study|Could Not Come Due to Covid|0|||
130577560|NCT03806127|470080351|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
130577561|NCT03806127|470080352|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
130577562|NCT03806127|470080351|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
130577563|NCT03806127|470080352|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
130577564|NCT03806127|470080351|FG000|Overall Study|Covid 19 Restrictions|2|||
130577565|NCT03806127|470080352|FG001|Overall Study|Covid 19 Restrictions|0|||
130577566|NCT03806127|470080351|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
130577567|NCT03806127|470080352|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
130577568|NCT03806127|470080351|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
130577569|NCT03806127|470080352|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
130577570|NCT01467492|470080353|FG000|Overall Study|Withdrawal by Subject|6|||
130577571|NCT01467492|470080354|FG001|Overall Study|Withdrawal by Subject|4|||
130577572|NCT01467492|470080353|FG000|Overall Study|Study Terminated by Sponsor|6|||
130577573|NCT01467492|470080354|FG001|Overall Study|Study Terminated by Sponsor|4|||
130577574|NCT01467492|470080353|FG000|Overall Study|Adverse Event|4|||
130577575|NCT01467492|470080354|FG001|Overall Study|Adverse Event|3|||
130577576|NCT01467492|470080353|FG000|Overall Study|Lost to Follow-up|3|||
130577577|NCT01467492|470080354|FG001|Overall Study|Lost to Follow-up|2|||
130577578|NCT01467492|470080353|FG000|Overall Study|Undefined|2|||
130577579|NCT01467492|470080354|FG001|Overall Study|Undefined|0|||
130577580|NCT01467492|470080353|FG000|Overall Study|Enrolled But Not Treated|1|||
130577581|NCT01467492|470080354|FG001|Overall Study|Enrolled But Not Treated|0|||
130577582|NCT02450487|470080356|FG000|Overall Study|Lost to Follow-up|3|||
130577583|NCT01790048|470080357|FG000|Overall Study|Incorrect Age|9|||
130577584|NCT01790048|470080358|FG001|Overall Study|Incorrect Age|14|||
130577585|NCT01790048|470080357|FG000|Overall Study|data entry error|0|||
130577586|NCT01790048|470080358|FG001|Overall Study|data entry error|1|||
130577587|NCT01790048|470080357|FG000|Overall Study|Other|0|||
130577588|NCT01790048|470080358|FG001|Overall Study|Other|2|||
130577589|NCT01790048|470080357|FG000|Overall Study|SAM at Enrollment|2|||
130577590|NCT01790048|470080358|FG001|Overall Study|SAM at Enrollment|0|||
130577591|NCT01790048|470080357|FG000|Overall Study|Measurement error|1|||
130577592|NCT01790048|470080358|FG001|Overall Study|Measurement error|0|||
130577593|NCT00159432|470080359|FG000|Overall Study|Adverse Event|1|||
130577594|NCT00159432|470080359|FG000|Overall Study|Death|1|||
130577595|NCT00159432|470080359|FG000|Overall Study|Lack of Efficacy|8|||
130577596|NCT05030311|470080360|FG000|Overall Study|Technical problems|0|||
130577597|NCT05030311|470080361|FG001|Overall Study|Technical problems|1|||
130577598|NCT05030311|470080360|FG000|Overall Study|Withdrawal by Subject|31|||
130577599|NCT05030311|470080361|FG001|Overall Study|Withdrawal by Subject|17|||
130577600|NCT05030311|470080360|FG000|Overall Study|Adverse Event|13|||
130577601|NCT05030311|470080361|FG001|Overall Study|Adverse Event|5|||
130577602|NCT05030311|470080360|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130526143|NCT03520075|469894449|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526144|NCT03520075|469894450|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526145|NCT03520075|469894451|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526146|NCT03520075|469894452|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526147|NCT03520075|469894453|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526148|NCT03520075|469894454|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526149|NCT03520075|469894455|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526150|NCT03520075|469894456|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
130526151|NCT03520075|469894457|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526152|NCT03520075|469894458|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526153|NCT03520075|469894459|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
130526154|NCT03520075|469894460|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526155|NCT03520075|469894461|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526156|NCT03520075|469894462|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526157|NCT03520075|469894463|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526158|NCT03520075|469894464|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526159|NCT03520075|469894465|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
130526160|NCT03520075|469894447|FG000|Phase 2 (Dose Expansion)|Death|0|||
130526161|NCT03520075|469894448|FG001|Phase 2 (Dose Expansion)|Death|0|||
130526162|NCT03520075|469894449|FG002|Phase 2 (Dose Expansion)|Death|0|||
130526163|NCT03520075|469894450|FG003|Phase 2 (Dose Expansion)|Death|0|||
130526164|NCT03520075|469894451|FG004|Phase 2 (Dose Expansion)|Death|0|||
130526165|NCT03520075|469894452|FG005|Phase 2 (Dose Expansion)|Death|0|||
130526166|NCT03520075|469894453|FG006|Phase 2 (Dose Expansion)|Death|0|||
130526167|NCT03520075|469894454|FG007|Phase 2 (Dose Expansion)|Death|0|||
130526168|NCT03520075|469894455|FG008|Phase 2 (Dose Expansion)|Death|0|||
130526169|NCT03520075|469894456|FG009|Phase 2 (Dose Expansion)|Death|0|||
130526170|NCT03520075|469894457|FG010|Phase 2 (Dose Expansion)|Death|0|||
130526171|NCT03520075|469894458|FG011|Phase 2 (Dose Expansion)|Death|0|||
130526172|NCT03520075|469894459|FG012|Phase 2 (Dose Expansion)|Death|0|||
130526173|NCT03520075|469894460|FG013|Phase 2 (Dose Expansion)|Death|20|||
130526174|NCT03520075|469894461|FG014|Phase 2 (Dose Expansion)|Death|13|||
130526175|NCT03520075|469894462|FG015|Phase 2 (Dose Expansion)|Death|9|||
130526176|NCT03520075|469894463|FG016|Phase 2 (Dose Expansion)|Death|5|||
130526177|NCT03520075|469894464|FG017|Phase 2 (Dose Expansion)|Death|14|||
130526178|NCT03520075|469894465|FG018|Phase 2 (Dose Expansion)|Death|12|||
130526179|NCT03520075|469894447|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526180|NCT03520075|469894448|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526181|NCT03520075|469894449|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526182|NCT03520075|469894450|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526183|NCT03520075|469894451|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526184|NCT03520075|469894452|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526185|NCT03520075|469894453|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526186|NCT03520075|469894454|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526187|NCT03520075|469894455|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526188|NCT03520075|469894456|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526189|NCT03520075|469894457|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526190|NCT03520075|469894458|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526191|NCT03520075|469894459|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526192|NCT03520075|469894460|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
130526193|NCT03520075|469894461|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
130526194|NCT03520075|469894462|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
130526195|NCT03520075|469894463|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
130526196|NCT03520075|469894464|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
130526197|NCT03520075|469894465|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
130526198|NCT03520075|469894447|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526199|NCT03520075|469894448|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526200|NCT03520075|469894449|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526201|NCT03520075|469894450|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526202|NCT03520075|469894451|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526203|NCT03520075|469894452|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526204|NCT03520075|469894453|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526205|NCT03520075|469894454|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526206|NCT03520075|469894455|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526207|NCT03520075|469894456|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526208|NCT03520075|469894457|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526209|NCT03520075|469894458|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526210|NCT03520075|469894459|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526211|NCT03520075|469894460|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526212|NCT03520075|469894461|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
130526213|NCT03520075|469894462|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
130526214|NCT03520075|469894463|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526215|NCT03520075|469894464|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
130526216|NCT03520075|469894465|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
130526217|NCT03520075|469894447|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526218|NCT03520075|469894448|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526219|NCT03520075|469894449|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526220|NCT03520075|469894450|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526221|NCT03520075|469894451|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526222|NCT03520075|469894452|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526223|NCT03520075|469894453|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526224|NCT03520075|469894454|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526225|NCT03520075|469894455|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526226|NCT03520075|469894456|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526227|NCT03520075|469894457|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526228|NCT03520075|469894458|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526229|NCT03520075|469894459|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526230|NCT03520075|469894460|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
130526231|NCT03520075|469894461|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526232|NCT03520075|469894462|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526233|NCT03520075|469894463|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
130526234|NCT03520075|469894464|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
130526235|NCT03520075|469894465|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
130526236|NCT02786004|469894466|FG000|Overall Study|Withdrawal by Subject|0|||
130526237|NCT02786004|469894467|FG001|Overall Study|Withdrawal by Subject|1|||
130526238|NCT00126659|469894471|FG000|Overall Study|Adverse Event|0|||
130526239|NCT00126659|469894472|FG001|Overall Study|Adverse Event|0|||
130526240|NCT00126659|469894473|FG002|Overall Study|Adverse Event|2|||
130526241|NCT02367352|469894474|FG000|Overall Study|Progressive disease|7|||
130526242|NCT02367352|469894475|FG001|Overall Study|Progressive disease|0|||
130526243|NCT02367352|469894476|FG002|Overall Study|Progressive disease|0|||
130526244|NCT02367352|469894474|FG000|Overall Study|Participant Received Alternative Therapy|1|||
130526245|NCT02367352|469894475|FG001|Overall Study|Participant Received Alternative Therapy|0|||
130526246|NCT02367352|469894476|FG002|Overall Study|Participant Received Alternative Therapy|0|||
130526247|NCT02367352|469894474|FG000|Overall Study|Adverse Event|1|||
130526248|NCT02367352|469894475|FG001|Overall Study|Adverse Event|0|||
130526249|NCT02367352|469894476|FG002|Overall Study|Adverse Event|0|||
130526250|NCT01013961|469894477|FG000|Overall Study|Adverse Event|2|||
130526251|NCT01013961|469894478|FG001|Overall Study|Adverse Event|2|||
130526252|NCT01013961|469894477|FG000|Overall Study|Withdrawal by Subject|1|||
130526253|NCT01013961|469894478|FG001|Overall Study|Withdrawal by Subject|0|||
130526254|NCT01013961|469894477|FG000|Overall Study|Physician Decision|0|||
130526255|NCT01013961|469894478|FG001|Overall Study|Physician Decision|1|||
130526256|NCT01375751|469894483|FG000|Overall Study|Other|0|||
130526257|NCT01375751|469894484|FG001|Overall Study|Other|1|||
130526258|NCT01375751|469894485|FG002|Overall Study|Other|0|||
130526259|NCT02980523|469894486|FG000|Overall Study|Lost to Follow-up|1|||
130526260|NCT02980523|469894487|FG001|Overall Study|Lost to Follow-up|4|||
130526261|NCT02980523|469894488|FG002|Overall Study|Lost to Follow-up|1|||
130526262|NCT02980523|469894489|FG003|Overall Study|Lost to Follow-up|2|||
130526263|NCT02980523|469894490|FG004|Overall Study|Lost to Follow-up|1|||
130526264|NCT02980523|469894486|FG000|Overall Study|Excluded from analysis|1|||
130526265|NCT02980523|469894487|FG001|Overall Study|Excluded from analysis|3|||
130526266|NCT02980523|469894488|FG002|Overall Study|Excluded from analysis|1|||
130526267|NCT02980523|469894489|FG003|Overall Study|Excluded from analysis|1|||
130526268|NCT02980523|469894490|FG004|Overall Study|Excluded from analysis|1|||
130526269|NCT02980523|469894486|FG000|Overall Study|Lack of Efficacy|1|||
130526270|NCT02980523|469894487|FG001|Overall Study|Lack of Efficacy|4|||
130526271|NCT02980523|469894488|FG002|Overall Study|Lack of Efficacy|4|||
130526272|NCT02980523|469894489|FG003|Overall Study|Lack of Efficacy|5|||
130526273|NCT02980523|469894490|FG004|Overall Study|Lack of Efficacy|8|||
130526274|NCT02980523|469894486|FG000|Overall Study|Did not receive intervention|0|||
130526275|NCT02980523|469894487|FG001|Overall Study|Did not receive intervention|0|||
130526276|NCT02980523|469894488|FG002|Overall Study|Did not receive intervention|0|||
130526277|NCT02980523|469894489|FG003|Overall Study|Did not receive intervention|1|||
130526278|NCT02980523|469894490|FG004|Overall Study|Did not receive intervention|0|||
130526279|NCT02375347|469894491|FG000|Overall Study|Protocol Violation|1|||
130526280|NCT00559377|469894492|FG000|Overall Study|Withdrawal by Subject|9|||
130526281|NCT00940875|469894493|FG000|Treatment Phase|Adverse Event|9|||
130526282|NCT00940875|469894494|FG001|Treatment Phase|Adverse Event|3|||
130526283|NCT00940875|469894493|FG000|Treatment Phase|Death|3|||
130526284|NCT00940875|469894494|FG001|Treatment Phase|Death|5|||
130526285|NCT00940875|469894493|FG000|Treatment Phase|Lack of Efficacy|1|||
130526286|NCT00940875|469894494|FG001|Treatment Phase|Lack of Efficacy|0|||
130526287|NCT00940875|469894493|FG000|Treatment Phase|Withdrawal by Subject|3|||
130526288|NCT00940875|469894494|FG001|Treatment Phase|Withdrawal by Subject|0|||
130526289|NCT00940875|469894493|FG000|Treatment Phase|Disease progression|9|||
130526290|NCT00940875|469894494|FG001|Treatment Phase|Disease progression|11|||
130526291|NCT00940875|469894493|FG000|Treatment Phase|Physician Decision|1|||
130526292|NCT00940875|469894494|FG001|Treatment Phase|Physician Decision|0|||
130526293|NCT00940875|469894493|FG000|Post-Study Treatment|Death|0|||
130526294|NCT00940875|469894494|FG001|Post-Study Treatment|Death|1|||
130526295|NCT00940875|469894493|FG000|Post-Study Treatment|Disease Progression|0|||
130526296|NCT00940875|469894494|FG001|Post-Study Treatment|Disease Progression|2|||
130526297|NCT00490945|469894495|FG000|Overall Study|Adverse Event|0|||
130526298|NCT00490945|469894496|FG001|Overall Study|Adverse Event|1|||
130526299|NCT00490945|469894497|FG002|Overall Study|Adverse Event|0|||
130526300|NCT00490945|469894498|FG003|Overall Study|Adverse Event|0|||
130526301|NCT00490945|469894499|FG004|Overall Study|Adverse Event|0|||
130526302|NCT05186311|469894508|FG000|Part A: Serum|Withdrawal by Subject|1|||
130526303|NCT02879383|469894509|FG000|First 24 Weeks|Physician Decision|0|||
130526304|NCT02879383|469894510|FG001|First 24 Weeks|Physician Decision|1|||
130526305|NCT02879383|469894511|FG002|First 24 Weeks|Physician Decision|0|||
130526306|NCT02879383|469894512|FG003|First 24 Weeks|Physician Decision|0|||
130526307|NCT02417441|469894521|FG000|Overall Study|Inconclusive due to missing data|52|||
130526308|NCT02417441|469894522|FG001|Overall Study|Inconclusive due to missing data|19|||
130526309|NCT00983853|469894523|FG000|Overall Study|Lost to Follow-up|1|||
130526310|NCT00983853|469894524|FG001|Overall Study|Lost to Follow-up|1|||
130526311|NCT00983853|469894525|FG002|Overall Study|Lost to Follow-up|2|||
130526312|NCT00983853|469894526|FG003|Overall Study|Lost to Follow-up|2|||
130526313|NCT00983853|469894527|FG004|Overall Study|Lost to Follow-up|2|||
130526314|NCT00983853|469894528|FG005|Overall Study|Lost to Follow-up|1|||
130526315|NCT00983853|469894523|FG000|Overall Study|Withdrawal by Subject|0|||
130526316|NCT00983853|469894524|FG001|Overall Study|Withdrawal by Subject|0|||
130526317|NCT00983853|469894525|FG002|Overall Study|Withdrawal by Subject|1|||
130526318|NCT00983853|469894526|FG003|Overall Study|Withdrawal by Subject|0|||
130526319|NCT00983853|469894527|FG004|Overall Study|Withdrawal by Subject|1|||
130526320|NCT00983853|469894528|FG005|Overall Study|Withdrawal by Subject|0|||
130526321|NCT00983853|469894523|FG000|Overall Study|Unable to come to study follow-up visits|0|||
130526322|NCT00983853|469894524|FG001|Overall Study|Unable to come to study follow-up visits|1|||
130526323|NCT00983853|469894525|FG002|Overall Study|Unable to come to study follow-up visits|0|||
130526324|NCT00983853|469894526|FG003|Overall Study|Unable to come to study follow-up visits|0|||
130526325|NCT00983853|469894527|FG004|Overall Study|Unable to come to study follow-up visits|0|||
130526326|NCT00983853|469894528|FG005|Overall Study|Unable to come to study follow-up visits|0|||
130526327|NCT03603639|469894529|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
130526328|NCT03603639|469894530|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
130526329|NCT03603639|469894531|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
130526330|NCT03603639|469894532|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
130526331|NCT03603639|469894533|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
130526332|NCT03603639|469894534|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
130526333|NCT03603639|469894529|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
130526334|NCT03603639|469894530|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
130526335|NCT03603639|469894531|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
130526336|NCT03603639|469894532|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
130526337|NCT03603639|469894533|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
130526338|NCT03603639|469894534|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
130526339|NCT02947100|469894543|FG000|Overall Study|study terminated early|3|||
130526340|NCT02947100|469894543|FG000|Overall Study|did not meet inclusion criteria|1|||
130526341|NCT00742326|469894546|FG000|Overall Study|Physician Decision|0|||
130526342|NCT00742326|469894547|FG001|Overall Study|Physician Decision|1|||
130526343|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
130526344|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
130526345|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
130526346|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
130526347|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
130526348|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
130526349|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
130526350|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
130526351|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
130526352|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
130526353|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
130526354|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
130526355|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
130526356|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
130526357|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
130526358|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
130526359|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
130526360|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
130526361|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Missing|2|||
130526362|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Missing|1|||
130526363|NCT00443209|469894549|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
130526364|NCT00443209|469894550|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
130526365|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
130526366|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
130526367|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
130526368|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
130526369|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
130526370|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
130526371|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
130526372|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
130526373|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
130526374|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
130526375|NCT00443209|469894549|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
130526376|NCT00443209|469894550|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
130526377|NCT01628692|469894551|FG000|Overall Study|Lack of Efficacy|4|||
130526378|NCT01628692|469894552|FG001|Overall Study|Lack of Efficacy|4|||
130526379|NCT01628692|469894553|FG002|Overall Study|Lack of Efficacy|5|||
130526380|NCT01628692|469894554|FG003|Overall Study|Lack of Efficacy|1|||
130526381|NCT01628692|469894555|FG004|Overall Study|Lack of Efficacy|4|||
130526382|NCT01628692|469894556|FG005|Overall Study|Lack of Efficacy|7|||
130526383|NCT01628692|469894551|FG000|Overall Study|Adverse Event|2|||
130526384|NCT01628692|469894552|FG001|Overall Study|Adverse Event|0|||
130526385|NCT01628692|469894553|FG002|Overall Study|Adverse Event|2|||
130526386|NCT01628692|469894554|FG003|Overall Study|Adverse Event|0|||
130526387|NCT01628692|469894555|FG004|Overall Study|Adverse Event|0|||
130526388|NCT01628692|469894556|FG005|Overall Study|Adverse Event|0|||
130526389|NCT01628692|469894551|FG000|Overall Study|Withdrawal by Subject|0|||
130526390|NCT01628692|469894552|FG001|Overall Study|Withdrawal by Subject|1|||
130526391|NCT01628692|469894553|FG002|Overall Study|Withdrawal by Subject|1|||
130526392|NCT01628692|469894554|FG003|Overall Study|Withdrawal by Subject|0|||
130526393|NCT01628692|469894555|FG004|Overall Study|Withdrawal by Subject|0|||
130526394|NCT01628692|469894556|FG005|Overall Study|Withdrawal by Subject|0|||
130526395|NCT01628692|469894551|FG000|Overall Study|Death|0|||
130526396|NCT01628692|469894552|FG001|Overall Study|Death|1|||
130526397|NCT01628692|469894553|FG002|Overall Study|Death|0|||
130526398|NCT01628692|469894554|FG003|Overall Study|Death|0|||
130526399|NCT01628692|469894555|FG004|Overall Study|Death|0|||
130526400|NCT01628692|469894556|FG005|Overall Study|Death|0|||
130526401|NCT01628692|469894551|FG000|Overall Study|Poor compliance/noncompliance|1|||
130526402|NCT01628692|469894552|FG001|Overall Study|Poor compliance/noncompliance|0|||
130526403|NCT01628692|469894553|FG002|Overall Study|Poor compliance/noncompliance|0|||
130526404|NCT01628692|469894554|FG003|Overall Study|Poor compliance/noncompliance|0|||
130526405|NCT01628692|469894555|FG004|Overall Study|Poor compliance/noncompliance|0|||
130526406|NCT01628692|469894556|FG005|Overall Study|Poor compliance/noncompliance|0|||
130526407|NCT01628692|469894551|FG000|Overall Study|Administrative reason by sponsor|0|||
130526408|NCT01628692|469894552|FG001|Overall Study|Administrative reason by sponsor|0|||
130577603|NCT05030311|470080361|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130577604|NCT05030311|470080360|FG000|Overall Study|Physician Decision|5|||
130577605|NCT05030311|470080361|FG001|Overall Study|Physician Decision|2|||
130577606|NCT05030311|470080360|FG000|Overall Study|Lost to Follow-up|5|||
130577607|NCT05030311|470080361|FG001|Overall Study|Lost to Follow-up|1|||
130526409|NCT01628692|469894553|FG002|Overall Study|Administrative reason by sponsor|0|||
130577608|NCT05030311|470080360|FG000|Overall Study|Protocol Violation|4|||
130577609|NCT05030311|470080361|FG001|Overall Study|Protocol Violation|4|||
130577610|NCT03042468|470080363|FG000|Overall Study|Death|0|||
130526410|NCT01628692|469894554|FG003|Overall Study|Administrative reason by sponsor|0|||
130526411|NCT01628692|469894555|FG004|Overall Study|Administrative reason by sponsor|0|||
130526412|NCT01628692|469894556|FG005|Overall Study|Administrative reason by sponsor|1|||
130526413|NCT01628692|469894551|FG000|Overall Study|Completed 12 Week only|0|||
130526414|NCT01628692|469894552|FG001|Overall Study|Completed 12 Week only|0|||
130526415|NCT01628692|469894553|FG002|Overall Study|Completed 12 Week only|0|||
130526416|NCT01628692|469894554|FG003|Overall Study|Completed 12 Week only|0|||
130526417|NCT01628692|469894555|FG004|Overall Study|Completed 12 Week only|0|||
130526418|NCT01628692|469894556|FG005|Overall Study|Completed 12 Week only|1|||
130577611|NCT03042468|470080364|FG001|Overall Study|Death|1|||
130577612|NCT03042468|470080365|FG002|Overall Study|Death|1|||
130526419|NCT00409409|469894557|FG000|Overall Study|Adverse Event|7|||
130526420|NCT00409409|469894558|FG001|Overall Study|Adverse Event|2|||
130526421|NCT00409409|469894557|FG000|Overall Study|Withdrawal by Subject|1|||
130526422|NCT00409409|469894558|FG001|Overall Study|Withdrawal by Subject|1|||
130526423|NCT00409409|469894557|FG000|Overall Study|Any other reason not above-mentioned|0|||
130526424|NCT00409409|469894558|FG001|Overall Study|Any other reason not above-mentioned|1|||
130526425|NCT03635086|469894562|FG000|Overall Study|Withdrawal of consent|0|||
130526426|NCT03635086|469894563|FG001|Overall Study|Withdrawal of consent|0|||
130526427|NCT03635086|469894564|FG002|Overall Study|Withdrawal of consent|1|||
130526428|NCT03635086|469894565|FG003|Overall Study|Withdrawal of consent|0|||
130526429|NCT03635086|469894566|FG004|Overall Study|Withdrawal of consent|0|||
130526430|NCT03635086|469894562|FG000|Overall Study|Adverse Event|0|||
130526431|NCT03635086|469894563|FG001|Overall Study|Adverse Event|1|||
130526432|NCT03635086|469894564|FG002|Overall Study|Adverse Event|0|||
130526433|NCT03635086|469894565|FG003|Overall Study|Adverse Event|0|||
130526434|NCT03635086|469894566|FG004|Overall Study|Adverse Event|0|||
130526435|NCT03635086|469894562|FG000|Overall Study|Lost to Follow-up|1|||
130526436|NCT03635086|469894563|FG001|Overall Study|Lost to Follow-up|0|||
130526437|NCT03635086|469894564|FG002|Overall Study|Lost to Follow-up|0|||
130526438|NCT03635086|469894565|FG003|Overall Study|Lost to Follow-up|0|||
130526439|NCT03635086|469894566|FG004|Overall Study|Lost to Follow-up|0|||
130526440|NCT00478205|469894567|FG000|Overall Study|Adverse Event|182|||
130526441|NCT00478205|469894568|FG001|Overall Study|Adverse Event|39|||
130526442|NCT00478205|469894567|FG000|Overall Study|Medication Non-compliance|9|||
130526443|NCT00478205|469894568|FG001|Overall Study|Medication Non-compliance|4|||
130526444|NCT00478205|469894567|FG000|Overall Study|Protocol Violation|15|||
130526445|NCT00478205|469894568|FG001|Overall Study|Protocol Violation|5|||
130526446|NCT00478205|469894567|FG000|Overall Study|Request of Investigator or Sponsor|4|||
130526447|NCT00478205|469894568|FG001|Overall Study|Request of Investigator or Sponsor|5|||
130526448|NCT00478205|469894567|FG000|Overall Study|Withdrawal by Subject|61|||
130526449|NCT00478205|469894568|FG001|Overall Study|Withdrawal by Subject|22|||
130526450|NCT00478205|469894567|FG000|Overall Study|Lack of Efficacy|1|||
130526451|NCT00478205|469894568|FG001|Overall Study|Lack of Efficacy|0|||
130526452|NCT00478205|469894567|FG000|Overall Study|Other|24|||
130526453|NCT00478205|469894568|FG001|Overall Study|Other|12|||
130526454|NCT01012947|469894569|FG000|Overall Study|Lost to Follow-up|131|||
130526455|NCT01012947|469894570|FG001|Overall Study|Lost to Follow-up|135|||
130526456|NCT01012947|469894571|FG002|Overall Study|Lost to Follow-up|130|||
130526457|NCT01012947|469894572|FG003|Overall Study|Lost to Follow-up|118|||
130526458|NCT01012947|469894573|FG004|Overall Study|Lost to Follow-up|142|||
130526459|NCT04016272|469894576|FG000|Overall Study|Withdrawal by Subject|1|||
130526460|NCT04016272|469894577|FG001|Overall Study|Withdrawal by Subject|2|||
130526461|NCT00825305|469894578|FG000|Overall Study|Adverse Event|1|||
130526462|NCT00825305|469894579|FG001|Overall Study|Adverse Event|1|||
130526463|NCT00825305|469894578|FG000|Overall Study|Withdrawal by Subject|6|||
130526464|NCT00825305|469894579|FG001|Overall Study|Withdrawal by Subject|12|||
130526465|NCT00825305|469894578|FG000|Overall Study|Inappropriate inclusion|1|||
130526466|NCT00825305|469894579|FG001|Overall Study|Inappropriate inclusion|0|||
130526467|NCT00825305|469894578|FG000|Overall Study|Protocol Violation|9|||
130526468|NCT00825305|469894579|FG001|Overall Study|Protocol Violation|9|||
130526469|NCT00825305|469894578|FG000|Overall Study|Can not be classified|0|||
130526470|NCT00825305|469894579|FG001|Overall Study|Can not be classified|1|||
130526471|NCT01850030|469894582|FG000|Overall Study|Adverse Event|64|||
130526472|NCT01850030|469894583|FG001|Overall Study|Adverse Event|82|||
130526473|NCT01850030|469894582|FG000|Overall Study|Lack of Efficacy|3|||
130526474|NCT01850030|469894583|FG001|Overall Study|Lack of Efficacy|1|||
130526475|NCT01850030|469894582|FG000|Overall Study|Lost to Follow-up|5|||
130526476|NCT01850030|469894583|FG001|Overall Study|Lost to Follow-up|5|||
130526477|NCT01850030|469894582|FG000|Overall Study|Withdrawal by Subject|3|||
130526478|NCT01850030|469894583|FG001|Overall Study|Withdrawal by Subject|4|||
130526479|NCT01850030|469894582|FG000|Overall Study|Protocol Violation|24|||
130526480|NCT01850030|469894583|FG001|Overall Study|Protocol Violation|28|||
130526481|NCT01850030|469894582|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
130526482|NCT01850030|469894583|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
130526483|NCT02638103|469894585|FG000|Overall Study|Adverse Event|13|||
130526484|NCT02638103|469894586|FG001|Overall Study|Adverse Event|12|||
130526485|NCT02638103|469894587|FG002|Overall Study|Adverse Event|19|||
130526486|NCT02638103|469894588|FG003|Overall Study|Adverse Event|12|||
130526487|NCT02638103|469894585|FG000|Overall Study|Withdrawal by Subject|43|||
130526488|NCT02638103|469894586|FG001|Overall Study|Withdrawal by Subject|53|||
130526489|NCT02638103|469894587|FG002|Overall Study|Withdrawal by Subject|30|||
130526490|NCT02638103|469894588|FG003|Overall Study|Withdrawal by Subject|61|||
130526491|NCT02638103|469894585|FG000|Overall Study|Protocol Violation|1|||
130526492|NCT02638103|469894586|FG001|Overall Study|Protocol Violation|2|||
130526493|NCT02638103|469894587|FG002|Overall Study|Protocol Violation|1|||
130526494|NCT02638103|469894588|FG003|Overall Study|Protocol Violation|4|||
130526495|NCT02638103|469894585|FG000|Overall Study|Pregnancy|2|||
130526496|NCT02638103|469894586|FG001|Overall Study|Pregnancy|3|||
130577613|NCT03042468|470080366|FG003|Overall Study|Death|0|||
130577614|NCT03042468|470080367|FG004|Overall Study|Death|0|||
130577615|NCT03042468|470080368|FG005|Overall Study|Death|0|||
130577616|NCT03042468|470080363|FG000|Overall Study|Withdrawal by Subject|0|||
130577617|NCT03042468|470080364|FG001|Overall Study|Withdrawal by Subject|0|||
130577618|NCT03042468|470080365|FG002|Overall Study|Withdrawal by Subject|0|||
130577619|NCT03042468|470080366|FG003|Overall Study|Withdrawal by Subject|0|||
130577620|NCT03042468|470080367|FG004|Overall Study|Withdrawal by Subject|0|||
130577621|NCT03042468|470080368|FG005|Overall Study|Withdrawal by Subject|1|||
130577622|NCT03042468|470080363|FG000|Overall Study|Lost to Follow-up|0|||
130577623|NCT03042468|470080364|FG001|Overall Study|Lost to Follow-up|0|||
130577624|NCT03042468|470080365|FG002|Overall Study|Lost to Follow-up|0|||
130577625|NCT03042468|470080366|FG003|Overall Study|Lost to Follow-up|0|||
130577626|NCT03042468|470080367|FG004|Overall Study|Lost to Follow-up|1|||
130577627|NCT03042468|470080368|FG005|Overall Study|Lost to Follow-up|1|||
130577628|NCT03286842|470080369|FG000|Overall Study|Patients rolled over to another study|80|||
130577629|NCT03178487|470080370|FG000|Period 1|Adverse Event|1|||
130577630|NCT03178487|470080371|FG001|Period 1|Adverse Event|2|||
130577631|NCT03178487|470080370|FG000|Period 1|Withdrawal by Subject|2|||
130577632|NCT03178487|470080371|FG001|Period 1|Withdrawal by Subject|1|||
130577633|NCT03178487|470080370|FG000|Period 1|Lost to Follow-up|1|||
130577634|NCT03178487|470080371|FG001|Period 1|Lost to Follow-up|0|||
130577635|NCT03178487|470080370|FG000|Period 1|Other|0|||
130577636|NCT03178487|470080371|FG001|Period 1|Other|1|||
130577637|NCT03178487|470080370|FG000|Period 2|Adverse Event|4|||
130577638|NCT03178487|470080371|FG001|Period 2|Adverse Event|4|||
130577639|NCT03178487|470080370|FG000|Period 2|Withdrawal by Subject|6|||
130577640|NCT03178487|470080371|FG001|Period 2|Withdrawal by Subject|6|||
130577641|NCT03178487|470080370|FG000|Period 2|Lost to Follow-up|2|||
130577642|NCT03178487|470080371|FG001|Period 2|Lost to Follow-up|2|||
130577643|NCT03178487|470080370|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
130577644|NCT03178487|470080371|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
130577645|NCT03178487|470080370|FG000|Period 2|Other|8|||
130577646|NCT03178487|470080371|FG001|Period 2|Other|7|||
130577647|NCT01453855|470080372|FG000|Overall Study|Adverse Event|3|||
130577648|NCT01453855|470080373|FG001|Overall Study|Adverse Event|4|||
130577649|NCT01453855|470080372|FG000|Overall Study|Lost to Follow-up|2|||
130577650|NCT01453855|470080373|FG001|Overall Study|Lost to Follow-up|1|||
130577651|NCT01453855|470080372|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
130577652|NCT01453855|470080373|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
130577653|NCT01453855|470080372|FG000|Overall Study|Noncompliance|1|||
130577654|NCT01453855|470080373|FG001|Overall Study|Noncompliance|0|||
130577655|NCT01453855|470080372|FG000|Overall Study|Inadequate Control of IOP|1|||
130577656|NCT01453855|470080373|FG001|Overall Study|Inadequate Control of IOP|5|||
130577657|NCT01453855|470080372|FG000|Overall Study|Other|0|||
130577658|NCT01453855|470080373|FG001|Overall Study|Other|1|||
130577659|NCT01239160|470080374|FG000|Overall Study|Lost to Follow-up|3|||
130577660|NCT01239160|470080375|FG001|Overall Study|Lost to Follow-up|5|||
130577661|NCT01239160|470080376|FG002|Overall Study|Lost to Follow-up|0|||
130577662|NCT01239160|470080374|FG000|Overall Study|Withdrawal by Subject|17|||
130577663|NCT01239160|470080375|FG001|Overall Study|Withdrawal by Subject|6|||
130577664|NCT01239160|470080376|FG002|Overall Study|Withdrawal by Subject|2|||
130577665|NCT01239160|470080374|FG000|Overall Study|Physician Decision|5|||
130577666|NCT01239160|470080375|FG001|Overall Study|Physician Decision|7|||
130577667|NCT01239160|470080376|FG002|Overall Study|Physician Decision|2|||
130577668|NCT01239160|470080374|FG000|Overall Study|Early Termination Due to Study Closure|0|||
130577669|NCT01239160|470080375|FG001|Overall Study|Early Termination Due to Study Closure|1|||
130577670|NCT01239160|470080376|FG002|Overall Study|Early Termination Due to Study Closure|6|||
130577671|NCT04781816|470080377|FG000|Overall Study|Adverse Event|0|||
130577672|NCT04781816|470080378|FG001|Overall Study|Adverse Event|1|||
130577673|NCT04781816|470080377|FG000|Overall Study|Withdrawal by Subject|1|||
130577674|NCT04781816|470080378|FG001|Overall Study|Withdrawal by Subject|1|||
130577675|NCT04781816|470080377|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
130577676|NCT04781816|470080378|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
130577677|NCT01789970|470080379|FG000|Open-label Titration Period|Adverse Event|68|||
130577678|NCT01789970|470080380|FG001|Open-label Titration Period|Adverse Event|0|||
130577679|NCT01789970|470080381|FG002|Open-label Titration Period|Adverse Event|0|||
130577680|NCT01789970|470080379|FG000|Open-label Titration Period|Lack of Efficacy|31|||
130577681|NCT01789970|470080380|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130577682|NCT01789970|470080381|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130577683|NCT01789970|470080379|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
130577684|NCT01789970|470080380|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130577685|NCT01789970|470080381|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130577686|NCT01789970|470080379|FG000|Open-label Titration Period|Protocol Violation|18|||
130526497|NCT02638103|469894587|FG002|Overall Study|Pregnancy|0|||
130526498|NCT02638103|469894588|FG003|Overall Study|Pregnancy|1|||
130526499|NCT02638103|469894585|FG000|Overall Study|Non-compliance to Study Procedures|2|||
130526500|NCT02638103|469894586|FG001|Overall Study|Non-compliance to Study Procedures|1|||
130526501|NCT02638103|469894587|FG002|Overall Study|Non-compliance to Study Procedures|1|||
130526502|NCT02638103|469894588|FG003|Overall Study|Non-compliance to Study Procedures|1|||
130526503|NCT02638103|469894585|FG000|Overall Study|Lost to Follow-up|26|||
130526504|NCT02638103|469894586|FG001|Overall Study|Lost to Follow-up|33|||
130526505|NCT02638103|469894587|FG002|Overall Study|Lost to Follow-up|20|||
130526506|NCT02638103|469894588|FG003|Overall Study|Lost to Follow-up|37|||
130526507|NCT02638103|469894585|FG000|Overall Study|Lack of Efficacy|14|||
130526508|NCT02638103|469894586|FG001|Overall Study|Lack of Efficacy|10|||
130526509|NCT02638103|469894587|FG002|Overall Study|Lack of Efficacy|12|||
130526510|NCT02638103|469894588|FG003|Overall Study|Lack of Efficacy|22|||
130526511|NCT02638103|469894585|FG000|Overall Study|Other than specified|5|||
130526512|NCT02638103|469894586|FG001|Overall Study|Other than specified|4|||
130526513|NCT02638103|469894587|FG002|Overall Study|Other than specified|2|||
130526514|NCT02638103|469894588|FG003|Overall Study|Other than specified|4|||
130526515|NCT02165826|469894596|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
130526516|NCT02165826|469894597|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
130526517|NCT02165826|469894598|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
130526518|NCT02165826|469894596|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
130526519|NCT02165826|469894597|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
130526520|NCT02165826|469894598|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
130526521|NCT02165826|469894596|FG000|Main Treatment Period|Lost to Follow-up|4|||
130526522|NCT02165826|469894597|FG001|Main Treatment Period|Lost to Follow-up|2|||
130526523|NCT02165826|469894598|FG002|Main Treatment Period|Lost to Follow-up|1|||
130526524|NCT02165826|469894596|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
130526525|NCT02165826|469894597|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
130526526|NCT02165826|469894598|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
130526527|NCT02165826|469894596|FG000|Main Treatment Period|Lack of Efficacy|2|||
130526528|NCT02165826|469894597|FG001|Main Treatment Period|Lack of Efficacy|0|||
130526529|NCT02165826|469894598|FG002|Main Treatment Period|Lack of Efficacy|0|||
130526530|NCT02165826|469894596|FG000|Main Treatment Period|Reason Not Specified|8|||
130526531|NCT02165826|469894597|FG001|Main Treatment Period|Reason Not Specified|5|||
130526532|NCT02165826|469894598|FG002|Main Treatment Period|Reason Not Specified|16|||
130526533|NCT02165826|469894596|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
130526534|NCT02165826|469894597|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
130526535|NCT02165826|469894598|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
130526536|NCT02165826|469894596|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
130526537|NCT02165826|469894597|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
130526538|NCT02165826|469894598|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
130526539|NCT02165826|469894596|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
130526540|NCT02165826|469894597|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
130526541|NCT02165826|469894598|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
130526542|NCT02165826|469894596|FG000|Down-Titration Period|Reason Not Specified|1|||
130526543|NCT02165826|469894597|FG001|Down-Titration Period|Reason Not Specified|0|||
130526544|NCT02165826|469894598|FG002|Down-Titration Period|Reason Not Specified|2|||
130526545|NCT01246999|469896238|FG000|Overall Study|Lost to Follow-up|0|||
130526546|NCT01246999|469896239|FG001|Overall Study|Lost to Follow-up|1|||
130526547|NCT01246999|469896240|FG002|Overall Study|Lost to Follow-up|0|||
130526548|NCT01246999|469896241|FG003|Overall Study|Lost to Follow-up|0|||
130526549|NCT01246999|469896238|FG000|Overall Study|Withdrawal by Subject|0|||
130526550|NCT01246999|469896239|FG001|Overall Study|Withdrawal by Subject|0|||
130526551|NCT01246999|469896240|FG002|Overall Study|Withdrawal by Subject|0|||
130526552|NCT01246999|469896241|FG003|Overall Study|Withdrawal by Subject|2|||
130526553|NCT01439867|469896246|FG000|Overall Study|Non-compliance|0|||
130526554|NCT01439867|469896247|FG001|Overall Study|Non-compliance|1|||
130526555|NCT01439867|469896246|FG000|Overall Study|Withdrawal by Subject|1|||
130526556|NCT01439867|469896247|FG001|Overall Study|Withdrawal by Subject|2|||
130526557|NCT01439867|469896246|FG000|Overall Study|Administrative Decision|4|||
130526558|NCT01439867|469896247|FG001|Overall Study|Administrative Decision|5|||
130526559|NCT01439867|469896246|FG000|Overall Study|Protocol-specified Criteria|1|||
130526560|NCT01439867|469896247|FG001|Overall Study|Protocol-specified Criteria|0|||
130526561|NCT00863512|469896248|FG000|Overall Study|Adverse Event|2|||
130526562|NCT00863512|469896249|FG001|Overall Study|Adverse Event|0|||
130526563|NCT00863512|469896248|FG000|Overall Study|Withdrawal by Subject|11|||
130526564|NCT00863512|469896249|FG001|Overall Study|Withdrawal by Subject|0|||
130526565|NCT00863512|469896248|FG000|Overall Study|Physician Decision|1|||
130526566|NCT00863512|469896249|FG001|Overall Study|Physician Decision|0|||
130526567|NCT02037477|469896250|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
130526568|NCT02037477|469896251|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
130526569|NCT02037477|469896252|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
130577687|NCT01789970|470080380|FG001|Open-label Titration Period|Protocol Violation|0|||
130577688|NCT01789970|470080381|FG002|Open-label Titration Period|Protocol Violation|0|||
130577689|NCT01789970|470080379|FG000|Open-label Titration Period|Lost to Follow-up|5|||
130577690|NCT01789970|470080380|FG001|Open-label Titration Period|Lost to Follow-up|0|||
130577691|NCT01789970|470080381|FG002|Open-label Titration Period|Lost to Follow-up|0|||
130577692|NCT01789970|470080379|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
130577693|NCT01789970|470080380|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
130577694|NCT01789970|470080381|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
130577695|NCT01789970|470080379|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
130577696|NCT01789970|470080380|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
130577697|NCT01789970|470080381|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
130577698|NCT01789970|470080379|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
130577699|NCT01789970|470080380|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
130577700|NCT01789970|470080381|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
130577701|NCT01789970|470080379|FG000|Open-label Titration Period|Pregnancy|2|||
130577702|NCT01789970|470080380|FG001|Open-label Titration Period|Pregnancy|0|||
130577703|NCT01789970|470080381|FG002|Open-label Titration Period|Pregnancy|0|||
130577704|NCT01789970|470080379|FG000|Open-label Titration Period|Other|76|||
130577705|NCT01789970|470080380|FG001|Open-label Titration Period|Other|0|||
130577706|NCT01789970|470080381|FG002|Open-label Titration Period|Other|0|||
130577707|NCT01789970|470080379|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
130577708|NCT01789970|470080380|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
130577709|NCT01789970|470080381|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
130577710|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
130577711|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
130577712|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
130577713|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130577714|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
130577715|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
130577716|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130577717|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130577718|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
130577719|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130577720|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
130577721|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
130577722|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
130577723|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
130577724|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
130577725|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
130577726|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
130577727|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
130577728|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130577729|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130577730|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
130577731|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
130577732|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
130577733|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
130577734|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
130577735|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130577736|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
130577737|NCT01789970|470080379|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
130577738|NCT01789970|470080380|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
130526570|NCT02037477|469896253|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
130526571|NCT02635360|469896254|FG000|Overall Study|Adverse Event|0|||
130526572|NCT02635360|469896255|FG001|Overall Study|Adverse Event|3|||
130526573|NCT02635360|469896254|FG000|Overall Study|Withdrawal by Subject|2|||
130526574|NCT02635360|469896255|FG001|Overall Study|Withdrawal by Subject|0|||
130526575|NCT02635360|469896254|FG000|Overall Study|Non-Compliance|3|||
130526576|NCT02635360|469896255|FG001|Overall Study|Non-Compliance|1|||
130526577|NCT02635360|469896254|FG000|Overall Study|Disease Progression|0|||
130526578|NCT02635360|469896255|FG001|Overall Study|Disease Progression|2|||
130526579|NCT02635360|469896254|FG000|Overall Study|Lost to Follow-up|1|||
130526580|NCT02635360|469896255|FG001|Overall Study|Lost to Follow-up|1|||
130577739|NCT01789970|470080381|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
130526581|NCT04978350|469896256|FG000|Overall Study|Lost to Follow-up|6|||
130526582|NCT00983749|469896259|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
130526583|NCT00983749|469896260|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
130526584|NCT01952847|469896261|FG000|Overall Study|Ineligible|1|||
130526585|NCT01952847|469896262|FG001|Overall Study|Ineligible|0|||
130526586|NCT01952847|469896263|FG002|Overall Study|Ineligible|0|||
130526587|NCT01952847|469896264|FG003|Overall Study|Ineligible|0|||
130526588|NCT01952847|469896261|FG000|Overall Study|Lack of Insurance Coverage|0|||
130526589|NCT01952847|469896262|FG001|Overall Study|Lack of Insurance Coverage|1|||
130526590|NCT01952847|469896263|FG002|Overall Study|Lack of Insurance Coverage|0|||
130526591|NCT01952847|469896264|FG003|Overall Study|Lack of Insurance Coverage|0|||
130526592|NCT01952847|469896261|FG000|Overall Study|Withdrawal by Subject|1|||
130526593|NCT01952847|469896262|FG001|Overall Study|Withdrawal by Subject|1|||
130526594|NCT01952847|469896263|FG002|Overall Study|Withdrawal by Subject|0|||
130526595|NCT01952847|469896264|FG003|Overall Study|Withdrawal by Subject|1|||
130526596|NCT02577003|469896267|FG000|Overall Study|Adverse Event|2|||
130526597|NCT02577003|469896268|FG001|Overall Study|Adverse Event|4|||
130526598|NCT02577003|469896267|FG000|Overall Study|Withdrawal by Subject|0|||
130526599|NCT02577003|469896268|FG001|Overall Study|Withdrawal by Subject|1|||
130526600|NCT03334253|469896270|FG000|Overall Study|Withdrawal by Subject|1|||
130526601|NCT03334253|469896271|FG001|Overall Study|Withdrawal by Subject|0|||
130526602|NCT03334253|469896270|FG000|Overall Study|Lost to Follow-up|4|||
130526603|NCT03334253|469896271|FG001|Overall Study|Lost to Follow-up|3|||
130526604|NCT03334253|469896270|FG000|Overall Study|Moved residence|2|||
130526605|NCT03334253|469896271|FG001|Overall Study|Moved residence|2|||
130526606|NCT00203047|469896272|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
130526607|NCT00203047|469896273|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
130526608|NCT00203047|469896272|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
130526609|NCT00203047|469896273|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
130526610|NCT00203047|469896272|FG000|Overall Study|Withdrawal by Subject|13|||
130526611|NCT00203047|469896273|FG001|Overall Study|Withdrawal by Subject|47|||
130526612|NCT00203047|469896272|FG000|Overall Study|Teva requested participant withdrawal|1|||
130526613|NCT00203047|469896273|FG001|Overall Study|Teva requested participant withdrawal|1|||
130526614|NCT00203047|469896272|FG000|Overall Study|Physician Decision|8|||
130526615|NCT00203047|469896273|FG001|Overall Study|Physician Decision|7|||
130526616|NCT00203047|469896272|FG000|Overall Study|Non-compliance|4|||
130526617|NCT00203047|469896273|FG001|Overall Study|Non-compliance|8|||
130526618|NCT00203047|469896272|FG000|Overall Study|Protocol Violation|1|||
130526619|NCT00203047|469896273|FG001|Overall Study|Protocol Violation|0|||
130526620|NCT00203047|469896272|FG000|Overall Study|Lost to Follow-up|11|||
130526621|NCT00203047|469896273|FG001|Overall Study|Lost to Follow-up|5|||
130526622|NCT00203047|469896272|FG000|Overall Study|Adverse Event|8|||
130526623|NCT00203047|469896273|FG001|Overall Study|Adverse Event|18|||
130526624|NCT00203047|469896272|FG000|Overall Study|Death|1|||
130526625|NCT00203047|469896273|FG001|Overall Study|Death|2|||
130526626|NCT00203047|469896272|FG000|Overall Study|Pregnancy|3|||
130526627|NCT00203047|469896273|FG001|Overall Study|Pregnancy|0|||
130526628|NCT00203047|469896272|FG000|Overall Study|Other|5|||
130526629|NCT00203047|469896273|FG001|Overall Study|Other|5|||
130526630|NCT00340704|469896276|FG000|PK Study|Adverse Event|0|||
130526631|NCT00340704|469896277|FG001|PK Study|Adverse Event|1|||
130526632|NCT00340704|469896278|FG002|PK Study|Adverse Event|0|||
130526633|NCT00340704|469896279|FG003|PK Study|Adverse Event|0|||
130526634|NCT00340704|469896280|FG004|PK Study|Adverse Event|0|||
130526635|NCT00340704|469896281|FG005|PK Study|Adverse Event|0|||
130526636|NCT00340704|469896282|FG006|PK Study|Adverse Event|0|||
130526637|NCT00340704|469896283|FG007|PK Study|Adverse Event|0|||
130526638|NCT00340704|469896284|FG008|PK Study|Adverse Event|0|||
130526639|NCT00340704|469896276|FG000|PK Study|Not treated|0|||
130526640|NCT00340704|469896277|FG001|PK Study|Not treated|0|||
130526641|NCT00340704|469896278|FG002|PK Study|Not treated|1|||
130526642|NCT00340704|469896279|FG003|PK Study|Not treated|0|||
130526643|NCT00340704|469896280|FG004|PK Study|Not treated|0|||
130526644|NCT00340704|469896281|FG005|PK Study|Not treated|0|||
130526645|NCT00340704|469896282|FG006|PK Study|Not treated|0|||
130526646|NCT00340704|469896283|FG007|PK Study|Not treated|0|||
130526647|NCT00340704|469896284|FG008|PK Study|Not treated|0|||
130526648|NCT00340704|469896276|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
130526649|NCT00340704|469896277|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
130526650|NCT00340704|469896278|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
130526651|NCT00340704|469896279|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
130526652|NCT00340704|469896280|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
130526653|NCT00340704|469896281|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
130526654|NCT00340704|469896282|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
130526655|NCT00340704|469896283|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
130526656|NCT00340704|469896284|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
130526657|NCT00340704|469896276|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130577740|NCT01121393|470080382|FG000|Overall Study|Progressive disease|201|||
130577741|NCT01121393|470080383|FG001|Overall Study|Progressive disease|20|||
130577742|NCT01121393|470080382|FG000|Overall Study|Other Adverse events|24|||
130577743|NCT01121393|470080383|FG001|Overall Study|Other Adverse events|45|||
130577744|NCT01121393|470080382|FG000|Overall Study|Non-compliant with protocol|0|||
130577745|NCT01121393|470080383|FG001|Overall Study|Non-compliant with protocol|3|||
130577746|NCT01121393|470080382|FG000|Overall Study|Lost to Follow-up|1|||
130577747|NCT01121393|470080383|FG001|Overall Study|Lost to Follow-up|0|||
130577748|NCT01121393|470080382|FG000|Overall Study|Refused cont. medication|7|||
130577749|NCT01121393|470080383|FG001|Overall Study|Refused cont. medication|7|||
130577750|NCT01121393|470080382|FG000|Overall Study|Not treated|3|||
130577751|NCT01121393|470080383|FG001|Overall Study|Not treated|9|||
130577752|NCT01121393|470080382|FG000|Overall Study|Other than listed|6|||
130577753|NCT01121393|470080383|FG001|Overall Study|Other than listed|0|||
130577754|NCT02296242|470080388|FG000|Overall Study|Death|1|||
130577755|NCT02296242|470080389|FG001|Overall Study|Death|1|||
130577756|NCT02296242|470080390|FG002|Overall Study|Death|1|||
130577757|NCT02296242|470080391|FG003|Overall Study|Death|1|||
130577758|NCT02296242|470080392|FG004|Overall Study|Death|1|||
130577759|NCT02296242|470080388|FG000|Overall Study|Withdrawal by Subject|0|||
130577760|NCT02296242|470080389|FG001|Overall Study|Withdrawal by Subject|0|||
130577761|NCT02296242|470080390|FG002|Overall Study|Withdrawal by Subject|1|||
130577762|NCT02296242|470080391|FG003|Overall Study|Withdrawal by Subject|1|||
130526658|NCT00340704|469896277|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526659|NCT00340704|469896278|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526660|NCT00340704|469896279|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526661|NCT00340704|469896280|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526662|NCT00340704|469896281|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
130526663|NCT00340704|469896282|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526664|NCT00340704|469896283|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526665|NCT00340704|469896284|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
130526666|NCT00340704|469896276|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526667|NCT00340704|469896277|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526668|NCT00340704|469896278|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526669|NCT00340704|469896279|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526670|NCT00340704|469896280|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
130526671|NCT00340704|469896281|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
130526672|NCT00340704|469896282|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526673|NCT00340704|469896283|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526674|NCT00340704|469896284|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
130526675|NCT00340704|469896276|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
130526676|NCT00340704|469896277|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
130526677|NCT00340704|469896278|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
130526678|NCT00340704|469896279|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
130526679|NCT00340704|469896280|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
130526680|NCT00340704|469896281|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
130526681|NCT00340704|469896282|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
130526682|NCT00340704|469896283|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
130526683|NCT00340704|469896284|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
130526684|NCT00121667|469896285|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
130526685|NCT00121667|469896286|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
130526686|NCT00121667|469896287|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
130526687|NCT00121667|469896288|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
130526688|NCT00121667|469896285|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
130526689|NCT00121667|469896286|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
130526690|NCT00121667|469896287|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
130526691|NCT00121667|469896288|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
130526692|NCT00121667|469896285|FG000|Short Term (ST) Period|Adverse Event|5|||
130526693|NCT00121667|469896286|FG001|Short Term (ST) Period|Adverse Event|6|||
130526694|NCT00121667|469896287|FG002|Short Term (ST) Period|Adverse Event|5|||
130526695|NCT00121667|469896288|FG003|Short Term (ST) Period|Adverse Event|3|||
130577763|NCT02296242|470080392|FG004|Overall Study|Withdrawal by Subject|3|||
130526696|NCT00121667|469896285|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
130577764|NCT02296242|470080388|FG000|Overall Study|Disease Progression|1|||
130577765|NCT02296242|470080389|FG001|Overall Study|Disease Progression|3|||
130577766|NCT02296242|470080390|FG002|Overall Study|Disease Progression|2|||
130577767|NCT02296242|470080391|FG003|Overall Study|Disease Progression|8|||
130577768|NCT02296242|470080392|FG004|Overall Study|Disease Progression|11|||
130577769|NCT02296242|470080388|FG000|Overall Study|Unacceptable Toxicity|0|||
130526697|NCT00121667|469896286|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
130526698|NCT00121667|469896287|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
130526699|NCT00121667|469896288|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
130526700|NCT00121667|469896285|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
130526701|NCT00121667|469896286|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
130526702|NCT00121667|469896287|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
130526703|NCT00121667|469896288|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
130526704|NCT00121667|469896285|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
130526705|NCT00121667|469896286|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
130526706|NCT00121667|469896287|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
130526707|NCT00121667|469896288|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
130526708|NCT00121667|469896285|FG000|Short Term (ST) Period|Other Reason|3|||
130526709|NCT00121667|469896286|FG001|Short Term (ST) Period|Other Reason|0|||
130526710|NCT00121667|469896287|FG002|Short Term (ST) Period|Other Reason|0|||
130526711|NCT00121667|469896288|FG003|Short Term (ST) Period|Other Reason|0|||
130526712|NCT00121667|469896285|FG000|Short Term (ST) Period|Death|0|||
130526713|NCT00121667|469896286|FG001|Short Term (ST) Period|Death|0|||
130526714|NCT00121667|469896287|FG002|Short Term (ST) Period|Death|0|||
130526715|NCT00121667|469896288|FG003|Short Term (ST) Period|Death|1|||
130526716|NCT00121667|469896285|FG000|Short Term (ST) Period|Pregnancy|0|||
130526717|NCT00121667|469896286|FG001|Short Term (ST) Period|Pregnancy|0|||
130526718|NCT00121667|469896287|FG002|Short Term (ST) Period|Pregnancy|0|||
130526719|NCT00121667|469896288|FG003|Short Term (ST) Period|Pregnancy|1|||
130526720|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
130526721|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
130526722|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
130526723|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
130526724|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
130526725|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
130526726|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
130526727|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
130526728|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
130526729|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
130526730|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
130526731|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
130526732|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
130526733|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
130526734|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
130526735|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
130526736|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
130526737|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
130526738|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
130526739|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
130526740|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
130526741|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
130526742|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
130526743|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
130526744|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
130526745|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
130526746|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
130526747|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
130526748|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
130526749|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
130526750|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
130526751|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
130526752|NCT00121667|469896285|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
130526753|NCT00121667|469896286|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
130526754|NCT00121667|469896287|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
130526755|NCT00121667|469896288|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
130526756|NCT01453023|469896289|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
130526757|NCT01453023|469896290|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
130526758|NCT01453023|469896289|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
130526759|NCT01453023|469896290|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
130526760|NCT01453023|469896289|FG000|Treatment Period 2|Protocol Violation|0|||
130577770|NCT02296242|470080389|FG001|Overall Study|Unacceptable Toxicity|0|||
130526761|NCT01453023|469896290|FG001|Treatment Period 2|Protocol Violation|1|||
130526762|NCT03016598|469896301|FG000|Overall Study|Lost to Follow-up|0|||
130526763|NCT03016598|469896302|FG001|Overall Study|Lost to Follow-up|2|||
130526764|NCT03513068|469896303|FG000|Overall Study|Death|1|||
130526765|NCT03513068|469896304|FG001|Overall Study|Death|0|||
130526766|NCT03513068|469896303|FG000|Overall Study|Withdrawal by Subject|4|||
130526767|NCT03513068|469896304|FG001|Overall Study|Withdrawal by Subject|6|||
130526768|NCT04547023|469896305|FG000|Overall Study|Did Not Receive Intervention|3|||
130526769|NCT04547023|469896306|FG001|Overall Study|Did Not Receive Intervention|2|||
130526770|NCT04547023|469896305|FG000|Overall Study|Lost to Follow-up|1|||
130526771|NCT04547023|469896306|FG001|Overall Study|Lost to Follow-up|1|||
130526772|NCT01262092|469896307|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
130526773|NCT01262092|469896308|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
130526774|NCT01262092|469896307|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
130526775|NCT01262092|469896308|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
130526776|NCT01262092|469896307|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
130526777|NCT01262092|469896308|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
130526778|NCT01262092|469896307|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
130526779|NCT01262092|469896308|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
130526780|NCT03784820|469896309|FG000|Overall Study|Lost to Follow-up|5|||
130526781|NCT03784820|469896310|FG001|Overall Study|Lost to Follow-up|5|||
130526782|NCT03784820|469896311|FG002|Overall Study|Lost to Follow-up|3|||
130526783|NCT03784820|469896312|FG003|Overall Study|Lost to Follow-up|3|||
130526784|NCT04147858|469896313|FG000|Overall Study|Adverse Event|6|||
130526785|NCT04147858|469896314|FG001|Overall Study|Adverse Event|6|||
130526786|NCT04147858|469896315|FG002|Overall Study|Adverse Event|6|||
130526787|NCT04147858|469896313|FG000|Overall Study|Lack of Efficacy|3|||
130526788|NCT04147858|469896314|FG001|Overall Study|Lack of Efficacy|3|||
130526789|NCT04147858|469896315|FG002|Overall Study|Lack of Efficacy|1|||
130526790|NCT04147858|469896313|FG000|Overall Study|Lost to Follow-up|1|||
130526791|NCT04147858|469896314|FG001|Overall Study|Lost to Follow-up|6|||
130526792|NCT04147858|469896315|FG002|Overall Study|Lost to Follow-up|2|||
130526793|NCT04147858|469896313|FG000|Overall Study|Withdrawal by Subject|3|||
130526794|NCT04147858|469896314|FG001|Overall Study|Withdrawal by Subject|4|||
130526795|NCT04147858|469896315|FG002|Overall Study|Withdrawal by Subject|10|||
130526796|NCT04147858|469896313|FG000|Overall Study|Subject Noncompliance, Other|4|||
130526797|NCT04147858|469896314|FG001|Overall Study|Subject Noncompliance, Other|3|||
130526798|NCT04147858|469896315|FG002|Overall Study|Subject Noncompliance, Other|1|||
130526799|NCT00658606|469896318|FG000|Overall Study|Adverse Event|2|||
130526800|NCT00658606|469896319|FG001|Overall Study|Adverse Event|1|||
130526801|NCT00658606|469896318|FG000|Overall Study|Lack of Efficacy|6|||
130526802|NCT00658606|469896319|FG001|Overall Study|Lack of Efficacy|3|||
130526803|NCT00658606|469896318|FG000|Overall Study|Lost to Follow-up|1|||
130526804|NCT00658606|469896319|FG001|Overall Study|Lost to Follow-up|0|||
130526805|NCT00658606|469896318|FG000|Overall Study|Withdrawal by Subject|7|||
130526806|NCT00658606|469896319|FG001|Overall Study|Withdrawal by Subject|16|||
130526807|NCT00658606|469896318|FG000|Overall Study|Lack of Compliance|0|||
130526808|NCT00658606|469896319|FG001|Overall Study|Lack of Compliance|3|||
130526809|NCT00365547|469896324|FG000|Overall Study|Insurance did not cover Avastin|1|||
130526810|NCT00365547|469896324|FG000|Overall Study|Screen failure|1|||
130526811|NCT00365547|469896324|FG000|Overall Study|Withdrawal by Subject|1|||
130526812|NCT03170518|469896325|FG000|Overall Study|Lost to Follow-up|4|||
130526813|NCT03170518|469896326|FG001|Overall Study|Lost to Follow-up|1|||
130526814|NCT03170518|469896327|FG002|Overall Study|Lost to Follow-up|0|||
130526815|NCT03170518|469896325|FG000|Overall Study|Physician Decision|1|||
130526816|NCT03170518|469896326|FG001|Overall Study|Physician Decision|0|||
130526817|NCT03170518|469896327|FG002|Overall Study|Physician Decision|0|||
130526818|NCT03170518|469896325|FG000|Overall Study|Withdrawal by Subject|4|||
130526819|NCT03170518|469896326|FG001|Overall Study|Withdrawal by Subject|5|||
130577771|NCT02296242|470080390|FG002|Overall Study|Unacceptable Toxicity|0|||
130526820|NCT03170518|469896327|FG002|Overall Study|Withdrawal by Subject|2|||
130526821|NCT03170518|469896325|FG000|Overall Study|Site terminated by sponsor|0|||
130526822|NCT03170518|469896326|FG001|Overall Study|Site terminated by sponsor|1|||
130526823|NCT03170518|469896327|FG002|Overall Study|Site terminated by sponsor|0|||
130526824|NCT03170518|469896325|FG000|Overall Study|Non-compliance with study drug|1|||
130526825|NCT03170518|469896326|FG001|Overall Study|Non-compliance with study drug|0|||
130526826|NCT03170518|469896327|FG002|Overall Study|Non-compliance with study drug|1|||
130526827|NCT03170518|469896325|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130526828|NCT03170518|469896326|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130526829|NCT03170518|469896327|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130577772|NCT02296242|470080391|FG003|Overall Study|Unacceptable Toxicity|0|||
130526830|NCT04428476|469896328|FG000|Overall Study|Withdrawal by Subject|1|||
130577773|NCT02296242|470080392|FG004|Overall Study|Unacceptable Toxicity|1|||
130526831|NCT04428476|469896328|FG000|Overall Study|Still on treatment|12|||
130526832|NCT00546078|469896329|FG000|Overall Study|Lost to Follow-up|1|||
130526833|NCT00546078|469896330|FG001|Overall Study|Lost to Follow-up|3|||
130577774|NCT02296242|470080388|FG000|Overall Study|Patient Condition Changed|0|||
130577775|NCT02296242|470080389|FG001|Overall Study|Patient Condition Changed|0|||
130577776|NCT02296242|470080390|FG002|Overall Study|Patient Condition Changed|2|||
130577777|NCT02296242|470080391|FG003|Overall Study|Patient Condition Changed|0|||
130577778|NCT02296242|470080392|FG004|Overall Study|Patient Condition Changed|1|||
130577779|NCT02296242|470080388|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
130577780|NCT02296242|470080389|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
130577781|NCT02296242|470080390|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
130577782|NCT02296242|470080391|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
130577783|NCT02296242|470080392|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
130577784|NCT02296242|470080388|FG000|Overall Study|Lost to Follow-up|1|||
130577785|NCT02296242|470080389|FG001|Overall Study|Lost to Follow-up|0|||
130577786|NCT02296242|470080390|FG002|Overall Study|Lost to Follow-up|0|||
130577787|NCT02296242|470080391|FG003|Overall Study|Lost to Follow-up|0|||
130577788|NCT02296242|470080392|FG004|Overall Study|Lost to Follow-up|0|||
130577789|NCT02296242|470080388|FG000|Overall Study|Need for Hydroxyurea|2|||
130577790|NCT02296242|470080389|FG001|Overall Study|Need for Hydroxyurea|0|||
130577791|NCT02296242|470080390|FG002|Overall Study|Need for Hydroxyurea|0|||
130577792|NCT02296242|470080391|FG003|Overall Study|Need for Hydroxyurea|0|||
130577793|NCT02296242|470080392|FG004|Overall Study|Need for Hydroxyurea|0|||
130577794|NCT02296242|470080388|FG000|Overall Study|Screened for Other Protocol|0|||
130577795|NCT02296242|470080389|FG001|Overall Study|Screened for Other Protocol|1|||
130577796|NCT02296242|470080390|FG002|Overall Study|Screened for Other Protocol|0|||
130577797|NCT02296242|470080391|FG003|Overall Study|Screened for Other Protocol|0|||
130577798|NCT02296242|470080392|FG004|Overall Study|Screened for Other Protocol|0|||
130577799|NCT02296242|470080388|FG000|Overall Study|Physician Decision|0|||
130577800|NCT02296242|470080389|FG001|Overall Study|Physician Decision|1|||
130577801|NCT02296242|470080390|FG002|Overall Study|Physician Decision|0|||
130577802|NCT02296242|470080391|FG003|Overall Study|Physician Decision|1|||
130577803|NCT02296242|470080392|FG004|Overall Study|Physician Decision|0|||
130577804|NCT02296242|470080388|FG000|Overall Study|Alternative Treatment|0|||
130577805|NCT02296242|470080389|FG001|Overall Study|Alternative Treatment|0|||
130577806|NCT02296242|470080390|FG002|Overall Study|Alternative Treatment|0|||
130577807|NCT02296242|470080391|FG003|Overall Study|Alternative Treatment|1|||
130577808|NCT02296242|470080392|FG004|Overall Study|Alternative Treatment|0|||
130577809|NCT02296242|470080388|FG000|Overall Study|Adverse Event|0|||
130577810|NCT02296242|470080389|FG001|Overall Study|Adverse Event|0|||
130577811|NCT02296242|470080390|FG002|Overall Study|Adverse Event|0|||
130577812|NCT02296242|470080391|FG003|Overall Study|Adverse Event|1|||
130577813|NCT02296242|470080392|FG004|Overall Study|Adverse Event|0|||
130577814|NCT02296242|470080388|FG000|Overall Study|Lack of Efficacy|0|||
130577815|NCT02296242|470080389|FG001|Overall Study|Lack of Efficacy|0|||
130577816|NCT02296242|470080390|FG002|Overall Study|Lack of Efficacy|0|||
130577817|NCT02296242|470080391|FG003|Overall Study|Lack of Efficacy|0|||
130577818|NCT02296242|470080392|FG004|Overall Study|Lack of Efficacy|3|||
130577819|NCT01639833|470080393|FG000|Overall Study|Death|4|||
130577820|NCT01639833|470080394|FG001|Overall Study|Death|2|||
130577821|NCT01639833|470080393|FG000|Overall Study|Withdrawal by Subject|2|||
130577822|NCT01639833|470080394|FG001|Overall Study|Withdrawal by Subject|2|||
130577823|NCT03033745|470080398|FG000|Overall Study|Protocol Violation|0|||
130577824|NCT03033745|470080399|FG001|Overall Study|Protocol Violation|0|||
130577825|NCT03033745|470080400|FG002|Overall Study|Protocol Violation|1|||
130577826|NCT03033745|470080398|FG000|Overall Study|Adverse Event|1|||
130577827|NCT03033745|470080399|FG001|Overall Study|Adverse Event|0|||
130577828|NCT03033745|470080400|FG002|Overall Study|Adverse Event|1|||
130577829|NCT03033745|470080398|FG000|Overall Study|Withdrawal by Subject|0|||
130577830|NCT03033745|470080399|FG001|Overall Study|Withdrawal by Subject|1|||
130577831|NCT03033745|470080400|FG002|Overall Study|Withdrawal by Subject|0|||
130577832|NCT00608985|470080401|FG000|Overall Study|Adverse Event|2|||
130577833|NCT00608985|470080402|FG001|Overall Study|Adverse Event|7|||
130577834|NCT00608985|470080403|FG002|Overall Study|Adverse Event|4|||
130577835|NCT00608985|470080404|FG003|Overall Study|Adverse Event|6|||
130577836|NCT00608985|470080401|FG000|Overall Study|Administrative/Other|7|||
130577837|NCT00608985|470080402|FG001|Overall Study|Administrative/Other|4|||
130577838|NCT00608985|470080403|FG002|Overall Study|Administrative/Other|1|||
130577839|NCT00608985|470080404|FG003|Overall Study|Administrative/Other|2|||
130577840|NCT00608985|470080401|FG000|Overall Study|Withdrawal of Consent|5|||
130577841|NCT00608985|470080402|FG001|Overall Study|Withdrawal of Consent|1|||
130577842|NCT00608985|470080403|FG002|Overall Study|Withdrawal of Consent|1|||
130577843|NCT00608985|470080404|FG003|Overall Study|Withdrawal of Consent|1|||
130577844|NCT00608985|470080401|FG000|Overall Study|Lost to Follow-up|2|||
130577845|NCT00608985|470080402|FG001|Overall Study|Lost to Follow-up|1|||
130577846|NCT00608985|470080403|FG002|Overall Study|Lost to Follow-up|0|||
130577847|NCT00608985|470080404|FG003|Overall Study|Lost to Follow-up|0|||
130577848|NCT02574637|470080405|FG000|Double-blind Period|Adverse Event|1|||
130577849|NCT02574637|470080406|FG001|Double-blind Period|Adverse Event|0|||
130577850|NCT02574637|470080407|FG002|Double-blind Period|Adverse Event|0|||
130577851|NCT02574637|470080408|FG003|Double-blind Period|Adverse Event|0|||
130577852|NCT02574637|470080409|FG004|Double-blind Period|Adverse Event|0|||
130577853|NCT02574637|470080410|FG005|Double-blind Period|Adverse Event|0|||
130577854|NCT02574637|470080411|FG006|Double-blind Period|Adverse Event|0|||
130577855|NCT02574637|470080412|FG007|Double-blind Period|Adverse Event|0|||
130577856|NCT02574637|470080413|FG008|Double-blind Period|Adverse Event|0|||
130577857|NCT02574637|470080414|FG009|Double-blind Period|Adverse Event|0|||
130577858|NCT02574637|470080405|FG000|Double-blind Period|Lack of Efficacy|0|||
130577859|NCT02574637|470080406|FG001|Double-blind Period|Lack of Efficacy|0|||
130577860|NCT02574637|470080407|FG002|Double-blind Period|Lack of Efficacy|2|||
130577861|NCT02574637|470080408|FG003|Double-blind Period|Lack of Efficacy|0|||
130577862|NCT02574637|470080409|FG004|Double-blind Period|Lack of Efficacy|0|||
130577863|NCT02574637|470080410|FG005|Double-blind Period|Lack of Efficacy|0|||
130577864|NCT02574637|470080411|FG006|Double-blind Period|Lack of Efficacy|0|||
130577865|NCT02574637|470080412|FG007|Double-blind Period|Lack of Efficacy|0|||
130577866|NCT02574637|470080413|FG008|Double-blind Period|Lack of Efficacy|0|||
130577867|NCT02574637|470080414|FG009|Double-blind Period|Lack of Efficacy|0|||
130577868|NCT02574637|470080405|FG000|Double-blind Period|Protocol Deviation|1|||
130577869|NCT02574637|470080406|FG001|Double-blind Period|Protocol Deviation|0|||
130577870|NCT02574637|470080407|FG002|Double-blind Period|Protocol Deviation|0|||
130577871|NCT02574637|470080408|FG003|Double-blind Period|Protocol Deviation|0|||
130577872|NCT02574637|470080409|FG004|Double-blind Period|Protocol Deviation|0|||
130577873|NCT02574637|470080410|FG005|Double-blind Period|Protocol Deviation|0|||
130577874|NCT02574637|470080411|FG006|Double-blind Period|Protocol Deviation|0|||
130577875|NCT02574637|470080412|FG007|Double-blind Period|Protocol Deviation|0|||
130577876|NCT02574637|470080413|FG008|Double-blind Period|Protocol Deviation|0|||
130577877|NCT02574637|470080414|FG009|Double-blind Period|Protocol Deviation|0|||
130577878|NCT02574637|470080405|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
130577879|NCT02574637|470080406|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
130577880|NCT02574637|470080407|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
130577881|NCT02574637|470080408|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
130577882|NCT02574637|470080409|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
130577883|NCT02574637|470080410|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
130577884|NCT02574637|470080411|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
130577885|NCT02574637|470080412|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
130577886|NCT02574637|470080413|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
130577887|NCT02574637|470080414|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
130577888|NCT02574637|470080405|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
130577889|NCT02574637|470080406|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
130577890|NCT02574637|470080407|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
130577891|NCT02574637|470080408|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
130577892|NCT02574637|470080409|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
130577893|NCT02574637|470080410|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
130577894|NCT02574637|470080411|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
130577895|NCT02574637|470080412|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
130577896|NCT02574637|470080413|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
130577897|NCT02574637|470080414|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
130577898|NCT02574637|470080405|FG000|Double-blind Period|Reason Not Specified|0|||
130577899|NCT02574637|470080406|FG001|Double-blind Period|Reason Not Specified|0|||
130577900|NCT02574637|470080407|FG002|Double-blind Period|Reason Not Specified|0|||
130577901|NCT02574637|470080408|FG003|Double-blind Period|Reason Not Specified|1|||
130577902|NCT02574637|470080409|FG004|Double-blind Period|Reason Not Specified|0|||
130577903|NCT02574637|470080410|FG005|Double-blind Period|Reason Not Specified|0|||
130577904|NCT02574637|470080411|FG006|Double-blind Period|Reason Not Specified|0|||
130577905|NCT02574637|470080412|FG007|Double-blind Period|Reason Not Specified|0|||
130577906|NCT02574637|470080413|FG008|Double-blind Period|Reason Not Specified|0|||
130577907|NCT02574637|470080414|FG009|Double-blind Period|Reason Not Specified|0|||
130577908|NCT02574637|470080405|FG000|Open-label (OL) Period|Adverse Event|0|||
130577909|NCT02574637|470080406|FG001|Open-label (OL) Period|Adverse Event|0|||
130577910|NCT02574637|470080407|FG002|Open-label (OL) Period|Adverse Event|0|||
130577911|NCT02574637|470080408|FG003|Open-label (OL) Period|Adverse Event|0|||
130577912|NCT02574637|470080409|FG004|Open-label (OL) Period|Adverse Event|0|||
130577913|NCT02574637|470080410|FG005|Open-label (OL) Period|Adverse Event|0|||
130577914|NCT02574637|470080411|FG006|Open-label (OL) Period|Adverse Event|0|||
130577915|NCT02574637|470080412|FG007|Open-label (OL) Period|Adverse Event|0|||
130577916|NCT02574637|470080413|FG008|Open-label (OL) Period|Adverse Event|1|||
130577917|NCT02574637|470080414|FG009|Open-label (OL) Period|Adverse Event|0|||
130577918|NCT02574637|470080405|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
130577919|NCT02574637|470080406|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
130577920|NCT02574637|470080407|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
130577921|NCT02574637|470080408|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
130577922|NCT02574637|470080409|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
130577923|NCT02574637|470080410|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
130577924|NCT02574637|470080411|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
130526834|NCT00546078|469896329|FG000|Overall Study|Withdrawal by Subject|2|||
130526835|NCT00546078|469896330|FG001|Overall Study|Withdrawal by Subject|3|||
130526836|NCT00546078|469896329|FG000|Overall Study|Other reason|1|||
130526837|NCT00546078|469896330|FG001|Overall Study|Other reason|1|||
130526838|NCT03023423|469896333|FG000|Overall Study|Death|5|||
130526839|NCT03023423|469896334|FG001|Overall Study|Death|12|||
130526840|NCT03023423|469896335|FG002|Overall Study|Death|20|||
130526841|NCT03023423|469896333|FG000|Overall Study|Other|0|||
130526842|NCT03023423|469896334|FG001|Overall Study|Other|2|||
130526843|NCT03023423|469896335|FG002|Overall Study|Other|2|||
130526844|NCT03023423|469896333|FG000|Overall Study|Ongoing|2|||
130526845|NCT03023423|469896334|FG001|Overall Study|Ongoing|32|||
130526846|NCT03023423|469896335|FG002|Overall Study|Ongoing|24|||
130526847|NCT03512197|469896336|FG000|Overall Study|Guardian decision|1|||
130526848|NCT03512197|469896337|FG001|Overall Study|Guardian decision|1|||
130526849|NCT03512197|469896336|FG000|Overall Study|Lack of Efficacy|19|||
130526850|NCT03512197|469896337|FG001|Overall Study|Lack of Efficacy|11|||
130526851|NCT03512197|469896336|FG000|Overall Study|New Therapy for Study Indication|16|||
130526852|NCT03512197|469896337|FG001|Overall Study|New Therapy for Study Indication|16|||
130526853|NCT03512197|469896336|FG000|Overall Study|Physician Decision|60|||
130526854|NCT03512197|469896337|FG001|Overall Study|Physician Decision|60|||
130526855|NCT03512197|469896336|FG000|Overall Study|Protocol Violation|0|||
130526856|NCT03512197|469896337|FG001|Overall Study|Protocol Violation|2|||
130526857|NCT03512197|469896336|FG000|Overall Study|Terminated by Sponsored|46|||
130526858|NCT03512197|469896337|FG001|Overall Study|Terminated by Sponsored|50|||
130526859|NCT03512197|469896336|FG000|Overall Study|Subject Decision|15|||
130526860|NCT03512197|469896337|FG001|Overall Study|Subject Decision|12|||
130526861|NCT03512197|469896336|FG000|Overall Study|Withdrawal of informed consent|20|||
130526862|NCT03512197|469896337|FG001|Overall Study|Withdrawal of informed consent|14|||
130526863|NCT03512197|469896336|FG000|Overall Study|Adverse Event|30|||
130526864|NCT03512197|469896337|FG001|Overall Study|Adverse Event|34|||
130526865|NCT03512197|469896336|FG000|Overall Study|Death|14|||
130526866|NCT03512197|469896337|FG001|Overall Study|Death|9|||
130526867|NCT03512197|469896336|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
130526868|NCT03512197|469896337|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
130526869|NCT03512197|469896336|FG000|Overall Study|Missing|3|||
130526870|NCT03512197|469896337|FG001|Overall Study|Missing|13|||
130526871|NCT03842436|469896338|FG000|Overall Study|Lost to Follow-up|1|||
130526872|NCT00490698|469896339|FG000|Overall Study|Withdrawal by Subject|1|||
130526873|NCT00490698|469896339|FG000|Overall Study|Disease Progression|7|||
130526874|NCT00490698|469896339|FG000|Overall Study|Physician Decision|2|||
130526875|NCT03358238|469896345|FG000|Overall Study|Withdrawal by Subject|0|||
130526876|NCT03358238|469896346|FG001|Overall Study|Withdrawal by Subject|1|||
130526877|NCT01431950|469896347|FG000|Overall Study|Study Site Closed/Terminated|7|||
130526878|NCT01431950|469896348|FG001|Overall Study|Study Site Closed/Terminated|3|||
130526879|NCT01431950|469896347|FG000|Overall Study|Withdrawal by Subject|4|||
130526880|NCT01431950|469896348|FG001|Overall Study|Withdrawal by Subject|3|||
130526881|NCT01431950|469896347|FG000|Overall Study|Protocol Violation|2|||
130526882|NCT01431950|469896348|FG001|Overall Study|Protocol Violation|3|||
130526883|NCT01431950|469896347|FG000|Overall Study|Adverse Event|2|||
130526884|NCT01431950|469896348|FG001|Overall Study|Adverse Event|2|||
130526885|NCT01431950|469896347|FG000|Overall Study|Physician Decision|2|||
130526886|NCT01431950|469896348|FG001|Overall Study|Physician Decision|1|||
130526887|NCT01431950|469896347|FG000|Overall Study|Lack of Efficacy|2|||
130526888|NCT01431950|469896348|FG001|Overall Study|Lack of Efficacy|1|||
130526889|NCT01431950|469896347|FG000|Overall Study|Lost to Follow-up|0|||
130526890|NCT01431950|469896348|FG001|Overall Study|Lost to Follow-up|1|||
130526891|NCT01431950|469896347|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130526892|NCT01431950|469896348|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130526893|NCT00583947|469896349|FG000|Cross-over Period|Adverse Event|2|||
130526894|NCT00583947|469896350|FG001|Cross-over Period|Adverse Event|0|||
130526895|NCT00583947|469896349|FG000|Cross-over Period|Withdrawal by Subject|2|||
130526896|NCT00583947|469896350|FG001|Cross-over Period|Withdrawal by Subject|0|||
130526897|NCT00583947|469896349|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
130526898|NCT00583947|469896350|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
130526899|NCT00583947|469896349|FG000|Cross-over Period|Other|1|||
130526900|NCT00583947|469896350|FG001|Cross-over Period|Other|1|||
130526901|NCT01740154|469896352|FG000|Overall Study|Adverse Event|1|||
130526902|NCT05226130|469896353|FG000|Overall Study|Lost to Follow-up|0|||
130526903|NCT05226130|469896354|FG001|Overall Study|Lost to Follow-up|1|||
130526904|NCT05226130|469896353|FG000|Overall Study|Not treatment adherent|0|||
130526905|NCT05226130|469896354|FG001|Overall Study|Not treatment adherent|2|||
130526906|NCT03358472|469896355|FG000|Overall Study|Death|6|||
130526907|NCT03358472|469896356|FG001|Overall Study|Death|3|||
130526908|NCT03358472|469896357|FG002|Overall Study|Death|10|||
130526909|NCT03358472|469896355|FG000|Overall Study|Physician Decision|0|||
130526910|NCT03358472|469896356|FG001|Overall Study|Physician Decision|1|||
130526911|NCT03358472|469896357|FG002|Overall Study|Physician Decision|0|||
130526912|NCT03358472|469896355|FG000|Overall Study|Withdrawal by Subject|0|||
130526913|NCT03358472|469896356|FG001|Overall Study|Withdrawal by Subject|0|||
130526914|NCT03358472|469896357|FG002|Overall Study|Withdrawal by Subject|1|||
130526915|NCT03358472|469896355|FG000|Overall Study|On-going at clinical cut off date|9|||
130526916|NCT03358472|469896356|FG001|Overall Study|On-going at clinical cut off date|6|||
130526917|NCT03358472|469896357|FG002|Overall Study|On-going at clinical cut off date|5|||
130526918|NCT02520310|469896358|FG000|At 6 Months Clinical Follow-up|Death|1|||
130526919|NCT02520310|469896358|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
130526920|NCT02520310|469896358|FG000|AT 3 Year Clinical Follow-up|Death|2|||
130526921|NCT02520310|469896358|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
130526922|NCT02520310|469896358|FG000|AT 4 Year Clinical Follow-up|Death|1|||
130526923|NCT02520310|469896358|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
130526924|NCT01340014|469896359|FG000|Period 1, First 7 Days|Adverse Event|1|||
130526925|NCT01340014|469896360|FG001|Period 1, First 7 Days|Adverse Event|0|||
130526926|NCT01340014|469896359|FG000|Period 1, First 7 Days|Personal Reasons|1|||
130526927|NCT01340014|469896360|FG001|Period 1, First 7 Days|Personal Reasons|0|||
130526928|NCT01340014|469896359|FG000|Period 2, Second 7 Days|Adverse Event|0|||
130526929|NCT01340014|469896360|FG001|Period 2, Second 7 Days|Adverse Event|1|||
130526930|NCT04535544|469896361|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
130526931|NCT04535544|469896362|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
130526932|NCT04535544|469896363|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
130526933|NCT04535544|469896364|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
130526934|NCT04535544|469896361|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
130526935|NCT04535544|469896362|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
130526936|NCT04535544|469896363|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
130526937|NCT04535544|469896364|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
130526938|NCT04535544|469896361|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
130526939|NCT04535544|469896362|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
130526940|NCT04535544|469896363|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
130526941|NCT04535544|469896364|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
130526942|NCT04535544|469896361|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
130526943|NCT04535544|469896362|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
130526944|NCT04535544|469896363|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
130526945|NCT04535544|469896364|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
130526946|NCT04535544|469896361|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
130526947|NCT04535544|469896362|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
130526948|NCT04535544|469896363|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
130526949|NCT04535544|469896364|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
130526950|NCT04535544|469896361|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
130526951|NCT04535544|469896362|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
130526952|NCT04535544|469896363|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
130526953|NCT04535544|469896364|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
130526954|NCT04535544|469896361|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
130526955|NCT04535544|469896362|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
130526956|NCT04535544|469896363|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
130526957|NCT04535544|469896364|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
130526958|NCT04535544|469896361|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
130526959|NCT04535544|469896362|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
130526960|NCT04535544|469896363|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
130526961|NCT04535544|469896364|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
130526962|NCT02194829|469896371|FG000|Overall Study|Adverse Event|2|||
130526963|NCT02194829|469896372|FG001|Overall Study|Adverse Event|2|||
130526964|NCT02194829|469896371|FG000|Overall Study|Death|0|||
130526965|NCT02194829|469896372|FG001|Overall Study|Death|1|||
130526966|NCT02194829|469896371|FG000|Overall Study|Disease progression|0|||
130526967|NCT02194829|469896372|FG001|Overall Study|Disease progression|1|||
130526968|NCT02194829|469896371|FG000|Overall Study|Withdrawal by Subject|0|||
130526969|NCT02194829|469896372|FG001|Overall Study|Withdrawal by Subject|1|||
130526970|NCT02194829|469896371|FG000|Overall Study|Never started protocol therapy|0|||
130526971|NCT02194829|469896372|FG001|Overall Study|Never started protocol therapy|1|||
130526972|NCT01124838|469896377|FG000|Overall Study|Miscellaneous|4|||
130526973|NCT01124838|469896378|FG001|Overall Study|Miscellaneous|2|||
130526974|NCT01124838|469896377|FG000|Overall Study|Adverse Event|7|||
130526975|NCT01124838|469896378|FG001|Overall Study|Adverse Event|11|||
130526976|NCT01124838|469896377|FG000|Overall Study|Lack of Efficacy|2|||
130526977|NCT01124838|469896378|FG001|Overall Study|Lack of Efficacy|0|||
130526978|NCT01124838|469896377|FG000|Overall Study|Withdrawal by Subject|3|||
130526979|NCT01124838|469896378|FG001|Overall Study|Withdrawal by Subject|2|||
130526980|NCT01124838|469896377|FG000|Overall Study|Lost to Follow-up|2|||
130526981|NCT01124838|469896378|FG001|Overall Study|Lost to Follow-up|0|||
130577925|NCT02574637|470080412|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
130577926|NCT02574637|470080413|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
130577927|NCT02574637|470080414|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
130577928|NCT02574637|470080405|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577929|NCT02574637|470080406|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577930|NCT02574637|470080407|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577931|NCT02574637|470080408|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577932|NCT02574637|470080409|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577933|NCT02574637|470080410|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130577934|NCT02574637|470080411|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
130577935|NCT02574637|470080412|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130577936|NCT02574637|470080413|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130577937|NCT02574637|470080414|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130577938|NCT04016311|470080415|FG000|Overall Study|Withdrawal by Subject|1|||
130577939|NCT04016311|470080416|FG001|Overall Study|Withdrawal by Subject|0|||
130577940|NCT02706730|470080418|FG000|Overall Study|Adverse Event|3|||
130577941|NCT02706730|470080418|FG000|Overall Study|Lack of Efficacy|5|||
130577942|NCT02706730|470080418|FG000|Overall Study|Withdrawal by Subject|11|||
130577943|NCT02706730|470080418|FG000|Overall Study|Study Terminated by Sponsor|11|||
130577944|NCT02706730|470080418|FG000|Overall Study|Subject chose not to receive injection|3|||
130577945|NCT02064387|470080419|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577946|NCT02064387|470080420|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577947|NCT02064387|470080421|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577948|NCT02064387|470080422|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577949|NCT02064387|470080423|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577950|NCT02064387|470080424|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577951|NCT02064387|470080425|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577952|NCT02064387|470080426|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
130526982|NCT04297618|469896379|FG000|Overall Study|Adverse Event|1|||
130526983|NCT04297618|469896379|FG000|Overall Study|Withdrawal by Subject|1|||
130526984|NCT02726945|469896380|FG000|Overall Study|Withdrawal by Subject|0|||
130526985|NCT02726945|469896381|FG001|Overall Study|Withdrawal by Subject|0|||
130526986|NCT02726945|469896382|FG002|Overall Study|Withdrawal by Subject|1|||
130526987|NCT02726945|469896380|FG000|Overall Study|Elected to have total knee replacement|0|||
130526988|NCT02726945|469896381|FG001|Overall Study|Elected to have total knee replacement|1|||
130526989|NCT02726945|469896382|FG002|Overall Study|Elected to have total knee replacement|0|||
130526990|NCT05992922|469896383|FG000|Overall Study|Adverse Event|6|||
130526991|NCT05992922|469896384|FG001|Overall Study|Adverse Event|0|||
130526992|NCT05992922|469896383|FG000|Overall Study|Sponsor Termination of Study|14|||
130526993|NCT05992922|469896384|FG001|Overall Study|Sponsor Termination of Study|20|||
130526994|NCT02172911|469898145|FG000|Overall Study|Serious Adverse Event|0|||
130526995|NCT02172911|469898146|FG001|Overall Study|Serious Adverse Event|1|||
130526996|NCT02172911|469898145|FG000|Overall Study|Progression of Disease|0|||
130526997|NCT02172911|469898146|FG001|Overall Study|Progression of Disease|1|||
130526998|NCT02172911|469898145|FG000|Overall Study|Loss of insurance coverage|1|||
130526999|NCT02172911|469898146|FG001|Overall Study|Loss of insurance coverage|0|||
130527000|NCT02737826|469898147|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
130527001|NCT02737826|469898148|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
130527002|NCT02737826|469898149|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
130527003|NCT00129935|469898150|FG000|Overall Study|Adverse Event|18|||
130527004|NCT00129935|469898151|FG001|Overall Study|Adverse Event|56|||
130527005|NCT00129935|469898150|FG000|Overall Study|Death|1|||
130527006|NCT00129935|469898151|FG001|Overall Study|Death|1|||
130527007|NCT00129935|469898150|FG000|Overall Study|Withdrawal by Subject|7|||
130527008|NCT00129935|469898151|FG001|Overall Study|Withdrawal by Subject|20|||
130527009|NCT00129935|469898150|FG000|Overall Study|Protocol Violation|0|||
130527010|NCT00129935|469898151|FG001|Overall Study|Protocol Violation|4|||
130527011|NCT00129935|469898150|FG000|Overall Study|Physician Decision|3|||
130527012|NCT00129935|469898151|FG001|Overall Study|Physician Decision|4|||
130577953|NCT02064387|470080427|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577954|NCT02064387|470080428|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
130527013|NCT00129935|469898150|FG000|Overall Study|Recurrence|1|||
130527014|NCT00129935|469898151|FG001|Overall Study|Recurrence|3|||
130577955|NCT02064387|470080429|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577956|NCT02064387|470080430|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130577957|NCT02064387|470080419|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577958|NCT02064387|470080420|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130527015|NCT00129935|469898150|FG000|Overall Study|Second primary|0|||
130527016|NCT00129935|469898151|FG001|Overall Study|Second primary|1|||
130527017|NCT00129935|469898150|FG000|Overall Study|Other|3|||
130527018|NCT00129935|469898151|FG001|Overall Study|Other|2|||
130527019|NCT00129935|469898150|FG000|Overall Study|Crossed to the other arm|2|||
130527020|NCT00129935|469898151|FG001|Overall Study|Crossed to the other arm|1|||
130577959|NCT02064387|470080421|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577960|NCT02064387|470080422|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577961|NCT02064387|470080423|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577962|NCT02064387|470080424|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577963|NCT02064387|470080425|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577964|NCT02064387|470080426|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
130577965|NCT02064387|470080427|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577966|NCT02064387|470080428|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577967|NCT02064387|470080429|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577968|NCT02064387|470080430|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130577969|NCT02064387|470080419|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577970|NCT02064387|470080420|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577971|NCT02064387|470080421|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130527021|NCT00129935|469898150|FG000|Overall Study|Incorrect study treatment|1|||
130527022|NCT00129935|469898151|FG001|Overall Study|Incorrect study treatment|0|||
130527023|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
130527024|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
130527025|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
130527026|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Death|4|||
130527027|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Death|2|||
130527028|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Death|3|||
130527029|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
130527030|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
130527031|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
130527032|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
130527033|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
130527034|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
130527035|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
130527036|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
130527037|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
130527038|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
130527039|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
130527040|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
130527041|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
130527042|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
130527043|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
130527044|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
130527045|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
130527046|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
130527047|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
130527048|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
130527049|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
130527050|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
130527051|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
130527052|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
130527053|NCT02783573|469898152|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
130527054|NCT02783573|469898153|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
130527055|NCT02783573|469898154|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
130527056|NCT02783573|469898152|FG000|Delayed-Start Period|Sponsor Decision|0|||
130527057|NCT02783573|469898153|FG001|Delayed-Start Period|Sponsor Decision|17|||
130527058|NCT02783573|469898154|FG002|Delayed-Start Period|Sponsor Decision|12|||
130527059|NCT00233480|469898155|FG000|Overall Study|Underwent status II heart transplant|0|||
130527060|NCT00233480|469898156|FG001|Overall Study|Underwent status II heart transplant|1|||
130527061|NCT00581893|469898157|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
130527062|NCT00581893|469898158|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
130577972|NCT02064387|470080422|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577973|NCT02064387|470080423|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130527063|NCT02797522|469898166|FG000|Overall Study|Study Terminated by Sponsor|0|||
130527064|NCT02797522|469898167|FG001|Overall Study|Study Terminated by Sponsor|0|||
130527065|NCT02797522|469898168|FG002|Overall Study|Study Terminated by Sponsor|0|||
130527066|NCT02797522|469898169|FG003|Overall Study|Study Terminated by Sponsor|0|||
130527067|NCT02797522|469898170|FG004|Overall Study|Study Terminated by Sponsor|0|||
130527068|NCT02797522|469898171|FG005|Overall Study|Study Terminated by Sponsor|0|||
130527069|NCT02797522|469898172|FG006|Overall Study|Study Terminated by Sponsor|0|||
130527070|NCT02797522|469898173|FG007|Overall Study|Study Terminated by Sponsor|4|||
130527071|NCT02797522|469898174|FG008|Overall Study|Study Terminated by Sponsor|2|||
130577974|NCT02064387|470080424|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577975|NCT02064387|470080425|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577976|NCT02064387|470080426|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577977|NCT02064387|470080427|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
130577978|NCT02064387|470080428|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577979|NCT02064387|470080429|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577980|NCT02064387|470080430|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130577981|NCT02064387|470080419|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
130577982|NCT02064387|470080420|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
130577983|NCT02064387|470080421|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
130577984|NCT02064387|470080422|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
130577985|NCT02064387|470080423|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
130577986|NCT02064387|470080424|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
130577987|NCT02064387|470080425|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
130577988|NCT02064387|470080426|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
130577989|NCT02064387|470080427|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
130577990|NCT02064387|470080428|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
130577991|NCT02064387|470080429|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
130577992|NCT02064387|470080430|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
130577993|NCT02064387|470080419|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577994|NCT02064387|470080420|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577995|NCT02064387|470080421|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577996|NCT02064387|470080422|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577997|NCT02064387|470080423|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577998|NCT02064387|470080424|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130577999|NCT02064387|470080425|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130578000|NCT02064387|470080426|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130578001|NCT02064387|470080427|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130578002|NCT02064387|470080428|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130578003|NCT02064387|470080429|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
130578004|NCT02064387|470080430|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130578005|NCT02499029|470080435|FG000|Overall Study|Lost to Follow-up|2|||
130578006|NCT02499029|470080436|FG001|Overall Study|Lost to Follow-up|2|||
130578007|NCT02499029|470080435|FG000|Overall Study|Physician Decision|2|||
130578008|NCT02499029|470080436|FG001|Overall Study|Physician Decision|1|||
130578009|NCT02499029|470080435|FG000|Overall Study|Death|1|||
130578010|NCT02499029|470080436|FG001|Overall Study|Death|0|||
130578011|NCT02436876|470080437|FG000|Overall Study|Lost to Follow-up|0|||
130578012|NCT02436876|470080438|FG001|Overall Study|Lost to Follow-up|1|||
130578013|NCT02436876|470080439|FG002|Overall Study|Lost to Follow-up|1|||
130578014|NCT02436876|470080440|FG003|Overall Study|Lost to Follow-up|1|||
130578015|NCT02436876|470080437|FG000|Overall Study|Withdrawal by Subject|1|||
130578016|NCT02436876|470080438|FG001|Overall Study|Withdrawal by Subject|0|||
130527072|NCT02797522|469898175|FG009|Overall Study|Study Terminated by Sponsor|4|||
130527073|NCT02797522|469898176|FG010|Overall Study|Study Terminated by Sponsor|1|||
130527074|NCT00725712|469898177|FG000|Overall Study|Withdrawal by Subject|2|||
130527075|NCT00725712|469898178|FG001|Overall Study|Withdrawal by Subject|1|||
130527076|NCT00725712|469898177|FG000|Overall Study|Protocol Violation|1|||
130527077|NCT00725712|469898178|FG001|Overall Study|Protocol Violation|0|||
130527078|NCT00725712|469898177|FG000|Overall Study|Progressive disease|37|||
130527079|NCT00725712|469898178|FG001|Overall Study|Progressive disease|16|||
130527080|NCT00725712|469898177|FG000|Overall Study|Clinical progression not based on RECIST|0|||
130527081|NCT00725712|469898178|FG001|Overall Study|Clinical progression not based on RECIST|3|||
130527082|NCT00725712|469898177|FG000|Overall Study|Adverse Event|5|||
130527083|NCT00725712|469898178|FG001|Overall Study|Adverse Event|5|||
130527084|NCT00725712|469898177|FG000|Overall Study|Death|2|||
130578017|NCT02436876|470080439|FG002|Overall Study|Withdrawal by Subject|0|||
130578018|NCT02436876|470080440|FG003|Overall Study|Withdrawal by Subject|1|||
130578019|NCT02436876|470080437|FG000|Overall Study|Physician Decision|0|||
130578020|NCT02436876|470080438|FG001|Overall Study|Physician Decision|2|||
130578021|NCT02436876|470080439|FG002|Overall Study|Physician Decision|1|||
130578022|NCT02436876|470080440|FG003|Overall Study|Physician Decision|0|||
130578023|NCT02436876|470080437|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
130578024|NCT02436876|470080438|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
130578025|NCT02436876|470080439|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
130527085|NCT00725712|469898178|FG001|Overall Study|Death|0|||
130527086|NCT00725712|469898177|FG000|Overall Study|Other: Death|1|||
130527087|NCT00725712|469898178|FG001|Overall Study|Other: Death|0|||
130527088|NCT00725712|469898177|FG000|Overall Study|Hospitalized, unable to continue|0|||
130527089|NCT00725712|469898178|FG001|Overall Study|Hospitalized, unable to continue|1|||
130527090|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
130527091|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
130527092|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
130527093|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
130527094|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
130527095|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
130527096|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
130527097|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
130527098|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
130527099|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
130527100|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
130527101|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
130527102|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
130527103|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
130527104|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
130527105|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
130527106|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
130527107|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
130527108|NCT00132678|469898179|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
130527109|NCT00132678|469898180|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
130527110|NCT00132678|469898181|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
130527111|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Death|2|||
130527112|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Death|0|||
130527113|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Death|0|||
130527114|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
130527115|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
130527116|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
130527117|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
130527118|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
130527119|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
130527120|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
130527121|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
130527122|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
130527123|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
130527124|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
130527125|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
130527126|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
130527127|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
130527128|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
130527129|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
130527130|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
130527131|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
130527132|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
130527133|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
130527134|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
130527135|NCT00132678|469898179|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
130527136|NCT00132678|469898180|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
130527137|NCT00132678|469898181|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
130527138|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
130527139|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
130527140|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
130527141|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
130527142|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
130527143|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
130527144|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
130527145|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
130527146|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
130527147|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
130527148|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
130527149|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
130527150|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
130527151|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
130527152|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
130578026|NCT02436876|470080440|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
130527153|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
130527154|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
130527155|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
130527156|NCT00132678|469898179|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
130527157|NCT00132678|469898180|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
130527158|NCT00132678|469898181|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
130527159|NCT01367847|469898182|FG000|Overall Study|Withdrawal by Subject|2|||
130527160|NCT01367847|469898183|FG001|Overall Study|Withdrawal by Subject|2|||
130527161|NCT02056626|469898184|FG000|Overall Study|patient did not follow directions|3|||
130527162|NCT02056626|469898185|FG001|Overall Study|patient did not follow directions|1|||
130527163|NCT02056626|469898186|FG002|Overall Study|patient did not follow directions|0|||
130527164|NCT02056626|469898187|FG003|Overall Study|patient did not follow directions|0|||
130527165|NCT01454739|469898191|FG000|Overall Study|Protocol Violation|2|||
130527166|NCT01454739|469898192|FG001|Overall Study|Protocol Violation|3|||
130527167|NCT01454739|469898191|FG000|Overall Study|Withdrawal by Subject|2|||
130527168|NCT01454739|469898192|FG001|Overall Study|Withdrawal by Subject|6|||
130527169|NCT01454739|469898191|FG000|Overall Study|Other|3|||
130527170|NCT01454739|469898192|FG001|Overall Study|Other|5|||
130527171|NCT01454739|469898191|FG000|Overall Study|Physician Decision|0|||
130527172|NCT01454739|469898192|FG001|Overall Study|Physician Decision|5|||
130527173|NCT01454739|469898191|FG000|Overall Study|Lost to Follow-up|0|||
130527174|NCT01454739|469898192|FG001|Overall Study|Lost to Follow-up|1|||
130527175|NCT01454739|469898191|FG000|Overall Study|Adverse Event|0|||
130527176|NCT01454739|469898192|FG001|Overall Study|Adverse Event|1|||
130527177|NCT01784523|469898195|FG000|Overall Study|Study closed early|7|||
130527178|NCT01784523|469898196|FG001|Overall Study|Study closed early|4|||
130527179|NCT04340947|469898197|FG000|7-day Washout Period|Lost to Follow-up|5|||
130527180|NCT04340947|469898198|FG001|7-day Washout Period|Lost to Follow-up|4|||
130527181|NCT01124097|469898202|FG000|Overall Study|Withdrawal by Subject|4|||
130527182|NCT01124097|469898203|FG001|Overall Study|Withdrawal by Subject|3|||
130527183|NCT01124097|469898204|FG002|Overall Study|Withdrawal by Subject|2|||
130527184|NCT01124097|469898205|FG003|Overall Study|Withdrawal by Subject|3|||
130527185|NCT01124097|469898202|FG000|Overall Study|Lack of Efficacy|2|||
130527186|NCT01124097|469898203|FG001|Overall Study|Lack of Efficacy|3|||
130527187|NCT01124097|469898204|FG002|Overall Study|Lack of Efficacy|1|||
130527188|NCT01124097|469898205|FG003|Overall Study|Lack of Efficacy|3|||
130527189|NCT01124097|469898202|FG000|Overall Study|Adverse Event|24|||
130527190|NCT01124097|469898203|FG001|Overall Study|Adverse Event|15|||
130578027|NCT00927095|470080442|FG000|Overall Study|Adverse Event|3|||
130578028|NCT00927095|470080443|FG001|Overall Study|Adverse Event|1|||
130578029|NCT00927095|470080444|FG002|Overall Study|Adverse Event|0|||
130578030|NCT00927095|470080442|FG000|Overall Study|Withdrawal by Subject|2|||
130578031|NCT00927095|470080443|FG001|Overall Study|Withdrawal by Subject|1|||
130578032|NCT00927095|470080444|FG002|Overall Study|Withdrawal by Subject|1|||
130578033|NCT00927095|470080442|FG000|Overall Study|Physician Decision|1|||
130578034|NCT00927095|470080443|FG001|Overall Study|Physician Decision|2|||
130578035|NCT00927095|470080444|FG002|Overall Study|Physician Decision|1|||
130578036|NCT02556255|470080445|FG000|Overall Study|Lost to Follow-up|4|||
130578037|NCT01290692|470080449|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
130578038|NCT04925752|470080450|FG000|Overall Study|Still on Study|1826|||
130578039|NCT04925752|470080451|FG001|Overall Study|Still on Study|926|||
130578040|NCT04925752|470080450|FG000|Overall Study|Withdrew Consent|128|||
130578041|NCT04925752|470080451|FG001|Overall Study|Withdrew Consent|59|||
130578042|NCT04925752|470080450|FG000|Overall Study|Lost to Follow-up|73|||
130578043|NCT04925752|470080451|FG001|Overall Study|Lost to Follow-up|47|||
130578044|NCT04925752|470080450|FG000|Overall Study|Randomized but Never Treated|12|||
130578045|NCT04925752|470080451|FG001|Overall Study|Randomized but Never Treated|9|||
130578046|NCT04925752|470080450|FG000|Overall Study|Hiv-1 Infection|6|||
130578047|NCT04925752|470080451|FG001|Overall Study|Hiv-1 Infection|7|||
130578048|NCT04925752|470080450|FG000|Overall Study|Investigator's discretion|8|||
130578049|NCT04925752|470080451|FG001|Overall Study|Investigator's discretion|5|||
130578050|NCT04925752|470080450|FG000|Overall Study|Non-compliance with Study Drug|8|||
130527191|NCT01124097|469898204|FG002|Overall Study|Adverse Event|15|||
130527192|NCT01124097|469898205|FG003|Overall Study|Adverse Event|7|||
130527193|NCT01124097|469898202|FG000|Overall Study|Protocol Violation|2|||
130527194|NCT01124097|469898203|FG001|Overall Study|Protocol Violation|0|||
130578051|NCT04925752|470080451|FG001|Overall Study|Non-compliance with Study Drug|5|||
130578052|NCT04925752|470080450|FG000|Overall Study|Adverse Event|5|||
130527195|NCT01124097|469898204|FG002|Overall Study|Protocol Violation|2|||
130527196|NCT01124097|469898205|FG003|Overall Study|Protocol Violation|1|||
130527197|NCT01124097|469898202|FG000|Overall Study|Physician Decision|2|||
130527198|NCT01124097|469898203|FG001|Overall Study|Physician Decision|1|||
130527199|NCT01124097|469898204|FG002|Overall Study|Physician Decision|0|||
130527200|NCT01124097|469898205|FG003|Overall Study|Physician Decision|0|||
130527201|NCT01677299|469898206|FG000|Overall Study|Adverse Event|0|||
130527202|NCT01677299|469898207|FG001|Overall Study|Adverse Event|2|||
130527203|NCT01677299|469898208|FG002|Overall Study|Adverse Event|1|||
130578053|NCT04925752|470080451|FG001|Overall Study|Adverse Event|2|||
130578054|NCT04925752|470080450|FG000|Overall Study|Death|4|||
130578055|NCT04925752|470080451|FG001|Overall Study|Death|2|||
130578056|NCT04925752|470080450|FG000|Overall Study|Protocol Violation|1|||
130578057|NCT04925752|470080451|FG001|Overall Study|Protocol Violation|3|||
130578058|NCT04925752|470080450|FG000|Overall Study|Withdrew Assent|1|||
130578059|NCT04925752|470080451|FG001|Overall Study|Withdrew Assent|0|||
130578060|NCT03467958|470080452|FG000|Overall Study|Adverse Event|20|||
130578061|NCT03467958|470080453|FG001|Overall Study|Adverse Event|32|||
130578062|NCT03467958|470080454|FG002|Overall Study|Adverse Event|5|||
130578063|NCT03467958|470080455|FG003|Overall Study|Adverse Event|3|||
130578064|NCT03467958|470080456|FG004|Overall Study|Adverse Event|3|||
130578065|NCT03467958|470080457|FG005|Overall Study|Adverse Event|3|||
130578066|NCT03467958|470080458|FG006|Overall Study|Adverse Event|6|||
130578067|NCT03467958|470080459|FG007|Overall Study|Adverse Event|5|||
130578068|NCT03467958|470080460|FG008|Overall Study|Adverse Event|0|||
130578069|NCT03467958|470080452|FG000|Overall Study|Lack of Efficacy|59|||
130578070|NCT03467958|470080453|FG001|Overall Study|Lack of Efficacy|120|||
130578071|NCT03467958|470080454|FG002|Overall Study|Lack of Efficacy|6|||
130578072|NCT03467958|470080455|FG003|Overall Study|Lack of Efficacy|9|||
130578073|NCT03467958|470080456|FG004|Overall Study|Lack of Efficacy|8|||
130578074|NCT03467958|470080457|FG005|Overall Study|Lack of Efficacy|9|||
130578075|NCT03467958|470080458|FG006|Overall Study|Lack of Efficacy|11|||
130578076|NCT03467958|470080459|FG007|Overall Study|Lack of Efficacy|9|||
130578077|NCT03467958|470080460|FG008|Overall Study|Lack of Efficacy|3|||
130578078|NCT03467958|470080452|FG000|Overall Study|Lost to Follow-up|1|||
130578079|NCT03467958|470080453|FG001|Overall Study|Lost to Follow-up|2|||
130578080|NCT03467958|470080454|FG002|Overall Study|Lost to Follow-up|1|||
130578081|NCT03467958|470080455|FG003|Overall Study|Lost to Follow-up|0|||
130578082|NCT03467958|470080456|FG004|Overall Study|Lost to Follow-up|4|||
130578083|NCT03467958|470080457|FG005|Overall Study|Lost to Follow-up|0|||
130578084|NCT03467958|470080458|FG006|Overall Study|Lost to Follow-up|0|||
130578085|NCT03467958|470080459|FG007|Overall Study|Lost to Follow-up|0|||
130578086|NCT03467958|470080460|FG008|Overall Study|Lost to Follow-up|0|||
130578087|NCT03467958|470080452|FG000|Overall Study|Other reasons|8|||
130578088|NCT03467958|470080453|FG001|Overall Study|Other reasons|14|||
130578089|NCT03467958|470080454|FG002|Overall Study|Other reasons|2|||
130578090|NCT03467958|470080455|FG003|Overall Study|Other reasons|1|||
130578091|NCT03467958|470080456|FG004|Overall Study|Other reasons|4|||
130578092|NCT03467958|470080457|FG005|Overall Study|Other reasons|0|||
130578093|NCT03467958|470080458|FG006|Overall Study|Other reasons|1|||
130578094|NCT03467958|470080459|FG007|Overall Study|Other reasons|0|||
130578095|NCT03467958|470080460|FG008|Overall Study|Other reasons|1|||
130578096|NCT03467958|470080452|FG000|Overall Study|Pregnancy|1|||
130578097|NCT03467958|470080453|FG001|Overall Study|Pregnancy|0|||
130578098|NCT03467958|470080454|FG002|Overall Study|Pregnancy|0|||
130578099|NCT03467958|470080455|FG003|Overall Study|Pregnancy|0|||
130578100|NCT03467958|470080456|FG004|Overall Study|Pregnancy|0|||
130578101|NCT03467958|470080457|FG005|Overall Study|Pregnancy|1|||
130578102|NCT03467958|470080458|FG006|Overall Study|Pregnancy|0|||
130578103|NCT03467958|470080459|FG007|Overall Study|Pregnancy|0|||
130578104|NCT03467958|470080460|FG008|Overall Study|Pregnancy|0|||
130578105|NCT03467958|470080452|FG000|Overall Study|Study terminated by sponsor|65|||
130578106|NCT03467958|470080453|FG001|Overall Study|Study terminated by sponsor|117|||
130578107|NCT03467958|470080454|FG002|Overall Study|Study terminated by sponsor|45|||
130578108|NCT03467958|470080455|FG003|Overall Study|Study terminated by sponsor|64|||
130578109|NCT03467958|470080456|FG004|Overall Study|Study terminated by sponsor|66|||
130578110|NCT03467958|470080457|FG005|Overall Study|Study terminated by sponsor|17|||
130578111|NCT03467958|470080458|FG006|Overall Study|Study terminated by sponsor|11|||
130578112|NCT03467958|470080459|FG007|Overall Study|Study terminated by sponsor|5|||
130578113|NCT03467958|470080460|FG008|Overall Study|Study terminated by sponsor|5|||
130578114|NCT03467958|470080452|FG000|Overall Study|Withdrawal by Subject|25|||
130578115|NCT03467958|470080453|FG001|Overall Study|Withdrawal by Subject|44|||
130578116|NCT03467958|470080454|FG002|Overall Study|Withdrawal by Subject|7|||
130578117|NCT03467958|470080455|FG003|Overall Study|Withdrawal by Subject|8|||
130578118|NCT03467958|470080456|FG004|Overall Study|Withdrawal by Subject|6|||
130578119|NCT03467958|470080457|FG005|Overall Study|Withdrawal by Subject|8|||
130578120|NCT03467958|470080458|FG006|Overall Study|Withdrawal by Subject|4|||
130578121|NCT03467958|470080459|FG007|Overall Study|Withdrawal by Subject|1|||
130578122|NCT03467958|470080460|FG008|Overall Study|Withdrawal by Subject|4|||
130578123|NCT02925156|470080462|FG000|Overall Study|Lost to Follow-up|27|||
130578124|NCT02925156|470080463|FG001|Overall Study|Lost to Follow-up|53|||
130578125|NCT02925156|470080464|FG002|Overall Study|Lost to Follow-up|51|||
130578126|NCT02925156|470080465|FG003|Overall Study|Lost to Follow-up|59|||
130578127|NCT02925156|470080466|FG004|Overall Study|Lost to Follow-up|89|||
130578128|NCT02925156|470080467|FG005|Overall Study|Lost to Follow-up|107|||
130578129|NCT02925156|470080468|FG006|Overall Study|Lost to Follow-up|34|||
130578130|NCT02925156|470080469|FG007|Overall Study|Lost to Follow-up|36|||
130578131|NCT02925156|470080470|FG008|Overall Study|Lost to Follow-up|73|||
130578132|NCT02925156|470080471|FG009|Overall Study|Lost to Follow-up|34|||
130578133|NCT00866307|470080472|FG000|Induction|Adverse Event|5|||
130578134|NCT00866307|470080473|FG001|Induction|Adverse Event|0|||
130578135|NCT00866307|470080474|FG002|Induction|Adverse Event|0|||
130578136|NCT00866307|470080472|FG000|Induction|Death|2|||
130578137|NCT00866307|470080473|FG001|Induction|Death|0|||
130578138|NCT00866307|470080474|FG002|Induction|Death|0|||
130578139|NCT00866307|470080472|FG000|Induction|Physician Decision|5|||
130578140|NCT00866307|470080473|FG001|Induction|Physician Decision|0|||
130578141|NCT00866307|470080474|FG002|Induction|Physician Decision|0|||
130578142|NCT00866307|470080472|FG000|Induction|Progressive Disease|1|||
130578143|NCT00866307|470080473|FG001|Induction|Progressive Disease|0|||
130578144|NCT00866307|470080474|FG002|Induction|Progressive Disease|0|||
130578145|NCT00866307|470080472|FG000|Induction|Identification of Patients with Day 29 M|3|||
130578146|NCT00866307|470080473|FG001|Induction|Identification of Patients with Day 29 M|0|||
130578147|NCT00866307|470080474|FG002|Induction|Identification of Patients with Day 29 M|0|||
130578148|NCT00866307|470080472|FG000|Induction|Inadequate cytognetic samples th|1|||
130578149|NCT00866307|470080473|FG001|Induction|Inadequate cytognetic samples th|0|||
130578150|NCT00866307|470080474|FG002|Induction|Inadequate cytognetic samples th|0|||
130578151|NCT00866307|470080472|FG000|Induction|Improper post-induction consent|2|||
130578152|NCT00866307|470080473|FG001|Induction|Improper post-induction consent|0|||
130578153|NCT00866307|470080474|FG002|Induction|Improper post-induction consent|0|||
130578154|NCT00866307|470080472|FG000|Induction|Study was closed at the time|1|||
130578155|NCT00866307|470080473|FG001|Induction|Study was closed at the time|0|||
130578156|NCT00866307|470080474|FG002|Induction|Study was closed at the time|0|||
130578157|NCT00866307|470080472|FG000|Consolidation/Maintenance|Adverse Event|0|||
130578158|NCT00866307|470080473|FG001|Consolidation/Maintenance|Adverse Event|0|||
130578159|NCT00866307|470080474|FG002|Consolidation/Maintenance|Adverse Event|8|||
130578160|NCT00866307|470080472|FG000|Consolidation/Maintenance|Death|0|||
130578161|NCT00866307|470080473|FG001|Consolidation/Maintenance|Death|0|||
130578162|NCT00866307|470080474|FG002|Consolidation/Maintenance|Death|1|||
130527204|NCT01677299|469898209|FG003|Overall Study|Adverse Event|0|||
130527205|NCT01677299|469898206|FG000|Overall Study|Withdrawal by Subject|0|||
130527206|NCT01677299|469898207|FG001|Overall Study|Withdrawal by Subject|1|||
130527207|NCT01677299|469898208|FG002|Overall Study|Withdrawal by Subject|0|||
130527208|NCT01677299|469898209|FG003|Overall Study|Withdrawal by Subject|1|||
130527209|NCT00193479|469898210|FG000|Induction Chemotherapy|Adverse Event|2|||
130527210|NCT00193479|469898210|FG000|Induction Chemotherapy|Disease Progression|1|||
130527211|NCT00193479|469898210|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
130527212|NCT00193479|469898210|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
130527213|NCT00872001|469898212|FG000|Overall Study|Adverse Event|34|||
130527214|NCT00872001|469898213|FG001|Overall Study|Adverse Event|23|||
130578163|NCT00866307|470080472|FG000|Consolidation/Maintenance|Physician Decision|0|||
130578164|NCT00866307|470080473|FG001|Consolidation/Maintenance|Physician Decision|3|||
130578165|NCT00866307|470080474|FG002|Consolidation/Maintenance|Physician Decision|2|||
130578166|NCT00866307|470080472|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
130578167|NCT00866307|470080473|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
130578168|NCT00866307|470080474|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
130578169|NCT00866307|470080472|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
130578170|NCT00866307|470080473|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
130578171|NCT00866307|470080474|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
130578172|NCT00866307|470080472|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
130578173|NCT00866307|470080473|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
130578174|NCT00866307|470080474|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
130578175|NCT00866307|470080472|FG000|Consolidation/Maintenance|Therapy error|0|||
130578176|NCT00866307|470080473|FG001|Consolidation/Maintenance|Therapy error|1|||
130578177|NCT00866307|470080474|FG002|Consolidation/Maintenance|Therapy error|0|||
130578178|NCT00866307|470080472|FG000|Consolidation/Maintenance|Non-compliance|0|||
130578179|NCT00866307|470080473|FG001|Consolidation/Maintenance|Non-compliance|0|||
130578180|NCT00866307|470080474|FG002|Consolidation/Maintenance|Non-compliance|1|||
130578181|NCT00866307|470080472|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
130527215|NCT00872001|469898212|FG000|Overall Study|Protocol Defined Clinical Event|5|||
130527216|NCT00872001|469898213|FG001|Overall Study|Protocol Defined Clinical Event|7|||
130527217|NCT00872001|469898212|FG000|Overall Study|Lost to Follow-up|13|||
130527218|NCT00872001|469898213|FG001|Overall Study|Lost to Follow-up|12|||
130578182|NCT00866307|470080473|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
130578183|NCT00866307|470080474|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
130578184|NCT02286947|470080477|FG000|Overall Study|Withdrawal by Subject|2|||
130578185|NCT01972074|470080485|FG000|Overall Study|Adverse Event|4|||
130578186|NCT01972074|470080486|FG001|Overall Study|Adverse Event|1|||
130578187|NCT01972074|470080487|FG002|Overall Study|Adverse Event|0|||
130578188|NCT01972074|470080485|FG000|Overall Study|Lack of Efficacy|1|||
130578189|NCT01972074|470080486|FG001|Overall Study|Lack of Efficacy|1|||
130527219|NCT00872001|469898212|FG000|Overall Study|Withdrawal by Subject|18|||
130527220|NCT00872001|469898213|FG001|Overall Study|Withdrawal by Subject|30|||
130527221|NCT00872001|469898212|FG000|Overall Study|Protocol Violation|5|||
130578190|NCT01972074|470080487|FG002|Overall Study|Lack of Efficacy|0|||
130578191|NCT01972074|470080485|FG000|Overall Study|Lost to Follow-up|0|||
130578192|NCT01972074|470080486|FG001|Overall Study|Lost to Follow-up|1|||
130578193|NCT01972074|470080487|FG002|Overall Study|Lost to Follow-up|1|||
130578194|NCT01972074|470080485|FG000|Overall Study|Withdrawal by Subject|1|||
130578195|NCT01972074|470080486|FG001|Overall Study|Withdrawal by Subject|1|||
130578196|NCT01972074|470080487|FG002|Overall Study|Withdrawal by Subject|1|||
130578197|NCT01972074|470080485|FG000|Overall Study|Scanner Unavailable|0|||
130578198|NCT01972074|470080486|FG001|Overall Study|Scanner Unavailable|0|||
130578199|NCT01972074|470080487|FG002|Overall Study|Scanner Unavailable|1|||
130578200|NCT05574062|470080488|FG000|Pre Run-In|Screening failure|3|||
130578201|NCT05574062|470080489|FG001|Pre Run-In|Screening failure|0|||
130578202|NCT05574062|470080490|FG002|Pre Run-In|Screening failure|0|||
130527222|NCT00872001|469898213|FG001|Overall Study|Protocol Violation|8|||
130527223|NCT00872001|469898212|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
130527224|NCT00872001|469898213|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
130527225|NCT00872001|469898212|FG000|Overall Study|Administrative|23|||
130527226|NCT00872001|469898213|FG001|Overall Study|Administrative|15|||
130527227|NCT02030002|469898214|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
130527228|NCT02030002|469898214|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
130527229|NCT02030002|469898214|FG000|Follow-up|Lost to Follow-up|2|||
130527230|NCT02413593|469898224|FG000|Overall Study|Lost to Follow-up|3|||
130527231|NCT02413593|469898224|FG000|Overall Study|Adverse Event|1|||
130527232|NCT01807182|469898225|FG000|Overall Study|Death|1|||
130527233|NCT01807182|469898225|FG000|Overall Study|New therapy|1|||
130527234|NCT01807182|469898225|FG000|Overall Study|Moved to hospice care|1|||
130527235|NCT00150618|469898227|FG000|Overall Study|Adverse Event|2|||
130527236|NCT00150618|469898228|FG001|Overall Study|Adverse Event|2|||
130527237|NCT00150618|469898229|FG002|Overall Study|Adverse Event|6|||
130527238|NCT00150618|469898230|FG003|Overall Study|Adverse Event|9|||
130527239|NCT00150618|469898231|FG004|Overall Study|Adverse Event|5|||
130527240|NCT00150618|469898227|FG000|Overall Study|Withdrawal by Subject|6|||
130527241|NCT00150618|469898228|FG001|Overall Study|Withdrawal by Subject|8|||
130527242|NCT00150618|469898229|FG002|Overall Study|Withdrawal by Subject|8|||
130527243|NCT00150618|469898230|FG003|Overall Study|Withdrawal by Subject|4|||
130527244|NCT00150618|469898231|FG004|Overall Study|Withdrawal by Subject|5|||
130527245|NCT00150618|469898227|FG000|Overall Study|Lost to Follow-up|4|||
130527246|NCT00150618|469898228|FG001|Overall Study|Lost to Follow-up|1|||
130527247|NCT00150618|469898229|FG002|Overall Study|Lost to Follow-up|5|||
130527248|NCT00150618|469898230|FG003|Overall Study|Lost to Follow-up|8|||
130527249|NCT00150618|469898231|FG004|Overall Study|Lost to Follow-up|4|||
130527250|NCT00150618|469898227|FG000|Overall Study|Protocol Violation|1|||
130527251|NCT00150618|469898228|FG001|Overall Study|Protocol Violation|0|||
130527252|NCT00150618|469898229|FG002|Overall Study|Protocol Violation|0|||
130527253|NCT00150618|469898230|FG003|Overall Study|Protocol Violation|0|||
130527254|NCT00150618|469898231|FG004|Overall Study|Protocol Violation|1|||
130527255|NCT00150618|469898227|FG000|Overall Study|Lack of Efficacy|1|||
130527256|NCT00150618|469898228|FG001|Overall Study|Lack of Efficacy|4|||
130527257|NCT00150618|469898229|FG002|Overall Study|Lack of Efficacy|7|||
130527258|NCT00150618|469898230|FG003|Overall Study|Lack of Efficacy|4|||
130527259|NCT00150618|469898231|FG004|Overall Study|Lack of Efficacy|6|||
130527260|NCT00150618|469898227|FG000|Overall Study|No study meds|0|||
130527261|NCT00150618|469898228|FG001|Overall Study|No study meds|0|||
130527262|NCT00150618|469898229|FG002|Overall Study|No study meds|0|||
130527263|NCT00150618|469898230|FG003|Overall Study|No study meds|0|||
130527264|NCT00150618|469898231|FG004|Overall Study|No study meds|2|||
130527265|NCT00150618|469898227|FG000|Overall Study|Physician Decision|0|||
130527266|NCT00150618|469898228|FG001|Overall Study|Physician Decision|2|||
130527267|NCT00150618|469898229|FG002|Overall Study|Physician Decision|0|||
130527268|NCT00150618|469898230|FG003|Overall Study|Physician Decision|0|||
130527269|NCT00150618|469898231|FG004|Overall Study|Physician Decision|1|||
130527270|NCT00150618|469898227|FG000|Overall Study|Lack of compliance|2|||
130527271|NCT00150618|469898228|FG001|Overall Study|Lack of compliance|1|||
130578203|NCT05574062|470080491|FG003|Pre Run-In|Screening failure|0|||
130578204|NCT05574062|470080492|FG004|Pre Run-In|Screening failure|0|||
130578205|NCT05574062|470080488|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
130578206|NCT05574062|470080489|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
130527272|NCT00150618|469898229|FG002|Overall Study|Lack of compliance|1|||
130527273|NCT00150618|469898230|FG003|Overall Study|Lack of compliance|0|||
130527274|NCT00150618|469898231|FG004|Overall Study|Lack of compliance|1|||
130527275|NCT00150618|469898227|FG000|Overall Study|Abnormal ECG|1|||
130527276|NCT00150618|469898228|FG001|Overall Study|Abnormal ECG|0|||
130527277|NCT00150618|469898229|FG002|Overall Study|Abnormal ECG|0|||
130527278|NCT00150618|469898230|FG003|Overall Study|Abnormal ECG|0|||
130527279|NCT00150618|469898231|FG004|Overall Study|Abnormal ECG|0|||
130527280|NCT00150618|469898227|FG000|Overall Study|Sponsor's decision|0|||
130527281|NCT00150618|469898228|FG001|Overall Study|Sponsor's decision|0|||
130527282|NCT00150618|469898229|FG002|Overall Study|Sponsor's decision|0|||
130527283|NCT00150618|469898230|FG003|Overall Study|Sponsor's decision|1|||
130578207|NCT05574062|470080490|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
130578208|NCT05574062|470080491|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
130578209|NCT05574062|470080492|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
130578210|NCT05574062|470080488|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
130578211|NCT05574062|470080489|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
130578212|NCT05574062|470080490|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
130578213|NCT05574062|470080491|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
130578214|NCT05574062|470080492|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
130578215|NCT05574062|470080488|FG000|Continuation Phase Period 1|Physician Decision|1|||
130578216|NCT05574062|470080489|FG001|Continuation Phase Period 1|Physician Decision|0|||
130578217|NCT05574062|470080490|FG002|Continuation Phase Period 1|Physician Decision|0|||
130578218|NCT05574062|470080491|FG003|Continuation Phase Period 1|Physician Decision|0|||
130578219|NCT05574062|470080492|FG004|Continuation Phase Period 1|Physician Decision|0|||
130578220|NCT05574062|470080488|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
130578221|NCT05574062|470080489|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
130578222|NCT05574062|470080490|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
130578223|NCT05574062|470080491|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
130578224|NCT05574062|470080492|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
130578225|NCT05574062|470080488|FG000|Continuation Phase Period 1|Adverse Event|1|||
130578226|NCT05574062|470080489|FG001|Continuation Phase Period 1|Adverse Event|0|||
130578227|NCT05574062|470080490|FG002|Continuation Phase Period 1|Adverse Event|0|||
130578228|NCT05574062|470080491|FG003|Continuation Phase Period 1|Adverse Event|0|||
130578229|NCT05574062|470080492|FG004|Continuation Phase Period 1|Adverse Event|0|||
130578230|NCT05574062|470080488|FG000|Continuation Phase Period 1|Death|1|||
130578231|NCT05574062|470080489|FG001|Continuation Phase Period 1|Death|0|||
130578232|NCT05574062|470080490|FG002|Continuation Phase Period 1|Death|0|||
130578233|NCT05574062|470080491|FG003|Continuation Phase Period 1|Death|0|||
130578234|NCT05574062|470080492|FG004|Continuation Phase Period 1|Death|0|||
130578235|NCT05574062|470080488|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
130578236|NCT05574062|470080489|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
130578237|NCT05574062|470080490|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
130578238|NCT05574062|470080491|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
130578239|NCT05574062|470080492|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
130578240|NCT01777581|470080493|FG000|Overall Study|Lost to Follow-up|1|||
130578241|NCT01777581|470080494|FG001|Overall Study|Lost to Follow-up|1|||
130578242|NCT01777581|470080493|FG000|Overall Study|Adverse Event|2|||
130578243|NCT01777581|470080494|FG001|Overall Study|Adverse Event|0|||
130578244|NCT01777581|470080493|FG000|Overall Study|Lack of Efficacy|0|||
130578245|NCT01777581|470080494|FG001|Overall Study|Lack of Efficacy|1|||
130578246|NCT04202679|470080503|FG000|Overall Study|Adverse Event|2|||
130578247|NCT04202679|470080504|FG001|Overall Study|Adverse Event|0|||
130578248|NCT04202679|470080503|FG000|Overall Study|Poor compliance to protocol|1|||
130578249|NCT04202679|470080504|FG001|Overall Study|Poor compliance to protocol|0|||
130578250|NCT04202679|470080503|FG000|Overall Study|Withdrawal by Subject|23|||
130578251|NCT04202679|470080504|FG001|Overall Study|Withdrawal by Subject|6|||
130578252|NCT00980538|470080505|FG000|Overall Study|Lost to Follow-up|20|||
130578253|NCT00980538|470080505|FG000|Overall Study|Sponsor's Decision|4|||
130578254|NCT00980538|470080505|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
130578255|NCT00980538|470080505|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
130578256|NCT00980538|470080505|FG000|Overall Study|Switch to Commercially Available Medication|25|||
130578257|NCT00980538|470080505|FG000|Overall Study|Participant Non-Compliant|9|||
130578258|NCT00980538|470080505|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
130578259|NCT00980538|470080505|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
130578260|NCT00980538|470080505|FG000|Overall Study|Other|60|||
130578261|NCT00980538|470080505|FG000|Overall Study|Other|1|||
130578262|NCT03864653|470080506|FG000|Overall Study|Withdrawal by Subject|1|||
130578263|NCT00546052|470080509|FG000|Overall Study|Adverse Event|47|||
130578264|NCT00546052|470080509|FG000|Overall Study|Lost to Follow-up|144|||
130578265|NCT00546052|470080509|FG000|Overall Study|Protocol Violation|9|||
130578266|NCT00546052|470080509|FG000|Overall Study|Withdrawal by Subject|20|||
130578267|NCT00546052|470080509|FG000|Overall Study|Non Compliance|7|||
130578268|NCT02482129|470080510|FG000|Overall Study|Adverse Event-prior to treatment|0|||
130578269|NCT02482129|470080511|FG001|Overall Study|Adverse Event-prior to treatment|1|||
130578270|NCT02482129|470080510|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
130578271|NCT02482129|470080511|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
130578272|NCT02482129|470080510|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
130578273|NCT02482129|470080511|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
130578274|NCT02482129|470080510|FG000|Overall Study|Criteria not met-prior to treatment|1|||
130578275|NCT02482129|470080511|FG001|Overall Study|Criteria not met-prior to treatment|0|||
130578276|NCT02482129|470080510|FG000|Overall Study|Adverse Event|1|||
130578277|NCT02482129|470080511|FG001|Overall Study|Adverse Event|0|||
130578278|NCT02482129|470080510|FG000|Overall Study|Withdrawal by Subject|2|||
130578279|NCT02482129|470080511|FG001|Overall Study|Withdrawal by Subject|0|||
130527284|NCT00150618|469898231|FG004|Overall Study|Sponsor's decision|0|||
130527285|NCT01791413|469898233|FG000|Overall Study|Lost to Follow-up|5|||
130527286|NCT01791413|469898234|FG001|Overall Study|Lost to Follow-up|1|||
130527287|NCT00250432|469898236|FG000|Overall Study|Adverse Event|25|||
130527288|NCT00250432|469898237|FG001|Overall Study|Adverse Event|29|||
130527289|NCT00250432|469898236|FG000|Overall Study|Lack of Efficacy|2|||
130527290|NCT00250432|469898237|FG001|Overall Study|Lack of Efficacy|1|||
130527291|NCT00250432|469898236|FG000|Overall Study|Lost to Follow-up|6|||
130527292|NCT00250432|469898237|FG001|Overall Study|Lost to Follow-up|5|||
130527293|NCT00250432|469898236|FG000|Overall Study|Patient Moved|0|||
130527294|NCT00250432|469898237|FG001|Overall Study|Patient Moved|1|||
130527295|NCT00250432|469898236|FG000|Overall Study|Protocol Violation|0|||
130527296|NCT00250432|469898237|FG001|Overall Study|Protocol Violation|3|||
130527297|NCT00250432|469898236|FG000|Overall Study|Withdrawal by Subject|6|||
130527298|NCT00250432|469898237|FG001|Overall Study|Withdrawal by Subject|2|||
130527299|NCT00250432|469898236|FG000|Overall Study|Pt died out of posttherapy report period|6|||
130527300|NCT00250432|469898237|FG001|Overall Study|Pt died out of posttherapy report period|5|||
130527301|NCT00250432|469898236|FG000|Overall Study|Pt was considered untreatable|0|||
130527302|NCT00250432|469898237|FG001|Overall Study|Pt was considered untreatable|1|||
130527303|NCT04946942|469898238|FG000|Overall Study|Lost to Follow-up|6|||
130527304|NCT04946942|469898239|FG001|Overall Study|Lost to Follow-up|2|||
130527305|NCT04946942|469898240|FG002|Overall Study|Lost to Follow-up|0|||
130527306|NCT04907357|469898241|FG000|Overall Study|Death|0|||
130527307|NCT04907357|469898242|FG001|Overall Study|Death|1|||
130527308|NCT04907357|469898241|FG000|Overall Study|Lost to Follow-up|9|||
130527309|NCT04907357|469898242|FG001|Overall Study|Lost to Follow-up|18|||
130527310|NCT04907357|469898241|FG000|Overall Study|Physician Decision|1|||
130527311|NCT04907357|469898242|FG001|Overall Study|Physician Decision|0|||
130527312|NCT04907357|469898241|FG000|Overall Study|Withdrawal by Subject|0|||
130527313|NCT04907357|469898242|FG001|Overall Study|Withdrawal by Subject|1|||
130527314|NCT04907357|469898241|FG000|Overall Study|Unable to attend visits|1|||
130527315|NCT04907357|469898242|FG001|Overall Study|Unable to attend visits|0|||
130527316|NCT04907357|469898241|FG000|Overall Study|Incarcerated|1|||
130527317|NCT04907357|469898242|FG001|Overall Study|Incarcerated|1|||
130527318|NCT04277507|469898243|FG000|Overall Study|Lost to Follow-up|17|||
130527319|NCT04277507|469898243|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
130527320|NCT04277507|469898243|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
130527321|NCT04277507|469898243|FG000|Overall Study|Withdrawal by Subject|3|||
130527322|NCT04277507|469898243|FG000|Overall Study|Death due to COVID-19|1|||
130527323|NCT04277507|469898243|FG000|Overall Study|Data missing for full evaluation|5|||
130527324|NCT00738283|469898249|FG000|Overall Study|Death|1|||
130527325|NCT00738283|469898249|FG000|Overall Study|Transfer to another facility|2|||
130527326|NCT00738283|469898249|FG000|Overall Study|Discharge home prior to end of study|1|||
130527327|NCT00486252|469898250|FG000|Overall Study|Adverse Event|7|||
130527328|NCT00486252|469898250|FG000|Overall Study|Lack of Efficacy|9|||
130527329|NCT00486252|469898250|FG000|Overall Study|Lost to Follow-up|24|||
130527330|NCT00486252|469898250|FG000|Overall Study|Other|18|||
130527331|NCT01210651|469898253|FG000|Overall Study|Lost to Follow-up|1|||
130527332|NCT01210651|469898254|FG001|Overall Study|Lost to Follow-up|1|||
130527333|NCT01210651|469898253|FG000|Overall Study|schedule conflicts|1|||
130527334|NCT01210651|469898254|FG001|Overall Study|schedule conflicts|5|||
130527335|NCT01210651|469898253|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
130527336|NCT01210651|469898254|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
130527337|NCT01210651|469898253|FG000|Overall Study|Withdrawal by Subject|1|||
130527338|NCT01210651|469898254|FG001|Overall Study|Withdrawal by Subject|1|||
130527339|NCT01210651|469898253|FG000|Overall Study|Injury outside study|2|||
130527340|NCT01210651|469898254|FG001|Overall Study|Injury outside study|0|||
130527341|NCT01261247|469898255|FG000|Overall Study|Ineligible|2|||
130527342|NCT02559310|469898256|FG000|Overall Study|Death|4|||
130527343|NCT02559310|469898257|FG001|Overall Study|Death|3|||
130527344|NCT02559310|469898256|FG000|Overall Study|Lost to Follow-up|5|||
130527345|NCT02559310|469898257|FG001|Overall Study|Lost to Follow-up|3|||
130527346|NCT02559310|469898256|FG000|Overall Study|Physician Decision|2|||
130527347|NCT02559310|469898257|FG001|Overall Study|Physician Decision|1|||
130527348|NCT02559310|469898256|FG000|Overall Study|Withdrawal by Subject|13|||
130527349|NCT02559310|469898257|FG001|Overall Study|Withdrawal by Subject|9|||
130527350|NCT02559310|469898256|FG000|Overall Study|Sponsor Decision|0|||
130527351|NCT02559310|469898257|FG001|Overall Study|Sponsor Decision|1|||
130527352|NCT02559310|469898256|FG000|Overall Study|Randomized but not treated|3|||
130527353|NCT02559310|469898257|FG001|Overall Study|Randomized but not treated|2|||
130527354|NCT02592707|469898258|FG000|Overall Study|Consent Withdrawn|0|||
130527355|NCT02592707|469898259|FG001|Overall Study|Consent Withdrawn|1|||
130527356|NCT02592707|469898260|FG002|Overall Study|Consent Withdrawn|2|||
130527357|NCT02592707|469898261|FG003|Overall Study|Consent Withdrawn|0|||
130527358|NCT02592707|469898258|FG000|Overall Study|Death|1|||
130527359|NCT02592707|469898259|FG001|Overall Study|Death|0|||
130527360|NCT02592707|469898260|FG002|Overall Study|Death|0|||
130527361|NCT02592707|469898261|FG003|Overall Study|Death|0|||
130527362|NCT02592707|469898258|FG000|Overall Study|Progressive Disease|4|||
130527363|NCT02592707|469898259|FG001|Overall Study|Progressive Disease|4|||
130527364|NCT02592707|469898260|FG002|Overall Study|Progressive Disease|3|||
130527365|NCT02592707|469898261|FG003|Overall Study|Progressive Disease|3|||
130527366|NCT02592707|469898258|FG000|Overall Study|Other|0|||
130527367|NCT02592707|469898259|FG001|Overall Study|Other|0|||
130527368|NCT02592707|469898260|FG002|Overall Study|Other|1|||
130527369|NCT02592707|469898261|FG003|Overall Study|Other|2|||
130527370|NCT02592707|469898258|FG000|Overall Study|Never entered LTFU period|1|||
130527371|NCT02592707|469898259|FG001|Overall Study|Never entered LTFU period|0|||
130527372|NCT02592707|469898260|FG002|Overall Study|Never entered LTFU period|0|||
130527373|NCT02592707|469898261|FG003|Overall Study|Never entered LTFU period|2|||
130527374|NCT00469859|469898262|FG000|Overall Study|Inevaluable|0|||
130527375|NCT00469859|469898263|FG001|Overall Study|Inevaluable|2|||
130527376|NCT04124471|469898264|FG000|Overall Study|screen failure|1|||
130527377|NCT04855734|469898265|FG000|Overall Study|Lost to Follow-up|2|||
130527378|NCT04855734|469898266|FG001|Overall Study|Lost to Follow-up|2|||
130527379|NCT05131477|469898268|FG000|PART 1|Withdrawal by Subject|2|||
130527380|NCT05131477|469898269|FG001|PART 1|Withdrawal by Subject|9|||
130527381|NCT05131477|469898270|FG002|PART 1|Withdrawal by Subject|6|||
130527382|NCT05131477|469898271|FG003|PART 1|Withdrawal by Subject|2|||
130527383|NCT05131477|469898272|FG004|PART 1|Withdrawal by Subject|8|||
130527384|NCT05131477|469898273|FG005|PART 1|Withdrawal by Subject|0|||
130527385|NCT05131477|469898274|FG006|PART 1|Withdrawal by Subject|0|||
130527386|NCT05131477|469898275|FG007|PART 1|Withdrawal by Subject|0|||
130527387|NCT05131477|469898276|FG008|PART 1|Withdrawal by Subject|0|||
130527388|NCT05131477|469898277|FG009|PART 1|Withdrawal by Subject|0|||
130527389|NCT05131477|469898278|FG010|PART 1|Withdrawal by Subject|0|||
130527390|NCT05131477|469898279|FG011|PART 1|Withdrawal by Subject|0|||
130527391|NCT05131477|469898280|FG012|PART 1|Withdrawal by Subject|0|||
130527392|NCT05131477|469898281|FG013|PART 1|Withdrawal by Subject|0|||
130527393|NCT05131477|469898268|FG000|PART 1|Physician Decision|1|||
130527394|NCT05131477|469898269|FG001|PART 1|Physician Decision|0|||
130527395|NCT05131477|469898270|FG002|PART 1|Physician Decision|0|||
130527396|NCT05131477|469898271|FG003|PART 1|Physician Decision|0|||
130527397|NCT05131477|469898272|FG004|PART 1|Physician Decision|0|||
130527398|NCT05131477|469898273|FG005|PART 1|Physician Decision|0|||
130527399|NCT05131477|469898274|FG006|PART 1|Physician Decision|0|||
130527400|NCT05131477|469898275|FG007|PART 1|Physician Decision|0|||
130527401|NCT05131477|469898276|FG008|PART 1|Physician Decision|0|||
130527402|NCT05131477|469898277|FG009|PART 1|Physician Decision|0|||
130527403|NCT05131477|469898278|FG010|PART 1|Physician Decision|0|||
130527404|NCT05131477|469898279|FG011|PART 1|Physician Decision|0|||
130527405|NCT05131477|469898280|FG012|PART 1|Physician Decision|0|||
130527406|NCT05131477|469898281|FG013|PART 1|Physician Decision|0|||
130527407|NCT05131477|469898268|FG000|PART 1|Adverse Event|3|||
130527408|NCT05131477|469898269|FG001|PART 1|Adverse Event|5|||
130527409|NCT05131477|469898270|FG002|PART 1|Adverse Event|1|||
130527410|NCT05131477|469898271|FG003|PART 1|Adverse Event|6|||
130527411|NCT05131477|469898272|FG004|PART 1|Adverse Event|4|||
130527412|NCT05131477|469898273|FG005|PART 1|Adverse Event|0|||
130527413|NCT05131477|469898274|FG006|PART 1|Adverse Event|0|||
130527414|NCT05131477|469898275|FG007|PART 1|Adverse Event|0|||
130527415|NCT05131477|469898276|FG008|PART 1|Adverse Event|0|||
130527416|NCT05131477|469898277|FG009|PART 1|Adverse Event|0|||
130527417|NCT05131477|469898278|FG010|PART 1|Adverse Event|0|||
130527418|NCT05131477|469898279|FG011|PART 1|Adverse Event|0|||
130527419|NCT05131477|469898280|FG012|PART 1|Adverse Event|0|||
130527420|NCT05131477|469898281|FG013|PART 1|Adverse Event|0|||
130527421|NCT05131477|469898268|FG000|PART 1|unclassified|1|||
130527422|NCT05131477|469898269|FG001|PART 1|unclassified|1|||
130527423|NCT05131477|469898270|FG002|PART 1|unclassified|0|||
130527424|NCT05131477|469898271|FG003|PART 1|unclassified|0|||
130527425|NCT05131477|469898272|FG004|PART 1|unclassified|4|||
130527426|NCT05131477|469898273|FG005|PART 1|unclassified|0|||
130527427|NCT05131477|469898274|FG006|PART 1|unclassified|0|||
130527428|NCT05131477|469898275|FG007|PART 1|unclassified|0|||
130527429|NCT05131477|469898276|FG008|PART 1|unclassified|0|||
130527430|NCT05131477|469898277|FG009|PART 1|unclassified|0|||
130527431|NCT05131477|469898278|FG010|PART 1|unclassified|0|||
130527432|NCT05131477|469898279|FG011|PART 1|unclassified|0|||
130527433|NCT05131477|469898280|FG012|PART 1|unclassified|0|||
130527434|NCT05131477|469898281|FG013|PART 1|unclassified|0|||
130527435|NCT05131477|469898268|FG000|PART 1|Randomized and not treated|0|||
130527436|NCT05131477|469898269|FG001|PART 1|Randomized and not treated|0|||
130527437|NCT05131477|469898270|FG002|PART 1|Randomized and not treated|0|||
130527438|NCT05131477|469898271|FG003|PART 1|Randomized and not treated|1|||
130527439|NCT05131477|469898272|FG004|PART 1|Randomized and not treated|1|||
130527440|NCT05131477|469898273|FG005|PART 1|Randomized and not treated|0|||
130527441|NCT05131477|469898274|FG006|PART 1|Randomized and not treated|0|||
130527442|NCT05131477|469898275|FG007|PART 1|Randomized and not treated|0|||
130527443|NCT05131477|469898276|FG008|PART 1|Randomized and not treated|0|||
130527444|NCT05131477|469898277|FG009|PART 1|Randomized and not treated|0|||
130527445|NCT05131477|469898278|FG010|PART 1|Randomized and not treated|0|||
130527446|NCT05131477|469898279|FG011|PART 1|Randomized and not treated|0|||
130527447|NCT05131477|469898280|FG012|PART 1|Randomized and not treated|0|||
130527448|NCT05131477|469898281|FG013|PART 1|Randomized and not treated|0|||
130527449|NCT05131477|469898268|FG000|PART 1|Protocol Violation|2|||
130527450|NCT05131477|469898269|FG001|PART 1|Protocol Violation|0|||
130527451|NCT05131477|469898270|FG002|PART 1|Protocol Violation|0|||
130527452|NCT05131477|469898271|FG003|PART 1|Protocol Violation|1|||
130527453|NCT05131477|469898272|FG004|PART 1|Protocol Violation|0|||
130527454|NCT05131477|469898273|FG005|PART 1|Protocol Violation|0|||
130527455|NCT05131477|469898274|FG006|PART 1|Protocol Violation|0|||
130527456|NCT05131477|469898275|FG007|PART 1|Protocol Violation|0|||
130527457|NCT05131477|469898276|FG008|PART 1|Protocol Violation|0|||
130527458|NCT05131477|469898277|FG009|PART 1|Protocol Violation|0|||
130527459|NCT05131477|469898278|FG010|PART 1|Protocol Violation|0|||
130527460|NCT05131477|469898279|FG011|PART 1|Protocol Violation|0|||
130527461|NCT05131477|469898280|FG012|PART 1|Protocol Violation|0|||
130527462|NCT05131477|469898281|FG013|PART 1|Protocol Violation|0|||
130527463|NCT05131477|469898268|FG000|PART 1|Lack of Efficacy|0|||
130527464|NCT05131477|469898269|FG001|PART 1|Lack of Efficacy|1|||
130527465|NCT05131477|469898270|FG002|PART 1|Lack of Efficacy|1|||
130527466|NCT05131477|469898271|FG003|PART 1|Lack of Efficacy|2|||
130527467|NCT05131477|469898272|FG004|PART 1|Lack of Efficacy|5|||
130527468|NCT05131477|469898273|FG005|PART 1|Lack of Efficacy|0|||
130527469|NCT05131477|469898274|FG006|PART 1|Lack of Efficacy|0|||
130527470|NCT05131477|469898275|FG007|PART 1|Lack of Efficacy|0|||
130527471|NCT05131477|469898276|FG008|PART 1|Lack of Efficacy|0|||
130527472|NCT05131477|469898277|FG009|PART 1|Lack of Efficacy|0|||
130527473|NCT05131477|469898278|FG010|PART 1|Lack of Efficacy|0|||
130527474|NCT05131477|469898279|FG011|PART 1|Lack of Efficacy|0|||
130527475|NCT05131477|469898280|FG012|PART 1|Lack of Efficacy|0|||
130527476|NCT05131477|469898281|FG013|PART 1|Lack of Efficacy|0|||
130527477|NCT05131477|469898268|FG000|PART 2|Withdrawal by Subject|0|||
130527478|NCT05131477|469898269|FG001|PART 2|Withdrawal by Subject|0|||
130527479|NCT05131477|469898270|FG002|PART 2|Withdrawal by Subject|0|||
130527480|NCT05131477|469898271|FG003|PART 2|Withdrawal by Subject|0|||
130527481|NCT05131477|469898272|FG004|PART 2|Withdrawal by Subject|0|||
130527482|NCT05131477|469898273|FG005|PART 2|Withdrawal by Subject|0|||
130527483|NCT05131477|469898274|FG006|PART 2|Withdrawal by Subject|2|||
130527484|NCT05131477|469898275|FG007|PART 2|Withdrawal by Subject|0|||
130527485|NCT05131477|469898276|FG008|PART 2|Withdrawal by Subject|0|||
130527486|NCT05131477|469898277|FG009|PART 2|Withdrawal by Subject|0|||
130527487|NCT05131477|469898278|FG010|PART 2|Withdrawal by Subject|2|||
130527488|NCT05131477|469898279|FG011|PART 2|Withdrawal by Subject|0|||
130527489|NCT05131477|469898280|FG012|PART 2|Withdrawal by Subject|2|||
130527490|NCT05131477|469898281|FG013|PART 2|Withdrawal by Subject|2|||
130527491|NCT05131477|469898268|FG000|PART 2|Other|0|||
130527492|NCT05131477|469898269|FG001|PART 2|Other|0|||
130527493|NCT05131477|469898270|FG002|PART 2|Other|0|||
130527494|NCT05131477|469898271|FG003|PART 2|Other|0|||
130527495|NCT05131477|469898272|FG004|PART 2|Other|0|||
130527496|NCT05131477|469898273|FG005|PART 2|Other|0|||
130527497|NCT05131477|469898274|FG006|PART 2|Other|0|||
130527498|NCT05131477|469898275|FG007|PART 2|Other|0|||
130527499|NCT05131477|469898276|FG008|PART 2|Other|1|||
130527500|NCT05131477|469898277|FG009|PART 2|Other|1|||
130527501|NCT05131477|469898278|FG010|PART 2|Other|0|||
130527502|NCT05131477|469898279|FG011|PART 2|Other|0|||
130527503|NCT05131477|469898280|FG012|PART 2|Other|1|||
130527504|NCT05131477|469898281|FG013|PART 2|Other|0|||
130527505|NCT05131477|469898268|FG000|PART 2|Lack of Efficacy|0|||
130527506|NCT05131477|469898269|FG001|PART 2|Lack of Efficacy|0|||
130527507|NCT05131477|469898270|FG002|PART 2|Lack of Efficacy|0|||
130527508|NCT05131477|469898271|FG003|PART 2|Lack of Efficacy|0|||
130527509|NCT05131477|469898272|FG004|PART 2|Lack of Efficacy|0|||
130527510|NCT05131477|469898273|FG005|PART 2|Lack of Efficacy|1|||
130527511|NCT05131477|469898274|FG006|PART 2|Lack of Efficacy|1|||
130527512|NCT05131477|469898275|FG007|PART 2|Lack of Efficacy|0|||
130527513|NCT05131477|469898276|FG008|PART 2|Lack of Efficacy|3|||
130527514|NCT05131477|469898277|FG009|PART 2|Lack of Efficacy|0|||
130527515|NCT05131477|469898278|FG010|PART 2|Lack of Efficacy|1|||
130527516|NCT05131477|469898279|FG011|PART 2|Lack of Efficacy|0|||
130527517|NCT05131477|469898280|FG012|PART 2|Lack of Efficacy|2|||
130527518|NCT05131477|469898281|FG013|PART 2|Lack of Efficacy|0|||
130527519|NCT05131477|469898268|FG000|PART 2|Unclassified|0|||
130527520|NCT05131477|469898269|FG001|PART 2|Unclassified|0|||
130527521|NCT05131477|469898270|FG002|PART 2|Unclassified|0|||
130527522|NCT05131477|469898271|FG003|PART 2|Unclassified|0|||
130527523|NCT05131477|469898272|FG004|PART 2|Unclassified|0|||
130527524|NCT05131477|469898273|FG005|PART 2|Unclassified|0|||
130527525|NCT05131477|469898274|FG006|PART 2|Unclassified|0|||
130527526|NCT05131477|469898275|FG007|PART 2|Unclassified|0|||
130527527|NCT05131477|469898276|FG008|PART 2|Unclassified|0|||
130527528|NCT05131477|469898277|FG009|PART 2|Unclassified|0|||
130527529|NCT05131477|469898278|FG010|PART 2|Unclassified|1|||
130527530|NCT05131477|469898279|FG011|PART 2|Unclassified|0|||
130527531|NCT05131477|469898280|FG012|PART 2|Unclassified|0|||
130527532|NCT05131477|469898281|FG013|PART 2|Unclassified|0|||
130527533|NCT05131477|469898268|FG000|PART 2|Re-randomized and not treated|0|||
130527534|NCT05131477|469898269|FG001|PART 2|Re-randomized and not treated|0|||
130527535|NCT05131477|469898270|FG002|PART 2|Re-randomized and not treated|0|||
130527536|NCT05131477|469898271|FG003|PART 2|Re-randomized and not treated|0|||
130527537|NCT05131477|469898272|FG004|PART 2|Re-randomized and not treated|0|||
130527538|NCT05131477|469898273|FG005|PART 2|Re-randomized and not treated|0|||
130527539|NCT05131477|469898274|FG006|PART 2|Re-randomized and not treated|0|||
130527540|NCT05131477|469898275|FG007|PART 2|Re-randomized and not treated|1|||
130527541|NCT05131477|469898276|FG008|PART 2|Re-randomized and not treated|0|||
130527542|NCT05131477|469898277|FG009|PART 2|Re-randomized and not treated|0|||
130527543|NCT05131477|469898278|FG010|PART 2|Re-randomized and not treated|1|||
130527544|NCT05131477|469898279|FG011|PART 2|Re-randomized and not treated|0|||
130527545|NCT05131477|469898280|FG012|PART 2|Re-randomized and not treated|1|||
130527546|NCT05131477|469898281|FG013|PART 2|Re-randomized and not treated|1|||
130527547|NCT05101993|469898282|FG000|Overall Study|Withdrawal by Subject|1|||
130527548|NCT04577573|469898283|FG000|Overall Study|Technical - invalid protocol|0|||
130527549|NCT04577573|469898284|FG001|Overall Study|Technical - invalid protocol|2|||
130527550|NCT04577573|469898285|FG002|Overall Study|Technical - invalid protocol|0|||
130527551|NCT06719986|469898286|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
130527552|NCT06719986|469898287|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
130527553|NCT06719986|469898288|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
130527554|NCT06719986|469898286|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
130527555|NCT06719986|469898287|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
130527556|NCT06719986|469898288|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
130527557|NCT02600897|469898290|FG000|Overall Study|Death|1|||
130527558|NCT02600897|469898291|FG001|Overall Study|Death|2|||
130527559|NCT02600897|469898292|FG002|Overall Study|Death|1|||
130527560|NCT02600897|469898293|FG003|Overall Study|Death|2|||
130527561|NCT02600897|469898294|FG004|Overall Study|Death|3|||
130527562|NCT02600897|469898295|FG005|Overall Study|Death|2|||
130527563|NCT02600897|469898296|FG006|Overall Study|Death|10|||
130527564|NCT02600897|469898297|FG007|Overall Study|Death|7|||
130527565|NCT02600897|469898298|FG008|Overall Study|Death|20|||
130527566|NCT02600897|469898290|FG000|Overall Study|Lost to Follow-up|1|||
130527567|NCT02600897|469898291|FG001|Overall Study|Lost to Follow-up|0|||
130527568|NCT02600897|469898292|FG002|Overall Study|Lost to Follow-up|0|||
130527569|NCT02600897|469898293|FG003|Overall Study|Lost to Follow-up|0|||
130527570|NCT02600897|469898294|FG004|Overall Study|Lost to Follow-up|0|||
130527571|NCT02600897|469898295|FG005|Overall Study|Lost to Follow-up|0|||
130527572|NCT02600897|469898296|FG006|Overall Study|Lost to Follow-up|0|||
130527573|NCT02600897|469898297|FG007|Overall Study|Lost to Follow-up|1|||
130527574|NCT02600897|469898298|FG008|Overall Study|Lost to Follow-up|0|||
130527575|NCT02600897|469898290|FG000|Overall Study|Withdrawal by Subject|0|||
130527576|NCT02600897|469898291|FG001|Overall Study|Withdrawal by Subject|0|||
130527577|NCT02600897|469898292|FG002|Overall Study|Withdrawal by Subject|0|||
130527578|NCT02600897|469898293|FG003|Overall Study|Withdrawal by Subject|0|||
130527579|NCT02600897|469898294|FG004|Overall Study|Withdrawal by Subject|0|||
130527580|NCT02600897|469898295|FG005|Overall Study|Withdrawal by Subject|0|||
130527581|NCT02600897|469898296|FG006|Overall Study|Withdrawal by Subject|0|||
130527582|NCT02600897|469898297|FG007|Overall Study|Withdrawal by Subject|4|||
130527583|NCT02600897|469898298|FG008|Overall Study|Withdrawal by Subject|2|||
130527584|NCT02600897|469898290|FG000|Overall Study|Reason Not Specified|0|||
130527585|NCT02600897|469898291|FG001|Overall Study|Reason Not Specified|0|||
130527586|NCT02600897|469898292|FG002|Overall Study|Reason Not Specified|0|||
130527587|NCT02600897|469898293|FG003|Overall Study|Reason Not Specified|0|||
130527588|NCT02600897|469898294|FG004|Overall Study|Reason Not Specified|0|||
130527589|NCT02600897|469898295|FG005|Overall Study|Reason Not Specified|0|||
130527590|NCT02600897|469898296|FG006|Overall Study|Reason Not Specified|0|||
130527591|NCT02600897|469898297|FG007|Overall Study|Reason Not Specified|0|||
130527592|NCT02600897|469898298|FG008|Overall Study|Reason Not Specified|1|||
130527593|NCT00592293|469899911|FG000|Overall Study|Withdrawal by Subject|1|||
130527594|NCT01606319|469899912|FG000|Overall Study|Lost to Follow-up|17|||
130527595|NCT01606319|469899913|FG001|Overall Study|Lost to Follow-up|14|||
130527596|NCT01606319|469899912|FG000|Overall Study|Withdrawal by Subject|9|||
130527597|NCT01606319|469899913|FG001|Overall Study|Withdrawal by Subject|12|||
130527598|NCT01606319|469899912|FG000|Overall Study|Physician Decision|1|||
130527599|NCT01606319|469899913|FG001|Overall Study|Physician Decision|2|||
130527600|NCT01606319|469899912|FG000|Overall Study|Lack of Efficacy|6|||
130527601|NCT01606319|469899913|FG001|Overall Study|Lack of Efficacy|8|||
130527602|NCT01606319|469899912|FG000|Overall Study|Adverse Event|1|||
130527603|NCT01606319|469899913|FG001|Overall Study|Adverse Event|4|||
130527604|NCT01594827|469899914|FG000|Overall Study|Adverse Event|1|||
130527605|NCT01594827|469899915|FG001|Overall Study|Adverse Event|0|||
130527606|NCT01594827|469899914|FG000|Overall Study|Physician Decision|3|||
130527607|NCT01594827|469899915|FG001|Overall Study|Physician Decision|0|||
130527608|NCT01821937|469899917|FG000|Overall Study|Adverse Event|0|||
130527609|NCT01821937|469899918|FG001|Overall Study|Adverse Event|3|||
130527610|NCT02406248|469899924|FG000|Overall Study|Death|7|||
130527611|NCT02406248|469899924|FG000|Overall Study|Withdrawal by Subject|2|||
130527612|NCT00790205|469899925|FG000|Overall Study|Lost to Follow-up|61|||
130527613|NCT00790205|469899926|FG001|Overall Study|Lost to Follow-up|71|||
130527614|NCT00790205|469899925|FG000|Overall Study|Withdrawal by Subject|299|||
130527615|NCT00790205|469899926|FG001|Overall Study|Withdrawal by Subject|363|||
130527616|NCT01834586|469899927|FG000|Overall Study|Adverse Event|1|||
130527617|NCT03482752|469899931|FG000|Overall Study|Withdrawal by Subject|2|||
130527618|NCT03482752|469899931|FG000|Overall Study|Lost to Follow-up|1|||
130527619|NCT03482752|469899931|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
130527620|NCT01080300|469899933|FG000|Overall Study|Adverse Event|49|||
130527621|NCT01080300|469899934|FG001|Overall Study|Adverse Event|35|||
130527622|NCT01080300|469899933|FG000|Overall Study|Lack of Efficacy|12|||
130527623|NCT01080300|469899934|FG001|Overall Study|Lack of Efficacy|15|||
130527624|NCT01080300|469899933|FG000|Overall Study|Protocol Violation|7|||
130527625|NCT01080300|469899934|FG001|Overall Study|Protocol Violation|13|||
130527626|NCT01080300|469899933|FG000|Overall Study|Lost to Follow-up|10|||
130527627|NCT01080300|469899934|FG001|Overall Study|Lost to Follow-up|6|||
130527628|NCT01080300|469899933|FG000|Overall Study|Death|0|||
130527629|NCT01080300|469899934|FG001|Overall Study|Death|1|||
130527630|NCT01080300|469899933|FG000|Overall Study|Withdrawal by Subject|12|||
130527631|NCT01080300|469899934|FG001|Overall Study|Withdrawal by Subject|28|||
130527632|NCT01080300|469899933|FG000|Overall Study|Reasons not specified|4|||
130527633|NCT01080300|469899934|FG001|Overall Study|Reasons not specified|6|||
130527634|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
130527635|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
130527636|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
130527637|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
130527638|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
130527639|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
130527640|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
130527641|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
130527642|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
130527643|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
130527644|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
130527645|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
130527646|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
130527647|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
130527648|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
130527649|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
130527650|NCT04210843|469899935|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
130527651|NCT04210843|469899936|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
130527652|NCT04210843|469899935|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
130527653|NCT04210843|469899936|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
130527654|NCT04210843|469899935|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
130527655|NCT04210843|469899936|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
130527656|NCT04210843|469899935|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
130527657|NCT04210843|469899936|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130527658|NCT04210843|469899935|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
130527659|NCT04210843|469899936|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
130527660|NCT04210843|469899935|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
130527661|NCT04210843|469899936|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
130527662|NCT04210843|469899935|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
130527663|NCT04210843|469899936|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
130527664|NCT04210843|469899935|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
130527665|NCT04210843|469899936|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
130527666|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
130527667|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
130527668|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
130527669|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
130527670|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
130527671|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
130527672|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
130527673|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
130527674|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
130527675|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
130527676|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
130527677|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
130527678|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
130527679|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
130527680|NCT04210843|469899935|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
130527681|NCT04210843|469899936|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
130527682|NCT01776008|469899937|FG000|Overall Study|ineligible|2|||
130527683|NCT02493946|469899939|FG000|DB Period|Withdrawal by Subject|8|||
130527684|NCT02493946|469899940|FG001|DB Period|Withdrawal by Subject|5|||
130527685|NCT02493946|469899941|FG002|DB Period|Withdrawal by Subject|0|||
130527686|NCT02493946|469899939|FG000|Open Label Period|Withdrawal by Subject|0|||
130527687|NCT02493946|469899940|FG001|Open Label Period|Withdrawal by Subject|0|||
130527688|NCT02493946|469899941|FG002|Open Label Period|Withdrawal by Subject|74|||
130527689|NCT02493946|469899939|FG000|Open Label Period|Adverse Event|0|||
130527690|NCT02493946|469899940|FG001|Open Label Period|Adverse Event|0|||
130527691|NCT02493946|469899941|FG002|Open Label Period|Adverse Event|4|||
130527692|NCT02493946|469899939|FG000|Open Label Period|Lost to Follow-up|0|||
130527693|NCT02493946|469899940|FG001|Open Label Period|Lost to Follow-up|0|||
130527694|NCT02493946|469899941|FG002|Open Label Period|Lost to Follow-up|1|||
130527695|NCT02493946|469899939|FG000|Open Label Period|Investigator decision, non-compliance|0|||
130527696|NCT02493946|469899940|FG001|Open Label Period|Investigator decision, non-compliance|0|||
130527697|NCT02493946|469899941|FG002|Open Label Period|Investigator decision, non-compliance|2|||
130527698|NCT02493946|469899939|FG000|Open Label Period|Investigator decision, non-availability|0|||
130527699|NCT02493946|469899940|FG001|Open Label Period|Investigator decision, non-availability|0|||
130527700|NCT02493946|469899941|FG002|Open Label Period|Investigator decision, non-availability|1|||
130527701|NCT02493946|469899939|FG000|Open Label Period|Pregnancy|0|||
130527702|NCT02493946|469899940|FG001|Open Label Period|Pregnancy|0|||
130527703|NCT02493946|469899941|FG002|Open Label Period|Pregnancy|3|||
130527704|NCT02493946|469899939|FG000|Open Label Period|Site error|0|||
130527705|NCT02493946|469899940|FG001|Open Label Period|Site error|0|||
130527706|NCT02493946|469899941|FG002|Open Label Period|Site error|1|||
130527707|NCT02353468|469899942|FG000|Overall Study|Study terminated|3|||
130527708|NCT00848484|469899943|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
130527709|NCT00848484|469899944|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
130527710|NCT00848484|469899943|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
130527711|NCT00848484|469899944|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
130527712|NCT00848484|469899943|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
130527713|NCT00848484|469899944|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
130527714|NCT00848484|469899943|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
130527715|NCT00848484|469899944|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
130527716|NCT00848484|469899943|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
130527717|NCT00848484|469899944|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
130527718|NCT03017742|469899951|FG000|Overall Study|Protocol Violation|36|||
130527719|NCT03017742|469899951|FG000|Overall Study|Withdrawal by Subject|37|||
130527720|NCT00762476|469899953|FG000|Overall Study|Adverse Event|7|||
130527721|NCT00762476|469899954|FG001|Overall Study|Adverse Event|1|||
130527722|NCT00762476|469899953|FG000|Overall Study|Lost to Follow-up|2|||
130527723|NCT00762476|469899954|FG001|Overall Study|Lost to Follow-up|0|||
130527724|NCT00762476|469899953|FG000|Overall Study|Protocol Violation|5|||
130527725|NCT00762476|469899954|FG001|Overall Study|Protocol Violation|6|||
130527726|NCT00762476|469899953|FG000|Overall Study|Physician Decision|2|||
130527727|NCT00762476|469899954|FG001|Overall Study|Physician Decision|14|||
130527728|NCT00762476|469899953|FG000|Overall Study|Withdrawal by Subject|6|||
130527729|NCT00762476|469899954|FG001|Overall Study|Withdrawal by Subject|12|||
130527730|NCT00762476|469899953|FG000|Overall Study|antibiotic use|0|||
130527731|NCT00762476|469899954|FG001|Overall Study|antibiotic use|1|||
130527732|NCT00762476|469899953|FG000|Overall Study|non-compliance with study visits|0|||
130527733|NCT00762476|469899954|FG001|Overall Study|non-compliance with study visits|2|||
130527734|NCT00762476|469899953|FG000|Overall Study|Seasonal allergies|1|||
130527735|NCT00762476|469899954|FG001|Overall Study|Seasonal allergies|0|||
130527736|NCT02878603|469899955|FG000|Overall Study|Lost to Follow-up|4|||
130527737|NCT02878603|469899956|FG001|Overall Study|Lost to Follow-up|1|||
130527738|NCT02878603|469899955|FG000|Overall Study|Withdrawal by Subject|1|||
130527739|NCT02878603|469899956|FG001|Overall Study|Withdrawal by Subject|1|||
130527740|NCT02878603|469899955|FG000|Overall Study|Death|1|||
130527741|NCT02878603|469899956|FG001|Overall Study|Death|0|||
130527742|NCT02878603|469899955|FG000|Overall Study|Physician Decision|0|||
130527743|NCT02878603|469899956|FG001|Overall Study|Physician Decision|3|||
130527744|NCT02838134|469899957|FG000|Overall Study|Lost to Follow-up|1|||
130527745|NCT02838134|469899958|FG001|Overall Study|Lost to Follow-up|2|||
130527746|NCT02838134|469899957|FG000|Overall Study|logistic problems|1|||
130527747|NCT02838134|469899958|FG001|Overall Study|logistic problems|1|||
130527748|NCT04674189|469899959|FG000|Overall Study|Adverse Event|0|||
130527749|NCT04674189|469899960|FG001|Overall Study|Adverse Event|0|||
130527750|NCT04674189|469899961|FG002|Overall Study|Adverse Event|1|||
130527751|NCT04674189|469899959|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
130527752|NCT04674189|469899960|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
130527753|NCT04674189|469899961|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
130527754|NCT04674189|469899959|FG000|Overall Study|Physician Decision|1|||
130527755|NCT04674189|469899960|FG001|Overall Study|Physician Decision|0|||
130527756|NCT04674189|469899961|FG002|Overall Study|Physician Decision|0|||
130527757|NCT04674189|469899959|FG000|Overall Study|Withdrawal by Participant|83|||
130527758|NCT04674189|469899960|FG001|Overall Study|Withdrawal by Participant|71|||
130527759|NCT04674189|469899961|FG002|Overall Study|Withdrawal by Participant|142|||
130527760|NCT04674189|469899959|FG000|Overall Study|Lost to Follow-up|55|||
130527761|NCT04674189|469899960|FG001|Overall Study|Lost to Follow-up|53|||
130527762|NCT04674189|469899961|FG002|Overall Study|Lost to Follow-up|44|||
130527763|NCT04674189|469899959|FG000|Overall Study|Miscellaneous|27|||
130527764|NCT04674189|469899960|FG001|Overall Study|Miscellaneous|23|||
130527765|NCT04674189|469899961|FG002|Overall Study|Miscellaneous|207|||
130527766|NCT04674189|469899959|FG000|Overall Study|Did Not Receive Treatment|3|||
130527767|NCT04674189|469899960|FG001|Overall Study|Did Not Receive Treatment|1|||
130527768|NCT04674189|469899961|FG002|Overall Study|Did Not Receive Treatment|2|||
130527769|NCT01564277|469899962|FG000|Overall Study|Protocol Violation|0|||
130527770|NCT01564277|469899963|FG001|Overall Study|Protocol Violation|1|||
130527771|NCT01564277|469899962|FG000|Overall Study|Physician Decision|1|||
130527772|NCT01564277|469899963|FG001|Overall Study|Physician Decision|0|||
130527773|NCT01637077|469899964|FG000|Overall Study|Cancel|1|||
130527774|NCT01637077|469899965|FG001|Overall Study|Cancel|1|||
130527775|NCT01637077|469899964|FG000|Overall Study|Withdrawal by Subject|1|||
130527776|NCT01637077|469899965|FG001|Overall Study|Withdrawal by Subject|0|||
130527777|NCT01637077|469899964|FG000|Overall Study|No cycle 1 questionnaire data|2|||
130527778|NCT01637077|469899965|FG001|Overall Study|No cycle 1 questionnaire data|0|||
130527779|NCT02595372|469899966|FG000|Overall Study|Adverse Event|6|||
130527780|NCT02595372|469899966|FG000|Overall Study|Physician Decision|2|||
130527781|NCT02595372|469899966|FG000|Overall Study|Disease Progression|1|||
130527782|NCT00794924|469899967|FG000|Overall Study|Lost to Follow-up|6|||
130527783|NCT00794924|469899968|FG001|Overall Study|Lost to Follow-up|8|||
130527784|NCT00794924|469899967|FG000|Overall Study|Withdrawal by Subject|48|||
130527785|NCT00794924|469899968|FG001|Overall Study|Withdrawal by Subject|60|||
130527786|NCT00794924|469899967|FG000|Overall Study|Adverse Event|6|||
130527787|NCT00794924|469899968|FG001|Overall Study|Adverse Event|2|||
130527788|NCT00953615|469899969|FG000|Overall Study|Adverse Event|1|||
130527789|NCT01594970|469899970|FG000|Overall Study|Non-Adverse Event Related|4|||
130527790|NCT01594970|469899971|FG001|Overall Study|Non-Adverse Event Related|5|||
130527791|NCT01594970|469899972|FG002|Overall Study|Non-Adverse Event Related|6|||
130527792|NCT01594970|469899970|FG000|Overall Study|Adverse Event|17|||
130527793|NCT01594970|469899971|FG001|Overall Study|Adverse Event|23|||
130527794|NCT01594970|469899972|FG002|Overall Study|Adverse Event|23|||
130527795|NCT01594970|469899970|FG000|Overall Study|Lost to Follow-up|54|||
130527796|NCT01594970|469899971|FG001|Overall Study|Lost to Follow-up|54|||
130527797|NCT01594970|469899972|FG002|Overall Study|Lost to Follow-up|37|||
130527798|NCT01969851|469899984|FG000|Overall Study|Adverse Event|0|||
130527799|NCT01969851|469899985|FG001|Overall Study|Adverse Event|0|||
130527800|NCT01969851|469899986|FG002|Overall Study|Adverse Event|3|||
130527801|NCT01969851|469899984|FG000|Overall Study|Lack of Efficacy|0|||
130527802|NCT01969851|469899985|FG001|Overall Study|Lack of Efficacy|3|||
130527803|NCT01969851|469899986|FG002|Overall Study|Lack of Efficacy|1|||
130527804|NCT01969851|469899984|FG000|Overall Study|Withdrawal by Subject|1|||
130527805|NCT01969851|469899985|FG001|Overall Study|Withdrawal by Subject|0|||
130527806|NCT01969851|469899986|FG002|Overall Study|Withdrawal by Subject|1|||
130527807|NCT01969851|469899984|FG000|Overall Study|No effective dose in Titration period|0|||
130527808|NCT01969851|469899985|FG001|Overall Study|No effective dose in Titration period|0|||
130527809|NCT01969851|469899986|FG002|Overall Study|No effective dose in Titration period|1|||
130527810|NCT01969851|469899984|FG000|Overall Study|Sponsor decision|0|||
130578280|NCT02482129|470080510|FG000|Overall Study|Criteria not met|1|||
130578281|NCT02482129|470080511|FG001|Overall Study|Criteria not met|0|||
130527811|NCT01969851|469899985|FG001|Overall Study|Sponsor decision|0|||
130527812|NCT01969851|469899986|FG002|Overall Study|Sponsor decision|1|||
130527813|NCT01299480|469899987|FG000|Overall Study|No longer willing to participate|19|||
130527814|NCT01299480|469899988|FG001|Overall Study|No longer willing to participate|17|||
130527815|NCT01299480|469899989|FG002|Overall Study|No longer willing to participate|14|||
130527816|NCT01299480|469899990|FG003|Overall Study|No longer willing to participate|13|||
130527817|NCT01299480|469899991|FG004|Overall Study|No longer willing to participate|10|||
130527818|NCT01299480|469899987|FG000|Overall Study|Protocol Violation|7|||
130527819|NCT01299480|469899988|FG001|Overall Study|Protocol Violation|5|||
130527820|NCT01299480|469899989|FG002|Overall Study|Protocol Violation|8|||
130527821|NCT01299480|469899990|FG003|Overall Study|Protocol Violation|1|||
130527822|NCT01299480|469899991|FG004|Overall Study|Protocol Violation|1|||
130527823|NCT01299480|469899987|FG000|Overall Study|Withdrawal by Subject|3|||
130527824|NCT01299480|469899988|FG001|Overall Study|Withdrawal by Subject|4|||
130527825|NCT01299480|469899989|FG002|Overall Study|Withdrawal by Subject|7|||
130527826|NCT01299480|469899990|FG003|Overall Study|Withdrawal by Subject|3|||
130527827|NCT01299480|469899991|FG004|Overall Study|Withdrawal by Subject|4|||
130527828|NCT01299480|469899987|FG000|Overall Study|Adverse Event|6|||
130527829|NCT01299480|469899988|FG001|Overall Study|Adverse Event|4|||
130527830|NCT01299480|469899989|FG002|Overall Study|Adverse Event|5|||
130527831|NCT01299480|469899990|FG003|Overall Study|Adverse Event|4|||
130527832|NCT01299480|469899991|FG004|Overall Study|Adverse Event|0|||
130527833|NCT01299480|469899987|FG000|Overall Study|Withdrawal due to pregnancy|0|||
130527834|NCT01299480|469899988|FG001|Overall Study|Withdrawal due to pregnancy|1|||
130527835|NCT01299480|469899989|FG002|Overall Study|Withdrawal due to pregnancy|1|||
130527836|NCT01299480|469899990|FG003|Overall Study|Withdrawal due to pregnancy|0|||
130527837|NCT01299480|469899991|FG004|Overall Study|Withdrawal due to pregnancy|0|||
130527838|NCT01299480|469899987|FG000|Overall Study|Physician Decision|1|||
130527839|NCT01299480|469899988|FG001|Overall Study|Physician Decision|1|||
130527840|NCT01299480|469899989|FG002|Overall Study|Physician Decision|0|||
130527841|NCT01299480|469899990|FG003|Overall Study|Physician Decision|2|||
130527842|NCT01299480|469899991|FG004|Overall Study|Physician Decision|0|||
130527843|NCT01299480|469899987|FG000|Overall Study|Lost to Follow-up|3|||
130527844|NCT01299480|469899988|FG001|Overall Study|Lost to Follow-up|1|||
130527845|NCT01299480|469899989|FG002|Overall Study|Lost to Follow-up|2|||
130527846|NCT01299480|469899990|FG003|Overall Study|Lost to Follow-up|1|||
130527847|NCT01299480|469899991|FG004|Overall Study|Lost to Follow-up|2|||
130527848|NCT01299480|469899987|FG000|Overall Study|Other|3|||
130527849|NCT01299480|469899988|FG001|Overall Study|Other|2|||
130527850|NCT01299480|469899989|FG002|Overall Study|Other|3|||
130527851|NCT01299480|469899990|FG003|Overall Study|Other|0|||
130527852|NCT01299480|469899991|FG004|Overall Study|Other|3|||
130527853|NCT01299480|469899987|FG000|Overall Study|Started, but not vaccinated|0|||
130527854|NCT01299480|469899988|FG001|Overall Study|Started, but not vaccinated|0|||
130527855|NCT01299480|469899989|FG002|Overall Study|Started, but not vaccinated|1|||
130527856|NCT01299480|469899990|FG003|Overall Study|Started, but not vaccinated|1|||
130527857|NCT01299480|469899991|FG004|Overall Study|Started, but not vaccinated|0|||
130527858|NCT02389764|469899993|FG000|Overall Study|Lack of Efficacy|9|||
130527859|NCT02498236|469899994|FG000|Overall Study|Did not show for testing|1|||
130527860|NCT02498236|469899995|FG001|Overall Study|Did not show for testing|0|||
130527861|NCT02498236|469899996|FG002|Overall Study|Did not show for testing|0|||
130527862|NCT02498236|469899997|FG003|Overall Study|Did not show for testing|0|||
130527863|NCT02498236|469899998|FG004|Overall Study|Did not show for testing|0|||
130527864|NCT02498236|469899999|FG005|Overall Study|Did not show for testing|0|||
130527865|NCT02498236|469900000|FG006|Overall Study|Did not show for testing|0|||
130527866|NCT02498236|469900001|FG007|Overall Study|Did not show for testing|1|||
130527867|NCT02498236|469899994|FG000|Overall Study|Equipment failure|0|||
130527868|NCT02498236|469899995|FG001|Overall Study|Equipment failure|0|||
130527869|NCT02498236|469899996|FG002|Overall Study|Equipment failure|0|||
130527870|NCT02498236|469899997|FG003|Overall Study|Equipment failure|0|||
130527871|NCT02498236|469899998|FG004|Overall Study|Equipment failure|0|||
130527872|NCT02498236|469899999|FG005|Overall Study|Equipment failure|0|||
130527873|NCT02498236|469900000|FG006|Overall Study|Equipment failure|1|||
130527874|NCT02498236|469900001|FG007|Overall Study|Equipment failure|0|||
130527875|NCT02498236|469899994|FG000|Overall Study|Withdrawal by Subject|0|||
130527876|NCT02498236|469899995|FG001|Overall Study|Withdrawal by Subject|0|||
130527877|NCT02498236|469899996|FG002|Overall Study|Withdrawal by Subject|0|||
130527878|NCT02498236|469899997|FG003|Overall Study|Withdrawal by Subject|0|||
130527879|NCT02498236|469899998|FG004|Overall Study|Withdrawal by Subject|1|||
130527880|NCT02498236|469899999|FG005|Overall Study|Withdrawal by Subject|0|||
130527881|NCT02498236|469900000|FG006|Overall Study|Withdrawal by Subject|0|||
130527882|NCT02498236|469900001|FG007|Overall Study|Withdrawal by Subject|0|||
130527883|NCT02296892|469900002|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
130527884|NCT02296892|469900003|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
130527885|NCT02296892|469900004|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
130527886|NCT02296892|469900002|FG000|Overall Study|Lost to Follow-up|5|||
130527887|NCT02296892|469900003|FG001|Overall Study|Lost to Follow-up|0|||
130527888|NCT02296892|469900004|FG002|Overall Study|Lost to Follow-up|1|||
130527889|NCT00383123|469900005|FG000|Overall Study|Adverse Event|1|||
130527890|NCT00383123|469900006|FG001|Overall Study|Adverse Event|0|||
130527891|NCT00383123|469900005|FG000|Overall Study|Lost to Follow-up|68|||
130527892|NCT00383123|469900006|FG001|Overall Study|Lost to Follow-up|61|||
130527893|NCT00383123|469900005|FG000|Overall Study|Protocol Violation|5|||
130527894|NCT00383123|469900006|FG001|Overall Study|Protocol Violation|1|||
130527895|NCT00383123|469900005|FG000|Overall Study|Withdrawal by Subject|27|||
130527896|NCT00383123|469900006|FG001|Overall Study|Withdrawal by Subject|18|||
130527897|NCT00383123|469900005|FG000|Overall Study|Other reason|10|||
130527898|NCT00383123|469900006|FG001|Overall Study|Other reason|6|||
130527899|NCT01814072|469900007|FG000|Overall Study|Lost to Follow-up|2|||
130527900|NCT01814072|469900008|FG001|Overall Study|Lost to Follow-up|2|||
130527901|NCT01814072|469900009|FG002|Overall Study|Lost to Follow-up|2|||
130527902|NCT01814072|469900010|FG003|Overall Study|Lost to Follow-up|0|||
130527903|NCT01814072|469900011|FG004|Overall Study|Lost to Follow-up|2|||
130527904|NCT01814072|469900012|FG005|Overall Study|Lost to Follow-up|3|||
130527905|NCT01814072|469900013|FG006|Overall Study|Lost to Follow-up|3|||
130527906|NCT01814072|469900014|FG007|Overall Study|Lost to Follow-up|1|||
130527907|NCT01814072|469900015|FG008|Overall Study|Lost to Follow-up|2|||
130527908|NCT01814072|469900016|FG009|Overall Study|Lost to Follow-up|3|||
130527909|NCT01814072|469900017|FG010|Overall Study|Lost to Follow-up|1|||
130527910|NCT01814072|469900018|FG011|Overall Study|Lost to Follow-up|2|||
130527911|NCT01814072|469900019|FG012|Overall Study|Lost to Follow-up|2|||
130527912|NCT01814072|469900020|FG013|Overall Study|Lost to Follow-up|1|||
130527913|NCT01814072|469900021|FG014|Overall Study|Lost to Follow-up|2|||
130527914|NCT01814072|469900022|FG015|Overall Study|Lost to Follow-up|1|||
130527915|NCT01814072|469900023|FG016|Overall Study|Lost to Follow-up|3|||
130527916|NCT01814072|469900024|FG017|Overall Study|Lost to Follow-up|1|||
130527917|NCT01814072|469900025|FG018|Overall Study|Lost to Follow-up|3|||
130527918|NCT01814072|469900026|FG019|Overall Study|Lost to Follow-up|3|||
130527919|NCT01814072|469900027|FG020|Overall Study|Lost to Follow-up|2|||
130527920|NCT01814072|469900028|FG021|Overall Study|Lost to Follow-up|1|||
130527921|NCT01814072|469900029|FG022|Overall Study|Lost to Follow-up|3|||
130527922|NCT01814072|469900030|FG023|Overall Study|Lost to Follow-up|1|||
130527923|NCT01814072|469900031|FG024|Overall Study|Lost to Follow-up|4|||
130527924|NCT01814072|469900032|FG025|Overall Study|Lost to Follow-up|1|||
130527925|NCT01814072|469900033|FG026|Overall Study|Lost to Follow-up|1|||
130527926|NCT01814072|469900034|FG027|Overall Study|Lost to Follow-up|2|||
130527927|NCT01814072|469900035|FG028|Overall Study|Lost to Follow-up|3|||
130527928|NCT01814072|469900036|FG029|Overall Study|Lost to Follow-up|3|||
130527929|NCT01814072|469900037|FG030|Overall Study|Lost to Follow-up|2|||
130527930|NCT01814072|469900038|FG031|Overall Study|Lost to Follow-up|0|||
130527931|NCT01814072|469900007|FG000|Overall Study|Withdrawal by Subject|2|||
130527932|NCT01814072|469900008|FG001|Overall Study|Withdrawal by Subject|0|||
130527933|NCT01814072|469900009|FG002|Overall Study|Withdrawal by Subject|1|||
130527934|NCT01814072|469900010|FG003|Overall Study|Withdrawal by Subject|0|||
130527935|NCT01814072|469900011|FG004|Overall Study|Withdrawal by Subject|2|||
130527936|NCT01814072|469900012|FG005|Overall Study|Withdrawal by Subject|3|||
130527937|NCT01814072|469900013|FG006|Overall Study|Withdrawal by Subject|1|||
130527938|NCT01814072|469900014|FG007|Overall Study|Withdrawal by Subject|0|||
130527939|NCT01814072|469900015|FG008|Overall Study|Withdrawal by Subject|1|||
130527940|NCT01814072|469900016|FG009|Overall Study|Withdrawal by Subject|2|||
130527941|NCT01814072|469900017|FG010|Overall Study|Withdrawal by Subject|0|||
130527942|NCT01814072|469900018|FG011|Overall Study|Withdrawal by Subject|0|||
130527943|NCT01814072|469900019|FG012|Overall Study|Withdrawal by Subject|1|||
130527944|NCT01814072|469900020|FG013|Overall Study|Withdrawal by Subject|1|||
130527945|NCT01814072|469900021|FG014|Overall Study|Withdrawal by Subject|1|||
130527946|NCT01814072|469900022|FG015|Overall Study|Withdrawal by Subject|1|||
130527947|NCT01814072|469900023|FG016|Overall Study|Withdrawal by Subject|0|||
130527948|NCT01814072|469900024|FG017|Overall Study|Withdrawal by Subject|0|||
130527949|NCT01814072|469900025|FG018|Overall Study|Withdrawal by Subject|0|||
130527950|NCT01814072|469900026|FG019|Overall Study|Withdrawal by Subject|2|||
130527951|NCT01814072|469900027|FG020|Overall Study|Withdrawal by Subject|0|||
130527952|NCT01814072|469900028|FG021|Overall Study|Withdrawal by Subject|0|||
130527953|NCT01814072|469900029|FG022|Overall Study|Withdrawal by Subject|1|||
130527954|NCT01814072|469900030|FG023|Overall Study|Withdrawal by Subject|0|||
130527955|NCT01814072|469900031|FG024|Overall Study|Withdrawal by Subject|2|||
130527956|NCT01814072|469900032|FG025|Overall Study|Withdrawal by Subject|1|||
130527957|NCT01814072|469900033|FG026|Overall Study|Withdrawal by Subject|1|||
130527958|NCT01814072|469900034|FG027|Overall Study|Withdrawal by Subject|2|||
130527959|NCT01814072|469900035|FG028|Overall Study|Withdrawal by Subject|1|||
130527960|NCT01814072|469900036|FG029|Overall Study|Withdrawal by Subject|0|||
130527961|NCT01814072|469900037|FG030|Overall Study|Withdrawal by Subject|0|||
130527962|NCT01814072|469900038|FG031|Overall Study|Withdrawal by Subject|0|||
130527963|NCT03566979|469900039|FG000|Overall Study|Withdrawal by Subject|2|||
130527964|NCT03566979|469900040|FG001|Overall Study|Withdrawal by Subject|0|||
130527965|NCT03566979|469900041|FG002|Overall Study|Withdrawal by Subject|1|||
130527966|NCT03566979|469900042|FG003|Overall Study|Withdrawal by Subject|1|||
130527967|NCT03566979|469900039|FG000|Overall Study|Lost to Follow-up|2|||
130527968|NCT03566979|469900040|FG001|Overall Study|Lost to Follow-up|7|||
130527969|NCT03566979|469900041|FG002|Overall Study|Lost to Follow-up|9|||
130527970|NCT03566979|469900042|FG003|Overall Study|Lost to Follow-up|5|||
130527971|NCT03566979|469900039|FG000|Overall Study|Adverse Event|1|||
130527972|NCT03566979|469900040|FG001|Overall Study|Adverse Event|0|||
130527973|NCT03566979|469900041|FG002|Overall Study|Adverse Event|0|||
130527974|NCT03566979|469900042|FG003|Overall Study|Adverse Event|0|||
130527975|NCT01011868|469900045|FG000|After Week 18 Follow-up|Adverse Event|8|||
130527976|NCT01011868|469900046|FG001|After Week 18 Follow-up|Adverse Event|6|||
130527977|NCT01011868|469900047|FG002|After Week 18 Follow-up|Adverse Event|13|||
130527978|NCT01011868|469900045|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
130527979|NCT01011868|469900046|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
130527980|NCT01011868|469900047|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
130527981|NCT01011868|469900045|FG000|After Week 18 Follow-up|Protocol Violation|1|||
130527982|NCT01011868|469900046|FG001|After Week 18 Follow-up|Protocol Violation|1|||
130527983|NCT01011868|469900047|FG002|After Week 18 Follow-up|Protocol Violation|1|||
130527984|NCT01011868|469900045|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
130527985|NCT01011868|469900046|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
130527986|NCT01011868|469900047|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
130527987|NCT01011868|469900045|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
130527988|NCT01011868|469900046|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
130527989|NCT01011868|469900047|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
130527990|NCT01011868|469900045|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
130527991|NCT01011868|469900046|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
130527992|NCT01011868|469900047|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
130527993|NCT01011868|469900045|FG000|After Week 78 Follow-up|Adverse Event|14|||
130527994|NCT01011868|469900046|FG001|After Week 78 Follow-up|Adverse Event|18|||
130527995|NCT01011868|469900047|FG002|After Week 78 Follow-up|Adverse Event|21|||
130527996|NCT01011868|469900045|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
130527997|NCT01011868|469900046|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
130527998|NCT01011868|469900047|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
130527999|NCT01011868|469900045|FG000|After Week 78 Follow-up|Protocol Violation|9|||
130528000|NCT01011868|469900046|FG001|After Week 78 Follow-up|Protocol Violation|1|||
130528001|NCT01011868|469900047|FG002|After Week 78 Follow-up|Protocol Violation|2|||
130528002|NCT01011868|469900045|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
130528003|NCT01011868|469900046|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
130528004|NCT01011868|469900047|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
130528005|NCT01011868|469900045|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
130528006|NCT01011868|469900046|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
130528007|NCT01011868|469900047|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
130528008|NCT01011868|469900045|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
130528009|NCT01011868|469900046|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
130528010|NCT01011868|469900047|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
130528011|NCT02336425|469900048|FG000|Overall Study|Study terminated.|2|||
130528012|NCT02336425|469900049|FG001|Overall Study|Study terminated.|2|||
130528013|NCT02336425|469900050|FG002|Overall Study|Study terminated.|3|||
130528014|NCT02336425|469900051|FG003|Overall Study|Study terminated.|3|||
130528015|NCT00978562|469900052|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
130528016|NCT01782690|469900053|FG000|Overall Study|Not reported|7|||
130528017|NCT01782690|469900053|FG000|Overall Study|Toxicity of gemcitabine|1|||
130528018|NCT01782690|469900053|FG000|Overall Study|Toxicity of erlotinib|1|||
130528019|NCT01782690|469900053|FG000|Overall Study|Lost to Follow-up|31|||
130528020|NCT01782690|469900053|FG000|Overall Study|Withdrawal of informed consent|2|||
130528021|NCT01782690|469900053|FG000|Overall Study|Absent rash|9|||
130528022|NCT01782690|469900053|FG000|Overall Study|Physician Decision|13|||
130528023|NCT01782690|469900053|FG000|Overall Study|Patient's wish|21|||
130528024|NCT01782690|469900053|FG000|Overall Study|Tumor progression|74|||
130528025|NCT01782690|469900053|FG000|Overall Study|Death|133|||
130528026|NCT01782690|469900053|FG000|Overall Study|Study completion unknown|7|||
130528027|NCT01948076|469900055|FG000|Overall Study|Withdrawal by Subject|0|||
130528028|NCT01948076|469900056|FG001|Overall Study|Withdrawal by Subject|1|||
130528029|NCT03732677|469900061|FG000|Overall Study|Terminated the study|154|||
130528030|NCT03732677|469900062|FG001|Overall Study|Terminated the study|197|||
130528031|NCT03732677|469900061|FG000|Overall Study|Continuing study off treatment|379|||
130528032|NCT03732677|469900062|FG001|Overall Study|Continuing study off treatment|333|||
130528033|NCT04013971|469900063|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
130528034|NCT04013971|469900064|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
130528035|NCT04013971|469900063|FG000|Overall Study|Missing biomechanical data|0|||
130528036|NCT04013971|469900064|FG001|Overall Study|Missing biomechanical data|1|||
130528037|NCT00344032|469900070|FG000|Overall Study|Adverse Event|0|||
130528038|NCT00344032|469900071|FG001|Overall Study|Adverse Event|1|||
130528039|NCT00344032|469900070|FG000|Overall Study|Withdrawal by Subject|6|||
130528040|NCT00344032|469900071|FG001|Overall Study|Withdrawal by Subject|2|||
130528041|NCT00344032|469900070|FG000|Overall Study|Lost to Follow-up|4|||
130528042|NCT00344032|469900071|FG001|Overall Study|Lost to Follow-up|6|||
130528043|NCT00344032|469900070|FG000|Overall Study|Physician Decision|4|||
130528044|NCT00344032|469900071|FG001|Overall Study|Physician Decision|1|||
130528045|NCT02065882|469900072|FG000|Part I: PK/PD|Screening failure|5|||
130528046|NCT02065882|469900072|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
130578282|NCT01928381|470080512|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
130528047|NCT02065882|469900072|FG000|Part I: PK/PD|Adverse Event|1|||
130528048|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|Screening failure|7|||
130528049|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
130528050|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
130528051|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
130528052|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
130528053|NCT02065882|469900072|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
130528054|NCT06840769|469900073|FG000|Overall Study|Withdrawal by Subject|1|||
130528055|NCT06840769|469900074|FG001|Overall Study|Withdrawal by Subject|0|||
130528056|NCT06840769|469900075|FG002|Overall Study|Withdrawal by Subject|0|||
130528057|NCT06840769|469900076|FG003|Overall Study|Withdrawal by Subject|0|||
130528058|NCT06840769|469900077|FG004|Overall Study|Withdrawal by Subject|0|||
130528059|NCT04949802|469902177|FG000|Overall Study|Lost to Follow-up|3|||
130528060|NCT02473965|469902178|FG000|Overall Study|Adverse Event|6|||
130528061|NCT02473965|469902179|FG001|Overall Study|Adverse Event|4|||
130528062|NCT02473965|469902178|FG000|Overall Study|MG worsening|4|||
130528063|NCT02473965|469902179|FG001|Overall Study|MG worsening|1|||
130528064|NCT02473965|469902178|FG000|Overall Study|Withdrawal by Subject|2|||
130528065|NCT02473965|469902179|FG001|Overall Study|Withdrawal by Subject|3|||
130528066|NCT02473965|469902178|FG000|Overall Study|Physician Decision|0|||
130528067|NCT02473965|469902179|FG001|Overall Study|Physician Decision|2|||
130528068|NCT03192462|469902180|FG000|Overall Study|Death|13|||
130528069|NCT03192462|469902181|FG001|Overall Study|Death|11|||
130528070|NCT03192462|469902182|FG002|Overall Study|Death|9|||
130528071|NCT03192462|469902180|FG000|Overall Study|Lost to Follow-up|0|||
130528072|NCT03192462|469902181|FG001|Overall Study|Lost to Follow-up|1|||
130528073|NCT03192462|469902182|FG002|Overall Study|Lost to Follow-up|0|||
130528074|NCT03192462|469902180|FG000|Overall Study|On follow up|0|||
130528075|NCT03192462|469902181|FG001|Overall Study|On follow up|0|||
130528076|NCT03192462|469902182|FG002|Overall Study|On follow up|3|||
130528077|NCT03816761|469902183|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
130528078|NCT03816761|469902184|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
130528079|NCT03816761|469902185|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
130528080|NCT03816761|469902186|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
130528081|NCT03816761|469902187|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
130528082|NCT03816761|469902188|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
130528083|NCT03816761|469902183|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
130528084|NCT03816761|469902184|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
130528085|NCT03816761|469902185|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
130528086|NCT03816761|469902186|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
130528087|NCT03816761|469902187|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
130528088|NCT03816761|469902188|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
130528089|NCT02419417|469902189|FG000|Overall Study|Disease progression|5|||
130528090|NCT02419417|469902190|FG001|Overall Study|Disease progression|4|||
130528091|NCT02419417|469902191|FG002|Overall Study|Disease progression|13|||
130528092|NCT02419417|469902192|FG003|Overall Study|Disease progression|10|||
130528093|NCT02419417|469902193|FG004|Overall Study|Disease progression|10|||
130528094|NCT02419417|469902194|FG005|Overall Study|Disease progression|3|||
130528095|NCT02419417|469902195|FG006|Overall Study|Disease progression|4|||
130528096|NCT02419417|469902196|FG007|Overall Study|Disease progression|5|||
130528097|NCT02419417|469902197|FG008|Overall Study|Disease progression|13|||
130528098|NCT02419417|469902198|FG009|Overall Study|Disease progression|9|||
130528099|NCT02419417|469902199|FG010|Overall Study|Disease progression|0|||
130528100|NCT02419417|469902189|FG000|Overall Study|Study drug toxicity|0|||
130528101|NCT02419417|469902190|FG001|Overall Study|Study drug toxicity|0|||
130528102|NCT02419417|469902191|FG002|Overall Study|Study drug toxicity|0|||
130528103|NCT02419417|469902192|FG003|Overall Study|Study drug toxicity|0|||
130528104|NCT02419417|469902193|FG004|Overall Study|Study drug toxicity|1|||
130528105|NCT02419417|469902194|FG005|Overall Study|Study drug toxicity|0|||
130528106|NCT02419417|469902195|FG006|Overall Study|Study drug toxicity|0|||
130528107|NCT02419417|469902196|FG007|Overall Study|Study drug toxicity|0|||
130528108|NCT02419417|469902197|FG008|Overall Study|Study drug toxicity|0|||
130528109|NCT02419417|469902198|FG009|Overall Study|Study drug toxicity|0|||
130528110|NCT02419417|469902199|FG010|Overall Study|Study drug toxicity|0|||
130528111|NCT02419417|469902189|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130528112|NCT02419417|469902190|FG001|Overall Study|Adverse event unrelated to study drug|0|||
130528113|NCT02419417|469902191|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130528114|NCT02419417|469902192|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130528115|NCT02419417|469902193|FG004|Overall Study|Adverse event unrelated to study drug|2|||
130528116|NCT02419417|469902194|FG005|Overall Study|Adverse event unrelated to study drug|1|||
130528117|NCT02419417|469902195|FG006|Overall Study|Adverse event unrelated to study drug|0|||
130528118|NCT02419417|469902196|FG007|Overall Study|Adverse event unrelated to study drug|1|||
130528119|NCT02419417|469902197|FG008|Overall Study|Adverse event unrelated to study drug|0|||
130578283|NCT01928381|470080513|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130528120|NCT02419417|469902198|FG009|Overall Study|Adverse event unrelated to study drug|0|||
130528121|NCT02419417|469902199|FG010|Overall Study|Adverse event unrelated to study drug|0|||
130528122|NCT02419417|469902189|FG000|Overall Study|Participant request to discontinue|0|||
130528123|NCT02419417|469902190|FG001|Overall Study|Participant request to discontinue|0|||
130528124|NCT02419417|469902191|FG002|Overall Study|Participant request to discontinue|0|||
130528125|NCT02419417|469902192|FG003|Overall Study|Participant request to discontinue|0|||
130528126|NCT02419417|469902193|FG004|Overall Study|Participant request to discontinue|0|||
130528127|NCT02419417|469902194|FG005|Overall Study|Participant request to discontinue|0|||
130528128|NCT02419417|469902195|FG006|Overall Study|Participant request to discontinue|0|||
130528129|NCT02419417|469902196|FG007|Overall Study|Participant request to discontinue|0|||
130528130|NCT02419417|469902197|FG008|Overall Study|Participant request to discontinue|0|||
130528131|NCT02419417|469902198|FG009|Overall Study|Participant request to discontinue|1|||
130528132|NCT02419417|469902199|FG010|Overall Study|Participant request to discontinue|0|||
130528133|NCT02419417|469902189|FG000|Overall Study|Withdrawal by Subject|0|||
130528134|NCT02419417|469902190|FG001|Overall Study|Withdrawal by Subject|0|||
130528135|NCT02419417|469902191|FG002|Overall Study|Withdrawal by Subject|0|||
130528136|NCT02419417|469902192|FG003|Overall Study|Withdrawal by Subject|0|||
130528137|NCT02419417|469902193|FG004|Overall Study|Withdrawal by Subject|0|||
130528138|NCT02419417|469902194|FG005|Overall Study|Withdrawal by Subject|0|||
130528139|NCT02419417|469902195|FG006|Overall Study|Withdrawal by Subject|0|||
130528140|NCT02419417|469902196|FG007|Overall Study|Withdrawal by Subject|0|||
130528141|NCT02419417|469902197|FG008|Overall Study|Withdrawal by Subject|0|||
130528142|NCT02419417|469902198|FG009|Overall Study|Withdrawal by Subject|0|||
130528143|NCT02419417|469902199|FG010|Overall Study|Withdrawal by Subject|1|||
130528144|NCT01240551|469902200|FG000|Overall Study|Refused further treatment|3|||
130528145|NCT01240551|469902201|FG001|Overall Study|Refused further treatment|2|||
130528146|NCT01240551|469902200|FG000|Overall Study|Lost to Follow-up|1|||
130528147|NCT01240551|469902201|FG001|Overall Study|Lost to Follow-up|1|||
130528148|NCT00078377|469902205|FG000|Overall Study|Adverse Event|2|||
130528149|NCT00078377|469902206|FG001|Overall Study|Adverse Event|5|||
130528150|NCT00078377|469902207|FG002|Overall Study|Adverse Event|1|||
130528151|NCT00078377|469902205|FG000|Overall Study|Lack of Efficacy|2|||
130528152|NCT00078377|469902206|FG001|Overall Study|Lack of Efficacy|0|||
130528153|NCT00078377|469902207|FG002|Overall Study|Lack of Efficacy|2|||
130528154|NCT00078377|469902205|FG000|Overall Study|Lost to Follow-up|0|||
130528155|NCT00078377|469902206|FG001|Overall Study|Lost to Follow-up|1|||
130528156|NCT00078377|469902207|FG002|Overall Study|Lost to Follow-up|1|||
130528157|NCT00078377|469902205|FG000|Overall Study|Physician Decision|2|||
130528158|NCT00078377|469902206|FG001|Overall Study|Physician Decision|0|||
130528159|NCT00078377|469902207|FG002|Overall Study|Physician Decision|0|||
130528160|NCT00078377|469902205|FG000|Overall Study|Withdrawal by Subject|3|||
130528161|NCT00078377|469902206|FG001|Overall Study|Withdrawal by Subject|4|||
130528162|NCT00078377|469902207|FG002|Overall Study|Withdrawal by Subject|4|||
130528163|NCT00078377|469902205|FG000|Overall Study|Miscellaneous|2|||
130528164|NCT00078377|469902206|FG001|Overall Study|Miscellaneous|6|||
130528165|NCT00078377|469902207|FG002|Overall Study|Miscellaneous|1|||
130528166|NCT01200342|469902208|FG000|Overall Study|Disease Progression|1|||
130528167|NCT00953147|469902209|FG000|Overall Study|Adverse Event|8|||
130528168|NCT00953147|469902210|FG001|Overall Study|Adverse Event|16|||
130528169|NCT00953147|469902211|FG002|Overall Study|Adverse Event|6|||
130528170|NCT00953147|469902209|FG000|Overall Study|Protocol Violation|2|||
130528171|NCT00953147|469902210|FG001|Overall Study|Protocol Violation|8|||
130528172|NCT00953147|469902211|FG002|Overall Study|Protocol Violation|4|||
130528173|NCT00953147|469902209|FG000|Overall Study|Withdrawal by Subject|13|||
130528174|NCT00953147|469902210|FG001|Overall Study|Withdrawal by Subject|15|||
130528175|NCT00953147|469902211|FG002|Overall Study|Withdrawal by Subject|12|||
130528176|NCT00953147|469902209|FG000|Overall Study|Lost to Follow-up|8|||
130528177|NCT00953147|469902210|FG001|Overall Study|Lost to Follow-up|9|||
130528178|NCT00953147|469902211|FG002|Overall Study|Lost to Follow-up|4|||
130528179|NCT00953147|469902209|FG000|Overall Study|Physician Decision|2|||
130528180|NCT00953147|469902210|FG001|Overall Study|Physician Decision|7|||
130528181|NCT00953147|469902211|FG002|Overall Study|Physician Decision|3|||
130528182|NCT00953147|469902209|FG000|Overall Study|Other|4|||
130528183|NCT00953147|469902210|FG001|Overall Study|Other|11|||
130528184|NCT00953147|469902211|FG002|Overall Study|Other|13|||
130528185|NCT01484431|469902212|FG000|Period 1: High Dose|Physician Decision|0|||
130528186|NCT01484431|469902213|FG001|Period 1: High Dose|Physician Decision|1|||
130528187|NCT01484431|469902214|FG002|Period 1: High Dose|Physician Decision|0|||
130528188|NCT01484431|469902212|FG000|Period 2|Death|0|||
130528189|NCT01484431|469902213|FG001|Period 2|Death|1|||
130528190|NCT01484431|469902214|FG002|Period 2|Death|1|||
130528191|NCT01484431|469902212|FG000|Period 2|Physician Decision|0|||
130528192|NCT01484431|469902213|FG001|Period 2|Physician Decision|0|||
130528193|NCT01484431|469902214|FG002|Period 2|Physician Decision|1|||
130528194|NCT01484431|469902212|FG000|Period 2|Non-Compliance with Study Drug|1|||
130528195|NCT01484431|469902213|FG001|Period 2|Non-Compliance with Study Drug|0|||
130528196|NCT01484431|469902214|FG002|Period 2|Non-Compliance with Study Drug|0|||
130528197|NCT02763215|469902217|FG000|Overall Study|Participants withdrew from study|3|||
130528198|NCT02763215|469902217|FG000|Overall Study|Missed visit|1|||
130528199|NCT02763215|469902217|FG000|Overall Study|Visit outside visit-window|1|||
130528200|NCT02763215|469902217|FG000|Overall Study|Death|1|||
130528201|NCT02763215|469902217|FG000|Overall Study|Lost to Follow-up|1|||
130528202|NCT00475644|469902218|FG000|Overall Study|Protocol Violation|13|||
130528203|NCT01411241|469902219|FG000|Overall Study|Protocol Violation|0|||
130528204|NCT01411241|469902220|FG001|Overall Study|Protocol Violation|5|||
130528205|NCT01411241|469902219|FG000|Overall Study|Withdrawal by Subject|9|||
130528206|NCT01411241|469902220|FG001|Overall Study|Withdrawal by Subject|10|||
130528207|NCT01411241|469902219|FG000|Overall Study|Serious Adverse Event|0|||
130528208|NCT01411241|469902220|FG001|Overall Study|Serious Adverse Event|3|||
130528209|NCT01411241|469902219|FG000|Overall Study|Lost to Follow-up|2|||
130528210|NCT01411241|469902220|FG001|Overall Study|Lost to Follow-up|4|||
130528211|NCT02980042|469902223|FG000|Overall Study|Lost to Follow-up|5|||
130528212|NCT02980042|469902224|FG001|Overall Study|Lost to Follow-up|0|||
130528213|NCT02980042|469902223|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
130528214|NCT02980042|469902224|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
130528215|NCT01020877|469902229|FG000|Second Intervention|Withdrawal by Subject|1|||
130528216|NCT01020877|469902230|FG001|Second Intervention|Withdrawal by Subject|0|||
130528217|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
130528218|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
130528219|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
130528220|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
130528221|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
130528222|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
130528223|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
130528224|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
130528225|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
130528226|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
130528227|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
130528228|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
130528229|NCT00790400|469902231|FG000|Double-blind Period (Core Phase)|Death|1|||
130528230|NCT00790400|469902232|FG001|Double-blind Period (Core Phase)|Death|0|||
130528231|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
130528232|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
130528233|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
130528234|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
130528235|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
130528236|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
130528237|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
130528238|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
130528239|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
130528240|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
130528241|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Death|1|||
130528242|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Death|0|||
130528243|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
130528244|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
130528245|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
130528246|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
130528247|NCT00790400|469902231|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
130528248|NCT00790400|469902232|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
130528249|NCT00078338|469902234|FG000|Overall Study|Adverse Event|31|||
130528250|NCT00078338|469902235|FG001|Overall Study|Adverse Event|24|||
130528251|NCT00078338|469902234|FG000|Overall Study|Lost to Follow-up|17|||
130528252|NCT00078338|469902235|FG001|Overall Study|Lost to Follow-up|2|||
130528253|NCT00078338|469902234|FG000|Overall Study|Protocol Violation|2|||
130528254|NCT00078338|469902235|FG001|Overall Study|Protocol Violation|2|||
130528255|NCT00078338|469902234|FG000|Overall Study|Disease Progression|4|||
130528256|NCT00078338|469902235|FG001|Overall Study|Disease Progression|7|||
130528257|NCT00078338|469902234|FG000|Overall Study|Other|28|||
130528258|NCT00078338|469902235|FG001|Overall Study|Other|16|||
130528259|NCT00078338|469902234|FG000|Overall Study|Subjects randomized, but not treated|3|||
130528260|NCT00078338|469902235|FG001|Overall Study|Subjects randomized, but not treated|3|||
130528261|NCT04292470|469902236|FG000|Overall Study|Withdrawal by Subject|0|||
130528262|NCT04292470|469902237|FG001|Overall Study|Withdrawal by Subject|1|||
130528263|NCT02906020|469902251|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
130528264|NCT02906020|469902252|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
130528265|NCT02906020|469902253|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
130528266|NCT02906020|469902254|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
130528267|NCT02906020|469902255|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
130528268|NCT02906020|469902256|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
130528269|NCT02906020|469902257|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
130528270|NCT02906020|469902258|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
130528271|NCT02906020|469902259|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
130528272|NCT02906020|469902260|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
130528273|NCT02906020|469902261|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
130528274|NCT02906020|469902262|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
130528275|NCT02906020|469902263|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
130528276|NCT02906020|469902264|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
130528277|NCT02906020|469902265|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
130528278|NCT02906020|469902266|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
130528279|NCT02906020|469902251|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528280|NCT02906020|469902252|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528281|NCT02906020|469902253|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528282|NCT02906020|469902254|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528283|NCT02906020|469902255|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528284|NCT02906020|469902256|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528285|NCT02906020|469902257|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528286|NCT02906020|469902258|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528287|NCT02906020|469902259|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
130528288|NCT02906020|469902260|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
130528289|NCT02906020|469902261|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528290|NCT02906020|469902262|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528291|NCT02906020|469902263|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528292|NCT02906020|469902264|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528293|NCT02906020|469902265|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528294|NCT02906020|469902266|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130528295|NCT02906020|469902251|FG000|Part 2: Double-blind Treatment Period|Other|0|||
130528296|NCT02906020|469902252|FG001|Part 2: Double-blind Treatment Period|Other|0|||
130528297|NCT02906020|469902253|FG002|Part 2: Double-blind Treatment Period|Other|0|||
130528298|NCT02906020|469902254|FG003|Part 2: Double-blind Treatment Period|Other|0|||
130528299|NCT02906020|469902255|FG004|Part 2: Double-blind Treatment Period|Other|0|||
130528300|NCT02906020|469902256|FG005|Part 2: Double-blind Treatment Period|Other|0|||
130528301|NCT02906020|469902257|FG006|Part 2: Double-blind Treatment Period|Other|0|||
130528302|NCT02906020|469902258|FG007|Part 2: Double-blind Treatment Period|Other|0|||
130528303|NCT02906020|469902259|FG008|Part 2: Double-blind Treatment Period|Other|6|||
130528304|NCT02906020|469902260|FG009|Part 2: Double-blind Treatment Period|Other|10|||
130528305|NCT02906020|469902261|FG010|Part 2: Double-blind Treatment Period|Other|0|||
130528306|NCT02906020|469902262|FG011|Part 2: Double-blind Treatment Period|Other|0|||
130528307|NCT02906020|469902263|FG012|Part 2: Double-blind Treatment Period|Other|0|||
130528308|NCT02906020|469902264|FG013|Part 2: Double-blind Treatment Period|Other|0|||
130528309|NCT02906020|469902265|FG014|Part 2: Double-blind Treatment Period|Other|0|||
130528310|NCT02906020|469902266|FG015|Part 2: Double-blind Treatment Period|Other|0|||
130528311|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528312|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528313|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528314|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528315|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528316|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528317|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528318|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528319|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528320|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528321|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528322|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528323|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
130528324|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
130528325|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528326|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
130528327|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528328|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528329|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528330|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528331|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528332|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528333|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528334|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528335|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528336|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528337|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528338|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528339|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
130528340|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
130528341|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
130528342|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
130528343|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528344|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528345|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528346|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528347|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528348|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528349|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528350|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528351|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528352|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528353|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528354|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528355|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
130528356|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
130528357|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528358|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130528359|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528360|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528361|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528362|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528363|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528364|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528365|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528366|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528367|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528368|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528369|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528370|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528371|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
130528372|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
130528373|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528374|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
130528375|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528376|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528377|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528378|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528379|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528380|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528381|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528382|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528383|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528384|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528385|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528386|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
130528387|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
130528388|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
130528389|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
130528390|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
130528391|NCT02906020|469902251|FG000|Part 2: Long-term Follow-up Period|Other|0|||
130528392|NCT02906020|469902252|FG001|Part 2: Long-term Follow-up Period|Other|0|||
130528393|NCT02906020|469902253|FG002|Part 2: Long-term Follow-up Period|Other|0|||
130528394|NCT02906020|469902254|FG003|Part 2: Long-term Follow-up Period|Other|0|||
130528395|NCT02906020|469902255|FG004|Part 2: Long-term Follow-up Period|Other|0|||
130528396|NCT02906020|469902256|FG005|Part 2: Long-term Follow-up Period|Other|0|||
130528397|NCT02906020|469902257|FG006|Part 2: Long-term Follow-up Period|Other|0|||
130528398|NCT02906020|469902258|FG007|Part 2: Long-term Follow-up Period|Other|0|||
130528399|NCT02906020|469902259|FG008|Part 2: Long-term Follow-up Period|Other|0|||
130528400|NCT02906020|469902260|FG009|Part 2: Long-term Follow-up Period|Other|0|||
130528401|NCT02906020|469902261|FG010|Part 2: Long-term Follow-up Period|Other|0|||
130578284|NCT01928381|470080514|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130528402|NCT02906020|469902262|FG011|Part 2: Long-term Follow-up Period|Other|0|||
130528403|NCT02906020|469902263|FG012|Part 2: Long-term Follow-up Period|Other|13|||
130528404|NCT02906020|469902264|FG013|Part 2: Long-term Follow-up Period|Other|8|||
130528405|NCT02906020|469902265|FG014|Part 2: Long-term Follow-up Period|Other|3|||
130528406|NCT02906020|469902266|FG015|Part 2: Long-term Follow-up Period|Other|2|||
130528407|NCT01375673|469902267|FG000|Overall Study|Withdrawal by Subject|0|||
130528408|NCT01375673|469902268|FG001|Overall Study|Withdrawal by Subject|1|||
130528409|NCT02179177|469902269|FG000|Overall Study|Lost to Follow-up|1|||
130528410|NCT02179177|469902270|FG001|Overall Study|Lost to Follow-up|1|||
130528411|NCT02179177|469902269|FG000|Overall Study|Withdrawal by Subject|1|||
130528412|NCT02179177|469902270|FG001|Overall Study|Withdrawal by Subject|1|||
130528413|NCT02153905|469902274|FG000|Overall Study|Death|1|||
130528414|NCT02153905|469902275|FG001|Overall Study|Death|0|||
130528415|NCT00351377|469902280|FG000|Overall Study|Adverse Event|5|||
130528416|NCT00351377|469902280|FG000|Overall Study|Death|1|||
130528417|NCT00351377|469902280|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130528418|NCT01516749|469902281|FG000|Active Therapy|Lost to Follow-up|1|||
130528419|NCT01516749|469902281|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
130528420|NCT01607879|469902282|FG000|Overall Study|Death|1|||
130528421|NCT01607879|469902283|FG001|Overall Study|Death|0|||
130528422|NCT03994731|469902284|FG000|Pegloticase + IMM Period|Death|2|||
130528423|NCT03994731|469902285|FG001|Pegloticase + IMM Period|Death|0|||
130528424|NCT03994731|469902284|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
130528425|NCT03994731|469902285|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
130528426|NCT03994731|469902284|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
130528427|NCT03994731|469902285|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
130528428|NCT00609947|469902290|FG000|Overall Study|Death|1|||
130528429|NCT01304498|469902291|FG000|Overall Study|Adverse Event|1|||
130528430|NCT01304498|469902292|FG001|Overall Study|Adverse Event|1|||
130528431|NCT01304498|469902291|FG000|Overall Study|Withdrawal by Subject|2|||
130528432|NCT01304498|469902292|FG001|Overall Study|Withdrawal by Subject|3|||
130528433|NCT01304498|469902291|FG000|Overall Study|Protocol Violation|1|||
130528434|NCT01304498|469902292|FG001|Overall Study|Protocol Violation|0|||
130528435|NCT01304498|469902291|FG000|Overall Study|Lost to Follow-up|2|||
130528436|NCT01304498|469902292|FG001|Overall Study|Lost to Follow-up|1|||
130528437|NCT02643628|469902293|FG000|Overall Study|Lost to Follow-up|1|||
130528438|NCT02643628|469902294|FG001|Overall Study|Lost to Follow-up|4|||
130528439|NCT02643628|469902293|FG000|Overall Study|Withdrawal by Subject|0|||
130528440|NCT02643628|469902294|FG001|Overall Study|Withdrawal by Subject|1|||
130528441|NCT02643628|469902293|FG000|Overall Study|Relocated out of state|0|||
130528442|NCT02643628|469902294|FG001|Overall Study|Relocated out of state|1|||
130528443|NCT01667549|469902303|FG000|Overall Study|Withdrawal by Subject|3|||
130528444|NCT01667549|469902304|FG001|Overall Study|Withdrawal by Subject|5|||
130528445|NCT01667549|469902305|FG002|Overall Study|Withdrawal by Subject|7|||
130528446|NCT01667549|469902306|FG003|Overall Study|Withdrawal by Subject|6|||
130528447|NCT01667549|469902307|FG004|Overall Study|Withdrawal by Subject|1|||
130528448|NCT02844777|469902308|FG000|Overall Study|Withdrawal by Subject|2|||
130528449|NCT02844777|469902309|FG001|Overall Study|Withdrawal by Subject|0|||
130528450|NCT02844777|469902310|FG002|Overall Study|Withdrawal by Subject|0|||
130528451|NCT04092452|469902311|FG000|Overall Study|Adverse Event|1|||
130528452|NCT04092452|469902312|FG001|Overall Study|Adverse Event|3|||
130528453|NCT04092452|469902313|FG002|Overall Study|Adverse Event|3|||
130528454|NCT04092452|469902314|FG003|Overall Study|Adverse Event|7|||
130528455|NCT04092452|469902311|FG000|Overall Study|Lack of Efficacy|1|||
130528456|NCT04092452|469902312|FG001|Overall Study|Lack of Efficacy|1|||
130528457|NCT04092452|469902313|FG002|Overall Study|Lack of Efficacy|1|||
130528458|NCT04092452|469902314|FG003|Overall Study|Lack of Efficacy|0|||
130528459|NCT04092452|469902311|FG000|Overall Study|Lost to Follow-up|4|||
130528460|NCT04092452|469902312|FG001|Overall Study|Lost to Follow-up|3|||
130528461|NCT04092452|469902313|FG002|Overall Study|Lost to Follow-up|5|||
130528462|NCT04092452|469902314|FG003|Overall Study|Lost to Follow-up|1|||
130528463|NCT04092452|469902311|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130528464|NCT04092452|469902312|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130528465|NCT04092452|469902313|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130528466|NCT04092452|469902314|FG003|Overall Study|Non-Compliance With Study Drug|1|||
130528467|NCT04092452|469902311|FG000|Overall Study|Physician Decision|1|||
130528468|NCT04092452|469902312|FG001|Overall Study|Physician Decision|0|||
130528469|NCT04092452|469902313|FG002|Overall Study|Physician Decision|1|||
130528470|NCT04092452|469902314|FG003|Overall Study|Physician Decision|0|||
130528471|NCT04092452|469902311|FG000|Overall Study|Pregnancy|2|||
130528472|NCT04092452|469902312|FG001|Overall Study|Pregnancy|0|||
130528473|NCT04092452|469902313|FG002|Overall Study|Pregnancy|0|||
130528474|NCT04092452|469902314|FG003|Overall Study|Pregnancy|0|||
130528475|NCT04092452|469902311|FG000|Overall Study|Protocol Deviation|1|||
130528476|NCT04092452|469902312|FG001|Overall Study|Protocol Deviation|0|||
130528477|NCT04092452|469902313|FG002|Overall Study|Protocol Deviation|0|||
130528478|NCT04092452|469902314|FG003|Overall Study|Protocol Deviation|0|||
130528479|NCT04092452|469902311|FG000|Overall Study|Withdrawal by Subject|3|||
130528480|NCT04092452|469902312|FG001|Overall Study|Withdrawal by Subject|10|||
130528481|NCT04092452|469902313|FG002|Overall Study|Withdrawal by Subject|3|||
130528482|NCT04092452|469902314|FG003|Overall Study|Withdrawal by Subject|5|||
130528483|NCT04092452|469902311|FG000|Overall Study|Other|0|||
130528484|NCT04092452|469902312|FG001|Overall Study|Other|0|||
130528485|NCT04092452|469902313|FG002|Overall Study|Other|1|||
130528486|NCT04092452|469902314|FG003|Overall Study|Other|2|||
130528487|NCT02127125|469902315|FG000|Overall Study|Lost to Follow-up|0|||
130528488|NCT02127125|469902316|FG001|Overall Study|Lost to Follow-up|0|||
130528489|NCT02127125|469902317|FG002|Overall Study|Lost to Follow-up|0|||
130528490|NCT02127125|469902318|FG003|Overall Study|Lost to Follow-up|0|||
130528491|NCT02127125|469902319|FG004|Overall Study|Lost to Follow-up|2|||
130528492|NCT02127125|469902320|FG005|Overall Study|Lost to Follow-up|1|||
130528493|NCT02127125|469902321|FG006|Overall Study|Lost to Follow-up|0|||
130528494|NCT02127125|469902322|FG007|Overall Study|Lost to Follow-up|0|||
130528495|NCT02127125|469902323|FG008|Overall Study|Lost to Follow-up|0|||
130528496|NCT02127125|469902315|FG000|Overall Study|Withdrawal by Subject|0|||
130528497|NCT02127125|469902316|FG001|Overall Study|Withdrawal by Subject|0|||
130528498|NCT02127125|469902317|FG002|Overall Study|Withdrawal by Subject|0|||
130528499|NCT02127125|469902318|FG003|Overall Study|Withdrawal by Subject|1|||
130528500|NCT02127125|469902319|FG004|Overall Study|Withdrawal by Subject|0|||
130528501|NCT02127125|469902320|FG005|Overall Study|Withdrawal by Subject|0|||
130528502|NCT02127125|469902321|FG006|Overall Study|Withdrawal by Subject|0|||
130528503|NCT02127125|469902322|FG007|Overall Study|Withdrawal by Subject|0|||
130528504|NCT02127125|469902323|FG008|Overall Study|Withdrawal by Subject|0|||
130528505|NCT02127125|469902315|FG000|Overall Study|Physician Decision|0|||
130528506|NCT02127125|469902316|FG001|Overall Study|Physician Decision|0|||
130528507|NCT02127125|469902317|FG002|Overall Study|Physician Decision|1|||
130528508|NCT02127125|469902318|FG003|Overall Study|Physician Decision|0|||
130528509|NCT02127125|469902319|FG004|Overall Study|Physician Decision|1|||
130528510|NCT02127125|469902320|FG005|Overall Study|Physician Decision|2|||
130528511|NCT02127125|469902321|FG006|Overall Study|Physician Decision|0|||
130528512|NCT02127125|469902322|FG007|Overall Study|Physician Decision|0|||
130528513|NCT02127125|469902323|FG008|Overall Study|Physician Decision|0|||
130528514|NCT02975102|469902325|FG000|Overall Study|Adverse Event|2|||
130528515|NCT02975102|469902326|FG001|Overall Study|Adverse Event|1|||
130528516|NCT01727505|469902330|FG000|First 24 Hours|Adverse Event|0|||
130528517|NCT01727505|469902331|FG001|First 24 Hours|Adverse Event|1|||
130528518|NCT01727505|469902330|FG000|Second 24 Hours|Missing data|0|||
130528519|NCT01727505|469902331|FG001|Second 24 Hours|Missing data|1|||
130528520|NCT01441635|469902332|FG000|Overall Study|Adverse Event|4|||
130528521|NCT01441635|469902333|FG001|Overall Study|Adverse Event|3|||
130528522|NCT01441635|469902334|FG002|Overall Study|Adverse Event|1|||
130528523|NCT01441635|469902335|FG003|Overall Study|Adverse Event|5|||
130528524|NCT01441635|469902336|FG004|Overall Study|Adverse Event|1|||
130528525|NCT01441635|469902337|FG005|Overall Study|Adverse Event|2|||
130528526|NCT01441635|469902338|FG006|Overall Study|Adverse Event|2|||
130528527|NCT01441635|469902339|FG007|Overall Study|Adverse Event|2|||
130528528|NCT01441635|469902340|FG008|Overall Study|Adverse Event|1|||
130528529|NCT01441635|469902341|FG009|Overall Study|Adverse Event|0|||
130528530|NCT01441635|469902332|FG000|Overall Study|Withdrawal by Subject|1|||
130528531|NCT01441635|469902333|FG001|Overall Study|Withdrawal by Subject|1|||
130528532|NCT01441635|469902334|FG002|Overall Study|Withdrawal by Subject|0|||
130528533|NCT01441635|469902335|FG003|Overall Study|Withdrawal by Subject|1|||
130528534|NCT01441635|469902336|FG004|Overall Study|Withdrawal by Subject|0|||
130578285|NCT01928381|470080515|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130528535|NCT01441635|469902337|FG005|Overall Study|Withdrawal by Subject|0|||
130528536|NCT01441635|469902338|FG006|Overall Study|Withdrawal by Subject|2|||
130528537|NCT01441635|469902339|FG007|Overall Study|Withdrawal by Subject|0|||
130528538|NCT01441635|469902340|FG008|Overall Study|Withdrawal by Subject|1|||
130528539|NCT01441635|469902341|FG009|Overall Study|Withdrawal by Subject|1|||
130528540|NCT01441635|469902332|FG000|Overall Study|Lost to Follow-up|0|||
130528541|NCT01441635|469902333|FG001|Overall Study|Lost to Follow-up|1|||
130528542|NCT01441635|469902334|FG002|Overall Study|Lost to Follow-up|1|||
130528543|NCT01441635|469902335|FG003|Overall Study|Lost to Follow-up|1|||
130528544|NCT01441635|469902336|FG004|Overall Study|Lost to Follow-up|1|||
130528545|NCT01441635|469902337|FG005|Overall Study|Lost to Follow-up|3|||
130528546|NCT01441635|469902338|FG006|Overall Study|Lost to Follow-up|1|||
130528547|NCT01441635|469902339|FG007|Overall Study|Lost to Follow-up|1|||
130528548|NCT01441635|469902340|FG008|Overall Study|Lost to Follow-up|0|||
130528549|NCT01441635|469902341|FG009|Overall Study|Lost to Follow-up|1|||
130528550|NCT01441635|469902332|FG000|Overall Study|Noncompliance|0|||
130528551|NCT01441635|469902333|FG001|Overall Study|Noncompliance|1|||
130528552|NCT01441635|469902334|FG002|Overall Study|Noncompliance|0|||
130528553|NCT01441635|469902335|FG003|Overall Study|Noncompliance|0|||
130528554|NCT01441635|469902336|FG004|Overall Study|Noncompliance|0|||
130528555|NCT01441635|469902337|FG005|Overall Study|Noncompliance|0|||
130528556|NCT01441635|469902338|FG006|Overall Study|Noncompliance|1|||
130528557|NCT01441635|469902339|FG007|Overall Study|Noncompliance|0|||
130528558|NCT01441635|469902340|FG008|Overall Study|Noncompliance|0|||
130528559|NCT01441635|469902341|FG009|Overall Study|Noncompliance|0|||
130528560|NCT01441635|469902332|FG000|Overall Study|Surgery or Invasive Intervention|0|||
130528561|NCT01441635|469902333|FG001|Overall Study|Surgery or Invasive Intervention|0|||
130528562|NCT01441635|469902334|FG002|Overall Study|Surgery or Invasive Intervention|1|||
130528563|NCT01441635|469902335|FG003|Overall Study|Surgery or Invasive Intervention|0|||
130528564|NCT01441635|469902336|FG004|Overall Study|Surgery or Invasive Intervention|0|||
130528565|NCT01441635|469902337|FG005|Overall Study|Surgery or Invasive Intervention|0|||
130528566|NCT01441635|469902338|FG006|Overall Study|Surgery or Invasive Intervention|0|||
130528567|NCT01441635|469902339|FG007|Overall Study|Surgery or Invasive Intervention|0|||
130528568|NCT01441635|469902340|FG008|Overall Study|Surgery or Invasive Intervention|0|||
130528569|NCT01441635|469902341|FG009|Overall Study|Surgery or Invasive Intervention|0|||
130528570|NCT01441635|469902332|FG000|Overall Study|Received Exclusionary Medication|1|||
130528571|NCT01441635|469902333|FG001|Overall Study|Received Exclusionary Medication|0|||
130528572|NCT01441635|469902334|FG002|Overall Study|Received Exclusionary Medication|0|||
130528573|NCT01441635|469902335|FG003|Overall Study|Received Exclusionary Medication|0|||
130528574|NCT01441635|469902336|FG004|Overall Study|Received Exclusionary Medication|0|||
130528575|NCT01441635|469902337|FG005|Overall Study|Received Exclusionary Medication|0|||
130528576|NCT01441635|469902338|FG006|Overall Study|Received Exclusionary Medication|0|||
130528577|NCT01441635|469902339|FG007|Overall Study|Received Exclusionary Medication|0|||
130528578|NCT01441635|469902340|FG008|Overall Study|Received Exclusionary Medication|0|||
130528579|NCT01441635|469902341|FG009|Overall Study|Received Exclusionary Medication|0|||
130528580|NCT01441635|469902332|FG000|Overall Study|Other|0|||
130528581|NCT01441635|469902333|FG001|Overall Study|Other|0|||
130528582|NCT01441635|469902334|FG002|Overall Study|Other|0|||
130528583|NCT01441635|469902335|FG003|Overall Study|Other|0|||
130528584|NCT01441635|469902336|FG004|Overall Study|Other|0|||
130528585|NCT01441635|469902337|FG005|Overall Study|Other|0|||
130528586|NCT01441635|469902338|FG006|Overall Study|Other|0|||
130528587|NCT01441635|469902339|FG007|Overall Study|Other|1|||
130528588|NCT01441635|469902340|FG008|Overall Study|Other|0|||
130528589|NCT01441635|469902341|FG009|Overall Study|Other|0|||
130528590|NCT01358331|469902342|FG000|Overall Study|Lost to Follow-up|0|||
130528591|NCT01358331|469902343|FG001|Overall Study|Lost to Follow-up|0|||
130528592|NCT01358331|469902344|FG002|Overall Study|Lost to Follow-up|0|||
130528593|NCT01358331|469902345|FG003|Overall Study|Lost to Follow-up|1|||
130528594|NCT01358331|469902346|FG004|Overall Study|Lost to Follow-up|0|||
130528595|NCT01358331|469902347|FG005|Overall Study|Lost to Follow-up|0|||
130528596|NCT01358331|469902342|FG000|Overall Study|Withdrawal by Subject|0|||
130528597|NCT01358331|469902343|FG001|Overall Study|Withdrawal by Subject|0|||
130528598|NCT01358331|469902344|FG002|Overall Study|Withdrawal by Subject|0|||
130528599|NCT01358331|469902345|FG003|Overall Study|Withdrawal by Subject|1|||
130528600|NCT01358331|469902346|FG004|Overall Study|Withdrawal by Subject|1|||
130528601|NCT01358331|469902347|FG005|Overall Study|Withdrawal by Subject|1|||
130528602|NCT01358331|469902342|FG000|Overall Study|Adverse Events|1|||
130528603|NCT01358331|469902343|FG001|Overall Study|Adverse Events|1|||
130528604|NCT01358331|469902344|FG002|Overall Study|Adverse Events|1|||
130528605|NCT01358331|469902345|FG003|Overall Study|Adverse Events|0|||
130528606|NCT01358331|469902346|FG004|Overall Study|Adverse Events|1|||
130528607|NCT01358331|469902347|FG005|Overall Study|Adverse Events|5|||
130528608|NCT01358331|469902342|FG000|Overall Study|Symptomatic Deterioration|0|||
130528609|NCT01358331|469902343|FG001|Overall Study|Symptomatic Deterioration|0|||
130528610|NCT01358331|469902344|FG002|Overall Study|Symptomatic Deterioration|0|||
130528611|NCT01358331|469902345|FG003|Overall Study|Symptomatic Deterioration|0|||
130528612|NCT01358331|469902346|FG004|Overall Study|Symptomatic Deterioration|1|||
130528613|NCT01358331|469902347|FG005|Overall Study|Symptomatic Deterioration|0|||
130528614|NCT01358331|469902342|FG000|Overall Study|Participants did not wish to continue|0|||
130528615|NCT01358331|469902343|FG001|Overall Study|Participants did not wish to continue|0|||
130528616|NCT01358331|469902344|FG002|Overall Study|Participants did not wish to continue|0|||
130528617|NCT01358331|469902345|FG003|Overall Study|Participants did not wish to continue|0|||
130528618|NCT01358331|469902346|FG004|Overall Study|Participants did not wish to continue|1|||
130528619|NCT01358331|469902347|FG005|Overall Study|Participants did not wish to continue|0|||
130528620|NCT01358331|469902342|FG000|Overall Study|Progress of disease under investigation|1|||
130528621|NCT01358331|469902343|FG001|Overall Study|Progress of disease under investigation|2|||
130528622|NCT01358331|469902344|FG002|Overall Study|Progress of disease under investigation|3|||
130528623|NCT01358331|469902345|FG003|Overall Study|Progress of disease under investigation|1|||
130528624|NCT01358331|469902346|FG004|Overall Study|Progress of disease under investigation|3|||
130528625|NCT01358331|469902347|FG005|Overall Study|Progress of disease under investigation|0|||
130528626|NCT03274895|469902348|FG000|Overall Study|Lack of Efficacy|1|||
130528627|NCT03274895|469902349|FG001|Overall Study|Lack of Efficacy|0|||
130528628|NCT03274895|469902348|FG000|Overall Study|Adverse Event|8|||
130528629|NCT03274895|469902349|FG001|Overall Study|Adverse Event|7|||
130528630|NCT03274895|469902348|FG000|Overall Study|Lost to Follow-up|1|||
130528631|NCT03274895|469902349|FG001|Overall Study|Lost to Follow-up|0|||
130528632|NCT03274895|469902348|FG000|Overall Study|Diagnosis not confirmed|3|||
130528633|NCT03274895|469902349|FG001|Overall Study|Diagnosis not confirmed|4|||
130528634|NCT00617929|469902367|FG000|Overall Study|Physician Decision|1|||
130528635|NCT04982575|469902368|FG000|Overall Study|Withdrawal by Subject|2|||
130528636|NCT04982575|469902369|FG001|Overall Study|Withdrawal by Subject|0|||
130528637|NCT04982575|469902370|FG002|Overall Study|Withdrawal by Subject|2|||
130528638|NCT01151423|469902371|FG000|Overall Study|Study terminated by Sponsor|9|||
130528639|NCT01151423|469902372|FG001|Overall Study|Study terminated by Sponsor|10|||
130528640|NCT01151423|469902371|FG000|Overall Study|Protocol Violation|0|||
130528641|NCT01151423|469902372|FG001|Overall Study|Protocol Violation|1|||
130528642|NCT01151423|469902371|FG000|Overall Study|Physician Decision|1|||
130528643|NCT01151423|469902372|FG001|Overall Study|Physician Decision|1|||
130528644|NCT01151423|469902371|FG000|Overall Study|Pregnancy|0|||
130528645|NCT01151423|469902372|FG001|Overall Study|Pregnancy|1|||
130528646|NCT01151423|469902371|FG000|Overall Study|Death|0|||
130528647|NCT01151423|469902372|FG001|Overall Study|Death|1|||
130528648|NCT01151423|469902371|FG000|Overall Study|Adverse Event|3|||
130528649|NCT01151423|469902372|FG001|Overall Study|Adverse Event|0|||
130528650|NCT01151423|469902371|FG000|Overall Study|Withdrawal by Subject|1|||
130528651|NCT01151423|469902372|FG001|Overall Study|Withdrawal by Subject|3|||
130528652|NCT01151423|469902371|FG000|Overall Study|Lost to Follow-up|1|||
130528653|NCT01151423|469902372|FG001|Overall Study|Lost to Follow-up|0|||
130528654|NCT01151423|469902371|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
130528655|NCT01151423|469902372|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
130528656|NCT01151423|469902371|FG000|Overall Study|Participated in other clinical trial|1|||
130528657|NCT01151423|469902372|FG001|Overall Study|Participated in other clinical trial|0|||
130528658|NCT02568397|469904996|FG000|Period 2|Withdrawal by Subject|0|||
130528659|NCT02568397|469904997|FG001|Period 2|Withdrawal by Subject|1|||
130528660|NCT02568397|469904996|FG000|Period 2|Physician Decision|0|||
130528661|NCT02568397|469904997|FG001|Period 2|Physician Decision|1|||
130528662|NCT01317875|469904998|FG000|Overall Study|Other|0|||
130528663|NCT01317875|469904999|FG001|Overall Study|Other|0|||
130528664|NCT01317875|469905000|FG002|Overall Study|Other|1|||
130528665|NCT01317875|469905001|FG003|Overall Study|Other|0|||
130528666|NCT01317875|469905002|FG004|Overall Study|Other|0|||
130528667|NCT01317875|469905003|FG005|Overall Study|Other|0|||
130528668|NCT01317875|469905004|FG006|Overall Study|Other|0|||
130528669|NCT01317875|469905005|FG007|Overall Study|Other|0|||
130528670|NCT01317875|469905006|FG008|Overall Study|Other|0|||
130528671|NCT01317875|469905007|FG009|Overall Study|Other|0|||
130528672|NCT01317875|469904998|FG000|Overall Study|Noncompliance with study drug|0|||
130528673|NCT01317875|469904999|FG001|Overall Study|Noncompliance with study drug|0|||
130528674|NCT01317875|469905000|FG002|Overall Study|Noncompliance with study drug|1|||
130528675|NCT01317875|469905001|FG003|Overall Study|Noncompliance with study drug|0|||
130528676|NCT01317875|469905002|FG004|Overall Study|Noncompliance with study drug|0|||
130528677|NCT01317875|469905003|FG005|Overall Study|Noncompliance with study drug|0|||
130528678|NCT01317875|469905004|FG006|Overall Study|Noncompliance with study drug|0|||
130528679|NCT01317875|469905005|FG007|Overall Study|Noncompliance with study drug|0|||
130528680|NCT01317875|469905006|FG008|Overall Study|Noncompliance with study drug|0|||
130528681|NCT01317875|469905007|FG009|Overall Study|Noncompliance with study drug|0|||
130528682|NCT01317875|469904998|FG000|Overall Study|Progressive Disease|1|||
130528683|NCT01317875|469904999|FG001|Overall Study|Progressive Disease|0|||
130528684|NCT01317875|469905000|FG002|Overall Study|Progressive Disease|2|||
130528685|NCT01317875|469905001|FG003|Overall Study|Progressive Disease|0|||
130528686|NCT01317875|469905002|FG004|Overall Study|Progressive Disease|1|||
130528687|NCT01317875|469905003|FG005|Overall Study|Progressive Disease|0|||
130528688|NCT01317875|469905004|FG006|Overall Study|Progressive Disease|0|||
130528689|NCT01317875|469905005|FG007|Overall Study|Progressive Disease|1|||
130528690|NCT01317875|469905006|FG008|Overall Study|Progressive Disease|0|||
130528691|NCT01317875|469905007|FG009|Overall Study|Progressive Disease|0|||
130528692|NCT01317875|469904998|FG000|Overall Study|Withdrawal by Subject|0|||
130528693|NCT01317875|469904999|FG001|Overall Study|Withdrawal by Subject|0|||
130528694|NCT01317875|469905000|FG002|Overall Study|Withdrawal by Subject|0|||
130528695|NCT01317875|469905001|FG003|Overall Study|Withdrawal by Subject|0|||
130528696|NCT01317875|469905002|FG004|Overall Study|Withdrawal by Subject|1|||
130528697|NCT01317875|469905003|FG005|Overall Study|Withdrawal by Subject|0|||
130528698|NCT01317875|469905004|FG006|Overall Study|Withdrawal by Subject|0|||
130528699|NCT01317875|469905005|FG007|Overall Study|Withdrawal by Subject|3|||
130528700|NCT01317875|469905006|FG008|Overall Study|Withdrawal by Subject|0|||
130528701|NCT01317875|469905007|FG009|Overall Study|Withdrawal by Subject|0|||
130528702|NCT01317875|469904998|FG000|Overall Study|Physician Decision|0|||
130528703|NCT01317875|469904999|FG001|Overall Study|Physician Decision|1|||
130528704|NCT01317875|469905000|FG002|Overall Study|Physician Decision|1|||
130528705|NCT01317875|469905001|FG003|Overall Study|Physician Decision|0|||
130528706|NCT01317875|469905002|FG004|Overall Study|Physician Decision|2|||
130528707|NCT01317875|469905003|FG005|Overall Study|Physician Decision|0|||
130528708|NCT01317875|469905004|FG006|Overall Study|Physician Decision|0|||
130528709|NCT01317875|469905005|FG007|Overall Study|Physician Decision|2|||
130528710|NCT01317875|469905006|FG008|Overall Study|Physician Decision|0|||
130528711|NCT01317875|469905007|FG009|Overall Study|Physician Decision|0|||
130528712|NCT01317875|469904998|FG000|Overall Study|Death|0|||
130528713|NCT01317875|469904999|FG001|Overall Study|Death|0|||
130528714|NCT01317875|469905000|FG002|Overall Study|Death|2|||
130528715|NCT01317875|469905001|FG003|Overall Study|Death|1|||
130528716|NCT01317875|469905002|FG004|Overall Study|Death|0|||
130528717|NCT01317875|469905003|FG005|Overall Study|Death|1|||
130528718|NCT01317875|469905004|FG006|Overall Study|Death|0|||
130528719|NCT01317875|469905005|FG007|Overall Study|Death|4|||
130528720|NCT01317875|469905006|FG008|Overall Study|Death|0|||
130528721|NCT01317875|469905007|FG009|Overall Study|Death|0|||
130528722|NCT01317875|469904998|FG000|Overall Study|Adverse Event|2|||
130528723|NCT01317875|469904999|FG001|Overall Study|Adverse Event|1|||
130528724|NCT01317875|469905000|FG002|Overall Study|Adverse Event|2|||
130528725|NCT01317875|469905001|FG003|Overall Study|Adverse Event|1|||
130528726|NCT01317875|469905002|FG004|Overall Study|Adverse Event|5|||
130528727|NCT01317875|469905003|FG005|Overall Study|Adverse Event|1|||
130528728|NCT01317875|469905004|FG006|Overall Study|Adverse Event|2|||
130528729|NCT01317875|469905005|FG007|Overall Study|Adverse Event|5|||
130528730|NCT01317875|469905006|FG008|Overall Study|Adverse Event|0|||
130528731|NCT01317875|469905007|FG009|Overall Study|Adverse Event|0|||
130528732|NCT02514239|469905008|FG000|Overall Study|Refused to continue trial medication|0|||
130528733|NCT02514239|469905009|FG001|Overall Study|Refused to continue trial medication|0|||
130528734|NCT02514239|469905010|FG002|Overall Study|Refused to continue trial medication|0|||
130528735|NCT02514239|469905011|FG003|Overall Study|Refused to continue trial medication|0|||
130528736|NCT02514239|469905012|FG004|Overall Study|Refused to continue trial medication|0|||
130528737|NCT02514239|469905013|FG005|Overall Study|Refused to continue trial medication|0|||
130528738|NCT02514239|469905014|FG006|Overall Study|Refused to continue trial medication|0|||
130528739|NCT02514239|469905015|FG007|Overall Study|Refused to continue trial medication|0|||
130528740|NCT02514239|469905016|FG008|Overall Study|Refused to continue trial medication|0|||
130528741|NCT02514239|469905017|FG009|Overall Study|Refused to continue trial medication|1|||
130528742|NCT02514239|469905008|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528743|NCT02514239|469905009|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528744|NCT02514239|469905010|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528745|NCT02514239|469905011|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528746|NCT02514239|469905012|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528747|NCT02514239|469905013|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528748|NCT02514239|469905014|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528749|NCT02514239|469905015|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
130528750|NCT02514239|469905016|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
130528751|NCT02514239|469905017|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
130528752|NCT02514239|469905008|FG000|Overall Study|Not treated|0|||
130528753|NCT02514239|469905009|FG001|Overall Study|Not treated|1|||
130528754|NCT02514239|469905010|FG002|Overall Study|Not treated|0|||
130528755|NCT02514239|469905011|FG003|Overall Study|Not treated|0|||
130528756|NCT02514239|469905012|FG004|Overall Study|Not treated|0|||
130528757|NCT02514239|469905013|FG005|Overall Study|Not treated|0|||
130528758|NCT02514239|469905014|FG006|Overall Study|Not treated|0|||
130528759|NCT02514239|469905015|FG007|Overall Study|Not treated|0|||
130528760|NCT02514239|469905016|FG008|Overall Study|Not treated|0|||
130528761|NCT02514239|469905017|FG009|Overall Study|Not treated|0|||
130528762|NCT02514239|469905008|FG000|Overall Study|Other Adverse Events|2|||
130528763|NCT02514239|469905009|FG001|Overall Study|Other Adverse Events|0|||
130528764|NCT02514239|469905010|FG002|Overall Study|Other Adverse Events|0|||
130528765|NCT02514239|469905011|FG003|Overall Study|Other Adverse Events|1|||
130528766|NCT02514239|469905012|FG004|Overall Study|Other Adverse Events|0|||
130528767|NCT02514239|469905013|FG005|Overall Study|Other Adverse Events|1|||
130528768|NCT02514239|469905014|FG006|Overall Study|Other Adverse Events|0|||
130528769|NCT02514239|469905015|FG007|Overall Study|Other Adverse Events|1|||
130528770|NCT02514239|469905016|FG008|Overall Study|Other Adverse Events|2|||
130528771|NCT02514239|469905017|FG009|Overall Study|Other Adverse Events|0|||
130528772|NCT02514239|469905008|FG000|Overall Study|Progressive disease|3|||
130528773|NCT02514239|469905009|FG001|Overall Study|Progressive disease|3|||
130528774|NCT02514239|469905010|FG002|Overall Study|Progressive disease|2|||
130528775|NCT02514239|469905011|FG003|Overall Study|Progressive disease|2|||
130528776|NCT02514239|469905012|FG004|Overall Study|Progressive disease|3|||
130528777|NCT02514239|469905013|FG005|Overall Study|Progressive disease|3|||
130528778|NCT02514239|469905014|FG006|Overall Study|Progressive disease|4|||
130528779|NCT02514239|469905015|FG007|Overall Study|Progressive disease|2|||
130528780|NCT02514239|469905016|FG008|Overall Study|Progressive disease|5|||
130528781|NCT02514239|469905017|FG009|Overall Study|Progressive disease|0|||
130528782|NCT01483144|469905018|FG000|Overall Study|Adverse Event|9|||
130528783|NCT01483144|469905019|FG001|Overall Study|Adverse Event|4|||
130528784|NCT01483144|469905020|FG002|Overall Study|Adverse Event|6|||
130528785|NCT01483144|469905018|FG000|Overall Study|Withdrawal by Subject|0|||
130528786|NCT01483144|469905019|FG001|Overall Study|Withdrawal by Subject|2|||
130528787|NCT01483144|469905020|FG002|Overall Study|Withdrawal by Subject|5|||
130528788|NCT01483144|469905018|FG000|Overall Study|Physician Decision|1|||
130528789|NCT01483144|469905019|FG001|Overall Study|Physician Decision|0|||
130528790|NCT01483144|469905020|FG002|Overall Study|Physician Decision|0|||
130528791|NCT01483144|469905018|FG000|Overall Study|Lost to Follow-up|2|||
130528792|NCT01483144|469905019|FG001|Overall Study|Lost to Follow-up|4|||
130528793|NCT01483144|469905020|FG002|Overall Study|Lost to Follow-up|1|||
130528794|NCT01483144|469905018|FG000|Overall Study|Protocol Violation|3|||
130528795|NCT01483144|469905019|FG001|Overall Study|Protocol Violation|3|||
130528796|NCT01483144|469905020|FG002|Overall Study|Protocol Violation|3|||
130528797|NCT03258723|469905023|FG000|Overall Study|COVID Interruption of study|54|||
130528798|NCT03258723|469905023|FG000|Overall Study|Lost to Follow-up|8|||
130528799|NCT01107899|469905027|FG000|Overall Study|Physician Decision|5|||
130528800|NCT01107899|469905028|FG001|Overall Study|Physician Decision|0|||
130528801|NCT01107899|469905029|FG002|Overall Study|Physician Decision|3|||
130528802|NCT01107899|469905027|FG000|Overall Study|Withdrawal by Subject|0|||
130528803|NCT01107899|469905028|FG001|Overall Study|Withdrawal by Subject|0|||
130528804|NCT01107899|469905029|FG002|Overall Study|Withdrawal by Subject|1|||
130528805|NCT00974259|469905030|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
130528806|NCT00974259|469905031|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
130528807|NCT00944229|469905034|FG000|Overall Study|Withdrawal by Subject|11|||
130528808|NCT00944229|469905034|FG000|Overall Study|Physician Decision|14|||
130528809|NCT01810939|469905039|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
130528810|NCT01810939|469905040|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
130528811|NCT01810939|469905041|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
130528812|NCT01810939|469905039|FG000|Part A Treatment Period|Protocol Violation|2|||
130528813|NCT01810939|469905040|FG001|Part A Treatment Period|Protocol Violation|0|||
130528814|NCT01810939|469905041|FG002|Part A Treatment Period|Protocol Violation|0|||
130528815|NCT01810939|469905039|FG000|Part A Treatment Period|Adverse Event|10|||
130528816|NCT01810939|469905040|FG001|Part A Treatment Period|Adverse Event|0|||
130528817|NCT01810939|469905041|FG002|Part A Treatment Period|Adverse Event|0|||
130528818|NCT01810939|469905039|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
130528819|NCT01810939|469905040|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
130528820|NCT01810939|469905041|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
130528821|NCT01810939|469905039|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
130528822|NCT01810939|469905040|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
130528823|NCT01810939|469905041|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
130528824|NCT01810939|469905039|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
130528825|NCT01810939|469905040|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
130528826|NCT01810939|469905041|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
130528827|NCT01810939|469905039|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
130528828|NCT01810939|469905040|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
130528829|NCT01810939|469905041|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
130528830|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
130528831|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
130528832|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
130528833|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
130528834|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
130528835|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
130528836|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
130528837|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
130528838|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
130528839|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
130528840|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
130528841|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
130528842|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
130528843|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
130528844|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
130528845|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
130528846|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
130528847|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
130528848|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
130528849|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
130528850|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
130528851|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
130528852|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
130528853|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
130528854|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
130528855|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
130528856|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
130528857|NCT01810939|469905039|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
130528858|NCT01810939|469905040|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
130528859|NCT01810939|469905041|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
130528860|NCT00079339|469905048|FG000|Overall Study|Adverse Event|1|||
130528861|NCT00079339|469905049|FG001|Overall Study|Adverse Event|7|||
130528862|NCT00079339|469905050|FG002|Overall Study|Adverse Event|2|||
130528863|NCT00079339|469905048|FG000|Overall Study|Death|1|||
130528864|NCT00079339|469905049|FG001|Overall Study|Death|0|||
130528865|NCT00079339|469905050|FG002|Overall Study|Death|0|||
130528866|NCT00079339|469905048|FG000|Overall Study|Non-compliance|0|||
130528867|NCT00079339|469905049|FG001|Overall Study|Non-compliance|0|||
130528868|NCT00079339|469905050|FG002|Overall Study|Non-compliance|1|||
130528869|NCT00079339|469905048|FG000|Overall Study|Withdrawal by Subject|0|||
130528870|NCT00079339|469905049|FG001|Overall Study|Withdrawal by Subject|4|||
130528871|NCT00079339|469905050|FG002|Overall Study|Withdrawal by Subject|1|||
130528872|NCT00079339|469905048|FG000|Overall Study|Disease progression|3|||
130528873|NCT00079339|469905049|FG001|Overall Study|Disease progression|28|||
130528874|NCT00079339|469905050|FG002|Overall Study|Disease progression|2|||
130528875|NCT00520845|469905051|FG000|Overall Study|Death|3|||
130528876|NCT00520845|469905051|FG000|Overall Study|Adverse Event|4|||
130528877|NCT00520845|469905051|FG000|Overall Study|Disease Progression, relapse|13|||
130528878|NCT00520845|469905051|FG000|Overall Study|Withdrawal by Subject|1|||
130528879|NCT00520845|469905051|FG000|Overall Study|Alternative Therapy|1|||
130528880|NCT03274453|469905052|FG000|Overall Study|Lost to Follow-up|2|||
130528881|NCT03274453|469905053|FG001|Overall Study|Lost to Follow-up|5|||
130528882|NCT03274453|469905054|FG002|Overall Study|Lost to Follow-up|4|||
130528883|NCT03274453|469905055|FG003|Overall Study|Lost to Follow-up|1|||
130528884|NCT03274453|469905052|FG000|Overall Study|Physician Decision|2|||
130528885|NCT03274453|469905053|FG001|Overall Study|Physician Decision|0|||
130528886|NCT03274453|469905054|FG002|Overall Study|Physician Decision|0|||
130528887|NCT03274453|469905055|FG003|Overall Study|Physician Decision|3|||
130528888|NCT03274453|469905052|FG000|Overall Study|Surgery Cancelled|0|||
130528889|NCT03274453|469905053|FG001|Overall Study|Surgery Cancelled|1|||
130528890|NCT03274453|469905054|FG002|Overall Study|Surgery Cancelled|0|||
130528891|NCT03274453|469905055|FG003|Overall Study|Surgery Cancelled|0|||
130528892|NCT00945672|469905058|FG000|Overall Study|Withdrawal by Subject|0|||
130528893|NCT00945672|469905059|FG001|Overall Study|Withdrawal by Subject|0|||
130528894|NCT00945672|469905060|FG002|Overall Study|Withdrawal by Subject|0|||
130528895|NCT00945672|469905061|FG003|Overall Study|Withdrawal by Subject|1|||
130528896|NCT03845140|469905064|FG000|Overall Study|Participant travelled outside study area|0|||
130528897|NCT03845140|469905065|FG001|Overall Study|Participant travelled outside study area|1|||
130528898|NCT03845140|469905066|FG002|Overall Study|Participant travelled outside study area|0|||
130528899|NCT03845140|469905067|FG003|Overall Study|Participant travelled outside study area|0|||
130528900|NCT03845140|469905068|FG004|Overall Study|Participant travelled outside study area|0|||
130528901|NCT03845140|469905069|FG005|Overall Study|Participant travelled outside study area|0|||
130528902|NCT01592045|469905070|FG000|Overall Study|Disease Progression|1|||
130528903|NCT01592045|469905071|FG001|Overall Study|Disease Progression|1|||
130528904|NCT01592045|469905070|FG000|Overall Study|Adverse Event|1|||
130528905|NCT01592045|469905071|FG001|Overall Study|Adverse Event|1|||
130528906|NCT01592045|469905070|FG000|Overall Study|Withdrawal by Subject|1|||
130528907|NCT01592045|469905071|FG001|Overall Study|Withdrawal by Subject|0|||
130528908|NCT01592045|469905070|FG000|Overall Study|Moved out of country|2|||
130528909|NCT01592045|469905071|FG001|Overall Study|Moved out of country|0|||
130528910|NCT01681992|469905074|FG000|Overall Study|Adverse Event|3|||
130528911|NCT01681992|469905075|FG001|Overall Study|Adverse Event|2|||
130528912|NCT01681992|469905076|FG002|Overall Study|Adverse Event|3|||
130528913|NCT01681992|469905074|FG000|Overall Study|Lost to Follow-up|36|||
130528914|NCT01681992|469905075|FG001|Overall Study|Lost to Follow-up|38|||
130528915|NCT01681992|469905076|FG002|Overall Study|Lost to Follow-up|53|||
130528916|NCT01681992|469905074|FG000|Overall Study|As Per Sponsor Decision|0|||
130528917|NCT01681992|469905075|FG001|Overall Study|As Per Sponsor Decision|0|||
130528918|NCT01681992|469905076|FG002|Overall Study|As Per Sponsor Decision|1|||
130528919|NCT01681992|469905074|FG000|Overall Study|Protocol Violation|0|||
130528920|NCT01681992|469905075|FG001|Overall Study|Protocol Violation|0|||
130528921|NCT01681992|469905076|FG002|Overall Study|Protocol Violation|1|||
130528922|NCT01681992|469905074|FG000|Overall Study|Withdrawal by Subject|27|||
130528923|NCT01681992|469905075|FG001|Overall Study|Withdrawal by Subject|30|||
130528924|NCT01681992|469905076|FG002|Overall Study|Withdrawal by Subject|25|||
130528925|NCT01661205|469905081|FG000|Overall Study|Physician Decision|2|||
130528926|NCT03111095|469905084|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
130528927|NCT03111095|469905085|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
130528928|NCT03111095|469905084|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
130528929|NCT03111095|469905085|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
130528930|NCT00504075|469905086|FG000|Overall Study|Adverse Event|1|||
130528931|NCT00504075|469905086|FG000|Overall Study|Lost to Follow-up|5|||
130528932|NCT00504075|469905086|FG000|Overall Study|Withdrawal by Subject|1|||
130528933|NCT00504075|469905086|FG000|Overall Study|Required other therapeutic intervention|1|||
130528934|NCT03812029|469905093|FG000|Overall Study|Protocol Violation|1|||
130528935|NCT03812029|469905094|FG001|Overall Study|Protocol Violation|0|||
130528936|NCT03812029|469905095|FG002|Overall Study|Protocol Violation|0|||
130528937|NCT03812029|469905096|FG003|Overall Study|Protocol Violation|1|||
130528938|NCT03812029|469905097|FG004|Overall Study|Protocol Violation|0|||
130528939|NCT03812029|469905093|FG000|Overall Study|Withdrawal by Subject|1|||
130528940|NCT03812029|469905094|FG001|Overall Study|Withdrawal by Subject|0|||
130528941|NCT03812029|469905095|FG002|Overall Study|Withdrawal by Subject|0|||
130528942|NCT03812029|469905096|FG003|Overall Study|Withdrawal by Subject|2|||
130528943|NCT03812029|469905097|FG004|Overall Study|Withdrawal by Subject|2|||
130528944|NCT03812029|469905093|FG000|Overall Study|Stopping rules|0|||
130528945|NCT03812029|469905094|FG001|Overall Study|Stopping rules|1|||
130528946|NCT03812029|469905095|FG002|Overall Study|Stopping rules|0|||
130528947|NCT03812029|469905096|FG003|Overall Study|Stopping rules|0|||
130528948|NCT03812029|469905097|FG004|Overall Study|Stopping rules|0|||
130528949|NCT03812029|469905093|FG000|Overall Study|Adverse Event|0|||
130528950|NCT03812029|469905094|FG001|Overall Study|Adverse Event|9|||
130528951|NCT03812029|469905095|FG002|Overall Study|Adverse Event|0|||
130528952|NCT03812029|469905096|FG003|Overall Study|Adverse Event|3|||
130528953|NCT03812029|469905097|FG004|Overall Study|Adverse Event|5|||
130528954|NCT03812029|469905093|FG000|Overall Study|Lost to Follow-up|0|||
130528955|NCT03812029|469905094|FG001|Overall Study|Lost to Follow-up|0|||
130528956|NCT03812029|469905095|FG002|Overall Study|Lost to Follow-up|0|||
130528957|NCT03812029|469905096|FG003|Overall Study|Lost to Follow-up|0|||
130528958|NCT03812029|469905097|FG004|Overall Study|Lost to Follow-up|3|||
130528959|NCT03149042|469905098|FG000|Overall Study|Invasive FFR not performed|21|||
130528960|NCT03149042|469905098|FG000|Overall Study|Poor CT Image Quality|1|||
130528961|NCT03149042|469905098|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
130528962|NCT04245345|469905109|FG000|Overall Study|Death|1|||
130528963|NCT04245345|469905109|FG000|Overall Study|Exited prior to implant|5|||
130528964|NCT04245345|469905109|FG000|Overall Study|Exited prior to 1-month|9|||
130528965|NCT04245345|469905109|FG000|Overall Study|Missed 1-month visit|3|||
130528966|NCT04245345|469905109|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
130528967|NCT04245345|469905109|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
130528968|NCT00732992|469905110|FG000|Overall Study|Adverse Event|1|||
130528969|NCT00732992|469905111|FG001|Overall Study|Adverse Event|1|||
130528970|NCT00732992|469905110|FG000|Overall Study|Objective Progression or Relapse|3|||
130528971|NCT00732992|469905111|FG001|Overall Study|Objective Progression or Relapse|5|||
130528972|NCT00732992|469905110|FG000|Overall Study|Global Deterioration of Health Status|1|||
130528973|NCT00732992|469905111|FG001|Overall Study|Global Deterioration of Health Status|0|||
130528974|NCT00732992|469905110|FG000|Overall Study|Withdrawal by Subject|1|||
130528975|NCT00732992|469905111|FG001|Overall Study|Withdrawal by Subject|0|||
130528976|NCT02344342|469905112|FG000|Overall Study|Industry partner dropped out|11|||
130528977|NCT02344342|469905113|FG001|Overall Study|Industry partner dropped out|9|||
130528978|NCT02344342|469905114|FG002|Overall Study|Industry partner dropped out|14|||
130528979|NCT02344342|469905115|FG003|Overall Study|Industry partner dropped out|10|||
130528980|NCT03355209|469905117|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
130528981|NCT03355209|469905118|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
130528982|NCT03355209|469905119|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
130528983|NCT03355209|469905120|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
130528984|NCT03355209|469905121|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
130528985|NCT03355209|469905122|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
130528986|NCT03355209|469905117|FG000|Part 1: Double-Blind Period|Death|0|||
130528987|NCT03355209|469905118|FG001|Part 1: Double-Blind Period|Death|0|||
130528988|NCT03355209|469905119|FG002|Part 1: Double-Blind Period|Death|1|||
130528989|NCT03355209|469905120|FG003|Part 1: Double-Blind Period|Death|0|||
130528990|NCT03355209|469905121|FG004|Part 1: Double-Blind Period|Death|0|||
130528991|NCT03355209|469905122|FG005|Part 1: Double-Blind Period|Death|0|||
130528992|NCT03355209|469905117|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
130528993|NCT03355209|469905118|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
130528994|NCT03355209|469905119|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
130528995|NCT03355209|469905120|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
130528996|NCT03355209|469905121|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
130528997|NCT03355209|469905122|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
130528998|NCT03355209|469905117|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
130528999|NCT03355209|469905118|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
130529000|NCT03355209|469905119|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
130529001|NCT03355209|469905120|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130529002|NCT03355209|469905121|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130529003|NCT03355209|469905122|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130529004|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
130529005|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
130529006|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
130529007|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
130529008|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
130529009|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
130529010|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
130529011|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
130529012|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
130529013|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
130529014|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
130529015|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
130529016|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
130529017|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
130529018|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
130529019|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
130529020|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
130529021|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
130529022|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
130529023|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
130529024|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
130529025|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
130529026|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
130529027|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
130529028|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
130529029|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
130529030|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
130529031|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130529032|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130529033|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130529034|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
130529035|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
130529036|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
130529037|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
130529038|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
130529039|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
130529040|NCT03355209|469905117|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
130529041|NCT03355209|469905118|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
130529042|NCT03355209|469905119|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
130529043|NCT03355209|469905120|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
130529044|NCT03355209|469905121|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
130529045|NCT03355209|469905122|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
130529046|NCT03690427|469905126|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
130529047|NCT03690427|469905127|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
130529048|NCT02609672|469905132|FG000|Overall Study|Lost to Follow-up|3|||
130529049|NCT02609672|469905133|FG001|Overall Study|Lost to Follow-up|1|||
130529050|NCT02956837|469905134|FG000|Overall Study|Serious Adverse Events|0|||
130529051|NCT02956837|469905135|FG001|Overall Study|Serious Adverse Events|1|||
130529052|NCT02956837|469905136|FG002|Overall Study|Serious Adverse Events|0|||
130529053|NCT02956837|469905137|FG003|Overall Study|Serious Adverse Events|0|||
130529054|NCT02956837|469905134|FG000|Overall Study|Withdrawal by Subject|0|||
130529055|NCT02956837|469905135|FG001|Overall Study|Withdrawal by Subject|1|||
130529056|NCT02956837|469905136|FG002|Overall Study|Withdrawal by Subject|0|||
130529057|NCT02956837|469905137|FG003|Overall Study|Withdrawal by Subject|3|||
130529058|NCT02956837|469905134|FG000|Overall Study|Lost to Follow-up|0|||
130529059|NCT02956837|469905135|FG001|Overall Study|Lost to Follow-up|1|||
130529060|NCT02956837|469905136|FG002|Overall Study|Lost to Follow-up|2|||
130529061|NCT02956837|469905137|FG003|Overall Study|Lost to Follow-up|0|||
130529062|NCT02597712|469905138|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
130529063|NCT02597712|469905139|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
130529064|NCT02597712|469905138|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
130529065|NCT02597712|469905139|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
130529066|NCT02597712|469905138|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
130529067|NCT02597712|469905139|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
130529068|NCT02637323|469905140|FG000|Overall Study|Lost to Follow-up|2|||
130529069|NCT02637323|469905141|FG001|Overall Study|Lost to Follow-up|0|||
130529070|NCT02637323|469905140|FG000|Overall Study|Protocol Violation|0|||
130529071|NCT02637323|469905141|FG001|Overall Study|Protocol Violation|1|||
130529072|NCT01825577|469905142|FG000|Overall Study|Physician Decision|2|||
130529073|NCT01825577|469905142|FG000|Overall Study|Withdrawal by Subject|1|||
130529074|NCT01825577|469905142|FG000|Overall Study|Withdrawn by family members|2|||
130529075|NCT01825577|469905142|FG000|Overall Study|Lack of Efficacy|3|||
130529076|NCT00358644|469905143|FG000|Overall Study|Progressive Disease|21|||
130529077|NCT00358644|469905143|FG000|Overall Study|Adverse Event|7|||
130529078|NCT00358644|469905143|FG000|Overall Study|Death|11|||
130529079|NCT00358644|469905143|FG000|Overall Study|Withdrawal by Subject|4|||
130529080|NCT00358644|469905143|FG000|Overall Study|Physician Decision|6|||
130529081|NCT00358644|469905143|FG000|Overall Study|Patient not eligible for study|1|||
130529082|NCT00513708|469905144|FG000|Overall Study|Lost to Follow-up|4|||
130529083|NCT00513708|469905145|FG001|Overall Study|Lost to Follow-up|4|||
130529084|NCT00513708|469905146|FG002|Overall Study|Lost to Follow-up|4|||
130529085|NCT03327831|469905147|FG000|Overall Study|Lost to Follow-up|2|||
130529086|NCT01162486|469905148|FG000|Overall Study|low ANC|1|||
130529087|NCT01162486|469905149|FG001|Overall Study|low ANC|0|||
130529088|NCT01162486|469905150|FG002|Overall Study|low ANC|0|||
130529089|NCT01162486|469905151|FG003|Overall Study|low ANC|0|||
130529090|NCT01162486|469905152|FG004|Overall Study|low ANC|0|||
130529091|NCT01162486|469905148|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
130529092|NCT01162486|469905149|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
130529093|NCT01162486|469905150|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
130529094|NCT01162486|469905151|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
130529095|NCT01162486|469905152|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
130529096|NCT01162486|469905148|FG000|Overall Study|elevated LFTs|0|||
130529097|NCT01162486|469905149|FG001|Overall Study|elevated LFTs|0|||
130529098|NCT01162486|469905150|FG002|Overall Study|elevated LFTs|1|||
130529099|NCT01162486|469905151|FG003|Overall Study|elevated LFTs|0|||
130529100|NCT01162486|469905152|FG004|Overall Study|elevated LFTs|0|||
130529101|NCT01162486|469905148|FG000|Overall Study|Pregnancy|0|||
130529102|NCT01162486|469905149|FG001|Overall Study|Pregnancy|0|||
130529103|NCT01162486|469905150|FG002|Overall Study|Pregnancy|0|||
130529104|NCT01162486|469905151|FG003|Overall Study|Pregnancy|1|||
130529105|NCT01162486|469905152|FG004|Overall Study|Pregnancy|0|||
130529106|NCT03332784|469905155|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529107|NCT03332784|469905156|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
130529108|NCT03332784|469905157|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529109|NCT03332784|469905158|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529110|NCT03332784|469905159|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529111|NCT03332784|469905160|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529112|NCT03332784|469905161|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529113|NCT03332784|469905162|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529114|NCT03332784|469905163|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529115|NCT03332784|469905164|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529116|NCT03332784|469905165|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529117|NCT03332784|469905166|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529118|NCT03332784|469905167|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529119|NCT03332784|469905168|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529120|NCT03332784|469905169|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
130529121|NCT03332784|469905170|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529122|NCT03332784|469905171|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529123|NCT03332784|469905172|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529124|NCT03332784|469905173|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130578286|NCT01928381|470080516|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130578287|NCT01928381|470080517|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130578288|NCT01928381|470080518|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130529125|NCT03332784|469905174|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
130529126|NCT00401258|469905175|FG000|Overall Study|Adverse Event|7|||
130529127|NCT01430468|469905176|FG000|Overall Study|Physician Decision|2|||
130529128|NCT01430468|469905177|FG001|Overall Study|Physician Decision|1|||
130529129|NCT01430468|469905176|FG000|Overall Study|Withdrawal by Subject|5|||
130529130|NCT01430468|469905177|FG001|Overall Study|Withdrawal by Subject|5|||
130529131|NCT00760747|469905182|FG000|Study Period II|Adverse Event|3|||
130529132|NCT00760747|469905183|FG001|Study Period II|Adverse Event|4|||
130529133|NCT00760747|469905182|FG000|Study Period II|Lack of Efficacy|0|||
130529134|NCT00760747|469905183|FG001|Study Period II|Lack of Efficacy|6|||
130529135|NCT00760747|469905182|FG000|Study Period II|Parent/Caregiver Decision|3|||
130529136|NCT00760747|469905183|FG001|Study Period II|Parent/Caregiver Decision|0|||
130529137|NCT00760747|469905182|FG000|Study Period II|Protocol Violation|6|||
130529138|NCT00760747|469905183|FG001|Study Period II|Protocol Violation|3|||
130529139|NCT00760747|469905182|FG000|Study Period II|Withdrawal by Subject|1|||
130529140|NCT00760747|469905183|FG001|Study Period II|Withdrawal by Subject|0|||
130529141|NCT00760747|469905182|FG000|Study Period II|No drug administered|0|||
130529142|NCT00760747|469905183|FG001|Study Period II|No drug administered|1|||
130529143|NCT00760747|469905182|FG000|Study Period III|Adverse Event|1|||
130529144|NCT00760747|469905183|FG001|Study Period III|Adverse Event|0|||
130529145|NCT00760747|469905182|FG000|Study Period III|Lack of Efficacy|1|||
130529146|NCT00760747|469905183|FG001|Study Period III|Lack of Efficacy|0|||
130529147|NCT00760747|469905182|FG000|Study Period III|Parent/Caregiver Decision|0|||
130529148|NCT00760747|469905183|FG001|Study Period III|Parent/Caregiver Decision|1|||
130529149|NCT00760747|469905182|FG000|Study Period III|Protocol Violation|1|||
130529150|NCT00760747|469905183|FG001|Study Period III|Protocol Violation|1|||
130529151|NCT00760747|469905182|FG000|Study Period III|Physician Decision|0|||
130529152|NCT00760747|469905183|FG001|Study Period III|Physician Decision|1|||
130529153|NCT01443923|469905184|FG000|Overall Study|Adverse Event|1|||
130529154|NCT01443923|469905185|FG001|Overall Study|Adverse Event|0|||
130529155|NCT00108745|469905186|FG000|Overall Study|Withdrawal by Subject|19|||
130529156|NCT00108745|469905187|FG001|Overall Study|Withdrawal by Subject|12|||
130529157|NCT00108745|469905188|FG002|Overall Study|Withdrawal by Subject|12|||
130529158|NCT00108745|469905186|FG000|Overall Study|Never Treated|8|||
130529159|NCT00108745|469905187|FG001|Overall Study|Never Treated|10|||
130529160|NCT00108745|469905188|FG002|Overall Study|Never Treated|12|||
130529161|NCT00108745|469905186|FG000|Overall Study|Ineligible|7|||
130529162|NCT00108745|469905187|FG001|Overall Study|Ineligible|13|||
130529163|NCT00108745|469905188|FG002|Overall Study|Ineligible|13|||
130529164|NCT01889069|469905189|FG000|Overall Study|Death|18|||
130529165|NCT01889069|469905189|FG000|Overall Study|Progression of Disease|14|||
130529166|NCT01889069|469905189|FG000|Overall Study|Lost to Follow-up|6|||
130529167|NCT01889069|469905189|FG000|Overall Study|Other|4|||
130529168|NCT01889069|469905189|FG000|Overall Study|Consent Withdrawal|3|||
130529169|NCT01426347|469905191|FG000|Overall Study|Lost to Follow-up|0|||
130529170|NCT01426347|469905192|FG001|Overall Study|Lost to Follow-up|3|||
130529171|NCT01426347|469905191|FG000|Overall Study|Protocol Violation|2|||
130529172|NCT01426347|469905192|FG001|Overall Study|Protocol Violation|0|||
130529173|NCT01426347|469905191|FG000|Overall Study|Withdrawal by Subject|5|||
130529174|NCT01426347|469905192|FG001|Overall Study|Withdrawal by Subject|0|||
130529175|NCT00455741|469905193|FG000|Overall Study|Physician Decision|0|||
130529176|NCT00455741|469905194|FG001|Overall Study|Physician Decision|1|||
130529177|NCT01245374|469905199|FG000|Overall Study|Protocol Violation|1|||
130529178|NCT01245374|469905199|FG000|Overall Study|Withdrawal by Subject|3|||
130529179|NCT00935532|469905200|FG000|Overall Study|Adverse Event|11|||
130529180|NCT00935532|469905201|FG001|Overall Study|Adverse Event|6|||
130529181|NCT00935532|469905200|FG000|Overall Study|Death|1|||
130529182|NCT00935532|469905201|FG001|Overall Study|Death|0|||
130529183|NCT00935532|469905200|FG000|Overall Study|Lost to Follow-up|1|||
130529184|NCT00935532|469905201|FG001|Overall Study|Lost to Follow-up|0|||
130529185|NCT00935532|469905200|FG000|Overall Study|Physician Decision|1|||
130529186|NCT00935532|469905201|FG001|Overall Study|Physician Decision|2|||
130529187|NCT00935532|469905200|FG000|Overall Study|Protocol Violation|2|||
130529188|NCT00935532|469905201|FG001|Overall Study|Protocol Violation|1|||
130529189|NCT00935532|469905200|FG000|Overall Study|Subject Decision|2|||
130529190|NCT00935532|469905201|FG001|Overall Study|Subject Decision|1|||
130529191|NCT00935532|469905200|FG000|Overall Study|Sponsor Decision|0|||
130529192|NCT00935532|469905201|FG001|Overall Study|Sponsor Decision|1|||
130529193|NCT00935532|469905200|FG000|Overall Study|Loss Glucose Control|4|||
130529194|NCT00935532|469905201|FG001|Overall Study|Loss Glucose Control|0|||
130529195|NCT04954326|469905202|FG000|Overall Study|Protocol Violation|0|||
130529196|NCT04954326|469905203|FG001|Overall Study|Protocol Violation|1|||
130529197|NCT04954326|469905202|FG000|Overall Study|Death|0|||
130529198|NCT04954326|469905203|FG001|Overall Study|Death|2|||
130529199|NCT04954326|469905202|FG000|Overall Study|Physician Decision|0|||
130529200|NCT04954326|469905203|FG001|Overall Study|Physician Decision|1|||
130529201|NCT00475228|469905204|FG000|Overall Study|Lost to Follow-up|17|||
130529202|NCT00475228|469905205|FG001|Overall Study|Lost to Follow-up|17|||
130529203|NCT01183390|469907583|FG000|First Intervention|Adverse Event|0|||
130529204|NCT01183390|469907584|FG001|First Intervention|Adverse Event|1|||
130529205|NCT02358668|469907585|FG000|Overall Study|Adverse Event|2|||
130529206|NCT02358668|469907586|FG001|Overall Study|Adverse Event|0|||
130529207|NCT02358668|469907587|FG002|Overall Study|Adverse Event|0|||
130529208|NCT02358668|469907585|FG000|Overall Study|Withdrawal by Subject|0|||
130529209|NCT02358668|469907586|FG001|Overall Study|Withdrawal by Subject|1|||
130529210|NCT02358668|469907587|FG002|Overall Study|Withdrawal by Subject|0|||
130529211|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Adverse Event|2|||
130529212|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Adverse Event|0|||
130529213|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Adverse Event|0|||
130529214|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Adverse Event|0|||
130529215|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
130529216|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
130529217|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
130529218|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
130529219|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
130529220|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
130529221|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
130529222|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130529223|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Physician Decision|1|||
130529224|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Physician Decision|0|||
130529225|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Physician Decision|0|||
130529226|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Physician Decision|0|||
130529227|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Pregnancy|1|||
130529228|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Pregnancy|0|||
130529229|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Pregnancy|0|||
130529230|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Pregnancy|0|||
130529231|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
130529232|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
130529233|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130529234|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130529235|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
130529236|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
130529237|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
130529238|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
130529239|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
130529240|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
130529241|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
130529242|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
130529243|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
130529244|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
130529245|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
130529246|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
130529247|NCT04057573|469907588|FG000|24-Week Double-Blind Period|Not Treated|1|||
130529248|NCT04057573|469907589|FG001|24-Week Double-Blind Period|Not Treated|0|||
130529249|NCT04057573|469907590|FG002|24-Week Double-Blind Period|Not Treated|0|||
130529250|NCT04057573|469907591|FG003|24-Week Double-Blind Period|Not Treated|0|||
130529251|NCT04057573|469907588|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
130529252|NCT04057573|469907589|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
130529253|NCT04057573|469907590|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
130529254|NCT04057573|469907591|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
130529255|NCT04057573|469907588|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
130529256|NCT04057573|469907589|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
130529257|NCT04057573|469907590|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
130529258|NCT04057573|469907591|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
130529259|NCT04057573|469907588|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
130529260|NCT04057573|469907589|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
130529261|NCT04057573|469907590|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
130529262|NCT04057573|469907591|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
130529263|NCT04057573|469907588|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
130529264|NCT04057573|469907589|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
130529265|NCT04057573|469907590|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
130529266|NCT04057573|469907591|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
130529267|NCT04057573|469907588|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
130529268|NCT04057573|469907589|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
130529269|NCT04057573|469907590|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
130529270|NCT04057573|469907591|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
130529271|NCT01730950|469907596|FG000|Overall Study|Protocol Violation|6|||
130529272|NCT01730950|469907597|FG001|Overall Study|Protocol Violation|6|||
130529273|NCT00667459|469907598|FG000|Overall Study|Death|0|||
130529274|NCT00667459|469907599|FG001|Overall Study|Death|2|||
130529275|NCT00667459|469907598|FG000|Overall Study|Lost to Follow-up|8|||
130529276|NCT00667459|469907599|FG001|Overall Study|Lost to Follow-up|43|||
130529277|NCT01381575|469907600|FG000|Overall Study|Serious Adverse Event|1|||
130529278|NCT01381575|469907601|FG001|Overall Study|Serious Adverse Event|0|||
130529279|NCT01381575|469907602|FG002|Overall Study|Serious Adverse Event|0|||
130529280|NCT01381575|469907600|FG000|Overall Study|Non-Serious Adverse Event|0|||
130529281|NCT01381575|469907601|FG001|Overall Study|Non-Serious Adverse Event|0|||
130529282|NCT01381575|469907602|FG002|Overall Study|Non-Serious Adverse Event|1|||
130529283|NCT01381575|469907600|FG000|Overall Study|Protocol Violation|0|||
130529284|NCT01381575|469907601|FG001|Overall Study|Protocol Violation|1|||
130529285|NCT01381575|469907602|FG002|Overall Study|Protocol Violation|1|||
130529286|NCT01381575|469907600|FG000|Overall Study|Withdrawal by Subject|15|||
130529287|NCT01381575|469907601|FG001|Overall Study|Withdrawal by Subject|9|||
130529288|NCT01381575|469907602|FG002|Overall Study|Withdrawal by Subject|7|||
130529289|NCT01381575|469907600|FG000|Overall Study|Migrated/moved from study area|2|||
130529290|NCT01381575|469907601|FG001|Overall Study|Migrated/moved from study area|12|||
130529291|NCT01381575|469907602|FG002|Overall Study|Migrated/moved from study area|2|||
130529292|NCT01381575|469907600|FG000|Overall Study|Lost to Follow-up|8|||
130529293|NCT01381575|469907601|FG001|Overall Study|Lost to Follow-up|17|||
130529294|NCT01381575|469907602|FG002|Overall Study|Lost to Follow-up|9|||
130529295|NCT01443403|469907603|FG000|Overall Study|Adverse Event|1|||
130529296|NCT01443403|469907604|FG001|Overall Study|Adverse Event|1|||
130529297|NCT01443403|469907605|FG002|Overall Study|Adverse Event|4|||
130529298|NCT01443403|469907606|FG003|Overall Study|Adverse Event|5|||
130529299|NCT01443403|469907603|FG000|Overall Study|Withdrawal by Subject|0|||
130529300|NCT01443403|469907604|FG001|Overall Study|Withdrawal by Subject|1|||
130529301|NCT01443403|469907605|FG002|Overall Study|Withdrawal by Subject|2|||
130529302|NCT01443403|469907606|FG003|Overall Study|Withdrawal by Subject|1|||
130529303|NCT01443403|469907603|FG000|Overall Study|Lost to Follow-up|0|||
130529304|NCT01443403|469907604|FG001|Overall Study|Lost to Follow-up|0|||
130529305|NCT01443403|469907605|FG002|Overall Study|Lost to Follow-up|0|||
130529306|NCT01443403|469907606|FG003|Overall Study|Lost to Follow-up|1|||
130529307|NCT01443403|469907603|FG000|Overall Study|Protocol Violation|2|||
130529308|NCT01443403|469907604|FG001|Overall Study|Protocol Violation|1|||
130529309|NCT01443403|469907605|FG002|Overall Study|Protocol Violation|1|||
130529310|NCT01443403|469907606|FG003|Overall Study|Protocol Violation|1|||
130529311|NCT01443403|469907603|FG000|Overall Study|Use of Prohibited Treatment|2|||
130529312|NCT01443403|469907604|FG001|Overall Study|Use of Prohibited Treatment|3|||
130529313|NCT01443403|469907605|FG002|Overall Study|Use of Prohibited Treatment|0|||
130529314|NCT01443403|469907606|FG003|Overall Study|Use of Prohibited Treatment|0|||
130529315|NCT01443403|469907603|FG000|Overall Study|Other - Miscellaneous|1|||
130529316|NCT01443403|469907604|FG001|Overall Study|Other - Miscellaneous|0|||
130529317|NCT01443403|469907605|FG002|Overall Study|Other - Miscellaneous|0|||
130529318|NCT01443403|469907606|FG003|Overall Study|Other - Miscellaneous|1|||
130529319|NCT00474526|469907607|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
130529320|NCT00474526|469907608|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
130529321|NCT00474526|469907609|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
130529322|NCT00474526|469907610|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
130529323|NCT00474526|469907611|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
130529324|NCT00474526|469907612|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
130529325|NCT00474526|469907613|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
130529326|NCT00474526|469907614|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
130529327|NCT00474526|469907615|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
130529328|NCT00474526|469907616|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
130529329|NCT00474526|469907617|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
130529330|NCT00474526|469907618|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
130529331|NCT00474526|469907619|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
130529332|NCT00474526|469907620|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
130529333|NCT00474526|469907621|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
130529334|NCT00474526|469907622|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
130529335|NCT00474526|469907623|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
130529336|NCT00474526|469907607|FG000|Overall Study|Adverse Event|2|||
130529337|NCT00474526|469907608|FG001|Overall Study|Adverse Event|0|||
130529338|NCT00474526|469907609|FG002|Overall Study|Adverse Event|2|||
130529339|NCT00474526|469907610|FG003|Overall Study|Adverse Event|4|||
130529340|NCT00474526|469907611|FG004|Overall Study|Adverse Event|2|||
130529341|NCT00474526|469907612|FG005|Overall Study|Adverse Event|1|||
130529342|NCT00474526|469907613|FG006|Overall Study|Adverse Event|1|||
130529343|NCT00474526|469907614|FG007|Overall Study|Adverse Event|0|||
130529344|NCT00474526|469907615|FG008|Overall Study|Adverse Event|0|||
130529345|NCT00474526|469907616|FG009|Overall Study|Adverse Event|0|||
130529346|NCT00474526|469907617|FG010|Overall Study|Adverse Event|0|||
130529347|NCT00474526|469907618|FG011|Overall Study|Adverse Event|0|||
130529348|NCT00474526|469907619|FG012|Overall Study|Adverse Event|0|||
130529349|NCT00474526|469907620|FG013|Overall Study|Adverse Event|0|||
130529350|NCT00474526|469907621|FG014|Overall Study|Adverse Event|1|||
130529351|NCT00474526|469907622|FG015|Overall Study|Adverse Event|1|||
130529352|NCT00474526|469907623|FG016|Overall Study|Adverse Event|0|||
130529353|NCT00474526|469907607|FG000|Overall Study|Death|0|||
130529354|NCT00474526|469907608|FG001|Overall Study|Death|0|||
130529355|NCT00474526|469907609|FG002|Overall Study|Death|0|||
130529356|NCT00474526|469907610|FG003|Overall Study|Death|0|||
130529357|NCT00474526|469907611|FG004|Overall Study|Death|0|||
130529358|NCT00474526|469907612|FG005|Overall Study|Death|0|||
130529359|NCT00474526|469907613|FG006|Overall Study|Death|0|||
130529360|NCT00474526|469907614|FG007|Overall Study|Death|0|||
130529361|NCT00474526|469907615|FG008|Overall Study|Death|0|||
130529362|NCT00474526|469907616|FG009|Overall Study|Death|0|||
130529363|NCT00474526|469907617|FG010|Overall Study|Death|0|||
130529364|NCT00474526|469907618|FG011|Overall Study|Death|0|||
130529365|NCT00474526|469907619|FG012|Overall Study|Death|0|||
130529366|NCT00474526|469907620|FG013|Overall Study|Death|3|||
130529367|NCT00474526|469907621|FG014|Overall Study|Death|0|||
130529368|NCT00474526|469907622|FG015|Overall Study|Death|0|||
130529369|NCT00474526|469907623|FG016|Overall Study|Death|0|||
130529370|NCT00474526|469907607|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529371|NCT00474526|469907608|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
130529372|NCT00474526|469907609|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529373|NCT00474526|469907610|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
130529374|NCT00474526|469907611|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
130529375|NCT00474526|469907612|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529376|NCT00474526|469907613|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529377|NCT00474526|469907614|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529378|NCT00474526|469907615|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529379|NCT00474526|469907616|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529380|NCT00474526|469907617|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529381|NCT00474526|469907618|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529382|NCT00474526|469907619|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529383|NCT00474526|469907620|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
130529384|NCT00474526|469907621|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
130529385|NCT00474526|469907622|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529386|NCT00474526|469907623|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
130529387|NCT00474526|469907607|FG000|Overall Study|Lost to Follow-up|8|||
130529388|NCT00474526|469907608|FG001|Overall Study|Lost to Follow-up|6|||
130529389|NCT00474526|469907609|FG002|Overall Study|Lost to Follow-up|13|||
130529390|NCT00474526|469907610|FG003|Overall Study|Lost to Follow-up|29|||
130529391|NCT00474526|469907611|FG004|Overall Study|Lost to Follow-up|11|||
130529392|NCT00474526|469907612|FG005|Overall Study|Lost to Follow-up|5|||
130529393|NCT00474526|469907613|FG006|Overall Study|Lost to Follow-up|8|||
130529394|NCT00474526|469907614|FG007|Overall Study|Lost to Follow-up|1|||
130529395|NCT00474526|469907615|FG008|Overall Study|Lost to Follow-up|0|||
130529396|NCT00474526|469907616|FG009|Overall Study|Lost to Follow-up|6|||
130529397|NCT00474526|469907617|FG010|Overall Study|Lost to Follow-up|2|||
130529398|NCT00474526|469907618|FG011|Overall Study|Lost to Follow-up|4|||
130529399|NCT00474526|469907619|FG012|Overall Study|Lost to Follow-up|6|||
130529400|NCT00474526|469907620|FG013|Overall Study|Lost to Follow-up|74|||
130529401|NCT00474526|469907621|FG014|Overall Study|Lost to Follow-up|29|||
130529402|NCT00474526|469907622|FG015|Overall Study|Lost to Follow-up|4|||
130529403|NCT00474526|469907623|FG016|Overall Study|Lost to Follow-up|5|||
130529404|NCT00474526|469907607|FG000|Overall Study|Protocol Violation|2|||
130529405|NCT00474526|469907608|FG001|Overall Study|Protocol Violation|6|||
130529406|NCT00474526|469907609|FG002|Overall Study|Protocol Violation|4|||
130529407|NCT00474526|469907610|FG003|Overall Study|Protocol Violation|12|||
130529408|NCT00474526|469907611|FG004|Overall Study|Protocol Violation|3|||
130529409|NCT00474526|469907612|FG005|Overall Study|Protocol Violation|1|||
130529410|NCT00474526|469907613|FG006|Overall Study|Protocol Violation|3|||
130529411|NCT00474526|469907614|FG007|Overall Study|Protocol Violation|0|||
130529412|NCT00474526|469907615|FG008|Overall Study|Protocol Violation|0|||
130529413|NCT00474526|469907616|FG009|Overall Study|Protocol Violation|4|||
130529414|NCT00474526|469907617|FG010|Overall Study|Protocol Violation|2|||
130529415|NCT00474526|469907618|FG011|Overall Study|Protocol Violation|2|||
130529416|NCT00474526|469907619|FG012|Overall Study|Protocol Violation|4|||
130529417|NCT00474526|469907620|FG013|Overall Study|Protocol Violation|19|||
130529418|NCT00474526|469907621|FG014|Overall Study|Protocol Violation|9|||
130529419|NCT00474526|469907622|FG015|Overall Study|Protocol Violation|6|||
130529420|NCT00474526|469907623|FG016|Overall Study|Protocol Violation|2|||
130529421|NCT00474526|469907607|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
130529422|NCT00474526|469907608|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
130529423|NCT00474526|469907609|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
130529424|NCT00474526|469907610|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
130529425|NCT00474526|469907611|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
130529426|NCT00474526|469907612|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
130529427|NCT00474526|469907613|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
130529428|NCT00474526|469907614|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
130529429|NCT00474526|469907615|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
130529430|NCT00474526|469907616|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
130529431|NCT00474526|469907617|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
130529432|NCT00474526|469907618|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
130529433|NCT00474526|469907619|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
130529434|NCT00474526|469907620|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
130529435|NCT00474526|469907621|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
130529436|NCT00474526|469907622|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
130529437|NCT00474526|469907623|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
130529438|NCT00474526|469907607|FG000|Overall Study|Withdrawal by Subject|9|||
130529439|NCT00474526|469907608|FG001|Overall Study|Withdrawal by Subject|24|||
130529440|NCT00474526|469907609|FG002|Overall Study|Withdrawal by Subject|21|||
130529441|NCT00474526|469907610|FG003|Overall Study|Withdrawal by Subject|52|||
130529442|NCT00474526|469907611|FG004|Overall Study|Withdrawal by Subject|38|||
130529443|NCT00474526|469907612|FG005|Overall Study|Withdrawal by Subject|6|||
130529444|NCT00474526|469907613|FG006|Overall Study|Withdrawal by Subject|12|||
130529445|NCT00474526|469907614|FG007|Overall Study|Withdrawal by Subject|4|||
130529446|NCT00474526|469907615|FG008|Overall Study|Withdrawal by Subject|4|||
130529447|NCT00474526|469907616|FG009|Overall Study|Withdrawal by Subject|13|||
130529448|NCT00474526|469907617|FG010|Overall Study|Withdrawal by Subject|5|||
130529449|NCT00474526|469907618|FG011|Overall Study|Withdrawal by Subject|4|||
130529450|NCT00474526|469907619|FG012|Overall Study|Withdrawal by Subject|4|||
130529451|NCT00474526|469907620|FG013|Overall Study|Withdrawal by Subject|37|||
130529452|NCT00474526|469907621|FG014|Overall Study|Withdrawal by Subject|22|||
130529453|NCT00474526|469907622|FG015|Overall Study|Withdrawal by Subject|1|||
130529454|NCT00474526|469907623|FG016|Overall Study|Withdrawal by Subject|1|||
130529455|NCT04546217|469907626|FG000|Overall Study|Withdrawal by Subject|2|||
130529456|NCT04546217|469907627|FG001|Overall Study|Withdrawal by Subject|0|||
130529457|NCT04546217|469907626|FG000|Overall Study|Uncontrolled hypertension|1|||
130529458|NCT04546217|469907627|FG001|Overall Study|Uncontrolled hypertension|0|||
130529459|NCT02550938|469907630|FG000|Overall Study|Lost to Follow-up|8|||
130529460|NCT02550938|469907631|FG001|Overall Study|Lost to Follow-up|7|||
130529461|NCT02550938|469907632|FG002|Overall Study|Lost to Follow-up|12|||
130529462|NCT02550938|469907633|FG003|Overall Study|Lost to Follow-up|11|||
130529463|NCT01251770|469907634|FG000|Overall Study|Protocol Violation|13|||
130529464|NCT01251770|469907635|FG001|Overall Study|Protocol Violation|7|||
130529465|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130529466|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130529467|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
130529468|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
130529469|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
130529470|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
130529471|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
130529472|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
130529473|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
130529474|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
130529475|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
130529476|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
130529477|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
130529478|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
130529479|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130529480|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130578289|NCT01928381|470080512|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
130529481|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130529482|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130529483|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130529484|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130529485|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
130529486|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130529487|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
130529488|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
130529489|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
130529490|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
130529491|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
130529492|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130529493|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529494|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529495|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529496|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529497|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
130529498|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529499|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130529500|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529501|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
130529502|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529503|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529504|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529505|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529506|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
130529507|NCT01888874|469907639|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
130529508|NCT01888874|469907640|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
130529509|NCT01888874|469907641|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
130529510|NCT01888874|469907642|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
130529511|NCT01888874|469907643|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
130529512|NCT01888874|469907644|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
130529513|NCT01888874|469907645|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
130529514|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
130529515|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
130529516|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
130529517|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130529518|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
130529519|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130529520|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130529521|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529522|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529523|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529524|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529525|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
130529526|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529527|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
130529528|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
130529529|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
130529530|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
130529531|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
130529532|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
130529533|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
130529534|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
130529535|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529536|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529537|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
130529538|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529539|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529540|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529541|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
130529542|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
130529543|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
130529544|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
130529545|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
130529546|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
130529547|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
130529548|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
130529549|NCT01888874|469907639|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
130529550|NCT01888874|469907640|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
130529551|NCT01888874|469907641|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
130529552|NCT01888874|469907642|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
130529553|NCT01888874|469907643|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
130529554|NCT01888874|469907644|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
130578290|NCT01928381|470080513|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
130529555|NCT01888874|469907645|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
130529556|NCT00953771|469907649|FG000|Overall Study|Death|1|||
130529557|NCT00953771|469907650|FG001|Overall Study|Death|0|||
130529558|NCT00884650|469907651|FG000|Overall Study|Did not return complete pain diaries|7|||
130529559|NCT00884650|469907652|FG001|Overall Study|Did not return complete pain diaries|7|||
130529560|NCT00884650|469907651|FG000|Overall Study|Admitted Post-Op|1|||
130529561|NCT00884650|469907652|FG001|Overall Study|Admitted Post-Op|0|||
130529562|NCT00884650|469907651|FG000|Overall Study|Femoral Stress Fracture|1|||
130529563|NCT00884650|469907652|FG001|Overall Study|Femoral Stress Fracture|0|||
130529564|NCT00884650|469907651|FG000|Overall Study|Pain Pump Complication|0|||
130529565|NCT00884650|469907652|FG001|Overall Study|Pain Pump Complication|1|||
130529566|NCT00979953|469907653|FG000|Overall Study|Adverse Event|5|||
130529567|NCT00979953|469907654|FG001|Overall Study|Adverse Event|2|||
130529568|NCT00979953|469907655|FG002|Overall Study|Adverse Event|17|||
130529569|NCT00979953|469907656|FG003|Overall Study|Adverse Event|4|||
130529570|NCT00979953|469907653|FG000|Overall Study|Lack of Efficacy|1|||
130529571|NCT00979953|469907654|FG001|Overall Study|Lack of Efficacy|2|||
130529572|NCT00979953|469907655|FG002|Overall Study|Lack of Efficacy|0|||
130529573|NCT00979953|469907656|FG003|Overall Study|Lack of Efficacy|0|||
130529574|NCT00979953|469907653|FG000|Overall Study|Lost to Follow-up|1|||
130529575|NCT00979953|469907654|FG001|Overall Study|Lost to Follow-up|1|||
130529576|NCT00979953|469907655|FG002|Overall Study|Lost to Follow-up|1|||
130529577|NCT00979953|469907656|FG003|Overall Study|Lost to Follow-up|0|||
130529578|NCT00979953|469907653|FG000|Overall Study|Withdrawal by Subject|0|||
130529579|NCT00979953|469907654|FG001|Overall Study|Withdrawal by Subject|0|||
130529580|NCT00979953|469907655|FG002|Overall Study|Withdrawal by Subject|2|||
130529581|NCT00979953|469907656|FG003|Overall Study|Withdrawal by Subject|1|||
130529582|NCT00979953|469907653|FG000|Overall Study|Protocol Violation|1|||
130529583|NCT00979953|469907654|FG001|Overall Study|Protocol Violation|0|||
130529584|NCT00979953|469907655|FG002|Overall Study|Protocol Violation|2|||
130529585|NCT00979953|469907656|FG003|Overall Study|Protocol Violation|2|||
130529586|NCT04052425|469907659|FG000|24-Week Double-blind Period|Adverse Event|0|||
130529587|NCT04052425|469907660|FG001|24-Week Double-blind Period|Adverse Event|1|||
130529588|NCT04052425|469907661|FG002|24-Week Double-blind Period|Adverse Event|0|||
130529589|NCT04052425|469907662|FG003|24-Week Double-blind Period|Adverse Event|0|||
130529590|NCT04052425|469907659|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
130529591|NCT04052425|469907660|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
130529592|NCT04052425|469907661|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
130529593|NCT04052425|469907662|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
130529594|NCT04052425|469907659|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
130529595|NCT04052425|469907660|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
130529596|NCT04052425|469907661|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
130529597|NCT04052425|469907662|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
130529598|NCT04052425|469907659|FG000|24-Week Double-blind Period|Physician Decision|1|||
130529599|NCT04052425|469907660|FG001|24-Week Double-blind Period|Physician Decision|0|||
130529600|NCT04052425|469907661|FG002|24-Week Double-blind Period|Physician Decision|0|||
130529601|NCT04052425|469907662|FG003|24-Week Double-blind Period|Physician Decision|0|||
130529602|NCT04052425|469907659|FG000|24-Week Double-blind Period|Protocol Violation|1|||
130529603|NCT04052425|469907660|FG001|24-Week Double-blind Period|Protocol Violation|0|||
130529604|NCT04052425|469907661|FG002|24-Week Double-blind Period|Protocol Violation|0|||
130529605|NCT04052425|469907662|FG003|24-Week Double-blind Period|Protocol Violation|0|||
130529606|NCT04052425|469907659|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
130529607|NCT04052425|469907660|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
130529608|NCT04052425|469907661|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
130529609|NCT04052425|469907662|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
130529610|NCT04052425|469907659|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
130529611|NCT04052425|469907660|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
130529612|NCT04052425|469907661|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
130529613|NCT04052425|469907662|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
130529614|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
130529615|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
130529616|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
130529617|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
130529618|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
130529619|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
130529620|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
130529621|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
130529622|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130529623|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130529624|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
130529625|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
130529626|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
130529627|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
130529628|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
130529629|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
130529630|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130529631|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130529632|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
130529633|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
130529634|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
130529635|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
130529636|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
130529637|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
130529638|NCT04052425|469907659|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
130529639|NCT04052425|469907660|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
130529640|NCT04052425|469907661|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
130529641|NCT04052425|469907662|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
130529642|NCT04334278|469907663|FG000|Overall Study|Lost to Follow-up|0|||
130529643|NCT04334278|469907664|FG001|Overall Study|Lost to Follow-up|3|||
130529644|NCT04334278|469907663|FG000|Overall Study|Withdrawal by Subject|4|||
130529645|NCT04334278|469907664|FG001|Overall Study|Withdrawal by Subject|2|||
130529646|NCT04829747|469907667|FG000|Overall Study|Protocol Violation|1|||
130529647|NCT02615509|469907668|FG000|Overall Study|Lost to Follow-up|134|||
130529648|NCT02615509|469907668|FG000|Overall Study|Death|4|||
130529649|NCT02615509|469907668|FG000|Overall Study|Withdrawal by Subject|8|||
130529650|NCT00425607|469907669|FG000|Overall Study|Death|1|||
130529651|NCT00425607|469907669|FG000|Overall Study|Withdrawal by Subject|1|||
130529652|NCT02563548|469907670|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
130529653|NCT02563548|469907671|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130529654|NCT02563548|469907672|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130529655|NCT02563548|469907673|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
130529656|NCT02563548|469907674|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130529657|NCT02563548|469907675|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130529658|NCT02563548|469907670|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
130529659|NCT02563548|469907671|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
130529660|NCT02563548|469907672|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
130529661|NCT02563548|469907673|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
130529662|NCT02563548|469907674|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
130529663|NCT02563548|469907675|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
130529664|NCT02563548|469907670|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130529665|NCT02563548|469907671|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130529666|NCT02563548|469907672|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
130529667|NCT02563548|469907673|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130529668|NCT02563548|469907674|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130529669|NCT02563548|469907675|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130529670|NCT02563548|469907670|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
130529671|NCT02563548|469907671|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
130529672|NCT02563548|469907672|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
130529673|NCT02563548|469907673|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
130529674|NCT02563548|469907674|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
130529675|NCT02563548|469907675|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
130529676|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
130529677|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
130529678|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
130529679|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
130529680|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
130529681|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
130529682|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
130529683|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
130529684|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
130529685|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
130578291|NCT01928381|470080514|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
130529686|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
130529687|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
130529688|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
130529689|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
130529690|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
130529691|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
130529692|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
130529693|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
130529694|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
130529695|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
130529696|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
130529697|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
130529698|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
130529699|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
130529700|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
130529701|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
130529702|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
130529703|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
130529704|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
130529705|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
130529706|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
130529707|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
130529708|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
130529709|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
130529710|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
130529711|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
130529712|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
130529713|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
130529714|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
130529715|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
130529716|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
130529717|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
130529718|NCT02563548|469907670|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130529719|NCT02563548|469907671|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130529720|NCT02563548|469907672|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130529721|NCT02563548|469907673|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130529722|NCT02563548|469907674|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
130529723|NCT02563548|469907675|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130529724|NCT01732549|469907678|FG000|Overall Study|Adverse Event|13|||
130529725|NCT01732549|469907679|FG001|Overall Study|Adverse Event|3|||
130529726|NCT01732549|469907678|FG000|Overall Study|Consent withdrawn|13|||
130529727|NCT01732549|469907679|FG001|Overall Study|Consent withdrawn|6|||
130529728|NCT01732549|469907678|FG000|Overall Study|Disease progression|37|||
130529729|NCT01732549|469907679|FG001|Overall Study|Disease progression|50|||
130529730|NCT01732549|469907678|FG000|Overall Study|Other|8|||
130529731|NCT01732549|469907679|FG001|Overall Study|Other|14|||
130529732|NCT00447590|469907682|FG000|Overall Study|Withdrawal by Subject|26|||
130529733|NCT00447590|469907682|FG000|Overall Study|Lost to Follow-up|24|||
130529734|NCT00447590|469907682|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
130529735|NCT01967069|469907683|FG000|Overall Study|Adverse Event|2|||
130578292|NCT01928381|470080515|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
130529736|NCT01967069|469907684|FG001|Overall Study|Adverse Event|2|||
130529737|NCT01967069|469907683|FG000|Overall Study|Lost to Follow-up|5|||
130529738|NCT01967069|469907684|FG001|Overall Study|Lost to Follow-up|2|||
130529739|NCT01967069|469907683|FG000|Overall Study|Withdrawal by Subject|1|||
130529740|NCT01967069|469907684|FG001|Overall Study|Withdrawal by Subject|3|||
130529741|NCT01967069|469907683|FG000|Overall Study|Lack of Efficacy|0|||
130578293|NCT01928381|470080516|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
130578294|NCT01928381|470080517|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
130578295|NCT01928381|470080518|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
130578296|NCT01928381|470080512|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
130578297|NCT01928381|470080513|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
130529742|NCT01967069|469907684|FG001|Overall Study|Lack of Efficacy|1|||
130529743|NCT03933462|469907691|FG000|Overall Study|Adverse Event|2|||
130529744|NCT03933462|469907692|FG001|Overall Study|Adverse Event|0|||
130529745|NCT00706654|469907697|FG000|Conversion Phase|Lost to Follow-up|4|||
130529746|NCT00706654|469907698|FG001|Conversion Phase|Lost to Follow-up|0|||
130529747|NCT00706654|469907699|FG002|Conversion Phase|Lost to Follow-up|0|||
130529748|NCT00706654|469907700|FG003|Conversion Phase|Lost to Follow-up|0|||
130578298|NCT01928381|470080514|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
130578299|NCT01928381|470080515|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
130578300|NCT01928381|470080516|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
130578301|NCT01928381|470080517|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
130578302|NCT01928381|470080518|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
130578303|NCT01928381|470080512|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
130578304|NCT01928381|470080513|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
130578305|NCT01928381|470080514|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
130578306|NCT01928381|470080515|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
130578307|NCT01928381|470080516|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
130578308|NCT01928381|470080517|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
130578309|NCT01928381|470080518|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
130578310|NCT01928381|470080512|FG000|Part 1 - Pain Training|Protocol Violation|1|||
130578311|NCT01928381|470080513|FG001|Part 1 - Pain Training|Protocol Violation|0|||
130578312|NCT01928381|470080514|FG002|Part 1 - Pain Training|Protocol Violation|0|||
130578313|NCT01928381|470080515|FG003|Part 1 - Pain Training|Protocol Violation|0|||
130578314|NCT01928381|470080516|FG004|Part 1 - Pain Training|Protocol Violation|0|||
130578315|NCT01928381|470080517|FG005|Part 1 - Pain Training|Protocol Violation|0|||
130578316|NCT01928381|470080518|FG006|Part 1 - Pain Training|Protocol Violation|0|||
130578317|NCT01928381|470080512|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
130578318|NCT01928381|470080513|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578319|NCT01928381|470080514|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578320|NCT01928381|470080515|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578321|NCT01928381|470080516|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578322|NCT01928381|470080517|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578323|NCT01928381|470080518|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130578324|NCT01928381|470080512|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
130578325|NCT01928381|470080513|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578326|NCT01928381|470080514|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578327|NCT01928381|470080515|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578328|NCT01928381|470080516|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578329|NCT01928381|470080517|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578330|NCT01928381|470080518|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130578331|NCT01928381|470080512|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
130578332|NCT01928381|470080513|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578333|NCT01928381|470080514|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578334|NCT01928381|470080515|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578335|NCT01928381|470080516|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578336|NCT01928381|470080517|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578337|NCT01928381|470080518|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130578338|NCT01928381|470080512|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
130578339|NCT01928381|470080513|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578340|NCT01928381|470080514|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578341|NCT01928381|470080515|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578342|NCT01928381|470080516|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578343|NCT01928381|470080517|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578344|NCT01928381|470080518|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130578345|NCT01928381|470080512|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578346|NCT01928381|470080513|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578347|NCT01928381|470080514|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
130578348|NCT01928381|470080515|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578349|NCT01928381|470080516|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578350|NCT01928381|470080517|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578351|NCT01928381|470080518|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
130578352|NCT01928381|470080512|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578353|NCT01928381|470080513|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578354|NCT01928381|470080514|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
130578355|NCT01928381|470080515|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578356|NCT01928381|470080516|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578357|NCT01928381|470080517|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578358|NCT01928381|470080518|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130578359|NCT01928381|470080512|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
130578360|NCT01928381|470080513|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
130578361|NCT01928381|470080514|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
130578362|NCT01928381|470080515|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
130578363|NCT01928381|470080516|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
130578364|NCT01928381|470080517|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
130578365|NCT01928381|470080518|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
130578366|NCT01928381|470080512|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
130578367|NCT01928381|470080513|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
130578368|NCT01928381|470080514|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
130578369|NCT01928381|470080515|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
130578370|NCT01928381|470080516|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
130578371|NCT01928381|470080517|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
130578372|NCT01928381|470080518|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
130578373|NCT01928381|470080512|FG000|Washout First Intervention|Protocol Violation|0|||
130578374|NCT01928381|470080513|FG001|Washout First Intervention|Protocol Violation|0|||
130578375|NCT01928381|470080514|FG002|Washout First Intervention|Protocol Violation|0|||
130578376|NCT01928381|470080515|FG003|Washout First Intervention|Protocol Violation|0|||
130578377|NCT01928381|470080516|FG004|Washout First Intervention|Protocol Violation|1|||
130578378|NCT01928381|470080517|FG005|Washout First Intervention|Protocol Violation|0|||
130578379|NCT01928381|470080518|FG006|Washout First Intervention|Protocol Violation|0|||
130578380|NCT01928381|470080512|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
130578381|NCT01928381|470080513|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
130578382|NCT01928381|470080514|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
130578383|NCT01928381|470080515|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
130578384|NCT01928381|470080516|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
130578385|NCT01928381|470080517|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
130578386|NCT01928381|470080518|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
130578387|NCT01928381|470080512|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578388|NCT01928381|470080513|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578389|NCT01928381|470080514|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
130578390|NCT01928381|470080515|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578391|NCT01928381|470080516|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578392|NCT01928381|470080517|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578393|NCT01928381|470080518|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
130578394|NCT03087955|470083058|FG000|Overall Study|Death|4|||
130578395|NCT03087955|470083059|FG001|Overall Study|Death|0|||
130578396|NCT03087955|470083058|FG000|Overall Study|Lack of Efficacy|2|||
130578397|NCT03087955|470083059|FG001|Overall Study|Lack of Efficacy|0|||
130578398|NCT03087955|470083058|FG000|Overall Study|Lost to Follow-up|1|||
130578399|NCT03087955|470083059|FG001|Overall Study|Lost to Follow-up|0|||
130578400|NCT04441905|470083060|FG000|Overall Study|Lost to Follow-up|1|||
130578401|NCT04441905|470083061|FG001|Overall Study|Lost to Follow-up|0|||
130578402|NCT04441905|470083062|FG002|Overall Study|Lost to Follow-up|0|||
130578403|NCT04441905|470083063|FG003|Overall Study|Lost to Follow-up|0|||
130578404|NCT04441905|470083064|FG004|Overall Study|Lost to Follow-up|0|||
130578405|NCT04441905|470083065|FG005|Overall Study|Lost to Follow-up|0|||
130578406|NCT04441905|470083060|FG000|Overall Study|Enrolled but treatment not administered|0|||
130578407|NCT04441905|470083061|FG001|Overall Study|Enrolled but treatment not administered|1|||
130578408|NCT04441905|470083062|FG002|Overall Study|Enrolled but treatment not administered|0|||
130578409|NCT04441905|470083063|FG003|Overall Study|Enrolled but treatment not administered|0|||
130578410|NCT04441905|470083064|FG004|Overall Study|Enrolled but treatment not administered|0|||
130578411|NCT04441905|470083065|FG005|Overall Study|Enrolled but treatment not administered|0|||
130578412|NCT04441905|470083060|FG000|Overall Study|Became ineligible after enrollment|0|||
130578413|NCT04441905|470083061|FG001|Overall Study|Became ineligible after enrollment|0|||
130578414|NCT04441905|470083062|FG002|Overall Study|Became ineligible after enrollment|0|||
130578415|NCT04441905|470083063|FG003|Overall Study|Became ineligible after enrollment|0|||
130578416|NCT04441905|470083064|FG004|Overall Study|Became ineligible after enrollment|1|||
130578417|NCT04441905|470083065|FG005|Overall Study|Became ineligible after enrollment|0|||
130578418|NCT04770753|470083066|FG000|Overall Study|Randomized, never treated|1|||
130578419|NCT04770753|470083067|FG001|Overall Study|Randomized, never treated|1|||
130578420|NCT04770753|470083066|FG000|Overall Study|Withdrawal by Subject|3|||
130578421|NCT04770753|470083067|FG001|Overall Study|Withdrawal by Subject|1|||
130578422|NCT04770753|470083066|FG000|Overall Study|Adverse Event|2|||
130578423|NCT04770753|470083067|FG001|Overall Study|Adverse Event|0|||
130578424|NCT04770753|470083066|FG000|Overall Study|Pregnancy|1|||
130578425|NCT04770753|470083067|FG001|Overall Study|Pregnancy|0|||
130578426|NCT04770753|470083066|FG000|Overall Study|Other un-specified|1|||
130578427|NCT04770753|470083067|FG001|Overall Study|Other un-specified|0|||
130578428|NCT02775851|470083068|FG000|Overall Study|Adverse Event|1|||
130578429|NCT02775851|470083069|FG001|Overall Study|Adverse Event|10|||
130578430|NCT02775851|470083068|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
130578431|NCT02775851|470083069|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
130578432|NCT02775851|470083068|FG000|Overall Study|Progression/Relapse|0|||
130578433|NCT02775851|470083069|FG001|Overall Study|Progression/Relapse|4|||
130578434|NCT02775851|470083068|FG000|Overall Study|Other - Not Protocol Specified|0|||
130578435|NCT02775851|470083069|FG001|Overall Study|Other - Not Protocol Specified|7|||
130578436|NCT02775851|470083068|FG000|Overall Study|Withdrawal by Subject|1|||
130578437|NCT02775851|470083069|FG001|Overall Study|Withdrawal by Subject|0|||
130578438|NCT03686397|470083070|FG000|Overall Study|Lack of Efficacy|3|||
130578439|NCT03686397|470083071|FG001|Overall Study|Lack of Efficacy|5|||
130578440|NCT03686397|470083070|FG000|Overall Study|Adverse Event|0|||
130578441|NCT03686397|470083071|FG001|Overall Study|Adverse Event|1|||
130578442|NCT03686397|470083070|FG000|Overall Study|Protocol Violation|0|||
130578443|NCT03686397|470083071|FG001|Overall Study|Protocol Violation|1|||
130578444|NCT03686397|470083070|FG000|Overall Study|Withdrawal by Subject|0|||
130578445|NCT03686397|470083071|FG001|Overall Study|Withdrawal by Subject|1|||
130578446|NCT03686397|470083070|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
130578447|NCT03686397|470083071|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
130578448|NCT00598975|470083074|FG000|Overall Study|Adverse Event|1|||
130578449|NCT00598975|470083075|FG001|Overall Study|Adverse Event|1|||
130578450|NCT00598975|470083074|FG000|Overall Study|Brain metastases|1|||
130578451|NCT00598975|470083075|FG001|Overall Study|Brain metastases|0|||
130578452|NCT00598975|470083074|FG000|Overall Study|Withdrawal by Subject|1|||
130578453|NCT00598975|470083075|FG001|Overall Study|Withdrawal by Subject|1|||
130578454|NCT00598975|470083074|FG000|Overall Study|Withdrawal of consent|0|||
130578455|NCT00598975|470083075|FG001|Overall Study|Withdrawal of consent|1|||
130578456|NCT00598975|470083074|FG000|Overall Study|Disease progression|8|||
130578457|NCT00598975|470083075|FG001|Overall Study|Disease progression|3|||
130578458|NCT00598975|470083074|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
130578459|NCT00598975|470083075|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
130578460|NCT01934140|470083077|FG000|Persistence Phase (Year 6-10)|Other|24|||
130578461|NCT01934140|470083078|FG001|Persistence Phase (Year 6-10)|Other|6|||
130578462|NCT01934140|470083077|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
130578463|NCT01934140|470083078|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
130578464|NCT01934140|470083077|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
130578465|NCT01934140|470083078|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
130578466|NCT01934140|470083077|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
130578467|NCT01934140|470083078|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
130578468|NCT01934140|470083077|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
130578469|NCT01934140|470083078|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
130578470|NCT01934140|470083077|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
130578471|NCT01934140|470083078|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
130578472|NCT01934140|470083077|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
130578473|NCT01934140|470083078|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
130578474|NCT01934140|470083077|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
130578475|NCT01934140|470083078|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
130578476|NCT00618748|470083084|FG000|Overall Study|Adverse Event|4|||
130578477|NCT00618748|470083085|FG001|Overall Study|Adverse Event|3|||
130578478|NCT00618748|470083086|FG002|Overall Study|Adverse Event|8|||
130578479|NCT00618748|470083084|FG000|Overall Study|Physician Decision|3|||
130578480|NCT00618748|470083085|FG001|Overall Study|Physician Decision|1|||
130578481|NCT00618748|470083086|FG002|Overall Study|Physician Decision|1|||
130578482|NCT00618748|470083084|FG000|Overall Study|Withdrawal by Subject|4|||
130578483|NCT00618748|470083085|FG001|Overall Study|Withdrawal by Subject|1|||
130578484|NCT00618748|470083086|FG002|Overall Study|Withdrawal by Subject|5|||
130578485|NCT00200850|470083087|FG000|Overall Study|relocation|1|||
130578486|NCT00200850|470083088|FG001|Overall Study|relocation|0|||
130578487|NCT00200850|470083089|FG002|Overall Study|relocation|1|||
130578488|NCT00200850|470083087|FG000|Overall Study|too busy|1|||
130578489|NCT00200850|470083088|FG001|Overall Study|too busy|0|||
130578490|NCT00200850|470083089|FG002|Overall Study|too busy|0|||
130578491|NCT00200850|470083087|FG000|Overall Study|Pregnancy|0|||
130578492|NCT00200850|470083088|FG001|Overall Study|Pregnancy|0|||
130578493|NCT00200850|470083089|FG002|Overall Study|Pregnancy|1|||
130578494|NCT00200850|470083087|FG000|Overall Study|Poor adherence|0|||
130578495|NCT00200850|470083088|FG001|Overall Study|Poor adherence|0|||
130578496|NCT00200850|470083089|FG002|Overall Study|Poor adherence|1|||
130578497|NCT00200850|470083087|FG000|Overall Study|optic neuritis|0|||
130578498|NCT00200850|470083088|FG001|Overall Study|optic neuritis|0|||
130578499|NCT00200850|470083089|FG002|Overall Study|optic neuritis|1|||
130578500|NCT00200850|470083087|FG000|Overall Study|Adverse Event|1|||
130578501|NCT00200850|470083088|FG001|Overall Study|Adverse Event|1|||
130578502|NCT00200850|470083089|FG002|Overall Study|Adverse Event|2|||
130578503|NCT02595879|470083094|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
130578504|NCT02595879|470083095|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
130578505|NCT04294459|470083096|FG000|Overall Study|Adverse Event|0|||
130578506|NCT04294459|470083097|FG001|Overall Study|Adverse Event|1|||
130578507|NCT01534676|470083098|FG000|Overall Study|Study closed due to poor enrollment|2|||
130578508|NCT01534676|470083099|FG001|Overall Study|Study closed due to poor enrollment|1|||
130578509|NCT02908880|470083101|FG000|Overall Study|Lost to Follow-up|4|||
130578510|NCT02908880|470083101|FG000|Overall Study|Explantation of the device|1|||
130578511|NCT02908880|470083101|FG000|Overall Study|Withdrawal by Subject|17|||
130578512|NCT02908880|470083101|FG000|Overall Study|Death|5|||
130529749|NCT00706654|469907697|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
130529750|NCT00706654|469907698|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
130529751|NCT00706654|469907699|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
130529752|NCT00706654|469907700|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
130529753|NCT00706654|469907697|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
130529754|NCT00706654|469907698|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
130529755|NCT00706654|469907699|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
130529756|NCT00706654|469907700|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
130529757|NCT00706654|469907697|FG000|Conversion Phase|Withdrawn by Investigator|14|||
130529758|NCT00706654|469907698|FG001|Conversion Phase|Withdrawn by Investigator|0|||
130529759|NCT00706654|469907699|FG002|Conversion Phase|Withdrawn by Investigator|0|||
130529760|NCT00706654|469907700|FG003|Conversion Phase|Withdrawn by Investigator|0|||
130529761|NCT00706654|469907697|FG000|Conversion Phase|Withdrew Consent|38|||
130529762|NCT00706654|469907698|FG001|Conversion Phase|Withdrew Consent|0|||
130529763|NCT00706654|469907699|FG002|Conversion Phase|Withdrew Consent|0|||
130529764|NCT00706654|469907700|FG003|Conversion Phase|Withdrew Consent|0|||
130529765|NCT00706654|469907697|FG000|Conversion Phase|Adverse Event|18|||
130529766|NCT00706654|469907698|FG001|Conversion Phase|Adverse Event|0|||
130529767|NCT00706654|469907699|FG002|Conversion Phase|Adverse Event|0|||
130529768|NCT00706654|469907700|FG003|Conversion Phase|Adverse Event|0|||
130529769|NCT00706654|469907697|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
130529770|NCT00706654|469907698|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130529771|NCT00706654|469907699|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130529772|NCT00706654|469907700|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130529773|NCT00706654|469907697|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
130529774|NCT00706654|469907698|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130529775|NCT00706654|469907699|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130529776|NCT00706654|469907700|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130529777|NCT00706654|469907697|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
130529778|NCT00706654|469907698|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
130529779|NCT00706654|469907699|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
130529780|NCT00706654|469907700|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
130529781|NCT00706654|469907697|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
130529782|NCT00706654|469907698|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
130529783|NCT00706654|469907699|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
130529784|NCT00706654|469907700|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
130529785|NCT00706654|469907697|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
130529786|NCT00706654|469907698|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130529787|NCT00706654|469907699|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130529788|NCT00706654|469907700|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130529789|NCT00706654|469907697|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
130529790|NCT00706654|469907698|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130529791|NCT00706654|469907699|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130529792|NCT00706654|469907700|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130529793|NCT00706654|469907697|FG000|Oral Stabilization Phase|Withdrew consent|55|||
130529794|NCT00706654|469907698|FG001|Oral Stabilization Phase|Withdrew consent|0|||
130529795|NCT00706654|469907699|FG002|Oral Stabilization Phase|Withdrew consent|0|||
130529796|NCT00706654|469907700|FG003|Oral Stabilization Phase|Withdrew consent|0|||
130529797|NCT00706654|469907697|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
130529798|NCT00706654|469907698|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
130529799|NCT00706654|469907699|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
130529800|NCT00706654|469907700|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
130529801|NCT00706654|469907697|FG000|Oral Stabilization Phase|Adverse Event|21|||
130529802|NCT00706654|469907698|FG001|Oral Stabilization Phase|Adverse Event|0|||
130529803|NCT00706654|469907699|FG002|Oral Stabilization Phase|Adverse Event|0|||
130529804|NCT00706654|469907700|FG003|Oral Stabilization Phase|Adverse Event|0|||
130529805|NCT00706654|469907697|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
130529806|NCT00706654|469907698|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130529807|NCT00706654|469907699|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130529808|NCT00706654|469907700|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130578513|NCT02421887|470083102|FG000|Overall Study|Lost to Follow-up|5|||
130578514|NCT02421887|470083103|FG001|Overall Study|Lost to Follow-up|0|||
130578515|NCT02421887|470083102|FG000|Overall Study|Withdrawal by Subject|8|||
130578516|NCT02421887|470083103|FG001|Overall Study|Withdrawal by Subject|5|||
130529809|NCT00706654|469907697|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
130529810|NCT00706654|469907698|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130529811|NCT00706654|469907699|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130529812|NCT00706654|469907700|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130529813|NCT00706654|469907697|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
130529814|NCT00706654|469907698|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
130529815|NCT00706654|469907699|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
130529816|NCT00706654|469907700|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
130529817|NCT00706654|469907697|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
130529818|NCT00706654|469907698|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
130529819|NCT00706654|469907699|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
130529820|NCT00706654|469907700|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
130529821|NCT00706654|469907697|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
130529822|NCT00706654|469907698|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
130529823|NCT00706654|469907699|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
130529824|NCT00706654|469907700|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
130529825|NCT00706654|469907697|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
130529826|NCT00706654|469907698|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
130529827|NCT00706654|469907699|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
130529828|NCT00706654|469907700|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
130529829|NCT00706654|469907697|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
130529830|NCT00706654|469907698|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
130529831|NCT00706654|469907699|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
130529832|NCT00706654|469907700|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
130529833|NCT00706654|469907697|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
130529834|NCT00706654|469907698|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
130529835|NCT00706654|469907699|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
130529836|NCT00706654|469907700|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
130529837|NCT00706654|469907697|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
130529838|NCT00706654|469907698|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
130529839|NCT00706654|469907699|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
130529840|NCT00706654|469907700|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
130529841|NCT00706654|469907697|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
130529842|NCT00706654|469907698|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
130529843|NCT00706654|469907699|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
130529844|NCT00706654|469907700|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
130529845|NCT00368875|469907706|FG000|Overall Study|Adverse Event|0|||
130529846|NCT00368875|469907707|FG001|Overall Study|Adverse Event|12|||
130529847|NCT00368875|469907706|FG000|Overall Study|Progressive disease|3|||
130529848|NCT00368875|469907707|FG001|Overall Study|Progressive disease|27|||
130529849|NCT00368875|469907706|FG000|Overall Study|Withdrawal by Subject|2|||
130529850|NCT00368875|469907707|FG001|Overall Study|Withdrawal by Subject|6|||
130529851|NCT00368875|469907706|FG000|Overall Study|Other Reason|0|||
130529852|NCT00368875|469907707|FG001|Overall Study|Other Reason|2|||
130529853|NCT00368875|469907706|FG000|Overall Study|Alternative Therapy|1|||
130529854|NCT00368875|469907707|FG001|Overall Study|Alternative Therapy|1|||
130529855|NCT01305239|469907708|FG000|Overall Study|Adverse Event|22|||
130529856|NCT01305239|469907708|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
130529857|NCT03229486|469907709|FG000|Overall Study|Protocol Violation|0|||
130529858|NCT03229486|469907710|FG001|Overall Study|Protocol Violation|1|||
130529859|NCT04160988|469907715|FG000|Overall Study|poor image quality|28|||
130529860|NCT00844597|469907716|FG000|Overall Study|Adverse Event|0|||
130529861|NCT00844597|469907717|FG001|Overall Study|Adverse Event|0|||
130529862|NCT00844597|469907718|FG002|Overall Study|Adverse Event|0|||
130529863|NCT00844597|469907719|FG003|Overall Study|Adverse Event|1|||
130529864|NCT00844597|469907720|FG004|Overall Study|Adverse Event|0|||
130529865|NCT00844597|469907721|FG005|Overall Study|Adverse Event|0|||
130529866|NCT02670122|469907722|FG000|Overall Study|Lost to Follow-up|4|||
130529867|NCT02762903|469907728|FG000|Overall Study|Lost to Follow-up|0|||
130529868|NCT02762903|469907729|FG001|Overall Study|Lost to Follow-up|1|||
130529869|NCT01228175|469907730|FG000|Overall Study|Lost to Follow-up|64|||
130529870|NCT01228175|469907731|FG001|Overall Study|Lost to Follow-up|50|||
130529871|NCT01228175|469907730|FG000|Overall Study|Withdrawal by Subject|1|||
130529872|NCT01228175|469907731|FG001|Overall Study|Withdrawal by Subject|2|||
130529873|NCT01228175|469907730|FG000|Overall Study|Physician Decision|1|||
130529874|NCT01228175|469907731|FG001|Overall Study|Physician Decision|1|||
130529875|NCT00243074|469907732|FG000|Overall Study|Ineligible|6|||
130529876|NCT00243074|469907732|FG000|Overall Study|Adverse Event|6|||
130529877|NCT00243074|469907732|FG000|Overall Study|Withdrawal by Subject|2|||
130529878|NCT00243074|469907732|FG000|Overall Study|Lack of Efficacy|36|||
130529879|NCT00243074|469907732|FG000|Overall Study|Death|2|||
130529880|NCT00243074|469907732|FG000|Overall Study|not protocol specified|1|||
130529881|NCT00243074|469907732|FG000|Overall Study|Did not receive any treatment|1|||
130578517|NCT02421887|470083102|FG000|Overall Study|Physician Decision|2|||
130578518|NCT02421887|470083103|FG001|Overall Study|Physician Decision|4|||
130578519|NCT02421887|470083102|FG000|Overall Study|Adverse Event|2|||
130578520|NCT02421887|470083103|FG001|Overall Study|Adverse Event|0|||
130578521|NCT03946670|470083109|FG000|Overall Study|Progressive Disease|26|||
130578522|NCT03946670|470083110|FG001|Overall Study|Progressive Disease|23|||
130529882|NCT00664534|469907733|FG000|Overall Study|Adverse Event|2|||
130529883|NCT00664534|469907734|FG001|Overall Study|Adverse Event|3|||
130529884|NCT00664534|469907733|FG000|Overall Study|Lost to Follow-up|6|||
130529885|NCT00664534|469907734|FG001|Overall Study|Lost to Follow-up|10|||
130529886|NCT00664534|469907733|FG000|Overall Study|Protocol Violation|10|||
130529887|NCT00664534|469907734|FG001|Overall Study|Protocol Violation|8|||
130529888|NCT00664534|469907733|FG000|Overall Study|Withdrawal by Subject|7|||
130529889|NCT00664534|469907734|FG001|Overall Study|Withdrawal by Subject|6|||
130529890|NCT00664534|469907733|FG000|Overall Study|Physician Decision|8|||
130529891|NCT00664534|469907734|FG001|Overall Study|Physician Decision|0|||
130529892|NCT00664534|469907733|FG000|Overall Study|Sponsor decision|8|||
130529893|NCT00664534|469907734|FG001|Overall Study|Sponsor decision|6|||
130529894|NCT03041792|469907737|FG000|Overall Study|Adverse Event|4|||
130529895|NCT03041792|469907738|FG001|Overall Study|Adverse Event|0|||
130529896|NCT03041792|469907737|FG000|Overall Study|Death in the family|0|||
130529897|NCT03041792|469907738|FG001|Overall Study|Death in the family|2|||
130529898|NCT03041792|469907737|FG000|Overall Study|Randomized but not treated|0|||
130529899|NCT03041792|469907738|FG001|Overall Study|Randomized but not treated|1|||
130529900|NCT04978090|469907739|FG000|Overall Study|unable to adequately fit device|2|||
130529901|NCT02227992|469907740|FG000|Overall Study|Lost to Follow-up|1|||
130529902|NCT02227992|469907741|FG001|Overall Study|Lost to Follow-up|1|||
130529903|NCT00996606|469907744|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
130529904|NCT00996606|469907744|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130529905|NCT00996606|469907744|FG000|Overall Study|Protocol Violation|1|||
130529906|NCT00996606|469907744|FG000|Overall Study|Withdrawal by Subject|3|||
130529907|NCT00632502|469907746|FG000|Overall Study|Adverse Event|0|||
130529908|NCT00632502|469907747|FG001|Overall Study|Adverse Event|1|||
130529909|NCT00632502|469907746|FG000|Overall Study|Randomized not treated|3|||
130529910|NCT00632502|469907747|FG001|Overall Study|Randomized not treated|0|||
130529911|NCT03075527|469907748|FG000|Overall Study|Death|1|||
130529912|NCT03075527|469907748|FG000|Overall Study|Withdrawal by Subject|1|||
130529913|NCT03075527|469907748|FG000|Overall Study|Physician Decision|3|||
130529914|NCT03075527|469907748|FG000|Overall Study|Progression/Relapse|14|||
130529915|NCT00681668|469907749|FG000|Overall Study|Protocol Violation|1|||
130529916|NCT00681668|469907749|FG000|Overall Study|Withdrawal by Subject|1|||
130529917|NCT02209181|469907750|FG000|Overall Study|Adverse Event|1|||
130529918|NCT02209181|469907751|FG001|Overall Study|Adverse Event|0|||
130529919|NCT02209181|469907752|FG002|Overall Study|Adverse Event|1|||
130529920|NCT02209181|469907753|FG003|Overall Study|Adverse Event|0|||
130529921|NCT02209181|469907750|FG000|Overall Study|Withdrawal by Subject|0|||
130529922|NCT02209181|469907751|FG001|Overall Study|Withdrawal by Subject|1|||
130529923|NCT02209181|469907752|FG002|Overall Study|Withdrawal by Subject|0|||
130529924|NCT02209181|469907753|FG003|Overall Study|Withdrawal by Subject|0|||
130529925|NCT04641962|469907759|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
130529926|NCT04641962|469907760|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
130529927|NCT04641962|469907761|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
130529928|NCT04641962|469907762|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
130529929|NCT04641962|469907763|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
130529930|NCT04641962|469907759|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
130529931|NCT04641962|469907760|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
130529932|NCT04641962|469907761|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
130529933|NCT04641962|469907762|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
130529934|NCT04641962|469907763|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
130529935|NCT04641962|469907759|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
130529936|NCT04641962|469907760|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
130529937|NCT04641962|469907761|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
130529938|NCT04641962|469907762|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
130529939|NCT04641962|469907763|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
130529940|NCT04641962|469907759|FG000|DBT Period: Up to 52 Weeks|Death|1|||
130529941|NCT04641962|469907760|FG001|DBT Period: Up to 52 Weeks|Death|0|||
130529942|NCT04641962|469907761|FG002|DBT Period: Up to 52 Weeks|Death|0|||
130529943|NCT04641962|469907762|FG003|DBT Period: Up to 52 Weeks|Death|0|||
130529944|NCT04641962|469907763|FG004|DBT Period: Up to 52 Weeks|Death|0|||
130578523|NCT03946670|470083109|FG000|Overall Study|Adverse Event|7|||
130578524|NCT03946670|470083110|FG001|Overall Study|Adverse Event|9|||
130578525|NCT03946670|470083109|FG000|Overall Study|Death|5|||
130529945|NCT04641962|469907759|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
130529946|NCT04641962|469907760|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
130529947|NCT04641962|469907761|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
130529948|NCT04641962|469907762|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
130529949|NCT04641962|469907763|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
130529950|NCT04641962|469907759|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
130529951|NCT04641962|469907760|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
130529952|NCT04641962|469907761|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
130529953|NCT04641962|469907762|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
130529954|NCT04641962|469907763|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
130529955|NCT04641962|469907759|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
130529956|NCT04641962|469907760|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
130529957|NCT04641962|469907761|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
130529958|NCT04641962|469907762|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
130529959|NCT04641962|469907763|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
130529960|NCT00862836|469907764|FG000|Overall Study|Withdrawal by Subject|1|||
130529961|NCT06926673|469907765|FG000|Overall Study|Lost to Follow-up|0|||
130529962|NCT06926673|469907766|FG001|Overall Study|Lost to Follow-up|0|||
130529963|NCT06926673|469907767|FG002|Overall Study|Lost to Follow-up|0|||
130529964|NCT06926673|469907768|FG003|Overall Study|Lost to Follow-up|1|||
130529965|NCT06926673|469907769|FG004|Overall Study|Lost to Follow-up|0|||
130529966|NCT06926673|469907770|FG005|Overall Study|Lost to Follow-up|0|||
130529967|NCT06926673|469907771|FG006|Overall Study|Lost to Follow-up|0|||
130529968|NCT06926673|469907765|FG000|Overall Study|Physician Decision|0|||
130529969|NCT06926673|469907766|FG001|Overall Study|Physician Decision|0|||
130529970|NCT06926673|469907767|FG002|Overall Study|Physician Decision|0|||
130529971|NCT06926673|469907768|FG003|Overall Study|Physician Decision|0|||
130529972|NCT06926673|469907769|FG004|Overall Study|Physician Decision|0|||
130529973|NCT06926673|469907770|FG005|Overall Study|Physician Decision|0|||
130529974|NCT06926673|469907771|FG006|Overall Study|Physician Decision|1|||
130529975|NCT06926673|469907765|FG000|Overall Study|Withdrawal by Subject|0|||
130529976|NCT06926673|469907766|FG001|Overall Study|Withdrawal by Subject|3|||
130529977|NCT06926673|469907767|FG002|Overall Study|Withdrawal by Subject|2|||
130529978|NCT06926673|469907768|FG003|Overall Study|Withdrawal by Subject|1|||
130529979|NCT06926673|469907769|FG004|Overall Study|Withdrawal by Subject|0|||
130529980|NCT06926673|469907770|FG005|Overall Study|Withdrawal by Subject|2|||
130529981|NCT06926673|469907771|FG006|Overall Study|Withdrawal by Subject|0|||
130529982|NCT02460575|469909547|FG000|Overall Study|Lost to Follow-up|1|||
130529983|NCT02460575|469909548|FG001|Overall Study|Lost to Follow-up|0|||
130529984|NCT04307940|469909549|FG000|Overall Study|Adverse Event|1|||
130529985|NCT04307940|469909550|FG001|Overall Study|Adverse Event|0|||
130529986|NCT04307940|469909551|FG002|Overall Study|Adverse Event|0|||
130578526|NCT03946670|470083110|FG001|Overall Study|Death|6|||
130578527|NCT03946670|470083109|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
130578528|NCT03946670|470083110|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
130578529|NCT03946670|470083109|FG000|Overall Study|Subject Decision|4|||
130578530|NCT03946670|470083110|FG001|Overall Study|Subject Decision|4|||
130578531|NCT03946670|470083109|FG000|Overall Study|Physician Decision|3|||
130578532|NCT03946670|470083110|FG001|Overall Study|Physician Decision|3|||
130578533|NCT03946670|470083109|FG000|Overall Study|New Therapy for Study Indication|1|||
130578534|NCT03946670|470083110|FG001|Overall Study|New Therapy for Study Indication|0|||
130578535|NCT03946670|470083109|FG000|Overall Study|Not treated|1|||
130578536|NCT03946670|470083110|FG001|Overall Study|Not treated|1|||
130578537|NCT04537208|470083113|FG000|Overall Study|Adverse Event|0|||
130578538|NCT04537208|470083114|FG001|Overall Study|Adverse Event|0|||
130578539|NCT04537208|470083115|FG002|Overall Study|Adverse Event|0|||
130578540|NCT04537208|470083116|FG003|Overall Study|Adverse Event|0|||
130578541|NCT04537208|470083117|FG004|Overall Study|Adverse Event|0|||
130578542|NCT04537208|470083118|FG005|Overall Study|Adverse Event|0|||
130578543|NCT04537208|470083119|FG006|Overall Study|Adverse Event|0|||
130578544|NCT04537208|470083120|FG007|Overall Study|Adverse Event|0|||
130578545|NCT04537208|470083121|FG008|Overall Study|Adverse Event|1|||
130578546|NCT04537208|470083122|FG009|Overall Study|Adverse Event|0|||
130529987|NCT04307940|469909549|FG000|Overall Study|Withdrawal by Subject|2|||
130529988|NCT04307940|469909550|FG001|Overall Study|Withdrawal by Subject|3|||
130529989|NCT04307940|469909551|FG002|Overall Study|Withdrawal by Subject|1|||
130529990|NCT04307940|469909549|FG000|Overall Study|Lost to Follow-up|2|||
130529991|NCT04307940|469909550|FG001|Overall Study|Lost to Follow-up|0|||
130578547|NCT04537208|470083123|FG010|Overall Study|Adverse Event|0|||
130578548|NCT04537208|470083113|FG000|Overall Study|Protocol deviation|0|||
130578549|NCT04537208|470083114|FG001|Overall Study|Protocol deviation|0|||
130529992|NCT04307940|469909551|FG002|Overall Study|Lost to Follow-up|1|||
130578550|NCT04537208|470083115|FG002|Overall Study|Protocol deviation|2|||
130578551|NCT04537208|470083116|FG003|Overall Study|Protocol deviation|0|||
130578552|NCT04537208|470083117|FG004|Overall Study|Protocol deviation|0|||
130529993|NCT05543174|469909552|FG000|Overall Study|Ongoing|7|||
130529994|NCT04896008|469909553|FG000|Overall Study|Ongoing|70|||
130529995|NCT04896008|469909554|FG001|Overall Study|Ongoing|38|||
130529996|NCT04896008|469909553|FG000|Overall Study|Adverse Event|0|||
130529997|NCT04896008|469909554|FG001|Overall Study|Adverse Event|2|||
130529998|NCT04896008|469909553|FG000|Overall Study|Death|5|||
130529999|NCT04896008|469909554|FG001|Overall Study|Death|10|||
130530000|NCT04896008|469909553|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
130530001|NCT04896008|469909554|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
130530002|NCT04896008|469909553|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
130530003|NCT04896008|469909554|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
130530004|NCT04896008|469909553|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
130530005|NCT04896008|469909554|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
130530006|NCT04896008|469909553|FG000|Overall Study|Withdrawal by Subject|1|||
130530007|NCT04896008|469909554|FG001|Overall Study|Withdrawal by Subject|4|||
130530008|NCT04896008|469909553|FG000|Overall Study|Investigator Decision|2|||
130530009|NCT04896008|469909554|FG001|Overall Study|Investigator Decision|0|||
130530010|NCT04896008|469909553|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
130530011|NCT04896008|469909554|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
130530012|NCT01270828|469909555|FG000|Pregabalin CR SB|Reason Unspecified|0|||
130530013|NCT01270828|469909556|FG001|Pregabalin CR SB|Reason Unspecified|0|||
130530014|NCT01270828|469909557|FG002|Pregabalin CR SB|Reason Unspecified|8|||
130530015|NCT01270828|469909555|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
130530016|NCT01270828|469909556|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
130530017|NCT01270828|469909557|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
130530018|NCT01270828|469909555|FG000|Pregabalin CR SB|Related adverse event|0|||
130530019|NCT01270828|469909556|FG001|Pregabalin CR SB|Related adverse event|0|||
130530020|NCT01270828|469909557|FG002|Pregabalin CR SB|Related adverse event|46|||
130530021|NCT01270828|469909555|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
130530022|NCT01270828|469909556|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
130530023|NCT01270828|469909557|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
130530024|NCT01270828|469909555|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
130530025|NCT01270828|469909556|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
130530026|NCT01270828|469909557|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
130530027|NCT01270828|469909555|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
130530028|NCT01270828|469909556|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
130530029|NCT01270828|469909557|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
130530030|NCT01270828|469909555|FG000|Pregabalin CR SB|Unrelated AE|0|||
130530031|NCT01270828|469909556|FG001|Pregabalin CR SB|Unrelated AE|0|||
130530032|NCT01270828|469909557|FG002|Pregabalin CR SB|Unrelated AE|8|||
130530033|NCT01270828|469909555|FG000|Pregabalin CR SB|Protocol Violation|0|||
130530034|NCT01270828|469909556|FG001|Pregabalin CR SB|Protocol Violation|0|||
130530035|NCT01270828|469909557|FG002|Pregabalin CR SB|Protocol Violation|8|||
130530036|NCT01270828|469909555|FG000|Double Blind Phase|Death|0|||
130530037|NCT01270828|469909556|FG001|Double Blind Phase|Death|1|||
130530038|NCT01270828|469909557|FG002|Double Blind Phase|Death|0|||
130530039|NCT01270828|469909555|FG000|Double Blind Phase|Protocol Violation|0|||
130530040|NCT01270828|469909556|FG001|Double Blind Phase|Protocol Violation|1|||
130530041|NCT01270828|469909557|FG002|Double Blind Phase|Protocol Violation|0|||
130530042|NCT01270828|469909555|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
130530043|NCT01270828|469909556|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
130530044|NCT01270828|469909557|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
130530045|NCT01270828|469909555|FG000|Double Blind Phase|Reason Unspecified|7|||
130530046|NCT01270828|469909556|FG001|Double Blind Phase|Reason Unspecified|4|||
130530047|NCT01270828|469909557|FG002|Double Blind Phase|Reason Unspecified|0|||
130530048|NCT01270828|469909555|FG000|Double Blind Phase|Withdrawal by Subject|6|||
130530049|NCT01270828|469909556|FG001|Double Blind Phase|Withdrawal by Subject|15|||
130530050|NCT01270828|469909557|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130530051|NCT01270828|469909555|FG000|Double Blind Phase|Lost to Follow-up|1|||
130530052|NCT01270828|469909556|FG001|Double Blind Phase|Lost to Follow-up|2|||
130530053|NCT01270828|469909557|FG002|Double Blind Phase|Lost to Follow-up|0|||
130530054|NCT01270828|469909555|FG000|Double Blind Phase|Lack of Efficacy|2|||
130530055|NCT01270828|469909556|FG001|Double Blind Phase|Lack of Efficacy|11|||
130530056|NCT01270828|469909557|FG002|Double Blind Phase|Lack of Efficacy|0|||
130530057|NCT01270828|469909555|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
130530058|NCT01270828|469909556|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
130530059|NCT01270828|469909557|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
130530060|NCT01270828|469909555|FG000|Double Blind Phase|Adverse event related to study drug|5|||
130578553|NCT04537208|470083118|FG005|Overall Study|Protocol deviation|2|||
130578554|NCT04537208|470083119|FG006|Overall Study|Protocol deviation|4|||
130578555|NCT04537208|470083120|FG007|Overall Study|Protocol deviation|0|||
130530061|NCT01270828|469909556|FG001|Double Blind Phase|Adverse event related to study drug|7|||
130530062|NCT01270828|469909557|FG002|Double Blind Phase|Adverse event related to study drug|0|||
130530063|NCT02963090|469909560|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
130530064|NCT02963090|469909561|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
130530065|NCT00709228|469909565|FG000|Overall Study|Not treated|14|||
130530066|NCT00709228|469909565|FG000|Overall Study|Eligibility criteria not met|281|||
130530067|NCT00709228|469909565|FG000|Overall Study|Adverse events|2|||
130530068|NCT00709228|469909565|FG000|Overall Study|Discontinued treatment|14|||
130530069|NCT00709228|469909565|FG000|Overall Study|Did not enter follow-up|4|||
130530070|NCT00709228|469909565|FG000|Overall Study|Discontinued follow-up|5|||
130530071|NCT00709228|469909565|FG000|Overall Study|Disease progression|1|||
130530072|NCT00709228|469909565|FG000|Overall Study|Lost to Follow-up|6|||
130530073|NCT00709228|469909565|FG000|Overall Study|Non-compliance|5|||
130530074|NCT04497389|469909566|FG000|Overall Study|Withdrawal by Subject|1|||
130530075|NCT04497389|469909567|FG001|Overall Study|Withdrawal by Subject|0|||
130530076|NCT00789360|469909568|FG000|Overall Study|Protocol Violation|3|||
130530077|NCT00789360|469909569|FG001|Overall Study|Protocol Violation|1|||
130530078|NCT00022659|469909570|FG000|Overall Study|Ineligible: wrong primary|1|||
130530079|NCT00022659|469909570|FG000|Overall Study|Never treated|1|||
130530080|NCT03322540|469909572|FG000|Overall Study|Death|21|||
130530081|NCT03322540|469909573|FG001|Overall Study|Death|28|||
130530082|NCT03322540|469909572|FG000|Overall Study|Lost to Follow-up|0|||
130530083|NCT03322540|469909573|FG001|Overall Study|Lost to Follow-up|1|||
130530084|NCT03322540|469909572|FG000|Overall Study|Physician Decision|7|||
130530085|NCT03322540|469909573|FG001|Overall Study|Physician Decision|6|||
130530086|NCT03322540|469909572|FG000|Overall Study|Withdrawal by Subject|3|||
130530087|NCT03322540|469909573|FG001|Overall Study|Withdrawal by Subject|1|||
130530088|NCT03322540|469909572|FG000|Overall Study|Study terminated by sponsor|0|||
130530089|NCT03322540|469909573|FG001|Overall Study|Study terminated by sponsor|1|||
130530090|NCT00968526|469909574|FG000|Overall Study|Adverse Event|2|||
130530091|NCT00968526|469909575|FG001|Overall Study|Adverse Event|0|||
130530092|NCT00968526|469909574|FG000|Overall Study|Migrated/moved from study area|1|||
130530093|NCT00968526|469909575|FG001|Overall Study|Migrated/moved from study area|0|||
130530094|NCT03926195|469909579|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
130530095|NCT03926195|469909580|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
130530096|NCT03926195|469909579|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
130530097|NCT03926195|469909580|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
130530098|NCT03926195|469909579|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
130530099|NCT03926195|469909580|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
130530100|NCT03926195|469909579|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
130530101|NCT03926195|469909580|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
130530102|NCT03926195|469909579|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
130530103|NCT03926195|469909580|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
130530104|NCT03926195|469909579|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
130530105|NCT03926195|469909580|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
130530106|NCT03054337|469909581|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
130530107|NCT03054337|469909582|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
130530108|NCT03054337|469909583|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
130530109|NCT03054337|469909584|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
130530110|NCT03054337|469909585|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
130530111|NCT03054337|469909586|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
130530112|NCT03738475|469909588|FG000|Overall Study|Participant Non-Compliance|1|||
130530113|NCT03738475|469909589|FG001|Overall Study|Participant Non-Compliance|0|||
130530114|NCT00737477|469909590|FG000|Overall Study|Adverse Event|9|||
130530115|NCT00737477|469909590|FG000|Overall Study|Death|9|||
130530116|NCT00737477|469909590|FG000|Overall Study|Treatment Refusal|1|||
130530117|NCT00737477|469909590|FG000|Overall Study|Withdrawal by Subject|1|||
130530118|NCT00737477|469909590|FG000|Overall Study|Renal Transplantation|10|||
130578556|NCT04537208|470083121|FG008|Overall Study|Protocol deviation|1|||
130578557|NCT04537208|470083122|FG009|Overall Study|Protocol deviation|0|||
130530119|NCT00737477|469909590|FG000|Overall Study|Other|4|||
130530120|NCT00581477|469909591|FG000|Overall Study|Physician Decision|2|||
130530121|NCT03106753|469909592|FG000|Overall Study|Withdrawal by Subject|0|||
130530122|NCT03106753|469909593|FG001|Overall Study|Withdrawal by Subject|1|||
130530123|NCT01853475|469909600|FG000|Overall Study|Withdrawal by Subject|0|||
130530124|NCT01853475|469909601|FG001|Overall Study|Withdrawal by Subject|1|||
130578558|NCT04537208|470083123|FG010|Overall Study|Protocol deviation|2|||
130578559|NCT04537208|470083113|FG000|Overall Study|Withdrawal by Subject|4|||
130578560|NCT04537208|470083114|FG001|Overall Study|Withdrawal by Subject|2|||
130578561|NCT04537208|470083115|FG002|Overall Study|Withdrawal by Subject|1|||
130578562|NCT04537208|470083116|FG003|Overall Study|Withdrawal by Subject|3|||
130578563|NCT04537208|470083117|FG004|Overall Study|Withdrawal by Subject|5|||
130578564|NCT04537208|470083118|FG005|Overall Study|Withdrawal by Subject|1|||
130578565|NCT04537208|470083119|FG006|Overall Study|Withdrawal by Subject|6|||
130578566|NCT04537208|470083120|FG007|Overall Study|Withdrawal by Subject|1|||
130578567|NCT04537208|470083121|FG008|Overall Study|Withdrawal by Subject|7|||
130578568|NCT04537208|470083122|FG009|Overall Study|Withdrawal by Subject|2|||
130578569|NCT04537208|470083123|FG010|Overall Study|Withdrawal by Subject|4|||
130578570|NCT04537208|470083113|FG000|Overall Study|Lost to Follow-up|4|||
130578571|NCT04537208|470083114|FG001|Overall Study|Lost to Follow-up|1|||
130578572|NCT04537208|470083115|FG002|Overall Study|Lost to Follow-up|3|||
130578573|NCT04537208|470083116|FG003|Overall Study|Lost to Follow-up|4|||
130578574|NCT04537208|470083117|FG004|Overall Study|Lost to Follow-up|3|||
130578575|NCT04537208|470083118|FG005|Overall Study|Lost to Follow-up|2|||
130578576|NCT04537208|470083119|FG006|Overall Study|Lost to Follow-up|3|||
130578577|NCT04537208|470083120|FG007|Overall Study|Lost to Follow-up|2|||
130578578|NCT04537208|470083121|FG008|Overall Study|Lost to Follow-up|7|||
130578579|NCT04537208|470083122|FG009|Overall Study|Lost to Follow-up|2|||
130578580|NCT04537208|470083123|FG010|Overall Study|Lost to Follow-up|2|||
130578581|NCT03083886|470083124|FG000|Overall Study|Withdrawal by Subject|51|||
130578582|NCT03083886|470083125|FG001|Overall Study|Withdrawal by Subject|73|||
130578583|NCT03083886|470083126|FG002|Overall Study|Withdrawal by Subject|104|||
130578584|NCT03083886|470083124|FG000|Overall Study|Missing Baseline data|43|||
130578585|NCT03083886|470083125|FG001|Overall Study|Missing Baseline data|42|||
130578586|NCT03083886|470083126|FG002|Overall Study|Missing Baseline data|31|||
130578587|NCT03083886|470083124|FG000|Overall Study|Investigator terminated|1|||
130578588|NCT03083886|470083125|FG001|Overall Study|Investigator terminated|6|||
130578589|NCT03083886|470083126|FG002|Overall Study|Investigator terminated|3|||
130578590|NCT04161495|470083127|FG000|Overall Study|Withdrawal by Subject|3|||
130578591|NCT04161495|470083128|FG001|Overall Study|Withdrawal by Subject|0|||
130578592|NCT04161495|470083127|FG000|Overall Study|Protocol Violation|1|||
130578593|NCT04161495|470083128|FG001|Overall Study|Protocol Violation|0|||
130578594|NCT04161495|470083127|FG000|Overall Study|Prohibited concomitant medication|3|||
130578595|NCT04161495|470083128|FG001|Overall Study|Prohibited concomitant medication|0|||
130578596|NCT04161495|470083127|FG000|Overall Study|Adverse Event|1|||
130578597|NCT04161495|470083128|FG001|Overall Study|Adverse Event|0|||
130578598|NCT04161495|470083127|FG000|Overall Study|Other - Unspecified|1|||
130578599|NCT04161495|470083128|FG001|Overall Study|Other - Unspecified|0|||
130578600|NCT04161495|470083127|FG000|Overall Study|Death|0|||
130578601|NCT04161495|470083128|FG001|Overall Study|Death|1|||
130578602|NCT03655756|470083129|FG000|Overall Study|Death|1|||
130578603|NCT00253630|470083130|FG000|Overall Study|ineligible|2|||
130578604|NCT00429858|470083131|FG000|Overall Study|Withdrawal by Subject|1|||
130578605|NCT00429858|470083131|FG000|Overall Study|Study Termination|1|||
130578606|NCT02062658|470083133|FG000|Overall Study|Withdrawal by Subject|1|||
130578607|NCT02062658|470083133|FG000|Overall Study|Lack of Efficacy|1|||
130578608|NCT02161562|470083134|FG000|Overall Study|Withdrawal by Subject|5|||
130578609|NCT02161562|470083135|FG001|Overall Study|Withdrawal by Subject|8|||
130578610|NCT02161562|470083134|FG000|Overall Study|Protocol Violation|9|||
130578611|NCT02161562|470083135|FG001|Overall Study|Protocol Violation|4|||
130578612|NCT02161562|470083134|FG000|Overall Study|Pregnancy|1|||
130578613|NCT02161562|470083135|FG001|Overall Study|Pregnancy|2|||
130578614|NCT02161562|470083134|FG000|Overall Study|Lost to Follow-up|3|||
130578615|NCT02161562|470083135|FG001|Overall Study|Lost to Follow-up|1|||
130578616|NCT02161562|470083134|FG000|Overall Study|Lack of Efficacy|4|||
130578617|NCT02161562|470083135|FG001|Overall Study|Lack of Efficacy|1|||
130578618|NCT02161562|470083134|FG000|Overall Study|Adverse Event|1|||
130578619|NCT02161562|470083135|FG001|Overall Study|Adverse Event|1|||
130578620|NCT02161562|470083134|FG000|Overall Study|Participant moved back to home country|1|||
130578621|NCT02161562|470083135|FG001|Overall Study|Participant moved back to home country|0|||
130578622|NCT02161562|470083134|FG000|Overall Study|Withdrew due to being out of the country|1|||
130578623|NCT02161562|470083135|FG001|Overall Study|Withdrew due to being out of the country|0|||
130578624|NCT02161562|470083134|FG000|Overall Study|Participant moved out of province|1|||
130578625|NCT02161562|470083135|FG001|Overall Study|Participant moved out of province|0|||
130578626|NCT02475655|470083136|FG000|Overall Study|Lost to Follow-up|0|||
130578627|NCT02475655|470083137|FG001|Overall Study|Lost to Follow-up|1|||
130578628|NCT00643994|470083139|FG000|Overall Study|Death|24|||
130578629|NCT00643994|470083139|FG000|Overall Study|Lost to Follow-up|72|||
130578630|NCT00257010|470083158|FG000|Overall Study|Lack of Efficacy|11|||
130578631|NCT00257010|470083158|FG000|Overall Study|Lost to Follow-up|53|||
130578632|NCT00257010|470083158|FG000|Overall Study|Withdrawal by Subject|34|||
130578633|NCT00257010|470083158|FG000|Overall Study|Adverse Event|10|||
130578634|NCT00257010|470083158|FG000|Overall Study|various|11|||
130578635|NCT00257010|470083158|FG000|Overall Study|no headache reported|9|||
130578636|NCT00197054|470083159|FG000|Overall Study|Withdrawal by Subject|9|||
130578637|NCT00197054|470083160|FG001|Overall Study|Withdrawal by Subject|3|||
130578638|NCT00197054|470083161|FG002|Overall Study|Withdrawal by Subject|3|||
130578639|NCT00197054|470083159|FG000|Overall Study|Moved from area|7|||
130578640|NCT00197054|470083160|FG001|Overall Study|Moved from area|14|||
130578641|NCT00197054|470083161|FG002|Overall Study|Moved from area|9|||
130578642|NCT00197054|470083159|FG000|Overall Study|Lost to Follow-up|1|||
130578643|NCT00197054|470083160|FG001|Overall Study|Lost to Follow-up|4|||
130578644|NCT00197054|470083161|FG002|Overall Study|Lost to Follow-up|0|||
130578645|NCT00323557|470083162|FG000|Overall Study|Physician Decision|1|||
130578646|NCT00323557|470083163|FG001|Overall Study|Physician Decision|0|||
130578647|NCT02450578|470083166|FG000|Overall Study|ECG abnormality so not treated|1|||
130578648|NCT02450578|470083167|FG001|Overall Study|ECG abnormality so not treated|0|||
130578649|NCT02450578|470083168|FG002|Overall Study|ECG abnormality so not treated|0|||
130578650|NCT02450578|470083169|FG003|Overall Study|ECG abnormality so not treated|0|||
130578651|NCT00662792|470083170|FG000|Period 1|Personal Reasons|0|||
130578652|NCT00662792|470083171|FG001|Period 1|Personal Reasons|0|||
130578653|NCT00662792|470083172|FG002|Period 1|Personal Reasons|1|||
130578654|NCT00662792|470083173|FG003|Period 1|Personal Reasons|0|||
130578655|NCT00662792|470083170|FG000|Period 1|Refused continuing medication|0|||
130578656|NCT00662792|470083171|FG001|Period 1|Refused continuing medication|1|||
130578657|NCT00662792|470083172|FG002|Period 1|Refused continuing medication|1|||
130578658|NCT00662792|470083173|FG003|Period 1|Refused continuing medication|0|||
130578659|NCT00662792|470083170|FG000|Period 1|Lost to Follow-up|1|||
130578660|NCT00662792|470083171|FG001|Period 1|Lost to Follow-up|0|||
130578661|NCT00662792|470083172|FG002|Period 1|Lost to Follow-up|0|||
130578662|NCT00662792|470083173|FG003|Period 1|Lost to Follow-up|0|||
130578663|NCT00662792|470083170|FG000|Period 1|Other adverse event (AE)|0|||
130578664|NCT00662792|470083171|FG001|Period 1|Other adverse event (AE)|2|||
130578665|NCT00662792|470083172|FG002|Period 1|Other adverse event (AE)|0|||
130578666|NCT00662792|470083173|FG003|Period 1|Other adverse event (AE)|0|||
130578667|NCT00662792|470083170|FG000|Period 1|Worsening of disease under study (AE)|1|||
130578668|NCT00662792|470083171|FG001|Period 1|Worsening of disease under study (AE)|3|||
130578669|NCT00662792|470083172|FG002|Period 1|Worsening of disease under study (AE)|2|||
130578670|NCT00662792|470083173|FG003|Period 1|Worsening of disease under study (AE)|0|||
130578671|NCT00662792|470083170|FG000|Period 1|Not treated|0|||
130578672|NCT00662792|470083171|FG001|Period 1|Not treated|1|||
130578673|NCT00662792|470083172|FG002|Period 1|Not treated|0|||
130578674|NCT00662792|470083173|FG003|Period 1|Not treated|0|||
130578675|NCT00662792|470083170|FG000|Period 2|Worsening of disease under study|1|||
130578676|NCT00662792|470083171|FG001|Period 2|Worsening of disease under study|0|||
130578677|NCT00662792|470083172|FG002|Period 2|Worsening of disease under study|0|||
130578678|NCT00662792|470083173|FG003|Period 2|Worsening of disease under study|3|||
130578679|NCT00662792|470083170|FG000|Period 3|Refused continuing medication|1|||
130578680|NCT00662792|470083171|FG001|Period 3|Refused continuing medication|0|||
130578681|NCT00662792|470083172|FG002|Period 3|Refused continuing medication|1|||
130578682|NCT00662792|470083173|FG003|Period 3|Refused continuing medication|0|||
130578683|NCT00662792|470083170|FG000|Period 3|Other adverse event (AE)|0|||
130578684|NCT00662792|470083171|FG001|Period 3|Other adverse event (AE)|0|||
130578685|NCT00662792|470083172|FG002|Period 3|Other adverse event (AE)|1|||
130578686|NCT00662792|470083173|FG003|Period 3|Other adverse event (AE)|1|||
130578687|NCT00662792|470083170|FG000|Period 4|Refused continuing medication|0|||
130578688|NCT00662792|470083171|FG001|Period 4|Refused continuing medication|1|||
130578689|NCT00662792|470083172|FG002|Period 4|Refused continuing medication|0|||
130578690|NCT00662792|470083173|FG003|Period 4|Refused continuing medication|0|||
130578691|NCT00662792|470083170|FG000|Period 4|Other adverse event (AE)|1|||
130578692|NCT00662792|470083171|FG001|Period 4|Other adverse event (AE)|0|||
130578693|NCT00662792|470083172|FG002|Period 4|Other adverse event (AE)|0|||
130578694|NCT00662792|470083173|FG003|Period 4|Other adverse event (AE)|0|||
130578695|NCT00662792|470083170|FG000|Period 4|Worsening of disease under study (AE)|0|||
130578696|NCT00662792|470083171|FG001|Period 4|Worsening of disease under study (AE)|0|||
130578697|NCT00662792|470083172|FG002|Period 4|Worsening of disease under study (AE)|0|||
130578698|NCT00662792|470083173|FG003|Period 4|Worsening of disease under study (AE)|1|||
130578699|NCT01699087|470083175|FG000|Overall Study|Lost to Follow-up|7|||
130578700|NCT01699087|470083175|FG000|Overall Study|Screen failure (prior to treatment)|15|||
130578701|NCT01699087|470083175|FG000|Overall Study|Unable to make future visits|2|||
130578702|NCT03021642|470083178|FG000|Washout Period (21 Days)|Adverse Event|1|||
130578703|NCT03021642|470083179|FG001|Washout Period (21 Days)|Adverse Event|1|||
130578704|NCT00756938|470083180|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
130578705|NCT00756938|470083181|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
130578706|NCT00756938|470083182|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
130578707|NCT00756938|470083183|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
130578708|NCT00756938|470083180|FG000|12-week Base Study|Protocol Violation|0|||
130578709|NCT00756938|470083181|FG001|12-week Base Study|Protocol Violation|0|||
130578710|NCT00756938|470083182|FG002|12-week Base Study|Protocol Violation|1|||
130578711|NCT00756938|470083183|FG003|12-week Base Study|Protocol Violation|0|||
130578712|NCT00756938|470083180|FG000|12-week Base Study|Lost to Follow-up|1|||
130578713|NCT00756938|470083181|FG001|12-week Base Study|Lost to Follow-up|0|||
130530125|NCT01853475|469909602|FG002|Overall Study|Withdrawal by Subject|0|||
130530126|NCT01023958|469909607|FG000|Overall Study|Progressive disease|48|||
130530127|NCT01023958|469909607|FG000|Overall Study|Other adverse event|1|||
130530128|NCT01023958|469909607|FG000|Overall Study|Refused to continue medication|1|||
130530129|NCT02159040|469909608|FG000|Overall Study|Death|1|||
130530130|NCT03080493|469909609|FG000|Overall Study|Did not provide NRS pain results|1|||
130530131|NCT03080493|469909610|FG001|Overall Study|Did not provide NRS pain results|0|||
130530132|NCT03080493|469909609|FG000|Overall Study|Adverse Event|0|||
130530133|NCT03080493|469909610|FG001|Overall Study|Adverse Event|1|||
130530134|NCT03080493|469909609|FG000|Overall Study|Randomization error (parity group)|0|||
130530135|NCT03080493|469909610|FG001|Overall Study|Randomization error (parity group)|1|||
130530136|NCT00755417|469909611|FG000|Overall Study|Adverse Event|28|||
130530137|NCT00755417|469909612|FG001|Overall Study|Adverse Event|20|||
130530138|NCT00755417|469909613|FG002|Overall Study|Adverse Event|7|||
130530139|NCT00755417|469909611|FG000|Overall Study|Lack of Efficacy|8|||
130530140|NCT00755417|469909612|FG001|Overall Study|Lack of Efficacy|4|||
130530141|NCT00755417|469909613|FG002|Overall Study|Lack of Efficacy|9|||
130530142|NCT00755417|469909611|FG000|Overall Study|Protocol Violation|2|||
130530143|NCT00755417|469909612|FG001|Overall Study|Protocol Violation|1|||
130530144|NCT00755417|469909613|FG002|Overall Study|Protocol Violation|1|||
130530145|NCT00755417|469909611|FG000|Overall Study|Lost to Follow-up|3|||
130530146|NCT00755417|469909612|FG001|Overall Study|Lost to Follow-up|0|||
130530147|NCT00755417|469909613|FG002|Overall Study|Lost to Follow-up|1|||
130530148|NCT00755417|469909611|FG000|Overall Study|Withdrawal by Subject|12|||
130530149|NCT00755417|469909612|FG001|Overall Study|Withdrawal by Subject|12|||
130530150|NCT00755417|469909613|FG002|Overall Study|Withdrawal by Subject|12|||
130530151|NCT00755417|469909611|FG000|Overall Study|Not specified or missing data|9|||
130530152|NCT00755417|469909612|FG001|Overall Study|Not specified or missing data|18|||
130530153|NCT00755417|469909613|FG002|Overall Study|Not specified or missing data|12|||
130530154|NCT02362503|469909615|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
130530155|NCT02362503|469909616|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
130530156|NCT02362503|469909617|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
130530157|NCT02362503|469909615|FG000|Double-blind Period-Up to 8 Days|Death|1|||
130530158|NCT02362503|469909616|FG001|Double-blind Period-Up to 8 Days|Death|0|||
130530159|NCT02362503|469909617|FG002|Double-blind Period-Up to 8 Days|Death|0|||
130530160|NCT02362503|469909615|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
130530161|NCT02362503|469909616|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
130530162|NCT02362503|469909617|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
130530163|NCT02362503|469909615|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
130530164|NCT02362503|469909616|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
130530165|NCT02362503|469909617|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
130530166|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
130530167|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
130530168|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
130530169|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
130530170|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
130530171|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
130530172|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
130530173|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
130530174|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
130530175|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
130530176|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
130530177|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
130530178|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
130530179|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
130530180|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
130530181|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
130530182|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
130530183|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
130530184|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
130530185|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
130530186|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
130530187|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
130530188|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
130530189|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
130530190|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
130530191|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
130578714|NCT00756938|470083182|FG002|12-week Base Study|Lost to Follow-up|0|||
130530192|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
130530193|NCT02362503|469909615|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
130530194|NCT02362503|469909616|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
130578715|NCT00756938|470083183|FG003|12-week Base Study|Lost to Follow-up|0|||
130578716|NCT00756938|470083180|FG000|Optional Extension|Lack of Efficacy|0|||
130578717|NCT00756938|470083181|FG001|Optional Extension|Lack of Efficacy|0|||
130578718|NCT00756938|470083182|FG002|Optional Extension|Lack of Efficacy|0|||
130578719|NCT00756938|470083183|FG003|Optional Extension|Lack of Efficacy|1|||
130578720|NCT00756938|470083180|FG000|Optional Extension|End of Study|0|||
130578721|NCT00756938|470083181|FG001|Optional Extension|End of Study|0|||
130578722|NCT00756938|470083182|FG002|Optional Extension|End of Study|0|||
130578723|NCT00756938|470083183|FG003|Optional Extension|End of Study|11|||
130578724|NCT00756938|470083180|FG000|Optional Extension|Protocol-specific criteria met|0|||
130578725|NCT00756938|470083181|FG001|Optional Extension|Protocol-specific criteria met|0|||
130578726|NCT00756938|470083182|FG002|Optional Extension|Protocol-specific criteria met|0|||
130578727|NCT00756938|470083183|FG003|Optional Extension|Protocol-specific criteria met|9|||
130578728|NCT00756938|470083180|FG000|Optional Extension|Physician Decision|0|||
130578729|NCT00756938|470083181|FG001|Optional Extension|Physician Decision|0|||
130578730|NCT00756938|470083182|FG002|Optional Extension|Physician Decision|0|||
130578731|NCT00756938|470083183|FG003|Optional Extension|Physician Decision|3|||
130578732|NCT00756938|470083180|FG000|Optional Extension|Lost to Follow-up|0|||
130578733|NCT00756938|470083181|FG001|Optional Extension|Lost to Follow-up|0|||
130578734|NCT00756938|470083182|FG002|Optional Extension|Lost to Follow-up|0|||
130578735|NCT00756938|470083183|FG003|Optional Extension|Lost to Follow-up|1|||
130578736|NCT00756938|470083180|FG000|Optional Extension|Protocol Violation|0|||
130578737|NCT00756938|470083181|FG001|Optional Extension|Protocol Violation|0|||
130578738|NCT00756938|470083182|FG002|Optional Extension|Protocol Violation|0|||
130578739|NCT00756938|470083183|FG003|Optional Extension|Protocol Violation|1|||
130578740|NCT00756938|470083180|FG000|Optional Extension|Withdrawal by Subject|0|||
130578741|NCT00756938|470083181|FG001|Optional Extension|Withdrawal by Subject|0|||
130578742|NCT00756938|470083182|FG002|Optional Extension|Withdrawal by Subject|0|||
130578743|NCT00756938|470083183|FG003|Optional Extension|Withdrawal by Subject|10|||
130578744|NCT00756938|470083180|FG000|Optional Extension|Adverse Event|0|||
130578745|NCT00756938|470083181|FG001|Optional Extension|Adverse Event|0|||
130578746|NCT00756938|470083182|FG002|Optional Extension|Adverse Event|0|||
130578747|NCT00756938|470083183|FG003|Optional Extension|Adverse Event|1|||
130578748|NCT00441545|470083184|FG000|First Intervention|Adverse Event|6|||
130578749|NCT00441545|470083185|FG001|First Intervention|Adverse Event|5|||
130578750|NCT00441545|470083184|FG000|First Intervention|Protocol Violation|2|||
130578751|NCT00441545|470083185|FG001|First Intervention|Protocol Violation|2|||
130578752|NCT00441545|470083184|FG000|First Intervention|Withdrawal by Subject|3|||
130578753|NCT00441545|470083185|FG001|First Intervention|Withdrawal by Subject|3|||
130578754|NCT00441545|470083184|FG000|First Intervention|Kidney transplant|1|||
130578755|NCT00441545|470083185|FG001|First Intervention|Kidney transplant|1|||
130578756|NCT00441545|470083184|FG000|First Intervention|Lack of Efficacy|2|||
130578757|NCT00441545|470083185|FG001|First Intervention|Lack of Efficacy|0|||
130578758|NCT00441545|470083184|FG000|First Intervention|Subject exceeded safety criteria|0|||
130578759|NCT00441545|470083185|FG001|First Intervention|Subject exceeded safety criteria|1|||
130578760|NCT00441545|470083184|FG000|First Intervention|Subject met an exclusionary criteria|1|||
130578761|NCT00441545|470083185|FG001|First Intervention|Subject met an exclusionary criteria|0|||
130578762|NCT00441545|470083184|FG000|First Intervention|Extended hospitalization|1|||
130578763|NCT00441545|470083185|FG001|First Intervention|Extended hospitalization|0|||
130578764|NCT00441545|470083184|FG000|First Intervention|Site error|1|||
130578765|NCT00441545|470083185|FG001|First Intervention|Site error|0|||
130578766|NCT00441545|470083184|FG000|First Intervention|Sponsor's request|1|||
130578767|NCT00441545|470083185|FG001|First Intervention|Sponsor's request|0|||
130578768|NCT00441545|470083184|FG000|Second Intervention|Adverse Event|5|||
130578769|NCT00441545|470083185|FG001|Second Intervention|Adverse Event|2|||
130578770|NCT00441545|470083184|FG000|Second Intervention|Protocol Violation|4|||
130578771|NCT00441545|470083185|FG001|Second Intervention|Protocol Violation|1|||
130578772|NCT00441545|470083184|FG000|Second Intervention|Withdrawal by Subject|1|||
130578773|NCT00441545|470083185|FG001|Second Intervention|Withdrawal by Subject|1|||
130578774|NCT00441545|470083184|FG000|Second Intervention|Kidney Transplant|1|||
130578775|NCT00441545|470083185|FG001|Second Intervention|Kidney Transplant|1|||
130578776|NCT00441545|470083184|FG000|Second Intervention|Lack of Efficacy|0|||
130578777|NCT00441545|470083185|FG001|Second Intervention|Lack of Efficacy|1|||
130578778|NCT00441545|470083184|FG000|Second Intervention|Subject exceeded safety criteria|1|||
130578779|NCT00441545|470083185|FG001|Second Intervention|Subject exceeded safety criteria|0|||
130578780|NCT00441545|470083184|FG000|Second Intervention|Subject moved|0|||
130578781|NCT00441545|470083185|FG001|Second Intervention|Subject moved|1|||
130578782|NCT02347176|470083186|FG000|Overall Study|Lost to Follow-up|2|||
130578783|NCT02347176|470083187|FG001|Overall Study|Lost to Follow-up|3|||
130578784|NCT02347176|470083188|FG002|Overall Study|Lost to Follow-up|1|||
130578785|NCT02347176|470083189|FG003|Overall Study|Lost to Follow-up|1|||
130578786|NCT02347176|470083186|FG000|Overall Study|Withdrawal by Subject|9|||
130578787|NCT02347176|470083187|FG001|Overall Study|Withdrawal by Subject|5|||
130578788|NCT02347176|470083188|FG002|Overall Study|Withdrawal by Subject|5|||
130578789|NCT02347176|470083189|FG003|Overall Study|Withdrawal by Subject|3|||
130578790|NCT02347176|470083186|FG000|Overall Study|Other|1|||
130578791|NCT02347176|470083187|FG001|Overall Study|Other|2|||
130578792|NCT02347176|470083188|FG002|Overall Study|Other|2|||
130578793|NCT02347176|470083189|FG003|Overall Study|Other|0|||
130578794|NCT02474082|470083190|FG000|Overall Study|Adverse Event|2|||
130578795|NCT02474082|470083191|FG001|Overall Study|Adverse Event|32|||
130578796|NCT02474082|470083190|FG000|Overall Study|Withdrawal of informed consent|1|||
130578797|NCT02474082|470083191|FG001|Overall Study|Withdrawal of informed consent|11|||
130578798|NCT02474082|470083190|FG000|Overall Study|Lost to Follow-up|2|||
130578799|NCT02474082|470083191|FG001|Overall Study|Lost to Follow-up|2|||
130578800|NCT02474082|470083190|FG000|Overall Study|Dose tapering not achieved|0|||
130578801|NCT02474082|470083191|FG001|Overall Study|Dose tapering not achieved|4|||
130578802|NCT02474082|470083190|FG000|Overall Study|Participant/guardian decision|1|||
130578803|NCT02474082|470083191|FG001|Overall Study|Participant/guardian decision|2|||
130578804|NCT02474082|470083190|FG000|Overall Study|Non-compliance with study treatment|0|||
130578805|NCT02474082|470083191|FG001|Overall Study|Non-compliance with study treatment|2|||
130578806|NCT02474082|470083190|FG000|Overall Study|Protocol deviation|0|||
130578807|NCT02474082|470083191|FG001|Overall Study|Protocol deviation|1|||
130578808|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
130578809|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
130578810|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
130578811|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
130578812|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130578813|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130578814|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
130578815|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130578816|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
130578817|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130578818|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130578819|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130578820|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
130578821|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
130578822|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
130578823|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
130578824|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
130578825|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
130578826|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
130578827|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
130578828|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130578829|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130578830|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130578831|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130578832|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
130578833|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130578834|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130578835|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130578836|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130578837|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130578838|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130578839|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
130578840|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130578841|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130578842|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130578843|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130578844|NCT03403205|470083194|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
130578845|NCT03403205|470083195|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130578846|NCT03403205|470083196|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
130578847|NCT03403205|470083197|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
130578848|NCT03403205|470083198|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130578849|NCT03403205|470083199|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130578850|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
130578851|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
130578852|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
130578853|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
130530195|NCT02362503|469909617|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
130530196|NCT02803593|469909618|FG000|Overall Study|Lost to Follow-up|17|||
130530197|NCT02803593|469909619|FG001|Overall Study|Lost to Follow-up|35|||
130530198|NCT05143138|469909620|FG000|Overall Study|Death|5|||
130530199|NCT05143138|469909621|FG001|Overall Study|Death|35|||
130578854|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
130578855|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
130530200|NCT05143138|469909622|FG002|Overall Study|Death|1|||
130530201|NCT05143138|469909620|FG000|Overall Study|Lost to Follow-up|2|||
130530202|NCT05143138|469909621|FG001|Overall Study|Lost to Follow-up|4|||
130530203|NCT05143138|469909622|FG002|Overall Study|Lost to Follow-up|0|||
130530204|NCT05143138|469909620|FG000|Overall Study|withdrawal|1|||
130530205|NCT05143138|469909621|FG001|Overall Study|withdrawal|1|||
130530206|NCT05143138|469909622|FG002|Overall Study|withdrawal|0|||
130530207|NCT02195479|469909625|FG000|Overall Study|Lost to Follow-up|18|||
130530208|NCT02195479|469909626|FG001|Overall Study|Lost to Follow-up|15|||
130530209|NCT02195479|469909625|FG000|Overall Study|Death|217|||
130530210|NCT02195479|469909626|FG001|Overall Study|Death|171|||
130530211|NCT02195479|469909625|FG000|Overall Study|Physician Decision|1|||
130530212|NCT02195479|469909626|FG001|Overall Study|Physician Decision|0|||
130578856|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
130578857|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
130578858|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
130578859|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
130578860|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
130578861|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
130578862|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Death|1|||
130578863|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Death|0|||
130578864|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Death|0|||
130578865|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Death|0|||
130578866|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Death|0|||
130578867|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Death|0|||
130578868|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
130578869|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130578870|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130578871|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130578872|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130578873|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130578874|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
130530213|NCT02195479|469909625|FG000|Overall Study|Withdrawal by Subject|30|||
130530214|NCT02195479|469909626|FG001|Overall Study|Withdrawal by Subject|30|||
130530215|NCT02195479|469909625|FG000|Overall Study|Other|3|||
130530216|NCT02195479|469909626|FG001|Overall Study|Other|4|||
130530217|NCT02195479|469909625|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
130530218|NCT02195479|469909626|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
130530219|NCT03443414|469909627|FG000|Overall Study|Adverse Event|6|||
130530220|NCT03443414|469909628|FG001|Overall Study|Adverse Event|0|||
130530221|NCT03443414|469909629|FG002|Overall Study|Adverse Event|4|||
130530222|NCT03443414|469909630|FG003|Overall Study|Adverse Event|2|||
130530223|NCT03443414|469909631|FG004|Overall Study|Adverse Event|3|||
130530224|NCT03443414|469909627|FG000|Overall Study|Withdrawal by Subject|3|||
130530225|NCT03443414|469909628|FG001|Overall Study|Withdrawal by Subject|2|||
130530226|NCT03443414|469909629|FG002|Overall Study|Withdrawal by Subject|2|||
130530227|NCT03443414|469909630|FG003|Overall Study|Withdrawal by Subject|2|||
130530228|NCT03443414|469909631|FG004|Overall Study|Withdrawal by Subject|1|||
130530229|NCT03443414|469909627|FG000|Overall Study|Death|0|||
130530230|NCT03443414|469909628|FG001|Overall Study|Death|1|||
130530231|NCT03443414|469909629|FG002|Overall Study|Death|0|||
130530232|NCT03443414|469909630|FG003|Overall Study|Death|1|||
130530233|NCT03443414|469909631|FG004|Overall Study|Death|0|||
130530234|NCT03443414|469909627|FG000|Overall Study|Reason not specified|2|||
130530235|NCT03443414|469909628|FG001|Overall Study|Reason not specified|0|||
130530236|NCT03443414|469909629|FG002|Overall Study|Reason not specified|0|||
130530237|NCT03443414|469909630|FG003|Overall Study|Reason not specified|0|||
130530238|NCT03443414|469909631|FG004|Overall Study|Reason not specified|1|||
130530239|NCT03325777|469909634|FG000|Overall Study|Lost to Follow-up|9|||
130530240|NCT03325777|469909635|FG001|Overall Study|Lost to Follow-up|12|||
130530241|NCT03004404|469909638|FG000|Period 2|Adverse Event|0|||
130530242|NCT03004404|469909639|FG001|Period 2|Adverse Event|0|||
130530243|NCT03004404|469909640|FG002|Period 2|Adverse Event|0|||
130530244|NCT03004404|469909641|FG003|Period 2|Adverse Event|0|||
130530245|NCT03004404|469909642|FG004|Period 2|Adverse Event|0|||
130530246|NCT03004404|469909643|FG005|Period 2|Adverse Event|0|||
130530247|NCT03004404|469909644|FG006|Period 2|Adverse Event|0|||
130530248|NCT03004404|469909645|FG007|Period 2|Adverse Event|0|||
130530249|NCT03004404|469909646|FG008|Period 2|Adverse Event|1|||
130530250|NCT03004404|469909647|FG009|Period 2|Adverse Event|0|||
130530251|NCT03004404|469909648|FG010|Period 2|Adverse Event|0|||
130530252|NCT03004404|469909649|FG011|Period 2|Adverse Event|0|||
130530253|NCT03004404|469909650|FG012|Period 2|Adverse Event|0|||
130530254|NCT03004404|469909651|FG013|Period 2|Adverse Event|0|||
130530255|NCT03004404|469909652|FG014|Period 2|Adverse Event|0|||
130530256|NCT03004404|469909653|FG015|Period 2|Adverse Event|1|||
130530257|NCT02522728|469909654|FG000|Overall Study|Withdrawal by Subject|6|||
130530258|NCT02522728|469909655|FG001|Overall Study|Withdrawal by Subject|6|||
130530259|NCT02522728|469909654|FG000|Overall Study|Death|4|||
130530260|NCT02522728|469909655|FG001|Overall Study|Death|3|||
130530261|NCT02522728|469909654|FG000|Overall Study|Adverse Event|2|||
130530262|NCT02522728|469909655|FG001|Overall Study|Adverse Event|1|||
130530263|NCT02522728|469909654|FG000|Overall Study|Did not receive randomized study device|0|||
130530264|NCT02522728|469909655|FG001|Overall Study|Did not receive randomized study device|1|||
130530265|NCT01099917|469909656|FG000|Overall Study|Adverse Event|3|||
130530266|NCT01099917|469909656|FG000|Overall Study|Not Treated|24|||
130530267|NCT01485120|469909668|FG000|Overall Study|Withdrawal by Subject|2|||
130530268|NCT00422734|469909669|FG000|Overall Study|Physician Decision|1|||
130530269|NCT00422734|469909670|FG001|Overall Study|Physician Decision|1|||
130530270|NCT00422734|469909669|FG000|Overall Study|Protocol Violation|1|||
130530271|NCT00422734|469909670|FG001|Overall Study|Protocol Violation|6|||
130530272|NCT00422734|469909669|FG000|Overall Study|Withdrawal by Subject|12|||
130530273|NCT00422734|469909670|FG001|Overall Study|Withdrawal by Subject|8|||
130530274|NCT00422734|469909669|FG000|Overall Study|Adverse Event|0|||
130530275|NCT00422734|469909670|FG001|Overall Study|Adverse Event|3|||
130530276|NCT00422734|469909669|FG000|Overall Study|Partner Decision|0|||
130530277|NCT00422734|469909670|FG001|Overall Study|Partner Decision|3|||
130530278|NCT01081886|469909671|FG000|Overall Study|Study termination|11|||
130530279|NCT01081886|469909672|FG001|Overall Study|Study termination|13|||
130530280|NCT02567708|469909673|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
130530281|NCT02567708|469909674|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
130530282|NCT02567708|469909673|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
130530283|NCT02567708|469909674|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
130530284|NCT02567708|469909673|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
130530285|NCT02567708|469909674|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
130530286|NCT02567708|469909673|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
130530287|NCT02567708|469909674|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
130530288|NCT04148651|469909675|FG000|Overall Study|Lost to Follow-up|2|||
130530289|NCT05262751|469909676|FG000|Washout Period 2|Adverse Event|1|||
130530290|NCT05262751|469909677|FG001|Washout Period 2|Adverse Event|0|||
130530291|NCT05262751|469909678|FG002|Washout Period 2|Adverse Event|0|||
130530292|NCT05262751|469909679|FG003|Washout Period 2|Adverse Event|0|||
130530293|NCT05262751|469909680|FG004|Washout Period 2|Adverse Event|0|||
130530294|NCT05262751|469909681|FG005|Washout Period 2|Adverse Event|0|||
130530295|NCT05262751|469909676|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
130530296|NCT05262751|469909677|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
130530297|NCT05262751|469909678|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
130530298|NCT05262751|469909679|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
130578875|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
130578876|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
130530299|NCT05262751|469909680|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
130530300|NCT05262751|469909681|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
130530301|NCT01001390|469909682|FG000|Overall Study|Failure to wear AFO device|2|||
130530302|NCT01001390|469909683|FG001|Overall Study|Failure to wear AFO device|0|||
130530303|NCT01151215|469909684|FG000|Overall Study|Worsening of condition under study|1|||
130530304|NCT01151215|469909685|FG001|Overall Study|Worsening of condition under study|1|||
130530305|NCT01151215|469909686|FG002|Overall Study|Worsening of condition under study|1|||
130530306|NCT01151215|469909684|FG000|Overall Study|Death|16|||
130530307|NCT01151215|469909685|FG001|Overall Study|Death|20|||
130530308|NCT01151215|469909686|FG002|Overall Study|Death|11|||
130578877|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
130530309|NCT01151215|469909684|FG000|Overall Study|Lost to Follow-up|0|||
130578878|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
130578879|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
130578880|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
130578881|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130578882|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130578883|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130578884|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130578885|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130578886|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
130578887|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
130578888|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
130578889|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
130578890|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
130578891|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
130578892|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
130578893|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
130578894|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
130578895|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
130578896|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
130578897|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
130578898|NCT03403205|470083194|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
130578899|NCT03403205|470083195|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
130578900|NCT03403205|470083196|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
130578901|NCT03403205|470083197|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
130578902|NCT03403205|470083198|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
130578903|NCT03403205|470083199|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
130578904|NCT01834729|470083200|FG000|Overall Study|Did not return bowel diaries|0|||
130578905|NCT01834729|470083201|FG001|Overall Study|Did not return bowel diaries|0|||
130578906|NCT01834729|470083202|FG002|Overall Study|Did not return bowel diaries|3|||
130578907|NCT01834729|470083203|FG003|Overall Study|Did not return bowel diaries|0|||
130578908|NCT01834729|470083200|FG000|Overall Study|Withdrawal by Subject|1|||
130578909|NCT01834729|470083201|FG001|Overall Study|Withdrawal by Subject|1|||
130578910|NCT01834729|470083202|FG002|Overall Study|Withdrawal by Subject|0|||
130578911|NCT01834729|470083203|FG003|Overall Study|Withdrawal by Subject|0|||
130578912|NCT01834729|470083200|FG000|Overall Study|Adverse Event|0|||
130578913|NCT01834729|470083201|FG001|Overall Study|Adverse Event|0|||
130578914|NCT01834729|470083202|FG002|Overall Study|Adverse Event|0|||
130578915|NCT01834729|470083203|FG003|Overall Study|Adverse Event|2|||
130578916|NCT02971670|470083204|FG000|Overall Study|Withdrawal by Subject|4|||
130578917|NCT02971670|470083205|FG001|Overall Study|Withdrawal by Subject|1|||
130578918|NCT02971670|470083206|FG002|Overall Study|Withdrawal by Subject|1|||
130578919|NCT02971670|470083207|FG003|Overall Study|Withdrawal by Subject|2|||
130578920|NCT00288080|470083208|FG000|Overall Study|Withdrawal by Subject|1|||
130578921|NCT00288080|470083209|FG001|Overall Study|Withdrawal by Subject|3|||
130578922|NCT00288080|470083208|FG000|Overall Study|Protocol Violation|25|||
130578923|NCT00288080|470083209|FG001|Overall Study|Protocol Violation|20|||
130578924|NCT02387580|470083213|FG000|Overall Study|Withdrawal by Subject|0|||
130578925|NCT02387580|470083214|FG001|Overall Study|Withdrawal by Subject|0|||
130578926|NCT02387580|470083215|FG002|Overall Study|Withdrawal by Subject|0|||
130578927|NCT02387580|470083216|FG003|Overall Study|Withdrawal by Subject|1|||
130578928|NCT02387580|470083217|FG004|Overall Study|Withdrawal by Subject|0|||
130578929|NCT02387580|470083218|FG005|Overall Study|Withdrawal by Subject|0|||
130578930|NCT02340663|470083220|FG000|Overall Study|Lost to Follow-up|1|||
130578931|NCT02340663|470083221|FG001|Overall Study|Lost to Follow-up|0|||
130578932|NCT02340663|470083220|FG000|Overall Study|Protocol Violation|1|||
130578933|NCT02340663|470083221|FG001|Overall Study|Protocol Violation|0|||
130578934|NCT02340663|470083220|FG000|Overall Study|Withdrawal by Subject|3|||
130578935|NCT02340663|470083221|FG001|Overall Study|Withdrawal by Subject|1|||
130578936|NCT02979431|470083222|FG000|Overall Study|Parent/guardian withdrew consent|2|||
130578937|NCT02979431|470083223|FG001|Overall Study|Parent/guardian withdrew consent|1|||
130578938|NCT02979431|470083224|FG002|Overall Study|Parent/guardian withdrew consent|1|||
130578939|NCT02979431|470083225|FG003|Overall Study|Parent/guardian withdrew consent|1|||
130578940|NCT02979431|470083222|FG000|Overall Study|Randomized but received no study drug|1|||
130578941|NCT02979431|470083223|FG001|Overall Study|Randomized but received no study drug|1|||
130578942|NCT02979431|470083224|FG002|Overall Study|Randomized but received no study drug|0|||
130578943|NCT02979431|470083225|FG003|Overall Study|Randomized but received no study drug|0|||
130578944|NCT02979431|470083222|FG000|Overall Study|Adverse Event|0|||
130578945|NCT02979431|470083223|FG001|Overall Study|Adverse Event|0|||
130578946|NCT02979431|470083224|FG002|Overall Study|Adverse Event|1|||
130578947|NCT02979431|470083225|FG003|Overall Study|Adverse Event|0|||
130578948|NCT02979431|470083222|FG000|Overall Study|Subject left country after Day14|1|||
130530310|NCT01151215|469909685|FG001|Overall Study|Lost to Follow-up|0|||
130530311|NCT01151215|469909686|FG002|Overall Study|Lost to Follow-up|3|||
130530312|NCT01151215|469909684|FG000|Overall Study|Withdrawal by Subject|3|||
130530313|NCT01151215|469909685|FG001|Overall Study|Withdrawal by Subject|1|||
130530314|NCT01151215|469909686|FG002|Overall Study|Withdrawal by Subject|2|||
130530315|NCT01151215|469909684|FG000|Overall Study|Disease progression|0|||
130530316|NCT01151215|469909685|FG001|Overall Study|Disease progression|1|||
130530317|NCT01151215|469909686|FG002|Overall Study|Disease progression|1|||
130530318|NCT01151215|469909684|FG000|Overall Study|Safety as judged by the investigator|0|||
130530319|NCT01151215|469909685|FG001|Overall Study|Safety as judged by the investigator|0|||
130530320|NCT01151215|469909686|FG002|Overall Study|Safety as judged by the investigator|1|||
130530321|NCT01721954|469909687|FG000|Overall Study|Death|58|||
130530322|NCT01721954|469909688|FG001|Overall Study|Death|64|||
130530323|NCT01721954|469909687|FG000|Overall Study|Withdrawal by Subject|8|||
130530324|NCT01721954|469909688|FG001|Overall Study|Withdrawal by Subject|4|||
130530325|NCT01721954|469909687|FG000|Overall Study|Adverse Event|2|||
130530326|NCT01721954|469909688|FG001|Overall Study|Adverse Event|0|||
130530327|NCT01721954|469909687|FG000|Overall Study|Lost to Follow-up|2|||
130530328|NCT01721954|469909688|FG001|Overall Study|Lost to Follow-up|1|||
130530329|NCT03392168|469909691|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
130530330|NCT03392168|469909692|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
130530331|NCT03392168|469909693|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
130530332|NCT03392168|469909694|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
130530333|NCT03392168|469909691|FG000|Period 2: Cohort 2|Other|0|||
130530334|NCT03392168|469909692|FG001|Period 2: Cohort 2|Other|1|||
130530335|NCT03392168|469909693|FG002|Period 2: Cohort 2|Other|0|||
130530336|NCT03392168|469909694|FG003|Period 2: Cohort 2|Other|0|||
130530337|NCT01154140|469909700|FG000|Overall Study|Death|71|||
130530338|NCT01154140|469909701|FG001|Overall Study|Death|81|||
130530339|NCT01154140|469909700|FG000|Overall Study|Lost to Follow-up|4|||
130530340|NCT01154140|469909701|FG001|Overall Study|Lost to Follow-up|5|||
130530341|NCT01154140|469909700|FG000|Overall Study|Withdrawal by Subject|12|||
130530342|NCT01154140|469909701|FG001|Overall Study|Withdrawal by Subject|13|||
130530343|NCT01154140|469909700|FG000|Overall Study|Other|3|||
130530344|NCT01154140|469909701|FG001|Overall Study|Other|1|||
130530345|NCT01154140|469909700|FG000|Overall Study|Randomized but not treated|1|||
130530346|NCT01154140|469909701|FG001|Overall Study|Randomized but not treated|2|||
130530347|NCT02992691|469909703|FG000|Overall Study|Adverse Event|2|||
130530348|NCT02992691|469909703|FG000|Overall Study|Withdrawal by Subject|1|||
130530349|NCT04276051|469909704|FG000|Overall Study|Lost to Follow-up|0|||
130530350|NCT04276051|469909705|FG001|Overall Study|Lost to Follow-up|1|||
130530351|NCT04276051|469909704|FG000|Overall Study|Physician Decision|0|||
130530352|NCT04276051|469909705|FG001|Overall Study|Physician Decision|1|||
130530353|NCT04276051|469909704|FG000|Overall Study|Withdrawal by Subject|1|||
130530354|NCT04276051|469909705|FG001|Overall Study|Withdrawal by Subject|1|||
130530355|NCT00392925|469909706|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
130530356|NCT00392925|469909707|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
130530357|NCT00392925|469909708|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
130530358|NCT00392925|469909709|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
130530359|NCT00392925|469909706|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
130530360|NCT00392925|469909707|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
130530361|NCT00392925|469909708|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
130530362|NCT00392925|469909709|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
130530363|NCT00392925|469909706|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
130530364|NCT00392925|469909707|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
130530365|NCT00392925|469909708|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
130530366|NCT00392925|469909709|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
130530367|NCT00392925|469909706|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
130530368|NCT00392925|469909707|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
130530369|NCT00392925|469909708|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
130530370|NCT00392925|469909709|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
130530371|NCT00392925|469909706|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
130530372|NCT00392925|469909707|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
130530373|NCT00392925|469909708|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
130530374|NCT00392925|469909709|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
130530375|NCT00392925|469909706|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
130530376|NCT00392925|469909707|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
130530377|NCT00392925|469909708|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
130530378|NCT00392925|469909709|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
130530379|NCT00392925|469909706|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
130530380|NCT00392925|469909707|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
130530381|NCT00392925|469909708|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
130578949|NCT02979431|470083223|FG001|Overall Study|Subject left country after Day14|0|||
130578950|NCT02979431|470083224|FG002|Overall Study|Subject left country after Day14|0|||
130578951|NCT02979431|470083225|FG003|Overall Study|Subject left country after Day14|0|||
130530382|NCT00392925|469909709|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
130530383|NCT00392925|469909706|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
130530384|NCT00392925|469909707|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
130530385|NCT00392925|469909708|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
130530386|NCT00392925|469909709|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
130530387|NCT00392925|469909706|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
130530388|NCT00392925|469909707|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
130530389|NCT00392925|469909708|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
130530390|NCT00392925|469909709|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
130530391|NCT01461005|469909713|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
130530392|NCT02579772|469909714|FG000|Overall Study|Withdrawal by Subject|0|||
130530393|NCT02579772|469909715|FG001|Overall Study|Withdrawal by Subject|1|||
130530394|NCT02579772|469909714|FG000|Overall Study|Usage of additional antioxidants|1|||
130530395|NCT02579772|469909715|FG001|Overall Study|Usage of additional antioxidants|0|||
130530396|NCT02579772|469909714|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
130530397|NCT02579772|469909715|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
130530398|NCT04147195|469909716|FG000|Overall Study|Adverse Event|0|||
130530399|NCT04147195|469909717|FG001|Overall Study|Adverse Event|3|||
130530400|NCT04147195|469909716|FG000|Overall Study|Study Terminated by Sponsor|4|||
130530401|NCT04147195|469909717|FG001|Overall Study|Study Terminated by Sponsor|2|||
130530402|NCT04147195|469909716|FG000|Overall Study|Withdrawal by Subject|0|||
130530403|NCT04147195|469909717|FG001|Overall Study|Withdrawal by Subject|1|||
130530404|NCT05823012|469909718|FG000|Titration Period|Adverse Event|1|||
130530405|NCT05823012|469909718|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
130530406|NCT05823012|469909718|FG000|Maintenance Period|Adverse Event|1|||
130530407|NCT05823012|469909718|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
130530408|NCT05823012|469909718|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
130530409|NCT01920477|469911508|FG000|Overall Study|Adverse Event|0|||
130530410|NCT01920477|469911509|FG001|Overall Study|Adverse Event|1|||
130530411|NCT01920477|469911508|FG000|Overall Study|Lack of Efficacy|1|||
130530412|NCT01920477|469911509|FG001|Overall Study|Lack of Efficacy|0|||
130530413|NCT01920477|469911508|FG000|Overall Study|Study closed/terminated|14|||
130530414|NCT01920477|469911509|FG001|Overall Study|Study closed/terminated|15|||
130530415|NCT01920477|469911508|FG000|Overall Study|Withdrawal by Subject|0|||
130530416|NCT01920477|469911509|FG001|Overall Study|Withdrawal by Subject|1|||
130530417|NCT01681277|469911512|FG000|Overall Study|Adverse Event|1|||
130530418|NCT01681277|469911513|FG001|Overall Study|Adverse Event|0|||
130530419|NCT01681277|469911514|FG002|Overall Study|Adverse Event|0|||
130530420|NCT01681277|469911515|FG003|Overall Study|Adverse Event|0|||
130530421|NCT01681277|469911516|FG004|Overall Study|Adverse Event|0|||
130530422|NCT02113124|469911517|FG000|Overall Study|Unable to retrieve blood sample|1|||
130530423|NCT02113124|469911518|FG001|Overall Study|Unable to retrieve blood sample|1|||
130530424|NCT02271984|469911524|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530425|NCT02271984|469911525|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530426|NCT02271984|469911526|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530427|NCT02271984|469911527|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530428|NCT02271984|469911528|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530429|NCT02271984|469911529|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
130530430|NCT02271984|469911530|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530431|NCT02271984|469911531|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
130530432|NCT02271984|469911532|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530433|NCT02271984|469911533|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530434|NCT02271984|469911534|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530435|NCT02271984|469911535|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130530436|NCT02521363|469911536|FG000|Overall Study|Withdrawal by Subject|1|||
130530437|NCT02521363|469911537|FG001|Overall Study|Withdrawal by Subject|2|||
130578952|NCT01656434|470083226|FG000|Overall Study|Adverse Event|199|||
130578953|NCT01656434|470083227|FG001|Overall Study|Adverse Event|63|||
130578954|NCT01656434|470083226|FG000|Overall Study|Enrollment terminated at trial site|2|||
130530438|NCT03374488|469911538|FG000|Overall Study|Death|13|||
130530439|NCT03374488|469911539|FG001|Overall Study|Death|13|||
130530440|NCT03374488|469911538|FG000|Overall Study|Withdrawal by Subject|3|||
130530441|NCT03374488|469911539|FG001|Overall Study|Withdrawal by Subject|1|||
130530442|NCT03374488|469911538|FG000|Overall Study|Physician Decision|3|||
130530443|NCT03374488|469911539|FG001|Overall Study|Physician Decision|0|||
130530444|NCT03104075|469911540|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
130530445|NCT03104075|469911541|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
130530446|NCT04024462|469911542|FG000|Overall Study|Withdrawal by Subject|6|||
130530447|NCT04024462|469911543|FG001|Overall Study|Withdrawal by Subject|7|||
130530448|NCT04024462|469911542|FG000|Overall Study|Progressive Disease|0|||
130530449|NCT04024462|469911543|FG001|Overall Study|Progressive Disease|1|||
130530450|NCT04024462|469911542|FG000|Overall Study|Adverse Event|0|||
130530451|NCT04024462|469911543|FG001|Overall Study|Adverse Event|1|||
130530452|NCT04024462|469911542|FG000|Overall Study|Death|0|||
130530453|NCT04024462|469911543|FG001|Overall Study|Death|1|||
130530454|NCT04024462|469911542|FG000|Overall Study|Lost to Follow-up|1|||
130530455|NCT04024462|469911543|FG001|Overall Study|Lost to Follow-up|0|||
130530456|NCT04024462|469911542|FG000|Overall Study|Ongoing in the Study|94|||
130530457|NCT04024462|469911543|FG001|Overall Study|Ongoing in the Study|89|||
130530458|NCT02870972|469911550|FG000|Overall Study|Adverse Event|1|||
130530459|NCT02870972|469911551|FG001|Overall Study|Adverse Event|0|||
130530460|NCT02870972|469911552|FG002|Overall Study|Adverse Event|0|||
130530461|NCT02870972|469911553|FG003|Overall Study|Adverse Event|0|||
130530462|NCT02870972|469911554|FG004|Overall Study|Adverse Event|0|||
130530463|NCT04400487|469911557|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130530464|NCT04400487|469911557|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
130530465|NCT04400487|469911557|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
130530466|NCT03559062|469911558|FG000|Overall Study|Other|0|||
130530467|NCT03559062|469911559|FG001|Overall Study|Other|1|||
130530468|NCT03559062|469911560|FG002|Overall Study|Other|0|||
130530469|NCT03445533|469911561|FG000|Overall Study|Progressive Disease|48|||
130530470|NCT03445533|469911562|FG001|Overall Study|Progressive Disease|81|||
130530471|NCT03445533|469911561|FG000|Overall Study|Adverse Event|60|||
130530472|NCT03445533|469911562|FG001|Overall Study|Adverse Event|64|||
130530473|NCT03445533|469911561|FG000|Overall Study|Death|9|||
130530474|NCT03445533|469911562|FG001|Overall Study|Death|19|||
130530475|NCT03445533|469911561|FG000|Overall Study|Miscellaneous|0|||
130530476|NCT03445533|469911562|FG001|Overall Study|Miscellaneous|16|||
130530477|NCT03445533|469911561|FG000|Overall Study|Withdrawal by Subject|3|||
130530478|NCT03445533|469911562|FG001|Overall Study|Withdrawal by Subject|4|||
130530479|NCT03445533|469911561|FG000|Overall Study|Physician Decision|1|||
130530480|NCT03445533|469911562|FG001|Overall Study|Physician Decision|3|||
130530481|NCT03445533|469911561|FG000|Overall Study|Sponsor Decision|0|||
130530482|NCT03445533|469911562|FG001|Overall Study|Sponsor Decision|1|||
130530483|NCT03445533|469911561|FG000|Overall Study|Lost to Follow-up|0|||
130530484|NCT03445533|469911562|FG001|Overall Study|Lost to Follow-up|1|||
130530485|NCT03445533|469911561|FG000|Overall Study|Never Received any Study Treatment|7|||
130530486|NCT03445533|469911562|FG001|Overall Study|Never Received any Study Treatment|4|||
130530487|NCT02493062|469911563|FG000|Overall Study|Physician Decision|12|||
130530488|NCT01327612|469911565|FG000|Overall Study|Withdrawal by Subject|0|||
130530489|NCT01327612|469911566|FG001|Overall Study|Withdrawal by Subject|0|||
130530490|NCT01327612|469911567|FG002|Overall Study|Withdrawal by Subject|0|||
130530491|NCT01327612|469911568|FG003|Overall Study|Withdrawal by Subject|0|||
130530492|NCT01327612|469911569|FG004|Overall Study|Withdrawal by Subject|0|||
130530493|NCT01327612|469911570|FG005|Overall Study|Withdrawal by Subject|1|||
130530494|NCT01327612|469911571|FG006|Overall Study|Withdrawal by Subject|0|||
130530495|NCT01327612|469911565|FG000|Overall Study|Disease Progression|1|||
130530496|NCT01327612|469911566|FG001|Overall Study|Disease Progression|1|||
130530497|NCT01327612|469911567|FG002|Overall Study|Disease Progression|1|||
130530498|NCT01327612|469911568|FG003|Overall Study|Disease Progression|0|||
130530499|NCT01327612|469911569|FG004|Overall Study|Disease Progression|1|||
130530500|NCT01327612|469911570|FG005|Overall Study|Disease Progression|2|||
130530501|NCT01327612|469911571|FG006|Overall Study|Disease Progression|2|||
130530502|NCT01327612|469911565|FG000|Overall Study|Administrative Decision|0|||
130530503|NCT01327612|469911566|FG001|Overall Study|Administrative Decision|0|||
130530504|NCT01327612|469911567|FG002|Overall Study|Administrative Decision|0|||
130530505|NCT01327612|469911568|FG003|Overall Study|Administrative Decision|1|||
130530506|NCT01327612|469911569|FG004|Overall Study|Administrative Decision|0|||
130530507|NCT01327612|469911570|FG005|Overall Study|Administrative Decision|0|||
130530508|NCT01327612|469911571|FG006|Overall Study|Administrative Decision|0|||
130530509|NCT01327612|469911565|FG000|Overall Study|Death|0|||
130530510|NCT01327612|469911566|FG001|Overall Study|Death|0|||
130530511|NCT01327612|469911567|FG002|Overall Study|Death|0|||
130530512|NCT01327612|469911568|FG003|Overall Study|Death|0|||
130530513|NCT01327612|469911569|FG004|Overall Study|Death|1|||
130578955|NCT01656434|470083227|FG001|Overall Study|Enrollment terminated at trial site|0|||
130578956|NCT01656434|470083226|FG000|Overall Study|Lost to Follow-up|309|||
130530514|NCT01327612|469911570|FG005|Overall Study|Death|0|||
130530515|NCT01327612|469911571|FG006|Overall Study|Death|0|||
130530516|NCT00426127|469911572|FG000|Overall Study|Adverse Event|1|||
130530517|NCT00426127|469911572|FG000|Overall Study|Removed due to disease progression|1|||
130530518|NCT05569421|469911573|FG000|Overall Study|Withdrawal by Subject|1|||
130530519|NCT05569421|469911574|FG001|Overall Study|Withdrawal by Subject|0|||
130530520|NCT05569421|469911575|FG002|Overall Study|Withdrawal by Subject|0|||
130578957|NCT01656434|470083227|FG001|Overall Study|Lost to Follow-up|76|||
130530521|NCT01689857|469911576|FG000|Overall Study|Lost to Follow-up|5|||
130530522|NCT01689857|469911577|FG001|Overall Study|Lost to Follow-up|2|||
130530523|NCT01730378|469911578|FG000|Overall Study|Lost to Follow-up|1|||
130530524|NCT01730378|469911579|FG001|Overall Study|Lost to Follow-up|0|||
130530525|NCT00874731|469911581|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
130530526|NCT00874731|469911582|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
130530527|NCT00874731|469911583|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
130530528|NCT00874731|469911581|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
130530529|NCT00874731|469911582|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
130530530|NCT00874731|469911583|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
130530531|NCT00874731|469911581|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
130530532|NCT00874731|469911582|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
130530533|NCT00874731|469911583|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
130530534|NCT00955708|469911584|FG000|Overall Study|Death|269|||
130530535|NCT00955708|469911584|FG000|Overall Study|Lost to Follow-up|72|||
130530536|NCT00955708|469911584|FG000|Overall Study|Physician Decision|36|||
130530537|NCT00955708|469911584|FG000|Overall Study|Protocol Violation|134|||
130530538|NCT00955708|469911584|FG000|Overall Study|Registry Conclusion|186|||
130530539|NCT00955708|469911584|FG000|Overall Study|Product removed from service|94|||
130530540|NCT00955708|469911584|FG000|Overall Study|Patient Refused to participate further|116|||
130530541|NCT00955708|469911584|FG000|Overall Study|Closure of study location|60|||
130530542|NCT00955708|469911584|FG000|Overall Study|Patient changed care provider/moved|91|||
130530543|NCT05105087|469911585|FG000|Overall Study|Withdrawal by Subject|2|||
130530544|NCT05105087|469911585|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
130530545|NCT01016262|469911588|FG000|Double-blind Phase|Adverse Event|0|||
130530546|NCT01016262|469911589|FG001|Double-blind Phase|Adverse Event|0|||
130530547|NCT01016262|469911590|FG002|Double-blind Phase|Adverse Event|1|||
130530548|NCT01016262|469911591|FG003|Double-blind Phase|Adverse Event|0|||
130530549|NCT01016262|469911592|FG004|Double-blind Phase|Adverse Event|0|||
130530550|NCT01016262|469911593|FG005|Double-blind Phase|Adverse Event|0|||
130530551|NCT01016262|469911588|FG000|Double-blind Phase|Lack of Efficacy|1|||
130530552|NCT01016262|469911589|FG001|Double-blind Phase|Lack of Efficacy|0|||
130530553|NCT01016262|469911590|FG002|Double-blind Phase|Lack of Efficacy|5|||
130530554|NCT01016262|469911591|FG003|Double-blind Phase|Lack of Efficacy|0|||
130530555|NCT01016262|469911592|FG004|Double-blind Phase|Lack of Efficacy|0|||
130530556|NCT01016262|469911593|FG005|Double-blind Phase|Lack of Efficacy|0|||
130530557|NCT01016262|469911588|FG000|Double-blind Phase|Disease Progression|0|||
130530558|NCT01016262|469911589|FG001|Double-blind Phase|Disease Progression|1|||
130530559|NCT01016262|469911590|FG002|Double-blind Phase|Disease Progression|2|||
130530560|NCT01016262|469911591|FG003|Double-blind Phase|Disease Progression|0|||
130530561|NCT01016262|469911592|FG004|Double-blind Phase|Disease Progression|0|||
130530562|NCT01016262|469911593|FG005|Double-blind Phase|Disease Progression|0|||
130530563|NCT01016262|469911588|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
130530564|NCT01016262|469911589|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
130530565|NCT01016262|469911590|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
130530566|NCT01016262|469911591|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
130530567|NCT01016262|469911592|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
130530568|NCT01016262|469911593|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
130530569|NCT01016262|469911588|FG000|Open-Label Phase|Adverse Event|0|||
130530570|NCT01016262|469911589|FG001|Open-Label Phase|Adverse Event|0|||
130530571|NCT01016262|469911590|FG002|Open-Label Phase|Adverse Event|0|||
130530572|NCT01016262|469911591|FG003|Open-Label Phase|Adverse Event|1|||
130530573|NCT01016262|469911592|FG004|Open-Label Phase|Adverse Event|0|||
130530574|NCT01016262|469911593|FG005|Open-Label Phase|Adverse Event|0|||
130530575|NCT01016262|469911588|FG000|Open-Label Phase|Lost to Follow-up|0|||
130530576|NCT01016262|469911589|FG001|Open-Label Phase|Lost to Follow-up|0|||
130530577|NCT01016262|469911590|FG002|Open-Label Phase|Lost to Follow-up|0|||
130530578|NCT01016262|469911591|FG003|Open-Label Phase|Lost to Follow-up|0|||
130530579|NCT01016262|469911592|FG004|Open-Label Phase|Lost to Follow-up|1|||
130530580|NCT01016262|469911593|FG005|Open-Label Phase|Lost to Follow-up|0|||
130530581|NCT01016262|469911588|FG000|Open-Label Phase|Lack of Efficacy|0|||
130530582|NCT01016262|469911589|FG001|Open-Label Phase|Lack of Efficacy|0|||
130530583|NCT01016262|469911590|FG002|Open-Label Phase|Lack of Efficacy|0|||
130530584|NCT01016262|469911591|FG003|Open-Label Phase|Lack of Efficacy|1|||
130530585|NCT01016262|469911592|FG004|Open-Label Phase|Lack of Efficacy|0|||
130530586|NCT01016262|469911593|FG005|Open-Label Phase|Lack of Efficacy|0|||
130530587|NCT01016262|469911588|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
130530588|NCT01016262|469911589|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
130530589|NCT01016262|469911590|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
130530590|NCT01016262|469911591|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
130530591|NCT01016262|469911592|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
130530592|NCT01016262|469911593|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
130530593|NCT01736540|469911594|FG000|Overall Study|Did not complete scan within 45 days|2|||
130530594|NCT01736540|469911594|FG000|Overall Study|Death|1|||
130530595|NCT01736540|469911594|FG000|Overall Study|Abnormal test procedure|1|||
130530596|NCT01736540|469911594|FG000|Overall Study|Withdrawal by Subject|5|||
130530597|NCT01736540|469911594|FG000|Overall Study|Protocol Violation|1|||
130530598|NCT01736540|469911594|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
130530599|NCT01736540|469911594|FG000|Overall Study|No show for MRI appointment|1|||
130530600|NCT01736540|469911594|FG000|Overall Study|Unable to make MRI appointment|3|||
130530601|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
130530602|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
130530603|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
130530604|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
130530605|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
130530606|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
130530607|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
130530608|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
130530609|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
130530610|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
130530611|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
130530612|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
130530613|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
130530614|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
130530615|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
130530616|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
130530617|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
130530618|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
130530619|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
130530620|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
130530621|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
130530622|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
130530623|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
130530624|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
130530625|NCT00479882|469911595|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
130530626|NCT00479882|469911596|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
130530627|NCT00479882|469911597|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
130530628|NCT00479882|469911598|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
130530629|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
130530630|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
130530631|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
130530632|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
130530633|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
130530634|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
130530635|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
130530636|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
130530637|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
130530638|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
130530639|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
130530640|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
130530641|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
130530642|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
130530643|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
130530644|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
130530645|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
130530646|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
130530647|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
130530648|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
130530649|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
130530650|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
130530651|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
130530652|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
130530653|NCT00479882|469911595|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
130530654|NCT00479882|469911596|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
130530655|NCT00479882|469911597|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
130530656|NCT00479882|469911598|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
130530657|NCT01132820|469911599|FG000|Overall Study|Ineligible: wrong cell type|1|||
130530658|NCT01132820|469911599|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
130578958|NCT01656434|470083226|FG000|Overall Study|Site discontinued study participation|24|||
130578959|NCT01656434|470083227|FG001|Overall Study|Site discontinued study participation|9|||
130578960|NCT01656434|470083226|FG000|Overall Study|Screen failure|2|||
130578961|NCT01656434|470083227|FG001|Overall Study|Screen failure|0|||
130578962|NCT01656434|470083226|FG000|Overall Study|Protocol Violation|7|||
130578963|NCT01656434|470083227|FG001|Overall Study|Protocol Violation|0|||
130578964|NCT01656434|470083226|FG000|Overall Study|Pregnancy wish|18|||
130578965|NCT01656434|470083227|FG001|Overall Study|Pregnancy wish|6|||
130578966|NCT01656434|470083226|FG000|Overall Study|Pregnancy|45|||
130578967|NCT01656434|470083227|FG001|Overall Study|Pregnancy|10|||
130578968|NCT01656434|470083226|FG000|Overall Study|Physician Decision|7|||
130578969|NCT01656434|470083227|FG001|Overall Study|Physician Decision|2|||
130578970|NCT01656434|470083226|FG000|Overall Study|Non-compliance with study drug|48|||
130578971|NCT01656434|470083227|FG001|Overall Study|Non-compliance with study drug|9|||
130578972|NCT01656434|470083226|FG000|Overall Study|Study terminated by sponsor|1501|||
130578973|NCT01656434|470083227|FG001|Overall Study|Study terminated by sponsor|348|||
130578974|NCT01656434|470083226|FG000|Overall Study|Participant discontinued; drug related|13|||
130578975|NCT01656434|470083227|FG001|Overall Study|Participant discontinued; drug related|4|||
130578976|NCT01656434|470083226|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
130578977|NCT01656434|470083227|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
130578978|NCT01656434|470083226|FG000|Overall Study|Non-compliance with protocol|39|||
130578979|NCT01656434|470083227|FG001|Overall Study|Non-compliance with protocol|15|||
130578980|NCT01656434|470083226|FG000|Overall Study|Participant moved|40|||
130578981|NCT01656434|470083227|FG001|Overall Study|Participant moved|12|||
130578982|NCT01656434|470083226|FG000|Overall Study|Participant withdrew consent|28|||
130578983|NCT01656434|470083227|FG001|Overall Study|Participant withdrew consent|9|||
130578984|NCT01656434|470083226|FG000|Overall Study|Withdrawal by Subject|64|||
130578985|NCT01656434|470083227|FG001|Overall Study|Withdrawal by Subject|7|||
130578986|NCT01580397|470083230|FG000|Overall Study|Lack of Efficacy|14|||
130578987|NCT02004873|470083231|FG000|Overall Study|Implant unsuccessful|6|||
130578988|NCT02004873|470083231|FG000|Overall Study|Awaiting 6-month visit|390|||
130578989|NCT02004873|470083231|FG000|Overall Study|Missed 6-month visit|4|||
130578990|NCT02004873|470083231|FG000|Overall Study|Death|23|||
130578991|NCT02004873|470083231|FG000|Overall Study|Withdrawal by Subject|1|||
130578992|NCT06098729|470083239|FG000|Overall Study|Withdrawal by Subject|1|||
130578993|NCT03033875|470083245|FG000|Overall Study|Withdrawal by Subject|5|||
130578994|NCT03033875|470083246|FG001|Overall Study|Withdrawal by Subject|9|||
130578995|NCT03033875|470083247|FG002|Overall Study|Withdrawal by Subject|4|||
130578996|NCT03033875|470083245|FG000|Overall Study|Other|14|||
130578997|NCT03033875|470083246|FG001|Overall Study|Other|15|||
130578998|NCT03033875|470083247|FG002|Overall Study|Other|8|||
130578999|NCT01060059|470083251|FG000|Overall Study|Adverse Event|1|||
130579000|NCT01060059|470083252|FG001|Overall Study|Adverse Event|1|||
130579001|NCT01060059|470083251|FG000|Overall Study|Death|2|||
130579002|NCT01060059|470083252|FG001|Overall Study|Death|3|||
130579003|NCT01060059|470083251|FG000|Overall Study|Lost to Follow-up|18|||
130579004|NCT01060059|470083252|FG001|Overall Study|Lost to Follow-up|34|||
130579005|NCT01060059|470083251|FG000|Overall Study|entry criteria not met|4|||
130579006|NCT01060059|470083252|FG001|Overall Study|entry criteria not met|3|||
130579007|NCT01060059|470083251|FG000|Overall Study|Withdrawal by Subject|35|||
130579008|NCT01060059|470083252|FG001|Overall Study|Withdrawal by Subject|23|||
130579009|NCT01060059|470083251|FG000|Overall Study|lack of glycemic control|2|||
130579010|NCT01060059|470083252|FG001|Overall Study|lack of glycemic control|1|||
130579011|NCT01060059|470083251|FG000|Overall Study|lack of compliance|5|||
130579012|NCT01060059|470083252|FG001|Overall Study|lack of compliance|2|||
130579013|NCT01614093|470083255|FG000|Overall Study|Withdrawal by Subject|1|||
130579014|NCT00848354|470083256|FG000|Phase 1|Adverse Event|5|||
130579015|NCT00848354|470083257|FG001|Phase 1|Adverse Event|4|||
130579016|NCT00848354|470083256|FG000|Phase 1|Discontinuation of study by sponsor|2|||
130579017|NCT00848354|470083257|FG001|Phase 1|Discontinuation of study by sponsor|1|||
130579018|NCT00848354|470083256|FG000|Phase 1|Failed to return|0|||
130579019|NCT00848354|470083257|FG001|Phase 1|Failed to return|1|||
130579020|NCT00848354|470083256|FG000|Phase 1|Lost to Follow-up|1|||
130579021|NCT00848354|470083257|FG001|Phase 1|Lost to Follow-up|1|||
130579022|NCT00848354|470083256|FG000|Phase 1|Unspecified Reason|1|||
130579023|NCT00848354|470083257|FG001|Phase 1|Unspecified Reason|1|||
130579024|NCT00848354|470083256|FG000|Phase 1|Protocol Violation|1|||
130579025|NCT00848354|470083257|FG001|Phase 1|Protocol Violation|1|||
130579026|NCT00848354|470083256|FG000|Phase 1|Withdrawal by Subject|2|||
130579027|NCT00848354|470083257|FG001|Phase 1|Withdrawal by Subject|4|||
130579028|NCT00848354|470083256|FG000|Phase 1|Lack of Efficacy|0|||
130579029|NCT00848354|470083257|FG001|Phase 1|Lack of Efficacy|1|||
130579030|NCT00848354|470083256|FG000|Phase 2 Year 1|Adverse Event|7|||
130579031|NCT00848354|470083257|FG001|Phase 2 Year 1|Adverse Event|2|||
130579032|NCT00848354|470083256|FG000|Phase 2 Year 1|Death|1|||
130579033|NCT00848354|470083257|FG001|Phase 2 Year 1|Death|0|||
130579034|NCT00848354|470083256|FG000|Phase 2 Year 1|Failed to Return|1|||
130579035|NCT00848354|470083257|FG001|Phase 2 Year 1|Failed to Return|1|||
130579036|NCT00848354|470083256|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
130579037|NCT00848354|470083257|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
130579038|NCT00848354|470083256|FG000|Phase 2 Year 1|Unspecified Reason|3|||
130579039|NCT00848354|470083257|FG001|Phase 2 Year 1|Unspecified Reason|0|||
130579040|NCT00848354|470083256|FG000|Phase 2 Year 1|Protocol Violation|4|||
130579041|NCT00848354|470083257|FG001|Phase 2 Year 1|Protocol Violation|1|||
130579042|NCT00848354|470083256|FG000|Phase 2 Year 1|Subject Request|1|||
130579043|NCT00848354|470083257|FG001|Phase 2 Year 1|Subject Request|2|||
130579044|NCT00848354|470083256|FG000|Phase 2 Year 2|Adverse Event|12|||
130579045|NCT00848354|470083257|FG001|Phase 2 Year 2|Adverse Event|2|||
130579046|NCT00848354|470083256|FG000|Phase 2 Year 2|Death|2|||
130579047|NCT00848354|470083257|FG001|Phase 2 Year 2|Death|0|||
130579048|NCT00848354|470083256|FG000|Phase 2 Year 2|Failed to return|3|||
130579049|NCT00848354|470083257|FG001|Phase 2 Year 2|Failed to return|0|||
130579050|NCT00848354|470083256|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
130579051|NCT00848354|470083257|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
130579052|NCT00848354|470083256|FG000|Phase 2 Year 2|Unspecified Reason|1|||
130579053|NCT00848354|470083257|FG001|Phase 2 Year 2|Unspecified Reason|0|||
130579054|NCT00848354|470083256|FG000|Phase 2 Year 2|Protocol Violation|1|||
130579055|NCT00848354|470083257|FG001|Phase 2 Year 2|Protocol Violation|1|||
130579056|NCT00848354|470083256|FG000|Phase 2 Year 2|Subject Request|1|||
130579057|NCT00848354|470083257|FG001|Phase 2 Year 2|Subject Request|1|||
130579058|NCT00848354|470083256|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
130579059|NCT00848354|470083257|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
130579060|NCT03718143|470085117|FG000|Overall Study|Death|1|||
130579061|NCT03718143|470085118|FG001|Overall Study|Death|0|||
130579062|NCT03718143|470085119|FG002|Overall Study|Death|0|||
130579063|NCT03718143|470085117|FG000|Overall Study|Progression of Disease|1|||
130579064|NCT03718143|470085118|FG001|Overall Study|Progression of Disease|0|||
130579065|NCT03718143|470085119|FG002|Overall Study|Progression of Disease|0|||
130579066|NCT03718143|470085117|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130579067|NCT03718143|470085118|FG001|Overall Study|Withdrawal of Informed Consent|2|||
130579068|NCT03718143|470085119|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130579069|NCT05064059|470085120|FG000|Overall Study|Death|199|||
130579070|NCT05064059|470085121|FG001|Overall Study|Death|196|||
130579071|NCT05064059|470085120|FG000|Overall Study|Physician Decision|4|||
130579072|NCT05064059|470085121|FG001|Overall Study|Physician Decision|2|||
130579073|NCT05064059|470085120|FG000|Overall Study|Sponsor Decision|14|||
130579074|NCT05064059|470085121|FG001|Overall Study|Sponsor Decision|11|||
130579075|NCT05064059|470085120|FG000|Overall Study|Withdrawal by Subject|4|||
130579076|NCT05064059|470085121|FG001|Overall Study|Withdrawal by Subject|11|||
130579077|NCT05227690|470085127|FG000|Overall Study|Adverse Event|5|||
130579078|NCT05227690|470085128|FG001|Overall Study|Adverse Event|6|||
130579079|NCT05227690|470085129|FG002|Overall Study|Adverse Event|10|||
130579080|NCT05227690|470085127|FG000|Overall Study|Lack of Efficacy|2|||
130579081|NCT05227690|470085128|FG001|Overall Study|Lack of Efficacy|4|||
130579082|NCT05227690|470085129|FG002|Overall Study|Lack of Efficacy|1|||
130579083|NCT05227690|470085127|FG000|Overall Study|Physician Decision|6|||
130579084|NCT05227690|470085128|FG001|Overall Study|Physician Decision|0|||
130579085|NCT05227690|470085129|FG002|Overall Study|Physician Decision|4|||
130579086|NCT05227690|470085127|FG000|Overall Study|Withdrawal of consent|28|||
130579087|NCT05227690|470085128|FG001|Overall Study|Withdrawal of consent|27|||
130579088|NCT05227690|470085129|FG002|Overall Study|Withdrawal of consent|21|||
130579089|NCT05227690|470085127|FG000|Overall Study|Other, not specified|2|||
130579090|NCT05227690|470085128|FG001|Overall Study|Other, not specified|2|||
130579091|NCT05227690|470085129|FG002|Overall Study|Other, not specified|1|||
130579092|NCT02770326|470085132|FG000|Overall Study|Death|3|||
130579093|NCT02770326|470085132|FG000|Overall Study|Lost to Follow-up|1|||
130579094|NCT02971202|470085133|FG000|Overall Study|Pregnancy|1|||
130579095|NCT02971202|470085134|FG001|Overall Study|Pregnancy|0|||
130579096|NCT02971202|470085135|FG002|Overall Study|Pregnancy|0|||
130579097|NCT02971202|470085133|FG000|Overall Study|screen fail after consent|1|||
130579098|NCT02971202|470085134|FG001|Overall Study|screen fail after consent|0|||
130579099|NCT02971202|470085135|FG002|Overall Study|screen fail after consent|1|||
130579100|NCT02634580|470085136|FG000|Double-blind Treatment Period|Subject Request|1|||
130579101|NCT02634580|470085137|FG001|Double-blind Treatment Period|Subject Request|0|||
130579102|NCT02634580|470085138|FG002|Double-blind Treatment Period|Subject Request|1|||
130579103|NCT02634580|470085139|FG003|Double-blind Treatment Period|Subject Request|1|||
130579104|NCT02634580|470085136|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130579105|NCT02634580|470085137|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
130579106|NCT02634580|470085138|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130579107|NCT02634580|470085139|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
130579108|NCT00584233|470085140|FG000|Overall Study|Withdrawal by Subject|5|||
130579109|NCT00584233|470085140|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
130579110|NCT02222714|470085141|FG000|Overall Study|Death|0|||
130579111|NCT02222714|470085142|FG001|Overall Study|Death|2|||
130579112|NCT02222714|470085143|FG002|Overall Study|Death|3|||
130579113|NCT02222714|470085144|FG003|Overall Study|Death|4|||
130530659|NCT01132820|469911599|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
130530660|NCT01132820|469911599|FG000|Overall Study|Never treated|1|||
130530661|NCT01132820|469911599|FG000|Overall Study|Inadequate data|1|||
130530662|NCT01370655|469911602|FG000|Period 1|Adverse Event|2|||
130530663|NCT01370655|469911603|FG001|Period 1|Adverse Event|0|||
130530664|NCT01370655|469911604|FG002|Period 1|Adverse Event|0|||
130530665|NCT01370655|469911605|FG003|Period 1|Adverse Event|0|||
130530666|NCT01370655|469911606|FG004|Period 1|Adverse Event|0|||
130530667|NCT01370655|469911607|FG005|Period 1|Adverse Event|0|||
130530668|NCT01370655|469911608|FG006|Period 1|Adverse Event|1|||
130530669|NCT01370655|469911609|FG007|Period 1|Adverse Event|0|||
130530670|NCT01370655|469911610|FG008|Period 1|Adverse Event|0|||
130530671|NCT01370655|469911611|FG009|Period 1|Adverse Event|0|||
130530672|NCT01370655|469911612|FG010|Period 1|Adverse Event|0|||
130530673|NCT01370655|469911613|FG011|Period 1|Adverse Event|0|||
130530674|NCT01370655|469911602|FG000|Period 2|Adverse Event|0|||
130530675|NCT01370655|469911603|FG001|Period 2|Adverse Event|0|||
130530676|NCT01370655|469911604|FG002|Period 2|Adverse Event|1|||
130530677|NCT01370655|469911605|FG003|Period 2|Adverse Event|0|||
130530678|NCT01370655|469911606|FG004|Period 2|Adverse Event|1|||
130530679|NCT01370655|469911607|FG005|Period 2|Adverse Event|0|||
130530680|NCT01370655|469911608|FG006|Period 2|Adverse Event|0|||
130530681|NCT01370655|469911609|FG007|Period 2|Adverse Event|1|||
130530682|NCT01370655|469911610|FG008|Period 2|Adverse Event|0|||
130530683|NCT01370655|469911611|FG009|Period 2|Adverse Event|0|||
130530684|NCT01370655|469911612|FG010|Period 2|Adverse Event|0|||
130530685|NCT01370655|469911613|FG011|Period 2|Adverse Event|0|||
130530686|NCT01370655|469911602|FG000|Period 2|met protocol specified stopping criteria|0|||
130530687|NCT01370655|469911603|FG001|Period 2|met protocol specified stopping criteria|0|||
130530688|NCT01370655|469911604|FG002|Period 2|met protocol specified stopping criteria|1|||
130530689|NCT01370655|469911605|FG003|Period 2|met protocol specified stopping criteria|0|||
130530690|NCT01370655|469911606|FG004|Period 2|met protocol specified stopping criteria|0|||
130530691|NCT01370655|469911607|FG005|Period 2|met protocol specified stopping criteria|0|||
130530692|NCT01370655|469911608|FG006|Period 2|met protocol specified stopping criteria|1|||
130530693|NCT01370655|469911609|FG007|Period 2|met protocol specified stopping criteria|0|||
130530694|NCT01370655|469911610|FG008|Period 2|met protocol specified stopping criteria|1|||
130530695|NCT01370655|469911611|FG009|Period 2|met protocol specified stopping criteria|0|||
130530696|NCT01370655|469911612|FG010|Period 2|met protocol specified stopping criteria|1|||
130530697|NCT01370655|469911613|FG011|Period 2|met protocol specified stopping criteria|0|||
130530698|NCT01370655|469911602|FG000|Period 2|Withdrawal by Subject|0|||
130530699|NCT01370655|469911603|FG001|Period 2|Withdrawal by Subject|0|||
130530700|NCT01370655|469911604|FG002|Period 2|Withdrawal by Subject|0|||
130530701|NCT01370655|469911605|FG003|Period 2|Withdrawal by Subject|0|||
130530702|NCT01370655|469911606|FG004|Period 2|Withdrawal by Subject|0|||
130530703|NCT01370655|469911607|FG005|Period 2|Withdrawal by Subject|0|||
130530704|NCT01370655|469911608|FG006|Period 2|Withdrawal by Subject|0|||
130530705|NCT01370655|469911609|FG007|Period 2|Withdrawal by Subject|0|||
130530706|NCT01370655|469911610|FG008|Period 2|Withdrawal by Subject|1|||
130530707|NCT01370655|469911611|FG009|Period 2|Withdrawal by Subject|0|||
130530708|NCT01370655|469911612|FG010|Period 2|Withdrawal by Subject|0|||
130530709|NCT01370655|469911613|FG011|Period 2|Withdrawal by Subject|0|||
130530710|NCT05000216|469911615|FG000|Stage 1|Lost to Follow-up|0|||
130530711|NCT05000216|469911616|FG001|Stage 1|Lost to Follow-up|0|||
130530712|NCT05000216|469911617|FG002|Stage 1|Lost to Follow-up|0|||
130530713|NCT05000216|469911618|FG003|Stage 1|Lost to Follow-up|0|||
130530714|NCT05000216|469911619|FG004|Stage 1|Lost to Follow-up|0|||
130530715|NCT05000216|469911620|FG005|Stage 1|Lost to Follow-up|0|||
130530716|NCT05000216|469911621|FG006|Stage 1|Lost to Follow-up|1|||
130530717|NCT05000216|469911622|FG007|Stage 1|Lost to Follow-up|1|||
130530718|NCT05000216|469911623|FG008|Stage 1|Lost to Follow-up|0|||
130530719|NCT05000216|469911624|FG009|Stage 1|Lost to Follow-up|2|||
130530720|NCT05000216|469911625|FG010|Stage 1|Lost to Follow-up|3|||
130530721|NCT05000216|469911626|FG011|Stage 1|Lost to Follow-up|0|||
130530722|NCT05000216|469911627|FG012|Stage 1|Lost to Follow-up|0|||
130530723|NCT05000216|469911628|FG013|Stage 1|Lost to Follow-up|0|||
130530724|NCT05000216|469911629|FG014|Stage 1|Lost to Follow-up|0|||
130530725|NCT05000216|469911630|FG015|Stage 1|Lost to Follow-up|0|||
130530726|NCT05000216|469911631|FG016|Stage 1|Lost to Follow-up|0|||
130530727|NCT05000216|469911632|FG017|Stage 1|Lost to Follow-up|0|||
130530728|NCT05000216|469911633|FG018|Stage 1|Lost to Follow-up|0|||
130530729|NCT05000216|469911634|FG019|Stage 1|Lost to Follow-up|0|||
130530730|NCT05000216|469911635|FG020|Stage 1|Lost to Follow-up|0|||
130530731|NCT05000216|469911636|FG021|Stage 1|Lost to Follow-up|0|||
130530732|NCT05000216|469911615|FG000|Stage 1|Physician Decision|0|||
130530733|NCT05000216|469911616|FG001|Stage 1|Physician Decision|0|||
130530734|NCT05000216|469911617|FG002|Stage 1|Physician Decision|0|||
130530735|NCT05000216|469911618|FG003|Stage 1|Physician Decision|0|||
130530736|NCT05000216|469911619|FG004|Stage 1|Physician Decision|0|||
130530737|NCT05000216|469911620|FG005|Stage 1|Physician Decision|0|||
130530738|NCT05000216|469911621|FG006|Stage 1|Physician Decision|0|||
130530739|NCT05000216|469911622|FG007|Stage 1|Physician Decision|1|||
130530740|NCT05000216|469911623|FG008|Stage 1|Physician Decision|1|||
130530741|NCT05000216|469911624|FG009|Stage 1|Physician Decision|0|||
130530742|NCT05000216|469911625|FG010|Stage 1|Physician Decision|0|||
130530743|NCT05000216|469911626|FG011|Stage 1|Physician Decision|0|||
130530744|NCT05000216|469911627|FG012|Stage 1|Physician Decision|0|||
130530745|NCT05000216|469911628|FG013|Stage 1|Physician Decision|0|||
130530746|NCT05000216|469911629|FG014|Stage 1|Physician Decision|0|||
130530747|NCT05000216|469911630|FG015|Stage 1|Physician Decision|0|||
130530748|NCT05000216|469911631|FG016|Stage 1|Physician Decision|0|||
130530749|NCT05000216|469911632|FG017|Stage 1|Physician Decision|0|||
130530750|NCT05000216|469911633|FG018|Stage 1|Physician Decision|0|||
130530751|NCT05000216|469911634|FG019|Stage 1|Physician Decision|0|||
130530752|NCT05000216|469911635|FG020|Stage 1|Physician Decision|0|||
130530753|NCT05000216|469911636|FG021|Stage 1|Physician Decision|0|||
130530754|NCT05000216|469911615|FG000|Stage 1|Withdrawal by Subject|0|||
130530755|NCT05000216|469911616|FG001|Stage 1|Withdrawal by Subject|1|||
130530756|NCT05000216|469911617|FG002|Stage 1|Withdrawal by Subject|0|||
130530757|NCT05000216|469911618|FG003|Stage 1|Withdrawal by Subject|0|||
130530758|NCT05000216|469911619|FG004|Stage 1|Withdrawal by Subject|0|||
130530759|NCT05000216|469911620|FG005|Stage 1|Withdrawal by Subject|0|||
130530760|NCT05000216|469911621|FG006|Stage 1|Withdrawal by Subject|0|||
130530761|NCT05000216|469911622|FG007|Stage 1|Withdrawal by Subject|0|||
130530762|NCT05000216|469911623|FG008|Stage 1|Withdrawal by Subject|0|||
130530763|NCT05000216|469911624|FG009|Stage 1|Withdrawal by Subject|3|||
130530764|NCT05000216|469911625|FG010|Stage 1|Withdrawal by Subject|10|||
130530765|NCT05000216|469911626|FG011|Stage 1|Withdrawal by Subject|0|||
130530766|NCT05000216|469911627|FG012|Stage 1|Withdrawal by Subject|0|||
130530767|NCT05000216|469911628|FG013|Stage 1|Withdrawal by Subject|0|||
130530768|NCT05000216|469911629|FG014|Stage 1|Withdrawal by Subject|0|||
130530769|NCT05000216|469911630|FG015|Stage 1|Withdrawal by Subject|0|||
130530770|NCT05000216|469911631|FG016|Stage 1|Withdrawal by Subject|0|||
130530771|NCT05000216|469911632|FG017|Stage 1|Withdrawal by Subject|0|||
130530772|NCT05000216|469911633|FG018|Stage 1|Withdrawal by Subject|0|||
130530773|NCT05000216|469911634|FG019|Stage 1|Withdrawal by Subject|0|||
130530774|NCT05000216|469911635|FG020|Stage 1|Withdrawal by Subject|0|||
130530775|NCT05000216|469911636|FG021|Stage 1|Withdrawal by Subject|0|||
130530776|NCT05000216|469911615|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
130530777|NCT05000216|469911616|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
130530778|NCT05000216|469911617|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
130530779|NCT05000216|469911618|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
130530780|NCT05000216|469911619|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
130530781|NCT05000216|469911620|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
130530782|NCT05000216|469911621|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
130530783|NCT05000216|469911622|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
130530784|NCT05000216|469911623|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
130530785|NCT05000216|469911624|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
130530786|NCT05000216|469911625|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
130530787|NCT05000216|469911626|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
130530788|NCT05000216|469911627|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
130530789|NCT05000216|469911628|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
130530790|NCT05000216|469911629|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
130530791|NCT05000216|469911630|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
130530792|NCT05000216|469911631|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
130530793|NCT05000216|469911632|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
130530794|NCT05000216|469911633|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
130530795|NCT05000216|469911634|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
130530796|NCT05000216|469911635|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
130530797|NCT05000216|469911636|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
130530798|NCT05000216|469911615|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530799|NCT05000216|469911616|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530800|NCT05000216|469911617|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530801|NCT05000216|469911618|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530802|NCT05000216|469911619|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530803|NCT05000216|469911620|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530804|NCT05000216|469911621|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530805|NCT05000216|469911622|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530806|NCT05000216|469911623|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
130530807|NCT05000216|469911624|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530808|NCT05000216|469911625|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530809|NCT05000216|469911626|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530810|NCT05000216|469911627|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530811|NCT05000216|469911628|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530812|NCT05000216|469911629|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530813|NCT05000216|469911630|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530814|NCT05000216|469911631|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530815|NCT05000216|469911632|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530816|NCT05000216|469911633|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530817|NCT05000216|469911634|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530818|NCT05000216|469911635|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530819|NCT05000216|469911636|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
130530820|NCT05000216|469911615|FG000|Stage 1|Other|0|||
130530821|NCT05000216|469911616|FG001|Stage 1|Other|0|||
130530822|NCT05000216|469911617|FG002|Stage 1|Other|0|||
130530823|NCT05000216|469911618|FG003|Stage 1|Other|0|||
130530824|NCT05000216|469911619|FG004|Stage 1|Other|1|||
130530825|NCT05000216|469911620|FG005|Stage 1|Other|0|||
130530826|NCT05000216|469911621|FG006|Stage 1|Other|0|||
130530827|NCT05000216|469911622|FG007|Stage 1|Other|2|||
130530828|NCT05000216|469911623|FG008|Stage 1|Other|0|||
130530829|NCT05000216|469911624|FG009|Stage 1|Other|0|||
130530830|NCT05000216|469911625|FG010|Stage 1|Other|1|||
130530831|NCT05000216|469911626|FG011|Stage 1|Other|1|||
130530832|NCT05000216|469911627|FG012|Stage 1|Other|0|||
130530833|NCT05000216|469911628|FG013|Stage 1|Other|0|||
130530834|NCT05000216|469911629|FG014|Stage 1|Other|0|||
130530835|NCT05000216|469911630|FG015|Stage 1|Other|0|||
130530836|NCT05000216|469911631|FG016|Stage 1|Other|0|||
130530837|NCT05000216|469911632|FG017|Stage 1|Other|0|||
130530838|NCT05000216|469911633|FG018|Stage 1|Other|0|||
130530839|NCT05000216|469911634|FG019|Stage 1|Other|0|||
130530840|NCT05000216|469911635|FG020|Stage 1|Other|0|||
130530841|NCT05000216|469911636|FG021|Stage 1|Other|0|||
130530842|NCT05000216|469911615|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
130530843|NCT05000216|469911616|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
130530844|NCT05000216|469911617|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
130530845|NCT05000216|469911618|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
130530846|NCT05000216|469911619|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
130530847|NCT05000216|469911620|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
130530848|NCT05000216|469911621|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
130530849|NCT05000216|469911622|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
130530850|NCT05000216|469911623|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
130530851|NCT05000216|469911624|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
130530852|NCT05000216|469911625|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
130530853|NCT05000216|469911626|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
130530854|NCT05000216|469911627|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
130530855|NCT05000216|469911628|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
130530856|NCT05000216|469911629|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
130530857|NCT05000216|469911630|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
130530858|NCT05000216|469911631|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
130530859|NCT05000216|469911632|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
130530860|NCT05000216|469911633|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
130530861|NCT05000216|469911634|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
130530862|NCT05000216|469911635|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
130530863|NCT05000216|469911636|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
130530864|NCT05000216|469911615|FG000|Stage 2|Lost to Follow-up|0|||
130530865|NCT05000216|469911616|FG001|Stage 2|Lost to Follow-up|0|||
130530866|NCT05000216|469911617|FG002|Stage 2|Lost to Follow-up|0|||
130530867|NCT05000216|469911618|FG003|Stage 2|Lost to Follow-up|0|||
130530868|NCT05000216|469911619|FG004|Stage 2|Lost to Follow-up|0|||
130530869|NCT05000216|469911620|FG005|Stage 2|Lost to Follow-up|0|||
130530870|NCT05000216|469911621|FG006|Stage 2|Lost to Follow-up|0|||
130530871|NCT05000216|469911622|FG007|Stage 2|Lost to Follow-up|0|||
130530872|NCT05000216|469911623|FG008|Stage 2|Lost to Follow-up|0|||
130530873|NCT05000216|469911624|FG009|Stage 2|Lost to Follow-up|0|||
130530874|NCT05000216|469911625|FG010|Stage 2|Lost to Follow-up|0|||
130530875|NCT05000216|469911626|FG011|Stage 2|Lost to Follow-up|0|||
130530876|NCT05000216|469911627|FG012|Stage 2|Lost to Follow-up|0|||
130530877|NCT05000216|469911628|FG013|Stage 2|Lost to Follow-up|0|||
130530878|NCT05000216|469911629|FG014|Stage 2|Lost to Follow-up|0|||
130530879|NCT05000216|469911630|FG015|Stage 2|Lost to Follow-up|0|||
130530880|NCT05000216|469911631|FG016|Stage 2|Lost to Follow-up|4|||
130530881|NCT05000216|469911632|FG017|Stage 2|Lost to Follow-up|0|||
130530882|NCT05000216|469911633|FG018|Stage 2|Lost to Follow-up|0|||
130530883|NCT05000216|469911634|FG019|Stage 2|Lost to Follow-up|0|||
130530884|NCT05000216|469911635|FG020|Stage 2|Lost to Follow-up|0|||
130530885|NCT05000216|469911636|FG021|Stage 2|Lost to Follow-up|0|||
130530886|NCT05000216|469911615|FG000|Stage 2|Physician Decision|0|||
130530887|NCT05000216|469911616|FG001|Stage 2|Physician Decision|0|||
130530888|NCT05000216|469911617|FG002|Stage 2|Physician Decision|0|||
130530889|NCT05000216|469911618|FG003|Stage 2|Physician Decision|0|||
130530890|NCT05000216|469911619|FG004|Stage 2|Physician Decision|0|||
130530891|NCT05000216|469911620|FG005|Stage 2|Physician Decision|0|||
130530892|NCT05000216|469911621|FG006|Stage 2|Physician Decision|0|||
130530893|NCT05000216|469911622|FG007|Stage 2|Physician Decision|0|||
130530894|NCT05000216|469911623|FG008|Stage 2|Physician Decision|0|||
130530895|NCT05000216|469911624|FG009|Stage 2|Physician Decision|0|||
130530896|NCT05000216|469911625|FG010|Stage 2|Physician Decision|0|||
130530897|NCT05000216|469911626|FG011|Stage 2|Physician Decision|0|||
130530898|NCT05000216|469911627|FG012|Stage 2|Physician Decision|1|||
130579114|NCT02222714|470085145|FG004|Overall Study|Death|6|||
130579115|NCT02222714|470085141|FG000|Overall Study|Withdrawal by Subject|0|||
130579116|NCT02222714|470085142|FG001|Overall Study|Withdrawal by Subject|0|||
130579117|NCT02222714|470085143|FG002|Overall Study|Withdrawal by Subject|1|||
130579118|NCT02222714|470085144|FG003|Overall Study|Withdrawal by Subject|0|||
130579119|NCT02222714|470085145|FG004|Overall Study|Withdrawal by Subject|1|||
130579120|NCT01285908|470085146|FG000|Baseline Measurement|unable to insert catheter|1|||
130530899|NCT05000216|469911628|FG013|Stage 2|Physician Decision|0|||
130530900|NCT05000216|469911629|FG014|Stage 2|Physician Decision|0|||
130530901|NCT05000216|469911630|FG015|Stage 2|Physician Decision|0|||
130530902|NCT05000216|469911631|FG016|Stage 2|Physician Decision|0|||
130530903|NCT05000216|469911632|FG017|Stage 2|Physician Decision|0|||
130530904|NCT05000216|469911633|FG018|Stage 2|Physician Decision|0|||
130530905|NCT05000216|469911634|FG019|Stage 2|Physician Decision|0|||
130530906|NCT05000216|469911635|FG020|Stage 2|Physician Decision|0|||
130530907|NCT05000216|469911636|FG021|Stage 2|Physician Decision|0|||
130530908|NCT05000216|469911615|FG000|Stage 2|Withdrawal by Subject|0|||
130530909|NCT05000216|469911616|FG001|Stage 2|Withdrawal by Subject|0|||
130530910|NCT05000216|469911617|FG002|Stage 2|Withdrawal by Subject|0|||
130530911|NCT05000216|469911618|FG003|Stage 2|Withdrawal by Subject|0|||
130530912|NCT05000216|469911619|FG004|Stage 2|Withdrawal by Subject|0|||
130530913|NCT05000216|469911620|FG005|Stage 2|Withdrawal by Subject|0|||
130530914|NCT05000216|469911621|FG006|Stage 2|Withdrawal by Subject|0|||
130530915|NCT05000216|469911622|FG007|Stage 2|Withdrawal by Subject|0|||
130530916|NCT05000216|469911623|FG008|Stage 2|Withdrawal by Subject|0|||
130530917|NCT05000216|469911624|FG009|Stage 2|Withdrawal by Subject|0|||
130530918|NCT05000216|469911625|FG010|Stage 2|Withdrawal by Subject|0|||
130530919|NCT05000216|469911626|FG011|Stage 2|Withdrawal by Subject|0|||
130530920|NCT05000216|469911627|FG012|Stage 2|Withdrawal by Subject|0|||
130530921|NCT05000216|469911628|FG013|Stage 2|Withdrawal by Subject|0|||
130530922|NCT05000216|469911629|FG014|Stage 2|Withdrawal by Subject|2|||
130530923|NCT05000216|469911630|FG015|Stage 2|Withdrawal by Subject|0|||
130530924|NCT05000216|469911631|FG016|Stage 2|Withdrawal by Subject|9|||
130530925|NCT05000216|469911632|FG017|Stage 2|Withdrawal by Subject|0|||
130530926|NCT05000216|469911633|FG018|Stage 2|Withdrawal by Subject|0|||
130530927|NCT05000216|469911634|FG019|Stage 2|Withdrawal by Subject|0|||
130530928|NCT05000216|469911635|FG020|Stage 2|Withdrawal by Subject|0|||
130530929|NCT05000216|469911636|FG021|Stage 2|Withdrawal by Subject|0|||
130530930|NCT05000216|469911615|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
130530931|NCT05000216|469911616|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
130530932|NCT05000216|469911617|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
130530933|NCT05000216|469911618|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
130530934|NCT05000216|469911619|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
130530935|NCT05000216|469911620|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
130530936|NCT05000216|469911621|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
130530937|NCT05000216|469911622|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
130530938|NCT05000216|469911623|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
130530939|NCT05000216|469911624|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
130530940|NCT05000216|469911625|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
130530941|NCT05000216|469911626|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
130530942|NCT05000216|469911627|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
130530943|NCT05000216|469911628|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
130530944|NCT05000216|469911629|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
130530945|NCT05000216|469911630|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
130530946|NCT05000216|469911631|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
130530947|NCT05000216|469911632|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
130530948|NCT05000216|469911633|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
130530949|NCT05000216|469911634|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
130530950|NCT05000216|469911635|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
130530951|NCT05000216|469911636|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
130530952|NCT05000216|469911615|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530953|NCT05000216|469911616|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530954|NCT05000216|469911617|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530955|NCT05000216|469911618|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530956|NCT05000216|469911619|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530957|NCT05000216|469911620|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530958|NCT05000216|469911621|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530959|NCT05000216|469911622|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530960|NCT05000216|469911623|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530961|NCT05000216|469911624|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530962|NCT05000216|469911625|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530963|NCT05000216|469911626|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530964|NCT05000216|469911627|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530965|NCT05000216|469911628|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130579121|NCT01285908|470085147|FG001|Baseline Measurement|unable to insert catheter|0|||
130579122|NCT01285908|470085148|FG002|Baseline Measurement|unable to insert catheter|0|||
130579123|NCT01285908|470085146|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
130579124|NCT01285908|470085147|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
130579125|NCT01285908|470085148|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
130579126|NCT01285908|470085146|FG000|Baseline Measurement|unable to tolerate procedure|1|||
130579127|NCT01285908|470085147|FG001|Baseline Measurement|unable to tolerate procedure|0|||
130579128|NCT01285908|470085148|FG002|Baseline Measurement|unable to tolerate procedure|0|||
130579129|NCT03529773|470085149|FG000|Overall Study|Adverse Event|0|||
130579130|NCT03529773|470085150|FG001|Overall Study|Adverse Event|0|||
130579131|NCT03529773|470085151|FG002|Overall Study|Adverse Event|0|||
130579132|NCT03529773|470085152|FG003|Overall Study|Adverse Event|0|||
130579133|NCT03529773|470085153|FG004|Overall Study|Adverse Event|0|||
130579134|NCT03529773|470085154|FG005|Overall Study|Adverse Event|0|||
130579135|NCT03529773|470085155|FG006|Overall Study|Adverse Event|0|||
130579136|NCT03529773|470085156|FG007|Overall Study|Adverse Event|0|||
130579137|NCT03529773|470085157|FG008|Overall Study|Adverse Event|0|||
130579138|NCT03529773|470085158|FG009|Overall Study|Adverse Event|0|||
130579139|NCT03529773|470085159|FG010|Overall Study|Adverse Event|0|||
130579140|NCT03529773|470085160|FG011|Overall Study|Adverse Event|0|||
130579141|NCT03529773|470085161|FG012|Overall Study|Adverse Event|0|||
130579142|NCT03529773|470085162|FG013|Overall Study|Adverse Event|0|||
130579143|NCT03529773|470085163|FG014|Overall Study|Adverse Event|0|||
130579144|NCT03529773|470085164|FG015|Overall Study|Adverse Event|0|||
130579145|NCT03529773|470085165|FG016|Overall Study|Adverse Event|0|||
130579146|NCT03529773|470085166|FG017|Overall Study|Adverse Event|0|||
130579147|NCT03529773|470085167|FG018|Overall Study|Adverse Event|0|||
130579148|NCT03529773|470085168|FG019|Overall Study|Adverse Event|0|||
130579149|NCT03529773|470085169|FG020|Overall Study|Adverse Event|0|||
130579150|NCT03529773|470085170|FG021|Overall Study|Adverse Event|0|||
130579151|NCT03529773|470085171|FG022|Overall Study|Adverse Event|0|||
130579152|NCT03529773|470085172|FG023|Overall Study|Adverse Event|0|||
130579153|NCT03529773|470085173|FG024|Overall Study|Adverse Event|0|||
130530966|NCT05000216|469911629|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
130530967|NCT05000216|469911630|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530968|NCT05000216|469911631|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
130530969|NCT05000216|469911632|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530970|NCT05000216|469911633|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530971|NCT05000216|469911634|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530972|NCT05000216|469911635|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530973|NCT05000216|469911636|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
130530974|NCT05000216|469911615|FG000|Stage 2|Other reason|0|||
130530975|NCT05000216|469911616|FG001|Stage 2|Other reason|0|||
130530976|NCT05000216|469911617|FG002|Stage 2|Other reason|0|||
130530977|NCT05000216|469911618|FG003|Stage 2|Other reason|0|||
130530978|NCT05000216|469911619|FG004|Stage 2|Other reason|0|||
130530979|NCT05000216|469911620|FG005|Stage 2|Other reason|0|||
130530980|NCT05000216|469911621|FG006|Stage 2|Other reason|0|||
130530981|NCT05000216|469911622|FG007|Stage 2|Other reason|0|||
130530982|NCT05000216|469911623|FG008|Stage 2|Other reason|0|||
130530983|NCT05000216|469911624|FG009|Stage 2|Other reason|0|||
130530984|NCT05000216|469911625|FG010|Stage 2|Other reason|0|||
130530985|NCT05000216|469911626|FG011|Stage 2|Other reason|0|||
130530986|NCT05000216|469911627|FG012|Stage 2|Other reason|0|||
130530987|NCT05000216|469911628|FG013|Stage 2|Other reason|0|||
130530988|NCT05000216|469911629|FG014|Stage 2|Other reason|0|||
130530989|NCT05000216|469911630|FG015|Stage 2|Other reason|0|||
130530990|NCT05000216|469911631|FG016|Stage 2|Other reason|1|||
130530991|NCT05000216|469911632|FG017|Stage 2|Other reason|0|||
130530992|NCT05000216|469911633|FG018|Stage 2|Other reason|0|||
130530993|NCT05000216|469911634|FG019|Stage 2|Other reason|0|||
130579154|NCT03529773|470085174|FG025|Overall Study|Adverse Event|0|||
130579155|NCT03529773|470085175|FG026|Overall Study|Adverse Event|0|||
130579156|NCT03529773|470085176|FG027|Overall Study|Adverse Event|0|||
130530994|NCT05000216|469911635|FG020|Stage 2|Other reason|0|||
130530995|NCT05000216|469911636|FG021|Stage 2|Other reason|0|||
130530996|NCT05000216|469911615|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
130530997|NCT05000216|469911616|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
130530998|NCT05000216|469911617|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
130530999|NCT05000216|469911618|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
130579157|NCT03529773|470085177|FG028|Overall Study|Adverse Event|0|||
130579158|NCT03529773|470085178|FG029|Overall Study|Adverse Event|0|||
130579159|NCT03529773|470085179|FG030|Overall Study|Adverse Event|1|||
130579160|NCT03529773|470085180|FG031|Overall Study|Adverse Event|0|||
130579161|NCT03529773|470085181|FG032|Overall Study|Adverse Event|0|||
130579162|NCT03529773|470085182|FG033|Overall Study|Adverse Event|0|||
130579163|NCT03529773|470085183|FG034|Overall Study|Adverse Event|0|||
130579164|NCT03529773|470085184|FG035|Overall Study|Adverse Event|1|||
130579165|NCT03529773|470085185|FG036|Overall Study|Adverse Event|0|||
130531000|NCT05000216|469911619|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
130579166|NCT03529773|470085186|FG037|Overall Study|Adverse Event|0|||
130579167|NCT03529773|470085187|FG038|Overall Study|Adverse Event|1|||
130579168|NCT03529773|470085188|FG039|Overall Study|Adverse Event|1|||
130579169|NCT03529773|470085149|FG000|Overall Study|Death|0|||
130579170|NCT03529773|470085150|FG001|Overall Study|Death|0|||
130579171|NCT03529773|470085151|FG002|Overall Study|Death|0|||
130579172|NCT03529773|470085152|FG003|Overall Study|Death|0|||
130579173|NCT03529773|470085153|FG004|Overall Study|Death|0|||
130579174|NCT03529773|470085154|FG005|Overall Study|Death|0|||
130579175|NCT03529773|470085155|FG006|Overall Study|Death|0|||
130579176|NCT03529773|470085156|FG007|Overall Study|Death|0|||
130579177|NCT03529773|470085157|FG008|Overall Study|Death|0|||
130579178|NCT03529773|470085158|FG009|Overall Study|Death|0|||
130579179|NCT03529773|470085159|FG010|Overall Study|Death|0|||
130579180|NCT03529773|470085160|FG011|Overall Study|Death|0|||
130579181|NCT03529773|470085161|FG012|Overall Study|Death|1|||
130579182|NCT03529773|470085162|FG013|Overall Study|Death|0|||
130579183|NCT03529773|470085163|FG014|Overall Study|Death|0|||
130579184|NCT03529773|470085164|FG015|Overall Study|Death|0|||
130579185|NCT03529773|470085165|FG016|Overall Study|Death|0|||
130579186|NCT03529773|470085166|FG017|Overall Study|Death|0|||
130579187|NCT03529773|470085167|FG018|Overall Study|Death|0|||
130579188|NCT03529773|470085168|FG019|Overall Study|Death|1|||
130579189|NCT03529773|470085169|FG020|Overall Study|Death|0|||
130579190|NCT03529773|470085170|FG021|Overall Study|Death|0|||
130579191|NCT03529773|470085171|FG022|Overall Study|Death|1|||
130579192|NCT03529773|470085172|FG023|Overall Study|Death|0|||
130579193|NCT03529773|470085173|FG024|Overall Study|Death|0|||
130579194|NCT03529773|470085174|FG025|Overall Study|Death|0|||
130579195|NCT03529773|470085175|FG026|Overall Study|Death|0|||
130579196|NCT03529773|470085176|FG027|Overall Study|Death|0|||
130579197|NCT03529773|470085177|FG028|Overall Study|Death|0|||
130579198|NCT03529773|470085178|FG029|Overall Study|Death|0|||
130579199|NCT03529773|470085179|FG030|Overall Study|Death|0|||
130579200|NCT03529773|470085180|FG031|Overall Study|Death|0|||
130579201|NCT03529773|470085181|FG032|Overall Study|Death|0|||
130579202|NCT03529773|470085182|FG033|Overall Study|Death|1|||
130579203|NCT03529773|470085183|FG034|Overall Study|Death|1|||
130579204|NCT03529773|470085184|FG035|Overall Study|Death|0|||
130579205|NCT03529773|470085185|FG036|Overall Study|Death|1|||
130579206|NCT03529773|470085186|FG037|Overall Study|Death|0|||
130579207|NCT03529773|470085187|FG038|Overall Study|Death|0|||
130579208|NCT03529773|470085188|FG039|Overall Study|Death|0|||
130579209|NCT03529773|470085149|FG000|Overall Study|Lost to Follow-up|0|||
130579210|NCT03529773|470085150|FG001|Overall Study|Lost to Follow-up|0|||
130579211|NCT03529773|470085151|FG002|Overall Study|Lost to Follow-up|1|||
130579212|NCT03529773|470085152|FG003|Overall Study|Lost to Follow-up|0|||
130579213|NCT03529773|470085153|FG004|Overall Study|Lost to Follow-up|1|||
130579214|NCT03529773|470085154|FG005|Overall Study|Lost to Follow-up|1|||
130579215|NCT03529773|470085155|FG006|Overall Study|Lost to Follow-up|0|||
130579216|NCT03529773|470085156|FG007|Overall Study|Lost to Follow-up|0|||
130579217|NCT03529773|470085157|FG008|Overall Study|Lost to Follow-up|0|||
130579218|NCT03529773|470085158|FG009|Overall Study|Lost to Follow-up|0|||
130579219|NCT03529773|470085159|FG010|Overall Study|Lost to Follow-up|0|||
130579220|NCT03529773|470085160|FG011|Overall Study|Lost to Follow-up|0|||
130579221|NCT03529773|470085161|FG012|Overall Study|Lost to Follow-up|0|||
130579222|NCT03529773|470085162|FG013|Overall Study|Lost to Follow-up|1|||
130579223|NCT03529773|470085163|FG014|Overall Study|Lost to Follow-up|4|||
130579224|NCT03529773|470085164|FG015|Overall Study|Lost to Follow-up|1|||
130579225|NCT03529773|470085165|FG016|Overall Study|Lost to Follow-up|1|||
130579226|NCT03529773|470085166|FG017|Overall Study|Lost to Follow-up|0|||
130579227|NCT03529773|470085167|FG018|Overall Study|Lost to Follow-up|1|||
130579228|NCT03529773|470085168|FG019|Overall Study|Lost to Follow-up|1|||
130579229|NCT03529773|470085169|FG020|Overall Study|Lost to Follow-up|2|||
130579230|NCT03529773|470085170|FG021|Overall Study|Lost to Follow-up|4|||
130579231|NCT03529773|470085171|FG022|Overall Study|Lost to Follow-up|3|||
130579232|NCT03529773|470085172|FG023|Overall Study|Lost to Follow-up|4|||
130579233|NCT03529773|470085173|FG024|Overall Study|Lost to Follow-up|3|||
130579234|NCT03529773|470085174|FG025|Overall Study|Lost to Follow-up|5|||
130579235|NCT03529773|470085175|FG026|Overall Study|Lost to Follow-up|5|||
130579236|NCT03529773|470085176|FG027|Overall Study|Lost to Follow-up|0|||
130579237|NCT03529773|470085177|FG028|Overall Study|Lost to Follow-up|0|||
130579238|NCT03529773|470085178|FG029|Overall Study|Lost to Follow-up|0|||
130579239|NCT03529773|470085179|FG030|Overall Study|Lost to Follow-up|1|||
130579240|NCT03529773|470085180|FG031|Overall Study|Lost to Follow-up|0|||
130579241|NCT03529773|470085181|FG032|Overall Study|Lost to Follow-up|0|||
130579242|NCT03529773|470085182|FG033|Overall Study|Lost to Follow-up|1|||
130579243|NCT03529773|470085183|FG034|Overall Study|Lost to Follow-up|1|||
130579244|NCT03529773|470085184|FG035|Overall Study|Lost to Follow-up|0|||
130579245|NCT03529773|470085185|FG036|Overall Study|Lost to Follow-up|0|||
130579246|NCT03529773|470085186|FG037|Overall Study|Lost to Follow-up|3|||
130579247|NCT03529773|470085187|FG038|Overall Study|Lost to Follow-up|1|||
130579248|NCT03529773|470085188|FG039|Overall Study|Lost to Follow-up|1|||
130531001|NCT05000216|469911620|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
130531002|NCT05000216|469911621|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
130531003|NCT05000216|469911622|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
130531004|NCT05000216|469911623|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
130531005|NCT05000216|469911624|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
130531006|NCT05000216|469911625|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
130531007|NCT05000216|469911626|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
130531008|NCT05000216|469911627|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
130531009|NCT05000216|469911628|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
130531010|NCT05000216|469911629|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
130531011|NCT05000216|469911630|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
130531012|NCT05000216|469911631|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
130531013|NCT05000216|469911632|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
130531014|NCT05000216|469911633|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
130531015|NCT05000216|469911634|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
130531016|NCT05000216|469911635|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
130531017|NCT05000216|469911636|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
130531018|NCT05000216|469911615|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531019|NCT05000216|469911616|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531020|NCT05000216|469911617|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531021|NCT05000216|469911618|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531022|NCT05000216|469911619|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531023|NCT05000216|469911620|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531024|NCT05000216|469911621|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531025|NCT05000216|469911622|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531026|NCT05000216|469911623|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531027|NCT05000216|469911624|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531028|NCT05000216|469911625|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531029|NCT05000216|469911626|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531030|NCT05000216|469911627|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531031|NCT05000216|469911628|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531032|NCT05000216|469911629|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531033|NCT05000216|469911630|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
130531034|NCT05000216|469911631|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531035|NCT05000216|469911632|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531036|NCT05000216|469911633|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531037|NCT05000216|469911634|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531038|NCT05000216|469911635|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531039|NCT05000216|469911636|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
130531040|NCT05000216|469911615|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531041|NCT05000216|469911616|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531042|NCT05000216|469911617|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531043|NCT05000216|469911618|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531044|NCT05000216|469911619|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531045|NCT05000216|469911620|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531046|NCT05000216|469911621|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531047|NCT05000216|469911622|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531048|NCT05000216|469911623|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531049|NCT05000216|469911624|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531050|NCT05000216|469911625|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531051|NCT05000216|469911626|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531052|NCT05000216|469911627|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531053|NCT05000216|469911628|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
130531054|NCT05000216|469911629|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531055|NCT05000216|469911630|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
130531056|NCT05000216|469911631|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531057|NCT05000216|469911632|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531058|NCT05000216|469911633|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
130531059|NCT05000216|469911634|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531060|NCT05000216|469911635|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531061|NCT05000216|469911636|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
130531062|NCT02057575|469911638|FG000|Overall Study|Adverse Event|0|||
130531063|NCT02057575|469911639|FG001|Overall Study|Adverse Event|2|||
130531064|NCT02057575|469911640|FG002|Overall Study|Adverse Event|0|||
130531065|NCT02057575|469911641|FG003|Overall Study|Adverse Event|1|||
130531066|NCT02057575|469911638|FG000|Overall Study|Withdrawal by Subject|1|||
130531067|NCT02057575|469911639|FG001|Overall Study|Withdrawal by Subject|0|||
130531068|NCT02057575|469911640|FG002|Overall Study|Withdrawal by Subject|0|||
130531069|NCT02057575|469911641|FG003|Overall Study|Withdrawal by Subject|0|||
130531070|NCT02057575|469911638|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
130579249|NCT03529773|470085149|FG000|Overall Study|No longer meets eligibility criteria|0|||
130579250|NCT03529773|470085150|FG001|Overall Study|No longer meets eligibility criteria|0|||
130579251|NCT03529773|470085151|FG002|Overall Study|No longer meets eligibility criteria|0|||
130579252|NCT03529773|470085152|FG003|Overall Study|No longer meets eligibility criteria|0|||
130579253|NCT03529773|470085153|FG004|Overall Study|No longer meets eligibility criteria|0|||
130579254|NCT03529773|470085154|FG005|Overall Study|No longer meets eligibility criteria|0|||
130579255|NCT03529773|470085155|FG006|Overall Study|No longer meets eligibility criteria|0|||
130579256|NCT03529773|470085156|FG007|Overall Study|No longer meets eligibility criteria|0|||
130579257|NCT03529773|470085157|FG008|Overall Study|No longer meets eligibility criteria|0|||
130579258|NCT03529773|470085158|FG009|Overall Study|No longer meets eligibility criteria|0|||
130579259|NCT03529773|470085159|FG010|Overall Study|No longer meets eligibility criteria|0|||
130579260|NCT03529773|470085160|FG011|Overall Study|No longer meets eligibility criteria|0|||
130579261|NCT03529773|470085161|FG012|Overall Study|No longer meets eligibility criteria|0|||
130579262|NCT03529773|470085162|FG013|Overall Study|No longer meets eligibility criteria|0|||
130579263|NCT03529773|470085163|FG014|Overall Study|No longer meets eligibility criteria|0|||
130579264|NCT03529773|470085164|FG015|Overall Study|No longer meets eligibility criteria|0|||
130579265|NCT03529773|470085165|FG016|Overall Study|No longer meets eligibility criteria|0|||
130579266|NCT03529773|470085166|FG017|Overall Study|No longer meets eligibility criteria|0|||
130579267|NCT03529773|470085167|FG018|Overall Study|No longer meets eligibility criteria|0|||
130579268|NCT03529773|470085168|FG019|Overall Study|No longer meets eligibility criteria|0|||
130579269|NCT03529773|470085169|FG020|Overall Study|No longer meets eligibility criteria|0|||
130579270|NCT03529773|470085170|FG021|Overall Study|No longer meets eligibility criteria|0|||
130579271|NCT03529773|470085171|FG022|Overall Study|No longer meets eligibility criteria|1|||
130579272|NCT03529773|470085172|FG023|Overall Study|No longer meets eligibility criteria|0|||
130579273|NCT03529773|470085173|FG024|Overall Study|No longer meets eligibility criteria|0|||
130579274|NCT03529773|470085174|FG025|Overall Study|No longer meets eligibility criteria|0|||
130579275|NCT03529773|470085175|FG026|Overall Study|No longer meets eligibility criteria|0|||
130579276|NCT03529773|470085176|FG027|Overall Study|No longer meets eligibility criteria|0|||
130579277|NCT03529773|470085177|FG028|Overall Study|No longer meets eligibility criteria|0|||
130579278|NCT03529773|470085178|FG029|Overall Study|No longer meets eligibility criteria|0|||
130579279|NCT03529773|470085179|FG030|Overall Study|No longer meets eligibility criteria|0|||
130579280|NCT03529773|470085180|FG031|Overall Study|No longer meets eligibility criteria|0|||
130579281|NCT03529773|470085181|FG032|Overall Study|No longer meets eligibility criteria|0|||
130579282|NCT03529773|470085182|FG033|Overall Study|No longer meets eligibility criteria|0|||
130579283|NCT03529773|470085183|FG034|Overall Study|No longer meets eligibility criteria|0|||
130579284|NCT03529773|470085184|FG035|Overall Study|No longer meets eligibility criteria|0|||
130579285|NCT03529773|470085185|FG036|Overall Study|No longer meets eligibility criteria|0|||
130579286|NCT03529773|470085186|FG037|Overall Study|No longer meets eligibility criteria|0|||
130579287|NCT03529773|470085187|FG038|Overall Study|No longer meets eligibility criteria|1|||
130579288|NCT03529773|470085188|FG039|Overall Study|No longer meets eligibility criteria|0|||
130579289|NCT03529773|470085149|FG000|Overall Study|Other|0|||
130579290|NCT03529773|470085150|FG001|Overall Study|Other|0|||
130579291|NCT03529773|470085151|FG002|Overall Study|Other|0|||
130579292|NCT03529773|470085152|FG003|Overall Study|Other|0|||
130579293|NCT03529773|470085153|FG004|Overall Study|Other|0|||
130579294|NCT03529773|470085154|FG005|Overall Study|Other|0|||
130579295|NCT03529773|470085155|FG006|Overall Study|Other|0|||
130531071|NCT02057575|469911639|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
130531072|NCT02057575|469911640|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
130531073|NCT02057575|469911641|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
130531074|NCT02057575|469911638|FG000|Overall Study|Protocol Violation|0|||
130531075|NCT02057575|469911639|FG001|Overall Study|Protocol Violation|1|||
130531076|NCT02057575|469911640|FG002|Overall Study|Protocol Violation|0|||
130531077|NCT02057575|469911641|FG003|Overall Study|Protocol Violation|0|||
130531078|NCT00332462|469911642|FG000|Overall Study|Adverse Event|5|||
130531079|NCT00332462|469911642|FG000|Overall Study|Abnormal Lab Value|1|||
130531080|NCT00332462|469911642|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130531081|NCT00332462|469911642|FG000|Overall Study|no longer requires study drug|1|||
130531082|NCT00332462|469911642|FG000|Overall Study|Death|3|||
130531083|NCT00332462|469911642|FG000|Overall Study|Graft Loss|2|||
130531084|NCT01643044|469911643|FG000|Overall Study|Lost to Follow-up|1|||
130531085|NCT01643044|469911644|FG001|Overall Study|Lost to Follow-up|1|||
130531086|NCT01643044|469911643|FG000|Overall Study|Miscarried baby|2|||
130531087|NCT01643044|469911644|FG001|Overall Study|Miscarried baby|2|||
130531088|NCT01643044|469911643|FG000|Overall Study|Delivered outside of hospital|1|||
130579296|NCT03529773|470085156|FG007|Overall Study|Other|0|||
130579297|NCT03529773|470085157|FG008|Overall Study|Other|0|||
130579298|NCT03529773|470085158|FG009|Overall Study|Other|0|||
130579299|NCT03529773|470085159|FG010|Overall Study|Other|0|||
130579300|NCT03529773|470085160|FG011|Overall Study|Other|0|||
130579301|NCT03529773|470085161|FG012|Overall Study|Other|1|||
130579302|NCT03529773|470085162|FG013|Overall Study|Other|0|||
130579303|NCT03529773|470085163|FG014|Overall Study|Other|2|||
130579304|NCT03529773|470085164|FG015|Overall Study|Other|0|||
130579305|NCT03529773|470085165|FG016|Overall Study|Other|0|||
130579306|NCT03529773|470085166|FG017|Overall Study|Other|3|||
130579307|NCT03529773|470085167|FG018|Overall Study|Other|0|||
130579308|NCT03529773|470085168|FG019|Overall Study|Other|0|||
130579309|NCT03529773|470085169|FG020|Overall Study|Other|1|||
130579310|NCT03529773|470085170|FG021|Overall Study|Other|0|||
130579311|NCT03529773|470085171|FG022|Overall Study|Other|1|||
130579312|NCT03529773|470085172|FG023|Overall Study|Other|0|||
130579313|NCT03529773|470085173|FG024|Overall Study|Other|3|||
130579314|NCT03529773|470085174|FG025|Overall Study|Other|2|||
130579315|NCT03529773|470085175|FG026|Overall Study|Other|2|||
130579316|NCT03529773|470085176|FG027|Overall Study|Other|0|||
130579317|NCT03529773|470085177|FG028|Overall Study|Other|0|||
130579318|NCT03529773|470085178|FG029|Overall Study|Other|0|||
130579319|NCT03529773|470085179|FG030|Overall Study|Other|0|||
130579320|NCT03529773|470085180|FG031|Overall Study|Other|0|||
130579321|NCT03529773|470085181|FG032|Overall Study|Other|0|||
130579322|NCT03529773|470085182|FG033|Overall Study|Other|0|||
130579323|NCT03529773|470085183|FG034|Overall Study|Other|1|||
130579324|NCT03529773|470085184|FG035|Overall Study|Other|1|||
130579325|NCT03529773|470085185|FG036|Overall Study|Other|0|||
130579326|NCT03529773|470085186|FG037|Overall Study|Other|0|||
130579327|NCT03529773|470085187|FG038|Overall Study|Other|0|||
130579328|NCT03529773|470085188|FG039|Overall Study|Other|0|||
130579329|NCT03529773|470085149|FG000|Overall Study|Physician Decision|0|||
130579330|NCT03529773|470085150|FG001|Overall Study|Physician Decision|0|||
130579331|NCT03529773|470085151|FG002|Overall Study|Physician Decision|0|||
130579332|NCT03529773|470085152|FG003|Overall Study|Physician Decision|0|||
130579333|NCT03529773|470085153|FG004|Overall Study|Physician Decision|0|||
130579334|NCT03529773|470085154|FG005|Overall Study|Physician Decision|0|||
130579335|NCT03529773|470085155|FG006|Overall Study|Physician Decision|0|||
130579336|NCT03529773|470085156|FG007|Overall Study|Physician Decision|0|||
130531089|NCT01643044|469911644|FG001|Overall Study|Delivered outside of hospital|2|||
130531090|NCT01735175|469911645|FG000|Overall Study|Withdrawal by Subject|9|||
130531091|NCT01735175|469911646|FG001|Overall Study|Withdrawal by Subject|2|||
130531092|NCT01735175|469911645|FG000|Overall Study|Lost to Follow-up|4|||
130531093|NCT01735175|469911646|FG001|Overall Study|Lost to Follow-up|2|||
130531094|NCT01735175|469911645|FG000|Overall Study|Death|3|||
130531095|NCT01735175|469911646|FG001|Overall Study|Death|2|||
130531096|NCT01735175|469911645|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
130531097|NCT01735175|469911646|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
130531098|NCT00659880|469911647|FG000|Overall Study|Lost to Follow-up|5|||
130531099|NCT01886287|469911648|FG000|Overall Study|Radiographic disease progression|1|||
130531100|NCT01886287|469911648|FG000|Overall Study|Clinical progression due to disease|1|||
130531101|NCT01031628|469911649|FG000|Overall Study|Study terminated early|0|||
130531102|NCT01031628|469911650|FG001|Overall Study|Study terminated early|1|||
130531103|NCT01031628|469911651|FG002|Overall Study|Study terminated early|3|||
130531104|NCT01031628|469911652|FG003|Overall Study|Study terminated early|0|||
130531105|NCT01266161|469911656|FG000|Overall Study|Ineligible|1|||
130531106|NCT01266161|469911657|FG001|Overall Study|Ineligible|0|||
130531107|NCT01266161|469911656|FG000|Overall Study|Lack of Efficacy|0|||
130531108|NCT01266161|469911657|FG001|Overall Study|Lack of Efficacy|1|||
130531109|NCT01266161|469911656|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
130531110|NCT01266161|469911657|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
130531111|NCT02990468|469911658|FG000|Phase 2: MTD|Change in treatment|0|||
130531112|NCT02990468|469911659|FG001|Phase 2: MTD|Change in treatment|0|||
130531113|NCT02990468|469911660|FG002|Phase 2: MTD|Change in treatment|1|||
130531114|NCT01436305|469911662|FG000|Overall Study|Death|1|||
130531115|NCT01436305|469911663|FG001|Overall Study|Death|0|||
130531116|NCT01436305|469911664|FG002|Overall Study|Death|0|||
130531117|NCT01436305|469911662|FG000|Overall Study|Lost to Follow-up|0|||
130531118|NCT01436305|469911663|FG001|Overall Study|Lost to Follow-up|1|||
130531119|NCT01436305|469911664|FG002|Overall Study|Lost to Follow-up|0|||
130531120|NCT01436305|469911662|FG000|Overall Study|Withdrawal by Subject|1|||
130579337|NCT03529773|470085157|FG008|Overall Study|Physician Decision|0|||
130579338|NCT03529773|470085158|FG009|Overall Study|Physician Decision|0|||
130579339|NCT03529773|470085159|FG010|Overall Study|Physician Decision|0|||
130579340|NCT03529773|470085160|FG011|Overall Study|Physician Decision|0|||
130579341|NCT03529773|470085161|FG012|Overall Study|Physician Decision|0|||
130579342|NCT03529773|470085162|FG013|Overall Study|Physician Decision|0|||
130579343|NCT03529773|470085163|FG014|Overall Study|Physician Decision|0|||
130579344|NCT03529773|470085164|FG015|Overall Study|Physician Decision|0|||
130531121|NCT01436305|469911663|FG001|Overall Study|Withdrawal by Subject|3|||
130531122|NCT01436305|469911664|FG002|Overall Study|Withdrawal by Subject|0|||
130531123|NCT03128671|469911667|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
130531124|NCT03128671|469911668|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
130531125|NCT03128671|469911667|FG000|Allocation|Death|1|||
130531126|NCT03128671|469911668|FG001|Allocation|Death|0|||
130531127|NCT03128671|469911667|FG000|Allocation|Withdrawal by Subject|4|||
130531128|NCT03128671|469911668|FG001|Allocation|Withdrawal by Subject|0|||
130531129|NCT03128671|469911667|FG000|Intervention|Withdrawal by Subject|11|||
130531130|NCT03128671|469911668|FG001|Intervention|Withdrawal by Subject|10|||
130531131|NCT03128671|469911667|FG000|Intervention|Palliative/hospice care initiated|9|||
130531132|NCT03128671|469911668|FG001|Intervention|Palliative/hospice care initiated|10|||
130531133|NCT03128671|469911667|FG000|Intervention|Death|13|||
130531134|NCT03128671|469911668|FG001|Intervention|Death|11|||
130531135|NCT03128671|469911667|FG000|Intervention|Interrupted by hurricane|1|||
130531136|NCT03128671|469911668|FG001|Intervention|Interrupted by hurricane|0|||
130531137|NCT03128671|469911667|FG000|Intervention|Physician Decision|2|||
130531138|NCT03128671|469911668|FG001|Intervention|Physician Decision|3|||
130531139|NCT04463680|469911669|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
130531140|NCT04463680|469911669|FG000|Overall Study|Not eligible due to implant duration of use|1|||
130531141|NCT04463680|469911669|FG000|Overall Study|Withdrawal by Subject|3|||
130531142|NCT05239598|469911672|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
130531143|NCT05239598|469911673|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
130531144|NCT05239598|469911672|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
130531145|NCT05239598|469911673|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
130531146|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Adverse Event|10|||
130531147|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Adverse Event|9|||
130531148|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Adverse Event|7|||
130531149|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
130531150|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
130531151|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
130531152|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
130531153|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
130531154|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
130531155|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Physician Decision|7|||
130531156|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Physician Decision|3|||
130531157|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Physician Decision|2|||
130531158|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Pregnancy|2|||
130531159|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Pregnancy|1|||
130531160|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Pregnancy|3|||
130531161|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
130531162|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
130531163|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
130531164|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
130531165|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
130531166|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
130531167|NCT02614183|469911678|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
130531168|NCT02614183|469911679|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
130531169|NCT02614183|469911680|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
130531170|NCT02614183|469911678|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
130531171|NCT02614183|469911679|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130531172|NCT02614183|469911680|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
130531173|NCT02614183|469911678|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
130531174|NCT02614183|469911679|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
130531175|NCT02614183|469911680|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
130531176|NCT02614183|469911678|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
130531177|NCT02614183|469911679|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
130531178|NCT02614183|469911680|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
130531179|NCT02614183|469911678|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
130531180|NCT02614183|469911679|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
130531181|NCT02614183|469911680|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
130531182|NCT04991753|469912963|FG000|Overall Study|Withdrawal by Subject|0|||
130531183|NCT04991753|469912964|FG001|Overall Study|Withdrawal by Subject|1|||
130531184|NCT03299049|469912965|FG000|Overall Study|On-going|486|||
130531185|NCT03299049|469912966|FG001|Overall Study|On-going|481|||
130531186|NCT03299049|469912965|FG000|Overall Study|Withdrawal by Subject|6|||
130531187|NCT03299049|469912966|FG001|Overall Study|Withdrawal by Subject|21|||
130531188|NCT03299049|469912965|FG000|Overall Study|Physician Decision|5|||
130531189|NCT03299049|469912966|FG001|Overall Study|Physician Decision|1|||
130531190|NCT03299049|469912965|FG000|Overall Study|Lost to Follow-up|2|||
130531191|NCT03299049|469912966|FG001|Overall Study|Lost to Follow-up|0|||
130531192|NCT03299049|469912965|FG000|Overall Study|Pregnancy|1|||
130531193|NCT03299049|469912966|FG001|Overall Study|Pregnancy|3|||
130579345|NCT03529773|470085165|FG016|Overall Study|Physician Decision|0|||
130579346|NCT03529773|470085166|FG017|Overall Study|Physician Decision|0|||
130579347|NCT03529773|470085167|FG018|Overall Study|Physician Decision|0|||
130579348|NCT03529773|470085168|FG019|Overall Study|Physician Decision|1|||
130579349|NCT03529773|470085169|FG020|Overall Study|Physician Decision|1|||
130579350|NCT03529773|470085170|FG021|Overall Study|Physician Decision|0|||
130579351|NCT03529773|470085171|FG022|Overall Study|Physician Decision|0|||
130579352|NCT03529773|470085172|FG023|Overall Study|Physician Decision|0|||
130579353|NCT03529773|470085173|FG024|Overall Study|Physician Decision|0|||
130579354|NCT03529773|470085174|FG025|Overall Study|Physician Decision|0|||
130579355|NCT03529773|470085175|FG026|Overall Study|Physician Decision|0|||
130579356|NCT03529773|470085176|FG027|Overall Study|Physician Decision|0|||
130579357|NCT03529773|470085177|FG028|Overall Study|Physician Decision|0|||
130579358|NCT03529773|470085178|FG029|Overall Study|Physician Decision|0|||
130579359|NCT03529773|470085179|FG030|Overall Study|Physician Decision|0|||
130579360|NCT03529773|470085180|FG031|Overall Study|Physician Decision|0|||
130579361|NCT03529773|470085181|FG032|Overall Study|Physician Decision|0|||
130579362|NCT03529773|470085182|FG033|Overall Study|Physician Decision|0|||
130579363|NCT03529773|470085183|FG034|Overall Study|Physician Decision|0|||
130579364|NCT03529773|470085184|FG035|Overall Study|Physician Decision|0|||
130579365|NCT03529773|470085185|FG036|Overall Study|Physician Decision|0|||
130579366|NCT03529773|470085186|FG037|Overall Study|Physician Decision|0|||
130579367|NCT03529773|470085187|FG038|Overall Study|Physician Decision|0|||
130579368|NCT03529773|470085188|FG039|Overall Study|Physician Decision|0|||
130579369|NCT03529773|470085149|FG000|Overall Study|Protocol Violation|0|||
130579370|NCT03529773|470085150|FG001|Overall Study|Protocol Violation|0|||
130579371|NCT03529773|470085151|FG002|Overall Study|Protocol Violation|0|||
130579372|NCT03529773|470085152|FG003|Overall Study|Protocol Violation|0|||
130579373|NCT03529773|470085153|FG004|Overall Study|Protocol Violation|0|||
130579374|NCT03529773|470085154|FG005|Overall Study|Protocol Violation|0|||
130579375|NCT03529773|470085155|FG006|Overall Study|Protocol Violation|0|||
130579376|NCT03529773|470085156|FG007|Overall Study|Protocol Violation|0|||
130579377|NCT03529773|470085157|FG008|Overall Study|Protocol Violation|0|||
130579378|NCT03529773|470085158|FG009|Overall Study|Protocol Violation|0|||
130579379|NCT03529773|470085159|FG010|Overall Study|Protocol Violation|0|||
130579380|NCT03529773|470085160|FG011|Overall Study|Protocol Violation|0|||
130579381|NCT03529773|470085161|FG012|Overall Study|Protocol Violation|0|||
130579382|NCT03529773|470085162|FG013|Overall Study|Protocol Violation|0|||
130579383|NCT03529773|470085163|FG014|Overall Study|Protocol Violation|0|||
130579384|NCT03529773|470085164|FG015|Overall Study|Protocol Violation|0|||
130579385|NCT03529773|470085165|FG016|Overall Study|Protocol Violation|0|||
130579386|NCT03529773|470085166|FG017|Overall Study|Protocol Violation|0|||
130579387|NCT03529773|470085167|FG018|Overall Study|Protocol Violation|0|||
130579388|NCT03529773|470085168|FG019|Overall Study|Protocol Violation|0|||
130579389|NCT03529773|470085169|FG020|Overall Study|Protocol Violation|0|||
130579390|NCT03529773|470085170|FG021|Overall Study|Protocol Violation|0|||
130579391|NCT03529773|470085171|FG022|Overall Study|Protocol Violation|0|||
130579392|NCT03529773|470085172|FG023|Overall Study|Protocol Violation|0|||
130579393|NCT03529773|470085173|FG024|Overall Study|Protocol Violation|0|||
130579394|NCT03529773|470085174|FG025|Overall Study|Protocol Violation|0|||
130579395|NCT03529773|470085175|FG026|Overall Study|Protocol Violation|0|||
130579396|NCT03529773|470085176|FG027|Overall Study|Protocol Violation|0|||
130579397|NCT03529773|470085177|FG028|Overall Study|Protocol Violation|0|||
130579398|NCT03529773|470085178|FG029|Overall Study|Protocol Violation|0|||
130579399|NCT03529773|470085179|FG030|Overall Study|Protocol Violation|1|||
130579400|NCT03529773|470085180|FG031|Overall Study|Protocol Violation|0|||
130579401|NCT03529773|470085181|FG032|Overall Study|Protocol Violation|0|||
130579402|NCT03529773|470085182|FG033|Overall Study|Protocol Violation|0|||
130579403|NCT03529773|470085183|FG034|Overall Study|Protocol Violation|0|||
130579404|NCT03529773|470085184|FG035|Overall Study|Protocol Violation|0|||
130579405|NCT03529773|470085185|FG036|Overall Study|Protocol Violation|0|||
130579406|NCT03529773|470085186|FG037|Overall Study|Protocol Violation|0|||
130579407|NCT03529773|470085187|FG038|Overall Study|Protocol Violation|0|||
130579408|NCT03529773|470085188|FG039|Overall Study|Protocol Violation|0|||
130579409|NCT03529773|470085149|FG000|Overall Study|Withdrawal by Subject|0|||
130579410|NCT03529773|470085150|FG001|Overall Study|Withdrawal by Subject|0|||
130579411|NCT03529773|470085151|FG002|Overall Study|Withdrawal by Subject|0|||
130579412|NCT03529773|470085152|FG003|Overall Study|Withdrawal by Subject|0|||
130579413|NCT03529773|470085153|FG004|Overall Study|Withdrawal by Subject|0|||
130579414|NCT03529773|470085154|FG005|Overall Study|Withdrawal by Subject|0|||
130579415|NCT03529773|470085155|FG006|Overall Study|Withdrawal by Subject|0|||
130579416|NCT03529773|470085156|FG007|Overall Study|Withdrawal by Subject|1|||
130579417|NCT03529773|470085157|FG008|Overall Study|Withdrawal by Subject|0|||
130579418|NCT03529773|470085158|FG009|Overall Study|Withdrawal by Subject|1|||
130579419|NCT03529773|470085159|FG010|Overall Study|Withdrawal by Subject|1|||
130579420|NCT03529773|470085160|FG011|Overall Study|Withdrawal by Subject|0|||
130579421|NCT03529773|470085161|FG012|Overall Study|Withdrawal by Subject|0|||
130579422|NCT03529773|470085162|FG013|Overall Study|Withdrawal by Subject|0|||
130579423|NCT03529773|470085163|FG014|Overall Study|Withdrawal by Subject|0|||
130579424|NCT03529773|470085164|FG015|Overall Study|Withdrawal by Subject|3|||
130579425|NCT03529773|470085165|FG016|Overall Study|Withdrawal by Subject|0|||
130579426|NCT03529773|470085166|FG017|Overall Study|Withdrawal by Subject|2|||
130579427|NCT03529773|470085167|FG018|Overall Study|Withdrawal by Subject|3|||
130579428|NCT03529773|470085168|FG019|Overall Study|Withdrawal by Subject|1|||
130579429|NCT03529773|470085169|FG020|Overall Study|Withdrawal by Subject|3|||
130579430|NCT03529773|470085170|FG021|Overall Study|Withdrawal by Subject|1|||
130579431|NCT03529773|470085171|FG022|Overall Study|Withdrawal by Subject|1|||
130579432|NCT03529773|470085172|FG023|Overall Study|Withdrawal by Subject|2|||
130579433|NCT03529773|470085173|FG024|Overall Study|Withdrawal by Subject|2|||
130579434|NCT03529773|470085174|FG025|Overall Study|Withdrawal by Subject|4|||
130579435|NCT03529773|470085175|FG026|Overall Study|Withdrawal by Subject|2|||
130579436|NCT03529773|470085176|FG027|Overall Study|Withdrawal by Subject|1|||
130579437|NCT03529773|470085177|FG028|Overall Study|Withdrawal by Subject|1|||
130579438|NCT03529773|470085178|FG029|Overall Study|Withdrawal by Subject|0|||
130579439|NCT03529773|470085179|FG030|Overall Study|Withdrawal by Subject|0|||
130579440|NCT03529773|470085180|FG031|Overall Study|Withdrawal by Subject|0|||
130579441|NCT03529773|470085181|FG032|Overall Study|Withdrawal by Subject|0|||
130579442|NCT03529773|470085182|FG033|Overall Study|Withdrawal by Subject|0|||
130579443|NCT03529773|470085183|FG034|Overall Study|Withdrawal by Subject|1|||
130579444|NCT03529773|470085184|FG035|Overall Study|Withdrawal by Subject|2|||
130579445|NCT03529773|470085185|FG036|Overall Study|Withdrawal by Subject|0|||
130579446|NCT03529773|470085186|FG037|Overall Study|Withdrawal by Subject|2|||
130579447|NCT03529773|470085187|FG038|Overall Study|Withdrawal by Subject|1|||
130579448|NCT03529773|470085188|FG039|Overall Study|Withdrawal by Subject|1|||
130579449|NCT03529773|470085149|FG000|Overall Study|Screen Failure|0|||
130579450|NCT03529773|470085150|FG001|Overall Study|Screen Failure|0|||
130579451|NCT03529773|470085151|FG002|Overall Study|Screen Failure|0|||
130579452|NCT03529773|470085152|FG003|Overall Study|Screen Failure|0|||
130579453|NCT03529773|470085153|FG004|Overall Study|Screen Failure|0|||
130579454|NCT03529773|470085154|FG005|Overall Study|Screen Failure|0|||
130579455|NCT03529773|470085155|FG006|Overall Study|Screen Failure|0|||
130579456|NCT03529773|470085156|FG007|Overall Study|Screen Failure|0|||
130579457|NCT03529773|470085157|FG008|Overall Study|Screen Failure|0|||
130579458|NCT03529773|470085158|FG009|Overall Study|Screen Failure|0|||
130579459|NCT03529773|470085159|FG010|Overall Study|Screen Failure|0|||
130579460|NCT03529773|470085160|FG011|Overall Study|Screen Failure|0|||
130579461|NCT03529773|470085161|FG012|Overall Study|Screen Failure|0|||
130579462|NCT03529773|470085162|FG013|Overall Study|Screen Failure|0|||
130579463|NCT03529773|470085163|FG014|Overall Study|Screen Failure|0|||
130579464|NCT03529773|470085164|FG015|Overall Study|Screen Failure|0|||
130579465|NCT03529773|470085165|FG016|Overall Study|Screen Failure|0|||
130579466|NCT03529773|470085166|FG017|Overall Study|Screen Failure|0|||
130579467|NCT03529773|470085167|FG018|Overall Study|Screen Failure|0|||
130579468|NCT03529773|470085168|FG019|Overall Study|Screen Failure|0|||
130579469|NCT03529773|470085169|FG020|Overall Study|Screen Failure|0|||
130579470|NCT03529773|470085170|FG021|Overall Study|Screen Failure|0|||
130579471|NCT03529773|470085171|FG022|Overall Study|Screen Failure|0|||
130579472|NCT03529773|470085172|FG023|Overall Study|Screen Failure|0|||
130579473|NCT03529773|470085173|FG024|Overall Study|Screen Failure|0|||
130579474|NCT03529773|470085174|FG025|Overall Study|Screen Failure|0|||
130579475|NCT03529773|470085175|FG026|Overall Study|Screen Failure|0|||
130579476|NCT03529773|470085176|FG027|Overall Study|Screen Failure|0|||
130579477|NCT03529773|470085177|FG028|Overall Study|Screen Failure|0|||
130579478|NCT03529773|470085178|FG029|Overall Study|Screen Failure|0|||
130579479|NCT03529773|470085179|FG030|Overall Study|Screen Failure|0|||
130579480|NCT03529773|470085180|FG031|Overall Study|Screen Failure|0|||
130579481|NCT03529773|470085181|FG032|Overall Study|Screen Failure|0|||
130579482|NCT03529773|470085182|FG033|Overall Study|Screen Failure|0|||
130579483|NCT03529773|470085183|FG034|Overall Study|Screen Failure|0|||
130579484|NCT03529773|470085184|FG035|Overall Study|Screen Failure|0|||
130579485|NCT03529773|470085185|FG036|Overall Study|Screen Failure|1|||
130579486|NCT03529773|470085186|FG037|Overall Study|Screen Failure|1|||
130579487|NCT03529773|470085187|FG038|Overall Study|Screen Failure|0|||
130579488|NCT03529773|470085188|FG039|Overall Study|Screen Failure|1|||
130579489|NCT03529773|470085149|FG000|Overall Study|Randomized but not vaccinated|0|||
130579490|NCT03529773|470085150|FG001|Overall Study|Randomized but not vaccinated|0|||
130579491|NCT03529773|470085151|FG002|Overall Study|Randomized but not vaccinated|0|||
130579492|NCT03529773|470085152|FG003|Overall Study|Randomized but not vaccinated|0|||
130579493|NCT03529773|470085153|FG004|Overall Study|Randomized but not vaccinated|0|||
130579494|NCT03529773|470085154|FG005|Overall Study|Randomized but not vaccinated|0|||
130579495|NCT03529773|470085155|FG006|Overall Study|Randomized but not vaccinated|0|||
130579496|NCT03529773|470085156|FG007|Overall Study|Randomized but not vaccinated|0|||
130579497|NCT03529773|470085157|FG008|Overall Study|Randomized but not vaccinated|0|||
130579498|NCT03529773|470085158|FG009|Overall Study|Randomized but not vaccinated|0|||
130579499|NCT03529773|470085159|FG010|Overall Study|Randomized but not vaccinated|0|||
130579500|NCT03529773|470085160|FG011|Overall Study|Randomized but not vaccinated|0|||
130579501|NCT03529773|470085161|FG012|Overall Study|Randomized but not vaccinated|0|||
130531194|NCT03299049|469912965|FG000|Overall Study|Protocol Violation|1|||
130531195|NCT03299049|469912966|FG001|Overall Study|Protocol Violation|1|||
130531196|NCT03299049|469912965|FG000|Overall Study|Lack of Efficacy|9|||
130531197|NCT03299049|469912966|FG001|Overall Study|Lack of Efficacy|3|||
130531198|NCT03299049|469912965|FG000|Overall Study|Adverse Event|12|||
130531199|NCT03299049|469912966|FG001|Overall Study|Adverse Event|13|||
130531200|NCT01901419|469912967|FG000|Overall Study|Protocol Violation|2|||
130531201|NCT01901419|469912968|FG001|Overall Study|Protocol Violation|6|||
130531202|NCT01901419|469912967|FG000|Overall Study|unavailable researchers|6|||
130531203|NCT01901419|469912968|FG001|Overall Study|unavailable researchers|3|||
130531204|NCT01667926|469912973|FG000|Overall Study|Withdrawal by Subject|1|||
130531205|NCT01667926|469912974|FG001|Overall Study|Withdrawal by Subject|2|||
130531206|NCT01667926|469912975|FG002|Overall Study|Withdrawal by Subject|2|||
130531207|NCT01667926|469912973|FG000|Overall Study|Physician Decision|0|||
130531208|NCT01667926|469912974|FG001|Overall Study|Physician Decision|0|||
130531209|NCT01667926|469912975|FG002|Overall Study|Physician Decision|1|||
130531210|NCT01667926|469912973|FG000|Overall Study|Time committment|0|||
130531211|NCT01667926|469912974|FG001|Overall Study|Time committment|0|||
130531212|NCT01667926|469912975|FG002|Overall Study|Time committment|2|||
130531213|NCT01667926|469912973|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
130531214|NCT01667926|469912974|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
130531215|NCT01667926|469912975|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
130531216|NCT01667926|469912973|FG000|Overall Study|Lost to Follow-up|1|||
130531217|NCT01667926|469912974|FG001|Overall Study|Lost to Follow-up|2|||
130531218|NCT01667926|469912975|FG002|Overall Study|Lost to Follow-up|1|||
130531219|NCT01667926|469912973|FG000|Overall Study|Side effects|3|||
130531220|NCT01667926|469912974|FG001|Overall Study|Side effects|0|||
130531221|NCT01667926|469912975|FG002|Overall Study|Side effects|0|||
130531222|NCT02412735|469912976|FG000|Overall Study|Adverse Event|0|||
130531223|NCT02412735|469912977|FG001|Overall Study|Adverse Event|1|||
130531224|NCT02412735|469912978|FG002|Overall Study|Adverse Event|2|||
130531225|NCT02412735|469912976|FG000|Overall Study|Withdrawal by Subject|23|||
130531226|NCT02412735|469912977|FG001|Overall Study|Withdrawal by Subject|27|||
130531227|NCT02412735|469912978|FG002|Overall Study|Withdrawal by Subject|22|||
130531228|NCT02412735|469912976|FG000|Overall Study|Investigator Decision|3|||
130531229|NCT02412735|469912977|FG001|Overall Study|Investigator Decision|3|||
130531230|NCT02412735|469912978|FG002|Overall Study|Investigator Decision|2|||
130531231|NCT02412735|469912976|FG000|Overall Study|Lost to Follow-up|17|||
130531232|NCT02412735|469912977|FG001|Overall Study|Lost to Follow-up|11|||
130531233|NCT02412735|469912978|FG002|Overall Study|Lost to Follow-up|18|||
130531234|NCT02412735|469912976|FG000|Overall Study|Reason not Specified|3|||
130531235|NCT02412735|469912977|FG001|Overall Study|Reason not Specified|2|||
130531236|NCT02412735|469912978|FG002|Overall Study|Reason not Specified|2|||
130531237|NCT04043143|469912979|FG000|Overall Study|Lost to Follow-up|5|||
130531238|NCT04043143|469912980|FG001|Overall Study|Lost to Follow-up|5|||
130531239|NCT04043143|469912979|FG000|Overall Study|screen failure|1|||
130531240|NCT04043143|469912980|FG001|Overall Study|screen failure|0|||
130531241|NCT03480932|469912981|FG000|Overall Study|Death|1|||
130531242|NCT03480932|469912982|FG001|Overall Study|Death|1|||
130531243|NCT03480932|469912983|FG002|Overall Study|Death|0|||
130531244|NCT03480932|469912981|FG000|Overall Study|Lost to Follow-up|0|||
130531245|NCT03480932|469912982|FG001|Overall Study|Lost to Follow-up|2|||
130531246|NCT03480932|469912983|FG002|Overall Study|Lost to Follow-up|3|||
130531247|NCT03480932|469912981|FG000|Overall Study|Incarcerated|2|||
130531248|NCT03480932|469912982|FG001|Overall Study|Incarcerated|2|||
130531249|NCT03480932|469912983|FG002|Overall Study|Incarcerated|2|||
130531250|NCT04624243|469912984|FG000|Overall Study|Death|0|||
130531251|NCT04624243|469912985|FG001|Overall Study|Death|1|||
130531252|NCT04624243|469912986|FG002|Overall Study|Death|0|||
130531253|NCT04624243|469912987|FG003|Overall Study|Death|0|||
130531254|NCT04624243|469912988|FG004|Overall Study|Death|0|||
130531255|NCT04624243|469912984|FG000|Overall Study|Lost to Follow-up|2|||
130531256|NCT04624243|469912985|FG001|Overall Study|Lost to Follow-up|3|||
130531257|NCT04624243|469912986|FG002|Overall Study|Lost to Follow-up|7|||
130531258|NCT04624243|469912987|FG003|Overall Study|Lost to Follow-up|1|||
130531259|NCT04624243|469912988|FG004|Overall Study|Lost to Follow-up|3|||
130531260|NCT04624243|469912984|FG000|Overall Study|Physician Decision|3|||
130531261|NCT04624243|469912985|FG001|Overall Study|Physician Decision|8|||
130531262|NCT04624243|469912986|FG002|Overall Study|Physician Decision|15|||
130531263|NCT04624243|469912987|FG003|Overall Study|Physician Decision|2|||
130531264|NCT04624243|469912988|FG004|Overall Study|Physician Decision|11|||
130531265|NCT04624243|469912984|FG000|Overall Study|Withdrawal by Subject|19|||
130531266|NCT04624243|469912985|FG001|Overall Study|Withdrawal by Subject|44|||
130531267|NCT04624243|469912986|FG002|Overall Study|Withdrawal by Subject|40|||
130531268|NCT04624243|469912987|FG003|Overall Study|Withdrawal by Subject|21|||
130531269|NCT04624243|469912988|FG004|Overall Study|Withdrawal by Subject|39|||
130531270|NCT04624243|469912984|FG000|Overall Study|Miscellaneous|3|||
130531271|NCT04624243|469912985|FG001|Overall Study|Miscellaneous|12|||
130531272|NCT04624243|469912986|FG002|Overall Study|Miscellaneous|9|||
130531273|NCT04624243|469912987|FG003|Overall Study|Miscellaneous|4|||
130531274|NCT04624243|469912988|FG004|Overall Study|Miscellaneous|6|||
130531275|NCT01923662|469912989|FG000|Overall Study|Withdrawal by Subject|1|||
130531276|NCT01294397|469912990|FG000|Overall Study|Withdrawal by Subject|1|||
130531277|NCT01294397|469912990|FG000|Overall Study|Administrative Decision|1|||
130531278|NCT01939353|469912991|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
130531279|NCT01939353|469912991|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
130531280|NCT01939353|469912991|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
130531281|NCT01939353|469912991|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130531282|NCT01939353|469912991|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
130531283|NCT05048238|469912999|FG000|Overall Study|Withdrawal by Subject|1|||
130531284|NCT01602510|469913004|FG000|Open Label Phase|Adverse Event|46|||
130531285|NCT01602510|469913005|FG001|Open Label Phase|Adverse Event|0|||
130531286|NCT01602510|469913006|FG002|Open Label Phase|Adverse Event|0|||
130531287|NCT01602510|469913004|FG000|Open Label Phase|Lack of Efficacy|22|||
130531288|NCT01602510|469913005|FG001|Open Label Phase|Lack of Efficacy|0|||
130531289|NCT01602510|469913006|FG002|Open Label Phase|Lack of Efficacy|0|||
130531290|NCT01602510|469913004|FG000|Open Label Phase|Protocol Violation|15|||
130531291|NCT01602510|469913005|FG001|Open Label Phase|Protocol Violation|0|||
130531292|NCT01602510|469913006|FG002|Open Label Phase|Protocol Violation|0|||
130531293|NCT01602510|469913004|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
130531294|NCT01602510|469913005|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
130531295|NCT01602510|469913006|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
130531296|NCT01602510|469913004|FG000|Open Label Phase|Lost to Follow-up|22|||
130531297|NCT01602510|469913005|FG001|Open Label Phase|Lost to Follow-up|0|||
130531298|NCT01602510|469913006|FG002|Open Label Phase|Lost to Follow-up|0|||
130531299|NCT01602510|469913004|FG000|Open Label Phase|Physician Decision|19|||
130531300|NCT01602510|469913005|FG001|Open Label Phase|Physician Decision|0|||
130531301|NCT01602510|469913006|FG002|Open Label Phase|Physician Decision|0|||
130531302|NCT01602510|469913004|FG000|Open Label Phase|Withdrawal by Subject|57|||
130531303|NCT01602510|469913005|FG001|Open Label Phase|Withdrawal by Subject|0|||
130531304|NCT01602510|469913006|FG002|Open Label Phase|Withdrawal by Subject|0|||
130531305|NCT01602510|469913004|FG000|Randomized Phase|Adverse Event|0|||
130531306|NCT01602510|469913005|FG001|Randomized Phase|Adverse Event|2|||
130531307|NCT01602510|469913006|FG002|Randomized Phase|Adverse Event|6|||
130531308|NCT01602510|469913004|FG000|Randomized Phase|Lack of Efficacy|0|||
130531309|NCT01602510|469913005|FG001|Randomized Phase|Lack of Efficacy|4|||
130531310|NCT01602510|469913006|FG002|Randomized Phase|Lack of Efficacy|4|||
130531311|NCT01602510|469913004|FG000|Randomized Phase|Protocol Violation|0|||
130531312|NCT01602510|469913005|FG001|Randomized Phase|Protocol Violation|3|||
130531313|NCT01602510|469913006|FG002|Randomized Phase|Protocol Violation|3|||
130531314|NCT01602510|469913004|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
130531315|NCT01602510|469913005|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
130531316|NCT01602510|469913006|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
130531317|NCT01602510|469913004|FG000|Randomized Phase|Lost to Follow-up|0|||
130531318|NCT01602510|469913005|FG001|Randomized Phase|Lost to Follow-up|1|||
130531319|NCT01602510|469913006|FG002|Randomized Phase|Lost to Follow-up|3|||
130531320|NCT01602510|469913004|FG000|Randomized Phase|Physician Decision|0|||
130531321|NCT01602510|469913005|FG001|Randomized Phase|Physician Decision|0|||
130531322|NCT01602510|469913006|FG002|Randomized Phase|Physician Decision|2|||
130531323|NCT01602510|469913004|FG000|Randomized Phase|Withdrawal by Subject|0|||
130531324|NCT01602510|469913005|FG001|Randomized Phase|Withdrawal by Subject|6|||
130531325|NCT01602510|469913006|FG002|Randomized Phase|Withdrawal by Subject|7|||
130531326|NCT03519204|469913007|FG000|Overall Study|Lost to Follow-up|3|||
130531327|NCT03519204|469913008|FG001|Overall Study|Lost to Follow-up|8|||
130531328|NCT03519204|469913007|FG000|Overall Study|Withdrawal by Subject|9|||
130531329|NCT03519204|469913008|FG001|Overall Study|Withdrawal by Subject|7|||
130531330|NCT03519204|469913007|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130531331|NCT03519204|469913008|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130531332|NCT00600613|469913013|FG000|Overall Study|Protocol Deviation|1|||
130531333|NCT01509547|469913016|FG000|Overall Study|Lost to Follow-up|24|||
130531334|NCT01509547|469913017|FG001|Overall Study|Lost to Follow-up|14|||
130531335|NCT01509547|469913016|FG000|Overall Study|Withdrawal by Subject|11|||
130531336|NCT01509547|469913017|FG001|Overall Study|Withdrawal by Subject|24|||
130531337|NCT01509547|469913016|FG000|Overall Study|Physician Decision|0|||
130531338|NCT01509547|469913017|FG001|Overall Study|Physician Decision|1|||
130531339|NCT00402051|469913022|FG000|Overall Study|Progressive Disease|13|||
130579502|NCT03529773|470085162|FG013|Overall Study|Randomized but not vaccinated|0|||
130579503|NCT03529773|470085163|FG014|Overall Study|Randomized but not vaccinated|0|||
130579504|NCT03529773|470085164|FG015|Overall Study|Randomized but not vaccinated|0|||
130579505|NCT03529773|470085165|FG016|Overall Study|Randomized but not vaccinated|0|||
130579506|NCT03529773|470085166|FG017|Overall Study|Randomized but not vaccinated|1|||
130579507|NCT03529773|470085167|FG018|Overall Study|Randomized but not vaccinated|0|||
130579508|NCT03529773|470085168|FG019|Overall Study|Randomized but not vaccinated|0|||
130579509|NCT03529773|470085169|FG020|Overall Study|Randomized but not vaccinated|0|||
130579510|NCT03529773|470085170|FG021|Overall Study|Randomized but not vaccinated|0|||
130579511|NCT03529773|470085171|FG022|Overall Study|Randomized but not vaccinated|0|||
130579512|NCT03529773|470085172|FG023|Overall Study|Randomized but not vaccinated|0|||
130579513|NCT03529773|470085173|FG024|Overall Study|Randomized but not vaccinated|0|||
130579514|NCT03529773|470085174|FG025|Overall Study|Randomized but not vaccinated|0|||
130579515|NCT03529773|470085175|FG026|Overall Study|Randomized but not vaccinated|0|||
130579516|NCT03529773|470085176|FG027|Overall Study|Randomized but not vaccinated|1|||
130579517|NCT03529773|470085177|FG028|Overall Study|Randomized but not vaccinated|0|||
130579518|NCT03529773|470085178|FG029|Overall Study|Randomized but not vaccinated|0|||
130579519|NCT03529773|470085179|FG030|Overall Study|Randomized but not vaccinated|0|||
130579520|NCT03529773|470085180|FG031|Overall Study|Randomized but not vaccinated|0|||
130579521|NCT03529773|470085181|FG032|Overall Study|Randomized but not vaccinated|0|||
130579522|NCT03529773|470085182|FG033|Overall Study|Randomized but not vaccinated|0|||
130579523|NCT03529773|470085183|FG034|Overall Study|Randomized but not vaccinated|0|||
130579524|NCT03529773|470085184|FG035|Overall Study|Randomized but not vaccinated|0|||
130579525|NCT03529773|470085185|FG036|Overall Study|Randomized but not vaccinated|0|||
130579526|NCT03529773|470085186|FG037|Overall Study|Randomized but not vaccinated|0|||
130579527|NCT03529773|470085187|FG038|Overall Study|Randomized but not vaccinated|0|||
130579528|NCT03529773|470085188|FG039|Overall Study|Randomized but not vaccinated|0|||
130579529|NCT01340209|470085189|FG000|Overall Study|Adverse Event|1|||
130579530|NCT01340209|470085190|FG001|Overall Study|Adverse Event|1|||
130579531|NCT01340209|470085191|FG002|Overall Study|Adverse Event|2|||
130579532|NCT01340209|470085189|FG000|Overall Study|Protocol Violation|1|||
130579533|NCT01340209|470085190|FG001|Overall Study|Protocol Violation|2|||
130579534|NCT01340209|470085191|FG002|Overall Study|Protocol Violation|1|||
130579535|NCT01340209|470085189|FG000|Overall Study|Withdrawal by Subject|0|||
130579536|NCT01340209|470085190|FG001|Overall Study|Withdrawal by Subject|0|||
130579537|NCT01340209|470085191|FG002|Overall Study|Withdrawal by Subject|1|||
130579538|NCT01340209|470085189|FG000|Overall Study|Other reason not defined above|3|||
130579539|NCT01340209|470085190|FG001|Overall Study|Other reason not defined above|5|||
130579540|NCT01340209|470085191|FG002|Overall Study|Other reason not defined above|4|||
130579541|NCT01537211|470085194|FG000|Overall Study|Lost to Follow-up|0|||
130579542|NCT01537211|470085195|FG001|Overall Study|Lost to Follow-up|1|||
130579543|NCT04142983|470085196|FG000|Overall Study|Lost to Follow-up|73|||
130579544|NCT04142983|470085196|FG000|Overall Study|Withdrawal by Subject|10|||
130579545|NCT04142983|470085196|FG000|Overall Study|Physician Decision|1|||
130579546|NCT04142983|470085196|FG000|Overall Study|Adverse Event|1|||
130579547|NCT04142983|470085196|FG000|Overall Study|No longer eligible|4|||
130579548|NCT04142983|470085196|FG000|Overall Study|Screen Failure|10|||
130579549|NCT00797823|470085204|FG000|First Period (Initial Randomization)|Physician Decision|1|||
130579550|NCT00797823|470085205|FG001|First Period (Initial Randomization)|Physician Decision|0|||
130579551|NCT00797823|470085206|FG002|First Period (Initial Randomization)|Physician Decision|0|||
130579552|NCT02809833|470085207|FG000|Overall Study|Death|3|||
130579553|NCT02809833|470085207|FG000|Overall Study|Intolerance|54|||
130579554|NCT02809833|470085207|FG000|Overall Study|Lack of Efficacy|89|||
130579555|NCT02809833|470085207|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
130579556|NCT02809833|470085207|FG000|Overall Study|Noncompliance|1|||
130579557|NCT02809833|470085207|FG000|Overall Study|Withdrawal by Subject|34|||
130579558|NCT02809833|470085207|FG000|Overall Study|Lost to Follow-up|35|||
130579559|NCT02809833|470085207|FG000|Overall Study|Adverse Event (AE)|24|||
130579560|NCT02809833|470085207|FG000|Overall Study|Other|5|||
130579561|NCT02809833|470085207|FG000|Overall Study|Missing Information|52|||
130579562|NCT00523991|470085208|FG000|Overall Study|Adverse Event|6|||
130579563|NCT00523991|470085209|FG001|Overall Study|Adverse Event|5|||
130579564|NCT00523991|470085208|FG000|Overall Study|Protocol Violation|1|||
130579565|NCT00523991|470085209|FG001|Overall Study|Protocol Violation|4|||
130579566|NCT00523991|470085208|FG000|Overall Study|Lost to Follow-up|4|||
130579567|NCT00523991|470085209|FG001|Overall Study|Lost to Follow-up|1|||
130579568|NCT00523991|470085208|FG000|Overall Study|Withdrawal by Subject|7|||
130579569|NCT00523991|470085209|FG001|Overall Study|Withdrawal by Subject|17|||
130579570|NCT00523991|470085208|FG000|Overall Study|Other reason (not specified)|3|||
130579571|NCT00523991|470085209|FG001|Overall Study|Other reason (not specified)|0|||
130579572|NCT00193063|470085210|FG000|Overall Study|Lack of Efficacy|3|||
130579573|NCT00193063|470085210|FG000|Overall Study|Adverse Event|1|||
130579574|NCT00744874|470085213|FG000|Overall Study|Lost to Follow-up|1|||
130579575|NCT00744874|470085213|FG000|Overall Study|Withdrawal by Subject|1|||
130579576|NCT00744874|470085213|FG000|Overall Study|Study Device not available at procedure|1|||
130579577|NCT00744874|470085213|FG000|Overall Study|Unable to accomodate schedule|1|||
130579578|NCT01127165|470085219|FG000|Overall Study|Adverse Event|2|||
130579579|NCT01127165|470085220|FG001|Overall Study|Adverse Event|2|||
130579580|NCT01127165|470085219|FG000|Overall Study|Lack of Efficacy|10|||
130579581|NCT01127165|470085220|FG001|Overall Study|Lack of Efficacy|8|||
130579582|NCT01127165|470085219|FG000|Overall Study|Lost to Follow-up|3|||
130579583|NCT01127165|470085220|FG001|Overall Study|Lost to Follow-up|5|||
130579584|NCT01127165|470085219|FG000|Overall Study|Withdrawal by Subject|1|||
130579585|NCT01127165|470085220|FG001|Overall Study|Withdrawal by Subject|3|||
130579586|NCT01127165|470085219|FG000|Overall Study|Protocol Violation|0|||
130579587|NCT01127165|470085220|FG001|Overall Study|Protocol Violation|1|||
130579588|NCT03175549|470085221|FG000|Overall Study|Lost to Follow-up|2|||
130579589|NCT03175549|470085222|FG001|Overall Study|Lost to Follow-up|2|||
130579590|NCT03175549|470085221|FG000|Overall Study|Medication non-compliance|2|||
130579591|NCT03175549|470085222|FG001|Overall Study|Medication non-compliance|2|||
130579592|NCT02435849|470085223|FG000|Overall Study|Death|23|||
130579593|NCT02435849|470085224|FG001|Overall Study|Death|0|||
130579594|NCT02435849|470085223|FG000|Overall Study|Lack of Efficacy|10|||
130579595|NCT02435849|470085224|FG001|Overall Study|Lack of Efficacy|0|||
130579596|NCT02435849|470085223|FG000|Overall Study|New therapy for study indication|8|||
130579597|NCT02435849|470085224|FG001|Overall Study|New therapy for study indication|0|||
130531340|NCT00402051|469913023|FG001|Overall Study|Progressive Disease|20|||
130579598|NCT02435849|470085223|FG000|Overall Study|Subject/guardian decision|5|||
130579599|NCT02435849|470085224|FG001|Overall Study|Subject/guardian decision|1|||
130579600|NCT02435849|470085223|FG000|Overall Study|Lost to Follow-up|1|||
130579601|NCT02435849|470085224|FG001|Overall Study|Lost to Follow-up|0|||
130531341|NCT00402051|469913022|FG000|Overall Study|Adverse Event|11|||
130531342|NCT00402051|469913023|FG001|Overall Study|Adverse Event|4|||
130531343|NCT00402051|469913022|FG000|Overall Study|Physician Decision|7|||
130531344|NCT00402051|469913023|FG001|Overall Study|Physician Decision|3|||
130531345|NCT00402051|469913022|FG000|Overall Study|Withdrawal by Subject|3|||
130531346|NCT00402051|469913023|FG001|Overall Study|Withdrawal by Subject|3|||
130531347|NCT00402051|469913022|FG000|Overall Study|Death - Related to Study Drug|1|||
130531348|NCT00402051|469913023|FG001|Overall Study|Death - Related to Study Drug|2|||
130531349|NCT00402051|469913022|FG000|Overall Study|Death Due to Study Disease|2|||
130531350|NCT00402051|469913023|FG001|Overall Study|Death Due to Study Disease|1|||
130531351|NCT00402051|469913022|FG000|Overall Study|Death Due to Adverse Event|0|||
130531352|NCT00402051|469913023|FG001|Overall Study|Death Due to Adverse Event|2|||
130531353|NCT00402051|469913022|FG000|Overall Study|Lost to Follow-up|1|||
130531354|NCT00402051|469913023|FG001|Overall Study|Lost to Follow-up|0|||
130531355|NCT02514551|469913024|FG000|Overall Study|Lost to Follow-up|0|||
130531356|NCT02514551|469913025|FG001|Overall Study|Lost to Follow-up|1|||
130531357|NCT02514551|469913024|FG000|Overall Study|Participant Never Treated|0|||
130531358|NCT02514551|469913025|FG001|Overall Study|Participant Never Treated|2|||
130531359|NCT00570908|469913040|FG000|Overall Study|Adverse Event|5|||
130531360|NCT00570908|469913040|FG000|Overall Study|Withdrawal by Subject|2|||
130531361|NCT01213524|469913041|FG000|Baseline|Withdrawal by Subject|5|||
130531362|NCT01213524|469913041|FG000|Baseline|high breath alcohol levels|1|||
130531363|NCT01213524|469913041|FG000|Baseline|Physician Decision|1|||
130531364|NCT01213524|469913041|FG000|Session 2|Withdrawal by Subject|5|||
130531365|NCT01213524|469913041|FG000|Session 3|Withdrawal by Subject|4|||
130531366|NCT01213524|469913041|FG000|Session 4|Physician Decision|1|||
130531367|NCT01213524|469913041|FG000|Session 4|Withdrawal by Subject|2|||
130531368|NCT05415748|469913050|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
130531369|NCT05415748|469913051|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
130531370|NCT05415748|469913052|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
130531371|NCT05415748|469913053|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
130531372|NCT05415748|469913050|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
130531373|NCT05415748|469913051|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
130531374|NCT05415748|469913052|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
130531375|NCT05415748|469913053|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
130531376|NCT00281320|469913056|FG000|Overall Study|Adverse Event|12|||
130531377|NCT00281320|469913057|FG001|Overall Study|Adverse Event|9|||
130531378|NCT00281320|469913056|FG000|Overall Study|Lack of Efficacy|4|||
130531379|NCT00281320|469913057|FG001|Overall Study|Lack of Efficacy|3|||
130531380|NCT00281320|469913056|FG000|Overall Study|Withdrawal by Subject|5|||
130531381|NCT00281320|469913057|FG001|Overall Study|Withdrawal by Subject|6|||
130531382|NCT00281320|469913056|FG000|Overall Study|Lost to Follow-up|1|||
130531383|NCT00281320|469913057|FG001|Overall Study|Lost to Follow-up|2|||
130531384|NCT00281320|469913056|FG000|Overall Study|Other|3|||
130531385|NCT00281320|469913057|FG001|Overall Study|Other|1|||
130531386|NCT01447576|469913068|FG000|Overall Study|Lost to Follow-up|52|||
130531387|NCT01447576|469913068|FG000|Overall Study|Adverse Event|127|||
130579602|NCT02435849|470085223|FG000|Overall Study|Physician Decision|1|||
130579603|NCT02435849|470085224|FG001|Overall Study|Physician Decision|0|||
130579604|NCT00763321|470085225|FG000|Open-label Period|Adverse Event|24|||
130579605|NCT00763321|470085226|FG001|Open-label Period|Adverse Event|0|||
130531388|NCT01447576|469913068|FG000|Overall Study|Participant met withdrawal criteria|40|||
130531389|NCT01447576|469913068|FG000|Overall Study|Withdrawal by Subject|100|||
130531390|NCT01447576|469913068|FG000|Overall Study|Protocol deviation|83|||
130531391|NCT01447576|469913068|FG000|Overall Study|Lack of Efficacy|68|||
130531392|NCT01447576|469913068|FG000|Overall Study|Physician Decision|6|||
130531393|NCT00975676|469913069|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
130531394|NCT00975676|469913070|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
130531395|NCT02548078|469913071|FG000|Overall Study|Serious adverse event/Adverse event|1|||
130531396|NCT02548078|469913072|FG001|Overall Study|Serious adverse event/Adverse event|0|||
130531397|NCT02548078|469913071|FG000|Overall Study|Moved from study area|3|||
130531398|NCT02548078|469913072|FG001|Overall Study|Moved from study area|3|||
130531399|NCT02548078|469913071|FG000|Overall Study|Lost to Follow-up|1|||
130531400|NCT02548078|469913072|FG001|Overall Study|Lost to Follow-up|3|||
130531401|NCT02998476|469913078|FG000|Overall Study|Lost to Follow-up|1|||
130531402|NCT02998476|469913079|FG001|Overall Study|Lost to Follow-up|0|||
130531403|NCT02998476|469913078|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
130531404|NCT02998476|469913079|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
130531405|NCT02998476|469913078|FG000|Overall Study|Withdrawal by Subject|1|||
130531406|NCT02998476|469913079|FG001|Overall Study|Withdrawal by Subject|2|||
130531407|NCT02998476|469913078|FG000|Overall Study|Death|45|||
130531408|NCT02998476|469913079|FG001|Overall Study|Death|2|||
130531409|NCT02998476|469913078|FG000|Overall Study|Other|6|||
130531410|NCT02998476|469913079|FG001|Overall Study|Other|1|||
130531411|NCT03277352|469913080|FG000|Overall Study|Study Terminated By Sponsor|2|||
130531412|NCT03277352|469913080|FG000|Overall Study|Withdrawal by Subject|4|||
130531413|NCT03277352|469913080|FG000|Overall Study|Death|4|||
130531414|NCT01435772|469913081|FG000|Overall Study|Adverse Event|1|||
130531415|NCT01435772|469913082|FG001|Overall Study|Adverse Event|0|||
130531416|NCT01435772|469913083|FG002|Overall Study|Adverse Event|2|||
130531417|NCT01435772|469913081|FG000|Overall Study|Withdrawal by Subject|0|||
130531418|NCT01435772|469913082|FG001|Overall Study|Withdrawal by Subject|1|||
130531419|NCT01435772|469913083|FG002|Overall Study|Withdrawal by Subject|3|||
130531420|NCT01435772|469913081|FG000|Overall Study|Other - study termination|2|||
130531421|NCT01435772|469913082|FG001|Overall Study|Other - study termination|2|||
130531422|NCT01435772|469913083|FG002|Overall Study|Other - study termination|10|||
130531423|NCT03238963|469913084|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
130531424|NCT03238963|469913085|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
130531425|NCT03238963|469913084|FG000|Overall Study|Withdrawal by Subject|1|||
130531426|NCT03238963|469913085|FG001|Overall Study|Withdrawal by Subject|1|||
130531427|NCT03238963|469913084|FG000|Overall Study|Lost to Follow-up|1|||
130531428|NCT03238963|469913085|FG001|Overall Study|Lost to Follow-up|0|||
130531429|NCT03238963|469913084|FG000|Overall Study|Protocol Violation|1|||
130531430|NCT03238963|469913085|FG001|Overall Study|Protocol Violation|1|||
130531431|NCT03238963|469913084|FG000|Overall Study|Adverse Event|1|||
130531432|NCT03238963|469913085|FG001|Overall Study|Adverse Event|0|||
130531433|NCT01424813|469913088|FG000|Overall Study|Withdrawal by Subject|3|||
130531434|NCT01424813|469913089|FG001|Overall Study|Withdrawal by Subject|0|||
130531435|NCT01424813|469913088|FG000|Overall Study|Protocol Violation|1|||
130531436|NCT01424813|469913089|FG001|Overall Study|Protocol Violation|0|||
130531437|NCT01424813|469913088|FG000|Overall Study|Other|1|||
130531438|NCT01424813|469913089|FG001|Overall Study|Other|2|||
130531439|NCT03838731|469915074|FG000|Overall Study|Pregnancy|0|||
130531440|NCT03838731|469915075|FG001|Overall Study|Pregnancy|1|||
130531441|NCT03838731|469915074|FG000|Overall Study|Withdrawal of consent|1|||
130531442|NCT03838731|469915075|FG001|Overall Study|Withdrawal of consent|0|||
130531443|NCT01088984|469915078|FG000|Phase 1|Death|2|||
130531444|NCT01088984|469915079|FG001|Phase 1|Death|1|||
130531445|NCT01088984|469915078|FG000|Phase 1|Disease Progression|2|||
130531446|NCT01088984|469915079|FG001|Phase 1|Disease Progression|4|||
130531447|NCT01088984|469915078|FG000|Phase 1|Other|1|||
130531448|NCT01088984|469915079|FG001|Phase 1|Other|1|||
130531449|NCT01088984|469915078|FG000|Phase 2|Death|0|||
130531450|NCT01088984|469915079|FG001|Phase 2|Death|5|||
130531451|NCT01088984|469915078|FG000|Phase 2|Withdrawal by Subject|0|||
130579606|NCT00763321|470085227|FG002|Open-label Period|Adverse Event|0|||
130579607|NCT00763321|470085225|FG000|Open-label Period|Lost to Follow-up|14|||
130531452|NCT01088984|469915079|FG001|Phase 2|Withdrawal by Subject|1|||
130531453|NCT01088984|469915078|FG000|Phase 2|DIsease Progression|0|||
130531454|NCT01088984|469915079|FG001|Phase 2|DIsease Progression|25|||
130531455|NCT01088984|469915078|FG000|Phase 2|Other|0|||
130531456|NCT01088984|469915079|FG001|Phase 2|Other|1|||
130579608|NCT00763321|470085226|FG001|Open-label Period|Lost to Follow-up|0|||
130531457|NCT04707664|469915080|FG000|Overall Study|Adverse Event|2|||
130531458|NCT04707664|469915081|FG001|Overall Study|Adverse Event|0|||
130531459|NCT04707664|469915080|FG000|Overall Study|Death|1|||
130531460|NCT04707664|469915081|FG001|Overall Study|Death|2|||
130531461|NCT04707664|469915080|FG000|Overall Study|Withdrawal by Subject|13|||
130531462|NCT04707664|469915081|FG001|Overall Study|Withdrawal by Subject|21|||
130531463|NCT04707664|469915080|FG000|Overall Study|Lost to Follow-up|11|||
130531464|NCT04707664|469915081|FG001|Overall Study|Lost to Follow-up|13|||
130531465|NCT04707664|469915080|FG000|Overall Study|Not treated|2|||
130531466|NCT04707664|469915081|FG001|Overall Study|Not treated|0|||
130531467|NCT00699153|469915082|FG000|Overall Study|Lost to Follow-up|1|||
130531468|NCT00699153|469915083|FG001|Overall Study|Lost to Follow-up|0|||
130531469|NCT00699153|469915082|FG000|Overall Study|Adverse Event|0|||
130531470|NCT00699153|469915083|FG001|Overall Study|Adverse Event|2|||
130531471|NCT00699153|469915082|FG000|Overall Study|Protocol Violation|1|||
130531472|NCT00699153|469915083|FG001|Overall Study|Protocol Violation|0|||
130531473|NCT00699153|469915082|FG000|Overall Study|Travel Problem|1|||
130531474|NCT00699153|469915083|FG001|Overall Study|Travel Problem|0|||
130531475|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
130531476|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
130531477|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
130531478|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
130531479|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Death|13|||
130531480|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Death|12|||
130531481|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Progression|257|||
130531482|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Progression|218|||
130531483|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
130531484|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
130531485|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
130531486|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
130531487|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
130531488|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
130531489|NCT01006980|469915087|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
130531490|NCT01006980|469915088|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
130531491|NCT01006980|469915087|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
130531492|NCT01006980|469915088|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
130531493|NCT01006980|469915087|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
130531494|NCT01006980|469915088|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
130531495|NCT01006980|469915087|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
130531496|NCT01006980|469915088|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
130531497|NCT01006980|469915087|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
130531498|NCT01006980|469915088|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
130531499|NCT01006980|469915087|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
130531500|NCT01006980|469915088|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
130531501|NCT02706405|469915097|FG000|Overall Study|Death|3|||
130531502|NCT02706405|469915098|FG001|Overall Study|Death|2|||
130531503|NCT02706405|469915099|FG002|Overall Study|Death|0|||
130531504|NCT02706405|469915100|FG003|Overall Study|Death|1|||
130531505|NCT02706405|469915101|FG004|Overall Study|Death|0|||
130531506|NCT02706405|469915102|FG005|Overall Study|Death|0|||
130531507|NCT02706405|469915103|FG006|Overall Study|Death|3|||
130531508|NCT02706405|469915104|FG007|Overall Study|Death|4|||
130531509|NCT02706405|469915097|FG000|Overall Study|Disease progression|0|||
130531510|NCT02706405|469915098|FG001|Overall Study|Disease progression|0|||
130531511|NCT02706405|469915099|FG002|Overall Study|Disease progression|0|||
130531512|NCT02706405|469915100|FG003|Overall Study|Disease progression|0|||
130531513|NCT02706405|469915101|FG004|Overall Study|Disease progression|0|||
130531514|NCT02706405|469915102|FG005|Overall Study|Disease progression|0|||
130531515|NCT02706405|469915103|FG006|Overall Study|Disease progression|0|||
130531516|NCT02706405|469915104|FG007|Overall Study|Disease progression|1|||
130531517|NCT02706405|469915097|FG000|Overall Study|Pt moved to new therapy|0|||
130531518|NCT02706405|469915098|FG001|Overall Study|Pt moved to new therapy|0|||
130531519|NCT02706405|469915099|FG002|Overall Study|Pt moved to new therapy|0|||
130531520|NCT02706405|469915100|FG003|Overall Study|Pt moved to new therapy|0|||
130531521|NCT02706405|469915101|FG004|Overall Study|Pt moved to new therapy|0|||
130531522|NCT02706405|469915102|FG005|Overall Study|Pt moved to new therapy|1|||
130531523|NCT02706405|469915103|FG006|Overall Study|Pt moved to new therapy|0|||
130531524|NCT02706405|469915104|FG007|Overall Study|Pt moved to new therapy|1|||
130531525|NCT02706405|469915097|FG000|Overall Study|Physician Decision|1|||
130531526|NCT02706405|469915098|FG001|Overall Study|Physician Decision|0|||
130531527|NCT02706405|469915099|FG002|Overall Study|Physician Decision|0|||
130531528|NCT02706405|469915100|FG003|Overall Study|Physician Decision|0|||
130531529|NCT02706405|469915101|FG004|Overall Study|Physician Decision|0|||
130531530|NCT02706405|469915102|FG005|Overall Study|Physician Decision|0|||
130531531|NCT02706405|469915103|FG006|Overall Study|Physician Decision|0|||
130531532|NCT02706405|469915104|FG007|Overall Study|Physician Decision|0|||
130531533|NCT01228318|469915105|FG000|Overall Study|Clinic no show to receive intervention|1|||
130531534|NCT01228318|469915106|FG001|Overall Study|Clinic no show to receive intervention|0|||
130531535|NCT01228318|469915105|FG000|Overall Study|Unable to contact|2|||
130531536|NCT01228318|469915106|FG001|Overall Study|Unable to contact|5|||
130531537|NCT01228318|469915105|FG000|Overall Study|Moved|0|||
130531538|NCT01228318|469915106|FG001|Overall Study|Moved|2|||
130531539|NCT01228318|469915105|FG000|Overall Study|Incarcerated|1|||
130579609|NCT00763321|470085227|FG002|Open-label Period|Lost to Follow-up|0|||
130579610|NCT00763321|470085225|FG000|Open-label Period|Withdrawal by Subject|7|||
130579611|NCT00763321|470085226|FG001|Open-label Period|Withdrawal by Subject|0|||
130579612|NCT00763321|470085227|FG002|Open-label Period|Withdrawal by Subject|0|||
130579613|NCT00763321|470085225|FG000|Open-label Period|Subject noncompliant|7|||
130579614|NCT00763321|470085226|FG001|Open-label Period|Subject noncompliant|0|||
130579615|NCT00763321|470085227|FG002|Open-label Period|Subject noncompliant|0|||
130579616|NCT00763321|470085225|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
130579617|NCT00763321|470085226|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
130579618|NCT00763321|470085227|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
130579619|NCT00763321|470085225|FG000|Open-label Period|Lack of Efficacy|2|||
130579620|NCT00763321|470085226|FG001|Open-label Period|Lack of Efficacy|0|||
130579621|NCT00763321|470085227|FG002|Open-label Period|Lack of Efficacy|0|||
130579622|NCT00763321|470085225|FG000|Open-label Period|Other|4|||
130579623|NCT00763321|470085226|FG001|Open-label Period|Other|0|||
130579624|NCT00763321|470085227|FG002|Open-label Period|Other|0|||
130579625|NCT00763321|470085225|FG000|Double-blind Period|Lack of Efficacy|0|||
130579626|NCT00763321|470085226|FG001|Double-blind Period|Lack of Efficacy|9|||
130579627|NCT00763321|470085227|FG002|Double-blind Period|Lack of Efficacy|17|||
130579628|NCT00763321|470085225|FG000|Double-blind Period|Adverse Event|0|||
130579629|NCT00763321|470085226|FG001|Double-blind Period|Adverse Event|4|||
130579630|NCT00763321|470085227|FG002|Double-blind Period|Adverse Event|4|||
130579631|NCT00763321|470085225|FG000|Double-blind Period|Lost to Follow-up|0|||
130579632|NCT00763321|470085226|FG001|Double-blind Period|Lost to Follow-up|4|||
130579633|NCT00763321|470085227|FG002|Double-blind Period|Lost to Follow-up|2|||
130579634|NCT00763321|470085225|FG000|Double-blind Period|Withdrawal by Subject|0|||
130579635|NCT00763321|470085226|FG001|Double-blind Period|Withdrawal by Subject|2|||
130579636|NCT00763321|470085227|FG002|Double-blind Period|Withdrawal by Subject|3|||
130579637|NCT00763321|470085225|FG000|Double-blind Period|Other|0|||
130579638|NCT00763321|470085226|FG001|Double-blind Period|Other|2|||
130579639|NCT00763321|470085227|FG002|Double-blind Period|Other|3|||
130579640|NCT02486757|470085228|FG000|Overall Study|Lost to Follow-up|1|||
130579641|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
130579642|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130579643|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130579644|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130579645|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130579646|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
130579647|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
130579648|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
130579649|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
130579650|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
130579651|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
130579652|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130579653|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130579654|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130579655|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130579656|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
130579657|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130579658|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130579659|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130579660|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130579661|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
130579662|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
130579663|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
130579664|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
130579665|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
130579666|NCT01017952|470085229|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
130579667|NCT01017952|470085230|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130579668|NCT01017952|470085231|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130579669|NCT01017952|470085232|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130579670|NCT01017952|470085233|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130579671|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
130579672|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
130579673|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
130579674|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
130579675|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
130579676|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130579677|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
130579678|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
130579679|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
130579680|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
130579681|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130579682|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
130579683|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
130579684|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
130579685|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
130579686|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
130579687|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130579688|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
130579689|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
130579690|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130579691|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130579692|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
130579693|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130579694|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
130579695|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
130579696|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130579697|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130579698|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130579699|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130579700|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130579701|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130579702|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130579703|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
130579704|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130579705|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
130579706|NCT01017952|470085229|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
130579707|NCT01017952|470085230|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
130579708|NCT01017952|470085231|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
130579709|NCT01017952|470085232|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
130579710|NCT01017952|470085233|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
130579711|NCT01064167|470085234|FG000|Overall Study|Protocol Violation|14|||
130579712|NCT01064167|470085235|FG001|Overall Study|Protocol Violation|15|||
130579713|NCT00725075|470085236|FG000|Overall Study|Use of Excluded Medication|0|||
130579714|NCT00725075|470085237|FG001|Overall Study|Use of Excluded Medication|1|||
130579715|NCT00725075|470085238|FG002|Overall Study|Use of Excluded Medication|0|||
130579716|NCT00725075|470085236|FG000|Overall Study|Protocol Violation|0|||
130579717|NCT00725075|470085237|FG001|Overall Study|Protocol Violation|0|||
130579718|NCT00725075|470085238|FG002|Overall Study|Protocol Violation|1|||
130579719|NCT00725075|470085236|FG000|Overall Study|Lost to Follow-up|1|||
130579720|NCT00725075|470085237|FG001|Overall Study|Lost to Follow-up|0|||
130579721|NCT00725075|470085238|FG002|Overall Study|Lost to Follow-up|0|||
130579722|NCT00725075|470085236|FG000|Overall Study|Withdrawal by Subject|4|||
130579723|NCT00725075|470085237|FG001|Overall Study|Withdrawal by Subject|5|||
130579724|NCT00725075|470085238|FG002|Overall Study|Withdrawal by Subject|4|||
130579725|NCT00725075|470085236|FG000|Overall Study|Adverse Event|2|||
130579726|NCT00725075|470085237|FG001|Overall Study|Adverse Event|1|||
130579727|NCT00725075|470085238|FG002|Overall Study|Adverse Event|1|||
130579728|NCT00725075|470085236|FG000|Overall Study|Worsening of Disease|2|||
130579729|NCT00725075|470085237|FG001|Overall Study|Worsening of Disease|1|||
130579730|NCT00725075|470085238|FG002|Overall Study|Worsening of Disease|2|||
130579731|NCT00725075|470085236|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
130579732|NCT00725075|470085237|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
130579733|NCT00725075|470085238|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
130579734|NCT00725075|470085236|FG000|Overall Study|Other|1|||
130579735|NCT00725075|470085237|FG001|Overall Study|Other|0|||
130579736|NCT00725075|470085238|FG002|Overall Study|Other|0|||
130579737|NCT01298492|470085239|FG000|Overall Study|Death|2|||
130579738|NCT01298492|470085239|FG000|Overall Study|Insufficient Clinical Response|22|||
130579739|NCT01298492|470085239|FG000|Overall Study|Lost to Follow-up|12|||
130579740|NCT01298492|470085239|FG000|Overall Study|Withdrawal by Subject|47|||
130579741|NCT01298492|470085239|FG000|Overall Study|Other (Unspecified)|7|||
130579742|NCT01298492|470085239|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
130579743|NCT01298492|470085239|FG000|Overall Study|Protocol Violation|2|||
130579744|NCT01298492|470085239|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
130579745|NCT01298492|470085239|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
130579746|NCT03984305|470085240|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
130579747|NCT03984305|470085241|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
130579748|NCT03984305|470085240|FG000|Overall Study|Withdrawal by Subject|3|||
130579749|NCT03984305|470085241|FG001|Overall Study|Withdrawal by Subject|3|||
130579750|NCT03984305|470085240|FG000|Overall Study|Lost to Follow-up|1|||
130579751|NCT03984305|470085241|FG001|Overall Study|Lost to Follow-up|0|||
130579752|NCT00352105|470085242|FG000|Overall Study|Death|5|||
130579753|NCT00352105|470085242|FG000|Overall Study|Withdrawal by Subject|5|||
130579754|NCT00352105|470085242|FG000|Overall Study|Lack of Efficacy|9|||
130579755|NCT00352105|470085242|FG000|Overall Study|Adverse Event|19|||
130579756|NCT00352105|470085242|FG000|Overall Study|Protocol Violation|2|||
130579757|NCT00087646|470085243|FG000|Overall Study|Adverse Event|37|||
130579758|NCT00087646|470085244|FG001|Overall Study|Adverse Event|6|||
130579759|NCT00087646|470085245|FG002|Overall Study|Adverse Event|18|||
130579760|NCT00087646|470085246|FG003|Overall Study|Adverse Event|20|||
130579761|NCT00087646|470085243|FG000|Overall Study|Death|0|||
130579762|NCT00087646|470085244|FG001|Overall Study|Death|1|||
130579763|NCT00087646|470085245|FG002|Overall Study|Death|0|||
130579764|NCT00087646|470085246|FG003|Overall Study|Death|0|||
130579765|NCT00087646|470085243|FG000|Overall Study|Withdrawal by Subject|6|||
130579766|NCT00087646|470085244|FG001|Overall Study|Withdrawal by Subject|1|||
130579767|NCT00087646|470085245|FG002|Overall Study|Withdrawal by Subject|2|||
130579768|NCT00087646|470085246|FG003|Overall Study|Withdrawal by Subject|2|||
130579769|NCT00087646|470085243|FG000|Overall Study|Insufficient therapeutic response|64|||
130579770|NCT00087646|470085244|FG001|Overall Study|Insufficient therapeutic response|24|||
130579771|NCT00087646|470085245|FG002|Overall Study|Insufficient therapeutic response|38|||
130579772|NCT00087646|470085246|FG003|Overall Study|Insufficient therapeutic response|51|||
130579773|NCT00087646|470085243|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
130579774|NCT00087646|470085244|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
130579775|NCT00087646|470085245|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
130579776|NCT00087646|470085246|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
130579777|NCT00087646|470085243|FG000|Overall Study|Failure to Return|5|||
130579778|NCT00087646|470085244|FG001|Overall Study|Failure to Return|2|||
130579779|NCT00087646|470085245|FG002|Overall Study|Failure to Return|2|||
130579780|NCT00087646|470085246|FG003|Overall Study|Failure to Return|3|||
130579781|NCT00087646|470085243|FG000|Overall Study|Administrative/Other|6|||
130579782|NCT00087646|470085244|FG001|Overall Study|Administrative/Other|1|||
130579783|NCT00087646|470085245|FG002|Overall Study|Administrative/Other|1|||
130579784|NCT00087646|470085246|FG003|Overall Study|Administrative/Other|2|||
130579785|NCT00087646|470085243|FG000|Overall Study|Other Protocol Violation|3|||
130579786|NCT00087646|470085244|FG001|Overall Study|Other Protocol Violation|1|||
130579787|NCT00087646|470085245|FG002|Overall Study|Other Protocol Violation|0|||
130579788|NCT00087646|470085246|FG003|Overall Study|Other Protocol Violation|0|||
130579789|NCT00087646|470085243|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130579790|NCT00087646|470085244|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130579791|NCT00087646|470085245|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
130579792|NCT00087646|470085246|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
130579793|NCT01235962|470085247|FG000|Overall Study|Withdrawal by Subject|20|||
130579794|NCT01235962|470085248|FG001|Overall Study|Withdrawal by Subject|19|||
130579795|NCT01235962|470085249|FG002|Overall Study|Withdrawal by Subject|62|||
130579796|NCT01235962|470085250|FG003|Overall Study|Withdrawal by Subject|49|||
130579797|NCT01235962|470085247|FG000|Overall Study|Lost to Follow-up|21|||
130579798|NCT01235962|470085248|FG001|Overall Study|Lost to Follow-up|16|||
130579799|NCT01235962|470085249|FG002|Overall Study|Lost to Follow-up|47|||
130579800|NCT01235962|470085250|FG003|Overall Study|Lost to Follow-up|32|||
130579801|NCT01235962|470085247|FG000|Overall Study|Physician Decision|5|||
130579802|NCT01235962|470085248|FG001|Overall Study|Physician Decision|0|||
130579803|NCT01235962|470085249|FG002|Overall Study|Physician Decision|9|||
130579804|NCT01235962|470085250|FG003|Overall Study|Physician Decision|5|||
130579805|NCT02902120|470085252|FG000|Overall Study|Lack of Efficacy|1|||
130579806|NCT01353703|470085253|FG000|Overall Study|Migrated/moved from study area|1|||
130579807|NCT01353703|470085254|FG001|Overall Study|Migrated/moved from study area|0|||
130579808|NCT01405053|470085260|FG000|Overall Study|Adverse Event|3|||
130579809|NCT01405053|470085261|FG001|Overall Study|Adverse Event|0|||
130579810|NCT01405053|470085260|FG000|Overall Study|Lost to Follow-up|0|||
130579811|NCT01405053|470085261|FG001|Overall Study|Lost to Follow-up|1|||
130579812|NCT01405053|470085260|FG000|Overall Study|Participant choice|2|||
130579813|NCT01405053|470085261|FG001|Overall Study|Participant choice|1|||
130579814|NCT01405053|470085260|FG000|Overall Study|Inadequate therapeutic effect|2|||
130579815|NCT01405053|470085261|FG001|Overall Study|Inadequate therapeutic effect|1|||
130579816|NCT01405053|470085260|FG000|Overall Study|Withdrawal by Subject|3|||
130579817|NCT01405053|470085261|FG001|Overall Study|Withdrawal by Subject|4|||
130579818|NCT01405053|470085260|FG000|Overall Study|Other|0|||
130579819|NCT01405053|470085261|FG001|Overall Study|Other|1|||
130579820|NCT02175680|470085269|FG000|Overall Study|non-compliance|1|||
130579821|NCT02175680|470085269|FG000|Overall Study|other non-medical reason|1|||
130579822|NCT01913483|470085274|FG000|Overall Study|Withdrawal by Subject|1|||
130579823|NCT01913483|470085275|FG001|Overall Study|Withdrawal by Subject|2|||
130579824|NCT01913483|470085274|FG000|Overall Study|Lost to Follow-up|6|||
130579825|NCT01913483|470085275|FG001|Overall Study|Lost to Follow-up|3|||
130579826|NCT01913483|470085274|FG000|Overall Study|Death|14|||
130579827|NCT01913483|470085275|FG001|Overall Study|Death|17|||
130579828|NCT02302963|470085276|FG000|Overall Study|Withdrawal by Subject|2|||
130579829|NCT02302963|470085277|FG001|Overall Study|Withdrawal by Subject|1|||
130579830|NCT02302963|470085276|FG000|Overall Study|Steroid injection|0|||
130579831|NCT02302963|470085277|FG001|Overall Study|Steroid injection|1|||
130579832|NCT02302963|470085276|FG000|Overall Study|Physician Decision|1|||
130579833|NCT02302963|470085277|FG001|Overall Study|Physician Decision|0|||
130579834|NCT01816243|470085278|FG000|Overall Study|Adverse Event|6|||
130579835|NCT01816243|470085278|FG000|Overall Study|Lost to Follow-up|1|||
130579836|NCT01816243|470085278|FG000|Overall Study|Lack of Efficacy|1|||
130579837|NCT01816243|470085278|FG000|Overall Study|Not eligible for the study|1|||
130579838|NCT01816243|470085278|FG000|Overall Study|Amputation|3|||
130579839|NCT00915343|470085279|FG000|Part B - Open Label Period|Treatment switch|0|||
130579840|NCT00915343|470085280|FG001|Part B - Open Label Period|Treatment switch|0|||
130579841|NCT00915343|470085281|FG002|Part B - Open Label Period|Treatment switch|1|||
130579842|NCT00915343|470085279|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
130579843|NCT00915343|470085280|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
130579844|NCT00915343|470085281|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
130579845|NCT01920711|470085282|FG000|Overall Study|Death|347|||
130579846|NCT01920711|470085283|FG001|Overall Study|Death|356|||
130579847|NCT01920711|470085282|FG000|Overall Study|Lost to Follow-up|13|||
130579848|NCT01920711|470085283|FG001|Overall Study|Lost to Follow-up|14|||
130579849|NCT01920711|470085282|FG000|Overall Study|Withdrawal by Subject|4|||
130579850|NCT01920711|470085283|FG001|Overall Study|Withdrawal by Subject|3|||
130579851|NCT01634555|470085284|FG000|Overall Study|Adverse Event|3|||
130579852|NCT01634555|470085284|FG000|Overall Study|Physician Decision|1|||
130579853|NCT00805740|470086478|FG000|Overall Study|Death|7|||
130579854|NCT00805740|470086479|FG001|Overall Study|Death|4|||
130579855|NCT00805740|470086478|FG000|Overall Study|Withdrawal by Subject|1|||
130579856|NCT00805740|470086479|FG001|Overall Study|Withdrawal by Subject|0|||
130579857|NCT00805740|470086478|FG000|Overall Study|Lost to Follow-up|1|||
130579858|NCT00805740|470086479|FG001|Overall Study|Lost to Follow-up|0|||
130579859|NCT00805740|470086478|FG000|Overall Study|Randomized, but not treated|2|||
130579860|NCT00805740|470086479|FG001|Overall Study|Randomized, but not treated|0|||
130579861|NCT04033367|470086480|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
130579862|NCT04033367|470086481|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
130579863|NCT04033367|470086480|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
130579864|NCT04033367|470086481|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130579865|NCT04033367|470086480|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
130579866|NCT04033367|470086481|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
130579867|NCT04033367|470086480|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
130579868|NCT04033367|470086481|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
130579869|NCT02723201|470086482|FG000|Second Intervention Period|Protocol Violation|1|||
130579870|NCT02723201|470086483|FG001|Second Intervention Period|Protocol Violation|0|||
130579871|NCT02723201|470086484|FG002|Second Intervention Period|Protocol Violation|0|||
130579872|NCT02723201|470086482|FG000|Second Intervention Period|Adverse Event|1|||
130579873|NCT02723201|470086483|FG001|Second Intervention Period|Adverse Event|0|||
130579874|NCT02723201|470086484|FG002|Second Intervention Period|Adverse Event|0|||
130579875|NCT03472560|470086485|FG000|Overall Study|Subject transfer to continuation protocol|0|||
130579876|NCT03472560|470086486|FG001|Overall Study|Subject transfer to continuation protocol|1|||
130579877|NCT03472560|470086485|FG000|Overall Study|Withdrawal by Subject|4|||
130579878|NCT03472560|470086486|FG001|Overall Study|Withdrawal by Subject|0|||
130579879|NCT03472560|470086485|FG000|Overall Study|Progressive disease|24|||
130579880|NCT03472560|470086486|FG001|Overall Study|Progressive disease|8|||
130579881|NCT03472560|470086485|FG000|Overall Study|Physician Decision|1|||
130579882|NCT03472560|470086486|FG001|Overall Study|Physician Decision|0|||
130579883|NCT03472560|470086485|FG000|Overall Study|Death|7|||
130579884|NCT03472560|470086486|FG001|Overall Study|Death|4|||
130579885|NCT03472560|470086485|FG000|Overall Study|Adverse Event|5|||
130579886|NCT03472560|470086486|FG001|Overall Study|Adverse Event|3|||
130579887|NCT03472560|470086485|FG000|Overall Study|Global deterioration of health status|0|||
130579888|NCT03472560|470086486|FG001|Overall Study|Global deterioration of health status|4|||
130579889|NCT01946178|470086487|FG000|Overall Study|Pregnancy|1|||
130579890|NCT01946178|470086487|FG000|Overall Study|Lost to Follow-up|1|||
130579891|NCT00491179|470086488|FG000|Overall Study|Adverse Event|5|||
130579892|NCT00491179|470086489|FG001|Overall Study|Adverse Event|1|||
130579893|NCT00491179|470086488|FG000|Overall Study|Withdrawal by Subject|2|||
130579894|NCT00491179|470086489|FG001|Overall Study|Withdrawal by Subject|1|||
130579895|NCT01505894|470086490|FG000|Overall Study|Adverse Event|1|||
130579896|NCT01505894|470086491|FG001|Overall Study|Adverse Event|0|||
130579897|NCT01505894|470086492|FG002|Overall Study|Adverse Event|0|||
130579898|NCT01505894|470086493|FG003|Overall Study|Adverse Event|0|||
130579899|NCT01505894|470086494|FG004|Overall Study|Adverse Event|0|||
130579900|NCT01505894|470086495|FG005|Overall Study|Adverse Event|0|||
130579901|NCT01505894|470086496|FG006|Overall Study|Adverse Event|0|||
130579902|NCT01505894|470086497|FG007|Overall Study|Adverse Event|0|||
130579903|NCT01505894|470086498|FG008|Overall Study|Adverse Event|0|||
130579904|NCT01505894|470086490|FG000|Overall Study|Other than specified|0|||
130579905|NCT01505894|470086491|FG001|Overall Study|Other than specified|0|||
130579906|NCT01505894|470086492|FG002|Overall Study|Other than specified|0|||
130579907|NCT01505894|470086493|FG003|Overall Study|Other than specified|0|||
130579908|NCT01505894|470086494|FG004|Overall Study|Other than specified|1|||
130579909|NCT01505894|470086495|FG005|Overall Study|Other than specified|0|||
130579910|NCT01505894|470086496|FG006|Overall Study|Other than specified|0|||
130579911|NCT01505894|470086497|FG007|Overall Study|Other than specified|0|||
130579912|NCT01505894|470086498|FG008|Overall Study|Other than specified|0|||
130579913|NCT01001702|470086499|FG000|Overall Study|Lost to Follow-up|7|||
130579914|NCT01001702|470086499|FG000|Overall Study|Adverse Event|7|||
130579915|NCT01001702|470086499|FG000|Overall Study|Sponsor Discontinued Study|4|||
130579916|NCT01001702|470086499|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
130579917|NCT01001702|470086499|FG000|Overall Study|Investigator withdrew Subject|10|||
130579918|NCT01001702|470086499|FG000|Overall Study|Withdrawal by Subject|19|||
130579919|NCT01001702|470086499|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
130579920|NCT04269395|470086500|FG000|Overall Study|Lost to Follow-up|1|||
130579921|NCT04269395|470086501|FG001|Overall Study|Lost to Follow-up|0|||
130579922|NCT04269395|470086500|FG000|Overall Study|Study terminated by Sponsor|13|||
130579923|NCT04269395|470086501|FG001|Overall Study|Study terminated by Sponsor|10|||
130579924|NCT00094757|470086502|FG000|Overall Study|Adverse Event|11|||
130579925|NCT00094757|470086503|FG001|Overall Study|Adverse Event|9|||
130579926|NCT00094757|470086504|FG002|Overall Study|Adverse Event|6|||
130579927|NCT00094757|470086502|FG000|Overall Study|Lack of Efficacy|11|||
130579928|NCT00094757|470086503|FG001|Overall Study|Lack of Efficacy|15|||
130579929|NCT00094757|470086504|FG002|Overall Study|Lack of Efficacy|8|||
130579930|NCT00094757|470086502|FG000|Overall Study|Lost to Follow-up|3|||
130579931|NCT00094757|470086503|FG001|Overall Study|Lost to Follow-up|5|||
130579932|NCT00094757|470086504|FG002|Overall Study|Lost to Follow-up|6|||
130579933|NCT00094757|470086502|FG000|Overall Study|Patient Moved|2|||
130579934|NCT00094757|470086503|FG001|Overall Study|Patient Moved|1|||
130579935|NCT00094757|470086504|FG002|Overall Study|Patient Moved|1|||
130579936|NCT00094757|470086502|FG000|Overall Study|Protocol Violation|8|||
130579937|NCT00094757|470086503|FG001|Overall Study|Protocol Violation|5|||
130579938|NCT00094757|470086504|FG002|Overall Study|Protocol Violation|3|||
130579939|NCT00094757|470086502|FG000|Overall Study|Withdrawal by Subject|14|||
130579940|NCT00094757|470086503|FG001|Overall Study|Withdrawal by Subject|21|||
130579941|NCT00094757|470086504|FG002|Overall Study|Withdrawal by Subject|5|||
130579942|NCT00094757|470086502|FG000|Overall Study|Other|3|||
130579943|NCT00094757|470086503|FG001|Overall Study|Other|3|||
130579944|NCT00094757|470086504|FG002|Overall Study|Other|1|||
130579945|NCT00094757|470086502|FG000|Overall Study|Protocol specified discontinuation|1|||
130579946|NCT00094757|470086503|FG001|Overall Study|Protocol specified discontinuation|3|||
130579947|NCT00094757|470086504|FG002|Overall Study|Protocol specified discontinuation|0|||
130579948|NCT00090545|470086505|FG000|Overall Study|Disease progression on study|21|||
130579949|NCT00090545|470086506|FG001|Overall Study|Disease progression on study|17|||
130579950|NCT00090545|470086505|FG000|Overall Study|Refused further treatment|1|||
130579951|NCT00090545|470086506|FG001|Overall Study|Refused further treatment|4|||
130579952|NCT00090545|470086505|FG000|Overall Study|Death|0|||
130579953|NCT00090545|470086506|FG001|Overall Study|Death|1|||
130531540|NCT01228318|469915106|FG001|Overall Study|Incarcerated|0|||
130531541|NCT01182441|469915111|FG000|Overall Study|Patient Still in Follow-up|152|||
130531542|NCT01182441|469915112|FG001|Overall Study|Patient Still in Follow-up|72|||
130531543|NCT01182441|469915111|FG000|Overall Study|Death|37|||
130531544|NCT01182441|469915112|FG001|Overall Study|Death|25|||
130531545|NCT01182441|469915111|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
130531546|NCT01182441|469915112|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
130531547|NCT01182441|469915111|FG000|Overall Study|Lost to Follow-up|5|||
130531548|NCT01182441|469915112|FG001|Overall Study|Lost to Follow-up|8|||
130531549|NCT01182441|469915111|FG000|Overall Study|Withdrawal by Subject|6|||
130531550|NCT01182441|469915112|FG001|Overall Study|Withdrawal by Subject|13|||
130531551|NCT01182441|469915111|FG000|Overall Study|Implant Not Attempted|4|||
130531552|NCT01182441|469915112|FG001|Overall Study|Implant Not Attempted|0|||
130531553|NCT01182441|469915111|FG000|Overall Study|Adverse Event|2|||
130531554|NCT01182441|469915112|FG001|Overall Study|Adverse Event|0|||
130531555|NCT01182441|469915111|FG000|Overall Study|Physician Decision|1|||
130531556|NCT01182441|469915112|FG001|Overall Study|Physician Decision|1|||
130531557|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
130531558|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
130531559|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130531560|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
130531561|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130531562|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130531563|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130531564|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
130531565|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130531566|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130531567|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
130531568|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130531569|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130531570|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
130531571|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130531572|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
130531573|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
130531574|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
130531575|NCT00603525|469915113|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
130531576|NCT00603525|469915114|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
130531577|NCT00603525|469915115|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
130531578|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130531579|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
130531580|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130531581|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130531582|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
130531583|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130531584|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130531585|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
130531586|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130531587|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130531588|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
130531589|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130531590|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130531591|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
130531592|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130531593|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130531594|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
130531595|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130531596|NCT00603525|469915113|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130531597|NCT00603525|469915114|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
130531598|NCT00603525|469915115|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130531599|NCT00603525|469915113|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
130531600|NCT00603525|469915114|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
130531601|NCT00603525|469915115|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
130531602|NCT04703192|469915119|FG000|Overall Study|Withdrawal by Subject|2|||
130531603|NCT04703192|469915120|FG001|Overall Study|Withdrawal by Subject|0|||
130531604|NCT04703192|469915119|FG000|Overall Study|Death|3|||
130531605|NCT04703192|469915120|FG001|Overall Study|Death|1|||
130531606|NCT04703192|469915119|FG000|Overall Study|Adverse Event|13|||
130531607|NCT04703192|469915120|FG001|Overall Study|Adverse Event|2|||
130531608|NCT04703192|469915119|FG000|Overall Study|Progressive or Relapsed Disease|46|||
130531609|NCT04703192|469915120|FG001|Overall Study|Progressive or Relapsed Disease|7|||
130531610|NCT04703192|469915119|FG000|Overall Study|Clinical Progression|19|||
130531611|NCT04703192|469915120|FG001|Overall Study|Clinical Progression|8|||
130531612|NCT04703192|469915119|FG000|Overall Study|Lost to Follow-up|1|||
130531613|NCT04703192|469915120|FG001|Overall Study|Lost to Follow-up|0|||
130531614|NCT04703192|469915119|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
130531615|NCT04703192|469915120|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
130531616|NCT04703192|469915119|FG000|Overall Study|Other|5|||
130531617|NCT04703192|469915120|FG001|Overall Study|Other|1|||
130531618|NCT00678301|469915121|FG000|Overall Study|Non-compliance with study procedures|0|||
130531619|NCT00678301|469915122|FG001|Overall Study|Non-compliance with study procedures|1|||
130531620|NCT00678301|469915121|FG000|Overall Study|Adverse Event|1|||
130531621|NCT00678301|469915122|FG001|Overall Study|Adverse Event|0|||
130531622|NCT00678301|469915121|FG000|Overall Study|Withdrawal by Subject|4|||
130531623|NCT00678301|469915122|FG001|Overall Study|Withdrawal by Subject|0|||
130531624|NCT00678301|469915121|FG000|Overall Study|Lost to Follow-up|3|||
130531625|NCT00678301|469915122|FG001|Overall Study|Lost to Follow-up|1|||
130531626|NCT03596762|469915133|FG000|Overall Study|Protocol Violation|0|||
130531627|NCT03596762|469915134|FG001|Overall Study|Protocol Violation|0|||
130531628|NCT03596762|469915135|FG002|Overall Study|Protocol Violation|0|||
130531629|NCT03596762|469915136|FG003|Overall Study|Protocol Violation|0|||
130531630|NCT03596762|469915137|FG004|Overall Study|Protocol Violation|1|||
130531631|NCT03596762|469915133|FG000|Overall Study|Adverse Event|2|||
130531632|NCT03596762|469915134|FG001|Overall Study|Adverse Event|0|||
130531633|NCT03596762|469915135|FG002|Overall Study|Adverse Event|1|||
130531634|NCT03596762|469915136|FG003|Overall Study|Adverse Event|0|||
130531635|NCT03596762|469915137|FG004|Overall Study|Adverse Event|5|||
130531636|NCT03596762|469915133|FG000|Overall Study|Withdrawal by Subject|2|||
130531637|NCT03596762|469915134|FG001|Overall Study|Withdrawal by Subject|1|||
130531638|NCT03596762|469915135|FG002|Overall Study|Withdrawal by Subject|0|||
130531639|NCT03596762|469915136|FG003|Overall Study|Withdrawal by Subject|1|||
130531640|NCT03596762|469915137|FG004|Overall Study|Withdrawal by Subject|1|||
130531641|NCT01263509|469915138|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
130531642|NCT01263509|469915139|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
130531643|NCT01263509|469915140|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
130531644|NCT01263509|469915141|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
130531645|NCT01263509|469915138|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130531646|NCT01263509|469915139|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
130531647|NCT01263509|469915140|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130531648|NCT01263509|469915141|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130531649|NCT01263509|469915138|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130531650|NCT01263509|469915139|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130531651|NCT01263509|469915140|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130531652|NCT01263509|469915141|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130531653|NCT01263509|469915138|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
130531654|NCT01263509|469915139|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
130531655|NCT01263509|469915140|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130531656|NCT01263509|469915141|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
130531657|NCT01263509|469915138|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
130531658|NCT01263509|469915139|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
130531659|NCT01263509|469915140|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
130531660|NCT01263509|469915141|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
130531661|NCT02593123|469915142|FG000|Overall Study|Physician Decision|2|||
130531662|NCT02593123|469915143|FG001|Overall Study|Physician Decision|1|||
130531663|NCT02593123|469915142|FG000|Overall Study|Relapse|1|||
130531664|NCT02593123|469915143|FG001|Overall Study|Relapse|1|||
130531665|NCT05071053|469915144|FG000|Overall Study|Progressive disease|30|||
130531666|NCT05071053|469915144|FG000|Overall Study|Adverse Event|5|||
130531667|NCT01261000|469915147|FG000|Overall Study|Screen failure|1|||
130531668|NCT00504777|469915148|FG000|Overall Study|Adverse Event|1|||
130531669|NCT01572740|469915149|FG000|Overall Study|Adverse Event|1|||
130531670|NCT01572740|469915150|FG001|Overall Study|Adverse Event|1|||
130531671|NCT01572740|469915149|FG000|Overall Study|Withdrawal by Subject|1|||
130531672|NCT01572740|469915150|FG001|Overall Study|Withdrawal by Subject|1|||
130531673|NCT01572740|469915149|FG000|Overall Study|unclassified|4|||
130531674|NCT01572740|469915150|FG001|Overall Study|unclassified|3|||
130531675|NCT01289210|469915151|FG000|Overall Study|Adverse Event|1|||
130531676|NCT01818531|469915152|FG000|Overall Study|Withdrawn for case delay after block|1|||
130531677|NCT01818531|469915153|FG001|Overall Study|Withdrawn for case delay after block|0|||
130531678|NCT01818531|469915152|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
130531679|NCT01818531|469915153|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
130531680|NCT01818531|469915152|FG000|Overall Study|Withdrawn for failure to place block|0|||
130531681|NCT01818531|469915153|FG001|Overall Study|Withdrawn for failure to place block|1|||
130531682|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
130531683|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
130531684|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
130531685|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
130531686|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
130531687|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
130531688|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
130531689|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
130531690|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
130531691|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
130531692|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531693|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531694|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
130531695|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
130531696|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531697|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531698|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531699|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
130531700|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
130531701|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531702|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531703|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531704|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
130531705|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531706|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531707|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531708|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
130531709|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
130531710|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
130531711|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
130531712|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
130531713|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
130531714|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
130531715|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
130531716|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
130531717|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
130531718|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
130531719|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
130531720|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
130531721|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
130531722|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
130531723|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
130531724|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
130531725|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
130531726|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
130531727|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
130531728|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
130531729|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
130531730|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
130531731|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
130531732|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
130531733|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
130531734|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
130531735|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
130531736|NCT00477490|469915156|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
130531737|NCT00477490|469915157|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
130531738|NCT00477490|469915158|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
130531739|NCT00477490|469915159|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
130531740|NCT00477490|469915160|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
130531741|NCT00477490|469915161|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
130531742|NCT00477490|469915162|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
130531743|NCT00477490|469915163|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
130531744|NCT00477490|469915164|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
130531745|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
130579954|NCT00090545|470086505|FG000|Overall Study|Adverse Event|0|||
130579955|NCT00090545|470086506|FG001|Overall Study|Adverse Event|2|||
130579956|NCT04317274|470086507|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
130579957|NCT04317274|470086508|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
130579958|NCT04317274|470086509|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
130579959|NCT04317274|470086510|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
130579960|NCT02568046|470086511|FG000|Overall Study|Adverse Event|0|||
130579961|NCT02568046|470086512|FG001|Overall Study|Adverse Event|1|||
130579962|NCT02568046|470086511|FG000|Overall Study|Death|2|||
130579963|NCT02568046|470086512|FG001|Overall Study|Death|0|||
130579964|NCT02568046|470086511|FG000|Overall Study|Progressive Disease|1|||
130579965|NCT02568046|470086512|FG001|Overall Study|Progressive Disease|0|||
130579966|NCT02568046|470086511|FG000|Overall Study|Withdrawal by Subject|2|||
130579967|NCT02568046|470086512|FG001|Overall Study|Withdrawal by Subject|1|||
130579968|NCT02568046|470086511|FG000|Overall Study|Other Events|0|||
130579969|NCT02568046|470086512|FG001|Overall Study|Other Events|1|||
130579970|NCT03403192|470086513|FG000|Overall Study|Lost to Follow-up|1|||
130579971|NCT03403192|470086514|FG001|Overall Study|Lost to Follow-up|2|||
130531746|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
130531747|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
130531748|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
130531749|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
130531750|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
130531751|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
130531752|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
130531753|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
130531754|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
130531755|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
130531756|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
130531757|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130531758|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130531759|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130531760|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130531761|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130531762|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
130531763|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130531764|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
130531765|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
130531766|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130531767|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
130531768|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130531769|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
130531770|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130531771|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130531772|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130531773|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130531774|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130531775|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130531776|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
130531777|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130531778|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130579972|NCT03403192|470086515|FG002|Overall Study|Lost to Follow-up|0|||
130531779|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
130531780|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
130531781|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531782|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
130579973|NCT03403192|470086516|FG003|Overall Study|Lost to Follow-up|0|||
130579974|NCT03403192|470086513|FG000|Overall Study|Unable to respond|0|||
130579975|NCT03403192|470086514|FG001|Overall Study|Unable to respond|1|||
130579976|NCT03403192|470086515|FG002|Overall Study|Unable to respond|0|||
130579977|NCT03403192|470086516|FG003|Overall Study|Unable to respond|0|||
130579978|NCT03403192|470086513|FG000|Overall Study|Incomplete|3|||
130579979|NCT03403192|470086514|FG001|Overall Study|Incomplete|1|||
130579980|NCT03403192|470086515|FG002|Overall Study|Incomplete|3|||
130579981|NCT03403192|470086516|FG003|Overall Study|Incomplete|6|||
130579982|NCT00379795|470086517|FG000|Overall Study|Death|31|||
130579983|NCT00379795|470086518|FG001|Overall Study|Death|8|||
130579984|NCT00379795|470086519|FG002|Overall Study|Death|6|||
130579985|NCT00379795|470086520|FG003|Overall Study|Death|4|||
130579986|NCT00379795|470086521|FG004|Overall Study|Death|7|||
130579987|NCT00379795|470086517|FG000|Overall Study|Adverse Event|17|||
130579988|NCT00379795|470086518|FG001|Overall Study|Adverse Event|3|||
130579989|NCT00379795|470086519|FG002|Overall Study|Adverse Event|3|||
130579990|NCT00379795|470086520|FG003|Overall Study|Adverse Event|1|||
130579991|NCT00379795|470086521|FG004|Overall Study|Adverse Event|4|||
130579992|NCT00379795|470086517|FG000|Overall Study|Lost to Follow-up|8|||
130579993|NCT00379795|470086518|FG001|Overall Study|Lost to Follow-up|1|||
130579994|NCT00379795|470086519|FG002|Overall Study|Lost to Follow-up|2|||
130579995|NCT00379795|470086520|FG003|Overall Study|Lost to Follow-up|1|||
130579996|NCT00379795|470086521|FG004|Overall Study|Lost to Follow-up|4|||
130579997|NCT00379795|470086517|FG000|Overall Study|Physician Decision|25|||
130579998|NCT00379795|470086518|FG001|Overall Study|Physician Decision|0|||
130579999|NCT00379795|470086519|FG002|Overall Study|Physician Decision|2|||
130580000|NCT00379795|470086520|FG003|Overall Study|Physician Decision|2|||
130580001|NCT00379795|470086521|FG004|Overall Study|Physician Decision|2|||
130580002|NCT00379795|470086517|FG000|Overall Study|Withdrawal by Subject|94|||
130580003|NCT00379795|470086518|FG001|Overall Study|Withdrawal by Subject|11|||
130580004|NCT00379795|470086519|FG002|Overall Study|Withdrawal by Subject|19|||
130580005|NCT00379795|470086520|FG003|Overall Study|Withdrawal by Subject|7|||
130580006|NCT00379795|470086521|FG004|Overall Study|Withdrawal by Subject|14|||
130580007|NCT00379795|470086517|FG000|Overall Study|Subject non-compliance|7|||
130580008|NCT00379795|470086518|FG001|Overall Study|Subject non-compliance|2|||
130580009|NCT00379795|470086519|FG002|Overall Study|Subject non-compliance|0|||
130580010|NCT00379795|470086520|FG003|Overall Study|Subject non-compliance|0|||
130580011|NCT00379795|470086521|FG004|Overall Study|Subject non-compliance|1|||
130580012|NCT00379795|470086517|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
130580013|NCT00379795|470086518|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130580014|NCT00379795|470086519|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130580015|NCT00379795|470086520|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
130580016|NCT00379795|470086521|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130580017|NCT00379795|470086517|FG000|Overall Study|Subjects condition mandated intervention|34|||
130580018|NCT00379795|470086518|FG001|Overall Study|Subjects condition mandated intervention|9|||
130580019|NCT00379795|470086519|FG002|Overall Study|Subjects condition mandated intervention|7|||
130580020|NCT00379795|470086520|FG003|Overall Study|Subjects condition mandated intervention|5|||
130531783|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531784|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531785|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531786|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531787|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531788|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531789|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130531790|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
130531791|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
130531792|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
130531793|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
130580021|NCT00379795|470086521|FG004|Overall Study|Subjects condition mandated intervention|7|||
130580022|NCT00379795|470086517|FG000|Overall Study|Sponsor's decision|257|||
130580023|NCT00379795|470086518|FG001|Overall Study|Sponsor's decision|17|||
130580024|NCT00379795|470086519|FG002|Overall Study|Sponsor's decision|54|||
130580025|NCT00379795|470086520|FG003|Overall Study|Sponsor's decision|47|||
130531794|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
130580026|NCT00379795|470086521|FG004|Overall Study|Sponsor's decision|10|||
130580027|NCT04849780|470086522|FG000|Period 1|Covid-19 Related|1|||
130580028|NCT04849780|470086523|FG001|Period 1|Covid-19 Related|0|||
130580029|NCT04849780|470086522|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
130580030|NCT04849780|470086523|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
130580031|NCT04849780|470086522|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
130580032|NCT04849780|470086523|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
130580033|NCT02551159|470086524|FG000|Overall Study|Death|352|||
130580034|NCT02551159|470086525|FG001|Overall Study|Death|174|||
130580035|NCT02551159|470086526|FG002|Overall Study|Death|161|||
130580036|NCT02551159|470086524|FG000|Overall Study|Withdrawal by Subject|8|||
130580037|NCT02551159|470086525|FG001|Overall Study|Withdrawal by Subject|5|||
130580038|NCT02551159|470086526|FG002|Overall Study|Withdrawal by Subject|16|||
130580039|NCT02551159|470086524|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
130580040|NCT02551159|470086525|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
130580041|NCT02551159|470086526|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
130580042|NCT00268242|470086527|FG000|Overall Study|Death|1|||
130580043|NCT00993928|470086528|FG000|Overall Study|Withdrawal by Subject|4|||
130580044|NCT00993928|470086529|FG001|Overall Study|Withdrawal by Subject|7|||
130580045|NCT00993928|470086528|FG000|Overall Study|ineligible|1|||
130580046|NCT00993928|470086529|FG001|Overall Study|ineligible|0|||
130580047|NCT01665144|470086530|FG000|Core Part|Withdrawal by Subject|96|||
130580048|NCT01665144|470086531|FG001|Core Part|Withdrawal by Subject|77|||
130580049|NCT01665144|470086532|FG002|Core Part|Withdrawal by Subject|0|||
130580050|NCT01665144|470086530|FG000|Core Part|Adverse Event|45|||
130580051|NCT01665144|470086531|FG001|Core Part|Adverse Event|18|||
130580052|NCT01665144|470086532|FG002|Core Part|Adverse Event|0|||
130580053|NCT01665144|470086530|FG000|Core Part|Lack of Efficacy|16|||
130580054|NCT01665144|470086531|FG001|Core Part|Lack of Efficacy|11|||
130580055|NCT01665144|470086532|FG002|Core Part|Lack of Efficacy|0|||
130580056|NCT01665144|470086530|FG000|Core Part|Lost to Follow-up|9|||
130580057|NCT01665144|470086531|FG001|Core Part|Lost to Follow-up|8|||
130580058|NCT01665144|470086532|FG002|Core Part|Lost to Follow-up|0|||
130580059|NCT01665144|470086530|FG000|Core Part|Physician Decision|13|||
130580060|NCT01665144|470086531|FG001|Core Part|Physician Decision|1|||
130580061|NCT01665144|470086532|FG002|Core Part|Physician Decision|0|||
130580062|NCT01665144|470086530|FG000|Core Part|Progressive disease|8|||
130580063|NCT01665144|470086531|FG001|Core Part|Progressive disease|4|||
130580064|NCT01665144|470086532|FG002|Core Part|Progressive disease|0|||
130580065|NCT01665144|470086530|FG000|Core Part|Non-compliance with study treatment|5|||
130580066|NCT01665144|470086531|FG001|Core Part|Non-compliance with study treatment|0|||
130580067|NCT01665144|470086532|FG002|Core Part|Non-compliance with study treatment|0|||
130580068|NCT01665144|470086530|FG000|Core Part|Death|3|||
130580069|NCT01665144|470086531|FG001|Core Part|Death|1|||
130580070|NCT01665144|470086532|FG002|Core Part|Death|0|||
130580071|NCT01665144|470086530|FG000|Core Part|Protocol deviation|3|||
130580072|NCT01665144|470086531|FG001|Core Part|Protocol deviation|1|||
130580073|NCT01665144|470086532|FG002|Core Part|Protocol deviation|0|||
130580074|NCT01665144|470086530|FG000|Core Part|New therapy for study indication|2|||
130580075|NCT01665144|470086531|FG001|Core Part|New therapy for study indication|1|||
130580076|NCT01665144|470086532|FG002|Core Part|New therapy for study indication|0|||
130580077|NCT01665144|470086530|FG000|Core Part|Technical problems|2|||
130580078|NCT01665144|470086531|FG001|Core Part|Technical problems|0|||
130580079|NCT01665144|470086532|FG002|Core Part|Technical problems|0|||
130580080|NCT01665144|470086530|FG000|Extension Part|Patient/guardian decision|180|||
130580081|NCT01665144|470086531|FG001|Extension Part|Patient/guardian decision|0|||
130580082|NCT01665144|470086532|FG002|Extension Part|Patient/guardian decision|98|||
130580083|NCT01665144|470086530|FG000|Extension Part|Adverse Event|104|||
130580084|NCT01665144|470086531|FG001|Extension Part|Adverse Event|0|||
130580085|NCT01665144|470086532|FG002|Extension Part|Adverse Event|59|||
130580086|NCT01665144|470086530|FG000|Extension Part|Study closed early|42|||
130580087|NCT01665144|470086531|FG001|Extension Part|Study closed early|0|||
130580088|NCT01665144|470086532|FG002|Extension Part|Study closed early|19|||
130580089|NCT01665144|470086530|FG000|Extension Part|Progressive disease|36|||
130580090|NCT01665144|470086531|FG001|Extension Part|Progressive disease|0|||
130580091|NCT01665144|470086532|FG002|Extension Part|Progressive disease|14|||
130580092|NCT01665144|470086530|FG000|Extension Part|Lack of Efficacy|37|||
130580093|NCT01665144|470086531|FG001|Extension Part|Lack of Efficacy|0|||
130580094|NCT01665144|470086532|FG002|Extension Part|Lack of Efficacy|12|||
130580095|NCT01665144|470086530|FG000|Extension Part|Physician Decision|29|||
130580096|NCT01665144|470086531|FG001|Extension Part|Physician Decision|0|||
130580097|NCT01665144|470086532|FG002|Extension Part|Physician Decision|13|||
130580098|NCT01665144|470086530|FG000|Extension Part|Technical problems|20|||
130580099|NCT01665144|470086531|FG001|Extension Part|Technical problems|0|||
130580100|NCT01665144|470086532|FG002|Extension Part|Technical problems|8|||
130580101|NCT01665144|470086530|FG000|Extension Part|Death|20|||
130580102|NCT01665144|470086531|FG001|Extension Part|Death|0|||
130580103|NCT01665144|470086532|FG002|Extension Part|Death|4|||
130580104|NCT01665144|470086530|FG000|Extension Part|Missing|12|||
130580105|NCT01665144|470086531|FG001|Extension Part|Missing|0|||
130580106|NCT01665144|470086532|FG002|Extension Part|Missing|6|||
130580107|NCT01665144|470086530|FG000|Extension Part|Lost to Follow-up|9|||
130580108|NCT01665144|470086531|FG001|Extension Part|Lost to Follow-up|0|||
130580109|NCT01665144|470086532|FG002|Extension Part|Lost to Follow-up|5|||
130580110|NCT01665144|470086530|FG000|Extension Part|New therapy for study indication|3|||
130580111|NCT01665144|470086531|FG001|Extension Part|New therapy for study indication|0|||
130580112|NCT01665144|470086532|FG002|Extension Part|New therapy for study indication|2|||
130580113|NCT01665144|470086530|FG000|Extension Part|Protocol deviation|3|||
130580114|NCT01665144|470086531|FG001|Extension Part|Protocol deviation|0|||
130580115|NCT01665144|470086532|FG002|Extension Part|Protocol deviation|0|||
130580116|NCT02317562|470086537|FG000|Overall Study|Physician Decision|1|||
130580117|NCT02317562|470086537|FG000|Overall Study|early termination of the study|8|||
130580118|NCT02317562|470086537|FG000|Overall Study|Lack of Efficacy|4|||
130580119|NCT02317562|470086537|FG000|Overall Study|Withdrawal by Subject|1|||
130580120|NCT03551743|470086538|FG000|Overall Study|Adverse Event|1|||
130580121|NCT03551743|470086539|FG001|Overall Study|Adverse Event|0|||
130580122|NCT03551743|470086540|FG002|Overall Study|Adverse Event|0|||
130580123|NCT03551743|470086541|FG003|Overall Study|Adverse Event|0|||
130580124|NCT03551743|470086538|FG000|Overall Study|Withdrawal by Subject|1|||
130580125|NCT03551743|470086539|FG001|Overall Study|Withdrawal by Subject|0|||
130580126|NCT03551743|470086540|FG002|Overall Study|Withdrawal by Subject|0|||
130580127|NCT03551743|470086541|FG003|Overall Study|Withdrawal by Subject|0|||
130580128|NCT00911989|470086542|FG000|Overall Study|Adverse Event|1|||
130580129|NCT01145066|470086543|FG000|Overall Study|To resume NSAIDs|2|||
130580130|NCT01145066|470086544|FG001|Overall Study|To resume NSAIDs|2|||
130580131|NCT01145066|470086545|FG002|Overall Study|To resume NSAIDs|1|||
130580132|NCT01145066|470086543|FG000|Overall Study|Non-related surgery|0|||
130580133|NCT01145066|470086544|FG001|Overall Study|Non-related surgery|0|||
130580134|NCT01145066|470086545|FG002|Overall Study|Non-related surgery|1|||
130580135|NCT01145066|470086543|FG000|Overall Study|Withdrawal by Subject|0|||
130580136|NCT01145066|470086544|FG001|Overall Study|Withdrawal by Subject|0|||
130580137|NCT01145066|470086545|FG002|Overall Study|Withdrawal by Subject|2|||
130580138|NCT01145066|470086543|FG000|Overall Study|To start new med|1|||
130580139|NCT01145066|470086544|FG001|Overall Study|To start new med|0|||
130580140|NCT01145066|470086545|FG002|Overall Study|To start new med|0|||
130580141|NCT01145066|470086543|FG000|Overall Study|problems swallowing capsule|1|||
130580142|NCT01145066|470086544|FG001|Overall Study|problems swallowing capsule|0|||
130580143|NCT01145066|470086545|FG002|Overall Study|problems swallowing capsule|0|||
130580144|NCT01145066|470086543|FG000|Overall Study|Abdominal discomfort|0|||
130580145|NCT01145066|470086544|FG001|Overall Study|Abdominal discomfort|1|||
130580146|NCT01145066|470086545|FG002|Overall Study|Abdominal discomfort|0|||
130580147|NCT01145066|470086543|FG000|Overall Study|Low platelet count|0|||
130580148|NCT01145066|470086544|FG001|Overall Study|Low platelet count|1|||
130580149|NCT01145066|470086545|FG002|Overall Study|Low platelet count|0|||
130580150|NCT03687502|470086551|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
130580151|NCT03687502|470086551|FG000|Overall Study|Lumason not available|1|||
130580152|NCT01724528|470086555|FG000|Overall Study|Death|3|||
130580153|NCT01724528|470086556|FG001|Overall Study|Death|0|||
130580154|NCT01724528|470086555|FG000|Overall Study|Withdrawal by Subject|0|||
130580155|NCT01724528|470086556|FG001|Overall Study|Withdrawal by Subject|2|||
130580156|NCT01724528|470086555|FG000|Overall Study|Protocol Violation|0|||
130580157|NCT01724528|470086556|FG001|Overall Study|Protocol Violation|1|||
130580158|NCT01724528|470086555|FG000|Overall Study|Patient refused to attend last visit|1|||
130580159|NCT01724528|470086556|FG001|Overall Study|Patient refused to attend last visit|0|||
130580160|NCT02937350|470086560|FG000|Overall Study|Withdrawal by Subject|0|||
130580161|NCT02937350|470086561|FG001|Overall Study|Withdrawal by Subject|1|||
130580162|NCT02937350|470086562|FG002|Overall Study|Withdrawal by Subject|0|||
130580163|NCT00803179|470086565|FG000|Overall Study|Lost to Follow-up|3|||
130580164|NCT04811716|470086567|FG000|Overall Study|Withdrawal by Subject|2|||
130580165|NCT04811716|470086568|FG001|Overall Study|Withdrawal by Subject|0|||
130580166|NCT01877083|470086572|FG000|Treatment Phase|Disease Progression|10|||
130580167|NCT01877083|470086572|FG000|Treatment Phase|Clinical Progression|1|||
130580168|NCT01877083|470086572|FG000|Treatment Phase|Adverse Event|6|||
130580169|NCT01877083|470086572|FG000|Treatment Phase|Withdrawal by Subject|2|||
130580170|NCT01877083|470086572|FG000|Treatment Phase|Lost to Follow-up|1|||
130580171|NCT01877083|470086572|FG000|Extension Phase|Disease Progression|3|||
130580172|NCT01877083|470086572|FG000|Extension Phase|Adverse Event|2|||
130580173|NCT00429585|470086575|FG000|Overall Study|Death|1|||
130580174|NCT00429585|470086576|FG001|Overall Study|Death|0|||
130580175|NCT00429585|470086575|FG000|Overall Study|Lost to Follow-up|27|||
130580176|NCT00429585|470086576|FG001|Overall Study|Lost to Follow-up|20|||
130580177|NCT00429585|470086575|FG000|Overall Study|Physician Decision|2|||
130580178|NCT00429585|470086576|FG001|Overall Study|Physician Decision|0|||
130580179|NCT01582308|470086577|FG000|Period 1|Withdrawal by Subject|0|||
130580180|NCT01582308|470086578|FG001|Period 1|Withdrawal by Subject|0|||
130580181|NCT01582308|470086579|FG002|Period 1|Withdrawal by Subject|0|||
130580182|NCT01582308|470086580|FG003|Period 1|Withdrawal by Subject|0|||
130580183|NCT01582308|470086581|FG004|Period 1|Withdrawal by Subject|0|||
130580184|NCT01582308|470086582|FG005|Period 1|Withdrawal by Subject|0|||
130580185|NCT01582308|470086583|FG006|Period 1|Withdrawal by Subject|1|||
130580186|NCT01582308|470086584|FG007|Period 1|Withdrawal by Subject|0|||
130580187|NCT01582308|470086585|FG008|Period 1|Withdrawal by Subject|0|||
130580188|NCT01582308|470086586|FG009|Period 1|Withdrawal by Subject|0|||
130580189|NCT01582308|470086577|FG000|10-day Washout Following Period 1|Physician Decision|0|||
130580190|NCT01582308|470086578|FG001|10-day Washout Following Period 1|Physician Decision|0|||
130580191|NCT01582308|470086579|FG002|10-day Washout Following Period 1|Physician Decision|0|||
130580192|NCT01582308|470086580|FG003|10-day Washout Following Period 1|Physician Decision|0|||
130580193|NCT01582308|470086581|FG004|10-day Washout Following Period 1|Physician Decision|1|||
130580194|NCT01582308|470086582|FG005|10-day Washout Following Period 1|Physician Decision|0|||
130580195|NCT01582308|470086583|FG006|10-day Washout Following Period 1|Physician Decision|0|||
130580196|NCT01582308|470086584|FG007|10-day Washout Following Period 1|Physician Decision|0|||
130580197|NCT01582308|470086585|FG008|10-day Washout Following Period 1|Physician Decision|0|||
130580198|NCT01582308|470086586|FG009|10-day Washout Following Period 1|Physician Decision|0|||
130580199|NCT01582308|470086577|FG000|Period 4|Physician Decision|1|||
130580200|NCT01582308|470086578|FG001|Period 4|Physician Decision|0|||
130580201|NCT01582308|470086579|FG002|Period 4|Physician Decision|0|||
130580202|NCT01582308|470086580|FG003|Period 4|Physician Decision|0|||
130580203|NCT01582308|470086581|FG004|Period 4|Physician Decision|0|||
130580204|NCT01582308|470086582|FG005|Period 4|Physician Decision|1|||
130580205|NCT01582308|470086583|FG006|Period 4|Physician Decision|0|||
130580206|NCT01582308|470086584|FG007|Period 4|Physician Decision|0|||
130580207|NCT01582308|470086585|FG008|Period 4|Physician Decision|0|||
130580208|NCT01582308|470086586|FG009|Period 4|Physician Decision|1|||
130580209|NCT06228586|470086591|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
130580210|NCT06228586|470086592|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
130580211|NCT01227902|470088460|FG000|Overall Study|Adverse Event|12|||
130580212|NCT01227902|470088461|FG001|Overall Study|Adverse Event|8|||
130580213|NCT01227902|470088462|FG002|Overall Study|Adverse Event|11|||
130580214|NCT01227902|470088463|FG003|Overall Study|Adverse Event|4|||
130580215|NCT01227902|470088460|FG000|Overall Study|Lack of Efficacy|1|||
130580216|NCT01227902|470088461|FG001|Overall Study|Lack of Efficacy|2|||
130580217|NCT01227902|470088462|FG002|Overall Study|Lack of Efficacy|2|||
130580218|NCT01227902|470088463|FG003|Overall Study|Lack of Efficacy|1|||
130580219|NCT01227902|470088460|FG000|Overall Study|Protocol Violation|1|||
130580220|NCT01227902|470088461|FG001|Overall Study|Protocol Violation|0|||
130580221|NCT01227902|470088462|FG002|Overall Study|Protocol Violation|0|||
130580222|NCT01227902|470088463|FG003|Overall Study|Protocol Violation|0|||
130580223|NCT01227902|470088460|FG000|Overall Study|Lost to Follow-up|0|||
130580224|NCT01227902|470088461|FG001|Overall Study|Lost to Follow-up|0|||
130580225|NCT01227902|470088462|FG002|Overall Study|Lost to Follow-up|1|||
130580226|NCT01227902|470088463|FG003|Overall Study|Lost to Follow-up|2|||
130580227|NCT01227902|470088460|FG000|Overall Study|Physician Decision|0|||
130580228|NCT01227902|470088461|FG001|Overall Study|Physician Decision|1|||
130580229|NCT01227902|470088462|FG002|Overall Study|Physician Decision|1|||
130580230|NCT01227902|470088463|FG003|Overall Study|Physician Decision|0|||
130580231|NCT01227902|470088460|FG000|Overall Study|Withdrawal by Subject|4|||
130580232|NCT01227902|470088461|FG001|Overall Study|Withdrawal by Subject|2|||
130580233|NCT01227902|470088462|FG002|Overall Study|Withdrawal by Subject|4|||
130580234|NCT01227902|470088463|FG003|Overall Study|Withdrawal by Subject|3|||
130580235|NCT01299766|470088471|FG000|Overall Study|Death|5|||
130580236|NCT01299766|470088472|FG001|Overall Study|Death|4|||
130580237|NCT01299766|470088471|FG000|Overall Study|Withdrawal by Subject|29|||
130580238|NCT01299766|470088472|FG001|Overall Study|Withdrawal by Subject|19|||
130580239|NCT00403260|470088475|FG000|Overall Study|Adverse Event|5|||
130580240|NCT00403260|470088476|FG001|Overall Study|Adverse Event|4|||
130580241|NCT00403260|470088475|FG000|Overall Study|Withdrawal by Subject|5|||
130580242|NCT00403260|470088476|FG001|Overall Study|Withdrawal by Subject|6|||
130580243|NCT00403260|470088475|FG000|Overall Study|Lost to Follow-up|49|||
130580244|NCT00403260|470088476|FG001|Overall Study|Lost to Follow-up|25|||
130580245|NCT00403260|470088475|FG000|Overall Study|Re-appearance of P. falciparum|34|||
130580246|NCT00403260|470088476|FG001|Overall Study|Re-appearance of P. falciparum|25|||
130580247|NCT00403260|470088475|FG000|Overall Study|P. vivax infection|26|||
130580248|NCT00403260|470088476|FG001|Overall Study|P. vivax infection|4|||
130580249|NCT00403260|470088475|FG000|Overall Study|Mixed infection with P. vivax|2|||
130580250|NCT00403260|470088476|FG001|Overall Study|Mixed infection with P. vivax|0|||
130580251|NCT00403260|470088475|FG000|Overall Study|Mixed infection with P. falciparum|1|||
130580252|NCT00403260|470088476|FG001|Overall Study|Mixed infection with P. falciparum|0|||
130580253|NCT00403260|470088475|FG000|Overall Study|P. vivax infection at screening|1|||
130580254|NCT00403260|470088476|FG001|Overall Study|P. vivax infection at screening|0|||
130580255|NCT00403260|470088475|FG000|Overall Study|P. ovale infection|1|||
130580256|NCT00403260|470088476|FG001|Overall Study|P. ovale infection|0|||
130580257|NCT00403260|470088475|FG000|Overall Study|Gametocyte re-appearance|1|||
130580258|NCT00403260|470088476|FG001|Overall Study|Gametocyte re-appearance|1|||
130580259|NCT00403260|470088475|FG000|Overall Study|Withdrawn from study accidentally|0|||
130580260|NCT00403260|470088476|FG001|Overall Study|Withdrawn from study accidentally|1|||
130580261|NCT01354028|470088477|FG000|Overall Study|Physician Decision|0|||
130580262|NCT01354028|470088478|FG001|Overall Study|Physician Decision|2|||
130580263|NCT01354028|470088477|FG000|Overall Study|Discharged before study start|2|||
130580264|NCT01354028|470088478|FG001|Overall Study|Discharged before study start|2|||
130580265|NCT01354028|470088477|FG000|Overall Study|No quiet alert state|0|||
130580266|NCT01354028|470088478|FG001|Overall Study|No quiet alert state|1|||
130580267|NCT00935883|470088481|FG000|Treatment Period|Physician Decision|1|||
130580268|NCT00935883|470088482|FG001|Treatment Period|Physician Decision|0|||
130580269|NCT00935883|470088481|FG000|Treatment Period|Withdrawal by Subject|0|||
130580270|NCT00935883|470088482|FG001|Treatment Period|Withdrawal by Subject|2|||
130580271|NCT01072344|470088486|FG000|Overall Study|Relasped-reached end point|7|||
130580272|NCT01072344|470088487|FG001|Overall Study|Relasped-reached end point|12|||
130580273|NCT01072344|470088486|FG000|Overall Study|Protocol Violation|1|||
130580274|NCT01072344|470088487|FG001|Overall Study|Protocol Violation|2|||
130580275|NCT01072344|470088486|FG000|Overall Study|Lost to Follow-up|3|||
130580276|NCT01072344|470088487|FG001|Overall Study|Lost to Follow-up|4|||
130580277|NCT01461044|470088494|FG000|Overall Study|Death|58|||
130580278|NCT01461044|470088495|FG001|Overall Study|Death|35|||
130580279|NCT01461044|470088494|FG000|Overall Study|Lost to Follow-up|12|||
130580280|NCT01461044|470088495|FG001|Overall Study|Lost to Follow-up|5|||
130580281|NCT00716976|470088496|FG000|Overall Study|Adverse Event|2|||
130580282|NCT00716976|470088497|FG001|Overall Study|Adverse Event|0|||
130580283|NCT00716976|470088496|FG000|Overall Study|Death|1|||
130580284|NCT00716976|470088497|FG001|Overall Study|Death|0|||
130580285|NCT00716976|470088496|FG000|Overall Study|Physician Decision|2|||
130580286|NCT00716976|470088497|FG001|Overall Study|Physician Decision|2|||
130580287|NCT00716976|470088496|FG000|Overall Study|Withdrawal by Subject|5|||
130580288|NCT00716976|470088497|FG001|Overall Study|Withdrawal by Subject|1|||
130580289|NCT00716976|470088496|FG000|Overall Study|Premature discontinuation cisplatin|5|||
130580290|NCT00716976|470088497|FG001|Overall Study|Premature discontinuation cisplatin|4|||
130580291|NCT00716976|470088496|FG000|Overall Study|Radiation during protocol|1|||
130580292|NCT00716976|470088497|FG001|Overall Study|Radiation during protocol|0|||
130580293|NCT00716976|470088496|FG000|Overall Study|Ineligibles|4|||
130580294|NCT00716976|470088497|FG001|Overall Study|Ineligibles|2|||
130580295|NCT00122135|470088498|FG000|Overall Study|Withdrawal by Subject|3|||
130580296|NCT00122135|470088499|FG001|Overall Study|Withdrawal by Subject|0|||
130580297|NCT00975156|470088505|FG000|Overall Study|Protocol Violation|0|||
130580298|NCT00975156|470088506|FG001|Overall Study|Protocol Violation|1|||
130580299|NCT00454779|470088511|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
130580300|NCT00454779|470088512|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
130580301|NCT00454779|470088511|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
130580302|NCT00454779|470088512|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
130580303|NCT00454779|470088511|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
130580304|NCT00454779|470088512|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
130580305|NCT00454779|470088511|FG000|First-line Treatment Phase|Protocol Violation|0|||
130580306|NCT00454779|470088512|FG001|First-line Treatment Phase|Protocol Violation|1|||
130580307|NCT00454779|470088511|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
130580308|NCT00454779|470088512|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
130580309|NCT00454779|470088511|FG000|First-line Treatment Phase|Ongoing|1|||
130580310|NCT00454779|470088512|FG001|First-line Treatment Phase|Ongoing|0|||
130580311|NCT00454779|470088511|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
130580312|NCT00454779|470088512|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
130580313|NCT00454779|470088511|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
130580314|NCT00454779|470088512|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
130580315|NCT00454779|470088511|FG000|Second-line Treatment Phase|Ongoing|0|||
130580316|NCT00454779|470088512|FG001|Second-line Treatment Phase|Ongoing|1|||
130580317|NCT05425563|470088515|FG000|Overall Study|Withdrawal by Subject|17|||
130580318|NCT00168831|470088516|FG000|Overall Study|Adverse Event|36|||
130580319|NCT00168831|470088517|FG001|Overall Study|Adverse Event|47|||
130580320|NCT00168831|470088518|FG002|Overall Study|Adverse Event|74|||
130580321|NCT00168831|470088516|FG000|Overall Study|Lost to Follow-up|5|||
130580322|NCT00168831|470088517|FG001|Overall Study|Lost to Follow-up|6|||
130580323|NCT00168831|470088518|FG002|Overall Study|Lost to Follow-up|4|||
130580324|NCT00168831|470088516|FG000|Overall Study|Withdrawal by Subject|7|||
130580325|NCT00168831|470088517|FG001|Overall Study|Withdrawal by Subject|14|||
130580326|NCT00168831|470088518|FG002|Overall Study|Withdrawal by Subject|19|||
130580327|NCT00168831|470088516|FG000|Overall Study|Protocol Violation|6|||
130580328|NCT00168831|470088517|FG001|Overall Study|Protocol Violation|11|||
130580329|NCT00168831|470088518|FG002|Overall Study|Protocol Violation|11|||
130580330|NCT00168831|470088516|FG000|Overall Study|Other|6|||
130580331|NCT00168831|470088517|FG001|Overall Study|Other|3|||
130580332|NCT00168831|470088518|FG002|Overall Study|Other|6|||
130580333|NCT01622569|470088522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
130580334|NCT01622569|470088523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
130580335|NCT01622569|470088524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
130580336|NCT01622569|470088525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130580337|NCT01622569|470088522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130580338|NCT01622569|470088523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130580339|NCT01622569|470088524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
130580340|NCT01622569|470088525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130580341|NCT01622569|470088522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
130580342|NCT01622569|470088523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130580343|NCT01622569|470088524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
130580344|NCT01622569|470088525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
130580345|NCT01622569|470088522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130580346|NCT01622569|470088523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
130580347|NCT01622569|470088524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130580348|NCT01622569|470088525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
130580349|NCT01622569|470088522|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130580350|NCT01622569|470088523|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130580351|NCT01622569|470088524|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130580352|NCT01622569|470088525|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130580353|NCT01622569|470088522|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130580354|NCT01622569|470088523|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
130580355|NCT01622569|470088524|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130580356|NCT01622569|470088525|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130580357|NCT01622569|470088522|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130580358|NCT01622569|470088523|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130580359|NCT01622569|470088524|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
130580360|NCT01622569|470088525|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130580361|NCT01622569|470088522|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130580362|NCT01622569|470088523|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130580363|NCT01622569|470088524|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130580364|NCT01622569|470088525|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
130580365|NCT02009878|470088526|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
130580366|NCT02009878|470088527|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130580367|NCT02009878|470088528|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
130580368|NCT01940484|470088531|FG000|Overall Study|Withdrawal by Subject|3|||
130580369|NCT01940484|470088531|FG000|Overall Study|Underwent transplantation|4|||
130580370|NCT01940484|470088531|FG000|Overall Study|Death|2|||
130580371|NCT01940484|470088531|FG000|Overall Study|Adverse Event|1|||
130580372|NCT00343512|470088538|FG000|Overall Study|Withdrawal by Subject|2|||
130580373|NCT00684515|470088539|FG000|Overall Study|Adverse Event|3|||
130580374|NCT00684515|470088540|FG001|Overall Study|Adverse Event|3|||
130580375|NCT00684515|470088541|FG002|Overall Study|Adverse Event|1|||
130580376|NCT00684515|470088539|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
130580377|NCT00684515|470088540|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
130580378|NCT00684515|470088541|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
130580379|NCT04428411|470088542|FG000|Overall Study|Lost to Follow-up|114|||
130580380|NCT00634569|470088543|FG000|Overall Study|Withdrawal by Subject|0|||
130580381|NCT00634569|470088544|FG001|Overall Study|Withdrawal by Subject|4|||
130580382|NCT00634569|470088543|FG000|Overall Study|Physician Decision|0|||
130580383|NCT00634569|470088544|FG001|Overall Study|Physician Decision|1|||
130580384|NCT01163786|470088545|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
130580385|NCT01163786|470088545|FG000|Treatment With Bortezomib|Adverse Event|2|||
130580386|NCT01163786|470088545|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
130580387|NCT02918019|470088546|FG000|Overall Study|Death|0|||
130580388|NCT02918019|470088547|FG001|Overall Study|Death|0|||
130580389|NCT02918019|470088548|FG002|Overall Study|Death|1|||
130580390|NCT02918019|470088549|FG003|Overall Study|Death|0|||
130580391|NCT02918019|470088546|FG000|Overall Study|Lost to Follow-up|1|||
130580392|NCT02918019|470088547|FG001|Overall Study|Lost to Follow-up|1|||
130580393|NCT02918019|470088548|FG002|Overall Study|Lost to Follow-up|0|||
130580394|NCT02918019|470088549|FG003|Overall Study|Lost to Follow-up|1|||
130580395|NCT02918019|470088546|FG000|Overall Study|Principal investigator request|0|||
130580396|NCT02918019|470088547|FG001|Overall Study|Principal investigator request|0|||
130580397|NCT02918019|470088548|FG002|Overall Study|Principal investigator request|0|||
130580398|NCT02918019|470088549|FG003|Overall Study|Principal investigator request|1|||
130580399|NCT02918019|470088546|FG000|Overall Study|Physician Decision|1|||
130580400|NCT02918019|470088547|FG001|Overall Study|Physician Decision|3|||
130580401|NCT02918019|470088548|FG002|Overall Study|Physician Decision|2|||
130580402|NCT02918019|470088549|FG003|Overall Study|Physician Decision|0|||
130580403|NCT02918019|470088546|FG000|Overall Study|Protocol deviation|1|||
130580404|NCT02918019|470088547|FG001|Overall Study|Protocol deviation|1|||
130580405|NCT02918019|470088548|FG002|Overall Study|Protocol deviation|0|||
130580406|NCT02918019|470088549|FG003|Overall Study|Protocol deviation|2|||
130580407|NCT02918019|470088546|FG000|Overall Study|Withdrawal by Subject|3|||
130580408|NCT02918019|470088547|FG001|Overall Study|Withdrawal by Subject|4|||
130580409|NCT02918019|470088548|FG002|Overall Study|Withdrawal by Subject|6|||
130580410|NCT02918019|470088549|FG003|Overall Study|Withdrawal by Subject|4|||
130580411|NCT02918019|470088546|FG000|Overall Study|Adverse Event|0|||
130580412|NCT02918019|470088547|FG001|Overall Study|Adverse Event|1|||
130580413|NCT02918019|470088548|FG002|Overall Study|Adverse Event|0|||
130580414|NCT02918019|470088549|FG003|Overall Study|Adverse Event|1|||
130580415|NCT01212185|470088550|FG000|Overall Study|Protocol Violation|2|||
130580416|NCT01212185|470088551|FG001|Overall Study|Protocol Violation|1|||
130580417|NCT04823949|470088555|FG000|Overall Study|Withdrawal by Subject|0|||
130580418|NCT04823949|470088556|FG001|Overall Study|Withdrawal by Subject|4|||
130580419|NCT04823949|470088555|FG000|Overall Study|Physician Decision|0|||
130580420|NCT04823949|470088556|FG001|Overall Study|Physician Decision|1|||
130580421|NCT01700192|470088558|FG000|Overall Study|Adverse Event|73|||
130580422|NCT01700192|470088559|FG001|Overall Study|Adverse Event|18|||
130580423|NCT01700192|470088558|FG000|Overall Study|Lack of Efficacy|1|||
130580424|NCT01700192|470088559|FG001|Overall Study|Lack of Efficacy|0|||
130580425|NCT01700192|470088558|FG000|Overall Study|Lost to Follow-up|42|||
130580426|NCT01700192|470088559|FG001|Overall Study|Lost to Follow-up|29|||
130580427|NCT01700192|470088558|FG000|Overall Study|Noncompliance with study drug|0|||
130580428|NCT01700192|470088559|FG001|Overall Study|Noncompliance with study drug|5|||
130580429|NCT01700192|470088558|FG000|Overall Study|Physician Decision|2|||
130580430|NCT01700192|470088559|FG001|Overall Study|Physician Decision|3|||
130580431|NCT01700192|470088558|FG000|Overall Study|Pregnancy|1|||
130580432|NCT01700192|470088559|FG001|Overall Study|Pregnancy|4|||
130580433|NCT01700192|470088558|FG000|Overall Study|Progressive disease|1|||
130580434|NCT01700192|470088559|FG001|Overall Study|Progressive disease|0|||
130580435|NCT01700192|470088558|FG000|Overall Study|Protocol Violation|3|||
130580436|NCT01700192|470088559|FG001|Overall Study|Protocol Violation|4|||
130580437|NCT01700192|470088558|FG000|Overall Study|Technical problems|0|||
130580438|NCT01700192|470088559|FG001|Overall Study|Technical problems|1|||
130580439|NCT01700192|470088558|FG000|Overall Study|Withdrawal by Subject|56|||
130580440|NCT01700192|470088559|FG001|Overall Study|Withdrawal by Subject|64|||
130580441|NCT01700192|470088558|FG000|Overall Study|Never received study drug|1|||
130580442|NCT01700192|470088559|FG001|Overall Study|Never received study drug|0|||
130580443|NCT02793232|470088560|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580444|NCT02793232|470088561|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580445|NCT02793232|470088562|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580446|NCT02793232|470088563|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580447|NCT02793232|470088564|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
130580448|NCT02793232|470088565|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580449|NCT02793232|470088566|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
130580450|NCT02793232|470088567|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130531795|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
130531796|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
130531797|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
130531798|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
130531799|NCT00477490|469915156|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531800|NCT00477490|469915157|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
130531801|NCT00477490|469915158|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
130531802|NCT00477490|469915159|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531803|NCT00477490|469915160|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
130531804|NCT00477490|469915161|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531805|NCT00477490|469915162|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531806|NCT00477490|469915163|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531807|NCT00477490|469915164|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130531808|NCT01110408|469915165|FG000|Overall Study|Protocol Violation|1|||
130531809|NCT01110408|469915166|FG001|Overall Study|Protocol Violation|0|||
130531810|NCT00669877|469915167|FG000|Overall Study|Disease Progression/Death|4|||
130531811|NCT01465763|469915168|FG000|Overall Study|Withdrawal by Subject|4|||
130531812|NCT01465763|469915169|FG001|Overall Study|Withdrawal by Subject|0|||
130531813|NCT01465763|469915170|FG002|Overall Study|Withdrawal by Subject|1|||
130531814|NCT01465763|469915168|FG000|Overall Study|Insufficient Clinical Response|11|||
130531815|NCT01465763|469915169|FG001|Overall Study|Insufficient Clinical Response|0|||
130531816|NCT01465763|469915170|FG002|Overall Study|Insufficient Clinical Response|1|||
130531817|NCT01465763|469915168|FG000|Overall Study|Adverse Event|9|||
130531818|NCT01465763|469915169|FG001|Overall Study|Adverse Event|0|||
130531819|NCT01465763|469915170|FG002|Overall Study|Adverse Event|1|||
130531820|NCT01465763|469915168|FG000|Overall Study|Other|2|||
130531821|NCT01465763|469915169|FG001|Overall Study|Other|0|||
130531822|NCT01465763|469915170|FG002|Overall Study|Other|0|||
130531823|NCT01465763|469915168|FG000|Overall Study|Protocol Violation|4|||
130531824|NCT01465763|469915169|FG001|Overall Study|Protocol Violation|1|||
130531825|NCT01465763|469915170|FG002|Overall Study|Protocol Violation|1|||
130531826|NCT01465763|469915168|FG000|Overall Study|Death|1|||
130531827|NCT01465763|469915169|FG001|Overall Study|Death|0|||
130531828|NCT01465763|469915170|FG002|Overall Study|Death|0|||
130531829|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
130531830|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
130531831|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
130531832|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
130531833|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531834|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531835|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531836|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531837|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531838|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531839|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531840|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
130531841|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
130531842|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
130531843|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
130531844|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
130531845|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531846|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531847|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531848|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531849|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531850|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531851|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531852|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130531853|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
130531854|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
130531855|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
130531856|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
130531857|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531858|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531859|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531860|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531861|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130580451|NCT02793232|470088568|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130580452|NCT03979274|470088571|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130580453|NCT03979274|470088572|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130580454|NCT00626093|470088573|FG000|Overall Study|Lost to Follow-up|5|||
130580455|NCT00626093|470088573|FG000|Overall Study|Death|1|||
130580456|NCT00626093|470088573|FG000|Overall Study|Physician Decision|4|||
130580457|NCT00626093|470088573|FG000|Overall Study|Withdrawal by Subject|6|||
130580458|NCT00626093|470088573|FG000|Overall Study|Protocol Violation|1|||
130580459|NCT00626093|470088573|FG000|Overall Study|One of the required devices not implante|6|||
130580460|NCT00603915|470088574|FG000|Overall Study|Physician Decision|1|||
130580461|NCT03891901|470088575|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
130580462|NCT03891901|470088576|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580463|NCT03891901|470088577|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580464|NCT03891901|470088578|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580465|NCT03891901|470088579|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580466|NCT03891901|470088580|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580467|NCT03891901|470088581|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580468|NCT03891901|470088582|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580469|NCT03891901|470088583|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130580470|NCT03891901|470088575|FG000|Overall Study|Adverse Event|2|||
130580471|NCT03891901|470088576|FG001|Overall Study|Adverse Event|2|||
130580472|NCT03891901|470088577|FG002|Overall Study|Adverse Event|0|||
130580473|NCT03891901|470088578|FG003|Overall Study|Adverse Event|0|||
130580474|NCT03891901|470088579|FG004|Overall Study|Adverse Event|0|||
130580475|NCT03891901|470088580|FG005|Overall Study|Adverse Event|0|||
130580476|NCT03891901|470088581|FG006|Overall Study|Adverse Event|0|||
130580477|NCT03891901|470088582|FG007|Overall Study|Adverse Event|0|||
130580478|NCT03891901|470088583|FG008|Overall Study|Adverse Event|0|||
130580479|NCT03891901|470088575|FG000|Overall Study|Poor venous access|1|||
130580480|NCT03891901|470088576|FG001|Overall Study|Poor venous access|0|||
130580481|NCT03891901|470088577|FG002|Overall Study|Poor venous access|0|||
130580482|NCT03891901|470088578|FG003|Overall Study|Poor venous access|0|||
130580483|NCT03891901|470088579|FG004|Overall Study|Poor venous access|0|||
130580484|NCT03891901|470088580|FG005|Overall Study|Poor venous access|0|||
130580485|NCT03891901|470088581|FG006|Overall Study|Poor venous access|0|||
130580486|NCT03891901|470088582|FG007|Overall Study|Poor venous access|0|||
130580487|NCT03891901|470088583|FG008|Overall Study|Poor venous access|0|||
130580488|NCT03891901|470088575|FG000|Overall Study|Withdrawal by Subject|0|||
130580489|NCT03891901|470088576|FG001|Overall Study|Withdrawal by Subject|2|||
130580490|NCT03891901|470088577|FG002|Overall Study|Withdrawal by Subject|0|||
130580491|NCT03891901|470088578|FG003|Overall Study|Withdrawal by Subject|0|||
130580492|NCT03891901|470088579|FG004|Overall Study|Withdrawal by Subject|0|||
130580493|NCT03891901|470088580|FG005|Overall Study|Withdrawal by Subject|0|||
130580494|NCT03891901|470088581|FG006|Overall Study|Withdrawal by Subject|0|||
130580495|NCT03891901|470088582|FG007|Overall Study|Withdrawal by Subject|0|||
130580496|NCT03891901|470088583|FG008|Overall Study|Withdrawal by Subject|0|||
130580497|NCT02026063|470088586|FG000|Overall Study|Physician Decision|0|||
130580498|NCT02026063|470088587|FG001|Overall Study|Physician Decision|10|||
130580499|NCT02026063|470088586|FG000|Overall Study|Noncompliance with Study Drug|1|||
130580500|NCT02026063|470088587|FG001|Overall Study|Noncompliance with Study Drug|1|||
130580501|NCT02026063|470088586|FG000|Overall Study|Withdrawal of Consent|1|||
130580502|NCT02026063|470088587|FG001|Overall Study|Withdrawal of Consent|6|||
130580503|NCT02026063|470088586|FG000|Overall Study|Adverse Event|5|||
130580504|NCT02026063|470088587|FG001|Overall Study|Adverse Event|20|||
130580505|NCT02026063|470088586|FG000|Overall Study|Lack of Efficacy|0|||
130580506|NCT02026063|470088587|FG001|Overall Study|Lack of Efficacy|4|||
130580507|NCT02026063|470088586|FG000|Overall Study|Lost to Follow-up|0|||
130580508|NCT02026063|470088587|FG001|Overall Study|Lost to Follow-up|1|||
130580509|NCT02026063|470088586|FG000|Overall Study|Reason not Specified|2|||
130580510|NCT02026063|470088587|FG001|Overall Study|Reason not Specified|7|||
130580511|NCT02154087|470088588|FG000|Overall Study|Study Termination|1|||
130580512|NCT01116544|470088589|FG000|Overall Study|Protocol Violation|1|||
130580513|NCT01116544|470088590|FG001|Overall Study|Protocol Violation|0|||
130580514|NCT01116544|470088589|FG000|Overall Study|Withdrawal by Subject|1|||
130580515|NCT01116544|470088590|FG001|Overall Study|Withdrawal by Subject|1|||
130580516|NCT00486278|470088591|FG000|Overall Study|Adverse Event|5|||
130580517|NCT00486278|470088591|FG000|Overall Study|Withdrawal by Subject|2|||
130531862|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531863|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531864|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130531865|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
130531866|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
130531867|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
130531868|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
130531869|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531870|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531871|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531872|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531873|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531874|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531875|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531876|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
130531877|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531878|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531879|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
130531880|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
130531881|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531882|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531883|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531884|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531885|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531886|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531887|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531888|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
130531889|NCT01646177|469915171|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
130531890|NCT01646177|469915172|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
130531891|NCT01646177|469915173|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
130531892|NCT01646177|469915174|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531893|NCT01646177|469915175|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531894|NCT01646177|469915176|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531895|NCT01646177|469915177|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531896|NCT01646177|469915178|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531897|NCT01646177|469915179|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531898|NCT01646177|469915180|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531899|NCT01646177|469915181|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531900|NCT01646177|469915182|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
130531901|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531902|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531903|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531904|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531905|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
130531906|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
130531907|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
130531908|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
130531909|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531910|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531911|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531912|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
130531913|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531914|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531915|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531916|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531917|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
130531918|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
130531919|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
130531920|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
130580518|NCT00486278|470088591|FG000|Overall Study|Physician Decision|2|||
130531921|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531922|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531923|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531924|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
130531925|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531926|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531927|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531928|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531929|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
130531930|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
130531931|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
130531932|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
130531933|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531934|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531935|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531936|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
130531937|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531938|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531939|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531940|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531941|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
130531942|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
130531943|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
130531944|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
130531945|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531946|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531947|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531948|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130531949|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531950|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531951|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531952|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531953|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
130531954|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
130531955|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
130531956|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
130531957|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531958|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531959|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531960|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
130531961|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531962|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531963|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531964|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531965|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
130531966|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
130580519|NCT04949841|470088596|FG000|Overall Study|Adverse Event|7|||
130531967|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531968|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
130580520|NCT04949841|470088596|FG000|Overall Study|Death|1|||
130580521|NCT04949841|470088596|FG000|Overall Study|Withdrawal by Subject|52|||
130580522|NCT04949841|470088596|FG000|Overall Study|Pregnancy|4|||
130580523|NCT04949841|470088596|FG000|Overall Study|Lost to Follow-up|9|||
130580524|NCT04949841|470088596|FG000|Overall Study|Lack of Efficacy|55|||
130580525|NCT04949841|470088596|FG000|Overall Study|Various reasons|9|||
130580526|NCT05168267|470088597|FG000|Overall Study|Withdrawal by Subject|2|||
130580527|NCT05168267|470088598|FG001|Overall Study|Withdrawal by Subject|1|||
130580528|NCT05168267|470088597|FG000|Overall Study|Withdrawn by Therapist|1|||
130580529|NCT05168267|470088598|FG001|Overall Study|Withdrawn by Therapist|1|||
130580530|NCT05168267|470088597|FG000|Overall Study|Left Facility|1|||
130580531|NCT05168267|470088598|FG001|Overall Study|Left Facility|0|||
130580532|NCT00500682|470088601|FG000|Overall Study|Adverse Event|37|||
130580533|NCT00500682|470088602|FG001|Overall Study|Adverse Event|29|||
130580534|NCT00500682|470088601|FG000|Overall Study|Death|25|||
130580535|NCT00500682|470088602|FG001|Overall Study|Death|16|||
130580536|NCT00500682|470088601|FG000|Overall Study|Lost to Follow-up|11|||
130580537|NCT00500682|470088602|FG001|Overall Study|Lost to Follow-up|11|||
130580538|NCT00500682|470088601|FG000|Overall Study|Physician Decision|6|||
130580539|NCT00500682|470088602|FG001|Overall Study|Physician Decision|10|||
130580540|NCT00500682|470088601|FG000|Overall Study|Pregnancy|2|||
130580541|NCT00500682|470088602|FG001|Overall Study|Pregnancy|0|||
130580542|NCT00500682|470088601|FG000|Overall Study|Protocol Violation|1|||
130580543|NCT00500682|470088602|FG001|Overall Study|Protocol Violation|3|||
130580544|NCT00500682|470088601|FG000|Overall Study|Withdrawal by Subject|80|||
130580545|NCT00500682|470088602|FG001|Overall Study|Withdrawal by Subject|74|||
130580546|NCT00500682|470088601|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
130580547|NCT00500682|470088602|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
130580548|NCT00772668|470088606|FG000|Overall Study|Physician Decision|3|||
130580549|NCT01182428|470088607|FG000|Overall Study|Physician Decision|1|||
130580550|NCT01182428|470088608|FG001|Overall Study|Physician Decision|0|||
130580551|NCT01182428|470088607|FG000|Overall Study|Lost to Follow-up|9|||
130580552|NCT01182428|470088608|FG001|Overall Study|Lost to Follow-up|1|||
130580553|NCT01182428|470088607|FG000|Overall Study|Withdrawal by Subject|1|||
130580554|NCT01182428|470088608|FG001|Overall Study|Withdrawal by Subject|0|||
130580555|NCT04484285|470090331|FG000|Overall Study|Unable to operate stimulator|3|||
130580556|NCT04484285|470090332|FG001|Overall Study|Unable to operate stimulator|0|||
130580557|NCT05280756|470090333|FG000|Overall Study|Lost to Follow-up|1|||
130580558|NCT05280756|470090334|FG001|Overall Study|Lost to Follow-up|1|||
130580559|NCT00768898|470090336|FG000|Overall Study|Unrelated injury|1|||
130580560|NCT00768898|470090336|FG000|Overall Study|Headache|1|||
130580561|NCT02527707|470090337|FG000|Overall Study|Adverse Event|1|||
130580562|NCT02527707|470090337|FG000|Overall Study|Adverse Event|1|||
130580563|NCT00930059|470090338|FG000|Overall Study|Death|1|||
130580564|NCT00930059|470090339|FG001|Overall Study|Death|0|||
130580565|NCT00930059|470090338|FG000|Overall Study|Did not meet entrance criteria|1|||
130580566|NCT00930059|470090339|FG001|Overall Study|Did not meet entrance criteria|1|||
130580567|NCT00930059|470090338|FG000|Overall Study|Withdrawal by Subject|3|||
130580568|NCT00930059|470090339|FG001|Overall Study|Withdrawal by Subject|4|||
130580569|NCT00930059|470090338|FG000|Overall Study|Other|1|||
130580570|NCT00930059|470090339|FG001|Overall Study|Other|0|||
130580571|NCT00930059|470090338|FG000|Overall Study|1 site terminated by sponsor|1|||
130580572|NCT00930059|470090339|FG001|Overall Study|1 site terminated by sponsor|1|||
130580573|NCT00930059|470090338|FG000|Overall Study|Adverse Event|1|||
130580574|NCT00930059|470090339|FG001|Overall Study|Adverse Event|6|||
130580575|NCT04002310|470090342|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
130580576|NCT04002310|470090343|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
130580577|NCT04002310|470090344|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
130580578|NCT04002310|470090345|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
130580579|NCT04002310|470090346|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
130580580|NCT00542997|470090347|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
130580581|NCT00542997|470090347|FG000|Wash in / Wash Out Period|Adverse Event|3|||
130580582|NCT00542997|470090347|FG000|Efficacy Period|Adverse Event|3|||
130580583|NCT02949128|470090350|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
130580584|NCT02949128|470090350|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
130580585|NCT02949128|470090350|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
130580586|NCT02949128|470090350|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
130580587|NCT02949128|470090350|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
130580588|NCT02949128|470090350|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
130580589|NCT02949128|470090350|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
130580590|NCT02949128|470090350|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
130580591|NCT02949128|470090350|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
130580592|NCT02949128|470090350|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
130580593|NCT03064763|470090352|FG000|Overall Study|Lost to Follow-up|1|||
130580594|NCT03064763|470090352|FG000|Overall Study|Death|8|||
130580595|NCT03160560|470090353|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
130580596|NCT03160560|470090354|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130580597|NCT03160560|470090355|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130580598|NCT03160560|470090356|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130580599|NCT03160560|470090353|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130580600|NCT03160560|470090354|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130580601|NCT03160560|470090355|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130580602|NCT03160560|470090356|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130580603|NCT00667576|470090357|FG000|Overall Study|Withdrawal by Subject|1|||
130580604|NCT00667576|470090358|FG001|Overall Study|Withdrawal by Subject|0|||
130580605|NCT00667576|470090359|FG002|Overall Study|Withdrawal by Subject|1|||
130580606|NCT00667576|470090360|FG003|Overall Study|Withdrawal by Subject|1|||
130580607|NCT00667576|470090361|FG004|Overall Study|Withdrawal by Subject|1|||
130580608|NCT00667576|470090357|FG000|Overall Study|Adverse Event|1|||
130580609|NCT00667576|470090358|FG001|Overall Study|Adverse Event|1|||
130580610|NCT00667576|470090359|FG002|Overall Study|Adverse Event|0|||
130580611|NCT00667576|470090360|FG003|Overall Study|Adverse Event|0|||
130580612|NCT00667576|470090361|FG004|Overall Study|Adverse Event|0|||
130580613|NCT00667576|470090357|FG000|Overall Study|Lost to Follow-up|0|||
130580614|NCT00667576|470090358|FG001|Overall Study|Lost to Follow-up|0|||
130580615|NCT00667576|470090359|FG002|Overall Study|Lost to Follow-up|1|||
130580616|NCT00667576|470090360|FG003|Overall Study|Lost to Follow-up|0|||
130580617|NCT00667576|470090361|FG004|Overall Study|Lost to Follow-up|0|||
130580618|NCT00667576|470090357|FG000|Overall Study|Protocol Violation|0|||
130580619|NCT00667576|470090358|FG001|Overall Study|Protocol Violation|0|||
130580620|NCT00667576|470090359|FG002|Overall Study|Protocol Violation|0|||
130580621|NCT00667576|470090360|FG003|Overall Study|Protocol Violation|1|||
130580622|NCT00667576|470090361|FG004|Overall Study|Protocol Violation|0|||
130580623|NCT00667576|470090357|FG000|Overall Study|Physician Decision|0|||
130580624|NCT00667576|470090358|FG001|Overall Study|Physician Decision|0|||
130580625|NCT00667576|470090359|FG002|Overall Study|Physician Decision|0|||
130580626|NCT00667576|470090360|FG003|Overall Study|Physician Decision|1|||
130580627|NCT00667576|470090361|FG004|Overall Study|Physician Decision|0|||
130580628|NCT00667576|470090357|FG000|Overall Study|Missed Visit|0|||
130580629|NCT00667576|470090358|FG001|Overall Study|Missed Visit|0|||
130580630|NCT00667576|470090359|FG002|Overall Study|Missed Visit|0|||
130580631|NCT00667576|470090360|FG003|Overall Study|Missed Visit|1|||
130580632|NCT00667576|470090361|FG004|Overall Study|Missed Visit|0|||
130580633|NCT01390389|470090362|FG000|Overall Study|Withdrawal by Subject|2|||
130580634|NCT01390389|470090363|FG001|Overall Study|Withdrawal by Subject|0|||
130580635|NCT01390389|470090362|FG000|Overall Study|Screen Fail|2|||
130580636|NCT01390389|470090363|FG001|Overall Study|Screen Fail|1|||
130580637|NCT02002975|470090364|FG000|Overall Study|Case Report Forms Uncollected|135|||
130580638|NCT02002975|470090364|FG000|Overall Study|Protocol Deviation|437|||
130580639|NCT01430442|470090367|FG000|Overall Study|Subject Withdrew Consent|3|||
130580640|NCT01430442|470090368|FG001|Overall Study|Subject Withdrew Consent|0|||
130580641|NCT01430442|470090369|FG002|Overall Study|Subject Withdrew Consent|1|||
130580642|NCT01430442|470090370|FG003|Overall Study|Subject Withdrew Consent|0|||
130580643|NCT01430442|470090371|FG004|Overall Study|Subject Withdrew Consent|2|||
130580644|NCT01430442|470090372|FG005|Overall Study|Subject Withdrew Consent|1|||
130580645|NCT01430442|470090373|FG006|Overall Study|Subject Withdrew Consent|5|||
130580646|NCT01430442|470090374|FG007|Overall Study|Subject Withdrew Consent|2|||
130580647|NCT01430442|470090367|FG000|Overall Study|Lost to Follow-up|2|||
130580648|NCT01430442|470090368|FG001|Overall Study|Lost to Follow-up|0|||
130580649|NCT01430442|470090369|FG002|Overall Study|Lost to Follow-up|1|||
130580650|NCT01430442|470090370|FG003|Overall Study|Lost to Follow-up|2|||
130580651|NCT01430442|470090371|FG004|Overall Study|Lost to Follow-up|2|||
130580652|NCT01430442|470090372|FG005|Overall Study|Lost to Follow-up|1|||
130580653|NCT01430442|470090373|FG006|Overall Study|Lost to Follow-up|5|||
130580654|NCT01430442|470090374|FG007|Overall Study|Lost to Follow-up|1|||
130580655|NCT01430442|470090367|FG000|Overall Study|Pregnancy|1|||
130580656|NCT01430442|470090368|FG001|Overall Study|Pregnancy|0|||
130580657|NCT01430442|470090369|FG002|Overall Study|Pregnancy|0|||
130580658|NCT01430442|470090370|FG003|Overall Study|Pregnancy|0|||
130580659|NCT01430442|470090371|FG004|Overall Study|Pregnancy|0|||
130580660|NCT01430442|470090372|FG005|Overall Study|Pregnancy|1|||
130580661|NCT01430442|470090373|FG006|Overall Study|Pregnancy|0|||
130580662|NCT01430442|470090374|FG007|Overall Study|Pregnancy|0|||
130580663|NCT01430442|470090367|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
130580664|NCT01430442|470090368|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
130580665|NCT01430442|470090369|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
130580666|NCT01430442|470090370|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
130580667|NCT01430442|470090371|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
130580668|NCT01430442|470090372|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
130580669|NCT01430442|470090373|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
130580670|NCT01430442|470090374|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
130580671|NCT00804687|470090378|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
130580672|NCT00804687|470090379|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
130580673|NCT00804687|470090380|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
130580674|NCT00804687|470090381|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
130580675|NCT00804687|470090382|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
130580676|NCT00804687|470090383|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
130580677|NCT00804687|470090378|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
130580678|NCT00804687|470090379|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
130580679|NCT00804687|470090380|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
130580680|NCT00804687|470090381|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
130580681|NCT00804687|470090382|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
130580682|NCT00804687|470090383|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
130580683|NCT00804687|470090378|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
130580684|NCT00804687|470090379|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
130580685|NCT00804687|470090380|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
130580686|NCT00804687|470090381|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
130580687|NCT00804687|470090382|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
130580688|NCT00804687|470090383|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
130580689|NCT00804687|470090378|FG000|Period 5: Treatment Period|Positive drug test|1|||
130580690|NCT00804687|470090379|FG001|Period 5: Treatment Period|Positive drug test|0|||
130580691|NCT00804687|470090380|FG002|Period 5: Treatment Period|Positive drug test|0|||
130580692|NCT00804687|470090381|FG003|Period 5: Treatment Period|Positive drug test|0|||
130580693|NCT00804687|470090382|FG004|Period 5: Treatment Period|Positive drug test|0|||
130580694|NCT00804687|470090383|FG005|Period 5: Treatment Period|Positive drug test|0|||
130580695|NCT00808444|470090384|FG000|Overall Study|Withdrawal by Subject|1|||
130580696|NCT00808444|470090385|FG001|Overall Study|Withdrawal by Subject|0|||
130580697|NCT00808444|470090384|FG000|Overall Study|Lost to Follow-up|0|||
130580698|NCT00808444|470090385|FG001|Overall Study|Lost to Follow-up|1|||
130580699|NCT03068325|470090386|FG000|Overall Study|Lost to Follow-up|5|||
130580700|NCT04093531|470090394|FG000|Overall Study|failed screening|4|||
130580701|NCT00272987|470090397|FG000|Overall Study|Adverse Event|1|||
130580702|NCT00272987|470090398|FG001|Overall Study|Adverse Event|0|||
130580703|NCT00272987|470090399|FG002|Overall Study|Adverse Event|0|||
130580704|NCT00272987|470090397|FG000|Overall Study|Lost to Follow-up|3|||
130580705|NCT00272987|470090398|FG001|Overall Study|Lost to Follow-up|1|||
130580706|NCT00272987|470090399|FG002|Overall Study|Lost to Follow-up|1|||
130580707|NCT00272987|470090397|FG000|Overall Study|Withdrawal by Subject|1|||
130580708|NCT00272987|470090398|FG001|Overall Study|Withdrawal by Subject|0|||
130580709|NCT00272987|470090399|FG002|Overall Study|Withdrawal by Subject|3|||
130580710|NCT00272987|470090397|FG000|Overall Study|Sponsor Terminated study|0|||
130580711|NCT00272987|470090398|FG001|Overall Study|Sponsor Terminated study|1|||
130580712|NCT00272987|470090399|FG002|Overall Study|Sponsor Terminated study|1|||
130580713|NCT00272987|470090397|FG000|Overall Study|Disease progression|1|||
130580714|NCT00272987|470090398|FG001|Overall Study|Disease progression|1|||
130580715|NCT00272987|470090399|FG002|Overall Study|Disease progression|2|||
130580716|NCT00272987|470090397|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
130580717|NCT00272987|470090398|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
130580718|NCT00272987|470090399|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
130580719|NCT00272987|470090397|FG000|Overall Study|Death|1|||
130580720|NCT00272987|470090398|FG001|Overall Study|Death|0|||
130580721|NCT00272987|470090399|FG002|Overall Study|Death|0|||
130580722|NCT03222349|470090400|FG000|Overall Study|Treatment B not done|5|||
130580723|NCT03222349|470090401|FG001|Overall Study|Treatment B not done|0|||
130580724|NCT03222349|470090400|FG000|Overall Study|Lost to Follow-up|1|||
130580725|NCT03222349|470090401|FG001|Overall Study|Lost to Follow-up|2|||
130580726|NCT03222349|470090400|FG000|Overall Study|Withdrawal by Subject|1|||
130580727|NCT03222349|470090401|FG001|Overall Study|Withdrawal by Subject|0|||
130580728|NCT03222349|470090400|FG000|Overall Study|Treatment A not done|0|||
130580729|NCT03222349|470090401|FG001|Overall Study|Treatment A not done|5|||
130580730|NCT03222349|470090400|FG000|Overall Study|Study terminated by sponsor|1|||
130580731|NCT03222349|470090401|FG001|Overall Study|Study terminated by sponsor|0|||
130580732|NCT01808612|470090405|FG000|Treatment Period|Adverse Event|8|||
130580733|NCT01808612|470090406|FG001|Treatment Period|Adverse Event|4|||
130580734|NCT01808612|470090407|FG002|Treatment Period|Adverse Event|3|||
130580735|NCT01808612|470090405|FG000|Treatment Period|Lost to Follow-up|2|||
130580736|NCT01808612|470090406|FG001|Treatment Period|Lost to Follow-up|2|||
130580737|NCT01808612|470090407|FG002|Treatment Period|Lost to Follow-up|1|||
130580738|NCT01808612|470090405|FG000|Treatment Period|Protocol Violation|1|||
130580739|NCT01808612|470090406|FG001|Treatment Period|Protocol Violation|0|||
130580740|NCT01808612|470090407|FG002|Treatment Period|Protocol Violation|0|||
130580741|NCT01808612|470090405|FG000|Treatment Period|Withdrawal by Subject|1|||
130580742|NCT01808612|470090406|FG001|Treatment Period|Withdrawal by Subject|0|||
130580743|NCT01808612|470090407|FG002|Treatment Period|Withdrawal by Subject|4|||
130580744|NCT01808612|470090405|FG000|Treatment Period|Physician Decision|1|||
130580745|NCT01808612|470090406|FG001|Treatment Period|Physician Decision|0|||
130580746|NCT01808612|470090407|FG002|Treatment Period|Physician Decision|4|||
130580747|NCT01808612|470090405|FG000|Treatment Period|Sponsor Decision|1|||
130580748|NCT01808612|470090406|FG001|Treatment Period|Sponsor Decision|0|||
130580749|NCT01808612|470090407|FG002|Treatment Period|Sponsor Decision|0|||
130580750|NCT01808612|470090405|FG000|Treatment Period|Lack of Efficacy|1|||
130580751|NCT01808612|470090406|FG001|Treatment Period|Lack of Efficacy|1|||
130580752|NCT01808612|470090407|FG002|Treatment Period|Lack of Efficacy|2|||
130580753|NCT01808612|470090405|FG000|Discontinuation Period|Adverse Event|1|||
130580754|NCT01808612|470090406|FG001|Discontinuation Period|Adverse Event|0|||
130580755|NCT01808612|470090407|FG002|Discontinuation Period|Adverse Event|0|||
130580756|NCT01808612|470090405|FG000|Discontinuation Period|Physician Decision|1|||
130580757|NCT01808612|470090406|FG001|Discontinuation Period|Physician Decision|0|||
130580758|NCT01808612|470090407|FG002|Discontinuation Period|Physician Decision|0|||
130580759|NCT01808612|470090405|FG000|Discontinuation Period|Lost to Follow-up|0|||
130580760|NCT01808612|470090406|FG001|Discontinuation Period|Lost to Follow-up|1|||
130580761|NCT01808612|470090407|FG002|Discontinuation Period|Lost to Follow-up|0|||
130580762|NCT01463098|470090408|FG000|Part A (11 Days)|Participant Choice|2|||
130580763|NCT01463098|470090409|FG001|Part A (11 Days)|Participant Choice|0|||
130580764|NCT01463098|470090410|FG002|Part A (11 Days)|Participant Choice|0|||
130580765|NCT01463098|470090411|FG003|Part A (11 Days)|Participant Choice|0|||
130580766|NCT01463098|470090412|FG004|Part A (11 Days)|Participant Choice|0|||
130580767|NCT01463098|470090413|FG005|Part A (11 Days)|Participant Choice|0|||
130580768|NCT01463098|470090414|FG006|Part A (11 Days)|Participant Choice|0|||
130580769|NCT01463098|470090415|FG007|Part A (11 Days)|Participant Choice|0|||
130580770|NCT01463098|470090416|FG008|Part A (11 Days)|Participant Choice|1|||
130580771|NCT01463098|470090417|FG009|Part A (11 Days)|Participant Choice|0|||
130580772|NCT01463098|470090418|FG010|Part A (11 Days)|Participant Choice|0|||
130580773|NCT01463098|470090419|FG011|Part A (11 Days)|Participant Choice|0|||
130580774|NCT01463098|470090420|FG012|Part A (11 Days)|Participant Choice|0|||
130580775|NCT01463098|470090421|FG013|Part A (11 Days)|Participant Choice|0|||
130580776|NCT01463098|470090408|FG000|Part A (11 Days)|Lost to Follow-up|0|||
130580777|NCT01463098|470090409|FG001|Part A (11 Days)|Lost to Follow-up|0|||
130580778|NCT01463098|470090410|FG002|Part A (11 Days)|Lost to Follow-up|0|||
130580779|NCT01463098|470090411|FG003|Part A (11 Days)|Lost to Follow-up|0|||
130580780|NCT01463098|470090412|FG004|Part A (11 Days)|Lost to Follow-up|1|||
130580781|NCT01463098|470090413|FG005|Part A (11 Days)|Lost to Follow-up|0|||
130580782|NCT01463098|470090414|FG006|Part A (11 Days)|Lost to Follow-up|0|||
130580783|NCT01463098|470090415|FG007|Part A (11 Days)|Lost to Follow-up|0|||
130580784|NCT01463098|470090416|FG008|Part A (11 Days)|Lost to Follow-up|0|||
130580785|NCT01463098|470090417|FG009|Part A (11 Days)|Lost to Follow-up|0|||
130580786|NCT01463098|470090418|FG010|Part A (11 Days)|Lost to Follow-up|0|||
130580787|NCT01463098|470090419|FG011|Part A (11 Days)|Lost to Follow-up|0|||
130580788|NCT01463098|470090420|FG012|Part A (11 Days)|Lost to Follow-up|0|||
130580789|NCT01463098|470090421|FG013|Part A (11 Days)|Lost to Follow-up|0|||
130580790|NCT01463098|470090408|FG000|Part B (11 Days)|Participant Choice|0|||
130580791|NCT01463098|470090409|FG001|Part B (11 Days)|Participant Choice|0|||
130580792|NCT01463098|470090410|FG002|Part B (11 Days)|Participant Choice|0|||
130580793|NCT01463098|470090411|FG003|Part B (11 Days)|Participant Choice|0|||
130580794|NCT01463098|470090412|FG004|Part B (11 Days)|Participant Choice|0|||
130580795|NCT01463098|470090413|FG005|Part B (11 Days)|Participant Choice|0|||
130580796|NCT01463098|470090414|FG006|Part B (11 Days)|Participant Choice|0|||
130580797|NCT01463098|470090415|FG007|Part B (11 Days)|Participant Choice|0|||
130580798|NCT01463098|470090416|FG008|Part B (11 Days)|Participant Choice|0|||
130580799|NCT01463098|470090417|FG009|Part B (11 Days)|Participant Choice|0|||
130580800|NCT01463098|470090418|FG010|Part B (11 Days)|Participant Choice|0|||
130580801|NCT01463098|470090419|FG011|Part B (11 Days)|Participant Choice|1|||
130580802|NCT01463098|470090420|FG012|Part B (11 Days)|Participant Choice|0|||
130580803|NCT01463098|470090421|FG013|Part B (11 Days)|Participant Choice|0|||
130580804|NCT00939692|470090426|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
130580805|NCT00939692|470090427|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
130580806|NCT00939692|470090426|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
130580807|NCT00939692|470090427|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
130580808|NCT01528787|470090428|FG000|Overall Study|Withdrawal by Subject|0|||
130580809|NCT01528787|470090429|FG001|Overall Study|Withdrawal by Subject|0|||
130580810|NCT01528787|470090430|FG002|Overall Study|Withdrawal by Subject|0|||
130580811|NCT01528787|470090431|FG003|Overall Study|Withdrawal by Subject|1|||
130580812|NCT01528787|470090428|FG000|Overall Study|Family Emergency|0|||
130580813|NCT01528787|470090429|FG001|Overall Study|Family Emergency|0|||
130580814|NCT01528787|470090430|FG002|Overall Study|Family Emergency|1|||
130580815|NCT01528787|470090431|FG003|Overall Study|Family Emergency|0|||
130531969|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531970|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531971|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531972|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
130531973|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531974|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531975|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531976|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531977|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
130531978|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
130531979|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
130531980|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
130531981|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531982|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531983|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531984|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
130531985|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
130531986|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
130531987|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
130531988|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
130531989|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
130531990|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
130531991|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
130531992|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
130531993|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
130531994|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
130531995|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
130531996|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
130531997|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130531998|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130531999|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532000|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532001|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
130532002|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
130532003|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
130532004|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
130532005|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532006|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532007|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532008|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
130532009|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532010|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532011|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532012|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532013|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532014|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532015|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532016|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
130532017|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532018|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532019|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532020|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130532021|NCT01646177|469915171|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130580816|NCT03433781|470090437|FG000|Overall Study|Progression of Disease|1|||
130580817|NCT03433781|470090438|FG001|Overall Study|Progression of Disease|0|||
130580818|NCT03433781|470090439|FG002|Overall Study|Progression of Disease|0|||
130580819|NCT03433781|470090437|FG000|Overall Study|Physician Decision|0|||
130580820|NCT03433781|470090438|FG001|Overall Study|Physician Decision|1|||
130580821|NCT03433781|470090439|FG002|Overall Study|Physician Decision|0|||
130580822|NCT03543410|470090443|FG000|Overall Study|Adverse Event|10|||
130580823|NCT03543410|470090444|FG001|Overall Study|Adverse Event|8|||
130580824|NCT03543410|470090445|FG002|Overall Study|Adverse Event|2|||
130580825|NCT03543410|470090443|FG000|Overall Study|Lack of Efficacy|0|||
130580826|NCT03543410|470090444|FG001|Overall Study|Lack of Efficacy|1|||
130580827|NCT03543410|470090445|FG002|Overall Study|Lack of Efficacy|0|||
130580828|NCT03543410|470090443|FG000|Overall Study|Lost to Follow-up|0|||
130580829|NCT03543410|470090444|FG001|Overall Study|Lost to Follow-up|1|||
130580830|NCT03543410|470090445|FG002|Overall Study|Lost to Follow-up|0|||
130580831|NCT03543410|470090443|FG000|Overall Study|Withdrawal by Subject|5|||
130580832|NCT03543410|470090444|FG001|Overall Study|Withdrawal by Subject|2|||
130580833|NCT03543410|470090445|FG002|Overall Study|Withdrawal by Subject|8|||
130580834|NCT03543410|470090443|FG000|Overall Study|Protocol Violation|0|||
130580835|NCT03543410|470090444|FG001|Overall Study|Protocol Violation|1|||
130580836|NCT03543410|470090445|FG002|Overall Study|Protocol Violation|0|||
130580837|NCT03543410|470090443|FG000|Overall Study|Due to COVID-19|4|||
130580838|NCT03543410|470090444|FG001|Overall Study|Due to COVID-19|0|||
130580839|NCT03543410|470090445|FG002|Overall Study|Due to COVID-19|2|||
130580840|NCT03543410|470090443|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
130580841|NCT03543410|470090444|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
130580842|NCT03543410|470090445|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
130580843|NCT03543410|470090443|FG000|Overall Study|Not Due to COVID-19|2|||
130580844|NCT03543410|470090444|FG001|Overall Study|Not Due to COVID-19|0|||
130580845|NCT03543410|470090445|FG002|Overall Study|Not Due to COVID-19|1|||
130580846|NCT02435914|470090446|FG000|Overall Study|Ocular Adverse Event|1|||
130580847|NCT02435914|470090447|FG001|Overall Study|Ocular Adverse Event|0|||
130580848|NCT02435914|470090448|FG002|Overall Study|Ocular Adverse Event|0|||
130580849|NCT02435914|470090449|FG003|Overall Study|Ocular Adverse Event|0|||
130580850|NCT02435914|470090446|FG000|Overall Study|Withdrawal by Subject|0|||
130580851|NCT02435914|470090447|FG001|Overall Study|Withdrawal by Subject|1|||
130580852|NCT02435914|470090448|FG002|Overall Study|Withdrawal by Subject|0|||
130580853|NCT02435914|470090449|FG003|Overall Study|Withdrawal by Subject|0|||
130580854|NCT02435914|470090446|FG000|Overall Study|Other Miscellaneous Reason|0|||
130580855|NCT02435914|470090447|FG001|Overall Study|Other Miscellaneous Reason|0|||
130580856|NCT02435914|470090448|FG002|Overall Study|Other Miscellaneous Reason|1|||
130580857|NCT02435914|470090449|FG003|Overall Study|Other Miscellaneous Reason|0|||
130580858|NCT02319044|470090469|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
130580859|NCT02319044|470090470|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
130580860|NCT02319044|470090471|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
130580861|NCT02319044|470090469|FG000|Overall Study|Withdrawal by Subject|3|||
130580862|NCT02319044|470090470|FG001|Overall Study|Withdrawal by Subject|3|||
130580863|NCT02319044|470090471|FG002|Overall Study|Withdrawal by Subject|6|||
130580864|NCT02319044|470090469|FG000|Overall Study|Condition under investigation worsened|100|||
130580865|NCT02319044|470090470|FG001|Overall Study|Condition under investigation worsened|50|||
130580866|NCT02319044|470090471|FG002|Overall Study|Condition under investigation worsened|46|||
130580867|NCT02319044|470090469|FG000|Overall Study|Adverse Event|17|||
130580868|NCT02319044|470090470|FG001|Overall Study|Adverse Event|2|||
130580869|NCT02319044|470090471|FG002|Overall Study|Adverse Event|8|||
130580870|NCT02319044|470090469|FG000|Overall Study|Study specific discontinuation criteria|2|||
130580871|NCT02319044|470090470|FG001|Overall Study|Study specific discontinuation criteria|2|||
130580872|NCT02319044|470090471|FG002|Overall Study|Study specific discontinuation criteria|1|||
130580873|NCT02319044|470090469|FG000|Overall Study|Not treated|0|||
130580874|NCT02319044|470090470|FG001|Overall Study|Not treated|2|||
130580875|NCT02319044|470090471|FG002|Overall Study|Not treated|2|||
130580876|NCT03434379|470090472|FG000|Global Period|Lost to Follow-up|3|||
130580877|NCT03434379|470090473|FG001|Global Period|Lost to Follow-up|6|||
130580878|NCT03434379|470090474|FG002|Global Period|Lost to Follow-up|0|||
130580879|NCT03434379|470090475|FG003|Global Period|Lost to Follow-up|0|||
130580880|NCT03434379|470090472|FG000|Global Period|Death|115|||
130580881|NCT03434379|470090473|FG001|Global Period|Death|228|||
130580882|NCT03434379|470090474|FG002|Global Period|Death|0|||
130580883|NCT03434379|470090475|FG003|Global Period|Death|0|||
130580884|NCT03434379|470090472|FG000|Global Period|Withdrawal by Subject|20|||
130580885|NCT03434379|470090473|FG001|Global Period|Withdrawal by Subject|21|||
130580886|NCT03434379|470090474|FG002|Global Period|Withdrawal by Subject|0|||
130580887|NCT03434379|470090475|FG003|Global Period|Withdrawal by Subject|0|||
130580888|NCT03434379|470090472|FG000|Global Period|Reason Unspecified|0|||
130580889|NCT03434379|470090473|FG001|Global Period|Reason Unspecified|1|||
130580890|NCT03434379|470090474|FG002|Global Period|Reason Unspecified|0|||
130580891|NCT03434379|470090475|FG003|Global Period|Reason Unspecified|0|||
130580892|NCT03434379|470090472|FG000|Global Period|Study Ended by Sponsor|26|||
130580893|NCT03434379|470090473|FG001|Global Period|Study Ended by Sponsor|80|||
130580894|NCT03434379|470090474|FG002|Global Period|Study Ended by Sponsor|0|||
130580895|NCT03434379|470090475|FG003|Global Period|Study Ended by Sponsor|0|||
130580896|NCT03434379|470090472|FG000|Global Period|Physician Decision|1|||
130580897|NCT03434379|470090473|FG001|Global Period|Physician Decision|0|||
130580898|NCT03434379|470090474|FG002|Global Period|Physician Decision|0|||
130580899|NCT03434379|470090475|FG003|Global Period|Physician Decision|0|||
130580900|NCT03434379|470090472|FG000|China Extension Period|Lost to Follow-up|0|||
130580901|NCT03434379|470090473|FG001|China Extension Period|Lost to Follow-up|0|||
130580902|NCT03434379|470090474|FG002|China Extension Period|Lost to Follow-up|2|||
130580903|NCT03434379|470090475|FG003|China Extension Period|Lost to Follow-up|3|||
130580904|NCT03434379|470090472|FG000|China Extension Period|Death|0|||
130580905|NCT03434379|470090473|FG001|China Extension Period|Death|0|||
130580906|NCT03434379|470090474|FG002|China Extension Period|Death|46|||
130580907|NCT03434379|470090475|FG003|China Extension Period|Death|88|||
130580908|NCT03434379|470090472|FG000|China Extension Period|Withdrawal by Subject|0|||
130580909|NCT03434379|470090473|FG001|China Extension Period|Withdrawal by Subject|0|||
130580910|NCT03434379|470090474|FG002|China Extension Period|Withdrawal by Subject|8|||
130580911|NCT03434379|470090475|FG003|China Extension Period|Withdrawal by Subject|6|||
130580912|NCT03434379|470090472|FG000|China Extension Period|Study Ended by Sponsor|0|||
130580913|NCT03434379|470090473|FG001|China Extension Period|Study Ended by Sponsor|0|||
130580914|NCT03434379|470090474|FG002|China Extension Period|Study Ended by Sponsor|5|||
130580915|NCT03434379|470090475|FG003|China Extension Period|Study Ended by Sponsor|36|||
130580916|NCT00573794|470090481|FG000|Overall Study|Adverse Event|81|||
130580917|NCT00573794|470090481|FG000|Overall Study|Withdrew Consent|90|||
130580918|NCT00573794|470090481|FG000|Overall Study|Lost to Follow-up|13|||
130580919|NCT00573794|470090481|FG000|Overall Study|Protocol Violation|6|||
130580920|NCT00573794|470090481|FG000|Overall Study|Lack of Efficacy|94|||
130580921|NCT00573794|470090481|FG000|Overall Study|Other|46|||
130580922|NCT04556617|470090483|FG000|Overall Study|progressive disease|0|||
130580923|NCT04556617|470090484|FG001|Overall Study|progressive disease|2|||
130580924|NCT04556617|470090485|FG002|Overall Study|progressive disease|2|||
130580925|NCT04556617|470090486|FG003|Overall Study|progressive disease|1|||
130580926|NCT04556617|470090487|FG004|Overall Study|progressive disease|1|||
130580927|NCT04556617|470090483|FG000|Overall Study|Physician Decision|0|||
130580928|NCT04556617|470090484|FG001|Overall Study|Physician Decision|0|||
130580929|NCT04556617|470090485|FG002|Overall Study|Physician Decision|2|||
130580930|NCT04556617|470090486|FG003|Overall Study|Physician Decision|0|||
130580931|NCT04556617|470090487|FG004|Overall Study|Physician Decision|0|||
130580932|NCT04556617|470090483|FG000|Overall Study|Adverse Event|0|||
130580933|NCT04556617|470090484|FG001|Overall Study|Adverse Event|0|||
130580934|NCT04556617|470090485|FG002|Overall Study|Adverse Event|2|||
130580935|NCT04556617|470090486|FG003|Overall Study|Adverse Event|3|||
130580936|NCT04556617|470090487|FG004|Overall Study|Adverse Event|0|||
130580937|NCT04556617|470090483|FG000|Overall Study|Withdrawal by Subject|0|||
130580938|NCT04556617|470090484|FG001|Overall Study|Withdrawal by Subject|2|||
130580939|NCT04556617|470090485|FG002|Overall Study|Withdrawal by Subject|1|||
130580940|NCT04556617|470090486|FG003|Overall Study|Withdrawal by Subject|1|||
130580941|NCT04556617|470090487|FG004|Overall Study|Withdrawal by Subject|0|||
130580942|NCT04556617|470090483|FG000|Overall Study|PSA increase|0|||
130580943|NCT04556617|470090484|FG001|Overall Study|PSA increase|1|||
130580944|NCT04556617|470090485|FG002|Overall Study|PSA increase|0|||
130580945|NCT04556617|470090486|FG003|Overall Study|PSA increase|0|||
130580946|NCT04556617|470090487|FG004|Overall Study|PSA increase|0|||
130580947|NCT04556617|470090483|FG000|Overall Study|Sponsor study termination|1|||
130580948|NCT04556617|470090484|FG001|Overall Study|Sponsor study termination|0|||
130580949|NCT04556617|470090485|FG002|Overall Study|Sponsor study termination|0|||
130580950|NCT04556617|470090486|FG003|Overall Study|Sponsor study termination|0|||
130580951|NCT04556617|470090487|FG004|Overall Study|Sponsor study termination|0|||
130580952|NCT03179436|470090488|FG000|Overall Study|Withdrawal by Subject|1|||
130580953|NCT03179436|470090489|FG001|Overall Study|Withdrawal by Subject|0|||
130580954|NCT03179436|470090490|FG002|Overall Study|Withdrawal by Subject|0|||
130580955|NCT03179436|470090491|FG003|Overall Study|Withdrawal by Subject|4|||
130580956|NCT03179436|470090492|FG004|Overall Study|Withdrawal by Subject|2|||
130580957|NCT03179436|470090493|FG005|Overall Study|Withdrawal by Subject|2|||
130580958|NCT03179436|470090494|FG006|Overall Study|Withdrawal by Subject|5|||
130580959|NCT03179436|470090495|FG007|Overall Study|Withdrawal by Subject|0|||
130580960|NCT03179436|470090496|FG008|Overall Study|Withdrawal by Subject|3|||
130580961|NCT03179436|470090497|FG009|Overall Study|Withdrawal by Subject|0|||
130580962|NCT03179436|470090498|FG010|Overall Study|Withdrawal by Subject|0|||
130532022|NCT01646177|469915172|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532023|NCT01646177|469915173|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532024|NCT01646177|469915174|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532025|NCT01646177|469915175|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532026|NCT01646177|469915176|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
130532027|NCT01646177|469915177|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
130532028|NCT01646177|469915178|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
130532029|NCT01646177|469915179|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532030|NCT01646177|469915180|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532031|NCT01646177|469915181|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532032|NCT01646177|469915182|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130532033|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532034|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532035|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532036|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532037|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532038|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532039|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532040|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
130532041|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
130532042|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
130532043|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
130532044|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
130532045|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532046|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532047|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532048|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532049|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532050|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532051|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532052|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
130532053|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
130532054|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
130532055|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
130532056|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
130532057|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532058|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532059|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532060|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532061|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532062|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532063|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532064|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
130532065|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
130532066|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
130532067|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
130532068|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
130532069|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532070|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532071|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532072|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532073|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532074|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532075|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532076|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
130532077|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
130532078|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
130532079|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
130532080|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
130532081|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532082|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532083|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532084|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130580963|NCT03179436|470090499|FG011|Overall Study|Withdrawal by Subject|0|||
130580964|NCT03179436|470090488|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130580965|NCT03179436|470090489|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130580966|NCT03179436|470090490|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130580967|NCT03179436|470090491|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130580968|NCT03179436|470090492|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130580969|NCT03179436|470090493|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130580970|NCT03179436|470090494|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130580971|NCT03179436|470090495|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
130580972|NCT03179436|470090496|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
130580973|NCT03179436|470090497|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
130580974|NCT03179436|470090498|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
130580975|NCT03179436|470090499|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
130580976|NCT03179436|470090488|FG000|Overall Study|Sponsor Decision|0|||
130580977|NCT03179436|470090489|FG001|Overall Study|Sponsor Decision|0|||
130580978|NCT03179436|470090490|FG002|Overall Study|Sponsor Decision|1|||
130580979|NCT03179436|470090491|FG003|Overall Study|Sponsor Decision|3|||
130580980|NCT03179436|470090492|FG004|Overall Study|Sponsor Decision|9|||
130580981|NCT03179436|470090493|FG005|Overall Study|Sponsor Decision|7|||
130580982|NCT03179436|470090494|FG006|Overall Study|Sponsor Decision|2|||
130580983|NCT03179436|470090495|FG007|Overall Study|Sponsor Decision|4|||
130580984|NCT03179436|470090496|FG008|Overall Study|Sponsor Decision|23|||
130580985|NCT03179436|470090497|FG009|Overall Study|Sponsor Decision|6|||
130580986|NCT03179436|470090498|FG010|Overall Study|Sponsor Decision|7|||
130580987|NCT03179436|470090499|FG011|Overall Study|Sponsor Decision|5|||
130580988|NCT03179436|470090488|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
130532085|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532086|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532087|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532088|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130532089|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
130532090|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
130532091|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
130532092|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
130532093|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532094|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532095|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532096|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532097|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532098|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532099|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532100|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
130532101|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
130532102|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
130532103|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
130532104|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
130532105|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532106|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532107|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532108|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532109|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532110|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532111|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532112|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532113|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
130532114|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
130532115|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
130532116|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
130532117|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532118|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130580989|NCT03179436|470090489|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
130580990|NCT03179436|470090490|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580991|NCT03179436|470090491|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580992|NCT03179436|470090492|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580993|NCT03179436|470090493|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
130580994|NCT03179436|470090494|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580995|NCT03179436|470090495|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580996|NCT03179436|470090496|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580997|NCT03179436|470090497|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580998|NCT03179436|470090498|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
130580999|NCT03179436|470090499|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
130581000|NCT03179436|470090488|FG000|Overall Study|Lost to Follow-up|1|||
130581001|NCT03179436|470090489|FG001|Overall Study|Lost to Follow-up|0|||
130581002|NCT03179436|470090490|FG002|Overall Study|Lost to Follow-up|0|||
130581003|NCT03179436|470090491|FG003|Overall Study|Lost to Follow-up|1|||
130581004|NCT03179436|470090492|FG004|Overall Study|Lost to Follow-up|0|||
130581005|NCT03179436|470090493|FG005|Overall Study|Lost to Follow-up|1|||
130581006|NCT03179436|470090494|FG006|Overall Study|Lost to Follow-up|0|||
130581007|NCT03179436|470090495|FG007|Overall Study|Lost to Follow-up|0|||
130581008|NCT03179436|470090496|FG008|Overall Study|Lost to Follow-up|1|||
130581009|NCT03179436|470090497|FG009|Overall Study|Lost to Follow-up|1|||
130581010|NCT03179436|470090498|FG010|Overall Study|Lost to Follow-up|0|||
130581011|NCT03179436|470090499|FG011|Overall Study|Lost to Follow-up|0|||
130581012|NCT03179436|470090488|FG000|Overall Study|Death|12|||
130581013|NCT03179436|470090489|FG001|Overall Study|Death|17|||
130581014|NCT03179436|470090490|FG002|Overall Study|Death|7|||
130581015|NCT03179436|470090491|FG003|Overall Study|Death|32|||
130581016|NCT03179436|470090492|FG004|Overall Study|Death|29|||
130581017|NCT03179436|470090493|FG005|Overall Study|Death|30|||
130581018|NCT03179436|470090494|FG006|Overall Study|Death|33|||
130581019|NCT03179436|470090495|FG007|Overall Study|Death|9|||
130581020|NCT03179436|470090496|FG008|Overall Study|Death|84|||
130581021|NCT03179436|470090497|FG009|Overall Study|Death|33|||
130581022|NCT03179436|470090498|FG010|Overall Study|Death|22|||
130532119|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532120|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532121|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532122|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532123|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532124|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532125|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
130532126|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
130532127|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
130532128|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
130532129|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532130|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532131|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532132|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532133|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532134|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532135|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532136|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532137|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
130532138|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130532139|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
130532140|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
130532141|NCT01646177|469915171|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130581023|NCT03179436|470090499|FG011|Overall Study|Death|15|||
130581024|NCT05702736|470090500|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
130581025|NCT05702736|470090501|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
130581026|NCT05702736|470090500|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
130581027|NCT05702736|470090501|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
130581028|NCT02531646|470090505|FG000|Overall Study|equip. image processing issue|5|||
130581029|NCT02531646|470090506|FG001|Overall Study|equip. image processing issue|1|||
130581030|NCT02531646|470090507|FG002|Overall Study|equip. image processing issue|0|||
130581031|NCT02320487|470090512|FG000|Overall Study|Reason not Specified|1|||
130581032|NCT02320487|470090512|FG000|Overall Study|Physician Decision|5|||
130581033|NCT02320487|470090512|FG000|Overall Study|Withdrawal by Subject|1|||
130581034|NCT02320487|470090512|FG000|Overall Study|Death|3|||
130532142|NCT01646177|469915172|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130581035|NCT02320487|470090512|FG000|Overall Study|Adverse Event|11|||
130581036|NCT00684957|470090513|FG000|Overall Study|Withdrawal by Subject|1|||
130581037|NCT00684957|470090514|FG001|Overall Study|Withdrawal by Subject|1|||
130581038|NCT00684957|470090513|FG000|Overall Study|Lost to Follow-up|1|||
130581039|NCT00684957|470090514|FG001|Overall Study|Lost to Follow-up|0|||
130581040|NCT04439175|470092356|FG000|Overall Study|Never started treatment|4|||
130581041|NCT04439175|470092356|FG000|Overall Study|Ineligible|5|||
130581042|NCT04439175|470092356|FG000|Overall Study|Adverse Event|6|||
130581043|NCT04439175|470092356|FG000|Overall Study|Death|4|||
130581044|NCT04439175|470092356|FG000|Overall Study|Disease progression|44|||
130581045|NCT04439175|470092356|FG000|Overall Study|Withdrawal by Subject|4|||
130581046|NCT04439175|470092356|FG000|Overall Study|Alternative Therapy|1|||
130581047|NCT04439175|470092356|FG000|Overall Study|Other|2|||
130581048|NCT02363478|470092357|FG000|Overall Study|Lost to Follow-up|4|||
130581049|NCT02363478|470092357|FG000|Overall Study|Adverse Event|4|||
130581050|NCT02152345|470092358|FG000|Overall Study|Case Cancellations|2|||
130581051|NCT02152345|470092359|FG001|Overall Study|Case Cancellations|4|||
130581052|NCT02152345|470092358|FG000|Overall Study|Withdrawal by Subject|2|||
130581053|NCT02152345|470092359|FG001|Overall Study|Withdrawal by Subject|1|||
130581054|NCT02554929|470092360|FG000|Overall Study|Lost to Follow-up|4|||
130581055|NCT02554929|470092361|FG001|Overall Study|Lost to Follow-up|4|||
130581056|NCT02554929|470092360|FG000|Overall Study|Withdrawal by Subject|2|||
130581057|NCT02554929|470092361|FG001|Overall Study|Withdrawal by Subject|8|||
130581058|NCT01916980|470092362|FG000|Overall Study|Adverse Event|4|||
130581059|NCT01916980|470092363|FG001|Overall Study|Adverse Event|2|||
130581060|NCT01916980|470092362|FG000|Overall Study|Lack of Efficacy|2|||
130581061|NCT01916980|470092363|FG001|Overall Study|Lack of Efficacy|2|||
130581062|NCT01916980|470092362|FG000|Overall Study|Withdrawal by Subject|1|||
130581063|NCT01916980|470092363|FG001|Overall Study|Withdrawal by Subject|0|||
130581064|NCT02324270|470092364|FG000|Overall Study|Withdrawal by Subject|0|||
130581065|NCT02324270|470092365|FG001|Overall Study|Withdrawal by Subject|1|||
130581066|NCT02324270|470092366|FG002|Overall Study|Withdrawal by Subject|0|||
130581067|NCT02324270|470092364|FG000|Overall Study|Lost to Follow-up|4|||
130581068|NCT02324270|470092365|FG001|Overall Study|Lost to Follow-up|3|||
130581069|NCT02324270|470092366|FG002|Overall Study|Lost to Follow-up|4|||
130581070|NCT02324270|470092364|FG000|Overall Study|Protocol Violation|0|||
130581071|NCT02324270|470092365|FG001|Overall Study|Protocol Violation|1|||
130581072|NCT02324270|470092366|FG002|Overall Study|Protocol Violation|1|||
130581073|NCT02324270|470092364|FG000|Overall Study|Non Compliance with Study Drug|1|||
130581074|NCT02324270|470092365|FG001|Overall Study|Non Compliance with Study Drug|2|||
130581075|NCT02324270|470092366|FG002|Overall Study|Non Compliance with Study Drug|0|||
130581076|NCT00546364|470092367|FG000|Overall Study|Disease progression|5|||
130581077|NCT00546364|470092368|FG001|Overall Study|Disease progression|11|||
130581078|NCT00546364|470092369|FG002|Overall Study|Disease progression|8|||
130581079|NCT00546364|470092367|FG000|Overall Study|Completed and off treatment|1|||
130581080|NCT00546364|470092368|FG001|Overall Study|Completed and off treatment|0|||
130581081|NCT00546364|470092369|FG002|Overall Study|Completed and off treatment|2|||
130581082|NCT00546364|470092367|FG000|Overall Study|Administrative reason by sponsor|1|||
130581083|NCT00546364|470092368|FG001|Overall Study|Administrative reason by sponsor|0|||
130581084|NCT00546364|470092369|FG002|Overall Study|Administrative reason by sponsor|0|||
130581085|NCT00546364|470092367|FG000|Overall Study|Poor compliance/noncompliance|0|||
130581086|NCT00546364|470092368|FG001|Overall Study|Poor compliance/noncompliance|0|||
130581087|NCT00546364|470092369|FG002|Overall Study|Poor compliance/noncompliance|1|||
130581088|NCT00546364|470092367|FG000|Overall Study|No longer meets study criteria|1|||
130581089|NCT00546364|470092368|FG001|Overall Study|No longer meets study criteria|1|||
130581090|NCT00546364|470092369|FG002|Overall Study|No longer meets study criteria|0|||
130581091|NCT00546364|470092367|FG000|Overall Study|Withdrawal by Subject|5|||
130581092|NCT00546364|470092368|FG001|Overall Study|Withdrawal by Subject|6|||
130581093|NCT00546364|470092369|FG002|Overall Study|Withdrawal by Subject|3|||
130581094|NCT00546364|470092367|FG000|Overall Study|Prior taxotere|1|||
130581095|NCT00546364|470092368|FG001|Overall Study|Prior taxotere|0|||
130581096|NCT00546364|470092369|FG002|Overall Study|Prior taxotere|0|||
130581097|NCT00546364|470092367|FG000|Overall Study|Mixed response|1|||
130581098|NCT00546364|470092368|FG001|Overall Study|Mixed response|0|||
130581099|NCT00546364|470092369|FG002|Overall Study|Mixed response|0|||
130581100|NCT00546364|470092367|FG000|Overall Study|Palliative treatment|1|||
130581101|NCT00546364|470092368|FG001|Overall Study|Palliative treatment|0|||
130581102|NCT00546364|470092369|FG002|Overall Study|Palliative treatment|1|||
130581103|NCT00546364|470092367|FG000|Overall Study|Target lesions resected|1|||
130581104|NCT00546364|470092368|FG001|Overall Study|Target lesions resected|0|||
130581105|NCT00546364|470092369|FG002|Overall Study|Target lesions resected|0|||
130581106|NCT00546364|470092367|FG000|Overall Study|Physician Decision|0|||
130581107|NCT00546364|470092368|FG001|Overall Study|Physician Decision|0|||
130581108|NCT00546364|470092369|FG002|Overall Study|Physician Decision|1|||
130581109|NCT00546364|470092367|FG000|Overall Study|Sponsor decision|0|||
130581110|NCT00546364|470092368|FG001|Overall Study|Sponsor decision|0|||
130581111|NCT00546364|470092369|FG002|Overall Study|Sponsor decision|1|||
130581112|NCT03786432|470092370|FG000|Overall Study|Screen Failure after consent|1|||
130581113|NCT03786432|470092370|FG000|Overall Study|Lost to Follow-up|4|||
130581114|NCT03786432|470092370|FG000|Overall Study|did not complete 12 month CT scan|1|||
130581115|NCT03968419|470092374|FG000|Treatment Period|Adverse Event|0|||
130581116|NCT03968419|470092375|FG001|Treatment Period|Adverse Event|0|||
130581117|NCT03968419|470092376|FG002|Treatment Period|Adverse Event|1|||
130581118|NCT03968419|470092374|FG000|Safety Follow-up Period|Death|3|||
130581119|NCT03968419|470092375|FG001|Safety Follow-up Period|Death|2|||
130581120|NCT03968419|470092376|FG002|Safety Follow-up Period|Death|1|||
130581121|NCT03968419|470092374|FG000|Safety Follow-up Period|Subject Decision|2|||
130581122|NCT03968419|470092375|FG001|Safety Follow-up Period|Subject Decision|1|||
130581123|NCT03968419|470092376|FG002|Safety Follow-up Period|Subject Decision|0|||
130581124|NCT03593915|470092377|FG000|Overall Study|Adverse Event|0|||
130581125|NCT03593915|470092378|FG001|Overall Study|Adverse Event|0|||
130581126|NCT03593915|470092379|FG002|Overall Study|Adverse Event|0|||
130581127|NCT03593915|470092380|FG003|Overall Study|Adverse Event|1|||
130581128|NCT03593915|470092381|FG004|Overall Study|Adverse Event|0|||
130581129|NCT03593915|470092382|FG005|Overall Study|Adverse Event|0|||
130581130|NCT03593915|470092377|FG000|Overall Study|Physician Decision|0|||
130581131|NCT03593915|470092378|FG001|Overall Study|Physician Decision|0|||
130581132|NCT03593915|470092379|FG002|Overall Study|Physician Decision|0|||
130581133|NCT03593915|470092380|FG003|Overall Study|Physician Decision|0|||
130581134|NCT03593915|470092381|FG004|Overall Study|Physician Decision|0|||
130581135|NCT03593915|470092382|FG005|Overall Study|Physician Decision|1|||
130581136|NCT01641939|470092385|FG000|Overall Study|Death|90|||
130581137|NCT01641939|470092386|FG001|Overall Study|Death|187|||
130581138|NCT01641939|470092387|FG002|Overall Study|Death|61|||
130581139|NCT01641939|470092385|FG000|Overall Study|Lost to Follow-up|3|||
130581140|NCT01641939|470092386|FG001|Overall Study|Lost to Follow-up|2|||
130581141|NCT01641939|470092387|FG002|Overall Study|Lost to Follow-up|1|||
130581142|NCT01641939|470092385|FG000|Overall Study|Withdrawal by Subject|14|||
130581143|NCT01641939|470092386|FG001|Overall Study|Withdrawal by Subject|11|||
130581144|NCT01641939|470092387|FG002|Overall Study|Withdrawal by Subject|5|||
130581145|NCT01641939|470092385|FG000|Overall Study|Study Terminated by Sponsor|10|||
130581146|NCT01641939|470092386|FG001|Overall Study|Study Terminated by Sponsor|28|||
130581147|NCT01641939|470092387|FG002|Overall Study|Study Terminated by Sponsor|3|||
130581148|NCT00772629|470092388|FG000|Overall Study|Subject was not vaccinated|1|||
130581149|NCT00772629|470092389|FG001|Overall Study|Subject was not vaccinated|0|||
130581150|NCT02894840|470092390|FG000|Overall Study|Lost to Follow-up|1|||
130581151|NCT02894840|470092391|FG001|Overall Study|Lost to Follow-up|0|||
130581152|NCT02894840|470092392|FG002|Overall Study|Lost to Follow-up|3|||
130581153|NCT02894840|470092393|FG003|Overall Study|Lost to Follow-up|0|||
130581154|NCT05162066|470092395|FG000|Overall Study|Adverse Event|1|||
130581155|NCT05162066|470092396|FG001|Overall Study|Adverse Event|0|||
130581156|NCT05162066|470092397|FG002|Overall Study|Adverse Event|0|||
130581157|NCT05162066|470092395|FG000|Overall Study|Perceived lack of efficacy|1|||
130581158|NCT05162066|470092396|FG001|Overall Study|Perceived lack of efficacy|0|||
130581159|NCT05162066|470092397|FG002|Overall Study|Perceived lack of efficacy|0|||
130581160|NCT00167245|470092398|FG000|Overall Study|Lost to Follow-up|20|||
130581161|NCT00167245|470092399|FG001|Overall Study|Lost to Follow-up|31|||
130581162|NCT00167245|470092398|FG000|Overall Study|Withdrawal by Subject|5|||
130581163|NCT00167245|470092399|FG001|Overall Study|Withdrawal by Subject|8|||
130581164|NCT00167245|470092398|FG000|Overall Study|Incarcerated|3|||
130581165|NCT00167245|470092399|FG001|Overall Study|Incarcerated|2|||
130581166|NCT00167245|470092398|FG000|Overall Study|Drowsy|1|||
130581167|NCT00167245|470092399|FG001|Overall Study|Drowsy|0|||
130581168|NCT01871090|470092400|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
130581169|NCT01871090|470092401|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
130581170|NCT01871090|470092400|FG000|Overall Study|Interrogation not completed correctly|1|||
130581171|NCT01871090|470092401|FG001|Overall Study|Interrogation not completed correctly|0|||
130581172|NCT01871090|470092400|FG000|Overall Study|Subject Non-Compliance|0|||
130581173|NCT01871090|470092401|FG001|Overall Study|Subject Non-Compliance|1|||
130581174|NCT00688909|470092406|FG000|Overall Study|Adverse Event|28|||
130581175|NCT00688909|470092406|FG000|Overall Study|Patient withdrew consent|2|||
130581176|NCT00688909|470092406|FG000|Overall Study|Administrative problems|1|||
130581177|NCT00688909|470092406|FG000|Overall Study|Protocol Violation|2|||
130581178|NCT01220414|470092407|FG000|Overall Study|Withdrawal by Subject|1|||
130581179|NCT01220414|470092408|FG001|Overall Study|Withdrawal by Subject|0|||
130581180|NCT01220414|470092409|FG002|Overall Study|Withdrawal by Subject|0|||
130581181|NCT01220414|470092410|FG003|Overall Study|Withdrawal by Subject|1|||
130581182|NCT00700180|470092413|FG000|Overall Study|Death|99|||
130581183|NCT00700180|470092414|FG001|Overall Study|Death|114|||
130581184|NCT00700180|470092413|FG000|Overall Study|Alive on treatment|5|||
130581185|NCT00700180|470092414|FG001|Overall Study|Alive on treatment|3|||
130581186|NCT00700180|470092413|FG000|Overall Study|Alive in follow-up|46|||
130581187|NCT00700180|470092414|FG001|Overall Study|Alive in follow-up|27|||
130581188|NCT00700180|470092413|FG000|Overall Study|Lost to Follow-up|4|||
130581189|NCT00700180|470092414|FG001|Overall Study|Lost to Follow-up|5|||
130581190|NCT03569202|470092418|FG000|Part 3|Physician Decision|1|||
130581191|NCT03569202|470092419|FG001|Part 3|Physician Decision|0|||
130532143|NCT01646177|469915173|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532144|NCT01646177|469915174|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532145|NCT01646177|469915175|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532146|NCT01646177|469915176|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532147|NCT01646177|469915177|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532148|NCT01646177|469915178|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532149|NCT01646177|469915179|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532150|NCT01646177|469915180|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
130532151|NCT01646177|469915181|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
130532152|NCT01646177|469915182|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
130532153|NCT02920970|469915183|FG000|First Intervention|Protocol Violation|0|||
130532154|NCT02920970|469915184|FG001|First Intervention|Protocol Violation|1|||
130532155|NCT02920970|469915183|FG000|First Intervention|Adverse Event|0|||
130532156|NCT02920970|469915184|FG001|First Intervention|Adverse Event|1|||
130532157|NCT02920970|469915183|FG000|Second Intervention|Poor Lens Fit|1|||
130532158|NCT02920970|469915184|FG001|Second Intervention|Poor Lens Fit|0|||
130532159|NCT01711853|469915187|FG000|Overall Study|Not treated|3|||
130532160|NCT01427725|469915190|FG000|Overall Study|Lost to Follow-up|17|||
130532161|NCT01427725|469915190|FG000|Overall Study|Protocol Violation|1|||
130532162|NCT01427725|469915190|FG000|Overall Study|Drug not administered|1|||
130532163|NCT01427725|469915190|FG000|Overall Study|Failure to visit|7|||
130532164|NCT01427725|469915190|FG000|Overall Study|Adverse Event|46|||
130532165|NCT01427725|469915190|FG000|Overall Study|Failure to visit after administration|40|||
130532166|NCT01427725|469915190|FG000|Overall Study|Patient's rejection|27|||
130532167|NCT01427725|469915190|FG000|Overall Study|Transfer to a different hospital|17|||
130532168|NCT01427725|469915190|FG000|Overall Study|Lack of Efficacy|8|||
130532169|NCT01427725|469915190|FG000|Overall Study|Death|7|||
130532170|NCT01427725|469915190|FG000|Overall Study|Symptom improvement|6|||
130532171|NCT01427725|469915190|FG000|Overall Study|AE and Patient's rejection|5|||
130532172|NCT01427725|469915190|FG000|Overall Study|Physician Decision|5|||
130532173|NCT01427725|469915190|FG000|Overall Study|Exacerbation of underlying disease|5|||
130532174|NCT01427725|469915190|FG000|Overall Study|Oral feeding difficulty|5|||
130532175|NCT01427725|469915190|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
130532176|NCT01427725|469915190|FG000|Overall Study|Forgetting prescription|1|||
130532177|NCT01427725|469915190|FG000|Overall Study|Other|2|||
130532178|NCT01374568|469915191|FG000|Overall Study|Lab unable to analyze BTM|0|||
130532179|NCT01374568|469915192|FG001|Overall Study|Lab unable to analyze BTM|2|||
130532180|NCT01912404|469915194|FG000|Overall Study|Due to personal reasons|1|||
130532181|NCT01912404|469915195|FG001|Overall Study|Due to personal reasons|0|||
130532182|NCT02269423|469915200|FG000|Overall Study|Discontinued due to change in residence|0|||
130532183|NCT02269423|469915201|FG001|Overall Study|Discontinued due to change in residence|1|||
130532184|NCT02269423|469915202|FG002|Overall Study|Discontinued due to change in residence|0|||
130532185|NCT02269423|469915203|FG003|Overall Study|Discontinued due to change in residence|1|||
130532186|NCT00755105|469915206|FG000|Overall Study|Withdrawal by Subject|9|||
130532187|NCT00755105|469915207|FG001|Overall Study|Withdrawal by Subject|11|||
130532188|NCT00755105|469915208|FG002|Overall Study|Withdrawal by Subject|4|||
130532189|NCT01281839|469915210|FG000|Overall Study|Lost to Follow-up|6|||
130532190|NCT01281839|469915211|FG001|Overall Study|Lost to Follow-up|3|||
130532191|NCT01281839|469915210|FG000|Overall Study|Withdrawal by Subject|4|||
130532192|NCT01281839|469915211|FG001|Overall Study|Withdrawal by Subject|10|||
130532193|NCT01281839|469915210|FG000|Overall Study|Reason not specified|0|||
130532194|NCT01281839|469915211|FG001|Overall Study|Reason not specified|1|||
130532195|NCT01277887|469915212|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
130532196|NCT01277887|469915213|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
130532197|NCT01277887|469915212|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
130532198|NCT01277887|469915213|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
130532199|NCT01277887|469915212|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
130532200|NCT01277887|469915213|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
130532201|NCT00415051|469915214|FG000|Overall Study|Protocol Violation|1|||
130532202|NCT01518153|469915219|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
130532203|NCT01518153|469915220|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
130532204|NCT01518153|469915221|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
130532205|NCT01518153|469915219|FG000|Stem Cell Transplant|Death|2|||
130532206|NCT01518153|469915220|FG001|Stem Cell Transplant|Death|0|||
130532207|NCT01518153|469915221|FG002|Stem Cell Transplant|Death|0|||
130532208|NCT01518153|469915219|FG000|Stem Cell Transplant|Secondary graft failure|1|||
130532209|NCT01518153|469915220|FG001|Stem Cell Transplant|Secondary graft failure|0|||
130532210|NCT01518153|469915221|FG002|Stem Cell Transplant|Secondary graft failure|0|||
130532211|NCT01518153|469915219|FG000|Stem Cell Transplant|Adverse Event|1|||
130532212|NCT01518153|469915220|FG001|Stem Cell Transplant|Adverse Event|0|||
130532213|NCT01518153|469915221|FG002|Stem Cell Transplant|Adverse Event|0|||
130532214|NCT01518153|469915219|FG000|Donor Lymphocyte Infusion|Death|0|||
130532215|NCT01518153|469915220|FG001|Donor Lymphocyte Infusion|Death|2|||
130532216|NCT01518153|469915221|FG002|Donor Lymphocyte Infusion|Death|1|||
130532217|NCT01754753|469915222|FG000|Overall Study|Study close|43|||
130532218|NCT01754753|469915223|FG001|Overall Study|Study close|44|||
130532219|NCT01754753|469915222|FG000|Overall Study|Lost to Follow-up|9|||
130532220|NCT01754753|469915223|FG001|Overall Study|Lost to Follow-up|5|||
130532221|NCT00856245|469915225|FG000|Overall Study|Was not transplanted|5|||
130532222|NCT01250509|469915226|FG000|Overall Study|Lost to Follow-up|5|||
130532223|NCT01250509|469915227|FG001|Overall Study|Lost to Follow-up|2|||
130532224|NCT00203268|469915231|FG000|Early Treatment|only treated one headache|2|||
130532225|NCT00203268|469915231|FG000|Early Treatment|Lost to Follow-up|1|||
130532226|NCT00203268|469915231|FG000|Early Treatment|Withdrawal by Subject|1|||
130532227|NCT01371708|469915234|FG000|Overall Study|Insufficient clinical response|3|||
130532228|NCT01371708|469915235|FG001|Overall Study|Insufficient clinical response|2|||
130532229|NCT01371708|469915236|FG002|Overall Study|Insufficient clinical response|0|||
130532230|NCT01371708|469915234|FG000|Overall Study|Lost to Follow-up|5|||
130532231|NCT01371708|469915235|FG001|Overall Study|Lost to Follow-up|9|||
130532232|NCT01371708|469915236|FG002|Overall Study|Lost to Follow-up|7|||
130532233|NCT01371708|469915234|FG000|Overall Study|Protocol Violation|2|||
130532234|NCT01371708|469915235|FG001|Overall Study|Protocol Violation|1|||
130532235|NCT01371708|469915236|FG002|Overall Study|Protocol Violation|2|||
130532236|NCT01371708|469915234|FG000|Overall Study|No longer willing to participate|7|||
130532237|NCT01371708|469915235|FG001|Overall Study|No longer willing to participate|7|||
130532238|NCT01371708|469915236|FG002|Overall Study|No longer willing to participate|13|||
130532239|NCT01371708|469915234|FG000|Overall Study|Medication error/not related to AE|0|||
130532240|NCT01371708|469915235|FG001|Overall Study|Medication error/not related to AE|1|||
130532241|NCT01371708|469915236|FG002|Overall Study|Medication error/not related to AE|0|||
130532242|NCT01371708|469915234|FG000|Overall Study|Other|3|||
130532243|NCT01371708|469915235|FG001|Overall Study|Other|2|||
130532244|NCT01371708|469915236|FG002|Overall Study|Other|4|||
130532245|NCT01371708|469915234|FG000|Overall Study|Adverse Event|5|||
130532246|NCT01371708|469915235|FG001|Overall Study|Adverse Event|8|||
130532247|NCT01371708|469915236|FG002|Overall Study|Adverse Event|12|||
130532248|NCT01371708|469915234|FG000|Overall Study|Started but did not receive treatment|1|||
130532249|NCT01371708|469915235|FG001|Overall Study|Started but did not receive treatment|0|||
130532250|NCT01371708|469915236|FG002|Overall Study|Started but did not receive treatment|1|||
130532251|NCT02819024|469915238|FG000|Overall Study|Withdrawal by Subject|1|||
130532252|NCT00792948|469915239|FG000|Overall Study|Adverse Event|6|||
130532253|NCT00792948|469915239|FG000|Overall Study|Death|4|||
130532254|NCT00792948|469915239|FG000|Overall Study|Withdrawal by Subject|3|||
130532255|NCT00792948|469915239|FG000|Overall Study|Ineligible|2|||
130532256|NCT00792948|469915239|FG000|Overall Study|Insurance denial - not treated|1|||
130532257|NCT00792948|469915239|FG000|Overall Study|Physician Decision|11|||
130532258|NCT00792948|469915239|FG000|Overall Study|Protocol Violation|1|||
130532259|NCT03832595|469915247|FG000|Overall Study|Death|142|||
130532260|NCT03832595|469915248|FG001|Overall Study|Death|130|||
130532261|NCT03832595|469915247|FG000|Overall Study|Medical management without dialysis|37|||
130532262|NCT03832595|469915248|FG001|Overall Study|Medical management without dialysis|1|||
130532263|NCT02397447|469915249|FG000|Overall Study|Lost to Follow-up|2|||
130532264|NCT02397447|469915250|FG001|Overall Study|Lost to Follow-up|2|||
130532265|NCT02304705|469917285|FG000|Overall Study|Withdrawal by Subject|2|||
130532266|NCT02304705|469917286|FG001|Overall Study|Withdrawal by Subject|0|||
130532267|NCT02304705|469917285|FG000|Overall Study|Physician Decision|2|||
130532268|NCT02304705|469917286|FG001|Overall Study|Physician Decision|4|||
130532269|NCT02304705|469917285|FG000|Overall Study|Death|0|||
130532270|NCT02304705|469917286|FG001|Overall Study|Death|1|||
130532271|NCT02304705|469917285|FG000|Overall Study|Lost to Follow-up|0|||
130532272|NCT02304705|469917286|FG001|Overall Study|Lost to Follow-up|2|||
130532273|NCT01195948|469917287|FG000|Overall Study|Lost to Follow-up|0|||
130532274|NCT01195948|469917288|FG001|Overall Study|Lost to Follow-up|1|||
130532275|NCT01195948|469917289|FG002|Overall Study|Lost to Follow-up|2|||
130532276|NCT00770029|469917290|FG000|Overall Study|Lost to Follow-up|2|||
130532277|NCT00770029|469917291|FG001|Overall Study|Lost to Follow-up|0|||
130532278|NCT00770029|469917290|FG000|Overall Study|Withdrawal by Subject|3|||
130532279|NCT00770029|469917291|FG001|Overall Study|Withdrawal by Subject|3|||
130532280|NCT00770029|469917290|FG000|Overall Study|Adverse Event|1|||
130532281|NCT00770029|469917291|FG001|Overall Study|Adverse Event|0|||
130532282|NCT02124811|469917292|FG000|Overall Study|Early termination|2|||
130532283|NCT02124811|469917293|FG001|Overall Study|Early termination|2|||
130532284|NCT02124811|469917292|FG000|Overall Study|Withdrawal by Subject|1|||
130532285|NCT02124811|469917293|FG001|Overall Study|Withdrawal by Subject|0|||
130532286|NCT01757197|469917296|FG000|Overall Study|Death|2|||
130532287|NCT01174446|469917300|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
130532288|NCT01174446|469917301|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
130532289|NCT01174446|469917302|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
130532290|NCT01174446|469917303|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
130532291|NCT01174446|469917300|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
130532292|NCT01174446|469917301|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
130532293|NCT01174446|469917302|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
130532294|NCT01174446|469917303|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
130532295|NCT01174446|469917300|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
130532296|NCT01174446|469917301|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
130532297|NCT01174446|469917302|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
130532298|NCT01174446|469917303|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
130532299|NCT01174446|469917300|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
130532300|NCT01174446|469917301|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
130532301|NCT01174446|469917302|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
130532302|NCT01174446|469917303|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
130532303|NCT01077128|469917304|FG000|Overall Study|Adverse Event|8|||
130532304|NCT01077128|469917304|FG000|Overall Study|Lack of Efficacy|1|||
130532305|NCT01077128|469917304|FG000|Overall Study|Disease exacerbation|1|||
130532306|NCT01077128|469917304|FG000|Overall Study|Adverse event and consent withdrawal|1|||
130532307|NCT01077128|469917304|FG000|Overall Study|Adverse event and disease exacerbation|1|||
130532308|NCT01077128|469917304|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
130532309|NCT01077128|469917304|FG000|Overall Study|Other|54|||
130532310|NCT00847626|469917307|FG000|Overall Study|Adverse Event|10|||
130532311|NCT00847626|469917308|FG001|Overall Study|Adverse Event|10|||
130532312|NCT00847626|469917309|FG002|Overall Study|Adverse Event|6|||
130581192|NCT03569202|470092418|FG000|Part 3|Other|1|||
130532313|NCT00847626|469917310|FG003|Overall Study|Adverse Event|19|||
130532314|NCT00847626|469917311|FG004|Overall Study|Adverse Event|11|||
130532315|NCT00847626|469917312|FG005|Overall Study|Adverse Event|22|||
130532316|NCT00847626|469917313|FG006|Overall Study|Adverse Event|4|||
130532317|NCT00847626|469917314|FG007|Overall Study|Adverse Event|6|||
130532318|NCT00847626|469917315|FG008|Overall Study|Adverse Event|3|||
130532319|NCT00847626|469917316|FG009|Overall Study|Adverse Event|6|||
130532320|NCT00847626|469917317|FG010|Overall Study|Adverse Event|6|||
130532321|NCT00847626|469917307|FG000|Overall Study|Protocol Violation|2|||
130532322|NCT00847626|469917308|FG001|Overall Study|Protocol Violation|1|||
130532323|NCT00847626|469917309|FG002|Overall Study|Protocol Violation|2|||
130532324|NCT00847626|469917310|FG003|Overall Study|Protocol Violation|1|||
130532325|NCT00847626|469917311|FG004|Overall Study|Protocol Violation|1|||
130532326|NCT00847626|469917312|FG005|Overall Study|Protocol Violation|1|||
130532327|NCT00847626|469917313|FG006|Overall Study|Protocol Violation|1|||
130532328|NCT00847626|469917314|FG007|Overall Study|Protocol Violation|1|||
130532329|NCT00847626|469917315|FG008|Overall Study|Protocol Violation|0|||
130532330|NCT00847626|469917316|FG009|Overall Study|Protocol Violation|1|||
130532331|NCT00847626|469917317|FG010|Overall Study|Protocol Violation|1|||
130581193|NCT03569202|470092419|FG001|Part 3|Other|1|||
130532332|NCT00847626|469917307|FG000|Overall Study|Lost to Follow-up|0|||
130532333|NCT00847626|469917308|FG001|Overall Study|Lost to Follow-up|1|||
130532334|NCT00847626|469917309|FG002|Overall Study|Lost to Follow-up|1|||
130532335|NCT00847626|469917310|FG003|Overall Study|Lost to Follow-up|1|||
130532336|NCT00847626|469917311|FG004|Overall Study|Lost to Follow-up|0|||
130532337|NCT00847626|469917312|FG005|Overall Study|Lost to Follow-up|3|||
130532338|NCT00847626|469917313|FG006|Overall Study|Lost to Follow-up|1|||
130532339|NCT00847626|469917314|FG007|Overall Study|Lost to Follow-up|3|||
130532340|NCT00847626|469917315|FG008|Overall Study|Lost to Follow-up|1|||
130532341|NCT00847626|469917316|FG009|Overall Study|Lost to Follow-up|0|||
130532342|NCT00847626|469917317|FG010|Overall Study|Lost to Follow-up|1|||
130532343|NCT00847626|469917307|FG000|Overall Study|Withdrawal by Subject|5|||
130532344|NCT00847626|469917308|FG001|Overall Study|Withdrawal by Subject|5|||
130532345|NCT00847626|469917309|FG002|Overall Study|Withdrawal by Subject|3|||
130532346|NCT00847626|469917310|FG003|Overall Study|Withdrawal by Subject|8|||
130532347|NCT00847626|469917311|FG004|Overall Study|Withdrawal by Subject|12|||
130532348|NCT00847626|469917312|FG005|Overall Study|Withdrawal by Subject|9|||
130532349|NCT00847626|469917313|FG006|Overall Study|Withdrawal by Subject|8|||
130532350|NCT00847626|469917314|FG007|Overall Study|Withdrawal by Subject|4|||
130532351|NCT00847626|469917315|FG008|Overall Study|Withdrawal by Subject|4|||
130532352|NCT00847626|469917316|FG009|Overall Study|Withdrawal by Subject|5|||
130532353|NCT00847626|469917317|FG010|Overall Study|Withdrawal by Subject|2|||
130532354|NCT00847626|469917307|FG000|Overall Study|Lack of Efficacy|3|||
130532355|NCT00847626|469917308|FG001|Overall Study|Lack of Efficacy|1|||
130532356|NCT00847626|469917309|FG002|Overall Study|Lack of Efficacy|0|||
130532357|NCT00847626|469917310|FG003|Overall Study|Lack of Efficacy|1|||
130532358|NCT00847626|469917311|FG004|Overall Study|Lack of Efficacy|2|||
130532359|NCT00847626|469917312|FG005|Overall Study|Lack of Efficacy|0|||
130532360|NCT00847626|469917313|FG006|Overall Study|Lack of Efficacy|6|||
130532361|NCT00847626|469917314|FG007|Overall Study|Lack of Efficacy|2|||
130532362|NCT00847626|469917315|FG008|Overall Study|Lack of Efficacy|5|||
130532363|NCT00847626|469917316|FG009|Overall Study|Lack of Efficacy|1|||
130532364|NCT00847626|469917317|FG010|Overall Study|Lack of Efficacy|7|||
130532365|NCT00847626|469917307|FG000|Overall Study|Other|1|||
130532366|NCT00847626|469917308|FG001|Overall Study|Other|5|||
130532367|NCT00847626|469917309|FG002|Overall Study|Other|4|||
130532368|NCT00847626|469917310|FG003|Overall Study|Other|1|||
130532369|NCT00847626|469917311|FG004|Overall Study|Other|2|||
130532370|NCT00847626|469917312|FG005|Overall Study|Other|2|||
130532371|NCT00847626|469917313|FG006|Overall Study|Other|2|||
130532372|NCT00847626|469917314|FG007|Overall Study|Other|3|||
130532373|NCT00847626|469917315|FG008|Overall Study|Other|1|||
130532374|NCT00847626|469917316|FG009|Overall Study|Other|1|||
130532375|NCT00847626|469917317|FG010|Overall Study|Other|3|||
130532376|NCT03057847|469917318|FG000|Overall Study|Lost to Follow-up|16|||
130532377|NCT01706705|469917320|FG000|Overall Study|Death|1|||
130532378|NCT01706705|469917320|FG000|Overall Study|Lack of Efficacy|13|||
130532379|NCT01706705|469917320|FG000|Overall Study|Non-clinical|6|||
130532380|NCT05627258|469917321|FG000|Overall Study|Lost to Follow-up|1|||
130532381|NCT05627258|469917322|FG001|Overall Study|Lost to Follow-up|0|||
130532382|NCT05627258|469917323|FG002|Overall Study|Lost to Follow-up|0|||
130532383|NCT05627258|469917324|FG003|Overall Study|Lost to Follow-up|0|||
130532384|NCT05627258|469917325|FG004|Overall Study|Lost to Follow-up|0|||
130532385|NCT05627258|469917326|FG005|Overall Study|Lost to Follow-up|0|||
130532386|NCT05627258|469917321|FG000|Overall Study|Withdrawal by Subject|0|||
130532387|NCT05627258|469917322|FG001|Overall Study|Withdrawal by Subject|0|||
130532388|NCT05627258|469917323|FG002|Overall Study|Withdrawal by Subject|0|||
130532389|NCT05627258|469917324|FG003|Overall Study|Withdrawal by Subject|0|||
130532390|NCT05627258|469917325|FG004|Overall Study|Withdrawal by Subject|2|||
130532391|NCT05627258|469917326|FG005|Overall Study|Withdrawal by Subject|0|||
130532392|NCT05627258|469917321|FG000|Overall Study|Enrolled, but product not administered|1|||
130532393|NCT05627258|469917322|FG001|Overall Study|Enrolled, but product not administered|0|||
130532394|NCT05627258|469917323|FG002|Overall Study|Enrolled, but product not administered|0|||
130532395|NCT05627258|469917324|FG003|Overall Study|Enrolled, but product not administered|0|||
130532396|NCT05627258|469917325|FG004|Overall Study|Enrolled, but product not administered|0|||
130532397|NCT05627258|469917326|FG005|Overall Study|Enrolled, but product not administered|0|||
130532398|NCT05627258|469917321|FG000|Overall Study|Other subject illness/injury|1|||
130532399|NCT05627258|469917322|FG001|Overall Study|Other subject illness/injury|0|||
130532400|NCT05627258|469917323|FG002|Overall Study|Other subject illness/injury|0|||
130532401|NCT05627258|469917324|FG003|Overall Study|Other subject illness/injury|0|||
130532402|NCT05627258|469917325|FG004|Overall Study|Other subject illness/injury|0|||
130532403|NCT05627258|469917326|FG005|Overall Study|Other subject illness/injury|0|||
130532404|NCT05627258|469917321|FG000|Overall Study|Subject moved from area|0|||
130532405|NCT05627258|469917322|FG001|Overall Study|Subject moved from area|0|||
130532406|NCT05627258|469917323|FG002|Overall Study|Subject moved from area|1|||
130532407|NCT05627258|469917324|FG003|Overall Study|Subject moved from area|0|||
130532408|NCT05627258|469917325|FG004|Overall Study|Subject moved from area|0|||
130532409|NCT05627258|469917326|FG005|Overall Study|Subject moved from area|0|||
130532410|NCT02138786|469917327|FG000|Overall Study|Adverse Event|0|||
130532411|NCT02138786|469917328|FG001|Overall Study|Adverse Event|2|||
130532412|NCT02138786|469917329|FG002|Overall Study|Adverse Event|1|||
130532413|NCT02138786|469917327|FG000|Overall Study|Death|1|||
130532414|NCT02138786|469917328|FG001|Overall Study|Death|7|||
130532415|NCT02138786|469917329|FG002|Overall Study|Death|2|||
130532416|NCT02138786|469917327|FG000|Overall Study|Disease Progression|1|||
130532417|NCT02138786|469917328|FG001|Overall Study|Disease Progression|1|||
130532418|NCT02138786|469917329|FG002|Overall Study|Disease Progression|3|||
130532419|NCT02138786|469917327|FG000|Overall Study|Withdrawal by Subject|1|||
130532420|NCT02138786|469917328|FG001|Overall Study|Withdrawal by Subject|2|||
130532421|NCT02138786|469917329|FG002|Overall Study|Withdrawal by Subject|0|||
130532422|NCT02138786|469917327|FG000|Overall Study|Patient's Wish|0|||
130532423|NCT02138786|469917328|FG001|Overall Study|Patient's Wish|2|||
130532424|NCT02138786|469917329|FG002|Overall Study|Patient's Wish|0|||
130532425|NCT02138786|469917327|FG000|Overall Study|Sponsor Terminated Study|0|||
130532426|NCT02138786|469917328|FG001|Overall Study|Sponsor Terminated Study|1|||
130532427|NCT02138786|469917329|FG002|Overall Study|Sponsor Terminated Study|1|||
130532428|NCT02138786|469917327|FG000|Overall Study|Non-Compliance|0|||
130532429|NCT02138786|469917328|FG001|Overall Study|Non-Compliance|0|||
130532430|NCT02138786|469917329|FG002|Overall Study|Non-Compliance|1|||
130532431|NCT02088957|469917330|FG000|Overall Study|Lack of Efficacy|1|||
130532432|NCT02088957|469917331|FG001|Overall Study|Lack of Efficacy|0|||
130532433|NCT01199068|469917332|FG000|Overall Study|Unacceptable toxicity|0|||
130532434|NCT01199068|469917333|FG001|Overall Study|Unacceptable toxicity|0|||
130532435|NCT01199068|469917334|FG002|Overall Study|Unacceptable toxicity|2|||
130532436|NCT01199068|469917332|FG000|Overall Study|Progressive disease|3|||
130532437|NCT01199068|469917333|FG001|Overall Study|Progressive disease|3|||
130532438|NCT01199068|469917334|FG002|Overall Study|Progressive disease|6|||
130532439|NCT01199068|469917332|FG000|Overall Study|Withdrawal by Subject|0|||
130532440|NCT01199068|469917333|FG001|Overall Study|Withdrawal by Subject|0|||
130532441|NCT01199068|469917334|FG002|Overall Study|Withdrawal by Subject|1|||
130532442|NCT03338296|469917335|FG000|Overall Study|Adverse Event|0|||
130532443|NCT03338296|469917336|FG001|Overall Study|Adverse Event|1|||
130532444|NCT03338296|469917335|FG000|Overall Study|Withdrawal by Subject|14|||
130532445|NCT03338296|469917336|FG001|Overall Study|Withdrawal by Subject|13|||
130532446|NCT03338296|469917335|FG000|Overall Study|Lost to Follow-up|10|||
130532447|NCT03338296|469917336|FG001|Overall Study|Lost to Follow-up|10|||
130532448|NCT03338296|469917335|FG000|Overall Study|Study Terminated by Sponsor|77|||
130532449|NCT03338296|469917336|FG001|Overall Study|Study Terminated by Sponsor|76|||
130532450|NCT03338296|469917335|FG000|Overall Study|Other|2|||
130532451|NCT03338296|469917336|FG001|Overall Study|Other|7|||
130532452|NCT03338296|469917335|FG000|Overall Study|Missing|0|||
130532453|NCT03338296|469917336|FG001|Overall Study|Missing|1|||
130532454|NCT02687035|469917341|FG000|Overall Study|Withdrawal by Subject|1|||
130532455|NCT02687035|469917341|FG000|Overall Study|Death|87|||
130532456|NCT02687035|469917341|FG000|Overall Study|Lost to Follow-up|1|||
130532457|NCT02687035|469917341|FG000|Overall Study|Missed Visit|87|||
130532458|NCT02687035|469917341|FG000|Overall Study|Did not receive Study Device|8|||
130532459|NCT00667394|469917342|FG000|Overall Study|Adverse Event|3|||
130532460|NCT00667394|469917343|FG001|Overall Study|Adverse Event|0|||
130532461|NCT00667394|469917342|FG000|Overall Study|Progressive disease|1|||
130532462|NCT00667394|469917343|FG001|Overall Study|Progressive disease|0|||
130532463|NCT04076943|469917345|FG000|Overall Study|Withdrawal by Subject|12|||
130532464|NCT04076943|469917345|FG000|Overall Study|Adverse Event|1|||
130532465|NCT04076943|469917345|FG000|Overall Study|Progressive Disease|2|||
130532466|NCT04076943|469917345|FG000|Overall Study|Death|13|||
130532467|NCT04076943|469917345|FG000|Overall Study|Other than specified|6|||
130532468|NCT02224703|469917351|FG000|Overall Study|Adverse Event|0|||
130532469|NCT02224703|469917352|FG001|Overall Study|Adverse Event|5|||
130532470|NCT02224703|469917353|FG002|Overall Study|Adverse Event|0|||
130532471|NCT02224703|469917351|FG000|Overall Study|Withdrawn by investigator|1|||
130532472|NCT02224703|469917352|FG001|Overall Study|Withdrawn by investigator|0|||
130532473|NCT02224703|469917353|FG002|Overall Study|Withdrawn by investigator|0|||
130532474|NCT02224703|469917351|FG000|Overall Study|Advised by medical monitor|1|||
130532475|NCT02224703|469917352|FG001|Overall Study|Advised by medical monitor|0|||
130532476|NCT02224703|469917353|FG002|Overall Study|Advised by medical monitor|0|||
130532477|NCT02224703|469917351|FG000|Overall Study|Withdrawn by parent/guardian|0|||
130532478|NCT02224703|469917352|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130532479|NCT02224703|469917353|FG002|Overall Study|Withdrawn by parent/guardian|0|||
130581194|NCT02415712|470092420|FG000|Overall Study|Protocol Violation|16|||
130532480|NCT02224703|469917351|FG000|Overall Study|Lack of Efficacy|1|||
130532481|NCT02224703|469917352|FG001|Overall Study|Lack of Efficacy|0|||
130581195|NCT01668654|470092421|FG000|Overall Study|Study Closed/Terminated|3|||
130532482|NCT02224703|469917353|FG002|Overall Study|Lack of Efficacy|0|||
130532483|NCT02922023|469917354|FG000|Overall Study|Lost to Follow-up|2|||
130532484|NCT02922023|469917355|FG001|Overall Study|Lost to Follow-up|0|||
130532485|NCT03538938|469917356|FG000|Overall Study|Death|0|||
130532486|NCT03538938|469917357|FG001|Overall Study|Death|0|||
130581196|NCT01668654|470092421|FG000|Overall Study|Withdrawal by Subject|1|||
130581197|NCT04557384|470092422|FG000|Overall Study|Study Terminated by Sponsor|1|||
130532487|NCT03538938|469917358|FG002|Overall Study|Death|2|||
130532488|NCT03538938|469917359|FG003|Overall Study|Death|0|||
130532489|NCT03538938|469917360|FG004|Overall Study|Death|0|||
130532490|NCT03538938|469917361|FG005|Overall Study|Death|1|||
130532491|NCT03538938|469917362|FG006|Overall Study|Death|0|||
130532492|NCT03538938|469917363|FG007|Overall Study|Death|1|||
130532493|NCT03538938|469917364|FG008|Overall Study|Death|1|||
130532494|NCT03538938|469917365|FG009|Overall Study|Death|1|||
130532495|NCT03538938|469917366|FG010|Overall Study|Death|0|||
130532496|NCT03538938|469917367|FG011|Overall Study|Death|0|||
130532497|NCT03538938|469917368|FG012|Overall Study|Death|1|||
130532498|NCT03538938|469917369|FG013|Overall Study|Death|1|||
130532499|NCT03538938|469917370|FG014|Overall Study|Death|0|||
130532500|NCT03538938|469917371|FG015|Overall Study|Death|1|||
130532501|NCT03538938|469917356|FG000|Overall Study|Withdrawal by Subject|4|||
130532502|NCT03538938|469917357|FG001|Overall Study|Withdrawal by Subject|6|||
130532503|NCT03538938|469917358|FG002|Overall Study|Withdrawal by Subject|5|||
130532504|NCT03538938|469917359|FG003|Overall Study|Withdrawal by Subject|3|||
130532505|NCT03538938|469917360|FG004|Overall Study|Withdrawal by Subject|0|||
130532506|NCT03538938|469917361|FG005|Overall Study|Withdrawal by Subject|0|||
130532507|NCT03538938|469917362|FG006|Overall Study|Withdrawal by Subject|3|||
130532508|NCT03538938|469917363|FG007|Overall Study|Withdrawal by Subject|1|||
130532509|NCT03538938|469917364|FG008|Overall Study|Withdrawal by Subject|5|||
130532510|NCT03538938|469917365|FG009|Overall Study|Withdrawal by Subject|1|||
130532511|NCT03538938|469917366|FG010|Overall Study|Withdrawal by Subject|2|||
130532512|NCT03538938|469917367|FG011|Overall Study|Withdrawal by Subject|1|||
130532513|NCT03538938|469917368|FG012|Overall Study|Withdrawal by Subject|3|||
130532514|NCT03538938|469917369|FG013|Overall Study|Withdrawal by Subject|0|||
130532515|NCT03538938|469917370|FG014|Overall Study|Withdrawal by Subject|2|||
130532516|NCT03538938|469917371|FG015|Overall Study|Withdrawal by Subject|4|||
130532517|NCT03538938|469917356|FG000|Overall Study|Incarcerated|0|||
130532518|NCT03538938|469917357|FG001|Overall Study|Incarcerated|0|||
130532519|NCT03538938|469917358|FG002|Overall Study|Incarcerated|0|||
130532520|NCT03538938|469917359|FG003|Overall Study|Incarcerated|0|||
130532521|NCT03538938|469917360|FG004|Overall Study|Incarcerated|0|||
130532522|NCT03538938|469917361|FG005|Overall Study|Incarcerated|0|||
130532523|NCT03538938|469917362|FG006|Overall Study|Incarcerated|0|||
130532524|NCT03538938|469917363|FG007|Overall Study|Incarcerated|0|||
130532525|NCT03538938|469917364|FG008|Overall Study|Incarcerated|0|||
130532526|NCT03538938|469917365|FG009|Overall Study|Incarcerated|0|||
130532527|NCT03538938|469917366|FG010|Overall Study|Incarcerated|0|||
130532528|NCT03538938|469917367|FG011|Overall Study|Incarcerated|1|||
130532529|NCT03538938|469917368|FG012|Overall Study|Incarcerated|0|||
130532530|NCT03538938|469917369|FG013|Overall Study|Incarcerated|0|||
130532531|NCT03538938|469917370|FG014|Overall Study|Incarcerated|0|||
130532532|NCT03538938|469917371|FG015|Overall Study|Incarcerated|0|||
130532533|NCT03995316|469917372|FG000|Overall Study|Lost to Follow-up|10|||
130532534|NCT03995316|469917373|FG001|Overall Study|Lost to Follow-up|3|||
130532535|NCT01361594|469917374|FG000|Overall Study|Withdrawal by Subject|1|||
130532536|NCT01361594|469917375|FG001|Overall Study|Withdrawal by Subject|2|||
130532537|NCT00780559|469917377|FG000|Overall Study|Lost to Follow-up|2|||
130532538|NCT00780559|469917378|FG001|Overall Study|Lost to Follow-up|7|||
130532539|NCT00780559|469917377|FG000|Overall Study|Death|1|||
130532540|NCT00780559|469917378|FG001|Overall Study|Death|0|||
130532541|NCT00839956|469917386|FG000|Overall Study|Adverse Event|2|||
130532542|NCT00839956|469917386|FG000|Overall Study|Lack of Efficacy|6|||
130532543|NCT00839956|469917386|FG000|Overall Study|Physician Decision|1|||
130532544|NCT00839956|469917386|FG000|Overall Study|Withdrawal by Subject|3|||
130532545|NCT02807883|469917387|FG000|Overall Study|Withdrawal by Subject|2|||
130532546|NCT01399918|469917391|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
130532547|NCT03197766|469917396|FG000|Overall Study|Withdrawal by Subject|2|||
130532548|NCT03197766|469917397|FG001|Overall Study|Withdrawal by Subject|0|||
130532549|NCT00972322|469917399|FG000|Overall Study|Adverse Event|2|||
130532550|NCT00972322|469917400|FG001|Overall Study|Adverse Event|1|||
130581198|NCT04557384|470092422|FG000|Overall Study|Death|1|||
130532551|NCT00972322|469917399|FG000|Overall Study|Positive drug screen|0|||
130532552|NCT00972322|469917400|FG001|Overall Study|Positive drug screen|1|||
130532553|NCT00972322|469917399|FG000|Overall Study|Lost to Follow-up|0|||
130532554|NCT00972322|469917400|FG001|Overall Study|Lost to Follow-up|1|||
130532555|NCT00972322|469917399|FG000|Overall Study|Consistently high glucose values|1|||
130532556|NCT00972322|469917400|FG001|Overall Study|Consistently high glucose values|0|||
130532557|NCT00277095|469917403|FG000|Overall Study|Death|2|||
130532558|NCT00277095|469917403|FG000|Overall Study|Explanted|7|||
130532559|NCT00277095|469917403|FG000|Overall Study|Lost to Follow-up|2|||
130532560|NCT00277095|469917403|FG000|Overall Study|Missed Follow-up|9|||
130532561|NCT00277095|469917403|FG000|Overall Study|Physician Decision|1|||
130532562|NCT05140915|469917405|FG000|Overall Study|Lost to Follow-up|2|||
130532563|NCT05140915|469917406|FG001|Overall Study|Lost to Follow-up|1|||
130532564|NCT04520659|469917407|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
130532565|NCT04520659|469917408|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
130532566|NCT04520659|469917409|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
130532567|NCT04520659|469917410|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
130532568|NCT04879849|469917415|FG000|Overall Study|Lost to Follow-up|0|||
130532569|NCT04879849|469917416|FG001|Overall Study|Lost to Follow-up|0|||
130532570|NCT04879849|469917417|FG002|Overall Study|Lost to Follow-up|0|||
130532571|NCT04879849|469917418|FG003|Overall Study|Lost to Follow-up|1|||
130532572|NCT04879849|469917419|FG004|Overall Study|Lost to Follow-up|0|||
130532573|NCT04879849|469917420|FG005|Overall Study|Lost to Follow-up|0|||
130532574|NCT04879849|469917421|FG006|Overall Study|Lost to Follow-up|0|||
130532575|NCT04879849|469917422|FG007|Overall Study|Lost to Follow-up|0|||
130532576|NCT04879849|469917415|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
130532577|NCT04879849|469917416|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
130532578|NCT04879849|469917417|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
130532579|NCT04879849|469917418|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
130532580|NCT04879849|469917419|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
130532581|NCT04879849|469917420|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
130532582|NCT04879849|469917421|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
130532583|NCT04879849|469917422|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
130532584|NCT04879849|469917415|FG000|Overall Study|Withdrawal by Subject|0|||
130532585|NCT04879849|469917416|FG001|Overall Study|Withdrawal by Subject|0|||
130532586|NCT04879849|469917417|FG002|Overall Study|Withdrawal by Subject|0|||
130532587|NCT04879849|469917418|FG003|Overall Study|Withdrawal by Subject|0|||
130532588|NCT04879849|469917419|FG004|Overall Study|Withdrawal by Subject|2|||
130532589|NCT04879849|469917420|FG005|Overall Study|Withdrawal by Subject|0|||
130532590|NCT04879849|469917421|FG006|Overall Study|Withdrawal by Subject|1|||
130532591|NCT04879849|469917422|FG007|Overall Study|Withdrawal by Subject|0|||
130532592|NCT04879849|469917415|FG000|Overall Study|Progressive Disease|0|||
130532593|NCT04879849|469917416|FG001|Overall Study|Progressive Disease|0|||
130532594|NCT04879849|469917417|FG002|Overall Study|Progressive Disease|1|||
130532595|NCT04879849|469917418|FG003|Overall Study|Progressive Disease|0|||
130532596|NCT04879849|469917419|FG004|Overall Study|Progressive Disease|0|||
130532597|NCT04879849|469917420|FG005|Overall Study|Progressive Disease|0|||
130532598|NCT04879849|469917421|FG006|Overall Study|Progressive Disease|0|||
130532599|NCT04879849|469917422|FG007|Overall Study|Progressive Disease|0|||
130532600|NCT04879849|469917415|FG000|Overall Study|Death|0|||
130532601|NCT04879849|469917416|FG001|Overall Study|Death|0|||
130532602|NCT04879849|469917417|FG002|Overall Study|Death|1|||
130532603|NCT04879849|469917418|FG003|Overall Study|Death|1|||
130532604|NCT04879849|469917419|FG004|Overall Study|Death|1|||
130532605|NCT04879849|469917420|FG005|Overall Study|Death|2|||
130532606|NCT04879849|469917421|FG006|Overall Study|Death|1|||
130532607|NCT04879849|469917422|FG007|Overall Study|Death|2|||
130532608|NCT04879849|469917415|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
130532609|NCT04879849|469917416|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
130532610|NCT04879849|469917417|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
130532611|NCT04879849|469917418|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
130532612|NCT04879849|469917419|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
130532613|NCT04879849|469917420|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
130532614|NCT04879849|469917421|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
130532615|NCT04879849|469917422|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
130532616|NCT04879849|469917415|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532617|NCT04879849|469917416|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532618|NCT04879849|469917417|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532619|NCT04879849|469917418|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532620|NCT04879849|469917419|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532621|NCT04879849|469917420|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532622|NCT04879849|469917421|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
130532623|NCT04879849|469917422|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130532624|NCT04879849|469917415|FG000|Overall Study|Reason Not Specified|1|||
130532625|NCT04879849|469917416|FG001|Overall Study|Reason Not Specified|0|||
130532626|NCT04879849|469917417|FG002|Overall Study|Reason Not Specified|0|||
130532627|NCT04879849|469917418|FG003|Overall Study|Reason Not Specified|0|||
130532628|NCT04879849|469917419|FG004|Overall Study|Reason Not Specified|0|||
130532629|NCT04879849|469917420|FG005|Overall Study|Reason Not Specified|0|||
130532630|NCT04879849|469917421|FG006|Overall Study|Reason Not Specified|0|||
130532631|NCT04879849|469917422|FG007|Overall Study|Reason Not Specified|0|||
130532632|NCT03361865|469917423|FG000|Overall Study|Death|17|||
130532633|NCT03361865|469917424|FG001|Overall Study|Death|18|||
130532634|NCT03361865|469917423|FG000|Overall Study|Physician Decision|1|||
130532635|NCT03361865|469917424|FG001|Overall Study|Physician Decision|9|||
130532636|NCT03361865|469917423|FG000|Overall Study|Withdrawal by Subject|1|||
130532637|NCT03361865|469917424|FG001|Overall Study|Withdrawal by Subject|0|||
130532638|NCT03852719|469917425|FG000|Overall Study|Withdrawal of consent|8|||
130532639|NCT03852719|469917426|FG001|Overall Study|Withdrawal of consent|8|||
130532640|NCT03852719|469917427|FG002|Overall Study|Withdrawal of consent|9|||
130532641|NCT03852719|469917425|FG000|Overall Study|Physician Decision|5|||
130532642|NCT03852719|469917426|FG001|Overall Study|Physician Decision|4|||
130532643|NCT03852719|469917427|FG002|Overall Study|Physician Decision|1|||
130532644|NCT03852719|469917425|FG000|Overall Study|Pregnancy|2|||
130532645|NCT03852719|469917426|FG001|Overall Study|Pregnancy|1|||
130532646|NCT03852719|469917427|FG002|Overall Study|Pregnancy|0|||
130532647|NCT03852719|469917425|FG000|Overall Study|Death|1|||
130532648|NCT03852719|469917426|FG001|Overall Study|Death|0|||
130532649|NCT03852719|469917427|FG002|Overall Study|Death|0|||
130532650|NCT03852719|469917425|FG000|Overall Study|Reason not Specified|3|||
130532651|NCT03852719|469917426|FG001|Overall Study|Reason not Specified|3|||
130532652|NCT03852719|469917427|FG002|Overall Study|Reason not Specified|5|||
130532653|NCT03852719|469917425|FG000|Overall Study|Adverse Event|2|||
130532654|NCT03852719|469917426|FG001|Overall Study|Adverse Event|1|||
130532655|NCT03852719|469917427|FG002|Overall Study|Adverse Event|4|||
130532656|NCT03852719|469917425|FG000|Overall Study|Progressive disease|1|||
130532657|NCT03852719|469917426|FG001|Overall Study|Progressive disease|4|||
130532658|NCT03852719|469917427|FG002|Overall Study|Progressive disease|1|||
130532659|NCT03852719|469917425|FG000|Overall Study|Lost to Follow-up|1|||
130532660|NCT03852719|469917426|FG001|Overall Study|Lost to Follow-up|0|||
130532661|NCT03852719|469917427|FG002|Overall Study|Lost to Follow-up|0|||
130532662|NCT05543187|469917430|FG000|Overall Study|Ongoing|3|||
130532663|NCT05543187|469917431|FG001|Overall Study|Ongoing|2|||
130532664|NCT03810235|469917432|FG000|Overall Study|Withdrawal by Subject|2|||
130532665|NCT03810235|469917433|FG001|Overall Study|Withdrawal by Subject|0|||
130532666|NCT04777864|469917434|FG000|Overall Study|Lost to Follow-up|8|||
130532667|NCT04777864|469917435|FG001|Overall Study|Lost to Follow-up|19|||
130532668|NCT01647542|469917436|FG000|Overall Study|Major Protocol Deviation|1|||
130532669|NCT01647542|469917437|FG001|Overall Study|Major Protocol Deviation|0|||
130532670|NCT01647542|469917438|FG002|Overall Study|Major Protocol Deviation|0|||
130532671|NCT01647542|469917436|FG000|Overall Study|Adverse Event|4|||
130532672|NCT01647542|469917437|FG001|Overall Study|Adverse Event|5|||
130532673|NCT01647542|469917438|FG002|Overall Study|Adverse Event|4|||
130532674|NCT01647542|469917436|FG000|Overall Study|Lost to Follow-up|0|||
130532675|NCT01647542|469917437|FG001|Overall Study|Lost to Follow-up|2|||
130532676|NCT01647542|469917438|FG002|Overall Study|Lost to Follow-up|2|||
130532677|NCT01647542|469917436|FG000|Overall Study|Withdrawal by Subject|6|||
130532678|NCT01647542|469917437|FG001|Overall Study|Withdrawal by Subject|4|||
130532679|NCT01647542|469917438|FG002|Overall Study|Withdrawal by Subject|0|||
130532680|NCT01647542|469917436|FG000|Overall Study|Study Termination|64|||
130532681|NCT01647542|469917437|FG001|Overall Study|Study Termination|61|||
130532682|NCT01647542|469917438|FG002|Overall Study|Study Termination|65|||
130532683|NCT01647542|469917436|FG000|Overall Study|Lack of Efficacy|1|||
130532684|NCT01647542|469917437|FG001|Overall Study|Lack of Efficacy|1|||
130532685|NCT01647542|469917438|FG002|Overall Study|Lack of Efficacy|0|||
130532686|NCT01647542|469917436|FG000|Overall Study|Death|0|||
130532687|NCT01647542|469917437|FG001|Overall Study|Death|0|||
130532688|NCT01647542|469917438|FG002|Overall Study|Death|1|||
130581199|NCT02397473|470092424|FG000|Treatment Phase|Adverse Event|1|||
130581200|NCT02397473|470092425|FG001|Treatment Phase|Adverse Event|2|||
130532689|NCT03086655|469917439|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
130532690|NCT03086655|469917440|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
130532691|NCT03086655|469917439|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
130532692|NCT03086655|469917440|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
130532693|NCT03086655|469917439|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
130532694|NCT03086655|469917440|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
130581201|NCT02397473|470092424|FG000|Treatment Phase|Lack of Efficacy|8|||
130581202|NCT02397473|470092425|FG001|Treatment Phase|Lack of Efficacy|1|||
130581203|NCT02397473|470092424|FG000|Treatment Phase|Lost to Follow-up|1|||
130581204|NCT02397473|470092425|FG001|Treatment Phase|Lost to Follow-up|0|||
130581205|NCT02397473|470092424|FG000|Treatment Phase|Withdrawal by Subject|2|||
130581206|NCT02397473|470092425|FG001|Treatment Phase|Withdrawal by Subject|1|||
130581207|NCT02397473|470092424|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
130581208|NCT02397473|470092425|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
130581209|NCT02397473|470092424|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
130581210|NCT02397473|470092425|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
130581211|NCT02397473|470092424|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
130581212|NCT02397473|470092425|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130581213|NCT02397473|470092424|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
130581214|NCT02397473|470092425|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
130581215|NCT02397473|470092424|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130581216|NCT02397473|470092425|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130581217|NCT00254566|470092427|FG000|Overall Study|Death|1|||
130581218|NCT00254566|470092428|FG001|Overall Study|Death|0|||
130581219|NCT00254566|470092427|FG000|Overall Study|Adverse Event|5|||
130581220|NCT00254566|470092428|FG001|Overall Study|Adverse Event|4|||
130581221|NCT00254566|470092427|FG000|Overall Study|Lack of Efficacy|12|||
130581222|NCT00254566|470092428|FG001|Overall Study|Lack of Efficacy|9|||
130581223|NCT00254566|470092427|FG000|Overall Study|Other|1|||
130581224|NCT00254566|470092428|FG001|Overall Study|Other|5|||
130581225|NCT00254566|470092427|FG000|Overall Study|Withdrawal by Subject|5|||
130581226|NCT00254566|470092428|FG001|Overall Study|Withdrawal by Subject|6|||
130581227|NCT00254566|470092427|FG000|Overall Study|Lost to Follow-up|7|||
130581228|NCT00254566|470092428|FG001|Overall Study|Lost to Follow-up|2|||
130581229|NCT00059202|470092429|FG000|Overall Study|Withdrawal by Subject|5|||
130581230|NCT00059202|470092430|FG001|Overall Study|Withdrawal by Subject|9|||
130581231|NCT00059202|470092429|FG000|Overall Study|Protocol Violation|1|||
130581232|NCT00059202|470092430|FG001|Overall Study|Protocol Violation|3|||
130581233|NCT00059202|470092429|FG000|Overall Study|drug toxicity|0|||
130581234|NCT00059202|470092430|FG001|Overall Study|drug toxicity|3|||
130581235|NCT02658448|470092435|FG000|Overall Study|Lost to Follow-up|1|||
130581236|NCT03106779|470092436|FG000|Overall Study|Lack of Efficacy|33|||
130581237|NCT03106779|470092437|FG001|Overall Study|Lack of Efficacy|24|||
130581238|NCT03106779|470092436|FG000|Overall Study|Adverse Event|8|||
130581239|NCT03106779|470092437|FG001|Overall Study|Adverse Event|16|||
130581240|NCT03106779|470092436|FG000|Overall Study|Physician Decision|10|||
130581241|NCT03106779|470092437|FG001|Overall Study|Physician Decision|6|||
130581242|NCT03106779|470092436|FG000|Overall Study|Patient/guardian decision|4|||
130581243|NCT03106779|470092437|FG001|Overall Study|Patient/guardian decision|3|||
130581244|NCT03106779|470092436|FG000|Overall Study|Progressive disease|1|||
130581245|NCT03106779|470092437|FG001|Overall Study|Progressive disease|3|||
130581246|NCT03106779|470092436|FG000|Overall Study|Lost to Follow-up|1|||
130581247|NCT03106779|470092437|FG001|Overall Study|Lost to Follow-up|2|||
130581248|NCT03106779|470092436|FG000|Overall Study|Death|1|||
130581249|NCT03106779|470092437|FG001|Overall Study|Death|0|||
130581250|NCT03106779|470092436|FG000|Overall Study|Protocol Violation|1|||
130581251|NCT03106779|470092437|FG001|Overall Study|Protocol Violation|0|||
130581252|NCT03106779|470092436|FG000|Overall Study|Not treated|1|||
130581253|NCT03106779|470092437|FG001|Overall Study|Not treated|0|||
130581254|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
130581255|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
130581256|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
130581257|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
130581258|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
130581259|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
130581260|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
130581261|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
130581262|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
130581263|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
130581264|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
130581265|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
130581266|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
130581267|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
130581268|NCT02288247|470092438|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
130581269|NCT02288247|470092439|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
130581270|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
130581271|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
130581272|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
130581273|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
130581274|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
130532695|NCT03086655|469917439|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
130532696|NCT03086655|469917440|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
130532697|NCT03086655|469917439|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
130532698|NCT03086655|469917440|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
130581275|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
130581276|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
130581277|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
130581278|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
130581279|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
130581280|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
130581281|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
130581282|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
130581283|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
130581284|NCT02288247|470092438|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
130581285|NCT02288247|470092439|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
130581286|NCT04652804|470092440|FG000|Overall Study|Ineligible post randomization|1|||
130581287|NCT04652804|470092441|FG001|Overall Study|Ineligible post randomization|0|||
130581288|NCT04652804|470092442|FG002|Overall Study|Ineligible post randomization|1|||
130581289|NCT04652804|470092443|FG003|Overall Study|Ineligible post randomization|0|||
130581290|NCT04652804|470092444|FG004|Overall Study|Ineligible post randomization|1|||
130581291|NCT04652804|470092445|FG005|Overall Study|Ineligible post randomization|1|||
130581292|NCT04652804|470092440|FG000|Overall Study|Missing SVR lab results|2|||
130581293|NCT04652804|470092441|FG001|Overall Study|Missing SVR lab results|0|||
130581294|NCT04652804|470092442|FG002|Overall Study|Missing SVR lab results|0|||
130581295|NCT04652804|470092443|FG003|Overall Study|Missing SVR lab results|0|||
130581296|NCT04652804|470092444|FG004|Overall Study|Missing SVR lab results|0|||
130581297|NCT04652804|470092445|FG005|Overall Study|Missing SVR lab results|0|||
130581298|NCT03634800|470092446|FG000|Overall Study|Adverse Event|1|||
130581299|NCT03634800|470092446|FG000|Overall Study|Disease Progression|4|||
130581300|NCT03634800|470092446|FG000|Overall Study|Withdrawal by Subject|1|||
130581301|NCT00364689|470092450|FG000|Overall Study|Lost to Follow-up|1|||
130581302|NCT00191451|470092458|FG000|Overall Study|Withdrawal by Subject|2|||
130581303|NCT00191451|470092459|FG001|Overall Study|Withdrawal by Subject|3|||
130581304|NCT00191451|470092460|FG002|Overall Study|Withdrawal by Subject|5|||
130581305|NCT00191451|470092458|FG000|Overall Study|Physician Decision|2|||
130581306|NCT00191451|470092459|FG001|Overall Study|Physician Decision|9|||
130581307|NCT00191451|470092460|FG002|Overall Study|Physician Decision|6|||
130581308|NCT00191451|470092458|FG000|Overall Study|Sponsor Decision|1|||
130581309|NCT00191451|470092459|FG001|Overall Study|Sponsor Decision|0|||
130581310|NCT00191451|470092460|FG002|Overall Study|Sponsor Decision|0|||
130581311|NCT00191451|470092458|FG000|Overall Study|Ineligible|0|||
130581312|NCT00191451|470092459|FG001|Overall Study|Ineligible|1|||
130581313|NCT00191451|470092460|FG002|Overall Study|Ineligible|0|||
130581314|NCT00191451|470092458|FG000|Overall Study|Reason Not Specified|2|||
130581315|NCT00191451|470092459|FG001|Overall Study|Reason Not Specified|1|||
130581316|NCT00191451|470092460|FG002|Overall Study|Reason Not Specified|3|||
130581317|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
130581318|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
130581319|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
130581320|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
130581321|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
130581322|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
130581323|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
130581324|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
130581325|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
130581326|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
130581327|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
130581328|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
130581329|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130581330|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130581331|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130581332|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
130581333|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
130581334|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
130581335|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
130581336|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
130581337|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
130581338|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
130581339|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
130581340|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
130581341|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Death|2|||
130581342|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Death|1|||
130532699|NCT03086655|469917439|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
130532700|NCT03086655|469917440|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
130532701|NCT03086655|469917439|FG000|12 Month Follow-up = Final Assessment|Death|0|||
130532702|NCT03086655|469917440|FG001|12 Month Follow-up = Final Assessment|Death|1|||
130532703|NCT05576662|469917441|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
130532704|NCT05576662|469917442|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
130532705|NCT05576662|469917441|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
130532706|NCT05576662|469917442|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
130532707|NCT05576662|469917441|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
130532708|NCT05576662|469917442|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
130532709|NCT05576662|469917441|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
130532710|NCT05576662|469917442|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
130532711|NCT03008005|469917443|FG000|Overall Study|Physician Decision|1|||
130532712|NCT03008005|469917444|FG001|Overall Study|Physician Decision|0|||
130532713|NCT03008005|469917445|FG002|Overall Study|Physician Decision|0|||
130532714|NCT03008005|469917443|FG000|Overall Study|Withdrawal by Subject|1|||
130532715|NCT03008005|469917444|FG001|Overall Study|Withdrawal by Subject|0|||
130532716|NCT03008005|469917445|FG002|Overall Study|Withdrawal by Subject|0|||
130532717|NCT03008005|469917443|FG000|Overall Study|Ineligible|0|||
130532718|NCT03008005|469917444|FG001|Overall Study|Ineligible|1|||
130532719|NCT03008005|469917445|FG002|Overall Study|Ineligible|0|||
130532720|NCT01040169|469917461|FG000|Overall Study|Lost to Follow-up|3|||
130532721|NCT01040169|469917462|FG001|Overall Study|Lost to Follow-up|8|||
130532722|NCT00350727|469917463|FG000|Phase I: Dose Escalation|Adverse Event|4|||
130532723|NCT00350727|469917464|FG001|Phase I: Dose Escalation|Adverse Event|0|||
130532724|NCT00350727|469917465|FG002|Phase I: Dose Escalation|Adverse Event|0|||
130532725|NCT00350727|469917463|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
130532726|NCT00350727|469917464|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
130532727|NCT00350727|469917465|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
130532728|NCT00350727|469917463|FG000|Phase I: Dose Escalation|Death|1|||
130532729|NCT00350727|469917464|FG001|Phase I: Dose Escalation|Death|0|||
130532730|NCT00350727|469917465|FG002|Phase I: Dose Escalation|Death|0|||
130532731|NCT00350727|469917463|FG000|Phase I: Dose Escalation|Physician Decision|1|||
130532732|NCT00350727|469917464|FG001|Phase I: Dose Escalation|Physician Decision|0|||
130532733|NCT00350727|469917465|FG002|Phase I: Dose Escalation|Physician Decision|0|||
130532734|NCT00350727|469917463|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
130532735|NCT00350727|469917464|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
130532736|NCT00350727|469917465|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
130532737|NCT00350727|469917463|FG000|Phase II|Disease Progression|0|||
130532738|NCT00350727|469917464|FG001|Phase II|Disease Progression|15|||
130532739|NCT00350727|469917465|FG002|Phase II|Disease Progression|16|||
130532740|NCT00350727|469917463|FG000|Phase II|Clinical Deterioration|0|||
130532741|NCT00350727|469917464|FG001|Phase II|Clinical Deterioration|1|||
130532742|NCT00350727|469917465|FG002|Phase II|Clinical Deterioration|0|||
130532743|NCT00350727|469917463|FG000|Phase II|Withdrawal by Subject|0|||
130532744|NCT00350727|469917464|FG001|Phase II|Withdrawal by Subject|2|||
130532745|NCT00350727|469917465|FG002|Phase II|Withdrawal by Subject|1|||
130532746|NCT00350727|469917463|FG000|Phase II|Adverse Event|0|||
130532747|NCT00350727|469917464|FG001|Phase II|Adverse Event|1|||
130532748|NCT00350727|469917465|FG002|Phase II|Adverse Event|1|||
130532749|NCT00350727|469917463|FG000|Phase II|Death|0|||
130532750|NCT00350727|469917464|FG001|Phase II|Death|0|||
130532751|NCT00350727|469917465|FG002|Phase II|Death|2|||
130532752|NCT00350727|469917463|FG000|Phase II|Sponsor Terminated Study|0|||
130532753|NCT00350727|469917464|FG001|Phase II|Sponsor Terminated Study|0|||
130532754|NCT00350727|469917465|FG002|Phase II|Sponsor Terminated Study|1|||
130532755|NCT00350727|469917463|FG000|Phase II|Enrolled in Rollover Study|0|||
130532756|NCT00350727|469917464|FG001|Phase II|Enrolled in Rollover Study|0|||
130532757|NCT00350727|469917465|FG002|Phase II|Enrolled in Rollover Study|1|||
130532758|NCT03633799|469917470|FG000|Overall Study|Adverse Event|349|||
130532759|NCT03633799|469917470|FG000|Overall Study|Withdrawal by Subject|288|||
130532760|NCT03633799|469917470|FG000|Overall Study|Lost to Follow-up|97|||
130581343|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Death|2|||
130581344|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Graft loss|0|||
130581345|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Graft loss|2|||
130581346|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Graft loss|0|||
130581347|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
130581348|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
130581349|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
130581350|NCT01114529|470092461|FG000|Completed Study Medication at Month 24|Missing|2|||
130581351|NCT01114529|470092462|FG001|Completed Study Medication at Month 24|Missing|0|||
130581352|NCT01114529|470092463|FG002|Completed Study Medication at Month 24|Missing|0|||
130581353|NCT01114529|470092461|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
130581354|NCT01114529|470092462|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
130581355|NCT01114529|470092463|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
130581356|NCT01114529|470092461|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
130581357|NCT01114529|470092462|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
130581358|NCT01114529|470092463|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
130581359|NCT01114529|470092461|FG000|Completed Study Phase at Month 24|Death|8|||
130581360|NCT01114529|470092462|FG001|Completed Study Phase at Month 24|Death|5|||
130581361|NCT01114529|470092463|FG002|Completed Study Phase at Month 24|Death|4|||
130581362|NCT01114529|470092461|FG000|Completed Study Phase at Month 24|Other|2|||
130581363|NCT01114529|470092462|FG001|Completed Study Phase at Month 24|Other|0|||
130581364|NCT01114529|470092463|FG002|Completed Study Phase at Month 24|Other|0|||
130581365|NCT01114529|470092461|FG000|Completed Study Phase at Month 24|Missing|2|||
130581366|NCT01114529|470092462|FG001|Completed Study Phase at Month 24|Missing|0|||
130581367|NCT01114529|470092463|FG002|Completed Study Phase at Month 24|Missing|0|||
130581368|NCT00132730|470092469|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
130581369|NCT00132730|470092470|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
130581370|NCT00132730|470092471|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
130581371|NCT00132730|470092472|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
130581372|NCT00132730|470092473|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
130581373|NCT00132730|470092474|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
130581374|NCT00132730|470092469|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
130581375|NCT00132730|470092470|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
130581376|NCT00132730|470092471|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130581377|NCT00132730|470092472|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130581378|NCT00132730|470092473|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130581379|NCT00132730|470092474|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130581380|NCT00132730|470092469|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
130581381|NCT00132730|470092470|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
130581382|NCT00132730|470092471|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
130581383|NCT00132730|470092472|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
130581384|NCT00132730|470092473|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
130581385|NCT00132730|470092474|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
130581386|NCT00132730|470092469|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130581387|NCT00132730|470092470|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130581388|NCT00132730|470092471|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
130581389|NCT00132730|470092472|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
130581390|NCT00132730|470092473|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130581391|NCT00132730|470092474|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130581392|NCT00132730|470092469|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130581393|NCT00132730|470092470|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130581394|NCT00132730|470092471|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
130581395|NCT00132730|470092472|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
130581396|NCT00132730|470092473|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130581397|NCT00132730|470092474|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130581398|NCT00132730|470092469|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130581399|NCT00132730|470092470|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130581400|NCT00132730|470092471|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130581401|NCT00132730|470092472|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
130581402|NCT00132730|470092473|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130581403|NCT00132730|470092474|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130532761|NCT03633799|469917470|FG000|Overall Study|Physician Decision|9|||
130532762|NCT03633799|469917470|FG000|Overall Study|Protocol Violation|4|||
130532763|NCT03633799|469917470|FG000|Overall Study|Pregnancy|20|||
130532764|NCT03633799|469917470|FG000|Overall Study|other|39|||
130532765|NCT03633799|469917470|FG000|Overall Study|ongoing within third year of study|106|||
130581404|NCT00132730|470092469|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130581405|NCT00132730|470092470|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130581406|NCT00132730|470092471|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
130581407|NCT00132730|470092472|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
130581408|NCT00132730|470092473|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130581409|NCT00132730|470092474|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130581410|NCT00132730|470092469|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130581411|NCT00132730|470092470|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130581412|NCT00132730|470092471|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130581413|NCT00132730|470092472|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130581414|NCT00132730|470092473|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
130581415|NCT00132730|470092474|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
130581416|NCT00132730|470092469|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130581417|NCT00132730|470092470|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130581418|NCT00132730|470092471|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130581419|NCT00132730|470092472|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130581420|NCT00132730|470092473|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
130581421|NCT00132730|470092474|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130581422|NCT00132730|470092469|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130581423|NCT00132730|470092470|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130581424|NCT00132730|470092471|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130581425|NCT00132730|470092472|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130581426|NCT00132730|470092473|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
130581427|NCT00132730|470092474|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130581428|NCT00132730|470092469|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130581429|NCT00132730|470092470|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130581430|NCT00132730|470092471|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130581431|NCT00132730|470092472|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130581432|NCT00132730|470092473|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
130581433|NCT00132730|470092474|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130581434|NCT00132730|470092469|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130581435|NCT00132730|470092470|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130581436|NCT00132730|470092471|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130581437|NCT00132730|470092472|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130581438|NCT00132730|470092473|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
130581439|NCT00132730|470092474|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
130581440|NCT01554579|470092475|FG000|Overall Study|Adverse Event|6|||
130581441|NCT01554579|470092476|FG001|Overall Study|Adverse Event|25|||
130581442|NCT01554579|470092475|FG000|Overall Study|Lack of Efficacy|2|||
130581443|NCT01554579|470092476|FG001|Overall Study|Lack of Efficacy|1|||
130581444|NCT01554579|470092475|FG000|Overall Study|Withdrawal by Subject|2|||
130581445|NCT01554579|470092476|FG001|Overall Study|Withdrawal by Subject|1|||
130581446|NCT01192347|470092477|FG000|Overall Study|Death|3|||
130581447|NCT01192347|470092477|FG000|Overall Study|Lost to Follow-up|3|||
130581448|NCT01192347|470092477|FG000|Overall Study|Withdrawal by Subject|1|||
130581449|NCT01192347|470092477|FG000|Overall Study|Adverse Event|1|||
130581450|NCT01192347|470092477|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
130581451|NCT01192347|470092477|FG000|Overall Study|Patient seen in different hospital|1|||
130581452|NCT01192347|470092477|FG000|Overall Study|Patient not visiting hospital regularly|1|||
130581453|NCT01192347|470092477|FG000|Overall Study|Patient did not show up for visits|1|||
130581454|NCT02623335|470092478|FG000|Overall Study|Death|8|||
130581455|NCT02623335|470092479|FG001|Overall Study|Death|7|||
130581456|NCT02623335|470092478|FG000|Overall Study|Lost to Follow-up|15|||
130581457|NCT02623335|470092479|FG001|Overall Study|Lost to Follow-up|23|||
130581458|NCT02623335|470092478|FG000|Overall Study|Withdrawal by Subject|2|||
130581459|NCT02623335|470092479|FG001|Overall Study|Withdrawal by Subject|5|||
130581460|NCT02623335|470092478|FG000|Overall Study|Protocol Violation|2|||
130581461|NCT02623335|470092479|FG001|Overall Study|Protocol Violation|1|||
130581462|NCT03739528|470092480|FG000|Overall Study|Not treated|8|||
130581463|NCT03739528|470092481|FG001|Overall Study|Not treated|12|||
130581464|NCT03739528|470092480|FG000|Overall Study|Treatment and study discontinued|6|||
130581465|NCT03739528|470092481|FG001|Overall Study|Treatment and study discontinued|2|||
130581466|NCT03739528|470092480|FG000|Overall Study|Treatment discontinued + study completed|1|||
130581467|NCT03739528|470092481|FG001|Overall Study|Treatment discontinued + study completed|3|||
130581468|NCT01046695|470092482|FG000|Overall Study|Subject had a pacemaker|0|||
130581469|NCT01046695|470092483|FG001|Overall Study|Subject had a pacemaker|1|||
130581470|NCT01046695|470092482|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
130581471|NCT01046695|470092483|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
130581472|NCT03072160|470092484|FG000|Overall Study|Adverse Event|3|||
130581473|NCT03072160|470092485|FG001|Overall Study|Adverse Event|1|||
130581474|NCT03072160|470092484|FG000|Overall Study|Refused further treatment|6|||
130581475|NCT03072160|470092485|FG001|Overall Study|Refused further treatment|1|||
130581476|NCT03072160|470092484|FG000|Overall Study|Physician Decision|1|||
130581477|NCT03072160|470092485|FG001|Overall Study|Physician Decision|0|||
130581478|NCT03072160|470092484|FG000|Overall Study|Disease progression on study|1|||
130581479|NCT03072160|470092485|FG001|Overall Study|Disease progression on study|1|||
130581480|NCT03072160|470092484|FG000|Overall Study|No contact|0|||
130581481|NCT03072160|470092485|FG001|Overall Study|No contact|1|||
130581482|NCT00408694|470092486|FG000|Overall Study|Ineligible|1|||
130581483|NCT00408694|470092486|FG000|Overall Study|No protocol treatment|1|||
130581484|NCT00666926|470092490|FG000|Overall Study|Adverse Event|0|||
130581485|NCT00666926|470092491|FG001|Overall Study|Adverse Event|0|||
130581486|NCT00666926|470092492|FG002|Overall Study|Adverse Event|0|||
130581487|NCT00666926|470092493|FG003|Overall Study|Adverse Event|0|||
130581488|NCT00666926|470092494|FG004|Overall Study|Adverse Event|0|||
130581489|NCT00666926|470092495|FG005|Overall Study|Adverse Event|0|||
130581490|NCT00666926|470092496|FG006|Overall Study|Adverse Event|0|||
130581491|NCT00666926|470092497|FG007|Overall Study|Adverse Event|0|||
130581492|NCT00666926|470092498|FG008|Overall Study|Adverse Event|0|||
130581493|NCT00666926|470092499|FG009|Overall Study|Adverse Event|2|||
130581494|NCT00666926|470092500|FG010|Overall Study|Adverse Event|2|||
130581495|NCT00666926|470092501|FG011|Overall Study|Adverse Event|2|||
130581496|NCT00666926|470092502|FG012|Overall Study|Adverse Event|0|||
130581497|NCT00666926|470092503|FG013|Overall Study|Adverse Event|1|||
130581498|NCT00666926|470092504|FG014|Overall Study|Adverse Event|0|||
130581499|NCT00666926|470092505|FG015|Overall Study|Adverse Event|0|||
130581500|NCT00666926|470092490|FG000|Overall Study|Laboratory abnormality|0|||
130581501|NCT00666926|470092491|FG001|Overall Study|Laboratory abnormality|0|||
130581502|NCT00666926|470092492|FG002|Overall Study|Laboratory abnormality|0|||
130581503|NCT00666926|470092493|FG003|Overall Study|Laboratory abnormality|0|||
130581504|NCT00666926|470092494|FG004|Overall Study|Laboratory abnormality|0|||
130581505|NCT00666926|470092495|FG005|Overall Study|Laboratory abnormality|0|||
130581506|NCT00666926|470092496|FG006|Overall Study|Laboratory abnormality|0|||
130581507|NCT00666926|470092497|FG007|Overall Study|Laboratory abnormality|0|||
130581508|NCT00666926|470092498|FG008|Overall Study|Laboratory abnormality|0|||
130581509|NCT00666926|470092499|FG009|Overall Study|Laboratory abnormality|0|||
130581510|NCT00666926|470092500|FG010|Overall Study|Laboratory abnormality|1|||
130581511|NCT00666926|470092501|FG011|Overall Study|Laboratory abnormality|0|||
130581512|NCT00666926|470092502|FG012|Overall Study|Laboratory abnormality|0|||
130581513|NCT00666926|470092503|FG013|Overall Study|Laboratory abnormality|0|||
130581514|NCT00666926|470092504|FG014|Overall Study|Laboratory abnormality|0|||
130581515|NCT00666926|470092505|FG015|Overall Study|Laboratory abnormality|1|||
130581516|NCT00666926|470092490|FG000|Overall Study|Lack of Efficacy|0|||
130581517|NCT00666926|470092491|FG001|Overall Study|Lack of Efficacy|0|||
130581518|NCT00666926|470092492|FG002|Overall Study|Lack of Efficacy|0|||
130581519|NCT00666926|470092493|FG003|Overall Study|Lack of Efficacy|0|||
130581520|NCT00666926|470092494|FG004|Overall Study|Lack of Efficacy|0|||
130581521|NCT00666926|470092495|FG005|Overall Study|Lack of Efficacy|1|||
130581522|NCT00666926|470092496|FG006|Overall Study|Lack of Efficacy|0|||
130581523|NCT00666926|470092497|FG007|Overall Study|Lack of Efficacy|0|||
130581524|NCT00666926|470092498|FG008|Overall Study|Lack of Efficacy|0|||
130581525|NCT00666926|470092499|FG009|Overall Study|Lack of Efficacy|0|||
130581526|NCT00666926|470092500|FG010|Overall Study|Lack of Efficacy|0|||
130581527|NCT00666926|470092501|FG011|Overall Study|Lack of Efficacy|1|||
130581528|NCT00666926|470092502|FG012|Overall Study|Lack of Efficacy|0|||
130581529|NCT00666926|470092503|FG013|Overall Study|Lack of Efficacy|0|||
130581530|NCT00666926|470092504|FG014|Overall Study|Lack of Efficacy|0|||
130581531|NCT00666926|470092505|FG015|Overall Study|Lack of Efficacy|0|||
130581532|NCT00666926|470092490|FG000|Overall Study|Lost to Follow-up|0|||
130581533|NCT00666926|470092491|FG001|Overall Study|Lost to Follow-up|0|||
130581534|NCT00666926|470092492|FG002|Overall Study|Lost to Follow-up|0|||
130581535|NCT00666926|470092493|FG003|Overall Study|Lost to Follow-up|1|||
130581536|NCT00666926|470092494|FG004|Overall Study|Lost to Follow-up|0|||
130581537|NCT00666926|470092495|FG005|Overall Study|Lost to Follow-up|0|||
130581538|NCT00666926|470092496|FG006|Overall Study|Lost to Follow-up|0|||
130581539|NCT00666926|470092497|FG007|Overall Study|Lost to Follow-up|0|||
130581540|NCT00666926|470092498|FG008|Overall Study|Lost to Follow-up|0|||
130581541|NCT00666926|470092499|FG009|Overall Study|Lost to Follow-up|0|||
130581542|NCT00666926|470092500|FG010|Overall Study|Lost to Follow-up|0|||
130581543|NCT00666926|470092501|FG011|Overall Study|Lost to Follow-up|0|||
130581544|NCT00666926|470092502|FG012|Overall Study|Lost to Follow-up|0|||
130581545|NCT00666926|470092503|FG013|Overall Study|Lost to Follow-up|0|||
130581546|NCT00666926|470092504|FG014|Overall Study|Lost to Follow-up|0|||
130581547|NCT00666926|470092505|FG015|Overall Study|Lost to Follow-up|0|||
130581548|NCT00666926|470092490|FG000|Overall Study|Other|2|||
130581549|NCT00666926|470092491|FG001|Overall Study|Other|4|||
130581550|NCT00666926|470092492|FG002|Overall Study|Other|3|||
130581551|NCT00666926|470092493|FG003|Overall Study|Other|3|||
130581552|NCT00666926|470092494|FG004|Overall Study|Other|3|||
130581553|NCT00666926|470092495|FG005|Overall Study|Other|3|||
130581554|NCT00666926|470092496|FG006|Overall Study|Other|4|||
130581555|NCT00666926|470092497|FG007|Overall Study|Other|0|||
130581556|NCT00666926|470092498|FG008|Overall Study|Other|3|||
130581557|NCT00666926|470092499|FG009|Overall Study|Other|5|||
130581558|NCT00666926|470092500|FG010|Overall Study|Other|3|||
130581559|NCT00666926|470092501|FG011|Overall Study|Other|26|||
130581560|NCT00666926|470092502|FG012|Overall Study|Other|3|||
130581561|NCT00666926|470092503|FG013|Overall Study|Other|2|||
130581562|NCT00666926|470092504|FG014|Overall Study|Other|4|||
130581563|NCT00666926|470092505|FG015|Overall Study|Other|4|||
130581564|NCT00666926|470092490|FG000|Overall Study|Withdrawal by Subject|0|||
130581565|NCT00666926|470092491|FG001|Overall Study|Withdrawal by Subject|0|||
130581566|NCT00666926|470092492|FG002|Overall Study|Withdrawal by Subject|0|||
130581567|NCT00666926|470092493|FG003|Overall Study|Withdrawal by Subject|0|||
130581568|NCT00666926|470092494|FG004|Overall Study|Withdrawal by Subject|0|||
130581569|NCT00666926|470092495|FG005|Overall Study|Withdrawal by Subject|0|||
130581570|NCT00666926|470092496|FG006|Overall Study|Withdrawal by Subject|0|||
130581571|NCT00666926|470092497|FG007|Overall Study|Withdrawal by Subject|1|||
130581572|NCT00666926|470092498|FG008|Overall Study|Withdrawal by Subject|0|||
130581573|NCT00666926|470092499|FG009|Overall Study|Withdrawal by Subject|3|||
130581574|NCT00666926|470092500|FG010|Overall Study|Withdrawal by Subject|0|||
130581575|NCT00666926|470092501|FG011|Overall Study|Withdrawal by Subject|3|||
130581576|NCT00666926|470092502|FG012|Overall Study|Withdrawal by Subject|0|||
130581577|NCT00666926|470092503|FG013|Overall Study|Withdrawal by Subject|1|||
130581578|NCT00666926|470092504|FG014|Overall Study|Withdrawal by Subject|3|||
130581579|NCT00666926|470092505|FG015|Overall Study|Withdrawal by Subject|3|||
130581580|NCT00666926|470092490|FG000|Overall Study|Death|0|||
130581581|NCT00666926|470092491|FG001|Overall Study|Death|0|||
130581582|NCT00666926|470092492|FG002|Overall Study|Death|0|||
130581583|NCT00666926|470092493|FG003|Overall Study|Death|0|||
130581584|NCT00666926|470092494|FG004|Overall Study|Death|0|||
130581585|NCT00666926|470092495|FG005|Overall Study|Death|0|||
130581586|NCT00666926|470092496|FG006|Overall Study|Death|0|||
130581587|NCT00666926|470092497|FG007|Overall Study|Death|0|||
130581588|NCT00666926|470092498|FG008|Overall Study|Death|0|||
130581589|NCT00666926|470092499|FG009|Overall Study|Death|0|||
130581590|NCT00666926|470092500|FG010|Overall Study|Death|0|||
130581591|NCT00666926|470092501|FG011|Overall Study|Death|1|||
130581592|NCT00666926|470092502|FG012|Overall Study|Death|0|||
130581593|NCT00666926|470092503|FG013|Overall Study|Death|0|||
130581594|NCT00666926|470092504|FG014|Overall Study|Death|0|||
130581595|NCT00666926|470092505|FG015|Overall Study|Death|0|||
130532766|NCT03633799|469917470|FG000|Overall Study|unsuccessful study drug placement|19|||
130532767|NCT03551691|469917471|FG000|Overall Study|Withdrawal by Subject|3|||
130532768|NCT03551691|469917472|FG001|Overall Study|Withdrawal by Subject|3|||
130532769|NCT03520712|469917473|FG000|Overall Study|Early termination of the study by Sponsor|2|||
130532770|NCT05855967|469917474|FG000|Overall Study|Withdrawal by Subject|7|||
130532771|NCT05855967|469917475|FG001|Overall Study|Withdrawal by Subject|5|||
130532772|NCT05855967|469917474|FG000|Overall Study|Lost to Follow-up|2|||
130532773|NCT05855967|469917475|FG001|Overall Study|Lost to Follow-up|1|||
130532774|NCT02446821|469917476|FG000|Overall Study|Adverse Event|28|||
130532775|NCT02446821|469917476|FG000|Overall Study|Withdrawal by Subject|6|||
130532776|NCT02446821|469917476|FG000|Overall Study|Lost to Follow-up|22|||
130532777|NCT02446821|469917476|FG000|Overall Study|other|9|||
130532778|NCT02446821|469917476|FG000|Overall Study|insertion failure|3|||
130532779|NCT04427280|469919307|FG000|Overall Study|Withdrawal by Subject|0|||
130532780|NCT04427280|469919308|FG001|Overall Study|Withdrawal by Subject|2|||
130532781|NCT04942366|469919316|FG000|Overall Study|Withdrawal by Subject|5|||
130532782|NCT04942366|469919317|FG001|Overall Study|Withdrawal by Subject|5|||
130532783|NCT04996004|469919318|FG000|Phase I|Death|1|||
130581596|NCT02883244|470092506|FG000|Overall Study|Lost to Follow-up|0|||
130532784|NCT04996004|469919319|FG001|Phase I|Death|2|||
130532785|NCT04996004|469919320|FG002|Phase I|Death|1|||
130532786|NCT04996004|469919321|FG003|Phase I|Death|0|||
130532787|NCT04996004|469919322|FG004|Phase I|Death|0|||
130532788|NCT04996004|469919323|FG005|Phase I|Death|0|||
130581597|NCT02883244|470092507|FG001|Overall Study|Lost to Follow-up|1|||
130581598|NCT00880256|470092508|FG000|Overall Study|Lost to Follow-up|28|||
130581599|NCT04871711|470092509|FG000|Overall Study|Withdrawal by Subject|11|||
130581600|NCT04871711|470092510|FG001|Overall Study|Withdrawal by Subject|5|||
130581601|NCT04871711|470092509|FG000|Overall Study|Lack of Efficacy|5|||
130532789|NCT04996004|469919318|FG000|Phase I|Study terminated by sponsor|2|||
130532790|NCT04996004|469919319|FG001|Phase I|Study terminated by sponsor|1|||
130532791|NCT04996004|469919320|FG002|Phase I|Study terminated by sponsor|2|||
130532792|NCT04996004|469919321|FG003|Phase I|Study terminated by sponsor|0|||
130581602|NCT04871711|470092510|FG001|Overall Study|Lack of Efficacy|7|||
130581603|NCT04871711|470092509|FG000|Overall Study|Adverse Event|2|||
130581604|NCT04871711|470092510|FG001|Overall Study|Adverse Event|6|||
130581605|NCT04871711|470092509|FG000|Overall Study|Various reasons|2|||
130581606|NCT04871711|470092510|FG001|Overall Study|Various reasons|1|||
130532793|NCT04996004|469919322|FG004|Phase I|Study terminated by sponsor|0|||
130532794|NCT04996004|469919323|FG005|Phase I|Study terminated by sponsor|0|||
130532795|NCT04996004|469919318|FG000|Phase II|Study terminated by sponsor|0|||
130532796|NCT04996004|469919319|FG001|Phase II|Study terminated by sponsor|0|||
130532797|NCT04996004|469919320|FG002|Phase II|Study terminated by sponsor|0|||
130532798|NCT04996004|469919321|FG003|Phase II|Study terminated by sponsor|20|||
130532799|NCT04996004|469919322|FG004|Phase II|Study terminated by sponsor|10|||
130532800|NCT04996004|469919323|FG005|Phase II|Study terminated by sponsor|10|||
130532801|NCT04996004|469919318|FG000|Phase II|Withdrawal by Subject|0|||
130532802|NCT04996004|469919319|FG001|Phase II|Withdrawal by Subject|0|||
130532803|NCT04996004|469919320|FG002|Phase II|Withdrawal by Subject|0|||
130532804|NCT04996004|469919321|FG003|Phase II|Withdrawal by Subject|0|||
130532805|NCT04996004|469919322|FG004|Phase II|Withdrawal by Subject|1|||
130532806|NCT04996004|469919323|FG005|Phase II|Withdrawal by Subject|2|||
130532807|NCT04996004|469919318|FG000|Phase II|Death|0|||
130532808|NCT04996004|469919319|FG001|Phase II|Death|0|||
130532809|NCT04996004|469919320|FG002|Phase II|Death|0|||
130532810|NCT04996004|469919321|FG003|Phase II|Death|12|||
130532811|NCT04996004|469919322|FG004|Phase II|Death|2|||
130532812|NCT04996004|469919323|FG005|Phase II|Death|9|||
130532813|NCT04996004|469919318|FG000|Phase II|Other|0|||
130532814|NCT04996004|469919319|FG001|Phase II|Other|0|||
130532815|NCT04996004|469919320|FG002|Phase II|Other|0|||
130532816|NCT04996004|469919321|FG003|Phase II|Other|0|||
130532817|NCT04996004|469919322|FG004|Phase II|Other|0|||
130532818|NCT04996004|469919323|FG005|Phase II|Other|1|||
130532819|NCT02942277|469919324|FG000|Year 1|Withdrawal by Subject|0|||
130532820|NCT02942277|469919325|FG001|Year 1|Withdrawal by Subject|0|||
130532821|NCT02942277|469919326|FG002|Year 1|Withdrawal by Subject|0|||
130532822|NCT02942277|469919327|FG003|Year 1|Withdrawal by Subject|0|||
130532823|NCT02942277|469919328|FG004|Year 1|Withdrawal by Subject|1|||
130532824|NCT02942277|469919329|FG005|Year 1|Withdrawal by Subject|3|||
130532825|NCT02942277|469919330|FG006|Year 1|Withdrawal by Subject|0|||
130532826|NCT02942277|469919331|FG007|Year 1|Withdrawal by Subject|1|||
130532827|NCT02942277|469919332|FG008|Year 1|Withdrawal by Subject|0|||
130532828|NCT02942277|469919333|FG009|Year 1|Withdrawal by Subject|0|||
130532829|NCT02942277|469919334|FG010|Year 1|Withdrawal by Subject|3|||
130532830|NCT02942277|469919324|FG000|Year 1|Travel|0|||
130532831|NCT02942277|469919325|FG001|Year 1|Travel|1|||
130532832|NCT02942277|469919326|FG002|Year 1|Travel|0|||
130532833|NCT02942277|469919327|FG003|Year 1|Travel|0|||
130532834|NCT02942277|469919328|FG004|Year 1|Travel|4|||
130532835|NCT02942277|469919329|FG005|Year 1|Travel|5|||
130532836|NCT02942277|469919330|FG006|Year 1|Travel|0|||
130532837|NCT02942277|469919331|FG007|Year 1|Travel|0|||
130532838|NCT02942277|469919332|FG008|Year 1|Travel|0|||
130532839|NCT02942277|469919333|FG009|Year 1|Travel|0|||
130532840|NCT02942277|469919334|FG010|Year 1|Travel|8|||
130532841|NCT02942277|469919324|FG000|Year 1|Joined Army|0|||
130532842|NCT02942277|469919325|FG001|Year 1|Joined Army|1|||
130532843|NCT02942277|469919326|FG002|Year 1|Joined Army|0|||
130532844|NCT02942277|469919327|FG003|Year 1|Joined Army|0|||
130532845|NCT02942277|469919328|FG004|Year 1|Joined Army|0|||
130532846|NCT02942277|469919329|FG005|Year 1|Joined Army|0|||
130532847|NCT02942277|469919330|FG006|Year 1|Joined Army|0|||
130532848|NCT02942277|469919331|FG007|Year 1|Joined Army|0|||
130532849|NCT02942277|469919332|FG008|Year 1|Joined Army|0|||
130532850|NCT02942277|469919333|FG009|Year 1|Joined Army|0|||
130532851|NCT02942277|469919334|FG010|Year 1|Joined Army|0|||
130532852|NCT02942277|469919324|FG000|Year 1|Subject met withdrawal criteria|0|||
130532853|NCT02942277|469919325|FG001|Year 1|Subject met withdrawal criteria|0|||
130532854|NCT02942277|469919326|FG002|Year 1|Subject met withdrawal criteria|0|||
130532855|NCT02942277|469919327|FG003|Year 1|Subject met withdrawal criteria|1|||
130532856|NCT02942277|469919328|FG004|Year 1|Subject met withdrawal criteria|0|||
130532857|NCT02942277|469919329|FG005|Year 1|Subject met withdrawal criteria|0|||
130532858|NCT02942277|469919330|FG006|Year 1|Subject met withdrawal criteria|0|||
130532859|NCT02942277|469919331|FG007|Year 1|Subject met withdrawal criteria|0|||
130532860|NCT02942277|469919332|FG008|Year 1|Subject met withdrawal criteria|0|||
130532861|NCT02942277|469919333|FG009|Year 1|Subject met withdrawal criteria|0|||
130532862|NCT02942277|469919334|FG010|Year 1|Subject met withdrawal criteria|0|||
130532863|NCT02942277|469919324|FG000|Year 1|Lost to Follow-up|0|||
130532864|NCT02942277|469919325|FG001|Year 1|Lost to Follow-up|0|||
130532865|NCT02942277|469919326|FG002|Year 1|Lost to Follow-up|0|||
130532866|NCT02942277|469919327|FG003|Year 1|Lost to Follow-up|0|||
130532867|NCT02942277|469919328|FG004|Year 1|Lost to Follow-up|1|||
130532868|NCT02942277|469919329|FG005|Year 1|Lost to Follow-up|0|||
130532869|NCT02942277|469919330|FG006|Year 1|Lost to Follow-up|0|||
130532870|NCT02942277|469919331|FG007|Year 1|Lost to Follow-up|0|||
130532871|NCT02942277|469919332|FG008|Year 1|Lost to Follow-up|0|||
130532872|NCT02942277|469919333|FG009|Year 1|Lost to Follow-up|0|||
130532873|NCT02942277|469919334|FG010|Year 1|Lost to Follow-up|2|||
130532874|NCT02942277|469919324|FG000|Year 1|Protocol Violation|0|||
130532875|NCT02942277|469919325|FG001|Year 1|Protocol Violation|0|||
130532876|NCT02942277|469919326|FG002|Year 1|Protocol Violation|0|||
130532877|NCT02942277|469919327|FG003|Year 1|Protocol Violation|0|||
130532878|NCT02942277|469919328|FG004|Year 1|Protocol Violation|1|||
130581607|NCT04871711|470092509|FG000|Overall Study|Lost to Follow-up|0|||
130581608|NCT04871711|470092510|FG001|Overall Study|Lost to Follow-up|2|||
130581609|NCT02183519|470092511|FG000|Overall Study|computer error|3|||
130581610|NCT02183519|470092512|FG001|Overall Study|computer error|0|||
130581611|NCT02183519|470092511|FG000|Overall Study|Did not respond to cough inducter|0|||
130581612|NCT02183519|470092512|FG001|Overall Study|Did not respond to cough inducter|3|||
130581613|NCT00695565|470092517|FG000|Overall Study|Lost to Follow-up|4|||
130581614|NCT00695565|470092518|FG001|Overall Study|Lost to Follow-up|4|||
130581615|NCT00695565|470092517|FG000|Overall Study|Adverse Event|3|||
130581616|NCT00695565|470092518|FG001|Overall Study|Adverse Event|1|||
130581617|NCT00695565|470092517|FG000|Overall Study|Protocol Violation|3|||
130581618|NCT00695565|470092518|FG001|Overall Study|Protocol Violation|1|||
130581619|NCT00695565|470092517|FG000|Overall Study|Withdrawal by Subject|1|||
130581620|NCT00695565|470092518|FG001|Overall Study|Withdrawal by Subject|1|||
130581621|NCT00695565|470092517|FG000|Overall Study|Lack of Efficacy|1|||
130581622|NCT00695565|470092518|FG001|Overall Study|Lack of Efficacy|1|||
130581623|NCT00695565|470092517|FG000|Overall Study|Subject did not follow instructions|1|||
130581624|NCT00695565|470092518|FG001|Overall Study|Subject did not follow instructions|1|||
130581625|NCT02419508|470092521|FG000|Overall Study|Adverse Event|9|||
130581626|NCT02419508|470092522|FG001|Overall Study|Adverse Event|3|||
130581627|NCT02419508|470092521|FG000|Overall Study|Withdrawal by Subject|1|||
130581628|NCT02419508|470092522|FG001|Overall Study|Withdrawal by Subject|0|||
130581629|NCT02419508|470092521|FG000|Overall Study|Other - Reason not specified|0|||
130581630|NCT02419508|470092522|FG001|Overall Study|Other - Reason not specified|1|||
130581631|NCT03110900|470092523|FG000|Overall Study|Sponsor withdrew|1|||
130581632|NCT03110900|470092524|FG001|Overall Study|Sponsor withdrew|1|||
130581633|NCT01583179|470094102|FG000|Overall Study|Screen failure|1|||
130581634|NCT01583179|470094103|FG001|Overall Study|Screen failure|2|||
130581635|NCT01613326|470094109|FG000|Overall Study|Adverse Event|7|||
130581636|NCT01613326|470094110|FG001|Overall Study|Adverse Event|5|||
130581637|NCT01613326|470094109|FG000|Overall Study|Withdrawal by Subject|3|||
130581638|NCT01613326|470094110|FG001|Overall Study|Withdrawal by Subject|4|||
130581639|NCT01613326|470094109|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130581640|NCT01613326|470094110|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130581641|NCT01613326|470094109|FG000|Overall Study|inability to use device|1|||
130581642|NCT01613326|470094110|FG001|Overall Study|inability to use device|0|||
130581643|NCT01613326|470094109|FG000|Overall Study|Lack of Efficacy|0|||
130581644|NCT01613326|470094110|FG001|Overall Study|Lack of Efficacy|1|||
130581645|NCT01613326|470094109|FG000|Overall Study|Lost to Follow-up|0|||
130581646|NCT01613326|470094110|FG001|Overall Study|Lost to Follow-up|1|||
130581647|NCT01613326|470094109|FG000|Overall Study|Administrative|0|||
130581648|NCT01613326|470094110|FG001|Overall Study|Administrative|2|||
130581649|NCT01613326|470094109|FG000|Overall Study|Protocol Violation|0|||
130581650|NCT01613326|470094110|FG001|Overall Study|Protocol Violation|1|||
130581651|NCT03980938|470094111|FG000|Treatment Period 1|Study Terminated|1|||
130581652|NCT03980938|470094112|FG001|Treatment Period 1|Study Terminated|1|||
130581653|NCT03980938|470094111|FG000|Treatment Period 2|Study Terminated|2|||
130581654|NCT03980938|470094112|FG001|Treatment Period 2|Study Terminated|2|||
130581655|NCT00840827|470094113|FG000|Overall Study|Adverse Event|1|||
130581656|NCT00840827|470094113|FG000|Overall Study|Lack of Efficacy|4|||
130581657|NCT00840827|470094113|FG000|Overall Study|Physician Decision|1|||
130581658|NCT01445535|470094114|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130581659|NCT01445535|470094115|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130581660|NCT01445535|470094116|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130581661|NCT01445535|470094117|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
130581662|NCT01445535|470094114|FG000|Overall Study|Disease progression|1|||
130581663|NCT01445535|470094115|FG001|Overall Study|Disease progression|0|||
130581664|NCT01445535|470094116|FG002|Overall Study|Disease progression|1|||
130581665|NCT01445535|470094117|FG003|Overall Study|Disease progression|0|||
130581666|NCT01445535|470094114|FG000|Overall Study|PI discretion|0|||
130532879|NCT02942277|469919329|FG005|Year 1|Protocol Violation|1|||
130532880|NCT02942277|469919330|FG006|Year 1|Protocol Violation|0|||
130532881|NCT02942277|469919331|FG007|Year 1|Protocol Violation|0|||
130532882|NCT02942277|469919332|FG008|Year 1|Protocol Violation|0|||
130532883|NCT02942277|469919333|FG009|Year 1|Protocol Violation|0|||
130532884|NCT02942277|469919334|FG010|Year 1|Protocol Violation|2|||
130532885|NCT02942277|469919324|FG000|Year 1|Pregnancy|0|||
130532886|NCT02942277|469919325|FG001|Year 1|Pregnancy|0|||
130532887|NCT02942277|469919326|FG002|Year 1|Pregnancy|0|||
130532888|NCT02942277|469919327|FG003|Year 1|Pregnancy|0|||
130532889|NCT02942277|469919328|FG004|Year 1|Pregnancy|0|||
130532890|NCT02942277|469919329|FG005|Year 1|Pregnancy|1|||
130532891|NCT02942277|469919330|FG006|Year 1|Pregnancy|0|||
130532892|NCT02942277|469919331|FG007|Year 1|Pregnancy|0|||
130532893|NCT02942277|469919332|FG008|Year 1|Pregnancy|0|||
130532894|NCT02942277|469919333|FG009|Year 1|Pregnancy|0|||
130532895|NCT02942277|469919334|FG010|Year 1|Pregnancy|0|||
130532896|NCT02942277|469919324|FG000|Year 2|Lost to Follow-up|0|||
130532897|NCT02942277|469919325|FG001|Year 2|Lost to Follow-up|0|||
130532898|NCT02942277|469919326|FG002|Year 2|Lost to Follow-up|0|||
130532899|NCT02942277|469919327|FG003|Year 2|Lost to Follow-up|0|||
130532900|NCT02942277|469919328|FG004|Year 2|Lost to Follow-up|2|||
130532901|NCT02942277|469919329|FG005|Year 2|Lost to Follow-up|1|||
130532902|NCT02942277|469919330|FG006|Year 2|Lost to Follow-up|0|||
130532903|NCT02942277|469919331|FG007|Year 2|Lost to Follow-up|0|||
130532904|NCT02942277|469919332|FG008|Year 2|Lost to Follow-up|0|||
130532905|NCT02942277|469919333|FG009|Year 2|Lost to Follow-up|0|||
130532906|NCT02942277|469919334|FG010|Year 2|Lost to Follow-up|0|||
130532907|NCT02942277|469919324|FG000|Year 2|Did not rescreen|0|||
130532908|NCT02942277|469919325|FG001|Year 2|Did not rescreen|0|||
130532909|NCT02942277|469919326|FG002|Year 2|Did not rescreen|1|||
130532910|NCT02942277|469919327|FG003|Year 2|Did not rescreen|1|||
130532911|NCT02942277|469919328|FG004|Year 2|Did not rescreen|9|||
130532912|NCT02942277|469919329|FG005|Year 2|Did not rescreen|6|||
130532913|NCT02942277|469919330|FG006|Year 2|Did not rescreen|0|||
130532914|NCT02942277|469919331|FG007|Year 2|Did not rescreen|1|||
130532915|NCT02942277|469919332|FG008|Year 2|Did not rescreen|0|||
130532916|NCT02942277|469919333|FG009|Year 2|Did not rescreen|0|||
130532917|NCT02942277|469919334|FG010|Year 2|Did not rescreen|21|||
130532918|NCT02942277|469919324|FG000|Year 2|Met withdrawal criteria|0|||
130532919|NCT02942277|469919325|FG001|Year 2|Met withdrawal criteria|0|||
130532920|NCT02942277|469919326|FG002|Year 2|Met withdrawal criteria|0|||
130532921|NCT02942277|469919327|FG003|Year 2|Met withdrawal criteria|0|||
130532922|NCT02942277|469919328|FG004|Year 2|Met withdrawal criteria|1|||
130532923|NCT02942277|469919329|FG005|Year 2|Met withdrawal criteria|2|||
130532924|NCT02942277|469919330|FG006|Year 2|Met withdrawal criteria|0|||
130532925|NCT02942277|469919331|FG007|Year 2|Met withdrawal criteria|0|||
130532926|NCT02942277|469919332|FG008|Year 2|Met withdrawal criteria|0|||
130532927|NCT02942277|469919333|FG009|Year 2|Met withdrawal criteria|0|||
130532928|NCT02942277|469919334|FG010|Year 2|Met withdrawal criteria|1|||
130532929|NCT02942277|469919324|FG000|Year 2|Travel|0|||
130532930|NCT02942277|469919325|FG001|Year 2|Travel|1|||
130532931|NCT02942277|469919326|FG002|Year 2|Travel|0|||
130532932|NCT02942277|469919327|FG003|Year 2|Travel|0|||
130532933|NCT02942277|469919328|FG004|Year 2|Travel|0|||
130532934|NCT02942277|469919329|FG005|Year 2|Travel|1|||
130532935|NCT02942277|469919330|FG006|Year 2|Travel|0|||
130532936|NCT02942277|469919331|FG007|Year 2|Travel|0|||
130532937|NCT02942277|469919332|FG008|Year 2|Travel|0|||
130532938|NCT02942277|469919333|FG009|Year 2|Travel|1|||
130532939|NCT02942277|469919334|FG010|Year 2|Travel|3|||
130532940|NCT02942277|469919324|FG000|Year 2|Non-compliant|0|||
130532941|NCT02942277|469919325|FG001|Year 2|Non-compliant|0|||
130532942|NCT02942277|469919326|FG002|Year 2|Non-compliant|0|||
130532943|NCT02942277|469919327|FG003|Year 2|Non-compliant|0|||
130532944|NCT02942277|469919328|FG004|Year 2|Non-compliant|1|||
130532945|NCT02942277|469919329|FG005|Year 2|Non-compliant|1|||
130532946|NCT02942277|469919330|FG006|Year 2|Non-compliant|0|||
130532947|NCT02942277|469919331|FG007|Year 2|Non-compliant|0|||
130532948|NCT02942277|469919332|FG008|Year 2|Non-compliant|0|||
130532949|NCT02942277|469919333|FG009|Year 2|Non-compliant|0|||
130532950|NCT02942277|469919334|FG010|Year 2|Non-compliant|0|||
130532951|NCT02942277|469919324|FG000|Year 2|Withdrawal by Subject|0|||
130532952|NCT02942277|469919325|FG001|Year 2|Withdrawal by Subject|0|||
130532953|NCT02942277|469919326|FG002|Year 2|Withdrawal by Subject|0|||
130532954|NCT02942277|469919327|FG003|Year 2|Withdrawal by Subject|0|||
130532955|NCT02942277|469919328|FG004|Year 2|Withdrawal by Subject|0|||
130532956|NCT02942277|469919329|FG005|Year 2|Withdrawal by Subject|0|||
130532957|NCT02942277|469919330|FG006|Year 2|Withdrawal by Subject|1|||
130532958|NCT02942277|469919331|FG007|Year 2|Withdrawal by Subject|0|||
130532959|NCT02942277|469919332|FG008|Year 2|Withdrawal by Subject|0|||
130532960|NCT02942277|469919333|FG009|Year 2|Withdrawal by Subject|0|||
130532961|NCT02942277|469919334|FG010|Year 2|Withdrawal by Subject|0|||
130532962|NCT05577715|469919335|FG000|Overall Study|Withdrawal by Subject|1|||
130532963|NCT05577715|469919335|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
130532964|NCT05577715|469919335|FG000|Overall Study|Lost to Follow-up|1|||
130581667|NCT01445535|470094115|FG001|Overall Study|PI discretion|0|||
130581668|NCT01445535|470094116|FG002|Overall Study|PI discretion|0|||
130581669|NCT01445535|470094117|FG003|Overall Study|PI discretion|1|||
130581670|NCT00420511|470094120|FG000|Overall Study|Adverse Event|1|||
130581671|NCT00420511|470094121|FG001|Overall Study|Adverse Event|1|||
130581672|NCT00420511|470094120|FG000|Overall Study|Lost to Follow-up|1|||
130581673|NCT00420511|470094121|FG001|Overall Study|Lost to Follow-up|0|||
130581674|NCT01337973|470094122|FG000|Overall Study|Lost to Follow-up|2|||
130581675|NCT01337973|470094123|FG001|Overall Study|Lost to Follow-up|4|||
130581676|NCT01337973|470094124|FG002|Overall Study|Lost to Follow-up|3|||
130581677|NCT01337973|470094122|FG000|Overall Study|Death|1|||
130581678|NCT01337973|470094123|FG001|Overall Study|Death|2|||
130581679|NCT01337973|470094124|FG002|Overall Study|Death|1|||
130581680|NCT01337973|470094122|FG000|Overall Study|Withdrawal by Subject|10|||
130581681|NCT01337973|470094123|FG001|Overall Study|Withdrawal by Subject|8|||
130581682|NCT01337973|470094124|FG002|Overall Study|Withdrawal by Subject|4|||
130581683|NCT01337973|470094122|FG000|Overall Study|missing data on primary outcome|3|||
130581684|NCT01337973|470094123|FG001|Overall Study|missing data on primary outcome|1|||
130581685|NCT01337973|470094124|FG002|Overall Study|missing data on primary outcome|3|||
130581686|NCT02624492|470094125|FG000|Overall Study|Adverse Event|2|||
130581687|NCT02624492|470094126|FG001|Overall Study|Adverse Event|2|||
130581688|NCT02624492|470094127|FG002|Overall Study|Adverse Event|2|||
130581689|NCT02624492|470094125|FG000|Overall Study|Progressive disease|0|||
130581690|NCT02624492|470094126|FG001|Overall Study|Progressive disease|2|||
130581691|NCT02624492|470094127|FG002|Overall Study|Progressive disease|3|||
130581692|NCT03555266|470094133|FG000|Overall Study|Protocol Violation|6|||
130581693|NCT03555266|470094134|FG001|Overall Study|Protocol Violation|4|||
130581694|NCT02167945|470094135|FG000|Overall Study|Adverse Event|16|||
130581695|NCT02167945|470094135|FG000|Overall Study|Withdrew Consent|42|||
130581696|NCT02167945|470094135|FG000|Overall Study|Lost to Follow-up|122|||
130581697|NCT02167945|470094135|FG000|Overall Study|COVID-19 logistical restrictions|6|||
130581698|NCT02167945|470094135|FG000|Overall Study|Other, not specified|63|||
130581699|NCT02239263|470094136|FG000|Overall Study|Protocol Violation|6|||
130581700|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Adverse Event|11|||
130581701|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Adverse Event|15|||
130581702|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
130581703|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
130581704|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
130581705|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
130581706|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
130581707|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
130581708|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130581709|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130581710|NCT01058096|470094138|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
130581711|NCT01058096|470094139|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
130581712|NCT04276207|470094140|FG000|Period 1|Withdrawal by Subject|0|||
130581713|NCT04276207|470094141|FG001|Period 1|Withdrawal by Subject|1|||
130581714|NCT02769624|470094142|FG000|Overall Study|Lost to Follow-up|0|||
130581715|NCT02769624|470094143|FG001|Overall Study|Lost to Follow-up|1|||
130581716|NCT04451330|470094144|FG000|Overall Study|Adverse Event|1|||
130581717|NCT04451330|470094145|FG001|Overall Study|Adverse Event|2|||
130581718|NCT04451330|470094144|FG000|Overall Study|Lost to Follow-up|5|||
130581719|NCT04451330|470094145|FG001|Overall Study|Lost to Follow-up|0|||
130581720|NCT04451330|470094144|FG000|Overall Study|Withdrawal by Subject|3|||
130532965|NCT05577715|469919335|FG000|Overall Study|Death|6|||
130532966|NCT05282121|469919339|FG000|Overall Study|Adverse Event|1|||
130532967|NCT05282121|469919340|FG001|Overall Study|Adverse Event|1|||
130532968|NCT05282121|469919341|FG002|Overall Study|Adverse Event|4|||
130532969|NCT05282121|469919342|FG003|Overall Study|Adverse Event|1|||
130532970|NCT05282121|469919339|FG000|Overall Study|Study Terminated by Sponsor|1|||
130532971|NCT05282121|469919340|FG001|Overall Study|Study Terminated by Sponsor|2|||
130532972|NCT05282121|469919341|FG002|Overall Study|Study Terminated by Sponsor|2|||
130532973|NCT05282121|469919342|FG003|Overall Study|Study Terminated by Sponsor|2|||
130532974|NCT05282121|469919339|FG000|Overall Study|Other than listed|0|||
130532975|NCT05282121|469919340|FG001|Overall Study|Other than listed|0|||
130532976|NCT05282121|469919341|FG002|Overall Study|Other than listed|1|||
130532977|NCT05282121|469919342|FG003|Overall Study|Other than listed|0|||
130532978|NCT05282121|469919339|FG000|Overall Study|No reason available|0|||
130532979|NCT05282121|469919340|FG001|Overall Study|No reason available|0|||
130532980|NCT05282121|469919341|FG002|Overall Study|No reason available|1|||
130532981|NCT05282121|469919342|FG003|Overall Study|No reason available|0|||
130532982|NCT01736189|469919343|FG000|Overall Study|Violation of registration criteria|41|||
130532983|NCT01736189|469919343|FG000|Overall Study|Protocol Violation|4|||
130532984|NCT01736189|469919343|FG000|Overall Study|Criteria and protocol violations|1|||
130532985|NCT03809039|469919346|FG000|Part 1|Withdrawal by Subject|1|||
130532986|NCT03809039|469919347|FG001|Part 1|Withdrawal by Subject|0|||
130532987|NCT03809039|469919348|FG002|Part 1|Withdrawal by Subject|0|||
130532988|NCT03809039|469919349|FG003|Part 1|Withdrawal by Subject|1|||
130532989|NCT03809039|469919350|FG004|Part 1|Withdrawal by Subject|0|||
130532990|NCT03809039|469919351|FG005|Part 1|Withdrawal by Subject|0|||
130532991|NCT03809039|469919352|FG006|Part 1|Withdrawal by Subject|0|||
130532992|NCT03809039|469919353|FG007|Part 1|Withdrawal by Subject|0|||
130532993|NCT03809039|469919354|FG008|Part 1|Withdrawal by Subject|0|||
130532994|NCT03809039|469919346|FG000|Part 3|Withdrawn by study termination|0|||
130532995|NCT03809039|469919347|FG001|Part 3|Withdrawn by study termination|0|||
130532996|NCT03809039|469919348|FG002|Part 3|Withdrawn by study termination|0|||
130532997|NCT03809039|469919349|FG003|Part 3|Withdrawn by study termination|0|||
130532998|NCT03809039|469919350|FG004|Part 3|Withdrawn by study termination|0|||
130532999|NCT03809039|469919351|FG005|Part 3|Withdrawn by study termination|0|||
130533000|NCT03809039|469919352|FG006|Part 3|Withdrawn by study termination|0|||
130533001|NCT03809039|469919353|FG007|Part 3|Withdrawn by study termination|2|||
130533002|NCT03809039|469919354|FG008|Part 3|Withdrawn by study termination|6|||
130533003|NCT00608868|469919357|FG000|Overall Study|Withdrawal by Subject|7|||
130533004|NCT00608868|469919357|FG000|Overall Study|Protocol Violation|3|||
130533005|NCT00608868|469919357|FG000|Overall Study|Lost to Follow-up|2|||
130533006|NCT00608868|469919357|FG000|Overall Study|Adverse Event|1|||
130533007|NCT00608868|469919357|FG000|Overall Study|Physician Decision|2|||
130533008|NCT01250925|469919358|FG000|Overall Study|Lost to Follow-up|1|||
130533009|NCT01250925|469919359|FG001|Overall Study|Lost to Follow-up|1|||
130533010|NCT01250925|469919360|FG002|Overall Study|Lost to Follow-up|0|||
130533011|NCT01250925|469919358|FG000|Overall Study|Withdrawal by Subject|2|||
130533012|NCT01250925|469919359|FG001|Overall Study|Withdrawal by Subject|0|||
130533013|NCT01250925|469919360|FG002|Overall Study|Withdrawal by Subject|0|||
130533014|NCT01250925|469919358|FG000|Overall Study|Protocol Violation|2|||
130533015|NCT01250925|469919359|FG001|Overall Study|Protocol Violation|0|||
130533016|NCT01250925|469919360|FG002|Overall Study|Protocol Violation|0|||
130533017|NCT01250925|469919358|FG000|Overall Study|Physician Decision|0|||
130533018|NCT01250925|469919359|FG001|Overall Study|Physician Decision|2|||
130533019|NCT01250925|469919360|FG002|Overall Study|Physician Decision|1|||
130533020|NCT01250925|469919358|FG000|Overall Study|Adverse Event|0|||
130533021|NCT01250925|469919359|FG001|Overall Study|Adverse Event|0|||
130533022|NCT01250925|469919360|FG002|Overall Study|Adverse Event|1|||
130533023|NCT04421950|469919361|FG000|Overall Study|Dropped or lost to follow up|4|||
130533024|NCT04421950|469919362|FG001|Overall Study|Dropped or lost to follow up|2|||
130533025|NCT01252355|469919363|FG000|Overall Study|Adverse Event|9|||
130533026|NCT01252355|469919364|FG001|Overall Study|Adverse Event|17|||
130533027|NCT01252355|469919365|FG002|Overall Study|Adverse Event|22|||
130533028|NCT01252355|469919363|FG000|Overall Study|Lack of Efficacy|6|||
130533029|NCT01252355|469919364|FG001|Overall Study|Lack of Efficacy|4|||
130533030|NCT01252355|469919365|FG002|Overall Study|Lack of Efficacy|2|||
130533031|NCT01252355|469919363|FG000|Overall Study|Lost to Follow-up|0|||
130533032|NCT01252355|469919364|FG001|Overall Study|Lost to Follow-up|0|||
130533033|NCT01252355|469919365|FG002|Overall Study|Lost to Follow-up|1|||
130581721|NCT04451330|470094145|FG001|Overall Study|Withdrawal by Subject|1|||
130581722|NCT04451330|470094144|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130581723|NCT04451330|470094145|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130581724|NCT04451330|470094144|FG000|Overall Study|Other than specified|0|||
130581725|NCT04451330|470094145|FG001|Overall Study|Other than specified|1|||
130581726|NCT05099640|470094146|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
130581727|NCT05099640|470094147|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
130581728|NCT05099640|470094148|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
130581729|NCT05099640|470094146|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
130581730|NCT05099640|470094147|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
130581731|NCT05099640|470094148|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
130581732|NCT05099640|470094146|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
130581733|NCT05099640|470094147|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
130581734|NCT05099640|470094148|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
130581735|NCT05099640|470094146|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
130581736|NCT05099640|470094147|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
130581737|NCT05099640|470094148|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
130581738|NCT05099640|470094146|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
130581739|NCT05099640|470094147|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
130581740|NCT05099640|470094148|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
130581741|NCT05099640|470094146|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
130581742|NCT05099640|470094147|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
130581743|NCT05099640|470094148|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
130581744|NCT00179959|470094149|FG000|Overall Study|Lost to Follow-up|3|||
130581745|NCT00179959|470094150|FG001|Overall Study|Lost to Follow-up|1|||
130581746|NCT00179959|470094149|FG000|Overall Study|Withdrawal by Subject|3|||
130581747|NCT00179959|470094150|FG001|Overall Study|Withdrawal by Subject|2|||
130581748|NCT03261531|470094151|FG000|Overall Study|Withdrawal by Subject|4|||
130581749|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
130581750|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
130581751|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
130581752|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Death|28|||
130581753|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Death|0|||
130581754|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Death|0|||
130581755|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
130581756|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
130581757|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
130581758|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
130581759|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
130581760|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
130581761|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
130581762|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
130581763|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
130581764|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
130581765|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
130581766|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
130581767|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
130581768|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
130581769|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
130581770|NCT00820755|470094152|FG000|Period 1: Combination Therapy Phase|Other|11|||
130581771|NCT00820755|470094153|FG001|Period 1: Combination Therapy Phase|Other|0|||
130581772|NCT00820755|470094154|FG002|Period 1: Combination Therapy Phase|Other|0|||
130581773|NCT00820755|470094152|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
130581774|NCT00820755|470094153|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
130581775|NCT00820755|470094154|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
130581776|NCT01225562|470094157|FG000|Overall Study|Withdrawal by Subject|52|||
130581777|NCT01225562|470094158|FG001|Overall Study|Withdrawal by Subject|50|||
130581778|NCT01225562|470094159|FG002|Overall Study|Withdrawal by Subject|52|||
130581779|NCT01225562|470094157|FG000|Overall Study|Lost to Follow-up|3|||
130581780|NCT01225562|470094158|FG001|Overall Study|Lost to Follow-up|6|||
130581781|NCT01225562|470094159|FG002|Overall Study|Lost to Follow-up|1|||
130581782|NCT01162421|470094163|FG000|Overall Study|Did not receive study drug|2|||
130581783|NCT01162421|470094164|FG001|Overall Study|Did not receive study drug|1|||
130581784|NCT01162421|470094163|FG000|Overall Study|Adverse Event|2|||
130581785|NCT01162421|470094164|FG001|Overall Study|Adverse Event|5|||
130581786|NCT01162421|470094163|FG000|Overall Study|Lost to Follow-up|0|||
130581787|NCT01162421|470094164|FG001|Overall Study|Lost to Follow-up|2|||
130581788|NCT01162421|470094163|FG000|Overall Study|Lack of Efficacy|2|||
130581789|NCT01162421|470094164|FG001|Overall Study|Lack of Efficacy|2|||
130581790|NCT01162421|470094163|FG000|Overall Study|Other|2|||
130581791|NCT01162421|470094164|FG001|Overall Study|Other|3|||
130581792|NCT01107444|470094166|FG000|Overall Study|Withdrawal by Subject|8|||
130581793|NCT01107444|470094167|FG001|Overall Study|Withdrawal by Subject|12|||
130581794|NCT01107444|470094166|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
130581795|NCT01107444|470094167|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
130581796|NCT00091832|470094169|FG000|Overall Study|Physician Decision|1|||
130581797|NCT00091832|470094170|FG001|Overall Study|Physician Decision|0|||
130581798|NCT00091832|470094171|FG002|Overall Study|Physician Decision|0|||
130581799|NCT00091832|470094172|FG003|Overall Study|Physician Decision|0|||
130581800|NCT00091832|470094173|FG004|Overall Study|Physician Decision|0|||
130581801|NCT00091832|470094174|FG005|Overall Study|Physician Decision|0|||
130581802|NCT00091832|470094169|FG000|Overall Study|Adverse Event|0|||
130581803|NCT00091832|470094170|FG001|Overall Study|Adverse Event|0|||
130581804|NCT00091832|470094171|FG002|Overall Study|Adverse Event|0|||
130581805|NCT00091832|470094172|FG003|Overall Study|Adverse Event|1|||
130581806|NCT00091832|470094173|FG004|Overall Study|Adverse Event|3|||
130581807|NCT00091832|470094174|FG005|Overall Study|Adverse Event|0|||
130581808|NCT00091832|470094169|FG000|Overall Study|Withdrawal by Subject|4|||
130581809|NCT00091832|470094170|FG001|Overall Study|Withdrawal by Subject|5|||
130581810|NCT00091832|470094171|FG002|Overall Study|Withdrawal by Subject|0|||
130581811|NCT00091832|470094172|FG003|Overall Study|Withdrawal by Subject|1|||
130581812|NCT00091832|470094173|FG004|Overall Study|Withdrawal by Subject|3|||
130581813|NCT00091832|470094174|FG005|Overall Study|Withdrawal by Subject|1|||
130581814|NCT00091832|470094169|FG000|Overall Study|Death|6|||
130581815|NCT00091832|470094170|FG001|Overall Study|Death|4|||
130581816|NCT00091832|470094171|FG002|Overall Study|Death|5|||
130581817|NCT00091832|470094172|FG003|Overall Study|Death|8|||
130581818|NCT00091832|470094173|FG004|Overall Study|Death|5|||
130581819|NCT00091832|470094174|FG005|Overall Study|Death|6|||
130581820|NCT00091832|470094169|FG000|Overall Study|Disease Progression|2|||
130581821|NCT00091832|470094170|FG001|Overall Study|Disease Progression|0|||
130581822|NCT00091832|470094171|FG002|Overall Study|Disease Progression|0|||
130581823|NCT00091832|470094172|FG003|Overall Study|Disease Progression|1|||
130581824|NCT00091832|470094173|FG004|Overall Study|Disease Progression|1|||
130581825|NCT00091832|470094174|FG005|Overall Study|Disease Progression|2|||
130581826|NCT00091832|470094169|FG000|Overall Study|Ineligibility Determined|0|||
130581827|NCT00091832|470094170|FG001|Overall Study|Ineligibility Determined|0|||
130581828|NCT00091832|470094171|FG002|Overall Study|Ineligibility Determined|1|||
130581829|NCT00091832|470094172|FG003|Overall Study|Ineligibility Determined|0|||
130581830|NCT00091832|470094173|FG004|Overall Study|Ineligibility Determined|1|||
130581831|NCT00091832|470094174|FG005|Overall Study|Ineligibility Determined|0|||
130581832|NCT00091832|470094169|FG000|Overall Study|Lost to Follow-up|1|||
130581833|NCT00091832|470094170|FG001|Overall Study|Lost to Follow-up|0|||
130581834|NCT00091832|470094171|FG002|Overall Study|Lost to Follow-up|3|||
130581835|NCT00091832|470094172|FG003|Overall Study|Lost to Follow-up|3|||
130581836|NCT00091832|470094173|FG004|Overall Study|Lost to Follow-up|2|||
130581837|NCT00091832|470094174|FG005|Overall Study|Lost to Follow-up|1|||
130581838|NCT00091832|470094169|FG000|Overall Study|Noncompliance|0|||
130581839|NCT00091832|470094170|FG001|Overall Study|Noncompliance|1|||
130581840|NCT00091832|470094171|FG002|Overall Study|Noncompliance|0|||
130581841|NCT00091832|470094172|FG003|Overall Study|Noncompliance|0|||
130581842|NCT00091832|470094173|FG004|Overall Study|Noncompliance|0|||
130581843|NCT00091832|470094174|FG005|Overall Study|Noncompliance|0|||
130581844|NCT00091832|470094169|FG000|Overall Study|Other|0|||
130581845|NCT00091832|470094170|FG001|Overall Study|Other|1|||
130581846|NCT00091832|470094171|FG002|Overall Study|Other|2|||
130581847|NCT00091832|470094172|FG003|Overall Study|Other|0|||
130581848|NCT00091832|470094173|FG004|Overall Study|Other|0|||
130581849|NCT00091832|470094174|FG005|Overall Study|Other|0|||
130581850|NCT00091832|470094169|FG000|Overall Study|Protocol Violation|0|||
130581851|NCT00091832|470094170|FG001|Overall Study|Protocol Violation|0|||
130581852|NCT00091832|470094171|FG002|Overall Study|Protocol Violation|1|||
130581853|NCT00091832|470094172|FG003|Overall Study|Protocol Violation|0|||
130581854|NCT00091832|470094173|FG004|Overall Study|Protocol Violation|0|||
130581855|NCT00091832|470094174|FG005|Overall Study|Protocol Violation|1|||
130581856|NCT00464178|470094175|FG000|Overall Study|Protocol Violation|1|||
130581857|NCT00464178|470094175|FG000|Overall Study|Withdrawal by Subject|1|||
130581858|NCT01557166|470094178|FG000|Overall Study|Adverse Event|20|||
130581859|NCT01557166|470094179|FG001|Overall Study|Adverse Event|6|||
130581860|NCT01557166|470094178|FG000|Overall Study|Lack of Efficacy|2|||
130581861|NCT01557166|470094179|FG001|Overall Study|Lack of Efficacy|1|||
130581862|NCT01557166|470094178|FG000|Overall Study|Protocol Violation|8|||
130581863|NCT01557166|470094179|FG001|Overall Study|Protocol Violation|5|||
130581864|NCT01557166|470094178|FG000|Overall Study|Withdrawn consent|12|||
130581865|NCT01557166|470094179|FG001|Overall Study|Withdrawn consent|20|||
130581866|NCT01557166|470094178|FG000|Overall Study|Target dose not tolerated|1|||
130581867|NCT01557166|470094179|FG001|Overall Study|Target dose not tolerated|0|||
130581868|NCT01557166|470094178|FG000|Overall Study|Psychiatric disorder|1|||
130581869|NCT01557166|470094179|FG001|Overall Study|Psychiatric disorder|0|||
130581870|NCT01557166|470094178|FG000|Overall Study|Unclassified|2|||
130581871|NCT01557166|470094179|FG001|Overall Study|Unclassified|5|||
130581872|NCT00946309|470094180|FG000|Overall Study|Protocol Violation|1|||
130581873|NCT00946309|470094181|FG001|Overall Study|Protocol Violation|0|||
130581874|NCT00946309|470094180|FG000|Overall Study|Lost to Follow-up|0|||
130581875|NCT00946309|470094181|FG001|Overall Study|Lost to Follow-up|1|||
130581876|NCT00946309|470094180|FG000|Overall Study|Procedure cancelled/discontinued|0|||
130581877|NCT00946309|470094181|FG001|Overall Study|Procedure cancelled/discontinued|3|||
130581878|NCT01465659|470094183|FG000|Completed 1 Cycle of Treatment|Death|0|||
130581879|NCT01465659|470094184|FG001|Completed 1 Cycle of Treatment|Death|1|||
130581880|NCT01465659|470094185|FG002|Completed 1 Cycle of Treatment|Death|0|||
130581881|NCT01465659|470094186|FG003|Completed 1 Cycle of Treatment|Death|0|||
130581882|NCT01465659|470094183|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
130581883|NCT01465659|470094184|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
130581884|NCT01465659|470094185|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
130581885|NCT01465659|470094186|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
130581886|NCT01465659|470094183|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130581887|NCT01465659|470094184|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
130581888|NCT01465659|470094185|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130581889|NCT01465659|470094186|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130581890|NCT01465659|470094183|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
130581891|NCT01465659|470094184|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
130581892|NCT01465659|470094185|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
130581893|NCT01465659|470094186|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
130581894|NCT01465659|470094183|FG000|Completed Follow for 1 Year|Death|6|||
130581895|NCT01465659|470094184|FG001|Completed Follow for 1 Year|Death|3|||
130581896|NCT01465659|470094185|FG002|Completed Follow for 1 Year|Death|2|||
130581897|NCT01465659|470094186|FG003|Completed Follow for 1 Year|Death|4|||
130581898|NCT02445586|470094191|FG000|Overall Study|Death|14|||
130581899|NCT02445586|470094191|FG000|Overall Study|Withdrawal by Subject|13|||
130581900|NCT02445586|470094191|FG000|Overall Study|Disease Progression|10|||
130581901|NCT02445586|470094191|FG000|Overall Study|Protocol Violation|1|||
130581902|NCT02445586|470094191|FG000|Overall Study|Medical Condition|1|||
130581903|NCT00428597|470094192|FG000|Overall Study|Randomized but not treated|3|||
130581904|NCT00428597|470094193|FG001|Overall Study|Randomized but not treated|3|||
130581905|NCT00428597|470094192|FG000|Overall Study|Objective Progression or Relapse|19|||
130581906|NCT00428597|470094193|FG001|Overall Study|Objective Progression or Relapse|47|||
130581907|NCT00428597|470094192|FG000|Overall Study|Study Terminated by Sponsor|41|||
130581908|NCT00428597|470094193|FG001|Overall Study|Study Terminated by Sponsor|16|||
130581909|NCT00428597|470094192|FG000|Overall Study|Adverse Event|15|||
130581910|NCT00428597|470094193|FG001|Overall Study|Adverse Event|7|||
130581911|NCT00428597|470094192|FG000|Overall Study|Global Deterioration of Health Status|1|||
130581912|NCT00428597|470094193|FG001|Overall Study|Global Deterioration of Health Status|5|||
130581913|NCT00428597|470094192|FG000|Overall Study|Protocol Violation|2|||
130581914|NCT00428597|470094193|FG001|Overall Study|Protocol Violation|1|||
130581915|NCT00428597|470094192|FG000|Overall Study|Withdrawal by Subject|2|||
130581916|NCT00428597|470094193|FG001|Overall Study|Withdrawal by Subject|1|||
130581917|NCT00428597|470094192|FG000|Overall Study|Other|1|||
130581918|NCT00428597|470094193|FG001|Overall Study|Other|1|||
130581919|NCT00428597|470094192|FG000|Overall Study|Lost to Follow-up|0|||
130581920|NCT00428597|470094193|FG001|Overall Study|Lost to Follow-up|1|||
130581921|NCT00428597|470094192|FG000|Overall Study|Pregnancy|1|||
130581922|NCT00428597|470094193|FG001|Overall Study|Pregnancy|0|||
130581923|NCT00428597|470094192|FG000|Overall Study|Death|1|||
130581924|NCT00428597|470094193|FG001|Overall Study|Death|3|||
130581925|NCT01469000|470094194|FG000|Overall Study|Withdrawal by Subject|16|||
130581926|NCT01469000|470094195|FG001|Overall Study|Withdrawal by Subject|3|||
130581927|NCT01469000|470094194|FG000|Overall Study|Sponsor Decision|4|||
130581928|NCT01469000|470094195|FG001|Overall Study|Sponsor Decision|1|||
130581929|NCT00686647|470094204|FG000|Overall Study|Lost to Follow-up|1|||
130581930|NCT00686647|470094204|FG000|Overall Study|Death|1|||
130581931|NCT05501119|470094213|FG000|Overall Study|Withdrawal by Subject|2|||
130581932|NCT05501119|470094213|FG000|Overall Study|Lost to Follow-up|5|||
130581933|NCT01725750|470094214|FG000|Overall Study|Adverse Event|1|||
130581934|NCT01725750|470094215|FG001|Overall Study|Adverse Event|0|||
130581935|NCT01725750|470094214|FG000|Overall Study|Lost to Follow-up|1|||
130581936|NCT01725750|470094215|FG001|Overall Study|Lost to Follow-up|1|||
130581937|NCT01725750|470094214|FG000|Overall Study|Withdrawal by Subject|0|||
130581938|NCT01725750|470094215|FG001|Overall Study|Withdrawal by Subject|9|||
130581939|NCT02542072|470094216|FG000|First Intervention (1 Month)|Adverse Event|1|||
130581940|NCT02542072|470094217|FG001|First Intervention (1 Month)|Adverse Event|1|||
130581941|NCT02542072|470094216|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
130581942|NCT02542072|470094217|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
130581943|NCT02542072|470094216|FG000|First Intervention (1 Month)|Lens discomfort|1|||
130581944|NCT02542072|470094217|FG001|First Intervention (1 Month)|Lens discomfort|2|||
130581945|NCT02542072|470094216|FG000|First Intervention (1 Month)|Protocol Violation|1|||
130581946|NCT02542072|470094217|FG001|First Intervention (1 Month)|Protocol Violation|0|||
130581947|NCT02542072|470094216|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
130581948|NCT02542072|470094217|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
130581949|NCT02542072|470094216|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
130581950|NCT02542072|470094217|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
130581951|NCT00654498|470094218|FG000|Overall Study|Not Treated|1|||
130581952|NCT00654498|470094219|FG001|Overall Study|Not Treated|0|||
130581953|NCT00654498|470094218|FG000|Overall Study|Adverse Event|6|||
130581954|NCT00654498|470094219|FG001|Overall Study|Adverse Event|1|||
130581955|NCT00654498|470094218|FG000|Overall Study|Protocol Violation|1|||
130581956|NCT00654498|470094219|FG001|Overall Study|Protocol Violation|1|||
130581957|NCT00654498|470094218|FG000|Overall Study|Lost to Follow-up|1|||
130581958|NCT00654498|470094219|FG001|Overall Study|Lost to Follow-up|5|||
130581959|NCT00654498|470094218|FG000|Overall Study|Withdrawal by Subject|1|||
130581960|NCT00654498|470094219|FG001|Overall Study|Withdrawal by Subject|0|||
130581961|NCT00654498|470094218|FG000|Overall Study|Other reason not defined above|4|||
130581962|NCT00654498|470094219|FG001|Overall Study|Other reason not defined above|5|||
130581963|NCT01356589|470094223|FG000|Overall Study|Enrolled, but not treated|3|||
130581964|NCT01356589|470094223|FG000|Overall Study|Dose data not recorded|2|||
130581965|NCT01462266|470094224|FG000|Overall Study|Adverse Event|7|||
130581966|NCT01462266|470094225|FG001|Overall Study|Adverse Event|6|||
130581967|NCT01462266|470094224|FG000|Overall Study|Death|2|||
130581968|NCT01462266|470094225|FG001|Overall Study|Death|1|||
130581969|NCT01462266|470094224|FG000|Overall Study|Lack of Efficacy|0|||
130581970|NCT01462266|470094225|FG001|Overall Study|Lack of Efficacy|2|||
130581971|NCT01462266|470094224|FG000|Overall Study|Lost to Follow-up|4|||
130581972|NCT01462266|470094225|FG001|Overall Study|Lost to Follow-up|3|||
130581973|NCT01462266|470094224|FG000|Overall Study|Non-compliance with study drug|3|||
130581974|NCT01462266|470094225|FG001|Overall Study|Non-compliance with study drug|0|||
130581975|NCT01462266|470094224|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
130581976|NCT01462266|470094225|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
130581977|NCT01462266|470094224|FG000|Overall Study|Physician Decision|2|||
130581978|NCT01462266|470094225|FG001|Overall Study|Physician Decision|5|||
130581979|NCT01462266|470094224|FG000|Overall Study|Protocol Violation|1|||
130581980|NCT01462266|470094225|FG001|Overall Study|Protocol Violation|3|||
130581981|NCT01462266|470094224|FG000|Overall Study|Withdrawal by Subject|7|||
130581982|NCT01462266|470094225|FG001|Overall Study|Withdrawal by Subject|2|||
130581983|NCT01462266|470094224|FG000|Overall Study|Screen failure|1|||
130581984|NCT01462266|470094225|FG001|Overall Study|Screen failure|1|||
130581985|NCT01106846|470094226|FG000|Overall Study|Change in surgical procedure|0|||
130581986|NCT01106846|470094227|FG001|Overall Study|Change in surgical procedure|1|||
130581987|NCT01738971|470094244|FG000|Overall Study|Lost to Follow-up|19|||
130581988|NCT01738971|470094245|FG001|Overall Study|Lost to Follow-up|30|||
130581989|NCT01738971|470094246|FG002|Overall Study|Lost to Follow-up|17|||
130581990|NCT01031446|470094249|FG000|Overall Study|Disease Progression|38|||
130581991|NCT01031446|470094249|FG000|Overall Study|Adverse Event|9|||
130581992|NCT01031446|470094249|FG000|Overall Study|Physician Decision|4|||
130581993|NCT01031446|470094249|FG000|Overall Study|Withdrawal by Subject|3|||
130581994|NCT01031446|470094249|FG000|Overall Study|Still on treatment|1|||
130581995|NCT02447848|470094250|FG000|Overall Study|Patient discharged|3|||
130581996|NCT02447848|470094250|FG000|Overall Study|Lack of Efficacy|4|||
130581997|NCT02447848|470094250|FG000|Overall Study|Withdrawal by Subject|4|||
130581998|NCT03344003|470094251|FG000|Overall Study|Switched to alternative treatment|1|||
130581999|NCT03344003|470094252|FG001|Overall Study|Switched to alternative treatment|0|||
130582000|NCT03344003|470094251|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
130582001|NCT03344003|470094252|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
130582002|NCT03631706|470094257|FG000|Overall Study|Randomized, not treated|1|||
130582003|NCT03631706|470094258|FG001|Overall Study|Randomized, not treated|0|||
130582004|NCT05847686|470095678|FG000|Overall Study|Withdrawal by Subject|3|||
130582005|NCT06272370|470095679|FG000|Overall Study|Lost to Follow-up|0|||
130582006|NCT06272370|470095680|FG001|Overall Study|Lost to Follow-up|3|||
130533034|NCT01252355|469919363|FG000|Overall Study|Poor Compliance to Protocol|1|||
130533035|NCT01252355|469919364|FG001|Overall Study|Poor Compliance to Protocol|1|||
130533036|NCT01252355|469919365|FG002|Overall Study|Poor Compliance to Protocol|1|||
130533037|NCT01252355|469919363|FG000|Overall Study|Progressive Disease|2|||
130533038|NCT01252355|469919364|FG001|Overall Study|Progressive Disease|0|||
130533039|NCT01252355|469919365|FG002|Overall Study|Progressive Disease|0|||
130533040|NCT01252355|469919363|FG000|Overall Study|Sponsor Early Termination of Study|149|||
130533041|NCT01252355|469919364|FG001|Overall Study|Sponsor Early Termination of Study|149|||
130533042|NCT01252355|469919365|FG002|Overall Study|Sponsor Early Termination of Study|146|||
130533043|NCT01252355|469919363|FG000|Overall Study|Randomized but not Treated|2|||
130533044|NCT01252355|469919364|FG001|Overall Study|Randomized but not Treated|0|||
130533045|NCT01252355|469919365|FG002|Overall Study|Randomized but not Treated|0|||
130533046|NCT01252355|469919363|FG000|Overall Study|Other Than Above|8|||
130533047|NCT01252355|469919364|FG001|Overall Study|Other Than Above|7|||
130533048|NCT01252355|469919365|FG002|Overall Study|Other Than Above|7|||
130533049|NCT00335140|469919368|FG000|Overall Study|Ineligible|1|||
130533050|NCT04546425|469919369|FG000|Overall Study|Protocol Violation|1|||
130533051|NCT04546425|469919370|FG001|Overall Study|Protocol Violation|1|||
130533052|NCT04546425|469919371|FG002|Overall Study|Protocol Violation|0|||
130533053|NCT04546425|469919372|FG003|Overall Study|Protocol Violation|0|||
130533054|NCT04546425|469919369|FG000|Overall Study|Adverse Event|3|||
130533055|NCT04546425|469919370|FG001|Overall Study|Adverse Event|0|||
130533056|NCT04546425|469919371|FG002|Overall Study|Adverse Event|0|||
130533057|NCT04546425|469919372|FG003|Overall Study|Adverse Event|0|||
130533058|NCT04546425|469919369|FG000|Overall Study|Lost to Follow-up|5|||
130533059|NCT04546425|469919370|FG001|Overall Study|Lost to Follow-up|4|||
130533060|NCT04546425|469919371|FG002|Overall Study|Lost to Follow-up|0|||
130533061|NCT04546425|469919372|FG003|Overall Study|Lost to Follow-up|0|||
130533062|NCT04546425|469919369|FG000|Overall Study|No Longer met eligibility criteria|3|||
130533063|NCT04546425|469919370|FG001|Overall Study|No Longer met eligibility criteria|3|||
130533064|NCT04546425|469919371|FG002|Overall Study|No Longer met eligibility criteria|1|||
130533065|NCT04546425|469919372|FG003|Overall Study|No Longer met eligibility criteria|1|||
130533066|NCT04546425|469919369|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130533067|NCT04546425|469919370|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130533068|NCT04546425|469919371|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130533069|NCT04546425|469919372|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130533070|NCT01725126|469919373|FG000|Overall Study|Protocol Violation|0|||
130533071|NCT01725126|469919374|FG001|Overall Study|Protocol Violation|1|||
130533072|NCT01725126|469919375|FG002|Overall Study|Protocol Violation|0|||
130533073|NCT01725126|469919376|FG003|Overall Study|Protocol Violation|0|||
130533074|NCT01725126|469919377|FG004|Overall Study|Protocol Violation|0|||
130533075|NCT01725126|469919378|FG005|Overall Study|Protocol Violation|0|||
130533076|NCT01725126|469919373|FG000|Overall Study|Withdrawal by Subject|0|||
130533077|NCT01725126|469919374|FG001|Overall Study|Withdrawal by Subject|0|||
130533078|NCT01725126|469919375|FG002|Overall Study|Withdrawal by Subject|0|||
130533079|NCT01725126|469919376|FG003|Overall Study|Withdrawal by Subject|1|||
130533080|NCT01725126|469919377|FG004|Overall Study|Withdrawal by Subject|0|||
130533081|NCT01725126|469919378|FG005|Overall Study|Withdrawal by Subject|0|||
130533082|NCT00677534|469919379|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
130533083|NCT00677534|469919379|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
130533084|NCT00677534|469919379|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
130533085|NCT00863681|469919389|FG000|Overall Study|Other|2|||
130533086|NCT00863681|469919390|FG001|Overall Study|Other|0|||
130533087|NCT00863681|469919391|FG002|Overall Study|Other|0|||
130533088|NCT00863681|469919389|FG000|Overall Study|Missing|1|||
130533089|NCT00863681|469919390|FG001|Overall Study|Missing|0|||
130533090|NCT00863681|469919391|FG002|Overall Study|Missing|0|||
130533091|NCT00863681|469919389|FG000|Overall Study|Death|40|||
130533092|NCT00863681|469919390|FG001|Overall Study|Death|23|||
130533093|NCT00863681|469919391|FG002|Overall Study|Death|6|||
130533094|NCT00863681|469919389|FG000|Overall Study|Withdrawal by Subject|12|||
130533095|NCT00863681|469919390|FG001|Overall Study|Withdrawal by Subject|5|||
130533096|NCT00863681|469919391|FG002|Overall Study|Withdrawal by Subject|2|||
130533097|NCT00863681|469919389|FG000|Overall Study|Protocol Violation|2|||
130533098|NCT00863681|469919390|FG001|Overall Study|Protocol Violation|0|||
130533099|NCT00863681|469919391|FG002|Overall Study|Protocol Violation|0|||
130533100|NCT00863681|469919389|FG000|Overall Study|Lost to Follow-up|3|||
130533101|NCT00863681|469919390|FG001|Overall Study|Lost to Follow-up|0|||
130533102|NCT00863681|469919391|FG002|Overall Study|Lost to Follow-up|3|||
130533103|NCT00863681|469919389|FG000|Overall Study|Adverse Event|28|||
130533104|NCT00863681|469919390|FG001|Overall Study|Adverse Event|10|||
130533105|NCT00863681|469919391|FG002|Overall Study|Adverse Event|6|||
130533106|NCT00863681|469919389|FG000|Overall Study|Lack of Efficacy|2|||
130533107|NCT00863681|469919390|FG001|Overall Study|Lack of Efficacy|2|||
130533108|NCT00863681|469919391|FG002|Overall Study|Lack of Efficacy|1|||
130582007|NCT06272370|470095681|FG002|Overall Study|Lost to Follow-up|1|||
130582008|NCT06272370|470095682|FG003|Overall Study|Lost to Follow-up|1|||
130582009|NCT05888103|470095684|FG000|Overall Study|Participant decision|3|||
130582010|NCT05888103|470095685|FG001|Overall Study|Participant decision|3|||
130582011|NCT00352534|470095686|FG000|Initial Staging|Ineligible|8|||
130582012|NCT00352534|470095687|FG001|Initial Staging|Ineligible|9|||
130582013|NCT00352534|470095688|FG002|Initial Staging|Ineligible|0|||
130582014|NCT00352534|470095689|FG003|Initial Staging|Ineligible|0|||
130582015|NCT00352534|470095690|FG004|Initial Staging|Ineligible|0|||
130582016|NCT00352534|470095691|FG005|Initial Staging|Ineligible|0|||
130582017|NCT00352534|470095692|FG006|Initial Staging|Ineligible|0|||
130582018|NCT00352534|470095686|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
130582019|NCT00352534|470095687|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
130582020|NCT00352534|470095688|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
130582021|NCT00352534|470095689|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
130582022|NCT00352534|470095690|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
130582023|NCT00352534|470095691|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
130582024|NCT00352534|470095692|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
130582025|NCT00352534|470095686|FG000|Final Risk Group Assignment|Physician Decision|0|||
130582026|NCT00352534|470095687|FG001|Final Risk Group Assignment|Physician Decision|0|||
130582027|NCT00352534|470095688|FG002|Final Risk Group Assignment|Physician Decision|0|||
130582028|NCT00352534|470095689|FG003|Final Risk Group Assignment|Physician Decision|0|||
130582029|NCT00352534|470095690|FG004|Final Risk Group Assignment|Physician Decision|0|||
130582030|NCT00352534|470095691|FG005|Final Risk Group Assignment|Physician Decision|8|||
130582031|NCT00352534|470095692|FG006|Final Risk Group Assignment|Physician Decision|0|||
130582032|NCT00352534|470095686|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582033|NCT00352534|470095687|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582034|NCT00352534|470095688|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582035|NCT00352534|470095689|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582036|NCT00352534|470095690|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582037|NCT00352534|470095691|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
130582038|NCT00352534|470095692|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
130582039|NCT00352534|470095686|FG000|Final Risk Group Assignment|Ineligible|0|||
130582040|NCT00352534|470095687|FG001|Final Risk Group Assignment|Ineligible|0|||
130582041|NCT00352534|470095688|FG002|Final Risk Group Assignment|Ineligible|3|||
130582042|NCT00352534|470095689|FG003|Final Risk Group Assignment|Ineligible|1|||
130582043|NCT00352534|470095690|FG004|Final Risk Group Assignment|Ineligible|0|||
130582044|NCT00352534|470095691|FG005|Final Risk Group Assignment|Ineligible|13|||
130582045|NCT00352534|470095692|FG006|Final Risk Group Assignment|Ineligible|0|||
130582046|NCT00352534|470095686|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582047|NCT00352534|470095687|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582048|NCT00352534|470095688|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582049|NCT00352534|470095689|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582050|NCT00352534|470095690|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582051|NCT00352534|470095691|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130582052|NCT00352534|470095692|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
130582053|NCT00352534|470095686|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582054|NCT00352534|470095687|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582055|NCT00352534|470095688|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582056|NCT00352534|470095689|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582057|NCT00352534|470095690|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582058|NCT00352534|470095691|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130582059|NCT00352534|470095692|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
130582060|NCT00352534|470095686|FG000|Final Risk Group Assignment|Death|0|||
130582061|NCT00352534|470095687|FG001|Final Risk Group Assignment|Death|0|||
130582062|NCT00352534|470095688|FG002|Final Risk Group Assignment|Death|0|||
130582063|NCT00352534|470095689|FG003|Final Risk Group Assignment|Death|0|||
130582064|NCT00352534|470095690|FG004|Final Risk Group Assignment|Death|0|||
130582065|NCT00352534|470095691|FG005|Final Risk Group Assignment|Death|2|||
130582066|NCT00352534|470095692|FG006|Final Risk Group Assignment|Death|0|||
130582067|NCT01602341|470095693|FG000|Overall Study|Adverse Event|0|||
130582068|NCT01602341|470095694|FG001|Overall Study|Adverse Event|1|||
130582069|NCT04439279|470095695|FG000|Overall Study|Adverse Event|7|||
130582070|NCT04439279|470095695|FG000|Overall Study|Death|4|||
130582071|NCT04439279|470095695|FG000|Overall Study|Disease progression|17|||
130582072|NCT04439279|470095695|FG000|Overall Study|Complicating disease|3|||
130582073|NCT04439279|470095695|FG000|Overall Study|Withdrawal by Subject|2|||
130582074|NCT04439279|470095695|FG000|Overall Study|Ineligible|1|||
130582075|NCT04439279|470095695|FG000|Overall Study|Treatment still ongoing|1|||
130582076|NCT03521791|470095696|FG000|Overall Study|Protocol Violation|7|||
130582077|NCT03521791|470095697|FG001|Overall Study|Protocol Violation|17|||
130582078|NCT02090855|470095698|FG000|Overall Study|no evaluable Standard of Truth results|2|||
130533109|NCT00863681|469919389|FG000|Overall Study|Non-compliance with study drug|1|||
130533110|NCT00863681|469919390|FG001|Overall Study|Non-compliance with study drug|3|||
130533111|NCT00863681|469919391|FG002|Overall Study|Non-compliance with study drug|0|||
130533112|NCT03031496|469919392|FG000|Period 1|Adverse Event|2|||
130533113|NCT03031496|469919393|FG001|Period 1|Adverse Event|0|||
130533114|NCT03031496|469919392|FG000|Period 1|Withdrawal by Subject|0|||
130533115|NCT03031496|469919393|FG001|Period 1|Withdrawal by Subject|2|||
130533116|NCT02979249|469919395|FG000|Overall Study|Lost to Follow-up|2|||
130533117|NCT02979249|469919395|FG000|Overall Study|Withdrawal by Subject|4|||
130533118|NCT01125046|469919396|FG000|First 6 Months of Treatment|Death|1|||
130533119|NCT01125046|469919396|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
130533120|NCT01125046|469919396|FG000|First 6 Months of Treatment|Non-compliance|1|||
130533121|NCT01125046|469919396|FG000|First 6 Months of Treatment|Surgery|1|||
130533122|NCT01125046|469919396|FG000|First 6 Months of Treatment|Progressive Disease|7|||
130533123|NCT01125046|469919396|FG000|First 6 Months of Treatment|Adverse Event|2|||
130533124|NCT01125046|469919396|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
130533125|NCT01125046|469919396|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
130533126|NCT01125046|469919396|FG000|Follow-up/Data Cut Off Point|Death|29|||
130533127|NCT01125046|469919396|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
130533128|NCT01685229|469919398|FG000|Overall Study|Subjects missing Study Exit form|3|||
130533129|NCT01685229|469919399|FG001|Overall Study|Subjects missing Study Exit form|1|||
130533130|NCT01685229|469919398|FG000|Overall Study|Lost to Follow-up|16|||
130533131|NCT01685229|469919399|FG001|Overall Study|Lost to Follow-up|10|||
130533132|NCT01685229|469919398|FG000|Overall Study|Withdrawal by Subject|6|||
130533133|NCT01685229|469919399|FG001|Overall Study|Withdrawal by Subject|5|||
130533134|NCT01685229|469919398|FG000|Overall Study|Death|1|||
130533135|NCT01685229|469919399|FG001|Overall Study|Death|0|||
130533136|NCT00895895|469919400|FG000|Period 1|Adverse Event|7|||
130533137|NCT00895895|469919401|FG001|Period 1|Adverse Event|6|||
130533138|NCT00895895|469919402|FG002|Period 1|Adverse Event|4|||
130533139|NCT00895895|469919403|FG003|Period 1|Adverse Event|6|||
130533140|NCT00895895|469919404|FG004|Period 1|Adverse Event|7|||
130533141|NCT00895895|469919400|FG000|Period 1|Death|0|||
130533142|NCT00895895|469919401|FG001|Period 1|Death|0|||
130533143|NCT00895895|469919402|FG002|Period 1|Death|0|||
130533144|NCT00895895|469919403|FG003|Period 1|Death|0|||
130533145|NCT00895895|469919404|FG004|Period 1|Death|1|||
130533146|NCT00895895|469919400|FG000|Period 1|discontinued by sponsor|2|||
130533147|NCT00895895|469919401|FG001|Period 1|discontinued by sponsor|1|||
130533148|NCT00895895|469919402|FG002|Period 1|discontinued by sponsor|2|||
130533149|NCT00895895|469919403|FG003|Period 1|discontinued by sponsor|1|||
130533150|NCT00895895|469919404|FG004|Period 1|discontinued by sponsor|1|||
130533151|NCT00895895|469919400|FG000|Period 1|failed to return|0|||
130533152|NCT00895895|469919401|FG001|Period 1|failed to return|0|||
130533153|NCT00895895|469919402|FG002|Period 1|failed to return|1|||
130533154|NCT00895895|469919403|FG003|Period 1|failed to return|0|||
130533155|NCT00895895|469919404|FG004|Period 1|failed to return|1|||
130533156|NCT00895895|469919400|FG000|Period 1|investigator request|0|||
130533157|NCT00895895|469919401|FG001|Period 1|investigator request|1|||
130533158|NCT00895895|469919402|FG002|Period 1|investigator request|0|||
130533159|NCT00895895|469919403|FG003|Period 1|investigator request|0|||
130533160|NCT00895895|469919404|FG004|Period 1|investigator request|0|||
130533161|NCT00895895|469919400|FG000|Period 1|Lost to Follow-up|2|||
130533162|NCT00895895|469919401|FG001|Period 1|Lost to Follow-up|1|||
130533163|NCT00895895|469919402|FG002|Period 1|Lost to Follow-up|3|||
130533164|NCT00895895|469919403|FG003|Period 1|Lost to Follow-up|2|||
130533165|NCT00895895|469919404|FG004|Period 1|Lost to Follow-up|3|||
130533166|NCT00895895|469919400|FG000|Period 1|Other|1|||
130533167|NCT00895895|469919401|FG001|Period 1|Other|2|||
130533168|NCT00895895|469919402|FG002|Period 1|Other|1|||
130533169|NCT00895895|469919403|FG003|Period 1|Other|1|||
130533170|NCT00895895|469919404|FG004|Period 1|Other|1|||
130533171|NCT00895895|469919400|FG000|Period 1|Protocol Violation|0|||
130533172|NCT00895895|469919401|FG001|Period 1|Protocol Violation|1|||
130533173|NCT00895895|469919402|FG002|Period 1|Protocol Violation|0|||
130533174|NCT00895895|469919403|FG003|Period 1|Protocol Violation|0|||
130533175|NCT00895895|469919404|FG004|Period 1|Protocol Violation|0|||
130533176|NCT00895895|469919400|FG000|Period 1|Withdrawal by Subject|6|||
130533177|NCT00895895|469919401|FG001|Period 1|Withdrawal by Subject|6|||
130533178|NCT00895895|469919402|FG002|Period 1|Withdrawal by Subject|8|||
130533179|NCT00895895|469919403|FG003|Period 1|Withdrawal by Subject|2|||
130533180|NCT00895895|469919404|FG004|Period 1|Withdrawal by Subject|4|||
130533181|NCT00895895|469919400|FG000|Period 1|unsatisfactory response-efficacy|2|||
130533182|NCT00895895|469919401|FG001|Period 1|unsatisfactory response-efficacy|0|||
130533183|NCT00895895|469919402|FG002|Period 1|unsatisfactory response-efficacy|0|||
130533184|NCT00895895|469919403|FG003|Period 1|unsatisfactory response-efficacy|0|||
130533185|NCT00895895|469919404|FG004|Period 1|unsatisfactory response-efficacy|0|||
130533186|NCT00895895|469919400|FG000|Period 1|randomized and not treated|1|||
130533187|NCT00895895|469919401|FG001|Period 1|randomized and not treated|3|||
130533188|NCT00895895|469919402|FG002|Period 1|randomized and not treated|1|||
130533189|NCT00895895|469919403|FG003|Period 1|randomized and not treated|1|||
130533190|NCT00895895|469919404|FG004|Period 1|randomized and not treated|2|||
130533191|NCT00895895|469919400|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
130533192|NCT00895895|469919401|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
130533193|NCT00895895|469919402|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
130533194|NCT00895895|469919403|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
130533195|NCT00895895|469919404|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
130533196|NCT00895895|469919400|FG000|After Period 1, Prior to Period 2|Other|0|||
130533197|NCT00895895|469919401|FG001|After Period 1, Prior to Period 2|Other|0|||
130533198|NCT00895895|469919402|FG002|After Period 1, Prior to Period 2|Other|1|||
130533199|NCT00895895|469919403|FG003|After Period 1, Prior to Period 2|Other|0|||
130533200|NCT00895895|469919404|FG004|After Period 1, Prior to Period 2|Other|0|||
130533201|NCT00895895|469919400|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
130533202|NCT00895895|469919401|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
130533203|NCT00895895|469919402|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
130533204|NCT00895895|469919403|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
130533205|NCT00895895|469919404|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
130533206|NCT00895895|469919400|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
130533207|NCT00895895|469919401|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
130533208|NCT00895895|469919402|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
130533209|NCT00895895|469919403|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
130533210|NCT00895895|469919404|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
130533211|NCT00895895|469919400|FG000|Period 2|Adverse Event|3|||
130533212|NCT00895895|469919401|FG001|Period 2|Adverse Event|3|||
130533213|NCT00895895|469919402|FG002|Period 2|Adverse Event|5|||
130533214|NCT00895895|469919403|FG003|Period 2|Adverse Event|2|||
130533215|NCT00895895|469919404|FG004|Period 2|Adverse Event|5|||
130533216|NCT00895895|469919400|FG000|Period 2|Death|0|||
130533217|NCT00895895|469919401|FG001|Period 2|Death|0|||
130533218|NCT00895895|469919402|FG002|Period 2|Death|1|||
130533219|NCT00895895|469919403|FG003|Period 2|Death|0|||
130533220|NCT00895895|469919404|FG004|Period 2|Death|0|||
130533221|NCT00895895|469919400|FG000|Period 2|discontinued by sponsor|44|||
130533222|NCT00895895|469919401|FG001|Period 2|discontinued by sponsor|44|||
130533223|NCT00895895|469919402|FG002|Period 2|discontinued by sponsor|38|||
130533224|NCT00895895|469919403|FG003|Period 2|discontinued by sponsor|46|||
130533225|NCT00895895|469919404|FG004|Period 2|discontinued by sponsor|37|||
130533226|NCT00895895|469919400|FG000|Period 2|failed to return|2|||
130533227|NCT00895895|469919401|FG001|Period 2|failed to return|0|||
130533228|NCT00895895|469919402|FG002|Period 2|failed to return|0|||
130533229|NCT00895895|469919403|FG003|Period 2|failed to return|0|||
130533230|NCT00895895|469919404|FG004|Period 2|failed to return|0|||
130533231|NCT00895895|469919400|FG000|Period 2|investigator request|2|||
130533232|NCT00895895|469919401|FG001|Period 2|investigator request|0|||
130533233|NCT00895895|469919402|FG002|Period 2|investigator request|0|||
130533234|NCT00895895|469919403|FG003|Period 2|investigator request|0|||
130533235|NCT00895895|469919404|FG004|Period 2|investigator request|0|||
130533236|NCT00895895|469919400|FG000|Period 2|Lost to Follow-up|1|||
130533237|NCT00895895|469919401|FG001|Period 2|Lost to Follow-up|2|||
130533238|NCT00895895|469919402|FG002|Period 2|Lost to Follow-up|1|||
130533239|NCT00895895|469919403|FG003|Period 2|Lost to Follow-up|1|||
130533240|NCT00895895|469919404|FG004|Period 2|Lost to Follow-up|0|||
130533241|NCT00895895|469919400|FG000|Period 2|Other|1|||
130533242|NCT00895895|469919401|FG001|Period 2|Other|1|||
130533243|NCT00895895|469919402|FG002|Period 2|Other|3|||
130533244|NCT00895895|469919403|FG003|Period 2|Other|1|||
130533245|NCT00895895|469919404|FG004|Period 2|Other|1|||
130533246|NCT00895895|469919400|FG000|Period 2|Protocol Violation|1|||
130533247|NCT00895895|469919401|FG001|Period 2|Protocol Violation|0|||
130533248|NCT00895895|469919402|FG002|Period 2|Protocol Violation|1|||
130533249|NCT00895895|469919403|FG003|Period 2|Protocol Violation|1|||
130533250|NCT00895895|469919404|FG004|Period 2|Protocol Violation|1|||
130533251|NCT00895895|469919400|FG000|Period 2|Withdrawal by Subject|0|||
130582079|NCT00680836|470095700|FG000|Overall Study|Withdrawal by Subject|3|||
130582080|NCT00680836|470095701|FG001|Overall Study|Withdrawal by Subject|0|||
130582081|NCT00680836|470095700|FG000|Overall Study|Lost to Follow-up|3|||
130582082|NCT00680836|470095701|FG001|Overall Study|Lost to Follow-up|1|||
130582083|NCT00680836|470095700|FG000|Overall Study|Physician Decision|2|||
130582084|NCT00680836|470095701|FG001|Overall Study|Physician Decision|1|||
130582085|NCT03038308|470095702|FG000|Overall Study|Surgical resection|1|||
130582086|NCT03038308|470095702|FG000|Overall Study|Withdrawal by Subject|2|||
130582087|NCT03038308|470095702|FG000|Overall Study|Lost to Follow-up|1|||
130582088|NCT01777763|470095714|FG000|Overall Study|Adverse Event|2|||
130582089|NCT01777763|470095715|FG001|Overall Study|Adverse Event|32|||
130582090|NCT01777763|470095714|FG000|Overall Study|Protocol Violation|1|||
130582091|NCT01777763|470095715|FG001|Overall Study|Protocol Violation|7|||
130582092|NCT01777763|470095714|FG000|Overall Study|Withdrawal by Subject|0|||
130582093|NCT01777763|470095715|FG001|Overall Study|Withdrawal by Subject|2|||
130582094|NCT01777763|470095714|FG000|Overall Study|Treatment Failure|1|||
130582095|NCT01777763|470095715|FG001|Overall Study|Treatment Failure|6|||
130582096|NCT05512949|470095724|FG000|Overall Study|Lost to Follow-up|4|||
130582097|NCT05512949|470095725|FG001|Overall Study|Lost to Follow-up|6|||
130582098|NCT05512949|470095726|FG002|Overall Study|Lost to Follow-up|2|||
130582099|NCT05512949|470095724|FG000|Overall Study|Protocol Violation|0|||
130582100|NCT05512949|470095725|FG001|Overall Study|Protocol Violation|0|||
130582101|NCT05512949|470095726|FG002|Overall Study|Protocol Violation|1|||
130582102|NCT05512949|470095724|FG000|Overall Study|Withdrawal by Subject|1|||
130582103|NCT05512949|470095725|FG001|Overall Study|Withdrawal by Subject|1|||
130582104|NCT05512949|470095726|FG002|Overall Study|Withdrawal by Subject|2|||
130582105|NCT05512949|470095724|FG000|Overall Study|Completion status unknown|1|||
130582106|NCT05512949|470095725|FG001|Overall Study|Completion status unknown|3|||
130582107|NCT05512949|470095726|FG002|Overall Study|Completion status unknown|0|||
130582108|NCT01246206|470095727|FG000|Overall Study|Patient did not receive study regiments.|1|||
130582109|NCT00568555|470095730|FG000|Overall Study|Withdrawal by Subject|1|||
130582110|NCT00568555|470095731|FG001|Overall Study|Withdrawal by Subject|1|||
130582111|NCT00860158|470095734|FG000|Overall Study|Study Terminated|1|||
130582112|NCT00669617|470095736|FG000|Period 1|Withdrawal by Subject|0|||
130582113|NCT00669617|470095737|FG001|Period 1|Withdrawal by Subject|0|||
130582114|NCT00669617|470095738|FG002|Period 1|Withdrawal by Subject|1|||
130582115|NCT00669617|470095739|FG003|Period 1|Withdrawal by Subject|0|||
130582116|NCT00669617|470095740|FG004|Period 1|Withdrawal by Subject|0|||
130582117|NCT00669617|470095736|FG000|Period 1|Protocol Deviation|0|||
130582118|NCT00669617|470095737|FG001|Period 1|Protocol Deviation|0|||
130582119|NCT00669617|470095738|FG002|Period 1|Protocol Deviation|0|||
130582120|NCT00669617|470095739|FG003|Period 1|Protocol Deviation|0|||
130582121|NCT00669617|470095740|FG004|Period 1|Protocol Deviation|1|||
130582122|NCT00669617|470095736|FG000|Period 3|Lost to Follow-up|1|||
130582123|NCT00669617|470095737|FG001|Period 3|Lost to Follow-up|0|||
130582124|NCT00669617|470095738|FG002|Period 3|Lost to Follow-up|0|||
130582125|NCT00669617|470095739|FG003|Period 3|Lost to Follow-up|0|||
130582126|NCT00669617|470095740|FG004|Period 3|Lost to Follow-up|0|||
130582127|NCT05499520|470095741|FG000|Overall Study|Lost to Follow-up|0|||
130582128|NCT05499520|470095742|FG001|Overall Study|Lost to Follow-up|0|||
130582129|NCT05499520|470095743|FG002|Overall Study|Lost to Follow-up|38|||
130582130|NCT05499520|470095744|FG003|Overall Study|Lost to Follow-up|41|||
130582131|NCT05499520|470095745|FG004|Overall Study|Lost to Follow-up|46|||
130582132|NCT05499520|470095746|FG005|Overall Study|Lost to Follow-up|0|||
130582133|NCT05499520|470095747|FG006|Overall Study|Lost to Follow-up|31|||
130582134|NCT05499520|470095748|FG007|Overall Study|Lost to Follow-up|45|||
130582135|NCT05499520|470095749|FG008|Overall Study|Lost to Follow-up|42|||
130582136|NCT05499520|470095750|FG009|Overall Study|Lost to Follow-up|0|||
130582137|NCT05499520|470095751|FG010|Overall Study|Lost to Follow-up|0|||
130582138|NCT05499520|470095752|FG011|Overall Study|Lost to Follow-up|37|||
130582139|NCT05499520|470095753|FG012|Overall Study|Lost to Follow-up|53|||
130582140|NCT05499520|470095754|FG013|Overall Study|Lost to Follow-up|49|||
130582141|NCT05499520|470095755|FG014|Overall Study|Lost to Follow-up|0|||
130582142|NCT05499520|470095756|FG015|Overall Study|Lost to Follow-up|36|||
130582143|NCT05499520|470095757|FG016|Overall Study|Lost to Follow-up|58|||
130582144|NCT05499520|470095758|FG017|Overall Study|Lost to Follow-up|53|||
130582145|NCT02494596|470095759|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130582146|NCT02494596|470095760|FG001|Overall Study|Insufficient Therapeutic Response|3|||
130582147|NCT02494596|470095761|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130582148|NCT02494596|470095759|FG000|Overall Study|Adverse Event|0|||
130582149|NCT02494596|470095760|FG001|Overall Study|Adverse Event|1|||
130582150|NCT02494596|470095761|FG002|Overall Study|Adverse Event|0|||
130582151|NCT02494596|470095759|FG000|Overall Study|Refused Treatment|0|||
130582152|NCT02494596|470095760|FG001|Overall Study|Refused Treatment|1|||
130582153|NCT02494596|470095761|FG002|Overall Study|Refused Treatment|0|||
130582154|NCT00584194|470095762|FG000|Overall Study|Other|135|||
130582155|NCT00559273|470095764|FG000|Correction Period (20 Weeks)|Death|3|||
130582156|NCT00559273|470095765|FG001|Correction Period (20 Weeks)|Death|4|||
130582157|NCT00559273|470095764|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
130533252|NCT00895895|469919401|FG001|Period 2|Withdrawal by Subject|2|||
130533253|NCT00895895|469919402|FG002|Period 2|Withdrawal by Subject|0|||
130533254|NCT00895895|469919403|FG003|Period 2|Withdrawal by Subject|3|||
130533255|NCT00895895|469919404|FG004|Period 2|Withdrawal by Subject|5|||
130533256|NCT00895895|469919400|FG000|Period 2|unsatisfactory response-efficacy|2|||
130533257|NCT00895895|469919401|FG001|Period 2|unsatisfactory response-efficacy|1|||
130533258|NCT00895895|469919402|FG002|Period 2|unsatisfactory response-efficacy|0|||
130533259|NCT00895895|469919403|FG003|Period 2|unsatisfactory response-efficacy|0|||
130533260|NCT00895895|469919404|FG004|Period 2|unsatisfactory response-efficacy|0|||
130533261|NCT00820170|469919407|FG000|Overall Study|Adverse Event|0|||
130533262|NCT00820170|469919408|FG001|Overall Study|Adverse Event|0|||
130533263|NCT00820170|469919409|FG002|Overall Study|Adverse Event|0|||
130533264|NCT00820170|469919410|FG003|Overall Study|Adverse Event|0|||
130533265|NCT00820170|469919411|FG004|Overall Study|Adverse Event|2|||
130533266|NCT00820170|469919407|FG000|Overall Study|Progressive Disease|0|||
130533267|NCT00820170|469919408|FG001|Overall Study|Progressive Disease|0|||
130533268|NCT00820170|469919409|FG002|Overall Study|Progressive Disease|0|||
130533269|NCT00820170|469919410|FG003|Overall Study|Progressive Disease|0|||
130533270|NCT00820170|469919411|FG004|Overall Study|Progressive Disease|2|||
130533271|NCT03682185|469919414|FG000|Overall Study|Lost to Follow-up|4|||
130533272|NCT03682185|469919415|FG001|Overall Study|Lost to Follow-up|7|||
130533273|NCT03682185|469919416|FG002|Overall Study|Lost to Follow-up|4|||
130533274|NCT03682185|469919417|FG003|Overall Study|Lost to Follow-up|7|||
130533275|NCT03682185|469919418|FG004|Overall Study|Lost to Follow-up|1|||
130533276|NCT03682185|469919414|FG000|Overall Study|Withdrawal by Subject|7|||
130533277|NCT03682185|469919415|FG001|Overall Study|Withdrawal by Subject|3|||
130533278|NCT03682185|469919416|FG002|Overall Study|Withdrawal by Subject|7|||
130533279|NCT03682185|469919417|FG003|Overall Study|Withdrawal by Subject|3|||
130533280|NCT03682185|469919418|FG004|Overall Study|Withdrawal by Subject|0|||
130533281|NCT04908631|469919419|FG000|Overall Study|Lost to Follow-up|1|||
130533282|NCT04908631|469919419|FG000|Overall Study|Physician Decision|1|||
130533283|NCT04908631|469919419|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
130533284|NCT02284009|469919420|FG000|Overall Study|Adverse Event|3|||
130533285|NCT02284009|469919421|FG001|Overall Study|Adverse Event|0|||
130533286|NCT02284009|469919420|FG000|Overall Study|Lost to Follow-up|1|||
130533287|NCT02284009|469919421|FG001|Overall Study|Lost to Follow-up|3|||
130533288|NCT02284009|469919420|FG000|Overall Study|Physician Decision|0|||
130533289|NCT02284009|469919421|FG001|Overall Study|Physician Decision|2|||
130533290|NCT02284009|469919420|FG000|Overall Study|Withdrawal by Subject|2|||
130533291|NCT02284009|469919421|FG001|Overall Study|Withdrawal by Subject|5|||
130533292|NCT04047862|469919434|FG000|Overall Study|Death|0|||
130533293|NCT04047862|469919435|FG001|Overall Study|Death|0|||
130533294|NCT04047862|469919436|FG002|Overall Study|Death|4|||
130533295|NCT04047862|469919437|FG003|Overall Study|Death|7|||
130533296|NCT04047862|469919438|FG004|Overall Study|Death|2|||
130533297|NCT04047862|469919439|FG005|Overall Study|Death|4|||
130533298|NCT04047862|469919440|FG006|Overall Study|Death|3|||
130533299|NCT04047862|469919441|FG007|Overall Study|Death|24|||
130533300|NCT04047862|469919442|FG008|Overall Study|Death|24|||
130533301|NCT04047862|469919443|FG009|Overall Study|Death|22|||
130533302|NCT04047862|469919444|FG010|Overall Study|Death|35|||
130533303|NCT04047862|469919445|FG011|Overall Study|Death|18|||
130533304|NCT04047862|469919446|FG012|Overall Study|Death|14|||
130533305|NCT04047862|469919447|FG013|Overall Study|Death|6|||
130533306|NCT04047862|469919448|FG014|Overall Study|Death|19|||
130533307|NCT04047862|469919449|FG015|Overall Study|Death|42|||
130533308|NCT04047862|469919450|FG016|Overall Study|Death|9|||
130533309|NCT04047862|469919451|FG017|Overall Study|Death|8|||
130533310|NCT04047862|469919452|FG018|Overall Study|Death|10|||
130533311|NCT04047862|469919434|FG000|Overall Study|Withdrawal by Subject|0|||
130533312|NCT04047862|469919435|FG001|Overall Study|Withdrawal by Subject|0|||
130533313|NCT04047862|469919436|FG002|Overall Study|Withdrawal by Subject|0|||
130533314|NCT04047862|469919437|FG003|Overall Study|Withdrawal by Subject|5|||
130533315|NCT04047862|469919438|FG004|Overall Study|Withdrawal by Subject|2|||
130533316|NCT04047862|469919439|FG005|Overall Study|Withdrawal by Subject|0|||
130533317|NCT04047862|469919440|FG006|Overall Study|Withdrawal by Subject|1|||
130533318|NCT04047862|469919441|FG007|Overall Study|Withdrawal by Subject|0|||
130533319|NCT04047862|469919442|FG008|Overall Study|Withdrawal by Subject|4|||
130533320|NCT04047862|469919443|FG009|Overall Study|Withdrawal by Subject|4|||
130533321|NCT04047862|469919444|FG010|Overall Study|Withdrawal by Subject|4|||
130533322|NCT04047862|469919445|FG011|Overall Study|Withdrawal by Subject|2|||
130533323|NCT04047862|469919446|FG012|Overall Study|Withdrawal by Subject|3|||
130533324|NCT04047862|469919447|FG013|Overall Study|Withdrawal by Subject|0|||
130533325|NCT04047862|469919448|FG014|Overall Study|Withdrawal by Subject|9|||
130533326|NCT04047862|469919449|FG015|Overall Study|Withdrawal by Subject|5|||
130533327|NCT04047862|469919450|FG016|Overall Study|Withdrawal by Subject|1|||
130533328|NCT04047862|469919451|FG017|Overall Study|Withdrawal by Subject|3|||
130533329|NCT04047862|469919452|FG018|Overall Study|Withdrawal by Subject|1|||
130533330|NCT04047862|469919434|FG000|Overall Study|Lost to Follow-up|0|||
130533331|NCT04047862|469919435|FG001|Overall Study|Lost to Follow-up|0|||
130582158|NCT00559273|470095765|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
130582159|NCT00559273|470095764|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
130582160|NCT00559273|470095765|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
130582161|NCT00559273|470095764|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
130582162|NCT00559273|470095765|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
130582163|NCT00559273|470095764|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
130582164|NCT00559273|470095765|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
130582165|NCT00559273|470095764|FG000|Evaluation Period (8 Weeks)|Death|1|||
130582166|NCT00559273|470095765|FG001|Evaluation Period (8 Weeks)|Death|3|||
130582167|NCT00559273|470095764|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
130582168|NCT00559273|470095765|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
130582169|NCT00559273|470095764|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
130582170|NCT00559273|470095765|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
130582171|NCT00559273|470095764|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
130582172|NCT00559273|470095765|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
130582173|NCT00395967|470095766|FG000|Treatment Period|Failed Mobilization|1|||
130582174|NCT00395967|470095766|FG000|Follow-up Period|Death|1|||
130582175|NCT00395967|470095766|FG000|Follow-up Period|Lost to Follow-up|1|||
130582176|NCT03118947|470095768|FG000|Overall Study|Adverse Event|7|||
130582177|NCT03118947|470095768|FG000|Overall Study|Death|3|||
130582178|NCT03118947|470095768|FG000|Overall Study|Lack of Efficacy|4|||
130582179|NCT03118947|470095768|FG000|Overall Study|Non-compliance with study drug|1|||
130582180|NCT03118947|470095768|FG000|Overall Study|Protocol Violation|2|||
130582181|NCT03118947|470095768|FG000|Overall Study|Withdrawal by Subject|3|||
130582182|NCT03118947|470095768|FG000|Overall Study|Withdrawal by caregiver|3|||
130582183|NCT03118947|470095768|FG000|Overall Study|Change in patient's living situation|4|||
130582184|NCT03118947|470095768|FG000|Overall Study|Lost to Follow-up|2|||
130582185|NCT00189462|470095771|FG000|Overall Study|Lack of Efficacy|5|||
130582186|NCT00189462|470095772|FG001|Overall Study|Lack of Efficacy|1|||
130582187|NCT00189462|470095771|FG000|Overall Study|Lost to Follow-up|18|||
130582188|NCT00189462|470095772|FG001|Overall Study|Lost to Follow-up|20|||
130582189|NCT00448708|470095773|FG000|Overall Study|Death|21|||
130582190|NCT00448708|470095774|FG001|Overall Study|Death|17|||
130582191|NCT00448708|470095773|FG000|Overall Study|Withdrawal by Subject|8|||
130582192|NCT00448708|470095774|FG001|Overall Study|Withdrawal by Subject|4|||
130582193|NCT00448708|470095773|FG000|Overall Study|Lost to Follow-up|6|||
130582194|NCT00448708|470095774|FG001|Overall Study|Lost to Follow-up|8|||
130582195|NCT00448708|470095773|FG000|Overall Study|not listed|0|||
130582196|NCT00448708|470095774|FG001|Overall Study|not listed|2|||
130582197|NCT02400255|470095776|FG000|Overall Study|Relapse|4|||
130582198|NCT02400255|470095777|FG001|Overall Study|Relapse|1|||
130582199|NCT02400255|470095778|FG002|Overall Study|Relapse|1|||
130582200|NCT02400255|470095779|FG003|Overall Study|Relapse|2|||
130582201|NCT02400255|470095776|FG000|Overall Study|Adverse Event|6|||
130582202|NCT02400255|470095777|FG001|Overall Study|Adverse Event|3|||
130582203|NCT02400255|470095778|FG002|Overall Study|Adverse Event|0|||
130582204|NCT02400255|470095779|FG003|Overall Study|Adverse Event|0|||
130582205|NCT02400255|470095776|FG000|Overall Study|Physician Decision|6|||
130582206|NCT02400255|470095777|FG001|Overall Study|Physician Decision|0|||
130582207|NCT02400255|470095778|FG002|Overall Study|Physician Decision|0|||
130582208|NCT02400255|470095779|FG003|Overall Study|Physician Decision|0|||
130582209|NCT02400255|470095776|FG000|Overall Study|Loss of insurance|1|||
130582210|NCT02400255|470095777|FG001|Overall Study|Loss of insurance|0|||
130582211|NCT02400255|470095778|FG002|Overall Study|Loss of insurance|0|||
130582212|NCT02400255|470095779|FG003|Overall Study|Loss of insurance|0|||
130582213|NCT01961544|470095780|FG000|Overall Study|Protocol Violation|1|||
130582214|NCT01961544|470095780|FG000|Overall Study|Withdrawal by Subject|7|||
130582215|NCT01961544|470095780|FG000|Overall Study|Adverse Event|1|||
130582216|NCT01961544|470095780|FG000|Overall Study|Physician Decision|2|||
130582217|NCT01961544|470095780|FG000|Overall Study|Poor Tolerance|1|||
130582218|NCT01961544|470095780|FG000|Overall Study|Aggravation of Steral Pain|1|||
130582219|NCT03665285|470095781|FG000|Overall Study|Started New Anticancer Treatment|1|||
130582220|NCT03665285|470095782|FG001|Overall Study|Started New Anticancer Treatment|1|||
130582221|NCT03665285|470095783|FG002|Overall Study|Started New Anticancer Treatment|2|||
130582222|NCT03665285|470095784|FG003|Overall Study|Started New Anticancer Treatment|4|||
130582223|NCT03665285|470095785|FG004|Overall Study|Started New Anticancer Treatment|1|||
130582224|NCT03665285|470095786|FG005|Overall Study|Started New Anticancer Treatment|1|||
130582225|NCT03665285|470095787|FG006|Overall Study|Started New Anticancer Treatment|2|||
130582226|NCT03665285|470095788|FG007|Overall Study|Started New Anticancer Treatment|15|||
130582227|NCT03665285|470095789|FG008|Overall Study|Started New Anticancer Treatment|1|||
130582228|NCT03665285|470095781|FG000|Overall Study|Disease Progression|0|||
130582229|NCT03665285|470095782|FG001|Overall Study|Disease Progression|0|||
130582230|NCT03665285|470095783|FG002|Overall Study|Disease Progression|3|||
130582231|NCT03665285|470095784|FG003|Overall Study|Disease Progression|1|||
130582232|NCT03665285|470095785|FG004|Overall Study|Disease Progression|0|||
130582233|NCT03665285|470095786|FG005|Overall Study|Disease Progression|0|||
130582234|NCT03665285|470095787|FG006|Overall Study|Disease Progression|0|||
130582235|NCT03665285|470095788|FG007|Overall Study|Disease Progression|7|||
130582236|NCT03665285|470095789|FG008|Overall Study|Disease Progression|1|||
130582237|NCT03665285|470095781|FG000|Overall Study|Hospice|0|||
130582238|NCT03665285|470095782|FG001|Overall Study|Hospice|0|||
130582239|NCT03665285|470095783|FG002|Overall Study|Hospice|0|||
130582240|NCT03665285|470095784|FG003|Overall Study|Hospice|0|||
130582241|NCT03665285|470095785|FG004|Overall Study|Hospice|0|||
130582242|NCT03665285|470095786|FG005|Overall Study|Hospice|0|||
130582243|NCT03665285|470095787|FG006|Overall Study|Hospice|0|||
130582244|NCT03665285|470095788|FG007|Overall Study|Hospice|2|||
130533332|NCT04047862|469919436|FG002|Overall Study|Lost to Follow-up|1|||
130533333|NCT04047862|469919437|FG003|Overall Study|Lost to Follow-up|0|||
130582245|NCT03665285|470095789|FG008|Overall Study|Hospice|0|||
130582246|NCT03665285|470095781|FG000|Overall Study|Withdrawal by Subject|0|||
130582247|NCT03665285|470095782|FG001|Overall Study|Withdrawal by Subject|0|||
130582248|NCT03665285|470095783|FG002|Overall Study|Withdrawal by Subject|0|||
130582249|NCT03665285|470095784|FG003|Overall Study|Withdrawal by Subject|0|||
130582250|NCT03665285|470095785|FG004|Overall Study|Withdrawal by Subject|1|||
130582251|NCT03665285|470095786|FG005|Overall Study|Withdrawal by Subject|0|||
130582252|NCT03665285|470095787|FG006|Overall Study|Withdrawal by Subject|0|||
130582253|NCT03665285|470095788|FG007|Overall Study|Withdrawal by Subject|2|||
130582254|NCT03665285|470095789|FG008|Overall Study|Withdrawal by Subject|0|||
130533334|NCT04047862|469919438|FG004|Overall Study|Lost to Follow-up|0|||
130533335|NCT04047862|469919439|FG005|Overall Study|Lost to Follow-up|0|||
130533336|NCT04047862|469919440|FG006|Overall Study|Lost to Follow-up|0|||
130533337|NCT04047862|469919441|FG007|Overall Study|Lost to Follow-up|1|||
130533338|NCT04047862|469919442|FG008|Overall Study|Lost to Follow-up|0|||
130533339|NCT04047862|469919443|FG009|Overall Study|Lost to Follow-up|1|||
130533340|NCT04047862|469919444|FG010|Overall Study|Lost to Follow-up|0|||
130533341|NCT04047862|469919445|FG011|Overall Study|Lost to Follow-up|3|||
130533342|NCT04047862|469919446|FG012|Overall Study|Lost to Follow-up|0|||
130533343|NCT04047862|469919447|FG013|Overall Study|Lost to Follow-up|0|||
130533344|NCT04047862|469919448|FG014|Overall Study|Lost to Follow-up|2|||
130533345|NCT04047862|469919449|FG015|Overall Study|Lost to Follow-up|2|||
130533346|NCT04047862|469919450|FG016|Overall Study|Lost to Follow-up|1|||
130533347|NCT04047862|469919451|FG017|Overall Study|Lost to Follow-up|0|||
130533348|NCT04047862|469919452|FG018|Overall Study|Lost to Follow-up|0|||
130533349|NCT04047862|469919434|FG000|Overall Study|Physician Decision|0|||
130533350|NCT04047862|469919435|FG001|Overall Study|Physician Decision|0|||
130533351|NCT04047862|469919436|FG002|Overall Study|Physician Decision|0|||
130533352|NCT04047862|469919437|FG003|Overall Study|Physician Decision|1|||
130533353|NCT04047862|469919438|FG004|Overall Study|Physician Decision|0|||
130533354|NCT04047862|469919439|FG005|Overall Study|Physician Decision|0|||
130533355|NCT04047862|469919440|FG006|Overall Study|Physician Decision|0|||
130533356|NCT04047862|469919441|FG007|Overall Study|Physician Decision|0|||
130533357|NCT04047862|469919442|FG008|Overall Study|Physician Decision|0|||
130533358|NCT04047862|469919443|FG009|Overall Study|Physician Decision|0|||
130533359|NCT04047862|469919444|FG010|Overall Study|Physician Decision|0|||
130533360|NCT04047862|469919445|FG011|Overall Study|Physician Decision|0|||
130533361|NCT04047862|469919446|FG012|Overall Study|Physician Decision|0|||
130533362|NCT04047862|469919447|FG013|Overall Study|Physician Decision|0|||
130533363|NCT04047862|469919448|FG014|Overall Study|Physician Decision|1|||
130533364|NCT04047862|469919449|FG015|Overall Study|Physician Decision|0|||
130533365|NCT04047862|469919450|FG016|Overall Study|Physician Decision|1|||
130582255|NCT03665285|470095781|FG000|Overall Study|Physician Decision|0|||
130582256|NCT03665285|470095782|FG001|Overall Study|Physician Decision|0|||
130582257|NCT03665285|470095783|FG002|Overall Study|Physician Decision|0|||
130582258|NCT03665285|470095784|FG003|Overall Study|Physician Decision|0|||
130582259|NCT03665285|470095785|FG004|Overall Study|Physician Decision|0|||
130582260|NCT03665285|470095786|FG005|Overall Study|Physician Decision|0|||
130533366|NCT04047862|469919451|FG017|Overall Study|Physician Decision|0|||
130533367|NCT04047862|469919452|FG018|Overall Study|Physician Decision|0|||
130533368|NCT04047862|469919434|FG000|Overall Study|Completed all Assessments|1|||
130533369|NCT04047862|469919435|FG001|Overall Study|Completed all Assessments|3|||
130533370|NCT04047862|469919436|FG002|Overall Study|Completed all Assessments|1|||
130582261|NCT03665285|470095787|FG006|Overall Study|Physician Decision|0|||
130582262|NCT03665285|470095788|FG007|Overall Study|Physician Decision|2|||
130533371|NCT04047862|469919437|FG003|Overall Study|Completed all Assessments|3|||
130533372|NCT04047862|469919438|FG004|Overall Study|Completed all Assessments|2|||
130533373|NCT04047862|469919439|FG005|Overall Study|Completed all Assessments|5|||
130533374|NCT04047862|469919440|FG006|Overall Study|Completed all Assessments|7|||
130582263|NCT03665285|470095789|FG008|Overall Study|Physician Decision|0|||
130582264|NCT00354601|470095790|FG000|Overall Study|Protocol Violation|1|||
130582265|NCT00354601|470095790|FG000|Overall Study|progression|1|||
130582266|NCT03603652|470095791|FG000|Overall Study|Death|2|||
130582267|NCT03213366|470095796|FG000|Overall Study|Lost to Follow-up|9|||
130582268|NCT03213366|470095797|FG001|Overall Study|Lost to Follow-up|4|||
130533375|NCT04047862|469919441|FG007|Overall Study|Completed all Assessments|0|||
130582269|NCT02532855|470095798|FG000|Overall Study|Lost to Follow-up|4|||
130582270|NCT02532855|470095799|FG001|Overall Study|Lost to Follow-up|3|||
130582271|NCT02532855|470095798|FG000|Overall Study|Withdrawal by Subject|4|||
130582272|NCT02532855|470095799|FG001|Overall Study|Withdrawal by Subject|8|||
130582273|NCT01727258|470095800|FG000|Overall Study|Adverse Event|0|||
130582274|NCT01727258|470095801|FG001|Overall Study|Adverse Event|2|||
130582275|NCT01727258|470095802|FG002|Overall Study|Adverse Event|0|||
130582276|NCT01727258|470095800|FG000|Overall Study|Noncompliance with Study Drug|0|||
130582277|NCT01727258|470095801|FG001|Overall Study|Noncompliance with Study Drug|0|||
130582278|NCT01727258|470095802|FG002|Overall Study|Noncompliance with Study Drug|1|||
130582279|NCT01727258|470095800|FG000|Overall Study|Withdrawal by Subject|1|||
130582280|NCT01727258|470095801|FG001|Overall Study|Withdrawal by Subject|1|||
130582281|NCT01727258|470095802|FG002|Overall Study|Withdrawal by Subject|0|||
130582282|NCT01727258|470095800|FG000|Overall Study|Lost to Follow-up|1|||
130582283|NCT01727258|470095801|FG001|Overall Study|Lost to Follow-up|0|||
130582284|NCT01727258|470095802|FG002|Overall Study|Lost to Follow-up|0|||
130582285|NCT01960855|470095803|FG000|Overall Study|Subject noncompliant|1|||
130582286|NCT01960855|470095804|FG001|Overall Study|Subject noncompliant|0|||
130582287|NCT01960855|470095805|FG002|Overall Study|Subject noncompliant|0|||
130582288|NCT01960855|470095806|FG003|Overall Study|Subject noncompliant|0|||
130582289|NCT01960855|470095807|FG004|Overall Study|Subject noncompliant|0|||
130582290|NCT01960855|470095803|FG000|Overall Study|Adverse Event|2|||
130582291|NCT01960855|470095804|FG001|Overall Study|Adverse Event|0|||
130582292|NCT01960855|470095805|FG002|Overall Study|Adverse Event|6|||
130582293|NCT01960855|470095806|FG003|Overall Study|Adverse Event|2|||
130582294|NCT01960855|470095807|FG004|Overall Study|Adverse Event|2|||
130582295|NCT01960855|470095803|FG000|Overall Study|Lack of Efficacy|1|||
130582296|NCT01960855|470095804|FG001|Overall Study|Lack of Efficacy|1|||
130582297|NCT01960855|470095805|FG002|Overall Study|Lack of Efficacy|0|||
130582298|NCT01960855|470095806|FG003|Overall Study|Lack of Efficacy|0|||
130533376|NCT04047862|469919442|FG008|Overall Study|Completed all Assessments|0|||
130533377|NCT04047862|469919443|FG009|Overall Study|Completed all Assessments|0|||
130533378|NCT04047862|469919444|FG010|Overall Study|Completed all Assessments|0|||
130533379|NCT04047862|469919445|FG011|Overall Study|Completed all Assessments|0|||
130533380|NCT04047862|469919446|FG012|Overall Study|Completed all Assessments|0|||
130533381|NCT04047862|469919447|FG013|Overall Study|Completed all Assessments|0|||
130533382|NCT04047862|469919448|FG014|Overall Study|Completed all Assessments|0|||
130533383|NCT04047862|469919449|FG015|Overall Study|Completed all Assessments|0|||
130533384|NCT04047862|469919450|FG016|Overall Study|Completed all Assessments|0|||
130533385|NCT04047862|469919451|FG017|Overall Study|Completed all Assessments|0|||
130533386|NCT04047862|469919452|FG018|Overall Study|Completed all Assessments|0|||
130533387|NCT04047862|469919434|FG000|Overall Study|Sponsor Decision|0|||
130533388|NCT04047862|469919435|FG001|Overall Study|Sponsor Decision|0|||
130533389|NCT04047862|469919436|FG002|Overall Study|Sponsor Decision|0|||
130533390|NCT04047862|469919437|FG003|Overall Study|Sponsor Decision|0|||
130533391|NCT04047862|469919438|FG004|Overall Study|Sponsor Decision|0|||
130533392|NCT04047862|469919439|FG005|Overall Study|Sponsor Decision|0|||
130533393|NCT04047862|469919440|FG006|Overall Study|Sponsor Decision|0|||
130533394|NCT04047862|469919441|FG007|Overall Study|Sponsor Decision|13|||
130533395|NCT04047862|469919442|FG008|Overall Study|Sponsor Decision|10|||
130533396|NCT04047862|469919443|FG009|Overall Study|Sponsor Decision|18|||
130533397|NCT04047862|469919444|FG010|Overall Study|Sponsor Decision|3|||
130533398|NCT04047862|469919445|FG011|Overall Study|Sponsor Decision|3|||
130533399|NCT04047862|469919446|FG012|Overall Study|Sponsor Decision|4|||
130533400|NCT04047862|469919447|FG013|Overall Study|Sponsor Decision|0|||
130533401|NCT04047862|469919448|FG014|Overall Study|Sponsor Decision|7|||
130533402|NCT04047862|469919449|FG015|Overall Study|Sponsor Decision|8|||
130533403|NCT04047862|469919450|FG016|Overall Study|Sponsor Decision|9|||
130533404|NCT04047862|469919451|FG017|Overall Study|Sponsor Decision|7|||
130533405|NCT04047862|469919452|FG018|Overall Study|Sponsor Decision|8|||
130533406|NCT04047862|469919434|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533407|NCT04047862|469919435|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533408|NCT04047862|469919436|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533409|NCT04047862|469919437|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533410|NCT04047862|469919438|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533411|NCT04047862|469919439|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533412|NCT04047862|469919440|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533413|NCT04047862|469919441|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
130533414|NCT04047862|469919442|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
130533415|NCT04047862|469919443|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533416|NCT04047862|469919444|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
130582299|NCT01960855|470095807|FG004|Overall Study|Lack of Efficacy|0|||
130533417|NCT04047862|469919445|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533418|NCT04047862|469919446|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533419|NCT04047862|469919447|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130533420|NCT04047862|469919448|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
130533421|NCT04047862|469919449|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
130533422|NCT04047862|469919450|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
130533423|NCT04047862|469919451|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
130533424|NCT04047862|469919452|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
130533425|NCT04047862|469919434|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533426|NCT04047862|469919435|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533427|NCT04047862|469919436|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533428|NCT04047862|469919437|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533429|NCT04047862|469919438|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533430|NCT04047862|469919439|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533431|NCT04047862|469919440|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533432|NCT04047862|469919441|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533433|NCT04047862|469919442|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533434|NCT04047862|469919443|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533435|NCT04047862|469919444|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533436|NCT04047862|469919445|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533437|NCT04047862|469919446|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533438|NCT04047862|469919447|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533439|NCT04047862|469919448|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533440|NCT04047862|469919449|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
130533441|NCT04047862|469919450|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533442|NCT04047862|469919451|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130533443|NCT04047862|469919452|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
130533444|NCT04047862|469919434|FG000|Overall Study|Other|0|||
130533445|NCT04047862|469919435|FG001|Overall Study|Other|0|||
130533446|NCT04047862|469919436|FG002|Overall Study|Other|0|||
130533447|NCT04047862|469919437|FG003|Overall Study|Other|0|||
130533448|NCT04047862|469919438|FG004|Overall Study|Other|0|||
130533449|NCT04047862|469919439|FG005|Overall Study|Other|0|||
130533450|NCT04047862|469919440|FG006|Overall Study|Other|0|||
130533451|NCT04047862|469919441|FG007|Overall Study|Other|0|||
130533452|NCT04047862|469919442|FG008|Overall Study|Other|0|||
130533453|NCT04047862|469919443|FG009|Overall Study|Other|0|||
130533454|NCT04047862|469919444|FG010|Overall Study|Other|0|||
130533455|NCT04047862|469919445|FG011|Overall Study|Other|0|||
130533456|NCT04047862|469919446|FG012|Overall Study|Other|0|||
130533457|NCT04047862|469919447|FG013|Overall Study|Other|0|||
130533458|NCT04047862|469919448|FG014|Overall Study|Other|2|||
130533459|NCT04047862|469919449|FG015|Overall Study|Other|1|||
130533460|NCT04047862|469919450|FG016|Overall Study|Other|1|||
130533461|NCT04047862|469919451|FG017|Overall Study|Other|1|||
130533462|NCT04047862|469919452|FG018|Overall Study|Other|0|||
130533463|NCT01876082|469920930|FG000|Overall Study|Withdrawal by Subject|0|||
130533464|NCT01876082|469920931|FG001|Overall Study|Withdrawal by Subject|2|||
130533465|NCT01876082|469920930|FG000|Overall Study|Protocol Violation|1|||
130533466|NCT01876082|469920931|FG001|Overall Study|Protocol Violation|0|||
130533467|NCT01876082|469920930|FG000|Overall Study|Adverse Event|1|||
130533468|NCT01876082|469920931|FG001|Overall Study|Adverse Event|1|||
130533469|NCT01876082|469920930|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
130533470|NCT01876082|469920931|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
130533471|NCT00626197|469920937|FG000|Overall Study|Did not cooperate|2|||
130533472|NCT00626197|469920938|FG001|Overall Study|Did not cooperate|6|||
130533473|NCT00626197|469920939|FG002|Overall Study|Did not cooperate|1|||
130533474|NCT00626197|469920937|FG000|Overall Study|Failure to return|6|||
130533475|NCT00626197|469920938|FG001|Overall Study|Failure to return|5|||
130533476|NCT00626197|469920939|FG002|Overall Study|Failure to return|6|||
130533477|NCT00626197|469920937|FG000|Overall Study|Adverse event, serious fatal|3|||
130533478|NCT00626197|469920938|FG001|Overall Study|Adverse event, serious fatal|6|||
130533479|NCT00626197|469920939|FG002|Overall Study|Adverse event, serious fatal|6|||
130533480|NCT00626197|469920937|FG000|Overall Study|Adverse Event|1|||
130533481|NCT00626197|469920938|FG001|Overall Study|Adverse Event|1|||
130533482|NCT00626197|469920939|FG002|Overall Study|Adverse Event|2|||
130533483|NCT00626197|469920937|FG000|Overall Study|Withdrawal by Subject|17|||
130533484|NCT00626197|469920938|FG001|Overall Study|Withdrawal by Subject|17|||
130533485|NCT00626197|469920939|FG002|Overall Study|Withdrawal by Subject|7|||
130533486|NCT00626197|469920937|FG000|Overall Study|Administrative reasons|15|||
130533487|NCT00626197|469920938|FG001|Overall Study|Administrative reasons|19|||
130533488|NCT00626197|469920939|FG002|Overall Study|Administrative reasons|55|||
130533489|NCT04833127|469920940|FG000|Overall Study|Lost to Follow-up|1|||
130533490|NCT04833127|469920941|FG001|Overall Study|Lost to Follow-up|1|||
130533491|NCT00461981|469920947|FG000|Overall Study|Lost to Follow-up|9|||
130533492|NCT00461981|469920948|FG001|Overall Study|Lost to Follow-up|6|||
130533493|NCT00461981|469920947|FG000|Overall Study|Withdrawal by Subject|2|||
130533494|NCT00461981|469920948|FG001|Overall Study|Withdrawal by Subject|3|||
130533495|NCT03301155|469920952|FG000|Overall Study|Сompliance with exclusion criteria|8|||
130533496|NCT03301155|469920953|FG001|Overall Study|Сompliance with exclusion criteria|7|||
130533497|NCT00731133|469920954|FG000|Overall Study|Withdrawal by Subject|10|||
130533498|NCT03510455|469920955|FG000|Overall Study|Physician Decision|1|||
130533499|NCT00384189|469920956|FG000|Overall Study|Reason Not Specified|50|||
130533500|NCT00384189|469920957|FG001|Overall Study|Reason Not Specified|57|||
130533501|NCT00384189|469920958|FG002|Overall Study|Reason Not Specified|58|||
130533502|NCT00384189|469920959|FG003|Overall Study|Reason Not Specified|40|||
130533503|NCT04958642|469920960|FG000|Overall Study|Transferred to OLEX program|3|||
130533504|NCT04958642|469920961|FG001|Overall Study|Transferred to OLEX program|0|||
130533505|NCT04958642|469920962|FG002|Overall Study|Transferred to OLEX program|5|||
130533506|NCT04958642|469920960|FG000|Overall Study|Death|0|||
130533507|NCT04958642|469920961|FG001|Overall Study|Death|0|||
130533508|NCT04958642|469920962|FG002|Overall Study|Death|1|||
130533509|NCT04958642|469920960|FG000|Overall Study|Withdrawal by Subject|4|||
130533510|NCT04958642|469920961|FG001|Overall Study|Withdrawal by Subject|9|||
130533511|NCT04958642|469920962|FG002|Overall Study|Withdrawal by Subject|13|||
130533512|NCT04958642|469920960|FG000|Overall Study|Investigator's Decision|0|||
130533513|NCT04958642|469920961|FG001|Overall Study|Investigator's Decision|0|||
130533514|NCT04958642|469920962|FG002|Overall Study|Investigator's Decision|1|||
130533515|NCT04958642|469920960|FG000|Overall Study|Adverse Event|1|||
130533516|NCT04958642|469920961|FG001|Overall Study|Adverse Event|0|||
130533517|NCT04958642|469920962|FG002|Overall Study|Adverse Event|1|||
130533518|NCT04958642|469920960|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
130533519|NCT04958642|469920961|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
130533520|NCT04958642|469920962|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
130533521|NCT04958642|469920960|FG000|Overall Study|Lost to Follow-up|1|||
130533522|NCT04958642|469920961|FG001|Overall Study|Lost to Follow-up|0|||
130533523|NCT04958642|469920962|FG002|Overall Study|Lost to Follow-up|0|||
130533524|NCT04958642|469920960|FG000|Overall Study|Transferred to EAP following study termination|0|||
130533525|NCT04958642|469920961|FG001|Overall Study|Transferred to EAP following study termination|0|||
130533526|NCT04958642|469920962|FG002|Overall Study|Transferred to EAP following study termination|1|||
130533527|NCT04958642|469920960|FG000|Overall Study|Transferred to Expanded Access Program|1|||
130533528|NCT04958642|469920961|FG001|Overall Study|Transferred to Expanded Access Program|0|||
130533529|NCT04958642|469920962|FG002|Overall Study|Transferred to Expanded Access Program|0|||
130533530|NCT02476175|469920966|FG000|Overall Study|Adverse Event|2|||
130533531|NCT03868787|469920971|FG000|Overall Study|Withdrawal by Subject|2|||
130533532|NCT03868787|469920972|FG001|Overall Study|Withdrawal by Subject|1|||
130533533|NCT01399697|469920985|FG000|Overall Study|Adverse Event|13|||
130533534|NCT01399697|469920986|FG001|Overall Study|Adverse Event|3|||
130533535|NCT01399697|469920987|FG002|Overall Study|Adverse Event|1|||
130533536|NCT01399697|469920985|FG000|Overall Study|Lost to Follow-up|2|||
130533537|NCT01399697|469920986|FG001|Overall Study|Lost to Follow-up|0|||
130533538|NCT01399697|469920987|FG002|Overall Study|Lost to Follow-up|0|||
130533539|NCT01399697|469920985|FG000|Overall Study|Withdrawal by Subject|8|||
130533540|NCT01399697|469920986|FG001|Overall Study|Withdrawal by Subject|0|||
130533541|NCT01399697|469920987|FG002|Overall Study|Withdrawal by Subject|0|||
130533542|NCT01399697|469920985|FG000|Overall Study|Investigator Decisión|1|||
130533543|NCT01399697|469920986|FG001|Overall Study|Investigator Decisión|0|||
130533544|NCT01399697|469920987|FG002|Overall Study|Investigator Decisión|2|||
130533545|NCT01399697|469920985|FG000|Overall Study|Lack of Efficacy|9|||
130533546|NCT01399697|469920986|FG001|Overall Study|Lack of Efficacy|0|||
130533547|NCT01399697|469920987|FG002|Overall Study|Lack of Efficacy|1|||
130533548|NCT01399697|469920985|FG000|Overall Study|Protocol Violation|2|||
130582300|NCT01960855|470095803|FG000|Overall Study|Other|2|||
130582301|NCT01960855|470095804|FG001|Overall Study|Other|1|||
130582302|NCT01960855|470095805|FG002|Overall Study|Other|1|||
130582303|NCT01960855|470095806|FG003|Overall Study|Other|1|||
130582304|NCT01960855|470095807|FG004|Overall Study|Other|0|||
130582305|NCT01960855|470095803|FG000|Overall Study|Consent withdrawn by subject|3|||
130582306|NCT01960855|470095804|FG001|Overall Study|Consent withdrawn by subject|1|||
130582307|NCT01960855|470095805|FG002|Overall Study|Consent withdrawn by subject|2|||
130582308|NCT01960855|470095806|FG003|Overall Study|Consent withdrawn by subject|1|||
130582309|NCT01960855|470095807|FG004|Overall Study|Consent withdrawn by subject|1|||
130582310|NCT01960855|470095803|FG000|Overall Study|Lost to Follow-up|2|||
130582311|NCT01960855|470095804|FG001|Overall Study|Lost to Follow-up|1|||
130582312|NCT01960855|470095805|FG002|Overall Study|Lost to Follow-up|0|||
130582313|NCT01960855|470095806|FG003|Overall Study|Lost to Follow-up|0|||
130582314|NCT01960855|470095807|FG004|Overall Study|Lost to Follow-up|2|||
130582315|NCT02058147|470095808|FG000|Overall Study|Randomized but not treated|0|||
130582316|NCT02058147|470095809|FG001|Overall Study|Randomized but not treated|0|||
130582317|NCT02058147|470095810|FG002|Overall Study|Randomized but not treated|1|||
130582318|NCT02058147|470095808|FG000|Overall Study|Adverse Event|12|||
130582319|NCT02058147|470095809|FG001|Overall Study|Adverse Event|9|||
130582320|NCT02058147|470095810|FG002|Overall Study|Adverse Event|21|||
130582321|NCT02058147|470095808|FG000|Overall Study|Lack of Efficacy|1|||
130582322|NCT02058147|470095809|FG001|Overall Study|Lack of Efficacy|0|||
130582323|NCT02058147|470095810|FG002|Overall Study|Lack of Efficacy|3|||
130582324|NCT02058147|470095808|FG000|Overall Study|Poor compliance to protocol|8|||
130582325|NCT02058147|470095809|FG001|Overall Study|Poor compliance to protocol|9|||
130582326|NCT02058147|470095810|FG002|Overall Study|Poor compliance to protocol|4|||
130582327|NCT02058147|470095808|FG000|Overall Study|Other than specified|8|||
130582328|NCT02058147|470095809|FG001|Overall Study|Other than specified|9|||
130582329|NCT02058147|470095810|FG002|Overall Study|Other than specified|0|||
130582330|NCT03604445|470095817|FG000|Overall Study|Death|0|||
130582331|NCT03604445|470095818|FG001|Overall Study|Death|0|||
130582332|NCT03604445|470095819|FG002|Overall Study|Death|0|||
130582333|NCT03604445|470095820|FG003|Overall Study|Death|0|||
130582334|NCT03604445|470095821|FG004|Overall Study|Death|0|||
130582335|NCT03604445|470095822|FG005|Overall Study|Death|0|||
130582336|NCT03604445|470095823|FG006|Overall Study|Death|0|||
130582337|NCT03604445|470095824|FG007|Overall Study|Death|0|||
130582338|NCT03604445|470095825|FG008|Overall Study|Death|1|||
130582339|NCT03604445|470095817|FG000|Overall Study|Withdrawal by Subject|0|||
130582340|NCT03604445|470095818|FG001|Overall Study|Withdrawal by Subject|0|||
130582341|NCT03604445|470095819|FG002|Overall Study|Withdrawal by Subject|0|||
130582342|NCT03604445|470095820|FG003|Overall Study|Withdrawal by Subject|0|||
130582343|NCT03604445|470095821|FG004|Overall Study|Withdrawal by Subject|0|||
130582344|NCT03604445|470095822|FG005|Overall Study|Withdrawal by Subject|0|||
130582345|NCT03604445|470095823|FG006|Overall Study|Withdrawal by Subject|1|||
130582346|NCT03604445|470095824|FG007|Overall Study|Withdrawal by Subject|0|||
130582347|NCT03604445|470095825|FG008|Overall Study|Withdrawal by Subject|0|||
130582348|NCT03604445|470095817|FG000|Overall Study|Missing visit|0|||
130582349|NCT03604445|470095818|FG001|Overall Study|Missing visit|0|||
130582350|NCT03604445|470095819|FG002|Overall Study|Missing visit|0|||
130582351|NCT03604445|470095820|FG003|Overall Study|Missing visit|0|||
130582352|NCT03604445|470095821|FG004|Overall Study|Missing visit|0|||
130582353|NCT03604445|470095822|FG005|Overall Study|Missing visit|1|||
130582354|NCT03604445|470095823|FG006|Overall Study|Missing visit|0|||
130582355|NCT03604445|470095824|FG007|Overall Study|Missing visit|1|||
130582356|NCT03604445|470095825|FG008|Overall Study|Missing visit|0|||
130582357|NCT03604445|470095817|FG000|Overall Study|Adverse Event|0|||
130582358|NCT03604445|470095818|FG001|Overall Study|Adverse Event|0|||
130582359|NCT03604445|470095819|FG002|Overall Study|Adverse Event|0|||
130582360|NCT03604445|470095820|FG003|Overall Study|Adverse Event|1|||
130582361|NCT03604445|470095821|FG004|Overall Study|Adverse Event|0|||
130582362|NCT03604445|470095822|FG005|Overall Study|Adverse Event|0|||
130582363|NCT03604445|470095823|FG006|Overall Study|Adverse Event|0|||
130582364|NCT03604445|470095824|FG007|Overall Study|Adverse Event|0|||
130582365|NCT03604445|470095825|FG008|Overall Study|Adverse Event|1|||
130582366|NCT01014585|470095830|FG000|Overall Study|Adverse Event|0|||
130582367|NCT01014585|470095831|FG001|Overall Study|Adverse Event|2|||
130582368|NCT01014585|470095832|FG002|Overall Study|Adverse Event|0|||
130582369|NCT01014585|470095833|FG003|Overall Study|Adverse Event|3|||
130582370|NCT01014585|470095830|FG000|Overall Study|Withdrawal by Subject|2|||
130582371|NCT01014585|470095831|FG001|Overall Study|Withdrawal by Subject|0|||
130582372|NCT01014585|470095832|FG002|Overall Study|Withdrawal by Subject|1|||
130582373|NCT01014585|470095833|FG003|Overall Study|Withdrawal by Subject|3|||
130582374|NCT01014585|470095830|FG000|Overall Study|Lost to Follow-up|0|||
130582375|NCT01014585|470095831|FG001|Overall Study|Lost to Follow-up|0|||
130582376|NCT01014585|470095832|FG002|Overall Study|Lost to Follow-up|0|||
130582377|NCT01014585|470095833|FG003|Overall Study|Lost to Follow-up|2|||
130582378|NCT01014585|470095830|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
130533549|NCT01399697|469920986|FG001|Overall Study|Protocol Violation|0|||
130533550|NCT01399697|469920987|FG002|Overall Study|Protocol Violation|0|||
130533551|NCT01399697|469920985|FG000|Overall Study|Non-Compliant|1|||
130533552|NCT01399697|469920986|FG001|Overall Study|Non-Compliant|0|||
130533553|NCT01399697|469920987|FG002|Overall Study|Non-Compliant|0|||
130533554|NCT01399697|469920985|FG000|Overall Study|Inclusion Error|2|||
130533555|NCT01399697|469920986|FG001|Overall Study|Inclusion Error|0|||
130533556|NCT01399697|469920987|FG002|Overall Study|Inclusion Error|0|||
130533557|NCT01399697|469920985|FG000|Overall Study|Positive result for hepatitis B|1|||
130533558|NCT01399697|469920986|FG001|Overall Study|Positive result for hepatitis B|0|||
130533559|NCT01399697|469920987|FG002|Overall Study|Positive result for hepatitis B|0|||
130533560|NCT01399697|469920985|FG000|Overall Study|Clinical RA remission|1|||
130533561|NCT01399697|469920986|FG001|Overall Study|Clinical RA remission|0|||
130533562|NCT01399697|469920987|FG002|Overall Study|Clinical RA remission|0|||
130533563|NCT01399697|469920985|FG000|Overall Study|Sponsor Decision|1|||
130533564|NCT01399697|469920986|FG001|Overall Study|Sponsor Decision|0|||
130533565|NCT01399697|469920987|FG002|Overall Study|Sponsor Decision|0|||
130582379|NCT01014585|470095831|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
130582380|NCT01014585|470095832|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
130582381|NCT01014585|470095833|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
130582382|NCT00773279|470095834|FG000|Period 1|Adverse Event|2|||
130582383|NCT00773279|470095835|FG001|Period 1|Adverse Event|1|||
130582384|NCT00773279|470095834|FG000|Period 1|Lack of Efficacy|0|||
130582385|NCT00773279|470095835|FG001|Period 1|Lack of Efficacy|2|||
130582386|NCT00773279|470095834|FG000|Period 1|Unclassified|5|||
130582387|NCT00773279|470095835|FG001|Period 1|Unclassified|1|||
130582388|NCT00773279|470095834|FG000|Period 2|Adverse Event|0|||
130582389|NCT00773279|470095835|FG001|Period 2|Adverse Event|1|||
130582390|NCT00773279|470095834|FG000|Period 2|Lack of Efficacy|1|||
130582391|NCT00773279|470095835|FG001|Period 2|Lack of Efficacy|0|||
130582392|NCT00773279|470095834|FG000|Period 2|Protocol Violation|0|||
130582393|NCT00773279|470095835|FG001|Period 2|Protocol Violation|3|||
130582394|NCT00773279|470095834|FG000|Period 2|Unclassified|2|||
130582395|NCT00773279|470095835|FG001|Period 2|Unclassified|2|||
130582396|NCT04178772|470095841|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
130582397|NCT04178772|470095841|FG000|Overall Study|study terminated early due to COVID-19|7|||
130582398|NCT00713219|470095842|FG000|Overall Study|Death|1|||
130582399|NCT00713219|470095842|FG000|Overall Study|Protocol Violation|1|||
130582400|NCT02817087|470095843|FG000|Overall Study|Withdrawal by Subject|2|||
130582401|NCT02817087|470095844|FG001|Overall Study|Withdrawal by Subject|0|||
130582402|NCT00508391|470095845|FG000|First Treatment|Withdrawal by Subject|6|||
130582403|NCT00508391|470095846|FG001|First Treatment|Withdrawal by Subject|3|||
130582404|NCT00508391|470095845|FG000|Second Treatment|Withdrawal by Subject|2|||
130582405|NCT00508391|470095846|FG001|Second Treatment|Withdrawal by Subject|0|||
130582406|NCT00802360|470095847|FG000|Overall Study|Stimulation failure|4|||
130582407|NCT00802360|470095848|FG001|Overall Study|Stimulation failure|0|||
130582408|NCT00802360|470095849|FG002|Overall Study|Stimulation failure|3|||
130582409|NCT00802360|470095850|FG003|Overall Study|Stimulation failure|3|||
130582410|NCT00802360|470095847|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
130582411|NCT00802360|470095848|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
130582412|NCT00802360|470095849|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
130582413|NCT00802360|470095850|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
130582414|NCT00802360|470095847|FG000|Overall Study|Cycle cancelled|0|||
130582415|NCT00802360|470095848|FG001|Overall Study|Cycle cancelled|1|||
130582416|NCT00802360|470095849|FG002|Overall Study|Cycle cancelled|1|||
130582417|NCT00802360|470095850|FG003|Overall Study|Cycle cancelled|1|||
130582418|NCT00802360|470095847|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130582419|NCT00802360|470095848|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130582420|NCT00802360|470095849|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130582421|NCT00802360|470095850|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
130582422|NCT00802360|470095847|FG000|Overall Study|No positive serum pregnancy|17|||
130582423|NCT00802360|470095848|FG001|Overall Study|No positive serum pregnancy|20|||
130582424|NCT00802360|470095849|FG002|Overall Study|No positive serum pregnancy|14|||
130582425|NCT00802360|470095850|FG003|Overall Study|No positive serum pregnancy|10|||
130582426|NCT00802360|470095847|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130582427|NCT00802360|470095848|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130582428|NCT00802360|470095849|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130582429|NCT00802360|470095850|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130582430|NCT00802360|470095847|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
130582431|NCT00802360|470095848|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
130582432|NCT00802360|470095849|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
130582433|NCT00802360|470095850|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
130582434|NCT00802360|470095847|FG000|Overall Study|Other|2|||
130582435|NCT00802360|470095848|FG001|Overall Study|Other|3|||
130582436|NCT00802360|470095849|FG002|Overall Study|Other|6|||
130582437|NCT00802360|470095850|FG003|Overall Study|Other|3|||
130582438|NCT02041962|470095851|FG000|Overall Study|Lost Aetna Coverage|43|||
130582439|NCT02041962|470095852|FG001|Overall Study|Lost Aetna Coverage|40|||
130582440|NCT02041962|470095851|FG000|Overall Study|Death|1|||
130582441|NCT02041962|470095852|FG001|Overall Study|Death|1|||
130582442|NCT02041962|470095851|FG000|Overall Study|Lost to Follow-up|37|||
130582443|NCT02041962|470095852|FG001|Overall Study|Lost to Follow-up|32|||
130582444|NCT02041962|470095851|FG000|Overall Study|Withdrawal by Subject|0|||
130582445|NCT02041962|470095852|FG001|Overall Study|Withdrawal by Subject|11|||
130582446|NCT01481896|470095853|FG000|Overall Study|Lost to Follow-up|12|||
130582447|NCT01990261|470095854|FG000|Overall Study|Death Before Treatment Start|2|||
130582448|NCT01990261|470095854|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
130582449|NCT01990261|470095854|FG000|Overall Study|Death From other Causes|1|||
130582450|NCT01990261|470095854|FG000|Overall Study|Disease Progression (PD)|8|||
130582451|NCT01990261|470095854|FG000|Overall Study|PD Before Treatment Start|1|||
130582452|NCT01990261|470095854|FG000|Overall Study|Dossier not Approved|1|||
130582453|NCT01990261|470095854|FG000|Overall Study|Lost to Follow-up|2|||
130582454|NCT04698629|470095857|FG000|Overall Study|Adverse Event|1|||
130582455|NCT00865020|470095858|FG000|Overall Study|Withdrawal by Subject|22|||
130582456|NCT00865020|470095859|FG001|Overall Study|Withdrawal by Subject|16|||
130582457|NCT00865020|470095858|FG000|Overall Study|Adverse Event|9|||
130582458|NCT00865020|470095859|FG001|Overall Study|Adverse Event|14|||
130582459|NCT00865020|470095858|FG000|Overall Study|Abnormal test procedure result(s)|6|||
130582460|NCT00865020|470095859|FG001|Overall Study|Abnormal test procedure result(s)|8|||
130582461|NCT00865020|470095858|FG000|Overall Study|Lost to Follow-up|6|||
130582462|NCT00865020|470095859|FG001|Overall Study|Lost to Follow-up|4|||
130582463|NCT00865020|470095858|FG000|Overall Study|Protocol deviation|4|||
130582464|NCT00865020|470095859|FG001|Overall Study|Protocol deviation|1|||
130582465|NCT00865020|470095858|FG000|Overall Study|Administrative problems|0|||
130582466|NCT00865020|470095859|FG001|Overall Study|Administrative problems|2|||
130582467|NCT00865020|470095858|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130582468|NCT00865020|470095859|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130582469|NCT00865020|470095858|FG000|Overall Study|Death|0|||
130582470|NCT00865020|470095859|FG001|Overall Study|Death|1|||
130582471|NCT00865020|470095858|FG000|Overall Study|Randomized but discontinued|2|||
130582472|NCT00865020|470095859|FG001|Overall Study|Randomized but discontinued|4|||
130582473|NCT03641560|470095860|FG000|Overall Study|Withdrawal by Subject|6|||
130582474|NCT03641560|470095860|FG000|Overall Study|Progressive disease|40|||
130582475|NCT03641560|470095860|FG000|Overall Study|Death|6|||
130582476|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
130582477|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
130582478|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
130582479|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
130582480|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
130582481|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
130582482|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
130582483|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
130582484|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
130582485|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
130582486|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
130582487|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
130582488|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
130582489|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
130582490|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
130582491|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
130582492|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
130582493|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
130582494|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
130582495|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
130582496|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
130582497|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
130582498|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
130582499|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
130582500|NCT04660643|470098771|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
130582501|NCT04660643|470098772|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
130582502|NCT04660643|470098773|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
130582503|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
130582504|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
130582505|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
130582506|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
130582507|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
130582508|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
130582509|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
130582510|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
130582511|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
130582512|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
130582513|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
130582514|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
130582515|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
130582516|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
130582517|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
130582518|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
130582519|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
130582520|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
130582521|NCT04660643|470098771|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
130582522|NCT04660643|470098772|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
130582523|NCT04660643|470098773|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
130582524|NCT03988907|470098774|FG000|Overall Study|Unable to complete visit|0|||
130582525|NCT03988907|470098775|FG001|Overall Study|Unable to complete visit|1|||
130582526|NCT02810964|470098776|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
130582527|NCT02810964|470098777|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
130582528|NCT02810964|470098776|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
130582529|NCT02810964|470098777|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
130582530|NCT02810964|470098776|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
130582531|NCT02810964|470098777|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
130582532|NCT02810964|470098776|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
130582533|NCT02810964|470098777|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
130582534|NCT01171820|470098779|FG000|Overall Study|Death|3|||
130582535|NCT01171820|470098780|FG001|Overall Study|Death|3|||
130582536|NCT01171820|470098779|FG000|Overall Study|Lost to Follow-up|0|||
130582537|NCT01171820|470098780|FG001|Overall Study|Lost to Follow-up|1|||
130582538|NCT01171820|470098779|FG000|Overall Study|Withdrawal by Subject|2|||
130582539|NCT01171820|470098780|FG001|Overall Study|Withdrawal by Subject|0|||
130533566|NCT02766777|469920992|FG000|Overall Study|Adverse Event|12|||
130533567|NCT02766777|469920992|FG000|Overall Study|Lost to Follow-up|16|||
130533568|NCT02766777|469920992|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130533569|NCT02766777|469920992|FG000|Overall Study|Protocol Violation|1|||
130533570|NCT02766777|469920992|FG000|Overall Study|Withdrawal by Subject|4|||
130533571|NCT04313608|469920993|FG000|Overall Study|Death|12|||
130533572|NCT04313608|469920994|FG001|Overall Study|Death|3|||
130533573|NCT02964325|469920995|FG000|Overall Study|Lost to Follow-up|3|||
130533574|NCT02964325|469920996|FG001|Overall Study|Lost to Follow-up|3|||
130533575|NCT02964325|469920995|FG000|Overall Study|Physician Decision|5|||
130533576|NCT02964325|469920996|FG001|Overall Study|Physician Decision|4|||
130533577|NCT02964325|469920995|FG000|Overall Study|Death|1|||
130533578|NCT02964325|469920996|FG001|Overall Study|Death|3|||
130533579|NCT02964325|469920995|FG000|Overall Study|Withdrawal by Subject|2|||
130533580|NCT02964325|469920996|FG001|Overall Study|Withdrawal by Subject|1|||
130533581|NCT02964325|469920995|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
130533582|NCT02964325|469920996|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
130533583|NCT02510040|469920997|FG000|Overall Study|Deemed no longer eligible|18|||
130533584|NCT02510040|469920998|FG001|Overall Study|Deemed no longer eligible|3|||
130533585|NCT02510040|469920999|FG002|Overall Study|Deemed no longer eligible|1|||
130533586|NCT00967005|469921007|FG000|Overall Study|Lost to Follow-up|7|||
130533587|NCT00967005|469921008|FG001|Overall Study|Lost to Follow-up|10|||
130533588|NCT01371825|469921011|FG000|Overall Study|Death|4|||
130533589|NCT03019640|469921012|FG000|Overall Study|Screen Failures|4|||
130533590|NCT03019640|469921012|FG000|Overall Study|Adverse Event|3|||
130533591|NCT03019640|469921012|FG000|Overall Study|Participant Relapsed|1|||
130533592|NCT00534495|469921018|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
130533593|NCT00534495|469921019|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
130533594|NCT00534495|469921020|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
130533595|NCT00534495|469921018|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
130533596|NCT00534495|469921019|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
130533597|NCT00534495|469921020|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
130533598|NCT00534495|469921018|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
130533599|NCT00534495|469921019|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
130533600|NCT00534495|469921020|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
130533601|NCT00534495|469921018|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
130533602|NCT00534495|469921019|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
130533603|NCT00534495|469921020|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
130533604|NCT00534495|469921018|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
130533605|NCT00534495|469921019|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
130533606|NCT00534495|469921020|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
130533607|NCT00534495|469921018|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
130533608|NCT00534495|469921019|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
130533609|NCT00534495|469921020|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
130533610|NCT00534495|469921018|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
130533611|NCT00534495|469921019|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
130533612|NCT00534495|469921020|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
130533613|NCT00534495|469921018|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
130533614|NCT00534495|469921019|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
130533615|NCT00534495|469921020|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
130533616|NCT00534495|469921018|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
130533617|NCT00534495|469921019|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
130533618|NCT00534495|469921020|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
130533619|NCT01162863|469921021|FG000|Overall Study|Lack of Efficacy|1|||
130533620|NCT01162863|469921022|FG001|Overall Study|Lack of Efficacy|0|||
130533621|NCT01162863|469921023|FG002|Overall Study|Lack of Efficacy|0|||
130533622|NCT01162863|469921021|FG000|Overall Study|Adverse Event|0|||
130533623|NCT01162863|469921022|FG001|Overall Study|Adverse Event|1|||
130533624|NCT01162863|469921023|FG002|Overall Study|Adverse Event|0|||
130533625|NCT00588692|469921024|FG000|Overall Study|Withdrawal by Subject|4|||
130533626|NCT00588692|469921025|FG001|Overall Study|Withdrawal by Subject|2|||
130533627|NCT00588692|469921024|FG000|Overall Study|Hip Surgery|0|||
130533628|NCT00588692|469921025|FG001|Overall Study|Hip Surgery|1|||
130533629|NCT00588692|469921024|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
130533630|NCT00588692|469921025|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
130533631|NCT00588692|469921024|FG000|Overall Study|Cancer|1|||
130533632|NCT00588692|469921025|FG001|Overall Study|Cancer|0|||
130533633|NCT00588692|469921024|FG000|Overall Study|Death|1|||
130533634|NCT00588692|469921025|FG001|Overall Study|Death|0|||
130533635|NCT03552523|469921026|FG000|Overall Study|Withdrawal by Subject|1|||
130533636|NCT03552523|469921027|FG001|Overall Study|Withdrawal by Subject|1|||
130533637|NCT04462289|469921028|FG000|Overall Study|Lost to Follow-up|4|||
130582540|NCT01171820|470098779|FG000|Overall Study|Physician Decision|0|||
130582541|NCT01171820|470098780|FG001|Overall Study|Physician Decision|1|||
130582542|NCT01171820|470098779|FG000|Overall Study|1-Year Missed Visit|1|||
130582543|NCT01171820|470098780|FG001|Overall Study|1-Year Missed Visit|1|||
130582544|NCT03969875|470098781|FG000|Overall Study|did not receive allocated intervention|3|||
130582545|NCT03969875|470098782|FG001|Overall Study|did not receive allocated intervention|3|||
130582546|NCT03969875|470098783|FG002|Overall Study|did not receive allocated intervention|4|||
130582547|NCT03969875|470098781|FG000|Overall Study|Protocol Violation|4|||
130582548|NCT03969875|470098782|FG001|Overall Study|Protocol Violation|2|||
130582549|NCT03969875|470098783|FG002|Overall Study|Protocol Violation|2|||
130582550|NCT01307033|470098784|FG000|8-week Double-blind Period|Adverse Event|2|||
130582551|NCT01307033|470098785|FG001|8-week Double-blind Period|Adverse Event|0|||
130582552|NCT01307033|470098786|FG002|8-week Double-blind Period|Adverse Event|0|||
130582553|NCT01307033|470098787|FG003|8-week Double-blind Period|Adverse Event|0|||
130582554|NCT01307033|470098784|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
130582555|NCT01307033|470098785|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
130582556|NCT01307033|470098786|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
130582557|NCT01307033|470098787|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
130582558|NCT01307033|470098784|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
130582559|NCT01307033|470098785|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
130582560|NCT01307033|470098786|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
130582561|NCT01307033|470098787|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
130582562|NCT01307033|470098784|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130582563|NCT01307033|470098785|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
130582564|NCT01307033|470098786|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130582565|NCT01307033|470098787|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130582566|NCT01307033|470098784|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
130582567|NCT01307033|470098785|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
130582568|NCT01307033|470098786|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
130582569|NCT01307033|470098787|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
130582570|NCT01307033|470098784|FG000|44-week Open-label Extension|Adverse Event|0|||
130582571|NCT01307033|470098785|FG001|44-week Open-label Extension|Adverse Event|0|||
130582572|NCT01307033|470098786|FG002|44-week Open-label Extension|Adverse Event|2|||
130582573|NCT01307033|470098787|FG003|44-week Open-label Extension|Adverse Event|1|||
130582574|NCT01307033|470098784|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
130582575|NCT01307033|470098785|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
130582576|NCT01307033|470098786|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
130582577|NCT01307033|470098787|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
130582578|NCT01307033|470098784|FG000|44-week Open-label Extension|Physician Decision|0|||
130582579|NCT01307033|470098785|FG001|44-week Open-label Extension|Physician Decision|0|||
130582580|NCT01307033|470098786|FG002|44-week Open-label Extension|Physician Decision|1|||
130582581|NCT01307033|470098787|FG003|44-week Open-label Extension|Physician Decision|0|||
130582582|NCT01307033|470098784|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130582583|NCT01307033|470098785|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130582584|NCT01307033|470098786|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130582585|NCT01307033|470098787|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
130582586|NCT01307033|470098784|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
130582587|NCT01307033|470098785|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
130582588|NCT01307033|470098786|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
130582589|NCT01307033|470098787|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
130582590|NCT01307033|470098784|FG000|44-week Open-label Extension|Death|0|||
130582591|NCT01307033|470098785|FG001|44-week Open-label Extension|Death|0|||
130582592|NCT01307033|470098786|FG002|44-week Open-label Extension|Death|0|||
130582593|NCT01307033|470098787|FG003|44-week Open-label Extension|Death|1|||
130582594|NCT01231555|470098788|FG000|Overall Study|Study terminated|8|||
130582595|NCT01231555|470098789|FG001|Overall Study|Study terminated|5|||
130582596|NCT01231555|470098790|FG002|Overall Study|Study terminated|8|||
130582597|NCT01231555|470098788|FG000|Overall Study|Withdrawal by Subject|0|||
130582598|NCT01231555|470098789|FG001|Overall Study|Withdrawal by Subject|2|||
130582599|NCT01231555|470098790|FG002|Overall Study|Withdrawal by Subject|0|||
130582600|NCT00947531|470098791|FG000|Overall Study|Withdrawal by Subject|10|||
130533638|NCT04462289|469921029|FG001|Overall Study|Lost to Follow-up|5|||
130533639|NCT04462289|469921028|FG000|Overall Study|Death|0|||
130533640|NCT04462289|469921029|FG001|Overall Study|Death|3|||
130533641|NCT04462289|469921028|FG000|Overall Study|Withdrawal by Subject|1|||
130533642|NCT04462289|469921029|FG001|Overall Study|Withdrawal by Subject|3|||
130533643|NCT03686423|469921030|FG000|Overall Study|Withdrawal by Subject|9|||
130533644|NCT03686423|469921030|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
130533645|NCT01077518|469921031|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
130533646|NCT01077518|469921032|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
130533647|NCT01077518|469921033|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
130533648|NCT01077518|469921031|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
130533649|NCT01077518|469921032|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
130533650|NCT01077518|469921033|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
130533651|NCT01077518|469921031|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
130533652|NCT01077518|469921032|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
130533653|NCT01077518|469921033|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
130533654|NCT01077518|469921031|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
130533655|NCT01077518|469921032|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
130533656|NCT01077518|469921033|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
130533657|NCT01077518|469921031|FG000|Optional Ofa Phase|Physician Decision|0|||
130533658|NCT01077518|469921032|FG001|Optional Ofa Phase|Physician Decision|0|||
130533659|NCT01077518|469921033|FG002|Optional Ofa Phase|Physician Decision|1|||
130533660|NCT01077518|469921031|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
130533661|NCT01077518|469921032|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
130533662|NCT01077518|469921033|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
130533663|NCT01077518|469921031|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
130533664|NCT01077518|469921032|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
130582601|NCT00947531|470098792|FG001|Overall Study|Withdrawal by Subject|7|||
130533665|NCT01077518|469921033|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
130582602|NCT00947531|470098791|FG000|Overall Study|Administrative Reason|0|||
130533666|NCT02387970|469921034|FG000|Overall Study|Did not complete 1-year follow up|1|||
130533667|NCT02387970|469921035|FG001|Overall Study|Did not complete 1-year follow up|2|||
130533668|NCT01436253|469921040|FG000|Overall Study|Lost to Follow-up|182|||
130533669|NCT01436253|469921040|FG000|Overall Study|Not meeting all eligibility criteria|117|||
130533670|NCT01495598|469921042|FG000|Overall Study|Death during follow up period|2|||
130533671|NCT01495598|469921042|FG000|Overall Study|Death on study|1|||
130533672|NCT01495598|469921042|FG000|Overall Study|Lost to Follow-up|3|||
130533673|NCT01495598|469921042|FG000|Overall Study|Physician Decision|8|||
130533674|NCT02671500|469921045|FG000|Overall Study|Lack of Efficacy|12|||
130533675|NCT02671500|469921045|FG000|Overall Study|Lost to Follow-up|2|||
130533676|NCT05511038|469921047|FG000|Overall|Withdrawal by Subject|5|||
130533677|NCT05511038|469921048|FG001|Overall|Withdrawal by Subject|3|||
130533678|NCT05511038|469921047|FG000|Overall|Screen Failure|20|||
130533679|NCT05511038|469921048|FG001|Overall|Screen Failure|1|||
130533680|NCT05511038|469921047|FG000|Overall|Physician Decision|3|||
130533681|NCT05511038|469921048|FG001|Overall|Physician Decision|0|||
130533682|NCT05511038|469921047|FG000|Overall|Lost to Follow-up|3|||
130533683|NCT05511038|469921048|FG001|Overall|Lost to Follow-up|0|||
130533684|NCT05511038|469921047|FG000|Overall|Death|1|||
130533685|NCT05511038|469921048|FG001|Overall|Death|0|||
130533686|NCT05511038|469921047|FG000|Screening|Withdrawal by Subject|1|||
130533687|NCT05511038|469921048|FG001|Screening|Withdrawal by Subject|0|||
130533688|NCT05511038|469921047|FG000|Screening|Lost to Follow Up (1 participant)|1|||
130533689|NCT05511038|469921048|FG001|Screening|Lost to Follow Up (1 participant)|0|||
130533690|NCT05511038|469921047|FG000|Screening|Screen Failure|3|||
130533691|NCT05511038|469921048|FG001|Screening|Screen Failure|0|||
130533692|NCT05511038|469921047|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
130533693|NCT05511038|469921048|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
130533694|NCT05511038|469921047|FG000|Treatment|Withdrawal by Subject|5|||
130533695|NCT05511038|469921048|FG001|Treatment|Withdrawal by Subject|3|||
130533696|NCT05511038|469921047|FG000|Treatment|Physician Decision|4|||
130533697|NCT05511038|469921048|FG001|Treatment|Physician Decision|0|||
130533698|NCT05511038|469921047|FG000|Treatment|Lost to Follow-up|2|||
130533699|NCT05511038|469921048|FG001|Treatment|Lost to Follow-up|0|||
130533700|NCT05511038|469921047|FG000|Treatment|Death|1|||
130533701|NCT05511038|469921048|FG001|Treatment|Death|0|||
130533702|NCT05511038|469921047|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
130533703|NCT05511038|469921048|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
130533704|NCT05511038|469921047|FG000|Treatment|Refuse by subject|1|||
130533705|NCT05511038|469921048|FG001|Treatment|Refuse by subject|0|||
130533706|NCT05511038|469921047|FG000|Treatment|Subject did not go to the site for visit|1|||
130533707|NCT05511038|469921048|FG001|Treatment|Subject did not go to the site for visit|0|||
130533708|NCT04485611|469921049|FG000|Prehabilitation|Physician Decision|1|||
130533709|NCT05292586|469921052|FG000|Overall Study|Withdrawal by Subject|3|||
130533710|NCT05292586|469921053|FG001|Overall Study|Withdrawal by Subject|10|||
130533711|NCT05292586|469921052|FG000|Overall Study|Randomization error|3|||
130533712|NCT05292586|469921053|FG001|Overall Study|Randomization error|7|||
130533713|NCT05292586|469921052|FG000|Overall Study|Adverse Event|3|||
130533714|NCT05292586|469921053|FG001|Overall Study|Adverse Event|0|||
130533715|NCT05292586|469921052|FG000|Overall Study|Lost to Follow-up|0|||
130533716|NCT05292586|469921053|FG001|Overall Study|Lost to Follow-up|1|||
130533717|NCT05292586|469921052|FG000|Overall Study|Patient refused treatment|1|||
130533718|NCT05292586|469921053|FG001|Overall Study|Patient refused treatment|0|||
130533719|NCT05292586|469921052|FG000|Overall Study|Patient could not travel to the study site|1|||
130533720|NCT05292586|469921053|FG001|Overall Study|Patient could not travel to the study site|0|||
130533721|NCT05292586|469921052|FG000|Overall Study|Technical issues with the masterscope|0|||
130533722|NCT05292586|469921053|FG001|Overall Study|Technical issues with the masterscope|3|||
130533723|NCT05292586|469921052|FG000|Overall Study|Patient moved to a different state|0|||
130533724|NCT05292586|469921053|FG001|Overall Study|Patient moved to a different state|1|||
130533725|NCT04531982|469921054|FG000|Overall Study|Withdrawal by Subject|10|||
130533726|NCT04531982|469921055|FG001|Overall Study|Withdrawal by Subject|11|||
130533727|NCT04531982|469921054|FG000|Overall Study|Adverse Event|6|||
130533728|NCT04531982|469921055|FG001|Overall Study|Adverse Event|14|||
130533729|NCT04531982|469921054|FG000|Overall Study|Protocol Violation|6|||
130533730|NCT04531982|469921055|FG001|Overall Study|Protocol Violation|9|||
130533731|NCT04531982|469921054|FG000|Overall Study|Non-compliance with study drug|3|||
130533732|NCT04531982|469921055|FG001|Overall Study|Non-compliance with study drug|2|||
130533733|NCT04531982|469921054|FG000|Overall Study|Use of prohibited medication|2|||
130533734|NCT04531982|469921055|FG001|Overall Study|Use of prohibited medication|0|||
130533735|NCT04531982|469921054|FG000|Overall Study|Lost to Follow-up|0|||
130533736|NCT04531982|469921055|FG001|Overall Study|Lost to Follow-up|1|||
130533737|NCT04531982|469921054|FG000|Overall Study|Geopolitical conflict|2|||
130533738|NCT04531982|469921055|FG001|Overall Study|Geopolitical conflict|0|||
130533739|NCT04531982|469921054|FG000|Overall Study|Lack of Efficacy|3|||
130533740|NCT04531982|469921055|FG001|Overall Study|Lack of Efficacy|1|||
130533741|NCT03841526|469921057|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
130533742|NCT03841526|469921058|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
130533743|NCT03841526|469921059|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
130533744|NCT03841526|469921060|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
130533745|NCT03841526|469921061|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
130533746|NCT03841526|469921062|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
130533747|NCT03841526|469921057|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
130533748|NCT03841526|469921058|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
130533749|NCT03841526|469921059|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
130533750|NCT03841526|469921060|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
130533751|NCT03841526|469921061|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
130533752|NCT03841526|469921062|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
130533753|NCT03841526|469921057|FG000|Outpatient Phase Treatment|Physician Decision|0|||
130533754|NCT03841526|469921058|FG001|Outpatient Phase Treatment|Physician Decision|1|||
130533755|NCT03841526|469921059|FG002|Outpatient Phase Treatment|Physician Decision|0|||
130533756|NCT03841526|469921060|FG003|Outpatient Phase Treatment|Physician Decision|0|||
130533757|NCT03841526|469921061|FG004|Outpatient Phase Treatment|Physician Decision|0|||
130533758|NCT03841526|469921062|FG005|Outpatient Phase Treatment|Physician Decision|0|||
130533759|NCT03841526|469921057|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
130533760|NCT03841526|469921058|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
130533761|NCT03841526|469921059|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
130533762|NCT03841526|469921060|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
130533763|NCT03841526|469921061|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
130533764|NCT03841526|469921062|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
130533765|NCT03829501|469922487|FG000|Overall Study|Withdrawal of Consent|2|||
130533766|NCT03829501|469922488|FG001|Overall Study|Withdrawal of Consent|0|||
130533767|NCT03829501|469922489|FG002|Overall Study|Withdrawal of Consent|3|||
130533768|NCT03829501|469922490|FG003|Overall Study|Withdrawal of Consent|0|||
130533769|NCT03829501|469922491|FG004|Overall Study|Withdrawal of Consent|1|||
130533770|NCT03829501|469922492|FG005|Overall Study|Withdrawal of Consent|1|||
130533771|NCT03829501|469922493|FG006|Overall Study|Withdrawal of Consent|0|||
130533772|NCT03829501|469922494|FG007|Overall Study|Withdrawal of Consent|10|||
130533773|NCT03829501|469922495|FG008|Overall Study|Withdrawal of Consent|10|||
130533774|NCT03829501|469922496|FG009|Overall Study|Withdrawal of Consent|3|||
130533775|NCT03829501|469922497|FG010|Overall Study|Withdrawal of Consent|4|||
130533776|NCT03829501|469922498|FG011|Overall Study|Withdrawal of Consent|4|||
130533777|NCT03829501|469922499|FG012|Overall Study|Withdrawal of Consent|4|||
130533778|NCT03829501|469922500|FG013|Overall Study|Withdrawal of Consent|0|||
130533779|NCT03829501|469922501|FG014|Overall Study|Withdrawal of Consent|3|||
130533780|NCT03829501|469922502|FG015|Overall Study|Withdrawal of Consent|0|||
130533781|NCT03829501|469922503|FG016|Overall Study|Withdrawal of Consent|1|||
130533782|NCT03829501|469922504|FG017|Overall Study|Withdrawal of Consent|1|||
130533783|NCT03829501|469922505|FG018|Overall Study|Withdrawal of Consent|0|||
130533784|NCT03829501|469922506|FG019|Overall Study|Withdrawal of Consent|0|||
130533785|NCT03829501|469922507|FG020|Overall Study|Withdrawal of Consent|3|||
130533786|NCT03829501|469922508|FG021|Overall Study|Withdrawal of Consent|0|||
130533787|NCT03829501|469922509|FG022|Overall Study|Withdrawal of Consent|1|||
130533788|NCT03829501|469922487|FG000|Overall Study|PD|0|||
130533789|NCT03829501|469922488|FG001|Overall Study|PD|0|||
130533790|NCT03829501|469922489|FG002|Overall Study|PD|0|||
130533791|NCT03829501|469922490|FG003|Overall Study|PD|2|||
130533792|NCT03829501|469922491|FG004|Overall Study|PD|0|||
130533793|NCT03829501|469922492|FG005|Overall Study|PD|0|||
130533794|NCT03829501|469922493|FG006|Overall Study|PD|0|||
130533795|NCT03829501|469922494|FG007|Overall Study|PD|0|||
130533796|NCT03829501|469922495|FG008|Overall Study|PD|0|||
130533797|NCT03829501|469922496|FG009|Overall Study|PD|0|||
130533798|NCT03829501|469922497|FG010|Overall Study|PD|0|||
130533799|NCT03829501|469922498|FG011|Overall Study|PD|0|||
130533800|NCT03829501|469922499|FG012|Overall Study|PD|0|||
130533801|NCT03829501|469922500|FG013|Overall Study|PD|0|||
130533802|NCT03829501|469922501|FG014|Overall Study|PD|0|||
130533803|NCT03829501|469922502|FG015|Overall Study|PD|1|||
130533804|NCT03829501|469922503|FG016|Overall Study|PD|0|||
130533805|NCT03829501|469922504|FG017|Overall Study|PD|0|||
130533806|NCT03829501|469922505|FG018|Overall Study|PD|0|||
130533807|NCT03829501|469922506|FG019|Overall Study|PD|0|||
130533808|NCT03829501|469922507|FG020|Overall Study|PD|1|||
130533809|NCT03829501|469922508|FG021|Overall Study|PD|0|||
130533810|NCT03829501|469922509|FG022|Overall Study|PD|0|||
130533811|NCT03829501|469922487|FG000|Overall Study|Study Terminated by Sponsor|0|||
130533812|NCT03829501|469922488|FG001|Overall Study|Study Terminated by Sponsor|0|||
130533813|NCT03829501|469922489|FG002|Overall Study|Study Terminated by Sponsor|0|||
130533814|NCT03829501|469922490|FG003|Overall Study|Study Terminated by Sponsor|0|||
130533815|NCT03829501|469922491|FG004|Overall Study|Study Terminated by Sponsor|0|||
130533816|NCT03829501|469922492|FG005|Overall Study|Study Terminated by Sponsor|0|||
130533817|NCT03829501|469922493|FG006|Overall Study|Study Terminated by Sponsor|0|||
130533818|NCT03829501|469922494|FG007|Overall Study|Study Terminated by Sponsor|3|||
130533819|NCT03829501|469922495|FG008|Overall Study|Study Terminated by Sponsor|1|||
130533820|NCT03829501|469922496|FG009|Overall Study|Study Terminated by Sponsor|0|||
130533821|NCT03829501|469922497|FG010|Overall Study|Study Terminated by Sponsor|0|||
130533822|NCT03829501|469922498|FG011|Overall Study|Study Terminated by Sponsor|0|||
130533823|NCT03829501|469922499|FG012|Overall Study|Study Terminated by Sponsor|0|||
130533824|NCT03829501|469922500|FG013|Overall Study|Study Terminated by Sponsor|0|||
130533825|NCT03829501|469922501|FG014|Overall Study|Study Terminated by Sponsor|3|||
130533826|NCT03829501|469922502|FG015|Overall Study|Study Terminated by Sponsor|2|||
130533827|NCT03829501|469922503|FG016|Overall Study|Study Terminated by Sponsor|2|||
130533828|NCT03829501|469922504|FG017|Overall Study|Study Terminated by Sponsor|0|||
130533829|NCT03829501|469922505|FG018|Overall Study|Study Terminated by Sponsor|0|||
130533830|NCT03829501|469922506|FG019|Overall Study|Study Terminated by Sponsor|0|||
130533831|NCT03829501|469922507|FG020|Overall Study|Study Terminated by Sponsor|1|||
130533832|NCT03829501|469922508|FG021|Overall Study|Study Terminated by Sponsor|0|||
130533833|NCT03829501|469922509|FG022|Overall Study|Study Terminated by Sponsor|3|||
130533834|NCT03829501|469922487|FG000|Overall Study|Lost to Follow Up|0|||
130533835|NCT03829501|469922488|FG001|Overall Study|Lost to Follow Up|0|||
130533836|NCT03829501|469922489|FG002|Overall Study|Lost to Follow Up|0|||
130533837|NCT03829501|469922490|FG003|Overall Study|Lost to Follow Up|0|||
130533838|NCT03829501|469922491|FG004|Overall Study|Lost to Follow Up|1|||
130533839|NCT03829501|469922492|FG005|Overall Study|Lost to Follow Up|0|||
130533840|NCT03829501|469922493|FG006|Overall Study|Lost to Follow Up|0|||
130533841|NCT03829501|469922494|FG007|Overall Study|Lost to Follow Up|2|||
130533842|NCT03829501|469922495|FG008|Overall Study|Lost to Follow Up|2|||
130533843|NCT03829501|469922496|FG009|Overall Study|Lost to Follow Up|0|||
130533844|NCT03829501|469922497|FG010|Overall Study|Lost to Follow Up|2|||
130533845|NCT03829501|469922498|FG011|Overall Study|Lost to Follow Up|1|||
130533846|NCT03829501|469922499|FG012|Overall Study|Lost to Follow Up|0|||
130533847|NCT03829501|469922500|FG013|Overall Study|Lost to Follow Up|1|||
130533848|NCT03829501|469922501|FG014|Overall Study|Lost to Follow Up|1|||
130533849|NCT03829501|469922502|FG015|Overall Study|Lost to Follow Up|0|||
130533850|NCT03829501|469922503|FG016|Overall Study|Lost to Follow Up|0|||
130533851|NCT03829501|469922504|FG017|Overall Study|Lost to Follow Up|0|||
130533852|NCT03829501|469922505|FG018|Overall Study|Lost to Follow Up|0|||
130533853|NCT03829501|469922506|FG019|Overall Study|Lost to Follow Up|0|||
130533854|NCT03829501|469922507|FG020|Overall Study|Lost to Follow Up|0|||
130533855|NCT03829501|469922508|FG021|Overall Study|Lost to Follow Up|0|||
130533856|NCT03829501|469922509|FG022|Overall Study|Lost to Follow Up|1|||
130533857|NCT03829501|469922487|FG000|Overall Study|Death|2|||
130533858|NCT03829501|469922488|FG001|Overall Study|Death|4|||
130533859|NCT03829501|469922489|FG002|Overall Study|Death|5|||
130533860|NCT03829501|469922490|FG003|Overall Study|Death|6|||
130533861|NCT03829501|469922491|FG004|Overall Study|Death|5|||
130533862|NCT03829501|469922492|FG005|Overall Study|Death|4|||
130533863|NCT03829501|469922493|FG006|Overall Study|Death|5|||
130533864|NCT03829501|469922494|FG007|Overall Study|Death|24|||
130533865|NCT03829501|469922495|FG008|Overall Study|Death|22|||
130533866|NCT03829501|469922496|FG009|Overall Study|Death|6|||
130533867|NCT03829501|469922497|FG010|Overall Study|Death|3|||
130533868|NCT03829501|469922498|FG011|Overall Study|Death|10|||
130533869|NCT03829501|469922499|FG012|Overall Study|Death|10|||
130533870|NCT03829501|469922500|FG013|Overall Study|Death|5|||
130533871|NCT03829501|469922501|FG014|Overall Study|Death|7|||
130533872|NCT03829501|469922502|FG015|Overall Study|Death|2|||
130533873|NCT03829501|469922503|FG016|Overall Study|Death|2|||
130533874|NCT03829501|469922504|FG017|Overall Study|Death|1|||
130533875|NCT03829501|469922505|FG018|Overall Study|Death|1|||
130533876|NCT03829501|469922506|FG019|Overall Study|Death|1|||
130533877|NCT03829501|469922507|FG020|Overall Study|Death|1|||
130533878|NCT03829501|469922508|FG021|Overall Study|Death|2|||
130533879|NCT03829501|469922509|FG022|Overall Study|Death|3|||
130533880|NCT03829501|469922487|FG000|Overall Study|Miscellaneous|0|||
130533881|NCT03829501|469922488|FG001|Overall Study|Miscellaneous|0|||
130533882|NCT03829501|469922489|FG002|Overall Study|Miscellaneous|1|||
130533883|NCT03829501|469922490|FG003|Overall Study|Miscellaneous|0|||
130533884|NCT03829501|469922491|FG004|Overall Study|Miscellaneous|0|||
130533885|NCT03829501|469922492|FG005|Overall Study|Miscellaneous|0|||
130533886|NCT03829501|469922493|FG006|Overall Study|Miscellaneous|0|||
130533887|NCT03829501|469922494|FG007|Overall Study|Miscellaneous|1|||
130533888|NCT03829501|469922495|FG008|Overall Study|Miscellaneous|0|||
130533889|NCT03829501|469922496|FG009|Overall Study|Miscellaneous|0|||
130533890|NCT03829501|469922497|FG010|Overall Study|Miscellaneous|0|||
130533891|NCT03829501|469922498|FG011|Overall Study|Miscellaneous|0|||
130533892|NCT03829501|469922499|FG012|Overall Study|Miscellaneous|0|||
130533893|NCT03829501|469922500|FG013|Overall Study|Miscellaneous|0|||
130533894|NCT03829501|469922501|FG014|Overall Study|Miscellaneous|0|||
130533895|NCT03829501|469922502|FG015|Overall Study|Miscellaneous|0|||
130533896|NCT03829501|469922503|FG016|Overall Study|Miscellaneous|0|||
130533897|NCT03829501|469922504|FG017|Overall Study|Miscellaneous|0|||
130533898|NCT03829501|469922505|FG018|Overall Study|Miscellaneous|0|||
130533899|NCT03829501|469922506|FG019|Overall Study|Miscellaneous|0|||
130533900|NCT03829501|469922507|FG020|Overall Study|Miscellaneous|0|||
130533901|NCT03829501|469922508|FG021|Overall Study|Miscellaneous|0|||
130533902|NCT03829501|469922509|FG022|Overall Study|Miscellaneous|1|||
130533903|NCT01123070|469922510|FG000|Part B Double Blind Period|Protocol Violation|0|||
130533904|NCT01123070|469922511|FG001|Part B Double Blind Period|Protocol Violation|0|||
130582603|NCT00947531|470098792|FG001|Overall Study|Administrative Reason|1|||
130582604|NCT00947531|470098791|FG000|Overall Study|Adverse Event|2|||
130582605|NCT00947531|470098792|FG001|Overall Study|Adverse Event|2|||
130533905|NCT01123070|469922512|FG002|Part B Double Blind Period|Protocol Violation|0|||
130533906|NCT01123070|469922513|FG003|Part B Double Blind Period|Protocol Violation|1|||
130533907|NCT01123070|469922510|FG000|Part B Double Blind Period|Adverse Event|0|||
130533908|NCT01123070|469922511|FG001|Part B Double Blind Period|Adverse Event|0|||
130533909|NCT01123070|469922512|FG002|Part B Double Blind Period|Adverse Event|2|||
130533910|NCT01123070|469922513|FG003|Part B Double Blind Period|Adverse Event|0|||
130533911|NCT01123070|469922510|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
130533912|NCT01123070|469922511|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
130582606|NCT00947531|470098791|FG000|Overall Study|Lack of Efficacy|1|||
130533913|NCT01123070|469922512|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
130533914|NCT01123070|469922513|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
130533915|NCT03284229|469922514|FG000|Overall Study|Lost to Follow-up|3|||
130533916|NCT04165031|469922515|FG000|Overall Study|Adverse Event|1|||
130533917|NCT04165031|469922516|FG001|Overall Study|Adverse Event|1|||
130533918|NCT04165031|469922517|FG002|Overall Study|Adverse Event|0|||
130533919|NCT04165031|469922518|FG003|Overall Study|Adverse Event|0|||
130533920|NCT04165031|469922519|FG004|Overall Study|Adverse Event|0|||
130533921|NCT04165031|469922520|FG005|Overall Study|Adverse Event|0|||
130533922|NCT04165031|469922515|FG000|Overall Study|Withdrawal by Subject|0|||
130533923|NCT04165031|469922516|FG001|Overall Study|Withdrawal by Subject|0|||
130533924|NCT04165031|469922517|FG002|Overall Study|Withdrawal by Subject|1|||
130533925|NCT04165031|469922518|FG003|Overall Study|Withdrawal by Subject|0|||
130533926|NCT04165031|469922519|FG004|Overall Study|Withdrawal by Subject|0|||
130533927|NCT04165031|469922520|FG005|Overall Study|Withdrawal by Subject|0|||
130533928|NCT01332630|469922521|FG000|Overall Study|Withdrawal by Subject|3|||
130533929|NCT03140280|469922522|FG000|Overall Study|Physician Decision|5|||
130533930|NCT00663702|469922531|FG000|Overall Study|Adverse Event|8|||
130533931|NCT00663702|469922532|FG001|Overall Study|Adverse Event|4|||
130533932|NCT00663702|469922531|FG000|Overall Study|Withdrawal by Subject|3|||
130533933|NCT00663702|469922532|FG001|Overall Study|Withdrawal by Subject|1|||
130533934|NCT00663702|469922531|FG000|Overall Study|Pregnancy|0|||
130533935|NCT00663702|469922532|FG001|Overall Study|Pregnancy|1|||
130533936|NCT00663702|469922531|FG000|Overall Study|Lost to Follow-up|3|||
130533937|NCT00663702|469922532|FG001|Overall Study|Lost to Follow-up|0|||
130533938|NCT00663702|469922531|FG000|Overall Study|Death|1|||
130533939|NCT00663702|469922532|FG001|Overall Study|Death|1|||
130533940|NCT00663702|469922531|FG000|Overall Study|Lack of Efficacy|3|||
130533941|NCT00663702|469922532|FG001|Overall Study|Lack of Efficacy|3|||
130533942|NCT01498887|469922533|FG000|Overall Study|Administrative problems|1|||
130533943|NCT01498887|469922534|FG001|Overall Study|Administrative problems|0|||
130533944|NCT01498887|469922533|FG000|Overall Study|Lost to Follow-up|1|||
130533945|NCT01498887|469922534|FG001|Overall Study|Lost to Follow-up|1|||
130533946|NCT01498887|469922533|FG000|Overall Study|Withdrawal by Subject|1|||
130533947|NCT01498887|469922534|FG001|Overall Study|Withdrawal by Subject|0|||
130533948|NCT01498887|469922533|FG000|Overall Study|Protocol Violation|1|||
130533949|NCT01498887|469922534|FG001|Overall Study|Protocol Violation|3|||
130533950|NCT01498887|469922533|FG000|Overall Study|Lack of Efficacy|5|||
130533951|NCT01498887|469922534|FG001|Overall Study|Lack of Efficacy|3|||
130533952|NCT01498887|469922533|FG000|Overall Study|Abnormal result from test procedure|1|||
130533953|NCT01498887|469922534|FG001|Overall Study|Abnormal result from test procedure|1|||
130533954|NCT01498887|469922533|FG000|Overall Study|Abnormal laboratory value|2|||
130533955|NCT01498887|469922534|FG001|Overall Study|Abnormal laboratory value|2|||
130533956|NCT01498887|469922533|FG000|Overall Study|Adverse Event|4|||
130533957|NCT01498887|469922534|FG001|Overall Study|Adverse Event|1|||
130533958|NCT00667225|469922537|FG000|Overall Study|Subject had no more lesions to treat.|1|||
130533959|NCT00667225|469922538|FG001|Overall Study|Subject had no more lesions to treat.|0|||
130533960|NCT00667225|469922537|FG000|Overall Study|Lost to Follow-up|0|||
130533961|NCT00667225|469922538|FG001|Overall Study|Lost to Follow-up|1|||
130533962|NCT02440425|469922539|FG000|Overall Study|Death likely due to disease progression|1|||
130533963|NCT02440425|469922539|FG000|Overall Study|Withdrawal by Subject|2|||
130533964|NCT02440425|469922539|FG000|Overall Study|Adverse Event|1|||
130533965|NCT02440425|469922539|FG000|Overall Study|Adverse Event/Ineligible|1|||
130533966|NCT00214019|469922540|FG000|Overall Study|Lost to Follow-up|11|||
130533967|NCT00214019|469922540|FG000|Overall Study|Withdrawal by Subject|2|||
130533968|NCT00214019|469922540|FG000|Overall Study|Screen Failed prior to randomization|17|||
130533969|NCT03635099|469922543|FG000|Period 1|Adverse Event|1|||
130533970|NCT03635099|469922544|FG001|Period 1|Adverse Event|0|||
130533971|NCT03635099|469922545|FG002|Period 1|Adverse Event|0|||
130533972|NCT03635099|469922546|FG003|Period 1|Adverse Event|1|||
130533973|NCT03635099|469922547|FG004|Period 1|Adverse Event|0|||
130533974|NCT03635099|469922548|FG005|Period 1|Adverse Event|0|||
130533975|NCT03635099|469922549|FG006|Period 1|Adverse Event|0|||
130533976|NCT03635099|469922550|FG007|Period 1|Adverse Event|0|||
130533977|NCT03635099|469922543|FG000|Period 1|Protocol Violation|0|||
130533978|NCT03635099|469922544|FG001|Period 1|Protocol Violation|0|||
130582607|NCT00947531|470098792|FG001|Overall Study|Lack of Efficacy|0|||
130582608|NCT00947531|470098791|FG000|Overall Study|Other|1|||
130582609|NCT00947531|470098792|FG001|Overall Study|Other|1|||
130582610|NCT01773421|470098794|FG000|Treatment Phase|Other|0|||
130582611|NCT01773421|470098795|FG001|Treatment Phase|Other|0|||
130582612|NCT01773421|470098796|FG002|Treatment Phase|Other|2|||
130582613|NCT01773421|470098797|FG003|Treatment Phase|Other|0|||
130582614|NCT01773421|470098798|FG004|Treatment Phase|Other|0|||
130582615|NCT01773421|470098799|FG005|Treatment Phase|Other|0|||
130582616|NCT01773421|470098800|FG006|Treatment Phase|Other|0|||
130582617|NCT01773421|470098794|FG000|Treatment Phase|Adverse Event|0|||
130582618|NCT01773421|470098795|FG001|Treatment Phase|Adverse Event|0|||
130582619|NCT01773421|470098796|FG002|Treatment Phase|Adverse Event|3|||
130582620|NCT01773421|470098797|FG003|Treatment Phase|Adverse Event|1|||
130582621|NCT01773421|470098798|FG004|Treatment Phase|Adverse Event|0|||
130582622|NCT01773421|470098799|FG005|Treatment Phase|Adverse Event|0|||
130582623|NCT01773421|470098800|FG006|Treatment Phase|Adverse Event|0|||
130582624|NCT01773421|470098794|FG000|Treatment Phase|Withdrawal by Subject|0|||
130582625|NCT01773421|470098795|FG001|Treatment Phase|Withdrawal by Subject|0|||
130582626|NCT01773421|470098796|FG002|Treatment Phase|Withdrawal by Subject|1|||
130582627|NCT01773421|470098797|FG003|Treatment Phase|Withdrawal by Subject|1|||
130582628|NCT01773421|470098798|FG004|Treatment Phase|Withdrawal by Subject|0|||
130582629|NCT01773421|470098799|FG005|Treatment Phase|Withdrawal by Subject|0|||
130582630|NCT01773421|470098800|FG006|Treatment Phase|Withdrawal by Subject|0|||
130582631|NCT01773421|470098794|FG000|Extension Phase|Other|0|||
130582632|NCT01773421|470098795|FG001|Extension Phase|Other|0|||
130582633|NCT01773421|470098796|FG002|Extension Phase|Other|0|||
130582634|NCT01773421|470098797|FG003|Extension Phase|Other|0|||
130582635|NCT01773421|470098798|FG004|Extension Phase|Other|1|||
130582636|NCT01773421|470098799|FG005|Extension Phase|Other|2|||
130582637|NCT01773421|470098800|FG006|Extension Phase|Other|0|||
130582638|NCT01773421|470098794|FG000|Extension Phase|Adverse Event|0|||
130582639|NCT01773421|470098795|FG001|Extension Phase|Adverse Event|0|||
130582640|NCT01773421|470098796|FG002|Extension Phase|Adverse Event|0|||
130582641|NCT01773421|470098797|FG003|Extension Phase|Adverse Event|0|||
130582642|NCT01773421|470098798|FG004|Extension Phase|Adverse Event|2|||
130582643|NCT01773421|470098799|FG005|Extension Phase|Adverse Event|0|||
130582644|NCT01773421|470098800|FG006|Extension Phase|Adverse Event|0|||
130582645|NCT03502330|470098801|FG000|Overall Study|Adverse Event|2|||
130582646|NCT03502330|470098802|FG001|Overall Study|Adverse Event|1|||
130582647|NCT03502330|470098803|FG002|Overall Study|Adverse Event|0|||
130582648|NCT03502330|470098804|FG003|Overall Study|Adverse Event|0|||
130582649|NCT03502330|470098805|FG004|Overall Study|Adverse Event|1|||
130582650|NCT03502330|470098806|FG005|Overall Study|Adverse Event|0|||
130582651|NCT03502330|470098807|FG006|Overall Study|Adverse Event|1|||
130582652|NCT03502330|470098808|FG007|Overall Study|Adverse Event|1|||
130582653|NCT03502330|470098809|FG008|Overall Study|Adverse Event|0|||
130582654|NCT03502330|470098801|FG000|Overall Study|Lack of Efficacy|1|||
130582655|NCT03502330|470098802|FG001|Overall Study|Lack of Efficacy|5|||
130582656|NCT03502330|470098803|FG002|Overall Study|Lack of Efficacy|3|||
130582657|NCT03502330|470098804|FG003|Overall Study|Lack of Efficacy|5|||
130582658|NCT03502330|470098805|FG004|Overall Study|Lack of Efficacy|1|||
130582659|NCT03502330|470098806|FG005|Overall Study|Lack of Efficacy|5|||
130582660|NCT03502330|470098807|FG006|Overall Study|Lack of Efficacy|5|||
130582661|NCT03502330|470098808|FG007|Overall Study|Lack of Efficacy|6|||
130582662|NCT03502330|470098809|FG008|Overall Study|Lack of Efficacy|0|||
130582663|NCT03502330|470098801|FG000|Overall Study|Physician Decision|0|||
130582664|NCT03502330|470098802|FG001|Overall Study|Physician Decision|0|||
130582665|NCT03502330|470098803|FG002|Overall Study|Physician Decision|0|||
130582666|NCT03502330|470098804|FG003|Overall Study|Physician Decision|0|||
130582667|NCT03502330|470098805|FG004|Overall Study|Physician Decision|1|||
130582668|NCT03502330|470098806|FG005|Overall Study|Physician Decision|0|||
130582669|NCT03502330|470098807|FG006|Overall Study|Physician Decision|0|||
130582670|NCT03502330|470098808|FG007|Overall Study|Physician Decision|0|||
130582671|NCT03502330|470098809|FG008|Overall Study|Physician Decision|0|||
130582672|NCT03502330|470098801|FG000|Overall Study|Withdrawal by Subject|0|||
130582673|NCT03502330|470098802|FG001|Overall Study|Withdrawal by Subject|0|||
130582674|NCT03502330|470098803|FG002|Overall Study|Withdrawal by Subject|0|||
130582675|NCT03502330|470098804|FG003|Overall Study|Withdrawal by Subject|0|||
130582676|NCT03502330|470098805|FG004|Overall Study|Withdrawal by Subject|0|||
130582677|NCT03502330|470098806|FG005|Overall Study|Withdrawal by Subject|1|||
130582678|NCT03502330|470098807|FG006|Overall Study|Withdrawal by Subject|0|||
130582679|NCT03502330|470098808|FG007|Overall Study|Withdrawal by Subject|1|||
130582680|NCT03502330|470098809|FG008|Overall Study|Withdrawal by Subject|0|||
130582681|NCT03502330|470098801|FG000|Overall Study|Death|0|||
130582682|NCT03502330|470098802|FG001|Overall Study|Death|0|||
130582683|NCT03502330|470098803|FG002|Overall Study|Death|0|||
130582684|NCT03502330|470098804|FG003|Overall Study|Death|0|||
130582685|NCT03502330|470098805|FG004|Overall Study|Death|0|||
130582686|NCT03502330|470098806|FG005|Overall Study|Death|0|||
130582687|NCT03502330|470098807|FG006|Overall Study|Death|2|||
130582688|NCT03502330|470098808|FG007|Overall Study|Death|0|||
130533979|NCT03635099|469922545|FG002|Period 1|Protocol Violation|1|||
130533980|NCT03635099|469922546|FG003|Period 1|Protocol Violation|0|||
130533981|NCT03635099|469922547|FG004|Period 1|Protocol Violation|0|||
130533982|NCT03635099|469922548|FG005|Period 1|Protocol Violation|0|||
130533983|NCT03635099|469922549|FG006|Period 1|Protocol Violation|0|||
130533984|NCT03635099|469922550|FG007|Period 1|Protocol Violation|0|||
130533985|NCT03635099|469922543|FG000|Period 1|Lost to Follow-up|0|||
130533986|NCT03635099|469922544|FG001|Period 1|Lost to Follow-up|0|||
130533987|NCT03635099|469922545|FG002|Period 1|Lost to Follow-up|1|||
130533988|NCT03635099|469922546|FG003|Period 1|Lost to Follow-up|2|||
130533989|NCT03635099|469922547|FG004|Period 1|Lost to Follow-up|1|||
130533990|NCT03635099|469922548|FG005|Period 1|Lost to Follow-up|0|||
130533991|NCT03635099|469922549|FG006|Period 1|Lost to Follow-up|1|||
130533992|NCT03635099|469922550|FG007|Period 1|Lost to Follow-up|2|||
130533993|NCT03635099|469922543|FG000|Period 1|Withdrawal by Subject|3|||
130533994|NCT03635099|469922544|FG001|Period 1|Withdrawal by Subject|3|||
130533995|NCT03635099|469922545|FG002|Period 1|Withdrawal by Subject|5|||
130533996|NCT03635099|469922546|FG003|Period 1|Withdrawal by Subject|2|||
130533997|NCT03635099|469922547|FG004|Period 1|Withdrawal by Subject|2|||
130533998|NCT03635099|469922548|FG005|Period 1|Withdrawal by Subject|0|||
130533999|NCT03635099|469922549|FG006|Period 1|Withdrawal by Subject|3|||
130534000|NCT03635099|469922550|FG007|Period 1|Withdrawal by Subject|0|||
130534001|NCT03635099|469922543|FG000|Period 1|History of suicidal ideation|0|||
130534002|NCT03635099|469922544|FG001|Period 1|History of suicidal ideation|0|||
130534003|NCT03635099|469922545|FG002|Period 1|History of suicidal ideation|1|||
130534004|NCT03635099|469922546|FG003|Period 1|History of suicidal ideation|0|||
130534005|NCT03635099|469922547|FG004|Period 1|History of suicidal ideation|0|||
130534006|NCT03635099|469922548|FG005|Period 1|History of suicidal ideation|0|||
130534007|NCT03635099|469922549|FG006|Period 1|History of suicidal ideation|0|||
130534008|NCT03635099|469922550|FG007|Period 1|History of suicidal ideation|0|||
130534009|NCT03635099|469922543|FG000|Period 1|pursue other treatment options|0|||
130534010|NCT03635099|469922544|FG001|Period 1|pursue other treatment options|0|||
130534011|NCT03635099|469922545|FG002|Period 1|pursue other treatment options|0|||
130534012|NCT03635099|469922546|FG003|Period 1|pursue other treatment options|0|||
130534013|NCT03635099|469922547|FG004|Period 1|pursue other treatment options|0|||
130534014|NCT03635099|469922548|FG005|Period 1|pursue other treatment options|1|||
130534015|NCT03635099|469922549|FG006|Period 1|pursue other treatment options|0|||
130534016|NCT03635099|469922550|FG007|Period 1|pursue other treatment options|0|||
130534017|NCT03635099|469922543|FG000|Not Eligible for Period 2|Pregnancy|0|||
130534018|NCT03635099|469922544|FG001|Not Eligible for Period 2|Pregnancy|0|||
130534019|NCT03635099|469922545|FG002|Not Eligible for Period 2|Pregnancy|0|||
130534020|NCT03635099|469922546|FG003|Not Eligible for Period 2|Pregnancy|1|||
130534021|NCT03635099|469922547|FG004|Not Eligible for Period 2|Pregnancy|0|||
130534022|NCT03635099|469922548|FG005|Not Eligible for Period 2|Pregnancy|0|||
130534023|NCT03635099|469922549|FG006|Not Eligible for Period 2|Pregnancy|0|||
130534024|NCT03635099|469922550|FG007|Not Eligible for Period 2|Pregnancy|0|||
130534025|NCT03635099|469922543|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
130534026|NCT03635099|469922544|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534027|NCT03635099|469922545|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534028|NCT03635099|469922546|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534029|NCT03635099|469922547|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534030|NCT03635099|469922548|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534031|NCT03635099|469922549|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534032|NCT03635099|469922550|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
130534033|NCT03635099|469922543|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
130534034|NCT03635099|469922544|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
130534035|NCT03635099|469922545|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
130534036|NCT03635099|469922546|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
130534037|NCT03635099|469922547|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
130534038|NCT03635099|469922548|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
130534039|NCT03635099|469922549|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
130534040|NCT03635099|469922550|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
130534041|NCT03635099|469922543|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
130534042|NCT03635099|469922544|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
130534043|NCT03635099|469922545|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
130534044|NCT03635099|469922546|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
130534045|NCT03635099|469922547|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
130534046|NCT03635099|469922548|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
130534047|NCT03635099|469922549|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
130534048|NCT03635099|469922550|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
130534049|NCT03635099|469922543|FG000|Period 2|Adverse Event|0|||
130534050|NCT03635099|469922544|FG001|Period 2|Adverse Event|0|||
130582689|NCT03502330|470098809|FG008|Overall Study|Death|0|||
130582690|NCT02804763|470098810|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
130582691|NCT02804763|470098811|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130582692|NCT02804763|470098812|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130582693|NCT02804763|470098813|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130582694|NCT02804763|470098810|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
130582695|NCT02804763|470098811|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
130582696|NCT02804763|470098812|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
130582697|NCT02804763|470098813|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
130582698|NCT02804763|470098810|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130582699|NCT02804763|470098811|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
130582700|NCT02804763|470098812|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130582701|NCT02804763|470098813|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130582702|NCT02804763|470098810|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
130582703|NCT02804763|470098811|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
130582704|NCT02804763|470098812|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
130582705|NCT02804763|470098813|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
130582706|NCT02804763|470098810|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
130582707|NCT02804763|470098811|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
130582708|NCT02804763|470098812|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
130582709|NCT02804763|470098813|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
130582710|NCT02804763|470098810|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130582711|NCT02804763|470098811|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
130582712|NCT02804763|470098812|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130582713|NCT02804763|470098813|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130582714|NCT02472847|470098814|FG000|Overall Study|Withdrawal by Subject|1|||
130582715|NCT02472847|470098815|FG001|Overall Study|Withdrawal by Subject|5|||
130582716|NCT04656990|470098816|FG000|Baseline|pandemic|20|||
130582717|NCT04656990|470098817|FG001|Baseline|pandemic|24|||
130582718|NCT04656990|470098816|FG000|Follow Up Period|Lost to Follow-up|61|||
130582719|NCT04656990|470098817|FG001|Follow Up Period|Lost to Follow-up|73|||
130582720|NCT00623831|470098820|FG000|Overall Study|Withdrawal by Subject|1|||
130582721|NCT00623831|470098821|FG001|Overall Study|Withdrawal by Subject|0|||
130582722|NCT00623831|470098820|FG000|Overall Study|Progressive Disease|0|||
130582723|NCT00623831|470098821|FG001|Overall Study|Progressive Disease|1|||
130582724|NCT00282243|470098822|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
130582725|NCT00282243|470098822|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
130582726|NCT00282243|470098822|FG000|Extension Treatment Period|Adverse Event|15|||
130582727|NCT00282243|470098822|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
130582728|NCT00282243|470098822|FG000|Extension Treatment Period|Non-compliance|2|||
130582729|NCT00282243|470098822|FG000|Extension Treatment Period|Physician Decision|1|||
130582730|NCT01070329|470098823|FG000|Overall Study|Adverse Event|13|||
130582731|NCT01070329|470098824|FG001|Overall Study|Adverse Event|10|||
130582732|NCT01070329|470098823|FG000|Overall Study|Lost to Follow-up|22|||
130582733|NCT01070329|470098824|FG001|Overall Study|Lost to Follow-up|12|||
130582734|NCT01070329|470098823|FG000|Overall Study|Withdrawal by Subject|9|||
130582735|NCT01070329|470098824|FG001|Overall Study|Withdrawal by Subject|11|||
130582736|NCT01070329|470098823|FG000|Overall Study|Protocol Violation|3|||
130582737|NCT01070329|470098824|FG001|Overall Study|Protocol Violation|8|||
130582738|NCT01070329|470098823|FG000|Overall Study|Lack of Efficacy|2|||
130582739|NCT01070329|470098824|FG001|Overall Study|Lack of Efficacy|6|||
130582740|NCT01070329|470098823|FG000|Overall Study|Physician Decision|2|||
130582741|NCT01070329|470098824|FG001|Overall Study|Physician Decision|1|||
130582742|NCT01070329|470098823|FG000|Overall Study|Entry Criteria Not Met|1|||
130582743|NCT01070329|470098824|FG001|Overall Study|Entry Criteria Not Met|0|||
130582744|NCT01070329|470098823|FG000|Overall Study|Sponsor Decision|0|||
130582745|NCT01070329|470098824|FG001|Overall Study|Sponsor Decision|1|||
130582746|NCT02863848|470098827|FG000|Overall Study|Lost to Follow-up|1|||
130582747|NCT02863848|470098828|FG001|Overall Study|Lost to Follow-up|1|||
130582748|NCT02863848|470098827|FG000|Overall Study|Protocol Violation|1|||
130582749|NCT02863848|470098828|FG001|Overall Study|Protocol Violation|2|||
130582750|NCT03588741|470098833|FG000|Overall Study|Withdrawal by Subject|1|||
130582751|NCT02522767|470098834|FG000|Double-blind|Withdrawal by Subject|8|||
130582752|NCT02522767|470098835|FG001|Double-blind|Withdrawal by Subject|11|||
130582753|NCT02522767|470098834|FG000|Double-blind|Lost to Follow-up|1|||
130582754|NCT02522767|470098835|FG001|Double-blind|Lost to Follow-up|0|||
130534051|NCT03635099|469922545|FG002|Period 2|Adverse Event|1|||
130534052|NCT03635099|469922546|FG003|Period 2|Adverse Event|0|||
130534053|NCT03635099|469922547|FG004|Period 2|Adverse Event|1|||
130534054|NCT03635099|469922548|FG005|Period 2|Adverse Event|0|||
130534055|NCT03635099|469922549|FG006|Period 2|Adverse Event|0|||
130534056|NCT03635099|469922550|FG007|Period 2|Adverse Event|0|||
130534057|NCT03635099|469922543|FG000|Period 2|Lost to Follow-up|0|||
130534058|NCT03635099|469922544|FG001|Period 2|Lost to Follow-up|0|||
130534059|NCT03635099|469922545|FG002|Period 2|Lost to Follow-up|1|||
130534060|NCT03635099|469922546|FG003|Period 2|Lost to Follow-up|0|||
130534061|NCT03635099|469922547|FG004|Period 2|Lost to Follow-up|4|||
130534062|NCT03635099|469922548|FG005|Period 2|Lost to Follow-up|0|||
130534063|NCT03635099|469922549|FG006|Period 2|Lost to Follow-up|0|||
130534064|NCT03635099|469922550|FG007|Period 2|Lost to Follow-up|0|||
130534065|NCT03635099|469922543|FG000|Period 2|Withdrawal by Subject|0|||
130534066|NCT03635099|469922544|FG001|Period 2|Withdrawal by Subject|0|||
130534067|NCT03635099|469922545|FG002|Period 2|Withdrawal by Subject|7|||
130534068|NCT03635099|469922546|FG003|Period 2|Withdrawal by Subject|4|||
130534069|NCT03635099|469922547|FG004|Period 2|Withdrawal by Subject|7|||
130534070|NCT03635099|469922548|FG005|Period 2|Withdrawal by Subject|0|||
130534071|NCT03635099|469922549|FG006|Period 2|Withdrawal by Subject|0|||
130534072|NCT03635099|469922550|FG007|Period 2|Withdrawal by Subject|0|||
130534073|NCT01068665|469922551|FG000|Overall Study|Adverse Event|5|||
130534074|NCT01068665|469922552|FG001|Overall Study|Adverse Event|4|||
130534075|NCT01068665|469922551|FG000|Overall Study|Lack of Efficacy|0|||
130534076|NCT01068665|469922552|FG001|Overall Study|Lack of Efficacy|2|||
130534077|NCT01068665|469922551|FG000|Overall Study|Protocol Violation|5|||
130534078|NCT01068665|469922552|FG001|Overall Study|Protocol Violation|2|||
130534079|NCT01068665|469922551|FG000|Overall Study|Withdrawal Criteria|3|||
130534080|NCT01068665|469922552|FG001|Overall Study|Withdrawal Criteria|9|||
130534081|NCT01068665|469922551|FG000|Overall Study|Other|17|||
130534082|NCT01068665|469922552|FG001|Overall Study|Other|12|||
130534083|NCT02807272|469922554|FG000|Overall Study|Death|9|||
130534084|NCT02807272|469922555|FG001|Overall Study|Death|5|||
130534085|NCT02807272|469922556|FG002|Overall Study|Death|2|||
130534086|NCT02807272|469922557|FG003|Overall Study|Death|0|||
130534087|NCT02807272|469922558|FG004|Overall Study|Death|1|||
130534088|NCT02807272|469922554|FG000|Overall Study|Lost to Follow-up|1|||
130534089|NCT02807272|469922555|FG001|Overall Study|Lost to Follow-up|0|||
130534090|NCT02807272|469922556|FG002|Overall Study|Lost to Follow-up|0|||
130534091|NCT02807272|469922557|FG003|Overall Study|Lost to Follow-up|0|||
130534092|NCT02807272|469922558|FG004|Overall Study|Lost to Follow-up|0|||
130534093|NCT02807272|469922554|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
130534094|NCT02807272|469922555|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
130534095|NCT02807272|469922556|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
130534096|NCT02807272|469922557|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
130534097|NCT02807272|469922558|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
130534098|NCT02807272|469922554|FG000|Overall Study|Protocol-defined Disease Progression|0|||
130534099|NCT02807272|469922555|FG001|Overall Study|Protocol-defined Disease Progression|1|||
130534100|NCT02807272|469922556|FG002|Overall Study|Protocol-defined Disease Progression|0|||
130534101|NCT02807272|469922557|FG003|Overall Study|Protocol-defined Disease Progression|0|||
130582755|NCT02522767|470098834|FG000|Double-blind|Adverse Event|1|||
130582756|NCT02522767|470098835|FG001|Double-blind|Adverse Event|10|||
130534102|NCT02807272|469922558|FG004|Overall Study|Protocol-defined Disease Progression|1|||
130534103|NCT02807272|469922554|FG000|Overall Study|Study Terminated by Sponsor|1|||
130534104|NCT02807272|469922555|FG001|Overall Study|Study Terminated by Sponsor|0|||
130534105|NCT02807272|469922556|FG002|Overall Study|Study Terminated by Sponsor|0|||
130534106|NCT02807272|469922557|FG003|Overall Study|Study Terminated by Sponsor|1|||
130534107|NCT02807272|469922558|FG004|Overall Study|Study Terminated by Sponsor|0|||
130534108|NCT02807272|469922554|FG000|Overall Study|Other|1|||
130534109|NCT02807272|469922555|FG001|Overall Study|Other|0|||
130534110|NCT02807272|469922556|FG002|Overall Study|Other|0|||
130534111|NCT02807272|469922557|FG003|Overall Study|Other|0|||
130534112|NCT02807272|469922558|FG004|Overall Study|Other|1|||
130582757|NCT02522767|470098834|FG000|Double-blind|Protocol Violation|0|||
130582758|NCT02522767|470098835|FG001|Double-blind|Protocol Violation|1|||
130582759|NCT02522767|470098834|FG000|Double-blind|Lack of Efficacy|0|||
130582760|NCT02522767|470098835|FG001|Double-blind|Lack of Efficacy|2|||
130582761|NCT02522767|470098834|FG000|Double-blind|Protocol Deviation|1|||
130582762|NCT02522767|470098835|FG001|Double-blind|Protocol Deviation|0|||
130582763|NCT02522767|470098834|FG000|Open-label|Withdrawal by Subject|2|||
130582764|NCT02522767|470098835|FG001|Open-label|Withdrawal by Subject|3|||
130582765|NCT02522767|470098834|FG000|Open-label|Lost to Follow-up|0|||
130582766|NCT02522767|470098835|FG001|Open-label|Lost to Follow-up|1|||
130582767|NCT02522767|470098834|FG000|Open-label|Adverse Event|2|||
130582768|NCT02522767|470098835|FG001|Open-label|Adverse Event|1|||
130582769|NCT02522767|470098834|FG000|Open-label|Lack of Efficacy|1|||
130582770|NCT02522767|470098835|FG001|Open-label|Lack of Efficacy|1|||
130582771|NCT02522767|470098834|FG000|Open-label|Protocol Violation|0|||
130582772|NCT02522767|470098835|FG001|Open-label|Protocol Violation|1|||
130582773|NCT00548548|470098836|FG000|Overall Study|Death|345|||
130582774|NCT00548548|470098837|FG001|Overall Study|Death|348|||
130582775|NCT00548548|470098836|FG000|Overall Study|Lost to Follow-up|17|||
130582776|NCT00548548|470098837|FG001|Overall Study|Lost to Follow-up|18|||
130582777|NCT01705691|470098838|FG000|Overall Study|Death|1|||
130582778|NCT01705691|470098839|FG001|Overall Study|Death|2|||
130582779|NCT01705691|470098838|FG000|Overall Study|Withdrawal by Subject|1|||
130582780|NCT01705691|470098839|FG001|Overall Study|Withdrawal by Subject|2|||
130582781|NCT01705691|470098838|FG000|Overall Study|Lost to Follow-up|1|||
130582782|NCT01705691|470098839|FG001|Overall Study|Lost to Follow-up|1|||
130582783|NCT01705691|470098838|FG000|Overall Study|Other|0|||
130582784|NCT01705691|470098839|FG001|Overall Study|Other|1|||
130582785|NCT02913313|470098840|FG000|Overall Study|DISEASE PROGRESSION|1|||
130582786|NCT02913313|470098841|FG001|Overall Study|DISEASE PROGRESSION|2|||
130582787|NCT02913313|470098842|FG002|Overall Study|DISEASE PROGRESSION|2|||
130582788|NCT02913313|470098843|FG003|Overall Study|DISEASE PROGRESSION|4|||
130582789|NCT02913313|470098844|FG004|Overall Study|DISEASE PROGRESSION|6|||
130582790|NCT02913313|470098845|FG005|Overall Study|DISEASE PROGRESSION|4|||
130582791|NCT02913313|470098846|FG006|Overall Study|DISEASE PROGRESSION|19|||
130582792|NCT02913313|470098847|FG007|Overall Study|DISEASE PROGRESSION|3|||
130582793|NCT02913313|470098848|FG008|Overall Study|DISEASE PROGRESSION|4|||
130582794|NCT02913313|470098849|FG009|Overall Study|DISEASE PROGRESSION|4|||
130582795|NCT02913313|470098850|FG010|Overall Study|DISEASE PROGRESSION|11|||
130582796|NCT02913313|470098851|FG011|Overall Study|DISEASE PROGRESSION|5|||
130582797|NCT02913313|470098852|FG012|Overall Study|DISEASE PROGRESSION|14|||
130582798|NCT02913313|470098853|FG013|Overall Study|DISEASE PROGRESSION|3|||
130582799|NCT02913313|470098840|FG000|Overall Study|Not Reported|0|||
130582800|NCT02913313|470098841|FG001|Overall Study|Not Reported|0|||
130582801|NCT02913313|470098842|FG002|Overall Study|Not Reported|0|||
130582802|NCT02913313|470098843|FG003|Overall Study|Not Reported|0|||
130582803|NCT02913313|470098844|FG004|Overall Study|Not Reported|1|||
130582804|NCT02913313|470098845|FG005|Overall Study|Not Reported|0|||
130582805|NCT02913313|470098846|FG006|Overall Study|Not Reported|0|||
130582806|NCT02913313|470098847|FG007|Overall Study|Not Reported|0|||
130582807|NCT02913313|470098848|FG008|Overall Study|Not Reported|0|||
130582808|NCT02913313|470098849|FG009|Overall Study|Not Reported|0|||
130582809|NCT02913313|470098850|FG010|Overall Study|Not Reported|4|||
130582810|NCT02913313|470098851|FG011|Overall Study|Not Reported|0|||
130582811|NCT02913313|470098852|FG012|Overall Study|Not Reported|0|||
130582812|NCT02913313|470098853|FG013|Overall Study|Not Reported|0|||
130582813|NCT02913313|470098840|FG000|Overall Study|Other reasons|0|||
130582814|NCT02913313|470098841|FG001|Overall Study|Other reasons|0|||
130582815|NCT02913313|470098842|FG002|Overall Study|Other reasons|0|||
130582816|NCT02913313|470098843|FG003|Overall Study|Other reasons|0|||
130582817|NCT02913313|470098844|FG004|Overall Study|Other reasons|1|||
130582818|NCT02913313|470098845|FG005|Overall Study|Other reasons|0|||
130582819|NCT02913313|470098846|FG006|Overall Study|Other reasons|0|||
130582820|NCT02913313|470098847|FG007|Overall Study|Other reasons|0|||
130582821|NCT02913313|470098848|FG008|Overall Study|Other reasons|0|||
130582822|NCT02913313|470098849|FG009|Overall Study|Other reasons|0|||
130582823|NCT02913313|470098850|FG010|Overall Study|Other reasons|1|||
130582824|NCT02913313|470098851|FG011|Overall Study|Other reasons|0|||
130582825|NCT02913313|470098852|FG012|Overall Study|Other reasons|0|||
130582826|NCT02913313|470098853|FG013|Overall Study|Other reasons|0|||
130582827|NCT02913313|470098840|FG000|Overall Study|Withdrawal by Subject|0|||
130582828|NCT02913313|470098841|FG001|Overall Study|Withdrawal by Subject|0|||
130582829|NCT02913313|470098842|FG002|Overall Study|Withdrawal by Subject|1|||
130582830|NCT02913313|470098843|FG003|Overall Study|Withdrawal by Subject|0|||
130582831|NCT02913313|470098844|FG004|Overall Study|Withdrawal by Subject|0|||
130582832|NCT02913313|470098845|FG005|Overall Study|Withdrawal by Subject|0|||
130582833|NCT02913313|470098846|FG006|Overall Study|Withdrawal by Subject|1|||
130582834|NCT02913313|470098847|FG007|Overall Study|Withdrawal by Subject|1|||
130582835|NCT02913313|470098848|FG008|Overall Study|Withdrawal by Subject|0|||
130534113|NCT04191616|469922560|FG000|Pre-assignment Period|Did not receive study treatment|2|||
130534114|NCT04191616|469922560|FG000|Treatment Period|Death|37|||
130534115|NCT04191616|469922560|FG000|Treatment Period|Sponsor decision|11|||
130534116|NCT04191616|469922560|FG000|Treatment Period|Withdrawal by Subject|4|||
130534117|NCT01038427|469922561|FG000|Overall Study|Lost to follow up|1|||
130534118|NCT01038427|469922562|FG001|Overall Study|Lost to follow up|1|||
130534119|NCT01038427|469922563|FG002|Overall Study|Lost to follow up|0|||
130534120|NCT01038427|469922561|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130534121|NCT01038427|469922562|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130534122|NCT01038427|469922563|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
130534123|NCT01038427|469922561|FG000|Overall Study|Withdrew consent|0|||
130534124|NCT01038427|469922562|FG001|Overall Study|Withdrew consent|0|||
130534125|NCT01038427|469922563|FG002|Overall Study|Withdrew consent|1|||
130534126|NCT01038427|469922561|FG000|Overall Study|Adverse Event|2|||
130534127|NCT01038427|469922562|FG001|Overall Study|Adverse Event|2|||
130534128|NCT01038427|469922563|FG002|Overall Study|Adverse Event|1|||
130534129|NCT01038427|469922561|FG000|Overall Study|Enrolled in error|0|||
130534130|NCT01038427|469922562|FG001|Overall Study|Enrolled in error|1|||
130534131|NCT01038427|469922563|FG002|Overall Study|Enrolled in error|1|||
130534132|NCT01038427|469922561|FG000|Overall Study|Other|0|||
130534133|NCT01038427|469922562|FG001|Overall Study|Other|2|||
130534134|NCT01038427|469922563|FG002|Overall Study|Other|0|||
130534135|NCT04230122|469922564|FG000|Overall Study|Lost to Follow-up|1|||
130534136|NCT04230122|469922565|FG001|Overall Study|Lost to Follow-up|0|||
130534137|NCT00604708|469922566|FG000|Overall Study|Withdrawal by Subject|9|||
130534138|NCT00604708|469922567|FG001|Overall Study|Withdrawal by Subject|10|||
130534139|NCT00604708|469922566|FG000|Overall Study|Protocol Violation|2|||
130534140|NCT00604708|469922567|FG001|Overall Study|Protocol Violation|8|||
130534141|NCT00604708|469922566|FG000|Overall Study|Lost to Follow-up|5|||
130534142|NCT00604708|469922567|FG001|Overall Study|Lost to Follow-up|5|||
130534143|NCT00604708|469922566|FG000|Overall Study|administrative reasons|9|||
130534144|NCT00604708|469922567|FG001|Overall Study|administrative reasons|11|||
130534145|NCT00604708|469922566|FG000|Overall Study|Adverse Event|6|||
130534146|NCT00604708|469922567|FG001|Overall Study|Adverse Event|6|||
130534147|NCT02180243|469922568|FG000|Overall Study|Withdrawal by Subject|12|||
130534148|NCT02180243|469922569|FG001|Overall Study|Withdrawal by Subject|12|||
130534149|NCT02180243|469922568|FG000|Overall Study|Lost to Follow-up|12|||
130534150|NCT02180243|469922569|FG001|Overall Study|Lost to Follow-up|2|||
130534151|NCT02202785|469922570|FG000|Overall Study|Study Terminated by Sponsor|1|||
130534152|NCT02202785|469922571|FG001|Overall Study|Study Terminated by Sponsor|6|||
130534153|NCT02202785|469922572|FG002|Overall Study|Study Terminated by Sponsor|4|||
130534154|NCT02202785|469922570|FG000|Overall Study|Withdrawal by Subject|0|||
130534155|NCT02202785|469922571|FG001|Overall Study|Withdrawal by Subject|1|||
130534156|NCT02202785|469922572|FG002|Overall Study|Withdrawal by Subject|0|||
130534157|NCT02202785|469922570|FG000|Overall Study|Lost to Follow-up|0|||
130534158|NCT02202785|469922571|FG001|Overall Study|Lost to Follow-up|1|||
130534159|NCT02202785|469922572|FG002|Overall Study|Lost to Follow-up|0|||
130534160|NCT02202785|469922570|FG000|Overall Study|Reason not Specified|10|||
130534161|NCT02202785|469922571|FG001|Overall Study|Reason not Specified|7|||
130534162|NCT02202785|469922572|FG002|Overall Study|Reason not Specified|13|||
130534163|NCT01137578|469922573|FG000|Overall Study|Participant requested to Discontinue|3|||
130534164|NCT01137578|469922574|FG001|Overall Study|Participant requested to Discontinue|0|||
130534165|NCT01137578|469922575|FG002|Overall Study|Participant requested to Discontinue|0|||
130534166|NCT01137578|469922573|FG000|Overall Study|Withdrawal by Subject|1|||
130534167|NCT01137578|469922574|FG001|Overall Study|Withdrawal by Subject|0|||
130534168|NCT01137578|469922575|FG002|Overall Study|Withdrawal by Subject|0|||
130534169|NCT01137578|469922573|FG000|Overall Study|Other|12|||
130534170|NCT01137578|469922574|FG001|Overall Study|Other|2|||
130534171|NCT01137578|469922575|FG002|Overall Study|Other|6|||
130534172|NCT04145700|469922576|FG000|Overall Study|Withdrawal by Subject|8|||
130534173|NCT04145700|469922577|FG001|Overall Study|Withdrawal by Subject|3|||
130534174|NCT00818779|469922580|FG000|Overall Study|Protocol Violation|1|||
130534175|NCT00818779|469922581|FG001|Overall Study|Protocol Violation|0|||
130534176|NCT00818779|469922580|FG000|Overall Study|Lost to Follow-up|1|||
130534177|NCT00818779|469922581|FG001|Overall Study|Lost to Follow-up|0|||
130534178|NCT00818779|469922580|FG000|Overall Study|Adverse Event|4|||
130534179|NCT00818779|469922581|FG001|Overall Study|Adverse Event|1|||
130534180|NCT04978493|469922582|FG000|Overall Study|No reason available|0|||
130534181|NCT04978493|469922583|FG001|Overall Study|No reason available|1|||
130534182|NCT04978493|469922582|FG000|Overall Study|Adverse Event|1|||
130534183|NCT04978493|469922583|FG001|Overall Study|Adverse Event|0|||
130534184|NCT01327846|469922586|FG000|Core Phase|Subject decision (vital status: missing)|1|||
130534185|NCT01327846|469922587|FG001|Core Phase|Subject decision (vital status: missing)|2|||
130534186|NCT01327846|469922588|FG002|Core Phase|Subject decision (vital status: missing)|2|||
130534187|NCT01327846|469922589|FG003|Core Phase|Subject decision (vital status: missing)|1|||
130534188|NCT01327846|469922586|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
130534189|NCT01327846|469922587|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
130582836|NCT02913313|470098849|FG009|Overall Study|Withdrawal by Subject|0|||
130582837|NCT02913313|470098850|FG010|Overall Study|Withdrawal by Subject|1|||
130582838|NCT02913313|470098851|FG011|Overall Study|Withdrawal by Subject|0|||
130582839|NCT02913313|470098852|FG012|Overall Study|Withdrawal by Subject|0|||
130582840|NCT02913313|470098853|FG013|Overall Study|Withdrawal by Subject|0|||
130582841|NCT02913313|470098840|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582842|NCT02913313|470098841|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582843|NCT02913313|470098842|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582844|NCT02913313|470098843|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582845|NCT02913313|470098844|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582846|NCT02913313|470098845|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582847|NCT02913313|470098846|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582848|NCT02913313|470098847|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582849|NCT02913313|470098848|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582850|NCT02913313|470098849|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582851|NCT02913313|470098850|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130582852|NCT02913313|470098851|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130582853|NCT02913313|470098852|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130582854|NCT02913313|470098853|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130582855|NCT02913313|470098840|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
130582856|NCT02913313|470098841|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
130582857|NCT02913313|470098842|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
130582858|NCT02913313|470098843|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
130582859|NCT02913313|470098844|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
130582860|NCT02913313|470098845|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
130582861|NCT02913313|470098846|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
130582862|NCT02913313|470098847|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
130582863|NCT02913313|470098848|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
130582864|NCT02913313|470098849|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
130582865|NCT02913313|470098850|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
130582866|NCT02913313|470098851|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
130582867|NCT02913313|470098852|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
130582868|NCT02913313|470098853|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
130582869|NCT04088409|470098854|FG000|Part A|Withdrawal by Subject|2|||
130582870|NCT04088409|470098855|FG001|Part A|Withdrawal by Subject|1|||
130582871|NCT04088409|470098854|FG000|Part A|Did Not Meet Randomization Criteria|2|||
130582872|NCT04088409|470098855|FG001|Part A|Did Not Meet Randomization Criteria|0|||
130582873|NCT04088409|470098854|FG000|Part A|Lack of Efficacy|9|||
130582874|NCT04088409|470098855|FG001|Part A|Lack of Efficacy|0|||
130582875|NCT04088409|470098854|FG000|Part A|Lost to Follow-up|1|||
130582876|NCT04088409|470098855|FG001|Part A|Lost to Follow-up|0|||
130582877|NCT04088409|470098854|FG000|Part A|Adverse Event|1|||
130582878|NCT04088409|470098855|FG001|Part A|Adverse Event|0|||
130582879|NCT04088409|470098854|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
130582880|NCT04088409|470098855|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
130582881|NCT04088409|470098854|FG000|Part B|Ongoing Treatment|10|||
130582882|NCT04088409|470098855|FG001|Part B|Ongoing Treatment|0|||
130582883|NCT04233229|470098856|FG000|Overall Study|Withdrawal by Subject|0|||
130582884|NCT04233229|470098857|FG001|Overall Study|Withdrawal by Subject|1|||
130582885|NCT04233229|470098856|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
130582886|NCT04233229|470098857|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
130582887|NCT04233229|470098856|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
130582888|NCT04233229|470098857|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
130582889|NCT00841763|470098858|FG000|Overall Study|Withdrawal by Subject|60|||
130582890|NCT00841763|470098859|FG001|Overall Study|Withdrawal by Subject|17|||
130582891|NCT00841763|470098860|FG002|Overall Study|Withdrawal by Subject|4|||
130582892|NCT00841763|470098861|FG003|Overall Study|Withdrawal by Subject|1|||
130582893|NCT00841763|470098858|FG000|Overall Study|Adverse Event|9|||
130582894|NCT00841763|470098859|FG001|Overall Study|Adverse Event|10|||
130582895|NCT00841763|470098860|FG002|Overall Study|Adverse Event|3|||
130582896|NCT00841763|470098861|FG003|Overall Study|Adverse Event|2|||
130582897|NCT00841763|470098858|FG000|Overall Study|Lost to Follow-up|63|||
130582898|NCT00841763|470098859|FG001|Overall Study|Lost to Follow-up|25|||
130582899|NCT00841763|470098860|FG002|Overall Study|Lost to Follow-up|0|||
130582900|NCT00841763|470098861|FG003|Overall Study|Lost to Follow-up|0|||
130582901|NCT00841763|470098858|FG000|Overall Study|Protocol Violation|20|||
130582902|NCT00841763|470098859|FG001|Overall Study|Protocol Violation|3|||
130582903|NCT00841763|470098860|FG002|Overall Study|Protocol Violation|1|||
130582904|NCT00841763|470098861|FG003|Overall Study|Protocol Violation|0|||
130534190|NCT01327846|469922588|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
130534191|NCT01327846|469922589|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
130534192|NCT01327846|469922586|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
130582905|NCT00841763|470098858|FG000|Overall Study|Administrative Reasons|3|||
130582906|NCT00841763|470098859|FG001|Overall Study|Administrative Reasons|1|||
130582907|NCT00841763|470098860|FG002|Overall Study|Administrative Reasons|0|||
130582908|NCT00841763|470098861|FG003|Overall Study|Administrative Reasons|0|||
130582909|NCT00841763|470098858|FG000|Overall Study|Unable to Classify|7|||
130582910|NCT00841763|470098859|FG001|Overall Study|Unable to Classify|1|||
130582911|NCT00841763|470098860|FG002|Overall Study|Unable to Classify|0|||
130582912|NCT00841763|470098861|FG003|Overall Study|Unable to Classify|0|||
130582913|NCT00648167|470098862|FG000|Overall Study|Adverse Event|6|||
130582914|NCT00648167|470098862|FG000|Overall Study|unable to swallow tablets|1|||
130582915|NCT00927368|470098863|FG000|Overall Study|enrollment in another study|1|||
130582916|NCT00927368|470098864|FG001|Overall Study|enrollment in another study|1|||
130582917|NCT00927368|470098865|FG002|Overall Study|enrollment in another study|2|||
130582918|NCT00927368|470098863|FG000|Overall Study|Lost to Follow-up|4|||
130582919|NCT00927368|470098864|FG001|Overall Study|Lost to Follow-up|0|||
130582920|NCT00927368|470098865|FG002|Overall Study|Lost to Follow-up|0|||
130582921|NCT00927368|470098863|FG000|Overall Study|equipment failure|1|||
130582922|NCT00927368|470098864|FG001|Overall Study|equipment failure|0|||
130582923|NCT00927368|470098865|FG002|Overall Study|equipment failure|0|||
130582924|NCT00927368|470098863|FG000|Overall Study|ineligible post randomization|0|||
130582925|NCT00927368|470098864|FG001|Overall Study|ineligible post randomization|3|||
130582926|NCT00927368|470098865|FG002|Overall Study|ineligible post randomization|1|||
130582927|NCT00927368|470098863|FG000|Overall Study|cancellation of surgery|0|||
130582928|NCT00927368|470098864|FG001|Overall Study|cancellation of surgery|1|||
130582929|NCT00927368|470098865|FG002|Overall Study|cancellation of surgery|2|||
130582930|NCT00440726|470098870|FG000|Phase 1|Dose-Limiting Toxicity|0|||
130582931|NCT00440726|470098871|FG001|Phase 1|Dose-Limiting Toxicity|1|||
130582932|NCT00440726|470098872|FG002|Phase 1|Dose-Limiting Toxicity|0|||
130582933|NCT00440726|470098870|FG000|Phase 1|Physician Decision|1|||
130582934|NCT00440726|470098871|FG001|Phase 1|Physician Decision|0|||
130582935|NCT00440726|470098872|FG002|Phase 1|Physician Decision|0|||
130582936|NCT00440726|470098870|FG000|Phase 2|Death|0|||
130582937|NCT00440726|470098871|FG001|Phase 2|Death|0|||
130582938|NCT00440726|470098872|FG002|Phase 2|Death|1|||
130582939|NCT00440726|470098870|FG000|Phase 2|Adverse Event|0|||
130582940|NCT00440726|470098871|FG001|Phase 2|Adverse Event|0|||
130582941|NCT00440726|470098872|FG002|Phase 2|Adverse Event|1|||
130582942|NCT00331409|470098873|FG000|Overall Study|Lack of Efficacy|4|||
130582943|NCT01482910|470098875|FG000|Overall Study|Adverse Event|6|||
130582944|NCT01482910|470098876|FG001|Overall Study|Adverse Event|5|||
130582945|NCT01482910|470098875|FG000|Overall Study|Lost to Follow-up|0|||
130582946|NCT01482910|470098876|FG001|Overall Study|Lost to Follow-up|1|||
130582947|NCT01482910|470098875|FG000|Overall Study|Protocol Violation|1|||
130582948|NCT01482910|470098876|FG001|Overall Study|Protocol Violation|1|||
130582949|NCT01482910|470098875|FG000|Overall Study|Withdrawal by Subject|7|||
130582950|NCT01482910|470098876|FG001|Overall Study|Withdrawal by Subject|2|||
130582951|NCT01482910|470098875|FG000|Overall Study|Death|1|||
130582952|NCT01482910|470098876|FG001|Overall Study|Death|0|||
130582953|NCT02614079|470098879|FG000|Overall Study|Withdrawal by Subject|1|||
130582954|NCT03370770|470098880|FG000|Overall Study|Patient was followed in another hospital center|1|||
130582955|NCT03370770|470098880|FG000|Overall Study|Progressive Disease|98|||
130582956|NCT03370770|470098880|FG000|Overall Study|Adverse Event|2|||
130582957|NCT03370770|470098880|FG000|Overall Study|Death|5|||
130582958|NCT00234039|470098881|FG000|Overall Study|Adverse Event|2|||
130582959|NCT00234039|470098881|FG000|Overall Study|Progression/relapse|34|||
130582960|NCT00234039|470098881|FG000|Overall Study|Other - Not Protocol Specified|3|||
130534193|NCT01327846|469922587|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
130534194|NCT01327846|469922588|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
130534195|NCT01327846|469922589|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
130534196|NCT01327846|469922586|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
130534197|NCT01327846|469922587|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
130582961|NCT00234039|470098881|FG000|Overall Study|Ineligible|9|||
130582962|NCT00234039|470098881|FG000|Overall Study|No Protocol Treatment Received|2|||
130582963|NCT03683394|470098884|FG000|Overall Study|Withdrawal by Subject|4|||
130582964|NCT03683394|470098885|FG001|Overall Study|Withdrawal by Subject|8|||
130582965|NCT03683394|470098884|FG000|Overall Study|Lost to Follow-up|7|||
130582966|NCT03683394|470098885|FG001|Overall Study|Lost to Follow-up|0|||
130582967|NCT03683394|470098884|FG000|Overall Study|Death|3|||
130582968|NCT03683394|470098885|FG001|Overall Study|Death|1|||
130582969|NCT00110019|470098886|FG000|Overall Study|Lack of Efficacy|253|||
130582970|NCT00110019|470098887|FG001|Overall Study|Lack of Efficacy|285|||
130582971|NCT00110019|470098886|FG000|Overall Study|Adverse Event|61|||
130582972|NCT00110019|470098887|FG001|Overall Study|Adverse Event|40|||
130582973|NCT00110019|470098886|FG000|Overall Study|Death|13|||
130582974|NCT00110019|470098887|FG001|Overall Study|Death|15|||
130582975|NCT00110019|470098886|FG000|Overall Study|Withdrawal by Subject|21|||
130534198|NCT01327846|469922588|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
130534199|NCT01327846|469922589|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
130534200|NCT01327846|469922586|FG000|Core Phase|Lost to Follow-up|3|||
130534201|NCT01327846|469922587|FG001|Core Phase|Lost to Follow-up|3|||
130534202|NCT01327846|469922588|FG002|Core Phase|Lost to Follow-up|4|||
130534203|NCT01327846|469922589|FG003|Core Phase|Lost to Follow-up|5|||
130534204|NCT01327846|469922586|FG000|Extension Phase|Study terminated by sponsor|1073|||
130534205|NCT01327846|469922587|FG001|Extension Phase|Study terminated by sponsor|1124|||
130534206|NCT01327846|469922588|FG002|Extension Phase|Study terminated by sponsor|1067|||
130534207|NCT01327846|469922589|FG003|Extension Phase|Study terminated by sponsor|1660|||
130534208|NCT01327846|469922586|FG000|Extension Phase|Withdrawal by Subject|20|||
130534209|NCT01327846|469922587|FG001|Extension Phase|Withdrawal by Subject|13|||
130534210|NCT01327846|469922588|FG002|Extension Phase|Withdrawal by Subject|19|||
130534211|NCT01327846|469922589|FG003|Extension Phase|Withdrawal by Subject|37|||
130534212|NCT01327846|469922586|FG000|Extension Phase|Lost to Follow-up|4|||
130534213|NCT01327846|469922587|FG001|Extension Phase|Lost to Follow-up|3|||
130534214|NCT01327846|469922588|FG002|Extension Phase|Lost to Follow-up|4|||
130534215|NCT01327846|469922589|FG003|Extension Phase|Lost to Follow-up|7|||
130534216|NCT01327846|469922586|FG000|Extension Phase|Technical Problems|2|||
130534217|NCT01327846|469922587|FG001|Extension Phase|Technical Problems|4|||
130534218|NCT01327846|469922588|FG002|Extension Phase|Technical Problems|2|||
130534219|NCT01327846|469922589|FG003|Extension Phase|Technical Problems|2|||
130534220|NCT01840410|469922590|FG000|Overall Study|Physician Decision|1|||
130534221|NCT01840410|469922591|FG001|Overall Study|Physician Decision|2|||
130534222|NCT01840410|469922590|FG000|Overall Study|Pregnancy|1|||
130534223|NCT01840410|469922591|FG001|Overall Study|Pregnancy|0|||
130534224|NCT01840410|469922590|FG000|Overall Study|Protocol deviation|1|||
130534225|NCT01840410|469922591|FG001|Overall Study|Protocol deviation|0|||
130534226|NCT01840410|469922590|FG000|Overall Study|Lost to Follow-up|1|||
130534227|NCT01840410|469922591|FG001|Overall Study|Lost to Follow-up|0|||
130534228|NCT01840410|469922590|FG000|Overall Study|Withdrawal by Subject|2|||
130534229|NCT01840410|469922591|FG001|Overall Study|Withdrawal by Subject|1|||
130534230|NCT01840410|469922590|FG000|Overall Study|Adverse Event|1|||
130534231|NCT01840410|469922591|FG001|Overall Study|Adverse Event|1|||
130534232|NCT04343976|469922592|FG000|Overall Study|Withdrawal by Subject|0|||
130534233|NCT04343976|469922593|FG001|Overall Study|Withdrawal by Subject|1|||
130534234|NCT00594880|469922594|FG000|Overall Study|Withdrawal by Subject|1|||
130534235|NCT00594880|469922595|FG001|Overall Study|Withdrawal by Subject|1|||
130534236|NCT00594880|469922594|FG000|Overall Study|Lost to Follow-up|1|||
130534237|NCT00594880|469922595|FG001|Overall Study|Lost to Follow-up|0|||
130534238|NCT00694109|469922596|FG000|Overall Study|Physician Decision|3|||
130534239|NCT00694109|469922596|FG000|Overall Study|Adverse Event|74|||
130534240|NCT00694109|469922596|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
130534241|NCT00694109|469922596|FG000|Overall Study|Lack of Efficacy|2|||
130534242|NCT00694109|469922596|FG000|Overall Study|Withdrawal by Subject|13|||
130534243|NCT00694109|469922596|FG000|Overall Study|Pregnancy|1|||
130534244|NCT00694109|469922596|FG000|Overall Study|Enrolled but not treated|1|||
130534245|NCT00694109|469922596|FG000|Overall Study|Other|2|||
130534246|NCT00694109|469922596|FG000|Overall Study|Consented but no additional treatment|3|||
130534247|NCT01254747|469922597|FG000|Overall Study|Unacceptable subjective vision|0|||
130534248|NCT01254747|469922598|FG001|Overall Study|Unacceptable subjective vision|0|||
130534249|NCT01254747|469922599|FG002|Overall Study|Unacceptable subjective vision|0|||
130534250|NCT01254747|469922600|FG003|Overall Study|Unacceptable subjective vision|2|||
130534251|NCT01254747|469922597|FG000|Overall Study|Difficult removal handling|0|||
130534252|NCT01254747|469922598|FG001|Overall Study|Difficult removal handling|0|||
130534253|NCT01254747|469922599|FG002|Overall Study|Difficult removal handling|1|||
130534254|NCT01254747|469922600|FG003|Overall Study|Difficult removal handling|0|||
130534255|NCT01254747|469922597|FG000|Overall Study|Symptoms and problems|0|||
130534256|NCT01254747|469922598|FG001|Overall Study|Symptoms and problems|2|||
130534257|NCT01254747|469922599|FG002|Overall Study|Symptoms and problems|1|||
130534258|NCT01254747|469922600|FG003|Overall Study|Symptoms and problems|0|||
130534259|NCT01254747|469922597|FG000|Overall Study|Lost to Follow-up|0|||
130534260|NCT01254747|469922598|FG001|Overall Study|Lost to Follow-up|0|||
130534261|NCT01254747|469922599|FG002|Overall Study|Lost to Follow-up|1|||
130534262|NCT01254747|469922600|FG003|Overall Study|Lost to Follow-up|0|||
130534263|NCT01254747|469922597|FG000|Overall Study|Biomicroscopy|0|||
130534264|NCT01254747|469922598|FG001|Overall Study|Biomicroscopy|0|||
130534265|NCT01254747|469922599|FG002|Overall Study|Biomicroscopy|1|||
130534266|NCT01254747|469922600|FG003|Overall Study|Biomicroscopy|0|||
130534267|NCT01254747|469922597|FG000|Overall Study|Discomfort|0|||
130534268|NCT01254747|469922598|FG001|Overall Study|Discomfort|4|||
130534269|NCT01254747|469922599|FG002|Overall Study|Discomfort|0|||
130534270|NCT01254747|469922600|FG003|Overall Study|Discomfort|0|||
130534271|NCT00846807|469922601|FG000|Overall Study|Adverse Event|270|||
130534272|NCT00846807|469922601|FG000|Overall Study|Lost to Follow-up|94|||
130534273|NCT00846807|469922601|FG000|Overall Study|Withdrawal by Subject|56|||
130534274|NCT00846807|469922601|FG000|Overall Study|Non compliant with European label|7|||
130534275|NCT00846807|469922601|FG000|Overall Study|Switch to other anticoagulants|89|||
130534276|NCT00846807|469922601|FG000|Overall Study|No prescription after hospital discharge|56|||
130534277|NCT00846807|469922601|FG000|Overall Study|Other|60|||
130534278|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
130534279|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
130534280|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
130534281|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
130534282|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
130534283|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
130534284|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
130534285|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
130534286|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
130534287|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
130534288|NCT00245960|469922602|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
130534289|NCT00245960|469922603|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
130582976|NCT00110019|470098887|FG001|Overall Study|Withdrawal by Subject|9|||
130582977|NCT00110019|470098886|FG000|Overall Study|alternative therapy|5|||
130582978|NCT00110019|470098887|FG001|Overall Study|alternative therapy|1|||
130582979|NCT00110019|470098886|FG000|Overall Study|complicating disease|1|||
130582980|NCT00110019|470098887|FG001|Overall Study|complicating disease|1|||
130582981|NCT00110019|470098886|FG000|Overall Study|symptom deterioration|13|||
130582982|NCT00110019|470098887|FG001|Overall Study|symptom deterioration|16|||
130582983|NCT00110019|470098886|FG000|Overall Study|Not start protocol therapy|17|||
130582984|NCT00110019|470098887|FG001|Overall Study|Not start protocol therapy|16|||
130582985|NCT00110019|470098886|FG000|Overall Study|other reasons|22|||
130534290|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
130534291|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
130534292|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
130534293|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
130534294|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
130534295|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
130534296|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
130534297|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
130534298|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
130534299|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
130534300|NCT00245960|469922602|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
130534301|NCT00245960|469922603|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
130534302|NCT00737698|469922604|FG000|Overall Study|Withdrawal by Subject|6|||
130534303|NCT00737698|469922605|FG001|Overall Study|Withdrawal by Subject|5|||
130534304|NCT00737698|469922606|FG002|Overall Study|Withdrawal by Subject|3|||
130534305|NCT00737698|469922604|FG000|Overall Study|Death|0|||
130534306|NCT00737698|469922605|FG001|Overall Study|Death|0|||
130534307|NCT00737698|469922606|FG002|Overall Study|Death|1|||
130534308|NCT01067846|469922607|FG000|Overall Study|Lost to Follow-up|17|||
130534309|NCT01067846|469922608|FG001|Overall Study|Lost to Follow-up|19|||
130534310|NCT01067846|469922607|FG000|Overall Study|Withdrawal by Subject|1|||
130534311|NCT01067846|469922608|FG001|Overall Study|Withdrawal by Subject|0|||
130534312|NCT01067846|469922607|FG000|Overall Study|participation in other tx study|1|||
130534313|NCT01067846|469922608|FG001|Overall Study|participation in other tx study|0|||
130534314|NCT02817906|469922609|FG000|Overall Study|Adverse Event|3|||
130534315|NCT02817906|469922610|FG001|Overall Study|Adverse Event|0|||
130534316|NCT02817906|469922609|FG000|Overall Study|Lack of Efficacy|1|||
130534317|NCT02817906|469922610|FG001|Overall Study|Lack of Efficacy|0|||
130534318|NCT02817906|469922609|FG000|Overall Study|Protocol Violation|1|||
130534319|NCT02817906|469922610|FG001|Overall Study|Protocol Violation|1|||
130534320|NCT02817906|469922609|FG000|Overall Study|Study Terminated by Sponsor|2|||
130534321|NCT02817906|469922610|FG001|Overall Study|Study Terminated by Sponsor|2|||
130534322|NCT02817906|469922609|FG000|Overall Study|Withdrawal by Subject|7|||
130534323|NCT02817906|469922610|FG001|Overall Study|Withdrawal by Subject|0|||
130534324|NCT02817906|469922609|FG000|Overall Study|Other|2|||
130534325|NCT02817906|469922610|FG001|Overall Study|Other|2|||
130534326|NCT04608773|469922612|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
130534327|NCT04608773|469922613|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
130582986|NCT00110019|470098887|FG001|Overall Study|other reasons|30|||
130582987|NCT04426695|470098890|FG000|Overall Study|Death|2|||
130582988|NCT04426695|470098891|FG001|Overall Study|Death|0|||
130534328|NCT04608773|469922612|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
130534329|NCT04608773|469922613|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130582989|NCT04426695|470098892|FG002|Overall Study|Death|1|||
130582990|NCT04426695|470098893|FG003|Overall Study|Death|27|||
130582991|NCT04426695|470098894|FG004|Overall Study|Death|25|||
130582992|NCT04426695|470098895|FG005|Overall Study|Death|21|||
130582993|NCT04426695|470098896|FG006|Overall Study|Death|42|||
130582994|NCT04426695|470098897|FG007|Overall Study|Death|23|||
130534330|NCT04608773|469922612|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
130534331|NCT04608773|469922613|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
130534332|NCT04608773|469922612|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
130534333|NCT04608773|469922613|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
130534334|NCT04608773|469922612|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
130534335|NCT04608773|469922613|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
130534336|NCT02833077|469922614|FG000|Overall Study|Adverse Event|1|||
130534337|NCT02833077|469922615|FG001|Overall Study|Adverse Event|2|||
130534338|NCT02833077|469922614|FG000|Overall Study|Lost to Follow-up|10|||
130534339|NCT02833077|469922615|FG001|Overall Study|Lost to Follow-up|1|||
130534340|NCT02833077|469922614|FG000|Overall Study|Personal Reasons|6|||
130534341|NCT02833077|469922615|FG001|Overall Study|Personal Reasons|4|||
130534342|NCT02833077|469922614|FG000|Overall Study|Protocol Deviation|0|||
130534343|NCT02833077|469922615|FG001|Overall Study|Protocol Deviation|1|||
130534344|NCT00316017|469922616|FG000|Overall Study|Protocol Violation|11|||
130534345|NCT00316017|469922617|FG001|Overall Study|Protocol Violation|13|||
130534346|NCT00316017|469922618|FG002|Overall Study|Protocol Violation|19|||
130534347|NCT01217437|469922619|FG000|Overall Study|Adverse Event|0|||
130534348|NCT01217437|469922620|FG001|Overall Study|Adverse Event|8|||
130534349|NCT01217437|469922619|FG000|Overall Study|Death|5|||
130534350|NCT01217437|469922620|FG001|Overall Study|Death|0|||
130534351|NCT01217437|469922619|FG000|Overall Study|Lack of Efficacy|29|||
130534352|NCT01217437|469922620|FG001|Overall Study|Lack of Efficacy|25|||
130534353|NCT01217437|469922619|FG000|Overall Study|Physician Decision|8|||
130534354|NCT01217437|469922620|FG001|Overall Study|Physician Decision|5|||
130534355|NCT01217437|469922619|FG000|Overall Study|Withdrawal by Subject|0|||
130534356|NCT01217437|469922620|FG001|Overall Study|Withdrawal by Subject|2|||
130534357|NCT01217437|469922619|FG000|Overall Study|Ineligible|1|||
130534358|NCT01217437|469922620|FG001|Overall Study|Ineligible|1|||
130534359|NCT06748729|469922622|FG000|Overall Study|Withdrawal by Subject|1|||
130534360|NCT01977677|469923547|FG000|Overall Study|Unrelated Adverse Event|0|||
130534361|NCT01977677|469923548|FG001|Overall Study|Unrelated Adverse Event|0|||
130534362|NCT01977677|469923549|FG002|Overall Study|Unrelated Adverse Event|1|||
130534363|NCT02993406|469923550|FG000|Overall Study|Withdrawal by Subject|170|||
130534364|NCT02993406|469923551|FG001|Overall Study|Withdrawal by Subject|196|||
130534365|NCT02993406|469923550|FG000|Overall Study|Physician Decision|3|||
130534366|NCT02993406|469923551|FG001|Overall Study|Physician Decision|5|||
130534367|NCT02993406|469923550|FG000|Overall Study|Lost to Follow-up|12|||
130534368|NCT02993406|469923551|FG001|Overall Study|Lost to Follow-up|13|||
130534369|NCT02993406|469923550|FG000|Overall Study|Unclassifiable Response|105|||
130534370|NCT02993406|469923551|FG001|Overall Study|Unclassifiable Response|139|||
130534371|NCT02993406|469923550|FG000|Overall Study|Administrative decision|1|||
130534372|NCT02993406|469923551|FG001|Overall Study|Administrative decision|0|||
130534373|NCT02993406|469923550|FG000|Overall Study|Sponsor decision|4|||
130534374|NCT02993406|469923551|FG001|Overall Study|Sponsor decision|5|||
130534375|NCT02248818|469923552|FG000|Screening|Protocol Violation|0|||
130534376|NCT02248818|469923553|FG001|Screening|Protocol Violation|0|||
130534377|NCT02248818|469923554|FG002|Screening|Protocol Violation|0|||
130534378|NCT02248818|469923555|FG003|Screening|Protocol Violation|0|||
130534379|NCT02248818|469923556|FG004|Screening|Protocol Violation|0|||
130534380|NCT02248818|469923557|FG005|Screening|Protocol Violation|0|||
130534381|NCT02248818|469923558|FG006|Screening|Protocol Violation|0|||
130534382|NCT02248818|469923559|FG007|Screening|Protocol Violation|0|||
130534383|NCT02248818|469923560|FG008|Screening|Protocol Violation|7|||
130534384|NCT02248818|469923552|FG000|Screening|Study fully enrolled|0|||
130534385|NCT02248818|469923553|FG001|Screening|Study fully enrolled|0|||
130534386|NCT02248818|469923554|FG002|Screening|Study fully enrolled|0|||
130534387|NCT02248818|469923555|FG003|Screening|Study fully enrolled|0|||
130534388|NCT02248818|469923556|FG004|Screening|Study fully enrolled|0|||
130534389|NCT02248818|469923557|FG005|Screening|Study fully enrolled|0|||
130534390|NCT02248818|469923558|FG006|Screening|Study fully enrolled|0|||
130534391|NCT02248818|469923559|FG007|Screening|Study fully enrolled|0|||
130534392|NCT02248818|469923560|FG008|Screening|Study fully enrolled|14|||
130534393|NCT02248818|469923552|FG000|Screening|Physician Decision|0|||
130534394|NCT02248818|469923553|FG001|Screening|Physician Decision|0|||
130534395|NCT02248818|469923554|FG002|Screening|Physician Decision|0|||
130534396|NCT02248818|469923555|FG003|Screening|Physician Decision|0|||
130534397|NCT02248818|469923556|FG004|Screening|Physician Decision|0|||
130534398|NCT02248818|469923557|FG005|Screening|Physician Decision|0|||
130534399|NCT02248818|469923558|FG006|Screening|Physician Decision|0|||
130534400|NCT02248818|469923559|FG007|Screening|Physician Decision|0|||
130534401|NCT02248818|469923560|FG008|Screening|Physician Decision|73|||
130534402|NCT02248818|469923552|FG000|Screening|Withdrawal by Subject|0|||
130534403|NCT02248818|469923553|FG001|Screening|Withdrawal by Subject|0|||
130534404|NCT02248818|469923554|FG002|Screening|Withdrawal by Subject|0|||
130534405|NCT02248818|469923555|FG003|Screening|Withdrawal by Subject|0|||
130534406|NCT02248818|469923556|FG004|Screening|Withdrawal by Subject|0|||
130534407|NCT02248818|469923557|FG005|Screening|Withdrawal by Subject|0|||
130534408|NCT02248818|469923558|FG006|Screening|Withdrawal by Subject|0|||
130534409|NCT02248818|469923559|FG007|Screening|Withdrawal by Subject|0|||
130582995|NCT04426695|470098898|FG008|Overall Study|Death|37|||
130582996|NCT04426695|470098899|FG009|Overall Study|Death|14|||
130582997|NCT04426695|470098900|FG010|Overall Study|Death|8|||
130582998|NCT04426695|470098901|FG011|Overall Study|Death|7|||
130582999|NCT04426695|470098902|FG012|Overall Study|Death|13|||
130583000|NCT04426695|470098903|FG013|Overall Study|Death|25|||
130583001|NCT04426695|470098904|FG014|Overall Study|Death|19|||
130583002|NCT04426695|470098905|FG015|Overall Study|Death|7|||
130583003|NCT04426695|470098906|FG016|Overall Study|Death|8|||
130583004|NCT04426695|470098907|FG017|Overall Study|Death|4|||
130583005|NCT04426695|470098890|FG000|Overall Study|Lost to Follow-up|2|||
130583006|NCT04426695|470098891|FG001|Overall Study|Lost to Follow-up|4|||
130583007|NCT04426695|470098892|FG002|Overall Study|Lost to Follow-up|1|||
130583008|NCT04426695|470098893|FG003|Overall Study|Lost to Follow-up|19|||
130583009|NCT04426695|470098894|FG004|Overall Study|Lost to Follow-up|10|||
130583010|NCT04426695|470098895|FG005|Overall Study|Lost to Follow-up|14|||
130583011|NCT04426695|470098896|FG006|Overall Study|Lost to Follow-up|5|||
130583012|NCT04426695|470098897|FG007|Overall Study|Lost to Follow-up|14|||
130583013|NCT04426695|470098898|FG008|Overall Study|Lost to Follow-up|10|||
130583014|NCT04426695|470098899|FG009|Overall Study|Lost to Follow-up|11|||
130583015|NCT04426695|470098900|FG010|Overall Study|Lost to Follow-up|12|||
130583016|NCT04426695|470098901|FG011|Overall Study|Lost to Follow-up|6|||
130583017|NCT04426695|470098902|FG012|Overall Study|Lost to Follow-up|2|||
130583018|NCT04426695|470098903|FG013|Overall Study|Lost to Follow-up|2|||
130583019|NCT04426695|470098904|FG014|Overall Study|Lost to Follow-up|2|||
130583020|NCT04426695|470098905|FG015|Overall Study|Lost to Follow-up|0|||
130583021|NCT04426695|470098906|FG016|Overall Study|Lost to Follow-up|0|||
130583022|NCT04426695|470098907|FG017|Overall Study|Lost to Follow-up|0|||
130583023|NCT04426695|470098890|FG000|Overall Study|Participant Decision|1|||
130583024|NCT04426695|470098891|FG001|Overall Study|Participant Decision|2|||
130583025|NCT04426695|470098892|FG002|Overall Study|Participant Decision|2|||
130583026|NCT04426695|470098893|FG003|Overall Study|Participant Decision|12|||
130583027|NCT04426695|470098894|FG004|Overall Study|Participant Decision|18|||
130583028|NCT04426695|470098895|FG005|Overall Study|Participant Decision|22|||
130583029|NCT04426695|470098896|FG006|Overall Study|Participant Decision|13|||
130583030|NCT04426695|470098897|FG007|Overall Study|Participant Decision|13|||
130583031|NCT04426695|470098898|FG008|Overall Study|Participant Decision|10|||
130583032|NCT04426695|470098899|FG009|Overall Study|Participant Decision|15|||
130583033|NCT04426695|470098900|FG010|Overall Study|Participant Decision|16|||
130583034|NCT04426695|470098901|FG011|Overall Study|Participant Decision|17|||
130583035|NCT04426695|470098902|FG012|Overall Study|Participant Decision|2|||
130583036|NCT04426695|470098903|FG013|Overall Study|Participant Decision|1|||
130583037|NCT04426695|470098904|FG014|Overall Study|Participant Decision|2|||
130583038|NCT04426695|470098905|FG015|Overall Study|Participant Decision|0|||
130583039|NCT04426695|470098906|FG016|Overall Study|Participant Decision|0|||
130583040|NCT04426695|470098907|FG017|Overall Study|Participant Decision|0|||
130583041|NCT04426695|470098890|FG000|Overall Study|Adverse Event|0|||
130583042|NCT04426695|470098891|FG001|Overall Study|Adverse Event|0|||
130583043|NCT04426695|470098892|FG002|Overall Study|Adverse Event|0|||
130583044|NCT04426695|470098893|FG003|Overall Study|Adverse Event|0|||
130583045|NCT04426695|470098894|FG004|Overall Study|Adverse Event|0|||
130583046|NCT04426695|470098895|FG005|Overall Study|Adverse Event|0|||
130583047|NCT04426695|470098896|FG006|Overall Study|Adverse Event|0|||
130583048|NCT04426695|470098897|FG007|Overall Study|Adverse Event|1|||
130583049|NCT04426695|470098898|FG008|Overall Study|Adverse Event|0|||
130583050|NCT04426695|470098899|FG009|Overall Study|Adverse Event|0|||
130583051|NCT04426695|470098900|FG010|Overall Study|Adverse Event|1|||
130583052|NCT04426695|470098901|FG011|Overall Study|Adverse Event|1|||
130534410|NCT02248818|469923560|FG008|Screening|Withdrawal by Subject|6|||
130534411|NCT02248818|469923552|FG000|Screening|Lost to Follow-up|0|||
130534412|NCT02248818|469923553|FG001|Screening|Lost to Follow-up|0|||
130534413|NCT02248818|469923554|FG002|Screening|Lost to Follow-up|0|||
130534414|NCT02248818|469923555|FG003|Screening|Lost to Follow-up|0|||
130534415|NCT02248818|469923556|FG004|Screening|Lost to Follow-up|0|||
130534416|NCT02248818|469923557|FG005|Screening|Lost to Follow-up|0|||
130534417|NCT02248818|469923558|FG006|Screening|Lost to Follow-up|0|||
130534418|NCT02248818|469923559|FG007|Screening|Lost to Follow-up|0|||
130534419|NCT02248818|469923560|FG008|Screening|Lost to Follow-up|7|||
130534420|NCT02248818|469923552|FG000|Randomised Study|Administrative - randomization error|0|||
130583053|NCT04426695|470098902|FG012|Overall Study|Adverse Event|0|||
130583054|NCT04426695|470098903|FG013|Overall Study|Adverse Event|0|||
130583055|NCT04426695|470098904|FG014|Overall Study|Adverse Event|0|||
130583056|NCT04426695|470098905|FG015|Overall Study|Adverse Event|0|||
130583057|NCT04426695|470098906|FG016|Overall Study|Adverse Event|0|||
130583058|NCT04426695|470098907|FG017|Overall Study|Adverse Event|0|||
130583059|NCT04426695|470098890|FG000|Overall Study|Sponsor Request|0|||
130583060|NCT04426695|470098891|FG001|Overall Study|Sponsor Request|0|||
130583061|NCT04426695|470098892|FG002|Overall Study|Sponsor Request|0|||
130583062|NCT04426695|470098893|FG003|Overall Study|Sponsor Request|0|||
130583063|NCT04426695|470098894|FG004|Overall Study|Sponsor Request|0|||
130583064|NCT04426695|470098895|FG005|Overall Study|Sponsor Request|0|||
130583065|NCT04426695|470098896|FG006|Overall Study|Sponsor Request|1|||
130583066|NCT04426695|470098897|FG007|Overall Study|Sponsor Request|0|||
130583067|NCT04426695|470098898|FG008|Overall Study|Sponsor Request|0|||
130583068|NCT04426695|470098899|FG009|Overall Study|Sponsor Request|0|||
130583069|NCT04426695|470098900|FG010|Overall Study|Sponsor Request|0|||
130583070|NCT04426695|470098901|FG011|Overall Study|Sponsor Request|0|||
130583071|NCT04426695|470098902|FG012|Overall Study|Sponsor Request|0|||
130583072|NCT04426695|470098903|FG013|Overall Study|Sponsor Request|0|||
130583073|NCT04426695|470098904|FG014|Overall Study|Sponsor Request|0|||
130583074|NCT04426695|470098905|FG015|Overall Study|Sponsor Request|0|||
130583075|NCT04426695|470098906|FG016|Overall Study|Sponsor Request|0|||
130583076|NCT04426695|470098907|FG017|Overall Study|Sponsor Request|0|||
130583077|NCT04426695|470098890|FG000|Overall Study|Physician Decision|0|||
130583078|NCT04426695|470098891|FG001|Overall Study|Physician Decision|0|||
130583079|NCT04426695|470098892|FG002|Overall Study|Physician Decision|0|||
130583080|NCT04426695|470098893|FG003|Overall Study|Physician Decision|0|||
130534421|NCT02248818|469923553|FG001|Randomised Study|Administrative - randomization error|0|||
130534422|NCT02248818|469923554|FG002|Randomised Study|Administrative - randomization error|0|||
130534423|NCT02248818|469923555|FG003|Randomised Study|Administrative - randomization error|0|||
130534424|NCT02248818|469923556|FG004|Randomised Study|Administrative - randomization error|0|||
130534425|NCT02248818|469923557|FG005|Randomised Study|Administrative - randomization error|8|||
130534426|NCT02248818|469923558|FG006|Randomised Study|Administrative - randomization error|0|||
130534427|NCT02248818|469923559|FG007|Randomised Study|Administrative - randomization error|0|||
130534428|NCT02248818|469923560|FG008|Randomised Study|Administrative - randomization error|0|||
130534429|NCT05262517|469923561|FG000|Overall Study|Randomized but not treated|5|||
130534430|NCT05262517|469923562|FG001|Overall Study|Randomized but not treated|11|||
130534431|NCT04325282|469923563|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130534432|NCT04325282|469923564|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130534433|NCT04325282|469923563|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
130534434|NCT04325282|469923564|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
130534435|NCT01283152|469923568|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
130534436|NCT01283152|469923569|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
130534437|NCT01283152|469923568|FG000|Overall Study|Refused HESA|1|||
130534438|NCT01283152|469923569|FG001|Overall Study|Refused HESA|0|||
130534439|NCT02643303|469923572|FG000|Overall Study|Progressive Disease|4|||
130534440|NCT02643303|469923573|FG001|Overall Study|Progressive Disease|4|||
130534441|NCT02643303|469923574|FG002|Overall Study|Progressive Disease|1|||
130534442|NCT02643303|469923575|FG003|Overall Study|Progressive Disease|12|||
130534443|NCT02643303|469923576|FG004|Overall Study|Progressive Disease|6|||
130534444|NCT02643303|469923577|FG005|Overall Study|Progressive Disease|4|||
130534445|NCT02643303|469923578|FG006|Overall Study|Progressive Disease|8|||
130534446|NCT02643303|469923579|FG007|Overall Study|Progressive Disease|2|||
130534447|NCT02643303|469923580|FG008|Overall Study|Progressive Disease|6|||
130534448|NCT02643303|469923572|FG000|Overall Study|Adverse Event|0|||
130534449|NCT02643303|469923573|FG001|Overall Study|Adverse Event|1|||
130534450|NCT02643303|469923574|FG002|Overall Study|Adverse Event|0|||
130534451|NCT02643303|469923575|FG003|Overall Study|Adverse Event|0|||
130534452|NCT02643303|469923576|FG004|Overall Study|Adverse Event|1|||
130534453|NCT02643303|469923577|FG005|Overall Study|Adverse Event|0|||
130534454|NCT02643303|469923578|FG006|Overall Study|Adverse Event|0|||
130534455|NCT02643303|469923579|FG007|Overall Study|Adverse Event|0|||
130534456|NCT02643303|469923580|FG008|Overall Study|Adverse Event|0|||
130534457|NCT02643303|469923572|FG000|Overall Study|Withdrawal by Subject|0|||
130534458|NCT02643303|469923573|FG001|Overall Study|Withdrawal by Subject|0|||
130534459|NCT02643303|469923574|FG002|Overall Study|Withdrawal by Subject|0|||
130534460|NCT02643303|469923575|FG003|Overall Study|Withdrawal by Subject|1|||
130534461|NCT02643303|469923576|FG004|Overall Study|Withdrawal by Subject|0|||
130534462|NCT02643303|469923577|FG005|Overall Study|Withdrawal by Subject|0|||
130534463|NCT02643303|469923578|FG006|Overall Study|Withdrawal by Subject|1|||
130534464|NCT02643303|469923579|FG007|Overall Study|Withdrawal by Subject|1|||
130534465|NCT02643303|469923580|FG008|Overall Study|Withdrawal by Subject|1|||
130534466|NCT04552899|469923587|FG000|Overall Study|Adverse Event|4|||
130534467|NCT04552899|469923588|FG001|Overall Study|Adverse Event|3|||
130534468|NCT04552899|469923587|FG000|Overall Study|Death|4|||
130534469|NCT04552899|469923588|FG001|Overall Study|Death|4|||
130534470|NCT04552899|469923587|FG000|Overall Study|Lost to Follow-up|8|||
130534471|NCT04552899|469923588|FG001|Overall Study|Lost to Follow-up|13|||
130534472|NCT04552899|469923587|FG000|Overall Study|Lung Transplant|4|||
130534473|NCT04552899|469923588|FG001|Overall Study|Lung Transplant|3|||
130583081|NCT04426695|470098894|FG004|Overall Study|Physician Decision|0|||
130583082|NCT04426695|470098895|FG005|Overall Study|Physician Decision|0|||
130534474|NCT04552899|469923587|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
130534475|NCT04552899|469923588|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
130534476|NCT04552899|469923587|FG000|Overall Study|Physician Decision|3|||
130534477|NCT04552899|469923588|FG001|Overall Study|Physician Decision|4|||
130534478|NCT04552899|469923587|FG000|Overall Study|Study Terminated By Sponsor|237|||
130534479|NCT04552899|469923588|FG001|Overall Study|Study Terminated By Sponsor|239|||
130534480|NCT04552899|469923587|FG000|Overall Study|Withdrawal by Subject|15|||
130534481|NCT04552899|469923588|FG001|Overall Study|Withdrawal by Subject|17|||
130534482|NCT01499303|469923589|FG000|Overall Study|Ongoing|2|||
130534483|NCT01499303|469923590|FG001|Overall Study|Ongoing|1|||
130534484|NCT01499303|469923589|FG000|Overall Study|Withdrawal by Subject|0|||
130534485|NCT01499303|469923590|FG001|Overall Study|Withdrawal by Subject|1|||
130534486|NCT01499303|469923589|FG000|Overall Study|Adverse Event|1|||
130534487|NCT01499303|469923590|FG001|Overall Study|Adverse Event|4|||
130534488|NCT01499303|469923589|FG000|Overall Study|Other|0|||
130534489|NCT01499303|469923590|FG001|Overall Study|Other|1|||
130534490|NCT02383940|469923599|FG000|Overall Study|Adverse Event|1|||
130534491|NCT02383940|469923600|FG001|Overall Study|Adverse Event|0|||
130534492|NCT02383940|469923599|FG000|Overall Study|Lost to Follow-up|2|||
130534493|NCT02383940|469923600|FG001|Overall Study|Lost to Follow-up|2|||
130534494|NCT02383940|469923599|FG000|Overall Study|Physician Decision|2|||
130534495|NCT02383940|469923600|FG001|Overall Study|Physician Decision|0|||
130534496|NCT02383940|469923599|FG000|Overall Study|Withdrawal by Subject|1|||
130534497|NCT02383940|469923600|FG001|Overall Study|Withdrawal by Subject|1|||
130534498|NCT02383940|469923599|FG000|Overall Study|Randomized but not treated|2|||
130534499|NCT02383940|469923600|FG001|Overall Study|Randomized but not treated|0|||
130534500|NCT02383940|469923599|FG000|Overall Study|Other than specified above|1|||
130534501|NCT02383940|469923600|FG001|Overall Study|Other than specified above|0|||
130534502|NCT04308590|469923601|FG000|Overall Study|Adverse Event|12|||
130534503|NCT04308590|469923602|FG001|Overall Study|Adverse Event|2|||
130534504|NCT04308590|469923601|FG000|Overall Study|Withdrawal by Subject|10|||
130534505|NCT04308590|469923602|FG001|Overall Study|Withdrawal by Subject|4|||
130534506|NCT04308590|469923601|FG000|Overall Study|Death|1|||
130534507|NCT04308590|469923602|FG001|Overall Study|Death|0|||
130534508|NCT04308590|469923601|FG000|Overall Study|Lost to Follow-up|1|||
130534509|NCT04308590|469923602|FG001|Overall Study|Lost to Follow-up|1|||
130534510|NCT04308590|469923601|FG000|Overall Study|Physician Decision|1|||
130534511|NCT04308590|469923602|FG001|Overall Study|Physician Decision|0|||
130534512|NCT04308590|469923601|FG000|Overall Study|Subject does not want to continue with Pi|0|||
130534513|NCT04308590|469923602|FG001|Overall Study|Subject does not want to continue with Pi|1|||
130534514|NCT03853551|469923603|FG000|Overall Study|Death|2|||
130534515|NCT03853551|469923603|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
130534516|NCT01401153|469923604|FG000|First Test Day|Learning disabilities; illness|1|||
130534517|NCT01401153|469923605|FG001|First Test Day|Learning disabilities; illness|10|||
130534518|NCT01401153|469923604|FG000|Second Test Day|illness|0|||
130534519|NCT01401153|469923605|FG001|Second Test Day|illness|5|||
130534520|NCT04187326|469923606|FG000|Overall Study|Lost to Follow-up|2|||
130534521|NCT04187326|469923607|FG001|Overall Study|Lost to Follow-up|1|||
130534522|NCT04187326|469923606|FG000|Overall Study|Computer error- task was only partially completed.|0|||
130534523|NCT04187326|469923607|FG001|Overall Study|Computer error- task was only partially completed.|1|||
130534524|NCT05235269|469923610|FG000|Overall Study|Adverse Event|1|||
130534525|NCT05235269|469923610|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
130534526|NCT05235269|469923610|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
130534527|NCT00798434|469923611|FG000|Double-Blind|Adverse Event|22|||
130534528|NCT00798434|469923612|FG001|Double-Blind|Adverse Event|46|||
130534529|NCT00798434|469923611|FG000|Double-Blind|Death|0|||
130534530|NCT00798434|469923612|FG001|Double-Blind|Death|1|||
130534531|NCT00798434|469923611|FG000|Double-Blind|Lost to Follow-up|1|||
130534532|NCT00798434|469923612|FG001|Double-Blind|Lost to Follow-up|0|||
130534533|NCT00798434|469923611|FG000|Double-Blind|Lack of Efficacy|8|||
130534534|NCT00798434|469923612|FG001|Double-Blind|Lack of Efficacy|12|||
130534535|NCT00798434|469923611|FG000|Double-Blind|Withdrawal by Subject|17|||
130534536|NCT00798434|469923612|FG001|Double-Blind|Withdrawal by Subject|14|||
130534537|NCT00798434|469923611|FG000|Double-Blind|Protocol Violation|1|||
130534538|NCT00798434|469923612|FG001|Double-Blind|Protocol Violation|4|||
130534539|NCT00798434|469923611|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
130534540|NCT00798434|469923612|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
130534541|NCT00798434|469923611|FG000|Double-Blind|Other|1|||
130534542|NCT00798434|469923612|FG001|Double-Blind|Other|0|||
130534543|NCT00798434|469923611|FG000|Double-Blind|Not Treated|3|||
130534544|NCT00798434|469923612|FG001|Double-Blind|Not Treated|6|||
130534545|NCT00798434|469923611|FG000|Open-Label|Adverse Event|33|||
130534546|NCT00798434|469923612|FG001|Open-Label|Adverse Event|11|||
130534547|NCT00798434|469923611|FG000|Open-Label|Lack of Efficacy|5|||
130534548|NCT00798434|469923612|FG001|Open-Label|Lack of Efficacy|11|||
130534549|NCT00798434|469923611|FG000|Open-Label|Withdrawal by Subject|2|||
130534550|NCT00798434|469923612|FG001|Open-Label|Withdrawal by Subject|7|||
130534551|NCT00798434|469923611|FG000|Open-Label|Protocol Violation|1|||
130534552|NCT00798434|469923612|FG001|Open-Label|Protocol Violation|0|||
130534553|NCT00798434|469923611|FG000|Open-Label|Other|1|||
130534554|NCT00798434|469923612|FG001|Open-Label|Other|2|||
130534555|NCT00798434|469923611|FG000|Open-Label|Not Treated|0|||
130534556|NCT00798434|469923612|FG001|Open-Label|Not Treated|1|||
130534557|NCT03898167|469923613|FG000|Overall Study|Terminated phone call early|7|||
130534558|NCT03898167|469923614|FG001|Overall Study|Terminated phone call early|0|||
130534559|NCT03898167|469923615|FG002|Overall Study|Terminated phone call early|0|||
130534560|NCT03898167|469923613|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
130534561|NCT03898167|469923614|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
130534562|NCT03898167|469923615|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
130534563|NCT05177354|469923616|FG000|Implant to 30-day Visit|Physician Decision|1|||
130534564|NCT05177354|469923616|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
130534565|NCT05177354|469923616|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
130534566|NCT05177354|469923616|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
130534567|NCT03548220|469923618|FG000|Overall Study|Lost to Follow-up|1|||
130534568|NCT03548220|469923619|FG001|Overall Study|Lost to Follow-up|0|||
130534569|NCT03548220|469923620|FG002|Overall Study|Lost to Follow-up|0|||
130534570|NCT03548220|469923621|FG003|Overall Study|Lost to Follow-up|0|||
130534571|NCT02906007|469923622|FG000|Overall Study|Physician Decision|0|||
130534572|NCT02906007|469923623|FG001|Overall Study|Physician Decision|0|||
130534573|NCT02906007|469923624|FG002|Overall Study|Physician Decision|1|||
130534574|NCT02906007|469923622|FG000|Overall Study|Died|1|||
130534575|NCT02906007|469923623|FG001|Overall Study|Died|0|||
130534576|NCT02906007|469923624|FG002|Overall Study|Died|0|||
130534577|NCT03570892|469923625|FG000|Overall Study|Death|51|||
130534578|NCT03570892|469923626|FG001|Overall Study|Death|45|||
130534579|NCT03570892|469923625|FG000|Overall Study|Subject decision|5|||
130534580|NCT03570892|469923626|FG001|Overall Study|Subject decision|3|||
130534581|NCT03570892|469923625|FG000|Overall Study|Protocol Violation|1|||
130534582|NCT03570892|469923626|FG001|Overall Study|Protocol Violation|4|||
130534583|NCT03570892|469923625|FG000|Overall Study|Physician Decision|0|||
130534584|NCT03570892|469923626|FG001|Overall Study|Physician Decision|2|||
130534585|NCT01901432|469924964|FG000|Overall Study|Adverse Event|0|||
130534586|NCT01901432|469924965|FG001|Overall Study|Adverse Event|1|||
130534587|NCT01901432|469924966|FG002|Overall Study|Adverse Event|1|||
130534588|NCT01901432|469924967|FG003|Overall Study|Adverse Event|0|||
130534589|NCT01901432|469924968|FG004|Overall Study|Adverse Event|1|||
130534590|NCT01901432|469924964|FG000|Overall Study|Withdrawal by Subject|0|||
130534591|NCT01901432|469924965|FG001|Overall Study|Withdrawal by Subject|0|||
130534592|NCT01901432|469924966|FG002|Overall Study|Withdrawal by Subject|1|||
130534593|NCT01901432|469924967|FG003|Overall Study|Withdrawal by Subject|0|||
130534594|NCT01901432|469924968|FG004|Overall Study|Withdrawal by Subject|5|||
130534595|NCT01901432|469924964|FG000|Overall Study|Physician Decision|0|||
130534596|NCT01901432|469924965|FG001|Overall Study|Physician Decision|0|||
130534597|NCT01901432|469924966|FG002|Overall Study|Physician Decision|0|||
130534598|NCT01901432|469924967|FG003|Overall Study|Physician Decision|0|||
130534599|NCT01901432|469924968|FG004|Overall Study|Physician Decision|2|||
130534600|NCT01901432|469924964|FG000|Overall Study|Patient decision to stop study drug|0|||
130534601|NCT01901432|469924965|FG001|Overall Study|Patient decision to stop study drug|0|||
130534602|NCT01901432|469924966|FG002|Overall Study|Patient decision to stop study drug|0|||
130534603|NCT01901432|469924967|FG003|Overall Study|Patient decision to stop study drug|0|||
130534604|NCT01901432|469924968|FG004|Overall Study|Patient decision to stop study drug|1|||
130534605|NCT00379288|469924969|FG000|Overall Study|Adverse Event|5|||
130534606|NCT00379288|469924970|FG001|Overall Study|Adverse Event|6|||
130534607|NCT00379288|469924971|FG002|Overall Study|Adverse Event|2|||
130534608|NCT00379288|469924972|FG003|Overall Study|Adverse Event|0|||
130534609|NCT00379288|469924969|FG000|Overall Study|Treatment Failure|0|||
130534610|NCT00379288|469924970|FG001|Overall Study|Treatment Failure|1|||
130534611|NCT00379288|469924971|FG002|Overall Study|Treatment Failure|0|||
130534612|NCT00379288|469924972|FG003|Overall Study|Treatment Failure|1|||
130534613|NCT00379288|469924969|FG000|Overall Study|Lost to Follow-up|3|||
130534614|NCT00379288|469924970|FG001|Overall Study|Lost to Follow-up|3|||
130534615|NCT00379288|469924971|FG002|Overall Study|Lost to Follow-up|2|||
130534616|NCT00379288|469924972|FG003|Overall Study|Lost to Follow-up|0|||
130534617|NCT00379288|469924969|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
130534618|NCT00379288|469924970|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
130534619|NCT00379288|469924971|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
130534620|NCT00379288|469924972|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
130534621|NCT00379288|469924969|FG000|Overall Study|Subject withdrew-related to study drug|1|||
130583083|NCT04426695|470098896|FG006|Overall Study|Physician Decision|0|||
130534622|NCT00379288|469924970|FG001|Overall Study|Subject withdrew-related to study drug|0|||
130534623|NCT00379288|469924971|FG002|Overall Study|Subject withdrew-related to study drug|0|||
130534624|NCT00379288|469924972|FG003|Overall Study|Subject withdrew-related to study drug|1|||
130534625|NCT00379288|469924969|FG000|Overall Study|Noncompliance with protocol|8|||
130534626|NCT00379288|469924970|FG001|Overall Study|Noncompliance with protocol|6|||
130534627|NCT00379288|469924971|FG002|Overall Study|Noncompliance with protocol|2|||
130534628|NCT00379288|469924972|FG003|Overall Study|Noncompliance with protocol|1|||
130534629|NCT00379288|469924969|FG000|Overall Study|Did not meet protocol eligibility|0|||
130534630|NCT00379288|469924970|FG001|Overall Study|Did not meet protocol eligibility|1|||
130534631|NCT00379288|469924971|FG002|Overall Study|Did not meet protocol eligibility|0|||
130534632|NCT00379288|469924972|FG003|Overall Study|Did not meet protocol eligibility|2|||
130534633|NCT00379288|469924969|FG000|Overall Study|Administrative|2|||
130534634|NCT00379288|469924970|FG001|Overall Study|Administrative|2|||
130534635|NCT00379288|469924971|FG002|Overall Study|Administrative|0|||
130534636|NCT00379288|469924972|FG003|Overall Study|Administrative|1|||
130534637|NCT00515671|469924983|FG000|Overall Study|Lost to Follow-up|13|||
130534638|NCT00515671|469924984|FG001|Overall Study|Lost to Follow-up|10|||
130534639|NCT00515671|469924983|FG000|Overall Study|Withdrawal by Subject|3|||
130534640|NCT00515671|469924984|FG001|Overall Study|Withdrawal by Subject|5|||
130534641|NCT00515671|469924983|FG000|Overall Study|incarcerated|1|||
130534642|NCT00515671|469924984|FG001|Overall Study|incarcerated|2|||
130534643|NCT00288639|469924987|FG000|Overall Study|Adverse Event|5|||
130534644|NCT00288639|469924987|FG000|Overall Study|Lack of Efficacy|4|||
130534645|NCT00288639|469924987|FG000|Overall Study|Withdrawal by Subject|2|||
130534646|NCT00288639|469924987|FG000|Overall Study|Other|1|||
130534647|NCT01014208|469924996|FG000|Overall Study|Lost to Follow-up|2|||
130534648|NCT01014208|469924997|FG001|Overall Study|Lost to Follow-up|5|||
130534649|NCT01014208|469924996|FG000|Overall Study|Participant Withdrew Consent|12|||
130534650|NCT01014208|469924997|FG001|Overall Study|Participant Withdrew Consent|12|||
130534651|NCT01014208|469924996|FG000|Overall Study|Did Not Receive Study Drug|2|||
130534652|NCT01014208|469924997|FG001|Overall Study|Did Not Receive Study Drug|0|||
130534653|NCT01014208|469924996|FG000|Overall Study|Study Closed/terminated|78|||
130534654|NCT01014208|469924997|FG001|Overall Study|Study Closed/terminated|83|||
130534655|NCT00527787|469925005|FG000|Overall Study|Adverse Event|14|||
130534656|NCT00527787|469925006|FG001|Overall Study|Adverse Event|24|||
130534657|NCT00527787|469925005|FG000|Overall Study|Withdrawal by Subject|13|||
130534658|NCT00527787|469925006|FG001|Overall Study|Withdrawal by Subject|25|||
130534659|NCT00527787|469925005|FG000|Overall Study|Lost to Follow-up|5|||
130534660|NCT00527787|469925006|FG001|Overall Study|Lost to Follow-up|2|||
130534661|NCT00527787|469925005|FG000|Overall Study|Duodenal Ulcer|1|||
130534662|NCT00527787|469925006|FG001|Overall Study|Duodenal Ulcer|10|||
130534663|NCT00527787|469925005|FG000|Overall Study|misc|5|||
130534664|NCT00527787|469925006|FG001|Overall Study|misc|2|||
130534665|NCT04939701|469925007|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
130534666|NCT04939701|469925008|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
130534667|NCT04939701|469925009|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
130534668|NCT04939701|469925007|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
130534669|NCT04939701|469925008|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
130534670|NCT04939701|469925009|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
130534671|NCT04939701|469925007|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
130534672|NCT04939701|469925008|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
130534673|NCT04939701|469925009|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
130534674|NCT04939701|469925007|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
130534675|NCT04939701|469925008|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
130534676|NCT04939701|469925009|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
130534677|NCT04939701|469925007|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
130534678|NCT04939701|469925008|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
130534679|NCT04939701|469925009|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
130534680|NCT04939701|469925007|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
130534681|NCT04939701|469925008|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
130534682|NCT04939701|469925009|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
130534683|NCT04939701|469925007|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
130534684|NCT04939701|469925008|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
130534685|NCT04939701|469925009|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
130534686|NCT02672852|469925011|FG000|Part A1|Disease Worsening|1|||
130534687|NCT02672852|469925012|FG001|Part A1|Disease Worsening|0|||
130534688|NCT02672852|469925013|FG002|Part A1|Disease Worsening|0|||
130534689|NCT02672852|469925014|FG003|Part A1|Disease Worsening|0|||
130534690|NCT02672852|469925015|FG004|Part A1|Disease Worsening|0|||
130534691|NCT02672852|469925016|FG005|Part A1|Disease Worsening|0|||
130534692|NCT02672852|469925017|FG006|Part A1|Disease Worsening|0|||
130534693|NCT02672852|469925011|FG000|Part A1|Adverse Event|0|||
130534694|NCT02672852|469925012|FG001|Part A1|Adverse Event|1|||
130534695|NCT02672852|469925013|FG002|Part A1|Adverse Event|0|||
130534696|NCT02672852|469925014|FG003|Part A1|Adverse Event|0|||
130534697|NCT02672852|469925015|FG004|Part A1|Adverse Event|0|||
130534698|NCT02672852|469925016|FG005|Part A1|Adverse Event|0|||
130534699|NCT02672852|469925017|FG006|Part A1|Adverse Event|0|||
130534700|NCT02672852|469925011|FG000|Part A1|Lost to Follow-up|1|||
130534701|NCT02672852|469925012|FG001|Part A1|Lost to Follow-up|2|||
130534702|NCT02672852|469925013|FG002|Part A1|Lost to Follow-up|0|||
130534703|NCT02672852|469925014|FG003|Part A1|Lost to Follow-up|0|||
130534704|NCT02672852|469925015|FG004|Part A1|Lost to Follow-up|0|||
130534705|NCT02672852|469925016|FG005|Part A1|Lost to Follow-up|0|||
130534706|NCT02672852|469925017|FG006|Part A1|Lost to Follow-up|0|||
130534707|NCT02672852|469925011|FG000|Part A1|Withdrawal by Subject|1|||
130534708|NCT02672852|469925012|FG001|Part A1|Withdrawal by Subject|1|||
130534709|NCT02672852|469925013|FG002|Part A1|Withdrawal by Subject|0|||
130534710|NCT02672852|469925014|FG003|Part A1|Withdrawal by Subject|0|||
130534711|NCT02672852|469925015|FG004|Part A1|Withdrawal by Subject|0|||
130534712|NCT02672852|469925016|FG005|Part A1|Withdrawal by Subject|0|||
130534713|NCT02672852|469925017|FG006|Part A1|Withdrawal by Subject|0|||
130534714|NCT02672852|469925011|FG000|Part A2|Disease worsening|0|||
130534715|NCT02672852|469925012|FG001|Part A2|Disease worsening|0|||
130534716|NCT02672852|469925013|FG002|Part A2|Disease worsening|1|||
130534717|NCT02672852|469925014|FG003|Part A2|Disease worsening|0|||
130534718|NCT02672852|469925015|FG004|Part A2|Disease worsening|0|||
130534719|NCT02672852|469925016|FG005|Part A2|Disease worsening|0|||
130534720|NCT02672852|469925017|FG006|Part A2|Disease worsening|0|||
130534721|NCT02672852|469925011|FG000|Part A2|Adverse Event|0|||
130534722|NCT02672852|469925012|FG001|Part A2|Adverse Event|0|||
130534723|NCT02672852|469925013|FG002|Part A2|Adverse Event|3|||
130534724|NCT02672852|469925014|FG003|Part A2|Adverse Event|0|||
130534725|NCT02672852|469925015|FG004|Part A2|Adverse Event|0|||
130534726|NCT02672852|469925016|FG005|Part A2|Adverse Event|0|||
130534727|NCT02672852|469925017|FG006|Part A2|Adverse Event|0|||
130534728|NCT02672852|469925011|FG000|Part A2|Lost to Follow-up|0|||
130534729|NCT02672852|469925012|FG001|Part A2|Lost to Follow-up|0|||
130534730|NCT02672852|469925013|FG002|Part A2|Lost to Follow-up|2|||
130534731|NCT02672852|469925014|FG003|Part A2|Lost to Follow-up|0|||
130534732|NCT02672852|469925015|FG004|Part A2|Lost to Follow-up|0|||
130534733|NCT02672852|469925016|FG005|Part A2|Lost to Follow-up|0|||
130534734|NCT02672852|469925017|FG006|Part A2|Lost to Follow-up|0|||
130534735|NCT02672852|469925011|FG000|Part A2|Withdrawal by Subject|0|||
130534736|NCT02672852|469925012|FG001|Part A2|Withdrawal by Subject|0|||
130534737|NCT02672852|469925013|FG002|Part A2|Withdrawal by Subject|1|||
130534738|NCT02672852|469925014|FG003|Part A2|Withdrawal by Subject|0|||
130534739|NCT02672852|469925015|FG004|Part A2|Withdrawal by Subject|0|||
130534740|NCT02672852|469925016|FG005|Part A2|Withdrawal by Subject|0|||
130534741|NCT02672852|469925017|FG006|Part A2|Withdrawal by Subject|0|||
130534742|NCT02672852|469925011|FG000|Part A2|Other|0|||
130534743|NCT02672852|469925012|FG001|Part A2|Other|0|||
130534744|NCT02672852|469925013|FG002|Part A2|Other|3|||
130534745|NCT02672852|469925014|FG003|Part A2|Other|0|||
130534746|NCT02672852|469925015|FG004|Part A2|Other|0|||
130534747|NCT02672852|469925016|FG005|Part A2|Other|0|||
130534748|NCT02672852|469925017|FG006|Part A2|Other|0|||
130534749|NCT02672852|469925011|FG000|Part A2|Not entered in Part B|0|||
130534750|NCT02672852|469925012|FG001|Part A2|Not entered in Part B|0|||
130534751|NCT02672852|469925013|FG002|Part A2|Not entered in Part B|0|||
130534752|NCT02672852|469925014|FG003|Part A2|Not entered in Part B|4|||
130534753|NCT02672852|469925015|FG004|Part A2|Not entered in Part B|0|||
130534754|NCT02672852|469925016|FG005|Part A2|Not entered in Part B|0|||
130534755|NCT02672852|469925017|FG006|Part A2|Not entered in Part B|0|||
130534756|NCT02672852|469925011|FG000|Part B|Disease worsening|0|||
130534757|NCT02672852|469925012|FG001|Part B|Disease worsening|0|||
130534758|NCT02672852|469925013|FG002|Part B|Disease worsening|0|||
130534759|NCT02672852|469925014|FG003|Part B|Disease worsening|0|||
130534760|NCT02672852|469925015|FG004|Part B|Disease worsening|1|||
130534761|NCT02672852|469925016|FG005|Part B|Disease worsening|0|||
130534762|NCT02672852|469925017|FG006|Part B|Disease worsening|1|||
130534763|NCT02672852|469925011|FG000|Part B|Worsening pre-existing condition|0|||
130534764|NCT02672852|469925012|FG001|Part B|Worsening pre-existing condition|0|||
130534765|NCT02672852|469925013|FG002|Part B|Worsening pre-existing condition|0|||
130534766|NCT02672852|469925014|FG003|Part B|Worsening pre-existing condition|0|||
130534767|NCT02672852|469925015|FG004|Part B|Worsening pre-existing condition|0|||
130534768|NCT02672852|469925016|FG005|Part B|Worsening pre-existing condition|1|||
130534769|NCT02672852|469925017|FG006|Part B|Worsening pre-existing condition|0|||
130534770|NCT02672852|469925011|FG000|Part B|Other adverse event|0|||
130534771|NCT02672852|469925012|FG001|Part B|Other adverse event|0|||
130534772|NCT02672852|469925013|FG002|Part B|Other adverse event|0|||
130534773|NCT02672852|469925014|FG003|Part B|Other adverse event|0|||
130534774|NCT02672852|469925015|FG004|Part B|Other adverse event|3|||
130534775|NCT02672852|469925016|FG005|Part B|Other adverse event|5|||
130534776|NCT02672852|469925017|FG006|Part B|Other adverse event|1|||
130534777|NCT02672852|469925011|FG000|Part B|Lost to Follow-up|0|||
130534778|NCT02672852|469925012|FG001|Part B|Lost to Follow-up|0|||
130583084|NCT04426695|470098897|FG007|Overall Study|Physician Decision|0|||
130583085|NCT04426695|470098898|FG008|Overall Study|Physician Decision|0|||
130583086|NCT04426695|470098899|FG009|Overall Study|Physician Decision|1|||
130583087|NCT04426695|470098900|FG010|Overall Study|Physician Decision|0|||
130583088|NCT04426695|470098901|FG011|Overall Study|Physician Decision|0|||
130583089|NCT04426695|470098902|FG012|Overall Study|Physician Decision|1|||
130583090|NCT04426695|470098903|FG013|Overall Study|Physician Decision|0|||
130583091|NCT04426695|470098904|FG014|Overall Study|Physician Decision|0|||
130583092|NCT04426695|470098905|FG015|Overall Study|Physician Decision|0|||
130583093|NCT04426695|470098906|FG016|Overall Study|Physician Decision|0|||
130583094|NCT04426695|470098907|FG017|Overall Study|Physician Decision|0|||
130583095|NCT04426695|470098890|FG000|Overall Study|Randomized but Never Treated|3|||
130583096|NCT04426695|470098891|FG001|Overall Study|Randomized but Never Treated|1|||
130583097|NCT04426695|470098892|FG002|Overall Study|Randomized but Never Treated|0|||
130583098|NCT04426695|470098893|FG003|Overall Study|Randomized but Never Treated|4|||
130583099|NCT04426695|470098894|FG004|Overall Study|Randomized but Never Treated|5|||
130583100|NCT04426695|470098895|FG005|Overall Study|Randomized but Never Treated|5|||
130583101|NCT04426695|470098896|FG006|Overall Study|Randomized but Never Treated|4|||
130583102|NCT04426695|470098897|FG007|Overall Study|Randomized but Never Treated|6|||
130583103|NCT04426695|470098898|FG008|Overall Study|Randomized but Never Treated|6|||
130583104|NCT04426695|470098899|FG009|Overall Study|Randomized but Never Treated|3|||
130583105|NCT04426695|470098900|FG010|Overall Study|Randomized but Never Treated|3|||
130583106|NCT04426695|470098901|FG011|Overall Study|Randomized but Never Treated|6|||
130583107|NCT04426695|470098902|FG012|Overall Study|Randomized but Never Treated|1|||
130583108|NCT04426695|470098903|FG013|Overall Study|Randomized but Never Treated|2|||
130583109|NCT04426695|470098904|FG014|Overall Study|Randomized but Never Treated|0|||
130583110|NCT04426695|470098905|FG015|Overall Study|Randomized but Never Treated|0|||
130583111|NCT04426695|470098906|FG016|Overall Study|Randomized but Never Treated|0|||
130583112|NCT04426695|470098907|FG017|Overall Study|Randomized but Never Treated|0|||
130583113|NCT04303000|470098908|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
130583114|NCT04303000|470098909|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
130583115|NCT04303000|470098910|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
130583116|NCT01109940|470098914|FG000|Overall Study|Administrative problems|2|||
130583117|NCT01109940|470098915|FG001|Overall Study|Administrative problems|0|||
130583118|NCT01109940|470098916|FG002|Overall Study|Administrative problems|0|||
130583119|NCT01109940|470098917|FG003|Overall Study|Administrative problems|0|||
130583120|NCT01109940|470098914|FG000|Overall Study|Serious Adverse Event|2|||
130583121|NCT01109940|470098915|FG001|Overall Study|Serious Adverse Event|1|||
130583122|NCT01109940|470098916|FG002|Overall Study|Serious Adverse Event|0|||
130583123|NCT01109940|470098917|FG003|Overall Study|Serious Adverse Event|0|||
130583124|NCT01109940|470098914|FG000|Overall Study|Lost to Follow-up|1|||
130583125|NCT01109940|470098915|FG001|Overall Study|Lost to Follow-up|0|||
130583126|NCT01109940|470098916|FG002|Overall Study|Lost to Follow-up|0|||
130583127|NCT01109940|470098917|FG003|Overall Study|Lost to Follow-up|0|||
130583128|NCT01109940|470098914|FG000|Overall Study|Patient withdrew consent|1|||
130583129|NCT01109940|470098915|FG001|Overall Study|Patient withdrew consent|1|||
130583130|NCT01109940|470098916|FG002|Overall Study|Patient withdrew consent|0|||
130583131|NCT01109940|470098917|FG003|Overall Study|Patient withdrew consent|0|||
130583132|NCT01109940|470098914|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130583133|NCT01109940|470098915|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130583134|NCT01109940|470098916|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130583135|NCT01109940|470098917|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130583136|NCT03653390|470098918|FG000|Overall Study|Lost to Follow-up|12|||
130583137|NCT03653390|470098919|FG001|Overall Study|Lost to Follow-up|8|||
130583138|NCT03653390|470098920|FG002|Overall Study|Lost to Follow-up|7|||
130583139|NCT03653390|470098918|FG000|Overall Study|Withdrawal by Subject|6|||
130583140|NCT03653390|470098919|FG001|Overall Study|Withdrawal by Subject|1|||
130583141|NCT03653390|470098920|FG002|Overall Study|Withdrawal by Subject|1|||
130583142|NCT03653390|470098918|FG000|Overall Study|Death|1|||
130583143|NCT03653390|470098919|FG001|Overall Study|Death|0|||
130583144|NCT03653390|470098920|FG002|Overall Study|Death|0|||
130583145|NCT03653390|470098918|FG000|Overall Study|Paper Survey Lost|1|||
130583146|NCT03653390|470098919|FG001|Overall Study|Paper Survey Lost|0|||
130583147|NCT03653390|470098920|FG002|Overall Study|Paper Survey Lost|0|||
130583148|NCT01262976|470098923|FG000|Up to Month 2|Serious Adverse Event|0|||
130583149|NCT01262976|470098924|FG001|Up to Month 2|Serious Adverse Event|0|||
130583150|NCT01262976|470098925|FG002|Up to Month 2|Serious Adverse Event|1|||
130583151|NCT01262976|470098926|FG003|Up to Month 2|Serious Adverse Event|0|||
130583152|NCT01262976|470098927|FG004|Up to Month 2|Serious Adverse Event|0|||
130583153|NCT01262976|470098928|FG005|Up to Month 2|Serious Adverse Event|0|||
130583154|NCT01262976|470098923|FG000|Up to Month 2|Withdrawal by Subject|1|||
130583155|NCT01262976|470098924|FG001|Up to Month 2|Withdrawal by Subject|0|||
130583156|NCT01262976|470098925|FG002|Up to Month 2|Withdrawal by Subject|0|||
130583157|NCT01262976|470098926|FG003|Up to Month 2|Withdrawal by Subject|0|||
130583158|NCT01262976|470098927|FG004|Up to Month 2|Withdrawal by Subject|0|||
130583159|NCT01262976|470098928|FG005|Up to Month 2|Withdrawal by Subject|0|||
130583160|NCT01262976|470098923|FG000|Up to Month 2|Migrated/moved from study area|0|||
130583161|NCT01262976|470098924|FG001|Up to Month 2|Migrated/moved from study area|1|||
130583162|NCT01262976|470098925|FG002|Up to Month 2|Migrated/moved from study area|0|||
130583163|NCT01262976|470098926|FG003|Up to Month 2|Migrated/moved from study area|0|||
130583164|NCT01262976|470098927|FG004|Up to Month 2|Migrated/moved from study area|1|||
130583165|NCT01262976|470098928|FG005|Up to Month 2|Migrated/moved from study area|1|||
130583166|NCT01262976|470098923|FG000|Up to Month 2|Lost to Follow-up|1|||
130583167|NCT01262976|470098924|FG001|Up to Month 2|Lost to Follow-up|0|||
130583168|NCT01262976|470098925|FG002|Up to Month 2|Lost to Follow-up|0|||
130583169|NCT01262976|470098926|FG003|Up to Month 2|Lost to Follow-up|1|||
130583170|NCT01262976|470098927|FG004|Up to Month 2|Lost to Follow-up|1|||
130583171|NCT01262976|470098928|FG005|Up to Month 2|Lost to Follow-up|1|||
130534779|NCT02672852|469925013|FG002|Part B|Lost to Follow-up|0|||
130534780|NCT02672852|469925014|FG003|Part B|Lost to Follow-up|0|||
130534781|NCT02672852|469925015|FG004|Part B|Lost to Follow-up|3|||
130534782|NCT02672852|469925016|FG005|Part B|Lost to Follow-up|4|||
130534783|NCT02672852|469925017|FG006|Part B|Lost to Follow-up|1|||
130534784|NCT02672852|469925011|FG000|Part B|Withdrawal by Subject|0|||
130534785|NCT02672852|469925012|FG001|Part B|Withdrawal by Subject|0|||
130534786|NCT02672852|469925013|FG002|Part B|Withdrawal by Subject|0|||
130534787|NCT02672852|469925014|FG003|Part B|Withdrawal by Subject|0|||
130534788|NCT02672852|469925015|FG004|Part B|Withdrawal by Subject|5|||
130534789|NCT02672852|469925016|FG005|Part B|Withdrawal by Subject|0|||
130534790|NCT02672852|469925017|FG006|Part B|Withdrawal by Subject|7|||
130534791|NCT02672852|469925011|FG000|Part B|Other|0|||
130534792|NCT02672852|469925012|FG001|Part B|Other|0|||
130534793|NCT02672852|469925013|FG002|Part B|Other|0|||
130534794|NCT02672852|469925014|FG003|Part B|Other|0|||
130534795|NCT02672852|469925015|FG004|Part B|Other|4|||
130534796|NCT02672852|469925016|FG005|Part B|Other|1|||
130534797|NCT02672852|469925017|FG006|Part B|Other|2|||
130534798|NCT00702962|469925018|FG000|Overall Study|Progressive disease|0|||
130534799|NCT00702962|469925019|FG001|Overall Study|Progressive disease|1|||
130534800|NCT00702962|469925018|FG000|Overall Study|Hospitalized for other health disorder|1|||
130583172|NCT01262976|470098923|FG000|Up to Month 2|Other|1|||
130583173|NCT01262976|470098924|FG001|Up to Month 2|Other|0|||
130583174|NCT01262976|470098925|FG002|Up to Month 2|Other|0|||
130583175|NCT01262976|470098926|FG003|Up to Month 2|Other|1|||
130583176|NCT01262976|470098927|FG004|Up to Month 2|Other|0|||
130583177|NCT01262976|470098928|FG005|Up to Month 2|Other|2|||
130583178|NCT01262976|470098923|FG000|Up to Month 7|Serious Adverse Event|0|||
130583179|NCT01262976|470098924|FG001|Up to Month 7|Serious Adverse Event|0|||
130534801|NCT00702962|469925019|FG001|Overall Study|Hospitalized for other health disorder|0|||
130534802|NCT02175641|469925020|FG000|Overall Study|Death|3|||
130534803|NCT02175641|469925021|FG001|Overall Study|Death|4|||
130534804|NCT02175641|469925020|FG000|Overall Study|Lost to Follow-up|4|||
130534805|NCT02175641|469925021|FG001|Overall Study|Lost to Follow-up|4|||
130583180|NCT01262976|470098925|FG002|Up to Month 7|Serious Adverse Event|2|||
130583181|NCT01262976|470098926|FG003|Up to Month 7|Serious Adverse Event|0|||
130583182|NCT01262976|470098927|FG004|Up to Month 7|Serious Adverse Event|0|||
130583183|NCT01262976|470098928|FG005|Up to Month 7|Serious Adverse Event|0|||
130583184|NCT01262976|470098923|FG000|Up to Month 7|Withdrawal by Subject|1|||
130583185|NCT01262976|470098924|FG001|Up to Month 7|Withdrawal by Subject|0|||
130583186|NCT01262976|470098925|FG002|Up to Month 7|Withdrawal by Subject|0|||
130583187|NCT01262976|470098926|FG003|Up to Month 7|Withdrawal by Subject|0|||
130583188|NCT01262976|470098927|FG004|Up to Month 7|Withdrawal by Subject|0|||
130583189|NCT01262976|470098928|FG005|Up to Month 7|Withdrawal by Subject|0|||
130583190|NCT01262976|470098923|FG000|Up to Month 7|Migrated/moved from study area|0|||
130583191|NCT01262976|470098924|FG001|Up to Month 7|Migrated/moved from study area|0|||
130583192|NCT01262976|470098925|FG002|Up to Month 7|Migrated/moved from study area|1|||
130534806|NCT02175641|469925020|FG000|Overall Study|Withdrawal by Subject|7|||
130534807|NCT02175641|469925021|FG001|Overall Study|Withdrawal by Subject|4|||
130534808|NCT02175641|469925020|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
130534809|NCT02175641|469925021|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
130534810|NCT02175641|469925020|FG000|Overall Study|Developed Contraindicated Condition|8|||
130534811|NCT02175641|469925021|FG001|Overall Study|Developed Contraindicated Condition|0|||
130534812|NCT01923467|469925023|FG000|Overall Study|Lost to Follow-up|62|||
130534813|NCT01923467|469925023|FG000|Overall Study|Subject non-interest|479|||
130534814|NCT01876901|469925024|FG000|Overall Study|Protocol Violation|10|||
130534815|NCT01876901|469925025|FG001|Overall Study|Protocol Violation|2|||
130534816|NCT01876901|469925024|FG000|Overall Study|No or other surgical intervention|7|||
130534817|NCT01876901|469925025|FG001|Overall Study|No or other surgical intervention|5|||
130534818|NCT02242097|469925026|FG000|Ibrutinib Treatment|Adverse Event|16|||
130534819|NCT02242097|469925026|FG000|Ibrutinib Treatment|Physician Decision|1|||
130534820|NCT02242097|469925026|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
130534821|NCT02242097|469925026|FG000|Ibrutinib Treatment|Death|1|||
130534822|NCT02242097|469925026|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
130534823|NCT02242097|469925026|FG000|Post Therapy Follow Up|Death|3|||
130534824|NCT02242097|469925026|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
130534825|NCT01598662|469925029|FG000|Overall Study|Lost to Follow-up|10|||
130534826|NCT01598662|469925030|FG001|Overall Study|Lost to Follow-up|17|||
130534827|NCT01598662|469925029|FG000|Overall Study|Physician Decision|1|||
130534828|NCT01598662|469925030|FG001|Overall Study|Physician Decision|2|||
130534829|NCT01598662|469925029|FG000|Overall Study|IUD expelled before month 6|0|||
130534830|NCT01598662|469925030|FG001|Overall Study|IUD expelled before month 6|2|||
130534831|NCT02574845|469925031|FG000|Overall Study|Consent withdrawn further participation|0|||
130534832|NCT02574845|469925032|FG001|Overall Study|Consent withdrawn further participation|0|||
130534833|NCT02574845|469925033|FG002|Overall Study|Consent withdrawn further participation|0|||
130534834|NCT02574845|469925034|FG003|Overall Study|Consent withdrawn further participation|0|||
130534835|NCT02574845|469925035|FG004|Overall Study|Consent withdrawn further participation|1|||
130534836|NCT02574845|469925036|FG005|Overall Study|Consent withdrawn further participation|0|||
130534837|NCT02574845|469925031|FG000|Overall Study|Adverse Event|0|||
130534838|NCT02574845|469925032|FG001|Overall Study|Adverse Event|1|||
130534839|NCT02574845|469925033|FG002|Overall Study|Adverse Event|0|||
130534840|NCT02574845|469925034|FG003|Overall Study|Adverse Event|0|||
130534841|NCT02574845|469925035|FG004|Overall Study|Adverse Event|0|||
130534842|NCT02574845|469925036|FG005|Overall Study|Adverse Event|1|||
130534843|NCT03435692|469925038|FG000|Overall Study|Lack of Efficacy|2|||
130534844|NCT03435692|469925039|FG001|Overall Study|Lack of Efficacy|2|||
130534845|NCT03435692|469925040|FG002|Overall Study|Lack of Efficacy|0|||
130534846|NCT00821587|469925045|FG000|Overall Study|Physician Decision|0|||
130534847|NCT00821587|469925046|FG001|Overall Study|Physician Decision|1|||
130534848|NCT02781090|469925049|FG000|3-Month Follow-Up|Missed Visit|20|||
130534849|NCT02781090|469925050|FG001|3-Month Follow-Up|Missed Visit|20|||
130534850|NCT02781090|469925049|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
130534851|NCT02781090|469925050|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
130534852|NCT02781090|469925049|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
130534853|NCT02781090|469925050|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
130534854|NCT02781090|469925049|FG000|3-Month Follow-Up|Death|1|||
130534855|NCT02781090|469925050|FG001|3-Month Follow-Up|Death|0|||
130534856|NCT02781090|469925049|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
130534857|NCT02781090|469925050|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
130534858|NCT02781090|469925049|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
130534859|NCT02781090|469925050|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
130534860|NCT02781090|469925049|FG000|6-Month Follow-Up|Death|0|||
130534861|NCT02781090|469925050|FG001|6-Month Follow-Up|Death|1|||
130534862|NCT00643617|469925051|FG000|Overall Study|Death|6|||
130534863|NCT00643617|469925052|FG001|Overall Study|Death|9|||
130534864|NCT00643617|469925051|FG000|Overall Study|Lost to Follow-up|42|||
130534865|NCT00643617|469925052|FG001|Overall Study|Lost to Follow-up|51|||
130534866|NCT01145898|469925053|FG000|3-year Treatment|medication change by treating physician|3|||
130534867|NCT01145898|469925054|FG001|3-year Treatment|medication change by treating physician|16|||
130534868|NCT01712061|469925055|FG000|Overall Study|Adverse Event|4|||
130583193|NCT01262976|470098926|FG003|Up to Month 7|Migrated/moved from study area|3|||
130583194|NCT01262976|470098927|FG004|Up to Month 7|Migrated/moved from study area|1|||
130583195|NCT01262976|470098928|FG005|Up to Month 7|Migrated/moved from study area|1|||
130583196|NCT01262976|470098923|FG000|Up to Month 7|Lost to Follow-up|1|||
130583197|NCT01262976|470098924|FG001|Up to Month 7|Lost to Follow-up|0|||
130583198|NCT01262976|470098925|FG002|Up to Month 7|Lost to Follow-up|1|||
130583199|NCT01262976|470098926|FG003|Up to Month 7|Lost to Follow-up|3|||
130583200|NCT01262976|470098927|FG004|Up to Month 7|Lost to Follow-up|1|||
130583201|NCT01262976|470098928|FG005|Up to Month 7|Lost to Follow-up|3|||
130583202|NCT01262976|470098923|FG000|Up to Month 7|Other|3|||
130583203|NCT01262976|470098924|FG001|Up to Month 7|Other|0|||
130583204|NCT01262976|470098925|FG002|Up to Month 7|Other|2|||
130583205|NCT01262976|470098926|FG003|Up to Month 7|Other|0|||
130583206|NCT01262976|470098927|FG004|Up to Month 7|Other|0|||
130583207|NCT01262976|470098928|FG005|Up to Month 7|Other|0|||
130583208|NCT01262976|470098923|FG000|Up to Year 1|Serious Adverse Event|0|||
130583209|NCT01262976|470098924|FG001|Up to Year 1|Serious Adverse Event|0|||
130583210|NCT01262976|470098925|FG002|Up to Year 1|Serious Adverse Event|2|||
130583211|NCT01262976|470098926|FG003|Up to Year 1|Serious Adverse Event|0|||
130583212|NCT01262976|470098927|FG004|Up to Year 1|Serious Adverse Event|0|||
130583213|NCT01262976|470098928|FG005|Up to Year 1|Serious Adverse Event|0|||
130583214|NCT01262976|470098923|FG000|Up to Year 1|Withdrawal by Subject|1|||
130583215|NCT01262976|470098924|FG001|Up to Year 1|Withdrawal by Subject|0|||
130583216|NCT01262976|470098925|FG002|Up to Year 1|Withdrawal by Subject|0|||
130583217|NCT01262976|470098926|FG003|Up to Year 1|Withdrawal by Subject|0|||
130583218|NCT01262976|470098927|FG004|Up to Year 1|Withdrawal by Subject|0|||
130583219|NCT01262976|470098928|FG005|Up to Year 1|Withdrawal by Subject|0|||
130583220|NCT01262976|470098923|FG000|Up to Year 1|Migrated/moved from study area|1|||
130583221|NCT01262976|470098924|FG001|Up to Year 1|Migrated/moved from study area|0|||
130583222|NCT01262976|470098925|FG002|Up to Year 1|Migrated/moved from study area|0|||
130583223|NCT01262976|470098926|FG003|Up to Year 1|Migrated/moved from study area|3|||
130583224|NCT01262976|470098927|FG004|Up to Year 1|Migrated/moved from study area|3|||
130583225|NCT01262976|470098928|FG005|Up to Year 1|Migrated/moved from study area|2|||
130583226|NCT01262976|470098923|FG000|Up to Year 1|Lost to Follow-up|4|||
130583227|NCT01262976|470098924|FG001|Up to Year 1|Lost to Follow-up|0|||
130583228|NCT01262976|470098925|FG002|Up to Year 1|Lost to Follow-up|0|||
130583229|NCT01262976|470098926|FG003|Up to Year 1|Lost to Follow-up|1|||
130583230|NCT01262976|470098927|FG004|Up to Year 1|Lost to Follow-up|6|||
130583231|NCT01262976|470098928|FG005|Up to Year 1|Lost to Follow-up|5|||
130583232|NCT01262976|470098923|FG000|Up to Year 1|Other|3|||
130583233|NCT01262976|470098924|FG001|Up to Year 1|Other|1|||
130583234|NCT01262976|470098925|FG002|Up to Year 1|Other|0|||
130583235|NCT01262976|470098926|FG003|Up to Year 1|Other|0|||
130583236|NCT01262976|470098927|FG004|Up to Year 1|Other|2|||
130583237|NCT01262976|470098928|FG005|Up to Year 1|Other|1|||
130583238|NCT01262976|470098923|FG000|Up to Year 1|Subjects with unknown completion status|0|||
130583239|NCT01262976|470098924|FG001|Up to Year 1|Subjects with unknown completion status|0|||
130583240|NCT01262976|470098925|FG002|Up to Year 1|Subjects with unknown completion status|1|||
130583241|NCT01262976|470098926|FG003|Up to Year 1|Subjects with unknown completion status|0|||
130583242|NCT01262976|470098927|FG004|Up to Year 1|Subjects with unknown completion status|0|||
130583243|NCT01262976|470098928|FG005|Up to Year 1|Subjects with unknown completion status|1|||
130583244|NCT01262976|470098923|FG000|Up to Year 2|Serious Adverse Event|0|||
130583245|NCT01262976|470098924|FG001|Up to Year 2|Serious Adverse Event|0|||
130583246|NCT01262976|470098925|FG002|Up to Year 2|Serious Adverse Event|2|||
130583247|NCT01262976|470098926|FG003|Up to Year 2|Serious Adverse Event|0|||
130583248|NCT01262976|470098927|FG004|Up to Year 2|Serious Adverse Event|0|||
130583249|NCT01262976|470098928|FG005|Up to Year 2|Serious Adverse Event|0|||
130583250|NCT01262976|470098923|FG000|Up to Year 2|Withdrawal by Subject|1|||
130583251|NCT01262976|470098924|FG001|Up to Year 2|Withdrawal by Subject|0|||
130583252|NCT01262976|470098925|FG002|Up to Year 2|Withdrawal by Subject|0|||
130583253|NCT01262976|470098926|FG003|Up to Year 2|Withdrawal by Subject|0|||
130583254|NCT01262976|470098927|FG004|Up to Year 2|Withdrawal by Subject|0|||
130583255|NCT01262976|470098928|FG005|Up to Year 2|Withdrawal by Subject|0|||
130583256|NCT01262976|470098923|FG000|Up to Year 2|Migrated/moved from study area|0|||
130583257|NCT01262976|470098924|FG001|Up to Year 2|Migrated/moved from study area|0|||
130583258|NCT01262976|470098925|FG002|Up to Year 2|Migrated/moved from study area|0|||
130583259|NCT01262976|470098926|FG003|Up to Year 2|Migrated/moved from study area|2|||
130583260|NCT01262976|470098927|FG004|Up to Year 2|Migrated/moved from study area|1|||
130583261|NCT01262976|470098928|FG005|Up to Year 2|Migrated/moved from study area|2|||
130583262|NCT01262976|470098923|FG000|Up to Year 2|Lost to Follow-up|1|||
130583263|NCT01262976|470098924|FG001|Up to Year 2|Lost to Follow-up|1|||
130583264|NCT01262976|470098925|FG002|Up to Year 2|Lost to Follow-up|2|||
130583265|NCT01262976|470098926|FG003|Up to Year 2|Lost to Follow-up|2|||
130583266|NCT01262976|470098927|FG004|Up to Year 2|Lost to Follow-up|3|||
130583267|NCT01262976|470098928|FG005|Up to Year 2|Lost to Follow-up|3|||
130583268|NCT01262976|470098923|FG000|Up to Year 2|Subjects with unknown completion status|0|||
130583269|NCT01262976|470098924|FG001|Up to Year 2|Subjects with unknown completion status|0|||
130583270|NCT01262976|470098925|FG002|Up to Year 2|Subjects with unknown completion status|1|||
130583271|NCT01262976|470098926|FG003|Up to Year 2|Subjects with unknown completion status|0|||
130583272|NCT01262976|470098927|FG004|Up to Year 2|Subjects with unknown completion status|0|||
130583273|NCT01262976|470098928|FG005|Up to Year 2|Subjects with unknown completion status|0|||
130583274|NCT01262976|470098923|FG000|Up to Year 2|Other|3|||
130583275|NCT01262976|470098924|FG001|Up to Year 2|Other|0|||
130583276|NCT01262976|470098925|FG002|Up to Year 2|Other|0|||
130583277|NCT01262976|470098926|FG003|Up to Year 2|Other|0|||
130583278|NCT01262976|470098927|FG004|Up to Year 2|Other|0|||
130583279|NCT01262976|470098928|FG005|Up to Year 2|Other|0|||
130583280|NCT01262976|470098923|FG000|Up to Year 3|Serious Adverse Event|0|||
130583281|NCT01262976|470098924|FG001|Up to Year 3|Serious Adverse Event|0|||
130583282|NCT01262976|470098925|FG002|Up to Year 3|Serious Adverse Event|2|||
130583283|NCT01262976|470098926|FG003|Up to Year 3|Serious Adverse Event|0|||
130583284|NCT01262976|470098927|FG004|Up to Year 3|Serious Adverse Event|0|||
130583285|NCT01262976|470098928|FG005|Up to Year 3|Serious Adverse Event|0|||
130583286|NCT01262976|470098923|FG000|Up to Year 3|Withdrawal by Subject|1|||
130583287|NCT01262976|470098924|FG001|Up to Year 3|Withdrawal by Subject|0|||
130534869|NCT01712061|469925056|FG001|Overall Study|Adverse Event|9|||
130534870|NCT01712061|469925057|FG002|Overall Study|Adverse Event|5|||
130534871|NCT01712061|469925055|FG000|Overall Study|Death|0|||
130534872|NCT01712061|469925056|FG001|Overall Study|Death|0|||
130534873|NCT01712061|469925057|FG002|Overall Study|Death|1|||
130534874|NCT01712061|469925055|FG000|Overall Study|Lost to Follow-up|1|||
130534875|NCT01712061|469925056|FG001|Overall Study|Lost to Follow-up|0|||
130534876|NCT01712061|469925057|FG002|Overall Study|Lost to Follow-up|1|||
130534877|NCT01712061|469925055|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
130534878|NCT01712061|469925056|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
130534879|NCT01712061|469925057|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
130534880|NCT01712061|469925055|FG000|Overall Study|Medication Error Without Associated AE|0|||
130534881|NCT01712061|469925056|FG001|Overall Study|Medication Error Without Associated AE|1|||
130534882|NCT01712061|469925057|FG002|Overall Study|Medication Error Without Associated AE|0|||
130534883|NCT01712061|469925055|FG000|Overall Study|Withdrawal by Subject|1|||
130534884|NCT01712061|469925056|FG001|Overall Study|Withdrawal by Subject|7|||
130534885|NCT01712061|469925057|FG002|Overall Study|Withdrawal by Subject|1|||
130534886|NCT01712061|469925055|FG000|Overall Study|Other|0|||
130534887|NCT01712061|469925056|FG001|Overall Study|Other|3|||
130534888|NCT01712061|469925057|FG002|Overall Study|Other|0|||
130534889|NCT00879775|469925058|FG000|Overall Study|Lost to Follow-up|2|||
130534890|NCT00879775|469925059|FG001|Overall Study|Lost to Follow-up|1|||
130534891|NCT02683785|469925062|FG000|Overall Study|Withdrawal by Subject|1|||
130534892|NCT02683785|469925063|FG001|Overall Study|Withdrawal by Subject|1|||
130534893|NCT02683785|469925062|FG000|Overall Study|Lost to Follow-up|0|||
130534894|NCT02683785|469925063|FG001|Overall Study|Lost to Follow-up|1|||
130534895|NCT02683785|469925062|FG000|Overall Study|Adverse Event|0|||
130534896|NCT02683785|469925063|FG001|Overall Study|Adverse Event|2|||
130534897|NCT01195623|469925064|FG000|Overall Study|Lost to Follow-up|35|||
130534898|NCT01195623|469925065|FG001|Overall Study|Lost to Follow-up|37|||
130534899|NCT01677767|469925071|FG000|Overall Study|Adverse Event|1|||
130583288|NCT01262976|470098925|FG002|Up to Year 3|Withdrawal by Subject|0|||
130583289|NCT01262976|470098926|FG003|Up to Year 3|Withdrawal by Subject|0|||
130583290|NCT01262976|470098927|FG004|Up to Year 3|Withdrawal by Subject|0|||
130583291|NCT01262976|470098928|FG005|Up to Year 3|Withdrawal by Subject|0|||
130583292|NCT01262976|470098923|FG000|Up to Year 3|Migrated/moved from study area|0|||
130583293|NCT01262976|470098924|FG001|Up to Year 3|Migrated/moved from study area|0|||
130583294|NCT01262976|470098925|FG002|Up to Year 3|Migrated/moved from study area|0|||
130583295|NCT01262976|470098926|FG003|Up to Year 3|Migrated/moved from study area|2|||
130583296|NCT01262976|470098927|FG004|Up to Year 3|Migrated/moved from study area|1|||
130583297|NCT01262976|470098928|FG005|Up to Year 3|Migrated/moved from study area|1|||
130583298|NCT01262976|470098923|FG000|Up to Year 3|Lost to Follow-up|2|||
130583299|NCT01262976|470098924|FG001|Up to Year 3|Lost to Follow-up|2|||
130583300|NCT01262976|470098925|FG002|Up to Year 3|Lost to Follow-up|4|||
130583301|NCT01262976|470098926|FG003|Up to Year 3|Lost to Follow-up|3|||
130583302|NCT01262976|470098927|FG004|Up to Year 3|Lost to Follow-up|1|||
130583303|NCT01262976|470098928|FG005|Up to Year 3|Lost to Follow-up|3|||
130583304|NCT01262976|470098923|FG000|Up to Year 3|Subjects with unknown completion status|0|||
130583305|NCT01262976|470098924|FG001|Up to Year 3|Subjects with unknown completion status|0|||
130583306|NCT01262976|470098925|FG002|Up to Year 3|Subjects with unknown completion status|1|||
130583307|NCT01262976|470098926|FG003|Up to Year 3|Subjects with unknown completion status|0|||
130583308|NCT01262976|470098927|FG004|Up to Year 3|Subjects with unknown completion status|0|||
130583309|NCT01262976|470098928|FG005|Up to Year 3|Subjects with unknown completion status|0|||
130583310|NCT01262976|470098923|FG000|Up to Year 3|Other|3|||
130583311|NCT01262976|470098924|FG001|Up to Year 3|Other|0|||
130583312|NCT01262976|470098925|FG002|Up to Year 3|Other|0|||
130583313|NCT01262976|470098926|FG003|Up to Year 3|Other|0|||
130583314|NCT01262976|470098927|FG004|Up to Year 3|Other|0|||
130583315|NCT01262976|470098928|FG005|Up to Year 3|Other|0|||
130583316|NCT01552681|470098929|FG000|Overall Study|Withdrawal by Subject|4|||
130583317|NCT01552681|470098930|FG001|Overall Study|Withdrawal by Subject|0|||
130583318|NCT01552681|470098929|FG000|Overall Study|Physician Decision|1|||
130583319|NCT01552681|470098930|FG001|Overall Study|Physician Decision|0|||
130583320|NCT01552681|470098929|FG000|Overall Study|Subject moved away|0|||
130583321|NCT01552681|470098930|FG001|Overall Study|Subject moved away|1|||
130583322|NCT02690194|470098931|FG000|Overall Study|Withdrawal by Subject|1|||
130583323|NCT02690194|470098932|FG001|Overall Study|Withdrawal by Subject|4|||
130583324|NCT02690194|470098933|FG002|Overall Study|Withdrawal by Subject|0|||
130583325|NCT01987908|470098935|FG000|Placebo Lead-in Period|Adverse Event|2|||
130583326|NCT01987908|470098936|FG001|Placebo Lead-in Period|Adverse Event|0|||
130583327|NCT01987908|470098937|FG002|Placebo Lead-in Period|Adverse Event|0|||
130583328|NCT01987908|470098935|FG000|Placebo Lead-in Period|Physician Decision|2|||
130583329|NCT01987908|470098936|FG001|Placebo Lead-in Period|Physician Decision|0|||
130583330|NCT01987908|470098937|FG002|Placebo Lead-in Period|Physician Decision|0|||
130583331|NCT01987908|470098935|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
130583332|NCT01987908|470098936|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
130583333|NCT01987908|470098937|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
130583334|NCT01987908|470098935|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
130583335|NCT01987908|470098936|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
130583336|NCT01987908|470098937|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
130583337|NCT01987908|470098935|FG000|Treatment Period|Adverse Event|0|||
130583338|NCT01987908|470098936|FG001|Treatment Period|Adverse Event|1|||
130583339|NCT01987908|470098937|FG002|Treatment Period|Adverse Event|1|||
130583340|NCT01987908|470098935|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
130583341|NCT01987908|470098936|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
130583342|NCT01987908|470098937|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
130583343|NCT01987908|470098935|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
130583344|NCT01987908|470098936|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
130583345|NCT01987908|470098937|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
130583346|NCT01262625|470098938|FG000|Overall Study|Administrative Error|1|||
130583347|NCT01262625|470098939|FG001|Overall Study|Administrative Error|1|||
130583348|NCT01262625|470098938|FG000|Overall Study|Site Closed|1|||
130583349|NCT01262625|470098939|FG001|Overall Study|Site Closed|0|||
130583350|NCT02789657|470098940|FG000|Overall Study|Withdrawal by Subject|2|||
130583351|NCT02789657|470098941|FG001|Overall Study|Withdrawal by Subject|0|||
130583352|NCT02789657|470098942|FG002|Overall Study|Withdrawal by Subject|0|||
130583353|NCT02789657|470098943|FG003|Overall Study|Withdrawal by Subject|0|||
130583354|NCT00236080|470098944|FG000|Overall Study|Adverse Event|0|||
130583355|NCT00236080|470098945|FG001|Overall Study|Adverse Event|0|||
130583356|NCT00236080|470098946|FG002|Overall Study|Adverse Event|3|||
130583357|NCT00236080|470098947|FG003|Overall Study|Adverse Event|1|||
130583358|NCT00236080|470098948|FG004|Overall Study|Adverse Event|0|||
130583359|NCT00236080|470098944|FG000|Overall Study|Lost to Follow-up|0|||
130583360|NCT00236080|470098945|FG001|Overall Study|Lost to Follow-up|1|||
130583361|NCT00236080|470098946|FG002|Overall Study|Lost to Follow-up|0|||
130583362|NCT00236080|470098947|FG003|Overall Study|Lost to Follow-up|0|||
130583363|NCT00236080|470098948|FG004|Overall Study|Lost to Follow-up|0|||
130534900|NCT01677767|469925071|FG000|Overall Study|Death|4|||
130534901|NCT01677767|469925071|FG000|Overall Study|Protocol Violation|4|||
130534902|NCT01677767|469925071|FG000|Overall Study|Withdrawal by Subject|10|||
130534903|NCT01677767|469925071|FG000|Overall Study|Non-compliance by the participants|3|||
130534904|NCT00842244|469925072|FG000|Overall Study|Death|3|||
130534905|NCT00842244|469925072|FG000|Overall Study|Withdrawal by Subject|1|||
130534906|NCT00842244|469925072|FG000|Overall Study|Other|17|||
130534907|NCT02233803|469925077|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
130534908|NCT02233803|469925078|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
130534909|NCT02233803|469925077|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
130534910|NCT02233803|469925078|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
130534911|NCT02233803|469925077|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
130534912|NCT02233803|469925078|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
130534913|NCT02233803|469925077|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
130534914|NCT02233803|469925078|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
130534915|NCT02233803|469925077|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
130534916|NCT02233803|469925078|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
130534917|NCT02233803|469925077|FG000|Washout Period (4-Wks)|Physician Decision|1|||
130534918|NCT02233803|469925078|FG001|Washout Period (4-Wks)|Physician Decision|0|||
130534919|NCT02233803|469925077|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
130534920|NCT02233803|469925078|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
130534921|NCT02233803|469925077|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
130534922|NCT02233803|469925078|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
130534923|NCT02233803|469925077|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
130534924|NCT02233803|469925078|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
130534925|NCT03846453|469925079|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
130534926|NCT03846453|469925080|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
130534927|NCT03846453|469925081|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
130534928|NCT03846453|469925079|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
130534929|NCT03846453|469925080|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
130534930|NCT03846453|469925081|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
130534931|NCT03846453|469925079|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
130534932|NCT03846453|469925080|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
130534933|NCT03846453|469925081|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
130534934|NCT03846453|469925079|FG000|Placebo Run-in (14 Days)|Other|2|||
130534935|NCT03846453|469925080|FG001|Placebo Run-in (14 Days)|Other|0|||
130534936|NCT03846453|469925081|FG002|Placebo Run-in (14 Days)|Other|0|||
130534937|NCT03846453|469925079|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
130534938|NCT03846453|469925080|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
130534939|NCT03846453|469925081|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
130534940|NCT03846453|469925079|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
130534941|NCT03846453|469925080|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
130534942|NCT03846453|469925081|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
130534943|NCT03846453|469925079|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
130534944|NCT03846453|469925080|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
130534945|NCT03846453|469925081|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
130534946|NCT03846453|469925079|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
130534947|NCT03846453|469925080|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
130534948|NCT03846453|469925081|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
130534949|NCT03846453|469925079|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
130534950|NCT03846453|469925080|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
130534951|NCT03846453|469925081|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
130534952|NCT00757627|469925082|FG000|Overall Study|Adverse Event|15|||
130534953|NCT00757627|469925082|FG000|Overall Study|Lack of Efficacy|10|||
130534954|NCT00757627|469925082|FG000|Overall Study|Lost to Follow-up|28|||
130534955|NCT00757627|469925082|FG000|Overall Study|Withdrawal by Subject|27|||
130534956|NCT00757627|469925082|FG000|Overall Study|Other|1|||
130534957|NCT00635661|469925083|FG000|Overall Study|Withdrawal by Subject|4|||
130534958|NCT00468143|469925086|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
130534959|NCT00468143|469925087|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
130534960|NCT00468143|469925086|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
130534961|NCT00468143|469925087|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
130534962|NCT01606670|469925088|FG000|Overall Study|Adverse Event|6|||
130534963|NCT01606670|469925088|FG000|Overall Study|Lack of Efficacy|2|||
130534964|NCT01606670|469925088|FG000|Overall Study|Lost to Follow-up|3|||
130534965|NCT01606670|469925088|FG000|Overall Study|Withdrawal by Subject|3|||
130534966|NCT01606670|469925088|FG000|Overall Study|Other Reason|2|||
130583364|NCT00236080|470098944|FG000|Overall Study|Physician Decision|1|||
130583365|NCT00236080|470098945|FG001|Overall Study|Physician Decision|0|||
130583366|NCT00236080|470098946|FG002|Overall Study|Physician Decision|1|||
130583367|NCT00236080|470098947|FG003|Overall Study|Physician Decision|1|||
130583368|NCT00236080|470098948|FG004|Overall Study|Physician Decision|1|||
130583369|NCT00236080|470098944|FG000|Overall Study|Withdrawal by Subject|1|||
130583370|NCT00236080|470098945|FG001|Overall Study|Withdrawal by Subject|0|||
130583371|NCT00236080|470098946|FG002|Overall Study|Withdrawal by Subject|0|||
130583372|NCT00236080|470098947|FG003|Overall Study|Withdrawal by Subject|0|||
130583373|NCT00236080|470098948|FG004|Overall Study|Withdrawal by Subject|0|||
130583374|NCT00236080|470098944|FG000|Overall Study|Miscellaneous|0|||
130583375|NCT00236080|470098945|FG001|Overall Study|Miscellaneous|0|||
130583376|NCT00236080|470098946|FG002|Overall Study|Miscellaneous|1|||
130583377|NCT00236080|470098947|FG003|Overall Study|Miscellaneous|0|||
130583378|NCT00236080|470098948|FG004|Overall Study|Miscellaneous|0|||
130583379|NCT03882424|470098949|FG000|Overall Study|Lost to Follow-up|3|||
130583380|NCT03882424|470098950|FG001|Overall Study|Lost to Follow-up|0|||
130583381|NCT03882424|470098951|FG002|Overall Study|Lost to Follow-up|0|||
130583382|NCT03882424|470098949|FG000|Overall Study|schedule conflict|1|||
130583383|NCT03882424|470098950|FG001|Overall Study|schedule conflict|0|||
130583384|NCT03882424|470098951|FG002|Overall Study|schedule conflict|0|||
130583385|NCT01214044|470098952|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
130583386|NCT01214044|470098952|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
130583387|NCT01214044|470098952|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
130583388|NCT01214044|470098952|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
130583389|NCT01214044|470098952|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
130583390|NCT01214044|470098952|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
130583391|NCT02772757|470098956|FG000|Overall Study|Withdrawal by Subject|1|||
130583392|NCT02772757|470098957|FG001|Overall Study|Withdrawal by Subject|0|||
130583393|NCT02772757|470098958|FG002|Overall Study|Withdrawal by Subject|1|||
130583394|NCT02772757|470098956|FG000|Overall Study|Protocol Violation|0|||
130583395|NCT02772757|470098957|FG001|Overall Study|Protocol Violation|0|||
130583396|NCT02772757|470098958|FG002|Overall Study|Protocol Violation|1|||
130583397|NCT02772757|470098956|FG000|Overall Study|Physician Decision|0|||
130583398|NCT02772757|470098957|FG001|Overall Study|Physician Decision|3|||
130583399|NCT02772757|470098958|FG002|Overall Study|Physician Decision|3|||
130583400|NCT04698525|470098959|FG000|Overall Study|Lost to Follow-up|1|||
130583401|NCT04698525|470098960|FG001|Overall Study|Lost to Follow-up|2|||
130583402|NCT04698525|470098959|FG000|Overall Study|Three suffered of Covid-19|2|||
130583403|NCT04698525|470098960|FG001|Overall Study|Three suffered of Covid-19|1|||
130583404|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
130583405|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130583406|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130583407|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130583408|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
130583409|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130583410|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130583411|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130583412|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
130583413|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130583414|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130583415|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130583416|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
130583417|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130583418|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130583419|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130583420|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
130583421|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130583422|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130583423|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130583424|NCT01360645|470098963|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
130583425|NCT01360645|470098964|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130583426|NCT01360645|470098965|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130583427|NCT01360645|470098966|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130583428|NCT01360645|470098963|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
130583429|NCT01360645|470098964|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
130583430|NCT01360645|470098965|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
130583431|NCT01360645|470098966|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
130583432|NCT01360645|470098963|FG000|Phase B (6 Weeks)|Adverse Event|0|||
130583433|NCT01360645|470098964|FG001|Phase B (6 Weeks)|Adverse Event|6|||
130583434|NCT01360645|470098965|FG002|Phase B (6 Weeks)|Adverse Event|0|||
130534967|NCT01559129|469925092|FG000|Treatment Phase|Adverse Event|0|||
130534968|NCT01559129|469925093|FG001|Treatment Phase|Adverse Event|2|||
130534969|NCT01559129|469925092|FG000|Treatment Phase|Progressive Disease|1|||
130534970|NCT01559129|469925093|FG001|Treatment Phase|Progressive Disease|1|||
130534971|NCT01559129|469925092|FG000|Treatment Phase|Lack of Efficacy|0|||
130534972|NCT01559129|469925093|FG001|Treatment Phase|Lack of Efficacy|1|||
130534973|NCT01559129|469925092|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
130534974|NCT01559129|469925093|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
130534975|NCT01559129|469925092|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
130534976|NCT01559129|469925093|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
130534977|NCT01559129|469925092|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
130534978|NCT01559129|469925093|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
130534979|NCT01559129|469925092|FG000|Open-label Extension Period|Adverse Event|1|||
130534980|NCT01559129|469925093|FG001|Open-label Extension Period|Adverse Event|0|||
130534981|NCT01559129|469925092|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
130534982|NCT01559129|469925093|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
130534983|NCT00368927|469925094|FG000|Overall Study|Lost to Follow-up|2|||
130534984|NCT00368927|469925095|FG001|Overall Study|Lost to Follow-up|0|||
130534985|NCT00368927|469925094|FG000|Overall Study|Adverse Event|1|||
130534986|NCT00368927|469925095|FG001|Overall Study|Adverse Event|1|||
130534987|NCT00368927|469925094|FG000|Overall Study|Withdrawal by Subject|1|||
130534988|NCT00368927|469925095|FG001|Overall Study|Withdrawal by Subject|2|||
130534989|NCT00368927|469925094|FG000|Overall Study|Physician Decision|1|||
130534990|NCT00368927|469925095|FG001|Overall Study|Physician Decision|0|||
130534991|NCT03525392|469925096|FG000|Overall Study|Adverse Event|1|||
130534992|NCT03525392|469925097|FG001|Overall Study|Adverse Event|0|||
130534993|NCT03525392|469925098|FG002|Overall Study|Adverse Event|2|||
130534994|NCT03525392|469925099|FG003|Overall Study|Adverse Event|0|||
130534995|NCT03525392|469925100|FG004|Overall Study|Adverse Event|0|||
130534996|NCT03525392|469925096|FG000|Overall Study|Progressive disease|0|||
130534997|NCT03525392|469925097|FG001|Overall Study|Progressive disease|1|||
130534998|NCT03525392|469925098|FG002|Overall Study|Progressive disease|1|||
130534999|NCT03525392|469925099|FG003|Overall Study|Progressive disease|3|||
130535000|NCT03525392|469925100|FG004|Overall Study|Progressive disease|1|||
130535001|NCT01946529|469925107|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
130535002|NCT01946529|469925108|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
130535003|NCT01946529|469925109|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
130535004|NCT01946529|469925107|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
130535005|NCT01946529|469925108|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
130535006|NCT01946529|469925109|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
130535007|NCT06655558|469925110|FG000|Overall Study|Protocol Violation|1|||
130535008|NCT03578887|469925111|FG000|Overall Study|Withdrawal by Subject|7|||
130535009|NCT03578887|469925112|FG001|Overall Study|Withdrawal by Subject|2|||
130535010|NCT03578887|469925113|FG002|Overall Study|Withdrawal by Subject|1|||
130535011|NCT03578887|469925111|FG000|Overall Study|Lost to Follow-up|13|||
130535012|NCT03578887|469925112|FG001|Overall Study|Lost to Follow-up|1|||
130535013|NCT03578887|469925113|FG002|Overall Study|Lost to Follow-up|4|||
130535014|NCT03578887|469925111|FG000|Overall Study|Physician Decision|0|||
130535015|NCT03578887|469925112|FG001|Overall Study|Physician Decision|1|||
130535016|NCT03578887|469925113|FG002|Overall Study|Physician Decision|1|||
130535017|NCT05718466|469926666|FG000|Overall Study|Withdrawal by Subject|1|||
130535018|NCT05718466|469926667|FG001|Overall Study|Withdrawal by Subject|2|||
130535019|NCT05718466|469926666|FG000|Overall Study|Death|0|||
130535020|NCT05718466|469926667|FG001|Overall Study|Death|1|||
130535021|NCT01099215|469926668|FG000|Overall Study|Withdrawal by Subject|1|||
130535022|NCT01099215|469926669|FG001|Overall Study|Withdrawal by Subject|0|||
130535023|NCT01099215|469926668|FG000|Overall Study|Adverse Event|0|||
130535024|NCT01099215|469926669|FG001|Overall Study|Adverse Event|1|||
130535025|NCT00387426|469926672|FG000|Overall Study|Lack of Response|7|||
130535026|NCT00387426|469926672|FG000|Overall Study|Toxicities|4|||
130535027|NCT00387426|469926672|FG000|Overall Study|Disease Progression|3|||
130535028|NCT00747227|469926679|FG000|Overall Study|Death|3|||
130535029|NCT00747227|469926680|FG001|Overall Study|Death|1|||
130535030|NCT00747227|469926679|FG000|Overall Study|Withdrawal by Subject|1|||
130535031|NCT00747227|469926680|FG001|Overall Study|Withdrawal by Subject|0|||
130535032|NCT00747227|469926679|FG000|Overall Study|Lost to Follow-up|1|||
130535033|NCT00747227|469926680|FG001|Overall Study|Lost to Follow-up|2|||
130535034|NCT00747227|469926679|FG000|Overall Study|Illness|1|||
130535035|NCT00747227|469926680|FG001|Overall Study|Illness|1|||
130535036|NCT03554629|469926681|FG000|Overall Study|Inadequate data|6|||
130535037|NCT00918879|469926682|FG000|Overall Study|Withdrawal by Subject|4|||
130535038|NCT00918879|469926683|FG001|Overall Study|Withdrawal by Subject|4|||
130535039|NCT00918879|469926682|FG000|Overall Study|Lost to Follow-up|1|||
130535040|NCT00918879|469926683|FG001|Overall Study|Lost to Follow-up|1|||
130535041|NCT00918879|469926682|FG000|Overall Study|Severe non-compliance to protocol|1|||
130535042|NCT00918879|469926683|FG001|Overall Study|Severe non-compliance to protocol|1|||
130535043|NCT00357110|469926684|FG000|Overall Study|Early study termination|5|||
130583435|NCT01360645|470098966|FG003|Phase B (6 Weeks)|Adverse Event|0|||
130535044|NCT00357110|469926685|FG001|Overall Study|Early study termination|5|||
130535045|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Physician Decision|2|||
130535046|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Physician Decision|0|||
130535047|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Physician Decision|0|||
130535048|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Adverse Event|33|||
130535049|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Adverse Event|0|||
130535050|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Adverse Event|0|||
130583436|NCT01360645|470098963|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130583437|NCT01360645|470098964|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
130583438|NCT01360645|470098965|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
130583439|NCT01360645|470098966|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130535051|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
130535052|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130535053|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130535054|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
130535055|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
130535056|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
130535057|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
130535058|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130535059|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130535060|NCT01008553|469926686|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
130535061|NCT01008553|469926687|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
130535062|NCT01008553|469926688|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
130535063|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
130535064|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
130535065|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
130535066|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
130535067|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
130535068|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
130535069|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
130535070|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
130535071|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
130535072|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
130535073|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
130535074|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
130535075|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130535076|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
130535077|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
130535078|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
130535079|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
130535080|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
130535081|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130535082|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130535083|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
130535084|NCT01008553|469926686|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
130535085|NCT01008553|469926687|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
130535086|NCT01008553|469926688|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
130535087|NCT01008410|469926690|FG000|Overall Study|Adverse Event|13|||
130535088|NCT01008410|469926691|FG001|Overall Study|Adverse Event|7|||
130535089|NCT01008410|469926690|FG000|Overall Study|Withdrawal by Subject|6|||
130535090|NCT01008410|469926691|FG001|Overall Study|Withdrawal by Subject|2|||
130535091|NCT01008410|469926690|FG000|Overall Study|Lost to Follow-up|1|||
130535092|NCT01008410|469926691|FG001|Overall Study|Lost to Follow-up|0|||
130583440|NCT01360645|470098963|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130583441|NCT01360645|470098964|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
130583442|NCT01360645|470098965|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
130583443|NCT01360645|470098966|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130583444|NCT01360645|470098963|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
130583445|NCT01360645|470098964|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
130583446|NCT01360645|470098965|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
130583447|NCT01360645|470098966|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
130583448|NCT01360645|470098963|FG000|Phase A+|Lost to Follow-up|0|||
130583449|NCT01360645|470098964|FG001|Phase A+|Lost to Follow-up|0|||
130535093|NCT01008410|469926690|FG000|Overall Study|Noncompliance|1|||
130535094|NCT01008410|469926691|FG001|Overall Study|Noncompliance|0|||
130535095|NCT01008410|469926690|FG000|Overall Study|Low Cortisol|2|||
130535096|NCT01008410|469926691|FG001|Overall Study|Low Cortisol|0|||
130535097|NCT01008410|469926690|FG000|Overall Study|Lack of Efficacy|2|||
130535098|NCT01008410|469926691|FG001|Overall Study|Lack of Efficacy|6|||
130535099|NCT01008410|469926690|FG000|Overall Study|Met Exclusion Criterion|0|||
130535100|NCT01008410|469926691|FG001|Overall Study|Met Exclusion Criterion|1|||
130535101|NCT03056300|469926694|FG000|Overall Study|Surgical reason per study protocol|3|||
130535102|NCT03563157|469926695|FG000|Overall Study|Progressive Disease|2|||
130535103|NCT05602727|469926698|FG000|Overall Study|Physician Decision|0|||
130535104|NCT05602727|469926699|FG001|Overall Study|Physician Decision|1|||
130535105|NCT05602727|469926700|FG002|Overall Study|Physician Decision|0|||
130535106|NCT05602727|469926698|FG000|Overall Study|Randomized by mistake without study medication|1|||
130535107|NCT05602727|469926699|FG001|Overall Study|Randomized by mistake without study medication|0|||
130535108|NCT05602727|469926700|FG002|Overall Study|Randomized by mistake without study medication|0|||
130535109|NCT05602727|469926698|FG000|Overall Study|Study termination by Sponsor|18|||
130535110|NCT05602727|469926699|FG001|Overall Study|Study termination by Sponsor|15|||
130535111|NCT05602727|469926700|FG002|Overall Study|Study termination by Sponsor|19|||
130535112|NCT05602727|469926698|FG000|Overall Study|Withdrawal by Subject|2|||
130535113|NCT05602727|469926699|FG001|Overall Study|Withdrawal by Subject|1|||
130535114|NCT05602727|469926700|FG002|Overall Study|Withdrawal by Subject|1|||
130535115|NCT05602727|469926698|FG000|Overall Study|Various reasons|1|||
130535116|NCT05602727|469926699|FG001|Overall Study|Various reasons|6|||
130535117|NCT05602727|469926700|FG002|Overall Study|Various reasons|1|||
130583450|NCT01360645|470098965|FG002|Phase A+|Lost to Follow-up|0|||
130583451|NCT01360645|470098966|FG003|Phase A+|Lost to Follow-up|7|||
130583452|NCT01360645|470098963|FG000|Phase A+|Adverse Event|0|||
130583453|NCT01360645|470098964|FG001|Phase A+|Adverse Event|0|||
130535118|NCT02187159|469926701|FG000|Overall Study|Protocol Violation|4|||
130535119|NCT02187159|469926702|FG001|Overall Study|Protocol Violation|6|||
130583454|NCT01360645|470098965|FG002|Phase A+|Adverse Event|0|||
130583455|NCT01360645|470098966|FG003|Phase A+|Adverse Event|2|||
130583456|NCT01360645|470098963|FG000|Phase A+|Met Withdrawal Criteria|0|||
130583457|NCT01360645|470098964|FG001|Phase A+|Met Withdrawal Criteria|0|||
130583458|NCT01360645|470098965|FG002|Phase A+|Met Withdrawal Criteria|0|||
130583459|NCT01360645|470098966|FG003|Phase A+|Met Withdrawal Criteria|4|||
130583460|NCT01360645|470098963|FG000|Phase A+|Physician Decision|0|||
130583461|NCT01360645|470098964|FG001|Phase A+|Physician Decision|0|||
130583462|NCT01360645|470098965|FG002|Phase A+|Physician Decision|0|||
130583463|NCT01360645|470098966|FG003|Phase A+|Physician Decision|2|||
130583464|NCT01360645|470098963|FG000|Phase A+|Withdrawal by Subject|0|||
130583465|NCT01360645|470098964|FG001|Phase A+|Withdrawal by Subject|0|||
130583466|NCT01360645|470098965|FG002|Phase A+|Withdrawal by Subject|0|||
130583467|NCT01360645|470098966|FG003|Phase A+|Withdrawal by Subject|5|||
130583468|NCT01360645|470098963|FG000|Phase A+|Protocol Deviation|0|||
130583469|NCT01360645|470098964|FG001|Phase A+|Protocol Deviation|0|||
130583470|NCT01360645|470098965|FG002|Phase A+|Protocol Deviation|0|||
130583471|NCT01360645|470098966|FG003|Phase A+|Protocol Deviation|4|||
130583472|NCT02251912|470098967|FG000|Overall Study|Withdrawal by Subject|2|||
130583473|NCT02251912|470098968|FG001|Overall Study|Withdrawal by Subject|3|||
130583474|NCT02251912|470098967|FG000|Overall Study|Adverse Event|0|||
130583475|NCT02251912|470098968|FG001|Overall Study|Adverse Event|2|||
130535120|NCT02187159|469926703|FG002|Overall Study|Protocol Violation|3|||
130535121|NCT02187159|469926704|FG003|Overall Study|Protocol Violation|4|||
130535122|NCT02187159|469926701|FG000|Overall Study|Lack of Efficacy|10|||
130535123|NCT02187159|469926702|FG001|Overall Study|Lack of Efficacy|5|||
130535124|NCT02187159|469926703|FG002|Overall Study|Lack of Efficacy|4|||
130535125|NCT02187159|469926704|FG003|Overall Study|Lack of Efficacy|7|||
130535126|NCT02187159|469926701|FG000|Overall Study|Adverse Event|28|||
130535127|NCT02187159|469926702|FG001|Overall Study|Adverse Event|33|||
130535128|NCT02187159|469926703|FG002|Overall Study|Adverse Event|42|||
130535129|NCT02187159|469926704|FG003|Overall Study|Adverse Event|50|||
130535130|NCT02187159|469926701|FG000|Overall Study|Withdrawal by Subject|24|||
130535131|NCT02187159|469926702|FG001|Overall Study|Withdrawal by Subject|28|||
130535132|NCT02187159|469926703|FG002|Overall Study|Withdrawal by Subject|25|||
130535133|NCT02187159|469926704|FG003|Overall Study|Withdrawal by Subject|26|||
130535134|NCT02187159|469926701|FG000|Overall Study|Other|3|||
130535135|NCT02187159|469926702|FG001|Overall Study|Other|7|||
130535136|NCT02187159|469926703|FG002|Overall Study|Other|3|||
130535137|NCT02187159|469926704|FG003|Overall Study|Other|9|||
130535138|NCT04020185|469926705|FG000|Overall Study|Death|0|||
130535139|NCT04020185|469926706|FG001|Overall Study|Death|0|||
130535140|NCT04020185|469926707|FG002|Overall Study|Death|1|||
130535141|NCT04020185|469926708|FG003|Overall Study|Death|2|||
130535142|NCT04020185|469926709|FG004|Overall Study|Death|1|||
130535143|NCT04020185|469926710|FG005|Overall Study|Death|0|||
130535144|NCT04020185|469926711|FG006|Overall Study|Death|1|||
130535145|NCT04020185|469926712|FG007|Overall Study|Death|0|||
130535146|NCT04020185|469926705|FG000|Overall Study|Consent withdrawn|1|||
130535147|NCT04020185|469926706|FG001|Overall Study|Consent withdrawn|0|||
130535148|NCT04020185|469926707|FG002|Overall Study|Consent withdrawn|0|||
130535149|NCT04020185|469926708|FG003|Overall Study|Consent withdrawn|0|||
130535150|NCT04020185|469926709|FG004|Overall Study|Consent withdrawn|2|||
130535151|NCT04020185|469926710|FG005|Overall Study|Consent withdrawn|0|||
130535152|NCT04020185|469926711|FG006|Overall Study|Consent withdrawn|1|||
130535153|NCT04020185|469926712|FG007|Overall Study|Consent withdrawn|1|||
130535154|NCT04020185|469926705|FG000|Overall Study|Patient in hospice|0|||
130583476|NCT01818726|470098969|FG000|Overall Study|Administrative reasons|5|||
130535155|NCT04020185|469926706|FG001|Overall Study|Patient in hospice|1|||
130535156|NCT04020185|469926707|FG002|Overall Study|Patient in hospice|0|||
130583477|NCT01818726|470098970|FG001|Overall Study|Administrative reasons|1|||
130583478|NCT01818726|470098969|FG000|Overall Study|Withdrawal by Subject|0|||
130583479|NCT01818726|470098970|FG001|Overall Study|Withdrawal by Subject|1|||
130535157|NCT04020185|469926708|FG003|Overall Study|Patient in hospice|0|||
130535158|NCT04020185|469926709|FG004|Overall Study|Patient in hospice|0|||
130535159|NCT04020185|469926710|FG005|Overall Study|Patient in hospice|0|||
130535160|NCT04020185|469926711|FG006|Overall Study|Patient in hospice|0|||
130535161|NCT04020185|469926712|FG007|Overall Study|Patient in hospice|0|||
130535162|NCT04020185|469926705|FG000|Overall Study|Continuing on expanded access|0|||
130535163|NCT04020185|469926706|FG001|Overall Study|Continuing on expanded access|0|||
130535164|NCT04020185|469926707|FG002|Overall Study|Continuing on expanded access|0|||
130535165|NCT04020185|469926708|FG003|Overall Study|Continuing on expanded access|0|||
130583480|NCT01818726|470098969|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
130583481|NCT01818726|470098970|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
130583482|NCT03336502|470098971|FG000|Overall Study|Physician Decision|0|||
130535166|NCT04020185|469926709|FG004|Overall Study|Continuing on expanded access|0|||
130535167|NCT04020185|469926710|FG005|Overall Study|Continuing on expanded access|0|||
130535168|NCT04020185|469926711|FG006|Overall Study|Continuing on expanded access|1|||
130535169|NCT04020185|469926712|FG007|Overall Study|Continuing on expanded access|1|||
130535170|NCT00567567|469926713|FG000|Overall Study|Adverse Event|0|||
130535171|NCT00567567|469926714|FG001|Overall Study|Adverse Event|2|||
130535172|NCT00567567|469926715|FG002|Overall Study|Adverse Event|5|||
130535173|NCT00567567|469926713|FG000|Overall Study|Death|8|||
130535174|NCT00567567|469926714|FG001|Overall Study|Death|1|||
130535175|NCT00567567|469926715|FG002|Overall Study|Death|5|||
130535176|NCT00567567|469926713|FG000|Overall Study|Lack of Efficacy|16|||
130535177|NCT00567567|469926714|FG001|Overall Study|Lack of Efficacy|17|||
130535178|NCT00567567|469926715|FG002|Overall Study|Lack of Efficacy|48|||
130535179|NCT00567567|469926713|FG000|Overall Study|Lost to Follow-up|0|||
130535180|NCT00567567|469926714|FG001|Overall Study|Lost to Follow-up|0|||
130535181|NCT00567567|469926715|FG002|Overall Study|Lost to Follow-up|1|||
130535182|NCT00567567|469926713|FG000|Overall Study|Physician Decision|16|||
130535183|NCT00567567|469926714|FG001|Overall Study|Physician Decision|18|||
130535184|NCT00567567|469926715|FG002|Overall Study|Physician Decision|84|||
130535185|NCT00567567|469926713|FG000|Overall Study|Withdrawal by Subject|0|||
130535186|NCT00567567|469926714|FG001|Overall Study|Withdrawal by Subject|0|||
130535187|NCT00567567|469926715|FG002|Overall Study|Withdrawal by Subject|2|||
130535188|NCT00567567|469926713|FG000|Overall Study|Ineligible|4|||
130535189|NCT00567567|469926714|FG001|Overall Study|Ineligible|0|||
130535190|NCT00567567|469926715|FG002|Overall Study|Ineligible|9|||
130535191|NCT00567567|469926713|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
130535192|NCT00567567|469926714|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
130535193|NCT00567567|469926715|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
130535194|NCT00567567|469926713|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
130535195|NCT00567567|469926714|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
130535196|NCT00567567|469926715|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
130535197|NCT00567567|469926713|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
130535198|NCT00567567|469926714|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
130535199|NCT00567567|469926715|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
130535200|NCT03433677|469926716|FG000|Period 1|Protocol Violation|1|||
130535201|NCT03433677|469926717|FG001|Period 1|Protocol Violation|0|||
130535202|NCT03433677|469926716|FG000|Period 2|Withdrawal by Subject|1|||
130535203|NCT03433677|469926717|FG001|Period 2|Withdrawal by Subject|1|||
130535204|NCT03330405|469926718|FG000|Overall Study|Other|1|||
130535205|NCT03330405|469926719|FG001|Overall Study|Other|3|||
130535206|NCT03330405|469926720|FG002|Overall Study|Other|1|||
130535207|NCT03330405|469926721|FG003|Overall Study|Other|0|||
130535208|NCT03330405|469926722|FG004|Overall Study|Other|2|||
130535209|NCT03330405|469926723|FG005|Overall Study|Other|0|||
130535210|NCT03330405|469926724|FG006|Overall Study|Other|1|||
130535211|NCT03330405|469926725|FG007|Overall Study|Other|0|||
130535212|NCT03330405|469926726|FG008|Overall Study|Other|0|||
130535213|NCT03330405|469926727|FG009|Overall Study|Other|0|||
130535214|NCT03330405|469926728|FG010|Overall Study|Other|0|||
130535215|NCT03330405|469926718|FG000|Overall Study|Progressive disease|8|||
130535216|NCT03330405|469926719|FG001|Overall Study|Progressive disease|27|||
130535217|NCT03330405|469926720|FG002|Overall Study|Progressive disease|4|||
130535218|NCT03330405|469926721|FG003|Overall Study|Progressive disease|18|||
130535219|NCT03330405|469926722|FG004|Overall Study|Progressive disease|16|||
130535220|NCT03330405|469926723|FG005|Overall Study|Progressive disease|14|||
130535221|NCT03330405|469926724|FG006|Overall Study|Progressive disease|7|||
130535222|NCT03330405|469926725|FG007|Overall Study|Progressive disease|29|||
130535223|NCT03330405|469926726|FG008|Overall Study|Progressive disease|9|||
130535224|NCT03330405|469926727|FG009|Overall Study|Progressive disease|11|||
130535225|NCT03330405|469926728|FG010|Overall Study|Progressive disease|5|||
130535226|NCT03330405|469926718|FG000|Overall Study|Withdrawal by Subject|1|||
130535227|NCT03330405|469926719|FG001|Overall Study|Withdrawal by Subject|4|||
130535228|NCT03330405|469926720|FG002|Overall Study|Withdrawal by Subject|0|||
130535229|NCT03330405|469926721|FG003|Overall Study|Withdrawal by Subject|1|||
130535230|NCT03330405|469926722|FG004|Overall Study|Withdrawal by Subject|1|||
130535231|NCT03330405|469926723|FG005|Overall Study|Withdrawal by Subject|1|||
130535232|NCT03330405|469926724|FG006|Overall Study|Withdrawal by Subject|0|||
130535233|NCT03330405|469926725|FG007|Overall Study|Withdrawal by Subject|2|||
130535234|NCT03330405|469926726|FG008|Overall Study|Withdrawal by Subject|2|||
130535235|NCT03330405|469926727|FG009|Overall Study|Withdrawal by Subject|1|||
130535236|NCT03330405|469926728|FG010|Overall Study|Withdrawal by Subject|1|||
130535237|NCT03330405|469926718|FG000|Overall Study|Global deterioration of health status|2|||
130535238|NCT03330405|469926719|FG001|Overall Study|Global deterioration of health status|3|||
130535239|NCT03330405|469926720|FG002|Overall Study|Global deterioration of health status|0|||
130535240|NCT03330405|469926721|FG003|Overall Study|Global deterioration of health status|2|||
130535241|NCT03330405|469926722|FG004|Overall Study|Global deterioration of health status|3|||
130535242|NCT03330405|469926723|FG005|Overall Study|Global deterioration of health status|3|||
130535243|NCT03330405|469926724|FG006|Overall Study|Global deterioration of health status|0|||
130535244|NCT03330405|469926725|FG007|Overall Study|Global deterioration of health status|2|||
130535245|NCT03330405|469926726|FG008|Overall Study|Global deterioration of health status|8|||
130535246|NCT03330405|469926727|FG009|Overall Study|Global deterioration of health status|4|||
130535247|NCT03330405|469926728|FG010|Overall Study|Global deterioration of health status|1|||
130535248|NCT03330405|469926718|FG000|Overall Study|Adverse Event|0|||
130535249|NCT03330405|469926719|FG001|Overall Study|Adverse Event|1|||
130535250|NCT03330405|469926720|FG002|Overall Study|Adverse Event|0|||
130535251|NCT03330405|469926721|FG003|Overall Study|Adverse Event|1|||
130535252|NCT03330405|469926722|FG004|Overall Study|Adverse Event|1|||
130535253|NCT03330405|469926723|FG005|Overall Study|Adverse Event|1|||
130535254|NCT03330405|469926724|FG006|Overall Study|Adverse Event|3|||
130535255|NCT03330405|469926725|FG007|Overall Study|Adverse Event|4|||
130535256|NCT03330405|469926726|FG008|Overall Study|Adverse Event|2|||
130535257|NCT03330405|469926727|FG009|Overall Study|Adverse Event|2|||
130535258|NCT03330405|469926728|FG010|Overall Study|Adverse Event|2|||
130535259|NCT03330405|469926718|FG000|Overall Study|Death|0|||
130535260|NCT03330405|469926719|FG001|Overall Study|Death|4|||
130535261|NCT03330405|469926720|FG002|Overall Study|Death|0|||
130535262|NCT03330405|469926721|FG003|Overall Study|Death|0|||
130535263|NCT03330405|469926722|FG004|Overall Study|Death|0|||
130535264|NCT03330405|469926723|FG005|Overall Study|Death|1|||
130535265|NCT03330405|469926724|FG006|Overall Study|Death|0|||
130535266|NCT03330405|469926725|FG007|Overall Study|Death|2|||
130535267|NCT03330405|469926726|FG008|Overall Study|Death|0|||
130535268|NCT03330405|469926727|FG009|Overall Study|Death|0|||
130535269|NCT03330405|469926728|FG010|Overall Study|Death|0|||
130535270|NCT03330405|469926718|FG000|Overall Study|Physician Decision|0|||
130535271|NCT03330405|469926719|FG001|Overall Study|Physician Decision|0|||
130535272|NCT03330405|469926720|FG002|Overall Study|Physician Decision|0|||
130535273|NCT03330405|469926721|FG003|Overall Study|Physician Decision|0|||
130535274|NCT03330405|469926722|FG004|Overall Study|Physician Decision|0|||
130535275|NCT03330405|469926723|FG005|Overall Study|Physician Decision|0|||
130535276|NCT03330405|469926724|FG006|Overall Study|Physician Decision|0|||
130535277|NCT03330405|469926725|FG007|Overall Study|Physician Decision|1|||
130535278|NCT03330405|469926726|FG008|Overall Study|Physician Decision|0|||
130535279|NCT03330405|469926727|FG009|Overall Study|Physician Decision|0|||
130535280|NCT03330405|469926728|FG010|Overall Study|Physician Decision|0|||
130535281|NCT03889704|469926729|FG000|Overall Study|Study terminated due to pandemic|1|||
130535282|NCT03482466|469926730|FG000|Overall Study|Protocol Violation|2|||
130535283|NCT04335591|469926731|FG000|Overall Study|Adverse Event|5|||
130535284|NCT04335591|469926732|FG001|Overall Study|Adverse Event|2|||
130535285|NCT04335591|469926733|FG002|Overall Study|Adverse Event|3|||
130535286|NCT04335591|469926734|FG003|Overall Study|Adverse Event|2|||
130535287|NCT04335591|469926731|FG000|Overall Study|Protocol Violation|1|||
130535288|NCT04335591|469926732|FG001|Overall Study|Protocol Violation|0|||
130535289|NCT04335591|469926733|FG002|Overall Study|Protocol Violation|0|||
130535290|NCT04335591|469926734|FG003|Overall Study|Protocol Violation|0|||
130535291|NCT04335591|469926731|FG000|Overall Study|Withdrawal by Subject|8|||
130535292|NCT04335591|469926732|FG001|Overall Study|Withdrawal by Subject|4|||
130535293|NCT04335591|469926733|FG002|Overall Study|Withdrawal by Subject|4|||
130535294|NCT04335591|469926734|FG003|Overall Study|Withdrawal by Subject|5|||
130535295|NCT04335591|469926731|FG000|Overall Study|Subject planning pregnancy|0|||
130535296|NCT04335591|469926732|FG001|Overall Study|Subject planning pregnancy|1|||
130535297|NCT04335591|469926733|FG002|Overall Study|Subject planning pregnancy|0|||
130535298|NCT04335591|469926734|FG003|Overall Study|Subject planning pregnancy|0|||
130535299|NCT04335591|469926731|FG000|Overall Study|Ukrainian Russian war conflict|4|||
130535300|NCT04335591|469926732|FG001|Overall Study|Ukrainian Russian war conflict|5|||
130535301|NCT04335591|469926733|FG002|Overall Study|Ukrainian Russian war conflict|2|||
130535302|NCT04335591|469926734|FG003|Overall Study|Ukrainian Russian war conflict|0|||
130535303|NCT03268603|469926735|FG000|Overall Study|Withdrawal by Subject|6|||
130535304|NCT03268603|469926735|FG000|Overall Study|Physician Decision|1|||
130535305|NCT03268603|469926735|FG000|Overall Study|Withdrawn due to disease progression|2|||
130535306|NCT02060370|469926736|FG000|Overall Study|Physician Decision|1|||
130535307|NCT00356408|469926737|FG000|Overall Study|Adverse Event|9|||
130535308|NCT00356408|469926737|FG000|Overall Study|Lack of Efficacy|36|||
130535309|NCT00356408|469926737|FG000|Overall Study|Lost to Follow-up|2|||
130535310|NCT00356408|469926737|FG000|Overall Study|Withdrawal by Subject|6|||
130535311|NCT00356408|469926737|FG000|Overall Study|Other: Principal investigator discretion|3|||
130535312|NCT00356408|469926737|FG000|Overall Study|Other: Sponsor request|1|||
130535313|NCT00356408|469926737|FG000|Overall Study|Other: Azathioprine stopped|1|||
130535314|NCT00356408|469926737|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
130535315|NCT00356408|469926737|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
130535316|NCT05487586|469926739|FG000|Overall Study|Death|22|||
130535317|NCT05487586|469926739|FG000|Overall Study|Physician Decision|1|||
130535318|NCT05487586|469926739|FG000|Overall Study|Transfer to another hospital|4|||
130535319|NCT05487586|469926739|FG000|Overall Study|Other|1|||
130535320|NCT01493427|469926740|FG000|Overall Study|Adverse Event|10|||
130535321|NCT01493427|469926740|FG000|Overall Study|Personal Reasons|4|||
130535322|NCT01493427|469926740|FG000|Overall Study|Lost to Follow-up|2|||
130535323|NCT01493427|469926740|FG000|Overall Study|Inability to Follow Instructions|2|||
130535324|NCT01493427|469926740|FG000|Overall Study|Other|2|||
130535325|NCT00565773|469926741|FG000|Overall Study|Withdrawal by Subject|1|||
130535326|NCT00565773|469926741|FG000|Overall Study|Physician Decision|1|||
130535327|NCT04798781|469926742|FG000|Overall Study|Withdrawal by Subject|1|||
130535328|NCT05775991|469926743|FG000|Overall Study|Withdrawal by Subject|0|||
130535329|NCT05775991|469926744|FG001|Overall Study|Withdrawal by Subject|0|||
130535330|NCT05775991|469926745|FG002|Overall Study|Withdrawal by Subject|2|||
130535331|NCT03921723|469926748|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
130535332|NCT03921723|469926748|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
130535333|NCT01461811|469926749|FG000|Overall Study|Adverse Event|2|||
130535334|NCT01461811|469926750|FG001|Overall Study|Adverse Event|1|||
130535335|NCT01461811|469926749|FG000|Overall Study|Subject decision unrelated to an AE|1|||
130535336|NCT01461811|469926750|FG001|Overall Study|Subject decision unrelated to an AE|1|||
130535337|NCT01461811|469926749|FG000|Overall Study|Noncompliance|1|||
130535338|NCT01461811|469926750|FG001|Overall Study|Noncompliance|1|||
130535339|NCT03015129|469926751|FG000|Overall Study|Death|2|||
130535340|NCT03015129|469926752|FG001|Overall Study|Death|2|||
130535341|NCT03015129|469926751|FG000|Overall Study|Lost to Follow-up|0|||
130535342|NCT03015129|469926752|FG001|Overall Study|Lost to Follow-up|1|||
130535343|NCT03015129|469926751|FG000|Overall Study|Progression of disease|38|||
130535344|NCT03015129|469926752|FG001|Overall Study|Progression of disease|33|||
130535345|NCT03015129|469926751|FG000|Overall Study|Adverse Event|0|||
130535346|NCT03015129|469926752|FG001|Overall Study|Adverse Event|4|||
130535347|NCT00406692|469926753|FG000|Overall Study|Withdrawal by Subject|4|||
130535348|NCT00406692|469926753|FG000|Overall Study|Physician Decision|1|||
130535349|NCT00406692|469926753|FG000|Overall Study|Adverse Event|1|||
130535350|NCT00406692|469926753|FG000|Overall Study|Lack of Efficacy|1|||
130535351|NCT04958200|469926760|FG000|Overall Study|Withdrawal by Subject|0|||
130535352|NCT04958200|469926761|FG001|Overall Study|Withdrawal by Subject|2|||
130535353|NCT04958200|469926760|FG000|Overall Study|Lost to Follow-up|3|||
130535354|NCT04958200|469926761|FG001|Overall Study|Lost to Follow-up|2|||
130535355|NCT04531098|469926762|FG000|Stage I|Adverse Event|0|||
130535356|NCT04531098|469926763|FG001|Stage I|Adverse Event|0|||
130535357|NCT04531098|469926764|FG002|Stage I|Adverse Event|3|||
130535358|NCT04531098|469926762|FG000|Stage I|Protocol Violation|0|||
130535359|NCT04531098|469926763|FG001|Stage I|Protocol Violation|0|||
130535360|NCT04531098|469926764|FG002|Stage I|Protocol Violation|5|||
130535361|NCT04531098|469926762|FG000|Stage I|Withdrawal by Subject|0|||
130535362|NCT04531098|469926763|FG001|Stage I|Withdrawal by Subject|5|||
130535363|NCT04531098|469926764|FG002|Stage I|Withdrawal by Subject|10|||
130535364|NCT04531098|469926762|FG000|Stage II|Adverse Event|1|||
130535365|NCT04531098|469926763|FG001|Stage II|Adverse Event|2|||
130535366|NCT04531098|469926764|FG002|Stage II|Adverse Event|0|||
130535367|NCT04531098|469926762|FG000|Stage II|Protocol Violation|1|||
130535368|NCT04531098|469926763|FG001|Stage II|Protocol Violation|2|||
130535369|NCT04531098|469926764|FG002|Stage II|Protocol Violation|0|||
130535370|NCT04531098|469926762|FG000|Stage II|Withdrawal by Subject|3|||
130535371|NCT04531098|469926763|FG001|Stage II|Withdrawal by Subject|1|||
130535372|NCT04531098|469926764|FG002|Stage II|Withdrawal by Subject|0|||
130535373|NCT04531098|469926762|FG000|Stage II|Moved from study area|8|||
130535374|NCT04531098|469926763|FG001|Stage II|Moved from study area|5|||
130535375|NCT04531098|469926764|FG002|Stage II|Moved from study area|0|||
130535376|NCT02628028|469926765|FG000|Dosing Period|Withdrawal by Subject|0|||
130535377|NCT02628028|469926766|FG001|Dosing Period|Withdrawal by Subject|0|||
130535378|NCT02628028|469926767|FG002|Dosing Period|Withdrawal by Subject|1|||
130535379|NCT02628028|469926768|FG003|Dosing Period|Withdrawal by Subject|0|||
130535380|NCT02628028|469926769|FG004|Dosing Period|Withdrawal by Subject|2|||
130535381|NCT02628028|469926770|FG005|Dosing Period|Withdrawal by Subject|4|||
130535382|NCT02628028|469926771|FG006|Dosing Period|Withdrawal by Subject|1|||
130535383|NCT02628028|469926772|FG007|Dosing Period|Withdrawal by Subject|1|||
130535384|NCT02628028|469926765|FG000|Dosing Period|Adverse Event|0|||
130535385|NCT02628028|469926766|FG001|Dosing Period|Adverse Event|0|||
130535386|NCT02628028|469926767|FG002|Dosing Period|Adverse Event|0|||
130535387|NCT02628028|469926768|FG003|Dosing Period|Adverse Event|0|||
130535388|NCT02628028|469926769|FG004|Dosing Period|Adverse Event|2|||
130535389|NCT02628028|469926770|FG005|Dosing Period|Adverse Event|1|||
130535390|NCT02628028|469926771|FG006|Dosing Period|Adverse Event|3|||
130535391|NCT02628028|469926772|FG007|Dosing Period|Adverse Event|2|||
130535392|NCT02628028|469926765|FG000|Dosing Period|Death|0|||
130535393|NCT02628028|469926766|FG001|Dosing Period|Death|0|||
130535394|NCT02628028|469926767|FG002|Dosing Period|Death|0|||
130583483|NCT03336502|470098972|FG001|Overall Study|Physician Decision|1|||
130583484|NCT03336502|470098971|FG000|Overall Study|Prohibited Drugs|1|||
130583485|NCT03336502|470098972|FG001|Overall Study|Prohibited Drugs|1|||
130583486|NCT03336502|470098971|FG000|Overall Study|Death|1|||
130583487|NCT03336502|470098972|FG001|Overall Study|Death|2|||
130583488|NCT03336502|470098971|FG000|Overall Study|Adverse Event|2|||
130583489|NCT03336502|470098972|FG001|Overall Study|Adverse Event|5|||
130583490|NCT00480857|470098973|FG000|Overall Study|Lack of Efficacy|2|||
130535395|NCT02628028|469926768|FG003|Dosing Period|Death|0|||
130535396|NCT02628028|469926769|FG004|Dosing Period|Death|0|||
130535397|NCT02628028|469926770|FG005|Dosing Period|Death|0|||
130535398|NCT02628028|469926771|FG006|Dosing Period|Death|0|||
130535399|NCT02628028|469926772|FG007|Dosing Period|Death|1|||
130535400|NCT02628028|469926765|FG000|Dosing Period|Lack of Efficacy|0|||
130535401|NCT02628028|469926766|FG001|Dosing Period|Lack of Efficacy|0|||
130535402|NCT02628028|469926767|FG002|Dosing Period|Lack of Efficacy|0|||
130535403|NCT02628028|469926768|FG003|Dosing Period|Lack of Efficacy|0|||
130535404|NCT02628028|469926769|FG004|Dosing Period|Lack of Efficacy|3|||
130535405|NCT02628028|469926770|FG005|Dosing Period|Lack of Efficacy|0|||
130535406|NCT02628028|469926771|FG006|Dosing Period|Lack of Efficacy|1|||
130535407|NCT02628028|469926772|FG007|Dosing Period|Lack of Efficacy|0|||
130535408|NCT02628028|469926765|FG000|Dosing Period|Study Terminated by Sponsor|0|||
130535409|NCT02628028|469926766|FG001|Dosing Period|Study Terminated by Sponsor|0|||
130535410|NCT02628028|469926767|FG002|Dosing Period|Study Terminated by Sponsor|0|||
130535411|NCT02628028|469926768|FG003|Dosing Period|Study Terminated by Sponsor|0|||
130535412|NCT02628028|469926769|FG004|Dosing Period|Study Terminated by Sponsor|7|||
130535413|NCT02628028|469926770|FG005|Dosing Period|Study Terminated by Sponsor|6|||
130535414|NCT02628028|469926771|FG006|Dosing Period|Study Terminated by Sponsor|7|||
130535415|NCT02628028|469926772|FG007|Dosing Period|Study Terminated by Sponsor|7|||
130535416|NCT02628028|469926765|FG000|Dosing Period|Physician Decision|0|||
130535417|NCT02628028|469926766|FG001|Dosing Period|Physician Decision|0|||
130535418|NCT02628028|469926767|FG002|Dosing Period|Physician Decision|0|||
130535419|NCT02628028|469926768|FG003|Dosing Period|Physician Decision|0|||
130535420|NCT02628028|469926769|FG004|Dosing Period|Physician Decision|0|||
130535421|NCT02628028|469926770|FG005|Dosing Period|Physician Decision|1|||
130535422|NCT02628028|469926771|FG006|Dosing Period|Physician Decision|0|||
130535423|NCT02628028|469926772|FG007|Dosing Period|Physician Decision|0|||
130535424|NCT02628028|469926765|FG000|Dosing Period|Site Terminated by Sponsor|0|||
130535425|NCT02628028|469926766|FG001|Dosing Period|Site Terminated by Sponsor|0|||
130535426|NCT02628028|469926767|FG002|Dosing Period|Site Terminated by Sponsor|0|||
130535427|NCT02628028|469926768|FG003|Dosing Period|Site Terminated by Sponsor|0|||
130535428|NCT02628028|469926769|FG004|Dosing Period|Site Terminated by Sponsor|0|||
130535429|NCT02628028|469926770|FG005|Dosing Period|Site Terminated by Sponsor|1|||
130535430|NCT02628028|469926771|FG006|Dosing Period|Site Terminated by Sponsor|1|||
130535431|NCT02628028|469926772|FG007|Dosing Period|Site Terminated by Sponsor|0|||
130535432|NCT02628028|469926765|FG000|Dosing Period|Lost to Follow-up|0|||
130535433|NCT02628028|469926766|FG001|Dosing Period|Lost to Follow-up|0|||
130535434|NCT02628028|469926767|FG002|Dosing Period|Lost to Follow-up|0|||
130535435|NCT02628028|469926768|FG003|Dosing Period|Lost to Follow-up|0|||
130583491|NCT00611247|470098974|FG000|Overall Study|Death|1|||
130535436|NCT02628028|469926769|FG004|Dosing Period|Lost to Follow-up|0|||
130535437|NCT02628028|469926770|FG005|Dosing Period|Lost to Follow-up|0|||
130583492|NCT00611247|470098975|FG001|Overall Study|Death|5|||
130583493|NCT00611247|470098974|FG000|Overall Study|Lack of Efficacy|1|||
130583494|NCT00611247|470098975|FG001|Overall Study|Lack of Efficacy|16|||
130535438|NCT02628028|469926771|FG006|Dosing Period|Lost to Follow-up|1|||
130535439|NCT02628028|469926772|FG007|Dosing Period|Lost to Follow-up|0|||
130535440|NCT02628028|469926765|FG000|Dosing Period|Other|0|||
130535441|NCT02628028|469926766|FG001|Dosing Period|Other|0|||
130535442|NCT02628028|469926767|FG002|Dosing Period|Other|0|||
130535443|NCT02628028|469926768|FG003|Dosing Period|Other|0|||
130583495|NCT01948830|470098976|FG000|Overall Study|Physician Decision|1|||
130583496|NCT01948830|470098977|FG001|Overall Study|Physician Decision|3|||
130535444|NCT02628028|469926769|FG004|Dosing Period|Other|2|||
130535445|NCT02628028|469926770|FG005|Dosing Period|Other|1|||
130535446|NCT02628028|469926771|FG006|Dosing Period|Other|2|||
130535447|NCT02628028|469926772|FG007|Dosing Period|Other|4|||
130535448|NCT02628028|469926765|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
130535449|NCT02628028|469926766|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
130583497|NCT01948830|470098976|FG000|Overall Study|Protocol deviation|1|||
130583498|NCT01948830|470098977|FG001|Overall Study|Protocol deviation|2|||
130535450|NCT02628028|469926767|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
130535451|NCT02628028|469926768|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
130535452|NCT02628028|469926769|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
130535453|NCT02628028|469926770|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
130535454|NCT02628028|469926771|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
130535455|NCT02628028|469926772|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
130535456|NCT02628028|469926765|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535457|NCT02628028|469926766|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535458|NCT02628028|469926767|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535459|NCT02628028|469926768|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535460|NCT02628028|469926769|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535461|NCT02628028|469926770|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
130535462|NCT02628028|469926771|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
130535463|NCT02628028|469926772|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
130535464|NCT02628028|469926765|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
130535465|NCT02628028|469926766|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
130535466|NCT02628028|469926767|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
130535467|NCT02628028|469926768|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
130535468|NCT02628028|469926769|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
130535469|NCT02628028|469926770|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
130535470|NCT02628028|469926771|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
130535471|NCT02628028|469926772|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
130535472|NCT02628028|469926765|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
130535473|NCT02628028|469926766|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
130535474|NCT02628028|469926767|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
130535475|NCT02628028|469926768|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
130535476|NCT02628028|469926769|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
130535477|NCT02628028|469926770|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
130535478|NCT02628028|469926771|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
130535479|NCT02628028|469926772|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
130535480|NCT02628028|469926765|FG000|Long-term Extension (LTE) Period|Other|0|||
130535481|NCT02628028|469926766|FG001|Long-term Extension (LTE) Period|Other|0|||
130535482|NCT02628028|469926767|FG002|Long-term Extension (LTE) Period|Other|0|||
130535483|NCT02628028|469926768|FG003|Long-term Extension (LTE) Period|Other|0|||
130535484|NCT02628028|469926769|FG004|Long-term Extension (LTE) Period|Other|0|||
130535485|NCT02628028|469926770|FG005|Long-term Extension (LTE) Period|Other|3|||
130535486|NCT02628028|469926771|FG006|Long-term Extension (LTE) Period|Other|4|||
130535487|NCT02628028|469926772|FG007|Long-term Extension (LTE) Period|Other|3|||
130535488|NCT02145468|469926773|FG000|Overall Study|Withdrawal by Subject|5|||
130535489|NCT02145468|469926774|FG001|Overall Study|Withdrawal by Subject|8|||
130535490|NCT04157400|469926775|FG000|Overall Study|Withdrawal by Subject|1|||
130535491|NCT04157400|469926775|FG000|Overall Study|Lost to Follow-up|3|||
130535492|NCT00623805|469926777|FG000|Overall Study|Adverse Event|9|||
130535493|NCT00623805|469926778|FG001|Overall Study|Adverse Event|6|||
130535494|NCT00623805|469926777|FG000|Overall Study|Death|2|||
130535495|NCT00623805|469926778|FG001|Overall Study|Death|0|||
130535496|NCT00623805|469926777|FG000|Overall Study|Lack of Efficacy|3|||
130535497|NCT00623805|469926778|FG001|Overall Study|Lack of Efficacy|7|||
130535498|NCT00623805|469926777|FG000|Overall Study|Lost to Follow-up|2|||
130535499|NCT00623805|469926778|FG001|Overall Study|Lost to Follow-up|2|||
130535500|NCT00623805|469926777|FG000|Overall Study|Protocol Violation|1|||
130535501|NCT00623805|469926778|FG001|Overall Study|Protocol Violation|1|||
130535502|NCT00623805|469926777|FG000|Overall Study|Reason not Specified|3|||
130535503|NCT00623805|469926778|FG001|Overall Study|Reason not Specified|6|||
130535504|NCT02336451|469926797|FG000|Overall Study|Adverse Event|1|||
130535505|NCT02336451|469926798|FG001|Overall Study|Adverse Event|2|||
130535506|NCT02336451|469926799|FG002|Overall Study|Adverse Event|0|||
130535507|NCT02336451|469926800|FG003|Overall Study|Adverse Event|6|||
130535508|NCT02336451|469926801|FG004|Overall Study|Adverse Event|4|||
130583499|NCT01948830|470098976|FG000|Overall Study|Lost to Follow-up|5|||
130583500|NCT01948830|470098977|FG001|Overall Study|Lost to Follow-up|4|||
130535509|NCT02336451|469926797|FG000|Overall Study|Death|6|||
130535510|NCT02336451|469926798|FG001|Overall Study|Death|2|||
130535511|NCT02336451|469926799|FG002|Overall Study|Death|3|||
130535512|NCT02336451|469926800|FG003|Overall Study|Death|6|||
130535513|NCT02336451|469926801|FG004|Overall Study|Death|6|||
130535514|NCT02336451|469926797|FG000|Overall Study|Physician Decision|9|||
130535515|NCT02336451|469926798|FG001|Overall Study|Physician Decision|6|||
130535516|NCT02336451|469926799|FG002|Overall Study|Physician Decision|7|||
130535517|NCT02336451|469926800|FG003|Overall Study|Physician Decision|16|||
130535518|NCT02336451|469926801|FG004|Overall Study|Physician Decision|3|||
130535519|NCT02336451|469926797|FG000|Overall Study|Progressive disease|23|||
130535520|NCT02336451|469926798|FG001|Overall Study|Progressive disease|26|||
130535521|NCT02336451|469926799|FG002|Overall Study|Progressive disease|2|||
130535522|NCT02336451|469926800|FG003|Overall Study|Progressive disease|14|||
130535523|NCT02336451|469926801|FG004|Overall Study|Progressive disease|4|||
130535524|NCT02336451|469926797|FG000|Overall Study|Protocol Violation|1|||
130535525|NCT02336451|469926798|FG001|Overall Study|Protocol Violation|0|||
130535526|NCT02336451|469926799|FG002|Overall Study|Protocol Violation|0|||
130535527|NCT02336451|469926800|FG003|Overall Study|Protocol Violation|0|||
130535528|NCT02336451|469926801|FG004|Overall Study|Protocol Violation|0|||
130535529|NCT02336451|469926797|FG000|Overall Study|Patient/guardian decision|2|||
130535530|NCT02336451|469926798|FG001|Overall Study|Patient/guardian decision|4|||
130535531|NCT02336451|469926799|FG002|Overall Study|Patient/guardian decision|0|||
130535532|NCT02336451|469926800|FG003|Overall Study|Patient/guardian decision|2|||
130535533|NCT02336451|469926801|FG004|Overall Study|Patient/guardian decision|1|||
130535534|NCT04998812|469926808|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
130535535|NCT04998812|469926809|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
130535536|NCT04998812|469926808|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
130535537|NCT04998812|469926809|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
130535538|NCT04998812|469926808|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
130535539|NCT04998812|469926809|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
130535540|NCT04998812|469926808|FG000|Vaccination Period|Ongoing in study|23|||
130535541|NCT04998812|469926809|FG001|Vaccination Period|Ongoing in study|23|||
130535542|NCT04893460|469926818|FG000|Overall Study|Lost to Follow-up|18|||
130535543|NCT01253135|469929286|FG000|Original Protocol|Protocol Amendment|15|||
130535544|NCT01253135|469929286|FG000|Amended Protocol|Non-compliance|1|||
130535545|NCT00833261|469929293|FG000|Overall Study|Withdrawal by Subject|4|||
130535546|NCT03248882|469929294|FG000|Overall Study|Adverse Event|3|||
130535547|NCT03248882|469929295|FG001|Overall Study|Adverse Event|3|||
130535548|NCT03248882|469929296|FG002|Overall Study|Adverse Event|2|||
130535549|NCT03248882|469929297|FG003|Overall Study|Adverse Event|6|||
130535550|NCT03248882|469929298|FG004|Overall Study|Adverse Event|9|||
130535551|NCT03248882|469929294|FG000|Overall Study|Lost to Follow-up|0|||
130535552|NCT03248882|469929295|FG001|Overall Study|Lost to Follow-up|0|||
130535553|NCT03248882|469929296|FG002|Overall Study|Lost to Follow-up|0|||
130535554|NCT03248882|469929297|FG003|Overall Study|Lost to Follow-up|0|||
130535555|NCT03248882|469929298|FG004|Overall Study|Lost to Follow-up|1|||
130535556|NCT03248882|469929294|FG000|Overall Study|Protocol Violation|2|||
130535557|NCT03248882|469929295|FG001|Overall Study|Protocol Violation|0|||
130535558|NCT03248882|469929296|FG002|Overall Study|Protocol Violation|2|||
130583501|NCT01948830|470098976|FG000|Overall Study|Withdrawal by Subject|14|||
130583502|NCT01948830|470098977|FG001|Overall Study|Withdrawal by Subject|17|||
130583503|NCT01948830|470098976|FG000|Overall Study|Adverse Event|9|||
130583504|NCT01948830|470098977|FG001|Overall Study|Adverse Event|2|||
130583505|NCT01948830|470098976|FG000|Overall Study|Death|3|||
130583506|NCT01948830|470098977|FG001|Overall Study|Death|4|||
130583507|NCT01890421|470098978|FG000|Overall Study|Adverse Event|1|||
130583508|NCT01890421|470098978|FG000|Overall Study|Other reason|10|||
130583509|NCT01133171|470098979|FG000|Overall Study|Withdrawal by Subject|1|||
130583510|NCT01133171|470098980|FG001|Overall Study|Withdrawal by Subject|2|||
130583511|NCT01133171|470098981|FG002|Overall Study|Withdrawal by Subject|0|||
130583512|NCT02526550|470098982|FG000|Overall Study|Lost to Follow-up|1|||
130583513|NCT03969888|470098983|FG000|Overall Study|Never Received Study Drug|0|||
130583514|NCT03969888|470098984|FG001|Overall Study|Never Received Study Drug|0|||
130583515|NCT03969888|470098985|FG002|Overall Study|Never Received Study Drug|1|||
130535559|NCT03248882|469929297|FG003|Overall Study|Protocol Violation|0|||
130535560|NCT03248882|469929298|FG004|Overall Study|Protocol Violation|1|||
130535561|NCT03248882|469929294|FG000|Overall Study|Withdrawal by Subject|2|||
130535562|NCT03248882|469929295|FG001|Overall Study|Withdrawal by Subject|2|||
130535563|NCT03248882|469929296|FG002|Overall Study|Withdrawal by Subject|3|||
130535564|NCT03248882|469929297|FG003|Overall Study|Withdrawal by Subject|4|||
130535565|NCT03248882|469929298|FG004|Overall Study|Withdrawal by Subject|2|||
130535566|NCT01156376|469929301|FG000|Overall Study|Adverse Event|1|||
130583516|NCT03969888|470098986|FG003|Overall Study|Never Received Study Drug|0|||
130583517|NCT03969888|470098987|FG004|Overall Study|Never Received Study Drug|0|||
130583518|NCT03969888|470098988|FG005|Overall Study|Never Received Study Drug|0|||
130535567|NCT01156376|469929302|FG001|Overall Study|Adverse Event|0|||
130535568|NCT01156376|469929303|FG002|Overall Study|Adverse Event|1|||
130535569|NCT01156376|469929301|FG000|Overall Study|Withdrawal by Subject|0|||
130535570|NCT01156376|469929302|FG001|Overall Study|Withdrawal by Subject|0|||
130535571|NCT01156376|469929303|FG002|Overall Study|Withdrawal by Subject|3|||
130535572|NCT01075958|469929304|FG000|Overall Study|Blood sample could not be obtained|44|||
130535573|NCT03733314|469929305|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
130583519|NCT03969888|470098989|FG006|Overall Study|Never Received Study Drug|1|||
130583520|NCT03969888|470098990|FG007|Overall Study|Never Received Study Drug|0|||
130583521|NCT03969888|470098983|FG000|Overall Study|Reason Not Specified|0|||
130583522|NCT03969888|470098984|FG001|Overall Study|Reason Not Specified|0|||
130583523|NCT03969888|470098985|FG002|Overall Study|Reason Not Specified|0|||
130583524|NCT03969888|470098986|FG003|Overall Study|Reason Not Specified|0|||
130583525|NCT03969888|470098987|FG004|Overall Study|Reason Not Specified|0|||
130583526|NCT03969888|470098988|FG005|Overall Study|Reason Not Specified|0|||
130583527|NCT03969888|470098989|FG006|Overall Study|Reason Not Specified|0|||
130583528|NCT03969888|470098990|FG007|Overall Study|Reason Not Specified|1|||
130583529|NCT01446419|470099002|FG000|Overall Study|Death|1|||
130583530|NCT01446419|470099003|FG001|Overall Study|Death|0|||
130583531|NCT01446419|470099002|FG000|Overall Study|Withdrawal by Subject|1|||
130583532|NCT01446419|470099003|FG001|Overall Study|Withdrawal by Subject|1|||
130583533|NCT01446419|470099002|FG000|Overall Study|Terminated per protocol|3|||
130583534|NCT01446419|470099003|FG001|Overall Study|Terminated per protocol|0|||
130583535|NCT02867761|470099006|FG000|Overall Study|Participant withdrawn by investigator|0|||
130583536|NCT02867761|470099007|FG001|Overall Study|Participant withdrawn by investigator|1|||
130583537|NCT02867761|470099006|FG000|Overall Study|Lost to Follow-up|25|||
130583538|NCT02867761|470099007|FG001|Overall Study|Lost to Follow-up|18|||
130583539|NCT02867761|470099006|FG000|Overall Study|Unable to complete protocol|3|||
130583540|NCT02867761|470099007|FG001|Overall Study|Unable to complete protocol|7|||
130583541|NCT04506294|470099008|FG000|Overall Study|Lost to Follow-up|70|||
130583542|NCT04506294|470099009|FG001|Overall Study|Lost to Follow-up|20|||
130583543|NCT04506294|470099008|FG000|Overall Study|Withdrawal by Subject|16|||
130583544|NCT04506294|470099009|FG001|Overall Study|Withdrawal by Subject|2|||
130583545|NCT01931059|470099010|FG000|Day 1|Pregnancy|0|||
130583546|NCT01931059|470099011|FG001|Day 1|Pregnancy|1|||
130583547|NCT01931059|470099010|FG000|Day3|Lost to Follow-up|1|||
130583548|NCT01931059|470099011|FG001|Day3|Lost to Follow-up|0|||
130583549|NCT00769119|470099012|FG000|Overall Study|Voluntary discontinuation|0|||
130583550|NCT00769119|470099013|FG001|Overall Study|Voluntary discontinuation|2|||
130583551|NCT00769119|470099012|FG000|Overall Study|Adverse Event|1|||
130583552|NCT00769119|470099013|FG001|Overall Study|Adverse Event|1|||
130583553|NCT00769119|470099012|FG000|Overall Study|Disallowed medication|1|||
130583554|NCT00769119|470099013|FG001|Overall Study|Disallowed medication|0|||
130583555|NCT01961115|470099017|FG000|Overall Study|Disease Progression|1|||
130583556|NCT01961115|470099018|FG001|Overall Study|Disease Progression|0|||
130583557|NCT01961115|470099019|FG002|Overall Study|Disease Progression|3|||
130583558|NCT01961115|470099017|FG000|Overall Study|Adverse Event|1|||
130583559|NCT01961115|470099018|FG001|Overall Study|Adverse Event|0|||
130583560|NCT01961115|470099019|FG002|Overall Study|Adverse Event|1|||
130583561|NCT00578643|470099020|FG000|Overall Study|Death|1|||
130583562|NCT00578643|470099020|FG000|Overall Study|Lost to Follow-up|1|||
130583563|NCT03828487|470099021|FG000|Overall Study|Physician Decision|1|||
130583564|NCT01445678|470099023|FG000|Overall Study|Adverse Event|12|||
130583565|NCT01445678|470099024|FG001|Overall Study|Adverse Event|8|||
130583566|NCT01445678|470099023|FG000|Overall Study|Lack of Efficacy|0|||
130583567|NCT01445678|470099024|FG001|Overall Study|Lack of Efficacy|2|||
130583568|NCT01445678|470099023|FG000|Overall Study|Lost to Follow-up|8|||
130583569|NCT01445678|470099024|FG001|Overall Study|Lost to Follow-up|5|||
130583570|NCT01445678|470099023|FG000|Overall Study|Protocol Violation|1|||
130583571|NCT01445678|470099024|FG001|Overall Study|Protocol Violation|1|||
130583572|NCT01445678|470099023|FG000|Overall Study|Withdrawal by Subject|9|||
130583573|NCT01445678|470099024|FG001|Overall Study|Withdrawal by Subject|5|||
130583574|NCT02307370|470099025|FG000|Overall Study|Death|5|||
130583575|NCT02307370|470099025|FG000|Overall Study|Lost to Follow-up|1|||
130583576|NCT02307370|470099025|FG000|Overall Study|Withdrawal by Subject|1|||
130583577|NCT02307370|470099025|FG000|Overall Study|Declined Addendum ICF|6|||
130583578|NCT02307370|470099025|FG000|Overall Study|No response during telephone contact|5|||
130583579|NCT02307370|470099025|FG000|Overall Study|Protocol Violation|1|||
130583580|NCT05900115|470100991|FG000|Overall Study|Lost to Follow-up|129|||
130583581|NCT05900115|470100992|FG001|Overall Study|Lost to Follow-up|98|||
130583582|NCT00388947|470100995|FG000|Overall Study|Protocol Violation|47|||
130583583|NCT04187092|470100996|FG000|Overall Study|Lost to Follow-up|1|||
130583584|NCT04187092|470100997|FG001|Overall Study|Lost to Follow-up|1|||
130583585|NCT04187092|470100996|FG000|Overall Study|Withdrawal by Subject|1|||
130583586|NCT04187092|470100997|FG001|Overall Study|Withdrawal by Subject|1|||
130583587|NCT04187092|470100996|FG000|Overall Study|Adverse Event|0|||
130583588|NCT04187092|470100997|FG001|Overall Study|Adverse Event|1|||
130583589|NCT00544869|470100999|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
130583590|NCT00544869|470101000|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
130583591|NCT00544869|470101001|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
130583592|NCT00544869|470100999|FG000|Overall Study|Adverse Event|6|||
130583593|NCT00544869|470101000|FG001|Overall Study|Adverse Event|1|||
130583594|NCT00544869|470101001|FG002|Overall Study|Adverse Event|0|||
130583595|NCT00544869|470100999|FG000|Overall Study|Lack of Efficacy|1|||
130583596|NCT00544869|470101000|FG001|Overall Study|Lack of Efficacy|1|||
130583597|NCT00544869|470101001|FG002|Overall Study|Lack of Efficacy|0|||
130583598|NCT00544869|470100999|FG000|Overall Study|Physician Decision|2|||
130583599|NCT00544869|470101000|FG001|Overall Study|Physician Decision|0|||
130583600|NCT00544869|470101001|FG002|Overall Study|Physician Decision|0|||
130583601|NCT00619502|470101004|FG000|Overall Study|Lost to Follow-up|8|||
130583602|NCT00619502|470101005|FG001|Overall Study|Lost to Follow-up|10|||
130583603|NCT01475734|470101006|FG000|Overall Study|Withdrawal by Subject|1|||
130583604|NCT01475734|470101007|FG001|Overall Study|Withdrawal by Subject|0|||
130583605|NCT01475734|470101006|FG000|Overall Study|Protocol Violation|1|||
130583606|NCT01475734|470101007|FG001|Overall Study|Protocol Violation|0|||
130583607|NCT01475734|470101006|FG000|Overall Study|Physician Decision|0|||
130583608|NCT01475734|470101007|FG001|Overall Study|Physician Decision|1|||
130583609|NCT00771472|470101008|FG000|Overall Study|Physician Decision|2|||
130583610|NCT00771472|470101009|FG001|Overall Study|Physician Decision|3|||
130583611|NCT00771472|470101008|FG000|Overall Study|Progressive Disease|3|||
130583612|NCT00771472|470101009|FG001|Overall Study|Progressive Disease|1|||
130583613|NCT00771472|470101008|FG000|Overall Study|Protocol Violation|1|||
130583614|NCT00771472|470101009|FG001|Overall Study|Protocol Violation|0|||
130583615|NCT00925600|470101012|FG000|Overall Study|Withdrawal by Subject|16|||
130583616|NCT00925600|470101013|FG001|Overall Study|Withdrawal by Subject|14|||
130583617|NCT00925600|470101012|FG000|Overall Study|Death|4|||
130583618|NCT00925600|470101013|FG001|Overall Study|Death|3|||
130583619|NCT00925600|470101012|FG000|Overall Study|Lost to Follow-up|2|||
130583620|NCT00925600|470101013|FG001|Overall Study|Lost to Follow-up|2|||
130583621|NCT00925600|470101012|FG000|Overall Study|Disease Progression|1|||
130583622|NCT00925600|470101013|FG001|Overall Study|Disease Progression|3|||
130583623|NCT00925600|470101012|FG000|Overall Study|Administrative Decision|1|||
130583624|NCT00925600|470101013|FG001|Overall Study|Administrative Decision|1|||
130583625|NCT00925600|470101012|FG000|Overall Study|Noncompliance|2|||
130583626|NCT00925600|470101013|FG001|Overall Study|Noncompliance|0|||
130583627|NCT00925600|470101012|FG000|Overall Study|Ineligibility Determined|2|||
130583628|NCT00925600|470101013|FG001|Overall Study|Ineligibility Determined|0|||
130583629|NCT00925600|470101012|FG000|Overall Study|Protocol Deviation|0|||
130583630|NCT00925600|470101013|FG001|Overall Study|Protocol Deviation|1|||
130583631|NCT00925600|470101012|FG000|Overall Study|Requirement for Alternative Therapy|0|||
130583632|NCT00925600|470101013|FG001|Overall Study|Requirement for Alternative Therapy|1|||
130583633|NCT00925600|470101012|FG000|Overall Study|Other|3|||
130583634|NCT00925600|470101013|FG001|Overall Study|Other|1|||
130583635|NCT00925600|470101012|FG000|Overall Study|Adverse Event|1|||
130583636|NCT00925600|470101013|FG001|Overall Study|Adverse Event|2|||
130583637|NCT01974817|470101016|FG000|Overall Study|Death|4|||
130583638|NCT01974817|470101016|FG000|Overall Study|Lost to Follow-up|2|||
130583639|NCT01974817|470101016|FG000|Overall Study|Protocol Violation|2|||
130583640|NCT01891643|470101017|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130583641|NCT01891643|470101018|FG001|Overall Study|Adverse event unrelated to study drug|5|||
130583642|NCT01891643|470101017|FG000|Overall Study|Disease Progression|4|||
130583643|NCT01891643|470101018|FG001|Overall Study|Disease Progression|3|||
130583644|NCT01891643|470101017|FG000|Overall Study|Study Drug Toxicity|3|||
130583645|NCT01891643|470101018|FG001|Overall Study|Study Drug Toxicity|0|||
130583646|NCT01891643|470101017|FG000|Overall Study|Maximum Clinical Benefit|0|||
130583647|NCT01891643|470101018|FG001|Overall Study|Maximum Clinical Benefit|1|||
130583648|NCT01891643|470101017|FG000|Overall Study|Poor/Non-compliance|0|||
130583649|NCT01891643|470101018|FG001|Overall Study|Poor/Non-compliance|1|||
130583650|NCT01891643|470101017|FG000|Overall Study|Participant request to discontinue|1|||
130583651|NCT01891643|470101018|FG001|Overall Study|Participant request to discontinue|0|||
130583652|NCT02965716|470101019|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130583653|NCT02965716|470101020|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
130583654|NCT02965716|470101019|FG000|Overall Study|Progression/Relapse|8|||
130583655|NCT02965716|470101020|FG001|Overall Study|Progression/Relapse|16|||
130583656|NCT02965716|470101019|FG000|Overall Study|Death|1|||
130583657|NCT02965716|470101020|FG001|Overall Study|Death|0|||
130583658|NCT02965716|470101019|FG000|Overall Study|Not Protocol Specified|1|||
130583659|NCT02965716|470101020|FG001|Overall Study|Not Protocol Specified|3|||
130583660|NCT04047797|470101021|FG000|Overall Study|Progressive Disease|1|||
130583661|NCT03523351|470101022|FG000|Overall Study|Death|13|||
130583662|NCT03523351|470101023|FG001|Overall Study|Death|11|||
130583663|NCT03523351|470101022|FG000|Overall Study|Lost to Follow-up|2|||
130535574|NCT03733314|469929306|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
130535575|NCT03733314|469929305|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
130535576|NCT03733314|469929306|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
130535577|NCT03733314|469929305|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
130535578|NCT03733314|469929306|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
130535579|NCT03733314|469929305|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
130535580|NCT03733314|469929306|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
130535581|NCT03733314|469929305|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
130535582|NCT03733314|469929306|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
130535583|NCT03733314|469929305|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
130535584|NCT03733314|469929306|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
130535585|NCT01240915|469929307|FG000|Overall Study|Adverse Event|0|||
130535586|NCT01240915|469929308|FG001|Overall Study|Adverse Event|0|||
130535587|NCT01240915|469929309|FG002|Overall Study|Adverse Event|0|||
130535588|NCT01240915|469929310|FG003|Overall Study|Adverse Event|1|||
130535589|NCT01240915|469929311|FG004|Overall Study|Adverse Event|0|||
130535590|NCT01240915|469929312|FG005|Overall Study|Adverse Event|2|||
130535591|NCT01240915|469929313|FG006|Overall Study|Adverse Event|0|||
130535592|NCT01240915|469929314|FG007|Overall Study|Adverse Event|0|||
130535593|NCT01240915|469929315|FG008|Overall Study|Adverse Event|1|||
130535594|NCT01240915|469929307|FG000|Overall Study|Lost to Follow-up|0|||
130535595|NCT01240915|469929308|FG001|Overall Study|Lost to Follow-up|0|||
130535596|NCT01240915|469929309|FG002|Overall Study|Lost to Follow-up|0|||
130535597|NCT01240915|469929310|FG003|Overall Study|Lost to Follow-up|0|||
130535598|NCT01240915|469929311|FG004|Overall Study|Lost to Follow-up|1|||
130535599|NCT01240915|469929312|FG005|Overall Study|Lost to Follow-up|1|||
130535600|NCT01240915|469929313|FG006|Overall Study|Lost to Follow-up|0|||
130535601|NCT01240915|469929314|FG007|Overall Study|Lost to Follow-up|1|||
130535602|NCT01240915|469929315|FG008|Overall Study|Lost to Follow-up|1|||
130535603|NCT01240915|469929307|FG000|Overall Study|Withdrawal by Subject|2|||
130535604|NCT01240915|469929308|FG001|Overall Study|Withdrawal by Subject|1|||
130535605|NCT01240915|469929309|FG002|Overall Study|Withdrawal by Subject|0|||
130535606|NCT01240915|469929310|FG003|Overall Study|Withdrawal by Subject|2|||
130535607|NCT01240915|469929311|FG004|Overall Study|Withdrawal by Subject|0|||
130535608|NCT01240915|469929312|FG005|Overall Study|Withdrawal by Subject|4|||
130535609|NCT01240915|469929313|FG006|Overall Study|Withdrawal by Subject|2|||
130535610|NCT01240915|469929314|FG007|Overall Study|Withdrawal by Subject|3|||
130535611|NCT01240915|469929315|FG008|Overall Study|Withdrawal by Subject|3|||
130535612|NCT01240915|469929307|FG000|Overall Study|Other|0|||
130535613|NCT01240915|469929308|FG001|Overall Study|Other|0|||
130535614|NCT01240915|469929309|FG002|Overall Study|Other|0|||
130535615|NCT01240915|469929310|FG003|Overall Study|Other|0|||
130535616|NCT01240915|469929311|FG004|Overall Study|Other|2|||
130535617|NCT01240915|469929312|FG005|Overall Study|Other|0|||
130535618|NCT01240915|469929313|FG006|Overall Study|Other|0|||
130535619|NCT01240915|469929314|FG007|Overall Study|Other|0|||
130535620|NCT01240915|469929315|FG008|Overall Study|Other|0|||
130535621|NCT01240915|469929307|FG000|Overall Study|Insufficient Clinical Response|0|||
130535622|NCT01240915|469929308|FG001|Overall Study|Insufficient Clinical Response|0|||
130535623|NCT01240915|469929309|FG002|Overall Study|Insufficient Clinical Response|0|||
130535624|NCT01240915|469929310|FG003|Overall Study|Insufficient Clinical Response|0|||
130535625|NCT01240915|469929311|FG004|Overall Study|Insufficient Clinical Response|1|||
130535626|NCT01240915|469929312|FG005|Overall Study|Insufficient Clinical Response|3|||
130535627|NCT01240915|469929313|FG006|Overall Study|Insufficient Clinical Response|6|||
130535628|NCT01240915|469929314|FG007|Overall Study|Insufficient Clinical Response|0|||
130535629|NCT01240915|469929315|FG008|Overall Study|Insufficient Clinical Response|3|||
130535630|NCT04514510|469929316|FG000|Overall Study|Lost to Follow-up|0|||
130535631|NCT04514510|469929317|FG001|Overall Study|Lost to Follow-up|1|||
130535632|NCT04514510|469929316|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
130535633|NCT04514510|469929317|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
130535634|NCT04488770|469929318|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535635|NCT04488770|469929319|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535636|NCT04488770|469929320|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535637|NCT04488770|469929321|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
130535638|NCT04488770|469929322|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535639|NCT04488770|469929323|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535640|NCT04488770|469929324|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535641|NCT04488770|469929325|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535642|NCT04488770|469929326|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535643|NCT04488770|469929327|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535644|NCT04488770|469929328|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535645|NCT04488770|469929329|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130583664|NCT03523351|470101023|FG001|Overall Study|Lost to Follow-up|3|||
130535646|NCT04488770|469929330|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130535647|NCT04488770|469929318|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
130535648|NCT04488770|469929319|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535649|NCT04488770|469929320|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535650|NCT04488770|469929321|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535651|NCT04488770|469929322|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535652|NCT04488770|469929323|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535653|NCT04488770|469929324|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535654|NCT04488770|469929325|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535655|NCT04488770|469929326|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535656|NCT04488770|469929327|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535657|NCT04488770|469929328|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535658|NCT04488770|469929329|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535659|NCT04488770|469929330|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130535660|NCT04488770|469929318|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535661|NCT04488770|469929319|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535662|NCT04488770|469929320|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535663|NCT04488770|469929321|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535664|NCT04488770|469929322|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535665|NCT04488770|469929323|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
130535666|NCT04488770|469929324|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
130535667|NCT04488770|469929325|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535668|NCT04488770|469929326|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535669|NCT04488770|469929327|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535670|NCT04488770|469929328|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535671|NCT04488770|469929329|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535672|NCT04488770|469929330|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130535673|NCT04488770|469929318|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535674|NCT04488770|469929319|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535675|NCT04488770|469929320|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535676|NCT04488770|469929321|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535677|NCT04488770|469929322|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
130535678|NCT04488770|469929323|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535679|NCT04488770|469929324|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535680|NCT04488770|469929325|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535681|NCT04488770|469929326|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535682|NCT04488770|469929327|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535683|NCT04488770|469929328|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535684|NCT04488770|469929329|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535685|NCT04488770|469929330|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
130535686|NCT01867333|469929331|FG000|Overall Study|Withdrawal by Subject|1|||
130535687|NCT01867333|469929332|FG001|Overall Study|Withdrawal by Subject|0|||
130535688|NCT01867333|469929331|FG000|Overall Study|Adverse Event|1|||
130535689|NCT01867333|469929332|FG001|Overall Study|Adverse Event|0|||
130535690|NCT01867333|469929331|FG000|Overall Study|Participant choice|1|||
130535691|NCT01867333|469929332|FG001|Overall Study|Participant choice|2|||
130535692|NCT01867333|469929331|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
130535693|NCT01867333|469929332|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
130535694|NCT01867333|469929331|FG000|Overall Study|Death|0|||
130535695|NCT01867333|469929332|FG001|Overall Study|Death|1|||
130535696|NCT01867333|469929331|FG000|Overall Study|Physician Decision|3|||
130535697|NCT01867333|469929332|FG001|Overall Study|Physician Decision|2|||
130535698|NCT01867333|469929331|FG000|Overall Study|Switched to alternative treatment|1|||
130535699|NCT01867333|469929332|FG001|Overall Study|Switched to alternative treatment|0|||
130535700|NCT02636725|469929335|FG000|Overall Study|Adverse Event|1|||
130535701|NCT05330676|469929338|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
130535702|NCT05330676|469929339|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
130535703|NCT03653208|469929340|FG000|Overall Study|Withdrawal by Subject|0|||
130535704|NCT03653208|469929341|FG001|Overall Study|Withdrawal by Subject|0|||
130535705|NCT03653208|469929342|FG002|Overall Study|Withdrawal by Subject|0|||
130535706|NCT03653208|469929343|FG003|Overall Study|Withdrawal by Subject|0|||
130535707|NCT03653208|469929344|FG004|Overall Study|Withdrawal by Subject|1|||
130535708|NCT03653208|469929345|FG005|Overall Study|Withdrawal by Subject|0|||
130535709|NCT03653208|469929346|FG006|Overall Study|Withdrawal by Subject|0|||
130535710|NCT03653208|469929347|FG007|Overall Study|Withdrawal by Subject|1|||
130535711|NCT03653208|469929348|FG008|Overall Study|Withdrawal by Subject|1|||
130583665|NCT03523351|470101022|FG000|Overall Study|Withdrawal by Subject|4|||
130535712|NCT00436605|469929349|FG000|Overall Study|Protocol Violation|3|||
130535713|NCT03752970|469929350|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
130535714|NCT03752970|469929351|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
130535715|NCT03752970|469929352|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
130535716|NCT03752970|469929350|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
130535717|NCT03752970|469929351|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
130535718|NCT03752970|469929352|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
130535719|NCT03752970|469929350|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
130535720|NCT03752970|469929351|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
130535721|NCT03752970|469929352|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
130535722|NCT03752970|469929350|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
130535723|NCT03752970|469929351|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
130535724|NCT03752970|469929352|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
130535725|NCT03752970|469929350|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
130535726|NCT03752970|469929351|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
130535727|NCT03752970|469929352|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
130535728|NCT01696045|469929355|FG000|Overall Study|Study drug toxicity|1|||
130535729|NCT01696045|469929356|FG001|Overall Study|Study drug toxicity|5|||
130535730|NCT01696045|469929355|FG000|Overall Study|Disease progression|2|||
130535731|NCT01696045|469929356|FG001|Overall Study|Disease progression|2|||
130535732|NCT00573859|469929357|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
130535733|NCT00573859|469929357|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
130535734|NCT02229851|469929364|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
130535735|NCT02229851|469929365|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
130535736|NCT02229851|469929366|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
130535737|NCT02229851|469929367|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
130535738|NCT02229851|469929368|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
130535739|NCT02229851|469929369|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
130535740|NCT02229851|469929370|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
130535741|NCT02229851|469929364|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535742|NCT02229851|469929365|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
130535743|NCT02229851|469929366|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535744|NCT02229851|469929367|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535745|NCT02229851|469929368|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535746|NCT02229851|469929369|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535747|NCT02229851|469929370|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
130535748|NCT02229851|469929364|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
130535749|NCT02229851|469929365|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
130535750|NCT02229851|469929366|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
130535751|NCT02229851|469929367|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
130535752|NCT02229851|469929368|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
130535753|NCT02229851|469929369|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
130535754|NCT02229851|469929370|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
130535755|NCT02229851|469929364|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535756|NCT02229851|469929365|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535757|NCT02229851|469929366|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
130535758|NCT02229851|469929367|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535759|NCT02229851|469929368|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535760|NCT02229851|469929369|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535761|NCT02229851|469929370|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
130535762|NCT02229851|469929364|FG000|Main Phase (Double-blind Phase)|Death|1|||
130535763|NCT02229851|469929365|FG001|Main Phase (Double-blind Phase)|Death|1|||
130535764|NCT02229851|469929366|FG002|Main Phase (Double-blind Phase)|Death|0|||
130535765|NCT02229851|469929367|FG003|Main Phase (Double-blind Phase)|Death|0|||
130535766|NCT02229851|469929368|FG004|Main Phase (Double-blind Phase)|Death|0|||
130535767|NCT02229851|469929369|FG005|Main Phase (Double-blind Phase)|Death|0|||
130535768|NCT02229851|469929370|FG006|Main Phase (Double-blind Phase)|Death|0|||
130535769|NCT02229851|469929364|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
130535770|NCT02229851|469929365|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
130535771|NCT02229851|469929366|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
130535772|NCT02229851|469929367|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
130535773|NCT02229851|469929368|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
130535774|NCT02229851|469929369|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
130583666|NCT03523351|470101023|FG001|Overall Study|Withdrawal by Subject|0|||
130535775|NCT02229851|469929370|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
130535776|NCT02229851|469929364|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
130583667|NCT03523351|470101022|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
130535777|NCT02229851|469929365|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
130535778|NCT02229851|469929366|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
130535779|NCT02229851|469929367|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
130535780|NCT02229851|469929368|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
130535781|NCT02229851|469929369|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
130535782|NCT02229851|469929370|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
130535783|NCT02229851|469929364|FG000|Extension Phase (Open-label Phase)|Death|0|||
130535784|NCT02229851|469929365|FG001|Extension Phase (Open-label Phase)|Death|0|||
130535785|NCT02229851|469929366|FG002|Extension Phase (Open-label Phase)|Death|0|||
130535786|NCT02229851|469929367|FG003|Extension Phase (Open-label Phase)|Death|1|||
130535787|NCT02229851|469929368|FG004|Extension Phase (Open-label Phase)|Death|0|||
130535788|NCT02229851|469929369|FG005|Extension Phase (Open-label Phase)|Death|1|||
130535789|NCT02229851|469929370|FG006|Extension Phase (Open-label Phase)|Death|1|||
130535790|NCT03284203|469929371|FG000|Overall Study|Lost to Follow-up|3|||
130535791|NCT03541200|469929372|FG000|Overall Study|Adverse Event|19|||
130535792|NCT03541200|469929372|FG000|Overall Study|Death|1|||
130535793|NCT03541200|469929372|FG000|Overall Study|Lost to Follow-up|10|||
130535794|NCT03541200|469929372|FG000|Overall Study|Physician Decision|1|||
130535795|NCT03541200|469929372|FG000|Overall Study|Protocol Violation|51|||
130535796|NCT03541200|469929372|FG000|Overall Study|Withdrawal by Subject|23|||
130535797|NCT03541200|469929372|FG000|Overall Study|other|8|||
130535798|NCT00864253|469929382|FG000|Overall Study|Adverse Event|56|||
130535799|NCT00864253|469929383|FG001|Overall Study|Adverse Event|11|||
130535800|NCT00864253|469929382|FG000|Overall Study|Unrelated Adverse Event|3|||
130535801|NCT00864253|469929383|FG001|Overall Study|Unrelated Adverse Event|1|||
130535802|NCT00864253|469929382|FG000|Overall Study|Physician Decision|11|||
130535803|NCT00864253|469929383|FG001|Overall Study|Physician Decision|15|||
130535804|NCT00864253|469929382|FG000|Overall Study|Protocol Violation|0|||
130535805|NCT00864253|469929383|FG001|Overall Study|Protocol Violation|2|||
130535806|NCT00864253|469929382|FG000|Overall Study|Lost to Follow-up|1|||
130535807|NCT00864253|469929383|FG001|Overall Study|Lost to Follow-up|1|||
130535808|NCT00864253|469929382|FG000|Overall Study|Withdrawal by Subject|18|||
130535809|NCT00864253|469929383|FG001|Overall Study|Withdrawal by Subject|18|||
130535810|NCT00864253|469929382|FG000|Overall Study|Death|1|||
130535811|NCT00864253|469929383|FG001|Overall Study|Death|0|||
130535812|NCT00864253|469929382|FG000|Overall Study|Ongoing|2|||
130535813|NCT00864253|469929383|FG001|Overall Study|Ongoing|3|||
130535814|NCT00864253|469929382|FG000|Overall Study|Untreated|7|||
130535815|NCT00864253|469929383|FG001|Overall Study|Untreated|7|||
130535816|NCT01896726|469929384|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
130535817|NCT01896726|469929384|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
130535818|NCT01128114|469929385|FG000|Overall Study|Treatment Withdrawn|6|||
130535819|NCT01128114|469929385|FG000|Overall Study|Screening Failed|2|||
130535820|NCT01111240|469929386|FG000|Overall Study|Adverse Event|190|||
130535821|NCT01111240|469929386|FG000|Overall Study|Lack of Efficacy|545|||
130535822|NCT01111240|469929386|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
130535823|NCT01111240|469929386|FG000|Overall Study|Other|312|||
130535824|NCT00208325|469929387|FG000|Overall Study|Death|18|||
130535825|NCT00208325|469929388|FG001|Overall Study|Death|19|||
130535826|NCT00208325|469929389|FG002|Overall Study|Death|7|||
130535827|NCT00208325|469929390|FG003|Overall Study|Death|5|||
130535828|NCT00208325|469929387|FG000|Overall Study|Withdrawal by Subject|0|||
130535829|NCT00208325|469929388|FG001|Overall Study|Withdrawal by Subject|1|||
130535830|NCT00208325|469929389|FG002|Overall Study|Withdrawal by Subject|0|||
130535831|NCT00208325|469929390|FG003|Overall Study|Withdrawal by Subject|0|||
130535832|NCT00208325|469929387|FG000|Overall Study|Revision|4|||
130535833|NCT00208325|469929388|FG001|Overall Study|Revision|1|||
130535834|NCT00208325|469929389|FG002|Overall Study|Revision|0|||
130535835|NCT00208325|469929390|FG003|Overall Study|Revision|4|||
130535836|NCT00208325|469929387|FG000|Overall Study|Lost to Follow-up|1|||
130535837|NCT00208325|469929388|FG001|Overall Study|Lost to Follow-up|0|||
130535838|NCT00208325|469929389|FG002|Overall Study|Lost to Follow-up|2|||
130535839|NCT00208325|469929390|FG003|Overall Study|Lost to Follow-up|0|||
130535840|NCT00208325|469929387|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
130535841|NCT00208325|469929388|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
130535842|NCT00208325|469929389|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
130535843|NCT00208325|469929390|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
130535844|NCT00208325|469929387|FG000|Overall Study|Does not wish to Continue in Study|5|||
130535845|NCT00208325|469929388|FG001|Overall Study|Does not wish to Continue in Study|8|||
130535846|NCT00208325|469929389|FG002|Overall Study|Does not wish to Continue in Study|3|||
130535847|NCT00208325|469929390|FG003|Overall Study|Does not wish to Continue in Study|2|||
130535848|NCT00208325|469929387|FG000|Overall Study|Other|2|||
130535849|NCT00208325|469929388|FG001|Overall Study|Other|1|||
130535850|NCT00208325|469929389|FG002|Overall Study|Other|1|||
130535851|NCT00208325|469929390|FG003|Overall Study|Other|0|||
130535852|NCT00208325|469929387|FG000|Overall Study|Mis-Randomized|17|||
130535853|NCT00208325|469929388|FG001|Overall Study|Mis-Randomized|20|||
130535854|NCT00208325|469929389|FG002|Overall Study|Mis-Randomized|0|||
130535855|NCT00208325|469929390|FG003|Overall Study|Mis-Randomized|0|||
130535856|NCT02206061|469929391|FG000|Overall Study|Withdrawal by Subject|4|||
130535857|NCT02206061|469929392|FG001|Overall Study|Withdrawal by Subject|7|||
130535858|NCT02206061|469929393|FG002|Overall Study|Withdrawal by Subject|1|||
130535859|NCT02206061|469929391|FG000|Overall Study|Lost to Follow-up|14|||
130535860|NCT02206061|469929392|FG001|Overall Study|Lost to Follow-up|7|||
130535861|NCT02206061|469929393|FG002|Overall Study|Lost to Follow-up|20|||
130535862|NCT01607476|469929394|FG000|Overall Study|Withdrawal by Subject|1|||
130535863|NCT01607476|469929395|FG001|Overall Study|Withdrawal by Subject|0|||
130535864|NCT01607476|469929396|FG002|Overall Study|Withdrawal by Subject|1|||
130535865|NCT01607476|469929394|FG000|Overall Study|Lost to Follow-up|0|||
130535866|NCT01607476|469929395|FG001|Overall Study|Lost to Follow-up|0|||
130535867|NCT01607476|469929396|FG002|Overall Study|Lost to Follow-up|2|||
130535868|NCT04445987|469929397|FG000|Overall Study|Adverse Event|0|||
130535869|NCT04445987|469929398|FG001|Overall Study|Adverse Event|0|||
130535870|NCT04445987|469929399|FG002|Overall Study|Adverse Event|1|||
130535871|NCT04445987|469929400|FG003|Overall Study|Adverse Event|0|||
130583668|NCT03523351|470101023|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
130583669|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
130583670|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
130583671|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
130583672|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130583673|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130583674|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130583675|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130583676|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130583677|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
130583678|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
130583679|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
130583680|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130583681|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130583682|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130583683|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130583684|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130583685|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
130583686|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
130583687|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
130583688|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130583689|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130583690|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130583691|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130583692|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130583693|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
130583694|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
130583695|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130583696|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130583697|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130583698|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130583699|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130583700|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130583701|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
130583702|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
130583703|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
130535872|NCT04445987|469929401|FG004|Overall Study|Adverse Event|4|||
130535873|NCT04445987|469929402|FG005|Overall Study|Adverse Event|0|||
130535874|NCT04445987|469929397|FG000|Overall Study|Lost to Follow-up|4|||
130535875|NCT04445987|469929398|FG001|Overall Study|Lost to Follow-up|3|||
130535876|NCT04445987|469929399|FG002|Overall Study|Lost to Follow-up|1|||
130535877|NCT04445987|469929400|FG003|Overall Study|Lost to Follow-up|1|||
130535878|NCT04445987|469929401|FG004|Overall Study|Lost to Follow-up|29|||
130535879|NCT04445987|469929402|FG005|Overall Study|Lost to Follow-up|0|||
130583704|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130583705|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130583706|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130583707|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130583708|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130535880|NCT04445987|469929397|FG000|Overall Study|Physician Decision|0|||
130583709|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
130583710|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
130583711|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583712|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583713|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583714|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583715|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583716|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130583717|NCT01097629|470101037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
130583718|NCT01097629|470101038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
130583719|NCT01097629|470101039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
130583720|NCT01097629|470101040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130583721|NCT01097629|470101041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130583722|NCT01097629|470101042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130583723|NCT01097629|470101043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130583724|NCT01097629|470101044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130583725|NCT01097629|470101037|FG000|DB RO Phase|Withdrawal by Subject|0|||
130583726|NCT01097629|470101038|FG001|DB RO Phase|Withdrawal by Subject|0|||
130583727|NCT01097629|470101039|FG002|DB RO Phase|Withdrawal by Subject|0|||
130583728|NCT01097629|470101040|FG003|DB RO Phase|Withdrawal by Subject|0|||
130583729|NCT01097629|470101041|FG004|DB RO Phase|Withdrawal by Subject|0|||
130583730|NCT01097629|470101042|FG005|DB RO Phase|Withdrawal by Subject|0|||
130583731|NCT01097629|470101043|FG006|DB RO Phase|Withdrawal by Subject|0|||
130583732|NCT01097629|470101044|FG007|DB RO Phase|Withdrawal by Subject|1|||
130583733|NCT01097629|470101037|FG000|DB RO Phase|Protocol Violation|0|||
130583734|NCT01097629|470101038|FG001|DB RO Phase|Protocol Violation|0|||
130583735|NCT01097629|470101039|FG002|DB RO Phase|Protocol Violation|0|||
130583736|NCT01097629|470101040|FG003|DB RO Phase|Protocol Violation|1|||
130583737|NCT01097629|470101041|FG004|DB RO Phase|Protocol Violation|0|||
130583738|NCT01097629|470101042|FG005|DB RO Phase|Protocol Violation|1|||
130583739|NCT01097629|470101043|FG006|DB RO Phase|Protocol Violation|1|||
130583740|NCT01097629|470101044|FG007|DB RO Phase|Protocol Violation|0|||
130583741|NCT01097629|470101037|FG000|DB RO Phase|Lost to Follow-up|0|||
130583742|NCT01097629|470101038|FG001|DB RO Phase|Lost to Follow-up|0|||
130583743|NCT01097629|470101039|FG002|DB RO Phase|Lost to Follow-up|0|||
130583744|NCT01097629|470101040|FG003|DB RO Phase|Lost to Follow-up|0|||
130583745|NCT01097629|470101041|FG004|DB RO Phase|Lost to Follow-up|0|||
130583746|NCT01097629|470101042|FG005|DB RO Phase|Lost to Follow-up|0|||
130583747|NCT01097629|470101043|FG006|DB RO Phase|Lost to Follow-up|2|||
130583748|NCT01097629|470101044|FG007|DB RO Phase|Lost to Follow-up|0|||
130583749|NCT02613208|470101046|FG000|Overall Study|Withdrawal by Subject|1|||
130583750|NCT02613208|470101046|FG000|Overall Study|Change of address|2|||
130583751|NCT02613208|470101046|FG000|Overall Study|Physician Decision|2|||
130583752|NCT02613208|470101046|FG000|Overall Study|Lost to Follow-up|5|||
130583753|NCT02613208|470101046|FG000|Overall Study|Death|37|||
130583754|NCT01400932|470101048|FG000|Overall Study|Adverse Event|10|||
130583755|NCT01400932|470101049|FG001|Overall Study|Adverse Event|5|||
130583756|NCT01400932|470101048|FG000|Overall Study|Lack of Efficacy|0|||
130583757|NCT01400932|470101049|FG001|Overall Study|Lack of Efficacy|3|||
130583758|NCT01400932|470101048|FG000|Overall Study|Withdrawal by Subject|2|||
130583759|NCT01400932|470101049|FG001|Overall Study|Withdrawal by Subject|6|||
130583760|NCT01400932|470101048|FG000|Overall Study|Lost to Follow-up|1|||
130583761|NCT01400932|470101049|FG001|Overall Study|Lost to Follow-up|0|||
130583762|NCT01400932|470101048|FG000|Overall Study|Protocol Deviation|0|||
130583763|NCT01400932|470101049|FG001|Overall Study|Protocol Deviation|1|||
130583764|NCT01400932|470101048|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130583765|NCT01400932|470101049|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130583766|NCT03244059|470101051|FG000|Specific Aim 1|Physician Decision|1|||
130583767|NCT03244059|470101052|FG001|Specific Aim 1|Physician Decision|0|||
130583768|NCT03244059|470101051|FG000|Specific Aim 2|Physician Decision|1|||
130583769|NCT03244059|470101052|FG001|Specific Aim 2|Physician Decision|0|||
130583770|NCT01276821|470101053|FG000|Overall Study|Protocol Violation|0|||
130583771|NCT01276821|470101054|FG001|Overall Study|Protocol Violation|1|||
130583772|NCT00270894|470101055|FG000|Overall Study|Adverse Event|1|||
130583773|NCT00270894|470101055|FG000|Overall Study|Withdrawal by Subject|1|||
130583774|NCT00605267|470101056|FG000|Overall Study|Adverse Event|0|||
130583775|NCT00605267|470101057|FG001|Overall Study|Adverse Event|1|||
130583776|NCT00605267|470101056|FG000|Overall Study|Lack of Efficacy|1|||
130583777|NCT00605267|470101057|FG001|Overall Study|Lack of Efficacy|5|||
130583778|NCT00605267|470101056|FG000|Overall Study|Withdrawal by Subject|2|||
130583779|NCT00605267|470101057|FG001|Overall Study|Withdrawal by Subject|3|||
130583780|NCT02939131|470101058|FG000|Overall Study|Unable to get to clinic|6|||
130535881|NCT04445987|469929398|FG001|Overall Study|Physician Decision|0|||
130535882|NCT04445987|469929399|FG002|Overall Study|Physician Decision|0|||
130535883|NCT04445987|469929400|FG003|Overall Study|Physician Decision|0|||
130535884|NCT04445987|469929401|FG004|Overall Study|Physician Decision|1|||
130535885|NCT04445987|469929402|FG005|Overall Study|Physician Decision|0|||
130535886|NCT04445987|469929397|FG000|Overall Study|Protocol Violation|1|||
130535887|NCT04445987|469929398|FG001|Overall Study|Protocol Violation|0|||
130535888|NCT04445987|469929399|FG002|Overall Study|Protocol Violation|0|||
130535889|NCT04445987|469929400|FG003|Overall Study|Protocol Violation|0|||
130535890|NCT04445987|469929401|FG004|Overall Study|Protocol Violation|2|||
130535891|NCT04445987|469929402|FG005|Overall Study|Protocol Violation|0|||
130535892|NCT04445987|469929397|FG000|Overall Study|Withdrawal by Subject|4|||
130535893|NCT04445987|469929398|FG001|Overall Study|Withdrawal by Subject|0|||
130535894|NCT04445987|469929399|FG002|Overall Study|Withdrawal by Subject|1|||
130535895|NCT04445987|469929400|FG003|Overall Study|Withdrawal by Subject|0|||
130535896|NCT04445987|469929401|FG004|Overall Study|Withdrawal by Subject|18|||
130535897|NCT04445987|469929402|FG005|Overall Study|Withdrawal by Subject|1|||
130535898|NCT04445987|469929397|FG000|Overall Study|Other reason|0|||
130535899|NCT04445987|469929398|FG001|Overall Study|Other reason|0|||
130535900|NCT04445987|469929399|FG002|Overall Study|Other reason|1|||
130535901|NCT04445987|469929400|FG003|Overall Study|Other reason|0|||
130535902|NCT04445987|469929401|FG004|Overall Study|Other reason|2|||
130535903|NCT04445987|469929402|FG005|Overall Study|Other reason|0|||
130535904|NCT01114880|469929403|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
130535905|NCT01114880|469929404|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
130535906|NCT01114880|469929403|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
130535907|NCT01114880|469929404|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
130535908|NCT01114880|469929403|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
130535909|NCT01114880|469929404|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
130535910|NCT01114880|469929403|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
130535911|NCT01114880|469929404|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
130535912|NCT01114880|469929403|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
130535913|NCT01114880|469929404|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
130535914|NCT01114880|469929403|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
130535915|NCT01114880|469929404|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
130535916|NCT04655027|469929410|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
130535917|NCT04655027|469929411|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
130535918|NCT03519997|469929414|FG000|Overall Study|Adverse Event|4|||
130535919|NCT03519997|469929414|FG000|Overall Study|Withdrawal by Subject|2|||
130535920|NCT03519997|469929414|FG000|Overall Study|Protocol Violation|1|||
130535921|NCT05543707|469929415|FG000|Overall Study|Study drug non-compliance/|5|||
130535922|NCT05543707|469929416|FG001|Overall Study|Study drug non-compliance/|0|||
130535923|NCT05543707|469929415|FG000|Overall Study|Withdrawal by Subject|1|||
130535924|NCT05543707|469929416|FG001|Overall Study|Withdrawal by Subject|1|||
130535925|NCT05543707|469929415|FG000|Overall Study|Adverse Event|1|||
130535926|NCT05543707|469929416|FG001|Overall Study|Adverse Event|0|||
130535927|NCT05543707|469929415|FG000|Overall Study|concurrent illness|0|||
130535928|NCT05543707|469929416|FG001|Overall Study|concurrent illness|1|||
130535929|NCT05543707|469929415|FG000|Overall Study|Pregnancy|1|||
130535930|NCT05543707|469929416|FG001|Overall Study|Pregnancy|1|||
130535931|NCT00186888|469929417|FG000|Overall Study|Toxicity|0|||
130535932|NCT00186888|469929418|FG001|Overall Study|Toxicity|1|||
130535933|NCT00186888|469929419|FG002|Overall Study|Toxicity|0|||
130535934|NCT00186888|469929417|FG000|Overall Study|Relapse or progression of disease|4|||
130535935|NCT00186888|469929418|FG001|Overall Study|Relapse or progression of disease|2|||
130535936|NCT00186888|469929419|FG002|Overall Study|Relapse or progression of disease|0|||
130535937|NCT03006848|469929420|FG000|Overall Study|Adverse Event|1|||
130535938|NCT03006848|469929420|FG000|Overall Study|Physician Decision|1|||
130535939|NCT03006848|469929420|FG000|Overall Study|Lack of Efficacy|16|||
130535940|NCT04372121|469929424|FG000|Overall Study|Lost to Follow-up|0|||
130535941|NCT04372121|469929425|FG001|Overall Study|Lost to Follow-up|0|||
130535942|NCT04372121|469929426|FG002|Overall Study|Lost to Follow-up|0|||
130535943|NCT04372121|469929427|FG003|Overall Study|Lost to Follow-up|1|||
130535944|NCT04372121|469929424|FG000|Overall Study|Protocol Violation|0|||
130535945|NCT04372121|469929425|FG001|Overall Study|Protocol Violation|0|||
130535946|NCT04372121|469929426|FG002|Overall Study|Protocol Violation|1|||
130535947|NCT04372121|469929427|FG003|Overall Study|Protocol Violation|0|||
130535948|NCT04372121|469929424|FG000|Overall Study|Withdrawal by Subject|3|||
130535949|NCT04372121|469929425|FG001|Overall Study|Withdrawal by Subject|1|||
130535950|NCT04372121|469929426|FG002|Overall Study|Withdrawal by Subject|0|||
130535951|NCT04372121|469929427|FG003|Overall Study|Withdrawal by Subject|0|||
130535952|NCT04372121|469929424|FG000|Overall Study|Study termination|6|||
130535953|NCT04372121|469929425|FG001|Overall Study|Study termination|5|||
130535954|NCT04372121|469929426|FG002|Overall Study|Study termination|1|||
130535955|NCT04372121|469929427|FG003|Overall Study|Study termination|1|||
130583781|NCT02939131|470101059|FG001|Overall Study|Unable to get to clinic|4|||
130535956|NCT04372121|469929424|FG000|Overall Study|Hysterectomy planned|1|||
130535957|NCT04372121|469929425|FG001|Overall Study|Hysterectomy planned|0|||
130535958|NCT04372121|469929426|FG002|Overall Study|Hysterectomy planned|0|||
130535959|NCT04372121|469929427|FG003|Overall Study|Hysterectomy planned|0|||
130535960|NCT02344290|469929428|FG000|Overall Study|Withdrawal by Subject|315|||
130535961|NCT02344290|469929429|FG001|Overall Study|Withdrawal by Subject|324|||
130535962|NCT02344290|469929428|FG000|Overall Study|Lost to Follow-up|258|||
130535963|NCT02344290|469929429|FG001|Overall Study|Lost to Follow-up|249|||
130535964|NCT02344290|469929428|FG000|Overall Study|Unable to get to clinic|69|||
130535965|NCT02344290|469929429|FG001|Overall Study|Unable to get to clinic|60|||
130535966|NCT02344290|469929428|FG000|Overall Study|Physician Decision|25|||
130535967|NCT02344290|469929429|FG001|Overall Study|Physician Decision|25|||
130535968|NCT02344290|469929428|FG000|Overall Study|Site Closure|15|||
130535969|NCT02344290|469929429|FG001|Overall Study|Site Closure|19|||
130535970|NCT02344290|469929428|FG000|Overall Study|Other|5|||
130535971|NCT02344290|469929429|FG001|Overall Study|Other|3|||
130535972|NCT03826030|469929430|FG000|Overall Study|Withdrawal by Subject|2|||
130535973|NCT03826030|469929431|FG001|Overall Study|Withdrawal by Subject|0|||
130535974|NCT03826030|469929432|FG002|Overall Study|Withdrawal by Subject|1|||
130535975|NCT03826030|469929430|FG000|Overall Study|Lost to Follow-up|1|||
130535976|NCT03826030|469929431|FG001|Overall Study|Lost to Follow-up|1|||
130535977|NCT03826030|469929432|FG002|Overall Study|Lost to Follow-up|1|||
130535978|NCT03826030|469929430|FG000|Overall Study|Too busy to return for visits|1|||
130535979|NCT03826030|469929431|FG001|Overall Study|Too busy to return for visits|0|||
130535980|NCT03826030|469929432|FG002|Overall Study|Too busy to return for visits|0|||
130535981|NCT03820947|469929437|FG000|Overall Study|Physician Decision|0|||
130535982|NCT03820947|469929438|FG001|Overall Study|Physician Decision|1|||
130535983|NCT03820947|469929439|FG002|Overall Study|Physician Decision|1|||
130535984|NCT03820947|469929440|FG003|Overall Study|Physician Decision|0|||
130535985|NCT03820947|469929441|FG004|Overall Study|Physician Decision|3|||
130535986|NCT03820947|469929437|FG000|Overall Study|Withdrawal by Subject|6|||
130535987|NCT03820947|469929438|FG001|Overall Study|Withdrawal by Subject|10|||
130535988|NCT03820947|469929439|FG002|Overall Study|Withdrawal by Subject|3|||
130535989|NCT03820947|469929440|FG003|Overall Study|Withdrawal by Subject|8|||
130535990|NCT03820947|469929441|FG004|Overall Study|Withdrawal by Subject|5|||
130535991|NCT03820947|469929437|FG000|Overall Study|Procedure Not Attempted|0|||
130535992|NCT03820947|469929438|FG001|Overall Study|Procedure Not Attempted|2|||
130535993|NCT03820947|469929439|FG002|Overall Study|Procedure Not Attempted|1|||
130535994|NCT03820947|469929440|FG003|Overall Study|Procedure Not Attempted|0|||
130535995|NCT03820947|469929441|FG004|Overall Study|Procedure Not Attempted|0|||
130535996|NCT03820947|469929437|FG000|Overall Study|Other Exit|1|||
130535997|NCT03820947|469929438|FG001|Overall Study|Other Exit|3|||
130535998|NCT03820947|469929439|FG002|Overall Study|Other Exit|3|||
130535999|NCT03820947|469929440|FG003|Overall Study|Other Exit|3|||
130536000|NCT03820947|469929441|FG004|Overall Study|Other Exit|0|||
130536001|NCT03820947|469929437|FG000|Overall Study|Follow-up Not Done|10|||
130536002|NCT03820947|469929438|FG001|Overall Study|Follow-up Not Done|13|||
130536003|NCT03820947|469929439|FG002|Overall Study|Follow-up Not Done|2|||
130536004|NCT03820947|469929440|FG003|Overall Study|Follow-up Not Done|3|||
130536005|NCT03820947|469929441|FG004|Overall Study|Follow-up Not Done|12|||
130536006|NCT03820947|469929437|FG000|Overall Study|Death|0|||
130536007|NCT03820947|469929438|FG001|Overall Study|Death|0|||
130536008|NCT03820947|469929439|FG002|Overall Study|Death|0|||
130536009|NCT03820947|469929440|FG003|Overall Study|Death|0|||
130536010|NCT03820947|469929441|FG004|Overall Study|Death|9|||
130536011|NCT03820947|469929437|FG000|Overall Study|Lost to Follow-up|4|||
130536012|NCT03820947|469929438|FG001|Overall Study|Lost to Follow-up|6|||
130536013|NCT03820947|469929439|FG002|Overall Study|Lost to Follow-up|0|||
130536014|NCT03820947|469929440|FG003|Overall Study|Lost to Follow-up|0|||
130536015|NCT03820947|469929441|FG004|Overall Study|Lost to Follow-up|9|||
130536016|NCT04500769|469931299|FG000|Overall Study|Withdrawal by Subject|5|||
130536017|NCT01967147|469931300|FG000|Overall Study|Adverse Event|5|||
130536018|NCT01967147|469931301|FG001|Overall Study|Adverse Event|2|||
130536019|NCT01967147|469931300|FG000|Overall Study|Lack of Efficacy|1|||
130536020|NCT01967147|469931301|FG001|Overall Study|Lack of Efficacy|4|||
130536021|NCT01967147|469931300|FG000|Overall Study|Lost to Follow-up|1|||
130536022|NCT01967147|469931301|FG001|Overall Study|Lost to Follow-up|2|||
130536023|NCT01967147|469931300|FG000|Overall Study|Withdrawal by Subject|2|||
130536024|NCT01967147|469931301|FG001|Overall Study|Withdrawal by Subject|4|||
130536025|NCT01967147|469931300|FG000|Overall Study|Non-compliance with Study Drug|0|||
130536026|NCT01967147|469931301|FG001|Overall Study|Non-compliance with Study Drug|3|||
130536027|NCT01967147|469931300|FG000|Overall Study|Other|4|||
130536028|NCT01967147|469931301|FG001|Overall Study|Other|5|||
130536029|NCT02218606|469931302|FG000|Overall Study|Adverse Event|1|||
130536030|NCT02218606|469931303|FG001|Overall Study|Adverse Event|1|||
130536031|NCT02218606|469931302|FG000|Overall Study|Death|15|||
130536032|NCT02218606|469931303|FG001|Overall Study|Death|28|||
130536033|NCT02218606|469931302|FG000|Overall Study|Physician Decision|0|||
130536034|NCT02218606|469931303|FG001|Overall Study|Physician Decision|1|||
130536035|NCT02218606|469931302|FG000|Overall Study|Withdrawal by Subject|4|||
130536036|NCT02218606|469931303|FG001|Overall Study|Withdrawal by Subject|0|||
130536037|NCT02218606|469931302|FG000|Overall Study|Noncompliance|1|||
130536038|NCT02218606|469931303|FG001|Overall Study|Noncompliance|0|||
130536039|NCT02218606|469931302|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
130536040|NCT02218606|469931303|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
130536041|NCT02218606|469931302|FG000|Overall Study|Other|2|||
130536042|NCT02218606|469931303|FG001|Overall Study|Other|1|||
130536043|NCT02218606|469931302|FG000|Overall Study|Never started treatment|0|||
130536044|NCT02218606|469931303|FG001|Overall Study|Never started treatment|1|||
130536045|NCT03203473|469931304|FG000|Induction Phase|Never started primary treatment|2|||
130536046|NCT03203473|469931305|FG001|Induction Phase|Never started primary treatment|0|||
130536047|NCT03203473|469931306|FG002|Induction Phase|Never started primary treatment|0|||
130536048|NCT03203473|469931304|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
130536049|NCT03203473|469931305|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
130536050|NCT03203473|469931306|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
130536051|NCT03203473|469931304|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
130536052|NCT03203473|469931305|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
130536053|NCT03203473|469931306|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
130536054|NCT03203473|469931304|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
130536055|NCT03203473|469931305|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
130536056|NCT03203473|469931306|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
130536057|NCT03203473|469931304|FG000|Arm Allocation Phase|started salvage therapy|0|||
130536058|NCT03203473|469931305|FG001|Arm Allocation Phase|started salvage therapy|5|||
130536059|NCT03203473|469931306|FG002|Arm Allocation Phase|started salvage therapy|0|||
130536060|NCT03203473|469931304|FG000|Arm Allocation Phase|Disease progression|0|||
130536061|NCT03203473|469931305|FG001|Arm Allocation Phase|Disease progression|0|||
130536062|NCT03203473|469931306|FG002|Arm Allocation Phase|Disease progression|37|||
130536063|NCT03203473|469931304|FG000|Arm Allocation Phase|Adverse Event|0|||
130536064|NCT03203473|469931305|FG001|Arm Allocation Phase|Adverse Event|0|||
130536065|NCT03203473|469931306|FG002|Arm Allocation Phase|Adverse Event|11|||
130536066|NCT03203473|469931304|FG000|Arm Allocation Phase|Physician Decision|0|||
130536067|NCT03203473|469931305|FG001|Arm Allocation Phase|Physician Decision|0|||
130536068|NCT03203473|469931306|FG002|Arm Allocation Phase|Physician Decision|3|||
130536069|NCT03203473|469931304|FG000|Arm Allocation Phase|Death|0|||
130536070|NCT03203473|469931305|FG001|Arm Allocation Phase|Death|0|||
130536071|NCT03203473|469931306|FG002|Arm Allocation Phase|Death|1|||
130536072|NCT03203473|469931304|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
130536073|NCT03203473|469931305|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
130536074|NCT03203473|469931306|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
130536075|NCT03203473|469931304|FG000|Arm Allocation Phase|Intercurrent illness|0|||
130536076|NCT03203473|469931305|FG001|Arm Allocation Phase|Intercurrent illness|0|||
130536077|NCT03203473|469931306|FG002|Arm Allocation Phase|Intercurrent illness|1|||
130536078|NCT03203473|469931304|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
130536079|NCT03203473|469931305|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
130536080|NCT03203473|469931306|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
130536081|NCT00890695|469931307|FG000|Overall Study|Protocol Violation|1|||
130536082|NCT00890695|469931308|FG001|Overall Study|Protocol Violation|0|||
130536083|NCT01255631|469931313|FG000|Overall Study|poor enrollment, no data analyzed|9|||
130536084|NCT01255631|469931314|FG001|Overall Study|poor enrollment, no data analyzed|6|||
130536085|NCT00568178|469931324|FG000|Double Blind Base Study|Adverse Event|0|||
130536086|NCT00568178|469931325|FG001|Double Blind Base Study|Adverse Event|2|||
130536087|NCT00568178|469931326|FG002|Double Blind Base Study|Adverse Event|1|||
130536088|NCT00568178|469931327|FG003|Double Blind Base Study|Adverse Event|2|||
130536089|NCT00568178|469931328|FG004|Double Blind Base Study|Adverse Event|0|||
130536090|NCT00568178|469931329|FG005|Double Blind Base Study|Adverse Event|0|||
130536091|NCT00568178|469931324|FG000|Double Blind Base Study|Lost to Follow-up|1|||
130536092|NCT00568178|469931325|FG001|Double Blind Base Study|Lost to Follow-up|0|||
130536093|NCT00568178|469931326|FG002|Double Blind Base Study|Lost to Follow-up|0|||
130536094|NCT00568178|469931327|FG003|Double Blind Base Study|Lost to Follow-up|1|||
130536095|NCT00568178|469931328|FG004|Double Blind Base Study|Lost to Follow-up|0|||
130536096|NCT00568178|469931329|FG005|Double Blind Base Study|Lost to Follow-up|0|||
130536097|NCT00568178|469931324|FG000|Double Blind Base Study|Physician Decision|1|||
130536098|NCT00568178|469931325|FG001|Double Blind Base Study|Physician Decision|1|||
130536099|NCT00568178|469931326|FG002|Double Blind Base Study|Physician Decision|0|||
130536100|NCT00568178|469931327|FG003|Double Blind Base Study|Physician Decision|1|||
130536101|NCT00568178|469931328|FG004|Double Blind Base Study|Physician Decision|0|||
130536102|NCT00568178|469931329|FG005|Double Blind Base Study|Physician Decision|0|||
130536103|NCT00568178|469931324|FG000|Double Blind Base Study|Protocol Violation|3|||
130536104|NCT00568178|469931325|FG001|Double Blind Base Study|Protocol Violation|2|||
130536105|NCT00568178|469931326|FG002|Double Blind Base Study|Protocol Violation|0|||
130536106|NCT00568178|469931327|FG003|Double Blind Base Study|Protocol Violation|0|||
130536107|NCT00568178|469931328|FG004|Double Blind Base Study|Protocol Violation|0|||
130536108|NCT00568178|469931329|FG005|Double Blind Base Study|Protocol Violation|0|||
130583782|NCT02939131|470101058|FG000|Overall Study|Lost to Follow-up|2|||
130583783|NCT02939131|470101059|FG001|Overall Study|Lost to Follow-up|4|||
130583784|NCT02939131|470101058|FG000|Overall Study|severe debilitation|1|||
130583785|NCT02939131|470101059|FG001|Overall Study|severe debilitation|0|||
130583786|NCT02939131|470101058|FG000|Overall Study|Other|0|||
130583787|NCT02939131|470101059|FG001|Overall Study|Other|1|||
130583788|NCT02939131|470101058|FG000|Overall Study|not willing to adhere to protocol|2|||
130583789|NCT02939131|470101059|FG001|Overall Study|not willing to adhere to protocol|0|||
130583790|NCT00793793|470101060|FG000|Overall Study|Adverse Event|0|||
130583791|NCT00793793|470101061|FG001|Overall Study|Adverse Event|0|||
130583792|NCT00793793|470101062|FG002|Overall Study|Adverse Event|1|||
130583793|NCT00793793|470101063|FG003|Overall Study|Adverse Event|1|||
130583794|NCT00793793|470101064|FG004|Overall Study|Adverse Event|0|||
130583795|NCT00793793|470101065|FG005|Overall Study|Adverse Event|1|||
130583796|NCT00793793|470101066|FG006|Overall Study|Adverse Event|2|||
130583797|NCT00793793|470101067|FG007|Overall Study|Adverse Event|0|||
130583798|NCT00793793|470101068|FG008|Overall Study|Adverse Event|0|||
130583799|NCT00793793|470101069|FG009|Overall Study|Adverse Event|0|||
130583800|NCT00793793|470101070|FG010|Overall Study|Adverse Event|0|||
130583801|NCT00793793|470101071|FG011|Overall Study|Adverse Event|2|||
130583802|NCT00793793|470101060|FG000|Overall Study|Protocol Violation|0|||
130583803|NCT00793793|470101061|FG001|Overall Study|Protocol Violation|0|||
130583804|NCT00793793|470101062|FG002|Overall Study|Protocol Violation|0|||
130583805|NCT00793793|470101063|FG003|Overall Study|Protocol Violation|1|||
130583806|NCT00793793|470101064|FG004|Overall Study|Protocol Violation|0|||
130583807|NCT00793793|470101065|FG005|Overall Study|Protocol Violation|0|||
130583808|NCT00793793|470101066|FG006|Overall Study|Protocol Violation|0|||
130583809|NCT00793793|470101067|FG007|Overall Study|Protocol Violation|0|||
130583810|NCT00793793|470101068|FG008|Overall Study|Protocol Violation|0|||
130583811|NCT00793793|470101069|FG009|Overall Study|Protocol Violation|0|||
130583812|NCT00793793|470101070|FG010|Overall Study|Protocol Violation|0|||
130583813|NCT00793793|470101071|FG011|Overall Study|Protocol Violation|0|||
130583814|NCT00793793|470101060|FG000|Overall Study|Lost to Follow-up|0|||
130583815|NCT00793793|470101061|FG001|Overall Study|Lost to Follow-up|0|||
130583816|NCT00793793|470101062|FG002|Overall Study|Lost to Follow-up|1|||
130583817|NCT00793793|470101063|FG003|Overall Study|Lost to Follow-up|0|||
130583818|NCT00793793|470101064|FG004|Overall Study|Lost to Follow-up|0|||
130583819|NCT00793793|470101065|FG005|Overall Study|Lost to Follow-up|0|||
130583820|NCT00793793|470101066|FG006|Overall Study|Lost to Follow-up|0|||
130583821|NCT00793793|470101067|FG007|Overall Study|Lost to Follow-up|0|||
130583822|NCT00793793|470101068|FG008|Overall Study|Lost to Follow-up|1|||
130583823|NCT00793793|470101069|FG009|Overall Study|Lost to Follow-up|3|||
130583824|NCT00793793|470101070|FG010|Overall Study|Lost to Follow-up|1|||
130583825|NCT00793793|470101071|FG011|Overall Study|Lost to Follow-up|0|||
130583826|NCT00793793|470101060|FG000|Overall Study|Withdrawal by Subject|0|||
130583827|NCT00793793|470101061|FG001|Overall Study|Withdrawal by Subject|0|||
130583828|NCT00793793|470101062|FG002|Overall Study|Withdrawal by Subject|0|||
130583829|NCT00793793|470101063|FG003|Overall Study|Withdrawal by Subject|0|||
130583830|NCT00793793|470101064|FG004|Overall Study|Withdrawal by Subject|1|||
130583831|NCT00793793|470101065|FG005|Overall Study|Withdrawal by Subject|0|||
130583832|NCT00793793|470101066|FG006|Overall Study|Withdrawal by Subject|0|||
130583833|NCT00793793|470101067|FG007|Overall Study|Withdrawal by Subject|0|||
130583834|NCT00793793|470101068|FG008|Overall Study|Withdrawal by Subject|1|||
130583835|NCT00793793|470101069|FG009|Overall Study|Withdrawal by Subject|0|||
130583836|NCT00793793|470101070|FG010|Overall Study|Withdrawal by Subject|0|||
130583837|NCT00793793|470101071|FG011|Overall Study|Withdrawal by Subject|0|||
130583838|NCT00793793|470101060|FG000|Overall Study|reason not specified|0|||
130583839|NCT00793793|470101061|FG001|Overall Study|reason not specified|1|||
130583840|NCT00793793|470101062|FG002|Overall Study|reason not specified|0|||
130583841|NCT00793793|470101063|FG003|Overall Study|reason not specified|1|||
130583842|NCT00793793|470101064|FG004|Overall Study|reason not specified|1|||
130583843|NCT00793793|470101065|FG005|Overall Study|reason not specified|1|||
130583844|NCT00793793|470101066|FG006|Overall Study|reason not specified|2|||
130583845|NCT00793793|470101067|FG007|Overall Study|reason not specified|0|||
130583846|NCT00793793|470101068|FG008|Overall Study|reason not specified|7|||
130583847|NCT00793793|470101069|FG009|Overall Study|reason not specified|6|||
130583848|NCT00793793|470101070|FG010|Overall Study|reason not specified|2|||
130583849|NCT00793793|470101071|FG011|Overall Study|reason not specified|4|||
130583850|NCT00950170|470101072|FG000|Overall Study|Parent/Legal Guardian Request|1|||
130583851|NCT00950170|470101072|FG000|Overall Study|Adverse Event|2|||
130583852|NCT00950170|470101072|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130583853|NCT01254669|470101073|FG000|Overall Study|Withdrawal by Subject|0|||
130583854|NCT01254669|470101074|FG001|Overall Study|Withdrawal by Subject|1|||
130583855|NCT01254669|470101073|FG000|Overall Study|time constraint|2|||
130583856|NCT01254669|470101074|FG001|Overall Study|time constraint|2|||
130583857|NCT01254669|470101073|FG000|Overall Study|called to clinic during intervention|1|||
130583858|NCT01254669|470101074|FG001|Overall Study|called to clinic during intervention|1|||
130583859|NCT04173741|470101075|FG000|Overall Study|IVC measurement cannot be done|1|||
130583860|NCT04173741|470101076|FG001|Overall Study|IVC measurement cannot be done|1|||
130583861|NCT02631538|470101077|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
130583862|NCT02631538|470101078|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
130583863|NCT02631538|470101079|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
130583864|NCT02631538|470101080|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
130583865|NCT02631538|470101077|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
130583866|NCT02631538|470101078|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
130583867|NCT02631538|470101079|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
130583868|NCT02631538|470101080|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
130583869|NCT02631538|470101077|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
130583870|NCT02631538|470101078|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
130583871|NCT02631538|470101079|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
130583872|NCT02631538|470101080|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
130583873|NCT02631538|470101077|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
130583874|NCT02631538|470101078|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
130583875|NCT02631538|470101079|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
130583876|NCT02631538|470101080|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
130583877|NCT02631538|470101077|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130583878|NCT02631538|470101078|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130583879|NCT02631538|470101079|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
130583880|NCT02631538|470101080|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130583881|NCT02631538|470101077|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
130536109|NCT00568178|469931324|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
130536110|NCT00568178|469931325|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
130536111|NCT00568178|469931326|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
130536112|NCT00568178|469931327|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
130536113|NCT00568178|469931328|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
130536114|NCT00568178|469931329|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
130536115|NCT00568178|469931324|FG000|Double Blind Base Study|Progressive Disease|0|||
130536116|NCT00568178|469931325|FG001|Double Blind Base Study|Progressive Disease|0|||
130536117|NCT00568178|469931326|FG002|Double Blind Base Study|Progressive Disease|0|||
130536118|NCT00568178|469931327|FG003|Double Blind Base Study|Progressive Disease|1|||
130536119|NCT00568178|469931328|FG004|Double Blind Base Study|Progressive Disease|0|||
130536120|NCT00568178|469931329|FG005|Double Blind Base Study|Progressive Disease|0|||
130536121|NCT00568178|469931324|FG000|Open Label Extension|Adverse Event|0|||
130536122|NCT00568178|469931325|FG001|Open Label Extension|Adverse Event|0|||
130536123|NCT00568178|469931326|FG002|Open Label Extension|Adverse Event|0|||
130536124|NCT00568178|469931327|FG003|Open Label Extension|Adverse Event|0|||
130536125|NCT00568178|469931328|FG004|Open Label Extension|Adverse Event|11|||
130536126|NCT00568178|469931329|FG005|Open Label Extension|Adverse Event|8|||
130536127|NCT00568178|469931324|FG000|Open Label Extension|Protocol Violation|0|||
130536128|NCT00568178|469931325|FG001|Open Label Extension|Protocol Violation|0|||
130536129|NCT00568178|469931326|FG002|Open Label Extension|Protocol Violation|0|||
130536130|NCT00568178|469931327|FG003|Open Label Extension|Protocol Violation|0|||
130536131|NCT00568178|469931328|FG004|Open Label Extension|Protocol Violation|1|||
130536132|NCT00568178|469931329|FG005|Open Label Extension|Protocol Violation|0|||
130536133|NCT00568178|469931324|FG000|Open Label Extension|Lost to Follow-up|0|||
130536134|NCT00568178|469931325|FG001|Open Label Extension|Lost to Follow-up|0|||
130536135|NCT00568178|469931326|FG002|Open Label Extension|Lost to Follow-up|0|||
130536136|NCT00568178|469931327|FG003|Open Label Extension|Lost to Follow-up|0|||
130536137|NCT00568178|469931328|FG004|Open Label Extension|Lost to Follow-up|6|||
130536138|NCT00568178|469931329|FG005|Open Label Extension|Lost to Follow-up|11|||
130536139|NCT00568178|469931324|FG000|Open Label Extension|Physician Decision|0|||
130536140|NCT00568178|469931325|FG001|Open Label Extension|Physician Decision|0|||
130536141|NCT00568178|469931326|FG002|Open Label Extension|Physician Decision|0|||
130536142|NCT00568178|469931327|FG003|Open Label Extension|Physician Decision|0|||
130536143|NCT00568178|469931328|FG004|Open Label Extension|Physician Decision|9|||
130536144|NCT00568178|469931329|FG005|Open Label Extension|Physician Decision|8|||
130536145|NCT00568178|469931324|FG000|Open Label Extension|Pregnancy|0|||
130536146|NCT00568178|469931325|FG001|Open Label Extension|Pregnancy|0|||
130536147|NCT00568178|469931326|FG002|Open Label Extension|Pregnancy|0|||
130536148|NCT00568178|469931327|FG003|Open Label Extension|Pregnancy|0|||
130536149|NCT00568178|469931328|FG004|Open Label Extension|Pregnancy|0|||
130536150|NCT00568178|469931329|FG005|Open Label Extension|Pregnancy|1|||
130536151|NCT00568178|469931324|FG000|Open Label Extension|Progressive Disease|0|||
130536152|NCT00568178|469931325|FG001|Open Label Extension|Progressive Disease|0|||
130536153|NCT00568178|469931326|FG002|Open Label Extension|Progressive Disease|0|||
130536154|NCT00568178|469931327|FG003|Open Label Extension|Progressive Disease|0|||
130536155|NCT00568178|469931328|FG004|Open Label Extension|Progressive Disease|3|||
130536156|NCT00568178|469931329|FG005|Open Label Extension|Progressive Disease|1|||
130536157|NCT00568178|469931324|FG000|Open Label Extension|Termination of Trial|0|||
130536158|NCT00568178|469931325|FG001|Open Label Extension|Termination of Trial|0|||
130536159|NCT00568178|469931326|FG002|Open Label Extension|Termination of Trial|0|||
130536160|NCT00568178|469931327|FG003|Open Label Extension|Termination of Trial|0|||
130536161|NCT00568178|469931328|FG004|Open Label Extension|Termination of Trial|45|||
130536162|NCT00568178|469931329|FG005|Open Label Extension|Termination of Trial|47|||
130536163|NCT00568178|469931324|FG000|Open Label Extension|Withdrawal by Subject|0|||
130536164|NCT00568178|469931325|FG001|Open Label Extension|Withdrawal by Subject|0|||
130536165|NCT00568178|469931326|FG002|Open Label Extension|Withdrawal by Subject|0|||
130536166|NCT00568178|469931327|FG003|Open Label Extension|Withdrawal by Subject|0|||
130536167|NCT00568178|469931328|FG004|Open Label Extension|Withdrawal by Subject|4|||
130536168|NCT00568178|469931329|FG005|Open Label Extension|Withdrawal by Subject|4|||
130536169|NCT01531673|469931330|FG000|Overall Study|Non-Compliance|0|||
130536170|NCT01531673|469931331|FG001|Overall Study|Non-Compliance|0|||
130536171|NCT01531673|469931332|FG002|Overall Study|Non-Compliance|0|||
130536172|NCT01531673|469931333|FG003|Overall Study|Non-Compliance|0|||
130536173|NCT01531673|469931334|FG004|Overall Study|Non-Compliance|0|||
130536174|NCT01531673|469931335|FG005|Overall Study|Non-Compliance|1|||
130536175|NCT01531673|469931336|FG006|Overall Study|Non-Compliance|0|||
130536176|NCT01531673|469931337|FG007|Overall Study|Non-Compliance|0|||
130536177|NCT01531673|469931338|FG008|Overall Study|Non-Compliance|0|||
130536178|NCT01531673|469931339|FG009|Overall Study|Non-Compliance|0|||
130536179|NCT01531673|469931340|FG010|Overall Study|Non-Compliance|0|||
130536180|NCT01531673|469931341|FG011|Overall Study|Non-Compliance|0|||
130536181|NCT01531673|469931342|FG012|Overall Study|Non-Compliance|0|||
130536182|NCT01531673|469931330|FG000|Overall Study|Adverse Event|0|||
130536183|NCT01531673|469931331|FG001|Overall Study|Adverse Event|1|||
130583882|NCT02631538|470101078|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
130583883|NCT02631538|470101079|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
130583884|NCT02631538|470101080|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
130583885|NCT00849667|470101084|FG000|Overall Study|Withdrawal by Subject|16|||
130583886|NCT00849667|470101085|FG001|Overall Study|Withdrawal by Subject|33|||
130583887|NCT00849667|470101086|FG002|Overall Study|Withdrawal by Subject|35|||
130583888|NCT00849667|470101084|FG000|Overall Study|Lost to Follow-up|8|||
130583889|NCT00849667|470101085|FG001|Overall Study|Lost to Follow-up|8|||
130583890|NCT00849667|470101086|FG002|Overall Study|Lost to Follow-up|8|||
130583891|NCT00849667|470101084|FG000|Overall Study|Adverse Event|1|||
130583892|NCT00849667|470101085|FG001|Overall Study|Adverse Event|2|||
130583893|NCT00849667|470101086|FG002|Overall Study|Adverse Event|0|||
130583894|NCT00849667|470101084|FG000|Overall Study|Other|18|||
130583895|NCT00849667|470101085|FG001|Overall Study|Other|19|||
130583896|NCT00849667|470101086|FG002|Overall Study|Other|18|||
130583897|NCT00849667|470101084|FG000|Overall Study|Progressive disease|119|||
130583898|NCT00849667|470101085|FG001|Overall Study|Progressive disease|100|||
130583899|NCT00849667|470101086|FG002|Overall Study|Progressive disease|112|||
130583900|NCT00849667|470101084|FG000|Overall Study|Sponsor decision|208|||
130583901|NCT00849667|470101085|FG001|Overall Study|Sponsor decision|204|||
130583902|NCT00849667|470101086|FG002|Overall Study|Sponsor decision|190|||
130583903|NCT00849667|470101084|FG000|Overall Study|Investigator discretion|0|||
130583904|NCT00849667|470101085|FG001|Overall Study|Investigator discretion|0|||
130583905|NCT00849667|470101086|FG002|Overall Study|Investigator discretion|1|||
130583906|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Adverse Event|21|||
130583907|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Adverse Event|6|||
130583908|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
130583909|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
130583910|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
130583911|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
130583912|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
130583913|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
130583914|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Physician Decision|0|||
130583915|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Physician Decision|3|||
130583916|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
130583917|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
130583918|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
130583919|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
130583920|NCT00510276|470101092|FG000|Acute Double-Blind Phase|Subject Decision|26|||
130583921|NCT00510276|470101093|FG001|Acute Double-Blind Phase|Subject Decision|28|||
130583922|NCT00510276|470101092|FG000|Extension Open-Label Phase|Adverse Event|9|||
130583923|NCT00510276|470101093|FG001|Extension Open-Label Phase|Adverse Event|18|||
130583924|NCT00510276|470101092|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
130583925|NCT00510276|470101093|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
130583926|NCT00510276|470101092|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
130583927|NCT00510276|470101093|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
130583928|NCT00510276|470101092|FG000|Extension Open-Label Phase|Physician Decision|2|||
130583929|NCT00510276|470101093|FG001|Extension Open-Label Phase|Physician Decision|3|||
130583930|NCT00510276|470101092|FG000|Extension Open-Label Phase|Protocol Violation|0|||
130583931|NCT00510276|470101093|FG001|Extension Open-Label Phase|Protocol Violation|1|||
130583932|NCT00510276|470101092|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
130583933|NCT00510276|470101093|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
130583934|NCT00510276|470101092|FG000|Extension Open-Label Phase|Subject Decision|7|||
130583935|NCT00510276|470101093|FG001|Extension Open-Label Phase|Subject Decision|9|||
130583936|NCT03486392|470101094|FG000|Overall Study|Lost to Follow-up|0|||
130583937|NCT03486392|470101095|FG001|Overall Study|Lost to Follow-up|0|||
130583938|NCT03486392|470101096|FG002|Overall Study|Lost to Follow-up|8|||
130583939|NCT03486392|470101097|FG003|Overall Study|Lost to Follow-up|5|||
130583940|NCT03486392|470101098|FG004|Overall Study|Lost to Follow-up|2|||
130583941|NCT03486392|470101094|FG000|Overall Study|Withdrawal by Subject|3|||
130583942|NCT03486392|470101095|FG001|Overall Study|Withdrawal by Subject|0|||
130583943|NCT03486392|470101096|FG002|Overall Study|Withdrawal by Subject|6|||
130583944|NCT03486392|470101097|FG003|Overall Study|Withdrawal by Subject|4|||
130583945|NCT03486392|470101098|FG004|Overall Study|Withdrawal by Subject|1|||
130583946|NCT03486392|470101094|FG000|Overall Study|Death|0|||
130583947|NCT03486392|470101095|FG001|Overall Study|Death|0|||
130583948|NCT03486392|470101096|FG002|Overall Study|Death|0|||
130583949|NCT03486392|470101097|FG003|Overall Study|Death|0|||
130583950|NCT03486392|470101098|FG004|Overall Study|Death|1|||
130583951|NCT00441792|470101101|FG000|Overall Study|Lost to Follow-up|0|||
130583952|NCT00441792|470101102|FG001|Overall Study|Lost to Follow-up|2|||
130583953|NCT00888355|470101109|FG000|Overall Study|Adverse Event|10|||
130583954|NCT00888355|470101110|FG001|Overall Study|Adverse Event|0|||
130583955|NCT00888355|470101111|FG002|Overall Study|Adverse Event|3|||
130583956|NCT00888355|470101112|FG003|Overall Study|Adverse Event|3|||
130583957|NCT00888355|470101109|FG000|Overall Study|Lack of Efficacy|9|||
130536184|NCT01531673|469931332|FG002|Overall Study|Adverse Event|0|||
130536185|NCT01531673|469931333|FG003|Overall Study|Adverse Event|0|||
130536186|NCT01531673|469931334|FG004|Overall Study|Adverse Event|0|||
130536187|NCT01531673|469931335|FG005|Overall Study|Adverse Event|0|||
130536188|NCT01531673|469931336|FG006|Overall Study|Adverse Event|0|||
130536189|NCT01531673|469931337|FG007|Overall Study|Adverse Event|0|||
130536190|NCT01531673|469931338|FG008|Overall Study|Adverse Event|0|||
130536191|NCT01531673|469931339|FG009|Overall Study|Adverse Event|0|||
130536192|NCT01531673|469931340|FG010|Overall Study|Adverse Event|0|||
130536193|NCT01531673|469931341|FG011|Overall Study|Adverse Event|0|||
130536194|NCT01531673|469931342|FG012|Overall Study|Adverse Event|0|||
130536195|NCT01531673|469931330|FG000|Overall Study|Lost to Follow-up|0|||
130536196|NCT01531673|469931331|FG001|Overall Study|Lost to Follow-up|0|||
130536197|NCT01531673|469931332|FG002|Overall Study|Lost to Follow-up|0|||
130536198|NCT01531673|469931333|FG003|Overall Study|Lost to Follow-up|0|||
130536199|NCT01531673|469931334|FG004|Overall Study|Lost to Follow-up|1|||
130536200|NCT01531673|469931335|FG005|Overall Study|Lost to Follow-up|0|||
130536201|NCT01531673|469931336|FG006|Overall Study|Lost to Follow-up|0|||
130536202|NCT01531673|469931337|FG007|Overall Study|Lost to Follow-up|0|||
130536203|NCT01531673|469931338|FG008|Overall Study|Lost to Follow-up|0|||
130536204|NCT01531673|469931339|FG009|Overall Study|Lost to Follow-up|0|||
130536205|NCT01531673|469931340|FG010|Overall Study|Lost to Follow-up|0|||
130536206|NCT01531673|469931341|FG011|Overall Study|Lost to Follow-up|0|||
130536207|NCT01531673|469931342|FG012|Overall Study|Lost to Follow-up|0|||
130536208|NCT01531673|469931330|FG000|Overall Study|Other|0|||
130536209|NCT01531673|469931331|FG001|Overall Study|Other|0|||
130536210|NCT01531673|469931332|FG002|Overall Study|Other|0|||
130536211|NCT01531673|469931333|FG003|Overall Study|Other|1|||
130536212|NCT01531673|469931334|FG004|Overall Study|Other|0|||
130536213|NCT01531673|469931335|FG005|Overall Study|Other|0|||
130536214|NCT01531673|469931336|FG006|Overall Study|Other|0|||
130536215|NCT01531673|469931337|FG007|Overall Study|Other|0|||
130536216|NCT01531673|469931338|FG008|Overall Study|Other|0|||
130536217|NCT01531673|469931339|FG009|Overall Study|Other|1|||
130536218|NCT01531673|469931340|FG010|Overall Study|Other|0|||
130536219|NCT01531673|469931341|FG011|Overall Study|Other|0|||
130536220|NCT01531673|469931342|FG012|Overall Study|Other|0|||
130536221|NCT00264303|469931343|FG000|Overall Study|Adverse Event|4|||
130536222|NCT00264303|469931344|FG001|Overall Study|Adverse Event|3|||
130536223|NCT00264303|469931343|FG000|Overall Study|Lack of Efficacy|10|||
130536224|NCT00264303|469931344|FG001|Overall Study|Lack of Efficacy|13|||
130536225|NCT00264303|469931343|FG000|Overall Study|Lost to Follow-up|3|||
130536226|NCT00264303|469931344|FG001|Overall Study|Lost to Follow-up|3|||
130536227|NCT00264303|469931343|FG000|Overall Study|Withdrawal by Subject|2|||
130536228|NCT00264303|469931344|FG001|Overall Study|Withdrawal by Subject|3|||
130536229|NCT00264303|469931343|FG000|Overall Study|Various reasons listed in study report|6|||
130536230|NCT00264303|469931344|FG001|Overall Study|Various reasons listed in study report|7|||
130536231|NCT02815579|469931345|FG000|Overall Study|Non-payment of loan down-payment|16|||
130536232|NCT02815579|469931346|FG001|Overall Study|Non-payment of loan down-payment|0|||
130536233|NCT02815579|469931345|FG000|Overall Study|Withdrawal by Subject|7|||
130536234|NCT02815579|469931346|FG001|Overall Study|Withdrawal by Subject|1|||
130536235|NCT02815579|469931345|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
130536236|NCT02815579|469931346|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
130536237|NCT02815579|469931345|FG000|Overall Study|Lost to Follow-up|7|||
130536238|NCT02815579|469931346|FG001|Overall Study|Lost to Follow-up|4|||
130536239|NCT02815579|469931345|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
130536240|NCT02815579|469931346|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
130536241|NCT02815579|469931345|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
130536242|NCT02815579|469931346|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
130536243|NCT02815579|469931345|FG000|Overall Study|Death|5|||
130536244|NCT02815579|469931346|FG001|Overall Study|Death|4|||
130536245|NCT02815579|469931345|FG000|Overall Study|Imprisoned|0|||
130536246|NCT02815579|469931346|FG001|Overall Study|Imprisoned|2|||
130536247|NCT02815579|469931345|FG000|Overall Study|Did not meet enrollment criteria|0|||
130536248|NCT02815579|469931346|FG001|Overall Study|Did not meet enrollment criteria|1|||
130536249|NCT02389452|469931347|FG000|Overall Study|Lost to Follow-up|13|||
130536250|NCT02389452|469931347|FG000|Overall Study|Adverse Event|1|||
130536251|NCT02389452|469931347|FG000|Overall Study|Withdrawal by Subject|5|||
130536252|NCT02389452|469931347|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
130536253|NCT02311673|469931348|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
130536254|NCT02311673|469931349|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
130536255|NCT02311673|469931350|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
130536256|NCT02311673|469931351|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
130536257|NCT00414908|469931362|FG000|Overall Study|Protocol Violation|1|||
130536258|NCT00414908|469931363|FG001|Overall Study|Protocol Violation|1|||
130536259|NCT01076153|469931364|FG000|Overall Study|Symptoms improved/resolved|10|||
130583958|NCT00888355|470101110|FG001|Overall Study|Lack of Efficacy|2|||
130583959|NCT00888355|470101111|FG002|Overall Study|Lack of Efficacy|5|||
130583960|NCT00888355|470101112|FG003|Overall Study|Lack of Efficacy|2|||
130583961|NCT00888355|470101109|FG000|Overall Study|Lost to Follow-up|0|||
130583962|NCT00888355|470101110|FG001|Overall Study|Lost to Follow-up|2|||
130583963|NCT00888355|470101111|FG002|Overall Study|Lost to Follow-up|2|||
130583964|NCT00888355|470101112|FG003|Overall Study|Lost to Follow-up|0|||
130583965|NCT00888355|470101109|FG000|Overall Study|Protocol Violation|3|||
130583966|NCT00888355|470101110|FG001|Overall Study|Protocol Violation|2|||
130583967|NCT00888355|470101111|FG002|Overall Study|Protocol Violation|1|||
130583968|NCT00888355|470101112|FG003|Overall Study|Protocol Violation|2|||
130583969|NCT00888355|470101109|FG000|Overall Study|Withdrawal by Subject|0|||
130583970|NCT00888355|470101110|FG001|Overall Study|Withdrawal by Subject|3|||
130583971|NCT00888355|470101111|FG002|Overall Study|Withdrawal by Subject|1|||
130583972|NCT00888355|470101112|FG003|Overall Study|Withdrawal by Subject|3|||
130583973|NCT01551693|470101114|FG000|Overall Study|Disease Progression|1|||
130583974|NCT01551693|470101115|FG001|Overall Study|Disease Progression|0|||
130583975|NCT01551693|470101114|FG000|Overall Study|Adverse Event|0|||
130583976|NCT01551693|470101115|FG001|Overall Study|Adverse Event|1|||
130583977|NCT01551693|470101114|FG000|Overall Study|Withdrawal by Subject|0|||
130536260|NCT01076153|469931364|FG000|Overall Study|Adverse Event|1|||
130536261|NCT00818168|469931365|FG000|Overall Study|Lack of Efficacy|18|||
130536262|NCT00818168|469931365|FG000|Overall Study|Pregnancy|2|||
130536263|NCT00818168|469931365|FG000|Overall Study|Withdrawal by Subject|16|||
130536264|NCT00818168|469931365|FG000|Overall Study|Lost to Follow-up|7|||
130536265|NCT00818168|469931365|FG000|Overall Study|Adverse Event|19|||
130536266|NCT00818168|469931365|FG000|Overall Study|Reason for Non-completion Not reported|6|||
130536267|NCT00818168|469931365|FG000|Overall Study|Participant Moved|2|||
130536268|NCT02040259|469931368|FG000|Overall Study|Death|280|||
130536269|NCT02040259|469931368|FG000|Overall Study|Lost to Follow-up|76|||
130536270|NCT02040259|469931368|FG000|Overall Study|Assessment not completed|3|||
130536271|NCT02040259|469931368|FG000|Overall Study|Withdrawal by Subject|4|||
130536272|NCT04476251|469931369|FG000|Overall Study|Not treated|1|||
130536273|NCT00316602|469931380|FG000|Overall Study|Withdrawal by Subject|3|||
130536274|NCT00316602|469931381|FG001|Overall Study|Withdrawal by Subject|2|||
130536275|NCT00316602|469931380|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
130536276|NCT00316602|469931381|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
130536277|NCT00316602|469931380|FG000|Overall Study|Adverse Event|1|||
130536278|NCT00316602|469931381|FG001|Overall Study|Adverse Event|0|||
130536279|NCT00316602|469931380|FG000|Overall Study|Other|3|||
130536280|NCT00316602|469931381|FG001|Overall Study|Other|6|||
130536281|NCT01142232|469931382|FG000|Overall Study|Adverse Event|1|||
130536282|NCT01142232|469931383|FG001|Overall Study|Adverse Event|2|||
130536283|NCT01142232|469931384|FG002|Overall Study|Adverse Event|1|||
130536284|NCT01142232|469931385|FG003|Overall Study|Adverse Event|0|||
130536285|NCT01142232|469931386|FG004|Overall Study|Adverse Event|4|||
130536286|NCT01142232|469931382|FG000|Overall Study|Death|0|||
130536287|NCT01142232|469931383|FG001|Overall Study|Death|0|||
130536288|NCT01142232|469931384|FG002|Overall Study|Death|0|||
130536289|NCT01142232|469931385|FG003|Overall Study|Death|0|||
130536290|NCT01142232|469931386|FG004|Overall Study|Death|1|||
130536291|NCT01142232|469931382|FG000|Overall Study|Disease Progression|2|||
130536292|NCT01142232|469931383|FG001|Overall Study|Disease Progression|0|||
130536293|NCT01142232|469931384|FG002|Overall Study|Disease Progression|1|||
130536294|NCT01142232|469931385|FG003|Overall Study|Disease Progression|2|||
130536295|NCT01142232|469931386|FG004|Overall Study|Disease Progression|12|||
130536296|NCT01142232|469931382|FG000|Overall Study|Withdrawal by Subject|0|||
130536297|NCT01142232|469931383|FG001|Overall Study|Withdrawal by Subject|0|||
130536298|NCT01142232|469931384|FG002|Overall Study|Withdrawal by Subject|0|||
130536299|NCT01142232|469931385|FG003|Overall Study|Withdrawal by Subject|1|||
130536300|NCT01142232|469931386|FG004|Overall Study|Withdrawal by Subject|3|||
130536301|NCT01142232|469931382|FG000|Overall Study|Physician Decision|0|||
130536302|NCT01142232|469931383|FG001|Overall Study|Physician Decision|1|||
130536303|NCT01142232|469931384|FG002|Overall Study|Physician Decision|0|||
130583978|NCT01551693|470101115|FG001|Overall Study|Withdrawal by Subject|1|||
130583979|NCT00130286|470101116|FG000|Overall Study|Withdrawal by Subject|0|||
130583980|NCT00130286|470101117|FG001|Overall Study|Withdrawal by Subject|1|||
130583981|NCT00130286|470101118|FG002|Overall Study|Withdrawal by Subject|2|||
130536304|NCT01142232|469931385|FG003|Overall Study|Physician Decision|2|||
130583982|NCT00130286|470101119|FG003|Overall Study|Withdrawal by Subject|2|||
130583983|NCT00130286|470101116|FG000|Overall Study|Adverse Event|0|||
130583984|NCT00130286|470101117|FG001|Overall Study|Adverse Event|0|||
130583985|NCT00130286|470101118|FG002|Overall Study|Adverse Event|2|||
130583986|NCT00130286|470101119|FG003|Overall Study|Adverse Event|0|||
130583987|NCT00130286|470101116|FG000|Overall Study|Missing lab specimens|0|||
130583988|NCT00130286|470101117|FG001|Overall Study|Missing lab specimens|2|||
130583989|NCT00130286|470101118|FG002|Overall Study|Missing lab specimens|0|||
130583990|NCT00130286|470101119|FG003|Overall Study|Missing lab specimens|0|||
130536305|NCT01142232|469931386|FG004|Overall Study|Physician Decision|10|||
130536306|NCT01142232|469931382|FG000|Overall Study|Alternative Therapy|0|||
130536307|NCT01142232|469931383|FG001|Overall Study|Alternative Therapy|1|||
130536308|NCT01142232|469931384|FG002|Overall Study|Alternative Therapy|1|||
130536309|NCT01142232|469931385|FG003|Overall Study|Alternative Therapy|0|||
130536310|NCT01142232|469931386|FG004|Overall Study|Alternative Therapy|1|||
130536311|NCT01142232|469931382|FG000|Overall Study|Off Trt for other complicating disease|0|||
130536312|NCT01142232|469931383|FG001|Overall Study|Off Trt for other complicating disease|0|||
130536313|NCT01142232|469931384|FG002|Overall Study|Off Trt for other complicating disease|0|||
130536314|NCT01142232|469931385|FG003|Overall Study|Off Trt for other complicating disease|0|||
130536315|NCT01142232|469931386|FG004|Overall Study|Off Trt for other complicating disease|1|||
130536316|NCT01142232|469931382|FG000|Overall Study|Noncompliance|0|||
130536317|NCT01142232|469931383|FG001|Overall Study|Noncompliance|0|||
130536318|NCT01142232|469931384|FG002|Overall Study|Noncompliance|0|||
130536319|NCT01142232|469931385|FG003|Overall Study|Noncompliance|0|||
130536320|NCT01142232|469931386|FG004|Overall Study|Noncompliance|2|||
130536321|NCT00626990|469931389|FG000|Overall Study|Lack of Efficacy|6|||
130536322|NCT00626990|469931390|FG001|Overall Study|Lack of Efficacy|7|||
130536323|NCT00626990|469931391|FG002|Overall Study|Lack of Efficacy|49|||
130536324|NCT00626990|469931392|FG003|Overall Study|Lack of Efficacy|40|||
130536325|NCT00626990|469931389|FG000|Overall Study|Adverse Event|1|||
130536326|NCT00626990|469931390|FG001|Overall Study|Adverse Event|7|||
130536327|NCT00626990|469931391|FG002|Overall Study|Adverse Event|14|||
130536328|NCT00626990|469931392|FG003|Overall Study|Adverse Event|28|||
130536329|NCT00626990|469931389|FG000|Overall Study|Death|0|||
130536330|NCT00626990|469931390|FG001|Overall Study|Death|1|||
130536331|NCT00626990|469931391|FG002|Overall Study|Death|0|||
130536332|NCT00626990|469931392|FG003|Overall Study|Death|0|||
130536333|NCT00626990|469931389|FG000|Overall Study|Withdrawal by Subject|3|||
130536334|NCT00626990|469931390|FG001|Overall Study|Withdrawal by Subject|1|||
130536335|NCT00626990|469931391|FG002|Overall Study|Withdrawal by Subject|5|||
130536336|NCT00626990|469931392|FG003|Overall Study|Withdrawal by Subject|11|||
130536337|NCT00626990|469931389|FG000|Overall Study|Protocol Violation|0|||
130536338|NCT00626990|469931390|FG001|Overall Study|Protocol Violation|1|||
130536339|NCT00626990|469931391|FG002|Overall Study|Protocol Violation|1|||
130536340|NCT00626990|469931392|FG003|Overall Study|Protocol Violation|0|||
130536341|NCT00626990|469931389|FG000|Overall Study|Various different reasons/missing|4|||
130536342|NCT00626990|469931390|FG001|Overall Study|Various different reasons/missing|8|||
130536343|NCT00626990|469931391|FG002|Overall Study|Various different reasons/missing|8|||
130536344|NCT00626990|469931392|FG003|Overall Study|Various different reasons/missing|16|||
130536345|NCT04138576|469931397|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
130536346|NCT00297427|469931398|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
130536347|NCT00297427|469931399|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
130536348|NCT00297427|469931398|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
130536349|NCT00297427|469931399|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
130536350|NCT00297427|469931398|FG000|Phase 1: Initial Intervention|Death|0|||
130536351|NCT00297427|469931399|FG001|Phase 1: Initial Intervention|Death|1|||
130536352|NCT00297427|469931398|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
130536353|NCT00297427|469931399|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
130536354|NCT00297427|469931398|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
130536355|NCT00297427|469931399|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
130536356|NCT00297427|469931398|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
130536357|NCT00297427|469931399|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
130536358|NCT00297427|469931398|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
130536359|NCT00297427|469931399|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
130536360|NCT00297427|469931398|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
130536361|NCT00297427|469931399|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
130536362|NCT02787044|469931402|FG000|Overall Study|Lost to Follow-up|15|||
130536363|NCT02787044|469931403|FG001|Overall Study|Lost to Follow-up|19|||
130536364|NCT02591953|469931405|FG000|Overall Study|Lost to Follow-up|6|||
130536365|NCT02591953|469931406|FG001|Overall Study|Lost to Follow-up|6|||
130536366|NCT01517295|469931409|FG000|Overall Study|Physician Decision|1|||
130536367|NCT01517295|469931410|FG001|Overall Study|Physician Decision|0|||
130536368|NCT02182947|469931411|FG000|Overall Study|Withdrawal by Subject|7|||
130536369|NCT02182947|469931411|FG000|Overall Study|Lost to Follow-up|3|||
130536370|NCT02182947|469931411|FG000|Overall Study|Failed screening activities|8|||
130536371|NCT01656200|469931412|FG000|Overall Study|Withdrawal by Subject|1|||
130536372|NCT04155047|469931418|FG000|Overall Study|Adverse Event|1|||
130536373|NCT04155047|469931419|FG001|Overall Study|Adverse Event|0|||
130536374|NCT04155047|469931418|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
130536375|NCT04155047|469931419|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
130536376|NCT03361605|469931422|FG000|Overall Study|Analyzable data not available|3|||
130536377|NCT02003222|469931429|FG000|Induction|Never started treatment|0|||
130583991|NCT02154425|470101124|FG000|Screening Period|Adverse Event|1|||
130583992|NCT02908516|470101131|FG000|Overall Study|Study Terminated|3|||
130583993|NCT02908516|470101132|FG001|Overall Study|Study Terminated|3|||
130583994|NCT00565617|470101135|FG000|Overall Study|Withdrawal by Subject|1|||
130583995|NCT01078805|470101138|FG000|Overall Study|Clinically significant abnormal lab|5|||
130583996|NCT01078805|470101138|FG000|Overall Study|Death|134|||
130583997|NCT01078805|470101138|FG000|Overall Study|Lost to Follow-up|676|||
130583998|NCT01078805|470101138|FG000|Overall Study|Physician Decision|169|||
130583999|NCT01078805|470101138|FG000|Overall Study|Serious adverse event|26|||
130584000|NCT01078805|470101138|FG000|Overall Study|Sponsor decision|46|||
130584001|NCT01078805|470101138|FG000|Overall Study|Withdrawal by Subject|739|||
130584002|NCT01078805|470101138|FG000|Overall Study|Other|173|||
130584003|NCT01078805|470101138|FG000|Overall Study|Didn't take study drug|82|||
130584004|NCT01609842|470101139|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
130584005|NCT01609842|470101140|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
130584006|NCT02474329|470101148|FG000|Overall Study|Withdraw or did not contribute data.|13|||
130584007|NCT00880750|470102466|FG000|First Intervention|Adverse Event|1|||
130584008|NCT00880750|470102467|FG001|First Intervention|Adverse Event|0|||
130584009|NCT00880750|470102466|FG000|First Intervention|Unable to collect urine|4|||
130584010|NCT00880750|470102467|FG001|First Intervention|Unable to collect urine|0|||
130584011|NCT00880750|470102466|FG000|First Intervention|Non-compliance with meals|0|||
130584012|NCT00880750|470102467|FG001|First Intervention|Non-compliance with meals|1|||
130584013|NCT00880750|470102466|FG000|First Intervention|Withdrawal by Subject|2|||
130584014|NCT00880750|470102467|FG001|First Intervention|Withdrawal by Subject|0|||
130584015|NCT00880750|470102466|FG000|First Intervention|Lost to Follow-up|2|||
130584016|NCT00880750|470102467|FG001|First Intervention|Lost to Follow-up|0|||
130584017|NCT00880750|470102466|FG000|Second Intervention|Withdrawal by Subject|2|||
130584018|NCT00880750|470102467|FG001|Second Intervention|Withdrawal by Subject|2|||
130584019|NCT00880750|470102466|FG000|Second Intervention|Protocol Violation|1|||
130584020|NCT00880750|470102467|FG001|Second Intervention|Protocol Violation|0|||
130584021|NCT00880750|470102466|FG000|Second Intervention|Unable to collect urine|1|||
130584022|NCT00880750|470102467|FG001|Second Intervention|Unable to collect urine|0|||
130584023|NCT00483327|470102471|FG000|Overall Study|Adverse Event|1|||
130584024|NCT00483327|470102471|FG000|Overall Study|Withdrawal by Subject|3|||
130584025|NCT00483327|470102471|FG000|Overall Study|Lost to Follow-up|4|||
130584026|NCT00483327|470102471|FG000|Overall Study|Patient Non Compliance|2|||
130584027|NCT00670007|470102472|FG000|Overall Study|Drug abuse|1|||
130584028|NCT00670007|470102472|FG000|Overall Study|Lung transplant|1|||
130584029|NCT00670007|470102472|FG000|Overall Study|Travel/Vacation|1|||
130584030|NCT00670007|470102472|FG000|Overall Study|Adverse event, serious fatal|1|||
130584031|NCT00670007|470102472|FG000|Overall Study|Adverse Event|1|||
130584032|NCT00670007|470102472|FG000|Overall Study|Withdrawal by Subject|4|||
130584033|NCT00618722|470102473|FG000|Overall Study|Refusal of Treatment|0|||
130584034|NCT00618722|470102474|FG001|Overall Study|Refusal of Treatment|0|||
130584035|NCT00618722|470102475|FG002|Overall Study|Refusal of Treatment|1|||
130584036|NCT00618722|470102476|FG003|Overall Study|Refusal of Treatment|0|||
130584037|NCT00618722|470102473|FG000|Overall Study|Patient Request|1|||
130584038|NCT00618722|470102474|FG001|Overall Study|Patient Request|1|||
130584039|NCT00618722|470102475|FG002|Overall Study|Patient Request|1|||
130584040|NCT00618722|470102476|FG003|Overall Study|Patient Request|1|||
130584041|NCT00618722|470102473|FG000|Overall Study|Inability to Complete Study Procedure|0|||
130584042|NCT00618722|470102474|FG001|Overall Study|Inability to Complete Study Procedure|1|||
130584043|NCT00618722|470102475|FG002|Overall Study|Inability to Complete Study Procedure|0|||
130584044|NCT00618722|470102476|FG003|Overall Study|Inability to Complete Study Procedure|0|||
130584045|NCT00618722|470102473|FG000|Overall Study|Lost to Follow-up|2|||
130584046|NCT00618722|470102474|FG001|Overall Study|Lost to Follow-up|0|||
130584047|NCT00618722|470102475|FG002|Overall Study|Lost to Follow-up|0|||
130584048|NCT00618722|470102476|FG003|Overall Study|Lost to Follow-up|2|||
130584049|NCT00618722|470102473|FG000|Overall Study|Miscellaneous Reasons|0|||
130584050|NCT00618722|470102474|FG001|Overall Study|Miscellaneous Reasons|0|||
130584051|NCT00618722|470102475|FG002|Overall Study|Miscellaneous Reasons|1|||
130584052|NCT00618722|470102476|FG003|Overall Study|Miscellaneous Reasons|1|||
130584053|NCT00200057|470102479|FG000|Overall Study|Lack of Efficacy|3|||
130584054|NCT00200057|470102479|FG000|Overall Study|Exited due to terminal illness of PI|2|||
130584055|NCT00200057|470102479|FG000|Overall Study|Withdrawal by Subject|1|||
130584056|NCT00200057|470102479|FG000|Overall Study|Change in medical condition|1|||
130584057|NCT00200057|470102479|FG000|Overall Study|Infection|1|||
130584058|NCT00200057|470102479|FG000|Overall Study|Death|1|||
130584059|NCT00778830|470102480|FG000|Overall Study|Ongoing at data cut-off|0|||
130584060|NCT00778830|470102481|FG001|Overall Study|Ongoing at data cut-off|1|||
130584061|NCT00132041|470102484|FG000|Baseline|Ineligible|6|||
130584062|NCT00132041|470102484|FG000|3 Months Post Ablation|Transplant|1|||
130584063|NCT00132041|470102484|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
130584064|NCT00132041|470102484|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
130584065|NCT00132041|470102484|FG000|6 Months Post Ablation|Death|2|||
130584066|NCT00132041|470102484|FG000|6 Months Post Ablation|Transplant|6|||
130536378|NCT02003222|469931430|FG001|Induction|Never started treatment|0|||
130536379|NCT02003222|469931431|FG002|Induction|Never started treatment|0|||
130536380|NCT02003222|469931432|FG003|Induction|Never started treatment|0|||
130536381|NCT02003222|469931433|FG004|Induction|Never started treatment|8|||
130536382|NCT02003222|469931429|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
130536383|NCT02003222|469931430|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
130536384|NCT02003222|469931431|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
130536385|NCT02003222|469931432|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
130536386|NCT02003222|469931433|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
130536387|NCT02003222|469931429|FG000|Induction|Adverse Event|0|||
130536388|NCT02003222|469931430|FG001|Induction|Adverse Event|0|||
130536389|NCT02003222|469931431|FG002|Induction|Adverse Event|0|||
130536390|NCT02003222|469931432|FG003|Induction|Adverse Event|0|||
130536391|NCT02003222|469931433|FG004|Induction|Adverse Event|13|||
130536392|NCT02003222|469931429|FG000|Induction|Alternative therapy|0|||
130536393|NCT02003222|469931430|FG001|Induction|Alternative therapy|0|||
130584067|NCT00132041|470102484|FG000|9 Months Post Ablation|Death|1|||
130584068|NCT00132041|470102484|FG000|9 Months Post Ablation|Transplant|1|||
130584069|NCT00132041|470102484|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
130584070|NCT00132041|470102484|FG000|12 Months Post Ablation|Death|1|||
130584071|NCT00132041|470102484|FG000|12 Months Post Ablation|Transplant|1|||
130584072|NCT00132041|470102484|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
130584073|NCT00132041|470102484|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
130584074|NCT00132041|470102484|FG000|15 Months Post Ablation|Death|1|||
130584075|NCT00132041|470102484|FG000|15 Months Post Ablation|Transplant|5|||
130584076|NCT00132041|470102484|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
130584077|NCT00132041|470102484|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
130584078|NCT00132041|470102484|FG000|18 Months Post Ablation|Transplant|1|||
130584079|NCT00132041|470102484|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
130584080|NCT00132041|470102484|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
130584081|NCT03609619|470102486|FG000|Overall Study|Adverse Event|1|||
130584082|NCT03609619|470102487|FG001|Overall Study|Adverse Event|0|||
130584083|NCT03609619|470102486|FG000|Overall Study|Lack of Efficacy|1|||
130584084|NCT03609619|470102487|FG001|Overall Study|Lack of Efficacy|2|||
130584085|NCT03609619|470102486|FG000|Overall Study|Protocol Violation|5|||
130584086|NCT03609619|470102487|FG001|Overall Study|Protocol Violation|0|||
130584087|NCT03609619|470102486|FG000|Overall Study|Withdrawal by Subject|2|||
130536394|NCT02003222|469931431|FG002|Induction|Alternative therapy|0|||
130536395|NCT02003222|469931432|FG003|Induction|Alternative therapy|0|||
130584088|NCT03609619|470102487|FG001|Overall Study|Withdrawal by Subject|3|||
130584089|NCT03609619|470102486|FG000|Overall Study|Lost to Follow-up|1|||
130584090|NCT03609619|470102487|FG001|Overall Study|Lost to Follow-up|1|||
130584091|NCT00956943|470102488|FG000|Overall Study|Lost to Follow-up|9|||
130584092|NCT00956943|470102489|FG001|Overall Study|Lost to Follow-up|10|||
130536396|NCT02003222|469931433|FG004|Induction|Alternative therapy|12|||
130536397|NCT02003222|469931429|FG000|Induction|Disease progression|0|||
130536398|NCT02003222|469931430|FG001|Induction|Disease progression|0|||
130584093|NCT02663895|470102490|FG000|Overall Study|Adverse Event|3|||
130584094|NCT02663895|470102490|FG000|Overall Study|Physician Decision|2|||
130584095|NCT02663895|470102490|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
130584096|NCT02663895|470102490|FG000|Overall Study|Withdrawal by Subject|1|||
130584097|NCT02911688|470102494|FG000|Washout|Lost to Follow-up|1|||
130584098|NCT02911688|470102495|FG001|Washout|Lost to Follow-up|1|||
130584099|NCT02911688|470102494|FG000|Washout|Withdrawal by Subject|0|||
130584100|NCT02911688|470102495|FG001|Washout|Withdrawal by Subject|1|||
130536399|NCT02003222|469931431|FG002|Induction|Disease progression|0|||
130536400|NCT02003222|469931432|FG003|Induction|Disease progression|0|||
130536401|NCT02003222|469931433|FG004|Induction|Disease progression|22|||
130536402|NCT02003222|469931429|FG000|Induction|Death|0|||
130536403|NCT02003222|469931430|FG001|Induction|Death|0|||
130536404|NCT02003222|469931431|FG002|Induction|Death|0|||
130536405|NCT02003222|469931432|FG003|Induction|Death|0|||
130536406|NCT02003222|469931433|FG004|Induction|Death|3|||
130536407|NCT02003222|469931429|FG000|Induction|Withdrawal by Subject|0|||
130536408|NCT02003222|469931430|FG001|Induction|Withdrawal by Subject|0|||
130536409|NCT02003222|469931431|FG002|Induction|Withdrawal by Subject|0|||
130536410|NCT02003222|469931432|FG003|Induction|Withdrawal by Subject|0|||
130536411|NCT02003222|469931433|FG004|Induction|Withdrawal by Subject|8|||
130536412|NCT02003222|469931429|FG000|Induction|Other reasons|0|||
130536413|NCT02003222|469931430|FG001|Induction|Other reasons|0|||
130536414|NCT02003222|469931431|FG002|Induction|Other reasons|0|||
130536415|NCT02003222|469931432|FG003|Induction|Other reasons|0|||
130536416|NCT02003222|469931433|FG004|Induction|Other reasons|22|||
130536417|NCT02003222|469931429|FG000|Intensification|Never started treatment|0|||
130536418|NCT02003222|469931430|FG001|Intensification|Never started treatment|0|||
130536419|NCT02003222|469931431|FG002|Intensification|Never started treatment|0|||
130536420|NCT02003222|469931432|FG003|Intensification|Never started treatment|0|||
130536421|NCT02003222|469931433|FG004|Intensification|Never started treatment|2|||
130536422|NCT02003222|469931429|FG000|Intensification|Adverse Event|0|||
130536423|NCT02003222|469931430|FG001|Intensification|Adverse Event|0|||
130536424|NCT02003222|469931431|FG002|Intensification|Adverse Event|0|||
130536425|NCT02003222|469931432|FG003|Intensification|Adverse Event|0|||
130536426|NCT02003222|469931433|FG004|Intensification|Adverse Event|6|||
130536427|NCT02003222|469931429|FG000|Intensification|Alternative therapy|0|||
130536428|NCT02003222|469931430|FG001|Intensification|Alternative therapy|0|||
130536429|NCT02003222|469931431|FG002|Intensification|Alternative therapy|0|||
130536430|NCT02003222|469931432|FG003|Intensification|Alternative therapy|0|||
130536431|NCT02003222|469931433|FG004|Intensification|Alternative therapy|8|||
130536432|NCT02003222|469931429|FG000|Intensification|Disease progression|0|||
130536433|NCT02003222|469931430|FG001|Intensification|Disease progression|0|||
130536434|NCT02003222|469931431|FG002|Intensification|Disease progression|0|||
130536435|NCT02003222|469931432|FG003|Intensification|Disease progression|0|||
130536436|NCT02003222|469931433|FG004|Intensification|Disease progression|18|||
130536437|NCT02003222|469931429|FG000|Intensification|Withdrawal by Subject|0|||
130536438|NCT02003222|469931430|FG001|Intensification|Withdrawal by Subject|0|||
130536439|NCT02003222|469931431|FG002|Intensification|Withdrawal by Subject|0|||
130536440|NCT02003222|469931432|FG003|Intensification|Withdrawal by Subject|0|||
130536441|NCT02003222|469931433|FG004|Intensification|Withdrawal by Subject|5|||
130536442|NCT02003222|469931429|FG000|Intensification|Other reasons|0|||
130536443|NCT02003222|469931430|FG001|Intensification|Other reasons|0|||
130536444|NCT02003222|469931431|FG002|Intensification|Other reasons|0|||
130536445|NCT02003222|469931432|FG003|Intensification|Other reasons|0|||
130536446|NCT02003222|469931433|FG004|Intensification|Other reasons|8|||
130536447|NCT01365481|469931434|FG000|Overall Study|Adverse Event|6|||
130536448|NCT01365481|469931435|FG001|Overall Study|Adverse Event|9|||
130536449|NCT01365481|469931436|FG002|Overall Study|Adverse Event|0|||
130536450|NCT01365481|469931437|FG003|Overall Study|Adverse Event|2|||
130536451|NCT01365481|469931434|FG000|Overall Study|Withdrawal by Subject|0|||
130536452|NCT01365481|469931435|FG001|Overall Study|Withdrawal by Subject|2|||
130536453|NCT01365481|469931436|FG002|Overall Study|Withdrawal by Subject|1|||
130536454|NCT01365481|469931437|FG003|Overall Study|Withdrawal by Subject|1|||
130536455|NCT01365481|469931434|FG000|Overall Study|Lost to Follow-up|1|||
130536456|NCT01365481|469931435|FG001|Overall Study|Lost to Follow-up|1|||
130536457|NCT01365481|469931436|FG002|Overall Study|Lost to Follow-up|2|||
130536458|NCT01365481|469931437|FG003|Overall Study|Lost to Follow-up|3|||
130536459|NCT01365481|469931434|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130536460|NCT01365481|469931435|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130536461|NCT01365481|469931436|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130536462|NCT01365481|469931437|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130536463|NCT01365481|469931434|FG000|Overall Study|Administrative problems|0|||
130536464|NCT01365481|469931435|FG001|Overall Study|Administrative problems|1|||
130536465|NCT01365481|469931436|FG002|Overall Study|Administrative problems|0|||
130536466|NCT01365481|469931437|FG003|Overall Study|Administrative problems|0|||
130536467|NCT01365481|469931434|FG000|Overall Study|Protocol deviation|0|||
130536468|NCT01365481|469931435|FG001|Overall Study|Protocol deviation|1|||
130536469|NCT01365481|469931436|FG002|Overall Study|Protocol deviation|0|||
130536470|NCT01365481|469931437|FG003|Overall Study|Protocol deviation|1|||
130536471|NCT01365481|469931434|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130536472|NCT01365481|469931435|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130536473|NCT01365481|469931436|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130536474|NCT01365481|469931437|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130536475|NCT00403767|469931442|FG000|Overall Study|Adverse Event|993|||
130536476|NCT00403767|469931443|FG001|Overall Study|Adverse Event|919|||
130536477|NCT00403767|469931442|FG000|Overall Study|Non-compliant with study medication|134|||
130536478|NCT00403767|469931443|FG001|Overall Study|Non-compliant with study medication|164|||
130536479|NCT00403767|469931442|FG000|Overall Study|Consent withdrawn|671|||
130536480|NCT00403767|469931443|FG001|Overall Study|Consent withdrawn|673|||
130536481|NCT00403767|469931442|FG000|Overall Study|Investigator dec./not protocol-related|191|||
130536482|NCT00403767|469931443|FG001|Overall Study|Investigator dec./not protocol-related|178|||
130536483|NCT00403767|469931442|FG000|Overall Study|Lost to Follow-up|6|||
130536484|NCT00403767|469931443|FG001|Overall Study|Lost to Follow-up|8|||
130536485|NCT00403767|469931442|FG000|Overall Study|Protocol Violation|142|||
130536486|NCT00403767|469931443|FG001|Overall Study|Protocol Violation|124|||
130536487|NCT00403767|469931442|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
130536488|NCT00403767|469931443|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
130536489|NCT00403767|469931442|FG000|Overall Study|Study terminated by sponsor|82|||
130536490|NCT00403767|469931443|FG001|Overall Study|Study terminated by sponsor|69|||
130536491|NCT00403767|469931442|FG000|Overall Study|Missing/incomplete data|1|||
130536492|NCT00403767|469931443|FG001|Overall Study|Missing/incomplete data|1|||
130536493|NCT01696955|469931444|FG000|Main Study|Protocol Violation|1|||
130536494|NCT01696955|469931445|FG001|Main Study|Protocol Violation|0|||
130536495|NCT01696955|469931444|FG000|Main Study|Withdrawal by Subject|1|||
130536496|NCT01696955|469931445|FG001|Main Study|Withdrawal by Subject|1|||
130536497|NCT03192475|469931446|FG000|Overall Study|Death|0|||
130536498|NCT03192475|469931447|FG001|Overall Study|Death|1|||
130536499|NCT03192475|469931446|FG000|Overall Study|Lost to Follow-up|13|||
130536500|NCT03192475|469931447|FG001|Overall Study|Lost to Follow-up|8|||
130536501|NCT01641159|469931448|FG000|Overall Study|Lost to Follow-up|2|||
130536502|NCT01641159|469931449|FG001|Overall Study|Lost to Follow-up|1|||
130536503|NCT01641159|469931448|FG000|Overall Study|Withdrawal by Subject|0|||
130536504|NCT01641159|469931449|FG001|Overall Study|Withdrawal by Subject|1|||
130536505|NCT00831129|469931453|FG000|Overall Study|Adverse Event|0|||
130536506|NCT00831129|469931454|FG001|Overall Study|Adverse Event|1|||
130536507|NCT00831129|469931453|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
130536508|NCT00831129|469931454|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
130536509|NCT01283516|469931455|FG000|Overall Study|Adverse Event|0|||
130536510|NCT01283516|469931456|FG001|Overall Study|Adverse Event|0|||
130536511|NCT01283516|469931457|FG002|Overall Study|Adverse Event|0|||
130536512|NCT01283516|469931458|FG003|Overall Study|Adverse Event|0|||
130536513|NCT01283516|469931459|FG004|Overall Study|Adverse Event|0|||
130536514|NCT01283516|469931460|FG005|Overall Study|Adverse Event|0|||
130536515|NCT01283516|469931461|FG006|Overall Study|Adverse Event|2|||
130536516|NCT01283516|469931462|FG007|Overall Study|Adverse Event|0|||
130536517|NCT01283516|469931463|FG008|Overall Study|Adverse Event|28|||
130536518|NCT01283516|469931455|FG000|Overall Study|Death|0|||
130536519|NCT01283516|469931456|FG001|Overall Study|Death|0|||
130536520|NCT01283516|469931457|FG002|Overall Study|Death|0|||
130536521|NCT01283516|469931458|FG003|Overall Study|Death|0|||
130536522|NCT01283516|469931459|FG004|Overall Study|Death|0|||
130536523|NCT01283516|469931460|FG005|Overall Study|Death|1|||
130584101|NCT02327260|470102496|FG000|Overall Study|Lost to Follow-up|2|||
130584102|NCT02327260|470102497|FG001|Overall Study|Lost to Follow-up|3|||
130584103|NCT02327260|470102498|FG002|Overall Study|Lost to Follow-up|2|||
130584104|NCT02327260|470102496|FG000|Overall Study|invalid phone number|1|||
130584105|NCT02327260|470102497|FG001|Overall Study|invalid phone number|1|||
130584106|NCT02327260|470102498|FG002|Overall Study|invalid phone number|0|||
130584107|NCT02327260|470102496|FG000|Overall Study|non-adherence to protocol|2|||
130584108|NCT02327260|470102497|FG001|Overall Study|non-adherence to protocol|0|||
130584109|NCT02327260|470102498|FG002|Overall Study|non-adherence to protocol|0|||
130584110|NCT02327260|470102496|FG000|Overall Study|cognitive concerns|1|||
130584111|NCT02327260|470102497|FG001|Overall Study|cognitive concerns|0|||
130584112|NCT02327260|470102498|FG002|Overall Study|cognitive concerns|0|||
130584113|NCT01748071|470102499|FG000|Overall Study|Adverse Event|2|||
130584114|NCT01748071|470102500|FG001|Overall Study|Adverse Event|2|||
130584115|NCT01748071|470102501|FG002|Overall Study|Adverse Event|0|||
130584116|NCT02720757|470102502|FG000|Overall Study|Other reason|5|||
130584117|NCT02720757|470102502|FG000|Overall Study|Loss of contact|4|||
130536524|NCT01283516|469931461|FG006|Overall Study|Death|0|||
130536525|NCT01283516|469931462|FG007|Overall Study|Death|1|||
130536526|NCT01283516|469931463|FG008|Overall Study|Death|12|||
130536527|NCT01283516|469931455|FG000|Overall Study|Disease Progression|2|||
130536528|NCT01283516|469931456|FG001|Overall Study|Disease Progression|2|||
130536529|NCT01283516|469931457|FG002|Overall Study|Disease Progression|3|||
130536530|NCT01283516|469931458|FG003|Overall Study|Disease Progression|3|||
130536531|NCT01283516|469931459|FG004|Overall Study|Disease Progression|13|||
130536532|NCT01283516|469931460|FG005|Overall Study|Disease Progression|8|||
130536533|NCT01283516|469931461|FG006|Overall Study|Disease Progression|6|||
130536534|NCT01283516|469931462|FG007|Overall Study|Disease Progression|3|||
130536535|NCT01283516|469931463|FG008|Overall Study|Disease Progression|139|||
130536536|NCT01283516|469931455|FG000|Overall Study|Withdrawal by Subject|0|||
130536537|NCT01283516|469931456|FG001|Overall Study|Withdrawal by Subject|0|||
130536538|NCT01283516|469931457|FG002|Overall Study|Withdrawal by Subject|0|||
130536539|NCT01283516|469931458|FG003|Overall Study|Withdrawal by Subject|0|||
130536540|NCT01283516|469931459|FG004|Overall Study|Withdrawal by Subject|1|||
130536541|NCT01283516|469931460|FG005|Overall Study|Withdrawal by Subject|0|||
130536542|NCT01283516|469931461|FG006|Overall Study|Withdrawal by Subject|1|||
130536543|NCT01283516|469931462|FG007|Overall Study|Withdrawal by Subject|0|||
130536544|NCT01283516|469931463|FG008|Overall Study|Withdrawal by Subject|36|||
130536545|NCT01283516|469931455|FG000|Overall Study|Administrative problems|0|||
130536546|NCT01283516|469931456|FG001|Overall Study|Administrative problems|0|||
130536547|NCT01283516|469931457|FG002|Overall Study|Administrative problems|0|||
130536548|NCT01283516|469931458|FG003|Overall Study|Administrative problems|0|||
130536549|NCT01283516|469931459|FG004|Overall Study|Administrative problems|0|||
130536550|NCT01283516|469931460|FG005|Overall Study|Administrative problems|1|||
130536551|NCT01283516|469931461|FG006|Overall Study|Administrative problems|1|||
130536552|NCT01283516|469931462|FG007|Overall Study|Administrative problems|1|||
130536553|NCT01283516|469931463|FG008|Overall Study|Administrative problems|39|||
130536554|NCT01283516|469931455|FG000|Overall Study|Lost to Follow-up|0|||
130536555|NCT01283516|469931456|FG001|Overall Study|Lost to Follow-up|0|||
130536556|NCT01283516|469931457|FG002|Overall Study|Lost to Follow-up|0|||
130536557|NCT01283516|469931458|FG003|Overall Study|Lost to Follow-up|0|||
130536558|NCT01283516|469931459|FG004|Overall Study|Lost to Follow-up|0|||
130536559|NCT01283516|469931460|FG005|Overall Study|Lost to Follow-up|0|||
130536560|NCT01283516|469931461|FG006|Overall Study|Lost to Follow-up|0|||
130536561|NCT01283516|469931462|FG007|Overall Study|Lost to Follow-up|0|||
130536562|NCT01283516|469931463|FG008|Overall Study|Lost to Follow-up|1|||
130536563|NCT01204710|469931464|FG000|Randomization Treatment|Lost to Follow-up|1|||
130584118|NCT02720757|470102502|FG000|Overall Study|Informed consent withdrawal|1|||
130584119|NCT02720757|470102502|FG000|Overall Study|Patients wish to withdraw|2|||
130584120|NCT02720757|470102502|FG000|Overall Study|Missing|3|||
130584121|NCT02720757|470102502|FG000|Overall Study|General exclusion|3|||
130584122|NCT00883493|470102503|FG000|Overall Study|Adverse Event|11|||
130584123|NCT00883493|470102504|FG001|Overall Study|Adverse Event|12|||
130584124|NCT00883493|470102503|FG000|Overall Study|Lack of Efficacy|4|||
130536564|NCT01204710|469931465|FG001|Randomization Treatment|Lost to Follow-up|0|||
130536565|NCT01204710|469931464|FG000|Randomization Treatment|Withdrawal by Subject|6|||
130536566|NCT01204710|469931465|FG001|Randomization Treatment|Withdrawal by Subject|5|||
130536567|NCT01204710|469931464|FG000|Randomization Treatment|Physician Decision|3|||
130536568|NCT01204710|469931465|FG001|Randomization Treatment|Physician Decision|2|||
130536569|NCT01204710|469931464|FG000|Randomization Treatment|Entry criteria not met|0|||
130536570|NCT01204710|469931465|FG001|Randomization Treatment|Entry criteria not met|1|||
130536571|NCT01204710|469931464|FG000|Randomization Treatment|Adverse Event|4|||
130536572|NCT01204710|469931465|FG001|Randomization Treatment|Adverse Event|2|||
130536573|NCT01204710|469931464|FG000|Randomization Treatment|Sponsor Decision|0|||
130584125|NCT00883493|470102504|FG001|Overall Study|Lack of Efficacy|3|||
130584126|NCT00883493|470102503|FG000|Overall Study|Lost to Follow-up|7|||
130584127|NCT00883493|470102504|FG001|Overall Study|Lost to Follow-up|6|||
130584128|NCT00883493|470102503|FG000|Overall Study|Withdrawal by Subject|11|||
130584129|NCT00883493|470102504|FG001|Overall Study|Withdrawal by Subject|20|||
130584130|NCT00883493|470102503|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
130584131|NCT00883493|470102504|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
130584132|NCT00883493|470102503|FG000|Overall Study|Study specific disc. criteria|2|||
130584133|NCT00883493|470102504|FG001|Overall Study|Study specific disc. criteria|0|||
130584134|NCT00883493|470102503|FG000|Overall Study|Other|5|||
130584135|NCT00883493|470102504|FG001|Overall Study|Other|3|||
130584136|NCT01731678|470102511|FG000|Overall Study|Withdrawal by Subject|3|||
130584137|NCT01731678|470102511|FG000|Overall Study|Did not meet inclusion criteria|1|||
130584138|NCT01731678|470102511|FG000|Overall Study|RMT too high, making TMS difficult|3|||
130584139|NCT02649634|470102513|FG000|Overall Study|Withdrawal by Subject|3|||
130584140|NCT02649634|470102514|FG001|Overall Study|Withdrawal by Subject|5|||
130584141|NCT02649634|470102513|FG000|Overall Study|Lost to Follow-up|0|||
130584142|NCT02649634|470102514|FG001|Overall Study|Lost to Follow-up|1|||
130584143|NCT01318122|470102515|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130584144|NCT01318122|470102516|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130584145|NCT01318122|470102517|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
130584146|NCT01318122|470102518|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130584147|NCT01318122|470102515|FG000|Enrolled - Long-Term Extension Study|Other|1|||
130584148|NCT01318122|470102516|FG001|Enrolled - Long-Term Extension Study|Other|0|||
130584149|NCT01318122|470102517|FG002|Enrolled - Long-Term Extension Study|Other|0|||
130584150|NCT01318122|470102518|FG003|Enrolled - Long-Term Extension Study|Other|0|||
130584151|NCT01318122|470102515|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
130584152|NCT01318122|470102516|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
130584153|NCT01318122|470102517|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
130584154|NCT01318122|470102518|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
130584155|NCT01318122|470102515|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
130584156|NCT01318122|470102516|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130584157|NCT01318122|470102517|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130584158|NCT01318122|470102518|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130584159|NCT01318122|470102515|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130584160|NCT01318122|470102516|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
130584161|NCT01318122|470102517|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130584162|NCT01318122|470102518|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130584163|NCT01318122|470102515|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130584164|NCT01318122|470102516|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130584165|NCT01318122|470102517|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
130584166|NCT01318122|470102518|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130584167|NCT01486199|470102519|FG000|Two Year Period Between Study Days|Physician Decision|1|||
130584168|NCT01486199|470102520|FG001|Two Year Period Between Study Days|Physician Decision|0|||
130584169|NCT02471716|470102522|FG000|Overall Study|Withdrawal by Subject|0|||
130584170|NCT02471716|470102523|FG001|Overall Study|Withdrawal by Subject|1|||
130584171|NCT02471716|470102524|FG002|Overall Study|Withdrawal by Subject|0|||
130584172|NCT02471716|470102525|FG003|Overall Study|Withdrawal by Subject|2|||
130584173|NCT02471716|470102526|FG004|Overall Study|Withdrawal by Subject|5|||
130584174|NCT02471716|470102522|FG000|Overall Study|Study Terminiated by sponsor|0|||
130584175|NCT02471716|470102523|FG001|Overall Study|Study Terminiated by sponsor|0|||
130584176|NCT02471716|470102524|FG002|Overall Study|Study Terminiated by sponsor|0|||
130584177|NCT02471716|470102525|FG003|Overall Study|Study Terminiated by sponsor|1|||
130584178|NCT02471716|470102526|FG004|Overall Study|Study Terminiated by sponsor|0|||
130584179|NCT02471716|470102522|FG000|Overall Study|Lost to Follow-up|0|||
130584180|NCT02471716|470102523|FG001|Overall Study|Lost to Follow-up|0|||
130584181|NCT02471716|470102524|FG002|Overall Study|Lost to Follow-up|0|||
130584182|NCT02471716|470102525|FG003|Overall Study|Lost to Follow-up|3|||
130584183|NCT02471716|470102526|FG004|Overall Study|Lost to Follow-up|2|||
130584184|NCT02471716|470102522|FG000|Overall Study|Death|0|||
130584185|NCT02471716|470102523|FG001|Overall Study|Death|0|||
130584186|NCT02471716|470102524|FG002|Overall Study|Death|0|||
130584187|NCT02471716|470102525|FG003|Overall Study|Death|1|||
130584188|NCT02471716|470102526|FG004|Overall Study|Death|0|||
130584189|NCT02471716|470102522|FG000|Overall Study|Other|0|||
130584190|NCT02471716|470102523|FG001|Overall Study|Other|0|||
130584191|NCT02471716|470102524|FG002|Overall Study|Other|0|||
130584192|NCT02471716|470102525|FG003|Overall Study|Other|8|||
130584193|NCT02471716|470102526|FG004|Overall Study|Other|9|||
130584194|NCT02211261|470102529|FG000|Overall Study|Withdrawal by Subject|0|||
130584195|NCT02211261|470102530|FG001|Overall Study|Withdrawal by Subject|0|||
130536574|NCT01204710|469931465|FG001|Randomization Treatment|Sponsor Decision|1|||
130536575|NCT01204710|469931464|FG000|Randomization Treatment|Worsening of General condition|0|||
130536576|NCT01204710|469931465|FG001|Randomization Treatment|Worsening of General condition|1|||
130536577|NCT01204710|469931464|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
130536578|NCT01204710|469931465|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
130536579|NCT01204710|469931464|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
130536580|NCT01204710|469931465|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
130536581|NCT01204710|469931464|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
130536582|NCT01204710|469931465|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
130536583|NCT01204710|469931464|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
130536584|NCT01204710|469931465|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
130536585|NCT01276379|469931466|FG000|Overall Study|Screening failure|40|||
130536586|NCT02001064|469931469|FG000|Overall Study|Withdrawal by Subject|2|||
130536587|NCT02001064|469931470|FG001|Overall Study|Withdrawal by Subject|1|||
130536588|NCT02108964|469931473|FG000|Overall Study|Progressive disease|15|||
130536589|NCT02108964|469931474|FG001|Overall Study|Progressive disease|31|||
130536590|NCT02108964|469931475|FG002|Overall Study|Progressive disease|54|||
130536591|NCT02108964|469931476|FG003|Overall Study|Progressive disease|7|||
130536592|NCT02108964|469931477|FG004|Overall Study|Progressive disease|20|||
130536593|NCT02108964|469931478|FG005|Overall Study|Progressive disease|4|||
130536594|NCT02108964|469931479|FG006|Overall Study|Progressive disease|6|||
130536595|NCT02108964|469931480|FG007|Overall Study|Progressive disease|33|||
130536596|NCT02108964|469931473|FG000|Overall Study|Physician Decision|1|||
130536597|NCT02108964|469931474|FG001|Overall Study|Physician Decision|5|||
130536598|NCT02108964|469931475|FG002|Overall Study|Physician Decision|7|||
130536599|NCT02108964|469931476|FG003|Overall Study|Physician Decision|1|||
130536600|NCT02108964|469931477|FG004|Overall Study|Physician Decision|2|||
130536601|NCT02108964|469931478|FG005|Overall Study|Physician Decision|1|||
130536602|NCT02108964|469931479|FG006|Overall Study|Physician Decision|1|||
130536603|NCT02108964|469931480|FG007|Overall Study|Physician Decision|3|||
130536604|NCT02108964|469931473|FG000|Overall Study|Adverse Event|0|||
130536605|NCT02108964|469931474|FG001|Overall Study|Adverse Event|0|||
130536606|NCT02108964|469931475|FG002|Overall Study|Adverse Event|4|||
130536607|NCT02108964|469931476|FG003|Overall Study|Adverse Event|0|||
130536608|NCT02108964|469931477|FG004|Overall Study|Adverse Event|1|||
130536609|NCT02108964|469931478|FG005|Overall Study|Adverse Event|0|||
130536610|NCT02108964|469931479|FG006|Overall Study|Adverse Event|3|||
130536611|NCT02108964|469931480|FG007|Overall Study|Adverse Event|2|||
130536612|NCT02108964|469931473|FG000|Overall Study|Death|1|||
130536613|NCT02108964|469931474|FG001|Overall Study|Death|1|||
130536614|NCT02108964|469931475|FG002|Overall Study|Death|4|||
130536615|NCT02108964|469931476|FG003|Overall Study|Death|0|||
130536616|NCT02108964|469931477|FG004|Overall Study|Death|3|||
130536617|NCT02108964|469931478|FG005|Overall Study|Death|0|||
130536618|NCT02108964|469931479|FG006|Overall Study|Death|0|||
130536619|NCT02108964|469931480|FG007|Overall Study|Death|2|||
130536620|NCT02108964|469931473|FG000|Overall Study|Subject/Guardian decision|0|||
130536621|NCT02108964|469931474|FG001|Overall Study|Subject/Guardian decision|1|||
130536622|NCT02108964|469931475|FG002|Overall Study|Subject/Guardian decision|4|||
130536623|NCT02108964|469931476|FG003|Overall Study|Subject/Guardian decision|0|||
130536624|NCT02108964|469931477|FG004|Overall Study|Subject/Guardian decision|2|||
130536625|NCT02108964|469931478|FG005|Overall Study|Subject/Guardian decision|0|||
130536626|NCT02108964|469931479|FG006|Overall Study|Subject/Guardian decision|1|||
130536627|NCT02108964|469931480|FG007|Overall Study|Subject/Guardian decision|2|||
130536628|NCT02108964|469931473|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536629|NCT02108964|469931474|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536630|NCT02108964|469931475|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536631|NCT02108964|469931476|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536632|NCT02108964|469931477|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536633|NCT02108964|469931478|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536634|NCT02108964|469931479|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130536635|NCT02108964|469931480|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
130536636|NCT00384397|469931481|FG000|Overall Study|Adverse Event|0|||
130536637|NCT00384397|469931482|FG001|Overall Study|Adverse Event|1|||
130536638|NCT00384397|469931483|FG002|Overall Study|Adverse Event|2|||
130536639|NCT00384397|469931481|FG000|Overall Study|Protocol Violation|7|||
130536640|NCT00384397|469931482|FG001|Overall Study|Protocol Violation|15|||
130536641|NCT00384397|469931483|FG002|Overall Study|Protocol Violation|13|||
130536642|NCT00384397|469931481|FG000|Overall Study|Lost to Follow-up|11|||
130536643|NCT00384397|469931482|FG001|Overall Study|Lost to Follow-up|13|||
130584196|NCT02211261|470102531|FG002|Overall Study|Withdrawal by Subject|1|||
130584197|NCT02211261|470102532|FG003|Overall Study|Withdrawal by Subject|0|||
130536644|NCT00384397|469931483|FG002|Overall Study|Lost to Follow-up|3|||
130536645|NCT00384397|469931481|FG000|Overall Study|Withdrawal by Subject|14|||
130536646|NCT00384397|469931482|FG001|Overall Study|Withdrawal by Subject|17|||
130536647|NCT00384397|469931483|FG002|Overall Study|Withdrawal by Subject|15|||
130536648|NCT01214642|469931484|FG000|Overall Study|Progressive Disease|3|||
130536649|NCT01214642|469931485|FG001|Overall Study|Progressive Disease|2|||
130536650|NCT01214642|469931486|FG002|Overall Study|Progressive Disease|3|||
130536651|NCT01214642|469931487|FG003|Overall Study|Progressive Disease|5|||
130536652|NCT01214642|469931488|FG004|Overall Study|Progressive Disease|5|||
130536653|NCT01214642|469931489|FG005|Overall Study|Progressive Disease|3|||
130536654|NCT01214642|469931490|FG006|Overall Study|Progressive Disease|5|||
130536655|NCT01214642|469931491|FG007|Overall Study|Progressive Disease|3|||
130536656|NCT01214642|469931492|FG008|Overall Study|Progressive Disease|10|||
130536657|NCT01214642|469931493|FG009|Overall Study|Progressive Disease|2|||
130536658|NCT01214642|469931494|FG010|Overall Study|Progressive Disease|1|||
130536659|NCT01214642|469931495|FG011|Overall Study|Progressive Disease|4|||
130536660|NCT01214642|469931484|FG000|Overall Study|Adverse Event|0|||
130536661|NCT01214642|469931485|FG001|Overall Study|Adverse Event|1|||
130536662|NCT01214642|469931486|FG002|Overall Study|Adverse Event|0|||
130536663|NCT01214642|469931487|FG003|Overall Study|Adverse Event|0|||
130536664|NCT01214642|469931488|FG004|Overall Study|Adverse Event|0|||
130536665|NCT01214642|469931489|FG005|Overall Study|Adverse Event|0|||
130536666|NCT01214642|469931490|FG006|Overall Study|Adverse Event|1|||
130536667|NCT01214642|469931491|FG007|Overall Study|Adverse Event|0|||
130536668|NCT01214642|469931492|FG008|Overall Study|Adverse Event|0|||
130536669|NCT01214642|469931493|FG009|Overall Study|Adverse Event|1|||
130536670|NCT01214642|469931494|FG010|Overall Study|Adverse Event|1|||
130536671|NCT01214642|469931495|FG011|Overall Study|Adverse Event|0|||
130536672|NCT01214642|469931484|FG000|Overall Study|Death|0|||
130536673|NCT01214642|469931485|FG001|Overall Study|Death|0|||
130536674|NCT01214642|469931486|FG002|Overall Study|Death|1|||
130536675|NCT01214642|469931487|FG003|Overall Study|Death|0|||
130536676|NCT01214642|469931488|FG004|Overall Study|Death|0|||
130536677|NCT01214642|469931489|FG005|Overall Study|Death|0|||
130536678|NCT01214642|469931490|FG006|Overall Study|Death|0|||
130536679|NCT01214642|469931491|FG007|Overall Study|Death|0|||
130536680|NCT01214642|469931492|FG008|Overall Study|Death|0|||
130536681|NCT01214642|469931493|FG009|Overall Study|Death|0|||
130536682|NCT01214642|469931494|FG010|Overall Study|Death|1|||
130536683|NCT01214642|469931495|FG011|Overall Study|Death|0|||
130536684|NCT01214642|469931484|FG000|Overall Study|Withdrawal by Subject|0|||
130536685|NCT01214642|469931485|FG001|Overall Study|Withdrawal by Subject|0|||
130536686|NCT01214642|469931486|FG002|Overall Study|Withdrawal by Subject|1|||
130536687|NCT01214642|469931487|FG003|Overall Study|Withdrawal by Subject|0|||
130536688|NCT01214642|469931488|FG004|Overall Study|Withdrawal by Subject|0|||
130536689|NCT01214642|469931489|FG005|Overall Study|Withdrawal by Subject|0|||
130536690|NCT01214642|469931490|FG006|Overall Study|Withdrawal by Subject|0|||
130536691|NCT01214642|469931491|FG007|Overall Study|Withdrawal by Subject|0|||
130536692|NCT01214642|469931492|FG008|Overall Study|Withdrawal by Subject|3|||
130536693|NCT01214642|469931493|FG009|Overall Study|Withdrawal by Subject|1|||
130536694|NCT01214642|469931494|FG010|Overall Study|Withdrawal by Subject|1|||
130536695|NCT01214642|469931495|FG011|Overall Study|Withdrawal by Subject|0|||
130536696|NCT01214642|469931484|FG000|Overall Study|Physician Decision|0|||
130536697|NCT01214642|469931485|FG001|Overall Study|Physician Decision|0|||
130536698|NCT01214642|469931486|FG002|Overall Study|Physician Decision|1|||
130536699|NCT01214642|469931487|FG003|Overall Study|Physician Decision|1|||
130536700|NCT01214642|469931488|FG004|Overall Study|Physician Decision|1|||
130536701|NCT01214642|469931489|FG005|Overall Study|Physician Decision|0|||
130536702|NCT01214642|469931490|FG006|Overall Study|Physician Decision|0|||
130536703|NCT01214642|469931491|FG007|Overall Study|Physician Decision|0|||
130536704|NCT01214642|469931492|FG008|Overall Study|Physician Decision|0|||
130536705|NCT01214642|469931493|FG009|Overall Study|Physician Decision|0|||
130584198|NCT02211261|470102533|FG004|Overall Study|Withdrawal by Subject|2|||
130536706|NCT01214642|469931494|FG010|Overall Study|Physician Decision|0|||
130536707|NCT01214642|469931495|FG011|Overall Study|Physician Decision|2|||
130536708|NCT01732822|469933305|FG000|Overall Study|Withdrawal by Subject|123|||
130536709|NCT01732822|469933306|FG001|Overall Study|Withdrawal by Subject|113|||
130536710|NCT02314780|469933307|FG000|Overall Study|organizational reasons|0|||
130536711|NCT02314780|469933308|FG001|Overall Study|organizational reasons|2|||
130536712|NCT02314780|469933309|FG002|Overall Study|organizational reasons|0|||
130536713|NCT02314780|469933307|FG000|Overall Study|Adverse Event|0|||
130536714|NCT02314780|469933308|FG001|Overall Study|Adverse Event|1|||
130536715|NCT02314780|469933309|FG002|Overall Study|Adverse Event|0|||
130536716|NCT00215137|469933313|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
130536717|NCT00215137|469933314|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
130536718|NCT00215137|469933315|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
130536719|NCT00215137|469933313|FG000|Randomization Period|Lost to Follow-up|0|||
130536720|NCT00215137|469933314|FG001|Randomization Period|Lost to Follow-up|1|||
130536721|NCT00215137|469933315|FG002|Randomization Period|Lost to Follow-up|0|||
130536722|NCT00215137|469933313|FG000|Randomization Period|Withdrawal by Subject|0|||
130536723|NCT00215137|469933314|FG001|Randomization Period|Withdrawal by Subject|1|||
130536724|NCT00215137|469933315|FG002|Randomization Period|Withdrawal by Subject|0|||
130536725|NCT03002220|469933317|FG000|Overall Study|Lack of Efficacy|2|||
130536726|NCT03002220|469933317|FG000|Overall Study|Withdrawal by Subject|3|||
130536727|NCT03002220|469933317|FG000|Overall Study|Adverse Event|2|||
130536728|NCT03002220|469933317|FG000|Overall Study|Disease progression|13|||
130536729|NCT03002220|469933317|FG000|Overall Study|Physician Decision|1|||
130536730|NCT01183260|469933320|FG000|Overall Study|Intraop screen failure|2|||
130536731|NCT01183260|469933321|FG001|Overall Study|Intraop screen failure|0|||
130536732|NCT01183260|469933320|FG000|Overall Study|Withdrawal by Subject|1|||
130536733|NCT01183260|469933321|FG001|Overall Study|Withdrawal by Subject|1|||
130536734|NCT01183260|469933320|FG000|Overall Study|Revised within 30 days|0|||
130536735|NCT01183260|469933321|FG001|Overall Study|Revised within 30 days|1|||
130536736|NCT01183260|469933320|FG000|Overall Study|Death|1|||
130536737|NCT01183260|469933321|FG001|Overall Study|Death|0|||
130536738|NCT00730275|469933322|FG000|Overall Study|Withdrawal by Subject|0|||
130536739|NCT00730275|469933323|FG001|Overall Study|Withdrawal by Subject|0|||
130536740|NCT00730275|469933324|FG002|Overall Study|Withdrawal by Subject|0|||
130536741|NCT00730275|469933325|FG003|Overall Study|Withdrawal by Subject|1|||
130536742|NCT03046121|469933330|FG000|Overall Study|Death|32|||
130536743|NCT03046121|469933331|FG001|Overall Study|Death|60|||
130536744|NCT03046121|469933330|FG000|Overall Study|Withdrawal by Subject|14|||
130536745|NCT03046121|469933331|FG001|Overall Study|Withdrawal by Subject|12|||
130536746|NCT00910039|469933332|FG000|Overall Study|Physician Decision|1|||
130536747|NCT03174431|469933342|FG000|Overall Study|Withdrawal by Subject|14|||
130536748|NCT03174431|469933343|FG001|Overall Study|Withdrawal by Subject|11|||
130536749|NCT03174431|469933342|FG000|Overall Study|alternative treatment|2|||
130536750|NCT03174431|469933343|FG001|Overall Study|alternative treatment|0|||
130536751|NCT03174431|469933342|FG000|Overall Study|Lost to Follow-up|1|||
130536752|NCT03174431|469933343|FG001|Overall Study|Lost to Follow-up|5|||
130536753|NCT03547739|469933344|FG000|Overall Study|Death|0|||
130536754|NCT03547739|469933345|FG001|Overall Study|Death|1|||
130536755|NCT03547739|469933346|FG002|Overall Study|Death|5|||
130536756|NCT03547739|469933344|FG000|Overall Study|Adverse Event|24|||
130536757|NCT03547739|469933345|FG001|Overall Study|Adverse Event|11|||
130536758|NCT03547739|469933346|FG002|Overall Study|Adverse Event|13|||
130536759|NCT03547739|469933344|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
130536760|NCT03547739|469933345|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
130536761|NCT03547739|469933346|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
130536762|NCT03547739|469933344|FG000|Overall Study|Lost to Follow-up|80|||
130584199|NCT02211261|470102534|FG005|Overall Study|Withdrawal by Subject|0|||
130584200|NCT02211261|470102535|FG006|Overall Study|Withdrawal by Subject|0|||
130584201|NCT02211261|470102536|FG007|Overall Study|Withdrawal by Subject|0|||
130584202|NCT02211261|470102537|FG008|Overall Study|Withdrawal by Subject|0|||
130584203|NCT02211261|470102538|FG009|Overall Study|Withdrawal by Subject|0|||
130584204|NCT02211261|470102539|FG010|Overall Study|Withdrawal by Subject|0|||
130584205|NCT02211261|470102529|FG000|Overall Study|Other|0|||
130584206|NCT02211261|470102530|FG001|Overall Study|Other|0|||
130584207|NCT02211261|470102531|FG002|Overall Study|Other|0|||
130584208|NCT02211261|470102532|FG003|Overall Study|Other|0|||
130584209|NCT02211261|470102533|FG004|Overall Study|Other|0|||
130584210|NCT02211261|470102534|FG005|Overall Study|Other|1|||
130584211|NCT02211261|470102535|FG006|Overall Study|Other|0|||
130584212|NCT02211261|470102536|FG007|Overall Study|Other|0|||
130584213|NCT02211261|470102537|FG008|Overall Study|Other|0|||
130584214|NCT02211261|470102538|FG009|Overall Study|Other|2|||
130584215|NCT02211261|470102539|FG010|Overall Study|Other|0|||
130584216|NCT02211261|470102529|FG000|Overall Study|Lost to Follow-up|0|||
130584217|NCT02211261|470102530|FG001|Overall Study|Lost to Follow-up|0|||
130584218|NCT02211261|470102531|FG002|Overall Study|Lost to Follow-up|0|||
130584219|NCT02211261|470102532|FG003|Overall Study|Lost to Follow-up|0|||
130584220|NCT02211261|470102533|FG004|Overall Study|Lost to Follow-up|0|||
130584221|NCT02211261|470102534|FG005|Overall Study|Lost to Follow-up|0|||
130584222|NCT02211261|470102535|FG006|Overall Study|Lost to Follow-up|0|||
130584223|NCT02211261|470102536|FG007|Overall Study|Lost to Follow-up|1|||
130584224|NCT02211261|470102537|FG008|Overall Study|Lost to Follow-up|0|||
130584225|NCT02211261|470102538|FG009|Overall Study|Lost to Follow-up|0|||
130584226|NCT02211261|470102539|FG010|Overall Study|Lost to Follow-up|0|||
130584227|NCT01737931|470102543|FG000|Overall Study|Withdrawal by Subject|0|||
130584228|NCT01737931|470102544|FG001|Overall Study|Withdrawal by Subject|1|||
130584229|NCT01737931|470102545|FG002|Overall Study|Withdrawal by Subject|1|||
130584230|NCT01737931|470102543|FG000|Overall Study|Physician Decision|0|||
130584231|NCT01737931|470102544|FG001|Overall Study|Physician Decision|1|||
130584232|NCT01737931|470102545|FG002|Overall Study|Physician Decision|0|||
130584233|NCT04897867|470102546|FG000|Overall Study|Withdrawal of Consent|1|||
130584234|NCT04897867|470102546|FG000|Overall Study|Pregnancy|1|||
130584235|NCT04897867|470102546|FG000|Overall Study|Lost to Follow-up|7|||
130584236|NCT04897867|470102546|FG000|Overall Study|Reason not Specified|2|||
130584237|NCT03183128|470102549|FG000|Overall Study|Adverse Event|1|||
130584238|NCT03183128|470102550|FG001|Overall Study|Adverse Event|2|||
130584239|NCT03183128|470102549|FG000|Overall Study|Withdrawal by Subject|1|||
130584240|NCT03183128|470102550|FG001|Overall Study|Withdrawal by Subject|8|||
130584241|NCT03183128|470102549|FG000|Overall Study|Protocol Violation|2|||
130584242|NCT03183128|470102550|FG001|Overall Study|Protocol Violation|0|||
130584243|NCT03183128|470102549|FG000|Overall Study|Lack of Efficacy|4|||
130584244|NCT03183128|470102550|FG001|Overall Study|Lack of Efficacy|27|||
130584245|NCT03183128|470102549|FG000|Overall Study|Lost to Follow-up|1|||
130584246|NCT03183128|470102550|FG001|Overall Study|Lost to Follow-up|0|||
130584247|NCT03183128|470102549|FG000|Overall Study|Death|2|||
130584248|NCT03183128|470102550|FG001|Overall Study|Death|0|||
130584249|NCT03183128|470102549|FG000|Overall Study|Physician Decision|1|||
130584250|NCT03183128|470102550|FG001|Overall Study|Physician Decision|0|||
130584251|NCT01171612|470102551|FG000|Overall Study|Lost to Follow-up|51|||
130584252|NCT00243659|470102552|FG000|Overall Study|Withdrawal by Subject|1|||
130584253|NCT00243659|470102553|FG001|Overall Study|Withdrawal by Subject|1|||
130584254|NCT00243659|470102552|FG000|Overall Study|Protocol Violation|1|||
130584255|NCT00243659|470102553|FG001|Overall Study|Protocol Violation|2|||
130584256|NCT03310970|470102554|FG000|Overall Study|Withdrawal by Subject|0|||
130584257|NCT03310970|470102555|FG001|Overall Study|Withdrawal by Subject|1|||
130584258|NCT00705263|470102556|FG000|Overall Study|Withdrawal by Subject|2|||
130584259|NCT01752023|470102557|FG000|Overall Study|Physician Decision|2|||
130584260|NCT01752023|470102558|FG001|Overall Study|Physician Decision|1|||
130584261|NCT02440581|470102559|FG000|Overall Study|Death|0|||
130584262|NCT02440581|470102560|FG001|Overall Study|Death|0|||
130584263|NCT02440581|470102561|FG002|Overall Study|Death|7|||
130584264|NCT02440581|470102562|FG003|Overall Study|Death|5|||
130584265|NCT02440581|470102559|FG000|Overall Study|Transplanted|1|||
130584266|NCT02440581|470102560|FG001|Overall Study|Transplanted|0|||
130584267|NCT02440581|470102561|FG002|Overall Study|Transplanted|3|||
130584268|NCT02440581|470102562|FG003|Overall Study|Transplanted|2|||
130584269|NCT02440581|470102559|FG000|Overall Study|Withdrawal by Subject|4|||
130584270|NCT02440581|470102560|FG001|Overall Study|Withdrawal by Subject|11|||
130584271|NCT02440581|470102561|FG002|Overall Study|Withdrawal by Subject|3|||
130584272|NCT02440581|470102562|FG003|Overall Study|Withdrawal by Subject|7|||
130584273|NCT03430986|470102563|FG000|24-week Control Period|Adverse Event|1|||
130584274|NCT03430986|470102564|FG001|24-week Control Period|Adverse Event|0|||
130584275|NCT03430986|470102563|FG000|24-week Control Period|Lost to Follow-up|2|||
130584276|NCT03430986|470102564|FG001|24-week Control Period|Lost to Follow-up|2|||
130584277|NCT03430986|470102563|FG000|24-week Control Period|Withdrawal by Participant|5|||
130584278|NCT03430986|470102564|FG001|24-week Control Period|Withdrawal by Participant|0|||
130536763|NCT03547739|469933345|FG001|Overall Study|Lost to Follow-up|84|||
130536764|NCT03547739|469933346|FG002|Overall Study|Lost to Follow-up|116|||
130536765|NCT02075073|469933347|FG000|Overall Study|Withdrawal by Subject|0|||
130536766|NCT02075073|469933348|FG001|Overall Study|Withdrawal by Subject|1|||
130536767|NCT02075073|469933349|FG002|Overall Study|Withdrawal by Subject|0|||
130536768|NCT02797080|469933357|FG000|Overall Study|Lost to Follow-up|1|||
130536769|NCT02797080|469933357|FG000|Overall Study|Withdrawal by Subject|1|||
130536770|NCT04035499|469933360|FG000|Overall Study|Death|2|||
130536771|NCT04035499|469933360|FG000|Overall Study|Withdrawal by Subject|1|||
130536772|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Adverse Event|1|||
130536773|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Adverse Event|1|||
130536774|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Adverse Event|2|||
130536775|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Adverse Event|5|||
130536776|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Adverse Event|0|||
130536777|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
130536778|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
130536779|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
130536780|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
130536781|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
130536782|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
130536783|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
130536784|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
130536785|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
130536786|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
130536787|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
130536788|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
130536789|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
130536790|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
130536791|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
130536792|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
130536793|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
130536794|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
130536795|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
130536796|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
130536797|NCT00951015|469933361|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
130536798|NCT00951015|469933362|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
130536799|NCT00951015|469933363|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
130536800|NCT00951015|469933364|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
130536801|NCT00951015|469933365|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
130536802|NCT00951015|469933361|FG000|Open-label Phase|Adverse Event|0|||
130536803|NCT00951015|469933362|FG001|Open-label Phase|Adverse Event|0|||
130536804|NCT00951015|469933363|FG002|Open-label Phase|Adverse Event|0|||
130536805|NCT00951015|469933364|FG003|Open-label Phase|Adverse Event|0|||
130536806|NCT00951015|469933365|FG004|Open-label Phase|Adverse Event|3|||
130536807|NCT00951015|469933361|FG000|Open-label Phase|Lack of Efficacy|0|||
130536808|NCT00951015|469933362|FG001|Open-label Phase|Lack of Efficacy|0|||
130536809|NCT00951015|469933363|FG002|Open-label Phase|Lack of Efficacy|0|||
130536810|NCT00951015|469933364|FG003|Open-label Phase|Lack of Efficacy|0|||
130536811|NCT00951015|469933365|FG004|Open-label Phase|Lack of Efficacy|1|||
130536812|NCT00951015|469933361|FG000|Open-label Phase|Protocol Violation|0|||
130536813|NCT00951015|469933362|FG001|Open-label Phase|Protocol Violation|0|||
130536814|NCT00951015|469933363|FG002|Open-label Phase|Protocol Violation|0|||
130536815|NCT00951015|469933364|FG003|Open-label Phase|Protocol Violation|0|||
130536816|NCT00951015|469933365|FG004|Open-label Phase|Protocol Violation|12|||
130536817|NCT00951015|469933361|FG000|Open-label Phase|Lost to Follow-up|0|||
130536818|NCT00951015|469933362|FG001|Open-label Phase|Lost to Follow-up|0|||
130536819|NCT00951015|469933363|FG002|Open-label Phase|Lost to Follow-up|0|||
130536820|NCT00951015|469933364|FG003|Open-label Phase|Lost to Follow-up|0|||
130536821|NCT00951015|469933365|FG004|Open-label Phase|Lost to Follow-up|12|||
130536822|NCT00951015|469933361|FG000|Open-label Phase|Withdrawal by Subject|0|||
130536823|NCT00951015|469933362|FG001|Open-label Phase|Withdrawal by Subject|0|||
130536824|NCT00951015|469933363|FG002|Open-label Phase|Withdrawal by Subject|0|||
130536825|NCT00951015|469933364|FG003|Open-label Phase|Withdrawal by Subject|0|||
130536826|NCT00951015|469933365|FG004|Open-label Phase|Withdrawal by Subject|14|||
130536827|NCT00951015|469933361|FG000|Open-label Phase|Physician Decision|0|||
130536828|NCT00951015|469933362|FG001|Open-label Phase|Physician Decision|0|||
130536829|NCT00951015|469933363|FG002|Open-label Phase|Physician Decision|0|||
130536830|NCT00951015|469933364|FG003|Open-label Phase|Physician Decision|0|||
130536831|NCT00951015|469933365|FG004|Open-label Phase|Physician Decision|8|||
130536832|NCT01208103|469933367|FG000|Overall Study|Adverse Event|1|||
130536833|NCT01208103|469933367|FG000|Overall Study|Withdrawal by Subject|1|||
130536834|NCT03819634|469933368|FG000|Overall Study|Physician Decision|2|||
130536835|NCT00299494|469933369|FG000|Overall Study|Withdrawal by Subject|0|||
130536836|NCT00299494|469933370|FG001|Overall Study|Withdrawal by Subject|0|||
130536837|NCT00299494|469933371|FG002|Overall Study|Withdrawal by Subject|0|||
130536838|NCT00299494|469933372|FG003|Overall Study|Withdrawal by Subject|3|||
130536839|NCT00299494|469933373|FG004|Overall Study|Withdrawal by Subject|1|||
130536840|NCT00299494|469933374|FG005|Overall Study|Withdrawal by Subject|4|||
130536841|NCT00299494|469933369|FG000|Overall Study|Physician Decision|0|||
130536842|NCT00299494|469933370|FG001|Overall Study|Physician Decision|0|||
130536843|NCT00299494|469933371|FG002|Overall Study|Physician Decision|0|||
130536844|NCT00299494|469933372|FG003|Overall Study|Physician Decision|0|||
130536845|NCT00299494|469933373|FG004|Overall Study|Physician Decision|1|||
130536846|NCT00299494|469933374|FG005|Overall Study|Physician Decision|0|||
130536847|NCT00299494|469933369|FG000|Overall Study|Death|3|||
130536848|NCT00299494|469933370|FG001|Overall Study|Death|1|||
130536849|NCT00299494|469933371|FG002|Overall Study|Death|4|||
130536850|NCT00299494|469933372|FG003|Overall Study|Death|6|||
130536851|NCT00299494|469933373|FG004|Overall Study|Death|18|||
130536852|NCT00299494|469933374|FG005|Overall Study|Death|19|||
130536853|NCT00299494|469933369|FG000|Overall Study|Lost to Follow-up|0|||
130536854|NCT00299494|469933370|FG001|Overall Study|Lost to Follow-up|0|||
130536855|NCT00299494|469933371|FG002|Overall Study|Lost to Follow-up|0|||
130536856|NCT00299494|469933372|FG003|Overall Study|Lost to Follow-up|0|||
130536857|NCT00299494|469933373|FG004|Overall Study|Lost to Follow-up|3|||
130536858|NCT00299494|469933374|FG005|Overall Study|Lost to Follow-up|1|||
130536859|NCT00299494|469933369|FG000|Overall Study|Other - Unspecified|0|||
130536860|NCT00299494|469933370|FG001|Overall Study|Other - Unspecified|0|||
130536861|NCT00299494|469933371|FG002|Overall Study|Other - Unspecified|0|||
130536862|NCT00299494|469933372|FG003|Overall Study|Other - Unspecified|0|||
130536863|NCT00299494|469933373|FG004|Overall Study|Other - Unspecified|3|||
130536864|NCT00299494|469933374|FG005|Overall Study|Other - Unspecified|1|||
130536865|NCT00299494|469933369|FG000|Overall Study|Other - site closure|0|||
130536866|NCT00299494|469933370|FG001|Overall Study|Other - site closure|0|||
130536867|NCT00299494|469933371|FG002|Overall Study|Other - site closure|0|||
130536868|NCT00299494|469933372|FG003|Overall Study|Other - site closure|1|||
130536869|NCT00299494|469933373|FG004|Overall Study|Other - site closure|1|||
130536870|NCT00299494|469933374|FG005|Overall Study|Other - site closure|1|||
130536871|NCT00416195|469933375|FG000|Overall Study|Adverse Event|1|||
130536872|NCT00416195|469933376|FG001|Overall Study|Adverse Event|2|||
130536873|NCT00416195|469933375|FG000|Overall Study|Protocol Violation|1|||
130536874|NCT00416195|469933376|FG001|Overall Study|Protocol Violation|1|||
130536875|NCT00416195|469933375|FG000|Overall Study|Other|0|||
130536876|NCT00416195|469933376|FG001|Overall Study|Other|1|||
130536877|NCT01417104|469933382|FG000|Overall Study|Withdrawal by Subject|5|||
130536878|NCT01417104|469933383|FG001|Overall Study|Withdrawal by Subject|1|||
130536879|NCT01417104|469933382|FG000|Overall Study|Failure to make contact|0|||
130536880|NCT01417104|469933383|FG001|Overall Study|Failure to make contact|1|||
130584279|NCT03430986|470102563|FG000|24-week Control Period|Protocol Deviation|0|||
130584280|NCT03430986|470102564|FG001|24-week Control Period|Protocol Deviation|2|||
130584281|NCT03430986|470102563|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
130584282|NCT03430986|470102564|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
130584283|NCT03430986|470102563|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
130584284|NCT03430986|470102564|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
130584285|NCT03186989|470102565|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584286|NCT03186989|470102566|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584287|NCT03186989|470102567|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130536881|NCT01417104|469933382|FG000|Overall Study|Adverse Event|1|||
130536882|NCT01417104|469933383|FG001|Overall Study|Adverse Event|0|||
130536883|NCT01305408|469933384|FG000|Overall Study|Adverse Event|10|||
130584288|NCT03186989|470102568|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130584289|NCT03186989|470102569|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130536884|NCT01305408|469933385|FG001|Overall Study|Adverse Event|7|||
130536885|NCT01305408|469933384|FG000|Overall Study|Lack of Efficacy|3|||
130536886|NCT01305408|469933385|FG001|Overall Study|Lack of Efficacy|4|||
130536887|NCT01305408|469933384|FG000|Overall Study|Withdrawal by Subject|9|||
130536888|NCT01305408|469933385|FG001|Overall Study|Withdrawal by Subject|9|||
130536889|NCT01305408|469933384|FG000|Overall Study|Protocol Violation|4|||
130536890|NCT01305408|469933385|FG001|Overall Study|Protocol Violation|6|||
130536891|NCT01305408|469933384|FG000|Overall Study|Lost to Follow-up|5|||
130536892|NCT01305408|469933385|FG001|Overall Study|Lost to Follow-up|3|||
130536893|NCT01305408|469933384|FG000|Overall Study|Noncompliance with study medication|0|||
130536894|NCT01305408|469933385|FG001|Overall Study|Noncompliance with study medication|1|||
130536895|NCT01305408|469933384|FG000|Overall Study|Noncompliance with study procedures|0|||
130536896|NCT01305408|469933385|FG001|Overall Study|Noncompliance with study procedures|1|||
130536897|NCT01305408|469933384|FG000|Overall Study|Other|1|||
130536898|NCT01305408|469933385|FG001|Overall Study|Other|0|||
130536899|NCT03101462|469933386|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
130536900|NCT03101462|469933387|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
130536901|NCT02530970|469933388|FG000|Overall Study|Adverse Event|8|||
130536902|NCT02530970|469933388|FG000|Overall Study|Lost to Follow-up|88|||
130536903|NCT02530970|469933388|FG000|Overall Study|Physician Decision|5|||
130536904|NCT02530970|469933388|FG000|Overall Study|Withdrawal by Subject|14|||
130536905|NCT02530970|469933388|FG000|Overall Study|Death|6|||
130536906|NCT02530970|469933388|FG000|Overall Study|Hospitalization|1|||
130536907|NCT02530970|469933388|FG000|Overall Study|Insurance|2|||
130536908|NCT02530970|469933388|FG000|Overall Study|Explant|2|||
130536909|NCT02530970|469933388|FG000|Overall Study|Change in Provider|5|||
130536910|NCT02530970|469933388|FG000|Overall Study|Relocation|3|||
130536911|NCT02770612|469933390|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
130536912|NCT00958841|469933395|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130536913|NCT00958841|469933395|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130584290|NCT03186989|470102570|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584291|NCT03186989|470102571|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584292|NCT03186989|470102572|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584293|NCT03186989|470102573|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584294|NCT03186989|470102574|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584295|NCT03186989|470102575|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130584296|NCT03186989|470102565|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584297|NCT03186989|470102566|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584298|NCT03186989|470102567|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584299|NCT03186989|470102568|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584300|NCT03186989|470102569|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584301|NCT03186989|470102570|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
130584302|NCT03186989|470102571|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584303|NCT03186989|470102572|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584304|NCT03186989|470102573|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584305|NCT03186989|470102574|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584306|NCT03186989|470102575|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130584307|NCT03186989|470102565|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584308|NCT03186989|470102566|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584309|NCT03186989|470102567|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584310|NCT03186989|470102568|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584311|NCT03186989|470102569|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584312|NCT03186989|470102570|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584313|NCT03186989|470102571|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
130584314|NCT03186989|470102572|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584315|NCT03186989|470102573|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584316|NCT03186989|470102574|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584317|NCT03186989|470102575|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130584318|NCT03186989|470102565|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584319|NCT03186989|470102566|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584320|NCT03186989|470102567|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584321|NCT03186989|470102568|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584322|NCT03186989|470102569|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584323|NCT03186989|470102570|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130584324|NCT03186989|470102571|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130584325|NCT03186989|470102572|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584326|NCT03186989|470102573|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130584327|NCT03186989|470102574|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130536914|NCT00958841|469933395|FG000|Overall Study|Administrative problems|1|||
130536915|NCT00958841|469933395|FG000|Overall Study|Adverse Event|8|||
130536916|NCT00958841|469933395|FG000|Overall Study|New cancer therapy|5|||
130536917|NCT00958841|469933395|FG000|Overall Study|Withdrawal by Subject|1|||
130536918|NCT00958841|469933395|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
130536919|NCT00958841|469933395|FG000|Overall Study|Completed M6/did not enter extension|27|||
130536920|NCT00958841|469933395|FG000|Overall Study|Discontinued prior to M*|28|||
130536921|NCT01152814|469933405|FG000|Overall Study|Lost to Follow-up|2|||
130536922|NCT01877239|469933406|FG000|Overall Study|Adverse Event|4|||
130536923|NCT01877239|469933406|FG000|Overall Study|Disease Remission|1|||
130536924|NCT01877239|469933406|FG000|Overall Study|Withdrawal by Subject|4|||
130536925|NCT01877239|469933406|FG000|Overall Study|Other|2|||
130536926|NCT01877239|469933406|FG000|Overall Study|Lack of Efficacy|4|||
130536927|NCT01877239|469933406|FG000|Overall Study|Data not available|35|||
130536928|NCT01669577|469933407|FG000|Overall Study|Death|22|||
130536929|NCT01669577|469933407|FG000|Overall Study|Lost to Follow-up|78|||
130536930|NCT01669577|469933407|FG000|Overall Study|Physician Decision|34|||
130536931|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
130536932|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
130536933|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
130536934|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
130536935|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
130536936|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
130536937|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
130536938|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
130536939|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
130536940|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
130536941|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130536942|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Adverse Event|0|||
130536943|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Adverse Event|3|||
130536944|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Adverse Event|2|||
130536945|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Adverse Event|13|||
130536946|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
130536947|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
130536948|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
130536949|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
130536950|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
130536951|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Patient's wish|0|||
130536952|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Patient's wish|0|||
130536953|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Patient's wish|19|||
130536954|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Patient's wish|9|||
130536955|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Patient's wish|20|||
130536956|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
130536957|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
130536958|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
130536959|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
130536960|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
130536961|NCT00444275|469933408|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
130536962|NCT00444275|469933409|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
130536963|NCT00444275|469933410|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
130536964|NCT00444275|469933411|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
130536965|NCT00444275|469933412|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
130536966|NCT00743431|469933413|FG000|Overall Study|Toxicity|6|||
130536967|NCT00743431|469933413|FG000|Overall Study|Tumor progression|56|||
130536968|NCT00743431|469933413|FG000|Overall Study|Withdrawal by Subject|13|||
130536969|NCT00743431|469933413|FG000|Overall Study|Death|9|||
130536970|NCT00743431|469933413|FG000|Overall Study|Reason for discontinuation not specified|29|||
130536971|NCT00743431|469933413|FG000|Overall Study|No documentation available|13|||
130536972|NCT03291288|469933414|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
130536973|NCT03291288|469933415|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
130536974|NCT03291288|469933414|FG000|Drug-drug Interaction Phase|Disease progression|1|||
130536975|NCT03291288|469933415|FG001|Drug-drug Interaction Phase|Disease progression|0|||
130536976|NCT03291288|469933414|FG000|Drug-drug Interaction Phase|Other|3|||
130536977|NCT03291288|469933415|FG001|Drug-drug Interaction Phase|Other|0|||
130536978|NCT03291288|469933414|FG000|Pexidartinib Only|Ongoing|0|||
130536979|NCT03291288|469933415|FG001|Pexidartinib Only|Ongoing|2|||
130536980|NCT04276415|469933416|FG000|Overall Study|Adverse Event|0|||
130536981|NCT04276415|469933417|FG001|Overall Study|Adverse Event|0|||
130536982|NCT04276415|469933418|FG002|Overall Study|Adverse Event|0|||
130536983|NCT04276415|469933419|FG003|Overall Study|Adverse Event|3|||
130536984|NCT04276415|469933420|FG004|Overall Study|Adverse Event|0|||
130536985|NCT04276415|469933421|FG005|Overall Study|Adverse Event|0|||
130536986|NCT04276415|469933416|FG000|Overall Study|Clinical progression|1|||
130536987|NCT04276415|469933417|FG001|Overall Study|Clinical progression|1|||
130536988|NCT04276415|469933418|FG002|Overall Study|Clinical progression|0|||
130536989|NCT04276415|469933419|FG003|Overall Study|Clinical progression|0|||
130536990|NCT04276415|469933420|FG004|Overall Study|Clinical progression|1|||
130536991|NCT04276415|469933421|FG005|Overall Study|Clinical progression|0|||
130536992|NCT04276415|469933416|FG000|Overall Study|Other|0|||
130536993|NCT04276415|469933417|FG001|Overall Study|Other|0|||
130536994|NCT04276415|469933418|FG002|Overall Study|Other|0|||
130536995|NCT04276415|469933419|FG003|Overall Study|Other|1|||
130536996|NCT04276415|469933420|FG004|Overall Study|Other|0|||
130536997|NCT04276415|469933421|FG005|Overall Study|Other|0|||
130536998|NCT04276415|469933416|FG000|Overall Study|Physician Decision|0|||
130536999|NCT04276415|469933417|FG001|Overall Study|Physician Decision|0|||
130537000|NCT04276415|469933418|FG002|Overall Study|Physician Decision|1|||
130537001|NCT04276415|469933419|FG003|Overall Study|Physician Decision|3|||
130537002|NCT04276415|469933420|FG004|Overall Study|Physician Decision|2|||
130537003|NCT04276415|469933421|FG005|Overall Study|Physician Decision|0|||
130537004|NCT04276415|469933416|FG000|Overall Study|Progressive disease|3|||
130537005|NCT04276415|469933417|FG001|Overall Study|Progressive disease|3|||
130537006|NCT04276415|469933418|FG002|Overall Study|Progressive disease|4|||
130537007|NCT04276415|469933419|FG003|Overall Study|Progressive disease|5|||
130537008|NCT04276415|469933420|FG004|Overall Study|Progressive disease|1|||
130537009|NCT04276415|469933421|FG005|Overall Study|Progressive disease|2|||
130537010|NCT04276415|469933416|FG000|Overall Study|Withdrawal by patient|0|||
130537011|NCT04276415|469933417|FG001|Overall Study|Withdrawal by patient|0|||
130537012|NCT04276415|469933418|FG002|Overall Study|Withdrawal by patient|0|||
130537013|NCT04276415|469933419|FG003|Overall Study|Withdrawal by patient|1|||
130537014|NCT04276415|469933420|FG004|Overall Study|Withdrawal by patient|2|||
130537015|NCT04276415|469933421|FG005|Overall Study|Withdrawal by patient|0|||
130537016|NCT03309813|469933422|FG000|Main Randomized Study|Withdrawal by Subject|1|||
130537017|NCT03309813|469933423|FG001|Main Randomized Study|Withdrawal by Subject|0|||
130537018|NCT01989169|469933426|FG000|Period 2|Adverse Event|0|||
130537019|NCT01989169|469933427|FG001|Period 2|Adverse Event|1|||
130537020|NCT02406677|469933428|FG000|Overall Study|Death|16|||
130537021|NCT02406677|469933429|FG001|Overall Study|Death|8|||
130537022|NCT02406677|469933428|FG000|Overall Study|Discharged without P2Y12|1|||
130537023|NCT02406677|469933429|FG001|Overall Study|Discharged without P2Y12|3|||
130537024|NCT02406677|469933428|FG000|Overall Study|Discharged on prasugrel|283|||
130537025|NCT02406677|469933429|FG001|Overall Study|Discharged on prasugrel|587|||
130537026|NCT02406677|469933428|FG000|Overall Study|Withdrawal by Subject|1|||
130537027|NCT02406677|469933429|FG001|Overall Study|Withdrawal by Subject|0|||
130537028|NCT04531904|469933430|FG000|Overall Study|Lost to Follow-up|1|||
130537029|NCT04531904|469933430|FG000|Overall Study|Death|14|||
130537030|NCT00283244|469933431|FG000|Overall Study|Adverse Event|0|||
130537031|NCT00283244|469933432|FG001|Overall Study|Adverse Event|8|||
130537032|NCT00283244|469933433|FG002|Overall Study|Adverse Event|11|||
130537033|NCT00283244|469933431|FG000|Overall Study|Death|4|||
130537034|NCT00283244|469933432|FG001|Overall Study|Death|3|||
130537035|NCT00283244|469933433|FG002|Overall Study|Death|2|||
130537036|NCT00283244|469933431|FG000|Overall Study|Lack of Efficacy|8|||
130537037|NCT00283244|469933432|FG001|Overall Study|Lack of Efficacy|32|||
130537038|NCT00283244|469933433|FG002|Overall Study|Lack of Efficacy|26|||
130537039|NCT00283244|469933431|FG000|Overall Study|Withdrawal by Subject|1|||
130537040|NCT00283244|469933432|FG001|Overall Study|Withdrawal by Subject|2|||
130537041|NCT00283244|469933433|FG002|Overall Study|Withdrawal by Subject|2|||
130537042|NCT00283244|469933431|FG000|Overall Study|Physician Decision|0|||
130537043|NCT00283244|469933432|FG001|Overall Study|Physician Decision|0|||
130537044|NCT00283244|469933433|FG002|Overall Study|Physician Decision|1|||
130537045|NCT00283244|469933431|FG000|Overall Study|Medical illness (other complicating dz)|4|||
130537046|NCT00283244|469933432|FG001|Overall Study|Medical illness (other complicating dz)|3|||
130537047|NCT00283244|469933433|FG002|Overall Study|Medical illness (other complicating dz)|6|||
130537048|NCT00283244|469933431|FG000|Overall Study|Clinical deterioration|1|||
130537049|NCT00283244|469933432|FG001|Overall Study|Clinical deterioration|3|||
130537050|NCT00283244|469933433|FG002|Overall Study|Clinical deterioration|3|||
130537051|NCT00586612|469933434|FG000|Primary Phase|Protocol Violation|1|||
130537052|NCT00586612|469933435|FG001|Primary Phase|Protocol Violation|0|||
130537053|NCT00586612|469933434|FG000|Primary Phase|Lost to Follow-up|0|||
130537054|NCT00586612|469933435|FG001|Primary Phase|Lost to Follow-up|1|||
130537055|NCT00586612|469933434|FG000|Primary Phase|Withdrawal by Subject|0|||
130537056|NCT00586612|469933435|FG001|Primary Phase|Withdrawal by Subject|2|||
130537057|NCT00586612|469933434|FG000|Booster Phase|Lost to Follow-up|3|||
130537058|NCT00586612|469933435|FG001|Booster Phase|Lost to Follow-up|1|||
130537059|NCT01609062|469933436|FG000|Extension Phase|Terminated by Sponsor|14|||
130537060|NCT01609062|469933437|FG001|Extension Phase|Terminated by Sponsor|9|||
130537061|NCT01609062|469933436|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
130537062|NCT01609062|469933437|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
130537063|NCT01609062|469933436|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
130537064|NCT01609062|469933437|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
130537065|NCT02738853|469933438|FG000|Enrollment|Inclusion/Exclusion not met|21|||
130537066|NCT02738853|469933438|FG000|Enrollment|Withdrawal by Subject|3|||
130537067|NCT02738853|469933438|FG000|Enrollment|Subject treated with commercially available device|6|||
130537068|NCT02738853|469933438|FG000|Enrollment|Study Enrollment Closed|3|||
130537069|NCT02738853|469933438|FG000|Procedure|Death|1|||
130537070|NCT02738853|469933438|FG000|1 Month|Death|2|||
130537071|NCT02738853|469933438|FG000|6 Month|Death|4|||
130537072|NCT02738853|469933438|FG000|6 Month|Withdrawal by Subject|2|||
130537073|NCT02738853|469933438|FG000|1 Year|Death|6|||
130537074|NCT02738853|469933438|FG000|1 Year|Withdrawal by Subject|1|||
130537075|NCT02738853|469933438|FG000|2 Year|Death|2|||
130537076|NCT02738853|469933438|FG000|2 Year|Lost to Follow-up|1|||
130537077|NCT02738853|469933438|FG000|3 Year|Death|2|||
130537078|NCT02738853|469933438|FG000|3 Year|Withdrawal by Subject|1|||
130537079|NCT02738853|469933438|FG000|4 Year|Death|9|||
130537080|NCT02738853|469933438|FG000|5 Year|Lost to Follow-up|4|||
130537081|NCT02235311|469933439|FG000|Overall Study|Lost to Follow-up|0|||
130537082|NCT02235311|469933440|FG001|Overall Study|Lost to Follow-up|1|||
130537083|NCT02235311|469933439|FG000|Overall Study|Protocol Violation|0|||
130537084|NCT02235311|469933440|FG001|Overall Study|Protocol Violation|1|||
130537085|NCT00658788|469933441|FG000|Overall Study|Adverse Event|11|||
130537086|NCT00658788|469933441|FG000|Overall Study|Withdrawal by Subject|13|||
130537087|NCT00658788|469933441|FG000|Overall Study|Lost to Follow-up|18|||
130584328|NCT03186989|470102575|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130584329|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
130584330|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
130584331|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
130584332|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584333|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584334|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584335|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584336|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584337|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130584338|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
130584339|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
130584340|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
130584341|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584342|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584343|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584344|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584345|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584346|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130584347|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130584348|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130584349|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584350|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584351|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584352|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584353|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584354|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584355|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130584356|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
130584357|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
130584358|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
130584359|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584360|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584361|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584362|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584363|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584364|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130584365|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
130584366|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
130584367|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584368|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584369|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584370|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584371|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130537088|NCT00658788|469933441|FG000|Overall Study|Treatment Discontinuation|32|||
130537089|NCT05384938|469933442|FG000|Overall Study|Withdrawal by Subject|8|||
130537090|NCT05384938|469933442|FG000|Overall Study|Lost to Follow-up|6|||
130537091|NCT05384938|469933442|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
130537092|NCT02626455|469933443|FG000|Overall Study|Other|1|||
130537093|NCT02626455|469933444|FG001|Overall Study|Other|1|||
130537094|NCT02626455|469933445|FG002|Overall Study|Other|0|||
130537095|NCT02626455|469933446|FG003|Overall Study|Other|0|||
130537096|NCT02626455|469933447|FG004|Overall Study|Other|0|||
130537097|NCT02626455|469933448|FG005|Overall Study|Other|17|||
130537098|NCT02626455|469933449|FG006|Overall Study|Other|23|||
130537099|NCT02626455|469933443|FG000|Overall Study|Withdrawal by Subject|1|||
130537100|NCT02626455|469933444|FG001|Overall Study|Withdrawal by Subject|0|||
130537101|NCT02626455|469933445|FG002|Overall Study|Withdrawal by Subject|0|||
130537102|NCT02626455|469933446|FG003|Overall Study|Withdrawal by Subject|0|||
130537103|NCT02626455|469933447|FG004|Overall Study|Withdrawal by Subject|0|||
130537104|NCT02626455|469933448|FG005|Overall Study|Withdrawal by Subject|10|||
130537105|NCT02626455|469933449|FG006|Overall Study|Withdrawal by Subject|6|||
130537106|NCT02626455|469933443|FG000|Overall Study|Physician Decision|0|||
130537107|NCT02626455|469933444|FG001|Overall Study|Physician Decision|2|||
130537108|NCT02626455|469933445|FG002|Overall Study|Physician Decision|2|||
130537109|NCT02626455|469933446|FG003|Overall Study|Physician Decision|2|||
130537110|NCT02626455|469933447|FG004|Overall Study|Physician Decision|1|||
130537111|NCT02626455|469933448|FG005|Overall Study|Physician Decision|10|||
130537112|NCT02626455|469933449|FG006|Overall Study|Physician Decision|3|||
130537113|NCT02626455|469933443|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537114|NCT02626455|469933444|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537115|NCT02626455|469933445|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537116|NCT02626455|469933446|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537117|NCT02626455|469933447|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537118|NCT02626455|469933448|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130537119|NCT02626455|469933449|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
130537120|NCT02626455|469933443|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537121|NCT02626455|469933444|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537122|NCT02626455|469933445|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537123|NCT02626455|469933446|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537124|NCT02626455|469933447|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537125|NCT02626455|469933448|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130537126|NCT02626455|469933449|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
130537127|NCT02626455|469933443|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130537128|NCT02626455|469933444|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130537129|NCT02626455|469933445|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130537130|NCT02626455|469933446|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130537131|NCT02626455|469933447|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130537132|NCT02626455|469933448|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
130537133|NCT02626455|469933449|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
130537134|NCT02626455|469933443|FG000|Overall Study|Patient decision|0|||
130537135|NCT02626455|469933444|FG001|Overall Study|Patient decision|1|||
130537136|NCT02626455|469933445|FG002|Overall Study|Patient decision|0|||
130537137|NCT02626455|469933446|FG003|Overall Study|Patient decision|0|||
130537138|NCT02626455|469933447|FG004|Overall Study|Patient decision|1|||
130537139|NCT02626455|469933448|FG005|Overall Study|Patient decision|36|||
130537140|NCT02626455|469933449|FG006|Overall Study|Patient decision|22|||
130537141|NCT02626455|469933443|FG000|Overall Study|Protocol Violation|0|||
130537142|NCT02626455|469933444|FG001|Overall Study|Protocol Violation|0|||
130537143|NCT02626455|469933445|FG002|Overall Study|Protocol Violation|0|||
130537144|NCT02626455|469933446|FG003|Overall Study|Protocol Violation|0|||
130537145|NCT02626455|469933447|FG004|Overall Study|Protocol Violation|0|||
130537146|NCT02626455|469933448|FG005|Overall Study|Protocol Violation|0|||
130537147|NCT02626455|469933449|FG006|Overall Study|Protocol Violation|1|||
130537148|NCT02626455|469933443|FG000|Overall Study|Progressive disease - radiological progression|0|||
130537149|NCT02626455|469933444|FG001|Overall Study|Progressive disease - radiological progression|0|||
130537150|NCT02626455|469933445|FG002|Overall Study|Progressive disease - radiological progression|0|||
130537151|NCT02626455|469933446|FG003|Overall Study|Progressive disease - radiological progression|0|||
130537152|NCT02626455|469933447|FG004|Overall Study|Progressive disease - radiological progression|0|||
130537153|NCT02626455|469933448|FG005|Overall Study|Progressive disease - radiological progression|11|||
130537154|NCT02626455|469933449|FG006|Overall Study|Progressive disease - radiological progression|22|||
130537155|NCT02626455|469933443|FG000|Overall Study|Progressive disease - clinical progression|0|||
130537156|NCT02626455|469933444|FG001|Overall Study|Progressive disease - clinical progression|0|||
130537157|NCT02626455|469933445|FG002|Overall Study|Progressive disease - clinical progression|0|||
130537158|NCT02626455|469933446|FG003|Overall Study|Progressive disease - clinical progression|0|||
130537159|NCT02626455|469933447|FG004|Overall Study|Progressive disease - clinical progression|0|||
130537160|NCT02626455|469933448|FG005|Overall Study|Progressive disease - clinical progression|1|||
130537161|NCT02626455|469933449|FG006|Overall Study|Progressive disease - clinical progression|2|||
130537162|NCT02626455|469933443|FG000|Overall Study|Lost to Follow-up|0|||
130537163|NCT02626455|469933444|FG001|Overall Study|Lost to Follow-up|0|||
130537164|NCT02626455|469933445|FG002|Overall Study|Lost to Follow-up|0|||
130537165|NCT02626455|469933446|FG003|Overall Study|Lost to Follow-up|0|||
130537166|NCT02626455|469933447|FG004|Overall Study|Lost to Follow-up|0|||
130537167|NCT02626455|469933448|FG005|Overall Study|Lost to Follow-up|1|||
130537168|NCT02626455|469933449|FG006|Overall Study|Lost to Follow-up|0|||
130537169|NCT02626455|469933443|FG000|Overall Study|AE not associated with clinical disease progression|1|||
130537170|NCT02626455|469933444|FG001|Overall Study|AE not associated with clinical disease progression|1|||
130537171|NCT02626455|469933445|FG002|Overall Study|AE not associated with clinical disease progression|0|||
130537172|NCT02626455|469933446|FG003|Overall Study|AE not associated with clinical disease progression|2|||
130537173|NCT02626455|469933447|FG004|Overall Study|AE not associated with clinical disease progression|1|||
130537174|NCT02626455|469933448|FG005|Overall Study|AE not associated with clinical disease progression|65|||
130537175|NCT02626455|469933449|FG006|Overall Study|AE not associated with clinical disease progression|21|||
130584372|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584373|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130584374|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584375|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584376|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
130584377|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584378|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584379|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584380|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584381|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584382|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130584383|NCT01583374|470102581|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584384|NCT01583374|470102582|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
130584385|NCT01583374|470102583|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584386|NCT01583374|470102584|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584387|NCT01583374|470102585|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584388|NCT01583374|470102586|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584389|NCT01583374|470102587|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584390|NCT01583374|470102588|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584391|NCT01583374|470102589|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
130584392|NCT01583374|470102581|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584393|NCT01583374|470102582|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584394|NCT01583374|470102583|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584395|NCT01583374|470102584|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584396|NCT01583374|470102585|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584397|NCT01583374|470102586|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584398|NCT01583374|470102587|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584399|NCT01583374|470102588|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
130584400|NCT01583374|470102589|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130584401|NCT01583374|470102581|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130584402|NCT01583374|470102582|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130584403|NCT01583374|470102583|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
130584404|NCT01583374|470102584|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130584405|NCT01583374|470102585|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130584406|NCT01583374|470102586|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130584407|NCT01583374|470102587|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130584408|NCT01583374|470102588|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130584409|NCT01583374|470102589|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130584410|NCT01583374|470102581|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130584411|NCT01583374|470102582|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130584412|NCT01583374|470102583|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130584413|NCT01583374|470102584|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
130584414|NCT01583374|470102585|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
130584415|NCT01583374|470102586|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130584416|NCT01583374|470102587|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
130584417|NCT01583374|470102588|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
130584418|NCT01583374|470102589|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130584419|NCT01583374|470102581|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584420|NCT01583374|470102582|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
130584421|NCT01583374|470102583|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
130584422|NCT01583374|470102584|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584423|NCT01583374|470102585|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
130584424|NCT01583374|470102586|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584425|NCT01583374|470102587|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584426|NCT01583374|470102588|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584427|NCT01583374|470102589|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130584428|NCT01583374|470102581|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130537176|NCT02626455|469933443|FG000|Overall Study|AE associated with clinical disease progression|0|||
130537177|NCT02626455|469933444|FG001|Overall Study|AE associated with clinical disease progression|0|||
130537178|NCT02626455|469933445|FG002|Overall Study|AE associated with clinical disease progression|0|||
130537179|NCT02626455|469933446|FG003|Overall Study|AE associated with clinical disease progression|0|||
130537180|NCT02626455|469933447|FG004|Overall Study|AE associated with clinical disease progression|0|||
130537181|NCT02626455|469933448|FG005|Overall Study|AE associated with clinical disease progression|1|||
130537182|NCT02626455|469933449|FG006|Overall Study|AE associated with clinical disease progression|2|||
130537183|NCT02626455|469933443|FG000|Overall Study|Study intervention never administered|0|||
130537184|NCT02626455|469933444|FG001|Overall Study|Study intervention never administered|0|||
130537185|NCT02626455|469933445|FG002|Overall Study|Study intervention never administered|0|||
130537186|NCT02626455|469933446|FG003|Overall Study|Study intervention never administered|0|||
130537187|NCT02626455|469933447|FG004|Overall Study|Study intervention never administered|0|||
130537188|NCT02626455|469933448|FG005|Overall Study|Study intervention never administered|1|||
130537189|NCT02626455|469933449|FG006|Overall Study|Study intervention never administered|3|||
130537190|NCT00166712|469934932|FG000|Overall Study|Death|0|||
130537191|NCT00166712|469934933|FG001|Overall Study|Death|1|||
130537192|NCT00166712|469934932|FG000|Overall Study|Adverse Event|1|||
130537193|NCT00166712|469934933|FG001|Overall Study|Adverse Event|0|||
130537194|NCT00166712|469934932|FG000|Overall Study|Withdrawal by Subject|1|||
130537195|NCT00166712|469934933|FG001|Overall Study|Withdrawal by Subject|2|||
130537196|NCT00166712|469934932|FG000|Overall Study|Physician Decision|0|||
130537197|NCT00166712|469934933|FG001|Overall Study|Physician Decision|2|||
130537198|NCT03986944|469934934|FG000|Overall Study|Adverse Event|1|||
130537199|NCT03986944|469934935|FG001|Overall Study|Adverse Event|2|||
130537200|NCT03986944|469934936|FG002|Overall Study|Adverse Event|3|||
130537201|NCT03986944|469934934|FG000|Overall Study|Protocol Violation|0|||
130537202|NCT03986944|469934935|FG001|Overall Study|Protocol Violation|1|||
130537203|NCT03986944|469934936|FG002|Overall Study|Protocol Violation|1|||
130537204|NCT03986944|469934934|FG000|Overall Study|Withdrawal by Subject|3|||
130537205|NCT03986944|469934935|FG001|Overall Study|Withdrawal by Subject|5|||
130537206|NCT03986944|469934936|FG002|Overall Study|Withdrawal by Subject|5|||
130537207|NCT03986944|469934934|FG000|Overall Study|Study termination|10|||
130537208|NCT03986944|469934935|FG001|Overall Study|Study termination|10|||
130537209|NCT03986944|469934936|FG002|Overall Study|Study termination|10|||
130537210|NCT03986944|469934934|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
130537211|NCT03986944|469934935|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
130537212|NCT03986944|469934936|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
130537213|NCT03986944|469934934|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
130537214|NCT03986944|469934935|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
130537215|NCT03986944|469934936|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
130537216|NCT01015560|469934938|FG000|Overall Study|Adverse Event|1|||
130537217|NCT01015560|469934938|FG000|Overall Study|Not protocol specified|1|||
130537218|NCT01015560|469934938|FG000|Overall Study|Withdrawal by Subject|1|||
130537219|NCT00640133|469934939|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
130537220|NCT00640133|469934940|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
130537221|NCT00640133|469934939|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
130537222|NCT00640133|469934940|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
130537223|NCT00640133|469934939|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
130537224|NCT00640133|469934940|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
130537225|NCT00128102|469934943|FG000|Overall Study|Site Discontinued|3|||
130537226|NCT00128102|469934944|FG001|Overall Study|Site Discontinued|6|||
130537227|NCT00128102|469934943|FG000|Overall Study|Other|0|||
130537228|NCT00128102|469934944|FG001|Overall Study|Other|1|||
130537229|NCT00128102|469934943|FG000|Overall Study|Progressive Disease|255|||
130537230|NCT00128102|469934944|FG001|Overall Study|Progressive Disease|285|||
130537231|NCT00128102|469934943|FG000|Overall Study|Adverse Event|34|||
130537232|NCT00128102|469934944|FG001|Overall Study|Adverse Event|11|||
130537233|NCT00128102|469934943|FG000|Overall Study|Death|12|||
130537234|NCT00128102|469934944|FG001|Overall Study|Death|13|||
130537235|NCT00128102|469934943|FG000|Overall Study|Physician Decision|3|||
130537236|NCT00128102|469934944|FG001|Overall Study|Physician Decision|3|||
130537237|NCT00128102|469934943|FG000|Overall Study|Withdrawal by Subject|19|||
130537238|NCT00128102|469934944|FG001|Overall Study|Withdrawal by Subject|11|||
130537239|NCT00128102|469934943|FG000|Overall Study|Protocol Violation|2|||
130537240|NCT00128102|469934944|FG001|Overall Study|Protocol Violation|2|||
130537241|NCT01202903|469934946|FG000|Overall Study|Administrative Probelms|1|||
130537242|NCT01202903|469934947|FG001|Overall Study|Administrative Probelms|4|||
130537243|NCT01202903|469934946|FG000|Overall Study|Protocol Violation|0|||
130537244|NCT01202903|469934947|FG001|Overall Study|Protocol Violation|1|||
130537245|NCT01202903|469934946|FG000|Overall Study|Death|1|||
130537246|NCT01202903|469934947|FG001|Overall Study|Death|0|||
130537247|NCT01202903|469934946|FG000|Overall Study|Lost to Follow-up|1|||
130584429|NCT01583374|470102582|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130584430|NCT01583374|470102583|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130584431|NCT01583374|470102584|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130584432|NCT01583374|470102585|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130584433|NCT01583374|470102586|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
130584434|NCT01583374|470102587|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130584435|NCT01583374|470102588|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130584436|NCT01583374|470102589|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130584437|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
130584438|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
130584439|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130584440|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130584441|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
130584442|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130584443|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130584444|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
130584445|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
130584446|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
130584447|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130584448|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
130584449|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
130584450|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
130584451|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
130584452|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130584453|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
130584454|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130584455|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584456|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584457|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584458|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584459|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130584460|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584461|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130584462|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130584463|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130584464|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
130537248|NCT01202903|469934947|FG001|Overall Study|Lost to Follow-up|1|||
130537249|NCT01202903|469934946|FG000|Overall Study|Lack of Efficacy|1|||
130537250|NCT01202903|469934947|FG001|Overall Study|Lack of Efficacy|3|||
130537251|NCT01202903|469934946|FG000|Overall Study|Adverse Event|3|||
130537252|NCT01202903|469934947|FG001|Overall Study|Adverse Event|3|||
130537253|NCT01202903|469934946|FG000|Overall Study|Withdrawal by Subject|4|||
130537254|NCT01202903|469934947|FG001|Overall Study|Withdrawal by Subject|4|||
130537255|NCT01302080|469934948|FG000|Overall Study|Withdrew Consent|92|||
130537256|NCT01302080|469934949|FG001|Overall Study|Withdrew Consent|39|||
130537257|NCT01302080|469934948|FG000|Overall Study|Patient/Family Moved|28|||
130537258|NCT01302080|469934949|FG001|Overall Study|Patient/Family Moved|3|||
130537259|NCT01302080|469934948|FG000|Overall Study|Lost to Follow-up|192|||
130537260|NCT01302080|469934949|FG001|Overall Study|Lost to Follow-up|93|||
130537261|NCT01302080|469934948|FG000|Overall Study|Death|1|||
130537262|NCT01302080|469934949|FG001|Overall Study|Death|0|||
130537263|NCT01302080|469934948|FG000|Overall Study|Other|52|||
130537264|NCT01302080|469934949|FG001|Overall Study|Other|8|||
130537265|NCT01302080|469934948|FG000|Overall Study|Reason Missing For Discontinuation|1|||
130537266|NCT01302080|469934949|FG001|Overall Study|Reason Missing For Discontinuation|0|||
130537267|NCT03339245|469934952|FG000|Overall Study|Adverse Event|1|||
130537268|NCT03339245|469934953|FG001|Overall Study|Adverse Event|1|||
130537269|NCT03339245|469934952|FG000|Overall Study|Withdrawal by Subject|1|||
130537270|NCT03339245|469934953|FG001|Overall Study|Withdrawal by Subject|0|||
130537271|NCT00837694|469934954|FG000|Overall Study|Lost to Follow-up|2|||
130537272|NCT00837694|469934955|FG001|Overall Study|Lost to Follow-up|0|||
130537273|NCT00837694|469934956|FG002|Overall Study|Lost to Follow-up|2|||
130537274|NCT00837694|469934957|FG003|Overall Study|Lost to Follow-up|1|||
130537275|NCT00837694|469934958|FG004|Overall Study|Lost to Follow-up|1|||
130537276|NCT00837694|469934959|FG005|Overall Study|Lost to Follow-up|1|||
130537277|NCT00306670|469934966|FG000|Overall Study|patients recruited; Genentech, the st|0|||
130537278|NCT00306670|469934967|FG001|Overall Study|patients recruited; Genentech, the st|2|||
130537279|NCT02735577|469934971|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
130537280|NCT02735577|469934971|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
130537281|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
130537282|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
130537283|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
130537284|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
130537285|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
130537286|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
130537287|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
130537288|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
130537289|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
130537290|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
130537291|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537292|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537293|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
130537294|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
130537295|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
130537296|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
130537297|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
130537298|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
130537299|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
130537300|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
130537301|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
130537302|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
130537303|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
130537304|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
130537305|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
130537306|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537307|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
130537308|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537309|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537310|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537311|NCT00833833|469934972|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
130537312|NCT00833833|469934973|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
130537313|NCT00833833|469934974|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
130537314|NCT00833833|469934975|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
130537315|NCT00833833|469934976|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
130537316|NCT00833833|469934977|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
130537317|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
130537318|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
130537319|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
130537320|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
130537321|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
130537322|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
130537323|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
130537324|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
130537325|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
130537326|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
130537327|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
130537328|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
130537329|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
130537330|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
130537331|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
130537332|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
130584465|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
130537333|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
130537334|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
130537335|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537336|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537337|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130537338|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130584466|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
130584467|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
130584468|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
130584469|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
130584470|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
130584471|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
130584472|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
130584473|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584474|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584475|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584476|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584477|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
130584478|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584479|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
130584480|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584481|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
130584482|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130584483|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130584484|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130584485|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130584486|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130584487|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130584488|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130584489|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130584490|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130584491|NCT01583374|470102581|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130584492|NCT01583374|470102582|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
130584493|NCT01583374|470102583|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130584494|NCT01583374|470102584|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
130584495|NCT01583374|470102585|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130584496|NCT01583374|470102586|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130584497|NCT01583374|470102587|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
130584498|NCT01583374|470102588|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130584499|NCT01583374|470102589|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130584500|NCT01292057|470102590|FG000|Overall Study|Protocol Violation|1|||
130584501|NCT01292057|470102591|FG001|Overall Study|Protocol Violation|1|||
130584502|NCT01292057|470102590|FG000|Overall Study|Lost to Follow-up|1|||
130584503|NCT01292057|470102591|FG001|Overall Study|Lost to Follow-up|1|||
130584504|NCT01506882|470102596|FG000|Overall Study|Lack of Efficacy|4|||
130584505|NCT01506882|470102597|FG001|Overall Study|Lack of Efficacy|3|||
130584506|NCT01506882|470102596|FG000|Overall Study|Lost to Follow-up|1|||
130584507|NCT01506882|470102597|FG001|Overall Study|Lost to Follow-up|0|||
130584508|NCT01506882|470102596|FG000|Overall Study|Withdrawal by Subject|9|||
130584509|NCT01506882|470102597|FG001|Overall Study|Withdrawal by Subject|3|||
130584510|NCT01506882|470102596|FG000|Overall Study|SAE, non-fatal|2|||
130584511|NCT01506882|470102597|FG001|Overall Study|SAE, non-fatal|0|||
130584512|NCT01506882|470102596|FG000|Overall Study|AE, non-serious non-fatal|3|||
130584513|NCT01506882|470102597|FG001|Overall Study|AE, non-serious non-fatal|1|||
130584514|NCT01506882|470102596|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130584515|NCT01506882|470102597|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130584516|NCT01506882|470102596|FG000|Overall Study|Other Reason|2|||
130584517|NCT01506882|470102597|FG001|Overall Study|Other Reason|0|||
130584518|NCT00821678|470102602|FG000|Overall Study|Withdrawal by Subject|8|||
130584519|NCT00821678|470102603|FG001|Overall Study|Withdrawal by Subject|0|||
130537339|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
130537340|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
130537341|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537342|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537343|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537344|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
130537345|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
130537346|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
130537347|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
130537348|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
130537349|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
130537350|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
130537351|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
130537352|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
130537353|NCT00833833|469934972|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
130537354|NCT00833833|469934973|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
130537355|NCT00833833|469934974|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
130537356|NCT00833833|469934975|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
130537357|NCT00833833|469934976|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
130537358|NCT00833833|469934977|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
130537359|NCT01994837|469934978|FG000|Overall Study|Progressive disease per protocol|23|||
130537360|NCT01994837|469934978|FG000|Overall Study|Adv event related to progressive disease|3|||
130537361|NCT01994837|469934978|FG000|Overall Study|Fatal progressive disease|2|||
130537362|NCT01994837|469934978|FG000|Overall Study|Adverse event not related to progression|1|||
130537363|NCT01994837|469934978|FG000|Overall Study|Chose palliative care|1|||
130537364|NCT01994837|469934978|FG000|Overall Study|Proceeded to transplant|1|||
130537365|NCT01994837|469934978|FG000|Overall Study|Removed from study due to no response|1|||
130537366|NCT01127893|469934979|FG000|Overall Study|Study Termination by the Sponsor|1|||
130537367|NCT00574873|469934980|FG000|Overall Study|Withdrawal by Subject|18|||
130537368|NCT00574873|469934981|FG001|Overall Study|Withdrawal by Subject|19|||
130537369|NCT00574873|469934980|FG000|Overall Study|Investigator request|18|||
130537370|NCT00574873|469934981|FG001|Overall Study|Investigator request|8|||
130537371|NCT00574873|469934980|FG000|Overall Study|Death|15|||
130537372|NCT00574873|469934981|FG001|Overall Study|Death|14|||
130537373|NCT00574873|469934980|FG000|Overall Study|Lost to Follow-up|14|||
130537374|NCT00574873|469934981|FG001|Overall Study|Lost to Follow-up|5|||
130537375|NCT00574873|469934980|FG000|Overall Study|Other|40|||
130537376|NCT00574873|469934981|FG001|Overall Study|Other|4|||
130537377|NCT00574873|469934980|FG000|Overall Study|Discontinuation of study by sponsor|5|||
130537378|NCT00574873|469934981|FG001|Overall Study|Discontinuation of study by sponsor|199|||
130537379|NCT00574873|469934980|FG000|Overall Study|Blank, site closed per local regulations|2|||
130537380|NCT00574873|469934981|FG001|Overall Study|Blank, site closed per local regulations|2|||
130537381|NCT00574873|469934980|FG000|Overall Study|Extension Study|126|||
130537382|NCT00574873|469934981|FG001|Overall Study|Extension Study|0|||
130537383|NCT03568318|469934987|FG000|Overall Study|Adverse Event|3|||
130537384|NCT03568318|469934988|FG001|Overall Study|Adverse Event|1|||
130537385|NCT03568318|469934989|FG002|Overall Study|Adverse Event|1|||
130537386|NCT03568318|469934990|FG003|Overall Study|Adverse Event|0|||
130537387|NCT03568318|469934991|FG004|Overall Study|Adverse Event|1|||
130537388|NCT03568318|469934992|FG005|Overall Study|Adverse Event|0|||
130537389|NCT03568318|469934987|FG000|Overall Study|Withdrawal by Subject|6|||
130537390|NCT03568318|469934988|FG001|Overall Study|Withdrawal by Subject|5|||
130537391|NCT03568318|469934989|FG002|Overall Study|Withdrawal by Subject|2|||
130537392|NCT03568318|469934990|FG003|Overall Study|Withdrawal by Subject|1|||
130537393|NCT03568318|469934991|FG004|Overall Study|Withdrawal by Subject|0|||
130537394|NCT03568318|469934992|FG005|Overall Study|Withdrawal by Subject|0|||
130537395|NCT03568318|469934987|FG000|Overall Study|Lost to Follow-up|3|||
130537396|NCT03568318|469934988|FG001|Overall Study|Lost to Follow-up|2|||
130537397|NCT03568318|469934989|FG002|Overall Study|Lost to Follow-up|2|||
130537398|NCT03568318|469934990|FG003|Overall Study|Lost to Follow-up|2|||
130537399|NCT03568318|469934991|FG004|Overall Study|Lost to Follow-up|1|||
130537400|NCT03568318|469934992|FG005|Overall Study|Lost to Follow-up|0|||
130537401|NCT03568318|469934987|FG000|Overall Study|Other|3|||
130537402|NCT03568318|469934988|FG001|Overall Study|Other|1|||
130537403|NCT03568318|469934989|FG002|Overall Study|Other|3|||
130537404|NCT03568318|469934990|FG003|Overall Study|Other|0|||
130537405|NCT03568318|469934991|FG004|Overall Study|Other|0|||
130537406|NCT03568318|469934992|FG005|Overall Study|Other|0|||
130537407|NCT03568318|469934987|FG000|Overall Study|Ongoing at Time of Analysis|5|||
130537408|NCT03568318|469934988|FG001|Overall Study|Ongoing at Time of Analysis|3|||
130537409|NCT03568318|469934989|FG002|Overall Study|Ongoing at Time of Analysis|2|||
130537410|NCT03568318|469934990|FG003|Overall Study|Ongoing at Time of Analysis|1|||
130537411|NCT03568318|469934991|FG004|Overall Study|Ongoing at Time of Analysis|0|||
130537412|NCT03568318|469934992|FG005|Overall Study|Ongoing at Time of Analysis|0|||
130537413|NCT01638429|469934995|FG000|Overall Study|Withdrawal by Subject|1|||
130537414|NCT03207451|469934996|FG000|Overall Study|scheduling conflict|1|||
130537415|NCT03207451|469934997|FG001|Overall Study|scheduling conflict|0|||
130537416|NCT03207451|469934998|FG002|Overall Study|scheduling conflict|2|||
130537417|NCT03207451|469934999|FG003|Overall Study|scheduling conflict|2|||
130537418|NCT03207451|469934996|FG000|Overall Study|Adverse Event|0|||
130537419|NCT03207451|469934997|FG001|Overall Study|Adverse Event|0|||
130537420|NCT03207451|469934998|FG002|Overall Study|Adverse Event|0|||
130537421|NCT03207451|469934999|FG003|Overall Study|Adverse Event|1|||
130537422|NCT02040584|469935001|FG000|Overall Study|Adverse Event|13|||
130537423|NCT02040584|469935002|FG001|Overall Study|Adverse Event|6|||
130537424|NCT02040584|469935001|FG000|Overall Study|Protocol Violation|9|||
130537425|NCT02040584|469935002|FG001|Overall Study|Protocol Violation|11|||
130537426|NCT02040584|469935001|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130537427|NCT02040584|469935002|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130537428|NCT02040584|469935001|FG000|Overall Study|Death|6|||
130537429|NCT02040584|469935002|FG001|Overall Study|Death|3|||
130537430|NCT02040584|469935001|FG000|Overall Study|Transplant rejection/retransplant|0|||
130537431|NCT02040584|469935002|FG001|Overall Study|Transplant rejection/retransplant|1|||
130537432|NCT02040584|469935001|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
130537433|NCT02040584|469935002|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
130537434|NCT01802567|469935003|FG000|Overall Study|Withdrawal by Subject|2|||
130537435|NCT01802567|469935003|FG000|Overall Study|Physician Decision|1|||
130537436|NCT01802567|469935003|FG000|Overall Study|Lack of Efficacy|7|||
130537437|NCT01802567|469935003|FG000|Overall Study|Consented but did not start therapy|7|||
130537438|NCT01802567|469935003|FG000|Overall Study|Protocol Violation|1|||
130537439|NCT03167359|469935004|FG000|Overall Study|Physician Decision|1|||
130537440|NCT03167359|469935004|FG000|Overall Study|Lost to Follow-up|1|||
130584520|NCT00821678|470102602|FG000|Overall Study|Lost to Follow-up|13|||
130584521|NCT00821678|470102603|FG001|Overall Study|Lost to Follow-up|12|||
130584522|NCT00821678|470102602|FG000|Overall Study|Death|0|||
130584523|NCT00821678|470102603|FG001|Overall Study|Death|2|||
130584524|NCT00376961|470104754|FG000|Initial Registration|Adverse Event|1|||
130584525|NCT00376961|470104755|FG001|Initial Registration|Adverse Event|0|||
130584526|NCT00376961|470104754|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
130584527|NCT00376961|470104755|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130584528|NCT00376961|470104754|FG000|Initial Registration|Progression/relapse|1|||
130584529|NCT00376961|470104755|FG001|Initial Registration|Progression/relapse|0|||
130584530|NCT00376961|470104754|FG000|Initial Registration|Ineligible|3|||
130584531|NCT00376961|470104755|FG001|Initial Registration|Ineligible|0|||
130584532|NCT00376961|470104754|FG000|Maintenance|Adverse Event|0|||
130584533|NCT00376961|470104755|FG001|Maintenance|Adverse Event|1|||
130584534|NCT00376961|470104754|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
130584535|NCT00376961|470104755|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
130584536|NCT00376961|470104754|FG000|Maintenance|Progression/relapse|0|||
130584537|NCT00376961|470104755|FG001|Maintenance|Progression/relapse|18|||
130584538|NCT00376961|470104754|FG000|Maintenance|Ineligible|0|||
130584539|NCT00376961|470104755|FG001|Maintenance|Ineligible|3|||
130584540|NCT01059448|470104756|FG000|Overall Study|Adverse Event|1|||
130584541|NCT01059448|470104757|FG001|Overall Study|Adverse Event|3|||
130584542|NCT01059448|470104758|FG002|Overall Study|Adverse Event|0|||
130584543|NCT01059448|470104759|FG003|Overall Study|Adverse Event|1|||
130584544|NCT01059448|470104756|FG000|Overall Study|Withdrawal by Subject|2|||
130584545|NCT01059448|470104757|FG001|Overall Study|Withdrawal by Subject|0|||
130584546|NCT01059448|470104758|FG002|Overall Study|Withdrawal by Subject|2|||
130584547|NCT01059448|470104759|FG003|Overall Study|Withdrawal by Subject|4|||
130584548|NCT01059448|470104756|FG000|Overall Study|Disease Progression|2|||
130584549|NCT01059448|470104757|FG001|Overall Study|Disease Progression|1|||
130584550|NCT01059448|470104758|FG002|Overall Study|Disease Progression|4|||
130584551|NCT01059448|470104759|FG003|Overall Study|Disease Progression|2|||
130584552|NCT01059448|470104756|FG000|Overall Study|Administrative Decision|43|||
130584553|NCT01059448|470104757|FG001|Overall Study|Administrative Decision|49|||
130584554|NCT01059448|470104758|FG002|Overall Study|Administrative Decision|45|||
130584555|NCT01059448|470104759|FG003|Overall Study|Administrative Decision|46|||
130584556|NCT01059448|470104756|FG000|Overall Study|Lost to Follow-up|0|||
130584557|NCT01059448|470104757|FG001|Overall Study|Lost to Follow-up|0|||
130584558|NCT01059448|470104758|FG002|Overall Study|Lost to Follow-up|2|||
130584559|NCT01059448|470104759|FG003|Overall Study|Lost to Follow-up|0|||
130584560|NCT01059448|470104756|FG000|Overall Study|Death|0|||
130584561|NCT01059448|470104757|FG001|Overall Study|Death|1|||
130584562|NCT01059448|470104758|FG002|Overall Study|Death|0|||
130584563|NCT01059448|470104759|FG003|Overall Study|Death|0|||
130584564|NCT01059448|470104756|FG000|Overall Study|Other|1|||
130584565|NCT01059448|470104757|FG001|Overall Study|Other|1|||
130584566|NCT01059448|470104758|FG002|Overall Study|Other|0|||
130584567|NCT01059448|470104759|FG003|Overall Study|Other|1|||
130584568|NCT02591615|470104760|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130584569|NCT02591615|470104761|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130584570|NCT02591615|470104762|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
130584571|NCT02591615|470104763|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130584572|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130584573|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
130584574|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130584575|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130584576|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
130584577|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
130584578|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
130584579|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
130584580|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
130584581|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
130584582|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
130584583|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
130584584|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
130584585|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
130584586|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
130584587|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
130584588|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130584589|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
130584590|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130584591|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130584592|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
130584593|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
130584594|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
130584595|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
130584596|NCT02591615|470104760|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
130584597|NCT02591615|470104761|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130584598|NCT02591615|470104762|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130584599|NCT02591615|470104763|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130584600|NCT02591615|470104760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
130584601|NCT02591615|470104761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
130584602|NCT02591615|470104762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
130584603|NCT02591615|470104763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
130584604|NCT02591615|470104760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
130584605|NCT02591615|470104761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
130584606|NCT02591615|470104762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
130584607|NCT02591615|470104763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
130584608|NCT02591615|470104760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
130584609|NCT02591615|470104761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
130584610|NCT02591615|470104762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
130584611|NCT02591615|470104763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
130584612|NCT02591615|470104760|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130537441|NCT03339583|469935005|FG000|First Intervention (14 Days)|Adverse Event|1|||
130537442|NCT03339583|469935006|FG001|First Intervention (14 Days)|Adverse Event|0|||
130537443|NCT03339583|469935005|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
130537444|NCT03339583|469935006|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
130537445|NCT03339583|469935005|FG000|Second Intervention (14 Days)|Adverse Event|0|||
130537446|NCT03339583|469935006|FG001|Second Intervention (14 Days)|Adverse Event|1|||
130537447|NCT03339583|469935005|FG000|Follow-up (14 Days)|Physician Decision|6|||
130537448|NCT03339583|469935006|FG001|Follow-up (14 Days)|Physician Decision|3|||
130537449|NCT01896557|469935007|FG000|Clopidogrel Alone|Adverse Event|1|||
130537450|NCT01896557|469935008|FG001|Clopidogrel Alone|Adverse Event|0|||
130537451|NCT01896557|469935007|FG000|Clopidogrel + GI Protector|low adherence|1|||
130537452|NCT01896557|469935008|FG001|Clopidogrel + GI Protector|low adherence|1|||
130537453|NCT01896557|469935007|FG000|Clopidogrel + GI Protector|Reading error|1|||
130537454|NCT01896557|469935008|FG001|Clopidogrel + GI Protector|Reading error|3|||
130537455|NCT00734591|469935009|FG000|Screening for Prospective Period|Site did not participate|1604|||
130537456|NCT00734591|469935010|FG001|Screening for Prospective Period|Site did not participate|1488|||
130537457|NCT00734591|469935009|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
130537458|NCT00734591|469935010|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
130537459|NCT00734591|469935009|FG000|Prospective Period|Withdrawal by Subject|11|||
130537460|NCT00734591|469935010|FG001|Prospective Period|Withdrawal by Subject|9|||
130537461|NCT00734591|469935009|FG000|Prospective Period|Lost to Follow-up|37|||
130537462|NCT00734591|469935010|FG001|Prospective Period|Lost to Follow-up|33|||
130537463|NCT00734591|469935009|FG000|Prospective Period|Study Terminated|1|||
130537464|NCT00734591|469935010|FG001|Prospective Period|Study Terminated|0|||
130537465|NCT00734591|469935009|FG000|Prospective Period|Other|2|||
130537466|NCT00734591|469935010|FG001|Prospective Period|Other|2|||
130537467|NCT02236988|469935013|FG000|Overall Study|Lost to Follow-up|0|||
130537468|NCT02236988|469935014|FG001|Overall Study|Lost to Follow-up|0|||
130537469|NCT02236988|469935015|FG002|Overall Study|Lost to Follow-up|0|||
130537470|NCT02236988|469935016|FG003|Overall Study|Lost to Follow-up|1|||
130537471|NCT02236988|469935013|FG000|Overall Study|Unable to Comply with Study Visits|0|||
130537472|NCT02236988|469935014|FG001|Overall Study|Unable to Comply with Study Visits|0|||
130537473|NCT02236988|469935015|FG002|Overall Study|Unable to Comply with Study Visits|0|||
130537474|NCT02236988|469935016|FG003|Overall Study|Unable to Comply with Study Visits|2|||
130537475|NCT00939822|469935019|FG000|Overall Study|Lost to Follow-up|1|||
130537476|NCT00939822|469935020|FG001|Overall Study|Lost to Follow-up|0|||
130537477|NCT00939822|469935019|FG000|Overall Study|withdrew from study due to busy schedule|1|||
130537478|NCT00939822|469935020|FG001|Overall Study|withdrew from study due to busy schedule|1|||
130537479|NCT00939822|469935019|FG000|Overall Study|Mental health issues|0|||
130537480|NCT00939822|469935020|FG001|Overall Study|Mental health issues|2|||
130537481|NCT03014011|469935021|FG000|First Intervention|Withdrawal by Subject|1|||
130537482|NCT03014011|469935022|FG001|First Intervention|Withdrawal by Subject|0|||
130537483|NCT03014011|469935021|FG000|Washout|Withdrawal by Subject|1|||
130537484|NCT03014011|469935022|FG001|Washout|Withdrawal by Subject|0|||
130537485|NCT02416453|469935023|FG000|Overall Study|Adverse Event|0|||
130584613|NCT02591615|470104761|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130584614|NCT02591615|470104762|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
130584615|NCT02591615|470104763|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130584616|NCT02591615|470104760|FG000|Maintenance MK-3475|Adverse Event|0|||
130584617|NCT02591615|470104761|FG001|Maintenance MK-3475|Adverse Event|3|||
130584618|NCT02591615|470104762|FG002|Maintenance MK-3475|Adverse Event|1|||
130584619|NCT02591615|470104763|FG003|Maintenance MK-3475|Adverse Event|2|||
130584620|NCT02591615|470104760|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
130584621|NCT02591615|470104761|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
130584622|NCT02591615|470104762|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
130584623|NCT02591615|470104763|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
130584624|NCT02591615|470104760|FG000|Maintenance MK-3475|Death|0|||
130584625|NCT02591615|470104761|FG001|Maintenance MK-3475|Death|1|||
130584626|NCT02591615|470104762|FG002|Maintenance MK-3475|Death|1|||
130584627|NCT02591615|470104763|FG003|Maintenance MK-3475|Death|0|||
130584628|NCT02591615|470104760|FG000|Maintenance MK-3475|Physician discretion|0|||
130584629|NCT02591615|470104761|FG001|Maintenance MK-3475|Physician discretion|0|||
130584630|NCT02591615|470104762|FG002|Maintenance MK-3475|Physician discretion|1|||
130584631|NCT02591615|470104763|FG003|Maintenance MK-3475|Physician discretion|0|||
130584632|NCT02591615|470104760|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
130584633|NCT02591615|470104761|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
130584634|NCT02591615|470104762|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
130584635|NCT02591615|470104763|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
130584636|NCT02591615|470104760|FG000|Maintenance MK-3475|In active treatment|2|||
130584637|NCT02591615|470104761|FG001|Maintenance MK-3475|In active treatment|0|||
130584638|NCT02591615|470104762|FG002|Maintenance MK-3475|In active treatment|0|||
130584639|NCT02591615|470104763|FG003|Maintenance MK-3475|In active treatment|1|||
130584640|NCT04188197|470104764|FG000|Overall Study|Lost to Follow-up|4|||
130584641|NCT04188197|470104765|FG001|Overall Study|Lost to Follow-up|1|||
130584642|NCT04188197|470104764|FG000|Overall Study|Withdrawal by Subject|1|||
130584643|NCT04188197|470104765|FG001|Overall Study|Withdrawal by Subject|1|||
130584644|NCT04188197|470104764|FG000|Overall Study|Pregnancy|0|||
130584645|NCT04188197|470104765|FG001|Overall Study|Pregnancy|1|||
130584646|NCT00809328|470104770|FG000|Overall Study|Lack of Efficacy|18|||
130584647|NCT00809328|470104770|FG000|Overall Study|Adverse Event|6|||
130584648|NCT00809328|470104770|FG000|Overall Study|Protocol Violation|3|||
130584649|NCT00809328|470104770|FG000|Overall Study|Withdrawal by Subject|2|||
130584650|NCT00066690|470104773|FG000|Overall Study|Adverse Event|145|||
130584651|NCT00066690|470104774|FG001|Overall Study|Adverse Event|58|||
130584652|NCT00066690|470104775|FG002|Overall Study|Adverse Event|126|||
130584653|NCT00066690|470104773|FG000|Overall Study|Death|3|||
130584654|NCT00066690|470104774|FG001|Overall Study|Death|0|||
130584655|NCT00066690|470104775|FG002|Overall Study|Death|2|||
130584656|NCT00066690|470104773|FG000|Overall Study|Lack of Efficacy|114|||
130584657|NCT00066690|470104774|FG001|Overall Study|Lack of Efficacy|110|||
130584658|NCT00066690|470104775|FG002|Overall Study|Lack of Efficacy|76|||
130584659|NCT00066690|470104773|FG000|Overall Study|Lost to Follow-up|40|||
130584660|NCT00066690|470104774|FG001|Overall Study|Lost to Follow-up|21|||
130584661|NCT00066690|470104775|FG002|Overall Study|Lost to Follow-up|29|||
130584662|NCT00066690|470104773|FG000|Overall Study|Withdrawal by Subject|50|||
130584663|NCT00066690|470104774|FG001|Overall Study|Withdrawal by Subject|55|||
130584664|NCT00066690|470104775|FG002|Overall Study|Withdrawal by Subject|49|||
130584665|NCT00066690|470104773|FG000|Overall Study|Treatment Ongoing|246|||
130584666|NCT00066690|470104774|FG001|Overall Study|Treatment Ongoing|278|||
130537486|NCT02416453|469935024|FG001|Overall Study|Adverse Event|0|||
130537487|NCT02416453|469935025|FG002|Overall Study|Adverse Event|0|||
130537488|NCT02416453|469935026|FG003|Overall Study|Adverse Event|2|||
130537489|NCT02416453|469935027|FG004|Overall Study|Adverse Event|0|||
130537490|NCT02416453|469935028|FG005|Overall Study|Adverse Event|1|||
130537491|NCT02416453|469935029|FG006|Overall Study|Adverse Event|0|||
130537492|NCT02416453|469935030|FG007|Overall Study|Adverse Event|0|||
130537493|NCT02416453|469935031|FG008|Overall Study|Adverse Event|0|||
130584667|NCT00066690|470104775|FG002|Overall Study|Treatment Ongoing|282|||
130584668|NCT03706365|470104779|FG000|Overall Study|Lost to Follow-up|7|||
130584669|NCT03706365|470104780|FG001|Overall Study|Lost to Follow-up|0|||
130584670|NCT03706365|470104779|FG000|Overall Study|Withdrawal by Subject|17|||
130584671|NCT03706365|470104780|FG001|Overall Study|Withdrawal by Subject|15|||
130584672|NCT03706365|470104779|FG000|Overall Study|On Study Treatment|51|||
130584673|NCT03706365|470104780|FG001|Overall Study|On Study Treatment|51|||
130584674|NCT03116113|470104781|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584675|NCT03116113|470104782|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584676|NCT03116113|470104783|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584677|NCT03116113|470104784|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584678|NCT03116113|470104785|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584679|NCT03116113|470104786|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584680|NCT03116113|470104787|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130584681|NCT03116113|470104788|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
130537494|NCT02416453|469935032|FG009|Overall Study|Adverse Event|0|||
130584682|NCT03116113|470104789|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
130584683|NCT02159807|470104791|FG000|Overall Study|Adverse Event|0|||
130584684|NCT02159807|470104792|FG001|Overall Study|Adverse Event|0|||
130584685|NCT02159807|470104793|FG002|Overall Study|Adverse Event|1|||
130584686|NCT02159807|470104791|FG000|Overall Study|No CSF|1|||
130584687|NCT02159807|470104792|FG001|Overall Study|No CSF|1|||
130584688|NCT02159807|470104793|FG002|Overall Study|No CSF|1|||
130584689|NCT02159807|470104791|FG000|Overall Study|elevated blood pressure|0|||
130584690|NCT02159807|470104792|FG001|Overall Study|elevated blood pressure|0|||
130584691|NCT02159807|470104793|FG002|Overall Study|elevated blood pressure|1|||
130584692|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
130584693|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
130584694|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
130584695|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
130584696|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
130584697|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
130584698|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
130584699|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
130584700|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130584701|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130584702|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130584703|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
130584704|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
130584705|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130584706|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130584707|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
130584708|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
130584709|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
130584710|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130584711|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130584712|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
130584713|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130584714|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130584715|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130584716|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130584717|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
130584718|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
130584719|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
130584720|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
130584721|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
130584722|NCT05195528|470104794|FG000|Placebo-controlled Treatment Period|Other|0|||
130584723|NCT05195528|470104795|FG001|Placebo-controlled Treatment Period|Other|0|||
130584724|NCT05195528|470104796|FG002|Placebo-controlled Treatment Period|Other|1|||
130584725|NCT05195528|470104797|FG003|Placebo-controlled Treatment Period|Other|0|||
130584726|NCT05195528|470104798|FG004|Placebo-controlled Treatment Period|Other|0|||
130584727|NCT05195528|470104794|FG000|Extension Period|PTE or AE or SAE|0|||
130584728|NCT05195528|470104795|FG001|Extension Period|PTE or AE or SAE|4|||
130584729|NCT05195528|470104796|FG002|Extension Period|PTE or AE or SAE|5|||
130584730|NCT05195528|470104797|FG003|Extension Period|PTE or AE or SAE|4|||
130584731|NCT05195528|470104798|FG004|Extension Period|PTE or AE or SAE|4|||
130584732|NCT05195528|470104794|FG000|Extension Period|Protocol Violation|0|||
130584733|NCT05195528|470104795|FG001|Extension Period|Protocol Violation|2|||
130584734|NCT05195528|470104796|FG002|Extension Period|Protocol Violation|1|||
130584735|NCT05195528|470104797|FG003|Extension Period|Protocol Violation|0|||
130584736|NCT05195528|470104798|FG004|Extension Period|Protocol Violation|1|||
130584737|NCT05195528|470104794|FG000|Extension Period|Lost to Follow-up|0|||
130584738|NCT05195528|470104795|FG001|Extension Period|Lost to Follow-up|6|||
130584739|NCT05195528|470104796|FG002|Extension Period|Lost to Follow-up|13|||
130584740|NCT05195528|470104797|FG003|Extension Period|Lost to Follow-up|3|||
130584741|NCT05195528|470104798|FG004|Extension Period|Lost to Follow-up|7|||
130584742|NCT05195528|470104794|FG000|Extension Period|Withdrawal by Subject|0|||
130584743|NCT05195528|470104795|FG001|Extension Period|Withdrawal by Subject|12|||
130584744|NCT05195528|470104796|FG002|Extension Period|Withdrawal by Subject|9|||
130537495|NCT02416453|469935033|FG010|Overall Study|Adverse Event|0|||
130537496|NCT02416453|469935023|FG000|Overall Study|Lost to Follow-up|1|||
130537497|NCT02416453|469935024|FG001|Overall Study|Lost to Follow-up|3|||
130537498|NCT02416453|469935025|FG002|Overall Study|Lost to Follow-up|0|||
130537499|NCT02416453|469935026|FG003|Overall Study|Lost to Follow-up|8|||
130537500|NCT02416453|469935027|FG004|Overall Study|Lost to Follow-up|0|||
130537501|NCT02416453|469935028|FG005|Overall Study|Lost to Follow-up|5|||
130537502|NCT02416453|469935029|FG006|Overall Study|Lost to Follow-up|1|||
130537503|NCT02416453|469935030|FG007|Overall Study|Lost to Follow-up|3|||
130537504|NCT02416453|469935031|FG008|Overall Study|Lost to Follow-up|1|||
130537505|NCT02416453|469935032|FG009|Overall Study|Lost to Follow-up|0|||
130537506|NCT02416453|469935033|FG010|Overall Study|Lost to Follow-up|0|||
130537507|NCT02416453|469935023|FG000|Overall Study|Physician Decision|0|||
130537508|NCT02416453|469935024|FG001|Overall Study|Physician Decision|0|||
130537509|NCT02416453|469935025|FG002|Overall Study|Physician Decision|0|||
130537510|NCT02416453|469935026|FG003|Overall Study|Physician Decision|0|||
130537511|NCT02416453|469935027|FG004|Overall Study|Physician Decision|0|||
130537512|NCT02416453|469935028|FG005|Overall Study|Physician Decision|1|||
130537513|NCT02416453|469935029|FG006|Overall Study|Physician Decision|1|||
130537514|NCT02416453|469935030|FG007|Overall Study|Physician Decision|1|||
130537515|NCT02416453|469935031|FG008|Overall Study|Physician Decision|0|||
130537516|NCT02416453|469935032|FG009|Overall Study|Physician Decision|0|||
130537517|NCT02416453|469935033|FG010|Overall Study|Physician Decision|0|||
130537518|NCT02416453|469935023|FG000|Overall Study|Withdrawal by Subject|2|||
130537519|NCT02416453|469935024|FG001|Overall Study|Withdrawal by Subject|0|||
130537520|NCT02416453|469935025|FG002|Overall Study|Withdrawal by Subject|0|||
130537521|NCT02416453|469935026|FG003|Overall Study|Withdrawal by Subject|5|||
130537522|NCT02416453|469935027|FG004|Overall Study|Withdrawal by Subject|1|||
130537523|NCT02416453|469935028|FG005|Overall Study|Withdrawal by Subject|8|||
130537524|NCT02416453|469935029|FG006|Overall Study|Withdrawal by Subject|0|||
130537525|NCT02416453|469935030|FG007|Overall Study|Withdrawal by Subject|8|||
130537526|NCT02416453|469935031|FG008|Overall Study|Withdrawal by Subject|4|||
130537527|NCT02416453|469935032|FG009|Overall Study|Withdrawal by Subject|0|||
130537528|NCT02416453|469935033|FG010|Overall Study|Withdrawal by Subject|0|||
130537529|NCT02416453|469935023|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537530|NCT02416453|469935024|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537531|NCT02416453|469935025|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
130537532|NCT02416453|469935026|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537533|NCT02416453|469935027|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537534|NCT02416453|469935028|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537535|NCT02416453|469935029|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537536|NCT02416453|469935030|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537537|NCT02416453|469935031|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537538|NCT02416453|469935032|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537539|NCT02416453|469935033|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
130537540|NCT02416453|469935023|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537541|NCT02416453|469935024|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537542|NCT02416453|469935025|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537543|NCT02416453|469935026|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537544|NCT02416453|469935027|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537545|NCT02416453|469935028|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
130537546|NCT02416453|469935029|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537547|NCT02416453|469935030|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537548|NCT02416453|469935031|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537549|NCT02416453|469935032|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537550|NCT02416453|469935033|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130537551|NCT00132873|469935046|FG000|Overall Study|Adverse Event|3|||
130537552|NCT00132873|469935046|FG000|Overall Study|Lost to Follow-up|1|||
130537553|NCT00132873|469935046|FG000|Overall Study|Lack of Efficacy|1|||
130537554|NCT00132873|469935046|FG000|Overall Study|Withdrawal by Subject|3|||
130537555|NCT00132873|469935046|FG000|Overall Study|Planned Pregnancy|1|||
130537556|NCT02045875|469935047|FG000|Overall Study|Lost to Follow-up|3|||
130537557|NCT02045875|469935048|FG001|Overall Study|Lost to Follow-up|0|||
130537558|NCT02045875|469935047|FG000|Overall Study|Withdrawal by Subject|4|||
130537559|NCT02045875|469935048|FG001|Overall Study|Withdrawal by Subject|3|||
130537560|NCT01803282|469935052|FG000|Overall Study|Progressive Disease|4|||
130537561|NCT01803282|469935053|FG001|Overall Study|Progressive Disease|3|||
130537562|NCT01803282|469935054|FG002|Overall Study|Progressive Disease|6|||
130537563|NCT01803282|469935055|FG003|Overall Study|Progressive Disease|22|||
130537564|NCT01803282|469935056|FG004|Overall Study|Progressive Disease|5|||
130537565|NCT01803282|469935057|FG005|Overall Study|Progressive Disease|8|||
130537566|NCT01803282|469935058|FG006|Overall Study|Progressive Disease|23|||
130537567|NCT01803282|469935059|FG007|Overall Study|Progressive Disease|24|||
130537568|NCT01803282|469935060|FG008|Overall Study|Progressive Disease|3|||
130537569|NCT01803282|469935061|FG009|Overall Study|Progressive Disease|29|||
130537570|NCT01803282|469935062|FG010|Overall Study|Progressive Disease|6|||
130537571|NCT01803282|469935063|FG011|Overall Study|Progressive Disease|11|||
130537572|NCT01803282|469935052|FG000|Overall Study|Death|0|||
130537573|NCT01803282|469935053|FG001|Overall Study|Death|0|||
130537574|NCT01803282|469935054|FG002|Overall Study|Death|0|||
130537575|NCT01803282|469935055|FG003|Overall Study|Death|0|||
130537576|NCT01803282|469935056|FG004|Overall Study|Death|2|||
130537577|NCT01803282|469935057|FG005|Overall Study|Death|1|||
130537578|NCT01803282|469935058|FG006|Overall Study|Death|1|||
130537579|NCT01803282|469935059|FG007|Overall Study|Death|5|||
130537580|NCT01803282|469935060|FG008|Overall Study|Death|1|||
130537581|NCT01803282|469935061|FG009|Overall Study|Death|1|||
130537582|NCT01803282|469935062|FG010|Overall Study|Death|0|||
130537583|NCT01803282|469935063|FG011|Overall Study|Death|0|||
130537584|NCT01803282|469935052|FG000|Overall Study|Withdrew Consent|0|||
130537585|NCT01803282|469935053|FG001|Overall Study|Withdrew Consent|0|||
130537586|NCT01803282|469935054|FG002|Overall Study|Withdrew Consent|0|||
130537587|NCT01803282|469935055|FG003|Overall Study|Withdrew Consent|6|||
130537588|NCT01803282|469935056|FG004|Overall Study|Withdrew Consent|1|||
130537589|NCT01803282|469935057|FG005|Overall Study|Withdrew Consent|0|||
130537590|NCT01803282|469935058|FG006|Overall Study|Withdrew Consent|8|||
130537591|NCT01803282|469935059|FG007|Overall Study|Withdrew Consent|3|||
130537592|NCT01803282|469935060|FG008|Overall Study|Withdrew Consent|1|||
130537593|NCT01803282|469935061|FG009|Overall Study|Withdrew Consent|5|||
130537594|NCT01803282|469935062|FG010|Overall Study|Withdrew Consent|0|||
130537595|NCT01803282|469935063|FG011|Overall Study|Withdrew Consent|1|||
130537596|NCT01803282|469935052|FG000|Overall Study|Investigator's Discretion|0|||
130537597|NCT01803282|469935053|FG001|Overall Study|Investigator's Discretion|0|||
130537598|NCT01803282|469935054|FG002|Overall Study|Investigator's Discretion|0|||
130537599|NCT01803282|469935055|FG003|Overall Study|Investigator's Discretion|7|||
130537600|NCT01803282|469935056|FG004|Overall Study|Investigator's Discretion|2|||
130537601|NCT01803282|469935057|FG005|Overall Study|Investigator's Discretion|1|||
130537602|NCT01803282|469935058|FG006|Overall Study|Investigator's Discretion|7|||
130537603|NCT01803282|469935059|FG007|Overall Study|Investigator's Discretion|10|||
130537604|NCT01803282|469935060|FG008|Overall Study|Investigator's Discretion|6|||
130537605|NCT01803282|469935061|FG009|Overall Study|Investigator's Discretion|7|||
130537606|NCT01803282|469935062|FG010|Overall Study|Investigator's Discretion|1|||
130537607|NCT01803282|469935063|FG011|Overall Study|Investigator's Discretion|0|||
130537608|NCT01803282|469935052|FG000|Overall Study|Adverse Event|0|||
130537609|NCT01803282|469935053|FG001|Overall Study|Adverse Event|0|||
130537610|NCT01803282|469935054|FG002|Overall Study|Adverse Event|0|||
130537611|NCT01803282|469935055|FG003|Overall Study|Adverse Event|0|||
130537612|NCT01803282|469935056|FG004|Overall Study|Adverse Event|0|||
130537613|NCT01803282|469935057|FG005|Overall Study|Adverse Event|0|||
130537614|NCT01803282|469935058|FG006|Overall Study|Adverse Event|1|||
130537615|NCT01803282|469935059|FG007|Overall Study|Adverse Event|2|||
130537616|NCT01803282|469935060|FG008|Overall Study|Adverse Event|0|||
130537617|NCT01803282|469935061|FG009|Overall Study|Adverse Event|1|||
130537618|NCT01803282|469935062|FG010|Overall Study|Adverse Event|0|||
130537619|NCT01803282|469935063|FG011|Overall Study|Adverse Event|3|||
130537620|NCT01803282|469935052|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130537621|NCT01803282|469935053|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130537622|NCT01803282|469935054|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130537623|NCT01803282|469935055|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130537624|NCT01803282|469935056|FG004|Overall Study|Non-Compliance with Study Drug|0|||
130537625|NCT01803282|469935057|FG005|Overall Study|Non-Compliance with Study Drug|0|||
130537626|NCT01803282|469935058|FG006|Overall Study|Non-Compliance with Study Drug|0|||
130537627|NCT01803282|469935059|FG007|Overall Study|Non-Compliance with Study Drug|0|||
130584745|NCT05195528|470104797|FG003|Extension Period|Withdrawal by Subject|6|||
130537628|NCT01803282|469935060|FG008|Overall Study|Non-Compliance with Study Drug|0|||
130537629|NCT01803282|469935061|FG009|Overall Study|Non-Compliance with Study Drug|0|||
130537630|NCT01803282|469935062|FG010|Overall Study|Non-Compliance with Study Drug|0|||
130537631|NCT01803282|469935063|FG011|Overall Study|Non-Compliance with Study Drug|0|||
130537632|NCT01803282|469935052|FG000|Overall Study|Unknown Reason|0|||
130537633|NCT01803282|469935053|FG001|Overall Study|Unknown Reason|0|||
130537634|NCT01803282|469935054|FG002|Overall Study|Unknown Reason|0|||
130537635|NCT01803282|469935055|FG003|Overall Study|Unknown Reason|0|||
130537636|NCT01803282|469935056|FG004|Overall Study|Unknown Reason|0|||
130537637|NCT01803282|469935057|FG005|Overall Study|Unknown Reason|0|||
130537638|NCT01803282|469935058|FG006|Overall Study|Unknown Reason|0|||
130537639|NCT01803282|469935059|FG007|Overall Study|Unknown Reason|1|||
130537640|NCT01803282|469935060|FG008|Overall Study|Unknown Reason|0|||
130537641|NCT01803282|469935061|FG009|Overall Study|Unknown Reason|0|||
130537642|NCT01803282|469935062|FG010|Overall Study|Unknown Reason|0|||
130537643|NCT01803282|469935063|FG011|Overall Study|Unknown Reason|0|||
130537644|NCT01803282|469935052|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
130537645|NCT01803282|469935053|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
130537646|NCT01803282|469935054|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
130537647|NCT01803282|469935055|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
130537648|NCT01803282|469935056|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
130537649|NCT01803282|469935057|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
130537650|NCT01803282|469935058|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
130537651|NCT01803282|469935059|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
130537652|NCT01803282|469935060|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
130537653|NCT01803282|469935061|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
130537654|NCT01803282|469935062|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
130537655|NCT01803282|469935063|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
130537656|NCT01803282|469935052|FG000|Overall Study|Enrolled but Never Treated|0|||
130537657|NCT01803282|469935053|FG001|Overall Study|Enrolled but Never Treated|0|||
130537658|NCT01803282|469935054|FG002|Overall Study|Enrolled but Never Treated|0|||
130537659|NCT01803282|469935055|FG003|Overall Study|Enrolled but Never Treated|0|||
130537660|NCT01803282|469935056|FG004|Overall Study|Enrolled but Never Treated|1|||
130537661|NCT01803282|469935057|FG005|Overall Study|Enrolled but Never Treated|0|||
130537662|NCT01803282|469935058|FG006|Overall Study|Enrolled but Never Treated|1|||
130537663|NCT01803282|469935059|FG007|Overall Study|Enrolled but Never Treated|1|||
130537664|NCT01803282|469935060|FG008|Overall Study|Enrolled but Never Treated|0|||
130537665|NCT01803282|469935061|FG009|Overall Study|Enrolled but Never Treated|1|||
130537666|NCT01803282|469935062|FG010|Overall Study|Enrolled but Never Treated|0|||
130537667|NCT01803282|469935063|FG011|Overall Study|Enrolled but Never Treated|0|||
130537668|NCT01743989|469935064|FG000|Treatment Phase|Unstable MR4.0|0|||
130537669|NCT01743989|469935065|FG001|Treatment Phase|Unstable MR4.0|6|||
130537670|NCT01743989|469935066|FG002|Treatment Phase|Unstable MR4.0|263|||
130537671|NCT01743989|469935064|FG000|Treatment Phase|Adverse Event|0|||
130537672|NCT01743989|469935065|FG001|Treatment Phase|Adverse Event|4|||
130537673|NCT01743989|469935066|FG002|Treatment Phase|Adverse Event|67|||
130537674|NCT01743989|469935064|FG000|Treatment Phase|Withdrawal by Subject|1|||
130537675|NCT01743989|469935065|FG001|Treatment Phase|Withdrawal by Subject|3|||
130537676|NCT01743989|469935066|FG002|Treatment Phase|Withdrawal by Subject|28|||
130537677|NCT01743989|469935064|FG000|Treatment Phase|Death|0|||
130537678|NCT01743989|469935065|FG001|Treatment Phase|Death|1|||
130537679|NCT01743989|469935066|FG002|Treatment Phase|Death|3|||
130537680|NCT01743989|469935064|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
130537681|NCT01743989|469935065|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
130537682|NCT01743989|469935066|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
130537683|NCT01743989|469935064|FG000|Treatment Phase|Protocol deviation|0|||
130537684|NCT01743989|469935065|FG001|Treatment Phase|Protocol deviation|0|||
130537685|NCT01743989|469935066|FG002|Treatment Phase|Protocol deviation|3|||
130537686|NCT01743989|469935064|FG000|Treatment Phase|Pregnancy|0|||
130537687|NCT01743989|469935065|FG001|Treatment Phase|Pregnancy|0|||
130537688|NCT01743989|469935066|FG002|Treatment Phase|Pregnancy|2|||
130537689|NCT01743989|469935064|FG000|Treatment Phase|Lost to Follow-up|0|||
130537690|NCT01743989|469935065|FG001|Treatment Phase|Lost to Follow-up|0|||
130537691|NCT01743989|469935066|FG002|Treatment Phase|Lost to Follow-up|2|||
130537692|NCT01743989|469935064|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
130537693|NCT01743989|469935065|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
130537694|NCT01743989|469935066|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
130537695|NCT01743989|469935064|FG000|Treatment Phase|Administrative problems|0|||
130537696|NCT01743989|469935065|FG001|Treatment Phase|Administrative problems|0|||
130537697|NCT01743989|469935066|FG002|Treatment Phase|Administrative problems|1|||
130537698|NCT01743989|469935064|FG000|Treatment Phase|New cancer (CML) therapy|0|||
130537699|NCT01743989|469935065|FG001|Treatment Phase|New cancer (CML) therapy|1|||
130537700|NCT01743989|469935066|FG002|Treatment Phase|New cancer (CML) therapy|0|||
130537701|NCT01743989|469935064|FG000|Treatment Phase|Physician Decision|0|||
130537702|NCT01743989|469935065|FG001|Treatment Phase|Physician Decision|0|||
130537703|NCT01743989|469935066|FG002|Treatment Phase|Physician Decision|3|||
130537704|NCT01743989|469935064|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
130537705|NCT01743989|469935065|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
130537706|NCT01743989|469935066|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
130537707|NCT01743989|469935064|FG000|Treatment Phase|Not randomized by mistake|0|||
130537708|NCT01743989|469935065|FG001|Treatment Phase|Not randomized by mistake|0|||
130537709|NCT01743989|469935066|FG002|Treatment Phase|Not randomized by mistake|1|||
130537710|NCT01743989|469935064|FG000|Treatment Phase|Included by mistake|0|||
130537711|NCT01743989|469935065|FG001|Treatment Phase|Included by mistake|0|||
130537712|NCT01743989|469935066|FG002|Treatment Phase|Included by mistake|1|||
130537713|NCT01743989|469935064|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
130537714|NCT01743989|469935065|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
130537715|NCT01743989|469935066|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
130537716|NCT01743989|469935064|FG000|TFR Phase|Adverse Event|0|||
130537717|NCT01743989|469935065|FG001|TFR Phase|Adverse Event|1|||
130537718|NCT01743989|469935066|FG002|TFR Phase|Adverse Event|0|||
130537719|NCT01743989|469935064|FG000|TFR Phase|Lost to Follow-up|0|||
130537720|NCT01743989|469935065|FG001|TFR Phase|Lost to Follow-up|2|||
130537721|NCT01743989|469935066|FG002|TFR Phase|Lost to Follow-up|0|||
130537722|NCT01743989|469935064|FG000|TFR Phase|Physician Decision|0|||
130537723|NCT01743989|469935065|FG001|TFR Phase|Physician Decision|1|||
130537724|NCT01743989|469935066|FG002|TFR Phase|Physician Decision|0|||
130537725|NCT01743989|469935064|FG000|TFR Phase|Logistical problems|0|||
130537726|NCT01743989|469935065|FG001|TFR Phase|Logistical problems|2|||
130537727|NCT01743989|469935066|FG002|TFR Phase|Logistical problems|0|||
130537728|NCT01743989|469935064|FG000|TFR Phase|Protocol deviation|0|||
130537729|NCT01743989|469935065|FG001|TFR Phase|Protocol deviation|1|||
130537730|NCT01743989|469935066|FG002|TFR Phase|Protocol deviation|0|||
130537731|NCT01743989|469935064|FG000|TFR Phase|Withdrawal by Subject|0|||
130537732|NCT01743989|469935065|FG001|TFR Phase|Withdrawal by Subject|2|||
130537733|NCT01743989|469935066|FG002|TFR Phase|Withdrawal by Subject|0|||
130537734|NCT01743989|469935064|FG000|Re-treatment Phase|Adverse Event|8|||
130537735|NCT01743989|469935065|FG001|Re-treatment Phase|Adverse Event|4|||
130537736|NCT01743989|469935066|FG002|Re-treatment Phase|Adverse Event|0|||
130537737|NCT01743989|469935064|FG000|Re-treatment Phase|Death|1|||
130537738|NCT01743989|469935065|FG001|Re-treatment Phase|Death|1|||
130537739|NCT01743989|469935066|FG002|Re-treatment Phase|Death|0|||
130537740|NCT01743989|469935064|FG000|Re-treatment Phase|Administrative problems|1|||
130537741|NCT01743989|469935065|FG001|Re-treatment Phase|Administrative problems|1|||
130537742|NCT01743989|469935066|FG002|Re-treatment Phase|Administrative problems|0|||
130537743|NCT01743989|469935064|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
130537744|NCT01743989|469935065|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
130537745|NCT01743989|469935066|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
130537746|NCT01743989|469935064|FG000|Re-treatment Phase|Unstable MR|1|||
130537747|NCT01743989|469935065|FG001|Re-treatment Phase|Unstable MR|0|||
130537748|NCT01743989|469935066|FG002|Re-treatment Phase|Unstable MR|0|||
130537749|NCT01743989|469935064|FG000|Re-treatment Phase|Physician Decision|0|||
130537750|NCT01743989|469935065|FG001|Re-treatment Phase|Physician Decision|1|||
130537751|NCT01743989|469935066|FG002|Re-treatment Phase|Physician Decision|0|||
130537752|NCT01743989|469935064|FG000|Re-treatment Phase|Lost to Follow-up|0|||
130537753|NCT01743989|469935065|FG001|Re-treatment Phase|Lost to Follow-up|1|||
130537754|NCT01743989|469935066|FG002|Re-treatment Phase|Lost to Follow-up|0|||
130537755|NCT00653523|469935071|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
130537756|NCT00653523|469935071|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
130537757|NCT00653523|469935071|FG000|Overall Study|Adverse Event|7|||
130537758|NCT00653523|469935071|FG000|Overall Study|Withdrawal by Subject|6|||
130537759|NCT00653523|469935071|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
130537760|NCT00653523|469935071|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
130537761|NCT02425904|469935072|FG000|Overall Study|Lost to Follow-up|1|||
130537762|NCT02425904|469935073|FG001|Overall Study|Lost to Follow-up|0|||
130537763|NCT02425904|469935072|FG000|Overall Study|Withdrawal by Subject|2|||
130537764|NCT02425904|469935073|FG001|Overall Study|Withdrawal by Subject|0|||
130537765|NCT02425904|469935072|FG000|Overall Study|Death|0|||
130537766|NCT02425904|469935073|FG001|Overall Study|Death|3|||
130537767|NCT03843554|469936457|FG000|Overall Study|Physician Decision|0|||
130537768|NCT03843554|469936458|FG001|Overall Study|Physician Decision|2|||
130537769|NCT04396366|469936461|FG000|Overall Study|Adverse Event|1|||
130537770|NCT04396366|469936462|FG001|Overall Study|Adverse Event|0|||
130537771|NCT00503139|469936463|FG000|Overall Study|Case Report Forms were not collected|4|||
130537772|NCT00503139|469936463|FG000|Overall Study|Protocol Violation|4|||
130537773|NCT00996476|469936464|FG000|Overall Study|Withdrawal by Subject|1|||
130537774|NCT00996476|469936465|FG001|Overall Study|Withdrawal by Subject|2|||
130537775|NCT00996476|469936466|FG002|Overall Study|Withdrawal by Subject|1|||
130537776|NCT00996476|469936467|FG003|Overall Study|Withdrawal by Subject|0|||
130537777|NCT00996476|469936468|FG004|Overall Study|Withdrawal by Subject|1|||
130537778|NCT00996476|469936464|FG000|Overall Study|Adverse Event|0|||
130537779|NCT00996476|469936465|FG001|Overall Study|Adverse Event|1|||
130537780|NCT00996476|469936466|FG002|Overall Study|Adverse Event|0|||
130537781|NCT00996476|469936467|FG003|Overall Study|Adverse Event|0|||
130537782|NCT00996476|469936468|FG004|Overall Study|Adverse Event|1|||
130584746|NCT05195528|470104798|FG004|Extension Period|Withdrawal by Subject|5|||
130584747|NCT05195528|470104794|FG000|Extension Period|Lack of Efficacy|0|||
130584748|NCT05195528|470104795|FG001|Extension Period|Lack of Efficacy|3|||
130584749|NCT05195528|470104796|FG002|Extension Period|Lack of Efficacy|0|||
130584750|NCT05195528|470104797|FG003|Extension Period|Lack of Efficacy|0|||
130584751|NCT05195528|470104798|FG004|Extension Period|Lack of Efficacy|2|||
130584752|NCT05195528|470104794|FG000|Extension Period|Not Treated|0|||
130584753|NCT05195528|470104795|FG001|Extension Period|Not Treated|0|||
130584754|NCT05195528|470104796|FG002|Extension Period|Not Treated|2|||
130584755|NCT05195528|470104797|FG003|Extension Period|Not Treated|3|||
130584756|NCT05195528|470104798|FG004|Extension Period|Not Treated|0|||
130584757|NCT05195528|470104794|FG000|Extension Period|Other|0|||
130584758|NCT05195528|470104795|FG001|Extension Period|Other|1|||
130584759|NCT05195528|470104796|FG002|Extension Period|Other|1|||
130584760|NCT05195528|470104797|FG003|Extension Period|Other|0|||
130584761|NCT05195528|470104798|FG004|Extension Period|Other|0|||
130584762|NCT01552902|470104799|FG000|Overall Study|Adverse Event|1|||
130584763|NCT01552902|470104800|FG001|Overall Study|Adverse Event|15|||
130584764|NCT01552902|470104801|FG002|Overall Study|Adverse Event|14|||
130584765|NCT01552902|470104799|FG000|Overall Study|Protocol Violation|3|||
130584766|NCT01552902|470104800|FG001|Overall Study|Protocol Violation|3|||
130584767|NCT01552902|470104801|FG002|Overall Study|Protocol Violation|3|||
130584768|NCT01552902|470104799|FG000|Overall Study|Lack of Efficacy|4|||
130584769|NCT01552902|470104800|FG001|Overall Study|Lack of Efficacy|3|||
130584770|NCT01552902|470104801|FG002|Overall Study|Lack of Efficacy|1|||
130584771|NCT01552902|470104799|FG000|Overall Study|Withdrawal by Subject|1|||
130584772|NCT01552902|470104800|FG001|Overall Study|Withdrawal by Subject|9|||
130584773|NCT01552902|470104801|FG002|Overall Study|Withdrawal by Subject|6|||
130584774|NCT01552902|470104799|FG000|Overall Study|Lost to Follow-up|1|||
130584775|NCT01552902|470104800|FG001|Overall Study|Lost to Follow-up|3|||
130584776|NCT01552902|470104801|FG002|Overall Study|Lost to Follow-up|6|||
130584777|NCT01552902|470104799|FG000|Overall Study|Other|3|||
130584778|NCT01552902|470104800|FG001|Overall Study|Other|4|||
130584779|NCT01552902|470104801|FG002|Overall Study|Other|3|||
130584780|NCT02487108|470104807|FG000|Overall Study|Adverse Event|1|||
130584781|NCT02487108|470104808|FG001|Overall Study|Adverse Event|6|||
130584782|NCT02487108|470104809|FG002|Overall Study|Adverse Event|12|||
130584783|NCT02487108|470104810|FG003|Overall Study|Adverse Event|6|||
130584784|NCT02487108|470104807|FG000|Overall Study|Withdrawal by Subject|8|||
130584785|NCT02487108|470104808|FG001|Overall Study|Withdrawal by Subject|5|||
130584786|NCT02487108|470104809|FG002|Overall Study|Withdrawal by Subject|5|||
130584787|NCT02487108|470104810|FG003|Overall Study|Withdrawal by Subject|0|||
130584788|NCT02487108|470104807|FG000|Overall Study|Non-compliance to study medication|3|||
130584789|NCT02487108|470104808|FG001|Overall Study|Non-compliance to study medication|2|||
130584790|NCT02487108|470104809|FG002|Overall Study|Non-compliance to study medication|5|||
130584791|NCT02487108|470104810|FG003|Overall Study|Non-compliance to study medication|4|||
130584792|NCT02487108|470104807|FG000|Overall Study|Protocol Violation|1|||
130584793|NCT02487108|470104808|FG001|Overall Study|Protocol Violation|1|||
130584794|NCT02487108|470104809|FG002|Overall Study|Protocol Violation|2|||
130584795|NCT02487108|470104810|FG003|Overall Study|Protocol Violation|0|||
130584796|NCT02487108|470104807|FG000|Overall Study|Non-compliance to study procedures|0|||
130584797|NCT02487108|470104808|FG001|Overall Study|Non-compliance to study procedures|0|||
130584798|NCT02487108|470104809|FG002|Overall Study|Non-compliance to study procedures|0|||
130584799|NCT02487108|470104810|FG003|Overall Study|Non-compliance to study procedures|1|||
130584800|NCT02487108|470104807|FG000|Overall Study|Other than specified|3|||
130584801|NCT02487108|470104808|FG001|Overall Study|Other than specified|2|||
130584802|NCT02487108|470104809|FG002|Overall Study|Other than specified|2|||
130584803|NCT02487108|470104810|FG003|Overall Study|Other than specified|0|||
130584804|NCT00600171|470104811|FG000|Overall Study|Adverse Event|0|||
130584805|NCT00600171|470104812|FG001|Overall Study|Adverse Event|1|||
130584806|NCT00600171|470104813|FG002|Overall Study|Adverse Event|0|||
130584807|NCT00600171|470104814|FG003|Overall Study|Adverse Event|0|||
130584808|NCT00600171|470104815|FG004|Overall Study|Adverse Event|1|||
130584809|NCT00600171|470104816|FG005|Overall Study|Adverse Event|0|||
130584810|NCT00600171|470104811|FG000|Overall Study|Lack of Efficacy|9|||
130584811|NCT00600171|470104812|FG001|Overall Study|Lack of Efficacy|12|||
130584812|NCT00600171|470104813|FG002|Overall Study|Lack of Efficacy|3|||
130584813|NCT00600171|470104814|FG003|Overall Study|Lack of Efficacy|5|||
130584814|NCT00600171|470104815|FG004|Overall Study|Lack of Efficacy|4|||
130584815|NCT00600171|470104816|FG005|Overall Study|Lack of Efficacy|0|||
130584816|NCT00600171|470104811|FG000|Overall Study|Protocol Violation|1|||
130584817|NCT00600171|470104812|FG001|Overall Study|Protocol Violation|2|||
130584818|NCT00600171|470104813|FG002|Overall Study|Protocol Violation|0|||
130584819|NCT00600171|470104814|FG003|Overall Study|Protocol Violation|1|||
130584820|NCT00600171|470104815|FG004|Overall Study|Protocol Violation|0|||
130584821|NCT00600171|470104816|FG005|Overall Study|Protocol Violation|0|||
130584822|NCT00600171|470104811|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130537783|NCT05540717|469936469|FG000|Overall Study|Lost to Follow-up|2|||
130537784|NCT05540717|469936470|FG001|Overall Study|Lost to Follow-up|5|||
130537785|NCT05540717|469936469|FG000|Overall Study|Withdrawal by Subject|6|||
130537786|NCT05540717|469936470|FG001|Overall Study|Withdrawal by Subject|6|||
130537787|NCT05540717|469936469|FG000|Overall Study|Sponsor request|1|||
130537788|NCT05540717|469936470|FG001|Overall Study|Sponsor request|0|||
130537789|NCT05540717|469936469|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
130537790|NCT05540717|469936470|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
130537791|NCT05540717|469936469|FG000|Overall Study|Other|0|||
130537792|NCT05540717|469936470|FG001|Overall Study|Other|1|||
130537793|NCT01940939|469936471|FG000|Overall Study|Withdrawal by Subject|2|||
130537794|NCT01940939|469936472|FG001|Overall Study|Withdrawal by Subject|8|||
130537795|NCT01470001|469936473|FG000|Overall Study|Lost to Follow-up|1|||
130537796|NCT01470001|469936474|FG001|Overall Study|Lost to Follow-up|1|||
130537797|NCT01470001|469936473|FG000|Overall Study|Physician Decision|2|||
130537798|NCT01470001|469936474|FG001|Overall Study|Physician Decision|0|||
130537799|NCT01470001|469936473|FG000|Overall Study|Withdrawal by Subject|2|||
130537800|NCT01470001|469936474|FG001|Overall Study|Withdrawal by Subject|1|||
130537801|NCT01895101|469936475|FG000|Overall Study|OPCAB procedure|1|||
130537802|NCT01895101|469936476|FG001|Overall Study|OPCAB procedure|1|||
130537803|NCT01895101|469936477|FG002|Overall Study|OPCAB procedure|3|||
130537804|NCT01895101|469936475|FG000|Overall Study|Withdrawal by Subject|0|||
130537805|NCT01895101|469936476|FG001|Overall Study|Withdrawal by Subject|1|||
130537806|NCT01895101|469936477|FG002|Overall Study|Withdrawal by Subject|2|||
130537807|NCT01895101|469936475|FG000|Overall Study|another study, enrolled in other study|0|||
130537808|NCT01895101|469936476|FG001|Overall Study|another study, enrolled in other study|1|||
130537809|NCT01895101|469936477|FG002|Overall Study|another study, enrolled in other study|0|||
130537810|NCT01895101|469936475|FG000|Overall Study|Death|0|||
130537811|NCT01895101|469936476|FG001|Overall Study|Death|1|||
130537812|NCT01895101|469936477|FG002|Overall Study|Death|0|||
130537813|NCT01895101|469936475|FG000|Overall Study|coagulation disorder|0|||
130537814|NCT01895101|469936476|FG001|Overall Study|coagulation disorder|1|||
130537815|NCT01895101|469936477|FG002|Overall Study|coagulation disorder|0|||
130537816|NCT04032613|469936480|FG000|Overall Study|Did not complete post-program assessment|5|||
130537817|NCT04032613|469936481|FG001|Overall Study|Did not complete post-program assessment|2|||
130537818|NCT01659853|469936482|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
130537819|NCT01659853|469936483|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
130537820|NCT01659853|469936482|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
130537821|NCT01659853|469936483|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
130537822|NCT03053518|469936486|FG000|Overall Study|Withdrawal by Subject|3|||
130537823|NCT03053518|469936486|FG000|Overall Study|Lost to Follow-up|2|||
130537824|NCT03053518|469936486|FG000|Overall Study|Ineligible|5|||
130537825|NCT02071290|469936487|FG000|Overall Study|Death|1|||
130537826|NCT02071290|469936488|FG001|Overall Study|Death|0|||
130537827|NCT02071290|469936487|FG000|Overall Study|Withdrawal by Subject|0|||
130537828|NCT02071290|469936488|FG001|Overall Study|Withdrawal by Subject|1|||
130537829|NCT02071290|469936487|FG000|Overall Study|Protocol Violation|3|||
130537830|NCT02071290|469936488|FG001|Overall Study|Protocol Violation|5|||
130537831|NCT02071290|469936487|FG000|Overall Study|Physician Decision|0|||
130537832|NCT02071290|469936488|FG001|Overall Study|Physician Decision|1|||
130537833|NCT05560243|469936492|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
130537834|NCT01072630|469936493|FG000|Overall Study|Adverse Event|11|||
130537835|NCT01072630|469936494|FG001|Overall Study|Adverse Event|19|||
130537836|NCT01072630|469936495|FG002|Overall Study|Adverse Event|2|||
130537837|NCT01072630|469936493|FG000|Overall Study|Lack of Efficacy|10|||
130537838|NCT01072630|469936494|FG001|Overall Study|Lack of Efficacy|10|||
130537839|NCT01072630|469936495|FG002|Overall Study|Lack of Efficacy|1|||
130537840|NCT01072630|469936493|FG000|Overall Study|Withdrawal by Subject|8|||
130537841|NCT01072630|469936494|FG001|Overall Study|Withdrawal by Subject|7|||
130537842|NCT01072630|469936495|FG002|Overall Study|Withdrawal by Subject|2|||
130537843|NCT01072630|469936493|FG000|Overall Study|Protocol Violation|10|||
130537844|NCT01072630|469936494|FG001|Overall Study|Protocol Violation|8|||
130537845|NCT01072630|469936495|FG002|Overall Study|Protocol Violation|4|||
130537846|NCT01072630|469936493|FG000|Overall Study|Lost to Follow-up|11|||
130537847|NCT01072630|469936494|FG001|Overall Study|Lost to Follow-up|11|||
130537848|NCT01072630|469936495|FG002|Overall Study|Lost to Follow-up|1|||
130537849|NCT01072630|469936493|FG000|Overall Study|Noncompliance with study medication|1|||
130537850|NCT01072630|469936494|FG001|Overall Study|Noncompliance with study medication|1|||
130537851|NCT01072630|469936495|FG002|Overall Study|Noncompliance with study medication|1|||
130537852|NCT01072630|469936493|FG000|Overall Study|Noncompliance with study procedures|1|||
130537853|NCT01072630|469936494|FG001|Overall Study|Noncompliance with study procedures|2|||
130537854|NCT01072630|469936495|FG002|Overall Study|Noncompliance with study procedures|1|||
130537855|NCT01072630|469936493|FG000|Overall Study|Other|3|||
130537856|NCT01072630|469936494|FG001|Overall Study|Other|2|||
130537857|NCT01072630|469936495|FG002|Overall Study|Other|1|||
130537858|NCT01232738|469936496|FG000|Overall Study|Death|3|||
130537859|NCT01232738|469936496|FG000|Overall Study|Physician Decision|2|||
130584823|NCT00600171|470104812|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130584824|NCT00600171|470104813|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
130584825|NCT00600171|470104814|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130584826|NCT00600171|470104815|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130584827|NCT00600171|470104816|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130584828|NCT00600171|470104811|FG000|Overall Study|Withdrawal by Subject|3|||
130584829|NCT00600171|470104812|FG001|Overall Study|Withdrawal by Subject|0|||
130584830|NCT00600171|470104813|FG002|Overall Study|Withdrawal by Subject|0|||
130584831|NCT00600171|470104814|FG003|Overall Study|Withdrawal by Subject|1|||
130584832|NCT00600171|470104815|FG004|Overall Study|Withdrawal by Subject|1|||
130584833|NCT00600171|470104816|FG005|Overall Study|Withdrawal by Subject|1|||
130584834|NCT00600171|470104811|FG000|Overall Study|Physician Decision|0|||
130584835|NCT00600171|470104812|FG001|Overall Study|Physician Decision|1|||
130584836|NCT00600171|470104813|FG002|Overall Study|Physician Decision|0|||
130584837|NCT00600171|470104814|FG003|Overall Study|Physician Decision|1|||
130584838|NCT00600171|470104815|FG004|Overall Study|Physician Decision|0|||
130584839|NCT00600171|470104816|FG005|Overall Study|Physician Decision|2|||
130537860|NCT01232738|469936496|FG000|Overall Study|Lost to Follow-up|1|||
130537861|NCT01232738|469936496|FG000|Overall Study|Withdrawal by Subject|2|||
130537862|NCT01232738|469936496|FG000|Overall Study|Adverse Event|5|||
130537863|NCT00338962|469936497|FG000|Overall Study|Lost to Follow-up|3|||
130537864|NCT00338962|469936498|FG001|Overall Study|Lost to Follow-up|3|||
130537865|NCT00338962|469936499|FG002|Overall Study|Lost to Follow-up|2|||
130537866|NCT00338962|469936500|FG003|Overall Study|Lost to Follow-up|3|||
130537867|NCT00338962|469936497|FG000|Overall Study|Withdrawal by Subject|1|||
130537868|NCT00338962|469936498|FG001|Overall Study|Withdrawal by Subject|0|||
130537869|NCT00338962|469936499|FG002|Overall Study|Withdrawal by Subject|0|||
130537870|NCT00338962|469936500|FG003|Overall Study|Withdrawal by Subject|0|||
130537871|NCT00338962|469936497|FG000|Overall Study|No Transportation|2|||
130537872|NCT00338962|469936498|FG001|Overall Study|No Transportation|0|||
130537873|NCT00338962|469936499|FG002|Overall Study|No Transportation|0|||
130537874|NCT00338962|469936500|FG003|Overall Study|No Transportation|0|||
130537875|NCT00338962|469936497|FG000|Overall Study|Time Constraint|2|||
130537876|NCT00338962|469936498|FG001|Overall Study|Time Constraint|0|||
130537877|NCT00338962|469936499|FG002|Overall Study|Time Constraint|0|||
130537878|NCT00338962|469936500|FG003|Overall Study|Time Constraint|0|||
130537879|NCT00338962|469936497|FG000|Overall Study|Moved|0|||
130537880|NCT00338962|469936498|FG001|Overall Study|Moved|1|||
130537881|NCT00338962|469936499|FG002|Overall Study|Moved|0|||
130537882|NCT00338962|469936500|FG003|Overall Study|Moved|0|||
130537883|NCT00338962|469936497|FG000|Overall Study|Adverse Event|0|||
130537884|NCT00338962|469936498|FG001|Overall Study|Adverse Event|0|||
130537885|NCT00338962|469936499|FG002|Overall Study|Adverse Event|2|||
130537886|NCT00338962|469936500|FG003|Overall Study|Adverse Event|0|||
130537887|NCT00338962|469936497|FG000|Overall Study|Poor Compliance|0|||
130537888|NCT00338962|469936498|FG001|Overall Study|Poor Compliance|0|||
130537889|NCT00338962|469936499|FG002|Overall Study|Poor Compliance|2|||
130537890|NCT00338962|469936500|FG003|Overall Study|Poor Compliance|0|||
130537891|NCT03214640|469936501|FG000|Overall Study|Protocol Violation|1|||
130537892|NCT03214640|469936502|FG001|Overall Study|Protocol Violation|2|||
130537893|NCT03214640|469936503|FG002|Overall Study|Protocol Violation|1|||
130537894|NCT03214640|469936504|FG003|Overall Study|Protocol Violation|4|||
130537895|NCT01253018|469936510|FG000|Overall Study|Lost to Follow-up|1|||
130537896|NCT01253018|469936511|FG001|Overall Study|Lost to Follow-up|1|||
130537897|NCT01253018|469936510|FG000|Overall Study|Robot Repair Issues|2|||
130537898|NCT01253018|469936511|FG001|Overall Study|Robot Repair Issues|0|||
130584840|NCT00600171|470104811|FG000|Overall Study|Lost to Follow-up|0|||
130584841|NCT00600171|470104812|FG001|Overall Study|Lost to Follow-up|0|||
130537899|NCT01253018|469936510|FG000|Overall Study|Withdrawal by Subject|1|||
130537900|NCT01253018|469936511|FG001|Overall Study|Withdrawal by Subject|1|||
130537901|NCT03449901|469936512|FG000|Overall Study|Progression|57|||
130537902|NCT03449901|469936513|FG001|Overall Study|Progression|12|||
130537903|NCT03449901|469936512|FG000|Overall Study|Adverse Event|3|||
130537904|NCT03449901|469936513|FG001|Overall Study|Adverse Event|0|||
130537905|NCT03449901|469936512|FG000|Overall Study|Death|6|||
130537906|NCT03449901|469936513|FG001|Overall Study|Death|2|||
130537907|NCT03449901|469936512|FG000|Overall Study|Withdrawal by Subject|12|||
130537908|NCT03449901|469936513|FG001|Overall Study|Withdrawal by Subject|1|||
130537909|NCT03449901|469936512|FG000|Overall Study|Physician Decision|1|||
130537910|NCT03449901|469936513|FG001|Overall Study|Physician Decision|0|||
130537911|NCT03449901|469936512|FG000|Overall Study|Patient elected for surgical intervention|1|||
130537912|NCT03449901|469936513|FG001|Overall Study|Patient elected for surgical intervention|0|||
130537913|NCT03449901|469936512|FG000|Overall Study|Patient off for other complicating disease|1|||
130537914|NCT03449901|469936513|FG001|Overall Study|Patient off for other complicating disease|0|||
130584842|NCT00600171|470104813|FG002|Overall Study|Lost to Follow-up|0|||
130584843|NCT00600171|470104814|FG003|Overall Study|Lost to Follow-up|1|||
130584844|NCT00600171|470104815|FG004|Overall Study|Lost to Follow-up|0|||
130537915|NCT03466073|469936514|FG000|Overall Study|Death|1|||
130537916|NCT03466073|469936515|FG001|Overall Study|Death|0|||
130537917|NCT03466073|469936516|FG002|Overall Study|Death|0|||
130537918|NCT03466073|469936517|FG003|Overall Study|Death|0|||
130537919|NCT03466073|469936518|FG004|Overall Study|Death|0|||
130537920|NCT03466073|469936519|FG005|Overall Study|Death|1|||
130584845|NCT00600171|470104816|FG005|Overall Study|Lost to Follow-up|0|||
130584846|NCT02367521|470104817|FG000|Overall Study|severe headache after intervention|2|||
130584847|NCT02367521|470104818|FG001|Overall Study|severe headache after intervention|0|||
130584848|NCT02367521|470104817|FG000|Overall Study|unable to find transportation|2|||
130584849|NCT02367521|470104818|FG001|Overall Study|unable to find transportation|0|||
130584850|NCT00542191|470104822|FG000|Overall Study|Death|3|||
130584851|NCT00469612|470104823|FG000|Overall Study|Study terminated before data collected|2|||
130584852|NCT00469612|470104824|FG001|Overall Study|Study terminated before data collected|0|||
130584853|NCT01084551|470104825|FG000|Overall Study|Adverse Event|2|||
130584854|NCT01084551|470104826|FG001|Overall Study|Adverse Event|9|||
130584855|NCT01084551|470104827|FG002|Overall Study|Adverse Event|4|||
130584856|NCT01084551|470104825|FG000|Overall Study|Lack of Efficacy|2|||
130584857|NCT01084551|470104826|FG001|Overall Study|Lack of Efficacy|0|||
130584858|NCT01084551|470104827|FG002|Overall Study|Lack of Efficacy|1|||
130584859|NCT01084551|470104825|FG000|Overall Study|Withdrawal by Subject|2|||
130584860|NCT01084551|470104826|FG001|Overall Study|Withdrawal by Subject|1|||
130584861|NCT01084551|470104827|FG002|Overall Study|Withdrawal by Subject|0|||
130584862|NCT01084551|470104825|FG000|Overall Study|Protocol Violation|2|||
130584863|NCT01084551|470104826|FG001|Overall Study|Protocol Violation|4|||
130584864|NCT01084551|470104827|FG002|Overall Study|Protocol Violation|0|||
130584865|NCT01084551|470104825|FG000|Overall Study|Lost to Follow-up|0|||
130584866|NCT01084551|470104826|FG001|Overall Study|Lost to Follow-up|0|||
130584867|NCT01084551|470104827|FG002|Overall Study|Lost to Follow-up|3|||
130584868|NCT01084551|470104825|FG000|Overall Study|Physician Decision|1|||
130584869|NCT01084551|470104826|FG001|Overall Study|Physician Decision|0|||
130584870|NCT01084551|470104827|FG002|Overall Study|Physician Decision|0|||
130584871|NCT00463476|470104830|FG000|Overall Study|Withdrawal by Subject|1|||
130537921|NCT00744757|469936520|FG000|Overall Study|Objective disease progression|7|||
130584872|NCT00463476|470104831|FG001|Overall Study|Withdrawal by Subject|2|||
130584873|NCT00463476|470104830|FG000|Overall Study|Lost to Follow-up|1|||
130584874|NCT00463476|470104831|FG001|Overall Study|Lost to Follow-up|1|||
130584875|NCT00988247|470104832|FG000|Overall Study|Adverse Event|17|||
130584876|NCT00988247|470104833|FG001|Overall Study|Adverse Event|3|||
130584877|NCT00988247|470104832|FG000|Overall Study|Withdrawal by Subject|44|||
130584878|NCT00988247|470104833|FG001|Overall Study|Withdrawal by Subject|13|||
130584879|NCT00988247|470104832|FG000|Overall Study|Pregnancy|1|||
130584880|NCT00988247|470104833|FG001|Overall Study|Pregnancy|2|||
130584881|NCT00988247|470104832|FG000|Overall Study|Lost to Follow-up|11|||
130584882|NCT00988247|470104833|FG001|Overall Study|Lost to Follow-up|2|||
130584883|NCT00988247|470104832|FG000|Overall Study|Protocol Violation|4|||
130584884|NCT00988247|470104833|FG001|Overall Study|Protocol Violation|5|||
130584885|NCT00988247|470104832|FG000|Overall Study|Sponsor requested withdrawal|3|||
130584886|NCT00988247|470104833|FG001|Overall Study|Sponsor requested withdrawal|1|||
130584887|NCT00988247|470104832|FG000|Overall Study|Other|3|||
130584888|NCT00988247|470104833|FG001|Overall Study|Other|0|||
130584889|NCT02661594|470104834|FG000|Overall Study|Protocol Violation|1|||
130584890|NCT02661594|470104835|FG001|Overall Study|Protocol Violation|0|||
130584891|NCT02661594|470104836|FG002|Overall Study|Protocol Violation|1|||
130584892|NCT02661594|470104837|FG003|Overall Study|Protocol Violation|0|||
130537922|NCT00744757|469936520|FG000|Overall Study|Physician Decision|5|||
130584893|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584894|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130584895|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584896|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584897|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584898|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
130584899|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130584900|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130584901|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130584902|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
130584903|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130584904|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130584905|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130584906|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130584907|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130584908|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130584909|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130584910|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130584911|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130584912|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
130584913|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584914|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130537923|NCT00744757|469936520|FG000|Overall Study|Withdrawal by Subject|1|||
130537924|NCT00744757|469936520|FG000|Overall Study|Death|6|||
130537925|NCT00744757|469936520|FG000|Overall Study|Adverse Event|2|||
130537926|NCT03682302|469936521|FG000|Overall Study|Lost to Follow-up|1|||
130537927|NCT03682302|469936522|FG001|Overall Study|Lost to Follow-up|2|||
130537928|NCT03682302|469936523|FG002|Overall Study|Lost to Follow-up|0|||
130537929|NCT03682302|469936524|FG003|Overall Study|Lost to Follow-up|1|||
130537930|NCT03682302|469936521|FG000|Overall Study|Study drug was not administered|0|||
130537931|NCT03682302|469936522|FG001|Overall Study|Study drug was not administered|0|||
130537932|NCT03682302|469936523|FG002|Overall Study|Study drug was not administered|1|||
130537933|NCT03682302|469936524|FG003|Overall Study|Study drug was not administered|1|||
130537934|NCT01585155|469936525|FG000|Overall Study|Adverse Event|1|||
130537935|NCT01585155|469936525|FG000|Overall Study|Lack of Efficacy|2|||
130537936|NCT01585155|469936525|FG000|Overall Study|Worsening ulcerative colitis|2|||
130537937|NCT03772587|469936530|FG000|Overall Study|COVID-19|0|||
130537938|NCT03772587|469936531|FG001|Overall Study|COVID-19|0|||
130537939|NCT03772587|469936532|FG002|Overall Study|COVID-19|1|||
130537940|NCT03772587|469936533|FG003|Overall Study|COVID-19|1|||
130537941|NCT03772587|469936534|FG004|Overall Study|COVID-19|0|||
130537942|NCT03772587|469936530|FG000|Overall Study|Withdrawal by Subject|1|||
130537943|NCT03772587|469936531|FG001|Overall Study|Withdrawal by Subject|0|||
130537944|NCT03772587|469936532|FG002|Overall Study|Withdrawal by Subject|0|||
130537945|NCT03772587|469936533|FG003|Overall Study|Withdrawal by Subject|0|||
130537946|NCT03772587|469936534|FG004|Overall Study|Withdrawal by Subject|0|||
130537947|NCT05260021|469936540|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
130537948|NCT05260021|469936541|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
130537949|NCT05260021|469936542|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
130537950|NCT05260021|469936540|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
130537951|NCT05260021|469936541|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
130537952|NCT05260021|469936542|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
130537953|NCT05260021|469936540|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
130537954|NCT05260021|469936541|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
130537955|NCT05260021|469936542|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
130537956|NCT05260021|469936540|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
130537957|NCT05260021|469936541|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
130537958|NCT05260021|469936542|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
130537959|NCT05260021|469936540|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
130537960|NCT05260021|469936541|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
130537961|NCT05260021|469936542|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
130537962|NCT03842358|469936543|FG000|Overall Study|Poor DOT probe contact with breast|2|||
130537963|NCT03842358|469936543|FG000|Overall Study|DOT system problem|1|||
130537964|NCT03842358|469936543|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
130537965|NCT03842358|469936543|FG000|Overall Study|No biopsy after physician review|4|||
130537966|NCT03842358|469936543|FG000|Overall Study|Patient withdrew|2|||
130537967|NCT01525238|469936544|FG000|Overall Study|Withdrawal by Subject|1|||
130537968|NCT01525238|469936545|FG001|Overall Study|Withdrawal by Subject|0|||
130537969|NCT01525238|469936546|FG002|Overall Study|Withdrawal by Subject|0|||
130537970|NCT04625413|469936547|FG000|Overall Study|Hospice|2|||
130537971|NCT04625413|469936547|FG000|Overall Study|Distress|1|||
130537972|NCT04625413|469936547|FG000|Overall Study|Not feeling well|1|||
130537973|NCT04679935|469936548|FG000|Overall Study|Death|0|||
130537974|NCT04679935|469936549|FG001|Overall Study|Death|1|||
130584915|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584916|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130584917|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584918|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130584919|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
130584920|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130584921|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130584922|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130584923|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
130584924|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
130584925|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
130584926|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
130584927|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
130584928|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130537975|NCT02993146|469936550|FG000|Overall Study|Withdrawal by Subject|0|||
130537976|NCT02993146|469936551|FG001|Overall Study|Withdrawal by Subject|0|||
130537977|NCT02993146|469936552|FG002|Overall Study|Withdrawal by Subject|1|||
130537978|NCT02993146|469936553|FG003|Overall Study|Withdrawal by Subject|1|||
130537979|NCT04362189|469936554|FG000|Overall Study|Lost to Follow-up|0|||
130537980|NCT04362189|469936555|FG001|Overall Study|Lost to Follow-up|1|||
130537981|NCT04362189|469936554|FG000|Overall Study|Withdrawal by Subject|1|||
130537982|NCT04362189|469936555|FG001|Overall Study|Withdrawal by Subject|0|||
130537983|NCT04362189|469936554|FG000|Overall Study|FDA Clinical Hold|7|||
130537984|NCT04362189|469936555|FG001|Overall Study|FDA Clinical Hold|2|||
130537985|NCT04362189|469936554|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
130537986|NCT04362189|469936555|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
130537987|NCT04362189|469936554|FG000|Overall Study|Adverse Event|0|||
130537988|NCT04362189|469936555|FG001|Overall Study|Adverse Event|2|||
130537989|NCT04362189|469936554|FG000|Overall Study|Death|4|||
130537990|NCT04362189|469936555|FG001|Overall Study|Death|1|||
130537991|NCT02111681|469936556|FG000|Overall Study|Death|5|||
130537992|NCT02111681|469936556|FG000|Overall Study|Lack of Efficacy|2|||
130537993|NCT02111681|469936556|FG000|Overall Study|Progression of disease|4|||
130537994|NCT01077271|469938856|FG000|Overall Study|Parental desire|8|||
130537995|NCT01077271|469938856|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
130537996|NCT01077271|469938856|FG000|Overall Study|Noncompliance|2|||
130537997|NCT01077271|469938856|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
130537998|NCT01077271|469938856|FG000|Overall Study|Changed doctors|2|||
130537999|NCT01077271|469938856|FG000|Overall Study|Parents thought too many injections|2|||
130538000|NCT01077271|469938856|FG000|Overall Study|End of RSV season nearly reached|1|||
130538001|NCT01077271|469938856|FG000|Overall Study|Mother unconvinced of the necessity|1|||
130538002|NCT03333876|469938857|FG000|Screening Period|Screen Failure|4|||
130538003|NCT03333876|469938857|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
130538004|NCT03333876|469938857|FG000|Mandibular Advancement|Adverse Event|2|||
130538005|NCT03333876|469938857|FG000|Mandibular Advancement|Product Damage|2|||
130538006|NCT00095498|469938858|FG000|Overall Study|Physician Decision|9|||
130538007|NCT00095498|469938859|FG001|Overall Study|Physician Decision|10|||
130538008|NCT00095498|469938860|FG002|Overall Study|Physician Decision|8|||
130538009|NCT00095498|469938858|FG000|Overall Study|Adverse Event|1|||
130538010|NCT00095498|469938859|FG001|Overall Study|Adverse Event|0|||
130538011|NCT00095498|469938860|FG002|Overall Study|Adverse Event|1|||
130538012|NCT00095498|469938858|FG000|Overall Study|Withdrawal by Subject|15|||
130538013|NCT00095498|469938859|FG001|Overall Study|Withdrawal by Subject|16|||
130538014|NCT00095498|469938860|FG002|Overall Study|Withdrawal by Subject|15|||
130538015|NCT00095498|469938858|FG000|Overall Study|Disease progression|0|||
130538016|NCT00095498|469938859|FG001|Overall Study|Disease progression|1|||
130538017|NCT00095498|469938860|FG002|Overall Study|Disease progression|1|||
130538018|NCT00095498|469938858|FG000|Overall Study|Ineligibility determined|3|||
130538019|NCT00095498|469938859|FG001|Overall Study|Ineligibility determined|0|||
130538020|NCT00095498|469938860|FG002|Overall Study|Ineligibility determined|2|||
130538021|NCT00095498|469938858|FG000|Overall Study|Lost to Follow-up|1|||
130538022|NCT00095498|469938859|FG001|Overall Study|Lost to Follow-up|1|||
130538023|NCT00095498|469938860|FG002|Overall Study|Lost to Follow-up|2|||
130538024|NCT00095498|469938858|FG000|Overall Study|Noncompliance|1|||
130538025|NCT00095498|469938859|FG001|Overall Study|Noncompliance|0|||
130538026|NCT00095498|469938860|FG002|Overall Study|Noncompliance|1|||
130538027|NCT00095498|469938858|FG000|Overall Study|Other|6|||
130538028|NCT00095498|469938859|FG001|Overall Study|Other|7|||
130538029|NCT00095498|469938860|FG002|Overall Study|Other|6|||
130538030|NCT00095498|469938858|FG000|Overall Study|Protocol Violation|0|||
130538031|NCT00095498|469938859|FG001|Overall Study|Protocol Violation|0|||
130538032|NCT00095498|469938860|FG002|Overall Study|Protocol Violation|1|||
130538033|NCT00095498|469938858|FG000|Overall Study|Requirement for alternative therapy|1|||
130538034|NCT00095498|469938859|FG001|Overall Study|Requirement for alternative therapy|0|||
130538035|NCT00095498|469938860|FG002|Overall Study|Requirement for alternative therapy|2|||
130538036|NCT05020327|469938861|FG000|Overall Study|Physician Decision|3|||
130538037|NCT05020327|469938862|FG001|Overall Study|Physician Decision|0|||
130538038|NCT05020327|469938863|FG002|Overall Study|Physician Decision|0|||
130538039|NCT05020327|469938861|FG000|Overall Study|Withdrawal by Subject|1|||
130538040|NCT05020327|469938862|FG001|Overall Study|Withdrawal by Subject|1|||
130538041|NCT05020327|469938863|FG002|Overall Study|Withdrawal by Subject|0|||
130538042|NCT05020327|469938861|FG000|Overall Study|personal/cultural, ineligible|12|||
130538043|NCT05020327|469938862|FG001|Overall Study|personal/cultural, ineligible|0|||
130538044|NCT05020327|469938863|FG002|Overall Study|personal/cultural, ineligible|0|||
130538045|NCT04684394|469938864|FG000|Overall Study|Death|1|||
130538046|NCT04684394|469938865|FG001|Overall Study|Death|2|||
130538047|NCT04684394|469938864|FG000|Overall Study|Lost to Follow-up|1|||
130538048|NCT04684394|469938865|FG001|Overall Study|Lost to Follow-up|0|||
130538049|NCT04684394|469938864|FG000|Overall Study|Withdrawal by Subject|2|||
130538050|NCT04684394|469938865|FG001|Overall Study|Withdrawal by Subject|0|||
130538051|NCT04684394|469938864|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
130538052|NCT04684394|469938865|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
130538053|NCT00591370|469938867|FG000|Overall Study|Not Treated|2|||
130538054|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
130538055|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
130538056|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
130538057|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
130538058|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
130538059|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
130538060|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
130538061|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
130538062|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
130538063|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
130538064|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
130538065|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
130538066|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Death|1|||
130538067|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Death|2|||
130538068|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Death|2|||
130538069|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Death|0|||
130538070|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Death|0|||
130538071|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Death|0|||
130538072|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
130538073|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
130538074|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
130538075|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
130538076|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
130538077|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
130538078|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
130538079|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130538080|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130538081|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130538082|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130538083|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130538084|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
130538085|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130538086|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130584929|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
130584930|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
130538087|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130538088|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130538089|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130538090|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
130584931|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
130584932|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130584933|NCT00289913|470104838|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
130584934|NCT00289913|470104839|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130584935|NCT00289913|470104840|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
130584936|NCT00289913|470104841|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130584937|NCT00289913|470104842|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130584938|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584939|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584940|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130584941|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584942|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130584943|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
130584944|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
130584945|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
130584946|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
130584947|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
130584948|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130584949|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
130584950|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130584951|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130584952|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130584953|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
130584954|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130584955|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
130584956|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130584957|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130584958|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130584959|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584960|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130584961|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584962|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130584963|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130584964|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130584965|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
130584966|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130584967|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130584968|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
130584969|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
130584970|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
130584971|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
130584972|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
130584973|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130584974|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
130584975|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
130584976|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130584977|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130584978|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
130584979|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130584980|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130584981|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130584982|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130584983|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130584984|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130584985|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130584986|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130584987|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
130584988|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130584989|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130584990|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130584991|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130584992|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
130584993|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130584994|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130584995|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130584996|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130584997|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
130584998|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130584999|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130585000|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130585001|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130585002|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
130585003|NCT00289913|470104838|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130585004|NCT00289913|470104839|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130585005|NCT00289913|470104840|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130585006|NCT00289913|470104841|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130585007|NCT00289913|470104842|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
130585008|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130585009|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130585010|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130585011|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130585012|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130585013|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
130585014|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
130585015|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
130585016|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
130585017|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
130585018|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130585019|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130585020|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130585021|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
130585022|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130585023|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130585024|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130585025|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130585026|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130585027|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130585028|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
130585029|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
130585030|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
130585031|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
130585032|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
130585033|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130585034|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
130585035|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
130585036|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130585037|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130585038|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130585039|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130585040|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130585041|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130585042|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
130585043|NCT00289913|470104838|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130585044|NCT00289913|470104839|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
130585045|NCT00289913|470104840|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130585046|NCT00289913|470104841|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130585047|NCT00289913|470104842|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130585048|NCT03502187|470104845|FG000|Overall Study|Withdrawal by Subject|4|||
130585049|NCT03502187|470104846|FG001|Overall Study|Withdrawal by Subject|3|||
130585050|NCT03502187|470104847|FG002|Overall Study|Withdrawal by Subject|3|||
130585051|NCT03502187|470104845|FG000|Overall Study|Lost to Follow-up|5|||
130585052|NCT03502187|470104846|FG001|Overall Study|Lost to Follow-up|4|||
130585053|NCT03502187|470104847|FG002|Overall Study|Lost to Follow-up|5|||
130585054|NCT00214461|470104848|FG000|Overall Study|Adverse Event|0|||
130585055|NCT00214461|470104849|FG001|Overall Study|Adverse Event|0|||
130585056|NCT00214461|470104850|FG002|Overall Study|Adverse Event|1|||
130585057|NCT00214461|470104851|FG003|Overall Study|Adverse Event|1|||
130585058|NCT00214461|470104848|FG000|Overall Study|Withdrawal by Subject|0|||
130585059|NCT00214461|470104849|FG001|Overall Study|Withdrawal by Subject|0|||
130585060|NCT00214461|470104850|FG002|Overall Study|Withdrawal by Subject|1|||
130585061|NCT00214461|470104851|FG003|Overall Study|Withdrawal by Subject|0|||
130585062|NCT02908100|470104853|FG000|Overall Study|Adverse Event|7|||
130585063|NCT02908100|470104854|FG001|Overall Study|Adverse Event|6|||
130585064|NCT02908100|470104855|FG002|Overall Study|Adverse Event|9|||
130585065|NCT02908100|470104853|FG000|Overall Study|Death|2|||
130585066|NCT02908100|470104854|FG001|Overall Study|Death|0|||
130585067|NCT02908100|470104855|FG002|Overall Study|Death|0|||
130585068|NCT02908100|470104853|FG000|Overall Study|Lack of Efficacy|2|||
130585069|NCT02908100|470104854|FG001|Overall Study|Lack of Efficacy|3|||
130585070|NCT02908100|470104855|FG002|Overall Study|Lack of Efficacy|3|||
130585071|NCT02908100|470104853|FG000|Overall Study|Lost to Follow-up|0|||
130585072|NCT02908100|470104854|FG001|Overall Study|Lost to Follow-up|1|||
130585073|NCT02908100|470104855|FG002|Overall Study|Lost to Follow-up|2|||
130585074|NCT02908100|470104853|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130585075|NCT02908100|470104854|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130585076|NCT02908100|470104855|FG002|Overall Study|Non-Compliance With Study Drug|2|||
130585077|NCT02908100|470104853|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
130585078|NCT02908100|470104854|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
130585079|NCT02908100|470104855|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
130585080|NCT02908100|470104853|FG000|Overall Study|Physician Decision|0|||
130585081|NCT02908100|470104854|FG001|Overall Study|Physician Decision|1|||
130585082|NCT02908100|470104855|FG002|Overall Study|Physician Decision|0|||
130585083|NCT02908100|470104853|FG000|Overall Study|Pregnancy|1|||
130585084|NCT02908100|470104854|FG001|Overall Study|Pregnancy|2|||
130585085|NCT02908100|470104855|FG002|Overall Study|Pregnancy|0|||
130585086|NCT02908100|470104853|FG000|Overall Study|Withdrawal by Subject|8|||
130585087|NCT02908100|470104854|FG001|Overall Study|Withdrawal by Subject|7|||
130585088|NCT02908100|470104855|FG002|Overall Study|Withdrawal by Subject|5|||
130585089|NCT02908100|470104853|FG000|Overall Study|Randomised in Error|1|||
130585090|NCT02908100|470104854|FG001|Overall Study|Randomised in Error|0|||
130585091|NCT02908100|470104855|FG002|Overall Study|Randomised in Error|0|||
130585092|NCT00400400|470104856|FG000|Overall Study|Adverse Event|9|||
130585093|NCT00400400|470104857|FG001|Overall Study|Adverse Event|8|||
130585094|NCT00400400|470104856|FG000|Overall Study|Protocol Violation|2|||
130585095|NCT00400400|470104857|FG001|Overall Study|Protocol Violation|0|||
130585096|NCT00400400|470104856|FG000|Overall Study|Withdrawal by Subject|1|||
130585097|NCT00400400|470104857|FG001|Overall Study|Withdrawal by Subject|3|||
130585098|NCT00400400|470104856|FG000|Overall Study|Administrative Problem|1|||
130585099|NCT00400400|470104857|FG001|Overall Study|Administrative Problem|0|||
130585100|NCT00400400|470104856|FG000|Overall Study|Lost to Follow-up|0|||
130585101|NCT00400400|470104857|FG001|Overall Study|Lost to Follow-up|1|||
130585102|NCT00400400|470104856|FG000|Overall Study|Did not receive study drug|1|||
130585103|NCT00400400|470104857|FG001|Overall Study|Did not receive study drug|3|||
130585104|NCT01688050|470104858|FG000|Overall Study|Death|7|||
130585105|NCT01688050|470104858|FG000|Overall Study|Conversion to open repair|1|||
130585106|NCT01688050|470104858|FG000|Overall Study|Lost to Follow-up|13|||
130585107|NCT01688050|470104858|FG000|Overall Study|Withdrawal by Subject|10|||
130585108|NCT00330187|470104871|FG000|Overall Study|Lost to Follow-up|12|||
130585109|NCT00330187|470104872|FG001|Overall Study|Lost to Follow-up|13|||
130585110|NCT00330187|470104873|FG002|Overall Study|Lost to Follow-up|14|||
130585111|NCT00330187|470104874|FG003|Overall Study|Lost to Follow-up|10|||
130585112|NCT00330187|470104871|FG000|Overall Study|Withdrawal by Subject|8|||
130585113|NCT00330187|470104872|FG001|Overall Study|Withdrawal by Subject|5|||
130585114|NCT00330187|470104873|FG002|Overall Study|Withdrawal by Subject|4|||
130585115|NCT00330187|470104874|FG003|Overall Study|Withdrawal by Subject|4|||
130585116|NCT03258814|470104875|FG000|Overall Study|Early Termination|4|||
130585117|NCT03258814|470104876|FG001|Overall Study|Early Termination|3|||
130585118|NCT03258814|470104877|FG002|Overall Study|Early Termination|10|||
130585119|NCT01413958|470104878|FG000|Overall Study|Lost to Follow-up|0|||
130585120|NCT01413958|470104879|FG001|Overall Study|Lost to Follow-up|1|||
130585121|NCT01900002|470104880|FG000|Overall Study|Withdrawal by Subject|2|||
130585122|NCT01900002|470104880|FG000|Overall Study|ineligible for Y-90|4|||
130585123|NCT01573910|470104887|FG000|Overall Study|Adverse Event|4|||
130585124|NCT01573910|470104888|FG001|Overall Study|Adverse Event|4|||
130585125|NCT01573910|470104887|FG000|Overall Study|Lost to Follow-up|2|||
130585126|NCT01573910|470104888|FG001|Overall Study|Lost to Follow-up|1|||
130585127|NCT01573910|470104887|FG000|Overall Study|Withdrawal by Subject|0|||
130585128|NCT01573910|470104888|FG001|Overall Study|Withdrawal by Subject|1|||
130585129|NCT01573910|470104887|FG000|Overall Study|Protocol Violation|3|||
130585130|NCT01573910|470104888|FG001|Overall Study|Protocol Violation|0|||
130585131|NCT01573910|470104887|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
130585132|NCT01573910|470104888|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
130585133|NCT00364182|470104891|FG000|First Intervention|Secondary prophylaxis|1|||
130585134|NCT00364182|470104892|FG001|First Intervention|Secondary prophylaxis|0|||
130585135|NCT00364182|470104893|FG002|First Intervention|Secondary prophylaxis|0|||
130585136|NCT00364182|470104891|FG000|First Intervention|Withdrawal by Subject|2|||
130585137|NCT00364182|470104892|FG001|First Intervention|Withdrawal by Subject|0|||
130585138|NCT00364182|470104893|FG002|First Intervention|Withdrawal by Subject|0|||
130585139|NCT00364182|470104891|FG000|Second Intervention|non-compliance|0|||
130585140|NCT00364182|470104892|FG001|Second Intervention|non-compliance|1|||
130585141|NCT00364182|470104893|FG002|Second Intervention|non-compliance|1|||
130585142|NCT00364182|470104891|FG000|Second Intervention|Protocol Violation|0|||
130585143|NCT00364182|470104892|FG001|Second Intervention|Protocol Violation|1|||
130585144|NCT00364182|470104893|FG002|Second Intervention|Protocol Violation|0|||
130585145|NCT00364182|470104891|FG000|Second Intervention|Adverse Event|0|||
130585146|NCT00364182|470104892|FG001|Second Intervention|Adverse Event|0|||
130585147|NCT00364182|470104893|FG002|Second Intervention|Adverse Event|1|||
130585148|NCT00364182|470104891|FG000|Third Intervention|non-compliance|0|||
130585149|NCT00364182|470104892|FG001|Third Intervention|non-compliance|1|||
130585150|NCT00364182|470104893|FG002|Third Intervention|non-compliance|0|||
130585151|NCT00364182|470104891|FG000|Third Intervention|Lost to Follow-up|0|||
130585152|NCT00364182|470104892|FG001|Third Intervention|Lost to Follow-up|0|||
130585153|NCT00364182|470104893|FG002|Third Intervention|Lost to Follow-up|1|||
130585154|NCT02601573|470104901|FG000|Overall Study|Lost to Follow-up|0|||
130585155|NCT02601573|470104902|FG001|Overall Study|Lost to Follow-up|3|||
130585156|NCT02601573|470104903|FG002|Overall Study|Lost to Follow-up|1|||
130585157|NCT02601573|470104904|FG003|Overall Study|Lost to Follow-up|0|||
130585158|NCT02601573|470104905|FG004|Overall Study|Lost to Follow-up|2|||
130585159|NCT02601573|470104901|FG000|Overall Study|Withdrawal by Subject|0|||
130585160|NCT02601573|470104902|FG001|Overall Study|Withdrawal by Subject|1|||
130585161|NCT02601573|470104903|FG002|Overall Study|Withdrawal by Subject|0|||
130585162|NCT02601573|470104904|FG003|Overall Study|Withdrawal by Subject|1|||
130585163|NCT02601573|470104905|FG004|Overall Study|Withdrawal by Subject|0|||
130585164|NCT00974220|470104906|FG000|Treatment Period 1|Adverse Event|2|||
130585165|NCT00974220|470104907|FG001|Treatment Period 1|Adverse Event|1|||
130585166|NCT00974220|470104906|FG000|Treatment Period 1|noncompliant subjects|0|||
130585167|NCT00974220|470104907|FG001|Treatment Period 1|noncompliant subjects|1|||
130585168|NCT02921425|470104908|FG000|Overall Study|Protocol Violation|9|||
130585169|NCT01227967|470104909|FG000|Overall Study|Protocol Violation|3|||
130585170|NCT01227967|470104910|FG001|Overall Study|Protocol Violation|1|||
130585171|NCT01227967|470104909|FG000|Overall Study|Death|0|||
130585172|NCT01227967|470104910|FG001|Overall Study|Death|1|||
130585173|NCT01227967|470104909|FG000|Overall Study|Lost to Follow-up|8|||
130585174|NCT01227967|470104910|FG001|Overall Study|Lost to Follow-up|3|||
130585175|NCT01227967|470104909|FG000|Overall Study|Withdrawal by Subject|4|||
130538091|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
130538092|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
130538093|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
130538094|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
130538095|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
130538096|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
130538097|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
130538098|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
130538099|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
130538100|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
130538101|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
130538102|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
130538103|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
130538104|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
130538105|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
130538106|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
130585176|NCT01227967|470104910|FG001|Overall Study|Withdrawal by Subject|3|||
130585177|NCT01227967|470104909|FG000|Overall Study|Physician Decision|0|||
130585178|NCT01227967|470104910|FG001|Overall Study|Physician Decision|1|||
130585179|NCT01227967|470104909|FG000|Overall Study|Never Started Treatment|0|||
130585180|NCT01227967|470104910|FG001|Overall Study|Never Started Treatment|4|||
130585181|NCT01227967|470104909|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
130585182|NCT01227967|470104910|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
130585183|NCT03403400|470104911|FG000|Overall Study|Lost to Follow-up|1|||
130585184|NCT03403400|470104912|FG001|Overall Study|Lost to Follow-up|0|||
130585185|NCT03403400|470104913|FG002|Overall Study|Lost to Follow-up|1|||
130585186|NCT03403400|470104911|FG000|Overall Study|Hospitalization|1|||
130585187|NCT03403400|470104912|FG001|Overall Study|Hospitalization|0|||
130585188|NCT03403400|470104913|FG002|Overall Study|Hospitalization|0|||
130585189|NCT03403400|470104911|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
130538107|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
130538108|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
130538109|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
130538110|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
130538111|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
130538112|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
130538113|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
130538114|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Site closure|0|||
130538115|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Site closure|0|||
130538116|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Site closure|1|||
130538117|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Site closure|0|||
130538118|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Site closure|0|||
130538119|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Site closure|0|||
130538120|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
130538121|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
130538122|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
130538123|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
130538124|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
130538125|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
130538126|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
130538127|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
130538128|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
130538129|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
130538130|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
130538131|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
130538132|NCT03439254|469938868|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
130538133|NCT03439254|469938869|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
130538134|NCT03439254|469938870|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
130538135|NCT03439254|469938871|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
130538136|NCT03439254|469938872|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
130538137|NCT03439254|469938873|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
130538138|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
130538139|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
130538140|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
130538141|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
130538142|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
130538143|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
130538144|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
130538145|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
130538146|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
130538147|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
130538148|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
130538149|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
130538150|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
130538151|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
130538152|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
130538153|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
130538154|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
130538155|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
130538156|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
130538157|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
130538158|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
130538159|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
130538160|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
130538161|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
130538162|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
130538163|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
130538164|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
130585190|NCT03403400|470104912|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
130538165|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
130538166|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
130538167|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
130538168|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
130538169|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
130538170|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
130538171|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
130538172|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
130538173|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
130538174|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
130538175|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
130538176|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
130538177|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
130538178|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
130538179|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
130538180|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
130538181|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
130538182|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
130538183|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
130538184|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
130538185|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
130538186|NCT03439254|469938868|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
130538187|NCT03439254|469938869|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
130538188|NCT03439254|469938870|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
130538189|NCT03439254|469938871|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
130538190|NCT03439254|469938872|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
130538191|NCT03439254|469938873|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
130538192|NCT02075476|469938875|FG000|Overall Study|Death|2|||
130538193|NCT02075476|469938876|FG001|Overall Study|Death|2|||
130538194|NCT02075476|469938875|FG000|Overall Study|Lost to Follow-up|1|||
130538195|NCT02075476|469938876|FG001|Overall Study|Lost to Follow-up|3|||
130538196|NCT00095056|469938877|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
130538197|NCT00095056|469938878|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
130538198|NCT00095056|469938877|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
130538199|NCT00095056|469938878|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
130538200|NCT00095056|469938877|FG000|Phase A (Weeks 0-12)|Death|1|||
130538201|NCT00095056|469938878|FG001|Phase A (Weeks 0-12)|Death|0|||
130538202|NCT00095056|469938877|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
130538203|NCT00095056|469938878|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
130538204|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
130538205|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
130538206|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
130538207|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
130538208|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
130538209|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
130538210|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
130538211|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
130538212|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Death|3|||
130538213|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Death|1|||
130538214|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
130538215|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
130538216|NCT00095056|469938877|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
130538217|NCT00095056|469938878|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
130538218|NCT02731690|469938884|FG000|Overall Study|Adverse Event|1|||
130538219|NCT02731690|469938884|FG000|Overall Study|Withdrawal by Subject|3|||
130538220|NCT02731690|469938884|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
130538221|NCT00923260|469938885|FG000|Overall Study|Lost to Follow-up|1|||
130538222|NCT00923260|469938886|FG001|Overall Study|Lost to Follow-up|1|||
130538223|NCT01262677|469938888|FG000|Overall Study|Does not meet entrance criteria|0|||
130538224|NCT01262677|469938889|FG001|Overall Study|Does not meet entrance criteria|2|||
130538225|NCT01262677|469938890|FG002|Overall Study|Does not meet entrance criteria|0|||
130538226|NCT01262677|469938888|FG000|Overall Study|Insufficient clinical response|0|||
130538227|NCT01262677|469938889|FG001|Overall Study|Insufficient clinical response|0|||
130538228|NCT01262677|469938890|FG002|Overall Study|Insufficient clinical response|1|||
130538229|NCT01262677|469938888|FG000|Overall Study|Lost to Follow-up|1|||
130538230|NCT01262677|469938889|FG001|Overall Study|Lost to Follow-up|0|||
130538231|NCT01262677|469938890|FG002|Overall Study|Lost to Follow-up|2|||
130538232|NCT01262677|469938888|FG000|Overall Study|No longer willing to participate|3|||
130538233|NCT01262677|469938889|FG001|Overall Study|No longer willing to participate|3|||
130538234|NCT01262677|469938890|FG002|Overall Study|No longer willing to participate|2|||
130538235|NCT01262677|469938888|FG000|Overall Study|Reason not provided|2|||
130538236|NCT01262677|469938889|FG001|Overall Study|Reason not provided|1|||
130538237|NCT01262677|469938890|FG002|Overall Study|Reason not provided|3|||
130538238|NCT01262677|469938888|FG000|Overall Study|Protocol Violation|0|||
130538239|NCT01262677|469938889|FG001|Overall Study|Protocol Violation|1|||
130538240|NCT01262677|469938890|FG002|Overall Study|Protocol Violation|1|||
130538241|NCT01262677|469938888|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
130538242|NCT01262677|469938889|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
130538243|NCT01262677|469938890|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
130538244|NCT00201643|469938896|FG000|Overall Study|Withdrawal by Subject|5|||
130538245|NCT00201643|469938897|FG001|Overall Study|Withdrawal by Subject|4|||
130538246|NCT03446781|469938906|FG000|Overall Study|Lost to Follow-up|11|||
130538247|NCT03446781|469938907|FG001|Overall Study|Lost to Follow-up|5|||
130538248|NCT03446781|469938906|FG000|Overall Study|Withdrawal by Subject|9|||
130538249|NCT03446781|469938907|FG001|Overall Study|Withdrawal by Subject|7|||
130538250|NCT03446781|469938906|FG000|Overall Study|Adverse Event|8|||
130538251|NCT03446781|469938907|FG001|Overall Study|Adverse Event|2|||
130538252|NCT03446781|469938906|FG000|Overall Study|Protocol Violation|0|||
130538253|NCT03446781|469938907|FG001|Overall Study|Protocol Violation|3|||
130538254|NCT04410523|469938911|FG000|Overall Study|Study terminated by sponsor|1|||
130538255|NCT04410523|469938912|FG001|Overall Study|Study terminated by sponsor|3|||
130538256|NCT04410523|469938913|FG002|Overall Study|Study terminated by sponsor|2|||
130538257|NCT04410523|469938914|FG003|Overall Study|Study terminated by sponsor|6|||
130538258|NCT04410523|469938915|FG004|Overall Study|Study terminated by sponsor|3|||
130538259|NCT04410523|469938916|FG005|Overall Study|Study terminated by sponsor|4|||
130538260|NCT04410523|469938911|FG000|Overall Study|Adverse Event|1|||
130538261|NCT04410523|469938912|FG001|Overall Study|Adverse Event|0|||
130538262|NCT04410523|469938913|FG002|Overall Study|Adverse Event|0|||
130538263|NCT04410523|469938914|FG003|Overall Study|Adverse Event|0|||
130538264|NCT04410523|469938915|FG004|Overall Study|Adverse Event|0|||
130538265|NCT04410523|469938916|FG005|Overall Study|Adverse Event|2|||
130538266|NCT04410523|469938911|FG000|Overall Study|Lost to Follow-up|0|||
130538267|NCT04410523|469938912|FG001|Overall Study|Lost to Follow-up|1|||
130538268|NCT04410523|469938913|FG002|Overall Study|Lost to Follow-up|0|||
130538269|NCT04410523|469938914|FG003|Overall Study|Lost to Follow-up|0|||
130538270|NCT04410523|469938915|FG004|Overall Study|Lost to Follow-up|0|||
130538271|NCT04410523|469938916|FG005|Overall Study|Lost to Follow-up|0|||
130538272|NCT04410523|469938911|FG000|Overall Study|Physician Decision|0|||
130538273|NCT04410523|469938912|FG001|Overall Study|Physician Decision|1|||
130538274|NCT04410523|469938913|FG002|Overall Study|Physician Decision|0|||
130538275|NCT04410523|469938914|FG003|Overall Study|Physician Decision|0|||
130538276|NCT04410523|469938915|FG004|Overall Study|Physician Decision|0|||
130538277|NCT04410523|469938916|FG005|Overall Study|Physician Decision|0|||
130538278|NCT04410523|469938911|FG000|Overall Study|Pregnancy|0|||
130538279|NCT04410523|469938912|FG001|Overall Study|Pregnancy|0|||
130538280|NCT04410523|469938913|FG002|Overall Study|Pregnancy|0|||
130538281|NCT04410523|469938914|FG003|Overall Study|Pregnancy|0|||
130538282|NCT04410523|469938915|FG004|Overall Study|Pregnancy|0|||
130538283|NCT04410523|469938916|FG005|Overall Study|Pregnancy|1|||
130538284|NCT04410523|469938911|FG000|Overall Study|Protocol deviation|0|||
130538285|NCT04410523|469938912|FG001|Overall Study|Protocol deviation|0|||
130538286|NCT04410523|469938913|FG002|Overall Study|Protocol deviation|0|||
130538287|NCT04410523|469938914|FG003|Overall Study|Protocol deviation|0|||
130538288|NCT04410523|469938915|FG004|Overall Study|Protocol deviation|0|||
130538289|NCT04410523|469938916|FG005|Overall Study|Protocol deviation|2|||
130538290|NCT04410523|469938911|FG000|Overall Study|Subject decision|2|||
130538291|NCT04410523|469938912|FG001|Overall Study|Subject decision|0|||
130538292|NCT04410523|469938913|FG002|Overall Study|Subject decision|0|||
130538293|NCT04410523|469938914|FG003|Overall Study|Subject decision|1|||
130538294|NCT04410523|469938915|FG004|Overall Study|Subject decision|0|||
130538295|NCT04410523|469938916|FG005|Overall Study|Subject decision|1|||
130538296|NCT00490490|469938917|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
130538297|NCT00490490|469938917|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
130538298|NCT00473265|469938918|FG000|Overall Study|Unrelated adverse event|5|||
130538299|NCT00473265|469938918|FG000|Overall Study|Off treatment early|15|||
130538300|NCT00370682|469938923|FG000|Overall Study|Moved from area|0|||
130538301|NCT00370682|469938924|FG001|Overall Study|Moved from area|2|||
130538302|NCT00370682|469938925|FG002|Overall Study|Moved from area|0|||
130538303|NCT00370682|469938923|FG000|Overall Study|Lost to Follow-up|0|||
130538304|NCT00370682|469938924|FG001|Overall Study|Lost to Follow-up|1|||
130538305|NCT00370682|469938925|FG002|Overall Study|Lost to Follow-up|1|||
130538306|NCT03651622|469938926|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
130585191|NCT03403400|470104913|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
130538307|NCT03651622|469938927|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
130538308|NCT03651622|469938928|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
130538309|NCT03651622|469938926|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
130538310|NCT03651622|469938927|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
130538311|NCT03651622|469938928|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
130538312|NCT03651622|469938926|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
130538313|NCT03651622|469938927|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
130538314|NCT03651622|469938928|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
130538315|NCT03651622|469938926|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
130538316|NCT03651622|469938927|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
130538317|NCT03651622|469938928|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
130538318|NCT03651622|469938926|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
130538319|NCT03651622|469938927|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
130538320|NCT03651622|469938928|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
130538321|NCT01519089|469938929|FG000|Overall Study|Adverse Event|4|||
130538322|NCT01519089|469938930|FG001|Overall Study|Adverse Event|4|||
130538323|NCT01519089|469938929|FG000|Overall Study|Lack of Efficacy|0|||
130538324|NCT01519089|469938930|FG001|Overall Study|Lack of Efficacy|2|||
130538325|NCT01519089|469938929|FG000|Overall Study|Lost to Follow-up|1|||
130538326|NCT01519089|469938930|FG001|Overall Study|Lost to Follow-up|0|||
130538327|NCT01519089|469938929|FG000|Overall Study|Withdrawal by Subject|0|||
130538328|NCT01519089|469938930|FG001|Overall Study|Withdrawal by Subject|2|||
130538329|NCT01519089|469938929|FG000|Overall Study|Other|2|||
130538330|NCT01519089|469938930|FG001|Overall Study|Other|6|||
130538331|NCT01519089|469938929|FG000|Overall Study|Not received study drug|0|||
130538332|NCT01519089|469938930|FG001|Overall Study|Not received study drug|1|||
130538333|NCT00127205|469938931|FG000|Overall Study|Adverse Event|228|||
130538334|NCT00127205|469938932|FG001|Overall Study|Adverse Event|387|||
130538335|NCT00127205|469938933|FG002|Overall Study|Adverse Event|273|||
130538336|NCT00127205|469938931|FG000|Overall Study|Death|8|||
130538337|NCT00127205|469938932|FG001|Overall Study|Death|6|||
130538338|NCT00127205|469938933|FG002|Overall Study|Death|5|||
130538339|NCT00127205|469938931|FG000|Overall Study|Withdrawal by Subject|318|||
130538340|NCT00127205|469938932|FG001|Overall Study|Withdrawal by Subject|310|||
130538341|NCT00127205|469938933|FG002|Overall Study|Withdrawal by Subject|172|||
130538342|NCT00127205|469938931|FG000|Overall Study|Other-non protocol specified|142|||
130538343|NCT00127205|469938932|FG001|Overall Study|Other-non protocol specified|129|||
130538344|NCT00127205|469938933|FG002|Overall Study|Other-non protocol specified|77|||
130538345|NCT00127205|469938931|FG000|Overall Study|Data not reported|6|||
130538346|NCT00127205|469938932|FG001|Overall Study|Data not reported|10|||
130538347|NCT00127205|469938933|FG002|Overall Study|Data not reported|1|||
130538348|NCT00127205|469938931|FG000|Overall Study|Progression|127|||
130538349|NCT00127205|469938932|FG001|Overall Study|Progression|131|||
130538350|NCT00127205|469938933|FG002|Overall Study|Progression|84|||
130538351|NCT03582943|469938936|FG000|Allocated to Groups|Withdrawal by Subject|1|||
130538352|NCT03582943|469938937|FG001|Allocated to Groups|Withdrawal by Subject|1|||
130538353|NCT03582943|469938936|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
130538354|NCT03582943|469938937|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
130538355|NCT03582943|469938936|FG000|Analyzed|Protocol Violation|4|||
130538356|NCT03582943|469938937|FG001|Analyzed|Protocol Violation|1|||
130538357|NCT05032872|469938942|FG000|Overall Study|Adverse Event|1|||
130538358|NCT05032872|469938943|FG001|Overall Study|Adverse Event|0|||
130538359|NCT05032872|469938942|FG000|Overall Study|Lost to Follow-up|2|||
130538360|NCT05032872|469938943|FG001|Overall Study|Lost to Follow-up|4|||
130538361|NCT05032872|469938942|FG000|Overall Study|Withdrawal by Subject|4|||
130538362|NCT05032872|469938943|FG001|Overall Study|Withdrawal by Subject|3|||
130538363|NCT05870228|469938944|FG000|Overall Study|Lost to Follow-up|2|||
130538364|NCT05870228|469938945|FG001|Overall Study|Lost to Follow-up|0|||
130538365|NCT05870228|469938944|FG000|Overall Study|Withdrawal by Subject|1|||
130538366|NCT05870228|469938945|FG001|Overall Study|Withdrawal by Subject|0|||
130538367|NCT00488475|469938946|FG000|Overall Study|Other|1754|||
130538368|NCT00798590|469938965|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
130538369|NCT00798590|469938966|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
130538370|NCT01280357|469938969|FG000|Overall Study|Excluded no internal monitoring|14|||
130538371|NCT01280357|469938969|FG000|Overall Study|IInsufficient data/No data supplied|12|||
130538372|NCT01259089|469938974|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130538373|NCT01259089|469938975|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130538374|NCT01259089|469938976|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130538375|NCT01259089|469938977|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130538376|NCT01259089|469938978|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130538377|NCT01259089|469938979|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
130538378|NCT01259089|469938974|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
130538379|NCT01259089|469938975|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
130538380|NCT01259089|469938976|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
130538381|NCT01259089|469938977|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
130538382|NCT01259089|469938978|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
130538383|NCT01259089|469938979|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
130538384|NCT01259089|469938974|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
130538385|NCT01259089|469938975|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
130538386|NCT01259089|469938976|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
130538387|NCT01259089|469938977|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
130538388|NCT01259089|469938978|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
130538389|NCT01259089|469938979|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
130538390|NCT01259089|469938974|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
130538391|NCT01259089|469938975|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
130538392|NCT01259089|469938976|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
130538393|NCT01259089|469938977|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
130538394|NCT01259089|469938978|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
130538395|NCT01259089|469938979|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
130538396|NCT01259089|469938974|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
130538397|NCT01259089|469938975|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
130538398|NCT01259089|469938976|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
130538399|NCT01259089|469938977|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
130538400|NCT01259089|469938978|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
130538401|NCT01259089|469938979|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
130538402|NCT01259089|469938974|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
130538403|NCT01259089|469938975|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
130538404|NCT01259089|469938976|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
130538405|NCT01259089|469938977|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
130538406|NCT01259089|469938978|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
130538407|NCT01259089|469938979|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
130538408|NCT01259089|469938974|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
130538409|NCT01259089|469938975|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
130538410|NCT01259089|469938976|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
130538411|NCT01259089|469938977|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
130538412|NCT01259089|469938978|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
130538413|NCT01259089|469938979|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
130538414|NCT01259089|469938974|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
130538415|NCT01259089|469938975|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
130538416|NCT01259089|469938976|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
130538417|NCT01259089|469938977|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
130538418|NCT01259089|469938978|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
130538419|NCT01259089|469938979|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
130538420|NCT01259089|469938974|FG000|Survival Follow up for Two Years|Death|3|||
130538421|NCT01259089|469938975|FG001|Survival Follow up for Two Years|Death|2|||
130538422|NCT01259089|469938976|FG002|Survival Follow up for Two Years|Death|2|||
130538423|NCT01259089|469938977|FG003|Survival Follow up for Two Years|Death|3|||
130538424|NCT01259089|469938978|FG004|Survival Follow up for Two Years|Death|6|||
130538425|NCT01259089|469938979|FG005|Survival Follow up for Two Years|Death|13|||
130538426|NCT01259089|469938974|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
130538427|NCT01259089|469938975|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
130538428|NCT01259089|469938976|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
130538429|NCT01259089|469938977|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
130538430|NCT01259089|469938978|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
130538431|NCT01259089|469938979|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
130538432|NCT01259089|469938974|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130538433|NCT01259089|469938975|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130538434|NCT01259089|469938976|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130538435|NCT01259089|469938977|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130585192|NCT01763164|470104914|FG000|Treatment Phase|Participant/Guardian decision|26|||
130585193|NCT01763164|470104915|FG001|Treatment Phase|Participant/Guardian decision|14|||
130585194|NCT01763164|470104914|FG000|Treatment Phase|Protocol Violation|1|||
130585195|NCT01763164|470104915|FG001|Treatment Phase|Protocol Violation|1|||
130585196|NCT01763164|470104914|FG000|Treatment Phase|Progressive Disease|142|||
130585197|NCT01763164|470104915|FG001|Treatment Phase|Progressive Disease|76|||
130585198|NCT01763164|470104914|FG000|Treatment Phase|Physician Decision|24|||
130585199|NCT01763164|470104915|FG001|Treatment Phase|Physician Decision|13|||
130585200|NCT01763164|470104914|FG000|Treatment Phase|Death|10|||
130585201|NCT01763164|470104915|FG001|Treatment Phase|Death|1|||
130585202|NCT01763164|470104914|FG000|Treatment Phase|Adverse Event|66|||
130585203|NCT01763164|470104915|FG001|Treatment Phase|Adverse Event|8|||
130585204|NCT01763164|470104914|FG000|Treatment Phase|Randomized but not Treated|0|||
130585205|NCT01763164|470104915|FG001|Treatment Phase|Randomized but not Treated|19|||
130585206|NCT01763164|470104914|FG000|Treatment Phase|Other|0|||
130585207|NCT01763164|470104915|FG001|Treatment Phase|Other|1|||
130585208|NCT01763164|470104914|FG000|Follow up Phase|New therapy for study indication|12|||
130585209|NCT01763164|470104915|FG001|Follow up Phase|New therapy for study indication|3|||
130585210|NCT01763164|470104914|FG000|Follow up Phase|Death|21|||
130585211|NCT01763164|470104915|FG001|Follow up Phase|Death|4|||
130585212|NCT01763164|470104914|FG000|Follow up Phase|Subject/guardian decision|9|||
130585213|NCT01763164|470104915|FG001|Follow up Phase|Subject/guardian decision|2|||
130585214|NCT01763164|470104914|FG000|Follow up Phase|Progressive disease|127|||
130585215|NCT01763164|470104915|FG001|Follow up Phase|Progressive disease|62|||
130585216|NCT01763164|470104914|FG000|Follow up Phase|Physician Decision|10|||
130538436|NCT01259089|469938978|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130538437|NCT01259089|469938979|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
130538438|NCT00886795|469938980|FG000|Overall Study|Lack of Efficacy|1|||
130538439|NCT02310100|469938981|FG000|Overall Study|Physician Decision|3|||
130538440|NCT02310100|469938981|FG000|Overall Study|Withdrawal by Subject|10|||
130538441|NCT02310100|469938981|FG000|Overall Study|Enrollment closure|1|||
130538442|NCT02310100|469938981|FG000|Overall Study|Unapproved ablation operator|1|||
130538443|NCT02310100|469938981|FG000|Overall Study|Visit compliance|1|||
130538444|NCT02310100|469938981|FG000|Overall Study|Lost to Follow-up|2|||
130538445|NCT00688870|469938984|FG000|Infant Series|Parent or legal guardian request|4|||
130538446|NCT00688870|469938985|FG001|Infant Series|Parent or legal guardian request|0|||
130538447|NCT01769326|469938996|FG000|Overall Study|Lost to Follow-up|1|||
130538448|NCT01769326|469938997|FG001|Overall Study|Lost to Follow-up|2|||
130538449|NCT01769326|469938998|FG002|Overall Study|Lost to Follow-up|0|||
130538450|NCT01769326|469938999|FG003|Overall Study|Lost to Follow-up|0|||
130538451|NCT01769326|469938996|FG000|Overall Study|unrelated injry|1|||
130538452|NCT01769326|469938997|FG001|Overall Study|unrelated injry|1|||
130538453|NCT01769326|469938998|FG002|Overall Study|unrelated injry|0|||
130538454|NCT01769326|469938999|FG003|Overall Study|unrelated injry|0|||
130538455|NCT01769326|469938996|FG000|Overall Study|got a job|0|||
130538456|NCT01769326|469938997|FG001|Overall Study|got a job|1|||
130538457|NCT01769326|469938998|FG002|Overall Study|got a job|0|||
130538458|NCT01769326|469938999|FG003|Overall Study|got a job|0|||
130538459|NCT01769326|469938996|FG000|Overall Study|Got sick and could not complete study|0|||
130538460|NCT01769326|469938997|FG001|Overall Study|Got sick and could not complete study|0|||
130538461|NCT01769326|469938998|FG002|Overall Study|Got sick and could not complete study|1|||
130538462|NCT01769326|469938999|FG003|Overall Study|Got sick and could not complete study|0|||
130538463|NCT01278173|469939000|FG000|Overall Study|Lack of Efficacy|13|||
130538464|NCT01278173|469939000|FG000|Overall Study|Adverse Event|8|||
130538465|NCT01278173|469939000|FG000|Overall Study|Administrative or other reason|4|||
130538466|NCT01278173|469939000|FG000|Overall Study|Protocol Violation|1|||
130538467|NCT01278173|469939000|FG000|Overall Study|Withdrawal by Subject|1|||
130538468|NCT04662931|469939002|FG000|Overall Study|Withdrawal by Subject|17|||
130538469|NCT04662931|469939002|FG000|Overall Study|Death|3|||
130538470|NCT04662931|469939002|FG000|Overall Study|Lost to Follow-up|3|||
130585217|NCT01763164|470104915|FG001|Follow up Phase|Physician Decision|3|||
130538471|NCT04662931|469939002|FG000|Overall Study|Guardian Decision|1|||
130538472|NCT01397422|469939004|FG000|Overall Study|Adverse Event|0|||
130538473|NCT01397422|469939005|FG001|Overall Study|Adverse Event|3|||
130538474|NCT01397422|469939006|FG002|Overall Study|Adverse Event|3|||
130538475|NCT01397422|469939007|FG003|Overall Study|Adverse Event|8|||
130538476|NCT01397422|469939004|FG000|Overall Study|Withdrawal by Subject|1|||
130585218|NCT01763164|470104914|FG000|Follow up Phase|Lost to Follow-up|1|||
130585219|NCT01763164|470104915|FG001|Follow up Phase|Lost to Follow-up|0|||
130585220|NCT01763164|470104914|FG000|Follow up Phase|Adverse Event|17|||
130585221|NCT01763164|470104915|FG001|Follow up Phase|Adverse Event|1|||
130538477|NCT01397422|469939005|FG001|Overall Study|Withdrawal by Subject|0|||
130585222|NCT01384292|470104919|FG000|Part B|Severe non-compliance to protocol|1|||
130585223|NCT01384292|470104920|FG001|Part B|Severe non-compliance to protocol|0|||
130585224|NCT01384292|470104921|FG002|Part B|Severe non-compliance to protocol|0|||
130538478|NCT01397422|469939006|FG002|Overall Study|Withdrawal by Subject|0|||
130538479|NCT01397422|469939007|FG003|Overall Study|Withdrawal by Subject|0|||
130538480|NCT01397422|469939004|FG000|Overall Study|Increased bradykinesia related to PD|1|||
130538481|NCT01397422|469939005|FG001|Overall Study|Increased bradykinesia related to PD|0|||
130538482|NCT01397422|469939006|FG002|Overall Study|Increased bradykinesia related to PD|0|||
130538483|NCT01397422|469939007|FG003|Overall Study|Increased bradykinesia related to PD|0|||
130538484|NCT05051462|469939008|FG000|Overall Study|Lost to Follow-up|1|||
130538485|NCT05051462|469939009|FG001|Overall Study|Lost to Follow-up|8|||
130538486|NCT05051462|469939008|FG000|Overall Study|Withdrawal by Subject|1|||
130538487|NCT05051462|469939009|FG001|Overall Study|Withdrawal by Subject|0|||
130538488|NCT05051462|469939008|FG000|Overall Study|Protocol Violation|0|||
130538489|NCT05051462|469939009|FG001|Overall Study|Protocol Violation|2|||
130538490|NCT05148962|469939010|FG000|Overall Study|Withdrawal by Subject|1|||
130538491|NCT05148962|469939011|FG001|Overall Study|Withdrawal by Subject|1|||
130538492|NCT05148962|469939012|FG002|Overall Study|Withdrawal by Subject|0|||
130538493|NCT05148962|469939013|FG003|Overall Study|Withdrawal by Subject|1|||
130538494|NCT05148962|469939014|FG004|Overall Study|Withdrawal by Subject|0|||
130538495|NCT05148962|469939010|FG000|Overall Study|Participant was early terminated per protocol|0|||
130538496|NCT05148962|469939011|FG001|Overall Study|Participant was early terminated per protocol|0|||
130538497|NCT05148962|469939012|FG002|Overall Study|Participant was early terminated per protocol|3|||
130538498|NCT05148962|469939013|FG003|Overall Study|Participant was early terminated per protocol|5|||
130538499|NCT05148962|469939014|FG004|Overall Study|Participant was early terminated per protocol|2|||
130538500|NCT05148962|469939010|FG000|Overall Study|Miscellaneous|0|||
130538501|NCT05148962|469939011|FG001|Overall Study|Miscellaneous|0|||
130538502|NCT05148962|469939012|FG002|Overall Study|Miscellaneous|0|||
130538503|NCT05148962|469939013|FG003|Overall Study|Miscellaneous|1|||
130538504|NCT05148962|469939014|FG004|Overall Study|Miscellaneous|0|||
130538505|NCT01200290|469939015|FG000|Treatment Period|Adverse Event|1|||
130538506|NCT01200290|469939015|FG000|Post-Treatment Follow-Up Period|Death|2|||
130538507|NCT01144377|469939016|FG000|52 Week Treatment Period|Adverse Event|0|||
130538508|NCT01144377|469939017|FG001|52 Week Treatment Period|Adverse Event|0|||
130538509|NCT01144377|469939018|FG002|52 Week Treatment Period|Adverse Event|3|||
130538510|NCT01144377|469939019|FG003|52 Week Treatment Period|Adverse Event|2|||
130538511|NCT01144377|469939020|FG004|52 Week Treatment Period|Adverse Event|1|||
130538512|NCT01144377|469939016|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
130538513|NCT01144377|469939017|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
130538514|NCT01144377|469939018|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
130538515|NCT01144377|469939019|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
130538516|NCT01144377|469939020|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
130538517|NCT01144377|469939016|FG000|52 Week Treatment Period|Protocol Violation|0|||
130538518|NCT01144377|469939017|FG001|52 Week Treatment Period|Protocol Violation|0|||
130538519|NCT01144377|469939018|FG002|52 Week Treatment Period|Protocol Violation|0|||
130538520|NCT01144377|469939019|FG003|52 Week Treatment Period|Protocol Violation|0|||
130538521|NCT01144377|469939020|FG004|52 Week Treatment Period|Protocol Violation|1|||
130538522|NCT01144377|469939016|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
130538523|NCT01144377|469939017|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
130538524|NCT01144377|469939018|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
130538525|NCT01144377|469939019|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
130538526|NCT01144377|469939020|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
130538527|NCT01144377|469939016|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
130538528|NCT01144377|469939017|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
130538529|NCT01144377|469939018|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
130538530|NCT01144377|469939019|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
130538531|NCT01144377|469939020|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
130538532|NCT01144377|469939016|FG000|52 Week Treatment Period|Sponsor Decision|0|||
130538533|NCT01144377|469939017|FG001|52 Week Treatment Period|Sponsor Decision|0|||
130538534|NCT01144377|469939018|FG002|52 Week Treatment Period|Sponsor Decision|0|||
130538535|NCT01144377|469939019|FG003|52 Week Treatment Period|Sponsor Decision|0|||
130538536|NCT01144377|469939020|FG004|52 Week Treatment Period|Sponsor Decision|1|||
130538537|NCT01144377|469939016|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
130538538|NCT01144377|469939017|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
130538539|NCT01144377|469939018|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
130538540|NCT01144377|469939019|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
130538541|NCT01144377|469939020|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
130538542|NCT01144377|469939016|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
130538543|NCT01144377|469939017|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
130538544|NCT01144377|469939018|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
130538545|NCT01144377|469939019|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
130538546|NCT01144377|469939020|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
130538547|NCT01144377|469939016|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
130538548|NCT01144377|469939017|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
130538549|NCT01144377|469939018|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
130538550|NCT01144377|469939019|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
130538551|NCT01144377|469939020|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
130538552|NCT00151281|469939021|FG000|Overall Study|Not evaluable|3|||
130538553|NCT04150068|469939022|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
130538554|NCT04150068|469939023|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
130538555|NCT04150068|469939024|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
130538556|NCT04150068|469939022|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
130538557|NCT04150068|469939023|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
130538558|NCT04150068|469939024|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
130538559|NCT00836745|469940484|FG000|Overall Study|Death|2|||
130538560|NCT00836745|469940484|FG000|Overall Study|Lost to Follow-up|10|||
130538561|NCT00836745|469940484|FG000|Overall Study|Adverse Event|3|||
130538562|NCT00836745|469940484|FG000|Overall Study|Objective progression or relapse|4|||
130538563|NCT00836745|469940484|FG000|Overall Study|Other|2|||
130538564|NCT02898077|469940486|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
130538565|NCT02898077|469940487|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
130538566|NCT02898077|469940486|FG000|Overall Study|Lost to Follow-up|4|||
130538567|NCT02898077|469940487|FG001|Overall Study|Lost to Follow-up|3|||
130538568|NCT02898077|469940486|FG000|Overall Study|Physician Decision|0|||
130538569|NCT02898077|469940487|FG001|Overall Study|Physician Decision|2|||
130538570|NCT02898077|469940486|FG000|Overall Study|Sponsor Decision|32|||
130538571|NCT02898077|469940487|FG001|Overall Study|Sponsor Decision|13|||
130538572|NCT02898077|469940486|FG000|Overall Study|Withdrawal by Subject|6|||
130538573|NCT02898077|469940487|FG001|Overall Study|Withdrawal by Subject|3|||
130538574|NCT02898077|469940486|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
130538575|NCT02898077|469940487|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
130538576|NCT02898077|469940486|FG000|Overall Study|Ended extension period|3|||
130538577|NCT02898077|469940487|FG001|Overall Study|Ended extension period|0|||
130538578|NCT00621777|469940488|FG000|Open Phase|Adverse Event|20|||
130538579|NCT00621777|469940489|FG001|Open Phase|Adverse Event|0|||
130538580|NCT00621777|469940488|FG000|Open Phase|Did not abstain during open phase|56|||
130538581|NCT00621777|469940489|FG001|Open Phase|Did not abstain during open phase|0|||
130538582|NCT00621777|469940488|FG000|Open Phase|Withdrawal by Subject|17|||
130538583|NCT00621777|469940489|FG001|Open Phase|Withdrawal by Subject|0|||
130585225|NCT01273064|470104924|FG000|Overall Study|Adverse Event|5|||
130585226|NCT01273064|470104925|FG001|Overall Study|Adverse Event|1|||
130585227|NCT01273064|470104926|FG002|Overall Study|Adverse Event|3|||
130585228|NCT01273064|470104927|FG003|Overall Study|Adverse Event|2|||
130585229|NCT01273064|470104928|FG004|Overall Study|Adverse Event|1|||
130585230|NCT01273064|470104924|FG000|Overall Study|Withdrawal by Subject|4|||
130585231|NCT01273064|470104925|FG001|Overall Study|Withdrawal by Subject|2|||
130585232|NCT01273064|470104926|FG002|Overall Study|Withdrawal by Subject|2|||
130585233|NCT01273064|470104927|FG003|Overall Study|Withdrawal by Subject|2|||
130585234|NCT01273064|470104928|FG004|Overall Study|Withdrawal by Subject|0|||
130585235|NCT01273064|470104924|FG000|Overall Study|Study Termination|13|||
130538584|NCT00621777|469940488|FG000|Open Phase|administrative|13|||
130538585|NCT00621777|469940489|FG001|Open Phase|administrative|0|||
130538586|NCT00621777|469940488|FG000|Open Phase|Lost to Follow-up|10|||
130538587|NCT00621777|469940489|FG001|Open Phase|Lost to Follow-up|0|||
130538588|NCT00621777|469940488|FG000|Randomized Phase|Adverse Event|3|||
130538589|NCT00621777|469940489|FG001|Randomized Phase|Adverse Event|3|||
130538590|NCT00621777|469940488|FG000|Randomized Phase|Lost to Follow-up|3|||
130538591|NCT00621777|469940489|FG001|Randomized Phase|Lost to Follow-up|3|||
130538592|NCT00621777|469940488|FG000|Randomized Phase|Withdrawal by Subject|1|||
130538593|NCT00621777|469940489|FG001|Randomized Phase|Withdrawal by Subject|9|||
130538594|NCT00621777|469940488|FG000|Randomized Phase|administrative|0|||
130538595|NCT00621777|469940489|FG001|Randomized Phase|administrative|3|||
130538596|NCT00621777|469940488|FG000|Randomized Phase|Death|0|||
130538597|NCT00621777|469940489|FG001|Randomized Phase|Death|1|||
130538598|NCT01239043|469940490|FG000|Overall Study|Protocol Violation|2|||
130585236|NCT01273064|470104925|FG001|Overall Study|Study Termination|27|||
130585237|NCT01273064|470104926|FG002|Overall Study|Study Termination|26|||
130585238|NCT01273064|470104927|FG003|Overall Study|Study Termination|16|||
130538599|NCT01239043|469940491|FG001|Overall Study|Protocol Violation|1|||
130585239|NCT01273064|470104928|FG004|Overall Study|Study Termination|8|||
130538600|NCT02121301|469940494|FG000|Overall Study|Protocol Violation|1|||
130585240|NCT01273064|470104924|FG000|Overall Study|Lost to Follow-up|1|||
130585241|NCT01273064|470104925|FG001|Overall Study|Lost to Follow-up|0|||
130585242|NCT01273064|470104926|FG002|Overall Study|Lost to Follow-up|0|||
130585243|NCT01273064|470104927|FG003|Overall Study|Lost to Follow-up|0|||
130585244|NCT01273064|470104928|FG004|Overall Study|Lost to Follow-up|0|||
130538601|NCT02121301|469940495|FG001|Overall Study|Protocol Violation|4|||
130538602|NCT02121301|469940496|FG002|Overall Study|Protocol Violation|1|||
130538603|NCT02663518|469940500|FG000|Part 1: Phase 1a Escalation|Death|0|||
130538604|NCT02663518|469940501|FG001|Part 1: Phase 1a Escalation|Death|0|||
130538605|NCT02663518|469940502|FG002|Part 1: Phase 1a Escalation|Death|1|||
130538606|NCT02663518|469940503|FG003|Part 1: Phase 1a Escalation|Death|0|||
130538607|NCT02663518|469940504|FG004|Part 1: Phase 1a Escalation|Death|0|||
130538608|NCT02663518|469940505|FG005|Part 1: Phase 1a Escalation|Death|0|||
130538609|NCT02663518|469940506|FG006|Part 1: Phase 1a Escalation|Death|0|||
130538610|NCT02663518|469940507|FG007|Part 1: Phase 1a Escalation|Death|0|||
130538611|NCT02663518|469940508|FG008|Part 1: Phase 1a Escalation|Death|0|||
130538612|NCT02663518|469940509|FG009|Part 1: Phase 1a Escalation|Death|0|||
130538613|NCT02663518|469940510|FG010|Part 1: Phase 1a Escalation|Death|0|||
130538614|NCT02663518|469940511|FG011|Part 1: Phase 1a Escalation|Death|0|||
130538615|NCT02663518|469940512|FG012|Part 1: Phase 1a Escalation|Death|0|||
130538616|NCT02663518|469940513|FG013|Part 1: Phase 1a Escalation|Death|0|||
130538617|NCT02663518|469940500|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130585245|NCT01273064|470104924|FG000|Overall Study|Physician Decision|0|||
130585246|NCT01273064|470104925|FG001|Overall Study|Physician Decision|0|||
130585247|NCT01273064|470104926|FG002|Overall Study|Physician Decision|0|||
130585248|NCT01273064|470104927|FG003|Overall Study|Physician Decision|0|||
130538618|NCT02663518|469940501|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538619|NCT02663518|469940502|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
130538620|NCT02663518|469940503|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538621|NCT02663518|469940504|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538622|NCT02663518|469940505|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538623|NCT02663518|469940506|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538624|NCT02663518|469940507|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538625|NCT02663518|469940508|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538626|NCT02663518|469940509|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538627|NCT02663518|469940510|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538628|NCT02663518|469940511|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538629|NCT02663518|469940512|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538630|NCT02663518|469940513|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130538631|NCT02663518|469940500|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
130538632|NCT02663518|469940501|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
130538633|NCT02663518|469940502|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
130538634|NCT02663518|469940503|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
130538635|NCT02663518|469940504|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538636|NCT02663518|469940505|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538637|NCT02663518|469940506|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538638|NCT02663518|469940507|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538639|NCT02663518|469940508|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130585249|NCT01273064|470104928|FG004|Overall Study|Physician Decision|1|||
130585250|NCT04062214|470104929|FG000|Week 12|Death|1|||
130585251|NCT04062214|470104930|FG001|Week 12|Death|1|||
130585252|NCT04062214|470104929|FG000|Week 12|Withdrawal by Subject|14|||
130585253|NCT04062214|470104930|FG001|Week 12|Withdrawal by Subject|13|||
130585254|NCT04062214|470104929|FG000|Week 12|Lost to Follow-up|55|||
130585255|NCT04062214|470104930|FG001|Week 12|Lost to Follow-up|68|||
130585256|NCT04062214|470104929|FG000|Week 12|Intermittent missing|31|||
130585257|NCT04062214|470104930|FG001|Week 12|Intermittent missing|29|||
130585258|NCT04062214|470104929|FG000|Week 36|Withdrawal by Subject|4|||
130585259|NCT04062214|470104930|FG001|Week 36|Withdrawal by Subject|5|||
130585260|NCT04062214|470104929|FG000|Week 36|Lost to Follow-up|50|||
130585261|NCT04062214|470104930|FG001|Week 36|Lost to Follow-up|46|||
130585262|NCT04062214|470104929|FG000|Week 36|Death|0|||
130585263|NCT04062214|470104930|FG001|Week 36|Death|1|||
130585264|NCT00291551|470104931|FG000|Overall Study|Death|7|||
130585265|NCT00291551|470104931|FG000|Overall Study|Withdrawal by Subject|6|||
130585266|NCT04666038|470104932|FG000|Overall Study|Progressive Disease|2|||
130585267|NCT04666038|470104933|FG001|Overall Study|Progressive Disease|0|||
130585268|NCT04666038|470104932|FG000|Overall Study|Death|38|||
130585269|NCT04666038|470104933|FG001|Overall Study|Death|32|||
130585270|NCT04666038|470104932|FG000|Overall Study|Withdrawal by Subject|10|||
130585271|NCT04666038|470104933|FG001|Overall Study|Withdrawal by Subject|19|||
130585272|NCT04666038|470104932|FG000|Overall Study|Lost to Follow-up|0|||
130585273|NCT04666038|470104933|FG001|Overall Study|Lost to Follow-up|2|||
130585274|NCT04666038|470104932|FG000|Overall Study|On Study Treatment|46|||
130585275|NCT04666038|470104933|FG001|Overall Study|On Study Treatment|5|||
130585276|NCT04666038|470104932|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
130585277|NCT04666038|470104933|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
130585278|NCT01512264|470104936|FG000|Overall Study|Lost to Follow-up|0|||
130585279|NCT01512264|470104937|FG001|Overall Study|Lost to Follow-up|0|||
130585280|NCT01512264|470104938|FG002|Overall Study|Lost to Follow-up|0|||
130585281|NCT01512264|470104939|FG003|Overall Study|Lost to Follow-up|1|||
130585282|NCT01282229|470104948|FG000|Overall Study|Protocol Violation|2|||
130585283|NCT00996203|470104949|FG000|Overall Study|Adverse Event|3|||
130585284|NCT00996203|470104949|FG000|Overall Study|Lost to Follow-up|1|||
130538640|NCT02663518|469940509|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538641|NCT02663518|469940510|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538642|NCT02663518|469940511|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130585285|NCT00996203|470104949|FG000|Overall Study|Lack of Efficacy|1|||
130585286|NCT00996203|470104949|FG000|Overall Study|Protocol Violation|2|||
130585287|NCT03686969|470104950|FG000|Overall Study|Study terminated|1|||
130585288|NCT03686969|470104951|FG001|Overall Study|Study terminated|0|||
130585289|NCT03094195|470104959|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
130585290|NCT03094195|470104960|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
130585291|NCT03094195|470104961|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
130585292|NCT03094195|470104962|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130538643|NCT02663518|469940512|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538644|NCT02663518|469940513|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130538645|NCT02663518|469940500|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
130538646|NCT02663518|469940501|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538647|NCT02663518|469940502|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
130538648|NCT02663518|469940503|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
130538649|NCT02663518|469940504|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538650|NCT02663518|469940505|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538651|NCT02663518|469940506|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538652|NCT02663518|469940507|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538653|NCT02663518|469940508|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538654|NCT02663518|469940509|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538655|NCT02663518|469940510|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538656|NCT02663518|469940511|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538657|NCT02663518|469940512|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538658|NCT02663518|469940513|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
130538659|NCT02663518|469940500|FG000|Part 1: Phase 1a Escalation|Other|0|||
130538660|NCT02663518|469940501|FG001|Part 1: Phase 1a Escalation|Other|0|||
130538661|NCT02663518|469940502|FG002|Part 1: Phase 1a Escalation|Other|2|||
130538662|NCT02663518|469940503|FG003|Part 1: Phase 1a Escalation|Other|0|||
130538663|NCT02663518|469940504|FG004|Part 1: Phase 1a Escalation|Other|0|||
130538664|NCT02663518|469940505|FG005|Part 1: Phase 1a Escalation|Other|0|||
130538665|NCT02663518|469940506|FG006|Part 1: Phase 1a Escalation|Other|0|||
130538666|NCT02663518|469940507|FG007|Part 1: Phase 1a Escalation|Other|0|||
130538667|NCT02663518|469940508|FG008|Part 1: Phase 1a Escalation|Other|0|||
130538668|NCT02663518|469940509|FG009|Part 1: Phase 1a Escalation|Other|0|||
130538669|NCT02663518|469940510|FG010|Part 1: Phase 1a Escalation|Other|0|||
130538670|NCT02663518|469940511|FG011|Part 1: Phase 1a Escalation|Other|0|||
130538671|NCT02663518|469940512|FG012|Part 1: Phase 1a Escalation|Other|0|||
130538672|NCT02663518|469940513|FG013|Part 1: Phase 1a Escalation|Other|0|||
130538673|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538674|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538675|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538676|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538677|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
130538678|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538679|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
130538680|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
130538681|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538682|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538683|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538684|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538685|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538686|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
130538687|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538688|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538689|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538690|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538691|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
130538692|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538693|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
130538694|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
130538695|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538696|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538697|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538698|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130585293|NCT03094195|470104963|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130538699|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538700|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
130538701|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538702|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538703|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538704|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538705|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
130538706|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538707|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538708|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538709|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538710|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538711|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538712|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538713|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538714|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130538715|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538716|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538717|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538718|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538719|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
130538720|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
130538721|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
130538722|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
130538723|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538724|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538725|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538726|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538727|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538728|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
130538729|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538730|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538731|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538732|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538733|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
130538734|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538735|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
130538736|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538737|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538738|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538739|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538740|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538741|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538742|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
130538743|NCT02663518|469940500|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538744|NCT02663518|469940501|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538745|NCT02663518|469940502|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538746|NCT02663518|469940503|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538747|NCT02663518|469940504|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538748|NCT02663518|469940505|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538749|NCT02663518|469940506|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
130538750|NCT02663518|469940507|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538751|NCT02663518|469940508|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538752|NCT02663518|469940509|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538753|NCT02663518|469940510|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538754|NCT02663518|469940511|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538755|NCT02663518|469940512|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538756|NCT02663518|469940513|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
130538757|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
130538758|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
130538759|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
130538760|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
130538761|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
130538762|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
130538763|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
130538764|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
130538765|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
130538766|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
130538767|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
130538768|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
130538769|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
130538770|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
130538771|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538772|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538773|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538774|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538775|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538776|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538777|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538778|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538779|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538780|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538781|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538782|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538783|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
130538784|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
130538785|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538786|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538787|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538788|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538789|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538790|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538791|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538792|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538793|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538794|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538795|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538796|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
130538797|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538798|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
130538799|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538800|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538801|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538802|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538803|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538804|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538805|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538806|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538807|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538808|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
130538809|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
130538810|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
130538811|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
130538812|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
130538813|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
130538814|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
130538815|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
130538816|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
130538817|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
130538818|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
130538819|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
130538820|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
130538821|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
130538822|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
130538823|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
130538824|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
130538825|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
130538826|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
130538827|NCT02663518|469940500|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538828|NCT02663518|469940501|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538829|NCT02663518|469940502|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538830|NCT02663518|469940503|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538831|NCT02663518|469940504|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538832|NCT02663518|469940505|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538833|NCT02663518|469940506|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538834|NCT02663518|469940507|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538835|NCT02663518|469940508|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538836|NCT02663518|469940509|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538837|NCT02663518|469940510|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538838|NCT02663518|469940511|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538839|NCT02663518|469940512|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
130538840|NCT02663518|469940513|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130538841|NCT03896152|469940519|FG000|Overall Study|Patient/guardian decision|1|||
130538842|NCT03896152|469940520|FG001|Overall Study|Patient/guardian decision|1|||
130538843|NCT03896152|469940519|FG000|Overall Study|Adverse Event|0|||
130538844|NCT03896152|469940520|FG001|Overall Study|Adverse Event|1|||
130538845|NCT03896152|469940519|FG000|Overall Study|Physician Decision|1|||
130538846|NCT03896152|469940520|FG001|Overall Study|Physician Decision|0|||
130538847|NCT03896152|469940519|FG000|Overall Study|Technical problems|1|||
130538848|NCT03896152|469940520|FG001|Overall Study|Technical problems|0|||
130538849|NCT00436852|469940521|FG000|Overall Study|Death|23|||
130538850|NCT00436852|469940522|FG001|Overall Study|Death|34|||
130538851|NCT00436852|469940521|FG000|Overall Study|Lack of Efficacy|9|||
130538852|NCT00436852|469940522|FG001|Overall Study|Lack of Efficacy|7|||
130538853|NCT00436852|469940521|FG000|Overall Study|Withdrawal by Subject|2|||
130538854|NCT00436852|469940522|FG001|Overall Study|Withdrawal by Subject|4|||
130538855|NCT00436852|469940521|FG000|Overall Study|Ineligible|1|||
130538856|NCT00436852|469940522|FG001|Overall Study|Ineligible|0|||
130538857|NCT00943852|469940523|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538858|NCT00943852|469940524|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538859|NCT00943852|469940525|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538860|NCT00943852|469940526|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
130538861|NCT00943852|469940527|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538862|NCT00943852|469940528|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538863|NCT00943852|469940529|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538864|NCT00943852|469940530|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538865|NCT00943852|469940531|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538866|NCT00943852|469940532|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130538867|NCT00943852|469940523|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538868|NCT00943852|469940524|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538869|NCT00943852|469940525|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538870|NCT00943852|469940526|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538871|NCT00943852|469940527|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538872|NCT00943852|469940528|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
130538873|NCT00943852|469940529|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538874|NCT00943852|469940530|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538875|NCT00943852|469940531|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538876|NCT00943852|469940532|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130538877|NCT00943852|469940523|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538878|NCT00943852|469940524|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538879|NCT00943852|469940525|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538880|NCT00943852|469940526|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538881|NCT00943852|469940527|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538882|NCT00943852|469940528|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538883|NCT00943852|469940529|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
130538884|NCT00943852|469940530|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538885|NCT00943852|469940531|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538886|NCT00943852|469940532|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130538887|NCT00943852|469940523|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538888|NCT00943852|469940524|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538889|NCT00943852|469940525|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538890|NCT00943852|469940526|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538891|NCT00943852|469940527|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538892|NCT00943852|469940528|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538893|NCT00943852|469940529|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538894|NCT00943852|469940530|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
130538895|NCT00943852|469940531|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538896|NCT00943852|469940532|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130538897|NCT00943852|469940523|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
130538898|NCT00943852|469940524|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538899|NCT00943852|469940525|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
130538900|NCT00943852|469940526|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
130538901|NCT00943852|469940527|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538902|NCT00943852|469940528|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538903|NCT00943852|469940529|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
130538904|NCT00943852|469940530|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538905|NCT00943852|469940531|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538906|NCT00943852|469940532|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130538907|NCT02141620|469940533|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
130538908|NCT02141620|469940534|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
130538909|NCT03377699|469940535|FG000|Overall Study|Withdrawal by Subject|2|||
130538910|NCT03377699|469940536|FG001|Overall Study|Withdrawal by Subject|9|||
130538911|NCT03377699|469940535|FG000|Overall Study|Lost to Follow-up|1|||
130538912|NCT03377699|469940536|FG001|Overall Study|Lost to Follow-up|1|||
130538913|NCT03377699|469940535|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
130538914|NCT03377699|469940536|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
130538915|NCT03377699|469940535|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
130538916|NCT03377699|469940536|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
130538917|NCT03377699|469940535|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
130538918|NCT03377699|469940536|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
130538919|NCT03377699|469940535|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
130538920|NCT03377699|469940536|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
130538921|NCT00307684|469940540|FG000|Open Label Phase|Lack of Efficacy|0|||
130538922|NCT00307684|469940541|FG001|Open Label Phase|Lack of Efficacy|0|||
130538923|NCT00307684|469940542|FG002|Open Label Phase|Lack of Efficacy|3|||
130538924|NCT00307684|469940540|FG000|Open Label Phase|Adverse Event|0|||
130538925|NCT00307684|469940541|FG001|Open Label Phase|Adverse Event|0|||
130538926|NCT00307684|469940542|FG002|Open Label Phase|Adverse Event|16|||
130538927|NCT00307684|469940540|FG000|Open Label Phase|Withdrawal by Subject|0|||
130538928|NCT00307684|469940541|FG001|Open Label Phase|Withdrawal by Subject|0|||
130538929|NCT00307684|469940542|FG002|Open Label Phase|Withdrawal by Subject|15|||
130538930|NCT00307684|469940540|FG000|Open Label Phase|Lost to Follow-up|0|||
130538931|NCT00307684|469940541|FG001|Open Label Phase|Lost to Follow-up|0|||
130538932|NCT00307684|469940542|FG002|Open Label Phase|Lost to Follow-up|11|||
130538933|NCT00307684|469940540|FG000|Open Label Phase|non compliance|0|||
130538934|NCT00307684|469940541|FG001|Open Label Phase|non compliance|0|||
130538935|NCT00307684|469940542|FG002|Open Label Phase|non compliance|5|||
130538936|NCT00307684|469940540|FG000|Open Label Phase|other|0|||
130538937|NCT00307684|469940541|FG001|Open Label Phase|other|0|||
130538938|NCT00307684|469940542|FG002|Open Label Phase|other|6|||
130538939|NCT00307684|469940540|FG000|Double Blind Phase|Lack of Efficacy|2|||
130538940|NCT00307684|469940541|FG001|Double Blind Phase|Lack of Efficacy|5|||
130538941|NCT00307684|469940542|FG002|Double Blind Phase|Lack of Efficacy|0|||
130538942|NCT02580305|469940543|FG000|Overall Study|Adverse Event|15|||
130538943|NCT02580305|469940544|FG001|Overall Study|Adverse Event|19|||
130538944|NCT02580305|469940545|FG002|Overall Study|Adverse Event|10|||
130538945|NCT02580305|469940543|FG000|Overall Study|Lack of Efficacy|5|||
130538946|NCT02580305|469940544|FG001|Overall Study|Lack of Efficacy|0|||
130538947|NCT02580305|469940545|FG002|Overall Study|Lack of Efficacy|2|||
130538948|NCT02580305|469940543|FG000|Overall Study|Protocol Violation|4|||
130538949|NCT02580305|469940544|FG001|Overall Study|Protocol Violation|9|||
130538950|NCT02580305|469940545|FG002|Overall Study|Protocol Violation|6|||
130538951|NCT02580305|469940543|FG000|Overall Study|Lost to Follow-up|4|||
130538952|NCT02580305|469940544|FG001|Overall Study|Lost to Follow-up|4|||
130538953|NCT02580305|469940545|FG002|Overall Study|Lost to Follow-up|2|||
130538954|NCT02580305|469940543|FG000|Overall Study|Withdrawal by Subject|11|||
130538955|NCT02580305|469940544|FG001|Overall Study|Withdrawal by Subject|9|||
130538956|NCT02580305|469940545|FG002|Overall Study|Withdrawal by Subject|7|||
130538957|NCT02580305|469940543|FG000|Overall Study|Randomized in error and never treated|4|||
130538958|NCT02580305|469940544|FG001|Overall Study|Randomized in error and never treated|8|||
130538959|NCT02580305|469940545|FG002|Overall Study|Randomized in error and never treated|5|||
130538960|NCT00224887|469940546|FG000|Overall Study|Pregnancy|6|||
130538961|NCT00224887|469940547|FG001|Overall Study|Pregnancy|6|||
130538962|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
130538963|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
130538964|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
130538965|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
130538966|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
130538967|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
130538968|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
130538969|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
130538970|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
130538971|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
130538972|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
130538973|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
130538974|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
130538975|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
130538976|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
130538977|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
130538978|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
130538979|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
130538980|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
130538981|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
130538982|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
130538983|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
130538984|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
130538985|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
130538986|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
130538987|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
130538988|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
130538989|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
130538990|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
130538991|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
130538992|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
130538993|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
130538994|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
130538995|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
130538996|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
130538997|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
130538998|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
130538999|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
130539000|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
130539001|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
130539002|NCT00700427|469940550|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
130539003|NCT00700427|469940551|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
130539004|NCT00700427|469940552|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
130539005|NCT00700427|469940553|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
130539006|NCT00700427|469940554|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
130539007|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
130539008|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
130539009|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
130539010|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
130539011|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
130539012|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
130539013|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
130539014|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
130539015|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
130539016|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
130539017|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
130539018|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
130539019|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
130539020|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
130539021|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
130539022|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
130539023|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
130539024|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
130539025|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
130539026|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
130539027|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
130539028|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
130539029|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
130539030|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
130539031|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
130539032|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
130539033|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
130539034|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
130539035|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
130539036|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
130539037|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
130585294|NCT03094195|470104964|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130585295|NCT03094195|470104965|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130585296|NCT03094195|470104966|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130585297|NCT03094195|470104959|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
130585298|NCT03094195|470104960|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
130585299|NCT03094195|470104961|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
130585300|NCT03094195|470104962|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130585301|NCT03094195|470104963|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130585302|NCT03094195|470104964|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130585303|NCT03094195|470104965|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130585304|NCT03094195|470104966|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130585305|NCT03094195|470104959|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585306|NCT03094195|470104960|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585307|NCT03094195|470104961|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130585308|NCT03094195|470104962|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585309|NCT03094195|470104963|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585310|NCT03094195|470104964|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585311|NCT03094195|470104965|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585312|NCT03094195|470104966|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130585313|NCT03094195|470104959|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585314|NCT03094195|470104960|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
130585315|NCT03094195|470104961|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
130585316|NCT03094195|470104962|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585317|NCT03094195|470104963|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585318|NCT03094195|470104964|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585319|NCT03094195|470104965|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585320|NCT03094195|470104966|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130585321|NCT01988090|470104969|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
130585322|NCT01988090|470104970|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
130585323|NCT01988090|470104969|FG000|Start Treament After Randomization|Protocol Violation|0|||
130585324|NCT01988090|470104970|FG001|Start Treament After Randomization|Protocol Violation|1|||
130585325|NCT01988090|470104969|FG000|Complete Study After Start|Withdrawal by Subject|2|||
130585326|NCT01988090|470104970|FG001|Complete Study After Start|Withdrawal by Subject|0|||
130585327|NCT01988090|470104969|FG000|Complete Study After Start|Protocol Violation|1|||
130585328|NCT01988090|470104970|FG001|Complete Study After Start|Protocol Violation|1|||
130585329|NCT03887130|470104975|FG000|Overall Study|Progressive disease|23|||
130585330|NCT03887130|470104976|FG001|Overall Study|Progressive disease|14|||
130585331|NCT03887130|470104977|FG002|Overall Study|Progressive disease|7|||
130585332|NCT03887130|470104975|FG000|Overall Study|Protocol Violation|3|||
130585333|NCT03887130|470104976|FG001|Overall Study|Protocol Violation|1|||
130585334|NCT03887130|470104977|FG002|Overall Study|Protocol Violation|2|||
130585335|NCT03887130|470104975|FG000|Overall Study|Drug related toxicity|7|||
130585336|NCT03887130|470104976|FG001|Overall Study|Drug related toxicity|7|||
130585337|NCT03887130|470104977|FG002|Overall Study|Drug related toxicity|13|||
130585338|NCT03887130|470104975|FG000|Overall Study|Non drug related toxicity|3|||
130585339|NCT03887130|470104976|FG001|Overall Study|Non drug related toxicity|0|||
130585340|NCT03887130|470104977|FG002|Overall Study|Non drug related toxicity|0|||
130585341|NCT03887130|470104975|FG000|Overall Study|Death|2|||
130585342|NCT03887130|470104976|FG001|Overall Study|Death|2|||
130585343|NCT03887130|470104977|FG002|Overall Study|Death|1|||
130585344|NCT03887130|470104975|FG000|Overall Study|Withdrawal by Subject|7|||
130585345|NCT03887130|470104976|FG001|Overall Study|Withdrawal by Subject|6|||
130585346|NCT03887130|470104977|FG002|Overall Study|Withdrawal by Subject|11|||
130585347|NCT03887130|470104975|FG000|Overall Study|other reason|6|||
130585348|NCT03887130|470104976|FG001|Overall Study|other reason|20|||
130585349|NCT03887130|470104977|FG002|Overall Study|other reason|17|||
130585350|NCT01439945|470104981|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130585351|NCT01439945|470104982|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130585352|NCT01439945|470104983|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130585353|NCT01439945|470104984|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130585354|NCT01439945|470104981|FG000|Double-Blind Treatment Phase|Ineligible|1|||
130585355|NCT01439945|470104982|FG001|Double-Blind Treatment Phase|Ineligible|2|||
130585356|NCT01439945|470104983|FG002|Double-Blind Treatment Phase|Ineligible|0|||
130585357|NCT01439945|470104984|FG003|Double-Blind Treatment Phase|Ineligible|1|||
130585358|NCT04082663|470104985|FG000|Overall Study|Adverse Event|6|||
130585359|NCT04082663|470104985|FG000|Overall Study|Lost to Follow-up|1|||
130585360|NCT02107703|470106507|FG000|Overall Study|Withdrawal by Subject|46|||
130585361|NCT02107703|470106508|FG001|Overall Study|Withdrawal by Subject|21|||
130585362|NCT02107703|470106507|FG000|Overall Study|Lost to Follow-up|20|||
130585363|NCT02107703|470106508|FG001|Overall Study|Lost to Follow-up|9|||
130585364|NCT02107703|470106507|FG000|Overall Study|On study treatment/follow up|48|||
130539038|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
130539039|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
130539040|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
130539041|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
130539042|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
130539043|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
130539044|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
130539045|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
130539046|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
130539047|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130539048|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
130539049|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130585365|NCT02107703|470106508|FG001|Overall Study|On study treatment/follow up|5|||
130585366|NCT06441877|470106509|FG000|Overall Study|Withdrawal by Subject|0|||
130585367|NCT06441877|470106510|FG001|Overall Study|Withdrawal by Subject|2|||
130585368|NCT06441877|470106511|FG002|Overall Study|Withdrawal by Subject|0|||
130585369|NCT06441877|470106512|FG003|Overall Study|Withdrawal by Subject|0|||
130585370|NCT01169779|470106517|FG000|Overall Study|Adverse Event|3|||
130585371|NCT01169779|470106518|FG001|Overall Study|Adverse Event|11|||
130585372|NCT01169779|470106517|FG000|Overall Study|Lack of Efficacy|1|||
130585373|NCT01169779|470106518|FG001|Overall Study|Lack of Efficacy|0|||
130585374|NCT01169779|470106517|FG000|Overall Study|Protocol Violation|1|||
130585375|NCT01169779|470106518|FG001|Overall Study|Protocol Violation|1|||
130585376|NCT01169779|470106517|FG000|Overall Study|Withdrawal by Subject|3|||
130539050|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130539051|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130539052|NCT00700427|469940550|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
130539053|NCT00700427|469940551|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
130539054|NCT00700427|469940552|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
130539055|NCT00700427|469940553|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
130539056|NCT00700427|469940554|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
130539057|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
130539058|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
130539059|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
130539060|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
130539061|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
130539062|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
130585377|NCT01169779|470106518|FG001|Overall Study|Withdrawal by Subject|2|||
130585378|NCT01169779|470106517|FG000|Overall Study|Familial and personal reasons|3|||
130585379|NCT01169779|470106518|FG001|Overall Study|Familial and personal reasons|3|||
130585380|NCT01279057|470106520|FG000|Overall Study|Adverse Event|1|||
130585381|NCT01279057|470106521|FG001|Overall Study|Adverse Event|0|||
130585382|NCT01279057|470106522|FG002|Overall Study|Adverse Event|1|||
130585383|NCT01279057|470106520|FG000|Overall Study|Insufficient therapeutic response|0|||
130585384|NCT01279057|470106521|FG001|Overall Study|Insufficient therapeutic response|0|||
130585385|NCT01279057|470106522|FG002|Overall Study|Insufficient therapeutic response|1|||
130585386|NCT01279057|470106520|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130585387|NCT01279057|470106521|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
130585388|NCT01279057|470106522|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130585389|NCT01279057|470106520|FG000|Overall Study|Withdrew consent|2|||
130585390|NCT01279057|470106521|FG001|Overall Study|Withdrew consent|0|||
130585391|NCT01279057|470106522|FG002|Overall Study|Withdrew consent|1|||
130585392|NCT01279057|470106520|FG000|Overall Study|Pregnancy|0|||
130585393|NCT01279057|470106521|FG001|Overall Study|Pregnancy|1|||
130585394|NCT01279057|470106522|FG002|Overall Study|Pregnancy|0|||
130585395|NCT01279057|470106520|FG000|Overall Study|Other|3|||
130585396|NCT01279057|470106521|FG001|Overall Study|Other|3|||
130585397|NCT01279057|470106522|FG002|Overall Study|Other|0|||
130585398|NCT01427309|470106524|FG000|Overall Study|Lost to Follow-up|130|||
130585399|NCT01427309|470106525|FG001|Overall Study|Lost to Follow-up|145|||
130585400|NCT01427309|470106526|FG002|Overall Study|Lost to Follow-up|122|||
130585401|NCT01427309|470106527|FG003|Overall Study|Lost to Follow-up|135|||
130585402|NCT01427309|470106524|FG000|Overall Study|Protocol Violation|42|||
130585403|NCT01427309|470106525|FG001|Overall Study|Protocol Violation|69|||
130585404|NCT01427309|470106526|FG002|Overall Study|Protocol Violation|125|||
130585405|NCT01427309|470106527|FG003|Overall Study|Protocol Violation|124|||
130585406|NCT01427309|470106524|FG000|Overall Study|Adverse Event|0|||
130585407|NCT01427309|470106525|FG001|Overall Study|Adverse Event|0|||
130585408|NCT01427309|470106526|FG002|Overall Study|Adverse Event|3|||
130585409|NCT01427309|470106527|FG003|Overall Study|Adverse Event|1|||
130585410|NCT01427309|470106524|FG000|Overall Study|Serious adverse event|52|||
130585411|NCT01427309|470106525|FG001|Overall Study|Serious adverse event|45|||
130585412|NCT01427309|470106526|FG002|Overall Study|Serious adverse event|50|||
130585413|NCT01427309|470106527|FG003|Overall Study|Serious adverse event|61|||
130585414|NCT01427309|470106524|FG000|Overall Study|Withdrawal by Subject|148|||
130585415|NCT01427309|470106525|FG001|Overall Study|Withdrawal by Subject|148|||
130585416|NCT01427309|470106526|FG002|Overall Study|Withdrawal by Subject|61|||
130585417|NCT01427309|470106527|FG003|Overall Study|Withdrawal by Subject|55|||
130585418|NCT03617705|470106530|FG000|Overall Study|Withdrawal by Subject|2|||
130585419|NCT03617705|470106530|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
130585420|NCT03617705|470106530|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
130585421|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
130585422|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
130585423|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
130585424|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
130585425|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
130585426|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
130585427|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
130585428|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
130585429|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
130585430|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
130585431|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
130585432|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
130585433|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
130585434|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
130585435|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
130585436|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
130585437|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
130585438|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
130585439|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
130585440|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
130585441|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
130585442|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
130585443|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
130585444|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
130585445|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
130585446|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
130585447|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
130585448|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
130585449|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130585450|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
130585451|NCT00849017|470106531|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
130585452|NCT00849017|470106532|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
130585453|NCT00849017|470106533|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
130585454|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
130585455|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130585456|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
130585457|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130585458|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
130585459|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
130585460|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
130585461|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
130585462|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
130585463|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
130585464|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
130585465|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
130585466|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
130585467|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130585468|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130585469|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
130585470|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
130585471|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
130585472|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
130585473|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
130585474|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
130585475|NCT00849017|470106531|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
130585476|NCT00849017|470106532|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
130585477|NCT00849017|470106533|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
130585478|NCT01061008|470106534|FG000|Overall Study|Badiocephalic fistula failed|3|||
130585479|NCT01061008|470106535|FG001|Overall Study|Badiocephalic fistula failed|2|||
130585480|NCT01061008|470106534|FG000|Overall Study|Death|1|||
130585481|NCT01061008|470106535|FG001|Overall Study|Death|0|||
130585482|NCT01061008|470106534|FG000|Overall Study|Withdrawal by Subject|1|||
130585483|NCT01061008|470106535|FG001|Overall Study|Withdrawal by Subject|3|||
130585484|NCT01061008|470106534|FG000|Overall Study|Unable to exercise following surgery|1|||
130585485|NCT01061008|470106535|FG001|Overall Study|Unable to exercise following surgery|0|||
130585486|NCT01061008|470106534|FG000|Overall Study|Adverse Event|0|||
130585487|NCT01061008|470106535|FG001|Overall Study|Adverse Event|1|||
130585488|NCT02024971|470106536|FG000|Overall Study|Data Not Available|30|||
130585489|NCT02024971|470106536|FG000|Overall Study|Lost to Follow-up|6|||
130585490|NCT00553462|470106544|FG000|Overall Study|Adverse Event|4|||
130585491|NCT00553462|470106544|FG000|Overall Study|Progression|4|||
130585492|NCT00553462|470106544|FG000|Overall Study|Withdrawal by Subject|5|||
130585493|NCT00553462|470106544|FG000|Overall Study|Physician Decision|1|||
130585494|NCT01869348|470106546|FG000|Overall Study|Withdrawal by Subject|1|||
130585495|NCT01869348|470106547|FG001|Overall Study|Withdrawal by Subject|1|||
130585496|NCT03075163|470106548|FG000|Overall Study|not eligible for treatment limb|138|||
130585497|NCT03075163|470106549|FG001|Overall Study|not eligible for treatment limb|138|||
130585498|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
130585499|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
130585500|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|Death|1|||
130585501|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|Death|0|||
130585502|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
130585503|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
130585504|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
130585505|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
130585506|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
130585507|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
130585508|NCT00110994|470106550|FG000|Double-blind (DB) Treatment|other reasons|2|||
130585509|NCT00110994|470106551|FG001|Double-blind (DB) Treatment|other reasons|3|||
130585510|NCT00110994|470106550|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
130585511|NCT00110994|470106551|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
130585512|NCT00110994|470106550|FG000|Active Follow-up|Other reasons|0|||
130585513|NCT00110994|470106551|FG001|Active Follow-up|Other reasons|2|||
130585514|NCT00110994|470106550|FG000|Long Term Follow-up|Death|19|||
130585515|NCT00110994|470106551|FG001|Long Term Follow-up|Death|17|||
130585516|NCT01299727|470106554|FG000|Overall Study|Withdrawal by Subject|1|||
130585517|NCT01299727|470106555|FG001|Overall Study|Withdrawal by Subject|0|||
130539063|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
130539064|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
130539065|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
130539066|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
130539067|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
130539068|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
130539069|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
130539070|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
130539071|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
130539072|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
130539073|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
130539074|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
130539075|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
130539076|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
130539077|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
130539078|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
130539079|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
130585518|NCT01299727|470106556|FG002|Overall Study|Withdrawal by Subject|0|||
130585519|NCT01299727|470106554|FG000|Overall Study|Adverse Event|0|||
130585520|NCT01299727|470106555|FG001|Overall Study|Adverse Event|0|||
130585521|NCT01299727|470106556|FG002|Overall Study|Adverse Event|1|||
130585522|NCT01299727|470106554|FG000|Overall Study|Completed the Treatment Period|3|||
130585523|NCT01299727|470106555|FG001|Overall Study|Completed the Treatment Period|4|||
130585524|NCT01299727|470106556|FG002|Overall Study|Completed the Treatment Period|3|||
130585525|NCT00944034|470106562|FG000|Overall Study|Inappropriate enrollment|0|||
130585526|NCT00944034|470106563|FG001|Overall Study|Inappropriate enrollment|1|||
130585527|NCT00944034|470106564|FG002|Overall Study|Inappropriate enrollment|0|||
130585528|NCT00944034|470106565|FG003|Overall Study|Inappropriate enrollment|1|||
130585529|NCT00944034|470106566|FG004|Overall Study|Inappropriate enrollment|2|||
130539080|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
130539081|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
130539082|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
130539083|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
130539084|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
130539085|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
130539086|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
130539087|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
130539088|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
130539089|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
130539090|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
130539091|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
130539092|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
130539093|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
130539094|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
130539095|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
130539096|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
130539097|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
130539098|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
130539099|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
130539100|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
130539101|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
130539102|NCT00700427|469940550|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
130539103|NCT00700427|469940551|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
130539104|NCT00700427|469940552|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
130539105|NCT00700427|469940553|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
130539106|NCT00700427|469940554|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
130539107|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
130539108|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
130539109|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
130539110|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
130539111|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
130539112|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
130539113|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
130539114|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
130539115|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
130539116|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
130539117|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
130539118|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
130539119|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
130539120|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
130539121|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
130539122|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
130539123|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
130539124|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
130539125|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
130539126|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
130539127|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
130539128|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
130539129|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
130539130|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
130539131|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
130539132|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
130539133|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
130539134|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
130539135|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
130539136|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
130539137|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
130539138|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
130539139|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
130539140|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
130539141|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
130539142|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
130585530|NCT00944034|470106567|FG005|Overall Study|Inappropriate enrollment|1|||
130539143|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
130539144|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
130539145|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
130539146|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
130539147|NCT00700427|469940550|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
130539148|NCT00700427|469940551|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
130539149|NCT00700427|469940552|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
130539150|NCT00700427|469940553|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
130539151|NCT00700427|469940554|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
130539152|NCT00941070|469940556|FG000|Overall Study|Patient non-compliant|1|||
130539153|NCT01163292|469940561|FG000|Overall Study|Lack of Efficacy|9|||
130539154|NCT01163292|469940562|FG001|Overall Study|Lack of Efficacy|0|||
130539155|NCT01163292|469940561|FG000|Overall Study|Adverse Event|6|||
130539156|NCT01163292|469940562|FG001|Overall Study|Adverse Event|0|||
130539157|NCT01163292|469940561|FG000|Overall Study|Initiation of biological therapy|0|||
130539158|NCT01163292|469940562|FG001|Overall Study|Initiation of biological therapy|15|||
130539159|NCT01163292|469940561|FG000|Overall Study|Sufficient response to adalimumab|8|||
130539160|NCT01163292|469940562|FG001|Overall Study|Sufficient response to adalimumab|0|||
130539161|NCT01163292|469940561|FG000|Overall Study|Refusal to receive adalimumab|7|||
130539162|NCT01163292|469940562|FG001|Overall Study|Refusal to receive adalimumab|0|||
130539163|NCT01163292|469940561|FG000|Overall Study|Economic reasons|6|||
130539164|NCT01163292|469940562|FG001|Overall Study|Economic reasons|0|||
130539165|NCT01163292|469940561|FG000|Overall Study|No further visits|5|||
130539166|NCT01163292|469940562|FG001|Overall Study|No further visits|7|||
130539167|NCT02643472|469940563|FG000|Overall Study|Death|2|||
130539168|NCT02643472|469940564|FG001|Overall Study|Death|5|||
130539169|NCT02643472|469940563|FG000|Overall Study|Withdrawal by Subject|3|||
130539170|NCT02643472|469940564|FG001|Overall Study|Withdrawal by Subject|2|||
130539171|NCT02643472|469940563|FG000|Overall Study|Protocol Violation|0|||
130539172|NCT02643472|469940564|FG001|Overall Study|Protocol Violation|1|||
130539173|NCT02643472|469940563|FG000|Overall Study|Lost to Follow-up|22|||
130539174|NCT02643472|469940564|FG001|Overall Study|Lost to Follow-up|26|||
130539175|NCT01215188|469940565|FG000|Overall Study|Lost to Follow-up|22|||
130539176|NCT01215188|469940566|FG001|Overall Study|Lost to Follow-up|22|||
130539177|NCT01215188|469940567|FG002|Overall Study|Lost to Follow-up|16|||
130539178|NCT01215188|469940565|FG000|Overall Study|Adverse Event|1|||
130539179|NCT01215188|469940566|FG001|Overall Study|Adverse Event|1|||
130539180|NCT01215188|469940567|FG002|Overall Study|Adverse Event|3|||
130539181|NCT01215188|469940565|FG000|Overall Study|Physician Decision|2|||
130539182|NCT01215188|469940566|FG001|Overall Study|Physician Decision|1|||
130539183|NCT01215188|469940567|FG002|Overall Study|Physician Decision|0|||
130539184|NCT01215188|469940565|FG000|Overall Study|Lack of Efficacy|0|||
130539185|NCT01215188|469940566|FG001|Overall Study|Lack of Efficacy|0|||
130539186|NCT01215188|469940567|FG002|Overall Study|Lack of Efficacy|1|||
130539187|NCT01215188|469940565|FG000|Overall Study|Protocol Violation|1|||
130539188|NCT01215188|469940566|FG001|Overall Study|Protocol Violation|1|||
130539189|NCT01215188|469940567|FG002|Overall Study|Protocol Violation|1|||
130539190|NCT01215188|469940565|FG000|Overall Study|Withdrawal by Subject|32|||
130539191|NCT01215188|469940566|FG001|Overall Study|Withdrawal by Subject|34|||
130539192|NCT01215188|469940567|FG002|Overall Study|Withdrawal by Subject|31|||
130539193|NCT01127763|469940568|FG000|Overall Study|Adverse Event|2|||
130539194|NCT01127763|469940568|FG000|Overall Study|Withdrawal by Subject|1|||
130539195|NCT01127763|469940568|FG000|Overall Study|Physician Decision|2|||
130539196|NCT00528931|469940571|FG000|Overall Study|Lost to Follow-up|1|||
130539197|NCT00291642|469940574|FG000|Overall Study|Adverse Event|1|||
130539198|NCT00291642|469940575|FG001|Overall Study|Adverse Event|0|||
130539199|NCT00291642|469940576|FG002|Overall Study|Adverse Event|1|||
130539200|NCT00291642|469940577|FG003|Overall Study|Adverse Event|0|||
130539201|NCT00291642|469940578|FG004|Overall Study|Adverse Event|1|||
130539202|NCT00291642|469940574|FG000|Overall Study|Patient missed visit|0|||
130539203|NCT00291642|469940575|FG001|Overall Study|Patient missed visit|0|||
130539204|NCT00291642|469940576|FG002|Overall Study|Patient missed visit|1|||
130539205|NCT00291642|469940577|FG003|Overall Study|Patient missed visit|0|||
130539206|NCT00291642|469940578|FG004|Overall Study|Patient missed visit|0|||
130539207|NCT00291642|469940574|FG000|Overall Study|Intake of prohibited medication|1|||
130539208|NCT00291642|469940575|FG001|Overall Study|Intake of prohibited medication|0|||
130539209|NCT00291642|469940576|FG002|Overall Study|Intake of prohibited medication|0|||
130539210|NCT00291642|469940577|FG003|Overall Study|Intake of prohibited medication|0|||
130539211|NCT00291642|469940578|FG004|Overall Study|Intake of prohibited medication|0|||
130539212|NCT00680992|469940581|FG000|Overall Study|Complete Resection (as per protocol)|25|||
130539213|NCT00680992|469940582|FG001|Overall Study|Complete Resection (as per protocol)|121|||
130539214|NCT00680992|469940583|FG002|Overall Study|Complete Resection (as per protocol)|0|||
130539215|NCT00680992|469940581|FG000|Overall Study|Administrative Decision|83|||
130539216|NCT00680992|469940582|FG001|Overall Study|Administrative Decision|42|||
130539217|NCT00680992|469940583|FG002|Overall Study|Administrative Decision|5|||
130539218|NCT00680992|469940581|FG000|Overall Study|End of Trial|32|||
130539219|NCT00680992|469940582|FG001|Overall Study|End of Trial|12|||
130539220|NCT00680992|469940583|FG002|Overall Study|End of Trial|3|||
130539221|NCT00680992|469940581|FG000|Overall Study|Withdrawal by Subject|33|||
130539222|NCT00680992|469940582|FG001|Overall Study|Withdrawal by Subject|11|||
130539223|NCT00680992|469940583|FG002|Overall Study|Withdrawal by Subject|1|||
130539224|NCT00680992|469940581|FG000|Overall Study|Adverse Event|21|||
130539225|NCT00680992|469940582|FG001|Overall Study|Adverse Event|19|||
130539226|NCT00680992|469940583|FG002|Overall Study|Adverse Event|1|||
130539227|NCT00680992|469940581|FG000|Overall Study|Other|19|||
130539228|NCT00680992|469940582|FG001|Overall Study|Other|14|||
130539229|NCT00680992|469940583|FG002|Overall Study|Other|1|||
130539230|NCT00680992|469940581|FG000|Overall Study|Disease Progression|21|||
130539231|NCT00680992|469940582|FG001|Overall Study|Disease Progression|9|||
130539232|NCT00680992|469940583|FG002|Overall Study|Disease Progression|0|||
130539233|NCT00680992|469940581|FG000|Overall Study|Lost to Follow-up|12|||
130539234|NCT00680992|469940582|FG001|Overall Study|Lost to Follow-up|14|||
130539235|NCT00680992|469940583|FG002|Overall Study|Lost to Follow-up|0|||
130539236|NCT00680992|469940581|FG000|Overall Study|Noncompliance|4|||
130539237|NCT00680992|469940582|FG001|Overall Study|Noncompliance|6|||
130539238|NCT00680992|469940583|FG002|Overall Study|Noncompliance|0|||
130539239|NCT00680992|469940581|FG000|Overall Study|Requirement for Alternative Therapy|8|||
130539240|NCT00680992|469940582|FG001|Overall Study|Requirement for Alternative Therapy|2|||
130539241|NCT00680992|469940583|FG002|Overall Study|Requirement for Alternative Therapy|0|||
130539242|NCT00680992|469940581|FG000|Overall Study|Pregnancy|5|||
130539243|NCT00680992|469940582|FG001|Overall Study|Pregnancy|0|||
130539244|NCT00680992|469940583|FG002|Overall Study|Pregnancy|1|||
130539245|NCT00680992|469940581|FG000|Overall Study|Death|5|||
130539246|NCT00680992|469940582|FG001|Overall Study|Death|1|||
130539247|NCT00680992|469940583|FG002|Overall Study|Death|0|||
130539248|NCT00680992|469940581|FG000|Overall Study|Ineligibility Determined|0|||
130539249|NCT00680992|469940582|FG001|Overall Study|Ineligibility Determined|1|||
130539250|NCT00680992|469940583|FG002|Overall Study|Ineligibility Determined|0|||
130539251|NCT06665919|469940585|FG000|Overall Study|Withdrawal by Subject|4|||
130539252|NCT06665919|469940586|FG001|Overall Study|Withdrawal by Subject|4|||
130539253|NCT06665919|469940587|FG002|Overall Study|Withdrawal by Subject|4|||
130539254|NCT06665919|469940585|FG000|Overall Study|Non-compliance to Treatment|4|||
130539255|NCT06665919|469940586|FG001|Overall Study|Non-compliance to Treatment|1|||
130539256|NCT06665919|469940587|FG002|Overall Study|Non-compliance to Treatment|6|||
130539257|NCT06665919|469940585|FG000|Overall Study|Lost to Follow-up|3|||
130539258|NCT06665919|469940586|FG001|Overall Study|Lost to Follow-up|0|||
130539259|NCT06665919|469940587|FG002|Overall Study|Lost to Follow-up|2|||
130539260|NCT06665919|469940585|FG000|Overall Study|Physician Decision|4|||
130539261|NCT06665919|469940586|FG001|Overall Study|Physician Decision|0|||
130539262|NCT06665919|469940587|FG002|Overall Study|Physician Decision|1|||
130539263|NCT00607724|469940588|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
130539264|NCT00607724|469940589|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
130539265|NCT00607724|469940590|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
130539266|NCT00607724|469940591|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
130539267|NCT00607724|469940592|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
130539268|NCT00607724|469940593|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
130539269|NCT00607724|469940594|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
130539270|NCT00607724|469940588|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
130539271|NCT00607724|469940589|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
130539272|NCT00607724|469940590|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
130539273|NCT00607724|469940591|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
130539274|NCT00607724|469940592|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
130539275|NCT00607724|469940593|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
130539276|NCT00607724|469940594|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
130539277|NCT00607724|469940588|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
130539278|NCT00607724|469940589|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
130539279|NCT00607724|469940590|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
130539280|NCT00607724|469940591|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
130539281|NCT00607724|469940592|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
130539282|NCT00607724|469940593|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
130539283|NCT00607724|469940594|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
130539284|NCT00607724|469940588|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
130539285|NCT00607724|469940589|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
130539286|NCT00607724|469940590|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
130539287|NCT00607724|469940591|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
130539288|NCT00607724|469940592|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
130539289|NCT00607724|469940593|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
130539290|NCT00607724|469940594|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
130539291|NCT00607724|469940588|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539292|NCT00607724|469940589|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539293|NCT00607724|469940590|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539294|NCT00607724|469940591|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
130539295|NCT00607724|469940592|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539296|NCT00607724|469940593|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539297|NCT00607724|469940594|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
130539298|NCT03738423|469940595|FG000|Overall Study|Withdrawal by Subject|9|||
130539299|NCT03738423|469940596|FG001|Overall Study|Withdrawal by Subject|12|||
130539300|NCT03738423|469940597|FG002|Overall Study|Withdrawal by Subject|9|||
130539301|NCT03738423|469940598|FG003|Overall Study|Withdrawal by Subject|12|||
130539302|NCT03738423|469940599|FG004|Overall Study|Withdrawal by Subject|10|||
130539303|NCT03738423|469940595|FG000|Overall Study|Lack of Efficacy|3|||
130539304|NCT03738423|469940596|FG001|Overall Study|Lack of Efficacy|1|||
130539305|NCT03738423|469940597|FG002|Overall Study|Lack of Efficacy|1|||
130539306|NCT03738423|469940598|FG003|Overall Study|Lack of Efficacy|1|||
130539307|NCT03738423|469940599|FG004|Overall Study|Lack of Efficacy|2|||
130539308|NCT03738423|469940595|FG000|Overall Study|Lost to Follow-up|1|||
130539309|NCT03738423|469940596|FG001|Overall Study|Lost to Follow-up|0|||
130539310|NCT03738423|469940597|FG002|Overall Study|Lost to Follow-up|1|||
130539311|NCT03738423|469940598|FG003|Overall Study|Lost to Follow-up|1|||
130539312|NCT03738423|469940599|FG004|Overall Study|Lost to Follow-up|0|||
130539313|NCT03738423|469940595|FG000|Overall Study|Protocol Violation|1|||
130539314|NCT03738423|469940596|FG001|Overall Study|Protocol Violation|0|||
130539315|NCT03738423|469940597|FG002|Overall Study|Protocol Violation|0|||
130539316|NCT03738423|469940598|FG003|Overall Study|Protocol Violation|0|||
130539317|NCT03738423|469940599|FG004|Overall Study|Protocol Violation|1|||
130539318|NCT03738423|469940595|FG000|Overall Study|Physician Decision|0|||
130539319|NCT03738423|469940596|FG001|Overall Study|Physician Decision|0|||
130539320|NCT03738423|469940597|FG002|Overall Study|Physician Decision|1|||
130539321|NCT03738423|469940598|FG003|Overall Study|Physician Decision|0|||
130539322|NCT03738423|469940599|FG004|Overall Study|Physician Decision|1|||
130539323|NCT03738423|469940595|FG000|Overall Study|Death|0|||
130539324|NCT03738423|469940596|FG001|Overall Study|Death|0|||
130539325|NCT03738423|469940597|FG002|Overall Study|Death|0|||
130539326|NCT03738423|469940598|FG003|Overall Study|Death|0|||
130539327|NCT03738423|469940599|FG004|Overall Study|Death|1|||
130539328|NCT03738423|469940595|FG000|Overall Study|Randomized but never treated|0|||
130539329|NCT03738423|469940596|FG001|Overall Study|Randomized but never treated|0|||
130539330|NCT03738423|469940597|FG002|Overall Study|Randomized but never treated|1|||
130539331|NCT03738423|469940598|FG003|Overall Study|Randomized but never treated|1|||
130539332|NCT03738423|469940599|FG004|Overall Study|Randomized but never treated|0|||
130539333|NCT01133418|469940600|FG000|Overall Study|Lost to Follow-up|5|||
130539334|NCT01133418|469940601|FG001|Overall Study|Lost to Follow-up|6|||
130539335|NCT05316701|469940602|FG000|Overall Study|Adverse Event|0|||
130539336|NCT05316701|469940603|FG001|Overall Study|Adverse Event|1|||
130539337|NCT05316701|469940602|FG000|Overall Study|Death|3|||
130539338|NCT05316701|469940603|FG001|Overall Study|Death|9|||
130585531|NCT00944034|470106568|FG006|Overall Study|Inappropriate enrollment|0|||
130585532|NCT00944034|470106569|FG007|Overall Study|Inappropriate enrollment|0|||
130585533|NCT00944034|470106570|FG008|Overall Study|Inappropriate enrollment|1|||
130585534|NCT00944034|470106571|FG009|Overall Study|Inappropriate enrollment|1|||
130585535|NCT00944034|470106572|FG010|Overall Study|Inappropriate enrollment|0|||
130585536|NCT00944034|470106573|FG011|Overall Study|Inappropriate enrollment|0|||
130585537|NCT00944034|470106562|FG000|Overall Study|Withdrawal by Subject|3|||
130585538|NCT00944034|470106563|FG001|Overall Study|Withdrawal by Subject|2|||
130585539|NCT00944034|470106564|FG002|Overall Study|Withdrawal by Subject|6|||
130585540|NCT00944034|470106565|FG003|Overall Study|Withdrawal by Subject|2|||
130585541|NCT00944034|470106566|FG004|Overall Study|Withdrawal by Subject|5|||
130585542|NCT00944034|470106567|FG005|Overall Study|Withdrawal by Subject|8|||
130585543|NCT00944034|470106568|FG006|Overall Study|Withdrawal by Subject|2|||
130585544|NCT00944034|470106569|FG007|Overall Study|Withdrawal by Subject|2|||
130585545|NCT00944034|470106570|FG008|Overall Study|Withdrawal by Subject|3|||
130585546|NCT00944034|470106571|FG009|Overall Study|Withdrawal by Subject|4|||
130585547|NCT00944034|470106572|FG010|Overall Study|Withdrawal by Subject|0|||
130585548|NCT00944034|470106573|FG011|Overall Study|Withdrawal by Subject|4|||
130585549|NCT00944034|470106562|FG000|Overall Study|Lost to Follow-up|0|||
130585550|NCT00944034|470106563|FG001|Overall Study|Lost to Follow-up|4|||
130585551|NCT00944034|470106564|FG002|Overall Study|Lost to Follow-up|2|||
130585552|NCT00944034|470106565|FG003|Overall Study|Lost to Follow-up|0|||
130585553|NCT00944034|470106566|FG004|Overall Study|Lost to Follow-up|5|||
130585554|NCT00944034|470106567|FG005|Overall Study|Lost to Follow-up|7|||
130539339|NCT05316701|469940602|FG000|Overall Study|Lost to Follow-up|1|||
130539340|NCT05316701|469940603|FG001|Overall Study|Lost to Follow-up|0|||
130539341|NCT05316701|469940602|FG000|Overall Study|Physician Decision|1|||
130539342|NCT05316701|469940603|FG001|Overall Study|Physician Decision|4|||
130539343|NCT05316701|469940602|FG000|Overall Study|Withdrawal by Subject|3|||
130539344|NCT05316701|469940603|FG001|Overall Study|Withdrawal by Subject|5|||
130539345|NCT05316701|469940602|FG000|Overall Study|Progression/Relapse|14|||
130539346|NCT05316701|469940603|FG001|Overall Study|Progression/Relapse|9|||
130539347|NCT05316701|469940602|FG000|Overall Study|Received Standard of Care|1|||
130539348|NCT05316701|469940603|FG001|Overall Study|Received Standard of Care|0|||
130539349|NCT05316701|469940602|FG000|Overall Study|Ongoing|70|||
130539350|NCT05316701|469940603|FG001|Overall Study|Ongoing|64|||
130539351|NCT04696653|469940604|FG000|Overall Study|left organization|18|||
130539352|NCT04696653|469940604|FG000|Overall Study|Lost to Follow-up|3|||
130539353|NCT04349631|469940605|FG000|Overall Study|Lost to Follow-up|3|||
130539354|NCT04349631|469940605|FG000|Overall Study|Withdrawal by Subject|7|||
130539355|NCT01982448|469940606|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
130539356|NCT01982448|469940607|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
130539357|NCT01982448|469940606|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
130539358|NCT01982448|469940607|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
130539359|NCT01982448|469940606|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
130539360|NCT01982448|469940607|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
130539361|NCT01982448|469940606|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
130539362|NCT01982448|469940607|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
130539363|NCT01198756|469942013|FG000|Overall Study|Adverse Event|0|||
130539364|NCT01198756|469942014|FG001|Overall Study|Adverse Event|0|||
130539365|NCT01198756|469942015|FG002|Overall Study|Adverse Event|0|||
130539366|NCT01198756|469942016|FG003|Overall Study|Adverse Event|1|||
130539367|NCT01198756|469942013|FG000|Overall Study|Protocol Violation|0|||
130539368|NCT01198756|469942014|FG001|Overall Study|Protocol Violation|0|||
130539369|NCT01198756|469942015|FG002|Overall Study|Protocol Violation|0|||
130539370|NCT01198756|469942016|FG003|Overall Study|Protocol Violation|2|||
130539371|NCT01198756|469942013|FG000|Overall Study|Withdrawal by Subject|9|||
130539372|NCT01198756|469942014|FG001|Overall Study|Withdrawal by Subject|4|||
130539373|NCT01198756|469942015|FG002|Overall Study|Withdrawal by Subject|7|||
130539374|NCT01198756|469942016|FG003|Overall Study|Withdrawal by Subject|5|||
130539375|NCT01198756|469942013|FG000|Overall Study|Lost to Follow-up|29|||
130539376|NCT01198756|469942014|FG001|Overall Study|Lost to Follow-up|36|||
130539377|NCT01198756|469942015|FG002|Overall Study|Lost to Follow-up|23|||
130539378|NCT01198756|469942016|FG003|Overall Study|Lost to Follow-up|18|||
130585555|NCT00944034|470106568|FG006|Overall Study|Lost to Follow-up|0|||
130585556|NCT00944034|470106569|FG007|Overall Study|Lost to Follow-up|1|||
130585557|NCT00944034|470106570|FG008|Overall Study|Lost to Follow-up|5|||
130585558|NCT00944034|470106571|FG009|Overall Study|Lost to Follow-up|1|||
130585559|NCT00944034|470106572|FG010|Overall Study|Lost to Follow-up|1|||
130585560|NCT00944034|470106573|FG011|Overall Study|Lost to Follow-up|0|||
130585561|NCT00944034|470106562|FG000|Overall Study|Death|0|||
130585562|NCT00944034|470106563|FG001|Overall Study|Death|0|||
130585563|NCT00944034|470106564|FG002|Overall Study|Death|1|||
130585564|NCT00944034|470106565|FG003|Overall Study|Death|0|||
130585565|NCT00944034|470106566|FG004|Overall Study|Death|0|||
130585566|NCT00944034|470106567|FG005|Overall Study|Death|0|||
130585567|NCT00944034|470106568|FG006|Overall Study|Death|0|||
130585568|NCT00944034|470106569|FG007|Overall Study|Death|0|||
130585569|NCT00944034|470106570|FG008|Overall Study|Death|0|||
130585570|NCT00944034|470106571|FG009|Overall Study|Death|0|||
130585571|NCT00944034|470106572|FG010|Overall Study|Death|0|||
130585572|NCT00944034|470106573|FG011|Overall Study|Death|0|||
130585573|NCT00944034|470106562|FG000|Overall Study|Protocol Violation|2|||
130585574|NCT00944034|470106563|FG001|Overall Study|Protocol Violation|0|||
130585575|NCT00944034|470106564|FG002|Overall Study|Protocol Violation|0|||
130585576|NCT00944034|470106565|FG003|Overall Study|Protocol Violation|1|||
130585577|NCT00944034|470106566|FG004|Overall Study|Protocol Violation|2|||
130585578|NCT00944034|470106567|FG005|Overall Study|Protocol Violation|3|||
130585579|NCT00944034|470106568|FG006|Overall Study|Protocol Violation|0|||
130585580|NCT00944034|470106569|FG007|Overall Study|Protocol Violation|1|||
130585581|NCT00944034|470106570|FG008|Overall Study|Protocol Violation|1|||
130585582|NCT00944034|470106571|FG009|Overall Study|Protocol Violation|4|||
130585583|NCT00944034|470106572|FG010|Overall Study|Protocol Violation|0|||
130585584|NCT00944034|470106573|FG011|Overall Study|Protocol Violation|0|||
130585585|NCT00944034|470106562|FG000|Overall Study|Unable to classify|0|||
130585586|NCT00944034|470106563|FG001|Overall Study|Unable to classify|0|||
130585587|NCT00944034|470106564|FG002|Overall Study|Unable to classify|0|||
130585588|NCT00944034|470106565|FG003|Overall Study|Unable to classify|0|||
130585589|NCT00944034|470106566|FG004|Overall Study|Unable to classify|0|||
130585590|NCT00944034|470106567|FG005|Overall Study|Unable to classify|1|||
130585591|NCT00944034|470106568|FG006|Overall Study|Unable to classify|1|||
130585592|NCT00944034|470106569|FG007|Overall Study|Unable to classify|1|||
130585593|NCT00944034|470106570|FG008|Overall Study|Unable to classify|0|||
130585594|NCT00944034|470106571|FG009|Overall Study|Unable to classify|0|||
130585595|NCT00944034|470106572|FG010|Overall Study|Unable to classify|0|||
130585596|NCT00944034|470106573|FG011|Overall Study|Unable to classify|0|||
130585597|NCT00944034|470106562|FG000|Overall Study|Administrative reason|0|||
130585598|NCT00944034|470106563|FG001|Overall Study|Administrative reason|0|||
130585599|NCT00944034|470106564|FG002|Overall Study|Administrative reason|0|||
130585600|NCT00944034|470106565|FG003|Overall Study|Administrative reason|0|||
130585601|NCT00944034|470106566|FG004|Overall Study|Administrative reason|0|||
130585602|NCT00944034|470106567|FG005|Overall Study|Administrative reason|0|||
130585603|NCT00944034|470106568|FG006|Overall Study|Administrative reason|1|||
130585604|NCT00944034|470106569|FG007|Overall Study|Administrative reason|0|||
130585605|NCT00944034|470106570|FG008|Overall Study|Administrative reason|0|||
130585606|NCT00944034|470106571|FG009|Overall Study|Administrative reason|0|||
130585607|NCT00944034|470106572|FG010|Overall Study|Administrative reason|0|||
130585608|NCT00944034|470106573|FG011|Overall Study|Administrative reason|0|||
130585609|NCT01570244|470106574|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
130585610|NCT00531960|470106579|FG000|Overall Study|Adverse Event|5|||
130585611|NCT00531960|470106580|FG001|Overall Study|Adverse Event|4|||
130585612|NCT00531960|470106579|FG000|Overall Study|Death|3|||
130585613|NCT00531960|470106580|FG001|Overall Study|Death|2|||
130585614|NCT00531960|470106579|FG000|Overall Study|Lack of Efficacy|42|||
130585615|NCT00531960|470106580|FG001|Overall Study|Lack of Efficacy|41|||
130585616|NCT00531960|470106579|FG000|Overall Study|Violation of Selection Criteria|2|||
130585617|NCT00531960|470106580|FG001|Overall Study|Violation of Selection Criteria|0|||
130585618|NCT00531960|470106579|FG000|Overall Study|Refused Treatment|5|||
130585619|NCT00531960|470106580|FG001|Overall Study|Refused Treatment|6|||
130585620|NCT00531960|470106579|FG000|Overall Study|Other|4|||
130585621|NCT00531960|470106580|FG001|Overall Study|Other|10|||
130585622|NCT01500057|470106581|FG000|Overall Study|Lost to Follow-up|6|||
130585623|NCT01500057|470106582|FG001|Overall Study|Lost to Follow-up|4|||
130585624|NCT04134494|470106588|FG000|Overall Study|Lost to Follow-up|2|||
130585625|NCT00781365|470106590|FG000|Overall Study|Withdrawal by Subject|13|||
130585626|NCT00781365|470106591|FG001|Overall Study|Withdrawal by Subject|8|||
130585627|NCT00781365|470106590|FG000|Overall Study|Did Not Attend Visit|20|||
130585628|NCT00781365|470106591|FG001|Overall Study|Did Not Attend Visit|28|||
130585629|NCT00781365|470106590|FG000|Overall Study|Language barrier|1|||
130585630|NCT00781365|470106591|FG001|Overall Study|Language barrier|0|||
130585631|NCT01879410|470106592|FG000|Overall Study|Adverse Event|9|||
130585632|NCT01879410|470106593|FG001|Overall Study|Adverse Event|14|||
130585633|NCT01879410|470106592|FG000|Overall Study|Lack of Efficacy|4|||
130585634|NCT01879410|470106593|FG001|Overall Study|Lack of Efficacy|6|||
130585635|NCT01879410|470106592|FG000|Overall Study|Protocol Violation|1|||
130585636|NCT01879410|470106593|FG001|Overall Study|Protocol Violation|7|||
130539379|NCT00901186|469942020|FG000|Overall Study|Lack of Efficacy|0|||
130585637|NCT01879410|470106592|FG000|Overall Study|Lost to Follow-up|2|||
130585638|NCT01879410|470106593|FG001|Overall Study|Lost to Follow-up|1|||
130585639|NCT01879410|470106592|FG000|Overall Study|Withdrawal by Subject|7|||
130539380|NCT00901186|469942021|FG001|Overall Study|Lack of Efficacy|1|||
130539381|NCT00901186|469942020|FG000|Overall Study|Abnormal laboratory values|0|||
130539382|NCT00901186|469942021|FG001|Overall Study|Abnormal laboratory values|1|||
130539383|NCT00901186|469942020|FG000|Overall Study|Lost to Follow-up|2|||
130539384|NCT00901186|469942021|FG001|Overall Study|Lost to Follow-up|0|||
130539385|NCT00901186|469942020|FG000|Overall Study|Adverse Event|2|||
130539386|NCT00901186|469942021|FG001|Overall Study|Adverse Event|4|||
130539387|NCT00901186|469942020|FG000|Overall Study|Administration problems|0|||
130539388|NCT00901186|469942021|FG001|Overall Study|Administration problems|1|||
130585640|NCT01879410|470106593|FG001|Overall Study|Withdrawal by Subject|8|||
130585641|NCT01879410|470106592|FG000|Overall Study|Randomised in Error|1|||
130585642|NCT01879410|470106593|FG001|Overall Study|Randomised in Error|2|||
130585643|NCT01756456|470106601|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130585644|NCT01756456|470106602|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130585645|NCT01756456|470106603|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130585646|NCT01756456|470106604|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130585647|NCT01756456|470106605|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130585648|NCT01756456|470106606|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130585649|NCT01756456|470106601|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130585650|NCT01756456|470106602|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130585651|NCT01756456|470106603|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130585652|NCT01756456|470106604|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
130585653|NCT01756456|470106605|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
130585654|NCT01756456|470106606|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130585655|NCT01756456|470106601|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130585656|NCT01756456|470106602|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
130585657|NCT01756456|470106603|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130585658|NCT01756456|470106604|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130585659|NCT01756456|470106605|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130585660|NCT01756456|470106606|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130585661|NCT01756456|470106601|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
130585662|NCT01756456|470106602|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
130585663|NCT01756456|470106603|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
130585664|NCT01756456|470106604|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
130585665|NCT01756456|470106605|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
130585666|NCT01756456|470106606|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
130585667|NCT01756456|470106601|FG000|Treatment Period: Phase I/II|Other causes|0|||
130585668|NCT01756456|470106602|FG001|Treatment Period: Phase I/II|Other causes|0|||
130585669|NCT01756456|470106603|FG002|Treatment Period: Phase I/II|Other causes|0|||
130585670|NCT01756456|470106604|FG003|Treatment Period: Phase I/II|Other causes|1|||
130585671|NCT01756456|470106605|FG004|Treatment Period: Phase I/II|Other causes|2|||
130585672|NCT01756456|470106606|FG005|Treatment Period: Phase I/II|Other causes|2|||
130585673|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
130585674|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
130585675|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
130585676|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
130585677|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
130585678|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
130585679|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130585680|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
130585681|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130539389|NCT00901186|469942020|FG000|Overall Study|Protocol deviations|5|||
130539390|NCT00901186|469942021|FG001|Overall Study|Protocol deviations|4|||
130539391|NCT00581555|469942024|FG000|Overall Study|Adverse Event|4|||
130539392|NCT00581555|469942025|FG001|Overall Study|Adverse Event|3|||
130585682|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130585683|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130585684|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130585685|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130585686|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130539393|NCT00581555|469942024|FG000|Overall Study|Physician Decision|3|||
130539394|NCT00581555|469942025|FG001|Overall Study|Physician Decision|2|||
130539395|NCT00581555|469942024|FG000|Overall Study|Withdrawal by Subject|18|||
130585687|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130585688|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130585689|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130585690|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
130585691|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
130585692|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
130585693|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
130585694|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
130585695|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
130585696|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
130585697|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130585698|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130585699|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
130585700|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
130585701|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130585702|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
130585703|NCT01756456|470106601|FG000|Follow Up Period Phase I/II|Other causes|0|||
130585704|NCT01756456|470106602|FG001|Follow Up Period Phase I/II|Other causes|0|||
130585705|NCT01756456|470106603|FG002|Follow Up Period Phase I/II|Other causes|0|||
130585706|NCT01756456|470106604|FG003|Follow Up Period Phase I/II|Other causes|1|||
130585707|NCT01756456|470106605|FG004|Follow Up Period Phase I/II|Other causes|3|||
130585708|NCT01756456|470106606|FG005|Follow Up Period Phase I/II|Other causes|5|||
130585709|NCT02658812|470106609|FG000|Overall Study|Disease Progression|7|||
130585710|NCT02658812|470106609|FG000|Overall Study|Unrelated to study treatment|1|||
130585711|NCT02658812|470106609|FG000|Overall Study|Adverse Event|1|||
130585712|NCT02411747|470106610|FG000|Overall Study|Withdrawal by Subject|1|||
130585713|NCT02411747|470106611|FG001|Overall Study|Withdrawal by Subject|0|||
130585714|NCT02411747|470106610|FG000|Overall Study|Protocol Violation|2|||
130585715|NCT02411747|470106611|FG001|Overall Study|Protocol Violation|4|||
130585716|NCT00560755|470106613|FG000|Overall Study|Protocol Violation|15|||
130585717|NCT00560755|470106613|FG000|Overall Study|Withdrawal by Subject|26|||
130585718|NCT00560755|470106613|FG000|Overall Study|Lost to Follow-up|9|||
130585719|NCT00560755|470106613|FG000|Overall Study|Adverse Event|8|||
130585720|NCT00560755|470106613|FG000|Overall Study|Physician Decision|2|||
130585721|NCT00848120|470106614|FG000|Overall Study|Adverse Event|1|||
130585722|NCT02116621|470106618|FG000|Baseline|Withdrawal by Subject|0|||
130585723|NCT02116621|470106619|FG001|Baseline|Withdrawal by Subject|4|||
130585724|NCT02116621|470106618|FG000|Three Month Follow-up|Death|1|||
130585725|NCT02116621|470106619|FG001|Three Month Follow-up|Death|1|||
130585726|NCT02116621|470106618|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
130585727|NCT02116621|470106619|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
130585728|NCT02116621|470106618|FG000|Three Month Follow-up|Lost to Follow-up|0|||
130585729|NCT02116621|470106619|FG001|Three Month Follow-up|Lost to Follow-up|1|||
130585730|NCT02116621|470106618|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
130585731|NCT02116621|470106619|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
130585732|NCT02116621|470106618|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
130585733|NCT02116621|470106619|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
130585734|NCT02116621|470106618|FG000|Six Month Follow-up|Lost to Follow-up|2|||
130585735|NCT02116621|470106619|FG001|Six Month Follow-up|Lost to Follow-up|1|||
130585736|NCT02116621|470106618|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
130585737|NCT02116621|470106619|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
130585738|NCT02116621|470106618|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
130585739|NCT02116621|470106619|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
130585740|NCT02116621|470106618|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
130585741|NCT02116621|470106619|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
130585742|NCT02116621|470106618|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
130585743|NCT02116621|470106619|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
130585744|NCT02116621|470106618|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
130585745|NCT02116621|470106619|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
130585746|NCT00961961|470106620|FG000|Phase I|Withdrawal by Subject|7|||
130585747|NCT00961961|470106621|FG001|Phase I|Withdrawal by Subject|0|||
130585748|NCT00961961|470106622|FG002|Phase I|Withdrawal by Subject|0|||
130585749|NCT00961961|470106623|FG003|Phase I|Withdrawal by Subject|0|||
130585750|NCT00961961|470106620|FG000|Phase I|Lost to Follow-up|10|||
130585751|NCT00961961|470106621|FG001|Phase I|Lost to Follow-up|0|||
130585752|NCT00961961|470106622|FG002|Phase I|Lost to Follow-up|0|||
130585753|NCT00961961|470106623|FG003|Phase I|Lost to Follow-up|0|||
130585754|NCT00961961|470106620|FG000|Phase I|Lack of Efficacy|94|||
130585755|NCT00961961|470106621|FG001|Phase I|Lack of Efficacy|0|||
130585756|NCT00961961|470106622|FG002|Phase I|Lack of Efficacy|0|||
130585757|NCT00961961|470106623|FG003|Phase I|Lack of Efficacy|0|||
130585758|NCT00961961|470106620|FG000|Phase I|Adverse Event|7|||
130585759|NCT00961961|470106621|FG001|Phase I|Adverse Event|0|||
130585760|NCT00961961|470106622|FG002|Phase I|Adverse Event|0|||
130585761|NCT00961961|470106623|FG003|Phase I|Adverse Event|0|||
130585762|NCT00961961|470106620|FG000|Phase I|Physician Decision|8|||
130539396|NCT00581555|469942025|FG001|Overall Study|Withdrawal by Subject|9|||
130539397|NCT00581555|469942024|FG000|Overall Study|Lost to Follow-up|2|||
130539398|NCT00581555|469942025|FG001|Overall Study|Lost to Follow-up|2|||
130539399|NCT00581555|469942024|FG000|Overall Study|Other reasons|16|||
130539400|NCT00581555|469942025|FG001|Overall Study|Other reasons|4|||
130539401|NCT05816330|469942026|FG000|Overall Study|Withdrawal by Subject|4|||
130539402|NCT05816330|469942027|FG001|Overall Study|Withdrawal by Subject|1|||
130539403|NCT03900416|469942028|FG000|Six Week Follow-up|Lost to Follow-up|1|||
130539404|NCT03900416|469942029|FG001|Six Week Follow-up|Lost to Follow-up|0|||
130539405|NCT03900416|469942028|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
130539406|NCT03900416|469942029|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
130539407|NCT03900416|469942028|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
130539408|NCT03900416|469942029|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
130539409|NCT03900416|469942028|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
130539410|NCT03900416|469942029|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
130539411|NCT03900416|469942028|FG000|Twelve Week Follow-up|Adverse Event|1|||
130539412|NCT03900416|469942029|FG001|Twelve Week Follow-up|Adverse Event|1|||
130539413|NCT03900416|469942028|FG000|Six Month Follow-up|Lost to Follow-up|4|||
130539414|NCT03900416|469942029|FG001|Six Month Follow-up|Lost to Follow-up|3|||
130539415|NCT03900416|469942028|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
130539416|NCT03900416|469942029|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
130539417|NCT00772330|469942030|FG000|Overall Study|Lost to Follow-up|3|||
130539418|NCT01353859|469942031|FG000|Overall Study|Adverse Event|3|||
130539419|NCT01353859|469942031|FG000|Overall Study|Lack of Efficacy|1|||
130539420|NCT03231800|469942032|FG000|Overall Study|Lost to Follow-up|0|||
130539421|NCT03231800|469942033|FG001|Overall Study|Lost to Follow-up|2|||
130539422|NCT03231800|469942032|FG000|Overall Study|Protocol Violation|1|||
130539423|NCT03231800|469942033|FG001|Overall Study|Protocol Violation|1|||
130539424|NCT03231800|469942032|FG000|Overall Study|reason not provided|2|||
130539425|NCT03231800|469942033|FG001|Overall Study|reason not provided|0|||
130539426|NCT00859222|469942034|FG000|Overall Study|Adverse Event|2|||
130539427|NCT00859222|469942035|FG001|Overall Study|Adverse Event|3|||
130539428|NCT00859222|469942036|FG002|Overall Study|Adverse Event|6|||
130539429|NCT00859222|469942037|FG003|Overall Study|Adverse Event|24|||
130539430|NCT00859222|469942038|FG004|Overall Study|Adverse Event|15|||
130539431|NCT00859222|469942034|FG000|Overall Study|DLT|1|||
130539432|NCT00859222|469942035|FG001|Overall Study|DLT|0|||
130539433|NCT00859222|469942036|FG002|Overall Study|DLT|0|||
130539434|NCT00859222|469942037|FG003|Overall Study|DLT|0|||
130539435|NCT00859222|469942038|FG004|Overall Study|DLT|0|||
130539436|NCT00400725|469942039|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
130539437|NCT00400725|469942040|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
130539438|NCT00400725|469942041|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
130539439|NCT00400725|469942039|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
130539440|NCT00400725|469942040|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
130539441|NCT00400725|469942041|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
130539442|NCT00400725|469942039|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
130585763|NCT00961961|470106621|FG001|Phase I|Physician Decision|0|||
130539443|NCT00400725|469942040|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
130539444|NCT00400725|469942041|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
130539445|NCT00400725|469942039|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
130539446|NCT00400725|469942040|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
130539447|NCT00400725|469942041|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
130539448|NCT00400725|469942039|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
130539449|NCT00400725|469942040|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
130539450|NCT00400725|469942041|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
130539451|NCT00400725|469942039|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
130539452|NCT00400725|469942040|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
130539453|NCT00400725|469942041|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
130539454|NCT00400725|469942039|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
130539455|NCT00400725|469942040|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
130539456|NCT00400725|469942041|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
130539457|NCT00400725|469942039|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
130539458|NCT00400725|469942040|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
130539459|NCT00400725|469942041|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
130539460|NCT00400725|469942039|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
130539461|NCT00400725|469942040|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
130539462|NCT00400725|469942041|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
130539463|NCT04075994|469942042|FG000|Overall Study|Withdrawal by Subject|8|||
130539464|NCT04075994|469942043|FG001|Overall Study|Withdrawal by Subject|9|||
130539465|NCT04075994|469942042|FG000|Overall Study|Adverse Event|2|||
130539466|NCT04075994|469942043|FG001|Overall Study|Adverse Event|2|||
130539467|NCT04075994|469942042|FG000|Overall Study|Investigator withdrew|3|||
130539468|NCT04075994|469942043|FG001|Overall Study|Investigator withdrew|1|||
130539469|NCT01941719|469942048|FG000|Overall Study|Lost to Follow-up|20|||
130539470|NCT01941719|469942049|FG001|Overall Study|Lost to Follow-up|19|||
130539471|NCT00252577|469942050|FG000|Overall Study|Lost to Follow-up|20|||
130539472|NCT01744392|469942053|FG000|Overall Study|Physician Decision|1|||
130539473|NCT01416389|469942054|FG000|Overall Study|Lost to Follow-up|1|||
130539474|NCT01416389|469942055|FG001|Overall Study|Lost to Follow-up|0|||
130539475|NCT01416389|469942054|FG000|Overall Study|Started New Therapy|2|||
130539476|NCT01416389|469942055|FG001|Overall Study|Started New Therapy|0|||
130539477|NCT01125514|469942056|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
130539478|NCT01125514|469942056|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
130539479|NCT01125514|469942056|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
130539480|NCT01125514|469942056|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
130539481|NCT01125514|469942056|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
130539482|NCT01125514|469942056|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
130539483|NCT00858364|469942059|FG000|Overall Study|Administrative Decision|3|||
130539484|NCT00858364|469942060|FG001|Overall Study|Administrative Decision|2|||
130539485|NCT00858364|469942059|FG000|Overall Study|Adverse Event|5|||
130539486|NCT00858364|469942060|FG001|Overall Study|Adverse Event|2|||
130539487|NCT00858364|469942059|FG000|Overall Study|Withdrawal by Subject|44|||
130539488|NCT00858364|469942060|FG001|Overall Study|Withdrawal by Subject|118|||
130539489|NCT00858364|469942059|FG000|Overall Study|Ineligibility Determined|1|||
130539490|NCT00858364|469942060|FG001|Overall Study|Ineligibility Determined|10|||
130539491|NCT00858364|469942059|FG000|Overall Study|Lost to Follow-up|24|||
130539492|NCT00858364|469942060|FG001|Overall Study|Lost to Follow-up|54|||
130539493|NCT00858364|469942059|FG000|Overall Study|Noncompliance|3|||
130539494|NCT00858364|469942060|FG001|Overall Study|Noncompliance|4|||
130539495|NCT00858364|469942059|FG000|Overall Study|Protocol Deviation|0|||
130539496|NCT00858364|469942060|FG001|Overall Study|Protocol Deviation|2|||
130539497|NCT00858364|469942059|FG000|Overall Study|Other|9|||
130539498|NCT00858364|469942060|FG001|Overall Study|Other|17|||
130539499|NCT00858364|469942059|FG000|Overall Study|Missing|1|||
130539500|NCT00858364|469942060|FG001|Overall Study|Missing|1|||
130539501|NCT00858364|469942059|FG000|Overall Study|Still on-study|114|||
130539502|NCT00858364|469942060|FG001|Overall Study|Still on-study|247|||
130539503|NCT02755818|469942061|FG000|Overall Study|Withdrawal by Subject|0|||
130539504|NCT02755818|469942062|FG001|Overall Study|Withdrawal by Subject|0|||
130539505|NCT02755818|469942063|FG002|Overall Study|Withdrawal by Subject|0|||
130539506|NCT02755818|469942064|FG003|Overall Study|Withdrawal by Subject|2|||
130539507|NCT02755818|469942061|FG000|Overall Study|withdrawal by PI|0|||
130539508|NCT02755818|469942062|FG001|Overall Study|withdrawal by PI|0|||
130539509|NCT02755818|469942063|FG002|Overall Study|withdrawal by PI|1|||
130539510|NCT02755818|469942064|FG003|Overall Study|withdrawal by PI|1|||
130539511|NCT02535091|469942071|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
130539512|NCT02535091|469942072|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
130539513|NCT02535091|469942073|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
130539514|NCT02535091|469942071|FG000|Overall Study|Withdrawal by Subject|14|||
130539515|NCT02535091|469942072|FG001|Overall Study|Withdrawal by Subject|5|||
130539516|NCT02535091|469942073|FG002|Overall Study|Withdrawal by Subject|121|||
130539517|NCT02535091|469942071|FG000|Overall Study|Adverse Event|9|||
130539518|NCT02535091|469942072|FG001|Overall Study|Adverse Event|4|||
130539519|NCT02535091|469942073|FG002|Overall Study|Adverse Event|170|||
130539520|NCT02535091|469942071|FG000|Overall Study|Other|4|||
130539521|NCT02535091|469942072|FG001|Overall Study|Other|3|||
130585764|NCT00961961|470106622|FG002|Phase I|Physician Decision|0|||
130585765|NCT00961961|470106623|FG003|Phase I|Physician Decision|0|||
130585766|NCT00961961|470106620|FG000|Phase II|Lost to Follow-up|0|||
130585767|NCT00961961|470106621|FG001|Phase II|Lost to Follow-up|0|||
130585768|NCT00961961|470106622|FG002|Phase II|Lost to Follow-up|10|||
130585769|NCT00961961|470106623|FG003|Phase II|Lost to Follow-up|7|||
130585770|NCT00961961|470106620|FG000|Phase II|Adverse Event|0|||
130585771|NCT00961961|470106621|FG001|Phase II|Adverse Event|0|||
130585772|NCT00961961|470106622|FG002|Phase II|Adverse Event|0|||
130585773|NCT00961961|470106623|FG003|Phase II|Adverse Event|1|||
130585774|NCT00961961|470106620|FG000|Phase II|Physician Decision|0|||
130585775|NCT00961961|470106621|FG001|Phase II|Physician Decision|0|||
130585776|NCT00961961|470106622|FG002|Phase II|Physician Decision|1|||
130585777|NCT00961961|470106623|FG003|Phase II|Physician Decision|0|||
130585778|NCT00961961|470106620|FG000|Phase II|Withdrawal by Subject|0|||
130585779|NCT00961961|470106621|FG001|Phase II|Withdrawal by Subject|0|||
130585780|NCT00961961|470106622|FG002|Phase II|Withdrawal by Subject|1|||
130585781|NCT00961961|470106623|FG003|Phase II|Withdrawal by Subject|0|||
130585782|NCT01412957|470106624|FG000|Overall Study|Withdrawal by Subject|6|||
130585783|NCT01412957|470106625|FG001|Overall Study|Withdrawal by Subject|22|||
130585784|NCT01412957|470106624|FG000|Overall Study|Lost to Follow-up|7|||
130585785|NCT01412957|470106625|FG001|Overall Study|Lost to Follow-up|2|||
130585786|NCT01412957|470106624|FG000|Overall Study|Death|136|||
130585787|NCT01412957|470106625|FG001|Overall Study|Death|133|||
130585788|NCT04722991|470106631|FG000|Overall Study|Adverse Event|12|||
130585789|NCT04722991|470106632|FG001|Overall Study|Adverse Event|4|||
130539522|NCT02535091|469942073|FG002|Overall Study|Other|81|||
130539523|NCT02535091|469942071|FG000|Overall Study|Lost to Follow-up|0|||
130539524|NCT02535091|469942072|FG001|Overall Study|Lost to Follow-up|1|||
130539525|NCT02535091|469942073|FG002|Overall Study|Lost to Follow-up|19|||
130539526|NCT02535091|469942071|FG000|Overall Study|Protocol Violation|0|||
130539527|NCT02535091|469942072|FG001|Overall Study|Protocol Violation|1|||
130539528|NCT02535091|469942073|FG002|Overall Study|Protocol Violation|11|||
130539529|NCT02535091|469942071|FG000|Overall Study|Pregnancy|0|||
130539530|NCT02535091|469942072|FG001|Overall Study|Pregnancy|0|||
130539531|NCT02535091|469942073|FG002|Overall Study|Pregnancy|7|||
130539532|NCT03223662|469942074|FG000|Overall Study|Physician Decision|1|||
130539533|NCT03223662|469942074|FG000|Overall Study|Study closure|1|||
130539534|NCT02217475|469942075|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
130539535|NCT02217475|469942076|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
130539536|NCT02217475|469942077|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
130539537|NCT02217475|469942075|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
130539538|NCT02217475|469942076|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
130539539|NCT02217475|469942077|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
130539540|NCT02217475|469942075|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
130539541|NCT02217475|469942076|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
130539542|NCT02217475|469942077|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
130539543|NCT02217475|469942075|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
130539544|NCT02217475|469942076|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
130539545|NCT02217475|469942077|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
130539546|NCT02217475|469942075|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
130539547|NCT02217475|469942076|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
130539548|NCT02217475|469942077|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
130539549|NCT02217475|469942075|FG000|Discontinued After Period 1|Adverse Event|1|||
130539550|NCT02217475|469942076|FG001|Discontinued After Period 1|Adverse Event|2|||
130539551|NCT02217475|469942077|FG002|Discontinued After Period 1|Adverse Event|0|||
130539552|NCT02217475|469942075|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
130539553|NCT02217475|469942076|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
130585790|NCT04722991|470106631|FG000|Overall Study|Death|2|||
130585791|NCT04722991|470106632|FG001|Overall Study|Death|0|||
130585792|NCT04722991|470106631|FG000|Overall Study|Lost to Follow-up|1|||
130585793|NCT04722991|470106632|FG001|Overall Study|Lost to Follow-up|1|||
130585794|NCT04722991|470106631|FG000|Overall Study|Withdrawal cirterion met|2|||
130585795|NCT04722991|470106632|FG001|Overall Study|Withdrawal cirterion met|2|||
130585796|NCT04722991|470106631|FG000|Overall Study|Other|1|||
130585797|NCT04722991|470106632|FG001|Overall Study|Other|0|||
130585798|NCT04722991|470106631|FG000|Overall Study|Non-compliance|0|||
130585799|NCT04722991|470106632|FG001|Overall Study|Non-compliance|1|||
130585800|NCT04722991|470106631|FG000|Overall Study|Withdrawal by Subject|0|||
130539554|NCT02217475|469942077|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
130539555|NCT02217475|469942075|FG000|Discontinued After Period 1|Physician Decision|0|||
130539556|NCT02217475|469942076|FG001|Discontinued After Period 1|Physician Decision|0|||
130539557|NCT02217475|469942077|FG002|Discontinued After Period 1|Physician Decision|1|||
130539558|NCT02217475|469942075|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
130539559|NCT02217475|469942076|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
130539560|NCT02217475|469942077|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
130539561|NCT02217475|469942075|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
130539562|NCT02217475|469942076|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
130539563|NCT02217475|469942077|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
130539564|NCT02217475|469942075|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
130539565|NCT02217475|469942076|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
130539566|NCT02217475|469942077|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
130539567|NCT02217475|469942075|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
130539568|NCT02217475|469942076|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
130539569|NCT02217475|469942077|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
130539570|NCT02217475|469942075|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
130539571|NCT02217475|469942076|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
130539572|NCT02217475|469942077|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
130539573|NCT00506441|469942078|FG000|Period 1; Open-label Period|Adverse Event|21|||
130539574|NCT00506441|469942079|FG001|Period 1; Open-label Period|Adverse Event|0|||
130539575|NCT00506441|469942078|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
130539576|NCT00506441|469942079|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
130539577|NCT00506441|469942078|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
130539578|NCT00506441|469942079|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
130539579|NCT00506441|469942078|FG000|Period 1; Open-label Period|Physician Decision|5|||
130539580|NCT00506441|469942079|FG001|Period 1; Open-label Period|Physician Decision|0|||
130539581|NCT00506441|469942078|FG000|Period 1; Open-label Period|Protocol Violation|9|||
130539582|NCT00506441|469942079|FG001|Period 1; Open-label Period|Protocol Violation|0|||
130539583|NCT00506441|469942078|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
130539584|NCT00506441|469942079|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
130539585|NCT00506441|469942078|FG000|Period 1; Open-label Period|Other Reasons|13|||
130539586|NCT00506441|469942079|FG001|Period 1; Open-label Period|Other Reasons|0|||
130539587|NCT00506441|469942078|FG000|Period 2; Double-blind Period|Adverse Event|0|||
130539588|NCT00506441|469942079|FG001|Period 2; Double-blind Period|Adverse Event|1|||
130539589|NCT00506441|469942078|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
130539590|NCT00506441|469942079|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
130539591|NCT00506441|469942078|FG000|Period 2; Double-blind Period|Physician Decision|1|||
130539592|NCT00506441|469942079|FG001|Period 2; Double-blind Period|Physician Decision|1|||
130539593|NCT00506441|469942078|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
130539594|NCT00506441|469942079|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
130539595|NCT00506441|469942078|FG000|Period 2; Double-blind Period|Other Reason|1|||
130539596|NCT00506441|469942079|FG001|Period 2; Double-blind Period|Other Reason|1|||
130539597|NCT01012414|469942080|FG000|Overall Study|Withdrawal by Subject|2|||
130539598|NCT01012414|469942080|FG000|Overall Study|Lost to Follow-up|1|||
130539599|NCT01012414|469942080|FG000|Overall Study|Trial was stopped before completed|7|||
130539600|NCT02601300|469942081|FG000|Induction Phase|Lack of Efficacy|2|||
130539601|NCT02601300|469942081|FG000|Induction Phase|Protocol Violation|1|||
130539602|NCT02601300|469942081|FG000|Extension Phase|Withdrawal by Subject|3|||
130539603|NCT02601300|469942081|FG000|Extension Phase|Adverse Event|4|||
130539604|NCT02601300|469942081|FG000|Extension Phase|Lack of Efficacy|10|||
130539605|NCT00992225|469942083|FG000|Overall Study|Entry Criteria Not Met|8|||
130539606|NCT00992225|469942083|FG000|Overall Study|Adverse Event|2|||
130539607|NCT02576587|469942088|FG000|Baseline|Equipment failure|0|||
130539608|NCT02576587|469942089|FG001|Baseline|Equipment failure|1|||
130539609|NCT02576587|469942088|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
130539610|NCT02576587|469942089|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
130539611|NCT02576587|469942088|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
130539612|NCT02576587|469942089|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
130539613|NCT02576587|469942088|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
130539614|NCT02576587|469942089|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
130539615|NCT00532493|469942090|FG000|Overall Study|Death|1|||
130539616|NCT00532493|469942091|FG001|Overall Study|Death|1|||
130539617|NCT00532493|469942090|FG000|Overall Study|Lost to Follow-up|10|||
130539618|NCT00532493|469942091|FG001|Overall Study|Lost to Follow-up|7|||
130539619|NCT00532493|469942090|FG000|Overall Study|Withdrawal by Subject|7|||
130539620|NCT00532493|469942091|FG001|Overall Study|Withdrawal by Subject|9|||
130539621|NCT00532493|469942090|FG000|Overall Study|Physician Decision|1|||
130539622|NCT00532493|469942091|FG001|Overall Study|Physician Decision|6|||
130539623|NCT00532493|469942090|FG000|Overall Study|Adverse Event|6|||
130539624|NCT00532493|469942091|FG001|Overall Study|Adverse Event|5|||
130539625|NCT00532493|469942090|FG000|Overall Study|Protocol Deviation|1|||
130539626|NCT00532493|469942091|FG001|Overall Study|Protocol Deviation|0|||
130539627|NCT00532493|469942090|FG000|Overall Study|Subject Moved Away|3|||
130539628|NCT00532493|469942091|FG001|Overall Study|Subject Moved Away|1|||
130539629|NCT00532493|469942090|FG000|Overall Study|Contraindicative Medication|1|||
130585801|NCT04722991|470106632|FG001|Overall Study|Withdrawal by Subject|1|||
130585802|NCT00413959|470106633|FG000|Overall Study|Pt had only one cycle.|1|||
130585803|NCT04343651|470106637|FG000|Overall Study|Physician Decision|2|||
130585804|NCT04343651|470106638|FG001|Overall Study|Physician Decision|1|||
130585805|NCT04343651|470106637|FG000|Overall Study|Lost to Follow-up|2|||
130585806|NCT04343651|470106638|FG001|Overall Study|Lost to Follow-up|1|||
130585807|NCT04343651|470106637|FG000|Overall Study|Protocol Violation|4|||
130585808|NCT04343651|470106638|FG001|Overall Study|Protocol Violation|6|||
130585809|NCT04343651|470106637|FG000|Overall Study|Missing|3|||
130585810|NCT04343651|470106638|FG001|Overall Study|Missing|9|||
130585811|NCT04343651|470106637|FG000|Overall Study|Withdrawal by Subject|0|||
130539630|NCT00532493|469942091|FG001|Overall Study|Contraindicative Medication|0|||
130539631|NCT01036438|469942092|FG000|Overall Study|Adverse Event|7|||
130539632|NCT01036438|469942093|FG001|Overall Study|Adverse Event|8|||
130539633|NCT01036438|469942092|FG000|Overall Study|Death|0|||
130539634|NCT01036438|469942093|FG001|Overall Study|Death|1|||
130539635|NCT01036438|469942092|FG000|Overall Study|No effect of study treatment|3|||
130539636|NCT01036438|469942093|FG001|Overall Study|No effect of study treatment|1|||
130539637|NCT00888927|469942094|FG000|Overall Study|Adverse Event|0|||
130539638|NCT00888927|469942095|FG001|Overall Study|Adverse Event|0|||
130539639|NCT00888927|469942096|FG002|Overall Study|Adverse Event|0|||
130539640|NCT00888927|469942097|FG003|Overall Study|Adverse Event|1|||
130539641|NCT00888927|469942094|FG000|Overall Study|Withdrawal of consent|0|||
130539642|NCT00888927|469942095|FG001|Overall Study|Withdrawal of consent|0|||
130539643|NCT00888927|469942096|FG002|Overall Study|Withdrawal of consent|0|||
130539644|NCT00888927|469942097|FG003|Overall Study|Withdrawal of consent|1|||
130539645|NCT03459443|469942098|FG000|Overall Study|Lack of Efficacy|3|||
130539646|NCT03459443|469942098|FG000|Overall Study|Adverse Event|1|||
130539647|NCT03459443|469942098|FG000|Overall Study|Sponsor's decision to close the study|18|||
130539648|NCT03702231|469942099|FG000|Overall Study|Withdrawal by Subject|1|||
130539649|NCT03702231|469942100|FG001|Overall Study|Withdrawal by Subject|0|||
130539650|NCT03702231|469942101|FG002|Overall Study|Withdrawal by Subject|0|||
130539651|NCT03702231|469942099|FG000|Overall Study|Protocol Violation|0|||
130539652|NCT03702231|469942100|FG001|Overall Study|Protocol Violation|0|||
130539653|NCT03702231|469942101|FG002|Overall Study|Protocol Violation|1|||
130539654|NCT03702231|469942099|FG000|Overall Study|Change in CLL Treatment|0|||
130539655|NCT03702231|469942100|FG001|Overall Study|Change in CLL Treatment|0|||
130539656|NCT03702231|469942101|FG002|Overall Study|Change in CLL Treatment|1|||
130539657|NCT03702231|469942099|FG000|Overall Study|COVID Pandemic|1|||
130539658|NCT03702231|469942100|FG001|Overall Study|COVID Pandemic|4|||
130539659|NCT03702231|469942101|FG002|Overall Study|COVID Pandemic|1|||
130539660|NCT03702231|469942099|FG000|Overall Study|Non-compliance|0|||
130539661|NCT03702231|469942100|FG001|Overall Study|Non-compliance|0|||
130539662|NCT03702231|469942101|FG002|Overall Study|Non-compliance|1|||
130539663|NCT03590366|469942102|FG000|Overall Study|Adverse Event|0|||
130539664|NCT03590366|469942103|FG001|Overall Study|Adverse Event|3|||
130539665|NCT03590366|469942102|FG000|Overall Study|Lost to Follow-up|3|||
130539666|NCT03590366|469942103|FG001|Overall Study|Lost to Follow-up|3|||
130539667|NCT03590366|469942102|FG000|Overall Study|Withdrawal by Subject|0|||
130539668|NCT03590366|469942103|FG001|Overall Study|Withdrawal by Subject|2|||
130539669|NCT04927247|469942106|FG000|Overall Study|Other|2|||
130539670|NCT04927247|469942107|FG001|Overall Study|Other|1|||
130539671|NCT04927247|469942106|FG000|Overall Study|Physician Decision|0|||
130539672|NCT04927247|469942107|FG001|Overall Study|Physician Decision|1|||
130539673|NCT04927247|469942106|FG000|Overall Study|Adverse Event|1|||
130539674|NCT04927247|469942107|FG001|Overall Study|Adverse Event|0|||
130539675|NCT00513305|469942111|FG000|Overall Study|Adverse Event|6|||
130539676|NCT00513305|469942112|FG001|Overall Study|Adverse Event|2|||
130539677|NCT00513305|469942111|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
130539678|NCT00513305|469942112|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
130539679|NCT00513305|469942111|FG000|Overall Study|Lack of Efficacy|8|||
130539680|NCT00513305|469942112|FG001|Overall Study|Lack of Efficacy|13|||
130539681|NCT00513305|469942111|FG000|Overall Study|Withdrawal by Subject|1|||
130585812|NCT04343651|470106638|FG001|Overall Study|Withdrawal by Subject|4|||
130585813|NCT04343651|470106637|FG000|Overall Study|Death|0|||
130585814|NCT04343651|470106638|FG001|Overall Study|Death|1|||
130539682|NCT00513305|469942112|FG001|Overall Study|Withdrawal by Subject|2|||
130539683|NCT00513305|469942111|FG000|Overall Study|Disease progression|8|||
130539684|NCT00513305|469942112|FG001|Overall Study|Disease progression|5|||
130539685|NCT00513305|469942111|FG000|Overall Study|Eligible for stem cell transplant|1|||
130539686|NCT00513305|469942112|FG001|Overall Study|Eligible for stem cell transplant|0|||
130539687|NCT00513305|469942111|FG000|Overall Study|Hematologic counts did not recover|1|||
130539688|NCT00513305|469942112|FG001|Overall Study|Hematologic counts did not recover|0|||
130539689|NCT00513305|469942111|FG000|Overall Study|Physician Decision|1|||
130539690|NCT00513305|469942112|FG001|Overall Study|Physician Decision|0|||
130539691|NCT00513305|469942111|FG000|Overall Study|Persistent hypocellularity|0|||
130539692|NCT00513305|469942112|FG001|Overall Study|Persistent hypocellularity|1|||
130539693|NCT00513305|469942111|FG000|Overall Study|Sponsor Decision|0|||
130539694|NCT00513305|469942112|FG001|Overall Study|Sponsor Decision|2|||
130539695|NCT05597787|469942123|FG000|Overall Study|Withdrawal by Subject|0|||
130539696|NCT05597787|469942124|FG001|Overall Study|Withdrawal by Subject|0|||
130539697|NCT05597787|469942125|FG002|Overall Study|Withdrawal by Subject|1|||
130539698|NCT05453201|469942127|FG000|Overall Study|Withdrawal by Subject|1|||
130539699|NCT03798691|469942128|FG000|Overall Study|Lost to Follow-up|2|||
130539700|NCT03798691|469942129|FG001|Overall Study|Lost to Follow-up|2|||
130539701|NCT02489968|469942133|FG000|Open-label Treatment Period|Adverse Event|14|||
130539702|NCT02489968|469942134|FG001|Open-label Treatment Period|Adverse Event|7|||
130539703|NCT02489968|469942135|FG002|Open-label Treatment Period|Adverse Event|0|||
130539704|NCT02489968|469942136|FG003|Open-label Treatment Period|Adverse Event|0|||
130539705|NCT02489968|469942137|FG004|Open-label Treatment Period|Adverse Event|0|||
130539706|NCT02489968|469942138|FG005|Open-label Treatment Period|Adverse Event|0|||
130539707|NCT02489968|469942133|FG000|Open-label Treatment Period|Protocol Violation|2|||
130539708|NCT02489968|469942134|FG001|Open-label Treatment Period|Protocol Violation|2|||
130539709|NCT02489968|469942135|FG002|Open-label Treatment Period|Protocol Violation|0|||
130539710|NCT02489968|469942136|FG003|Open-label Treatment Period|Protocol Violation|0|||
130539711|NCT02489968|469942137|FG004|Open-label Treatment Period|Protocol Violation|0|||
130539712|NCT02489968|469942138|FG005|Open-label Treatment Period|Protocol Violation|0|||
130539713|NCT02489968|469942133|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130539714|NCT02489968|469942134|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
130539715|NCT02489968|469942135|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130539716|NCT02489968|469942136|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
130539717|NCT02489968|469942137|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
130539718|NCT02489968|469942138|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
130539719|NCT02489968|469942133|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
130539720|NCT02489968|469942134|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
130539721|NCT02489968|469942135|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130539722|NCT02489968|469942136|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
130539723|NCT02489968|469942137|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
130539724|NCT02489968|469942138|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
130539725|NCT02489968|469942133|FG000|Open-label Treatment Period|Other than specified above|204|||
130539726|NCT02489968|469942134|FG001|Open-label Treatment Period|Other than specified above|189|||
130539727|NCT02489968|469942135|FG002|Open-label Treatment Period|Other than specified above|0|||
130539728|NCT02489968|469942136|FG003|Open-label Treatment Period|Other than specified above|0|||
130539729|NCT02489968|469942137|FG004|Open-label Treatment Period|Other than specified above|0|||
130539730|NCT02489968|469942138|FG005|Open-label Treatment Period|Other than specified above|0|||
130539731|NCT02489968|469942133|FG000|Double-blind Treatment Period|Adverse Event|0|||
130539732|NCT02489968|469942134|FG001|Double-blind Treatment Period|Adverse Event|0|||
130539733|NCT02489968|469942135|FG002|Double-blind Treatment Period|Adverse Event|2|||
130539734|NCT02489968|469942136|FG003|Double-blind Treatment Period|Adverse Event|6|||
130539735|NCT02489968|469942137|FG004|Double-blind Treatment Period|Adverse Event|4|||
130539736|NCT02489968|469942138|FG005|Double-blind Treatment Period|Adverse Event|5|||
130539737|NCT02489968|469942133|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130539738|NCT02489968|469942134|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130539739|NCT02489968|469942135|FG002|Double-blind Treatment Period|Protocol Violation|0|||
130539740|NCT02489968|469942136|FG003|Double-blind Treatment Period|Protocol Violation|0|||
130539741|NCT02489968|469942137|FG004|Double-blind Treatment Period|Protocol Violation|1|||
130539742|NCT02489968|469942138|FG005|Double-blind Treatment Period|Protocol Violation|1|||
130539743|NCT02489968|469942133|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130539744|NCT02489968|469942134|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130585815|NCT04343651|470106637|FG000|Overall Study|Did not start treatment|1|||
130539745|NCT02489968|469942135|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130539746|NCT02489968|469942136|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
130539747|NCT02489968|469942137|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130539748|NCT02489968|469942138|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
130539749|NCT02489968|469942133|FG000|Double-blind Treatment Period|Other than specified above|0|||
130539750|NCT02489968|469942134|FG001|Double-blind Treatment Period|Other than specified above|0|||
130539751|NCT02489968|469942135|FG002|Double-blind Treatment Period|Other than specified above|0|||
130539752|NCT02489968|469942136|FG003|Double-blind Treatment Period|Other than specified above|0|||
130539753|NCT02489968|469942137|FG004|Double-blind Treatment Period|Other than specified above|1|||
130539754|NCT02489968|469942138|FG005|Double-blind Treatment Period|Other than specified above|0|||
130539755|NCT01865747|469942142|FG000|Overall Study (ITT)|Adverse Event|32|||
130539756|NCT01865747|469942143|FG001|Overall Study (ITT)|Adverse Event|31|||
130539757|NCT01865747|469942142|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
130539758|NCT01865747|469942143|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
130539759|NCT01865747|469942142|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
130539760|NCT01865747|469942143|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
130539761|NCT01865747|469942142|FG000|Overall Study (ITT)|Protocol Violation|1|||
130539762|NCT01865747|469942143|FG001|Overall Study (ITT)|Protocol Violation|1|||
130539763|NCT01865747|469942142|FG000|Overall Study (ITT)|Physician Decision|5|||
130539764|NCT01865747|469942143|FG001|Overall Study (ITT)|Physician Decision|2|||
130539765|NCT01865747|469942142|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
130539766|NCT01865747|469942143|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
130539767|NCT01865747|469942142|FG000|Overall Study (ITT)|Sponsor Decision|0|||
130539768|NCT01865747|469942143|FG001|Overall Study (ITT)|Sponsor Decision|1|||
130539769|NCT01865747|469942142|FG000|Overall Study (ITT)|Progressive Disease|122|||
130539770|NCT01865747|469942143|FG001|Overall Study (ITT)|Progressive Disease|158|||
130539771|NCT01865747|469942142|FG000|Overall Study (ITT)|Reason Not Provided|0|||
130539772|NCT01865747|469942143|FG001|Overall Study (ITT)|Reason Not Provided|1|||
130539773|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
130539774|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
130539775|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
130539776|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
130539777|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
130539778|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
130539779|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
130539780|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
130539781|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
130539782|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
130539783|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
130539784|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
130539785|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
130539786|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
130539787|NCT01865747|469942142|FG000|Primary Intent to Treat (PITT)|Other|0|||
130539788|NCT01865747|469942143|FG001|Primary Intent to Treat (PITT)|Other|1|||
130539789|NCT02592876|469942144|FG000|Overall Study|Withdrawal by Subject|3|||
130539790|NCT02592876|469942145|FG001|Overall Study|Withdrawal by Subject|3|||
130539791|NCT02592876|469942144|FG000|Overall Study|Study Termination by Sponsor|32|||
130539792|NCT02592876|469942145|FG001|Overall Study|Study Termination by Sponsor|27|||
130539793|NCT02592876|469942144|FG000|Overall Study|Lost to Follow-up|0|||
130539794|NCT02592876|469942145|FG001|Overall Study|Lost to Follow-up|1|||
130539795|NCT02592876|469942144|FG000|Overall Study|Death|6|||
130539796|NCT02592876|469942145|FG001|Overall Study|Death|9|||
130539797|NCT00611975|469942148|FG000|Overall Study|Withdrawal by Subject|3|||
130539798|NCT00611975|469942149|FG001|Overall Study|Withdrawal by Subject|7|||
130539799|NCT00611975|469942148|FG000|Overall Study|Pregnancy|2|||
130539800|NCT00611975|469942149|FG001|Overall Study|Pregnancy|1|||
130539801|NCT03465904|469942150|FG000|Overall Study|Withdrawal by Subject|9|||
130539802|NCT03465904|469942151|FG001|Overall Study|Withdrawal by Subject|5|||
130539803|NCT03465904|469942150|FG000|Overall Study|Lost to Follow-up|11|||
130539804|NCT03465904|469942151|FG001|Overall Study|Lost to Follow-up|9|||
130539805|NCT03465904|469942150|FG000|Overall Study|Protocol Violation|20|||
130539806|NCT03465904|469942151|FG001|Overall Study|Protocol Violation|15|||
130539807|NCT01305200|469942153|FG000|Overall Study|Physician Decision|4|||
130539808|NCT01305200|469942154|FG001|Overall Study|Physician Decision|6|||
130539809|NCT01305200|469942155|FG002|Overall Study|Physician Decision|1|||
130539810|NCT01305200|469942153|FG000|Overall Study|Withdrawal by Subject|24|||
130539811|NCT01305200|469942154|FG001|Overall Study|Withdrawal by Subject|21|||
130539812|NCT01305200|469942155|FG002|Overall Study|Withdrawal by Subject|1|||
130539813|NCT01305200|469942153|FG000|Overall Study|Ineligible|1|||
130539814|NCT01305200|469942154|FG001|Overall Study|Ineligible|2|||
130539815|NCT01305200|469942155|FG002|Overall Study|Ineligible|1|||
130539816|NCT01305200|469942153|FG000|Overall Study|Death|0|||
130539817|NCT01305200|469942154|FG001|Overall Study|Death|2|||
130539818|NCT01305200|469942155|FG002|Overall Study|Death|0|||
130539819|NCT02980731|469943522|FG000|Overall Study|Death|63|||
130539820|NCT02980731|469943522|FG000|Overall Study|Withdrawal by Subject|6|||
130539821|NCT02980731|469943522|FG000|Overall Study|Lost to Follow-up|5|||
130539822|NCT02980731|469943522|FG000|Overall Study|Study terminated by Sponsor|4|||
130539823|NCT02980731|469943522|FG000|Overall Study|Completed survival follow-up period|65|||
130539824|NCT02980731|469943522|FG000|Overall Study|COVID-19 infection|1|||
130585816|NCT04343651|470106638|FG001|Overall Study|Did not start treatment|1|||
130585817|NCT04343651|470106637|FG000|Overall Study|Patient did not complete visits 3-6|0|||
130585818|NCT04343651|470106638|FG001|Overall Study|Patient did not complete visits 3-6|1|||
130585819|NCT02246621|470106639|FG000|Overall Study|Withdrawal by Subject|28|||
130585820|NCT02246621|470106640|FG001|Overall Study|Withdrawal by Subject|16|||
130585821|NCT02246621|470106639|FG000|Overall Study|Lost to Follow-up|1|||
130585822|NCT02246621|470106640|FG001|Overall Study|Lost to Follow-up|0|||
130585823|NCT02246621|470106639|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
130585824|NCT02246621|470106640|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
130585825|NCT01459614|470106641|FG000|Overall Study|Adverse Event|1|||
130585826|NCT01459614|470106642|FG001|Overall Study|Adverse Event|0|||
130585827|NCT03136107|470106652|FG000|Overall Study|Other (Not specified)|1|||
130585828|NCT03283085|470106653|FG000|Overall Study|Adverse Event|18|||
130585829|NCT03283085|470106654|FG001|Overall Study|Adverse Event|3|||
130585830|NCT03283085|470106655|FG002|Overall Study|Adverse Event|13|||
130585831|NCT03283085|470106656|FG003|Overall Study|Adverse Event|0|||
130585832|NCT03283085|470106657|FG004|Overall Study|Adverse Event|0|||
130585833|NCT03283085|470106658|FG005|Overall Study|Adverse Event|5|||
130585834|NCT03283085|470106653|FG000|Overall Study|Death|0|||
130585835|NCT03283085|470106654|FG001|Overall Study|Death|0|||
130585836|NCT03283085|470106655|FG002|Overall Study|Death|3|||
130585837|NCT03283085|470106656|FG003|Overall Study|Death|1|||
130585838|NCT03283085|470106657|FG004|Overall Study|Death|0|||
130585839|NCT03283085|470106658|FG005|Overall Study|Death|0|||
130585840|NCT03283085|470106653|FG000|Overall Study|Withdrawal by Subject|42|||
130585841|NCT03283085|470106654|FG001|Overall Study|Withdrawal by Subject|21|||
130585842|NCT03283085|470106655|FG002|Overall Study|Withdrawal by Subject|66|||
130585843|NCT03283085|470106656|FG003|Overall Study|Withdrawal by Subject|3|||
130585844|NCT03283085|470106657|FG004|Overall Study|Withdrawal by Subject|3|||
130585845|NCT03283085|470106658|FG005|Overall Study|Withdrawal by Subject|5|||
130585846|NCT03283085|470106653|FG000|Overall Study|Physician Decision|14|||
130585847|NCT03283085|470106654|FG001|Overall Study|Physician Decision|8|||
130585848|NCT03283085|470106655|FG002|Overall Study|Physician Decision|19|||
130585849|NCT03283085|470106656|FG003|Overall Study|Physician Decision|0|||
130585850|NCT03283085|470106657|FG004|Overall Study|Physician Decision|0|||
130585851|NCT03283085|470106658|FG005|Overall Study|Physician Decision|2|||
130585852|NCT03283085|470106653|FG000|Overall Study|Site Terminated by Sponsor|1|||
130585853|NCT03283085|470106654|FG001|Overall Study|Site Terminated by Sponsor|0|||
130585854|NCT03283085|470106655|FG002|Overall Study|Site Terminated by Sponsor|3|||
130585855|NCT03283085|470106656|FG003|Overall Study|Site Terminated by Sponsor|0|||
130585856|NCT03283085|470106657|FG004|Overall Study|Site Terminated by Sponsor|0|||
130585857|NCT03283085|470106658|FG005|Overall Study|Site Terminated by Sponsor|0|||
130585858|NCT03283085|470106653|FG000|Overall Study|Lost to Follow-up|2|||
130585859|NCT03283085|470106654|FG001|Overall Study|Lost to Follow-up|0|||
130585860|NCT03283085|470106655|FG002|Overall Study|Lost to Follow-up|2|||
130585861|NCT03283085|470106656|FG003|Overall Study|Lost to Follow-up|0|||
130585862|NCT03283085|470106657|FG004|Overall Study|Lost to Follow-up|0|||
130585863|NCT03283085|470106658|FG005|Overall Study|Lost to Follow-up|1|||
130585864|NCT03283085|470106653|FG000|Overall Study|Pregnancy|0|||
130585865|NCT03283085|470106654|FG001|Overall Study|Pregnancy|0|||
130585866|NCT03283085|470106655|FG002|Overall Study|Pregnancy|1|||
130585867|NCT03283085|470106656|FG003|Overall Study|Pregnancy|0|||
130585868|NCT03283085|470106657|FG004|Overall Study|Pregnancy|0|||
130585869|NCT03283085|470106658|FG005|Overall Study|Pregnancy|0|||
130585870|NCT03283085|470106653|FG000|Overall Study|Lack of Efficacy|12|||
130585871|NCT03283085|470106654|FG001|Overall Study|Lack of Efficacy|6|||
130585872|NCT03283085|470106655|FG002|Overall Study|Lack of Efficacy|24|||
130585873|NCT03283085|470106656|FG003|Overall Study|Lack of Efficacy|1|||
130585874|NCT03283085|470106657|FG004|Overall Study|Lack of Efficacy|1|||
130585875|NCT03283085|470106658|FG005|Overall Study|Lack of Efficacy|0|||
130585876|NCT03283085|470106653|FG000|Overall Study|Reason not Specified|0|||
130585877|NCT03283085|470106654|FG001|Overall Study|Reason not Specified|4|||
130585878|NCT03283085|470106655|FG002|Overall Study|Reason not Specified|8|||
130585879|NCT03283085|470106656|FG003|Overall Study|Reason not Specified|0|||
130585880|NCT03283085|470106657|FG004|Overall Study|Reason not Specified|0|||
130585881|NCT03283085|470106658|FG005|Overall Study|Reason not Specified|1|||
130585882|NCT02292771|470106662|FG000|Overall Study|Withdrawal by Subject|2|||
130585883|NCT02292771|470106663|FG001|Overall Study|Withdrawal by Subject|1|||
130585884|NCT02292771|470106662|FG000|Overall Study|Lost to Follow-up|2|||
130539825|NCT02980731|469943522|FG000|Overall Study|Other, not specified|66|||
130539826|NCT01290315|469943523|FG000|Overall Study|Adverse Event|0|||
130539827|NCT01290315|469943524|FG001|Overall Study|Adverse Event|0|||
130539828|NCT01290315|469943525|FG002|Overall Study|Adverse Event|0|||
130539829|NCT01290315|469943526|FG003|Overall Study|Adverse Event|3|||
130539830|NCT01290315|469943523|FG000|Overall Study|Selection criteria/compliance|2|||
130539831|NCT01290315|469943524|FG001|Overall Study|Selection criteria/compliance|1|||
130539832|NCT01290315|469943525|FG002|Overall Study|Selection criteria/compliance|0|||
130539833|NCT01290315|469943526|FG003|Overall Study|Selection criteria/compliance|2|||
130539834|NCT01290315|469943523|FG000|Overall Study|Lost to Follow-up|0|||
130539835|NCT01290315|469943524|FG001|Overall Study|Lost to Follow-up|1|||
130539836|NCT01290315|469943525|FG002|Overall Study|Lost to Follow-up|0|||
130539837|NCT01290315|469943526|FG003|Overall Study|Lost to Follow-up|0|||
130539838|NCT01290315|469943523|FG000|Overall Study|Withdrawal by Subject|1|||
130539839|NCT01290315|469943524|FG001|Overall Study|Withdrawal by Subject|1|||
130539840|NCT01290315|469943525|FG002|Overall Study|Withdrawal by Subject|0|||
130539841|NCT01290315|469943526|FG003|Overall Study|Withdrawal by Subject|0|||
130539842|NCT00591721|469943527|FG000|Overall Study|Withdrawal by Subject|10|||
130539843|NCT00591721|469943528|FG001|Overall Study|Withdrawal by Subject|10|||
130539844|NCT00591721|469943527|FG000|Overall Study|Lost to Follow-up|1|||
130539845|NCT00591721|469943528|FG001|Overall Study|Lost to Follow-up|4|||
130539846|NCT00591721|469943527|FG000|Overall Study|Intervention not received|10|||
130539847|NCT00591721|469943528|FG001|Overall Study|Intervention not received|8|||
130539848|NCT03809429|469943531|FG000|Overall Study|Withdrawal by Subject|7|||
130539849|NCT03809429|469943532|FG001|Overall Study|Withdrawal by Subject|3|||
130539850|NCT03809429|469943531|FG000|Overall Study|Adverse Event|6|||
130539851|NCT03809429|469943532|FG001|Overall Study|Adverse Event|9|||
130539852|NCT03809429|469943531|FG000|Overall Study|COVID-19|3|||
130539853|NCT03809429|469943532|FG001|Overall Study|COVID-19|1|||
130539854|NCT03809429|469943531|FG000|Overall Study|Participant was discontinued by investigator|12|||
130539855|NCT03809429|469943532|FG001|Overall Study|Participant was discontinued by investigator|7|||
130539856|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Adverse Event|6|||
130539857|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Adverse Event|6|||
130539858|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Death|1|||
130539859|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Death|1|||
130539860|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130539861|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130539862|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
130539863|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
130539864|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Physician Decision|1|||
130539865|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Physician Decision|4|||
130539866|NCT03828747|469943533|FG000|Double-Blind Treatment Period|Various reasons|5|||
130539867|NCT03828747|469943534|FG001|Double-Blind Treatment Period|Various reasons|3|||
130539868|NCT03828747|469943533|FG000|Open-Label Extension|Adverse Event|9|||
130539869|NCT03828747|469943534|FG001|Open-Label Extension|Adverse Event|7|||
130539870|NCT03828747|469943533|FG000|Open-Label Extension|Death|0|||
130539871|NCT03828747|469943534|FG001|Open-Label Extension|Death|2|||
130539872|NCT03828747|469943533|FG000|Open-Label Extension|Lost to Follow-up|4|||
130539873|NCT03828747|469943534|FG001|Open-Label Extension|Lost to Follow-up|0|||
130539874|NCT03828747|469943533|FG000|Open-Label Extension|Withdrawal by Subject|31|||
130539875|NCT03828747|469943534|FG001|Open-Label Extension|Withdrawal by Subject|30|||
130539876|NCT03828747|469943533|FG000|Open-Label Extension|Various reasons|4|||
130539877|NCT03828747|469943534|FG001|Open-Label Extension|Various reasons|4|||
130539878|NCT03828747|469943533|FG000|Open-Label Extension|Physician Decision|6|||
130539879|NCT03828747|469943534|FG001|Open-Label Extension|Physician Decision|2|||
130539880|NCT01144052|469943535|FG000|Overall Study|Withdrawal by Subject|1|||
130539881|NCT01144052|469943536|FG001|Overall Study|Withdrawal by Subject|1|||
130539882|NCT00424385|469943537|FG000|Cohort 0|Withdrawal by Subject|5|||
130539883|NCT00424385|469943537|FG000|Cohort 0|Physician Decision|1|||
130539884|NCT00424385|469943537|FG000|Cohort 1|Withdrawal by Subject|1|||
130539885|NCT02683876|469943538|FG000|Overall Study|samples damaged during shipping|2|||
130539886|NCT02683876|469943539|FG001|Overall Study|samples damaged during shipping|0|||
130539887|NCT03980808|469943562|FG000|Overall Study|Lost to Follow-up|2|||
130539888|NCT03980808|469943563|FG001|Overall Study|Lost to Follow-up|2|||
130539889|NCT01655693|469943564|FG000|Overall Study|Progression of Disease|92|||
130539890|NCT01655693|469943565|FG001|Overall Study|Progression of Disease|76|||
130539891|NCT01655693|469943566|FG002|Overall Study|Progression of Disease|58|||
130539892|NCT01655693|469943564|FG000|Overall Study|Death|8|||
130539893|NCT01655693|469943565|FG001|Overall Study|Death|9|||
130539894|NCT01655693|469943566|FG002|Overall Study|Death|12|||
130585885|NCT02292771|470106663|FG001|Overall Study|Lost to Follow-up|1|||
130585886|NCT04574999|470108647|FG000|Overall Study|Adverse Event|1|||
130585887|NCT04574999|470108648|FG001|Overall Study|Adverse Event|0|||
130585888|NCT04574999|470108647|FG000|Overall Study|Lack of Efficacy|2|||
130585889|NCT04574999|470108648|FG001|Overall Study|Lack of Efficacy|3|||
130585890|NCT04574999|470108647|FG000|Overall Study|Protocol Violation|1|||
130585891|NCT04574999|470108648|FG001|Overall Study|Protocol Violation|0|||
130585892|NCT04574999|470108647|FG000|Overall Study|Withdrawal by Subject|2|||
130585893|NCT04574999|470108648|FG001|Overall Study|Withdrawal by Subject|2|||
130585894|NCT04574999|470108647|FG000|Overall Study|Lost to Follow-up|1|||
130585895|NCT04574999|470108648|FG001|Overall Study|Lost to Follow-up|0|||
130585896|NCT04574999|470108647|FG000|Overall Study|Personal problems|1|||
130585897|NCT04574999|470108648|FG001|Overall Study|Personal problems|0|||
130585898|NCT04574999|470108647|FG000|Overall Study|Previous planned surgery|1|||
130585899|NCT04574999|470108648|FG001|Overall Study|Previous planned surgery|0|||
130585900|NCT00008385|470108649|FG000|Overall Study|Off treatment reasons not reported|79|||
130585901|NCT00008385|470108650|FG001|Overall Study|Off treatment reasons not reported|70|||
130585902|NCT00008385|470108649|FG000|Overall Study|Progressive disease|52|||
130585903|NCT00008385|470108650|FG001|Overall Study|Progressive disease|117|||
130585904|NCT00008385|470108649|FG000|Overall Study|Adverse Event|8|||
130585905|NCT00008385|470108650|FG001|Overall Study|Adverse Event|20|||
130585906|NCT00008385|470108649|FG000|Overall Study|Death|12|||
130585907|NCT00008385|470108650|FG001|Overall Study|Death|18|||
130585908|NCT00008385|470108649|FG000|Overall Study|Withdrawal by Subject|67|||
130585909|NCT00008385|470108650|FG001|Overall Study|Withdrawal by Subject|157|||
130585910|NCT00008385|470108649|FG000|Overall Study|Start non-protocol therapy|3|||
130585911|NCT00008385|470108650|FG001|Overall Study|Start non-protocol therapy|1|||
130585912|NCT00008385|470108649|FG000|Overall Study|Other complicating disease|17|||
130585913|NCT00008385|470108650|FG001|Overall Study|Other complicating disease|30|||
130585914|NCT00008385|470108649|FG000|Overall Study|Maximum dose reached|0|||
130585915|NCT00008385|470108650|FG001|Overall Study|Maximum dose reached|2|||
130585916|NCT00008385|470108649|FG000|Overall Study|Other|105|||
130585917|NCT00008385|470108650|FG001|Overall Study|Other|212|||
130585918|NCT00008385|470108649|FG000|Overall Study|Not start protocol therapy|44|||
130585919|NCT00008385|470108650|FG001|Overall Study|Not start protocol therapy|175|||
130585920|NCT00582556|470108651|FG000|Overall Study|Withdrawal by Subject|0|||
130585921|NCT00582556|470108652|FG001|Overall Study|Withdrawal by Subject|1|||
130585922|NCT00582556|470108653|FG002|Overall Study|Withdrawal by Subject|1|||
130585923|NCT00582556|470108651|FG000|Overall Study|Physician Decision|0|||
130585924|NCT00582556|470108652|FG001|Overall Study|Physician Decision|0|||
130585925|NCT00582556|470108653|FG002|Overall Study|Physician Decision|1|||
130585926|NCT01993888|470108656|FG000|Overall Study|Death|1|||
130585927|NCT01993888|470108657|FG001|Overall Study|Death|1|||
130585928|NCT01993888|470108656|FG000|Overall Study|Lost to Follow-up|1|||
130585929|NCT01993888|470108657|FG001|Overall Study|Lost to Follow-up|1|||
130585930|NCT01993888|470108656|FG000|Overall Study|Withdrawal by Subject|0|||
130585931|NCT01993888|470108657|FG001|Overall Study|Withdrawal by Subject|1|||
130539895|NCT01655693|469943564|FG000|Overall Study|Serious Adverse Event|3|||
130539896|NCT01655693|469943565|FG001|Overall Study|Serious Adverse Event|15|||
130539897|NCT01655693|469943566|FG002|Overall Study|Serious Adverse Event|11|||
130539898|NCT01655693|469943564|FG000|Overall Study|Withdrawal by Subject|3|||
130539899|NCT01655693|469943565|FG001|Overall Study|Withdrawal by Subject|2|||
130539900|NCT01655693|469943566|FG002|Overall Study|Withdrawal by Subject|20|||
130539901|NCT01655693|469943564|FG000|Overall Study|Adverse Event|3|||
130539902|NCT01655693|469943565|FG001|Overall Study|Adverse Event|11|||
130539903|NCT01655693|469943566|FG002|Overall Study|Adverse Event|3|||
130539904|NCT01655693|469943564|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
130539905|NCT01655693|469943565|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
130539906|NCT01655693|469943566|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
130539907|NCT01655693|469943564|FG000|Overall Study|Non-Compliance|0|||
130539908|NCT01655693|469943565|FG001|Overall Study|Non-Compliance|0|||
130539909|NCT01655693|469943566|FG002|Overall Study|Non-Compliance|7|||
130539910|NCT01655693|469943564|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
130539911|NCT01655693|469943565|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
130585932|NCT00832819|470108658|FG000|Overall Study|Adverse Event|0|||
130585933|NCT00832819|470108659|FG001|Overall Study|Adverse Event|1|||
130585934|NCT00832819|470108660|FG002|Overall Study|Adverse Event|0|||
130585935|NCT00832819|470108658|FG000|Overall Study|Protocol Violation|0|||
130585936|NCT00832819|470108659|FG001|Overall Study|Protocol Violation|0|||
130585937|NCT00832819|470108660|FG002|Overall Study|Protocol Violation|1|||
130585938|NCT00317044|470108661|FG000|Overall Study|Protocol Violation|28|||
130585939|NCT00317044|470108662|FG001|Overall Study|Protocol Violation|22|||
130585940|NCT00317044|470108663|FG002|Overall Study|Protocol Violation|20|||
130585941|NCT00317044|470108661|FG000|Overall Study|Adverse Event|4|||
130585942|NCT00317044|470108662|FG001|Overall Study|Adverse Event|7|||
130585943|NCT00317044|470108663|FG002|Overall Study|Adverse Event|4|||
130585944|NCT00317044|470108661|FG000|Overall Study|Withdrawal by Subject|10|||
130585945|NCT00317044|470108662|FG001|Overall Study|Withdrawal by Subject|7|||
130585946|NCT00317044|470108663|FG002|Overall Study|Withdrawal by Subject|12|||
130585947|NCT00317044|470108661|FG000|Overall Study|Lost to Follow-up|0|||
130585948|NCT00317044|470108662|FG001|Overall Study|Lost to Follow-up|2|||
130585949|NCT00317044|470108663|FG002|Overall Study|Lost to Follow-up|3|||
130585950|NCT00317044|470108661|FG000|Overall Study|Multiple Reasons|6|||
130585951|NCT00317044|470108662|FG001|Overall Study|Multiple Reasons|2|||
130585952|NCT00317044|470108663|FG002|Overall Study|Multiple Reasons|6|||
130585953|NCT05742984|470108664|FG000|Overall Study|Adverse Event|0|||
130585954|NCT05742984|470108665|FG001|Overall Study|Adverse Event|0|||
130585955|NCT05742984|470108666|FG002|Overall Study|Adverse Event|1|||
130585956|NCT05742984|470108667|FG003|Overall Study|Adverse Event|0|||
130585957|NCT05742984|470108668|FG004|Overall Study|Adverse Event|1|||
130585958|NCT05742984|470108669|FG005|Overall Study|Adverse Event|1|||
130585959|NCT05742984|470108664|FG000|Overall Study|Withdrawal by Subject|0|||
130585960|NCT05742984|470108665|FG001|Overall Study|Withdrawal by Subject|1|||
130585961|NCT05742984|470108666|FG002|Overall Study|Withdrawal by Subject|0|||
130585962|NCT05742984|470108667|FG003|Overall Study|Withdrawal by Subject|0|||
130585963|NCT05742984|470108668|FG004|Overall Study|Withdrawal by Subject|0|||
130585964|NCT05742984|470108669|FG005|Overall Study|Withdrawal by Subject|2|||
130585965|NCT00379340|470108670|FG000|Overall Study|Death|0|||
130585966|NCT00379340|470108671|FG001|Overall Study|Death|0|||
130585967|NCT00379340|470108672|FG002|Overall Study|Death|0|||
130585968|NCT00379340|470108673|FG003|Overall Study|Death|2|||
130585969|NCT00379340|470108674|FG004|Overall Study|Death|0|||
130585970|NCT00379340|470108670|FG000|Overall Study|Lack of Efficacy|6|||
130585971|NCT00379340|470108671|FG001|Overall Study|Lack of Efficacy|1|||
130585972|NCT00379340|470108672|FG002|Overall Study|Lack of Efficacy|0|||
130585973|NCT00379340|470108673|FG003|Overall Study|Lack of Efficacy|4|||
130585974|NCT00379340|470108674|FG004|Overall Study|Lack of Efficacy|3|||
130585975|NCT00379340|470108670|FG000|Overall Study|Physician Decision|6|||
130585976|NCT00379340|470108671|FG001|Overall Study|Physician Decision|2|||
130585977|NCT00379340|470108672|FG002|Overall Study|Physician Decision|1|||
130585978|NCT00379340|470108673|FG003|Overall Study|Physician Decision|2|||
130585979|NCT00379340|470108674|FG004|Overall Study|Physician Decision|3|||
130585980|NCT00379340|470108670|FG000|Overall Study|Withdrawal by Subject|0|||
130585981|NCT00379340|470108671|FG001|Overall Study|Withdrawal by Subject|0|||
130585982|NCT00379340|470108672|FG002|Overall Study|Withdrawal by Subject|0|||
130585983|NCT00379340|470108673|FG003|Overall Study|Withdrawal by Subject|1|||
130585984|NCT00379340|470108674|FG004|Overall Study|Withdrawal by Subject|0|||
130585985|NCT00379340|470108670|FG000|Overall Study|Refusal of further protocol therapy|1|||
130585986|NCT00379340|470108671|FG001|Overall Study|Refusal of further protocol therapy|0|||
130585987|NCT00379340|470108672|FG002|Overall Study|Refusal of further protocol therapy|1|||
130585988|NCT00379340|470108673|FG003|Overall Study|Refusal of further protocol therapy|1|||
130585989|NCT00379340|470108674|FG004|Overall Study|Refusal of further protocol therapy|7|||
130585990|NCT00379340|470108670|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
130585991|NCT00379340|470108671|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
130585992|NCT00379340|470108672|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
130585993|NCT00379340|470108673|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
130585994|NCT00379340|470108674|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
130585995|NCT00379340|470108670|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
130585996|NCT00379340|470108671|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
130585997|NCT00379340|470108672|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
130585998|NCT00379340|470108673|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
130585999|NCT00379340|470108674|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
130586000|NCT02162862|470108678|FG000|Overall Study|Lost to Follow-up|0|||
130586001|NCT02162862|470108679|FG001|Overall Study|Lost to Follow-up|11|||
130539912|NCT01655693|469943566|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
130539913|NCT01655693|469943564|FG000|Overall Study|Protocol Violation|1|||
130539914|NCT01655693|469943565|FG001|Overall Study|Protocol Violation|0|||
130539915|NCT01655693|469943566|FG002|Overall Study|Protocol Violation|3|||
130539916|NCT01655693|469943564|FG000|Overall Study|Lost to Follow-up|1|||
130539917|NCT01655693|469943565|FG001|Overall Study|Lost to Follow-up|0|||
130539918|NCT01655693|469943566|FG002|Overall Study|Lost to Follow-up|1|||
130539919|NCT01655693|469943564|FG000|Overall Study|Screening Failure|1|||
130539920|NCT01655693|469943565|FG001|Overall Study|Screening Failure|0|||
130539921|NCT01655693|469943566|FG002|Overall Study|Screening Failure|0|||
130539922|NCT01655693|469943564|FG000|Overall Study|Other|8|||
130539923|NCT01655693|469943565|FG001|Overall Study|Other|6|||
130539924|NCT01655693|469943566|FG002|Overall Study|Other|15|||
130539925|NCT00929110|469943567|FG000|Overall Study|Adverse Event|40|||
130539926|NCT00929110|469943568|FG001|Overall Study|Adverse Event|29|||
130539927|NCT00929110|469943569|FG002|Overall Study|Adverse Event|18|||
130539928|NCT00929110|469943567|FG000|Overall Study|Subject withdrew consent|40|||
130539929|NCT00929110|469943568|FG001|Overall Study|Subject withdrew consent|23|||
130539930|NCT00929110|469943569|FG002|Overall Study|Subject withdrew consent|26|||
130539931|NCT00929110|469943567|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
130539932|NCT00929110|469943568|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
130539933|NCT00929110|469943569|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
130539934|NCT00929110|469943567|FG000|Overall Study|Lost to Follow-up|7|||
130539935|NCT00929110|469943568|FG001|Overall Study|Lost to Follow-up|7|||
130539936|NCT00929110|469943569|FG002|Overall Study|Lost to Follow-up|3|||
130539937|NCT00929110|469943567|FG000|Overall Study|Protocol deviation|5|||
130539938|NCT00929110|469943568|FG001|Overall Study|Protocol deviation|2|||
130539939|NCT00929110|469943569|FG002|Overall Study|Protocol deviation|4|||
130539940|NCT00929110|469943567|FG000|Overall Study|Administrative problems|4|||
130539941|NCT00929110|469943568|FG001|Overall Study|Administrative problems|1|||
130539942|NCT00929110|469943569|FG002|Overall Study|Administrative problems|2|||
130539943|NCT00929110|469943567|FG000|Overall Study|Death|2|||
130539944|NCT00929110|469943568|FG001|Overall Study|Death|2|||
130539945|NCT00929110|469943569|FG002|Overall Study|Death|2|||
130539946|NCT00929110|469943567|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130539947|NCT00929110|469943568|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130539948|NCT00929110|469943569|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130539949|NCT00929110|469943567|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130539950|NCT00929110|469943568|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130539951|NCT00929110|469943569|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130539952|NCT00929110|469943567|FG000|Overall Study|Patient inability to use the device|0|||
130539953|NCT00929110|469943568|FG001|Overall Study|Patient inability to use the device|1|||
130539954|NCT00929110|469943569|FG002|Overall Study|Patient inability to use the device|0|||
130539955|NCT02285153|469943570|FG000|Overall Study|Adverse Event|1|||
130539956|NCT02285153|469943571|FG001|Overall Study|Adverse Event|0|||
130539957|NCT00548262|469943572|FG000|Overall Study|Death|21|||
130539958|NCT00548262|469943572|FG000|Overall Study|Adverse Event|2|||
130539959|NCT00548262|469943572|FG000|Overall Study|Lack of Efficacy|4|||
130539960|NCT00548262|469943572|FG000|Overall Study|Lost to Follow-up|1|||
130539961|NCT00548262|469943572|FG000|Overall Study|Other|3|||
130539962|NCT00548262|469943572|FG000|Overall Study|Withdrawal by Subject|1|||
130539963|NCT01712659|469943573|FG000|Dose Escalation|Physician Decision|0|||
130539964|NCT01712659|469943574|FG001|Dose Escalation|Physician Decision|1|||
130539965|NCT01712659|469943575|FG002|Dose Escalation|Physician Decision|0|||
130539966|NCT01712659|469943576|FG003|Dose Escalation|Physician Decision|0|||
130539967|NCT01712659|469943577|FG004|Dose Escalation|Physician Decision|0|||
130539968|NCT01712659|469943573|FG000|Dose Escalation|Unable to take study drug|0|||
130539969|NCT01712659|469943574|FG001|Dose Escalation|Unable to take study drug|1|||
130539970|NCT01712659|469943575|FG002|Dose Escalation|Unable to take study drug|0|||
130539971|NCT01712659|469943576|FG003|Dose Escalation|Unable to take study drug|0|||
130539972|NCT01712659|469943577|FG004|Dose Escalation|Unable to take study drug|0|||
130539973|NCT01712659|469943573|FG000|Dose Expansion|Early disease progression|1|||
130539974|NCT01712659|469943574|FG001|Dose Expansion|Early disease progression|0|||
130539975|NCT01712659|469943575|FG002|Dose Expansion|Early disease progression|0|||
130539976|NCT01712659|469943576|FG003|Dose Expansion|Early disease progression|0|||
130539977|NCT01712659|469943577|FG004|Dose Expansion|Early disease progression|0|||
130539978|NCT01712659|469943573|FG000|Dose Expansion|Physician Decision|1|||
130539979|NCT01712659|469943574|FG001|Dose Expansion|Physician Decision|0|||
130539980|NCT01712659|469943575|FG002|Dose Expansion|Physician Decision|0|||
130539981|NCT01712659|469943576|FG003|Dose Expansion|Physician Decision|0|||
130539982|NCT01712659|469943577|FG004|Dose Expansion|Physician Decision|0|||
130539983|NCT00948766|469943579|FG000|Core Study|Adverse Event|73|||
130539984|NCT00948766|469943580|FG001|Core Study|Adverse Event|51|||
130539985|NCT00948766|469943579|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
130539986|NCT00948766|469943580|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
130539987|NCT00948766|469943579|FG000|Core Study|Patient Withdrew Consent|27|||
130539988|NCT00948766|469943580|FG001|Core Study|Patient Withdrew Consent|46|||
130539989|NCT00948766|469943579|FG000|Core Study|Lost to Follow-up|3|||
130539990|NCT00948766|469943580|FG001|Core Study|Lost to Follow-up|2|||
130539991|NCT00948766|469943579|FG000|Core Study|Administrative Problems|2|||
130539992|NCT00948766|469943580|FG001|Core Study|Administrative Problems|2|||
130539993|NCT00948766|469943579|FG000|Core Study|Death|1|||
130539994|NCT00948766|469943580|FG001|Core Study|Death|1|||
130539995|NCT00948766|469943579|FG000|Core Study|Protocol Deviation|8|||
130539996|NCT00948766|469943580|FG001|Core Study|Protocol Deviation|10|||
130539997|NCT00948766|469943579|FG000|Extension Study|Adverse Event|43|||
130539998|NCT00948766|469943580|FG001|Extension Study|Adverse Event|0|||
130539999|NCT00948766|469943579|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
130540000|NCT00948766|469943580|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
130540001|NCT00948766|469943579|FG000|Extension Study|Study Drug No Longer Required|1|||
130540002|NCT00948766|469943580|FG001|Extension Study|Study Drug No Longer Required|0|||
130540003|NCT00948766|469943579|FG000|Extension Study|Patient Withdrew Consent|32|||
130540004|NCT00948766|469943580|FG001|Extension Study|Patient Withdrew Consent|0|||
130540005|NCT00948766|469943579|FG000|Extension Study|Lost to Follow-up|8|||
130540006|NCT00948766|469943580|FG001|Extension Study|Lost to Follow-up|0|||
130540007|NCT00948766|469943579|FG000|Extension Study|Administrative Problems|1|||
130540008|NCT00948766|469943580|FG001|Extension Study|Administrative Problems|0|||
130586002|NCT02162862|470108680|FG002|Overall Study|Lost to Follow-up|0|||
130586003|NCT02162862|470108678|FG000|Overall Study|Subject did not feel the med was needed|0|||
130586004|NCT02162862|470108679|FG001|Overall Study|Subject did not feel the med was needed|0|||
130586005|NCT02162862|470108680|FG002|Overall Study|Subject did not feel the med was needed|4|||
130586006|NCT01703000|470108683|FG000|Overall Study|Death|1|||
130586007|NCT03822884|470108684|FG000|Overall Study|Withdrawal by Subject|0|||
130586008|NCT03822884|470108685|FG001|Overall Study|Withdrawal by Subject|0|||
130586009|NCT03822884|470108686|FG002|Overall Study|Withdrawal by Subject|0|||
130586010|NCT03822884|470108687|FG003|Overall Study|Withdrawal by Subject|0|||
130586011|NCT03822884|470108688|FG004|Overall Study|Withdrawal by Subject|1|||
130586012|NCT03822884|470108689|FG005|Overall Study|Withdrawal by Subject|0|||
130586013|NCT00432237|470108695|FG000|Overall Study|Adverse Event|0|||
130586014|NCT00432237|470108696|FG001|Overall Study|Adverse Event|0|||
130586015|NCT00432237|470108697|FG002|Overall Study|Adverse Event|0|||
130586016|NCT00432237|470108698|FG003|Overall Study|Adverse Event|1|||
130586017|NCT00432237|470108695|FG000|Overall Study|Lack of Efficacy|0|||
130586018|NCT00432237|470108696|FG001|Overall Study|Lack of Efficacy|0|||
130586019|NCT00432237|470108697|FG002|Overall Study|Lack of Efficacy|0|||
130586020|NCT00432237|470108698|FG003|Overall Study|Lack of Efficacy|1|||
130586021|NCT00432237|470108695|FG000|Overall Study|Lost to Follow-up|10|||
130586022|NCT00432237|470108696|FG001|Overall Study|Lost to Follow-up|10|||
130586023|NCT00432237|470108697|FG002|Overall Study|Lost to Follow-up|18|||
130586024|NCT00432237|470108698|FG003|Overall Study|Lost to Follow-up|18|||
130586025|NCT00432237|470108695|FG000|Overall Study|Physician Decision|1|||
130586026|NCT00432237|470108696|FG001|Overall Study|Physician Decision|3|||
130586027|NCT00432237|470108697|FG002|Overall Study|Physician Decision|2|||
130586028|NCT00432237|470108698|FG003|Overall Study|Physician Decision|1|||
130586029|NCT00432237|470108695|FG000|Overall Study|Pregnancy|0|||
130586030|NCT00432237|470108696|FG001|Overall Study|Pregnancy|1|||
130540009|NCT00948766|469943579|FG000|Extension Study|Death|4|||
130586031|NCT00432237|470108697|FG002|Overall Study|Pregnancy|0|||
130586032|NCT00432237|470108698|FG003|Overall Study|Pregnancy|0|||
130586033|NCT00432237|470108695|FG000|Overall Study|Protocol Violation|13|||
130586034|NCT00432237|470108696|FG001|Overall Study|Protocol Violation|10|||
130540010|NCT00948766|469943580|FG001|Extension Study|Death|0|||
130540011|NCT02153073|469943584|FG000|Overall Study|Case Report Forms Uncollected|230|||
130540012|NCT02153073|469943584|FG000|Overall Study|Protocol Deviation|68|||
130540013|NCT03592745|469943585|FG000|Overall Study|Adverse Event|0|||
130586035|NCT00432237|470108697|FG002|Overall Study|Protocol Violation|11|||
130586036|NCT00432237|470108698|FG003|Overall Study|Protocol Violation|8|||
130586037|NCT00432237|470108695|FG000|Overall Study|Withdrawal by Subject|5|||
130586038|NCT00432237|470108696|FG001|Overall Study|Withdrawal by Subject|6|||
130586039|NCT00432237|470108697|FG002|Overall Study|Withdrawal by Subject|9|||
130540014|NCT03592745|469943586|FG001|Overall Study|Adverse Event|2|||
130540015|NCT03592745|469943585|FG000|Overall Study|Lost to Follow-up|2|||
130540016|NCT03592745|469943586|FG001|Overall Study|Lost to Follow-up|0|||
130540017|NCT03592745|469943585|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
130540018|NCT03592745|469943586|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
130540019|NCT00738894|469943587|FG000|Overall Study|Lost to Follow-up|23|||
130540020|NCT00738894|469943588|FG001|Overall Study|Lost to Follow-up|13|||
130540021|NCT00738894|469943587|FG000|Overall Study|Withdrawal by Subject|10|||
130540022|NCT00738894|469943588|FG001|Overall Study|Withdrawal by Subject|15|||
130540023|NCT00738894|469943587|FG000|Overall Study|Physician Decision|4|||
130540024|NCT00738894|469943588|FG001|Overall Study|Physician Decision|5|||
130540025|NCT00738894|469943587|FG000|Overall Study|Death|2|||
130540026|NCT00738894|469943588|FG001|Overall Study|Death|0|||
130540027|NCT01081665|469943589|FG000|Overall Study|Death|41|||
130540028|NCT01081665|469943589|FG000|Overall Study|Lost to Follow-up|18|||
130540029|NCT01081665|469943589|FG000|Overall Study|Withdrawal by Subject|17|||
130540030|NCT01081665|469943589|FG000|Overall Study|Change of dialysis unit|10|||
130540031|NCT01081665|469943589|FG000|Overall Study|Regulation of iPTH|5|||
130540032|NCT01081665|469943589|FG000|Overall Study|Change in renal replacement therapy|2|||
130540033|NCT01081665|469943589|FG000|Overall Study|Adverse Event|1|||
130540034|NCT01081665|469943589|FG000|Overall Study|Lack of Efficacy|1|||
130540035|NCT01413503|469943598|FG000|Overall Study|Lost to Follow-up|1|||
130540036|NCT02546921|469943599|FG000|Overall Study|Adverse Event|0|||
130540037|NCT02546921|469943600|FG001|Overall Study|Adverse Event|5|||
130540038|NCT02546921|469943601|FG002|Overall Study|Adverse Event|2|||
130540039|NCT02546921|469943602|FG003|Overall Study|Adverse Event|0|||
130540040|NCT02546921|469943603|FG004|Overall Study|Adverse Event|0|||
130540041|NCT02546921|469943604|FG005|Overall Study|Adverse Event|0|||
130540042|NCT02546921|469943605|FG006|Overall Study|Adverse Event|0|||
130540043|NCT02546921|469943599|FG000|Overall Study|Evidence of Disease Progression|1|||
130540044|NCT02546921|469943600|FG001|Overall Study|Evidence of Disease Progression|0|||
130540045|NCT02546921|469943601|FG002|Overall Study|Evidence of Disease Progression|0|||
130540046|NCT02546921|469943602|FG003|Overall Study|Evidence of Disease Progression|0|||
130540047|NCT02546921|469943603|FG004|Overall Study|Evidence of Disease Progression|1|||
130540048|NCT02546921|469943604|FG005|Overall Study|Evidence of Disease Progression|0|||
130540049|NCT02546921|469943605|FG006|Overall Study|Evidence of Disease Progression|0|||
130540050|NCT02546921|469943599|FG000|Overall Study|Patient Choice|0|||
130540051|NCT02546921|469943600|FG001|Overall Study|Patient Choice|1|||
130540052|NCT02546921|469943601|FG002|Overall Study|Patient Choice|0|||
130540053|NCT02546921|469943602|FG003|Overall Study|Patient Choice|0|||
130540054|NCT02546921|469943603|FG004|Overall Study|Patient Choice|0|||
130540055|NCT02546921|469943604|FG005|Overall Study|Patient Choice|1|||
130540056|NCT02546921|469943605|FG006|Overall Study|Patient Choice|0|||
130540057|NCT01373151|469943606|FG000|Period 1|Lack of Efficacy|3|||
130540058|NCT01373151|469943607|FG001|Period 1|Lack of Efficacy|0|||
130540059|NCT01373151|469943608|FG002|Period 1|Lack of Efficacy|0|||
130540060|NCT01373151|469943609|FG003|Period 1|Lack of Efficacy|0|||
130540061|NCT01373151|469943610|FG004|Period 1|Lack of Efficacy|1|||
130540062|NCT01373151|469943611|FG005|Period 1|Lack of Efficacy|0|||
130540063|NCT01373151|469943612|FG006|Period 1|Lack of Efficacy|0|||
130540064|NCT01373151|469943606|FG000|Period 1|Adverse Event|0|||
130540065|NCT01373151|469943607|FG001|Period 1|Adverse Event|0|||
130540066|NCT01373151|469943608|FG002|Period 1|Adverse Event|1|||
130540067|NCT01373151|469943609|FG003|Period 1|Adverse Event|0|||
130540068|NCT01373151|469943610|FG004|Period 1|Adverse Event|4|||
130540069|NCT01373151|469943611|FG005|Period 1|Adverse Event|3|||
130540070|NCT01373151|469943612|FG006|Period 1|Adverse Event|0|||
130586040|NCT00432237|470108698|FG003|Overall Study|Withdrawal by Subject|11|||
130586041|NCT00432237|470108695|FG000|Overall Study|Lack of Qualifying Event|38|||
130586042|NCT00432237|470108696|FG001|Overall Study|Lack of Qualifying Event|71|||
130586043|NCT00432237|470108697|FG002|Overall Study|Lack of Qualifying Event|69|||
130586044|NCT00432237|470108698|FG003|Overall Study|Lack of Qualifying Event|84|||
130586045|NCT01354132|470108699|FG000|Randomization|Physician Decision|1|||
130586046|NCT01354132|470108700|FG001|Randomization|Physician Decision|0|||
130586047|NCT01354132|470108699|FG000|Randomization|Withdrawal by Subject|0|||
130586048|NCT01354132|470108700|FG001|Randomization|Withdrawal by Subject|1|||
130586049|NCT01354132|470108699|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
130586050|NCT01354132|470108700|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
130586051|NCT01354132|470108699|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
130586052|NCT01354132|470108700|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
130586053|NCT01354132|470108699|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
130586054|NCT01354132|470108700|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
130586055|NCT00603239|470108701|FG000|Overall Study|Adverse Event|4|||
130586056|NCT00603239|470108702|FG001|Overall Study|Adverse Event|1|||
130586057|NCT00603239|470108701|FG000|Overall Study|Entry criteria not met|0|||
130586058|NCT00603239|470108702|FG001|Overall Study|Entry criteria not met|1|||
130586059|NCT00603239|470108701|FG000|Overall Study|Loss of glucose control|3|||
130586060|NCT00603239|470108702|FG001|Overall Study|Loss of glucose control|0|||
130586061|NCT00603239|470108701|FG000|Overall Study|Lost to Follow-up|2|||
130586062|NCT00603239|470108702|FG001|Overall Study|Lost to Follow-up|1|||
130586063|NCT00603239|470108701|FG000|Overall Study|Physician Decision|2|||
130586064|NCT00603239|470108702|FG001|Overall Study|Physician Decision|0|||
130586065|NCT00603239|470108701|FG000|Overall Study|Protocol Violation|2|||
130586066|NCT00603239|470108702|FG001|Overall Study|Protocol Violation|0|||
130586067|NCT00603239|470108701|FG000|Overall Study|Subject decision|2|||
130586068|NCT00603239|470108702|FG001|Overall Study|Subject decision|1|||
130586069|NCT02357420|470108703|FG000|Overall Study|Adverse Event|3|||
130586070|NCT02357420|470108704|FG001|Overall Study|Adverse Event|3|||
130586071|NCT02357420|470108705|FG002|Overall Study|Adverse Event|8|||
130586072|NCT02357420|470108706|FG003|Overall Study|Adverse Event|9|||
130586073|NCT02357420|470108703|FG000|Overall Study|Investigator Decision|1|||
130586074|NCT02357420|470108704|FG001|Overall Study|Investigator Decision|0|||
130586075|NCT02357420|470108705|FG002|Overall Study|Investigator Decision|0|||
130586076|NCT02357420|470108706|FG003|Overall Study|Investigator Decision|0|||
130586077|NCT02357420|470108703|FG000|Overall Study|Prohibited Medication|1|||
130586078|NCT02357420|470108704|FG001|Overall Study|Prohibited Medication|1|||
130586079|NCT02357420|470108705|FG002|Overall Study|Prohibited Medication|0|||
130586080|NCT02357420|470108706|FG003|Overall Study|Prohibited Medication|0|||
130540071|NCT01373151|469943606|FG000|Period 1|Withdrawal by Subject|2|||
130540072|NCT01373151|469943607|FG001|Period 1|Withdrawal by Subject|0|||
130540073|NCT01373151|469943608|FG002|Period 1|Withdrawal by Subject|3|||
130540074|NCT01373151|469943609|FG003|Period 1|Withdrawal by Subject|1|||
130540075|NCT01373151|469943610|FG004|Period 1|Withdrawal by Subject|0|||
130540076|NCT01373151|469943611|FG005|Period 1|Withdrawal by Subject|1|||
130540077|NCT01373151|469943612|FG006|Period 1|Withdrawal by Subject|0|||
130540078|NCT01373151|469943606|FG000|Period 2|Lack of Efficacy|9|||
130540079|NCT01373151|469943607|FG001|Period 2|Lack of Efficacy|0|||
130540080|NCT01373151|469943608|FG002|Period 2|Lack of Efficacy|0|||
130540081|NCT01373151|469943609|FG003|Period 2|Lack of Efficacy|1|||
130540082|NCT01373151|469943610|FG004|Period 2|Lack of Efficacy|2|||
130540083|NCT01373151|469943611|FG005|Period 2|Lack of Efficacy|0|||
130540084|NCT01373151|469943612|FG006|Period 2|Lack of Efficacy|3|||
130540085|NCT01373151|469943606|FG000|Period 2|Adverse Event|0|||
130540086|NCT01373151|469943607|FG001|Period 2|Adverse Event|0|||
130540087|NCT01373151|469943608|FG002|Period 2|Adverse Event|3|||
130540088|NCT01373151|469943609|FG003|Period 2|Adverse Event|3|||
130540089|NCT01373151|469943610|FG004|Period 2|Adverse Event|0|||
130540090|NCT01373151|469943611|FG005|Period 2|Adverse Event|0|||
130540091|NCT01373151|469943612|FG006|Period 2|Adverse Event|1|||
130540092|NCT01373151|469943606|FG000|Period 2|subject request to discontinue|0|||
130540093|NCT01373151|469943607|FG001|Period 2|subject request to discontinue|1|||
130540094|NCT01373151|469943608|FG002|Period 2|subject request to discontinue|0|||
130540095|NCT01373151|469943609|FG003|Period 2|subject request to discontinue|0|||
130540096|NCT01373151|469943610|FG004|Period 2|subject request to discontinue|0|||
130540097|NCT01373151|469943611|FG005|Period 2|subject request to discontinue|0|||
130540098|NCT01373151|469943612|FG006|Period 2|subject request to discontinue|0|||
130540099|NCT01373151|469943606|FG000|Period 2|Withdrawal by Subject|0|||
130540100|NCT01373151|469943607|FG001|Period 2|Withdrawal by Subject|0|||
130540101|NCT01373151|469943608|FG002|Period 2|Withdrawal by Subject|0|||
130540102|NCT01373151|469943609|FG003|Period 2|Withdrawal by Subject|1|||
130540103|NCT01373151|469943610|FG004|Period 2|Withdrawal by Subject|0|||
130540104|NCT01373151|469943611|FG005|Period 2|Withdrawal by Subject|0|||
130540105|NCT01373151|469943612|FG006|Period 2|Withdrawal by Subject|0|||
130540106|NCT01373151|469943606|FG000|Period 2|Other|0|||
130540107|NCT01373151|469943607|FG001|Period 2|Other|0|||
130540108|NCT01373151|469943608|FG002|Period 2|Other|1|||
130540109|NCT01373151|469943609|FG003|Period 2|Other|0|||
130540110|NCT01373151|469943610|FG004|Period 2|Other|0|||
130540111|NCT01373151|469943611|FG005|Period 2|Other|0|||
130540112|NCT01373151|469943612|FG006|Period 2|Other|1|||
130540113|NCT03026075|469943616|FG000|Overall Study|Physician Decision|1|||
130540114|NCT03381339|469943617|FG000|Overall Study|Protocol Violation|4|||
130540115|NCT03381339|469943618|FG001|Overall Study|Protocol Violation|3|||
130540116|NCT03381339|469943617|FG000|Overall Study|Lost to Follow-up|0|||
130540117|NCT03381339|469943618|FG001|Overall Study|Lost to Follow-up|1|||
130540118|NCT00293059|469943620|FG000|Overall Study|Adverse Event|12|||
130540119|NCT00293059|469943621|FG001|Overall Study|Adverse Event|4|||
130540120|NCT00293059|469943620|FG000|Overall Study|Lack of Efficacy|2|||
130540121|NCT00293059|469943621|FG001|Overall Study|Lack of Efficacy|0|||
130540122|NCT00293059|469943620|FG000|Overall Study|Lost to Follow-up|2|||
130540123|NCT00293059|469943621|FG001|Overall Study|Lost to Follow-up|3|||
130540124|NCT00293059|469943620|FG000|Overall Study|Pregnancy|1|||
130540125|NCT00293059|469943621|FG001|Overall Study|Pregnancy|1|||
130540126|NCT00293059|469943620|FG000|Overall Study|Protocol Violation|2|||
130540127|NCT00293059|469943621|FG001|Overall Study|Protocol Violation|0|||
130540128|NCT00293059|469943620|FG000|Overall Study|Withdrawal by Subject|11|||
130540129|NCT00293059|469943621|FG001|Overall Study|Withdrawal by Subject|5|||
130540130|NCT00293059|469943620|FG000|Overall Study|Participant moved out of state|1|||
130540131|NCT00293059|469943621|FG001|Overall Study|Participant moved out of state|0|||
130540132|NCT00293059|469943620|FG000|Overall Study|Participant stopped study drug|1|||
130586081|NCT02357420|470108703|FG000|Overall Study|Protocol Non-compliance|0|||
130586082|NCT02357420|470108704|FG001|Overall Study|Protocol Non-compliance|0|||
130586083|NCT02357420|470108705|FG002|Overall Study|Protocol Non-compliance|0|||
130586084|NCT02357420|470108706|FG003|Overall Study|Protocol Non-compliance|1|||
130586085|NCT02357420|470108703|FG000|Overall Study|Withdrawn Consent|4|||
130586086|NCT02357420|470108704|FG001|Overall Study|Withdrawn Consent|8|||
130586087|NCT02357420|470108705|FG002|Overall Study|Withdrawn Consent|6|||
130586088|NCT02357420|470108706|FG003|Overall Study|Withdrawn Consent|6|||
130586089|NCT02357420|470108703|FG000|Overall Study|Lost to Follow-up|3|||
130586090|NCT02357420|470108704|FG001|Overall Study|Lost to Follow-up|0|||
130586091|NCT02357420|470108705|FG002|Overall Study|Lost to Follow-up|2|||
130586092|NCT02357420|470108706|FG003|Overall Study|Lost to Follow-up|3|||
130586093|NCT00928070|470108709|FG000|Overall Study|Lost to Follow-up|1|||
130586094|NCT00928070|470108710|FG001|Overall Study|Lost to Follow-up|2|||
130586095|NCT00928070|470108709|FG000|Overall Study|Withdrawal by Subject|10|||
130586096|NCT00928070|470108710|FG001|Overall Study|Withdrawal by Subject|3|||
130586097|NCT00928070|470108709|FG000|Overall Study|Adverse Event|14|||
130586098|NCT00928070|470108710|FG001|Overall Study|Adverse Event|26|||
130586099|NCT00928070|470108709|FG000|Overall Study|Lack of Efficacy|9|||
130586100|NCT00928070|470108710|FG001|Overall Study|Lack of Efficacy|5|||
130586101|NCT00928070|470108709|FG000|Overall Study|Did not meet entrance criteria|16|||
130586102|NCT00928070|470108710|FG001|Overall Study|Did not meet entrance criteria|9|||
130586103|NCT00928070|470108709|FG000|Overall Study|Protocol Violation|6|||
130586104|NCT00928070|470108710|FG001|Overall Study|Protocol Violation|5|||
130586105|NCT00928070|470108709|FG000|Overall Study|Randomized but not treated|2|||
130586106|NCT00928070|470108710|FG001|Overall Study|Randomized but not treated|2|||
130586107|NCT00928070|470108709|FG000|Overall Study|Other|5|||
130586108|NCT00928070|470108710|FG001|Overall Study|Other|5|||
130586109|NCT00191854|470108711|FG000|Overall Study|Death|26|||
130586110|NCT00191854|470108712|FG001|Overall Study|Death|23|||
130586111|NCT00191854|470108713|FG002|Overall Study|Death|29|||
130586112|NCT00191854|470108711|FG000|Overall Study|Lost to Follow-up|7|||
130586113|NCT00191854|470108712|FG001|Overall Study|Lost to Follow-up|5|||
130586114|NCT00191854|470108713|FG002|Overall Study|Lost to Follow-up|5|||
130586115|NCT00191854|470108711|FG000|Overall Study|Withdrawal by Subject|4|||
130586116|NCT00191854|470108712|FG001|Overall Study|Withdrawal by Subject|2|||
130586117|NCT00191854|470108713|FG002|Overall Study|Withdrawal by Subject|3|||
130586118|NCT00191854|470108711|FG000|Overall Study|Sponsor Decision|0|||
130586119|NCT00191854|470108712|FG001|Overall Study|Sponsor Decision|0|||
130586120|NCT00191854|470108713|FG002|Overall Study|Sponsor Decision|1|||
130586121|NCT00191854|470108711|FG000|Overall Study|Screen Failure|0|||
130586122|NCT00191854|470108712|FG001|Overall Study|Screen Failure|0|||
130586123|NCT00191854|470108713|FG002|Overall Study|Screen Failure|1|||
130586124|NCT05254418|470108717|FG000|Overall Study|Adverse Event|2|||
130586125|NCT06118385|470108718|FG000|Overall Study|Protocol Violation|0|||
130586126|NCT06118385|470108719|FG001|Overall Study|Protocol Violation|0|||
130586127|NCT06118385|470108720|FG002|Overall Study|Protocol Violation|0|||
130586128|NCT06118385|470108721|FG003|Overall Study|Protocol Violation|0|||
130586129|NCT06118385|470108722|FG004|Overall Study|Protocol Violation|0|||
130586130|NCT06118385|470108723|FG005|Overall Study|Protocol Violation|0|||
130586131|NCT06118385|470108724|FG006|Overall Study|Protocol Violation|0|||
130586132|NCT06118385|470108725|FG007|Overall Study|Protocol Violation|0|||
130586133|NCT06118385|470108726|FG008|Overall Study|Protocol Violation|1|||
130586134|NCT06118385|470108727|FG009|Overall Study|Protocol Violation|0|||
130586135|NCT06118385|470108728|FG010|Overall Study|Protocol Violation|0|||
130586136|NCT06118385|470108729|FG011|Overall Study|Protocol Violation|0|||
130586137|NCT06118385|470108718|FG000|Overall Study|Out-of-range blood tests|0|||
130586138|NCT06118385|470108719|FG001|Overall Study|Out-of-range blood tests|0|||
130586139|NCT06118385|470108720|FG002|Overall Study|Out-of-range blood tests|0|||
130586140|NCT06118385|470108721|FG003|Overall Study|Out-of-range blood tests|0|||
130586141|NCT06118385|470108722|FG004|Overall Study|Out-of-range blood tests|0|||
130586142|NCT06118385|470108723|FG005|Overall Study|Out-of-range blood tests|0|||
130586143|NCT06118385|470108724|FG006|Overall Study|Out-of-range blood tests|0|||
130586144|NCT06118385|470108725|FG007|Overall Study|Out-of-range blood tests|0|||
130586145|NCT06118385|470108726|FG008|Overall Study|Out-of-range blood tests|1|||
130586146|NCT06118385|470108727|FG009|Overall Study|Out-of-range blood tests|0|||
130586147|NCT06118385|470108728|FG010|Overall Study|Out-of-range blood tests|0|||
130586148|NCT06118385|470108729|FG011|Overall Study|Out-of-range blood tests|0|||
130586149|NCT01323478|470108730|FG000|Overall Study|Adverse Event|7|||
130586150|NCT01323478|470108730|FG000|Overall Study|Lack of Efficacy|4|||
130586151|NCT01323478|470108730|FG000|Overall Study|Non-compliance With Study Product|3|||
130586152|NCT01323478|470108730|FG000|Overall Study|Protocol Violation|1|||
130586153|NCT01323478|470108730|FG000|Overall Study|Withdrawal of Consent|1|||
130586154|NCT01323478|470108730|FG000|Overall Study|Administrative or Other Reasons|8|||
130586155|NCT02411448|470108731|FG000|Overall Study|Withdrawal by Subject|1|||
130586156|NCT02411448|470108732|FG001|Overall Study|Withdrawal by Subject|14|||
130586157|NCT02411448|470108733|FG002|Overall Study|Withdrawal by Subject|9|||
130540133|NCT00293059|469943621|FG001|Overall Study|Participant stopped study drug|0|||
130540134|NCT00293059|469943620|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
130540135|NCT00293059|469943621|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
130540136|NCT00293059|469943620|FG000|Overall Study|missing|3|||
130540137|NCT00293059|469943621|FG001|Overall Study|missing|5|||
130540138|NCT02227199|469943625|FG000|Overall Study|Physician Decision|0|||
130540139|NCT02227199|469943626|FG001|Overall Study|Physician Decision|0|||
130540140|NCT02227199|469943627|FG002|Overall Study|Physician Decision|1|||
130540141|NCT02227199|469943625|FG000|Overall Study|Adverse Event|0|||
130540142|NCT02227199|469943626|FG001|Overall Study|Adverse Event|0|||
130540143|NCT02227199|469943627|FG002|Overall Study|Adverse Event|3|||
130540144|NCT01934790|469943628|FG000|Treatment|Adverse Event|3|||
130540145|NCT01934790|469943628|FG000|Treatment|Clinical progression|6|||
130540146|NCT01934790|469943628|FG000|Treatment|Radiological progression|4|||
130540147|NCT01934790|469943628|FG000|Treatment|Withdrawal by Subject|2|||
130540148|NCT01934790|469943628|FG000|Treatment|Study drug never administered|1|||
130540149|NCT01934790|469943628|FG000|Active Follow up|Death|20|||
130540150|NCT01934790|469943628|FG000|Active Follow up|Physician Decision|2|||
130540151|NCT01934790|469943628|FG000|Active Follow up|Progressive disease|1|||
130540152|NCT01934790|469943628|FG000|Active Follow up|Other reason|1|||
130540153|NCT00552929|469943631|FG000|Overall Study|Lost to Follow-up|0|||
130540154|NCT00552929|469943632|FG001|Overall Study|Lost to Follow-up|0|||
130540155|NCT00552929|469943633|FG002|Overall Study|Lost to Follow-up|0|||
130540156|NCT00552929|469943634|FG003|Overall Study|Lost to Follow-up|0|||
130540157|NCT00552929|469943635|FG004|Overall Study|Lost to Follow-up|0|||
130540158|NCT00552929|469943636|FG005|Overall Study|Lost to Follow-up|0|||
130540159|NCT00552929|469943637|FG006|Overall Study|Lost to Follow-up|0|||
130540160|NCT00552929|469943638|FG007|Overall Study|Lost to Follow-up|0|||
130540161|NCT00552929|469943639|FG008|Overall Study|Lost to Follow-up|1|||
130540162|NCT00552929|469943640|FG009|Overall Study|Lost to Follow-up|0|||
130540163|NCT00552929|469943631|FG000|Overall Study|Not Eligible|0|||
130540164|NCT00552929|469943632|FG001|Overall Study|Not Eligible|0|||
130540165|NCT00552929|469943633|FG002|Overall Study|Not Eligible|0|||
130540166|NCT00552929|469943634|FG003|Overall Study|Not Eligible|0|||
130540167|NCT00552929|469943635|FG004|Overall Study|Not Eligible|0|||
130540168|NCT00552929|469943636|FG005|Overall Study|Not Eligible|1|||
130540169|NCT00552929|469943637|FG006|Overall Study|Not Eligible|0|||
130540170|NCT00552929|469943638|FG007|Overall Study|Not Eligible|0|||
130540171|NCT00552929|469943639|FG008|Overall Study|Not Eligible|0|||
130540172|NCT00552929|469943640|FG009|Overall Study|Not Eligible|0|||
130540173|NCT01147536|469943646|FG000|Overall Study|Administrative study close|2|||
130540174|NCT01147536|469943646|FG000|Overall Study|Death|1|||
130540175|NCT04577001|469943650|FG000|Overall Study|Subject became ineligible|0|||
130540176|NCT04577001|469943651|FG001|Overall Study|Subject became ineligible|1|||
130540177|NCT01241604|469943652|FG000|Screening Period|Screen Failure|3|||
130540178|NCT01241604|469943653|FG001|Screening Period|Screen Failure|0|||
130540179|NCT01241604|469943654|FG002|Screening Period|Screen Failure|0|||
130540180|NCT05110690|469943655|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
130540181|NCT05110690|469943655|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
130540182|NCT05110690|469943655|FG000|Completion of Intervention|Lost to Follow-up|1|||
130540183|NCT05110690|469943655|FG000|Completion of Intervention|Death|1|||
130540184|NCT05110690|469943655|FG000|Completion of Intervention|Withdrawal by Subject|2|||
130540185|NCT03973931|469943658|FG000|Overall Study|Lost to Follow-up|47|||
130540186|NCT03973931|469943659|FG001|Overall Study|Lost to Follow-up|63|||
130540187|NCT03973931|469943660|FG002|Overall Study|Lost to Follow-up|51|||
130540188|NCT03973931|469943661|FG003|Overall Study|Lost to Follow-up|54|||
130540189|NCT03973931|469943658|FG000|Overall Study|opted out|6|||
130540190|NCT03973931|469943659|FG001|Overall Study|opted out|5|||
130540191|NCT03973931|469943660|FG002|Overall Study|opted out|5|||
130540192|NCT03973931|469943661|FG003|Overall Study|opted out|1|||
130540193|NCT00925353|469943662|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
130540194|NCT03507777|469945153|FG000|Overall Study|Lost to Follow-up|5|||
130540195|NCT03507777|469945154|FG001|Overall Study|Lost to Follow-up|7|||
130540196|NCT03507777|469945153|FG000|Overall Study|Withdrawal by Subject|6|||
130540197|NCT03507777|469945154|FG001|Overall Study|Withdrawal by Subject|11|||
130540198|NCT03507777|469945153|FG000|Overall Study|Death|30|||
130540199|NCT03507777|469945154|FG001|Overall Study|Death|44|||
130540200|NCT03507777|469945153|FG000|Overall Study|Other Reasons|3|||
130540201|NCT03507777|469945154|FG001|Overall Study|Other Reasons|8|||
130540202|NCT01879722|469945155|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130540203|NCT01879722|469945156|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130540204|NCT01879722|469945157|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130540205|NCT01879722|469945158|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130540206|NCT01879722|469945159|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
130540207|NCT01879722|469945160|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
130540208|NCT01879722|469945161|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
130540209|NCT01879722|469945162|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
130540210|NCT01879722|469945163|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
130540211|NCT01879722|469945164|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
130540212|NCT01879722|469945155|FG000|Overall Study|Voluntary Withdrawal|0|||
130540213|NCT01879722|469945156|FG001|Overall Study|Voluntary Withdrawal|0|||
130540214|NCT01879722|469945157|FG002|Overall Study|Voluntary Withdrawal|0|||
130540215|NCT01879722|469945158|FG003|Overall Study|Voluntary Withdrawal|0|||
130540216|NCT01879722|469945159|FG004|Overall Study|Voluntary Withdrawal|0|||
130540217|NCT01879722|469945160|FG005|Overall Study|Voluntary Withdrawal|0|||
130540218|NCT01879722|469945161|FG006|Overall Study|Voluntary Withdrawal|0|||
130540219|NCT01879722|469945162|FG007|Overall Study|Voluntary Withdrawal|0|||
130540220|NCT01879722|469945163|FG008|Overall Study|Voluntary Withdrawal|1|||
130540221|NCT01879722|469945164|FG009|Overall Study|Voluntary Withdrawal|0|||
130540222|NCT01253304|469945165|FG000|Overall Study|Adverse Event|0|||
130540223|NCT01253304|469945166|FG001|Overall Study|Adverse Event|0|||
130540224|NCT01253304|469945167|FG002|Overall Study|Adverse Event|0|||
130540225|NCT01253304|469945168|FG003|Overall Study|Adverse Event|1|||
130540226|NCT01327495|469945169|FG000|Overall Study|Adverse Event|2|||
130540227|NCT01327495|469945170|FG001|Overall Study|Adverse Event|1|||
130540228|NCT01327495|469945171|FG002|Overall Study|Adverse Event|1|||
130540229|NCT01327495|469945172|FG003|Overall Study|Adverse Event|0|||
130540230|NCT01327495|469945173|FG004|Overall Study|Adverse Event|0|||
130540231|NCT01327495|469945174|FG005|Overall Study|Adverse Event|2|||
130540232|NCT01327495|469945169|FG000|Overall Study|Withdrawal by Subject|0|||
130540233|NCT01327495|469945170|FG001|Overall Study|Withdrawal by Subject|1|||
130540234|NCT01327495|469945171|FG002|Overall Study|Withdrawal by Subject|1|||
130540235|NCT01327495|469945172|FG003|Overall Study|Withdrawal by Subject|0|||
130540236|NCT01327495|469945173|FG004|Overall Study|Withdrawal by Subject|1|||
130540237|NCT01327495|469945174|FG005|Overall Study|Withdrawal by Subject|0|||
130540238|NCT01327495|469945169|FG000|Overall Study|Physician Decision|0|||
130540239|NCT01327495|469945170|FG001|Overall Study|Physician Decision|0|||
130540240|NCT01327495|469945171|FG002|Overall Study|Physician Decision|0|||
130540241|NCT01327495|469945172|FG003|Overall Study|Physician Decision|0|||
130540242|NCT01327495|469945173|FG004|Overall Study|Physician Decision|2|||
130540243|NCT01327495|469945174|FG005|Overall Study|Physician Decision|0|||
130540244|NCT00006011|469945175|FG000|Overall Study|Disease progression|13|||
130540245|NCT00006011|469945176|FG001|Overall Study|Disease progression|6|||
130540246|NCT00006011|469945177|FG002|Overall Study|Disease progression|26|||
130540247|NCT00006011|469945175|FG000|Overall Study|Refused further treatment|15|||
130540248|NCT00006011|469945176|FG001|Overall Study|Refused further treatment|13|||
130540249|NCT00006011|469945177|FG002|Overall Study|Refused further treatment|26|||
130540250|NCT00006011|469945175|FG000|Overall Study|Adverse Event|15|||
130540251|NCT00006011|469945176|FG001|Overall Study|Adverse Event|39|||
130540252|NCT00006011|469945177|FG002|Overall Study|Adverse Event|5|||
130540253|NCT00006011|469945175|FG000|Overall Study|Death|0|||
130540254|NCT00006011|469945176|FG001|Overall Study|Death|1|||
130540255|NCT00006011|469945177|FG002|Overall Study|Death|2|||
130540256|NCT00006011|469945175|FG000|Overall Study|Other|4|||
130540257|NCT00006011|469945176|FG001|Overall Study|Other|2|||
130540258|NCT00006011|469945177|FG002|Overall Study|Other|5|||
130540259|NCT00006011|469945175|FG000|Overall Study|Ineligible|18|||
130540260|NCT00006011|469945176|FG001|Overall Study|Ineligible|16|||
130540261|NCT00006011|469945177|FG002|Overall Study|Ineligible|9|||
130540262|NCT03212989|469945179|FG000|Overall Study|Physician Decision|8|||
130540263|NCT03047395|469945182|FG000|Overall Study|Adverse Event|142|||
130540264|NCT03047395|469945182|FG000|Overall Study|Withdrawal by Subject|155|||
130540265|NCT03047395|469945182|FG000|Overall Study|Lost to Follow-up|144|||
130540266|NCT03047395|469945182|FG000|Overall Study|COVID-19 Infection|2|||
130540267|NCT03047395|469945182|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
130540268|NCT03047395|469945182|FG000|Overall Study|Other, Not Specified|117|||
130540269|NCT03484273|469945183|FG000|Overall Study|Equipment Malfunction|1|||
130540270|NCT03484273|469945183|FG000|Overall Study|Data excluded from analysis|1|||
130540271|NCT00560066|469945186|FG000|Overall Study|Death|2|||
130540272|NCT00560066|469945187|FG001|Overall Study|Death|1|||
130540273|NCT00560066|469945186|FG000|Overall Study|Withdrawal by Subject|0|||
130540274|NCT00560066|469945187|FG001|Overall Study|Withdrawal by Subject|3|||
130540275|NCT00560066|469945186|FG000|Overall Study|Lost to Follow-up|4|||
130540276|NCT00560066|469945187|FG001|Overall Study|Lost to Follow-up|10|||
130540277|NCT00560066|469945186|FG000|Overall Study|Protocol Violation|0|||
130540278|NCT00560066|469945187|FG001|Overall Study|Protocol Violation|1|||
130540279|NCT00560066|469945186|FG000|Overall Study|Administrative reason|0|||
130540280|NCT00560066|469945187|FG001|Overall Study|Administrative reason|5|||
130540281|NCT00560066|469945186|FG000|Overall Study|Missing primary reason|0|||
130540282|NCT00560066|469945187|FG001|Overall Study|Missing primary reason|2|||
130540283|NCT00620282|469945194|FG000|Overall Study|Adverse Event|0|||
130540284|NCT00620282|469945195|FG001|Overall Study|Adverse Event|1|||
130540285|NCT00620282|469945196|FG002|Overall Study|Adverse Event|0|||
130540286|NCT00620282|469945194|FG000|Overall Study|Arterial line unable to be placed|0|||
130540287|NCT00620282|469945195|FG001|Overall Study|Arterial line unable to be placed|0|||
130540288|NCT00620282|469945196|FG002|Overall Study|Arterial line unable to be placed|1|||
130540289|NCT00620282|469945194|FG000|Overall Study|Withdrawal by Subject|0|||
130540290|NCT00620282|469945195|FG001|Overall Study|Withdrawal by Subject|1|||
130586158|NCT02411448|470108731|FG000|Overall Study|Other|0|||
130586159|NCT02411448|470108732|FG001|Overall Study|Other|2|||
130586160|NCT02411448|470108733|FG002|Overall Study|Other|0|||
130586161|NCT02411448|470108731|FG000|Overall Study|Did not receive study treatment|0|||
130586162|NCT02411448|470108732|FG001|Overall Study|Did not receive study treatment|3|||
130586163|NCT02411448|470108733|FG002|Overall Study|Did not receive study treatment|0|||
130586164|NCT02411448|470108731|FG000|Overall Study|Alive on study treatment|3|||
130586165|NCT02411448|470108732|FG001|Overall Study|Alive on study treatment|64|||
130586166|NCT02411448|470108733|FG002|Overall Study|Alive on study treatment|43|||
130586167|NCT02771522|470108736|FG000|Overall Study|Lost to Follow-up|3|||
130586168|NCT02771522|470108736|FG000|Overall Study|Withdrawal by Subject|2|||
130586169|NCT02771522|470108736|FG000|Overall Study|No white spot lesions|3|||
130586170|NCT05655377|470108737|FG000|Overall Study|Withdrawal by Subject|2|||
130586171|NCT01256177|470108738|FG000|Overall Study|Withdrawal by Subject|23|||
130586172|NCT01256177|470108739|FG001|Overall Study|Withdrawal by Subject|22|||
130586173|NCT01256177|470108738|FG000|Overall Study|Lost to Follow-up|2|||
130586174|NCT01256177|470108739|FG001|Overall Study|Lost to Follow-up|2|||
130586175|NCT01256177|470108738|FG000|Overall Study|Adverse Event|8|||
130586176|NCT01256177|470108739|FG001|Overall Study|Adverse Event|9|||
130586177|NCT01256177|470108738|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130540291|NCT00620282|469945196|FG002|Overall Study|Withdrawal by Subject|0|||
130540292|NCT01258595|469945197|FG000|Overall Study|Lost to Follow-up|1|||
130540293|NCT01258595|469945198|FG001|Overall Study|Lost to Follow-up|0|||
130540294|NCT01258595|469945197|FG000|Overall Study|Withdrawal by Subject|0|||
130540295|NCT01258595|469945198|FG001|Overall Study|Withdrawal by Subject|1|||
130540296|NCT02703259|469945199|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
130540297|NCT02703259|469945200|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
130540298|NCT02703259|469945199|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
130540299|NCT02703259|469945200|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
130540300|NCT02703259|469945199|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
130586178|NCT01256177|470108739|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130540301|NCT02703259|469945200|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
130540302|NCT04738292|469945205|FG000|Overall Study|Death|1|||
130540303|NCT03122223|469945206|FG000|Overall Study|Withdrawal by Subject|2|||
130540304|NCT03122223|469945207|FG001|Overall Study|Withdrawal by Subject|2|||
130540305|NCT03122223|469945208|FG002|Overall Study|Withdrawal by Subject|1|||
130540306|NCT03122223|469945209|FG003|Overall Study|Withdrawal by Subject|0|||
130540307|NCT03122223|469945206|FG000|Overall Study|Lost to Follow-up|0|||
130540308|NCT03122223|469945207|FG001|Overall Study|Lost to Follow-up|2|||
130540309|NCT03122223|469945208|FG002|Overall Study|Lost to Follow-up|2|||
130540310|NCT03122223|469945209|FG003|Overall Study|Lost to Follow-up|0|||
130540311|NCT03122223|469945206|FG000|Overall Study|Participant unable to adhere|1|||
130540312|NCT03122223|469945207|FG001|Overall Study|Participant unable to adhere|1|||
130540313|NCT03122223|469945208|FG002|Overall Study|Participant unable to adhere|1|||
130540314|NCT03122223|469945209|FG003|Overall Study|Participant unable to adhere|0|||
130540315|NCT01820585|469945211|FG000|Overall Study|Adverse Event|9|||
130540316|NCT01820585|469945212|FG001|Overall Study|Adverse Event|13|||
130540317|NCT01820585|469945213|FG002|Overall Study|Adverse Event|23|||
130540318|NCT01820585|469945214|FG003|Overall Study|Adverse Event|34|||
130540319|NCT01820585|469945211|FG000|Overall Study|Lack of Efficacy|9|||
130540320|NCT01820585|469945212|FG001|Overall Study|Lack of Efficacy|7|||
130540321|NCT01820585|469945213|FG002|Overall Study|Lack of Efficacy|5|||
130540322|NCT01820585|469945214|FG003|Overall Study|Lack of Efficacy|1|||
130540323|NCT01820585|469945211|FG000|Overall Study|Withdrawal by Subject|3|||
130540324|NCT01820585|469945212|FG001|Overall Study|Withdrawal by Subject|7|||
130540325|NCT01820585|469945213|FG002|Overall Study|Withdrawal by Subject|3|||
130540326|NCT01820585|469945214|FG003|Overall Study|Withdrawal by Subject|8|||
130540327|NCT01820585|469945211|FG000|Overall Study|Lost to Follow-up|3|||
130540328|NCT01820585|469945212|FG001|Overall Study|Lost to Follow-up|3|||
130540329|NCT01820585|469945213|FG002|Overall Study|Lost to Follow-up|0|||
130540330|NCT01820585|469945214|FG003|Overall Study|Lost to Follow-up|3|||
130540331|NCT01820585|469945211|FG000|Overall Study|Protocol Violation|3|||
130540332|NCT01820585|469945212|FG001|Overall Study|Protocol Violation|1|||
130586179|NCT01256177|470108738|FG000|Overall Study|Condition under Investigation Worsened|1|||
130586180|NCT01256177|470108739|FG001|Overall Study|Condition under Investigation Worsened|0|||
130586181|NCT01256177|470108738|FG000|Overall Study|Lack of Efficacy|11|||
130586182|NCT01256177|470108739|FG001|Overall Study|Lack of Efficacy|2|||
130540333|NCT01820585|469945213|FG002|Overall Study|Protocol Violation|1|||
130540334|NCT01820585|469945214|FG003|Overall Study|Protocol Violation|1|||
130586183|NCT01256177|470108738|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
130586184|NCT01256177|470108739|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
130540335|NCT01820585|469945211|FG000|Overall Study|Subject non-compliance|0|||
130540336|NCT01820585|469945212|FG001|Overall Study|Subject non-compliance|0|||
130586185|NCT03624946|470108743|FG000|Overall Study|Lost to Follow-up|0|||
130586186|NCT03624946|470108744|FG001|Overall Study|Lost to Follow-up|1|||
130586187|NCT00331006|470108745|FG000|Screening Phase|Withdrawal by Subject|1|||
130586188|NCT00331006|470108745|FG000|Screening Phase|enrollment halted|1|||
130540337|NCT01820585|469945213|FG002|Overall Study|Subject non-compliance|1|||
130540338|NCT01820585|469945214|FG003|Overall Study|Subject non-compliance|2|||
130540339|NCT01820585|469945211|FG000|Overall Study|at sponsor request|0|||
130586189|NCT00331006|470108745|FG000|Screening Phase|Lost to Follow-up|1|||
130586190|NCT00331006|470108745|FG000|Screening Phase|Ineligible for treatment phase|4|||
130586191|NCT00331006|470108745|FG000|Treatment Phase|Withdrawal by Subject|1|||
130586192|NCT00331006|470108745|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
130586193|NCT00331006|470108745|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
130586194|NCT01950819|470108746|FG000|Overall Study|Graft Loss|35|||
130586195|NCT01950819|470108747|FG001|Overall Study|Graft Loss|30|||
130586196|NCT01950819|470108746|FG000|Overall Study|Death|29|||
130586197|NCT01950819|470108747|FG001|Overall Study|Death|34|||
130586198|NCT01950819|470108746|FG000|Overall Study|Subject / Gardian decision|54|||
130586199|NCT01950819|470108747|FG001|Overall Study|Subject / Gardian decision|51|||
130586200|NCT01950819|470108746|FG000|Overall Study|technical problems|2|||
130586201|NCT01950819|470108747|FG001|Overall Study|technical problems|0|||
130586202|NCT01950819|470108746|FG000|Overall Study|Pregnancy|0|||
130586203|NCT01950819|470108747|FG001|Overall Study|Pregnancy|2|||
130586204|NCT01950819|470108746|FG000|Overall Study|Lost to Follow-up|9|||
130586205|NCT01950819|470108747|FG001|Overall Study|Lost to Follow-up|17|||
130586206|NCT02928952|470108751|FG000|Overall Study|Lost to Follow-up|5|||
130586207|NCT02928952|470108752|FG001|Overall Study|Lost to Follow-up|5|||
130586208|NCT02928952|470108751|FG000|Overall Study|Withdrawal by Subject|5|||
130540340|NCT01820585|469945212|FG001|Overall Study|at sponsor request|0|||
130540341|NCT01820585|469945213|FG002|Overall Study|at sponsor request|1|||
130540342|NCT01820585|469945214|FG003|Overall Study|at sponsor request|0|||
130586209|NCT02928952|470108752|FG001|Overall Study|Withdrawal by Subject|1|||
130586210|NCT02928952|470108751|FG000|Overall Study|Physician Decision|0|||
130586211|NCT02928952|470108752|FG001|Overall Study|Physician Decision|1|||
130586212|NCT00723957|470108753|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130586213|NCT00723957|470108754|FG001|Overall Study|Adverse event unrelated to study drug|4|||
130586214|NCT00723957|470108753|FG000|Overall Study|Death|3|||
130540343|NCT01820585|469945211|FG000|Overall Study|Pregnancy|0|||
130540344|NCT01820585|469945212|FG001|Overall Study|Pregnancy|1|||
130540345|NCT01820585|469945213|FG002|Overall Study|Pregnancy|0|||
130540346|NCT01820585|469945214|FG003|Overall Study|Pregnancy|0|||
130540347|NCT02544451|469945215|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
130540348|NCT02544451|469945216|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
130540349|NCT02544451|469945217|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
130540350|NCT02544451|469945218|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
130540351|NCT02544451|469945215|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
130540352|NCT02544451|469945216|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
130540353|NCT02544451|469945217|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
130540354|NCT02544451|469945218|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
130540355|NCT02544451|469945215|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
130540356|NCT02544451|469945216|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
130540357|NCT02544451|469945217|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
130540358|NCT02544451|469945218|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
130540359|NCT02544451|469945215|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
130540360|NCT02544451|469945216|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
130540361|NCT02544451|469945217|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
130540362|NCT02544451|469945218|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
130540363|NCT02544451|469945215|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
130540364|NCT02544451|469945216|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
130540365|NCT02544451|469945217|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
130586215|NCT00723957|470108754|FG001|Overall Study|Death|4|||
130586216|NCT00723957|470108753|FG000|Overall Study|Disease progression|27|||
130586217|NCT00723957|470108754|FG001|Overall Study|Disease progression|25|||
130540366|NCT02544451|469945218|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
130540367|NCT02544451|469945215|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
130586218|NCT00723957|470108753|FG000|Overall Study|Maximum clinical benefit|4|||
130586219|NCT00723957|470108754|FG001|Overall Study|Maximum clinical benefit|5|||
130586220|NCT00723957|470108753|FG000|Overall Study|Investigator decision|1|||
130586221|NCT00723957|470108754|FG001|Overall Study|Investigator decision|1|||
130586222|NCT00723957|470108753|FG000|Overall Study|Study drug toxicity|4|||
130586223|NCT00723957|470108754|FG001|Overall Study|Study drug toxicity|6|||
130586224|NCT00723957|470108753|FG000|Overall Study|Withdrawal by Subject|7|||
130540368|NCT02544451|469945216|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
130540369|NCT02544451|469945217|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
130540370|NCT02544451|469945218|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
130540371|NCT00998790|469945219|FG000|Overall Study|Withdrawal by Subject|21|||
130540372|NCT01489891|469945220|FG000|Overall Study|Endoscopy failure|1|||
130540373|NCT01489891|469945221|FG001|Overall Study|Endoscopy failure|0|||
130540374|NCT03001076|469945222|FG000|Overall Study|Withdrawal by patient|2|||
130540375|NCT03001076|469945223|FG001|Overall Study|Withdrawal by patient|0|||
130540376|NCT03001076|469945222|FG000|Overall Study|Other|1|||
130540377|NCT03001076|469945223|FG001|Overall Study|Other|0|||
130540378|NCT03001076|469945222|FG000|Overall Study|Adverse Event|3|||
130540379|NCT03001076|469945223|FG001|Overall Study|Adverse Event|3|||
130540380|NCT03001076|469945222|FG000|Overall Study|Sponsor decision|1|||
130540381|NCT03001076|469945223|FG001|Overall Study|Sponsor decision|0|||
130540382|NCT03001076|469945222|FG000|Overall Study|Lost to Follow-up|0|||
130540383|NCT03001076|469945223|FG001|Overall Study|Lost to Follow-up|2|||
130540384|NCT03189745|469945224|FG000|Overall Study|Conflict in work schedule of participant|1|||
130540385|NCT03189745|469945225|FG001|Overall Study|Conflict in work schedule of participant|1|||
130540386|NCT00895154|469945226|FG000|Overall Study|Lost to Follow-up|1|||
130540387|NCT00895154|469945227|FG001|Overall Study|Lost to Follow-up|1|||
130540388|NCT00895154|469945226|FG000|Overall Study|Withdrawal by Subject|0|||
130586225|NCT00723957|470108754|FG001|Overall Study|Withdrawal by Subject|5|||
130586226|NCT00723957|470108753|FG000|Overall Study|Reason not analyzed|1|||
130586227|NCT00723957|470108754|FG001|Overall Study|Reason not analyzed|0|||
130586228|NCT00723957|470108753|FG000|Overall Study|Never received treatment|3|||
130586229|NCT00723957|470108754|FG001|Overall Study|Never received treatment|3|||
130586230|NCT01850615|470108756|FG000|Overall Study|Protocol Violation|4|||
130586231|NCT01850615|470108757|FG001|Overall Study|Protocol Violation|1|||
130586232|NCT01850615|470108756|FG000|Overall Study|Adverse Event|2|||
130586233|NCT01850615|470108757|FG001|Overall Study|Adverse Event|1|||
130586234|NCT01850615|470108756|FG000|Overall Study|Withdrawal by Subject|3|||
130586235|NCT01850615|470108757|FG001|Overall Study|Withdrawal by Subject|1|||
130586236|NCT01850615|470108756|FG000|Overall Study|Lost to Follow-up|0|||
130586237|NCT01850615|470108757|FG001|Overall Study|Lost to Follow-up|1|||
130540389|NCT00895154|469945227|FG001|Overall Study|Withdrawal by Subject|1|||
130540390|NCT01993927|469945228|FG000|Overall Study|Case Report Forms Uncollected|18|||
130586238|NCT01850615|470108756|FG000|Overall Study|Unclassified|0|||
130586239|NCT01850615|470108757|FG001|Overall Study|Unclassified|1|||
130586240|NCT00706628|470108758|FG000|Overall Study|Other Adverse Event|16|||
130540391|NCT01993927|469945228|FG000|Overall Study|Protocol Violation|11|||
130540392|NCT00777088|469945229|FG000|Overall Study|PED Treatment not attempted|1|||
130540393|NCT02729831|469945231|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
130540394|NCT02729831|469945232|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
130540395|NCT02729831|469945233|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
130540396|NCT02729831|469945234|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
130540397|NCT02729831|469945231|FG000|1 Week Post-visit|Lost to Follow-up|43|||
130540398|NCT02729831|469945232|FG001|1 Week Post-visit|Lost to Follow-up|40|||
130586241|NCT00706628|470108759|FG001|Overall Study|Other Adverse Event|5|||
130540399|NCT02729831|469945233|FG002|1 Week Post-visit|Lost to Follow-up|38|||
130540400|NCT02729831|469945234|FG003|1 Week Post-visit|Lost to Follow-up|36|||
130540401|NCT02729831|469945231|FG000|6 Month Follow-up|Lost to Follow-up|54|||
130540402|NCT02729831|469945232|FG001|6 Month Follow-up|Lost to Follow-up|51|||
130540403|NCT02729831|469945233|FG002|6 Month Follow-up|Lost to Follow-up|48|||
130540404|NCT02729831|469945234|FG003|6 Month Follow-up|Lost to Follow-up|42|||
130540405|NCT02729831|469945231|FG000|6 Month Follow-up|Death|1|||
130586242|NCT00706628|470108760|FG002|Overall Study|Other Adverse Event|5|||
130586243|NCT00706628|470108761|FG003|Overall Study|Other Adverse Event|2|||
130586244|NCT00706628|470108758|FG000|Overall Study|Non compliant with protocol|0|||
130540406|NCT02729831|469945232|FG001|6 Month Follow-up|Death|3|||
130540407|NCT02729831|469945233|FG002|6 Month Follow-up|Death|0|||
130586245|NCT00706628|470108759|FG001|Overall Study|Non compliant with protocol|1|||
130586246|NCT00706628|470108760|FG002|Overall Study|Non compliant with protocol|0|||
130586247|NCT00706628|470108761|FG003|Overall Study|Non compliant with protocol|0|||
130586248|NCT00706628|470108758|FG000|Overall Study|Consent withdrawn|6|||
130586249|NCT00706628|470108759|FG001|Overall Study|Consent withdrawn|1|||
130586250|NCT00706628|470108760|FG002|Overall Study|Consent withdrawn|3|||
130586251|NCT00706628|470108761|FG003|Overall Study|Consent withdrawn|0|||
130586252|NCT00706628|470108758|FG000|Overall Study|Progressive disease|20|||
130586253|NCT00706628|470108759|FG001|Overall Study|Progressive disease|13|||
130586254|NCT00706628|470108760|FG002|Overall Study|Progressive disease|8|||
130586255|NCT00706628|470108761|FG003|Overall Study|Progressive disease|1|||
130586256|NCT00706628|470108758|FG000|Overall Study|Other than those stated above|4|||
130586257|NCT00706628|470108759|FG001|Overall Study|Other than those stated above|0|||
130586258|NCT00706628|470108760|FG002|Overall Study|Other than those stated above|0|||
130586259|NCT00706628|470108761|FG003|Overall Study|Other than those stated above|0|||
130540408|NCT02729831|469945234|FG003|6 Month Follow-up|Death|1|||
130540409|NCT03117998|469945235|FG000|Overall Study|Adverse Event|1|||
130540410|NCT03117998|469945236|FG001|Overall Study|Adverse Event|0|||
130540411|NCT03117998|469945237|FG002|Overall Study|Adverse Event|0|||
130540412|NCT03117998|469945238|FG003|Overall Study|Adverse Event|0|||
130540413|NCT03117998|469945239|FG004|Overall Study|Adverse Event|0|||
130540414|NCT03117998|469945240|FG005|Overall Study|Adverse Event|0|||
130540415|NCT03117998|469945235|FG000|Overall Study|Withdrawal by Subject|0|||
130540416|NCT03117998|469945236|FG001|Overall Study|Withdrawal by Subject|0|||
130540417|NCT03117998|469945237|FG002|Overall Study|Withdrawal by Subject|2|||
130540418|NCT03117998|469945238|FG003|Overall Study|Withdrawal by Subject|3|||
130540419|NCT03117998|469945239|FG004|Overall Study|Withdrawal by Subject|3|||
130540420|NCT03117998|469945240|FG005|Overall Study|Withdrawal by Subject|0|||
130540421|NCT03117998|469945235|FG000|Overall Study|Physician Decision|0|||
130540422|NCT03117998|469945236|FG001|Overall Study|Physician Decision|1|||
130540423|NCT03117998|469945237|FG002|Overall Study|Physician Decision|1|||
130540424|NCT03117998|469945238|FG003|Overall Study|Physician Decision|0|||
130540425|NCT03117998|469945239|FG004|Overall Study|Physician Decision|0|||
130540426|NCT03117998|469945240|FG005|Overall Study|Physician Decision|0|||
130540427|NCT03117998|469945235|FG000|Overall Study|Lost to Follow-up|0|||
130540428|NCT03117998|469945236|FG001|Overall Study|Lost to Follow-up|0|||
130540429|NCT03117998|469945237|FG002|Overall Study|Lost to Follow-up|0|||
130540430|NCT03117998|469945238|FG003|Overall Study|Lost to Follow-up|1|||
130540431|NCT03117998|469945239|FG004|Overall Study|Lost to Follow-up|4|||
130540432|NCT03117998|469945240|FG005|Overall Study|Lost to Follow-up|0|||
130540433|NCT03117998|469945235|FG000|Overall Study|Subject noncompliance|0|||
130540434|NCT03117998|469945236|FG001|Overall Study|Subject noncompliance|0|||
130540435|NCT03117998|469945237|FG002|Overall Study|Subject noncompliance|1|||
130540436|NCT03117998|469945238|FG003|Overall Study|Subject noncompliance|0|||
130540437|NCT03117998|469945239|FG004|Overall Study|Subject noncompliance|0|||
130540438|NCT03117998|469945240|FG005|Overall Study|Subject noncompliance|2|||
130540439|NCT03117998|469945235|FG000|Overall Study|Protocol Violation|0|||
130540440|NCT03117998|469945236|FG001|Overall Study|Protocol Violation|0|||
130540441|NCT03117998|469945237|FG002|Overall Study|Protocol Violation|0|||
130540442|NCT03117998|469945238|FG003|Overall Study|Protocol Violation|0|||
130540443|NCT03117998|469945239|FG004|Overall Study|Protocol Violation|0|||
130540444|NCT03117998|469945240|FG005|Overall Study|Protocol Violation|1|||
130540445|NCT00438672|469945241|FG000|Overall Study|Lost to Follow-up|7|||
130540446|NCT00438672|469945242|FG001|Overall Study|Lost to Follow-up|9|||
130540447|NCT01468181|469945243|FG000|Overall Study|Adverse Event|8|||
130540448|NCT01468181|469945244|FG001|Overall Study|Adverse Event|1|||
130540449|NCT01468181|469945245|FG002|Overall Study|Adverse Event|6|||
130540450|NCT01468181|469945246|FG003|Overall Study|Adverse Event|2|||
130540451|NCT01468181|469945247|FG004|Overall Study|Adverse Event|2|||
130540452|NCT01468181|469945243|FG000|Overall Study|Protocol Violation|2|||
130540453|NCT01468181|469945244|FG001|Overall Study|Protocol Violation|0|||
130540454|NCT01468181|469945245|FG002|Overall Study|Protocol Violation|1|||
130540455|NCT01468181|469945246|FG003|Overall Study|Protocol Violation|0|||
130540456|NCT01468181|469945247|FG004|Overall Study|Protocol Violation|1|||
130540457|NCT01468181|469945243|FG000|Overall Study|Physician Decision|0|||
130540458|NCT01468181|469945244|FG001|Overall Study|Physician Decision|0|||
130540459|NCT01468181|469945245|FG002|Overall Study|Physician Decision|0|||
130540460|NCT01468181|469945246|FG003|Overall Study|Physician Decision|1|||
130540461|NCT01468181|469945247|FG004|Overall Study|Physician Decision|1|||
130540462|NCT01468181|469945243|FG000|Overall Study|Lost to Follow-up|0|||
130540463|NCT01468181|469945244|FG001|Overall Study|Lost to Follow-up|0|||
130540464|NCT01468181|469945245|FG002|Overall Study|Lost to Follow-up|1|||
130540465|NCT01468181|469945246|FG003|Overall Study|Lost to Follow-up|0|||
130540466|NCT01468181|469945247|FG004|Overall Study|Lost to Follow-up|1|||
130586260|NCT00706628|470108758|FG000|Overall Study|Not treated|1|||
130586261|NCT00706628|470108759|FG001|Overall Study|Not treated|1|||
130586262|NCT00706628|470108760|FG002|Overall Study|Not treated|0|||
130586263|NCT00706628|470108761|FG003|Overall Study|Not treated|0|||
130586264|NCT02266433|470108766|FG000|Overall Study|Lost to Follow-up|54|||
130540467|NCT01468181|469945243|FG000|Overall Study|Withdrawal by Subject|0|||
130540468|NCT01468181|469945244|FG001|Overall Study|Withdrawal by Subject|1|||
130540469|NCT01468181|469945245|FG002|Overall Study|Withdrawal by Subject|0|||
130540470|NCT01468181|469945246|FG003|Overall Study|Withdrawal by Subject|0|||
130540471|NCT01468181|469945247|FG004|Overall Study|Withdrawal by Subject|0|||
130540472|NCT00320528|469945251|FG000|Study Period II|Adverse Event|3|||
130540473|NCT00320528|469945252|FG001|Study Period II|Adverse Event|4|||
130540474|NCT00320528|469945253|FG002|Study Period II|Adverse Event|8|||
130540475|NCT00320528|469945251|FG000|Study Period II|Parent/Caregiver Decision|8|||
130540476|NCT00320528|469945252|FG001|Study Period II|Parent/Caregiver Decision|3|||
130540477|NCT00320528|469945253|FG002|Study Period II|Parent/Caregiver Decision|11|||
130540478|NCT00320528|469945251|FG000|Study Period II|Withdrawal by Subject|0|||
130540479|NCT00320528|469945252|FG001|Study Period II|Withdrawal by Subject|1|||
130540480|NCT00320528|469945253|FG002|Study Period II|Withdrawal by Subject|1|||
130586265|NCT02266433|470108767|FG001|Overall Study|Lost to Follow-up|46|||
130586266|NCT02266433|470108766|FG000|Overall Study|Withdrawal by Subject|5|||
130586267|NCT02266433|470108767|FG001|Overall Study|Withdrawal by Subject|7|||
130586268|NCT04525703|470108771|FG000|Overall Study|Lost to Follow-up|6|||
130586269|NCT04525703|470108772|FG001|Overall Study|Lost to Follow-up|15|||
130586270|NCT04525703|470108773|FG002|Overall Study|Lost to Follow-up|8|||
130586271|NCT01285349|470108774|FG000|Overall Study|Lost to Follow-up|27|||
130586272|NCT01285349|470108775|FG001|Overall Study|Lost to Follow-up|20|||
130586273|NCT01285349|470108776|FG002|Overall Study|Lost to Follow-up|27|||
130586274|NCT00712348|470108777|FG000|Overall Study|Withdrawal by Subject|1|||
130586275|NCT01375764|470108779|FG000|Overall Study|Lost to Follow-up|0|||
130586276|NCT01375764|470108780|FG001|Overall Study|Lost to Follow-up|1|||
130586277|NCT01375764|470108781|FG002|Overall Study|Lost to Follow-up|0|||
130586278|NCT01375764|470108782|FG003|Overall Study|Lost to Follow-up|0|||
130586279|NCT01375764|470108783|FG004|Overall Study|Lost to Follow-up|0|||
130586280|NCT01375764|470108779|FG000|Overall Study|Withdrawal by Subject|2|||
130586281|NCT01375764|470108780|FG001|Overall Study|Withdrawal by Subject|0|||
130586282|NCT01375764|470108781|FG002|Overall Study|Withdrawal by Subject|0|||
130586283|NCT01375764|470108782|FG003|Overall Study|Withdrawal by Subject|0|||
130586284|NCT01375764|470108783|FG004|Overall Study|Withdrawal by Subject|1|||
130586285|NCT01375764|470108779|FG000|Overall Study|Other|0|||
130586286|NCT01375764|470108780|FG001|Overall Study|Other|0|||
130586287|NCT01375764|470108781|FG002|Overall Study|Other|0|||
130586288|NCT01375764|470108782|FG003|Overall Study|Other|1|||
130586289|NCT01375764|470108783|FG004|Overall Study|Other|0|||
130586290|NCT03595280|470108784|FG000|Overall Study|Lost to Follow-up|6|||
130586291|NCT03595280|470108785|FG001|Overall Study|Lost to Follow-up|9|||
130586292|NCT03595280|470108786|FG002|Overall Study|Lost to Follow-up|15|||
130586293|NCT01194440|470108787|FG000|Baseline (First Dose)|Reason not specified|4|||
130586294|NCT01194440|470108787|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
130586295|NCT01194440|470108787|FG000|Baseline (First Dose)|Change in therapy|1|||
130586296|NCT01194440|470108787|FG000|Baseline (First Dose)|Adverse Event|1|||
130586297|NCT01194440|470108787|FG000|6-months (2nd Dose)|Change in therapy|4|||
130586298|NCT00854828|470108788|FG000|Overall Study|Death|1|||
130586299|NCT00854828|470108789|FG001|Overall Study|Death|0|||
130586300|NCT00854828|470108790|FG002|Overall Study|Death|0|||
130586301|NCT00854828|470108791|FG003|Overall Study|Death|0|||
130586302|NCT00854828|470108788|FG000|Overall Study|Withdrawal by Subject|1|||
130586303|NCT00854828|470108789|FG001|Overall Study|Withdrawal by Subject|1|||
130586304|NCT00854828|470108790|FG002|Overall Study|Withdrawal by Subject|0|||
130586305|NCT00854828|470108791|FG003|Overall Study|Withdrawal by Subject|9|||
130586306|NCT00854828|470108788|FG000|Overall Study|Missed 24mo visit|1|||
130586307|NCT00854828|470108789|FG001|Overall Study|Missed 24mo visit|1|||
130586308|NCT00854828|470108790|FG002|Overall Study|Missed 24mo visit|8|||
130586309|NCT00854828|470108791|FG003|Overall Study|Missed 24mo visit|8|||
130586310|NCT04957290|470108793|FG000|Overall Study|Progressive disease|3|||
130586311|NCT04957290|470108794|FG001|Overall Study|Progressive disease|3|||
130586312|NCT04957290|470108795|FG002|Overall Study|Progressive disease|2|||
130586313|NCT04957290|470108796|FG003|Overall Study|Progressive disease|0|||
130586314|NCT04957290|470108797|FG004|Overall Study|Progressive disease|0|||
130586315|NCT04957290|470108798|FG005|Overall Study|Progressive disease|0|||
130586316|NCT04957290|470108793|FG000|Overall Study|Withdrawal by Subject|1|||
130586317|NCT04957290|470108794|FG001|Overall Study|Withdrawal by Subject|0|||
130586318|NCT04957290|470108795|FG002|Overall Study|Withdrawal by Subject|1|||
130586319|NCT04957290|470108796|FG003|Overall Study|Withdrawal by Subject|0|||
130586320|NCT04957290|470108797|FG004|Overall Study|Withdrawal by Subject|0|||
130586321|NCT04957290|470108798|FG005|Overall Study|Withdrawal by Subject|0|||
130586322|NCT04957290|470108793|FG000|Overall Study|Death|0|||
130586323|NCT04957290|470108794|FG001|Overall Study|Death|2|||
130586324|NCT04957290|470108795|FG002|Overall Study|Death|1|||
130586325|NCT04957290|470108796|FG003|Overall Study|Death|0|||
130586326|NCT04957290|470108797|FG004|Overall Study|Death|0|||
130586327|NCT04957290|470108798|FG005|Overall Study|Death|0|||
130586328|NCT04957290|470108793|FG000|Overall Study|non compliance with study drug|0|||
130586329|NCT04957290|470108794|FG001|Overall Study|non compliance with study drug|1|||
130586330|NCT04957290|470108795|FG002|Overall Study|non compliance with study drug|0|||
130586331|NCT04957290|470108796|FG003|Overall Study|non compliance with study drug|0|||
130586332|NCT04957290|470108797|FG004|Overall Study|non compliance with study drug|0|||
130586333|NCT04957290|470108798|FG005|Overall Study|non compliance with study drug|0|||
130586334|NCT04957290|470108793|FG000|Overall Study|none specified.|0|||
130586335|NCT04957290|470108794|FG001|Overall Study|none specified.|1|||
130586336|NCT04957290|470108795|FG002|Overall Study|none specified.|2|||
130586337|NCT04957290|470108796|FG003|Overall Study|none specified.|0|||
130586338|NCT04957290|470108797|FG004|Overall Study|none specified.|0|||
130586339|NCT04957290|470108798|FG005|Overall Study|none specified.|0|||
130586340|NCT04957290|470108793|FG000|Overall Study|unacceptable toxicity|0|||
130586341|NCT04957290|470108794|FG001|Overall Study|unacceptable toxicity|0|||
130586342|NCT04957290|470108795|FG002|Overall Study|unacceptable toxicity|1|||
130586343|NCT04957290|470108796|FG003|Overall Study|unacceptable toxicity|0|||
130586344|NCT04957290|470108797|FG004|Overall Study|unacceptable toxicity|0|||
130586345|NCT04957290|470108798|FG005|Overall Study|unacceptable toxicity|0|||
130586346|NCT04957290|470108793|FG000|Overall Study|Adverse Event|0|||
130586347|NCT04957290|470108794|FG001|Overall Study|Adverse Event|0|||
130586348|NCT04957290|470108795|FG002|Overall Study|Adverse Event|1|||
130586349|NCT04957290|470108796|FG003|Overall Study|Adverse Event|0|||
130586350|NCT04957290|470108797|FG004|Overall Study|Adverse Event|0|||
130586351|NCT04957290|470108798|FG005|Overall Study|Adverse Event|0|||
130586352|NCT04957290|470108793|FG000|Overall Study|study terminated by sponsor|0|||
130586353|NCT04957290|470108794|FG001|Overall Study|study terminated by sponsor|0|||
130586354|NCT04957290|470108795|FG002|Overall Study|study terminated by sponsor|2|||
130586355|NCT04957290|470108796|FG003|Overall Study|study terminated by sponsor|0|||
130586356|NCT04957290|470108797|FG004|Overall Study|study terminated by sponsor|0|||
130586357|NCT04957290|470108798|FG005|Overall Study|study terminated by sponsor|0|||
130586358|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586359|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586360|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586361|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
130586362|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586363|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
130586364|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586365|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586366|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586367|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586368|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586369|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586370|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586371|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586372|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586373|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586374|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586375|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586376|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586377|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586378|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586379|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586380|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130586381|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130586382|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
130586383|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130586384|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
130586385|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130586386|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130586387|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130586388|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586389|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586390|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586391|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586392|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586393|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586394|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586395|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586396|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586397|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586398|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586399|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586400|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586401|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586402|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586403|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130586404|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130586405|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
130586406|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130586407|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
130586408|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
130586409|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
130586410|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130586411|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130586412|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586413|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586414|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586415|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586416|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586417|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586418|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586419|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586420|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586421|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586422|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586423|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586424|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586425|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586426|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130586427|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586428|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586429|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
130586430|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586431|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
130586432|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586433|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586434|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586435|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586436|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586437|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586438|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586439|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586440|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586441|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586442|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586443|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586444|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586445|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586446|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586447|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586448|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586449|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130586450|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
130586451|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586452|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586453|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
130586454|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586455|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586456|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586457|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586458|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586459|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586460|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586461|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586462|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586463|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586464|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586465|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586466|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586467|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586468|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586469|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586470|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586471|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586472|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130586473|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586474|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586475|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
130586476|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586477|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586478|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586479|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586480|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130540481|NCT00320528|469945251|FG000|Study Period II|Entry Criteria Exclusion|0|||
130540482|NCT00320528|469945252|FG001|Study Period II|Entry Criteria Exclusion|2|||
130540483|NCT00320528|469945253|FG002|Study Period II|Entry Criteria Exclusion|2|||
130540484|NCT00320528|469945251|FG000|Study Period III|Adverse Event|1|||
130540485|NCT00320528|469945252|FG001|Study Period III|Adverse Event|0|||
130540486|NCT00320528|469945253|FG002|Study Period III|Adverse Event|0|||
130540487|NCT00320528|469945251|FG000|Study Period III|Lost to Follow-up|1|||
130540488|NCT00320528|469945252|FG001|Study Period III|Lost to Follow-up|0|||
130540489|NCT00320528|469945253|FG002|Study Period III|Lost to Follow-up|0|||
130540490|NCT00320528|469945251|FG000|Study Period III|Withdrawal by Subject|1|||
130540491|NCT00320528|469945252|FG001|Study Period III|Withdrawal by Subject|1|||
130586481|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586482|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130540492|NCT00320528|469945253|FG002|Study Period III|Withdrawal by Subject|2|||
130540493|NCT00320528|469945251|FG000|Study Period III|Lack of Efficacy|2|||
130540494|NCT00320528|469945252|FG001|Study Period III|Lack of Efficacy|0|||
130540495|NCT00320528|469945253|FG002|Study Period III|Lack of Efficacy|0|||
130540496|NCT00320528|469945251|FG000|Study Period III|Parent/Caregiver Decision|14|||
130540497|NCT00320528|469945252|FG001|Study Period III|Parent/Caregiver Decision|3|||
130540498|NCT00320528|469945253|FG002|Study Period III|Parent/Caregiver Decision|11|||
130540499|NCT00320528|469945251|FG000|Study Period III|Protocol Violation|0|||
130540500|NCT00320528|469945252|FG001|Study Period III|Protocol Violation|1|||
130540501|NCT00320528|469945253|FG002|Study Period III|Protocol Violation|0|||
130540502|NCT00320528|469945251|FG000|Study Period III|Physician Decision|0|||
130540503|NCT00320528|469945252|FG001|Study Period III|Physician Decision|1|||
130540504|NCT00320528|469945253|FG002|Study Period III|Physician Decision|2|||
130540505|NCT00320528|469945251|FG000|Study Period III|Sponsor Decision|0|||
130540506|NCT00320528|469945252|FG001|Study Period III|Sponsor Decision|0|||
130540507|NCT00320528|469945253|FG002|Study Period III|Sponsor Decision|1|||
130540508|NCT00320528|469945251|FG000|Study Period III|Atomoxetine Commercially Available|68|||
130540509|NCT00320528|469945252|FG001|Study Period III|Atomoxetine Commercially Available|25|||
130540510|NCT00320528|469945253|FG002|Study Period III|Atomoxetine Commercially Available|90|||
130540511|NCT04828837|469945254|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
130540512|NCT04828837|469945255|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
130540513|NCT04828837|469945254|FG000|Overall Study|Lost to Follow-up|2|||
130540514|NCT04828837|469945255|FG001|Overall Study|Lost to Follow-up|6|||
130540515|NCT04828837|469945254|FG000|Overall Study|Lack of Efficacy|1|||
130540516|NCT04828837|469945255|FG001|Overall Study|Lack of Efficacy|0|||
130540517|NCT04828837|469945254|FG000|Overall Study|Admitted due to pneumothorax.|1|||
130540518|NCT04828837|469945255|FG001|Overall Study|Admitted due to pneumothorax.|0|||
130540519|NCT04828837|469945254|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
130540520|NCT04828837|469945255|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
130540521|NCT00545753|469945256|FG000|Overall Study|Withdrawal by Subject|0|||
130540522|NCT00545753|469945257|FG001|Overall Study|Withdrawal by Subject|1|||
130540523|NCT00545753|469945258|FG002|Overall Study|Withdrawal by Subject|10|||
130540524|NCT00545753|469945256|FG000|Overall Study|Lost to Follow-up|13|||
130540525|NCT00545753|469945257|FG001|Overall Study|Lost to Follow-up|3|||
130540526|NCT00545753|469945258|FG002|Overall Study|Lost to Follow-up|12|||
130540527|NCT00545753|469945256|FG000|Overall Study|Protocol Violation|3|||
130540528|NCT00545753|469945257|FG001|Overall Study|Protocol Violation|1|||
130540529|NCT00545753|469945258|FG002|Overall Study|Protocol Violation|4|||
130540530|NCT01081132|469945265|FG000|Overall Study|Lack of Efficacy|25|||
130540531|NCT01081132|469945266|FG001|Overall Study|Lack of Efficacy|9|||
130540532|NCT01081132|469945265|FG000|Overall Study|Withdrawal by Subject|13|||
130540533|NCT01081132|469945266|FG001|Overall Study|Withdrawal by Subject|16|||
130540534|NCT01081132|469945265|FG000|Overall Study|Lost to Follow-up|4|||
130540535|NCT01081132|469945266|FG001|Overall Study|Lost to Follow-up|11|||
130540536|NCT01081132|469945265|FG000|Overall Study|Adverse Event|3|||
130540537|NCT01081132|469945266|FG001|Overall Study|Adverse Event|9|||
130540538|NCT01081132|469945265|FG000|Overall Study|Non Compliance|4|||
130540539|NCT01081132|469945266|FG001|Overall Study|Non Compliance|2|||
130540540|NCT01081132|469945265|FG000|Overall Study|Lack Of Compliance|0|||
130540541|NCT01081132|469945266|FG001|Overall Study|Lack Of Compliance|1|||
130586483|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586484|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586485|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130540542|NCT01081132|469945265|FG000|Overall Study|Missed Visits|1|||
130540543|NCT01081132|469945266|FG001|Overall Study|Missed Visits|1|||
130540544|NCT01081132|469945265|FG000|Overall Study|Stopped Taking Meds|2|||
130540545|NCT01081132|469945266|FG001|Overall Study|Stopped Taking Meds|0|||
130540546|NCT01081132|469945265|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
130540547|NCT01081132|469945266|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
130540548|NCT01081132|469945265|FG000|Overall Study|Declined Taper Phase|0|||
130540549|NCT01081132|469945266|FG001|Overall Study|Declined Taper Phase|1|||
130540550|NCT01081132|469945265|FG000|Overall Study|Protocol Violation|3|||
130540551|NCT01081132|469945266|FG001|Overall Study|Protocol Violation|1|||
130540552|NCT02297139|469945267|FG000|Overall Study|Disease progression|0|||
130540553|NCT02297139|469945268|FG001|Overall Study|Disease progression|1|||
130540554|NCT02297139|469945267|FG000|Overall Study|Study drug toxicity|0|||
130540555|NCT02297139|469945268|FG001|Overall Study|Study drug toxicity|4|||
130540556|NCT02297139|469945267|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130540557|NCT02297139|469945268|FG001|Overall Study|Participant request to discontinue study treatment|1|||
130540558|NCT02297139|469945267|FG000|Overall Study|Maximum clinical benefit|1|||
130540559|NCT02297139|469945268|FG001|Overall Study|Maximum clinical benefit|0|||
130540560|NCT02297139|469945267|FG000|Overall Study|Administrative reason by sponsor|0|||
130540561|NCT02297139|469945268|FG001|Overall Study|Administrative reason by sponsor|2|||
130540562|NCT02297139|469945267|FG000|Overall Study|Other reasons|0|||
130540563|NCT02297139|469945268|FG001|Overall Study|Other reasons|8|||
130540564|NCT02101385|469945269|FG000|Study Treatment|Disease Progression|9|||
130540565|NCT02101385|469945270|FG001|Study Treatment|Disease Progression|3|||
130540566|NCT02101385|469945269|FG000|Study Treatment|Alternative therapy|0|||
130540567|NCT02101385|469945270|FG001|Study Treatment|Alternative therapy|1|||
130540568|NCT02101385|469945269|FG000|Study Treatment|No treatment, per protocol criteria|0|||
130540569|NCT02101385|469945270|FG001|Study Treatment|No treatment, per protocol criteria|4|||
130540570|NCT02101385|469945269|FG000|Study Treatment|Patient Non compliance|0|||
130540571|NCT02101385|469945270|FG001|Study Treatment|Patient Non compliance|2|||
130540572|NCT02101385|469945269|FG000|Study Treatment|Withdrawal by Subject|5|||
130540573|NCT02101385|469945270|FG001|Study Treatment|Withdrawal by Subject|2|||
130540574|NCT02101385|469945269|FG000|Study Treatment|screen failure|1|||
130540575|NCT02101385|469945270|FG001|Study Treatment|screen failure|0|||
130540576|NCT02101385|469945269|FG000|Study Treatment|AE/Side Effects/Complications|8|||
130540577|NCT02101385|469945270|FG001|Study Treatment|AE/Side Effects/Complications|0|||
130540578|NCT02101385|469945269|FG000|Study Treatment|Lost to Follow-up|1|||
130540579|NCT02101385|469945270|FG001|Study Treatment|Lost to Follow-up|0|||
130540580|NCT02101385|469945269|FG000|Study Treatment|Disease Progression before treatment|1|||
130540581|NCT02101385|469945270|FG001|Study Treatment|Disease Progression before treatment|0|||
130540582|NCT02101385|469945269|FG000|Study Treatment|Death|1|||
130540583|NCT02101385|469945270|FG001|Study Treatment|Death|0|||
130540584|NCT02101385|469945269|FG000|Follow up|Lost to Follow-up|4|||
130540585|NCT02101385|469945270|FG001|Follow up|Lost to Follow-up|9|||
130540586|NCT02101385|469945269|FG000|Follow up|Refused to follow up|5|||
130540587|NCT02101385|469945270|FG001|Follow up|Refused to follow up|4|||
130540588|NCT02101385|469945269|FG000|Follow up|Death|21|||
130540589|NCT02101385|469945270|FG001|Follow up|Death|39|||
130540590|NCT02101385|469945269|FG000|Follow up|study completed|33|||
130540591|NCT02101385|469945270|FG001|Follow up|study completed|52|||
130540592|NCT02101385|469945269|FG000|Follow up|screen failure|2|||
130540593|NCT02101385|469945270|FG001|Follow up|screen failure|0|||
130540594|NCT02101385|469945269|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
130540595|NCT02101385|469945270|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
130540596|NCT02101385|469945269|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
130540597|NCT02101385|469945270|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
130540598|NCT02101385|469945269|FG000|Follow up|Withdrawal by Subject|2|||
130540599|NCT02101385|469945270|FG001|Follow up|Withdrawal by Subject|2|||
130540600|NCT02101385|469945269|FG000|Follow up|PI requested closure of site|0|||
130540601|NCT02101385|469945270|FG001|Follow up|PI requested closure of site|5|||
130540602|NCT02432196|469945271|FG000|Overall Study|Exit - did not receive study device|1|||
130540603|NCT02432196|469945271|FG000|Overall Study|Death|2|||
130540604|NCT02432196|469945271|FG000|Overall Study|Reoperation|3|||
130540605|NCT01942785|469945272|FG000|Overall Study|Adverse Event|2|||
130540606|NCT01942785|469945272|FG000|Overall Study|Withdrawal by Subject|1|||
130540607|NCT01942785|469945272|FG000|Overall Study|Protocol Violation|1|||
130540608|NCT01905150|469945273|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
130540609|NCT01905150|469945274|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
130540610|NCT03762200|469945279|FG000|Overall Study|Death|2|||
130540611|NCT02631577|469945280|FG000|Overall Study|Death|1|||
130540612|NCT02631577|469945281|FG001|Overall Study|Death|7|||
130540613|NCT02631577|469945280|FG000|Overall Study|Withdrawal by Subject|0|||
130586486|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130540614|NCT02631577|469945281|FG001|Overall Study|Withdrawal by Subject|3|||
130540615|NCT01593787|469945282|FG000|Overall Study|Adverse Event|1|||
130540616|NCT01593787|469945283|FG001|Overall Study|Adverse Event|0|||
130540617|NCT01593787|469945284|FG002|Overall Study|Adverse Event|0|||
130540618|NCT03981861|469945290|FG000|Overall Study|Withdrawal by Subject|3|||
130540619|NCT05618912|469945291|FG000|Overall Study|Lost to Follow-up|14|||
130586487|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586488|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586489|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586490|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586491|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586492|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586493|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586494|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586495|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130586496|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586497|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586498|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
130586499|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586500|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586501|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586502|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586503|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586504|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586505|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586506|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586507|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586508|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586509|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586510|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586511|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586512|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586513|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586514|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586515|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586516|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586517|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586518|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130586519|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586520|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586521|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586522|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
130586523|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586524|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586525|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586526|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586527|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586528|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586529|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586530|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586531|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586532|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586533|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586534|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586535|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586536|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586537|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586538|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586539|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586540|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586541|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130586542|NCT00896532|470108799|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586543|NCT00896532|470108800|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130586544|NCT00896532|470108801|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130540620|NCT05618912|469945292|FG001|Overall Study|Lost to Follow-up|19|||
130540621|NCT01022112|469945293|FG000|Overall Study|Adverse Event|1|||
130540622|NCT01022112|469945294|FG001|Overall Study|Adverse Event|2|||
130540623|NCT01022112|469945295|FG002|Overall Study|Adverse Event|0|||
130540624|NCT01022112|469945296|FG003|Overall Study|Adverse Event|1|||
130540625|NCT01022112|469945297|FG004|Overall Study|Adverse Event|0|||
130540626|NCT01022112|469945293|FG000|Overall Study|Lack of Efficacy|1|||
130540627|NCT01022112|469945294|FG001|Overall Study|Lack of Efficacy|0|||
130540628|NCT01022112|469945295|FG002|Overall Study|Lack of Efficacy|0|||
130540629|NCT01022112|469945296|FG003|Overall Study|Lack of Efficacy|0|||
130540630|NCT01022112|469945297|FG004|Overall Study|Lack of Efficacy|1|||
130540631|NCT01022112|469945293|FG000|Overall Study|Physician Decision|0|||
130540632|NCT01022112|469945294|FG001|Overall Study|Physician Decision|0|||
130540633|NCT01022112|469945295|FG002|Overall Study|Physician Decision|1|||
130540634|NCT01022112|469945296|FG003|Overall Study|Physician Decision|0|||
130540635|NCT01022112|469945297|FG004|Overall Study|Physician Decision|1|||
130540636|NCT01022112|469945293|FG000|Overall Study|Withdrawal by Subject|0|||
130540637|NCT01022112|469945294|FG001|Overall Study|Withdrawal by Subject|1|||
130540638|NCT01022112|469945295|FG002|Overall Study|Withdrawal by Subject|2|||
130540639|NCT01022112|469945296|FG003|Overall Study|Withdrawal by Subject|2|||
130540640|NCT01022112|469945297|FG004|Overall Study|Withdrawal by Subject|1|||
130540641|NCT01022112|469945293|FG000|Overall Study|Fasting plasma glucose level increased|1|||
130586545|NCT00896532|470108802|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130586546|NCT00896532|470108803|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130586547|NCT00896532|470108804|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586548|NCT00896532|470108805|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586549|NCT00896532|470108806|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586550|NCT00896532|470108807|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586551|NCT00896532|470108808|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586552|NCT00896532|470108809|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586553|NCT00896532|470108810|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586554|NCT00896532|470108811|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586555|NCT00896532|470108812|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586556|NCT00896532|470108813|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586557|NCT00896532|470108814|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586558|NCT00896532|470108815|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586559|NCT00896532|470108816|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586560|NCT00896532|470108817|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586561|NCT00896532|470108818|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586562|NCT00896532|470108819|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586563|NCT00896532|470108820|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586564|NCT00896532|470108821|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130586565|NCT00896532|470108799|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586566|NCT00896532|470108800|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586567|NCT00896532|470108801|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586568|NCT00896532|470108802|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586569|NCT00896532|470108803|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586570|NCT00896532|470108804|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586571|NCT00896532|470108805|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586572|NCT00896532|470108806|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586573|NCT00896532|470108807|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
130586574|NCT00896532|470108808|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130540642|NCT01022112|469945294|FG001|Overall Study|Fasting plasma glucose level increased|0|||
130540643|NCT01022112|469945295|FG002|Overall Study|Fasting plasma glucose level increased|0|||
130540644|NCT01022112|469945296|FG003|Overall Study|Fasting plasma glucose level increased|0|||
130540645|NCT01022112|469945297|FG004|Overall Study|Fasting plasma glucose level increased|7|||
130586575|NCT00896532|470108809|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586576|NCT00896532|470108810|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586577|NCT00896532|470108811|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586578|NCT00896532|470108812|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586579|NCT00896532|470108813|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586580|NCT00896532|470108814|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586581|NCT00896532|470108815|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586582|NCT00896532|470108816|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586583|NCT00896532|470108817|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586584|NCT00896532|470108818|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586585|NCT00896532|470108819|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586586|NCT00896532|470108820|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586587|NCT00896532|470108821|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130586588|NCT00896532|470108799|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586589|NCT00896532|470108800|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586590|NCT00896532|470108801|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586591|NCT00896532|470108802|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586592|NCT00896532|470108803|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586593|NCT00896532|470108804|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586594|NCT00896532|470108805|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586595|NCT00896532|470108806|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586596|NCT00896532|470108807|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586597|NCT00896532|470108808|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586598|NCT00896532|470108809|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586599|NCT00896532|470108810|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586600|NCT00896532|470108811|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
130586601|NCT00896532|470108812|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586602|NCT00896532|470108813|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586603|NCT00896532|470108814|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586604|NCT00896532|470108815|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586605|NCT00896532|470108816|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586606|NCT00896532|470108817|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586607|NCT00896532|470108818|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586608|NCT00896532|470108819|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586609|NCT00896532|470108820|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586610|NCT00896532|470108821|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130586611|NCT00896532|470108799|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586612|NCT00896532|470108800|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586613|NCT00896532|470108801|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586614|NCT00896532|470108802|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586615|NCT00896532|470108803|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586616|NCT00896532|470108804|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586617|NCT00896532|470108805|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586618|NCT00896532|470108806|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586619|NCT00896532|470108807|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586620|NCT00896532|470108808|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586621|NCT00896532|470108809|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
130586622|NCT00896532|470108810|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586623|NCT00896532|470108811|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
130586624|NCT00896532|470108812|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586625|NCT00896532|470108813|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586626|NCT00896532|470108814|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586627|NCT00896532|470108815|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586628|NCT00896532|470108816|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586629|NCT00896532|470108817|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586630|NCT00896532|470108818|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586631|NCT00896532|470108819|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586632|NCT00896532|470108820|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586633|NCT00896532|470108821|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130586634|NCT00896532|470108799|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586635|NCT00896532|470108800|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586636|NCT00896532|470108801|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586637|NCT00896532|470108802|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586638|NCT00896532|470108803|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586639|NCT00896532|470108804|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586640|NCT00896532|470108805|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586641|NCT00896532|470108806|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586642|NCT00896532|470108807|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586643|NCT00896532|470108808|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586644|NCT00896532|470108809|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586645|NCT00896532|470108810|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586646|NCT00896532|470108811|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
130586647|NCT00896532|470108812|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
130586648|NCT00896532|470108813|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586649|NCT00896532|470108814|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586650|NCT00896532|470108815|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586651|NCT00896532|470108816|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586652|NCT00896532|470108817|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586653|NCT00896532|470108818|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586654|NCT00896532|470108819|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586655|NCT00896532|470108820|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586656|NCT00896532|470108821|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130586657|NCT00896532|470108799|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
130586658|NCT00896532|470108800|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
130586659|NCT00896532|470108801|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
130586660|NCT00896532|470108802|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
130586661|NCT00896532|470108803|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
130586662|NCT00896532|470108804|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
130586663|NCT00896532|470108805|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
130586664|NCT00896532|470108806|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
130586665|NCT00896532|470108807|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
130586666|NCT00896532|470108808|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
130586667|NCT00896532|470108809|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
130586668|NCT00896532|470108810|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
130586669|NCT00896532|470108811|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
130586670|NCT00896532|470108812|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
130586671|NCT00896532|470108813|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
130586672|NCT00896532|470108814|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
130586673|NCT00896532|470108815|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
130586674|NCT00896532|470108816|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
130586675|NCT00896532|470108817|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
130586676|NCT00896532|470108818|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
130586677|NCT00896532|470108819|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
130586678|NCT00896532|470108820|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
130586679|NCT00896532|470108821|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
130586680|NCT00896532|470108799|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586681|NCT00896532|470108800|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586682|NCT00896532|470108801|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586683|NCT00896532|470108802|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586684|NCT00896532|470108803|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586685|NCT00896532|470108804|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586686|NCT00896532|470108805|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586687|NCT00896532|470108806|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586688|NCT00896532|470108807|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586689|NCT00896532|470108808|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586690|NCT00896532|470108809|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586691|NCT00896532|470108810|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586692|NCT00896532|470108811|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586693|NCT00896532|470108812|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586694|NCT00896532|470108813|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586695|NCT00896532|470108814|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
130586696|NCT00896532|470108815|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
130586697|NCT00896532|470108816|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586698|NCT00896532|470108817|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586699|NCT00896532|470108818|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586700|NCT00896532|470108819|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586701|NCT00896532|470108820|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586702|NCT00896532|470108821|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130586703|NCT00896532|470108799|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586704|NCT00896532|470108800|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586705|NCT00896532|470108801|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586706|NCT00896532|470108802|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586707|NCT00896532|470108803|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586708|NCT00896532|470108804|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586709|NCT00896532|470108805|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586710|NCT00896532|470108806|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586711|NCT00896532|470108807|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586712|NCT00896532|470108808|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586713|NCT00896532|470108809|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586714|NCT00896532|470108810|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586715|NCT00896532|470108811|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586716|NCT00896532|470108812|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586717|NCT00896532|470108813|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586718|NCT00896532|470108814|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
130586719|NCT00896532|470108815|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
130586720|NCT00896532|470108816|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
130586721|NCT00896532|470108817|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586722|NCT00896532|470108818|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586723|NCT00896532|470108819|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586724|NCT00896532|470108820|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586725|NCT00896532|470108821|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130586726|NCT00896532|470108799|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586727|NCT00896532|470108800|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586728|NCT00896532|470108801|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586729|NCT00896532|470108802|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586730|NCT00896532|470108803|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586731|NCT00896532|470108804|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586732|NCT00896532|470108805|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586733|NCT00896532|470108806|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586734|NCT00896532|470108807|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586735|NCT00896532|470108808|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586736|NCT00896532|470108809|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586737|NCT00896532|470108810|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586738|NCT00896532|470108811|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586739|NCT00896532|470108812|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586740|NCT00896532|470108813|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586741|NCT00896532|470108814|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586742|NCT00896532|470108815|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
130586743|NCT00896532|470108816|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586744|NCT00896532|470108817|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586745|NCT00896532|470108818|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586746|NCT00896532|470108819|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586747|NCT00896532|470108820|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586748|NCT00896532|470108821|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130586749|NCT00896532|470108799|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
130586750|NCT00896532|470108800|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
130586751|NCT00896532|470108801|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
130586752|NCT00896532|470108802|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
130586753|NCT00896532|470108803|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
130586754|NCT00896532|470108804|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
130586755|NCT00896532|470108805|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
130586756|NCT00896532|470108806|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
130586757|NCT00896532|470108807|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
130586758|NCT00896532|470108808|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
130586759|NCT00896532|470108809|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
130586760|NCT00896532|470108810|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
130586761|NCT00896532|470108811|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
130586762|NCT00896532|470108812|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
130586763|NCT00896532|470108813|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
130586764|NCT00896532|470108814|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
130586765|NCT00896532|470108815|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
130586766|NCT00896532|470108816|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
130586767|NCT00896532|470108817|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
130586768|NCT00896532|470108818|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
130586769|NCT00896532|470108819|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
130586770|NCT00896532|470108820|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
130586771|NCT00896532|470108821|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
130586772|NCT00896532|470108799|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586773|NCT00896532|470108800|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586774|NCT00896532|470108801|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586775|NCT00896532|470108802|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586776|NCT00896532|470108803|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586777|NCT00896532|470108804|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586778|NCT00896532|470108805|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586779|NCT00896532|470108806|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586780|NCT00896532|470108807|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586781|NCT00896532|470108808|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586782|NCT00896532|470108809|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586783|NCT00896532|470108810|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586784|NCT00896532|470108811|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586785|NCT00896532|470108812|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586786|NCT00896532|470108813|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586787|NCT00896532|470108814|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586788|NCT00896532|470108815|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
130586789|NCT00896532|470108816|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586790|NCT00896532|470108817|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586791|NCT00896532|470108818|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586792|NCT00896532|470108819|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586793|NCT00896532|470108820|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586794|NCT00896532|470108821|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130586795|NCT00896532|470108799|FG000|Months 48-72: Follow-on Phase|Death|0|||
130586796|NCT00896532|470108800|FG001|Months 48-72: Follow-on Phase|Death|0|||
130586797|NCT00896532|470108801|FG002|Months 48-72: Follow-on Phase|Death|0|||
130586798|NCT00896532|470108802|FG003|Months 48-72: Follow-on Phase|Death|0|||
130586799|NCT00896532|470108803|FG004|Months 48-72: Follow-on Phase|Death|0|||
130586800|NCT00896532|470108804|FG005|Months 48-72: Follow-on Phase|Death|0|||
130586801|NCT00896532|470108805|FG006|Months 48-72: Follow-on Phase|Death|0|||
130586802|NCT00896532|470108806|FG007|Months 48-72: Follow-on Phase|Death|0|||
130586803|NCT00896532|470108807|FG008|Months 48-72: Follow-on Phase|Death|0|||
130586804|NCT00896532|470108808|FG009|Months 48-72: Follow-on Phase|Death|0|||
130586805|NCT00896532|470108809|FG010|Months 48-72: Follow-on Phase|Death|0|||
130586806|NCT00896532|470108810|FG011|Months 48-72: Follow-on Phase|Death|0|||
130586807|NCT00896532|470108811|FG012|Months 48-72: Follow-on Phase|Death|0|||
130586808|NCT00896532|470108812|FG013|Months 48-72: Follow-on Phase|Death|0|||
130586809|NCT00896532|470108813|FG014|Months 48-72: Follow-on Phase|Death|0|||
130586810|NCT00896532|470108814|FG015|Months 48-72: Follow-on Phase|Death|0|||
130586811|NCT00896532|470108815|FG016|Months 48-72: Follow-on Phase|Death|0|||
130586812|NCT00896532|470108816|FG017|Months 48-72: Follow-on Phase|Death|0|||
130586813|NCT00896532|470108817|FG018|Months 48-72: Follow-on Phase|Death|1|||
130586814|NCT00896532|470108818|FG019|Months 48-72: Follow-on Phase|Death|0|||
130586815|NCT00896532|470108819|FG020|Months 48-72: Follow-on Phase|Death|0|||
130586816|NCT00896532|470108820|FG021|Months 48-72: Follow-on Phase|Death|0|||
130586817|NCT00896532|470108821|FG022|Months 48-72: Follow-on Phase|Death|0|||
130586818|NCT00896532|470108799|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586819|NCT00896532|470108800|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586820|NCT00896532|470108801|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586821|NCT00896532|470108802|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586822|NCT00896532|470108803|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586823|NCT00896532|470108804|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586824|NCT00896532|470108805|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586825|NCT00896532|470108806|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586826|NCT00896532|470108807|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586827|NCT00896532|470108808|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586828|NCT00896532|470108809|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586829|NCT00896532|470108810|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586830|NCT00896532|470108811|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586831|NCT00896532|470108812|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586832|NCT00896532|470108813|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586833|NCT00896532|470108814|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586834|NCT00896532|470108815|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586835|NCT00896532|470108816|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586836|NCT00896532|470108817|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586837|NCT00896532|470108818|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586838|NCT00896532|470108819|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586839|NCT00896532|470108820|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
130586840|NCT00896532|470108821|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130586841|NCT00896532|470108799|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586842|NCT00896532|470108800|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586843|NCT00896532|470108801|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586844|NCT00896532|470108802|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586845|NCT00896532|470108803|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586846|NCT00896532|470108804|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586847|NCT00896532|470108805|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586848|NCT00896532|470108806|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586849|NCT00896532|470108807|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586850|NCT00896532|470108808|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586851|NCT00896532|470108809|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586852|NCT00896532|470108810|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586853|NCT00896532|470108811|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586854|NCT00896532|470108812|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586855|NCT00896532|470108813|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586856|NCT00896532|470108814|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586857|NCT00896532|470108815|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586858|NCT00896532|470108816|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586859|NCT00896532|470108817|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586860|NCT00896532|470108818|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586861|NCT00896532|470108819|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586862|NCT00896532|470108820|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
130586863|NCT00896532|470108821|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130586864|NCT02149810|470108822|FG000|Overall Study|Physician Decision|1|||
130586865|NCT02149810|470108823|FG001|Overall Study|Physician Decision|2|||
130586866|NCT02149810|470108822|FG000|Overall Study|Lost to Follow-up|2|||
130586867|NCT02149810|470108823|FG001|Overall Study|Lost to Follow-up|1|||
130586868|NCT02149810|470108822|FG000|Overall Study|Withdrawal by Subject|5|||
130586869|NCT02149810|470108823|FG001|Overall Study|Withdrawal by Subject|1|||
130586870|NCT01176916|470108824|FG000|Overall Study|Adverse Event|61|||
130586871|NCT01176916|470108824|FG000|Overall Study|Death|1|||
130586872|NCT01176916|470108824|FG000|Overall Study|Lost to Follow-up|15|||
130586873|NCT01176916|470108824|FG000|Overall Study|Objective progression or relapse|17|||
130586874|NCT01176916|470108824|FG000|Overall Study|Protocol Violation|24|||
130586875|NCT01176916|470108824|FG000|Overall Study|Withdrawal by Subject|37|||
130586876|NCT01176916|470108824|FG000|Overall Study|Other|6|||
130586877|NCT01176916|470108824|FG000|Overall Study|Withdrawal prior to Treatment|6|||
130586878|NCT03158220|470108825|FG000|Overall Study|Screen Failure|0|||
130586879|NCT03158220|470108826|FG001|Overall Study|Screen Failure|1|||
130586880|NCT03158220|470108825|FG000|Overall Study|Withdrawal by Subject|8|||
130586881|NCT03158220|470108826|FG001|Overall Study|Withdrawal by Subject|9|||
130586882|NCT03158220|470108825|FG000|Overall Study|Status unknown|0|||
130586883|NCT03158220|470108826|FG001|Overall Study|Status unknown|1|||
130586884|NCT03158220|470108825|FG000|Overall Study|Lost to Follow-up|8|||
130586885|NCT03158220|470108826|FG001|Overall Study|Lost to Follow-up|5|||
130586886|NCT03158220|470108825|FG000|Overall Study|Physician Decision|1|||
130586887|NCT03158220|470108826|FG001|Overall Study|Physician Decision|0|||
130586888|NCT01015833|470108827|FG000|Overall Study|Death|1|||
130586889|NCT01015833|470108828|FG001|Overall Study|Death|0|||
130586890|NCT01015833|470108827|FG000|Overall Study|Withdrawal by Subject|3|||
130586891|NCT01015833|470108828|FG001|Overall Study|Withdrawal by Subject|2|||
130586892|NCT01015833|470108827|FG000|Overall Study|Adverse Event|0|||
130586893|NCT01015833|470108828|FG001|Overall Study|Adverse Event|1|||
130586894|NCT01015833|470108827|FG000|Overall Study|Physician Decision|2|||
130586895|NCT01015833|470108828|FG001|Overall Study|Physician Decision|0|||
130586896|NCT01015833|470108827|FG000|Overall Study|Symptomatic deterioration|0|||
130586897|NCT01015833|470108828|FG001|Overall Study|Symptomatic deterioration|1|||
130586898|NCT01015833|470108827|FG000|Overall Study|Other|5|||
130586899|NCT01015833|470108828|FG001|Overall Study|Other|1|||
130586900|NCT01015833|470108827|FG000|Overall Study|Motor Vehicle Accidents|1|||
130586901|NCT01015833|470108828|FG001|Overall Study|Motor Vehicle Accidents|0|||
130586902|NCT01015833|470108827|FG000|Overall Study|Did not start treatment|1|||
130586903|NCT01015833|470108828|FG001|Overall Study|Did not start treatment|0|||
130586904|NCT01671280|470108829|FG000|Overall Study|Withdrawal by Subject|2|||
130586905|NCT01959165|470108830|FG000|Overall Study|Adverse Event|0|||
130586906|NCT01959165|470108831|FG001|Overall Study|Adverse Event|0|||
130586907|NCT01959165|470108832|FG002|Overall Study|Adverse Event|0|||
130586908|NCT01959165|470108833|FG003|Overall Study|Adverse Event|1|||
130586909|NCT01959165|470108830|FG000|Overall Study|Lack of Efficacy|1|||
130586910|NCT01959165|470108831|FG001|Overall Study|Lack of Efficacy|0|||
130586911|NCT01959165|470108832|FG002|Overall Study|Lack of Efficacy|0|||
130586912|NCT01959165|470108833|FG003|Overall Study|Lack of Efficacy|0|||
130586913|NCT01959165|470108830|FG000|Overall Study|overdose|0|||
130586914|NCT01959165|470108831|FG001|Overall Study|overdose|0|||
130586915|NCT01959165|470108832|FG002|Overall Study|overdose|0|||
130586916|NCT01959165|470108833|FG003|Overall Study|overdose|1|||
130586917|NCT01959165|470108830|FG000|Overall Study|Welfare recipient|0|||
130586918|NCT01959165|470108831|FG001|Overall Study|Welfare recipient|1|||
130586919|NCT01959165|470108832|FG002|Overall Study|Welfare recipient|0|||
130586920|NCT01959165|470108833|FG003|Overall Study|Welfare recipient|0|||
130586921|NCT00927563|470108846|FG000|Overall Study|Lost to Follow-up|1|||
130586922|NCT00927563|470108846|FG000|Overall Study|Withdrawal by Subject|1|||
130586923|NCT02899156|470108847|FG000|Overall Study|Death|1|||
130586924|NCT02899156|470108848|FG001|Overall Study|Death|0|||
130586925|NCT02899156|470108847|FG000|Overall Study|Physician Decision|0|||
130586926|NCT02899156|470108848|FG001|Overall Study|Physician Decision|1|||
130586927|NCT00787787|470108854|FG000|Overall Study|Lack of Efficacy|4|||
130586928|NCT00787787|470108854|FG000|Overall Study|Adverse Event|3|||
130586929|NCT01468987|470108855|FG000|Overall Study|Adverse Event|12|||
130586930|NCT01468987|470108856|FG001|Overall Study|Adverse Event|9|||
130586931|NCT01468987|470108855|FG000|Overall Study|Death|4|||
130586932|NCT01468987|470108856|FG001|Overall Study|Death|1|||
130586933|NCT01468987|470108855|FG000|Overall Study|Lost to Follow-up|10|||
130586934|NCT01468987|470108856|FG001|Overall Study|Lost to Follow-up|5|||
130586935|NCT01468987|470108855|FG000|Overall Study|Protocol Violation|8|||
130586936|NCT01468987|470108856|FG001|Overall Study|Protocol Violation|2|||
130586937|NCT01468987|470108855|FG000|Overall Study|Withdrawal by Subject|28|||
130586938|NCT01468987|470108856|FG001|Overall Study|Withdrawal by Subject|28|||
130586939|NCT01468987|470108855|FG000|Overall Study|Physician Decision|8|||
130586940|NCT01468987|470108856|FG001|Overall Study|Physician Decision|15|||
130586941|NCT01468987|470108855|FG000|Overall Study|Sponsor Decision|1|||
130586942|NCT01468987|470108856|FG001|Overall Study|Sponsor Decision|0|||
130586943|NCT05032950|470108858|FG000|Overall Study|Adverse Event|0|||
130586944|NCT05032950|470108859|FG001|Overall Study|Adverse Event|0|||
130586945|NCT05032950|470108860|FG002|Overall Study|Adverse Event|1|||
130586946|NCT05032950|470108861|FG003|Overall Study|Adverse Event|1|||
130586947|NCT05032950|470108862|FG004|Overall Study|Adverse Event|0|||
130586948|NCT05032950|470108863|FG005|Overall Study|Adverse Event|0|||
130586949|NCT02959814|470108865|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
130586950|NCT02959814|470108865|FG000|Overall Study|Excluded based on anatomical criteria|2|||
130586951|NCT02959814|470108865|FG000|Overall Study|Protocol Violation|7|||
130586952|NCT02959814|470108865|FG000|Overall Study|FFR not measured|2|||
130586953|NCT02959814|470108865|FG000|Overall Study|In-procedure QFR not computed|6|||
130586954|NCT02959814|470108865|FG000|Overall Study|Excluded by FFR core-lab|24|||
130586955|NCT01245673|470108868|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
130586956|NCT01929135|470108870|FG000|Overall Study|Lost to Follow-up|1|||
130586957|NCT01929135|470108871|FG001|Overall Study|Lost to Follow-up|1|||
130586958|NCT02425098|470108872|FG000|Overall Study|Lost to Follow-up|7|||
130586959|NCT02425098|470108873|FG001|Overall Study|Lost to Follow-up|7|||
130586960|NCT02425098|470108872|FG000|Overall Study|Withdrawal by Subject|4|||
130586961|NCT02425098|470108873|FG001|Overall Study|Withdrawal by Subject|8|||
130586962|NCT02425098|470108872|FG000|Overall Study|Pregnancy|2|||
130586963|NCT02425098|470108873|FG001|Overall Study|Pregnancy|0|||
130586964|NCT02425098|470108872|FG000|Overall Study|Reason not Specified|0|||
130586965|NCT02425098|470108873|FG001|Overall Study|Reason not Specified|1|||
130586966|NCT02078219|470108874|FG000|Overall Study|Other|2|||
130586967|NCT02078219|470108875|FG001|Overall Study|Other|2|||
130586968|NCT02078219|470108876|FG002|Overall Study|Other|3|||
130586969|NCT02078219|470108877|FG003|Overall Study|Other|0|||
130586970|NCT02078219|470108878|FG004|Overall Study|Other|1|||
130586971|NCT02078219|470108874|FG000|Overall Study|Withdrawal by Subject|0|||
130586972|NCT02078219|470108875|FG001|Overall Study|Withdrawal by Subject|1|||
130586973|NCT02078219|470108876|FG002|Overall Study|Withdrawal by Subject|0|||
130586974|NCT02078219|470108877|FG003|Overall Study|Withdrawal by Subject|1|||
130586975|NCT02078219|470108878|FG004|Overall Study|Withdrawal by Subject|1|||
130586976|NCT02078219|470108874|FG000|Overall Study|Protocol Violation|0|||
130586977|NCT02078219|470108875|FG001|Overall Study|Protocol Violation|0|||
130586978|NCT02078219|470108876|FG002|Overall Study|Protocol Violation|0|||
130586979|NCT02078219|470108877|FG003|Overall Study|Protocol Violation|1|||
130586980|NCT02078219|470108878|FG004|Overall Study|Protocol Violation|0|||
130586981|NCT02078219|470108874|FG000|Overall Study|Death|0|||
130586982|NCT02078219|470108875|FG001|Overall Study|Death|0|||
130586983|NCT02078219|470108876|FG002|Overall Study|Death|0|||
130586984|NCT02078219|470108877|FG003|Overall Study|Death|1|||
130586985|NCT02078219|470108878|FG004|Overall Study|Death|0|||
130586986|NCT02078219|470108874|FG000|Overall Study|Adverse Event|1|||
130586987|NCT02078219|470108875|FG001|Overall Study|Adverse Event|1|||
130586988|NCT02078219|470108876|FG002|Overall Study|Adverse Event|3|||
130586989|NCT02078219|470108877|FG003|Overall Study|Adverse Event|1|||
130586990|NCT02078219|470108878|FG004|Overall Study|Adverse Event|0|||
130586991|NCT00127127|470110433|FG000|Overall Study|Adverse Event|0|||
130586992|NCT00127127|470110434|FG001|Overall Study|Adverse Event|2|||
130586993|NCT00127127|470110435|FG002|Overall Study|Adverse Event|0|||
130586994|NCT00127127|470110436|FG003|Overall Study|Adverse Event|1|||
130586995|NCT00127127|470110433|FG000|Overall Study|Lack of Efficacy|1|||
130586996|NCT00127127|470110434|FG001|Overall Study|Lack of Efficacy|3|||
130586997|NCT00127127|470110435|FG002|Overall Study|Lack of Efficacy|0|||
130586998|NCT00127127|470110436|FG003|Overall Study|Lack of Efficacy|2|||
130586999|NCT01805180|470110437|FG000|Lead-in Donor Phase|screen failure|1|||
130587000|NCT01805180|470110438|FG001|Lead-in Donor Phase|screen failure|0|||
130587001|NCT01805180|470110439|FG002|Lead-in Donor Phase|screen failure|0|||
130587002|NCT00398112|470110441|FG000|Overall Study|Adverse Event|4|||
130587003|NCT00398112|470110441|FG000|Overall Study|Disease progression|9|||
130587004|NCT00398112|470110441|FG000|Overall Study|Alternative treatment|1|||
130587005|NCT00398112|470110441|FG000|Overall Study|Withdrawal by Subject|3|||
130587006|NCT00398112|470110441|FG000|Overall Study|Death|1|||
130587007|NCT05148884|470110442|FG000|Overall Study|Withdrawal by Subject|3|||
130587008|NCT05148884|470110443|FG001|Overall Study|Withdrawal by Subject|0|||
130587009|NCT05148884|470110442|FG000|Overall Study|Deep brain stimulation operation|0|||
130587010|NCT05148884|470110443|FG001|Overall Study|Deep brain stimulation operation|1|||
130587011|NCT00365989|470110444|FG000|Overall Study|Withdrawal by Subject|1|||
130587012|NCT00365989|470110444|FG000|Overall Study|Non-compliance|1|||
130587013|NCT00851903|470110446|FG000|Overall Study|Withdrawal by Subject|2|||
130587014|NCT02318095|470110447|FG000|Overall Study|Adverse Event|1|||
130587015|NCT00686127|470110448|FG000|Overall Study|Withdrawal by Subject|14|||
130587016|NCT00686127|470110449|FG001|Overall Study|Withdrawal by Subject|6|||
130587017|NCT02300129|470110450|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130587018|NCT02300129|470110451|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
130587019|NCT02300129|470110452|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130587020|NCT02300129|470110453|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130587021|NCT02300129|470110450|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130587022|NCT02300129|470110451|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130587023|NCT02300129|470110452|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130587024|NCT02300129|470110453|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
130587025|NCT02300129|470110450|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
130587026|NCT02300129|470110451|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130587027|NCT02300129|470110452|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130587028|NCT02300129|470110453|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130587029|NCT00522392|470110456|FG000|Overall Study|Disease progression|0|||
130587030|NCT00522392|470110457|FG001|Overall Study|Disease progression|3|||
130587031|NCT00522392|470110456|FG000|Overall Study|Adverse Event|7|||
130587032|NCT00522392|470110457|FG001|Overall Study|Adverse Event|7|||
130587033|NCT00522392|470110456|FG000|Overall Study|Withdrawal by Subject|1|||
130587034|NCT00522392|470110457|FG001|Overall Study|Withdrawal by Subject|1|||
130587035|NCT00522392|470110456|FG000|Overall Study|Physician Decision|0|||
130587036|NCT00522392|470110457|FG001|Overall Study|Physician Decision|1|||
130587037|NCT00522392|470110456|FG000|Overall Study|Non-compliance|0|||
130587038|NCT00522392|470110457|FG001|Overall Study|Non-compliance|1|||
130587039|NCT00103012|470110458|FG000|Overall Study|Withdrawal by Subject|2|||
130587040|NCT00103012|470110459|FG001|Overall Study|Withdrawal by Subject|1|||
130587041|NCT00103012|470110460|FG002|Overall Study|Withdrawal by Subject|2|||
130587042|NCT00103012|470110458|FG000|Overall Study|Pregnancy|1|||
130587043|NCT00103012|470110459|FG001|Overall Study|Pregnancy|0|||
130587044|NCT00103012|470110460|FG002|Overall Study|Pregnancy|0|||
130587045|NCT00103012|470110458|FG000|Overall Study|Adverse Event|0|||
130587046|NCT00103012|470110459|FG001|Overall Study|Adverse Event|0|||
130587047|NCT00103012|470110460|FG002|Overall Study|Adverse Event|1|||
130587048|NCT00103012|470110458|FG000|Overall Study|Subject non-compliant with medications|0|||
130587049|NCT00103012|470110459|FG001|Overall Study|Subject non-compliant with medications|0|||
130587050|NCT00103012|470110460|FG002|Overall Study|Subject non-compliant with medications|1|||
130587051|NCT00430755|470110463|FG000|Overall Study|Withdrawal by Subject|53|||
130587052|NCT05211336|470110468|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
130587053|NCT05211336|470110469|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
130587054|NCT05211336|470110468|FG000|Overall Study|Progressive disease|0|||
130587055|NCT05211336|470110469|FG001|Overall Study|Progressive disease|4|||
130587056|NCT05211336|470110468|FG000|Overall Study|Death due to myocardial infarction|0|||
130587057|NCT05211336|470110469|FG001|Overall Study|Death due to myocardial infarction|1|||
130587058|NCT05211336|470110468|FG000|Overall Study|Death due to unknown cause|0|||
130587059|NCT05211336|470110469|FG001|Overall Study|Death due to unknown cause|1|||
130587060|NCT05211336|470110468|FG000|Overall Study|Worsening kidney function and quality of response|0|||
130587061|NCT05211336|470110469|FG001|Overall Study|Worsening kidney function and quality of response|1|||
130587062|NCT05019131|470110478|FG000|Overall Study|Lost to Follow-up|0|||
130587063|NCT05019131|470110479|FG001|Overall Study|Lost to Follow-up|3|||
130587064|NCT03575104|470110480|FG000|Overall Study|Adverse Event|4|||
130587065|NCT03575104|470110481|FG001|Overall Study|Adverse Event|3|||
130587066|NCT03575104|470110482|FG002|Overall Study|Adverse Event|4|||
130587067|NCT03575104|470110480|FG000|Overall Study|Withdrawal by Subject|13|||
130587068|NCT03575104|470110481|FG001|Overall Study|Withdrawal by Subject|16|||
130587069|NCT03575104|470110482|FG002|Overall Study|Withdrawal by Subject|11|||
130587070|NCT03575104|470110480|FG000|Overall Study|Other reasons|6|||
130587071|NCT03575104|470110481|FG001|Overall Study|Other reasons|8|||
130587072|NCT03575104|470110482|FG002|Overall Study|Other reasons|6|||
130587073|NCT03575104|470110480|FG000|Overall Study|Lost to Follow-up|1|||
130587074|NCT03575104|470110481|FG001|Overall Study|Lost to Follow-up|2|||
130587075|NCT03575104|470110482|FG002|Overall Study|Lost to Follow-up|1|||
130587076|NCT00332709|470110483|FG000|Overall Study|Adverse Event|11|||
130587077|NCT00332709|470110484|FG001|Overall Study|Adverse Event|14|||
130587078|NCT00332709|470110483|FG000|Overall Study|Withdrawal by Subject|2|||
130587079|NCT00332709|470110484|FG001|Overall Study|Withdrawal by Subject|3|||
130587080|NCT00332709|470110483|FG000|Overall Study|Lost to Follow-up|2|||
130587081|NCT00332709|470110484|FG001|Overall Study|Lost to Follow-up|0|||
130587082|NCT00332709|470110483|FG000|Overall Study|Administrative Problems|0|||
130587083|NCT00332709|470110484|FG001|Overall Study|Administrative Problems|3|||
130587084|NCT00332709|470110483|FG000|Overall Study|Abnormal test procedure result|1|||
130587085|NCT00332709|470110484|FG001|Overall Study|Abnormal test procedure result|0|||
130587086|NCT04684420|470110485|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130587087|NCT04684420|470110486|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130587088|NCT04684420|470110487|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
130587089|NCT04684420|470110488|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
130587090|NCT04684420|470110485|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
130587091|NCT04684420|470110486|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
130587092|NCT04684420|470110487|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
130587093|NCT04684420|470110488|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
130587094|NCT03480802|470110491|FG000|Overall Study|Lost to Follow-up|5|||
130587095|NCT03480802|470110492|FG001|Overall Study|Lost to Follow-up|1|||
130587096|NCT03480802|470110491|FG000|Overall Study|Withdrawal by Subject|2|||
130587097|NCT03480802|470110492|FG001|Overall Study|Withdrawal by Subject|1|||
130587098|NCT03480802|470110491|FG000|Overall Study|Relocated|0|||
130587099|NCT03480802|470110492|FG001|Overall Study|Relocated|1|||
130587100|NCT01409928|470110493|FG000|Overall Study|Physician Decision|12|||
130587101|NCT01728779|470110496|FG000|Overall Study|Withdrawal by Subject|1|||
130587102|NCT00624520|470110497|FG000|Overall Study|Withdrawal by Subject|12|||
130587103|NCT00624520|470110498|FG001|Overall Study|Withdrawal by Subject|7|||
130587104|NCT00624520|470110497|FG000|Overall Study|Death|0|||
130587105|NCT00624520|470110498|FG001|Overall Study|Death|1|||
130587106|NCT01925209|470110499|FG000|Treatment Epoch|Physician Decision|1|||
130587107|NCT01925209|470110500|FG001|Treatment Epoch|Physician Decision|0|||
130587108|NCT01925209|470110501|FG002|Treatment Epoch|Physician Decision|0|||
130587109|NCT01925209|470110502|FG003|Treatment Epoch|Physician Decision|0|||
130587110|NCT01925209|470110499|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
130587111|NCT01925209|470110500|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
130587112|NCT01925209|470110501|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
130587113|NCT01925209|470110502|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
130587114|NCT01925209|470110499|FG000|Treatment Epoch|Death|1|||
130587115|NCT01925209|470110500|FG001|Treatment Epoch|Death|0|||
130587116|NCT01925209|470110501|FG002|Treatment Epoch|Death|0|||
130587117|NCT01925209|470110502|FG003|Treatment Epoch|Death|0|||
130587118|NCT01925209|470110499|FG000|Treatment Epoch|Protocol deviation|0|||
130587119|NCT01925209|470110500|FG001|Treatment Epoch|Protocol deviation|0|||
130587120|NCT01925209|470110501|FG002|Treatment Epoch|Protocol deviation|1|||
130587121|NCT01925209|470110502|FG003|Treatment Epoch|Protocol deviation|1|||
130587122|NCT01925209|470110499|FG000|Treatment Epoch|Withdrawal by Subject|4|||
130587123|NCT01925209|470110500|FG001|Treatment Epoch|Withdrawal by Subject|3|||
130587124|NCT01925209|470110501|FG002|Treatment Epoch|Withdrawal by Subject|3|||
130587125|NCT01925209|470110502|FG003|Treatment Epoch|Withdrawal by Subject|2|||
130587126|NCT01925209|470110499|FG000|Treatment Epoch|Adverse Event|3|||
130587127|NCT01925209|470110500|FG001|Treatment Epoch|Adverse Event|5|||
130587128|NCT01925209|470110501|FG002|Treatment Epoch|Adverse Event|3|||
130587129|NCT01925209|470110502|FG003|Treatment Epoch|Adverse Event|1|||
130587130|NCT01925209|470110499|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
130587131|NCT01925209|470110500|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
130587132|NCT01925209|470110501|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
130587133|NCT01925209|470110502|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
130587134|NCT01925209|470110499|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
130587135|NCT01925209|470110500|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
130587136|NCT01925209|470110501|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
130587137|NCT01925209|470110502|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
130587138|NCT01925209|470110499|FG000|Follow-up|Adverse Event|1|||
130587139|NCT01925209|470110500|FG001|Follow-up|Adverse Event|4|||
130587140|NCT01925209|470110501|FG002|Follow-up|Adverse Event|0|||
130587141|NCT01925209|470110502|FG003|Follow-up|Adverse Event|1|||
130587142|NCT01925209|470110499|FG000|Follow-up|Physician Decision|0|||
130587143|NCT01925209|470110500|FG001|Follow-up|Physician Decision|0|||
130587144|NCT01925209|470110501|FG002|Follow-up|Physician Decision|1|||
130587145|NCT01925209|470110502|FG003|Follow-up|Physician Decision|0|||
130587146|NCT01925209|470110499|FG000|Follow-up|Non-compliance with study treatment|0|||
130587147|NCT01925209|470110500|FG001|Follow-up|Non-compliance with study treatment|0|||
130587148|NCT01925209|470110501|FG002|Follow-up|Non-compliance with study treatment|0|||
130587149|NCT01925209|470110502|FG003|Follow-up|Non-compliance with study treatment|1|||
130587150|NCT01925209|470110499|FG000|Follow-up|Withdrawal by Subject|0|||
130587151|NCT01925209|470110500|FG001|Follow-up|Withdrawal by Subject|2|||
130587152|NCT01925209|470110501|FG002|Follow-up|Withdrawal by Subject|0|||
130587153|NCT01925209|470110502|FG003|Follow-up|Withdrawal by Subject|2|||
130587154|NCT02796755|470110503|FG000|Overall Study|Adverse Event|2|||
130587155|NCT02796755|470110504|FG001|Overall Study|Adverse Event|0|||
130587156|NCT04398732|470110508|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
130587157|NCT00556426|470110509|FG000|Overall Study|Withdrawal by Subject|3|||
130587158|NCT00556426|470110509|FG000|Overall Study|Death|6|||
130587159|NCT01596257|470110511|FG000|Overall Study|Inadequate Collection|23|||
130587160|NCT01596257|470110512|FG001|Overall Study|Inadequate Collection|19|||
130587161|NCT02347631|470110516|FG000|First Intervention (2 Months)|Adverse Event|1|||
130587162|NCT02347631|470110517|FG001|First Intervention (2 Months)|Adverse Event|1|||
130587163|NCT02347631|470110516|FG000|First Intervention (2 Months)|Pregnancy|1|||
130587164|NCT02347631|470110517|FG001|First Intervention (2 Months)|Pregnancy|0|||
130587165|NCT02347631|470110516|FG000|First Intervention (2 Months)|Moved out of area|0|||
130587166|NCT02347631|470110517|FG001|First Intervention (2 Months)|Moved out of area|2|||
130587167|NCT02347631|470110516|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
130587168|NCT02347631|470110517|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
130587169|NCT02347631|470110516|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
130587170|NCT02347631|470110517|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
130587171|NCT02347631|470110516|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
130587172|NCT02347631|470110517|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
130587173|NCT02347631|470110516|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
130587174|NCT02347631|470110517|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
130587175|NCT02347631|470110516|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
130587176|NCT02347631|470110517|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
130587177|NCT00934102|470110519|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
130587178|NCT00934102|470110520|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
130587179|NCT00934102|470110521|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
130587180|NCT02318784|470110522|FG000|Overall Study|Adverse Event|13|||
130587181|NCT02318784|470110522|FG000|Overall Study|Death|2|||
130587182|NCT02318784|470110522|FG000|Overall Study|Progressive Disease|37|||
130587183|NCT02318784|470110522|FG000|Overall Study|Withdrawal by Subject|10|||
130587184|NCT02304926|470110523|FG000|Overall Study|Lost to Follow-up|2|||
130587185|NCT02304926|470110524|FG001|Overall Study|Lost to Follow-up|1|||
130587186|NCT00792298|470110526|FG000|Treatment Period 1|Adverse Event|0|||
130587187|NCT00792298|470110527|FG001|Treatment Period 1|Adverse Event|1|||
130587188|NCT00792298|470110528|FG002|Treatment Period 1|Adverse Event|0|||
130587189|NCT00792298|470110529|FG003|Treatment Period 1|Adverse Event|1|||
130587190|NCT00792298|470110530|FG004|Treatment Period 1|Adverse Event|0|||
130587191|NCT00792298|470110531|FG005|Treatment Period 1|Adverse Event|1|||
130587192|NCT00792298|470110532|FG006|Treatment Period 1|Adverse Event|1|||
130587193|NCT00792298|470110533|FG007|Treatment Period 1|Adverse Event|0|||
130587194|NCT00792298|470110526|FG000|Treatment Period 1|Lack of Efficacy|0|||
130587195|NCT00792298|470110527|FG001|Treatment Period 1|Lack of Efficacy|0|||
130587196|NCT00792298|470110528|FG002|Treatment Period 1|Lack of Efficacy|1|||
130587197|NCT00792298|470110529|FG003|Treatment Period 1|Lack of Efficacy|0|||
130587198|NCT00792298|470110530|FG004|Treatment Period 1|Lack of Efficacy|0|||
130587199|NCT00792298|470110531|FG005|Treatment Period 1|Lack of Efficacy|0|||
130587200|NCT00792298|470110532|FG006|Treatment Period 1|Lack of Efficacy|0|||
130587201|NCT00792298|470110533|FG007|Treatment Period 1|Lack of Efficacy|0|||
130587202|NCT00792298|470110526|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130587203|NCT00792298|470110527|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130587204|NCT00792298|470110528|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130587205|NCT00792298|470110529|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130587206|NCT00792298|470110530|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130587207|NCT00792298|470110531|FG005|Treatment Period 1|Withdrawal by Subject|2|||
130587208|NCT00792298|470110532|FG006|Treatment Period 1|Withdrawal by Subject|1|||
130587209|NCT00792298|470110533|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130587210|NCT00792298|470110526|FG000|Treatment Period 1|Lost to Follow-up|0|||
130587211|NCT00792298|470110527|FG001|Treatment Period 1|Lost to Follow-up|0|||
130587212|NCT00792298|470110528|FG002|Treatment Period 1|Lost to Follow-up|0|||
130587213|NCT00792298|470110529|FG003|Treatment Period 1|Lost to Follow-up|0|||
130587214|NCT00792298|470110530|FG004|Treatment Period 1|Lost to Follow-up|0|||
130587215|NCT00792298|470110531|FG005|Treatment Period 1|Lost to Follow-up|0|||
130587216|NCT00792298|470110532|FG006|Treatment Period 1|Lost to Follow-up|1|||
130587217|NCT00792298|470110533|FG007|Treatment Period 1|Lost to Follow-up|0|||
130587218|NCT00792298|470110526|FG000|Treatment Period 1|Physician Decision|0|||
130587219|NCT00792298|470110527|FG001|Treatment Period 1|Physician Decision|0|||
130587220|NCT00792298|470110528|FG002|Treatment Period 1|Physician Decision|0|||
130587221|NCT00792298|470110529|FG003|Treatment Period 1|Physician Decision|1|||
130587222|NCT00792298|470110530|FG004|Treatment Period 1|Physician Decision|0|||
130587223|NCT00792298|470110531|FG005|Treatment Period 1|Physician Decision|0|||
130587224|NCT00792298|470110532|FG006|Treatment Period 1|Physician Decision|1|||
130587225|NCT00792298|470110533|FG007|Treatment Period 1|Physician Decision|0|||
130587226|NCT00792298|470110526|FG000|Treatment Period 1|Protocol Violation|0|||
130587227|NCT00792298|470110527|FG001|Treatment Period 1|Protocol Violation|0|||
130587228|NCT00792298|470110528|FG002|Treatment Period 1|Protocol Violation|0|||
130587229|NCT00792298|470110529|FG003|Treatment Period 1|Protocol Violation|0|||
130587230|NCT00792298|470110530|FG004|Treatment Period 1|Protocol Violation|0|||
130587231|NCT00792298|470110531|FG005|Treatment Period 1|Protocol Violation|0|||
130587232|NCT00792298|470110532|FG006|Treatment Period 1|Protocol Violation|0|||
130587233|NCT00792298|470110533|FG007|Treatment Period 1|Protocol Violation|1|||
130587234|NCT00792298|470110526|FG000|Washout|Adverse Event|0|||
130587235|NCT00792298|470110527|FG001|Washout|Adverse Event|0|||
130587236|NCT00792298|470110528|FG002|Washout|Adverse Event|0|||
130587237|NCT00792298|470110529|FG003|Washout|Adverse Event|0|||
130587238|NCT00792298|470110530|FG004|Washout|Adverse Event|0|||
130587239|NCT00792298|470110531|FG005|Washout|Adverse Event|1|||
130587240|NCT00792298|470110532|FG006|Washout|Adverse Event|0|||
130587241|NCT00792298|470110533|FG007|Washout|Adverse Event|0|||
130587242|NCT00792298|470110526|FG000|Washout|Withdrawal by Subject|0|||
130587243|NCT00792298|470110527|FG001|Washout|Withdrawal by Subject|0|||
130587244|NCT00792298|470110528|FG002|Washout|Withdrawal by Subject|1|||
130587245|NCT00792298|470110529|FG003|Washout|Withdrawal by Subject|0|||
130587246|NCT00792298|470110530|FG004|Washout|Withdrawal by Subject|0|||
130587247|NCT00792298|470110531|FG005|Washout|Withdrawal by Subject|1|||
130587248|NCT00792298|470110532|FG006|Washout|Withdrawal by Subject|0|||
130587249|NCT00792298|470110533|FG007|Washout|Withdrawal by Subject|0|||
130587250|NCT00792298|470110526|FG000|Treatment Period 2|Lack of Efficacy|0|||
130587251|NCT00792298|470110527|FG001|Treatment Period 2|Lack of Efficacy|0|||
130587252|NCT00792298|470110528|FG002|Treatment Period 2|Lack of Efficacy|0|||
130587253|NCT00792298|470110529|FG003|Treatment Period 2|Lack of Efficacy|0|||
130587254|NCT00792298|470110530|FG004|Treatment Period 2|Lack of Efficacy|1|||
130587255|NCT00792298|470110531|FG005|Treatment Period 2|Lack of Efficacy|0|||
130587256|NCT00792298|470110532|FG006|Treatment Period 2|Lack of Efficacy|0|||
130587257|NCT00792298|470110533|FG007|Treatment Period 2|Lack of Efficacy|0|||
130587258|NCT00792298|470110526|FG000|Treatment Period 2|Physician Decision|0|||
130587259|NCT00792298|470110527|FG001|Treatment Period 2|Physician Decision|0|||
130587260|NCT00792298|470110528|FG002|Treatment Period 2|Physician Decision|0|||
130587261|NCT00792298|470110529|FG003|Treatment Period 2|Physician Decision|0|||
130587262|NCT00792298|470110530|FG004|Treatment Period 2|Physician Decision|0|||
130587263|NCT00792298|470110531|FG005|Treatment Period 2|Physician Decision|0|||
130587264|NCT00792298|470110532|FG006|Treatment Period 2|Physician Decision|1|||
130587265|NCT00792298|470110533|FG007|Treatment Period 2|Physician Decision|0|||
130587266|NCT00792298|470110526|FG000|Treatment Period 2|Pregnancy|0|||
130587267|NCT00792298|470110527|FG001|Treatment Period 2|Pregnancy|0|||
130587268|NCT00792298|470110528|FG002|Treatment Period 2|Pregnancy|1|||
130587269|NCT00792298|470110529|FG003|Treatment Period 2|Pregnancy|0|||
130587270|NCT00792298|470110530|FG004|Treatment Period 2|Pregnancy|0|||
130587271|NCT00792298|470110531|FG005|Treatment Period 2|Pregnancy|0|||
130587272|NCT00792298|470110532|FG006|Treatment Period 2|Pregnancy|0|||
130587273|NCT00792298|470110533|FG007|Treatment Period 2|Pregnancy|0|||
130587274|NCT00792298|470110526|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130587275|NCT00792298|470110527|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130587276|NCT00792298|470110528|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130587277|NCT00792298|470110529|FG003|Treatment Period 2|Withdrawal by Subject|2|||
130587278|NCT00792298|470110530|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130587279|NCT00792298|470110531|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130587280|NCT00792298|470110532|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130587281|NCT00792298|470110533|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130587282|NCT04007159|470110539|FG000|Induction Phase|(missed study visits)|16|||
130587283|NCT04007159|470110539|FG000|Induction Phase|Withdrawal by Subject|4|||
130587284|NCT04007159|470110539|FG000|Induction Phase|Adverse Event|2|||
130587285|NCT04007159|470110539|FG000|Challenge Phase|missed study visits|3|||
130587286|NCT02388295|470110540|FG000|Dose Escalation Week 1|Adverse Event|1|||
130587287|NCT02388295|470110541|FG001|Dose Escalation Week 1|Adverse Event|2|||
130587288|NCT02388295|470110542|FG002|Dose Escalation Week 1|Adverse Event|1|||
130587289|NCT02388295|470110540|FG000|Dose Escalation Week 1|Determined not eligible|1|||
130587290|NCT02388295|470110541|FG001|Dose Escalation Week 1|Determined not eligible|1|||
130587291|NCT02388295|470110542|FG002|Dose Escalation Week 1|Determined not eligible|1|||
130587292|NCT02388295|470110540|FG000|Dose Escalation Week 2|Protocol Violation|0|||
130587293|NCT02388295|470110541|FG001|Dose Escalation Week 2|Protocol Violation|1|||
130587294|NCT02388295|470110542|FG002|Dose Escalation Week 2|Protocol Violation|0|||
130587295|NCT02388295|470110540|FG000|Dose Escalation Week 2|Determined not eligible|1|||
130587296|NCT02388295|470110541|FG001|Dose Escalation Week 2|Determined not eligible|1|||
130587297|NCT02388295|470110542|FG002|Dose Escalation Week 2|Determined not eligible|1|||
130587298|NCT02388295|470110540|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
130587299|NCT02388295|470110541|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
130587300|NCT02388295|470110542|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
130587301|NCT04258579|470110544|FG000|Overall Study|Withdrawal by Subject|7|||
130587302|NCT04258579|470110544|FG000|Overall Study|Lost to Follow-up|3|||
130587303|NCT04258579|470110544|FG000|Overall Study|Protocol Violation|2|||
130587304|NCT04258579|470110544|FG000|Overall Study|Adverse Event|1|||
130587305|NCT02076165|470110546|FG000|Overall Study|Lost to Follow-up|7|||
130587306|NCT02076165|470110547|FG001|Overall Study|Lost to Follow-up|5|||
130587307|NCT02076165|470110546|FG000|Overall Study|Refused follow-up assessment|1|||
130587308|NCT02076165|470110547|FG001|Overall Study|Refused follow-up assessment|1|||
130587309|NCT03157531|470110551|FG000|Overall Study|Death|2|||
130587310|NCT03157531|470110551|FG000|Overall Study|Lost to Follow-up|4|||
130587311|NCT01838044|470110555|FG000|Overall Study|Adverse Event|4|||
130587312|NCT01838044|470110556|FG001|Overall Study|Adverse Event|6|||
130587313|NCT01838044|470110555|FG000|Overall Study|Protocol Violation|3|||
130587314|NCT01838044|470110556|FG001|Overall Study|Protocol Violation|3|||
130587315|NCT01838044|470110555|FG000|Overall Study|Withdrawal by Subject|0|||
130587316|NCT01838044|470110556|FG001|Overall Study|Withdrawal by Subject|2|||
130587317|NCT01838044|470110555|FG000|Overall Study|Insufficient clinical response|1|||
130587318|NCT01838044|470110556|FG001|Overall Study|Insufficient clinical response|2|||
130587319|NCT01838044|470110555|FG000|Overall Study|Medication error without associated AE|0|||
130587320|NCT01838044|470110556|FG001|Overall Study|Medication error without associated AE|1|||
130587321|NCT01838044|470110555|FG000|Overall Study|Lost to Follow-up|0|||
130587322|NCT01838044|470110556|FG001|Overall Study|Lost to Follow-up|2|||
130587323|NCT03529409|470110561|FG000|Randomized|Lost to Follow-up|0|||
130587324|NCT03529409|470110562|FG001|Randomized|Lost to Follow-up|0|||
130587325|NCT03529409|470110563|FG002|Randomized|Lost to Follow-up|4|||
130587326|NCT03529409|470110561|FG000|Randomized|Excluded|0|||
130587327|NCT03529409|470110562|FG001|Randomized|Excluded|0|||
130587328|NCT03529409|470110563|FG002|Randomized|Excluded|1|||
130587329|NCT03529409|470110561|FG000|Post-treatment Assessment|Death|1|||
130587330|NCT03529409|470110562|FG001|Post-treatment Assessment|Death|0|||
130587331|NCT03529409|470110563|FG002|Post-treatment Assessment|Death|0|||
130587332|NCT03529409|470110561|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
130587333|NCT03529409|470110562|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
130587334|NCT03529409|470110563|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
130587335|NCT03529409|470110561|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
130587336|NCT03529409|470110562|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
130587337|NCT03529409|470110563|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
130587338|NCT03529409|470110561|FG000|Follow-up Assessment|Death|1|||
130587339|NCT03529409|470110562|FG001|Follow-up Assessment|Death|0|||
130587340|NCT03529409|470110563|FG002|Follow-up Assessment|Death|0|||
130587341|NCT03529409|470110561|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
130587342|NCT03529409|470110562|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
130587343|NCT03529409|470110563|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
130587344|NCT01497262|470110566|FG000|Overall Study|Abnormal Lab Values|4|||
130587345|NCT01497262|470110566|FG000|Overall Study|Abnormal Test Procedure Result|1|||
130587346|NCT01497262|470110566|FG000|Overall Study|Physician Decision|1|||
130587347|NCT01497262|470110566|FG000|Overall Study|Withdrawal by Subject|2|||
130587348|NCT01497262|470110566|FG000|Overall Study|Adverse Event|2|||
130587349|NCT01497262|470110566|FG000|Overall Study|Protocol Violation|1|||
130587350|NCT03437447|470110567|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130587351|NCT03437447|470110568|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130587352|NCT03437447|470110569|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130587353|NCT00484315|470110570|FG000|12-Month Clinical Follow-up|Death|6|||
130587354|NCT00484315|470110571|FG001|12-Month Clinical Follow-up|Death|2|||
130587355|NCT00484315|470110570|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
130587356|NCT00484315|470110571|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
130587357|NCT00484315|470110570|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
130587358|NCT00484315|470110571|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
130587359|NCT00484315|470110570|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
130587360|NCT00484315|470110571|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
130587361|NCT00484315|470110570|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
130587362|NCT00484315|470110571|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
130587363|NCT00484315|470110570|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
130587364|NCT00484315|470110571|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
130587365|NCT00484315|470110570|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
130587366|NCT00484315|470110571|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
130587367|NCT00943683|470110572|FG000|Overall Study|Adverse Event|3|||
130587368|NCT00943683|470110573|FG001|Overall Study|Adverse Event|3|||
130587369|NCT00943683|470110572|FG000|Overall Study|Lost to Follow-up|1|||
130587370|NCT00943683|470110573|FG001|Overall Study|Lost to Follow-up|1|||
130587371|NCT00943683|470110572|FG000|Overall Study|Protocol Violation|1|||
130587372|NCT00943683|470110573|FG001|Overall Study|Protocol Violation|2|||
130587373|NCT00943683|470110572|FG000|Overall Study|Withdrawal by Subject|1|||
130587374|NCT00943683|470110573|FG001|Overall Study|Withdrawal by Subject|0|||
130587375|NCT00943683|470110572|FG000|Overall Study|Patient Moved|1|||
130587376|NCT00943683|470110573|FG001|Overall Study|Patient Moved|0|||
130587377|NCT01551745|470110574|FG000|Overall Study|Withdrawal by Subject|1|||
130587378|NCT01551745|470110574|FG000|Overall Study|Disease Progression|2|||
130587379|NCT00749190|470110575|FG000|Overall Study|Adverse Event|0|||
130587380|NCT00749190|470110576|FG001|Overall Study|Adverse Event|2|||
130587381|NCT00749190|470110577|FG002|Overall Study|Adverse Event|0|||
130587382|NCT00749190|470110578|FG003|Overall Study|Adverse Event|4|||
130587383|NCT00749190|470110579|FG004|Overall Study|Adverse Event|0|||
130587384|NCT00749190|470110580|FG005|Overall Study|Adverse Event|3|||
130587385|NCT00749190|470110581|FG006|Overall Study|Adverse Event|0|||
130587386|NCT00749190|470110575|FG000|Overall Study|Lack of Efficacy|3|||
130587387|NCT00749190|470110576|FG001|Overall Study|Lack of Efficacy|1|||
130587388|NCT00749190|470110577|FG002|Overall Study|Lack of Efficacy|1|||
130587389|NCT00749190|470110578|FG003|Overall Study|Lack of Efficacy|0|||
130587390|NCT00749190|470110579|FG004|Overall Study|Lack of Efficacy|0|||
130587391|NCT00749190|470110580|FG005|Overall Study|Lack of Efficacy|1|||
130587392|NCT00749190|470110581|FG006|Overall Study|Lack of Efficacy|0|||
130587393|NCT00749190|470110575|FG000|Overall Study|Withdrawal by Subject|2|||
130587394|NCT00749190|470110576|FG001|Overall Study|Withdrawal by Subject|1|||
130587395|NCT00749190|470110577|FG002|Overall Study|Withdrawal by Subject|0|||
130587396|NCT00749190|470110578|FG003|Overall Study|Withdrawal by Subject|0|||
130587397|NCT00749190|470110579|FG004|Overall Study|Withdrawal by Subject|0|||
130587398|NCT00749190|470110580|FG005|Overall Study|Withdrawal by Subject|1|||
130587399|NCT00749190|470110581|FG006|Overall Study|Withdrawal by Subject|0|||
130587400|NCT00749190|470110575|FG000|Overall Study|Protocol Violation|0|||
130587401|NCT00749190|470110576|FG001|Overall Study|Protocol Violation|1|||
130587402|NCT00749190|470110577|FG002|Overall Study|Protocol Violation|0|||
130587403|NCT00749190|470110578|FG003|Overall Study|Protocol Violation|0|||
130587404|NCT00749190|470110579|FG004|Overall Study|Protocol Violation|0|||
130587405|NCT00749190|470110580|FG005|Overall Study|Protocol Violation|0|||
130587406|NCT00749190|470110581|FG006|Overall Study|Protocol Violation|1|||
130587407|NCT00749190|470110575|FG000|Overall Study|Other reason not defined above|0|||
130587408|NCT00749190|470110576|FG001|Overall Study|Other reason not defined above|0|||
130587409|NCT00749190|470110577|FG002|Overall Study|Other reason not defined above|0|||
130587410|NCT00749190|470110578|FG003|Overall Study|Other reason not defined above|1|||
130587411|NCT00749190|470110579|FG004|Overall Study|Other reason not defined above|0|||
130587412|NCT00749190|470110580|FG005|Overall Study|Other reason not defined above|0|||
130587413|NCT00749190|470110581|FG006|Overall Study|Other reason not defined above|0|||
130587414|NCT00355121|470110582|FG000|Overall Study|Did not receive study vaccine|1|||
130587415|NCT00355121|470110583|FG001|Overall Study|Did not receive study vaccine|0|||
130587416|NCT00355121|470110584|FG002|Overall Study|Did not receive study vaccine|1|||
130587417|NCT00355121|470110582|FG000|Overall Study|Adverse Event|0|||
130587418|NCT00355121|470110583|FG001|Overall Study|Adverse Event|1|||
130587419|NCT00355121|470110584|FG002|Overall Study|Adverse Event|0|||
130587420|NCT00355121|470110582|FG000|Overall Study|Protocol Violation|7|||
130587421|NCT00355121|470110583|FG001|Overall Study|Protocol Violation|9|||
130587422|NCT00355121|470110584|FG002|Overall Study|Protocol Violation|1|||
130587423|NCT00355121|470110582|FG000|Overall Study|Lost to Follow-up|4|||
130587424|NCT00355121|470110583|FG001|Overall Study|Lost to Follow-up|7|||
130587425|NCT00355121|470110584|FG002|Overall Study|Lost to Follow-up|1|||
130587426|NCT00355121|470110582|FG000|Overall Study|Withdrawal by Subject|9|||
130587427|NCT00355121|470110583|FG001|Overall Study|Withdrawal by Subject|10|||
130587428|NCT00355121|470110584|FG002|Overall Study|Withdrawal by Subject|2|||
130587429|NCT00355121|470110582|FG000|Overall Study|Serious adverse events|0|||
130587430|NCT00355121|470110583|FG001|Overall Study|Serious adverse events|2|||
130587431|NCT00355121|470110584|FG002|Overall Study|Serious adverse events|0|||
130587432|NCT01565980|470110591|FG000|Overall Study|Death|1|||
130587433|NCT01565980|470110592|FG001|Overall Study|Death|0|||
130587434|NCT01565980|470110591|FG000|Overall Study|Lost to Follow-up|1|||
130587435|NCT01565980|470110592|FG001|Overall Study|Lost to Follow-up|0|||
130587436|NCT01565980|470110591|FG000|Overall Study|health complications|1|||
130587437|NCT01565980|470110592|FG001|Overall Study|health complications|1|||
130587438|NCT01565980|470110591|FG000|Overall Study|stopped medical treatment|1|||
130587439|NCT01565980|470110592|FG001|Overall Study|stopped medical treatment|0|||
130587440|NCT01565980|470110591|FG000|Overall Study|Withdrawal by Subject|0|||
130587441|NCT01565980|470110592|FG001|Overall Study|Withdrawal by Subject|3|||
130587442|NCT01468311|470110596|FG000|Overall Study|mobilization failure|1|||
130587443|NCT01468311|470110596|FG000|Overall Study|Withdrawal by Subject|1|||
130587444|NCT02689492|470112925|FG000|Overall Study|Lost to Follow-up|61|||
130587445|NCT02689492|470112925|FG000|Overall Study|Withdrawal by Subject|11|||
130587446|NCT02689492|470112925|FG000|Overall Study|Death|9|||
130587447|NCT02689492|470112925|FG000|Overall Study|Physician Decision|2|||
130587448|NCT02689492|470112925|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
130587449|NCT02689492|470112925|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
130587450|NCT02689492|470112925|FG000|Overall Study|Other than listed|1|||
130587451|NCT02029976|470112926|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
130587452|NCT02029976|470112927|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
130587453|NCT02029976|470112926|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
130587454|NCT02029976|470112927|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
130587455|NCT02029976|470112926|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
130587456|NCT02029976|470112927|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
130587457|NCT02029976|470112926|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
130587458|NCT02029976|470112927|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
130587459|NCT04025632|470112928|FG000|Overall Study|Adverse Event|1|||
130587460|NCT04025632|470112929|FG001|Overall Study|Adverse Event|1|||
130587461|NCT04025632|470112928|FG000|Overall Study|Withdrawal by Subject|1|||
130587462|NCT04025632|470112929|FG001|Overall Study|Withdrawal by Subject|1|||
130587463|NCT04025632|470112928|FG000|Overall Study|Study Terminated by Sponsor|10|||
130587464|NCT04025632|470112929|FG001|Overall Study|Study Terminated by Sponsor|9|||
130587465|NCT04025632|470112928|FG000|Overall Study|Physician Decision|3|||
130587466|NCT04025632|470112929|FG001|Overall Study|Physician Decision|1|||
130587467|NCT01524991|470112930|FG000|Overall Study|Adverse Event|12|||
130587468|NCT01524991|470112930|FG000|Overall Study|Death|1|||
130587469|NCT01524991|470112930|FG000|Overall Study|Disease ProgressionDu|17|||
130587470|NCT01524991|470112930|FG000|Overall Study|Other complicating disease|1|||
130587471|NCT01524991|470112930|FG000|Overall Study|Withdrawal by Subject|2|||
130587472|NCT01524991|470112930|FG000|Overall Study|Symptomatic Deterioration|1|||
130587473|NCT00408005|470112951|FG000|Induction|Adverse Event|19|||
130587474|NCT00408005|470112952|FG001|Induction|Adverse Event|3|||
130587475|NCT00408005|470112953|FG002|Induction|Adverse Event|0|||
130587476|NCT00408005|470112954|FG003|Induction|Adverse Event|0|||
130587477|NCT00408005|470112955|FG004|Induction|Adverse Event|0|||
130587478|NCT00408005|470112956|FG005|Induction|Adverse Event|0|||
130587479|NCT00408005|470112957|FG006|Induction|Adverse Event|0|||
130587480|NCT00408005|470112958|FG007|Induction|Adverse Event|0|||
130587481|NCT00408005|470112951|FG000|Induction|Death|6|||
130587482|NCT00408005|470112952|FG001|Induction|Death|0|||
130587483|NCT00408005|470112953|FG002|Induction|Death|0|||
130587484|NCT00408005|470112954|FG003|Induction|Death|0|||
130587485|NCT00408005|470112955|FG004|Induction|Death|0|||
130587486|NCT00408005|470112956|FG005|Induction|Death|0|||
130587487|NCT00408005|470112957|FG006|Induction|Death|0|||
130587488|NCT00408005|470112958|FG007|Induction|Death|0|||
130587489|NCT00408005|470112951|FG000|Induction|Physician Decision|83|||
130587490|NCT00408005|470112952|FG001|Induction|Physician Decision|9|||
130587491|NCT00408005|470112953|FG002|Induction|Physician Decision|0|||
130587492|NCT00408005|470112954|FG003|Induction|Physician Decision|0|||
130587493|NCT00408005|470112955|FG004|Induction|Physician Decision|0|||
130587494|NCT00408005|470112956|FG005|Induction|Physician Decision|0|||
130587495|NCT00408005|470112957|FG006|Induction|Physician Decision|0|||
130587496|NCT00408005|470112958|FG007|Induction|Physician Decision|0|||
130587497|NCT00408005|470112951|FG000|Induction|Withdrawal by Subject|2|||
130587498|NCT00408005|470112952|FG001|Induction|Withdrawal by Subject|4|||
130587499|NCT00408005|470112953|FG002|Induction|Withdrawal by Subject|0|||
130587500|NCT00408005|470112954|FG003|Induction|Withdrawal by Subject|0|||
130587501|NCT00408005|470112955|FG004|Induction|Withdrawal by Subject|0|||
130587502|NCT00408005|470112956|FG005|Induction|Withdrawal by Subject|0|||
130587503|NCT00408005|470112957|FG006|Induction|Withdrawal by Subject|0|||
130587504|NCT00408005|470112958|FG007|Induction|Withdrawal by Subject|0|||
130587505|NCT00408005|470112951|FG000|Induction|Ineligible|33|||
130587506|NCT00408005|470112952|FG001|Induction|Ineligible|14|||
130587507|NCT00408005|470112953|FG002|Induction|Ineligible|0|||
130587508|NCT00408005|470112954|FG003|Induction|Ineligible|0|||
130587509|NCT00408005|470112955|FG004|Induction|Ineligible|0|||
130587510|NCT00408005|470112956|FG005|Induction|Ineligible|0|||
130587511|NCT00408005|470112957|FG006|Induction|Ineligible|0|||
130587512|NCT00408005|470112958|FG007|Induction|Ineligible|0|||
130587513|NCT00408005|470112951|FG000|Induction|Refusal of Further Protocol Therapy|225|||
130587514|NCT00408005|470112952|FG001|Induction|Refusal of Further Protocol Therapy|44|||
130587515|NCT00408005|470112953|FG002|Induction|Refusal of Further Protocol Therapy|0|||
130587516|NCT00408005|470112954|FG003|Induction|Refusal of Further Protocol Therapy|0|||
130587517|NCT00408005|470112955|FG004|Induction|Refusal of Further Protocol Therapy|0|||
130587518|NCT00408005|470112956|FG005|Induction|Refusal of Further Protocol Therapy|0|||
130587519|NCT00408005|470112957|FG006|Induction|Refusal of Further Protocol Therapy|0|||
130587520|NCT00408005|470112958|FG007|Induction|Refusal of Further Protocol Therapy|0|||
130587521|NCT00408005|470112951|FG000|Induction|Entered another COG therapeutic protocol|4|||
130587522|NCT00408005|470112952|FG001|Induction|Entered another COG therapeutic protocol|0|||
130587523|NCT00408005|470112953|FG002|Induction|Entered another COG therapeutic protocol|0|||
130587524|NCT00408005|470112954|FG003|Induction|Entered another COG therapeutic protocol|0|||
130587525|NCT00408005|470112955|FG004|Induction|Entered another COG therapeutic protocol|0|||
130587526|NCT00408005|470112956|FG005|Induction|Entered another COG therapeutic protocol|0|||
130587527|NCT00408005|470112957|FG006|Induction|Entered another COG therapeutic protocol|0|||
130587528|NCT00408005|470112958|FG007|Induction|Entered another COG therapeutic protocol|0|||
130587529|NCT00408005|470112951|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
130587530|NCT00408005|470112952|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
130587531|NCT00408005|470112953|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
130587532|NCT00408005|470112954|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
130587533|NCT00408005|470112955|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
130587534|NCT00408005|470112956|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
130587535|NCT00408005|470112957|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
130587536|NCT00408005|470112958|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
130587537|NCT00408005|470112951|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
130587538|NCT00408005|470112952|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
130587539|NCT00408005|470112953|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
130587540|NCT00408005|470112954|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
130587541|NCT00408005|470112955|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
130587542|NCT00408005|470112956|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
130587543|NCT00408005|470112957|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
130587544|NCT00408005|470112958|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
130587545|NCT00408005|470112951|FG000|Induction|Progressive Disease|0|||
130587546|NCT00408005|470112952|FG001|Induction|Progressive Disease|1|||
130587547|NCT00408005|470112953|FG002|Induction|Progressive Disease|0|||
130587548|NCT00408005|470112954|FG003|Induction|Progressive Disease|0|||
130587549|NCT00408005|470112955|FG004|Induction|Progressive Disease|0|||
130587550|NCT00408005|470112956|FG005|Induction|Progressive Disease|0|||
130587551|NCT00408005|470112957|FG006|Induction|Progressive Disease|0|||
130587552|NCT00408005|470112958|FG007|Induction|Progressive Disease|0|||
130587553|NCT00408005|470112951|FG000|Induction|Inevaluable|18|||
130587554|NCT00408005|470112952|FG001|Induction|Inevaluable|14|||
130587555|NCT00408005|470112953|FG002|Induction|Inevaluable|0|||
130587556|NCT00408005|470112954|FG003|Induction|Inevaluable|0|||
130587557|NCT00408005|470112955|FG004|Induction|Inevaluable|0|||
130587558|NCT00408005|470112956|FG005|Induction|Inevaluable|0|||
130587559|NCT00408005|470112957|FG006|Induction|Inevaluable|0|||
130587560|NCT00408005|470112958|FG007|Induction|Inevaluable|0|||
130587561|NCT00408005|470112951|FG000|Induction|Failed to Complete Randomization|3|||
130587562|NCT00408005|470112952|FG001|Induction|Failed to Complete Randomization|2|||
130587563|NCT00408005|470112953|FG002|Induction|Failed to Complete Randomization|0|||
130587564|NCT00408005|470112954|FG003|Induction|Failed to Complete Randomization|0|||
130587565|NCT00408005|470112955|FG004|Induction|Failed to Complete Randomization|0|||
130587566|NCT00408005|470112956|FG005|Induction|Failed to Complete Randomization|0|||
130587567|NCT00408005|470112957|FG006|Induction|Failed to Complete Randomization|0|||
130587568|NCT00408005|470112958|FG007|Induction|Failed to Complete Randomization|0|||
130587569|NCT00408005|470112951|FG000|Induction|Protocol Deviation|3|||
130587570|NCT00408005|470112952|FG001|Induction|Protocol Deviation|1|||
130587571|NCT00408005|470112953|FG002|Induction|Protocol Deviation|0|||
130587572|NCT00408005|470112954|FG003|Induction|Protocol Deviation|0|||
130587573|NCT00408005|470112955|FG004|Induction|Protocol Deviation|0|||
130587574|NCT00408005|470112956|FG005|Induction|Protocol Deviation|0|||
130587575|NCT00408005|470112957|FG006|Induction|Protocol Deviation|0|||
130587576|NCT00408005|470112958|FG007|Induction|Protocol Deviation|0|||
130587577|NCT00408005|470112951|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
130587578|NCT00408005|470112952|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587579|NCT00408005|470112953|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587580|NCT00408005|470112954|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587581|NCT00408005|470112955|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587582|NCT00408005|470112956|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587583|NCT00408005|470112957|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587584|NCT00408005|470112958|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
130587585|NCT00408005|470112951|FG000|Induction|Recurrent leukemia|1|||
130587586|NCT00408005|470112952|FG001|Induction|Recurrent leukemia|0|||
130587587|NCT00408005|470112953|FG002|Induction|Recurrent leukemia|0|||
130587588|NCT00408005|470112954|FG003|Induction|Recurrent leukemia|0|||
130587589|NCT00408005|470112955|FG004|Induction|Recurrent leukemia|0|||
130587590|NCT00408005|470112956|FG005|Induction|Recurrent leukemia|0|||
130587591|NCT00408005|470112957|FG006|Induction|Recurrent leukemia|0|||
130587592|NCT00408005|470112958|FG007|Induction|Recurrent leukemia|0|||
130587593|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130587594|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130587595|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
130587596|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
130587597|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
130587598|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
130587599|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
130587600|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130587601|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
130587602|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
130587603|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
130587604|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
130587605|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
130587606|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
130587607|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
130587608|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
130587609|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587610|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587611|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
130587612|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587613|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
130587614|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587615|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587616|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130587617|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130587618|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130587619|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
130587620|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
130587621|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
130587622|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
130587623|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
130587624|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
130587625|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130587626|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130587627|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
130587628|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
130587629|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130587630|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
130587631|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130587632|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130587633|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
130587634|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
130587635|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
130587636|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
130587637|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
130587638|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
130587639|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
130587640|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
130587641|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587642|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587643|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587644|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587645|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
130587646|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587647|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587648|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130587649|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130587650|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130587651|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
130587652|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130587653|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130587654|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130587655|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130587656|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130587657|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130587658|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130587659|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130587660|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130587661|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
130587662|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130587663|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
130587664|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
130587665|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587666|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587667|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587668|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587669|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587670|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
130587671|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587672|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130587673|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130587674|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130587675|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
130587676|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
130587677|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
130587678|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
130587679|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130587680|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130587681|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587682|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587683|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587684|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587685|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
130587686|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
130587687|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587688|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130587689|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130587690|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130587691|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
130587692|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
130587693|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
130587694|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
130587695|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
130587696|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130587697|NCT00408005|470112951|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130587698|NCT00408005|470112952|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130587699|NCT00408005|470112953|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
130587700|NCT00408005|470112954|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130587701|NCT00408005|470112955|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130587702|NCT00408005|470112956|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130587703|NCT00408005|470112957|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130587704|NCT00408005|470112958|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130587705|NCT03155997|470112959|FG000|Overall Study|Withdrawal by Subject|119|||
130587706|NCT03155997|470112960|FG001|Overall Study|Withdrawal by Subject|134|||
130587707|NCT03155997|470112959|FG000|Overall Study|Lost to Follow-up|12|||
130587708|NCT03155997|470112960|FG001|Overall Study|Lost to Follow-up|13|||
130587709|NCT03155997|470112959|FG000|Overall Study|Missing disposition data|0|||
130587710|NCT03155997|470112960|FG001|Overall Study|Missing disposition data|1|||
130587711|NCT03155997|470112959|FG000|Overall Study|On study treatment|2027|||
130587712|NCT03155997|470112960|FG001|Overall Study|On study treatment|2074|||
130587713|NCT01848145|470112961|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
130587714|NCT01848145|470112961|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
130587715|NCT01848145|470112961|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
130587716|NCT01848145|470112961|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
130587717|NCT01848145|470112961|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
130587718|NCT01848145|470112961|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
130587719|NCT01848145|470112961|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
130587720|NCT04067518|470112962|FG000|Overall Study|Adverse Event|1|||
130587721|NCT04067518|470112963|FG001|Overall Study|Adverse Event|3|||
130587722|NCT04067518|470112962|FG000|Overall Study|Screen failures|0|||
130587723|NCT04067518|470112963|FG001|Overall Study|Screen failures|1|||
130587724|NCT04067518|470112962|FG000|Overall Study|Enrolled but not treated|0|||
130587725|NCT04067518|470112963|FG001|Overall Study|Enrolled but not treated|1|||
130587726|NCT00862251|470112964|FG000|Overall Study|Adverse Event|8|||
130587727|NCT00862251|470112965|FG001|Overall Study|Adverse Event|3|||
130587728|NCT00862251|470112966|FG002|Overall Study|Adverse Event|1|||
130587729|NCT00862251|470112964|FG000|Overall Study|Lost to Follow-up|0|||
130587730|NCT00862251|470112965|FG001|Overall Study|Lost to Follow-up|0|||
130587731|NCT00862251|470112966|FG002|Overall Study|Lost to Follow-up|1|||
130587732|NCT00862251|470112964|FG000|Overall Study|Protocol Violation|2|||
130587733|NCT00862251|470112965|FG001|Overall Study|Protocol Violation|0|||
130587734|NCT00862251|470112966|FG002|Overall Study|Protocol Violation|1|||
130587735|NCT00862251|470112964|FG000|Overall Study|Withdrawal by Subject|9|||
130587736|NCT00862251|470112965|FG001|Overall Study|Withdrawal by Subject|2|||
130587737|NCT00862251|470112966|FG002|Overall Study|Withdrawal by Subject|6|||
130587738|NCT00675025|470112967|FG000|Overall Study|Study Terminated by Sponsor|38|||
130587739|NCT00675025|470112968|FG001|Overall Study|Study Terminated by Sponsor|42|||
130587740|NCT00675025|470112967|FG000|Overall Study|Adverse Event|6|||
130587741|NCT00675025|470112968|FG001|Overall Study|Adverse Event|11|||
130587742|NCT00675025|470112967|FG000|Overall Study|Lost to Follow-up|6|||
130587743|NCT00675025|470112968|FG001|Overall Study|Lost to Follow-up|4|||
130587744|NCT00675025|470112967|FG000|Overall Study|Withdrawal by Subject|4|||
130587745|NCT00675025|470112968|FG001|Overall Study|Withdrawal by Subject|6|||
130587746|NCT02054702|470112972|FG000|Overall Study|Lost to Follow-up|3|||
130587747|NCT02054702|470112973|FG001|Overall Study|Lost to Follow-up|5|||
130587748|NCT02054702|470112972|FG000|Overall Study|Adverse Event|3|||
130587749|NCT02054702|470112973|FG001|Overall Study|Adverse Event|1|||
130587750|NCT02054702|470112972|FG000|Overall Study|Met Withdrawal Criteria|4|||
130587751|NCT02054702|470112973|FG001|Overall Study|Met Withdrawal Criteria|1|||
130587752|NCT02054702|470112972|FG000|Overall Study|Physician Decision|0|||
130587753|NCT02054702|470112973|FG001|Overall Study|Physician Decision|1|||
130587754|NCT02054702|470112972|FG000|Overall Study|Withdrawal by Subject|14|||
130587755|NCT02054702|470112973|FG001|Overall Study|Withdrawal by Subject|4|||
130587756|NCT03417440|470112982|FG000|Overall Study|Lost to Follow-up|0|||
130587757|NCT03417440|470112983|FG001|Overall Study|Lost to Follow-up|1|||
130587758|NCT03417440|470112984|FG002|Overall Study|Lost to Follow-up|0|||
130587759|NCT03417440|470112985|FG003|Overall Study|Lost to Follow-up|0|||
130587760|NCT03417440|470112986|FG004|Overall Study|Lost to Follow-up|1|||
130587761|NCT03417440|470112987|FG005|Overall Study|Lost to Follow-up|0|||
130587762|NCT03417440|470112988|FG006|Overall Study|Lost to Follow-up|0|||
130587763|NCT03417440|470112989|FG007|Overall Study|Lost to Follow-up|0|||
130587764|NCT03417440|470112982|FG000|Overall Study|Withdrawal by Subject|2|||
130587765|NCT03417440|470112983|FG001|Overall Study|Withdrawal by Subject|0|||
130587766|NCT03417440|470112984|FG002|Overall Study|Withdrawal by Subject|2|||
130587767|NCT03417440|470112985|FG003|Overall Study|Withdrawal by Subject|1|||
130587768|NCT03417440|470112986|FG004|Overall Study|Withdrawal by Subject|1|||
130587769|NCT03417440|470112987|FG005|Overall Study|Withdrawal by Subject|0|||
130587770|NCT03417440|470112988|FG006|Overall Study|Withdrawal by Subject|0|||
130587771|NCT03417440|470112989|FG007|Overall Study|Withdrawal by Subject|1|||
130587772|NCT03304522|470112990|FG000|Overall Study|Adverse Event|0|||
130587773|NCT03304522|470112991|FG001|Overall Study|Adverse Event|4|||
130587774|NCT03304522|470112990|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130587775|NCT03304522|470112991|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130587776|NCT03304522|470112990|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
130587777|NCT03304522|470112991|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
130587778|NCT03304522|470112990|FG000|Overall Study|Other|0|||
130587779|NCT03304522|470112991|FG001|Overall Study|Other|1|||
130587780|NCT02013544|470112994|FG000|Overall Study|Adverse Event|5|||
130587781|NCT02013544|470112995|FG001|Overall Study|Adverse Event|5|||
130587782|NCT02013544|470112994|FG000|Overall Study|Lost to Follow-up|2|||
130587783|NCT02013544|470112995|FG001|Overall Study|Lost to Follow-up|3|||
130587784|NCT02013544|470112994|FG000|Overall Study|Withdrawal by Subject|2|||
130587785|NCT02013544|470112995|FG001|Overall Study|Withdrawal by Subject|8|||
130587786|NCT02013544|470112994|FG000|Overall Study|Physician Decision|0|||
130587787|NCT02013544|470112995|FG001|Overall Study|Physician Decision|1|||
130587788|NCT02013544|470112994|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
130587789|NCT02013544|470112995|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
130587790|NCT00238264|470112996|FG000|Overall Study|Death|7|||
130587791|NCT00238264|470112996|FG000|Overall Study|Lost to Follow-up|18|||
130587792|NCT00238264|470112996|FG000|Overall Study|Withdrawal by Subject|4|||
130587793|NCT00238264|470112996|FG000|Overall Study|Ineligible|7|||
130587794|NCT00885365|470112999|FG000|4 Weeks ON Treatment|Adverse Event|2|||
130587795|NCT00885365|470113000|FG001|4 Weeks ON Treatment|Adverse Event|4|||
130587796|NCT00885365|470112999|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
130587797|NCT00885365|470113000|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
130587798|NCT00885365|470112999|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
130587799|NCT00885365|470113000|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
130587800|NCT02706938|470113001|FG000|First Period, 6 Weeks|Adverse Event|8|||
130587801|NCT02706938|470113002|FG001|First Period, 6 Weeks|Adverse Event|0|||
130587802|NCT02706938|470113001|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
130587803|NCT02706938|470113002|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
130587804|NCT02706938|470113001|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
130587805|NCT02706938|470113002|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
130587806|NCT02706938|470113001|FG000|Second Period, 6 Weeks|Adverse Event|0|||
130587807|NCT02706938|470113002|FG001|Second Period, 6 Weeks|Adverse Event|7|||
130587808|NCT02706938|470113001|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
130587809|NCT02706938|470113002|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
130587810|NCT03838484|470113003|FG000|Overall Study|Lost to Follow-up|0|||
130587811|NCT03838484|470113004|FG001|Overall Study|Lost to Follow-up|1|||
130587812|NCT03838484|470113005|FG002|Overall Study|Lost to Follow-up|0|||
130587813|NCT03838484|470113006|FG003|Overall Study|Lost to Follow-up|0|||
130587814|NCT00813995|470113007|FG000|Overall Study|Clinical adverse event|9|||
130587815|NCT00813995|470113008|FG001|Overall Study|Clinical adverse event|3|||
130587816|NCT00813995|470113007|FG000|Overall Study|Laboratory adverse event|0|||
130587817|NCT00813995|470113008|FG001|Overall Study|Laboratory adverse event|2|||
130587818|NCT00813995|470113007|FG000|Overall Study|Lack of Efficacy|1|||
130587819|NCT00813995|470113008|FG001|Overall Study|Lack of Efficacy|0|||
130587820|NCT00813995|470113007|FG000|Overall Study|Lost to Follow-up|4|||
130587821|NCT00813995|470113008|FG001|Overall Study|Lost to Follow-up|2|||
130587822|NCT00813995|470113007|FG000|Overall Study|Other reason|2|||
130587823|NCT00813995|470113008|FG001|Overall Study|Other reason|2|||
130587824|NCT00813995|470113007|FG000|Overall Study|Protocol Violation|3|||
130587825|NCT00813995|470113008|FG001|Overall Study|Protocol Violation|2|||
130587826|NCT00813995|470113007|FG000|Overall Study|Subject moved|4|||
130587827|NCT00813995|470113008|FG001|Overall Study|Subject moved|0|||
130587828|NCT00813995|470113007|FG000|Overall Study|Withdrawal by Subject|0|||
130587829|NCT00813995|470113008|FG001|Overall Study|Withdrawal by Subject|5|||
130587830|NCT02507349|470113009|FG000|Overall Study|Death|12|||
130587831|NCT02507349|470113010|FG001|Overall Study|Death|16|||
130587832|NCT02507349|470113009|FG000|Overall Study|Withdrawal by Subject|1|||
130587833|NCT02507349|470113010|FG001|Overall Study|Withdrawal by Subject|1|||
130587834|NCT02507349|470113009|FG000|Overall Study|Lost to Follow-up|174|||
130587835|NCT02507349|470113010|FG001|Overall Study|Lost to Follow-up|144|||
130587836|NCT00860470|470113019|FG000|Overall Study|Death|6|||
130587837|NCT00860470|470113020|FG001|Overall Study|Death|10|||
130587838|NCT00860470|470113019|FG000|Overall Study|Moved away|8|||
130587839|NCT00860470|470113020|FG001|Overall Study|Moved away|10|||
130587840|NCT00860470|470113019|FG000|Overall Study|Lost to Follow-up|34|||
130587841|NCT00860470|470113020|FG001|Overall Study|Lost to Follow-up|39|||
130587842|NCT02700984|470113022|FG000|Overall Study|Death|2|||
130587843|NCT02700984|470113023|FG001|Overall Study|Death|1|||
130587844|NCT02700984|470113022|FG000|Overall Study|Lost to Follow-up|2|||
130587845|NCT02700984|470113023|FG001|Overall Study|Lost to Follow-up|1|||
130587846|NCT02700984|470113022|FG000|Overall Study|Physician Decision|0|||
130587847|NCT02700984|470113023|FG001|Overall Study|Physician Decision|1|||
130587848|NCT02700984|470113022|FG000|Overall Study|Withdrawal by Subject|8|||
130587849|NCT02700984|470113023|FG001|Overall Study|Withdrawal by Subject|9|||
130587850|NCT02700984|470113022|FG000|Overall Study|Reason not specified|3|||
130587851|NCT02700984|470113023|FG001|Overall Study|Reason not specified|2|||
130587852|NCT00473876|470113033|FG000|Overall Study|Lost to Follow-up|3|||
130587853|NCT00473876|470113034|FG001|Overall Study|Lost to Follow-up|1|||
130587854|NCT00348140|470113035|FG000|Overall Study|Adverse Event|46|||
130587855|NCT00348140|470113036|FG001|Overall Study|Adverse Event|49|||
130587856|NCT00348140|470113037|FG002|Overall Study|Adverse Event|78|||
130587857|NCT00348140|470113035|FG000|Overall Study|Lost to Follow-up|4|||
130587858|NCT00348140|470113036|FG001|Overall Study|Lost to Follow-up|4|||
130587859|NCT00348140|470113037|FG002|Overall Study|Lost to Follow-up|4|||
130587860|NCT00348140|470113035|FG000|Overall Study|Protocol Violation|12|||
130587861|NCT00348140|470113036|FG001|Overall Study|Protocol Violation|13|||
130587862|NCT00348140|470113037|FG002|Overall Study|Protocol Violation|14|||
130587863|NCT00348140|470113035|FG000|Overall Study|Withdrawal by Subject|32|||
130587864|NCT00348140|470113036|FG001|Overall Study|Withdrawal by Subject|40|||
130587865|NCT00348140|470113037|FG002|Overall Study|Withdrawal by Subject|40|||
130587866|NCT00348140|470113035|FG000|Overall Study|Non-compliance|8|||
130587867|NCT00348140|470113036|FG001|Overall Study|Non-compliance|13|||
130587868|NCT00348140|470113037|FG002|Overall Study|Non-compliance|5|||
130587869|NCT00348140|470113035|FG000|Overall Study|Participant at risk due to study drug|2|||
130587870|NCT00348140|470113036|FG001|Overall Study|Participant at risk due to study drug|0|||
130587871|NCT00348140|470113037|FG002|Overall Study|Participant at risk due to study drug|0|||
130587872|NCT00348140|470113035|FG000|Overall Study|Conditional medication increased dose|1|||
130587873|NCT00348140|470113036|FG001|Overall Study|Conditional medication increased dose|0|||
130587874|NCT00348140|470113037|FG002|Overall Study|Conditional medication increased dose|0|||
130587875|NCT00348140|470113035|FG000|Overall Study|Caregiver related|4|||
130587876|NCT00348140|470113036|FG001|Overall Study|Caregiver related|7|||
130587877|NCT00348140|470113037|FG002|Overall Study|Caregiver related|3|||
130587878|NCT00348140|470113035|FG000|Overall Study|Participant hospitalised|3|||
130587879|NCT00348140|470113036|FG001|Overall Study|Participant hospitalised|0|||
130587880|NCT00348140|470113037|FG002|Overall Study|Participant hospitalised|0|||
130587881|NCT00348140|470113035|FG000|Overall Study|Efficacy related|1|||
130587882|NCT00348140|470113036|FG001|Overall Study|Efficacy related|1|||
130587883|NCT00348140|470113037|FG002|Overall Study|Efficacy related|0|||
130587884|NCT00348140|470113035|FG000|Overall Study|Administration related|3|||
130587885|NCT00348140|470113036|FG001|Overall Study|Administration related|1|||
130587886|NCT00348140|470113037|FG002|Overall Study|Administration related|1|||
130587887|NCT00348140|470113035|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
130587888|NCT00348140|470113036|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
130587889|NCT00348140|470113037|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
130587890|NCT00348140|470113035|FG000|Overall Study|Participant unwell|1|||
130587891|NCT00348140|470113036|FG001|Overall Study|Participant unwell|0|||
130587892|NCT00348140|470113037|FG002|Overall Study|Participant unwell|0|||
130587893|NCT00348140|470113035|FG000|Overall Study|Screen failure|1|||
130587894|NCT00348140|470113036|FG001|Overall Study|Screen failure|0|||
130587895|NCT00348140|470113037|FG002|Overall Study|Screen failure|0|||
130587896|NCT00348140|470113035|FG000|Overall Study|Investigator decided to discontinue|4|||
130587897|NCT00348140|470113036|FG001|Overall Study|Investigator decided to discontinue|1|||
130587898|NCT00348140|470113037|FG002|Overall Study|Investigator decided to discontinue|4|||
130587899|NCT00348140|470113035|FG000|Overall Study|Decided to discontinue on their own|1|||
130587900|NCT00348140|470113036|FG001|Overall Study|Decided to discontinue on their own|4|||
130587901|NCT00348140|470113037|FG002|Overall Study|Decided to discontinue on their own|1|||
130587902|NCT00348140|470113035|FG000|Overall Study|Use of prohibited drug|1|||
130587903|NCT00348140|470113036|FG001|Overall Study|Use of prohibited drug|0|||
130587904|NCT00348140|470113037|FG002|Overall Study|Use of prohibited drug|2|||
130587905|NCT00348140|470113035|FG000|Overall Study|Disease progression|1|||
130587906|NCT00348140|470113036|FG001|Overall Study|Disease progression|2|||
130587907|NCT00348140|470113037|FG002|Overall Study|Disease progression|5|||
130587908|NCT00348140|470113035|FG000|Overall Study|Increased risk of cardiac infarction|0|||
130587909|NCT00348140|470113036|FG001|Overall Study|Increased risk of cardiac infarction|1|||
130587910|NCT00348140|470113037|FG002|Overall Study|Increased risk of cardiac infarction|0|||
130587911|NCT00348140|470113035|FG000|Overall Study|Serious adverse event|0|||
130587912|NCT00348140|470113036|FG001|Overall Study|Serious adverse event|1|||
130587913|NCT00348140|470113037|FG002|Overall Study|Serious adverse event|0|||
130587914|NCT00348140|470113035|FG000|Overall Study|Abnormal ECG|0|||
130587915|NCT00348140|470113036|FG001|Overall Study|Abnormal ECG|1|||
130587916|NCT00348140|470113037|FG002|Overall Study|Abnormal ECG|3|||
130587917|NCT00348140|470113035|FG000|Overall Study|Participant died|0|||
130587918|NCT00348140|470113036|FG001|Overall Study|Participant died|1|||
130587919|NCT00348140|470113037|FG002|Overall Study|Participant died|0|||
130587920|NCT00348140|470113035|FG000|Overall Study|Exclusion criteria met|0|||
130587921|NCT00348140|470113036|FG001|Overall Study|Exclusion criteria met|0|||
130587922|NCT00348140|470113037|FG002|Overall Study|Exclusion criteria met|1|||
130587923|NCT00348140|470113035|FG000|Overall Study|Memory declined|0|||
130587924|NCT00348140|470113036|FG001|Overall Study|Memory declined|0|||
130587925|NCT00348140|470113037|FG002|Overall Study|Memory declined|1|||
130587926|NCT03371355|470113040|FG000|Overall Study|Investigator judgment|0|||
130587927|NCT03371355|470113041|FG001|Overall Study|Investigator judgment|0|||
130587928|NCT03371355|470113042|FG002|Overall Study|Investigator judgment|1|||
130587929|NCT03371355|470113043|FG003|Overall Study|Investigator judgment|1|||
130587930|NCT03371355|470113040|FG000|Overall Study|Voluntary withdrawal|1|||
130587931|NCT03371355|470113041|FG001|Overall Study|Voluntary withdrawal|0|||
130587932|NCT03371355|470113042|FG002|Overall Study|Voluntary withdrawal|1|||
130587933|NCT03371355|470113043|FG003|Overall Study|Voluntary withdrawal|2|||
130587934|NCT03371355|470113040|FG000|Overall Study|Adverse Event|0|||
130587935|NCT03371355|470113041|FG001|Overall Study|Adverse Event|1|||
130587936|NCT03371355|470113042|FG002|Overall Study|Adverse Event|2|||
130587937|NCT03371355|470113043|FG003|Overall Study|Adverse Event|3|||
130587938|NCT03371355|470113040|FG000|Overall Study|Reason not Specified|0|||
130587939|NCT03371355|470113041|FG001|Overall Study|Reason not Specified|1|||
130587940|NCT03371355|470113042|FG002|Overall Study|Reason not Specified|0|||
130587941|NCT03371355|470113043|FG003|Overall Study|Reason not Specified|1|||
130587942|NCT02868892|470113044|FG000|Overall Study|Investigator left site and no follow-up|6|||
130587943|NCT01662648|470113045|FG000|Overall Study|Death|1|||
130587944|NCT01662648|470113046|FG001|Overall Study|Death|3|||
130587945|NCT01662648|470113045|FG000|Overall Study|Adverse Event|40|||
130587946|NCT01662648|470113046|FG001|Overall Study|Adverse Event|37|||
130587947|NCT01662648|470113045|FG000|Overall Study|Lack of Efficacy|17|||
130587948|NCT01662648|470113046|FG001|Overall Study|Lack of Efficacy|16|||
130587949|NCT01662648|470113045|FG000|Overall Study|Participant ineligible to continue trial|1|||
130587950|NCT01662648|470113046|FG001|Overall Study|Participant ineligible to continue trial|1|||
130587951|NCT01662648|470113045|FG000|Overall Study|Lost to Follow-up|24|||
130587952|NCT01662648|470113046|FG001|Overall Study|Lost to Follow-up|36|||
130587953|NCT01662648|470113045|FG000|Overall Study|Withdrawal by Subject|36|||
130587954|NCT01662648|470113046|FG001|Overall Study|Withdrawal by Subject|53|||
130587955|NCT01662648|470113045|FG000|Overall Study|Participant non-compliant|16|||
130587956|NCT01662648|470113046|FG001|Overall Study|Participant non-compliant|20|||
130587957|NCT01662648|470113045|FG000|Overall Study|Other|8|||
130587958|NCT01662648|470113046|FG001|Overall Study|Other|11|||
130587959|NCT01662648|470113045|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
130587960|NCT01662648|470113046|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
130587961|NCT01662648|470113045|FG000|Overall Study|LOE and other reason unspecified|1|||
130587962|NCT01662648|470113046|FG001|Overall Study|LOE and other reason unspecified|0|||
130587963|NCT01662648|470113045|FG000|Overall Study|LOE and Participant non-compliant|0|||
130587964|NCT01662648|470113046|FG001|Overall Study|LOE and Participant non-compliant|1|||
130587965|NCT00619957|470113048|FG000|Month 24 Double-Blind|Adverse Event|9|||
130587966|NCT00619957|470113049|FG001|Month 24 Double-Blind|Adverse Event|7|||
130587967|NCT00619957|470113048|FG000|Month 24 Double-Blind|Protocol Violation|1|||
130587968|NCT00619957|470113049|FG001|Month 24 Double-Blind|Protocol Violation|0|||
130587969|NCT00619957|470113048|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
130587970|NCT00619957|470113049|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
130587971|NCT00619957|470113048|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
130587972|NCT00619957|470113049|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
130587973|NCT00619957|470113048|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
130587974|NCT00619957|470113049|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
130587975|NCT00619957|470113048|FG000|Month 48 Open-Label|Adverse Event|4|||
130587976|NCT00619957|470113049|FG001|Month 48 Open-Label|Adverse Event|4|||
130587977|NCT00619957|470113048|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
130587978|NCT00619957|470113049|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
130587979|NCT00619957|470113048|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
130587980|NCT00619957|470113049|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
130587981|NCT02292212|470113051|FG000|ViE Phase|Withdrawal by Subject|1|||
130587982|NCT02292212|470113051|FG000|ViE Phase|Protocol Violation|2|||
130587983|NCT01791855|470113054|FG000|Overall Study|Adverse Event|0|||
130587984|NCT01791855|470113055|FG001|Overall Study|Adverse Event|0|||
130587985|NCT01791855|470113056|FG002|Overall Study|Adverse Event|0|||
130587986|NCT01791855|470113057|FG003|Overall Study|Adverse Event|1|||
130587987|NCT01791855|470113054|FG000|Overall Study|Randomized, not treated|0|||
130587988|NCT01791855|470113055|FG001|Overall Study|Randomized, not treated|1|||
130587989|NCT01791855|470113056|FG002|Overall Study|Randomized, not treated|0|||
130587990|NCT01791855|470113057|FG003|Overall Study|Randomized, not treated|0|||
130587991|NCT00772447|470113058|FG000|Overall Study|Withdrawal by Subject|9|||
130587992|NCT00772447|470113059|FG001|Overall Study|Withdrawal by Subject|5|||
130587993|NCT00772447|470113058|FG000|Overall Study|Physician Decision|4|||
130587994|NCT00772447|470113059|FG001|Overall Study|Physician Decision|8|||
130587995|NCT00772447|470113058|FG000|Overall Study|Lost to Follow-up|2|||
130587996|NCT00772447|470113059|FG001|Overall Study|Lost to Follow-up|4|||
130587997|NCT00772447|470113058|FG000|Overall Study|incorrect enrolment|3|||
130587998|NCT00772447|470113059|FG001|Overall Study|incorrect enrolment|4|||
130587999|NCT00772447|470113058|FG000|Overall Study|Protocol Violation|0|||
130588000|NCT00772447|470113059|FG001|Overall Study|Protocol Violation|1|||
130588001|NCT00772447|470113058|FG000|Overall Study|all others|2|||
130588002|NCT00772447|470113059|FG001|Overall Study|all others|2|||
130588003|NCT01957137|470113063|FG000|Randomized Portion|Adverse Event|1|||
130588004|NCT01957137|470113063|FG000|Randomized Portion|Withdrawal by Subject|1|||
130588005|NCT02497001|470113064|FG000|Overall Study|Lost to Follow-up|10|||
130588006|NCT02497001|470113065|FG001|Overall Study|Lost to Follow-up|2|||
130588007|NCT02497001|470113066|FG002|Overall Study|Lost to Follow-up|0|||
130588008|NCT02497001|470113067|FG003|Overall Study|Lost to Follow-up|2|||
130588009|NCT02497001|470113064|FG000|Overall Study|Adverse Event|28|||
130588010|NCT02497001|470113065|FG001|Overall Study|Adverse Event|30|||
130588011|NCT02497001|470113066|FG002|Overall Study|Adverse Event|11|||
130588012|NCT02497001|470113067|FG003|Overall Study|Adverse Event|11|||
130588013|NCT02497001|470113064|FG000|Overall Study|Withdrawal by Subject|14|||
130588014|NCT02497001|470113065|FG001|Overall Study|Withdrawal by Subject|37|||
130588015|NCT02497001|470113066|FG002|Overall Study|Withdrawal by Subject|19|||
130588016|NCT02497001|470113067|FG003|Overall Study|Withdrawal by Subject|15|||
130588017|NCT02497001|470113064|FG000|Overall Study|Physician Decision|5|||
130588018|NCT02497001|470113065|FG001|Overall Study|Physician Decision|11|||
130588019|NCT02497001|470113066|FG002|Overall Study|Physician Decision|5|||
130588020|NCT02497001|470113067|FG003|Overall Study|Physician Decision|1|||
130588021|NCT02497001|470113064|FG000|Overall Study|subjects that were not treated|1|||
130588022|NCT02497001|470113065|FG001|Overall Study|subjects that were not treated|2|||
130588023|NCT02497001|470113066|FG002|Overall Study|subjects that were not treated|2|||
130588024|NCT02497001|470113067|FG003|Overall Study|subjects that were not treated|1|||
130588025|NCT02497001|470113064|FG000|Overall Study|Major Protocol Deviation|3|||
130588026|NCT02497001|470113065|FG001|Overall Study|Major Protocol Deviation|4|||
130588027|NCT02497001|470113066|FG002|Overall Study|Major Protocol Deviation|4|||
130588028|NCT02497001|470113067|FG003|Overall Study|Major Protocol Deviation|4|||
130588029|NCT02497001|470113064|FG000|Overall Study|Lack of Efficacy|10|||
130588030|NCT02497001|470113065|FG001|Overall Study|Lack of Efficacy|16|||
130588031|NCT02497001|470113066|FG002|Overall Study|Lack of Efficacy|6|||
130588032|NCT02497001|470113067|FG003|Overall Study|Lack of Efficacy|6|||
130588033|NCT02497001|470113064|FG000|Overall Study|Protocol Violation|3|||
130588034|NCT02497001|470113065|FG001|Overall Study|Protocol Violation|1|||
130588035|NCT02497001|470113066|FG002|Overall Study|Protocol Violation|3|||
130588036|NCT02497001|470113067|FG003|Overall Study|Protocol Violation|1|||
130588037|NCT03898063|470113068|FG000|Overall Study|Withdrawal by Subject|10|||
130588038|NCT03898063|470113069|FG001|Overall Study|Withdrawal by Subject|8|||
130588039|NCT02949830|470113070|FG000|Overall Study|Adverse Event|1|||
130588040|NCT02949830|470113070|FG000|Overall Study|Withdrawal by Subject|1|||
130588041|NCT00054132|470113071|FG000|Overall Study|Not Treated|1|||
130588042|NCT01290887|470113072|FG000|Overall Study|Adverse Event|6|||
130588043|NCT01290887|470113073|FG001|Overall Study|Adverse Event|11|||
130588044|NCT01290887|470113072|FG000|Overall Study|Lack of Efficacy|4|||
130588045|NCT01290887|470113073|FG001|Overall Study|Lack of Efficacy|5|||
130588046|NCT01290887|470113072|FG000|Overall Study|Withdrawal by Subject|26|||
130588047|NCT01290887|470113073|FG001|Overall Study|Withdrawal by Subject|32|||
130588048|NCT01290887|470113072|FG000|Overall Study|Protocol Violation|2|||
130588049|NCT01290887|470113073|FG001|Overall Study|Protocol Violation|1|||
130588050|NCT01290887|470113072|FG000|Overall Study|Lost to Follow-up|4|||
130588051|NCT01290887|470113073|FG001|Overall Study|Lost to Follow-up|4|||
130588052|NCT01290887|470113072|FG000|Overall Study|Non-compliance to study procedures|0|||
130588053|NCT01290887|470113073|FG001|Overall Study|Non-compliance to study procedures|1|||
130588054|NCT01290887|470113072|FG000|Overall Study|Non-compliance to study medications|1|||
130588055|NCT01290887|470113073|FG001|Overall Study|Non-compliance to study medications|0|||
130588056|NCT01290887|470113072|FG000|Overall Study|Sponsor closure of study|420|||
130588057|NCT01290887|470113073|FG001|Overall Study|Sponsor closure of study|476|||
130588058|NCT01290887|470113072|FG000|Overall Study|Other|3|||
130588059|NCT01290887|470113073|FG001|Overall Study|Other|6|||
130588060|NCT01795547|470113074|FG000|Overall Study|Adverse Event|16|||
130588061|NCT01795547|470113075|FG001|Overall Study|Adverse Event|27|||
130588062|NCT01795547|470113074|FG000|Overall Study|Lack of Efficacy|8|||
130588063|NCT01795547|470113075|FG001|Overall Study|Lack of Efficacy|3|||
130588064|NCT01795547|470113074|FG000|Overall Study|Protocol Violation|6|||
130588065|NCT01795547|470113075|FG001|Overall Study|Protocol Violation|4|||
130588066|NCT01795547|470113074|FG000|Overall Study|Lost to Follow-up|2|||
130588067|NCT01795547|470113075|FG001|Overall Study|Lost to Follow-up|5|||
130588068|NCT01795547|470113074|FG000|Overall Study|Withdrawal of consent|7|||
130588069|NCT01795547|470113075|FG001|Overall Study|Withdrawal of consent|12|||
130588070|NCT01795547|470113074|FG000|Overall Study|Not Treated|4|||
130588071|NCT01795547|470113075|FG001|Overall Study|Not Treated|10|||
130588072|NCT01795547|470113074|FG000|Overall Study|Non-compliance with IMP|1|||
130588073|NCT01795547|470113075|FG001|Overall Study|Non-compliance with IMP|1|||
130588074|NCT01795547|470113074|FG000|Overall Study|Others|4|||
130588075|NCT01795547|470113075|FG001|Overall Study|Others|1|||
130588076|NCT01795547|470113074|FG000|Overall Study|Not stated|0|||
130588077|NCT01795547|470113075|FG001|Overall Study|Not stated|1|||
130588078|NCT02764541|470113079|FG000|Overall Study|Withdrawal by Subject|0|||
130588079|NCT02764541|470113080|FG001|Overall Study|Withdrawal by Subject|0|||
130588080|NCT02764541|470113081|FG002|Overall Study|Withdrawal by Subject|0|||
130588081|NCT02764541|470113082|FG003|Overall Study|Withdrawal by Subject|0|||
130588082|NCT02764541|470113083|FG004|Overall Study|Withdrawal by Subject|1|||
130588083|NCT02764541|470113084|FG005|Overall Study|Withdrawal by Subject|1|||
130588084|NCT02764541|470113085|FG006|Overall Study|Withdrawal by Subject|0|||
130588085|NCT02764541|470113086|FG007|Overall Study|Withdrawal by Subject|1|||
130588086|NCT02764541|470113079|FG000|Overall Study|Adverse Event|1|||
130588087|NCT02764541|470113080|FG001|Overall Study|Adverse Event|0|||
130588088|NCT02764541|470113081|FG002|Overall Study|Adverse Event|0|||
130588089|NCT02764541|470113082|FG003|Overall Study|Adverse Event|0|||
130588090|NCT02764541|470113083|FG004|Overall Study|Adverse Event|0|||
130588091|NCT02764541|470113084|FG005|Overall Study|Adverse Event|0|||
130588092|NCT02764541|470113085|FG006|Overall Study|Adverse Event|1|||
130588093|NCT02764541|470113086|FG007|Overall Study|Adverse Event|0|||
130588094|NCT02764541|470113079|FG000|Overall Study|Metastasis|1|||
130588095|NCT02764541|470113080|FG001|Overall Study|Metastasis|0|||
130588096|NCT02764541|470113081|FG002|Overall Study|Metastasis|0|||
130588097|NCT02764541|470113082|FG003|Overall Study|Metastasis|0|||
130588098|NCT02764541|470113083|FG004|Overall Study|Metastasis|0|||
130588099|NCT02764541|470113084|FG005|Overall Study|Metastasis|0|||
130588100|NCT02764541|470113085|FG006|Overall Study|Metastasis|0|||
130588101|NCT02764541|470113086|FG007|Overall Study|Metastasis|0|||
130588102|NCT02764541|470113079|FG000|Overall Study|Disease progression|1|||
130588103|NCT02764541|470113080|FG001|Overall Study|Disease progression|1|||
130588104|NCT02764541|470113081|FG002|Overall Study|Disease progression|0|||
130588105|NCT02764541|470113082|FG003|Overall Study|Disease progression|0|||
130588106|NCT02764541|470113083|FG004|Overall Study|Disease progression|0|||
130588107|NCT02764541|470113084|FG005|Overall Study|Disease progression|0|||
130588108|NCT02764541|470113085|FG006|Overall Study|Disease progression|0|||
130588109|NCT02764541|470113086|FG007|Overall Study|Disease progression|1|||
130588110|NCT02764541|470113079|FG000|Overall Study|Protocol Violation|0|||
130588111|NCT02764541|470113080|FG001|Overall Study|Protocol Violation|0|||
130588112|NCT02764541|470113081|FG002|Overall Study|Protocol Violation|0|||
130588113|NCT02764541|470113082|FG003|Overall Study|Protocol Violation|1|||
130588114|NCT02764541|470113083|FG004|Overall Study|Protocol Violation|0|||
130588115|NCT02764541|470113084|FG005|Overall Study|Protocol Violation|1|||
130588116|NCT02764541|470113085|FG006|Overall Study|Protocol Violation|0|||
130588117|NCT02764541|470113086|FG007|Overall Study|Protocol Violation|0|||
130588118|NCT02764541|470113079|FG000|Overall Study|Physician Decision|0|||
130588119|NCT02764541|470113080|FG001|Overall Study|Physician Decision|0|||
130588120|NCT02764541|470113081|FG002|Overall Study|Physician Decision|0|||
130588121|NCT02764541|470113082|FG003|Overall Study|Physician Decision|1|||
130588122|NCT02764541|470113083|FG004|Overall Study|Physician Decision|0|||
130588123|NCT02764541|470113084|FG005|Overall Study|Physician Decision|0|||
130588124|NCT02764541|470113085|FG006|Overall Study|Physician Decision|0|||
130588125|NCT02764541|470113086|FG007|Overall Study|Physician Decision|1|||
130588126|NCT02764541|470113079|FG000|Overall Study|Three Cycles completed before surgery|0|||
130588127|NCT02764541|470113080|FG001|Overall Study|Three Cycles completed before surgery|0|||
130588128|NCT02764541|470113081|FG002|Overall Study|Three Cycles completed before surgery|0|||
130588129|NCT02764541|470113082|FG003|Overall Study|Three Cycles completed before surgery|1|||
130588130|NCT02764541|470113083|FG004|Overall Study|Three Cycles completed before surgery|0|||
130588131|NCT02764541|470113084|FG005|Overall Study|Three Cycles completed before surgery|0|||
130588132|NCT02764541|470113085|FG006|Overall Study|Three Cycles completed before surgery|0|||
130588133|NCT02764541|470113086|FG007|Overall Study|Three Cycles completed before surgery|0|||
130588134|NCT02764541|470113079|FG000|Overall Study|Patient Compliance|0|||
130588135|NCT02764541|470113080|FG001|Overall Study|Patient Compliance|0|||
130588136|NCT02764541|470113081|FG002|Overall Study|Patient Compliance|1|||
130588137|NCT02764541|470113082|FG003|Overall Study|Patient Compliance|0|||
130588138|NCT02764541|470113083|FG004|Overall Study|Patient Compliance|0|||
130588139|NCT02764541|470113084|FG005|Overall Study|Patient Compliance|0|||
130588140|NCT02764541|470113085|FG006|Overall Study|Patient Compliance|0|||
130588141|NCT02764541|470113086|FG007|Overall Study|Patient Compliance|0|||
130588142|NCT02764541|470113079|FG000|Overall Study|Death|0|||
130588143|NCT02764541|470113080|FG001|Overall Study|Death|0|||
130588144|NCT02764541|470113081|FG002|Overall Study|Death|0|||
130588145|NCT02764541|470113082|FG003|Overall Study|Death|0|||
130588146|NCT02764541|470113083|FG004|Overall Study|Death|0|||
130588147|NCT02764541|470113084|FG005|Overall Study|Death|0|||
130588148|NCT02764541|470113085|FG006|Overall Study|Death|1|||
130588149|NCT02764541|470113086|FG007|Overall Study|Death|0|||
130588150|NCT02764541|470113079|FG000|Overall Study|Insurance reasons|0|||
130588151|NCT02764541|470113080|FG001|Overall Study|Insurance reasons|0|||
130588152|NCT02764541|470113081|FG002|Overall Study|Insurance reasons|0|||
130588153|NCT02764541|470113082|FG003|Overall Study|Insurance reasons|0|||
130588154|NCT02764541|470113083|FG004|Overall Study|Insurance reasons|0|||
130588155|NCT02764541|470113084|FG005|Overall Study|Insurance reasons|0|||
130588156|NCT02764541|470113085|FG006|Overall Study|Insurance reasons|1|||
130588157|NCT02764541|470113086|FG007|Overall Study|Insurance reasons|0|||
130588158|NCT02040142|470113092|FG000|Overall Study|Lost to Follow-up|5|||
130588159|NCT02040142|470113092|FG000|Overall Study|Death|17|||
130588160|NCT02040142|470113092|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
130588161|NCT02330419|470113093|FG000|Overall Study|Lost to Follow-up|3|||
130588162|NCT02330419|470113094|FG001|Overall Study|Lost to Follow-up|7|||
130588163|NCT01813890|470113097|FG000|Overall Study|Adverse Event|0|||
130588164|NCT01813890|470113098|FG001|Overall Study|Adverse Event|3|||
130588165|NCT01813890|470113099|FG002|Overall Study|Adverse Event|4|||
130588166|NCT01813890|470113097|FG000|Overall Study|Lack of Efficacy|9|||
130588167|NCT01813890|470113098|FG001|Overall Study|Lack of Efficacy|1|||
130588168|NCT01813890|470113099|FG002|Overall Study|Lack of Efficacy|2|||
130588169|NCT04439123|470113100|FG000|Overall Study|Adverse Event|11|||
130588170|NCT04439123|470113100|FG000|Overall Study|Death|1|||
130588171|NCT04439123|470113100|FG000|Overall Study|Disease progression|19|||
130588172|NCT04439123|470113100|FG000|Overall Study|Withdrawal by Subject|2|||
130588173|NCT04439123|470113100|FG000|Overall Study|Still on treatment|2|||
130588174|NCT03952559|470113101|FG000|Double Blind Treatment Period|Adverse Event|0|||
130588175|NCT03952559|470113102|FG001|Double Blind Treatment Period|Adverse Event|2|||
130588176|NCT03952559|470113103|FG002|Double Blind Treatment Period|Adverse Event|1|||
130588177|NCT03952559|470113104|FG003|Double Blind Treatment Period|Adverse Event|0|||
130588178|NCT03952559|470113105|FG004|Double Blind Treatment Period|Adverse Event|1|||
130588179|NCT03952559|470113101|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
130588180|NCT03952559|470113102|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
130588181|NCT03952559|470113103|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
130588182|NCT03952559|470113104|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
130588183|NCT03952559|470113105|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130588184|NCT03952559|470113101|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130588185|NCT03952559|470113102|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130588186|NCT03952559|470113103|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
130588187|NCT03952559|470113104|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
130588188|NCT03952559|470113105|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130588189|NCT03952559|470113101|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
130588190|NCT03952559|470113102|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
130588191|NCT03952559|470113103|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
130588192|NCT03952559|470113104|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
130588193|NCT03952559|470113105|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
130588194|NCT01870739|470113108|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
130588195|NCT01870739|470113109|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
130588196|NCT01870739|470113108|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
130588197|NCT01870739|470113109|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
130588198|NCT01870739|470113108|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
130588199|NCT01870739|470113109|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
130588200|NCT01870739|470113108|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
130588201|NCT01870739|470113109|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
130588202|NCT01870739|470113108|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
130588203|NCT01870739|470113109|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
130588204|NCT01870739|470113108|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
130588205|NCT01870739|470113109|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
130588206|NCT01870739|470113108|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
130588207|NCT01870739|470113109|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
130588208|NCT01986062|470113110|FG000|Overall Study|Lost to Follow-up|1|||
130588209|NCT01986062|470113111|FG001|Overall Study|Lost to Follow-up|0|||
130588210|NCT01986062|470113110|FG000|Overall Study|Withdrawal by Subject|0|||
130588211|NCT01986062|470113111|FG001|Overall Study|Withdrawal by Subject|1|||
130588212|NCT03538743|470113112|FG000|Overall Study|Adverse Event|0|||
130588213|NCT03538743|470113113|FG001|Overall Study|Adverse Event|0|||
130588214|NCT03538743|470113114|FG002|Overall Study|Adverse Event|1|||
130588215|NCT03538743|470113115|FG003|Overall Study|Adverse Event|1|||
130588216|NCT03538743|470113116|FG004|Overall Study|Adverse Event|0|||
130588217|NCT03538743|470113117|FG005|Overall Study|Adverse Event|0|||
130588218|NCT03538743|470113118|FG006|Overall Study|Adverse Event|0|||
130588219|NCT03538743|470113119|FG007|Overall Study|Adverse Event|0|||
130588220|NCT03538743|470113120|FG008|Overall Study|Adverse Event|0|||
130588221|NCT03538743|470113112|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
130588222|NCT03538743|470113113|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
130588223|NCT03538743|470113114|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
130588224|NCT03538743|470113115|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
130588225|NCT03538743|470113116|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
130588226|NCT03538743|470113117|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
130588227|NCT03538743|470113118|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
130588228|NCT03538743|470113119|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
130588229|NCT03538743|470113120|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
130588230|NCT03538743|470113112|FG000|Overall Study|Withdrawal by Subject|0|||
130588231|NCT03538743|470113113|FG001|Overall Study|Withdrawal by Subject|0|||
130588232|NCT03538743|470113114|FG002|Overall Study|Withdrawal by Subject|0|||
130588233|NCT03538743|470113115|FG003|Overall Study|Withdrawal by Subject|1|||
130588234|NCT03538743|470113116|FG004|Overall Study|Withdrawal by Subject|0|||
130588235|NCT03538743|470113117|FG005|Overall Study|Withdrawal by Subject|0|||
130588236|NCT03538743|470113118|FG006|Overall Study|Withdrawal by Subject|0|||
130588237|NCT03538743|470113119|FG007|Overall Study|Withdrawal by Subject|0|||
130588238|NCT03538743|470113120|FG008|Overall Study|Withdrawal by Subject|0|||
130588239|NCT04640766|470113121|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
130588240|NCT00630331|470113122|FG000|Overall Study|Death|2|||
130588241|NCT00630331|470113123|FG001|Overall Study|Death|1|||
130588242|NCT00630331|470113124|FG002|Overall Study|Death|1|||
130588243|NCT00630331|470113122|FG000|Overall Study|Adverse Event|1|||
130588244|NCT00630331|470113123|FG001|Overall Study|Adverse Event|0|||
130588245|NCT00630331|470113124|FG002|Overall Study|Adverse Event|0|||
130588246|NCT00630331|470113122|FG000|Overall Study|Withdrawal by Subject|12|||
130588247|NCT00630331|470113123|FG001|Overall Study|Withdrawal by Subject|7|||
130588248|NCT00630331|470113124|FG002|Overall Study|Withdrawal by Subject|5|||
130588249|NCT00630331|470113122|FG000|Overall Study|Lost to Follow-up|175|||
130588250|NCT00630331|470113123|FG001|Overall Study|Lost to Follow-up|143|||
130588251|NCT00630331|470113124|FG002|Overall Study|Lost to Follow-up|170|||
130588252|NCT00630331|470113122|FG000|Overall Study|Inappropriate enrollment|3|||
130588253|NCT00630331|470113123|FG001|Overall Study|Inappropriate enrollment|6|||
130588254|NCT00630331|470113124|FG002|Overall Study|Inappropriate enrollment|3|||
130588255|NCT00630331|470113122|FG000|Overall Study|Unable to classify|9|||
130588256|NCT00630331|470113123|FG001|Overall Study|Unable to classify|4|||
130588257|NCT00630331|470113124|FG002|Overall Study|Unable to classify|3|||
130588258|NCT00630331|470113122|FG000|Overall Study|Protocol Violation|4|||
130588259|NCT00630331|470113123|FG001|Overall Study|Protocol Violation|5|||
130588260|NCT00630331|470113124|FG002|Overall Study|Protocol Violation|6|||
130588261|NCT01827384|470113126|FG000|Overall Study|Switched to alternative treatment|0|||
130588262|NCT01827384|470113127|FG001|Overall Study|Switched to alternative treatment|0|||
130588263|NCT01827384|470113128|FG002|Overall Study|Switched to alternative treatment|0|||
130588264|NCT01827384|470113129|FG003|Overall Study|Switched to alternative treatment|0|||
130588265|NCT01827384|470113130|FG004|Overall Study|Switched to alternative treatment|0|||
130588266|NCT01827384|470113131|FG005|Overall Study|Switched to alternative treatment|0|||
130588267|NCT01827384|470113132|FG006|Overall Study|Switched to alternative treatment|0|||
130588268|NCT01827384|470113133|FG007|Overall Study|Switched to alternative treatment|0|||
130588269|NCT01827384|470113134|FG008|Overall Study|Switched to alternative treatment|0|||
130588270|NCT01827384|470113135|FG009|Overall Study|Switched to alternative treatment|0|||
130588271|NCT01827384|470113136|FG010|Overall Study|Switched to alternative treatment|0|||
130588272|NCT01827384|470113137|FG011|Overall Study|Switched to alternative treatment|0|||
130588273|NCT01827384|470113138|FG012|Overall Study|Switched to alternative treatment|0|||
130588274|NCT01827384|470113139|FG013|Overall Study|Switched to alternative treatment|2|||
130588275|NCT01827384|470113126|FG000|Overall Study|Disease progression before treatment|0|||
130588276|NCT01827384|470113127|FG001|Overall Study|Disease progression before treatment|0|||
130588277|NCT01827384|470113128|FG002|Overall Study|Disease progression before treatment|0|||
130588278|NCT01827384|470113129|FG003|Overall Study|Disease progression before treatment|0|||
130588279|NCT01827384|470113130|FG004|Overall Study|Disease progression before treatment|0|||
130588280|NCT01827384|470113131|FG005|Overall Study|Disease progression before treatment|0|||
130588281|NCT01827384|470113132|FG006|Overall Study|Disease progression before treatment|0|||
130588282|NCT01827384|470113133|FG007|Overall Study|Disease progression before treatment|0|||
130588283|NCT01827384|470113134|FG008|Overall Study|Disease progression before treatment|0|||
130588284|NCT01827384|470113135|FG009|Overall Study|Disease progression before treatment|0|||
130588285|NCT01827384|470113136|FG010|Overall Study|Disease progression before treatment|0|||
130588286|NCT01827384|470113137|FG011|Overall Study|Disease progression before treatment|0|||
130588287|NCT01827384|470113138|FG012|Overall Study|Disease progression before treatment|0|||
130588288|NCT01827384|470113139|FG013|Overall Study|Disease progression before treatment|4|||
130588289|NCT01827384|470113126|FG000|Overall Study|Ineligible|0|||
130588290|NCT01827384|470113127|FG001|Overall Study|Ineligible|0|||
130588291|NCT01827384|470113128|FG002|Overall Study|Ineligible|0|||
130588292|NCT01827384|470113129|FG003|Overall Study|Ineligible|0|||
130588293|NCT01827384|470113130|FG004|Overall Study|Ineligible|0|||
130588294|NCT01827384|470113131|FG005|Overall Study|Ineligible|0|||
130588295|NCT01827384|470113132|FG006|Overall Study|Ineligible|0|||
130588296|NCT01827384|470113133|FG007|Overall Study|Ineligible|0|||
130588297|NCT01827384|470113134|FG008|Overall Study|Ineligible|0|||
130588298|NCT01827384|470113135|FG009|Overall Study|Ineligible|0|||
130588299|NCT01827384|470113136|FG010|Overall Study|Ineligible|0|||
130588300|NCT01827384|470113137|FG011|Overall Study|Ineligible|0|||
130588301|NCT01827384|470113138|FG012|Overall Study|Ineligible|0|||
130588302|NCT01827384|470113139|FG013|Overall Study|Ineligible|19|||
130588303|NCT01827384|470113126|FG000|Overall Study|Participant died before treatment|0|||
130588304|NCT01827384|470113127|FG001|Overall Study|Participant died before treatment|0|||
130588305|NCT01827384|470113128|FG002|Overall Study|Participant died before treatment|0|||
130588306|NCT01827384|470113129|FG003|Overall Study|Participant died before treatment|0|||
130588307|NCT01827384|470113130|FG004|Overall Study|Participant died before treatment|0|||
130588308|NCT01827384|470113131|FG005|Overall Study|Participant died before treatment|0|||
130588309|NCT01827384|470113132|FG006|Overall Study|Participant died before treatment|0|||
130588310|NCT01827384|470113133|FG007|Overall Study|Participant died before treatment|0|||
130588311|NCT01827384|470113134|FG008|Overall Study|Participant died before treatment|0|||
130588312|NCT01827384|470113135|FG009|Overall Study|Participant died before treatment|0|||
130588313|NCT01827384|470113136|FG010|Overall Study|Participant died before treatment|0|||
130588314|NCT01827384|470113137|FG011|Overall Study|Participant died before treatment|0|||
130588315|NCT01827384|470113138|FG012|Overall Study|Participant died before treatment|0|||
130588316|NCT01827384|470113139|FG013|Overall Study|Participant died before treatment|5|||
130588317|NCT01827384|470113126|FG000|Overall Study|Insufficient tumor cells|0|||
130588318|NCT01827384|470113127|FG001|Overall Study|Insufficient tumor cells|0|||
130588319|NCT01827384|470113128|FG002|Overall Study|Insufficient tumor cells|0|||
130588320|NCT01827384|470113129|FG003|Overall Study|Insufficient tumor cells|0|||
130588321|NCT01827384|470113130|FG004|Overall Study|Insufficient tumor cells|0|||
130588322|NCT01827384|470113131|FG005|Overall Study|Insufficient tumor cells|0|||
130588323|NCT01827384|470113132|FG006|Overall Study|Insufficient tumor cells|0|||
130588324|NCT01827384|470113133|FG007|Overall Study|Insufficient tumor cells|0|||
130588325|NCT01827384|470113134|FG008|Overall Study|Insufficient tumor cells|0|||
130588326|NCT01827384|470113135|FG009|Overall Study|Insufficient tumor cells|0|||
130588327|NCT01827384|470113136|FG010|Overall Study|Insufficient tumor cells|0|||
130588328|NCT01827384|470113137|FG011|Overall Study|Insufficient tumor cells|0|||
130588329|NCT01827384|470113138|FG012|Overall Study|Insufficient tumor cells|0|||
130588330|NCT01827384|470113139|FG013|Overall Study|Insufficient tumor cells|13|||
130588331|NCT01827384|470113126|FG000|Overall Study|No actionable mutation|0|||
130588332|NCT01827384|470113127|FG001|Overall Study|No actionable mutation|0|||
130588333|NCT01827384|470113128|FG002|Overall Study|No actionable mutation|0|||
130588334|NCT01827384|470113129|FG003|Overall Study|No actionable mutation|0|||
130588335|NCT01827384|470113130|FG004|Overall Study|No actionable mutation|0|||
130588336|NCT01827384|470113131|FG005|Overall Study|No actionable mutation|0|||
130588337|NCT01827384|470113132|FG006|Overall Study|No actionable mutation|0|||
130588338|NCT01827384|470113133|FG007|Overall Study|No actionable mutation|0|||
130588339|NCT01827384|470113134|FG008|Overall Study|No actionable mutation|0|||
130588340|NCT01827384|470113135|FG009|Overall Study|No actionable mutation|0|||
130588341|NCT01827384|470113136|FG010|Overall Study|No actionable mutation|0|||
130588342|NCT01827384|470113137|FG011|Overall Study|No actionable mutation|0|||
130588343|NCT01827384|470113138|FG012|Overall Study|No actionable mutation|0|||
130588344|NCT01827384|470113139|FG013|Overall Study|No actionable mutation|73|||
130648329|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130648330|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648331|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130588345|NCT01827384|470113126|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130588346|NCT01827384|470113127|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
130588347|NCT01827384|470113128|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
130588348|NCT01827384|470113129|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
130588349|NCT01827384|470113130|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
130588350|NCT01827384|470113131|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
130588351|NCT01827384|470113132|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
130588352|NCT01827384|470113133|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
130588353|NCT01827384|470113134|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
130588354|NCT01827384|470113135|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
130588355|NCT01827384|470113136|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
130588356|NCT01827384|470113137|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
130588357|NCT01827384|470113138|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
130588358|NCT01827384|470113139|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
130588359|NCT01955707|470113149|FG000|Overall Study|Adverse Event|1|||
130588360|NCT01955707|470113150|FG001|Overall Study|Adverse Event|2|||
130588361|NCT01955707|470113149|FG000|Overall Study|Lost to Follow-up|2|||
130588362|NCT01955707|470113150|FG001|Overall Study|Lost to Follow-up|1|||
130588363|NCT01955707|470113149|FG000|Overall Study|Withdrawal by Subject|0|||
130588364|NCT01955707|470113150|FG001|Overall Study|Withdrawal by Subject|3|||
130588365|NCT01955707|470113149|FG000|Overall Study|Death|13|||
130588366|NCT01955707|470113150|FG001|Overall Study|Death|14|||
130588367|NCT01955707|470113149|FG000|Overall Study|Other|4|||
130588368|NCT01955707|470113150|FG001|Overall Study|Other|2|||
130588369|NCT01817790|470113151|FG000|Overall Study|Adverse Event|0|||
130588370|NCT01817790|470113152|FG001|Overall Study|Adverse Event|2|||
130588371|NCT01817790|470113151|FG000|Overall Study|Lost to Follow-up|0|||
130588372|NCT01817790|470113152|FG001|Overall Study|Lost to Follow-up|1|||
130588373|NCT01817790|470113151|FG000|Overall Study|Protocol Violation|2|||
130588374|NCT01817790|470113152|FG001|Overall Study|Protocol Violation|1|||
130588375|NCT01817790|470113151|FG000|Overall Study|Withdrawal by Subject|1|||
130588376|NCT01817790|470113152|FG001|Overall Study|Withdrawal by Subject|3|||
130588377|NCT01817790|470113151|FG000|Overall Study|Other: Could not attend appointment|1|||
130588378|NCT01817790|470113152|FG001|Overall Study|Other: Could not attend appointment|1|||
130588379|NCT01671345|470113153|FG000|Overall Study|Lost to Follow-up|10|||
130588380|NCT01671345|470113154|FG001|Overall Study|Lost to Follow-up|6|||
130588381|NCT01671345|470113153|FG000|Overall Study|visit with non-participating physician|3|||
130588382|NCT01671345|470113154|FG001|Overall Study|visit with non-participating physician|3|||
130588383|NCT03636906|470113155|FG000|Overall Study|Adverse Event|0|||
130588384|NCT03636906|470113156|FG001|Overall Study|Adverse Event|0|||
130588385|NCT03636906|470113157|FG002|Overall Study|Adverse Event|1|||
130588386|NCT03636906|470113155|FG000|Overall Study|Lost to Follow-up|1|||
130588387|NCT03636906|470113156|FG001|Overall Study|Lost to Follow-up|0|||
130588388|NCT03636906|470113157|FG002|Overall Study|Lost to Follow-up|0|||
130588389|NCT03636906|470113155|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
130588390|NCT03636906|470113156|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
130588391|NCT03636906|470113157|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
130588392|NCT03636906|470113155|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130588393|NCT03636906|470113156|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130588394|NCT03636906|470113157|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
130588395|NCT03636906|470113155|FG000|Overall Study|Other|0|||
130588396|NCT03636906|470113156|FG001|Overall Study|Other|0|||
130588397|NCT03636906|470113157|FG002|Overall Study|Other|1|||
130588398|NCT04280081|470113160|FG000|Overall Study|Adverse Event|4|||
130588399|NCT04280081|470113160|FG000|Overall Study|Death|2|||
130588400|NCT04280081|470113160|FG000|Overall Study|Progressive Disease|6|||
130588401|NCT03219164|470115085|FG000|Overall Study|Study Terminated by Sponsor|16|||
130588402|NCT03219164|470115086|FG001|Overall Study|Study Terminated by Sponsor|12|||
130588403|NCT03219164|470115085|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
130588404|NCT03219164|470115086|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
130588405|NCT03219164|470115085|FG000|Overall Study|Lost to Follow-up|1|||
130588406|NCT03219164|470115086|FG001|Overall Study|Lost to Follow-up|1|||
130588407|NCT03219164|470115085|FG000|Overall Study|Adverse Event|1|||
130588408|NCT03219164|470115086|FG001|Overall Study|Adverse Event|0|||
130588409|NCT03219164|470115085|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130588410|NCT03219164|470115086|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130588411|NCT03219164|470115085|FG000|Overall Study|Protocol Violation|0|||
130588412|NCT03219164|470115086|FG001|Overall Study|Protocol Violation|1|||
130588413|NCT03219164|470115085|FG000|Overall Study|Withdrew Assent|1|||
130588414|NCT03219164|470115086|FG001|Overall Study|Withdrew Assent|0|||
130588415|NCT02338843|470115087|FG000|Overall Study|Adverse Event|2|||
130588416|NCT02338843|470115088|FG001|Overall Study|Adverse Event|1|||
130588417|NCT02338843|470115087|FG000|Overall Study|Death|40|||
130588418|NCT02338843|470115088|FG001|Overall Study|Death|53|||
130588419|NCT02338843|470115087|FG000|Overall Study|Physician Decision|1|||
130588420|NCT02338843|470115088|FG001|Overall Study|Physician Decision|0|||
130588421|NCT02338843|470115087|FG000|Overall Study|Withdrawal by Subject|0|||
130588422|NCT02338843|470115088|FG001|Overall Study|Withdrawal by Subject|2|||
130588423|NCT02338843|470115087|FG000|Overall Study|Subject Recovered|0|||
130588424|NCT02338843|470115088|FG001|Overall Study|Subject Recovered|2|||
130588425|NCT02338843|470115087|FG000|Overall Study|Discontinued prior to randomizat|1|||
130588426|NCT02338843|470115088|FG001|Overall Study|Discontinued prior to randomizat|0|||
130588427|NCT00023322|470115089|FG000|Overall Study|Lost to Follow-up|1|||
130588428|NCT01793792|470115100|FG000|Overall Study|Death|5|||
130588429|NCT01793792|470115100|FG000|Overall Study|Lost to Follow-up|5|||
130588430|NCT01793792|470115100|FG000|Overall Study|Withdrawal by Subject|1|||
130588431|NCT01793792|470115100|FG000|Overall Study|Device Not Implanted|1|||
130588432|NCT02185521|470115103|FG000|Overall Study|Withdrawal by Subject|1|||
130588433|NCT02185521|470115103|FG000|Overall Study|Protocol Violation|1|||
130588434|NCT01341457|470115104|FG000|Overall Study|Adverse Event|2|||
130588435|NCT01341457|470115105|FG001|Overall Study|Adverse Event|0|||
130588436|NCT03124459|470115110|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130588437|NCT03124459|470115111|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130588438|NCT03124459|470115112|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130588439|NCT03124459|470115113|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130588440|NCT03124459|470115114|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
130588441|NCT03124459|470115115|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130588442|NCT03124459|470115110|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130588443|NCT03124459|470115111|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130588444|NCT03124459|470115112|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130588445|NCT03124459|470115113|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130588446|NCT03124459|470115114|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
130588447|NCT03124459|470115115|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130588448|NCT03124459|470115110|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130588449|NCT03124459|470115111|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130588450|NCT03124459|470115112|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130588451|NCT03124459|470115113|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
130588452|NCT03124459|470115114|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
130588453|NCT03124459|470115115|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130588454|NCT03124459|470115110|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130588455|NCT03124459|470115111|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130588456|NCT03124459|470115112|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130588457|NCT03124459|470115113|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
130588458|NCT03124459|470115114|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
130588459|NCT03124459|470115115|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130588460|NCT03124459|470115110|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130588461|NCT03124459|470115111|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130588462|NCT03124459|470115112|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130588463|NCT03124459|470115113|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130588464|NCT03124459|470115114|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130588465|NCT03124459|470115115|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
130588466|NCT03124459|470115110|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130588467|NCT03124459|470115111|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130588468|NCT03124459|470115112|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130588469|NCT03124459|470115113|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130588470|NCT03124459|470115114|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130588471|NCT03124459|470115115|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
130588472|NCT01717638|470115120|FG000|Overall Study|Lost to Follow-up|0|||
130588473|NCT01717638|470115121|FG001|Overall Study|Lost to Follow-up|0|||
130588474|NCT01717638|470115122|FG002|Overall Study|Lost to Follow-up|0|||
130588475|NCT01717638|470115123|FG003|Overall Study|Lost to Follow-up|0|||
130588476|NCT01717638|470115124|FG004|Overall Study|Lost to Follow-up|0|||
130588477|NCT01717638|470115125|FG005|Overall Study|Lost to Follow-up|1|||
130588478|NCT01717638|470115126|FG006|Overall Study|Lost to Follow-up|0|||
130588479|NCT01717638|470115127|FG007|Overall Study|Lost to Follow-up|0|||
130588480|NCT01717638|470115128|FG008|Overall Study|Lost to Follow-up|0|||
130588481|NCT01717638|470115129|FG009|Overall Study|Lost to Follow-up|0|||
130588482|NCT01717638|470115130|FG010|Overall Study|Lost to Follow-up|0|||
130588483|NCT01717638|470115131|FG011|Overall Study|Lost to Follow-up|0|||
130588484|NCT01717638|470115132|FG012|Overall Study|Lost to Follow-up|0|||
130588485|NCT01717638|470115120|FG000|Overall Study|Father in hospital|0|||
130588486|NCT01717638|470115121|FG001|Overall Study|Father in hospital|0|||
130588487|NCT01717638|470115122|FG002|Overall Study|Father in hospital|0|||
130588488|NCT01717638|470115123|FG003|Overall Study|Father in hospital|0|||
130588489|NCT01717638|470115124|FG004|Overall Study|Father in hospital|0|||
130588490|NCT01717638|470115125|FG005|Overall Study|Father in hospital|0|||
130588491|NCT01717638|470115126|FG006|Overall Study|Father in hospital|0|||
130588492|NCT01717638|470115127|FG007|Overall Study|Father in hospital|0|||
130588493|NCT01717638|470115128|FG008|Overall Study|Father in hospital|0|||
130588494|NCT01717638|470115129|FG009|Overall Study|Father in hospital|0|||
130588495|NCT01717638|470115130|FG010|Overall Study|Father in hospital|0|||
130588496|NCT01717638|470115131|FG011|Overall Study|Father in hospital|0|||
130588497|NCT01717638|470115132|FG012|Overall Study|Father in hospital|1|||
130588498|NCT01717638|470115120|FG000|Overall Study|Withdrawal by Subject|0|||
130588499|NCT01717638|470115121|FG001|Overall Study|Withdrawal by Subject|1|||
130588500|NCT01717638|470115122|FG002|Overall Study|Withdrawal by Subject|1|||
130588501|NCT01717638|470115123|FG003|Overall Study|Withdrawal by Subject|0|||
130588502|NCT01717638|470115124|FG004|Overall Study|Withdrawal by Subject|1|||
130588503|NCT01717638|470115125|FG005|Overall Study|Withdrawal by Subject|0|||
130588504|NCT01717638|470115126|FG006|Overall Study|Withdrawal by Subject|2|||
130588505|NCT01717638|470115127|FG007|Overall Study|Withdrawal by Subject|1|||
130588506|NCT01717638|470115128|FG008|Overall Study|Withdrawal by Subject|2|||
130588507|NCT01717638|470115129|FG009|Overall Study|Withdrawal by Subject|1|||
130588508|NCT01717638|470115130|FG010|Overall Study|Withdrawal by Subject|0|||
130588509|NCT01717638|470115131|FG011|Overall Study|Withdrawal by Subject|0|||
130588510|NCT01717638|470115132|FG012|Overall Study|Withdrawal by Subject|18|||
130588511|NCT00434967|470115135|FG000|Overall Study|Adverse Event|2|||
130588512|NCT00434967|470115136|FG001|Overall Study|Adverse Event|4|||
130588513|NCT00434967|470115137|FG002|Overall Study|Adverse Event|3|||
130588514|NCT00434967|470115138|FG003|Overall Study|Adverse Event|3|||
130588515|NCT00434967|470115135|FG000|Overall Study|Lost to Follow-up|0|||
130588516|NCT00434967|470115136|FG001|Overall Study|Lost to Follow-up|0|||
130588517|NCT00434967|470115137|FG002|Overall Study|Lost to Follow-up|1|||
130588518|NCT00434967|470115138|FG003|Overall Study|Lost to Follow-up|0|||
130588519|NCT00434967|470115135|FG000|Overall Study|Withdrawal by Subject|2|||
130588520|NCT00434967|470115136|FG001|Overall Study|Withdrawal by Subject|2|||
130588521|NCT00434967|470115137|FG002|Overall Study|Withdrawal by Subject|4|||
130588522|NCT00434967|470115138|FG003|Overall Study|Withdrawal by Subject|6|||
130588523|NCT00434967|470115135|FG000|Overall Study|Randomized in error|0|||
130588524|NCT00434967|470115136|FG001|Overall Study|Randomized in error|0|||
130588525|NCT00434967|470115137|FG002|Overall Study|Randomized in error|0|||
130588526|NCT00434967|470115138|FG003|Overall Study|Randomized in error|1|||
130588527|NCT00434967|470115135|FG000|Overall Study|Protocol Violation|0|||
130588528|NCT00434967|470115136|FG001|Overall Study|Protocol Violation|1|||
130588529|NCT00434967|470115137|FG002|Overall Study|Protocol Violation|0|||
130588530|NCT00434967|470115138|FG003|Overall Study|Protocol Violation|1|||
130588531|NCT00434967|470115135|FG000|Overall Study|Physician Decision|1|||
130588532|NCT00434967|470115136|FG001|Overall Study|Physician Decision|1|||
130588533|NCT00434967|470115137|FG002|Overall Study|Physician Decision|1|||
130588534|NCT00434967|470115138|FG003|Overall Study|Physician Decision|0|||
130588535|NCT00434967|470115135|FG000|Overall Study|Patient Disposition Challenges|2|||
130588536|NCT00434967|470115136|FG001|Overall Study|Patient Disposition Challenges|0|||
130588537|NCT00434967|470115137|FG002|Overall Study|Patient Disposition Challenges|0|||
130588538|NCT00434967|470115138|FG003|Overall Study|Patient Disposition Challenges|3|||
130588539|NCT00501228|470115139|FG000|Overall Study|Withdrawal by Subject|1|||
130588540|NCT03804684|470115140|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
130588541|NCT03804684|470115141|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
130588542|NCT01756274|470115142|FG000|Overall Study|Protocol Violation|2|||
130588543|NCT01756274|470115142|FG000|Overall Study|Laboratory error|1|||
130588544|NCT01147926|470115143|FG000|Overall Study|Subject Withdrew Consent|9|||
130588545|NCT01147926|470115144|FG001|Overall Study|Subject Withdrew Consent|10|||
130588546|NCT01147926|470115143|FG000|Overall Study|Adverse Event|7|||
130588547|NCT01147926|470115144|FG001|Overall Study|Adverse Event|6|||
130588548|NCT01147926|470115143|FG000|Overall Study|Subject Non-Compliant|5|||
130588549|NCT01147926|470115144|FG001|Overall Study|Subject Non-Compliant|4|||
130588550|NCT01147926|470115143|FG000|Overall Study|Principal investigator left hospital|1|||
130588551|NCT01147926|470115144|FG001|Overall Study|Principal investigator left hospital|3|||
130588552|NCT01147926|470115143|FG000|Overall Study|Selection criteria not met|3|||
130588553|NCT01147926|470115144|FG001|Overall Study|Selection criteria not met|1|||
130588554|NCT01147926|470115143|FG000|Overall Study|Lost to Follow-up|0|||
130588555|NCT01147926|470115144|FG001|Overall Study|Lost to Follow-up|2|||
130588556|NCT01147926|470115143|FG000|Overall Study|Sponsor's Decision|0|||
130588557|NCT01147926|470115144|FG001|Overall Study|Sponsor's Decision|1|||
130588558|NCT01147926|470115143|FG000|Overall Study|Lack of Efficacy|1|||
130588559|NCT01147926|470115144|FG001|Overall Study|Lack of Efficacy|0|||
130588560|NCT01147926|470115143|FG000|Overall Study|Too busy, no time for study|1|||
130588561|NCT01147926|470115144|FG001|Overall Study|Too busy, no time for study|0|||
130588562|NCT01147926|470115143|FG000|Overall Study|Went on holiday|0|||
130588563|NCT01147926|470115144|FG001|Overall Study|Went on holiday|1|||
130588564|NCT01147926|470115143|FG000|Overall Study|Colonoscopy result|0|||
130588565|NCT01147926|470115144|FG001|Overall Study|Colonoscopy result|1|||
130588566|NCT00486603|470115149|FG000|Overall Study|Withdrawal by Subject|1|||
130588567|NCT00486603|470115150|FG001|Overall Study|Withdrawal by Subject|0|||
130588568|NCT00486603|470115151|FG002|Overall Study|Withdrawal by Subject|0|||
130588569|NCT00486603|470115152|FG003|Overall Study|Withdrawal by Subject|0|||
130588570|NCT00486603|470115153|FG004|Overall Study|Withdrawal by Subject|0|||
130588571|NCT00486603|470115149|FG000|Overall Study|Physician Decision|0|||
130588572|NCT00486603|470115150|FG001|Overall Study|Physician Decision|1|||
130588573|NCT00486603|470115151|FG002|Overall Study|Physician Decision|0|||
130588574|NCT00486603|470115152|FG003|Overall Study|Physician Decision|0|||
130588575|NCT00486603|470115153|FG004|Overall Study|Physician Decision|0|||
130588576|NCT01670994|470115154|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
130588577|NCT01670994|470115155|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
130588578|NCT01670994|470115154|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
130588579|NCT01670994|470115155|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
130588580|NCT01670994|470115154|FG000|Overall Study|Patient experienced DLT|0|||
130588581|NCT01670994|470115155|FG001|Overall Study|Patient experienced DLT|1|||
130588582|NCT01295125|470115157|FG000|Overall Study|Study stopped prematurely|9|||
130588583|NCT01824979|470115159|FG000|Overall Study|Withdrawal by Subject|5|||
130588584|NCT01824979|470115160|FG001|Overall Study|Withdrawal by Subject|0|||
130588585|NCT01824979|470115159|FG000|Overall Study|Physician Decision|2|||
130588586|NCT01824979|470115160|FG001|Overall Study|Physician Decision|0|||
130588587|NCT01824979|470115159|FG000|Overall Study|Protocol Violation|6|||
130588588|NCT01824979|470115160|FG001|Overall Study|Protocol Violation|13|||
130588589|NCT04336163|470115165|FG000|Overall Study|Lost to Follow-up|55|||
130588590|NCT04336163|470115166|FG001|Overall Study|Lost to Follow-up|0|||
130588591|NCT01686568|470115170|FG000|Main Study|Withdrawal by Subject|1|||
130588592|NCT01686568|470115171|FG001|Main Study|Withdrawal by Subject|3|||
130588593|NCT01686568|470115170|FG000|Main Study|Noncompliance with protocol|0|||
130588594|NCT01686568|470115171|FG001|Main Study|Noncompliance with protocol|1|||
130588595|NCT01686568|470115170|FG000|Main Study|Liver enzymes above range of exclusion|1|||
130588596|NCT01686568|470115171|FG001|Main Study|Liver enzymes above range of exclusion|0|||
130588597|NCT01686568|470115170|FG000|Sub-Study|Not consented for sub-study|2|||
130588598|NCT01686568|470115171|FG001|Sub-Study|Not consented for sub-study|2|||
130588599|NCT02978222|470115172|FG000|Overall Study|Withdrawal by Subject|2|||
130588600|NCT02978222|470115173|FG001|Overall Study|Withdrawal by Subject|2|||
130588601|NCT02978222|470115172|FG000|Overall Study|Physician Decision|2|||
130588602|NCT02978222|470115173|FG001|Overall Study|Physician Decision|0|||
130588603|NCT02978222|470115172|FG000|Overall Study|Adverse Event|0|||
130588604|NCT02978222|470115173|FG001|Overall Study|Adverse Event|1|||
130588605|NCT02978222|470115172|FG000|Overall Study|Death|1|||
130588606|NCT02978222|470115173|FG001|Overall Study|Death|0|||
130588607|NCT02978222|470115172|FG000|Overall Study|Disease Progression|32|||
130588608|NCT02978222|470115173|FG001|Overall Study|Disease Progression|32|||
130588609|NCT02978222|470115172|FG000|Overall Study|Early Study Termination|24|||
130588610|NCT02978222|470115173|FG001|Overall Study|Early Study Termination|21|||
130588611|NCT01614964|470115176|FG000|Overall Study|Withdrawal by Subject|2|||
130588612|NCT01614964|470115177|FG001|Overall Study|Withdrawal by Subject|0|||
130588613|NCT01614964|470115176|FG000|Overall Study|Lost to Follow-up|3|||
130588614|NCT01614964|470115177|FG001|Overall Study|Lost to Follow-up|0|||
130588615|NCT00888238|470115178|FG000|Washout Period After Period 2|Adverse Event|0|||
130588616|NCT00888238|470115179|FG001|Washout Period After Period 2|Adverse Event|0|||
130588617|NCT00888238|470115180|FG002|Washout Period After Period 2|Adverse Event|1|||
130588618|NCT01032629|470115181|FG000|Overall Study|Closed Site|21|||
130588619|NCT01032629|470115182|FG001|Overall Study|Closed Site|18|||
130588620|NCT01032629|470115183|FG002|Overall Study|Closed Site|16|||
130588621|NCT01032629|470115181|FG000|Overall Study|Withdrawal by Subject|50|||
130588622|NCT01032629|470115182|FG001|Overall Study|Withdrawal by Subject|36|||
130588623|NCT01032629|470115183|FG002|Overall Study|Withdrawal by Subject|35|||
130588624|NCT01032629|470115181|FG000|Overall Study|Lost to Follow-up|74|||
130588625|NCT01032629|470115182|FG001|Overall Study|Lost to Follow-up|47|||
130588626|NCT01032629|470115183|FG002|Overall Study|Lost to Follow-up|37|||
130588627|NCT03751111|470115187|FG000|Overall Study|Lack of Efficacy|9|||
130588628|NCT03751111|470115188|FG001|Overall Study|Lack of Efficacy|30|||
130588629|NCT03751111|470115187|FG000|Overall Study|Adverse Event|3|||
130588630|NCT03751111|470115188|FG001|Overall Study|Adverse Event|2|||
130588631|NCT00868790|470115189|FG000|Period 1|Adverse Event|1|||
130588632|NCT00868790|470115190|FG001|Period 1|Adverse Event|0|||
130588633|NCT00868790|470115191|FG002|Period 1|Adverse Event|0|||
130588634|NCT00868790|470115192|FG003|Period 1|Adverse Event|0|||
130588635|NCT00868790|470115193|FG004|Period 1|Adverse Event|0|||
130588636|NCT00868790|470115194|FG005|Period 1|Adverse Event|0|||
130588637|NCT00868790|470115195|FG006|Period 1|Adverse Event|0|||
130588638|NCT00868790|470115196|FG007|Period 1|Adverse Event|3|||
130588639|NCT00868790|470115197|FG008|Period 1|Adverse Event|1|||
130588640|NCT00868790|470115198|FG009|Period 1|Adverse Event|0|||
130588641|NCT00868790|470115199|FG010|Period 1|Adverse Event|0|||
130588642|NCT00868790|470115200|FG011|Period 1|Adverse Event|0|||
130588643|NCT00868790|470115201|FG012|Period 1|Adverse Event|0|||
130588644|NCT00868790|470115202|FG013|Period 1|Adverse Event|1|||
130588645|NCT00868790|470115189|FG000|Period 1|Protocol Violation|1|||
130588646|NCT00868790|470115190|FG001|Period 1|Protocol Violation|0|||
130588647|NCT00868790|470115191|FG002|Period 1|Protocol Violation|0|||
130588648|NCT00868790|470115192|FG003|Period 1|Protocol Violation|0|||
130588649|NCT00868790|470115193|FG004|Period 1|Protocol Violation|0|||
130588650|NCT00868790|470115194|FG005|Period 1|Protocol Violation|0|||
130588651|NCT00868790|470115195|FG006|Period 1|Protocol Violation|0|||
130588652|NCT00868790|470115196|FG007|Period 1|Protocol Violation|0|||
130588653|NCT00868790|470115197|FG008|Period 1|Protocol Violation|0|||
130588654|NCT00868790|470115198|FG009|Period 1|Protocol Violation|0|||
130588655|NCT00868790|470115199|FG010|Period 1|Protocol Violation|0|||
130588656|NCT00868790|470115200|FG011|Period 1|Protocol Violation|0|||
130588657|NCT00868790|470115201|FG012|Period 1|Protocol Violation|0|||
130588658|NCT00868790|470115202|FG013|Period 1|Protocol Violation|0|||
130588659|NCT00868790|470115189|FG000|Period 1|Withdrawal by Subject|0|||
130588660|NCT00868790|470115190|FG001|Period 1|Withdrawal by Subject|1|||
130588661|NCT00868790|470115191|FG002|Period 1|Withdrawal by Subject|0|||
130588662|NCT00868790|470115192|FG003|Period 1|Withdrawal by Subject|0|||
130588663|NCT00868790|470115193|FG004|Period 1|Withdrawal by Subject|0|||
130588664|NCT00868790|470115194|FG005|Period 1|Withdrawal by Subject|0|||
130588665|NCT00868790|470115195|FG006|Period 1|Withdrawal by Subject|0|||
130588666|NCT00868790|470115196|FG007|Period 1|Withdrawal by Subject|0|||
130588667|NCT00868790|470115197|FG008|Period 1|Withdrawal by Subject|0|||
130588668|NCT00868790|470115198|FG009|Period 1|Withdrawal by Subject|0|||
130588669|NCT00868790|470115199|FG010|Period 1|Withdrawal by Subject|0|||
130588670|NCT00868790|470115200|FG011|Period 1|Withdrawal by Subject|0|||
130588671|NCT00868790|470115201|FG012|Period 1|Withdrawal by Subject|0|||
130588672|NCT00868790|470115202|FG013|Period 1|Withdrawal by Subject|1|||
130588673|NCT00868790|470115189|FG000|Period 1|Abnormal Triglycerides|0|||
130588674|NCT00868790|470115190|FG001|Period 1|Abnormal Triglycerides|0|||
130588675|NCT00868790|470115191|FG002|Period 1|Abnormal Triglycerides|0|||
130588676|NCT00868790|470115192|FG003|Period 1|Abnormal Triglycerides|0|||
130588677|NCT00868790|470115193|FG004|Period 1|Abnormal Triglycerides|1|||
130588678|NCT00868790|470115194|FG005|Period 1|Abnormal Triglycerides|0|||
130588679|NCT00868790|470115195|FG006|Period 1|Abnormal Triglycerides|0|||
130588680|NCT00868790|470115196|FG007|Period 1|Abnormal Triglycerides|0|||
130588681|NCT00868790|470115197|FG008|Period 1|Abnormal Triglycerides|0|||
130588682|NCT00868790|470115198|FG009|Period 1|Abnormal Triglycerides|0|||
130588683|NCT00868790|470115199|FG010|Period 1|Abnormal Triglycerides|0|||
130588684|NCT00868790|470115200|FG011|Period 1|Abnormal Triglycerides|0|||
130588685|NCT00868790|470115201|FG012|Period 1|Abnormal Triglycerides|0|||
130588686|NCT00868790|470115202|FG013|Period 1|Abnormal Triglycerides|0|||
130588687|NCT00868790|470115189|FG000|Period 1|Lost to Follow-up|0|||
130588688|NCT00868790|470115190|FG001|Period 1|Lost to Follow-up|0|||
130588689|NCT00868790|470115191|FG002|Period 1|Lost to Follow-up|0|||
130588690|NCT00868790|470115192|FG003|Period 1|Lost to Follow-up|0|||
130588691|NCT00868790|470115193|FG004|Period 1|Lost to Follow-up|0|||
130588692|NCT00868790|470115194|FG005|Period 1|Lost to Follow-up|1|||
130588693|NCT00868790|470115195|FG006|Period 1|Lost to Follow-up|0|||
130588694|NCT00868790|470115196|FG007|Period 1|Lost to Follow-up|0|||
130588695|NCT00868790|470115197|FG008|Period 1|Lost to Follow-up|0|||
130588696|NCT00868790|470115198|FG009|Period 1|Lost to Follow-up|0|||
130588697|NCT00868790|470115199|FG010|Period 1|Lost to Follow-up|0|||
130588698|NCT00868790|470115200|FG011|Period 1|Lost to Follow-up|0|||
130588699|NCT00868790|470115201|FG012|Period 1|Lost to Follow-up|0|||
130588700|NCT00868790|470115202|FG013|Period 1|Lost to Follow-up|0|||
130588701|NCT00868790|470115189|FG000|Period 2|Adverse Event|0|||
130588702|NCT00868790|470115190|FG001|Period 2|Adverse Event|0|||
130588703|NCT00868790|470115191|FG002|Period 2|Adverse Event|0|||
130588704|NCT00868790|470115192|FG003|Period 2|Adverse Event|0|||
130588705|NCT00868790|470115193|FG004|Period 2|Adverse Event|0|||
130588706|NCT00868790|470115194|FG005|Period 2|Adverse Event|0|||
130588707|NCT00868790|470115195|FG006|Period 2|Adverse Event|0|||
130588708|NCT00868790|470115196|FG007|Period 2|Adverse Event|0|||
130588709|NCT00868790|470115197|FG008|Period 2|Adverse Event|1|||
130588710|NCT00868790|470115198|FG009|Period 2|Adverse Event|0|||
130588711|NCT00868790|470115199|FG010|Period 2|Adverse Event|0|||
130588712|NCT00868790|470115200|FG011|Period 2|Adverse Event|0|||
130588713|NCT00868790|470115201|FG012|Period 2|Adverse Event|0|||
130588714|NCT00868790|470115202|FG013|Period 2|Adverse Event|0|||
130588715|NCT00868790|470115189|FG000|Period 2|Lost to Follow-up|0|||
130588716|NCT00868790|470115190|FG001|Period 2|Lost to Follow-up|1|||
130588717|NCT00868790|470115191|FG002|Period 2|Lost to Follow-up|0|||
130588718|NCT00868790|470115192|FG003|Period 2|Lost to Follow-up|0|||
130588719|NCT00868790|470115193|FG004|Period 2|Lost to Follow-up|0|||
130588720|NCT00868790|470115194|FG005|Period 2|Lost to Follow-up|1|||
130588721|NCT00868790|470115195|FG006|Period 2|Lost to Follow-up|0|||
130588722|NCT00868790|470115196|FG007|Period 2|Lost to Follow-up|0|||
130588723|NCT00868790|470115197|FG008|Period 2|Lost to Follow-up|0|||
130588724|NCT00868790|470115198|FG009|Period 2|Lost to Follow-up|0|||
130588725|NCT00868790|470115199|FG010|Period 2|Lost to Follow-up|0|||
130588726|NCT00868790|470115200|FG011|Period 2|Lost to Follow-up|0|||
130588727|NCT00868790|470115201|FG012|Period 2|Lost to Follow-up|0|||
130588728|NCT00868790|470115202|FG013|Period 2|Lost to Follow-up|0|||
130588729|NCT00868790|470115189|FG000|Period 2|Withdrawal by Subject|0|||
130588730|NCT00868790|470115190|FG001|Period 2|Withdrawal by Subject|0|||
130588731|NCT00868790|470115191|FG002|Period 2|Withdrawal by Subject|0|||
130588732|NCT00868790|470115192|FG003|Period 2|Withdrawal by Subject|0|||
130588733|NCT00868790|470115193|FG004|Period 2|Withdrawal by Subject|0|||
130588734|NCT00868790|470115194|FG005|Period 2|Withdrawal by Subject|0|||
130588735|NCT00868790|470115195|FG006|Period 2|Withdrawal by Subject|0|||
130588736|NCT00868790|470115196|FG007|Period 2|Withdrawal by Subject|0|||
130588737|NCT00868790|470115197|FG008|Period 2|Withdrawal by Subject|1|||
130588738|NCT00868790|470115198|FG009|Period 2|Withdrawal by Subject|0|||
130588739|NCT00868790|470115199|FG010|Period 2|Withdrawal by Subject|0|||
130588740|NCT00868790|470115200|FG011|Period 2|Withdrawal by Subject|0|||
130588741|NCT00868790|470115201|FG012|Period 2|Withdrawal by Subject|0|||
130588742|NCT00868790|470115202|FG013|Period 2|Withdrawal by Subject|1|||
130588743|NCT00868790|470115189|FG000|Period 3|Adverse Event|0|||
130588744|NCT00868790|470115190|FG001|Period 3|Adverse Event|0|||
130588745|NCT00868790|470115191|FG002|Period 3|Adverse Event|0|||
130588746|NCT00868790|470115192|FG003|Period 3|Adverse Event|0|||
130588747|NCT00868790|470115193|FG004|Period 3|Adverse Event|0|||
130588748|NCT00868790|470115194|FG005|Period 3|Adverse Event|0|||
130588749|NCT00868790|470115195|FG006|Period 3|Adverse Event|0|||
130588750|NCT00868790|470115196|FG007|Period 3|Adverse Event|0|||
130588751|NCT00868790|470115197|FG008|Period 3|Adverse Event|0|||
130588752|NCT00868790|470115198|FG009|Period 3|Adverse Event|1|||
130588753|NCT00868790|470115199|FG010|Period 3|Adverse Event|0|||
130588754|NCT00868790|470115200|FG011|Period 3|Adverse Event|0|||
130588755|NCT00868790|470115201|FG012|Period 3|Adverse Event|0|||
130588756|NCT00868790|470115202|FG013|Period 3|Adverse Event|0|||
130588757|NCT00868790|470115189|FG000|Period 3|Protocol Violation|0|||
130588758|NCT00868790|470115190|FG001|Period 3|Protocol Violation|0|||
130588759|NCT00868790|470115191|FG002|Period 3|Protocol Violation|0|||
130588760|NCT00868790|470115192|FG003|Period 3|Protocol Violation|0|||
130588761|NCT00868790|470115193|FG004|Period 3|Protocol Violation|0|||
130588762|NCT00868790|470115194|FG005|Period 3|Protocol Violation|0|||
130588763|NCT00868790|470115195|FG006|Period 3|Protocol Violation|0|||
130588764|NCT00868790|470115196|FG007|Period 3|Protocol Violation|0|||
130588765|NCT00868790|470115197|FG008|Period 3|Protocol Violation|0|||
130588766|NCT00868790|470115198|FG009|Period 3|Protocol Violation|0|||
130588767|NCT00868790|470115199|FG010|Period 3|Protocol Violation|1|||
130588768|NCT00868790|470115200|FG011|Period 3|Protocol Violation|0|||
130588769|NCT00868790|470115201|FG012|Period 3|Protocol Violation|0|||
130588770|NCT00868790|470115202|FG013|Period 3|Protocol Violation|0|||
130588771|NCT00868790|470115189|FG000|Period 3|Study Terminated by Sponsor|0|||
130588772|NCT00868790|470115190|FG001|Period 3|Study Terminated by Sponsor|0|||
130588773|NCT00868790|470115191|FG002|Period 3|Study Terminated by Sponsor|0|||
130588774|NCT00868790|470115192|FG003|Period 3|Study Terminated by Sponsor|1|||
130588775|NCT00868790|470115193|FG004|Period 3|Study Terminated by Sponsor|0|||
130588776|NCT00868790|470115194|FG005|Period 3|Study Terminated by Sponsor|0|||
130588777|NCT00868790|470115195|FG006|Period 3|Study Terminated by Sponsor|0|||
130588778|NCT00868790|470115196|FG007|Period 3|Study Terminated by Sponsor|0|||
130588779|NCT00868790|470115197|FG008|Period 3|Study Terminated by Sponsor|0|||
130588780|NCT00868790|470115198|FG009|Period 3|Study Terminated by Sponsor|0|||
130588781|NCT00868790|470115199|FG010|Period 3|Study Terminated by Sponsor|0|||
130588782|NCT00868790|470115200|FG011|Period 3|Study Terminated by Sponsor|0|||
130588783|NCT00868790|470115201|FG012|Period 3|Study Terminated by Sponsor|0|||
130588784|NCT00868790|470115202|FG013|Period 3|Study Terminated by Sponsor|0|||
130588785|NCT00868790|470115189|FG000|Period 4|Adverse Event|0|||
130588786|NCT00868790|470115190|FG001|Period 4|Adverse Event|0|||
130588787|NCT00868790|470115191|FG002|Period 4|Adverse Event|0|||
130588788|NCT00868790|470115192|FG003|Period 4|Adverse Event|0|||
130588789|NCT00868790|470115193|FG004|Period 4|Adverse Event|0|||
130588790|NCT00868790|470115194|FG005|Period 4|Adverse Event|0|||
130588791|NCT00868790|470115195|FG006|Period 4|Adverse Event|0|||
130588792|NCT00868790|470115196|FG007|Period 4|Adverse Event|1|||
130588793|NCT00868790|470115197|FG008|Period 4|Adverse Event|0|||
130588794|NCT00868790|470115198|FG009|Period 4|Adverse Event|0|||
130588795|NCT00868790|470115199|FG010|Period 4|Adverse Event|1|||
130588796|NCT00868790|470115200|FG011|Period 4|Adverse Event|0|||
130588797|NCT00868790|470115201|FG012|Period 4|Adverse Event|1|||
130588798|NCT00868790|470115202|FG013|Period 4|Adverse Event|0|||
130588799|NCT00868790|470115189|FG000|Period 4|Lost to Follow-up|0|||
130588800|NCT00868790|470115190|FG001|Period 4|Lost to Follow-up|0|||
130588801|NCT00868790|470115191|FG002|Period 4|Lost to Follow-up|0|||
130588802|NCT00868790|470115192|FG003|Period 4|Lost to Follow-up|0|||
130588803|NCT00868790|470115193|FG004|Period 4|Lost to Follow-up|0|||
130588804|NCT00868790|470115194|FG005|Period 4|Lost to Follow-up|0|||
130588805|NCT00868790|470115195|FG006|Period 4|Lost to Follow-up|0|||
130588806|NCT00868790|470115196|FG007|Period 4|Lost to Follow-up|1|||
130588807|NCT00868790|470115197|FG008|Period 4|Lost to Follow-up|0|||
130588808|NCT00868790|470115198|FG009|Period 4|Lost to Follow-up|0|||
130588809|NCT00868790|470115199|FG010|Period 4|Lost to Follow-up|0|||
130588810|NCT00868790|470115200|FG011|Period 4|Lost to Follow-up|0|||
130588811|NCT00868790|470115201|FG012|Period 4|Lost to Follow-up|0|||
130588812|NCT00868790|470115202|FG013|Period 4|Lost to Follow-up|0|||
130588813|NCT00868790|470115189|FG000|Period 4|Study Terminated by Sponsor|2|||
130588814|NCT00868790|470115190|FG001|Period 4|Study Terminated by Sponsor|0|||
130588815|NCT00868790|470115191|FG002|Period 4|Study Terminated by Sponsor|0|||
130588816|NCT00868790|470115192|FG003|Period 4|Study Terminated by Sponsor|0|||
130588817|NCT00868790|470115193|FG004|Period 4|Study Terminated by Sponsor|0|||
130588818|NCT00868790|470115194|FG005|Period 4|Study Terminated by Sponsor|0|||
130588819|NCT00868790|470115195|FG006|Period 4|Study Terminated by Sponsor|0|||
130588820|NCT00868790|470115196|FG007|Period 4|Study Terminated by Sponsor|1|||
130588821|NCT00868790|470115197|FG008|Period 4|Study Terminated by Sponsor|2|||
130588822|NCT00868790|470115198|FG009|Period 4|Study Terminated by Sponsor|0|||
130588823|NCT00868790|470115199|FG010|Period 4|Study Terminated by Sponsor|2|||
130588824|NCT00868790|470115200|FG011|Period 4|Study Terminated by Sponsor|1|||
130588825|NCT00868790|470115201|FG012|Period 4|Study Terminated by Sponsor|0|||
130588826|NCT00868790|470115202|FG013|Period 4|Study Terminated by Sponsor|1|||
130588827|NCT00868790|470115189|FG000|Period 4|Abnormal ALT/AST|0|||
130588828|NCT00868790|470115190|FG001|Period 4|Abnormal ALT/AST|0|||
130588829|NCT00868790|470115191|FG002|Period 4|Abnormal ALT/AST|1|||
130588830|NCT00868790|470115192|FG003|Period 4|Abnormal ALT/AST|0|||
130588831|NCT00868790|470115193|FG004|Period 4|Abnormal ALT/AST|0|||
130588832|NCT00868790|470115194|FG005|Period 4|Abnormal ALT/AST|0|||
130588833|NCT00868790|470115195|FG006|Period 4|Abnormal ALT/AST|0|||
130588834|NCT00868790|470115196|FG007|Period 4|Abnormal ALT/AST|0|||
130588835|NCT00868790|470115197|FG008|Period 4|Abnormal ALT/AST|0|||
130588836|NCT00868790|470115198|FG009|Period 4|Abnormal ALT/AST|0|||
130588837|NCT00868790|470115199|FG010|Period 4|Abnormal ALT/AST|0|||
130588838|NCT00868790|470115200|FG011|Period 4|Abnormal ALT/AST|0|||
130588839|NCT00868790|470115201|FG012|Period 4|Abnormal ALT/AST|0|||
130588840|NCT00868790|470115202|FG013|Period 4|Abnormal ALT/AST|0|||
130588841|NCT00868790|470115189|FG000|Post-study|Withdrawal by Subject|0|||
130588842|NCT00868790|470115190|FG001|Post-study|Withdrawal by Subject|0|||
130588843|NCT00868790|470115191|FG002|Post-study|Withdrawal by Subject|0|||
130588844|NCT00868790|470115192|FG003|Post-study|Withdrawal by Subject|0|||
130588845|NCT00868790|470115193|FG004|Post-study|Withdrawal by Subject|1|||
130588846|NCT00868790|470115194|FG005|Post-study|Withdrawal by Subject|0|||
130588847|NCT00868790|470115195|FG006|Post-study|Withdrawal by Subject|0|||
130588848|NCT00868790|470115196|FG007|Post-study|Withdrawal by Subject|0|||
130588849|NCT00868790|470115197|FG008|Post-study|Withdrawal by Subject|0|||
130588850|NCT00868790|470115198|FG009|Post-study|Withdrawal by Subject|0|||
130588851|NCT00868790|470115199|FG010|Post-study|Withdrawal by Subject|0|||
130588852|NCT00868790|470115200|FG011|Post-study|Withdrawal by Subject|0|||
130588853|NCT00868790|470115201|FG012|Post-study|Withdrawal by Subject|0|||
130588854|NCT00868790|470115202|FG013|Post-study|Withdrawal by Subject|0|||
130588855|NCT00868790|470115189|FG000|Post-study|Excluded Medication|0|||
130588856|NCT00868790|470115190|FG001|Post-study|Excluded Medication|0|||
130588857|NCT00868790|470115191|FG002|Post-study|Excluded Medication|0|||
130588858|NCT00868790|470115192|FG003|Post-study|Excluded Medication|0|||
130588859|NCT00868790|470115193|FG004|Post-study|Excluded Medication|0|||
130588860|NCT00868790|470115194|FG005|Post-study|Excluded Medication|0|||
130588861|NCT00868790|470115195|FG006|Post-study|Excluded Medication|0|||
130588862|NCT00868790|470115196|FG007|Post-study|Excluded Medication|2|||
130588863|NCT00868790|470115197|FG008|Post-study|Excluded Medication|0|||
130588864|NCT00868790|470115198|FG009|Post-study|Excluded Medication|1|||
130588865|NCT00868790|470115199|FG010|Post-study|Excluded Medication|0|||
130588866|NCT00868790|470115200|FG011|Post-study|Excluded Medication|0|||
130588867|NCT00868790|470115201|FG012|Post-study|Excluded Medication|0|||
130588868|NCT00868790|470115202|FG013|Post-study|Excluded Medication|0|||
130588869|NCT03377634|470115206|FG000|Study Period|Adverse Event|1|||
130588870|NCT03377634|470115207|FG001|Study Period|Adverse Event|0|||
130588871|NCT03377634|470115206|FG000|Study Period|Withdrawal by Subject|1|||
130588872|NCT03377634|470115207|FG001|Study Period|Withdrawal by Subject|0|||
130588891|NCT01264939|470115210|FG000|Overall Study|Adverse Event|1|||
130588892|NCT01264939|470115211|FG001|Overall Study|Adverse Event|3|||
130588893|NCT01264939|470115210|FG000|Overall Study|Lost to Follow-up|0|||
130588894|NCT01264939|470115211|FG001|Overall Study|Lost to Follow-up|3|||
130588895|NCT01264939|470115210|FG000|Overall Study|Physician Decision|1|||
130588896|NCT01264939|470115211|FG001|Overall Study|Physician Decision|1|||
130588897|NCT01264939|470115210|FG000|Overall Study|Patient/Guardian Decision|8|||
130588898|NCT01264939|470115211|FG001|Overall Study|Patient/Guardian Decision|10|||
130588899|NCT01264939|470115210|FG000|Overall Study|Disease Progression|8|||
130588900|NCT01264939|470115211|FG001|Overall Study|Disease Progression|11|||
130588901|NCT00737529|470115219|FG000|Overall Study|Disease Progression|95|||
130588902|NCT00737529|470115219|FG000|Overall Study|Adverse Event|24|||
130588903|NCT00737529|470115219|FG000|Overall Study|Withdrawal by Subject|5|||
130588904|NCT00737529|470115219|FG000|Overall Study|Death|4|||
130588905|NCT00737529|470115219|FG000|Overall Study|Protocol Violation|1|||
130588906|NCT00737529|470115219|FG000|Overall Study|Other|4|||
130588907|NCT01145560|470115220|FG000|Overall Study|Withdrawal by Subject|2|||
130588908|NCT01145560|470115221|FG001|Overall Study|Withdrawal by Subject|1|||
130588909|NCT01145560|470115222|FG002|Overall Study|Withdrawal by Subject|0|||
130588910|NCT01145560|470115220|FG000|Overall Study|Lost to Follow-up|1|||
130588911|NCT01145560|470115221|FG001|Overall Study|Lost to Follow-up|1|||
130588912|NCT01145560|470115222|FG002|Overall Study|Lost to Follow-up|1|||
130588913|NCT01145560|470115220|FG000|Overall Study|No study drug by 24h after organ failure|1|||
130588914|NCT01145560|470115221|FG001|Overall Study|No study drug by 24h after organ failure|0|||
130588915|NCT01145560|470115222|FG002|Overall Study|No study drug by 24h after organ failure|0|||
130588916|NCT01145560|470115220|FG000|Overall Study|Accidental unblinding of study treatment|0|||
130588917|NCT01145560|470115221|FG001|Overall Study|Accidental unblinding of study treatment|1|||
130588918|NCT01145560|470115222|FG002|Overall Study|Accidental unblinding of study treatment|0|||
130588919|NCT01145560|470115220|FG000|Overall Study|False insurance information|0|||
130588920|NCT01145560|470115221|FG001|Overall Study|False insurance information|1|||
130588921|NCT01145560|470115222|FG002|Overall Study|False insurance information|0|||
130588922|NCT01145560|470115220|FG000|Overall Study|Withdrawal of therapy|0|||
130588923|NCT01145560|470115221|FG001|Overall Study|Withdrawal of therapy|0|||
130588924|NCT01145560|470115222|FG002|Overall Study|Withdrawal of therapy|1|||
130588925|NCT03040024|470115223|FG000|Overall Study|Adverse Event|0|||
130588926|NCT03040024|470115224|FG001|Overall Study|Adverse Event|1|||
130588927|NCT03040024|470115225|FG002|Overall Study|Adverse Event|0|||
130588928|NCT03040024|470115223|FG000|Overall Study|Death|0|||
130588929|NCT03040024|470115224|FG001|Overall Study|Death|1|||
130588930|NCT03040024|470115225|FG002|Overall Study|Death|0|||
130588931|NCT03040024|470115223|FG000|Overall Study|Physician Decision|0|||
130588932|NCT03040024|470115224|FG001|Overall Study|Physician Decision|0|||
130588933|NCT03040024|470115225|FG002|Overall Study|Physician Decision|1|||
130588934|NCT01526148|470115234|FG000|Overall Study|Adverse Event|6|||
130588935|NCT01526148|470115235|FG001|Overall Study|Adverse Event|5|||
130588936|NCT01526148|470115234|FG000|Overall Study|Lost to Follow-up|3|||
130588937|NCT01526148|470115235|FG001|Overall Study|Lost to Follow-up|6|||
130588938|NCT01526148|470115234|FG000|Overall Study|Withdrawal by Subject|2|||
130588939|NCT01526148|470115235|FG001|Overall Study|Withdrawal by Subject|0|||
130588940|NCT01526148|470115234|FG000|Overall Study|Unstable Medical Condition|1|||
130588941|NCT01526148|470115235|FG001|Overall Study|Unstable Medical Condition|0|||
130588942|NCT01526148|470115234|FG000|Overall Study|Unable to discontinue concomitant med|1|||
130588943|NCT01526148|470115235|FG001|Overall Study|Unable to discontinue concomitant med|0|||
130588944|NCT01526148|470115234|FG000|Overall Study|Moved out of state|1|||
130588945|NCT01526148|470115235|FG001|Overall Study|Moved out of state|0|||
130588946|NCT01526148|470115234|FG000|Overall Study|Incarcerated|0|||
130588947|NCT01526148|470115235|FG001|Overall Study|Incarcerated|2|||
130588948|NCT01173653|470115236|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
130588949|NCT01173653|470115237|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
130588950|NCT02452762|470115238|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
130588951|NCT02452762|470115239|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
130588952|NCT02452762|470115238|FG000|Overall Study|Withdrawal by Subject|1|||
130588953|NCT02452762|470115239|FG001|Overall Study|Withdrawal by Subject|0|||
130588954|NCT01818297|470115240|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
130588955|NCT01818297|470115241|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
130588956|NCT01818297|470115240|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
130588957|NCT01818297|470115241|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
130588958|NCT01818297|470115240|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
130588959|NCT01818297|470115241|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
130588960|NCT00584870|470115242|FG000|Overall Study|Adverse Event|4|||
130588961|NCT00584870|470115243|FG001|Overall Study|Adverse Event|3|||
130588962|NCT00584870|470115244|FG002|Overall Study|Adverse Event|2|||
130588963|NCT00584870|470115242|FG000|Overall Study|Lost to Follow-up|4|||
130588964|NCT00584870|470115243|FG001|Overall Study|Lost to Follow-up|1|||
130588965|NCT00584870|470115244|FG002|Overall Study|Lost to Follow-up|1|||
130588966|NCT00584870|470115242|FG000|Overall Study|Lack of Efficacy|7|||
130588967|NCT00584870|470115243|FG001|Overall Study|Lack of Efficacy|14|||
130588968|NCT00584870|470115244|FG002|Overall Study|Lack of Efficacy|8|||
130588969|NCT00584870|470115242|FG000|Overall Study|Withdrawal by Subject|10|||
130588970|NCT00584870|470115243|FG001|Overall Study|Withdrawal by Subject|5|||
130588971|NCT00584870|470115244|FG002|Overall Study|Withdrawal by Subject|3|||
130588972|NCT00584870|470115242|FG000|Overall Study|Protocol Violation|1|||
130588973|NCT00584870|470115243|FG001|Overall Study|Protocol Violation|1|||
130588974|NCT00584870|470115244|FG002|Overall Study|Protocol Violation|2|||
130588975|NCT00584870|470115242|FG000|Overall Study|Did not met entrance criteria|1|||
130588976|NCT00584870|470115243|FG001|Overall Study|Did not met entrance criteria|0|||
130588977|NCT00584870|470115244|FG002|Overall Study|Did not met entrance criteria|0|||
130588978|NCT00584870|470115242|FG000|Overall Study|Other|2|||
130588979|NCT00584870|470115243|FG001|Overall Study|Other|0|||
130588980|NCT00584870|470115244|FG002|Overall Study|Other|0|||
130588981|NCT00584870|470115242|FG000|Overall Study|Randomized but not treated|0|||
130588982|NCT00584870|470115243|FG001|Overall Study|Randomized but not treated|1|||
130588983|NCT00584870|470115244|FG002|Overall Study|Randomized but not treated|2|||
130588984|NCT02675075|470115245|FG000|Overall Study|Lost to Follow-up|3|||
130588985|NCT02675075|470115246|FG001|Overall Study|Lost to Follow-up|0|||
130588986|NCT00675597|470115247|FG000|Overall Study|Withdrawal by Subject|3|||
130588987|NCT00631137|470115248|FG000|Overall Study|Withdrawal by Subject|1|||
130588988|NCT00631137|470115249|FG001|Overall Study|Withdrawal by Subject|0|||
130588989|NCT03682120|470115250|FG000|Overall Study|Lost to Follow-up|11|||
130588990|NCT03682120|470115251|FG001|Overall Study|Lost to Follow-up|4|||
130588991|NCT03682120|470115252|FG002|Overall Study|Lost to Follow-up|5|||
130588992|NCT03682120|470115253|FG003|Overall Study|Lost to Follow-up|2|||
130588993|NCT03682120|470115250|FG000|Overall Study|Physician Decision|1|||
130588994|NCT03682120|470115251|FG001|Overall Study|Physician Decision|0|||
130588995|NCT03682120|470115252|FG002|Overall Study|Physician Decision|0|||
130588996|NCT03682120|470115253|FG003|Overall Study|Physician Decision|0|||
130588997|NCT03682120|470115250|FG000|Overall Study|Withdrawal by Subject|1|||
130588998|NCT03682120|470115251|FG001|Overall Study|Withdrawal by Subject|2|||
130588999|NCT03682120|470115252|FG002|Overall Study|Withdrawal by Subject|3|||
130589000|NCT03682120|470115253|FG003|Overall Study|Withdrawal by Subject|0|||
130589001|NCT03682120|470115250|FG000|Overall Study|Death|0|||
130589002|NCT03682120|470115251|FG001|Overall Study|Death|1|||
130589003|NCT03682120|470115252|FG002|Overall Study|Death|0|||
130589004|NCT03682120|470115253|FG003|Overall Study|Death|0|||
130589005|NCT03682120|470115250|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
130589006|NCT03682120|470115251|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
130589007|NCT03682120|470115252|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
130589008|NCT03682120|470115253|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
130589009|NCT03308188|470115254|FG000|Overall Study|Withdrawal by Subject|0|||
130589010|NCT03308188|470115255|FG001|Overall Study|Withdrawal by Subject|3|||
130589011|NCT03308188|470115254|FG000|Overall Study|Death|0|||
130589012|NCT03308188|470115255|FG001|Overall Study|Death|1|||
130589013|NCT02901431|470115256|FG000|PK Part|Adverse Event|0|||
130589014|NCT02901431|470115257|FG001|PK Part|Adverse Event|1|||
130589015|NCT02901431|470115258|FG002|PK Part|Adverse Event|0|||
130589016|NCT02901431|470115259|FG003|PK Part|Adverse Event|0|||
130589017|NCT02901431|470115260|FG004|PK Part|Adverse Event|0|||
130589018|NCT02901431|470115261|FG005|PK Part|Adverse Event|0|||
130589019|NCT02901431|470115262|FG006|PK Part|Adverse Event|0|||
130589020|NCT02901431|470115263|FG007|PK Part|Adverse Event|0|||
130589021|NCT02901431|470115264|FG008|PK Part|Adverse Event|0|||
130589022|NCT02901431|470115265|FG009|PK Part|Adverse Event|0|||
130589023|NCT02901431|470115266|FG010|PK Part|Adverse Event|0|||
130589024|NCT02901431|470115267|FG011|PK Part|Adverse Event|0|||
130589025|NCT02901431|470115268|FG012|PK Part|Adverse Event|0|||
130589026|NCT02901431|470115256|FG000|PK Part|Lost to Follow-up|0|||
130589027|NCT02901431|470115257|FG001|PK Part|Lost to Follow-up|0|||
130589028|NCT02901431|470115258|FG002|PK Part|Lost to Follow-up|1|||
130589029|NCT02901431|470115259|FG003|PK Part|Lost to Follow-up|0|||
130589030|NCT02901431|470115260|FG004|PK Part|Lost to Follow-up|0|||
130589031|NCT02901431|470115261|FG005|PK Part|Lost to Follow-up|0|||
130589032|NCT02901431|470115262|FG006|PK Part|Lost to Follow-up|0|||
130589033|NCT02901431|470115263|FG007|PK Part|Lost to Follow-up|0|||
130589034|NCT02901431|470115264|FG008|PK Part|Lost to Follow-up|0|||
130589035|NCT02901431|470115265|FG009|PK Part|Lost to Follow-up|0|||
130589036|NCT02901431|470115266|FG010|PK Part|Lost to Follow-up|0|||
130589037|NCT02901431|470115267|FG011|PK Part|Lost to Follow-up|0|||
130589038|NCT02901431|470115268|FG012|PK Part|Lost to Follow-up|0|||
130589039|NCT02901431|470115256|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
130589040|NCT02901431|470115257|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589041|NCT02901431|470115258|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589042|NCT02901431|470115259|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589043|NCT02901431|470115260|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589044|NCT02901431|470115261|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589045|NCT02901431|470115262|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589046|NCT02901431|470115263|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589047|NCT02901431|470115264|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589048|NCT02901431|470115265|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589049|NCT02901431|470115266|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589050|NCT02901431|470115267|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589051|NCT02901431|470115268|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130589052|NCT02901431|470115256|FG000|PK Part|Pending dose confirmation|0|||
130589053|NCT02901431|470115257|FG001|PK Part|Pending dose confirmation|1|||
130589054|NCT02901431|470115258|FG002|PK Part|Pending dose confirmation|0|||
130589055|NCT02901431|470115259|FG003|PK Part|Pending dose confirmation|0|||
130589056|NCT02901431|470115260|FG004|PK Part|Pending dose confirmation|0|||
130589057|NCT02901431|470115261|FG005|PK Part|Pending dose confirmation|0|||
130589058|NCT02901431|470115262|FG006|PK Part|Pending dose confirmation|0|||
130589059|NCT02901431|470115263|FG007|PK Part|Pending dose confirmation|0|||
130589060|NCT02901431|470115264|FG008|PK Part|Pending dose confirmation|0|||
130589061|NCT02901431|470115265|FG009|PK Part|Pending dose confirmation|0|||
130589062|NCT02901431|470115266|FG010|PK Part|Pending dose confirmation|0|||
130589063|NCT02901431|470115267|FG011|PK Part|Pending dose confirmation|0|||
130589064|NCT02901431|470115268|FG012|PK Part|Pending dose confirmation|0|||
130589065|NCT02901431|470115256|FG000|PK Part|8 weeks of treatment ran out|2|||
130589066|NCT02901431|470115257|FG001|PK Part|8 weeks of treatment ran out|0|||
130589067|NCT02901431|470115258|FG002|PK Part|8 weeks of treatment ran out|0|||
130589068|NCT02901431|470115259|FG003|PK Part|8 weeks of treatment ran out|0|||
130589069|NCT02901431|470115260|FG004|PK Part|8 weeks of treatment ran out|0|||
130589070|NCT02901431|470115261|FG005|PK Part|8 weeks of treatment ran out|0|||
130589071|NCT02901431|470115262|FG006|PK Part|8 weeks of treatment ran out|0|||
130589072|NCT02901431|470115263|FG007|PK Part|8 weeks of treatment ran out|0|||
130589073|NCT02901431|470115264|FG008|PK Part|8 weeks of treatment ran out|0|||
130589074|NCT02901431|470115265|FG009|PK Part|8 weeks of treatment ran out|0|||
130589075|NCT02901431|470115266|FG010|PK Part|8 weeks of treatment ran out|0|||
130589076|NCT02901431|470115267|FG011|PK Part|8 weeks of treatment ran out|0|||
130589077|NCT02901431|470115268|FG012|PK Part|8 weeks of treatment ran out|0|||
130589078|NCT02901431|470115256|FG000|PK Part|Stopped treatment after 8 weeks|1|||
130589079|NCT02901431|470115257|FG001|PK Part|Stopped treatment after 8 weeks|0|||
130589080|NCT02901431|470115258|FG002|PK Part|Stopped treatment after 8 weeks|1|||
130589081|NCT02901431|470115259|FG003|PK Part|Stopped treatment after 8 weeks|0|||
130589082|NCT02901431|470115260|FG004|PK Part|Stopped treatment after 8 weeks|0|||
130589083|NCT02901431|470115261|FG005|PK Part|Stopped treatment after 8 weeks|0|||
130589084|NCT02901431|470115262|FG006|PK Part|Stopped treatment after 8 weeks|0|||
130589085|NCT02901431|470115263|FG007|PK Part|Stopped treatment after 8 weeks|0|||
130589086|NCT02901431|470115264|FG008|PK Part|Stopped treatment after 8 weeks|0|||
130589087|NCT02901431|470115265|FG009|PK Part|Stopped treatment after 8 weeks|0|||
130589088|NCT02901431|470115266|FG010|PK Part|Stopped treatment after 8 weeks|0|||
130589089|NCT02901431|470115267|FG011|PK Part|Stopped treatment after 8 weeks|0|||
130589090|NCT02901431|470115268|FG012|PK Part|Stopped treatment after 8 weeks|0|||
130589091|NCT02901431|470115256|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
130589092|NCT02901431|470115257|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589093|NCT02901431|470115258|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
130589094|NCT02901431|470115259|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589095|NCT02901431|470115260|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589096|NCT02901431|470115261|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589097|NCT02901431|470115262|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589098|NCT02901431|470115263|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589099|NCT02901431|470115264|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589100|NCT02901431|470115265|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589101|NCT02901431|470115266|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589102|NCT02901431|470115267|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589103|NCT02901431|470115268|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130589104|NCT02901431|470115256|FG000|PK Part|Discontinued per Sponsor|0|||
130589105|NCT02901431|470115257|FG001|PK Part|Discontinued per Sponsor|3|||
130589106|NCT02901431|470115258|FG002|PK Part|Discontinued per Sponsor|0|||
130589107|NCT02901431|470115259|FG003|PK Part|Discontinued per Sponsor|0|||
130589108|NCT02901431|470115260|FG004|PK Part|Discontinued per Sponsor|0|||
130589109|NCT02901431|470115261|FG005|PK Part|Discontinued per Sponsor|0|||
130589110|NCT02901431|470115262|FG006|PK Part|Discontinued per Sponsor|0|||
130589111|NCT02901431|470115263|FG007|PK Part|Discontinued per Sponsor|0|||
130589112|NCT02901431|470115264|FG008|PK Part|Discontinued per Sponsor|0|||
130589113|NCT02901431|470115265|FG009|PK Part|Discontinued per Sponsor|0|||
130589114|NCT02901431|470115266|FG010|PK Part|Discontinued per Sponsor|0|||
130589115|NCT02901431|470115267|FG011|PK Part|Discontinued per Sponsor|0|||
130589116|NCT02901431|470115268|FG012|PK Part|Discontinued per Sponsor|0|||
130589117|NCT02901431|470115256|FG000|PK Part|Withdrawal by Subject|1|||
130589118|NCT02901431|470115257|FG001|PK Part|Withdrawal by Subject|1|||
130589119|NCT02901431|470115258|FG002|PK Part|Withdrawal by Subject|3|||
130589120|NCT02901431|470115259|FG003|PK Part|Withdrawal by Subject|0|||
130589121|NCT02901431|470115260|FG004|PK Part|Withdrawal by Subject|0|||
130589122|NCT02901431|470115261|FG005|PK Part|Withdrawal by Subject|0|||
130589123|NCT02901431|470115262|FG006|PK Part|Withdrawal by Subject|0|||
130589124|NCT02901431|470115263|FG007|PK Part|Withdrawal by Subject|0|||
130589125|NCT02901431|470115264|FG008|PK Part|Withdrawal by Subject|0|||
130589126|NCT02901431|470115265|FG009|PK Part|Withdrawal by Subject|0|||
130589127|NCT02901431|470115266|FG010|PK Part|Withdrawal by Subject|0|||
130589128|NCT02901431|470115267|FG011|PK Part|Withdrawal by Subject|0|||
130589129|NCT02901431|470115268|FG012|PK Part|Withdrawal by Subject|0|||
130589130|NCT02901431|470115256|FG000|Main Treatment Part|Adverse Event|0|||
130589131|NCT02901431|470115257|FG001|Main Treatment Part|Adverse Event|0|||
130589132|NCT02901431|470115258|FG002|Main Treatment Part|Adverse Event|0|||
130589133|NCT02901431|470115259|FG003|Main Treatment Part|Adverse Event|3|||
130589134|NCT02901431|470115260|FG004|Main Treatment Part|Adverse Event|3|||
130589135|NCT02901431|470115261|FG005|Main Treatment Part|Adverse Event|4|||
130589136|NCT02901431|470115262|FG006|Main Treatment Part|Adverse Event|1|||
130589137|NCT02901431|470115263|FG007|Main Treatment Part|Adverse Event|0|||
130589138|NCT02901431|470115264|FG008|Main Treatment Part|Adverse Event|0|||
130589139|NCT02901431|470115265|FG009|Main Treatment Part|Adverse Event|0|||
130589140|NCT02901431|470115266|FG010|Main Treatment Part|Adverse Event|0|||
130589141|NCT02901431|470115267|FG011|Main Treatment Part|Adverse Event|0|||
130589142|NCT02901431|470115268|FG012|Main Treatment Part|Adverse Event|0|||
130589143|NCT02901431|470115256|FG000|Main Treatment Part|Lack of Efficacy|0|||
130589144|NCT02901431|470115257|FG001|Main Treatment Part|Lack of Efficacy|0|||
130589145|NCT02901431|470115258|FG002|Main Treatment Part|Lack of Efficacy|0|||
130589146|NCT02901431|470115259|FG003|Main Treatment Part|Lack of Efficacy|1|||
130589147|NCT02901431|470115260|FG004|Main Treatment Part|Lack of Efficacy|0|||
130589148|NCT02901431|470115261|FG005|Main Treatment Part|Lack of Efficacy|0|||
130589149|NCT02901431|470115262|FG006|Main Treatment Part|Lack of Efficacy|0|||
130589150|NCT02901431|470115263|FG007|Main Treatment Part|Lack of Efficacy|0|||
130589151|NCT02901431|470115264|FG008|Main Treatment Part|Lack of Efficacy|0|||
130589152|NCT02901431|470115265|FG009|Main Treatment Part|Lack of Efficacy|0|||
130589153|NCT02901431|470115266|FG010|Main Treatment Part|Lack of Efficacy|0|||
130589154|NCT02901431|470115267|FG011|Main Treatment Part|Lack of Efficacy|0|||
130589155|NCT02901431|470115268|FG012|Main Treatment Part|Lack of Efficacy|0|||
130589156|NCT02901431|470115256|FG000|Main Treatment Part|Lost to Follow-up|0|||
130589157|NCT02901431|470115257|FG001|Main Treatment Part|Lost to Follow-up|0|||
130589158|NCT02901431|470115258|FG002|Main Treatment Part|Lost to Follow-up|0|||
130589159|NCT02901431|470115259|FG003|Main Treatment Part|Lost to Follow-up|3|||
130589160|NCT02901431|470115260|FG004|Main Treatment Part|Lost to Follow-up|1|||
130589161|NCT02901431|470115261|FG005|Main Treatment Part|Lost to Follow-up|2|||
130589162|NCT02901431|470115262|FG006|Main Treatment Part|Lost to Follow-up|3|||
130589163|NCT02901431|470115263|FG007|Main Treatment Part|Lost to Follow-up|0|||
130589164|NCT02901431|470115264|FG008|Main Treatment Part|Lost to Follow-up|0|||
130589165|NCT02901431|470115265|FG009|Main Treatment Part|Lost to Follow-up|0|||
130589166|NCT02901431|470115266|FG010|Main Treatment Part|Lost to Follow-up|0|||
130589167|NCT02901431|470115267|FG011|Main Treatment Part|Lost to Follow-up|0|||
130589168|NCT02901431|470115268|FG012|Main Treatment Part|Lost to Follow-up|0|||
130589169|NCT02901431|470115256|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
130589170|NCT02901431|470115257|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
130589171|NCT02901431|470115258|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
130589172|NCT02901431|470115259|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
130589173|NCT02901431|470115260|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
130589174|NCT02901431|470115261|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
130589175|NCT02901431|470115262|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
130589176|NCT02901431|470115263|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
130589177|NCT02901431|470115264|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
130589178|NCT02901431|470115265|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
130589179|NCT02901431|470115266|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
130589180|NCT02901431|470115267|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
130589181|NCT02901431|470115268|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
130589182|NCT02901431|470115256|FG000|Main Treatment Part|Physician Decision|0|||
130589183|NCT02901431|470115257|FG001|Main Treatment Part|Physician Decision|0|||
130589184|NCT02901431|470115258|FG002|Main Treatment Part|Physician Decision|0|||
130589185|NCT02901431|470115259|FG003|Main Treatment Part|Physician Decision|1|||
130589186|NCT02901431|470115260|FG004|Main Treatment Part|Physician Decision|0|||
130589187|NCT02901431|470115261|FG005|Main Treatment Part|Physician Decision|0|||
130589188|NCT02901431|470115262|FG006|Main Treatment Part|Physician Decision|1|||
130589189|NCT02901431|470115263|FG007|Main Treatment Part|Physician Decision|0|||
130589190|NCT02901431|470115264|FG008|Main Treatment Part|Physician Decision|0|||
130589191|NCT02901431|470115265|FG009|Main Treatment Part|Physician Decision|0|||
130589192|NCT02901431|470115266|FG010|Main Treatment Part|Physician Decision|0|||
130589193|NCT02901431|470115267|FG011|Main Treatment Part|Physician Decision|0|||
130589194|NCT02901431|470115268|FG012|Main Treatment Part|Physician Decision|0|||
130589195|NCT02901431|470115256|FG000|Main Treatment Part|Withdrawal by Subject|0|||
130589196|NCT02901431|470115257|FG001|Main Treatment Part|Withdrawal by Subject|0|||
130589197|NCT02901431|470115258|FG002|Main Treatment Part|Withdrawal by Subject|0|||
130589198|NCT02901431|470115259|FG003|Main Treatment Part|Withdrawal by Subject|18|||
130589199|NCT02901431|470115260|FG004|Main Treatment Part|Withdrawal by Subject|3|||
130589200|NCT02901431|470115261|FG005|Main Treatment Part|Withdrawal by Subject|5|||
130589201|NCT02901431|470115262|FG006|Main Treatment Part|Withdrawal by Subject|6|||
130589202|NCT02901431|470115263|FG007|Main Treatment Part|Withdrawal by Subject|0|||
130589203|NCT02901431|470115264|FG008|Main Treatment Part|Withdrawal by Subject|0|||
130589204|NCT02901431|470115265|FG009|Main Treatment Part|Withdrawal by Subject|0|||
130589205|NCT02901431|470115266|FG010|Main Treatment Part|Withdrawal by Subject|0|||
130589206|NCT02901431|470115267|FG011|Main Treatment Part|Withdrawal by Subject|0|||
130589207|NCT02901431|470115268|FG012|Main Treatment Part|Withdrawal by Subject|0|||
130589208|NCT02901431|470115256|FG000|Open Label Part|Adverse Event|0|||
130589209|NCT02901431|470115257|FG001|Open Label Part|Adverse Event|0|||
130589210|NCT02901431|470115258|FG002|Open Label Part|Adverse Event|0|||
130589211|NCT02901431|470115259|FG003|Open Label Part|Adverse Event|0|||
130589212|NCT02901431|470115260|FG004|Open Label Part|Adverse Event|0|||
130589213|NCT02901431|470115261|FG005|Open Label Part|Adverse Event|0|||
130589214|NCT02901431|470115262|FG006|Open Label Part|Adverse Event|0|||
130589215|NCT02901431|470115263|FG007|Open Label Part|Adverse Event|0|||
130589216|NCT02901431|470115264|FG008|Open Label Part|Adverse Event|4|||
130589217|NCT02901431|470115265|FG009|Open Label Part|Adverse Event|4|||
130589218|NCT02901431|470115266|FG010|Open Label Part|Adverse Event|0|||
130589219|NCT02901431|470115267|FG011|Open Label Part|Adverse Event|4|||
130589220|NCT02901431|470115268|FG012|Open Label Part|Adverse Event|1|||
130589221|NCT02901431|470115256|FG000|Open Label Part|Lost to Follow-up|0|||
130589222|NCT02901431|470115257|FG001|Open Label Part|Lost to Follow-up|0|||
130589223|NCT02901431|470115258|FG002|Open Label Part|Lost to Follow-up|0|||
130589224|NCT02901431|470115259|FG003|Open Label Part|Lost to Follow-up|0|||
130589225|NCT02901431|470115260|FG004|Open Label Part|Lost to Follow-up|0|||
130589226|NCT02901431|470115261|FG005|Open Label Part|Lost to Follow-up|0|||
130589227|NCT02901431|470115262|FG006|Open Label Part|Lost to Follow-up|0|||
130589228|NCT02901431|470115263|FG007|Open Label Part|Lost to Follow-up|0|||
130589229|NCT02901431|470115264|FG008|Open Label Part|Lost to Follow-up|2|||
130589230|NCT02901431|470115265|FG009|Open Label Part|Lost to Follow-up|2|||
130589231|NCT02901431|470115266|FG010|Open Label Part|Lost to Follow-up|1|||
130589232|NCT02901431|470115267|FG011|Open Label Part|Lost to Follow-up|1|||
130589233|NCT02901431|470115268|FG012|Open Label Part|Lost to Follow-up|1|||
130589234|NCT02901431|470115256|FG000|Open Label Part|Physician Decision|0|||
130589235|NCT02901431|470115257|FG001|Open Label Part|Physician Decision|0|||
130589236|NCT02901431|470115258|FG002|Open Label Part|Physician Decision|0|||
130589237|NCT02901431|470115259|FG003|Open Label Part|Physician Decision|0|||
130589238|NCT02901431|470115260|FG004|Open Label Part|Physician Decision|0|||
130589239|NCT02901431|470115261|FG005|Open Label Part|Physician Decision|0|||
130589240|NCT02901431|470115262|FG006|Open Label Part|Physician Decision|0|||
130589241|NCT02901431|470115263|FG007|Open Label Part|Physician Decision|0|||
130589242|NCT02901431|470115264|FG008|Open Label Part|Physician Decision|1|||
130589243|NCT02901431|470115265|FG009|Open Label Part|Physician Decision|1|||
130589244|NCT02901431|470115266|FG010|Open Label Part|Physician Decision|0|||
130589245|NCT02901431|470115267|FG011|Open Label Part|Physician Decision|0|||
130589246|NCT02901431|470115268|FG012|Open Label Part|Physician Decision|0|||
130589247|NCT02901431|470115256|FG000|Open Label Part|Study Terminated By Sponsor|0|||
130589248|NCT02901431|470115257|FG001|Open Label Part|Study Terminated By Sponsor|0|||
130589249|NCT02901431|470115258|FG002|Open Label Part|Study Terminated By Sponsor|0|||
130589250|NCT02901431|470115259|FG003|Open Label Part|Study Terminated By Sponsor|0|||
130589251|NCT02901431|470115260|FG004|Open Label Part|Study Terminated By Sponsor|0|||
130589252|NCT02901431|470115261|FG005|Open Label Part|Study Terminated By Sponsor|0|||
130589253|NCT02901431|470115262|FG006|Open Label Part|Study Terminated By Sponsor|0|||
130589254|NCT02901431|470115263|FG007|Open Label Part|Study Terminated By Sponsor|0|||
130589255|NCT02901431|470115264|FG008|Open Label Part|Study Terminated By Sponsor|35|||
130589256|NCT02901431|470115265|FG009|Open Label Part|Study Terminated By Sponsor|12|||
130589257|NCT02901431|470115266|FG010|Open Label Part|Study Terminated By Sponsor|21|||
130589258|NCT02901431|470115267|FG011|Open Label Part|Study Terminated By Sponsor|31|||
130589259|NCT02901431|470115268|FG012|Open Label Part|Study Terminated By Sponsor|0|||
130589260|NCT02901431|470115256|FG000|Open Label Part|Withdrawal by Subject|0|||
130589261|NCT02901431|470115257|FG001|Open Label Part|Withdrawal by Subject|0|||
130589262|NCT02901431|470115258|FG002|Open Label Part|Withdrawal by Subject|0|||
130589263|NCT02901431|470115259|FG003|Open Label Part|Withdrawal by Subject|0|||
130589264|NCT02901431|470115260|FG004|Open Label Part|Withdrawal by Subject|0|||
130589265|NCT02901431|470115261|FG005|Open Label Part|Withdrawal by Subject|0|||
130589266|NCT02901431|470115262|FG006|Open Label Part|Withdrawal by Subject|0|||
130589267|NCT02901431|470115263|FG007|Open Label Part|Withdrawal by Subject|0|||
130589268|NCT02901431|470115264|FG008|Open Label Part|Withdrawal by Subject|6|||
130589269|NCT02901431|470115265|FG009|Open Label Part|Withdrawal by Subject|5|||
130589270|NCT02901431|470115266|FG010|Open Label Part|Withdrawal by Subject|7|||
130589271|NCT02901431|470115267|FG011|Open Label Part|Withdrawal by Subject|3|||
130589272|NCT02901431|470115268|FG012|Open Label Part|Withdrawal by Subject|1|||
130589273|NCT04672083|470115269|FG000|Overall Study|Lost to Follow-up|1|||
130589274|NCT04672083|470115270|FG001|Overall Study|Lost to Follow-up|0|||
130589275|NCT04672083|470115271|FG002|Overall Study|Lost to Follow-up|0|||
130589276|NCT04672083|470115272|FG003|Overall Study|Lost to Follow-up|0|||
130589277|NCT04672083|470115273|FG004|Overall Study|Lost to Follow-up|0|||
130589278|NCT02048904|470115274|FG000|Overall Study|Withdrawal by Subject|7|||
130589279|NCT02048904|470115274|FG000|Overall Study|Physician Decision|70|||
130589280|NCT04752384|470115275|FG000|Overall Study|Withdrawal by Subject|1|||
130589281|NCT04752384|470115275|FG000|Overall Study|Death|1|||
130589282|NCT02732951|470117064|FG000|Overall Study|Other than listed|1|||
130589283|NCT02732951|470117065|FG001|Overall Study|Other than listed|0|||
130589284|NCT02732951|470117064|FG000|Overall Study|Lost to Follow-up|0|||
130589285|NCT02732951|470117065|FG001|Overall Study|Lost to Follow-up|1|||
130589286|NCT02732951|470117064|FG000|Overall Study|Adverse Event|4|||
130589287|NCT02732951|470117065|FG001|Overall Study|Adverse Event|4|||
130589288|NCT02732951|470117064|FG000|Overall Study|Protocol Violation|0|||
130589289|NCT02732951|470117065|FG001|Overall Study|Protocol Violation|1|||
130589290|NCT01750918|470117066|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
130589291|NCT01750918|470117067|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
130589292|NCT01750918|470117068|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
130589293|NCT01750918|470117069|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
130589294|NCT01750918|470117070|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
130589295|NCT01750918|470117071|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
130589296|NCT01750918|470117072|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
130589297|NCT01750918|470117073|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
130589298|NCT01750918|470117066|FG000|Overall Study|Lost to Follow-up|0|||
130589299|NCT01750918|470117067|FG001|Overall Study|Lost to Follow-up|0|||
130589300|NCT01750918|470117068|FG002|Overall Study|Lost to Follow-up|2|||
130589301|NCT01750918|470117069|FG003|Overall Study|Lost to Follow-up|2|||
130589302|NCT01750918|470117070|FG004|Overall Study|Lost to Follow-up|0|||
130589303|NCT01750918|470117071|FG005|Overall Study|Lost to Follow-up|0|||
130589304|NCT01750918|470117072|FG006|Overall Study|Lost to Follow-up|0|||
130589305|NCT01750918|470117073|FG007|Overall Study|Lost to Follow-up|1|||
130589306|NCT01750918|470117066|FG000|Overall Study|Withdrawal by Subject|0|||
130589307|NCT01750918|470117067|FG001|Overall Study|Withdrawal by Subject|0|||
130589308|NCT01750918|470117068|FG002|Overall Study|Withdrawal by Subject|1|||
130589309|NCT01750918|470117069|FG003|Overall Study|Withdrawal by Subject|2|||
130589310|NCT01750918|470117070|FG004|Overall Study|Withdrawal by Subject|1|||
130589311|NCT01750918|470117071|FG005|Overall Study|Withdrawal by Subject|1|||
130589312|NCT01750918|470117072|FG006|Overall Study|Withdrawal by Subject|2|||
130589313|NCT01750918|470117073|FG007|Overall Study|Withdrawal by Subject|2|||
130589314|NCT04840667|470117078|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
130589315|NCT01609933|470117089|FG000|Overall Study|Adverse Event|1|||
130589316|NCT01609933|470117089|FG000|Overall Study|Withdrawal by Subject|3|||
130589317|NCT00224016|470117090|FG000|Titration Period|Withdrawal by Subject|0|||
130589318|NCT00224016|470117091|FG001|Titration Period|Withdrawal by Subject|1|||
130589319|NCT00224016|470117090|FG000|Titration Period|Lost to Follow-up|1|||
130589320|NCT00224016|470117091|FG001|Titration Period|Lost to Follow-up|0|||
130589321|NCT00224016|470117090|FG000|Maintenance Period|Withdrawal by Subject|2|||
130589322|NCT00224016|470117091|FG001|Maintenance Period|Withdrawal by Subject|0|||
130589323|NCT00224016|470117090|FG000|Maintenance Period|Lost to Follow-up|0|||
130589324|NCT00224016|470117091|FG001|Maintenance Period|Lost to Follow-up|1|||
130589325|NCT01252966|470117092|FG000|Overall Study|Lost to Follow-up|16|||
130589326|NCT01252966|470117093|FG001|Overall Study|Lost to Follow-up|10|||
130589327|NCT01252966|470117092|FG000|Overall Study|Withdrawal by Subject|7|||
130589328|NCT01252966|470117093|FG001|Overall Study|Withdrawal by Subject|3|||
130589329|NCT01903876|470117098|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
130589330|NCT01903876|470117099|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
130589331|NCT01903876|470117098|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
130589332|NCT01903876|470117099|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
130589333|NCT00496366|470117100|FG000|Overall Study|Death|1|||
130589334|NCT04317690|470117103|FG000|Overall Study|did not have complete information for primary outcome|0|||
130589335|NCT04317690|470117104|FG001|Overall Study|did not have complete information for primary outcome|4|||
130589336|NCT04317690|470117105|FG002|Overall Study|did not have complete information for primary outcome|0|||
130589337|NCT04317690|470117106|FG003|Overall Study|did not have complete information for primary outcome|2|||
130589338|NCT04317690|470117107|FG004|Overall Study|did not have complete information for primary outcome|0|||
130589339|NCT02612909|470117108|FG000|Phase 2|Withdrawal by Subject|2|||
130589340|NCT02612909|470117109|FG001|Phase 2|Withdrawal by Subject|5|||
130589341|NCT02612909|470117110|FG002|Phase 2|Withdrawal by Subject|0|||
130589342|NCT02612909|470117111|FG003|Phase 2|Withdrawal by Subject|0|||
130589343|NCT02612909|470117112|FG004|Phase 2|Withdrawal by Subject|0|||
130589344|NCT02612909|470117108|FG000|Phase 2|Pregnancy|0|||
130589345|NCT02612909|470117109|FG001|Phase 2|Pregnancy|0|||
130589346|NCT02612909|470117110|FG002|Phase 2|Pregnancy|1|||
130589347|NCT02612909|470117111|FG003|Phase 2|Pregnancy|0|||
130589348|NCT02612909|470117112|FG004|Phase 2|Pregnancy|0|||
130589349|NCT02612909|470117108|FG000|Phase 3|Withdrawal by Subject|0|||
130589350|NCT02612909|470117109|FG001|Phase 3|Withdrawal by Subject|0|||
130589351|NCT02612909|470117110|FG002|Phase 3|Withdrawal by Subject|0|||
130589352|NCT02612909|470117111|FG003|Phase 3|Withdrawal by Subject|1|||
130589353|NCT02612909|470117112|FG004|Phase 3|Withdrawal by Subject|0|||
130589354|NCT01901224|470117113|FG000|Overall Study|study was not funded and terminated|2|||
130589355|NCT03902080|470117114|FG000|Overall Study|Adverse Event|17|||
130589356|NCT03902080|470117115|FG001|Overall Study|Adverse Event|15|||
130589357|NCT03902080|470117114|FG000|Overall Study|Withdrawal by Subject|28|||
130589358|NCT03902080|470117115|FG001|Overall Study|Withdrawal by Subject|35|||
130589359|NCT03902080|470117114|FG000|Overall Study|Lost to Follow-up|6|||
130589360|NCT03902080|470117115|FG001|Overall Study|Lost to Follow-up|7|||
130589361|NCT03902080|470117114|FG000|Overall Study|Other|3|||
130589362|NCT03902080|470117115|FG001|Overall Study|Other|5|||
130589363|NCT03902080|470117114|FG000|Overall Study|Non compliance|4|||
130589364|NCT03902080|470117115|FG001|Overall Study|Non compliance|3|||
130589365|NCT03902080|470117114|FG000|Overall Study|Physician Decision|5|||
130589366|NCT03902080|470117115|FG001|Overall Study|Physician Decision|1|||
130589367|NCT03902080|470117114|FG000|Overall Study|Protocol Violation|3|||
130589368|NCT03902080|470117115|FG001|Overall Study|Protocol Violation|3|||
130589369|NCT03902080|470117114|FG000|Overall Study|Lack of Efficacy|1|||
130589370|NCT03902080|470117115|FG001|Overall Study|Lack of Efficacy|3|||
130589371|NCT03902080|470117114|FG000|Overall Study|Withdrawn prior to dosing|0|||
130589372|NCT03902080|470117115|FG001|Overall Study|Withdrawn prior to dosing|1|||
130589373|NCT00391976|470117116|FG000|Overall Study|Adverse Event|0|||
130589374|NCT00391976|470117117|FG001|Overall Study|Adverse Event|0|||
130589375|NCT00391976|470117118|FG002|Overall Study|Adverse Event|1|||
130589376|NCT00391976|470117116|FG000|Overall Study|Withdrawal of consent|0|||
130589377|NCT00391976|470117117|FG001|Overall Study|Withdrawal of consent|1|||
130589378|NCT00391976|470117118|FG002|Overall Study|Withdrawal of consent|1|||
130589379|NCT00391976|470117116|FG000|Overall Study|Lost to Follow-up|1|||
130589380|NCT00391976|470117117|FG001|Overall Study|Lost to Follow-up|2|||
130589381|NCT00391976|470117118|FG002|Overall Study|Lost to Follow-up|0|||
130589382|NCT00391976|470117116|FG000|Overall Study|Inappropriate enrollment|1|||
130589383|NCT00391976|470117117|FG001|Overall Study|Inappropriate enrollment|1|||
130589384|NCT00391976|470117118|FG002|Overall Study|Inappropriate enrollment|0|||
130589385|NCT00391976|470117116|FG000|Overall Study|Protocol deviation/violation|4|||
130589386|NCT00391976|470117117|FG001|Overall Study|Protocol deviation/violation|2|||
130589387|NCT00391976|470117118|FG002|Overall Study|Protocol deviation/violation|1|||
130589388|NCT00391976|470117116|FG000|Overall Study|Recurrence/no eradication of infection|21|||
130589389|NCT00391976|470117117|FG001|Overall Study|Recurrence/no eradication of infection|19|||
130589390|NCT00391976|470117118|FG002|Overall Study|Recurrence/no eradication of infection|0|||
130589391|NCT00391976|470117116|FG000|Overall Study|Unable to classify|0|||
130589392|NCT00391976|470117117|FG001|Overall Study|Unable to classify|0|||
130589393|NCT00391976|470117118|FG002|Overall Study|Unable to classify|1|||
130589394|NCT00391976|470117116|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
130589395|NCT00391976|470117117|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
130589396|NCT00391976|470117118|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
130589397|NCT01701258|470117123|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
130589398|NCT01701258|470117124|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
130589399|NCT01701258|470117125|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
130589400|NCT01701258|470117126|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
130589401|NCT01701258|470117127|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
130589402|NCT01701258|470117128|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
130589403|NCT01701258|470117129|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
130589404|NCT01701258|470117130|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
130589405|NCT01701258|470117131|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
130589406|NCT01701258|470117132|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
130589407|NCT01701258|470117133|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
130589408|NCT01701258|470117134|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
130589409|NCT01701258|470117135|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
130589410|NCT01701258|470117123|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
130589411|NCT01701258|470117124|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
130589412|NCT01701258|470117125|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
130589413|NCT01701258|470117126|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
130589414|NCT01701258|470117127|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
130589415|NCT01701258|470117128|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
130589416|NCT01701258|470117129|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
130589417|NCT01701258|470117130|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
130589418|NCT01701258|470117131|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
130589419|NCT01701258|470117132|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
130589420|NCT01701258|470117133|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
130589421|NCT01701258|470117134|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
130589422|NCT01701258|470117135|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
130589423|NCT01701258|470117123|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
130589424|NCT01701258|470117124|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
130589425|NCT01701258|470117125|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
130589426|NCT01701258|470117126|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
130589427|NCT01701258|470117127|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
130589428|NCT01701258|470117128|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
130589429|NCT01701258|470117129|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
130589430|NCT01701258|470117130|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
130589431|NCT01701258|470117131|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
130589432|NCT01701258|470117132|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
130589433|NCT01701258|470117133|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
130589434|NCT01701258|470117134|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
130589435|NCT01701258|470117135|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
130589436|NCT01701258|470117123|FG000|Assessment and Scheduling|Investigator Terminated|2|||
130589437|NCT01701258|470117124|FG001|Assessment and Scheduling|Investigator Terminated|0|||
130589438|NCT01701258|470117125|FG002|Assessment and Scheduling|Investigator Terminated|0|||
130589439|NCT01701258|470117126|FG003|Assessment and Scheduling|Investigator Terminated|0|||
130589440|NCT01701258|470117127|FG004|Assessment and Scheduling|Investigator Terminated|0|||
130589441|NCT01701258|470117128|FG005|Assessment and Scheduling|Investigator Terminated|0|||
130589442|NCT01701258|470117129|FG006|Assessment and Scheduling|Investigator Terminated|0|||
130589443|NCT01701258|470117130|FG007|Assessment and Scheduling|Investigator Terminated|0|||
130589444|NCT01701258|470117131|FG008|Assessment and Scheduling|Investigator Terminated|0|||
130589445|NCT01701258|470117132|FG009|Assessment and Scheduling|Investigator Terminated|0|||
130589446|NCT01701258|470117133|FG010|Assessment and Scheduling|Investigator Terminated|0|||
130589447|NCT01701258|470117134|FG011|Assessment and Scheduling|Investigator Terminated|0|||
130589448|NCT01701258|470117135|FG012|Assessment and Scheduling|Investigator Terminated|0|||
130589449|NCT03093402|470117136|FG000|Overall Study|Lost to Follow-up|1|||
130589450|NCT03093402|470117137|FG001|Overall Study|Lost to Follow-up|0|||
130589451|NCT03093402|470117138|FG002|Overall Study|Lost to Follow-up|0|||
130589452|NCT03093402|470117139|FG003|Overall Study|Lost to Follow-up|0|||
130589453|NCT03093402|470117136|FG000|Overall Study|Withdrawal by Subject|3|||
130589454|NCT03093402|470117137|FG001|Overall Study|Withdrawal by Subject|3|||
130589455|NCT03093402|470117138|FG002|Overall Study|Withdrawal by Subject|0|||
130589456|NCT03093402|470117139|FG003|Overall Study|Withdrawal by Subject|1|||
130589457|NCT03093402|470117136|FG000|Overall Study|Withdrew prior to dosing|2|||
130589458|NCT03093402|470117137|FG001|Overall Study|Withdrew prior to dosing|1|||
130589459|NCT03093402|470117138|FG002|Overall Study|Withdrew prior to dosing|2|||
130589460|NCT03093402|470117139|FG003|Overall Study|Withdrew prior to dosing|3|||
130589461|NCT03093402|470117136|FG000|Overall Study|Ineligible for study|1|||
130589462|NCT03093402|470117137|FG001|Overall Study|Ineligible for study|0|||
130589463|NCT03093402|470117138|FG002|Overall Study|Ineligible for study|0|||
130589464|NCT03093402|470117139|FG003|Overall Study|Ineligible for study|0|||
130589465|NCT03093402|470117136|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
130589466|NCT03093402|470117137|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
130589467|NCT03093402|470117138|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
130589468|NCT03093402|470117139|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
130589469|NCT02429856|470117142|FG000|Overall Study|Death|12|||
130589470|NCT02429856|470117143|FG001|Overall Study|Death|13|||
130589471|NCT02429856|470117142|FG000|Overall Study|Lost to Follow-up|6|||
130589472|NCT02429856|470117143|FG001|Overall Study|Lost to Follow-up|5|||
130589473|NCT02429856|470117142|FG000|Overall Study|Withdrawal by Subject|1|||
130589474|NCT02429856|470117143|FG001|Overall Study|Withdrawal by Subject|1|||
130589475|NCT00763009|470117150|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
130589476|NCT03514914|470117152|FG000|Overall Study|Death|3|||
130589477|NCT03514914|470117153|FG001|Overall Study|Death|3|||
130589478|NCT03514914|470117152|FG000|Overall Study|Lost to Follow-up|117|||
130589479|NCT03514914|470117153|FG001|Overall Study|Lost to Follow-up|89|||
130589480|NCT00891735|470117154|FG000|Overall Study|Adverse Event|2|||
130589481|NCT00891735|470117155|FG001|Overall Study|Adverse Event|0|||
130589482|NCT00891735|470117156|FG002|Overall Study|Adverse Event|2|||
130589483|NCT00891735|470117157|FG003|Overall Study|Adverse Event|0|||
130589484|NCT00891735|470117154|FG000|Overall Study|Death|8|||
130589485|NCT00891735|470117155|FG001|Overall Study|Death|5|||
130589486|NCT00891735|470117156|FG002|Overall Study|Death|4|||
130589487|NCT00891735|470117157|FG003|Overall Study|Death|5|||
130589488|NCT00891735|470117154|FG000|Overall Study|Lost to Follow-up|2|||
130589489|NCT00891735|470117155|FG001|Overall Study|Lost to Follow-up|2|||
130589490|NCT00891735|470117156|FG002|Overall Study|Lost to Follow-up|2|||
130589491|NCT00891735|470117157|FG003|Overall Study|Lost to Follow-up|2|||
130589492|NCT00891735|470117154|FG000|Overall Study|Physician's decision to withdraw patient|1|||
130589493|NCT00891735|470117155|FG001|Overall Study|Physician's decision to withdraw patient|0|||
130589494|NCT00891735|470117156|FG002|Overall Study|Physician's decision to withdraw patient|0|||
130589495|NCT00891735|470117157|FG003|Overall Study|Physician's decision to withdraw patient|0|||
130589496|NCT00891735|470117154|FG000|Overall Study|Patient's decision to withdraw|4|||
130589497|NCT00891735|470117155|FG001|Overall Study|Patient's decision to withdraw|9|||
130589498|NCT00891735|470117156|FG002|Overall Study|Patient's decision to withdraw|4|||
130589499|NCT00891735|470117157|FG003|Overall Study|Patient's decision to withdraw|8|||
130589500|NCT01651780|470117165|FG000|Overall Study|Physician decision: No 30-day visit|2|||
130589501|NCT01651780|470117166|FG001|Overall Study|Physician decision: No 30-day visit|1|||
130589502|NCT01651780|470117165|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
130589503|NCT01651780|470117166|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
130589504|NCT01651780|470117165|FG000|Overall Study|Withdrawal by Subject|2|||
130589505|NCT01651780|470117166|FG001|Overall Study|Withdrawal by Subject|0|||
130589506|NCT01651780|470117165|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
130589507|NCT01651780|470117166|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130589508|NCT01651780|470117165|FG000|Overall Study|Lost to Follow-up|1|||
130589509|NCT01651780|470117166|FG001|Overall Study|Lost to Follow-up|2|||
130589510|NCT01651780|470117165|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
130589511|NCT01651780|470117166|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
130589512|NCT03029832|470117167|FG000|Overall Study|Safety Follow-Up Completed|2|||
130589513|NCT03029832|470117168|FG001|Overall Study|Safety Follow-Up Completed|0|||
130589514|NCT03029832|470117167|FG000|Overall Study|Death due to Disease Progression|1|||
130589515|NCT03029832|470117168|FG001|Overall Study|Death due to Disease Progression|0|||
130589516|NCT03029832|470117167|FG000|Overall Study|Study Terminated By Sponsor|1|||
130589517|NCT03029832|470117168|FG001|Overall Study|Study Terminated By Sponsor|1|||
130589518|NCT01628926|470117169|FG000|Overall Study|Adverse Event|13|||
130589519|NCT01628926|470117170|FG001|Overall Study|Adverse Event|11|||
130589520|NCT01628926|470117171|FG002|Overall Study|Adverse Event|9|||
130589521|NCT01628926|470117169|FG000|Overall Study|Lack of Efficacy|2|||
130589522|NCT01628926|470117170|FG001|Overall Study|Lack of Efficacy|1|||
130589523|NCT01628926|470117171|FG002|Overall Study|Lack of Efficacy|5|||
130589524|NCT01628926|470117169|FG000|Overall Study|Withdrawal by Subject|6|||
130589525|NCT01628926|470117170|FG001|Overall Study|Withdrawal by Subject|4|||
130589526|NCT01628926|470117171|FG002|Overall Study|Withdrawal by Subject|2|||
130589527|NCT01628926|470117169|FG000|Overall Study|Protocol Violation|0|||
130589528|NCT01628926|470117170|FG001|Overall Study|Protocol Violation|1|||
130589529|NCT01628926|470117171|FG002|Overall Study|Protocol Violation|0|||
130589530|NCT01628926|470117169|FG000|Overall Study|Discontinuation criteria|3|||
130589531|NCT01628926|470117170|FG001|Overall Study|Discontinuation criteria|4|||
130589532|NCT01628926|470117171|FG002|Overall Study|Discontinuation criteria|0|||
130589533|NCT01628926|470117169|FG000|Overall Study|Physician Decision|2|||
130589534|NCT01628926|470117170|FG001|Overall Study|Physician Decision|2|||
130589535|NCT01628926|470117171|FG002|Overall Study|Physician Decision|1|||
130589536|NCT01412229|470117172|FG000|Overall Study|Physician Decision|1|||
130589537|NCT00151892|470117179|FG000|Overall Study|Lack of Efficacy|50|||
130589538|NCT00151892|470117180|FG001|Overall Study|Lack of Efficacy|57|||
130589539|NCT00151892|470117179|FG000|Overall Study|Patient request|10|||
130589540|NCT00151892|470117180|FG001|Overall Study|Patient request|7|||
130589541|NCT00151892|470117179|FG000|Overall Study|Lost to Follow-up|5|||
130589542|NCT00151892|470117180|FG001|Overall Study|Lost to Follow-up|10|||
130589543|NCT00151892|470117179|FG000|Overall Study|Adverse Event|6|||
130589544|NCT00151892|470117180|FG001|Overall Study|Adverse Event|3|||
130589545|NCT00151892|470117179|FG000|Overall Study|Protocol Violation|3|||
130589546|NCT00151892|470117180|FG001|Overall Study|Protocol Violation|3|||
130589547|NCT00151892|470117179|FG000|Overall Study|Non-compliance|0|||
130589548|NCT00151892|470117180|FG001|Overall Study|Non-compliance|1|||
130589549|NCT00151892|470117179|FG000|Overall Study|Pregnancy|0|||
130589550|NCT00151892|470117180|FG001|Overall Study|Pregnancy|1|||
130589551|NCT00151892|470117179|FG000|Overall Study|Did not return for a visit|1|||
130589552|NCT00151892|470117180|FG001|Overall Study|Did not return for a visit|0|||
130589553|NCT00151892|470117179|FG000|Overall Study|Used prohibited corticosteroids|1|||
130589554|NCT00151892|470117180|FG001|Overall Study|Used prohibited corticosteroids|0|||
130589555|NCT00151892|470117179|FG000|Overall Study|Lack of study medication at center|0|||
130589556|NCT00151892|470117180|FG001|Overall Study|Lack of study medication at center|1|||
130589557|NCT01889602|470117181|FG000|First Intervention|Adverse Event|1|||
130589558|NCT01889602|470117182|FG001|First Intervention|Adverse Event|1|||
130589559|NCT01889602|470117183|FG002|First Intervention|Adverse Event|1|||
130589560|NCT01889602|470117181|FG000|First Intervention|Protocol Violation|0|||
130589561|NCT01889602|470117182|FG001|First Intervention|Protocol Violation|1|||
130589562|NCT01889602|470117183|FG002|First Intervention|Protocol Violation|1|||
130589563|NCT01889602|470117181|FG000|First Intervention|Study ending|0|||
130589564|NCT01889602|470117182|FG001|First Intervention|Study ending|1|||
130589565|NCT01889602|470117183|FG002|First Intervention|Study ending|0|||
130589566|NCT01889602|470117181|FG000|Second Intervention|Adverse Event|0|||
130589567|NCT01889602|470117182|FG001|Second Intervention|Adverse Event|0|||
130589568|NCT01889602|470117183|FG002|Second Intervention|Adverse Event|1|||
130589569|NCT01889602|470117181|FG000|Second Intervention|Study ending|1|||
130589570|NCT01889602|470117182|FG001|Second Intervention|Study ending|0|||
130589571|NCT01889602|470117183|FG002|Second Intervention|Study ending|0|||
130589572|NCT01889602|470117181|FG000|Second Intervention|Withdrawal by Subject|0|||
130589573|NCT01889602|470117182|FG001|Second Intervention|Withdrawal by Subject|0|||
130589574|NCT01889602|470117183|FG002|Second Intervention|Withdrawal by Subject|1|||
130589575|NCT01889602|470117181|FG000|Third Intervention|Protocol Violation|1|||
130589576|NCT01889602|470117182|FG001|Third Intervention|Protocol Violation|0|||
130589577|NCT01889602|470117183|FG002|Third Intervention|Protocol Violation|0|||
130589578|NCT01889602|470117181|FG000|Third Intervention|Withdrawal by Subject|2|||
130589579|NCT01889602|470117182|FG001|Third Intervention|Withdrawal by Subject|2|||
130589580|NCT01889602|470117183|FG002|Third Intervention|Withdrawal by Subject|0|||
130589581|NCT00404092|470117184|FG000|Overall Study|Death|1|||
130589582|NCT00404092|470117185|FG001|Overall Study|Death|0|||
130589583|NCT00404092|470117186|FG002|Overall Study|Death|0|||
130589584|NCT00404092|470117187|FG003|Overall Study|Death|0|||
130589585|NCT00404092|470117184|FG000|Overall Study|Adverse Event|0|||
130589586|NCT00404092|470117185|FG001|Overall Study|Adverse Event|0|||
130589587|NCT00404092|470117186|FG002|Overall Study|Adverse Event|1|||
130589588|NCT00404092|470117187|FG003|Overall Study|Adverse Event|0|||
130589589|NCT04223609|470117192|FG000|Overall Study|Adverse Event|0|||
130589590|NCT04223609|470117193|FG001|Overall Study|Adverse Event|1|||
130589591|NCT04223609|470117192|FG000|Overall Study|Missed last visit|0|||
130589592|NCT04223609|470117193|FG001|Overall Study|Missed last visit|1|||
130589593|NCT01275222|470117196|FG000|Phase l by Treatment|Adverse Event|1|||
130589594|NCT01275222|470117197|FG001|Phase l by Treatment|Adverse Event|4|||
130589595|NCT01275222|470117198|FG002|Phase l by Treatment|Adverse Event|2|||
130589596|NCT01275222|470117199|FG003|Phase l by Treatment|Adverse Event|3|||
130589597|NCT01275222|470117200|FG004|Phase l by Treatment|Adverse Event|0|||
130589598|NCT01275222|470117201|FG005|Phase l by Treatment|Adverse Event|0|||
130589599|NCT01275222|470117196|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130589600|NCT01275222|470117197|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130589601|NCT01275222|470117198|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
130589602|NCT01275222|470117199|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130589603|NCT01275222|470117200|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130589604|NCT01275222|470117201|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130589605|NCT01275222|470117196|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130589606|NCT01275222|470117197|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130589607|NCT01275222|470117198|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130589608|NCT01275222|470117199|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
130589609|NCT01275222|470117200|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130589610|NCT01275222|470117201|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130589611|NCT01275222|470117196|FG000|Phase l by Treatment|Disease progression|12|||
130589612|NCT01275222|470117197|FG001|Phase l by Treatment|Disease progression|8|||
130589613|NCT01275222|470117198|FG002|Phase l by Treatment|Disease progression|2|||
130589614|NCT01275222|470117199|FG003|Phase l by Treatment|Disease progression|5|||
130589615|NCT01275222|470117200|FG004|Phase l by Treatment|Disease progression|0|||
130589616|NCT01275222|470117201|FG005|Phase l by Treatment|Disease progression|0|||
130589617|NCT01275222|470117196|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
130589618|NCT01275222|470117197|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
130589619|NCT01275222|470117198|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
130589620|NCT01275222|470117199|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
130589621|NCT01275222|470117200|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
130589622|NCT01275222|470117201|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
130589623|NCT01275222|470117196|FG000|Phase l by Treatment|Death|0|||
130589624|NCT01275222|470117197|FG001|Phase l by Treatment|Death|1|||
130589625|NCT01275222|470117198|FG002|Phase l by Treatment|Death|0|||
130589626|NCT01275222|470117199|FG003|Phase l by Treatment|Death|1|||
130589627|NCT01275222|470117200|FG004|Phase l by Treatment|Death|0|||
130589628|NCT01275222|470117201|FG005|Phase l by Treatment|Death|0|||
130589629|NCT01275222|470117196|FG000|Phase ll by Stratum|Adverse Event|0|||
130589630|NCT01275222|470117197|FG001|Phase ll by Stratum|Adverse Event|0|||
130589631|NCT01275222|470117198|FG002|Phase ll by Stratum|Adverse Event|0|||
130589632|NCT01275222|470117199|FG003|Phase ll by Stratum|Adverse Event|0|||
130589633|NCT01275222|470117200|FG004|Phase ll by Stratum|Adverse Event|2|||
130589634|NCT01275222|470117201|FG005|Phase ll by Stratum|Adverse Event|10|||
130589635|NCT01275222|470117196|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
130589636|NCT01275222|470117197|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
130589637|NCT01275222|470117198|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
130589638|NCT01275222|470117199|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
130589639|NCT01275222|470117200|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
130589640|NCT01275222|470117201|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
130589641|NCT01275222|470117196|FG000|Phase ll by Stratum|Disease progression|0|||
130589642|NCT01275222|470117197|FG001|Phase ll by Stratum|Disease progression|0|||
130589643|NCT01275222|470117198|FG002|Phase ll by Stratum|Disease progression|0|||
130589644|NCT01275222|470117199|FG003|Phase ll by Stratum|Disease progression|0|||
130589645|NCT01275222|470117200|FG004|Phase ll by Stratum|Disease progression|23|||
130589646|NCT01275222|470117201|FG005|Phase ll by Stratum|Disease progression|31|||
130589647|NCT01275222|470117196|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
130589648|NCT01275222|470117197|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
130589649|NCT01275222|470117198|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
130589650|NCT01275222|470117199|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
130589651|NCT01275222|470117200|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
130589652|NCT01275222|470117201|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
130589653|NCT01275222|470117196|FG000|Phase ll by Stratum|Death|0|||
130589654|NCT01275222|470117197|FG001|Phase ll by Stratum|Death|0|||
130589655|NCT01275222|470117198|FG002|Phase ll by Stratum|Death|0|||
130589656|NCT01275222|470117199|FG003|Phase ll by Stratum|Death|0|||
130589657|NCT01275222|470117200|FG004|Phase ll by Stratum|Death|1|||
130589658|NCT01275222|470117201|FG005|Phase ll by Stratum|Death|1|||
130589659|NCT03440944|470117202|FG000|Overall Study|Physician Decision|1|||
130589660|NCT03440944|470117203|FG001|Overall Study|Physician Decision|0|||
130589661|NCT03440944|470117202|FG000|Overall Study|No Acceptable Vasculature|0|||
130589662|NCT03440944|470117203|FG001|Overall Study|No Acceptable Vasculature|1|||
130589663|NCT00591734|470117204|FG000|Overall Study|Lack of Efficacy|35|||
130589664|NCT00591734|470117204|FG000|Overall Study|Adverse Event|5|||
130589665|NCT00591734|470117204|FG000|Overall Study|Physician Decision|5|||
130589666|NCT00591734|470117204|FG000|Overall Study|Intercurrent Illness|8|||
130589667|NCT01661790|470117205|FG000|Overall Study|Lost to Follow-up|0|||
130589668|NCT01661790|470117206|FG001|Overall Study|Lost to Follow-up|2|||
130589669|NCT00784758|470117207|FG000|Overall Study|Withdrawal by Subject|3|||
130589670|NCT00784758|470117208|FG001|Overall Study|Withdrawal by Subject|0|||
130589671|NCT00784758|470117207|FG000|Overall Study|Adverse Event|1|||
130589672|NCT00784758|470117208|FG001|Overall Study|Adverse Event|0|||
130589673|NCT00891202|470117209|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
130589674|NCT00891202|470117210|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130589675|NCT00891202|470117211|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130589676|NCT00891202|470117212|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130589677|NCT00891202|470117209|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130589678|NCT00891202|470117210|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130589679|NCT00891202|470117211|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
130589680|NCT00891202|470117212|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130589681|NCT00891202|470117209|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130589682|NCT00891202|470117210|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130589683|NCT00891202|470117211|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
130589684|NCT00891202|470117212|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130589685|NCT00891202|470117209|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
130589686|NCT00891202|470117210|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
130589687|NCT00891202|470117211|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
130589688|NCT00891202|470117212|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
130589689|NCT01291017|470117215|FG000|Overall Study|Lost to Follow-up|2|||
130589690|NCT01291017|470117215|FG000|Overall Study|Withdrawal by Subject|3|||
130589691|NCT04980391|470117216|FG000|Overall Study|Death|0|||
130589692|NCT04980391|470117217|FG001|Overall Study|Death|0|||
130589693|NCT04980391|470117218|FG002|Overall Study|Death|1|||
130589694|NCT04980391|470117219|FG003|Overall Study|Death|1|||
130589695|NCT04980391|470117216|FG000|Overall Study|Lost to Follow-up|3|||
130589696|NCT04980391|470117217|FG001|Overall Study|Lost to Follow-up|3|||
130589697|NCT04980391|470117218|FG002|Overall Study|Lost to Follow-up|2|||
130589698|NCT04980391|470117219|FG003|Overall Study|Lost to Follow-up|3|||
130589699|NCT04980391|470117216|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
130589700|NCT04980391|470117217|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130589701|NCT04980391|470117218|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130589702|NCT04980391|470117219|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130589703|NCT04980391|470117216|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130589704|NCT04980391|470117217|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130589705|NCT04980391|470117218|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130589706|NCT04980391|470117219|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130589707|NCT04980391|470117216|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130589708|NCT04980391|470117217|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130589709|NCT04980391|470117218|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
130589710|NCT04980391|470117219|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130589711|NCT03690869|470117220|FG000|Overall Study|Adverse Event|0|||
130589712|NCT03690869|470117221|FG001|Overall Study|Adverse Event|0|||
130589713|NCT03690869|470117222|FG002|Overall Study|Adverse Event|0|||
130589714|NCT03690869|470117223|FG003|Overall Study|Adverse Event|1|||
130589715|NCT03690869|470117224|FG004|Overall Study|Adverse Event|0|||
130589716|NCT03690869|470117225|FG005|Overall Study|Adverse Event|0|||
130589717|NCT03690869|470117226|FG006|Overall Study|Adverse Event|0|||
130589718|NCT03690869|470117227|FG007|Overall Study|Adverse Event|1|||
130589719|NCT03690869|470117228|FG008|Overall Study|Adverse Event|0|||
130589720|NCT03690869|470117229|FG009|Overall Study|Adverse Event|1|||
130589721|NCT03690869|470117220|FG000|Overall Study|Death|1|||
130589722|NCT03690869|470117221|FG001|Overall Study|Death|1|||
130589723|NCT03690869|470117222|FG002|Overall Study|Death|1|||
130589724|NCT03690869|470117223|FG003|Overall Study|Death|4|||
130589725|NCT03690869|470117224|FG004|Overall Study|Death|2|||
130589726|NCT03690869|470117225|FG005|Overall Study|Death|5|||
130589727|NCT03690869|470117226|FG006|Overall Study|Death|3|||
130589728|NCT03690869|470117227|FG007|Overall Study|Death|2|||
130589729|NCT03690869|470117228|FG008|Overall Study|Death|0|||
130589730|NCT03690869|470117229|FG009|Overall Study|Death|3|||
130589731|NCT03690869|470117220|FG000|Overall Study|Lost to Follow-up|0|||
130589732|NCT03690869|470117221|FG001|Overall Study|Lost to Follow-up|0|||
130589733|NCT03690869|470117222|FG002|Overall Study|Lost to Follow-up|1|||
130589734|NCT03690869|470117223|FG003|Overall Study|Lost to Follow-up|0|||
130589735|NCT03690869|470117224|FG004|Overall Study|Lost to Follow-up|0|||
130589736|NCT03690869|470117225|FG005|Overall Study|Lost to Follow-up|0|||
130589737|NCT03690869|470117226|FG006|Overall Study|Lost to Follow-up|0|||
130589738|NCT03690869|470117227|FG007|Overall Study|Lost to Follow-up|0|||
130589739|NCT03690869|470117228|FG008|Overall Study|Lost to Follow-up|0|||
130589740|NCT03690869|470117229|FG009|Overall Study|Lost to Follow-up|0|||
130589741|NCT03690869|470117220|FG000|Overall Study|Other Treatment|1|||
130589742|NCT03690869|470117221|FG001|Overall Study|Other Treatment|1|||
130589743|NCT03690869|470117222|FG002|Overall Study|Other Treatment|1|||
130589744|NCT03690869|470117223|FG003|Overall Study|Other Treatment|2|||
130589745|NCT03690869|470117224|FG004|Overall Study|Other Treatment|3|||
130589746|NCT03690869|470117225|FG005|Overall Study|Other Treatment|1|||
130589747|NCT03690869|470117226|FG006|Overall Study|Other Treatment|2|||
130589748|NCT03690869|470117227|FG007|Overall Study|Other Treatment|7|||
130589749|NCT03690869|470117228|FG008|Overall Study|Other Treatment|0|||
130589750|NCT03690869|470117229|FG009|Overall Study|Other Treatment|3|||
130589751|NCT03690869|470117220|FG000|Overall Study|Physician Decision|0|||
130589752|NCT03690869|470117221|FG001|Overall Study|Physician Decision|1|||
130589753|NCT03690869|470117222|FG002|Overall Study|Physician Decision|0|||
130589754|NCT03690869|470117223|FG003|Overall Study|Physician Decision|0|||
130589755|NCT03690869|470117224|FG004|Overall Study|Physician Decision|0|||
130589756|NCT03690869|470117225|FG005|Overall Study|Physician Decision|0|||
130589757|NCT03690869|470117226|FG006|Overall Study|Physician Decision|0|||
130589758|NCT03690869|470117227|FG007|Overall Study|Physician Decision|0|||
130589759|NCT03690869|470117228|FG008|Overall Study|Physician Decision|0|||
130589760|NCT03690869|470117229|FG009|Overall Study|Physician Decision|0|||
130589761|NCT03690869|470117220|FG000|Overall Study|Progressive Disease|1|||
130589762|NCT03690869|470117221|FG001|Overall Study|Progressive Disease|2|||
130589763|NCT03690869|470117222|FG002|Overall Study|Progressive Disease|0|||
130589764|NCT03690869|470117223|FG003|Overall Study|Progressive Disease|1|||
130589765|NCT03690869|470117224|FG004|Overall Study|Progressive Disease|0|||
130589766|NCT03690869|470117225|FG005|Overall Study|Progressive Disease|0|||
130589767|NCT03690869|470117226|FG006|Overall Study|Progressive Disease|0|||
130589768|NCT03690869|470117227|FG007|Overall Study|Progressive Disease|0|||
130589769|NCT03690869|470117228|FG008|Overall Study|Progressive Disease|1|||
130589770|NCT03690869|470117229|FG009|Overall Study|Progressive Disease|1|||
130589771|NCT03690869|470117220|FG000|Overall Study|Subject Decision|0|||
130589772|NCT03690869|470117221|FG001|Overall Study|Subject Decision|0|||
130589773|NCT03690869|470117222|FG002|Overall Study|Subject Decision|0|||
130589774|NCT03690869|470117223|FG003|Overall Study|Subject Decision|1|||
130589775|NCT03690869|470117224|FG004|Overall Study|Subject Decision|0|||
130589776|NCT03690869|470117225|FG005|Overall Study|Subject Decision|0|||
130589777|NCT03690869|470117226|FG006|Overall Study|Subject Decision|0|||
130589778|NCT03690869|470117227|FG007|Overall Study|Subject Decision|1|||
130589779|NCT03690869|470117228|FG008|Overall Study|Subject Decision|0|||
130589780|NCT03690869|470117229|FG009|Overall Study|Subject Decision|0|||
130589781|NCT01431287|470119386|FG000|Overall Study|not treated|0|||
130589782|NCT01431287|470119387|FG001|Overall Study|not treated|0|||
130589783|NCT01431287|470119388|FG002|Overall Study|not treated|1|||
130589784|NCT01431287|470119389|FG003|Overall Study|not treated|0|||
130589785|NCT01431287|470119390|FG004|Overall Study|not treated|0|||
130589786|NCT01431287|470119386|FG000|Overall Study|Adverse Event|59|||
130589787|NCT01431287|470119387|FG001|Overall Study|Adverse Event|57|||
130589788|NCT01431287|470119388|FG002|Overall Study|Adverse Event|53|||
130589789|NCT01431287|470119389|FG003|Overall Study|Adverse Event|33|||
130589790|NCT01431287|470119390|FG004|Overall Study|Adverse Event|41|||
130589791|NCT01431287|470119386|FG000|Overall Study|Non compliant with protocol|6|||
130589792|NCT01431287|470119387|FG001|Overall Study|Non compliant with protocol|6|||
130589793|NCT01431287|470119388|FG002|Overall Study|Non compliant with protocol|5|||
130589794|NCT01431287|470119389|FG003|Overall Study|Non compliant with protocol|6|||
130589795|NCT01431287|470119390|FG004|Overall Study|Non compliant with protocol|5|||
130589796|NCT01431287|470119386|FG000|Overall Study|Lost to Follow-up|0|||
130589797|NCT01431287|470119387|FG001|Overall Study|Lost to Follow-up|3|||
130589798|NCT01431287|470119388|FG002|Overall Study|Lost to Follow-up|2|||
130589799|NCT01431287|470119389|FG003|Overall Study|Lost to Follow-up|3|||
130589800|NCT01431287|470119390|FG004|Overall Study|Lost to Follow-up|1|||
130589801|NCT01431287|470119386|FG000|Overall Study|Consent withdrawn not due to AE|29|||
130589802|NCT01431287|470119387|FG001|Overall Study|Consent withdrawn not due to AE|30|||
130589803|NCT01431287|470119388|FG002|Overall Study|Consent withdrawn not due to AE|34|||
130589804|NCT01431287|470119389|FG003|Overall Study|Consent withdrawn not due to AE|19|||
130589805|NCT01431287|470119390|FG004|Overall Study|Consent withdrawn not due to AE|29|||
130589806|NCT01431287|470119386|FG000|Overall Study|not stated above|4|||
130589807|NCT01431287|470119387|FG001|Overall Study|not stated above|2|||
130589808|NCT01431287|470119388|FG002|Overall Study|not stated above|2|||
130589809|NCT01431287|470119389|FG003|Overall Study|not stated above|2|||
130589810|NCT01431287|470119390|FG004|Overall Study|not stated above|1|||
130589811|NCT02224664|470119392|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
130589812|NCT02224664|470119393|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130589813|NCT02224664|470119394|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130589814|NCT02224664|470119395|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130589815|NCT02224664|470119396|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130589816|NCT02224664|470119392|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
130589817|NCT02224664|470119393|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
130589818|NCT02224664|470119394|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
130589819|NCT02224664|470119395|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
130589820|NCT02224664|470119396|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
130589821|NCT02224664|470119392|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130589822|NCT02224664|470119393|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130589823|NCT02224664|470119394|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130589824|NCT02224664|470119395|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
130589825|NCT02224664|470119396|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
130589826|NCT05047523|470119398|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130589827|NCT05047523|470119399|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130589828|NCT05047523|470119400|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
130589829|NCT05047523|470119401|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130589830|NCT05047523|470119402|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130589831|NCT05047523|470119403|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130589832|NCT05047523|470119398|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130589833|NCT05047523|470119399|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
130589834|NCT05047523|470119400|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130589835|NCT05047523|470119401|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130589836|NCT05047523|470119402|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130589837|NCT05047523|470119403|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130589838|NCT05047523|470119398|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
130589839|NCT05047523|470119399|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
130589840|NCT05047523|470119400|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
130589841|NCT05047523|470119401|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
130589842|NCT05047523|470119402|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
130589843|NCT05047523|470119403|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
130589844|NCT05047523|470119398|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
130589845|NCT05047523|470119399|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130589846|NCT05047523|470119400|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130589847|NCT05047523|470119401|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130589848|NCT05047523|470119402|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130589849|NCT05047523|470119403|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130589850|NCT05047523|470119398|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130589851|NCT05047523|470119399|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130589852|NCT05047523|470119400|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130589853|NCT05047523|470119401|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130589854|NCT05047523|470119402|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
130589855|NCT05047523|470119403|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
130589856|NCT05047523|470119398|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
130589857|NCT05047523|470119399|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
130589858|NCT05047523|470119400|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
130589859|NCT05047523|470119401|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
130589860|NCT05047523|470119402|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
130589861|NCT05047523|470119403|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
130589862|NCT03658889|470119404|FG000|Overall Study|Protocol Violation|2|||
130589863|NCT03658889|470119405|FG001|Overall Study|Protocol Violation|0|||
130589864|NCT00206726|470119415|FG000|Overall Study|Delayed recovery of blood counts|1|||
130589865|NCT00206726|470119415|FG000|Overall Study|Progressive disease or relapsed disease|18|||
130589866|NCT00206726|470119415|FG000|Overall Study|Placed on new protocol|1|||
130589867|NCT00206726|470119415|FG000|Overall Study|Bone marrow transplant|1|||
130589868|NCT00206726|470119415|FG000|Overall Study|Adverse Event|17|||
130589869|NCT00206726|470119415|FG000|Overall Study|Death|4|||
130589870|NCT00206726|470119415|FG000|Overall Study|Protocol Violation|1|||
130589871|NCT00206726|470119415|FG000|Overall Study|Withdrawal by Subject|8|||
130589872|NCT01719757|470119417|FG000|Overall Study|Adverse Event|38|||
130589873|NCT01719757|470119417|FG000|Overall Study|Withdrawal by Subject|15|||
130589874|NCT01719757|470119417|FG000|Overall Study|Lost to Follow-up|20|||
130589875|NCT01719757|470119417|FG000|Overall Study|Protocol Violation|1|||
130589876|NCT01719757|470119417|FG000|Overall Study|well controlled pain|27|||
130589877|NCT02626338|470119418|FG000|Overall Study|Lack of Efficacy|3|||
130589878|NCT02626338|470119419|FG001|Overall Study|Lack of Efficacy|2|||
130589879|NCT02626338|470119420|FG002|Overall Study|Lack of Efficacy|0|||
130589880|NCT00450580|470119426|FG000|Overall Study|Adverse Event|5|||
130589881|NCT00450580|470119427|FG001|Overall Study|Adverse Event|7|||
130589882|NCT00450580|470119426|FG000|Overall Study|Lost to Follow-up|4|||
130589883|NCT00450580|470119427|FG001|Overall Study|Lost to Follow-up|5|||
130589884|NCT00450580|470119426|FG000|Overall Study|Withdrawal by Subject|2|||
130589885|NCT00450580|470119427|FG001|Overall Study|Withdrawal by Subject|2|||
130589886|NCT00450580|470119426|FG000|Overall Study|Protocol Violation|1|||
130589887|NCT00450580|470119427|FG001|Overall Study|Protocol Violation|1|||
130589888|NCT00450580|470119426|FG000|Overall Study|Protocol-defined virologic failure|1|||
130589889|NCT00450580|470119427|FG001|Overall Study|Protocol-defined virologic failure|0|||
130589890|NCT00450580|470119426|FG000|Overall Study|Could not comply with scheduled visits|1|||
130589891|NCT00450580|470119427|FG001|Overall Study|Could not comply with scheduled visits|0|||
130589892|NCT00450580|470119426|FG000|Overall Study|Patient went to Brazil|1|||
130589893|NCT00450580|470119427|FG001|Overall Study|Patient went to Brazil|0|||
130589894|NCT00450580|470119426|FG000|Overall Study|Patient could not swallow Norvir|1|||
130589895|NCT00450580|470119427|FG001|Overall Study|Patient could not swallow Norvir|0|||
130589896|NCT00450580|470119426|FG000|Overall Study|Withdrawal due to pregnancy|0|||
130589897|NCT00450580|470119427|FG001|Overall Study|Withdrawal due to pregnancy|1|||
130589898|NCT01154101|470119429|FG000|Overall Study|Adverse Event|0|||
130589899|NCT01154101|470119430|FG001|Overall Study|Adverse Event|2|||
130589900|NCT01154101|470119431|FG002|Overall Study|Adverse Event|1|||
130589901|NCT01154101|470119432|FG003|Overall Study|Adverse Event|1|||
130589902|NCT01154101|470119433|FG004|Overall Study|Adverse Event|0|||
130589903|NCT01154101|470119429|FG000|Overall Study|Lost to Follow-up|0|||
130589904|NCT01154101|470119430|FG001|Overall Study|Lost to Follow-up|1|||
130589905|NCT01154101|470119431|FG002|Overall Study|Lost to Follow-up|0|||
130589906|NCT01154101|470119432|FG003|Overall Study|Lost to Follow-up|1|||
130589907|NCT01154101|470119433|FG004|Overall Study|Lost to Follow-up|0|||
130589908|NCT01154101|470119429|FG000|Overall Study|Withdrawal by Subject|0|||
130589909|NCT01154101|470119430|FG001|Overall Study|Withdrawal by Subject|1|||
130589910|NCT01154101|470119431|FG002|Overall Study|Withdrawal by Subject|2|||
130589911|NCT01154101|470119432|FG003|Overall Study|Withdrawal by Subject|0|||
130589912|NCT01154101|470119433|FG004|Overall Study|Withdrawal by Subject|1|||
130589913|NCT00393718|470119434|FG000|Overall Study|Adverse Event|20|||
130589914|NCT00393718|470119435|FG001|Overall Study|Adverse Event|8|||
130589915|NCT00393718|470119434|FG000|Overall Study|Protocol Violation|1|||
130589916|NCT00393718|470119435|FG001|Overall Study|Protocol Violation|2|||
130589917|NCT00393718|470119434|FG000|Overall Study|Lack of Efficacy|10|||
130589918|NCT00393718|470119435|FG001|Overall Study|Lack of Efficacy|9|||
130589919|NCT00393718|470119434|FG000|Overall Study|Hypoglycaemia|3|||
130589920|NCT00393718|470119435|FG001|Overall Study|Hypoglycaemia|2|||
130589921|NCT00393718|470119434|FG000|Overall Study|Subject decision|5|||
130589922|NCT00393718|470119435|FG001|Overall Study|Subject decision|0|||
130589923|NCT00393718|470119434|FG000|Overall Study|Withdrawal of consent|2|||
130589924|NCT00393718|470119435|FG001|Overall Study|Withdrawal of consent|1|||
130589925|NCT00393718|470119434|FG000|Overall Study|Missed measurement|1|||
130589926|NCT00393718|470119435|FG001|Overall Study|Missed measurement|0|||
130589927|NCT00393718|470119434|FG000|Overall Study|Move|1|||
130589928|NCT00393718|470119435|FG001|Overall Study|Move|0|||
130589929|NCT04125680|470119437|FG000|Overall Study|Lost to Follow-up|15|||
130589930|NCT01562028|470119438|FG000|Overall Study|Withdrawal by Subject|1|||
130589931|NCT01562028|470119439|FG001|Overall Study|Withdrawal by Subject|1|||
130589932|NCT01562028|470119438|FG000|Overall Study|Lost to Follow-up|2|||
130589933|NCT01562028|470119439|FG001|Overall Study|Lost to Follow-up|1|||
130589934|NCT02360098|470119440|FG000|Overall Study|Physician Decision|7|||
130589935|NCT04938648|470119445|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
130589936|NCT04938648|470119446|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
130589937|NCT04938648|470119445|FG000|Overall Study|Patient too ill|0|||
130589938|NCT04938648|470119446|FG001|Overall Study|Patient too ill|1|||
130589939|NCT04938648|470119445|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
130589940|NCT04938648|470119446|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
130589941|NCT04938648|470119445|FG000|Overall Study|Patient did not have memory problems|1|||
130589942|NCT04938648|470119446|FG001|Overall Study|Patient did not have memory problems|1|||
130589943|NCT04938648|470119445|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
130589944|NCT04938648|470119446|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
130589945|NCT04938648|470119445|FG000|Overall Study|Care partner could not be reached|0|||
130589946|NCT04938648|470119446|FG001|Overall Study|Care partner could not be reached|1|||
130589947|NCT04938648|470119445|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
130589948|NCT04938648|470119446|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
130589949|NCT04938648|470119445|FG000|Overall Study|Withdrawal by Subject|2|||
130589950|NCT04938648|470119446|FG001|Overall Study|Withdrawal by Subject|1|||
130589951|NCT03293654|470119447|FG000|Overall Study|Lost to Follow-up|0|||
130589952|NCT03293654|470119448|FG001|Overall Study|Lost to Follow-up|1|||
130589953|NCT03293654|470119449|FG002|Overall Study|Lost to Follow-up|0|||
130589954|NCT01919307|470119450|FG000|Overall Study|Withdrawal by Subject|9|||
130589955|NCT02542267|470119452|FG000|Overall Study|Withdrawal by Subject|10|||
130589956|NCT02542267|470119452|FG000|Overall Study|Physician Decision|6|||
130589957|NCT02542267|470119452|FG000|Overall Study|Lost to Follow-up|4|||
130589958|NCT02542267|470119452|FG000|Overall Study|Death|13|||
130589959|NCT02542267|470119452|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
130589960|NCT02542267|470119452|FG000|Overall Study|Other|9|||
130589961|NCT01355289|470119453|FG000|Core Study|Adverse Event, Non-Fatal|1|||
130589962|NCT01355289|470119454|FG001|Core Study|Adverse Event, Non-Fatal|0|||
130589963|NCT01355289|470119455|FG002|Core Study|Adverse Event, Non-Fatal|0|||
130589964|NCT01355289|470119456|FG003|Core Study|Adverse Event, Non-Fatal|0|||
130589965|NCT01355289|470119457|FG004|Core Study|Adverse Event, Non-Fatal|0|||
130589966|NCT01355289|470119453|FG000|Core Study|Inadequate Therapeutic Effect|0|||
130589967|NCT01355289|470119454|FG001|Core Study|Inadequate Therapeutic Effect|0|||
130589968|NCT01355289|470119455|FG002|Core Study|Inadequate Therapeutic Effect|0|||
130589969|NCT01355289|470119456|FG003|Core Study|Inadequate Therapeutic Effect|1|||
130589970|NCT01355289|470119457|FG004|Core Study|Inadequate Therapeutic Effect|0|||
130589971|NCT01355289|470119453|FG000|Core Study|Other|0|||
130589972|NCT01355289|470119454|FG001|Core Study|Other|0|||
130589973|NCT01355289|470119455|FG002|Core Study|Other|0|||
130589974|NCT01355289|470119456|FG003|Core Study|Other|1|||
130589975|NCT01355289|470119457|FG004|Core Study|Other|0|||
130589976|NCT01355289|470119453|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
130589977|NCT01355289|470119454|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
130589978|NCT01355289|470119455|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
130589979|NCT01355289|470119456|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
130589980|NCT01355289|470119457|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
130589981|NCT01355289|470119453|FG000|Open Label Extension|Lost to Follow-up|0|||
130589982|NCT01355289|470119454|FG001|Open Label Extension|Lost to Follow-up|0|||
130589983|NCT01355289|470119455|FG002|Open Label Extension|Lost to Follow-up|0|||
130589984|NCT01355289|470119456|FG003|Open Label Extension|Lost to Follow-up|0|||
130589985|NCT01355289|470119457|FG004|Open Label Extension|Lost to Follow-up|1|||
130589986|NCT01355289|470119453|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
130589987|NCT01355289|470119454|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
130589988|NCT01355289|470119455|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
130589989|NCT01355289|470119456|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
130589990|NCT01355289|470119457|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
130589991|NCT01355289|470119453|FG000|Open Label Extension|Other|0|||
130589992|NCT01355289|470119454|FG001|Open Label Extension|Other|0|||
130589993|NCT01355289|470119455|FG002|Open Label Extension|Other|0|||
130589994|NCT01355289|470119456|FG003|Open Label Extension|Other|0|||
130589995|NCT01355289|470119457|FG004|Open Label Extension|Other|3|||
130589996|NCT01085682|470119458|FG000|Overall Study|Withdrawal by Subject|25|||
130589997|NCT01085682|470119459|FG001|Overall Study|Withdrawal by Subject|25|||
130589998|NCT01451645|470119460|FG000|Overall Study|Protocol Violation|1|||
130589999|NCT01451645|470119461|FG001|Overall Study|Protocol Violation|0|||
130590000|NCT01451645|470119460|FG000|Overall Study|Adverse Event|0|||
130590001|NCT01451645|470119461|FG001|Overall Study|Adverse Event|3|||
130590002|NCT01451645|470119460|FG000|Overall Study|Withdrawal by Subject|4|||
130590003|NCT01451645|470119461|FG001|Overall Study|Withdrawal by Subject|2|||
130590004|NCT01451645|470119460|FG000|Overall Study|Lost to Follow-up|4|||
130590005|NCT01451645|470119461|FG001|Overall Study|Lost to Follow-up|3|||
130590006|NCT02207907|470119472|FG000|Overall Study|Lost to Follow-up|3|||
130590007|NCT02207907|470119473|FG001|Overall Study|Lost to Follow-up|1|||
130590008|NCT02207907|470119472|FG000|Overall Study|Withdrawal by Subject|5|||
130590009|NCT02207907|470119473|FG001|Overall Study|Withdrawal by Subject|6|||
130590010|NCT02207907|470119472|FG000|Overall Study|Did not meet study criteria|3|||
130590011|NCT02207907|470119473|FG001|Overall Study|Did not meet study criteria|0|||
130590012|NCT02207907|470119472|FG000|Overall Study|Pregnancy|0|||
130590013|NCT02207907|470119473|FG001|Overall Study|Pregnancy|1|||
130590014|NCT00158184|470119474|FG000|Overall Study|personal issues|3|||
130590015|NCT00158184|470119475|FG001|Overall Study|personal issues|1|||
130590016|NCT00158184|470119474|FG000|Overall Study|failed for follow unit/study rules|2|||
130590017|NCT00158184|470119475|FG001|Overall Study|failed for follow unit/study rules|0|||
130590018|NCT00158184|470119474|FG000|Overall Study|Adverse Event|1|||
130590019|NCT00158184|470119475|FG001|Overall Study|Adverse Event|1|||
130590020|NCT05340504|470119476|FG000|Overall Study|Withdrawal by Subject|1|||
130590021|NCT05340504|470119477|FG001|Overall Study|Withdrawal by Subject|0|||
130590022|NCT02620020|470119480|FG000|Overall Study|Adverse Event|8|||
130590023|NCT02620020|470119481|FG001|Overall Study|Adverse Event|4|||
130590024|NCT02620020|470119482|FG002|Overall Study|Adverse Event|3|||
130590025|NCT02620020|470119483|FG003|Overall Study|Adverse Event|5|||
130590026|NCT02620020|470119480|FG000|Overall Study|Lost to Follow-up|4|||
130590027|NCT02620020|470119481|FG001|Overall Study|Lost to Follow-up|8|||
130590028|NCT02620020|470119482|FG002|Overall Study|Lost to Follow-up|1|||
130590029|NCT02620020|470119483|FG003|Overall Study|Lost to Follow-up|4|||
130590030|NCT02620020|470119480|FG000|Overall Study|Physician Decision|7|||
130590031|NCT02620020|470119481|FG001|Overall Study|Physician Decision|4|||
130590032|NCT02620020|470119482|FG002|Overall Study|Physician Decision|3|||
130590033|NCT02620020|470119483|FG003|Overall Study|Physician Decision|4|||
130590034|NCT02620020|470119480|FG000|Overall Study|Protocol Violation|5|||
130590035|NCT02620020|470119481|FG001|Overall Study|Protocol Violation|2|||
130590036|NCT02620020|470119482|FG002|Overall Study|Protocol Violation|1|||
130590037|NCT02620020|470119483|FG003|Overall Study|Protocol Violation|1|||
130590038|NCT02620020|470119480|FG000|Overall Study|Withdrawal by Subject|20|||
130590039|NCT02620020|470119481|FG001|Overall Study|Withdrawal by Subject|16|||
130590040|NCT02620020|470119482|FG002|Overall Study|Withdrawal by Subject|17|||
130590041|NCT02620020|470119483|FG003|Overall Study|Withdrawal by Subject|12|||
130590042|NCT02620020|470119480|FG000|Overall Study|Death|0|||
130590043|NCT02620020|470119481|FG001|Overall Study|Death|1|||
130590044|NCT02620020|470119482|FG002|Overall Study|Death|0|||
130590045|NCT02620020|470119483|FG003|Overall Study|Death|0|||
130590046|NCT02393209|470119484|FG000|Overall Study|Study Terminated by Sponsor|1|||
130590047|NCT02393209|470119485|FG001|Overall Study|Study Terminated by Sponsor|1|||
130590048|NCT02393209|470119486|FG002|Overall Study|Study Terminated by Sponsor|0|||
130590049|NCT02393209|470119487|FG003|Overall Study|Study Terminated by Sponsor|0|||
130590050|NCT02393209|470119484|FG000|Overall Study|Withdrawal by Patient|1|||
130590051|NCT02393209|470119485|FG001|Overall Study|Withdrawal by Patient|0|||
130590052|NCT02393209|470119486|FG002|Overall Study|Withdrawal by Patient|0|||
130590053|NCT02393209|470119487|FG003|Overall Study|Withdrawal by Patient|0|||
130590054|NCT02393209|470119484|FG000|Overall Study|Death|2|||
130590055|NCT02393209|470119485|FG001|Overall Study|Death|2|||
130590056|NCT02393209|470119486|FG002|Overall Study|Death|0|||
130590057|NCT02393209|470119487|FG003|Overall Study|Death|0|||
130590058|NCT02393209|470119484|FG000|Overall Study|Death due to Disease Progression|2|||
130590059|NCT02393209|470119485|FG001|Overall Study|Death due to Disease Progression|2|||
130590060|NCT02393209|470119486|FG002|Overall Study|Death due to Disease Progression|0|||
130590061|NCT02393209|470119487|FG003|Overall Study|Death due to Disease Progression|0|||
130590062|NCT02393209|470119484|FG000|Overall Study|Death from Legionella Infection|0|||
130590063|NCT02393209|470119485|FG001|Overall Study|Death from Legionella Infection|1|||
130590064|NCT02393209|470119486|FG002|Overall Study|Death from Legionella Infection|0|||
130590065|NCT02393209|470119487|FG003|Overall Study|Death from Legionella Infection|0|||
130590066|NCT02393209|470119484|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
130590067|NCT02393209|470119485|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
130590068|NCT02393209|470119486|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
130590069|NCT02393209|470119487|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
130590070|NCT02393209|470119484|FG000|Overall Study|Lost to Follow-up|0|||
130590071|NCT02393209|470119485|FG001|Overall Study|Lost to Follow-up|1|||
130590072|NCT02393209|470119486|FG002|Overall Study|Lost to Follow-up|0|||
130590073|NCT02393209|470119487|FG003|Overall Study|Lost to Follow-up|0|||
130590074|NCT00755079|470119488|FG000|Overall Study|Lost to Follow-up|1|||
130590075|NCT00755079|470119489|FG001|Overall Study|Lost to Follow-up|3|||
130590076|NCT00755079|470119488|FG000|Overall Study|Adverse Event|0|||
130590077|NCT00755079|470119489|FG001|Overall Study|Adverse Event|1|||
130590078|NCT00755079|470119488|FG000|Overall Study|Withdrawal by Subject|0|||
130590079|NCT00755079|470119489|FG001|Overall Study|Withdrawal by Subject|2|||
130590080|NCT01709331|470119492|FG000|Overall Study|Adverse Event|1|||
130590081|NCT03896295|470119495|FG000|Overall Study|Adverse Event|0|||
130590082|NCT03896295|470119496|FG001|Overall Study|Adverse Event|1|||
130590083|NCT03896295|470119495|FG000|Overall Study|COVID-19|7|||
130590084|NCT03896295|470119496|FG001|Overall Study|COVID-19|29|||
130590085|NCT00700804|470119497|FG000|Overall Study|Withdrawal by Subject|1|||
130590086|NCT00700804|470119498|FG001|Overall Study|Withdrawal by Subject|2|||
130590087|NCT00700804|470119497|FG000|Overall Study|Protocol Violation|1|||
130590088|NCT00700804|470119498|FG001|Overall Study|Protocol Violation|1|||
130590089|NCT00700804|470119497|FG000|Overall Study|Loose Stools|1|||
130590090|NCT00700804|470119498|FG001|Overall Study|Loose Stools|1|||
130590091|NCT02500537|470119499|FG000|Overall Study|Death|2|||
130590092|NCT02500537|470119500|FG001|Overall Study|Death|0|||
130590093|NCT02500537|470119499|FG000|Overall Study|Lost to Follow-up|0|||
130590094|NCT02500537|470119500|FG001|Overall Study|Lost to Follow-up|1|||
130590095|NCT02500537|470119499|FG000|Overall Study|Withdrawal by Subject|1|||
130590096|NCT02500537|470119500|FG001|Overall Study|Withdrawal by Subject|0|||
130590097|NCT02875223|470119505|FG000|Overall Study|Other reasons|0|||
130590098|NCT02875223|470119506|FG001|Overall Study|Other reasons|0|||
130590099|NCT02875223|470119507|FG002|Overall Study|Other reasons|1|||
130590100|NCT02875223|470119508|FG003|Overall Study|Other reasons|0|||
130590101|NCT02875223|470119509|FG004|Overall Study|Other reasons|1|||
130590102|NCT02875223|470119510|FG005|Overall Study|Other reasons|2|||
130590103|NCT02875223|470119511|FG006|Overall Study|Other reasons|0|||
130590104|NCT02875223|470119512|FG007|Overall Study|Other reasons|2|||
130590105|NCT02875223|470119513|FG008|Overall Study|Other reasons|0|||
130590106|NCT02875223|470119514|FG009|Overall Study|Other reasons|0|||
130590107|NCT02875223|470119515|FG010|Overall Study|Other reasons|0|||
130590108|NCT02875223|470119516|FG011|Overall Study|Other reasons|0|||
130590109|NCT02875223|470119517|FG012|Overall Study|Other reasons|0|||
130590110|NCT02875223|470119505|FG000|Overall Study|Withdrawal by Subject|0|||
130590111|NCT02875223|470119506|FG001|Overall Study|Withdrawal by Subject|0|||
130590112|NCT02875223|470119507|FG002|Overall Study|Withdrawal by Subject|0|||
130590113|NCT02875223|470119508|FG003|Overall Study|Withdrawal by Subject|0|||
130590114|NCT02875223|470119509|FG004|Overall Study|Withdrawal by Subject|1|||
130590115|NCT02875223|470119510|FG005|Overall Study|Withdrawal by Subject|1|||
130590116|NCT02875223|470119511|FG006|Overall Study|Withdrawal by Subject|0|||
130590117|NCT02875223|470119512|FG007|Overall Study|Withdrawal by Subject|0|||
130590118|NCT02875223|470119513|FG008|Overall Study|Withdrawal by Subject|1|||
130590119|NCT02875223|470119514|FG009|Overall Study|Withdrawal by Subject|0|||
130590120|NCT02875223|470119515|FG010|Overall Study|Withdrawal by Subject|0|||
130590121|NCT02875223|470119516|FG011|Overall Study|Withdrawal by Subject|0|||
130590122|NCT02875223|470119517|FG012|Overall Study|Withdrawal by Subject|0|||
130590123|NCT02875223|470119505|FG000|Overall Study|Progressive disease|0|||
130590124|NCT02875223|470119506|FG001|Overall Study|Progressive disease|0|||
130590125|NCT02875223|470119507|FG002|Overall Study|Progressive disease|1|||
130590126|NCT02875223|470119508|FG003|Overall Study|Progressive disease|0|||
130590127|NCT02875223|470119509|FG004|Overall Study|Progressive disease|0|||
130590128|NCT02875223|470119510|FG005|Overall Study|Progressive disease|0|||
130590129|NCT02875223|470119511|FG006|Overall Study|Progressive disease|0|||
130590130|NCT02875223|470119512|FG007|Overall Study|Progressive disease|0|||
130590131|NCT02875223|470119513|FG008|Overall Study|Progressive disease|0|||
130590132|NCT02875223|470119514|FG009|Overall Study|Progressive disease|12|||
130590133|NCT02875223|470119515|FG010|Overall Study|Progressive disease|2|||
130590134|NCT02875223|470119516|FG011|Overall Study|Progressive disease|3|||
130590135|NCT02875223|470119517|FG012|Overall Study|Progressive disease|6|||
130590136|NCT02875223|470119505|FG000|Overall Study|Death|4|||
130590137|NCT02875223|470119506|FG001|Overall Study|Death|4|||
130590138|NCT02875223|470119507|FG002|Overall Study|Death|3|||
130590139|NCT02875223|470119508|FG003|Overall Study|Death|4|||
130590140|NCT02875223|470119509|FG004|Overall Study|Death|2|||
130590141|NCT02875223|470119510|FG005|Overall Study|Death|3|||
130590142|NCT02875223|470119511|FG006|Overall Study|Death|5|||
130590143|NCT02875223|470119512|FG007|Overall Study|Death|7|||
130590144|NCT02875223|470119513|FG008|Overall Study|Death|3|||
130590145|NCT02875223|470119514|FG009|Overall Study|Death|2|||
130590146|NCT02875223|470119515|FG010|Overall Study|Death|0|||
130590147|NCT02875223|470119516|FG011|Overall Study|Death|0|||
130590148|NCT02875223|470119517|FG012|Overall Study|Death|0|||
130590149|NCT02875223|470119505|FG000|Overall Study|Lost to Follow-up|0|||
130590150|NCT02875223|470119506|FG001|Overall Study|Lost to Follow-up|1|||
130590151|NCT02875223|470119507|FG002|Overall Study|Lost to Follow-up|1|||
130590152|NCT02875223|470119508|FG003|Overall Study|Lost to Follow-up|0|||
130590153|NCT02875223|470119509|FG004|Overall Study|Lost to Follow-up|1|||
130590154|NCT02875223|470119510|FG005|Overall Study|Lost to Follow-up|0|||
130590155|NCT02875223|470119511|FG006|Overall Study|Lost to Follow-up|1|||
130590156|NCT02875223|470119512|FG007|Overall Study|Lost to Follow-up|1|||
130590157|NCT02875223|470119513|FG008|Overall Study|Lost to Follow-up|0|||
130590158|NCT02875223|470119514|FG009|Overall Study|Lost to Follow-up|0|||
130590159|NCT02875223|470119515|FG010|Overall Study|Lost to Follow-up|0|||
130590160|NCT02875223|470119516|FG011|Overall Study|Lost to Follow-up|0|||
130590161|NCT02875223|470119517|FG012|Overall Study|Lost to Follow-up|0|||
130590162|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
130590163|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
130590164|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
130590165|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130590166|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130590167|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130590168|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
130590169|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
130590170|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
130590171|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130590172|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130590173|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130590174|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
130590175|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
130590176|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
130590177|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130590178|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130590179|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130590180|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
130590181|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130590182|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130590183|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130590184|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130590185|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130590186|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
130590187|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
130590188|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
130590189|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130590190|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130590191|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130590192|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
130590193|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
130590194|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
130590195|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130590196|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130590197|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130590198|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
130590199|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
130590200|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
130590201|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
130590202|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
130590203|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
130590204|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
130590205|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
130590206|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
130590207|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130590208|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130590209|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130590210|NCT01707992|470119520|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
130590211|NCT01707992|470119521|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
130590212|NCT01707992|470119522|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
130590213|NCT01707992|470119523|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130590214|NCT01707992|470119524|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130590215|NCT01707992|470119525|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130590216|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
130590217|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
130590218|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
130590219|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
130590220|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
130590221|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
130590222|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130590223|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130590224|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130590225|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
130590226|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
130590227|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
130590228|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130590229|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130590230|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130590231|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
130590232|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
130590233|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
130590234|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
130590235|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
130590236|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
130590237|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
130590238|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
130590239|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
130590240|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130590241|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130590242|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130590243|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
130590244|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
130590245|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
130590246|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Death|0|||
130590247|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Death|0|||
130590248|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Death|0|||
130590249|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Death|2|||
130590250|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Death|0|||
130590251|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Death|0|||
130590252|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
130590253|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
130590254|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
130590255|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
130590256|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
130590257|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
130590258|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
130590259|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
130590260|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
130590261|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
130590262|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
130590263|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
130590264|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130590265|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130590266|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130590267|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
130590268|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
130590269|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
130590270|NCT01707992|470119520|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130590271|NCT01707992|470119521|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130590272|NCT01707992|470119522|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130590273|NCT01707992|470119523|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130590274|NCT01707992|470119524|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
130590275|NCT01707992|470119525|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130590276|NCT02654002|470119527|FG000|Overall Study|Adverse Event|0|||
130590277|NCT02654002|470119528|FG001|Overall Study|Adverse Event|0|||
130590278|NCT02654002|470119529|FG002|Overall Study|Adverse Event|0|||
130590279|NCT02654002|470119530|FG003|Overall Study|Adverse Event|0|||
130590280|NCT02654002|470119531|FG004|Overall Study|Adverse Event|0|||
130590281|NCT02654002|470119532|FG005|Overall Study|Adverse Event|0|||
130590282|NCT02654002|470119533|FG006|Overall Study|Adverse Event|1|||
130590283|NCT02654002|470119534|FG007|Overall Study|Adverse Event|0|||
130590284|NCT02654002|470119535|FG008|Overall Study|Adverse Event|0|||
130590285|NCT02654002|470119527|FG000|Overall Study|Withdrew Consent|0|||
130590286|NCT02654002|470119528|FG001|Overall Study|Withdrew Consent|0|||
130590287|NCT02654002|470119529|FG002|Overall Study|Withdrew Consent|0|||
130590288|NCT02654002|470119530|FG003|Overall Study|Withdrew Consent|0|||
130590289|NCT02654002|470119531|FG004|Overall Study|Withdrew Consent|0|||
130590290|NCT02654002|470119532|FG005|Overall Study|Withdrew Consent|1|||
130590291|NCT02654002|470119533|FG006|Overall Study|Withdrew Consent|0|||
130590292|NCT02654002|470119534|FG007|Overall Study|Withdrew Consent|1|||
130590293|NCT02654002|470119535|FG008|Overall Study|Withdrew Consent|0|||
130590294|NCT03313050|470119537|FG000|Stage 2: 12 Months|Adverse Event|0|||
130590295|NCT03313050|470119538|FG001|Stage 2: 12 Months|Adverse Event|0|||
130590296|NCT03313050|470119539|FG002|Stage 2: 12 Months|Adverse Event|0|||
130590297|NCT03313050|470119540|FG003|Stage 2: 12 Months|Adverse Event|1|||
130590298|NCT03313050|470119537|FG000|Stage 2: 12 Months|Death|0|||
130590299|NCT03313050|470119538|FG001|Stage 2: 12 Months|Death|0|||
130590300|NCT03313050|470119539|FG002|Stage 2: 12 Months|Death|3|||
130590301|NCT03313050|470119540|FG003|Stage 2: 12 Months|Death|0|||
130590302|NCT03313050|470119537|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
130590303|NCT03313050|470119538|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
130590304|NCT03313050|470119539|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
130590305|NCT03313050|470119540|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
130590306|NCT03313050|470119537|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130590307|NCT03313050|470119538|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130590308|NCT03313050|470119539|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130590309|NCT03313050|470119540|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
130590310|NCT03313050|470119537|FG000|Stage 2: 12 Months|Protocol deviation|0|||
130590311|NCT03313050|470119538|FG001|Stage 2: 12 Months|Protocol deviation|0|||
130590312|NCT03313050|470119539|FG002|Stage 2: 12 Months|Protocol deviation|7|||
130590313|NCT03313050|470119540|FG003|Stage 2: 12 Months|Protocol deviation|7|||
130590314|NCT03313050|470119537|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
130590315|NCT03313050|470119538|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
130590316|NCT03313050|470119539|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
130590317|NCT03313050|470119540|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
130590318|NCT03313050|470119537|FG000|Stage 2: 12 Months|Other|0|||
130590319|NCT03313050|470119538|FG001|Stage 2: 12 Months|Other|0|||
130590320|NCT03313050|470119539|FG002|Stage 2: 12 Months|Other|0|||
130590321|NCT03313050|470119540|FG003|Stage 2: 12 Months|Other|1|||
130590322|NCT04211337|470119541|FG000|Overall Study|On Treatment|175|||
130590323|NCT04211337|470119542|FG001|Overall Study|On Treatment|40|||
130590324|NCT04211337|470119541|FG000|Overall Study|Withdrawal by Subject|0|||
130590325|NCT04211337|470119542|FG001|Overall Study|Withdrawal by Subject|2|||
130590326|NCT02847598|470119551|FG000|Overall Study|Adverse Event|0|||
130590327|NCT02847598|470119552|FG001|Overall Study|Adverse Event|0|||
130590328|NCT02847598|470119553|FG002|Overall Study|Adverse Event|0|||
130590329|NCT02847598|470119554|FG003|Overall Study|Adverse Event|0|||
130590330|NCT02847598|470119555|FG004|Overall Study|Adverse Event|0|||
130590331|NCT02847598|470119556|FG005|Overall Study|Adverse Event|0|||
130590332|NCT02847598|470119557|FG006|Overall Study|Adverse Event|0|||
130590333|NCT02847598|470119558|FG007|Overall Study|Adverse Event|1|||
130590334|NCT02847598|470119551|FG000|Overall Study|Consent withdrawn|2|||
130590335|NCT02847598|470119552|FG001|Overall Study|Consent withdrawn|0|||
130590336|NCT02847598|470119553|FG002|Overall Study|Consent withdrawn|0|||
130590337|NCT02847598|470119554|FG003|Overall Study|Consent withdrawn|4|||
130590338|NCT02847598|470119555|FG004|Overall Study|Consent withdrawn|3|||
130590339|NCT02847598|470119556|FG005|Overall Study|Consent withdrawn|2|||
130590340|NCT02847598|470119557|FG006|Overall Study|Consent withdrawn|1|||
130590341|NCT02847598|470119558|FG007|Overall Study|Consent withdrawn|3|||
130590342|NCT02847598|470119551|FG000|Overall Study|Death|3|||
130590343|NCT02847598|470119552|FG001|Overall Study|Death|0|||
130590344|NCT02847598|470119553|FG002|Overall Study|Death|0|||
130590345|NCT02847598|470119554|FG003|Overall Study|Death|0|||
130590346|NCT02847598|470119555|FG004|Overall Study|Death|0|||
130590347|NCT02847598|470119556|FG005|Overall Study|Death|0|||
130590348|NCT02847598|470119557|FG006|Overall Study|Death|0|||
130590349|NCT02847598|470119558|FG007|Overall Study|Death|0|||
130590350|NCT02847598|470119551|FG000|Overall Study|Lost to Follow-up|0|||
130590351|NCT02847598|470119552|FG001|Overall Study|Lost to Follow-up|0|||
130590352|NCT02847598|470119553|FG002|Overall Study|Lost to Follow-up|0|||
130590353|NCT02847598|470119554|FG003|Overall Study|Lost to Follow-up|0|||
130590354|NCT02847598|470119555|FG004|Overall Study|Lost to Follow-up|0|||
130590355|NCT02847598|470119556|FG005|Overall Study|Lost to Follow-up|1|||
130590356|NCT02847598|470119557|FG006|Overall Study|Lost to Follow-up|1|||
130590357|NCT02847598|470119558|FG007|Overall Study|Lost to Follow-up|0|||
130590358|NCT02848833|470119559|FG000|Overall Study|subject who are duplicated|1|||
130590359|NCT02848833|470119559|FG000|Overall Study|have not taken the study drug|11|||
130590360|NCT02848833|470119559|FG000|Overall Study|follow-up failure|6|||
130590361|NCT02848833|470119559|FG000|Overall Study|Protocol Violation|119|||
130590362|NCT04167345|470119560|FG000|Overall Study|Other|1|||
130590363|NCT04167345|470119561|FG001|Overall Study|Other|1|||
130590364|NCT04167345|470119562|FG002|Overall Study|Other|0|||
130590365|NCT04167345|470119563|FG003|Overall Study|Other|0|||
130590366|NCT04167345|470119564|FG004|Overall Study|Other|0|||
130590367|NCT06119191|470119567|FG000|Overall Study|Adverse Event|0|||
130590368|NCT06119191|470119568|FG001|Overall Study|Adverse Event|1|||
130590369|NCT06119191|470119567|FG000|Overall Study|Protocol Violation|1|||
130590370|NCT06119191|470119568|FG001|Overall Study|Protocol Violation|0|||
130590371|NCT03896581|470121680|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
130590372|NCT03896581|470121681|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
130590373|NCT03896581|470121680|FG000|Overall Study|Withdrawal by Subject|4|||
130590374|NCT03896581|470121681|FG001|Overall Study|Withdrawal by Subject|1|||
130590375|NCT03896581|470121680|FG000|Overall Study|Lost to Follow-up|1|||
130590376|NCT03896581|470121681|FG001|Overall Study|Lost to Follow-up|0|||
130590377|NCT03896581|470121680|FG000|Overall Study|Lack of Efficacy|2|||
130590378|NCT03896581|470121681|FG001|Overall Study|Lack of Efficacy|1|||
130590379|NCT03896581|470121680|FG000|Overall Study|Adverse event, non-fatal|0|||
130590380|NCT03896581|470121681|FG001|Overall Study|Adverse event, non-fatal|2|||
130590381|NCT00960076|470121693|FG000|Overall Study|Adverse Event|1|||
130590382|NCT00960076|470121694|FG001|Overall Study|Adverse Event|7|||
130590383|NCT00960076|470121693|FG000|Overall Study|No longer met study criteria|1|||
130590384|NCT00960076|470121694|FG001|Overall Study|No longer met study criteria|5|||
130590385|NCT00960076|470121693|FG000|Overall Study|Withdrawal by Subject|1|||
130590386|NCT00960076|470121694|FG001|Overall Study|Withdrawal by Subject|2|||
130590387|NCT00960076|470121693|FG000|Overall Study|Lost to Follow-up|3|||
130590388|NCT00960076|470121694|FG001|Overall Study|Lost to Follow-up|3|||
130590389|NCT00960076|470121693|FG000|Overall Study|Severe non-compliance to protocol|1|||
130590390|NCT00960076|470121694|FG001|Overall Study|Severe non-compliance to protocol|2|||
130590391|NCT00960076|470121693|FG000|Overall Study|Hyperglycemia|1|||
130590392|NCT00960076|470121694|FG001|Overall Study|Hyperglycemia|5|||
130590393|NCT00960076|470121693|FG000|Overall Study|Did not attend the termination visit|0|||
130590394|NCT00960076|470121694|FG001|Overall Study|Did not attend the termination visit|1|||
130590395|NCT00500266|470121695|FG000|Overall Study|Death|3|||
130590396|NCT00500266|470121695|FG000|Overall Study|Lost to Follow-up|3|||
130590397|NCT00500266|470121695|FG000|Overall Study|Withdrawal by Subject|3|||
130590398|NCT00500266|470121695|FG000|Overall Study|Assigned, not treated|4|||
130590399|NCT03263806|470121698|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
130590400|NCT03263806|470121699|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
130590401|NCT03263806|470121698|FG000|Overall Study|Withdrawal by Subject|0|||
130590402|NCT03263806|470121699|FG001|Overall Study|Withdrawal by Subject|1|||
130590403|NCT03263806|470121698|FG000|Overall Study|Study Termination|5|||
130590404|NCT03263806|470121699|FG001|Overall Study|Study Termination|6|||
130590405|NCT00110305|470121702|FG000|Overall Study|Adverse Event|46|||
130590406|NCT00110305|470121703|FG001|Overall Study|Adverse Event|13|||
130590407|NCT00110305|470121702|FG000|Overall Study|Sponsors Decision|1|||
130590408|NCT00110305|470121703|FG001|Overall Study|Sponsors Decision|0|||
130590409|NCT00110305|470121702|FG000|Overall Study|Subject Non-Compliant|9|||
130590410|NCT00110305|470121703|FG001|Overall Study|Subject Non-Compliant|2|||
130590411|NCT00110305|470121702|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
130590412|NCT00110305|470121703|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
130590413|NCT00110305|470121702|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
130590414|NCT00110305|470121703|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
130590415|NCT00110305|470121702|FG000|Overall Study|Protocol Violation|0|||
130590416|NCT00110305|470121703|FG001|Overall Study|Protocol Violation|1|||
130590417|NCT00110305|470121702|FG000|Overall Study|Withdrawal by Subject|7|||
130590418|NCT00110305|470121703|FG001|Overall Study|Withdrawal by Subject|7|||
130590419|NCT00110305|470121702|FG000|Overall Study|Lost to Follow-up|20|||
130590420|NCT00110305|470121703|FG001|Overall Study|Lost to Follow-up|3|||
130590421|NCT00110305|470121702|FG000|Overall Study|Other|8|||
130590422|NCT00110305|470121703|FG001|Overall Study|Other|2|||
130590423|NCT05113940|470121706|FG000|Part A (18 Days)|Adverse Event|0|||
130590424|NCT05113940|470121707|FG001|Part A (18 Days)|Adverse Event|0|||
130590425|NCT05113940|470121708|FG002|Part A (18 Days)|Adverse Event|1|||
130590426|NCT05113940|470121709|FG003|Part A (18 Days)|Adverse Event|1|||
130590427|NCT05113940|470121710|FG004|Part A (18 Days)|Adverse Event|1|||
130590428|NCT05113940|470121711|FG005|Part A (18 Days)|Adverse Event|0|||
130590429|NCT05113940|470121712|FG006|Part A (18 Days)|Adverse Event|0|||
130590430|NCT05113940|470121713|FG007|Part A (18 Days)|Adverse Event|0|||
130590431|NCT05113940|470121714|FG008|Part A (18 Days)|Adverse Event|0|||
130590432|NCT05113940|470121715|FG009|Part A (18 Days)|Adverse Event|0|||
130590433|NCT05113940|470121716|FG010|Part A (18 Days)|Adverse Event|0|||
130590434|NCT05113940|470121717|FG011|Part A (18 Days)|Adverse Event|2|||
130590435|NCT05113940|470121718|FG012|Part A (18 Days)|Adverse Event|0|||
130590436|NCT05113940|470121719|FG013|Part A (18 Days)|Adverse Event|0|||
130590437|NCT05113940|470121720|FG014|Part A (18 Days)|Adverse Event|0|||
130590438|NCT05113940|470121706|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590439|NCT05113940|470121707|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590440|NCT05113940|470121708|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590441|NCT05113940|470121709|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590442|NCT05113940|470121710|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590443|NCT05113940|470121711|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590444|NCT05113940|470121712|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590445|NCT05113940|470121713|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590446|NCT05113940|470121714|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590447|NCT05113940|470121715|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590448|NCT05113940|470121716|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590449|NCT05113940|470121717|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590450|NCT05113940|470121718|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590451|NCT05113940|470121719|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
130590452|NCT05113940|470121720|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
130590453|NCT03619213|470121723|FG000|Overall Study|Lost to Follow-up|2|||
130590454|NCT03619213|470121724|FG001|Overall Study|Lost to Follow-up|1|||
130590455|NCT03619213|470121723|FG000|Overall Study|Withdrawal by Subject|8|||
130590456|NCT03619213|470121724|FG001|Overall Study|Withdrawal by Subject|10|||
130590457|NCT02886702|470121728|FG000|Overall Study|Other|4|||
130590458|NCT02886702|470121729|FG001|Overall Study|Other|3|||
130590459|NCT02886702|470121730|FG002|Overall Study|Other|9|||
130590460|NCT02886702|470121728|FG000|Overall Study|Withdrawal by Subject|24|||
130590461|NCT02886702|470121729|FG001|Overall Study|Withdrawal by Subject|18|||
130590462|NCT02886702|470121730|FG002|Overall Study|Withdrawal by Subject|22|||
130590463|NCT02886702|470121728|FG000|Overall Study|Significant Worsening of Condition|0|||
130590464|NCT02886702|470121729|FG001|Overall Study|Significant Worsening of Condition|1|||
130590465|NCT02886702|470121730|FG002|Overall Study|Significant Worsening of Condition|0|||
130590466|NCT02886702|470121728|FG000|Overall Study|Protocol Violation|2|||
130590467|NCT02886702|470121729|FG001|Overall Study|Protocol Violation|2|||
130590468|NCT02886702|470121730|FG002|Overall Study|Protocol Violation|1|||
130590469|NCT02886702|470121728|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130590470|NCT02886702|470121729|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130590471|NCT02886702|470121730|FG002|Overall Study|Non-Compliance With Study Drug|4|||
130590472|NCT02886702|470121728|FG000|Overall Study|Lost to Follow-up|11|||
130590473|NCT02886702|470121729|FG001|Overall Study|Lost to Follow-up|13|||
130590474|NCT02886702|470121730|FG002|Overall Study|Lost to Follow-up|8|||
130590475|NCT02886702|470121728|FG000|Overall Study|Lack of Efficacy|3|||
130590476|NCT02886702|470121729|FG001|Overall Study|Lack of Efficacy|4|||
130590477|NCT02886702|470121730|FG002|Overall Study|Lack of Efficacy|5|||
130590478|NCT02886702|470121728|FG000|Overall Study|Adverse Event|4|||
130590479|NCT02886702|470121729|FG001|Overall Study|Adverse Event|9|||
130590480|NCT02886702|470121730|FG002|Overall Study|Adverse Event|3|||
130590481|NCT02886702|470121728|FG000|Overall Study|Administrative Reasons|0|||
130590482|NCT02886702|470121729|FG001|Overall Study|Administrative Reasons|0|||
130590483|NCT02886702|470121730|FG002|Overall Study|Administrative Reasons|1|||
130590484|NCT01262898|470121733|FG000|Overall Study|Protocol Violation|1|||
130590485|NCT01262898|470121734|FG001|Overall Study|Protocol Violation|1|||
130590486|NCT01262898|470121735|FG002|Overall Study|Protocol Violation|0|||
130590487|NCT01262898|470121736|FG003|Overall Study|Protocol Violation|0|||
130590488|NCT01262898|470121733|FG000|Overall Study|Lost to Follow-up|1|||
130590489|NCT01262898|470121734|FG001|Overall Study|Lost to Follow-up|0|||
130590490|NCT01262898|470121735|FG002|Overall Study|Lost to Follow-up|0|||
130590491|NCT01262898|470121736|FG003|Overall Study|Lost to Follow-up|0|||
130590492|NCT01262898|470121733|FG000|Overall Study|Withdrawal by Subject|1|||
130590493|NCT01262898|470121734|FG001|Overall Study|Withdrawal by Subject|1|||
130590494|NCT01262898|470121735|FG002|Overall Study|Withdrawal by Subject|0|||
130590495|NCT01262898|470121736|FG003|Overall Study|Withdrawal by Subject|0|||
130590496|NCT02731742|470121737|FG000|Overall Study|Death|1|||
130590497|NCT02731742|470121738|FG001|Overall Study|Death|2|||
130590498|NCT02731742|470121739|FG002|Overall Study|Death|5|||
130590499|NCT02731742|470121740|FG003|Overall Study|Death|0|||
130590500|NCT02731742|470121737|FG000|Overall Study|Physician Decision|0|||
130590501|NCT02731742|470121738|FG001|Overall Study|Physician Decision|0|||
130590502|NCT02731742|470121739|FG002|Overall Study|Physician Decision|0|||
130590503|NCT02731742|470121740|FG003|Overall Study|Physician Decision|1|||
130590504|NCT02731742|470121737|FG000|Overall Study|Study Terminated by Sponsor|2|||
130590505|NCT02731742|470121738|FG001|Overall Study|Study Terminated by Sponsor|1|||
130590506|NCT02731742|470121739|FG002|Overall Study|Study Terminated by Sponsor|1|||
130590507|NCT02731742|470121740|FG003|Overall Study|Study Terminated by Sponsor|1|||
130590508|NCT00502840|470121741|FG000|Overall Study|Adverse Event|5|||
130590509|NCT00502840|470121741|FG000|Overall Study|Additional or changed therapy|48|||
130590510|NCT00502840|470121741|FG000|Overall Study|Lack of Efficacy|11|||
130590511|NCT00502840|470121741|FG000|Overall Study|Protocol Violation|4|||
130590512|NCT00502840|470121741|FG000|Overall Study|Withdrawal by Subject|5|||
130590513|NCT00502840|470121741|FG000|Overall Study|Lost to Follow-up|6|||
130590514|NCT00502840|470121741|FG000|Overall Study|Administrative problems|1|||
130590515|NCT00502840|470121741|FG000|Overall Study|Other|20|||
130590516|NCT01974323|470121742|FG000|Overall Study|Other Reasons|25|||
130590517|NCT01974323|470121743|FG001|Overall Study|Other Reasons|28|||
130590518|NCT01974323|470121742|FG000|Overall Study|Protocol Violation|2|||
130590519|NCT01974323|470121743|FG001|Overall Study|Protocol Violation|2|||
130590520|NCT01974323|470121742|FG000|Overall Study|Personal Reasons|15|||
130590521|NCT01974323|470121743|FG001|Overall Study|Personal Reasons|19|||
130590522|NCT01974323|470121742|FG000|Overall Study|Lost to Follow-up|45|||
130590523|NCT01974323|470121743|FG001|Overall Study|Lost to Follow-up|40|||
130590524|NCT01974323|470121742|FG000|Overall Study|Pregnancy|2|||
130590525|NCT01974323|470121743|FG001|Overall Study|Pregnancy|1|||
130590526|NCT01974323|470121742|FG000|Overall Study|Lack of Efficacy|1|||
130590527|NCT01974323|470121743|FG001|Overall Study|Lack of Efficacy|1|||
130590528|NCT01974323|470121742|FG000|Overall Study|Adverse Event|2|||
130590529|NCT01974323|470121743|FG001|Overall Study|Adverse Event|2|||
130590530|NCT00461175|470121744|FG000|Overall Study|Protocol Violation|522|||
130590531|NCT00461175|470121745|FG001|Overall Study|Protocol Violation|365|||
130590532|NCT00331760|470121746|FG000|Overall Study|Ineligible / no protocol treatment|15|||
130590533|NCT00331760|470121747|FG001|Overall Study|Ineligible / no protocol treatment|8|||
130590534|NCT03093155|470121749|FG000|Overall Study|Not Eligible|1|||
130590535|NCT03093155|470121750|FG001|Overall Study|Not Eligible|0|||
130590536|NCT03093155|470121749|FG000|Overall Study|Withdrawal by Subject|0|||
130590537|NCT03093155|470121750|FG001|Overall Study|Withdrawal by Subject|1|||
130590538|NCT00619229|470121751|FG000|Overall Study|Withdrawal by Subject|1|||
130590539|NCT00619229|470121752|FG001|Overall Study|Withdrawal by Subject|1|||
130590540|NCT00619229|470121751|FG000|Overall Study|Lost to Follow-up|1|||
130590541|NCT00619229|470121752|FG001|Overall Study|Lost to Follow-up|0|||
130590542|NCT00619229|470121751|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
130590543|NCT00619229|470121752|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
130590544|NCT00619229|470121751|FG000|Overall Study|Investigator planned Cataract Operation|1|||
130590545|NCT00619229|470121752|FG001|Overall Study|Investigator planned Cataract Operation|0|||
130590546|NCT01700829|470121753|FG000|Overall Study|Withdrawal by Subject|1|||
130590547|NCT01700829|470121754|FG001|Overall Study|Withdrawal by Subject|1|||
130590548|NCT02786901|470121755|FG000|Overall Study|Adverse Event|1|||
130590549|NCT02786901|470121756|FG001|Overall Study|Adverse Event|1|||
130590550|NCT02786901|470121757|FG002|Overall Study|Adverse Event|2|||
130590551|NCT02786901|470121755|FG000|Overall Study|Physician Decision|1|||
130590552|NCT02786901|470121756|FG001|Overall Study|Physician Decision|0|||
130590553|NCT02786901|470121757|FG002|Overall Study|Physician Decision|0|||
130590554|NCT02786901|470121755|FG000|Overall Study|Rescue Therapy Use|71|||
130590555|NCT02786901|470121756|FG001|Overall Study|Rescue Therapy Use|49|||
130590556|NCT02786901|470121757|FG002|Overall Study|Rescue Therapy Use|33|||
130590557|NCT02786901|470121755|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
130590558|NCT02786901|470121756|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
130590559|NCT02786901|470121757|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
130590560|NCT02786901|470121755|FG000|Overall Study|Disallowed medication|1|||
130590561|NCT02786901|470121756|FG001|Overall Study|Disallowed medication|1|||
130590562|NCT02786901|470121757|FG002|Overall Study|Disallowed medication|0|||
130590563|NCT02786901|470121755|FG000|Overall Study|Randomized in error|2|||
130590564|NCT02786901|470121756|FG001|Overall Study|Randomized in error|0|||
130590565|NCT02786901|470121757|FG002|Overall Study|Randomized in error|1|||
130590566|NCT03367871|470121758|FG000|Overall Study|Lost to Follow-up|1|||
130590567|NCT01075178|470121759|FG000|Subject Matching|eligible but not matched|130|||
130590568|NCT01075178|470121760|FG001|Subject Matching|eligible but not matched|403|||
130590569|NCT01075178|470121759|FG000|Subject Chart Review|died before chart review period|0|||
130590570|NCT01075178|470121760|FG001|Subject Chart Review|died before chart review period|2|||
130590571|NCT01075178|470121759|FG000|Subject Chart Review|no data collected due to site closure|3|||
130590572|NCT01075178|470121760|FG001|Subject Chart Review|no data collected due to site closure|4|||
130590573|NCT01075178|470121759|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
130590574|NCT01075178|470121760|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
130590575|NCT02983604|470121761|FG000|Overall Study|Enrolled but not Treated|0|||
130590576|NCT02983604|470121762|FG001|Overall Study|Enrolled but not Treated|0|||
130590577|NCT02983604|470121763|FG002|Overall Study|Enrolled but not Treated|1|||
130590578|NCT02983604|470121764|FG003|Overall Study|Enrolled but not Treated|0|||
130590579|NCT01111604|470121765|FG000|Overall Study|Lost to Follow-up|0|||
130590580|NCT01111604|470121766|FG001|Overall Study|Lost to Follow-up|0|||
130590581|NCT01111604|470121767|FG002|Overall Study|Lost to Follow-up|1|||
130590582|NCT01111604|470121765|FG000|Overall Study|Withdrew Consent|3|||
130590583|NCT01111604|470121766|FG001|Overall Study|Withdrew Consent|0|||
130590584|NCT01111604|470121767|FG002|Overall Study|Withdrew Consent|2|||
130590585|NCT01111604|470121765|FG000|Overall Study|Withdrawal by Subject|2|||
130590586|NCT01111604|470121766|FG001|Overall Study|Withdrawal by Subject|0|||
130590587|NCT01111604|470121767|FG002|Overall Study|Withdrawal by Subject|0|||
130590588|NCT01111604|470121765|FG000|Overall Study|Death|1|||
130590589|NCT01111604|470121766|FG001|Overall Study|Death|0|||
130590590|NCT01111604|470121767|FG002|Overall Study|Death|0|||
130590591|NCT01111604|470121765|FG000|Overall Study|Met Exclusion Criteria|2|||
130590592|NCT01111604|470121766|FG001|Overall Study|Met Exclusion Criteria|0|||
130590593|NCT01111604|470121767|FG002|Overall Study|Met Exclusion Criteria|0|||
130590594|NCT00316264|470121769|FG000|Overall Study|Lost to Follow-up|0|||
130590595|NCT00316264|470121770|FG001|Overall Study|Lost to Follow-up|1|||
130590596|NCT00316264|470121771|FG002|Overall Study|Lost to Follow-up|0|||
130590597|NCT00316264|470121769|FG000|Overall Study|Withdrawal of Consent|3|||
130590598|NCT00316264|470121770|FG001|Overall Study|Withdrawal of Consent|5|||
130590599|NCT00316264|470121771|FG002|Overall Study|Withdrawal of Consent|6|||
130590600|NCT00316264|470121769|FG000|Overall Study|Death|2|||
130590601|NCT00316264|470121770|FG001|Overall Study|Death|0|||
130590602|NCT00316264|470121771|FG002|Overall Study|Death|0|||
130590603|NCT00316264|470121769|FG000|Overall Study|Other|1|||
130590604|NCT00316264|470121770|FG001|Overall Study|Other|1|||
130590605|NCT00316264|470121771|FG002|Overall Study|Other|0|||
130590606|NCT00607048|470121772|FG000|Overall Study|Adverse Event|0|||
130590607|NCT00607048|470121773|FG001|Overall Study|Adverse Event|1|||
130590608|NCT00607048|470121774|FG002|Overall Study|Adverse Event|0|||
130590609|NCT00607048|470121775|FG003|Overall Study|Adverse Event|0|||
130590610|NCT00607048|470121776|FG004|Overall Study|Adverse Event|4|||
130590611|NCT00607048|470121777|FG005|Overall Study|Adverse Event|0|||
130590612|NCT00607048|470121772|FG000|Overall Study|Global deterioration of health|1|||
130590613|NCT00607048|470121773|FG001|Overall Study|Global deterioration of health|0|||
130590614|NCT00607048|470121774|FG002|Overall Study|Global deterioration of health|0|||
130590615|NCT00607048|470121775|FG003|Overall Study|Global deterioration of health|0|||
130590616|NCT00607048|470121776|FG004|Overall Study|Global deterioration of health|0|||
130590617|NCT00607048|470121777|FG005|Overall Study|Global deterioration of health|0|||
130590618|NCT00607048|470121772|FG000|Overall Study|Objective disease progression - relapse|1|||
130590619|NCT00607048|470121773|FG001|Overall Study|Objective disease progression - relapse|2|||
130590620|NCT00607048|470121774|FG002|Overall Study|Objective disease progression - relapse|4|||
130590621|NCT00607048|470121775|FG003|Overall Study|Objective disease progression - relapse|2|||
130590622|NCT00607048|470121776|FG004|Overall Study|Objective disease progression - relapse|2|||
130590623|NCT00607048|470121777|FG005|Overall Study|Objective disease progression - relapse|2|||
130590624|NCT00607048|470121772|FG000|Overall Study|Withdrawal by Subject|0|||
130590625|NCT00607048|470121773|FG001|Overall Study|Withdrawal by Subject|0|||
130590626|NCT00607048|470121774|FG002|Overall Study|Withdrawal by Subject|0|||
130590627|NCT00607048|470121775|FG003|Overall Study|Withdrawal by Subject|1|||
130590628|NCT00607048|470121776|FG004|Overall Study|Withdrawal by Subject|0|||
130590629|NCT00607048|470121777|FG005|Overall Study|Withdrawal by Subject|2|||
130590630|NCT00607048|470121772|FG000|Overall Study|Other|1|||
130590631|NCT00607048|470121773|FG001|Overall Study|Other|1|||
130590632|NCT00607048|470121774|FG002|Overall Study|Other|0|||
130590633|NCT00607048|470121775|FG003|Overall Study|Other|0|||
130590634|NCT00607048|470121776|FG004|Overall Study|Other|0|||
130590635|NCT00607048|470121777|FG005|Overall Study|Other|1|||
130590636|NCT03926143|470121778|FG000|Overall Study|Physician Decision|3|||
130590637|NCT03926143|470121778|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
130590638|NCT03926143|470121778|FG000|Overall Study|Adverse Event|2|||
130590639|NCT03926143|470121778|FG000|Overall Study|Progressive disease|3|||
130590640|NCT03545282|470121780|FG000|Overall Study|Lost to Follow-up|15|||
130590641|NCT03545282|470121781|FG001|Overall Study|Lost to Follow-up|10|||
130590642|NCT03545282|470121780|FG000|Overall Study|Withdrawal by Subject|2|||
130590643|NCT03545282|470121781|FG001|Overall Study|Withdrawal by Subject|2|||
130590644|NCT02582671|470121782|FG000|Overall Study|Failure to return|1|||
130590645|NCT02582671|470121782|FG000|Overall Study|Other, not specified|1|||
130590646|NCT01287104|470121783|FG000|Overall Study|Patient developed progressive disease|1|||
130590647|NCT01287104|470121784|FG001|Overall Study|Patient developed progressive disease|1|||
130590648|NCT01287104|470121785|FG002|Overall Study|Patient developed progressive disease|3|||
130590649|NCT01287104|470121786|FG003|Overall Study|Patient developed progressive disease|2|||
130590650|NCT01287104|470121783|FG000|Overall Study|Donor anaphylaxis|0|||
130590651|NCT01287104|470121784|FG001|Overall Study|Donor anaphylaxis|1|||
130590652|NCT01287104|470121785|FG002|Overall Study|Donor anaphylaxis|0|||
130590653|NCT01287104|470121786|FG003|Overall Study|Donor anaphylaxis|1|||
130590654|NCT01287104|470121783|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
130590655|NCT01287104|470121784|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
130590656|NCT01287104|470121785|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
130590657|NCT01287104|470121786|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
130590658|NCT01287104|470121783|FG000|Overall Study|Low donor chimerism|0|||
130590659|NCT01287104|470121784|FG001|Overall Study|Low donor chimerism|1|||
130590660|NCT01287104|470121785|FG002|Overall Study|Low donor chimerism|0|||
130590661|NCT01287104|470121786|FG003|Overall Study|Low donor chimerism|0|||
130590662|NCT01287104|470121783|FG000|Overall Study|NK cells did not meet release criteria|0|||
130590663|NCT01287104|470121784|FG001|Overall Study|NK cells did not meet release criteria|1|||
130590664|NCT01287104|470121785|FG002|Overall Study|NK cells did not meet release criteria|0|||
130590665|NCT01287104|470121786|FG003|Overall Study|NK cells did not meet release criteria|0|||
130590666|NCT03068715|470121791|FG000|Overall Study|No longer met inclusion criteria|1|||
130590667|NCT03068715|470121792|FG001|Overall Study|No longer met inclusion criteria|0|||
130590668|NCT01276288|470121793|FG000|Overall Study|Adverse Event|1|||
130590669|NCT01276288|470121794|FG001|Overall Study|Adverse Event|1|||
130590670|NCT01276288|470121795|FG002|Overall Study|Adverse Event|0|||
130590671|NCT01276288|470121796|FG003|Overall Study|Adverse Event|0|||
130590672|NCT01276288|470121793|FG000|Overall Study|not treated|1|||
130590673|NCT01276288|470121794|FG001|Overall Study|not treated|0|||
130590674|NCT01276288|470121795|FG002|Overall Study|not treated|0|||
130590675|NCT01276288|470121796|FG003|Overall Study|not treated|0|||
130590676|NCT03168867|470121797|FG000|Overall Study|Withdrawal by Subject|1|||
130590677|NCT03168867|470121798|FG001|Overall Study|Withdrawal by Subject|5|||
130590678|NCT04964258|470121799|FG000|Overall Study|Lost to Follow-up|1|||
130590679|NCT04964258|470121800|FG001|Overall Study|Lost to Follow-up|0|||
130590680|NCT04964258|470121801|FG002|Overall Study|Lost to Follow-up|0|||
130590681|NCT04964258|470121802|FG003|Overall Study|Lost to Follow-up|0|||
130590682|NCT04964258|470121803|FG004|Overall Study|Lost to Follow-up|0|||
130590683|NCT04964258|470121804|FG005|Overall Study|Lost to Follow-up|1|||
130590684|NCT04964258|470121805|FG006|Overall Study|Lost to Follow-up|0|||
130590685|NCT04964258|470121806|FG007|Overall Study|Lost to Follow-up|0|||
130590686|NCT04964258|470121807|FG008|Overall Study|Lost to Follow-up|0|||
130590687|NCT04964258|470121808|FG009|Overall Study|Lost to Follow-up|0|||
130590688|NCT04964258|470121809|FG010|Overall Study|Lost to Follow-up|0|||
130590689|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130590690|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130590691|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
130590692|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590693|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590694|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590695|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590696|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590697|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130590698|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
130590699|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130590700|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
130590701|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590702|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590703|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590704|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590705|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590706|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130590707|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
130590708|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130590709|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
130590710|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590711|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590712|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590713|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590714|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590715|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130590716|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590717|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590718|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
130590719|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590720|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590721|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590722|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590723|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590724|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130590725|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
130590726|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130590727|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
130590728|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590729|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590730|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590731|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590732|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590733|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130590734|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130590735|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590736|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590737|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590738|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590739|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590740|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590741|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590742|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130590743|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
130590744|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
130590745|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590746|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590747|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590748|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590749|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590750|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590751|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130590752|NCT01307423|470121815|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590753|NCT01307423|470121816|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
130590754|NCT01307423|470121817|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
130590755|NCT01307423|470121818|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590756|NCT01307423|470121819|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590757|NCT01307423|470121820|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590758|NCT01307423|470121821|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590759|NCT01307423|470121822|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590760|NCT01307423|470121823|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130590761|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130590762|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
130590763|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130590764|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130590765|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130590766|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130590767|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130590768|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130590769|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130590770|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130590771|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
130590772|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
130590773|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
130590774|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
130590775|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130590776|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130590777|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130590778|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130590779|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590780|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590781|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590782|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590783|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590784|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
130590785|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590786|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590787|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130590788|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130590789|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
130590790|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
130590791|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130590792|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130590793|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
130590794|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
130590795|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130590796|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130590797|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590798|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590799|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590800|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
130590801|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590802|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590803|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590804|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590805|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130590806|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
130590807|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
130590808|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
130590809|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
130590810|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
130590811|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
130590812|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
130590813|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
130590814|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
130590815|NCT01307423|470121815|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590816|NCT01307423|470121816|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590817|NCT01307423|470121817|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590818|NCT01307423|470121818|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590819|NCT01307423|470121819|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590820|NCT01307423|470121820|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
130590821|NCT01307423|470121821|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590822|NCT01307423|470121822|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590823|NCT01307423|470121823|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130590824|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130590825|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
130590826|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
130590827|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130590828|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130590829|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130590830|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130590831|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
130590832|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
130590833|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130590834|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
130590835|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
130590836|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130590837|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130590838|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130590839|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130590840|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
130590841|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
130590842|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590843|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590844|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
130590845|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590846|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590847|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590848|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590849|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590850|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130590851|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130590852|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
130590853|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
130590854|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130590855|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130590856|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130590857|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130590858|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
130590859|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
130590860|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590861|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130590862|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590863|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590864|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590865|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590866|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130590867|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130590868|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130590869|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130590870|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
130590871|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130590872|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130590873|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130590874|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130590875|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130590876|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
130590877|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
130590878|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130590879|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130590880|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
130590881|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130590882|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130590883|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130590884|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130590885|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
130590886|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130590887|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590888|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
130590889|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
130590890|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590891|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590892|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590893|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590894|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590895|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130590896|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130590897|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
130590898|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
130590899|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130590900|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130590901|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130590902|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130590903|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
130590904|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
130590905|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130590906|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
130590907|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
130590908|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130590909|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130590910|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130590911|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130590912|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130590913|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130590914|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590915|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130590916|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590917|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590918|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590919|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590920|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590921|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130590922|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130590923|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590924|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
130590925|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590926|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590927|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590928|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590929|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590930|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590931|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130590932|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590933|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130590934|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590935|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590936|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590937|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590938|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590939|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130590940|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130590941|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130590942|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
130590943|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
130590944|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130590945|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130590946|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130590947|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130590948|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
130590949|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
130590950|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590951|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590952|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
130590953|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590954|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590955|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590956|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590957|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590958|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130590959|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590960|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590961|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590962|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590963|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590964|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590965|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590966|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130590967|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130590968|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590969|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130590970|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130590971|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590972|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590973|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590974|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590975|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130590976|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130590977|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590978|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
130590979|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
130590980|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590981|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590982|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590983|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590984|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590985|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130590986|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590987|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
130590988|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
130590989|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590990|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590991|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590992|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590993|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130590994|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130590995|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130590996|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
130590997|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130590998|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130590999|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130591000|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130591001|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130591002|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130591003|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130591004|NCT01307423|470121815|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591005|NCT01307423|470121816|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591006|NCT01307423|470121817|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
130591007|NCT01307423|470121818|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591008|NCT01307423|470121819|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591009|NCT01307423|470121820|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591010|NCT01307423|470121821|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130591011|NCT01307423|470121822|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
130591012|NCT01307423|470121823|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
130591013|NCT00481065|470121824|FG000|Overall Study|Adverse event or death|1|||
130591014|NCT00481065|470121825|FG001|Overall Study|Adverse event or death|1|||
130591015|NCT00481065|470121826|FG002|Overall Study|Adverse event or death|3|||
130591016|NCT00481065|470121827|FG003|Overall Study|Adverse event or death|0|||
130591017|NCT00481065|470121828|FG004|Overall Study|Adverse event or death|2|||
130591018|NCT00481065|470121829|FG005|Overall Study|Adverse event or death|0|||
130591019|NCT00481065|470121830|FG006|Overall Study|Adverse event or death|1|||
130591020|NCT00481065|470121831|FG007|Overall Study|Adverse event or death|1|||
130591021|NCT00481065|470121824|FG000|Overall Study|Withdrawal by Subject|11|||
130591022|NCT00481065|470121825|FG001|Overall Study|Withdrawal by Subject|12|||
130591023|NCT00481065|470121826|FG002|Overall Study|Withdrawal by Subject|7|||
130591024|NCT00481065|470121827|FG003|Overall Study|Withdrawal by Subject|11|||
130591025|NCT00481065|470121828|FG004|Overall Study|Withdrawal by Subject|13|||
130591026|NCT00481065|470121829|FG005|Overall Study|Withdrawal by Subject|12|||
130591027|NCT00481065|470121830|FG006|Overall Study|Withdrawal by Subject|9|||
130591028|NCT00481065|470121831|FG007|Overall Study|Withdrawal by Subject|10|||
130591029|NCT00481065|470121824|FG000|Overall Study|Lost to Follow-up|4|||
130591030|NCT00481065|470121825|FG001|Overall Study|Lost to Follow-up|2|||
130591031|NCT00481065|470121826|FG002|Overall Study|Lost to Follow-up|4|||
130591032|NCT00481065|470121827|FG003|Overall Study|Lost to Follow-up|3|||
130591033|NCT00481065|470121828|FG004|Overall Study|Lost to Follow-up|3|||
130591034|NCT00481065|470121829|FG005|Overall Study|Lost to Follow-up|3|||
130591035|NCT00481065|470121830|FG006|Overall Study|Lost to Follow-up|2|||
130591036|NCT00481065|470121831|FG007|Overall Study|Lost to Follow-up|5|||
130591037|NCT00481065|470121824|FG000|Overall Study|Inappropriate enrollment|4|||
130591038|NCT00481065|470121825|FG001|Overall Study|Inappropriate enrollment|0|||
130591039|NCT00481065|470121826|FG002|Overall Study|Inappropriate enrollment|2|||
130591040|NCT00481065|470121827|FG003|Overall Study|Inappropriate enrollment|0|||
130591041|NCT00481065|470121828|FG004|Overall Study|Inappropriate enrollment|2|||
130591042|NCT00481065|470121829|FG005|Overall Study|Inappropriate enrollment|1|||
130591043|NCT00481065|470121830|FG006|Overall Study|Inappropriate enrollment|0|||
130591044|NCT00481065|470121831|FG007|Overall Study|Inappropriate enrollment|1|||
130591045|NCT00481065|470121824|FG000|Overall Study|Administrative reason|0|||
130591046|NCT00481065|470121825|FG001|Overall Study|Administrative reason|0|||
130591047|NCT00481065|470121826|FG002|Overall Study|Administrative reason|0|||
130591048|NCT00481065|470121827|FG003|Overall Study|Administrative reason|0|||
130591049|NCT00481065|470121828|FG004|Overall Study|Administrative reason|0|||
130591050|NCT00481065|470121829|FG005|Overall Study|Administrative reason|2|||
130591051|NCT00481065|470121830|FG006|Overall Study|Administrative reason|1|||
130591052|NCT00481065|470121831|FG007|Overall Study|Administrative reason|0|||
130591053|NCT00481065|470121824|FG000|Overall Study|Protocol Violation|2|||
130591054|NCT00481065|470121825|FG001|Overall Study|Protocol Violation|1|||
130591055|NCT00481065|470121826|FG002|Overall Study|Protocol Violation|1|||
130591056|NCT00481065|470121827|FG003|Overall Study|Protocol Violation|1|||
130591057|NCT00481065|470121828|FG004|Overall Study|Protocol Violation|2|||
130591058|NCT00481065|470121829|FG005|Overall Study|Protocol Violation|6|||
130591059|NCT00481065|470121830|FG006|Overall Study|Protocol Violation|3|||
130591060|NCT00481065|470121831|FG007|Overall Study|Protocol Violation|2|||
130591061|NCT00481065|470121824|FG000|Overall Study|Unable to classify|0|||
130591062|NCT00481065|470121825|FG001|Overall Study|Unable to classify|1|||
130591063|NCT00481065|470121826|FG002|Overall Study|Unable to classify|2|||
130591064|NCT00481065|470121827|FG003|Overall Study|Unable to classify|0|||
130591065|NCT00481065|470121828|FG004|Overall Study|Unable to classify|1|||
130591066|NCT00481065|470121829|FG005|Overall Study|Unable to classify|0|||
130591067|NCT00481065|470121830|FG006|Overall Study|Unable to classify|0|||
130591068|NCT00481065|470121831|FG007|Overall Study|Unable to classify|0|||
130591069|NCT01926626|470121832|FG000|Overall Study|Withdrawal by Subject|15|||
130591070|NCT01926626|470121832|FG000|Overall Study|Lost to Follow-up|7|||
130591071|NCT02382133|470121833|FG000|Overall Study|Death|22|||
130591072|NCT02382133|470121833|FG000|Overall Study|transfer out of ICU|4|||
130591073|NCT02382133|470121833|FG000|Overall Study|Physician Decision|2|||
130591074|NCT02382133|470121833|FG000|Overall Study|arterial catheter loss|4|||
130591075|NCT02382133|470121833|FG000|Overall Study|pressure injury both sites|1|||
130591076|NCT00655928|470121834|FG000|Overall Study|Withdrawal by Subject|2|||
130591077|NCT00655928|470121835|FG001|Overall Study|Withdrawal by Subject|1|||
130591078|NCT00655928|470121834|FG000|Overall Study|Physician Decision|1|||
130591079|NCT00655928|470121835|FG001|Overall Study|Physician Decision|1|||
130591080|NCT04906707|470121836|FG000|Overall Study|Withdrawal by Subject|2|||
130591081|NCT04906707|470121837|FG001|Overall Study|Withdrawal by Subject|0|||
130591082|NCT04906707|470121836|FG000|Overall Study|Withdrawal due to PI decision|1|||
130591083|NCT04906707|470121837|FG001|Overall Study|Withdrawal due to PI decision|0|||
130591084|NCT04906707|470121836|FG000|Overall Study|Lost to Follow-up|0|||
130591085|NCT04906707|470121837|FG001|Overall Study|Lost to Follow-up|1|||
130591086|NCT01976806|470121838|FG000|Overall Study|Lost to Follow-up|1|||
130591087|NCT01976806|470121839|FG001|Overall Study|Lost to Follow-up|4|||
130591088|NCT01976806|470121838|FG000|Overall Study|Adverse Event|1|||
130591089|NCT01976806|470121839|FG001|Overall Study|Adverse Event|1|||
130591090|NCT01976806|470121838|FG000|Overall Study|Withdrawal by Subject|1|||
130591091|NCT01976806|470121839|FG001|Overall Study|Withdrawal by Subject|1|||
130591092|NCT01523873|470121846|FG000|Overall Study|Protocol Violation|422|||
130591093|NCT00998738|470121847|FG000|Overall Study|Uknown|1|||
130591100|NCT03019549|470123858|FG000|Washout|DId not meet genotype criteria|11|||
130591101|NCT03019549|470123858|FG000|Period 2|Adverse Event|2|||
130591102|NCT03019549|470123858|FG000|Period 2|Physician Decision|2|||
130591103|NCT03019549|470123858|FG000|Period 2|Withdrawal by Subject|1|||
130591104|NCT01412879|470123859|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
130591105|NCT01412879|470123860|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
130591106|NCT01412879|470123861|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
130591107|NCT01412879|470123859|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
130591108|NCT01412879|470123860|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
130591109|NCT01412879|470123861|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
130591110|NCT01412879|470123859|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
130591111|NCT01412879|470123860|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
130591112|NCT01412879|470123861|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
130591113|NCT01412879|470123859|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
130591114|NCT01412879|470123860|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
130591115|NCT01412879|470123861|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
130591116|NCT01412879|470123859|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
130591117|NCT01412879|470123860|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
130591118|NCT01412879|470123861|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
130591119|NCT02109029|470123862|FG000|Part B|Adverse Event|0|||
130591120|NCT02109029|470123863|FG001|Part B|Adverse Event|0|||
130591121|NCT02109029|470123864|FG002|Part B|Adverse Event|0|||
130591122|NCT02109029|470123865|FG003|Part B|Adverse Event|0|||
130591123|NCT02109029|470123866|FG004|Part B|Adverse Event|1|||
130591124|NCT02109029|470123867|FG005|Part B|Adverse Event|1|||
130591125|NCT01445171|470123874|FG000|Overall Study|Lost to Follow-up|11|||
130591126|NCT01445171|470123874|FG000|Overall Study|Withdrawal by Subject|16|||
130591127|NCT01445171|470123874|FG000|Overall Study|Death|51|||
130591128|NCT01445171|470123874|FG000|Overall Study|Subjects declined to return for followup|9|||
130591129|NCT01445171|470123874|FG000|Overall Study|Consented but did not receive device|8|||
130591130|NCT03195894|470123875|FG000|Overall Study|"An example is Started other treatment."|4|||
130591131|NCT03195894|470123876|FG001|Overall Study|"An example is Started other treatment."|5|||
130591132|NCT03195894|470123875|FG000|Overall Study|Withdrawal by Subject|15|||
130591133|NCT03195894|470123876|FG001|Overall Study|Withdrawal by Subject|4|||
130591134|NCT03195894|470123875|FG000|Overall Study|Lost to Follow-up|14|||
130591135|NCT03195894|470123876|FG001|Overall Study|Lost to Follow-up|19|||
130591136|NCT00162773|470123880|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
130591137|NCT02091440|470123881|FG000|Overall Study|Death|2|||
130591138|NCT00768222|470123882|FG000|Overall Study|Lost to Follow-up|1|||
130591139|NCT00768222|470123883|FG001|Overall Study|Lost to Follow-up|1|||
130591140|NCT00768222|470123882|FG000|Overall Study|Withdrawal by Subject|3|||
130591141|NCT00768222|470123883|FG001|Overall Study|Withdrawal by Subject|1|||
130591142|NCT00768222|470123882|FG000|Overall Study|Protocol Violation|0|||
130591143|NCT00768222|470123883|FG001|Overall Study|Protocol Violation|2|||
130591144|NCT00278629|470123890|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
130591145|NCT03323749|470123891|FG000|Double-blind Period|Lost to Follow-up|4|||
130591146|NCT03323749|470123892|FG001|Double-blind Period|Lost to Follow-up|5|||
130591147|NCT03323749|470123891|FG000|Double-blind Period|Adverse Event|3|||
130591148|NCT03323749|470123892|FG001|Double-blind Period|Adverse Event|1|||
130591149|NCT03323749|470123891|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
130591150|NCT03323749|470123892|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
130591151|NCT03323749|470123891|FG000|Open-Label Period|Adverse Event|3|||
130591152|NCT03323749|470123892|FG001|Open-Label Period|Adverse Event|10|||
130591153|NCT03323749|470123891|FG000|Open-Label Period|Withdrawal by Subject|7|||
130591154|NCT03323749|470123892|FG001|Open-Label Period|Withdrawal by Subject|5|||
130591155|NCT03263091|470123894|FG000|OL Component|Withdrawal by Subject|1|||
130591156|NCT03263091|470123895|FG001|OL Component|Withdrawal by Subject|1|||
130591157|NCT03263091|470123896|FG002|OL Component|Withdrawal by Subject|0|||
130591158|NCT03263091|470123897|FG003|OL Component|Withdrawal by Subject|0|||
130591159|NCT03263091|470123898|FG004|OL Component|Withdrawal by Subject|0|||
130591160|NCT03263091|470123899|FG005|OL Component|Withdrawal by Subject|0|||
130591161|NCT03263091|470123894|FG000|OL Component|Physician Decision|0|||
130591162|NCT03263091|470123895|FG001|OL Component|Physician Decision|1|||
130591163|NCT03263091|470123896|FG002|OL Component|Physician Decision|2|||
130591164|NCT03263091|470123897|FG003|OL Component|Physician Decision|0|||
130591165|NCT03263091|470123898|FG004|OL Component|Physician Decision|0|||
130591166|NCT03263091|470123899|FG005|OL Component|Physician Decision|0|||
130591167|NCT03263091|470123894|FG000|OL Component|Death|1|||
130591168|NCT03263091|470123895|FG001|OL Component|Death|0|||
130591169|NCT03263091|470123896|FG002|OL Component|Death|0|||
130591170|NCT03263091|470123897|FG003|OL Component|Death|0|||
130591171|NCT03263091|470123898|FG004|OL Component|Death|0|||
130591172|NCT03263091|470123899|FG005|OL Component|Death|0|||
130591173|NCT03263091|470123894|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
130591174|NCT03263091|470123895|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
130591175|NCT03263091|470123896|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
130591176|NCT03263091|470123897|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
130591177|NCT03263091|470123898|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
130591178|NCT03263091|470123899|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
130591179|NCT03263091|470123894|FG000|OL High-EPO Component|Physician Decision|0|||
130591180|NCT03263091|470123895|FG001|OL High-EPO Component|Physician Decision|0|||
130591181|NCT03263091|470123896|FG002|OL High-EPO Component|Physician Decision|0|||
130591182|NCT03263091|470123897|FG003|OL High-EPO Component|Physician Decision|1|||
130591183|NCT03263091|470123898|FG004|OL High-EPO Component|Physician Decision|0|||
130591184|NCT03263091|470123899|FG005|OL High-EPO Component|Physician Decision|0|||
130591185|NCT03263091|470123894|FG000|OL High-EPO Component|Death|0|||
130591186|NCT03263091|470123895|FG001|OL High-EPO Component|Death|0|||
130591187|NCT03263091|470123896|FG002|OL High-EPO Component|Death|0|||
130591188|NCT03263091|470123897|FG003|OL High-EPO Component|Death|3|||
130591189|NCT03263091|470123898|FG004|OL High-EPO Component|Death|0|||
130591190|NCT03263091|470123899|FG005|OL High-EPO Component|Death|0|||
130591191|NCT03263091|470123894|FG000|DB Component|Withdrawal by Subject|0|||
130591192|NCT03263091|470123895|FG001|DB Component|Withdrawal by Subject|0|||
130591193|NCT03263091|470123896|FG002|DB Component|Withdrawal by Subject|0|||
130591194|NCT03263091|470123897|FG003|DB Component|Withdrawal by Subject|0|||
130591195|NCT03263091|470123898|FG004|DB Component|Withdrawal by Subject|22|||
130591196|NCT03263091|470123899|FG005|DB Component|Withdrawal by Subject|8|||
130591197|NCT03263091|470123894|FG000|DB Component|Physician Decision|0|||
130591198|NCT03263091|470123895|FG001|DB Component|Physician Decision|0|||
130591199|NCT03263091|470123896|FG002|DB Component|Physician Decision|0|||
130591200|NCT03263091|470123897|FG003|DB Component|Physician Decision|0|||
130591201|NCT03263091|470123898|FG004|DB Component|Physician Decision|3|||
130591202|NCT03263091|470123899|FG005|DB Component|Physician Decision|1|||
130591203|NCT03263091|470123894|FG000|DB Component|Adverse Event|0|||
130591204|NCT03263091|470123895|FG001|DB Component|Adverse Event|0|||
130591205|NCT03263091|470123896|FG002|DB Component|Adverse Event|0|||
130591206|NCT03263091|470123897|FG003|DB Component|Adverse Event|0|||
130591207|NCT03263091|470123898|FG004|DB Component|Adverse Event|2|||
130591208|NCT03263091|470123899|FG005|DB Component|Adverse Event|1|||
130591209|NCT03263091|470123894|FG000|DB Component|Lost to Follow-up|0|||
130591210|NCT03263091|470123895|FG001|DB Component|Lost to Follow-up|0|||
130591211|NCT03263091|470123896|FG002|DB Component|Lost to Follow-up|0|||
130591212|NCT03263091|470123897|FG003|DB Component|Lost to Follow-up|0|||
130591213|NCT03263091|470123898|FG004|DB Component|Lost to Follow-up|2|||
130591214|NCT03263091|470123899|FG005|DB Component|Lost to Follow-up|1|||
130591215|NCT03263091|470123894|FG000|DB Component|Death|0|||
130591216|NCT03263091|470123895|FG001|DB Component|Death|0|||
130591217|NCT03263091|470123896|FG002|DB Component|Death|0|||
130591218|NCT03263091|470123897|FG003|DB Component|Death|0|||
130591219|NCT03263091|470123898|FG004|DB Component|Death|7|||
130591220|NCT03263091|470123899|FG005|DB Component|Death|4|||
130591221|NCT03263091|470123894|FG000|DB Component|Other than specified|0|||
130591222|NCT03263091|470123895|FG001|DB Component|Other than specified|0|||
130591223|NCT03263091|470123896|FG002|DB Component|Other than specified|0|||
130591224|NCT03263091|470123897|FG003|DB Component|Other than specified|0|||
130591225|NCT03263091|470123898|FG004|DB Component|Other than specified|8|||
130591226|NCT03263091|470123899|FG005|DB Component|Other than specified|6|||
130591227|NCT02468193|470123900|FG000|Overall Study|Adverse Event|4|||
130591228|NCT02468193|470123900|FG000|Overall Study|Subject/ Guardian decision|2|||
130591229|NCT00826748|470123901|FG000|Overall Study|Withdrawal by Subject|0|||
130591230|NCT00826748|470123902|FG001|Overall Study|Withdrawal by Subject|0|||
130591231|NCT00826748|470123903|FG002|Overall Study|Withdrawal by Subject|2|||
130591232|NCT00826748|470123901|FG000|Overall Study|Physician Decision|0|||
130591233|NCT00826748|470123902|FG001|Overall Study|Physician Decision|0|||
130591234|NCT00826748|470123903|FG002|Overall Study|Physician Decision|1|||
130591235|NCT00826748|470123901|FG000|Overall Study|Samples Did Not pass QC|0|||
130591236|NCT00826748|470123902|FG001|Overall Study|Samples Did Not pass QC|0|||
130591237|NCT00826748|470123903|FG002|Overall Study|Samples Did Not pass QC|1|||
130591238|NCT03312218|470123906|FG000|Overall Study|Never signed in to access the app|54|||
130591239|NCT03312218|470123907|FG001|Overall Study|Never signed in to access the app|58|||
130591240|NCT01887912|470123909|FG000|Overall Study|Serious adverse event|400|||
130591241|NCT01887912|470123910|FG001|Overall Study|Serious adverse event|198|||
130591242|NCT01887912|470123909|FG000|Overall Study|Other Adverse Event|34|||
130591243|NCT01887912|470123910|FG001|Overall Study|Other Adverse Event|15|||
130591244|NCT01887912|470123909|FG000|Overall Study|Protocol Violation|67|||
130591245|NCT01887912|470123910|FG001|Overall Study|Protocol Violation|37|||
130591246|NCT01887912|470123909|FG000|Overall Study|Lost to Follow-up|163|||
130591247|NCT01887912|470123910|FG001|Overall Study|Lost to Follow-up|74|||
130591248|NCT01887912|470123909|FG000|Overall Study|Withdrawal by Subject|606|||
130591249|NCT01887912|470123910|FG001|Overall Study|Withdrawal by Subject|349|||
130591250|NCT01887912|470123909|FG000|Overall Study|Other|122|||
130591251|NCT01887912|470123910|FG001|Overall Study|Other|58|||
130591252|NCT05067127|470123913|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130591253|NCT05067127|470123914|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
130591254|NCT05067127|470123915|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130591255|NCT05067127|470123916|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130591256|NCT05067127|470123913|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130591257|NCT05067127|470123914|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
130591258|NCT05067127|470123915|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130591259|NCT05067127|470123916|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130591260|NCT05067127|470123913|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
130591261|NCT05067127|470123914|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130591262|NCT05067127|470123915|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130591263|NCT05067127|470123916|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130591264|NCT05067127|470123913|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130591265|NCT05067127|470123914|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
130591266|NCT05067127|470123915|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130591267|NCT05067127|470123916|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130591268|NCT05067127|470123913|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
130591269|NCT05067127|470123914|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
130591270|NCT05067127|470123915|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
130591271|NCT05067127|470123916|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
130591272|NCT05067127|470123913|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130591273|NCT05067127|470123914|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130591274|NCT05067127|470123915|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130591275|NCT05067127|470123916|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
130591276|NCT05067127|470123913|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130591277|NCT05067127|470123914|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130591278|NCT05067127|470123915|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
130591279|NCT05067127|470123916|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
130591280|NCT04462536|470123917|FG000|Overall Study|Withdrawal by Subject|3|||
130591281|NCT04462536|470123918|FG001|Overall Study|Withdrawal by Subject|9|||
130591282|NCT04462536|470123917|FG000|Overall Study|Lost to Follow-up|2|||
130591283|NCT04462536|470123918|FG001|Overall Study|Lost to Follow-up|4|||
130591284|NCT04439266|470123922|FG000|Overall Study|Ineligible|1|||
130591285|NCT04439266|470123922|FG000|Overall Study|Adverse Event|1|||
130591286|NCT04439266|470123922|FG000|Overall Study|Death|1|||
130591287|NCT04439266|470123922|FG000|Overall Study|Disease progression|1|||
130591288|NCT04439266|470123922|FG000|Overall Study|Still on treatment|1|||
130591289|NCT06161012|470123925|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130591290|NCT06161012|470123926|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130591291|NCT02601950|470123927|FG000|Overall Study|Participant enrolled in rollover study|0|||
130591292|NCT02601950|470123928|FG001|Overall Study|Participant enrolled in rollover study|0|||
130591293|NCT02601950|470123929|FG002|Overall Study|Participant enrolled in rollover study|1|||
130591294|NCT02601950|470123930|FG003|Overall Study|Participant enrolled in rollover study|0|||
130591295|NCT02601950|470123931|FG004|Overall Study|Participant enrolled in rollover study|1|||
130591296|NCT02601950|470123932|FG005|Overall Study|Participant enrolled in rollover study|1|||
130591297|NCT02601950|470123933|FG006|Overall Study|Participant enrolled in rollover study|1|||
130591298|NCT02601950|470123934|FG007|Overall Study|Participant enrolled in rollover study|0|||
130591299|NCT02601950|470123927|FG000|Overall Study|Disease progression - radiological|21|||
130591300|NCT02601950|470123928|FG001|Overall Study|Disease progression - radiological|26|||
130591301|NCT02601950|470123929|FG002|Overall Study|Disease progression - radiological|22|||
130591302|NCT02601950|470123930|FG003|Overall Study|Disease progression - radiological|11|||
130591303|NCT02601950|470123931|FG004|Overall Study|Disease progression - radiological|46|||
130591304|NCT02601950|470123932|FG005|Overall Study|Disease progression - radiological|52|||
130591305|NCT02601950|470123933|FG006|Overall Study|Disease progression - radiological|7|||
130591306|NCT02601950|470123934|FG007|Overall Study|Disease progression - radiological|5|||
130591307|NCT02601950|470123927|FG000|Overall Study|Disease progression - clinical|3|||
130591308|NCT02601950|470123928|FG001|Overall Study|Disease progression - clinical|5|||
130591309|NCT02601950|470123929|FG002|Overall Study|Disease progression - clinical|4|||
130591310|NCT02601950|470123930|FG003|Overall Study|Disease progression - clinical|2|||
130591311|NCT02601950|470123931|FG004|Overall Study|Disease progression - clinical|6|||
130591312|NCT02601950|470123932|FG005|Overall Study|Disease progression - clinical|6|||
130591313|NCT02601950|470123933|FG006|Overall Study|Disease progression - clinical|5|||
130591314|NCT02601950|470123934|FG007|Overall Study|Disease progression - clinical|1|||
130591315|NCT02601950|470123927|FG000|Overall Study|Death|6|||
130591316|NCT02601950|470123928|FG001|Overall Study|Death|0|||
130591317|NCT02601950|470123929|FG002|Overall Study|Death|3|||
130591318|NCT02601950|470123930|FG003|Overall Study|Death|1|||
130591319|NCT02601950|470123931|FG004|Overall Study|Death|4|||
130591320|NCT02601950|470123932|FG005|Overall Study|Death|1|||
130591321|NCT02601950|470123933|FG006|Overall Study|Death|0|||
130591322|NCT02601950|470123934|FG007|Overall Study|Death|0|||
130591323|NCT02601950|470123927|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591324|NCT02601950|470123928|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591325|NCT02601950|470123929|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591326|NCT02601950|470123930|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591327|NCT02601950|470123931|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591328|NCT02601950|470123932|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
130591329|NCT02601950|470123933|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591330|NCT02601950|470123934|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130591331|NCT02601950|470123927|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
130591332|NCT02601950|470123928|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
130591333|NCT02601950|470123929|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
130591334|NCT02601950|470123930|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
130591335|NCT02601950|470123931|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
130591336|NCT02601950|470123932|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
130591337|NCT02601950|470123933|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
130591338|NCT02601950|470123934|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
130591339|NCT02601950|470123927|FG000|Overall Study|Non-compliance|0|||
130591340|NCT02601950|470123928|FG001|Overall Study|Non-compliance|1|||
130591341|NCT02601950|470123929|FG002|Overall Study|Non-compliance|0|||
130591342|NCT02601950|470123930|FG003|Overall Study|Non-compliance|0|||
130591343|NCT02601950|470123931|FG004|Overall Study|Non-compliance|0|||
130591344|NCT02601950|470123932|FG005|Overall Study|Non-compliance|1|||
130591345|NCT02601950|470123933|FG006|Overall Study|Non-compliance|1|||
130591346|NCT02601950|470123934|FG007|Overall Study|Non-compliance|0|||
130591347|NCT02601950|470123927|FG000|Overall Study|Participant refused further study treatment|0|||
130591348|NCT02601950|470123928|FG001|Overall Study|Participant refused further study treatment|1|||
130591349|NCT02601950|470123929|FG002|Overall Study|Participant refused further study treatment|1|||
130591350|NCT02601950|470123930|FG003|Overall Study|Participant refused further study treatment|0|||
130591351|NCT02601950|470123931|FG004|Overall Study|Participant refused further study treatment|2|||
130591352|NCT02601950|470123932|FG005|Overall Study|Participant refused further study treatment|2|||
130591353|NCT02601950|470123933|FG006|Overall Study|Participant refused further study treatment|2|||
130591354|NCT02601950|470123934|FG007|Overall Study|Participant refused further study treatment|1|||
130591355|NCT02601950|470123927|FG000|Overall Study|Investigator discretion|1|||
130591356|NCT02601950|470123928|FG001|Overall Study|Investigator discretion|0|||
130591357|NCT02601950|470123929|FG002|Overall Study|Investigator discretion|1|||
130591358|NCT02601950|470123930|FG003|Overall Study|Investigator discretion|0|||
130591359|NCT02601950|470123931|FG004|Overall Study|Investigator discretion|1|||
130591360|NCT02601950|470123932|FG005|Overall Study|Investigator discretion|1|||
130591361|NCT02601950|470123933|FG006|Overall Study|Investigator discretion|1|||
130591362|NCT02601950|470123934|FG007|Overall Study|Investigator discretion|0|||
130591363|NCT02601950|470123927|FG000|Overall Study|Other|0|||
130591364|NCT02601950|470123928|FG001|Overall Study|Other|0|||
130591365|NCT02601950|470123929|FG002|Overall Study|Other|0|||
130591366|NCT02601950|470123930|FG003|Overall Study|Other|0|||
130591367|NCT02601950|470123931|FG004|Overall Study|Other|2|||
130591368|NCT02601950|470123932|FG005|Overall Study|Other|2|||
130591369|NCT02601950|470123933|FG006|Overall Study|Other|1|||
130591370|NCT02601950|470123934|FG007|Overall Study|Other|0|||
130591371|NCT03049449|470123937|FG000|Overall Study|Did not receive treatment.|0|||
130591372|NCT03049449|470123938|FG001|Overall Study|Did not receive treatment.|0|||
130591373|NCT03049449|470123939|FG002|Overall Study|Did not receive treatment.|0|||
130591374|NCT03049449|470123940|FG003|Overall Study|Did not receive treatment.|0|||
130591375|NCT03049449|470123941|FG004|Overall Study|Did not receive treatment.|0|||
130591376|NCT03049449|470123942|FG005|Overall Study|Did not receive treatment.|0|||
130591377|NCT03049449|470123943|FG006|Overall Study|Did not receive treatment.|0|||
130591378|NCT03049449|470123944|FG007|Overall Study|Did not receive treatment.|0|||
130591379|NCT03049449|470123945|FG008|Overall Study|Did not receive treatment.|1|||
130591380|NCT03049449|470123946|FG009|Overall Study|Did not receive treatment.|0|||
130591381|NCT03049449|470123937|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
130591382|NCT03049449|470123938|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
130591383|NCT03049449|470123939|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
130591384|NCT03049449|470123940|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
130591385|NCT03049449|470123941|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
130591386|NCT03049449|470123942|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
130591387|NCT03049449|470123943|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
130591388|NCT03049449|470123944|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
130591389|NCT03049449|470123945|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
130591390|NCT03049449|470123946|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
130591391|NCT03049449|470123937|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591392|NCT03049449|470123938|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591393|NCT03049449|470123939|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591394|NCT03049449|470123940|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591395|NCT03049449|470123941|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591396|NCT03049449|470123942|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591397|NCT03049449|470123943|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591398|NCT03049449|470123944|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
130591399|NCT03049449|470123945|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130591400|NCT03049449|470123946|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
130591401|NCT00442598|470123947|FG000|Overall Study|Adverse Event|1|||
130591402|NCT00442598|470123948|FG001|Overall Study|Adverse Event|0|||
130591403|NCT00442598|470123949|FG002|Overall Study|Adverse Event|0|||
130591404|NCT00442598|470123947|FG000|Overall Study|Tumor progression|3|||
130591405|NCT00442598|470123948|FG001|Overall Study|Tumor progression|4|||
130591406|NCT00442598|470123949|FG002|Overall Study|Tumor progression|0|||
130591407|NCT00442598|470123947|FG000|Overall Study|Clinical deterioration|1|||
130591408|NCT00442598|470123948|FG001|Overall Study|Clinical deterioration|2|||
130591409|NCT00442598|470123949|FG002|Overall Study|Clinical deterioration|0|||
130591410|NCT00442598|470123947|FG000|Overall Study|CA125 progression|0|||
130591411|NCT00442598|470123948|FG001|Overall Study|CA125 progression|1|||
130591412|NCT00442598|470123949|FG002|Overall Study|CA125 progression|0|||
130591413|NCT00442598|470123947|FG000|Overall Study|Reduced creatinine clearance|1|||
130591414|NCT00442598|470123948|FG001|Overall Study|Reduced creatinine clearance|0|||
130591415|NCT00442598|470123949|FG002|Overall Study|Reduced creatinine clearance|0|||
130591416|NCT00442598|470123947|FG000|Overall Study|Death|0|||
130591417|NCT00442598|470123948|FG001|Overall Study|Death|1|||
130591418|NCT00442598|470123949|FG002|Overall Study|Death|0|||
130591419|NCT01147497|470123950|FG000|Overall Study|failed insertion|2|||
130591420|NCT01147497|470123951|FG001|Overall Study|failed insertion|0|||
130591421|NCT00355264|470123954|FG000|Extension (Variable Duration)|Adverse Event|1|||
130591422|NCT00355264|470123954|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
130591423|NCT01157117|470123955|FG000|Overall Study|Dosing Symptoms|0|||
130591424|NCT01157117|470123956|FG001|Overall Study|Dosing Symptoms|4|||
130591425|NCT01157117|470123957|FG002|Overall Study|Dosing Symptoms|0|||
130591426|NCT01157117|470123955|FG000|Overall Study|Withdrawal by Subject|4|||
130591427|NCT01157117|470123956|FG001|Overall Study|Withdrawal by Subject|1|||
130591428|NCT01157117|470123957|FG002|Overall Study|Withdrawal by Subject|1|||
130591429|NCT01157117|470123955|FG000|Overall Study|Lack of Efficacy|1|||
130591430|NCT01157117|470123956|FG001|Overall Study|Lack of Efficacy|1|||
130591431|NCT01157117|470123957|FG002|Overall Study|Lack of Efficacy|0|||
130591432|NCT01157117|470123955|FG000|Overall Study|Lost to Follow-up|0|||
130591433|NCT01157117|470123956|FG001|Overall Study|Lost to Follow-up|0|||
130591434|NCT01157117|470123957|FG002|Overall Study|Lost to Follow-up|1|||
130591435|NCT01157117|470123955|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
130591436|NCT01157117|470123956|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
130591437|NCT01157117|470123957|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
130591438|NCT00826514|470123958|FG000|Overall Study|Adverse Event|1|||
130591439|NCT00826514|470123959|FG001|Overall Study|Adverse Event|1|||
130591440|NCT00826514|470123958|FG000|Overall Study|Lack of Efficacy|0|||
130591441|NCT00826514|470123959|FG001|Overall Study|Lack of Efficacy|1|||
130591442|NCT00826514|470123958|FG000|Overall Study|Withdrawal by Subject|2|||
130591443|NCT00826514|470123959|FG001|Overall Study|Withdrawal by Subject|3|||
130591444|NCT03663166|470123962|FG000|Overall Study|Withdrawal by Subject|1|||
130591445|NCT02209506|470123970|FG000|Overall Study|Withdrawal by Subject|0|||
130591446|NCT02209506|470123971|FG001|Overall Study|Withdrawal by Subject|0|||
130591447|NCT02209506|470123972|FG002|Overall Study|Withdrawal by Subject|0|||
130591448|NCT02209506|470123973|FG003|Overall Study|Withdrawal by Subject|0|||
130591449|NCT02209506|470123974|FG004|Overall Study|Withdrawal by Subject|1|||
130591450|NCT00098787|470123975|FG000|Overall Study|Never started treatment|3|||
130591451|NCT00098787|470123976|FG001|Overall Study|Never started treatment|2|||
130591452|NCT00098787|470123977|FG002|Overall Study|Never started treatment|1|||
130591453|NCT00098787|470123975|FG000|Overall Study|Ineligible|9|||
130591454|NCT00098787|470123976|FG001|Overall Study|Ineligible|7|||
130591455|NCT00098787|470123977|FG002|Overall Study|Ineligible|3|||
130591456|NCT00098787|470123975|FG000|Overall Study|Disease progression|28|||
130591457|NCT00098787|470123976|FG001|Overall Study|Disease progression|17|||
130591458|NCT00098787|470123977|FG002|Overall Study|Disease progression|23|||
130591459|NCT00098787|470123975|FG000|Overall Study|Adverse Event|8|||
130591460|NCT00098787|470123976|FG001|Overall Study|Adverse Event|17|||
130591461|NCT00098787|470123977|FG002|Overall Study|Adverse Event|8|||
130591462|NCT00098787|470123975|FG000|Overall Study|Death|6|||
130591463|NCT00098787|470123976|FG001|Overall Study|Death|1|||
130591464|NCT00098787|470123977|FG002|Overall Study|Death|0|||
130591465|NCT00098787|470123975|FG000|Overall Study|Withdrawal by Subject|4|||
130591466|NCT00098787|470123976|FG001|Overall Study|Withdrawal by Subject|12|||
130591467|NCT00098787|470123977|FG002|Overall Study|Withdrawal by Subject|6|||
130591468|NCT00098787|470123975|FG000|Overall Study|Alternative therapy|8|||
130591469|NCT00098787|470123976|FG001|Overall Study|Alternative therapy|13|||
130591470|NCT00098787|470123977|FG002|Overall Study|Alternative therapy|13|||
130591471|NCT00098787|470123975|FG000|Overall Study|Other|7|||
130591472|NCT00098787|470123976|FG001|Overall Study|Other|6|||
130591473|NCT00098787|470123977|FG002|Overall Study|Other|9|||
130591474|NCT01360996|470123980|FG000|Overall Study|Withdrawal by Subject|4|||
130591475|NCT01360996|470123981|FG001|Overall Study|Withdrawal by Subject|3|||
130591476|NCT01360996|470123982|FG002|Overall Study|Withdrawal by Subject|2|||
130591477|NCT01360996|470123980|FG000|Overall Study|Noncompliant|2|||
130591478|NCT01360996|470123981|FG001|Overall Study|Noncompliant|0|||
130591479|NCT01360996|470123982|FG002|Overall Study|Noncompliant|0|||
130591480|NCT02537678|470123983|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
130591481|NCT02537678|470123984|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
130591482|NCT02537678|470123983|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
130591483|NCT02537678|470123984|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
130591484|NCT02537678|470123983|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
130591485|NCT02537678|470123984|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
130591486|NCT02537678|470123983|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
130591487|NCT02537678|470123984|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
130591488|NCT02537678|470123983|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
130591489|NCT02537678|470123984|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
130591490|NCT02537678|470123983|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
130591491|NCT02537678|470123984|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
130591492|NCT02537678|470123983|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
130591493|NCT02537678|470123984|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
130591494|NCT04348851|470123985|FG000|Post-Test 1|Withdrawal by Subject|0|||
130591495|NCT04348851|470123986|FG001|Post-Test 1|Withdrawal by Subject|1|||
130591496|NCT04348851|470123987|FG002|Post-Test 1|Withdrawal by Subject|0|||
130591497|NCT04348851|470123988|FG003|Post-Test 1|Withdrawal by Subject|0|||
130591498|NCT04348851|470123985|FG000|Post-Test 1|Lost to Follow-up|0|||
130591499|NCT04348851|470123986|FG001|Post-Test 1|Lost to Follow-up|1|||
130591500|NCT04348851|470123987|FG002|Post-Test 1|Lost to Follow-up|0|||
130591501|NCT04348851|470123988|FG003|Post-Test 1|Lost to Follow-up|0|||
130591502|NCT04348851|470123985|FG000|Post-Test 2|Stroke survivor death|0|||
130591503|NCT04348851|470123986|FG001|Post-Test 2|Stroke survivor death|1|||
130591504|NCT04348851|470123987|FG002|Post-Test 2|Stroke survivor death|0|||
130591505|NCT04348851|470123988|FG003|Post-Test 2|Stroke survivor death|1|||
130591506|NCT02965378|470123989|FG000|Overall Study|Progression|16|||
130591507|NCT02965378|470123990|FG001|Overall Study|Progression|4|||
130591508|NCT02965378|470123989|FG000|Overall Study|Adverse Event|5|||
130591509|NCT02965378|470123990|FG001|Overall Study|Adverse Event|2|||
130591510|NCT02965378|470123989|FG000|Overall Study|Death|2|||
130591511|NCT02965378|470123990|FG001|Overall Study|Death|0|||
130591512|NCT02965378|470123989|FG000|Overall Study|Refusal|2|||
130591513|NCT02965378|470123990|FG001|Overall Study|Refusal|1|||
130591514|NCT02965378|470123989|FG000|Overall Study|Not protocol specified|0|||
130591515|NCT02965378|470123990|FG001|Overall Study|Not protocol specified|2|||
130591516|NCT00629083|470123991|FG000|Overall Study|Adverse Event|0|||
130591517|NCT00629083|470123992|FG001|Overall Study|Adverse Event|2|||
130591518|NCT00629083|470123991|FG000|Overall Study|Lack of Efficacy|3|||
130591519|NCT00629083|470123992|FG001|Overall Study|Lack of Efficacy|1|||
130591520|NCT00629083|470123991|FG000|Overall Study|Withdrawal by Subject|10|||
130591521|NCT00629083|470123992|FG001|Overall Study|Withdrawal by Subject|2|||
130591522|NCT00629083|470123991|FG000|Overall Study|Lost to Follow-up|12|||
130591523|NCT00629083|470123992|FG001|Overall Study|Lost to Follow-up|8|||
130591524|NCT00629083|470123991|FG000|Overall Study|Moved out of country/state|2|||
130591525|NCT00629083|470123992|FG001|Overall Study|Moved out of country/state|1|||
130591526|NCT00629083|470123991|FG000|Overall Study|Refused to return for 12 month visit|1|||
130591527|NCT00629083|470123992|FG001|Overall Study|Refused to return for 12 month visit|0|||
130591528|NCT02909153|470123993|FG000|Overall Study|Withdrawal by Subject|0|||
130591529|NCT02909153|470123994|FG001|Overall Study|Withdrawal by Subject|1|||
130591530|NCT02909153|470123995|FG002|Overall Study|Withdrawal by Subject|0|||
130591531|NCT02909153|470123996|FG003|Overall Study|Withdrawal by Subject|0|||
130591532|NCT02909153|470123997|FG004|Overall Study|Withdrawal by Subject|0|||
130591533|NCT01147809|470124000|FG000|Phase I (168 Days)|Adverse Event|0|||
130591534|NCT01147809|470124001|FG001|Phase I (168 Days)|Adverse Event|0|||
130591535|NCT01147809|470124002|FG002|Phase I (168 Days)|Adverse Event|0|||
130591536|NCT01147809|470124003|FG003|Phase I (168 Days)|Adverse Event|1|||
130591537|NCT01147809|470124004|FG004|Phase I (168 Days)|Adverse Event|0|||
130591538|NCT01147809|470124005|FG005|Phase I (168 Days)|Adverse Event|0|||
130591539|NCT01147809|470124000|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
130591540|NCT01147809|470124001|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
130591541|NCT01147809|470124002|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
130591542|NCT01147809|470124003|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
130591543|NCT01147809|470124004|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
130591544|NCT01147809|470124005|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
130591545|NCT01147809|470124000|FG000|Phase I (168 Days)|Physician Decision|0|||
130591546|NCT01147809|470124001|FG001|Phase I (168 Days)|Physician Decision|1|||
130591547|NCT01147809|470124002|FG002|Phase I (168 Days)|Physician Decision|2|||
130591548|NCT01147809|470124003|FG003|Phase I (168 Days)|Physician Decision|0|||
130591549|NCT01147809|470124004|FG004|Phase I (168 Days)|Physician Decision|0|||
130591550|NCT01147809|470124005|FG005|Phase I (168 Days)|Physician Decision|0|||
130591551|NCT01147809|470124000|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
130591552|NCT01147809|470124001|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
130591553|NCT01147809|470124002|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
130591554|NCT01147809|470124003|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
130591555|NCT01147809|470124004|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
130591556|NCT01147809|470124005|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
130591557|NCT01147809|470124000|FG000|Phase II (168 Days)|Adverse Event|0|||
130591558|NCT01147809|470124001|FG001|Phase II (168 Days)|Adverse Event|0|||
130591559|NCT01147809|470124002|FG002|Phase II (168 Days)|Adverse Event|0|||
130591560|NCT01147809|470124003|FG003|Phase II (168 Days)|Adverse Event|0|||
130591561|NCT01147809|470124004|FG004|Phase II (168 Days)|Adverse Event|3|||
130591562|NCT01147809|470124005|FG005|Phase II (168 Days)|Adverse Event|6|||
130591563|NCT01147809|470124000|FG000|Phase II (168 Days)|Protocol Violation|0|||
130591564|NCT01147809|470124001|FG001|Phase II (168 Days)|Protocol Violation|0|||
130591565|NCT01147809|470124002|FG002|Phase II (168 Days)|Protocol Violation|0|||
130591566|NCT01147809|470124003|FG003|Phase II (168 Days)|Protocol Violation|0|||
130591567|NCT01147809|470124004|FG004|Phase II (168 Days)|Protocol Violation|0|||
130591568|NCT01147809|470124005|FG005|Phase II (168 Days)|Protocol Violation|1|||
130591569|NCT01147809|470124000|FG000|Phase II (168 Days)|Physician Decision|0|||
130591570|NCT01147809|470124001|FG001|Phase II (168 Days)|Physician Decision|0|||
130591571|NCT01147809|470124002|FG002|Phase II (168 Days)|Physician Decision|0|||
130591572|NCT01147809|470124003|FG003|Phase II (168 Days)|Physician Decision|0|||
130591573|NCT01147809|470124004|FG004|Phase II (168 Days)|Physician Decision|5|||
130591574|NCT01147809|470124005|FG005|Phase II (168 Days)|Physician Decision|11|||
130591575|NCT01147809|470124000|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
130591576|NCT01147809|470124001|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
130591577|NCT01147809|470124002|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
130591578|NCT01147809|470124003|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
130591579|NCT01147809|470124004|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
130591580|NCT01147809|470124005|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
130591581|NCT01147809|470124000|FG000|Phase II (168 Days)|Ongoing|0|||
130591582|NCT01147809|470124001|FG001|Phase II (168 Days)|Ongoing|0|||
130591583|NCT01147809|470124002|FG002|Phase II (168 Days)|Ongoing|0|||
130591584|NCT01147809|470124003|FG003|Phase II (168 Days)|Ongoing|0|||
130591585|NCT01147809|470124004|FG004|Phase II (168 Days)|Ongoing|1|||
130591586|NCT01147809|470124005|FG005|Phase II (168 Days)|Ongoing|0|||
130591587|NCT01499290|470124006|FG000|Overall Study|Withdrawal by Subject|22|||
130591588|NCT01499290|470124007|FG001|Overall Study|Withdrawal by Subject|15|||
130591589|NCT01499290|470124006|FG000|Overall Study|Not specified in study report|11|||
130591590|NCT01499290|470124007|FG001|Overall Study|Not specified in study report|5|||
130591591|NCT01499290|470124006|FG000|Overall Study|Condition improved/subject recovered|1|||
130591592|NCT01499290|470124007|FG001|Overall Study|Condition improved/subject recovered|0|||
130591593|NCT01499290|470124006|FG000|Overall Study|Lack of Efficacy|7|||
130591594|NCT01499290|470124007|FG001|Overall Study|Lack of Efficacy|8|||
130591595|NCT01499290|470124006|FG000|Overall Study|Adverse Event|14|||
130591596|NCT01499290|470124007|FG001|Overall Study|Adverse Event|7|||
130591597|NCT04052139|470124008|FG000|Overall Study|Lost to Follow-up|2|||
130591598|NCT04052139|470124009|FG001|Overall Study|Lost to Follow-up|0|||
130591599|NCT04052139|470124010|FG002|Overall Study|Lost to Follow-up|0|||
130591600|NCT04052139|470124008|FG000|Overall Study|Withdrawal by Subject|1|||
130591601|NCT04052139|470124009|FG001|Overall Study|Withdrawal by Subject|0|||
130591602|NCT04052139|470124010|FG002|Overall Study|Withdrawal by Subject|0|||
130591603|NCT03406962|470124011|FG000|Overall Study|Death|2|||
130591604|NCT03406962|470124011|FG000|Overall Study|Adverse Event|1|||
130591605|NCT00190775|470124012|FG000|Overall Study|Adverse Event|57|||
130591606|NCT00190775|470124013|FG001|Overall Study|Adverse Event|22|||
130591607|NCT00190775|470124012|FG000|Overall Study|Satisfactory Response|1|||
130591608|NCT00190775|470124013|FG001|Overall Study|Satisfactory Response|0|||
130591609|NCT00190775|470124012|FG000|Overall Study|Lack of Efficacy|28|||
130591610|NCT00190775|470124013|FG001|Overall Study|Lack of Efficacy|32|||
130591611|NCT00190775|470124012|FG000|Overall Study|Lost to Follow-up|31|||
130591612|NCT00190775|470124013|FG001|Overall Study|Lost to Follow-up|23|||
130591613|NCT00190775|470124012|FG000|Overall Study|Participant Moved|0|||
130591614|NCT00190775|470124013|FG001|Overall Study|Participant Moved|1|||
130591615|NCT00190775|470124012|FG000|Overall Study|Withdrawal by Subject|24|||
130591616|NCT00190775|470124013|FG001|Overall Study|Withdrawal by Subject|13|||
130591617|NCT00190775|470124012|FG000|Overall Study|Sponsor Decision|1|||
130591618|NCT00190775|470124013|FG001|Overall Study|Sponsor Decision|0|||
130591619|NCT00190775|470124012|FG000|Overall Study|Physician Decision|3|||
130591620|NCT00190775|470124013|FG001|Overall Study|Physician Decision|0|||
130591621|NCT00190775|470124012|FG000|Overall Study|Noncompliance|3|||
130591622|NCT00190775|470124013|FG001|Overall Study|Noncompliance|5|||
130591623|NCT00190775|470124012|FG000|Overall Study|Protocol Violation|0|||
130591624|NCT00190775|470124013|FG001|Overall Study|Protocol Violation|1|||
130591625|NCT00190775|470124012|FG000|Overall Study|Exclusion Criteria Met|1|||
130591626|NCT00190775|470124013|FG001|Overall Study|Exclusion Criteria Met|3|||
130591627|NCT00519077|470124014|FG000|Overall Study|Death|6|||
130591628|NCT00519077|470124014|FG000|Overall Study|Other|2|||
130591629|NCT01967225|470124015|FG000|Overall Study|Adverse Event|3|||
130591630|NCT01967225|470124016|FG001|Overall Study|Adverse Event|1|||
130591631|NCT01967225|470124015|FG000|Overall Study|Withdrawal by Subject|2|||
130591632|NCT01967225|470124016|FG001|Overall Study|Withdrawal by Subject|1|||
130591633|NCT01967225|470124015|FG000|Overall Study|Lack of Efficacy|1|||
130591634|NCT01967225|470124016|FG001|Overall Study|Lack of Efficacy|1|||
130591635|NCT01967225|470124015|FG000|Overall Study|Switching to other therapy|2|||
130591636|NCT01967225|470124016|FG001|Overall Study|Switching to other therapy|0|||
130591637|NCT01967225|470124015|FG000|Overall Study|Protocol driven decision point|1|||
130591638|NCT01967225|470124016|FG001|Overall Study|Protocol driven decision point|0|||
130591639|NCT01967225|470124015|FG000|Overall Study|Logistical difficulties|1|||
130591640|NCT01967225|470124016|FG001|Overall Study|Logistical difficulties|0|||
130591641|NCT01967225|470124015|FG000|Overall Study|Protocol Violation|2|||
130591642|NCT01967225|470124016|FG001|Overall Study|Protocol Violation|0|||
130591643|NCT00327444|470124017|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
130591644|NCT00327444|470124018|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
130591645|NCT00327444|470124017|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
130591646|NCT00327444|470124018|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
130591647|NCT00327444|470124017|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
130591648|NCT00327444|470124018|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
130591649|NCT00327444|470124017|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
130591650|NCT00327444|470124018|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
130591651|NCT00327444|470124017|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
130591652|NCT00327444|470124018|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
130591653|NCT00327444|470124017|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
130591654|NCT00327444|470124018|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
130591655|NCT00327444|470124017|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
130591656|NCT00327444|470124018|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
130591657|NCT00327444|470124017|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
130591658|NCT00327444|470124018|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
130591659|NCT04439344|470124019|FG000|Overall Study|Never started threapy|3|||
130591660|NCT04439344|470124019|FG000|Overall Study|Ineligible|3|||
130591661|NCT04439344|470124019|FG000|Overall Study|Adverse Event|13|||
130591662|NCT04439344|470124019|FG000|Overall Study|Death|2|||
130591663|NCT04439344|470124019|FG000|Overall Study|Disease progression|29|||
130591664|NCT04439344|470124019|FG000|Overall Study|Withdrawal by Subject|2|||
130591665|NCT04439344|470124019|FG000|Overall Study|Alternative therapy|1|||
130591666|NCT00552110|470124020|FG000|Overall Study|Serious or Life-Threatening AE|0|||
130591667|NCT00552110|470124021|FG001|Overall Study|Serious or Life-Threatening AE|0|||
130591668|NCT00552110|470124022|FG002|Overall Study|Serious or Life-Threatening AE|1|||
130591669|NCT00552110|470124023|FG003|Overall Study|Serious or Life-Threatening AE|0|||
130591670|NCT00552110|470124024|FG004|Overall Study|Serious or Life-Threatening AE|0|||
130591671|NCT00552110|470124020|FG000|Overall Study|Lack of Efficacy|1|||
130591672|NCT00552110|470124021|FG001|Overall Study|Lack of Efficacy|0|||
130591673|NCT00552110|470124022|FG002|Overall Study|Lack of Efficacy|0|||
130591674|NCT00552110|470124023|FG003|Overall Study|Lack of Efficacy|1|||
130591675|NCT00552110|470124024|FG004|Overall Study|Lack of Efficacy|4|||
130591676|NCT00552110|470124020|FG000|Overall Study|Withdrawal by Subject|0|||
130591677|NCT00552110|470124021|FG001|Overall Study|Withdrawal by Subject|2|||
130591678|NCT00552110|470124022|FG002|Overall Study|Withdrawal by Subject|0|||
130591679|NCT00552110|470124023|FG003|Overall Study|Withdrawal by Subject|3|||
130591680|NCT00552110|470124024|FG004|Overall Study|Withdrawal by Subject|2|||
130591681|NCT00552110|470124020|FG000|Overall Study|Lost to Follow-up|0|||
130591682|NCT00552110|470124021|FG001|Overall Study|Lost to Follow-up|0|||
130591683|NCT00552110|470124022|FG002|Overall Study|Lost to Follow-up|0|||
130591684|NCT00552110|470124023|FG003|Overall Study|Lost to Follow-up|1|||
130591685|NCT00552110|470124024|FG004|Overall Study|Lost to Follow-up|1|||
130591686|NCT00552110|470124020|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
130591687|NCT00552110|470124021|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
130591688|NCT00552110|470124022|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
130591689|NCT00552110|470124023|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
130591690|NCT00552110|470124024|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
130591691|NCT00552110|470124020|FG000|Overall Study|Withdrawn per Sponsor|0|||
130591692|NCT00552110|470124021|FG001|Overall Study|Withdrawn per Sponsor|1|||
130591693|NCT00552110|470124022|FG002|Overall Study|Withdrawn per Sponsor|0|||
130591694|NCT00552110|470124023|FG003|Overall Study|Withdrawn per Sponsor|0|||
130591695|NCT00552110|470124024|FG004|Overall Study|Withdrawn per Sponsor|1|||
130591696|NCT00552110|470124020|FG000|Overall Study|Use of Prohibited Medication|1|||
130591697|NCT00552110|470124021|FG001|Overall Study|Use of Prohibited Medication|1|||
130591698|NCT00552110|470124022|FG002|Overall Study|Use of Prohibited Medication|0|||
130591699|NCT00552110|470124023|FG003|Overall Study|Use of Prohibited Medication|0|||
130591700|NCT00552110|470124024|FG004|Overall Study|Use of Prohibited Medication|0|||
130591701|NCT00552110|470124020|FG000|Overall Study|Delay of Study due to Relabeling|0|||
130591702|NCT00552110|470124021|FG001|Overall Study|Delay of Study due to Relabeling|0|||
130591703|NCT00552110|470124022|FG002|Overall Study|Delay of Study due to Relabeling|0|||
130591704|NCT00552110|470124023|FG003|Overall Study|Delay of Study due to Relabeling|1|||
130591705|NCT00552110|470124024|FG004|Overall Study|Delay of Study due to Relabeling|0|||
130591706|NCT00552110|470124020|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
130591707|NCT00552110|470124021|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
130591708|NCT00552110|470124022|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
130591709|NCT00552110|470124023|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
130591710|NCT00552110|470124024|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
130591711|NCT00552110|470124020|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
130591712|NCT00552110|470124021|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
130591713|NCT00552110|470124022|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
130591714|NCT00552110|470124023|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
130591715|NCT00552110|470124024|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
130591716|NCT01672957|470124025|FG000|Overall Study|Protocol Violation|48|||
130591717|NCT01672957|470124025|FG000|Overall Study|Death|2|||
130591718|NCT01672957|470124025|FG000|Overall Study|ICF Signed After Transplantation|5|||
130591719|NCT01511445|470124026|FG000|Overall Study|Lost to Follow-up|3|||
130591720|NCT01511445|470124027|FG001|Overall Study|Lost to Follow-up|1|||
130591721|NCT01511445|470124026|FG000|Overall Study|Protocol Violation|1|||
130591722|NCT01511445|470124027|FG001|Overall Study|Protocol Violation|3|||
130591723|NCT01511445|470124026|FG000|Overall Study|Protocol Violation|1|||
130591724|NCT01511445|470124027|FG001|Overall Study|Protocol Violation|0|||
130591725|NCT00490542|470124032|FG000|Overall Study|Lost to Follow-up|3|||
130591726|NCT00490542|470124033|FG001|Overall Study|Lost to Follow-up|0|||
130591727|NCT00490542|470124032|FG000|Overall Study|Adverse Event|3|||
130591728|NCT00490542|470124033|FG001|Overall Study|Adverse Event|3|||
130591729|NCT00490542|470124032|FG000|Overall Study|Lack of Efficacy|1|||
130591730|NCT00490542|470124033|FG001|Overall Study|Lack of Efficacy|1|||
130591731|NCT04696861|470124034|FG000|Overall Study|Death|1|||
130591732|NCT04696861|470124035|FG001|Overall Study|Death|0|||
130591733|NCT04696861|470124034|FG000|Overall Study|Lost to Follow-up|3|||
130591734|NCT04696861|470124035|FG001|Overall Study|Lost to Follow-up|0|||
130591735|NCT00818259|470124036|FG000|Part I|Withdrawal by Subject|1|||
130591736|NCT00818259|470124037|FG001|Part I|Withdrawal by Subject|0|||
130591737|NCT00818259|470124038|FG002|Part I|Withdrawal by Subject|0|||
130591738|NCT00818259|470124039|FG003|Part I|Withdrawal by Subject|0|||
130591739|NCT00818259|470124040|FG004|Part I|Withdrawal by Subject|0|||
130591740|NCT00818259|470124041|FG005|Part I|Withdrawal by Subject|0|||
130591741|NCT00818259|470124042|FG006|Part I|Withdrawal by Subject|0|||
130591742|NCT00818259|470124043|FG007|Part I|Withdrawal by Subject|0|||
130591743|NCT00818259|470124044|FG008|Part I|Withdrawal by Subject|0|||
130591744|NCT00818259|470124036|FG000|Part II|Physician Decision|0|||
130591745|NCT00818259|470124037|FG001|Part II|Physician Decision|0|||
130591746|NCT00818259|470124038|FG002|Part II|Physician Decision|1|||
130591747|NCT00818259|470124039|FG003|Part II|Physician Decision|0|||
130591748|NCT00818259|470124040|FG004|Part II|Physician Decision|0|||
130591749|NCT00818259|470124041|FG005|Part II|Physician Decision|0|||
130591750|NCT00818259|470124042|FG006|Part II|Physician Decision|0|||
130591751|NCT00818259|470124043|FG007|Part II|Physician Decision|0|||
130591752|NCT00818259|470124044|FG008|Part II|Physician Decision|0|||
130591753|NCT00818259|470124036|FG000|Part II|Lack of Efficacy|0|||
130591754|NCT00818259|470124037|FG001|Part II|Lack of Efficacy|0|||
130591755|NCT00818259|470124038|FG002|Part II|Lack of Efficacy|0|||
130591756|NCT00818259|470124039|FG003|Part II|Lack of Efficacy|1|||
130591757|NCT00818259|470124040|FG004|Part II|Lack of Efficacy|0|||
130591758|NCT00818259|470124041|FG005|Part II|Lack of Efficacy|0|||
130591759|NCT00818259|470124042|FG006|Part II|Lack of Efficacy|0|||
130591760|NCT00818259|470124043|FG007|Part II|Lack of Efficacy|0|||
130591761|NCT00818259|470124044|FG008|Part II|Lack of Efficacy|0|||
130591762|NCT00818259|470124036|FG000|Part II|Not Treated|0|||
130591763|NCT00818259|470124037|FG001|Part II|Not Treated|0|||
130591764|NCT00818259|470124038|FG002|Part II|Not Treated|0|||
130591765|NCT00818259|470124039|FG003|Part II|Not Treated|1|||
130591766|NCT00818259|470124040|FG004|Part II|Not Treated|0|||
130591767|NCT00818259|470124041|FG005|Part II|Not Treated|0|||
130591768|NCT00818259|470124042|FG006|Part II|Not Treated|0|||
130591769|NCT00818259|470124043|FG007|Part II|Not Treated|0|||
130591770|NCT00818259|470124044|FG008|Part II|Not Treated|0|||
130591771|NCT00818259|470124036|FG000|Part IV|Physician Decision|0|||
130591772|NCT00818259|470124037|FG001|Part IV|Physician Decision|0|||
130591773|NCT00818259|470124038|FG002|Part IV|Physician Decision|0|||
130591774|NCT00818259|470124039|FG003|Part IV|Physician Decision|0|||
130591775|NCT00818259|470124040|FG004|Part IV|Physician Decision|0|||
130591776|NCT00818259|470124041|FG005|Part IV|Physician Decision|1|||
130591777|NCT00818259|470124042|FG006|Part IV|Physician Decision|0|||
130591778|NCT00818259|470124043|FG007|Part IV|Physician Decision|0|||
130591779|NCT00818259|470124044|FG008|Part IV|Physician Decision|0|||
130591780|NCT00818259|470124036|FG000|Part V|Adverse Event|0|||
130591781|NCT00818259|470124037|FG001|Part V|Adverse Event|0|||
130591782|NCT00818259|470124038|FG002|Part V|Adverse Event|0|||
130591783|NCT00818259|470124039|FG003|Part V|Adverse Event|0|||
130591784|NCT00818259|470124040|FG004|Part V|Adverse Event|0|||
130591785|NCT00818259|470124041|FG005|Part V|Adverse Event|0|||
130591786|NCT00818259|470124042|FG006|Part V|Adverse Event|0|||
130591787|NCT00818259|470124043|FG007|Part V|Adverse Event|1|||
130591788|NCT00818259|470124044|FG008|Part V|Adverse Event|0|||
130591789|NCT01053429|470124045|FG000|Overall Study|Adverse Event|64|||
130591790|NCT01053429|470124045|FG000|Overall Study|Other|309|||
130591791|NCT00752986|470124048|FG000|Overall Study|Withdrawal by Subject|2|||
130591792|NCT00752986|470124049|FG001|Overall Study|Withdrawal by Subject|1|||
130591793|NCT00752986|470124050|FG002|Overall Study|Withdrawal by Subject|2|||
130591794|NCT00752986|470124048|FG000|Overall Study|Protocol Violation|3|||
130591795|NCT00752986|470124049|FG001|Overall Study|Protocol Violation|0|||
130591796|NCT00752986|470124050|FG002|Overall Study|Protocol Violation|0|||
130591797|NCT00924703|470124053|FG000|Overall Study|Withdrawal by Subject|11|||
130591798|NCT00924703|470124053|FG000|Overall Study|Physician Decision|5|||
130591799|NCT00924703|470124053|FG000|Overall Study|Lost to Follow-up|3|||
130591800|NCT00924703|470124053|FG000|Overall Study|Adverse Event|2|||
130591801|NCT00924703|470124053|FG000|Overall Study|Withdrawal by Sponsor|1|||
130591802|NCT00666562|470124054|FG000|Overall Study|Withdrawal by Subject|0|||
130591803|NCT00666562|470124055|FG001|Overall Study|Withdrawal by Subject|1|||
130591804|NCT00666562|470124056|FG002|Overall Study|Withdrawal by Subject|0|||
130591805|NCT00666562|470124054|FG000|Overall Study|Concomitant Medication|0|||
130591806|NCT00666562|470124055|FG001|Overall Study|Concomitant Medication|1|||
130591807|NCT00666562|470124056|FG002|Overall Study|Concomitant Medication|0|||
130591808|NCT01587989|470124058|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
130591809|NCT01587989|470124059|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
130591810|NCT01587989|470124060|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
130591811|NCT01587989|470124058|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
130591812|NCT01587989|470124059|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
130591813|NCT01587989|470124060|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
130591814|NCT01587989|470124058|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
130591815|NCT01587989|470124059|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
130591816|NCT01587989|470124060|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
130591817|NCT01587989|470124058|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
130591818|NCT01587989|470124059|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
130591819|NCT01587989|470124060|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
130591820|NCT01587989|470124058|FG000|Randomized Study Treatment|Screening failure|0|||
130591821|NCT01587989|470124059|FG001|Randomized Study Treatment|Screening failure|1|||
130591822|NCT01587989|470124060|FG002|Randomized Study Treatment|Screening failure|0|||
130591823|NCT01587989|470124058|FG000|Randomized Study Treatment|Physician Decision|0|||
130591824|NCT01587989|470124059|FG001|Randomized Study Treatment|Physician Decision|0|||
130591825|NCT01587989|470124060|FG002|Randomized Study Treatment|Physician Decision|1|||
130591826|NCT00684177|470124064|FG000|Overall Study|Adverse Event|4|||
130591827|NCT00684177|470124065|FG001|Overall Study|Adverse Event|3|||
130591828|NCT00684177|470124064|FG000|Overall Study|Lack of Efficacy|10|||
130591829|NCT00684177|470124065|FG001|Overall Study|Lack of Efficacy|15|||
130591830|NCT00684177|470124064|FG000|Overall Study|Protocol Violation|1|||
130591831|NCT00684177|470124065|FG001|Overall Study|Protocol Violation|0|||
130591832|NCT00684177|470124064|FG000|Overall Study|Lost to Follow-up|2|||
130591833|NCT00684177|470124065|FG001|Overall Study|Lost to Follow-up|1|||
130591834|NCT00684177|470124064|FG000|Overall Study|Physician Decision|2|||
130591835|NCT00684177|470124065|FG001|Overall Study|Physician Decision|0|||
130591836|NCT00684177|470124064|FG000|Overall Study|Withdrawal by Subject|1|||
130591837|NCT00684177|470124065|FG001|Overall Study|Withdrawal by Subject|2|||
130591838|NCT00684177|470124064|FG000|Overall Study|Other|1|||
130591839|NCT00684177|470124065|FG001|Overall Study|Other|2|||
130591840|NCT04375761|470126235|FG000|Overall Study|Death|1|||
130591841|NCT04375761|470126236|FG001|Overall Study|Death|2|||
130591842|NCT04375761|470126235|FG000|Overall Study|Lost to Follow-up|203|||
130591843|NCT04375761|470126236|FG001|Overall Study|Lost to Follow-up|380|||
130591844|NCT04375761|470126235|FG000|Overall Study|Withdrawal by Subject|47|||
130591845|NCT04375761|470126236|FG001|Overall Study|Withdrawal by Subject|98|||
130591846|NCT04375761|470126235|FG000|Overall Study|Noncompliance with study procedure|121|||
130591847|NCT04375761|470126236|FG001|Overall Study|Noncompliance with study procedure|251|||
130591848|NCT04375761|470126235|FG000|Overall Study|Reimbursement not enough|1|||
130591849|NCT04375761|470126236|FG001|Overall Study|Reimbursement not enough|2|||
130591850|NCT04375761|470126235|FG000|Overall Study|Unforeseen family circumstances|1|||
130591851|NCT04375761|470126236|FG001|Overall Study|Unforeseen family circumstances|3|||
130591852|NCT04375761|470126235|FG000|Overall Study|Test too painful|1|||
130591853|NCT04375761|470126236|FG001|Overall Study|Test too painful|1|||
130591854|NCT04375761|470126235|FG000|Overall Study|Moved|0|||
130591855|NCT04375761|470126236|FG001|Overall Study|Moved|2|||
130591856|NCT04375761|470126235|FG000|Overall Study|Nonresponsive|0|||
130591857|NCT04375761|470126236|FG001|Overall Study|Nonresponsive|5|||
130591858|NCT03797001|470126237|FG000|Overall Study|Withdrawn due to COVID19|4|||
130591859|NCT03797001|470126238|FG001|Overall Study|Withdrawn due to COVID19|0|||
130591860|NCT03797001|470126237|FG000|Overall Study|Withdrawal by Subject|7|||
130591861|NCT03797001|470126238|FG001|Overall Study|Withdrawal by Subject|6|||
130591862|NCT03797001|470126237|FG000|Overall Study|Adverse Event|0|||
130591863|NCT03797001|470126238|FG001|Overall Study|Adverse Event|1|||
130591864|NCT05630846|470126241|FG000|Overall Study|Death|1|||
130591865|NCT05630846|470126242|FG001|Overall Study|Death|0|||
130591866|NCT05630846|470126243|FG002|Overall Study|Death|0|||
130591867|NCT05630846|470126244|FG003|Overall Study|Death|0|||
130591868|NCT05630846|470126241|FG000|Overall Study|Withdrawal by Subject|3|||
130591869|NCT05630846|470126242|FG001|Overall Study|Withdrawal by Subject|3|||
130591870|NCT05630846|470126243|FG002|Overall Study|Withdrawal by Subject|4|||
130591871|NCT05630846|470126244|FG003|Overall Study|Withdrawal by Subject|1|||
130591872|NCT05630846|470126241|FG000|Overall Study|Lost to Follow-up|6|||
130591873|NCT05630846|470126242|FG001|Overall Study|Lost to Follow-up|5|||
130591874|NCT05630846|470126243|FG002|Overall Study|Lost to Follow-up|2|||
130591875|NCT05630846|470126244|FG003|Overall Study|Lost to Follow-up|5|||
130591876|NCT05630846|470126241|FG000|Overall Study|Other|1|||
130591877|NCT05630846|470126242|FG001|Overall Study|Other|0|||
130591878|NCT05630846|470126243|FG002|Overall Study|Other|0|||
130591879|NCT05630846|470126244|FG003|Overall Study|Other|0|||
130591880|NCT05556616|470126245|FG000|Overall Study|Withdrawal by Subject|1|||
130591881|NCT05556616|470126246|FG001|Overall Study|Withdrawal by Subject|0|||
130591882|NCT05556616|470126247|FG002|Overall Study|Withdrawal by Subject|0|||
130591883|NCT05556616|470126248|FG003|Overall Study|Withdrawal by Subject|0|||
130591884|NCT05556616|470126249|FG004|Overall Study|Withdrawal by Subject|0|||
130591885|NCT05556616|470126250|FG005|Overall Study|Withdrawal by Subject|0|||
130591886|NCT05556616|470126251|FG006|Overall Study|Withdrawal by Subject|0|||
130591887|NCT05556616|470126245|FG000|Overall Study|Death|0|||
130591888|NCT05556616|470126246|FG001|Overall Study|Death|0|||
130591889|NCT05556616|470126247|FG002|Overall Study|Death|2|||
130591890|NCT05556616|470126248|FG003|Overall Study|Death|1|||
130591891|NCT05556616|470126249|FG004|Overall Study|Death|0|||
130591892|NCT05556616|470126250|FG005|Overall Study|Death|0|||
130591893|NCT05556616|470126251|FG006|Overall Study|Death|0|||
130591894|NCT05556616|470126245|FG000|Overall Study|Study Terminated by Sponsor|0|||
130591895|NCT05556616|470126246|FG001|Overall Study|Study Terminated by Sponsor|3|||
130591896|NCT05556616|470126247|FG002|Overall Study|Study Terminated by Sponsor|0|||
130591897|NCT05556616|470126248|FG003|Overall Study|Study Terminated by Sponsor|0|||
130591898|NCT05556616|470126249|FG004|Overall Study|Study Terminated by Sponsor|0|||
130591899|NCT05556616|470126250|FG005|Overall Study|Study Terminated by Sponsor|0|||
130591900|NCT05556616|470126251|FG006|Overall Study|Study Terminated by Sponsor|0|||
130591901|NCT00075881|470126254|FG000|Overall Study|Lack of Efficacy|18|||
130591902|NCT00075881|470126254|FG000|Overall Study|Adverse Event|7|||
130591903|NCT00075881|470126254|FG000|Overall Study|Death|1|||
130591904|NCT00075881|470126254|FG000|Overall Study|Withdrawal by Subject|2|||
130591905|NCT00075881|470126254|FG000|Overall Study|Protocol Violation|4|||
130591906|NCT00075881|470126254|FG000|Overall Study|other complicating disease|3|||
130591907|NCT00075881|470126254|FG000|Overall Study|other|4|||
130591908|NCT00075881|470126254|FG000|Overall Study|missing data|2|||
130591909|NCT00075881|470126254|FG000|Overall Study|Ineligible|1|||
130591910|NCT00075881|470126254|FG000|Overall Study|never start protocol therapy|1|||
130591911|NCT02031679|470126255|FG000|Overall Study|Protocol Violation|0|||
130591912|NCT02031679|470126256|FG001|Overall Study|Protocol Violation|1|||
130591913|NCT02031679|470126255|FG000|Overall Study|Lack of Efficacy|0|||
130591914|NCT02031679|470126256|FG001|Overall Study|Lack of Efficacy|1|||
130591915|NCT04030195|470126257|FG000|Overall Study|Withdrawal by Subject|2|||
130591916|NCT04030195|470126258|FG001|Overall Study|Withdrawal by Subject|0|||
130591917|NCT04030195|470126259|FG002|Overall Study|Withdrawal by Subject|0|||
130591918|NCT02251743|470126261|FG000|Overall Study|Withdrawal by Subject|1|||
130591919|NCT02251743|470126262|FG001|Overall Study|Withdrawal by Subject|1|||
130591920|NCT00215150|470126263|FG000|Open Label Phase|Lost to Follow-up|7|||
130591921|NCT00215150|470126263|FG000|Open Label Phase|Withdrawal by Subject|1|||
130591922|NCT00215150|470126263|FG000|Open Label Phase|Did not complete a post base visit|13|||
130591923|NCT00215150|470126263|FG000|Open Label Phase|Did not meet randomization criteria|9|||
130591924|NCT00215150|470126263|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
130591925|NCT00215150|470126263|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
130591926|NCT00215150|470126263|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
130591927|NCT01028352|470126268|FG000|Overall Study|Ineligible due to baseline average pain|5|||
130591928|NCT01028352|470126268|FG000|Overall Study|Withdrawal by Subject|1|||
130591929|NCT00260208|470126270|FG000|Overall Study|Subject withdrew consent|11|||
130591930|NCT00260208|470126271|FG001|Overall Study|Subject withdrew consent|7|||
130591931|NCT00260208|470126270|FG000|Overall Study|Lost to Follow-up|6|||
130591932|NCT00260208|470126271|FG001|Overall Study|Lost to Follow-up|1|||
130591933|NCT00260208|470126270|FG000|Overall Study|Death|12|||
130591934|NCT00260208|470126271|FG001|Overall Study|Death|10|||
130591935|NCT00260208|470126270|FG000|Overall Study|Missing|18|||
130591936|NCT00260208|470126271|FG001|Overall Study|Missing|16|||
130591937|NCT03095703|470126278|FG000|Overall Study|Withdrawal by Subject|1|||
130591938|NCT02665689|470126292|FG000|Overall Study|Adverse Event|1|||
130591939|NCT02665689|470126293|FG001|Overall Study|Adverse Event|0|||
130591940|NCT02665689|470126292|FG000|Overall Study|Trial termination|1|||
130591941|NCT02665689|470126293|FG001|Overall Study|Trial termination|1|||
130591942|NCT02665689|470126292|FG000|Overall Study|Lost to Follow-up|0|||
130591943|NCT02665689|470126293|FG001|Overall Study|Lost to Follow-up|1|||
130591944|NCT00824564|470126294|FG000|Overall Study|Lost to Follow-up|5|||
130591945|NCT00824564|470126295|FG001|Overall Study|Lost to Follow-up|7|||
130591946|NCT00824564|470126294|FG000|Overall Study|Withdrawal by Subject|1|||
130591947|NCT00824564|470126295|FG001|Overall Study|Withdrawal by Subject|1|||
130591948|NCT00824564|470126294|FG000|Overall Study|Other|1|||
130591949|NCT00824564|470126295|FG001|Overall Study|Other|2|||
130591950|NCT00824564|470126294|FG000|Overall Study|Randomized, but not treated|1|||
130591951|NCT00824564|470126295|FG001|Overall Study|Randomized, but not treated|0|||
130591952|NCT00486902|470126296|FG000|Overall Study|Withdrawal by Subject|1|||
130591953|NCT00486902|470126297|FG001|Overall Study|Withdrawal by Subject|2|||
130591954|NCT00486902|470126296|FG000|Overall Study|decision for postpartum tubal ligation|3|||
130591955|NCT00486902|470126297|FG001|Overall Study|decision for postpartum tubal ligation|1|||
130591956|NCT00486902|470126296|FG000|Overall Study|spinal anesthetic protocal violation|1|||
130591957|NCT00486902|470126297|FG001|Overall Study|spinal anesthetic protocal violation|1|||
130591958|NCT00486902|470126296|FG000|Overall Study|Did not meet inclusion criteria|1|||
130591959|NCT00486902|470126297|FG001|Overall Study|Did not meet inclusion criteria|0|||
130591960|NCT00486902|470126296|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
130591961|NCT00486902|470126297|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
130591962|NCT01552057|470126308|FG000|Overall Study|Adverse Event|14|||
130591963|NCT01552057|470126309|FG001|Overall Study|Adverse Event|15|||
130591964|NCT01552057|470126308|FG000|Overall Study|Lack of Efficacy|8|||
130591965|NCT01552057|470126309|FG001|Overall Study|Lack of Efficacy|23|||
130591966|NCT01552057|470126308|FG000|Overall Study|Withdrawal by Subject|5|||
130591967|NCT01552057|470126309|FG001|Overall Study|Withdrawal by Subject|8|||
130591968|NCT01552057|470126308|FG000|Overall Study|Entry Criteria Not Met|2|||
130591969|NCT01552057|470126309|FG001|Overall Study|Entry Criteria Not Met|2|||
130591970|NCT01552057|470126308|FG000|Overall Study|Physician Decision|1|||
130591971|NCT01552057|470126309|FG001|Overall Study|Physician Decision|0|||
130591972|NCT00476086|470126310|FG000|Overall Study|Alternative therapy|1|||
130591973|NCT00476086|470126310|FG000|Overall Study|Progressive Disease|4|||
130591974|NCT02900092|470126311|FG000|Overall Study|Adverse Event|1|||
130591975|NCT05817045|470126327|FG000|Overall Study|Protocol Violation|0|||
130591976|NCT05817045|470126328|FG001|Overall Study|Protocol Violation|3|||
130591977|NCT05817045|470126327|FG000|Overall Study|Withdrawal by Subject|10|||
130591978|NCT05817045|470126328|FG001|Overall Study|Withdrawal by Subject|7|||
130591979|NCT05817045|470126327|FG000|Overall Study|Physician Decision|3|||
130591980|NCT05817045|470126328|FG001|Overall Study|Physician Decision|0|||
130591981|NCT05817045|470126327|FG000|Overall Study|Lost to Follow-up|0|||
130591982|NCT05817045|470126328|FG001|Overall Study|Lost to Follow-up|1|||
130591983|NCT05817045|470126327|FG000|Overall Study|Device Deficiency|1|||
130591984|NCT05817045|470126328|FG001|Overall Study|Device Deficiency|0|||
130591985|NCT05817045|470126327|FG000|Overall Study|System Error|1|||
130591986|NCT05817045|470126328|FG001|Overall Study|System Error|0|||
130591987|NCT04889209|470126329|FG000|All Cohorts Except 15E|Adverse Event|0|||
130591988|NCT04889209|470126330|FG001|All Cohorts Except 15E|Adverse Event|0|||
130591989|NCT04889209|470126331|FG002|All Cohorts Except 15E|Adverse Event|0|||
130591990|NCT04889209|470126332|FG003|All Cohorts Except 15E|Adverse Event|0|||
130591991|NCT04889209|470126333|FG004|All Cohorts Except 15E|Adverse Event|0|||
130591992|NCT04889209|470126334|FG005|All Cohorts Except 15E|Adverse Event|0|||
130591993|NCT04889209|470126335|FG006|All Cohorts Except 15E|Adverse Event|1|||
130591994|NCT04889209|470126336|FG007|All Cohorts Except 15E|Adverse Event|0|||
130591995|NCT04889209|470126337|FG008|All Cohorts Except 15E|Adverse Event|0|||
130591996|NCT04889209|470126338|FG009|All Cohorts Except 15E|Adverse Event|0|||
130591997|NCT04889209|470126339|FG010|All Cohorts Except 15E|Adverse Event|0|||
130591998|NCT04889209|470126340|FG011|All Cohorts Except 15E|Adverse Event|0|||
130591999|NCT04889209|470126341|FG012|All Cohorts Except 15E|Adverse Event|0|||
130592000|NCT04889209|470126342|FG013|All Cohorts Except 15E|Adverse Event|0|||
130592001|NCT04889209|470126343|FG014|All Cohorts Except 15E|Adverse Event|0|||
130592002|NCT04889209|470126344|FG015|All Cohorts Except 15E|Adverse Event|0|||
130592003|NCT04889209|470126345|FG016|All Cohorts Except 15E|Adverse Event|0|||
130592004|NCT04889209|470126346|FG017|All Cohorts Except 15E|Adverse Event|0|||
130592005|NCT04889209|470126329|FG000|All Cohorts Except 15E|Death|0|||
130592006|NCT04889209|470126330|FG001|All Cohorts Except 15E|Death|1|||
130592007|NCT04889209|470126331|FG002|All Cohorts Except 15E|Death|0|||
130592008|NCT04889209|470126332|FG003|All Cohorts Except 15E|Death|0|||
130592009|NCT04889209|470126333|FG004|All Cohorts Except 15E|Death|0|||
130592010|NCT04889209|470126334|FG005|All Cohorts Except 15E|Death|0|||
130592011|NCT04889209|470126335|FG006|All Cohorts Except 15E|Death|0|||
130592012|NCT04889209|470126336|FG007|All Cohorts Except 15E|Death|0|||
130592013|NCT04889209|470126337|FG008|All Cohorts Except 15E|Death|0|||
130592014|NCT04889209|470126338|FG009|All Cohorts Except 15E|Death|0|||
130592015|NCT04889209|470126339|FG010|All Cohorts Except 15E|Death|0|||
130592016|NCT04889209|470126340|FG011|All Cohorts Except 15E|Death|0|||
130592017|NCT04889209|470126341|FG012|All Cohorts Except 15E|Death|0|||
130592018|NCT04889209|470126342|FG013|All Cohorts Except 15E|Death|0|||
130592019|NCT04889209|470126343|FG014|All Cohorts Except 15E|Death|0|||
130592020|NCT04889209|470126344|FG015|All Cohorts Except 15E|Death|0|||
130592021|NCT04889209|470126345|FG016|All Cohorts Except 15E|Death|0|||
130592022|NCT04889209|470126346|FG017|All Cohorts Except 15E|Death|0|||
130592023|NCT04889209|470126329|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
130592024|NCT04889209|470126330|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
130592025|NCT04889209|470126331|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
130592026|NCT04889209|470126332|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
130592027|NCT04889209|470126333|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
130592028|NCT04889209|470126334|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
130592029|NCT04889209|470126335|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
130592030|NCT04889209|470126336|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
130592031|NCT04889209|470126337|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
130592032|NCT04889209|470126338|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
130592033|NCT04889209|470126339|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
130592034|NCT04889209|470126340|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
130592035|NCT04889209|470126341|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
130592036|NCT04889209|470126342|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
130592037|NCT04889209|470126343|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
130592038|NCT04889209|470126344|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
130592039|NCT04889209|470126345|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
130592040|NCT04889209|470126346|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
130592041|NCT04889209|470126329|FG000|All Cohorts Except 15E|Physician Decision|0|||
130592042|NCT04889209|470126330|FG001|All Cohorts Except 15E|Physician Decision|0|||
130592043|NCT04889209|470126331|FG002|All Cohorts Except 15E|Physician Decision|0|||
130592044|NCT04889209|470126332|FG003|All Cohorts Except 15E|Physician Decision|0|||
130592045|NCT04889209|470126333|FG004|All Cohorts Except 15E|Physician Decision|1|||
130592046|NCT04889209|470126334|FG005|All Cohorts Except 15E|Physician Decision|0|||
130592047|NCT04889209|470126335|FG006|All Cohorts Except 15E|Physician Decision|0|||
130592048|NCT04889209|470126336|FG007|All Cohorts Except 15E|Physician Decision|1|||
130592049|NCT04889209|470126337|FG008|All Cohorts Except 15E|Physician Decision|0|||
130592050|NCT04889209|470126338|FG009|All Cohorts Except 15E|Physician Decision|1|||
130592051|NCT04889209|470126339|FG010|All Cohorts Except 15E|Physician Decision|0|||
130592052|NCT04889209|470126340|FG011|All Cohorts Except 15E|Physician Decision|1|||
130592053|NCT04889209|470126341|FG012|All Cohorts Except 15E|Physician Decision|1|||
130592054|NCT04889209|470126342|FG013|All Cohorts Except 15E|Physician Decision|0|||
130592055|NCT04889209|470126343|FG014|All Cohorts Except 15E|Physician Decision|0|||
130592056|NCT04889209|470126344|FG015|All Cohorts Except 15E|Physician Decision|0|||
130592057|NCT04889209|470126345|FG016|All Cohorts Except 15E|Physician Decision|0|||
130592058|NCT04889209|470126346|FG017|All Cohorts Except 15E|Physician Decision|0|||
130592059|NCT04889209|470126329|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
130592060|NCT04889209|470126330|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
130592061|NCT04889209|470126331|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
130592062|NCT04889209|470126332|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
130592063|NCT04889209|470126333|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
130592064|NCT04889209|470126334|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592065|NCT04889209|470126335|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592066|NCT04889209|470126336|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
130592067|NCT04889209|470126337|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592068|NCT04889209|470126338|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592069|NCT04889209|470126339|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592070|NCT04889209|470126340|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592071|NCT04889209|470126341|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592072|NCT04889209|470126342|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
130592073|NCT04889209|470126343|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
130592074|NCT04889209|470126344|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
130592075|NCT04889209|470126345|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
130592076|NCT04889209|470126346|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
130592077|NCT04889209|470126329|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
130592078|NCT04889209|470126330|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
130592079|NCT04889209|470126331|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592080|NCT04889209|470126332|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592081|NCT04889209|470126333|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592082|NCT04889209|470126334|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130592083|NCT04889209|470126335|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592084|NCT04889209|470126336|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130592085|NCT04889209|470126337|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592086|NCT04889209|470126338|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130592087|NCT04889209|470126339|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592088|NCT04889209|470126340|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592089|NCT04889209|470126341|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592090|NCT04889209|470126342|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592091|NCT04889209|470126343|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592092|NCT04889209|470126344|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592093|NCT04889209|470126345|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130592094|NCT04889209|470126346|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130592095|NCT04889209|470126329|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592096|NCT04889209|470126330|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592097|NCT04889209|470126331|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592098|NCT04889209|470126332|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
130592099|NCT04889209|470126333|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592100|NCT04889209|470126334|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592101|NCT04889209|470126335|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592102|NCT04889209|470126336|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592103|NCT04889209|470126337|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592104|NCT04889209|470126338|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592105|NCT04889209|470126339|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592106|NCT04889209|470126340|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592107|NCT04889209|470126341|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592108|NCT04889209|470126342|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592109|NCT04889209|470126343|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592110|NCT04889209|470126344|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592111|NCT04889209|470126345|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592112|NCT04889209|470126346|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130592113|NCT04889209|470126329|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592114|NCT04889209|470126330|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592115|NCT04889209|470126331|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592116|NCT04889209|470126332|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592117|NCT04889209|470126333|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592118|NCT04889209|470126334|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592119|NCT04889209|470126335|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592120|NCT04889209|470126336|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592121|NCT04889209|470126337|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592122|NCT04889209|470126338|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592123|NCT04889209|470126339|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592124|NCT04889209|470126340|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592125|NCT04889209|470126341|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592126|NCT04889209|470126342|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592127|NCT04889209|470126343|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592128|NCT04889209|470126344|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592129|NCT04889209|470126345|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130592130|NCT04889209|470126346|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130592131|NCT04889209|470126329|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592132|NCT04889209|470126330|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592133|NCT04889209|470126331|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592134|NCT04889209|470126332|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592135|NCT04889209|470126333|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592136|NCT04889209|470126334|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592137|NCT04889209|470126335|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592138|NCT04889209|470126336|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592139|NCT04889209|470126337|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592140|NCT04889209|470126338|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592141|NCT04889209|470126339|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592142|NCT04889209|470126340|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592143|NCT04889209|470126341|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592144|NCT04889209|470126342|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592145|NCT04889209|470126343|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592146|NCT04889209|470126344|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592147|NCT04889209|470126345|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130592148|NCT04889209|470126346|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
130592149|NCT04889209|470126329|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592150|NCT04889209|470126330|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592151|NCT04889209|470126331|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592152|NCT04889209|470126332|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592153|NCT04889209|470126333|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592154|NCT04889209|470126334|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592155|NCT04889209|470126335|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592156|NCT04889209|470126336|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592157|NCT04889209|470126337|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592158|NCT04889209|470126338|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592159|NCT04889209|470126339|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592160|NCT04889209|470126340|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592161|NCT04889209|470126341|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592162|NCT04889209|470126342|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592163|NCT04889209|470126343|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592164|NCT04889209|470126344|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592165|NCT04889209|470126345|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130592166|NCT04889209|470126346|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
130592167|NCT04889209|470126329|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592168|NCT04889209|470126330|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592169|NCT04889209|470126331|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592170|NCT04889209|470126332|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592171|NCT04889209|470126333|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592172|NCT04889209|470126334|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592173|NCT04889209|470126335|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592174|NCT04889209|470126336|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592175|NCT04889209|470126337|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592176|NCT04889209|470126338|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592177|NCT04889209|470126339|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592178|NCT04889209|470126340|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592179|NCT04889209|470126341|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592180|NCT04889209|470126342|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592181|NCT04889209|470126343|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
130592182|NCT04889209|470126344|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592183|NCT04889209|470126345|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592184|NCT04889209|470126346|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130592185|NCT01725165|470126351|FG000|Overall Study|Death|11|||
130592186|NCT01725165|470126352|FG001|Overall Study|Death|18|||
130592187|NCT02688647|470126355|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
130592188|NCT02688647|470126356|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
130592189|NCT02688647|470126355|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
130592190|NCT02688647|470126356|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
130592191|NCT02688647|470126355|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
130592192|NCT02688647|470126356|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
130592193|NCT02688647|470126355|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
130592194|NCT02688647|470126356|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
130592195|NCT02688647|470126355|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
130592196|NCT02688647|470126356|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
130592197|NCT02688647|470126355|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
130592198|NCT02688647|470126356|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
130592199|NCT02688647|470126355|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
130592200|NCT02688647|470126356|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
130592201|NCT00382967|470126357|FG000|Overall Study|Protocol Violation|1|||
130592202|NCT00382967|470126358|FG001|Overall Study|Protocol Violation|1|||
130592203|NCT00474240|470126359|FG000|Overall Study|Withdrawal by Subject|1|||
130592204|NCT00474240|470126360|FG001|Overall Study|Withdrawal by Subject|1|||
130592205|NCT00474240|470126361|FG002|Overall Study|Withdrawal by Subject|0|||
130592206|NCT00474240|470126362|FG003|Overall Study|Withdrawal by Subject|2|||
130592207|NCT00474240|470126363|FG004|Overall Study|Withdrawal by Subject|3|||
130592208|NCT00474240|470126364|FG005|Overall Study|Withdrawal by Subject|1|||
130592209|NCT00474240|470126359|FG000|Overall Study|Adverse Event|0|||
130592210|NCT00474240|470126360|FG001|Overall Study|Adverse Event|0|||
130592211|NCT00474240|470126361|FG002|Overall Study|Adverse Event|9|||
130592212|NCT00474240|470126362|FG003|Overall Study|Adverse Event|14|||
130592213|NCT00474240|470126363|FG004|Overall Study|Adverse Event|5|||
130592214|NCT00474240|470126364|FG005|Overall Study|Adverse Event|16|||
130592215|NCT00474240|470126359|FG000|Overall Study|Removed due to lab value|0|||
130592216|NCT00474240|470126360|FG001|Overall Study|Removed due to lab value|0|||
130592217|NCT00474240|470126361|FG002|Overall Study|Removed due to lab value|0|||
130592218|NCT00474240|470126362|FG003|Overall Study|Removed due to lab value|0|||
130592219|NCT00474240|470126363|FG004|Overall Study|Removed due to lab value|0|||
130592220|NCT00474240|470126364|FG005|Overall Study|Removed due to lab value|1|||
130592221|NCT04026568|470126370|FG000|Overall Study|study terminated|0|||
130592222|NCT04026568|470126371|FG001|Overall Study|study terminated|1|||
130592223|NCT02197377|470126372|FG000|Overall Study|Insertion Failure|0|||
130592224|NCT02197377|470126373|FG001|Overall Study|Insertion Failure|3|||
130592225|NCT01773473|470126374|FG000|Overall Study|Adverse Event|3|||
130592226|NCT01773473|470126375|FG001|Overall Study|Adverse Event|2|||
130592227|NCT01773473|470126374|FG000|Overall Study|Protocol Violation|0|||
130592228|NCT01773473|470126375|FG001|Overall Study|Protocol Violation|4|||
130592229|NCT01773473|470126374|FG000|Overall Study|Physician Decision|3|||
130592230|NCT01773473|470126375|FG001|Overall Study|Physician Decision|5|||
130592231|NCT01773473|470126374|FG000|Overall Study|Sponsor Decision|2|||
130592232|NCT01773473|470126375|FG001|Overall Study|Sponsor Decision|0|||
130592233|NCT01773473|470126374|FG000|Overall Study|Lack of Efficacy|0|||
130592234|NCT01773473|470126375|FG001|Overall Study|Lack of Efficacy|1|||
130592235|NCT01773473|470126374|FG000|Overall Study|Non-Compliance with study drug|1|||
130592236|NCT01773473|470126375|FG001|Overall Study|Non-Compliance with study drug|4|||
130592237|NCT01773473|470126374|FG000|Overall Study|Withdrawal by Subject|5|||
130592238|NCT01773473|470126375|FG001|Overall Study|Withdrawal by Subject|3|||
130592239|NCT01773473|470126374|FG000|Overall Study|Lost to Follow-up|2|||
130592240|NCT01773473|470126375|FG001|Overall Study|Lost to Follow-up|0|||
130592241|NCT02561156|470126376|FG000|Part 2|Adverse Event|0|||
130592242|NCT02561156|470126377|FG001|Part 2|Adverse Event|0|||
130592243|NCT02561156|470126378|FG002|Part 2|Adverse Event|0|||
130592244|NCT02561156|470126379|FG003|Part 2|Adverse Event|0|||
130592245|NCT02561156|470126380|FG004|Part 2|Adverse Event|0|||
130592246|NCT02561156|470126381|FG005|Part 2|Adverse Event|0|||
130592247|NCT02561156|470126382|FG006|Part 2|Adverse Event|0|||
130592248|NCT02561156|470126383|FG007|Part 2|Adverse Event|0|||
130592249|NCT02561156|470126384|FG008|Part 2|Adverse Event|0|||
130592250|NCT02561156|470126385|FG009|Part 2|Adverse Event|0|||
130592251|NCT02561156|470126386|FG010|Part 2|Adverse Event|0|||
130592252|NCT02561156|470126387|FG011|Part 2|Adverse Event|1|||
130592253|NCT02561156|470126388|FG012|Part 2|Adverse Event|0|||
130592254|NCT01071070|470126392|FG000|Overall Study|Adverse Event|0|||
130592255|NCT01071070|470126393|FG001|Overall Study|Adverse Event|3|||
130592256|NCT01071070|470126392|FG000|Overall Study|Withdrawal by Subject|1|||
130592257|NCT01071070|470126393|FG001|Overall Study|Withdrawal by Subject|0|||
130592258|NCT01071070|470126392|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
130592259|NCT01071070|470126393|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
130592260|NCT01071070|470126392|FG000|Overall Study|Hypercalcemia|1|||
130592261|NCT01071070|470126393|FG001|Overall Study|Hypercalcemia|0|||
130592262|NCT02203149|470126396|FG000|Part 1|Adverse Event|0|||
130592263|NCT02203149|470126397|FG001|Part 1|Adverse Event|1|||
130592264|NCT02203149|470126398|FG002|Part 1|Adverse Event|0|||
130592265|NCT02203149|470126399|FG003|Part 1|Adverse Event|0|||
130592266|NCT02203149|470126400|FG004|Part 1|Adverse Event|0|||
130592267|NCT02203149|470126396|FG000|Part 2|Death|0|||
130592268|NCT02203149|470126397|FG001|Part 2|Death|0|||
130592269|NCT02203149|470126398|FG002|Part 2|Death|1|||
130592270|NCT02203149|470126399|FG003|Part 2|Death|1|||
130592271|NCT02203149|470126400|FG004|Part 2|Death|0|||
130592272|NCT02203149|470126396|FG000|Part 2|Withdrawal by Subject|0|||
130592273|NCT02203149|470126397|FG001|Part 2|Withdrawal by Subject|0|||
130592274|NCT02203149|470126398|FG002|Part 2|Withdrawal by Subject|0|||
130592275|NCT02203149|470126399|FG003|Part 2|Withdrawal by Subject|1|||
130592276|NCT02203149|470126400|FG004|Part 2|Withdrawal by Subject|0|||
130592277|NCT02203149|470126396|FG000|Part 2|Adverse Event|0|||
130592278|NCT02203149|470126397|FG001|Part 2|Adverse Event|0|||
130592279|NCT02203149|470126398|FG002|Part 2|Adverse Event|0|||
130592280|NCT02203149|470126399|FG003|Part 2|Adverse Event|1|||
130592281|NCT02203149|470126400|FG004|Part 2|Adverse Event|1|||
130592282|NCT01454076|470126402|FG000|Overall Study|Other|2|||
130592283|NCT01454076|470126403|FG001|Overall Study|Other|0|||
130592284|NCT01454076|470126404|FG002|Overall Study|Other|0|||
130592285|NCT01454076|470126405|FG003|Overall Study|Other|1|||
130592286|NCT01454076|470126406|FG004|Overall Study|Other|2|||
130592287|NCT01454076|470126402|FG000|Overall Study|Withdrawal by Subject|3|||
130592288|NCT01454076|470126403|FG001|Overall Study|Withdrawal by Subject|4|||
130592289|NCT01454076|470126404|FG002|Overall Study|Withdrawal by Subject|2|||
130592290|NCT01454076|470126405|FG003|Overall Study|Withdrawal by Subject|1|||
130592291|NCT01454076|470126406|FG004|Overall Study|Withdrawal by Subject|2|||
130592292|NCT01454076|470126402|FG000|Overall Study|Adverse Event|8|||
130592293|NCT01454076|470126403|FG001|Overall Study|Adverse Event|2|||
130592294|NCT01454076|470126404|FG002|Overall Study|Adverse Event|7|||
130592295|NCT01454076|470126405|FG003|Overall Study|Adverse Event|0|||
130592296|NCT01454076|470126406|FG004|Overall Study|Adverse Event|2|||
130592297|NCT01478958|470126407|FG000|Overall Study|Withdrawal by Subject|1|||
130592298|NCT01478958|470126408|FG001|Overall Study|Withdrawal by Subject|1|||
130592299|NCT01478958|470126409|FG002|Overall Study|Withdrawal by Subject|1|||
130592300|NCT01478958|470126407|FG000|Overall Study|Weight loss|1|||
130592301|NCT01478958|470126408|FG001|Overall Study|Weight loss|0|||
130592302|NCT01478958|470126409|FG002|Overall Study|Weight loss|0|||
130592303|NCT01478958|470126407|FG000|Overall Study|Re-located|0|||
130592304|NCT01478958|470126408|FG001|Overall Study|Re-located|1|||
130592305|NCT01478958|470126409|FG002|Overall Study|Re-located|0|||
130592306|NCT01478958|470126407|FG000|Overall Study|Unable to comply|0|||
130592307|NCT01478958|470126408|FG001|Overall Study|Unable to comply|0|||
130592308|NCT01478958|470126409|FG002|Overall Study|Unable to comply|2|||
130592309|NCT04373460|470126418|FG000|Overall Study|Did not receive tranfusion|18|||
130592310|NCT04373460|470126419|FG001|Overall Study|Did not receive tranfusion|26|||
130592311|NCT00642642|470126420|FG000|Treatment & Follow Up|Adverse Event|2|||
130592312|NCT00642642|470126420|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
130592313|NCT00642642|470126420|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
130592314|NCT02337387|470126423|FG000|Overall Study|Adverse Event|0|||
130592315|NCT02337387|470126424|FG001|Overall Study|Adverse Event|1|||
130592316|NCT02337387|470126425|FG002|Overall Study|Adverse Event|0|||
130592317|NCT02337387|470126426|FG003|Overall Study|Adverse Event|0|||
130592318|NCT02337387|470126423|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
130592319|NCT02337387|470126424|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
130592320|NCT02337387|470126425|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
130592321|NCT02337387|470126426|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
130592322|NCT01856114|470126427|FG000|Overall Study|Withdrawal by Subject|1|||
130592323|NCT01856114|470126428|FG001|Overall Study|Withdrawal by Subject|0|||
130592324|NCT01856114|470126427|FG000|Overall Study|Adverse Event|1|||
130592325|NCT01856114|470126428|FG001|Overall Study|Adverse Event|0|||
130592326|NCT02272790|470126429|FG000|Overall Study|Physician Decision|0|||
130592327|NCT02272790|470126430|FG001|Overall Study|Physician Decision|1|||
130592328|NCT02272790|470126431|FG002|Overall Study|Physician Decision|0|||
130592329|NCT02272790|470126432|FG003|Overall Study|Physician Decision|0|||
130592330|NCT02272790|470126433|FG004|Overall Study|Physician Decision|0|||
130592331|NCT02272790|470126434|FG005|Overall Study|Physician Decision|0|||
130592332|NCT00332202|470126435|FG000|Overall Study|Adverse Event|72|||
130592333|NCT00332202|470126436|FG001|Overall Study|Adverse Event|28|||
130592334|NCT00332202|470126435|FG000|Overall Study|Lost to Follow-up|2|||
130592335|NCT00332202|470126436|FG001|Overall Study|Lost to Follow-up|1|||
130592336|NCT00332202|470126435|FG000|Overall Study|Physician Decision|6|||
130592337|NCT00332202|470126436|FG001|Overall Study|Physician Decision|8|||
130592338|NCT00332202|470126435|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
130592339|NCT00332202|470126436|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
130592340|NCT00332202|470126435|FG000|Overall Study|Protocol Violation|7|||
130592341|NCT00332202|470126436|FG001|Overall Study|Protocol Violation|2|||
130592342|NCT00332202|470126435|FG000|Overall Study|Sponsor Decision|1|||
130592343|NCT00332202|470126436|FG001|Overall Study|Sponsor Decision|2|||
130592344|NCT00332202|470126435|FG000|Overall Study|Withdrawal by Subject|36|||
130592345|NCT00332202|470126436|FG001|Overall Study|Withdrawal by Subject|17|||
130592346|NCT00332202|470126435|FG000|Overall Study|Progressive Disease|106|||
130592347|NCT00332202|470126436|FG001|Overall Study|Progressive Disease|60|||
130592348|NCT00332202|470126435|FG000|Overall Study|Death|5|||
130592349|NCT00332202|470126436|FG001|Overall Study|Death|2|||
130592350|NCT01237951|470126442|FG000|Overall Study|Death|1|||
130592351|NCT00275561|470126444|FG000|Overall Study|Withdrawal by Subject|0|||
130592352|NCT00275561|470126445|FG001|Overall Study|Withdrawal by Subject|1|||
130592353|NCT00275561|470126444|FG000|Overall Study|Travel|1|||
130592354|NCT00275561|470126445|FG001|Overall Study|Travel|1|||
130592355|NCT00275561|470126444|FG000|Overall Study|Scheduling|1|||
130592356|NCT00275561|470126445|FG001|Overall Study|Scheduling|2|||
130592357|NCT00275561|470126444|FG000|Overall Study|Family Issues|0|||
130592358|NCT00275561|470126445|FG001|Overall Study|Family Issues|2|||
130592359|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
130592360|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
130592361|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130592362|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130592363|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130592364|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
130592365|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
130592366|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130592367|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130592368|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130592369|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
130592370|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130592371|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130592372|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130592373|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130592374|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130592375|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
130592376|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130592377|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130592378|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130592379|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
130592380|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
130592381|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130592382|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130592383|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130592384|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
130592385|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
130592386|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130592387|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130592388|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130592389|NCT02660580|470128684|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
130592390|NCT02660580|470128685|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
130592391|NCT02660580|470128686|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130592392|NCT02660580|470128687|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130592393|NCT02660580|470128688|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130592394|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130592395|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130592396|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
130592397|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130592398|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
130592399|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130592400|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130592401|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
130592402|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130592403|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
130592404|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
130592405|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
130592406|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
130592407|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
130592408|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
130592409|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
130592410|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
130592411|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
130592412|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
130592413|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
130592414|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
130592415|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
130592416|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
130592417|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
130592418|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
130592419|NCT02660580|470128684|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130592420|NCT02660580|470128685|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130592421|NCT02660580|470128686|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130592422|NCT02660580|470128687|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
130592423|NCT02660580|470128688|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
130592424|NCT00377962|470128689|FG000|Core Study: 0-12 Months|Adverse Event|18|||
130592425|NCT00377962|470128690|FG001|Core Study: 0-12 Months|Adverse Event|2|||
130592426|NCT00377962|470128689|FG000|Core Study: 0-12 Months|Death|3|||
130592427|NCT00377962|470128690|FG001|Core Study: 0-12 Months|Death|0|||
130592428|NCT00377962|470128689|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
130592429|NCT00377962|470128690|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
130592430|NCT00377962|470128689|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
130592431|NCT00377962|470128690|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
130592432|NCT00377962|470128689|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
130592433|NCT00377962|470128690|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
130592434|NCT00377962|470128689|FG000|Extension Study: 12-24 Months|Death|1|||
130592435|NCT00377962|470128690|FG001|Extension Study: 12-24 Months|Death|1|||
130592436|NCT00377962|470128689|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
130592437|NCT00377962|470128690|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
130592438|NCT00377962|470128689|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
130592439|NCT00377962|470128690|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
130592440|NCT00377962|470128689|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
130592441|NCT00377962|470128690|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
130592442|NCT00742781|470128691|FG000|Overall Study|Withdrawal by Subject|3|||
130592443|NCT03539432|470128692|FG000|Overall Study|Lost to Follow-up|0|||
130592444|NCT03539432|470128693|FG001|Overall Study|Lost to Follow-up|1|||
130592445|NCT02443402|470128694|FG000|Overall Study|Withdrawal by Subject|3|||
130592446|NCT02443402|470128695|FG001|Overall Study|Withdrawal by Subject|1|||
130592447|NCT02443402|470128694|FG000|Overall Study|Screen Failure|1|||
130592448|NCT02443402|470128695|FG001|Overall Study|Screen Failure|2|||
130592449|NCT04178590|470128698|FG000|Overall Study|Pregnancy|1|||
130592450|NCT04178590|470128698|FG000|Overall Study|Lost to Follow-up|1|||
130592451|NCT01389245|470128699|FG000|Overall Study|Protocol Violation|10|||
130592452|NCT01389245|470128699|FG000|Overall Study|Lost to Follow-up|3|||
130592453|NCT01389245|470128699|FG000|Overall Study|Withdrawal by Subject|2|||
130592454|NCT02292849|470128700|FG000|Overall Study|Lost to Follow-up|0|||
130592455|NCT02292849|470128701|FG001|Overall Study|Lost to Follow-up|2|||
130592456|NCT02292849|470128702|FG002|Overall Study|Lost to Follow-up|2|||
130592457|NCT02292849|470128700|FG000|Overall Study|Physician Decision|4|||
130592458|NCT02292849|470128701|FG001|Overall Study|Physician Decision|0|||
130592459|NCT02292849|470128702|FG002|Overall Study|Physician Decision|0|||
130592460|NCT00364793|470128703|FG000|Overall Study|Adverse Event|2|||
130592461|NCT00364793|470128704|FG001|Overall Study|Adverse Event|0|||
130592462|NCT00364793|470128705|FG002|Overall Study|Adverse Event|0|||
130592463|NCT00364793|470128706|FG003|Overall Study|Adverse Event|0|||
130592464|NCT00364793|470128703|FG000|Overall Study|Death|1|||
130592465|NCT00364793|470128704|FG001|Overall Study|Death|0|||
130592466|NCT00364793|470128705|FG002|Overall Study|Death|1|||
130592467|NCT00364793|470128706|FG003|Overall Study|Death|0|||
130592468|NCT00364793|470128703|FG000|Overall Study|Lack of Efficacy|3|||
130592469|NCT00364793|470128704|FG001|Overall Study|Lack of Efficacy|3|||
130592470|NCT00364793|470128705|FG002|Overall Study|Lack of Efficacy|1|||
130592471|NCT00364793|470128706|FG003|Overall Study|Lack of Efficacy|1|||
130592472|NCT00364793|470128703|FG000|Overall Study|Lost to Follow-up|1|||
130592473|NCT00364793|470128704|FG001|Overall Study|Lost to Follow-up|0|||
130592474|NCT00364793|470128705|FG002|Overall Study|Lost to Follow-up|2|||
130592475|NCT00364793|470128706|FG003|Overall Study|Lost to Follow-up|0|||
130592476|NCT00364793|470128703|FG000|Overall Study|Poor or non-compliance|1|||
130592477|NCT00364793|470128704|FG001|Overall Study|Poor or non-compliance|1|||
130592478|NCT00364793|470128705|FG002|Overall Study|Poor or non-compliance|0|||
130592479|NCT00364793|470128706|FG003|Overall Study|Poor or non-compliance|1|||
130592480|NCT00364793|470128703|FG000|Overall Study|No longer meets criteria|0|||
130592481|NCT00364793|470128704|FG001|Overall Study|No longer meets criteria|0|||
130592482|NCT00364793|470128705|FG002|Overall Study|No longer meets criteria|0|||
130592483|NCT00364793|470128706|FG003|Overall Study|No longer meets criteria|1|||
130592484|NCT00364793|470128703|FG000|Overall Study|Withdrawal by Subject|0|||
130592485|NCT00364793|470128704|FG001|Overall Study|Withdrawal by Subject|1|||
130592486|NCT00364793|470128705|FG002|Overall Study|Withdrawal by Subject|0|||
130592487|NCT00364793|470128706|FG003|Overall Study|Withdrawal by Subject|0|||
130592488|NCT05127486|470128707|FG000|Overall Study|Adverse Event|2|||
130592489|NCT05127486|470128708|FG001|Overall Study|Adverse Event|4|||
130592490|NCT05127486|470128707|FG000|Overall Study|Lack of Efficacy|1|||
130592491|NCT05127486|470128708|FG001|Overall Study|Lack of Efficacy|0|||
130592492|NCT05127486|470128707|FG000|Overall Study|Pregnancy|0|||
130592493|NCT05127486|470128708|FG001|Overall Study|Pregnancy|1|||
130592494|NCT05127486|470128707|FG000|Overall Study|Physician Decision|4|||
130592495|NCT05127486|470128708|FG001|Overall Study|Physician Decision|1|||
130592496|NCT05127486|470128707|FG000|Overall Study|Withdrawal by Subject|14|||
130592497|NCT05127486|470128708|FG001|Overall Study|Withdrawal by Subject|13|||
130592498|NCT05127486|470128707|FG000|Overall Study|Lost to Follow-up|5|||
130592499|NCT05127486|470128708|FG001|Overall Study|Lost to Follow-up|8|||
130592500|NCT01287754|470128711|FG000|Overall Study|Death|2|||
130592501|NCT01287754|470128712|FG001|Overall Study|Death|12|||
130592502|NCT01287754|470128711|FG000|Overall Study|Lost to Follow-up|1|||
130592503|NCT01287754|470128712|FG001|Overall Study|Lost to Follow-up|6|||
130592504|NCT01287754|470128711|FG000|Overall Study|Protocol Violation|0|||
130592505|NCT01287754|470128712|FG001|Overall Study|Protocol Violation|3|||
130592506|NCT04971226|470128713|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130592507|NCT04971226|470128714|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130592508|NCT04971226|470128715|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
130592509|NCT04971226|470128716|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
130592510|NCT04971226|470128713|FG000|Overall Study|Adverse Event|6|||
130592511|NCT04971226|470128714|FG001|Overall Study|Adverse Event|5|||
130592512|NCT04971226|470128715|FG002|Overall Study|Adverse Event|11|||
130592513|NCT04971226|470128716|FG003|Overall Study|Adverse Event|10|||
130592514|NCT04971226|470128713|FG000|Overall Study|Progressive disease|2|||
130592515|NCT04971226|470128714|FG001|Overall Study|Progressive disease|0|||
130592516|NCT04971226|470128715|FG002|Overall Study|Progressive disease|3|||
130592517|NCT04971226|470128716|FG003|Overall Study|Progressive disease|1|||
130592518|NCT04971226|470128713|FG000|Overall Study|Protocol Deviation|1|||
130592519|NCT04971226|470128714|FG001|Overall Study|Protocol Deviation|0|||
130592520|NCT04971226|470128715|FG002|Overall Study|Protocol Deviation|1|||
130592521|NCT04971226|470128716|FG003|Overall Study|Protocol Deviation|1|||
130592522|NCT04971226|470128713|FG000|Overall Study|Subject Decision|0|||
130592523|NCT04971226|470128714|FG001|Overall Study|Subject Decision|1|||
130592524|NCT04971226|470128715|FG002|Overall Study|Subject Decision|1|||
130592525|NCT04971226|470128716|FG003|Overall Study|Subject Decision|1|||
130592526|NCT04971226|470128713|FG000|Overall Study|Pregnancy|0|||
130592527|NCT04971226|470128714|FG001|Overall Study|Pregnancy|0|||
130592528|NCT04971226|470128715|FG002|Overall Study|Pregnancy|0|||
130592529|NCT04971226|470128716|FG003|Overall Study|Pregnancy|1|||
130592530|NCT04971226|470128713|FG000|Overall Study|Participants not treated|1|||
130592531|NCT04971226|470128714|FG001|Overall Study|Participants not treated|0|||
130592532|NCT04971226|470128715|FG002|Overall Study|Participants not treated|2|||
130592533|NCT04971226|470128716|FG003|Overall Study|Participants not treated|1|||
130592534|NCT00001337|470128718|FG000|Overall Study|Switched to alternate treatment|2|||
130592535|NCT00001337|470128719|FG001|Overall Study|Switched to alternate treatment|2|||
130592536|NCT00001337|470128720|FG002|Overall Study|Switched to alternate treatment|0|||
130592537|NCT00001337|470128718|FG000|Overall Study|Refused further treatment|2|||
130592538|NCT00001337|470128719|FG001|Overall Study|Refused further treatment|1|||
130592539|NCT00001337|470128720|FG002|Overall Study|Refused further treatment|0|||
130592540|NCT00001337|470128718|FG000|Overall Study|Began other Tx|1|||
130592541|NCT00001337|470128719|FG001|Overall Study|Began other Tx|0|||
130592542|NCT00001337|470128720|FG002|Overall Study|Began other Tx|0|||
130592543|NCT00001337|470128718|FG000|Overall Study|Physician Decision|3|||
130592544|NCT00001337|470128719|FG001|Overall Study|Physician Decision|1|||
130592545|NCT00001337|470128720|FG002|Overall Study|Physician Decision|0|||
130592546|NCT00001337|470128718|FG000|Overall Study|Doesn't have NHL|0|||
130592547|NCT00001337|470128719|FG001|Overall Study|Doesn't have NHL|1|||
130592548|NCT00001337|470128720|FG002|Overall Study|Doesn't have NHL|0|||
130592549|NCT00001337|470128718|FG000|Overall Study|Non protocol tx needed|3|||
130592550|NCT00001337|470128719|FG001|Overall Study|Non protocol tx needed|1|||
130592551|NCT00001337|470128720|FG002|Overall Study|Non protocol tx needed|0|||
130592552|NCT00001337|470128718|FG000|Overall Study|Protocol change|1|||
130592553|NCT00001337|470128719|FG001|Overall Study|Protocol change|0|||
130592554|NCT00001337|470128720|FG002|Overall Study|Protocol change|0|||
130592555|NCT00001337|470128718|FG000|Overall Study|2nd primary disease|0|||
130592556|NCT00001337|470128719|FG001|Overall Study|2nd primary disease|0|||
130592557|NCT00001337|470128720|FG002|Overall Study|2nd primary disease|1|||
130592558|NCT00001337|470128718|FG000|Overall Study|Death during follow up period|9|||
130592559|NCT00001337|470128719|FG001|Overall Study|Death during follow up period|4|||
130592560|NCT00001337|470128720|FG002|Overall Study|Death during follow up period|0|||
130592561|NCT00001337|470128718|FG000|Overall Study|Death on study|19|||
130592562|NCT00001337|470128719|FG001|Overall Study|Death on study|9|||
130592563|NCT00001337|470128720|FG002|Overall Study|Death on study|0|||
130592564|NCT00001337|470128718|FG000|Overall Study|Disease progression during follow-up period|3|||
130592565|NCT00001337|470128719|FG001|Overall Study|Disease progression during follow-up period|1|||
130592566|NCT00001337|470128720|FG002|Overall Study|Disease progression during follow-up period|0|||
130592567|NCT00001337|470128718|FG000|Overall Study|Disease progression on study|33|||
130592568|NCT00001337|470128719|FG001|Overall Study|Disease progression on study|41|||
130592569|NCT00001337|470128720|FG002|Overall Study|Disease progression on study|0|||
130592570|NCT00001337|470128718|FG000|Overall Study|Lost to further follow-up|10|||
130592571|NCT00001337|470128719|FG001|Overall Study|Lost to further follow-up|6|||
130592572|NCT00001337|470128720|FG002|Overall Study|Lost to further follow-up|0|||
130592573|NCT00001337|470128718|FG000|Overall Study|2nd malignancy|1|||
130592574|NCT00001337|470128719|FG001|Overall Study|2nd malignancy|0|||
130592575|NCT00001337|470128720|FG002|Overall Study|2nd malignancy|0|||
130592576|NCT00001337|470128718|FG000|Overall Study|Treatment for second lymphoma|0|||
130592577|NCT00001337|470128719|FG001|Overall Study|Treatment for second lymphoma|1|||
130592578|NCT00001337|470128720|FG002|Overall Study|Treatment for second lymphoma|0|||
130592579|NCT00001337|470128718|FG000|Overall Study|Transfer to transplant|0|||
130592580|NCT00001337|470128719|FG001|Overall Study|Transfer to transplant|1|||
130592581|NCT00001337|470128720|FG002|Overall Study|Transfer to transplant|0|||
130592582|NCT05590377|470128723|FG000|Overall Study|Death|1|||
130592583|NCT05590377|470128724|FG001|Overall Study|Death|1|||
130592584|NCT05590377|470128725|FG002|Overall Study|Death|2|||
130592585|NCT05590377|470128726|FG003|Overall Study|Death|0|||
130592586|NCT05590377|470128727|FG004|Overall Study|Death|0|||
130592587|NCT05590377|470128723|FG000|Overall Study|Study Terminated by Sponsor|1|||
130592588|NCT05590377|470128724|FG001|Overall Study|Study Terminated by Sponsor|5|||
130592589|NCT05590377|470128725|FG002|Overall Study|Study Terminated by Sponsor|4|||
130592590|NCT05590377|470128726|FG003|Overall Study|Study Terminated by Sponsor|0|||
130592591|NCT05590377|470128727|FG004|Overall Study|Study Terminated by Sponsor|0|||
130592592|NCT05590377|470128723|FG000|Overall Study|Withdrawal by Subject|1|||
130592593|NCT05590377|470128724|FG001|Overall Study|Withdrawal by Subject|0|||
130592594|NCT05590377|470128725|FG002|Overall Study|Withdrawal by Subject|0|||
130592595|NCT05590377|470128726|FG003|Overall Study|Withdrawal by Subject|0|||
130592596|NCT05590377|470128727|FG004|Overall Study|Withdrawal by Subject|0|||
130592597|NCT00828464|470128728|FG000|Overall Study|Withdrawal by Subject|1|||
130592598|NCT02599402|470128729|FG000|Overall Study|Disease progression|153|||
130592599|NCT02599402|470128729|FG000|Overall Study|Study drug toxicity|201|||
130592600|NCT02599402|470128729|FG000|Overall Study|Death|26|||
130592601|NCT02599402|470128729|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
130592602|NCT02599402|470128729|FG000|Overall Study|Participant request to discontinue study treatment|13|||
130592603|NCT02599402|470128729|FG000|Overall Study|Participant withdrew consent|5|||
130592604|NCT02599402|470128729|FG000|Overall Study|Lost to Follow-up|1|||
130592605|NCT02599402|470128729|FG000|Overall Study|Maximum Clinical Benefit|7|||
130592606|NCT02599402|470128729|FG000|Overall Study|Poor/non-compliance|1|||
130592607|NCT02599402|470128729|FG000|Overall Study|Pregnancy|1|||
130592608|NCT02599402|470128729|FG000|Overall Study|Participant no longer met study criteria|7|||
130592609|NCT02599402|470128729|FG000|Overall Study|Other Reasons|95|||
130592610|NCT00809133|470128730|FG000|Overall Study|Progressive disease|2|||
130592611|NCT00809133|470128731|FG001|Overall Study|Progressive disease|5|||
130592612|NCT00809133|470128732|FG002|Overall Study|Progressive disease|5|||
130592613|NCT00809133|470128733|FG003|Overall Study|Progressive disease|3|||
130592614|NCT00809133|470128734|FG004|Overall Study|Progressive disease|4|||
130592615|NCT00809133|470128735|FG005|Overall Study|Progressive disease|1|||
130592616|NCT00809133|470128736|FG006|Overall Study|Progressive disease|3|||
130592617|NCT00809133|470128737|FG007|Overall Study|Progressive disease|3|||
130592618|NCT00809133|470128738|FG008|Overall Study|Progressive disease|3|||
130592619|NCT00809133|470128739|FG009|Overall Study|Progressive disease|9|||
130592620|NCT00809133|470128740|FG010|Overall Study|Progressive disease|5|||
130592621|NCT00809133|470128741|FG011|Overall Study|Progressive disease|7|||
130592622|NCT00809133|470128742|FG012|Overall Study|Progressive disease|5|||
130592623|NCT00809133|470128743|FG013|Overall Study|Progressive disease|4|||
130592624|NCT00809133|470128730|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592625|NCT00809133|470128731|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592626|NCT00809133|470128732|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592627|NCT00809133|470128733|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592628|NCT00809133|470128734|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592629|NCT00809133|470128735|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130592630|NCT00809133|470128736|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130592631|NCT00809133|470128737|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130592632|NCT00809133|470128738|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592633|NCT00809133|470128739|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592634|NCT00809133|470128740|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592635|NCT00809133|470128741|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592636|NCT00809133|470128742|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130592637|NCT00809133|470128743|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130592638|NCT00809133|470128730|FG000|Overall Study|Other adverse event|1|||
130592639|NCT00809133|470128731|FG001|Overall Study|Other adverse event|1|||
130592640|NCT00809133|470128732|FG002|Overall Study|Other adverse event|1|||
130592641|NCT00809133|470128733|FG003|Overall Study|Other adverse event|0|||
130592642|NCT00809133|470128734|FG004|Overall Study|Other adverse event|0|||
130592643|NCT00809133|470128735|FG005|Overall Study|Other adverse event|3|||
130592644|NCT00809133|470128736|FG006|Overall Study|Other adverse event|2|||
130592645|NCT00809133|470128737|FG007|Overall Study|Other adverse event|4|||
130592646|NCT00809133|470128738|FG008|Overall Study|Other adverse event|0|||
130592647|NCT00809133|470128739|FG009|Overall Study|Other adverse event|0|||
130592648|NCT00809133|470128740|FG010|Overall Study|Other adverse event|1|||
130592649|NCT00809133|470128741|FG011|Overall Study|Other adverse event|1|||
130592650|NCT00809133|470128742|FG012|Overall Study|Other adverse event|0|||
130592651|NCT00809133|470128743|FG013|Overall Study|Other adverse event|1|||
130592652|NCT00809133|470128730|FG000|Overall Study|Lost to Follow-up|0|||
130592653|NCT00809133|470128731|FG001|Overall Study|Lost to Follow-up|0|||
130592654|NCT00809133|470128732|FG002|Overall Study|Lost to Follow-up|0|||
130592655|NCT00809133|470128733|FG003|Overall Study|Lost to Follow-up|0|||
130592656|NCT00809133|470128734|FG004|Overall Study|Lost to Follow-up|0|||
130592657|NCT00809133|470128735|FG005|Overall Study|Lost to Follow-up|1|||
130592658|NCT00809133|470128736|FG006|Overall Study|Lost to Follow-up|0|||
130592659|NCT00809133|470128737|FG007|Overall Study|Lost to Follow-up|0|||
130592660|NCT00809133|470128738|FG008|Overall Study|Lost to Follow-up|0|||
130592661|NCT00809133|470128739|FG009|Overall Study|Lost to Follow-up|0|||
130592662|NCT00809133|470128740|FG010|Overall Study|Lost to Follow-up|0|||
130592663|NCT00809133|470128741|FG011|Overall Study|Lost to Follow-up|0|||
130592664|NCT00809133|470128742|FG012|Overall Study|Lost to Follow-up|0|||
130592665|NCT00809133|470128743|FG013|Overall Study|Lost to Follow-up|0|||
130592666|NCT00809133|470128730|FG000|Overall Study|Consent withdrawn|0|||
130592667|NCT00809133|470128731|FG001|Overall Study|Consent withdrawn|0|||
130592668|NCT00809133|470128732|FG002|Overall Study|Consent withdrawn|0|||
130592669|NCT00809133|470128733|FG003|Overall Study|Consent withdrawn|0|||
130592670|NCT00809133|470128734|FG004|Overall Study|Consent withdrawn|1|||
130592671|NCT00809133|470128735|FG005|Overall Study|Consent withdrawn|0|||
130592672|NCT00809133|470128736|FG006|Overall Study|Consent withdrawn|0|||
130592673|NCT00809133|470128737|FG007|Overall Study|Consent withdrawn|0|||
130592674|NCT00809133|470128738|FG008|Overall Study|Consent withdrawn|0|||
130592675|NCT00809133|470128739|FG009|Overall Study|Consent withdrawn|0|||
130592676|NCT00809133|470128740|FG010|Overall Study|Consent withdrawn|0|||
130592677|NCT00809133|470128741|FG011|Overall Study|Consent withdrawn|0|||
130592678|NCT00809133|470128742|FG012|Overall Study|Consent withdrawn|0|||
130592679|NCT00809133|470128743|FG013|Overall Study|Consent withdrawn|0|||
130592680|NCT00809133|470128730|FG000|Overall Study|Other not mentioned above|0|||
130592681|NCT00809133|470128731|FG001|Overall Study|Other not mentioned above|1|||
130592682|NCT00809133|470128732|FG002|Overall Study|Other not mentioned above|0|||
130592683|NCT00809133|470128733|FG003|Overall Study|Other not mentioned above|0|||
130592684|NCT00809133|470128734|FG004|Overall Study|Other not mentioned above|0|||
130592685|NCT00809133|470128735|FG005|Overall Study|Other not mentioned above|1|||
130592686|NCT00809133|470128736|FG006|Overall Study|Other not mentioned above|0|||
130592687|NCT00809133|470128737|FG007|Overall Study|Other not mentioned above|0|||
130592688|NCT00809133|470128738|FG008|Overall Study|Other not mentioned above|0|||
130592689|NCT00809133|470128739|FG009|Overall Study|Other not mentioned above|0|||
130592690|NCT00809133|470128740|FG010|Overall Study|Other not mentioned above|0|||
130592691|NCT00809133|470128741|FG011|Overall Study|Other not mentioned above|0|||
130592692|NCT00809133|470128742|FG012|Overall Study|Other not mentioned above|0|||
130592693|NCT00809133|470128743|FG013|Overall Study|Other not mentioned above|0|||
130592694|NCT00833092|470128744|FG000|Overall Study|Withdrawal by Subject|2|||
130592695|NCT00833092|470128745|FG001|Overall Study|Withdrawal by Subject|3|||
130592696|NCT00833092|470128744|FG000|Overall Study|Protocol Violation|2|||
130592697|NCT00833092|470128745|FG001|Overall Study|Protocol Violation|1|||
130592698|NCT00833092|470128744|FG000|Overall Study|Diarrhea|0|||
130592699|NCT00833092|470128745|FG001|Overall Study|Diarrhea|2|||
130592700|NCT00833092|470128744|FG000|Overall Study|constipation|0|||
130592701|NCT00833092|470128745|FG001|Overall Study|constipation|1|||
130592702|NCT00699192|470128746|FG000|Overall Study|Missing|1|||
130592703|NCT00699192|470128747|FG001|Overall Study|Missing|1|||
130592704|NCT00699192|470128748|FG002|Overall Study|Missing|1|||
130592705|NCT00699192|470128746|FG000|Overall Study|Adverse Event|9|||
130592706|NCT00699192|470128747|FG001|Overall Study|Adverse Event|4|||
130592707|NCT00699192|470128748|FG002|Overall Study|Adverse Event|3|||
130592708|NCT00699192|470128746|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130592709|NCT00699192|470128747|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130592710|NCT00699192|470128748|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130592711|NCT00699192|470128746|FG000|Overall Study|Lack of Efficacy|0|||
130592712|NCT00699192|470128747|FG001|Overall Study|Lack of Efficacy|0|||
130592713|NCT00699192|470128748|FG002|Overall Study|Lack of Efficacy|1|||
130592714|NCT00699192|470128746|FG000|Overall Study|Withdrawal by Subject|3|||
130592715|NCT00699192|470128747|FG001|Overall Study|Withdrawal by Subject|2|||
130592716|NCT00699192|470128748|FG002|Overall Study|Withdrawal by Subject|4|||
130592717|NCT00699192|470128746|FG000|Overall Study|Administrative problems|1|||
130592718|NCT00699192|470128747|FG001|Overall Study|Administrative problems|3|||
130592719|NCT00699192|470128748|FG002|Overall Study|Administrative problems|1|||
130592720|NCT00699192|470128746|FG000|Overall Study|Protocol Violation|2|||
130592721|NCT00699192|470128747|FG001|Overall Study|Protocol Violation|2|||
130592722|NCT00699192|470128748|FG002|Overall Study|Protocol Violation|0|||
130592723|NCT01025635|470128758|FG000|Overall Study|Withdrawal by Subject|6|||
130592724|NCT01025635|470128759|FG001|Overall Study|Withdrawal by Subject|7|||
130592725|NCT01025635|470128758|FG000|Overall Study|Protocol Violation|4|||
130592726|NCT01025635|470128759|FG001|Overall Study|Protocol Violation|2|||
130592727|NCT01025635|470128758|FG000|Overall Study|Lack of Efficacy|0|||
130592728|NCT01025635|470128759|FG001|Overall Study|Lack of Efficacy|1|||
130592729|NCT01025635|470128758|FG000|Overall Study|Lost to Follow-up|9|||
130592730|NCT01025635|470128759|FG001|Overall Study|Lost to Follow-up|13|||
130592731|NCT01025635|470128758|FG000|Overall Study|Reason not known|4|||
130592732|NCT01025635|470128759|FG001|Overall Study|Reason not known|2|||
130592733|NCT00727402|470128760|FG000|Overall Study|Physician Decision|116|||
130592734|NCT00929240|470128761|FG000|Initial Treatment Phase|Adverse Event|31|||
130592735|NCT00929240|470128762|FG001|Initial Treatment Phase|Adverse Event|0|||
130592736|NCT00929240|470128763|FG002|Initial Treatment Phase|Adverse Event|0|||
130592737|NCT00929240|470128761|FG000|Initial Treatment Phase|Disease progression|41|||
130592738|NCT00929240|470128762|FG001|Initial Treatment Phase|Disease progression|0|||
130592739|NCT00929240|470128763|FG002|Initial Treatment Phase|Disease progression|0|||
130592740|NCT00929240|470128761|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
130592741|NCT00929240|470128762|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
130592742|NCT00929240|470128763|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
130592743|NCT00929240|470128761|FG000|Initial Treatment Phase|Protocol Violation|5|||
130592744|NCT00929240|470128762|FG001|Initial Treatment Phase|Protocol Violation|0|||
130592745|NCT00929240|470128763|FG002|Initial Treatment Phase|Protocol Violation|0|||
130592746|NCT00929240|470128761|FG000|Initial Treatment Phase|Death|2|||
130592747|NCT00929240|470128762|FG001|Initial Treatment Phase|Death|0|||
130592748|NCT00929240|470128763|FG002|Initial Treatment Phase|Death|0|||
130592749|NCT00929240|470128761|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
130592750|NCT00929240|470128762|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
130592751|NCT00929240|470128763|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
130592752|NCT00929240|470128761|FG000|Initial Treatment Phase|Physician Decision|4|||
130592753|NCT00929240|470128762|FG001|Initial Treatment Phase|Physician Decision|0|||
130592754|NCT00929240|470128763|FG002|Initial Treatment Phase|Physician Decision|0|||
130592755|NCT00929240|470128761|FG000|Maintenance Phase|Disease progression|0|||
130592756|NCT00929240|470128762|FG001|Maintenance Phase|Disease progression|73|||
130592757|NCT00929240|470128763|FG002|Maintenance Phase|Disease progression|60|||
130592758|NCT00929240|470128761|FG000|Maintenance Phase|Adverse Event|0|||
130592759|NCT00929240|470128762|FG001|Maintenance Phase|Adverse Event|9|||
130592760|NCT00929240|470128763|FG002|Maintenance Phase|Adverse Event|12|||
130592761|NCT00929240|470128761|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130592762|NCT00929240|470128762|FG001|Maintenance Phase|Withdrawal by Subject|2|||
130592763|NCT00929240|470128763|FG002|Maintenance Phase|Withdrawal by Subject|6|||
130592764|NCT00929240|470128761|FG000|Maintenance Phase|Protocol Violation|0|||
130592765|NCT00929240|470128762|FG001|Maintenance Phase|Protocol Violation|1|||
130592766|NCT00929240|470128763|FG002|Maintenance Phase|Protocol Violation|0|||
130592767|NCT00929240|470128761|FG000|Maintenance Phase|Health authority/Study termination|0|||
130592768|NCT00929240|470128762|FG001|Maintenance Phase|Health authority/Study termination|1|||
130592769|NCT00929240|470128763|FG002|Maintenance Phase|Health authority/Study termination|2|||
130592770|NCT00929240|470128761|FG000|Maintenance Phase|Physician Decision|0|||
130592771|NCT00929240|470128762|FG001|Maintenance Phase|Physician Decision|2|||
130592772|NCT00929240|470128763|FG002|Maintenance Phase|Physician Decision|1|||
130592773|NCT00929240|470128761|FG000|Maintenance Phase|Change of treatment|0|||
130592774|NCT00929240|470128762|FG001|Maintenance Phase|Change of treatment|4|||
130592775|NCT00929240|470128763|FG002|Maintenance Phase|Change of treatment|0|||
130592776|NCT00929240|470128761|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
130592777|NCT00929240|470128762|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
130592778|NCT00929240|470128763|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
130592779|NCT00929240|470128761|FG000|Maintenance Phase|Participant not treated|0|||
130592780|NCT00929240|470128762|FG001|Maintenance Phase|Participant not treated|2|||
130592781|NCT00929240|470128763|FG002|Maintenance Phase|Participant not treated|0|||
130592782|NCT05292755|470128764|FG000|Overall Study|Lost to Follow-up|5|||
130592783|NCT05292755|470128765|FG001|Overall Study|Lost to Follow-up|9|||
130592784|NCT01193686|470128766|FG000|Overall Study|Withdrawal by Subject|4|||
130592785|NCT01193686|470128767|FG001|Overall Study|Withdrawal by Subject|1|||
130592786|NCT01193686|470128766|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
130592787|NCT01193686|470128767|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
130592788|NCT03401749|470128768|FG000|Overall Study|Lost to Follow-up|20|||
130592789|NCT03401749|470128769|FG001|Overall Study|Lost to Follow-up|16|||
130592790|NCT03401749|470128770|FG002|Overall Study|Lost to Follow-up|26|||
130592791|NCT00432809|470128771|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
130592792|NCT00432809|470128772|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
130592793|NCT00432809|470128773|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
130592794|NCT00432809|470128771|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
130592795|NCT00432809|470128772|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
130592796|NCT00432809|470128773|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
130592797|NCT03075839|470128774|FG000|Overall Study|Lost to Follow-up|4|||
130592798|NCT04433117|470128775|FG000|Overall Study|Withdrawal by Subject|1|||
130592799|NCT04433117|470128776|FG001|Overall Study|Withdrawal by Subject|0|||
130592800|NCT00707577|470128777|FG000|Overall Study|Withdrawal by Subject|3|||
130592801|NCT00707577|470128778|FG001|Overall Study|Withdrawal by Subject|2|||
130592802|NCT00707577|470128777|FG000|Overall Study|Lost to Follow-up|34|||
130592803|NCT00707577|470128778|FG001|Overall Study|Lost to Follow-up|25|||
130592804|NCT00707577|470128777|FG000|Overall Study|Left employment|13|||
130592805|NCT00707577|470128778|FG001|Overall Study|Left employment|10|||
130592806|NCT00707577|470128777|FG000|Overall Study|Pregnancy|4|||
130592807|NCT00707577|470128778|FG001|Overall Study|Pregnancy|1|||
130592808|NCT03853694|470128779|FG000|Overall Study|Protocol Violation|3|||
130592809|NCT03853694|470128780|FG001|Overall Study|Protocol Violation|5|||
130592810|NCT03853694|470128781|FG002|Overall Study|Protocol Violation|3|||
130592811|NCT03853694|470128779|FG000|Overall Study|Delivered early|0|||
130592812|NCT03853694|470128780|FG001|Overall Study|Delivered early|1|||
130592813|NCT03853694|470128781|FG002|Overall Study|Delivered early|0|||
130592814|NCT03853694|470128779|FG000|Overall Study|not suitable to proceed|0|||
130592815|NCT03853694|470128780|FG001|Overall Study|not suitable to proceed|1|||
130592816|NCT03853694|470128781|FG002|Overall Study|not suitable to proceed|0|||
130592817|NCT03853694|470128779|FG000|Overall Study|difficult surgery|0|||
130592818|NCT03853694|470128780|FG001|Overall Study|difficult surgery|0|||
130592819|NCT03853694|470128781|FG002|Overall Study|difficult surgery|1|||
130592820|NCT03853694|470128779|FG000|Overall Study|Lost to Follow-up|0|||
130592821|NCT03853694|470128780|FG001|Overall Study|Lost to Follow-up|1|||
130592822|NCT03853694|470128781|FG002|Overall Study|Lost to Follow-up|0|||
130592823|NCT03853694|470128779|FG000|Overall Study|Withdrawal by Subject|0|||
130592824|NCT03853694|470128780|FG001|Overall Study|Withdrawal by Subject|1|||
130592825|NCT03853694|470128781|FG002|Overall Study|Withdrawal by Subject|0|||
130592826|NCT05089708|470128782|FG000|Overall Study|Lost to Follow-up|9|||
130592827|NCT05089708|470128783|FG001|Overall Study|Lost to Follow-up|7|||
130592828|NCT05089708|470128782|FG000|Overall Study|Withdrawal by Subject|3|||
130592829|NCT05089708|470128783|FG001|Overall Study|Withdrawal by Subject|1|||
130592830|NCT05089708|470128782|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
130592831|NCT05089708|470128783|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
130592832|NCT05089708|470128782|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
130592833|NCT05089708|470128783|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
130592834|NCT02209766|470128785|FG000|Overall Study|Withdrawal by Subject|0|||
130592835|NCT02209766|470128786|FG001|Overall Study|Withdrawal by Subject|0|||
130592836|NCT02209766|470128787|FG002|Overall Study|Withdrawal by Subject|0|||
130592837|NCT02209766|470128788|FG003|Overall Study|Withdrawal by Subject|1|||
130592838|NCT02209766|470128789|FG004|Overall Study|Withdrawal by Subject|0|||
130592839|NCT00805207|470128790|FG000|Overall Study|Protocol Violation|0|||
130592840|NCT00805207|470128791|FG001|Overall Study|Protocol Violation|0|||
130592841|NCT00805207|470128792|FG002|Overall Study|Protocol Violation|1|||
130592842|NCT00805207|470128793|FG003|Overall Study|Protocol Violation|0|||
130592843|NCT00805207|470128794|FG004|Overall Study|Protocol Violation|0|||
130592844|NCT00805207|470128795|FG005|Overall Study|Protocol Violation|0|||
130592845|NCT00805207|470128796|FG006|Overall Study|Protocol Violation|0|||
130592846|NCT00805207|470128797|FG007|Overall Study|Protocol Violation|0|||
130592847|NCT00805207|470128798|FG008|Overall Study|Protocol Violation|0|||
130592848|NCT00805207|470128790|FG000|Overall Study|Physician Decision|0|||
130592849|NCT00805207|470128791|FG001|Overall Study|Physician Decision|1|||
130592850|NCT00805207|470128792|FG002|Overall Study|Physician Decision|0|||
130592851|NCT00805207|470128793|FG003|Overall Study|Physician Decision|0|||
130592852|NCT00805207|470128794|FG004|Overall Study|Physician Decision|0|||
130592853|NCT00805207|470128795|FG005|Overall Study|Physician Decision|1|||
130592854|NCT00805207|470128796|FG006|Overall Study|Physician Decision|0|||
130592855|NCT00805207|470128797|FG007|Overall Study|Physician Decision|0|||
130592856|NCT00805207|470128798|FG008|Overall Study|Physician Decision|0|||
130592857|NCT00805207|470128790|FG000|Overall Study|Withdrawal by Subject|0|||
130592858|NCT00805207|470128791|FG001|Overall Study|Withdrawal by Subject|1|||
130592859|NCT00805207|470128792|FG002|Overall Study|Withdrawal by Subject|0|||
130592860|NCT00805207|470128793|FG003|Overall Study|Withdrawal by Subject|0|||
130592861|NCT00805207|470128794|FG004|Overall Study|Withdrawal by Subject|1|||
130592862|NCT00805207|470128795|FG005|Overall Study|Withdrawal by Subject|2|||
130592863|NCT00805207|470128796|FG006|Overall Study|Withdrawal by Subject|0|||
130592864|NCT00805207|470128797|FG007|Overall Study|Withdrawal by Subject|0|||
130592865|NCT00805207|470128798|FG008|Overall Study|Withdrawal by Subject|0|||
130592866|NCT00064701|470128799|FG000|One Year Post-transplant|Did not receive study drug|7|||
130592867|NCT00064701|470128800|FG001|One Year Post-transplant|Did not receive study drug|12|||
130592868|NCT00064701|470128801|FG002|One Year Post-transplant|Did not receive study drug|11|||
130592869|NCT00064701|470128799|FG000|One Year Post-transplant|Adverse Event|23|||
130592870|NCT00064701|470128800|FG001|One Year Post-transplant|Adverse Event|19|||
130592871|NCT00064701|470128801|FG002|One Year Post-transplant|Adverse Event|37|||
130592872|NCT00064701|470128799|FG000|One Year Post-transplant|Rejection|0|||
130592873|NCT00064701|470128800|FG001|One Year Post-transplant|Rejection|1|||
130592874|NCT00064701|470128801|FG002|One Year Post-transplant|Rejection|16|||
130592875|NCT00064701|470128799|FG000|One Year Post-transplant|Non-compliance|4|||
130592876|NCT00064701|470128800|FG001|One Year Post-transplant|Non-compliance|2|||
130592877|NCT00064701|470128801|FG002|One Year Post-transplant|Non-compliance|5|||
130592878|NCT00064701|470128799|FG000|One Year Post-transplant|Graft Failure|3|||
130592879|NCT00064701|470128800|FG001|One Year Post-transplant|Graft Failure|2|||
130592880|NCT00064701|470128801|FG002|One Year Post-transplant|Graft Failure|1|||
130592881|NCT00064701|470128799|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
130592882|NCT00064701|470128800|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
130592883|NCT00064701|470128801|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
130592884|NCT00064701|470128799|FG000|One Year Post-transplant|Lost to Follow-up|1|||
130592885|NCT00064701|470128800|FG001|One Year Post-transplant|Lost to Follow-up|0|||
130592886|NCT00064701|470128801|FG002|One Year Post-transplant|Lost to Follow-up|0|||
130592887|NCT00064701|470128799|FG000|One Year Post-transplant|Converted to rapamycin|1|||
130592888|NCT00064701|470128800|FG001|One Year Post-transplant|Converted to rapamycin|0|||
130592889|NCT00064701|470128801|FG002|One Year Post-transplant|Converted to rapamycin|0|||
130592890|NCT00064701|470128799|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
130592891|NCT00064701|470128800|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
130592892|NCT00064701|470128801|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
130592893|NCT00064701|470128799|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
130592894|NCT00064701|470128800|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
130592895|NCT00064701|470128801|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
130592896|NCT00064701|470128799|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
130592897|NCT00064701|470128800|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
130592898|NCT00064701|470128801|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
130592899|NCT00064701|470128799|FG000|One Year Post-transplant|Poor absorption|0|||
130592900|NCT00064701|470128800|FG001|One Year Post-transplant|Poor absorption|1|||
130592901|NCT00064701|470128801|FG002|One Year Post-transplant|Poor absorption|0|||
130592902|NCT00064701|470128799|FG000|One Year Post-transplant|Pancreas transplant|0|||
130592903|NCT00064701|470128800|FG001|One Year Post-transplant|Pancreas transplant|0|||
130592904|NCT00064701|470128801|FG002|One Year Post-transplant|Pancreas transplant|1|||
130592905|NCT00064701|470128799|FG000|Clinical Continuation Phase|Adverse Event|12|||
130592906|NCT00064701|470128800|FG001|Clinical Continuation Phase|Adverse Event|21|||
130592907|NCT00064701|470128801|FG002|Clinical Continuation Phase|Adverse Event|14|||
130592908|NCT00064701|470128799|FG000|Clinical Continuation Phase|Non-compliance|8|||
130592909|NCT00064701|470128800|FG001|Clinical Continuation Phase|Non-compliance|6|||
130592910|NCT00064701|470128801|FG002|Clinical Continuation Phase|Non-compliance|7|||
130592911|NCT00064701|470128799|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
130592912|NCT00064701|470128800|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
130592913|NCT00064701|470128801|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
130592914|NCT00064701|470128799|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
130592915|NCT00064701|470128800|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
130592916|NCT00064701|470128801|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
130592917|NCT00064701|470128799|FG000|Clinical Continuation Phase|Graft Failure|5|||
130592918|NCT00064701|470128800|FG001|Clinical Continuation Phase|Graft Failure|5|||
130592919|NCT00064701|470128801|FG002|Clinical Continuation Phase|Graft Failure|2|||
130592920|NCT00064701|470128799|FG000|Clinical Continuation Phase|Rejection|1|||
130592921|NCT00064701|470128800|FG001|Clinical Continuation Phase|Rejection|2|||
130592922|NCT00064701|470128801|FG002|Clinical Continuation Phase|Rejection|2|||
130592923|NCT00064701|470128799|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
130592924|NCT00064701|470128800|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
130592925|NCT00064701|470128801|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
130592926|NCT00064701|470128799|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
130592927|NCT00064701|470128800|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
130592928|NCT00064701|470128801|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
130592929|NCT00064701|470128799|FG000|Clinical Continuation Phase|Physician Decision|1|||
130592930|NCT00064701|470128800|FG001|Clinical Continuation Phase|Physician Decision|3|||
130592931|NCT00064701|470128801|FG002|Clinical Continuation Phase|Physician Decision|0|||
130592932|NCT00064701|470128799|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
130592933|NCT00064701|470128800|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
130592934|NCT00064701|470128801|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
130592935|NCT00064701|470128799|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
130592936|NCT00064701|470128800|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
130592937|NCT00064701|470128801|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
130592938|NCT00064701|470128799|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
130592939|NCT00064701|470128800|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
130592940|NCT00064701|470128801|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
130592941|NCT00064701|470128799|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
130592942|NCT00064701|470128800|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
130592943|NCT00064701|470128801|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
130592944|NCT00064701|470128799|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
130592945|NCT00064701|470128800|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
130592946|NCT00064701|470128801|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
130592947|NCT00064701|470128799|FG000|Clinical Continuation Phase|Patient opted out|0|||
130592948|NCT00064701|470128800|FG001|Clinical Continuation Phase|Patient opted out|0|||
130592949|NCT00064701|470128801|FG002|Clinical Continuation Phase|Patient opted out|1|||
130592950|NCT01491945|470128803|FG000|Overall Study|Death|30|||
130592951|NCT01491945|470128803|FG000|Overall Study|Withdrwan/LTF|16|||
130592952|NCT01491945|470128803|FG000|Overall Study|Conversion|4|||
130592953|NCT01491945|470128803|FG000|Overall Study|Missed Visit|1|||
130592954|NCT05681715|470128804|FG000|Training Period (6-weeks)|Adverse Event|3|||
130592955|NCT05681715|470128805|FG001|Training Period (6-weeks)|Adverse Event|0|||
130592956|NCT05681715|470128806|FG002|Training Period (6-weeks)|Adverse Event|0|||
130592957|NCT05681715|470128804|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
130592958|NCT05681715|470128805|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
130592959|NCT05681715|470128806|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
130592960|NCT05681715|470128804|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
130592961|NCT05681715|470128805|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
130592962|NCT05681715|470128806|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
130592963|NCT05681715|470128804|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
130592964|NCT05681715|470128805|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
130592965|NCT05681715|470128806|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
130592966|NCT05681715|470128804|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
130592967|NCT05681715|470128805|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
130592968|NCT05681715|470128806|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
130592969|NCT05681715|470128804|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
130592970|NCT05681715|470128805|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
130592971|NCT05681715|470128806|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
130592972|NCT05681715|470128804|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
130592973|NCT05681715|470128805|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
130592974|NCT05681715|470128806|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
130592975|NCT05681715|470128804|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
130592976|NCT05681715|470128805|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
130592977|NCT05681715|470128806|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
130592978|NCT03770403|470128807|FG000|Overall Study|Adverse Event|8|||
130592979|NCT03770403|470128807|FG000|Overall Study|Death|5|||
130592980|NCT03770403|470128807|FG000|Overall Study|Physician Decision|1|||
130592981|NCT03770403|470128807|FG000|Overall Study|Sponsor decision|1|||
130592982|NCT03770403|470128807|FG000|Overall Study|Study terminated by Sponsor|1|||
130592983|NCT03770403|470128807|FG000|Overall Study|Withdrawal by Subject|13|||
130592984|NCT03770403|470128807|FG000|Overall Study|Other|88|||
130592985|NCT02305563|470128812|FG000|Treatment Period|Disease progression|0|||
130592986|NCT02305563|470128813|FG001|Treatment Period|Disease progression|0|||
130592987|NCT02305563|470128814|FG002|Treatment Period|Disease progression|15|||
130592988|NCT02305563|470128815|FG003|Treatment Period|Disease progression|6|||
130592989|NCT02305563|470128816|FG004|Treatment Period|Disease progression|6|||
130592990|NCT02305563|470128812|FG000|Treatment Period|Study drug toxicity|0|||
130592991|NCT02305563|470128813|FG001|Treatment Period|Study drug toxicity|0|||
130592992|NCT02305563|470128814|FG002|Treatment Period|Study drug toxicity|0|||
130592993|NCT02305563|470128815|FG003|Treatment Period|Study drug toxicity|1|||
130592994|NCT02305563|470128816|FG004|Treatment Period|Study drug toxicity|2|||
130592995|NCT02305563|470128812|FG000|Treatment Period|Death|0|||
130592996|NCT02305563|470128813|FG001|Treatment Period|Death|0|||
130592997|NCT02305563|470128814|FG002|Treatment Period|Death|1|||
130592998|NCT02305563|470128815|FG003|Treatment Period|Death|2|||
130592999|NCT02305563|470128816|FG004|Treatment Period|Death|1|||
130593000|NCT02305563|470128812|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
130593001|NCT02305563|470128813|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
130593002|NCT02305563|470128814|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
130593003|NCT02305563|470128815|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
130593004|NCT02305563|470128816|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
130593005|NCT02305563|470128812|FG000|Treatment Period|Participant request to stop therapy|0|||
130593006|NCT02305563|470128813|FG001|Treatment Period|Participant request to stop therapy|2|||
130593007|NCT02305563|470128814|FG002|Treatment Period|Participant request to stop therapy|0|||
130593008|NCT02305563|470128815|FG003|Treatment Period|Participant request to stop therapy|1|||
130593009|NCT02305563|470128816|FG004|Treatment Period|Participant request to stop therapy|0|||
130593010|NCT02305563|470128812|FG000|Treatment Period|Participant withdrew consent|0|||
130593011|NCT02305563|470128813|FG001|Treatment Period|Participant withdrew consent|0|||
130593012|NCT02305563|470128814|FG002|Treatment Period|Participant withdrew consent|1|||
130593013|NCT02305563|470128815|FG003|Treatment Period|Participant withdrew consent|1|||
130593014|NCT02305563|470128816|FG004|Treatment Period|Participant withdrew consent|1|||
130593015|NCT02305563|470128812|FG000|Treatment Period|Maximum clinical benefit|0|||
130593016|NCT02305563|470128813|FG001|Treatment Period|Maximum clinical benefit|0|||
130593017|NCT02305563|470128814|FG002|Treatment Period|Maximum clinical benefit|0|||
130593018|NCT02305563|470128815|FG003|Treatment Period|Maximum clinical benefit|0|||
130593019|NCT02305563|470128816|FG004|Treatment Period|Maximum clinical benefit|1|||
130593020|NCT02305563|470128812|FG000|Treatment Period|Poor/non-compliance|0|||
130593021|NCT02305563|470128813|FG001|Treatment Period|Poor/non-compliance|0|||
130593022|NCT02305563|470128814|FG002|Treatment Period|Poor/non-compliance|0|||
130593023|NCT02305563|470128815|FG003|Treatment Period|Poor/non-compliance|0|||
130593024|NCT02305563|470128816|FG004|Treatment Period|Poor/non-compliance|1|||
130593025|NCT02305563|470128812|FG000|Treatment Period|Administrative reason by Sponsor|0|||
130593026|NCT02305563|470128813|FG001|Treatment Period|Administrative reason by Sponsor|0|||
130593027|NCT02305563|470128814|FG002|Treatment Period|Administrative reason by Sponsor|0|||
130593028|NCT02305563|470128815|FG003|Treatment Period|Administrative reason by Sponsor|0|||
130593029|NCT02305563|470128816|FG004|Treatment Period|Administrative reason by Sponsor|1|||
130593030|NCT02305563|470128812|FG000|Treatment Period|other reason|2|||
130593031|NCT02305563|470128813|FG001|Treatment Period|other reason|0|||
130593032|NCT02305563|470128814|FG002|Treatment Period|other reason|2|||
130593033|NCT02305563|470128815|FG003|Treatment Period|other reason|2|||
130593034|NCT02305563|470128816|FG004|Treatment Period|other reason|1|||
130593035|NCT02305563|470128812|FG000|Treatment Period|Randomized but not treated|0|||
130593036|NCT02305563|470128813|FG001|Treatment Period|Randomized but not treated|0|||
130593037|NCT02305563|470128814|FG002|Treatment Period|Randomized but not treated|0|||
130593038|NCT02305563|470128815|FG003|Treatment Period|Randomized but not treated|0|||
130593039|NCT02305563|470128816|FG004|Treatment Period|Randomized but not treated|2|||
130593040|NCT02305563|470128812|FG000|Treatment Period|added ULO, then disease progression|0|||
130593041|NCT02305563|470128813|FG001|Treatment Period|added ULO, then disease progression|0|||
130593042|NCT02305563|470128814|FG002|Treatment Period|added ULO, then disease progression|0|||
130593043|NCT02305563|470128815|FG003|Treatment Period|added ULO, then disease progression|0|||
130593044|NCT02305563|470128816|FG004|Treatment Period|added ULO, then disease progression|4|||
130593045|NCT02305563|470128812|FG000|Treatment Period|added ULO; then other reason|0|||
130593046|NCT02305563|470128813|FG001|Treatment Period|added ULO; then other reason|0|||
130593047|NCT02305563|470128814|FG002|Treatment Period|added ULO; then other reason|0|||
130593048|NCT02305563|470128815|FG003|Treatment Period|added ULO; then other reason|0|||
130593049|NCT02305563|470128816|FG004|Treatment Period|added ULO; then other reason|1|||
130593050|NCT02305563|470128812|FG000|Treatment Period|added ULO, then request to stop|0|||
130593051|NCT02305563|470128813|FG001|Treatment Period|added ULO, then request to stop|0|||
130593052|NCT02305563|470128814|FG002|Treatment Period|added ULO, then request to stop|0|||
130593053|NCT02305563|470128815|FG003|Treatment Period|added ULO, then request to stop|0|||
130593054|NCT02305563|470128816|FG004|Treatment Period|added ULO, then request to stop|1|||
130593055|NCT02305563|470128812|FG000|Follow-up Period|Death|0|||
130593056|NCT02305563|470128813|FG001|Follow-up Period|Death|0|||
130593057|NCT02305563|470128814|FG002|Follow-up Period|Death|5|||
130593058|NCT02305563|470128815|FG003|Follow-up Period|Death|4|||
130593059|NCT02305563|470128816|FG004|Follow-up Period|Death|7|||
130593060|NCT02305563|470128812|FG000|Follow-up Period|Participant withdrew consent|0|||
130593061|NCT02305563|470128813|FG001|Follow-up Period|Participant withdrew consent|0|||
130593062|NCT02305563|470128814|FG002|Follow-up Period|Participant withdrew consent|2|||
130593063|NCT02305563|470128815|FG003|Follow-up Period|Participant withdrew consent|1|||
130593064|NCT02305563|470128816|FG004|Follow-up Period|Participant withdrew consent|0|||
130593065|NCT02305563|470128812|FG000|Follow-up Period|other reason|0|||
130593066|NCT02305563|470128813|FG001|Follow-up Period|other reason|0|||
130593067|NCT02305563|470128814|FG002|Follow-up Period|other reason|0|||
130593068|NCT02305563|470128815|FG003|Follow-up Period|other reason|0|||
130593069|NCT02305563|470128816|FG004|Follow-up Period|other reason|1|||
130593070|NCT02305563|470128812|FG000|Follow-up Period|Followup no longer required per protocol|3|||
130593071|NCT02305563|470128813|FG001|Follow-up Period|Followup no longer required per protocol|3|||
130593072|NCT02305563|470128814|FG002|Follow-up Period|Followup no longer required per protocol|4|||
130593073|NCT02305563|470128815|FG003|Follow-up Period|Followup no longer required per protocol|1|||
130593074|NCT02305563|470128816|FG004|Follow-up Period|Followup no longer required per protocol|4|||
130593075|NCT02700451|470128820|FG000|Overall Study|Protocol Violation|2|||
130593076|NCT02700451|470128821|FG001|Overall Study|Protocol Violation|2|||
130593077|NCT02700451|470128822|FG002|Overall Study|Protocol Violation|3|||
130593078|NCT02700451|470128820|FG000|Overall Study|Discontinued intervention|14|||
130593079|NCT02700451|470128821|FG001|Overall Study|Discontinued intervention|15|||
130593080|NCT02700451|470128822|FG002|Overall Study|Discontinued intervention|14|||
130593081|NCT00454207|470128823|FG000|Overall Study|Adverse Event|3|||
130593082|NCT00454207|470128824|FG001|Overall Study|Adverse Event|1|||
130593083|NCT00454207|470128823|FG000|Overall Study|Lack of Efficacy|1|||
130593084|NCT00454207|470128824|FG001|Overall Study|Lack of Efficacy|0|||
130593085|NCT00454207|470128823|FG000|Overall Study|Protocol Violation|0|||
130593086|NCT00454207|470128824|FG001|Overall Study|Protocol Violation|1|||
130593087|NCT00981526|470128827|FG000|Overall Study|Withdrawal by Subject|0|||
130593088|NCT00981526|470128828|FG001|Overall Study|Withdrawal by Subject|2|||
130593089|NCT00981526|470128827|FG000|Overall Study|Physician Decision|4|||
130593090|NCT00981526|470128828|FG001|Overall Study|Physician Decision|4|||
130593091|NCT01564784|470128829|FG000|Overall Study|Other|1|||
130593092|NCT01564784|470128830|FG001|Overall Study|Other|0|||
130593093|NCT01564784|470128829|FG000|Overall Study|Subject refused further follow-up|1|||
130593094|NCT01564784|470128830|FG001|Overall Study|Subject refused further follow-up|6|||
130593095|NCT01564784|470128829|FG000|Overall Study|Lost to Follow-up|1|||
130593096|NCT01564784|470128830|FG001|Overall Study|Lost to Follow-up|1|||
130593097|NCT01564784|470128829|FG000|Overall Study|Death|131|||
130593098|NCT01564784|470128830|FG001|Overall Study|Death|126|||
130593099|NCT03871491|470128831|FG000|Overall Study|Withdrawal by Subject|14|||
130593100|NCT03871491|470128832|FG001|Overall Study|Withdrawal by Subject|14|||
130593101|NCT03871491|470128833|FG002|Overall Study|Withdrawal by Subject|14|||
130593102|NCT03871491|470128834|FG003|Overall Study|Withdrawal by Subject|14|||
130593103|NCT03871491|470128831|FG000|Overall Study|Physician Decision|0|||
130593104|NCT03871491|470128832|FG001|Overall Study|Physician Decision|0|||
130593105|NCT03871491|470128833|FG002|Overall Study|Physician Decision|1|||
130593106|NCT03871491|470128834|FG003|Overall Study|Physician Decision|1|||
130593107|NCT03871491|470128831|FG000|Overall Study|Lost to Follow-up|50|||
130593108|NCT03871491|470128832|FG001|Overall Study|Lost to Follow-up|15|||
130593109|NCT03871491|470128833|FG002|Overall Study|Lost to Follow-up|36|||
130593110|NCT03871491|470128834|FG003|Overall Study|Lost to Follow-up|11|||
130593111|NCT05202808|470128835|FG000|Overall Study|Lost to Follow-up|3|||
130593112|NCT05202808|470128836|FG001|Overall Study|Lost to Follow-up|1|||
130593113|NCT04439331|470128837|FG000|Overall Study|Never Start Protocol Therapy|2|||
130593114|NCT04439331|470128837|FG000|Overall Study|Ineligible|2|||
130593115|NCT04439331|470128837|FG000|Overall Study|Mutation Status Not Confirmed|1|||
130593116|NCT04439331|470128837|FG000|Overall Study|Adverse Event|1|||
130593117|NCT04439331|470128837|FG000|Overall Study|Death|1|||
130593118|NCT04439331|470128837|FG000|Overall Study|Disease Progression|20|||
130593119|NCT04439331|470128837|FG000|Overall Study|Withdrawal by Subject|6|||
130593120|NCT04439331|470128837|FG000|Overall Study|Physician Decision|1|||
130593121|NCT04439331|470128837|FG000|Overall Study|Other Complicating Disease|1|||
130593122|NCT02495948|470128838|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
130593123|NCT02495948|470128839|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
130593124|NCT02495948|470128838|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
130593125|NCT02495948|470128839|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
130593126|NCT02747004|470128841|FG000|Overall Study|Withdrawal by Subject|8|||
130593127|NCT02747004|470128842|FG001|Overall Study|Withdrawal by Subject|5|||
130593128|NCT02747004|470128843|FG002|Overall Study|Withdrawal by Subject|4|||
130593129|NCT02747004|470128841|FG000|Overall Study|Lost to Follow-up|1|||
130593130|NCT02747004|470128842|FG001|Overall Study|Lost to Follow-up|2|||
130593131|NCT02747004|470128843|FG002|Overall Study|Lost to Follow-up|2|||
130593132|NCT02747004|470128841|FG000|Overall Study|on study treatment/follow-up|48|||
130593133|NCT02747004|470128842|FG001|Overall Study|on study treatment/follow-up|42|||
130593134|NCT02747004|470128843|FG002|Overall Study|on study treatment/follow-up|41|||
130593135|NCT01444300|470128844|FG000|Overall Study|Adverse Event|4|||
130593136|NCT01444300|470128845|FG001|Overall Study|Adverse Event|0|||
130593137|NCT04429022|470128850|FG000|Overall Study|Protocol Violation|18|||
130593138|NCT04429022|470128851|FG001|Overall Study|Protocol Violation|1|||
130593139|NCT01769105|470128852|FG000|First Intervention|Protocol Violation|2|||
130593140|NCT01769105|470128853|FG001|First Intervention|Protocol Violation|2|||
130593141|NCT01769105|470128852|FG000|Cross-over|Lost to Follow-up|5|||
130593142|NCT01769105|470128853|FG001|Cross-over|Lost to Follow-up|0|||
130593143|NCT00963807|470128854|FG000|Overall Study|Physician Decision|2|||
130593144|NCT00963807|470128854|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
130593145|NCT00963807|470128854|FG000|Overall Study|Disease progression|15|||
130593146|NCT00045032|470128855|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
130593147|NCT00045032|470128856|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
130593148|NCT00045032|470128857|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
130593149|NCT00045032|470128855|FG000|Overall Study|Death|22|||
130593150|NCT00045032|470128856|FG001|Overall Study|Death|24|||
130593151|NCT00045032|470128857|FG002|Overall Study|Death|17|||
130593152|NCT00045032|470128855|FG000|Overall Study|Insufficient Therapeutic Response|542|||
130593153|NCT00045032|470128856|FG001|Overall Study|Insufficient Therapeutic Response|437|||
130593154|NCT00045032|470128857|FG002|Overall Study|Insufficient Therapeutic Response|445|||
130593155|NCT00045032|470128855|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
130593156|NCT00045032|470128856|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
130593157|NCT00045032|470128857|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
130593158|NCT00045032|470128855|FG000|Overall Study|Other Protocol Violation|2|||
130593159|NCT00045032|470128856|FG001|Overall Study|Other Protocol Violation|0|||
130593160|NCT00045032|470128857|FG002|Overall Study|Other Protocol Violation|1|||
130593161|NCT00045032|470128855|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
130593162|NCT00045032|470128856|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
130593163|NCT00045032|470128857|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
130593164|NCT00045032|470128855|FG000|Overall Study|Failure to Return|57|||
130593165|NCT00045032|470128856|FG001|Overall Study|Failure to Return|62|||
130593166|NCT00045032|470128857|FG002|Overall Study|Failure to Return|61|||
130593167|NCT00045032|470128855|FG000|Overall Study|Other|93|||
130593168|NCT00045032|470128856|FG001|Overall Study|Other|84|||
130593169|NCT00045032|470128857|FG002|Overall Study|Other|105|||
130593170|NCT00473694|470131052|FG000|Overall Study|Adverse Event|0|||
130593171|NCT00473694|470131053|FG001|Overall Study|Adverse Event|1|||
130593172|NCT00473694|470131054|FG002|Overall Study|Adverse Event|0|||
130593173|NCT00473694|470131055|FG003|Overall Study|Adverse Event|0|||
130593174|NCT00473694|470131052|FG000|Overall Study|Participants did not receive treatment|11|||
130593175|NCT00473694|470131053|FG001|Overall Study|Participants did not receive treatment|3|||
130593176|NCT00473694|470131054|FG002|Overall Study|Participants did not receive treatment|5|||
130593177|NCT00473694|470131055|FG003|Overall Study|Participants did not receive treatment|6|||
130593178|NCT00473694|470131052|FG000|Overall Study|Lost to Follow-up|0|||
130593179|NCT00473694|470131053|FG001|Overall Study|Lost to Follow-up|0|||
130593180|NCT00473694|470131054|FG002|Overall Study|Lost to Follow-up|0|||
130593181|NCT00473694|470131055|FG003|Overall Study|Lost to Follow-up|1|||
130593182|NCT00506389|470131063|FG000|In-treatment Period|Other|3|||
130593183|NCT00506389|470131064|FG001|In-treatment Period|Other|3|||
130593184|NCT00506389|470131065|FG002|In-treatment Period|Other|4|||
130593185|NCT00506389|470131063|FG000|In-treatment Period|Lost to Follow-up|0|||
130593186|NCT00506389|470131064|FG001|In-treatment Period|Lost to Follow-up|0|||
130593187|NCT00506389|470131065|FG002|In-treatment Period|Lost to Follow-up|1|||
130593188|NCT00506389|470131063|FG000|In-treatment Period|Lack of compliance|1|||
130593189|NCT00506389|470131064|FG001|In-treatment Period|Lack of compliance|0|||
130593190|NCT00506389|470131065|FG002|In-treatment Period|Lack of compliance|0|||
130593191|NCT00506389|470131063|FG000|In-treatment Period|Reasons not related to trial|4|||
130593192|NCT00506389|470131064|FG001|In-treatment Period|Reasons not related to trial|1|||
130593193|NCT00506389|470131065|FG002|In-treatment Period|Reasons not related to trial|0|||
130593194|NCT00506389|470131063|FG000|In-treatment Period|Withdrawal by Subject|3|||
130593195|NCT00506389|470131064|FG001|In-treatment Period|Withdrawal by Subject|3|||
130593196|NCT00506389|470131065|FG002|In-treatment Period|Withdrawal by Subject|4|||
130593197|NCT00506389|470131063|FG000|In-treatment Period|Lack of Efficacy|0|||
130593198|NCT00506389|470131064|FG001|In-treatment Period|Lack of Efficacy|2|||
130593199|NCT00506389|470131065|FG002|In-treatment Period|Lack of Efficacy|0|||
130593200|NCT00506389|470131063|FG000|In-treatment Period|Adverse Event|11|||
130593201|NCT00506389|470131064|FG001|In-treatment Period|Adverse Event|5|||
130593202|NCT00506389|470131065|FG002|In-treatment Period|Adverse Event|2|||
130593203|NCT00506389|470131063|FG000|In-treatment Period|Randomized but not treated|4|||
130593204|NCT00506389|470131064|FG001|In-treatment Period|Randomized but not treated|1|||
130593205|NCT00506389|470131065|FG002|In-treatment Period|Randomized but not treated|1|||
130593206|NCT05224258|470131066|FG000|Overall Study|Withdrawal by Subject|1|||
130593207|NCT05224258|470131067|FG001|Overall Study|Withdrawal by Subject|1|||
130593208|NCT05224258|470131066|FG000|Overall Study|Physician Decision|1|||
130593209|NCT05224258|470131067|FG001|Overall Study|Physician Decision|1|||
130593210|NCT05224258|470131066|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130593211|NCT05224258|470131067|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130593212|NCT05224258|470131066|FG000|Overall Study|Study Product No Longer in Use|1|||
130593213|NCT05224258|470131067|FG001|Overall Study|Study Product No Longer in Use|0|||
130593214|NCT05224258|470131066|FG000|Overall Study|Adverse Event|0|||
130593215|NCT05224258|470131067|FG001|Overall Study|Adverse Event|1|||
130593216|NCT05224258|470131066|FG000|Overall Study|Protocol Deviation|0|||
130593217|NCT05224258|470131067|FG001|Overall Study|Protocol Deviation|1|||
130593218|NCT01381094|470131068|FG000|Overall Study|Adverse Event|1|||
130593219|NCT01381094|470131069|FG001|Overall Study|Adverse Event|2|||
130593220|NCT01381094|470131070|FG002|Overall Study|Adverse Event|0|||
130593221|NCT01381094|470131071|FG003|Overall Study|Adverse Event|1|||
130593222|NCT01381094|470131072|FG004|Overall Study|Adverse Event|0|||
130593223|NCT01381094|470131068|FG000|Overall Study|Lost to Follow-up|0|||
130593224|NCT01381094|470131069|FG001|Overall Study|Lost to Follow-up|0|||
130593225|NCT01381094|470131070|FG002|Overall Study|Lost to Follow-up|0|||
130593226|NCT01381094|470131071|FG003|Overall Study|Lost to Follow-up|0|||
130593227|NCT01381094|470131072|FG004|Overall Study|Lost to Follow-up|1|||
130593228|NCT01381094|470131068|FG000|Overall Study|Withdrawal of informed consent|0|||
130593229|NCT01381094|470131069|FG001|Overall Study|Withdrawal of informed consent|1|||
130593230|NCT01381094|470131070|FG002|Overall Study|Withdrawal of informed consent|0|||
130593231|NCT01381094|470131071|FG003|Overall Study|Withdrawal of informed consent|0|||
130593232|NCT01381094|470131072|FG004|Overall Study|Withdrawal of informed consent|0|||
130593233|NCT01381094|470131068|FG000|Overall Study|Participant given Aranesp injection|1|||
130593234|NCT01381094|470131069|FG001|Overall Study|Participant given Aranesp injection|0|||
130593235|NCT01381094|470131070|FG002|Overall Study|Participant given Aranesp injection|0|||
130593236|NCT01381094|470131071|FG003|Overall Study|Participant given Aranesp injection|0|||
130593237|NCT01381094|470131072|FG004|Overall Study|Participant given Aranesp injection|0|||
130593238|NCT01934504|470131075|FG000|Overall Study|Protocol Deviation|0|||
130593239|NCT01934504|470131076|FG001|Overall Study|Protocol Deviation|0|||
130593240|NCT01934504|470131077|FG002|Overall Study|Protocol Deviation|0|||
130593241|NCT01934504|470131078|FG003|Overall Study|Protocol Deviation|2|||
130593242|NCT01934504|470131075|FG000|Overall Study|Study Terminated by Sponsor|1|||
130593243|NCT01934504|470131076|FG001|Overall Study|Study Terminated by Sponsor|0|||
130593244|NCT01934504|470131077|FG002|Overall Study|Study Terminated by Sponsor|5|||
130593245|NCT01934504|470131078|FG003|Overall Study|Study Terminated by Sponsor|5|||
130593246|NCT00541307|470131079|FG000|Overall Study|Death|5|||
130593247|NCT00541307|470131079|FG000|Overall Study|Physician Decision|3|||
130593248|NCT00541307|470131079|FG000|Overall Study|Withdrawal by Subject|6|||
130593249|NCT00541307|470131079|FG000|Overall Study|Lost to Follow-up|4|||
130593250|NCT00541307|470131079|FG000|Overall Study|Subject returned early (outside window)|1|||
130593251|NCT00541307|470131079|FG000|Overall Study|Surgical Bypass|5|||
130593252|NCT03615222|470131084|FG000|Overall Study|Ineligible|26|||
130593253|NCT03615222|470131084|FG000|Overall Study|Withdrawal by Subject|7|||
130593254|NCT03615222|470131084|FG000|Overall Study|Death|1|||
130593255|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
130593256|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
130593257|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
130593258|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130593259|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130593260|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130593261|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
130593262|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130593263|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130593264|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130593265|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130593266|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130593267|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
130593268|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130593269|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130593270|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130593271|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130593272|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130593273|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
130593274|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
130593275|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
130593276|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130593277|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130593278|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130593279|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130593280|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
130593281|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130593282|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130593283|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130593284|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130593285|NCT03895203|470131085|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130593286|NCT03895203|470131086|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
130593287|NCT03895203|470131087|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130593288|NCT03895203|470131088|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130593289|NCT03895203|470131089|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130593290|NCT03895203|470131090|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130593291|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130593292|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130593293|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130593294|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
130593295|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130593296|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130593297|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130593298|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130593299|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130593300|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
130593301|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
130593302|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
130593303|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130593304|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130593305|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130593306|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
130593307|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
130593308|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
130593309|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130593310|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130593311|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130593312|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
130593313|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
130593314|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130593315|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130593316|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130593317|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130593318|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
130593319|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
130593320|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
130593321|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130593322|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130593323|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130593324|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
130593325|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130593326|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130593327|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130593328|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130593329|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130593330|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
130593331|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130593332|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130593333|NCT03895203|470131085|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130593334|NCT03895203|470131086|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130593335|NCT03895203|470131087|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130593336|NCT03895203|470131088|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130593337|NCT03895203|470131089|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130593338|NCT03895203|470131090|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
130593339|NCT00996840|470131091|FG000|Overall Study|Adverse Event|0|||
130593340|NCT00996840|470131092|FG001|Overall Study|Adverse Event|1|||
130593341|NCT00996840|470131093|FG002|Overall Study|Adverse Event|0|||
130593342|NCT00996840|470131094|FG003|Overall Study|Adverse Event|0|||
130593343|NCT00996840|470131095|FG004|Overall Study|Adverse Event|0|||
130593344|NCT00996840|470131091|FG000|Overall Study|Physician Decision|0|||
130593345|NCT00996840|470131092|FG001|Overall Study|Physician Decision|0|||
130593346|NCT00996840|470131093|FG002|Overall Study|Physician Decision|1|||
130593347|NCT00996840|470131094|FG003|Overall Study|Physician Decision|1|||
130593348|NCT00996840|470131095|FG004|Overall Study|Physician Decision|2|||
130593349|NCT00996840|470131091|FG000|Overall Study|Withdrawal by Subject|1|||
130593350|NCT00996840|470131092|FG001|Overall Study|Withdrawal by Subject|1|||
130593351|NCT00996840|470131093|FG002|Overall Study|Withdrawal by Subject|0|||
130593352|NCT00996840|470131094|FG003|Overall Study|Withdrawal by Subject|0|||
130593353|NCT00996840|470131095|FG004|Overall Study|Withdrawal by Subject|0|||
130593354|NCT00886938|470131096|FG000|Overall Study|Adverse Event|1|||
130593355|NCT00886938|470131096|FG000|Overall Study|Withdrawal by Subject|1|||
130593356|NCT00363415|470131097|FG000|Overall Study|Progressive Disease|196|||
130593357|NCT00363415|470131098|FG001|Overall Study|Progressive Disease|107|||
130593358|NCT00363415|470131097|FG000|Overall Study|Sponsor Decision|67|||
130593359|NCT00363415|470131098|FG001|Overall Study|Sponsor Decision|31|||
130593360|NCT00363415|470131097|FG000|Overall Study|Death|32|||
130593361|NCT00363415|470131098|FG001|Overall Study|Death|29|||
130593362|NCT00363415|470131097|FG000|Overall Study|Adverse Event|24|||
130593363|NCT00363415|470131098|FG001|Overall Study|Adverse Event|15|||
130593364|NCT00363415|470131097|FG000|Overall Study|Physician Decision|18|||
130593365|NCT00363415|470131098|FG001|Overall Study|Physician Decision|35|||
130593366|NCT00363415|470131097|FG000|Overall Study|Entry Criteria Not Met|11|||
130593367|NCT00363415|470131098|FG001|Overall Study|Entry Criteria Not Met|10|||
130593368|NCT00363415|470131097|FG000|Overall Study|Withdrawal by Subject|9|||
130593369|NCT00363415|470131098|FG001|Overall Study|Withdrawal by Subject|15|||
130593370|NCT00363415|470131097|FG000|Overall Study|Lost to Follow-up|3|||
130593371|NCT00363415|470131098|FG001|Overall Study|Lost to Follow-up|3|||
130593372|NCT00363415|470131097|FG000|Overall Study|Protocol Violation|1|||
130593373|NCT00363415|470131098|FG001|Overall Study|Protocol Violation|4|||
130593374|NCT05027802|470131101|FG000|Overall Study|Adverse Event|2|||
130593375|NCT05027802|470131101|FG000|Overall Study|Withdrawal by Subject|18|||
130593376|NCT05027802|470131101|FG000|Overall Study|Death|2|||
130593377|NCT05027802|470131101|FG000|Overall Study|Other|1|||
130593378|NCT03872180|470131104|FG000|Overall Study|Adverse Event|4|||
130593379|NCT03872180|470131104|FG000|Overall Study|Lack of Efficacy|2|||
130593380|NCT01506141|470131105|FG000|Overall Study|Adverse Event|0|||
130593381|NCT01506141|470131106|FG001|Overall Study|Adverse Event|2|||
130593382|NCT01506141|470131105|FG000|Overall Study|Participation Terminated by Investigator|1|||
130593383|NCT01506141|470131106|FG001|Overall Study|Participation Terminated by Investigator|1|||
130593384|NCT01506141|470131105|FG000|Overall Study|Site Terminated by Sponsor|2|||
130593385|NCT01506141|470131106|FG001|Overall Study|Site Terminated by Sponsor|0|||
130593386|NCT01506141|470131105|FG000|Overall Study|Reason Not Specified|4|||
130593387|NCT01506141|470131106|FG001|Overall Study|Reason Not Specified|2|||
130593388|NCT04607408|470131107|FG000|Overall Study|Lost to Follow-up|0|||
130593389|NCT04607408|470131108|FG001|Overall Study|Lost to Follow-up|0|||
130593390|NCT04607408|470131109|FG002|Overall Study|Lost to Follow-up|0|||
130593391|NCT04607408|470131110|FG003|Overall Study|Lost to Follow-up|1|||
130593392|NCT04607408|470131111|FG004|Overall Study|Lost to Follow-up|0|||
130593393|NCT04607408|470131107|FG000|Overall Study|Withdrawal by Subject|0|||
130593394|NCT04607408|470131108|FG001|Overall Study|Withdrawal by Subject|1|||
130593395|NCT04607408|470131109|FG002|Overall Study|Withdrawal by Subject|0|||
130593396|NCT04607408|470131110|FG003|Overall Study|Withdrawal by Subject|1|||
130593397|NCT04607408|470131111|FG004|Overall Study|Withdrawal by Subject|0|||
130593398|NCT02725788|470131116|FG000|Overall Study|Lost to Follow-up|1|||
130593399|NCT02725788|470131117|FG001|Overall Study|Lost to Follow-up|1|||
130593400|NCT02725788|470131116|FG000|Overall Study|Protocol Violation|0|||
130593401|NCT02725788|470131117|FG001|Overall Study|Protocol Violation|1|||
130593402|NCT04919564|470131120|FG000|Overall Study|Lost to Follow-up|1|||
130593403|NCT04919564|470131121|FG001|Overall Study|Lost to Follow-up|0|||
130593404|NCT04919564|470131120|FG000|Overall Study|Physician Decision|1|||
130593405|NCT04919564|470131121|FG001|Overall Study|Physician Decision|1|||
130593406|NCT01241786|470131122|FG000|Overall Study|Lack of Efficacy|5|||
130593407|NCT01051739|470131124|FG000|Overall Study|Death|3|||
130593408|NCT01051739|470131125|FG001|Overall Study|Death|3|||
130593409|NCT01051739|470131124|FG000|Overall Study|Withdrawal by Subject|25|||
130593410|NCT01051739|470131125|FG001|Overall Study|Withdrawal by Subject|10|||
130593411|NCT02499952|470131126|FG000|Overall Study|Lost to Follow-up|1|||
130593412|NCT02499952|470131126|FG000|Overall Study|Death|9|||
130593413|NCT01440101|470131127|FG000|Overall Study|Adverse Event|2|||
130593414|NCT01440101|470131128|FG001|Overall Study|Adverse Event|0|||
130593415|NCT01440101|470131129|FG002|Overall Study|Adverse Event|0|||
130593416|NCT01440101|470131127|FG000|Overall Study|Withdrawal by Subject|0|||
130593417|NCT01440101|470131128|FG001|Overall Study|Withdrawal by Subject|3|||
130593418|NCT01440101|470131129|FG002|Overall Study|Withdrawal by Subject|1|||
130593419|NCT01440101|470131127|FG000|Overall Study|Other|0|||
130593420|NCT01440101|470131128|FG001|Overall Study|Other|1|||
130593421|NCT01440101|470131129|FG002|Overall Study|Other|0|||
130593422|NCT00636818|470131133|FG000|Overall Study|Adverse Event|1|||
130593423|NCT00636818|470131133|FG000|Overall Study|Lost to Follow-up|2|||
130593424|NCT00636818|470131133|FG000|Overall Study|Entry Criteria Exclusion|3|||
130593425|NCT00636818|470131133|FG000|Overall Study|Protocol Violation|1|||
130593426|NCT00636818|470131133|FG000|Overall Study|Withdrawal by Subject|4|||
130593427|NCT00074958|470131134|FG000|Overall Study|Adverse Event|1|||
130593428|NCT02115308|470131140|FG000|Overall Study|Safety Screening|2|||
130593429|NCT02115308|470131141|FG001|Overall Study|Safety Screening|2|||
130593430|NCT01658514|470131149|FG000|Overall Study|Protocol Violation|1|||
130593431|NCT01658514|470131150|FG001|Overall Study|Protocol Violation|0|||
130593432|NCT01658514|470131151|FG002|Overall Study|Protocol Violation|2|||
130593433|NCT02344576|470131155|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
130593434|NCT02344576|470131156|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
130593435|NCT02344576|470131157|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
130593436|NCT02344576|470131158|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
130593437|NCT02344576|470131155|FG000|1-Month Follow-Up|Death|13|||
130593438|NCT02344576|470131156|FG001|1-Month Follow-Up|Death|8|||
130593439|NCT02344576|470131157|FG002|1-Month Follow-Up|Death|0|||
130593440|NCT02344576|470131158|FG003|1-Month Follow-Up|Death|0|||
130593441|NCT02344576|470131155|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
130593442|NCT02344576|470131156|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
130593443|NCT02344576|470131157|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
130593444|NCT02344576|470131158|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
130593445|NCT02344576|470131155|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
130593446|NCT02344576|470131156|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
130593447|NCT02344576|470131157|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
130593448|NCT02344576|470131158|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
130593449|NCT02344576|470131155|FG000|6-Month Follow-Up|Death|14|||
130593450|NCT02344576|470131156|FG001|6-Month Follow-Up|Death|14|||
130593451|NCT02344576|470131157|FG002|6-Month Follow-Up|Death|0|||
130593452|NCT02344576|470131158|FG003|6-Month Follow-Up|Death|0|||
130593453|NCT02344576|470131155|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
130593454|NCT02344576|470131156|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
130593455|NCT02344576|470131157|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
130593456|NCT02344576|470131158|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
130593457|NCT02344576|470131155|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
130593458|NCT02344576|470131156|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
130593459|NCT02344576|470131157|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
130593460|NCT02344576|470131158|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
130593461|NCT04325503|470131173|FG000|Overall Study|Withdrawal by Subject|1|||
130593462|NCT04325503|470131173|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
130593463|NCT03832387|470131174|FG000|Overall Study|Protocol Violation|2|||
130593464|NCT03832387|470131175|FG001|Overall Study|Protocol Violation|6|||
130593465|NCT03832387|470131174|FG000|Overall Study|EXCLUSION CRITERIA|3|||
130593466|NCT03832387|470131175|FG001|Overall Study|EXCLUSION CRITERIA|1|||
130593467|NCT00144170|470131176|FG000|Overall Study|Adverse Event|84|||
130593468|NCT00144170|470131177|FG001|Overall Study|Adverse Event|41|||
130593469|NCT00144170|470131176|FG000|Overall Study|Protocol Violation|23|||
130593470|NCT00144170|470131177|FG001|Overall Study|Protocol Violation|16|||
130593471|NCT00144170|470131176|FG000|Overall Study|Lost to Follow-up|5|||
130593472|NCT00144170|470131177|FG001|Overall Study|Lost to Follow-up|10|||
130593473|NCT00144170|470131176|FG000|Overall Study|Withdrawal by Subject|29|||
130593474|NCT00144170|470131177|FG001|Overall Study|Withdrawal by Subject|13|||
130593475|NCT00144170|470131176|FG000|Overall Study|Other reason not defined above|211|||
130593476|NCT00144170|470131177|FG001|Overall Study|Other reason not defined above|316|||
130593477|NCT00702143|470131178|FG000|Overall Study|Lost to Follow-up|0|||
130593478|NCT00702143|470131179|FG001|Overall Study|Lost to Follow-up|0|||
130593479|NCT00702143|470131180|FG002|Overall Study|Lost to Follow-up|1|||
130593480|NCT06218251|470131181|FG000|Overall Study|Lost to Follow-up|4|||
130593481|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
130593482|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
130593483|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130593484|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130593485|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130593486|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
130593487|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
130593488|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130593489|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130593490|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130593491|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
130593492|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130593493|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130593494|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130593495|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130593496|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
130593497|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130593498|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130593499|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130593500|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130593501|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Death|0|||
130593502|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Death|1|||
130593503|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Death|0|||
130593504|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Death|0|||
130593505|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Death|0|||
130593506|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130593507|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
130593508|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130593509|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130593510|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130593511|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
130593512|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130593513|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130593514|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130593515|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130593516|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
130593517|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130593518|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130593519|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130593520|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130593521|NCT05087030|470131182|FG000|Main Period (Week 0 to Week 52)|Other|1|||
130593522|NCT05087030|470131183|FG001|Main Period (Week 0 to Week 52)|Other|2|||
130593523|NCT05087030|470131184|FG002|Main Period (Week 0 to Week 52)|Other|0|||
130593524|NCT05087030|470131185|FG003|Main Period (Week 0 to Week 52)|Other|0|||
130593525|NCT05087030|470131186|FG004|Main Period (Week 0 to Week 52)|Other|0|||
130593526|NCT05087030|470131182|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130593527|NCT05087030|470131183|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130593528|NCT05087030|470131184|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130593529|NCT05087030|470131185|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130593530|NCT05087030|470131186|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
130593531|NCT04826900|470131187|FG000|Overall Study|Family factor|1|||
130593532|NCT04826900|470131188|FG001|Overall Study|Family factor|1|||
130593533|NCT00686543|470131189|FG000|Overall Study|Adverse Event|9|||
130593534|NCT00686543|470131190|FG001|Overall Study|Adverse Event|1|||
130593535|NCT00686543|470131191|FG002|Overall Study|Adverse Event|3|||
130593536|NCT00686543|470131192|FG003|Overall Study|Adverse Event|2|||
130593537|NCT00686543|470131189|FG000|Overall Study|Withdrawal by Subject|2|||
130593538|NCT00686543|470131190|FG001|Overall Study|Withdrawal by Subject|0|||
130593539|NCT00686543|470131191|FG002|Overall Study|Withdrawal by Subject|0|||
130593540|NCT00686543|470131192|FG003|Overall Study|Withdrawal by Subject|0|||
130593541|NCT00686543|470131189|FG000|Overall Study|Protocol Violation|3|||
130593542|NCT00686543|470131190|FG001|Overall Study|Protocol Violation|0|||
130593543|NCT00686543|470131191|FG002|Overall Study|Protocol Violation|2|||
130593544|NCT00686543|470131192|FG003|Overall Study|Protocol Violation|1|||
130593545|NCT00609622|470131193|FG000|Overall Study|Adverse Event|14|||
130593546|NCT00609622|470131194|FG001|Overall Study|Adverse Event|10|||
130593547|NCT00609622|470131193|FG000|Overall Study|Withdrawal by Subject|4|||
130593548|NCT00609622|470131194|FG001|Overall Study|Withdrawal by Subject|20|||
130593549|NCT00609622|470131193|FG000|Overall Study|Death|1|||
130593550|NCT00609622|470131194|FG001|Overall Study|Death|4|||
130593551|NCT00609622|470131193|FG000|Overall Study|Protocol Violation|1|||
130593552|NCT00609622|470131194|FG001|Overall Study|Protocol Violation|1|||
130593553|NCT00609622|470131193|FG000|Overall Study|Objective progression or relapse|47|||
130593554|NCT00609622|470131194|FG001|Overall Study|Objective progression or relapse|41|||
130593555|NCT00609622|470131193|FG000|Overall Study|Study terminated by sponsor|16|||
130593556|NCT00609622|470131194|FG001|Overall Study|Study terminated by sponsor|3|||
130593557|NCT00609622|470131193|FG000|Overall Study|Other|7|||
130593558|NCT00609622|470131194|FG001|Overall Study|Other|14|||
130593559|NCT00609622|470131193|FG000|Overall Study|Global deterioration of health status|6|||
130593560|NCT00609622|470131194|FG001|Overall Study|Global deterioration of health status|2|||
130593561|NCT02370121|470131195|FG000|Overall Study|Lost to Follow-up|1|||
130593562|NCT02370121|470131196|FG001|Overall Study|Lost to Follow-up|1|||
130593569|NCT02582658|470131207|FG000|Overall Study|Failure to Return|10|||
130593570|NCT02582658|470131207|FG000|Overall Study|Insufficient Virological Response|2|||
130593571|NCT02582658|470131207|FG000|Overall Study|Withdrawn Consent|1|||
130593572|NCT02582658|470131207|FG000|Overall Study|Death|1|||
130593573|NCT02582658|470131207|FG000|Overall Study|Not further specified|11|||
130593574|NCT01024244|470132651|FG000|Overall Study|Adverse Event|1|||
130593575|NCT01024244|470132652|FG001|Overall Study|Adverse Event|2|||
130593576|NCT01024244|470132653|FG002|Overall Study|Adverse Event|0|||
130593577|NCT01024244|470132654|FG003|Overall Study|Adverse Event|1|||
130593578|NCT01024244|470132655|FG004|Overall Study|Adverse Event|2|||
130593579|NCT01024244|470132651|FG000|Overall Study|Entry Criteria Not Met|0|||
130593580|NCT01024244|470132652|FG001|Overall Study|Entry Criteria Not Met|1|||
130593581|NCT01024244|470132653|FG002|Overall Study|Entry Criteria Not Met|0|||
130593582|NCT01024244|470132654|FG003|Overall Study|Entry Criteria Not Met|0|||
130593583|NCT01024244|470132655|FG004|Overall Study|Entry Criteria Not Met|0|||
130593584|NCT01024244|470132651|FG000|Overall Study|Lack of Efficacy|1|||
130593585|NCT01024244|470132652|FG001|Overall Study|Lack of Efficacy|0|||
130593586|NCT01024244|470132653|FG002|Overall Study|Lack of Efficacy|0|||
130593587|NCT01024244|470132654|FG003|Overall Study|Lack of Efficacy|0|||
130593588|NCT01024244|470132655|FG004|Overall Study|Lack of Efficacy|0|||
130593589|NCT01024244|470132651|FG000|Overall Study|Protocol Violation|1|||
130593590|NCT01024244|470132652|FG001|Overall Study|Protocol Violation|0|||
130593591|NCT01024244|470132653|FG002|Overall Study|Protocol Violation|0|||
130593592|NCT01024244|470132654|FG003|Overall Study|Protocol Violation|0|||
130593593|NCT01024244|470132655|FG004|Overall Study|Protocol Violation|2|||
130593594|NCT01024244|470132651|FG000|Overall Study|Sponsor Decision|14|||
130593595|NCT01024244|470132652|FG001|Overall Study|Sponsor Decision|7|||
130593596|NCT01024244|470132653|FG002|Overall Study|Sponsor Decision|14|||
130593597|NCT01024244|470132654|FG003|Overall Study|Sponsor Decision|12|||
130593598|NCT01024244|470132655|FG004|Overall Study|Sponsor Decision|10|||
130593599|NCT01024244|470132651|FG000|Overall Study|Withdrawal by Subject|0|||
130593600|NCT01024244|470132652|FG001|Overall Study|Withdrawal by Subject|1|||
130593601|NCT01024244|470132653|FG002|Overall Study|Withdrawal by Subject|0|||
130593602|NCT01024244|470132654|FG003|Overall Study|Withdrawal by Subject|0|||
130593603|NCT01024244|470132655|FG004|Overall Study|Withdrawal by Subject|0|||
130593604|NCT04645797|470132665|FG000|Overall Study|Disease Progression|3|||
130593605|NCT04645797|470132666|FG001|Overall Study|Disease Progression|3|||
130593606|NCT04645797|470132667|FG002|Overall Study|Disease Progression|1|||
130593607|NCT04645797|470132668|FG003|Overall Study|Disease Progression|0|||
130593608|NCT04645797|470132669|FG004|Overall Study|Disease Progression|0|||
130593609|NCT04645797|470132670|FG005|Overall Study|Disease Progression|0|||
130593610|NCT04645797|470132671|FG006|Overall Study|Disease Progression|0|||
130593611|NCT04645797|470132665|FG000|Overall Study|Death|3|||
130593612|NCT04645797|470132666|FG001|Overall Study|Death|1|||
130593613|NCT04645797|470132667|FG002|Overall Study|Death|0|||
130593614|NCT04645797|470132668|FG003|Overall Study|Death|0|||
130593615|NCT04645797|470132669|FG004|Overall Study|Death|0|||
130593616|NCT04645797|470132670|FG005|Overall Study|Death|0|||
130593617|NCT04645797|470132671|FG006|Overall Study|Death|0|||
130593618|NCT00733902|470132673|FG000|Overall Study|Death|0|||
130593619|NCT00733902|470132674|FG001|Overall Study|Death|0|||
130593620|NCT00733902|470132675|FG002|Overall Study|Death|0|||
130593621|NCT00733902|470132676|FG003|Overall Study|Death|1|||
130593622|NCT00733902|470132673|FG000|Overall Study|Adverse Event|3|||
130593623|NCT00733902|470132674|FG001|Overall Study|Adverse Event|4|||
130593624|NCT00733902|470132675|FG002|Overall Study|Adverse Event|7|||
130593625|NCT00733902|470132676|FG003|Overall Study|Adverse Event|11|||
130593626|NCT00733902|470132673|FG000|Overall Study|Lack of Efficacy|56|||
130593627|NCT00733902|470132674|FG001|Overall Study|Lack of Efficacy|21|||
130593628|NCT00733902|470132675|FG002|Overall Study|Lack of Efficacy|34|||
130593629|NCT00733902|470132676|FG003|Overall Study|Lack of Efficacy|23|||
130593630|NCT00733902|470132673|FG000|Overall Study|Protocol Violation|4|||
130593631|NCT00733902|470132674|FG001|Overall Study|Protocol Violation|6|||
130593632|NCT00733902|470132675|FG002|Overall Study|Protocol Violation|3|||
130593633|NCT00733902|470132676|FG003|Overall Study|Protocol Violation|3|||
130593634|NCT00733902|470132673|FG000|Overall Study|Withdrawal by Subject|10|||
130593635|NCT00733902|470132674|FG001|Overall Study|Withdrawal by Subject|5|||
130593636|NCT00733902|470132675|FG002|Overall Study|Withdrawal by Subject|4|||
130593637|NCT00733902|470132676|FG003|Overall Study|Withdrawal by Subject|16|||
130593638|NCT00733902|470132673|FG000|Overall Study|Entered extension study|89|||
130593639|NCT00733902|470132674|FG001|Overall Study|Entered extension study|124|||
130593640|NCT00733902|470132675|FG002|Overall Study|Entered extension study|111|||
130593641|NCT00733902|470132676|FG003|Overall Study|Entered extension study|109|||
130593642|NCT00733902|470132673|FG000|Overall Study|Randomized but not treated|2|||
130593643|NCT00733902|470132674|FG001|Overall Study|Randomized but not treated|2|||
130593644|NCT00733902|470132675|FG002|Overall Study|Randomized but not treated|2|||
130593645|NCT00733902|470132676|FG003|Overall Study|Randomized but not treated|1|||
130593646|NCT00049127|470132677|FG000|Overall Study|Withdrawal by Subject|0|||
130593647|NCT00049127|470132678|FG001|Overall Study|Withdrawal by Subject|0|||
130593648|NCT00049127|470132679|FG002|Overall Study|Withdrawal by Subject|1|||
130593649|NCT00049127|470132680|FG003|Overall Study|Withdrawal by Subject|0|||
130593650|NCT00049127|470132681|FG004|Overall Study|Withdrawal by Subject|0|||
130593651|NCT02582515|470132682|FG000|Overall Study|Withdrawal by Subject|0|||
130593652|NCT02582515|470132683|FG001|Overall Study|Withdrawal by Subject|1|||
130593653|NCT00775021|470132684|FG000|First Intervention|Lost to Follow-up|1|||
130593654|NCT00775021|470132685|FG001|First Intervention|Lost to Follow-up|0|||
130593655|NCT00775021|470132684|FG000|Second Intervention|Adverse Event|0|||
130593656|NCT00775021|470132685|FG001|Second Intervention|Adverse Event|1|||
130593657|NCT00870688|470132686|FG000|Overall Study|Lost to Follow-up|2|||
130593658|NCT00870688|470132686|FG000|Overall Study|Death, Unrelated|1|||
130593659|NCT00870688|470132686|FG000|Overall Study|Granules in the Stools|1|||
130593660|NCT04927312|470132693|FG000|Overall Study|Adverse Event|1|||
130593661|NCT04927312|470132693|FG000|Overall Study|Death|1|||
130593662|NCT04927312|470132693|FG000|Overall Study|Withdrawal by Subject|1|||
130593663|NCT04927312|470132693|FG000|Overall Study|Other|1|||
130593664|NCT01122927|470132694|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
130593665|NCT01122927|470132695|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
130593666|NCT01122927|470132694|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
130593667|NCT01122927|470132695|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130593668|NCT01122927|470132694|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
130593669|NCT01122927|470132695|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
130593670|NCT01122927|470132694|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
130593671|NCT01122927|470132695|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130593672|NCT01122927|470132694|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
130593673|NCT01122927|470132695|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
130593674|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
130593675|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
130593676|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
130593677|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
130593678|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
130593679|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
130593680|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
130593681|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
130593682|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
130593683|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
130593684|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
130593685|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
130593686|NCT01122927|470132694|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
130593687|NCT01122927|470132695|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
130593688|NCT01676961|470132698|FG000|Overall Study|Death|3|||
130593689|NCT01676961|470132698|FG000|Overall Study|Lost to Follow-up|1|||
130593690|NCT01676961|470132698|FG000|Overall Study|Withdrawal by Subject|1|||
130593691|NCT00117312|470132699|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
130593692|NCT00117312|470132700|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
130593693|NCT00117312|470132701|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
130593694|NCT00117312|470132702|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
130593695|NCT00117312|470132699|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
130593696|NCT00117312|470132700|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
130593697|NCT00117312|470132701|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
130593698|NCT00117312|470132702|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
130593699|NCT00117312|470132699|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
130593700|NCT00117312|470132700|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
130593701|NCT00117312|470132701|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
130593702|NCT00117312|470132702|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
130593703|NCT00117312|470132699|FG000|Overall Study|Other|0|||
130593704|NCT00117312|470132700|FG001|Overall Study|Other|1|||
130593705|NCT00117312|470132701|FG002|Overall Study|Other|3|||
130593706|NCT00117312|470132702|FG003|Overall Study|Other|1|||
130593707|NCT00117312|470132699|FG000|Overall Study|Patient choice|0|||
130593708|NCT00117312|470132700|FG001|Overall Study|Patient choice|0|||
130593709|NCT00117312|470132701|FG002|Overall Study|Patient choice|2|||
130593710|NCT00117312|470132702|FG003|Overall Study|Patient choice|1|||
130593711|NCT00117312|470132699|FG000|Overall Study|Adverse Event|0|||
130593712|NCT00117312|470132700|FG001|Overall Study|Adverse Event|2|||
130593713|NCT00117312|470132701|FG002|Overall Study|Adverse Event|0|||
130593714|NCT00117312|470132702|FG003|Overall Study|Adverse Event|0|||
130593715|NCT00117312|470132699|FG000|Overall Study|Protocol Violation|0|||
130593716|NCT00117312|470132700|FG001|Overall Study|Protocol Violation|1|||
130593717|NCT00117312|470132701|FG002|Overall Study|Protocol Violation|3|||
130593718|NCT00117312|470132702|FG003|Overall Study|Protocol Violation|0|||
130593719|NCT00117312|470132699|FG000|Overall Study|PSA decrease <=50%|0|||
130593720|NCT00117312|470132700|FG001|Overall Study|PSA decrease <=50%|2|||
130593721|NCT00117312|470132701|FG002|Overall Study|PSA decrease <=50%|2|||
130593722|NCT00117312|470132702|FG003|Overall Study|PSA decrease <=50%|4|||
130593723|NCT00117312|470132699|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
130593724|NCT00117312|470132700|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
130593725|NCT00117312|470132701|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
130593726|NCT00117312|470132702|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
130593727|NCT00117312|470132699|FG000|Overall Study|Hepatic abnormality|0|||
130593728|NCT00117312|470132700|FG001|Overall Study|Hepatic abnormality|1|||
130593729|NCT00117312|470132701|FG002|Overall Study|Hepatic abnormality|0|||
130593730|NCT00117312|470132702|FG003|Overall Study|Hepatic abnormality|1|||
130593731|NCT00117312|470132699|FG000|Overall Study|Withdrawal by Subject|0|||
130593732|NCT00117312|470132700|FG001|Overall Study|Withdrawal by Subject|2|||
130593733|NCT00117312|470132701|FG002|Overall Study|Withdrawal by Subject|0|||
130593734|NCT00117312|470132702|FG003|Overall Study|Withdrawal by Subject|0|||
130593735|NCT00195650|470132703|FG000|Overall Study|Adverse Event|194|||
130593736|NCT00195650|470132703|FG000|Overall Study|Lack of Efficacy|99|||
130593737|NCT00195650|470132703|FG000|Overall Study|Withdrawal by Subject|67|||
130593738|NCT00195650|470132703|FG000|Overall Study|Lost to Follow-up|44|||
130593739|NCT00195650|470132703|FG000|Overall Study|Death|23|||
130593740|NCT00195650|470132703|FG000|Overall Study|Protocol Violation|15|||
130593741|NCT00195650|470132703|FG000|Overall Study|Administrative reasons|83|||
130593742|NCT02371629|470132709|FG000|Overall Study|Patient decision|14|||
130593743|NCT02371629|470132710|FG001|Overall Study|Patient decision|10|||
130593744|NCT02371629|470132709|FG000|Overall Study|Adverse Event|8|||
130593745|NCT02371629|470132710|FG001|Overall Study|Adverse Event|8|||
130593746|NCT02371629|470132709|FG000|Overall Study|Physician Decision|2|||
130593747|NCT02371629|470132710|FG001|Overall Study|Physician Decision|3|||
130593748|NCT02371629|470132709|FG000|Overall Study|Death|1|||
130593749|NCT02371629|470132710|FG001|Overall Study|Death|1|||
130593750|NCT02371629|470132709|FG000|Overall Study|Noncompliance with study treatment|1|||
130593751|NCT02371629|470132710|FG001|Overall Study|Noncompliance with study treatment|0|||
130593752|NCT02371629|470132709|FG000|Overall Study|Lack of Efficacy|0|||
130593753|NCT02371629|470132710|FG001|Overall Study|Lack of Efficacy|2|||
130593754|NCT02371629|470132709|FG000|Overall Study|Protocol deviation|0|||
130593755|NCT02371629|470132710|FG001|Overall Study|Protocol deviation|1|||
130593756|NCT00201851|470132711|FG000|Overall Study|Lost to Follow-up|2|||
130593757|NCT00201851|470132712|FG001|Overall Study|Lost to Follow-up|1|||
130593758|NCT00201851|470132713|FG002|Overall Study|Lost to Follow-up|0|||
130593759|NCT00201851|470132711|FG000|Overall Study|Ineligible post enrollment|6|||
130593760|NCT00201851|470132712|FG001|Overall Study|Ineligible post enrollment|1|||
130593761|NCT00201851|470132713|FG002|Overall Study|Ineligible post enrollment|1|||
130593762|NCT00749203|470132717|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
130593763|NCT00749203|470132718|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
130593764|NCT00749203|470132717|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
130593765|NCT00749203|470132718|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
130593766|NCT00749203|470132717|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
130593767|NCT00749203|470132718|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
130593768|NCT00749203|470132717|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
130593769|NCT00749203|470132718|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
130593770|NCT00749203|470132717|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
130593771|NCT00749203|470132718|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
130593772|NCT00749203|470132717|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
130593773|NCT00749203|470132718|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
130593774|NCT02853760|470132719|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
130593775|NCT02853760|470132720|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
130593776|NCT02853760|470132721|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
130593777|NCT02853760|470132722|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
130593778|NCT02853760|470132723|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
130593779|NCT02853760|470132724|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
130593780|NCT01243268|470132725|FG000|Overall Study|Lost to Follow-up|4|||
130593781|NCT01243268|470132725|FG000|Overall Study|Protocol Violation|51|||
130593782|NCT01243268|470132725|FG000|Overall Study|Deviation with contract date|7|||
130593783|NCT01243268|470132725|FG000|Overall Study|Duplicate subject|2|||
130593784|NCT00957853|470132726|FG000|Overall Study|Withdrawal by Subject|1|||
130593785|NCT00957853|470132727|FG001|Overall Study|Withdrawal by Subject|0|||
130593786|NCT00957853|470132728|FG002|Overall Study|Withdrawal by Subject|0|||
130593787|NCT00004980|470132729|FG000|Overall Study|Withdrawal by Subject|1|||
130593788|NCT00004980|470132730|FG001|Overall Study|Withdrawal by Subject|0|||
130593789|NCT00004980|470132729|FG000|Overall Study|memory difficulties|1|||
130593790|NCT00004980|470132730|FG001|Overall Study|memory difficulties|1|||
130593791|NCT00004980|470132729|FG000|Overall Study|Physician Decision|0|||
130593792|NCT00004980|470132730|FG001|Overall Study|Physician Decision|1|||
130593793|NCT03577990|470132731|FG000|Overall Study|Lost to Follow-up|4|||
130593794|NCT03577990|470132732|FG001|Overall Study|Lost to Follow-up|6|||
130593795|NCT03577990|470132731|FG000|Overall Study|Withdrawal by Subject|4|||
130593796|NCT03577990|470132732|FG001|Overall Study|Withdrawal by Subject|7|||
130593797|NCT04996797|470132737|FG000|Overall Study|Adverse Event|0|||
130593798|NCT04996797|470132738|FG001|Overall Study|Adverse Event|2|||
130593799|NCT04996797|470132739|FG002|Overall Study|Adverse Event|0|||
130593800|NCT04996797|470132740|FG003|Overall Study|Adverse Event|1|||
130593801|NCT04996797|470132737|FG000|Overall Study|Lack of Efficacy|0|||
130593802|NCT04996797|470132738|FG001|Overall Study|Lack of Efficacy|2|||
130593803|NCT04996797|470132739|FG002|Overall Study|Lack of Efficacy|0|||
130593804|NCT04996797|470132740|FG003|Overall Study|Lack of Efficacy|0|||
130593805|NCT04996797|470132737|FG000|Overall Study|Prohibited Medication|0|||
130593806|NCT04996797|470132738|FG001|Overall Study|Prohibited Medication|1|||
130593807|NCT04996797|470132739|FG002|Overall Study|Prohibited Medication|0|||
130593808|NCT04996797|470132740|FG003|Overall Study|Prohibited Medication|0|||
130593809|NCT04996797|470132737|FG000|Overall Study|Ongoing|68|||
130593810|NCT04996797|470132738|FG001|Overall Study|Ongoing|60|||
130593811|NCT04996797|470132739|FG002|Overall Study|Ongoing|22|||
130593812|NCT04996797|470132740|FG003|Overall Study|Ongoing|20|||
130593813|NCT04996797|470132737|FG000|Overall Study|Withdrawal by Subject|0|||
130593814|NCT04996797|470132738|FG001|Overall Study|Withdrawal by Subject|2|||
130593815|NCT04996797|470132739|FG002|Overall Study|Withdrawal by Subject|0|||
130593816|NCT04996797|470132740|FG003|Overall Study|Withdrawal by Subject|0|||
130593817|NCT02793544|470132741|FG000|Overall Study|Death|10|||
130593818|NCT02793544|470132742|FG001|Overall Study|Death|8|||
130593819|NCT02793544|470132741|FG000|Overall Study|Lost to Follow-up|2|||
130593820|NCT02793544|470132742|FG001|Overall Study|Lost to Follow-up|0|||
130593821|NCT02793544|470132741|FG000|Overall Study|Withdrawal by Subject|1|||
130593822|NCT02793544|470132742|FG001|Overall Study|Withdrawal by Subject|0|||
130593823|NCT03372941|470132745|FG000|Overall Study|Lost to Follow-up|2|||
130593824|NCT03372941|470132746|FG001|Overall Study|Lost to Follow-up|4|||
130593825|NCT00741819|470132747|FG000|Overall Study|Adverse Event|3|||
130593826|NCT00741819|470132747|FG000|Overall Study|Withdrawal by Subject|3|||
130593827|NCT00741819|470132747|FG000|Overall Study|Death|1|||
130593828|NCT00741819|470132747|FG000|Overall Study|Disease progression|1|||
130593829|NCT01126580|470132748|FG000|Overall Study|Adverse Event|14|||
130593830|NCT01126580|470132749|FG001|Overall Study|Adverse Event|8|||
130593831|NCT01126580|470132750|FG002|Overall Study|Adverse Event|12|||
130593832|NCT01126580|470132748|FG000|Overall Study|Withdrawal by Subject|11|||
130593833|NCT01126580|470132749|FG001|Overall Study|Withdrawal by Subject|19|||
130593834|NCT01126580|470132750|FG002|Overall Study|Withdrawal by Subject|14|||
130593835|NCT01126580|470132748|FG000|Overall Study|Sponsor Decision|5|||
130593836|NCT01126580|470132749|FG001|Overall Study|Sponsor Decision|4|||
130593837|NCT01126580|470132750|FG002|Overall Study|Sponsor Decision|7|||
130593838|NCT01126580|470132748|FG000|Overall Study|Physician Decision|1|||
130593839|NCT01126580|470132749|FG001|Overall Study|Physician Decision|1|||
130593840|NCT01126580|470132750|FG002|Overall Study|Physician Decision|2|||
130593841|NCT01126580|470132748|FG000|Overall Study|Entry Criteria Not Met|1|||
130593842|NCT01126580|470132749|FG001|Overall Study|Entry Criteria Not Met|1|||
130593843|NCT01126580|470132750|FG002|Overall Study|Entry Criteria Not Met|2|||
130593844|NCT01126580|470132748|FG000|Overall Study|Lack of Efficacy|2|||
130593845|NCT01126580|470132749|FG001|Overall Study|Lack of Efficacy|3|||
130593846|NCT01126580|470132750|FG002|Overall Study|Lack of Efficacy|4|||
130593847|NCT01126580|470132748|FG000|Overall Study|Protocol Violation|0|||
130593848|NCT01126580|470132749|FG001|Overall Study|Protocol Violation|1|||
130593849|NCT01126580|470132750|FG002|Overall Study|Protocol Violation|2|||
130593850|NCT01126580|470132748|FG000|Overall Study|Lost to Follow-up|15|||
130593851|NCT01126580|470132749|FG001|Overall Study|Lost to Follow-up|13|||
130593852|NCT01126580|470132750|FG002|Overall Study|Lost to Follow-up|9|||
130593853|NCT01126580|470132748|FG000|Overall Study|Treatment Non-compliance|0|||
130593854|NCT01126580|470132749|FG001|Overall Study|Treatment Non-compliance|2|||
130593855|NCT01126580|470132750|FG002|Overall Study|Treatment Non-compliance|3|||
130593856|NCT01708057|470132751|FG000|Overall Study|Withdrawal due to study termination.|1|||
130593857|NCT01708057|470132752|FG001|Overall Study|Withdrawal due to study termination.|1|||
130593858|NCT01708057|470132753|FG002|Overall Study|Withdrawal due to study termination.|1|||
130593859|NCT00538681|470132754|FG000|Overall Study|Progressive Disease|7|||
130593860|NCT00538681|470132755|FG001|Overall Study|Progressive Disease|0|||
130593861|NCT00538681|470132756|FG002|Overall Study|Progressive Disease|1|||
130593862|NCT00538681|470132757|FG003|Overall Study|Progressive Disease|0|||
130593863|NCT00538681|470132754|FG000|Overall Study|Sponsor Decision|1|||
130593864|NCT00538681|470132755|FG001|Overall Study|Sponsor Decision|3|||
130593865|NCT00538681|470132756|FG002|Overall Study|Sponsor Decision|8|||
130593866|NCT00538681|470132757|FG003|Overall Study|Sponsor Decision|9|||
130593867|NCT00538681|470132754|FG000|Overall Study|Adverse Event|1|||
130593868|NCT00538681|470132755|FG001|Overall Study|Adverse Event|1|||
130593869|NCT00538681|470132756|FG002|Overall Study|Adverse Event|1|||
130593870|NCT00538681|470132757|FG003|Overall Study|Adverse Event|0|||
130593871|NCT00538681|470132754|FG000|Overall Study|Death|0|||
130593872|NCT00538681|470132755|FG001|Overall Study|Death|0|||
130593873|NCT00538681|470132756|FG002|Overall Study|Death|1|||
130593874|NCT00538681|470132757|FG003|Overall Study|Death|1|||
130593875|NCT00538681|470132754|FG000|Overall Study|Investigator Decision|0|||
130593876|NCT00538681|470132755|FG001|Overall Study|Investigator Decision|0|||
130593877|NCT00538681|470132756|FG002|Overall Study|Investigator Decision|0|||
130593878|NCT00538681|470132757|FG003|Overall Study|Investigator Decision|1|||
130593879|NCT02970929|470132758|FG000|Overall Study|Adverse Event|18|||
130593880|NCT02970929|470132758|FG000|Overall Study|Lack of Efficacy|8|||
130593881|NCT02970929|470132758|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
130593882|NCT02970929|470132758|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
130593883|NCT02970929|470132758|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
130593884|NCT02970929|470132758|FG000|Overall Study|LOST TO FOLLOWUP|6|||
130593885|NCT02970929|470132758|FG000|Overall Study|MOVED OUT OF STATE|1|||
130593886|NCT02970929|470132758|FG000|Overall Study|Withdrawal by Subject|16|||
130593887|NCT05369806|470132761|FG000|Overall Study|Lost to Follow-up|1|||
130593888|NCT03929250|470132762|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
130593889|NCT03929250|470132763|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
130593890|NCT04194944|470132764|FG000|Overall Study|Lost to Follow-up|3|||
130593891|NCT04194944|470132765|FG001|Overall Study|Lost to Follow-up|0|||
130593892|NCT04194944|470132764|FG000|Overall Study|Withdrawal by Subject|2|||
130593893|NCT04194944|470132765|FG001|Overall Study|Withdrawal by Subject|2|||
130593894|NCT04194944|470132764|FG000|Overall Study|On Treatment|93|||
130593895|NCT04194944|470132765|FG001|Overall Study|On Treatment|30|||
130593896|NCT02581995|470132768|FG000|Overall Study|Unspecified other|3|||
130593897|NCT02581995|470132768|FG000|Overall Study|Adverse Event|6|||
130593898|NCT02581995|470132768|FG000|Overall Study|Lost to Follow-up|5|||
130593899|NCT02581995|470132768|FG000|Overall Study|Withdrawal by participant|12|||
130593900|NCT02581995|470132768|FG000|Overall Study|Physician Decision|1|||
130593901|NCT02581995|470132768|FG000|Overall Study|Death|4|||
130593902|NCT01324830|470134526|FG000|Overall Study|Progressive Disease|3|||
130593903|NCT01324830|470134527|FG001|Overall Study|Progressive Disease|2|||
130593904|NCT01324830|470134528|FG002|Overall Study|Progressive Disease|3|||
130593905|NCT01324830|470134529|FG003|Overall Study|Progressive Disease|3|||
130593906|NCT01324830|470134530|FG004|Overall Study|Progressive Disease|6|||
130593907|NCT01324830|470134531|FG005|Overall Study|Progressive Disease|6|||
130593908|NCT01324830|470134532|FG006|Overall Study|Progressive Disease|3|||
130593909|NCT01324830|470134533|FG007|Overall Study|Progressive Disease|3|||
130593910|NCT01324830|470134534|FG008|Overall Study|Progressive Disease|3|||
130593911|NCT01324830|470134535|FG009|Overall Study|Progressive Disease|6|||
130593912|NCT01324830|470134536|FG010|Overall Study|Progressive Disease|2|||
130593913|NCT01324830|470134537|FG011|Overall Study|Progressive Disease|1|||
130593914|NCT01324830|470134538|FG012|Overall Study|Progressive Disease|1|||
130593915|NCT01324830|470134539|FG013|Overall Study|Progressive Disease|1|||
130593916|NCT01324830|470134540|FG014|Overall Study|Progressive Disease|1|||
130593917|NCT01324830|470134541|FG015|Overall Study|Progressive Disease|3|||
130593918|NCT01324830|470134542|FG016|Overall Study|Progressive Disease|2|||
130593919|NCT01324830|470134543|FG017|Overall Study|Progressive Disease|3|||
130593920|NCT01324830|470134544|FG018|Overall Study|Progressive Disease|4|||
130593921|NCT01324830|470134526|FG000|Overall Study|Dose limiting toxicity|0|||
130593922|NCT01324830|470134527|FG001|Overall Study|Dose limiting toxicity|0|||
130593923|NCT01324830|470134528|FG002|Overall Study|Dose limiting toxicity|0|||
130593924|NCT01324830|470134529|FG003|Overall Study|Dose limiting toxicity|0|||
130593925|NCT01324830|470134530|FG004|Overall Study|Dose limiting toxicity|1|||
130593926|NCT01324830|470134531|FG005|Overall Study|Dose limiting toxicity|0|||
130593927|NCT01324830|470134532|FG006|Overall Study|Dose limiting toxicity|0|||
130593928|NCT01324830|470134533|FG007|Overall Study|Dose limiting toxicity|0|||
130593929|NCT01324830|470134534|FG008|Overall Study|Dose limiting toxicity|0|||
130593930|NCT01324830|470134535|FG009|Overall Study|Dose limiting toxicity|0|||
130593931|NCT01324830|470134536|FG010|Overall Study|Dose limiting toxicity|0|||
130593932|NCT01324830|470134537|FG011|Overall Study|Dose limiting toxicity|0|||
130593933|NCT01324830|470134538|FG012|Overall Study|Dose limiting toxicity|0|||
130593934|NCT01324830|470134539|FG013|Overall Study|Dose limiting toxicity|0|||
130593935|NCT01324830|470134540|FG014|Overall Study|Dose limiting toxicity|0|||
130593936|NCT01324830|470134541|FG015|Overall Study|Dose limiting toxicity|0|||
130593937|NCT01324830|470134542|FG016|Overall Study|Dose limiting toxicity|1|||
130593938|NCT01324830|470134543|FG017|Overall Study|Dose limiting toxicity|1|||
130593939|NCT01324830|470134544|FG018|Overall Study|Dose limiting toxicity|1|||
130593940|NCT01324830|470134526|FG000|Overall Study|Reason not mentioned above|0|||
130593941|NCT01324830|470134527|FG001|Overall Study|Reason not mentioned above|0|||
130593942|NCT01324830|470134528|FG002|Overall Study|Reason not mentioned above|0|||
130593943|NCT01324830|470134529|FG003|Overall Study|Reason not mentioned above|0|||
130593944|NCT01324830|470134530|FG004|Overall Study|Reason not mentioned above|0|||
130593945|NCT01324830|470134531|FG005|Overall Study|Reason not mentioned above|0|||
130593946|NCT01324830|470134532|FG006|Overall Study|Reason not mentioned above|0|||
130593947|NCT01324830|470134533|FG007|Overall Study|Reason not mentioned above|0|||
130593948|NCT01324830|470134534|FG008|Overall Study|Reason not mentioned above|0|||
130593949|NCT01324830|470134535|FG009|Overall Study|Reason not mentioned above|0|||
130593950|NCT01324830|470134536|FG010|Overall Study|Reason not mentioned above|0|||
130593951|NCT01324830|470134537|FG011|Overall Study|Reason not mentioned above|0|||
130593952|NCT01324830|470134538|FG012|Overall Study|Reason not mentioned above|0|||
130593953|NCT01324830|470134539|FG013|Overall Study|Reason not mentioned above|0|||
130593954|NCT01324830|470134540|FG014|Overall Study|Reason not mentioned above|0|||
130593955|NCT01324830|470134541|FG015|Overall Study|Reason not mentioned above|0|||
130593956|NCT01324830|470134542|FG016|Overall Study|Reason not mentioned above|0|||
130593957|NCT01324830|470134543|FG017|Overall Study|Reason not mentioned above|1|||
130593958|NCT01324830|470134544|FG018|Overall Study|Reason not mentioned above|0|||
130593959|NCT01324830|470134526|FG000|Overall Study|Adverse Event, serious fatal|0|||
130593960|NCT01324830|470134527|FG001|Overall Study|Adverse Event, serious fatal|1|||
130593961|NCT01324830|470134528|FG002|Overall Study|Adverse Event, serious fatal|0|||
130593962|NCT01324830|470134529|FG003|Overall Study|Adverse Event, serious fatal|0|||
130593963|NCT01324830|470134530|FG004|Overall Study|Adverse Event, serious fatal|0|||
130593964|NCT01324830|470134531|FG005|Overall Study|Adverse Event, serious fatal|0|||
130593965|NCT01324830|470134532|FG006|Overall Study|Adverse Event, serious fatal|0|||
130593966|NCT01324830|470134533|FG007|Overall Study|Adverse Event, serious fatal|0|||
130593967|NCT01324830|470134534|FG008|Overall Study|Adverse Event, serious fatal|0|||
130593968|NCT01324830|470134535|FG009|Overall Study|Adverse Event, serious fatal|0|||
130593969|NCT01324830|470134536|FG010|Overall Study|Adverse Event, serious fatal|0|||
130593970|NCT01324830|470134537|FG011|Overall Study|Adverse Event, serious fatal|0|||
130593971|NCT01324830|470134538|FG012|Overall Study|Adverse Event, serious fatal|0|||
130593972|NCT01324830|470134539|FG013|Overall Study|Adverse Event, serious fatal|0|||
130593973|NCT01324830|470134540|FG014|Overall Study|Adverse Event, serious fatal|0|||
130593974|NCT01324830|470134541|FG015|Overall Study|Adverse Event, serious fatal|0|||
130593975|NCT01324830|470134542|FG016|Overall Study|Adverse Event, serious fatal|0|||
130593976|NCT01324830|470134543|FG017|Overall Study|Adverse Event, serious fatal|0|||
130593977|NCT01324830|470134544|FG018|Overall Study|Adverse Event, serious fatal|0|||
130593978|NCT01324830|470134526|FG000|Overall Study|Adverse Event, non-fatal|0|||
130593979|NCT01324830|470134527|FG001|Overall Study|Adverse Event, non-fatal|0|||
130593980|NCT01324830|470134528|FG002|Overall Study|Adverse Event, non-fatal|0|||
130593981|NCT01324830|470134529|FG003|Overall Study|Adverse Event, non-fatal|0|||
130593982|NCT01324830|470134530|FG004|Overall Study|Adverse Event, non-fatal|0|||
130593983|NCT01324830|470134531|FG005|Overall Study|Adverse Event, non-fatal|0|||
130593984|NCT01324830|470134532|FG006|Overall Study|Adverse Event, non-fatal|0|||
130593985|NCT01324830|470134533|FG007|Overall Study|Adverse Event, non-fatal|0|||
130593986|NCT01324830|470134534|FG008|Overall Study|Adverse Event, non-fatal|2|||
130593987|NCT01324830|470134535|FG009|Overall Study|Adverse Event, non-fatal|0|||
130593988|NCT01324830|470134536|FG010|Overall Study|Adverse Event, non-fatal|1|||
130593989|NCT01324830|470134537|FG011|Overall Study|Adverse Event, non-fatal|0|||
130593990|NCT01324830|470134538|FG012|Overall Study|Adverse Event, non-fatal|0|||
130593991|NCT01324830|470134539|FG013|Overall Study|Adverse Event, non-fatal|0|||
130593992|NCT01324830|470134540|FG014|Overall Study|Adverse Event, non-fatal|0|||
130593993|NCT01324830|470134541|FG015|Overall Study|Adverse Event, non-fatal|0|||
130593994|NCT01324830|470134542|FG016|Overall Study|Adverse Event, non-fatal|0|||
130593995|NCT01324830|470134543|FG017|Overall Study|Adverse Event, non-fatal|1|||
130593996|NCT01324830|470134544|FG018|Overall Study|Adverse Event, non-fatal|0|||
130593997|NCT01324830|470134526|FG000|Overall Study|Withdrawal by Subject|0|||
130593998|NCT01324830|470134527|FG001|Overall Study|Withdrawal by Subject|0|||
130593999|NCT01324830|470134528|FG002|Overall Study|Withdrawal by Subject|0|||
130594000|NCT01324830|470134529|FG003|Overall Study|Withdrawal by Subject|0|||
130594001|NCT01324830|470134530|FG004|Overall Study|Withdrawal by Subject|0|||
130594002|NCT01324830|470134531|FG005|Overall Study|Withdrawal by Subject|1|||
130594003|NCT01324830|470134532|FG006|Overall Study|Withdrawal by Subject|0|||
130594004|NCT01324830|470134533|FG007|Overall Study|Withdrawal by Subject|0|||
130594005|NCT01324830|470134534|FG008|Overall Study|Withdrawal by Subject|0|||
130594006|NCT01324830|470134535|FG009|Overall Study|Withdrawal by Subject|0|||
130594007|NCT01324830|470134536|FG010|Overall Study|Withdrawal by Subject|1|||
130594008|NCT01324830|470134537|FG011|Overall Study|Withdrawal by Subject|0|||
130594009|NCT01324830|470134538|FG012|Overall Study|Withdrawal by Subject|0|||
130594010|NCT01324830|470134539|FG013|Overall Study|Withdrawal by Subject|0|||
130594011|NCT01324830|470134540|FG014|Overall Study|Withdrawal by Subject|0|||
130594012|NCT01324830|470134541|FG015|Overall Study|Withdrawal by Subject|0|||
130594013|NCT01324830|470134542|FG016|Overall Study|Withdrawal by Subject|0|||
130594014|NCT01324830|470134543|FG017|Overall Study|Withdrawal by Subject|0|||
130594015|NCT01324830|470134544|FG018|Overall Study|Withdrawal by Subject|1|||
130594016|NCT01485614|470134545|FG000|Randomization|Not Treated|1|||
130594017|NCT01485614|470134546|FG001|Randomization|Not Treated|0|||
130594018|NCT01485614|470134547|FG002|Randomization|Not Treated|0|||
130594019|NCT01485614|470134548|FG003|Randomization|Not Treated|0|||
130594020|NCT01485614|470134545|FG000|Weeks 0-20|Lost to Follow-up|2|||
130594021|NCT01485614|470134546|FG001|Weeks 0-20|Lost to Follow-up|0|||
130594022|NCT01485614|470134547|FG002|Weeks 0-20|Lost to Follow-up|0|||
130594023|NCT01485614|470134548|FG003|Weeks 0-20|Lost to Follow-up|0|||
130594024|NCT01485614|470134545|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
130594025|NCT01485614|470134546|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
130594026|NCT01485614|470134547|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
130594027|NCT01485614|470134548|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
130594028|NCT01485614|470134545|FG000|Weeks 0-20|Withdrawal by Subject|3|||
130594029|NCT01485614|470134546|FG001|Weeks 0-20|Withdrawal by Subject|2|||
130594030|NCT01485614|470134547|FG002|Weeks 0-20|Withdrawal by Subject|1|||
130594031|NCT01485614|470134548|FG003|Weeks 0-20|Withdrawal by Subject|0|||
130594032|NCT01485614|470134545|FG000|Weeks 20-54|Lost to Follow-up|4|||
130594033|NCT01485614|470134546|FG001|Weeks 20-54|Lost to Follow-up|3|||
130594034|NCT01485614|470134547|FG002|Weeks 20-54|Lost to Follow-up|1|||
130594035|NCT01485614|470134548|FG003|Weeks 20-54|Lost to Follow-up|0|||
130594036|NCT01485614|470134545|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
130594037|NCT01485614|470134546|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
130594038|NCT01485614|470134547|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
130594039|NCT01485614|470134548|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
130594040|NCT01485614|470134545|FG000|Weeks 20-54|Withdrawal by Subject|5|||
130594041|NCT01485614|470134546|FG001|Weeks 20-54|Withdrawal by Subject|3|||
130594042|NCT01485614|470134547|FG002|Weeks 20-54|Withdrawal by Subject|0|||
130594043|NCT01485614|470134548|FG003|Weeks 20-54|Withdrawal by Subject|0|||
130594044|NCT02210780|470134549|FG000|Overall Study|Adverse Event|0|||
130594045|NCT02210780|470134550|FG001|Overall Study|Adverse Event|5|||
130594046|NCT02210780|470134549|FG000|Overall Study|Lost to Follow-up|2|||
130594047|NCT02210780|470134550|FG001|Overall Study|Lost to Follow-up|1|||
130594048|NCT02210780|470134549|FG000|Overall Study|Withdrawal by Subject|1|||
130594049|NCT02210780|470134550|FG001|Overall Study|Withdrawal by Subject|1|||
130594050|NCT02210780|470134549|FG000|Overall Study|Physician Decision|1|||
130594051|NCT02210780|470134550|FG001|Overall Study|Physician Decision|0|||
130594052|NCT02210780|470134549|FG000|Overall Study|Protocol Violation|1|||
130594053|NCT02210780|470134550|FG001|Overall Study|Protocol Violation|0|||
130594054|NCT02210780|470134549|FG000|Overall Study|Other than specified above|0|||
130594055|NCT02210780|470134550|FG001|Overall Study|Other than specified above|1|||
130594056|NCT00942409|470134551|FG000|Overall Study|Lack of Efficacy|1|||
130594057|NCT00942409|470134551|FG000|Overall Study|study drug unavailable|2|||
130594058|NCT01486264|470134554|FG000|Overall Study|Death|1|||
130594059|NCT01486264|470134555|FG001|Overall Study|Death|1|||
130594060|NCT01486264|470134554|FG000|Overall Study|Adverse Event|3|||
130594061|NCT01486264|470134555|FG001|Overall Study|Adverse Event|3|||
130594062|NCT01486264|470134554|FG000|Overall Study|Lack of Efficacy|6|||
130594063|NCT01486264|470134555|FG001|Overall Study|Lack of Efficacy|10|||
130594064|NCT01486264|470134554|FG000|Overall Study|Withdrawal by Subject|7|||
130594065|NCT01486264|470134555|FG001|Overall Study|Withdrawal by Subject|18|||
130594066|NCT01486264|470134554|FG000|Overall Study|Physician Decision|1|||
130594067|NCT01486264|470134555|FG001|Overall Study|Physician Decision|1|||
130594068|NCT01486264|470134554|FG000|Overall Study|Protocol Violation|3|||
130594069|NCT01486264|470134555|FG001|Overall Study|Protocol Violation|0|||
130594070|NCT01486264|470134554|FG000|Overall Study|Lost to Follow-up|3|||
130594071|NCT01486264|470134555|FG001|Overall Study|Lost to Follow-up|2|||
130594072|NCT01486264|470134554|FG000|Overall Study|Other|5|||
130594073|NCT01486264|470134555|FG001|Overall Study|Other|11|||
130594074|NCT01486264|470134554|FG000|Overall Study|Not treated|0|||
130594075|NCT01486264|470134555|FG001|Overall Study|Not treated|1|||
130594076|NCT00684814|470134561|FG000|Washout Period of 7 Days|Adverse Event|1|||
130594077|NCT00684814|470134562|FG001|Washout Period of 7 Days|Adverse Event|2|||
130594078|NCT00684814|470134561|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130594079|NCT00684814|470134562|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130594080|NCT00684814|470134561|FG000|Second Intervention|Adverse Event|1|||
130594081|NCT00684814|470134562|FG001|Second Intervention|Adverse Event|0|||
130594082|NCT03812510|470134565|FG000|Overall Study|Lost to Follow-up|39|||
130594083|NCT03812510|470134565|FG000|Overall Study|Withdrawal by Subject|42|||
130594084|NCT03812510|470134565|FG000|Overall Study|Physician Decision|2|||
130594085|NCT03812510|470134565|FG000|Overall Study|Study Terminated by Sponsor|9|||
130594086|NCT03812510|470134565|FG000|Overall Study|Did Not Start Study Medication|55|||
130594087|NCT03812510|470134565|FG000|Overall Study|Adverse Event|5|||
130594088|NCT00768560|470134566|FG000|Intervention Set 1|Adverse Event|0|||
130594089|NCT00768560|470134567|FG001|Intervention Set 1|Adverse Event|1|||
130594090|NCT00768560|470134568|FG002|Intervention Set 1|Adverse Event|0|||
130594091|NCT00768560|470134569|FG003|Intervention Set 1|Adverse Event|0|||
130594092|NCT00768560|470134570|FG004|Intervention Set 1|Adverse Event|0|||
130594093|NCT00768560|470134571|FG005|Intervention Set 1|Adverse Event|0|||
130594094|NCT01128387|470134572|FG000|Overall Study|Physician Decision|0|||
130594095|NCT01128387|470134573|FG001|Overall Study|Physician Decision|1|||
130594096|NCT02635204|470134574|FG000|Overall Study|Adverse Event|1|||
130594097|NCT02635204|470134575|FG001|Overall Study|Adverse Event|0|||
130594098|NCT02635204|470134574|FG000|Overall Study|Lost to Follow-up|1|||
130594099|NCT02635204|470134575|FG001|Overall Study|Lost to Follow-up|1|||
130594100|NCT01535235|470134576|FG000|Overall Study|Adverse Event|1|||
130594101|NCT01535235|470134577|FG001|Overall Study|Adverse Event|0|||
130594102|NCT00858832|470134578|FG000|Overall Study|became ineligible: delivered vaginally|1|||
130594103|NCT00858832|470134579|FG001|Overall Study|became ineligible: delivered vaginally|0|||
130594104|NCT00858832|470134578|FG000|Overall Study|Adverse Event|0|||
130594105|NCT00858832|470134579|FG001|Overall Study|Adverse Event|1|||
130594106|NCT00389207|470134581|FG000|Overall Study|Adverse Event|26|||
130594107|NCT00389207|470134582|FG001|Overall Study|Adverse Event|32|||
130594108|NCT00389207|470134583|FG002|Overall Study|Adverse Event|10|||
130594109|NCT00389207|470134581|FG000|Overall Study|Protocol Violation|3|||
130594110|NCT00389207|470134582|FG001|Overall Study|Protocol Violation|1|||
130594111|NCT00389207|470134583|FG002|Overall Study|Protocol Violation|4|||
130594112|NCT00389207|470134581|FG000|Overall Study|Lost to Follow-up|12|||
130594113|NCT00389207|470134582|FG001|Overall Study|Lost to Follow-up|9|||
130594114|NCT00389207|470134583|FG002|Overall Study|Lost to Follow-up|7|||
130594115|NCT00389207|470134581|FG000|Overall Study|Withdrawal by Subject|5|||
130594116|NCT00389207|470134582|FG001|Overall Study|Withdrawal by Subject|7|||
130594117|NCT00389207|470134583|FG002|Overall Study|Withdrawal by Subject|11|||
130594118|NCT00389207|470134581|FG000|Overall Study|Other|17|||
130594119|NCT00389207|470134582|FG001|Overall Study|Other|23|||
130594120|NCT00389207|470134583|FG002|Overall Study|Other|9|||
130594121|NCT01794780|470134584|FG000|Overall Study|Adverse Event|0|||
130594122|NCT01794780|470134585|FG001|Overall Study|Adverse Event|1|||
130594123|NCT01794780|470134586|FG002|Overall Study|Adverse Event|2|||
130594124|NCT01794780|470134587|FG003|Overall Study|Adverse Event|0|||
130594125|NCT01794780|470134588|FG004|Overall Study|Adverse Event|0|||
130594126|NCT01794780|470134589|FG005|Overall Study|Adverse Event|0|||
130594127|NCT01794780|470134590|FG006|Overall Study|Adverse Event|0|||
130594128|NCT01794780|470134591|FG007|Overall Study|Adverse Event|0|||
130594129|NCT01794780|470134584|FG000|Overall Study|Death|0|||
130594130|NCT01794780|470134585|FG001|Overall Study|Death|2|||
130594131|NCT01794780|470134586|FG002|Overall Study|Death|14|||
130594132|NCT01794780|470134587|FG003|Overall Study|Death|1|||
130594133|NCT01794780|470134588|FG004|Overall Study|Death|0|||
130594134|NCT01794780|470134589|FG005|Overall Study|Death|9|||
130594135|NCT01794780|470134590|FG006|Overall Study|Death|4|||
130594136|NCT01794780|470134591|FG007|Overall Study|Death|0|||
130594137|NCT01794780|470134584|FG000|Overall Study|Lost to Follow-up|10|||
130594138|NCT01794780|470134585|FG001|Overall Study|Lost to Follow-up|64|||
130594139|NCT01794780|470134586|FG002|Overall Study|Lost to Follow-up|165|||
130594140|NCT01794780|470134587|FG003|Overall Study|Lost to Follow-up|53|||
130594141|NCT01794780|470134588|FG004|Overall Study|Lost to Follow-up|2|||
130594142|NCT01794780|470134589|FG005|Overall Study|Lost to Follow-up|99|||
130594143|NCT01794780|470134590|FG006|Overall Study|Lost to Follow-up|30|||
130594144|NCT01794780|470134591|FG007|Overall Study|Lost to Follow-up|5|||
130594145|NCT01794780|470134584|FG000|Overall Study|Withdrew informed consent|7|||
130594146|NCT01794780|470134585|FG001|Overall Study|Withdrew informed consent|17|||
130594147|NCT01794780|470134586|FG002|Overall Study|Withdrew informed consent|36|||
130594148|NCT01794780|470134587|FG003|Overall Study|Withdrew informed consent|9|||
130594149|NCT01794780|470134588|FG004|Overall Study|Withdrew informed consent|0|||
130594150|NCT01794780|470134589|FG005|Overall Study|Withdrew informed consent|48|||
130594151|NCT01794780|470134590|FG006|Overall Study|Withdrew informed consent|4|||
130594152|NCT01794780|470134591|FG007|Overall Study|Withdrew informed consent|3|||
130594153|NCT01794780|470134584|FG000|Overall Study|Other|0|||
130594154|NCT01794780|470134585|FG001|Overall Study|Other|12|||
130594155|NCT01794780|470134586|FG002|Overall Study|Other|25|||
130594156|NCT01794780|470134587|FG003|Overall Study|Other|20|||
130594157|NCT01794780|470134588|FG004|Overall Study|Other|1|||
130594158|NCT01794780|470134589|FG005|Overall Study|Other|24|||
130594159|NCT01794780|470134590|FG006|Overall Study|Other|4|||
130594160|NCT01794780|470134591|FG007|Overall Study|Other|1|||
130594161|NCT03527043|470134592|FG000|Overall Study|Withdrawal by Subject|1|||
130594162|NCT03527043|470134593|FG001|Overall Study|Withdrawal by Subject|0|||
130594163|NCT02120417|470134594|FG000|Overall Study|Death|5|||
130594164|NCT02120417|470134595|FG001|Overall Study|Death|1|||
130594165|NCT02120417|470134594|FG000|Overall Study|Adverse Event|3|||
130594166|NCT02120417|470134595|FG001|Overall Study|Adverse Event|9|||
130594167|NCT02120417|470134594|FG000|Overall Study|Participant decision|4|||
130594168|NCT02120417|470134595|FG001|Overall Study|Participant decision|4|||
130594169|NCT02120417|470134594|FG000|Overall Study|Disease progression|41|||
130594170|NCT02120417|470134595|FG001|Overall Study|Disease progression|45|||
130594171|NCT02120417|470134594|FG000|Overall Study|Noncompliance with study treatment|0|||
130594172|NCT02120417|470134595|FG001|Overall Study|Noncompliance with study treatment|2|||
130594173|NCT02120417|470134594|FG000|Overall Study|Physician Decision|2|||
130594174|NCT02120417|470134595|FG001|Overall Study|Physician Decision|3|||
130594175|NCT02120417|470134594|FG000|Overall Study|Other unspecified|5|||
130594176|NCT02120417|470134595|FG001|Overall Study|Other unspecified|4|||
130594177|NCT02286102|470134596|FG000|Overall Study|Screen Failure|1|||
130594178|NCT02286102|470134597|FG001|Overall Study|Screen Failure|1|||
130594179|NCT02469246|470134598|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
130594180|NCT02469246|470134599|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
130594181|NCT02469246|470134598|FG000|Double-Blind Phase|Adverse Event|12|||
130594182|NCT02469246|470134599|FG001|Double-Blind Phase|Adverse Event|9|||
130594183|NCT02469246|470134598|FG000|Double-Blind Phase|Death|2|||
130594184|NCT02469246|470134599|FG001|Double-Blind Phase|Death|0|||
130594185|NCT02469246|470134598|FG000|Double-Blind Phase|Lack of Efficacy|2|||
130594186|NCT02469246|470134599|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130594187|NCT02469246|470134598|FG000|Double-Blind Phase|Investigator's Discretion|8|||
130594188|NCT02469246|470134599|FG001|Double-Blind Phase|Investigator's Discretion|8|||
130594189|NCT02469246|470134598|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130594190|NCT02469246|470134599|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130594191|NCT02469246|470134598|FG000|Double-Blind Phase|Protocol Violation|1|||
130594192|NCT02469246|470134599|FG001|Double-Blind Phase|Protocol Violation|1|||
130594193|NCT02469246|470134598|FG000|Double-Blind Phase|Withdrew Consent|25|||
130594194|NCT02469246|470134599|FG001|Double-Blind Phase|Withdrew Consent|25|||
130594195|NCT02469246|470134598|FG000|Double-Blind Phase|Lost to Follow-up|9|||
130594196|NCT02469246|470134599|FG001|Double-Blind Phase|Lost to Follow-up|5|||
130594197|NCT03293680|470134600|FG000|Overall Study|Death|1|||
130594198|NCT03293680|470134600|FG000|Overall Study|Did not meet inclusion criteria|8|||
130594199|NCT02690701|470134603|FG000|Treatment Period 1|Adverse Event|2|||
130594200|NCT02690701|470134604|FG001|Treatment Period 1|Adverse Event|2|||
130594201|NCT02690701|470134603|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130594202|NCT02690701|470134604|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130594203|NCT02690701|470134603|FG000|Treatment Period 2|Adverse Event|2|||
130594204|NCT02690701|470134604|FG001|Treatment Period 2|Adverse Event|0|||
130594205|NCT02690701|470134603|FG000|Treatment Period 2|Lack of Efficacy|1|||
130594206|NCT02690701|470134604|FG001|Treatment Period 2|Lack of Efficacy|0|||
130594207|NCT02690701|470134603|FG000|Treatment Period 2|Lost to Follow-up|0|||
130594208|NCT02690701|470134604|FG001|Treatment Period 2|Lost to Follow-up|2|||
130594209|NCT02690701|470134603|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130594210|NCT02690701|470134604|FG001|Treatment Period 2|Withdrawal by Subject|2|||
130594211|NCT02690701|470134603|FG000|Treatment Period 2|Protocol Violation|0|||
130594212|NCT02690701|470134604|FG001|Treatment Period 2|Protocol Violation|1|||
130594213|NCT01642212|470134605|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
130594214|NCT01642212|470134606|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130594215|NCT01642212|470134607|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130594216|NCT01642212|470134608|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130594217|NCT01642212|470134609|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130594218|NCT01642212|470134605|FG000|Double-blind Treatment|Other|0|||
130594219|NCT01642212|470134606|FG001|Double-blind Treatment|Other|2|||
130594220|NCT01642212|470134607|FG002|Double-blind Treatment|Other|1|||
130594221|NCT01642212|470134608|FG003|Double-blind Treatment|Other|0|||
130594222|NCT01642212|470134609|FG004|Double-blind Treatment|Other|0|||
130594223|NCT01642212|470134605|FG000|Double-blind Treatment|Non-compliance|0|||
130594224|NCT01642212|470134606|FG001|Double-blind Treatment|Non-compliance|1|||
130594225|NCT01642212|470134607|FG002|Double-blind Treatment|Non-compliance|0|||
130594226|NCT01642212|470134608|FG003|Double-blind Treatment|Non-compliance|0|||
130594227|NCT01642212|470134609|FG004|Double-blind Treatment|Non-compliance|0|||
130594228|NCT01642212|470134605|FG000|Double-blind Treatment|Adverse Event|0|||
130594229|NCT01642212|470134606|FG001|Double-blind Treatment|Adverse Event|0|||
130594230|NCT01642212|470134607|FG002|Double-blind Treatment|Adverse Event|1|||
130594231|NCT01642212|470134608|FG003|Double-blind Treatment|Adverse Event|0|||
130594232|NCT01642212|470134609|FG004|Double-blind Treatment|Adverse Event|0|||
130594233|NCT01642212|470134605|FG000|Open-label Extension|Adverse Event|0|||
130594234|NCT01642212|470134606|FG001|Open-label Extension|Adverse Event|0|||
130594235|NCT01642212|470134607|FG002|Open-label Extension|Adverse Event|0|||
130594236|NCT01642212|470134608|FG003|Open-label Extension|Adverse Event|3|||
130594237|NCT01642212|470134609|FG004|Open-label Extension|Adverse Event|0|||
130594238|NCT01642212|470134605|FG000|Open-label Extension|Sponsor Decision|0|||
130594239|NCT01642212|470134606|FG001|Open-label Extension|Sponsor Decision|0|||
130594240|NCT01642212|470134607|FG002|Open-label Extension|Sponsor Decision|0|||
130594241|NCT01642212|470134608|FG003|Open-label Extension|Sponsor Decision|7|||
130594242|NCT01642212|470134609|FG004|Open-label Extension|Sponsor Decision|4|||
130594243|NCT01642212|470134605|FG000|Open-label Extension|Consent Withdrawn|0|||
130594244|NCT01642212|470134606|FG001|Open-label Extension|Consent Withdrawn|0|||
130594245|NCT01642212|470134607|FG002|Open-label Extension|Consent Withdrawn|0|||
130594246|NCT01642212|470134608|FG003|Open-label Extension|Consent Withdrawn|0|||
130594247|NCT01642212|470134609|FG004|Open-label Extension|Consent Withdrawn|2|||
130594248|NCT01642212|470134605|FG000|Open-label Extension|Lost to Follow-up|0|||
130594249|NCT01642212|470134606|FG001|Open-label Extension|Lost to Follow-up|0|||
130594250|NCT01642212|470134607|FG002|Open-label Extension|Lost to Follow-up|0|||
130594251|NCT01642212|470134608|FG003|Open-label Extension|Lost to Follow-up|0|||
130594252|NCT01642212|470134609|FG004|Open-label Extension|Lost to Follow-up|1|||
130594253|NCT01642212|470134605|FG000|Open-label Extension|Other|0|||
130594254|NCT01642212|470134606|FG001|Open-label Extension|Other|0|||
130594255|NCT01642212|470134607|FG002|Open-label Extension|Other|0|||
130594256|NCT01642212|470134608|FG003|Open-label Extension|Other|0|||
130594257|NCT01642212|470134609|FG004|Open-label Extension|Other|1|||
130594258|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
130594259|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130594260|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130594261|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130594262|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130594263|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
130594264|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130594265|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
130594266|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
130594267|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130594268|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130594269|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
130594270|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
130594271|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
130594272|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130594273|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130594274|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130594275|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
130594276|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
130594277|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
130594278|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
130594279|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
130594280|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
130594281|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
130594282|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
130594283|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
130594284|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
130594285|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
130594286|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
130594287|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
130594288|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
130594289|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
130594290|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
130594291|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
130594292|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
130594293|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
130594294|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
130594295|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
130594296|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
130594297|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
130594298|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
130594299|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
130594300|NCT00100048|470134610|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130594301|NCT00100048|470134611|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130594302|NCT00100048|470134612|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130594303|NCT00100048|470134613|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
130594304|NCT00100048|470134614|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130594305|NCT00100048|470134615|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130594306|NCT01624142|470134617|FG000|Overall Study|Withdrawal by Subject|14|||
130594307|NCT01624142|470134618|FG001|Overall Study|Withdrawal by Subject|4|||
130594308|NCT01624142|470134617|FG000|Overall Study|Death|3|||
130594309|NCT01624142|470134618|FG001|Overall Study|Death|6|||
130594310|NCT01624142|470134617|FG000|Overall Study|Study Closure|12|||
130594311|NCT01624142|470134618|FG001|Overall Study|Study Closure|6|||
130594312|NCT01624142|470134617|FG000|Overall Study|Lost to Follow-up|2|||
130594313|NCT01624142|470134618|FG001|Overall Study|Lost to Follow-up|0|||
130594314|NCT01624142|470134617|FG000|Overall Study|Other|1|||
130594315|NCT01624142|470134618|FG001|Overall Study|Other|0|||
130594316|NCT01822561|470134619|FG000|Overall Study|Withdrawal by Subject|2|||
130594317|NCT02597062|470134622|FG000|Overall Study|Ineligible|1|||
130594318|NCT00947349|470134628|FG000|Triple Treatment Combination Period|Adverse Event|0|||
130594319|NCT00947349|470134629|FG001|Triple Treatment Combination Period|Adverse Event|1|||
130594320|NCT00947349|470134630|FG002|Triple Treatment Combination Period|Adverse Event|0|||
130594321|NCT00947349|470134631|FG003|Triple Treatment Combination Period|Adverse Event|0|||
130594322|NCT00947349|470134628|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
130594323|NCT00947349|470134629|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
130594324|NCT00947349|470134630|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
130594325|NCT00947349|470134631|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
130594326|NCT00947349|470134628|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
130594327|NCT00947349|470134629|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
130594328|NCT00947349|470134630|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
130594329|NCT00947349|470134631|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
130594330|NCT00947349|470134628|FG000|Overall Study Standard of Care|Other|0|||
130594331|NCT00947349|470134629|FG001|Overall Study Standard of Care|Other|0|||
130594332|NCT00947349|470134630|FG002|Overall Study Standard of Care|Other|0|||
130594333|NCT00947349|470134631|FG003|Overall Study Standard of Care|Other|1|||
130594334|NCT00140855|470134632|FG000|Overall Study|Progressive disease|2|||
130594335|NCT05262764|470134644|FG000|Overall Study|Case report form not collected|9|||
130594336|NCT05262764|470134644|FG000|Overall Study|No patient visits after entry|23|||
130594337|NCT05262764|470134644|FG000|Overall Study|Registration rule not followed|2|||
130594338|NCT05262764|470134644|FG000|Overall Study|Patient of non-chronic heart failure|1|||
130594339|NCT01392183|470134645|FG000|First Drug Administration|Adverse Event|3|||
130594340|NCT01392183|470134646|FG001|First Drug Administration|Adverse Event|2|||
130594341|NCT01392183|470134645|FG000|First Drug Administration|Death|1|||
130594342|NCT01392183|470134646|FG001|First Drug Administration|Death|0|||
130594343|NCT01392183|470134645|FG000|First Drug Administration|Withdrawal by Subject|10|||
130594344|NCT01392183|470134646|FG001|First Drug Administration|Withdrawal by Subject|17|||
130594345|NCT04321343|470134647|FG000|Overall Study|Adverse Event|0|||
130594346|NCT04321343|470134648|FG001|Overall Study|Adverse Event|0|||
130594347|NCT04321343|470134649|FG002|Overall Study|Adverse Event|1|||
130594348|NCT04321343|470134650|FG003|Overall Study|Adverse Event|0|||
130594349|NCT04321343|470134647|FG000|Overall Study|Death|0|||
130594350|NCT04321343|470134648|FG001|Overall Study|Death|0|||
130594351|NCT04321343|470134649|FG002|Overall Study|Death|0|||
130594352|NCT04321343|470134650|FG003|Overall Study|Death|1|||
130594353|NCT04321343|470134647|FG000|Overall Study|Pregnancy|1|||
130594354|NCT04321343|470134648|FG001|Overall Study|Pregnancy|0|||
130594355|NCT04321343|470134649|FG002|Overall Study|Pregnancy|0|||
130594356|NCT04321343|470134650|FG003|Overall Study|Pregnancy|0|||
130594357|NCT04321343|470134647|FG000|Overall Study|Protocol Violation|1|||
130594358|NCT04321343|470134648|FG001|Overall Study|Protocol Violation|1|||
130594359|NCT04321343|470134649|FG002|Overall Study|Protocol Violation|1|||
130594360|NCT04321343|470134650|FG003|Overall Study|Protocol Violation|1|||
130594361|NCT04321343|470134647|FG000|Overall Study|Withdrawal by Subject|0|||
130594362|NCT04321343|470134648|FG001|Overall Study|Withdrawal by Subject|6|||
130594363|NCT04321343|470134649|FG002|Overall Study|Withdrawal by Subject|0|||
130594364|NCT04321343|470134650|FG003|Overall Study|Withdrawal by Subject|2|||
130594365|NCT04321343|470134647|FG000|Overall Study|Lost to Follow-up|2|||
130594366|NCT04321343|470134648|FG001|Overall Study|Lost to Follow-up|2|||
130594367|NCT04321343|470134649|FG002|Overall Study|Lost to Follow-up|1|||
130594368|NCT04321343|470134650|FG003|Overall Study|Lost to Follow-up|3|||
130594369|NCT03430310|470134651|FG000|Overall Study|Protocol Violation|2|||
130594370|NCT03430310|470134652|FG001|Overall Study|Protocol Violation|0|||
130594371|NCT03430310|470134651|FG000|Overall Study|Withdrawal by Subject|3|||
130594372|NCT03430310|470134652|FG001|Overall Study|Withdrawal by Subject|2|||
130594373|NCT03430310|470134651|FG000|Overall Study|COVID shutdown March 2020|0|||
130594374|NCT03430310|470134652|FG001|Overall Study|COVID shutdown March 2020|1|||
130594375|NCT01331161|470134654|FG000|Overall Study|Physician Decision|1|||
130594376|NCT01331161|470134655|FG001|Overall Study|Physician Decision|0|||
130594377|NCT01331161|470134654|FG000|Overall Study|Lost to Follow-up|0|||
130594378|NCT01331161|470134655|FG001|Overall Study|Lost to Follow-up|1|||
130594379|NCT01331161|470134654|FG000|Overall Study|Pregnancy|0|||
130594380|NCT01331161|470134655|FG001|Overall Study|Pregnancy|1|||
130594381|NCT01097044|470134656|FG000|Overall Study|Withdrawal by Subject|4|||
130594382|NCT01097044|470134657|FG001|Overall Study|Withdrawal by Subject|4|||
130594383|NCT01097044|470134656|FG000|Overall Study|Lost to Follow-up|1|||
130594384|NCT01097044|470134657|FG001|Overall Study|Lost to Follow-up|0|||
130594385|NCT01097044|470134656|FG000|Overall Study|Withdrawal by Sponsor|0|||
130594386|NCT01097044|470134657|FG001|Overall Study|Withdrawal by Sponsor|1|||
130594387|NCT02770807|470134662|FG000|Overall Study|Adverse Event|3|||
130594388|NCT02770807|470134663|FG001|Overall Study|Adverse Event|3|||
130594389|NCT02770807|470134664|FG002|Overall Study|Adverse Event|1|||
130594390|NCT02770807|470134662|FG000|Overall Study|Withdrawal by Subject|7|||
130594391|NCT02770807|470134663|FG001|Overall Study|Withdrawal by Subject|3|||
130594392|NCT02770807|470134664|FG002|Overall Study|Withdrawal by Subject|4|||
130594393|NCT02770807|470134662|FG000|Overall Study|Other|0|||
130594394|NCT02770807|470134663|FG001|Overall Study|Other|1|||
130594395|NCT02770807|470134664|FG002|Overall Study|Other|0|||
130594396|NCT02770807|470134662|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
130594397|NCT02770807|470134663|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
130594398|NCT02770807|470134664|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
130594399|NCT02770807|470134662|FG000|Overall Study|Physician Decision|0|||
130594400|NCT02770807|470134663|FG001|Overall Study|Physician Decision|0|||
130594401|NCT02770807|470134664|FG002|Overall Study|Physician Decision|1|||
130594402|NCT03277196|470134665|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
130594403|NCT03277196|470134665|FG000|Overall Study|Lost to Follow-up|3|||
130594404|NCT03277196|470134665|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130594405|NCT03277196|470134665|FG000|Overall Study|Other|2|||
130594406|NCT01056107|470136457|FG000|Overall Study|Withdrawal by Subject|0|||
130594407|NCT01056107|470136458|FG001|Overall Study|Withdrawal by Subject|1|||
130594408|NCT01056107|470136459|FG002|Overall Study|Withdrawal by Subject|3|||
130594409|NCT01056107|470136460|FG003|Overall Study|Withdrawal by Subject|0|||
130594410|NCT02017444|470136461|FG000|Overall Study|Physician Decision|1|||
130594411|NCT02017444|470136462|FG001|Overall Study|Physician Decision|0|||
130594412|NCT02017444|470136461|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
130594413|NCT02017444|470136462|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
130594414|NCT03874234|470136464|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594415|NCT03874234|470136465|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594416|NCT03874234|470136466|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594417|NCT03874234|470136467|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
130594418|NCT03874234|470136468|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594419|NCT03874234|470136469|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594420|NCT03874234|470136470|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594421|NCT03874234|470136471|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594422|NCT03874234|470136472|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594423|NCT03874234|470136473|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594424|NCT03874234|470136474|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594425|NCT03874234|470136475|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594426|NCT03874234|470136476|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130594427|NCT03874234|470136464|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
130594428|NCT03874234|470136465|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594429|NCT03874234|470136466|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594430|NCT03874234|470136467|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594431|NCT03874234|470136468|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594432|NCT03874234|470136469|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594433|NCT03874234|470136470|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594434|NCT03874234|470136471|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594435|NCT03874234|470136472|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594436|NCT03874234|470136473|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594437|NCT03874234|470136474|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594438|NCT03874234|470136475|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594439|NCT03874234|470136476|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130594440|NCT03874234|470136464|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594441|NCT03874234|470136465|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594442|NCT03874234|470136466|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594443|NCT03874234|470136467|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
130594444|NCT03874234|470136468|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594445|NCT03874234|470136469|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594446|NCT03874234|470136470|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594447|NCT03874234|470136471|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594448|NCT03874234|470136472|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594449|NCT03874234|470136473|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594450|NCT03874234|470136474|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594451|NCT03874234|470136475|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594452|NCT03874234|470136476|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130594453|NCT03874234|470136464|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594454|NCT03874234|470136465|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594455|NCT03874234|470136466|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594456|NCT03874234|470136467|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594457|NCT03874234|470136468|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
130594458|NCT03874234|470136469|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594459|NCT03874234|470136470|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594460|NCT03874234|470136471|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594461|NCT03874234|470136472|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594462|NCT03874234|470136473|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594463|NCT03874234|470136474|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594464|NCT03874234|470136475|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594465|NCT03874234|470136476|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130594466|NCT03874234|470136464|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594467|NCT03874234|470136465|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594468|NCT03874234|470136466|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594469|NCT03874234|470136467|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594470|NCT03874234|470136468|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594471|NCT03874234|470136469|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594472|NCT03874234|470136470|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594473|NCT03874234|470136471|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
130594474|NCT03874234|470136472|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594475|NCT03874234|470136473|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594476|NCT03874234|470136474|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594477|NCT03874234|470136475|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594478|NCT03874234|470136476|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130594479|NCT03874234|470136464|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594480|NCT03874234|470136465|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594481|NCT03874234|470136466|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594482|NCT03874234|470136467|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594483|NCT03874234|470136468|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
130594484|NCT03874234|470136469|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
130594485|NCT03874234|470136470|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594486|NCT03874234|470136471|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594487|NCT03874234|470136472|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594488|NCT03874234|470136473|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594489|NCT03874234|470136474|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594490|NCT03874234|470136475|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594491|NCT03874234|470136476|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130594492|NCT03874234|470136464|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594493|NCT03874234|470136465|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594494|NCT03874234|470136466|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594495|NCT03874234|470136467|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594496|NCT03874234|470136468|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594497|NCT03874234|470136469|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594498|NCT03874234|470136470|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
130594499|NCT03874234|470136471|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594500|NCT03874234|470136472|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594501|NCT03874234|470136473|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594502|NCT03874234|470136474|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594503|NCT03874234|470136475|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594504|NCT03874234|470136476|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130594505|NCT03874234|470136464|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594506|NCT03874234|470136465|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594507|NCT03874234|470136466|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594508|NCT03874234|470136467|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594509|NCT03874234|470136468|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
130594510|NCT03874234|470136469|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594511|NCT03874234|470136470|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594512|NCT03874234|470136471|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594513|NCT03874234|470136472|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594514|NCT03874234|470136473|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594515|NCT03874234|470136474|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594516|NCT03874234|470136475|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594517|NCT03874234|470136476|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130594518|NCT01821963|470136478|FG000|Overall Study|Adverse Event|1|||
130594519|NCT00783289|470136479|FG000|Overall Study|Protocol Violation|0|||
130594520|NCT00783289|470136480|FG001|Overall Study|Protocol Violation|1|||
130594521|NCT00783289|470136481|FG002|Overall Study|Protocol Violation|0|||
130594522|NCT00783289|470136482|FG003|Overall Study|Protocol Violation|0|||
130594523|NCT01896232|470136483|FG000|Overall Study|Death|6|||
130594524|NCT01896232|470136484|FG001|Overall Study|Death|10|||
130594525|NCT01896232|470136483|FG000|Overall Study|Withdrawal by Subject|32|||
130594526|NCT01896232|470136484|FG001|Overall Study|Withdrawal by Subject|31|||
130594527|NCT01896232|470136483|FG000|Overall Study|Sponsor Decision|2|||
130594528|NCT01896232|470136484|FG001|Overall Study|Sponsor Decision|0|||
130594529|NCT01896232|470136483|FG000|Overall Study|Lost to Follow-up|9|||
130594530|NCT01896232|470136484|FG001|Overall Study|Lost to Follow-up|12|||
130594531|NCT00686205|470136485|FG000|Overall Study|Protocol Violation|127|||
130594532|NCT00686205|470136486|FG001|Overall Study|Protocol Violation|0|||
130594533|NCT00686205|470136485|FG000|Overall Study|Withdrawal by Subject|2|||
130594534|NCT00686205|470136486|FG001|Overall Study|Withdrawal by Subject|0|||
130594535|NCT00686205|470136485|FG000|Overall Study|Specimen handling procedure altered|5878|||
130594536|NCT00686205|470136486|FG001|Overall Study|Specimen handling procedure altered|0|||
130594537|NCT00686205|470136485|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
130594538|NCT00686205|470136486|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
130594539|NCT00265941|470136487|FG000|Overall Study|Protocol Violation|22|||
130594540|NCT00265941|470136488|FG001|Overall Study|Protocol Violation|25|||
130594541|NCT00265941|470136487|FG000|Overall Study|Lost to Follow-up|1|||
130594542|NCT00265941|470136488|FG001|Overall Study|Lost to Follow-up|1|||
130594543|NCT03816995|470136491|FG000|Overall Study|Withdrawal by Subject|3|||
130594544|NCT03816995|470136492|FG001|Overall Study|Withdrawal by Subject|1|||
130594545|NCT03816995|470136491|FG000|Overall Study|Cancelled Surgery|8|||
130594546|NCT03816995|470136492|FG001|Overall Study|Cancelled Surgery|12|||
130594547|NCT03816995|470136491|FG000|Overall Study|No wound protector used|11|||
130594548|NCT03816995|470136492|FG001|Overall Study|No wound protector used|17|||
130594549|NCT03816995|470136491|FG000|Overall Study|Protocol Violation|2|||
130594550|NCT03816995|470136492|FG001|Overall Study|Protocol Violation|3|||
130594551|NCT03976401|470136500|FG000|Overall Study|Adverse Event|2|||
130594552|NCT03976401|470136501|FG001|Overall Study|Adverse Event|0|||
130594553|NCT03976401|470136502|FG002|Overall Study|Adverse Event|4|||
130594554|NCT03976401|470136503|FG003|Overall Study|Adverse Event|1|||
130594555|NCT03976401|470136504|FG004|Overall Study|Adverse Event|1|||
130594556|NCT03976401|470136505|FG005|Overall Study|Adverse Event|0|||
130594557|NCT03976401|470136500|FG000|Overall Study|Withdrawal by Subject|0|||
130594558|NCT03976401|470136501|FG001|Overall Study|Withdrawal by Subject|1|||
130594559|NCT03976401|470136502|FG002|Overall Study|Withdrawal by Subject|0|||
130594560|NCT03976401|470136503|FG003|Overall Study|Withdrawal by Subject|0|||
130594561|NCT03976401|470136504|FG004|Overall Study|Withdrawal by Subject|0|||
130594562|NCT03976401|470136505|FG005|Overall Study|Withdrawal by Subject|1|||
130594563|NCT03976401|470136500|FG000|Overall Study|Physician Decision|0|||
130594564|NCT03976401|470136501|FG001|Overall Study|Physician Decision|0|||
130594565|NCT03976401|470136502|FG002|Overall Study|Physician Decision|1|||
130594566|NCT03976401|470136503|FG003|Overall Study|Physician Decision|0|||
130594567|NCT03976401|470136504|FG004|Overall Study|Physician Decision|0|||
130594568|NCT03976401|470136505|FG005|Overall Study|Physician Decision|0|||
130594569|NCT03976401|470136500|FG000|Overall Study|Lost to Follow-up|1|||
130594570|NCT03976401|470136501|FG001|Overall Study|Lost to Follow-up|2|||
130594571|NCT03976401|470136502|FG002|Overall Study|Lost to Follow-up|0|||
130594572|NCT03976401|470136503|FG003|Overall Study|Lost to Follow-up|0|||
130594573|NCT03976401|470136504|FG004|Overall Study|Lost to Follow-up|0|||
130594574|NCT03976401|470136505|FG005|Overall Study|Lost to Follow-up|0|||
130594575|NCT03976401|470136500|FG000|Overall Study|Protocol Violation|0|||
130594576|NCT03976401|470136501|FG001|Overall Study|Protocol Violation|1|||
130594577|NCT03976401|470136502|FG002|Overall Study|Protocol Violation|0|||
130594578|NCT03976401|470136503|FG003|Overall Study|Protocol Violation|0|||
130594579|NCT03976401|470136504|FG004|Overall Study|Protocol Violation|0|||
130594580|NCT03976401|470136505|FG005|Overall Study|Protocol Violation|0|||
130594581|NCT03976401|470136500|FG000|Overall Study|Withdrew Consent|0|||
130594582|NCT03976401|470136501|FG001|Overall Study|Withdrew Consent|0|||
130594583|NCT03976401|470136502|FG002|Overall Study|Withdrew Consent|0|||
130594584|NCT03976401|470136503|FG003|Overall Study|Withdrew Consent|1|||
130594585|NCT03976401|470136504|FG004|Overall Study|Withdrew Consent|0|||
130594586|NCT03976401|470136505|FG005|Overall Study|Withdrew Consent|0|||
130594587|NCT01503021|470136508|FG000|Overall Study|Adverse Event|7|||
130594588|NCT01503021|470136509|FG001|Overall Study|Adverse Event|6|||
130594589|NCT01503021|470136508|FG000|Overall Study|Death|0|||
130594590|NCT01503021|470136509|FG001|Overall Study|Death|2|||
130594591|NCT01503021|470136508|FG000|Overall Study|Lost to Follow-up|2|||
130594592|NCT01503021|470136509|FG001|Overall Study|Lost to Follow-up|0|||
130594593|NCT01503021|470136508|FG000|Overall Study|Physician Decision|3|||
130594594|NCT01503021|470136509|FG001|Overall Study|Physician Decision|0|||
130594595|NCT01503021|470136508|FG000|Overall Study|Protocol Violation|1|||
130594596|NCT01503021|470136509|FG001|Overall Study|Protocol Violation|3|||
130594597|NCT01503021|470136508|FG000|Overall Study|Withdrawal by Subject|9|||
130594598|NCT01503021|470136509|FG001|Overall Study|Withdrawal by Subject|8|||
130594599|NCT01503021|470136508|FG000|Overall Study|Moved, received transplant, etc.|5|||
130594600|NCT01503021|470136509|FG001|Overall Study|Moved, received transplant, etc.|7|||
130594601|NCT00817414|470136510|FG000|Overall Study|Adverse Event|1|||
130594602|NCT00817414|470136511|FG001|Overall Study|Adverse Event|1|||
130594603|NCT00817414|470136512|FG002|Overall Study|Adverse Event|1|||
130594604|NCT00817414|470136513|FG003|Overall Study|Adverse Event|0|||
130594605|NCT00817414|470136514|FG004|Overall Study|Adverse Event|0|||
130594606|NCT00817414|470136510|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
130594607|NCT00817414|470136511|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
130594608|NCT00817414|470136512|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
130594609|NCT00817414|470136513|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
130594610|NCT00817414|470136514|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
130594611|NCT00817414|470136510|FG000|Overall Study|Withdrawal by Subject|1|||
130594612|NCT00817414|470136511|FG001|Overall Study|Withdrawal by Subject|1|||
130594613|NCT00817414|470136512|FG002|Overall Study|Withdrawal by Subject|0|||
130594614|NCT00817414|470136513|FG003|Overall Study|Withdrawal by Subject|0|||
130594615|NCT00817414|470136514|FG004|Overall Study|Withdrawal by Subject|0|||
130594616|NCT00817414|470136510|FG000|Overall Study|Lost to Follow-up|0|||
130594617|NCT00817414|470136511|FG001|Overall Study|Lost to Follow-up|0|||
130594618|NCT00817414|470136512|FG002|Overall Study|Lost to Follow-up|1|||
130594619|NCT00817414|470136513|FG003|Overall Study|Lost to Follow-up|1|||
130594620|NCT00817414|470136514|FG004|Overall Study|Lost to Follow-up|1|||
130594621|NCT00817414|470136510|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130594622|NCT00817414|470136511|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130594623|NCT00817414|470136512|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130594624|NCT00817414|470136513|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
130594625|NCT00817414|470136514|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130594626|NCT00817414|470136510|FG000|Overall Study|Protocol Violation|0|||
130594627|NCT00817414|470136511|FG001|Overall Study|Protocol Violation|0|||
130594628|NCT00817414|470136512|FG002|Overall Study|Protocol Violation|0|||
130594629|NCT00817414|470136513|FG003|Overall Study|Protocol Violation|0|||
130594630|NCT00817414|470136514|FG004|Overall Study|Protocol Violation|1|||
130594631|NCT00097539|470136517|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
130594632|NCT00097539|470136518|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
130594633|NCT00097539|470136519|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
130594634|NCT00097539|470136520|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
130594635|NCT00097539|470136521|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
130594636|NCT00097539|470136522|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
130594637|NCT00097539|470136523|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
130594638|NCT00097539|470136517|FG000|Overall Study|Withdrawal by Subject|925|||
130594639|NCT00097539|470136518|FG001|Overall Study|Withdrawal by Subject|323|||
130594640|NCT00097539|470136519|FG002|Overall Study|Withdrawal by Subject|346|||
130594641|NCT00097539|470136520|FG003|Overall Study|Withdrawal by Subject|217|||
130594642|NCT00097539|470136521|FG004|Overall Study|Withdrawal by Subject|68|||
130594643|NCT00097539|470136522|FG005|Overall Study|Withdrawal by Subject|229|||
130594644|NCT00097539|470136523|FG006|Overall Study|Withdrawal by Subject|3|||
130594645|NCT00097539|470136517|FG000|Overall Study|Participant Non-compliant|2140|||
130594646|NCT00097539|470136518|FG001|Overall Study|Participant Non-compliant|567|||
130594647|NCT00097539|470136519|FG002|Overall Study|Participant Non-compliant|1067|||
130594648|NCT00097539|470136520|FG003|Overall Study|Participant Non-compliant|353|||
130594649|NCT00097539|470136521|FG004|Overall Study|Participant Non-compliant|136|||
130594650|NCT00097539|470136522|FG005|Overall Study|Participant Non-compliant|543|||
130594651|NCT00097539|470136523|FG006|Overall Study|Participant Non-compliant|18|||
130594652|NCT00097539|470136517|FG000|Overall Study|Lack of Efficacy|249|||
130594653|NCT00097539|470136518|FG001|Overall Study|Lack of Efficacy|122|||
130594654|NCT00097539|470136519|FG002|Overall Study|Lack of Efficacy|202|||
130594655|NCT00097539|470136520|FG003|Overall Study|Lack of Efficacy|105|||
130594656|NCT00097539|470136521|FG004|Overall Study|Lack of Efficacy|45|||
130594657|NCT00097539|470136522|FG005|Overall Study|Lack of Efficacy|228|||
130594658|NCT00097539|470136523|FG006|Overall Study|Lack of Efficacy|5|||
130594659|NCT00097539|470136517|FG000|Overall Study|Adverse Event|78|||
130594660|NCT00097539|470136518|FG001|Overall Study|Adverse Event|133|||
130594661|NCT00097539|470136519|FG002|Overall Study|Adverse Event|37|||
130594662|NCT00097539|470136520|FG003|Overall Study|Adverse Event|27|||
130594663|NCT00097539|470136521|FG004|Overall Study|Adverse Event|30|||
130594664|NCT00097539|470136522|FG005|Overall Study|Adverse Event|59|||
130594665|NCT00097539|470136523|FG006|Overall Study|Adverse Event|1|||
130594666|NCT00097539|470136517|FG000|Overall Study|Death|2|||
130594667|NCT00097539|470136518|FG001|Overall Study|Death|7|||
130594668|NCT00097539|470136519|FG002|Overall Study|Death|0|||
130594669|NCT00097539|470136520|FG003|Overall Study|Death|0|||
130594670|NCT00097539|470136521|FG004|Overall Study|Death|1|||
130594671|NCT00097539|470136522|FG005|Overall Study|Death|3|||
130594672|NCT00097539|470136523|FG006|Overall Study|Death|0|||
130594673|NCT00097539|470136517|FG000|Overall Study|Reasons Other Than Above|3602|||
130594674|NCT00097539|470136518|FG001|Overall Study|Reasons Other Than Above|1382|||
130594675|NCT00097539|470136519|FG002|Overall Study|Reasons Other Than Above|1757|||
130594676|NCT00097539|470136520|FG003|Overall Study|Reasons Other Than Above|692|||
130594677|NCT00097539|470136521|FG004|Overall Study|Reasons Other Than Above|361|||
130594678|NCT00097539|470136522|FG005|Overall Study|Reasons Other Than Above|1244|||
130594679|NCT00097539|470136523|FG006|Overall Study|Reasons Other Than Above|34|||
130594680|NCT00097539|470136517|FG000|Overall Study|Reason not Specified|111|||
130594681|NCT00097539|470136518|FG001|Overall Study|Reason not Specified|49|||
130594682|NCT00097539|470136519|FG002|Overall Study|Reason not Specified|53|||
130594683|NCT00097539|470136520|FG003|Overall Study|Reason not Specified|21|||
130594684|NCT00097539|470136521|FG004|Overall Study|Reason not Specified|11|||
130594685|NCT00097539|470136522|FG005|Overall Study|Reason not Specified|40|||
130594686|NCT00097539|470136523|FG006|Overall Study|Reason not Specified|2|||
130594687|NCT03941548|470136524|FG000|Overall Study|Adverse Event|0|||
130594688|NCT03941548|470136525|FG001|Overall Study|Adverse Event|1|||
130594689|NCT03941548|470136524|FG000|Overall Study|Lost to Follow-up|0|||
130594690|NCT03941548|470136525|FG001|Overall Study|Lost to Follow-up|1|||
130594691|NCT03941548|470136524|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
130594692|NCT03941548|470136525|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
130594693|NCT02945657|470136528|FG000|Overall Study|Adverse Event|1|||
130594694|NCT02945657|470136528|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130594695|NCT03584009|470136535|FG000|Overall Study|Death|25|||
130594696|NCT03584009|470136536|FG001|Overall Study|Death|18|||
130594697|NCT03584009|470136535|FG000|Overall Study|Lost to Follow-up|0|||
130594698|NCT03584009|470136536|FG001|Overall Study|Lost to Follow-up|1|||
130594699|NCT03584009|470136535|FG000|Overall Study|Physician Decision|1|||
130594700|NCT03584009|470136536|FG001|Overall Study|Physician Decision|1|||
130594701|NCT03584009|470136535|FG000|Overall Study|Study Terminated by Sponsor|22|||
130594702|NCT03584009|470136536|FG001|Overall Study|Study Terminated by Sponsor|30|||
130594703|NCT03584009|470136535|FG000|Overall Study|Withdrawal by Subject|3|||
130594704|NCT03584009|470136536|FG001|Overall Study|Withdrawal by Subject|2|||
130594705|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
130594706|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
130594707|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
130594708|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
130594709|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
130594710|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
130594711|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
130594712|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
130594713|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
130594714|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
130594715|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
130594716|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
130594717|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
130594718|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
130594719|NCT00446030|470136537|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
130594720|NCT00446030|470136538|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
130594721|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
130594722|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
130594723|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
130594724|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
130594725|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
130594726|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
130594727|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
130594728|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
130594729|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
130594730|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
130594731|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
130594732|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
130594733|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
130594734|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
130594735|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
130594736|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
130594737|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
130594738|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
130594739|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
130594740|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
130594741|NCT00446030|470136537|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
130594742|NCT00446030|470136538|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
130594743|NCT02886715|470136539|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130594744|NCT02886715|470136540|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130594745|NCT02886715|470136541|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130594746|NCT02886715|470136539|FG000|Overall Study|Adverse Event|4|||
130594747|NCT02886715|470136540|FG001|Overall Study|Adverse Event|2|||
130594748|NCT02886715|470136541|FG002|Overall Study|Adverse Event|0|||
130594749|NCT02886715|470136539|FG000|Overall Study|Lack of Efficacy|0|||
130594750|NCT02886715|470136540|FG001|Overall Study|Lack of Efficacy|2|||
130594751|NCT02886715|470136541|FG002|Overall Study|Lack of Efficacy|1|||
130594752|NCT02886715|470136539|FG000|Overall Study|Lost to Follow-up|29|||
130594753|NCT02886715|470136540|FG001|Overall Study|Lost to Follow-up|26|||
130594754|NCT02886715|470136541|FG002|Overall Study|Lost to Follow-up|10|||
130594755|NCT02886715|470136539|FG000|Overall Study|Pregnancy|1|||
130594756|NCT02886715|470136540|FG001|Overall Study|Pregnancy|1|||
130594757|NCT02886715|470136541|FG002|Overall Study|Pregnancy|1|||
130594758|NCT02886715|470136539|FG000|Overall Study|Protocol Violation|3|||
130594759|NCT02886715|470136540|FG001|Overall Study|Protocol Violation|2|||
130594760|NCT02886715|470136541|FG002|Overall Study|Protocol Violation|1|||
130594761|NCT02886715|470136539|FG000|Overall Study|Withdrawal by Subject|20|||
130594762|NCT02886715|470136540|FG001|Overall Study|Withdrawal by Subject|18|||
130594763|NCT02886715|470136541|FG002|Overall Study|Withdrawal by Subject|5|||
130594764|NCT02886715|470136539|FG000|Overall Study|missing|7|||
130594765|NCT02886715|470136540|FG001|Overall Study|missing|2|||
130594766|NCT02886715|470136541|FG002|Overall Study|missing|2|||
130594767|NCT00222105|470136542|FG000|Overall Study|Removed due to wrong diagnosis|1|||
130594768|NCT00222105|470136542|FG000|Overall Study|Withdrawal by Subject|1|||
130594769|NCT00222105|470136542|FG000|Overall Study|Adverse Event|8|||
130594770|NCT00222105|470136542|FG000|Overall Study|Treatment delays|2|||
130594771|NCT00222105|470136542|FG000|Overall Study|Death|2|||
130594772|NCT00503399|470136543|FG000|Overall Study|Death|2|||
130594773|NCT00503399|470136544|FG001|Overall Study|Death|1|||
130594774|NCT00503399|470136543|FG000|Overall Study|Protocol Violation|1|||
130594775|NCT00503399|470136544|FG001|Overall Study|Protocol Violation|0|||
130594776|NCT00503399|470136543|FG000|Overall Study|Withdrawal by Subject|4|||
130594777|NCT00503399|470136544|FG001|Overall Study|Withdrawal by Subject|2|||
130594778|NCT00503399|470136543|FG000|Overall Study|Adverse Event|0|||
130594779|NCT00503399|470136544|FG001|Overall Study|Adverse Event|3|||
130594780|NCT00503399|470136543|FG000|Overall Study|Lost to Follow-up|0|||
130594781|NCT00503399|470136544|FG001|Overall Study|Lost to Follow-up|2|||
130594782|NCT01120626|470136547|FG000|Overall Study|Withdrawal by Subject|1|||
130594783|NCT01120626|470136548|FG001|Overall Study|Withdrawal by Subject|0|||
130594784|NCT01073943|470136564|FG000|Overall Study|Withdrawal by Subject|8|||
130594785|NCT01073943|470136565|FG001|Overall Study|Withdrawal by Subject|2|||
130594786|NCT01073943|470136564|FG000|Overall Study|Protocol Violation|2|||
130594787|NCT01073943|470136565|FG001|Overall Study|Protocol Violation|1|||
130594788|NCT01073943|470136564|FG000|Overall Study|Adverse Event|1|||
130594789|NCT01073943|470136565|FG001|Overall Study|Adverse Event|1|||
130594790|NCT01073943|470136564|FG000|Overall Study|Lost to Follow-up|0|||
130594791|NCT01073943|470136565|FG001|Overall Study|Lost to Follow-up|2|||
130594792|NCT01073943|470136564|FG000|Overall Study|Power outage; colonoscopy not done|1|||
130594793|NCT01073943|470136565|FG001|Overall Study|Power outage; colonoscopy not done|0|||
130594794|NCT01073943|470136564|FG000|Overall Study|Subject forgot|0|||
130594795|NCT01073943|470136565|FG001|Overall Study|Subject forgot|1|||
130594796|NCT01073943|470136564|FG000|Overall Study|Unable to return for follow-up|0|||
130594797|NCT01073943|470136565|FG001|Overall Study|Unable to return for follow-up|1|||
130594798|NCT01073943|470136564|FG000|Overall Study|Could not tolerate prep|1|||
130594799|NCT01073943|470136565|FG001|Overall Study|Could not tolerate prep|0|||
130594800|NCT00824421|470136566|FG000|Overall Study|Adverse Event|6|||
130594801|NCT00824421|470136567|FG001|Overall Study|Adverse Event|6|||
130594802|NCT00824421|470136568|FG002|Overall Study|Adverse Event|6|||
130594803|NCT00824421|470136566|FG000|Overall Study|Death|0|||
130594804|NCT00824421|470136567|FG001|Overall Study|Death|1|||
130594805|NCT00824421|470136568|FG002|Overall Study|Death|0|||
130594806|NCT00824421|470136566|FG000|Overall Study|Lack of Efficacy|5|||
130594807|NCT00824421|470136567|FG001|Overall Study|Lack of Efficacy|7|||
130594808|NCT00824421|470136568|FG002|Overall Study|Lack of Efficacy|4|||
130594809|NCT00824421|470136566|FG000|Overall Study|Lost to Follow-up|2|||
130594810|NCT00824421|470136567|FG001|Overall Study|Lost to Follow-up|3|||
130594811|NCT00824421|470136568|FG002|Overall Study|Lost to Follow-up|0|||
130594812|NCT00824421|470136566|FG000|Overall Study|Pregnancy|1|||
130594813|NCT00824421|470136567|FG001|Overall Study|Pregnancy|0|||
130594814|NCT00824421|470136568|FG002|Overall Study|Pregnancy|1|||
130594815|NCT00824421|470136566|FG000|Overall Study|Withdrawal by Subject|2|||
130594816|NCT00824421|470136567|FG001|Overall Study|Withdrawal by Subject|3|||
130594817|NCT00824421|470136568|FG002|Overall Study|Withdrawal by Subject|3|||
130594818|NCT00824421|470136566|FG000|Overall Study|Randomized but not Treated|1|||
130594819|NCT00824421|470136567|FG001|Overall Study|Randomized but not Treated|1|||
130594820|NCT00824421|470136568|FG002|Overall Study|Randomized but not Treated|0|||
130594821|NCT00824421|470136566|FG000|Overall Study|Other|0|||
130594822|NCT00824421|470136567|FG001|Overall Study|Other|1|||
130594823|NCT00824421|470136568|FG002|Overall Study|Other|0|||
130594824|NCT03830281|470136571|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
130594825|NCT03830281|470136572|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
130594826|NCT03830281|470136571|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
130594827|NCT03830281|470136572|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
130594828|NCT03830281|470136571|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
130594829|NCT03830281|470136572|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
130594830|NCT03830281|470136571|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
130594831|NCT03830281|470136572|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
130594832|NCT03830281|470136571|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
130594833|NCT03830281|470136572|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
130594834|NCT03830281|470136571|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
130594835|NCT03830281|470136572|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
130594836|NCT03830281|470136571|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
130594837|NCT03830281|470136572|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
130594838|NCT03830281|470136571|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
130594839|NCT03830281|470136572|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
130594840|NCT03830281|470136571|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
130594841|NCT03830281|470136572|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
130594842|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
130594843|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
130594844|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
130594845|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
130594846|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
130594847|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
130594848|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Personal issues|2|||
130594849|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Personal issues|0|||
130594850|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Personal issues|0|||
130594851|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Too busy|7|||
130594852|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Too busy|1|||
130594853|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Too busy|0|||
130594854|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Pain|2|||
130594855|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Pain|0|||
130594856|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Pain|0|||
130594857|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Moved|1|||
130594858|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Moved|0|||
130594859|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Moved|0|||
130594860|NCT00594399|470136573|FG000|Initial 3 Month Counseling|Family illness|1|||
130594861|NCT00594399|470136574|FG001|Initial 3 Month Counseling|Family illness|0|||
130594862|NCT00594399|470136575|FG002|Initial 3 Month Counseling|Family illness|0|||
130594863|NCT00594399|470136573|FG000|Rerandomization Arm 1 Only|Death|2|||
130594864|NCT00594399|470136574|FG001|Rerandomization Arm 1 Only|Death|1|||
130594865|NCT00594399|470136575|FG002|Rerandomization Arm 1 Only|Death|0|||
130594866|NCT00594399|470136573|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
130594867|NCT00594399|470136574|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
130594868|NCT00594399|470136575|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
130594869|NCT00659438|470136577|FG000|Overall Study|Withdrawal by Subject|2|||
130594870|NCT00659438|470136578|FG001|Overall Study|Withdrawal by Subject|2|||
130594871|NCT00659438|470136577|FG000|Overall Study|Death|11|||
130594872|NCT00659438|470136578|FG001|Overall Study|Death|6|||
130594873|NCT00659438|470136577|FG000|Overall Study|Lost to Follow-up|1|||
130594874|NCT00659438|470136578|FG001|Overall Study|Lost to Follow-up|0|||
130594875|NCT03192904|470136579|FG000|Overall Study|Physician Decision|3|||
130594876|NCT03192904|470136580|FG001|Overall Study|Physician Decision|1|||
130594877|NCT03192904|470136579|FG000|Overall Study|Lost to Follow-up|0|||
130594878|NCT03192904|470136580|FG001|Overall Study|Lost to Follow-up|1|||
130594879|NCT01309737|470136581|FG000|Week 0 to 16|Death|1|||
130594880|NCT01309737|470136582|FG001|Week 0 to 16|Death|0|||
130594881|NCT01309737|470136583|FG002|Week 0 to 16|Death|1|||
130594882|NCT01309737|470136584|FG003|Week 0 to 16|Death|0|||
130594883|NCT01309737|470136585|FG004|Week 0 to 16|Death|0|||
130594884|NCT01309737|470136581|FG000|Week 0 to 16|Adverse Event|11|||
130594885|NCT01309737|470136582|FG001|Week 0 to 16|Adverse Event|10|||
130594886|NCT01309737|470136583|FG002|Week 0 to 16|Adverse Event|5|||
130594887|NCT01309737|470136584|FG003|Week 0 to 16|Adverse Event|0|||
130594888|NCT01309737|470136585|FG004|Week 0 to 16|Adverse Event|0|||
130594889|NCT01309737|470136581|FG000|Week 0 to 16|Lack of Efficacy|15|||
130594890|NCT01309737|470136582|FG001|Week 0 to 16|Lack of Efficacy|2|||
130594891|NCT01309737|470136583|FG002|Week 0 to 16|Lack of Efficacy|24|||
130594892|NCT01309737|470136584|FG003|Week 0 to 16|Lack of Efficacy|0|||
130594893|NCT01309737|470136585|FG004|Week 0 to 16|Lack of Efficacy|0|||
130594894|NCT01309737|470136581|FG000|Week 0 to 16|Lost to Follow-up|7|||
130594895|NCT01309737|470136582|FG001|Week 0 to 16|Lost to Follow-up|8|||
130594896|NCT01309737|470136583|FG002|Week 0 to 16|Lost to Follow-up|3|||
130594897|NCT01309737|470136584|FG003|Week 0 to 16|Lost to Follow-up|0|||
130594898|NCT01309737|470136585|FG004|Week 0 to 16|Lost to Follow-up|0|||
130594899|NCT01309737|470136581|FG000|Week 0 to 16|Withdrawal by Subject|7|||
130594900|NCT01309737|470136582|FG001|Week 0 to 16|Withdrawal by Subject|6|||
130594901|NCT01309737|470136583|FG002|Week 0 to 16|Withdrawal by Subject|7|||
130594902|NCT01309737|470136584|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130594903|NCT01309737|470136585|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130594904|NCT01309737|470136581|FG000|Week 0 to 16|Other|10|||
130594905|NCT01309737|470136582|FG001|Week 0 to 16|Other|14|||
130594906|NCT01309737|470136583|FG002|Week 0 to 16|Other|4|||
130594907|NCT01309737|470136584|FG003|Week 0 to 16|Other|0|||
130594908|NCT01309737|470136585|FG004|Week 0 to 16|Other|0|||
130594909|NCT01309737|470136581|FG000|Week 0 to 16|Randomized, but not treated|1|||
130594910|NCT01309737|470136582|FG001|Week 0 to 16|Randomized, but not treated|0|||
130594911|NCT01309737|470136583|FG002|Week 0 to 16|Randomized, but not treated|0|||
130594912|NCT01309737|470136584|FG003|Week 0 to 16|Randomized, but not treated|0|||
130594913|NCT01309737|470136585|FG004|Week 0 to 16|Randomized, but not treated|0|||
130594914|NCT01309737|470136581|FG000|Week 16 to 52|Death|0|||
130594915|NCT01309737|470136582|FG001|Week 16 to 52|Death|0|||
130594916|NCT01309737|470136583|FG002|Week 16 to 52|Death|0|||
130594917|NCT01309737|470136584|FG003|Week 16 to 52|Death|0|||
130594918|NCT01309737|470136585|FG004|Week 16 to 52|Death|1|||
130594919|NCT01309737|470136581|FG000|Week 16 to 52|Adverse Event|7|||
130594920|NCT01309737|470136582|FG001|Week 16 to 52|Adverse Event|7|||
130594921|NCT01309737|470136583|FG002|Week 16 to 52|Adverse Event|0|||
130594922|NCT01309737|470136584|FG003|Week 16 to 52|Adverse Event|6|||
130594923|NCT01309737|470136585|FG004|Week 16 to 52|Adverse Event|5|||
130594924|NCT01309737|470136581|FG000|Week 16 to 52|Lack of Efficacy|107|||
130594925|NCT01309737|470136582|FG001|Week 16 to 52|Lack of Efficacy|76|||
130594926|NCT01309737|470136583|FG002|Week 16 to 52|Lack of Efficacy|0|||
130594927|NCT01309737|470136584|FG003|Week 16 to 52|Lack of Efficacy|25|||
130594928|NCT01309737|470136585|FG004|Week 16 to 52|Lack of Efficacy|21|||
130594929|NCT01309737|470136581|FG000|Week 16 to 52|Lost to Follow-up|4|||
130594930|NCT01309737|470136582|FG001|Week 16 to 52|Lost to Follow-up|2|||
130594931|NCT01309737|470136583|FG002|Week 16 to 52|Lost to Follow-up|0|||
130594932|NCT01309737|470136584|FG003|Week 16 to 52|Lost to Follow-up|1|||
130594933|NCT01309737|470136585|FG004|Week 16 to 52|Lost to Follow-up|4|||
130594934|NCT01309737|470136581|FG000|Week 16 to 52|Withdrawal by Subject|5|||
130594935|NCT01309737|470136582|FG001|Week 16 to 52|Withdrawal by Subject|6|||
130594936|NCT01309737|470136583|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130594937|NCT01309737|470136584|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130594938|NCT01309737|470136585|FG004|Week 16 to 52|Withdrawal by Subject|2|||
130594939|NCT01309737|470136581|FG000|Week 16 to 52|Other|10|||
130594940|NCT01309737|470136582|FG001|Week 16 to 52|Other|12|||
130594941|NCT01309737|470136583|FG002|Week 16 to 52|Other|0|||
130594942|NCT01309737|470136584|FG003|Week 16 to 52|Other|2|||
130594943|NCT01309737|470136585|FG004|Week 16 to 52|Other|0|||
130594944|NCT01442181|470136586|FG000|Overall Study|patient refused surgery|1|||
130594945|NCT01442181|470136587|FG001|Overall Study|patient refused surgery|0|||
130594946|NCT01442181|470136586|FG000|Overall Study|no insurance for surgery|1|||
130594947|NCT01442181|470136587|FG001|Overall Study|no insurance for surgery|0|||
130594948|NCT01442181|470136586|FG000|Overall Study|low ejection factor|0|||
130594949|NCT01442181|470136587|FG001|Overall Study|low ejection factor|1|||
130594950|NCT01442181|470136586|FG000|Overall Study|Lost to Follow-up|1|||
130594951|NCT01442181|470136587|FG001|Overall Study|Lost to Follow-up|1|||
130594952|NCT01442181|470136586|FG000|Overall Study|patient in an additional study|1|||
130594953|NCT01442181|470136587|FG001|Overall Study|patient in an additional study|0|||
130594954|NCT01442181|470136586|FG000|Overall Study|atrial fibrillation not noted|0|||
130594955|NCT01442181|470136587|FG001|Overall Study|atrial fibrillation not noted|1|||
130594956|NCT00709202|470136588|FG000|Overall Study|Withdrawal by Subject|6|||
130594957|NCT00709202|470136589|FG001|Overall Study|Withdrawal by Subject|6|||
130594958|NCT02240706|470136592|FG000|Overall Study|Lack of Efficacy|2|||
130594959|NCT02240706|470136593|FG001|Overall Study|Lack of Efficacy|2|||
130594960|NCT02240706|470136594|FG002|Overall Study|Lack of Efficacy|2|||
130594961|NCT02240706|470136595|FG003|Overall Study|Lack of Efficacy|2|||
130594962|NCT02240706|470136596|FG004|Overall Study|Lack of Efficacy|5|||
130594963|NCT02240706|470136597|FG005|Overall Study|Lack of Efficacy|0|||
130594964|NCT02240706|470136598|FG006|Overall Study|Lack of Efficacy|0|||
130594965|NCT02240706|470136592|FG000|Overall Study|Adverse Event|1|||
130594966|NCT02240706|470136593|FG001|Overall Study|Adverse Event|0|||
130594967|NCT02240706|470136594|FG002|Overall Study|Adverse Event|1|||
130594968|NCT02240706|470136595|FG003|Overall Study|Adverse Event|0|||
130594969|NCT02240706|470136596|FG004|Overall Study|Adverse Event|2|||
130594970|NCT02240706|470136597|FG005|Overall Study|Adverse Event|0|||
130594971|NCT02240706|470136598|FG006|Overall Study|Adverse Event|0|||
130594972|NCT02240706|470136592|FG000|Overall Study|Progressive disease|0|||
130594973|NCT02240706|470136593|FG001|Overall Study|Progressive disease|0|||
130594974|NCT02240706|470136594|FG002|Overall Study|Progressive disease|0|||
130594975|NCT02240706|470136595|FG003|Overall Study|Progressive disease|0|||
130594976|NCT02240706|470136596|FG004|Overall Study|Progressive disease|1|||
130594977|NCT02240706|470136597|FG005|Overall Study|Progressive disease|0|||
130594978|NCT02240706|470136598|FG006|Overall Study|Progressive disease|0|||
130594979|NCT02240706|470136592|FG000|Overall Study|Dose limiting toxicity|0|||
130594980|NCT02240706|470136593|FG001|Overall Study|Dose limiting toxicity|0|||
130594981|NCT02240706|470136594|FG002|Overall Study|Dose limiting toxicity|0|||
130594982|NCT02240706|470136595|FG003|Overall Study|Dose limiting toxicity|0|||
130594983|NCT02240706|470136596|FG004|Overall Study|Dose limiting toxicity|1|||
130594984|NCT02240706|470136597|FG005|Overall Study|Dose limiting toxicity|0|||
130594985|NCT02240706|470136598|FG006|Overall Study|Dose limiting toxicity|0|||
130594986|NCT02240706|470136592|FG000|Overall Study|Refused to continue taking medication|0|||
130594987|NCT02240706|470136593|FG001|Overall Study|Refused to continue taking medication|1|||
130594988|NCT02240706|470136594|FG002|Overall Study|Refused to continue taking medication|3|||
130594989|NCT02240706|470136595|FG003|Overall Study|Refused to continue taking medication|1|||
130594990|NCT02240706|470136596|FG004|Overall Study|Refused to continue taking medication|2|||
130594991|NCT02240706|470136597|FG005|Overall Study|Refused to continue taking medication|0|||
130594992|NCT02240706|470136598|FG006|Overall Study|Refused to continue taking medication|0|||
130594993|NCT02240706|470136592|FG000|Overall Study|Insurance billing concerns|0|||
130594994|NCT02240706|470136593|FG001|Overall Study|Insurance billing concerns|0|||
130594995|NCT02240706|470136594|FG002|Overall Study|Insurance billing concerns|0|||
130594996|NCT02240706|470136595|FG003|Overall Study|Insurance billing concerns|1|||
130594997|NCT02240706|470136596|FG004|Overall Study|Insurance billing concerns|0|||
130594998|NCT02240706|470136597|FG005|Overall Study|Insurance billing concerns|0|||
130594999|NCT02240706|470136598|FG006|Overall Study|Insurance billing concerns|0|||
130595000|NCT03934684|470136599|FG000|Overall Study|Participants continuing in study|11|||
130595001|NCT03934684|470136600|FG001|Overall Study|Participants continuing in study|4|||
130595002|NCT03934684|470136599|FG000|Overall Study|Discontinuation of carfilzomib|20|||
130595003|NCT03934684|470136600|FG001|Overall Study|Discontinuation of carfilzomib|30|||
130595004|NCT03934684|470136599|FG000|Overall Study|Death|2|||
130595005|NCT03934684|470136600|FG001|Overall Study|Death|2|||
130595006|NCT03934684|470136599|FG000|Overall Study|Lost to Follow-up|2|||
130595007|NCT03934684|470136600|FG001|Overall Study|Lost to Follow-up|5|||
130595008|NCT03934684|470136599|FG000|Overall Study|Withdrawal by Subject|7|||
130595009|NCT03934684|470136600|FG001|Overall Study|Withdrawal by Subject|8|||
130595010|NCT01731002|470136601|FG000|Overall Study|Adverse Event|0|||
130595011|NCT01731002|470136602|FG001|Overall Study|Adverse Event|2|||
130595012|NCT01731002|470136603|FG002|Overall Study|Adverse Event|2|||
130595013|NCT01731002|470136601|FG000|Overall Study|Non-Compliant|0|||
130595014|NCT01731002|470136602|FG001|Overall Study|Non-Compliant|1|||
130595015|NCT01731002|470136603|FG002|Overall Study|Non-Compliant|0|||
130595016|NCT01731002|470136601|FG000|Overall Study|Lost to Follow-up|1|||
130595017|NCT01731002|470136602|FG001|Overall Study|Lost to Follow-up|0|||
130595018|NCT01731002|470136603|FG002|Overall Study|Lost to Follow-up|0|||
130595019|NCT01731002|470136601|FG000|Overall Study|Test Agent Discontinuation|0|||
130595020|NCT01731002|470136602|FG001|Overall Study|Test Agent Discontinuation|1|||
130595021|NCT01731002|470136603|FG002|Overall Study|Test Agent Discontinuation|0|||
130595022|NCT01731002|470136601|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
130595023|NCT01731002|470136602|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
130595024|NCT01731002|470136603|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
130595025|NCT01731002|470136601|FG000|Overall Study|Elevated IOP|1|||
130595026|NCT01731002|470136602|FG001|Overall Study|Elevated IOP|0|||
130595027|NCT01731002|470136603|FG002|Overall Study|Elevated IOP|0|||
130595028|NCT01731002|470136601|FG000|Overall Study|Inappropriate use of study medications|0|||
130595029|NCT01731002|470136602|FG001|Overall Study|Inappropriate use of study medications|0|||
130595030|NCT01731002|470136603|FG002|Overall Study|Inappropriate use of study medications|1|||
130595031|NCT01697345|470136604|FG000|Overall Study|Withdrawal by Subject|1|||
130595032|NCT03476239|470136605|FG000|Overall Study|Withdrawal by Subject|10|||
130595033|NCT03476239|470136605|FG000|Overall Study|Death|80|||
130595034|NCT03476239|470136605|FG000|Overall Study|Lost to Follow-up|8|||
130595035|NCT01446809|470136609|FG000|Overall Study|Adverse Event|0|||
130595036|NCT01446809|470136610|FG001|Overall Study|Adverse Event|0|||
130595037|NCT01446809|470136611|FG002|Overall Study|Adverse Event|1|||
130595038|NCT01446809|470136609|FG000|Overall Study|Failure to complete study procedures|0|||
130595039|NCT01446809|470136610|FG001|Overall Study|Failure to complete study procedures|0|||
130595040|NCT01446809|470136611|FG002|Overall Study|Failure to complete study procedures|1|||
130595041|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
130595042|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
130595043|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
130595044|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
130595045|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
130595046|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130595047|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130595048|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130595049|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130595050|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
130595051|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130595052|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130595053|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130595054|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
130595055|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130595056|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
130595057|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
130595058|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
130595059|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
130595060|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
130595061|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
130595062|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
130595063|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
130595064|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
130595065|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
130595066|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
130595067|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
130595068|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
130595069|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
130595070|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
130595071|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130595072|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
130595073|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130595074|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130595075|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
130595076|NCT00785577|470136612|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130595077|NCT00785577|470136613|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
130595078|NCT00785577|470136614|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130595079|NCT00785577|470136615|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130595080|NCT00785577|470136616|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
130595081|NCT00785577|470136612|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130595082|NCT00785577|470136613|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130595083|NCT00785577|470136614|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130595084|NCT00785577|470136615|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
130595085|NCT00785577|470136616|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130595086|NCT00785577|470136612|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
130595087|NCT00785577|470136613|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
130595088|NCT00785577|470136614|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
130595089|NCT00785577|470136615|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
130595090|NCT00785577|470136616|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
130595091|NCT01682044|470136617|FG000|Overall Study|Death|1|||
130595092|NCT01682044|470136617|FG000|Overall Study|Progression|3|||
130595093|NCT03972488|470136618|FG000|Overall Study|Progressive disease|42|||
130595094|NCT03972488|470136619|FG001|Overall Study|Progressive disease|44|||
130595095|NCT03972488|470136618|FG000|Overall Study|Physician Decision|13|||
130595096|NCT03972488|470136619|FG001|Overall Study|Physician Decision|7|||
130595097|NCT03972488|470136618|FG000|Overall Study|Adverse Event|8|||
130595098|NCT03972488|470136619|FG001|Overall Study|Adverse Event|1|||
130595099|NCT03972488|470136618|FG000|Overall Study|Death|4|||
130595100|NCT03972488|470136619|FG001|Overall Study|Death|4|||
130595101|NCT03972488|470136618|FG000|Overall Study|Withdrawal by Subject|3|||
130595102|NCT03972488|470136619|FG001|Overall Study|Withdrawal by Subject|4|||
130595103|NCT03972488|470136618|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
130595104|NCT03972488|470136619|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
130595105|NCT01826214|470138124|FG000|Overall Study|Adverse Event|7|||
130595106|NCT01826214|470138125|FG001|Overall Study|Adverse Event|6|||
130595107|NCT01826214|470138124|FG000|Overall Study|Death|3|||
130595108|NCT01826214|470138125|FG001|Overall Study|Death|1|||
130595109|NCT01826214|470138124|FG000|Overall Study|Lost to Follow-up|1|||
130595110|NCT01826214|470138125|FG001|Overall Study|Lost to Follow-up|0|||
130595111|NCT01826214|470138124|FG000|Overall Study|Physician Decision|0|||
130595112|NCT01826214|470138125|FG001|Overall Study|Physician Decision|2|||
130595113|NCT01826214|470138124|FG000|Overall Study|Progressive disease|22|||
130595114|NCT01826214|470138125|FG001|Overall Study|Progressive disease|21|||
130595115|NCT01826214|470138124|FG000|Overall Study|Study terminated by Sponsor|0|||
130595116|NCT01826214|470138125|FG001|Overall Study|Study terminated by Sponsor|1|||
130595117|NCT01826214|470138124|FG000|Overall Study|Subject/guardian decision|2|||
130595118|NCT01826214|470138125|FG001|Overall Study|Subject/guardian decision|3|||
130595119|NCT01614457|470138133|FG000|Overall Study|Non-Compliance|1|||
130595120|NCT01614457|470138134|FG001|Overall Study|Non-Compliance|0|||
130595121|NCT01614457|470138133|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
130595122|NCT01614457|470138134|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
130595123|NCT00374556|470138137|FG000|Overall Study|Lost to Follow-up|1|||
130595124|NCT00374556|470138138|FG001|Overall Study|Lost to Follow-up|0|||
130595125|NCT00374556|470138137|FG000|Overall Study|Removed at baseline due to medical cond|0|||
130595126|NCT00374556|470138138|FG001|Overall Study|Removed at baseline due to medical cond|1|||
130595127|NCT01756157|470138151|FG000|First Intervention Period|Withdrawal by Subject|1|||
130595128|NCT01756157|470138152|FG001|First Intervention Period|Withdrawal by Subject|0|||
130595129|NCT01756157|470138151|FG000|First Intervention Period|Lost to Follow-up|0|||
130595130|NCT01756157|470138152|FG001|First Intervention Period|Lost to Follow-up|2|||
130595131|NCT02799381|470138155|FG000|Overall Study|Withdrew consent|3|||
130595132|NCT02799381|470138156|FG001|Overall Study|Withdrew consent|2|||
130595133|NCT02799381|470138155|FG000|Overall Study|Adverse Event|0|||
130595134|NCT02799381|470138156|FG001|Overall Study|Adverse Event|1|||
130595135|NCT02799381|470138155|FG000|Overall Study|Participant did not take any study drug|1|||
130595136|NCT02799381|470138156|FG001|Overall Study|Participant did not take any study drug|0|||
130595137|NCT03368859|470138157|FG000|Overall Study|Withdrew Consent|5|||
130595138|NCT03368859|470138158|FG001|Overall Study|Withdrew Consent|4|||
130595139|NCT03368859|470138157|FG000|Overall Study|Death|12|||
130595140|NCT03368859|470138158|FG001|Overall Study|Death|6|||
130595141|NCT03368859|470138157|FG000|Overall Study|Study terminated by Sponsor|18|||
130595142|NCT03368859|470138158|FG001|Overall Study|Study terminated by Sponsor|23|||
130595143|NCT03368859|470138157|FG000|Overall Study|Other|1|||
130595144|NCT03368859|470138158|FG001|Overall Study|Other|1|||
130595145|NCT03952130|470138159|FG000|Overall Study|Adverse Event|0|||
130595146|NCT03952130|470138160|FG001|Overall Study|Adverse Event|1|||
130595147|NCT03952130|470138159|FG000|Overall Study|Lost to Follow-up|1|||
130595148|NCT03952130|470138160|FG001|Overall Study|Lost to Follow-up|0|||
130595149|NCT03952130|470138159|FG000|Overall Study|Withdrawal by Subject|1|||
130595150|NCT03952130|470138160|FG001|Overall Study|Withdrawal by Subject|5|||
130595151|NCT01713348|470138161|FG000|Overall Study|Withdrawal by Subject|3|||
130595152|NCT01713348|470138162|FG001|Overall Study|Withdrawal by Subject|2|||
130595153|NCT01713348|470138163|FG002|Overall Study|Withdrawal by Subject|2|||
130595154|NCT01713348|470138164|FG003|Overall Study|Withdrawal by Subject|0|||
130595155|NCT01713348|470138161|FG000|Overall Study|Lost to Follow-up|1|||
130595156|NCT01713348|470138162|FG001|Overall Study|Lost to Follow-up|0|||
130595157|NCT01713348|470138163|FG002|Overall Study|Lost to Follow-up|0|||
130595158|NCT01713348|470138164|FG003|Overall Study|Lost to Follow-up|0|||
130595159|NCT05882890|470138167|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
130595160|NCT00613314|470138170|FG000|Overall Study|Adverse Event|5|||
130595161|NCT00613314|470138170|FG000|Overall Study|Protocol Violation|14|||
130595162|NCT00613314|470138170|FG000|Overall Study|Lost to Follow-up|46|||
130595163|NCT00613314|470138170|FG000|Overall Study|Other reason not defined above|90|||
130595164|NCT01584024|470138171|FG000|Overall Study|Lost to Follow-up|10|||
130595165|NCT01584024|470138171|FG000|Overall Study|Withdrawal by Subject|3|||
130595166|NCT01217606|470138172|FG000|Initial Treatment Phase|Other Reasons|0|||
130595167|NCT01217606|470138173|FG001|Initial Treatment Phase|Other Reasons|2|||
130595168|NCT01217606|470138172|FG000|Initial Treatment Phase|Protocol Violation|3|||
130595169|NCT01217606|470138173|FG001|Initial Treatment Phase|Protocol Violation|2|||
130595170|NCT01217606|470138172|FG000|Initial Treatment Phase|Personal Reasons|0|||
130595171|NCT01217606|470138173|FG001|Initial Treatment Phase|Personal Reasons|2|||
130595172|NCT01217606|470138172|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
130595173|NCT01217606|470138173|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
130595174|NCT01217606|470138172|FG000|Initial Treatment Phase|Adverse Event|10|||
130595175|NCT01217606|470138173|FG001|Initial Treatment Phase|Adverse Event|6|||
130595176|NCT01217606|470138172|FG000|9-Month Masked Extension|Adverse Event|3|||
130595177|NCT01217606|470138173|FG001|9-Month Masked Extension|Adverse Event|6|||
130595178|NCT01217606|470138172|FG000|9-Month Masked Extension|Other Reasons|4|||
130595179|NCT01217606|470138173|FG001|9-Month Masked Extension|Other Reasons|4|||
130595180|NCT01217606|470138172|FG000|9-Month Masked Extension|Personal Reasons|2|||
130595181|NCT01217606|470138173|FG001|9-Month Masked Extension|Personal Reasons|1|||
130595182|NCT01217606|470138172|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
130595183|NCT01217606|470138173|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
130595184|NCT01217606|470138172|FG000|9-Month Masked Extension|Pregnancy|1|||
130595185|NCT01217606|470138173|FG001|9-Month Masked Extension|Pregnancy|0|||
130595186|NCT01217606|470138172|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
130595187|NCT01217606|470138173|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
130595188|NCT04419506|470138176|FG000|Overall Study|Adverse Event|0|||
130595189|NCT04419506|470138177|FG001|Overall Study|Adverse Event|10|||
130595190|NCT04419506|470138178|FG002|Overall Study|Adverse Event|0|||
130595191|NCT04419506|470138179|FG003|Overall Study|Adverse Event|3|||
130595192|NCT04419506|470138176|FG000|Overall Study|Withdrawal by Subject|0|||
130595193|NCT04419506|470138177|FG001|Overall Study|Withdrawal by Subject|0|||
130595194|NCT04419506|470138178|FG002|Overall Study|Withdrawal by Subject|0|||
130595195|NCT04419506|470138179|FG003|Overall Study|Withdrawal by Subject|1|||
130595196|NCT04419506|470138176|FG000|Overall Study|poor-compliance|0|||
130595197|NCT04419506|470138177|FG001|Overall Study|poor-compliance|0|||
130595198|NCT04419506|470138178|FG002|Overall Study|poor-compliance|0|||
130595199|NCT04419506|470138179|FG003|Overall Study|poor-compliance|1|||
130595200|NCT01845025|470138180|FG000|Overall Study|Adverse Event|6|||
130595201|NCT01845025|470138181|FG001|Overall Study|Adverse Event|3|||
130595202|NCT01845025|470138180|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130595203|NCT01845025|470138181|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130595204|NCT01845025|470138180|FG000|Overall Study|Withdrawal by Subject|48|||
130595205|NCT01845025|470138181|FG001|Overall Study|Withdrawal by Subject|44|||
130595206|NCT01845025|470138180|FG000|Overall Study|Lost to Follow-up|13|||
130595207|NCT01845025|470138181|FG001|Overall Study|Lost to Follow-up|13|||
130595208|NCT01845025|470138180|FG000|Overall Study|Administrative problems|8|||
130595209|NCT01845025|470138181|FG001|Overall Study|Administrative problems|8|||
130595210|NCT01845025|470138180|FG000|Overall Study|Death|2|||
130595211|NCT01845025|470138181|FG001|Overall Study|Death|0|||
130595212|NCT01845025|470138180|FG000|Overall Study|Protocol deviation|3|||
130595213|NCT01845025|470138181|FG001|Overall Study|Protocol deviation|6|||
130595214|NCT01845025|470138180|FG000|Overall Study|Missing|1|||
130595215|NCT01845025|470138181|FG001|Overall Study|Missing|1|||
130595216|NCT02966314|470138183|FG000|Overall Study|Lost to Follow-up|1|||
130595217|NCT02966314|470138184|FG001|Overall Study|Lost to Follow-up|0|||
130595218|NCT01242111|470138185|FG000|Overall Study|Adverse Event|1|||
130595219|NCT01242111|470138185|FG000|Overall Study|Withdrawal by Subject|1|||
130595220|NCT01242111|470138185|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
130595221|NCT02015819|470138186|FG000|Overall Study|Rickham catheter was misaligned|0|||
130595222|NCT02015819|470138187|FG001|Overall Study|Rickham catheter was misaligned|0|||
130595223|NCT02015819|470138188|FG002|Overall Study|Rickham catheter was misaligned|0|||
130595224|NCT02015819|470138189|FG003|Overall Study|Rickham catheter was misaligned|1|||
130595225|NCT00813748|470138198|FG000|Skin Test Substudy|Physician Decision|0|||
130595226|NCT00813748|470138199|FG001|Skin Test Substudy|Physician Decision|1|||
130595227|NCT00283387|470138200|FG000|First Intervention|Subject non-compliant|1|||
130595228|NCT00283387|470138201|FG001|First Intervention|Subject non-compliant|1|||
130595229|NCT00283387|470138200|FG000|First Intervention|Withdrawal by Subject|0|||
130595230|NCT00283387|470138201|FG001|First Intervention|Withdrawal by Subject|1|||
130595231|NCT00728416|470138205|FG000|Overall Study|Adverse Event|1|||
130595232|NCT00728416|470138206|FG001|Overall Study|Adverse Event|1|||
130595233|NCT00728416|470138205|FG000|Overall Study|Treatment Failure|0|||
130595234|NCT00728416|470138206|FG001|Overall Study|Treatment Failure|1|||
130595235|NCT00728416|470138205|FG000|Overall Study|Withdrawal by Subject|1|||
130595236|NCT00728416|470138206|FG001|Overall Study|Withdrawal by Subject|0|||
130595237|NCT00356915|470138211|FG000|Overall Study|Non compliance|1|||
130595238|NCT00356915|470138212|FG001|Overall Study|Non compliance|2|||
130595239|NCT00356915|470138213|FG002|Overall Study|Non compliance|1|||
130595240|NCT00356915|470138211|FG000|Overall Study|Protocol Violation|2|||
130595241|NCT00356915|470138212|FG001|Overall Study|Protocol Violation|3|||
130595242|NCT00356915|470138213|FG002|Overall Study|Protocol Violation|2|||
130595243|NCT00356915|470138211|FG000|Overall Study|Withdrawal by Subject|14|||
130595244|NCT00356915|470138212|FG001|Overall Study|Withdrawal by Subject|14|||
130595245|NCT00356915|470138213|FG002|Overall Study|Withdrawal by Subject|10|||
130595246|NCT00356915|470138211|FG000|Overall Study|Lack of Efficacy|0|||
130595247|NCT00356915|470138212|FG001|Overall Study|Lack of Efficacy|0|||
130595248|NCT00356915|470138213|FG002|Overall Study|Lack of Efficacy|3|||
130595249|NCT00356915|470138211|FG000|Overall Study|Lost to Follow-up|27|||
130595250|NCT00356915|470138212|FG001|Overall Study|Lost to Follow-up|34|||
130595251|NCT00356915|470138213|FG002|Overall Study|Lost to Follow-up|14|||
130595252|NCT00356915|470138211|FG000|Overall Study|Administrative Decision|0|||
130595253|NCT00356915|470138212|FG001|Overall Study|Administrative Decision|0|||
130595254|NCT00356915|470138213|FG002|Overall Study|Administrative Decision|1|||
130595255|NCT00356915|470138211|FG000|Overall Study|Physician Decision|0|||
130595256|NCT00356915|470138212|FG001|Overall Study|Physician Decision|2|||
130595257|NCT00356915|470138213|FG002|Overall Study|Physician Decision|0|||
130595258|NCT00356915|470138211|FG000|Overall Study|Adverse Event|21|||
130595259|NCT00356915|470138212|FG001|Overall Study|Adverse Event|31|||
130595260|NCT00356915|470138213|FG002|Overall Study|Adverse Event|8|||
130595261|NCT00356915|470138211|FG000|Overall Study|Miscellaneous reasons|11|||
130595262|NCT00356915|470138212|FG001|Overall Study|Miscellaneous reasons|8|||
130595263|NCT00356915|470138213|FG002|Overall Study|Miscellaneous reasons|3|||
130595264|NCT00509106|470138214|FG000|Overall Study|Adverse Event|3|||
130595265|NCT00509106|470138215|FG001|Overall Study|Adverse Event|2|||
130595266|NCT00509106|470138214|FG000|Overall Study|Noncompliance|0|||
130595267|NCT00509106|470138215|FG001|Overall Study|Noncompliance|1|||
130595268|NCT00509106|470138214|FG000|Overall Study|At the request of sponsor/investigator|1|||
130595269|NCT00509106|470138215|FG001|Overall Study|At the request of sponsor/investigator|2|||
130595270|NCT00509106|470138214|FG000|Overall Study|Withdrew consent|4|||
130595271|NCT00509106|470138215|FG001|Overall Study|Withdrew consent|8|||
130595272|NCT00509106|470138214|FG000|Overall Study|Lost to Follow-up|16|||
130595273|NCT00509106|470138215|FG001|Overall Study|Lost to Follow-up|10|||
130595274|NCT00509106|470138214|FG000|Overall Study|Other|1|||
130595275|NCT00509106|470138215|FG001|Overall Study|Other|0|||
130595276|NCT00509106|470138214|FG000|Overall Study|Death|6|||
130595277|NCT00509106|470138215|FG001|Overall Study|Death|6|||
130595278|NCT00488631|470138221|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
130595279|NCT00488631|470138222|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
130595280|NCT00488631|470138223|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
130595281|NCT00488631|470138224|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
130595282|NCT00488631|470138225|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
130595283|NCT00488631|470138226|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
130595284|NCT00488631|470138227|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
130595285|NCT00488631|470138228|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
130595286|NCT00488631|470138229|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
130595287|NCT00488631|470138230|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
130595288|NCT00488631|470138221|FG000|Double Blind Period (Week 0-54)|Death|0|||
130595289|NCT00488631|470138222|FG001|Double Blind Period (Week 0-54)|Death|0|||
130595290|NCT00488631|470138223|FG002|Double Blind Period (Week 0-54)|Death|0|||
130595291|NCT00488631|470138224|FG003|Double Blind Period (Week 0-54)|Death|0|||
130595292|NCT00488631|470138225|FG004|Double Blind Period (Week 0-54)|Death|0|||
130595293|NCT00488631|470138226|FG005|Double Blind Period (Week 0-54)|Death|1|||
130595294|NCT00488631|470138227|FG006|Double Blind Period (Week 0-54)|Death|0|||
130595295|NCT00488631|470138228|FG007|Double Blind Period (Week 0-54)|Death|0|||
130595296|NCT00488631|470138229|FG008|Double Blind Period (Week 0-54)|Death|0|||
130595297|NCT00488631|470138230|FG009|Double Blind Period (Week 0-54)|Death|0|||
130595298|NCT00488631|470138221|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
130595299|NCT00488631|470138222|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
130595300|NCT00488631|470138223|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
130595301|NCT00488631|470138224|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
130595302|NCT00488631|470138225|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
130595303|NCT00488631|470138226|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
130595304|NCT00488631|470138227|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130595305|NCT00488631|470138228|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130595306|NCT00488631|470138229|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130595307|NCT00488631|470138230|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130595308|NCT00488631|470138221|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
130595309|NCT00488631|470138222|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
130595310|NCT00488631|470138223|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
130595311|NCT00488631|470138224|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130595312|NCT00488631|470138225|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
130595313|NCT00488631|470138226|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
130595314|NCT00488631|470138227|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130595315|NCT00488631|470138228|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130595316|NCT00488631|470138229|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130595317|NCT00488631|470138230|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130595318|NCT00488631|470138221|FG000|Double Blind Period (Week 0-54)|Other|6|||
130595319|NCT00488631|470138222|FG001|Double Blind Period (Week 0-54)|Other|12|||
130595320|NCT00488631|470138223|FG002|Double Blind Period (Week 0-54)|Other|10|||
130595321|NCT00488631|470138224|FG003|Double Blind Period (Week 0-54)|Other|11|||
130595322|NCT00488631|470138225|FG004|Double Blind Period (Week 0-54)|Other|14|||
130595323|NCT00488631|470138226|FG005|Double Blind Period (Week 0-54)|Other|34|||
130595324|NCT00488631|470138227|FG006|Double Blind Period (Week 0-54)|Other|0|||
130595325|NCT00488631|470138228|FG007|Double Blind Period (Week 0-54)|Other|0|||
130595326|NCT00488631|470138229|FG008|Double Blind Period (Week 0-54)|Other|0|||
130595327|NCT00488631|470138230|FG009|Double Blind Period (Week 0-54)|Other|0|||
130595328|NCT00488631|470138221|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595329|NCT00488631|470138222|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595330|NCT00488631|470138223|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595331|NCT00488631|470138224|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595332|NCT00488631|470138225|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595333|NCT00488631|470138226|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595334|NCT00488631|470138227|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
130595335|NCT00488631|470138228|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
130595336|NCT00488631|470138229|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
130595337|NCT00488631|470138230|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130595338|NCT00488631|470138221|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
130595339|NCT00488631|470138222|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
130595340|NCT00488631|470138223|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
130595341|NCT00488631|470138224|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
130595342|NCT00488631|470138225|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
130595343|NCT00488631|470138226|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
130595344|NCT00488631|470138227|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
130595345|NCT00488631|470138228|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
130595346|NCT00488631|470138229|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
130595347|NCT00488631|470138230|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
130595348|NCT00488631|470138221|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595349|NCT00488631|470138222|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595350|NCT00488631|470138223|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595351|NCT00488631|470138224|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595352|NCT00488631|470138225|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595353|NCT00488631|470138226|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130595354|NCT00488631|470138227|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
130595355|NCT00488631|470138228|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
130595356|NCT00488631|470138229|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
130595357|NCT00488631|470138230|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
130595358|NCT00488631|470138221|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595359|NCT00488631|470138222|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595360|NCT00488631|470138223|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595361|NCT00488631|470138224|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595362|NCT00488631|470138225|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595363|NCT00488631|470138226|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595364|NCT00488631|470138227|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
130595365|NCT00488631|470138228|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595366|NCT00488631|470138229|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
130595367|NCT00488631|470138230|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130595368|NCT00488631|470138221|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595369|NCT00488631|470138222|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595370|NCT00488631|470138223|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595371|NCT00488631|470138224|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595372|NCT00488631|470138225|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595373|NCT00488631|470138226|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595374|NCT00488631|470138227|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
130595375|NCT00488631|470138228|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
130595376|NCT00488631|470138229|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
130595377|NCT00488631|470138230|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130595378|NCT00927485|470138232|FG000|Overall Study|Adverse Event|4|||
130595379|NCT00927485|470138233|FG001|Overall Study|Adverse Event|2|||
130595380|NCT00927485|470138232|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
130595381|NCT00927485|470138233|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
130595382|NCT01985321|470138234|FG000|Overall Study|Protocol Violation|4|||
130595383|NCT01985321|470138235|FG001|Overall Study|Protocol Violation|3|||
130595384|NCT01985321|470138234|FG000|Overall Study|Withdrawal by Subject|1|||
130595385|NCT01985321|470138235|FG001|Overall Study|Withdrawal by Subject|0|||
130595386|NCT01985321|470138234|FG000|Overall Study|Lost to Follow-up|5|||
130595387|NCT01985321|470138235|FG001|Overall Study|Lost to Follow-up|2|||
130595388|NCT01985321|470138234|FG000|Overall Study|Subject treated wrong type of sore|1|||
130595389|NCT01985321|470138235|FG001|Overall Study|Subject treated wrong type of sore|0|||
130595390|NCT02201940|470138236|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
130595391|NCT02201940|470138237|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
130595392|NCT02201940|470138236|FG000|Overall Study|Lack of Efficacy|2|||
130595393|NCT02201940|470138237|FG001|Overall Study|Lack of Efficacy|113|||
130595394|NCT02201940|470138236|FG000|Overall Study|Lost to Follow-up|5|||
130595395|NCT02201940|470138237|FG001|Overall Study|Lost to Follow-up|0|||
130595396|NCT02201940|470138236|FG000|Overall Study|Withdrew Consent|2|||
130595397|NCT02201940|470138237|FG001|Overall Study|Withdrew Consent|1|||
130595398|NCT02201940|470138236|FG000|Overall Study|Investigator's Discretion|1|||
130595399|NCT02201940|470138237|FG001|Overall Study|Investigator's Discretion|1|||
130595400|NCT02201940|470138236|FG000|Overall Study|Death|1|||
130595401|NCT02201940|470138237|FG001|Overall Study|Death|0|||
130595402|NCT02201940|470138236|FG000|Overall Study|Adverse Event|0|||
130595403|NCT02201940|470138237|FG001|Overall Study|Adverse Event|1|||
130595404|NCT03953118|470138238|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
130595405|NCT03953118|470138239|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
130595406|NCT00424398|470138240|FG000|Overall Study|Withdrawal by Subject|2|||
130595407|NCT00424398|470138241|FG001|Overall Study|Withdrawal by Subject|1|||
130595408|NCT00424398|470138242|FG002|Overall Study|Withdrawal by Subject|0|||
130595409|NCT00424398|470138240|FG000|Overall Study|Subject met exclusion criteria|1|||
130595410|NCT00424398|470138241|FG001|Overall Study|Subject met exclusion criteria|0|||
130595411|NCT00424398|470138242|FG002|Overall Study|Subject met exclusion criteria|0|||
130595412|NCT01023789|470138243|FG000|3 - Year Visit|Death|29|||
130595413|NCT01023789|470138243|FG000|3 - Year Visit|Withdrawal of consent|1|||
130595414|NCT01023789|470138243|FG000|3 - Year Visit|Lost to Follow-up|13|||
130595415|NCT02034123|470138248|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595416|NCT02034123|470138249|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595417|NCT02034123|470138250|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595418|NCT02034123|470138251|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595419|NCT02034123|470138252|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130595420|NCT02034123|470138253|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595421|NCT02034123|470138254|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595422|NCT02034123|470138255|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130595423|NCT02034123|470138256|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130595424|NCT02034123|470138257|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595425|NCT02034123|470138258|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595426|NCT02034123|470138259|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595427|NCT02034123|470138260|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595428|NCT02034123|470138261|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595429|NCT02034123|470138262|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595430|NCT02034123|470138263|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595431|NCT02034123|470138264|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595432|NCT02034123|470138265|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130595433|NCT02034123|470138248|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595434|NCT02034123|470138249|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595435|NCT02034123|470138250|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595436|NCT02034123|470138251|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
130595437|NCT02034123|470138252|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595438|NCT02034123|470138253|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595439|NCT02034123|470138254|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595440|NCT02034123|470138255|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595441|NCT02034123|470138256|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595442|NCT02034123|470138257|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595443|NCT02034123|470138258|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595444|NCT02034123|470138259|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595445|NCT02034123|470138260|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595446|NCT02034123|470138261|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595447|NCT02034123|470138262|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595448|NCT02034123|470138263|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595449|NCT02034123|470138264|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595450|NCT02034123|470138265|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130595451|NCT02034123|470138248|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595452|NCT02034123|470138249|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595453|NCT02034123|470138250|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595454|NCT02034123|470138251|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595455|NCT02034123|470138252|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595456|NCT02034123|470138253|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595457|NCT02034123|470138254|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595458|NCT02034123|470138255|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595459|NCT02034123|470138256|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
130595460|NCT02034123|470138257|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595461|NCT02034123|470138258|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595462|NCT02034123|470138259|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595463|NCT02034123|470138260|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595464|NCT02034123|470138261|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595465|NCT02034123|470138262|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595466|NCT02034123|470138263|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595467|NCT02034123|470138264|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595468|NCT02034123|470138265|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130595469|NCT02034123|470138248|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595470|NCT02034123|470138249|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595471|NCT02034123|470138250|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595472|NCT02034123|470138251|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
130595473|NCT02034123|470138252|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
130595474|NCT02034123|470138253|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595475|NCT02034123|470138254|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595476|NCT02034123|470138255|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595477|NCT02034123|470138256|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595478|NCT02034123|470138257|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595479|NCT02034123|470138258|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595480|NCT02034123|470138259|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595481|NCT02034123|470138260|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595482|NCT02034123|470138261|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595483|NCT02034123|470138262|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595484|NCT02034123|470138263|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595485|NCT02034123|470138264|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595486|NCT02034123|470138265|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130595487|NCT00246259|470138266|FG000|Overall Study|Other|3|||
130595488|NCT00246259|470138267|FG001|Overall Study|Other|3|||
130595489|NCT00246259|470138266|FG000|Overall Study|Not stable by Week 18|2|||
130595490|NCT00246259|470138267|FG001|Overall Study|Not stable by Week 18|1|||
130595491|NCT00246259|470138266|FG000|Overall Study|Participant non-compliant|4|||
130595492|NCT00246259|470138267|FG001|Overall Study|Participant non-compliant|9|||
130595493|NCT00246259|470138266|FG000|Overall Study|Lack of Efficacy|2|||
130595494|NCT00246259|470138267|FG001|Overall Study|Lack of Efficacy|2|||
130595495|NCT00246259|470138266|FG000|Overall Study|Investigator withdrew participant|2|||
130595496|NCT00246259|470138267|FG001|Overall Study|Investigator withdrew participant|0|||
130595497|NCT00246259|470138266|FG000|Overall Study|Adverse Event|5|||
130595498|NCT00246259|470138267|FG001|Overall Study|Adverse Event|0|||
130595499|NCT00246259|470138266|FG000|Overall Study|Lost to Follow-up|3|||
130595500|NCT00246259|470138267|FG001|Overall Study|Lost to Follow-up|4|||
130595501|NCT00246259|470138266|FG000|Overall Study|Withdrawal by Subject|5|||
130595502|NCT00246259|470138267|FG001|Overall Study|Withdrawal by Subject|1|||
130595503|NCT00246259|470138266|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
130595504|NCT00246259|470138267|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
130595505|NCT03133767|470138269|FG000|Overall Study|Lost to Follow-up|38|||
130595506|NCT03133767|470138270|FG001|Overall Study|Lost to Follow-up|24|||
130595507|NCT03133767|470138269|FG000|Overall Study|Protocol Violation|0|||
130595508|NCT03133767|470138270|FG001|Overall Study|Protocol Violation|1|||
130595509|NCT00613626|470138272|FG000|Overall Study|Ineligible|0|||
130595510|NCT00613626|470138273|FG001|Overall Study|Ineligible|1|||
130595511|NCT00613626|470138274|FG002|Overall Study|Ineligible|0|||
130595512|NCT02333227|470138275|FG000|Overall Study|Lost to Follow-up|137|||
130595513|NCT02333227|470138276|FG001|Overall Study|Lost to Follow-up|106|||
130595514|NCT02333227|470138275|FG000|Overall Study|Pregnancy Interrupted|42|||
130595515|NCT02333227|470138276|FG001|Overall Study|Pregnancy Interrupted|89|||
130595516|NCT02333227|470138275|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
130595517|NCT02333227|470138276|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
130595518|NCT01299025|470138277|FG000|Overall Study|Withdrawal by Subject|2|||
130595519|NCT01299025|470138278|FG001|Overall Study|Withdrawal by Subject|1|||
130595520|NCT01299025|470138277|FG000|Overall Study|Lost to Follow-up|1|||
130595521|NCT01299025|470138278|FG001|Overall Study|Lost to Follow-up|0|||
130595522|NCT01624194|470138279|FG000|Overall Study|Lost to Follow-up|1|||
130595523|NCT01624194|470138280|FG001|Overall Study|Lost to Follow-up|0|||
130595524|NCT01624194|470138279|FG000|Overall Study|Withdrawal by Subject|1|||
130595525|NCT01624194|470138280|FG001|Overall Study|Withdrawal by Subject|0|||
130595526|NCT01076179|470138281|FG000|Overall Study|Withdrawal by Subject|1|||
130595527|NCT05480514|470138282|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
130595528|NCT05480514|470138283|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
130595529|NCT05480514|470138282|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
130595530|NCT05480514|470138283|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
130595531|NCT05480514|470138282|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130595532|NCT05480514|470138283|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130595533|NCT05480514|470138282|FG000|Period 1|Covid-19 Related|1|||
130595534|NCT05480514|470138283|FG001|Period 1|Covid-19 Related|0|||
130595535|NCT05480514|470138282|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
130595536|NCT05480514|470138283|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
130595537|NCT04091217|470138284|FG000|Overall Study|Lost to Follow-up|2|||
130595538|NCT05662332|470138285|FG000|Overall Study|Death|3|||
130595539|NCT05662332|470138286|FG001|Overall Study|Death|3|||
130595540|NCT05662332|470138285|FG000|Overall Study|Lost to Follow-up|3|||
130595541|NCT05662332|470138286|FG001|Overall Study|Lost to Follow-up|8|||
130595542|NCT05662332|470138285|FG000|Overall Study|Physician Decision|1|||
130595543|NCT05662332|470138286|FG001|Overall Study|Physician Decision|2|||
130595544|NCT05662332|470138285|FG000|Overall Study|Protocol Deviation|2|||
130595545|NCT05662332|470138286|FG001|Overall Study|Protocol Deviation|1|||
130595546|NCT05662332|470138285|FG000|Overall Study|Withdrawal by Subject|14|||
130595547|NCT05662332|470138286|FG001|Overall Study|Withdrawal by Subject|14|||
130595548|NCT05662332|470138285|FG000|Overall Study|Assigned Treatment by Mistake|5|||
130595549|NCT05662332|470138286|FG001|Overall Study|Assigned Treatment by Mistake|7|||
130595550|NCT05662332|470138285|FG000|Overall Study|Non-compliance with study drug|4|||
130595551|NCT05662332|470138286|FG001|Overall Study|Non-compliance with study drug|1|||
130595552|NCT05662332|470138285|FG000|Overall Study|Due to Bariatric surgery|1|||
130595553|NCT05662332|470138286|FG001|Overall Study|Due to Bariatric surgery|0|||
130595554|NCT05662332|470138285|FG000|Overall Study|Subject Moving out of State|0|||
130595555|NCT05662332|470138286|FG001|Overall Study|Subject Moving out of State|1|||
130595556|NCT05662332|470138285|FG000|Overall Study|Subject Missed the Schedule|1|||
130595557|NCT05662332|470138286|FG001|Overall Study|Subject Missed the Schedule|0|||
130595558|NCT05662332|470138285|FG000|Overall Study|The Patient Moved to Another City|1|||
130595559|NCT05662332|470138286|FG001|Overall Study|The Patient Moved to Another City|0|||
130595560|NCT04885257|470138287|FG000|Overall Study|Withdrawal by Subject|1|||
130595561|NCT04885257|470138288|FG001|Overall Study|Withdrawal by Subject|0|||
130595562|NCT00256295|470138289|FG000|Overall Study|Withdrawal by Subject|3|||
130595563|NCT00256295|470138289|FG000|Overall Study|Death|1|||
130595564|NCT01659151|470138301|FG000|Overall Study|Inadequate TIL growth|1|||
130595565|NCT01901328|470138302|FG000|Overall Study|Lost to Follow-up|1|||
130595566|NCT01901328|470138303|FG001|Overall Study|Lost to Follow-up|0|||
130595567|NCT01901328|470138302|FG000|Overall Study|Physician Decision|0|||
130595568|NCT01901328|470138303|FG001|Overall Study|Physician Decision|1|||
130595569|NCT01901328|470138302|FG000|Overall Study|Protocol Violation|1|||
130595570|NCT01901328|470138303|FG001|Overall Study|Protocol Violation|1|||
130595571|NCT01901328|470138302|FG000|Overall Study|Study Terminated by Sponsor|19|||
130595572|NCT01901328|470138303|FG001|Overall Study|Study Terminated by Sponsor|16|||
130595573|NCT01901328|470138302|FG000|Overall Study|Withdrawal by Subject|1|||
130595574|NCT01901328|470138303|FG001|Overall Study|Withdrawal by Subject|2|||
130595575|NCT01901328|470138302|FG000|Overall Study|Lack of Efficacy|0|||
130595576|NCT01901328|470138303|FG001|Overall Study|Lack of Efficacy|1|||
130595577|NCT04865731|470138304|FG000|Overall Study|Physician Decision|2|||
130595578|NCT04865731|470138305|FG001|Overall Study|Physician Decision|1|||
130595579|NCT04865731|470138304|FG000|Overall Study|Adverse Event|1|||
130595580|NCT04865731|470138305|FG001|Overall Study|Adverse Event|0|||
130595581|NCT04865731|470138304|FG000|Overall Study|Withdrawal by Subject|0|||
130595582|NCT04865731|470138305|FG001|Overall Study|Withdrawal by Subject|1|||
130595583|NCT01672892|470139408|FG000|Overall Study|Protocol Violation|7|||
130595584|NCT01672892|470139409|FG001|Overall Study|Protocol Violation|3|||
130595585|NCT00942162|470139422|FG000|Overall Study|Death|45|||
130595586|NCT00942162|470139423|FG001|Overall Study|Death|35|||
130595587|NCT00942162|470139424|FG002|Overall Study|Death|0|||
130595588|NCT00942162|470139422|FG000|Overall Study|Withdrawal by Subject|7|||
130595589|NCT00942162|470139423|FG001|Overall Study|Withdrawal by Subject|2|||
130595590|NCT00942162|470139424|FG002|Overall Study|Withdrawal by Subject|0|||
130595591|NCT00942162|470139422|FG000|Overall Study|Lost to Follow-up|4|||
130595592|NCT00942162|470139423|FG001|Overall Study|Lost to Follow-up|0|||
130595593|NCT00942162|470139424|FG002|Overall Study|Lost to Follow-up|0|||
130595594|NCT00942162|470139422|FG000|Overall Study|Other|14|||
130595595|NCT00942162|470139423|FG001|Overall Study|Other|13|||
130595596|NCT00942162|470139424|FG002|Overall Study|Other|2|||
130595597|NCT01006356|470139425|FG000|Overall Study|Adverse Event|6|||
130595598|NCT01006356|470139425|FG000|Overall Study|Physician Decision|1|||
130595599|NCT01006356|470139425|FG000|Overall Study|Paticipants did not cooperate|6|||
130595600|NCT01006356|470139425|FG000|Overall Study|Withdrawal by Subject|1|||
130595601|NCT01006356|470139425|FG000|Overall Study|Choice by participants|2|||
130595602|NCT01006356|470139425|FG000|Overall Study|Protocol Violation|3|||
130595603|NCT01006356|470139425|FG000|Overall Study|Other|23|||
130595604|NCT02424539|470139433|FG000|Overall Study|Adverse Event|0|||
130595605|NCT02424539|470139434|FG001|Overall Study|Adverse Event|0|||
130595606|NCT02424539|470139435|FG002|Overall Study|Adverse Event|1|||
130595607|NCT02424539|470139433|FG000|Overall Study|Physician Decision|0|||
130595608|NCT02424539|470139434|FG001|Overall Study|Physician Decision|0|||
130595609|NCT02424539|470139435|FG002|Overall Study|Physician Decision|1|||
130595610|NCT02424539|470139433|FG000|Overall Study|Withdrawal by Subject|3|||
130595611|NCT02424539|470139434|FG001|Overall Study|Withdrawal by Subject|1|||
130595612|NCT02424539|470139435|FG002|Overall Study|Withdrawal by Subject|0|||
130595613|NCT02424539|470139433|FG000|Overall Study|Other: Reached stopping criteria|11|||
130595614|NCT02424539|470139434|FG001|Overall Study|Other: Reached stopping criteria|7|||
130595615|NCT02424539|470139435|FG002|Overall Study|Other: Reached stopping criteria|6|||
130595616|NCT04893265|470139436|FG000|Overall Study|Withdrawal by Subject|2|||
130595617|NCT04893265|470139437|FG001|Overall Study|Withdrawal by Subject|5|||
130595618|NCT04893265|470139436|FG000|Overall Study|Lost to Follow-up|0|||
130595619|NCT04893265|470139437|FG001|Overall Study|Lost to Follow-up|4|||
130595620|NCT03090191|470139442|FG000|Overall Study|Adverse Event|90|||
130595621|NCT03090191|470139443|FG001|Overall Study|Adverse Event|72|||
130595622|NCT03090191|470139442|FG000|Overall Study|Death|365|||
130595623|NCT03090191|470139443|FG001|Overall Study|Death|358|||
130595624|NCT03090191|470139442|FG000|Overall Study|Lost to Follow-up|382|||
130595625|NCT03090191|470139443|FG001|Overall Study|Lost to Follow-up|394|||
130595626|NCT03090191|470139442|FG000|Overall Study|Physician Decision|77|||
130595627|NCT03090191|470139443|FG001|Overall Study|Physician Decision|66|||
130595628|NCT03090191|470139442|FG000|Overall Study|Protocol Violation|43|||
130595629|NCT03090191|470139443|FG001|Overall Study|Protocol Violation|52|||
130595630|NCT03090191|470139442|FG000|Overall Study|Withdrawal by Subject|2160|||
130595631|NCT03090191|470139443|FG001|Overall Study|Withdrawal by Subject|2133|||
130595632|NCT03090191|470139442|FG000|Overall Study|Site terminated|7|||
130595633|NCT03090191|470139443|FG001|Overall Study|Site terminated|8|||
130595634|NCT03090191|470139442|FG000|Overall Study|Other|66|||
130595635|NCT03090191|470139443|FG001|Overall Study|Other|60|||
130595636|NCT03090191|470139442|FG000|Overall Study|Withdrawn before any study vaccination|43|||
130595637|NCT03090191|470139443|FG001|Overall Study|Withdrawn before any study vaccination|52|||
130595638|NCT04723537|470139445|FG000|Overall Study|Withdrawal by Subject|3|||
130595639|NCT04723537|470139446|FG001|Overall Study|Withdrawal by Subject|0|||
130595640|NCT04723537|470139447|FG002|Overall Study|Withdrawal by Subject|0|||
130595641|NCT04723537|470139445|FG000|Overall Study|Physician Decision|0|||
130595642|NCT04723537|470139446|FG001|Overall Study|Physician Decision|0|||
130595643|NCT04723537|470139447|FG002|Overall Study|Physician Decision|1|||
130595644|NCT04723537|470139445|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130595645|NCT04723537|470139446|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130595646|NCT04723537|470139447|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130595647|NCT02432807|470139448|FG000|Overall Study|Adverse Event|0|||
130595648|NCT02432807|470139449|FG001|Overall Study|Adverse Event|2|||
130595649|NCT02432807|470139448|FG000|Overall Study|Lost to Follow-up|1|||
130595650|NCT02432807|470139449|FG001|Overall Study|Lost to Follow-up|0|||
130595651|NCT02432807|470139448|FG000|Overall Study|Withdrawal by Subject|1|||
130595652|NCT02432807|470139449|FG001|Overall Study|Withdrawal by Subject|1|||
130595653|NCT02432807|470139448|FG000|Overall Study|Other|1|||
130595654|NCT02432807|470139449|FG001|Overall Study|Other|1|||
130595655|NCT01021007|470139453|FG000|Overall Study|Lost to Follow-up|1|||
130595656|NCT01021007|470139454|FG001|Overall Study|Lost to Follow-up|1|||
130595657|NCT01021007|470139453|FG000|Overall Study|Adverse Event|1|||
130595658|NCT01021007|470139454|FG001|Overall Study|Adverse Event|3|||
130595659|NCT01929083|470139459|FG000|Intervention 1|Lost to Follow-up|2|||
130595660|NCT01929083|470139460|FG001|Intervention 1|Lost to Follow-up|0|||
130595661|NCT01929083|470139459|FG000|Intervention 1|Nonadherent to study medications|1|||
130595662|NCT01929083|470139460|FG001|Intervention 1|Nonadherent to study medications|0|||
130595663|NCT01929083|470139459|FG000|Intervention 2|Adverse Event|0|||
130595664|NCT01929083|470139460|FG001|Intervention 2|Adverse Event|1|||
130595665|NCT00087438|470139462|FG000|Overall Study|Ineligible / No protocol treatment|4|||
130595666|NCT00466505|470139463|FG000|Overall Study|disease progression|13|||
130595667|NCT00466505|470139463|FG000|Overall Study|Adverse Event|4|||
130595668|NCT00811252|470139464|FG000|Overall Study|Adverse Event|6|||
130595669|NCT00811252|470139465|FG001|Overall Study|Adverse Event|10|||
130595670|NCT00811252|470139466|FG002|Overall Study|Adverse Event|15|||
130595671|NCT00811252|470139464|FG000|Overall Study|Lack of Efficacy|7|||
130595672|NCT00811252|470139465|FG001|Overall Study|Lack of Efficacy|2|||
130595673|NCT00811252|470139466|FG002|Overall Study|Lack of Efficacy|0|||
130595674|NCT00811252|470139464|FG000|Overall Study|Protocol Violation|3|||
130595675|NCT00811252|470139465|FG001|Overall Study|Protocol Violation|3|||
130595676|NCT00811252|470139466|FG002|Overall Study|Protocol Violation|2|||
130595677|NCT00811252|470139464|FG000|Overall Study|Withdrawal of Consent|1|||
130595678|NCT00811252|470139465|FG001|Overall Study|Withdrawal of Consent|2|||
130595679|NCT00811252|470139466|FG002|Overall Study|Withdrawal of Consent|2|||
130595680|NCT00811252|470139464|FG000|Overall Study|Lost to Follow-up|0|||
130595681|NCT00811252|470139465|FG001|Overall Study|Lost to Follow-up|0|||
130595682|NCT00811252|470139466|FG002|Overall Study|Lost to Follow-up|2|||
130595683|NCT00811252|470139464|FG000|Overall Study|Administrative or Other Reasons|0|||
130595684|NCT00811252|470139465|FG001|Overall Study|Administrative or Other Reasons|3|||
130595685|NCT00811252|470139466|FG002|Overall Study|Administrative or Other Reasons|2|||
130595686|NCT01931865|470139467|FG000|Overall Study|Lost to Follow-up|2|||
130595687|NCT01931865|470139467|FG000|Overall Study|Withdrawal by Subject|2|||
130595688|NCT01244737|470139473|FG000|Overall Study|Physician Decision|2|||
130595689|NCT01244737|470139474|FG001|Overall Study|Physician Decision|18|||
130595690|NCT01244737|470139475|FG002|Overall Study|Physician Decision|5|||
130595691|NCT01244737|470139473|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
130595692|NCT01244737|470139474|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
130595693|NCT01244737|470139475|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
130595694|NCT01244737|470139473|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
130595695|NCT01244737|470139474|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
130595696|NCT01244737|470139475|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
130595697|NCT01244737|470139473|FG000|Overall Study|MIB immunopathology results not available|3|||
130595698|NCT01244737|470139474|FG001|Overall Study|MIB immunopathology results not available|2|||
130595699|NCT01244737|470139475|FG002|Overall Study|MIB immunopathology results not available|0|||
130595700|NCT01244737|470139473|FG000|Overall Study|PET data failure|0|||
130595701|NCT01244737|470139474|FG001|Overall Study|PET data failure|1|||
130595702|NCT01244737|470139475|FG002|Overall Study|PET data failure|0|||
130595703|NCT01244737|470139473|FG000|Overall Study|Withdrawal by Subject|0|||
130595704|NCT01244737|470139474|FG001|Overall Study|Withdrawal by Subject|0|||
130595705|NCT01244737|470139475|FG002|Overall Study|Withdrawal by Subject|1|||
130595706|NCT00730236|470139476|FG000|Overall Study|Adverse Event|4|||
130595707|NCT00730236|470139476|FG000|Overall Study|Withdrawal by Subject|1|||
130595708|NCT00730236|470139476|FG000|Overall Study|Non-compliance|1|||
130595709|NCT03486314|470139477|FG000|Part A|Adverse Event|1|||
130595710|NCT03486314|470139478|FG001|Part A|Adverse Event|0|||
130595711|NCT03486314|470139479|FG002|Part A|Adverse Event|0|||
130595712|NCT03486314|470139477|FG000|Part A|Symptomatic Deterioration|2|||
130595713|NCT03486314|470139478|FG001|Part A|Symptomatic Deterioration|0|||
130595714|NCT03486314|470139479|FG002|Part A|Symptomatic Deterioration|0|||
130595715|NCT02604264|470139483|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
130595716|NCT02604264|470139484|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
130595717|NCT04003610|470139485|FG000|Overall Study|Lost to Follow-up|0|||
130595718|NCT04003610|470139486|FG001|Overall Study|Lost to Follow-up|1|||
130595719|NCT04003610|470139487|FG002|Overall Study|Lost to Follow-up|0|||
130595720|NCT04003610|470139485|FG000|Overall Study|Death|0|||
130595721|NCT04003610|470139486|FG001|Overall Study|Death|0|||
130595722|NCT04003610|470139487|FG002|Overall Study|Death|3|||
130595723|NCT04003610|470139485|FG000|Overall Study|Study Terminated by Sponsor|0|||
130595724|NCT04003610|470139486|FG001|Overall Study|Study Terminated by Sponsor|0|||
130595725|NCT04003610|470139487|FG002|Overall Study|Study Terminated by Sponsor|3|||
130595726|NCT03301857|470139492|FG000|Overall Study|Death|0|||
130595727|NCT03301857|470139493|FG001|Overall Study|Death|2|||
130595728|NCT03301857|470139492|FG000|Overall Study|Lost to Follow-up|4|||
130595729|NCT03301857|470139493|FG001|Overall Study|Lost to Follow-up|2|||
130595730|NCT03301857|470139492|FG000|Overall Study|Decision by Sponsor|6|||
130595731|NCT03301857|470139493|FG001|Overall Study|Decision by Sponsor|0|||
130595732|NCT03301857|470139492|FG000|Overall Study|Withdrawal by Subject|12|||
130595733|NCT03301857|470139493|FG001|Overall Study|Withdrawal by Subject|4|||
130595734|NCT00855439|470139494|FG000|Overall Study|Withdrawal by Subject|2|||
130595735|NCT00855439|470139495|FG001|Overall Study|Withdrawal by Subject|0|||
130595736|NCT00855439|470139494|FG000|Overall Study|Pregnancy|1|||
130595737|NCT00855439|470139495|FG001|Overall Study|Pregnancy|0|||
130595738|NCT00816036|470139508|FG000|Overall Study|Death|47|||
130595739|NCT00816036|470139509|FG001|Overall Study|Death|28|||
130595740|NCT00816036|470139508|FG000|Overall Study|Lost to Follow-up|75|||
130595741|NCT00816036|470139509|FG001|Overall Study|Lost to Follow-up|57|||
130595742|NCT00816036|470139508|FG000|Overall Study|Withdrawal by Subject|54|||
130595743|NCT00816036|470139509|FG001|Overall Study|Withdrawal by Subject|23|||
130595744|NCT03212261|470139510|FG000|Overall Study|Became ineligible d/t tech|2|||
130595745|NCT03212261|470139510|FG000|Overall Study|Tech Trouble- No first study visit|1|||
130595746|NCT03212261|470139510|FG000|Overall Study|Lost to Follow-up|7|||
130595747|NCT03212261|470139510|FG000|Overall Study|Family Emergency|1|||
130595748|NCT03212261|470139510|FG000|Overall Study|Too busy/ No time|5|||
130595749|NCT00628355|470139513|FG000|Overall Study|Withdrawal by Subject|1|||
130595750|NCT00628355|470139514|FG001|Overall Study|Withdrawal by Subject|1|||
130595751|NCT03542682|470139515|FG000|Overall Study|COVID-19 Protocol|0|||
130595752|NCT03542682|470139516|FG001|Overall Study|COVID-19 Protocol|1|||
130595753|NCT03232073|470139520|FG000|Overall Study|Death|1|||
130595754|NCT03232073|470139521|FG001|Overall Study|Death|0|||
130595755|NCT03232073|470139520|FG000|Overall Study|Adverse Event|7|||
130595756|NCT03232073|470139521|FG001|Overall Study|Adverse Event|12|||
130595757|NCT03232073|470139520|FG000|Overall Study|Lost to Follow-up|6|||
130595758|NCT03232073|470139521|FG001|Overall Study|Lost to Follow-up|6|||
130595759|NCT03232073|470139520|FG000|Overall Study|Lack of Efficacy|10|||
130595760|NCT03232073|470139521|FG001|Overall Study|Lack of Efficacy|8|||
130595761|NCT03232073|470139520|FG000|Overall Study|Physician Decision|9|||
130595762|NCT03232073|470139521|FG001|Overall Study|Physician Decision|2|||
130595763|NCT03232073|470139520|FG000|Overall Study|Withdrawal by Subject|54|||
130595764|NCT03232073|470139521|FG001|Overall Study|Withdrawal by Subject|39|||
130595765|NCT04909463|470141311|FG000|Overall Study|Withdrawal by Subject|0|||
130595766|NCT04909463|470141312|FG001|Overall Study|Withdrawal by Subject|1|||
130595767|NCT04909463|470141313|FG002|Overall Study|Withdrawal by Subject|0|||
130595768|NCT04909463|470141314|FG003|Overall Study|Withdrawal by Subject|0|||
130595769|NCT04909463|470141311|FG000|Overall Study|Lost to Follow-up|2|||
130595770|NCT04909463|470141312|FG001|Overall Study|Lost to Follow-up|1|||
130595771|NCT04909463|470141313|FG002|Overall Study|Lost to Follow-up|1|||
130595772|NCT04909463|470141314|FG003|Overall Study|Lost to Follow-up|0|||
130595773|NCT00853632|470141315|FG000|Overall Study|Death|88|||
130595774|NCT00853632|470141315|FG000|Overall Study|Withdrawal by Subject|45|||
130595775|NCT00853632|470141315|FG000|Overall Study|Lost to Follow-up|30|||
130595776|NCT00853632|470141315|FG000|Overall Study|Reoperation/Explant|17|||
130595777|NCT00853632|470141315|FG000|Overall Study|Exit with other reason|22|||
130595778|NCT00886821|470141316|FG000|Stage 2|Adverse Event|0|||
130595779|NCT00886821|470141317|FG001|Stage 2|Adverse Event|0|||
130595780|NCT00886821|470141318|FG002|Stage 2|Adverse Event|0|||
130595781|NCT00886821|470141319|FG003|Stage 2|Adverse Event|0|||
130595782|NCT00886821|470141320|FG004|Stage 2|Adverse Event|0|||
130595783|NCT00886821|470141321|FG005|Stage 2|Adverse Event|0|||
130595784|NCT00886821|470141322|FG006|Stage 2|Adverse Event|0|||
130595785|NCT00886821|470141323|FG007|Stage 2|Adverse Event|0|||
130595786|NCT00886821|470141324|FG008|Stage 2|Adverse Event|0|||
130595787|NCT00886821|470141325|FG009|Stage 2|Adverse Event|0|||
130595788|NCT00886821|470141326|FG010|Stage 2|Adverse Event|0|||
130595789|NCT00886821|470141327|FG011|Stage 2|Adverse Event|1|||
130595790|NCT00886821|470141328|FG012|Stage 2|Adverse Event|3|||
130595791|NCT00886821|470141329|FG013|Stage 2|Adverse Event|0|||
130595792|NCT00886821|470141316|FG000|Stage 2|Lost to Follow-up|0|||
130595793|NCT00886821|470141317|FG001|Stage 2|Lost to Follow-up|0|||
130595794|NCT00886821|470141318|FG002|Stage 2|Lost to Follow-up|0|||
130595795|NCT00886821|470141319|FG003|Stage 2|Lost to Follow-up|0|||
130595796|NCT00886821|470141320|FG004|Stage 2|Lost to Follow-up|0|||
130595797|NCT00886821|470141321|FG005|Stage 2|Lost to Follow-up|0|||
130595798|NCT00886821|470141322|FG006|Stage 2|Lost to Follow-up|0|||
130595799|NCT00886821|470141323|FG007|Stage 2|Lost to Follow-up|0|||
130595800|NCT00886821|470141324|FG008|Stage 2|Lost to Follow-up|0|||
130595801|NCT00886821|470141325|FG009|Stage 2|Lost to Follow-up|0|||
130595802|NCT00886821|470141326|FG010|Stage 2|Lost to Follow-up|0|||
130595803|NCT00886821|470141327|FG011|Stage 2|Lost to Follow-up|0|||
130595804|NCT00886821|470141328|FG012|Stage 2|Lost to Follow-up|2|||
130595805|NCT00886821|470141329|FG013|Stage 2|Lost to Follow-up|1|||
130595806|NCT00914628|470141330|FG000|Overall Study|Death|35|||
130595807|NCT00914628|470141331|FG001|Overall Study|Death|17|||
130595808|NCT00914628|470141330|FG000|Overall Study|Medical decision|4|||
130595809|NCT00914628|470141331|FG001|Overall Study|Medical decision|0|||
130595810|NCT00914628|470141330|FG000|Overall Study|Protocol Violation|1|||
130595811|NCT00914628|470141331|FG001|Overall Study|Protocol Violation|0|||
130595812|NCT00914628|470141330|FG000|Overall Study|Lack of Efficacy|1|||
130595813|NCT00914628|470141331|FG001|Overall Study|Lack of Efficacy|0|||
130595814|NCT00914628|470141330|FG000|Overall Study|non-randomized|1|||
130595815|NCT00914628|470141331|FG001|Overall Study|non-randomized|0|||
130595816|NCT00914628|470141330|FG000|Overall Study|Relapse|1|||
130595817|NCT00914628|470141331|FG001|Overall Study|Relapse|2|||
130595818|NCT00914628|470141330|FG000|Overall Study|Study terminated by Sponsor|14|||
130595819|NCT00914628|470141331|FG001|Overall Study|Study terminated by Sponsor|8|||
130595820|NCT00914628|470141330|FG000|Overall Study|Patients who did not receive a single dose|7|||
130595821|NCT00914628|470141331|FG001|Overall Study|Patients who did not receive a single dose|1|||
130595822|NCT03311126|470141332|FG000|Induction|Death|1|||
130595823|NCT03311126|470141332|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
130595824|NCT02579603|470141333|FG000|Overall Study|Not treated|1|||
130595825|NCT02579603|470141334|FG001|Overall Study|Not treated|0|||
130595826|NCT02579603|470141333|FG000|Overall Study|Adverse Event|2|||
130595827|NCT02579603|470141334|FG001|Overall Study|Adverse Event|2|||
130595828|NCT02579603|470141333|FG000|Overall Study|Other than stated|1|||
130595829|NCT02579603|470141334|FG001|Overall Study|Other than stated|0|||
130595830|NCT00469079|470141335|FG000|Overall Study|Lack of Efficacy|3|||
130595831|NCT00469079|470141336|FG001|Overall Study|Lack of Efficacy|8|||
130595832|NCT00469079|470141337|FG002|Overall Study|Lack of Efficacy|5|||
130595833|NCT00469079|470141335|FG000|Overall Study|Adverse Event|1|||
130595834|NCT00469079|470141336|FG001|Overall Study|Adverse Event|3|||
130595835|NCT00469079|470141337|FG002|Overall Study|Adverse Event|2|||
130595836|NCT00469079|470141335|FG000|Overall Study|Lost to Follow-up|4|||
130595837|NCT00469079|470141336|FG001|Overall Study|Lost to Follow-up|8|||
130595838|NCT00469079|470141337|FG002|Overall Study|Lost to Follow-up|10|||
130595839|NCT00469079|470141335|FG000|Overall Study|Withdrawal by Subject|1|||
130595840|NCT00469079|470141336|FG001|Overall Study|Withdrawal by Subject|2|||
130595841|NCT00469079|470141337|FG002|Overall Study|Withdrawal by Subject|2|||
130595842|NCT00469079|470141335|FG000|Overall Study|Ineligible|0|||
130595843|NCT00469079|470141336|FG001|Overall Study|Ineligible|1|||
130595844|NCT00469079|470141337|FG002|Overall Study|Ineligible|0|||
130595845|NCT02698410|470141338|FG000|Overall Study|Adverse Event|2|||
130595846|NCT02698410|470141338|FG000|Overall Study|Withdrawal by Subject|1|||
130595847|NCT02698410|470141338|FG000|Overall Study|Other|1|||
130595848|NCT04331899|470141342|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
130595849|NCT04331899|470141343|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
130595850|NCT00719810|470141346|FG000|Overall Study|Adverse Event|0|||
130595851|NCT00719810|470141347|FG001|Overall Study|Adverse Event|2|||
130595852|NCT00719810|470141348|FG002|Overall Study|Adverse Event|3|||
130595853|NCT00719810|470141346|FG000|Overall Study|Lost to Follow-up|2|||
130595854|NCT00719810|470141347|FG001|Overall Study|Lost to Follow-up|0|||
130595855|NCT00719810|470141348|FG002|Overall Study|Lost to Follow-up|3|||
130595856|NCT00719810|470141346|FG000|Overall Study|Physician Decision|0|||
130595857|NCT00719810|470141347|FG001|Overall Study|Physician Decision|1|||
130595858|NCT00719810|470141348|FG002|Overall Study|Physician Decision|0|||
130595859|NCT00719810|470141346|FG000|Overall Study|Withdrawal by Subject|1|||
130595860|NCT00719810|470141347|FG001|Overall Study|Withdrawal by Subject|1|||
130595861|NCT00719810|470141348|FG002|Overall Study|Withdrawal by Subject|2|||
130595862|NCT00573131|470141351|FG000|Overall Study|Withdrawal by Subject|10|||
130595863|NCT00573131|470141352|FG001|Overall Study|Withdrawal by Subject|8|||
130595864|NCT00893789|470141353|FG000|Overall Study|Withdrawal by Subject|3|||
130595865|NCT00893789|470141354|FG001|Overall Study|Withdrawal by Subject|1|||
130595866|NCT00893789|470141355|FG002|Overall Study|Withdrawal by Subject|3|||
130595867|NCT00893789|470141356|FG003|Overall Study|Withdrawal by Subject|1|||
130595868|NCT00893789|470141353|FG000|Overall Study|Noncompliance With Study Drug|1|||
130595869|NCT00893789|470141354|FG001|Overall Study|Noncompliance With Study Drug|0|||
130595870|NCT00893789|470141355|FG002|Overall Study|Noncompliance With Study Drug|1|||
130595871|NCT00893789|470141356|FG003|Overall Study|Noncompliance With Study Drug|2|||
130595872|NCT00893789|470141353|FG000|Overall Study|Noncompliance With Study Procedures|1|||
130595873|NCT00893789|470141354|FG001|Overall Study|Noncompliance With Study Procedures|0|||
130595874|NCT00893789|470141355|FG002|Overall Study|Noncompliance With Study Procedures|0|||
130595875|NCT00893789|470141356|FG003|Overall Study|Noncompliance With Study Procedures|0|||
130595876|NCT00893789|470141353|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
130595877|NCT00893789|470141354|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
130595878|NCT00893789|470141355|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
130595879|NCT00893789|470141356|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
130595880|NCT00893789|470141353|FG000|Overall Study|Adverse Event|0|||
130595881|NCT00893789|470141354|FG001|Overall Study|Adverse Event|2|||
130595882|NCT00893789|470141355|FG002|Overall Study|Adverse Event|1|||
130595883|NCT00893789|470141356|FG003|Overall Study|Adverse Event|5|||
130595884|NCT00893789|470141353|FG000|Overall Study|Protocol Violation|0|||
130595885|NCT00893789|470141354|FG001|Overall Study|Protocol Violation|1|||
130595886|NCT00893789|470141355|FG002|Overall Study|Protocol Violation|1|||
130595887|NCT00893789|470141356|FG003|Overall Study|Protocol Violation|4|||
130595888|NCT00893789|470141353|FG000|Overall Study|Lost to Follow-up|0|||
130595889|NCT00893789|470141354|FG001|Overall Study|Lost to Follow-up|0|||
130595890|NCT00893789|470141355|FG002|Overall Study|Lost to Follow-up|0|||
130595891|NCT00893789|470141356|FG003|Overall Study|Lost to Follow-up|1|||
130595892|NCT02024464|470141357|FG000|Overall Study|Discontinued|5|||
130595893|NCT02024464|470141358|FG001|Overall Study|Discontinued|4|||
130595894|NCT02024464|470141357|FG000|Overall Study|Missed Visits|1|||
130595895|NCT02024464|470141358|FG001|Overall Study|Missed Visits|0|||
130595896|NCT02024464|470141357|FG000|Overall Study|Lost to Follow-up|4|||
130595897|NCT02024464|470141358|FG001|Overall Study|Lost to Follow-up|7|||
130595898|NCT05408858|470141363|FG000|Overall Study|no longer met eligibility criteria|1|||
130595899|NCT02037919|470141365|FG000|Overall Study|Lost to Follow-up|30|||
130595900|NCT02037919|470141366|FG001|Overall Study|Lost to Follow-up|45|||
130595901|NCT01973283|470141369|FG000|Overall Study|Lost to Follow-up|4|||
130595902|NCT03717922|470141377|FG000|Overall Study|Lost to Follow-up|2|||
130595903|NCT03717922|470141378|FG001|Overall Study|Lost to Follow-up|2|||
130595904|NCT01697215|470141389|FG000|Overall Study|Physician Decision|5|||
130595905|NCT01697215|470141389|FG000|Overall Study|Malfunction|9|||
130595906|NCT01697215|470141389|FG000|Overall Study|CXR not available|9|||
130595907|NCT00900796|470141392|FG000|Phase 1|Lacked sufficient information|4|||
130595908|NCT00900796|470141392|FG000|Phase 1|Missing information at Week 16|7|||
130595909|NCT00900796|470141392|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
130595910|NCT00900796|470141392|FG000|Phase 2|Lost to Follow-up|5|||
130595911|NCT01772134|470141415|FG000|Overall Study|Adverse Event|6|||
130595912|NCT01772134|470141416|FG001|Overall Study|Adverse Event|5|||
130595913|NCT01772134|470141417|FG002|Overall Study|Adverse Event|10|||
130595914|NCT01772134|470141415|FG000|Overall Study|Withdrew Consent|3|||
130595915|NCT01772134|470141416|FG001|Overall Study|Withdrew Consent|1|||
130595916|NCT01772134|470141417|FG002|Overall Study|Withdrew Consent|5|||
130595917|NCT01772134|470141415|FG000|Overall Study|Lost to Follow-up|2|||
130595918|NCT01772134|470141416|FG001|Overall Study|Lost to Follow-up|0|||
130595919|NCT01772134|470141417|FG002|Overall Study|Lost to Follow-up|0|||
130595920|NCT01772134|470141415|FG000|Overall Study|Protocol Deviation|4|||
130595921|NCT01772134|470141416|FG001|Overall Study|Protocol Deviation|3|||
130595922|NCT01772134|470141417|FG002|Overall Study|Protocol Deviation|3|||
130595923|NCT01772134|470141415|FG000|Overall Study|Lack of Efficacy|11|||
130595924|NCT01772134|470141416|FG001|Overall Study|Lack of Efficacy|5|||
130595925|NCT01772134|470141417|FG002|Overall Study|Lack of Efficacy|3|||
130595926|NCT01772134|470141415|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
130595927|NCT01772134|470141416|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
130595928|NCT01772134|470141417|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
130595929|NCT01772134|470141415|FG000|Overall Study|Randomized Study Medication Not Received|2|||
130595930|NCT01772134|470141416|FG001|Overall Study|Randomized Study Medication Not Received|0|||
130595931|NCT01772134|470141417|FG002|Overall Study|Randomized Study Medication Not Received|1|||
130595932|NCT05502289|470141422|FG000|Period 1|Out Of Window|1|||
130595933|NCT05502289|470141423|FG001|Period 1|Out Of Window|0|||
130595934|NCT03022461|470141424|FG000|Overall Study|Death|3|||
130595935|NCT03459040|470141425|FG000|Overall Study|Death|8|||
130595936|NCT03459040|470141425|FG000|Overall Study|Withdrawal by Subject|1|||
130595937|NCT00986349|470141426|FG000|Overall Study|Unsuccessful implant procedure|3|||
130595938|NCT00986349|470141426|FG000|Overall Study|Adverse Event|2|||
130595939|NCT00986349|470141426|FG000|Overall Study|Physician Decision|1|||
130595940|NCT00986349|470141426|FG000|Overall Study|device migration|1|||
130595941|NCT02299934|470141427|FG000|Overall Study|Termination of study|13|||
130595942|NCT00561353|470141428|FG000|Overall Study|Subject reached a virologic endpoint|2|||
130595943|NCT00561353|470141429|FG001|Overall Study|Subject reached a virologic endpoint|1|||
130595944|NCT00561353|470141430|FG002|Overall Study|Subject reached a virologic endpoint|1|||
130595945|NCT00561353|470141431|FG003|Overall Study|Subject reached a virologic endpoint|4|||
130595946|NCT00561353|470141432|FG004|Overall Study|Subject reached a virologic endpoint|1|||
130595947|NCT00561353|470141433|FG005|Overall Study|Subject reached a virologic endpoint|3|||
130595948|NCT00561353|470141434|FG006|Overall Study|Subject reached a virologic endpoint|4|||
130595949|NCT00561353|470141435|FG007|Overall Study|Subject reached a virologic endpoint|4|||
130595950|NCT00561353|470141436|FG008|Overall Study|Subject reached a virologic endpoint|5|||
130595951|NCT00561353|470141437|FG009|Overall Study|Subject reached a virologic endpoint|0|||
130595952|NCT00561353|470141428|FG000|Overall Study|Subject ineligible to continue the trial|0|||
130595953|NCT00561353|470141429|FG001|Overall Study|Subject ineligible to continue the trial|0|||
130595954|NCT00561353|470141430|FG002|Overall Study|Subject ineligible to continue the trial|0|||
130595955|NCT00561353|470141431|FG003|Overall Study|Subject ineligible to continue the trial|0|||
130595956|NCT00561353|470141432|FG004|Overall Study|Subject ineligible to continue the trial|0|||
130595957|NCT00561353|470141433|FG005|Overall Study|Subject ineligible to continue the trial|1|||
130595958|NCT00561353|470141434|FG006|Overall Study|Subject ineligible to continue the trial|1|||
130595959|NCT00561353|470141435|FG007|Overall Study|Subject ineligible to continue the trial|0|||
130595960|NCT00561353|470141436|FG008|Overall Study|Subject ineligible to continue the trial|2|||
130595961|NCT00561353|470141437|FG009|Overall Study|Subject ineligible to continue the trial|1|||
130595962|NCT00561353|470141428|FG000|Overall Study|Other|1|||
130595963|NCT00561353|470141429|FG001|Overall Study|Other|0|||
130595964|NCT00561353|470141430|FG002|Overall Study|Other|1|||
130595965|NCT00561353|470141431|FG003|Overall Study|Other|0|||
130595966|NCT00561353|470141432|FG004|Overall Study|Other|0|||
130595967|NCT00561353|470141433|FG005|Overall Study|Other|2|||
130595968|NCT00561353|470141434|FG006|Overall Study|Other|0|||
130595969|NCT00561353|470141435|FG007|Overall Study|Other|0|||
130595970|NCT00561353|470141436|FG008|Overall Study|Other|0|||
130595971|NCT00561353|470141437|FG009|Overall Study|Other|0|||
130595972|NCT00561353|470141428|FG000|Overall Study|Adverse Event|0|||
130595973|NCT00561353|470141429|FG001|Overall Study|Adverse Event|0|||
130595974|NCT00561353|470141430|FG002|Overall Study|Adverse Event|0|||
130595975|NCT00561353|470141431|FG003|Overall Study|Adverse Event|2|||
130595976|NCT00561353|470141432|FG004|Overall Study|Adverse Event|0|||
130595977|NCT00561353|470141433|FG005|Overall Study|Adverse Event|0|||
130595978|NCT00561353|470141434|FG006|Overall Study|Adverse Event|1|||
130595979|NCT00561353|470141435|FG007|Overall Study|Adverse Event|0|||
130595980|NCT00561353|470141436|FG008|Overall Study|Adverse Event|0|||
130595981|NCT00561353|470141437|FG009|Overall Study|Adverse Event|1|||
130595982|NCT00561353|470141428|FG000|Overall Study|Lost to Follow-up|2|||
130595983|NCT00561353|470141429|FG001|Overall Study|Lost to Follow-up|0|||
130595984|NCT00561353|470141430|FG002|Overall Study|Lost to Follow-up|1|||
130595985|NCT00561353|470141431|FG003|Overall Study|Lost to Follow-up|0|||
130595986|NCT00561353|470141432|FG004|Overall Study|Lost to Follow-up|0|||
130595987|NCT00561353|470141433|FG005|Overall Study|Lost to Follow-up|0|||
130595988|NCT00561353|470141434|FG006|Overall Study|Lost to Follow-up|0|||
130595989|NCT00561353|470141435|FG007|Overall Study|Lost to Follow-up|0|||
130595990|NCT00561353|470141436|FG008|Overall Study|Lost to Follow-up|0|||
130595991|NCT00561353|470141437|FG009|Overall Study|Lost to Follow-up|0|||
130595992|NCT00561353|470141428|FG000|Overall Study|Withdrawal by Subject|0|||
130595993|NCT00561353|470141429|FG001|Overall Study|Withdrawal by Subject|2|||
130595994|NCT00561353|470141430|FG002|Overall Study|Withdrawal by Subject|0|||
130595995|NCT00561353|470141431|FG003|Overall Study|Withdrawal by Subject|0|||
130595996|NCT00561353|470141432|FG004|Overall Study|Withdrawal by Subject|0|||
130595997|NCT00561353|470141433|FG005|Overall Study|Withdrawal by Subject|0|||
130595998|NCT00561353|470141434|FG006|Overall Study|Withdrawal by Subject|0|||
130595999|NCT00561353|470141435|FG007|Overall Study|Withdrawal by Subject|0|||
130596000|NCT00561353|470141436|FG008|Overall Study|Withdrawal by Subject|0|||
130596001|NCT00561353|470141437|FG009|Overall Study|Withdrawal by Subject|0|||
130596002|NCT01273818|470141438|FG000|Overall Study|Physician Decision|13|||
130596003|NCT01273818|470141439|FG001|Overall Study|Physician Decision|2|||
130596004|NCT01273818|470141440|FG002|Overall Study|Physician Decision|9|||
130596005|NCT03815175|470141441|FG000|Overall Study|Subject Lost to Follow-up|6|||
130596006|NCT03815175|470141441|FG000|Overall Study|Subject Withdrew Consent|48|||
130596007|NCT03815175|470141441|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
130596008|NCT03815175|470141441|FG000|Overall Study|Death|86|||
130596009|NCT03815175|470141441|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
130596010|NCT03815175|470141441|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
130596011|NCT03815175|470141441|FG000|Overall Study|Other Status Change Reason|1|||
130596012|NCT03815175|470141441|FG000|Overall Study|Missed Visit|12|||
130596013|NCT00457639|470141442|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
130596014|NCT00457639|470141443|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
130596015|NCT00457639|470141442|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
130596016|NCT00457639|470141443|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
130596017|NCT00457639|470141442|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
130596018|NCT00457639|470141443|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
130596019|NCT02117687|470141444|FG000|Overall Study|Lost to Follow-up|0|||
130596020|NCT02117687|470141445|FG001|Overall Study|Lost to Follow-up|1|||
130596021|NCT02117687|470141444|FG000|Overall Study|Adverse Event|0|||
130596022|NCT02117687|470141445|FG001|Overall Study|Adverse Event|2|||
130596023|NCT02117687|470141444|FG000|Overall Study|Other Reasons|1|||
130596024|NCT02117687|470141445|FG001|Overall Study|Other Reasons|1|||
130596025|NCT03528681|470143196|FG000|Open-Label Phase|Physician Decision|2|||
130596026|NCT03528681|470143197|FG001|Open-Label Phase|Physician Decision|0|||
130596027|NCT03528681|470143198|FG002|Open-Label Phase|Physician Decision|0|||
130596028|NCT03528681|470143199|FG003|Open-Label Phase|Physician Decision|0|||
130596029|NCT03528681|470143196|FG000|Open-Label Phase|Withdrawal by Subject|8|||
130596030|NCT03528681|470143197|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130596031|NCT03528681|470143198|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130596032|NCT03528681|470143199|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130596033|NCT03528681|470143196|FG000|Open-Label Phase|(Not collected)|4|||
130596034|NCT03528681|470143197|FG001|Open-Label Phase|(Not collected)|0|||
130596035|NCT03528681|470143198|FG002|Open-Label Phase|(Not collected)|0|||
130596036|NCT03528681|470143199|FG003|Open-Label Phase|(Not collected)|0|||
130596037|NCT03528681|470143196|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
130596038|NCT03528681|470143197|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
130596039|NCT03528681|470143198|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
130596040|NCT03528681|470143199|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
130596041|NCT03528681|470143196|FG000|Randomized Treatment Phase|Physician Decision|0|||
130596042|NCT03528681|470143197|FG001|Randomized Treatment Phase|Physician Decision|5|||
130596043|NCT03528681|470143198|FG002|Randomized Treatment Phase|Physician Decision|1|||
130596044|NCT03528681|470143199|FG003|Randomized Treatment Phase|Physician Decision|2|||
130596045|NCT03528681|470143196|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
130596046|NCT03528681|470143197|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
130596047|NCT03528681|470143198|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
130596048|NCT03528681|470143199|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
130596049|NCT03528681|470143196|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
130596050|NCT03528681|470143197|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
130596051|NCT03528681|470143198|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
130596052|NCT03528681|470143199|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
130596053|NCT03528681|470143196|FG000|Randomized Treatment Phase|(Not collected)|0|||
130596054|NCT03528681|470143197|FG001|Randomized Treatment Phase|(Not collected)|4|||
130596055|NCT03528681|470143198|FG002|Randomized Treatment Phase|(Not collected)|6|||
130596056|NCT03528681|470143199|FG003|Randomized Treatment Phase|(Not collected)|5|||
130596057|NCT01416181|470143207|FG000|Part 1|Other|10|||
130596058|NCT01416181|470143208|FG001|Part 1|Other|24|||
130596059|NCT01416181|470143207|FG000|Part 1|Death|0|||
130596060|NCT01416181|470143208|FG001|Part 1|Death|1|||
130596061|NCT01416181|470143207|FG000|Part 1|Investigator Decision|7|||
130596062|NCT01416181|470143208|FG001|Part 1|Investigator Decision|6|||
130596063|NCT01416181|470143207|FG000|Part 1|Withdrawal by Subject|74|||
130596064|NCT01416181|470143208|FG001|Part 1|Withdrawal by Subject|48|||
130596065|NCT01416181|470143207|FG000|Part 1|Lack of Efficacy|16|||
130596066|NCT01416181|470143208|FG001|Part 1|Lack of Efficacy|8|||
130596067|NCT01416181|470143207|FG000|Part 1|Lost to Follow-up|1|||
130596068|NCT01416181|470143208|FG001|Part 1|Lost to Follow-up|1|||
130596069|NCT01416181|470143207|FG000|Part 1|Adverse Event|15|||
130596070|NCT01416181|470143208|FG001|Part 1|Adverse Event|18|||
130596071|NCT01416181|470143207|FG000|Part 1|Ongoing in Follow-Up|14|||
130596072|NCT01416181|470143208|FG001|Part 1|Ongoing in Follow-Up|8|||
130596073|NCT01416181|470143207|FG000|Part 2|Adverse Event|11|||
130596074|NCT01416181|470143208|FG001|Part 2|Adverse Event|4|||
130596075|NCT01416181|470143207|FG000|Part 2|Other|234|||
130596076|NCT01416181|470143208|FG001|Part 2|Other|267|||
130596077|NCT01416181|470143207|FG000|Part 2|Investigator Decision|6|||
130596078|NCT01416181|470143208|FG001|Part 2|Investigator Decision|7|||
130596079|NCT01416181|470143207|FG000|Part 2|Withdrawal by Subject|14|||
130596080|NCT01416181|470143208|FG001|Part 2|Withdrawal by Subject|5|||
130596081|NCT01416181|470143207|FG000|Part 2|Lack of Efficacy|4|||
130596082|NCT01416181|470143208|FG001|Part 2|Lack of Efficacy|1|||
130596083|NCT01416181|470143207|FG000|Part 2|Lost to Follow-up|2|||
130596084|NCT01416181|470143208|FG001|Part 2|Lost to Follow-up|2|||
130596085|NCT02981472|470143209|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
130596086|NCT02981472|470143210|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
130596087|NCT02981472|470143209|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130596088|NCT02981472|470143210|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130596089|NCT02981472|470143209|FG000|Treatment Period|Adverse Event|6|||
130596090|NCT02981472|470143210|FG001|Treatment Period|Adverse Event|1|||
130596091|NCT02981472|470143209|FG000|Treatment Period|Participant withdrew consent|1|||
130596092|NCT02981472|470143210|FG001|Treatment Period|Participant withdrew consent|0|||
130596093|NCT02981472|470143209|FG000|Treatment Period|Lost to Follow-up|0|||
130596094|NCT02981472|470143210|FG001|Treatment Period|Lost to Follow-up|1|||
130596095|NCT00621023|470143213|FG000|Overall Study|Death|5|||
130596096|NCT00621023|470143213|FG000|Overall Study|Follow up discontinued|1|||
130596097|NCT02559505|470143224|FG000|Overall Study|Lost to Follow-up|23|||
130596098|NCT02559505|470143225|FG001|Overall Study|Lost to Follow-up|20|||
130596099|NCT02559505|470143224|FG000|Overall Study|Withdrawal by Subject|4|||
130596100|NCT02559505|470143225|FG001|Overall Study|Withdrawal by Subject|2|||
130596101|NCT00698516|470143226|FG000|Overall Study|Study Termination|2|||
130596102|NCT00698516|470143226|FG000|Overall Study|Withdrawal by Subject|3|||
130596103|NCT02586805|470143231|FG000|Overall Study|Withdrawal by Subject|3|||
130596104|NCT02586805|470143232|FG001|Overall Study|Withdrawal by Subject|1|||
130596105|NCT02586805|470143233|FG002|Overall Study|Withdrawal by Subject|1|||
130596106|NCT02586805|470143234|FG003|Overall Study|Withdrawal by Subject|2|||
130596107|NCT02586805|470143231|FG000|Overall Study|Adverse Event|2|||
130596108|NCT02586805|470143232|FG001|Overall Study|Adverse Event|0|||
130596109|NCT02586805|470143233|FG002|Overall Study|Adverse Event|1|||
130596110|NCT02586805|470143234|FG003|Overall Study|Adverse Event|0|||
130596111|NCT02586805|470143231|FG000|Overall Study|Lost to Follow-up|0|||
130596112|NCT02586805|470143232|FG001|Overall Study|Lost to Follow-up|0|||
130596113|NCT02586805|470143233|FG002|Overall Study|Lost to Follow-up|1|||
130596114|NCT02586805|470143234|FG003|Overall Study|Lost to Follow-up|0|||
130596115|NCT02586805|470143231|FG000|Overall Study|Physician Decision|1|||
130596116|NCT02586805|470143232|FG001|Overall Study|Physician Decision|0|||
130596117|NCT02586805|470143233|FG002|Overall Study|Physician Decision|0|||
130596118|NCT02586805|470143234|FG003|Overall Study|Physician Decision|0|||
130596119|NCT01859403|470143235|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
130596120|NCT01859403|470143236|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
130596121|NCT01859403|470143235|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
130596122|NCT01859403|470143236|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
130596123|NCT01859403|470143235|FG000|Primary Endpoint Measure|Physician Decision|0|||
130596124|NCT01859403|470143236|FG001|Primary Endpoint Measure|Physician Decision|1|||
130596125|NCT01859403|470143235|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
130596126|NCT01859403|470143236|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
130596127|NCT01121406|470143238|FG000|Overall Study|Progressive disease RECIST|44|||
130596128|NCT01121406|470143239|FG001|Overall Study|Progressive disease RECIST|28|||
130596129|NCT01121406|470143238|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
130596130|NCT01121406|470143239|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
130596131|NCT01121406|470143238|FG000|Overall Study|Other AE|3|||
130596132|NCT01121406|470143239|FG001|Overall Study|Other AE|10|||
130596133|NCT01121406|470143238|FG000|Overall Study|Non-compliant with protocol|0|||
130596134|NCT01121406|470143239|FG001|Overall Study|Non-compliant with protocol|2|||
130596135|NCT01121406|470143238|FG000|Overall Study|Lost to Follow-up|0|||
130596136|NCT01121406|470143239|FG001|Overall Study|Lost to Follow-up|1|||
130596137|NCT01121406|470143238|FG000|Overall Study|Refused continuation of study med.|1|||
130596138|NCT01121406|470143239|FG001|Overall Study|Refused continuation of study med.|2|||
130596139|NCT01121406|470143238|FG000|Overall Study|Reason other than specified above|2|||
130596140|NCT01121406|470143239|FG001|Overall Study|Reason other than specified above|6|||
130596141|NCT01121406|470143238|FG000|Overall Study|Not treated|1|||
130596142|NCT01121406|470143239|FG001|Overall Study|Not treated|0|||
130596143|NCT01829048|470143240|FG000|Overall Study|Withdrawal by Subject|0|||
130596144|NCT01829048|470143241|FG001|Overall Study|Withdrawal by Subject|0|||
130596145|NCT01829048|470143242|FG002|Overall Study|Withdrawal by Subject|0|||
130596146|NCT01829048|470143243|FG003|Overall Study|Withdrawal by Subject|2|||
130596147|NCT01829048|470143244|FG004|Overall Study|Withdrawal by Subject|0|||
130596148|NCT00504257|470143245|FG000|Overall Study|Withdrawal by Subject|2|||
130596149|NCT00504257|470143245|FG000|Overall Study|ineligible histology|2|||
130596150|NCT02750410|470143247|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130596151|NCT02750410|470143248|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130596152|NCT02750410|470143247|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130596153|NCT02750410|470143248|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130596154|NCT02750410|470143247|FG000|Open-Label Extension Period|Adverse Event|5|||
130596155|NCT02750410|470143248|FG001|Open-Label Extension Period|Adverse Event|3|||
130596156|NCT02750410|470143247|FG000|Open-Label Extension Period|Protocol Violation|0|||
130596157|NCT02750410|470143248|FG001|Open-Label Extension Period|Protocol Violation|1|||
130596158|NCT02750410|470143247|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
130596159|NCT02750410|470143248|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
130596160|NCT02504541|470143249|FG000|Overall Study|Adverse Event|4|||
130596161|NCT02504541|470143249|FG000|Overall Study|Withdrawal by Subject|4|||
130596162|NCT02504541|470143249|FG000|Overall Study|Lost to Follow-up|1|||
130596163|NCT02504541|470143249|FG000|Overall Study|Met Stopping Criteria|1|||
130596164|NCT02504541|470143249|FG000|Overall Study|Protocol Violation|2|||
130596165|NCT02504541|470143249|FG000|Overall Study|Termination by Sponsor|1|||
130596166|NCT02504541|470143249|FG000|Overall Study|Other|2|||
130596167|NCT02504541|470143249|FG000|Overall Study|Multiple|5|||
130596168|NCT01531725|470143250|FG000|Overall Study|Protocol Violation|5|||
130596169|NCT02317510|470143251|FG000|Overall Study|Adverse Event|0|||
130596170|NCT02317510|470143252|FG001|Overall Study|Adverse Event|1|||
130596171|NCT00500071|470143253|FG000|Screening and Washout Phase|Protocol Violation|1|||
130596172|NCT00500071|470143253|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
130596173|NCT00500071|470143253|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
130596174|NCT00500071|470143253|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
130596175|NCT00500071|470143253|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
130596176|NCT00500071|470143253|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
130596177|NCT00500071|470143253|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
130596178|NCT00472303|470143254|FG000|Titration Phase|Adverse Event|22|||
130596179|NCT00472303|470143255|FG001|Titration Phase|Adverse Event|12|||
130596180|NCT00472303|470143256|FG002|Titration Phase|Adverse Event|0|||
130596181|NCT00472303|470143254|FG000|Titration Phase|Death|4|||
130596182|NCT00472303|470143255|FG001|Titration Phase|Death|2|||
130596183|NCT00472303|470143256|FG002|Titration Phase|Death|0|||
130596184|NCT00472303|470143254|FG000|Titration Phase|Lack of Efficacy|10|||
130596185|NCT00472303|470143255|FG001|Titration Phase|Lack of Efficacy|0|||
130596186|NCT00472303|470143256|FG002|Titration Phase|Lack of Efficacy|0|||
130596187|NCT00472303|470143254|FG000|Titration Phase|Withdrawal by Subject|16|||
130596188|NCT00472303|470143255|FG001|Titration Phase|Withdrawal by Subject|13|||
130596189|NCT00472303|470143256|FG002|Titration Phase|Withdrawal by Subject|0|||
130596190|NCT00472303|470143254|FG000|Titration Phase|Trial Medication non-compliant|4|||
130596191|NCT00472303|470143255|FG001|Titration Phase|Trial Medication non-compliant|1|||
130596192|NCT00472303|470143256|FG002|Titration Phase|Trial Medication non-compliant|0|||
130596193|NCT00472303|470143254|FG000|Titration Phase|Other|3|||
130596194|NCT00472303|470143255|FG001|Titration Phase|Other|1|||
130596195|NCT00472303|470143256|FG002|Titration Phase|Other|0|||
130596196|NCT00472303|470143254|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
130596197|NCT00472303|470143255|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
130596198|NCT00472303|470143256|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
130596199|NCT00472303|470143254|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
130596200|NCT00472303|470143255|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
130596201|NCT00472303|470143256|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
130596202|NCT00472303|470143254|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
130596203|NCT00472303|470143255|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
130596204|NCT00472303|470143256|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
130596205|NCT00472303|470143254|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
130596206|NCT00472303|470143255|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
130596207|NCT00472303|470143256|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
130596208|NCT00472303|470143254|FG000|Discontinuations After Titration Phase|Other|5|||
130596209|NCT00472303|470143255|FG001|Discontinuations After Titration Phase|Other|0|||
130596210|NCT00472303|470143256|FG002|Discontinuations After Titration Phase|Other|0|||
130596211|NCT00472303|470143254|FG000|Maintenance Phase|Adverse Event|5|||
130596212|NCT00472303|470143255|FG001|Maintenance Phase|Adverse Event|6|||
130596213|NCT00472303|470143256|FG002|Maintenance Phase|Adverse Event|6|||
130596214|NCT00472303|470143254|FG000|Maintenance Phase|Death|3|||
130596215|NCT00472303|470143255|FG001|Maintenance Phase|Death|0|||
130596216|NCT00472303|470143256|FG002|Maintenance Phase|Death|2|||
130596217|NCT00472303|470143254|FG000|Maintenance Phase|Lack of Efficacy|2|||
130596218|NCT00472303|470143255|FG001|Maintenance Phase|Lack of Efficacy|2|||
130596219|NCT00472303|470143256|FG002|Maintenance Phase|Lack of Efficacy|4|||
130596220|NCT00472303|470143254|FG000|Maintenance Phase|Withdrawal by Subject|6|||
130596221|NCT00472303|470143255|FG001|Maintenance Phase|Withdrawal by Subject|7|||
130596222|NCT00472303|470143256|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130596223|NCT00472303|470143254|FG000|Maintenance Phase|Trial medication non-compliant|0|||
130596224|NCT00472303|470143255|FG001|Maintenance Phase|Trial medication non-compliant|0|||
130596225|NCT00472303|470143256|FG002|Maintenance Phase|Trial medication non-compliant|1|||
130596226|NCT00472303|470143254|FG000|Maintenance Phase|Resolution of pain|0|||
130596227|NCT00472303|470143255|FG001|Maintenance Phase|Resolution of pain|0|||
130596228|NCT00472303|470143256|FG002|Maintenance Phase|Resolution of pain|1|||
130596229|NCT00472303|470143254|FG000|Maintenance Phase|Other|1|||
130596230|NCT00472303|470143255|FG001|Maintenance Phase|Other|1|||
130596231|NCT00472303|470143256|FG002|Maintenance Phase|Other|0|||
130596232|NCT03182738|470143257|FG000|Overall Study|Lost to Follow-up|9|||
130596233|NCT03182738|470143258|FG001|Overall Study|Lost to Follow-up|3|||
130596234|NCT03182738|470143257|FG000|Overall Study|Pregnancy|0|||
130596235|NCT03182738|470143258|FG001|Overall Study|Pregnancy|1|||
130596236|NCT03182738|470143257|FG000|Overall Study|Withdrawal by Subject|0|||
130596237|NCT03182738|470143258|FG001|Overall Study|Withdrawal by Subject|1|||
130596238|NCT03596164|470143261|FG000|Overall Study|Adverse Event|0|||
130596239|NCT03596164|470143262|FG001|Overall Study|Adverse Event|1|||
130596240|NCT03596164|470143261|FG000|Overall Study|Death|1|||
130596241|NCT03596164|470143262|FG001|Overall Study|Death|0|||
130596242|NCT04112914|470143263|FG000|Overall Study|Lost to Follow-up|13|||
130596243|NCT04112914|470143264|FG001|Overall Study|Lost to Follow-up|9|||
130596244|NCT04112914|470143263|FG000|Overall Study|Withdrawal by Subject|1|||
130596245|NCT04112914|470143264|FG001|Overall Study|Withdrawal by Subject|0|||
130596246|NCT03427073|470143265|FG000|Overall Study|Disease Progression|1|||
130596247|NCT03427073|470143266|FG001|Overall Study|Disease Progression|1|||
130596248|NCT03427073|470143267|FG002|Overall Study|Disease Progression|1|||
130596249|NCT03427073|470143268|FG003|Overall Study|Disease Progression|3|||
130596250|NCT03427073|470143269|FG004|Overall Study|Disease Progression|3|||
130596251|NCT03427073|470143270|FG005|Overall Study|Disease Progression|4|||
130596252|NCT03427073|470143271|FG006|Overall Study|Disease Progression|2|||
130596253|NCT03427073|470143272|FG007|Overall Study|Disease Progression|3|||
130596254|NCT03427073|470143265|FG000|Overall Study|Physician Decision|0|||
130596255|NCT03427073|470143266|FG001|Overall Study|Physician Decision|0|||
130596256|NCT03427073|470143267|FG002|Overall Study|Physician Decision|0|||
130596257|NCT03427073|470143268|FG003|Overall Study|Physician Decision|0|||
130596258|NCT03427073|470143269|FG004|Overall Study|Physician Decision|0|||
130596259|NCT03427073|470143270|FG005|Overall Study|Physician Decision|0|||
130596260|NCT03427073|470143271|FG006|Overall Study|Physician Decision|1|||
130596261|NCT03427073|470143272|FG007|Overall Study|Physician Decision|1|||
130596262|NCT01486238|470143276|FG000|Overall Study|Death|0|||
130596263|NCT01486238|470143277|FG001|Overall Study|Death|2|||
130596264|NCT01486238|470143276|FG000|Overall Study|Withdrawal by Subject|2|||
130596265|NCT01486238|470143277|FG001|Overall Study|Withdrawal by Subject|1|||
130596266|NCT01486238|470143276|FG000|Overall Study|Lost to Follow-up|0|||
130596267|NCT01486238|470143277|FG001|Overall Study|Lost to Follow-up|3|||
130596268|NCT02835495|470143279|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
130596269|NCT02835495|470143280|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
130596270|NCT02835495|470143279|FG000|Overall Study|Declined in-person follow-up visit|4|||
130596271|NCT02835495|470143280|FG001|Overall Study|Declined in-person follow-up visit|2|||
130596272|NCT02318602|470143282|FG000|Overall Study|Adverse Event|0|||
130596273|NCT02318602|470143283|FG001|Overall Study|Adverse Event|1|||
130596274|NCT02318602|470143284|FG002|Overall Study|Adverse Event|1|||
130596275|NCT02318602|470143282|FG000|Overall Study|Withdrawal by Subject|0|||
130596276|NCT02318602|470143283|FG001|Overall Study|Withdrawal by Subject|3|||
130596277|NCT02318602|470143284|FG002|Overall Study|Withdrawal by Subject|0|||
130596278|NCT02318602|470143282|FG000|Overall Study|Death|1|||
130596279|NCT02318602|470143283|FG001|Overall Study|Death|0|||
130596280|NCT02318602|470143284|FG002|Overall Study|Death|0|||
130596281|NCT02318602|470143282|FG000|Overall Study|Guardian decision to withdraw|0|||
130596282|NCT02318602|470143283|FG001|Overall Study|Guardian decision to withdraw|0|||
130596283|NCT02318602|470143284|FG002|Overall Study|Guardian decision to withdraw|1|||
130596284|NCT00693706|470143285|FG000|Overall Study|Protocol Violation|0|||
130596285|NCT00693706|470143286|FG001|Overall Study|Protocol Violation|1|||
130596286|NCT01873950|470143287|FG000|Period 5|Withdrawal by Subject|0|||
130596287|NCT01873950|470143288|FG001|Period 5|Withdrawal by Subject|0|||
130596288|NCT01873950|470143289|FG002|Period 5|Withdrawal by Subject|0|||
130596289|NCT01873950|470143290|FG003|Period 5|Withdrawal by Subject|1|||
130596290|NCT01873950|470143291|FG004|Period 5|Withdrawal by Subject|0|||
130596291|NCT05421754|470143292|FG000|Overall Study|Technical issue with sensor|1|||
130596292|NCT02580058|470143293|FG000|Overall Study|Adverse Event|16|||
130596293|NCT02580058|470143294|FG001|Overall Study|Adverse Event|30|||
130596294|NCT02580058|470143295|FG002|Overall Study|Adverse Event|20|||
130596295|NCT02580058|470143293|FG000|Overall Study|Death|4|||
130596296|NCT02580058|470143294|FG001|Overall Study|Death|4|||
130596297|NCT02580058|470143295|FG002|Overall Study|Death|5|||
130596298|NCT02580058|470143293|FG000|Overall Study|Physician Decision|1|||
130596299|NCT02580058|470143294|FG001|Overall Study|Physician Decision|3|||
130596300|NCT02580058|470143295|FG002|Overall Study|Physician Decision|11|||
130596301|NCT02580058|470143293|FG000|Overall Study|Other|5|||
130596302|NCT02580058|470143294|FG001|Overall Study|Other|1|||
130596303|NCT02580058|470143295|FG002|Overall Study|Other|3|||
130596304|NCT02580058|470143293|FG000|Overall Study|Withdrawal by Subject|4|||
130596305|NCT02580058|470143294|FG001|Overall Study|Withdrawal by Subject|7|||
130596306|NCT02580058|470143295|FG002|Overall Study|Withdrawal by Subject|31|||
130596307|NCT02580058|470143293|FG000|Overall Study|Global Deterioration of Health Status|19|||
130596308|NCT02580058|470143294|FG001|Overall Study|Global Deterioration of Health Status|18|||
130596309|NCT02580058|470143295|FG002|Overall Study|Global Deterioration of Health Status|24|||
130596310|NCT02580058|470143293|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
130596311|NCT02580058|470143294|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130596312|NCT02580058|470143295|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
130596313|NCT02580058|470143293|FG000|Overall Study|Progressive Disease|137|||
130596314|NCT02580058|470143294|FG001|Overall Study|Progressive Disease|125|||
130596315|NCT02580058|470143295|FG002|Overall Study|Progressive Disease|94|||
130596316|NCT02580058|470143293|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130596317|NCT02580058|470143294|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130596318|NCT02580058|470143295|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130596319|NCT01193335|470143297|FG000|After Infant Series|Lost to Follow-up|1|||
130596320|NCT01193335|470143298|FG001|After Infant Series|Lost to Follow-up|2|||
130596321|NCT01193335|470143297|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
130596322|NCT01193335|470143298|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
130596323|NCT01193335|470143297|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
130596324|NCT01193335|470143298|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
130596325|NCT01193335|470143297|FG000|1-Year Follow-up|Lost to Follow-up|4|||
130596326|NCT01193335|470143298|FG001|1-Year Follow-up|Lost to Follow-up|0|||
130596327|NCT01193335|470143297|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
130596328|NCT01193335|470143298|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
130596329|NCT01193335|470143297|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
130596330|NCT01193335|470143298|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
130596331|NCT01733329|470143299|FG000|Overall Study|Protocol Violation|1|||
130596332|NCT01733329|470143300|FG001|Overall Study|Protocol Violation|1|||
130596333|NCT01733329|470143299|FG000|Overall Study|Uterine artery injury|1|||
130596334|NCT01733329|470143300|FG001|Overall Study|Uterine artery injury|0|||
130596335|NCT02388776|470143302|FG000|Overall Study|Death|1|||
130596336|NCT02388776|470143302|FG000|Overall Study|Lost to Follow-up|1|||
130596337|NCT03826914|470143303|FG000|Overall Study|Withdrawal by Subject|1|||
130596338|NCT03826914|470143304|FG001|Overall Study|Withdrawal by Subject|1|||
130596339|NCT04233424|470143307|FG000|Overall Study|Death|15|||
130596340|NCT04233424|470143308|FG001|Overall Study|Death|16|||
130596341|NCT04233424|470143307|FG000|Overall Study|Withdrawal by Subject|2|||
130596342|NCT04233424|470143308|FG001|Overall Study|Withdrawal by Subject|8|||
130596343|NCT04233424|470143307|FG000|Overall Study|Physician Decision|1|||
130596344|NCT04233424|470143308|FG001|Overall Study|Physician Decision|3|||
130596345|NCT04233424|470143307|FG000|Overall Study|Protocol Violation|3|||
130596346|NCT04233424|470143308|FG001|Overall Study|Protocol Violation|1|||
130596347|NCT04233424|470143307|FG000|Overall Study|Lost to Follow-up|1|||
130596348|NCT04233424|470143308|FG001|Overall Study|Lost to Follow-up|3|||
130596349|NCT04233424|470143307|FG000|Overall Study|subject refuse to visit site|2|||
130596350|NCT04233424|470143308|FG001|Overall Study|subject refuse to visit site|0|||
130596351|NCT02698189|470143309|FG000|Overall Study|Physician Decision|3|||
130596352|NCT02698189|470143310|FG001|Overall Study|Physician Decision|0|||
130596353|NCT02698189|470143309|FG000|Overall Study|Progressive disease|0|||
130596354|NCT02698189|470143310|FG001|Overall Study|Progressive disease|5|||
130596355|NCT02698189|470143309|FG000|Overall Study|Study terminated by sponsor|0|||
130596356|NCT02698189|470143310|FG001|Overall Study|Study terminated by sponsor|1|||
130596357|NCT01254344|470143313|FG000|Overall Study|Adverse Event|2|||
130596358|NCT01254344|470143314|FG001|Overall Study|Adverse Event|5|||
130596359|NCT01254344|470143313|FG000|Overall Study|Physician Decision|7|||
130596360|NCT01254344|470143314|FG001|Overall Study|Physician Decision|4|||
130596361|NCT01254344|470143313|FG000|Overall Study|Protocol Violation|1|||
130596362|NCT01254344|470143314|FG001|Overall Study|Protocol Violation|4|||
130596363|NCT01254344|470143313|FG000|Overall Study|Withdrawal by Subject|3|||
130596364|NCT01254344|470143314|FG001|Overall Study|Withdrawal by Subject|6|||
130596365|NCT01982630|470143315|FG000|Overall Study|Adverse Event|2|||
130596366|NCT01982630|470143316|FG001|Overall Study|Adverse Event|0|||
130596367|NCT01982630|470143317|FG002|Overall Study|Adverse Event|1|||
130596368|NCT01982630|470143318|FG003|Overall Study|Adverse Event|0|||
130596369|NCT01982630|470143319|FG004|Overall Study|Adverse Event|1|||
130596370|NCT01982630|470143320|FG005|Overall Study|Adverse Event|2|||
130596371|NCT01982630|470143321|FG006|Overall Study|Adverse Event|1|||
130596372|NCT01982630|470143322|FG007|Overall Study|Adverse Event|0|||
130596373|NCT01982630|470143315|FG000|Overall Study|Physician Decision|1|||
130596374|NCT01982630|470143316|FG001|Overall Study|Physician Decision|0|||
130596375|NCT01982630|470143317|FG002|Overall Study|Physician Decision|2|||
130596376|NCT01982630|470143318|FG003|Overall Study|Physician Decision|1|||
130596377|NCT01982630|470143319|FG004|Overall Study|Physician Decision|2|||
130596378|NCT01982630|470143320|FG005|Overall Study|Physician Decision|0|||
130596379|NCT01982630|470143321|FG006|Overall Study|Physician Decision|0|||
130596380|NCT01982630|470143322|FG007|Overall Study|Physician Decision|0|||
130596381|NCT01982630|470143315|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596382|NCT01982630|470143316|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596383|NCT01982630|470143317|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
130596384|NCT01982630|470143318|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596385|NCT01982630|470143319|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596386|NCT01982630|470143320|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596387|NCT01982630|470143321|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596388|NCT01982630|470143322|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130596389|NCT01982630|470143315|FG000|Overall Study|Withdrawal by Subject|0|||
130596390|NCT01982630|470143316|FG001|Overall Study|Withdrawal by Subject|0|||
130596391|NCT01982630|470143317|FG002|Overall Study|Withdrawal by Subject|0|||
130596392|NCT01982630|470143318|FG003|Overall Study|Withdrawal by Subject|0|||
130596393|NCT01982630|470143319|FG004|Overall Study|Withdrawal by Subject|0|||
130596394|NCT01982630|470143320|FG005|Overall Study|Withdrawal by Subject|1|||
130596395|NCT01982630|470143321|FG006|Overall Study|Withdrawal by Subject|0|||
130596396|NCT01982630|470143322|FG007|Overall Study|Withdrawal by Subject|0|||
130596397|NCT00820040|470143325|FG000|Overall Study|Death|1|||
130596398|NCT00820040|470143325|FG000|Overall Study|Sponsor terminated study|1|||
130596399|NCT00820040|470143325|FG000|Overall Study|Screen failure|1|||
130596400|NCT03822468|470143330|FG000|Treatment Period|Progressive disease|98|||
130596401|NCT03822468|470143331|FG001|Treatment Period|Progressive disease|94|||
130596402|NCT03822468|470143330|FG000|Treatment Period|Adverse Event|21|||
130596403|NCT03822468|470143331|FG001|Treatment Period|Adverse Event|24|||
130596404|NCT03822468|470143330|FG000|Treatment Period|Withdrawal by Subject|9|||
130596405|NCT03822468|470143331|FG001|Treatment Period|Withdrawal by Subject|5|||
130596406|NCT03822468|470143330|FG000|Treatment Period|Physician Decision|9|||
130596407|NCT03822468|470143331|FG001|Treatment Period|Physician Decision|7|||
130596408|NCT03822468|470143330|FG000|Treatment Period|Protocol Violation|2|||
130596409|NCT03822468|470143331|FG001|Treatment Period|Protocol Violation|1|||
130596410|NCT03822468|470143330|FG000|Treatment Period|Death|2|||
130596411|NCT03822468|470143331|FG001|Treatment Period|Death|3|||
130596412|NCT03822468|470143330|FG000|Treatment Period|Lost to Follow-up|1|||
130596413|NCT03822468|470143331|FG001|Treatment Period|Lost to Follow-up|1|||
130596414|NCT03822468|470143330|FG000|Treatment Period|Sponsor decision|46|||
130596415|NCT03822468|470143331|FG001|Treatment Period|Sponsor decision|53|||
130596416|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
130596417|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
130596418|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
130596419|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
130596420|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Death|1|||
130596421|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130596422|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130596423|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130596424|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130596425|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130596426|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
130596427|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130596428|NCT03822468|470143330|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
130596429|NCT03822468|470143331|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
130596430|NCT03248128|470143332|FG000|Overall Study|Lost to Follow-up|1|||
130596431|NCT03248128|470143333|FG001|Overall Study|Lost to Follow-up|0|||
130596432|NCT03248128|470143332|FG000|Overall Study|Withdrawal by Subject|16|||
130596433|NCT03248128|470143333|FG001|Overall Study|Withdrawal by Subject|14|||
130596434|NCT03248128|470143332|FG000|Overall Study|Site Closed|4|||
130596435|NCT03248128|470143333|FG001|Overall Study|Site Closed|3|||
130596436|NCT03248128|470143332|FG000|Overall Study|Randomized, but did not receive treatment|1|||
130596437|NCT03248128|470143333|FG001|Overall Study|Randomized, but did not receive treatment|3|||
130596438|NCT01914679|470143334|FG000|Overall Study|Lack of Efficacy|1|||
130596439|NCT01914679|470143334|FG000|Overall Study|Sponsor terminated study|4|||
130596440|NCT02722044|470143335|FG000|Overall Study|Adverse Event|2|||
130596441|NCT02722044|470143335|FG000|Overall Study|Physician Decision|1|||
130596442|NCT02722044|470143335|FG000|Overall Study|Withdrawal by Subject|1|||
130596443|NCT02722044|470143335|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
130596444|NCT00002850|470143337|FG000|Overall Study|Death|4|||
130596445|NCT00002850|470143338|FG001|Overall Study|Death|1|||
130596446|NCT00002850|470143339|FG002|Overall Study|Death|3|||
130596447|NCT00002850|470143337|FG000|Overall Study|Protocol Violation|1|||
130596448|NCT00002850|470143338|FG001|Overall Study|Protocol Violation|0|||
130596449|NCT00002850|470143339|FG002|Overall Study|Protocol Violation|1|||
130596450|NCT00002850|470143337|FG000|Overall Study|Withdrawal by Subject|0|||
130596451|NCT00002850|470143338|FG001|Overall Study|Withdrawal by Subject|1|||
130596452|NCT00002850|470143339|FG002|Overall Study|Withdrawal by Subject|0|||
130596453|NCT00955110|470144790|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
130596454|NCT00955110|470144790|FG000|Treatment Phase|Adverse Event|2|||
130596455|NCT00955110|470144790|FG000|Treatment Phase|Administrative reasons|2|||
130596456|NCT00955110|470144790|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
130596457|NCT00955110|470144790|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
130596458|NCT04430348|470144793|FG000|Overall Study|Death|3|||
130596459|NCT04430348|470144794|FG001|Overall Study|Death|2|||
130596460|NCT04430348|470144795|FG002|Overall Study|Death|2|||
130596461|NCT04430348|470144796|FG003|Overall Study|Death|2|||
130596462|NCT04430348|470144797|FG004|Overall Study|Death|2|||
130596463|NCT04430348|470144798|FG005|Overall Study|Death|3|||
130596464|NCT04430348|470144793|FG000|Overall Study|Lost to Follow-up|0|||
130596465|NCT04430348|470144794|FG001|Overall Study|Lost to Follow-up|0|||
130596466|NCT04430348|470144795|FG002|Overall Study|Lost to Follow-up|0|||
130596467|NCT04430348|470144796|FG003|Overall Study|Lost to Follow-up|1|||
130596468|NCT04430348|470144797|FG004|Overall Study|Lost to Follow-up|0|||
130596469|NCT04430348|470144798|FG005|Overall Study|Lost to Follow-up|0|||
130596470|NCT04430348|470144793|FG000|Overall Study|Adverse Event|0|||
130596471|NCT04430348|470144794|FG001|Overall Study|Adverse Event|0|||
130596472|NCT04430348|470144795|FG002|Overall Study|Adverse Event|0|||
130596473|NCT04430348|470144796|FG003|Overall Study|Adverse Event|0|||
130596474|NCT04430348|470144797|FG004|Overall Study|Adverse Event|0|||
130596475|NCT04430348|470144798|FG005|Overall Study|Adverse Event|1|||
130596476|NCT04430348|470144793|FG000|Overall Study|Withdrawal by Subject|0|||
130596477|NCT04430348|470144794|FG001|Overall Study|Withdrawal by Subject|1|||
130596478|NCT04430348|470144795|FG002|Overall Study|Withdrawal by Subject|0|||
130596479|NCT04430348|470144796|FG003|Overall Study|Withdrawal by Subject|0|||
130596480|NCT04430348|470144797|FG004|Overall Study|Withdrawal by Subject|0|||
130596481|NCT04430348|470144798|FG005|Overall Study|Withdrawal by Subject|1|||
130596482|NCT04430348|470144793|FG000|Overall Study|Study Terminated by Sponsor|0|||
130596483|NCT04430348|470144794|FG001|Overall Study|Study Terminated by Sponsor|0|||
130596484|NCT04430348|470144795|FG002|Overall Study|Study Terminated by Sponsor|2|||
130596485|NCT04430348|470144796|FG003|Overall Study|Study Terminated by Sponsor|0|||
130596486|NCT04430348|470144797|FG004|Overall Study|Study Terminated by Sponsor|1|||
130596487|NCT04430348|470144798|FG005|Overall Study|Study Terminated by Sponsor|1|||
130596488|NCT00756002|470144809|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130596489|NCT00756002|470144810|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130596490|NCT00756002|470144809|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130596491|NCT00756002|470144810|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130596492|NCT00756002|470144809|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
130596493|NCT00756002|470144810|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
130596494|NCT00756002|470144809|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
130596495|NCT00756002|470144810|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
130596496|NCT00756002|470144809|FG000|Double-Blind Treatment Period|Other|2|||
130596497|NCT00756002|470144810|FG001|Double-Blind Treatment Period|Other|2|||
130596498|NCT01126619|470144811|FG000|Overall Study|Not eligible for the study|2|||
130596499|NCT01126619|470144811|FG000|Overall Study|Investigator decision|4|||
130596500|NCT01126619|470144811|FG000|Overall Study|Serious adverse event|1|||
130596501|NCT01126619|470144811|FG000|Overall Study|Withdrawal by Subject|9|||
130596502|NCT01126619|470144811|FG000|Overall Study|Non-compliance|1|||
130596503|NCT00892437|470144820|FG000|Randomized Phase|Randomized but not treated|6|||
130596504|NCT00892437|470144821|FG001|Randomized Phase|Randomized but not treated|0|||
130596505|NCT00892437|470144820|FG000|Randomized Phase|Adverse Event|2|||
130596506|NCT00892437|470144821|FG001|Randomized Phase|Adverse Event|2|||
130596507|NCT00892437|470144820|FG000|Randomized Phase|Lost to Follow-up|1|||
130596508|NCT00892437|470144821|FG001|Randomized Phase|Lost to Follow-up|3|||
130596509|NCT00892437|470144820|FG000|Randomized Phase|Investigator's Discretion|1|||
130596510|NCT00892437|470144821|FG001|Randomized Phase|Investigator's Discretion|0|||
130596511|NCT00892437|470144820|FG000|Randomized Phase|Withdrew Consent|1|||
130596512|NCT00892437|470144821|FG001|Randomized Phase|Withdrew Consent|0|||
130596513|NCT00892437|470144820|FG000|Open-Label Extension Phase|Adverse Event|4|||
130596514|NCT00892437|470144821|FG001|Open-Label Extension Phase|Adverse Event|2|||
130596515|NCT00892437|470144820|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
130596516|NCT00892437|470144821|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
130596517|NCT00892437|470144820|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
130596518|NCT00892437|470144821|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130596519|NCT00892437|470144820|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
130596520|NCT00892437|470144821|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
130596521|NCT00892437|470144820|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
130596522|NCT00892437|470144821|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
130596523|NCT03185130|470144822|FG000|Overall Study|Withdrawal by Subject|0|||
130596524|NCT03185130|470144823|FG001|Overall Study|Withdrawal by Subject|2|||
130596525|NCT01925703|470144824|FG000|Overall Study|Physician Decision|1|||
130596526|NCT01925703|470144824|FG000|Overall Study|Lost to Follow-up|2|||
130596527|NCT01925703|470144824|FG000|Overall Study|Discharge prior to full iron repletion|1|||
130596528|NCT01238120|470144830|FG000|Overall Study|Withdrawal by Subject|4|||
130596529|NCT01238120|470144831|FG001|Overall Study|Withdrawal by Subject|1|||
130596530|NCT01238120|470144832|FG002|Overall Study|Withdrawal by Subject|2|||
130596531|NCT01238120|470144833|FG003|Overall Study|Withdrawal by Subject|5|||
130596532|NCT01238120|470144830|FG000|Overall Study|Lost to Follow-up|2|||
130596533|NCT01238120|470144831|FG001|Overall Study|Lost to Follow-up|0|||
130596534|NCT01238120|470144832|FG002|Overall Study|Lost to Follow-up|1|||
130596535|NCT01238120|470144833|FG003|Overall Study|Lost to Follow-up|1|||
130596536|NCT01238120|470144830|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
130596537|NCT01238120|470144831|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
130596538|NCT01238120|470144832|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
130596539|NCT01238120|470144833|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
130596540|NCT02498652|470144836|FG000|Overall Study|Protocol Violation|0|||
130596541|NCT02498652|470144837|FG001|Overall Study|Protocol Violation|1|||
130596542|NCT02500550|470144844|FG000|Overall Study|Death|7|||
130596543|NCT04334148|470144845|FG000|Overall Study|positive nasal swab at baseline|0|||
130596544|NCT04334148|470144846|FG001|Overall Study|positive nasal swab at baseline|1|||
130596545|NCT00922935|470144847|FG000|Overall Study|Protocol Violation|0|||
130596546|NCT00922935|470144848|FG001|Overall Study|Protocol Violation|3|||
130596547|NCT00922935|470144849|FG002|Overall Study|Protocol Violation|0|||
130596548|NCT00922935|470144847|FG000|Overall Study|Physician Decision|1|||
130596549|NCT00922935|470144848|FG001|Overall Study|Physician Decision|1|||
130596550|NCT00922935|470144849|FG002|Overall Study|Physician Decision|0|||
130596551|NCT00922935|470144847|FG000|Overall Study|Lost to Follow-up|0|||
130596552|NCT00922935|470144848|FG001|Overall Study|Lost to Follow-up|1|||
130596553|NCT00922935|470144849|FG002|Overall Study|Lost to Follow-up|0|||
130596554|NCT00542828|470144850|FG000|Overall Study|Physician Decision|1|||
130596555|NCT00542828|470144850|FG000|Overall Study|Need for Prohibited Treatment|3|||
130596556|NCT00542828|470144850|FG000|Overall Study|Study Prematurely Discontinued|7|||
130596557|NCT00542828|470144850|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
130596558|NCT01499576|470144853|FG000|Overall Study|Physician Decision|12|||
130596559|NCT01499576|470144853|FG000|Overall Study|Withdrawal by Subject|9|||
130596560|NCT03228186|470144854|FG000|Overall Study|Patient never started treatment|1|||
130596561|NCT04283461|470144855|FG000|Overall Study|Enrolled in separate trial|0|||
130596562|NCT04283461|470144856|FG001|Overall Study|Enrolled in separate trial|0|||
130596563|NCT04283461|470144857|FG002|Overall Study|Enrolled in separate trial|8|||
130596564|NCT04283461|470144858|FG003|Overall Study|Enrolled in separate trial|13|||
130596565|NCT04283461|470144859|FG004|Overall Study|Enrolled in separate trial|12|||
130596566|NCT04283461|470144860|FG005|Overall Study|Enrolled in separate trial|0|||
130596567|NCT04283461|470144861|FG006|Overall Study|Enrolled in separate trial|0|||
130596568|NCT04283461|470144862|FG007|Overall Study|Enrolled in separate trial|8|||
130596569|NCT04283461|470144863|FG008|Overall Study|Enrolled in separate trial|0|||
130596570|NCT04283461|470144864|FG009|Overall Study|Enrolled in separate trial|0|||
130596571|NCT04283461|470144865|FG010|Overall Study|Enrolled in separate trial|0|||
130596572|NCT04283461|470144866|FG011|Overall Study|Enrolled in separate trial|7|||
130596573|NCT04283461|470144867|FG012|Overall Study|Enrolled in separate trial|0|||
130596574|NCT04246047|470144868|FG000|Overall Study|Death|50|||
130596575|NCT04246047|470144869|FG001|Overall Study|Death|77|||
130596576|NCT04246047|470144868|FG000|Overall Study|Lost to Follow-up|1|||
130596577|NCT04246047|470144869|FG001|Overall Study|Lost to Follow-up|3|||
130596578|NCT04246047|470144868|FG000|Overall Study|Physician Decision|4|||
130596579|NCT04246047|470144869|FG001|Overall Study|Physician Decision|10|||
130596580|NCT04246047|470144868|FG000|Overall Study|Withdrawal by Subject|19|||
130596581|NCT04246047|470144869|FG001|Overall Study|Withdrawal by Subject|26|||
130596582|NCT04246047|470144868|FG000|Overall Study|Ongoing|169|||
130596583|NCT04246047|470144869|FG001|Overall Study|Ongoing|135|||
130596584|NCT05139030|470144873|FG000|Overall Study|Withdrawal by Subject|1|||
130596585|NCT05139030|470144874|FG001|Overall Study|Withdrawal by Subject|3|||
130596586|NCT05139030|470144873|FG000|Overall Study|Adverse Event|0|||
130596587|NCT05139030|470144874|FG001|Overall Study|Adverse Event|1|||
130596588|NCT05139030|470144873|FG000|Overall Study|Failure to meet continuation criteria|0|||
130596589|NCT05139030|470144874|FG001|Overall Study|Failure to meet continuation criteria|1|||
130596590|NCT02502864|470144882|FG000|Overall Study|Withdrawal by Subject|1|||
130596591|NCT03772327|470144883|FG000|Overall Study|Lost to Follow-up|3|||
130596592|NCT03772327|470144884|FG001|Overall Study|Lost to Follow-up|4|||
130596593|NCT03772327|470144883|FG000|Overall Study|Withdrawal by Subject|2|||
130596594|NCT03772327|470144884|FG001|Overall Study|Withdrawal by Subject|3|||
130596595|NCT03517436|470144893|FG000|Overall Study|Death|3|||
130596596|NCT03517436|470144893|FG000|Overall Study|Withdrawal by Subject|4|||
130596597|NCT03517436|470144893|FG000|Overall Study|Did not receive study valve.|1|||
130596598|NCT04375878|470144897|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
130596599|NCT04375878|470144898|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
130596600|NCT04375878|470144899|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130596601|NCT04375878|470144900|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130596602|NCT04375878|470144901|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130596603|NCT04375878|470144902|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130596604|NCT04375878|470144897|FG000|Crossover First and Second Interventions|Adverse Event|0|||
130596605|NCT04375878|470144898|FG001|Crossover First and Second Interventions|Adverse Event|0|||
130596606|NCT04375878|470144899|FG002|Crossover First and Second Interventions|Adverse Event|1|||
130596607|NCT04375878|470144900|FG003|Crossover First and Second Interventions|Adverse Event|0|||
130596608|NCT04375878|470144901|FG004|Crossover First and Second Interventions|Adverse Event|0|||
130596609|NCT04375878|470144902|FG005|Crossover First and Second Interventions|Adverse Event|0|||
130596610|NCT04375878|470144897|FG000|Extension Phase|Withdrawal by Subject|0|||
130596611|NCT04375878|470144898|FG001|Extension Phase|Withdrawal by Subject|0|||
130596612|NCT04375878|470144899|FG002|Extension Phase|Withdrawal by Subject|0|||
130596613|NCT04375878|470144900|FG003|Extension Phase|Withdrawal by Subject|0|||
130596614|NCT04375878|470144901|FG004|Extension Phase|Withdrawal by Subject|1|||
130596615|NCT04375878|470144902|FG005|Extension Phase|Withdrawal by Subject|0|||
130596616|NCT02493751|470144903|FG000|Overall Study|Withdrawal by Subject|2|||
130596617|NCT02493751|470144904|FG001|Overall Study|Withdrawal by Subject|8|||
130596618|NCT02493751|470144903|FG000|Overall Study|Death|6|||
130596619|NCT02493751|470144904|FG001|Overall Study|Death|13|||
130596620|NCT02493751|470144903|FG000|Overall Study|Lost to Follow-up|2|||
130596621|NCT02493751|470144904|FG001|Overall Study|Lost to Follow-up|3|||
130596622|NCT02493751|470144903|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
130596623|NCT02493751|470144904|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
130596624|NCT01259466|470144905|FG000|Overall Study|Withdrawal by Subject|1|||
130596625|NCT01259466|470144906|FG001|Overall Study|Withdrawal by Subject|9|||
130596626|NCT01824602|470144907|FG000|Overall Study|Withdrawal by Subject|0|||
130596627|NCT01824602|470144908|FG001|Overall Study|Withdrawal by Subject|0|||
130596628|NCT01824602|470144909|FG002|Overall Study|Withdrawal by Subject|1|||
130596629|NCT01824602|470144910|FG003|Overall Study|Withdrawal by Subject|2|||
130596630|NCT01824602|470144907|FG000|Overall Study|Patient non-compliance|0|||
130596631|NCT01824602|470144908|FG001|Overall Study|Patient non-compliance|0|||
130596632|NCT01824602|470144909|FG002|Overall Study|Patient non-compliance|1|||
130596633|NCT01824602|470144910|FG003|Overall Study|Patient non-compliance|0|||
130596634|NCT01824602|470144907|FG000|Overall Study|Adverse Event|1|||
130596635|NCT01824602|470144908|FG001|Overall Study|Adverse Event|0|||
130596636|NCT01824602|470144909|FG002|Overall Study|Adverse Event|2|||
130596637|NCT01824602|470144910|FG003|Overall Study|Adverse Event|2|||
130596638|NCT01824602|470144907|FG000|Overall Study|Treatment failure|0|||
130596639|NCT01824602|470144908|FG001|Overall Study|Treatment failure|0|||
130596640|NCT01824602|470144909|FG002|Overall Study|Treatment failure|0|||
130596641|NCT01824602|470144910|FG003|Overall Study|Treatment failure|1|||
130596642|NCT05300087|470144913|FG000|Overall Study|Withdrawal by Subject|0|||
130596643|NCT05300087|470144914|FG001|Overall Study|Withdrawal by Subject|1|||
130596644|NCT00761215|470144915|FG000|Overall Study|Randomized but didn't receive drug|1|||
130596645|NCT00761215|470144916|FG001|Overall Study|Randomized but didn't receive drug|1|||
130596646|NCT00761215|470144917|FG002|Overall Study|Randomized but didn't receive drug|2|||
130596647|NCT00761215|470144915|FG000|Overall Study|Lost to Follow-up|6|||
130596648|NCT00761215|470144916|FG001|Overall Study|Lost to Follow-up|3|||
130596649|NCT00761215|470144917|FG002|Overall Study|Lost to Follow-up|6|||
130596650|NCT00761215|470144915|FG000|Overall Study|Withdrawal by Subject|1|||
130596651|NCT00761215|470144916|FG001|Overall Study|Withdrawal by Subject|0|||
130596652|NCT00761215|470144917|FG002|Overall Study|Withdrawal by Subject|0|||
130596653|NCT00761215|470144915|FG000|Overall Study|Bacteremia|1|||
130596654|NCT00761215|470144916|FG001|Overall Study|Bacteremia|0|||
130596655|NCT00761215|470144917|FG002|Overall Study|Bacteremia|0|||
130596656|NCT01450137|470144921|FG000|Up to Week 12|Adverse Event|2|||
130596657|NCT01450137|470144922|FG001|Up to Week 12|Adverse Event|1|||
130596658|NCT01450137|470144921|FG000|Up to Week 12|Withdrawal by Subject|0|||
130596659|NCT01450137|470144922|FG001|Up to Week 12|Withdrawal by Subject|2|||
130596660|NCT01450137|470144921|FG000|Week 12 to Study End|Death|0|||
130596661|NCT01450137|470144922|FG001|Week 12 to Study End|Death|1|||
130596662|NCT01450137|470144921|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
130596663|NCT01450137|470144922|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
130596664|NCT01687673|470144935|FG000|Overall Study|Physician Decision|1|||
130596665|NCT00618956|470144936|FG000|Overall Study|Adverse Event|10|||
130596666|NCT00618956|470144937|FG001|Overall Study|Adverse Event|34|||
130596667|NCT00618956|470144936|FG000|Overall Study|Lack of Efficacy|2|||
130596668|NCT00618956|470144937|FG001|Overall Study|Lack of Efficacy|1|||
130596669|NCT00618956|470144936|FG000|Overall Study|Withdrawal by Subject|5|||
130596670|NCT00618956|470144937|FG001|Overall Study|Withdrawal by Subject|7|||
130596671|NCT00618956|470144936|FG000|Overall Study|Lost to Follow-up|4|||
130596672|NCT00618956|470144937|FG001|Overall Study|Lost to Follow-up|5|||
130596673|NCT00618956|470144936|FG000|Overall Study|Protocol Violation|2|||
130596674|NCT00618956|470144937|FG001|Overall Study|Protocol Violation|2|||
130596675|NCT00618956|470144936|FG000|Overall Study|did not meet criteria, non-compliance|2|||
130596676|NCT00618956|470144937|FG001|Overall Study|did not meet criteria, non-compliance|1|||
130596677|NCT02006576|470144938|FG000|Overall Study|Withdrawal by Subject|4|||
130596678|NCT02006576|470144939|FG001|Overall Study|Withdrawal by Subject|6|||
130596679|NCT02006576|470144940|FG002|Overall Study|Withdrawal by Subject|2|||
130596680|NCT02006576|470144938|FG000|Overall Study|Death|0|||
130596681|NCT02006576|470144939|FG001|Overall Study|Death|0|||
130596682|NCT02006576|470144940|FG002|Overall Study|Death|1|||
130596683|NCT02006576|470144938|FG000|Overall Study|Lost to Follow-up|1|||
130596684|NCT02006576|470144939|FG001|Overall Study|Lost to Follow-up|0|||
130596685|NCT02006576|470144940|FG002|Overall Study|Lost to Follow-up|1|||
130596686|NCT02006576|470144938|FG000|Overall Study|Screen Failure, too sick, other|13|||
130596687|NCT02006576|470144939|FG001|Overall Study|Screen Failure, too sick, other|1|||
130596688|NCT02006576|470144940|FG002|Overall Study|Screen Failure, too sick, other|13|||
130596689|NCT03478683|470144942|FG000|Overall Study|Adverse Event|5|||
130596690|NCT03478683|470144943|FG001|Overall Study|Adverse Event|3|||
130596691|NCT03478683|470144942|FG000|Overall Study|Lost to Follow-up|0|||
130596692|NCT03478683|470144943|FG001|Overall Study|Lost to Follow-up|5|||
130596693|NCT03478683|470144942|FG000|Overall Study|Physician Decision|1|||
130596694|NCT03478683|470144943|FG001|Overall Study|Physician Decision|3|||
130596695|NCT03478683|470144942|FG000|Overall Study|Withdrawal by Subject|7|||
130596696|NCT03478683|470144943|FG001|Overall Study|Withdrawal by Subject|7|||
130596697|NCT02332915|470144948|FG000|Overall Study|Moved out of region|3|||
130596698|NCT02332915|470144949|FG001|Overall Study|Moved out of region|0|||
130596699|NCT02332915|470144948|FG000|Overall Study|Unrelated illness|1|||
130596700|NCT02332915|470144949|FG001|Overall Study|Unrelated illness|1|||
130596701|NCT02332915|470144948|FG000|Overall Study|Travel distance prohibitive|0|||
130596702|NCT02332915|470144949|FG001|Overall Study|Travel distance prohibitive|1|||
130596703|NCT02332915|470144948|FG000|Overall Study|did not meet inclusion criteria|2|||
130596704|NCT02332915|470144949|FG001|Overall Study|did not meet inclusion criteria|4|||
130596705|NCT05847881|470144953|FG000|Overall Study|Principal Investigator Decision|8|||
130596706|NCT05847881|470144953|FG000|Overall Study|Withdrawal by Subject|2|||
130596707|NCT01084252|470146649|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596708|NCT01084252|470146650|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596709|NCT01084252|470146651|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596710|NCT01084252|470146652|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596711|NCT01084252|470146653|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596712|NCT01084252|470146654|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596713|NCT01084252|470146655|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596714|NCT01084252|470146656|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596715|NCT01084252|470146657|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596716|NCT01084252|470146658|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596717|NCT01084252|470146659|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596718|NCT01084252|470146660|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596719|NCT01084252|470146661|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
130596720|NCT01084252|470146662|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130596721|NCT04493619|470146664|FG000|Overall Study|Death|4|||
130596722|NCT04493619|470146665|FG001|Overall Study|Death|3|||
130596723|NCT04493619|470146666|FG002|Overall Study|Death|3|||
130596724|NCT04493619|470146667|FG003|Overall Study|Death|4|||
130596725|NCT04493619|470146664|FG000|Overall Study|Study discontinued early|10|||
130596726|NCT04493619|470146665|FG001|Overall Study|Study discontinued early|0|||
130596727|NCT04493619|470146666|FG002|Overall Study|Study discontinued early|4|||
130596728|NCT04493619|470146667|FG003|Overall Study|Study discontinued early|8|||
130596729|NCT04493619|470146664|FG000|Overall Study|Lost to Follow-up|0|||
130596730|NCT04493619|470146665|FG001|Overall Study|Lost to Follow-up|0|||
130596731|NCT04493619|470146666|FG002|Overall Study|Lost to Follow-up|0|||
130596732|NCT04493619|470146667|FG003|Overall Study|Lost to Follow-up|1|||
130596733|NCT02128490|470146670|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130596734|NCT02128490|470146671|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130596735|NCT02128490|470146672|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130596736|NCT02128490|470146673|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130596737|NCT02128490|470146674|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130596738|NCT02128490|470146670|FG000|Overall Study|Major Protocol Deviation|1|||
130596739|NCT02128490|470146671|FG001|Overall Study|Major Protocol Deviation|2|||
130596740|NCT02128490|470146672|FG002|Overall Study|Major Protocol Deviation|0|||
130596741|NCT02128490|470146673|FG003|Overall Study|Major Protocol Deviation|2|||
130596742|NCT02128490|470146674|FG004|Overall Study|Major Protocol Deviation|2|||
130596743|NCT02128490|470146670|FG000|Overall Study|Lost to Follow-up|0|||
130596744|NCT02128490|470146671|FG001|Overall Study|Lost to Follow-up|0|||
130596745|NCT02128490|470146672|FG002|Overall Study|Lost to Follow-up|1|||
130596746|NCT02128490|470146673|FG003|Overall Study|Lost to Follow-up|1|||
130596747|NCT02128490|470146674|FG004|Overall Study|Lost to Follow-up|1|||
130596748|NCT02128490|470146670|FG000|Overall Study|Voluntary Withdrawal|3|||
130596749|NCT02128490|470146671|FG001|Overall Study|Voluntary Withdrawal|3|||
130596750|NCT02128490|470146672|FG002|Overall Study|Voluntary Withdrawal|1|||
130596751|NCT02128490|470146673|FG003|Overall Study|Voluntary Withdrawal|1|||
130596752|NCT02128490|470146674|FG004|Overall Study|Voluntary Withdrawal|2|||
130596753|NCT02128490|470146670|FG000|Overall Study|Lack of Efficacy|0|||
130596754|NCT02128490|470146671|FG001|Overall Study|Lack of Efficacy|1|||
130596755|NCT02128490|470146672|FG002|Overall Study|Lack of Efficacy|0|||
130596756|NCT02128490|470146673|FG003|Overall Study|Lack of Efficacy|0|||
130596757|NCT02128490|470146674|FG004|Overall Study|Lack of Efficacy|0|||
130596758|NCT02128490|470146670|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130596759|NCT02128490|470146671|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130596760|NCT02128490|470146672|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130596761|NCT02128490|470146673|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130596762|NCT02128490|470146674|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
130596763|NCT02128490|470146670|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130596764|NCT02128490|470146671|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130596765|NCT02128490|470146672|FG002|Overall Study|Other Miscellaneous Reasons|2|||
130596766|NCT02128490|470146673|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130596767|NCT02128490|470146674|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130596768|NCT02243176|470146675|FG000|Overall Study|Other reason|1|||
130596769|NCT02243176|470146676|FG001|Overall Study|Other reason|2|||
130596770|NCT02243176|470146675|FG000|Overall Study|protocol specified withdrawal critera|1|||
130596771|NCT02243176|470146676|FG001|Overall Study|protocol specified withdrawal critera|3|||
130596772|NCT02243176|470146675|FG000|Overall Study|Protocol Violation|2|||
130596773|NCT02243176|470146676|FG001|Overall Study|Protocol Violation|1|||
130596774|NCT02243176|470146675|FG000|Overall Study|Withdrawal by Subject|8|||
130596775|NCT02243176|470146676|FG001|Overall Study|Withdrawal by Subject|7|||
130596776|NCT02243176|470146675|FG000|Overall Study|Adverse Event|2|||
130596777|NCT02243176|470146676|FG001|Overall Study|Adverse Event|2|||
130596778|NCT02342171|470146680|FG000|Overall Study|Death|4|||
130596779|NCT02342171|470146681|FG001|Overall Study|Death|87|||
130596780|NCT02342171|470146680|FG000|Overall Study|Received favipiravir|10|||
130596781|NCT02342171|470146681|FG001|Overall Study|Received favipiravir|0|||
130596782|NCT02342171|470146680|FG000|Overall Study|Missing cycle treshold value|1|||
130596783|NCT02342171|470146681|FG001|Overall Study|Missing cycle treshold value|0|||
130596784|NCT02342171|470146680|FG000|Overall Study|Unknown outcome|0|||
130596785|NCT02342171|470146681|FG001|Overall Study|Unknown outcome|1|||
130596786|NCT02342171|470146680|FG000|Overall Study|Missing age data|0|||
130596787|NCT02342171|470146681|FG001|Overall Study|Missing age data|1|||
130596788|NCT03518840|470146684|FG000|Overall Study|Lost to Follow-up|6|||
130596789|NCT03704051|470146685|FG000|Overall Study|Withdrawal by Subject|4|||
130596790|NCT03704051|470146686|FG001|Overall Study|Withdrawal by Subject|0|||
130596791|NCT03715465|470146687|FG000|Overall Study|Withdrawal by Subject|1|||
130596792|NCT03715465|470146688|FG001|Overall Study|Withdrawal by Subject|2|||
130596793|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
130596794|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
130596795|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
130596796|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
130596797|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
130596798|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
130596799|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
130596800|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
130596801|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
130596802|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
130596803|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
130596804|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
130596805|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
130596806|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
130596807|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
130596808|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
130596809|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
130596810|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
130596811|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Death|0|||
130596812|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Death|1|||
130596813|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Death|0|||
130596814|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
130596815|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
130596816|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
130596817|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
130596818|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
130596819|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
130596820|NCT00430781|470146698|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
130596821|NCT00430781|470146699|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
130596822|NCT00430781|470146700|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
130596823|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
130596824|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
130596825|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
130596826|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
130596827|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
130596828|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
130596829|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
130596830|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
130596831|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
130596832|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
130596833|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
130596834|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
130596835|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Other|0|||
130596836|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Other|1|||
130596837|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Other|0|||
130596838|NCT00430781|470146698|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
130596839|NCT00430781|470146699|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
130596840|NCT00430781|470146700|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
130596841|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
130596842|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
130596843|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
130596844|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
130596845|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
130596846|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
130596847|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
130596848|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
130596849|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
130596850|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
130596851|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
130596852|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
130596853|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
130596854|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
130596855|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
130596856|NCT00430781|470146698|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
130596857|NCT00430781|470146699|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
130596858|NCT00430781|470146700|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
130596859|NCT02158533|470146701|FG000|Stage 1|Adverse Event|6|||
130596860|NCT02158533|470146702|FG001|Stage 1|Adverse Event|4|||
130596861|NCT02158533|470146703|FG002|Stage 1|Adverse Event|7|||
130596862|NCT02158533|470146704|FG003|Stage 1|Adverse Event|0|||
130596863|NCT02158533|470146705|FG004|Stage 1|Adverse Event|0|||
130596864|NCT02158533|470146706|FG005|Stage 1|Adverse Event|0|||
130596865|NCT02158533|470146701|FG000|Stage 1|Withdrawal by Subject|3|||
130596866|NCT02158533|470146702|FG001|Stage 1|Withdrawal by Subject|2|||
130596867|NCT02158533|470146703|FG002|Stage 1|Withdrawal by Subject|1|||
130596868|NCT02158533|470146704|FG003|Stage 1|Withdrawal by Subject|0|||
130596869|NCT02158533|470146705|FG004|Stage 1|Withdrawal by Subject|0|||
130596870|NCT02158533|470146706|FG005|Stage 1|Withdrawal by Subject|0|||
130596871|NCT02158533|470146701|FG000|Stage 1|Lack of Efficacy|1|||
130596872|NCT02158533|470146702|FG001|Stage 1|Lack of Efficacy|0|||
130596873|NCT02158533|470146703|FG002|Stage 1|Lack of Efficacy|0|||
130596874|NCT02158533|470146704|FG003|Stage 1|Lack of Efficacy|0|||
130596875|NCT02158533|470146705|FG004|Stage 1|Lack of Efficacy|0|||
130596876|NCT02158533|470146706|FG005|Stage 1|Lack of Efficacy|0|||
130596877|NCT02158533|470146701|FG000|Stage 1|Lost to Follow-up|3|||
130596878|NCT02158533|470146702|FG001|Stage 1|Lost to Follow-up|1|||
130596879|NCT02158533|470146703|FG002|Stage 1|Lost to Follow-up|0|||
130596880|NCT02158533|470146704|FG003|Stage 1|Lost to Follow-up|0|||
130596881|NCT02158533|470146705|FG004|Stage 1|Lost to Follow-up|0|||
130596882|NCT02158533|470146706|FG005|Stage 1|Lost to Follow-up|0|||
130596883|NCT02158533|470146701|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
130596884|NCT02158533|470146702|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
130596885|NCT02158533|470146703|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
130596886|NCT02158533|470146704|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
130596887|NCT02158533|470146705|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
130596888|NCT02158533|470146706|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
130596889|NCT02158533|470146701|FG000|Stage 1|Non-compliance with study visits|1|||
130596890|NCT02158533|470146702|FG001|Stage 1|Non-compliance with study visits|0|||
130596891|NCT02158533|470146703|FG002|Stage 1|Non-compliance with study visits|0|||
130596892|NCT02158533|470146704|FG003|Stage 1|Non-compliance with study visits|0|||
130596893|NCT02158533|470146705|FG004|Stage 1|Non-compliance with study visits|0|||
130596894|NCT02158533|470146706|FG005|Stage 1|Non-compliance with study visits|0|||
130596895|NCT02158533|470146701|FG000|Stage 2|Adverse Event|0|||
130596896|NCT02158533|470146702|FG001|Stage 2|Adverse Event|0|||
130596897|NCT02158533|470146703|FG002|Stage 2|Adverse Event|0|||
130596898|NCT02158533|470146704|FG003|Stage 2|Adverse Event|0|||
130596899|NCT02158533|470146705|FG004|Stage 2|Adverse Event|0|||
130596900|NCT02158533|470146706|FG005|Stage 2|Adverse Event|1|||
130596901|NCT02158533|470146701|FG000|Stage 2|Lack of Efficacy|0|||
130596902|NCT02158533|470146702|FG001|Stage 2|Lack of Efficacy|0|||
130596903|NCT02158533|470146703|FG002|Stage 2|Lack of Efficacy|0|||
130596904|NCT02158533|470146704|FG003|Stage 2|Lack of Efficacy|0|||
130596905|NCT02158533|470146705|FG004|Stage 2|Lack of Efficacy|1|||
130596906|NCT02158533|470146706|FG005|Stage 2|Lack of Efficacy|0|||
130596907|NCT02158533|470146701|FG000|Stage 2|Lost to Follow-up|0|||
130596908|NCT02158533|470146702|FG001|Stage 2|Lost to Follow-up|0|||
130596909|NCT02158533|470146703|FG002|Stage 2|Lost to Follow-up|0|||
130596910|NCT02158533|470146704|FG003|Stage 2|Lost to Follow-up|1|||
130596911|NCT02158533|470146705|FG004|Stage 2|Lost to Follow-up|1|||
130596912|NCT02158533|470146706|FG005|Stage 2|Lost to Follow-up|2|||
130596913|NCT02158533|470146701|FG000|Stage 2|Withdrawal by Subject|0|||
130596914|NCT02158533|470146702|FG001|Stage 2|Withdrawal by Subject|0|||
130596915|NCT02158533|470146703|FG002|Stage 2|Withdrawal by Subject|0|||
130596916|NCT02158533|470146704|FG003|Stage 2|Withdrawal by Subject|0|||
130596917|NCT02158533|470146705|FG004|Stage 2|Withdrawal by Subject|1|||
130596918|NCT02158533|470146706|FG005|Stage 2|Withdrawal by Subject|2|||
130596919|NCT02158533|470146701|FG000|Stage 2|Physician Decision|0|||
130596920|NCT02158533|470146702|FG001|Stage 2|Physician Decision|0|||
130596921|NCT02158533|470146703|FG002|Stage 2|Physician Decision|0|||
130596922|NCT02158533|470146704|FG003|Stage 2|Physician Decision|0|||
130596923|NCT02158533|470146705|FG004|Stage 2|Physician Decision|1|||
130596924|NCT02158533|470146706|FG005|Stage 2|Physician Decision|0|||
130596925|NCT02158533|470146701|FG000|Stage 2|Pregnancy|0|||
130596926|NCT02158533|470146702|FG001|Stage 2|Pregnancy|0|||
130596927|NCT02158533|470146703|FG002|Stage 2|Pregnancy|0|||
130596928|NCT02158533|470146704|FG003|Stage 2|Pregnancy|1|||
130596929|NCT02158533|470146705|FG004|Stage 2|Pregnancy|0|||
130596930|NCT02158533|470146706|FG005|Stage 2|Pregnancy|0|||
130596931|NCT02158533|470146701|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
130596932|NCT02158533|470146702|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
130596933|NCT02158533|470146703|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
130596934|NCT02158533|470146704|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
130596935|NCT02158533|470146705|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
130596936|NCT02158533|470146706|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
130596937|NCT02158533|470146701|FG000|Stage 2|Non-adherence with study visits|0|||
130596938|NCT02158533|470146702|FG001|Stage 2|Non-adherence with study visits|0|||
130596939|NCT02158533|470146703|FG002|Stage 2|Non-adherence with study visits|0|||
130596940|NCT02158533|470146704|FG003|Stage 2|Non-adherence with study visits|0|||
130596941|NCT02158533|470146705|FG004|Stage 2|Non-adherence with study visits|0|||
130596942|NCT02158533|470146706|FG005|Stage 2|Non-adherence with study visits|1|||
130596943|NCT04329949|470146709|FG000|Overall Study|Death|36|||
130596944|NCT04329949|470146709|FG000|Overall Study|Withdrawal by Subject|4|||
130596945|NCT04329949|470146709|FG000|Overall Study|Termination of study by sponsor|3|||
130596946|NCT01335971|470146714|FG000|Overall Study|Withdrawal by Subject|1|||
130596947|NCT01335971|470146715|FG001|Overall Study|Withdrawal by Subject|0|||
130596948|NCT01335971|470146716|FG002|Overall Study|Withdrawal by Subject|0|||
130596949|NCT01335971|470146714|FG000|Overall Study|Did not complete bronchoscopy|1|||
130596950|NCT01335971|470146715|FG001|Overall Study|Did not complete bronchoscopy|1|||
130596951|NCT01335971|470146716|FG002|Overall Study|Did not complete bronchoscopy|1|||
130596952|NCT00384956|470146717|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
130596953|NCT00917384|470146718|FG000|Overall Study|Lost to Follow-up|4|||
130596954|NCT00917384|470146719|FG001|Overall Study|Lost to Follow-up|2|||
130596955|NCT00917384|470146718|FG000|Overall Study|Withdrawal by Subject|10|||
130596956|NCT00917384|470146719|FG001|Overall Study|Withdrawal by Subject|2|||
130596957|NCT00149214|470146721|FG000|Overall Study|Adverse Event|12|||
130596958|NCT00149214|470146722|FG001|Overall Study|Adverse Event|9|||
130596959|NCT00149214|470146721|FG000|Overall Study|Withdrawal by Subject|4|||
130596960|NCT00149214|470146722|FG001|Overall Study|Withdrawal by Subject|1|||
130596961|NCT00149214|470146721|FG000|Overall Study|Physician Decision|3|||
130596962|NCT00149214|470146722|FG001|Overall Study|Physician Decision|3|||
130596963|NCT00149214|470146721|FG000|Overall Study|Sponsor Decision|0|||
130596964|NCT00149214|470146722|FG001|Overall Study|Sponsor Decision|1|||
130596965|NCT00149214|470146721|FG000|Overall Study|Progressive Disease|7|||
130596966|NCT00149214|470146722|FG001|Overall Study|Progressive Disease|3|||
130596967|NCT01451515|470146726|FG000|Overall Study|Death|0|||
130596968|NCT01451515|470146727|FG001|Overall Study|Death|1|||
130596969|NCT01451515|470146728|FG002|Overall Study|Death|0|||
130596970|NCT01451515|470146726|FG000|Overall Study|Withdrawal by Subject|0|||
130596971|NCT01451515|470146727|FG001|Overall Study|Withdrawal by Subject|1|||
130596972|NCT01451515|470146728|FG002|Overall Study|Withdrawal by Subject|0|||
130596973|NCT01451515|470146726|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
130596974|NCT01451515|470146727|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
130596975|NCT01451515|470146728|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
130596976|NCT01451515|470146726|FG000|Overall Study|Relapse (except CNS)|1|||
130596977|NCT01451515|470146727|FG001|Overall Study|Relapse (except CNS)|1|||
130596978|NCT01451515|470146728|FG002|Overall Study|Relapse (except CNS)|0|||
130596979|NCT00174941|470146729|FG000|Overall Study|Adverse Event|1|||
130596980|NCT00174941|470146730|FG001|Overall Study|Adverse Event|10|||
130596981|NCT00174941|470146731|FG002|Overall Study|Adverse Event|2|||
130596982|NCT00174941|470146732|FG003|Overall Study|Adverse Event|13|||
130596983|NCT00174941|470146729|FG000|Overall Study|Protocol Violation|0|||
130596984|NCT00174941|470146730|FG001|Overall Study|Protocol Violation|1|||
130596985|NCT00174941|470146731|FG002|Overall Study|Protocol Violation|0|||
130596986|NCT00174941|470146732|FG003|Overall Study|Protocol Violation|1|||
130596987|NCT00174941|470146729|FG000|Overall Study|Lost to Follow-up|0|||
130596988|NCT00174941|470146730|FG001|Overall Study|Lost to Follow-up|3|||
130596989|NCT00174941|470146731|FG002|Overall Study|Lost to Follow-up|2|||
130596990|NCT00174941|470146732|FG003|Overall Study|Lost to Follow-up|5|||
130596991|NCT00174941|470146729|FG000|Overall Study|Personal Reason(s)|0|||
130596992|NCT00174941|470146730|FG001|Overall Study|Personal Reason(s)|14|||
130596993|NCT00174941|470146731|FG002|Overall Study|Personal Reason(s)|8|||
130596994|NCT00174941|470146732|FG003|Overall Study|Personal Reason(s)|22|||
130596995|NCT00174941|470146729|FG000|Overall Study|Gout Flare|0|||
130596996|NCT00174941|470146730|FG001|Overall Study|Gout Flare|4|||
130596997|NCT00174941|470146731|FG002|Overall Study|Gout Flare|4|||
130596998|NCT00174941|470146732|FG003|Overall Study|Gout Flare|8|||
130596999|NCT00174941|470146729|FG000|Overall Study|Reason Not Specified|1|||
130597000|NCT00174941|470146730|FG001|Overall Study|Reason Not Specified|6|||
130597001|NCT00174941|470146731|FG002|Overall Study|Reason Not Specified|2|||
130597002|NCT00174941|470146732|FG003|Overall Study|Reason Not Specified|9|||
130597003|NCT03351244|470146737|FG000|Overall Study|Adverse Event|7|||
130597004|NCT03351244|470146738|FG001|Overall Study|Adverse Event|11|||
130597005|NCT03351244|470146739|FG002|Overall Study|Adverse Event|12|||
130597006|NCT03351244|470146737|FG000|Overall Study|Investigator's decision|0|||
130597007|NCT03351244|470146738|FG001|Overall Study|Investigator's decision|0|||
130597008|NCT03351244|470146739|FG002|Overall Study|Investigator's decision|2|||
130597009|NCT03351244|470146737|FG000|Overall Study|System error|0|||
130597010|NCT03351244|470146738|FG001|Overall Study|System error|0|||
130597011|NCT03351244|470146739|FG002|Overall Study|System error|2|||
130597012|NCT03351244|470146737|FG000|Overall Study|COVID-19 restrictions|3|||
130597013|NCT03351244|470146738|FG001|Overall Study|COVID-19 restrictions|0|||
130597014|NCT03351244|470146739|FG002|Overall Study|COVID-19 restrictions|1|||
130597015|NCT03351244|470146737|FG000|Overall Study|Non-compliance|2|||
130597016|NCT03351244|470146738|FG001|Overall Study|Non-compliance|5|||
130597017|NCT03351244|470146739|FG002|Overall Study|Non-compliance|0|||
130597018|NCT03351244|470146737|FG000|Overall Study|Withdrawal by Subject|11|||
130597019|NCT03351244|470146738|FG001|Overall Study|Withdrawal by Subject|16|||
130597020|NCT03351244|470146739|FG002|Overall Study|Withdrawal by Subject|13|||
130597021|NCT03351244|470146737|FG000|Overall Study|Lost to Follow-up|2|||
130597022|NCT03351244|470146738|FG001|Overall Study|Lost to Follow-up|6|||
130597023|NCT03351244|470146739|FG002|Overall Study|Lost to Follow-up|4|||
130597024|NCT03351244|470146737|FG000|Overall Study|Protocol Violation|2|||
130597025|NCT03351244|470146738|FG001|Overall Study|Protocol Violation|2|||
130597026|NCT03351244|470146739|FG002|Overall Study|Protocol Violation|0|||
130597027|NCT04899271|470146740|FG000|Overall Study|Lost to Follow-up|1|||
130597028|NCT04899271|470146741|FG001|Overall Study|Lost to Follow-up|0|||
130597029|NCT04899271|470146740|FG000|Overall Study|Subject request/consent withdrawal|2|||
130597030|NCT04899271|470146741|FG001|Overall Study|Subject request/consent withdrawal|0|||
130597031|NCT03215277|470146743|FG000|Overall Study|Adverse Event|2|||
130597032|NCT03215277|470146744|FG001|Overall Study|Adverse Event|3|||
130597033|NCT03215277|470146743|FG000|Overall Study|Death|1|||
130597034|NCT03215277|470146744|FG001|Overall Study|Death|0|||
130597035|NCT03215277|470146743|FG000|Overall Study|Lost to Follow-up|0|||
130597036|NCT03215277|470146744|FG001|Overall Study|Lost to Follow-up|1|||
130597037|NCT03215277|470146743|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
130597038|NCT03215277|470146744|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
130597039|NCT04786210|470146745|FG000|Overall Study|Lost to Follow-up|2|||
130597040|NCT04786210|470146745|FG000|Overall Study|Withdrawal by Subject|4|||
130597041|NCT00587223|470146746|FG000|Overall Study|Adverse Event|1|||
130597042|NCT00195351|470146747|FG000|Overall Study|Lost to Follow-up|9|||
130597043|NCT00195351|470146748|FG001|Overall Study|Lost to Follow-up|9|||
130597044|NCT00195351|470146747|FG000|Overall Study|Withdrawal by Subject|6|||
130597045|NCT00195351|470146748|FG001|Overall Study|Withdrawal by Subject|3|||
130597046|NCT00195351|470146747|FG000|Overall Study|Protocol Deviation|3|||
130597047|NCT00195351|470146748|FG001|Overall Study|Protocol Deviation|2|||
130597048|NCT00195351|470146747|FG000|Overall Study|Death|3|||
130597049|NCT00195351|470146748|FG001|Overall Study|Death|1|||
130597050|NCT00195351|470146747|FG000|Overall Study|Lack of Efficacy|0|||
130597051|NCT00195351|470146748|FG001|Overall Study|Lack of Efficacy|1|||
130597052|NCT00971321|470146749|FG000|Up to Month 7|Withdrawal by Subject|1|||
130597053|NCT00971321|470146750|FG001|Up to Month 7|Withdrawal by Subject|0|||
130597054|NCT00971321|470146749|FG000|Up to Month 7|Migrated/moved from study area|3|||
130597055|NCT00971321|470146750|FG001|Up to Month 7|Migrated/moved from study area|2|||
130597056|NCT00971321|470146749|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
130597057|NCT00971321|470146750|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
130597058|NCT00971321|470146749|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
130597059|NCT00971321|470146750|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
130597060|NCT00971321|470146749|FG000|Up to Month 11-12|Lost to Follow-up|1|||
130597061|NCT00971321|470146750|FG001|Up to Month 11-12|Lost to Follow-up|0|||
130597062|NCT00519623|470146753|FG000|Overall Study|Adverse Event|1|||
130597063|NCT02296840|470146759|FG000|Overall Study|Adverse Event|1|||
130597064|NCT02296840|470146760|FG001|Overall Study|Adverse Event|1|||
130597065|NCT02296840|470146759|FG000|Overall Study|Protocol Violation|2|||
130597066|NCT02296840|470146760|FG001|Overall Study|Protocol Violation|1|||
130597067|NCT02296840|470146759|FG000|Overall Study|Lost to Follow-up|6|||
130597068|NCT02296840|470146760|FG001|Overall Study|Lost to Follow-up|17|||
130597069|NCT00104871|470146761|FG000|Overall Study|Not evaluable|1|||
130597070|NCT02485717|470146764|FG000|Overall Study|Lost to Follow-up|6|||
130597071|NCT02485717|470146765|FG001|Overall Study|Lost to Follow-up|0|||
130597072|NCT02485717|470146766|FG002|Overall Study|Lost to Follow-up|0|||
130597073|NCT02485717|470146764|FG000|Overall Study|Withdrawal by Subject|0|||
130597074|NCT02485717|470146765|FG001|Overall Study|Withdrawal by Subject|0|||
130597075|NCT02485717|470146766|FG002|Overall Study|Withdrawal by Subject|1|||
130597076|NCT02485717|470146764|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
130597077|NCT02485717|470146765|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
130597078|NCT02485717|470146766|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
130597079|NCT02485717|470146764|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
130597080|NCT02485717|470146765|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
130597081|NCT02485717|470146766|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
130597082|NCT01476787|470146774|FG000|Treatment|Progression|64|||
130597083|NCT01476787|470146775|FG001|Treatment|Progression|71|||
130597084|NCT01476787|470146774|FG000|Treatment|Toxicity|44|||
130597085|NCT01476787|470146775|FG001|Treatment|Toxicity|16|||
130597086|NCT01476787|470146774|FG000|Treatment|Death|0|||
130597087|NCT01476787|470146775|FG001|Treatment|Death|1|||
130597088|NCT01476787|470146774|FG000|Treatment|Withdrawal by Subject|3|||
130597089|NCT01476787|470146775|FG001|Treatment|Withdrawal by Subject|14|||
130597090|NCT01476787|470146774|FG000|Treatment|Major protocol violation|1|||
130597091|NCT01476787|470146775|FG001|Treatment|Major protocol violation|6|||
130597092|NCT01476787|470146774|FG000|Treatment|Other reasons|10|||
130597093|NCT01476787|470146775|FG001|Treatment|Other reasons|22|||
130597094|NCT01476787|470146774|FG000|Treatment|Concurrent illness|12|||
130597095|NCT01476787|470146775|FG001|Treatment|Concurrent illness|9|||
130597096|NCT01476787|470146774|FG000|Treatment|Insufficient response|15|||
130597097|NCT01476787|470146775|FG001|Treatment|Insufficient response|3|||
130597098|NCT01476787|470146774|FG000|Treatment|Voluntary treatment discontinuation|8|||
130597099|NCT01476787|470146775|FG001|Treatment|Voluntary treatment discontinuation|4|||
130597100|NCT01926886|470146776|FG000|Overall Study|Administrative/other|1|||
130597101|NCT01926886|470146777|FG001|Overall Study|Administrative/other|0|||
130597102|NCT01926886|470146776|FG000|Overall Study|Adverse event/intercurrent illness|4|||
130597103|NCT01926886|470146777|FG001|Overall Study|Adverse event/intercurrent illness|0|||
130597104|NCT01926886|470146776|FG000|Overall Study|Disease progression/recurrence|4|||
130597105|NCT01926886|470146777|FG001|Overall Study|Disease progression/recurrence|0|||
130597106|NCT01926886|470146776|FG000|Overall Study|Withdrawal by Subject|15|||
130597107|NCT01926886|470146777|FG001|Overall Study|Withdrawal by Subject|0|||
130597108|NCT01926886|470146776|FG000|Overall Study|Failure to return|3|||
130597109|NCT01926886|470146777|FG001|Overall Study|Failure to return|0|||
130597110|NCT01926886|470146776|FG000|Overall Study|Recurrence of disease|1|||
130597111|NCT01926886|470146777|FG001|Overall Study|Recurrence of disease|0|||
130597112|NCT01926886|470146776|FG000|Overall Study|Progression of disease|2|||
130597113|NCT01926886|470146777|FG001|Overall Study|Progression of disease|0|||
130597114|NCT01926886|470146776|FG000|Overall Study|Death|1|||
130597115|NCT01926886|470146777|FG001|Overall Study|Death|0|||
130597116|NCT01926886|470146776|FG000|Overall Study|Did not cooperate|1|||
130597117|NCT01926886|470146777|FG001|Overall Study|Did not cooperate|0|||
130597118|NCT01450540|470146778|FG000|Overall Study|Withdrawal by Subject|19|||
130597119|NCT01450540|470146779|FG001|Overall Study|Withdrawal by Subject|13|||
130597120|NCT01450540|470146778|FG000|Overall Study|protocol deviation|3|||
130597121|NCT01450540|470146779|FG001|Overall Study|protocol deviation|23|||
130597122|NCT01662999|470146788|FG000|Period 3|Withdrawal by Subject|0|||
130597123|NCT01662999|470146789|FG001|Period 3|Withdrawal by Subject|1|||
130597124|NCT01662999|470146790|FG002|Period 3|Withdrawal by Subject|0|||
130597125|NCT01662999|470146791|FG003|Period 3|Withdrawal by Subject|0|||
130597126|NCT01662999|470146792|FG004|Period 3|Withdrawal by Subject|0|||
130597127|NCT01662999|470146793|FG005|Period 3|Withdrawal by Subject|0|||
130597128|NCT02234622|470146794|FG000|Overall Study|Withdrawal by Subject|16|||
130597129|NCT02234622|470146795|FG001|Overall Study|Withdrawal by Subject|22|||
130597130|NCT02234622|470146794|FG000|Overall Study|Lost to Follow-up|27|||
130597131|NCT02234622|470146795|FG001|Overall Study|Lost to Follow-up|14|||
130597132|NCT04090164|470146796|FG000|Overall Study|incomplete data on file|245|||
130597133|NCT04090164|470146797|FG001|Overall Study|incomplete data on file|0|||
130597134|NCT01877655|470146804|FG000|Overall Study|Death|57|||
130597135|NCT01877655|470146805|FG001|Overall Study|Death|52|||
130597136|NCT01877655|470146804|FG000|Overall Study|Withdrawal by Subject|18|||
130597137|NCT01877655|470146805|FG001|Overall Study|Withdrawal by Subject|26|||
130597138|NCT01877655|470146804|FG000|Overall Study|Physician Decision|11|||
130597139|NCT01877655|470146805|FG001|Overall Study|Physician Decision|10|||
130597140|NCT01877655|470146804|FG000|Overall Study|Miscellaneous|4|||
130597141|NCT01877655|470146805|FG001|Overall Study|Miscellaneous|4|||
130597142|NCT01877655|470146804|FG000|Overall Study|Randomized but Never Received Drug|8|||
130597143|NCT01877655|470146805|FG001|Overall Study|Randomized but Never Received Drug|5|||
130597144|NCT03497689|470146806|FG000|Overall Study|Adverse Event|2|||
130597145|NCT03497689|470146806|FG000|Overall Study|Death|1|||
130597146|NCT03497689|470146806|FG000|Overall Study|Physician Decision|1|||
130597147|NCT03497689|470146806|FG000|Overall Study|Withdrawal by Subject|1|||
130597148|NCT03497689|470146806|FG000|Overall Study|Protocol Violation|2|||
130597149|NCT03191786|470146807|FG000|Overall Study|Death|236|||
130597150|NCT03191786|470146808|FG001|Overall Study|Death|127|||
130597151|NCT03191786|470146807|FG000|Overall Study|Lost to Follow-up|9|||
130597152|NCT03191786|470146808|FG001|Overall Study|Lost to Follow-up|3|||
130597153|NCT03191786|470146807|FG000|Overall Study|Physician Decision|1|||
130597154|NCT03191786|470146808|FG001|Overall Study|Physician Decision|0|||
130597155|NCT03191786|470146807|FG000|Overall Study|Moved to Post Trial Access Program|30|||
130597156|NCT03191786|470146808|FG001|Overall Study|Moved to Post Trial Access Program|5|||
130597157|NCT03191786|470146807|FG000|Overall Study|Withdrawal by Subject|26|||
130597158|NCT03191786|470146808|FG001|Overall Study|Withdrawal by Subject|16|||
130597159|NCT04513158|470146811|FG000|Overall Study|Screen Failure|1|||
130648332|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648333|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648334|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648335|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648336|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
130648337|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648338|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648339|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648340|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648341|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130648342|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648343|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648344|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648345|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648346|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648347|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
130648348|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648349|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130648350|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130597160|NCT02517515|470148975|FG000|Overall Study|Adverse Event|0|||
130597161|NCT02517515|470148976|FG001|Overall Study|Adverse Event|1|||
130597162|NCT02517515|470148975|FG000|Overall Study|Withdrew Consent|0|||
130597163|NCT02517515|470148976|FG001|Overall Study|Withdrew Consent|1|||
130597164|NCT02517515|470148975|FG000|Overall Study|Lost to Follow-up|1|||
130597165|NCT02517515|470148976|FG001|Overall Study|Lost to Follow-up|0|||
130597166|NCT02517515|470148975|FG000|Overall Study|Other|1|||
130597167|NCT02517515|470148976|FG001|Overall Study|Other|0|||
130597168|NCT03716726|470148979|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
130597169|NCT03716726|470148980|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
130597170|NCT03716726|470148979|FG000|12 Months Followup|Lost to Follow-up|10|||
130597171|NCT03716726|470148980|FG001|12 Months Followup|Lost to Follow-up|17|||
130597172|NCT02786537|470148983|FG000|As Randomized|Adverse Event|0|||
130597173|NCT02786537|470148984|FG001|As Randomized|Adverse Event|11|||
130597174|NCT02786537|470148985|FG002|As Randomized|Adverse Event|0|||
130597175|NCT02786537|470148986|FG003|As Randomized|Adverse Event|4|||
130597176|NCT02786537|470148987|FG004|As Randomized|Adverse Event|6|||
130597177|NCT02786537|470148988|FG005|As Randomized|Adverse Event|2|||
130597178|NCT02786537|470148983|FG000|As Randomized|Lack of Efficacy|0|||
130597179|NCT02786537|470148984|FG001|As Randomized|Lack of Efficacy|0|||
130597180|NCT02786537|470148985|FG002|As Randomized|Lack of Efficacy|0|||
130597181|NCT02786537|470148986|FG003|As Randomized|Lack of Efficacy|1|||
130597182|NCT02786537|470148987|FG004|As Randomized|Lack of Efficacy|0|||
130597183|NCT02786537|470148988|FG005|As Randomized|Lack of Efficacy|0|||
130597184|NCT02786537|470148983|FG000|As Randomized|Withdrawal by Subject|1|||
130597185|NCT02786537|470148984|FG001|As Randomized|Withdrawal by Subject|2|||
130597186|NCT02786537|470148985|FG002|As Randomized|Withdrawal by Subject|0|||
130597187|NCT02786537|470148986|FG003|As Randomized|Withdrawal by Subject|1|||
130597188|NCT02786537|470148987|FG004|As Randomized|Withdrawal by Subject|1|||
130597189|NCT02786537|470148988|FG005|As Randomized|Withdrawal by Subject|0|||
130597190|NCT02786537|470148983|FG000|As Randomized|Death|0|||
130597191|NCT02786537|470148984|FG001|As Randomized|Death|2|||
130597192|NCT02786537|470148985|FG002|As Randomized|Death|0|||
130597193|NCT02786537|470148986|FG003|As Randomized|Death|3|||
130597194|NCT02786537|470148987|FG004|As Randomized|Death|1|||
130597195|NCT02786537|470148988|FG005|As Randomized|Death|0|||
130597196|NCT02786537|470148983|FG000|As Randomized|Non-compliance with study drug|1|||
130597197|NCT02786537|470148984|FG001|As Randomized|Non-compliance with study drug|11|||
130597198|NCT02786537|470148985|FG002|As Randomized|Non-compliance with study drug|0|||
130597199|NCT02786537|470148986|FG003|As Randomized|Non-compliance with study drug|1|||
130597200|NCT02786537|470148987|FG004|As Randomized|Non-compliance with study drug|0|||
130597201|NCT02786537|470148988|FG005|As Randomized|Non-compliance with study drug|1|||
130597202|NCT02786537|470148983|FG000|As Randomized|Lost to treatment follow-up|4|||
130597203|NCT02786537|470148984|FG001|As Randomized|Lost to treatment follow-up|32|||
130597204|NCT02786537|470148985|FG002|As Randomized|Lost to treatment follow-up|0|||
130597205|NCT02786537|470148986|FG003|As Randomized|Lost to treatment follow-up|24|||
130597206|NCT02786537|470148987|FG004|As Randomized|Lost to treatment follow-up|4|||
130597207|NCT02786537|470148988|FG005|As Randomized|Lost to treatment follow-up|4|||
130597208|NCT02786537|470148983|FG000|As Randomized|Incarceration|0|||
130597209|NCT02786537|470148984|FG001|As Randomized|Incarceration|1|||
130597210|NCT02786537|470148985|FG002|As Randomized|Incarceration|0|||
130597211|NCT02786537|470148986|FG003|As Randomized|Incarceration|0|||
130597212|NCT02786537|470148987|FG004|As Randomized|Incarceration|0|||
130597213|NCT02786537|470148988|FG005|As Randomized|Incarceration|0|||
130597214|NCT02786537|470148983|FG000|As Randomized|Opiate Dependency Relapse|0|||
130597215|NCT02786537|470148984|FG001|As Randomized|Opiate Dependency Relapse|1|||
130597216|NCT02786537|470148985|FG002|As Randomized|Opiate Dependency Relapse|0|||
130597217|NCT02786537|470148986|FG003|As Randomized|Opiate Dependency Relapse|0|||
130597218|NCT02786537|470148987|FG004|As Randomized|Opiate Dependency Relapse|0|||
130597219|NCT02786537|470148988|FG005|As Randomized|Opiate Dependency Relapse|0|||
130597220|NCT02786537|470148983|FG000|As Randomized|HCV drugs stolen from pt|0|||
130597221|NCT02786537|470148984|FG001|As Randomized|HCV drugs stolen from pt|1|||
130597222|NCT02786537|470148985|FG002|As Randomized|HCV drugs stolen from pt|0|||
130597223|NCT02786537|470148986|FG003|As Randomized|HCV drugs stolen from pt|0|||
130597224|NCT02786537|470148987|FG004|As Randomized|HCV drugs stolen from pt|0|||
130597225|NCT02786537|470148988|FG005|As Randomized|HCV drugs stolen from pt|0|||
130597226|NCT02786537|470148983|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
130597227|NCT02786537|470148984|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
130597228|NCT02786537|470148985|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
130597229|NCT02786537|470148986|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
130597230|NCT02786537|470148987|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
130597231|NCT02786537|470148988|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
130597232|NCT02786537|470148983|FG000|As Randomized|Subject lost insurance|0|||
130597233|NCT02786537|470148984|FG001|As Randomized|Subject lost insurance|0|||
130597234|NCT02786537|470148985|FG002|As Randomized|Subject lost insurance|0|||
130597235|NCT02786537|470148986|FG003|As Randomized|Subject lost insurance|1|||
130597236|NCT02786537|470148987|FG004|As Randomized|Subject lost insurance|0|||
130597237|NCT02786537|470148988|FG005|As Randomized|Subject lost insurance|0|||
130597238|NCT02786537|470148983|FG000|As Treated|Adverse Event|0|||
130597239|NCT02786537|470148984|FG001|As Treated|Adverse Event|11|||
130597240|NCT02786537|470148985|FG002|As Treated|Adverse Event|0|||
130597241|NCT02786537|470148986|FG003|As Treated|Adverse Event|4|||
130597242|NCT02786537|470148987|FG004|As Treated|Adverse Event|6|||
130597243|NCT02786537|470148988|FG005|As Treated|Adverse Event|2|||
130597244|NCT02786537|470148983|FG000|As Treated|Death|0|||
130597245|NCT02786537|470148984|FG001|As Treated|Death|2|||
130597246|NCT02786537|470148985|FG002|As Treated|Death|0|||
130597247|NCT02786537|470148986|FG003|As Treated|Death|3|||
130597248|NCT02786537|470148987|FG004|As Treated|Death|1|||
130597249|NCT02786537|470148988|FG005|As Treated|Death|0|||
130597250|NCT02786537|470148983|FG000|As Treated|Lack of Efficacy|0|||
130597251|NCT02786537|470148984|FG001|As Treated|Lack of Efficacy|0|||
130597252|NCT02786537|470148985|FG002|As Treated|Lack of Efficacy|0|||
130597253|NCT02786537|470148986|FG003|As Treated|Lack of Efficacy|1|||
130597254|NCT02786537|470148987|FG004|As Treated|Lack of Efficacy|0|||
130597255|NCT02786537|470148988|FG005|As Treated|Lack of Efficacy|0|||
130597256|NCT02786537|470148983|FG000|As Treated|Lost to Follow-up|4|||
130597257|NCT02786537|470148984|FG001|As Treated|Lost to Follow-up|32|||
130597258|NCT02786537|470148985|FG002|As Treated|Lost to Follow-up|0|||
130597259|NCT02786537|470148986|FG003|As Treated|Lost to Follow-up|25|||
130597260|NCT02786537|470148987|FG004|As Treated|Lost to Follow-up|4|||
130597261|NCT02786537|470148988|FG005|As Treated|Lost to Follow-up|4|||
130597262|NCT02786537|470148983|FG000|As Treated|Non-compliance with study drug|1|||
130597263|NCT02786537|470148984|FG001|As Treated|Non-compliance with study drug|11|||
130597264|NCT02786537|470148985|FG002|As Treated|Non-compliance with study drug|0|||
130597265|NCT02786537|470148986|FG003|As Treated|Non-compliance with study drug|1|||
130597266|NCT02786537|470148987|FG004|As Treated|Non-compliance with study drug|0|||
130597267|NCT02786537|470148988|FG005|As Treated|Non-compliance with study drug|1|||
130597268|NCT02786537|470148983|FG000|As Treated|Lost insurance|0|||
130597269|NCT02786537|470148984|FG001|As Treated|Lost insurance|0|||
130597270|NCT02786537|470148985|FG002|As Treated|Lost insurance|0|||
130597271|NCT02786537|470148986|FG003|As Treated|Lost insurance|1|||
130597272|NCT02786537|470148987|FG004|As Treated|Lost insurance|0|||
130597273|NCT02786537|470148988|FG005|As Treated|Lost insurance|0|||
130597274|NCT02786537|470148983|FG000|As Treated|Withdrawal by Subject|1|||
130597275|NCT02786537|470148984|FG001|As Treated|Withdrawal by Subject|2|||
130597276|NCT02786537|470148985|FG002|As Treated|Withdrawal by Subject|0|||
130597277|NCT02786537|470148986|FG003|As Treated|Withdrawal by Subject|0|||
130597278|NCT02786537|470148987|FG004|As Treated|Withdrawal by Subject|1|||
130597279|NCT02786537|470148988|FG005|As Treated|Withdrawal by Subject|0|||
130597280|NCT02786537|470148983|FG000|As Treated|Incarceration|0|||
130597281|NCT02786537|470148984|FG001|As Treated|Incarceration|1|||
130597282|NCT02786537|470148985|FG002|As Treated|Incarceration|0|||
130597283|NCT02786537|470148986|FG003|As Treated|Incarceration|0|||
130597284|NCT02786537|470148987|FG004|As Treated|Incarceration|0|||
130597285|NCT02786537|470148988|FG005|As Treated|Incarceration|0|||
130597286|NCT02786537|470148983|FG000|As Treated|Opiate dependency relapse|0|||
130597287|NCT02786537|470148984|FG001|As Treated|Opiate dependency relapse|1|||
130597288|NCT02786537|470148985|FG002|As Treated|Opiate dependency relapse|0|||
130597289|NCT02786537|470148986|FG003|As Treated|Opiate dependency relapse|0|||
130597290|NCT02786537|470148987|FG004|As Treated|Opiate dependency relapse|0|||
130597291|NCT02786537|470148988|FG005|As Treated|Opiate dependency relapse|0|||
130597292|NCT02786537|470148983|FG000|As Treated|Drugs stolen from patient|0|||
130597293|NCT02786537|470148984|FG001|As Treated|Drugs stolen from patient|1|||
130597294|NCT02786537|470148985|FG002|As Treated|Drugs stolen from patient|0|||
130597295|NCT02786537|470148986|FG003|As Treated|Drugs stolen from patient|0|||
130597296|NCT02786537|470148987|FG004|As Treated|Drugs stolen from patient|0|||
130597297|NCT02786537|470148988|FG005|As Treated|Drugs stolen from patient|0|||
130597298|NCT02786537|470148983|FG000|As Treated|Advised to stop tx after loss of meds|0|||
130597299|NCT02786537|470148984|FG001|As Treated|Advised to stop tx after loss of meds|1|||
130597300|NCT02786537|470148985|FG002|As Treated|Advised to stop tx after loss of meds|0|||
130597301|NCT02786537|470148986|FG003|As Treated|Advised to stop tx after loss of meds|0|||
130597302|NCT02786537|470148987|FG004|As Treated|Advised to stop tx after loss of meds|0|||
130597303|NCT02786537|470148988|FG005|As Treated|Advised to stop tx after loss of meds|0|||
130597304|NCT01981187|470148989|FG000|Overall Study|Participant/guardian decision|2|||
130597305|NCT01981187|470148989|FG000|Overall Study|Physician Decision|1|||
130597306|NCT01981187|470148989|FG000|Overall Study|Disease progression|2|||
130597307|NCT01981187|470148989|FG000|Overall Study|Adverse Event|7|||
130597308|NCT02638012|470148990|FG000|Overall Study|Lost to Follow-up|1|||
130597309|NCT00443560|470148994|FG000|Overall Study|No intrathecal dose|58|||
130597310|NCT00443560|470148995|FG001|Overall Study|No intrathecal dose|26|||
130597311|NCT00443560|470148994|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
130597312|NCT00443560|470148995|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
130597313|NCT01943539|470148996|FG000|Overall Study|Non-compliance with at-home intervention|4|||
130597314|NCT01943539|470148997|FG001|Overall Study|Non-compliance with at-home intervention|0|||
130597315|NCT02413255|470148998|FG000|Overall Study|Voluntary Withdrawal|0|||
130597316|NCT02413255|470148999|FG001|Overall Study|Voluntary Withdrawal|0|||
130597317|NCT02413255|470149000|FG002|Overall Study|Voluntary Withdrawal|0|||
130597318|NCT02413255|470149001|FG003|Overall Study|Voluntary Withdrawal|0|||
130597319|NCT02413255|470149002|FG004|Overall Study|Voluntary Withdrawal|0|||
130597320|NCT02413255|470149003|FG005|Overall Study|Voluntary Withdrawal|0|||
130597321|NCT02413255|470149004|FG006|Overall Study|Voluntary Withdrawal|0|||
130597322|NCT02413255|470149005|FG007|Overall Study|Voluntary Withdrawal|0|||
130597323|NCT02413255|470149006|FG008|Overall Study|Voluntary Withdrawal|0|||
130597324|NCT02413255|470149007|FG009|Overall Study|Voluntary Withdrawal|0|||
130597325|NCT02413255|470149008|FG010|Overall Study|Voluntary Withdrawal|0|||
130597326|NCT02413255|470149009|FG011|Overall Study|Voluntary Withdrawal|0|||
130597327|NCT02413255|470149010|FG012|Overall Study|Voluntary Withdrawal|0|||
130597328|NCT02413255|470149011|FG013|Overall Study|Voluntary Withdrawal|0|||
130597329|NCT02413255|470149012|FG014|Overall Study|Voluntary Withdrawal|1|||
130597330|NCT02413255|470149013|FG015|Overall Study|Voluntary Withdrawal|0|||
130597331|NCT02413255|470149014|FG016|Overall Study|Voluntary Withdrawal|0|||
130597332|NCT03199911|470149015|FG000|Overall Study|Lost to Follow-up|5|||
130597333|NCT03199911|470149016|FG001|Overall Study|Lost to Follow-up|5|||
130597334|NCT03199911|470149015|FG000|Overall Study|Did not proceed with surgery|2|||
130597335|NCT03199911|470149016|FG001|Overall Study|Did not proceed with surgery|1|||
130597336|NCT01009463|470149017|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
130597337|NCT01009463|470149018|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130597338|NCT01009463|470149019|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130597339|NCT01009463|470149020|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130597340|NCT01009463|470149021|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130597341|NCT01009463|470149017|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
130597342|NCT01009463|470149018|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
130597343|NCT01009463|470149019|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
130597344|NCT01009463|470149020|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
130597345|NCT01009463|470149021|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
130597346|NCT01009463|470149017|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
130597347|NCT01009463|470149018|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130597348|NCT01009463|470149019|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130597349|NCT01009463|470149020|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130597350|NCT01009463|470149021|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130597351|NCT01009463|470149017|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
130597352|NCT01009463|470149018|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
130597353|NCT01009463|470149019|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
130597354|NCT01009463|470149020|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
130597355|NCT01009463|470149021|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
130597356|NCT01009463|470149017|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
130597357|NCT01009463|470149018|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130597358|NCT01009463|470149019|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130597359|NCT01009463|470149020|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130597360|NCT01009463|470149021|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130597361|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
130597362|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
130597363|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
130597364|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
130597365|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
130597366|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130597367|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
130597368|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
130597369|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
130597370|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
130597371|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130597372|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
130597373|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
130597374|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
130597375|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
130597376|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
130597377|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130597378|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130597379|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130597380|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130648351|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130597381|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130597382|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
130597383|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
130597384|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130597385|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
130597386|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130597387|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
130597388|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130597389|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130597390|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130597391|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130597392|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
130597393|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
130597394|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130597395|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
130597396|NCT01009463|470149017|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
130597397|NCT01009463|470149018|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
130597398|NCT01009463|470149019|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
130597399|NCT01009463|470149020|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
130597400|NCT01009463|470149021|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
130597401|NCT02333331|470149022|FG000|Overall Study|Adverse Event|1|||
130597402|NCT02333331|470149023|FG001|Overall Study|Adverse Event|0|||
130597403|NCT02333331|470149024|FG002|Overall Study|Adverse Event|4|||
130597404|NCT02333331|470149025|FG003|Overall Study|Adverse Event|1|||
130597405|NCT02333331|470149022|FG000|Overall Study|Death|0|||
130597406|NCT02333331|470149023|FG001|Overall Study|Death|0|||
130597407|NCT02333331|470149024|FG002|Overall Study|Death|2|||
130597408|NCT02333331|470149025|FG003|Overall Study|Death|0|||
130597409|NCT02333331|470149022|FG000|Overall Study|Lost to Follow-up|0|||
130597410|NCT02333331|470149023|FG001|Overall Study|Lost to Follow-up|0|||
130597411|NCT02333331|470149024|FG002|Overall Study|Lost to Follow-up|1|||
130597412|NCT02333331|470149025|FG003|Overall Study|Lost to Follow-up|0|||
130597413|NCT02333331|470149022|FG000|Overall Study|Physician Decision|0|||
130597414|NCT02333331|470149023|FG001|Overall Study|Physician Decision|1|||
130597415|NCT02333331|470149024|FG002|Overall Study|Physician Decision|0|||
130597416|NCT02333331|470149025|FG003|Overall Study|Physician Decision|0|||
130597417|NCT02333331|470149022|FG000|Overall Study|Protocol Deviation|0|||
130597418|NCT02333331|470149023|FG001|Overall Study|Protocol Deviation|3|||
130597419|NCT02333331|470149024|FG002|Overall Study|Protocol Deviation|2|||
130597420|NCT02333331|470149025|FG003|Overall Study|Protocol Deviation|1|||
130597421|NCT02333331|470149022|FG000|Overall Study|Patient/Guardian Decision|1|||
130597422|NCT02333331|470149023|FG001|Overall Study|Patient/Guardian Decision|2|||
130597423|NCT02333331|470149024|FG002|Overall Study|Patient/Guardian Decision|9|||
130597424|NCT02333331|470149025|FG003|Overall Study|Patient/Guardian Decision|1|||
130597425|NCT01494038|470149026|FG000|Overall Study|Protocol Violation|1|||
130597426|NCT01494038|470149027|FG001|Overall Study|Protocol Violation|1|||
130597427|NCT01494038|470149026|FG000|Overall Study|Lost to Follow-up|18|||
130597428|NCT01494038|470149027|FG001|Overall Study|Lost to Follow-up|20|||
130597429|NCT01494038|470149026|FG000|Overall Study|Withdrawal by Subject|44|||
130597430|NCT01494038|470149027|FG001|Overall Study|Withdrawal by Subject|34|||
130597431|NCT01494038|470149026|FG000|Overall Study|Not able to get to clinic|21|||
130597432|NCT01494038|470149027|FG001|Overall Study|Not able to get to clinic|15|||
130597433|NCT01494038|470149026|FG000|Overall Study|Not willing to adhere to reqs|2|||
130597434|NCT01494038|470149027|FG001|Overall Study|Not willing to adhere to reqs|9|||
130597435|NCT01494038|470149026|FG000|Overall Study|Death|2|||
130597436|NCT01494038|470149027|FG001|Overall Study|Death|4|||
130597437|NCT02874794|470149028|FG000|Overall Study|Physician Decision|3|||
130597438|NCT02874794|470149029|FG001|Overall Study|Physician Decision|2|||
130597439|NCT02874794|470149028|FG000|Overall Study|Withdrawal by Subject|2|||
130597440|NCT02874794|470149029|FG001|Overall Study|Withdrawal by Subject|8|||
130597441|NCT02874794|470149028|FG000|Overall Study|Death|2|||
130597442|NCT02874794|470149029|FG001|Overall Study|Death|1|||
130597443|NCT00537940|470149030|FG000|Overall Study|Adverse Event|20|||
130597444|NCT00537940|470149031|FG001|Overall Study|Adverse Event|19|||
130597445|NCT00537940|470149030|FG000|Overall Study|Lack of Efficacy|8|||
130597446|NCT00537940|470149031|FG001|Overall Study|Lack of Efficacy|16|||
130597447|NCT00537940|470149030|FG000|Overall Study|Lost to Follow-up|23|||
130597448|NCT00537940|470149031|FG001|Overall Study|Lost to Follow-up|29|||
130597449|NCT00537940|470149030|FG000|Overall Study|Withdrawal by Subject|113|||
130597450|NCT00537940|470149031|FG001|Overall Study|Withdrawal by Subject|95|||
130597451|NCT00537940|470149030|FG000|Overall Study|Protocol Violation|6|||
130597452|NCT00537940|470149031|FG001|Overall Study|Protocol Violation|4|||
130597453|NCT00537940|470149030|FG000|Overall Study|Pregnancy|1|||
130597454|NCT00537940|470149031|FG001|Overall Study|Pregnancy|1|||
130597455|NCT00537940|470149030|FG000|Overall Study|Study terminated by sponsor|2|||
130597456|NCT00537940|470149031|FG001|Overall Study|Study terminated by sponsor|3|||
130597457|NCT00537940|470149030|FG000|Overall Study|Other|10|||
130597458|NCT00537940|470149031|FG001|Overall Study|Other|12|||
130597459|NCT05309668|470149033|FG000|Overall Study|Ongoing at data cut-off|14|||
130597460|NCT05309668|470149034|FG001|Overall Study|Ongoing at data cut-off|17|||
130597461|NCT05309668|470149035|FG002|Overall Study|Ongoing at data cut-off|4|||
130597462|NCT02401256|470149036|FG000|Overall Study|Adverse Event|5|||
130597463|NCT02401256|470149036|FG000|Overall Study|Withdrawal by Subject|12|||
130597464|NCT00345605|470149040|FG000|Arm 1|Adverse Event|0|||
130597465|NCT00345605|470149041|FG001|Arm 1|Adverse Event|1|||
130597466|NCT00345605|470149040|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
130597467|NCT00345605|470149041|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
130597468|NCT03180736|470149042|FG000|Overall Study|Adverse Event|3|||
130597469|NCT03180736|470149043|FG001|Overall Study|Adverse Event|4|||
130597470|NCT03180736|470149042|FG000|Overall Study|Death|10|||
130597471|NCT03180736|470149043|FG001|Overall Study|Death|7|||
130597472|NCT03180736|470149042|FG000|Overall Study|Withdrawal by Subject|5|||
130597473|NCT03180736|470149043|FG001|Overall Study|Withdrawal by Subject|12|||
130597474|NCT03180736|470149042|FG000|Overall Study|Lost to Follow-up|1|||
130597475|NCT03180736|470149043|FG001|Overall Study|Lost to Follow-up|0|||
130597476|NCT03180736|470149042|FG000|Overall Study|Lack of Efficacy|66|||
130597477|NCT03180736|470149043|FG001|Overall Study|Lack of Efficacy|87|||
130597478|NCT03180736|470149042|FG000|Overall Study|Physician Decision|4|||
130597479|NCT03180736|470149043|FG001|Overall Study|Physician Decision|7|||
130597480|NCT03180736|470149042|FG000|Overall Study|randomized but not treated|2|||
130597481|NCT03180736|470149043|FG001|Overall Study|randomized but not treated|3|||
130597482|NCT01059812|470149044|FG000|Overall Study|Adverse Event|9|||
130597483|NCT01059812|470149045|FG001|Overall Study|Adverse Event|5|||
130597484|NCT01059812|470149044|FG000|Overall Study|Lack of Efficacy|2|||
130597485|NCT01059812|470149045|FG001|Overall Study|Lack of Efficacy|2|||
130597486|NCT01059812|470149044|FG000|Overall Study|Protocol Violation|3|||
130597487|NCT01059812|470149045|FG001|Overall Study|Protocol Violation|1|||
130597488|NCT01059812|470149044|FG000|Overall Study|Withdrawal Criteria|9|||
130597489|NCT01059812|470149045|FG001|Overall Study|Withdrawal Criteria|4|||
130597490|NCT01059812|470149044|FG000|Overall Study|Unclassified|14|||
130597491|NCT01059812|470149045|FG001|Overall Study|Unclassified|4|||
130597492|NCT01389128|470149046|FG000|Overall Study|Fetal distress|1|||
130597493|NCT01389128|470149047|FG001|Overall Study|Fetal distress|0|||
130597494|NCT01389128|470149046|FG000|Overall Study|Cervix dilation stop|1|||
130597495|NCT01389128|470149047|FG001|Overall Study|Cervix dilation stop|2|||
130597496|NCT01389128|470149046|FG000|Overall Study|Rapid labor evolution|3|||
130597497|NCT01389128|470149047|FG001|Overall Study|Rapid labor evolution|2|||
130597498|NCT01389128|470149046|FG000|Overall Study|Intolerance to procedure|0|||
130597499|NCT01389128|470149047|FG001|Overall Study|Intolerance to procedure|2|||
130597500|NCT01458340|470149054|FG000|Overall Study|Adverse Event|5|||
130597501|NCT01458340|470149055|FG001|Overall Study|Adverse Event|4|||
130597502|NCT01458340|470149056|FG002|Overall Study|Adverse Event|2|||
130597503|NCT01458340|470149054|FG000|Overall Study|Lost to Follow-up|3|||
130597504|NCT01458340|470149055|FG001|Overall Study|Lost to Follow-up|3|||
130597505|NCT01458340|470149056|FG002|Overall Study|Lost to Follow-up|10|||
130597506|NCT01458340|470149054|FG000|Overall Study|Miscellaneous|0|||
130597507|NCT01458340|470149055|FG001|Overall Study|Miscellaneous|1|||
130597508|NCT01458340|470149056|FG002|Overall Study|Miscellaneous|0|||
130597509|NCT01458340|470149054|FG000|Overall Study|Physician Decision|1|||
130597510|NCT01458340|470149055|FG001|Overall Study|Physician Decision|1|||
130597511|NCT01458340|470149056|FG002|Overall Study|Physician Decision|2|||
130597512|NCT01458340|470149054|FG000|Overall Study|Protocol Violation|6|||
130597513|NCT01458340|470149055|FG001|Overall Study|Protocol Violation|6|||
130597514|NCT01458340|470149056|FG002|Overall Study|Protocol Violation|5|||
130597515|NCT01458340|470149054|FG000|Overall Study|Withdrawal by Subject|12|||
130597516|NCT01458340|470149055|FG001|Overall Study|Withdrawal by Subject|6|||
130597517|NCT01458340|470149056|FG002|Overall Study|Withdrawal by Subject|4|||
130597518|NCT03126227|470149057|FG000|Overall Study|Adverse Event|43|||
130597519|NCT03126227|470149058|FG001|Overall Study|Adverse Event|4|||
130597520|NCT03126227|470149057|FG000|Overall Study|Death|0|||
130597521|NCT03126227|470149058|FG001|Overall Study|Death|1|||
130597522|NCT03126227|470149057|FG000|Overall Study|Lost to Follow-up|0|||
130597523|NCT03126227|470149058|FG001|Overall Study|Lost to Follow-up|1|||
130597524|NCT03126227|470149057|FG000|Overall Study|Physician Decision|2|||
130597525|NCT03126227|470149058|FG001|Overall Study|Physician Decision|0|||
130597526|NCT03126227|470149057|FG000|Overall Study|Protocol Violation|1|||
130597527|NCT03126227|470149058|FG001|Overall Study|Protocol Violation|0|||
130597528|NCT03126227|470149057|FG000|Overall Study|Withdrawal by Subject|19|||
130597529|NCT03126227|470149058|FG001|Overall Study|Withdrawal by Subject|3|||
130648352|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130597530|NCT03126227|470149057|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
130597531|NCT03126227|470149058|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
130597532|NCT03126227|470149057|FG000|Overall Study|Lack of dosing compliance|2|||
130597533|NCT03126227|470149058|FG001|Overall Study|Lack of dosing compliance|0|||
130597534|NCT03126227|470149057|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
130597535|NCT03126227|470149058|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
130597536|NCT03126227|470149057|FG000|Overall Study|Scheduling conflict|1|||
130597537|NCT03126227|470149058|FG001|Overall Study|Scheduling conflict|0|||
130597538|NCT03230097|470149061|FG000|Overall Study|Adverse Event|2|||
130597539|NCT03230097|470149062|FG001|Overall Study|Adverse Event|1|||
130597540|NCT03230097|470149061|FG000|Overall Study|non-compliance|0|||
130597541|NCT03230097|470149062|FG001|Overall Study|non-compliance|1|||
130597542|NCT03230097|470149061|FG000|Overall Study|Lost to Follow-up|2|||
130597543|NCT03230097|470149062|FG001|Overall Study|Lost to Follow-up|4|||
130597544|NCT03230097|470149061|FG000|Overall Study|Withdrawal by Subject|7|||
130597545|NCT03230097|470149062|FG001|Overall Study|Withdrawal by Subject|3|||
130597546|NCT03230097|470149061|FG000|Overall Study|Trial termination|4|||
130597547|NCT03230097|470149062|FG001|Overall Study|Trial termination|5|||
130597548|NCT03230097|470149061|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
130597549|NCT03230097|470149062|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
130597550|NCT03230097|470149061|FG000|Overall Study|outcome event|0|||
130597551|NCT03230097|470149062|FG001|Overall Study|outcome event|1|||
130597552|NCT03056287|470149063|FG000|Overall Study|Withdrawal by Subject|0|||
130597553|NCT03056287|470149064|FG001|Overall Study|Withdrawal by Subject|1|||
130597554|NCT03056287|470149065|FG002|Overall Study|Withdrawal by Subject|0|||
130597555|NCT03056287|470149066|FG003|Overall Study|Withdrawal by Subject|0|||
130597556|NCT03056287|470149063|FG000|Overall Study|move out of area|0|||
130597557|NCT03056287|470149064|FG001|Overall Study|move out of area|0|||
130597558|NCT03056287|470149065|FG002|Overall Study|move out of area|1|||
130597559|NCT03056287|470149066|FG003|Overall Study|move out of area|1|||
130597560|NCT00947154|470149067|FG000|Overall Study|Lost to Follow-up|1|||
130597561|NCT03794986|470149068|FG000|Overall Study|0 Sessions Attended|34|||
130597562|NCT03794986|470149069|FG001|Overall Study|0 Sessions Attended|37|||
130597563|NCT03794986|470149068|FG000|Overall Study|Withdrawal by Subject|4|||
130597564|NCT03794986|470149069|FG001|Overall Study|Withdrawal by Subject|6|||
130597565|NCT03794986|470149068|FG000|Overall Study|Protocol Violation|1|||
130597566|NCT03794986|470149069|FG001|Overall Study|Protocol Violation|0|||
130597567|NCT05309083|470149070|FG000|Overall Study|Withdrawal by Subject|2|||
130597568|NCT01165229|470149071|FG000|Overall Study|Serious Adverse Event|456|||
130597569|NCT01165229|470149072|FG001|Overall Study|Serious Adverse Event|487|||
130597570|NCT01165229|470149071|FG000|Overall Study|Non-Serious Adverse Event|47|||
130597571|NCT01165229|470149072|FG001|Overall Study|Non-Serious Adverse Event|15|||
130597572|NCT01165229|470149071|FG000|Overall Study|Protocol Violation|6|||
130597573|NCT01165229|470149072|FG001|Overall Study|Protocol Violation|8|||
130597574|NCT01165229|470149071|FG000|Overall Study|Withdrawal by Subject|387|||
130597575|NCT01165229|470149072|FG001|Overall Study|Withdrawal by Subject|396|||
130597576|NCT01165229|470149071|FG000|Overall Study|Migrated/moved from study area|51|||
130597577|NCT01165229|470149072|FG001|Overall Study|Migrated/moved from study area|46|||
130597578|NCT01165229|470149071|FG000|Overall Study|Lost to Follow-up|123|||
130597579|NCT01165229|470149072|FG001|Overall Study|Lost to Follow-up|133|||
130597580|NCT01165229|470149071|FG000|Overall Study|Suspected HZ Episode|2|||
130597581|NCT01165229|470149072|FG001|Overall Study|Suspected HZ Episode|2|||
130597582|NCT01165229|470149071|FG000|Overall Study|No reason from the subject|108|||
130597583|NCT01165229|470149072|FG001|Overall Study|No reason from the subject|102|||
130597584|NCT01165229|470149071|FG000|Overall Study|Unknown completion status|0|||
130597585|NCT01165229|470149072|FG001|Overall Study|Unknown completion status|1|||
130597586|NCT00881205|470149076|FG000|Overall Study|Adverse Event|8|||
130597587|NCT00881205|470149077|FG001|Overall Study|Adverse Event|3|||
130597588|NCT00881205|470149076|FG000|Overall Study|Withdrawal by Subject|1|||
130597589|NCT00881205|470149077|FG001|Overall Study|Withdrawal by Subject|2|||
130597590|NCT00881205|470149076|FG000|Overall Study|Lost to Follow-up|0|||
130597591|NCT00881205|470149077|FG001|Overall Study|Lost to Follow-up|1|||
130597592|NCT00881205|470149076|FG000|Overall Study|Administrative problems|1|||
130597593|NCT00881205|470149077|FG001|Overall Study|Administrative problems|1|||
130597594|NCT00881205|470149076|FG000|Overall Study|Condition no longer requires drug|1|||
130597595|NCT00881205|470149077|FG001|Overall Study|Condition no longer requires drug|0|||
130597596|NCT00465569|470149080|FG000|Overall Study|persistent eczema during dose escalation|1|||
130597597|NCT00465569|470149081|FG001|Overall Study|persistent eczema during dose escalation|0|||
130597598|NCT00849212|470149082|FG000|Overall Study|Lack of Efficacy|1|||
130597599|NCT00849212|470149082|FG000|Overall Study|Withdrawal by Subject|3|||
130597600|NCT00849212|470149082|FG000|Overall Study|Adverse Event|2|||
130597601|NCT00849212|470149082|FG000|Overall Study|Miscellaneous|1|||
130597602|NCT00095303|470149083|FG000|Main Study|Lost to Follow-up|91|||
130597603|NCT00095303|470149084|FG001|Main Study|Lost to Follow-up|87|||
130597604|NCT00095303|470149083|FG000|Follow Up Study|Lost to Follow-up|59|||
130597605|NCT00095303|470149084|FG001|Follow Up Study|Lost to Follow-up|58|||
130597606|NCT01364467|470149085|FG000|Overall Study|Lost to Follow-up|1|||
130597607|NCT01364467|470149086|FG001|Overall Study|Lost to Follow-up|2|||
130597608|NCT01634243|470149089|FG000|Overall Study|Adverse Event|5|||
130597609|NCT01634243|470149090|FG001|Overall Study|Adverse Event|5|||
130597610|NCT01634243|470149089|FG000|Overall Study|Lack of Efficacy|1|||
130597611|NCT01634243|470149090|FG001|Overall Study|Lack of Efficacy|0|||
130597612|NCT00845429|470149102|FG000|Overall Study|Protocol Violation|5|||
130597613|NCT00845429|470149103|FG001|Overall Study|Protocol Violation|4|||
130597614|NCT00845429|470149104|FG002|Overall Study|Protocol Violation|7|||
130597615|NCT00845429|470149102|FG000|Overall Study|Lost to Follow-up|7|||
130597616|NCT00845429|470149103|FG001|Overall Study|Lost to Follow-up|9|||
130597617|NCT00845429|470149104|FG002|Overall Study|Lost to Follow-up|10|||
130597618|NCT00845429|470149102|FG000|Overall Study|Withdrawal by Subject|2|||
130597619|NCT00845429|470149103|FG001|Overall Study|Withdrawal by Subject|2|||
130597620|NCT00845429|470149104|FG002|Overall Study|Withdrawal by Subject|2|||
130597621|NCT00845429|470149102|FG000|Overall Study|Serious adverse event|0|||
130597622|NCT00845429|470149103|FG001|Overall Study|Serious adverse event|0|||
130597623|NCT00845429|470149104|FG002|Overall Study|Serious adverse event|1|||
130597624|NCT02111369|470149108|FG000|Overall Study|Lost to Follow-up|2|||
130597625|NCT02111369|470149108|FG000|Overall Study|Withdrawal by Subject|1|||
130597626|NCT03240081|470149112|FG000|Overall Study|Withdrawal by Subject|0|||
130597627|NCT03240081|470149113|FG001|Overall Study|Withdrawal by Subject|2|||
130597628|NCT03240081|470149112|FG000|Overall Study|Lost to Follow-up|0|||
130597629|NCT03240081|470149113|FG001|Overall Study|Lost to Follow-up|1|||
130597630|NCT00883753|470149114|FG000|Overall Study|Adverse Event|37|||
130597631|NCT00883753|470149114|FG000|Overall Study|Death|2|||
130597632|NCT00883753|470149114|FG000|Overall Study|Insufficient therapeutic response|16|||
130597633|NCT00883753|470149114|FG000|Overall Study|Lost to Follow-up|4|||
130597634|NCT00883753|470149114|FG000|Overall Study|Violation of selection criteria at entry|7|||
130597635|NCT00883753|470149114|FG000|Overall Study|Protocol Violation|2|||
130597636|NCT00883753|470149114|FG000|Overall Study|Refused treatment|4|||
130597637|NCT00883753|470149114|FG000|Overall Study|Withdrew consent|10|||
130597638|NCT00883753|470149114|FG000|Overall Study|Investigator's decision|17|||
130597639|NCT00883753|470149114|FG000|Overall Study|Administrative/Other|8|||
130597640|NCT01480180|470149117|FG000|Main Phase|Withdrawal criteria|12|||
130597641|NCT01480180|470149118|FG001|Main Phase|Withdrawal criteria|1|||
130597642|NCT01480180|470149119|FG002|Main Phase|Withdrawal criteria|0|||
130597643|NCT01480180|470149120|FG003|Main Phase|Withdrawal criteria|0|||
130597644|NCT01480180|470149121|FG004|Main Phase|Withdrawal criteria|0|||
130597645|NCT01480180|470149122|FG005|Main Phase|Withdrawal criteria|0|||
130597646|NCT01480180|470149117|FG000|Main Phase|Lack of Efficacy|1|||
130597647|NCT01480180|470149118|FG001|Main Phase|Lack of Efficacy|0|||
130597648|NCT01480180|470149119|FG002|Main Phase|Lack of Efficacy|0|||
130597649|NCT01480180|470149120|FG003|Main Phase|Lack of Efficacy|0|||
130597650|NCT01480180|470149121|FG004|Main Phase|Lack of Efficacy|0|||
130597651|NCT01480180|470149122|FG005|Main Phase|Lack of Efficacy|0|||
130597652|NCT01480180|470149117|FG000|Main Phase|Non-compliance|3|||
130597653|NCT01480180|470149118|FG001|Main Phase|Non-compliance|0|||
130597654|NCT01480180|470149119|FG002|Main Phase|Non-compliance|0|||
130597655|NCT01480180|470149120|FG003|Main Phase|Non-compliance|0|||
130597656|NCT01480180|470149121|FG004|Main Phase|Non-compliance|0|||
130597657|NCT01480180|470149122|FG005|Main Phase|Non-compliance|0|||
130597658|NCT01480180|470149117|FG000|Main Phase|Unclassified|3|||
130597659|NCT01480180|470149118|FG001|Main Phase|Unclassified|0|||
130597660|NCT01480180|470149119|FG002|Main Phase|Unclassified|0|||
130597661|NCT01480180|470149120|FG003|Main Phase|Unclassified|0|||
130597662|NCT01480180|470149121|FG004|Main Phase|Unclassified|0|||
130597663|NCT01480180|470149122|FG005|Main Phase|Unclassified|0|||
130597664|NCT01480180|470149117|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
130597665|NCT01480180|470149118|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
130597666|NCT01480180|470149119|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
130597667|NCT01480180|470149120|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
130597668|NCT01480180|470149121|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
130597669|NCT01480180|470149122|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
130597670|NCT01480180|470149117|FG000|Extension Phase, Part 1|Unclassified|0|||
130597671|NCT01480180|470149118|FG001|Extension Phase, Part 1|Unclassified|0|||
130597672|NCT01480180|470149119|FG002|Extension Phase, Part 1|Unclassified|1|||
130597673|NCT01480180|470149120|FG003|Extension Phase, Part 1|Unclassified|0|||
130597674|NCT01480180|470149121|FG004|Extension Phase, Part 1|Unclassified|0|||
130597675|NCT01480180|470149122|FG005|Extension Phase, Part 1|Unclassified|0|||
130597676|NCT01480180|470149117|FG000|Extension Phase, Part 1|Adverse Event|0|||
130597677|NCT01480180|470149118|FG001|Extension Phase, Part 1|Adverse Event|0|||
130597678|NCT01480180|470149119|FG002|Extension Phase, Part 1|Adverse Event|4|||
130597679|NCT01480180|470149120|FG003|Extension Phase, Part 1|Adverse Event|1|||
130597680|NCT01480180|470149121|FG004|Extension Phase, Part 1|Adverse Event|0|||
130597681|NCT01480180|470149122|FG005|Extension Phase, Part 1|Adverse Event|0|||
130597682|NCT01480180|470149117|FG000|Extension Phase, Part 1|Change of treatment|0|||
130597683|NCT01480180|470149118|FG001|Extension Phase, Part 1|Change of treatment|0|||
130597684|NCT01480180|470149119|FG002|Extension Phase, Part 1|Change of treatment|0|||
130597685|NCT01480180|470149120|FG003|Extension Phase, Part 1|Change of treatment|9|||
130597686|NCT01480180|470149121|FG004|Extension Phase, Part 1|Change of treatment|0|||
130597687|NCT01480180|470149122|FG005|Extension Phase, Part 1|Change of treatment|0|||
130597688|NCT01480180|470149117|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
130597689|NCT01480180|470149118|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
130597690|NCT01480180|470149119|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
130597691|NCT01480180|470149120|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
130597692|NCT01480180|470149121|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
130597693|NCT01480180|470149122|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
130597694|NCT01480180|470149117|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
130597695|NCT01480180|470149118|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
130597696|NCT01480180|470149119|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
130597697|NCT01480180|470149120|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
130597698|NCT01480180|470149121|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
130597699|NCT01480180|470149122|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
130597700|NCT01480180|470149117|FG000|Extension Phase, Part 2|Unclassified|0|||
130597701|NCT01480180|470149118|FG001|Extension Phase, Part 2|Unclassified|0|||
130597702|NCT01480180|470149119|FG002|Extension Phase, Part 2|Unclassified|3|||
130597703|NCT01480180|470149120|FG003|Extension Phase, Part 2|Unclassified|1|||
130597704|NCT01480180|470149121|FG004|Extension Phase, Part 2|Unclassified|1|||
130597705|NCT01480180|470149122|FG005|Extension Phase, Part 2|Unclassified|0|||
130597706|NCT01919411|470149127|FG000|Overall Study|Lost to Follow-up|2|||
130597707|NCT01919411|470149128|FG001|Overall Study|Lost to Follow-up|4|||
130597708|NCT01919411|470149127|FG000|Overall Study|Physician Decision|1|||
130597709|NCT01919411|470149128|FG001|Overall Study|Physician Decision|0|||
130597710|NCT01919411|470149127|FG000|Overall Study|Protocol Violation|2|||
130597711|NCT01919411|470149128|FG001|Overall Study|Protocol Violation|1|||
130597712|NCT01650805|470149129|FG000|Overall Study|Withdrawal by Subject|1|||
130597713|NCT01650805|470149130|FG001|Overall Study|Withdrawal by Subject|0|||
130597714|NCT01887210|470149131|FG000|Overall Study|Withdrawal by Subject|1|||
130597715|NCT01887210|470149132|FG001|Overall Study|Withdrawal by Subject|3|||
130597716|NCT01887210|470149131|FG000|Overall Study|Lost to Follow-up|0|||
130597717|NCT01887210|470149132|FG001|Overall Study|Lost to Follow-up|1|||
130597718|NCT00840463|470149133|FG000|Overall Study|Adverse Event|1|||
130597719|NCT00840463|470149134|FG001|Overall Study|Adverse Event|0|||
130597720|NCT02452359|470149135|FG000|Overall Study|Adverse Event|1|||
130597721|NCT02452359|470149135|FG000|Overall Study|Lost to Follow-up|15|||
130597722|NCT02452359|470149135|FG000|Overall Study|Pregnancy|1|||
130597723|NCT02452359|470149135|FG000|Overall Study|Withdrawal by Subject|4|||
130597724|NCT02515669|470149140|FG000|228 Week Open-Label Phase|Other|0|||
130597725|NCT02515669|470149141|FG001|228 Week Open-Label Phase|Other|0|||
130597726|NCT02515669|470149142|FG002|228 Week Open-Label Phase|Other|1|||
130597727|NCT02515669|470149143|FG003|228 Week Open-Label Phase|Other|4|||
130597728|NCT02515669|470149140|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
130597729|NCT02515669|470149141|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
130597730|NCT02515669|470149142|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
130597731|NCT02515669|470149143|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
130597732|NCT02515669|470149140|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
130597733|NCT02515669|470149141|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
130597734|NCT02515669|470149142|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
130597735|NCT02515669|470149143|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
130597736|NCT02515669|470149140|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
130597737|NCT02515669|470149141|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
130597738|NCT02515669|470149142|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
130597739|NCT02515669|470149143|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
130597740|NCT02515669|470149140|FG000|228 Week Open-Label Phase|Missing|0|||
130597741|NCT02515669|470149141|FG001|228 Week Open-Label Phase|Missing|2|||
130597742|NCT02515669|470149142|FG002|228 Week Open-Label Phase|Missing|2|||
130597743|NCT02515669|470149143|FG003|228 Week Open-Label Phase|Missing|2|||
130597744|NCT03750838|470149144|FG000|Overall Study|Lost to Follow-up|10|||
130597745|NCT03750838|470149145|FG001|Overall Study|Lost to Follow-up|6|||
130597746|NCT00630032|470149149|FG000|Overall Study|Death|55|||
130597747|NCT00630032|470149150|FG001|Overall Study|Death|49|||
130597748|NCT00630032|470149149|FG000|Overall Study|Withdrawal by Subject|3|||
130597749|NCT00630032|470149150|FG001|Overall Study|Withdrawal by Subject|2|||
130597750|NCT00630032|470149149|FG000|Overall Study|Lost to Follow-up|18|||
130597751|NCT00630032|470149150|FG001|Overall Study|Lost to Follow-up|31|||
130597752|NCT00630032|470149149|FG000|Overall Study|Protocol Violation|1|||
130597753|NCT00630032|470149150|FG001|Overall Study|Protocol Violation|0|||
130597754|NCT00630032|470149149|FG000|Overall Study|Patient has moved|1|||
130597755|NCT00630032|470149150|FG001|Overall Study|Patient has moved|1|||
130597756|NCT00630032|470149149|FG000|Overall Study|Disease progression|1|||
130597757|NCT00630032|470149150|FG001|Overall Study|Disease progression|1|||
130597758|NCT00630032|470149149|FG000|Overall Study|End of monitoring in US centers|11|||
130597759|NCT00630032|470149150|FG001|Overall Study|End of monitoring in US centers|11|||
130597760|NCT03439345|470150499|FG000|Overall Study|Lost to Follow-up|0|||
130597761|NCT03439345|470150500|FG001|Overall Study|Lost to Follow-up|1|||
130597762|NCT03439345|470150499|FG000|Overall Study|Consent withdrawn|0|||
130597763|NCT03439345|470150500|FG001|Overall Study|Consent withdrawn|1|||
130597764|NCT05635838|470150503|FG000|16-Week DBVC Period|Adverse Event|2|||
130597765|NCT05635838|470150504|FG001|16-Week DBVC Period|Adverse Event|0|||
130597766|NCT05635838|470150505|FG002|16-Week DBVC Period|Adverse Event|0|||
130597767|NCT05635838|470150506|FG003|16-Week DBVC Period|Adverse Event|0|||
130597768|NCT05635838|470150503|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
130597769|NCT05635838|470150504|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
130597770|NCT05635838|470150505|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
130597771|NCT05635838|470150506|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
130597772|NCT05635838|470150503|FG000|16-Week DBVC Period|Physician Decision|0|||
130597773|NCT05635838|470150504|FG001|16-Week DBVC Period|Physician Decision|1|||
130597774|NCT05635838|470150505|FG002|16-Week DBVC Period|Physician Decision|0|||
130597775|NCT05635838|470150506|FG003|16-Week DBVC Period|Physician Decision|0|||
130597776|NCT05635838|470150503|FG000|16-Week DBVC Period|Protocol Violation|1|||
130597777|NCT05635838|470150504|FG001|16-Week DBVC Period|Protocol Violation|0|||
130597778|NCT05635838|470150505|FG002|16-Week DBVC Period|Protocol Violation|0|||
130597779|NCT05635838|470150506|FG003|16-Week DBVC Period|Protocol Violation|0|||
130597780|NCT05635838|470150503|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
130597781|NCT05635838|470150504|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
130597782|NCT05635838|470150505|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
130597783|NCT05635838|470150506|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
130597784|NCT05635838|470150503|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
130597785|NCT05635838|470150504|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130597786|NCT05635838|470150505|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130597787|NCT05635838|470150506|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130597788|NCT05635838|470150503|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
130597789|NCT05635838|470150504|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
130597790|NCT05635838|470150505|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
130597791|NCT05635838|470150506|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
130597792|NCT05635838|470150503|FG000|16-Week OLE Period|Adverse Event|0|||
130597793|NCT05635838|470150504|FG001|16-Week OLE Period|Adverse Event|0|||
130597794|NCT05635838|470150505|FG002|16-Week OLE Period|Adverse Event|0|||
130597795|NCT05635838|470150506|FG003|16-Week OLE Period|Adverse Event|2|||
130597796|NCT05635838|470150503|FG000|16-Week OLE Period|Lost to Follow-up|0|||
130597797|NCT05635838|470150504|FG001|16-Week OLE Period|Lost to Follow-up|0|||
130597798|NCT05635838|470150505|FG002|16-Week OLE Period|Lost to Follow-up|1|||
130597799|NCT05635838|470150506|FG003|16-Week OLE Period|Lost to Follow-up|3|||
130597800|NCT05635838|470150503|FG000|16-Week OLE Period|Physician Decision|0|||
130597801|NCT05635838|470150504|FG001|16-Week OLE Period|Physician Decision|0|||
130597802|NCT05635838|470150505|FG002|16-Week OLE Period|Physician Decision|0|||
130597803|NCT05635838|470150506|FG003|16-Week OLE Period|Physician Decision|1|||
130597804|NCT05635838|470150503|FG000|16-Week OLE Period|Protocol Violation|0|||
130597805|NCT05635838|470150504|FG001|16-Week OLE Period|Protocol Violation|0|||
130597806|NCT05635838|470150505|FG002|16-Week OLE Period|Protocol Violation|1|||
130597807|NCT05635838|470150506|FG003|16-Week OLE Period|Protocol Violation|1|||
130597808|NCT05635838|470150503|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
130597809|NCT05635838|470150504|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
130597810|NCT05635838|470150505|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
130597811|NCT05635838|470150506|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
130597812|NCT05635838|470150503|FG000|16-Week OLE Period|Pregnancy|0|||
130597813|NCT05635838|470150504|FG001|16-Week OLE Period|Pregnancy|0|||
130597814|NCT05635838|470150505|FG002|16-Week OLE Period|Pregnancy|1|||
130597815|NCT05635838|470150506|FG003|16-Week OLE Period|Pregnancy|0|||
130597816|NCT05165394|470150508|FG000|Overall Study|Withdrawal by Subject|5|||
130597817|NCT05165394|470150509|FG001|Overall Study|Withdrawal by Subject|1|||
130597818|NCT05165394|470150508|FG000|Overall Study|Lost to Follow-up|1|||
130597819|NCT05165394|470150509|FG001|Overall Study|Lost to Follow-up|2|||
130597820|NCT05165394|470150508|FG000|Overall Study|Other Than Specified|0|||
130597821|NCT05165394|470150509|FG001|Overall Study|Other Than Specified|1|||
130597822|NCT00875420|470150511|FG000|Overall Study|Adverse Event|0|||
130597823|NCT00875420|470150512|FG001|Overall Study|Adverse Event|1|||
130597824|NCT00875420|470150513|FG002|Overall Study|Adverse Event|1|||
130597825|NCT00875420|470150514|FG003|Overall Study|Adverse Event|0|||
130597826|NCT00875420|470150515|FG004|Overall Study|Adverse Event|0|||
130597827|NCT00875420|470150511|FG000|Overall Study|Inability to complete study procedures|1|||
130597828|NCT00875420|470150512|FG001|Overall Study|Inability to complete study procedures|0|||
130597829|NCT00875420|470150513|FG002|Overall Study|Inability to complete study procedures|1|||
130597830|NCT00875420|470150514|FG003|Overall Study|Inability to complete study procedures|1|||
130597831|NCT00875420|470150515|FG004|Overall Study|Inability to complete study procedures|1|||
130597832|NCT00875420|470150511|FG000|Overall Study|Lost to Follow-up|1|||
130597833|NCT00875420|470150512|FG001|Overall Study|Lost to Follow-up|0|||
130597834|NCT00875420|470150513|FG002|Overall Study|Lost to Follow-up|0|||
130597835|NCT00875420|470150514|FG003|Overall Study|Lost to Follow-up|0|||
130597836|NCT00875420|470150515|FG004|Overall Study|Lost to Follow-up|0|||
130597837|NCT00875420|470150511|FG000|Overall Study|Personal reason|0|||
130597838|NCT00875420|470150512|FG001|Overall Study|Personal reason|0|||
130597839|NCT00875420|470150513|FG002|Overall Study|Personal reason|0|||
130597840|NCT00875420|470150514|FG003|Overall Study|Personal reason|0|||
130597841|NCT00875420|470150515|FG004|Overall Study|Personal reason|1|||
130597842|NCT00875420|470150511|FG000|Overall Study|Prohibited medication|0|||
130597843|NCT00875420|470150512|FG001|Overall Study|Prohibited medication|0|||
130597844|NCT00875420|470150513|FG002|Overall Study|Prohibited medication|0|||
130597845|NCT00875420|470150514|FG003|Overall Study|Prohibited medication|1|||
130597846|NCT00875420|470150515|FG004|Overall Study|Prohibited medication|0|||
130597847|NCT00875420|470150511|FG000|Overall Study|Sponsor decision|0|||
130597848|NCT00875420|470150512|FG001|Overall Study|Sponsor decision|1|||
130597849|NCT00875420|470150513|FG002|Overall Study|Sponsor decision|0|||
130597850|NCT00875420|470150514|FG003|Overall Study|Sponsor decision|0|||
130597851|NCT00875420|470150515|FG004|Overall Study|Sponsor decision|0|||
130597852|NCT00875420|470150511|FG000|Overall Study|Withdrawal by Subject|0|||
130597853|NCT00875420|470150512|FG001|Overall Study|Withdrawal by Subject|0|||
130597854|NCT00875420|470150513|FG002|Overall Study|Withdrawal by Subject|1|||
130597855|NCT00875420|470150514|FG003|Overall Study|Withdrawal by Subject|0|||
130597856|NCT00875420|470150515|FG004|Overall Study|Withdrawal by Subject|0|||
130597857|NCT00001259|470150518|FG000|Study 2|Adverse Event|0|||
130597858|NCT00001259|470150519|FG001|Study 2|Adverse Event|0|||
130597859|NCT00001259|470150520|FG002|Study 2|Adverse Event|0|||
130597860|NCT00001259|470150521|FG003|Study 2|Adverse Event|0|||
130597861|NCT00001259|470150522|FG004|Study 2|Adverse Event|2|||
130597862|NCT00001259|470150523|FG005|Study 2|Adverse Event|0|||
130597863|NCT00001259|470150524|FG006|Study 2|Adverse Event|0|||
130597864|NCT03705494|470150525|FG000|Overall Study|Lost to Follow-up|2|||
130597865|NCT03705494|470150526|FG001|Overall Study|Lost to Follow-up|1|||
130597866|NCT03705494|470150525|FG000|Overall Study|Withdrawal by Subject|5|||
130597867|NCT03705494|470150526|FG001|Overall Study|Withdrawal by Subject|2|||
130597868|NCT02629393|470150532|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
130597869|NCT02629393|470150532|FG000|Overall Study|Physician Decision|1|||
130597870|NCT02089737|470150534|FG000|Overall Study|Survey form not completed|5|||
130597871|NCT02089737|470150534|FG000|Overall Study|Not treated|1|||
130597872|NCT01362322|470150539|FG000|Overall Study|Withdrawal by Subject|3|||
130597873|NCT01362322|470150540|FG001|Overall Study|Withdrawal by Subject|1|||
130597874|NCT01362322|470150539|FG000|Overall Study|Lost to Follow-up|2|||
130597875|NCT01362322|470150540|FG001|Overall Study|Lost to Follow-up|6|||
130597876|NCT02413398|470150543|FG000|Overall Study|Lost to Follow-up|2|||
130597877|NCT02413398|470150544|FG001|Overall Study|Lost to Follow-up|4|||
130597878|NCT02413398|470150543|FG000|Overall Study|Withdrawal by Subject|1|||
130597879|NCT02413398|470150544|FG001|Overall Study|Withdrawal by Subject|1|||
130597880|NCT02413398|470150543|FG000|Overall Study|Other Eligibility criteria|1|||
130597881|NCT02413398|470150544|FG001|Overall Study|Other Eligibility criteria|2|||
130597882|NCT02286960|470150565|FG000|Overall Study|Lost to Follow-up|3|||
130597883|NCT02286960|470150566|FG001|Overall Study|Lost to Follow-up|3|||
130597884|NCT00440401|470150567|FG000|Overall Study|Adverse Event|2|||
130597885|NCT00440401|470150568|FG001|Overall Study|Adverse Event|1|||
130597886|NCT00440401|470150567|FG000|Overall Study|Other|2|||
130597887|NCT00440401|470150568|FG001|Overall Study|Other|5|||
130597888|NCT00091793|470150569|FG000|Overall Study|Adverse Event|1|||
130597889|NCT00091793|470150570|FG001|Overall Study|Adverse Event|2|||
130597890|NCT00091793|470150569|FG000|Overall Study|Withdrawal by Subject|10|||
130597891|NCT00091793|470150570|FG001|Overall Study|Withdrawal by Subject|15|||
130597892|NCT00091793|470150569|FG000|Overall Study|Ineligibility determined|2|||
130597893|NCT00091793|470150570|FG001|Overall Study|Ineligibility determined|0|||
130597894|NCT00091793|470150569|FG000|Overall Study|Lost to Follow-up|7|||
130597895|NCT00091793|470150570|FG001|Overall Study|Lost to Follow-up|5|||
130597896|NCT00091793|470150569|FG000|Overall Study|Noncompliance|2|||
130597897|NCT00091793|470150570|FG001|Overall Study|Noncompliance|0|||
130597898|NCT00091793|470150569|FG000|Overall Study|Other|2|||
130597899|NCT00091793|470150570|FG001|Overall Study|Other|0|||
130597900|NCT00550238|470150571|FG000|Overall Study|Adverse Event|88|||
130597901|NCT00550238|470150571|FG000|Overall Study|Death|34|||
130597902|NCT00550238|470150571|FG000|Overall Study|Disease progression|46|||
130597903|NCT00550238|470150571|FG000|Overall Study|Withdrawal by Subject|167|||
130597904|NCT00550238|470150571|FG000|Overall Study|Physician Decision|31|||
130597905|NCT00550238|470150571|FG000|Overall Study|Patient noncompliance|25|||
130597906|NCT00550238|470150571|FG000|Overall Study|Lost to Follow-up|13|||
130597907|NCT00550238|470150571|FG000|Overall Study|Sponsor decision|55|||
130597908|NCT00184054|470150574|FG000|Overall Study|Adverse Event|1|||
130597909|NCT01591330|470150577|FG000|Period 1|Adverse Event|1|||
130597910|NCT01591330|470150578|FG001|Period 1|Adverse Event|0|||
130597911|NCT01591330|470150579|FG002|Period 1|Adverse Event|0|||
130597912|NCT01591330|470150580|FG003|Period 1|Adverse Event|0|||
130597913|NCT01591330|470150577|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
130597914|NCT01591330|470150578|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130597915|NCT01591330|470150579|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130597916|NCT01591330|470150580|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130597917|NCT01591330|470150577|FG000|Period 2|Adverse Event|1|||
130597918|NCT01591330|470150578|FG001|Period 2|Adverse Event|0|||
130597919|NCT01591330|470150579|FG002|Period 2|Adverse Event|0|||
130597920|NCT01591330|470150580|FG003|Period 2|Adverse Event|0|||
130597921|NCT04800315|470150584|FG000|Randomization|Did not receive study treatment|1|||
130597922|NCT04800315|470150585|FG001|Randomization|Did not receive study treatment|0|||
130597923|NCT04800315|470150586|FG002|Randomization|Did not receive study treatment|0|||
130597924|NCT04800315|470150587|FG003|Randomization|Did not receive study treatment|0|||
130597925|NCT04800315|470150584|FG000|Treatment Period|Adverse Event|4|||
130597926|NCT04800315|470150585|FG001|Treatment Period|Adverse Event|2|||
130597927|NCT04800315|470150586|FG002|Treatment Period|Adverse Event|1|||
130597928|NCT04800315|470150587|FG003|Treatment Period|Adverse Event|2|||
130597929|NCT04800315|470150584|FG000|Treatment Period|Lack of Efficacy|1|||
130597930|NCT04800315|470150585|FG001|Treatment Period|Lack of Efficacy|0|||
130597931|NCT04800315|470150586|FG002|Treatment Period|Lack of Efficacy|0|||
130597932|NCT04800315|470150587|FG003|Treatment Period|Lack of Efficacy|3|||
130597933|NCT04800315|470150584|FG000|Treatment Period|Lost to Follow-up|0|||
130597934|NCT04800315|470150585|FG001|Treatment Period|Lost to Follow-up|1|||
130597935|NCT04800315|470150586|FG002|Treatment Period|Lost to Follow-up|2|||
130597936|NCT04800315|470150587|FG003|Treatment Period|Lost to Follow-up|2|||
130597937|NCT04800315|470150584|FG000|Treatment Period|Withdrawal by participant|0|||
130597938|NCT04800315|470150585|FG001|Treatment Period|Withdrawal by participant|0|||
130597939|NCT04800315|470150586|FG002|Treatment Period|Withdrawal by participant|0|||
130597940|NCT04800315|470150587|FG003|Treatment Period|Withdrawal by participant|4|||
130597941|NCT04800315|470150584|FG000|Treatment Period|Other Reasons|0|||
130597942|NCT04800315|470150585|FG001|Treatment Period|Other Reasons|2|||
130597943|NCT04800315|470150586|FG002|Treatment Period|Other Reasons|0|||
130597944|NCT04800315|470150587|FG003|Treatment Period|Other Reasons|1|||
130597945|NCT00753922|470150588|FG000|Overall Study|Lost to Follow-up|155|||
130597946|NCT00753922|470150589|FG001|Overall Study|Lost to Follow-up|24|||
130597947|NCT00753922|470150590|FG002|Overall Study|Lost to Follow-up|28|||
130597948|NCT00753922|470150591|FG003|Overall Study|Lost to Follow-up|5|||
130597949|NCT00753922|470150588|FG000|Overall Study|Withdrawal by Subject|9|||
130597950|NCT00753922|470150589|FG001|Overall Study|Withdrawal by Subject|11|||
130597951|NCT00753922|470150590|FG002|Overall Study|Withdrawal by Subject|4|||
130597952|NCT00753922|470150591|FG003|Overall Study|Withdrawal by Subject|2|||
130597953|NCT00753922|470150588|FG000|Overall Study|Patient Non-compliance|55|||
130597954|NCT00753922|470150589|FG001|Overall Study|Patient Non-compliance|22|||
130597955|NCT00753922|470150590|FG002|Overall Study|Patient Non-compliance|14|||
130597956|NCT00753922|470150591|FG003|Overall Study|Patient Non-compliance|11|||
130597957|NCT00753922|470150588|FG000|Overall Study|Patients Not Completing Visit|11|||
130597958|NCT00753922|470150589|FG001|Overall Study|Patients Not Completing Visit|0|||
130597959|NCT00753922|470150590|FG002|Overall Study|Patients Not Completing Visit|1|||
130597960|NCT00753922|470150591|FG003|Overall Study|Patients Not Completing Visit|0|||
130597961|NCT00753922|470150588|FG000|Overall Study|Death|2|||
130597962|NCT00753922|470150589|FG001|Overall Study|Death|23|||
130597963|NCT00753922|470150590|FG002|Overall Study|Death|2|||
130597964|NCT00753922|470150591|FG003|Overall Study|Death|1|||
130597965|NCT00753922|470150588|FG000|Overall Study|Discontinuation Due to Explantation|14|||
130597966|NCT00753922|470150589|FG001|Overall Study|Discontinuation Due to Explantation|14|||
130597967|NCT00753922|470150590|FG002|Overall Study|Discontinuation Due to Explantation|14|||
130597968|NCT00753922|470150591|FG003|Overall Study|Discontinuation Due to Explantation|4|||
130597969|NCT02932267|470150592|FG000|Overall Study|Withdrawal by Subject|3|||
130597970|NCT02932267|470150592|FG000|Overall Study|Lost to Follow-up|4|||
130597971|NCT02932267|470150592|FG000|Overall Study|Pregnancy|1|||
130597972|NCT02453841|470150595|FG000|Overall Study|Protocol Violation|1|||
130597973|NCT02453841|470150595|FG000|Overall Study|Unable to obtain blood samples|2|||
130597974|NCT02190591|470150596|FG000|Overall Study|Withdrawal by Subject|1|||
130597975|NCT02190591|470150597|FG001|Overall Study|Withdrawal by Subject|8|||
130597976|NCT02190591|470150596|FG000|Overall Study|Protocol Violation|1|||
130597977|NCT02190591|470150597|FG001|Overall Study|Protocol Violation|0|||
130597978|NCT02190591|470150596|FG000|Overall Study|did not use peanut ball as instructed|0|||
130597979|NCT02190591|470150597|FG001|Overall Study|did not use peanut ball as instructed|2|||
130597980|NCT02190591|470150596|FG000|Overall Study|face presentation so she was ineligible|0|||
130597981|NCT02190591|470150597|FG001|Overall Study|face presentation so she was ineligible|1|||
130597982|NCT03851510|470150598|FG000|Overall Study|Screen Fail|1|||
130597983|NCT03851510|470150598|FG000|Overall Study|Adverse Event|1|||
130597984|NCT03851510|470150598|FG000|Overall Study|Withdrawal by Subject|1|||
130597985|NCT03598777|470150599|FG000|Overall Study|Study Terminated by Sponsor|3|||
130597986|NCT03598777|470150600|FG001|Overall Study|Study Terminated by Sponsor|0|||
130597987|NCT03598777|470150601|FG002|Overall Study|Study Terminated by Sponsor|0|||
130597988|NCT03598777|470150602|FG003|Overall Study|Study Terminated by Sponsor|0|||
130597989|NCT03598777|470150603|FG004|Overall Study|Study Terminated by Sponsor|15|||
130597990|NCT03598777|470150599|FG000|Overall Study|Withdrawal by Subject|1|||
130597991|NCT03598777|470150600|FG001|Overall Study|Withdrawal by Subject|1|||
130597992|NCT03598777|470150601|FG002|Overall Study|Withdrawal by Subject|0|||
130597993|NCT03598777|470150602|FG003|Overall Study|Withdrawal by Subject|0|||
130597994|NCT03598777|470150603|FG004|Overall Study|Withdrawal by Subject|0|||
130597995|NCT03598777|470150599|FG000|Overall Study|Adverse Event|1|||
130597996|NCT03598777|470150600|FG001|Overall Study|Adverse Event|0|||
130597997|NCT03598777|470150601|FG002|Overall Study|Adverse Event|0|||
130597998|NCT03598777|470150602|FG003|Overall Study|Adverse Event|0|||
130597999|NCT03598777|470150603|FG004|Overall Study|Adverse Event|0|||
130598000|NCT03598777|470150599|FG000|Overall Study|Lost to Follow-up|1|||
130598001|NCT03598777|470150600|FG001|Overall Study|Lost to Follow-up|0|||
130598002|NCT03598777|470150601|FG002|Overall Study|Lost to Follow-up|0|||
130598003|NCT03598777|470150602|FG003|Overall Study|Lost to Follow-up|0|||
130598004|NCT03598777|470150603|FG004|Overall Study|Lost to Follow-up|0|||
130598005|NCT00072189|470150604|FG000|Overall Study|Withdrawal by Subject|1|||
130598006|NCT00144300|470150605|FG000|Overall Study|Adverse Event|18|||
130598007|NCT00144300|470150606|FG001|Overall Study|Adverse Event|16|||
130598008|NCT00144300|470150605|FG000|Overall Study|Protocol Violation|1|||
130598009|NCT00144300|470150606|FG001|Overall Study|Protocol Violation|3|||
130598010|NCT00144300|470150605|FG000|Overall Study|Lost to Follow-up|3|||
130598011|NCT00144300|470150606|FG001|Overall Study|Lost to Follow-up|0|||
130598012|NCT00144300|470150605|FG000|Overall Study|Withdrawal by Subject|6|||
130598013|NCT00144300|470150606|FG001|Overall Study|Withdrawal by Subject|6|||
130598014|NCT00144300|470150605|FG000|Overall Study|Other reason (not specified)|1|||
130598015|NCT00144300|470150606|FG001|Overall Study|Other reason (not specified)|3|||
130598016|NCT01933672|470150609|FG000|Metformin Run-in Period|Adverse Event|1|||
130598017|NCT01933672|470150610|FG001|Metformin Run-in Period|Adverse Event|0|||
130598018|NCT01933672|470150611|FG002|Metformin Run-in Period|Adverse Event|0|||
130598019|NCT01933672|470150612|FG003|Metformin Run-in Period|Adverse Event|0|||
130598020|NCT01933672|470150613|FG004|Metformin Run-in Period|Adverse Event|0|||
130598021|NCT01933672|470150614|FG005|Metformin Run-in Period|Adverse Event|0|||
130598022|NCT01933672|470150615|FG006|Metformin Run-in Period|Adverse Event|0|||
130598023|NCT01933672|470150609|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
130598024|NCT01933672|470150610|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598025|NCT01933672|470150611|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598026|NCT01933672|470150612|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598027|NCT01933672|470150613|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598028|NCT01933672|470150614|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598029|NCT01933672|470150615|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130598030|NCT01933672|470150609|FG000|Metformin Run-in Period|Other|5|||
130598031|NCT01933672|470150610|FG001|Metformin Run-in Period|Other|0|||
130598032|NCT01933672|470150611|FG002|Metformin Run-in Period|Other|0|||
130598033|NCT01933672|470150612|FG003|Metformin Run-in Period|Other|0|||
130598034|NCT01933672|470150613|FG004|Metformin Run-in Period|Other|0|||
130598035|NCT01933672|470150614|FG005|Metformin Run-in Period|Other|0|||
130598036|NCT01933672|470150615|FG006|Metformin Run-in Period|Other|0|||
130598037|NCT01933672|470150609|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598038|NCT01933672|470150610|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598039|NCT01933672|470150611|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598040|NCT01933672|470150612|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598041|NCT01933672|470150613|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
130598042|NCT01933672|470150614|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598043|NCT01933672|470150615|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598044|NCT01933672|470150609|FG000|First Intervention Period (12-16 Days)|Other|0|||
130598045|NCT01933672|470150610|FG001|First Intervention Period (12-16 Days)|Other|0|||
130598046|NCT01933672|470150611|FG002|First Intervention Period (12-16 Days)|Other|1|||
130598047|NCT01933672|470150612|FG003|First Intervention Period (12-16 Days)|Other|0|||
130598048|NCT01933672|470150613|FG004|First Intervention Period (12-16 Days)|Other|0|||
130598049|NCT01933672|470150614|FG005|First Intervention Period (12-16 Days)|Other|1|||
130598050|NCT01933672|470150615|FG006|First Intervention Period (12-16 Days)|Other|0|||
130598051|NCT01933672|470150609|FG000|Second Intervention Period (12-16 Days)|Other|0|||
130598052|NCT01933672|470150610|FG001|Second Intervention Period (12-16 Days)|Other|1|||
130598053|NCT01933672|470150611|FG002|Second Intervention Period (12-16 Days)|Other|1|||
130598054|NCT01933672|470150612|FG003|Second Intervention Period (12-16 Days)|Other|0|||
130598055|NCT01933672|470150613|FG004|Second Intervention Period (12-16 Days)|Other|0|||
130598056|NCT01933672|470150614|FG005|Second Intervention Period (12-16 Days)|Other|0|||
130598057|NCT01933672|470150615|FG006|Second Intervention Period (12-16 Days)|Other|0|||
130598058|NCT01933672|470150609|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598059|NCT01933672|470150610|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598060|NCT01933672|470150611|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598061|NCT01933672|470150612|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
130598062|NCT01933672|470150613|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598063|NCT01933672|470150614|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598064|NCT01933672|470150615|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130598065|NCT01933672|470150609|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598066|NCT01933672|470150610|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
130598067|NCT01933672|470150611|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598068|NCT01933672|470150612|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598069|NCT01933672|470150613|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598070|NCT01933672|470150614|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598071|NCT01933672|470150615|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130598072|NCT02426086|470150617|FG000|Overall Study|Death|33|||
130598073|NCT02426086|470150618|FG001|Overall Study|Death|36|||
130598074|NCT02426086|470150617|FG000|Overall Study|Lost to Follow-up|2|||
130598075|NCT02426086|470150618|FG001|Overall Study|Lost to Follow-up|0|||
130598076|NCT02426086|470150617|FG000|Overall Study|Study Terminated by Sponsor|5|||
130598077|NCT02426086|470150618|FG001|Overall Study|Study Terminated by Sponsor|14|||
130598078|NCT02426086|470150617|FG000|Overall Study|Withdrawal by Subject|8|||
130598079|NCT02426086|470150618|FG001|Overall Study|Withdrawal by Subject|9|||
130598080|NCT00524303|470150619|FG000|Overall Study|Lost to Follow-up|6|||
130598081|NCT00524303|470150620|FG001|Overall Study|Lost to Follow-up|0|||
130598082|NCT00524303|470150621|FG002|Overall Study|Lost to Follow-up|3|||
130598083|NCT00524303|470150619|FG000|Overall Study|Protocol Violation|0|||
130598084|NCT00524303|470150620|FG001|Overall Study|Protocol Violation|1|||
130598085|NCT00524303|470150621|FG002|Overall Study|Protocol Violation|1|||
130598086|NCT00524303|470150619|FG000|Overall Study|Withdrawal by Subject|3|||
130598087|NCT00524303|470150620|FG001|Overall Study|Withdrawal by Subject|0|||
130598088|NCT00524303|470150621|FG002|Overall Study|Withdrawal by Subject|4|||
130598089|NCT00524303|470150619|FG000|Overall Study|Death|0|||
130598090|NCT00524303|470150620|FG001|Overall Study|Death|2|||
130598091|NCT00524303|470150621|FG002|Overall Study|Death|3|||
130598092|NCT00524303|470150619|FG000|Overall Study|Adverse Event|1|||
130598093|NCT00524303|470150620|FG001|Overall Study|Adverse Event|2|||
130598094|NCT00524303|470150621|FG002|Overall Study|Adverse Event|3|||
130598095|NCT00524303|470150619|FG000|Overall Study|Did not Complete Study Dosing|1|||
130598096|NCT00524303|470150620|FG001|Overall Study|Did not Complete Study Dosing|0|||
130598097|NCT00524303|470150621|FG002|Overall Study|Did not Complete Study Dosing|0|||
130598098|NCT00524303|470150619|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
130598099|NCT00524303|470150620|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
130598100|NCT00524303|470150621|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
130598101|NCT00524303|470150619|FG000|Overall Study|Disease Progression|0|||
130598102|NCT00524303|470150620|FG001|Overall Study|Disease Progression|4|||
130598103|NCT00524303|470150621|FG002|Overall Study|Disease Progression|1|||
130598104|NCT00524303|470150619|FG000|Overall Study|Disease Recurrence|0|||
130598105|NCT00524303|470150620|FG001|Overall Study|Disease Recurrence|1|||
130598106|NCT00524303|470150621|FG002|Overall Study|Disease Recurrence|0|||
130598107|NCT00524303|470150619|FG000|Overall Study|Sponsor Request|0|||
130598108|NCT00524303|470150620|FG001|Overall Study|Sponsor Request|0|||
130598109|NCT00524303|470150621|FG002|Overall Study|Sponsor Request|1|||
130598110|NCT00524303|470150619|FG000|Overall Study|Physician Decision|0|||
130598111|NCT00524303|470150620|FG001|Overall Study|Physician Decision|0|||
130598112|NCT00524303|470150621|FG002|Overall Study|Physician Decision|1|||
130598113|NCT00524303|470150619|FG000|Overall Study|Completed 5 years|0|||
130598114|NCT00524303|470150620|FG001|Overall Study|Completed 5 years|0|||
130598115|NCT00524303|470150621|FG002|Overall Study|Completed 5 years|1|||
130598116|NCT01769404|470150630|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
130598117|NCT01769404|470150631|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
130598118|NCT01769404|470150630|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130598119|NCT01769404|470150631|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130598120|NCT01769404|470150630|FG000|Treatment Period 1|Sponsor decision|1|||
130598121|NCT01769404|470150631|FG001|Treatment Period 1|Sponsor decision|0|||
130598122|NCT01769404|470150630|FG000|Treatment Period 2|Sponsor decision|7|||
130598123|NCT01769404|470150631|FG001|Treatment Period 2|Sponsor decision|0|||
130598124|NCT00538733|470150632|FG000|Overall Study|Adverse Event|8|||
130598125|NCT00538733|470150632|FG000|Overall Study|Death|1|||
130598126|NCT00538733|470150632|FG000|Overall Study|declined to participate|2|||
130598127|NCT00538733|470150632|FG000|Overall Study|still on therapy|1|||
130598128|NCT00095121|470150635|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
130598129|NCT00095121|470150636|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
130598130|NCT00095121|470150635|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
130598131|NCT00095121|470150636|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
130598132|NCT03167619|470152534|FG000|Overall Study|Death|11|||
130598133|NCT03167619|470152535|FG001|Overall Study|Death|8|||
130598134|NCT03167619|470152534|FG000|Overall Study|Withdrawal by Subject|1|||
130598135|NCT03167619|470152535|FG001|Overall Study|Withdrawal by Subject|2|||
130598136|NCT03167619|470152534|FG000|Overall Study|Physician Decision|0|||
130598137|NCT03167619|470152535|FG001|Overall Study|Physician Decision|1|||
130598138|NCT02082184|470152536|FG000|Overall Study|Adverse Event|1|||
130598139|NCT02082184|470152537|FG001|Overall Study|Adverse Event|0|||
130598140|NCT02082184|470152536|FG000|Overall Study|Medical diagnosis|1|||
130598141|NCT02082184|470152537|FG001|Overall Study|Medical diagnosis|2|||
130598142|NCT02082184|470152536|FG000|Overall Study|Device associated symptoms|5|||
130598143|NCT02082184|470152537|FG001|Overall Study|Device associated symptoms|0|||
130598144|NCT02082184|470152536|FG000|Overall Study|Withdrawal by Subject|3|||
130598145|NCT02082184|470152537|FG001|Overall Study|Withdrawal by Subject|2|||
130598146|NCT02082184|470152536|FG000|Overall Study|Protocol Violation|0|||
130598147|NCT02082184|470152537|FG001|Overall Study|Protocol Violation|6|||
130598148|NCT02082184|470152536|FG000|Overall Study|Lost to Follow-up|0|||
130598149|NCT02082184|470152537|FG001|Overall Study|Lost to Follow-up|2|||
130598150|NCT02082184|470152536|FG000|Overall Study|Subject non-compliance|0|||
130598151|NCT02082184|470152537|FG001|Overall Study|Subject non-compliance|1|||
130598152|NCT01062399|470152540|FG000|Overall Study|Protocol Violation|0|||
130598153|NCT01062399|470152541|FG001|Overall Study|Protocol Violation|1|||
130598154|NCT01062399|470152542|FG002|Overall Study|Protocol Violation|0|||
130598155|NCT01062399|470152543|FG003|Overall Study|Protocol Violation|6|||
130598156|NCT01062399|470152544|FG004|Overall Study|Protocol Violation|4|||
130598157|NCT05299892|470152550|FG000|Overall Study|Withdrawal by Subject|2|||
130598158|NCT02397655|470152551|FG000|Overall Study|data not completed|1301|||
130598159|NCT03334214|470152552|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130598160|NCT03334214|470152553|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130598161|NCT03334214|470152552|FG000|Overall Study|Withdrawal by Subject|0|||
130598162|NCT03334214|470152553|FG001|Overall Study|Withdrawal by Subject|1|||
130598163|NCT03334214|470152552|FG000|Overall Study|Other|1|||
130598164|NCT03334214|470152553|FG001|Overall Study|Other|0|||
130598165|NCT00474253|470152557|FG000|Overall Study|Withdrew consent|2|||
130598166|NCT00474253|470152558|FG001|Overall Study|Withdrew consent|0|||
130598167|NCT00474253|470152557|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
130598168|NCT00474253|470152558|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
130598169|NCT00474253|470152557|FG000|Overall Study|Lost to Follow-up|1|||
130598170|NCT00474253|470152558|FG001|Overall Study|Lost to Follow-up|0|||
130598171|NCT00474253|470152557|FG000|Overall Study|Discharged prior to study completion|0|||
130598172|NCT00474253|470152558|FG001|Overall Study|Discharged prior to study completion|1|||
130598173|NCT03133481|470152559|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
130598174|NCT03133481|470152560|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
130598175|NCT00637728|470152571|FG000|Double-blind Phase|Adverse Event|1|||
130598176|NCT00637728|470152572|FG001|Double-blind Phase|Adverse Event|0|||
130598177|NCT00637728|470152573|FG002|Double-blind Phase|Adverse Event|0|||
130598178|NCT00637728|470152571|FG000|Double-blind Phase|Non-compliance|2|||
130598179|NCT00637728|470152572|FG001|Double-blind Phase|Non-compliance|0|||
130598180|NCT00637728|470152573|FG002|Double-blind Phase|Non-compliance|0|||
130598181|NCT00637728|470152571|FG000|Double-blind Phase|Study Discontinued|1|||
130598182|NCT00637728|470152572|FG001|Double-blind Phase|Study Discontinued|1|||
130598183|NCT00637728|470152573|FG002|Double-blind Phase|Study Discontinued|0|||
130598184|NCT02723630|470152574|FG000|Intervention Period 1|Adverse Event|1|||
130598185|NCT02723630|470152575|FG001|Intervention Period 1|Adverse Event|0|||
130598186|NCT02723630|470152576|FG002|Intervention Period 1|Adverse Event|0|||
130598187|NCT02723630|470152577|FG003|Intervention Period 1|Adverse Event|0|||
130598188|NCT02723630|470152578|FG004|Intervention Period 1|Adverse Event|0|||
130598189|NCT02723630|470152579|FG005|Intervention Period 1|Adverse Event|0|||
130598190|NCT02723630|470152574|FG000|Intervention Period 3|consumption of restricted item|0|||
130598191|NCT02723630|470152575|FG001|Intervention Period 3|consumption of restricted item|1|||
130598192|NCT02723630|470152576|FG002|Intervention Period 3|consumption of restricted item|0|||
130598193|NCT02723630|470152577|FG003|Intervention Period 3|consumption of restricted item|0|||
130598194|NCT02723630|470152578|FG004|Intervention Period 3|consumption of restricted item|0|||
130598195|NCT02723630|470152579|FG005|Intervention Period 3|consumption of restricted item|0|||
130598196|NCT00779038|470152580|FG000|Overall Study|Study Prematurely Terminated|13|||
130598197|NCT00537745|470152581|FG000|Overall Study|Did not meet eligibility criteria|2|||
130598198|NCT00537745|470152581|FG000|Overall Study|Withdrawal by Subject|2|||
130598199|NCT00537745|470152581|FG000|Overall Study|Subject unable to provide Interlock info|1|||
130598200|NCT01184989|470152582|FG000|Overall Study|Adverse Event|11|||
130598201|NCT01184989|470152582|FG000|Overall Study|Withdrawal by Subject|1|||
130598202|NCT01570491|470152583|FG000|Overall Study|Lost to Follow-up|3|||
130598203|NCT01570491|470152584|FG001|Overall Study|Lost to Follow-up|1|||
130598204|NCT01570491|470152583|FG000|Overall Study|treatment: not given or discontinued|2|||
130598205|NCT01570491|470152584|FG001|Overall Study|treatment: not given or discontinued|0|||
130598206|NCT03047213|470152585|FG000|Overall Study|Withdrawal by Subject|2|||
130598207|NCT03047213|470152586|FG001|Overall Study|Withdrawal by Subject|0|||
130598208|NCT03047213|470152585|FG000|Overall Study|Adverse Event|2|||
130598209|NCT03047213|470152586|FG001|Overall Study|Adverse Event|0|||
130598210|NCT00482001|470152587|FG000|Overall Study|Protocol Violation|1|||
130598211|NCT00482001|470152588|FG001|Overall Study|Protocol Violation|1|||
130598212|NCT05370157|470152591|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
130598213|NCT05370157|470152592|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
130598214|NCT05370157|470152591|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
130598215|NCT05370157|470152592|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
130598216|NCT03700892|470152593|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
130598217|NCT03700892|470152594|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
130598218|NCT03700892|470152595|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
130598219|NCT00258154|470152603|FG000|Overall Study|Adverse Event|1|||
130598220|NCT00258154|470152604|FG001|Overall Study|Adverse Event|0|||
130598221|NCT00258154|470152603|FG000|Overall Study|Lost to Follow-up|0|||
130598222|NCT00258154|470152604|FG001|Overall Study|Lost to Follow-up|1|||
130598223|NCT00258154|470152603|FG000|Overall Study|Protocol Violation|2|||
130598224|NCT00258154|470152604|FG001|Overall Study|Protocol Violation|1|||
130598225|NCT00258154|470152603|FG000|Overall Study|Withdrawal by Subject|3|||
130598226|NCT00258154|470152604|FG001|Overall Study|Withdrawal by Subject|4|||
130598227|NCT00258154|470152603|FG000|Overall Study|Patient Moved|3|||
130598228|NCT00258154|470152604|FG001|Overall Study|Patient Moved|1|||
130598229|NCT00754390|470152609|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
130598230|NCT00754390|470152609|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
130598231|NCT00754390|470152609|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
130598232|NCT00754390|470152609|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
130598233|NCT01009294|470152610|FG000|Overall Study|Study discontinued by Sponsor|6|||
130598234|NCT01856673|470152611|FG000|Overall Study|Withdrawal by Subject|44|||
130598235|NCT01856673|470152612|FG001|Overall Study|Withdrawal by Subject|50|||
130598236|NCT01856673|470152613|FG002|Overall Study|Withdrawal by Subject|33|||
130598237|NCT01856673|470152611|FG000|Overall Study|Lost to Follow-up|31|||
130598238|NCT01856673|470152612|FG001|Overall Study|Lost to Follow-up|34|||
130598239|NCT01856673|470152613|FG002|Overall Study|Lost to Follow-up|0|||
130598240|NCT01856673|470152611|FG000|Overall Study|Unknown reasons|9|||
130598241|NCT01856673|470152612|FG001|Overall Study|Unknown reasons|0|||
130598242|NCT01856673|470152613|FG002|Overall Study|Unknown reasons|0|||
130598243|NCT01856673|470152611|FG000|Overall Study|Psychologist decision|1|||
130598244|NCT01856673|470152612|FG001|Overall Study|Psychologist decision|0|||
130598245|NCT01856673|470152613|FG002|Overall Study|Psychologist decision|0|||
130598246|NCT01856673|470152611|FG000|Overall Study|Paperwork errors|8|||
130598247|NCT01856673|470152612|FG001|Overall Study|Paperwork errors|0|||
130598248|NCT01856673|470152613|FG002|Overall Study|Paperwork errors|0|||
130598249|NCT01856673|470152611|FG000|Overall Study|Death|1|||
130598250|NCT01856673|470152612|FG001|Overall Study|Death|1|||
130598251|NCT01856673|470152613|FG002|Overall Study|Death|0|||
130598252|NCT01856673|470152611|FG000|Overall Study|Protocol Violation|1|||
130598253|NCT01856673|470152612|FG001|Overall Study|Protocol Violation|0|||
130598254|NCT01856673|470152613|FG002|Overall Study|Protocol Violation|1|||
130598255|NCT04332419|470152614|FG000|Overall Study|Withdrawal by Subject|1|||
130598256|NCT04222725|470152617|FG000|Overall Study|Adverse Event|0|||
130598257|NCT04222725|470152618|FG001|Overall Study|Adverse Event|1|||
130598258|NCT04222725|470152619|FG002|Overall Study|Adverse Event|0|||
130598259|NCT04222725|470152620|FG003|Overall Study|Adverse Event|0|||
130598260|NCT04925570|470152621|FG000|Overall Study|Protocol Violation|24|||
130598261|NCT04925570|470152622|FG001|Overall Study|Protocol Violation|30|||
130598262|NCT04925570|470152621|FG000|Overall Study|Withdrawal by Subject|0|||
130598263|NCT04925570|470152622|FG001|Overall Study|Withdrawal by Subject|2|||
130598264|NCT00658333|470152623|FG000|Overall Study|Adverse Event|2|||
130598265|NCT00658333|470152624|FG001|Overall Study|Adverse Event|1|||
130598266|NCT00828451|470152625|FG000|Overall Study|Death|2|||
130598267|NCT00828451|470152625|FG000|Overall Study|Lack of intravenous line|7|||
130598268|NCT00828451|470152625|FG000|Overall Study|Withdrawal by Subject|1|||
130598269|NCT00828451|470152625|FG000|Overall Study|Deterioration in clinical status|1|||
130598270|NCT00667277|470152628|FG000|Overall Study|Withdrawal by Subject|2|||
130598271|NCT00519532|470152629|FG000|Overall Study|Adverse Event|11|||
130598272|NCT00519532|470152629|FG000|Overall Study|Withdrawal by Subject|5|||
130598273|NCT00519532|470152629|FG000|Overall Study|Lost to Follow-up|2|||
130598274|NCT05121103|470152630|FG000|Overall Study|Progressive disease|2|||
130598275|NCT05121103|470152631|FG001|Overall Study|Progressive disease|1|||
130598276|NCT05121103|470152632|FG002|Overall Study|Progressive disease|6|||
130598277|NCT05121103|470152630|FG000|Overall Study|Physician Decision|2|||
130598278|NCT05121103|470152631|FG001|Overall Study|Physician Decision|1|||
130598279|NCT05121103|470152632|FG002|Overall Study|Physician Decision|0|||
130598280|NCT05121103|470152630|FG000|Overall Study|Withdrawal by Subject|0|||
130598281|NCT05121103|470152631|FG001|Overall Study|Withdrawal by Subject|1|||
130598282|NCT05121103|470152632|FG002|Overall Study|Withdrawal by Subject|0|||
130598283|NCT03138564|470152633|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
130598284|NCT03138564|470152634|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
130598285|NCT03138564|470152633|FG000|Overall Study|Lost to Follow-up|16|||
130598286|NCT03138564|470152634|FG001|Overall Study|Lost to Follow-up|2|||
130598287|NCT03138564|470152633|FG000|Overall Study|Withdrawal by Subject|48|||
130598288|NCT03138564|470152634|FG001|Overall Study|Withdrawal by Subject|4|||
130598289|NCT03138564|470152633|FG000|Overall Study|No longer met eligibility criteria|2|||
130598290|NCT03138564|470152634|FG001|Overall Study|No longer met eligibility criteria|0|||
130598291|NCT03138564|470152633|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
130598292|NCT03138564|470152634|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
130598293|NCT03138564|470152633|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
130598294|NCT03138564|470152634|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
130598295|NCT03138564|470152633|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
130598296|NCT03138564|470152634|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
130598297|NCT03138564|470152633|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
130598298|NCT03138564|470152634|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
130598299|NCT00814710|470152635|FG000|Overall Study|Adverse Event|1|||
130598300|NCT00814710|470152636|FG001|Overall Study|Adverse Event|0|||
130598301|NCT00814710|470152635|FG000|Overall Study|Lost to Follow-up|7|||
130598302|NCT00814710|470152636|FG001|Overall Study|Lost to Follow-up|3|||
130598303|NCT03443024|470152637|FG000|Overall Study|Adverse Event|2|||
130598304|NCT03443024|470152638|FG001|Overall Study|Adverse Event|4|||
130598305|NCT03443024|470152639|FG002|Overall Study|Adverse Event|3|||
130598306|NCT03443024|470152640|FG003|Overall Study|Adverse Event|1|||
130598307|NCT03443024|470152637|FG000|Overall Study|Lost to Follow-up|9|||
130598308|NCT03443024|470152638|FG001|Overall Study|Lost to Follow-up|9|||
130598309|NCT03443024|470152639|FG002|Overall Study|Lost to Follow-up|7|||
130598310|NCT03443024|470152640|FG003|Overall Study|Lost to Follow-up|5|||
130598311|NCT03443024|470152637|FG000|Overall Study|Withdrawal by Subject|8|||
130598312|NCT03443024|470152638|FG001|Overall Study|Withdrawal by Subject|15|||
130598313|NCT03443024|470152639|FG002|Overall Study|Withdrawal by Subject|9|||
130598314|NCT03443024|470152640|FG003|Overall Study|Withdrawal by Subject|23|||
130598315|NCT03443024|470152637|FG000|Overall Study|Physician Decision|1|||
130598316|NCT03443024|470152638|FG001|Overall Study|Physician Decision|2|||
130598317|NCT03443024|470152639|FG002|Overall Study|Physician Decision|0|||
130598318|NCT03443024|470152640|FG003|Overall Study|Physician Decision|1|||
130598319|NCT03443024|470152637|FG000|Overall Study|Sponsor Decision|1|||
130598320|NCT03443024|470152638|FG001|Overall Study|Sponsor Decision|1|||
130598321|NCT03443024|470152639|FG002|Overall Study|Sponsor Decision|0|||
130598322|NCT03443024|470152640|FG003|Overall Study|Sponsor Decision|0|||
130598323|NCT03443024|470152637|FG000|Overall Study|Protocol Deviation|0|||
130598324|NCT03443024|470152638|FG001|Overall Study|Protocol Deviation|0|||
130598325|NCT03443024|470152639|FG002|Overall Study|Protocol Deviation|0|||
130598326|NCT03443024|470152640|FG003|Overall Study|Protocol Deviation|2|||
130598327|NCT00624338|470152642|FG000|Overall Study|Adverse Event|14|||
130598328|NCT00624338|470152643|FG001|Overall Study|Adverse Event|14|||
130598329|NCT00624338|470152644|FG002|Overall Study|Adverse Event|18|||
130598330|NCT00624338|470152642|FG000|Overall Study|Lost to Follow-up|1|||
130598331|NCT00624338|470152643|FG001|Overall Study|Lost to Follow-up|0|||
130598332|NCT00624338|470152644|FG002|Overall Study|Lost to Follow-up|0|||
130598333|NCT00624338|470152642|FG000|Overall Study|Lack of Efficacy|11|||
130598334|NCT00624338|470152643|FG001|Overall Study|Lack of Efficacy|3|||
130598335|NCT00624338|470152644|FG002|Overall Study|Lack of Efficacy|14|||
130598336|NCT00624338|470152642|FG000|Overall Study|Protocol Violation|3|||
130598337|NCT00624338|470152643|FG001|Overall Study|Protocol Violation|3|||
130598338|NCT00624338|470152644|FG002|Overall Study|Protocol Violation|2|||
130598339|NCT00624338|470152642|FG000|Overall Study|Death|0|||
130598340|NCT00624338|470152643|FG001|Overall Study|Death|2|||
130598341|NCT00624338|470152644|FG002|Overall Study|Death|0|||
130598342|NCT00624338|470152642|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
130598343|NCT00624338|470152643|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
130598344|NCT00624338|470152644|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
130598345|NCT00624338|470152642|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
130598346|NCT00624338|470152643|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
130598347|NCT00624338|470152644|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
130598348|NCT00624338|470152642|FG000|Overall Study|Other|15|||
130598349|NCT00624338|470152643|FG001|Overall Study|Other|5|||
130598350|NCT00624338|470152644|FG002|Overall Study|Other|9|||
130598351|NCT00624338|470152642|FG000|Overall Study|Randomized but not treated|2|||
130598352|NCT00624338|470152643|FG001|Overall Study|Randomized but not treated|1|||
130598353|NCT00624338|470152644|FG002|Overall Study|Randomized but not treated|3|||
130598354|NCT01548638|470152645|FG000|Overall Study|Protocol Violation|3|||
130598355|NCT01548638|470152645|FG000|Overall Study|Withdrawal by Subject|1|||
130598356|NCT05593432|470152646|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
130598357|NCT05593432|470152647|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
130598358|NCT05593432|470152648|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
130598359|NCT05593432|470152649|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
130598360|NCT05593432|470152646|FG000|16-Week OLE Period|Lack of Efficacy|0|||
130598361|NCT05593432|470152647|FG001|16-Week OLE Period|Lack of Efficacy|0|||
130598362|NCT05593432|470152648|FG002|16-Week OLE Period|Lack of Efficacy|0|||
130598363|NCT05593432|470152649|FG003|16-Week OLE Period|Lack of Efficacy|1|||
130598364|NCT05593432|470152646|FG000|16-Week OLE Period|Lost to Follow-up|0|||
130598365|NCT05593432|470152647|FG001|16-Week OLE Period|Lost to Follow-up|0|||
130598366|NCT05593432|470152648|FG002|16-Week OLE Period|Lost to Follow-up|1|||
130598367|NCT05593432|470152649|FG003|16-Week OLE Period|Lost to Follow-up|2|||
130598368|NCT05593432|470152646|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
130598369|NCT05593432|470152647|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
130598370|NCT05593432|470152648|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
130598371|NCT05593432|470152649|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
130598372|NCT03885284|470152650|FG000|Overall Study|Disease Progression|1|||
130598373|NCT03885284|470152651|FG001|Overall Study|Disease Progression|3|||
130598374|NCT03885284|470152650|FG000|Overall Study|Physician Decision|0|||
130598375|NCT03885284|470152651|FG001|Overall Study|Physician Decision|1|||
130598376|NCT05897853|470152654|FG000|Overall Study|Lost to Follow-up|2|||
130598377|NCT05897853|470152655|FG001|Overall Study|Lost to Follow-up|0|||
130598378|NCT05897853|470152654|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
130598379|NCT05897853|470152655|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
130598380|NCT02609399|470152662|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
130598381|NCT02609399|470152663|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
130598382|NCT02609399|470152662|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
130598383|NCT02609399|470152663|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
130598384|NCT02609399|470152662|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
130598385|NCT02609399|470152663|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
130598386|NCT04458857|470152664|FG000|Overall Study|Adverse Event|0|||
130598387|NCT04458857|470152665|FG001|Overall Study|Adverse Event|1|||
130598388|NCT04458857|470152666|FG002|Overall Study|Adverse Event|0|||
130598389|NCT04458857|470152664|FG000|Overall Study|Withdrawal by Subject|2|||
130598390|NCT04458857|470152665|FG001|Overall Study|Withdrawal by Subject|0|||
130598391|NCT04458857|470152666|FG002|Overall Study|Withdrawal by Subject|0|||
130598392|NCT04458857|470152664|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130598393|NCT04458857|470152665|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130598394|NCT04458857|470152666|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130598395|NCT04458857|470152664|FG000|Overall Study|Non-compliance with study drug|0|||
130598396|NCT04458857|470152665|FG001|Overall Study|Non-compliance with study drug|1|||
130598397|NCT04458857|470152666|FG002|Overall Study|Non-compliance with study drug|0|||
130598398|NCT04458857|470152664|FG000|Overall Study|Lost to Follow-up|4|||
130598399|NCT04458857|470152665|FG001|Overall Study|Lost to Follow-up|1|||
130598400|NCT04458857|470152666|FG002|Overall Study|Lost to Follow-up|0|||
130598401|NCT02986373|470152667|FG000|Overall Study|Adverse Event|4|||
130598402|NCT02986373|470152667|FG000|Overall Study|Lost to Follow-up|1|||
130598403|NCT02986373|470152667|FG000|Overall Study|Withdrawal by Subject|10|||
130598404|NCT02986373|470152667|FG000|Overall Study|Other|24|||
130598405|NCT01151137|470152670|FG000|Overall Study|Death|15|||
130598406|NCT01151137|470152671|FG001|Overall Study|Death|27|||
130598407|NCT01151137|470152670|FG000|Overall Study|Lost to Follow-up|1|||
130598408|NCT01151137|470152671|FG001|Overall Study|Lost to Follow-up|1|||
130598409|NCT03414359|470152672|FG000|Overall Study|Lack of Efficacy|1|||
130598410|NCT03414359|470152673|FG001|Overall Study|Lack of Efficacy|1|||
130598411|NCT03414359|470152672|FG000|Overall Study|Protocol Violation|0|||
130598412|NCT03414359|470152673|FG001|Overall Study|Protocol Violation|1|||
130598413|NCT02273973|470152676|FG000|Overall Study|Adverse Event|4|||
130598414|NCT02273973|470152677|FG001|Overall Study|Adverse Event|0|||
130598415|NCT02273973|470152676|FG000|Overall Study|Withdrawal by Subject|2|||
130598416|NCT02273973|470152677|FG001|Overall Study|Withdrawal by Subject|3|||
130598417|NCT02273973|470152676|FG000|Overall Study|Death|1|||
130598418|NCT02273973|470152677|FG001|Overall Study|Death|0|||
130598419|NCT02273973|470152676|FG000|Overall Study|Non-compliance|1|||
130598420|NCT02273973|470152677|FG001|Overall Study|Non-compliance|0|||
130598421|NCT02273973|470152676|FG000|Overall Study|Protocol Violation|1|||
130598422|NCT02273973|470152677|FG001|Overall Study|Protocol Violation|0|||
130598423|NCT02273973|470152676|FG000|Overall Study|Progression of disease|0|||
130598424|NCT02273973|470152677|FG001|Overall Study|Progression of disease|2|||
130598425|NCT02273973|470152676|FG000|Overall Study|Lost to Follow-up|0|||
130598426|NCT02273973|470152677|FG001|Overall Study|Lost to Follow-up|1|||
130598427|NCT02273973|470152676|FG000|Overall Study|Physician Decision|0|||
130598428|NCT02273973|470152677|FG001|Overall Study|Physician Decision|1|||
130598429|NCT02273973|470152676|FG000|Overall Study|Reason not specified|0|||
130598430|NCT02273973|470152677|FG001|Overall Study|Reason not specified|1|||
130598431|NCT01739595|470152678|FG000|Overall Study|Adverse Event|3|||
130598432|NCT01739595|470152679|FG001|Overall Study|Adverse Event|0|||
130598433|NCT01739595|470152680|FG002|Overall Study|Adverse Event|0|||
130598434|NCT01739595|470152678|FG000|Overall Study|Lost to Follow-up|2|||
130598435|NCT01739595|470152679|FG001|Overall Study|Lost to Follow-up|0|||
130598436|NCT01739595|470152680|FG002|Overall Study|Lost to Follow-up|0|||
130598437|NCT01739595|470152678|FG000|Overall Study|Withdrawal by Subject|2|||
130598438|NCT01739595|470152679|FG001|Overall Study|Withdrawal by Subject|1|||
130598439|NCT01739595|470152680|FG002|Overall Study|Withdrawal by Subject|2|||
130598440|NCT01739595|470152678|FG000|Overall Study|Eligibility issue|3|||
130598441|NCT01739595|470152679|FG001|Overall Study|Eligibility issue|0|||
130598442|NCT01739595|470152680|FG002|Overall Study|Eligibility issue|0|||
130598443|NCT01739595|470152678|FG000|Overall Study|Protocol Violation|1|||
130598444|NCT01739595|470152679|FG001|Overall Study|Protocol Violation|0|||
130598445|NCT01739595|470152680|FG002|Overall Study|Protocol Violation|0|||
130598446|NCT01739595|470152678|FG000|Overall Study|Lab assessment|1|||
130598447|NCT01739595|470152679|FG001|Overall Study|Lab assessment|0|||
130598448|NCT01739595|470152680|FG002|Overall Study|Lab assessment|0|||
130598449|NCT01739595|470152678|FG000|Overall Study|Drug discrepancy|1|||
130598450|NCT01739595|470152679|FG001|Overall Study|Drug discrepancy|0|||
130598451|NCT01739595|470152680|FG002|Overall Study|Drug discrepancy|0|||
130598452|NCT01282814|470152681|FG000|First Intervention|Emesis During Dosing Interval|0|||
130598453|NCT01282814|470152682|FG001|First Intervention|Emesis During Dosing Interval|3|||
130598454|NCT01282814|470152681|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
130598455|NCT01282814|470152682|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130598456|NCT00957372|470152683|FG000|PART I|Lost to Follow-up|0|||
130598457|NCT00957372|470152684|FG001|PART I|Lost to Follow-up|0|||
130598458|NCT00957372|470152685|FG002|PART I|Lost to Follow-up|1|||
130598459|NCT00957372|470152686|FG003|PART I|Lost to Follow-up|0|||
130598460|NCT00957372|470152683|FG000|PART II|Withdrawal by Subject|0|||
130598461|NCT00957372|470152684|FG001|PART II|Withdrawal by Subject|0|||
130598462|NCT00957372|470152685|FG002|PART II|Withdrawal by Subject|0|||
130598463|NCT00957372|470152686|FG003|PART II|Withdrawal by Subject|8|||
130598464|NCT00957372|470152683|FG000|PART II|Physician Decision|0|||
130598465|NCT00957372|470152684|FG001|PART II|Physician Decision|0|||
130598466|NCT00957372|470152685|FG002|PART II|Physician Decision|0|||
130598467|NCT00957372|470152686|FG003|PART II|Physician Decision|1|||
130598468|NCT00957372|470152683|FG000|PART II|Pregnancy|0|||
130598469|NCT00957372|470152684|FG001|PART II|Pregnancy|0|||
130598470|NCT00957372|470152685|FG002|PART II|Pregnancy|0|||
130598471|NCT00957372|470152686|FG003|PART II|Pregnancy|1|||
130598472|NCT00957372|470152683|FG000|PART II|Not Know|0|||
130598473|NCT00957372|470152684|FG001|PART II|Not Know|0|||
130598474|NCT00957372|470152685|FG002|PART II|Not Know|0|||
130598475|NCT00957372|470152686|FG003|PART II|Not Know|20|||
130598476|NCT00957372|470152683|FG000|PART II|Adverse Event|0|||
130598477|NCT00957372|470152684|FG001|PART II|Adverse Event|0|||
130598478|NCT00957372|470152685|FG002|PART II|Adverse Event|0|||
130598479|NCT00957372|470152686|FG003|PART II|Adverse Event|10|||
130598480|NCT00957372|470152683|FG000|PART II|Patient non-compliance|0|||
130598481|NCT00957372|470152684|FG001|PART II|Patient non-compliance|0|||
130598482|NCT00957372|470152685|FG002|PART II|Patient non-compliance|0|||
130598483|NCT00957372|470152686|FG003|PART II|Patient non-compliance|4|||
130598484|NCT02403206|470152687|FG000|Overall Study|Lost to Follow-up|4|||
130598485|NCT02403206|470152688|FG001|Overall Study|Lost to Follow-up|3|||
130598486|NCT02403206|470152687|FG000|Overall Study|Physician Decision|2|||
130598487|NCT02403206|470152688|FG001|Overall Study|Physician Decision|0|||
130598488|NCT02403206|470152687|FG000|Overall Study|Withdrawal by Subject|3|||
130598489|NCT02403206|470152688|FG001|Overall Study|Withdrawal by Subject|3|||
130598490|NCT02403206|470152687|FG000|Overall Study|Reason not given|2|||
130598491|NCT02403206|470152688|FG001|Overall Study|Reason not given|4|||
130598492|NCT01287117|470152691|FG000|Overall Study|Adverse Event|2|||
130598493|NCT01287117|470152692|FG001|Overall Study|Adverse Event|1|||
130598494|NCT01287117|470152693|FG002|Overall Study|Adverse Event|1|||
130598495|NCT01287117|470152694|FG003|Overall Study|Adverse Event|1|||
130598496|NCT01287117|470152691|FG000|Overall Study|Lost to Follow-up|1|||
130598497|NCT01287117|470152692|FG001|Overall Study|Lost to Follow-up|1|||
130598498|NCT01287117|470152693|FG002|Overall Study|Lost to Follow-up|0|||
130598499|NCT01287117|470152694|FG003|Overall Study|Lost to Follow-up|0|||
130598500|NCT01287117|470152691|FG000|Overall Study|Physician Decision|0|||
130598501|NCT01287117|470152692|FG001|Overall Study|Physician Decision|1|||
130598502|NCT01287117|470152693|FG002|Overall Study|Physician Decision|1|||
130598503|NCT01287117|470152694|FG003|Overall Study|Physician Decision|1|||
130598504|NCT01287117|470152691|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
130598505|NCT01287117|470152692|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
130598506|NCT01287117|470152693|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
130598507|NCT01287117|470152694|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
130598508|NCT01287117|470152691|FG000|Overall Study|Disease Progression|10|||
130598509|NCT01287117|470152692|FG001|Overall Study|Disease Progression|5|||
130598510|NCT01287117|470152693|FG002|Overall Study|Disease Progression|6|||
130598511|NCT01287117|470152694|FG003|Overall Study|Disease Progression|5|||
130598512|NCT01676116|470152695|FG000|Overall Study|Withdrawal criteria|2|||
130598513|NCT01676116|470152696|FG001|Overall Study|Withdrawal criteria|14|||
130598514|NCT01676116|470152695|FG000|Overall Study|Adverse Event|1|||
130598515|NCT01676116|470152696|FG001|Overall Study|Adverse Event|2|||
130598516|NCT01676116|470152695|FG000|Overall Study|Unclassified|4|||
130598517|NCT01676116|470152696|FG001|Overall Study|Unclassified|10|||
130598518|NCT01676116|470152695|FG000|Overall Study|Protocol Violation|9|||
130598519|NCT01676116|470152696|FG001|Overall Study|Protocol Violation|3|||
130598520|NCT00778999|470152703|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
130598521|NCT00778999|470152704|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
130598522|NCT00778999|470152703|FG000|Overall Study|Did not receive recFSH|14|||
130598523|NCT00778999|470152704|FG001|Overall Study|Did not receive recFSH|20|||
130598524|NCT02032524|470152705|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
130598525|NCT02032524|470152706|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
130598526|NCT02032524|470152707|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
130598527|NCT02032524|470152708|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
130598528|NCT02032524|470152709|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
130598529|NCT02032524|470152710|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
130598530|NCT02032524|470152705|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130598531|NCT02032524|470152706|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130598532|NCT02032524|470152707|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130598533|NCT02032524|470152708|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
130598534|NCT02032524|470152709|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130598535|NCT02032524|470152710|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
130598536|NCT02032524|470152705|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
130598537|NCT02032524|470152706|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
130598538|NCT02032524|470152707|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
130598539|NCT02032524|470152708|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
130598540|NCT02032524|470152709|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
130598541|NCT02032524|470152710|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
130598542|NCT02032524|470152705|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130598543|NCT02032524|470152706|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
130598544|NCT02032524|470152707|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130598545|NCT02032524|470152708|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130598546|NCT02032524|470152709|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
130598547|NCT02032524|470152710|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130598548|NCT02032524|470152705|FG000|Period 2: LTS13769 Study|Other|0|||
130598549|NCT02032524|470152706|FG001|Period 2: LTS13769 Study|Other|0|||
130598550|NCT02032524|470152707|FG002|Period 2: LTS13769 Study|Other|0|||
130598551|NCT02032524|470152708|FG003|Period 2: LTS13769 Study|Other|0|||
130598552|NCT02032524|470152709|FG004|Period 2: LTS13769 Study|Other|0|||
130598553|NCT02032524|470152710|FG005|Period 2: LTS13769 Study|Other|1|||
130598554|NCT02975349|470152711|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130598555|NCT02975349|470152712|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130598556|NCT02975349|470152713|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130598557|NCT02975349|470152714|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130598558|NCT02975349|470152715|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130598559|NCT02975349|470152716|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130598560|NCT02975349|470152717|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130598561|NCT02975349|470152711|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130598562|NCT02975349|470152712|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598563|NCT02975349|470152713|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598564|NCT02975349|470152714|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598565|NCT02975349|470152715|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598566|NCT02975349|470152716|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598567|NCT02975349|470152717|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130598568|NCT02975349|470152711|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
130598569|NCT02975349|470152712|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
130598570|NCT02975349|470152713|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
130598571|NCT02975349|470152714|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130598572|NCT02975349|470152715|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130598573|NCT02975349|470152716|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
130598574|NCT02975349|470152717|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130598575|NCT02975349|470152711|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130598576|NCT02975349|470152712|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130598577|NCT02975349|470152713|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130598578|NCT02975349|470152714|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130598579|NCT02975349|470152715|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
130598580|NCT02975349|470152716|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130598581|NCT02975349|470152717|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130598582|NCT02975349|470152711|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130598583|NCT02975349|470152712|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
130598584|NCT02975349|470152713|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130598585|NCT02975349|470152714|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
130598586|NCT02975349|470152715|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
130598587|NCT02975349|470152716|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
130598588|NCT02975349|470152717|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130598589|NCT02975349|470152711|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598590|NCT02975349|470152712|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598591|NCT02975349|470152713|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598592|NCT02975349|470152714|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
130598593|NCT02975349|470152715|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598594|NCT02975349|470152716|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598595|NCT02975349|470152717|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130598596|NCT02975349|470152711|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598597|NCT02975349|470152712|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
130598598|NCT02975349|470152713|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598599|NCT02975349|470152714|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598600|NCT02975349|470152715|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598601|NCT02975349|470152716|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598602|NCT02975349|470152717|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130598603|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
130598604|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
130598605|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
130598606|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130598607|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130598608|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
130598609|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130598610|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598611|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598612|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598613|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598614|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
130598615|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598616|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130598617|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130598618|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130598619|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130598620|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130598621|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
130598622|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130598623|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
130598624|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
130598625|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
130598626|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
130598627|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
130598628|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
130598629|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
130598630|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
130598631|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130598632|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130598633|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130598634|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130598635|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130598636|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130598637|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
130598638|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130598639|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130598640|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
130598641|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130598642|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130598643|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
130598644|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130598645|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
130598646|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
130598647|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
130598648|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
130598649|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
130598650|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
130598651|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
130598652|NCT02975349|470152711|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
130598653|NCT02975349|470152712|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
130598654|NCT02975349|470152713|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
130598655|NCT02975349|470152714|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
130598656|NCT02975349|470152715|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
130598657|NCT02975349|470152716|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
130598658|NCT02975349|470152717|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
130598659|NCT03567187|470152720|FG000|Overall Study|Lost to Follow-up|18|||
130598660|NCT02032875|470152723|FG000|Treatment Period|Adverse Event|1|||
130598661|NCT02032875|470152724|FG001|Treatment Period|Adverse Event|0|||
130598662|NCT02032875|470152723|FG000|Treatment Period|Liver transplant, No extension needed|0|||
130598663|NCT02032875|470152724|FG001|Treatment Period|Liver transplant, No extension needed|1|||
130598664|NCT02032875|470152723|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
130598665|NCT02032875|470152724|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
130598666|NCT02032875|470152723|FG000|Follow-up Period|Death|0|||
130598667|NCT02032875|470152724|FG001|Follow-up Period|Death|1|||
130598668|NCT02032875|470152723|FG000|Follow-up Period|Virologic Relapse|3|||
130598669|NCT02032875|470152724|FG001|Follow-up Period|Virologic Relapse|10|||
130598670|NCT04358458|470152725|FG000|Overall Study|Death|1|||
130598671|NCT04358458|470152726|FG001|Overall Study|Death|1|||
130598672|NCT04358458|470152727|FG002|Overall Study|Death|3|||
130598673|NCT04358458|470152728|FG003|Overall Study|Death|8|||
130598674|NCT04358458|470152729|FG004|Overall Study|Death|1|||
130598675|NCT04358458|470152730|FG005|Overall Study|Death|6|||
130598676|NCT04358458|470152731|FG006|Overall Study|Death|2|||
130598677|NCT04358458|470152732|FG007|Overall Study|Death|3|||
130598678|NCT04358458|470152725|FG000|Overall Study|Lost to Follow-up|0|||
130598679|NCT04358458|470152726|FG001|Overall Study|Lost to Follow-up|0|||
130598680|NCT04358458|470152727|FG002|Overall Study|Lost to Follow-up|0|||
130598681|NCT04358458|470152728|FG003|Overall Study|Lost to Follow-up|0|||
130598682|NCT04358458|470152729|FG004|Overall Study|Lost to Follow-up|0|||
130598683|NCT04358458|470152730|FG005|Overall Study|Lost to Follow-up|0|||
130598684|NCT04358458|470152731|FG006|Overall Study|Lost to Follow-up|0|||
130598685|NCT04358458|470152732|FG007|Overall Study|Lost to Follow-up|1|||
130598686|NCT04358458|470152725|FG000|Overall Study|Site is closing study participation|0|||
130598687|NCT04358458|470152726|FG001|Overall Study|Site is closing study participation|0|||
130598688|NCT04358458|470152727|FG002|Overall Study|Site is closing study participation|0|||
130598689|NCT04358458|470152728|FG003|Overall Study|Site is closing study participation|1|||
130598690|NCT04358458|470152729|FG004|Overall Study|Site is closing study participation|0|||
130598691|NCT04358458|470152730|FG005|Overall Study|Site is closing study participation|0|||
130598692|NCT04358458|470152731|FG006|Overall Study|Site is closing study participation|0|||
130598693|NCT04358458|470152732|FG007|Overall Study|Site is closing study participation|0|||
130598694|NCT04358458|470152725|FG000|Overall Study|Sponsor request|2|||
130598695|NCT04358458|470152726|FG001|Overall Study|Sponsor request|3|||
130598696|NCT04358458|470152727|FG002|Overall Study|Sponsor request|3|||
130598697|NCT04358458|470152728|FG003|Overall Study|Sponsor request|0|||
130598698|NCT04358458|470152729|FG004|Overall Study|Sponsor request|2|||
130598699|NCT04358458|470152730|FG005|Overall Study|Sponsor request|3|||
130598700|NCT04358458|470152731|FG006|Overall Study|Sponsor request|1|||
130598701|NCT04358458|470152732|FG007|Overall Study|Sponsor request|1|||
130598702|NCT04358458|470152725|FG000|Overall Study|Withdrawal by Subject|0|||
130598703|NCT04358458|470152726|FG001|Overall Study|Withdrawal by Subject|0|||
130598704|NCT04358458|470152727|FG002|Overall Study|Withdrawal by Subject|1|||
130598705|NCT04358458|470152728|FG003|Overall Study|Withdrawal by Subject|1|||
130598706|NCT04358458|470152729|FG004|Overall Study|Withdrawal by Subject|0|||
130598707|NCT04358458|470152730|FG005|Overall Study|Withdrawal by Subject|1|||
130598708|NCT04358458|470152731|FG006|Overall Study|Withdrawal by Subject|0|||
130598709|NCT04358458|470152732|FG007|Overall Study|Withdrawal by Subject|1|||
130598710|NCT01266148|470154307|FG000|Overall Study|Adverse Event|2|||
130598711|NCT01266148|470154308|FG001|Overall Study|Adverse Event|0|||
130598712|NCT01266148|470154307|FG000|Overall Study|Ongoing rejection|1|||
130598713|NCT01266148|470154308|FG001|Overall Study|Ongoing rejection|0|||
130598714|NCT01266148|470154307|FG000|Overall Study|2 2R rejections|1|||
130598715|NCT01266148|470154308|FG001|Overall Study|2 2R rejections|0|||
130598716|NCT01266148|470154307|FG000|Overall Study|Death|2|||
130598717|NCT01266148|470154308|FG001|Overall Study|Death|3|||
130598718|NCT01266148|470154307|FG000|Overall Study|missing mGFR value + AE|1|||
130598719|NCT01266148|470154308|FG001|Overall Study|missing mGFR value + AE|0|||
130598720|NCT01853228|470154309|FG000|Phase 1|Lack of Efficacy|8|||
130598721|NCT01853228|470154310|FG001|Phase 1|Lack of Efficacy|0|||
130598722|NCT01853228|470154309|FG000|Phase 1|Other|1|||
130598723|NCT01853228|470154310|FG001|Phase 1|Other|0|||
130598724|NCT01853228|470154309|FG000|Phase 2|Physician Decision|0|||
130598725|NCT01853228|470154310|FG001|Phase 2|Physician Decision|1|||
130598726|NCT01853228|470154309|FG000|Phase 2|Proceed To Transplant|0|||
130598727|NCT01853228|470154310|FG001|Phase 2|Proceed To Transplant|3|||
130598728|NCT01853228|470154309|FG000|Phase 2|Lack of Efficacy|0|||
130598729|NCT01853228|470154310|FG001|Phase 2|Lack of Efficacy|4|||
130598730|NCT01348919|470154312|FG000|Overall Study|Adverse Event|3|||
130598731|NCT01348919|470154313|FG001|Overall Study|Adverse Event|1|||
130598732|NCT01348919|470154314|FG002|Overall Study|Adverse Event|0|||
130598733|NCT01348919|470154312|FG000|Overall Study|Withdrawal by Subject|0|||
130598734|NCT01348919|470154313|FG001|Overall Study|Withdrawal by Subject|1|||
130598735|NCT01348919|470154314|FG002|Overall Study|Withdrawal by Subject|0|||
130598736|NCT01348919|470154312|FG000|Overall Study|Disease progression|0|||
130598737|NCT01348919|470154313|FG001|Overall Study|Disease progression|1|||
130598738|NCT01348919|470154314|FG002|Overall Study|Disease progression|1|||
130598739|NCT04426630|470154315|FG000|Overall Study|Death|4|||
130598740|NCT04426630|470154315|FG000|Overall Study|Lost to Follow-up|2|||
130598741|NCT04328623|470154325|FG000|Overall Study|Protocol Violation|0|||
130598742|NCT04328623|470154326|FG001|Overall Study|Protocol Violation|1|||
130598743|NCT00849693|470154327|FG000|Acute Treatment Phase|Adverse Event|12|||
130598744|NCT00849693|470154328|FG001|Acute Treatment Phase|Adverse Event|7|||
130598745|NCT00849693|470154329|FG002|Acute Treatment Phase|Adverse Event|6|||
130598746|NCT00849693|470154330|FG003|Acute Treatment Phase|Adverse Event|4|||
130598747|NCT00849693|470154327|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
130598748|NCT00849693|470154328|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
130598749|NCT00849693|470154329|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
130598750|NCT00849693|470154330|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
130598751|NCT00849693|470154327|FG000|Acute Treatment Phase|Protocol Violation|1|||
130598752|NCT00849693|470154328|FG001|Acute Treatment Phase|Protocol Violation|5|||
130598753|NCT00849693|470154329|FG002|Acute Treatment Phase|Protocol Violation|2|||
130598754|NCT00849693|470154330|FG003|Acute Treatment Phase|Protocol Violation|6|||
130598755|NCT00849693|470154327|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
130598756|NCT00849693|470154328|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
130598757|NCT00849693|470154329|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
130598758|NCT00849693|470154330|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
130598759|NCT00849693|470154327|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
130598760|NCT00849693|470154328|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
130598761|NCT00849693|470154329|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
130598762|NCT00849693|470154330|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
130598763|NCT00849693|470154327|FG000|Acute Treatment Phase|Physician Decision|2|||
130598764|NCT00849693|470154328|FG001|Acute Treatment Phase|Physician Decision|1|||
130598765|NCT00849693|470154329|FG002|Acute Treatment Phase|Physician Decision|2|||
130598766|NCT00849693|470154330|FG003|Acute Treatment Phase|Physician Decision|1|||
130598767|NCT00849693|470154327|FG000|Acute Treatment Phase|Sponsor decision|0|||
130598768|NCT00849693|470154328|FG001|Acute Treatment Phase|Sponsor decision|0|||
130598769|NCT00849693|470154329|FG002|Acute Treatment Phase|Sponsor decision|1|||
130598770|NCT00849693|470154330|FG003|Acute Treatment Phase|Sponsor decision|0|||
130598771|NCT00849693|470154327|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
130598772|NCT00849693|470154328|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
130598773|NCT00849693|470154329|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
130598774|NCT00849693|470154330|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
130598775|NCT00849693|470154327|FG000|Extension Phase|Adverse Event|4|||
130598776|NCT00849693|470154328|FG001|Extension Phase|Adverse Event|6|||
130598777|NCT00849693|470154329|FG002|Extension Phase|Adverse Event|3|||
130598778|NCT00849693|470154330|FG003|Extension Phase|Adverse Event|7|||
130598779|NCT00849693|470154327|FG000|Extension Phase|Lost to Follow-up|7|||
130598780|NCT00849693|470154328|FG001|Extension Phase|Lost to Follow-up|5|||
130598781|NCT00849693|470154329|FG002|Extension Phase|Lost to Follow-up|6|||
130598782|NCT00849693|470154330|FG003|Extension Phase|Lost to Follow-up|6|||
130598783|NCT00849693|470154327|FG000|Extension Phase|Protocol Violation|0|||
130598784|NCT00849693|470154328|FG001|Extension Phase|Protocol Violation|3|||
130598785|NCT00849693|470154329|FG002|Extension Phase|Protocol Violation|2|||
130598786|NCT00849693|470154330|FG003|Extension Phase|Protocol Violation|3|||
130598787|NCT00849693|470154327|FG000|Extension Phase|Withdrawal by Subject|6|||
130598788|NCT00849693|470154328|FG001|Extension Phase|Withdrawal by Subject|9|||
130598789|NCT00849693|470154329|FG002|Extension Phase|Withdrawal by Subject|10|||
130598790|NCT00849693|470154330|FG003|Extension Phase|Withdrawal by Subject|15|||
130598791|NCT00849693|470154327|FG000|Extension Phase|Parent or caregiver decision|9|||
130598792|NCT00849693|470154328|FG001|Extension Phase|Parent or caregiver decision|4|||
130598793|NCT00849693|470154329|FG002|Extension Phase|Parent or caregiver decision|10|||
130598794|NCT00849693|470154330|FG003|Extension Phase|Parent or caregiver decision|5|||
130598795|NCT00849693|470154327|FG000|Extension Phase|Physician Decision|1|||
130598796|NCT00849693|470154328|FG001|Extension Phase|Physician Decision|1|||
130598797|NCT00849693|470154329|FG002|Extension Phase|Physician Decision|2|||
130598798|NCT00849693|470154330|FG003|Extension Phase|Physician Decision|0|||
130598799|NCT00849693|470154327|FG000|Extension Phase|Sponsor decision|1|||
130598800|NCT00849693|470154328|FG001|Extension Phase|Sponsor decision|0|||
130598801|NCT00849693|470154329|FG002|Extension Phase|Sponsor decision|0|||
130598802|NCT00849693|470154330|FG003|Extension Phase|Sponsor decision|1|||
130598803|NCT00849693|470154327|FG000|Extension Phase|Lack of Efficacy|2|||
130598804|NCT00849693|470154328|FG001|Extension Phase|Lack of Efficacy|2|||
130598805|NCT00849693|470154329|FG002|Extension Phase|Lack of Efficacy|2|||
130598806|NCT00849693|470154330|FG003|Extension Phase|Lack of Efficacy|1|||
130598807|NCT00634543|470154331|FG000|Overall Study|Other|1|||
130598808|NCT00634543|470154332|FG001|Overall Study|Other|2|||
130598809|NCT00634543|470154331|FG000|Overall Study|Protocol Violation|3|||
130598810|NCT00634543|470154332|FG001|Overall Study|Protocol Violation|3|||
130598811|NCT00634543|470154331|FG000|Overall Study|Adverse Event|11|||
130598812|NCT00634543|470154332|FG001|Overall Study|Adverse Event|11|||
130598813|NCT00634543|470154331|FG000|Overall Study|Withdrawal by Subject|4|||
130598814|NCT00634543|470154332|FG001|Overall Study|Withdrawal by Subject|4|||
130598815|NCT00634543|470154331|FG000|Overall Study|Lost to Follow-up|0|||
130598816|NCT00634543|470154332|FG001|Overall Study|Lost to Follow-up|1|||
130598817|NCT00077623|470154333|FG000|Overall Study|Adverse Event|1|||
130598818|NCT00077623|470154334|FG001|Overall Study|Adverse Event|0|||
130598819|NCT00077623|470154335|FG002|Overall Study|Adverse Event|1|||
130598820|NCT00077623|470154333|FG000|Overall Study|Withdrawal by Subject|2|||
130598821|NCT00077623|470154334|FG001|Overall Study|Withdrawal by Subject|10|||
130598822|NCT00077623|470154335|FG002|Overall Study|Withdrawal by Subject|1|||
130598823|NCT00077623|470154333|FG000|Overall Study|Other-Non safety reason|18|||
130598824|NCT00077623|470154334|FG001|Overall Study|Other-Non safety reason|15|||
130598825|NCT00077623|470154335|FG002|Overall Study|Other-Non safety reason|19|||
130598826|NCT00077623|470154333|FG000|Overall Study|Insufficient therapeutic response|2|||
130598827|NCT00077623|470154334|FG001|Overall Study|Insufficient therapeutic response|0|||
130598828|NCT00077623|470154335|FG002|Overall Study|Insufficient therapeutic response|0|||
130598829|NCT00077623|470154333|FG000|Overall Study|Death|12|||
130598830|NCT00077623|470154334|FG001|Overall Study|Death|18|||
130598831|NCT00077623|470154335|FG002|Overall Study|Death|11|||
130598832|NCT00077623|470154333|FG000|Overall Study|Failure to return|1|||
130598833|NCT00077623|470154334|FG001|Overall Study|Failure to return|0|||
130598834|NCT00077623|470154335|FG002|Overall Study|Failure to return|0|||
130598835|NCT02465034|470154336|FG000|Overall Study|Withdrawal by Subject|1|||
130598836|NCT02465034|470154337|FG001|Overall Study|Withdrawal by Subject|1|||
130598837|NCT02465034|470154336|FG000|Overall Study|Screen fail|2|||
130598838|NCT02465034|470154337|FG001|Overall Study|Screen fail|0|||
130598839|NCT02465034|470154336|FG000|Overall Study|Could not be scheduled for study visit|0|||
130598840|NCT02465034|470154337|FG001|Overall Study|Could not be scheduled for study visit|5|||
130598841|NCT02138110|470154341|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
130598842|NCT02138110|470154341|FG000|Overall Scaffold Implantation|Death|3|||
130598843|NCT00882713|470154344|FG000|Overall Study|Adverse Event|2|||
130598844|NCT00882713|470154344|FG000|Overall Study|Death|3|||
130598845|NCT00882713|470154344|FG000|Overall Study|Administrative reasons|4|||
130598846|NCT00882713|470154344|FG000|Overall Study|refused treatment/withdrew consent|4|||
130598847|NCT00882713|470154344|FG000|Overall Study|Blood transfusion|2|||
130598848|NCT00882713|470154344|FG000|Overall Study|Insufficient therapeutic response|3|||
130598849|NCT00882713|470154344|FG000|Overall Study|Failure to return|2|||
130598850|NCT00882713|470154344|FG000|Overall Study|Other - Reasons|2|||
130598851|NCT02760602|470154347|FG000|Overall Study|Withdrawal by Subject|1|||
130598852|NCT02760602|470154348|FG001|Overall Study|Withdrawal by Subject|0|||
130598853|NCT02760602|470154347|FG000|Overall Study|Terminated by sponsor|12|||
130598854|NCT02760602|470154348|FG001|Overall Study|Terminated by sponsor|13|||
130598855|NCT01736683|470154357|FG000|Overall Study|Disease Relapse|0|||
130598856|NCT01736683|470154358|FG001|Overall Study|Disease Relapse|0|||
130598857|NCT01736683|470154359|FG002|Overall Study|Disease Relapse|2|||
130598858|NCT01736683|470154360|FG003|Overall Study|Disease Relapse|1|||
130598859|NCT01736683|470154361|FG004|Overall Study|Disease Relapse|0|||
130598860|NCT01736683|470154357|FG000|Overall Study|Adverse Event|0|||
130598861|NCT01736683|470154358|FG001|Overall Study|Adverse Event|2|||
130598862|NCT01736683|470154359|FG002|Overall Study|Adverse Event|2|||
130598863|NCT01736683|470154360|FG003|Overall Study|Adverse Event|3|||
130598864|NCT01736683|470154361|FG004|Overall Study|Adverse Event|2|||
130598865|NCT01736683|470154357|FG000|Overall Study|Withdrawal by Subject|0|||
130598866|NCT01736683|470154358|FG001|Overall Study|Withdrawal by Subject|0|||
130598867|NCT01736683|470154359|FG002|Overall Study|Withdrawal by Subject|3|||
130598868|NCT01736683|470154360|FG003|Overall Study|Withdrawal by Subject|1|||
130598869|NCT01736683|470154361|FG004|Overall Study|Withdrawal by Subject|1|||
130598870|NCT01736683|470154357|FG000|Overall Study|Lack of Therapeutic Effect|7|||
130598871|NCT01736683|470154358|FG001|Overall Study|Lack of Therapeutic Effect|4|||
130598872|NCT01736683|470154359|FG002|Overall Study|Lack of Therapeutic Effect|13|||
130598873|NCT01736683|470154360|FG003|Overall Study|Lack of Therapeutic Effect|20|||
130598874|NCT01736683|470154361|FG004|Overall Study|Lack of Therapeutic Effect|1|||
130598875|NCT01736683|470154357|FG000|Overall Study|Progressive Disease|0|||
130598876|NCT01736683|470154358|FG001|Overall Study|Progressive Disease|0|||
130598877|NCT01736683|470154359|FG002|Overall Study|Progressive Disease|0|||
130598878|NCT01736683|470154360|FG003|Overall Study|Progressive Disease|1|||
130598879|NCT01736683|470154361|FG004|Overall Study|Progressive Disease|0|||
130598880|NCT01736683|470154357|FG000|Overall Study|Other|0|||
130598881|NCT01736683|470154358|FG001|Overall Study|Other|0|||
130598882|NCT01736683|470154359|FG002|Overall Study|Other|1|||
130598883|NCT01736683|470154360|FG003|Overall Study|Other|9|||
130598884|NCT01736683|470154361|FG004|Overall Study|Other|1|||
130598885|NCT01260181|470154362|FG000|Overall Study|Decision of Investigator|1|||
130598886|NCT01588197|470154365|FG000|Overall Study|Lack of Efficacy|0|||
130598887|NCT01588197|470154366|FG001|Overall Study|Lack of Efficacy|1|||
130598888|NCT01588197|470154365|FG000|Overall Study|No MRI|1|||
130598889|NCT01588197|470154366|FG001|Overall Study|No MRI|0|||
130598890|NCT01844076|470154367|FG000|Overall Study|Adverse Event|1|||
130598891|NCT01844076|470154368|FG001|Overall Study|Adverse Event|0|||
130598892|NCT01844076|470154369|FG002|Overall Study|Adverse Event|0|||
130598893|NCT01844076|470154370|FG003|Overall Study|Adverse Event|0|||
130598894|NCT01844076|470154367|FG000|Overall Study|Withdrawal by Subject|1|||
130598895|NCT01844076|470154368|FG001|Overall Study|Withdrawal by Subject|0|||
130598896|NCT01844076|470154369|FG002|Overall Study|Withdrawal by Subject|0|||
130598897|NCT01844076|470154370|FG003|Overall Study|Withdrawal by Subject|0|||
130598898|NCT00635102|470154373|FG000|Overall Study|Withdrawal by Subject|7|||
130598899|NCT00635102|470154374|FG001|Overall Study|Withdrawal by Subject|8|||
130598900|NCT01938625|470154376|FG000|Overall Study|Withdrawal by Subject|0|||
130598901|NCT01938625|470154377|FG001|Overall Study|Withdrawal by Subject|1|||
130598902|NCT01938625|470154376|FG000|Overall Study|Adverse Event|0|||
130598903|NCT01938625|470154377|FG001|Overall Study|Adverse Event|1|||
130598904|NCT02088034|470154378|FG000|Overall Study|Lost to Follow-up|1|||
130598905|NCT02088034|470154379|FG001|Overall Study|Lost to Follow-up|1|||
130598906|NCT02088034|470154380|FG002|Overall Study|Lost to Follow-up|0|||
130598907|NCT02088034|470154378|FG000|Overall Study|Pregnancy|2|||
130598908|NCT02088034|470154379|FG001|Overall Study|Pregnancy|1|||
130598909|NCT02088034|470154380|FG002|Overall Study|Pregnancy|2|||
130598910|NCT01937312|470154381|FG000|Overall Study|Adverse Event|10|||
130598911|NCT01937312|470154382|FG001|Overall Study|Adverse Event|1|||
130598912|NCT01937312|470154381|FG000|Overall Study|Lack of Efficacy|0|||
130598913|NCT01937312|470154382|FG001|Overall Study|Lack of Efficacy|1|||
130598914|NCT01937312|470154381|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
130598915|NCT01937312|470154382|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
130598916|NCT01025336|470154385|FG000|Overall Study|Protocol Violation|0|||
130598917|NCT01025336|470154386|FG001|Overall Study|Protocol Violation|0|||
130598918|NCT01025336|470154387|FG002|Overall Study|Protocol Violation|0|||
130598919|NCT01025336|470154388|FG003|Overall Study|Protocol Violation|2|||
130598920|NCT01025336|470154389|FG004|Overall Study|Protocol Violation|0|||
130598921|NCT00593112|470154392|FG000|Overall Study|Scan Anxiety|3|||
130598922|NCT00593112|470154393|FG001|Overall Study|Scan Anxiety|0|||
130598923|NCT00593112|470154392|FG000|Overall Study|Abnormal Scan|1|||
130598924|NCT00593112|470154393|FG001|Overall Study|Abnormal Scan|0|||
130598925|NCT00593112|470154392|FG000|Overall Study|Unreadable Scan|1|||
130598926|NCT00593112|470154393|FG001|Overall Study|Unreadable Scan|0|||
130598927|NCT00593112|470154392|FG000|Overall Study|Withdrawal by Subject|5|||
130598928|NCT00593112|470154393|FG001|Overall Study|Withdrawal by Subject|0|||
130598929|NCT04407507|470154394|FG000|Overall Study|Withdrawal by Subject|0|||
130598930|NCT04407507|470154395|FG001|Overall Study|Withdrawal by Subject|1|||
130598931|NCT00847613|470154396|FG000|Overall Study|Ongoing at cut-off date|250|||
130598932|NCT00847613|470154397|FG001|Overall Study|Ongoing at cut-off date|265|||
130598933|NCT00847613|470154398|FG002|Overall Study|Ongoing at cut-off date|64|||
130598934|NCT00847613|470154399|FG003|Overall Study|Ongoing at cut-off date|64|||
130598935|NCT00847613|470154396|FG000|Overall Study|Death|1|||
130598936|NCT00847613|470154397|FG001|Overall Study|Death|1|||
130598937|NCT00847613|470154398|FG002|Overall Study|Death|0|||
130598938|NCT00847613|470154399|FG003|Overall Study|Death|0|||
130598939|NCT00847613|470154396|FG000|Overall Study|Adverse Event|36|||
130598940|NCT00847613|470154397|FG001|Overall Study|Adverse Event|26|||
130598941|NCT00847613|470154398|FG002|Overall Study|Adverse Event|5|||
130598942|NCT00847613|470154399|FG003|Overall Study|Adverse Event|6|||
130598943|NCT00847613|470154396|FG000|Overall Study|Lack of Efficacy|7|||
130598944|NCT00847613|470154397|FG001|Overall Study|Lack of Efficacy|3|||
130598945|NCT00847613|470154398|FG002|Overall Study|Lack of Efficacy|3|||
130598946|NCT00847613|470154399|FG003|Overall Study|Lack of Efficacy|1|||
130598947|NCT00847613|470154396|FG000|Overall Study|Study terminated by Sponsor|1|||
130598948|NCT00847613|470154397|FG001|Overall Study|Study terminated by Sponsor|0|||
130598949|NCT00847613|470154398|FG002|Overall Study|Study terminated by Sponsor|2|||
130598950|NCT00847613|470154399|FG003|Overall Study|Study terminated by Sponsor|1|||
130598951|NCT00847613|470154396|FG000|Overall Study|Lost to Follow-up|5|||
130598952|NCT00847613|470154397|FG001|Overall Study|Lost to Follow-up|0|||
130598953|NCT00847613|470154398|FG002|Overall Study|Lost to Follow-up|0|||
130598954|NCT00847613|470154399|FG003|Overall Study|Lost to Follow-up|3|||
130598955|NCT00847613|470154396|FG000|Overall Study|Protocol Violation|6|||
130598956|NCT00847613|470154397|FG001|Overall Study|Protocol Violation|6|||
130598957|NCT00847613|470154398|FG002|Overall Study|Protocol Violation|3|||
130598958|NCT00847613|470154399|FG003|Overall Study|Protocol Violation|1|||
130598959|NCT00847613|470154396|FG000|Overall Study|Pregnancy|1|||
130598960|NCT00847613|470154397|FG001|Overall Study|Pregnancy|1|||
130598961|NCT00847613|470154398|FG002|Overall Study|Pregnancy|0|||
130598962|NCT00847613|470154399|FG003|Overall Study|Pregnancy|0|||
130598963|NCT00847613|470154396|FG000|Overall Study|Site closure|1|||
130598964|NCT00847613|470154397|FG001|Overall Study|Site closure|0|||
130598965|NCT00847613|470154398|FG002|Overall Study|Site closure|0|||
130598966|NCT00847613|470154399|FG003|Overall Study|Site closure|1|||
130598967|NCT00847613|470154396|FG000|Overall Study|Withdrawal by Subject|8|||
130598968|NCT00847613|470154397|FG001|Overall Study|Withdrawal by Subject|11|||
130598969|NCT00847613|470154398|FG002|Overall Study|Withdrawal by Subject|2|||
130598970|NCT00847613|470154399|FG003|Overall Study|Withdrawal by Subject|2|||
130598971|NCT00847613|470154396|FG000|Overall Study|Participant moved|4|||
130598972|NCT00847613|470154397|FG001|Overall Study|Participant moved|1|||
130598973|NCT00847613|470154398|FG002|Overall Study|Participant moved|0|||
130598974|NCT00847613|470154399|FG003|Overall Study|Participant moved|0|||
130598975|NCT00847613|470154396|FG000|Overall Study|Sponsor request|0|||
130598976|NCT00847613|470154397|FG001|Overall Study|Sponsor request|1|||
130598977|NCT00847613|470154398|FG002|Overall Study|Sponsor request|0|||
130598978|NCT00847613|470154399|FG003|Overall Study|Sponsor request|0|||
130598979|NCT00847613|470154396|FG000|Overall Study|Randomized, but not treated|0|||
130598980|NCT00847613|470154397|FG001|Overall Study|Randomized, but not treated|3|||
130598981|NCT00847613|470154398|FG002|Overall Study|Randomized, but not treated|0|||
130598982|NCT00847613|470154399|FG003|Overall Study|Randomized, but not treated|0|||
130598983|NCT00847613|470154396|FG000|Overall Study|Other|1|||
130598984|NCT00847613|470154397|FG001|Overall Study|Other|1|||
130598985|NCT00847613|470154398|FG002|Overall Study|Other|2|||
130598986|NCT00847613|470154399|FG003|Overall Study|Other|0|||
130598987|NCT03368404|470154410|FG000|Overall Study|Adverse Event|2|||
130598988|NCT03368404|470154411|FG001|Overall Study|Adverse Event|1|||
130598989|NCT03368404|470154410|FG000|Overall Study|Withdrawal by Subject|1|||
130598990|NCT03368404|470154411|FG001|Overall Study|Withdrawal by Subject|1|||
130598991|NCT04725682|470154412|FG000|Overall Study|Withdrawal by Subject|7|||
130598992|NCT04725682|470154413|FG001|Overall Study|Withdrawal by Subject|5|||
130598993|NCT04725682|470154412|FG000|Overall Study|Failed to comply with the requirements|2|||
130598994|NCT04725682|470154413|FG001|Overall Study|Failed to comply with the requirements|1|||
130598995|NCT04725682|470154412|FG000|Overall Study|Adverse Event|1|||
130598996|NCT04725682|470154413|FG001|Overall Study|Adverse Event|1|||
130598997|NCT04725682|470154412|FG000|Overall Study|Death|0|||
130598998|NCT04725682|470154413|FG001|Overall Study|Death|1|||
130598999|NCT01607892|470154415|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
130599000|NCT01607892|470154416|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
130599001|NCT01607892|470154417|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
130599002|NCT01607892|470154418|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
130599003|NCT01607892|470154419|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
130599004|NCT01607892|470154415|FG000|Overall Study|Death|4|||
130599005|NCT01607892|470154416|FG001|Overall Study|Death|2|||
130599006|NCT01607892|470154417|FG002|Overall Study|Death|8|||
130599007|NCT01607892|470154418|FG003|Overall Study|Death|10|||
130599008|NCT01607892|470154419|FG004|Overall Study|Death|3|||
130599009|NCT01607892|470154415|FG000|Overall Study|Investigator discretion|2|||
130599010|NCT01607892|470154416|FG001|Overall Study|Investigator discretion|4|||
130599011|NCT01607892|470154417|FG002|Overall Study|Investigator discretion|4|||
130599012|NCT01607892|470154418|FG003|Overall Study|Investigator discretion|8|||
130599013|NCT01607892|470154419|FG004|Overall Study|Investigator discretion|0|||
130599014|NCT01607892|470154415|FG000|Overall Study|Other treatments became available|1|||
130599015|NCT01607892|470154416|FG001|Overall Study|Other treatments became available|1|||
130599016|NCT01607892|470154417|FG002|Overall Study|Other treatments became available|0|||
130599017|NCT01607892|470154418|FG003|Overall Study|Other treatments became available|0|||
130599018|NCT01607892|470154419|FG004|Overall Study|Other treatments became available|2|||
130599019|NCT01607892|470154415|FG000|Overall Study|Intercurrent illness|1|||
130599020|NCT01607892|470154416|FG001|Overall Study|Intercurrent illness|0|||
130599021|NCT01607892|470154417|FG002|Overall Study|Intercurrent illness|0|||
130599022|NCT01607892|470154418|FG003|Overall Study|Intercurrent illness|3|||
130599023|NCT01607892|470154419|FG004|Overall Study|Intercurrent illness|0|||
130599024|NCT01607892|470154415|FG000|Overall Study|Non-Compliance with study procedures|0|||
130599025|NCT01607892|470154416|FG001|Overall Study|Non-Compliance with study procedures|0|||
130599026|NCT01607892|470154417|FG002|Overall Study|Non-Compliance with study procedures|1|||
130599027|NCT01607892|470154418|FG003|Overall Study|Non-Compliance with study procedures|0|||
130599028|NCT01607892|470154419|FG004|Overall Study|Non-Compliance with study procedures|0|||
130599029|NCT01607892|470154415|FG000|Overall Study|Consent withdrawn by participant|9|||
130599030|NCT01607892|470154416|FG001|Overall Study|Consent withdrawn by participant|4|||
130599031|NCT01607892|470154417|FG002|Overall Study|Consent withdrawn by participant|24|||
130599032|NCT01607892|470154418|FG003|Overall Study|Consent withdrawn by participant|14|||
130599033|NCT01607892|470154419|FG004|Overall Study|Consent withdrawn by participant|4|||
130599034|NCT01607892|470154415|FG000|Overall Study|Disease progression|38|||
130599035|NCT01607892|470154416|FG001|Overall Study|Disease progression|13|||
130599036|NCT01607892|470154417|FG002|Overall Study|Disease progression|37|||
130599037|NCT01607892|470154418|FG003|Overall Study|Disease progression|57|||
130599038|NCT01607892|470154419|FG004|Overall Study|Disease progression|9|||
130599039|NCT01607892|470154415|FG000|Overall Study|Incidence or severity of Adverse events|3|||
130599040|NCT01607892|470154416|FG001|Overall Study|Incidence or severity of Adverse events|3|||
130599041|NCT01607892|470154417|FG002|Overall Study|Incidence or severity of Adverse events|7|||
130599042|NCT01607892|470154418|FG003|Overall Study|Incidence or severity of Adverse events|2|||
130599043|NCT01607892|470154419|FG004|Overall Study|Incidence or severity of Adverse events|6|||
130599044|NCT03022422|470154421|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
130599045|NCT03022422|470154422|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
130599046|NCT03022422|470154423|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
130599047|NCT03022422|470154424|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
130599048|NCT03022422|470154425|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
130599049|NCT03022422|470154426|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
130599050|NCT01444391|470154427|FG000|Overall Study|Death|1|||
130599051|NCT02031146|470155965|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130599052|NCT02031146|470155966|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130599053|NCT02031146|470155967|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130599054|NCT02031146|470155968|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
130599055|NCT02031146|470155969|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
130599056|NCT02031146|470155970|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
130599057|NCT02031146|470155971|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
130599058|NCT01582282|470155974|FG000|Overall Study|Adverse Event|1|||
130599059|NCT01582282|470155975|FG001|Overall Study|Adverse Event|1|||
130599060|NCT01582282|470155976|FG002|Overall Study|Adverse Event|0|||
130599061|NCT01582282|470155974|FG000|Overall Study|Lost to Follow-up|1|||
130599062|NCT01582282|470155975|FG001|Overall Study|Lost to Follow-up|0|||
130599063|NCT01582282|470155976|FG002|Overall Study|Lost to Follow-up|0|||
130599064|NCT01582282|470155974|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
130599065|NCT01582282|470155975|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
130599066|NCT01582282|470155976|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
130599067|NCT02495077|470155977|FG000|Overall Study|Adverse Event|0|||
130599068|NCT02495077|470155978|FG001|Overall Study|Adverse Event|1|||
130599069|NCT02495077|470155979|FG002|Overall Study|Adverse Event|1|||
130599070|NCT02495077|470155980|FG003|Overall Study|Adverse Event|0|||
130599071|NCT02495077|470155977|FG000|Overall Study|Death|3|||
130599072|NCT02495077|470155978|FG001|Overall Study|Death|5|||
130599073|NCT02495077|470155979|FG002|Overall Study|Death|0|||
130599074|NCT02495077|470155980|FG003|Overall Study|Death|0|||
130599075|NCT02495077|470155977|FG000|Overall Study|Lost to Follow-up|6|||
130599076|NCT02495077|470155978|FG001|Overall Study|Lost to Follow-up|4|||
130599077|NCT02495077|470155979|FG002|Overall Study|Lost to Follow-up|0|||
130599078|NCT02495077|470155980|FG003|Overall Study|Lost to Follow-up|0|||
130599079|NCT02495077|470155977|FG000|Overall Study|Physician Decision|2|||
130599080|NCT02495077|470155978|FG001|Overall Study|Physician Decision|1|||
130599081|NCT02495077|470155979|FG002|Overall Study|Physician Decision|4|||
130599082|NCT02495077|470155980|FG003|Overall Study|Physician Decision|0|||
130599083|NCT02495077|470155977|FG000|Overall Study|Protocol Violation|0|||
130599084|NCT02495077|470155978|FG001|Overall Study|Protocol Violation|1|||
130599085|NCT02495077|470155979|FG002|Overall Study|Protocol Violation|0|||
130599086|NCT02495077|470155980|FG003|Overall Study|Protocol Violation|0|||
130599087|NCT02495077|470155977|FG000|Overall Study|Screen Failure|0|||
130599088|NCT02495077|470155978|FG001|Overall Study|Screen Failure|0|||
130599089|NCT02495077|470155979|FG002|Overall Study|Screen Failure|0|||
130599090|NCT02495077|470155980|FG003|Overall Study|Screen Failure|48|||
130599091|NCT02495077|470155977|FG000|Overall Study|Withdrawal by Subject|7|||
130599092|NCT02495077|470155978|FG001|Overall Study|Withdrawal by Subject|7|||
130599093|NCT02495077|470155979|FG002|Overall Study|Withdrawal by Subject|7|||
130599094|NCT02495077|470155980|FG003|Overall Study|Withdrawal by Subject|0|||
130599095|NCT02495077|470155977|FG000|Overall Study|Covid-19 research restrictions|1|||
130599096|NCT02495077|470155978|FG001|Overall Study|Covid-19 research restrictions|0|||
130599097|NCT02495077|470155979|FG002|Overall Study|Covid-19 research restrictions|0|||
130599098|NCT02495077|470155980|FG003|Overall Study|Covid-19 research restrictions|0|||
130599099|NCT02495077|470155977|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
130599100|NCT02495077|470155978|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
130599101|NCT02495077|470155979|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
130599102|NCT02495077|470155980|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
130599103|NCT02495077|470155977|FG000|Overall Study|Incarcerated|0|||
130599104|NCT02495077|470155978|FG001|Overall Study|Incarcerated|1|||
130599105|NCT02495077|470155979|FG002|Overall Study|Incarcerated|0|||
130599106|NCT02495077|470155980|FG003|Overall Study|Incarcerated|0|||
130599107|NCT02495077|470155977|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
130599108|NCT02495077|470155978|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
130599109|NCT02495077|470155979|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
130599110|NCT02495077|470155980|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
130599111|NCT02495077|470155977|FG000|Overall Study|Timing of transplant and randomization|0|||
130599112|NCT02495077|470155978|FG001|Overall Study|Timing of transplant and randomization|0|||
130599113|NCT02495077|470155979|FG002|Overall Study|Timing of transplant and randomization|5|||
130599114|NCT02495077|470155980|FG003|Overall Study|Timing of transplant and randomization|0|||
130599115|NCT02742649|470155987|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
130599116|NCT02742649|470155988|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130599117|NCT02742649|470155989|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130599118|NCT02742649|470155990|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130599119|NCT02742649|470155991|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130599120|NCT02742649|470155987|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130599121|NCT02742649|470155988|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130599122|NCT02742649|470155989|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130599123|NCT02742649|470155990|FG003|Double-Blind Treatment Period|Adverse Event|0|||
130599124|NCT02742649|470155991|FG004|Double-Blind Treatment Period|Adverse Event|0|||
130599125|NCT02742649|470155987|FG000|Open-Label Period|Lost to Follow-up|0|||
130599126|NCT02742649|470155988|FG001|Open-Label Period|Lost to Follow-up|0|||
130599127|NCT02742649|470155989|FG002|Open-Label Period|Lost to Follow-up|0|||
130599128|NCT02742649|470155990|FG003|Open-Label Period|Lost to Follow-up|0|||
130599129|NCT02742649|470155991|FG004|Open-Label Period|Lost to Follow-up|1|||
130599130|NCT03937986|470155994|FG000|Overall Study|COVID-19 Pandemic|1|||
130599131|NCT00744055|470156000|FG000|Overall Study|Withdrawal by Subject|6|||
130599132|NCT00744055|470156001|FG001|Overall Study|Withdrawal by Subject|9|||
130599133|NCT00744055|470156000|FG000|Overall Study|Lack of Efficacy|0|||
130599134|NCT00744055|470156001|FG001|Overall Study|Lack of Efficacy|1|||
130599135|NCT00744055|470156000|FG000|Overall Study|Physician Decision|0|||
130599136|NCT00744055|470156001|FG001|Overall Study|Physician Decision|2|||
130599137|NCT00744055|470156000|FG000|Overall Study|Protocol Violation|1|||
130599138|NCT00744055|470156001|FG001|Overall Study|Protocol Violation|1|||
130599139|NCT00744055|470156000|FG000|Overall Study|Lost to Follow-up|0|||
130599140|NCT00744055|470156001|FG001|Overall Study|Lost to Follow-up|1|||
130599141|NCT02767570|470156004|FG000|Overall Study|Lost to Follow-up|3|||
130599142|NCT02767570|470156005|FG001|Overall Study|Lost to Follow-up|0|||
130599143|NCT02767570|470156004|FG000|Overall Study|COVID shutdown|2|||
130599144|NCT02767570|470156005|FG001|Overall Study|COVID shutdown|5|||
130599145|NCT02767570|470156004|FG000|Overall Study|Increased pain|2|||
130599146|NCT02767570|470156005|FG001|Overall Study|Increased pain|0|||
130599147|NCT02767570|470156004|FG000|Overall Study|Withdrawal by Subject|1|||
130599148|NCT02767570|470156005|FG001|Overall Study|Withdrawal by Subject|3|||
130599149|NCT02767570|470156004|FG000|Overall Study|Unrelated medical issue|1|||
130599150|NCT02767570|470156005|FG001|Overall Study|Unrelated medical issue|1|||
130599151|NCT02767570|470156004|FG000|Overall Study|Received intra-articular injection|0|||
130599152|NCT02767570|470156005|FG001|Overall Study|Received intra-articular injection|1|||
130599153|NCT00151411|470156006|FG000|Overall Study|Lost to Follow-up|15|||
130599154|NCT00151411|470156007|FG001|Overall Study|Lost to Follow-up|19|||
130599155|NCT00151411|470156006|FG000|Overall Study|Withdrawal by Subject|12|||
130599156|NCT00151411|470156007|FG001|Overall Study|Withdrawal by Subject|20|||
130599157|NCT00151411|470156006|FG000|Overall Study|Adverse Event|6|||
130599158|NCT00151411|470156007|FG001|Overall Study|Adverse Event|0|||
130599159|NCT00151411|470156006|FG000|Overall Study|Pregnancy|0|||
130599160|NCT00151411|470156007|FG001|Overall Study|Pregnancy|4|||
130599161|NCT00417612|470156008|FG000|Overall Study|Errant diagnosis|0|||
130599162|NCT00417612|470156009|FG001|Overall Study|Errant diagnosis|1|||
130599163|NCT00417612|470156008|FG000|Overall Study|Adverse Event|2|||
130599164|NCT00417612|470156009|FG001|Overall Study|Adverse Event|0|||
130599165|NCT00417612|470156008|FG000|Overall Study|Protocol Violation|0|||
130599166|NCT00417612|470156009|FG001|Overall Study|Protocol Violation|2|||
130599167|NCT00417612|470156008|FG000|Overall Study|Lost to Follow-up|1|||
130599168|NCT00417612|470156009|FG001|Overall Study|Lost to Follow-up|0|||
130599169|NCT01712438|470156012|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
130599170|NCT01712438|470156012|FG000|Overall Study|Ongoing ITI treatment|6|||
130599171|NCT01712438|470156012|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
130599172|NCT01712438|470156012|FG000|Overall Study|Prematurely Discontinued|25|||
130599173|NCT01157169|470156015|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
130599174|NCT01157169|470156016|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
130599175|NCT01157169|470156015|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
130599176|NCT01157169|470156016|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
130599177|NCT01123889|470156017|FG000|Overall Study|Lost to Follow-up|3|||
130599178|NCT01123889|470156018|FG001|Overall Study|Lost to Follow-up|1|||
130599179|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
130599180|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
130599181|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
130599182|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
130599183|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
130599184|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
130599185|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
130599186|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
130599187|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
130599188|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
130599189|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
130599190|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
130599191|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
130599192|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
130599193|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
130599194|NCT01330381|470156021|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
130599195|NCT01330381|470156022|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
130599196|NCT01330381|470156023|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
130599197|NCT01330381|470156021|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
130599198|NCT01330381|470156022|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
130599199|NCT01330381|470156023|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
130599200|NCT01330381|470156021|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
130599201|NCT01330381|470156022|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
130599202|NCT01330381|470156023|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
130599203|NCT01330381|470156021|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
130599204|NCT01330381|470156022|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
130599205|NCT01330381|470156023|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
130599206|NCT01330381|470156021|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
130599207|NCT01330381|470156022|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
130599208|NCT01330381|470156023|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
130599209|NCT03846947|470156024|FG000|Overall Study|technical issues with imaging sequence|2|||
130599210|NCT00224107|470156025|FG000|Overall Study|Adverse Event|20|||
130599211|NCT00224107|470156026|FG001|Overall Study|Adverse Event|6|||
130599212|NCT00224107|470156025|FG000|Overall Study|Protocol Violation|2|||
130599213|NCT00224107|470156026|FG001|Overall Study|Protocol Violation|3|||
130599214|NCT00224107|470156025|FG000|Overall Study|Withdrawal by Subject|1|||
130599215|NCT00224107|470156026|FG001|Overall Study|Withdrawal by Subject|4|||
130599216|NCT00224107|470156025|FG000|Overall Study|Lack of Efficacy|2|||
130599217|NCT00224107|470156026|FG001|Overall Study|Lack of Efficacy|0|||
130599218|NCT00224107|470156025|FG000|Overall Study|Lost to Follow-up|4|||
130599219|NCT00224107|470156026|FG001|Overall Study|Lost to Follow-up|0|||
130599220|NCT00224107|470156025|FG000|Overall Study|Physician Decision|1|||
130599221|NCT00224107|470156026|FG001|Overall Study|Physician Decision|0|||
130599222|NCT00224107|470156025|FG000|Overall Study|Other|1|||
130599223|NCT00224107|470156026|FG001|Overall Study|Other|1|||
130599224|NCT00685178|470156027|FG000|Overall Study|Adverse Event|1|||
130599225|NCT00685178|470156028|FG001|Overall Study|Adverse Event|5|||
130599226|NCT00685178|470156029|FG002|Overall Study|Adverse Event|2|||
130599227|NCT00685178|470156030|FG003|Overall Study|Adverse Event|4|||
130599228|NCT00685178|470156027|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
130599229|NCT00685178|470156028|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
130599230|NCT00685178|470156029|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
130599231|NCT00685178|470156030|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
130599232|NCT00685178|470156027|FG000|Overall Study|voluntary study discharge|4|||
130599233|NCT00685178|470156028|FG001|Overall Study|voluntary study discharge|5|||
130599234|NCT00685178|470156029|FG002|Overall Study|voluntary study discharge|1|||
130599235|NCT00685178|470156030|FG003|Overall Study|voluntary study discharge|1|||
130599236|NCT00685178|470156027|FG000|Overall Study|incarcerated|1|||
130599237|NCT00685178|470156028|FG001|Overall Study|incarcerated|3|||
130599238|NCT00685178|470156029|FG002|Overall Study|incarcerated|7|||
130599239|NCT00685178|470156030|FG003|Overall Study|incarcerated|0|||
130599240|NCT00685178|470156027|FG000|Overall Study|administrative (disciplinary) discharge|0|||
130599241|NCT00685178|470156028|FG001|Overall Study|administrative (disciplinary) discharge|1|||
130599242|NCT00685178|470156029|FG002|Overall Study|administrative (disciplinary) discharge|0|||
130599243|NCT00685178|470156030|FG003|Overall Study|administrative (disciplinary) discharge|2|||
130599244|NCT00685178|470156027|FG000|Overall Study|Pregnancy|0|||
130599245|NCT00685178|470156028|FG001|Overall Study|Pregnancy|0|||
130599246|NCT00685178|470156029|FG002|Overall Study|Pregnancy|0|||
130599247|NCT00685178|470156030|FG003|Overall Study|Pregnancy|1|||
130599248|NCT01408537|470156033|FG000|Overall Study|Withdrawal by Subject|2|||
130599249|NCT01408537|470156033|FG000|Overall Study|Protocol Violation|3|||
130599250|NCT01408537|470156033|FG000|Overall Study|Lost to Follow-up|3|||
130599251|NCT02046564|470156037|FG000|Overall Study|Adverse Event|6|||
130599252|NCT02046564|470156038|FG001|Overall Study|Adverse Event|3|||
130599253|NCT02046564|470156037|FG000|Overall Study|Physician Decision|0|||
130599254|NCT02046564|470156038|FG001|Overall Study|Physician Decision|1|||
130599255|NCT02046564|470156037|FG000|Overall Study|Protocol Violation|3|||
130599256|NCT02046564|470156038|FG001|Overall Study|Protocol Violation|1|||
130599257|NCT02046564|470156037|FG000|Overall Study|Withdrawal by Subject|4|||
130599258|NCT02046564|470156038|FG001|Overall Study|Withdrawal by Subject|10|||
130599259|NCT02046564|470156037|FG000|Overall Study|Subject met withdrawal criteria|2|||
130599260|NCT02046564|470156038|FG001|Overall Study|Subject met withdrawal criteria|5|||
130599261|NCT00984659|470156039|FG000|2-week Run-in Period|Adverse Event|8|||
130599262|NCT00984659|470156040|FG001|2-week Run-in Period|Adverse Event|0|||
130599263|NCT00984659|470156041|FG002|2-week Run-in Period|Adverse Event|0|||
130599264|NCT00984659|470156042|FG003|2-week Run-in Period|Adverse Event|0|||
130599265|NCT00984659|470156039|FG000|2-week Run-in Period|Protocol Violation|5|||
130599266|NCT00984659|470156040|FG001|2-week Run-in Period|Protocol Violation|0|||
130599267|NCT00984659|470156041|FG002|2-week Run-in Period|Protocol Violation|0|||
130599268|NCT00984659|470156042|FG003|2-week Run-in Period|Protocol Violation|0|||
130599269|NCT00984659|470156039|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
130599270|NCT00984659|470156040|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
130599271|NCT00984659|470156041|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
130599272|NCT00984659|470156042|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
130599273|NCT00984659|470156039|FG000|2-week Run-in Period|Lost to Follow-up|3|||
130599274|NCT00984659|470156040|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130599275|NCT00984659|470156041|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130599276|NCT00984659|470156042|FG003|2-week Run-in Period|Lost to Follow-up|0|||
130599277|NCT00984659|470156039|FG000|2-week Run-in Period|Physician Decision|10|||
130599278|NCT00984659|470156040|FG001|2-week Run-in Period|Physician Decision|0|||
130599279|NCT00984659|470156041|FG002|2-week Run-in Period|Physician Decision|0|||
130599280|NCT00984659|470156042|FG003|2-week Run-in Period|Physician Decision|0|||
130599281|NCT00984659|470156039|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
130599282|NCT00984659|470156040|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130599283|NCT00984659|470156041|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130599284|NCT00984659|470156042|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
130599285|NCT00984659|470156039|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
130599286|NCT00984659|470156040|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130599287|NCT00984659|470156041|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130599288|NCT00984659|470156042|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130599289|NCT00984659|470156039|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
130599290|NCT00984659|470156040|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
130599291|NCT00984659|470156041|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
130599292|NCT00984659|470156042|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
130599293|NCT00984659|470156039|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
130599294|NCT00984659|470156040|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
130599295|NCT00984659|470156041|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
130599296|NCT00984659|470156042|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
130599297|NCT00984659|470156039|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
130599298|NCT00984659|470156040|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
130599299|NCT00984659|470156041|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
130599300|NCT00984659|470156042|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
130599301|NCT00984659|470156039|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130599302|NCT00984659|470156040|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130599303|NCT00984659|470156041|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
130599304|NCT00984659|470156042|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130599305|NCT00984659|470156039|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130599306|NCT00984659|470156040|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
130599307|NCT00984659|470156041|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
130599308|NCT00984659|470156042|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
130599309|NCT00308620|470156043|FG000|Overall Study|Death|1|||
130599310|NCT00308620|470156044|FG001|Overall Study|Death|1|||
130599311|NCT00308620|470156045|FG002|Overall Study|Death|0|||
130599312|NCT00308620|470156043|FG000|Overall Study|Lost to Follow-up|0|||
130599313|NCT00308620|470156044|FG001|Overall Study|Lost to Follow-up|0|||
130599314|NCT00308620|470156045|FG002|Overall Study|Lost to Follow-up|1|||
130599315|NCT03894540|470156049|FG000|Overall Study|Adverse Event|0|||
130599316|NCT03894540|470156050|FG001|Overall Study|Adverse Event|0|||
130599317|NCT03894540|470156051|FG002|Overall Study|Adverse Event|0|||
130599318|NCT03894540|470156052|FG003|Overall Study|Adverse Event|0|||
130599319|NCT03894540|470156053|FG004|Overall Study|Adverse Event|1|||
130599320|NCT03894540|470156054|FG005|Overall Study|Adverse Event|0|||
130599321|NCT03894540|470156049|FG000|Overall Study|Withdrawal by Subject|0|||
130599322|NCT03894540|470156050|FG001|Overall Study|Withdrawal by Subject|0|||
130599323|NCT03894540|470156051|FG002|Overall Study|Withdrawal by Subject|0|||
130599324|NCT03894540|470156052|FG003|Overall Study|Withdrawal by Subject|0|||
130599325|NCT03894540|470156053|FG004|Overall Study|Withdrawal by Subject|1|||
130599326|NCT03894540|470156054|FG005|Overall Study|Withdrawal by Subject|0|||
130599327|NCT03894540|470156049|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
130599328|NCT03894540|470156050|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
130599329|NCT03894540|470156051|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
130599330|NCT03894540|470156052|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
130599331|NCT03894540|470156053|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
130599332|NCT03894540|470156054|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
130599333|NCT03894540|470156049|FG000|Overall Study|Progressive Disease Clinical|1|||
130599334|NCT03894540|470156050|FG001|Overall Study|Progressive Disease Clinical|1|||
130599335|NCT03894540|470156051|FG002|Overall Study|Progressive Disease Clinical|0|||
130599336|NCT03894540|470156052|FG003|Overall Study|Progressive Disease Clinical|1|||
130599337|NCT03894540|470156053|FG004|Overall Study|Progressive Disease Clinical|5|||
130599338|NCT03894540|470156054|FG005|Overall Study|Progressive Disease Clinical|1|||
130599339|NCT03894540|470156049|FG000|Overall Study|Study termination by sponsor|0|||
130599340|NCT03894540|470156050|FG001|Overall Study|Study termination by sponsor|0|||
130599341|NCT03894540|470156051|FG002|Overall Study|Study termination by sponsor|0|||
130599342|NCT03894540|470156052|FG003|Overall Study|Study termination by sponsor|0|||
130599343|NCT03894540|470156053|FG004|Overall Study|Study termination by sponsor|2|||
130599344|NCT03894540|470156054|FG005|Overall Study|Study termination by sponsor|0|||
130599345|NCT03043365|470156055|FG000|Weeks 0 to Week 8|Adverse Event|1|||
130599346|NCT03043365|470156056|FG001|Weeks 0 to Week 8|Adverse Event|3|||
130599347|NCT03043365|470156055|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
130599348|NCT03043365|470156056|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
130599349|NCT03043365|470156055|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
130599350|NCT03043365|470156056|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
130599351|NCT05372315|470156057|FG000|Overall Study|Withdrawal by Subject|1|||
130599352|NCT05372315|470156058|FG001|Overall Study|Withdrawal by Subject|0|||
130599353|NCT01508676|470156061|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
130599354|NCT01508676|470156062|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
130599355|NCT01508676|470156061|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
130599356|NCT01508676|470156062|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
130599357|NCT01508676|470156061|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
130599358|NCT01508676|470156062|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
130599359|NCT01508676|470156061|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
130599360|NCT01508676|470156062|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
130599361|NCT01508676|470156061|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
130599362|NCT01508676|470156062|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
130599363|NCT02532543|470156063|FG000|Overall Study|Lost to Follow-up|0|||
130599364|NCT02532543|470156064|FG001|Overall Study|Lost to Follow-up|0|||
130599365|NCT02532543|470156065|FG002|Overall Study|Lost to Follow-up|1|||
130599366|NCT02532543|470156066|FG003|Overall Study|Lost to Follow-up|0|||
130599367|NCT00650585|470156068|FG000|Overall Study|Lost to Follow-up|505|||
130599368|NCT00650585|470156069|FG001|Overall Study|Lost to Follow-up|482|||
130599369|NCT00650585|470156068|FG000|Overall Study|No parental consent|935|||
130599370|NCT00650585|470156069|FG001|Overall Study|No parental consent|866|||
130599371|NCT00650585|470156068|FG000|Overall Study|Excluded/ruled ineligible|357|||
130599372|NCT00650585|470156069|FG001|Overall Study|Excluded/ruled ineligible|129|||
130599373|NCT00923091|470156072|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
130599374|NCT00923091|470156073|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
130599375|NCT00923091|470156074|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
130599376|NCT00923091|470156075|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
130599377|NCT00923091|470156076|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
130599378|NCT00923091|470156077|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
130599379|NCT00923091|470156078|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
130599380|NCT00923091|470156079|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
130599381|NCT00923091|470156080|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130599382|NCT00923091|470156081|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130599383|NCT00923091|470156082|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130599384|NCT00923091|470156083|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130599385|NCT00923091|470156084|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130599386|NCT00923091|470156072|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
130599387|NCT00923091|470156073|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
130599388|NCT00923091|470156074|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130599389|NCT00923091|470156075|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
130599390|NCT00923091|470156076|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
130599391|NCT00923091|470156077|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
130599392|NCT00923091|470156078|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130599393|NCT00923091|470156079|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130599394|NCT00923091|470156080|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130599395|NCT00923091|470156081|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130599396|NCT00923091|470156082|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130599397|NCT00923091|470156083|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130599398|NCT00923091|470156084|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130599399|NCT00923091|470156072|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130599400|NCT00923091|470156073|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130599401|NCT00923091|470156074|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130599402|NCT00923091|470156075|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
130599403|NCT00923091|470156076|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
130599404|NCT00923091|470156077|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
130599405|NCT00923091|470156078|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
130599406|NCT00923091|470156079|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
130599407|NCT00923091|470156080|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130599408|NCT00923091|470156081|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130599409|NCT00923091|470156082|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130599410|NCT00923091|470156083|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130599411|NCT00923091|470156084|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130599412|NCT00923091|470156072|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599413|NCT00923091|470156073|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599414|NCT00923091|470156074|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599415|NCT00923091|470156075|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599416|NCT00923091|470156076|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599417|NCT00923091|470156077|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
130599418|NCT00923091|470156078|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599419|NCT00923091|470156079|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599420|NCT00923091|470156080|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599421|NCT00923091|470156081|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599422|NCT00923091|470156082|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599423|NCT00923091|470156083|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599424|NCT00923091|470156084|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130599425|NCT00923091|470156072|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599426|NCT00923091|470156073|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130599427|NCT00923091|470156074|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599428|NCT00923091|470156075|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130599429|NCT00923091|470156076|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599430|NCT00923091|470156077|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130599431|NCT00923091|470156078|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599432|NCT00923091|470156079|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599433|NCT00923091|470156080|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599434|NCT00923091|470156081|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599435|NCT00923091|470156082|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599436|NCT00923091|470156083|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599437|NCT00923091|470156084|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130599438|NCT00923091|470156072|FG000|Period III (Single-Blind)|Adverse Event|5|||
130599439|NCT00923091|470156073|FG001|Period III (Single-Blind)|Adverse Event|0|||
130599440|NCT00923091|470156074|FG002|Period III (Single-Blind)|Adverse Event|0|||
130599441|NCT00923091|470156075|FG003|Period III (Single-Blind)|Adverse Event|0|||
130599442|NCT00923091|470156076|FG004|Period III (Single-Blind)|Adverse Event|0|||
130599443|NCT00923091|470156077|FG005|Period III (Single-Blind)|Adverse Event|0|||
130599444|NCT00923091|470156078|FG006|Period III (Single-Blind)|Adverse Event|0|||
130599445|NCT00923091|470156079|FG007|Period III (Single-Blind)|Adverse Event|0|||
130599446|NCT00923091|470156080|FG008|Period III (Single-Blind)|Adverse Event|0|||
130599447|NCT00923091|470156081|FG009|Period III (Single-Blind)|Adverse Event|0|||
130599448|NCT00923091|470156082|FG010|Period III (Single-Blind)|Adverse Event|0|||
130599449|NCT00923091|470156083|FG011|Period III (Single-Blind)|Adverse Event|0|||
130599450|NCT00923091|470156084|FG012|Period III (Single-Blind)|Adverse Event|0|||
130599451|NCT00923091|470156072|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
130599452|NCT00923091|470156073|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599453|NCT00923091|470156074|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599454|NCT00923091|470156075|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599455|NCT00923091|470156076|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599456|NCT00923091|470156077|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599457|NCT00923091|470156078|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599458|NCT00923091|470156079|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599459|NCT00923091|470156080|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599460|NCT00923091|470156081|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599461|NCT00923091|470156082|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599462|NCT00923091|470156083|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599463|NCT00923091|470156084|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
130599464|NCT00923091|470156072|FG000|Period III (Single-Blind)|Protocol Violation|3|||
130599465|NCT00923091|470156073|FG001|Period III (Single-Blind)|Protocol Violation|0|||
130599466|NCT00923091|470156074|FG002|Period III (Single-Blind)|Protocol Violation|0|||
130599467|NCT00923091|470156075|FG003|Period III (Single-Blind)|Protocol Violation|0|||
130599468|NCT00923091|470156076|FG004|Period III (Single-Blind)|Protocol Violation|0|||
130599469|NCT00923091|470156077|FG005|Period III (Single-Blind)|Protocol Violation|0|||
130599470|NCT00923091|470156078|FG006|Period III (Single-Blind)|Protocol Violation|0|||
130599471|NCT00923091|470156079|FG007|Period III (Single-Blind)|Protocol Violation|0|||
130599472|NCT00923091|470156080|FG008|Period III (Single-Blind)|Protocol Violation|0|||
130599473|NCT00923091|470156081|FG009|Period III (Single-Blind)|Protocol Violation|0|||
130599474|NCT00923091|470156082|FG010|Period III (Single-Blind)|Protocol Violation|0|||
130599475|NCT00923091|470156083|FG011|Period III (Single-Blind)|Protocol Violation|0|||
130599476|NCT00923091|470156084|FG012|Period III (Single-Blind)|Protocol Violation|0|||
130599477|NCT00923091|470156072|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
130599478|NCT00923091|470156073|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
130599479|NCT00923091|470156074|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
130599480|NCT00923091|470156075|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
130599481|NCT00923091|470156076|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
130599482|NCT00923091|470156077|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
130599483|NCT00923091|470156078|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
130599484|NCT00923091|470156079|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
130599485|NCT00923091|470156080|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
130599486|NCT00923091|470156081|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
130599487|NCT00923091|470156082|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
130599488|NCT00923091|470156083|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
130599489|NCT00923091|470156084|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
130599490|NCT00923091|470156072|FG000|Period IV (Double-Blind)|Adverse Event|2|||
130599491|NCT00923091|470156073|FG001|Period IV (Double-Blind)|Adverse Event|0|||
130599492|NCT00923091|470156074|FG002|Period IV (Double-Blind)|Adverse Event|0|||
130599493|NCT00923091|470156075|FG003|Period IV (Double-Blind)|Adverse Event|0|||
130599494|NCT00923091|470156076|FG004|Period IV (Double-Blind)|Adverse Event|0|||
130599495|NCT00923091|470156077|FG005|Period IV (Double-Blind)|Adverse Event|0|||
130599496|NCT00923091|470156078|FG006|Period IV (Double-Blind)|Adverse Event|0|||
130599497|NCT00923091|470156079|FG007|Period IV (Double-Blind)|Adverse Event|0|||
130599498|NCT00923091|470156080|FG008|Period IV (Double-Blind)|Adverse Event|0|||
130599499|NCT00923091|470156081|FG009|Period IV (Double-Blind)|Adverse Event|0|||
130599500|NCT00923091|470156082|FG010|Period IV (Double-Blind)|Adverse Event|0|||
130599501|NCT00923091|470156083|FG011|Period IV (Double-Blind)|Adverse Event|0|||
130599502|NCT00923091|470156084|FG012|Period IV (Double-Blind)|Adverse Event|0|||
130599503|NCT00923091|470156072|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599504|NCT00923091|470156073|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
130599505|NCT00923091|470156074|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599506|NCT00923091|470156075|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599507|NCT00923091|470156076|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599508|NCT00923091|470156077|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599509|NCT00923091|470156078|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599510|NCT00923091|470156079|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599511|NCT00923091|470156080|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599512|NCT00923091|470156081|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599513|NCT00923091|470156082|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599514|NCT00923091|470156083|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599515|NCT00923091|470156084|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130599516|NCT00923091|470156072|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
130599517|NCT00923091|470156073|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
130599518|NCT00923091|470156074|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
130599519|NCT00923091|470156075|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
130599520|NCT00923091|470156076|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
130599521|NCT00923091|470156077|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
130599522|NCT00923091|470156078|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
130599523|NCT00923091|470156079|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
130599524|NCT00923091|470156080|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
130599525|NCT00923091|470156081|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
130599526|NCT00923091|470156082|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
130599527|NCT00923091|470156083|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
130599528|NCT00923091|470156084|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
130599529|NCT00923091|470156072|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599530|NCT00923091|470156073|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599531|NCT00923091|470156074|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599532|NCT00923091|470156075|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599533|NCT00923091|470156076|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599534|NCT00923091|470156077|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599535|NCT00923091|470156078|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599536|NCT00923091|470156079|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599537|NCT00923091|470156080|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
130599538|NCT00923091|470156081|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599539|NCT00923091|470156082|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599540|NCT00923091|470156083|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
130599541|NCT00923091|470156084|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
130599542|NCT00923091|470156072|FG000|Period V (Double -Blind)|Protocol Violation|0|||
130599543|NCT00923091|470156073|FG001|Period V (Double -Blind)|Protocol Violation|0|||
130599544|NCT00923091|470156074|FG002|Period V (Double -Blind)|Protocol Violation|0|||
130599545|NCT00923091|470156075|FG003|Period V (Double -Blind)|Protocol Violation|0|||
130599546|NCT00923091|470156076|FG004|Period V (Double -Blind)|Protocol Violation|0|||
130599547|NCT00923091|470156077|FG005|Period V (Double -Blind)|Protocol Violation|0|||
130599548|NCT00923091|470156078|FG006|Period V (Double -Blind)|Protocol Violation|0|||
130599549|NCT00923091|470156079|FG007|Period V (Double -Blind)|Protocol Violation|0|||
130599550|NCT00923091|470156080|FG008|Period V (Double -Blind)|Protocol Violation|0|||
130599551|NCT00923091|470156081|FG009|Period V (Double -Blind)|Protocol Violation|0|||
130599552|NCT00923091|470156082|FG010|Period V (Double -Blind)|Protocol Violation|0|||
130599553|NCT00923091|470156083|FG011|Period V (Double -Blind)|Protocol Violation|0|||
130599554|NCT00923091|470156084|FG012|Period V (Double -Blind)|Protocol Violation|1|||
130599555|NCT00923091|470156072|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
130599556|NCT00923091|470156073|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
130599557|NCT00923091|470156074|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
130599558|NCT00923091|470156075|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
130599559|NCT00923091|470156076|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
130599560|NCT00923091|470156077|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
130599561|NCT00923091|470156078|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
130599562|NCT00923091|470156079|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
130599563|NCT00923091|470156080|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
130599564|NCT00923091|470156081|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
130599565|NCT00923091|470156082|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
130599566|NCT00923091|470156083|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
130599567|NCT00923091|470156084|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
130599568|NCT00923091|470156072|FG000|Period VI (Open-Label)|Adverse Event|17|||
130599569|NCT00923091|470156073|FG001|Period VI (Open-Label)|Adverse Event|0|||
130599570|NCT00923091|470156074|FG002|Period VI (Open-Label)|Adverse Event|4|||
130599571|NCT00923091|470156075|FG003|Period VI (Open-Label)|Adverse Event|1|||
130599572|NCT00923091|470156076|FG004|Period VI (Open-Label)|Adverse Event|1|||
130599573|NCT00923091|470156077|FG005|Period VI (Open-Label)|Adverse Event|0|||
130599574|NCT00923091|470156078|FG006|Period VI (Open-Label)|Adverse Event|0|||
130599575|NCT00923091|470156079|FG007|Period VI (Open-Label)|Adverse Event|0|||
130599576|NCT00923091|470156080|FG008|Period VI (Open-Label)|Adverse Event|0|||
130599577|NCT00923091|470156081|FG009|Period VI (Open-Label)|Adverse Event|0|||
130599578|NCT00923091|470156082|FG010|Period VI (Open-Label)|Adverse Event|0|||
130599579|NCT00923091|470156083|FG011|Period VI (Open-Label)|Adverse Event|0|||
130599580|NCT00923091|470156084|FG012|Period VI (Open-Label)|Adverse Event|0|||
130599581|NCT00923091|470156072|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
130599582|NCT00923091|470156073|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
130599583|NCT00923091|470156074|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
130599584|NCT00923091|470156075|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599585|NCT00923091|470156076|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
130599586|NCT00923091|470156077|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599587|NCT00923091|470156078|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599588|NCT00923091|470156079|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599589|NCT00923091|470156080|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599590|NCT00923091|470156081|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599591|NCT00923091|470156082|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599592|NCT00923091|470156083|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599593|NCT00923091|470156084|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
130599594|NCT00923091|470156072|FG000|Period VI (Open-Label)|Protocol Violation|6|||
130599595|NCT00923091|470156073|FG001|Period VI (Open-Label)|Protocol Violation|1|||
130599596|NCT00923091|470156074|FG002|Period VI (Open-Label)|Protocol Violation|3|||
130599597|NCT00923091|470156075|FG003|Period VI (Open-Label)|Protocol Violation|1|||
130599598|NCT00923091|470156076|FG004|Period VI (Open-Label)|Protocol Violation|4|||
130599599|NCT00923091|470156077|FG005|Period VI (Open-Label)|Protocol Violation|0|||
130599600|NCT00923091|470156078|FG006|Period VI (Open-Label)|Protocol Violation|0|||
130599601|NCT00923091|470156079|FG007|Period VI (Open-Label)|Protocol Violation|0|||
130599602|NCT00923091|470156080|FG008|Period VI (Open-Label)|Protocol Violation|0|||
130599603|NCT00923091|470156081|FG009|Period VI (Open-Label)|Protocol Violation|0|||
130599604|NCT00923091|470156082|FG010|Period VI (Open-Label)|Protocol Violation|0|||
130599605|NCT00923091|470156083|FG011|Period VI (Open-Label)|Protocol Violation|0|||
130599606|NCT00923091|470156084|FG012|Period VI (Open-Label)|Protocol Violation|0|||
130599607|NCT00923091|470156072|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
130599608|NCT00923091|470156073|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
130599609|NCT00923091|470156074|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
130599610|NCT00923091|470156075|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
130599611|NCT00923091|470156076|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
130599612|NCT00923091|470156077|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
130599613|NCT00923091|470156078|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
130599614|NCT00923091|470156079|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
130599615|NCT00923091|470156080|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
130599616|NCT00923091|470156081|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
130599617|NCT00923091|470156082|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
130599618|NCT00923091|470156083|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
130599619|NCT00923091|470156084|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
130599620|NCT00923091|470156072|FG000|Period VI (Open-Label)|Other Reason|0|||
130599621|NCT00923091|470156073|FG001|Period VI (Open-Label)|Other Reason|0|||
130599622|NCT00923091|470156074|FG002|Period VI (Open-Label)|Other Reason|0|||
130599623|NCT00923091|470156075|FG003|Period VI (Open-Label)|Other Reason|1|||
130599624|NCT00923091|470156076|FG004|Period VI (Open-Label)|Other Reason|1|||
130599625|NCT00923091|470156077|FG005|Period VI (Open-Label)|Other Reason|0|||
130599626|NCT00923091|470156078|FG006|Period VI (Open-Label)|Other Reason|0|||
130599627|NCT00923091|470156079|FG007|Period VI (Open-Label)|Other Reason|0|||
130599628|NCT00923091|470156080|FG008|Period VI (Open-Label)|Other Reason|0|||
130599629|NCT00923091|470156081|FG009|Period VI (Open-Label)|Other Reason|0|||
130599630|NCT00923091|470156082|FG010|Period VI (Open-Label)|Other Reason|0|||
130599631|NCT00923091|470156083|FG011|Period VI (Open-Label)|Other Reason|0|||
130599632|NCT00923091|470156084|FG012|Period VI (Open-Label)|Other Reason|0|||
130599633|NCT00467649|470156085|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
130599634|NCT00467649|470156086|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
130599635|NCT00467649|470156087|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
130599636|NCT00467649|470156088|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
130599637|NCT00467649|470156089|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
130599638|NCT00467649|470156090|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
130599639|NCT00467649|470156085|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
130599640|NCT00467649|470156086|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
130599641|NCT00467649|470156087|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
130599642|NCT00467649|470156088|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
130599643|NCT00467649|470156089|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
130599644|NCT00467649|470156090|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
130599645|NCT00467649|470156085|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
130599646|NCT00467649|470156086|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
130599647|NCT00467649|470156087|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130599648|NCT00467649|470156088|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130599649|NCT00467649|470156089|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130599650|NCT00467649|470156090|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130599651|NCT00467649|470156085|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
130599652|NCT00467649|470156086|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
130599653|NCT00467649|470156087|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130599654|NCT00467649|470156088|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130599655|NCT00467649|470156089|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130599656|NCT00467649|470156090|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130599657|NCT00467649|470156085|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130599658|NCT00467649|470156086|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130599659|NCT00467649|470156087|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130599660|NCT00467649|470156088|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
130599661|NCT00467649|470156089|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130599662|NCT00467649|470156090|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130599663|NCT00467649|470156085|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130599664|NCT00467649|470156086|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130599665|NCT00467649|470156087|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130599666|NCT00467649|470156088|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
130599667|NCT00467649|470156089|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130599668|NCT00467649|470156090|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130599669|NCT00467649|470156085|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130599670|NCT00467649|470156086|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130599671|NCT00467649|470156087|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130599672|NCT00467649|470156088|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130599673|NCT00467649|470156089|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130599674|NCT00467649|470156090|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
130599675|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Adverse Event|12|||
130599676|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Adverse Event|3|||
130599677|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Adverse Event|4|||
130599678|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Adverse Event|2|||
130599679|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
130599680|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
130599681|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
130599682|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
130599683|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
130599684|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
130599685|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
130599686|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
130599687|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
130599688|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
130599689|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
130599690|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
130599691|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
130599692|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
130599693|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
130599694|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
130599695|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
130599696|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
130599697|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
130599698|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
130599699|NCT02436239|470156093|FG000|Open-Lable Treatment Period|Other Reason|1|||
130599700|NCT02436239|470156094|FG001|Open-Lable Treatment Period|Other Reason|1|||
130599701|NCT02436239|470156095|FG002|Open-Lable Treatment Period|Other Reason|0|||
130599702|NCT02436239|470156096|FG003|Open-Lable Treatment Period|Other Reason|0|||
130599703|NCT02436239|470156093|FG000|Down-Taper Period|Withdrawal by Subject|4|||
130599704|NCT02436239|470156094|FG001|Down-Taper Period|Withdrawal by Subject|4|||
130599705|NCT02436239|470156095|FG002|Down-Taper Period|Withdrawal by Subject|1|||
130599706|NCT02436239|470156096|FG003|Down-Taper Period|Withdrawal by Subject|2|||
130599707|NCT02782715|470156102|FG000|Overall Study|Withdrawal by Subject|1|||
130599708|NCT00995371|470156106|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
130599709|NCT00995371|470156107|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
130599710|NCT02983292|470156108|FG000|Overall Study|Participant unwell & cannot travel|2|||
130599711|NCT02983292|470156108|FG000|Overall Study|Lost to Follow-up|3|||
130599712|NCT02983292|470156108|FG000|Overall Study|Participant withdrew consent|2|||
130599713|NCT02983292|470156108|FG000|Overall Study|Revision|7|||
130599714|NCT02983292|470156108|FG000|Overall Study|Death|1|||
130599715|NCT02983292|470156108|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
130599716|NCT02983292|470156108|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
130599717|NCT02983292|470156108|FG000|Overall Study|Participant relocation|1|||
130599718|NCT00964795|470156109|FG000|Overall Study|Withdrawal by Subject|79|||
130599719|NCT00964795|470156109|FG000|Overall Study|Adverse Event|12|||
130599720|NCT00964795|470156109|FG000|Overall Study|Death|14|||
130599721|NCT00964795|470156109|FG000|Overall Study|Lost to Follow-up|7|||
130599722|NCT00964795|470156109|FG000|Overall Study|Termination of Study by Sponsor|169|||
130599723|NCT00964795|470156109|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
130599724|NCT00964795|470156109|FG000|Overall Study|Other|23|||
130599725|NCT00586690|470156114|FG000|Overall Study|Death|2|||
130599726|NCT00586690|470156115|FG001|Overall Study|Death|0|||
130599727|NCT00586690|470156114|FG000|Overall Study|Disease Progression|10|||
130599728|NCT00586690|470156115|FG001|Overall Study|Disease Progression|0|||
130599729|NCT00586690|470156114|FG000|Overall Study|Adverse Event|1|||
130599730|NCT00586690|470156115|FG001|Overall Study|Adverse Event|0|||
130599731|NCT00586690|470156114|FG000|Overall Study|Lack of Efficacy|2|||
130599732|NCT00586690|470156115|FG001|Overall Study|Lack of Efficacy|0|||
130599733|NCT00586690|470156114|FG000|Overall Study|Lab can't accommodate|1|||
130599734|NCT00586690|470156115|FG001|Overall Study|Lab can't accommodate|0|||
130599735|NCT00857246|470156116|FG000|Induction Regimen|Adverse Event|1|||
130599736|NCT00857246|470156116|FG000|Induction Regimen|disease-related complications|1|||
130599737|NCT00857246|470156116|FG000|Induction Regimen|Withdrawal by Subject|1|||
130599738|NCT00857246|470156116|FG000|Surgery (Curative)|disease progression|6|||
130599739|NCT00857246|470156116|FG000|ChemoRT|Withdrawal by Subject|1|||
130599740|NCT00857246|470156116|FG000|ChemoRT|Adverse Event|2|||
130599741|NCT01524289|470156125|FG000|Overall Study|Lost to Follow-up|0|||
130599742|NCT01524289|470156126|FG001|Overall Study|Lost to Follow-up|1|||
130599743|NCT01524289|470156125|FG000|Overall Study|Physician Decision|1|||
130599744|NCT01524289|470156126|FG001|Overall Study|Physician Decision|0|||
130599745|NCT01524289|470156125|FG000|Overall Study|Protocol Violation|5|||
130599746|NCT01524289|470156126|FG001|Overall Study|Protocol Violation|1|||
130599747|NCT01524289|470156125|FG000|Overall Study|Withdrawal by Subject|11|||
130599748|NCT01524289|470156126|FG001|Overall Study|Withdrawal by Subject|7|||
130599749|NCT01524289|470156125|FG000|Overall Study|Adverse Event|12|||
130599750|NCT01524289|470156126|FG001|Overall Study|Adverse Event|5|||
130599751|NCT01524289|470156125|FG000|Overall Study|Did not take study medication|1|||
130599752|NCT01524289|470156126|FG001|Overall Study|Did not take study medication|0|||
130599753|NCT02104180|470156127|FG000|Overall Study|Protocol Violation|1|||
130599754|NCT02104180|470156128|FG001|Overall Study|Protocol Violation|0|||
130599755|NCT02704429|470156129|FG000|Part A: 24 Weeks|Adverse Event|3|||
130599756|NCT02704429|470156130|FG001|Part A: 24 Weeks|Adverse Event|0|||
130599757|NCT02704429|470156129|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
130599758|NCT02704429|470156130|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
130599759|NCT02209597|470156133|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
130599760|NCT02209597|470156133|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
130599761|NCT02209597|470156133|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
130599762|NCT02209597|470156133|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
130599763|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Adverse Event|37|||
130599764|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Adverse Event|0|||
130599765|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Adverse Event|0|||
130599766|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Adverse Event|0|||
130599767|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Death|2|||
130599768|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Death|0|||
130599769|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Death|0|||
130599770|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Death|0|||
130599771|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
130599772|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
130599773|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
130599774|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
130599775|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
130599776|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
130599777|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
130599778|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
130599779|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
130599780|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
130599781|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
130599782|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
130599783|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
130599784|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130599785|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130599786|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130599787|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Physician Decision|4|||
130599788|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Physician Decision|0|||
130599789|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Physician Decision|0|||
130599790|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Physician Decision|0|||
130599791|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Pregnancy|1|||
130599792|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Pregnancy|0|||
130599793|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Pregnancy|0|||
130599794|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Pregnancy|0|||
130599795|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
130599796|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
130599797|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
130599798|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
130599799|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
130599800|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
130599801|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
130599802|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
130599803|NCT01855789|470156135|FG000|1) Baseline up to Week 24|Other|4|||
130599804|NCT01855789|470156136|FG001|1) Baseline up to Week 24|Other|0|||
130599805|NCT01855789|470156137|FG002|1) Baseline up to Week 24|Other|0|||
130599806|NCT01855789|470156138|FG003|1) Baseline up to Week 24|Other|0|||
130599807|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
130599808|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
130599809|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
130599810|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
130599811|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130599812|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130599813|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130599814|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
130599815|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
130599816|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
130599817|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
130599818|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
130599819|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
130599820|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
130599821|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
130599822|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
130599823|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
130599824|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
130599825|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
130599826|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
130599827|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
130599828|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
130599829|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
130599830|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
130599831|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
130599832|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
130599833|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
130599834|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
130599835|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
130599836|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
130599837|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
130599838|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
130599839|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
130599840|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
130599841|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
130599842|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
130599843|NCT01855789|470156135|FG000|2) Week 24 up to End of Study|Other|0|||
130599844|NCT01855789|470156136|FG001|2) Week 24 up to End of Study|Other|0|||
130599845|NCT01855789|470156137|FG002|2) Week 24 up to End of Study|Other|0|||
130599846|NCT01855789|470156138|FG003|2) Week 24 up to End of Study|Other|1|||
130599847|NCT03067311|470156139|FG000|Overall Study|Lost to Follow-up|1|||
130599848|NCT03067311|470156140|FG001|Overall Study|Lost to Follow-up|1|||
130599849|NCT03067311|470156139|FG000|Overall Study|Moved away|1|||
130599850|NCT03067311|470156140|FG001|Overall Study|Moved away|1|||
130599851|NCT00907738|470156141|FG000|Overall Study|Adverse Event|2|||
130599852|NCT00907738|470156142|FG001|Overall Study|Adverse Event|0|||
130599853|NCT00907738|470156143|FG002|Overall Study|Adverse Event|1|||
130599854|NCT00907738|470156144|FG003|Overall Study|Adverse Event|0|||
130599855|NCT00907738|470156145|FG004|Overall Study|Adverse Event|0|||
130599856|NCT00907738|470156141|FG000|Overall Study|not specified or withdrew consent|3|||
130599857|NCT00907738|470156142|FG001|Overall Study|not specified or withdrew consent|0|||
130599858|NCT00907738|470156143|FG002|Overall Study|not specified or withdrew consent|0|||
130599859|NCT00907738|470156144|FG003|Overall Study|not specified or withdrew consent|0|||
130599860|NCT00907738|470156145|FG004|Overall Study|not specified or withdrew consent|0|||
130599861|NCT00907738|470156141|FG000|Overall Study|Disease progression|8|||
130599862|NCT00907738|470156142|FG001|Overall Study|Disease progression|1|||
130599863|NCT00907738|470156143|FG002|Overall Study|Disease progression|6|||
130599864|NCT00907738|470156144|FG003|Overall Study|Disease progression|4|||
130599865|NCT00907738|470156145|FG004|Overall Study|Disease progression|2|||
130599866|NCT01089725|470156146|FG000|Overall Study|Adverse Event|1|||
130599867|NCT01089725|470156147|FG001|Overall Study|Adverse Event|1|||
130599868|NCT01089725|470156148|FG002|Overall Study|Adverse Event|0|||
130599869|NCT01089725|470156149|FG003|Overall Study|Adverse Event|0|||
130599870|NCT01089725|470156150|FG004|Overall Study|Adverse Event|2|||
130599871|NCT01089725|470156146|FG000|Overall Study|Lack of Efficacy|4|||
130599872|NCT01089725|470156147|FG001|Overall Study|Lack of Efficacy|3|||
130599873|NCT01089725|470156148|FG002|Overall Study|Lack of Efficacy|1|||
130599874|NCT01089725|470156149|FG003|Overall Study|Lack of Efficacy|0|||
130599875|NCT01089725|470156150|FG004|Overall Study|Lack of Efficacy|4|||
130599876|NCT01089725|470156146|FG000|Overall Study|Lost to Follow-up|2|||
130599877|NCT01089725|470156147|FG001|Overall Study|Lost to Follow-up|2|||
130599878|NCT01089725|470156148|FG002|Overall Study|Lost to Follow-up|0|||
130599879|NCT01089725|470156149|FG003|Overall Study|Lost to Follow-up|3|||
130599880|NCT01089725|470156150|FG004|Overall Study|Lost to Follow-up|0|||
130599881|NCT01089725|470156146|FG000|Overall Study|Protocol Violation|0|||
130599882|NCT01089725|470156147|FG001|Overall Study|Protocol Violation|0|||
130599883|NCT01089725|470156148|FG002|Overall Study|Protocol Violation|1|||
130599884|NCT01089725|470156149|FG003|Overall Study|Protocol Violation|1|||
130599885|NCT01089725|470156150|FG004|Overall Study|Protocol Violation|0|||
130599886|NCT01089725|470156146|FG000|Overall Study|Withdrawal by Subject|5|||
130599887|NCT01089725|470156147|FG001|Overall Study|Withdrawal by Subject|5|||
130599888|NCT01089725|470156148|FG002|Overall Study|Withdrawal by Subject|4|||
130599889|NCT01089725|470156149|FG003|Overall Study|Withdrawal by Subject|5|||
130599890|NCT01089725|470156150|FG004|Overall Study|Withdrawal by Subject|4|||
130599891|NCT01089725|470156146|FG000|Overall Study|Study Terminated by Sponsor|51|||
130599892|NCT01089725|470156147|FG001|Overall Study|Study Terminated by Sponsor|56|||
130599893|NCT01089725|470156148|FG002|Overall Study|Study Terminated by Sponsor|53|||
130599894|NCT01089725|470156149|FG003|Overall Study|Study Terminated by Sponsor|68|||
130599895|NCT01089725|470156150|FG004|Overall Study|Study Terminated by Sponsor|68|||
130599896|NCT01089725|470156146|FG000|Overall Study|Randomized, but not treated|0|||
130599897|NCT01089725|470156147|FG001|Overall Study|Randomized, but not treated|1|||
130599898|NCT01089725|470156148|FG002|Overall Study|Randomized, but not treated|2|||
130599899|NCT01089725|470156149|FG003|Overall Study|Randomized, but not treated|1|||
130599900|NCT01089725|470156150|FG004|Overall Study|Randomized, but not treated|2|||
130599901|NCT01089725|470156146|FG000|Overall Study|Other|3|||
130599902|NCT01089725|470156147|FG001|Overall Study|Other|0|||
130599903|NCT01089725|470156148|FG002|Overall Study|Other|0|||
130599904|NCT01089725|470156149|FG003|Overall Study|Other|1|||
130599905|NCT01089725|470156150|FG004|Overall Study|Other|0|||
130599906|NCT01486316|470157627|FG000|Overall Study|Device explanted with/without re-implant|3|||
130599907|NCT01486316|470157628|FG001|Overall Study|Device explanted with/without re-implant|2|||
130599908|NCT01486316|470157629|FG002|Overall Study|Device explanted with/without re-implant|0|||
130599909|NCT01486316|470157630|FG003|Overall Study|Device explanted with/without re-implant|2|||
130599910|NCT01486316|470157627|FG000|Overall Study|Not meeting eligibility criteria|0|||
130599911|NCT01486316|470157628|FG001|Overall Study|Not meeting eligibility criteria|0|||
130599912|NCT01486316|470157629|FG002|Overall Study|Not meeting eligibility criteria|1|||
130599913|NCT01486316|470157630|FG003|Overall Study|Not meeting eligibility criteria|0|||
130599914|NCT01486316|470157627|FG000|Overall Study|Withdrawal by Subject|1|||
130599915|NCT01486316|470157628|FG001|Overall Study|Withdrawal by Subject|0|||
130599916|NCT01486316|470157629|FG002|Overall Study|Withdrawal by Subject|3|||
130599917|NCT01486316|470157630|FG003|Overall Study|Withdrawal by Subject|0|||
130599918|NCT01486316|470157627|FG000|Overall Study|Physician Decision|0|||
130599919|NCT01486316|470157628|FG001|Overall Study|Physician Decision|0|||
130599920|NCT01486316|470157629|FG002|Overall Study|Physician Decision|1|||
130599921|NCT01486316|470157630|FG003|Overall Study|Physician Decision|0|||
130599922|NCT01486316|470157627|FG000|Overall Study|Death|0|||
130599923|NCT01486316|470157628|FG001|Overall Study|Death|1|||
130599924|NCT01486316|470157629|FG002|Overall Study|Death|0|||
130599925|NCT01486316|470157630|FG003|Overall Study|Death|0|||
130599926|NCT02114203|470157646|FG000|Overall Study|Adverse Event|0|||
130599927|NCT02114203|470157647|FG001|Overall Study|Adverse Event|1|||
130599928|NCT02114203|470157648|FG002|Overall Study|Adverse Event|0|||
130599929|NCT02114203|470157646|FG000|Overall Study|Withdrawal by Subject|0|||
130599930|NCT02114203|470157647|FG001|Overall Study|Withdrawal by Subject|1|||
130599931|NCT02114203|470157648|FG002|Overall Study|Withdrawal by Subject|0|||
130599932|NCT01518699|470157650|FG000|Period 2|Protocol Violation|1|||
130599933|NCT01518699|470157651|FG001|Period 2|Protocol Violation|1|||
130599934|NCT01518699|470157652|FG002|Period 2|Protocol Violation|0|||
130599935|NCT01518699|470157653|FG003|Period 2|Protocol Violation|0|||
130599936|NCT01518699|470157654|FG004|Period 2|Protocol Violation|0|||
130599937|NCT01518699|470157655|FG005|Period 2|Protocol Violation|0|||
130599938|NCT01518699|470157650|FG000|Period 2|Lost to Follow-up|0|||
130599939|NCT01518699|470157651|FG001|Period 2|Lost to Follow-up|1|||
130599940|NCT01518699|470157652|FG002|Period 2|Lost to Follow-up|0|||
130599941|NCT01518699|470157653|FG003|Period 2|Lost to Follow-up|0|||
130599942|NCT01518699|470157654|FG004|Period 2|Lost to Follow-up|0|||
130599943|NCT01518699|470157655|FG005|Period 2|Lost to Follow-up|0|||
130599944|NCT01518699|470157650|FG000|Period 2|Adverse Event|1|||
130599945|NCT01518699|470157651|FG001|Period 2|Adverse Event|0|||
130599946|NCT01518699|470157652|FG002|Period 2|Adverse Event|0|||
130599947|NCT01518699|470157653|FG003|Period 2|Adverse Event|0|||
130599948|NCT01518699|470157654|FG004|Period 2|Adverse Event|0|||
130599949|NCT01518699|470157655|FG005|Period 2|Adverse Event|0|||
130599950|NCT02839746|470157657|FG000|Overall Study|Not met selection criteria|12|||
130599951|NCT01978912|470157658|FG000|Overall Study|Adverse Event|0|||
130599952|NCT01978912|470157659|FG001|Overall Study|Adverse Event|1|||
130599953|NCT01978912|470157660|FG002|Overall Study|Adverse Event|0|||
130599954|NCT01978912|470157661|FG003|Overall Study|Adverse Event|0|||
130599955|NCT01978912|470157658|FG000|Overall Study|Lost to Follow-up|1|||
130599956|NCT01978912|470157659|FG001|Overall Study|Lost to Follow-up|1|||
130599957|NCT01978912|470157660|FG002|Overall Study|Lost to Follow-up|0|||
130599958|NCT01978912|470157661|FG003|Overall Study|Lost to Follow-up|1|||
130599959|NCT01978912|470157658|FG000|Overall Study|Withdrawal by Subject|1|||
130599960|NCT01978912|470157659|FG001|Overall Study|Withdrawal by Subject|0|||
130599961|NCT01978912|470157660|FG002|Overall Study|Withdrawal by Subject|2|||
130599962|NCT01978912|470157661|FG003|Overall Study|Withdrawal by Subject|2|||
130599963|NCT01978912|470157658|FG000|Overall Study|Lumbar Surgery|1|||
130599964|NCT01978912|470157659|FG001|Overall Study|Lumbar Surgery|0|||
130599965|NCT01978912|470157660|FG002|Overall Study|Lumbar Surgery|1|||
130599966|NCT01978912|470157661|FG003|Overall Study|Lumbar Surgery|0|||
130599967|NCT01978912|470157658|FG000|Overall Study|Intradiscal Steroid Injection|0|||
130599968|NCT01978912|470157659|FG001|Overall Study|Intradiscal Steroid Injection|1|||
130599969|NCT01978912|470157660|FG002|Overall Study|Intradiscal Steroid Injection|0|||
130599970|NCT01978912|470157661|FG003|Overall Study|Intradiscal Steroid Injection|0|||
130599971|NCT04220866|470157662|FG000|Overall Study|Death|4|||
130599972|NCT04220866|470157663|FG001|Overall Study|Death|5|||
130599973|NCT04220866|470157662|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
130599974|NCT04220866|470157663|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
130599975|NCT04220866|470157662|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
130599976|NCT04220866|470157663|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
130599977|NCT04220866|470157662|FG000|Overall Study|Withdrawal by Subject|0|||
130599978|NCT04220866|470157663|FG001|Overall Study|Withdrawal by Subject|1|||
130599979|NCT03515538|470157664|FG000|Overall Study|Lack of Efficacy|2|||
130599980|NCT03515538|470157665|FG001|Overall Study|Lack of Efficacy|0|||
130599981|NCT03515538|470157666|FG002|Overall Study|Lack of Efficacy|2|||
130599982|NCT03515538|470157667|FG003|Overall Study|Lack of Efficacy|0|||
130599983|NCT03515538|470157664|FG000|Overall Study|Death|0|||
130599984|NCT03515538|470157665|FG001|Overall Study|Death|0|||
130599985|NCT03515538|470157666|FG002|Overall Study|Death|1|||
130599986|NCT03515538|470157667|FG003|Overall Study|Death|0|||
130599987|NCT03515538|470157664|FG000|Overall Study|Protocol Violation|0|||
130599988|NCT03515538|470157665|FG001|Overall Study|Protocol Violation|0|||
130599989|NCT03515538|470157666|FG002|Overall Study|Protocol Violation|0|||
130599990|NCT03515538|470157667|FG003|Overall Study|Protocol Violation|1|||
130599991|NCT03515538|470157664|FG000|Overall Study|Screen failure (baseline dropout)|0|||
130599992|NCT03515538|470157665|FG001|Overall Study|Screen failure (baseline dropout)|1|||
130599993|NCT03515538|470157666|FG002|Overall Study|Screen failure (baseline dropout)|0|||
130599994|NCT03515538|470157667|FG003|Overall Study|Screen failure (baseline dropout)|0|||
130599995|NCT03515538|470157664|FG000|Overall Study|Withdrawal by Subject|2|||
130599996|NCT03515538|470157665|FG001|Overall Study|Withdrawal by Subject|2|||
130599997|NCT03515538|470157666|FG002|Overall Study|Withdrawal by Subject|1|||
130599998|NCT03515538|470157667|FG003|Overall Study|Withdrawal by Subject|3|||
130599999|NCT03515538|470157664|FG000|Overall Study|Physician Decision|1|||
130600000|NCT03515538|470157665|FG001|Overall Study|Physician Decision|0|||
130600001|NCT03515538|470157666|FG002|Overall Study|Physician Decision|0|||
130600002|NCT03515538|470157667|FG003|Overall Study|Physician Decision|1|||
130600003|NCT00546351|470157673|FG000|Overall Study|Adverse Event|76|||
130600004|NCT00546351|470157673|FG000|Overall Study|Lack of Efficacy|15|||
130600005|NCT00546351|470157673|FG000|Overall Study|Withdrawal by Subject|109|||
130600006|NCT00546351|470157673|FG000|Overall Study|Lost to Follow-up|9|||
130600007|NCT00546351|470157673|FG000|Overall Study|Protocol Deviation|1|||
130600008|NCT00546351|470157673|FG000|Overall Study|Unsatisfactory compliance|9|||
130600009|NCT00546351|470157673|FG000|Overall Study|Other reasons for premature termination|17|||
130600010|NCT03952650|470157674|FG000|Overall Study|TRAVEL|0|||
130600011|NCT03952650|470157675|FG001|Overall Study|TRAVEL|4|||
130600012|NCT03952650|470157676|FG002|Overall Study|TRAVEL|0|||
130600013|NCT03952650|470157677|FG003|Overall Study|TRAVEL|4|||
130600014|NCT03952650|470157678|FG004|Overall Study|TRAVEL|0|||
130600015|NCT03952650|470157679|FG005|Overall Study|TRAVEL|3|||
130600016|NCT03952650|470157680|FG006|Overall Study|TRAVEL|2|||
130600017|NCT03952650|470157674|FG000|Overall Study|Withdrawal by Subject|0|||
130600018|NCT03952650|470157675|FG001|Overall Study|Withdrawal by Subject|2|||
130600019|NCT03952650|470157676|FG002|Overall Study|Withdrawal by Subject|0|||
130600020|NCT03952650|470157677|FG003|Overall Study|Withdrawal by Subject|3|||
130600021|NCT03952650|470157678|FG004|Overall Study|Withdrawal by Subject|0|||
130600022|NCT03952650|470157679|FG005|Overall Study|Withdrawal by Subject|1|||
130600023|NCT03952650|470157680|FG006|Overall Study|Withdrawal by Subject|1|||
130600024|NCT03952650|470157674|FG000|Overall Study|Lost to Follow-up|0|||
130600025|NCT03952650|470157675|FG001|Overall Study|Lost to Follow-up|1|||
130600026|NCT03952650|470157676|FG002|Overall Study|Lost to Follow-up|0|||
130600027|NCT03952650|470157677|FG003|Overall Study|Lost to Follow-up|0|||
130600028|NCT03952650|470157678|FG004|Overall Study|Lost to Follow-up|0|||
130600029|NCT03952650|470157679|FG005|Overall Study|Lost to Follow-up|1|||
130600030|NCT03952650|470157680|FG006|Overall Study|Lost to Follow-up|1|||
130600031|NCT03952650|470157674|FG000|Overall Study|Received wrong vaccine and travelled|0|||
130600032|NCT03952650|470157675|FG001|Overall Study|Received wrong vaccine and travelled|0|||
130600033|NCT03952650|470157676|FG002|Overall Study|Received wrong vaccine and travelled|0|||
130600034|NCT03952650|470157677|FG003|Overall Study|Received wrong vaccine and travelled|0|||
130600035|NCT03952650|470157678|FG004|Overall Study|Received wrong vaccine and travelled|0|||
130600036|NCT03952650|470157679|FG005|Overall Study|Received wrong vaccine and travelled|1|||
130600037|NCT03952650|470157680|FG006|Overall Study|Received wrong vaccine and travelled|0|||
130600038|NCT03952650|470157674|FG000|Overall Study|Unable to make study visit|0|||
130600039|NCT03952650|470157675|FG001|Overall Study|Unable to make study visit|0|||
130600040|NCT03952650|470157676|FG002|Overall Study|Unable to make study visit|0|||
130600041|NCT03952650|470157677|FG003|Overall Study|Unable to make study visit|0|||
130600042|NCT03952650|470157678|FG004|Overall Study|Unable to make study visit|0|||
130600043|NCT03952650|470157679|FG005|Overall Study|Unable to make study visit|1|||
130600044|NCT03952650|470157680|FG006|Overall Study|Unable to make study visit|0|||
130600045|NCT01357239|470157681|FG000|Stratum: All Patients|Adverse Event|0|||
130600046|NCT01357239|470157682|FG001|Stratum: All Patients|Adverse Event|0|||
130600047|NCT01357239|470157683|FG002|Stratum: All Patients|Adverse Event|1|||
130600048|NCT01357239|470157684|FG003|Stratum: All Patients|Adverse Event|1|||
130600049|NCT01357239|470157681|FG000|Stratum: All Patients|Subject withdrew consent|0|||
130600050|NCT01357239|470157682|FG001|Stratum: All Patients|Subject withdrew consent|0|||
130600051|NCT01357239|470157683|FG002|Stratum: All Patients|Subject withdrew consent|1|||
130600052|NCT01357239|470157684|FG003|Stratum: All Patients|Subject withdrew consent|1|||
130600053|NCT01357239|470157681|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
130600054|NCT01357239|470157682|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
130600055|NCT01357239|470157683|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
130600056|NCT01357239|470157684|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
130600057|NCT01357239|470157681|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
130600058|NCT01357239|470157682|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
130600059|NCT01357239|470157683|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
130600060|NCT01357239|470157684|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
130600061|NCT01357239|470157681|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
130600062|NCT01357239|470157682|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
130600063|NCT01357239|470157683|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
130600064|NCT01357239|470157684|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
130600065|NCT00545818|470157693|FG000|Overall Study|Protocol Violation|1|||
130600066|NCT00545818|470157694|FG001|Overall Study|Protocol Violation|0|||
130600067|NCT00545818|470157693|FG000|Overall Study|Adverse Event|1|||
130600068|NCT00545818|470157694|FG001|Overall Study|Adverse Event|1|||
130600069|NCT00545818|470157693|FG000|Overall Study|Lost to Follow-up|1|||
130600070|NCT00545818|470157694|FG001|Overall Study|Lost to Follow-up|6|||
130600071|NCT00609609|470157695|FG000|Overall Study|Withdrawal by Subject|2|||
130600072|NCT00609609|470157696|FG001|Overall Study|Withdrawal by Subject|0|||
130600073|NCT00609609|470157695|FG000|Overall Study|Progression|4|||
130600074|NCT00609609|470157696|FG001|Overall Study|Progression|2|||
130600075|NCT00670111|470157697|FG000|Enrollment to One Month|Testing Failure|0|||
130600076|NCT00670111|470157698|FG001|Enrollment to One Month|Testing Failure|0|||
130600077|NCT00670111|470157699|FG002|Enrollment to One Month|Testing Failure|13|||
130600078|NCT00670111|470157697|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
130600079|NCT00670111|470157698|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
130600080|NCT00670111|470157699|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
130600081|NCT00670111|470157697|FG000|Enrollment to One Month|Physician Decision|1|||
130600082|NCT00670111|470157698|FG001|Enrollment to One Month|Physician Decision|0|||
130600083|NCT00670111|470157699|FG002|Enrollment to One Month|Physician Decision|0|||
130600084|NCT03988751|470157700|FG000|Overall Study|Withdrawal by Subject|1|||
130600085|NCT03988751|470157701|FG001|Overall Study|Withdrawal by Subject|0|||
130600086|NCT03988751|470157700|FG000|Overall Study|Protocol Violation|0|||
130600087|NCT03988751|470157701|FG001|Overall Study|Protocol Violation|1|||
130600088|NCT00844883|470157702|FG000|Overall Study|Bridged to liver transplant|3|||
130600089|NCT00844883|470157702|FG000|Overall Study|Bridged to resection|1|||
130600090|NCT02623361|470157705|FG000|Overall Study|Protocol Violation|0|||
130600091|NCT02623361|470157706|FG001|Overall Study|Protocol Violation|1|||
130600092|NCT02623361|470157705|FG000|Overall Study|Withdrawal by Subject|0|||
130600093|NCT02623361|470157706|FG001|Overall Study|Withdrawal by Subject|1|||
130600094|NCT03000452|470157709|FG000|Treatment Period|Death|1|||
130600095|NCT03000452|470157709|FG000|Treatment Period|Progressive Disease (PD)|14|||
130600096|NCT03000452|470157709|FG000|Treatment Period|Physician Decision|1|||
130600097|NCT03000452|470157709|FG000|Treatment Period|Miscellaneous|2|||
130600098|NCT03000452|470157709|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
130600099|NCT03000452|470157709|FG000|Follow-Up Period|Death|3|||
130600100|NCT03000452|470157709|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130600101|NCT00537823|470157712|FG000|Overall Study|Adverse Event|2|||
130600102|NCT00537823|470157713|FG001|Overall Study|Adverse Event|0|||
130600103|NCT03065530|470157714|FG000|Overall Study|Lack of Efficacy|1|||
130600104|NCT03065530|470157715|FG001|Overall Study|Lack of Efficacy|1|||
130600105|NCT03065530|470157716|FG002|Overall Study|Lack of Efficacy|0|||
130600106|NCT03065530|470157717|FG003|Overall Study|Lack of Efficacy|1|||
130600107|NCT03065530|470157714|FG000|Overall Study|Protocol Violation|1|||
130600108|NCT03065530|470157715|FG001|Overall Study|Protocol Violation|0|||
130600109|NCT03065530|470157716|FG002|Overall Study|Protocol Violation|1|||
130600110|NCT03065530|470157717|FG003|Overall Study|Protocol Violation|1|||
130600111|NCT03455543|470157718|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
130600112|NCT03455543|470157719|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
130600113|NCT03455543|470157720|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
130600114|NCT03455543|470157718|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
130600115|NCT03455543|470157719|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
130600116|NCT03455543|470157720|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
130600117|NCT03455543|470157718|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
130600118|NCT03455543|470157719|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
130600119|NCT03455543|470157720|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
130600120|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
130600121|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
130600122|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
130600123|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
130600124|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
130600125|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
130600126|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
130600127|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
130600128|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
130600129|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
130600130|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
130600131|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
130600132|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
130600133|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
130600134|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
130600135|NCT03455543|470157718|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
130600136|NCT03455543|470157719|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
130600137|NCT03455543|470157720|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
130600138|NCT02873221|470157721|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130600139|NCT02873221|470157722|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
130600140|NCT02873221|470157723|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
130600141|NCT02873221|470157721|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
130600142|NCT02873221|470157722|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
130600143|NCT02873221|470157723|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
130600144|NCT02873221|470157721|FG000|Treatment Period|Protocol Violation|2|||
130600145|NCT02873221|470157722|FG001|Treatment Period|Protocol Violation|5|||
130600146|NCT02873221|470157723|FG002|Treatment Period|Protocol Violation|8|||
130600147|NCT02873221|470157721|FG000|Treatment Period|Pregnancy|4|||
130600148|NCT02873221|470157722|FG001|Treatment Period|Pregnancy|6|||
130600149|NCT02873221|470157723|FG002|Treatment Period|Pregnancy|3|||
130600150|NCT02873221|470157721|FG000|Treatment Period|Lack of Qualifying Event|0|||
130600151|NCT02873221|470157722|FG001|Treatment Period|Lack of Qualifying Event|3|||
130600152|NCT02873221|470157723|FG002|Treatment Period|Lack of Qualifying Event|1|||
130600153|NCT02873221|470157721|FG000|Treatment Period|Withdrawal of Consent|52|||
130600154|NCT02873221|470157722|FG001|Treatment Period|Withdrawal of Consent|51|||
130600155|NCT02873221|470157723|FG002|Treatment Period|Withdrawal of Consent|41|||
130600156|NCT02873221|470157721|FG000|Treatment Period|Lack of Efficacy|0|||
130600157|NCT02873221|470157722|FG001|Treatment Period|Lack of Efficacy|17|||
130600158|NCT02873221|470157723|FG002|Treatment Period|Lack of Efficacy|12|||
130600159|NCT02873221|470157721|FG000|Treatment Period|Adverse Event|4|||
130600160|NCT02873221|470157722|FG001|Treatment Period|Adverse Event|9|||
130600161|NCT02873221|470157723|FG002|Treatment Period|Adverse Event|11|||
130600162|NCT02873221|470157721|FG000|Treatment Period|Lost to Follow-up|26|||
130600163|NCT02873221|470157722|FG001|Treatment Period|Lost to Follow-up|30|||
130600164|NCT02873221|470157723|FG002|Treatment Period|Lost to Follow-up|26|||
130600165|NCT02873221|470157721|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130600166|NCT02873221|470157722|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
130600167|NCT02873221|470157723|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130600168|NCT02873221|470157721|FG000|Safety Follow-up Period|Protocol Violation|0|||
130600169|NCT02873221|470157722|FG001|Safety Follow-up Period|Protocol Violation|0|||
130600170|NCT02873221|470157723|FG002|Safety Follow-up Period|Protocol Violation|1|||
130600171|NCT02873221|470157721|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
130600172|NCT02873221|470157722|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
130600173|NCT02873221|470157723|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
130600174|NCT02873221|470157721|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
130600175|NCT02873221|470157722|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
130600176|NCT02873221|470157723|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
130600177|NCT00852930|470157726|FG000|Overall Study|Withdrawal by Subject|1|||
130600178|NCT00852930|470157727|FG001|Overall Study|Withdrawal by Subject|1|||
130600179|NCT00852930|470157728|FG002|Overall Study|Withdrawal by Subject|1|||
130600180|NCT00852930|470157726|FG000|Overall Study|Physician Decision|0|||
130600181|NCT00852930|470157727|FG001|Overall Study|Physician Decision|0|||
130600182|NCT00852930|470157728|FG002|Overall Study|Physician Decision|1|||
130600183|NCT00479466|470157729|FG000|Overall Study|Adverse Event|5|||
130600184|NCT00479466|470157730|FG001|Overall Study|Adverse Event|1|||
130600185|NCT00479466|470157731|FG002|Overall Study|Adverse Event|0|||
130600186|NCT00479466|470157732|FG003|Overall Study|Adverse Event|1|||
130600187|NCT00479466|470157733|FG004|Overall Study|Adverse Event|2|||
130600188|NCT00479466|470157734|FG005|Overall Study|Adverse Event|0|||
130600189|NCT00479466|470157729|FG000|Overall Study|Hyperglycemia|0|||
130600190|NCT00479466|470157730|FG001|Overall Study|Hyperglycemia|0|||
130600191|NCT00479466|470157731|FG002|Overall Study|Hyperglycemia|0|||
130600192|NCT00479466|470157732|FG003|Overall Study|Hyperglycemia|0|||
130600193|NCT00479466|470157733|FG004|Overall Study|Hyperglycemia|0|||
130600194|NCT00479466|470157734|FG005|Overall Study|Hyperglycemia|1|||
130600195|NCT00479466|470157729|FG000|Overall Study|Lack of Efficacy|2|||
130600196|NCT00479466|470157730|FG001|Overall Study|Lack of Efficacy|0|||
130600197|NCT00479466|470157731|FG002|Overall Study|Lack of Efficacy|1|||
130600198|NCT00479466|470157732|FG003|Overall Study|Lack of Efficacy|0|||
130600199|NCT00479466|470157733|FG004|Overall Study|Lack of Efficacy|0|||
130600200|NCT00479466|470157734|FG005|Overall Study|Lack of Efficacy|0|||
130600201|NCT00479466|470157729|FG000|Overall Study|Lost to Follow-up|0|||
130600202|NCT00479466|470157730|FG001|Overall Study|Lost to Follow-up|1|||
130600203|NCT00479466|470157731|FG002|Overall Study|Lost to Follow-up|1|||
130600204|NCT00479466|470157732|FG003|Overall Study|Lost to Follow-up|0|||
130600205|NCT00479466|470157733|FG004|Overall Study|Lost to Follow-up|2|||
130600206|NCT00479466|470157734|FG005|Overall Study|Lost to Follow-up|2|||
130600207|NCT00479466|470157729|FG000|Overall Study|Physician Decision|2|||
130600208|NCT00479466|470157730|FG001|Overall Study|Physician Decision|1|||
130600209|NCT00479466|470157731|FG002|Overall Study|Physician Decision|1|||
130600210|NCT00479466|470157732|FG003|Overall Study|Physician Decision|0|||
130600211|NCT00479466|470157733|FG004|Overall Study|Physician Decision|0|||
130600212|NCT00479466|470157734|FG005|Overall Study|Physician Decision|0|||
130600213|NCT00479466|470157729|FG000|Overall Study|Pregnancy|0|||
130600214|NCT00479466|470157730|FG001|Overall Study|Pregnancy|0|||
130600215|NCT00479466|470157731|FG002|Overall Study|Pregnancy|0|||
130600216|NCT00479466|470157732|FG003|Overall Study|Pregnancy|0|||
130600217|NCT00479466|470157733|FG004|Overall Study|Pregnancy|1|||
130600218|NCT00479466|470157734|FG005|Overall Study|Pregnancy|0|||
130600219|NCT00479466|470157729|FG000|Overall Study|Protocol Violation|1|||
130600220|NCT00479466|470157730|FG001|Overall Study|Protocol Violation|0|||
130600221|NCT00479466|470157731|FG002|Overall Study|Protocol Violation|0|||
130600222|NCT00479466|470157732|FG003|Overall Study|Protocol Violation|0|||
130600223|NCT00479466|470157733|FG004|Overall Study|Protocol Violation|0|||
130600224|NCT00479466|470157734|FG005|Overall Study|Protocol Violation|0|||
130600225|NCT00479466|470157729|FG000|Overall Study|Withdrawal by Subject|3|||
130600226|NCT00479466|470157730|FG001|Overall Study|Withdrawal by Subject|5|||
130600227|NCT00479466|470157731|FG002|Overall Study|Withdrawal by Subject|0|||
130600228|NCT00479466|470157732|FG003|Overall Study|Withdrawal by Subject|2|||
130600229|NCT00479466|470157733|FG004|Overall Study|Withdrawal by Subject|3|||
130600230|NCT00479466|470157734|FG005|Overall Study|Withdrawal by Subject|1|||
130600231|NCT01325493|470157735|FG000|Overall Study|Protocol Violation|0|||
130600232|NCT01325493|470157736|FG001|Overall Study|Protocol Violation|1|||
130600233|NCT01325493|470157735|FG000|Overall Study|loss of neuromonitoring signals|0|||
130600234|NCT01325493|470157736|FG001|Overall Study|loss of neuromonitoring signals|2|||
130600235|NCT01325493|470157735|FG000|Overall Study|Allergy|1|||
130600236|NCT01325493|470157736|FG001|Overall Study|Allergy|0|||
130600237|NCT02052960|470157748|FG000|Overall Study|Adverse Event|19|||
130600238|NCT02052960|470157749|FG001|Overall Study|Adverse Event|17|||
130600239|NCT02052960|470157748|FG000|Overall Study|Protocol Violation|4|||
130600240|NCT02052960|470157749|FG001|Overall Study|Protocol Violation|3|||
130600241|NCT02052960|470157748|FG000|Overall Study|Withdrawal by Subject|6|||
130600242|NCT02052960|470157749|FG001|Overall Study|Withdrawal by Subject|11|||
130600243|NCT02052960|470157748|FG000|Overall Study|Other|25|||
130600244|NCT02052960|470157749|FG001|Overall Study|Other|15|||
130600245|NCT03633331|470157752|FG000|Overall Study|Withdrawal by Subject|1|||
130600246|NCT03233048|470157753|FG000|Overall Study|Withdrawal by Subject|1|||
130600247|NCT01396525|470157754|FG000|Overall Study|Withdrawal by Subject|8|||
130600248|NCT01396525|470157754|FG000|Overall Study|Death|14|||
130600249|NCT01396525|470157754|FG000|Overall Study|Lost to Follow-up|4|||
130600250|NCT03114969|470157755|FG000|Overall Study|Lost to Follow-up|0|||
130600251|NCT03114969|470157756|FG001|Overall Study|Lost to Follow-up|0|||
130600252|NCT03114969|470157757|FG002|Overall Study|Lost to Follow-up|3|||
130600253|NCT03114969|470157758|FG003|Overall Study|Lost to Follow-up|2|||
130600254|NCT03114969|470157759|FG004|Overall Study|Lost to Follow-up|0|||
130600255|NCT03114969|470157760|FG005|Overall Study|Lost to Follow-up|0|||
130600256|NCT03114969|470157761|FG006|Overall Study|Lost to Follow-up|0|||
130600257|NCT03114969|470157762|FG007|Overall Study|Lost to Follow-up|0|||
130600258|NCT03114969|470157763|FG008|Overall Study|Lost to Follow-up|0|||
130600259|NCT03114969|470157755|FG000|Overall Study|Adverse Event|0|||
130600260|NCT03114969|470157756|FG001|Overall Study|Adverse Event|0|||
130600261|NCT03114969|470157757|FG002|Overall Study|Adverse Event|1|||
130600262|NCT03114969|470157758|FG003|Overall Study|Adverse Event|0|||
130600263|NCT03114969|470157759|FG004|Overall Study|Adverse Event|0|||
130600264|NCT03114969|470157760|FG005|Overall Study|Adverse Event|1|||
130600265|NCT03114969|470157761|FG006|Overall Study|Adverse Event|1|||
130600266|NCT03114969|470157762|FG007|Overall Study|Adverse Event|0|||
130600267|NCT03114969|470157763|FG008|Overall Study|Adverse Event|2|||
130600268|NCT00949650|470157764|FG000|Overall Study|Progressive disease|188|||
130600269|NCT00949650|470157765|FG001|Overall Study|Progressive disease|19|||
130600270|NCT00949650|470157764|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
130600271|NCT00949650|470157765|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
130600272|NCT00949650|470157764|FG000|Overall Study|Other Adverse Event (AE)|28|||
130600273|NCT00949650|470157765|FG001|Overall Study|Other Adverse Event (AE)|17|||
130600274|NCT00949650|470157764|FG000|Overall Study|Protocol Violation|1|||
130600275|NCT00949650|470157765|FG001|Overall Study|Protocol Violation|4|||
130600276|NCT00949650|470157764|FG000|Overall Study|Refusal to continue medication|7|||
130600277|NCT00949650|470157765|FG001|Overall Study|Refusal to continue medication|11|||
130600278|NCT00949650|470157764|FG000|Overall Study|Not treated|1|||
130600279|NCT00949650|470157765|FG001|Overall Study|Not treated|4|||
130600280|NCT00949650|470157764|FG000|Overall Study|Other not specified above|5|||
130600281|NCT00949650|470157765|FG001|Overall Study|Other not specified above|0|||
130600282|NCT01743027|470157774|FG000|Overall Study|Adverse Event|2|||
130600283|NCT01743027|470157775|FG001|Overall Study|Adverse Event|0|||
130600284|NCT01743027|470157776|FG002|Overall Study|Adverse Event|0|||
130600285|NCT01743027|470157777|FG003|Overall Study|Adverse Event|0|||
130600286|NCT01743027|470157774|FG000|Overall Study|Lost to Follow-up|0|||
130600287|NCT01743027|470157775|FG001|Overall Study|Lost to Follow-up|0|||
130600288|NCT01743027|470157776|FG002|Overall Study|Lost to Follow-up|2|||
130600289|NCT01743027|470157777|FG003|Overall Study|Lost to Follow-up|0|||
130600290|NCT01743027|470157774|FG000|Overall Study|Progressive Disease|1|||
130600291|NCT01743027|470157775|FG001|Overall Study|Progressive Disease|4|||
130600292|NCT01743027|470157776|FG002|Overall Study|Progressive Disease|3|||
130600293|NCT01743027|470157777|FG003|Overall Study|Progressive Disease|0|||
130600294|NCT01743027|470157774|FG000|Overall Study|Protocol Violation|1|||
130600295|NCT01743027|470157775|FG001|Overall Study|Protocol Violation|1|||
130600296|NCT01743027|470157776|FG002|Overall Study|Protocol Violation|1|||
130600297|NCT01743027|470157777|FG003|Overall Study|Protocol Violation|0|||
130600298|NCT01743027|470157774|FG000|Overall Study|Withdrawal by Subject|1|||
130600299|NCT01743027|470157775|FG001|Overall Study|Withdrawal by Subject|0|||
130600300|NCT01743027|470157776|FG002|Overall Study|Withdrawal by Subject|3|||
130600301|NCT01743027|470157777|FG003|Overall Study|Withdrawal by Subject|1|||
130600302|NCT00450866|470157778|FG000|Overall Study|Adverse Event|0|||
130600303|NCT00450866|470157779|FG001|Overall Study|Adverse Event|1|||
130600304|NCT00450866|470157778|FG000|Overall Study|Withdrawal by Subject|5|||
130600305|NCT00450866|470157779|FG001|Overall Study|Withdrawal by Subject|2|||
130600306|NCT00450866|470157778|FG000|Overall Study|Death|1|||
130600307|NCT00450866|470157779|FG001|Overall Study|Death|0|||
130600308|NCT00450866|470157778|FG000|Overall Study|Physician Decision|1|||
130600309|NCT00450866|470157779|FG001|Overall Study|Physician Decision|0|||
130600310|NCT02111811|470157782|FG000|Treatment Phase|Lost to Follow-up|22|||
130600311|NCT02111811|470157783|FG001|Treatment Phase|Lost to Follow-up|18|||
130600312|NCT02111811|470157782|FG000|Treatment Phase|Death|2|||
130600313|NCT02111811|470157783|FG001|Treatment Phase|Death|0|||
130600314|NCT02111811|470157782|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
130600315|NCT02111811|470157783|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
130600316|NCT02111811|470157782|FG000|Follow up Period (Aim 2)|Death|2|||
130600317|NCT02111811|470157783|FG001|Follow up Period (Aim 2)|Death|0|||
130600318|NCT00069121|470157785|FG000|Overall Study|Death|286|||
130600319|NCT00069121|470157786|FG001|Overall Study|Death|242|||
130600320|NCT00069121|470157785|FG000|Overall Study|Withdrawal by Subject|18|||
130600321|NCT00069121|470157786|FG001|Overall Study|Withdrawal by Subject|20|||
130600322|NCT00069121|470157785|FG000|Overall Study|Lost to Follow-up|63|||
130600323|NCT00069121|470157786|FG001|Overall Study|Lost to Follow-up|63|||
130600324|NCT00231478|470157792|FG000|Overall Study|Protocol Violation|3|||
130600325|NCT00231478|470157793|FG001|Overall Study|Protocol Violation|2|||
130600326|NCT00231478|470157792|FG000|Overall Study|Refused Treatment|1|||
130600327|NCT00231478|470157793|FG001|Overall Study|Refused Treatment|1|||
130600328|NCT00231478|470157792|FG000|Overall Study|Withdrawal by Subject|1|||
130600329|NCT00231478|470157793|FG001|Overall Study|Withdrawal by Subject|0|||
130600330|NCT00231478|470157792|FG000|Overall Study|Adverse Event|0|||
130600331|NCT00231478|470157793|FG001|Overall Study|Adverse Event|1|||
130600332|NCT00231478|470157792|FG000|Overall Study|Administrative|3|||
130600333|NCT00231478|470157793|FG001|Overall Study|Administrative|2|||
130600334|NCT00393458|470157803|FG000|Overall Study|Adverse Event|35|||
130600335|NCT00393458|470157804|FG001|Overall Study|Adverse Event|24|||
130600336|NCT00393458|470157805|FG002|Overall Study|Adverse Event|40|||
130600337|NCT00393458|470157806|FG003|Overall Study|Adverse Event|35|||
130600338|NCT00393458|470157803|FG000|Overall Study|Subject withdrew consent|27|||
130600339|NCT00393458|470157804|FG001|Overall Study|Subject withdrew consent|40|||
130600340|NCT00393458|470157805|FG002|Overall Study|Subject withdrew consent|33|||
130600341|NCT00393458|470157806|FG003|Overall Study|Subject withdrew consent|50|||
130600342|NCT00393458|470157803|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
130600343|NCT00393458|470157804|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
130600344|NCT00393458|470157805|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
130600345|NCT00393458|470157806|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
130600346|NCT00393458|470157803|FG000|Overall Study|Protocol deviation|11|||
130600347|NCT00393458|470157804|FG001|Overall Study|Protocol deviation|11|||
130600348|NCT00393458|470157805|FG002|Overall Study|Protocol deviation|11|||
130600349|NCT00393458|470157806|FG003|Overall Study|Protocol deviation|10|||
130600350|NCT00393458|470157803|FG000|Overall Study|Administrative problems|7|||
130600351|NCT00393458|470157804|FG001|Overall Study|Administrative problems|8|||
130600352|NCT00393458|470157805|FG002|Overall Study|Administrative problems|5|||
130600353|NCT00393458|470157806|FG003|Overall Study|Administrative problems|2|||
130600354|NCT00393458|470157803|FG000|Overall Study|Lost to Follow-up|5|||
130600355|NCT00393458|470157804|FG001|Overall Study|Lost to Follow-up|6|||
130600356|NCT00393458|470157805|FG002|Overall Study|Lost to Follow-up|5|||
130600357|NCT00393458|470157806|FG003|Overall Study|Lost to Follow-up|3|||
130600358|NCT00393458|470157803|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130600359|NCT00393458|470157804|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130600360|NCT00393458|470157805|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130600361|NCT00393458|470157806|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130600362|NCT00393458|470157803|FG000|Overall Study|Death|1|||
130600363|NCT00393458|470157804|FG001|Overall Study|Death|1|||
130600364|NCT00393458|470157805|FG002|Overall Study|Death|5|||
130600365|NCT00393458|470157806|FG003|Overall Study|Death|5|||
130600366|NCT00393458|470157803|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130600367|NCT00393458|470157804|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130600368|NCT00393458|470157805|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130600369|NCT00393458|470157806|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130600370|NCT00393458|470157803|FG000|Overall Study|Subject no longer requires study drug|0|||
130600371|NCT00393458|470157804|FG001|Overall Study|Subject no longer requires study drug|1|||
130600372|NCT00393458|470157805|FG002|Overall Study|Subject no longer requires study drug|0|||
130600373|NCT00393458|470157806|FG003|Overall Study|Subject no longer requires study drug|0|||
130600374|NCT00104104|470157815|FG000|Overall Study|Adverse Event|8|||
130600375|NCT00104104|470157816|FG001|Overall Study|Adverse Event|8|||
130600376|NCT00104104|470157815|FG000|Overall Study|Abnormal laboratory value(s)|20|||
130600377|NCT00104104|470157816|FG001|Overall Study|Abnormal laboratory value(s)|14|||
130600378|NCT00104104|470157815|FG000|Overall Study|Lack of Efficacy|0|||
130600379|NCT00104104|470157816|FG001|Overall Study|Lack of Efficacy|3|||
130600380|NCT00104104|470157815|FG000|Overall Study|Condition no longer requires study drug|7|||
130600381|NCT00104104|470157816|FG001|Overall Study|Condition no longer requires study drug|4|||
130600382|NCT00104104|470157815|FG000|Overall Study|Protocol Violation|5|||
130600383|NCT00104104|470157816|FG001|Overall Study|Protocol Violation|2|||
130600384|NCT00104104|470157815|FG000|Overall Study|Withdrawal by Subject|11|||
130600385|NCT00104104|470157816|FG001|Overall Study|Withdrawal by Subject|15|||
130600386|NCT00104104|470157815|FG000|Overall Study|Lost to Follow-up|3|||
130600387|NCT00104104|470157816|FG001|Overall Study|Lost to Follow-up|7|||
130600388|NCT00104104|470157815|FG000|Overall Study|Administrative problems|12|||
130600389|NCT00104104|470157816|FG001|Overall Study|Administrative problems|13|||
130600390|NCT00104104|470157815|FG000|Overall Study|Death|9|||
130600391|NCT00104104|470157816|FG001|Overall Study|Death|6|||
130600392|NCT01821677|470157817|FG000|Overall Study|Adverse Event|4|||
130600393|NCT01821677|470157818|FG001|Overall Study|Adverse Event|6|||
130600394|NCT01821677|470157819|FG002|Overall Study|Adverse Event|5|||
130600395|NCT01821677|470157817|FG000|Overall Study|Physician Decision|1|||
130600396|NCT01821677|470157818|FG001|Overall Study|Physician Decision|4|||
130600397|NCT01821677|470157819|FG002|Overall Study|Physician Decision|1|||
130600398|NCT01821677|470157817|FG000|Overall Study|Non-compliance|0|||
130600399|NCT01821677|470157818|FG001|Overall Study|Non-compliance|1|||
130600400|NCT01821677|470157819|FG002|Overall Study|Non-compliance|2|||
130600401|NCT01821677|470157817|FG000|Overall Study|Lost to Follow-up|2|||
130600402|NCT01821677|470157818|FG001|Overall Study|Lost to Follow-up|1|||
130600403|NCT01821677|470157819|FG002|Overall Study|Lost to Follow-up|3|||
130600404|NCT01821677|470157817|FG000|Overall Study|Protocol Violation|0|||
130600405|NCT01821677|470157818|FG001|Overall Study|Protocol Violation|0|||
130600406|NCT01821677|470157819|FG002|Overall Study|Protocol Violation|2|||
130600407|NCT01821677|470157817|FG000|Overall Study|Withdrawal by Subject|7|||
130600408|NCT01821677|470157818|FG001|Overall Study|Withdrawal by Subject|3|||
130600409|NCT01821677|470157819|FG002|Overall Study|Withdrawal by Subject|2|||
130600410|NCT01821677|470157817|FG000|Overall Study|Other|9|||
130600411|NCT01821677|470157818|FG001|Overall Study|Other|0|||
130600412|NCT01821677|470157819|FG002|Overall Study|Other|0|||
130600413|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
130600414|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
130600415|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
130600416|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
130600417|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
130600418|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130600419|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130600420|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130600421|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
130600422|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
130600423|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
130600424|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
130600425|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130600426|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130600427|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
130600428|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130600429|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
130600430|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130600431|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130600432|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
130600433|NCT01894516|470159534|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130600434|NCT01894516|470159535|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
130600435|NCT01894516|470159536|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
130600436|NCT01894516|470159537|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130600437|NCT01894516|470159534|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
130600438|NCT01894516|470159535|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
130600439|NCT01894516|470159536|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
130600440|NCT01894516|470159537|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
130600441|NCT01894516|470159534|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130600442|NCT01894516|470159535|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130600443|NCT01894516|470159536|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
130600444|NCT01894516|470159537|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130600445|NCT03635190|470159538|FG000|Overall Study|Lost to Follow-up|4|||
130600446|NCT03635190|470159538|FG000|Overall Study|Death|3|||
130600447|NCT03635190|470159538|FG000|Overall Study|Withdrawal by Subject|1|||
130600448|NCT03635190|470159538|FG000|Overall Study|Patient moved and did not return for follow up|1|||
130600449|NCT03692910|470159539|FG000|Overall Study|Lost to Follow-up|4|||
130600450|NCT03692910|470159540|FG001|Overall Study|Lost to Follow-up|0|||
130600451|NCT03692910|470159541|FG002|Overall Study|Lost to Follow-up|0|||
130600452|NCT03692910|470159539|FG000|Overall Study|Withdrawal by Subject|2|||
130600453|NCT03692910|470159540|FG001|Overall Study|Withdrawal by Subject|0|||
130600454|NCT03692910|470159541|FG002|Overall Study|Withdrawal by Subject|0|||
130600455|NCT01981122|470159542|FG000|Overall Study|Withdrawal by Subject|0|||
130600456|NCT01981122|470159543|FG001|Overall Study|Withdrawal by Subject|2|||
130600457|NCT01981122|470159542|FG000|Overall Study|Protocol Violation|0|||
130600458|NCT01981122|470159543|FG001|Overall Study|Protocol Violation|1|||
130600459|NCT01981122|470159542|FG000|Overall Study|Lost to Follow-up|0|||
130600460|NCT01981122|470159543|FG001|Overall Study|Lost to Follow-up|1|||
130600461|NCT01981122|470159542|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
130600462|NCT01981122|470159543|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
130600463|NCT01981122|470159542|FG000|Overall Study|Death|14|||
130600464|NCT01981122|470159543|FG001|Overall Study|Death|15|||
130600465|NCT01277289|470159545|FG000|Overall Study|fragile vein|1|||
130600466|NCT01277289|470159546|FG001|Overall Study|fragile vein|0|||
130600467|NCT01277289|470159545|FG000|Overall Study|Physician Decision|1|||
130600468|NCT01277289|470159546|FG001|Overall Study|Physician Decision|0|||
130600469|NCT01277289|470159545|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
130600470|NCT01277289|470159546|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
130600471|NCT01277289|470159545|FG000|Overall Study|Protocol Violation|1|||
130600472|NCT01277289|470159546|FG001|Overall Study|Protocol Violation|1|||
130600473|NCT01277289|470159545|FG000|Overall Study|Adverse Event|2|||
130600474|NCT01277289|470159546|FG001|Overall Study|Adverse Event|1|||
130600475|NCT01277289|470159545|FG000|Overall Study|consent withdrawn|1|||
130600476|NCT01277289|470159546|FG001|Overall Study|consent withdrawn|1|||
130600477|NCT01277289|470159545|FG000|Overall Study|premature closure of the study|4|||
130600478|NCT01277289|470159546|FG001|Overall Study|premature closure of the study|2|||
130600479|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
130600480|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
130600481|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
130600482|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
130600483|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
130600484|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
130600485|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
130600486|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
130600487|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
130600488|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
130600489|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
130600490|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
130600491|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
130600492|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
130600493|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
130600494|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
130600495|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
130600496|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
130600497|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
130600498|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
130600499|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
130600500|NCT00092547|470159547|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
130600501|NCT00092547|470159548|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
130600502|NCT00092547|470159549|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
130600503|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
130600504|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
130600505|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
130600506|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
130600507|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
130600508|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
130600509|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
130600510|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
130600511|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
130600512|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
130600513|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
130600514|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
130600515|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
130600516|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
130600517|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
130600518|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
130600519|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
130600520|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
130600521|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
130600522|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
130600523|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
130600524|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
130600525|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
130600526|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
130600527|NCT00092547|470159547|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
130600528|NCT00092547|470159548|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
130600529|NCT00092547|470159549|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
130600530|NCT00092547|470159547|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
130600531|NCT00092547|470159548|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
130600532|NCT00092547|470159549|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
130600533|NCT00092547|470159547|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
130600534|NCT00092547|470159548|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
130600535|NCT00092547|470159549|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
130600536|NCT00092547|470159547|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
130600537|NCT00092547|470159548|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
130600538|NCT00092547|470159549|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
130600539|NCT00092547|470159547|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
130600540|NCT00092547|470159548|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
130600541|NCT00092547|470159549|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
130600542|NCT01539837|470159550|FG000|Overall Study|reduce neutrophil level|0|||
130600543|NCT01539837|470159551|FG001|Overall Study|reduce neutrophil level|1|||
130600544|NCT01539837|470159552|FG002|Overall Study|reduce neutrophil level|1|||
130600545|NCT01539837|470159550|FG000|Overall Study|bad compliance|0|||
130600546|NCT01539837|470159551|FG001|Overall Study|bad compliance|0|||
130600547|NCT01539837|470159552|FG002|Overall Study|bad compliance|1|||
130600548|NCT01334125|470159561|FG000|Overall Study|Lost to Follow-up|3|||
130600549|NCT01334125|470159562|FG001|Overall Study|Lost to Follow-up|3|||
130600550|NCT00401973|470159565|FG000|Overall Study|Adverse Event|2|||
130600551|NCT00401973|470159566|FG001|Overall Study|Adverse Event|8|||
130600552|NCT00401973|470159567|FG002|Overall Study|Adverse Event|4|||
130600553|NCT00401973|470159565|FG000|Overall Study|Clinical Relapse|0|||
130600554|NCT00401973|470159566|FG001|Overall Study|Clinical Relapse|1|||
130600555|NCT00401973|470159567|FG002|Overall Study|Clinical Relapse|1|||
130600556|NCT00401973|470159565|FG000|Overall Study|Lack of Efficacy|0|||
130600557|NCT00401973|470159566|FG001|Overall Study|Lack of Efficacy|0|||
130600558|NCT00401973|470159567|FG002|Overall Study|Lack of Efficacy|3|||
130600559|NCT00401973|470159565|FG000|Overall Study|Lost to Follow-up|2|||
130600560|NCT00401973|470159566|FG001|Overall Study|Lost to Follow-up|2|||
130600561|NCT00401973|470159567|FG002|Overall Study|Lost to Follow-up|2|||
130600562|NCT00401973|470159565|FG000|Overall Study|Physician Decision|2|||
130600563|NCT00401973|470159566|FG001|Overall Study|Physician Decision|0|||
130600564|NCT00401973|470159567|FG002|Overall Study|Physician Decision|1|||
130600565|NCT00401973|470159565|FG000|Overall Study|Protocol Violation|1|||
130600566|NCT00401973|470159566|FG001|Overall Study|Protocol Violation|2|||
130600567|NCT00401973|470159567|FG002|Overall Study|Protocol Violation|3|||
130600568|NCT00401973|470159565|FG000|Overall Study|Sponsor Decision|0|||
130600569|NCT00401973|470159566|FG001|Overall Study|Sponsor Decision|1|||
130600570|NCT00401973|470159567|FG002|Overall Study|Sponsor Decision|0|||
130600571|NCT00401973|470159565|FG000|Overall Study|Withdrawal by Subject|4|||
130600572|NCT00401973|470159566|FG001|Overall Study|Withdrawal by Subject|12|||
130600573|NCT00401973|470159567|FG002|Overall Study|Withdrawal by Subject|9|||
130600574|NCT05523362|470159568|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
130600575|NCT05523362|470159568|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
130600576|NCT05523362|470159568|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
130600577|NCT05523362|470159568|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
130600578|NCT04075604|470159569|FG000|Overall Study|Adverse Event|0|||
130600579|NCT04075604|470159570|FG001|Overall Study|Adverse Event|0|||
130600580|NCT04075604|470159571|FG002|Overall Study|Adverse Event|3|||
130600581|NCT04075604|470159569|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130600582|NCT04075604|470159570|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130600583|NCT04075604|470159571|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130600584|NCT04075604|470159569|FG000|Overall Study|Participant withdrew consent|0|||
130600585|NCT04075604|470159570|FG001|Overall Study|Participant withdrew consent|0|||
130600586|NCT04075604|470159571|FG002|Overall Study|Participant withdrew consent|1|||
130600587|NCT04075604|470159569|FG000|Overall Study|Other reasons|1|||
130600588|NCT04075604|470159570|FG001|Overall Study|Other reasons|0|||
130600589|NCT04075604|470159571|FG002|Overall Study|Other reasons|0|||
130600590|NCT04075604|470159569|FG000|Overall Study|Disease progression|0|||
130600591|NCT04075604|470159570|FG001|Overall Study|Disease progression|1|||
130600592|NCT04075604|470159571|FG002|Overall Study|Disease progression|0|||
130600593|NCT04075604|470159569|FG000|Overall Study|Study drug toxicity|0|||
130600594|NCT04075604|470159570|FG001|Overall Study|Study drug toxicity|5|||
130600595|NCT04075604|470159571|FG002|Overall Study|Study drug toxicity|1|||
130600596|NCT04329923|470159574|FG000|Overall Study|Withdrawal by Subject|1|||
130600597|NCT04329923|470159575|FG001|Overall Study|Withdrawal by Subject|4|||
130600598|NCT04329923|470159576|FG002|Overall Study|Withdrawal by Subject|1|||
130600599|NCT04329923|470159577|FG003|Overall Study|Withdrawal by Subject|1|||
130600600|NCT04329923|470159578|FG004|Overall Study|Withdrawal by Subject|1|||
130600601|NCT04329923|470159579|FG005|Overall Study|Withdrawal by Subject|1|||
130600602|NCT04329923|470159574|FG000|Overall Study|early termination of study|0|||
130600603|NCT04329923|470159575|FG001|Overall Study|early termination of study|0|||
130600604|NCT04329923|470159576|FG002|Overall Study|early termination of study|0|||
130600605|NCT04329923|470159577|FG003|Overall Study|early termination of study|0|||
130600606|NCT04329923|470159578|FG004|Overall Study|early termination of study|1|||
130600607|NCT04329923|470159579|FG005|Overall Study|early termination of study|2|||
130600608|NCT04329923|470159574|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130600609|NCT04329923|470159575|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130600610|NCT04329923|470159576|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130600611|NCT04329923|470159577|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130600612|NCT04329923|470159578|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130600613|NCT04329923|470159579|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
130600614|NCT01272180|470159580|FG000|Overall Study|Adverse Event|0|||
130600615|NCT01272180|470159581|FG001|Overall Study|Adverse Event|0|||
130600616|NCT01272180|470159582|FG002|Overall Study|Adverse Event|1|||
130600617|NCT01272180|470159583|FG003|Overall Study|Adverse Event|0|||
130600618|NCT01272180|470159580|FG000|Overall Study|Withdrawal by Subject|2|||
130600619|NCT01272180|470159581|FG001|Overall Study|Withdrawal by Subject|6|||
130600620|NCT01272180|470159582|FG002|Overall Study|Withdrawal by Subject|3|||
130600621|NCT01272180|470159583|FG003|Overall Study|Withdrawal by Subject|2|||
130600622|NCT01272180|470159580|FG000|Overall Study|Lost to Follow-up|15|||
130600623|NCT01272180|470159581|FG001|Overall Study|Lost to Follow-up|14|||
130600624|NCT01272180|470159582|FG002|Overall Study|Lost to Follow-up|8|||
130600625|NCT01272180|470159583|FG003|Overall Study|Lost to Follow-up|10|||
130600626|NCT01272180|470159580|FG000|Overall Study|Inappropriate enrollment|0|||
130600627|NCT01272180|470159581|FG001|Overall Study|Inappropriate enrollment|0|||
130600628|NCT01272180|470159582|FG002|Overall Study|Inappropriate enrollment|1|||
130600629|NCT01272180|470159583|FG003|Overall Study|Inappropriate enrollment|1|||
130600630|NCT01272180|470159580|FG000|Overall Study|Protocol Violation|0|||
130600631|NCT01272180|470159581|FG001|Overall Study|Protocol Violation|1|||
130600632|NCT01272180|470159582|FG002|Overall Study|Protocol Violation|0|||
130600633|NCT01272180|470159583|FG003|Overall Study|Protocol Violation|1|||
130600634|NCT01183858|470159584|FG000|Overall Study|Death not related to Progressive Disease|5|||
130600635|NCT01183858|470159585|FG001|Overall Study|Death not related to Progressive Disease|6|||
130600636|NCT01183858|470159584|FG000|Overall Study|Adverse Event|14|||
130600637|NCT01183858|470159585|FG001|Overall Study|Adverse Event|11|||
130600638|NCT01183858|470159584|FG000|Overall Study|Investigator's Decision|0|||
130600639|NCT01183858|470159585|FG001|Overall Study|Investigator's Decision|3|||
130600640|NCT01183858|470159584|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130600641|NCT01183858|470159585|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130600642|NCT01183858|470159584|FG000|Overall Study|Refused Treatment|1|||
130600643|NCT01183858|470159585|FG001|Overall Study|Refused Treatment|4|||
130600644|NCT01183858|470159584|FG000|Overall Study|Withdrew Consent|4|||
130600645|NCT01183858|470159585|FG001|Overall Study|Withdrew Consent|4|||
130600646|NCT01183858|470159584|FG000|Overall Study|Discontinued Smoking|3|||
130600647|NCT01183858|470159585|FG001|Overall Study|Discontinued Smoking|1|||
130600648|NCT01183858|470159584|FG000|Overall Study|Protocol Violation|1|||
130600649|NCT01183858|470159585|FG001|Overall Study|Protocol Violation|0|||
130600650|NCT01183858|470159584|FG000|Overall Study|Administrative/Other|6|||
130600651|NCT01183858|470159585|FG001|Overall Study|Administrative/Other|6|||
130600652|NCT01183858|470159584|FG000|Overall Study|Progressive Disease|112|||
130600653|NCT01183858|470159585|FG001|Overall Study|Progressive Disease|115|||
130600654|NCT01183858|470159584|FG000|Overall Study|Death related to Progressive Disease|4|||
130600655|NCT01183858|470159585|FG001|Overall Study|Death related to Progressive Disease|5|||
130600656|NCT01183858|470159584|FG000|Overall Study|Lost to Follow-up|1|||
130600657|NCT01183858|470159585|FG001|Overall Study|Lost to Follow-up|1|||
130600658|NCT03842709|470159586|FG000|Overall Study|Withdrawal by Subject|3|||
130600659|NCT03842709|470159587|FG001|Overall Study|Withdrawal by Subject|3|||
130600660|NCT03842709|470159586|FG000|Overall Study|Lost to Follow-up|1|||
130600661|NCT03842709|470159587|FG001|Overall Study|Lost to Follow-up|0|||
130600662|NCT00641147|470159588|FG000|Completed 4 Months.|Physician Decision|1|||
130600663|NCT00641147|470159589|FG001|Completed 4 Months.|Physician Decision|0|||
130600664|NCT00641147|470159588|FG000|Completed 4 Months.|Adverse Event|1|||
130600665|NCT00641147|470159589|FG001|Completed 4 Months.|Adverse Event|0|||
130600666|NCT00641147|470159588|FG000|Completed 8 Months.|Physician Decision|2|||
130600667|NCT00641147|470159589|FG001|Completed 8 Months.|Physician Decision|1|||
130600668|NCT00641147|470159588|FG000|Completed 8 Months.|non compliance|1|||
130600669|NCT00641147|470159589|FG001|Completed 8 Months.|non compliance|0|||
130600670|NCT00641147|470159588|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
130600671|NCT00641147|470159589|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
130600672|NCT00641147|470159588|FG000|Completed 12 Months.|Physician Decision|1|||
130600673|NCT00641147|470159589|FG001|Completed 12 Months.|Physician Decision|1|||
130600674|NCT00641147|470159588|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
130600675|NCT00641147|470159589|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
130600676|NCT00641147|470159588|FG000|Completed 16 Months.|Physician Decision|1|||
130600677|NCT00641147|470159589|FG001|Completed 16 Months.|Physician Decision|0|||
130600678|NCT00641147|470159588|FG000|Completed 16 Months.|Lost to Follow-up|1|||
130600679|NCT00641147|470159589|FG001|Completed 16 Months.|Lost to Follow-up|0|||
130600680|NCT00791128|470159590|FG000|Overall Study|Adverse Event|4|||
130600681|NCT00791128|470159590|FG000|Overall Study|Device migration|2|||
130600682|NCT00791128|470159590|FG000|Overall Study|non-compliance by subject|2|||
130600683|NCT00791128|470159590|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
130600684|NCT01629667|470159591|FG000|Overall Study|Lost to Follow-up|0|||
130600685|NCT01629667|470159592|FG001|Overall Study|Lost to Follow-up|1|||
130600686|NCT01629667|470159593|FG002|Overall Study|Lost to Follow-up|1|||
130600687|NCT01629667|470159591|FG000|Overall Study|Withdrawal by Subject|31|||
130600688|NCT01629667|470159592|FG001|Overall Study|Withdrawal by Subject|20|||
130600689|NCT01629667|470159593|FG002|Overall Study|Withdrawal by Subject|28|||
130600690|NCT01629667|470159591|FG000|Overall Study|Death|1|||
130600691|NCT01629667|470159592|FG001|Overall Study|Death|5|||
130600692|NCT01629667|470159593|FG002|Overall Study|Death|3|||
130600693|NCT01629667|470159591|FG000|Overall Study|Randomized, not treated|2|||
130600694|NCT01629667|470159592|FG001|Overall Study|Randomized, not treated|1|||
130600695|NCT01629667|470159593|FG002|Overall Study|Randomized, not treated|0|||
130600696|NCT01629667|470159591|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
130600697|NCT01629667|470159592|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
130600698|NCT01629667|470159593|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
130600699|NCT01629667|470159591|FG000|Overall Study|Requiring lung transplant|2|||
130600700|NCT01629667|470159592|FG001|Overall Study|Requiring lung transplant|1|||
130600701|NCT01629667|470159593|FG002|Overall Study|Requiring lung transplant|3|||
130600702|NCT01629667|470159591|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
130600703|NCT01629667|470159592|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
130600704|NCT01629667|470159593|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
130600705|NCT01629667|470159591|FG000|Overall Study|Started other medicine|1|||
130600706|NCT01629667|470159592|FG001|Overall Study|Started other medicine|0|||
130600707|NCT01629667|470159593|FG002|Overall Study|Started other medicine|1|||
130600708|NCT01629667|470159591|FG000|Overall Study|Site error in safety follow-up|0|||
130600709|NCT01629667|470159592|FG001|Overall Study|Site error in safety follow-up|0|||
130600710|NCT01629667|470159593|FG002|Overall Study|Site error in safety follow-up|1|||
130600711|NCT01629667|470159591|FG000|Overall Study|Enrolled in another clinical study|0|||
130600712|NCT01629667|470159592|FG001|Overall Study|Enrolled in another clinical study|1|||
130600713|NCT01629667|470159593|FG002|Overall Study|Enrolled in another clinical study|0|||
130600714|NCT01629667|470159591|FG000|Overall Study|Code break|1|||
130600715|NCT01629667|470159592|FG001|Overall Study|Code break|0|||
130600716|NCT01629667|470159593|FG002|Overall Study|Code break|0|||
130600717|NCT02424149|470159594|FG000|Overall Study|surgery cancelled|2|||
130600718|NCT02424149|470159595|FG001|Overall Study|surgery cancelled|0|||
130600719|NCT02424149|470159594|FG000|Overall Study|Withdrawal by Subject|0|||
130600720|NCT02424149|470159595|FG001|Overall Study|Withdrawal by Subject|1|||
130600721|NCT00592683|470159596|FG000|Overall Study|Found ineligible|0|||
130600722|NCT00592683|470159597|FG001|Overall Study|Found ineligible|1|||
130600723|NCT00592683|470159596|FG000|Overall Study|Withdrawal by Subject|1|||
130600724|NCT00592683|470159597|FG001|Overall Study|Withdrawal by Subject|0|||
130600725|NCT00592683|470159596|FG000|Overall Study|Adverse Event|0|||
130600726|NCT00592683|470159597|FG001|Overall Study|Adverse Event|2|||
130600727|NCT00592683|470159596|FG000|Overall Study|Protocol Violation|1|||
130600728|NCT00592683|470159597|FG001|Overall Study|Protocol Violation|0|||
130600729|NCT00592683|470159596|FG000|Overall Study|Study drug expired|1|||
130600730|NCT00592683|470159597|FG001|Overall Study|Study drug expired|0|||
130600731|NCT00592683|470159596|FG000|Overall Study|Other|1|||
130600732|NCT00592683|470159597|FG001|Overall Study|Other|0|||
130600733|NCT00592683|470159596|FG000|Overall Study|Lost to Follow-up|0|||
130600734|NCT00592683|470159597|FG001|Overall Study|Lost to Follow-up|1|||
130600735|NCT01050062|470159600|FG000|Overall Study|Adverse Event|75|||
130600736|NCT01050062|470159601|FG001|Overall Study|Adverse Event|22|||
130600737|NCT01050062|470159600|FG000|Overall Study|Lost to Follow-up|83|||
130600738|NCT01050062|470159601|FG001|Overall Study|Lost to Follow-up|35|||
130600739|NCT01050062|470159600|FG000|Overall Study|Lack of Efficacy|22|||
130600740|NCT01050062|470159601|FG001|Overall Study|Lack of Efficacy|35|||
130600741|NCT01050062|470159600|FG000|Overall Study|Physician Decision|74|||
130600742|NCT01050062|470159601|FG001|Overall Study|Physician Decision|9|||
130600743|NCT01050062|470159600|FG000|Overall Study|Others|17|||
130600744|NCT01050062|470159601|FG001|Overall Study|Others|11|||
130600745|NCT02441803|470159604|FG000|Overall Study|Physician Decision|0|||
130600746|NCT02441803|470159605|FG001|Overall Study|Physician Decision|2|||
130600747|NCT02441803|470159606|FG002|Overall Study|Physician Decision|2|||
130600748|NCT01512368|470159612|FG000|Overall Study|Protocol Violation|3|||
130600749|NCT00328198|470159613|FG000|Treatment|Adverse Event|21|||
130600750|NCT00328198|470159613|FG000|Treatment|Death|1|||
130600751|NCT00328198|470159613|FG000|Treatment|Physician Decision|5|||
130600752|NCT00328198|470159613|FG000|Treatment|Withdrawal by Subject|5|||
130600753|NCT00328198|470159613|FG000|Treatment|Evidence of disease progression|2|||
130600754|NCT00328198|470159613|FG000|Treatment|Non-compliance|1|||
130600755|NCT00328198|470159613|FG000|Treatment|Confirmed complete response, MRD -|3|||
130600756|NCT00328198|470159613|FG000|Follow-up|Lost to Follow-up|4|||
130600757|NCT00328198|470159613|FG000|Follow-up|Death|31|||
130600758|NCT02717546|470159615|FG000|Overall Study|Lost to Follow-up|12|||
130600759|NCT02614794|470159617|FG000|Overall Study|Death|258|||
130600760|NCT02614794|470159618|FG001|Overall Study|Death|151|||
130600761|NCT02614794|470159617|FG000|Overall Study|Study closure by Sponsor|119|||
130600762|NCT02614794|470159618|FG001|Overall Study|Study closure by Sponsor|45|||
130600763|NCT02614794|470159617|FG000|Overall Study|Withdrawal by Subject|24|||
130600764|NCT02614794|470159618|FG001|Overall Study|Withdrawal by Subject|5|||
130600765|NCT02614794|470159617|FG000|Overall Study|Lost to Follow-up|7|||
130600766|NCT02614794|470159618|FG001|Overall Study|Lost to Follow-up|0|||
130600767|NCT02614794|470159617|FG000|Overall Study|Physician Decision|1|||
130600768|NCT02614794|470159618|FG001|Overall Study|Physician Decision|1|||
130600769|NCT02614794|470159617|FG000|Overall Study|Hospital closure|1|||
130600770|NCT02614794|470159618|FG001|Overall Study|Hospital closure|0|||
130600771|NCT03396471|470159623|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
130600772|NCT03396471|470159623|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
130600773|NCT03396471|470159623|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
130600774|NCT03396471|470159623|FG000|Study Treatment - Up to 22 Months|Death|2|||
130600775|NCT03396471|470159623|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
130600776|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|Death|9|||
130600777|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
130600778|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
130600779|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|study terminated|1|||
130600780|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
130600781|NCT03396471|470159623|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
130600782|NCT03237845|470159627|FG000|Overall Study|Adverse Event|0|||
130600783|NCT03237845|470159628|FG001|Overall Study|Adverse Event|1|||
130600784|NCT03237845|470159627|FG000|Overall Study|Lost to Follow-up|13|||
130600785|NCT03237845|470159628|FG001|Overall Study|Lost to Follow-up|10|||
130600786|NCT03237845|470159627|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
130600787|NCT03237845|470159628|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
130600788|NCT03237845|470159627|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
130600789|NCT03237845|470159628|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
130600790|NCT03237845|470159627|FG000|Overall Study|Physician Decision|1|||
130600791|NCT03237845|470159628|FG001|Overall Study|Physician Decision|2|||
130600792|NCT03237845|470159627|FG000|Overall Study|Pregnancy|1|||
130600793|NCT03237845|470159628|FG001|Overall Study|Pregnancy|0|||
130600794|NCT03237845|470159627|FG000|Overall Study|Protocol Deviation|0|||
130600795|NCT03237845|470159628|FG001|Overall Study|Protocol Deviation|1|||
130600796|NCT03237845|470159627|FG000|Overall Study|Technical Problems|8|||
130600797|NCT03237845|470159628|FG001|Overall Study|Technical Problems|1|||
130600798|NCT03237845|470159627|FG000|Overall Study|Withdrawal by Subject|3|||
130600799|NCT03237845|470159628|FG001|Overall Study|Withdrawal by Subject|3|||
130600800|NCT03237845|470159627|FG000|Overall Study|Other Reasons|4|||
130600801|NCT03237845|470159628|FG001|Overall Study|Other Reasons|0|||
130600802|NCT01645280|470159632|FG000|Overall Study|Death|0|||
130600803|NCT01645280|470159633|FG001|Overall Study|Death|1|||
130600804|NCT01645280|470159634|FG002|Overall Study|Death|0|||
130600805|NCT01645280|470159635|FG003|Overall Study|Death|0|||
130600806|NCT01645280|470159636|FG004|Overall Study|Death|0|||
130600807|NCT01645280|470159632|FG000|Overall Study|Withdrawal by Subject|4|||
130600808|NCT01645280|470159633|FG001|Overall Study|Withdrawal by Subject|0|||
130600809|NCT01645280|470159634|FG002|Overall Study|Withdrawal by Subject|2|||
130600810|NCT01645280|470159635|FG003|Overall Study|Withdrawal by Subject|4|||
130600811|NCT01645280|470159636|FG004|Overall Study|Withdrawal by Subject|5|||
130600812|NCT01645280|470159632|FG000|Overall Study|Lost to Follow-up|0|||
130600813|NCT01645280|470159633|FG001|Overall Study|Lost to Follow-up|0|||
130600814|NCT01645280|470159634|FG002|Overall Study|Lost to Follow-up|0|||
130600815|NCT01645280|470159635|FG003|Overall Study|Lost to Follow-up|2|||
130600816|NCT01645280|470159636|FG004|Overall Study|Lost to Follow-up|1|||
130600817|NCT01645280|470159632|FG000|Overall Study|Other|1|||
130600818|NCT01645280|470159633|FG001|Overall Study|Other|1|||
130600819|NCT01645280|470159634|FG002|Overall Study|Other|2|||
130600820|NCT01645280|470159635|FG003|Overall Study|Other|0|||
130600821|NCT01645280|470159636|FG004|Overall Study|Other|0|||
130600822|NCT01645280|470159632|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
130600823|NCT01645280|470159633|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
130600824|NCT01645280|470159634|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
130600825|NCT01645280|470159635|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
130600826|NCT01645280|470159636|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
130600827|NCT00234104|470159641|FG000|Overall Study|Adverse Event|4|||
130600828|NCT00234104|470159642|FG001|Overall Study|Adverse Event|0|||
130600829|NCT00234104|470159643|FG002|Overall Study|Adverse Event|3|||
130600830|NCT00234104|470159644|FG003|Overall Study|Adverse Event|5|||
130600831|NCT00234104|470159641|FG000|Overall Study|Protocol Violation|0|||
130600832|NCT00234104|470159642|FG001|Overall Study|Protocol Violation|0|||
130600833|NCT00234104|470159643|FG002|Overall Study|Protocol Violation|0|||
130600834|NCT00234104|470159644|FG003|Overall Study|Protocol Violation|1|||
130600835|NCT00234104|470159641|FG000|Overall Study|Physician Decision|0|||
130600836|NCT00234104|470159642|FG001|Overall Study|Physician Decision|1|||
130600837|NCT00234104|470159643|FG002|Overall Study|Physician Decision|2|||
130600838|NCT00234104|470159644|FG003|Overall Study|Physician Decision|2|||
130600839|NCT02460822|470159645|FG000|Overall Study|Withdrawal by Subject|1|||
130600840|NCT03849560|470159646|FG000|Overall Study|Withdrawal by Subject|1|||
130600841|NCT03849560|470159647|FG001|Overall Study|Withdrawal by Subject|0|||
130600842|NCT03849560|470159648|FG002|Overall Study|Withdrawal by Subject|0|||
130600843|NCT04045613|470159649|FG000|Overall Study|Adverse Event|2|||
130600844|NCT04045613|470159650|FG001|Overall Study|Adverse Event|2|||
130600845|NCT04045613|470159651|FG002|Overall Study|Adverse Event|1|||
130600846|NCT04045613|470159652|FG003|Overall Study|Adverse Event|1|||
130600847|NCT04045613|470159653|FG004|Overall Study|Adverse Event|0|||
130600848|NCT04045613|470159654|FG005|Overall Study|Adverse Event|0|||
130600849|NCT04045613|470159655|FG006|Overall Study|Adverse Event|1|||
130600850|NCT04045613|470159649|FG000|Overall Study|Withdrawal by Subject|0|||
130600851|NCT04045613|470159650|FG001|Overall Study|Withdrawal by Subject|5|||
130600852|NCT04045613|470159651|FG002|Overall Study|Withdrawal by Subject|0|||
130600853|NCT04045613|470159652|FG003|Overall Study|Withdrawal by Subject|0|||
130600854|NCT04045613|470159653|FG004|Overall Study|Withdrawal by Subject|0|||
130600855|NCT04045613|470159654|FG005|Overall Study|Withdrawal by Subject|1|||
130600856|NCT04045613|470159655|FG006|Overall Study|Withdrawal by Subject|0|||
130600857|NCT04045613|470159649|FG000|Overall Study|Physician Decision|2|||
130600858|NCT04045613|470159650|FG001|Overall Study|Physician Decision|0|||
130600859|NCT04045613|470159651|FG002|Overall Study|Physician Decision|0|||
130600860|NCT04045613|470159652|FG003|Overall Study|Physician Decision|0|||
130600861|NCT04045613|470159653|FG004|Overall Study|Physician Decision|1|||
130600862|NCT04045613|470159654|FG005|Overall Study|Physician Decision|0|||
130600863|NCT04045613|470159655|FG006|Overall Study|Physician Decision|0|||
130600864|NCT04045613|470159649|FG000|Overall Study|Death|3|||
130600865|NCT04045613|470159650|FG001|Overall Study|Death|0|||
130600866|NCT04045613|470159651|FG002|Overall Study|Death|0|||
130600867|NCT04045613|470159652|FG003|Overall Study|Death|0|||
130600868|NCT04045613|470159653|FG004|Overall Study|Death|0|||
130600869|NCT04045613|470159654|FG005|Overall Study|Death|0|||
130600870|NCT04045613|470159655|FG006|Overall Study|Death|1|||
130600871|NCT04045613|470159649|FG000|Overall Study|Other reasons|0|||
130600872|NCT04045613|470159650|FG001|Overall Study|Other reasons|1|||
130600873|NCT04045613|470159651|FG002|Overall Study|Other reasons|0|||
130600874|NCT04045613|470159652|FG003|Overall Study|Other reasons|0|||
130600875|NCT04045613|470159653|FG004|Overall Study|Other reasons|0|||
130600876|NCT04045613|470159654|FG005|Overall Study|Other reasons|0|||
130600877|NCT04045613|470159655|FG006|Overall Study|Other reasons|1|||
130600878|NCT04045613|470159649|FG000|Overall Study|Progressive disease: Clinical progression|1|||
130600879|NCT04045613|470159650|FG001|Overall Study|Progressive disease: Clinical progression|0|||
130600880|NCT04045613|470159651|FG002|Overall Study|Progressive disease: Clinical progression|3|||
130600881|NCT04045613|470159652|FG003|Overall Study|Progressive disease: Clinical progression|1|||
130600882|NCT04045613|470159653|FG004|Overall Study|Progressive disease: Clinical progression|1|||
130600883|NCT04045613|470159654|FG005|Overall Study|Progressive disease: Clinical progression|3|||
130600884|NCT04045613|470159655|FG006|Overall Study|Progressive disease: Clinical progression|3|||
130600885|NCT04045613|470159649|FG000|Overall Study|Progressive disease: Radiological progression|24|||
130600886|NCT04045613|470159650|FG001|Overall Study|Progressive disease: Radiological progression|6|||
130600887|NCT04045613|470159651|FG002|Overall Study|Progressive disease: Radiological progression|8|||
130600888|NCT04045613|470159652|FG003|Overall Study|Progressive disease: Radiological progression|0|||
130600889|NCT04045613|470159653|FG004|Overall Study|Progressive disease: Radiological progression|6|||
130600890|NCT04045613|470159654|FG005|Overall Study|Progressive disease: Radiological progression|6|||
130600891|NCT04045613|470159655|FG006|Overall Study|Progressive disease: Radiological progression|11|||
130600892|NCT01633060|470159658|FG000|Randomization Phase|Protocol deviation|1|||
130600893|NCT01633060|470159659|FG001|Randomization Phase|Protocol deviation|2|||
130600894|NCT01633060|470159658|FG000|Randomization Phase|Technical problem|0|||
130600895|NCT01633060|470159659|FG001|Randomization Phase|Technical problem|1|||
130600896|NCT01633060|470159658|FG000|Treatment Phase|Adverse Event|24|||
130600897|NCT01633060|470159659|FG001|Treatment Phase|Adverse Event|3|||
130600898|NCT01633060|470159658|FG000|Treatment Phase|Lost to Follow-up|1|||
130600899|NCT01633060|470159659|FG001|Treatment Phase|Lost to Follow-up|0|||
130600900|NCT01633060|470159658|FG000|Treatment Phase|Physician Decision|16|||
130600901|NCT01633060|470159659|FG001|Treatment Phase|Physician Decision|7|||
130600902|NCT01633060|470159658|FG000|Treatment Phase|Progressive Disease|210|||
130600903|NCT01633060|470159659|FG001|Treatment Phase|Progressive Disease|120|||
130600904|NCT01633060|470159658|FG000|Treatment Phase|Protocol Deviation|1|||
130600905|NCT01633060|470159659|FG001|Treatment Phase|Protocol Deviation|0|||
130600906|NCT01633060|470159658|FG000|Treatment Phase|Study Terminated by sponsor|7|||
130600907|NCT01633060|470159659|FG001|Treatment Phase|Study Terminated by sponsor|3|||
130600908|NCT01633060|470159658|FG000|Treatment Phase|Subject/guardian decision|25|||
130600909|NCT01633060|470159659|FG001|Treatment Phase|Subject/guardian decision|4|||
130600910|NCT01633060|470159658|FG000|Treatment Phase|Death|4|||
130600911|NCT01633060|470159659|FG001|Treatment Phase|Death|3|||
130600912|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
130600913|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130600914|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
130600915|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
130600916|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
130600917|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
130600918|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
130600919|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
130600920|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130600921|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130600922|NCT01633060|470159658|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
130600923|NCT01633060|470159659|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
130600924|NCT00491530|470159665|FG000|Overall Study|Adverse Event|6|||
130600925|NCT00491530|470159666|FG001|Overall Study|Adverse Event|1|||
130600926|NCT00491530|470159667|FG002|Overall Study|Adverse Event|2|||
130600927|NCT00491530|470159665|FG000|Overall Study|Withdrawal by Subject|3|||
130600928|NCT00491530|470159666|FG001|Overall Study|Withdrawal by Subject|0|||
130600929|NCT00491530|470159667|FG002|Overall Study|Withdrawal by Subject|0|||
130600930|NCT00491530|470159665|FG000|Overall Study|Lost to Follow-up|3|||
130600931|NCT00491530|470159666|FG001|Overall Study|Lost to Follow-up|2|||
130600932|NCT00491530|470159667|FG002|Overall Study|Lost to Follow-up|2|||
130600933|NCT00491530|470159665|FG000|Overall Study|Lack of Efficacy|0|||
130600934|NCT00491530|470159666|FG001|Overall Study|Lack of Efficacy|1|||
130600935|NCT00491530|470159667|FG002|Overall Study|Lack of Efficacy|0|||
130600936|NCT00491530|470159665|FG000|Overall Study|Investigator Discretion|0|||
130600937|NCT00491530|470159666|FG001|Overall Study|Investigator Discretion|1|||
130600938|NCT00491530|470159667|FG002|Overall Study|Investigator Discretion|0|||
130600939|NCT00491530|470159665|FG000|Overall Study|Patient Request|0|||
130600940|NCT00491530|470159666|FG001|Overall Study|Patient Request|1|||
130600941|NCT00491530|470159667|FG002|Overall Study|Patient Request|0|||
130600942|NCT00491530|470159665|FG000|Overall Study|Use of Prohibited Medication|0|||
130600943|NCT00491530|470159666|FG001|Overall Study|Use of Prohibited Medication|0|||
130600944|NCT00491530|470159667|FG002|Overall Study|Use of Prohibited Medication|1|||
130600945|NCT02168946|470159668|FG000|Overall Study|Adverse Event|8|||
130600946|NCT02168946|470159669|FG001|Overall Study|Adverse Event|5|||
130600947|NCT02168946|470159668|FG000|Overall Study|Lost to Follow-up|3|||
130600948|NCT02168946|470159669|FG001|Overall Study|Lost to Follow-up|0|||
130600949|NCT02168946|470159668|FG000|Overall Study|Subject unable to come back for visits|1|||
130600950|NCT02168946|470159669|FG001|Overall Study|Subject unable to come back for visits|0|||
130600951|NCT00553787|470159671|FG000|Overall Study|Adverse Event|34|||
130600952|NCT00553787|470159672|FG001|Overall Study|Adverse Event|21|||
130600953|NCT00553787|470159673|FG002|Overall Study|Adverse Event|67|||
130600954|NCT00553787|470159671|FG000|Overall Study|Lost to Follow-up|132|||
130600955|NCT00553787|470159672|FG001|Overall Study|Lost to Follow-up|44|||
130600956|NCT00553787|470159673|FG002|Overall Study|Lost to Follow-up|78|||
130600957|NCT00553787|470159671|FG000|Overall Study|Withdrawal by Subject|151|||
130600958|NCT00553787|470159672|FG001|Overall Study|Withdrawal by Subject|40|||
130600959|NCT00553787|470159673|FG002|Overall Study|Withdrawal by Subject|83|||
130600960|NCT00553787|470159671|FG000|Overall Study|Lack of Efficacy|31|||
130600961|NCT00553787|470159672|FG001|Overall Study|Lack of Efficacy|1|||
130600962|NCT00553787|470159673|FG002|Overall Study|Lack of Efficacy|3|||
130600963|NCT00553787|470159671|FG000|Overall Study|Pregnancy|0|||
130600964|NCT00553787|470159672|FG001|Overall Study|Pregnancy|1|||
130600965|NCT00553787|470159673|FG002|Overall Study|Pregnancy|2|||
130600966|NCT00553787|470159671|FG000|Overall Study|non compliance|4|||
130600967|NCT00553787|470159672|FG001|Overall Study|non compliance|0|||
130600968|NCT00553787|470159673|FG002|Overall Study|non compliance|11|||
130600969|NCT00553787|470159671|FG000|Overall Study|Requirement for restricted medication|8|||
130600970|NCT00553787|470159672|FG001|Overall Study|Requirement for restricted medication|7|||
130600971|NCT00553787|470159673|FG002|Overall Study|Requirement for restricted medication|5|||
130600972|NCT00553787|470159671|FG000|Overall Study|Other|18|||
130600973|NCT00553787|470159672|FG001|Overall Study|Other|10|||
130600974|NCT00553787|470159673|FG002|Overall Study|Other|13|||
130600975|NCT05258058|470159692|FG000|Overall Study|Withdrawal by Subject|2|||
130600976|NCT04579393|470159693|FG000|Overall Study|Withdrawal by Subject|2|||
130600977|NCT04579393|470159694|FG001|Overall Study|Withdrawal by Subject|2|||
130600978|NCT04579393|470159693|FG000|Overall Study|Death|1|||
130600979|NCT04579393|470159694|FG001|Overall Study|Death|3|||
130600980|NCT02725177|470159700|FG000|Overall Study|Physician Decision|4|||
130600981|NCT02725177|470159700|FG000|Overall Study|Adverse Event|1|||
130600982|NCT00793585|470159703|FG000|Overall Study|Adverse Event|1|||
130600983|NCT00793585|470159704|FG001|Overall Study|Adverse Event|1|||
130600984|NCT00793585|470159703|FG000|Overall Study|Protocol Violation|1|||
130600985|NCT00793585|470159704|FG001|Overall Study|Protocol Violation|2|||
130600986|NCT00377299|470159705|FG000|Overall Study|Lost to Follow-up|14|||
130600987|NCT00377299|470159706|FG001|Overall Study|Lost to Follow-up|19|||
130600988|NCT00377299|470159705|FG000|Overall Study|Adverse Event|0|||
130600989|NCT00377299|470159706|FG001|Overall Study|Adverse Event|1|||
130600990|NCT00377299|470159705|FG000|Overall Study|Withdrawal by Subject|5|||
130600991|NCT00377299|470159706|FG001|Overall Study|Withdrawal by Subject|4|||
130600992|NCT00035815|470159710|FG000|Overall Study|Withdrawal by Subject|17|||
130600993|NCT00035815|470159711|FG001|Overall Study|Withdrawal by Subject|11|||
130600994|NCT02699515|470161189|FG000|Overall Study|Death|3|||
130600995|NCT02699515|470161190|FG001|Overall Study|Death|3|||
130600996|NCT02699515|470161191|FG002|Overall Study|Death|3|||
130600997|NCT02699515|470161192|FG003|Overall Study|Death|23|||
130600998|NCT02699515|470161193|FG004|Overall Study|Death|22|||
130600999|NCT02699515|470161194|FG005|Overall Study|Death|23|||
130601000|NCT02699515|470161195|FG006|Overall Study|Death|3|||
130601001|NCT02699515|470161196|FG007|Overall Study|Death|5|||
130601002|NCT02699515|470161189|FG000|Overall Study|Withdrawal by Subject|0|||
130601003|NCT02699515|470161190|FG001|Overall Study|Withdrawal by Subject|0|||
130601004|NCT02699515|470161191|FG002|Overall Study|Withdrawal by Subject|3|||
130601005|NCT02699515|470161192|FG003|Overall Study|Withdrawal by Subject|1|||
130601006|NCT02699515|470161193|FG004|Overall Study|Withdrawal by Subject|5|||
130601007|NCT02699515|470161194|FG005|Overall Study|Withdrawal by Subject|3|||
130601008|NCT02699515|470161195|FG006|Overall Study|Withdrawal by Subject|0|||
130601009|NCT02699515|470161196|FG007|Overall Study|Withdrawal by Subject|1|||
130601010|NCT02699515|470161189|FG000|Overall Study|Other|1|||
130601011|NCT02699515|470161190|FG001|Overall Study|Other|0|||
130601012|NCT02699515|470161191|FG002|Overall Study|Other|1|||
130601013|NCT02699515|470161192|FG003|Overall Study|Other|6|||
130601014|NCT02699515|470161193|FG004|Overall Study|Other|4|||
130601015|NCT02699515|470161194|FG005|Overall Study|Other|3|||
130601016|NCT02699515|470161195|FG006|Overall Study|Other|0|||
130601017|NCT02699515|470161196|FG007|Overall Study|Other|0|||
130601018|NCT00375934|470161198|FG000|Overall Study|Adverse Event|1|||
130601019|NCT00375934|470161199|FG001|Overall Study|Adverse Event|1|||
130601020|NCT00375934|470161198|FG000|Overall Study|Withdrawal by Subject|2|||
130601021|NCT00375934|470161199|FG001|Overall Study|Withdrawal by Subject|2|||
130601022|NCT00375934|470161198|FG000|Overall Study|Lack of Efficacy|0|||
130601023|NCT00375934|470161199|FG001|Overall Study|Lack of Efficacy|2|||
130601024|NCT00375934|470161198|FG000|Overall Study|Physician Decision|0|||
130601025|NCT00375934|470161199|FG001|Overall Study|Physician Decision|1|||
130601026|NCT03191396|470161200|FG000|Overall Study|Lost to Follow-up|0|||
130601027|NCT03191396|470161201|FG001|Overall Study|Lost to Follow-up|3|||
130601028|NCT03191396|470161200|FG000|Overall Study|Withdrawal by Subject|3|||
130601029|NCT03191396|470161201|FG001|Overall Study|Withdrawal by Subject|2|||
130601030|NCT01300286|470161202|FG000|Overall Study|did not get dosed|1|||
130601031|NCT03060577|470161205|FG000|Overall Study|Withdrawal by Subject|25|||
130601032|NCT03060577|470161206|FG001|Overall Study|Withdrawal by Subject|5|||
130601033|NCT03060577|470161205|FG000|Overall Study|Physician Decision|4|||
130601034|NCT03060577|470161206|FG001|Overall Study|Physician Decision|3|||
130601035|NCT03060577|470161205|FG000|Overall Study|Lost to Follow-up|3|||
130601036|NCT03060577|470161206|FG001|Overall Study|Lost to Follow-up|0|||
130601037|NCT03060577|470161205|FG000|Overall Study|Death|7|||
130601038|NCT03060577|470161206|FG001|Overall Study|Death|1|||
130601039|NCT03060577|470161205|FG000|Overall Study|Adverse Event|9|||
130601040|NCT03060577|470161206|FG001|Overall Study|Adverse Event|1|||
130601041|NCT03060577|470161205|FG000|Overall Study|Inclusion/Exclusion|1|||
130601042|NCT03060577|470161206|FG001|Overall Study|Inclusion/Exclusion|0|||
130601043|NCT03060577|470161205|FG000|Overall Study|Other|8|||
130601044|NCT03060577|470161206|FG001|Overall Study|Other|2|||
130601045|NCT03216265|470161210|FG000|Overall Study|Adverse Event|2|||
130601046|NCT03216265|470161211|FG001|Overall Study|Adverse Event|0|||
130601047|NCT03216265|470161212|FG002|Overall Study|Adverse Event|2|||
130601048|NCT03216265|470161210|FG000|Overall Study|Lost to Follow-up|0|||
130601049|NCT03216265|470161211|FG001|Overall Study|Lost to Follow-up|1|||
130601050|NCT03216265|470161212|FG002|Overall Study|Lost to Follow-up|0|||
130601051|NCT03216265|470161210|FG000|Overall Study|Withdrawal by Subject|0|||
130601052|NCT03216265|470161211|FG001|Overall Study|Withdrawal by Subject|0|||
130601053|NCT03216265|470161212|FG002|Overall Study|Withdrawal by Subject|1|||
130601054|NCT01650779|470161215|FG000|Overall Study|Withdrawal by Subject|1|||
130601055|NCT03666143|470161216|FG000|Overall Study|Death|158|||
130601056|NCT03666143|470161216|FG000|Overall Study|Sponsor Decision|31|||
130601057|NCT03666143|470161216|FG000|Overall Study|Withdrawal by Subject|11|||
130601058|NCT03666143|470161216|FG000|Overall Study|Lost to Follow-up|5|||
130601059|NCT03666143|470161216|FG000|Overall Study|Physician Decision|1|||
130601060|NCT03666143|470161216|FG000|Overall Study|Rolled into extension study|9|||
130601061|NCT03666143|470161216|FG000|Overall Study|Progressive Disease|1|||
130601062|NCT02747043|470161219|FG000|Overall Study|Other|1|||
130601063|NCT02747043|470161220|FG001|Overall Study|Other|1|||
130601064|NCT02747043|470161219|FG000|Overall Study|Adverse Event|3|||
130601065|NCT02747043|470161220|FG001|Overall Study|Adverse Event|1|||
130601066|NCT02747043|470161219|FG000|Overall Study|Withdrawal by Subject|1|||
130601067|NCT02747043|470161220|FG001|Overall Study|Withdrawal by Subject|1|||
130601068|NCT02747043|470161219|FG000|Overall Study|Physician Decision|1|||
130601069|NCT02747043|470161220|FG001|Overall Study|Physician Decision|1|||
130601070|NCT02747043|470161219|FG000|Overall Study|Protocol Violation|0|||
130601071|NCT02747043|470161220|FG001|Overall Study|Protocol Violation|1|||
130601072|NCT02747043|470161219|FG000|Overall Study|Disease progression|4|||
130601073|NCT02747043|470161220|FG001|Overall Study|Disease progression|0|||
130601074|NCT01295905|470161227|FG000|Overall Study|Did not meet inclusion criteria|1|||
130601075|NCT01295905|470161228|FG001|Overall Study|Did not meet inclusion criteria|0|||
130601076|NCT01295905|470161227|FG000|Overall Study|Met exclusion criteria|1|||
130601077|NCT01295905|470161228|FG001|Overall Study|Met exclusion criteria|0|||
130601078|NCT03707977|470161230|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
130601079|NCT03707977|470161231|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
130601080|NCT03707977|470161232|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
130601081|NCT03707977|470161230|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
130601082|NCT03707977|470161231|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
130601083|NCT03707977|470161232|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
130601084|NCT02640612|470161233|FG000|Overall Study|Adverse Event|6|||
130601085|NCT02640612|470161234|FG001|Overall Study|Adverse Event|7|||
130601086|NCT02640612|470161235|FG002|Overall Study|Adverse Event|2|||
130601087|NCT02640612|470161233|FG000|Overall Study|Death|1|||
130601088|NCT02640612|470161234|FG001|Overall Study|Death|0|||
130601089|NCT02640612|470161235|FG002|Overall Study|Death|0|||
130601090|NCT02640612|470161233|FG000|Overall Study|Withdrawal by Subject|10|||
130601091|NCT02640612|470161234|FG001|Overall Study|Withdrawal by Subject|3|||
130601092|NCT02640612|470161235|FG002|Overall Study|Withdrawal by Subject|3|||
130601093|NCT02640612|470161233|FG000|Overall Study|Lost to Follow-up|4|||
130601094|NCT02640612|470161234|FG001|Overall Study|Lost to Follow-up|1|||
130601095|NCT02640612|470161235|FG002|Overall Study|Lost to Follow-up|1|||
130601096|NCT02640612|470161233|FG000|Overall Study|Protocol Violation|0|||
130601097|NCT02640612|470161234|FG001|Overall Study|Protocol Violation|2|||
130601098|NCT02640612|470161235|FG002|Overall Study|Protocol Violation|0|||
130601099|NCT02640612|470161233|FG000|Overall Study|Lack of Efficacy|1|||
130601100|NCT02640612|470161234|FG001|Overall Study|Lack of Efficacy|1|||
130601101|NCT02640612|470161235|FG002|Overall Study|Lack of Efficacy|0|||
130601102|NCT01720667|470161236|FG000|Overall Study|Adverse Event|1|||
130601103|NCT01720667|470161237|FG001|Overall Study|Adverse Event|1|||
130601104|NCT01720667|470161236|FG000|Overall Study|Withdrawal by Subject|3|||
130601105|NCT01720667|470161237|FG001|Overall Study|Withdrawal by Subject|0|||
130601106|NCT03472534|470161238|FG000|Overall Study|Withdrawal by Subject|9|||
130601107|NCT03472534|470161238|FG000|Overall Study|Adverse Event|2|||
130601108|NCT01319929|470161242|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
130601109|NCT01319929|470161243|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
130601110|NCT01319929|470161242|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
130601111|NCT01319929|470161243|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
130601112|NCT01319929|470161242|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
130601113|NCT01319929|470161243|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
130601114|NCT01319929|470161242|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
130601115|NCT01319929|470161243|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
130601116|NCT01319929|470161242|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
130601117|NCT01319929|470161243|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
130601118|NCT01221233|470161244|FG000|Overall Study|Withdrawal by Subject|3|||
130601119|NCT01221233|470161245|FG001|Overall Study|Withdrawal by Subject|1|||
130601120|NCT03865407|470161247|FG000|Overall Study|Adverse Event|1|||
130601121|NCT03865407|470161248|FG001|Overall Study|Adverse Event|0|||
130601122|NCT03865407|470161247|FG000|Overall Study|Withdrawal by Subject|1|||
130601123|NCT03865407|470161248|FG001|Overall Study|Withdrawal by Subject|0|||
130601124|NCT03865407|470161247|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
130601125|NCT03865407|470161248|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
130601126|NCT02117050|470161249|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
130601127|NCT00546819|470161252|FG000|Overall Study|Adverse Event|2|||
130601128|NCT00546819|470161253|FG001|Overall Study|Adverse Event|3|||
130601129|NCT00546819|470161252|FG000|Overall Study|Lost to Follow-up|2|||
130601130|NCT00546819|470161253|FG001|Overall Study|Lost to Follow-up|1|||
130601131|NCT00546819|470161252|FG000|Overall Study|Withdrawal by Subject|4|||
130601132|NCT00546819|470161253|FG001|Overall Study|Withdrawal by Subject|2|||
130601133|NCT02859415|470161255|FG000|Overall Study|Physician Decision|1|||
130601134|NCT02859415|470161256|FG001|Overall Study|Physician Decision|0|||
130601135|NCT02859415|470161255|FG000|Overall Study|Off treatment due to cardiac event|0|||
130601136|NCT02859415|470161256|FG001|Overall Study|Off treatment due to cardiac event|1|||
130601137|NCT01174784|470161257|FG000|Overall Study|Screen fails|4|||
130601138|NCT04601272|470161259|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
130601139|NCT04601272|470161260|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
130601140|NCT04601272|470161261|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
130601141|NCT00414440|470161264|FG000|Core Period|Withdrawal by Subject|70|||
130601142|NCT00414440|470161265|FG001|Core Period|Withdrawal by Subject|32|||
130601143|NCT00414440|470161264|FG000|Extension Period|Lost to Follow-up|44|||
130601144|NCT00414440|470161265|FG001|Extension Period|Lost to Follow-up|52|||
130601145|NCT00414440|470161264|FG000|Extension Period|Did not consent to continue follow up|61|||
130601146|NCT00414440|470161265|FG001|Extension Period|Did not consent to continue follow up|54|||
130601147|NCT00414440|470161264|FG000|Extension Period|Other|1|||
130601148|NCT00414440|470161265|FG001|Extension Period|Other|1|||
130601149|NCT00414440|470161264|FG000|Extension Period|Administrative|16|||
130601150|NCT00414440|470161265|FG001|Extension Period|Administrative|16|||
130601151|NCT00414440|470161264|FG000|Extension Period|Death|1|||
130601152|NCT00414440|470161265|FG001|Extension Period|Death|2|||
130601153|NCT00414440|470161264|FG000|Extension Period|Withdrawal by Subject|9|||
130601154|NCT00414440|470161265|FG001|Extension Period|Withdrawal by Subject|7|||
130601155|NCT00414440|470161264|FG000|Extension Period|Not included in follow up period|18|||
130601156|NCT00414440|470161265|FG001|Extension Period|Not included in follow up period|8|||
130601157|NCT02498821|470161266|FG000|Overall Study|Screen failure|3|||
130601158|NCT02498821|470161267|FG001|Overall Study|Screen failure|5|||
130601159|NCT01716169|470161268|FG000|Overall Study|Adverse Event|1|||
130601160|NCT01716169|470161268|FG000|Overall Study|Lost to Follow-up|1|||
130601161|NCT01716169|470161268|FG000|Overall Study|Withdrawal by Subject|1|||
130601162|NCT01716169|470161268|FG000|Overall Study|inconsistent dressing application|1|||
130601163|NCT02285010|470161269|FG000|Overall Study|not abdominal hysterectomy|2|||
130601164|NCT02285010|470161270|FG001|Overall Study|not abdominal hysterectomy|0|||
130601165|NCT02285010|470161269|FG000|Overall Study|Not spinal anesthesia|3|||
130601166|NCT02285010|470161270|FG001|Overall Study|Not spinal anesthesia|1|||
130601167|NCT01478347|470161275|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
130601168|NCT01478347|470161275|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
130601169|NCT01478347|470161275|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
130601170|NCT00196937|470161276|FG000|Overall Study|Serious Adverse Event|1|||
130601171|NCT00196937|470161277|FG001|Overall Study|Serious Adverse Event|0|||
130601172|NCT00196937|470161278|FG002|Overall Study|Serious Adverse Event|0|||
130601173|NCT00196937|470161276|FG000|Overall Study|Non-serious adverse event|1|||
130601174|NCT00196937|470161277|FG001|Overall Study|Non-serious adverse event|1|||
130601175|NCT00196937|470161278|FG002|Overall Study|Non-serious adverse event|1|||
130601176|NCT00196937|470161276|FG000|Overall Study|Withdrawal by Subject|0|||
130601177|NCT00196937|470161277|FG001|Overall Study|Withdrawal by Subject|0|||
130601178|NCT00196937|470161278|FG002|Overall Study|Withdrawal by Subject|2|||
130601179|NCT00196937|470161276|FG000|Overall Study|Lost to Follow-up|4|||
130601180|NCT00196937|470161277|FG001|Overall Study|Lost to Follow-up|3|||
130601181|NCT00196937|470161278|FG002|Overall Study|Lost to Follow-up|3|||
130601182|NCT00196937|470161276|FG000|Overall Study|Other|3|||
130601183|NCT00196937|470161277|FG001|Overall Study|Other|1|||
130601184|NCT00196937|470161278|FG002|Overall Study|Other|1|||
130601185|NCT01056523|470161279|FG000|Overall Study|Death|1|||
130601186|NCT01056523|470161280|FG001|Overall Study|Death|0|||
130601187|NCT01056523|470161281|FG002|Overall Study|Death|2|||
130601188|NCT01056523|470161282|FG003|Overall Study|Death|3|||
130601189|NCT01056523|470161283|FG004|Overall Study|Death|0|||
130601190|NCT01056523|470161284|FG005|Overall Study|Death|0|||
130601191|NCT01056523|470161285|FG006|Overall Study|Death|1|||
130601192|NCT03429556|470161288|FG000|Overall Study|Lost to Follow-up|0|||
130601193|NCT03429556|470161289|FG001|Overall Study|Lost to Follow-up|1|||
130601194|NCT03429556|470161290|FG002|Overall Study|Lost to Follow-up|0|||
130601195|NCT03429556|470161291|FG003|Overall Study|Lost to Follow-up|0|||
130601196|NCT01863758|470161294|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
130601197|NCT01863758|470161294|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
130601198|NCT02369510|470161295|FG000|Overall Study|Spilled Medication|1|||
130601199|NCT02369510|470161296|FG001|Overall Study|Spilled Medication|2|||
130601200|NCT02369510|470161297|FG002|Overall Study|Spilled Medication|1|||
130601201|NCT02369510|470161295|FG000|Overall Study|Epidural Activation|1|||
130601202|NCT02369510|470161296|FG001|Overall Study|Epidural Activation|1|||
130601203|NCT02369510|470161297|FG002|Overall Study|Epidural Activation|5|||
130601204|NCT04952389|470161303|FG000|Overall Study|Withdrawal by Subject|8|||
130601205|NCT04952389|470161304|FG001|Overall Study|Withdrawal by Subject|4|||
130601206|NCT02050048|470161305|FG000|Overall Study|Lost to Follow-up|0|||
130601207|NCT02050048|470161306|FG001|Overall Study|Lost to Follow-up|1|||
130601208|NCT02050048|470161305|FG000|Overall Study|Death|1|||
130601209|NCT02050048|470161306|FG001|Overall Study|Death|0|||
130601210|NCT02050048|470161305|FG000|Overall Study|Ineligible after ERCP|4|||
130601211|NCT02050048|470161306|FG001|Overall Study|Ineligible after ERCP|1|||
130601212|NCT04285723|470161312|FG000|Overall Study|Subject decision|1|||
130601213|NCT04285723|470161313|FG001|Overall Study|Subject decision|2|||
130601214|NCT04285723|470161312|FG000|Overall Study|Physician Decision|1|||
130601215|NCT04285723|470161313|FG001|Overall Study|Physician Decision|0|||
130601216|NCT04285723|470161312|FG000|Overall Study|No efficiency|1|||
130601217|NCT04285723|470161313|FG001|Overall Study|No efficiency|0|||
130601218|NCT01507246|470161315|FG000|Overall Study|Required different surgical procedures|2|||
130601219|NCT01507246|470161316|FG001|Overall Study|Required different surgical procedures|1|||
130601220|NCT02903511|470161322|FG000|Overall Study|Withdrawal by Subject|1|||
130601221|NCT02903511|470161323|FG001|Overall Study|Withdrawal by Subject|0|||
130601222|NCT02903511|470161322|FG000|Overall Study|Lost to Follow-up|3|||
130601223|NCT02903511|470161323|FG001|Overall Study|Lost to Follow-up|2|||
130601224|NCT00969618|470161324|FG000|Overall Study|Adverse Event|29|||
130601225|NCT00969618|470161324|FG000|Overall Study|Entry Criteria Not Met|3|||
130601226|NCT00969618|470161324|FG000|Overall Study|Lack of Efficacy|2|||
130601227|NCT00969618|470161324|FG000|Overall Study|Lost to Follow-up|7|||
130601228|NCT00969618|470161324|FG000|Overall Study|Physician Decision|1|||
130601229|NCT00969618|470161324|FG000|Overall Study|Protocol Violation|9|||
130601230|NCT00969618|470161324|FG000|Overall Study|Withdrawal by Subject|27|||
130601231|NCT05363293|470161329|FG000|Overall Study|Withdrawal by Subject|1|||
130601232|NCT05363293|470161330|FG001|Overall Study|Withdrawal by Subject|0|||
130601233|NCT05363293|470161331|FG002|Overall Study|Withdrawal by Subject|0|||
130601234|NCT05363293|470161332|FG003|Overall Study|Withdrawal by Subject|0|||
130601235|NCT05363293|470161333|FG004|Overall Study|Withdrawal by Subject|0|||
130601236|NCT05363293|470161334|FG005|Overall Study|Withdrawal by Subject|0|||
130601237|NCT05363293|470161335|FG006|Overall Study|Withdrawal by Subject|0|||
130601238|NCT05363293|470161336|FG007|Overall Study|Withdrawal by Subject|0|||
130601239|NCT05363293|470161337|FG008|Overall Study|Withdrawal by Subject|0|||
130601240|NCT05363293|470161338|FG009|Overall Study|Withdrawal by Subject|0|||
130601241|NCT02452970|470163226|FG000|Overall Study|Adverse Event|1|||
130601242|NCT02400346|470163227|FG000|Overall Study|Adverse Event|24|||
130601243|NCT02400346|470163227|FG000|Overall Study|Lack of Efficacy|9|||
130601244|NCT02400346|470163227|FG000|Overall Study|Non-compliance with IMP|1|||
130601245|NCT02400346|470163227|FG000|Overall Study|Withdrawal by Subject|7|||
130601246|NCT02400346|470163227|FG000|Overall Study|Administrative or other reason(s)|2|||
130601247|NCT02400346|470163227|FG000|Overall Study|Lost to Follow-up|1|||
130601248|NCT01283581|470163228|FG000|Overall Study|Lost to Follow-up|8|||
130601249|NCT01283581|470163229|FG001|Overall Study|Lost to Follow-up|6|||
130601250|NCT01283581|470163230|FG002|Overall Study|Lost to Follow-up|8|||
130601251|NCT01283581|470163228|FG000|Overall Study|Withdrawal by Subject|2|||
130601252|NCT01283581|470163229|FG001|Overall Study|Withdrawal by Subject|5|||
130601253|NCT01283581|470163230|FG002|Overall Study|Withdrawal by Subject|2|||
130601254|NCT01283581|470163228|FG000|Overall Study|Adverse Event|1|||
130601255|NCT01283581|470163229|FG001|Overall Study|Adverse Event|1|||
130601256|NCT01283581|470163230|FG002|Overall Study|Adverse Event|4|||
130601257|NCT01283581|470163228|FG000|Overall Study|Physician Decision|0|||
130601258|NCT01283581|470163229|FG001|Overall Study|Physician Decision|1|||
130601259|NCT01283581|470163230|FG002|Overall Study|Physician Decision|2|||
130601260|NCT01283581|470163228|FG000|Overall Study|Protocol Violation|0|||
130601261|NCT01283581|470163229|FG001|Overall Study|Protocol Violation|1|||
130601262|NCT01283581|470163230|FG002|Overall Study|Protocol Violation|2|||
130601263|NCT01283581|470163228|FG000|Overall Study|Noncompliance|1|||
130601264|NCT01283581|470163229|FG001|Overall Study|Noncompliance|0|||
130601265|NCT01283581|470163230|FG002|Overall Study|Noncompliance|0|||
130601266|NCT01283581|470163228|FG000|Overall Study|Investigator unblinded|0|||
130601267|NCT01283581|470163229|FG001|Overall Study|Investigator unblinded|0|||
130601268|NCT01283581|470163230|FG002|Overall Study|Investigator unblinded|1|||
130601269|NCT01283581|470163228|FG000|Overall Study|"Early termination"|0|||
130601270|NCT01283581|470163229|FG001|Overall Study|"Early termination"|0|||
130601271|NCT01283581|470163230|FG002|Overall Study|"Early termination"|1|||
130601272|NCT00486226|470163231|FG000|Overall Study|Death|3|||
130601273|NCT00486226|470163231|FG000|Overall Study|Adverse Event|1|||
130601274|NCT00486226|470163231|FG000|Overall Study|Withdrawal by Subject|1|||
130601275|NCT00486226|470163231|FG000|Overall Study|Lost to Follow-up|8|||
130601276|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
130601277|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
130601278|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
130601279|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
130601280|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
130601281|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
130601282|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
130601283|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
130601284|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
130601285|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
130601286|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
130601287|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
130601288|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
130601289|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
130601290|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
130601291|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
130601292|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
130601293|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
130601294|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
130601295|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
130601296|NCT01259492|470163232|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
130601297|NCT01259492|470163233|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
130601298|NCT01259492|470163234|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
130601299|NCT01259492|470163235|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
130601300|NCT01259492|470163232|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
130601301|NCT01259492|470163233|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
130601302|NCT01259492|470163234|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
130601303|NCT01259492|470163235|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
130601304|NCT01259492|470163232|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
130601305|NCT01259492|470163233|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
130601306|NCT01259492|470163234|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
130601307|NCT01259492|470163235|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
130601308|NCT01259492|470163232|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
130601309|NCT01259492|470163233|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
130601310|NCT01259492|470163234|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
130601311|NCT01259492|470163235|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
130601312|NCT01259492|470163232|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130601313|NCT01259492|470163233|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130601314|NCT01259492|470163234|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
130601315|NCT01259492|470163235|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130601316|NCT01259492|470163232|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
130601317|NCT01259492|470163233|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
130601318|NCT01259492|470163234|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
130601319|NCT01259492|470163235|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
130601320|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
130601321|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
130601322|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
130601323|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
130601324|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130601325|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130601326|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130601327|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
130601328|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130601329|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130601330|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
130601331|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130601332|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
130601333|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
130601334|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
130601335|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
130601336|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
130601337|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130601338|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130601339|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130601340|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
130601341|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
130601342|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
130601343|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
130601344|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
130601345|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
130601346|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
130601347|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
130601348|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130601349|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130601350|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
130601351|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130601352|NCT01259492|470163232|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
130601353|NCT01259492|470163233|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
130601354|NCT01259492|470163234|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
130601355|NCT01259492|470163235|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
130601356|NCT01058369|470163243|FG000|Overall Study|Adverse Event|1|||
130601357|NCT01058369|470163243|FG000|Overall Study|Early termination study|1|||
130601358|NCT02584634|470163248|FG000|Overall Study|Adverse Event|3|||
130601359|NCT02584634|470163249|FG001|Overall Study|Adverse Event|5|||
130601360|NCT02584634|470163248|FG000|Overall Study|Death|0|||
130601361|NCT02584634|470163249|FG001|Overall Study|Death|1|||
130601362|NCT02584634|470163248|FG000|Overall Study|Lost to Follow-up|0|||
130601363|NCT02584634|470163249|FG001|Overall Study|Lost to Follow-up|1|||
130601364|NCT02584634|470163248|FG000|Overall Study|Physician Decision|1|||
130601365|NCT02584634|470163249|FG001|Overall Study|Physician Decision|2|||
130601366|NCT02584634|470163248|FG000|Overall Study|Progressive disease|7|||
130601367|NCT02584634|470163249|FG001|Overall Study|Progressive disease|15|||
130601368|NCT02584634|470163248|FG000|Overall Study|Withdrawal by Subject|1|||
130601369|NCT02584634|470163249|FG001|Overall Study|Withdrawal by Subject|1|||
130601370|NCT02584634|470163248|FG000|Overall Study|Other|0|||
130601371|NCT02584634|470163249|FG001|Overall Study|Other|6|||
130601372|NCT00283712|470163250|FG000|Overall Study|Death|0|||
130601373|NCT00283712|470163251|FG001|Overall Study|Death|1|||
130601374|NCT00098345|470163253|FG000|Overall Study|Adverse Event|7|||
130601375|NCT00098345|470163253|FG000|Overall Study|Withdrawal by Subject|2|||
130601376|NCT00098345|470163253|FG000|Overall Study|progression|4|||
130601377|NCT02564120|470163256|FG000|Overall Study|Did not return release forms|160|||
130601378|NCT02564120|470163256|FG000|Overall Study|Death|58|||
130601379|NCT02564120|470163256|FG000|Overall Study|Withdrawal by Subject|204|||
130601380|NCT02564120|470163256|FG000|Overall Study|Other medical condition|24|||
130601381|NCT01966731|470163259|FG000|Overall Study|Death|2|||
130601382|NCT01966731|470163259|FG000|Overall Study|Lost to Follow-up|1|||
130601383|NCT01966731|470163259|FG000|Overall Study|Physician Decision|2|||
130601384|NCT01966731|470163259|FG000|Overall Study|Follow up is not complete|600|||
130601385|NCT01966731|470163259|FG000|Overall Study|Screening Failure|29|||
130601386|NCT01966731|470163259|FG000|Overall Study|Found to be ineligible|1|||
130601387|NCT01380093|470163261|FG000|Naloxone Challenge Phase|Screen failures|21|||
130601388|NCT01380093|470163262|FG001|Naloxone Challenge Phase|Screen failures|0|||
130601389|NCT01380093|470163263|FG002|Naloxone Challenge Phase|Screen failures|0|||
130601390|NCT01380093|470163264|FG003|Naloxone Challenge Phase|Screen failures|0|||
130601391|NCT01380093|470163265|FG004|Naloxone Challenge Phase|Screen failures|0|||
130601392|NCT01380093|470163266|FG005|Naloxone Challenge Phase|Screen failures|0|||
130601393|NCT01380093|470163267|FG006|Naloxone Challenge Phase|Screen failures|0|||
130601394|NCT01380093|470163268|FG007|Naloxone Challenge Phase|Screen failures|0|||
130601395|NCT01380093|470163269|FG008|Naloxone Challenge Phase|Screen failures|0|||
130601396|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601397|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
130601398|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601399|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601400|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601401|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601402|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601403|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601404|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130601405|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601406|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
130601407|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
130601408|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601409|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601410|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601411|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601412|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601413|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130601414|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601415|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
130601416|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601417|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601418|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601419|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601420|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601421|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601422|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130601423|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601424|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
130601425|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
130601426|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601427|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601428|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601429|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601430|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601431|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130601432|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601433|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
130601434|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
130601435|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601436|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601437|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601438|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601439|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601440|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130601441|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601442|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601443|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
130601444|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601445|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601446|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601447|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601448|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601449|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
130601450|NCT01380093|470163261|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601451|NCT01380093|470163262|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601452|NCT01380093|470163263|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
130601453|NCT01380093|470163264|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601454|NCT01380093|470163265|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601455|NCT01380093|470163266|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601456|NCT01380093|470163267|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601457|NCT01380093|470163268|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601458|NCT01380093|470163269|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130601459|NCT01380093|470163261|FG000|Treatment Phase: Second Intervention|Other|0|||
130601460|NCT01380093|470163262|FG001|Treatment Phase: Second Intervention|Other|0|||
130601461|NCT01380093|470163263|FG002|Treatment Phase: Second Intervention|Other|0|||
130601462|NCT01380093|470163264|FG003|Treatment Phase: Second Intervention|Other|1|||
130601463|NCT01380093|470163265|FG004|Treatment Phase: Second Intervention|Other|0|||
130601464|NCT01380093|470163266|FG005|Treatment Phase: Second Intervention|Other|0|||
130601465|NCT01380093|470163267|FG006|Treatment Phase: Second Intervention|Other|0|||
130601466|NCT01380093|470163268|FG007|Treatment Phase: Second Intervention|Other|0|||
130601467|NCT01380093|470163269|FG008|Treatment Phase: Second Intervention|Other|0|||
130601468|NCT01380093|470163261|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
130601469|NCT01380093|470163262|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
130601470|NCT01380093|470163263|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
130601471|NCT01380093|470163264|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
130601472|NCT01380093|470163265|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
130601473|NCT01380093|470163266|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
130601474|NCT01380093|470163267|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
130601475|NCT01380093|470163268|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
130601476|NCT01380093|470163269|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
130601477|NCT01380093|470163261|FG000|Treatment Phase: Third Intervention|Other|0|||
130601478|NCT01380093|470163262|FG001|Treatment Phase: Third Intervention|Other|0|||
130601479|NCT01380093|470163263|FG002|Treatment Phase: Third Intervention|Other|0|||
130601480|NCT01380093|470163264|FG003|Treatment Phase: Third Intervention|Other|0|||
130601481|NCT01380093|470163265|FG004|Treatment Phase: Third Intervention|Other|0|||
130601482|NCT01380093|470163266|FG005|Treatment Phase: Third Intervention|Other|0|||
130601483|NCT01380093|470163267|FG006|Treatment Phase: Third Intervention|Other|0|||
130601484|NCT01380093|470163268|FG007|Treatment Phase: Third Intervention|Other|0|||
130601485|NCT01380093|470163269|FG008|Treatment Phase: Third Intervention|Other|1|||
130601486|NCT04734873|470163270|FG000|Overall Study|Lost to Follow-up|1|||
130601487|NCT04734873|470163271|FG001|Overall Study|Lost to Follow-up|3|||
130601488|NCT04734873|470163272|FG002|Overall Study|Lost to Follow-up|2|||
130601489|NCT04734873|470163270|FG000|Overall Study|Randomized but not dosed|1|||
130601490|NCT04734873|470163271|FG001|Overall Study|Randomized but not dosed|0|||
130601491|NCT04734873|470163272|FG002|Overall Study|Randomized but not dosed|1|||
130601492|NCT00201201|470163273|FG000|Overall Study|Death|0|||
130601493|NCT00201201|470163274|FG001|Overall Study|Death|2|||
130601494|NCT00201201|470163273|FG000|Overall Study|Withdrawal by Subject|5|||
130601495|NCT00201201|470163274|FG001|Overall Study|Withdrawal by Subject|5|||
130601496|NCT01342640|470163276|FG000|Overall Study|Adverse Event|3|||
130601497|NCT01342640|470163276|FG000|Overall Study|Protocol Violation|16|||
130601498|NCT01342640|470163276|FG000|Overall Study|Lost to Follow-up|21|||
130601499|NCT01342640|470163276|FG000|Overall Study|Other|1|||
130601500|NCT04101422|470163278|FG000|Overall Study|Ineligible|1|||
130601501|NCT04101422|470163279|FG001|Overall Study|Ineligible|0|||
130601502|NCT04101422|470163280|FG002|Overall Study|Ineligible|9|||
130601503|NCT04101422|470163281|FG003|Overall Study|Ineligible|0|||
130601504|NCT04101422|470163278|FG000|Overall Study|Withdrawal by Subject|0|||
130601505|NCT04101422|470163279|FG001|Overall Study|Withdrawal by Subject|0|||
130601506|NCT04101422|470163280|FG002|Overall Study|Withdrawal by Subject|1|||
130601507|NCT04101422|470163281|FG003|Overall Study|Withdrawal by Subject|0|||
130601508|NCT04101422|470163278|FG000|Overall Study|Not attending to the stimuli|0|||
130601509|NCT04101422|470163279|FG001|Overall Study|Not attending to the stimuli|0|||
130601510|NCT04101422|470163280|FG002|Overall Study|Not attending to the stimuli|4|||
130601511|NCT04101422|470163281|FG003|Overall Study|Not attending to the stimuli|0|||
130601512|NCT04101422|470163278|FG000|Overall Study|Did not download app|0|||
130601513|NCT04101422|470163279|FG001|Overall Study|Did not download app|0|||
130601514|NCT04101422|470163280|FG002|Overall Study|Did not download app|0|||
130601515|NCT04101422|470163281|FG003|Overall Study|Did not download app|17|||
130601516|NCT04101422|470163278|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130601517|NCT04101422|470163279|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130601518|NCT04101422|470163280|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130601519|NCT04101422|470163281|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
130601520|NCT00718861|470163284|FG000|Overall Study|Withdrawal by Subject|15|||
130601521|NCT00718861|470163285|FG001|Overall Study|Withdrawal by Subject|10|||
130601522|NCT00718861|470163284|FG000|Overall Study|Adverse Event|2|||
130601523|NCT00718861|470163285|FG001|Overall Study|Adverse Event|1|||
130601524|NCT00718861|470163284|FG000|Overall Study|Lost to Follow-up|2|||
130601525|NCT00718861|470163285|FG001|Overall Study|Lost to Follow-up|1|||
130601526|NCT00718861|470163284|FG000|Overall Study|Administrative Problems|1|||
130601527|NCT00718861|470163285|FG001|Overall Study|Administrative Problems|1|||
130601528|NCT00718861|470163284|FG000|Overall Study|Death|1|||
130601529|NCT00718861|470163285|FG001|Overall Study|Death|5|||
130601530|NCT01749735|470163287|FG000|Overall Study|Withdrawal by Subject|1|||
130601531|NCT01749735|470163288|FG001|Overall Study|Withdrawal by Subject|0|||
130601532|NCT04382651|470163289|FG000|Overall Study|Death|26|||
130601533|NCT04382651|470163290|FG001|Overall Study|Death|23|||
130601534|NCT04382651|470163289|FG000|Overall Study|Lost to Follow-up|3|||
130601535|NCT04382651|470163290|FG001|Overall Study|Lost to Follow-up|4|||
130601536|NCT04382651|470163289|FG000|Overall Study|Withdrawal by Subject|2|||
130601537|NCT04382651|470163290|FG001|Overall Study|Withdrawal by Subject|0|||
130601538|NCT04382651|470163289|FG000|Overall Study|Physician Decision|0|||
130601539|NCT04382651|470163290|FG001|Overall Study|Physician Decision|1|||
130601540|NCT01873742|470163291|FG000|Overall Study|Lost to Follow-up|68|||
130601541|NCT01873742|470163292|FG001|Overall Study|Lost to Follow-up|76|||
130601542|NCT00790296|470163294|FG000|Overall Study|Did not meet study eligibility criteria|1|||
130601543|NCT00790296|470163295|FG001|Overall Study|Did not meet study eligibility criteria|1|||
130601544|NCT00790296|470163294|FG000|Overall Study|Adverse Event|0|||
130601545|NCT00790296|470163295|FG001|Overall Study|Adverse Event|1|||
130601546|NCT02612077|470163296|FG000|Overall Study|Adverse Event|3|||
130601547|NCT02612077|470163296|FG000|Overall Study|Withdrawal by Subject|9|||
130601548|NCT02612077|470163296|FG000|Overall Study|Protocol Violation|28|||
130601549|NCT02612077|470163296|FG000|Overall Study|Lost to Follow-up|20|||
130601550|NCT02612077|470163296|FG000|Overall Study|Death|377|||
130601551|NCT02612077|470163296|FG000|Overall Study|Moved or Changed Medical Team|23|||
130601552|NCT02612077|470163296|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
130601553|NCT02612077|470163296|FG000|Overall Study|Disease Progression|3|||
130601554|NCT02612077|470163296|FG000|Overall Study|Unknown reason|2|||
130601555|NCT01971476|470163297|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
130601556|NCT01971476|470163298|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
130601557|NCT01971476|470163299|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
130601558|NCT01971476|470163297|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
130601559|NCT01971476|470163298|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
130601560|NCT01971476|470163299|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
130601561|NCT01971476|470163297|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
130601562|NCT01971476|470163298|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
130601563|NCT01971476|470163299|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
130601564|NCT02075255|470163300|FG000|Overall Study|Study specific withdrawal criteria|0|||
130601565|NCT02075255|470163301|FG001|Overall Study|Study specific withdrawal criteria|1|||
130601566|NCT02075255|470163302|FG002|Overall Study|Study specific withdrawal criteria|1|||
130601567|NCT02075255|470163300|FG000|Overall Study|Withdrawal by Subject|4|||
130601568|NCT02075255|470163301|FG001|Overall Study|Withdrawal by Subject|1|||
130601569|NCT02075255|470163302|FG002|Overall Study|Withdrawal by Subject|0|||
130601570|NCT02075255|470163300|FG000|Overall Study|Lost to Follow-up|0|||
130601571|NCT02075255|470163301|FG001|Overall Study|Lost to Follow-up|0|||
130601572|NCT02075255|470163302|FG002|Overall Study|Lost to Follow-up|1|||
130601573|NCT02075255|470163300|FG000|Overall Study|Adverse Event|0|||
130601574|NCT02075255|470163301|FG001|Overall Study|Adverse Event|0|||
130601575|NCT02075255|470163302|FG002|Overall Study|Adverse Event|1|||
130601576|NCT02075255|470163300|FG000|Overall Study|Death|0|||
130601577|NCT02075255|470163301|FG001|Overall Study|Death|2|||
130601578|NCT02075255|470163302|FG002|Overall Study|Death|0|||
130601579|NCT01088412|470163303|FG000|Overall Study|Adverse Event|38|||
130601580|NCT01088412|470163304|FG001|Overall Study|Adverse Event|0|||
130601581|NCT01088412|470163305|FG002|Overall Study|Adverse Event|0|||
130601582|NCT01088412|470163303|FG000|Overall Study|Death|42|||
130601583|NCT01088412|470163304|FG001|Overall Study|Death|6|||
130601584|NCT01088412|470163305|FG002|Overall Study|Death|0|||
130601585|NCT01088412|470163303|FG000|Overall Study|Other Reason per Case Report Form|2089|||
130601586|NCT01088412|470163304|FG001|Overall Study|Other Reason per Case Report Form|103|||
130601587|NCT01088412|470163305|FG002|Overall Study|Other Reason per Case Report Form|9|||
130601588|NCT01088412|470163303|FG000|Overall Study|Withdrawal by Subject|1761|||
130601589|NCT01088412|470163304|FG001|Overall Study|Withdrawal by Subject|25|||
130601590|NCT01088412|470163305|FG002|Overall Study|Withdrawal by Subject|1|||
130601591|NCT01088412|470163303|FG000|Overall Study|Received Another GH Product|79|||
130601592|NCT01088412|470163304|FG001|Overall Study|Received Another GH Product|0|||
130601593|NCT01088412|470163305|FG002|Overall Study|Received Another GH Product|0|||
130601594|NCT01088412|470163303|FG000|Overall Study|Participant Moved|601|||
130601595|NCT01088412|470163304|FG001|Overall Study|Participant Moved|21|||
130601596|NCT01088412|470163305|FG002|Overall Study|Participant Moved|2|||
130601597|NCT01088412|470163303|FG000|Overall Study|Physician Decision|1041|||
130601598|NCT01088412|470163304|FG001|Overall Study|Physician Decision|8|||
130601599|NCT01088412|470163305|FG002|Overall Study|Physician Decision|4|||
130601600|NCT01088412|470163303|FG000|Overall Study|Sponsor Decision|4467|||
130601601|NCT01088412|470163304|FG001|Overall Study|Sponsor Decision|79|||
130601602|NCT01088412|470163305|FG002|Overall Study|Sponsor Decision|23|||
130601603|NCT01088412|470163303|FG000|Overall Study|Third Party Required to Change Brand|487|||
130601604|NCT01088412|470163304|FG001|Overall Study|Third Party Required to Change Brand|0|||
130601605|NCT01088412|470163305|FG002|Overall Study|Third Party Required to Change Brand|0|||
130601606|NCT01088412|470163303|FG000|Overall Study|Lost to Follow-up|3052|||
130601607|NCT01088412|470163304|FG001|Overall Study|Lost to Follow-up|130|||
130601608|NCT01088412|470163305|FG002|Overall Study|Lost to Follow-up|11|||
130601609|NCT01088412|470163303|FG000|Overall Study|Study Summary Not Completed|4360|||
130601610|NCT01088412|470163304|FG001|Overall Study|Study Summary Not Completed|64|||
130601611|NCT01088412|470163305|FG002|Overall Study|Study Summary Not Completed|22|||
130601612|NCT00301067|470163306|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
130601613|NCT00301067|470163307|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
130601614|NCT00301067|470163308|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
130601615|NCT00301067|470163309|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
130601616|NCT00301067|470163306|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
130601617|NCT00301067|470163307|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130601618|NCT00301067|470163308|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130601619|NCT00301067|470163309|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
130601620|NCT00301067|470163306|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
130601621|NCT00301067|470163307|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
130601622|NCT00301067|470163308|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
130601623|NCT00301067|470163309|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
130601624|NCT00301067|470163306|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
130601625|NCT00301067|470163307|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
130601626|NCT00301067|470163308|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
130601627|NCT00301067|470163309|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
130601628|NCT00301067|470163306|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
130601629|NCT00301067|470163307|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
130601630|NCT00301067|470163308|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
130601631|NCT00301067|470163309|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
130601632|NCT00301067|470163306|FG000|Follow up Until Death|Alive at last data cut point|1|||
130601633|NCT00301067|470163307|FG001|Follow up Until Death|Alive at last data cut point|0|||
130601634|NCT00301067|470163308|FG002|Follow up Until Death|Alive at last data cut point|0|||
130601635|NCT00301067|470163309|FG003|Follow up Until Death|Alive at last data cut point|1|||
130601636|NCT01208181|470163311|FG000|Part 1|Withdrawal by Subject|11|||
130601637|NCT01208181|470163312|FG001|Part 1|Withdrawal by Subject|10|||
130601638|NCT01208181|470163313|FG002|Part 1|Withdrawal by Subject|0|||
130601639|NCT01208181|470163314|FG003|Part 1|Withdrawal by Subject|0|||
130601640|NCT01208181|470163315|FG004|Part 1|Withdrawal by Subject|0|||
130601641|NCT01208181|470163311|FG000|Part 1|Technical problem|5|||
130601642|NCT01208181|470163312|FG001|Part 1|Technical problem|0|||
130601643|NCT01208181|470163313|FG002|Part 1|Technical problem|0|||
130601644|NCT01208181|470163314|FG003|Part 1|Technical problem|0|||
130601645|NCT01208181|470163315|FG004|Part 1|Technical problem|0|||
130601646|NCT01208181|470163311|FG000|Part 1|Protocol Violation|10|||
130601647|NCT01208181|470163312|FG001|Part 1|Protocol Violation|5|||
130601648|NCT01208181|470163313|FG002|Part 1|Protocol Violation|0|||
130601649|NCT01208181|470163314|FG003|Part 1|Protocol Violation|0|||
130601650|NCT01208181|470163315|FG004|Part 1|Protocol Violation|0|||
130601651|NCT01208181|470163311|FG000|Part 1|Physician Decision|4|||
130601652|NCT01208181|470163312|FG001|Part 1|Physician Decision|0|||
130601653|NCT01208181|470163313|FG002|Part 1|Physician Decision|0|||
130601654|NCT01208181|470163314|FG003|Part 1|Physician Decision|0|||
130601655|NCT01208181|470163315|FG004|Part 1|Physician Decision|0|||
130601656|NCT01208181|470163311|FG000|Part 1|Non-compliance with study drug|1|||
130601657|NCT01208181|470163312|FG001|Part 1|Non-compliance with study drug|1|||
130601658|NCT01208181|470163313|FG002|Part 1|Non-compliance with study drug|0|||
130601659|NCT01208181|470163314|FG003|Part 1|Non-compliance with study drug|0|||
130601660|NCT01208181|470163315|FG004|Part 1|Non-compliance with study drug|0|||
130601661|NCT01208181|470163311|FG000|Part 1|Lost to Follow-up|5|||
130601662|NCT01208181|470163312|FG001|Part 1|Lost to Follow-up|3|||
130601663|NCT01208181|470163313|FG002|Part 1|Lost to Follow-up|0|||
130601664|NCT01208181|470163314|FG003|Part 1|Lost to Follow-up|0|||
130601665|NCT01208181|470163315|FG004|Part 1|Lost to Follow-up|1|||
130601666|NCT01208181|470163311|FG000|Part 1|Lack of Efficacy|37|||
130601667|NCT01208181|470163312|FG001|Part 1|Lack of Efficacy|12|||
130601668|NCT01208181|470163313|FG002|Part 1|Lack of Efficacy|0|||
130601669|NCT01208181|470163314|FG003|Part 1|Lack of Efficacy|0|||
130601670|NCT01208181|470163315|FG004|Part 1|Lack of Efficacy|17|||
130601671|NCT01208181|470163311|FG000|Part 1|Adverse Event|26|||
130601672|NCT01208181|470163312|FG001|Part 1|Adverse Event|24|||
130601673|NCT01208181|470163313|FG002|Part 1|Adverse Event|0|||
130601674|NCT01208181|470163314|FG003|Part 1|Adverse Event|0|||
130601675|NCT01208181|470163315|FG004|Part 1|Adverse Event|4|||
130601676|NCT01208181|470163311|FG000|Part 2|Adverse Event|0|||
130601677|NCT01208181|470163312|FG001|Part 2|Adverse Event|0|||
130601678|NCT01208181|470163313|FG002|Part 2|Adverse Event|6|||
130601679|NCT01208181|470163314|FG003|Part 2|Adverse Event|7|||
130601680|NCT01208181|470163315|FG004|Part 2|Adverse Event|0|||
130601681|NCT01208181|470163311|FG000|Part 2|Withdrawal by Subject|0|||
130601682|NCT01208181|470163312|FG001|Part 2|Withdrawal by Subject|0|||
130601683|NCT01208181|470163313|FG002|Part 2|Withdrawal by Subject|1|||
130601684|NCT01208181|470163314|FG003|Part 2|Withdrawal by Subject|1|||
130601685|NCT01208181|470163315|FG004|Part 2|Withdrawal by Subject|0|||
130601686|NCT01208181|470163311|FG000|Part 2|Protocol Violation|0|||
130601687|NCT01208181|470163312|FG001|Part 2|Protocol Violation|0|||
130601688|NCT01208181|470163313|FG002|Part 2|Protocol Violation|1|||
130601689|NCT01208181|470163314|FG003|Part 2|Protocol Violation|0|||
130601690|NCT01208181|470163315|FG004|Part 2|Protocol Violation|0|||
130601691|NCT01208181|470163311|FG000|Part 2|Physician Decision|0|||
130601692|NCT01208181|470163312|FG001|Part 2|Physician Decision|0|||
130601693|NCT01208181|470163313|FG002|Part 2|Physician Decision|1|||
130601694|NCT01208181|470163314|FG003|Part 2|Physician Decision|2|||
130601695|NCT01208181|470163315|FG004|Part 2|Physician Decision|0|||
130601696|NCT01208181|470163311|FG000|Part 2|Non-compliance with study drug|0|||
130601697|NCT01208181|470163312|FG001|Part 2|Non-compliance with study drug|0|||
130601698|NCT01208181|470163313|FG002|Part 2|Non-compliance with study drug|1|||
130601699|NCT01208181|470163314|FG003|Part 2|Non-compliance with study drug|1|||
130601700|NCT01208181|470163315|FG004|Part 2|Non-compliance with study drug|0|||
130601701|NCT01208181|470163311|FG000|Part 2|Lost to Follow-up|0|||
130601702|NCT01208181|470163312|FG001|Part 2|Lost to Follow-up|0|||
130601703|NCT01208181|470163313|FG002|Part 2|Lost to Follow-up|1|||
130601704|NCT01208181|470163314|FG003|Part 2|Lost to Follow-up|2|||
130601705|NCT01208181|470163315|FG004|Part 2|Lost to Follow-up|0|||
130601706|NCT01208181|470163311|FG000|Part 2|Lack of Efficacy|0|||
130601707|NCT01208181|470163312|FG001|Part 2|Lack of Efficacy|0|||
130601708|NCT01208181|470163313|FG002|Part 2|Lack of Efficacy|5|||
130601709|NCT01208181|470163314|FG003|Part 2|Lack of Efficacy|7|||
130601710|NCT01208181|470163315|FG004|Part 2|Lack of Efficacy|0|||
130601711|NCT01457339|470163316|FG000|Period 3 (100 mg)|Adverse Event|0|||
130601712|NCT01457339|470163317|FG001|Period 3 (100 mg)|Adverse Event|1|||
130601713|NCT01457339|470163316|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
130601714|NCT01457339|470163317|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
130601715|NCT01457339|470163316|FG000|Period 6 (250 mg)|Family Emergency|1|||
130601716|NCT01457339|470163317|FG001|Period 6 (250 mg)|Family Emergency|0|||
130601717|NCT01457339|470163316|FG000|Period 6 (250 mg)|Personal appointment|0|||
130601718|NCT01457339|470163317|FG001|Period 6 (250 mg)|Personal appointment|1|||
130601719|NCT01751646|470163320|FG000|Overall Study|Lost to Follow-up|5|||
130601720|NCT01751646|470163321|FG001|Overall Study|Lost to Follow-up|1|||
130601721|NCT01751646|470163320|FG000|Overall Study|Withdrawal by Subject|0|||
130601722|NCT01751646|470163321|FG001|Overall Study|Withdrawal by Subject|4|||
130601723|NCT01751646|470163320|FG000|Overall Study|Starting hormone therapy|1|||
130601724|NCT01751646|470163321|FG001|Overall Study|Starting hormone therapy|0|||
130601725|NCT01751646|470163320|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
130601726|NCT01751646|470163321|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
130601727|NCT01751646|470163320|FG000|Overall Study|Inadvertent enrollment|1|||
130601728|NCT01751646|470163321|FG001|Overall Study|Inadvertent enrollment|1|||
130601729|NCT01751646|470163320|FG000|Overall Study|Moved out of the area|1|||
130601730|NCT01751646|470163321|FG001|Overall Study|Moved out of the area|5|||
130601731|NCT01751646|470163320|FG000|Overall Study|Inability to attend required visits|0|||
130601732|NCT01751646|470163321|FG001|Overall Study|Inability to attend required visits|1|||
130601733|NCT01751646|470163320|FG000|Overall Study|Off study due to multiple obligations|0|||
130601734|NCT01751646|470163321|FG001|Overall Study|Off study due to multiple obligations|1|||
130601735|NCT01751646|470163320|FG000|Overall Study|Fails to comply with study requirements|0|||
130601736|NCT01751646|470163321|FG001|Overall Study|Fails to comply with study requirements|1|||
130601737|NCT01751646|470163320|FG000|Overall Study|Childcare issues|1|||
130601738|NCT01751646|470163321|FG001|Overall Study|Childcare issues|1|||
130601739|NCT02335450|470163322|FG000|Overall Study|Pregnancy|1|||
130601740|NCT02973815|470163323|FG000|Post Intervention|Death|1|||
130601741|NCT02973815|470163324|FG001|Post Intervention|Death|0|||
130601742|NCT02973815|470163323|FG000|Post Intervention|Lost to Follow-up|7|||
130601743|NCT02973815|470163324|FG001|Post Intervention|Lost to Follow-up|24|||
130601744|NCT02973815|470163323|FG000|Follow-up|Lost to Follow-up|2|||
130601745|NCT02973815|470163324|FG001|Follow-up|Lost to Follow-up|0|||
130601746|NCT02613572|470163325|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
130601747|NCT02613572|470163326|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
130601748|NCT02613572|470163327|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
130601749|NCT02613572|470163325|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
130601750|NCT02613572|470163326|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
130601751|NCT02613572|470163327|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
130601752|NCT04542291|470163328|FG000|Overall Study|Adverse Event|1|||
130601753|NCT04542291|470163328|FG000|Overall Study|Physician Decision|2|||
130601754|NCT04538950|470163333|FG000|Overall Study|Pulmonary Issues|2|||
130601755|NCT04538950|470163333|FG000|Overall Study|illness|2|||
130601756|NCT00853905|470163334|FG000|Overall Study|Lost to Follow-up|1|||
130601757|NCT00853905|470163335|FG001|Overall Study|Lost to Follow-up|3|||
130601758|NCT00853905|470163334|FG000|Overall Study|Withdrawal by Subject|0|||
130601759|NCT00853905|470163335|FG001|Overall Study|Withdrawal by Subject|1|||
130601760|NCT00853905|470163334|FG000|Overall Study|never had surgery|1|||
130601761|NCT00853905|470163335|FG001|Overall Study|never had surgery|0|||
130601762|NCT00970294|470163338|FG000|Overall Study|Physician Decision|4|||
130601763|NCT00970294|470163338|FG000|Overall Study|Withdrawal by Subject|1|||
130601764|NCT00847561|470163339|FG000|Overall Study|Withdrawal by Subject|4|||
130601765|NCT00847561|470163340|FG001|Overall Study|Withdrawal by Subject|3|||
130601766|NCT00847561|470163339|FG000|Overall Study|Unable to schedule|9|||
130601767|NCT00847561|470163340|FG001|Overall Study|Unable to schedule|1|||
130601768|NCT01333189|470163341|FG000|Overall Study|Time constraints|1|||
130601769|NCT01333189|470163342|FG001|Overall Study|Time constraints|0|||
130601770|NCT01333189|470163341|FG000|Overall Study|Adverse Event|1|||
130601771|NCT01333189|470163342|FG001|Overall Study|Adverse Event|0|||
130601772|NCT01333189|470163341|FG000|Overall Study|Transportation difficulties|0|||
130601773|NCT01333189|470163342|FG001|Overall Study|Transportation difficulties|1|||
130601774|NCT01333189|470163341|FG000|Overall Study|Moved from region|0|||
130601775|NCT01333189|470163342|FG001|Overall Study|Moved from region|1|||
130601776|NCT01787591|470163344|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130601777|NCT01787591|470163345|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130601778|NCT01787591|470163346|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130601779|NCT01787591|470163347|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
130601780|NCT02489630|470163349|FG000|Overall Study|Oversedation|1|||
130601781|NCT02489630|470163350|FG001|Overall Study|Oversedation|1|||
130601782|NCT02489630|470163349|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
130601783|NCT02489630|470163350|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
130601784|NCT01326962|470163351|FG000|Overall Study|Adverse Event|1|||
130601785|NCT01326962|470163351|FG000|Overall Study|Withdrawal by Subject|1|||
130601786|NCT01326962|470163351|FG000|Overall Study|Lost to Follow-up|3|||
130601787|NCT01326962|470163351|FG000|Overall Study|Other|2|||
130601788|NCT04799782|470163353|FG000|Washout|Physician Decision|2|||
130601789|NCT04799782|470163354|FG001|Washout|Physician Decision|0|||
130601790|NCT04799782|470163353|FG000|Washout|Withdrawal by Subject|0|||
130601791|NCT04799782|470163354|FG001|Washout|Withdrawal by Subject|2|||
130601792|NCT04799782|470163353|FG000|Washout|Lost to Follow-up|0|||
130601793|NCT04799782|470163354|FG001|Washout|Lost to Follow-up|1|||
130601794|NCT02606877|470163355|FG000|Overall Study|Adverse Event|3|||
130601795|NCT02606877|470163356|FG001|Overall Study|Adverse Event|0|||
130601796|NCT02606877|470163355|FG000|Overall Study|Non-compliance with protocol|0|||
130601797|NCT02606877|470163356|FG001|Overall Study|Non-compliance with protocol|1|||
130601798|NCT02606877|470163355|FG000|Overall Study|Other than listed above|1|||
130601799|NCT02606877|470163356|FG001|Overall Study|Other than listed above|0|||
130601800|NCT01318902|470163361|FG000|Overall Study|Symptomatic Deterioration|0|||
130601801|NCT01318902|470163362|FG001|Overall Study|Symptomatic Deterioration|1|||
130601802|NCT01318902|470163363|FG002|Overall Study|Symptomatic Deterioration|1|||
130601803|NCT01318902|470163364|FG003|Overall Study|Symptomatic Deterioration|2|||
130601804|NCT01318902|470163361|FG000|Overall Study|Withdrawal by Patient|0|||
130601805|NCT01318902|470163362|FG001|Overall Study|Withdrawal by Patient|1|||
130601806|NCT01318902|470163363|FG002|Overall Study|Withdrawal by Patient|0|||
130601807|NCT01318902|470163364|FG003|Overall Study|Withdrawal by Patient|3|||
130601808|NCT01318902|470163361|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130601809|NCT01318902|470163362|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130601810|NCT01318902|470163363|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130601811|NCT01318902|470163364|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
130601812|NCT01318902|470163361|FG000|Overall Study|Adverse Event|0|||
130601813|NCT01318902|470163362|FG001|Overall Study|Adverse Event|1|||
130601814|NCT01318902|470163363|FG002|Overall Study|Adverse Event|0|||
130601815|NCT01318902|470163364|FG003|Overall Study|Adverse Event|0|||
130601816|NCT01318902|470163361|FG000|Overall Study|Terminated by Sponsor|0|||
130601817|NCT01318902|470163362|FG001|Overall Study|Terminated by Sponsor|0|||
130601818|NCT01318902|470163363|FG002|Overall Study|Terminated by Sponsor|1|||
130601819|NCT01318902|470163364|FG003|Overall Study|Terminated by Sponsor|0|||
130601820|NCT00128206|470165391|FG000|Overall Study|Lost to Follow-up|137|||
130601821|NCT00128206|470165392|FG001|Overall Study|Lost to Follow-up|118|||
130601822|NCT00128206|470165391|FG000|Overall Study|Adverse Event|0|||
130601823|NCT00128206|470165392|FG001|Overall Study|Adverse Event|2|||
130601824|NCT03270085|470165393|FG000|Overall Study|Withdrawal by Subject|1|||
130601825|NCT03270085|470165394|FG001|Overall Study|Withdrawal by Subject|0|||
130601826|NCT01269125|470165396|FG000|Overall Study|Adverse Event|3|||
130601827|NCT01269125|470165397|FG001|Overall Study|Adverse Event|5|||
130601828|NCT01269125|470165398|FG002|Overall Study|Adverse Event|0|||
130601829|NCT01269125|470165396|FG000|Overall Study|Lost to Follow-up|4|||
130601830|NCT01269125|470165397|FG001|Overall Study|Lost to Follow-up|0|||
130601831|NCT01269125|470165398|FG002|Overall Study|Lost to Follow-up|0|||
130601832|NCT01040832|470165399|FG000|Overall Study|Adverse Event|4|||
130601833|NCT01040832|470165400|FG001|Overall Study|Adverse Event|5|||
130601834|NCT01040832|470165399|FG000|Overall Study|Death|4|||
130601835|NCT01040832|470165400|FG001|Overall Study|Death|6|||
130601836|NCT01040832|470165399|FG000|Overall Study|Withdrawal by Subject|2|||
130601837|NCT01040832|470165400|FG001|Overall Study|Withdrawal by Subject|3|||
130601838|NCT01040832|470165399|FG000|Overall Study|Progressive disease|32|||
130601839|NCT01040832|470165400|FG001|Overall Study|Progressive disease|17|||
130601840|NCT01040832|470165399|FG000|Overall Study|Symptomatic deterioration|2|||
130601841|NCT01040832|470165400|FG001|Overall Study|Symptomatic deterioration|5|||
130601842|NCT01040832|470165399|FG000|Overall Study|Other|2|||
130601843|NCT01040832|470165400|FG001|Overall Study|Other|1|||
130601846|NCT00663858|470165404|FG000|Overall Study|Adverse Event|9|||
130601847|NCT00663858|470165405|FG001|Overall Study|Adverse Event|1|||
130601848|NCT00663858|470165406|FG002|Overall Study|Adverse Event|6|||
130601849|NCT00663858|470165404|FG000|Overall Study|Lack of Efficacy|5|||
130601850|NCT00663858|470165405|FG001|Overall Study|Lack of Efficacy|1|||
130601851|NCT00663858|470165406|FG002|Overall Study|Lack of Efficacy|3|||
130601852|NCT00663858|470165404|FG000|Overall Study|Withdrawal by Subject|7|||
130601853|NCT00663858|470165405|FG001|Overall Study|Withdrawal by Subject|3|||
130601854|NCT00663858|470165406|FG002|Overall Study|Withdrawal by Subject|3|||
130601855|NCT00663858|470165404|FG000|Overall Study|Protocol Violation|5|||
130601856|NCT00663858|470165405|FG001|Overall Study|Protocol Violation|3|||
130601857|NCT00663858|470165406|FG002|Overall Study|Protocol Violation|4|||
130601858|NCT00663858|470165404|FG000|Overall Study|Other|8|||
130601859|NCT00663858|470165405|FG001|Overall Study|Other|2|||
130601860|NCT00663858|470165406|FG002|Overall Study|Other|4|||
130601861|NCT02940886|470165407|FG000|Overall Study|Adverse Event|7|||
130601862|NCT02940886|470165408|FG001|Overall Study|Adverse Event|3|||
130601863|NCT02940886|470165407|FG000|Overall Study|Protocol Violation|0|||
130601864|NCT02940886|470165408|FG001|Overall Study|Protocol Violation|2|||
130601865|NCT02940886|470165407|FG000|Overall Study|Withdrawal by Subject|28|||
130601866|NCT02940886|470165408|FG001|Overall Study|Withdrawal by Subject|20|||
130601867|NCT02940886|470165407|FG000|Overall Study|Death|1|||
130601868|NCT02940886|470165408|FG001|Overall Study|Death|0|||
130601869|NCT02940886|470165407|FG000|Overall Study|Lack of Efficacy|1|||
130601870|NCT02940886|470165408|FG001|Overall Study|Lack of Efficacy|0|||
130601871|NCT02940886|470165407|FG000|Overall Study|Lost to Follow-up|49|||
130601872|NCT02940886|470165408|FG001|Overall Study|Lost to Follow-up|21|||
130601873|NCT02940886|470165407|FG000|Overall Study|Physician Decision|9|||
130601874|NCT02940886|470165408|FG001|Overall Study|Physician Decision|4|||
130601875|NCT02940886|470165407|FG000|Overall Study|Sponsor decision|0|||
130601876|NCT02940886|470165408|FG001|Overall Study|Sponsor decision|1|||
130601877|NCT02940886|470165407|FG000|Overall Study|No treatment|7|||
130601878|NCT02940886|470165408|FG001|Overall Study|No treatment|2|||
130601879|NCT02940886|470165407|FG000|Overall Study|Enrolment error|0|||
130601880|NCT02940886|470165408|FG001|Overall Study|Enrolment error|1|||
130601881|NCT01306058|470165412|FG000|Overall Study|Death|1|||
130601882|NCT01306058|470165412|FG000|Overall Study|Enrolled but did not get treatment|1|||
130601883|NCT01666444|470165413|FG000|Overall Study|Did not initiate treatment|2|||
130601884|NCT01666444|470165414|FG001|Overall Study|Did not initiate treatment|1|||
130601885|NCT00592358|470165421|FG000|Overall Study|Withdrawal by Subject|2|||
130601886|NCT00592358|470165421|FG000|Overall Study|Adverse Event|1|||
130601887|NCT00592358|470165421|FG000|Overall Study|Lack of Efficacy|2|||
130601888|NCT00592358|470165421|FG000|Overall Study|Inability to swallow pills|1|||
130601889|NCT00084682|470165422|FG000|Overall Study|Withdrawal by Subject|1|||
130601890|NCT01166659|470165423|FG000|Overall Study|Subject Decision|8|||
130601891|NCT01166659|470165423|FG000|Overall Study|Investigator Decision|2|||
130601892|NCT01166659|470165423|FG000|Overall Study|Death|1|||
130601893|NCT01166659|470165423|FG000|Overall Study|Lost to Follow-up|1|||
130601894|NCT01166659|470165423|FG000|Overall Study|Study Closed at Site|1|||
130601895|NCT03238248|470165433|FG000|Overall Study|Death|5|||
130601896|NCT03238248|470165433|FG000|Overall Study|Withdrawal by Subject|7|||
130601897|NCT03238248|470165433|FG000|Overall Study|Participant proceeding to transplant|10|||
130601898|NCT03238248|470165433|FG000|Overall Study|Lack of Efficacy|4|||
130601899|NCT03238248|470165433|FG000|Overall Study|Physician Decision|3|||
130601900|NCT03238248|470165433|FG000|Overall Study|Transitioning to another study|1|||
130601901|NCT03238248|470165433|FG000|Overall Study|No longer benefiting|1|||
130601902|NCT03238248|470165433|FG000|Overall Study|Other complicating disease|1|||
130601903|NCT03238248|470165433|FG000|Overall Study|Adverse Event|5|||
130601904|NCT03238248|470165433|FG000|Overall Study|Disease progression|26|||
130601905|NCT03238248|470165433|FG000|Overall Study|N/A participant is still on treatment|1|||
130601906|NCT03238248|470165433|FG000|Overall Study|Decline in condition|1|||
130601907|NCT03238248|470165433|FG000|Overall Study|Alternative therapy|2|||
130601908|NCT01013883|470165440|FG000|Overall Study|Lost to Follow-up|2|||
130601909|NCT01013883|470165441|FG001|Overall Study|Lost to Follow-up|2|||
130601910|NCT01371838|470165442|FG000|Overall Study|Withdrawal by Subject|27|||
130601911|NCT01371838|470165443|FG001|Overall Study|Withdrawal by Subject|33|||
130601912|NCT01371838|470165442|FG000|Overall Study|Lost to Follow-up|10|||
130601913|NCT01371838|470165443|FG001|Overall Study|Lost to Follow-up|20|||
130601914|NCT01371838|470165442|FG000|Overall Study|Death|3|||
130601915|NCT01371838|470165443|FG001|Overall Study|Death|4|||
130601916|NCT01371838|470165442|FG000|Overall Study|Protocol Violation|3|||
130601917|NCT01371838|470165443|FG001|Overall Study|Protocol Violation|0|||
130601918|NCT01371838|470165442|FG000|Overall Study|Investigator Decision|3|||
130601919|NCT01371838|470165443|FG001|Overall Study|Investigator Decision|8|||
130601920|NCT01371838|470165442|FG000|Overall Study|Last follow-up visit not conducted|2|||
130601921|NCT01371838|470165443|FG001|Overall Study|Last follow-up visit not conducted|0|||
130601922|NCT01371838|470165442|FG000|Overall Study|Lack of therapeutic response|0|||
130601923|NCT01371838|470165443|FG001|Overall Study|Lack of therapeutic response|1|||
130601924|NCT01371838|470165442|FG000|Overall Study|Surgery|1|||
130601925|NCT01371838|470165443|FG001|Overall Study|Surgery|0|||
130601926|NCT02241512|470165444|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
130601927|NCT02241512|470165445|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
130601928|NCT00641043|470165448|FG000|Overall Study|Adverse Event|6|||
130601929|NCT00641043|470165449|FG001|Overall Study|Adverse Event|4|||
130601930|NCT00641043|470165448|FG000|Overall Study|Protocol Violation|2|||
130601931|NCT00641043|470165449|FG001|Overall Study|Protocol Violation|3|||
130601932|NCT00641043|470165448|FG000|Overall Study|Lost to Follow-up|3|||
130601933|NCT00641043|470165449|FG001|Overall Study|Lost to Follow-up|2|||
130601934|NCT00641043|470165448|FG000|Overall Study|Withdrawal by Subject|4|||
130601935|NCT00641043|470165449|FG001|Overall Study|Withdrawal by Subject|4|||
130601936|NCT00641043|470165448|FG000|Overall Study|Other incl. lack of efficacy|4|||
130601937|NCT00641043|470165449|FG001|Overall Study|Other incl. lack of efficacy|2|||
130601938|NCT00474630|470165450|FG000|Overall Study|Adverse Event|98|||
130601939|NCT00474630|470165451|FG001|Overall Study|Adverse Event|26|||
130601940|NCT00474630|470165450|FG000|Overall Study|Lost to Follow-up|22|||
130601941|NCT00474630|470165451|FG001|Overall Study|Lost to Follow-up|15|||
130601942|NCT00474630|470165450|FG000|Overall Study|Withdrawal by Subject|21|||
130601943|NCT00474630|470165451|FG001|Overall Study|Withdrawal by Subject|15|||
130601944|NCT00474630|470165450|FG000|Overall Study|Protocol Violation|3|||
130601945|NCT00474630|470165451|FG001|Overall Study|Protocol Violation|4|||
130601946|NCT00474630|470165450|FG000|Overall Study|Lack of Efficacy|5|||
130601947|NCT00474630|470165451|FG001|Overall Study|Lack of Efficacy|6|||
130601948|NCT00474630|470165450|FG000|Overall Study|Drug noncompliance, other|11|||
130601949|NCT00474630|470165451|FG001|Overall Study|Drug noncompliance, other|4|||
130601950|NCT04275310|470165452|FG000|Overall Study|Non-randomized due to running out of funding|4|||
130601951|NCT04275310|470165453|FG001|Overall Study|Non-randomized due to running out of funding|0|||
130601952|NCT03088605|470165454|FG000|Overall Study|Withdrawal by Subject|1|||
130601953|NCT03088605|470165455|FG001|Overall Study|Withdrawal by Subject|0|||
130601954|NCT02225223|470165456|FG000|Overall Study|Death|10|||
130601955|NCT02225223|470165457|FG001|Overall Study|Death|1|||
130601956|NCT02225223|470165456|FG000|Overall Study|Lost to Follow-up|5|||
130601957|NCT02225223|470165457|FG001|Overall Study|Lost to Follow-up|0|||
130601958|NCT02225223|470165456|FG000|Overall Study|Other|1|||
130601959|NCT02225223|470165457|FG001|Overall Study|Other|2|||
130601960|NCT02225223|470165456|FG000|Overall Study|Physician Decision|1|||
130601961|NCT02225223|470165457|FG001|Overall Study|Physician Decision|0|||
130601962|NCT02225223|470165456|FG000|Overall Study|Withdrawal by Subject|2|||
130601963|NCT02225223|470165457|FG001|Overall Study|Withdrawal by Subject|2|||
130601964|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
130601965|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130601966|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130601967|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130601968|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
130601969|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130601970|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130601971|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130601972|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
130601973|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130601974|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130601975|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130601976|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
130601977|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130601978|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130601979|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130601980|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
130601981|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130601982|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130601983|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130601984|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
130601985|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130601986|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130601987|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130601988|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
130601989|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130601990|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130601991|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130601992|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
130601993|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130601994|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130601995|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130601996|NCT00958568|470165459|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
130601997|NCT00958568|470165460|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130601998|NCT00958568|470165461|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130601999|NCT00958568|470165462|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130602000|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130602001|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
130602002|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130602003|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130602004|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130602005|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
130602006|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130602007|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130602008|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130602009|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
130602010|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130602011|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130602012|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130602013|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
130602014|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130602015|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130602016|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130602017|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
130602018|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130602019|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130602020|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130602021|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
130602022|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130602023|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130602024|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130602025|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
130602026|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130602027|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130602028|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130602029|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
130602030|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130602031|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130602032|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130602033|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
130602034|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130602035|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130602036|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130602037|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
130602038|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130602039|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130602040|NCT00958568|470165459|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130602041|NCT00958568|470165460|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
130602042|NCT00958568|470165461|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130602043|NCT00958568|470165462|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130602044|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
130602045|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
130602046|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
130602047|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
130602048|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
130602049|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
130602050|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
130602051|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
130602052|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
130602053|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
130602054|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
130602055|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
130602056|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
130602057|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
130602058|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
130602059|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
130602060|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
130602061|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
130602062|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
130602063|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
130602064|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
130602065|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
130602066|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
130602067|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
130602068|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
130602069|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
130602070|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
130602071|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
130602072|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130602073|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130602074|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
130602075|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130602076|NCT00958568|470165459|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130602077|NCT00958568|470165460|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130602078|NCT00958568|470165461|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
130602079|NCT00958568|470165462|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130602080|NCT01936649|470165473|FG000|Overall Study|Withdrawal by Subject|4|||
130602081|NCT01936649|470165473|FG000|Overall Study|Physician Decision|2|||
130602082|NCT01936649|470165473|FG000|Overall Study|Protocol Violation|2|||
130602083|NCT01936649|470165473|FG000|Overall Study|Other than specified above|5|||
130602084|NCT04498910|470165476|FG000|Overall Study|Lost to Follow-up|0|||
130602085|NCT04498910|470165477|FG001|Overall Study|Lost to Follow-up|1|||
130602086|NCT04498910|470165476|FG000|Overall Study|Withdrawal by Subject|2|||
130602087|NCT04498910|470165477|FG001|Overall Study|Withdrawal by Subject|1|||
130602088|NCT04498910|470165476|FG000|Overall Study|Adverse Event|1|||
130602089|NCT04498910|470165477|FG001|Overall Study|Adverse Event|0|||
130602090|NCT00909090|470165478|FG000|Overall Study|Lost to Follow-up|17|||
130602091|NCT00909090|470165479|FG001|Overall Study|Lost to Follow-up|17|||
130602092|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
130602093|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
130602094|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130602095|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
130602096|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130602097|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130602098|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
130602099|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130602100|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130602101|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130602102|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130602103|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130602104|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
130602105|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
130602106|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
130602107|NCT00611455|470165483|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
130602108|NCT00611455|470165484|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
130602109|NCT00611455|470165485|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
130602110|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130602111|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
130602112|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130602113|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130602114|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
130602115|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130602116|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130602117|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
130602118|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130602119|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130602120|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
130602121|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130602122|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130602123|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
130602124|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130602125|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
130602126|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
130602127|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
130602128|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130602129|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
130602130|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130602131|NCT00611455|470165483|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130602132|NCT00611455|470165484|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
130602133|NCT00611455|470165485|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130602134|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
130602135|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
130602136|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
130602137|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
130602138|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
130602139|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
130602140|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
130602141|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
130602142|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
130602143|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
130602144|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
130602145|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
130602146|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
130602147|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
130602148|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
130602149|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
130602150|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
130602151|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
130602152|NCT00611455|470165483|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
130602153|NCT00611455|470165484|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
130602154|NCT00611455|470165485|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
130602155|NCT04983901|470165486|FG000|Overall Study|Death|1|||
130602156|NCT04983901|470165487|FG001|Overall Study|Death|4|||
130602157|NCT04983901|470165486|FG000|Overall Study|Lost to Follow-up|3|||
130602158|NCT04983901|470165487|FG001|Overall Study|Lost to Follow-up|0|||
130602159|NCT04983901|470165486|FG000|Overall Study|Protocol Violation|1|||
130602160|NCT04983901|470165487|FG001|Overall Study|Protocol Violation|0|||
130602161|NCT04983901|470165486|FG000|Overall Study|Withdrawal by Subject|1|||
130602162|NCT04983901|470165487|FG001|Overall Study|Withdrawal by Subject|2|||
130602163|NCT03671369|470165492|FG000|Overall Study|Other|1|||
130602164|NCT03671369|470165492|FG000|Overall Study|Withdrawal by Subject|289|||
130602165|NCT03671369|470165492|FG000|Overall Study|Not willing to be vaccinated|1|||
130602166|NCT02732912|470165493|FG000|Overall Study|Discharged before night|2|||
130602167|NCT02732912|470165494|FG001|Overall Study|Discharged before night|6|||
130602168|NCT02732912|470165493|FG000|Overall Study|Incomplete completion of questionnaire|2|||
130602169|NCT02732912|470165494|FG001|Overall Study|Incomplete completion of questionnaire|3|||
130602170|NCT02732912|470165493|FG000|Overall Study|No outcome; discharged or refused|6|||
130602171|NCT02732912|470165494|FG001|Overall Study|No outcome; discharged or refused|9|||
130602172|NCT01507545|470165499|FG000|Overall Study|Withdrawal by Subject|6|||
130602173|NCT01507545|470165500|FG001|Overall Study|Withdrawal by Subject|2|||
130602174|NCT01507545|470165499|FG000|Overall Study|Lost to Follow-up|1|||
130602175|NCT01507545|470165500|FG001|Overall Study|Lost to Follow-up|0|||
130602176|NCT01507545|470165499|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
130602177|NCT01507545|470165500|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
130602178|NCT01507545|470165499|FG000|Overall Study|Progressive disease|60|||
130602179|NCT01507545|470165500|FG001|Overall Study|Progressive disease|27|||
130602180|NCT01507545|470165499|FG000|Overall Study|Other|6|||
130602181|NCT01507545|470165500|FG001|Overall Study|Other|4|||
130602182|NCT01671488|470165501|FG000|Overall Study|Withdrawal by Subject|1|||
130602183|NCT01022853|470165502|FG000|Overall Study|Progressive disease|2|||
130602184|NCT01022853|470165503|FG001|Overall Study|Progressive disease|3|||
130602185|NCT01022853|470165504|FG002|Overall Study|Progressive disease|11|||
130602186|NCT01022853|470165505|FG003|Overall Study|Progressive disease|7|||
130602187|NCT01022853|470165506|FG004|Overall Study|Progressive disease|1|||
130602188|NCT01022853|470165502|FG000|Overall Study|Dose-limiting toxicity|0|||
130602189|NCT01022853|470165503|FG001|Overall Study|Dose-limiting toxicity|0|||
130602190|NCT01022853|470165504|FG002|Overall Study|Dose-limiting toxicity|0|||
130602191|NCT01022853|470165505|FG003|Overall Study|Dose-limiting toxicity|0|||
130602192|NCT01022853|470165506|FG004|Overall Study|Dose-limiting toxicity|1|||
130602193|NCT01022853|470165502|FG000|Overall Study|Withdrawal by Subject|0|||
130602194|NCT01022853|470165503|FG001|Overall Study|Withdrawal by Subject|1|||
130602195|NCT01022853|470165504|FG002|Overall Study|Withdrawal by Subject|1|||
130602196|NCT01022853|470165505|FG003|Overall Study|Withdrawal by Subject|1|||
130602197|NCT01022853|470165506|FG004|Overall Study|Withdrawal by Subject|0|||
130602198|NCT01022853|470165502|FG000|Overall Study|Other not stated above|1|||
130602199|NCT01022853|470165503|FG001|Overall Study|Other not stated above|0|||
130602200|NCT01022853|470165504|FG002|Overall Study|Other not stated above|1|||
130602201|NCT01022853|470165505|FG003|Overall Study|Other not stated above|0|||
130602202|NCT01022853|470165506|FG004|Overall Study|Other not stated above|0|||
130602203|NCT01753518|470165507|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
130602204|NCT01753518|470165508|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
130602205|NCT01753518|470165507|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
130602206|NCT01753518|470165508|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
130602207|NCT01753518|470165507|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
130602208|NCT01753518|470165508|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
130602209|NCT01753518|470165507|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
130602210|NCT01753518|470165508|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
130602211|NCT01214434|470165509|FG000|Overall Study|Withdrawal by Subject|1|||
130602212|NCT01214434|470165510|FG001|Overall Study|Withdrawal by Subject|0|||
130602213|NCT01214434|470165509|FG000|Overall Study|Lost to Follow-up|2|||
130602214|NCT01214434|470165510|FG001|Overall Study|Lost to Follow-up|2|||
130602215|NCT01214434|470165509|FG000|Overall Study|Site error|1|||
130602216|NCT01214434|470165510|FG001|Overall Study|Site error|0|||
130602217|NCT00138151|470165511|FG000|Overall Study|Withdrawal by Subject|3|||
130602218|NCT00138151|470165511|FG000|Overall Study|Physician Decision|1|||
130602219|NCT03503773|470165512|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
130602220|NCT03503773|470165513|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
130602221|NCT03503773|470165512|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
130602222|NCT03503773|470165513|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
130602223|NCT03503773|470165512|FG000|Overall Study|Not completing the primary ABPM|3|||
130602224|NCT03503773|470165513|FG001|Overall Study|Not completing the primary ABPM|1|||
130602225|NCT03503773|470165512|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130602226|NCT03503773|470165513|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130602227|NCT02675517|470165519|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
130602228|NCT02675517|470165519|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
130602229|NCT00425438|470165520|FG000|Overall Study|Termination by Sponsor|25|||
130602230|NCT00425438|470165521|FG001|Overall Study|Termination by Sponsor|27|||
130602231|NCT02619253|470165522|FG000|Overall Study|Adverse Event|0|||
130602232|NCT02619253|470165523|FG001|Overall Study|Adverse Event|0|||
130602233|NCT02619253|470165524|FG002|Overall Study|Adverse Event|1|||
130602234|NCT02619253|470165525|FG003|Overall Study|Adverse Event|1|||
130602235|NCT02619253|470165526|FG004|Overall Study|Adverse Event|3|||
130602236|NCT02619253|470165522|FG000|Overall Study|Alternative Therapy|0|||
130602237|NCT02619253|470165523|FG001|Overall Study|Alternative Therapy|0|||
130602238|NCT02619253|470165524|FG002|Overall Study|Alternative Therapy|1|||
130602239|NCT02619253|470165525|FG003|Overall Study|Alternative Therapy|0|||
130602240|NCT02619253|470165526|FG004|Overall Study|Alternative Therapy|0|||
130602241|NCT02619253|470165522|FG000|Overall Study|Death|0|||
130602242|NCT02619253|470165523|FG001|Overall Study|Death|0|||
130602243|NCT02619253|470165524|FG002|Overall Study|Death|0|||
130602244|NCT02619253|470165525|FG003|Overall Study|Death|1|||
130602245|NCT02619253|470165526|FG004|Overall Study|Death|0|||
130602246|NCT02619253|470165522|FG000|Overall Study|Disease Progression|4|||
130602247|NCT02619253|470165523|FG001|Overall Study|Disease Progression|2|||
130602248|NCT02619253|470165524|FG002|Overall Study|Disease Progression|8|||
130602249|NCT02619253|470165525|FG003|Overall Study|Disease Progression|9|||
130602250|NCT02619253|470165526|FG004|Overall Study|Disease Progression|10|||
130602251|NCT02619253|470165522|FG000|Overall Study|Needed a disqualifying therapy|0|||
130602252|NCT02619253|470165523|FG001|Overall Study|Needed a disqualifying therapy|0|||
130602253|NCT02619253|470165524|FG002|Overall Study|Needed a disqualifying therapy|1|||
130602254|NCT02619253|470165525|FG003|Overall Study|Needed a disqualifying therapy|0|||
130602255|NCT02619253|470165526|FG004|Overall Study|Needed a disqualifying therapy|0|||
130602256|NCT02619253|470165522|FG000|Overall Study|Transferred to hospice|0|||
130602257|NCT02619253|470165523|FG001|Overall Study|Transferred to hospice|0|||
130602258|NCT02619253|470165524|FG002|Overall Study|Transferred to hospice|1|||
130602259|NCT02619253|470165525|FG003|Overall Study|Transferred to hospice|0|||
130602260|NCT02619253|470165526|FG004|Overall Study|Transferred to hospice|0|||
130602261|NCT02619253|470165522|FG000|Overall Study|Physician Decision|0|||
130602262|NCT02619253|470165523|FG001|Overall Study|Physician Decision|1|||
130602263|NCT02619253|470165524|FG002|Overall Study|Physician Decision|2|||
130602264|NCT02619253|470165525|FG003|Overall Study|Physician Decision|3|||
130602265|NCT02619253|470165526|FG004|Overall Study|Physician Decision|0|||
130602266|NCT02619253|470165522|FG000|Overall Study|Withdrawal by Subject|0|||
130602267|NCT02619253|470165523|FG001|Overall Study|Withdrawal by Subject|1|||
130602268|NCT02619253|470165524|FG002|Overall Study|Withdrawal by Subject|0|||
130602269|NCT02619253|470165525|FG003|Overall Study|Withdrawal by Subject|0|||
130602270|NCT02619253|470165526|FG004|Overall Study|Withdrawal by Subject|2|||
130602271|NCT00514449|470165527|FG000|Overall Study|Withdrawal by Subject|1|||
130602272|NCT00514449|470165528|FG001|Overall Study|Withdrawal by Subject|2|||
130602273|NCT00514449|470165527|FG000|Overall Study|Protocol Violation|1|||
130602274|NCT00514449|470165528|FG001|Overall Study|Protocol Violation|2|||
130602275|NCT00514449|470165527|FG000|Overall Study|Lost to Follow-up|1|||
130602276|NCT00514449|470165528|FG001|Overall Study|Lost to Follow-up|0|||
130602277|NCT00942708|470165531|FG000|Overall Study|Withdrawal by Subject|1|||
130602278|NCT01426386|470165536|FG000|Overall Study|Adverse Event|0|||
130602279|NCT01426386|470165537|FG001|Overall Study|Adverse Event|1|||
130602280|NCT01426386|470165538|FG002|Overall Study|Adverse Event|0|||
130602281|NCT01426386|470165539|FG003|Overall Study|Adverse Event|0|||
130602282|NCT01426386|470165540|FG004|Overall Study|Adverse Event|0|||
130602283|NCT01426386|470165541|FG005|Overall Study|Adverse Event|0|||
130602284|NCT01426386|470165536|FG000|Overall Study|Did not attend scheduled visit|1|||
130602285|NCT01426386|470165537|FG001|Overall Study|Did not attend scheduled visit|4|||
130602286|NCT01426386|470165538|FG002|Overall Study|Did not attend scheduled visit|0|||
130602287|NCT01426386|470165539|FG003|Overall Study|Did not attend scheduled visit|0|||
130602288|NCT01426386|470165540|FG004|Overall Study|Did not attend scheduled visit|2|||
130602289|NCT01426386|470165541|FG005|Overall Study|Did not attend scheduled visit|1|||
130602290|NCT01426386|470165536|FG000|Overall Study|Poor response|2|||
130602291|NCT01426386|470165537|FG001|Overall Study|Poor response|1|||
130602292|NCT01426386|470165538|FG002|Overall Study|Poor response|2|||
130602293|NCT01426386|470165539|FG003|Overall Study|Poor response|0|||
130602294|NCT01426386|470165540|FG004|Overall Study|Poor response|1|||
130602295|NCT01426386|470165541|FG005|Overall Study|Poor response|0|||
130602296|NCT01426386|470165536|FG000|Overall Study|Personal reasons|0|||
130602297|NCT01426386|470165537|FG001|Overall Study|Personal reasons|0|||
130602298|NCT01426386|470165538|FG002|Overall Study|Personal reasons|0|||
130602299|NCT01426386|470165539|FG003|Overall Study|Personal reasons|0|||
130602300|NCT01426386|470165540|FG004|Overall Study|Personal reasons|1|||
130602301|NCT01426386|470165541|FG005|Overall Study|Personal reasons|0|||
130602302|NCT01096667|470165542|FG000|Overall Study|Lost to Follow-up|1|||
130602303|NCT01096667|470165543|FG001|Overall Study|Lost to Follow-up|1|||
130602304|NCT01096667|470165544|FG002|Overall Study|Lost to Follow-up|1|||
130602305|NCT01096667|470165545|FG003|Overall Study|Lost to Follow-up|0|||
130602306|NCT01096667|470165546|FG004|Overall Study|Lost to Follow-up|0|||
130602307|NCT01096667|470165542|FG000|Overall Study|Withdrawal by Subject|1|||
130602308|NCT01096667|470165543|FG001|Overall Study|Withdrawal by Subject|0|||
130602309|NCT01096667|470165544|FG002|Overall Study|Withdrawal by Subject|0|||
130602310|NCT01096667|470165545|FG003|Overall Study|Withdrawal by Subject|1|||
130602311|NCT01096667|470165546|FG004|Overall Study|Withdrawal by Subject|0|||
130602312|NCT01096667|470165542|FG000|Overall Study|Reason not available|0|||
130602313|NCT01096667|470165543|FG001|Overall Study|Reason not available|1|||
130602314|NCT01096667|470165544|FG002|Overall Study|Reason not available|1|||
130602315|NCT01096667|470165545|FG003|Overall Study|Reason not available|1|||
130602316|NCT01096667|470165546|FG004|Overall Study|Reason not available|0|||
130602317|NCT01096667|470165542|FG000|Overall Study|Protocol Violation|0|||
130602318|NCT01096667|470165543|FG001|Overall Study|Protocol Violation|0|||
130602319|NCT01096667|470165544|FG002|Overall Study|Protocol Violation|0|||
130602320|NCT01096667|470165545|FG003|Overall Study|Protocol Violation|1|||
130602321|NCT01096667|470165546|FG004|Overall Study|Protocol Violation|0|||
130602322|NCT01096667|470165542|FG000|Overall Study|Not treated|1|||
130602323|NCT01096667|470165543|FG001|Overall Study|Not treated|0|||
130602324|NCT01096667|470165544|FG002|Overall Study|Not treated|0|||
130602325|NCT01096667|470165545|FG003|Overall Study|Not treated|0|||
130602326|NCT01096667|470165546|FG004|Overall Study|Not treated|0|||
130602327|NCT00306891|470165547|FG000|Part A|Withdrawal by Subject|1|||
130602328|NCT00306891|470165548|FG001|Part A|Withdrawal by Subject|1|||
130602329|NCT00306891|470165549|FG002|Part A|Withdrawal by Subject|0|||
130602330|NCT00306891|470165550|FG003|Part A|Withdrawal by Subject|0|||
130602331|NCT00306891|470165547|FG000|Part A|Condition under investigation worsened|2|||
130602332|NCT00306891|470165548|FG001|Part A|Condition under investigation worsened|2|||
130602333|NCT00306891|470165549|FG002|Part A|Condition under investigation worsened|0|||
130602334|NCT00306891|470165550|FG003|Part A|Condition under investigation worsened|0|||
130602335|NCT00306891|470165547|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130602336|NCT00306891|470165548|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
130602337|NCT00306891|470165549|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130602338|NCT00306891|470165550|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130602339|NCT00306891|470165547|FG000|Part A|Partial bowel obstruction|1|||
130602340|NCT00306891|470165548|FG001|Part A|Partial bowel obstruction|0|||
130602341|NCT00306891|470165549|FG002|Part A|Partial bowel obstruction|0|||
130602342|NCT00306891|470165550|FG003|Part A|Partial bowel obstruction|0|||
130602343|NCT00306891|470165547|FG000|Part A|Reaccumul. of ascites following drainage|0|||
130602344|NCT00306891|470165548|FG001|Part A|Reaccumul. of ascites following drainage|1|||
130602345|NCT00306891|470165549|FG002|Part A|Reaccumul. of ascites following drainage|0|||
130602346|NCT00306891|470165550|FG003|Part A|Reaccumul. of ascites following drainage|0|||
130602347|NCT00306891|470165547|FG000|Part A|Suspicion of second malignancy|0|||
130602348|NCT00306891|470165548|FG001|Part A|Suspicion of second malignancy|1|||
130602349|NCT00306891|470165549|FG002|Part A|Suspicion of second malignancy|0|||
130602350|NCT00306891|470165550|FG003|Part A|Suspicion of second malignancy|0|||
130602351|NCT00306891|470165547|FG000|Part A|QTC interval outwith elig. criteria|1|||
130602352|NCT00306891|470165548|FG001|Part A|QTC interval outwith elig. criteria|0|||
130602353|NCT00306891|470165549|FG002|Part A|QTC interval outwith elig. criteria|0|||
130602354|NCT00306891|470165550|FG003|Part A|QTC interval outwith elig. criteria|0|||
130602355|NCT00306891|470165547|FG000|Part B|Death|0|||
130602356|NCT00306891|470165548|FG001|Part B|Death|0|||
130602357|NCT00306891|470165549|FG002|Part B|Death|1|||
130602358|NCT00306891|470165550|FG003|Part B|Death|2|||
130602359|NCT00306891|470165547|FG000|Part B|Adverse Event|0|||
130602360|NCT00306891|470165548|FG001|Part B|Adverse Event|0|||
130602361|NCT00306891|470165549|FG002|Part B|Adverse Event|5|||
130602362|NCT00306891|470165550|FG003|Part B|Adverse Event|5|||
130602363|NCT00306891|470165547|FG000|Part B|Withdrawal by Subject|0|||
130602364|NCT00306891|470165548|FG001|Part B|Withdrawal by Subject|0|||
130602365|NCT00306891|470165549|FG002|Part B|Withdrawal by Subject|3|||
130602366|NCT00306891|470165550|FG003|Part B|Withdrawal by Subject|1|||
130602367|NCT00306891|470165547|FG000|Part B|Condition under investigation worsened|0|||
130602368|NCT00306891|470165548|FG001|Part B|Condition under investigation worsened|0|||
130602369|NCT00306891|470165549|FG002|Part B|Condition under investigation worsened|2|||
130602370|NCT00306891|470165550|FG003|Part B|Condition under investigation worsened|8|||
130602371|NCT00306891|470165547|FG000|Part B|Development of study specific disc crit.|0|||
130602372|NCT00306891|470165548|FG001|Part B|Development of study specific disc crit.|0|||
130602373|NCT00306891|470165549|FG002|Part B|Development of study specific disc crit.|0|||
130602374|NCT00306891|470165550|FG003|Part B|Development of study specific disc crit.|1|||
130602375|NCT00673673|470165551|FG000|Overall Study|Progressive disease|27|||
130602376|NCT00673673|470165551|FG000|Overall Study|Adverse Event|4|||
130602377|NCT00673673|470165551|FG000|Overall Study|Withdrawal by Subject|3|||
130602378|NCT00673673|470165551|FG000|Overall Study|Investigators' discretion|2|||
130602379|NCT00206518|470165552|FG000|Overall Study|Lack of Efficacy|6|||
130602380|NCT00206518|470165553|FG001|Overall Study|Lack of Efficacy|4|||
130602381|NCT00206518|470165552|FG000|Overall Study|Adverse Event|2|||
130602382|NCT00206518|470165553|FG001|Overall Study|Adverse Event|1|||
130602383|NCT00206518|470165552|FG000|Overall Study|Physician Decision|1|||
130602384|NCT00206518|470165553|FG001|Overall Study|Physician Decision|0|||
130602385|NCT00206518|470165552|FG000|Overall Study|Protocol Violation|1|||
130602386|NCT00206518|470165553|FG001|Overall Study|Protocol Violation|1|||
130602387|NCT00465738|470165555|FG000|Overall Study|Lost to Follow-up|2|||
130602388|NCT00465738|470165556|FG001|Overall Study|Lost to Follow-up|0|||
130602389|NCT00465738|470165555|FG000|Overall Study|Adverse Event|0|||
130602390|NCT00465738|470165556|FG001|Overall Study|Adverse Event|1|||
130602391|NCT00465738|470165555|FG000|Overall Study|Withdrawal by Subject|2|||
130602392|NCT00465738|470165556|FG001|Overall Study|Withdrawal by Subject|0|||
130602393|NCT00465738|470165555|FG000|Overall Study|Other|2|||
130602394|NCT00465738|470165556|FG001|Overall Study|Other|5|||
130602395|NCT02792777|470165557|FG000|Overall Study|Withdrawal by Subject|2|||
130602396|NCT02792777|470165558|FG001|Overall Study|Withdrawal by Subject|0|||
130602397|NCT02792777|470165557|FG000|Overall Study|Recording malfunction|2|||
130602398|NCT02792777|470165558|FG001|Overall Study|Recording malfunction|0|||
130602399|NCT02792777|470165557|FG000|Overall Study|Later determined to be ineligible|2|||
130602400|NCT02792777|470165558|FG001|Overall Study|Later determined to be ineligible|0|||
130602401|NCT02792777|470165557|FG000|Overall Study|Participant interviewed twice|1|||
130602402|NCT02792777|470165558|FG001|Overall Study|Participant interviewed twice|0|||
130602403|NCT00515463|470165561|FG000|Overall Study|Physician Decision|4|||
130602404|NCT00515463|470165562|FG001|Overall Study|Physician Decision|2|||
130602405|NCT00515463|470165561|FG000|Overall Study|Adverse Event|1|||
130602406|NCT00515463|470165562|FG001|Overall Study|Adverse Event|2|||
130602407|NCT00515463|470165561|FG000|Overall Study|Withdrawal by Subject|3|||
130602408|NCT00515463|470165562|FG001|Overall Study|Withdrawal by Subject|4|||
130602409|NCT00515463|470165561|FG000|Overall Study|Lost to Follow-up|6|||
130602410|NCT00515463|470165562|FG001|Overall Study|Lost to Follow-up|5|||
130602411|NCT00515463|470165561|FG000|Overall Study|Other|0|||
130602412|NCT00515463|470165562|FG001|Overall Study|Other|1|||
130602413|NCT02269319|470165563|FG000|Overall Study|Lost to Follow-up|4|||
130602414|NCT02269319|470165564|FG001|Overall Study|Lost to Follow-up|3|||
130602415|NCT02269319|470165563|FG000|Overall Study|Adverse Event|0|||
130602416|NCT02269319|470165564|FG001|Overall Study|Adverse Event|1|||
130602417|NCT02269319|470165563|FG000|Overall Study|Instructions not followed|1|||
130602418|NCT02269319|470165564|FG001|Overall Study|Instructions not followed|0|||
130602419|NCT05243550|470166945|FG000|Overall Study|Ongoing in the Study|171|||
130602420|NCT05243550|470166945|FG000|Overall Study|Withdrawal by Subject|10|||
130602421|NCT05243550|470166945|FG000|Overall Study|Lost to Follow-up|7|||
130602422|NCT05243550|470166945|FG000|Overall Study|Adverse Event|3|||
130602423|NCT05243550|470166945|FG000|Overall Study|Noncompliance|1|||
130602424|NCT05243550|470166945|FG000|Overall Study|Physician Decision|1|||
130602425|NCT05243550|470166945|FG000|Overall Study|Other Reason|4|||
130602426|NCT00893113|470166950|FG000|Overall Study|Lost to Follow-up|4|||
130602427|NCT00893113|470166951|FG001|Overall Study|Lost to Follow-up|8|||
130602428|NCT00893113|470166950|FG000|Overall Study|Early Termination|1|||
130602429|NCT00893113|470166951|FG001|Overall Study|Early Termination|1|||
130602430|NCT00893113|470166950|FG000|Overall Study|Withdrew Consent|8|||
130602431|NCT00893113|470166951|FG001|Overall Study|Withdrew Consent|7|||
130602432|NCT04655586|470166961|FG000|Overall Study|Physician Decision|1|||
130602433|NCT04655586|470166962|FG001|Overall Study|Physician Decision|3|||
130602434|NCT04655586|470166963|FG002|Overall Study|Physician Decision|4|||
130602435|NCT04655586|470166961|FG000|Overall Study|Withdrawal by Subject|1|||
130602436|NCT04655586|470166962|FG001|Overall Study|Withdrawal by Subject|3|||
130602437|NCT04655586|470166963|FG002|Overall Study|Withdrawal by Subject|1|||
130602438|NCT00891657|470166968|FG000|Overall Study|Withdrawal by Subject|1|||
130602439|NCT00891657|470166969|FG001|Overall Study|Withdrawal by Subject|1|||
130602440|NCT02927171|470166972|FG000|Overall Study|Lost to Follow-up|0|||
130602441|NCT02927171|470166973|FG001|Overall Study|Lost to Follow-up|1|||
130602442|NCT04530825|470166978|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
130602443|NCT04530825|470166979|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
130602444|NCT04530825|470166980|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
130602445|NCT04530825|470166981|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
130602446|NCT04530825|470166978|FG000|Overall Study|Did not complete follow-up|3|||
130602447|NCT04530825|470166979|FG001|Overall Study|Did not complete follow-up|0|||
130602448|NCT04530825|470166980|FG002|Overall Study|Did not complete follow-up|0|||
130602449|NCT04530825|470166981|FG003|Overall Study|Did not complete follow-up|0|||
130602450|NCT00850499|470166983|FG000|Overall Study|Adverse Event|3|||
130602451|NCT00850499|470166984|FG001|Overall Study|Adverse Event|1|||
130602452|NCT00850499|470166983|FG000|Overall Study|Lack of Efficacy|0|||
130602453|NCT00850499|470166984|FG001|Overall Study|Lack of Efficacy|1|||
130602454|NCT00552305|470166985|FG000|Overall Study|Adverse Event|43|||
130602455|NCT00552305|470166985|FG000|Overall Study|Lack of Efficacy|120|||
130602456|NCT00552305|470166985|FG000|Overall Study|Lost to Follow-up|4|||
130602457|NCT00552305|470166985|FG000|Overall Study|Protocol Violation|3|||
130602458|NCT00552305|470166985|FG000|Overall Study|Withdrawal by Subject|44|||
130602459|NCT00552305|470166985|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
130602460|NCT00552305|470166985|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
130602461|NCT00552305|470166985|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
130602462|NCT00552305|470166985|FG000|Overall Study|Unsatisfactory compliance|11|||
130602463|NCT00552305|470166985|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
130602464|NCT00552305|470166985|FG000|Overall Study|AE/Other: prohibited drug required|1|||
130602465|NCT00552305|470166985|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
130602466|NCT00552305|470166985|FG000|Overall Study|Other: Site closed|4|||
130602467|NCT00552305|470166985|FG000|Overall Study|Other: Personal problems|1|||
130602468|NCT00552305|470166985|FG000|Overall Study|Other: Unable to attend visits|1|||
130602469|NCT00552305|470166985|FG000|Overall Study|Other: Subject underwent surgery|4|||
130602470|NCT00552305|470166985|FG000|Overall Study|Other: Subject became pregnant|1|||
130602471|NCT00552305|470166985|FG000|Overall Study|Other: Health problems, not drug related|1|||
130602472|NCT00552305|470166985|FG000|Overall Study|Other: Subject moved from area|2|||
130602473|NCT00552305|470166985|FG000|Overall Study|Other: Subject incarcerated|1|||
130602474|NCT00552305|470166985|FG000|Overall Study|Other: Subject went to rehab|1|||
130602475|NCT01849848|470166986|FG000|Overall Study|Physician Decision|1|||
130602476|NCT01849848|470166986|FG000|Overall Study|Progression of the primary disease|3|||
130602477|NCT01839188|470166987|FG000|Overall Study|Withdrawal by Subject|1|||
130602478|NCT03494725|470166988|FG000|Overall Study|Withdrawal by Subject|0|||
130602479|NCT03494725|470166989|FG001|Overall Study|Withdrawal by Subject|2|||
130602480|NCT03494725|470166988|FG000|Overall Study|Antibiotic use|1|||
130602481|NCT03494725|470166989|FG001|Overall Study|Antibiotic use|0|||
130602482|NCT00149825|470166993|FG000|Overall Study|Intolerance to medication side effects|1|||
130602483|NCT00149825|470166994|FG001|Overall Study|Intolerance to medication side effects|2|||
130602484|NCT00149825|470166993|FG000|Overall Study|Time commitments|2|||
130602485|NCT00149825|470166994|FG001|Overall Study|Time commitments|1|||
130602486|NCT00149825|470166993|FG000|Overall Study|Not liking insomnia therapy|1|||
130602487|NCT00149825|470166994|FG001|Overall Study|Not liking insomnia therapy|0|||
130602488|NCT00149825|470166993|FG000|Overall Study|Other|1|||
130602489|NCT00149825|470166994|FG001|Overall Study|Other|0|||
130602490|NCT01359982|470166995|FG000|Overall Study|Adverse Event|2|||
130602491|NCT01359982|470166996|FG001|Overall Study|Adverse Event|0|||
130602492|NCT01359982|470166997|FG002|Overall Study|Adverse Event|0|||
130602493|NCT01359982|470166998|FG003|Overall Study|Adverse Event|1|||
130602494|NCT01359982|470166999|FG004|Overall Study|Adverse Event|0|||
130602495|NCT01359982|470167000|FG005|Overall Study|Adverse Event|0|||
130602496|NCT01359982|470166995|FG000|Overall Study|Death|1|||
130602497|NCT01359982|470166996|FG001|Overall Study|Death|0|||
130602498|NCT01359982|470166997|FG002|Overall Study|Death|0|||
130602499|NCT01359982|470166998|FG003|Overall Study|Death|0|||
130602500|NCT01359982|470166999|FG004|Overall Study|Death|0|||
130602501|NCT01359982|470167000|FG005|Overall Study|Death|0|||
130602502|NCT03694522|470167002|FG000|Overall Study|Withdrawal by Subject|8|||
130602503|NCT03694522|470167003|FG001|Overall Study|Withdrawal by Subject|10|||
130602504|NCT03694522|470167002|FG000|Overall Study|Physician Decision|53|||
130602505|NCT03694522|470167003|FG001|Overall Study|Physician Decision|54|||
130602506|NCT03694522|470167002|FG000|Overall Study|Other|1|||
130602507|NCT03694522|470167003|FG001|Overall Study|Other|1|||
130602508|NCT03694522|470167002|FG000|Overall Study|Lost to Follow-up|0|||
130602509|NCT03694522|470167003|FG001|Overall Study|Lost to Follow-up|1|||
130602510|NCT02760407|470167004|FG000|Overall Study|Death|2|||
130602511|NCT02760407|470167005|FG001|Overall Study|Death|3|||
130602512|NCT02760407|470167006|FG002|Overall Study|Death|1|||
130602513|NCT02760407|470167007|FG003|Overall Study|Death|1|||
130602514|NCT02760407|470167004|FG000|Overall Study|Lost to Follow-up|1|||
130602515|NCT02760407|470167005|FG001|Overall Study|Lost to Follow-up|7|||
130602516|NCT02760407|470167006|FG002|Overall Study|Lost to Follow-up|4|||
130602517|NCT02760407|470167007|FG003|Overall Study|Lost to Follow-up|6|||
130602518|NCT02760407|470167004|FG000|Overall Study|Withdrawal by Subject|25|||
130602519|NCT02760407|470167005|FG001|Overall Study|Withdrawal by Subject|31|||
130602520|NCT02760407|470167006|FG002|Overall Study|Withdrawal by Subject|37|||
130602521|NCT02760407|470167007|FG003|Overall Study|Withdrawal by Subject|25|||
130602522|NCT02760407|470167004|FG000|Overall Study|Violation of Eligibility criteria|0|||
130602523|NCT02760407|470167005|FG001|Overall Study|Violation of Eligibility criteria|0|||
130602524|NCT02760407|470167006|FG002|Overall Study|Violation of Eligibility criteria|1|||
130602525|NCT02760407|470167007|FG003|Overall Study|Violation of Eligibility criteria|1|||
130602526|NCT02760407|470167004|FG000|Overall Study|Personal reasons|0|||
130602527|NCT02760407|470167005|FG001|Overall Study|Personal reasons|0|||
130602528|NCT02760407|470167006|FG002|Overall Study|Personal reasons|0|||
130602529|NCT02760407|470167007|FG003|Overall Study|Personal reasons|1|||
130602530|NCT02760407|470167004|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
130602531|NCT02760407|470167005|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130602532|NCT02760407|470167006|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130602533|NCT02760407|470167007|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130602534|NCT02760407|470167004|FG000|Overall Study|Use of prohibited Medication|0|||
130602535|NCT02760407|470167005|FG001|Overall Study|Use of prohibited Medication|0|||
130602536|NCT02760407|470167006|FG002|Overall Study|Use of prohibited Medication|1|||
130602537|NCT02760407|470167007|FG003|Overall Study|Use of prohibited Medication|0|||
130602538|NCT02760407|470167004|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130602539|NCT02760407|470167005|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130602540|NCT02760407|470167006|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
130602541|NCT02760407|470167007|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130602542|NCT02760407|470167004|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
130602543|NCT02760407|470167005|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130602544|NCT02760407|470167006|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130602545|NCT02760407|470167007|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130602546|NCT02760407|470167004|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
130602547|NCT02760407|470167005|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
130602548|NCT02760407|470167006|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
130602549|NCT02760407|470167007|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
130602550|NCT02760407|470167004|FG000|Overall Study|Inadequately Enrolled|0|||
130602551|NCT02760407|470167005|FG001|Overall Study|Inadequately Enrolled|0|||
130602552|NCT02760407|470167006|FG002|Overall Study|Inadequately Enrolled|0|||
130602553|NCT02760407|470167007|FG003|Overall Study|Inadequately Enrolled|1|||
130602554|NCT02760407|470167004|FG000|Overall Study|Withdrawal By PI's Decision|0|||
130602555|NCT02760407|470167005|FG001|Overall Study|Withdrawal By PI's Decision|1|||
130602556|NCT02760407|470167006|FG002|Overall Study|Withdrawal By PI's Decision|0|||
130602557|NCT02760407|470167007|FG003|Overall Study|Withdrawal By PI's Decision|0|||
130602558|NCT02760407|470167004|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
130602559|NCT02760407|470167005|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
130602560|NCT02760407|470167006|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
130602561|NCT02760407|470167007|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
130602562|NCT02760407|470167004|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130602563|NCT02760407|470167005|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130602564|NCT02760407|470167006|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
130602565|NCT02760407|470167007|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130602566|NCT02760407|470167004|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
130602567|NCT02760407|470167005|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130602568|NCT02760407|470167006|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130602569|NCT02760407|470167007|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130602570|NCT02760407|470167004|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
130602571|NCT02760407|470167005|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
130602572|NCT02760407|470167006|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
130602573|NCT02760407|470167007|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
130602574|NCT02760407|470167004|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
130602575|NCT02760407|470167005|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130602576|NCT02760407|470167006|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130602577|NCT02760407|470167007|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130602578|NCT02760407|470167004|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
130602579|NCT02760407|470167005|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130602580|NCT02760407|470167006|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130602581|NCT02760407|470167007|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130602582|NCT02760407|470167004|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
130602583|NCT02760407|470167005|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
130602584|NCT02760407|470167006|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
130602585|NCT02760407|470167007|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
130602586|NCT02760407|470167004|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
130602587|NCT02760407|470167005|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130602588|NCT02760407|470167006|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130602589|NCT02760407|470167007|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130602590|NCT02760407|470167004|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
130602591|NCT02760407|470167005|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
130602592|NCT02760407|470167006|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
130602593|NCT02760407|470167007|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
130602594|NCT01748760|470167008|FG000|Overall Study|Withdrawal by Subject|1|||
130602595|NCT01748760|470167009|FG001|Overall Study|Withdrawal by Subject|1|||
130602596|NCT01748760|470167008|FG000|Overall Study|Lost to Follow-up|5|||
130602597|NCT01748760|470167009|FG001|Overall Study|Lost to Follow-up|1|||
130602598|NCT03245814|470167010|FG000|Overall Study|Lost to Follow-up|5|||
130602599|NCT03245814|470167011|FG001|Overall Study|Lost to Follow-up|8|||
130602600|NCT03245814|470167010|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
130602601|NCT03245814|470167011|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
130602602|NCT01164501|470167012|FG000|Overall Study|Not treated|2|||
130602603|NCT01164501|470167013|FG001|Overall Study|Not treated|0|||
130602604|NCT01164501|470167014|FG002|Overall Study|Not treated|1|||
130602605|NCT01164501|470167012|FG000|Overall Study|Adverse Event|18|||
130602606|NCT01164501|470167013|FG001|Overall Study|Adverse Event|4|||
130602607|NCT01164501|470167014|FG002|Overall Study|Adverse Event|21|||
130602608|NCT01164501|470167012|FG000|Overall Study|Lack of Efficacy|0|||
130602609|NCT01164501|470167013|FG001|Overall Study|Lack of Efficacy|0|||
130602610|NCT01164501|470167014|FG002|Overall Study|Lack of Efficacy|1|||
130602611|NCT01164501|470167012|FG000|Overall Study|Non compliant with protocol|1|||
130602612|NCT01164501|470167013|FG001|Overall Study|Non compliant with protocol|1|||
130602613|NCT01164501|470167014|FG002|Overall Study|Non compliant with protocol|4|||
130602614|NCT01164501|470167012|FG000|Overall Study|Lost to Follow-up|3|||
130602615|NCT01164501|470167013|FG001|Overall Study|Lost to Follow-up|0|||
130602616|NCT01164501|470167014|FG002|Overall Study|Lost to Follow-up|3|||
130602617|NCT01164501|470167012|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
130602618|NCT01164501|470167013|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
130602619|NCT01164501|470167014|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
130602620|NCT01164501|470167012|FG000|Overall Study|Other reason not defined above|9|||
130602621|NCT01164501|470167013|FG001|Overall Study|Other reason not defined above|1|||
130602622|NCT01164501|470167014|FG002|Overall Study|Other reason not defined above|4|||
130602623|NCT00945191|470167015|FG000|Overall Study|Did not achieve a complete response|18|||
130602624|NCT00945191|470167015|FG000|Overall Study|Participant relocated to another state|1|||
130602625|NCT00945191|470167015|FG000|Overall Study|Disease progression|3|||
130602626|NCT00945191|470167015|FG000|Overall Study|Serious adverse event or adverse event|1|||
130602627|NCT00945191|470167015|FG000|Overall Study|Investigator's discretion|1|||
130602628|NCT00394914|470167018|FG000|Treatment Period|Adverse Event|0|||
130602629|NCT00394914|470167019|FG001|Treatment Period|Adverse Event|3|||
130602630|NCT00394914|470167020|FG002|Treatment Period|Adverse Event|1|||
130602631|NCT00394914|470167018|FG000|Treatment Period|Lost to Follow-up|0|||
130602632|NCT00394914|470167019|FG001|Treatment Period|Lost to Follow-up|1|||
130602633|NCT00394914|470167020|FG002|Treatment Period|Lost to Follow-up|0|||
130602634|NCT00394914|470167018|FG000|Treatment Period|Withdrawal by Subject|0|||
130602635|NCT00394914|470167019|FG001|Treatment Period|Withdrawal by Subject|2|||
130602636|NCT00394914|470167020|FG002|Treatment Period|Withdrawal by Subject|2|||
130602637|NCT00394914|470167018|FG000|Treatment Period|Noncompliance with protocol|0|||
130602638|NCT00394914|470167019|FG001|Treatment Period|Noncompliance with protocol|3|||
130602639|NCT00394914|470167020|FG002|Treatment Period|Noncompliance with protocol|2|||
130602640|NCT00394914|470167018|FG000|Treatment Period|Did not meet protocol eligibility|0|||
130602641|NCT00394914|470167019|FG001|Treatment Period|Did not meet protocol eligibility|1|||
130602642|NCT00394914|470167020|FG002|Treatment Period|Did not meet protocol eligibility|1|||
130602643|NCT00312377|470167025|FG000|Overall Study|Death|403|||
130602644|NCT00312377|470167026|FG001|Overall Study|Death|418|||
130602645|NCT00312377|470167025|FG000|Overall Study|Withdrawal by Subject|23|||
130602646|NCT00312377|470167026|FG001|Overall Study|Withdrawal by Subject|30|||
130602647|NCT00312377|470167025|FG000|Overall Study|Lost to Follow-up|9|||
130602648|NCT00312377|470167026|FG001|Overall Study|Lost to Follow-up|12|||
130602649|NCT00312377|470167025|FG000|Overall Study|Non-compliance|0|||
130602650|NCT00312377|470167026|FG001|Overall Study|Non-compliance|2|||
130602651|NCT00312377|470167025|FG000|Overall Study|Randomised but never received treatment|6|||
130602652|NCT00312377|470167026|FG001|Overall Study|Randomised but never received treatment|6|||
130602653|NCT00312377|470167025|FG000|Overall Study|Discontinue treatment survival follow up|202|||
130602654|NCT00312377|470167026|FG001|Overall Study|Discontinue treatment survival follow up|200|||
130602655|NCT00312377|470167025|FG000|Overall Study|Site ended participation in study|1|||
130602656|NCT00312377|470167026|FG001|Overall Study|Site ended participation in study|0|||
130602657|NCT00872898|470167027|FG000|Part Two - Double Blind|Adverse Event|4|||
130602658|NCT00872898|470167028|FG001|Part Two - Double Blind|Adverse Event|3|||
130602659|NCT00872898|470167027|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
130602660|NCT00872898|470167028|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
130602661|NCT00872898|470167027|FG000|Part Two - Double Blind|Protocol Violation|1|||
130602662|NCT00872898|470167028|FG001|Part Two - Double Blind|Protocol Violation|0|||
130602663|NCT00872898|470167027|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
130602664|NCT00872898|470167028|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
130602665|NCT00872898|470167027|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
130602666|NCT00872898|470167028|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
130602667|NCT00872898|470167027|FG000|Part Two - Double Blind|Other reasons|2|||
130602668|NCT00872898|470167028|FG001|Part Two - Double Blind|Other reasons|0|||
130602669|NCT01004146|470167029|FG000|Overall Study|Withdrawal by Subject|4|||
130602670|NCT01004146|470167030|FG001|Overall Study|Withdrawal by Subject|5|||
130602671|NCT01001494|470167042|FG000|Overall Study|Adverse Event|8|||
130602672|NCT01001494|470167043|FG001|Overall Study|Adverse Event|4|||
130602673|NCT01001494|470167044|FG002|Overall Study|Adverse Event|6|||
130602674|NCT01001494|470167042|FG000|Overall Study|Protocol Violation|0|||
130602675|NCT01001494|470167043|FG001|Overall Study|Protocol Violation|1|||
130602676|NCT01001494|470167044|FG002|Overall Study|Protocol Violation|1|||
130602677|NCT01001494|470167042|FG000|Overall Study|Lost to Follow-up|2|||
130602678|NCT01001494|470167043|FG001|Overall Study|Lost to Follow-up|0|||
130602679|NCT01001494|470167044|FG002|Overall Study|Lost to Follow-up|1|||
130602680|NCT01001494|470167042|FG000|Overall Study|Withdrawal by Subject|9|||
130602681|NCT01001494|470167043|FG001|Overall Study|Withdrawal by Subject|7|||
130602682|NCT01001494|470167044|FG002|Overall Study|Withdrawal by Subject|17|||
130602683|NCT01001494|470167042|FG000|Overall Study|COPD exacerbation|3|||
130602684|NCT01001494|470167043|FG001|Overall Study|COPD exacerbation|4|||
130602685|NCT01001494|470167044|FG002|Overall Study|COPD exacerbation|5|||
130602686|NCT01001494|470167042|FG000|Overall Study|Lack of Efficacy|2|||
130602687|NCT01001494|470167043|FG001|Overall Study|Lack of Efficacy|0|||
130602688|NCT01001494|470167044|FG002|Overall Study|Lack of Efficacy|8|||
130602689|NCT01001494|470167042|FG000|Overall Study|Other|0|||
130602690|NCT01001494|470167043|FG001|Overall Study|Other|1|||
130602691|NCT01001494|470167044|FG002|Overall Study|Other|3|||
130602692|NCT02179398|470167045|FG000|Overall Study|Lack of obligatory data|3|||
130602693|NCT02179398|470167046|FG001|Overall Study|Lack of obligatory data|3|||
130602694|NCT02179398|470167045|FG000|Overall Study|Lost to Follow-up|0|||
130602695|NCT02179398|470167046|FG001|Overall Study|Lost to Follow-up|1|||
130602696|NCT00408681|470167053|FG000|Overall Study|Lack of Efficacy|2|||
130602697|NCT00408681|470167053|FG000|Overall Study|Adverse Event|7|||
130602698|NCT02519231|470167056|FG000|Overall Study|Lost to Follow-up|2|||
130602699|NCT02519231|470167057|FG001|Overall Study|Lost to Follow-up|5|||
130602700|NCT02519231|470167056|FG000|Overall Study|Withdrawal by Subject|0|||
130602701|NCT02519231|470167057|FG001|Overall Study|Withdrawal by Subject|1|||
130602702|NCT00447421|470167058|FG000|Overall Study|Lack of Efficacy|1|||
130602703|NCT00447421|470167058|FG000|Overall Study|Adverse Event|3|||
130602704|NCT00447421|470167058|FG000|Overall Study|Sponsor Decision|2|||
130602705|NCT02124798|470167060|FG000|Overall Study|Adverse Event|3|||
130602706|NCT02124798|470167060|FG000|Overall Study|Lost to Follow-up|1|||
130602707|NCT01707147|470167063|FG000|Overall Study|Administered Trajenta prior to contract|5|||
130602708|NCT01707147|470167063|FG000|Overall Study|Patients who have not taken Trajenta|1|||
130602709|NCT01707147|470167063|FG000|Overall Study|Follow-up failure|17|||
130602710|NCT01707147|470167063|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
130602711|NCT02053246|470167064|FG000|Overall Study|Withdrawal by Subject|3|||
130602712|NCT02053246|470167064|FG000|Overall Study|Physician Decision|1|||
130602713|NCT02795156|470167065|FG000|Overall Study|Progressive Disease|22|||
130602714|NCT02795156|470167066|FG001|Overall Study|Progressive Disease|7|||
130602715|NCT02795156|470167067|FG002|Overall Study|Progressive Disease|34|||
130602716|NCT02795156|470167068|FG003|Overall Study|Progressive Disease|7|||
130602717|NCT02795156|470167065|FG000|Overall Study|Adverse Event|13|||
130602718|NCT02795156|470167066|FG001|Overall Study|Adverse Event|2|||
130602719|NCT02795156|470167067|FG002|Overall Study|Adverse Event|3|||
130602720|NCT02795156|470167068|FG003|Overall Study|Adverse Event|2|||
130602721|NCT02795156|470167065|FG000|Overall Study|Death|1|||
130602722|NCT02795156|470167066|FG001|Overall Study|Death|1|||
130602723|NCT02795156|470167067|FG002|Overall Study|Death|1|||
130602724|NCT02795156|470167068|FG003|Overall Study|Death|0|||
130602725|NCT02795156|470167065|FG000|Overall Study|Physician Decision|1|||
130602726|NCT02795156|470167066|FG001|Overall Study|Physician Decision|0|||
130602727|NCT02795156|470167067|FG002|Overall Study|Physician Decision|1|||
130602728|NCT02795156|470167068|FG003|Overall Study|Physician Decision|0|||
130602729|NCT02795156|470167065|FG000|Overall Study|Withdrawal by Subject|2|||
130602730|NCT02795156|470167066|FG001|Overall Study|Withdrawal by Subject|0|||
130602731|NCT02795156|470167067|FG002|Overall Study|Withdrawal by Subject|3|||
130602732|NCT02795156|470167068|FG003|Overall Study|Withdrawal by Subject|0|||
130602733|NCT00815308|470167069|FG000|Overall Study|Adverse Event|4|||
130602734|NCT00815308|470167069|FG000|Overall Study|Withdrawal by Subject|0|||
130602735|NCT00815308|470167069|FG000|Overall Study|Protocol Violation|6|||
130602736|NCT00638846|470167073|FG000|Overall Study|Adverse Event|0|||
130602737|NCT00638846|470167074|FG001|Overall Study|Adverse Event|1|||
130602738|NCT00638846|470167073|FG000|Overall Study|Lost to Follow-up|3|||
130602739|NCT00638846|470167074|FG001|Overall Study|Lost to Follow-up|2|||
130602740|NCT00638846|470167073|FG000|Overall Study|lens issue|1|||
130602741|NCT00638846|470167074|FG001|Overall Study|lens issue|3|||
130602742|NCT01171521|470167077|FG000|Overall Study|Lost to Follow-up|5|||
130602743|NCT01171521|470167077|FG000|Overall Study|screen failure|1|||
130602744|NCT00652093|470167082|FG000|Overall Study|Withdrawal by Subject|0|||
130602745|NCT00652093|470167083|FG001|Overall Study|Withdrawal by Subject|0|||
130602746|NCT00652093|470167084|FG002|Overall Study|Withdrawal by Subject|1|||
130602747|NCT00652093|470167085|FG003|Overall Study|Withdrawal by Subject|0|||
130602748|NCT00652093|470167086|FG004|Overall Study|Withdrawal by Subject|1|||
130602749|NCT00652093|470167087|FG005|Overall Study|Withdrawal by Subject|0|||
130602750|NCT00652093|470167082|FG000|Overall Study|Physician Decision|0|||
130602751|NCT00652093|470167083|FG001|Overall Study|Physician Decision|0|||
130602752|NCT00652093|470167084|FG002|Overall Study|Physician Decision|0|||
130602753|NCT00652093|470167085|FG003|Overall Study|Physician Decision|0|||
130602754|NCT00652093|470167086|FG004|Overall Study|Physician Decision|1|||
130602755|NCT00652093|470167087|FG005|Overall Study|Physician Decision|0|||
130602756|NCT01589094|470167088|FG000|Overall Study|Did not receive treatment|2|||
130602757|NCT03575468|470167089|FG000|Overall Study|Withdrawal by Subject|3|||
130602758|NCT03575468|470167090|FG001|Overall Study|Withdrawal by Subject|0|||
130602759|NCT03575468|470167089|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
130602760|NCT03575468|470167090|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
130602761|NCT03575468|470167089|FG000|Overall Study|Lost to Follow-up|13|||
130602762|NCT03575468|470167090|FG001|Overall Study|Lost to Follow-up|17|||
130602763|NCT05094154|470168448|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
130602764|NCT05094154|470168449|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
130602765|NCT05094154|470168448|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
130602766|NCT05094154|470168449|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
130602767|NCT02531035|470168458|FG000|Overall Study|Death|0|||
130602768|NCT02531035|470168459|FG001|Overall Study|Death|1|||
130602769|NCT02531035|470168458|FG000|Overall Study|Protocol Violation|1|||
130602770|NCT02531035|470168459|FG001|Overall Study|Protocol Violation|1|||
130602771|NCT02531035|470168458|FG000|Overall Study|Noncompliance with study drug|8|||
130602772|NCT02531035|470168459|FG001|Overall Study|Noncompliance with study drug|3|||
130602773|NCT02531035|470168458|FG000|Overall Study|Physician Decision|1|||
130602774|NCT02531035|470168459|FG001|Overall Study|Physician Decision|0|||
130602775|NCT02531035|470168458|FG000|Overall Study|Adverse Event|16|||
130602776|NCT02531035|470168459|FG001|Overall Study|Adverse Event|45|||
130602777|NCT02531035|470168458|FG000|Overall Study|Other|3|||
130602778|NCT02531035|470168459|FG001|Overall Study|Other|2|||
130602779|NCT02531035|470168458|FG000|Overall Study|Withdrawal by Subject|42|||
130602780|NCT02531035|470168459|FG001|Overall Study|Withdrawal by Subject|32|||
130602781|NCT02531035|470168458|FG000|Overall Study|Lost to Follow-up|8|||
130602782|NCT02531035|470168459|FG001|Overall Study|Lost to Follow-up|10|||
130602783|NCT02531035|470168458|FG000|Overall Study|Randomized, not treated|2|||
130602784|NCT02531035|470168459|FG001|Overall Study|Randomized, not treated|1|||
130602785|NCT03032068|470168469|FG000|Overall Study|Adverse Event|1|||
130602786|NCT01597622|470168470|FG000|Overall Study|Adverse Event|7|||
130602787|NCT01597622|470168470|FG000|Overall Study|Lack of Efficacy|3|||
130602788|NCT01597622|470168470|FG000|Overall Study|Protocol Violation|1|||
130602789|NCT01597622|470168470|FG000|Overall Study|Lost to Follow-up|1|||
130602790|NCT01597622|470168470|FG000|Overall Study|Investigator Discretion|5|||
130602791|NCT01597622|470168470|FG000|Overall Study|Withdrawal by Subject|20|||
130602792|NCT01597622|470168470|FG000|Overall Study|Death|1|||
130602793|NCT00500149|470168471|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
130602794|NCT00500149|470168472|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
130602795|NCT00500149|470168471|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
130602796|NCT00500149|470168472|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
130602797|NCT00500149|470168471|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
130602798|NCT00500149|470168472|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
130602799|NCT00500149|470168471|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
130602800|NCT00500149|470168472|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
130602801|NCT00500149|470168471|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
130602802|NCT00500149|470168472|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
130602803|NCT00500149|470168471|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
130602804|NCT00500149|470168472|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
130602805|NCT00500149|470168471|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
130602806|NCT00500149|470168472|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
130602807|NCT00521339|470168473|FG000|Treatment Phase|Adverse Event|2|||
130602808|NCT00521339|470168474|FG001|Treatment Phase|Adverse Event|0|||
130602809|NCT00521339|470168475|FG002|Treatment Phase|Adverse Event|0|||
130602810|NCT00521339|470168473|FG000|Treatment Phase|Intolerability to study drug|2|||
130602811|NCT00521339|470168474|FG001|Treatment Phase|Intolerability to study drug|0|||
130602812|NCT00521339|470168475|FG002|Treatment Phase|Intolerability to study drug|0|||
130602813|NCT00521339|470168473|FG000|Treatment Phase|Lack of Efficacy|3|||
130602814|NCT00521339|470168474|FG001|Treatment Phase|Lack of Efficacy|0|||
130602815|NCT00521339|470168475|FG002|Treatment Phase|Lack of Efficacy|0|||
130602816|NCT00521339|470168473|FG000|Treatment Phase|Withdrawal by Subject|3|||
130602817|NCT00521339|470168474|FG001|Treatment Phase|Withdrawal by Subject|0|||
130602818|NCT00521339|470168475|FG002|Treatment Phase|Withdrawal by Subject|0|||
130602819|NCT00521339|470168473|FG000|Treatment Phase|Lost to Follow-up|1|||
130602820|NCT00521339|470168474|FG001|Treatment Phase|Lost to Follow-up|0|||
130602821|NCT00521339|470168475|FG002|Treatment Phase|Lost to Follow-up|0|||
130602822|NCT00521339|470168473|FG000|Treatment Phase|Protocol Violation|1|||
130602823|NCT00521339|470168474|FG001|Treatment Phase|Protocol Violation|0|||
130602824|NCT00521339|470168475|FG002|Treatment Phase|Protocol Violation|0|||
130602825|NCT00521339|470168473|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
130602826|NCT00521339|470168474|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
130602827|NCT00521339|470168475|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
130602828|NCT00521339|470168473|FG000|Treatment Extension Phase|Death|0|||
130602829|NCT00521339|470168474|FG001|Treatment Extension Phase|Death|0|||
130602830|NCT00521339|470168475|FG002|Treatment Extension Phase|Death|1|||
130602831|NCT00089843|470168476|FG000|Overall Study|Withdrawal by Subject|1|||
130602832|NCT00089843|470168477|FG001|Overall Study|Withdrawal by Subject|4|||
130602833|NCT00089843|470168478|FG002|Overall Study|Withdrawal by Subject|5|||
130602834|NCT00089843|470168479|FG003|Overall Study|Withdrawal by Subject|6|||
130602835|NCT00089843|470168476|FG000|Overall Study|Physician Decision|1|||
130602836|NCT00089843|470168477|FG001|Overall Study|Physician Decision|0|||
130602837|NCT00089843|470168478|FG002|Overall Study|Physician Decision|0|||
130602838|NCT00089843|470168479|FG003|Overall Study|Physician Decision|1|||
130602839|NCT03314519|470168480|FG000|Overall Study|Protocol Violation|3|||
130602840|NCT03314519|470168481|FG001|Overall Study|Protocol Violation|2|||
130602841|NCT03042611|470168482|FG000|Core Phase|Withdrawal by Subject|13|||
130602842|NCT03042611|470168483|FG001|Core Phase|Withdrawal by Subject|4|||
130602843|NCT03042611|470168484|FG002|Core Phase|Withdrawal by Subject|0|||
130602844|NCT03042611|470168485|FG003|Core Phase|Withdrawal by Subject|0|||
130602845|NCT03042611|470168482|FG000|Core Phase|Death|232|||
130602846|NCT03042611|470168483|FG001|Core Phase|Death|110|||
130602847|NCT03042611|470168484|FG002|Core Phase|Death|0|||
130602848|NCT03042611|470168485|FG003|Core Phase|Death|0|||
130602849|NCT03042611|470168482|FG000|Core Phase|Lost to Follow-up|4|||
130602850|NCT03042611|470168483|FG001|Core Phase|Lost to Follow-up|7|||
130602851|NCT03042611|470168484|FG002|Core Phase|Lost to Follow-up|0|||
130602852|NCT03042611|470168485|FG003|Core Phase|Lost to Follow-up|0|||
130602853|NCT03042611|470168482|FG000|Core Phase|Physician Decision|7|||
130602854|NCT03042611|470168483|FG001|Core Phase|Physician Decision|2|||
130602855|NCT03042611|470168484|FG002|Core Phase|Physician Decision|0|||
130602856|NCT03042611|470168485|FG003|Core Phase|Physician Decision|0|||
130602857|NCT03042611|470168482|FG000|Core Phase|Study Closed|0|||
130602858|NCT03042611|470168483|FG001|Core Phase|Study Closed|1|||
130602859|NCT03042611|470168484|FG002|Core Phase|Study Closed|0|||
130602860|NCT03042611|470168485|FG003|Core Phase|Study Closed|0|||
130602861|NCT03042611|470168482|FG000|Extension Phase|Death|0|||
130602862|NCT03042611|470168483|FG001|Extension Phase|Death|0|||
130602863|NCT03042611|470168484|FG002|Extension Phase|Death|34|||
130602864|NCT03042611|470168485|FG003|Extension Phase|Death|16|||
130602865|NCT03042611|470168482|FG000|Extension Phase|Lost to Follow-up|0|||
130602866|NCT03042611|470168483|FG001|Extension Phase|Lost to Follow-up|0|||
130602867|NCT03042611|470168484|FG002|Extension Phase|Lost to Follow-up|1|||
130602868|NCT03042611|470168485|FG003|Extension Phase|Lost to Follow-up|1|||
130602869|NCT03042611|470168482|FG000|Extension Phase|Study Closed|0|||
130602870|NCT03042611|470168483|FG001|Extension Phase|Study Closed|0|||
130602871|NCT03042611|470168484|FG002|Extension Phase|Study Closed|17|||
130602872|NCT03042611|470168485|FG003|Extension Phase|Study Closed|11|||
130602873|NCT00950690|470168488|FG000|Overall Study|Death|4|||
130602874|NCT00950690|470168488|FG000|Overall Study|Adverse Event|15|||
130602875|NCT00950690|470168488|FG000|Overall Study|Lack of Efficacy|22|||
130602876|NCT00950690|470168488|FG000|Overall Study|Lost to Follow-up|40|||
130602877|NCT00950690|470168488|FG000|Overall Study|Other|163|||
130602878|NCT01713036|470168489|FG000|Overall Study|Death|1|||
130602879|NCT03567291|470168492|FG000|Period I|Adverse Event|14|||
130602880|NCT03567291|470168493|FG001|Period I|Adverse Event|0|||
130602881|NCT03567291|470168494|FG002|Period I|Adverse Event|0|||
130602882|NCT03567291|470168495|FG003|Period I|Adverse Event|0|||
130602883|NCT03567291|470168492|FG000|Period I|Protocol Violation|1|||
130602884|NCT03567291|470168493|FG001|Period I|Protocol Violation|0|||
130602885|NCT03567291|470168494|FG002|Period I|Protocol Violation|0|||
130602886|NCT03567291|470168495|FG003|Period I|Protocol Violation|0|||
130602887|NCT03567291|470168492|FG000|Period I|Withdrawal by Subject|23|||
130602888|NCT03567291|470168493|FG001|Period I|Withdrawal by Subject|0|||
130602889|NCT03567291|470168494|FG002|Period I|Withdrawal by Subject|0|||
130602890|NCT03567291|470168495|FG003|Period I|Withdrawal by Subject|0|||
130602891|NCT03567291|470168492|FG000|Period I|Lost to Follow-up|2|||
130602892|NCT03567291|470168493|FG001|Period I|Lost to Follow-up|0|||
130602893|NCT03567291|470168494|FG002|Period I|Lost to Follow-up|0|||
130602894|NCT03567291|470168495|FG003|Period I|Lost to Follow-up|0|||
130602895|NCT03567291|470168492|FG000|Period I|Terminated by sponsor|44|||
130602896|NCT03567291|470168493|FG001|Period I|Terminated by sponsor|0|||
130602897|NCT03567291|470168494|FG002|Period I|Terminated by sponsor|0|||
130602898|NCT03567291|470168495|FG003|Period I|Terminated by sponsor|0|||
130602899|NCT03567291|470168492|FG000|Period I|Missing or unknown|7|||
130602900|NCT03567291|470168493|FG001|Period I|Missing or unknown|0|||
130602901|NCT03567291|470168494|FG002|Period I|Missing or unknown|0|||
130602902|NCT03567291|470168495|FG003|Period I|Missing or unknown|0|||
130602903|NCT03567291|470168492|FG000|Period II|Adverse Event|0|||
130602904|NCT03567291|470168493|FG001|Period II|Adverse Event|1|||
130602905|NCT03567291|470168494|FG002|Period II|Adverse Event|0|||
130602906|NCT03567291|470168495|FG003|Period II|Adverse Event|0|||
130602907|NCT03567291|470168492|FG000|Period II|Missing or unknown|0|||
130602908|NCT03567291|470168493|FG001|Period II|Missing or unknown|2|||
130602909|NCT03567291|470168494|FG002|Period II|Missing or unknown|1|||
130602910|NCT03567291|470168495|FG003|Period II|Missing or unknown|0|||
130602911|NCT03567291|470168492|FG000|Period III|Adverse Event|0|||
130602912|NCT03567291|470168493|FG001|Period III|Adverse Event|0|||
130602913|NCT03567291|470168494|FG002|Period III|Adverse Event|0|||
130602914|NCT03567291|470168495|FG003|Period III|Adverse Event|4|||
130602915|NCT03567291|470168492|FG000|Period III|Withdrawal by Subject|0|||
130602916|NCT03567291|470168493|FG001|Period III|Withdrawal by Subject|0|||
130602917|NCT03567291|470168494|FG002|Period III|Withdrawal by Subject|0|||
130602918|NCT03567291|470168495|FG003|Period III|Withdrawal by Subject|4|||
130602919|NCT03567291|470168492|FG000|Period III|Lost to Follow-up|0|||
130602920|NCT03567291|470168493|FG001|Period III|Lost to Follow-up|0|||
130602921|NCT03567291|470168494|FG002|Period III|Lost to Follow-up|0|||
130602922|NCT03567291|470168495|FG003|Period III|Lost to Follow-up|1|||
130602923|NCT03567291|470168492|FG000|Period III|Terminated by sponsor|0|||
130602924|NCT03567291|470168493|FG001|Period III|Terminated by sponsor|0|||
130602925|NCT03567291|470168494|FG002|Period III|Terminated by sponsor|0|||
130602926|NCT03567291|470168495|FG003|Period III|Terminated by sponsor|68|||
130602927|NCT03567291|470168492|FG000|Period III|Missing or unknown|0|||
130602928|NCT03567291|470168493|FG001|Period III|Missing or unknown|0|||
130602929|NCT03567291|470168494|FG002|Period III|Missing or unknown|0|||
130602930|NCT03567291|470168495|FG003|Period III|Missing or unknown|8|||
130602931|NCT01103349|470168496|FG000|Overall Study|Adverse Event|8|||
130602932|NCT01103349|470168497|FG001|Overall Study|Adverse Event|5|||
130602933|NCT01103349|470168498|FG002|Overall Study|Adverse Event|3|||
130602934|NCT01103349|470168496|FG000|Overall Study|Consent withdrawn|1|||
130602935|NCT01103349|470168497|FG001|Overall Study|Consent withdrawn|0|||
130602936|NCT01103349|470168498|FG002|Overall Study|Consent withdrawn|0|||
130602937|NCT01103349|470168496|FG000|Overall Study|Incorrectly included in the trial|1|||
130602938|NCT01103349|470168497|FG001|Overall Study|Incorrectly included in the trial|0|||
130602939|NCT01103349|470168498|FG002|Overall Study|Incorrectly included in the trial|0|||
130602940|NCT01103349|470168496|FG000|Overall Study|Withdrawal by Subject|1|||
130602941|NCT01103349|470168497|FG001|Overall Study|Withdrawal by Subject|1|||
130602942|NCT01103349|470168498|FG002|Overall Study|Withdrawal by Subject|0|||
130602943|NCT01103349|470168496|FG000|Overall Study|did not want to take trial medication|0|||
130602944|NCT01103349|470168497|FG001|Overall Study|did not want to take trial medication|1|||
130602945|NCT01103349|470168498|FG002|Overall Study|did not want to take trial medication|0|||
130602946|NCT01103349|470168496|FG000|Overall Study|forgot to take medication|0|||
130602947|NCT01103349|470168497|FG001|Overall Study|forgot to take medication|0|||
130602948|NCT01103349|470168498|FG002|Overall Study|forgot to take medication|1|||
130602949|NCT00090285|470168499|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
130602950|NCT00090285|470168500|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
130602951|NCT00090285|470168501|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130602952|NCT00090285|470168502|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130602953|NCT00090285|470168503|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130602954|NCT00090285|470168504|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130602955|NCT00090285|470168499|FG000|Base Study Vaccination Period|Adverse Event|2|||
130602956|NCT00090285|470168500|FG001|Base Study Vaccination Period|Adverse Event|4|||
130602957|NCT00090285|470168501|FG002|Base Study Vaccination Period|Adverse Event|0|||
130602958|NCT00090285|470168502|FG003|Base Study Vaccination Period|Adverse Event|0|||
130602959|NCT00090285|470168503|FG004|Base Study Vaccination Period|Adverse Event|0|||
130602960|NCT00090285|470168504|FG005|Base Study Vaccination Period|Adverse Event|0|||
130602961|NCT00090285|470168499|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
130602962|NCT00090285|470168500|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
130602963|NCT00090285|470168501|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130602964|NCT00090285|470168502|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130602965|NCT00090285|470168503|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130602966|NCT00090285|470168504|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
130602967|NCT00090285|470168499|FG000|Base Study Vaccination Period|Protocol Violation|2|||
130602968|NCT00090285|470168500|FG001|Base Study Vaccination Period|Protocol Violation|3|||
130602969|NCT00090285|470168501|FG002|Base Study Vaccination Period|Protocol Violation|0|||
130602970|NCT00090285|470168502|FG003|Base Study Vaccination Period|Protocol Violation|0|||
130602971|NCT00090285|470168503|FG004|Base Study Vaccination Period|Protocol Violation|0|||
130602972|NCT00090285|470168504|FG005|Base Study Vaccination Period|Protocol Violation|0|||
130602973|NCT00090285|470168499|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
130602974|NCT00090285|470168500|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
130602975|NCT00090285|470168501|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130602976|NCT00090285|470168502|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130602977|NCT00090285|470168503|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130602978|NCT00090285|470168504|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
130602979|NCT00090285|470168499|FG000|Base Study Vaccination Period|Uncooperative|2|||
130602980|NCT00090285|470168500|FG001|Base Study Vaccination Period|Uncooperative|2|||
130602981|NCT00090285|470168501|FG002|Base Study Vaccination Period|Uncooperative|0|||
130602982|NCT00090285|470168502|FG003|Base Study Vaccination Period|Uncooperative|0|||
130602983|NCT00090285|470168503|FG004|Base Study Vaccination Period|Uncooperative|0|||
130602984|NCT00090285|470168504|FG005|Base Study Vaccination Period|Uncooperative|0|||
130602985|NCT00090285|470168499|FG000|Base Study Vaccination Period|Moved|20|||
130602986|NCT00090285|470168500|FG001|Base Study Vaccination Period|Moved|21|||
130602987|NCT00090285|470168501|FG002|Base Study Vaccination Period|Moved|0|||
130602988|NCT00090285|470168502|FG003|Base Study Vaccination Period|Moved|0|||
130602989|NCT00090285|470168503|FG004|Base Study Vaccination Period|Moved|0|||
130602990|NCT00090285|470168504|FG005|Base Study Vaccination Period|Moved|0|||
130602991|NCT00090285|470168499|FG000|Base Study Vaccination Period|Site Terminated|1|||
130602992|NCT00090285|470168500|FG001|Base Study Vaccination Period|Site Terminated|0|||
130602993|NCT00090285|470168501|FG002|Base Study Vaccination Period|Site Terminated|0|||
130602994|NCT00090285|470168502|FG003|Base Study Vaccination Period|Site Terminated|0|||
130602995|NCT00090285|470168503|FG004|Base Study Vaccination Period|Site Terminated|0|||
130602996|NCT00090285|470168504|FG005|Base Study Vaccination Period|Site Terminated|0|||
130602997|NCT00090285|470168499|FG000|Base Study Vaccination Period|Other|2|||
130602998|NCT00090285|470168500|FG001|Base Study Vaccination Period|Other|2|||
130602999|NCT00090285|470168501|FG002|Base Study Vaccination Period|Other|0|||
130603000|NCT00090285|470168502|FG003|Base Study Vaccination Period|Other|0|||
130603001|NCT00090285|470168503|FG004|Base Study Vaccination Period|Other|0|||
130603002|NCT00090285|470168504|FG005|Base Study Vaccination Period|Other|0|||
130603003|NCT00090285|470168499|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
130603004|NCT00090285|470168500|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
130603005|NCT00090285|470168501|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
130603006|NCT00090285|470168502|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
130603007|NCT00090285|470168503|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
130603008|NCT00090285|470168504|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
130603009|NCT00090285|470168499|FG000|Base Study Vaccination Period|HIV positive|1|||
130603010|NCT00090285|470168500|FG001|Base Study Vaccination Period|HIV positive|1|||
130603011|NCT00090285|470168501|FG002|Base Study Vaccination Period|HIV positive|0|||
130603012|NCT00090285|470168502|FG003|Base Study Vaccination Period|HIV positive|0|||
130603013|NCT00090285|470168503|FG004|Base Study Vaccination Period|HIV positive|0|||
130603014|NCT00090285|470168504|FG005|Base Study Vaccination Period|HIV positive|0|||
130603015|NCT00090285|470168499|FG000|Base Study Follow-up Period|Adverse Event|3|||
130603016|NCT00090285|470168500|FG001|Base Study Follow-up Period|Adverse Event|10|||
130603017|NCT00090285|470168501|FG002|Base Study Follow-up Period|Adverse Event|0|||
130603018|NCT00090285|470168502|FG003|Base Study Follow-up Period|Adverse Event|0|||
130603019|NCT00090285|470168503|FG004|Base Study Follow-up Period|Adverse Event|0|||
130603020|NCT00090285|470168504|FG005|Base Study Follow-up Period|Adverse Event|0|||
130603021|NCT00090285|470168499|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
130603022|NCT00090285|470168500|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
130603023|NCT00090285|470168501|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
130603024|NCT00090285|470168502|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
130603025|NCT00090285|470168503|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130603026|NCT00090285|470168504|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
130603027|NCT00090285|470168499|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
130603028|NCT00090285|470168500|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
130603029|NCT00090285|470168501|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130603030|NCT00090285|470168502|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130603031|NCT00090285|470168503|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130603032|NCT00090285|470168504|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
130603033|NCT00090285|470168499|FG000|Base Study Follow-up Period|Moved|41|||
130603034|NCT00090285|470168500|FG001|Base Study Follow-up Period|Moved|36|||
130603035|NCT00090285|470168501|FG002|Base Study Follow-up Period|Moved|0|||
130603036|NCT00090285|470168502|FG003|Base Study Follow-up Period|Moved|0|||
130603037|NCT00090285|470168503|FG004|Base Study Follow-up Period|Moved|0|||
130603038|NCT00090285|470168504|FG005|Base Study Follow-up Period|Moved|0|||
130603039|NCT00090285|470168499|FG000|Base Study Follow-up Period|Other|2|||
130603040|NCT00090285|470168500|FG001|Base Study Follow-up Period|Other|0|||
130603041|NCT00090285|470168501|FG002|Base Study Follow-up Period|Other|0|||
130603042|NCT00090285|470168502|FG003|Base Study Follow-up Period|Other|0|||
130603043|NCT00090285|470168503|FG004|Base Study Follow-up Period|Other|0|||
130603044|NCT00090285|470168504|FG005|Base Study Follow-up Period|Other|0|||
130603045|NCT00090285|470168499|FG000|Base Study Follow-up Period|Protocol Violation|1|||
130603046|NCT00090285|470168500|FG001|Base Study Follow-up Period|Protocol Violation|0|||
130603047|NCT00090285|470168501|FG002|Base Study Follow-up Period|Protocol Violation|0|||
130603048|NCT00090285|470168502|FG003|Base Study Follow-up Period|Protocol Violation|0|||
130603049|NCT00090285|470168503|FG004|Base Study Follow-up Period|Protocol Violation|0|||
130603050|NCT00090285|470168504|FG005|Base Study Follow-up Period|Protocol Violation|0|||
130603051|NCT00090285|470168499|FG000|Base Study Follow-up Period|Uncooperative|3|||
130603052|NCT00090285|470168500|FG001|Base Study Follow-up Period|Uncooperative|4|||
130603053|NCT00090285|470168501|FG002|Base Study Follow-up Period|Uncooperative|0|||
130603054|NCT00090285|470168502|FG003|Base Study Follow-up Period|Uncooperative|0|||
130603055|NCT00090285|470168503|FG004|Base Study Follow-up Period|Uncooperative|0|||
130603056|NCT00090285|470168504|FG005|Base Study Follow-up Period|Uncooperative|0|||
130603057|NCT00090285|470168499|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
130603058|NCT00090285|470168500|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
130603059|NCT00090285|470168501|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
130603060|NCT00090285|470168502|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
130603061|NCT00090285|470168503|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
130603062|NCT00090285|470168504|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
130603063|NCT00090285|470168499|FG000|Extension 1|Adverse Event|0|||
130603064|NCT00090285|470168500|FG001|Extension 1|Adverse Event|0|||
130603065|NCT00090285|470168501|FG002|Extension 1|Adverse Event|2|||
130603066|NCT00090285|470168502|FG003|Extension 1|Adverse Event|0|||
130603067|NCT00090285|470168503|FG004|Extension 1|Adverse Event|0|||
130603068|NCT00090285|470168504|FG005|Extension 1|Adverse Event|0|||
130603069|NCT00090285|470168499|FG000|Extension 1|Lost to Follow-up|0|||
130603070|NCT00090285|470168500|FG001|Extension 1|Lost to Follow-up|0|||
130603071|NCT00090285|470168501|FG002|Extension 1|Lost to Follow-up|35|||
130603072|NCT00090285|470168502|FG003|Extension 1|Lost to Follow-up|0|||
130603073|NCT00090285|470168503|FG004|Extension 1|Lost to Follow-up|0|||
130603074|NCT00090285|470168504|FG005|Extension 1|Lost to Follow-up|0|||
130603075|NCT00090285|470168499|FG000|Extension 1|Withdrawal by Subject|0|||
130603076|NCT00090285|470168500|FG001|Extension 1|Withdrawal by Subject|0|||
130603077|NCT00090285|470168501|FG002|Extension 1|Withdrawal by Subject|13|||
130603078|NCT00090285|470168502|FG003|Extension 1|Withdrawal by Subject|1|||
130603079|NCT00090285|470168503|FG004|Extension 1|Withdrawal by Subject|0|||
130603080|NCT00090285|470168504|FG005|Extension 1|Withdrawal by Subject|0|||
130603081|NCT00090285|470168499|FG000|Extension 1|Other|0|||
130603082|NCT00090285|470168500|FG001|Extension 1|Other|0|||
130603083|NCT00090285|470168501|FG002|Extension 1|Other|4|||
130603084|NCT00090285|470168502|FG003|Extension 1|Other|0|||
130603085|NCT00090285|470168503|FG004|Extension 1|Other|0|||
130603086|NCT00090285|470168504|FG005|Extension 1|Other|0|||
130603087|NCT00090285|470168499|FG000|Extension 1|Moved|0|||
130603088|NCT00090285|470168500|FG001|Extension 1|Moved|0|||
130603089|NCT00090285|470168501|FG002|Extension 1|Moved|3|||
130603090|NCT00090285|470168502|FG003|Extension 1|Moved|0|||
130603091|NCT00090285|470168503|FG004|Extension 1|Moved|0|||
130603092|NCT00090285|470168504|FG005|Extension 1|Moved|0|||
130603093|NCT00090285|470168499|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
130603094|NCT00090285|470168500|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
130603095|NCT00090285|470168501|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
130603096|NCT00090285|470168502|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
130603097|NCT00090285|470168503|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
130603098|NCT00090285|470168504|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
130603099|NCT00090285|470168499|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130603100|NCT00090285|470168500|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130603101|NCT00090285|470168501|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130603102|NCT00090285|470168502|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130603103|NCT00090285|470168503|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
130603104|NCT00090285|470168504|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
130603105|NCT00090285|470168499|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130603106|NCT00090285|470168500|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130603107|NCT00090285|470168501|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130603108|NCT00090285|470168502|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130603109|NCT00090285|470168503|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
130603110|NCT00090285|470168504|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
130603111|NCT00090285|470168499|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
130603112|NCT00090285|470168500|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
130603113|NCT00090285|470168501|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
130603114|NCT00090285|470168502|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
130603115|NCT00090285|470168503|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
130603116|NCT00090285|470168504|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
130603117|NCT00907478|470168505|FG000|Overall Study|Ineligibility determined|0|||
130603118|NCT00907478|470168506|FG001|Overall Study|Ineligibility determined|0|||
130603119|NCT00907478|470168507|FG002|Overall Study|Ineligibility determined|1|||
130603120|NCT00907478|470168505|FG000|Overall Study|Noncompliance|0|||
130603121|NCT00907478|470168506|FG001|Overall Study|Noncompliance|0|||
130603122|NCT00907478|470168507|FG002|Overall Study|Noncompliance|1|||
130603123|NCT00907478|470168505|FG000|Overall Study|Adverse Event|3|||
130603124|NCT00907478|470168506|FG001|Overall Study|Adverse Event|1|||
130603125|NCT00907478|470168507|FG002|Overall Study|Adverse Event|2|||
130603126|NCT00907478|470168505|FG000|Overall Study|Withdrawal by Subject|8|||
130603127|NCT00907478|470168506|FG001|Overall Study|Withdrawal by Subject|9|||
130603128|NCT00907478|470168507|FG002|Overall Study|Withdrawal by Subject|6|||
130603129|NCT00907478|470168505|FG000|Overall Study|Requirement for alternative therapy|1|||
130603130|NCT00907478|470168506|FG001|Overall Study|Requirement for alternative therapy|2|||
130603131|NCT00907478|470168507|FG002|Overall Study|Requirement for alternative therapy|3|||
130603132|NCT00907478|470168505|FG000|Overall Study|Physician Decision|2|||
130603133|NCT00907478|470168506|FG001|Overall Study|Physician Decision|0|||
130603134|NCT00907478|470168507|FG002|Overall Study|Physician Decision|3|||
130603135|NCT00907478|470168505|FG000|Overall Study|Death|4|||
130603136|NCT00907478|470168506|FG001|Overall Study|Death|2|||
130603137|NCT00907478|470168507|FG002|Overall Study|Death|1|||
130603138|NCT00907478|470168505|FG000|Overall Study|Protocol-specified criteria|5|||
130603139|NCT00907478|470168506|FG001|Overall Study|Protocol-specified criteria|2|||
130603140|NCT00907478|470168507|FG002|Overall Study|Protocol-specified criteria|3|||
130603141|NCT00907478|470168505|FG000|Overall Study|Pregnancy|0|||
130603142|NCT00907478|470168506|FG001|Overall Study|Pregnancy|1|||
130603143|NCT00907478|470168507|FG002|Overall Study|Pregnancy|1|||
130603144|NCT00907478|470168505|FG000|Overall Study|Lost to Follow-up|1|||
130603145|NCT00907478|470168506|FG001|Overall Study|Lost to Follow-up|0|||
130603146|NCT00907478|470168507|FG002|Overall Study|Lost to Follow-up|0|||
130603147|NCT00907478|470168505|FG000|Overall Study|Other|3|||
130603148|NCT00907478|470168506|FG001|Overall Study|Other|0|||
130603149|NCT00907478|470168507|FG002|Overall Study|Other|1|||
130603150|NCT02639182|470168508|FG000|Overall Study|Disease Progression|50|||
130603151|NCT02639182|470168509|FG001|Overall Study|Disease Progression|49|||
130603152|NCT02639182|470168508|FG000|Overall Study|Adverse Event|7|||
130603153|NCT02639182|470168509|FG001|Overall Study|Adverse Event|5|||
130603154|NCT02639182|470168508|FG000|Overall Study|Physician Decision|3|||
130603155|NCT02639182|470168509|FG001|Overall Study|Physician Decision|3|||
130603156|NCT02639182|470168508|FG000|Overall Study|Withdrew Consent|5|||
130603157|NCT02639182|470168509|FG001|Overall Study|Withdrew Consent|4|||
130603158|NCT02639182|470168508|FG000|Overall Study|Lost to Follow-up|0|||
130603159|NCT02639182|470168509|FG001|Overall Study|Lost to Follow-up|1|||
130603160|NCT02639182|470168508|FG000|Overall Study|Study Closure|1|||
130603161|NCT02639182|470168509|FG001|Overall Study|Study Closure|2|||
130603162|NCT02639182|470168508|FG000|Overall Study|Sponsor Ended Study|0|||
130603163|NCT02639182|470168509|FG001|Overall Study|Sponsor Ended Study|1|||
130603164|NCT02639182|470168508|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
130603165|NCT02639182|470168509|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
130603166|NCT03069690|470168510|FG000|Pregnancy Intervention|Pregnancy loss|9|||
130603167|NCT03069690|470168511|FG001|Pregnancy Intervention|Pregnancy loss|4|||
130603168|NCT03069690|470168512|FG002|Pregnancy Intervention|Pregnancy loss|0|||
130603169|NCT03069690|470168513|FG003|Pregnancy Intervention|Pregnancy loss|0|||
130603170|NCT03069690|470168514|FG004|Pregnancy Intervention|Pregnancy loss|0|||
130603171|NCT03069690|470168515|FG005|Pregnancy Intervention|Pregnancy loss|0|||
130603172|NCT03069690|470168510|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
130603173|NCT03069690|470168511|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
130603174|NCT03069690|470168512|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
130603175|NCT03069690|470168513|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
130603176|NCT03069690|470168514|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
130603177|NCT03069690|470168515|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
130603178|NCT03069690|470168510|FG000|Postpartum Intervention|Lost to Follow-up|0|||
130603179|NCT03069690|470168511|FG001|Postpartum Intervention|Lost to Follow-up|0|||
130603180|NCT03069690|470168512|FG002|Postpartum Intervention|Lost to Follow-up|5|||
130603181|NCT03069690|470168513|FG003|Postpartum Intervention|Lost to Follow-up|5|||
130603182|NCT03069690|470168514|FG004|Postpartum Intervention|Lost to Follow-up|2|||
130603183|NCT03069690|470168515|FG005|Postpartum Intervention|Lost to Follow-up|4|||
130603184|NCT03268746|470168520|FG000|Overall Study|Withdrawal by Subject|1|||
130603185|NCT01372878|470168521|FG000|Overall Study|Withdrawal by Subject|63|||
130603186|NCT01372878|470168521|FG000|Overall Study|Protocol Violation|17|||
130603187|NCT01372878|470168521|FG000|Overall Study|incomplete study procedure|104|||
130603188|NCT00117338|470168522|FG000|Overall Study|Adverse Event|0|||
130603189|NCT00117338|470168523|FG001|Overall Study|Adverse Event|1|||
130603190|NCT00117338|470168522|FG000|Overall Study|Protocol Violation|3|||
130603191|NCT00117338|470168523|FG001|Overall Study|Protocol Violation|2|||
130603192|NCT00117338|470168522|FG000|Overall Study|Withdrawal by Subject|1|||
130603193|NCT00117338|470168523|FG001|Overall Study|Withdrawal by Subject|0|||
130603194|NCT00117338|470168522|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
130603195|NCT00117338|470168523|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
130603196|NCT00117338|470168522|FG000|Overall Study|Lack of Efficacy|0|||
130603197|NCT00117338|470168523|FG001|Overall Study|Lack of Efficacy|1|||
130603198|NCT02240628|470168526|FG000|Overall Study|Physician Decision|6|||
130603199|NCT02240628|470168527|FG001|Overall Study|Physician Decision|5|||
130603200|NCT02385123|470168528|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
130603201|NCT01070303|470168532|FG000|Overall Study|Adverse Event|39|||
130603202|NCT01070303|470168532|FG000|Overall Study|Withdrawal by Subject|20|||
130603203|NCT01070303|470168532|FG000|Overall Study|Lost to Follow-up|9|||
130603204|NCT01070303|470168532|FG000|Overall Study|Protocol Violation|0|||
130603205|NCT01070303|470168532|FG000|Overall Study|Lack of Efficacy|2|||
130603206|NCT01070303|470168532|FG000|Overall Study|Administrative Reason|1|||
130603207|NCT01070303|470168532|FG000|Overall Study|Other|18|||
130603208|NCT02345434|470168533|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
130603209|NCT02345434|470168534|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
130603210|NCT02926573|470168535|FG000|Overall Study|Nausea|1|||
130603211|NCT02926573|470168536|FG001|Overall Study|Nausea|0|||
130603212|NCT02926573|470168535|FG000|Overall Study|Remain intubated|2|||
130603213|NCT02926573|470168536|FG001|Overall Study|Remain intubated|2|||
130603214|NCT02926573|470168535|FG000|Overall Study|Change in surgery plan|3|||
130603215|NCT02926573|470168536|FG001|Overall Study|Change in surgery plan|1|||
130603216|NCT02926573|470168535|FG000|Overall Study|Change to outpatient status|5|||
130603217|NCT02926573|470168536|FG001|Overall Study|Change to outpatient status|1|||
130603218|NCT02926573|470168535|FG000|Overall Study|Withdrawal by Subject|0|||
130603219|NCT02926573|470168536|FG001|Overall Study|Withdrawal by Subject|2|||
130603220|NCT02926573|470168535|FG000|Overall Study|Return to operating room|0|||
130603221|NCT02926573|470168536|FG001|Overall Study|Return to operating room|2|||
130603222|NCT02926573|470168535|FG000|Overall Study|Delirium|0|||
130603223|NCT02926573|470168536|FG001|Overall Study|Delirium|1|||
130603224|NCT00858702|470168539|FG000|Overall Study|Lack of Efficacy|1|||
130603225|NCT00858702|470168540|FG001|Overall Study|Lack of Efficacy|0|||
130603226|NCT00858702|470168539|FG000|Overall Study|Protocol Violation|1|||
130603227|NCT00858702|470168540|FG001|Overall Study|Protocol Violation|1|||
130603228|NCT00858702|470168539|FG000|Overall Study|Other|2|||
130603229|NCT00858702|470168540|FG001|Overall Study|Other|1|||
130603230|NCT00858702|470168539|FG000|Overall Study|Withdrawal by Subject|1|||
130603231|NCT00858702|470168540|FG001|Overall Study|Withdrawal by Subject|0|||
130603232|NCT02416908|470168546|FG000|Dose Escalation Phase|Adverse Event|0|||
130603233|NCT02416908|470168547|FG001|Dose Escalation Phase|Adverse Event|0|||
130603234|NCT02416908|470168548|FG002|Dose Escalation Phase|Adverse Event|3|||
130603235|NCT02416908|470168549|FG003|Dose Escalation Phase|Adverse Event|0|||
130603236|NCT02416908|470168546|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130603237|NCT02416908|470168547|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130603238|NCT02416908|470168548|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
130603239|NCT02416908|470168549|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130603240|NCT00940342|470168552|FG000|Overall Study|Adverse Event|0|||
130603241|NCT00940342|470168553|FG001|Overall Study|Adverse Event|2|||
130603242|NCT00940342|470168554|FG002|Overall Study|Adverse Event|1|||
130603243|NCT03792750|470168556|FG000|Overall Study|Death|3|||
130603244|NCT02902809|470168557|FG000|Overall Study|Discontinuation of asthma program|28|||
130603245|NCT00532259|470168558|FG000|Overall Study|Withdrawal by Subject|2|||
130603246|NCT00532259|470168558|FG000|Overall Study|Adverse Event|1|||
130603247|NCT00532259|470168558|FG000|Overall Study|Death|1|||
130603248|NCT00532259|470168558|FG000|Overall Study|Lack of Efficacy|21|||
130603249|NCT00532259|470168558|FG000|Overall Study|Lost to Follow-up|3|||
130603250|NCT00532259|470168558|FG000|Overall Study|Physician Decision|3|||
130603251|NCT00532259|470168558|FG000|Overall Study|Protocol Violation|1|||
130603252|NCT00793104|470168559|FG000|Overall Study|Lost to Follow-up|1|||
130603253|NCT00700752|470168562|FG000|First Intervention|Withdrawal by Subject|0|||
130603254|NCT00700752|470168563|FG001|First Intervention|Withdrawal by Subject|2|||
130603255|NCT01302769|470168564|FG000|Overall Study|Lost to Follow-up|1|||
130603256|NCT01302769|470168565|FG001|Overall Study|Lost to Follow-up|1|||
130603257|NCT04983940|470168566|FG000|Overall Study|Lost to Follow-up|14|||
130603258|NCT04983940|470168566|FG000|Overall Study|Lack of Efficacy|2|||
130603259|NCT01645930|470168567|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
130603260|NCT01645930|470168567|FG000|Overall Study|Progressive Disease|12|||
130603261|NCT01645930|470168567|FG000|Overall Study|Adverse Event|4|||
130603262|NCT01645930|470168567|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
130603263|NCT01645930|470168567|FG000|Overall Study|Withdrawal by Participant|2|||
130603264|NCT01645930|470168567|FG000|Overall Study|Reason not Defined|1|||
130603265|NCT02522377|470168568|FG000|Overall Study|Withdrawal by Subject|1|||
130603266|NCT02522377|470168569|FG001|Overall Study|Withdrawal by Subject|0|||
130603267|NCT02522377|470168568|FG000|Overall Study|Remission Achieved|3|||
130603268|NCT02522377|470168569|FG001|Overall Study|Remission Achieved|0|||
130603269|NCT02263365|470168573|FG000|Overall Study|Physician Decision|22|||
130603270|NCT02263365|470168574|FG001|Overall Study|Physician Decision|18|||
130603271|NCT02707757|470168579|FG000|Overall Study|Protocol Violation|3|||
130603272|NCT02707757|470168580|FG001|Overall Study|Protocol Violation|2|||
130603273|NCT02707757|470168579|FG000|Overall Study|Withdrawal by Subject|2|||
130603274|NCT02707757|470168580|FG001|Overall Study|Withdrawal by Subject|0|||
130603275|NCT02707757|470168579|FG000|Overall Study|Death|0|||
130603276|NCT02707757|470168580|FG001|Overall Study|Death|1|||
130603277|NCT02707757|470168579|FG000|Overall Study|Adverse Event|6|||
130603278|NCT02707757|470168580|FG001|Overall Study|Adverse Event|4|||
130603279|NCT02707757|470168579|FG000|Overall Study|Renal transplant/elective operation|1|||
130603280|NCT02707757|470168580|FG001|Overall Study|Renal transplant/elective operation|5|||
130603281|NCT00734929|470168581|FG000|Overall Study|Lost to Follow-up|1|||
130603282|NCT00734929|470168582|FG001|Overall Study|Lost to Follow-up|2|||
130603283|NCT00734929|470168581|FG000|Overall Study|No intervention/ screen fail|5|||
130603284|NCT00734929|470168582|FG001|Overall Study|No intervention/ screen fail|3|||
130603285|NCT03176966|470168583|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
130603286|NCT03176966|470168584|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
130603287|NCT03176966|470168583|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
130603288|NCT03176966|470168584|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
130603289|NCT03176966|470168583|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
130603290|NCT03176966|470168584|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
130603291|NCT03176966|470168583|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
130603292|NCT03176966|470168584|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
130603293|NCT03176966|470168583|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
130603294|NCT03176966|470168584|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
130603295|NCT03176966|470168583|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
130603296|NCT03176966|470168584|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
130603297|NCT03176966|470168583|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
130603298|NCT03176966|470168584|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
130603299|NCT01696877|470168590|FG000|Overall Study|Adverse Event|0|||
130603300|NCT01696877|470168591|FG001|Overall Study|Adverse Event|1|||
130603301|NCT02961764|470168592|FG000|Overall Study|Protocol Violation|0|||
130603302|NCT02961764|470168593|FG001|Overall Study|Protocol Violation|1|||
130603303|NCT02961764|470168592|FG000|Overall Study|Death|2|||
130603304|NCT02961764|470168593|FG001|Overall Study|Death|0|||
130603305|NCT02961764|470168592|FG000|Overall Study|Lost to Follow-up|35|||
130603306|NCT02961764|470168593|FG001|Overall Study|Lost to Follow-up|24|||
130603307|NCT02961764|470168592|FG000|Overall Study|Withdrawal by Subject|2|||
130603308|NCT02961764|470168593|FG001|Overall Study|Withdrawal by Subject|0|||
130603309|NCT01422304|470168594|FG000|Overall Study|Adverse Event|0|||
130603310|NCT01422304|470168595|FG001|Overall Study|Adverse Event|1|||
130603311|NCT01422304|470168594|FG000|Overall Study|Lost to Follow-up|14|||
130603312|NCT01422304|470168595|FG001|Overall Study|Lost to Follow-up|20|||
130603313|NCT01422304|470168594|FG000|Overall Study|Never Entered Follow-up|2|||
130603314|NCT01422304|470168595|FG001|Overall Study|Never Entered Follow-up|1|||
130603315|NCT01422304|470168594|FG000|Overall Study|Protocol Violation|1|||
130603316|NCT01422304|470168595|FG001|Overall Study|Protocol Violation|0|||
130603317|NCT01422304|470168594|FG000|Overall Study|Withdrawal by Subject|4|||
130603318|NCT01422304|470168595|FG001|Overall Study|Withdrawal by Subject|2|||
130603319|NCT01422304|470168594|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130603320|NCT01422304|470168595|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
130603321|NCT01422304|470168594|FG000|Overall Study|Not Treated|3|||
130603322|NCT01422304|470168595|FG001|Overall Study|Not Treated|11|||
130603323|NCT00469014|470168596|FG000|Initial Phase Randomization|Disease Progression|0|||
130603324|NCT00469014|470168597|FG001|Initial Phase Randomization|Disease Progression|1|||
130603325|NCT00469014|470168598|FG002|Initial Phase Randomization|Disease Progression|1|||
130603326|NCT00469014|470168599|FG003|Initial Phase Randomization|Disease Progression|0|||
130603327|NCT00469014|470168596|FG000|Initial Phase Randomization|No Response|1|||
130603328|NCT00469014|470168597|FG001|Initial Phase Randomization|No Response|0|||
130603329|NCT00469014|470168598|FG002|Initial Phase Randomization|No Response|0|||
130603330|NCT00469014|470168599|FG003|Initial Phase Randomization|No Response|1|||
130603331|NCT00469014|470168596|FG000|Adaptive Randomization|Not Evaluable|1|||
130603332|NCT00469014|470168597|FG001|Adaptive Randomization|Not Evaluable|0|||
130603333|NCT00469014|470168598|FG002|Adaptive Randomization|Not Evaluable|0|||
130603334|NCT00469014|470168599|FG003|Adaptive Randomization|Not Evaluable|1|||
130603335|NCT00469014|470168596|FG000|Adaptive Randomization|No Response|0|||
130603336|NCT00469014|470168597|FG001|Adaptive Randomization|No Response|1|||
130603337|NCT00469014|470168598|FG002|Adaptive Randomization|No Response|0|||
130603338|NCT00469014|470168599|FG003|Adaptive Randomization|No Response|0|||
130603339|NCT00469014|470168596|FG000|Adaptive Randomization|Death|0|||
130603340|NCT00469014|470168597|FG001|Adaptive Randomization|Death|0|||
130603341|NCT00469014|470168598|FG002|Adaptive Randomization|Death|1|||
130603342|NCT00469014|470168599|FG003|Adaptive Randomization|Death|0|||
130603343|NCT00866294|470168600|FG000|Overall Study|Adverse Event|12|||
130603344|NCT00866294|470168601|FG001|Overall Study|Adverse Event|13|||
130603345|NCT00866294|470168602|FG002|Overall Study|Adverse Event|9|||
130603346|NCT00866294|470168600|FG000|Overall Study|Lack of Efficacy|7|||
130603347|NCT00866294|470168601|FG001|Overall Study|Lack of Efficacy|1|||
130603348|NCT00866294|470168602|FG002|Overall Study|Lack of Efficacy|0|||
130603349|NCT00866294|470168600|FG000|Overall Study|Protocol Violation|2|||
130603350|NCT00866294|470168601|FG001|Overall Study|Protocol Violation|0|||
130603351|NCT00866294|470168602|FG002|Overall Study|Protocol Violation|0|||
130603352|NCT00866294|470168600|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
130603353|NCT00866294|470168601|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130603354|NCT00866294|470168602|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130603355|NCT00866294|470168600|FG000|Overall Study|Lost to Follow-up|1|||
130603356|NCT00866294|470168601|FG001|Overall Study|Lost to Follow-up|3|||
130603357|NCT00866294|470168602|FG002|Overall Study|Lost to Follow-up|0|||
130603358|NCT00866294|470168600|FG000|Overall Study|Physician Decision|6|||
130603359|NCT00866294|470168601|FG001|Overall Study|Physician Decision|2|||
130603360|NCT00866294|470168602|FG002|Overall Study|Physician Decision|1|||
130603361|NCT00916721|470168603|FG000|Overall Study|Lost to Follow-up|0|||
130603362|NCT00916721|470168604|FG001|Overall Study|Lost to Follow-up|1|||
130603363|NCT00916721|470168603|FG000|Overall Study|Adverse Event|6|||
130603364|NCT00916721|470168604|FG001|Overall Study|Adverse Event|3|||
130603365|NCT00916721|470168603|FG000|Overall Study|Withdrawal by Subject|2|||
130603366|NCT00916721|470168604|FG001|Overall Study|Withdrawal by Subject|2|||
130603367|NCT00916721|470168603|FG000|Overall Study|Protocol Violation|2|||
130603368|NCT00916721|470168604|FG001|Overall Study|Protocol Violation|4|||
130603369|NCT01903434|470168608|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
130603370|NCT01903434|470168609|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
130603371|NCT01903434|470168608|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
130603372|NCT01903434|470168609|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
130603373|NCT01469052|470168612|FG000|Overall Study|Adverse Event|2|||
130603374|NCT01469052|470168613|FG001|Overall Study|Adverse Event|3|||
130603375|NCT01469052|470168614|FG002|Overall Study|Adverse Event|0|||
130603376|NCT01469052|470168615|FG003|Overall Study|Adverse Event|2|||
130603377|NCT01469052|470168616|FG004|Overall Study|Adverse Event|0|||
130603378|NCT01469052|470168617|FG005|Overall Study|Adverse Event|1|||
130603379|NCT01469052|470168612|FG000|Overall Study|Progressive disease|3|||
130603380|NCT01469052|470168613|FG001|Overall Study|Progressive disease|0|||
130603381|NCT01469052|470168614|FG002|Overall Study|Progressive disease|5|||
130603382|NCT01469052|470168615|FG003|Overall Study|Progressive disease|3|||
130603383|NCT01469052|470168616|FG004|Overall Study|Progressive disease|7|||
130603384|NCT01469052|470168617|FG005|Overall Study|Progressive disease|2|||
130603385|NCT01469052|470168612|FG000|Overall Study|Lack of Efficacy|0|||
130603386|NCT01469052|470168613|FG001|Overall Study|Lack of Efficacy|0|||
130603387|NCT01469052|470168614|FG002|Overall Study|Lack of Efficacy|0|||
130603388|NCT01469052|470168615|FG003|Overall Study|Lack of Efficacy|0|||
130603389|NCT01469052|470168616|FG004|Overall Study|Lack of Efficacy|0|||
130603390|NCT01469052|470168617|FG005|Overall Study|Lack of Efficacy|2|||
130603391|NCT01469052|470168612|FG000|Overall Study|Moved to rollover protocol|1|||
130603392|NCT01469052|470168613|FG001|Overall Study|Moved to rollover protocol|0|||
130603393|NCT01469052|470168614|FG002|Overall Study|Moved to rollover protocol|1|||
130603394|NCT01469052|470168615|FG003|Overall Study|Moved to rollover protocol|0|||
130603395|NCT01469052|470168616|FG004|Overall Study|Moved to rollover protocol|0|||
130603396|NCT01469052|470168617|FG005|Overall Study|Moved to rollover protocol|1|||
130603397|NCT01469052|470168612|FG000|Overall Study|Other|0|||
130603398|NCT01469052|470168613|FG001|Overall Study|Other|1|||
130603399|NCT01469052|470168614|FG002|Overall Study|Other|0|||
130603400|NCT01469052|470168615|FG003|Overall Study|Other|0|||
130603401|NCT01469052|470168616|FG004|Overall Study|Other|1|||
130603402|NCT01469052|470168617|FG005|Overall Study|Other|0|||
130603403|NCT01519427|470168622|FG000|Overall Study|disease progression|2|||
130603404|NCT03894904|470168623|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
130603405|NCT03894904|470168624|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
130603406|NCT03894904|470168623|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
130603407|NCT03894904|470168624|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
130603408|NCT02190435|470168625|FG000|Overall Study|First 12 patients were lead-ins|12|||
130603409|NCT02190435|470168626|FG001|Overall Study|First 12 patients were lead-ins|0|||
130603410|NCT02190435|470168625|FG000|Overall Study|3 consented screen fails|3|||
130603411|NCT02190435|470168626|FG001|Overall Study|3 consented screen fails|0|||
130603412|NCT01781026|470168627|FG000|Overall Study|Lack of Efficacy|2|||
130603413|NCT05270694|470169764|FG000|Overall Study|Death|1|||
130603414|NCT05270694|470169764|FG000|Overall Study|Medical issues impacted ability to participate|2|||
130603415|NCT05270694|470169764|FG000|Overall Study|Lost to Follow-up|3|||
130603416|NCT05270694|470169764|FG000|Overall Study|Withdrawal by Subject|3|||
130603417|NCT01991977|470169765|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
130603418|NCT01991977|470169765|FG000|Overall Study|Withdrew after start of treatment|5|||
130603419|NCT01240811|470169766|FG000|Overall Study|Physician Decision|0|||
130603420|NCT01240811|470169767|FG001|Overall Study|Physician Decision|1|||
130603421|NCT01240811|470169768|FG002|Overall Study|Physician Decision|0|||
130603422|NCT01240811|470169766|FG000|Overall Study|Withdrawal by Subject|0|||
130603423|NCT01240811|470169767|FG001|Overall Study|Withdrawal by Subject|0|||
130603424|NCT01240811|470169768|FG002|Overall Study|Withdrawal by Subject|1|||
130603425|NCT01543490|470169771|FG000|Overall Study|Adverse Event|4|||
130603426|NCT01543490|470169772|FG001|Overall Study|Adverse Event|0|||
130603427|NCT01543490|470169771|FG000|Overall Study|Physician Decision|1|||
130603428|NCT01543490|470169772|FG001|Overall Study|Physician Decision|0|||
130603429|NCT01543490|470169771|FG000|Overall Study|Lack of Efficacy|3|||
130603430|NCT01543490|470169772|FG001|Overall Study|Lack of Efficacy|3|||
130603431|NCT01543490|470169771|FG000|Overall Study|Lost to Follow-up|5|||
130603432|NCT01543490|470169772|FG001|Overall Study|Lost to Follow-up|0|||
130603433|NCT01543490|470169771|FG000|Overall Study|Withdrawal by Subject|2|||
130603434|NCT01543490|470169772|FG001|Overall Study|Withdrawal by Subject|0|||
130603435|NCT01543490|470169771|FG000|Overall Study|Other-Various Administrative Reasons|1|||
130603436|NCT01543490|470169772|FG001|Overall Study|Other-Various Administrative Reasons|2|||
130603437|NCT03918642|470169775|FG000|Overall Study|Lost to Follow-up|12|||
130603438|NCT03918642|470169776|FG001|Overall Study|Lost to Follow-up|10|||
130603439|NCT03825042|470169777|FG000|Overall Study|Adverse Event|1|||
130603440|NCT03825042|470169778|FG001|Overall Study|Adverse Event|0|||
130603441|NCT03825042|470169777|FG000|Overall Study|Withdrawal by Subject|1|||
130603442|NCT03825042|470169778|FG001|Overall Study|Withdrawal by Subject|0|||
130603443|NCT01988012|470169786|FG000|Overall Study|Adverse Event|5|||
130603444|NCT01988012|470169786|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130603445|NCT01988012|470169786|FG000|Overall Study|Patient Withdrawal of Consent|4|||
130603446|NCT01988012|470169786|FG000|Overall Study|Lost to Follow-up|1|||
130603447|NCT01988012|470169786|FG000|Overall Study|Physician Decision|1|||
130603448|NCT01988012|470169786|FG000|Overall Study|Protocol Violation|1|||
130603449|NCT01228071|470169787|FG000|Overall Study|Protocol Violation|1|||
130603450|NCT01228071|470169787|FG000|Overall Study|Withdrawal by Subject|1|||
130603451|NCT00553059|470169788|FG000|Overall Study|Deemed ineligible|1|||
130603452|NCT00553059|470169789|FG001|Overall Study|Deemed ineligible|1|||
130603453|NCT00553059|470169788|FG000|Overall Study|Drug supply not available|0|||
130603454|NCT00553059|470169789|FG001|Overall Study|Drug supply not available|1|||
130603455|NCT00859898|470169793|FG000|Overall Study|Lack of Efficacy|0|||
130603456|NCT00859898|470169794|FG001|Overall Study|Lack of Efficacy|1|||
130603457|NCT00859898|470169795|FG002|Overall Study|Lack of Efficacy|1|||
130603458|NCT00859898|470169793|FG000|Overall Study|Adverse Event|4|||
130603459|NCT00859898|470169794|FG001|Overall Study|Adverse Event|9|||
130603460|NCT00859898|470169795|FG002|Overall Study|Adverse Event|8|||
130603461|NCT00859898|470169793|FG000|Overall Study|Withdrawal by Subject|11|||
130603462|NCT00859898|470169794|FG001|Overall Study|Withdrawal by Subject|8|||
130603463|NCT00859898|470169795|FG002|Overall Study|Withdrawal by Subject|11|||
130603464|NCT00859898|470169793|FG000|Overall Study|Death|0|||
130603465|NCT00859898|470169794|FG001|Overall Study|Death|0|||
130603466|NCT00859898|470169795|FG002|Overall Study|Death|1|||
130603467|NCT00859898|470169793|FG000|Overall Study|Lost to Follow-up|10|||
130603468|NCT00859898|470169794|FG001|Overall Study|Lost to Follow-up|11|||
130603469|NCT00859898|470169795|FG002|Overall Study|Lost to Follow-up|5|||
130603470|NCT00859898|470169793|FG000|Overall Study|poor/non-compliance|2|||
130603471|NCT00859898|470169794|FG001|Overall Study|poor/non-compliance|0|||
130603472|NCT00859898|470169795|FG002|Overall Study|poor/non-compliance|0|||
130603473|NCT00859898|470169793|FG000|Overall Study|No longer meets criteria|0|||
130603474|NCT00859898|470169794|FG001|Overall Study|No longer meets criteria|1|||
130603475|NCT00859898|470169795|FG002|Overall Study|No longer meets criteria|0|||
130603476|NCT00859898|470169793|FG000|Overall Study|non-specified|1|||
130603477|NCT00859898|470169794|FG001|Overall Study|non-specified|1|||
130603478|NCT00859898|470169795|FG002|Overall Study|non-specified|1|||
130603479|NCT01302041|470169796|FG000|Overall Study|Death|5|||
130603480|NCT01302041|470169796|FG000|Overall Study|Withdrawal by Subject|4|||
130603481|NCT01302041|470169796|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
130603482|NCT01302041|470169796|FG000|Overall Study|Other-Miscellaneous Reason|2|||
130603483|NCT04504032|470169799|FG000|Overall Study|Adverse Event|1|||
130603484|NCT04504032|470169800|FG001|Overall Study|Adverse Event|2|||
130603485|NCT04504032|470169799|FG000|Overall Study|Lost to Follow-up|6|||
130603486|NCT04504032|470169800|FG001|Overall Study|Lost to Follow-up|9|||
130603487|NCT04504032|470169799|FG000|Overall Study|Protocol Violation|2|||
130603488|NCT04504032|470169800|FG001|Overall Study|Protocol Violation|0|||
130603489|NCT04504032|470169799|FG000|Overall Study|Study terminated by sponsor|1|||
130603490|NCT04504032|470169800|FG001|Overall Study|Study terminated by sponsor|2|||
130603491|NCT04504032|470169799|FG000|Overall Study|Withdrawal by Subject|9|||
130603492|NCT04504032|470169800|FG001|Overall Study|Withdrawal by Subject|11|||
130603493|NCT04504032|470169799|FG000|Overall Study|Disease progression prior to dosing|15|||
130603494|NCT04504032|470169800|FG001|Overall Study|Disease progression prior to dosing|3|||
130603495|NCT04504032|470169799|FG000|Overall Study|Drug supply issues|1|||
130603496|NCT04504032|470169800|FG001|Overall Study|Drug supply issues|1|||
130603497|NCT04504032|470169799|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
130603498|NCT04504032|470169800|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
130603499|NCT00771030|470169801|FG000|Overall Study|Adverse Event|0|||
130603500|NCT00771030|470169802|FG001|Overall Study|Adverse Event|1|||
130603501|NCT00771030|470169803|FG002|Overall Study|Adverse Event|0|||
130603502|NCT00771030|470169804|FG003|Overall Study|Adverse Event|0|||
130603503|NCT00771030|470169805|FG004|Overall Study|Adverse Event|0|||
130603504|NCT00771030|470169806|FG005|Overall Study|Adverse Event|0|||
130603505|NCT00771030|470169807|FG006|Overall Study|Adverse Event|0|||
130603506|NCT05232097|470169818|FG000|Overall Study|Physician Decision|1|||
130603507|NCT01172288|470169819|FG000|Overall Study|Adverse Event|1|||
130603508|NCT01172288|470169820|FG001|Overall Study|Adverse Event|0|||
130603509|NCT01172288|470169819|FG000|Overall Study|Protocol Violation|0|||
130603510|NCT01172288|470169820|FG001|Overall Study|Protocol Violation|1|||
130603511|NCT01327339|470169821|FG000|Overall Study|Protocol Violation|8|||
130603512|NCT01158950|470169827|FG000|1st Intervention (1 Day)|Physician Decision|1|||
130603513|NCT01158950|470169828|FG001|1st Intervention (1 Day)|Physician Decision|2|||
130603514|NCT00510692|470169830|FG000|Overall Study|Adverse Event|1|||
130603515|NCT00510692|470169831|FG001|Overall Study|Adverse Event|3|||
130603516|NCT00510692|470169830|FG000|Overall Study|Withdrawal by Subject|1|||
130603517|NCT00510692|470169831|FG001|Overall Study|Withdrawal by Subject|0|||
130603518|NCT01845077|470169832|FG000|Washout Period|Lost to Follow-up|0|||
130603519|NCT01845077|470169833|FG001|Washout Period|Lost to Follow-up|1|||
130603520|NCT01845077|470169834|FG002|Washout Period|Lost to Follow-up|0|||
130603521|NCT01845077|470169835|FG003|Washout Period|Lost to Follow-up|1|||
130603522|NCT01845077|470169836|FG004|Washout Period|Lost to Follow-up|0|||
130603523|NCT01845077|470169837|FG005|Washout Period|Lost to Follow-up|1|||
130603524|NCT01845077|470169832|FG000|Washout Period|Adverse Event|1|||
130603525|NCT01845077|470169833|FG001|Washout Period|Adverse Event|0|||
130603526|NCT01845077|470169834|FG002|Washout Period|Adverse Event|0|||
130603527|NCT01845077|470169835|FG003|Washout Period|Adverse Event|0|||
130603528|NCT01845077|470169836|FG004|Washout Period|Adverse Event|0|||
130603529|NCT01845077|470169837|FG005|Washout Period|Adverse Event|0|||
130603530|NCT01845077|470169832|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
130603531|NCT01845077|470169833|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
130603532|NCT01845077|470169834|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
130603533|NCT01845077|470169835|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
130603534|NCT01845077|470169836|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
130603535|NCT01845077|470169837|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
130603536|NCT01845077|470169832|FG000|Washout Period|Protocol Violation|0|||
130603537|NCT01845077|470169833|FG001|Washout Period|Protocol Violation|0|||
130603538|NCT01845077|470169834|FG002|Washout Period|Protocol Violation|0|||
130603539|NCT01845077|470169835|FG003|Washout Period|Protocol Violation|1|||
130603540|NCT01845077|470169836|FG004|Washout Period|Protocol Violation|1|||
130603541|NCT01845077|470169837|FG005|Washout Period|Protocol Violation|0|||
130603542|NCT01797432|470169841|FG000|Overall Study|Lost to Follow-up|1|||
130603543|NCT01797432|470169841|FG000|Overall Study|Adverse Event|1|||
130603544|NCT01797432|470169841|FG000|Overall Study|Withdrawal by Subject|1|||
130603545|NCT01797432|470169841|FG000|Overall Study|lived too far from study site|1|||
130603546|NCT01137435|470169842|FG000|Overall Study|Lost to Follow-up|24|||
130603547|NCT01137435|470169842|FG000|Overall Study|Off label usage|4|||
130603548|NCT02955186|470169844|FG000|Overall Study|Withdrawal by Subject|6|||
130603549|NCT02955186|470169845|FG001|Overall Study|Withdrawal by Subject|2|||
130603550|NCT02955186|470169844|FG000|Overall Study|Protocol Violation|1|||
130603551|NCT02955186|470169845|FG001|Overall Study|Protocol Violation|0|||
130603552|NCT03461289|470169846|FG000|Overall Study|Death|1|||
130603553|NCT01632878|470169847|FG000|Screening|Physician Decision|268|||
130603554|NCT01632878|470169847|FG000|Treatment|Lost to Follow-up|41|||
130603555|NCT01632878|470169847|FG000|Treatment|Withdrawal by Subject|36|||
130603556|NCT01632878|470169847|FG000|Treatment|Physician Decision|34|||
130603557|NCT01632878|470169847|FG000|Treatment|missing information|4|||
130603558|NCT01632878|470169847|FG000|Treatment|no information on study completion|43|||
130603559|NCT00081289|470169848|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
130603560|NCT00081289|470169849|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
130603561|NCT00081289|470169848|FG000|Overall Study|Ineligible / no protocol treatment|3|||
130603562|NCT00081289|470169849|FG001|Overall Study|Ineligible / no protocol treatment|4|||
130603563|NCT02749370|470169850|FG000|Overall Study|Withdrawal by Subject|11|||
130603564|NCT02749370|470169850|FG000|Overall Study|Lost to Follow-up|3|||
130603565|NCT03242759|470169851|FG000|Overall Study|Adverse Event|5|||
130603566|NCT03242759|470169852|FG001|Overall Study|Adverse Event|1|||
130603567|NCT03242759|470169851|FG000|Overall Study|Withdrawal by Subject|4|||
130603568|NCT03242759|470169852|FG001|Overall Study|Withdrawal by Subject|3|||
130603569|NCT03242759|470169851|FG000|Overall Study|Lost to Follow-up|3|||
130603570|NCT03242759|470169852|FG001|Overall Study|Lost to Follow-up|1|||
130603571|NCT03242759|470169851|FG000|Overall Study|Administrative problems|1|||
130603572|NCT03242759|470169852|FG001|Overall Study|Administrative problems|1|||
130603573|NCT03242759|470169851|FG000|Overall Study|Death|22|||
130603574|NCT03242759|470169852|FG001|Overall Study|Death|0|||
130603575|NCT03242759|470169851|FG000|Overall Study|Change visit schedule|0|||
130603576|NCT03242759|470169852|FG001|Overall Study|Change visit schedule|1|||
130603577|NCT02522481|470169857|FG000|Overall Study|discontinued|1|||
130603578|NCT02522481|470169857|FG000|Overall Study|Not dosed|2|||
130603579|NCT00404768|470169860|FG000|Part A and B|Withdrawn due to labor progression|1|||
130603580|NCT00404768|470169861|FG001|Part A and B|Withdrawn due to labor progression|0|||
130603581|NCT00404768|470169862|FG002|Part A and B|Withdrawn due to labor progression|0|||
130603582|NCT00404768|470169863|FG003|Part A and B|Withdrawn due to labor progression|0|||
130603583|NCT00404768|470169860|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
130603584|NCT00404768|470169861|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
130603585|NCT00404768|470169862|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
130603586|NCT00404768|470169863|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
130603587|NCT00404768|470169860|FG000|Part C|Adverse Event|0|||
130603588|NCT00404768|470169861|FG001|Part C|Adverse Event|0|||
130603589|NCT00404768|470169862|FG002|Part C|Adverse Event|0|||
130603590|NCT00404768|470169863|FG003|Part C|Adverse Event|3|||
130603591|NCT00404768|470169860|FG000|Part C|Lost to Follow-up|0|||
130603592|NCT00404768|470169861|FG001|Part C|Lost to Follow-up|0|||
130603593|NCT00404768|470169862|FG002|Part C|Lost to Follow-up|3|||
130603594|NCT00404768|470169863|FG003|Part C|Lost to Follow-up|1|||
130603595|NCT00404768|470169860|FG000|Part C|Withdrawal by Subject|0|||
130603596|NCT00404768|470169861|FG001|Part C|Withdrawal by Subject|0|||
130603597|NCT00404768|470169862|FG002|Part C|Withdrawal by Subject|2|||
130603598|NCT00404768|470169863|FG003|Part C|Withdrawal by Subject|1|||
130603599|NCT00404768|470169860|FG000|Part C|Early withdrawal from study medication|0|||
130603600|NCT00404768|470169861|FG001|Part C|Early withdrawal from study medication|0|||
130603601|NCT00404768|470169862|FG002|Part C|Early withdrawal from study medication|1|||
130603602|NCT00404768|470169863|FG003|Part C|Early withdrawal from study medication|0|||
130603603|NCT00404768|470169860|FG000|Part C|Participant did not respond to therapy|0|||
130603604|NCT00404768|470169861|FG001|Part C|Participant did not respond to therapy|0|||
130603605|NCT00404768|470169862|FG002|Part C|Participant did not respond to therapy|1|||
130603606|NCT00404768|470169863|FG003|Part C|Participant did not respond to therapy|1|||
130603607|NCT00404768|470169860|FG000|Part C|Physician withdrew the study medication|0|||
130603608|NCT00404768|470169861|FG001|Part C|Physician withdrew the study medication|0|||
130603609|NCT00404768|470169862|FG002|Part C|Physician withdrew the study medication|1|||
130603610|NCT00404768|470169863|FG003|Part C|Physician withdrew the study medication|0|||
130603611|NCT00404768|470169860|FG000|Part C|Participant delivered baby|0|||
130603612|NCT00404768|470169861|FG001|Part C|Participant delivered baby|0|||
130603613|NCT00404768|470169862|FG002|Part C|Participant delivered baby|0|||
130603614|NCT00404768|470169863|FG003|Part C|Participant delivered baby|1|||
130603615|NCT00404768|470169860|FG000|Part C|Unsatisfactory uterine response to IP|0|||
130603616|NCT00404768|470169861|FG001|Part C|Unsatisfactory uterine response to IP|0|||
130603617|NCT00404768|470169862|FG002|Part C|Unsatisfactory uterine response to IP|0|||
130603618|NCT00404768|470169863|FG003|Part C|Unsatisfactory uterine response to IP|1|||
130603619|NCT00404768|470169860|FG000|Part C|Active labor|0|||
130603620|NCT00404768|470169861|FG001|Part C|Active labor|0|||
130603621|NCT00404768|470169862|FG002|Part C|Active labor|0|||
130603622|NCT00404768|470169863|FG003|Part C|Active labor|1|||
130603623|NCT00404768|470169860|FG000|Part C|Lack of Efficacy|0|||
130603624|NCT00404768|470169861|FG001|Part C|Lack of Efficacy|0|||
130603625|NCT00404768|470169862|FG002|Part C|Lack of Efficacy|0|||
130603626|NCT00404768|470169863|FG003|Part C|Lack of Efficacy|2|||
130603627|NCT00404768|470169860|FG000|Part C|Treatment failure|0|||
130603628|NCT00404768|470169861|FG001|Part C|Treatment failure|0|||
130603629|NCT00404768|470169862|FG002|Part C|Treatment failure|0|||
130603630|NCT00404768|470169863|FG003|Part C|Treatment failure|1|||
130603631|NCT00404768|470169860|FG000|Part C|Investigator discretion|0|||
130603632|NCT00404768|470169861|FG001|Part C|Investigator discretion|0|||
130603633|NCT00404768|470169862|FG002|Part C|Investigator discretion|0|||
130603634|NCT00404768|470169863|FG003|Part C|Investigator discretion|1|||
130603635|NCT00404768|470169860|FG000|Part C|Researcher suspended study medication|0|||
130603636|NCT00404768|470169861|FG001|Part C|Researcher suspended study medication|0|||
130603637|NCT00404768|470169862|FG002|Part C|Researcher suspended study medication|0|||
130603638|NCT00404768|470169863|FG003|Part C|Researcher suspended study medication|1|||
130603639|NCT03123939|470169864|FG000|Overall Study|Lack of Efficacy|6|||
130603640|NCT03123939|470169864|FG000|Overall Study|Death|5|||
130603641|NCT03123939|470169864|FG000|Overall Study|Physician Decision|2|||
130603642|NCT03123939|470169864|FG000|Overall Study|Subject/guardian decision|2|||
130603643|NCT03123939|470169864|FG000|Overall Study|Lost to Follow-up|1|||
130603644|NCT03123939|470169864|FG000|Overall Study|New therapy for study indication|1|||
130603645|NCT03123939|470169864|FG000|Overall Study|Protocol deviation|1|||
130603646|NCT03123939|470169864|FG000|Overall Study|Progressive disease|18|||
130603647|NCT03123939|470169864|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
130603648|NCT03123939|470169864|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
130603649|NCT04773041|470169865|FG000|Overall Study|Unable to data match|1|||
130603650|NCT04773041|470169866|FG001|Overall Study|Unable to data match|0|||
130603651|NCT04773041|470169867|FG002|Overall Study|Unable to data match|0|||
130603652|NCT01118143|470169868|FG000|Overall Study|Withdrawal by Subject|2|||
130603653|NCT01118143|470169869|FG001|Overall Study|Withdrawal by Subject|5|||
130603654|NCT02112448|470169870|FG000|Overall Study|lab values precluding use of ketorolac|2|||
130603655|NCT02112448|470169871|FG001|Overall Study|lab values precluding use of ketorolac|2|||
130603656|NCT02112448|470169870|FG000|Overall Study|Protocol Violation|1|||
130603657|NCT02112448|470169871|FG001|Overall Study|Protocol Violation|2|||
130603658|NCT02112448|470169870|FG000|Overall Study|Physician Decision|4|||
130603659|NCT02112448|470169871|FG001|Overall Study|Physician Decision|6|||
130603660|NCT02112448|470169870|FG000|Overall Study|required heparin so could not use ketoro|1|||
130603661|NCT02112448|470169871|FG001|Overall Study|required heparin so could not use ketoro|0|||
130603662|NCT02100657|470171449|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
130603663|NCT02100657|470171450|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
130603664|NCT02100657|470171451|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
130603665|NCT02100657|470171449|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
130603666|NCT02100657|470171450|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
130603667|NCT02100657|470171451|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
130603668|NCT02100657|470171449|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
130603669|NCT02100657|470171450|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
130603670|NCT02100657|470171451|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
130603671|NCT02100657|470171449|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
130603672|NCT02100657|470171450|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
130603673|NCT02100657|470171451|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
130603674|NCT02100657|470171449|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
130603675|NCT02100657|470171450|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
130603676|NCT02100657|470171451|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
130603677|NCT02100657|470171449|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
130603678|NCT02100657|470171450|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
130603679|NCT02100657|470171451|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
130603680|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
130603681|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
130603682|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
130603683|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Death|0|||
130603684|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Death|0|||
130603685|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Death|1|||
130603686|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
130603687|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
130603688|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
130603689|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
130603690|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
130603691|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
130603692|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
130603693|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
130603694|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
130603695|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
130603696|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
130603697|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
130603698|NCT02100657|470171449|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
130603699|NCT02100657|470171450|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
130603700|NCT02100657|470171451|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
130603701|NCT04168645|470171453|FG000|Overall Study|Lost to Follow-up|23|||
130603702|NCT04168645|470171454|FG001|Overall Study|Lost to Follow-up|28|||
130603703|NCT04168645|470171455|FG002|Overall Study|Lost to Follow-up|15|||
130603704|NCT04168645|470171456|FG003|Overall Study|Lost to Follow-up|12|||
130603705|NCT04168645|470171453|FG000|Overall Study|Death|1|||
130603706|NCT04168645|470171454|FG001|Overall Study|Death|1|||
130603707|NCT04168645|470171455|FG002|Overall Study|Death|0|||
130603708|NCT04168645|470171456|FG003|Overall Study|Death|0|||
130603709|NCT04168645|470171453|FG000|Overall Study|Withdrawal by Subject|5|||
130603710|NCT04168645|470171454|FG001|Overall Study|Withdrawal by Subject|2|||
130603711|NCT04168645|470171455|FG002|Overall Study|Withdrawal by Subject|2|||
130603712|NCT04168645|470171456|FG003|Overall Study|Withdrawal by Subject|2|||
130603713|NCT04168645|470171453|FG000|Overall Study|Administrative Withdrawal|3|||
130603714|NCT04168645|470171454|FG001|Overall Study|Administrative Withdrawal|1|||
130603715|NCT04168645|470171455|FG002|Overall Study|Administrative Withdrawal|1|||
130603716|NCT04168645|470171456|FG003|Overall Study|Administrative Withdrawal|3|||
130603717|NCT03132805|470171459|FG000|Overall Study|Lost to Follow-up|142|||
130603718|NCT03132805|470171460|FG001|Overall Study|Lost to Follow-up|141|||
130603719|NCT03132805|470171461|FG002|Overall Study|Lost to Follow-up|113|||
130603720|NCT01158534|470171464|FG000|Overall Study|Withdrawal by Subject|1|||
130603721|NCT01158534|470171464|FG000|Overall Study|Death|1|||
130603722|NCT01158534|470171464|FG000|Overall Study|Other|1|||
130603723|NCT02115815|470171465|FG000|Overall Study|Withdrawal by Subject|2|||
130603724|NCT02115815|470171466|FG001|Overall Study|Withdrawal by Subject|0|||
130603725|NCT02115815|470171467|FG002|Overall Study|Withdrawal by Subject|0|||
130603726|NCT02115815|470171468|FG003|Overall Study|Withdrawal by Subject|0|||
130603727|NCT02115815|470171469|FG004|Overall Study|Withdrawal by Subject|0|||
130603728|NCT02115815|470171470|FG005|Overall Study|Withdrawal by Subject|0|||
130603729|NCT02115815|470171471|FG006|Overall Study|Withdrawal by Subject|0|||
130603730|NCT02115815|470171465|FG000|Overall Study|Not enough drug to dose participant|0|||
130603731|NCT02115815|470171466|FG001|Overall Study|Not enough drug to dose participant|0|||
130603732|NCT02115815|470171467|FG002|Overall Study|Not enough drug to dose participant|0|||
130603733|NCT02115815|470171468|FG003|Overall Study|Not enough drug to dose participant|0|||
130603734|NCT02115815|470171469|FG004|Overall Study|Not enough drug to dose participant|0|||
130603735|NCT02115815|470171470|FG005|Overall Study|Not enough drug to dose participant|1|||
130603736|NCT02115815|470171471|FG006|Overall Study|Not enough drug to dose participant|0|||
130603737|NCT02115815|470171465|FG000|Overall Study|Missed appointment, randomized in error|0|||
130603738|NCT02115815|470171466|FG001|Overall Study|Missed appointment, randomized in error|0|||
130603739|NCT02115815|470171467|FG002|Overall Study|Missed appointment, randomized in error|0|||
130603740|NCT02115815|470171468|FG003|Overall Study|Missed appointment, randomized in error|0|||
130603741|NCT02115815|470171469|FG004|Overall Study|Missed appointment, randomized in error|0|||
130603742|NCT02115815|470171470|FG005|Overall Study|Missed appointment, randomized in error|1|||
130603743|NCT02115815|470171471|FG006|Overall Study|Missed appointment, randomized in error|0|||
130603744|NCT04003155|470171472|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
130603745|NCT04003155|470171473|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
130603746|NCT04003155|470171474|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
130603747|NCT04003155|470171475|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
130603748|NCT04003155|470171476|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
130603749|NCT04003155|470171472|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
130603750|NCT04003155|470171473|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
130603751|NCT04003155|470171474|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130603752|NCT04003155|470171475|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130603753|NCT04003155|470171476|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130603754|NCT04003155|470171472|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
130603755|NCT04003155|470171473|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
130603756|NCT04003155|470171474|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
130603757|NCT04003155|470171475|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
130603758|NCT04003155|470171476|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
130603759|NCT04003155|470171472|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
130603760|NCT04003155|470171473|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
130603761|NCT04003155|470171474|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
130603762|NCT04003155|470171475|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
130603763|NCT04003155|470171476|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
130603764|NCT04003155|470171472|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
130603765|NCT04003155|470171473|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
130603766|NCT04003155|470171474|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
130603767|NCT04003155|470171475|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
130603768|NCT04003155|470171476|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
130603769|NCT04003155|470171472|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
130603770|NCT04003155|470171473|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
130603771|NCT04003155|470171474|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
130603772|NCT04003155|470171475|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
130603773|NCT04003155|470171476|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
130603774|NCT04003155|470171472|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
130603775|NCT04003155|470171473|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130603776|NCT04003155|470171474|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
130603777|NCT04003155|470171475|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130603778|NCT04003155|470171476|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130603779|NCT04003155|470171472|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
130603780|NCT04003155|470171473|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
130603781|NCT04003155|470171474|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
130603782|NCT04003155|470171475|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
130603783|NCT04003155|470171476|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
130603784|NCT04003155|470171472|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
130603785|NCT04003155|470171473|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
130603786|NCT04003155|470171474|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
130603787|NCT04003155|470171475|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
130603788|NCT04003155|470171476|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
130603789|NCT01912872|470171477|FG000|Overall Study|Lost to Follow-up|2|||
130603790|NCT01912872|470171478|FG001|Overall Study|Lost to Follow-up|3|||
130603791|NCT01912872|470171479|FG002|Overall Study|Lost to Follow-up|5|||
130603792|NCT01912872|470171480|FG003|Overall Study|Lost to Follow-up|5|||
130603793|NCT01912872|470171477|FG000|Overall Study|Other unspecified|3|||
130603794|NCT01912872|470171478|FG001|Overall Study|Other unspecified|1|||
130603795|NCT01912872|470171479|FG002|Overall Study|Other unspecified|3|||
130603796|NCT01912872|470171480|FG003|Overall Study|Other unspecified|0|||
130603797|NCT01912872|470171477|FG000|Overall Study|Informed consent withdrawn|0|||
130603798|NCT01912872|470171478|FG001|Overall Study|Informed consent withdrawn|0|||
130603799|NCT01912872|470171479|FG002|Overall Study|Informed consent withdrawn|1|||
130603800|NCT01912872|470171480|FG003|Overall Study|Informed consent withdrawn|1|||
130603801|NCT01912872|470171477|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
130603802|NCT01912872|470171478|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
130603803|NCT01912872|470171479|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
130603804|NCT01912872|470171480|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
130603805|NCT01912872|470171477|FG000|Overall Study|Protocol Violation|0|||
130603806|NCT01912872|470171478|FG001|Overall Study|Protocol Violation|0|||
130603807|NCT01912872|470171479|FG002|Overall Study|Protocol Violation|1|||
130603808|NCT01912872|470171480|FG003|Overall Study|Protocol Violation|0|||
130603809|NCT01912872|470171477|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130603810|NCT01912872|470171478|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130603811|NCT01912872|470171479|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130603812|NCT01912872|470171480|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
130603813|NCT01912872|470171477|FG000|Overall Study|Withdrawal of study medication|0|||
130603814|NCT01912872|470171478|FG001|Overall Study|Withdrawal of study medication|0|||
130603815|NCT01912872|470171479|FG002|Overall Study|Withdrawal of study medication|0|||
130603816|NCT01912872|470171480|FG003|Overall Study|Withdrawal of study medication|2|||
130603817|NCT01912872|470171477|FG000|Overall Study|Missing|0|||
130603818|NCT01912872|470171478|FG001|Overall Study|Missing|0|||
130603819|NCT01912872|470171479|FG002|Overall Study|Missing|0|||
130603820|NCT01912872|470171480|FG003|Overall Study|Missing|1|||
130603821|NCT02778867|470171481|FG000|Phase 1|Withdrawal by Subject|2|||
130603822|NCT02778867|470171482|FG001|Phase 1|Withdrawal by Subject|3|||
130603823|NCT02778867|470171483|FG002|Phase 1|Withdrawal by Subject|0|||
130603824|NCT02778867|470171484|FG003|Phase 1|Withdrawal by Subject|0|||
130603825|NCT02778867|470171481|FG000|Phase 2|Withdrawal by Subject|0|||
130603826|NCT02778867|470171482|FG001|Phase 2|Withdrawal by Subject|0|||
130603827|NCT02778867|470171483|FG002|Phase 2|Withdrawal by Subject|1|||
130603828|NCT02778867|470171484|FG003|Phase 2|Withdrawal by Subject|0|||
130603829|NCT02778867|470171481|FG000|Phase 2|Physician Decision|0|||
130603830|NCT02778867|470171482|FG001|Phase 2|Physician Decision|0|||
130603831|NCT02778867|470171483|FG002|Phase 2|Physician Decision|0|||
130603832|NCT02778867|470171484|FG003|Phase 2|Physician Decision|1|||
130603833|NCT02778867|470171481|FG000|Phase 2|Adverse Event|0|||
130603834|NCT02778867|470171482|FG001|Phase 2|Adverse Event|0|||
130603835|NCT02778867|470171483|FG002|Phase 2|Adverse Event|0|||
130603836|NCT02778867|470171484|FG003|Phase 2|Adverse Event|1|||
130603837|NCT00589472|470171488|FG000|Overall Study|Adverse Event|1|||
130603838|NCT01651052|470171491|FG000|Overall Study|Death|21|||
130603839|NCT01651052|470171491|FG000|Overall Study|Explant|1|||
130603840|NCT01651052|470171491|FG000|Overall Study|Withdrawal by Subject|1|||
130603841|NCT01651052|470171491|FG000|Overall Study|Lost to Follow-up|3|||
130603842|NCT00871858|470171494|FG000|Overall Study|Protocol Violation|3|||
130603843|NCT00871858|470171495|FG001|Overall Study|Protocol Violation|4|||
130603844|NCT00871858|470171494|FG000|Overall Study|Adverse Event|1|||
130603845|NCT00871858|470171495|FG001|Overall Study|Adverse Event|1|||
130603846|NCT00871858|470171494|FG000|Overall Study|Withdrawal by Subject|1|||
130603847|NCT00871858|470171495|FG001|Overall Study|Withdrawal by Subject|1|||
130603848|NCT00871858|470171494|FG000|Overall Study|Lost to Follow-up|0|||
130603849|NCT00871858|470171495|FG001|Overall Study|Lost to Follow-up|1|||
130603850|NCT01188798|470171496|FG000|Overall Study|Death|0|||
130603851|NCT01188798|470171497|FG001|Overall Study|Death|1|||
130603852|NCT01188798|470171496|FG000|Overall Study|Required additional transplant|1|||
130603853|NCT01188798|470171497|FG001|Overall Study|Required additional transplant|1|||
130603854|NCT01188798|470171496|FG000|Overall Study|Protocol closure|1|||
130603855|NCT01188798|470171497|FG001|Overall Study|Protocol closure|1|||
130603856|NCT02795767|470171498|FG000|Overall Study|Received Commercial Emicizumab|1|||
130603857|NCT02795767|470171499|FG001|Overall Study|Received Commercial Emicizumab|0|||
130603858|NCT02795767|470171500|FG002|Overall Study|Received Commercial Emicizumab|0|||
130603859|NCT03662334|470171505|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
130603860|NCT03662334|470171506|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
130603861|NCT01097330|470171514|FG000|Overall Study|Study terminated early|7|||
130603862|NCT01097330|470171515|FG001|Overall Study|Study terminated early|5|||
130603863|NCT02746679|470171524|FG000|Overall Study|Lost to Follow-up|4|||
130603864|NCT02746679|470171525|FG001|Overall Study|Lost to Follow-up|6|||
130603865|NCT00501852|470171526|FG000|Overall Study|Adverse Event|3|||
130603866|NCT00501852|470171526|FG000|Overall Study|Withdrawal by Subject|2|||
130603867|NCT01416610|470171529|FG000|Overall Study|Adverse Event|4|||
130603868|NCT01416610|470171529|FG000|Overall Study|Adverse Event -Patient decision|3|||
130603869|NCT01416610|470171529|FG000|Overall Study|Lack of Efficacy|4|||
130603870|NCT01416610|470171529|FG000|Overall Study|No reason given|5|||
130603871|NCT01416610|470171529|FG000|Overall Study|Withdrawal by Subject|13|||
130603872|NCT01416610|470171529|FG000|Overall Study|Lost to Follow-up|7|||
130603873|NCT01416610|470171529|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
130603874|NCT01927562|470171531|FG000|Overall Study|Lost to Follow-up|30|||
130603875|NCT01927562|470171531|FG000|Overall Study|Withdrawal by Subject|3|||
130603876|NCT01927562|470171531|FG000|Overall Study|Physician Decision|5|||
130603877|NCT00642616|470171532|FG000|Overall Study|Adverse Event|2|||
130603878|NCT00642616|470171533|FG001|Overall Study|Adverse Event|0|||
130603879|NCT00642616|470171534|FG002|Overall Study|Adverse Event|1|||
130603880|NCT00642616|470171535|FG003|Overall Study|Adverse Event|0|||
130603881|NCT00642616|470171532|FG000|Overall Study|Study Terminated by Sponsor|7|||
130603882|NCT00642616|470171533|FG001|Overall Study|Study Terminated by Sponsor|6|||
130603883|NCT00642616|470171534|FG002|Overall Study|Study Terminated by Sponsor|4|||
130603884|NCT00642616|470171535|FG003|Overall Study|Study Terminated by Sponsor|5|||
130603885|NCT00642616|470171532|FG000|Overall Study|Withdrawal by Subject|0|||
130603886|NCT00642616|470171533|FG001|Overall Study|Withdrawal by Subject|1|||
130603887|NCT00642616|470171534|FG002|Overall Study|Withdrawal by Subject|1|||
130603888|NCT00642616|470171535|FG003|Overall Study|Withdrawal by Subject|1|||
130603889|NCT00642616|470171532|FG000|Overall Study|Protocol Violation|0|||
130603890|NCT00642616|470171533|FG001|Overall Study|Protocol Violation|0|||
130603891|NCT00642616|470171534|FG002|Overall Study|Protocol Violation|2|||
130603892|NCT00642616|470171535|FG003|Overall Study|Protocol Violation|0|||
130603893|NCT00642616|470171532|FG000|Overall Study|Physician Decision|0|||
130603894|NCT00642616|470171533|FG001|Overall Study|Physician Decision|0|||
130603895|NCT00642616|470171534|FG002|Overall Study|Physician Decision|1|||
130603896|NCT00642616|470171535|FG003|Overall Study|Physician Decision|1|||
130603897|NCT00492921|470171536|FG000|Overall Study|Death|1|||
130603898|NCT00492921|470171537|FG001|Overall Study|Death|0|||
130603899|NCT00492921|470171538|FG002|Overall Study|Death|1|||
130603900|NCT00399802|470171539|FG000|Overall Study|Adverse Event|0|||
130603901|NCT00399802|470171540|FG001|Overall Study|Adverse Event|2|||
130603902|NCT00399802|470171539|FG000|Overall Study|Participant discontinued by mistake|0|||
130603903|NCT00399802|470171540|FG001|Overall Study|Participant discontinued by mistake|1|||
130603904|NCT00542815|470171541|FG000|Overall Study|Adverse Event|19|||
130603905|NCT00542815|470171542|FG001|Overall Study|Adverse Event|6|||
130603906|NCT00542815|470171543|FG002|Overall Study|Adverse Event|9|||
130603907|NCT00542815|470171541|FG000|Overall Study|Death|10|||
130603908|NCT00542815|470171542|FG001|Overall Study|Death|7|||
130603909|NCT00542815|470171543|FG002|Overall Study|Death|3|||
130603910|NCT00542815|470171541|FG000|Overall Study|Lack of Efficacy|9|||
130603911|NCT00542815|470171542|FG001|Overall Study|Lack of Efficacy|2|||
130603912|NCT00542815|470171543|FG002|Overall Study|Lack of Efficacy|0|||
130603913|NCT00542815|470171541|FG000|Overall Study|Physician Decision|2|||
130603914|NCT00542815|470171542|FG001|Overall Study|Physician Decision|1|||
130603915|NCT00542815|470171543|FG002|Overall Study|Physician Decision|0|||
130603916|NCT00542815|470171541|FG000|Overall Study|Protocol Violation|1|||
130603917|NCT00542815|470171542|FG001|Overall Study|Protocol Violation|1|||
130603918|NCT00542815|470171543|FG002|Overall Study|Protocol Violation|2|||
130603919|NCT00542815|470171541|FG000|Overall Study|Withdrawal by Subject|41|||
130603920|NCT00542815|470171542|FG001|Overall Study|Withdrawal by Subject|5|||
130603921|NCT00542815|470171543|FG002|Overall Study|Withdrawal by Subject|8|||
130603922|NCT00542815|470171541|FG000|Overall Study|Other reasons|24|||
130603923|NCT00542815|470171542|FG001|Overall Study|Other reasons|10|||
130603924|NCT00542815|470171543|FG002|Overall Study|Other reasons|10|||
130603925|NCT01520922|470171544|FG000|Treatment Phase|Physician Decision|2|||
130603926|NCT01520922|470171545|FG001|Treatment Phase|Physician Decision|1|||
130603927|NCT01520922|470171544|FG000|Treatment Phase|Progression|0|||
130603928|NCT01520922|470171545|FG001|Treatment Phase|Progression|2|||
130603929|NCT01520922|470171544|FG000|Treatment Phase|Adverse Event|3|||
130603930|NCT01520922|470171545|FG001|Treatment Phase|Adverse Event|5|||
130603931|NCT01520922|470171544|FG000|Follow up|Lost to Follow-up|0|||
130603932|NCT01520922|470171545|FG001|Follow up|Lost to Follow-up|1|||
130603933|NCT01520922|470171544|FG000|Survival Follow-up|Withdrawal by Subject|1|||
130603934|NCT01520922|470171545|FG001|Survival Follow-up|Withdrawal by Subject|0|||
130603935|NCT04770155|470171550|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603936|NCT04770155|470171551|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603937|NCT04770155|470171552|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603938|NCT04770155|470171553|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603939|NCT04770155|470171554|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603940|NCT04770155|470171555|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603941|NCT04770155|470171556|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603942|NCT04770155|470171557|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130603943|NCT00864227|470171558|FG000|Overall Study|Withdrawal by Subject|1|||
130603944|NCT00864227|470171558|FG000|Overall Study|Disease Relapse/Progression|3|||
130603945|NCT01765764|470171562|FG000|Treatment Period|Adverse Event|1|||
130603946|NCT01765764|470171563|FG001|Treatment Period|Adverse Event|2|||
130603947|NCT01765764|470171564|FG002|Treatment Period|Adverse Event|1|||
130603948|NCT01765764|470171562|FG000|Treatment Period|Lost to Follow-up|0|||
130603949|NCT01765764|470171563|FG001|Treatment Period|Lost to Follow-up|3|||
130603950|NCT01765764|470171564|FG002|Treatment Period|Lost to Follow-up|2|||
130603951|NCT01765764|470171562|FG000|Treatment Period|Personal Reasons|1|||
130603952|NCT01765764|470171563|FG001|Treatment Period|Personal Reasons|2|||
130603953|NCT01765764|470171564|FG002|Treatment Period|Personal Reasons|1|||
130603954|NCT01765764|470171562|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
130603955|NCT01765764|470171563|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
130603956|NCT01765764|470171564|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
130603957|NCT01558089|470171565|FG000|Overall Study|Adverse Event|1|||
130603958|NCT01558089|470171565|FG000|Overall Study|Lack of Efficacy|1|||
130603959|NCT01558089|470171565|FG000|Overall Study|Lost to Follow-up|5|||
130603960|NCT01558089|470171565|FG000|Overall Study|Withdrawal by Subject|6|||
130603961|NCT00935220|470171575|FG000|Overall Study|Adverse Event|1|||
130603962|NCT00935220|470171575|FG000|Overall Study|Other reason (not specified)|1|||
130603963|NCT00798967|470171576|FG000|Overall Study|Adverse Event|2|||
130603964|NCT00798967|470171577|FG001|Overall Study|Adverse Event|3|||
130603965|NCT00798967|470171576|FG000|Overall Study|Withdrawal by Subject|0|||
130603966|NCT00798967|470171577|FG001|Overall Study|Withdrawal by Subject|1|||
130603967|NCT00798967|470171576|FG000|Overall Study|Physician Decision|1|||
130603968|NCT00798967|470171577|FG001|Overall Study|Physician Decision|0|||
130603969|NCT00798967|470171576|FG000|Overall Study|Randomized in error by site|1|||
130603970|NCT00798967|470171577|FG001|Overall Study|Randomized in error by site|0|||
130603971|NCT01415440|470171580|FG000|Overall Study|Lost to Follow-up|0|||
130603972|NCT01415440|470171581|FG001|Overall Study|Lost to Follow-up|1|||
130603973|NCT01415440|470171582|FG002|Overall Study|Lost to Follow-up|2|||
130603974|NCT01415440|470171580|FG000|Overall Study|Physician Decision|3|||
130603975|NCT01415440|470171581|FG001|Overall Study|Physician Decision|0|||
130603976|NCT01415440|470171582|FG002|Overall Study|Physician Decision|0|||
130603977|NCT01415440|470171580|FG000|Overall Study|Withdrawal by Subject|1|||
130603978|NCT01415440|470171581|FG001|Overall Study|Withdrawal by Subject|0|||
130603979|NCT01415440|470171582|FG002|Overall Study|Withdrawal by Subject|0|||
130603980|NCT00336492|470171583|FG000|Overall Study|Adverse Event|4|||
130603981|NCT00336492|470171584|FG001|Overall Study|Adverse Event|3|||
130603982|NCT00336492|470171585|FG002|Overall Study|Adverse Event|6|||
130603983|NCT00336492|470171583|FG000|Overall Study|Lack of Efficacy|6|||
130603984|NCT00336492|470171584|FG001|Overall Study|Lack of Efficacy|1|||
130603985|NCT00336492|470171585|FG002|Overall Study|Lack of Efficacy|4|||
130603986|NCT00336492|470171583|FG000|Overall Study|Other|5|||
130603987|NCT00336492|470171584|FG001|Overall Study|Other|0|||
130603988|NCT00336492|470171585|FG002|Overall Study|Other|1|||
130603989|NCT00227877|470171586|FG000|Pre-visit Assessment|Technical difficulties|7|||
130603990|NCT00227877|470171587|FG001|Pre-visit Assessment|Technical difficulties|3|||
130603991|NCT00227877|470171588|FG002|Pre-visit Assessment|Technical difficulties|0|||
130603992|NCT00227877|470171589|FG003|Pre-visit Assessment|Technical difficulties|0|||
130603993|NCT00227877|470171586|FG000|Post-visit Checklist|Lost to Follow-up|24|||
130603994|NCT00227877|470171587|FG001|Post-visit Checklist|Lost to Follow-up|13|||
130603995|NCT00227877|470171588|FG002|Post-visit Checklist|Lost to Follow-up|1|||
130603996|NCT00227877|470171589|FG003|Post-visit Checklist|Lost to Follow-up|0|||
130603997|NCT00227877|470171586|FG000|3-months Follow-up|Completed late|135|||
130603998|NCT00227877|470171587|FG001|3-months Follow-up|Completed late|128|||
130603999|NCT00227877|470171588|FG002|3-months Follow-up|Completed late|34|||
130604000|NCT00227877|470171589|FG003|3-months Follow-up|Completed late|8|||
130604001|NCT00227877|470171586|FG000|3-months Follow-up|Lost to Follow-up|178|||
130604002|NCT00227877|470171587|FG001|3-months Follow-up|Lost to Follow-up|139|||
130604003|NCT00227877|470171588|FG002|3-months Follow-up|Lost to Follow-up|18|||
130604004|NCT00227877|470171589|FG003|3-months Follow-up|Lost to Follow-up|13|||
130604005|NCT00227877|470171586|FG000|12-months Follow-up|Completed late|78|||
130604006|NCT00227877|470171587|FG001|12-months Follow-up|Completed late|74|||
130604007|NCT00227877|470171588|FG002|12-months Follow-up|Completed late|1|||
130604008|NCT00227877|470171589|FG003|12-months Follow-up|Completed late|0|||
130604009|NCT00227877|470171586|FG000|12-months Follow-up|Lost to Follow-up|232|||
130604010|NCT00227877|470171587|FG001|12-months Follow-up|Lost to Follow-up|189|||
130604011|NCT00227877|470171588|FG002|12-months Follow-up|Lost to Follow-up|30|||
130604012|NCT00227877|470171589|FG003|12-months Follow-up|Lost to Follow-up|26|||
130604013|NCT00633139|470171591|FG000|Overall Study|Non compliance|0|||
130604014|NCT00633139|470171592|FG001|Overall Study|Non compliance|0|||
130604015|NCT00633139|470171593|FG002|Overall Study|Non compliance|1|||
130604016|NCT00633139|470171591|FG000|Overall Study|Withdrawal by Subject|0|||
130604017|NCT00633139|470171592|FG001|Overall Study|Withdrawal by Subject|1|||
130604018|NCT00633139|470171593|FG002|Overall Study|Withdrawal by Subject|0|||
130604019|NCT02160977|470171595|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
130604020|NCT02160977|470171596|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
130604021|NCT02160977|470171595|FG000|Three Months After Surgery|Lost to Follow-up|0|||
130604022|NCT02160977|470171596|FG001|Three Months After Surgery|Lost to Follow-up|2|||
130604023|NCT02160977|470171595|FG000|Six Months After Surgery|Lost to Follow-up|2|||
130604024|NCT02160977|470171596|FG001|Six Months After Surgery|Lost to Follow-up|1|||
130604025|NCT01522651|470171600|FG000|Overall Study|Adverse Event|3|||
130604026|NCT01522651|470171601|FG001|Overall Study|Adverse Event|4|||
130604027|NCT01522651|470171602|FG002|Overall Study|Adverse Event|4|||
130604028|NCT01522651|470171603|FG003|Overall Study|Adverse Event|5|||
130604029|NCT01522651|470171604|FG004|Overall Study|Adverse Event|4|||
130604030|NCT01522651|470171600|FG000|Overall Study|Cardioversion|1|||
130604031|NCT01522651|470171601|FG001|Overall Study|Cardioversion|0|||
130604032|NCT01522651|470171602|FG002|Overall Study|Cardioversion|0|||
130604033|NCT01522651|470171603|FG003|Overall Study|Cardioversion|0|||
130604034|NCT01522651|470171604|FG004|Overall Study|Cardioversion|0|||
130604035|NCT01522651|470171600|FG000|Overall Study|Device Malfunction|0|||
130604036|NCT01522651|470171601|FG001|Overall Study|Device Malfunction|1|||
130604037|NCT01522651|470171602|FG002|Overall Study|Device Malfunction|0|||
130604038|NCT01522651|470171603|FG003|Overall Study|Device Malfunction|0|||
130604039|NCT01522651|470171604|FG004|Overall Study|Device Malfunction|0|||
130604040|NCT01522651|470171600|FG000|Overall Study|Investigator's Discretion|0|||
130604041|NCT01522651|470171601|FG001|Overall Study|Investigator's Discretion|1|||
130604042|NCT01522651|470171602|FG002|Overall Study|Investigator's Discretion|0|||
130604043|NCT01522651|470171603|FG003|Overall Study|Investigator's Discretion|0|||
130604044|NCT01522651|470171604|FG004|Overall Study|Investigator's Discretion|0|||
130604045|NCT01522651|470171600|FG000|Overall Study|Protocol Violation|3|||
130604046|NCT01522651|470171601|FG001|Overall Study|Protocol Violation|0|||
130604047|NCT01522651|470171602|FG002|Overall Study|Protocol Violation|0|||
130604048|NCT01522651|470171603|FG003|Overall Study|Protocol Violation|0|||
130604049|NCT01522651|470171604|FG004|Overall Study|Protocol Violation|0|||
130604050|NCT01522651|470171600|FG000|Overall Study|Reason Not Specified|0|||
130604051|NCT01522651|470171601|FG001|Overall Study|Reason Not Specified|0|||
130604052|NCT01522651|470171602|FG002|Overall Study|Reason Not Specified|0|||
130604053|NCT01522651|470171603|FG003|Overall Study|Reason Not Specified|1|||
130604054|NCT01522651|470171604|FG004|Overall Study|Reason Not Specified|0|||
130604055|NCT01522651|470171600|FG000|Overall Study|Participant Non-Compliance|1|||
130604056|NCT01522651|470171601|FG001|Overall Study|Participant Non-Compliance|0|||
130604057|NCT01522651|470171602|FG002|Overall Study|Participant Non-Compliance|0|||
130604058|NCT01522651|470171603|FG003|Overall Study|Participant Non-Compliance|0|||
130604059|NCT01522651|470171604|FG004|Overall Study|Participant Non-Compliance|0|||
130604060|NCT01522651|470171600|FG000|Overall Study|Withdrew Consent|1|||
130604061|NCT01522651|470171601|FG001|Overall Study|Withdrew Consent|1|||
130604062|NCT01522651|470171602|FG002|Overall Study|Withdrew Consent|0|||
130604063|NCT01522651|470171603|FG003|Overall Study|Withdrew Consent|1|||
130604064|NCT01522651|470171604|FG004|Overall Study|Withdrew Consent|1|||
130604065|NCT01522651|470171600|FG000|Overall Study|Randomized but Never Treated|0|||
130604066|NCT01522651|470171601|FG001|Overall Study|Randomized but Never Treated|1|||
130604067|NCT01522651|470171602|FG002|Overall Study|Randomized but Never Treated|0|||
130604068|NCT01522651|470171603|FG003|Overall Study|Randomized but Never Treated|1|||
130604069|NCT01522651|470171604|FG004|Overall Study|Randomized but Never Treated|1|||
130604070|NCT02658656|470171605|FG000|Screening|Failed eligibility criteria|0|||
130604071|NCT02658656|470171606|FG001|Screening|Failed eligibility criteria|0|||
130604072|NCT02658656|470171607|FG002|Screening|Failed eligibility criteria|263|||
130604073|NCT02658656|470171605|FG000|Randomization|Withdrawal by Subject|8|||
130604074|NCT02658656|470171606|FG001|Randomization|Withdrawal by Subject|7|||
130604075|NCT02658656|470171607|FG002|Randomization|Withdrawal by Subject|0|||
130604076|NCT02658656|470171605|FG000|Randomization|Lost to Follow-up|1|||
130604077|NCT02658656|470171606|FG001|Randomization|Lost to Follow-up|3|||
130604078|NCT02658656|470171607|FG002|Randomization|Lost to Follow-up|0|||
130604079|NCT02658656|470171605|FG000|Randomization|Adverse Event|4|||
130604080|NCT02658656|470171606|FG001|Randomization|Adverse Event|0|||
130604081|NCT02658656|470171607|FG002|Randomization|Adverse Event|0|||
130604082|NCT02658656|470171605|FG000|Randomization|Administrative Termination|3|||
130604083|NCT02658656|470171606|FG001|Randomization|Administrative Termination|1|||
130604084|NCT02658656|470171607|FG002|Randomization|Administrative Termination|0|||
130604085|NCT02658656|470171605|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
130604086|NCT02658656|470171606|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
130604087|NCT02658656|470171607|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
130604088|NCT02658656|470171605|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
130604089|NCT02658656|470171606|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
130604090|NCT02658656|470171607|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
130604091|NCT02658656|470171605|FG000|Randomization|Not eligible for Randomization|1|||
130604092|NCT02658656|470171606|FG001|Randomization|Not eligible for Randomization|0|||
130604093|NCT02658656|470171607|FG002|Randomization|Not eligible for Randomization|0|||
130604094|NCT02658656|470171605|FG000|Randomization|Protocol Violation|1|||
130604095|NCT02658656|470171606|FG001|Randomization|Protocol Violation|0|||
130604096|NCT02658656|470171607|FG002|Randomization|Protocol Violation|0|||
130604097|NCT01937130|470173000|FG000|Overall Study|Withdrawal by Subject|0|||
130604098|NCT01937130|470173001|FG001|Overall Study|Withdrawal by Subject|0|||
130604099|NCT01937130|470173002|FG002|Overall Study|Withdrawal by Subject|0|||
130604100|NCT01937130|470173003|FG003|Overall Study|Withdrawal by Subject|1|||
130604101|NCT01937130|470173000|FG000|Overall Study|Adverse Event|0|||
130604102|NCT01937130|470173001|FG001|Overall Study|Adverse Event|1|||
130604103|NCT01937130|470173002|FG002|Overall Study|Adverse Event|0|||
130604104|NCT01937130|470173003|FG003|Overall Study|Adverse Event|1|||
130604105|NCT01937130|470173000|FG000|Overall Study|Death|1|||
130604106|NCT01937130|470173001|FG001|Overall Study|Death|1|||
130604107|NCT01937130|470173002|FG002|Overall Study|Death|1|||
130604108|NCT01937130|470173003|FG003|Overall Study|Death|0|||
130604109|NCT01937130|470173000|FG000|Overall Study|Lost to Follow-up|2|||
130604110|NCT01937130|470173001|FG001|Overall Study|Lost to Follow-up|0|||
130604111|NCT01937130|470173002|FG002|Overall Study|Lost to Follow-up|2|||
130604112|NCT01937130|470173003|FG003|Overall Study|Lost to Follow-up|0|||
130604113|NCT01937130|470173000|FG000|Overall Study|Physician Decision|0|||
130604114|NCT01937130|470173001|FG001|Overall Study|Physician Decision|1|||
130604115|NCT01937130|470173002|FG002|Overall Study|Physician Decision|0|||
130604116|NCT01937130|470173003|FG003|Overall Study|Physician Decision|0|||
130604117|NCT01937130|470173000|FG000|Overall Study|Patients unable to swallow|0|||
130604118|NCT01937130|470173001|FG001|Overall Study|Patients unable to swallow|1|||
130604119|NCT01937130|470173002|FG002|Overall Study|Patients unable to swallow|0|||
130604120|NCT01937130|470173003|FG003|Overall Study|Patients unable to swallow|0|||
130604121|NCT01937130|470173000|FG000|Overall Study|Patient lost to FU due to death|2|||
130604122|NCT01937130|470173001|FG001|Overall Study|Patient lost to FU due to death|0|||
130604123|NCT01937130|470173002|FG002|Overall Study|Patient lost to FU due to death|0|||
130604124|NCT01937130|470173003|FG003|Overall Study|Patient lost to FU due to death|0|||
130604125|NCT03504774|470173008|FG000|Overall Study|Adverse Event|2|||
130604126|NCT03504774|470173009|FG001|Overall Study|Adverse Event|0|||
130604127|NCT03504774|470173008|FG000|Overall Study|Lost to Follow-up|0|||
130604128|NCT03504774|470173009|FG001|Overall Study|Lost to Follow-up|1|||
130604129|NCT03504774|470173008|FG000|Overall Study|Protocol Violation|11|||
130604130|NCT03504774|470173009|FG001|Overall Study|Protocol Violation|3|||
130604131|NCT03504774|470173008|FG000|Overall Study|failed wk 52 DBPCFC|1|||
130604132|NCT03504774|470173009|FG001|Overall Study|failed wk 52 DBPCFC|0|||
130604133|NCT00915005|470173015|FG000|Overall Study|Withdrawal by Subject|4|||
130604134|NCT00915005|470173016|FG001|Overall Study|Withdrawal by Subject|4|||
130604135|NCT00915005|470173015|FG000|Overall Study|Patient preferred protons therapy|6|||
130604136|NCT00915005|470173016|FG001|Overall Study|Patient preferred protons therapy|0|||
130604137|NCT00915005|470173015|FG000|Overall Study|Insurance denial|3|||
130604138|NCT00915005|470173016|FG001|Overall Study|Insurance denial|15|||
130604139|NCT03554005|470173019|FG000|Overall Study|Not in participant's best interest|0|||
130604140|NCT03554005|470173020|FG001|Overall Study|Not in participant's best interest|0|||
130604141|NCT03554005|470173021|FG002|Overall Study|Not in participant's best interest|0|||
130604142|NCT03554005|470173022|FG003|Overall Study|Not in participant's best interest|0|||
130604143|NCT03554005|470173023|FG004|Overall Study|Not in participant's best interest|0|||
130604144|NCT03554005|470173024|FG005|Overall Study|Not in participant's best interest|1|||
130604145|NCT03554005|470173019|FG000|Overall Study|Disease Progression|1|||
130604146|NCT03554005|470173020|FG001|Overall Study|Disease Progression|1|||
130604147|NCT03554005|470173021|FG002|Overall Study|Disease Progression|1|||
130604148|NCT03554005|470173022|FG003|Overall Study|Disease Progression|1|||
130604149|NCT03554005|470173023|FG004|Overall Study|Disease Progression|5|||
130604150|NCT03554005|470173024|FG005|Overall Study|Disease Progression|6|||
130604151|NCT03554005|470173019|FG000|Overall Study|Adverse Event|0|||
130604152|NCT03554005|470173020|FG001|Overall Study|Adverse Event|0|||
130604153|NCT03554005|470173021|FG002|Overall Study|Adverse Event|0|||
130604154|NCT03554005|470173022|FG003|Overall Study|Adverse Event|0|||
130604155|NCT03554005|470173023|FG004|Overall Study|Adverse Event|0|||
130604156|NCT03554005|470173024|FG005|Overall Study|Adverse Event|3|||
130604157|NCT03554005|470173019|FG000|Overall Study|Physician Decision|0|||
130604158|NCT03554005|470173020|FG001|Overall Study|Physician Decision|0|||
130604159|NCT03554005|470173021|FG002|Overall Study|Physician Decision|0|||
130604160|NCT03554005|470173022|FG003|Overall Study|Physician Decision|0|||
130604161|NCT03554005|470173023|FG004|Overall Study|Physician Decision|1|||
130604162|NCT03554005|470173024|FG005|Overall Study|Physician Decision|0|||
130604163|NCT03554005|470173019|FG000|Overall Study|Other|0|||
130604164|NCT03554005|470173020|FG001|Overall Study|Other|0|||
130604165|NCT03554005|470173021|FG002|Overall Study|Other|0|||
130604166|NCT03554005|470173022|FG003|Overall Study|Other|0|||
130604167|NCT03554005|470173023|FG004|Overall Study|Other|0|||
130604168|NCT03554005|470173024|FG005|Overall Study|Other|1|||
130604169|NCT00631488|470173025|FG000|Overall Study|Adverse Event|1|||
130604170|NCT00631488|470173026|FG001|Overall Study|Adverse Event|0|||
130604171|NCT00631488|470173027|FG002|Overall Study|Adverse Event|0|||
130604172|NCT00631488|470173025|FG000|Overall Study|Lost to Follow-up|2|||
130604173|NCT00631488|470173026|FG001|Overall Study|Lost to Follow-up|2|||
130604174|NCT00631488|470173027|FG002|Overall Study|Lost to Follow-up|0|||
130604175|NCT00631488|470173025|FG000|Overall Study|Physician Decision|1|||
130604176|NCT00631488|470173026|FG001|Overall Study|Physician Decision|0|||
130604177|NCT00631488|470173027|FG002|Overall Study|Physician Decision|1|||
130604178|NCT00631488|470173025|FG000|Overall Study|Protocol Violation|0|||
130604179|NCT00631488|470173026|FG001|Overall Study|Protocol Violation|0|||
130604180|NCT00631488|470173027|FG002|Overall Study|Protocol Violation|1|||
130604181|NCT03648476|470173028|FG000|Overall Study|Withdrawal by Subject|2|||
130604182|NCT03648476|470173029|FG001|Overall Study|Withdrawal by Subject|1|||
130604183|NCT02855411|470173031|FG000|Overall Study|Study terminated by sponsor|21|||
130604184|NCT02855411|470173031|FG000|Overall Study|Does not meet entrance criteria|14|||
130604185|NCT02546856|470173034|FG000|4 Months Evaluation|Death|2|||
130604186|NCT02546856|470173035|FG001|4 Months Evaluation|Death|3|||
130604187|NCT02546856|470173034|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
130604188|NCT02546856|470173035|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
130604189|NCT02546856|470173034|FG000|4 Months Evaluation|Lost to Follow-up|3|||
130604190|NCT02546856|470173035|FG001|4 Months Evaluation|Lost to Follow-up|3|||
130604191|NCT02546856|470173034|FG000|4 Months Evaluation|Physician Decision|3|||
130604192|NCT02546856|470173035|FG001|4 Months Evaluation|Physician Decision|0|||
130604193|NCT02546856|470173034|FG000|4 Months Evaluation|Working or living abroad|5|||
130604194|NCT02546856|470173035|FG001|4 Months Evaluation|Working or living abroad|1|||
130604195|NCT02546856|470173034|FG000|4 Months Evaluation|reasons not due to titration|4|||
130604196|NCT02546856|470173035|FG001|4 Months Evaluation|reasons not due to titration|1|||
130604197|NCT02546856|470173034|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
130604198|NCT02546856|470173035|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
130604199|NCT02546856|470173034|FG000|6 Months Evaluation|Death|1|||
130604200|NCT02546856|470173035|FG001|6 Months Evaluation|Death|1|||
130604201|NCT02546856|470173034|FG000|6 Months Evaluation|Lost to Follow-up|1|||
130604202|NCT02546856|470173035|FG001|6 Months Evaluation|Lost to Follow-up|1|||
130604203|NCT02546856|470173034|FG000|6 Months Evaluation|Working or living abroad|6|||
130604204|NCT02546856|470173035|FG001|6 Months Evaluation|Working or living abroad|4|||
130604205|NCT02546856|470173034|FG000|6 Months Evaluation|reasons not due to titration|0|||
130604206|NCT02546856|470173035|FG001|6 Months Evaluation|reasons not due to titration|1|||
130604207|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
130604208|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
130604209|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
130604210|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130604211|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130604212|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130604213|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130604214|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130604215|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
130604216|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
130604217|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
130604218|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130604219|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130604220|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130604221|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130604222|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130604223|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
130604224|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
130604225|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
130604226|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130604227|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130604228|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130604229|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130604230|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130604231|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130604232|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130604233|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604234|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604235|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604236|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604237|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604238|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130604239|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
130604240|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
130604241|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
130604242|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130604243|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130604244|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130604245|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130604246|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130604247|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
130604248|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
130604249|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604250|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604251|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604252|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604253|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604254|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130604255|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
130604256|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
130604257|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604258|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604259|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604260|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604261|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604262|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130604263|NCT01097616|470173037|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604264|NCT01097616|470173038|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604265|NCT01097616|470173039|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
130604266|NCT01097616|470173040|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604267|NCT01097616|470173041|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604268|NCT01097616|470173042|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604269|NCT01097616|470173043|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604270|NCT01097616|470173044|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130604271|NCT01097616|470173037|FG000|Optional DB EXT Phase|Adverse Event|0|||
130604272|NCT01097616|470173038|FG001|Optional DB EXT Phase|Adverse Event|7|||
130604273|NCT01097616|470173039|FG002|Optional DB EXT Phase|Adverse Event|2|||
130604274|NCT01097616|470173040|FG003|Optional DB EXT Phase|Adverse Event|0|||
130604275|NCT01097616|470173041|FG004|Optional DB EXT Phase|Adverse Event|0|||
130604276|NCT01097616|470173042|FG005|Optional DB EXT Phase|Adverse Event|0|||
130604277|NCT01097616|470173043|FG006|Optional DB EXT Phase|Adverse Event|0|||
130604278|NCT01097616|470173044|FG007|Optional DB EXT Phase|Adverse Event|0|||
130604279|NCT01097616|470173037|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
130604280|NCT01097616|470173038|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
130604281|NCT01097616|470173039|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
130604282|NCT01097616|470173040|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
130604283|NCT01097616|470173041|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
130604284|NCT01097616|470173042|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
130604285|NCT01097616|470173043|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
130604286|NCT01097616|470173044|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
130604287|NCT01097616|470173037|FG000|Optional DB EXT Phase|Protocol Violation|0|||
130604288|NCT01097616|470173038|FG001|Optional DB EXT Phase|Protocol Violation|2|||
130604289|NCT01097616|470173039|FG002|Optional DB EXT Phase|Protocol Violation|3|||
130604290|NCT01097616|470173040|FG003|Optional DB EXT Phase|Protocol Violation|0|||
130604291|NCT01097616|470173041|FG004|Optional DB EXT Phase|Protocol Violation|0|||
130604292|NCT01097616|470173042|FG005|Optional DB EXT Phase|Protocol Violation|0|||
130604293|NCT01097616|470173043|FG006|Optional DB EXT Phase|Protocol Violation|0|||
130604294|NCT01097616|470173044|FG007|Optional DB EXT Phase|Protocol Violation|0|||
130604295|NCT01097616|470173037|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
130604296|NCT01097616|470173038|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
130604297|NCT01097616|470173039|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
130604298|NCT01097616|470173040|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
130604299|NCT01097616|470173041|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
130604300|NCT01097616|470173042|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
130604301|NCT01097616|470173043|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
130604302|NCT01097616|470173044|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
130604303|NCT01097616|470173037|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
130604304|NCT01097616|470173038|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
130604305|NCT01097616|470173039|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
130604306|NCT01097616|470173040|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
130604307|NCT01097616|470173041|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
130604308|NCT01097616|470173042|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
130604309|NCT01097616|470173043|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
130604310|NCT01097616|470173044|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
130604311|NCT01097616|470173037|FG000|Optional DB EXT Phase|Physician Decision|1|||
130604312|NCT01097616|470173038|FG001|Optional DB EXT Phase|Physician Decision|0|||
130604313|NCT01097616|470173039|FG002|Optional DB EXT Phase|Physician Decision|0|||
130604314|NCT01097616|470173040|FG003|Optional DB EXT Phase|Physician Decision|0|||
130604315|NCT01097616|470173041|FG004|Optional DB EXT Phase|Physician Decision|0|||
130604316|NCT01097616|470173042|FG005|Optional DB EXT Phase|Physician Decision|0|||
130604317|NCT01097616|470173043|FG006|Optional DB EXT Phase|Physician Decision|0|||
130604318|NCT01097616|470173044|FG007|Optional DB EXT Phase|Physician Decision|0|||
130604319|NCT01097616|470173037|FG000|DB RO Phase|Adverse Event|0|||
130604320|NCT01097616|470173038|FG001|DB RO Phase|Adverse Event|0|||
130604321|NCT01097616|470173039|FG002|DB RO Phase|Adverse Event|0|||
130604322|NCT01097616|470173040|FG003|DB RO Phase|Adverse Event|0|||
130604323|NCT01097616|470173041|FG004|DB RO Phase|Adverse Event|0|||
130604324|NCT01097616|470173042|FG005|DB RO Phase|Adverse Event|0|||
130604325|NCT01097616|470173043|FG006|DB RO Phase|Adverse Event|1|||
130604326|NCT01097616|470173044|FG007|DB RO Phase|Adverse Event|0|||
130604327|NCT01097616|470173037|FG000|DB RO Phase|Withdrawal by Subject|0|||
130604328|NCT01097616|470173038|FG001|DB RO Phase|Withdrawal by Subject|0|||
130604329|NCT01097616|470173039|FG002|DB RO Phase|Withdrawal by Subject|0|||
130604330|NCT01097616|470173040|FG003|DB RO Phase|Withdrawal by Subject|0|||
130604331|NCT01097616|470173041|FG004|DB RO Phase|Withdrawal by Subject|0|||
130604332|NCT01097616|470173042|FG005|DB RO Phase|Withdrawal by Subject|1|||
130604333|NCT01097616|470173043|FG006|DB RO Phase|Withdrawal by Subject|0|||
130604334|NCT01097616|470173044|FG007|DB RO Phase|Withdrawal by Subject|0|||
130604335|NCT01097616|470173037|FG000|DB RO Phase|Lost to Follow-up|0|||
130604336|NCT01097616|470173038|FG001|DB RO Phase|Lost to Follow-up|0|||
130604337|NCT01097616|470173039|FG002|DB RO Phase|Lost to Follow-up|0|||
130604338|NCT01097616|470173040|FG003|DB RO Phase|Lost to Follow-up|1|||
130604339|NCT01097616|470173041|FG004|DB RO Phase|Lost to Follow-up|1|||
130604340|NCT01097616|470173042|FG005|DB RO Phase|Lost to Follow-up|0|||
130604341|NCT01097616|470173043|FG006|DB RO Phase|Lost to Follow-up|0|||
130604342|NCT01097616|470173044|FG007|DB RO Phase|Lost to Follow-up|1|||
130604343|NCT01097616|470173037|FG000|DB RO Phase|Not Treated in RO|0|||
130604344|NCT01097616|470173038|FG001|DB RO Phase|Not Treated in RO|0|||
130604345|NCT01097616|470173039|FG002|DB RO Phase|Not Treated in RO|0|||
130604346|NCT01097616|470173040|FG003|DB RO Phase|Not Treated in RO|0|||
130604347|NCT01097616|470173041|FG004|DB RO Phase|Not Treated in RO|0|||
130604348|NCT01097616|470173042|FG005|DB RO Phase|Not Treated in RO|1|||
130604349|NCT01097616|470173043|FG006|DB RO Phase|Not Treated in RO|0|||
130604350|NCT01097616|470173044|FG007|DB RO Phase|Not Treated in RO|0|||
130604351|NCT00130208|470173045|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
130604352|NCT00130208|470173046|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
130604353|NCT00130208|470173045|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
130604354|NCT00130208|470173046|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
130604355|NCT00130208|470173045|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
130604356|NCT00130208|470173046|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
130604357|NCT00130208|470173045|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
130604358|NCT00130208|470173046|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
130604359|NCT00130208|470173045|FG000|Maintenance Period (26 Weeks)|Other|1|||
130604360|NCT00130208|470173046|FG001|Maintenance Period (26 Weeks)|Other|1|||
130604361|NCT00130208|470173045|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
130604362|NCT00130208|470173046|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
130604363|NCT00130208|470173045|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
130604364|NCT00130208|470173046|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
130604365|NCT00130208|470173045|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
130604366|NCT00130208|470173046|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
130604367|NCT00130208|470173045|FG000|Washout Period (8 Weeks)|Other|1|||
130604368|NCT00130208|470173046|FG001|Washout Period (8 Weeks)|Other|1|||
130604369|NCT01703819|470173050|FG000|Overall Study|Adverse Event|0|||
130604370|NCT01703819|470173051|FG001|Overall Study|Adverse Event|1|||
130604371|NCT01703819|470173050|FG000|Overall Study|Withdrawal by Subject|0|||
130604372|NCT01703819|470173051|FG001|Overall Study|Withdrawal by Subject|1|||
130604373|NCT04230486|470173052|FG000|Overall Study|Screen Failure|1|||
130604374|NCT03215264|470173053|FG000|Dose Level 2|Adverse Event|0|||
130604375|NCT03215264|470173054|FG001|Dose Level 2|Adverse Event|1|||
130604376|NCT03215264|470173055|FG002|Dose Level 2|Adverse Event|0|||
130604377|NCT03215264|470173053|FG000|Dose Level 3|Withdrawal by Subject|0|||
130604378|NCT03215264|470173054|FG001|Dose Level 3|Withdrawal by Subject|0|||
130604379|NCT03215264|470173055|FG002|Dose Level 3|Withdrawal by Subject|1|||
130604380|NCT02145156|470173056|FG000|Overall Study|No match to vaccination records|60|||
130604381|NCT02145156|470173057|FG001|Overall Study|No match to vaccination records|52|||
130604382|NCT02145156|470173058|FG002|Overall Study|No match to vaccination records|41|||
130604383|NCT02234583|470173061|FG000|Overall Study|Adverse Event|172|||
130604384|NCT02234583|470173062|FG001|Overall Study|Adverse Event|156|||
130604385|NCT02234583|470173061|FG000|Overall Study|Withdrawal by Subject|109|||
130604386|NCT02234583|470173062|FG001|Overall Study|Withdrawal by Subject|157|||
130604387|NCT02234583|470173061|FG000|Overall Study|Lost to Follow-up|0|||
130604388|NCT02234583|470173062|FG001|Overall Study|Lost to Follow-up|1|||
130604389|NCT02234583|470173061|FG000|Overall Study|Lack of Efficacy|58|||
130604390|NCT02234583|470173062|FG001|Overall Study|Lack of Efficacy|103|||
130604391|NCT02234583|470173061|FG000|Overall Study|Protocol Violation|35|||
130604392|NCT02234583|470173062|FG001|Overall Study|Protocol Violation|42|||
130604393|NCT02234583|470173061|FG000|Overall Study|Other|39|||
130604394|NCT02234583|470173062|FG001|Overall Study|Other|97|||
130604395|NCT02805907|470173063|FG000|Overall Study|Lost to Follow-up|3|||
130604396|NCT02805907|470173064|FG001|Overall Study|Lost to Follow-up|3|||
130604397|NCT03408873|470173065|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
130604398|NCT03408873|470173065|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
130604399|NCT03408873|470173065|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
130604400|NCT03408873|470173065|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
130604401|NCT03408873|470173065|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
130604402|NCT03408873|470173065|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
130604403|NCT01264965|470173066|FG000|Overall Study|Withdrawal by Subject|10|||
130604404|NCT01797783|470173067|FG000|Overall Study|Adverse Event|1|||
130604405|NCT01797783|470173068|FG001|Overall Study|Adverse Event|1|||
130604406|NCT01797783|470173067|FG000|Overall Study|Withdrawal by Subject|1|||
130604407|NCT01797783|470173068|FG001|Overall Study|Withdrawal by Subject|0|||
130604408|NCT00532883|470173069|FG000|Overall Study|Adverse Event|1|||
130604409|NCT00532883|470173070|FG001|Overall Study|Adverse Event|0|||
130604410|NCT00532883|470173071|FG002|Overall Study|Adverse Event|0|||
130604411|NCT00532883|470173072|FG003|Overall Study|Adverse Event|1|||
130604412|NCT00532883|470173069|FG000|Overall Study|Lost to Follow-up|1|||
130604413|NCT00532883|470173070|FG001|Overall Study|Lost to Follow-up|1|||
130604414|NCT00532883|470173071|FG002|Overall Study|Lost to Follow-up|1|||
130604415|NCT00532883|470173072|FG003|Overall Study|Lost to Follow-up|0|||
130604416|NCT00532883|470173069|FG000|Overall Study|Withdrawal by Subject|0|||
130604417|NCT00532883|470173070|FG001|Overall Study|Withdrawal by Subject|1|||
130604418|NCT00532883|470173071|FG002|Overall Study|Withdrawal by Subject|1|||
130604419|NCT00532883|470173072|FG003|Overall Study|Withdrawal by Subject|0|||
130604420|NCT00532883|470173069|FG000|Overall Study|Subject was Nonadherent|0|||
130604421|NCT00532883|470173070|FG001|Overall Study|Subject was Nonadherent|1|||
130604422|NCT00532883|470173071|FG002|Overall Study|Subject was Nonadherent|1|||
130604423|NCT00532883|470173072|FG003|Overall Study|Subject was Nonadherent|0|||
130604424|NCT00532883|470173069|FG000|Overall Study|Early Study Termination|4|||
130604425|NCT00532883|470173070|FG001|Overall Study|Early Study Termination|4|||
130604426|NCT00532883|470173071|FG002|Overall Study|Early Study Termination|1|||
130604427|NCT00532883|470173072|FG003|Overall Study|Early Study Termination|4|||
130604428|NCT03799718|470173073|FG000|Overall Study|Adverse Event|2|||
130604429|NCT02202031|470173074|FG000|Overall Study|Lost to Follow-up|1|||
130604430|NCT02202031|470173075|FG001|Overall Study|Lost to Follow-up|0|||
130604431|NCT02202031|470173074|FG000|Overall Study|Too Busy|1|||
130604432|NCT02202031|470173075|FG001|Overall Study|Too Busy|3|||
130604433|NCT02202031|470173074|FG000|Overall Study|Illness/Medical Reason|0|||
130604434|NCT02202031|470173075|FG001|Overall Study|Illness/Medical Reason|2|||
130604435|NCT02202031|470173074|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
130604436|NCT02202031|470173075|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
130604437|NCT01024465|470173083|FG000|Overall Study|Adverse Event|2|||
130604438|NCT01024465|470173083|FG000|Overall Study|Physician Decision|1|||
130604439|NCT03078608|470173084|FG000|Overall Study|Death|1|||
130604440|NCT03078608|470173085|FG001|Overall Study|Death|2|||
130604441|NCT03078608|470173086|FG002|Overall Study|Death|0|||
130604442|NCT03078608|470173087|FG003|Overall Study|Death|0|||
130604443|NCT03078608|470173084|FG000|Overall Study|Withdrawal by Subject|8|||
130604444|NCT03078608|470173085|FG001|Overall Study|Withdrawal by Subject|1|||
130604445|NCT03078608|470173086|FG002|Overall Study|Withdrawal by Subject|0|||
130604446|NCT03078608|470173087|FG003|Overall Study|Withdrawal by Subject|0|||
130604447|NCT03078608|470173084|FG000|Overall Study|Lost to Follow-up|5|||
130604448|NCT03078608|470173085|FG001|Overall Study|Lost to Follow-up|8|||
130604449|NCT03078608|470173086|FG002|Overall Study|Lost to Follow-up|4|||
130604450|NCT03078608|470173087|FG003|Overall Study|Lost to Follow-up|1|||
130604451|NCT00723840|470173088|FG000|Overall Study|Lost to Follow-up|2|||
130604452|NCT00723840|470173088|FG000|Overall Study|Failure to return|18|||
130604453|NCT00723840|470173088|FG000|Overall Study|Withdrawal by Subject|55|||
130604454|NCT00723840|470173088|FG000|Overall Study|Serious Adverse Events|3|||
130604455|NCT00723840|470173088|FG000|Overall Study|Other Medical Event|2|||
130604456|NCT00723840|470173088|FG000|Overall Study|Unspecified reason|2|||
130604457|NCT02853331|470173094|FG000|Overall Study|Death|59|||
130604458|NCT02853331|470173095|FG001|Overall Study|Death|95|||
130604459|NCT02853331|470173094|FG000|Overall Study|Withdrawal by Subject|5|||
130604460|NCT02853331|470173095|FG001|Overall Study|Withdrawal by Subject|9|||
130604461|NCT02853331|470173094|FG000|Overall Study|Ongoing in study|368|||
130604462|NCT02853331|470173095|FG001|Overall Study|Ongoing in study|325|||
130604463|NCT02086565|470173101|FG000|Overall Study|Lost to Follow-up|9|||
130604464|NCT02086565|470173102|FG001|Overall Study|Lost to Follow-up|7|||
130604465|NCT02086565|470173101|FG000|Overall Study|Withdrawal by Subject|2|||
130604466|NCT02086565|470173102|FG001|Overall Study|Withdrawal by Subject|1|||
130604467|NCT02086565|470173101|FG000|Overall Study|Death|3|||
130604468|NCT02086565|470173102|FG001|Overall Study|Death|2|||
130604469|NCT02086565|470173101|FG000|Overall Study|withdrawn by research team|2|||
130604470|NCT02086565|470173102|FG001|Overall Study|withdrawn by research team|2|||
130604471|NCT02116972|470173105|FG000|Overall Study|Adverse Event|4|||
130604472|NCT02116972|470173106|FG001|Overall Study|Adverse Event|4|||
130604473|NCT02116972|470173107|FG002|Overall Study|Adverse Event|1|||
130604474|NCT02116972|470173105|FG000|Overall Study|Withdrawal by Subject|1|||
130604475|NCT02116972|470173106|FG001|Overall Study|Withdrawal by Subject|1|||
130604476|NCT02116972|470173107|FG002|Overall Study|Withdrawal by Subject|5|||
130604477|NCT02116972|470173105|FG000|Overall Study|Protocol Violation|1|||
130604478|NCT02116972|470173106|FG001|Overall Study|Protocol Violation|0|||
130604479|NCT02116972|470173107|FG002|Overall Study|Protocol Violation|1|||
130604480|NCT02116972|470173105|FG000|Overall Study|Lost to Follow-up|4|||
130604481|NCT02116972|470173106|FG001|Overall Study|Lost to Follow-up|3|||
130604482|NCT02116972|470173107|FG002|Overall Study|Lost to Follow-up|1|||
130604483|NCT02116972|470173105|FG000|Overall Study|Lack of Efficacy|6|||
130604484|NCT02116972|470173106|FG001|Overall Study|Lack of Efficacy|6|||
130604485|NCT02116972|470173107|FG002|Overall Study|Lack of Efficacy|5|||
130604486|NCT02116972|470173105|FG000|Overall Study|scheduling conflicts and relocation|3|||
130604487|NCT02116972|470173106|FG001|Overall Study|scheduling conflicts and relocation|3|||
130604488|NCT02116972|470173107|FG002|Overall Study|scheduling conflicts and relocation|6|||
130604489|NCT00784784|470173108|FG000|Overall Study|Withdrawal by Subject|2|||
130604490|NCT00784784|470173109|FG001|Overall Study|Withdrawal by Subject|2|||
130604491|NCT01400971|470173110|FG000|Overall Study|Death|82|||
130604492|NCT01400971|470173110|FG000|Overall Study|Lost to Follow-up|196|||
130604493|NCT01400971|470173110|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
130604494|NCT01400971|470173110|FG000|Overall Study|Physician Decision|57|||
130604495|NCT01400971|470173110|FG000|Overall Study|Withdrawal by Subject|158|||
130604496|NCT01400971|470173110|FG000|Overall Study|Other|422|||
130604497|NCT03290300|470173113|FG000|Overall Study|Lost to Follow-up|3|||
130604498|NCT00487279|470173117|FG000|Overall Study|Death|1|||
130604499|NCT00487279|470173118|FG001|Overall Study|Death|0|||
130604500|NCT00487279|470173117|FG000|Overall Study|Withdrawal by Subject|0|||
130604501|NCT00487279|470173118|FG001|Overall Study|Withdrawal by Subject|2|||
130604502|NCT01618656|470173120|FG000|Overall Study|Withdrawal by Subject|7|||
130604503|NCT01618656|470173121|FG001|Overall Study|Withdrawal by Subject|3|||
130604504|NCT01618656|470173120|FG000|Overall Study|Physician Decision|1|||
130604505|NCT01618656|470173121|FG001|Overall Study|Physician Decision|1|||
130604506|NCT01899144|470173122|FG000|Treatment Period 2|Other|1|||
130604507|NCT01899144|470173122|FG000|Treatment Period 3|Other|2|||
130604508|NCT01899144|470173122|FG000|Treatment Period 5|Other|1|||
130604509|NCT00751881|470173123|FG000|Core Treatment Period|Not treated|1|||
130604510|NCT00751881|470173124|FG001|Core Treatment Period|Not treated|1|||
130604511|NCT00751881|470173125|FG002|Core Treatment Period|Not treated|2|||
130604512|NCT00751881|470173123|FG000|Core Treatment Period|Adverse Event|26|||
130604513|NCT00751881|470173124|FG001|Core Treatment Period|Adverse Event|54|||
130604514|NCT00751881|470173125|FG002|Core Treatment Period|Adverse Event|58|||
130604515|NCT00751881|470173123|FG000|Core Treatment Period|Lack of Efficacy|37|||
130604516|NCT00751881|470173124|FG001|Core Treatment Period|Lack of Efficacy|30|||
130604517|NCT00751881|470173125|FG002|Core Treatment Period|Lack of Efficacy|20|||
130604518|NCT00751881|470173123|FG000|Core Treatment Period|Poor compliance to protocol|15|||
130604519|NCT00751881|470173124|FG001|Core Treatment Period|Poor compliance to protocol|3|||
130604520|NCT00751881|470173125|FG002|Core Treatment Period|Poor compliance to protocol|4|||
130604521|NCT00751881|470173123|FG000|Core Treatment Period|Lost to Follow-up|6|||
130604522|NCT00751881|470173124|FG001|Core Treatment Period|Lost to Follow-up|4|||
130604523|NCT00751881|470173125|FG002|Core Treatment Period|Lost to Follow-up|3|||
130604524|NCT00751881|470173123|FG000|Core Treatment Period|Other: protocol deviation|3|||
130604525|NCT00751881|470173124|FG001|Core Treatment Period|Other: protocol deviation|3|||
130604526|NCT00751881|470173125|FG002|Core Treatment Period|Other: protocol deviation|7|||
130604527|NCT00751881|470173123|FG000|Core Treatment Period|Other: wish to parent|5|||
130604528|NCT00751881|470173124|FG001|Core Treatment Period|Other: wish to parent|7|||
130604529|NCT00751881|470173125|FG002|Core Treatment Period|Other: wish to parent|4|||
130604530|NCT00751881|470173123|FG000|Core Treatment Period|Other: personal/family constraints|6|||
130604531|NCT00751881|470173124|FG001|Core Treatment Period|Other: personal/family constraints|7|||
130604532|NCT00751881|470173125|FG002|Core Treatment Period|Other: personal/family constraints|10|||
130604533|NCT00751881|470173123|FG000|Core Treatment Period|Other: MS treatment change|6|||
130604534|NCT00751881|470173124|FG001|Core Treatment Period|Other: MS treatment change|4|||
130604535|NCT00751881|470173125|FG002|Core Treatment Period|Other: MS treatment change|4|||
130604536|NCT00751881|470173123|FG000|Core Treatment Period|Other: tolerability complaints|2|||
130604537|NCT00751881|470173124|FG001|Core Treatment Period|Other: tolerability complaints|0|||
130604538|NCT00751881|470173125|FG002|Core Treatment Period|Other: tolerability complaints|0|||
130604539|NCT00751881|470173123|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
130604540|NCT00751881|470173124|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
130604541|NCT00751881|470173125|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
130604542|NCT00751881|470173123|FG000|Extension Study Period|Adverse Event|18|||
130604543|NCT00751881|470173124|FG001|Extension Study Period|Adverse Event|20|||
130604544|NCT00751881|470173125|FG002|Extension Study Period|Adverse Event|21|||
130604545|NCT00751881|470173123|FG000|Extension Study Period|Lack of Efficacy|14|||
130604546|NCT00751881|470173124|FG001|Extension Study Period|Lack of Efficacy|10|||
130604547|NCT00751881|470173125|FG002|Extension Study Period|Lack of Efficacy|20|||
130604548|NCT00751881|470173123|FG000|Extension Study Period|Lost to Follow-up|4|||
130604549|NCT00751881|470173124|FG001|Extension Study Period|Lost to Follow-up|9|||
130604550|NCT00751881|470173125|FG002|Extension Study Period|Lost to Follow-up|6|||
130604551|NCT00751881|470173123|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
130604552|NCT00751881|470173124|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
130604553|NCT00751881|470173125|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
130604554|NCT00751881|470173123|FG000|Extension Study Period|Other than specified above|26|||
130604555|NCT00751881|470173124|FG001|Extension Study Period|Other than specified above|30|||
130604556|NCT00751881|470173125|FG002|Extension Study Period|Other than specified above|18|||
130604557|NCT03117049|470173133|FG000|Overall Study|Continued the follow-up period|109|||
130604558|NCT03117049|470173134|FG001|Overall Study|Continued the follow-up period|129|||
130604559|NCT03117049|470173133|FG000|Overall Study|Died|82|||
130604560|NCT03117049|470173134|FG001|Overall Study|Died|93|||
130604561|NCT03117049|470173133|FG000|Overall Study|Consent withdrawal|7|||
130604562|NCT03117049|470173134|FG001|Overall Study|Consent withdrawal|6|||
130604563|NCT03117049|470173133|FG000|Overall Study|Missing contact|3|||
130604564|NCT03117049|470173134|FG001|Overall Study|Missing contact|3|||
130604565|NCT00651118|470173135|FG000|Overall Study|Adverse Event|4|||
130604566|NCT00651118|470173136|FG001|Overall Study|Adverse Event|0|||
130604567|NCT00651118|470173137|FG002|Overall Study|Adverse Event|1|||
130604568|NCT00651118|470173138|FG003|Overall Study|Adverse Event|1|||
130604569|NCT00651118|470173135|FG000|Overall Study|Protocol Violation|2|||
130604570|NCT00651118|470173136|FG001|Overall Study|Protocol Violation|2|||
130604571|NCT00651118|470173137|FG002|Overall Study|Protocol Violation|6|||
130604572|NCT00651118|470173138|FG003|Overall Study|Protocol Violation|2|||
130604573|NCT00651118|470173135|FG000|Overall Study|Lost to Follow-up|2|||
130604574|NCT00651118|470173136|FG001|Overall Study|Lost to Follow-up|0|||
130604575|NCT00651118|470173137|FG002|Overall Study|Lost to Follow-up|1|||
130604576|NCT00651118|470173138|FG003|Overall Study|Lost to Follow-up|2|||
130604577|NCT00651118|470173135|FG000|Overall Study|administrative|1|||
130604578|NCT00651118|470173136|FG001|Overall Study|administrative|4|||
130604579|NCT00651118|470173137|FG002|Overall Study|administrative|2|||
130604580|NCT00651118|470173138|FG003|Overall Study|administrative|1|||
130604581|NCT00651118|470173135|FG000|Overall Study|Withdrawal by Subject|0|||
130604582|NCT00651118|470173136|FG001|Overall Study|Withdrawal by Subject|1|||
130604583|NCT00651118|470173137|FG002|Overall Study|Withdrawal by Subject|1|||
130604584|NCT00651118|470173138|FG003|Overall Study|Withdrawal by Subject|1|||
130604585|NCT00839098|470173139|FG000|Overall Study|Withdrawal by Subject|2|||
130604586|NCT00839098|470173140|FG001|Overall Study|Withdrawal by Subject|1|||
130604587|NCT00839098|470173141|FG002|Overall Study|Withdrawal by Subject|7|||
130604588|NCT00365976|470173144|FG000|Overall Study|Withdrawal by Subject|1|||
130604589|NCT00365976|470173145|FG001|Overall Study|Withdrawal by Subject|5|||
130604590|NCT00408421|470175050|FG000|Treatment Initial Randomization|Adverse Event|5|||
130604591|NCT00408421|470175051|FG001|Treatment Initial Randomization|Adverse Event|9|||
130604592|NCT00408421|470175052|FG002|Treatment Initial Randomization|Adverse Event|0|||
130604593|NCT00408421|470175050|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
130604594|NCT00408421|470175051|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
130604595|NCT00408421|470175052|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
130604596|NCT00408421|470175050|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
130604597|NCT00408421|470175051|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
130604598|NCT00408421|470175052|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
130604599|NCT00408421|470175050|FG000|Treatment Initial Randomization|Physician Decision|1|||
130604600|NCT00408421|470175051|FG001|Treatment Initial Randomization|Physician Decision|0|||
130604601|NCT00408421|470175052|FG002|Treatment Initial Randomization|Physician Decision|0|||
130604602|NCT00408421|470175050|FG000|Treatment Initial Randomization|Protocol Violation|0|||
130604603|NCT00408421|470175051|FG001|Treatment Initial Randomization|Protocol Violation|1|||
130604604|NCT00408421|470175052|FG002|Treatment Initial Randomization|Protocol Violation|0|||
130604605|NCT00408421|470175050|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
130604606|NCT00408421|470175051|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
130604607|NCT00408421|470175052|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
130604608|NCT00408421|470175050|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
130604609|NCT00408421|470175051|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
130604610|NCT00408421|470175052|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
130604611|NCT00408421|470175050|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
130604612|NCT00408421|470175051|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
130604613|NCT00408421|470175052|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
130604614|NCT00408421|470175050|FG000|Treatment Re-Randomization|Adverse Event|2|||
130604615|NCT00408421|470175051|FG001|Treatment Re-Randomization|Adverse Event|2|||
130604616|NCT00408421|470175052|FG002|Treatment Re-Randomization|Adverse Event|4|||
130604617|NCT00408421|470175050|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
130604618|NCT00408421|470175051|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
130604619|NCT00408421|470175052|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
130604620|NCT00408421|470175050|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
130604621|NCT00408421|470175051|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
130604622|NCT00408421|470175052|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
130604623|NCT00408421|470175050|FG000|Treatment Re-Randomization|Physician Decision|1|||
130604624|NCT00408421|470175051|FG001|Treatment Re-Randomization|Physician Decision|3|||
130604625|NCT00408421|470175052|FG002|Treatment Re-Randomization|Physician Decision|0|||
130604626|NCT00408421|470175050|FG000|Treatment Re-Randomization|Protocol Violation|1|||
130604627|NCT00408421|470175051|FG001|Treatment Re-Randomization|Protocol Violation|1|||
130604628|NCT00408421|470175052|FG002|Treatment Re-Randomization|Protocol Violation|0|||
130604629|NCT00408421|470175050|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
130604630|NCT00408421|470175051|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
130604631|NCT00408421|470175052|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
130604632|NCT02322892|470175055|FG000|Overall Study|Surgery cancelled|1|||
130604633|NCT02322892|470175056|FG001|Overall Study|Surgery cancelled|2|||
130604634|NCT02322892|470175055|FG000|Overall Study|Met exclusion criteria|0|||
130604635|NCT02322892|470175056|FG001|Overall Study|Met exclusion criteria|1|||
130604636|NCT02322892|470175055|FG000|Overall Study|Protocol Violation|1|||
130604637|NCT02322892|470175056|FG001|Overall Study|Protocol Violation|0|||
130604638|NCT02125331|470175059|FG000|Overall Study|Protocol Violation|1|||
130604639|NCT02125331|470175060|FG001|Overall Study|Protocol Violation|0|||
130604640|NCT02125331|470175059|FG000|Overall Study|technical problem|2|||
130604641|NCT02125331|470175060|FG001|Overall Study|technical problem|0|||
130604642|NCT02125331|470175059|FG000|Overall Study|screen failure|2|||
130604643|NCT02125331|470175060|FG001|Overall Study|screen failure|0|||
130604644|NCT03009539|470175061|FG000|Overall Study|Lost to Follow-up|132|||
130604645|NCT03009539|470175062|FG001|Overall Study|Lost to Follow-up|113|||
130604646|NCT03009539|470175063|FG002|Overall Study|Lost to Follow-up|132|||
130604647|NCT03009539|470175064|FG003|Overall Study|Lost to Follow-up|113|||
130604648|NCT03151148|470175065|FG000|Overall Study|Lost to Follow-up|1|||
130604649|NCT03151148|470175066|FG001|Overall Study|Lost to Follow-up|0|||
130604650|NCT03151148|470175065|FG000|Overall Study|Withdrawal by Subject|1|||
130604651|NCT03151148|470175066|FG001|Overall Study|Withdrawal by Subject|0|||
130604652|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
130604653|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
130604654|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
130604655|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
130604656|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
130604657|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
130604658|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
130604659|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
130604660|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
130604661|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
130604662|NCT00710034|470175067|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
130604663|NCT00710034|470175068|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
130604664|NCT00710034|470175067|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
130604665|NCT00710034|470175068|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
130604666|NCT00710034|470175067|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
130604667|NCT00710034|470175068|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
130604668|NCT00710034|470175067|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
130604669|NCT00710034|470175068|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
130604670|NCT00710034|470175067|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
130604671|NCT00710034|470175068|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
130604672|NCT00710034|470175067|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
130604673|NCT00710034|470175068|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
130604674|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
130604675|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
130604676|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
130604677|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
130604678|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Death|8|||
130604679|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Death|3|||
130604680|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
130604681|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
130604682|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
130604683|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
130604684|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
130604685|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
130604686|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
130604687|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
130604688|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
130604689|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
130604690|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
130604691|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
130604692|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
130604693|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
130604694|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
130604695|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
130604696|NCT00494871|470175069|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
130604697|NCT00494871|470175070|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
130604698|NCT00494871|470175069|FG000|Follow-up (FU) Period|Adverse Event|1|||
130604699|NCT00494871|470175070|FG001|Follow-up (FU) Period|Adverse Event|1|||
130604700|NCT00494871|470175069|FG000|Follow-up (FU) Period|Death|13|||
130604701|NCT00494871|470175070|FG001|Follow-up (FU) Period|Death|12|||
130604702|NCT00494871|470175069|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
130604703|NCT00494871|470175070|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
130604704|NCT00494871|470175069|FG000|Follow-up (FU) Period|Physician Decision|0|||
130604705|NCT00494871|470175070|FG001|Follow-up (FU) Period|Physician Decision|1|||
130604706|NCT00494871|470175069|FG000|Follow-up (FU) Period|Protocol Violation|1|||
130604707|NCT00494871|470175070|FG001|Follow-up (FU) Period|Protocol Violation|0|||
130604708|NCT00494871|470175069|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
130604709|NCT00494871|470175070|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
130604710|NCT00494871|470175069|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
130604711|NCT00494871|470175070|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
130604712|NCT04543955|470175071|FG000|Overall Study|Company cancelled study|1|||
130604713|NCT04543955|470175072|FG001|Overall Study|Company cancelled study|0|||
130604714|NCT02601001|470175075|FG000|Dosing Period 2|Adverse Event|0|||
130604715|NCT02601001|470175076|FG001|Dosing Period 2|Adverse Event|0|||
130604716|NCT02601001|470175077|FG002|Dosing Period 2|Adverse Event|0|||
130604717|NCT02601001|470175078|FG003|Dosing Period 2|Adverse Event|0|||
130604718|NCT02601001|470175079|FG004|Dosing Period 2|Adverse Event|0|||
130604719|NCT02601001|470175080|FG005|Dosing Period 2|Adverse Event|0|||
130604720|NCT02601001|470175081|FG006|Dosing Period 2|Adverse Event|1|||
130604721|NCT02433210|470175083|FG000|Overall Study|Physician Decision|1|||
130604722|NCT02433210|470175084|FG001|Overall Study|Physician Decision|0|||
130604723|NCT02433210|470175085|FG002|Overall Study|Physician Decision|0|||
130604724|NCT01614769|470175090|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
130604725|NCT01614769|470175091|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
130604726|NCT01614769|470175092|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
130604727|NCT01614769|470175093|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
130604728|NCT01614769|470175094|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
130604729|NCT01614769|470175095|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
130604730|NCT01614769|470175090|FG000|Period 1|Protocol Violation|0|||
130604731|NCT01614769|470175091|FG001|Period 1|Protocol Violation|0|||
130604732|NCT01614769|470175092|FG002|Period 1|Protocol Violation|0|||
130604733|NCT01614769|470175093|FG003|Period 1|Protocol Violation|1|||
130604734|NCT01614769|470175094|FG004|Period 1|Protocol Violation|0|||
130604735|NCT01614769|470175095|FG005|Period 1|Protocol Violation|0|||
130604736|NCT01614769|470175090|FG000|Period 1|Withdrawal by Subject|1|||
130604737|NCT01614769|470175091|FG001|Period 1|Withdrawal by Subject|0|||
130604738|NCT01614769|470175092|FG002|Period 1|Withdrawal by Subject|0|||
130604739|NCT01614769|470175093|FG003|Period 1|Withdrawal by Subject|0|||
130604740|NCT01614769|470175094|FG004|Period 1|Withdrawal by Subject|0|||
130604741|NCT01614769|470175095|FG005|Period 1|Withdrawal by Subject|0|||
130604742|NCT01614769|470175090|FG000|Period 3|Withdrawal by Subject|0|||
130604743|NCT01614769|470175091|FG001|Period 3|Withdrawal by Subject|0|||
130604744|NCT01614769|470175092|FG002|Period 3|Withdrawal by Subject|1|||
130604745|NCT01614769|470175093|FG003|Period 3|Withdrawal by Subject|0|||
130604746|NCT01614769|470175094|FG004|Period 3|Withdrawal by Subject|0|||
130604747|NCT01614769|470175095|FG005|Period 3|Withdrawal by Subject|0|||
130604748|NCT03123354|470175098|FG000|Overall Study|Physician Decision|6|||
130604749|NCT01958671|470175099|FG000|Overall Study|Adverse Event|1|||
130604750|NCT01958671|470175100|FG001|Overall Study|Adverse Event|1|||
130604751|NCT01958671|470175101|FG002|Overall Study|Adverse Event|5|||
130604752|NCT01958671|470175099|FG000|Overall Study|Death|1|||
130604753|NCT01958671|470175100|FG001|Overall Study|Death|0|||
130604754|NCT01958671|470175101|FG002|Overall Study|Death|0|||
130604755|NCT01958671|470175099|FG000|Overall Study|Excluded medication|0|||
130604756|NCT01958671|470175100|FG001|Overall Study|Excluded medication|0|||
130604757|NCT01958671|470175101|FG002|Overall Study|Excluded medication|1|||
130604758|NCT01958671|470175099|FG000|Overall Study|Hyperglycemia|0|||
130604759|NCT01958671|470175100|FG001|Overall Study|Hyperglycemia|0|||
130604760|NCT01958671|470175101|FG002|Overall Study|Hyperglycemia|2|||
130604761|NCT01958671|470175099|FG000|Overall Study|Lost to Follow-up|7|||
130604762|NCT01958671|470175100|FG001|Overall Study|Lost to Follow-up|11|||
130604763|NCT01958671|470175101|FG002|Overall Study|Lost to Follow-up|7|||
130604764|NCT01958671|470175099|FG000|Overall Study|Non-compliance with study drug|1|||
130604765|NCT01958671|470175100|FG001|Overall Study|Non-compliance with study drug|1|||
130604766|NCT01958671|470175101|FG002|Overall Study|Non-compliance with study drug|1|||
130604767|NCT01958671|470175099|FG000|Overall Study|Pregnancy|0|||
130604768|NCT01958671|470175100|FG001|Overall Study|Pregnancy|0|||
130604769|NCT01958671|470175101|FG002|Overall Study|Pregnancy|1|||
130604770|NCT01958671|470175099|FG000|Overall Study|Protocol Violation|0|||
130604771|NCT01958671|470175100|FG001|Overall Study|Protocol Violation|1|||
130604772|NCT01958671|470175101|FG002|Overall Study|Protocol Violation|0|||
130604773|NCT01958671|470175099|FG000|Overall Study|Study site terminated by sponsor|1|||
130604774|NCT01958671|470175100|FG001|Overall Study|Study site terminated by sponsor|0|||
130604775|NCT01958671|470175101|FG002|Overall Study|Study site terminated by sponsor|1|||
130604776|NCT01958671|470175099|FG000|Overall Study|Participant moved|0|||
130604777|NCT01958671|470175100|FG001|Overall Study|Participant moved|0|||
130604778|NCT01958671|470175101|FG002|Overall Study|Participant moved|1|||
130604779|NCT01958671|470175099|FG000|Overall Study|Withdrawal by Subject|8|||
130604780|NCT01958671|470175100|FG001|Overall Study|Withdrawal by Subject|10|||
130604781|NCT01958671|470175101|FG002|Overall Study|Withdrawal by Subject|13|||
130604782|NCT04760314|470175102|FG000|Induction Period|Withdrawal by Subject|0|||
130604783|NCT04760314|470175103|FG001|Induction Period|Withdrawal by Subject|1|||
130604784|NCT04760314|470175104|FG002|Induction Period|Withdrawal by Subject|1|||
130604785|NCT04760314|470175105|FG003|Induction Period|Withdrawal by Subject|0|||
130604786|NCT04760314|470175106|FG004|Induction Period|Withdrawal by Subject|0|||
130604787|NCT04760314|470175107|FG005|Induction Period|Withdrawal by Subject|0|||
130604788|NCT04760314|470175108|FG006|Induction Period|Withdrawal by Subject|0|||
130604789|NCT04760314|470175109|FG007|Induction Period|Withdrawal by Subject|0|||
130604790|NCT04760314|470175110|FG008|Induction Period|Withdrawal by Subject|0|||
130604791|NCT04760314|470175111|FG009|Induction Period|Withdrawal by Subject|0|||
130604792|NCT04760314|470175112|FG010|Induction Period|Withdrawal by Subject|0|||
130604793|NCT04760314|470175102|FG000|Induction Period|Adverse Event|0|||
130604794|NCT04760314|470175103|FG001|Induction Period|Adverse Event|0|||
130604795|NCT04760314|470175104|FG002|Induction Period|Adverse Event|2|||
130604796|NCT04760314|470175105|FG003|Induction Period|Adverse Event|0|||
130604797|NCT04760314|470175106|FG004|Induction Period|Adverse Event|0|||
130604798|NCT04760314|470175107|FG005|Induction Period|Adverse Event|0|||
130604799|NCT04760314|470175108|FG006|Induction Period|Adverse Event|0|||
130604800|NCT04760314|470175109|FG007|Induction Period|Adverse Event|0|||
130604801|NCT04760314|470175110|FG008|Induction Period|Adverse Event|0|||
130604802|NCT04760314|470175111|FG009|Induction Period|Adverse Event|0|||
130604803|NCT04760314|470175112|FG010|Induction Period|Adverse Event|0|||
130604804|NCT04760314|470175102|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604805|NCT04760314|470175103|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604806|NCT04760314|470175104|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604807|NCT04760314|470175105|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
130604808|NCT04760314|470175106|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
130604809|NCT04760314|470175107|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
130604810|NCT04760314|470175108|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
130604811|NCT04760314|470175109|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604812|NCT04760314|470175110|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604813|NCT04760314|470175111|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604814|NCT04760314|470175112|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
130604815|NCT04760314|470175102|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604816|NCT04760314|470175103|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604817|NCT04760314|470175104|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604818|NCT04760314|470175105|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
130604819|NCT04760314|470175106|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604820|NCT04760314|470175107|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
130604821|NCT04760314|470175108|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
130604822|NCT04760314|470175109|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604823|NCT04760314|470175110|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604824|NCT04760314|470175111|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604825|NCT04760314|470175112|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130604826|NCT04760314|470175102|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604827|NCT04760314|470175103|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604828|NCT04760314|470175104|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604829|NCT04760314|470175105|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604830|NCT04760314|470175106|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
130604831|NCT04760314|470175107|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604832|NCT04760314|470175108|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604833|NCT04760314|470175109|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604834|NCT04760314|470175110|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604835|NCT04760314|470175111|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604836|NCT04760314|470175112|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130604837|NCT04760314|470175102|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
130604838|NCT04760314|470175103|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
130604839|NCT04760314|470175104|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
130604840|NCT04760314|470175105|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
130604841|NCT04760314|470175106|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
130604842|NCT04760314|470175107|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
130604843|NCT04760314|470175108|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
130604844|NCT04760314|470175109|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
130604845|NCT04760314|470175110|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
130604846|NCT04760314|470175111|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
130604847|NCT04760314|470175112|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
130604848|NCT04760314|470175102|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604849|NCT04760314|470175103|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604850|NCT04760314|470175104|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604851|NCT04760314|470175105|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604852|NCT04760314|470175106|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604853|NCT04760314|470175107|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604854|NCT04760314|470175108|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604855|NCT04760314|470175109|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130604856|NCT04760314|470175110|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130604857|NCT04760314|470175111|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130604858|NCT04760314|470175112|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130604859|NCT04760314|470175102|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604860|NCT04760314|470175103|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604861|NCT04760314|470175104|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604862|NCT04760314|470175105|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604863|NCT04760314|470175106|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604864|NCT04760314|470175107|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604865|NCT04760314|470175108|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604866|NCT04760314|470175109|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
130604867|NCT04760314|470175110|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
130604868|NCT04760314|470175111|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
130604869|NCT04760314|470175112|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130604870|NCT04760314|470175102|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604871|NCT04760314|470175103|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604872|NCT04760314|470175104|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604873|NCT04760314|470175105|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604874|NCT04760314|470175106|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604875|NCT04760314|470175107|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604876|NCT04760314|470175108|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604877|NCT04760314|470175109|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
130604878|NCT04760314|470175110|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604879|NCT04760314|470175111|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604880|NCT04760314|470175112|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130604881|NCT04760314|470175102|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604882|NCT04760314|470175103|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604883|NCT04760314|470175104|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604884|NCT04760314|470175105|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604885|NCT04760314|470175106|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604886|NCT04760314|470175107|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604887|NCT04760314|470175108|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604888|NCT04760314|470175109|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604889|NCT04760314|470175110|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
130604890|NCT04760314|470175111|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
130604891|NCT04760314|470175112|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130604892|NCT00960440|470175114|FG000|Overall Study|Death|0|||
130604893|NCT00960440|470175115|FG001|Overall Study|Death|0|||
130604894|NCT00960440|470175116|FG002|Overall Study|Death|0|||
130604895|NCT00960440|470175117|FG003|Overall Study|Death|1|||
130604896|NCT00960440|470175114|FG000|Overall Study|Adverse Event|12|||
130604897|NCT00960440|470175115|FG001|Overall Study|Adverse Event|12|||
130604898|NCT00960440|470175116|FG002|Overall Study|Adverse Event|4|||
130604899|NCT00960440|470175117|FG003|Overall Study|Adverse Event|4|||
130604900|NCT00960440|470175114|FG000|Overall Study|Lack of Efficacy|2|||
130604901|NCT00960440|470175115|FG001|Overall Study|Lack of Efficacy|5|||
130604902|NCT00960440|470175116|FG002|Overall Study|Lack of Efficacy|3|||
130604903|NCT00960440|470175117|FG003|Overall Study|Lack of Efficacy|8|||
130604904|NCT00960440|470175114|FG000|Overall Study|Protocol Violation|2|||
130604905|NCT00960440|470175115|FG001|Overall Study|Protocol Violation|8|||
130604906|NCT00960440|470175116|FG002|Overall Study|Protocol Violation|3|||
130604907|NCT00960440|470175117|FG003|Overall Study|Protocol Violation|4|||
130604908|NCT00960440|470175114|FG000|Overall Study|Withdrawal by Subject|9|||
130604909|NCT00960440|470175115|FG001|Overall Study|Withdrawal by Subject|5|||
130604910|NCT00960440|470175116|FG002|Overall Study|Withdrawal by Subject|2|||
130604911|NCT00960440|470175117|FG003|Overall Study|Withdrawal by Subject|1|||
130604912|NCT00960440|470175114|FG000|Overall Study|Other|1|||
130604913|NCT00960440|470175115|FG001|Overall Study|Other|1|||
130604914|NCT00960440|470175116|FG002|Overall Study|Other|1|||
130604915|NCT00960440|470175117|FG003|Overall Study|Other|0|||
130604916|NCT02421120|470175118|FG000|Overall Study|Adverse Event|1|||
130604917|NCT02207530|470175119|FG000|Overall Study|Worsening condition under investigation|78|||
130604918|NCT02207530|470175119|FG000|Overall Study|Patient decision to stop study treatment|5|||
130604919|NCT02207530|470175119|FG000|Overall Study|Adverse Event|8|||
130604920|NCT02345161|470175120|FG000|Overall Study|Withdrawal by Subject|25|||
130604921|NCT02345161|470175121|FG001|Overall Study|Withdrawal by Subject|33|||
130604922|NCT02345161|470175120|FG000|Overall Study|Adverse Event|16|||
130604923|NCT02345161|470175121|FG001|Overall Study|Adverse Event|19|||
130604924|NCT02345161|470175120|FG000|Overall Study|Physician Decision|4|||
130604925|NCT02345161|470175121|FG001|Overall Study|Physician Decision|4|||
130604926|NCT02345161|470175120|FG000|Overall Study|Lost to Follow-up|0|||
130604927|NCT02345161|470175121|FG001|Overall Study|Lost to Follow-up|1|||
130604928|NCT00305006|470175131|FG000|Overall Study|Withdrawal by Subject|1|||
130604929|NCT00305006|470175132|FG001|Overall Study|Withdrawal by Subject|0|||
130604930|NCT00305006|470175131|FG000|Overall Study|Failure to complete pretest|0|||
130604931|NCT00305006|470175132|FG001|Overall Study|Failure to complete pretest|1|||
130604932|NCT02606045|470175133|FG000|Overall Study|Study closed before treament could begin|1|||
130604933|NCT02606045|470175134|FG001|Overall Study|Study closed before treament could begin|2|||
130604934|NCT00907881|470175135|FG000|Overall Study|Lost to Follow-up|59|||
130604935|NCT00907881|470175135|FG000|Overall Study|Noncompliance|5|||
130604936|NCT00907881|470175135|FG000|Overall Study|Withdrawal by Subject|5|||
130604937|NCT00907881|470175135|FG000|Overall Study|Protocol Violation|1|||
130604938|NCT00907881|470175135|FG000|Overall Study|Missing discontinuation information|15|||
130604939|NCT01996319|470175138|FG000|Overall Study|Protocol Violation|1|||
130604940|NCT01996319|470175139|FG001|Overall Study|Protocol Violation|0|||
130604941|NCT01996319|470175138|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
130604942|NCT01996319|470175139|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
130604943|NCT01996319|470175138|FG000|Overall Study|Adverse Event|2|||
130604944|NCT01996319|470175139|FG001|Overall Study|Adverse Event|2|||
130604945|NCT01671085|470175140|FG000|Overall Study|Withdrawal by Subject|1|||
130604946|NCT01671085|470175141|FG001|Overall Study|Withdrawal by Subject|0|||
130604947|NCT00637273|470175142|FG000|Overall Study|Adverse Event|11|||
130604948|NCT00637273|470175143|FG001|Overall Study|Adverse Event|5|||
130604949|NCT00637273|470175144|FG002|Overall Study|Adverse Event|7|||
130604950|NCT00637273|470175142|FG000|Overall Study|Lost to Follow-up|8|||
130604951|NCT00637273|470175143|FG001|Overall Study|Lost to Follow-up|9|||
130604952|NCT00637273|470175144|FG002|Overall Study|Lost to Follow-up|13|||
130604953|NCT00637273|470175142|FG000|Overall Study|Protocol Violation|2|||
130604954|NCT00637273|470175143|FG001|Overall Study|Protocol Violation|4|||
130604955|NCT00637273|470175144|FG002|Overall Study|Protocol Violation|1|||
130604956|NCT00637273|470175142|FG000|Overall Study|Withdrawal of Consent|18|||
130604957|NCT00637273|470175143|FG001|Overall Study|Withdrawal of Consent|6|||
130604958|NCT00637273|470175144|FG002|Overall Study|Withdrawal of Consent|18|||
130604959|NCT00637273|470175142|FG000|Overall Study|Investigator Decision|1|||
130604960|NCT00637273|470175143|FG001|Overall Study|Investigator Decision|3|||
130604961|NCT00637273|470175144|FG002|Overall Study|Investigator Decision|1|||
130604962|NCT00637273|470175142|FG000|Overall Study|Administrative|2|||
130604963|NCT00637273|470175143|FG001|Overall Study|Administrative|0|||
130604964|NCT00637273|470175144|FG002|Overall Study|Administrative|0|||
130604965|NCT00637273|470175142|FG000|Overall Study|Loss of Glucose Control|1|||
130604966|NCT00637273|470175143|FG001|Overall Study|Loss of Glucose Control|1|||
130604967|NCT00637273|470175144|FG002|Overall Study|Loss of Glucose Control|1|||
130604968|NCT00986258|470175145|FG000|Observation Period|Not eligible to be dosed|11|||
130604969|NCT00986258|470175145|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
130604970|NCT00986258|470175145|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
130604971|NCT00986258|470175145|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
130604972|NCT00986258|470175145|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
130604973|NCT00986258|470175145|FG000|Titration and Optimal Dose Period|Other|1|||
130604974|NCT00986258|470175145|FG000|Maintenance Period|Adverse Event|5|||
130604975|NCT00986258|470175145|FG000|Maintenance Period|Lack of Efficacy|2|||
130604976|NCT00986258|470175145|FG000|Maintenance Period|Withdrawal by Subject|2|||
130604977|NCT02616029|470175147|FG000|Overall Study|Adverse Event|1|||
130604978|NCT02616029|470175148|FG001|Overall Study|Adverse Event|0|||
130604979|NCT02616029|470175147|FG000|Overall Study|Death|0|||
130604980|NCT02616029|470175148|FG001|Overall Study|Death|1|||
130604981|NCT02616029|470175147|FG000|Overall Study|Protocol Violation|1|||
130604982|NCT02616029|470175148|FG001|Overall Study|Protocol Violation|0|||
130604983|NCT02616029|470175147|FG000|Overall Study|Withdrew Consent|1|||
130604984|NCT02616029|470175148|FG001|Overall Study|Withdrew Consent|0|||
130604985|NCT02616029|470175147|FG000|Overall Study|Enrolled and Never Treated|1|||
130604986|NCT02616029|470175148|FG001|Overall Study|Enrolled and Never Treated|1|||
130604987|NCT03964415|470175159|FG000|Overall Study|Sponsor's decision|1563|||
130604988|NCT03964415|470175160|FG001|Overall Study|Sponsor's decision|1528|||
130604989|NCT03964415|470175159|FG000|Overall Study|Lost to Follow-up|139|||
130604990|NCT03964415|470175160|FG001|Overall Study|Lost to Follow-up|146|||
130604991|NCT03964415|470175159|FG000|Overall Study|Withdrawal by Subject|68|||
130604992|NCT03964415|470175160|FG001|Overall Study|Withdrawal by Subject|72|||
130604993|NCT03964415|470175159|FG000|Overall Study|Physician Decision|34|||
130604994|NCT03964415|470175160|FG001|Overall Study|Physician Decision|48|||
130604995|NCT03964415|470175159|FG000|Overall Study|Adverse Event|3|||
130604996|NCT03964415|470175160|FG001|Overall Study|Adverse Event|0|||
130604997|NCT03964415|470175159|FG000|Overall Study|Death|4|||
130604998|NCT03964415|470175160|FG001|Overall Study|Death|6|||
130604999|NCT03964415|470175159|FG000|Overall Study|Protocol Violation|1|||
130605000|NCT03964415|470175160|FG001|Overall Study|Protocol Violation|4|||
130605001|NCT03964415|470175159|FG000|Overall Study|Other|35|||
130605002|NCT03964415|470175160|FG001|Overall Study|Other|38|||
130605003|NCT03964415|470175159|FG000|Overall Study|Randomized but not treated|6|||
130605004|NCT03964415|470175160|FG001|Overall Study|Randomized but not treated|7|||
130605005|NCT01734993|470175161|FG000|Overall Study|Adverse Event|1|||
130605006|NCT01734993|470175161|FG000|Overall Study|Lack of Efficacy|1|||
130605007|NCT04156646|470175165|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
130605008|NCT04156646|470175166|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
130605009|NCT00863928|470175173|FG000|Overall Study|Protocol Violation|26|||
130605010|NCT00863928|470175174|FG001|Overall Study|Protocol Violation|0|||
130605011|NCT00863928|470175173|FG000|Overall Study|Withdrawal by Subject|3|||
130605012|NCT00863928|470175174|FG001|Overall Study|Withdrawal by Subject|0|||
130605013|NCT00863928|470175173|FG000|Overall Study|surgery cancellation|4|||
130605014|NCT00863928|470175174|FG001|Overall Study|surgery cancellation|0|||
130605015|NCT00863928|470175173|FG000|Overall Study|medication allergy|3|||
130605016|NCT00863928|470175174|FG001|Overall Study|medication allergy|0|||
130605017|NCT04172831|470175177|FG000|Overall Study|Adverse Event|21|||
130605018|NCT04172831|470175178|FG001|Overall Study|Adverse Event|9|||
130605019|NCT04172831|470175177|FG000|Overall Study|Lack of Efficacy|2|||
130605020|NCT04172831|470175178|FG001|Overall Study|Lack of Efficacy|8|||
130605021|NCT04172831|470175177|FG000|Overall Study|Physician Decision|0|||
130605022|NCT04172831|470175178|FG001|Overall Study|Physician Decision|1|||
130605023|NCT04172831|470175177|FG000|Overall Study|Withdrawal by Subject|12|||
130605024|NCT04172831|470175178|FG001|Overall Study|Withdrawal by Subject|11|||
130605025|NCT04172831|470175177|FG000|Overall Study|Lost to Follow-up|4|||
130605026|NCT04172831|470175178|FG001|Overall Study|Lost to Follow-up|9|||
130605027|NCT04172831|470175177|FG000|Overall Study|COVID-19 related crisis|3|||
130605028|NCT04172831|470175178|FG001|Overall Study|COVID-19 related crisis|3|||
130605029|NCT04172831|470175177|FG000|Overall Study|Subject non-compliance|1|||
130605030|NCT04172831|470175178|FG001|Overall Study|Subject non-compliance|1|||
130605031|NCT04172831|470175177|FG000|Overall Study|Family emergency|1|||
130605032|NCT04172831|470175178|FG001|Overall Study|Family emergency|0|||
130605033|NCT01041573|470175179|FG000|Overall Study|Withdrawal by Subject|2|||
130605034|NCT01041573|470175180|FG001|Overall Study|Withdrawal by Subject|5|||
130605035|NCT01041573|470175181|FG002|Overall Study|Withdrawal by Subject|2|||
130605036|NCT01041573|470175182|FG003|Overall Study|Withdrawal by Subject|0|||
130605037|NCT01041573|470175179|FG000|Overall Study|Death|1|||
130605038|NCT01041573|470175180|FG001|Overall Study|Death|0|||
130605039|NCT01041573|470175181|FG002|Overall Study|Death|0|||
130605040|NCT01041573|470175182|FG003|Overall Study|Death|0|||
130605041|NCT01041573|470175179|FG000|Overall Study|Lost to Follow-up|0|||
130605042|NCT01041573|470175180|FG001|Overall Study|Lost to Follow-up|1|||
130605043|NCT01041573|470175181|FG002|Overall Study|Lost to Follow-up|2|||
130605044|NCT01041573|470175182|FG003|Overall Study|Lost to Follow-up|1|||
130605045|NCT01041573|470175179|FG000|Overall Study|Adverse Event|0|||
130605046|NCT01041573|470175180|FG001|Overall Study|Adverse Event|2|||
130605047|NCT01041573|470175181|FG002|Overall Study|Adverse Event|0|||
130605048|NCT01041573|470175182|FG003|Overall Study|Adverse Event|0|||
130605049|NCT01041573|470175179|FG000|Overall Study|relocation|1|||
130605050|NCT01041573|470175180|FG001|Overall Study|relocation|4|||
130605051|NCT01041573|470175181|FG002|Overall Study|relocation|3|||
130605052|NCT01041573|470175182|FG003|Overall Study|relocation|1|||
130605053|NCT01041573|470175179|FG000|Overall Study|further blood extraction|0|||
130605054|NCT01041573|470175180|FG001|Overall Study|further blood extraction|1|||
130605055|NCT01041573|470175181|FG002|Overall Study|further blood extraction|0|||
130605056|NCT01041573|470175182|FG003|Overall Study|further blood extraction|0|||
130605057|NCT01041573|470175179|FG000|Overall Study|positive to anti-HCV|1|||
130605058|NCT01041573|470175180|FG001|Overall Study|positive to anti-HCV|0|||
130605059|NCT01041573|470175181|FG002|Overall Study|positive to anti-HCV|0|||
130605060|NCT01041573|470175182|FG003|Overall Study|positive to anti-HCV|0|||
130605061|NCT01276847|470175184|FG000|Overall Study|Withdrawal by Subject|1|||
130605062|NCT01276847|470175185|FG001|Overall Study|Withdrawal by Subject|0|||
130605063|NCT01276847|470175186|FG002|Overall Study|Withdrawal by Subject|0|||
130605064|NCT03321929|470175189|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
130605065|NCT00530712|470175195|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
130605066|NCT00530712|470175195|FG000|30 Day Follow-up Visit|Missed Visit|5|||
130605067|NCT00530712|470175195|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
130605068|NCT00530712|470175195|FG000|6 Month Follow-up Visit|Missed Visit|3|||
130605069|NCT00530712|470175195|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
130605070|NCT00530712|470175195|FG000|6 Month Follow-up Visit|Death|2|||
130605071|NCT00530712|470175195|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
130605072|NCT00530712|470175195|FG000|12 Month Follow-up Visit|Missed Visit|3|||
130605073|NCT00530712|470175195|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
130605074|NCT00530712|470175195|FG000|12 Month Follow-up Visit|Death|9|||
130605075|NCT02399475|470175200|FG000|Overall Study|Physician Decision|1|||
130605076|NCT02399475|470175201|FG001|Overall Study|Physician Decision|0|||
130605077|NCT02260193|470175202|FG000|Overall Study|Lack of Efficacy|0|||
130605078|NCT02260193|470175203|FG001|Overall Study|Lack of Efficacy|1|||
130605079|NCT02260193|470175204|FG002|Overall Study|Lack of Efficacy|6|||
130605080|NCT02260193|470175202|FG000|Overall Study|Adverse Event|3|||
130605081|NCT02260193|470175203|FG001|Overall Study|Adverse Event|4|||
130605082|NCT02260193|470175204|FG002|Overall Study|Adverse Event|1|||
130605083|NCT02260193|470175202|FG000|Overall Study|Protocol Violation|0|||
130605084|NCT02260193|470175203|FG001|Overall Study|Protocol Violation|4|||
130605085|NCT02260193|470175204|FG002|Overall Study|Protocol Violation|0|||
130605086|NCT02260193|470175202|FG000|Overall Study|Withdrawal by Subject|3|||
130605087|NCT02260193|470175203|FG001|Overall Study|Withdrawal by Subject|0|||
130605088|NCT02260193|470175204|FG002|Overall Study|Withdrawal by Subject|2|||
130605089|NCT02260193|470175202|FG000|Overall Study|Kidney Transplantation|0|||
130605090|NCT02260193|470175203|FG001|Overall Study|Kidney Transplantation|0|||
130605091|NCT02260193|470175204|FG002|Overall Study|Kidney Transplantation|1|||
130605092|NCT01963117|470175212|FG000|Overall Study|Death|1|||
130605093|NCT04430582|470175213|FG000|Overall Study|Found to meet exclusionary criteria|1|||
130605094|NCT04430582|470175214|FG001|Overall Study|Found to meet exclusionary criteria|0|||
130605095|NCT04430582|470175213|FG000|Overall Study|Withdrawal by Subject|0|||
130605096|NCT04430582|470175214|FG001|Overall Study|Withdrawal by Subject|1|||
130605097|NCT04267562|470176661|FG000|Assessed for Eligibility|Screen Failure|64|||
130605098|NCT04267562|470176661|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
130605099|NCT04267562|470176661|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
130605100|NCT04267562|470176661|FG000|Assessed for Eligibility|Site closure|6|||
130605101|NCT04267562|470176661|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
130605102|NCT04267562|470176661|FG000|Assessed for Eligibility|Physician Decision|1|||
130605103|NCT04267562|470176661|FG000|Month 24|Elective hysterectomy|1|||
130605104|NCT04267562|470176661|FG000|Month 24|Lost to Follow-up|1|||
130605105|NCT04267562|470176661|FG000|Month 36|Elective hysterectomy|2|||
130605106|NCT04267562|470176661|FG000|Month 36|Lost to Follow-up|3|||
130605107|NCT01850563|470176662|FG000|Overall Study|Not eligible|3|||
130605108|NCT01850563|470176663|FG001|Overall Study|Not eligible|0|||
130605109|NCT04359823|470176664|FG000|Overall Study|Lost to Follow-up|0|||
130605110|NCT04359823|470176665|FG001|Overall Study|Lost to Follow-up|1|||
130605111|NCT04359823|470176664|FG000|Overall Study|Withdrawal by Subject|0|||
130605112|NCT04359823|470176665|FG001|Overall Study|Withdrawal by Subject|1|||
130605113|NCT01989546|470176668|FG000|Overall Study|Clinical Progression|1|||
130605114|NCT01989546|470176668|FG000|Overall Study|Disease progression on study|8|||
130605115|NCT01505491|470176671|FG000|Overall Study|Other reason not listed|1|||
130605116|NCT01505491|470176672|FG001|Overall Study|Other reason not listed|0|||
130605117|NCT01505491|470176673|FG002|Overall Study|Other reason not listed|0|||
130605118|NCT01505491|470176671|FG000|Overall Study|Withdrawal by Subject|1|||
130605119|NCT01505491|470176672|FG001|Overall Study|Withdrawal by Subject|1|||
130605120|NCT01505491|470176673|FG002|Overall Study|Withdrawal by Subject|4|||
130605121|NCT01505491|470176671|FG000|Overall Study|Lost to Follow-up|0|||
130605122|NCT01505491|470176672|FG001|Overall Study|Lost to Follow-up|0|||
130605123|NCT01505491|470176673|FG002|Overall Study|Lost to Follow-up|1|||
130605124|NCT01740440|470176682|FG000|Overall Study|Lost to Follow-up|3|||
130605125|NCT00367640|470176683|FG000|Overall Study|Adverse Event|3|||
130605126|NCT00367640|470176684|FG001|Overall Study|Adverse Event|6|||
130605127|NCT00367640|470176685|FG002|Overall Study|Adverse Event|8|||
130605128|NCT00367640|470176686|FG003|Overall Study|Adverse Event|0|||
130605129|NCT00367640|470176683|FG000|Overall Study|Withdrawal by Subject|8|||
130605130|NCT00367640|470176684|FG001|Overall Study|Withdrawal by Subject|11|||
130605131|NCT00367640|470176685|FG002|Overall Study|Withdrawal by Subject|8|||
130605132|NCT00367640|470176686|FG003|Overall Study|Withdrawal by Subject|6|||
130605133|NCT00367640|470176683|FG000|Overall Study|Any other reason not above-mentioned|7|||
130605134|NCT00367640|470176684|FG001|Overall Study|Any other reason not above-mentioned|5|||
130605135|NCT00367640|470176685|FG002|Overall Study|Any other reason not above-mentioned|3|||
130605136|NCT00367640|470176686|FG003|Overall Study|Any other reason not above-mentioned|4|||
130605137|NCT02214186|470176698|FG000|Overall Study|Lost to Follow-up|1|||
130605138|NCT02214186|470176699|FG001|Overall Study|Lost to Follow-up|1|||
130605139|NCT02214186|470176698|FG000|Overall Study|Protocol Violation|1|||
130605140|NCT02214186|470176699|FG001|Overall Study|Protocol Violation|1|||
130605141|NCT01525849|470176700|FG000|Overall Study|Lost to Follow-up|3|||
130605142|NCT01525849|470176701|FG001|Overall Study|Lost to Follow-up|2|||
130605143|NCT01525849|470176700|FG000|Overall Study|Withdrawal by Subject|1|||
130605144|NCT01525849|470176701|FG001|Overall Study|Withdrawal by Subject|9|||
130605145|NCT01525849|470176700|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
130605146|NCT01525849|470176701|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
130605147|NCT01525849|470176700|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
130605148|NCT01525849|470176701|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
130605149|NCT00339183|470176702|FG000|Overall Study|Adverse Event|5|||
130605150|NCT00339183|470176703|FG001|Overall Study|Adverse Event|3|||
130605151|NCT00339183|470176702|FG000|Overall Study|Withdrawal by Subject|16|||
130605152|NCT00339183|470176703|FG001|Overall Study|Withdrawal by Subject|19|||
130605153|NCT00339183|470176702|FG000|Overall Study|Physician Decision|2|||
130605154|NCT00339183|470176703|FG001|Overall Study|Physician Decision|4|||
130605155|NCT00339183|470176702|FG000|Overall Study|Lost to Follow-up|17|||
130605156|NCT00339183|470176703|FG001|Overall Study|Lost to Follow-up|17|||
130605157|NCT00339183|470176702|FG000|Overall Study|Protocol-specified criteria|12|||
130605158|NCT00339183|470176703|FG001|Overall Study|Protocol-specified criteria|8|||
130605159|NCT00339183|470176702|FG000|Overall Study|Missing reason|3|||
130605160|NCT00339183|470176703|FG001|Overall Study|Missing reason|1|||
130605161|NCT00339183|470176702|FG000|Overall Study|Other|46|||
130605162|NCT00339183|470176703|FG001|Overall Study|Other|40|||
130605163|NCT00339183|470176702|FG000|Overall Study|Ongoing|20|||
130605164|NCT00339183|470176703|FG001|Overall Study|Ongoing|13|||
130605165|NCT00793819|470176704|FG000|Overall Study|Adverse Event|8|||
130605166|NCT00793819|470176705|FG001|Overall Study|Adverse Event|4|||
130605167|NCT00793819|470176704|FG000|Overall Study|Lack of Efficacy|1|||
130605168|NCT00793819|470176705|FG001|Overall Study|Lack of Efficacy|1|||
130605169|NCT00793819|470176704|FG000|Overall Study|Withdrawal by Subject|4|||
130605170|NCT00793819|470176705|FG001|Overall Study|Withdrawal by Subject|3|||
130605171|NCT00793819|470176704|FG000|Overall Study|Lost to Follow-up|1|||
130605172|NCT00793819|470176705|FG001|Overall Study|Lost to Follow-up|1|||
130605173|NCT00446446|470176706|FG000|Overall Study|Death|10|||
130605174|NCT00446446|470176706|FG000|Overall Study|Withdrawal by Subject|6|||
130605175|NCT00446446|470176706|FG000|Overall Study|Other|4|||
130605176|NCT00446446|470176706|FG000|Overall Study|Disease Progession|2|||
130605177|NCT00446446|470176706|FG000|Overall Study|Adverse Event|1|||
130605178|NCT00446446|470176706|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
130605179|NCT00611130|470176707|FG000|Overall Study|Lost to Follow-up|25|||
130605180|NCT00611130|470176708|FG001|Overall Study|Lost to Follow-up|29|||
130605181|NCT00611130|470176707|FG000|Overall Study|Protocol noncompliance|7|||
130605182|NCT00611130|470176708|FG001|Overall Study|Protocol noncompliance|6|||
130605183|NCT00611130|470176707|FG000|Overall Study|Withdrawal by Subject|6|||
130605184|NCT00611130|470176708|FG001|Overall Study|Withdrawal by Subject|5|||
130605185|NCT00611130|470176707|FG000|Overall Study|Other|5|||
130605186|NCT00611130|470176708|FG001|Overall Study|Other|4|||
130605187|NCT00611130|470176707|FG000|Overall Study|Incarceration|3|||
130605188|NCT00611130|470176708|FG001|Overall Study|Incarceration|2|||
130605189|NCT00611130|470176707|FG000|Overall Study|Administrative|1|||
130605190|NCT00611130|470176708|FG001|Overall Study|Administrative|1|||
130605191|NCT00611130|470176707|FG000|Overall Study|Adverse Event|1|||
130605192|NCT00611130|470176708|FG001|Overall Study|Adverse Event|0|||
130605193|NCT00611130|470176707|FG000|Overall Study|Death|1|||
130605194|NCT00611130|470176708|FG001|Overall Study|Death|0|||
130605195|NCT01455428|470176709|FG000|Overall Study|Protocol Violation|2|||
130605196|NCT01455428|470176710|FG001|Overall Study|Protocol Violation|1|||
130605197|NCT01455428|470176709|FG000|Overall Study|Adverse Event|6|||
130605198|NCT01455428|470176710|FG001|Overall Study|Adverse Event|2|||
130605199|NCT01455428|470176709|FG000|Overall Study|Lost to Follow-up|1|||
130605200|NCT01455428|470176710|FG001|Overall Study|Lost to Follow-up|1|||
130605201|NCT01455428|470176709|FG000|Overall Study|Withdrawal by Subject|2|||
130605202|NCT01455428|470176710|FG001|Overall Study|Withdrawal by Subject|5|||
130605203|NCT01455428|470176709|FG000|Overall Study|Did not meet entrance criteria|0|||
130605204|NCT01455428|470176710|FG001|Overall Study|Did not meet entrance criteria|2|||
130605205|NCT01455428|470176709|FG000|Overall Study|Insufficient clinical response|0|||
130605206|NCT01455428|470176710|FG001|Overall Study|Insufficient clinical response|2|||
130605207|NCT01455428|470176709|FG000|Overall Study|Did not receive treatment|1|||
130605208|NCT01455428|470176710|FG001|Overall Study|Did not receive treatment|1|||
130605209|NCT01455428|470176709|FG000|Overall Study|Other|2|||
130605210|NCT01455428|470176710|FG001|Overall Study|Other|4|||
130605211|NCT03303339|470176711|FG000|Overall Study|Death|2|||
130605212|NCT03303339|470176712|FG001|Overall Study|Death|2|||
130605213|NCT03303339|470176713|FG002|Overall Study|Death|2|||
130605214|NCT03303339|470176714|FG003|Overall Study|Death|1|||
130605215|NCT03303339|470176715|FG004|Overall Study|Death|4|||
130605216|NCT03303339|470176716|FG005|Overall Study|Death|2|||
130605217|NCT03303339|470176717|FG006|Overall Study|Death|2|||
130605218|NCT03303339|470176718|FG007|Overall Study|Death|2|||
130605219|NCT03303339|470176719|FG008|Overall Study|Death|3|||
130605220|NCT03303339|470176720|FG009|Overall Study|Death|3|||
130605221|NCT03303339|470176721|FG010|Overall Study|Death|4|||
130605222|NCT03303339|470176722|FG011|Overall Study|Death|24|||
130605223|NCT03303339|470176711|FG000|Overall Study|Study Terminated by Sponsor|0|||
130605224|NCT03303339|470176712|FG001|Overall Study|Study Terminated by Sponsor|0|||
130605225|NCT03303339|470176713|FG002|Overall Study|Study Terminated by Sponsor|0|||
130605226|NCT03303339|470176714|FG003|Overall Study|Study Terminated by Sponsor|0|||
130605227|NCT03303339|470176715|FG004|Overall Study|Study Terminated by Sponsor|0|||
130605228|NCT03303339|470176716|FG005|Overall Study|Study Terminated by Sponsor|0|||
130605229|NCT03303339|470176717|FG006|Overall Study|Study Terminated by Sponsor|0|||
130605230|NCT03303339|470176718|FG007|Overall Study|Study Terminated by Sponsor|0|||
130605231|NCT03303339|470176719|FG008|Overall Study|Study Terminated by Sponsor|1|||
130605232|NCT03303339|470176720|FG009|Overall Study|Study Terminated by Sponsor|0|||
130605233|NCT03303339|470176721|FG010|Overall Study|Study Terminated by Sponsor|1|||
130605234|NCT03303339|470176722|FG011|Overall Study|Study Terminated by Sponsor|1|||
130605235|NCT03303339|470176711|FG000|Overall Study|Withdrawal by Subject|1|||
130605236|NCT03303339|470176712|FG001|Overall Study|Withdrawal by Subject|0|||
130605237|NCT03303339|470176713|FG002|Overall Study|Withdrawal by Subject|0|||
130605238|NCT03303339|470176714|FG003|Overall Study|Withdrawal by Subject|0|||
130605239|NCT03303339|470176715|FG004|Overall Study|Withdrawal by Subject|0|||
130605240|NCT03303339|470176716|FG005|Overall Study|Withdrawal by Subject|1|||
130605241|NCT03303339|470176717|FG006|Overall Study|Withdrawal by Subject|1|||
130605242|NCT03303339|470176718|FG007|Overall Study|Withdrawal by Subject|0|||
130605243|NCT03303339|470176719|FG008|Overall Study|Withdrawal by Subject|0|||
130605244|NCT03303339|470176720|FG009|Overall Study|Withdrawal by Subject|0|||
130605245|NCT03303339|470176721|FG010|Overall Study|Withdrawal by Subject|0|||
130605246|NCT03303339|470176722|FG011|Overall Study|Withdrawal by Subject|2|||
130605247|NCT03303339|470176711|FG000|Overall Study|Physician Decision|0|||
130605248|NCT03303339|470176712|FG001|Overall Study|Physician Decision|0|||
130605249|NCT03303339|470176713|FG002|Overall Study|Physician Decision|0|||
130605250|NCT03303339|470176714|FG003|Overall Study|Physician Decision|0|||
130605251|NCT03303339|470176715|FG004|Overall Study|Physician Decision|1|||
130605252|NCT03303339|470176716|FG005|Overall Study|Physician Decision|0|||
130605253|NCT03303339|470176717|FG006|Overall Study|Physician Decision|0|||
130605254|NCT03303339|470176718|FG007|Overall Study|Physician Decision|0|||
130605255|NCT03303339|470176719|FG008|Overall Study|Physician Decision|0|||
130605256|NCT03303339|470176720|FG009|Overall Study|Physician Decision|0|||
130605257|NCT03303339|470176721|FG010|Overall Study|Physician Decision|0|||
130605258|NCT03303339|470176722|FG011|Overall Study|Physician Decision|0|||
130605259|NCT03303339|470176711|FG000|Overall Study|Safety/Non-compliance|0|||
130605260|NCT03303339|470176712|FG001|Overall Study|Safety/Non-compliance|0|||
130605261|NCT03303339|470176713|FG002|Overall Study|Safety/Non-compliance|0|||
130605262|NCT03303339|470176714|FG003|Overall Study|Safety/Non-compliance|0|||
130605263|NCT03303339|470176715|FG004|Overall Study|Safety/Non-compliance|0|||
130605264|NCT03303339|470176716|FG005|Overall Study|Safety/Non-compliance|0|||
130605265|NCT03303339|470176717|FG006|Overall Study|Safety/Non-compliance|0|||
130605266|NCT03303339|470176718|FG007|Overall Study|Safety/Non-compliance|0|||
130605267|NCT03303339|470176719|FG008|Overall Study|Safety/Non-compliance|0|||
130605268|NCT03303339|470176720|FG009|Overall Study|Safety/Non-compliance|0|||
130605269|NCT03303339|470176721|FG010|Overall Study|Safety/Non-compliance|0|||
130605270|NCT03303339|470176722|FG011|Overall Study|Safety/Non-compliance|1|||
130605271|NCT02062151|470176723|FG000|Overall Study|screen failure|1|||
130605272|NCT00751101|470176726|FG000|Overall Study|Withdrawal by Subject|1|||
130605273|NCT00751101|470176727|FG001|Overall Study|Withdrawal by Subject|0|||
130605274|NCT00751101|470176726|FG000|Overall Study|No HFS / Never Started Patch/|0|||
130605275|NCT00751101|470176727|FG001|Overall Study|No HFS / Never Started Patch/|4|||
130605276|NCT00751101|470176726|FG000|Overall Study|Never began capecitabine|1|||
130605277|NCT00751101|470176727|FG001|Overall Study|Never began capecitabine|0|||
130605278|NCT00751101|470176726|FG000|Overall Study|Physician Decision|0|||
130605279|NCT00751101|470176727|FG001|Overall Study|Physician Decision|1|||
130605280|NCT01905397|470176730|FG000|Overall Study|Death|0|||
130605281|NCT01905397|470176731|FG001|Overall Study|Death|1|||
130605282|NCT01905397|470176730|FG000|Overall Study|Withdrawal by Subject|2|||
130605283|NCT01905397|470176731|FG001|Overall Study|Withdrawal by Subject|0|||
130605284|NCT01905397|470176730|FG000|Overall Study|Surgery canceled/aborted|9|||
130605285|NCT01905397|470176731|FG001|Overall Study|Surgery canceled/aborted|5|||
130605286|NCT01905397|470176730|FG000|Overall Study|Incision < 7 cm|2|||
130605287|NCT01905397|470176731|FG001|Overall Study|Incision < 7 cm|0|||
130605288|NCT01905397|470176730|FG000|Overall Study|Wrong treatment|1|||
130605289|NCT01905397|470176731|FG001|Overall Study|Wrong treatment|1|||
130605290|NCT01905397|470176730|FG000|Overall Study|Device not applied|3|||
130605291|NCT01905397|470176731|FG001|Overall Study|Device not applied|0|||
130605292|NCT01905397|470176730|FG000|Overall Study|Dressing not applied in operating room|1|||
130605293|NCT01905397|470176731|FG001|Overall Study|Dressing not applied in operating room|0|||
130605294|NCT01905397|470176730|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
130605295|NCT01905397|470176731|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
130605296|NCT00455858|470176735|FG000|Overall Study|Lost to Follow-up|2|||
130605297|NCT00455858|470176735|FG000|Overall Study|Protocol Violation|1|||
130605298|NCT00455858|470176735|FG000|Overall Study|Lack of Efficacy|1|||
130605299|NCT00455858|470176735|FG000|Overall Study|Well controlled FPG without insulin|1|||
130605300|NCT00455858|470176735|FG000|Overall Study|Withdrawal|1|||
130605301|NCT02092389|470176737|FG000|Overall Study|Adverse Event|1|||
130605302|NCT02092389|470176737|FG000|Overall Study|Other|5|||
130605303|NCT01242020|470176738|FG000|Overall Study|Withdrawal by Subject|2|||
130605304|NCT01242020|470176739|FG001|Overall Study|Withdrawal by Subject|0|||
130605305|NCT01242020|470176738|FG000|Overall Study|Failed screening|1|||
130605306|NCT01242020|470176739|FG001|Overall Study|Failed screening|0|||
130605307|NCT00231062|470176744|FG000|Overall Study|Physician Decision|6|||
130605308|NCT01052012|470176745|FG000|Overall Study|Not treated|2|||
130605309|NCT01052012|470176746|FG001|Overall Study|Not treated|5|||
130605310|NCT01052012|470176747|FG002|Overall Study|Not treated|0|||
130605311|NCT01052012|470176748|FG003|Overall Study|Not treated|0|||
130605312|NCT01052012|470176749|FG004|Overall Study|Not treated|11|||
130605313|NCT01052012|470176750|FG005|Overall Study|Not treated|8|||
130605314|NCT01052012|470176745|FG000|Overall Study|Adverse Event|1|||
130605315|NCT01052012|470176746|FG001|Overall Study|Adverse Event|0|||
130605316|NCT01052012|470176747|FG002|Overall Study|Adverse Event|0|||
130605317|NCT01052012|470176748|FG003|Overall Study|Adverse Event|1|||
130605318|NCT01052012|470176749|FG004|Overall Study|Adverse Event|0|||
130605319|NCT01052012|470176750|FG005|Overall Study|Adverse Event|0|||
130605320|NCT01052012|470176745|FG000|Overall Study|Lost to Follow-up|0|||
130605321|NCT01052012|470176746|FG001|Overall Study|Lost to Follow-up|0|||
130605322|NCT01052012|470176747|FG002|Overall Study|Lost to Follow-up|0|||
130605323|NCT01052012|470176748|FG003|Overall Study|Lost to Follow-up|0|||
130605324|NCT01052012|470176749|FG004|Overall Study|Lost to Follow-up|1|||
130605325|NCT01052012|470176750|FG005|Overall Study|Lost to Follow-up|0|||
130605326|NCT01052012|470176745|FG000|Overall Study|Withdrawal by Subject|1|||
130605327|NCT01052012|470176746|FG001|Overall Study|Withdrawal by Subject|1|||
130605328|NCT01052012|470176747|FG002|Overall Study|Withdrawal by Subject|0|||
130605329|NCT01052012|470176748|FG003|Overall Study|Withdrawal by Subject|0|||
130605330|NCT01052012|470176749|FG004|Overall Study|Withdrawal by Subject|3|||
130605331|NCT01052012|470176750|FG005|Overall Study|Withdrawal by Subject|1|||
130605332|NCT01052012|470176745|FG000|Overall Study|Physician Decision|0|||
130605333|NCT01052012|470176746|FG001|Overall Study|Physician Decision|0|||
130605334|NCT01052012|470176747|FG002|Overall Study|Physician Decision|0|||
130605335|NCT01052012|470176748|FG003|Overall Study|Physician Decision|0|||
130605336|NCT01052012|470176749|FG004|Overall Study|Physician Decision|0|||
130605337|NCT01052012|470176750|FG005|Overall Study|Physician Decision|1|||
130605338|NCT01052012|470176745|FG000|Overall Study|Other|0|||
130605339|NCT01052012|470176746|FG001|Overall Study|Other|0|||
130605340|NCT01052012|470176747|FG002|Overall Study|Other|0|||
130605341|NCT01052012|470176748|FG003|Overall Study|Other|0|||
130605342|NCT01052012|470176749|FG004|Overall Study|Other|1|||
130605343|NCT01052012|470176750|FG005|Overall Study|Other|0|||
130605344|NCT02119104|470176755|FG000|Overall Study|Protocol Violation|16|||
130605345|NCT02698423|470176756|FG000|Overall Study|Lost to Follow-up|19|||
130605346|NCT02698423|470176757|FG001|Overall Study|Lost to Follow-up|24|||
130605347|NCT01651260|470176759|FG000|Overall Study|unable to apply product|3|||
130605348|NCT02144220|470176760|FG000|Overall Study|technology incompatibility|9|||
130605349|NCT02144220|470176760|FG000|Overall Study|Lack of Efficacy|4|||
130605350|NCT02144220|470176760|FG000|Overall Study|Physician Decision|3|||
130605351|NCT02144220|470176760|FG000|Overall Study|Withdrawal by Subject|2|||
130605352|NCT02144220|470176760|FG000|Overall Study|Protocol Violation|1|||
130605353|NCT01952015|470176763|FG000|Induction|Protocol Violation|1|||
130605354|NCT01952015|470176763|FG000|Maintenance|Adverse Event|2|||
130605355|NCT01952015|470176763|FG000|Treatment Period 3|Physician Decision|9|||
130605356|NCT02239094|470176764|FG000|Overall Study|Withdrawal by Subject|1|||
130605357|NCT02239094|470176764|FG000|Overall Study|Remitted before started|1|||
130605358|NCT01597193|470176765|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
130605359|NCT01597193|470176766|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
130605360|NCT01597193|470176767|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130605361|NCT01597193|470176768|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130605362|NCT01597193|470176769|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130605363|NCT01597193|470176770|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130605364|NCT01597193|470176771|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130605365|NCT01597193|470176765|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130605366|NCT01597193|470176766|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130605367|NCT01597193|470176767|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130605368|NCT01597193|470176768|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
130605369|NCT01597193|470176769|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
130605370|NCT01597193|470176770|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
130605371|NCT01597193|470176771|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130605372|NCT01597193|470176765|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
130605373|NCT01597193|470176766|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
130605374|NCT01597193|470176767|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
130605375|NCT01597193|470176768|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
130605376|NCT01597193|470176769|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
130605377|NCT01597193|470176770|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
130605378|NCT01597193|470176771|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
130605379|NCT01597193|470176765|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605380|NCT01597193|470176766|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605381|NCT01597193|470176767|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605382|NCT01597193|470176768|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605383|NCT01597193|470176769|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605384|NCT01597193|470176770|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
130605385|NCT01597193|470176771|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130605386|NCT01597193|470176765|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130605387|NCT01597193|470176766|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130605388|NCT01597193|470176767|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130605389|NCT01597193|470176768|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
130605390|NCT01597193|470176769|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130605391|NCT01597193|470176770|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
130605392|NCT01597193|470176771|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130605393|NCT02508701|470176772|FG000|Overall Study|Lost to Follow-up|9|||
130605394|NCT02508701|470176773|FG001|Overall Study|Lost to Follow-up|5|||
130605395|NCT02508701|470176774|FG002|Overall Study|Lost to Follow-up|5|||
130605396|NCT02508701|470176775|FG003|Overall Study|Lost to Follow-up|3|||
130605397|NCT03184701|470176776|FG000|Overall Study|Death|3|||
130605398|NCT03184701|470176776|FG000|Overall Study|Physician Decision|3|||
130605399|NCT03184701|470176776|FG000|Overall Study|Withdrawal by Subject|6|||
130605400|NCT03184701|470176776|FG000|Overall Study|Lost to Follow-up|5|||
130605401|NCT01259297|470176780|FG000|Double Blind Randomized Period|Death|1|||
130605402|NCT01259297|470176781|FG001|Double Blind Randomized Period|Death|1|||
130605403|NCT01259297|470176782|FG002|Double Blind Randomized Period|Death|1|||
130605404|NCT01259297|470176783|FG003|Double Blind Randomized Period|Death|2|||
130605405|NCT01259297|470176784|FG004|Double Blind Randomized Period|Death|1|||
130605406|NCT01259297|470176785|FG005|Double Blind Randomized Period|Death|5|||
130605407|NCT01259297|470176786|FG006|Double Blind Randomized Period|Death|2|||
130605408|NCT01259297|470176787|FG007|Double Blind Randomized Period|Death|1|||
130605409|NCT01259297|470176780|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130605410|NCT01259297|470176781|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130605411|NCT01259297|470176782|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
130605412|NCT01259297|470176783|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
130605413|NCT01259297|470176784|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
130605414|NCT01259297|470176785|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130605415|NCT01259297|470176786|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130605416|NCT01259297|470176787|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130605417|NCT01259297|470176780|FG000|Double Blind Randomized Period|Other reasons|0|||
130605418|NCT01259297|470176781|FG001|Double Blind Randomized Period|Other reasons|1|||
130605419|NCT01259297|470176782|FG002|Double Blind Randomized Period|Other reasons|0|||
130605420|NCT01259297|470176783|FG003|Double Blind Randomized Period|Other reasons|0|||
130605421|NCT01259297|470176784|FG004|Double Blind Randomized Period|Other reasons|1|||
130605422|NCT01259297|470176785|FG005|Double Blind Randomized Period|Other reasons|2|||
130605423|NCT01259297|470176786|FG006|Double Blind Randomized Period|Other reasons|3|||
130605424|NCT01259297|470176787|FG007|Double Blind Randomized Period|Other reasons|1|||
130605425|NCT01345786|470176792|FG000|Overall Study|Adverse Event|0|||
130605426|NCT01345786|470176793|FG001|Overall Study|Adverse Event|1|||
130605427|NCT01345786|470176794|FG002|Overall Study|Adverse Event|3|||
130605428|NCT01345786|470176795|FG003|Overall Study|Adverse Event|1|||
130605429|NCT01345786|470176792|FG000|Overall Study|Subject withdrew consent|2|||
130605430|NCT01345786|470176793|FG001|Overall Study|Subject withdrew consent|2|||
130605431|NCT01345786|470176794|FG002|Overall Study|Subject withdrew consent|1|||
130605432|NCT01345786|470176795|FG003|Overall Study|Subject withdrew consent|0|||
130605433|NCT01345786|470176792|FG000|Overall Study|Noncompliance with protocol|1|||
130605434|NCT01345786|470176793|FG001|Overall Study|Noncompliance with protocol|0|||
130605435|NCT01345786|470176794|FG002|Overall Study|Noncompliance with protocol|1|||
130605436|NCT01345786|470176795|FG003|Overall Study|Noncompliance with protocol|0|||
130605437|NCT01345786|470176792|FG000|Overall Study|Administrative|3|||
130605438|NCT01345786|470176793|FG001|Overall Study|Administrative|5|||
130605439|NCT01345786|470176794|FG002|Overall Study|Administrative|0|||
130605440|NCT01345786|470176795|FG003|Overall Study|Administrative|0|||
130605441|NCT01345786|470176792|FG000|Overall Study|Lost to Follow-up|0|||
130605442|NCT01345786|470176793|FG001|Overall Study|Lost to Follow-up|0|||
130605443|NCT01345786|470176794|FG002|Overall Study|Lost to Follow-up|0|||
130605444|NCT01345786|470176795|FG003|Overall Study|Lost to Follow-up|2|||
130605445|NCT01070784|470176798|FG000|Overall Study|Withdrawal by Subject|6|||
130605446|NCT01070784|470176799|FG001|Overall Study|Withdrawal by Subject|9|||
130605447|NCT01070784|470176798|FG000|Overall Study|Adverse Event|14|||
130605448|NCT01070784|470176799|FG001|Overall Study|Adverse Event|9|||
130605449|NCT01000064|470176801|FG000|Overall Study|Withdrawal by Subject|1|||
130605450|NCT01000064|470176802|FG001|Overall Study|Withdrawal by Subject|1|||
130605451|NCT02518620|470176803|FG000|Overall Study|Adverse Event|23|||
130605452|NCT02518620|470176804|FG001|Overall Study|Adverse Event|11|||
130605453|NCT02518620|470176803|FG000|Overall Study|Lack of Efficacy|2|||
130605454|NCT02518620|470176804|FG001|Overall Study|Lack of Efficacy|0|||
130605455|NCT02518620|470176803|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130605456|NCT02518620|470176804|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130605457|NCT02518620|470176803|FG000|Overall Study|Physician Decision|1|||
130605458|NCT02518620|470176804|FG001|Overall Study|Physician Decision|1|||
130605459|NCT02518620|470176803|FG000|Overall Study|Sponsor's Decision|0|||
130605460|NCT02518620|470176804|FG001|Overall Study|Sponsor's Decision|3|||
130605461|NCT02518620|470176803|FG000|Overall Study|Lost to Follow-up|1|||
130605462|NCT02518620|470176804|FG001|Overall Study|Lost to Follow-up|1|||
130605463|NCT02518620|470176803|FG000|Overall Study|Withdrawal by Subject|17|||
130605464|NCT02518620|470176804|FG001|Overall Study|Withdrawal by Subject|9|||
130605465|NCT02518620|470176803|FG000|Overall Study|Death|1|||
130605466|NCT02518620|470176804|FG001|Overall Study|Death|0|||
130605467|NCT02518620|470176803|FG000|Overall Study|Pregnancy Wish|3|||
130605468|NCT02518620|470176804|FG001|Overall Study|Pregnancy Wish|0|||
130605469|NCT02518620|470176803|FG000|Overall Study|Pregnancy|1|||
130605470|NCT02518620|470176804|FG001|Overall Study|Pregnancy|0|||
130605471|NCT02518620|470176803|FG000|Overall Study|Relocation|2|||
130605472|NCT02518620|470176804|FG001|Overall Study|Relocation|1|||
130605473|NCT00085540|470176805|FG000|Overall Study|Withdrawal by Subject|0|||
130605474|NCT00085540|470176806|FG001|Overall Study|Withdrawal by Subject|1|||
130605475|NCT00085540|470176805|FG000|Overall Study|Protocol Violation|0|||
130605476|NCT00085540|470176806|FG001|Overall Study|Protocol Violation|1|||
130605477|NCT01518192|470176809|FG000|Overall Study|Lost to Follow-up|29|||
130605478|NCT01518192|470176810|FG001|Overall Study|Lost to Follow-up|26|||
130605479|NCT01518192|470176811|FG002|Overall Study|Lost to Follow-up|35|||
130605480|NCT03141307|470176814|FG000|In-Hospital|Withdrawal by Subject|0|||
130605481|NCT03141307|470176815|FG001|In-Hospital|Withdrawal by Subject|2|||
130605482|NCT03141307|470176814|FG000|In-Hospital|Protocol Violation|4|||
130605483|NCT03141307|470176815|FG001|In-Hospital|Protocol Violation|0|||
130605484|NCT03141307|470176814|FG000|Follow-Up|Lost to Follow-up|97|||
130605485|NCT03141307|470176815|FG001|Follow-Up|Lost to Follow-up|54|||
130605486|NCT03090737|470176816|FG000|Overall Study|Other reasons|1|||
130605487|NCT03090737|470176816|FG000|Overall Study|Completed treatment as per protocol|17|||
130605488|NCT03090737|470176816|FG000|Overall Study|Maximum clinical benefit|2|||
130605489|NCT03090737|470176816|FG000|Overall Study|Adverse event unrelated to study drug|7|||
130605490|NCT03090737|470176816|FG000|Overall Study|Study drug toxicity|4|||
130605491|NCT03090737|470176816|FG000|Overall Study|Disease progression|98|||
130605492|NCT01770353|470176819|FG000|Overall Study|Progressive disease|2|||
130605493|NCT01770353|470176820|FG001|Overall Study|Progressive disease|1|||
130605494|NCT01770353|470176819|FG000|Overall Study|Adverse Event|0|||
130605495|NCT01770353|470176820|FG001|Overall Study|Adverse Event|1|||
130605496|NCT01770353|470176819|FG000|Overall Study|Protocol Violation|1|||
130605497|NCT01770353|470176820|FG001|Overall Study|Protocol Violation|0|||
130605498|NCT01770353|470176819|FG000|Overall Study|Physician Decision|0|||
130605499|NCT01770353|470176820|FG001|Overall Study|Physician Decision|3|||
130605500|NCT01770353|470176819|FG000|Overall Study|Clinical deterioration|3|||
130605501|NCT01770353|470176820|FG001|Overall Study|Clinical deterioration|6|||
130605502|NCT01770353|470176819|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
130605503|NCT01770353|470176820|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
130605504|NCT02574312|470176821|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
130605505|NCT02574312|470176822|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
130605506|NCT02078713|470178974|FG000|Overall Study|Lost to Follow-up|49|||
130605507|NCT02078713|470178975|FG001|Overall Study|Lost to Follow-up|55|||
130605508|NCT02078713|470178976|FG002|Overall Study|Lost to Follow-up|0|||
130605509|NCT02078713|470178977|FG003|Overall Study|Lost to Follow-up|0|||
130605510|NCT02078713|470178974|FG000|Overall Study|Pregnant at baseline|3|||
130605511|NCT02078713|470178975|FG001|Overall Study|Pregnant at baseline|5|||
130605512|NCT02078713|470178976|FG002|Overall Study|Pregnant at baseline|0|||
130605513|NCT02078713|470178977|FG003|Overall Study|Pregnant at baseline|0|||
130605514|NCT02078713|470178974|FG000|Overall Study|Enrolled twice|0|||
130605515|NCT02078713|470178975|FG001|Overall Study|Enrolled twice|1|||
130605516|NCT02078713|470178976|FG002|Overall Study|Enrolled twice|0|||
130605517|NCT02078713|470178977|FG003|Overall Study|Enrolled twice|0|||
130605518|NCT00696657|470178982|FG000|Overall Study|Protocol Violation|0|||
130605519|NCT00696657|470178983|FG001|Overall Study|Protocol Violation|0|||
130605520|NCT00696657|470178984|FG002|Overall Study|Protocol Violation|0|||
130605521|NCT00696657|470178985|FG003|Overall Study|Protocol Violation|0|||
130605522|NCT00696657|470178986|FG004|Overall Study|Protocol Violation|0|||
130605523|NCT00696657|470178987|FG005|Overall Study|Protocol Violation|1|||
130605524|NCT00696657|470178988|FG006|Overall Study|Protocol Violation|0|||
130605525|NCT00696657|470178989|FG007|Overall Study|Protocol Violation|0|||
130605526|NCT00696657|470178990|FG008|Overall Study|Protocol Violation|1|||
130605527|NCT00696657|470178982|FG000|Overall Study|Lack of Efficacy|0|||
130605528|NCT00696657|470178983|FG001|Overall Study|Lack of Efficacy|1|||
130605529|NCT00696657|470178984|FG002|Overall Study|Lack of Efficacy|0|||
130605530|NCT00696657|470178985|FG003|Overall Study|Lack of Efficacy|0|||
130605531|NCT00696657|470178986|FG004|Overall Study|Lack of Efficacy|0|||
130605532|NCT00696657|470178987|FG005|Overall Study|Lack of Efficacy|0|||
130605533|NCT00696657|470178988|FG006|Overall Study|Lack of Efficacy|0|||
130605534|NCT00696657|470178989|FG007|Overall Study|Lack of Efficacy|0|||
130605535|NCT00696657|470178990|FG008|Overall Study|Lack of Efficacy|0|||
130605536|NCT00696657|470178982|FG000|Overall Study|Withdrawal criteria|1|||
130605537|NCT00696657|470178983|FG001|Overall Study|Withdrawal criteria|3|||
130605538|NCT00696657|470178984|FG002|Overall Study|Withdrawal criteria|2|||
130605539|NCT00696657|470178985|FG003|Overall Study|Withdrawal criteria|2|||
130605540|NCT00696657|470178986|FG004|Overall Study|Withdrawal criteria|0|||
130605541|NCT00696657|470178987|FG005|Overall Study|Withdrawal criteria|0|||
130605542|NCT00696657|470178988|FG006|Overall Study|Withdrawal criteria|1|||
130605543|NCT00696657|470178989|FG007|Overall Study|Withdrawal criteria|1|||
130605544|NCT00696657|470178990|FG008|Overall Study|Withdrawal criteria|2|||
130605545|NCT00696657|470178982|FG000|Overall Study|Unclassified|0|||
130605546|NCT00696657|470178983|FG001|Overall Study|Unclassified|1|||
130605547|NCT00696657|470178984|FG002|Overall Study|Unclassified|3|||
130605548|NCT00696657|470178985|FG003|Overall Study|Unclassified|2|||
130605549|NCT00696657|470178986|FG004|Overall Study|Unclassified|4|||
130605550|NCT00696657|470178987|FG005|Overall Study|Unclassified|2|||
130605551|NCT00696657|470178988|FG006|Overall Study|Unclassified|0|||
130605552|NCT00696657|470178989|FG007|Overall Study|Unclassified|0|||
130605553|NCT00696657|470178990|FG008|Overall Study|Unclassified|1|||
130605554|NCT00696657|470178982|FG000|Overall Study|Adverse Event|0|||
130605555|NCT00696657|470178983|FG001|Overall Study|Adverse Event|0|||
130605556|NCT00696657|470178984|FG002|Overall Study|Adverse Event|3|||
130605557|NCT00696657|470178985|FG003|Overall Study|Adverse Event|7|||
130605558|NCT00696657|470178986|FG004|Overall Study|Adverse Event|6|||
130605559|NCT00696657|470178987|FG005|Overall Study|Adverse Event|9|||
130605560|NCT00696657|470178988|FG006|Overall Study|Adverse Event|14|||
130605561|NCT00696657|470178989|FG007|Overall Study|Adverse Event|2|||
130605562|NCT00696657|470178990|FG008|Overall Study|Adverse Event|5|||
130605563|NCT01790438|470178991|FG000|Overall Study|Adverse Event|3|||
130605564|NCT01790438|470178992|FG001|Overall Study|Adverse Event|2|||
130605565|NCT01790438|470178991|FG000|Overall Study|Death|4|||
130605566|NCT01790438|470178992|FG001|Overall Study|Death|0|||
130605567|NCT01790438|470178991|FG000|Overall Study|Lost to Follow-up|5|||
130605568|NCT01790438|470178992|FG001|Overall Study|Lost to Follow-up|2|||
130605569|NCT01790438|470178991|FG000|Overall Study|Withdrawal by Subject|13|||
130605570|NCT01790438|470178992|FG001|Overall Study|Withdrawal by Subject|2|||
130605571|NCT01790438|470178991|FG000|Overall Study|Physician Decision|3|||
130605572|NCT01790438|470178992|FG001|Overall Study|Physician Decision|1|||
130605573|NCT01790438|470178991|FG000|Overall Study|Sponsor Decision|0|||
130605574|NCT01790438|470178992|FG001|Overall Study|Sponsor Decision|3|||
130605575|NCT01790438|470178991|FG000|Overall Study|Protocol Required Discontinuation|7|||
130605576|NCT01790438|470178992|FG001|Overall Study|Protocol Required Discontinuation|1|||
130605577|NCT02090114|470178996|FG000|Overall Study|Withdrawal by Subject|3|||
130605578|NCT02090114|470178997|FG001|Overall Study|Withdrawal by Subject|6|||
130605579|NCT02090114|470178998|FG002|Overall Study|Withdrawal by Subject|2|||
130605580|NCT02090114|470178999|FG003|Overall Study|Withdrawal by Subject|1|||
130605581|NCT02090114|470178996|FG000|Overall Study|Physician Decision|5|||
130605582|NCT02090114|470178997|FG001|Overall Study|Physician Decision|0|||
130605583|NCT02090114|470178998|FG002|Overall Study|Physician Decision|1|||
130605584|NCT02090114|470178999|FG003|Overall Study|Physician Decision|1|||
130605585|NCT02090114|470178996|FG000|Overall Study|Adverse Event|1|||
130605586|NCT02090114|470178997|FG001|Overall Study|Adverse Event|2|||
130605587|NCT02090114|470178998|FG002|Overall Study|Adverse Event|2|||
130605588|NCT02090114|470178999|FG003|Overall Study|Adverse Event|0|||
130605589|NCT02090114|470178996|FG000|Overall Study|Progressive Disease|20|||
130605590|NCT02090114|470178997|FG001|Overall Study|Progressive Disease|21|||
130605591|NCT02090114|470178998|FG002|Overall Study|Progressive Disease|23|||
130605592|NCT02090114|470178999|FG003|Overall Study|Progressive Disease|6|||
130605593|NCT02090114|470178996|FG000|Overall Study|Death|1|||
130605594|NCT02090114|470178997|FG001|Overall Study|Death|0|||
130605595|NCT02090114|470178998|FG002|Overall Study|Death|1|||
130605596|NCT02090114|470178999|FG003|Overall Study|Death|0|||
130605597|NCT00059215|470179002|FG000|Overall Study|Adverse Event|5|||
130605598|NCT00059215|470179003|FG001|Overall Study|Adverse Event|5|||
130605599|NCT00059215|470179004|FG002|Overall Study|Adverse Event|9|||
130605600|NCT00059215|470179005|FG003|Overall Study|Adverse Event|9|||
130605601|NCT00059215|470179002|FG000|Overall Study|Death|0|||
130605602|NCT00059215|470179003|FG001|Overall Study|Death|0|||
130605603|NCT00059215|470179004|FG002|Overall Study|Death|3|||
130605604|NCT00059215|470179005|FG003|Overall Study|Death|0|||
130605605|NCT00059215|470179002|FG000|Overall Study|Lost to Follow-up|1|||
130605606|NCT00059215|470179003|FG001|Overall Study|Lost to Follow-up|2|||
130605607|NCT00059215|470179004|FG002|Overall Study|Lost to Follow-up|0|||
130605608|NCT00059215|470179005|FG003|Overall Study|Lost to Follow-up|0|||
130605609|NCT00059215|470179002|FG000|Overall Study|Withdrawal by Subject|4|||
130605610|NCT00059215|470179003|FG001|Overall Study|Withdrawal by Subject|4|||
130605611|NCT00059215|470179004|FG002|Overall Study|Withdrawal by Subject|1|||
130605612|NCT00059215|470179005|FG003|Overall Study|Withdrawal by Subject|3|||
130605613|NCT00059215|470179002|FG000|Overall Study|Protocol Violation|1|||
130605614|NCT00059215|470179003|FG001|Overall Study|Protocol Violation|0|||
130605615|NCT00059215|470179004|FG002|Overall Study|Protocol Violation|1|||
130605616|NCT00059215|470179005|FG003|Overall Study|Protocol Violation|0|||
130605617|NCT00059215|470179002|FG000|Overall Study|Protocol entry criteria not met|1|||
130605618|NCT00059215|470179003|FG001|Overall Study|Protocol entry criteria not met|1|||
130605619|NCT00059215|470179004|FG002|Overall Study|Protocol entry criteria not met|0|||
130605620|NCT00059215|470179005|FG003|Overall Study|Protocol entry criteria not met|2|||
130605621|NCT00059215|470179002|FG000|Overall Study|Physician Decision|1|||
130605622|NCT00059215|470179003|FG001|Overall Study|Physician Decision|2|||
130605623|NCT00059215|470179004|FG002|Overall Study|Physician Decision|1|||
130605624|NCT00059215|470179005|FG003|Overall Study|Physician Decision|1|||
130605625|NCT04439838|470179006|FG000|Overall Study|Withdrawal by Subject|0|||
130605626|NCT04439838|470179007|FG001|Overall Study|Withdrawal by Subject|0|||
130605627|NCT04439838|470179008|FG002|Overall Study|Withdrawal by Subject|0|||
130605628|NCT04439838|470179009|FG003|Overall Study|Withdrawal by Subject|0|||
130605629|NCT04439838|470179010|FG004|Overall Study|Withdrawal by Subject|0|||
130605630|NCT04439838|470179011|FG005|Overall Study|Withdrawal by Subject|0|||
130605631|NCT04439838|470179012|FG006|Overall Study|Withdrawal by Subject|0|||
130605632|NCT04439838|470179013|FG007|Overall Study|Withdrawal by Subject|0|||
130605633|NCT04439838|470179014|FG008|Overall Study|Withdrawal by Subject|1|||
130605634|NCT04494633|470179015|FG000|Overall Study|Lost to Follow-up|5|||
130605635|NCT04494633|470179016|FG001|Overall Study|Lost to Follow-up|3|||
130605636|NCT04494633|470179015|FG000|Overall Study|Protocol Violation|1|||
130605637|NCT04494633|470179016|FG001|Overall Study|Protocol Violation|1|||
130605638|NCT00414310|470179017|FG000|Overall Study|Not treated|1|||
130605639|NCT00414310|470179018|FG001|Overall Study|Not treated|0|||
130605640|NCT01781429|470179019|FG000|Overall Study|Death|0|||
130605641|NCT01781429|470179020|FG001|Overall Study|Death|0|||
130605642|NCT01781429|470179021|FG002|Overall Study|Death|0|||
130605643|NCT01781429|470179022|FG003|Overall Study|Death|0|||
130605644|NCT01781429|470179023|FG004|Overall Study|Death|0|||
130605645|NCT01781429|470179024|FG005|Overall Study|Death|0|||
130605646|NCT01781429|470179025|FG006|Overall Study|Death|0|||
130605647|NCT01781429|470179026|FG007|Overall Study|Death|0|||
130605648|NCT01781429|470179027|FG008|Overall Study|Death|0|||
130605649|NCT01781429|470179028|FG009|Overall Study|Death|1|||
130605650|NCT01781429|470179029|FG010|Overall Study|Death|0|||
130605651|NCT01781429|470179030|FG011|Overall Study|Death|0|||
130605652|NCT01781429|470179031|FG012|Overall Study|Death|1|||
130605653|NCT01781429|470179032|FG013|Overall Study|Death|0|||
130605654|NCT01781429|470179033|FG014|Overall Study|Death|1|||
130605655|NCT01781429|470179034|FG015|Overall Study|Death|0|||
130605656|NCT01781429|470179019|FG000|Overall Study|Withdrawal by Subject|0|||
130605657|NCT01781429|470179020|FG001|Overall Study|Withdrawal by Subject|0|||
130605658|NCT01781429|470179021|FG002|Overall Study|Withdrawal by Subject|0|||
130605659|NCT01781429|470179022|FG003|Overall Study|Withdrawal by Subject|0|||
130605660|NCT01781429|470179023|FG004|Overall Study|Withdrawal by Subject|0|||
130605661|NCT01781429|470179024|FG005|Overall Study|Withdrawal by Subject|0|||
130605662|NCT01781429|470179025|FG006|Overall Study|Withdrawal by Subject|0|||
130605663|NCT01781429|470179026|FG007|Overall Study|Withdrawal by Subject|0|||
130605664|NCT01781429|470179027|FG008|Overall Study|Withdrawal by Subject|1|||
130605665|NCT01781429|470179028|FG009|Overall Study|Withdrawal by Subject|3|||
130605666|NCT01781429|470179029|FG010|Overall Study|Withdrawal by Subject|1|||
130605667|NCT01781429|470179030|FG011|Overall Study|Withdrawal by Subject|1|||
130605668|NCT01781429|470179031|FG012|Overall Study|Withdrawal by Subject|5|||
130605669|NCT01781429|470179032|FG013|Overall Study|Withdrawal by Subject|2|||
130605670|NCT01781429|470179033|FG014|Overall Study|Withdrawal by Subject|3|||
130605671|NCT01781429|470179034|FG015|Overall Study|Withdrawal by Subject|0|||
130605672|NCT01781429|470179019|FG000|Overall Study|Disease Progression|1|||
130605673|NCT01781429|470179020|FG001|Overall Study|Disease Progression|0|||
130605674|NCT01781429|470179021|FG002|Overall Study|Disease Progression|1|||
130605675|NCT01781429|470179022|FG003|Overall Study|Disease Progression|1|||
130605676|NCT01781429|470179023|FG004|Overall Study|Disease Progression|1|||
130605677|NCT01781429|470179024|FG005|Overall Study|Disease Progression|4|||
130605678|NCT01781429|470179025|FG006|Overall Study|Disease Progression|7|||
130605679|NCT01781429|470179026|FG007|Overall Study|Disease Progression|4|||
130605680|NCT01781429|470179027|FG008|Overall Study|Disease Progression|6|||
130605681|NCT01781429|470179028|FG009|Overall Study|Disease Progression|15|||
130605682|NCT01781429|470179029|FG010|Overall Study|Disease Progression|15|||
130605683|NCT01781429|470179030|FG011|Overall Study|Disease Progression|15|||
130605684|NCT01781429|470179031|FG012|Overall Study|Disease Progression|15|||
130605685|NCT01781429|470179032|FG013|Overall Study|Disease Progression|4|||
130605686|NCT01781429|470179033|FG014|Overall Study|Disease Progression|11|||
130605687|NCT01781429|470179034|FG015|Overall Study|Disease Progression|0|||
130605688|NCT01781429|470179019|FG000|Overall Study|Unacceptable Toxicity|0|||
130605689|NCT01781429|470179020|FG001|Overall Study|Unacceptable Toxicity|0|||
130605690|NCT01781429|470179021|FG002|Overall Study|Unacceptable Toxicity|0|||
130605691|NCT01781429|470179022|FG003|Overall Study|Unacceptable Toxicity|0|||
130605692|NCT01781429|470179023|FG004|Overall Study|Unacceptable Toxicity|0|||
130605693|NCT01781429|470179024|FG005|Overall Study|Unacceptable Toxicity|0|||
130605694|NCT01781429|470179025|FG006|Overall Study|Unacceptable Toxicity|0|||
130605695|NCT01781429|470179026|FG007|Overall Study|Unacceptable Toxicity|0|||
130605696|NCT01781429|470179027|FG008|Overall Study|Unacceptable Toxicity|0|||
130605697|NCT01781429|470179028|FG009|Overall Study|Unacceptable Toxicity|0|||
130605698|NCT01781429|470179029|FG010|Overall Study|Unacceptable Toxicity|0|||
130605699|NCT01781429|470179030|FG011|Overall Study|Unacceptable Toxicity|2|||
130605700|NCT01781429|470179031|FG012|Overall Study|Unacceptable Toxicity|0|||
130605701|NCT01781429|470179032|FG013|Overall Study|Unacceptable Toxicity|0|||
130605702|NCT01781429|470179033|FG014|Overall Study|Unacceptable Toxicity|0|||
130605703|NCT01781429|470179034|FG015|Overall Study|Unacceptable Toxicity|0|||
130605704|NCT01781429|470179019|FG000|Overall Study|Patient Condition Changed|0|||
130605705|NCT01781429|470179020|FG001|Overall Study|Patient Condition Changed|0|||
130605706|NCT01781429|470179021|FG002|Overall Study|Patient Condition Changed|0|||
130605707|NCT01781429|470179022|FG003|Overall Study|Patient Condition Changed|0|||
130605708|NCT01781429|470179023|FG004|Overall Study|Patient Condition Changed|0|||
130605709|NCT01781429|470179024|FG005|Overall Study|Patient Condition Changed|0|||
130605710|NCT01781429|470179025|FG006|Overall Study|Patient Condition Changed|0|||
130605711|NCT01781429|470179026|FG007|Overall Study|Patient Condition Changed|0|||
130605712|NCT01781429|470179027|FG008|Overall Study|Patient Condition Changed|0|||
130605713|NCT01781429|470179028|FG009|Overall Study|Patient Condition Changed|4|||
130605714|NCT01781429|470179029|FG010|Overall Study|Patient Condition Changed|0|||
130605715|NCT01781429|470179030|FG011|Overall Study|Patient Condition Changed|1|||
130605716|NCT01781429|470179031|FG012|Overall Study|Patient Condition Changed|0|||
130605717|NCT01781429|470179032|FG013|Overall Study|Patient Condition Changed|1|||
130605718|NCT01781429|470179033|FG014|Overall Study|Patient Condition Changed|0|||
130605719|NCT01781429|470179034|FG015|Overall Study|Patient Condition Changed|0|||
130605720|NCT01781429|470179019|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
130605721|NCT01781429|470179020|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
130605722|NCT01781429|470179021|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
130605723|NCT01781429|470179022|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
130605724|NCT01781429|470179023|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
130605725|NCT01781429|470179024|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
130605726|NCT01781429|470179025|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
130605727|NCT01781429|470179026|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
130605728|NCT01781429|470179027|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
130605729|NCT01781429|470179028|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
130605730|NCT01781429|470179029|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
130605731|NCT01781429|470179030|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
130605732|NCT01781429|470179031|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
130605733|NCT01781429|470179032|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
130605734|NCT01781429|470179033|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
130605735|NCT01781429|470179034|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
130605736|NCT01781429|470179019|FG000|Overall Study|Enrolled, but not treated|0|||
130605737|NCT01781429|470179020|FG001|Overall Study|Enrolled, but not treated|0|||
130605738|NCT01781429|470179021|FG002|Overall Study|Enrolled, but not treated|0|||
130605739|NCT01781429|470179022|FG003|Overall Study|Enrolled, but not treated|0|||
130605740|NCT01781429|470179023|FG004|Overall Study|Enrolled, but not treated|0|||
130605741|NCT01781429|470179024|FG005|Overall Study|Enrolled, but not treated|0|||
130605742|NCT01781429|470179025|FG006|Overall Study|Enrolled, but not treated|0|||
130605743|NCT01781429|470179026|FG007|Overall Study|Enrolled, but not treated|0|||
130605744|NCT01781429|470179027|FG008|Overall Study|Enrolled, but not treated|0|||
130605745|NCT01781429|470179028|FG009|Overall Study|Enrolled, but not treated|0|||
130605746|NCT01781429|470179029|FG010|Overall Study|Enrolled, but not treated|1|||
130605747|NCT01781429|470179030|FG011|Overall Study|Enrolled, but not treated|0|||
130605748|NCT01781429|470179031|FG012|Overall Study|Enrolled, but not treated|0|||
130605749|NCT01781429|470179032|FG013|Overall Study|Enrolled, but not treated|0|||
130605750|NCT01781429|470179033|FG014|Overall Study|Enrolled, but not treated|0|||
130605751|NCT01781429|470179034|FG015|Overall Study|Enrolled, but not treated|0|||
130605752|NCT00390780|470179035|FG000|Overall Study|Not completed|10|||
130605753|NCT00390780|470179036|FG001|Overall Study|Not completed|4|||
130605754|NCT00390780|470179035|FG000|Overall Study|Protocol Violation|6|||
130605755|NCT00390780|470179036|FG001|Overall Study|Protocol Violation|4|||
130605756|NCT00390780|470179035|FG000|Overall Study|Lost to Follow-up|3|||
130605757|NCT00390780|470179036|FG001|Overall Study|Lost to Follow-up|6|||
130605758|NCT00390780|470179035|FG000|Overall Study|Adverse Event|2|||
130605759|NCT00390780|470179036|FG001|Overall Study|Adverse Event|3|||
130605760|NCT00390780|470179035|FG000|Overall Study|Death|1|||
130605761|NCT00390780|470179036|FG001|Overall Study|Death|3|||
130605762|NCT00390780|470179035|FG000|Overall Study|Withdrawal by Subject|1|||
130605763|NCT00390780|470179036|FG001|Overall Study|Withdrawal by Subject|2|||
130605764|NCT00390780|470179035|FG000|Overall Study|Inclusion criteria not satisfied|0|||
130605765|NCT00390780|470179036|FG001|Overall Study|Inclusion criteria not satisfied|2|||
130605766|NCT00390780|470179035|FG000|Overall Study|Lost to follow up and other reasons|0|||
130605767|NCT00390780|470179036|FG001|Overall Study|Lost to follow up and other reasons|1|||
130605768|NCT00390780|470179035|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
130605769|NCT00390780|470179036|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
130605770|NCT00390780|470179035|FG000|Overall Study|SAE, death|0|||
130605771|NCT00390780|470179036|FG001|Overall Study|SAE, death|1|||
130605772|NCT01070550|470179037|FG000|Overall Study|Adverse Event|43|||
130605773|NCT01070550|470179038|FG001|Overall Study|Adverse Event|1|||
130605774|NCT01070550|470179039|FG002|Overall Study|Adverse Event|3|||
130605775|NCT01070550|470179040|FG003|Overall Study|Adverse Event|0|||
130605776|NCT01070550|470179041|FG004|Overall Study|Adverse Event|0|||
130605777|NCT01070550|470179042|FG005|Overall Study|Adverse Event|0|||
130605778|NCT01070550|470179037|FG000|Overall Study|Death|20|||
130605779|NCT01070550|470179038|FG001|Overall Study|Death|4|||
130605780|NCT01070550|470179039|FG002|Overall Study|Death|3|||
130605781|NCT01070550|470179040|FG003|Overall Study|Death|0|||
130605782|NCT01070550|470179041|FG004|Overall Study|Death|0|||
130605783|NCT01070550|470179042|FG005|Overall Study|Death|0|||
130605784|NCT01070550|470179037|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
130605785|NCT01070550|470179038|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130605786|NCT01070550|470179039|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130605787|NCT01070550|470179040|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130605788|NCT01070550|470179041|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130605789|NCT01070550|470179042|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130605790|NCT01070550|470179037|FG000|Overall Study|Early termination|3|||
130605791|NCT01070550|470179038|FG001|Overall Study|Early termination|0|||
130605792|NCT01070550|470179039|FG002|Overall Study|Early termination|0|||
130605793|NCT01070550|470179040|FG003|Overall Study|Early termination|0|||
130605794|NCT01070550|470179041|FG004|Overall Study|Early termination|0|||
130605795|NCT01070550|470179042|FG005|Overall Study|Early termination|0|||
130605796|NCT01070550|470179037|FG000|Overall Study|Failed to return|450|||
130605797|NCT01070550|470179038|FG001|Overall Study|Failed to return|33|||
130605798|NCT01070550|470179039|FG002|Overall Study|Failed to return|144|||
130605799|NCT01070550|470179040|FG003|Overall Study|Failed to return|40|||
130605800|NCT01070550|470179041|FG004|Overall Study|Failed to return|1|||
130605801|NCT01070550|470179042|FG005|Overall Study|Failed to return|2|||
130605802|NCT01070550|470179037|FG000|Overall Study|Incomplete treatment|2|||
130605803|NCT01070550|470179038|FG001|Overall Study|Incomplete treatment|0|||
130605804|NCT01070550|470179039|FG002|Overall Study|Incomplete treatment|0|||
130605805|NCT01070550|470179040|FG003|Overall Study|Incomplete treatment|0|||
130605806|NCT01070550|470179041|FG004|Overall Study|Incomplete treatment|0|||
130605807|NCT01070550|470179042|FG005|Overall Study|Incomplete treatment|0|||
130605808|NCT01070550|470179037|FG000|Overall Study|Lab test not done|22|||
130605809|NCT01070550|470179038|FG001|Overall Study|Lab test not done|3|||
130605810|NCT01070550|470179039|FG002|Overall Study|Lab test not done|4|||
130605811|NCT01070550|470179040|FG003|Overall Study|Lab test not done|1|||
130605812|NCT01070550|470179041|FG004|Overall Study|Lab test not done|0|||
130605813|NCT01070550|470179042|FG005|Overall Study|Lab test not done|1|||
130605814|NCT01070550|470179037|FG000|Overall Study|Lack of Efficacy|65|||
130605815|NCT01070550|470179038|FG001|Overall Study|Lack of Efficacy|1|||
130605816|NCT01070550|470179039|FG002|Overall Study|Lack of Efficacy|5|||
130605817|NCT01070550|470179040|FG003|Overall Study|Lack of Efficacy|5|||
130605818|NCT01070550|470179041|FG004|Overall Study|Lack of Efficacy|0|||
130605819|NCT01070550|470179042|FG005|Overall Study|Lack of Efficacy|1|||
130605820|NCT01070550|470179037|FG000|Overall Study|Miscellaneous|12|||
130605821|NCT01070550|470179038|FG001|Overall Study|Miscellaneous|2|||
130605822|NCT01070550|470179039|FG002|Overall Study|Miscellaneous|3|||
130605823|NCT01070550|470179040|FG003|Overall Study|Miscellaneous|1|||
130605824|NCT01070550|470179041|FG004|Overall Study|Miscellaneous|0|||
130605825|NCT01070550|470179042|FG005|Overall Study|Miscellaneous|0|||
130605826|NCT01070550|470179037|FG000|Overall Study|New treatment started|3|||
130605827|NCT01070550|470179038|FG001|Overall Study|New treatment started|1|||
130605828|NCT01070550|470179039|FG002|Overall Study|New treatment started|0|||
130605829|NCT01070550|470179040|FG003|Overall Study|New treatment started|2|||
130605830|NCT01070550|470179041|FG004|Overall Study|New treatment started|0|||
130605831|NCT01070550|470179042|FG005|Overall Study|New treatment started|0|||
130605832|NCT01070550|470179037|FG000|Overall Study|Non-responders|493|||
130605833|NCT01070550|470179038|FG001|Overall Study|Non-responders|4|||
130605834|NCT01070550|470179039|FG002|Overall Study|Non-responders|21|||
130605835|NCT01070550|470179040|FG003|Overall Study|Non-responders|20|||
130605836|NCT01070550|470179041|FG004|Overall Study|Non-responders|0|||
130605837|NCT01070550|470179042|FG005|Overall Study|Non-responders|2|||
130605838|NCT01070550|470179037|FG000|Overall Study|Not categorized|33|||
130605839|NCT01070550|470179038|FG001|Overall Study|Not categorized|2|||
130605840|NCT01070550|470179039|FG002|Overall Study|Not categorized|6|||
130605841|NCT01070550|470179040|FG003|Overall Study|Not categorized|1|||
130605842|NCT01070550|470179041|FG004|Overall Study|Not categorized|0|||
130605843|NCT01070550|470179042|FG005|Overall Study|Not categorized|1|||
130605844|NCT01070550|470179037|FG000|Overall Study|Protocol Violation|15|||
130605845|NCT01070550|470179038|FG001|Overall Study|Protocol Violation|1|||
130605846|NCT01070550|470179039|FG002|Overall Study|Protocol Violation|1|||
130605847|NCT01070550|470179040|FG003|Overall Study|Protocol Violation|1|||
130605848|NCT01070550|470179041|FG004|Overall Study|Protocol Violation|0|||
130605849|NCT01070550|470179042|FG005|Overall Study|Protocol Violation|0|||
130605850|NCT01070550|470179037|FG000|Overall Study|Relapse|44|||
130605851|NCT01070550|470179038|FG001|Overall Study|Relapse|5|||
130605852|NCT01070550|470179039|FG002|Overall Study|Relapse|14|||
130605853|NCT01070550|470179040|FG003|Overall Study|Relapse|4|||
130605854|NCT01070550|470179041|FG004|Overall Study|Relapse|0|||
130605855|NCT01070550|470179042|FG005|Overall Study|Relapse|0|||
130605856|NCT01070550|470179037|FG000|Overall Study|Result not available|3|||
130605857|NCT01070550|470179038|FG001|Overall Study|Result not available|1|||
130605858|NCT01070550|470179039|FG002|Overall Study|Result not available|3|||
130605859|NCT01070550|470179040|FG003|Overall Study|Result not available|0|||
130605860|NCT01070550|470179041|FG004|Overall Study|Result not available|0|||
130605861|NCT01070550|470179042|FG005|Overall Study|Result not available|0|||
130605862|NCT01070550|470179037|FG000|Overall Study|Screen failure|1|||
130605863|NCT01070550|470179038|FG001|Overall Study|Screen failure|0|||
130605864|NCT01070550|470179039|FG002|Overall Study|Screen failure|0|||
130605865|NCT01070550|470179040|FG003|Overall Study|Screen failure|0|||
130605866|NCT01070550|470179041|FG004|Overall Study|Screen failure|0|||
130605867|NCT01070550|470179042|FG005|Overall Study|Screen failure|0|||
130605868|NCT01070550|470179037|FG000|Overall Study|Sponsor decision|1|||
130605869|NCT01070550|470179038|FG001|Overall Study|Sponsor decision|0|||
130605870|NCT01070550|470179039|FG002|Overall Study|Sponsor decision|0|||
130605871|NCT01070550|470179040|FG003|Overall Study|Sponsor decision|0|||
130605872|NCT01070550|470179041|FG004|Overall Study|Sponsor decision|0|||
130605873|NCT01070550|470179042|FG005|Overall Study|Sponsor decision|0|||
130605874|NCT01070550|470179037|FG000|Overall Study|Treatment duration shortened|1|||
130605875|NCT01070550|470179038|FG001|Overall Study|Treatment duration shortened|0|||
130605876|NCT01070550|470179039|FG002|Overall Study|Treatment duration shortened|0|||
130605877|NCT01070550|470179040|FG003|Overall Study|Treatment duration shortened|0|||
130605878|NCT01070550|470179041|FG004|Overall Study|Treatment duration shortened|0|||
130605879|NCT01070550|470179042|FG005|Overall Study|Treatment duration shortened|0|||
130605880|NCT01070550|470179037|FG000|Overall Study|Treatment interrupted|7|||
130605881|NCT01070550|470179038|FG001|Overall Study|Treatment interrupted|0|||
130605882|NCT01070550|470179039|FG002|Overall Study|Treatment interrupted|1|||
130605883|NCT01070550|470179040|FG003|Overall Study|Treatment interrupted|1|||
130605884|NCT01070550|470179041|FG004|Overall Study|Treatment interrupted|0|||
130605885|NCT01070550|470179042|FG005|Overall Study|Treatment interrupted|0|||
130605886|NCT01070550|470179037|FG000|Overall Study|Treatment not started|14|||
130605887|NCT01070550|470179038|FG001|Overall Study|Treatment not started|2|||
130605888|NCT01070550|470179039|FG002|Overall Study|Treatment not started|4|||
130605889|NCT01070550|470179040|FG003|Overall Study|Treatment not started|0|||
130605890|NCT01070550|470179041|FG004|Overall Study|Treatment not started|0|||
130605891|NCT01070550|470179042|FG005|Overall Study|Treatment not started|0|||
130605892|NCT01070550|470179037|FG000|Overall Study|Treatment restarted|0|||
130605893|NCT01070550|470179038|FG001|Overall Study|Treatment restarted|1|||
130605894|NCT01070550|470179039|FG002|Overall Study|Treatment restarted|0|||
130605895|NCT01070550|470179040|FG003|Overall Study|Treatment restarted|0|||
130605896|NCT01070550|470179041|FG004|Overall Study|Treatment restarted|0|||
130605897|NCT01070550|470179042|FG005|Overall Study|Treatment restarted|0|||
130605898|NCT01070550|470179037|FG000|Overall Study|Treatment stopped|3|||
130605899|NCT01070550|470179038|FG001|Overall Study|Treatment stopped|0|||
130605900|NCT01070550|470179039|FG002|Overall Study|Treatment stopped|0|||
130605901|NCT01070550|470179040|FG003|Overall Study|Treatment stopped|0|||
130605902|NCT01070550|470179041|FG004|Overall Study|Treatment stopped|0|||
130605903|NCT01070550|470179042|FG005|Overall Study|Treatment stopped|0|||
130605904|NCT01070550|470179037|FG000|Overall Study|Treatment unavailable|1|||
130605905|NCT01070550|470179038|FG001|Overall Study|Treatment unavailable|0|||
130605906|NCT01070550|470179039|FG002|Overall Study|Treatment unavailable|0|||
130605907|NCT01070550|470179040|FG003|Overall Study|Treatment unavailable|0|||
130605908|NCT01070550|470179041|FG004|Overall Study|Treatment unavailable|0|||
130605909|NCT01070550|470179042|FG005|Overall Study|Treatment unavailable|0|||
130605910|NCT01070550|470179037|FG000|Overall Study|Treatment was stopped early|7|||
130605911|NCT01070550|470179038|FG001|Overall Study|Treatment was stopped early|0|||
130605912|NCT01070550|470179039|FG002|Overall Study|Treatment was stopped early|0|||
130605913|NCT01070550|470179040|FG003|Overall Study|Treatment was stopped early|0|||
130605914|NCT01070550|470179041|FG004|Overall Study|Treatment was stopped early|0|||
130605915|NCT01070550|470179042|FG005|Overall Study|Treatment was stopped early|0|||
130605916|NCT01070550|470179037|FG000|Overall Study|Other|5|||
130605917|NCT01070550|470179038|FG001|Overall Study|Other|0|||
130605918|NCT01070550|470179039|FG002|Overall Study|Other|0|||
130605919|NCT01070550|470179040|FG003|Overall Study|Other|1|||
130605920|NCT01070550|470179041|FG004|Overall Study|Other|0|||
130605921|NCT01070550|470179042|FG005|Overall Study|Other|0|||
130605922|NCT01070550|470179037|FG000|Overall Study|Withdrawal by Subject|35|||
130605923|NCT01070550|470179038|FG001|Overall Study|Withdrawal by Subject|0|||
130605924|NCT01070550|470179039|FG002|Overall Study|Withdrawal by Subject|3|||
130605925|NCT01070550|470179040|FG003|Overall Study|Withdrawal by Subject|0|||
130605926|NCT01070550|470179041|FG004|Overall Study|Withdrawal by Subject|0|||
130605927|NCT01070550|470179042|FG005|Overall Study|Withdrawal by Subject|0|||
130605928|NCT01585961|470179043|FG000|Overall Study|Death|6|||
130605929|NCT01585961|470179043|FG000|Overall Study|Physician Decision|1|||
130605930|NCT01585961|470179043|FG000|Overall Study|Decision to use non-study catheter|1|||
130605931|NCT01585961|470179043|FG000|Overall Study|Withdrawal by Subject|1|||
130605932|NCT01585961|470179043|FG000|Overall Study|Lost to Follow-up|23|||
130605933|NCT01585961|470179043|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
130605934|NCT00109733|470179044|FG000|Overall Study|Protocol Violation|0|||
130605935|NCT00109733|470179045|FG001|Overall Study|Protocol Violation|1|||
130605936|NCT00109733|470179044|FG000|Overall Study|Stopped taking study drug|1|||
130605937|NCT00109733|470179045|FG001|Overall Study|Stopped taking study drug|1|||
130605938|NCT00109733|470179044|FG000|Overall Study|Non-compliant|0|||
130605939|NCT00109733|470179045|FG001|Overall Study|Non-compliant|1|||
130605940|NCT00109733|470179044|FG000|Overall Study|Could not commit time for study|1|||
130605941|NCT00109733|470179045|FG001|Overall Study|Could not commit time for study|1|||
130605942|NCT06094296|470179050|FG000|Overall Study|Progressive Disease|1|||
130605943|NCT06094296|470179051|FG001|Overall Study|Progressive Disease|0|||
130605944|NCT06094296|470179052|FG002|Overall Study|Progressive Disease|0|||
130605945|NCT06094296|470179053|FG003|Overall Study|Progressive Disease|0|||
130605946|NCT03332667|470179054|FG000|Overall Study|Adverse Event|0|||
130605947|NCT03332667|470179055|FG001|Overall Study|Adverse Event|0|||
130605948|NCT03332667|470179056|FG002|Overall Study|Adverse Event|2|||
130605949|NCT03332667|470179057|FG003|Overall Study|Adverse Event|1|||
130605950|NCT03332667|470179054|FG000|Overall Study|Withdrawal by Subject|2|||
130605951|NCT03332667|470179055|FG001|Overall Study|Withdrawal by Subject|1|||
130605952|NCT03332667|470179056|FG002|Overall Study|Withdrawal by Subject|5|||
130605953|NCT03332667|470179057|FG003|Overall Study|Withdrawal by Subject|1|||
130605954|NCT03332667|470179054|FG000|Overall Study|Disease Progression or Relapse|2|||
130605955|NCT03332667|470179055|FG001|Overall Study|Disease Progression or Relapse|1|||
130605956|NCT03332667|470179056|FG002|Overall Study|Disease Progression or Relapse|3|||
130605957|NCT03332667|470179057|FG003|Overall Study|Disease Progression or Relapse|0|||
130605958|NCT03332667|470179054|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130605959|NCT03332667|470179055|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130605960|NCT03332667|470179056|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
130605961|NCT03332667|470179057|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130605962|NCT03332667|470179054|FG000|Overall Study|No Treatment Received|0|||
130605963|NCT03332667|470179055|FG001|Overall Study|No Treatment Received|0|||
130605964|NCT03332667|470179056|FG002|Overall Study|No Treatment Received|1|||
130605965|NCT03332667|470179057|FG003|Overall Study|No Treatment Received|0|||
130605966|NCT04964063|470179058|FG000|Overall Study|Adverse Event|4|||
130605967|NCT04964063|470179058|FG000|Overall Study|Lost to Follow-up|47|||
130605968|NCT04964063|470179058|FG000|Overall Study|Withdrawal by Subject|5|||
130605969|NCT04964063|470179058|FG000|Overall Study|Baseline Tasks Expired|41|||
130605970|NCT04964063|470179058|FG000|Overall Study|Participant withdrawn in error|1|||
130605971|NCT01035606|470179059|FG000|Overall Study|change in health, job demands,family|3|||
130605972|NCT01035606|470179060|FG001|Overall Study|change in health, job demands,family|3|||
130605973|NCT01035606|470179061|FG002|Overall Study|change in health, job demands,family|4|||
130605974|NCT01809262|470179062|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605975|NCT01809262|470179063|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605976|NCT01809262|470179064|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605977|NCT01809262|470179065|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605978|NCT01809262|470179066|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
130605979|NCT01809262|470179067|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605980|NCT01809262|470179068|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605981|NCT01809262|470179069|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605982|NCT01809262|470179070|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605983|NCT01809262|470179071|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
130605984|NCT01809262|470179062|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605985|NCT01809262|470179063|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
130605986|NCT01809262|470179064|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605987|NCT01809262|470179065|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605988|NCT01809262|470179066|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605989|NCT01809262|470179067|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605990|NCT01809262|470179068|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605991|NCT01809262|470179069|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605992|NCT01809262|470179070|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605993|NCT01809262|470179071|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130605994|NCT02064439|470179073|FG000|Overall Study|Adverse Event|51|||
130605995|NCT02064439|470179074|FG001|Overall Study|Adverse Event|47|||
130605996|NCT02064439|470179075|FG002|Overall Study|Adverse Event|46|||
130605997|NCT02064439|470179073|FG000|Overall Study|Death|0|||
130605998|NCT02064439|470179074|FG001|Overall Study|Death|2|||
130605999|NCT02064439|470179075|FG002|Overall Study|Death|3|||
130606000|NCT02064439|470179073|FG000|Overall Study|Withdrawal by Subject|29|||
130606001|NCT02064439|470179074|FG001|Overall Study|Withdrawal by Subject|18|||
130606002|NCT02064439|470179075|FG002|Overall Study|Withdrawal by Subject|26|||
130606003|NCT02064439|470179073|FG000|Overall Study|Protocol Violation|3|||
130606004|NCT02064439|470179074|FG001|Overall Study|Protocol Violation|5|||
130606005|NCT02064439|470179075|FG002|Overall Study|Protocol Violation|3|||
130606006|NCT02064439|470179073|FG000|Overall Study|Lost to Follow-up|1|||
130606007|NCT02064439|470179074|FG001|Overall Study|Lost to Follow-up|3|||
130606008|NCT02064439|470179075|FG002|Overall Study|Lost to Follow-up|4|||
130606009|NCT02064439|470179073|FG000|Overall Study|Non-compliance with study medication|21|||
130606010|NCT02064439|470179074|FG001|Overall Study|Non-compliance with study medication|19|||
130606011|NCT02064439|470179075|FG002|Overall Study|Non-compliance with study medication|23|||
130606012|NCT02064439|470179073|FG000|Overall Study|Physician Decision|0|||
130606013|NCT02064439|470179074|FG001|Overall Study|Physician Decision|1|||
130606014|NCT02064439|470179075|FG002|Overall Study|Physician Decision|1|||
130606015|NCT02064439|470179073|FG000|Overall Study|Logistical difficulties|6|||
130606016|NCT02064439|470179074|FG001|Overall Study|Logistical difficulties|5|||
130606017|NCT02064439|470179075|FG002|Overall Study|Logistical difficulties|2|||
130606018|NCT02064439|470179073|FG000|Overall Study|Efficacy outcome reached|18|||
130606019|NCT02064439|470179074|FG001|Overall Study|Efficacy outcome reached|16|||
130606020|NCT02064439|470179075|FG002|Overall Study|Efficacy outcome reached|57|||
130606021|NCT02064439|470179073|FG000|Overall Study|Safety outcome reached|12|||
130606022|NCT02064439|470179074|FG001|Overall Study|Safety outcome reached|20|||
130606023|NCT02064439|470179075|FG002|Overall Study|Safety outcome reached|10|||
130606024|NCT02064439|470179073|FG000|Overall Study|Other|2|||
130606025|NCT02064439|470179074|FG001|Overall Study|Other|2|||
130606026|NCT02064439|470179075|FG002|Overall Study|Other|7|||
130606027|NCT02433288|470179076|FG000|Overall Study|Severe non-compliance to protocol|13|||
130606028|NCT02433288|470179077|FG001|Overall Study|Severe non-compliance to protocol|7|||
130606029|NCT02433288|470179076|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
130606030|NCT02433288|470179077|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
130606031|NCT02433288|470179076|FG000|Overall Study|Withdrawal by Subject|101|||
130606032|NCT02433288|470179077|FG001|Overall Study|Withdrawal by Subject|99|||
130606033|NCT02433288|470179076|FG000|Overall Study|Lost to Follow-up|2|||
130606034|NCT02433288|470179077|FG001|Overall Study|Lost to Follow-up|14|||
130606035|NCT02433288|470179076|FG000|Overall Study|Death|0|||
130606036|NCT02433288|470179077|FG001|Overall Study|Death|3|||
130606037|NCT03350750|470179078|FG000|Overall Study|Death|1|||
130606038|NCT03350750|470179079|FG001|Overall Study|Death|1|||
130606039|NCT01120093|470179084|FG000|Treatment Period 1|Adverse Event|0|||
130606040|NCT01120093|470179085|FG001|Treatment Period 1|Adverse Event|0|||
130606041|NCT01120093|470179086|FG002|Treatment Period 1|Adverse Event|1|||
130606042|NCT01120093|470179087|FG003|Treatment Period 1|Adverse Event|0|||
130606043|NCT01120093|470179088|FG004|Treatment Period 1|Adverse Event|1|||
130606044|NCT01120093|470179084|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130606045|NCT01120093|470179085|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130606046|NCT01120093|470179086|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130606047|NCT01120093|470179087|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130606048|NCT01120093|470179088|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130606049|NCT01120093|470179084|FG000|Treatment Period 2|Adverse Event|0|||
130606050|NCT01120093|470179085|FG001|Treatment Period 2|Adverse Event|0|||
130606051|NCT01120093|470179086|FG002|Treatment Period 2|Adverse Event|0|||
130606052|NCT01120093|470179087|FG003|Treatment Period 2|Adverse Event|1|||
130606053|NCT01120093|470179088|FG004|Treatment Period 2|Adverse Event|0|||
130606054|NCT01120093|470179084|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130606055|NCT01120093|470179085|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130606056|NCT01120093|470179086|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130606057|NCT01120093|470179087|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130606058|NCT01120093|470179088|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130606059|NCT01120093|470179084|FG000|Treatment Period 3|Lack of Efficacy|0|||
130606060|NCT01120093|470179085|FG001|Treatment Period 3|Lack of Efficacy|0|||
130606061|NCT01120093|470179086|FG002|Treatment Period 3|Lack of Efficacy|0|||
130606062|NCT01120093|470179087|FG003|Treatment Period 3|Lack of Efficacy|1|||
130606063|NCT01120093|470179088|FG004|Treatment Period 3|Lack of Efficacy|0|||
130606064|NCT01120093|470179084|FG000|Treatment Period 3|Adverse Event|0|||
130606065|NCT01120093|470179085|FG001|Treatment Period 3|Adverse Event|0|||
130606066|NCT01120093|470179086|FG002|Treatment Period 3|Adverse Event|0|||
130606067|NCT01120093|470179087|FG003|Treatment Period 3|Adverse Event|0|||
130606068|NCT01120093|470179088|FG004|Treatment Period 3|Adverse Event|1|||
130606069|NCT01120093|470179084|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130606070|NCT01120093|470179085|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130606071|NCT01120093|470179086|FG002|Treatment Period 3|Withdrawal by Subject|1|||
130606072|NCT01120093|470179087|FG003|Treatment Period 3|Withdrawal by Subject|0|||
130606073|NCT01120093|470179088|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130606074|NCT01120093|470179084|FG000|Treatment Period 4|Adverse Event|1|||
130606075|NCT01120093|470179085|FG001|Treatment Period 4|Adverse Event|0|||
130606076|NCT01120093|470179086|FG002|Treatment Period 4|Adverse Event|0|||
130606077|NCT01120093|470179087|FG003|Treatment Period 4|Adverse Event|0|||
130606078|NCT01120093|470179088|FG004|Treatment Period 4|Adverse Event|0|||
130606079|NCT01120093|470179084|FG000|Treatment Period 5|Adverse Event|0|||
130606080|NCT01120093|470179085|FG001|Treatment Period 5|Adverse Event|1|||
130606081|NCT01120093|470179086|FG002|Treatment Period 5|Adverse Event|0|||
130606082|NCT01120093|470179087|FG003|Treatment Period 5|Adverse Event|1|||
130606083|NCT01120093|470179088|FG004|Treatment Period 5|Adverse Event|0|||
130606084|NCT01849250|470179089|FG000|Overall Study|Withdrawal by Subject|1|||
130606085|NCT01849250|470179090|FG001|Overall Study|Withdrawal by Subject|0|||
130606086|NCT01849250|470179089|FG000|Overall Study|Not Evaluable|5|||
130606087|NCT01849250|470179090|FG001|Overall Study|Not Evaluable|3|||
130606088|NCT01849250|470179089|FG000|Overall Study|Screen Failure|1|||
130606089|NCT01849250|470179090|FG001|Overall Study|Screen Failure|0|||
130606090|NCT01063751|470179094|FG000|Overall Study|Censored from analyses|42|||
130606091|NCT01063751|470179094|FG000|Overall Study|Withdrawal by Subject|34|||
130606092|NCT01063751|470179094|FG000|Overall Study|Lost to Follow-up|30|||
130606093|NCT01063751|470179094|FG000|Overall Study|Death|13|||
130606094|NCT01063751|470179094|FG000|Overall Study|Sponsored Terminated Study|60|||
130606095|NCT01063751|470179094|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
130606096|NCT01063751|470179094|FG000|Overall Study|Investigator site closed|10|||
130606097|NCT01063751|470179094|FG000|Overall Study|Revision|6|||
130606098|NCT01063751|470179094|FG000|Overall Study|Physician Decision|4|||
130606099|NCT00406315|470179098|FG000|Overall Study|Death|1|||
130606100|NCT00406315|470179098|FG000|Overall Study|Adverse Event|39|||
130606101|NCT00406315|470179098|FG000|Overall Study|Laboratory Abnormality|4|||
130606102|NCT00406315|470179098|FG000|Overall Study|Lack of Efficacy|13|||
130606103|NCT00406315|470179098|FG000|Overall Study|Other|33|||
130606104|NCT00406315|470179098|FG000|Overall Study|Lost to Follow-up|21|||
130606105|NCT00406315|470179098|FG000|Overall Study|Withdrawal by Subject|30|||
130606106|NCT01312428|470179099|FG000|Overall Study|Study Termination|3|||
130606107|NCT01312428|470179100|FG001|Overall Study|Study Termination|4|||
130606108|NCT00257192|470179101|FG000|Overall Study|Adverse Event|21|||
130606109|NCT00257192|470179102|FG001|Overall Study|Adverse Event|10|||
130606110|NCT00257192|470179101|FG000|Overall Study|Laboratory abnormality|1|||
130606111|NCT00257192|470179102|FG001|Overall Study|Laboratory abnormality|1|||
130606112|NCT00257192|470179101|FG000|Overall Study|Lost to Follow-up|3|||
130606113|NCT00257192|470179102|FG001|Overall Study|Lost to Follow-up|3|||
130606114|NCT00257192|470179101|FG000|Overall Study|Insufficient clinical response|18|||
130606115|NCT00257192|470179102|FG001|Overall Study|Insufficient clinical response|18|||
130606116|NCT00257192|470179101|FG000|Overall Study|Withdrawal by Subject|14|||
130606117|NCT00257192|470179102|FG001|Overall Study|Withdrawal by Subject|2|||
130606118|NCT00257192|470179101|FG000|Overall Study|Randomized but not treated|0|||
130606119|NCT00257192|470179102|FG001|Overall Study|Randomized but not treated|1|||
130606120|NCT00257192|470179101|FG000|Overall Study|Study terminated by sponsor|1|||
130606121|NCT00257192|470179102|FG001|Overall Study|Study terminated by sponsor|0|||
130606122|NCT00257192|470179101|FG000|Overall Study|Miscellaneous|0|||
130606123|NCT00257192|470179102|FG001|Overall Study|Miscellaneous|4|||
130606124|NCT00570739|470179103|FG000|Overall Study|Adverse Event|8|||
130606125|NCT00570739|470179104|FG001|Overall Study|Adverse Event|6|||
130606126|NCT00570739|470179105|FG002|Overall Study|Adverse Event|2|||
130606127|NCT00570739|470179106|FG003|Overall Study|Adverse Event|2|||
130606128|NCT00570739|470179103|FG000|Overall Study|Lost to Follow-up|4|||
130606129|NCT00570739|470179104|FG001|Overall Study|Lost to Follow-up|5|||
130606130|NCT00570739|470179105|FG002|Overall Study|Lost to Follow-up|4|||
130606131|NCT00570739|470179106|FG003|Overall Study|Lost to Follow-up|1|||
130606132|NCT00570739|470179103|FG000|Overall Study|Physician Decision|1|||
130606133|NCT00570739|470179104|FG001|Overall Study|Physician Decision|1|||
130606134|NCT00570739|470179105|FG002|Overall Study|Physician Decision|0|||
130606135|NCT00570739|470179106|FG003|Overall Study|Physician Decision|0|||
130606136|NCT00570739|470179103|FG000|Overall Study|Withdrawal by Subject|7|||
130606137|NCT00570739|470179104|FG001|Overall Study|Withdrawal by Subject|7|||
130606138|NCT00570739|470179105|FG002|Overall Study|Withdrawal by Subject|3|||
130606139|NCT00570739|470179106|FG003|Overall Study|Withdrawal by Subject|5|||
130606140|NCT00570739|470179103|FG000|Overall Study|Required restricted medication|0|||
130606141|NCT00570739|470179104|FG001|Overall Study|Required restricted medication|0|||
130606142|NCT00570739|470179105|FG002|Overall Study|Required restricted medication|1|||
130606143|NCT00570739|470179106|FG003|Overall Study|Required restricted medication|0|||
130606144|NCT00570739|470179103|FG000|Overall Study|Met discontinuation criteria|1|||
130606145|NCT00570739|470179104|FG001|Overall Study|Met discontinuation criteria|0|||
130606146|NCT00570739|470179105|FG002|Overall Study|Met discontinuation criteria|1|||
130606147|NCT00570739|470179106|FG003|Overall Study|Met discontinuation criteria|1|||
130606148|NCT00570739|470179103|FG000|Overall Study|Other|0|||
130606149|NCT00570739|470179104|FG001|Overall Study|Other|2|||
130606150|NCT00570739|470179105|FG002|Overall Study|Other|5|||
130606151|NCT00570739|470179106|FG003|Overall Study|Other|3|||
130606152|NCT01921270|470179111|FG000|Overall Study|Withdrawal by Subject|1|||
130606153|NCT00844428|470179112|FG000|Screening Period|Screen Failure|3|||
130606154|NCT00844428|470179112|FG000|Extension Treatment Period|Death|1|||
130606155|NCT00844428|470179112|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
130606156|NCT00789477|470179113|FG000|Overall Study|Withdrawal by Subject|2|||
130606157|NCT00789477|470179114|FG001|Overall Study|Withdrawal by Subject|1|||
130606158|NCT00789477|470179115|FG002|Overall Study|Withdrawal by Subject|3|||
130606159|NCT00789477|470179116|FG003|Overall Study|Withdrawal by Subject|2|||
130606160|NCT00789477|470179117|FG004|Overall Study|Withdrawal by Subject|3|||
130606161|NCT00789477|470179113|FG000|Overall Study|Protocol Violation|1|||
130606162|NCT00789477|470179114|FG001|Overall Study|Protocol Violation|0|||
130606163|NCT00789477|470179115|FG002|Overall Study|Protocol Violation|0|||
130606164|NCT00789477|470179116|FG003|Overall Study|Protocol Violation|1|||
130606165|NCT00789477|470179117|FG004|Overall Study|Protocol Violation|0|||
130606166|NCT00789477|470179113|FG000|Overall Study|Adverse Event|3|||
130606167|NCT00789477|470179114|FG001|Overall Study|Adverse Event|3|||
130606168|NCT00789477|470179115|FG002|Overall Study|Adverse Event|1|||
130606169|NCT00789477|470179116|FG003|Overall Study|Adverse Event|0|||
130606170|NCT00789477|470179117|FG004|Overall Study|Adverse Event|0|||
130606171|NCT00789477|470179113|FG000|Overall Study|Death|1|||
130606172|NCT00789477|470179114|FG001|Overall Study|Death|1|||
130606173|NCT00789477|470179115|FG002|Overall Study|Death|2|||
130606174|NCT00789477|470179116|FG003|Overall Study|Death|2|||
130606175|NCT00789477|470179117|FG004|Overall Study|Death|0|||
130606176|NCT00789477|470179113|FG000|Overall Study|Lost to Follow-up|0|||
130606177|NCT00789477|470179114|FG001|Overall Study|Lost to Follow-up|1|||
130606178|NCT00789477|470179115|FG002|Overall Study|Lost to Follow-up|4|||
130606179|NCT00789477|470179116|FG003|Overall Study|Lost to Follow-up|2|||
130606180|NCT00789477|470179117|FG004|Overall Study|Lost to Follow-up|4|||
130606181|NCT00789477|470179113|FG000|Overall Study|Lack of Efficacy|2|||
130606182|NCT00789477|470179114|FG001|Overall Study|Lack of Efficacy|0|||
130606183|NCT00789477|470179115|FG002|Overall Study|Lack of Efficacy|0|||
130606184|NCT00789477|470179116|FG003|Overall Study|Lack of Efficacy|0|||
130606185|NCT00789477|470179117|FG004|Overall Study|Lack of Efficacy|0|||
130606186|NCT00789477|470179113|FG000|Overall Study|Other|2|||
130606187|NCT00789477|470179114|FG001|Overall Study|Other|0|||
130606188|NCT00789477|470179115|FG002|Overall Study|Other|1|||
130606189|NCT00789477|470179116|FG003|Overall Study|Other|3|||
130606190|NCT00789477|470179117|FG004|Overall Study|Other|0|||
130606191|NCT01844700|470179118|FG000|Overall Study|Lack of Efficacy|1|||
130606192|NCT01844700|470179119|FG001|Overall Study|Lack of Efficacy|0|||
130606193|NCT01844700|470179118|FG000|Overall Study|refused medication switch|1|||
130606194|NCT01844700|470179119|FG001|Overall Study|refused medication switch|0|||
130606195|NCT01844700|470179118|FG000|Overall Study|Withdrawal by Subject|1|||
130606196|NCT01844700|470179119|FG001|Overall Study|Withdrawal by Subject|0|||
130606197|NCT01844700|470179118|FG000|Overall Study|stopped taking meds|0|||
130606198|NCT01844700|470179119|FG001|Overall Study|stopped taking meds|1|||
130606199|NCT02680847|470179120|FG000|Overall Study|Other|2|||
130606200|NCT02680847|470179121|FG001|Overall Study|Other|0|||
130606201|NCT02680847|470179122|FG002|Overall Study|Other|0|||
130606202|NCT02680847|470179120|FG000|Overall Study|No longer met eligibility criteria|2|||
130606203|NCT02680847|470179121|FG001|Overall Study|No longer met eligibility criteria|2|||
130606204|NCT02680847|470179122|FG002|Overall Study|No longer met eligibility criteria|0|||
130606205|NCT02680847|470179120|FG000|Overall Study|Unwilling to participate in study|1|||
130606206|NCT02680847|470179121|FG001|Overall Study|Unwilling to participate in study|1|||
130606207|NCT02680847|470179122|FG002|Overall Study|Unwilling to participate in study|0|||
130606208|NCT02680847|470179120|FG000|Overall Study|Lack of Efficacy|0|||
130606209|NCT02680847|470179121|FG001|Overall Study|Lack of Efficacy|0|||
130606210|NCT02680847|470179122|FG002|Overall Study|Lack of Efficacy|2|||
130606211|NCT02680847|470179120|FG000|Overall Study|Adverse Event|0|||
130606212|NCT02680847|470179121|FG001|Overall Study|Adverse Event|0|||
130606213|NCT02680847|470179122|FG002|Overall Study|Adverse Event|1|||
130606214|NCT02375698|470179123|FG000|Overall Study|Withdrawal by Subject|0|||
130606215|NCT02375698|470179124|FG001|Overall Study|Withdrawal by Subject|2|||
130606216|NCT02375698|470179123|FG000|Overall Study|Physician Decision|2|||
130606217|NCT02375698|470179124|FG001|Overall Study|Physician Decision|0|||
130606218|NCT00772967|470179127|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
130606219|NCT00772967|470179128|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
130606220|NCT00772967|470179129|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
130606221|NCT00772967|470179130|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
130606222|NCT00772967|470179131|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
130606223|NCT00772967|470179132|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
130606224|NCT00772967|470179127|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130606225|NCT00772967|470179128|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
130606226|NCT00772967|470179129|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130606227|NCT00772967|470179130|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130606228|NCT00772967|470179131|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130606229|NCT00772967|470179132|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130606230|NCT00772967|470179127|FG000|Crossover Treatment 3|Adverse Event|0|||
130606231|NCT00772967|470179128|FG001|Crossover Treatment 3|Adverse Event|0|||
130606232|NCT00772967|470179129|FG002|Crossover Treatment 3|Adverse Event|0|||
130606233|NCT00772967|470179130|FG003|Crossover Treatment 3|Adverse Event|0|||
130606234|NCT00772967|470179131|FG004|Crossover Treatment 3|Adverse Event|1|||
130606235|NCT00772967|470179132|FG005|Crossover Treatment 3|Adverse Event|0|||
130606236|NCT01595646|470179133|FG000|Overall Study|Withdrawal by Subject|1|||
130606237|NCT01595646|470179134|FG001|Overall Study|Withdrawal by Subject|0|||
130606238|NCT01595646|470179135|FG002|Overall Study|Withdrawal by Subject|0|||
130606239|NCT01161524|470179138|FG000|Core Study (23 Weeks)|Adverse Event|3|||
130606240|NCT01161524|470179139|FG001|Core Study (23 Weeks)|Adverse Event|0|||
130606241|NCT01161524|470179140|FG002|Core Study (23 Weeks)|Adverse Event|0|||
130606242|NCT01161524|470179138|FG000|Core Study (23 Weeks)|Other|1|||
130606243|NCT01161524|470179139|FG001|Core Study (23 Weeks)|Other|0|||
130606244|NCT01161524|470179140|FG002|Core Study (23 Weeks)|Other|0|||
130606245|NCT01161524|470179138|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
130606246|NCT01161524|470179139|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
130606247|NCT01161524|470179140|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
130606248|NCT01161524|470179138|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
130606249|NCT01161524|470179139|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
130606250|NCT01161524|470179140|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
130606251|NCT01161524|470179138|FG000|Core Study (23 Weeks)|Subject Choice|3|||
130606252|NCT01161524|470179139|FG001|Core Study (23 Weeks)|Subject Choice|2|||
130606253|NCT01161524|470179140|FG002|Core Study (23 Weeks)|Subject Choice|0|||
130606254|NCT01161524|470179138|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
130606255|NCT01161524|470179139|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
130606256|NCT01161524|470179140|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
130606257|NCT01161524|470179138|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
130606258|NCT01161524|470179139|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
130606259|NCT01161524|470179140|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
130606260|NCT01161524|470179138|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
130606261|NCT01161524|470179139|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
130606262|NCT01161524|470179140|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
130606263|NCT01161524|470179138|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
130606264|NCT01161524|470179139|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
130606265|NCT01161524|470179140|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
130606266|NCT01161524|470179138|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
130606267|NCT01161524|470179139|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
130606268|NCT01161524|470179140|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
130606269|NCT02021812|470179145|FG000|Overall Study|Death|8|||
130606270|NCT02021812|470179145|FG000|Overall Study|Withdrawal by Subject|3|||
130606271|NCT02021812|470179145|FG000|Overall Study|Lost to Follow-up|2|||
130606272|NCT02021812|470179145|FG000|Overall Study|Refuse to return, COVD 19|2|||
130606273|NCT03634072|470179146|FG000|Overall Study|Early termination of overall study|1|||
130606274|NCT03634072|470179147|FG001|Overall Study|Early termination of overall study|0|||
130606275|NCT00592501|470179149|FG000|Overall Study|Withdrawal by Subject|1|||
130606276|NCT00592501|470179149|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
130606277|NCT00053846|470179150|FG000|Overall Study|Changed mind|8|||
130606278|NCT00053846|470179151|FG001|Overall Study|Changed mind|13|||
130606279|NCT00053846|470179150|FG000|Overall Study|Became too ill|8|||
130606280|NCT00053846|470179151|FG001|Overall Study|Became too ill|7|||
130606281|NCT00053846|470179150|FG000|Overall Study|Expired|5|||
130606282|NCT00053846|470179151|FG001|Overall Study|Expired|0|||
130606283|NCT00053846|470179150|FG000|Overall Study|Became ineligible|3|||
130606284|NCT00053846|470179151|FG001|Overall Study|Became ineligible|1|||
130606285|NCT00053846|470179150|FG000|Overall Study|Did not return data|1|||
130606286|NCT00053846|470179151|FG001|Overall Study|Did not return data|2|||
130606287|NCT00053846|470179150|FG000|Overall Study|Quit due to side effects|1|||
130606288|NCT00053846|470179151|FG001|Overall Study|Quit due to side effects|3|||
130606289|NCT00053846|470179150|FG000|Overall Study|Pills too large|0|||
130606290|NCT00053846|470179151|FG001|Overall Study|Pills too large|1|||
130606291|NCT03880227|470179156|FG000|First Visit|Withdrawal by Subject|1|||
130606292|NCT03880227|470179157|FG001|First Visit|Withdrawal by Subject|0|||
130606293|NCT03880227|470179158|FG002|First Visit|Withdrawal by Subject|0|||
130606294|NCT03880227|470179159|FG003|First Visit|Withdrawal by Subject|0|||
130606295|NCT03880227|470179156|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
130606296|NCT03880227|470179157|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
130606297|NCT03880227|470179158|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
130606298|NCT03880227|470179159|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
130606299|NCT03880227|470179156|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130606300|NCT03880227|470179157|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130606301|NCT03880227|470179158|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
130606302|NCT03880227|470179159|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130606303|NCT03880227|470179156|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130606304|NCT03880227|470179157|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130606305|NCT03880227|470179158|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
130606306|NCT03880227|470179159|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130606307|NCT02229864|470179160|FG000|Overall Study|Death|2|||
130606308|NCT02229864|470179160|FG000|Overall Study|Lost to Follow-up|1|||
130606309|NCT01929044|470179161|FG000|Overall Study|Adverse Event|1|||
130606310|NCT01929044|470179162|FG001|Overall Study|Adverse Event|0|||
130606311|NCT01929044|470179161|FG000|Overall Study|Protocol Violation|9|||
130606312|NCT01929044|470179162|FG001|Overall Study|Protocol Violation|14|||
130606313|NCT01929044|470179161|FG000|Overall Study|Not Treated|1|||
130606314|NCT01929044|470179162|FG001|Overall Study|Not Treated|3|||
130606315|NCT02815397|470179163|FG000|Overall Study|Physician Decision|2|||
130606316|NCT01605396|470179164|FG000|Overall Study|Adverse Event|5|||
130606317|NCT01605396|470179165|FG001|Overall Study|Adverse Event|3|||
130606318|NCT01605396|470179164|FG000|Overall Study|Lost to Follow-up|1|||
130606319|NCT01605396|470179165|FG001|Overall Study|Lost to Follow-up|0|||
130606320|NCT01605396|470179164|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130606321|NCT01605396|470179165|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130606322|NCT01605396|470179164|FG000|Overall Study|Physician Decision|2|||
130606323|NCT01605396|470179165|FG001|Overall Study|Physician Decision|2|||
130606324|NCT01605396|470179164|FG000|Overall Study|Progressive Disease|23|||
130606325|NCT01605396|470179165|FG001|Overall Study|Progressive Disease|27|||
130606326|NCT01605396|470179164|FG000|Overall Study|Withdrawal by Subject|4|||
130606327|NCT01605396|470179165|FG001|Overall Study|Withdrawal by Subject|2|||
130606328|NCT01605396|470179164|FG000|Overall Study|Transfer Off Study|4|||
130606329|NCT01605396|470179165|FG001|Overall Study|Transfer Off Study|5|||
130606330|NCT03607682|470179166|FG000|Overall Study|Withdrawal by Subject|1|||
130606331|NCT03607682|470179166|FG000|Overall Study|Disease progression|1|||
130606332|NCT00376688|470179167|FG000|Overall Study|Adverse Event|3|||
130606333|NCT00376688|470179167|FG000|Overall Study|Death|1|||
130606334|NCT01254604|470180772|FG000|Overall Study|Lost to Follow-up|1|||
130606335|NCT01254604|470180773|FG001|Overall Study|Lost to Follow-up|1|||
130606336|NCT01254604|470180772|FG000|Overall Study|Protocol Violation|2|||
130606337|NCT01254604|470180773|FG001|Overall Study|Protocol Violation|2|||
130606338|NCT01254604|470180772|FG000|Overall Study|Withdrawal by Subject|2|||
130606339|NCT01254604|470180773|FG001|Overall Study|Withdrawal by Subject|4|||
130606340|NCT01254604|470180772|FG000|Overall Study|Adverse Event|3|||
130606341|NCT01254604|470180773|FG001|Overall Study|Adverse Event|2|||
130606342|NCT03074162|470180774|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130606343|NCT03074162|470180775|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130606344|NCT03074162|470180776|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
130606345|NCT03074162|470180777|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130606346|NCT03074162|470180778|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130606347|NCT03074162|470180779|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130606348|NCT03074162|470180774|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130606349|NCT03074162|470180775|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130606350|NCT03074162|470180776|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
130606351|NCT03074162|470180777|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130606352|NCT03074162|470180778|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130606353|NCT03074162|470180779|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
130606354|NCT03074162|470180774|FG000|Period 3|Withdrawal by Subject|1|||
130606355|NCT03074162|470180775|FG001|Period 3|Withdrawal by Subject|0|||
130606356|NCT03074162|470180776|FG002|Period 3|Withdrawal by Subject|0|||
130606357|NCT03074162|470180777|FG003|Period 3|Withdrawal by Subject|0|||
130606358|NCT03074162|470180778|FG004|Period 3|Withdrawal by Subject|1|||
130606359|NCT03074162|470180779|FG005|Period 3|Withdrawal by Subject|0|||
130606360|NCT01993329|470180780|FG000|Period 2|Adverse Event|0|||
130606361|NCT01993329|470180781|FG001|Period 2|Adverse Event|0|||
130606362|NCT01993329|470180782|FG002|Period 2|Adverse Event|0|||
130606363|NCT01993329|470180783|FG003|Period 2|Adverse Event|0|||
130606364|NCT01993329|470180784|FG004|Period 2|Adverse Event|0|||
130606365|NCT01993329|470180785|FG005|Period 2|Adverse Event|1|||
130606366|NCT01993329|470180780|FG000|Wash-out|Personal reasons|0|||
130606367|NCT01993329|470180781|FG001|Wash-out|Personal reasons|1|||
130606368|NCT01993329|470180782|FG002|Wash-out|Personal reasons|0|||
130606369|NCT01993329|470180783|FG003|Wash-out|Personal reasons|0|||
130606370|NCT01993329|470180784|FG004|Wash-out|Personal reasons|0|||
130606371|NCT01993329|470180785|FG005|Wash-out|Personal reasons|0|||
130606372|NCT05070429|470180786|FG000|Overall Study|Death|0|||
130606373|NCT05070429|470180787|FG001|Overall Study|Death|4|||
130606374|NCT05070429|470180786|FG000|Overall Study|Withdrawal by Subject|2|||
130606375|NCT05070429|470180787|FG001|Overall Study|Withdrawal by Subject|1|||
130606376|NCT05070429|470180786|FG000|Overall Study|Other|15|||
130606377|NCT05070429|470180787|FG001|Overall Study|Other|5|||
130606378|NCT02948777|470180788|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
130606379|NCT02311478|470180789|FG000|Overall Study|Withdrawal by Subject|1|||
130606380|NCT02311478|470180789|FG000|Overall Study|Lost to Follow-up|5|||
130606381|NCT02311478|470180789|FG000|Overall Study|Failed IUD Insertion|1|||
130606382|NCT03242928|470180790|FG000|Overall Study|Adverse Event|2|||
130606383|NCT03242928|470180791|FG001|Overall Study|Adverse Event|1|||
130606384|NCT03242928|470180790|FG000|Overall Study|Lost to Follow-up|2|||
130606385|NCT03242928|470180791|FG001|Overall Study|Lost to Follow-up|0|||
130606386|NCT03242928|470180790|FG000|Overall Study|Physician Decision|0|||
130606387|NCT03242928|470180791|FG001|Overall Study|Physician Decision|1|||
130606388|NCT03242928|470180790|FG000|Overall Study|Withdrawal by Subject|5|||
130606389|NCT03242928|470180791|FG001|Overall Study|Withdrawal by Subject|3|||
130606390|NCT03276936|470180792|FG000|Overall Study|Adverse Event|4|||
130606391|NCT03276936|470180793|FG001|Overall Study|Adverse Event|2|||
130606392|NCT03276936|470180792|FG000|Overall Study|Lost to Follow-up|16|||
130606393|NCT03276936|470180793|FG001|Overall Study|Lost to Follow-up|13|||
130606394|NCT03276936|470180792|FG000|Overall Study|Withdrawal by Subject|30|||
130606395|NCT03276936|470180793|FG001|Overall Study|Withdrawal by Subject|20|||
130606396|NCT03276936|470180792|FG000|Overall Study|Not mentioned|6|||
130606397|NCT03276936|470180793|FG001|Overall Study|Not mentioned|3|||
130606398|NCT03041116|470180794|FG000|Double-blind|Death|0|||
130606399|NCT03041116|470180795|FG001|Double-blind|Death|2|||
130606400|NCT03041116|470180794|FG000|Double-blind|Withdrawal by Subject|0|||
130606401|NCT03041116|470180795|FG001|Double-blind|Withdrawal by Subject|4|||
130606402|NCT03041116|470180794|FG000|Open-label|Death|1|||
130606403|NCT03041116|470180795|FG001|Open-label|Death|0|||
130606404|NCT03041116|470180794|FG000|Open-label|Termination of the study by Sponsor|39|||
130606405|NCT03041116|470180795|FG001|Open-label|Termination of the study by Sponsor|37|||
130606406|NCT03041116|470180794|FG000|Open-label|Withdrawal by Subject|1|||
130606407|NCT03041116|470180795|FG001|Open-label|Withdrawal by Subject|0|||
130606408|NCT00943319|470180796|FG000|Overall Study|Death|1|||
130606409|NCT02043301|470180797|FG000|Overall Study|Discontinued|0|||
130606410|NCT02043301|470180798|FG001|Overall Study|Discontinued|1|||
130606411|NCT02043301|470180799|FG002|Overall Study|Discontinued|0|||
130606412|NCT01798134|470180800|FG000|Overall Study|Lost to Follow-up|1|||
130606413|NCT01798134|470180800|FG000|Overall Study|Withdrawal by Subject|3|||
130606414|NCT01798134|470180800|FG000|Overall Study|Death|2|||
130606415|NCT01798134|470180800|FG000|Overall Study|Adverse Event|3|||
130606416|NCT01798134|470180800|FG000|Overall Study|Physician Decision|3|||
130606417|NCT01798134|470180800|FG000|Overall Study|Liver transplant/surgery|4|||
130606418|NCT02023164|470180801|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
130606419|NCT02023164|470180802|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
130606420|NCT02436577|470180803|FG000|Overall Study|Protocol Deviation|0|||
130606421|NCT02436577|470180804|FG001|Overall Study|Protocol Deviation|1|||
130606422|NCT02436577|470180805|FG002|Overall Study|Protocol Deviation|0|||
130606423|NCT02436577|470180806|FG003|Overall Study|Protocol Deviation|0|||
130606424|NCT02436577|470180807|FG004|Overall Study|Protocol Deviation|0|||
130606425|NCT02436577|470180808|FG005|Overall Study|Protocol Deviation|0|||
130606426|NCT03703375|470180812|FG000|Randomization Period|Withdrawal by Subject|0|||
130606427|NCT03703375|470180813|FG001|Randomization Period|Withdrawal by Subject|0|||
130606428|NCT03703375|470180814|FG002|Randomization Period|Withdrawal by Subject|0|||
130606429|NCT03703375|470180815|FG003|Randomization Period|Withdrawal by Subject|1|||
130606430|NCT03703375|470180812|FG000|Randomization Period|Completed safety run-in treatment|7|||
130606431|NCT03703375|470180813|FG001|Randomization Period|Completed safety run-in treatment|0|||
130606432|NCT03703375|470180814|FG002|Randomization Period|Completed safety run-in treatment|0|||
130606433|NCT03703375|470180815|FG003|Randomization Period|Completed safety run-in treatment|0|||
130606434|NCT03703375|470180812|FG000|Treatment Period|Other Reasons|0|||
130606435|NCT03703375|470180813|FG001|Treatment Period|Other Reasons|1|||
130606436|NCT03703375|470180814|FG002|Treatment Period|Other Reasons|0|||
130606437|NCT03703375|470180815|FG003|Treatment Period|Other Reasons|3|||
130606438|NCT03703375|470180812|FG000|Treatment Period|Consent Withdrawal|0|||
130606439|NCT03703375|470180813|FG001|Treatment Period|Consent Withdrawal|0|||
130606440|NCT03703375|470180814|FG002|Treatment Period|Consent Withdrawal|0|||
130606441|NCT03703375|470180815|FG003|Treatment Period|Consent Withdrawal|1|||
130606442|NCT03703375|470180812|FG000|Treatment Period|Death|1|||
130606443|NCT03703375|470180813|FG001|Treatment Period|Death|0|||
130606444|NCT03703375|470180814|FG002|Treatment Period|Death|1|||
130606445|NCT03703375|470180815|FG003|Treatment Period|Death|2|||
130606446|NCT03703375|470180812|FG000|Treatment Period|Toxicity of Study Treatment|2|||
130606447|NCT03703375|470180813|FG001|Treatment Period|Toxicity of Study Treatment|0|||
130606448|NCT03703375|470180814|FG002|Treatment Period|Toxicity of Study Treatment|4|||
130606449|NCT03703375|470180815|FG003|Treatment Period|Toxicity of Study Treatment|1|||
130606450|NCT03703375|470180812|FG000|Treatment Period|Progression|32|||
130606451|NCT03703375|470180813|FG001|Treatment Period|Progression|1|||
130606452|NCT03703375|470180814|FG002|Treatment Period|Progression|7|||
130606453|NCT03703375|470180815|FG003|Treatment Period|Progression|11|||
130606454|NCT03703375|470180812|FG000|Treatment Period|Completed treatment|7|||
130606455|NCT03703375|470180813|FG001|Treatment Period|Completed treatment|2|||
130606456|NCT03703375|470180814|FG002|Treatment Period|Completed treatment|0|||
130606457|NCT03703375|470180815|FG003|Treatment Period|Completed treatment|0|||
130606458|NCT02678741|470180818|FG000|Overall Study|Death|4|||
130606459|NCT02678741|470180818|FG000|Overall Study|Withdrawal by Subject|1|||
130606460|NCT02678741|470180818|FG000|Overall Study|ineligible|3|||
130606461|NCT02678741|470180818|FG000|Overall Study|Not RECIST Measurable|2|||
130606462|NCT02678741|470180818|FG000|Overall Study|Lack of Efficacy|10|||
130606463|NCT00903032|470180819|FG000|Overall Study|Withdrawal by Subject|5|||
130606464|NCT00903032|470180820|FG001|Overall Study|Withdrawal by Subject|3|||
130606465|NCT00903032|470180819|FG000|Overall Study|Lost to Follow-up|2|||
130606466|NCT00903032|470180820|FG001|Overall Study|Lost to Follow-up|2|||
130606467|NCT00931892|470180821|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
130606468|NCT00931892|470180822|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
130606469|NCT01876732|470180823|FG000|Overall Study|MMA was not over 800mg/dL|75|||
130606470|NCT01258348|470180828|FG000|Overall Study|Adverse Event|1|||
130606471|NCT01258348|470180829|FG001|Overall Study|Adverse Event|1|||
130606472|NCT01258348|470180830|FG002|Overall Study|Adverse Event|3|||
130606473|NCT01258348|470180831|FG003|Overall Study|Adverse Event|2|||
130606474|NCT01258348|470180832|FG004|Overall Study|Adverse Event|4|||
130606475|NCT01258348|470180828|FG000|Overall Study|Progressive Disease|0|||
130606476|NCT01258348|470180829|FG001|Overall Study|Progressive Disease|3|||
130606477|NCT01258348|470180830|FG002|Overall Study|Progressive Disease|0|||
130606478|NCT01258348|470180831|FG003|Overall Study|Progressive Disease|2|||
130606479|NCT01258348|470180832|FG004|Overall Study|Progressive Disease|2|||
130606480|NCT01258348|470180828|FG000|Overall Study|Physician Decision|0|||
130606481|NCT01258348|470180829|FG001|Overall Study|Physician Decision|0|||
130606482|NCT01258348|470180830|FG002|Overall Study|Physician Decision|0|||
130606483|NCT01258348|470180831|FG003|Overall Study|Physician Decision|2|||
130606484|NCT01258348|470180832|FG004|Overall Study|Physician Decision|0|||
130606485|NCT01258348|470180828|FG000|Overall Study|Withdrawal by Subject|0|||
130606486|NCT01258348|470180829|FG001|Overall Study|Withdrawal by Subject|1|||
130606487|NCT01258348|470180830|FG002|Overall Study|Withdrawal by Subject|0|||
130606488|NCT01258348|470180831|FG003|Overall Study|Withdrawal by Subject|0|||
130606489|NCT01258348|470180832|FG004|Overall Study|Withdrawal by Subject|0|||
130606490|NCT02184143|470180833|FG000|Overall Study|Withdrawal by Subject|4|||
130606491|NCT02184143|470180834|FG001|Overall Study|Withdrawal by Subject|4|||
130606492|NCT02184143|470180833|FG000|Overall Study|Lost to Follow-up|5|||
130606493|NCT02184143|470180834|FG001|Overall Study|Lost to Follow-up|3|||
130606494|NCT02184143|470180833|FG000|Overall Study|Death|1|||
130606495|NCT02184143|470180834|FG001|Overall Study|Death|0|||
130606496|NCT00321984|470180835|FG000|Overall Study|Adverse Event|9|||
130606497|NCT00321984|470180836|FG001|Overall Study|Adverse Event|6|||
130606498|NCT00321984|470180837|FG002|Overall Study|Adverse Event|8|||
130606499|NCT00321984|470180835|FG000|Overall Study|Protocol Violation|0|||
130606500|NCT00321984|470180836|FG001|Overall Study|Protocol Violation|1|||
130606501|NCT00321984|470180837|FG002|Overall Study|Protocol Violation|1|||
130606502|NCT00321984|470180835|FG000|Overall Study|Lost to Follow-up|2|||
130606503|NCT00321984|470180836|FG001|Overall Study|Lost to Follow-up|4|||
130606504|NCT00321984|470180837|FG002|Overall Study|Lost to Follow-up|2|||
130606505|NCT00321984|470180835|FG000|Overall Study|Withdrawal by Subject|8|||
130606506|NCT00321984|470180836|FG001|Overall Study|Withdrawal by Subject|6|||
130606507|NCT00321984|470180837|FG002|Overall Study|Withdrawal by Subject|5|||
130606508|NCT00321984|470180835|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
130606509|NCT00321984|470180836|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
130606510|NCT00321984|470180837|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130606511|NCT00321984|470180835|FG000|Overall Study|Lack of Efficacy|3|||
130606512|NCT00321984|470180836|FG001|Overall Study|Lack of Efficacy|1|||
130606513|NCT00321984|470180837|FG002|Overall Study|Lack of Efficacy|3|||
130606514|NCT00321984|470180835|FG000|Overall Study|Noncompliant|0|||
130606515|NCT00321984|470180836|FG001|Overall Study|Noncompliant|0|||
130606516|NCT00321984|470180837|FG002|Overall Study|Noncompliant|2|||
130606517|NCT00321984|470180835|FG000|Overall Study|Pregnancy|0|||
130606518|NCT00321984|470180836|FG001|Overall Study|Pregnancy|1|||
130606519|NCT00321984|470180837|FG002|Overall Study|Pregnancy|0|||
130606520|NCT00321984|470180835|FG000|Overall Study|Per Subject Request|1|||
130606521|NCT00321984|470180836|FG001|Overall Study|Per Subject Request|0|||
130606522|NCT00321984|470180837|FG002|Overall Study|Per Subject Request|0|||
130606523|NCT00321984|470180835|FG000|Overall Study|Per Investigator Request|1|||
130606524|NCT00321984|470180836|FG001|Overall Study|Per Investigator Request|0|||
130606525|NCT00321984|470180837|FG002|Overall Study|Per Investigator Request|0|||
130606526|NCT00321984|470180835|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
130606527|NCT00321984|470180836|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
130606528|NCT00321984|470180837|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
130606529|NCT02137772|470180839|FG000|Overall Study|Adverse Event|6|||
130606530|NCT02137772|470180840|FG001|Overall Study|Adverse Event|3|||
130606531|NCT02137772|470180839|FG000|Overall Study|Death|71|||
130606532|NCT02137772|470180840|FG001|Overall Study|Death|44|||
130606533|NCT02137772|470180839|FG000|Overall Study|Lost to Follow-up|8|||
130606534|NCT02137772|470180840|FG001|Overall Study|Lost to Follow-up|4|||
130606535|NCT02137772|470180839|FG000|Overall Study|Physician Decision|15|||
130606536|NCT02137772|470180840|FG001|Overall Study|Physician Decision|5|||
130606537|NCT02137772|470180839|FG000|Overall Study|Withdrawal by Subject|28|||
130606538|NCT02137772|470180840|FG001|Overall Study|Withdrawal by Subject|17|||
130606539|NCT02137772|470180839|FG000|Overall Study|Non-compliance with study drug|1|||
130606540|NCT02137772|470180840|FG001|Overall Study|Non-compliance with study drug|0|||
130606541|NCT02137772|470180839|FG000|Overall Study|Not treated|3|||
130606542|NCT02137772|470180840|FG001|Overall Study|Not treated|2|||
130606543|NCT00803244|470180841|FG000|Overall Study|Adverse Event|1|||
130606544|NCT00803244|470180842|FG001|Overall Study|Adverse Event|2|||
130606545|NCT00803244|470180841|FG000|Overall Study|Withdrawal by Subject|2|||
130606546|NCT00803244|470180842|FG001|Overall Study|Withdrawal by Subject|3|||
130606547|NCT00803244|470180841|FG000|Overall Study|Any other reason not above-mentioned|4|||
130606548|NCT00803244|470180842|FG001|Overall Study|Any other reason not above-mentioned|10|||
130606549|NCT00616239|470180844|FG000|Overall Study|Withdrawal by Subject|2|||
130606550|NCT02873715|470180845|FG000|Overall Study|Lost to Follow-up|84|||
130606551|NCT02873715|470180846|FG001|Overall Study|Lost to Follow-up|94|||
130606552|NCT02873715|470180845|FG000|Overall Study|Withdrawal by Subject|7|||
130606553|NCT02873715|470180846|FG001|Overall Study|Withdrawal by Subject|26|||
130606554|NCT03241173|470180850|FG000|Overall Study|Death|3|||
130606555|NCT03241173|470180851|FG001|Overall Study|Death|2|||
130606556|NCT03241173|470180852|FG002|Overall Study|Death|4|||
130606557|NCT03241173|470180853|FG003|Overall Study|Death|4|||
130606558|NCT03241173|470180854|FG004|Overall Study|Death|2|||
130606559|NCT03241173|470180855|FG005|Overall Study|Death|2|||
130606560|NCT03241173|470180856|FG006|Overall Study|Death|3|||
130606561|NCT03241173|470180857|FG007|Overall Study|Death|1|||
130606562|NCT03241173|470180858|FG008|Overall Study|Death|0|||
130606563|NCT03241173|470180859|FG009|Overall Study|Death|5|||
130606564|NCT03241173|470180860|FG010|Overall Study|Death|4|||
130606565|NCT03241173|470180861|FG011|Overall Study|Death|3|||
130606566|NCT03241173|470180862|FG012|Overall Study|Death|0|||
130606567|NCT03241173|470180863|FG013|Overall Study|Death|0|||
130606568|NCT03241173|470180864|FG014|Overall Study|Death|0|||
130606569|NCT03241173|470180850|FG000|Overall Study|Withdrawal by Subject|0|||
130606570|NCT03241173|470180851|FG001|Overall Study|Withdrawal by Subject|0|||
130606571|NCT03241173|470180852|FG002|Overall Study|Withdrawal by Subject|1|||
130606572|NCT03241173|470180853|FG003|Overall Study|Withdrawal by Subject|0|||
130606573|NCT03241173|470180854|FG004|Overall Study|Withdrawal by Subject|0|||
130606574|NCT03241173|470180855|FG005|Overall Study|Withdrawal by Subject|1|||
130606575|NCT03241173|470180856|FG006|Overall Study|Withdrawal by Subject|0|||
130606576|NCT03241173|470180857|FG007|Overall Study|Withdrawal by Subject|0|||
130606577|NCT03241173|470180858|FG008|Overall Study|Withdrawal by Subject|0|||
130606578|NCT03241173|470180859|FG009|Overall Study|Withdrawal by Subject|0|||
130606579|NCT03241173|470180860|FG010|Overall Study|Withdrawal by Subject|0|||
130606580|NCT03241173|470180861|FG011|Overall Study|Withdrawal by Subject|0|||
130606581|NCT03241173|470180862|FG012|Overall Study|Withdrawal by Subject|0|||
130606582|NCT03241173|470180863|FG013|Overall Study|Withdrawal by Subject|0|||
130606583|NCT03241173|470180864|FG014|Overall Study|Withdrawal by Subject|0|||
130606584|NCT03241173|470180850|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130606585|NCT03241173|470180851|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130606586|NCT03241173|470180852|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606587|NCT03241173|470180853|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130606588|NCT03241173|470180854|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130606589|NCT03241173|470180855|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130606590|NCT03241173|470180856|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130606591|NCT03241173|470180857|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130606592|NCT03241173|470180858|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606593|NCT03241173|470180859|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606594|NCT03241173|470180860|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130606595|NCT03241173|470180861|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
130606596|NCT03241173|470180862|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606597|NCT03241173|470180863|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606598|NCT03241173|470180864|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130606599|NCT03241173|470180850|FG000|Overall Study|Lost to Follow-up|0|||
130606600|NCT03241173|470180851|FG001|Overall Study|Lost to Follow-up|0|||
130606601|NCT03241173|470180852|FG002|Overall Study|Lost to Follow-up|0|||
130606602|NCT03241173|470180853|FG003|Overall Study|Lost to Follow-up|0|||
130606603|NCT03241173|470180854|FG004|Overall Study|Lost to Follow-up|1|||
130606604|NCT03241173|470180855|FG005|Overall Study|Lost to Follow-up|0|||
130606605|NCT03241173|470180856|FG006|Overall Study|Lost to Follow-up|0|||
130606606|NCT03241173|470180857|FG007|Overall Study|Lost to Follow-up|0|||
130606607|NCT03241173|470180858|FG008|Overall Study|Lost to Follow-up|0|||
130606608|NCT03241173|470180859|FG009|Overall Study|Lost to Follow-up|1|||
130606609|NCT03241173|470180860|FG010|Overall Study|Lost to Follow-up|0|||
130606610|NCT03241173|470180861|FG011|Overall Study|Lost to Follow-up|0|||
130606611|NCT03241173|470180862|FG012|Overall Study|Lost to Follow-up|0|||
130606612|NCT03241173|470180863|FG013|Overall Study|Lost to Follow-up|0|||
130606613|NCT03241173|470180864|FG014|Overall Study|Lost to Follow-up|0|||
130606614|NCT00564629|470180865|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
130606615|NCT00564629|470180866|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
130606616|NCT03648996|470180867|FG000|Overall Study|Withdrawal by Subject|0|||
130606617|NCT03648996|470180868|FG001|Overall Study|Withdrawal by Subject|2|||
130606618|NCT03648996|470180869|FG002|Overall Study|Withdrawal by Subject|2|||
130606619|NCT03648996|470180867|FG000|Overall Study|Physician Decision|2|||
130606620|NCT03648996|470180868|FG001|Overall Study|Physician Decision|0|||
130606621|NCT03648996|470180869|FG002|Overall Study|Physician Decision|0|||
130606622|NCT00590681|470180873|FG000|Overall Study|Withdrawal by Subject|7|||
130606623|NCT00590681|470180873|FG000|Overall Study|Adverse Event|8|||
130606624|NCT00590681|470180873|FG000|Overall Study|Death|3|||
130606625|NCT00590681|470180873|FG000|Overall Study|Lost to Follow-up|1|||
130606626|NCT00590681|470180873|FG000|Overall Study|disease progression|1|||
130606627|NCT00443430|470180876|FG000|Overall Study|Lack of Efficacy|3|||
130606628|NCT00443430|470180877|FG001|Overall Study|Lack of Efficacy|3|||
130606629|NCT00443430|470180876|FG000|Overall Study|Adverse Event|1|||
130606630|NCT00443430|470180877|FG001|Overall Study|Adverse Event|1|||
130606631|NCT00064662|470180879|FG000|Overall Study|Death|1|||
130606632|NCT00064662|470180880|FG001|Overall Study|Death|1|||
130606633|NCT00064662|470180879|FG000|Overall Study|Lost to Follow-up|57|||
130606634|NCT00064662|470180880|FG001|Overall Study|Lost to Follow-up|44|||
130606635|NCT00064662|470180879|FG000|Overall Study|Withdrawal by Subject|14|||
130606636|NCT00064662|470180880|FG001|Overall Study|Withdrawal by Subject|14|||
130606637|NCT00064662|470180879|FG000|Overall Study|Administratively withdrawn|2|||
130606638|NCT00064662|470180880|FG001|Overall Study|Administratively withdrawn|2|||
130606639|NCT00504166|470180881|FG000|Overall Study|Adverse Event|1|||
130606640|NCT00504166|470180882|FG001|Overall Study|Adverse Event|4|||
130606641|NCT00504166|470180881|FG000|Overall Study|Withdrawal by Subject|3|||
130606642|NCT00504166|470180882|FG001|Overall Study|Withdrawal by Subject|6|||
130606643|NCT00504166|470180881|FG000|Overall Study|Physician Decision|1|||
130606644|NCT00504166|470180882|FG001|Overall Study|Physician Decision|1|||
130606645|NCT00504166|470180881|FG000|Overall Study|Lost to Follow-up|1|||
130606646|NCT00504166|470180882|FG001|Overall Study|Lost to Follow-up|3|||
130606647|NCT02650284|470180887|FG000|Overall Study|Lost to Follow-up|3|||
130606648|NCT02650284|470180888|FG001|Overall Study|Lost to Follow-up|3|||
130606649|NCT02650284|470180887|FG000|Overall Study|Consent incorrectly taken|0|||
130606650|NCT02650284|470180888|FG001|Overall Study|Consent incorrectly taken|1|||
130606651|NCT02807454|470180895|FG000|Overall Study|Adverse Event|1|||
130606652|NCT02807454|470180896|FG001|Overall Study|Adverse Event|0|||
130606653|NCT02807454|470180895|FG000|Overall Study|Withdrawal by Subject|0|||
130606654|NCT02807454|470180896|FG001|Overall Study|Withdrawal by Subject|1|||
130606655|NCT02807454|470180895|FG000|Overall Study|Progressive Disease|30|||
130606656|NCT02807454|470180896|FG001|Overall Study|Progressive Disease|3|||
130606657|NCT02807454|470180895|FG000|Overall Study|Other Reasons|1|||
130606658|NCT02807454|470180896|FG001|Overall Study|Other Reasons|1|||
130606659|NCT01165203|470180897|FG000|Active Phase|Serious Adverse Event|1|||
130606660|NCT01165203|470180898|FG001|Active Phase|Serious Adverse Event|0|||
130606661|NCT01165203|470180897|FG000|Active Phase|Withdrawal by Subject|2|||
130606662|NCT01165203|470180898|FG001|Active Phase|Withdrawal by Subject|1|||
130606663|NCT01165203|470180897|FG000|Active Phase|Migrated/moved from study area|0|||
130606664|NCT01165203|470180898|FG001|Active Phase|Migrated/moved from study area|1|||
130606665|NCT01165203|470180897|FG000|Active Phase|Lost to Follow-up|2|||
130606666|NCT01165203|470180898|FG001|Active Phase|Lost to Follow-up|0|||
130606667|NCT01165203|470180897|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
130606668|NCT01165203|470180898|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
130606669|NCT01165203|470180897|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
130606670|NCT01165203|470180898|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
130606671|NCT01165203|470180897|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
130606672|NCT01165203|470180898|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
130606673|NCT01165203|470180897|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
130606674|NCT01165203|470180898|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
130606675|NCT01165203|470180897|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
130606676|NCT01165203|470180898|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
130606677|NCT00374907|470180899|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
130606678|NCT00374907|470180900|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
130606679|NCT00374907|470180899|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
130606680|NCT00374907|470180900|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
130606681|NCT00374907|470180899|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
130606682|NCT00374907|470180900|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
130606683|NCT00374907|470180899|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
130606684|NCT00374907|470180900|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
130606685|NCT00374907|470180899|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
130606686|NCT00374907|470180900|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
130606687|NCT01780389|470180905|FG000|Overall Study|Adverse Event|1|||
130606688|NCT02582749|470180907|FG000|Overall Study|Study terminated by funder|5|||
130606689|NCT02582749|470180908|FG001|Overall Study|Study terminated by funder|10|||
130606690|NCT02582749|470180907|FG000|Overall Study|Withdrawal by Subject|0|||
130606691|NCT02582749|470180908|FG001|Overall Study|Withdrawal by Subject|1|||
130606692|NCT01323673|470180911|FG000|Overall Study|Adverse Event|0|||
130606693|NCT01323673|470180912|FG001|Overall Study|Adverse Event|1|||
130606694|NCT01323673|470180911|FG000|Overall Study|Lost to Follow-up|0|||
130606695|NCT01323673|470180912|FG001|Overall Study|Lost to Follow-up|1|||
130606696|NCT01323673|470180911|FG000|Overall Study|Protocol Violation|1|||
130606697|NCT01323673|470180912|FG001|Overall Study|Protocol Violation|0|||
130606698|NCT01323673|470180911|FG000|Overall Study|Withdrawal by Subject|2|||
130606699|NCT01323673|470180912|FG001|Overall Study|Withdrawal by Subject|3|||
130606700|NCT04598165|470180913|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
130606701|NCT04598165|470180914|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
130606702|NCT04598165|470180913|FG000|Completed 6-week Follow-up|Death|2|||
130606703|NCT04598165|470180914|FG001|Completed 6-week Follow-up|Death|1|||
130606704|NCT04598165|470180913|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
130606705|NCT04598165|470180914|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
130606706|NCT04598165|470180913|FG000|Completed 6-week Follow-up|Ineligible|4|||
130606707|NCT04598165|470180914|FG001|Completed 6-week Follow-up|Ineligible|3|||
130606708|NCT04598165|470180913|FG000|Completed 6-week Follow-up|Partner refusal|0|||
130606709|NCT04598165|470180914|FG001|Completed 6-week Follow-up|Partner refusal|1|||
130606710|NCT04598165|470180913|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
130606711|NCT04598165|470180914|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
130606712|NCT01200511|470180915|FG000|Overall Study|Lost to Follow-up|3|||
130606713|NCT01200511|470180915|FG000|Overall Study|Withdrawal by Subject|1|||
130606714|NCT01200511|470180915|FG000|Overall Study|Adverse Event|1|||
130606715|NCT04229446|470180919|FG000|Overall Study|Death|12|||
130606716|NCT04229446|470180920|FG001|Overall Study|Death|10|||
130606717|NCT04229446|470180919|FG000|Overall Study|Lost to Follow-up|5|||
130606718|NCT04229446|470180920|FG001|Overall Study|Lost to Follow-up|8|||
130606719|NCT02566525|470180921|FG000|Overall Study|Protocol Violation|3|||
130606720|NCT02566525|470180922|FG001|Overall Study|Protocol Violation|5|||
130606721|NCT00337467|470180923|FG000|Overall Study|Adverse Event|3|||
130606722|NCT00337467|470180923|FG000|Overall Study|Subject Withdrew Consent|2|||
130606723|NCT00337467|470180923|FG000|Overall Study|Pregnancy|1|||
130606724|NCT00337467|470180923|FG000|Overall Study|Lost to Follow-up|2|||
130606725|NCT00337467|470180923|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
130606726|NCT04083222|470180924|FG000|Overall Study|Voluntary Withdrawal|0|||
130606727|NCT04083222|470180925|FG001|Overall Study|Voluntary Withdrawal|1|||
130606728|NCT04083222|470180924|FG000|Overall Study|Reason not Specified|0|||
130606729|NCT04083222|470180925|FG001|Overall Study|Reason not Specified|1|||
130606730|NCT03103750|470180926|FG000|Overall Study|Adverse Event|1|||
130606731|NCT03103750|470180927|FG001|Overall Study|Adverse Event|0|||
130606732|NCT03103750|470180926|FG000|Overall Study|Lost to Follow-up|1|||
130606733|NCT03103750|470180927|FG001|Overall Study|Lost to Follow-up|0|||
130606734|NCT03103750|470180926|FG000|Overall Study|PET Equipment Related|2|||
130606735|NCT03103750|470180927|FG001|Overall Study|PET Equipment Related|2|||
130606736|NCT01663740|470180935|FG000|Overall Study|Lost to Follow-up|1|||
130606737|NCT01663740|470180936|FG001|Overall Study|Lost to Follow-up|4|||
130606738|NCT01663740|470180935|FG000|Overall Study|Other|9|||
130606739|NCT01663740|470180936|FG001|Overall Study|Other|2|||
130606740|NCT01663740|470180935|FG000|Overall Study|Inclusion/Exclusion not met|1|||
130606741|NCT01663740|470180936|FG001|Overall Study|Inclusion/Exclusion not met|0|||
130606742|NCT01663740|470180935|FG000|Overall Study|Death|0|||
130606743|NCT01663740|470180936|FG001|Overall Study|Death|1|||
130606744|NCT01663740|470180935|FG000|Overall Study|Withdrawal by Subject|2|||
130606745|NCT01663740|470180936|FG001|Overall Study|Withdrawal by Subject|1|||
130606746|NCT01663740|470180935|FG000|Overall Study|No end of study status|3|||
130606747|NCT01663740|470180936|FG001|Overall Study|No end of study status|0|||
130606748|NCT04400318|470182520|FG000|Overall Study|Adverse Event|1|||
130606749|NCT04400318|470182521|FG001|Overall Study|Adverse Event|0|||
130606750|NCT04400318|470182520|FG000|Overall Study|Withdrawal by Subject|1|||
130606751|NCT04400318|470182521|FG001|Overall Study|Withdrawal by Subject|1|||
130606752|NCT04400318|470182520|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
130606753|NCT04400318|470182521|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
130606754|NCT00747617|470182522|FG000|Overall Study|Lost to Follow-up|3|||
130606755|NCT00747617|470182523|FG001|Overall Study|Lost to Follow-up|1|||
130606756|NCT02279524|470182524|FG000|Overall Study|Withdrawal by Subject|3|||
130606757|NCT02279524|470182525|FG001|Overall Study|Withdrawal by Subject|6|||
130606758|NCT02279524|470182526|FG002|Overall Study|Withdrawal by Subject|3|||
130606759|NCT02279524|470182524|FG000|Overall Study|Adverse Event|4|||
130606760|NCT02279524|470182525|FG001|Overall Study|Adverse Event|3|||
130606761|NCT02279524|470182526|FG002|Overall Study|Adverse Event|2|||
130606762|NCT02279524|470182524|FG000|Overall Study|Lost to Follow-up|1|||
130606763|NCT02279524|470182525|FG001|Overall Study|Lost to Follow-up|1|||
130606764|NCT02279524|470182526|FG002|Overall Study|Lost to Follow-up|0|||
130606765|NCT02279524|470182524|FG000|Overall Study|Disallowed medication|1|||
130606766|NCT02279524|470182525|FG001|Overall Study|Disallowed medication|1|||
130606767|NCT02279524|470182526|FG002|Overall Study|Disallowed medication|2|||
130606768|NCT02279524|470182524|FG000|Overall Study|Bariatric surgery|1|||
130606769|NCT02279524|470182525|FG001|Overall Study|Bariatric surgery|0|||
130606770|NCT02279524|470182526|FG002|Overall Study|Bariatric surgery|0|||
130606771|NCT00912015|470182530|FG000|Overall Study|Lack of Efficacy|1|||
130606772|NCT00912015|470182531|FG001|Overall Study|Lack of Efficacy|0|||
130606773|NCT00912015|470182532|FG002|Overall Study|Lack of Efficacy|0|||
130606774|NCT00912015|470182533|FG003|Overall Study|Lack of Efficacy|0|||
130606775|NCT00912015|470182530|FG000|Overall Study|Withdrawal by Subject|8|||
130606776|NCT00912015|470182531|FG001|Overall Study|Withdrawal by Subject|8|||
130606777|NCT00912015|470182532|FG002|Overall Study|Withdrawal by Subject|3|||
130606778|NCT00912015|470182533|FG003|Overall Study|Withdrawal by Subject|0|||
130606779|NCT00912015|470182530|FG000|Overall Study|Protocol Violation|1|||
130606780|NCT00912015|470182531|FG001|Overall Study|Protocol Violation|0|||
130606781|NCT00912015|470182532|FG002|Overall Study|Protocol Violation|0|||
130606782|NCT00912015|470182533|FG003|Overall Study|Protocol Violation|1|||
130606783|NCT00912015|470182530|FG000|Overall Study|Adverse Event|6|||
130606784|NCT00912015|470182531|FG001|Overall Study|Adverse Event|0|||
130606785|NCT00912015|470182532|FG002|Overall Study|Adverse Event|0|||
130606786|NCT00912015|470182533|FG003|Overall Study|Adverse Event|1|||
130606787|NCT01356602|470182534|FG000|Overall Study|Protocol Deviation|0|||
130606788|NCT01356602|470182535|FG001|Overall Study|Protocol Deviation|1|||
130606789|NCT01356602|470182536|FG002|Overall Study|Protocol Deviation|1|||
130606790|NCT01356602|470182534|FG000|Overall Study|Administrative Problems|1|||
130606791|NCT01356602|470182535|FG001|Overall Study|Administrative Problems|4|||
130606792|NCT01356602|470182536|FG002|Overall Study|Administrative Problems|5|||
130606793|NCT01356602|470182534|FG000|Overall Study|Lost to Follow-up|4|||
130606794|NCT01356602|470182535|FG001|Overall Study|Lost to Follow-up|5|||
130606795|NCT01356602|470182536|FG002|Overall Study|Lost to Follow-up|6|||
130606796|NCT01356602|470182534|FG000|Overall Study|Withdrawal by Subject|4|||
130606797|NCT01356602|470182535|FG001|Overall Study|Withdrawal by Subject|3|||
130606798|NCT01356602|470182536|FG002|Overall Study|Withdrawal by Subject|7|||
130606799|NCT01356602|470182534|FG000|Overall Study|Lack of Efficacy|0|||
130606800|NCT01356602|470182535|FG001|Overall Study|Lack of Efficacy|1|||
130606801|NCT01356602|470182536|FG002|Overall Study|Lack of Efficacy|4|||
130606802|NCT01356602|470182534|FG000|Overall Study|Adverse Event|0|||
130606803|NCT01356602|470182535|FG001|Overall Study|Adverse Event|1|||
130606804|NCT01356602|470182536|FG002|Overall Study|Adverse Event|1|||
130606805|NCT01115569|470182537|FG000|Conversion/Titration Phase|Adverse Event|59|||
130606806|NCT01115569|470182538|FG001|Conversion/Titration Phase|Adverse Event|0|||
130606807|NCT01115569|470182537|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
130606808|NCT01115569|470182538|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
130606809|NCT01115569|470182537|FG000|Conversion/Titration Phase|Physician Decision|5|||
130606810|NCT01115569|470182538|FG001|Conversion/Titration Phase|Physician Decision|0|||
130606811|NCT01115569|470182537|FG000|Conversion/Titration Phase|Protocol Violation|68|||
130606812|NCT01115569|470182538|FG001|Conversion/Titration Phase|Protocol Violation|0|||
130606813|NCT01115569|470182537|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
130606814|NCT01115569|470182538|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
130606815|NCT01115569|470182537|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
130606816|NCT01115569|470182538|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
130606817|NCT01115569|470182537|FG000|Maintenance Phase|Adverse Event|0|||
130606818|NCT01115569|470182538|FG001|Maintenance Phase|Adverse Event|43|||
130606819|NCT01115569|470182537|FG000|Maintenance Phase|Lost to Follow-up|0|||
130606820|NCT01115569|470182538|FG001|Maintenance Phase|Lost to Follow-up|8|||
130606821|NCT01115569|470182537|FG000|Maintenance Phase|Physician Decision|0|||
130606822|NCT01115569|470182538|FG001|Maintenance Phase|Physician Decision|3|||
130606823|NCT01115569|470182537|FG000|Maintenance Phase|Protocol Violation|0|||
130606824|NCT01115569|470182538|FG001|Maintenance Phase|Protocol Violation|9|||
130606825|NCT01115569|470182537|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130606826|NCT01115569|470182538|FG001|Maintenance Phase|Withdrawal by Subject|27|||
130606827|NCT01115569|470182537|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
130606828|NCT01115569|470182538|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
130606829|NCT01115569|470182537|FG000|Maintenance Phase|Administrative|0|||
130606830|NCT01115569|470182538|FG001|Maintenance Phase|Administrative|1|||
130606831|NCT03097328|470182540|FG000|Overall Study|Still on Therapy|2|||
130606832|NCT03097328|470182540|FG000|Overall Study|Progressive Disease|29|||
130606833|NCT03097328|470182540|FG000|Overall Study|Adverse Event|4|||
130606834|NCT03097328|470182540|FG000|Overall Study|Withdrawal by Subject|1|||
130606835|NCT03097328|470182540|FG000|Overall Study|Physician Decision|1|||
130606836|NCT03097328|470182540|FG000|Overall Study|Patient Decision|1|||
130606837|NCT03097328|470182540|FG000|Overall Study|Ineligible for Study Drug|1|||
130606838|NCT02653976|470182541|FG000|Overall Study|Withdrawal by Subject|5|||
130606839|NCT02653976|470182541|FG000|Overall Study|Death|4|||
130606840|NCT00883558|470182542|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
130606841|NCT00883558|470182543|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
130606842|NCT00883558|470182544|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
130606843|NCT00883558|470182542|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
130606844|NCT00883558|470182543|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
130606845|NCT00883558|470182544|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
130606846|NCT00883558|470182542|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
130606847|NCT00883558|470182543|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
130606848|NCT00883558|470182544|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
130606849|NCT00883558|470182542|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
130606850|NCT00883558|470182543|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
130606851|NCT00883558|470182544|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
130606852|NCT00883558|470182542|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
130606853|NCT00883558|470182543|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
130606854|NCT00883558|470182544|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
130606855|NCT00625365|470182545|FG000|Overall Study|Withdrawal by Subject|1|||
130606856|NCT00625365|470182545|FG000|Overall Study|No IV access|5|||
130606857|NCT00625365|470182545|FG000|Overall Study|VSD|1|||
130606858|NCT00536731|470182562|FG000|Overall Study|Adverse Event|3|||
130606859|NCT00536731|470182563|FG001|Overall Study|Adverse Event|2|||
130606860|NCT00536731|470182564|FG002|Overall Study|Adverse Event|3|||
130606861|NCT00536731|470182562|FG000|Overall Study|Withdrawal by Subject|0|||
130606862|NCT00536731|470182563|FG001|Overall Study|Withdrawal by Subject|2|||
130606863|NCT00536731|470182564|FG002|Overall Study|Withdrawal by Subject|0|||
130606864|NCT00536731|470182562|FG000|Overall Study|Intake of prohibited conc. medication|0|||
130606865|NCT00536731|470182563|FG001|Overall Study|Intake of prohibited conc. medication|0|||
130606866|NCT00536731|470182564|FG002|Overall Study|Intake of prohibited conc. medication|1|||
130606867|NCT00536731|470182562|FG000|Overall Study|Safety reasons|0|||
130606868|NCT00536731|470182563|FG001|Overall Study|Safety reasons|0|||
130606869|NCT00536731|470182564|FG002|Overall Study|Safety reasons|1|||
130606870|NCT00536731|470182562|FG000|Overall Study|Other|1|||
130606871|NCT00536731|470182563|FG001|Overall Study|Other|1|||
130606872|NCT00536731|470182564|FG002|Overall Study|Other|0|||
130606873|NCT01675531|470182565|FG000|Overall Study|Adverse Event|9|||
130606874|NCT01675531|470182565|FG000|Overall Study|Withdrawal by Subject|7|||
130606875|NCT01675531|470182565|FG000|Overall Study|Lack of Efficacy|1|||
130606876|NCT01675531|470182565|FG000|Overall Study|Protocol Violation|8|||
130606877|NCT00623467|470182566|FG000|Overall Study|Lost to Follow-up|1|||
130606878|NCT00623467|470182566|FG000|Overall Study|Protocol Violation|4|||
130606879|NCT00623467|470182566|FG000|Overall Study|Withdrawal by Subject|2|||
130606880|NCT02795988|470182571|FG000|Phase 1b|Withdrawal by Subject|0|||
130606881|NCT02795988|470182572|FG001|Phase 1b|Withdrawal by Subject|1|||
130606882|NCT02795988|470182573|FG002|Phase 1b|Withdrawal by Subject|0|||
130606883|NCT02795988|470182574|FG003|Phase 1b|Withdrawal by Subject|0|||
130606884|NCT02795988|470182575|FG004|Phase 1b|Withdrawal by Subject|0|||
130606885|NCT02795988|470182576|FG005|Phase 1b|Withdrawal by Subject|0|||
130606886|NCT02795988|470182577|FG006|Phase 1b|Withdrawal by Subject|0|||
130606887|NCT02795988|470182571|FG000|Phase 1b|Death|1|||
130606888|NCT02795988|470182572|FG001|Phase 1b|Death|2|||
130606889|NCT02795988|470182573|FG002|Phase 1b|Death|1|||
130606890|NCT02795988|470182574|FG003|Phase 1b|Death|0|||
130606891|NCT02795988|470182575|FG004|Phase 1b|Death|0|||
130606892|NCT02795988|470182576|FG005|Phase 1b|Death|0|||
130606893|NCT02795988|470182577|FG006|Phase 1b|Death|0|||
130606894|NCT02795988|470182571|FG000|Phase 1b|Physician Decision|0|||
130606895|NCT02795988|470182572|FG001|Phase 1b|Physician Decision|0|||
130606896|NCT02795988|470182573|FG002|Phase 1b|Physician Decision|1|||
130606897|NCT02795988|470182574|FG003|Phase 1b|Physician Decision|0|||
130606898|NCT02795988|470182575|FG004|Phase 1b|Physician Decision|0|||
130606899|NCT02795988|470182576|FG005|Phase 1b|Physician Decision|0|||
130606900|NCT02795988|470182577|FG006|Phase 1b|Physician Decision|0|||
130606901|NCT02795988|470182571|FG000|Phase 1b|Progressive Disease|2|||
130606902|NCT02795988|470182572|FG001|Phase 1b|Progressive Disease|2|||
130606903|NCT02795988|470182573|FG002|Phase 1b|Progressive Disease|0|||
130606904|NCT02795988|470182574|FG003|Phase 1b|Progressive Disease|0|||
130606905|NCT02795988|470182575|FG004|Phase 1b|Progressive Disease|0|||
130606906|NCT02795988|470182576|FG005|Phase 1b|Progressive Disease|0|||
130606907|NCT02795988|470182577|FG006|Phase 1b|Progressive Disease|0|||
130606908|NCT02795988|470182571|FG000|Phase 2|Withdrawal by Subject|0|||
130606909|NCT02795988|470182572|FG001|Phase 2|Withdrawal by Subject|0|||
130606910|NCT02795988|470182573|FG002|Phase 2|Withdrawal by Subject|0|||
130606911|NCT02795988|470182574|FG003|Phase 2|Withdrawal by Subject|1|||
130606912|NCT02795988|470182575|FG004|Phase 2|Withdrawal by Subject|0|||
130606913|NCT02795988|470182576|FG005|Phase 2|Withdrawal by Subject|0|||
130606914|NCT02795988|470182577|FG006|Phase 2|Withdrawal by Subject|0|||
130606915|NCT02795988|470182571|FG000|Phase 2|Death|0|||
130606916|NCT02795988|470182572|FG001|Phase 2|Death|0|||
130606917|NCT02795988|470182573|FG002|Phase 2|Death|0|||
130606918|NCT02795988|470182574|FG003|Phase 2|Death|17|||
130606919|NCT02795988|470182575|FG004|Phase 2|Death|17|||
130606920|NCT02795988|470182576|FG005|Phase 2|Death|0|||
130606921|NCT02795988|470182577|FG006|Phase 2|Death|0|||
130606922|NCT02795988|470182571|FG000|Phase 2|Other|0|||
130606923|NCT02795988|470182572|FG001|Phase 2|Other|0|||
130606924|NCT02795988|470182573|FG002|Phase 2|Other|0|||
130606925|NCT02795988|470182574|FG003|Phase 2|Other|1|||
130606926|NCT02795988|470182575|FG004|Phase 2|Other|0|||
130606927|NCT02795988|470182576|FG005|Phase 2|Other|0|||
130606928|NCT02795988|470182577|FG006|Phase 2|Other|0|||
130606929|NCT02795988|470182571|FG000|Phase 2 Extension|Death|0|||
130606930|NCT02795988|470182572|FG001|Phase 2 Extension|Death|0|||
130606931|NCT02795988|470182573|FG002|Phase 2 Extension|Death|0|||
130606932|NCT02795988|470182574|FG003|Phase 2 Extension|Death|0|||
130606933|NCT02795988|470182575|FG004|Phase 2 Extension|Death|0|||
130606934|NCT02795988|470182576|FG005|Phase 2 Extension|Death|5|||
130606935|NCT02795988|470182577|FG006|Phase 2 Extension|Death|6|||
130606936|NCT02795988|470182571|FG000|Phase 2 Extension|Other reasons|0|||
130606937|NCT02795988|470182572|FG001|Phase 2 Extension|Other reasons|0|||
130606938|NCT02795988|470182573|FG002|Phase 2 Extension|Other reasons|0|||
130606939|NCT02795988|470182574|FG003|Phase 2 Extension|Other reasons|0|||
130606940|NCT02795988|470182575|FG004|Phase 2 Extension|Other reasons|0|||
130606941|NCT02795988|470182576|FG005|Phase 2 Extension|Other reasons|2|||
130606942|NCT02795988|470182577|FG006|Phase 2 Extension|Other reasons|1|||
130606943|NCT02834403|470182578|FG000|Overall Study|Physician Decision|2|||
130606944|NCT02834403|470182579|FG001|Overall Study|Physician Decision|1|||
130606945|NCT02834403|470182580|FG002|Overall Study|Physician Decision|2|||
130606946|NCT02834403|470182581|FG003|Overall Study|Physician Decision|1|||
130606947|NCT02834403|470182582|FG004|Overall Study|Physician Decision|1|||
130606948|NCT02834403|470182583|FG005|Overall Study|Physician Decision|2|||
130606949|NCT02834403|470182584|FG006|Overall Study|Physician Decision|12|||
130606950|NCT02834403|470182578|FG000|Overall Study|Adverse Event|0|||
130606951|NCT02834403|470182579|FG001|Overall Study|Adverse Event|0|||
130606952|NCT02834403|470182580|FG002|Overall Study|Adverse Event|0|||
130606953|NCT02834403|470182581|FG003|Overall Study|Adverse Event|0|||
130606954|NCT02834403|470182582|FG004|Overall Study|Adverse Event|1|||
130606955|NCT02834403|470182583|FG005|Overall Study|Adverse Event|1|||
130606956|NCT02834403|470182584|FG006|Overall Study|Adverse Event|3|||
130606957|NCT02834403|470182578|FG000|Overall Study|Withdrawal by Subject|0|||
130606958|NCT02834403|470182579|FG001|Overall Study|Withdrawal by Subject|1|||
130606959|NCT02834403|470182580|FG002|Overall Study|Withdrawal by Subject|0|||
130606960|NCT02834403|470182581|FG003|Overall Study|Withdrawal by Subject|0|||
130606961|NCT02834403|470182582|FG004|Overall Study|Withdrawal by Subject|1|||
130606962|NCT02834403|470182583|FG005|Overall Study|Withdrawal by Subject|0|||
130606963|NCT02834403|470182584|FG006|Overall Study|Withdrawal by Subject|0|||
130606964|NCT02834403|470182578|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
130606965|NCT02834403|470182579|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
130606966|NCT02834403|470182580|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
130606967|NCT02834403|470182581|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
130606968|NCT02834403|470182582|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
130606969|NCT02834403|470182583|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
130606970|NCT02834403|470182584|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
130606971|NCT02341014|470182585|FG000|Overall Study|Adverse Event|0|||
130606972|NCT02341014|470182586|FG001|Overall Study|Adverse Event|1|||
130606973|NCT02341014|470182587|FG002|Overall Study|Adverse Event|0|||
130606974|NCT02341014|470182588|FG003|Overall Study|Adverse Event|0|||
130606975|NCT02341014|470182589|FG004|Overall Study|Adverse Event|2|||
130606976|NCT04705597|470182590|FG000|Overall Study|Death|16|||
130606977|NCT04705597|470182591|FG001|Overall Study|Death|9|||
130606978|NCT04705597|470182590|FG000|Overall Study|Lost to Follow-up|1|||
130606979|NCT04705597|470182591|FG001|Overall Study|Lost to Follow-up|0|||
130606980|NCT04705597|470182590|FG000|Overall Study|Withdrawal by Subject|1|||
130606981|NCT04705597|470182591|FG001|Overall Study|Withdrawal by Subject|2|||
130606982|NCT00273858|470182603|FG000|Overall Study|Not completed 24 month observation time|334|||
130606983|NCT00273858|470182603|FG000|Overall Study|Lost to Follow-up|101|||
130606984|NCT00273858|470182603|FG000|Overall Study|Withdrawal by Subject|21|||
130606985|NCT00273858|470182603|FG000|Overall Study|Adverse Event|81|||
130606986|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
130606987|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
130606988|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
130606989|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
130606990|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
130606991|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
130606992|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
130606993|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
130606994|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
130606995|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
130606996|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
130606997|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
130606998|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
130606999|NCT02232516|470182604|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
130607000|NCT02232516|470182604|FG000|Survival Follow-up|Death|15|||
130607001|NCT02232516|470182604|FG000|Survival Follow-up|Withdrawal by Subject|3|||
130607002|NCT02232516|470182604|FG000|Survival Follow-up|Lost to Follow-up|1|||
130607003|NCT02232516|470182604|FG000|Survival Follow-up|Still in follow-up|5|||
130607004|NCT00972244|470182605|FG000|Overall Study|Incorrect Enrolment|1|||
130607005|NCT00972244|470182606|FG001|Overall Study|Incorrect Enrolment|0|||
130607006|NCT00972244|470182607|FG002|Overall Study|Incorrect Enrolment|0|||
130607007|NCT00972244|470182608|FG003|Overall Study|Incorrect Enrolment|0|||
130607008|NCT00972244|470182609|FG004|Overall Study|Incorrect Enrolment|0|||
130607009|NCT00972244|470182605|FG000|Overall Study|Adverse Event|0|||
130607010|NCT00972244|470182606|FG001|Overall Study|Adverse Event|1|||
130607011|NCT00972244|470182607|FG002|Overall Study|Adverse Event|1|||
130607012|NCT00972244|470182608|FG003|Overall Study|Adverse Event|0|||
130607013|NCT00972244|470182609|FG004|Overall Study|Adverse Event|0|||
130607014|NCT00972244|470182605|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
130607015|NCT00972244|470182606|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130607016|NCT00972244|470182607|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130607017|NCT00972244|470182608|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
130607018|NCT00972244|470182609|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
130607019|NCT00972244|470182605|FG000|Overall Study|Withdrawal by Subject|1|||
130607020|NCT00972244|470182606|FG001|Overall Study|Withdrawal by Subject|2|||
130607021|NCT00972244|470182607|FG002|Overall Study|Withdrawal by Subject|1|||
130607022|NCT00972244|470182608|FG003|Overall Study|Withdrawal by Subject|0|||
130607023|NCT00972244|470182609|FG004|Overall Study|Withdrawal by Subject|1|||
130607024|NCT00972244|470182605|FG000|Overall Study|Safety|0|||
130607025|NCT00972244|470182606|FG001|Overall Study|Safety|0|||
130607026|NCT00972244|470182607|FG002|Overall Study|Safety|0|||
130607027|NCT00972244|470182608|FG003|Overall Study|Safety|0|||
130607028|NCT00972244|470182609|FG004|Overall Study|Safety|1|||
130607029|NCT00972244|470182605|FG000|Overall Study|Death|1|||
130607030|NCT00972244|470182606|FG001|Overall Study|Death|0|||
130607031|NCT00972244|470182607|FG002|Overall Study|Death|0|||
130607032|NCT00972244|470182608|FG003|Overall Study|Death|0|||
130607033|NCT00972244|470182609|FG004|Overall Study|Death|0|||
130607034|NCT00972244|470182605|FG000|Overall Study|Various|0|||
130607035|NCT00972244|470182606|FG001|Overall Study|Various|0|||
130607036|NCT00972244|470182607|FG002|Overall Study|Various|0|||
130607037|NCT00972244|470182608|FG003|Overall Study|Various|0|||
130607038|NCT00972244|470182609|FG004|Overall Study|Various|2|||
130607039|NCT01234402|470182615|FG000|Overall Study|Lost to Follow-up|0|||
130607040|NCT01234402|470182616|FG001|Overall Study|Lost to Follow-up|1|||
130607041|NCT01234402|470182617|FG002|Overall Study|Lost to Follow-up|3|||
130607042|NCT01234402|470182615|FG000|Overall Study|Withdrawal by Subject|1|||
130607043|NCT01234402|470182616|FG001|Overall Study|Withdrawal by Subject|3|||
130607044|NCT01234402|470182617|FG002|Overall Study|Withdrawal by Subject|4|||
130607045|NCT01234402|470182615|FG000|Overall Study|Never treated: Death|0|||
130607046|NCT01234402|470182616|FG001|Overall Study|Never treated: Death|0|||
130607047|NCT01234402|470182617|FG002|Overall Study|Never treated: Death|1|||
130607048|NCT01234402|470182615|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
130607049|NCT01234402|470182616|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
130607050|NCT01234402|470182617|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
130607051|NCT01234402|470182615|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
130607052|NCT01234402|470182616|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
130607053|NCT01234402|470182617|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
130607054|NCT02417233|470182621|FG000|Overall Study|Death|4|||
130607055|NCT02417233|470182622|FG001|Overall Study|Death|10|||
130607056|NCT02417233|470182623|FG002|Overall Study|Death|14|||
130607057|NCT02417233|470182621|FG000|Overall Study|Lost to Follow-up|27|||
130607058|NCT02417233|470182622|FG001|Overall Study|Lost to Follow-up|39|||
130607059|NCT02417233|470182623|FG002|Overall Study|Lost to Follow-up|34|||
130607060|NCT02417233|470182621|FG000|Overall Study|Protocol Violation|2|||
130607061|NCT02417233|470182622|FG001|Overall Study|Protocol Violation|0|||
130607062|NCT02417233|470182623|FG002|Overall Study|Protocol Violation|2|||
130607063|NCT02417233|470182621|FG000|Overall Study|Withdrawal by Subject|2|||
130607064|NCT02417233|470182622|FG001|Overall Study|Withdrawal by Subject|1|||
130607065|NCT02417233|470182623|FG002|Overall Study|Withdrawal by Subject|8|||
130607066|NCT02417233|470182621|FG000|Overall Study|Relocation out of study area|1|||
130607067|NCT02417233|470182622|FG001|Overall Study|Relocation out of study area|0|||
130607068|NCT02417233|470182623|FG002|Overall Study|Relocation out of study area|1|||
130607069|NCT02417233|470182621|FG000|Overall Study|Mentally unstable|0|||
130607070|NCT02417233|470182622|FG001|Overall Study|Mentally unstable|1|||
130607071|NCT02417233|470182623|FG002|Overall Study|Mentally unstable|0|||
130607072|NCT03649321|470182624|FG000|Overall Study|Withdrawal by Subject|1|||
130607073|NCT03649321|470182625|FG001|Overall Study|Withdrawal by Subject|0|||
130607074|NCT03649321|470182624|FG000|Overall Study|Death|1|||
130607075|NCT03649321|470182625|FG001|Overall Study|Death|0|||
130607076|NCT01702363|470182626|FG000|Overall Study|Adverse Event|14|||
130607077|NCT01702363|470182626|FG000|Overall Study|Lack of Efficacy|4|||
130607078|NCT01702363|470182626|FG000|Overall Study|Withdrawal by Subject|2|||
130607079|NCT01293032|470182627|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130607080|NCT01293032|470182628|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130607081|NCT01293032|470182629|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
130607082|NCT01293032|470182630|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130607083|NCT01293032|470182627|FG000|Treatment|Adverse Event|0|||
130607084|NCT01293032|470182628|FG001|Treatment|Adverse Event|0|||
130607085|NCT01293032|470182629|FG002|Treatment|Adverse Event|1|||
130607086|NCT01293032|470182630|FG003|Treatment|Adverse Event|1|||
130607087|NCT01293032|470182627|FG000|Treatment|Withdrawal by Subject|2|||
130607088|NCT01293032|470182628|FG001|Treatment|Withdrawal by Subject|4|||
130607089|NCT01293032|470182629|FG002|Treatment|Withdrawal by Subject|0|||
130607090|NCT01293032|470182630|FG003|Treatment|Withdrawal by Subject|0|||
130607091|NCT01293032|470182627|FG000|Treatment|Disease Progression, relapse|0|||
130607092|NCT01293032|470182628|FG001|Treatment|Disease Progression, relapse|1|||
130607093|NCT01293032|470182629|FG002|Treatment|Disease Progression, relapse|0|||
130607094|NCT01293032|470182630|FG003|Treatment|Disease Progression, relapse|0|||
130607095|NCT02985450|470182640|FG000|Overall Study|Lost to Follow-up|7|||
130607096|NCT00431847|470182643|FG000|Overall Study|completion of less than two study visits|6|||
130607097|NCT00431847|470182644|FG001|Overall Study|completion of less than two study visits|3|||
130607098|NCT00431847|470182645|FG002|Overall Study|completion of less than two study visits|4|||
130607099|NCT00431847|470182646|FG003|Overall Study|completion of less than two study visits|14|||
130607100|NCT00431847|470182647|FG004|Overall Study|completion of less than two study visits|0|||
130607101|NCT00431847|470182643|FG000|Overall Study|Protocol Violation|0|||
130607102|NCT00431847|470182644|FG001|Overall Study|Protocol Violation|0|||
130607103|NCT00431847|470182645|FG002|Overall Study|Protocol Violation|0|||
130607104|NCT00431847|470182646|FG003|Overall Study|Protocol Violation|0|||
130607105|NCT00431847|470182647|FG004|Overall Study|Protocol Violation|1|||
130607106|NCT01469013|470182648|FG000|Part A (Treatment Period)|Adverse Event|1|||
130607107|NCT01469013|470182649|FG001|Part A (Treatment Period)|Adverse Event|0|||
130607108|NCT01469013|470182650|FG002|Part A (Treatment Period)|Adverse Event|0|||
130607109|NCT01469013|470182651|FG003|Part A (Treatment Period)|Adverse Event|0|||
130607110|NCT01469013|470182652|FG004|Part A (Treatment Period)|Adverse Event|1|||
130607111|NCT01469013|470182653|FG005|Part A (Treatment Period)|Adverse Event|0|||
130607112|NCT01469013|470182654|FG006|Part A (Treatment Period)|Adverse Event|0|||
130607113|NCT01469013|470182655|FG007|Part A (Treatment Period)|Adverse Event|0|||
130607114|NCT01469013|470182656|FG008|Part A (Treatment Period)|Adverse Event|0|||
130607115|NCT01469013|470182657|FG009|Part A (Treatment Period)|Adverse Event|0|||
130607116|NCT01469013|470182658|FG010|Part A (Treatment Period)|Adverse Event|0|||
130607117|NCT01469013|470182659|FG011|Part A (Treatment Period)|Adverse Event|0|||
130607118|NCT01469013|470182660|FG012|Part A (Treatment Period)|Adverse Event|0|||
130607119|NCT01469013|470182648|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607120|NCT01469013|470182649|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607121|NCT01469013|470182650|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
130607122|NCT01469013|470182651|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607123|NCT01469013|470182652|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607124|NCT01469013|470182653|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607125|NCT01469013|470182654|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607126|NCT01469013|470182655|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607127|NCT01469013|470182656|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607128|NCT01469013|470182657|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607129|NCT01469013|470182658|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607130|NCT01469013|470182659|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607131|NCT01469013|470182660|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
130607132|NCT01469013|470182648|FG000|Part B (Extension Period)|Adverse Event|0|||
130607133|NCT01469013|470182649|FG001|Part B (Extension Period)|Adverse Event|0|||
130607134|NCT01469013|470182650|FG002|Part B (Extension Period)|Adverse Event|0|||
130607135|NCT01469013|470182651|FG003|Part B (Extension Period)|Adverse Event|0|||
130607136|NCT01469013|470182652|FG004|Part B (Extension Period)|Adverse Event|0|||
130607137|NCT01469013|470182653|FG005|Part B (Extension Period)|Adverse Event|2|||
130607138|NCT01469013|470182654|FG006|Part B (Extension Period)|Adverse Event|5|||
130607139|NCT01469013|470182655|FG007|Part B (Extension Period)|Adverse Event|5|||
130607140|NCT01469013|470182656|FG008|Part B (Extension Period)|Adverse Event|3|||
130607141|NCT01469013|470182657|FG009|Part B (Extension Period)|Adverse Event|3|||
130607142|NCT01469013|470182658|FG010|Part B (Extension Period)|Adverse Event|1|||
130607143|NCT01469013|470182659|FG011|Part B (Extension Period)|Adverse Event|6|||
130607144|NCT01469013|470182660|FG012|Part B (Extension Period)|Adverse Event|3|||
130607145|NCT01469013|470182648|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
130607146|NCT01469013|470182649|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
130607147|NCT01469013|470182650|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
130607148|NCT01469013|470182651|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
130607149|NCT01469013|470182652|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
130607150|NCT01469013|470182653|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
130607151|NCT01469013|470182654|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
130607152|NCT01469013|470182655|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
130607153|NCT01469013|470182656|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
130607154|NCT01469013|470182657|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
130607155|NCT01469013|470182658|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
130607156|NCT01469013|470182659|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
130607157|NCT01469013|470182660|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
130607158|NCT00002663|470182661|FG000|Overall Study|Death|4|||
130607159|NCT00002663|470182662|FG001|Overall Study|Death|1|||
130607160|NCT00002663|470182663|FG002|Overall Study|Death|1|||
130607161|NCT00002663|470182664|FG003|Overall Study|Death|0|||
130607162|NCT00002663|470182665|FG004|Overall Study|Death|0|||
130607163|NCT00002663|470182666|FG005|Overall Study|Death|13|||
130607164|NCT00002663|470182667|FG006|Overall Study|Death|0|||
130607165|NCT00002663|470182668|FG007|Overall Study|Death|1|||
130607166|NCT00002663|470182669|FG008|Overall Study|Death|1|||
130607167|NCT00002663|470182670|FG009|Overall Study|Death|1|||
130607168|NCT00002663|470182661|FG000|Overall Study|Lost to Follow-up|3|||
130607169|NCT00002663|470182662|FG001|Overall Study|Lost to Follow-up|0|||
130607170|NCT00002663|470182663|FG002|Overall Study|Lost to Follow-up|0|||
130607171|NCT00002663|470182664|FG003|Overall Study|Lost to Follow-up|1|||
130607172|NCT00002663|470182665|FG004|Overall Study|Lost to Follow-up|0|||
130607173|NCT00002663|470182666|FG005|Overall Study|Lost to Follow-up|1|||
130607174|NCT00002663|470182667|FG006|Overall Study|Lost to Follow-up|0|||
130607175|NCT00002663|470182668|FG007|Overall Study|Lost to Follow-up|0|||
130607176|NCT00002663|470182669|FG008|Overall Study|Lost to Follow-up|0|||
130607177|NCT00002663|470182670|FG009|Overall Study|Lost to Follow-up|0|||
130607178|NCT00002663|470182661|FG000|Overall Study|Other|0|||
130607179|NCT00002663|470182662|FG001|Overall Study|Other|1|||
130607180|NCT00002663|470182663|FG002|Overall Study|Other|0|||
130607181|NCT00002663|470182664|FG003|Overall Study|Other|0|||
130607182|NCT00002663|470182665|FG004|Overall Study|Other|0|||
130607183|NCT00002663|470182666|FG005|Overall Study|Other|1|||
130607184|NCT00002663|470182667|FG006|Overall Study|Other|1|||
130607185|NCT00002663|470182668|FG007|Overall Study|Other|0|||
130607186|NCT00002663|470182669|FG008|Overall Study|Other|0|||
130607187|NCT00002663|470182670|FG009|Overall Study|Other|0|||
130607188|NCT00002663|470182661|FG000|Overall Study|Physician Decision|0|||
130607189|NCT00002663|470182662|FG001|Overall Study|Physician Decision|0|||
130607190|NCT00002663|470182663|FG002|Overall Study|Physician Decision|0|||
130607191|NCT00002663|470182664|FG003|Overall Study|Physician Decision|0|||
130607192|NCT00002663|470182665|FG004|Overall Study|Physician Decision|1|||
130607193|NCT00002663|470182666|FG005|Overall Study|Physician Decision|0|||
130607194|NCT00002663|470182667|FG006|Overall Study|Physician Decision|0|||
130607195|NCT00002663|470182668|FG007|Overall Study|Physician Decision|0|||
130607196|NCT00002663|470182669|FG008|Overall Study|Physician Decision|1|||
130607197|NCT00002663|470182670|FG009|Overall Study|Physician Decision|1|||
130607198|NCT00002663|470182661|FG000|Overall Study|Adverse Event|0|||
130607199|NCT00002663|470182662|FG001|Overall Study|Adverse Event|0|||
130607200|NCT00002663|470182663|FG002|Overall Study|Adverse Event|0|||
130607201|NCT00002663|470182664|FG003|Overall Study|Adverse Event|1|||
130607202|NCT00002663|470182665|FG004|Overall Study|Adverse Event|0|||
130607203|NCT00002663|470182666|FG005|Overall Study|Adverse Event|0|||
130607204|NCT00002663|470182667|FG006|Overall Study|Adverse Event|0|||
130607205|NCT00002663|470182668|FG007|Overall Study|Adverse Event|1|||
130607206|NCT00002663|470182669|FG008|Overall Study|Adverse Event|0|||
130607207|NCT00002663|470182670|FG009|Overall Study|Adverse Event|0|||
130607208|NCT02142894|470182672|FG000|Overall Study|Protocol Violation|8|||
130607209|NCT00739297|470182673|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
130607210|NCT00739297|470182674|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
130607211|NCT00739297|470182675|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
130607212|NCT00739297|470182676|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
130607213|NCT00739297|470182677|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
130607214|NCT00739297|470182678|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
130607215|NCT00739297|470182679|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
130607216|NCT00739297|470182673|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130607217|NCT00739297|470182674|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130607218|NCT00739297|470182675|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130607219|NCT00739297|470182676|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130607220|NCT00739297|470182677|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130607221|NCT00739297|470182678|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
130607222|NCT00739297|470182679|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
130607223|NCT02084134|470182683|FG000|Overall Study|Protocol Violation|4|||
130607224|NCT02084134|470182684|FG001|Overall Study|Protocol Violation|2|||
130607225|NCT02084134|470182683|FG000|Overall Study|Death|0|||
130607226|NCT02084134|470182684|FG001|Overall Study|Death|1|||
130607227|NCT02379923|470182685|FG000|Overall Study|Death|5|||
130607228|NCT00426751|470182686|FG000|Overall Study|Adverse Event|8|||
130607229|NCT00426751|470182687|FG001|Overall Study|Adverse Event|1|||
130607230|NCT00426751|470182686|FG000|Overall Study|Lost to Follow-up|7|||
130607231|NCT00426751|470182687|FG001|Overall Study|Lost to Follow-up|6|||
130607232|NCT00426751|470182686|FG000|Overall Study|Consent Withdrawn|0|||
130607233|NCT00426751|470182687|FG001|Overall Study|Consent Withdrawn|1|||
130607234|NCT00426751|470182686|FG000|Overall Study|Other Reasons|7|||
130607235|NCT00426751|470182687|FG001|Overall Study|Other Reasons|12|||
130607236|NCT00968253|470182688|FG000|Overall Study|Death|0|||
130607237|NCT00968253|470182689|FG001|Overall Study|Death|0|||
130607238|NCT00968253|470182690|FG002|Overall Study|Death|2|||
130607239|NCT00968253|470182688|FG000|Overall Study|Withdrawal by Subject|0|||
130607240|NCT00968253|470182689|FG001|Overall Study|Withdrawal by Subject|0|||
130607241|NCT00968253|470182690|FG002|Overall Study|Withdrawal by Subject|1|||
130607242|NCT00968253|470182688|FG000|Overall Study|Disease Progression|0|||
130607243|NCT00968253|470182689|FG001|Overall Study|Disease Progression|3|||
130607244|NCT00968253|470182690|FG002|Overall Study|Disease Progression|3|||
130607245|NCT00968253|470182688|FG000|Overall Study|Adverse Event|0|||
130607246|NCT00968253|470182689|FG001|Overall Study|Adverse Event|0|||
130607247|NCT00968253|470182690|FG002|Overall Study|Adverse Event|1|||
130607248|NCT03141086|470182692|FG000|Overall Study|Study Terminated By Sponsor|1|||
130607249|NCT03141086|470182693|FG001|Overall Study|Study Terminated By Sponsor|1|||
130607250|NCT03141086|470182692|FG000|Overall Study|Withdrawal by Subject|0|||
130607251|NCT03141086|470182693|FG001|Overall Study|Withdrawal by Subject|1|||
130607252|NCT03141086|470182692|FG000|Overall Study|Protocol Violation|0|||
130607253|NCT03141086|470182693|FG001|Overall Study|Protocol Violation|1|||
130607254|NCT03141086|470182692|FG000|Overall Study|Adverse Event|0|||
130607255|NCT03141086|470182693|FG001|Overall Study|Adverse Event|2|||
130607256|NCT02488759|470182694|FG000|Overall Study|Disease progression|73|||
130607257|NCT02488759|470182695|FG001|Overall Study|Disease progression|111|||
130607258|NCT02488759|470182696|FG002|Overall Study|Disease progression|62|||
130607259|NCT02488759|470182697|FG003|Overall Study|Disease progression|7|||
130607260|NCT02488759|470182698|FG004|Overall Study|Disease progression|4|||
130607261|NCT02488759|470182699|FG005|Overall Study|Disease progression|2|||
130607262|NCT02488759|470182694|FG000|Overall Study|Study drug toxicity|11|||
130607263|NCT02488759|470182695|FG001|Overall Study|Study drug toxicity|33|||
130607264|NCT02488759|470182696|FG002|Overall Study|Study drug toxicity|31|||
130607265|NCT02488759|470182697|FG003|Overall Study|Study drug toxicity|0|||
130607266|NCT02488759|470182698|FG004|Overall Study|Study drug toxicity|0|||
130607267|NCT02488759|470182699|FG005|Overall Study|Study drug toxicity|2|||
130607268|NCT02488759|470182694|FG000|Overall Study|Adverse event unrelated to study drug|9|||
130607269|NCT02488759|470182695|FG001|Overall Study|Adverse event unrelated to study drug|11|||
130607270|NCT02488759|470182696|FG002|Overall Study|Adverse event unrelated to study drug|7|||
130607271|NCT02488759|470182697|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130607272|NCT02488759|470182698|FG004|Overall Study|Adverse event unrelated to study drug|1|||
130607273|NCT02488759|470182699|FG005|Overall Study|Adverse event unrelated to study drug|0|||
130607274|NCT02488759|470182694|FG000|Overall Study|Participant request to discontinue study treatment|6|||
130607275|NCT02488759|470182695|FG001|Overall Study|Participant request to discontinue study treatment|8|||
130607276|NCT02488759|470182696|FG002|Overall Study|Participant request to discontinue study treatment|4|||
130607277|NCT02488759|470182697|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130607278|NCT02488759|470182698|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130607279|NCT02488759|470182699|FG005|Overall Study|Participant request to discontinue study treatment|0|||
130607280|NCT02488759|470182694|FG000|Overall Study|Withdrawal by Subject|4|||
130607281|NCT02488759|470182695|FG001|Overall Study|Withdrawal by Subject|0|||
130607282|NCT02488759|470182696|FG002|Overall Study|Withdrawal by Subject|3|||
130607283|NCT02488759|470182697|FG003|Overall Study|Withdrawal by Subject|0|||
130607284|NCT02488759|470182698|FG004|Overall Study|Withdrawal by Subject|0|||
130607285|NCT02488759|470182699|FG005|Overall Study|Withdrawal by Subject|2|||
130607286|NCT02488759|470182694|FG000|Overall Study|Lost to Follow-up|0|||
130607287|NCT02488759|470182695|FG001|Overall Study|Lost to Follow-up|0|||
130607288|NCT02488759|470182696|FG002|Overall Study|Lost to Follow-up|2|||
130607289|NCT02488759|470182697|FG003|Overall Study|Lost to Follow-up|0|||
130607290|NCT02488759|470182698|FG004|Overall Study|Lost to Follow-up|0|||
130607291|NCT02488759|470182699|FG005|Overall Study|Lost to Follow-up|0|||
130607292|NCT02488759|470182694|FG000|Overall Study|Maximum clinical benefit|3|||
130607293|NCT02488759|470182695|FG001|Overall Study|Maximum clinical benefit|0|||
130607294|NCT02488759|470182696|FG002|Overall Study|Maximum clinical benefit|1|||
130607295|NCT02488759|470182697|FG003|Overall Study|Maximum clinical benefit|0|||
130607296|NCT02488759|470182698|FG004|Overall Study|Maximum clinical benefit|0|||
130607297|NCT02488759|470182699|FG005|Overall Study|Maximum clinical benefit|0|||
130607298|NCT02488759|470182694|FG000|Overall Study|Other reasons|7|||
130607299|NCT02488759|470182695|FG001|Overall Study|Other reasons|32|||
130607300|NCT02488759|470182696|FG002|Overall Study|Other reasons|23|||
130607301|NCT02488759|470182697|FG003|Overall Study|Other reasons|1|||
130607302|NCT02488759|470182698|FG004|Overall Study|Other reasons|1|||
130607303|NCT02488759|470182699|FG005|Overall Study|Other reasons|1|||
130607304|NCT02429427|470182700|FG000|Overall Study|Adverse Event|220|||
130607305|NCT02429427|470182701|FG001|Overall Study|Adverse Event|92|||
130607306|NCT02429427|470182700|FG000|Overall Study|Protocol Violation|10|||
130607307|NCT02429427|470182701|FG001|Overall Study|Protocol Violation|6|||
130607308|NCT02429427|470182700|FG000|Overall Study|Lost to Follow-up|15|||
130607309|NCT02429427|470182701|FG001|Overall Study|Lost to Follow-up|6|||
130607310|NCT02429427|470182700|FG000|Overall Study|Withdrawal by Subject|64|||
130607311|NCT02429427|470182701|FG001|Overall Study|Withdrawal by Subject|34|||
130607312|NCT02429427|470182700|FG000|Overall Study|Other|62|||
130607313|NCT02429427|470182701|FG001|Overall Study|Other|41|||
130607314|NCT00719732|470182702|FG000|Overall Study|Lost to Follow-up|20|||
130607315|NCT00719732|470182702|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
130607316|NCT00719732|470182702|FG000|Overall Study|Illness not associated with device|1|||
130607317|NCT03625986|470184082|FG000|Randomization Period|Lost to Follow-up|7|||
130607318|NCT03625986|470184083|FG001|Randomization Period|Lost to Follow-up|12|||
130607319|NCT03625986|470184082|FG000|Randomization Period|Withdrawal by Subject|10|||
130607320|NCT03625986|470184083|FG001|Randomization Period|Withdrawal by Subject|6|||
130607321|NCT04920084|470184085|FG000|Overall Study|Adverse Event|1|||
130607322|NCT04920084|470184085|FG000|Overall Study|Lost to Follow-up|2|||
130607323|NCT04920084|470184085|FG000|Overall Study|Withdrawal by Subject|2|||
130607324|NCT01096446|470184086|FG000|Overall Study|Death|1|||
130607325|NCT01096446|470184087|FG001|Overall Study|Death|0|||
130607326|NCT01096446|470184086|FG000|Overall Study|Protocol Violation|2|||
130607327|NCT01096446|470184087|FG001|Overall Study|Protocol Violation|0|||
130607328|NCT00620321|470184088|FG000|Overall Study|Adverse Event|1|||
130607329|NCT00620321|470184089|FG001|Overall Study|Adverse Event|1|||
130607330|NCT00620321|470184088|FG000|Overall Study|Death|1|||
130607331|NCT00620321|470184089|FG001|Overall Study|Death|1|||
130607332|NCT00620321|470184088|FG000|Overall Study|Physician Decision|0|||
130607333|NCT00620321|470184089|FG001|Overall Study|Physician Decision|7|||
130607334|NCT00620321|470184088|FG000|Overall Study|Progressive Disease|5|||
130607335|NCT00620321|470184089|FG001|Overall Study|Progressive Disease|5|||
130607336|NCT00620321|470184088|FG000|Overall Study|Sponsor Decision|0|||
130607337|NCT00620321|470184089|FG001|Overall Study|Sponsor Decision|1|||
130607338|NCT00620321|470184088|FG000|Overall Study|Withdrawal by Subject|1|||
130607339|NCT00620321|470184089|FG001|Overall Study|Withdrawal by Subject|1|||
130607340|NCT04191967|470184090|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
130607341|NCT04191967|470184090|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
130607342|NCT01431144|470184091|FG000|Overall Study|Implant mobility and removal|2|||
130607343|NCT01431144|470184092|FG001|Overall Study|Implant mobility and removal|0|||
130607344|NCT02410902|470184098|FG000|Overall Study|Adverse Event|2|||
130607345|NCT02410902|470184099|FG001|Overall Study|Adverse Event|3|||
130607346|NCT02410902|470184098|FG000|Overall Study|Lost to Follow-up|4|||
130607347|NCT02410902|470184099|FG001|Overall Study|Lost to Follow-up|1|||
130607348|NCT02410902|470184098|FG000|Overall Study|Protocol Violation|1|||
130607349|NCT02410902|470184099|FG001|Overall Study|Protocol Violation|4|||
130607350|NCT02410902|470184098|FG000|Overall Study|Withdrawal by Subject|6|||
130607351|NCT02410902|470184099|FG001|Overall Study|Withdrawal by Subject|8|||
130607352|NCT02410902|470184098|FG000|Overall Study|Non-Compliance|8|||
130607353|NCT02410902|470184099|FG001|Overall Study|Non-Compliance|2|||
130607354|NCT01746732|470184100|FG000|Lead-In Period|Withdrawal by Subject|1|||
130607355|NCT01746732|470184101|FG001|Lead-In Period|Withdrawal by Subject|0|||
130607356|NCT01746732|470184102|FG002|Lead-In Period|Withdrawal by Subject|0|||
130607357|NCT01746732|470184100|FG000|Period 1|Physician Decision|0|||
130607358|NCT01746732|470184101|FG001|Period 1|Physician Decision|1|||
130607359|NCT01746732|470184102|FG002|Period 1|Physician Decision|0|||
130607360|NCT01746732|470184100|FG000|Period 2|Withdrawal by Subject|0|||
130607361|NCT01746732|470184101|FG001|Period 2|Withdrawal by Subject|0|||
130607362|NCT01746732|470184102|FG002|Period 2|Withdrawal by Subject|2|||
130607363|NCT01746732|470184100|FG000|Period 2|Adverse Event|0|||
130607364|NCT01746732|470184101|FG001|Period 2|Adverse Event|0|||
130607365|NCT01746732|470184102|FG002|Period 2|Adverse Event|1|||
130607366|NCT01746732|470184100|FG000|Period 2|Lost to Follow-up|0|||
130607367|NCT01746732|470184101|FG001|Period 2|Lost to Follow-up|0|||
130607368|NCT01746732|470184102|FG002|Period 2|Lost to Follow-up|1|||
130607369|NCT03509207|470184103|FG000|Overall Study|Death|2|||
130607370|NCT02817555|470184104|FG000|Overall Study|Death|1|||
130607371|NCT02817555|470184105|FG001|Overall Study|Death|3|||
130607372|NCT02817555|470184104|FG000|Overall Study|moved away|1|||
130607373|NCT02817555|470184105|FG001|Overall Study|moved away|0|||
130607374|NCT02817555|470184104|FG000|Overall Study|transplant|1|||
130607375|NCT02817555|470184105|FG001|Overall Study|transplant|1|||
130607376|NCT02817555|470184104|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
130607377|NCT02817555|470184105|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
130607378|NCT00137436|470184106|FG000|Overall Study|Adverse Event|13|||
130607379|NCT00137436|470184106|FG000|Overall Study|Death|2|||
130607380|NCT00137436|470184106|FG000|Overall Study|Lack of Efficacy|17|||
130607381|NCT00137436|470184106|FG000|Overall Study|Withdrawal by Subject|6|||
130607382|NCT00137436|470184106|FG000|Overall Study|Other|5|||
130607383|NCT04657016|470184107|FG000|Overall Study|Adverse Event|2|||
130607384|NCT04657016|470184108|FG001|Overall Study|Adverse Event|4|||
130607385|NCT04657016|470184107|FG000|Overall Study|Death|1|||
130607386|NCT04657016|470184108|FG001|Overall Study|Death|1|||
130607387|NCT04657016|470184107|FG000|Overall Study|Lost to Follow-up|24|||
130607388|NCT04657016|470184108|FG001|Overall Study|Lost to Follow-up|12|||
130607389|NCT04657016|470184107|FG000|Overall Study|Physician Decision|1|||
130607390|NCT04657016|470184108|FG001|Overall Study|Physician Decision|2|||
130607391|NCT04657016|470184107|FG000|Overall Study|Pregnancy|2|||
130607392|NCT04657016|470184108|FG001|Overall Study|Pregnancy|2|||
130607393|NCT04657016|470184107|FG000|Overall Study|Protocol Deviation|1|||
130607394|NCT04657016|470184108|FG001|Overall Study|Protocol Deviation|0|||
130607395|NCT04657016|470184107|FG000|Overall Study|Withdrawal by Subject|28|||
130607396|NCT04657016|470184108|FG001|Overall Study|Withdrawal by Subject|14|||
130607397|NCT04657016|470184107|FG000|Overall Study|Other - as reported by the investigator|6|||
130607398|NCT04657016|470184108|FG001|Overall Study|Other - as reported by the investigator|0|||
130607399|NCT01104558|470184109|FG000|Overall Study|Protocol Violation|6|||
130607400|NCT01104558|470184109|FG000|Overall Study|Missing of primary efficacy assessment|10|||
130607401|NCT01104558|470184109|FG000|Overall Study|Missing of genetic analysis results|1|||
130607402|NCT01755195|470184110|FG000|Overall Study|Participant noncompliance|2|||
130607403|NCT01755195|470184110|FG000|Overall Study|Switched to alternative treatment|4|||
130607404|NCT01755195|470184110|FG000|Overall Study|Withdrawal by Subject|1|||
130607405|NCT01755195|470184110|FG000|Overall Study|Participant refused to start treatment|1|||
130607406|NCT01755195|470184110|FG000|Overall Study|Participant has been consented for another trial|1|||
130607407|NCT01755195|470184110|FG000|Overall Study|Refused further treatment|3|||
130607408|NCT01755195|470184110|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
130607409|NCT01931462|470184111|FG000|Overall Study|Withdrawal by Subject|1|||
130607410|NCT02361762|470184112|FG000|Overall Study|Withdrawal by Subject|0|||
130607411|NCT02361762|470184113|FG001|Overall Study|Withdrawal by Subject|1|||
130607412|NCT02361762|470184112|FG000|Overall Study|Lost to Follow-up|0|||
130607413|NCT02361762|470184113|FG001|Overall Study|Lost to Follow-up|1|||
130607414|NCT02819310|470184114|FG000|Overall Study|Withdrawal by Subject|37|||
130607415|NCT02819310|470184114|FG000|Overall Study|Lost to Follow-up|16|||
130607416|NCT02819310|470184114|FG000|Overall Study|Adverse Event|13|||
130607417|NCT02819310|470184114|FG000|Overall Study|Lack of Efficacy|5|||
130607418|NCT02819310|470184114|FG000|Overall Study|Physician Decision|8|||
130607419|NCT02819310|470184114|FG000|Overall Study|Protocol Violation|30|||
130607420|NCT01881620|470184122|FG000|Overall Study|Protocol Violation|4|||
130607421|NCT04467164|470184126|FG000|Washout (1 Week)|Lost to Follow-up|2|||
130607422|NCT04467164|470184127|FG001|Washout (1 Week)|Lost to Follow-up|0|||
130607423|NCT01675011|470184135|FG000|Overall Study|Trial terminated by Sponsor|3|||
130607424|NCT01675011|470184136|FG001|Overall Study|Trial terminated by Sponsor|1|||
130607425|NCT00615290|470184137|FG000|Overall Study|Adverse Event|2|||
130607426|NCT00615290|470184137|FG000|Overall Study|Lost to Follow-up|3|||
130607427|NCT00615290|470184137|FG000|Overall Study|Withdrawal by Subject|1|||
130607428|NCT00615290|470184137|FG000|Overall Study|Other|2|||
130607429|NCT01252134|470184138|FG000|Period 1, 8 Hours|Personal Reasons|0|||
130607430|NCT01252134|470184139|FG001|Period 1, 8 Hours|Personal Reasons|1|||
130607431|NCT01252134|470184140|FG002|Period 1, 8 Hours|Personal Reasons|1|||
130607432|NCT01252134|470184141|FG003|Period 1, 8 Hours|Personal Reasons|0|||
130607433|NCT01252134|470184142|FG004|Period 1, 8 Hours|Personal Reasons|0|||
130607434|NCT01252134|470184143|FG005|Period 1, 8 Hours|Personal Reasons|0|||
130607435|NCT03650452|470184144|FG000|Overall Study|Physician Decision|1|||
130607436|NCT03650452|470184145|FG001|Overall Study|Physician Decision|0|||
130607437|NCT03650452|470184144|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130607438|NCT03650452|470184145|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130607439|NCT03650452|470184144|FG000|Overall Study|Adverse Event|3|||
130607440|NCT03650452|470184145|FG001|Overall Study|Adverse Event|4|||
130607441|NCT03650452|470184144|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
130607442|NCT03650452|470184145|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
130607443|NCT02273050|470184146|FG000|Overall Study|Adverse Event|4|||
130607444|NCT02273050|470184147|FG001|Overall Study|Adverse Event|3|||
130607445|NCT02273050|470184148|FG002|Overall Study|Adverse Event|3|||
130607446|NCT02273050|470184146|FG000|Overall Study|Death|0|||
130607447|NCT02273050|470184147|FG001|Overall Study|Death|0|||
130607448|NCT02273050|470184148|FG002|Overall Study|Death|1|||
130607449|NCT02273050|470184146|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
130607450|NCT02273050|470184147|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
130607451|NCT02273050|470184148|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
130607452|NCT02273050|470184146|FG000|Overall Study|Lack of Efficacy|0|||
130607453|NCT02273050|470184147|FG001|Overall Study|Lack of Efficacy|1|||
130607454|NCT02273050|470184148|FG002|Overall Study|Lack of Efficacy|1|||
130607455|NCT02273050|470184146|FG000|Overall Study|Withdrawal by Subject|17|||
130607456|NCT02273050|470184147|FG001|Overall Study|Withdrawal by Subject|14|||
130607457|NCT02273050|470184148|FG002|Overall Study|Withdrawal by Subject|16|||
130607458|NCT02273050|470184146|FG000|Overall Study|Lost to Follow-up|0|||
130607459|NCT02273050|470184147|FG001|Overall Study|Lost to Follow-up|2|||
130607460|NCT02273050|470184148|FG002|Overall Study|Lost to Follow-up|3|||
130607461|NCT02273050|470184146|FG000|Overall Study|Protocol Violation|3|||
130607462|NCT02273050|470184147|FG001|Overall Study|Protocol Violation|1|||
130607463|NCT02273050|470184148|FG002|Overall Study|Protocol Violation|4|||
130607464|NCT01795898|470184150|FG000|Overall Study|Adverse Event|27|||
130607465|NCT01795898|470184150|FG000|Overall Study|Lost to Follow-up|20|||
130607466|NCT01795898|470184150|FG000|Overall Study|Withdrawal of consent|6|||
130607467|NCT01795898|470184150|FG000|Overall Study|Diagnosed with metastasis|1|||
130607468|NCT01795898|470184150|FG000|Overall Study|No pain|1|||
130607469|NCT01795898|470184150|FG000|Overall Study|Death|1|||
130607470|NCT01795898|470184150|FG000|Overall Study|Withdrew consent & had adverse events|3|||
130607471|NCT01795898|470184150|FG000|Overall Study|Physician Decision|1|||
130607472|NCT03539458|470184151|FG000|Overall Study|Death|1|||
130607473|NCT01703286|470184152|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
130607474|NCT01703286|470184153|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
130607475|NCT01703286|470184154|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
130607476|NCT01703286|470184155|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
130607477|NCT01703286|470184156|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
130607478|NCT01703286|470184157|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
130607479|NCT01703286|470184152|FG000|Period 2 Including Washout|Adverse Event|0|||
130607480|NCT01703286|470184153|FG001|Period 2 Including Washout|Adverse Event|0|||
130607481|NCT01703286|470184154|FG002|Period 2 Including Washout|Adverse Event|0|||
130607482|NCT01703286|470184155|FG003|Period 2 Including Washout|Adverse Event|1|||
130607483|NCT01703286|470184156|FG004|Period 2 Including Washout|Adverse Event|0|||
130607484|NCT01703286|470184157|FG005|Period 2 Including Washout|Adverse Event|0|||
130607485|NCT01984346|470184158|FG000|Overall Study|Physician Decision|4|||
130607486|NCT01984346|470184159|FG001|Overall Study|Physician Decision|2|||
130607487|NCT01984346|470184158|FG000|Overall Study|Withdrawal by Subject|2|||
130607488|NCT01984346|470184159|FG001|Overall Study|Withdrawal by Subject|2|||
130607489|NCT01984346|470184158|FG000|Overall Study|Enrollment Closed|8|||
130607490|NCT01984346|470184159|FG001|Overall Study|Enrollment Closed|1|||
130607491|NCT01984346|470184158|FG000|Overall Study|Insurance Coverage|1|||
130607492|NCT01984346|470184159|FG001|Overall Study|Insurance Coverage|0|||
130607493|NCT01984346|470184158|FG000|Overall Study|Intra-operative Exclusion|2|||
130607494|NCT01984346|470184159|FG001|Overall Study|Intra-operative Exclusion|0|||
130607495|NCT02531373|470184160|FG000|Overall Study|Lack of Efficacy|0|||
130607496|NCT02531373|470184161|FG001|Overall Study|Lack of Efficacy|0|||
130607497|NCT02531373|470184162|FG002|Overall Study|Lack of Efficacy|0|||
130607498|NCT02531373|470184163|FG003|Overall Study|Lack of Efficacy|0|||
130607499|NCT02531373|470184164|FG004|Overall Study|Lack of Efficacy|3|||
130607500|NCT02531373|470184165|FG005|Overall Study|Lack of Efficacy|2|||
130607501|NCT02531373|470184166|FG006|Overall Study|Lack of Efficacy|4|||
130607502|NCT02531373|470184167|FG007|Overall Study|Lack of Efficacy|8|||
130607503|NCT02531373|470184168|FG008|Overall Study|Lack of Efficacy|5|||
130607504|NCT02531373|470184160|FG000|Overall Study|Lost to Follow-up|0|||
130607505|NCT02531373|470184161|FG001|Overall Study|Lost to Follow-up|0|||
130607506|NCT02531373|470184162|FG002|Overall Study|Lost to Follow-up|0|||
130607507|NCT02531373|470184163|FG003|Overall Study|Lost to Follow-up|0|||
130607508|NCT02531373|470184164|FG004|Overall Study|Lost to Follow-up|0|||
130607509|NCT02531373|470184165|FG005|Overall Study|Lost to Follow-up|2|||
130607510|NCT02531373|470184166|FG006|Overall Study|Lost to Follow-up|2|||
130607511|NCT02531373|470184167|FG007|Overall Study|Lost to Follow-up|0|||
130607512|NCT02531373|470184168|FG008|Overall Study|Lost to Follow-up|0|||
130607513|NCT02531373|470184160|FG000|Overall Study|Physician Decision|0|||
130607514|NCT02531373|470184161|FG001|Overall Study|Physician Decision|0|||
130607515|NCT02531373|470184162|FG002|Overall Study|Physician Decision|0|||
130607516|NCT02531373|470184163|FG003|Overall Study|Physician Decision|0|||
130607517|NCT02531373|470184164|FG004|Overall Study|Physician Decision|2|||
130607518|NCT02531373|470184165|FG005|Overall Study|Physician Decision|1|||
130607519|NCT02531373|470184166|FG006|Overall Study|Physician Decision|0|||
130607520|NCT02531373|470184167|FG007|Overall Study|Physician Decision|0|||
130607521|NCT02531373|470184168|FG008|Overall Study|Physician Decision|0|||
130607522|NCT02531373|470184160|FG000|Overall Study|Protocol Violation|0|||
130607523|NCT02531373|470184161|FG001|Overall Study|Protocol Violation|0|||
130607524|NCT02531373|470184162|FG002|Overall Study|Protocol Violation|0|||
130607525|NCT02531373|470184163|FG003|Overall Study|Protocol Violation|0|||
130607526|NCT02531373|470184164|FG004|Overall Study|Protocol Violation|0|||
130607527|NCT02531373|470184165|FG005|Overall Study|Protocol Violation|1|||
130607528|NCT02531373|470184166|FG006|Overall Study|Protocol Violation|1|||
130607529|NCT02531373|470184167|FG007|Overall Study|Protocol Violation|0|||
130607530|NCT02531373|470184168|FG008|Overall Study|Protocol Violation|1|||
130607531|NCT02531373|470184160|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130607532|NCT02531373|470184161|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130607533|NCT02531373|470184162|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130607534|NCT02531373|470184163|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130607535|NCT02531373|470184164|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130607536|NCT02531373|470184165|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
130607537|NCT02531373|470184166|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
130607538|NCT02531373|470184167|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
130607539|NCT02531373|470184168|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
130607540|NCT02531373|470184160|FG000|Overall Study|Withdrawal by Subject|0|||
130607541|NCT02531373|470184161|FG001|Overall Study|Withdrawal by Subject|0|||
130607542|NCT02531373|470184162|FG002|Overall Study|Withdrawal by Subject|0|||
130607543|NCT02531373|470184163|FG003|Overall Study|Withdrawal by Subject|0|||
130607544|NCT02531373|470184164|FG004|Overall Study|Withdrawal by Subject|3|||
130607545|NCT02531373|470184165|FG005|Overall Study|Withdrawal by Subject|0|||
130607546|NCT02531373|470184166|FG006|Overall Study|Withdrawal by Subject|0|||
130607547|NCT02531373|470184167|FG007|Overall Study|Withdrawal by Subject|0|||
130607548|NCT02531373|470184168|FG008|Overall Study|Withdrawal by Subject|0|||
130607549|NCT05058664|470184171|FG000|Overall Study|No follow-up data provided|4|||
130607550|NCT05058664|470184172|FG001|Overall Study|No follow-up data provided|0|||
130607551|NCT05058664|470184173|FG002|Overall Study|No follow-up data provided|2|||
130607552|NCT05058664|470184171|FG000|Overall Study|Withdrawal by Subject|0|||
130607553|NCT05058664|470184172|FG001|Overall Study|Withdrawal by Subject|0|||
130607554|NCT05058664|470184173|FG002|Overall Study|Withdrawal by Subject|1|||
130607555|NCT01597557|470184174|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
130607556|NCT01597557|470184175|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
130607557|NCT02389816|470184176|FG000|Overall Study|Randomized but Not Treated|1|||
130607558|NCT02389816|470184177|FG001|Overall Study|Randomized but Not Treated|0|||
130607559|NCT02389816|470184178|FG002|Overall Study|Randomized but Not Treated|0|||
130607560|NCT02389816|470184176|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
130607561|NCT02389816|470184177|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
130607562|NCT02389816|470184178|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
130607563|NCT02389816|470184176|FG000|Overall Study|Major Protocol Deviation|1|||
130607564|NCT02389816|470184177|FG001|Overall Study|Major Protocol Deviation|0|||
130607565|NCT02389816|470184178|FG002|Overall Study|Major Protocol Deviation|0|||
130607566|NCT02389816|470184176|FG000|Overall Study|Lost to Follow-up|1|||
130607567|NCT02389816|470184177|FG001|Overall Study|Lost to Follow-up|0|||
130607568|NCT02389816|470184178|FG002|Overall Study|Lost to Follow-up|0|||
130607569|NCT02389816|470184176|FG000|Overall Study|Withdrawal of Consent|6|||
130607570|NCT02389816|470184177|FG001|Overall Study|Withdrawal of Consent|4|||
130607571|NCT02389816|470184178|FG002|Overall Study|Withdrawal of Consent|4|||
130607572|NCT02389816|470184176|FG000|Overall Study|Lack of Efficacy|1|||
130607573|NCT02389816|470184177|FG001|Overall Study|Lack of Efficacy|0|||
130607574|NCT02389816|470184178|FG002|Overall Study|Lack of Efficacy|0|||
130607575|NCT02389816|470184176|FG000|Overall Study|Non Compliance with Study Drug|1|||
130607576|NCT02389816|470184177|FG001|Overall Study|Non Compliance with Study Drug|1|||
130607577|NCT02389816|470184178|FG002|Overall Study|Non Compliance with Study Drug|1|||
130607578|NCT02389816|470184176|FG000|Overall Study|Reason not Specified|0|||
130607579|NCT02389816|470184177|FG001|Overall Study|Reason not Specified|2|||
130607580|NCT02389816|470184178|FG002|Overall Study|Reason not Specified|0|||
130607581|NCT01594476|470184179|FG000|Overall Study|Protocol Violation|1|||
130607582|NCT01594476|470184180|FG001|Overall Study|Protocol Violation|3|||
130607583|NCT01603641|470184183|FG000|Overall Study|Did not Receive Treatment|3|||
130607584|NCT01603641|470184183|FG000|Overall Study|Adverse Event|1|||
130607585|NCT01603641|470184183|FG000|Overall Study|Lack of Efficacy|1|||
130607586|NCT01603641|470184183|FG000|Overall Study|Lost to Follow-up|6|||
130607587|NCT01603641|470184183|FG000|Overall Study|Personal Reasons|18|||
130607588|NCT01603641|470184183|FG000|Overall Study|Other Miscellaneous Reasons|6|||
130607589|NCT03161678|470184184|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130607590|NCT03161678|470184185|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130607591|NCT03161678|470184186|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130607592|NCT03161678|470184187|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
130607593|NCT03161678|470184188|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130607594|NCT03161678|470184189|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130607595|NCT03161678|470184184|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
130607596|NCT03161678|470184185|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
130607597|NCT03161678|470184186|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
130607598|NCT03161678|470184187|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
130607599|NCT03161678|470184188|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
130607600|NCT03161678|470184189|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
130607601|NCT03161678|470184184|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
130607602|NCT03161678|470184185|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
130607603|NCT03161678|470184186|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
130607604|NCT03161678|470184187|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
130607605|NCT03161678|470184188|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
130607606|NCT03161678|470184189|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
130607607|NCT03161678|470184184|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130607608|NCT03161678|470184185|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130607609|NCT03161678|470184186|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130607610|NCT03161678|470184187|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
130607611|NCT03161678|470184188|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130607612|NCT03161678|470184189|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130607613|NCT01757704|470184190|FG000|Overall Study|Protocol Violation|1|||
130607614|NCT01757704|470184191|FG001|Overall Study|Protocol Violation|3|||
130607615|NCT01879618|470184192|FG000|Overall Study|Does not meet entrance criteria|1|||
130607616|NCT01879618|470184192|FG000|Overall Study|Withdrawal by Subject|1|||
130607617|NCT01879618|470184192|FG000|Overall Study|Surgery;changed schedule; not available|8|||
130607618|NCT01879618|470184192|FG000|Overall Study|Protocol Violation|6|||
130607619|NCT01879618|470184192|FG000|Overall Study|Adverse Event|5|||
130607620|NCT02890329|470184195|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130607621|NCT02890329|470184196|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
130607622|NCT02890329|470184197|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130607623|NCT02890329|470184198|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130607624|NCT02890329|470184199|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130607625|NCT02890329|470184200|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130607626|NCT02890329|470184195|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
130607627|NCT02890329|470184196|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
130607628|NCT02890329|470184197|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130607629|NCT02890329|470184198|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130607630|NCT02890329|470184199|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130607631|NCT02890329|470184200|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130607632|NCT02890329|470184195|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130607633|NCT02890329|470184196|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130607634|NCT02890329|470184197|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130607635|NCT02890329|470184198|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
130607636|NCT02890329|470184199|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130607637|NCT02890329|470184200|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130607638|NCT02890329|470184195|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130607639|NCT02890329|470184196|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130607640|NCT02890329|470184197|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
130607641|NCT02890329|470184198|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130607642|NCT02890329|470184199|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130607643|NCT02890329|470184200|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130607644|NCT00938327|470184201|FG000|Overall Study|Adverse Event|2|||
130607645|NCT00938327|470184201|FG000|Overall Study|Protocol Violation|1|||
130607646|NCT00938327|470184201|FG000|Overall Study|Withdrawal by Subject|4|||
130607647|NCT00938327|470184201|FG000|Overall Study|Lost to Follow-up|37|||
130607648|NCT00938327|470184201|FG000|Overall Study|2nd dose received outside of the study|7|||
130607649|NCT00938327|470184201|FG000|Overall Study|Vaccine not received as out of stock|9|||
130607650|NCT02749721|470184202|FG000|Screening|Withdrawal by Subject|1|||
130607651|NCT02749721|470184202|FG000|Screening|Lost to Follow-up|2|||
130607652|NCT02749721|470184202|FG000|Screening|Protocol Violation|3|||
130607653|NCT02749721|470184202|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
130607654|NCT02749721|470184202|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
130607655|NCT02691247|470184203|FG000|Overall Study|Withdrawal by Subject|1|||
130607656|NCT02691247|470184204|FG001|Overall Study|Withdrawal by Subject|2|||
130607657|NCT02691247|470184205|FG002|Overall Study|Withdrawal by Subject|2|||
130607658|NCT02691247|470184203|FG000|Overall Study|Lost to Follow-up|2|||
130607659|NCT02691247|470184204|FG001|Overall Study|Lost to Follow-up|0|||
130607660|NCT02691247|470184205|FG002|Overall Study|Lost to Follow-up|1|||
130607661|NCT02552355|470184206|FG000|Overall Study|Adverse Event|0|||
130607662|NCT02552355|470184207|FG001|Overall Study|Adverse Event|2|||
130607663|NCT02552355|470184208|FG002|Overall Study|Adverse Event|2|||
130607664|NCT02552355|470184209|FG003|Overall Study|Adverse Event|0|||
130607665|NCT02552355|470184206|FG000|Overall Study|Withdrawal by Subject|0|||
130607666|NCT02552355|470184207|FG001|Overall Study|Withdrawal by Subject|0|||
130607667|NCT02552355|470184208|FG002|Overall Study|Withdrawal by Subject|0|||
130607668|NCT02552355|470184209|FG003|Overall Study|Withdrawal by Subject|1|||
130607669|NCT01519245|470184210|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
130607670|NCT01519245|470184211|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
130607671|NCT00933335|470184212|FG000|Overall Study|Lost to Follow-up|1|||
130607672|NCT00933335|470184213|FG001|Overall Study|Lost to Follow-up|3|||
130607673|NCT00933335|470184212|FG000|Overall Study|Withdrawal by Subject|0|||
130607674|NCT00933335|470184213|FG001|Overall Study|Withdrawal by Subject|1|||
130607675|NCT00933335|470184212|FG000|Overall Study|Progressive Disease|0|||
130607676|NCT00933335|470184213|FG001|Overall Study|Progressive Disease|11|||
130607677|NCT00933335|470184212|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
130607678|NCT00933335|470184213|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
130607679|NCT00933335|470184212|FG000|Overall Study|Co-morbid Illness|1|||
130607680|NCT00933335|470184213|FG001|Overall Study|Co-morbid Illness|0|||
130607681|NCT01095250|470184219|FG000|Overall Study|administrative reasons|8|||
130607682|NCT01095250|470184220|FG001|Overall Study|administrative reasons|10|||
130607683|NCT01095250|470184221|FG002|Overall Study|administrative reasons|7|||
130607684|NCT01095250|470184222|FG003|Overall Study|administrative reasons|5|||
130607685|NCT01095250|470184219|FG000|Overall Study|Withdrawal by Subject|0|||
130607686|NCT01095250|470184220|FG001|Overall Study|Withdrawal by Subject|0|||
130607687|NCT01095250|470184221|FG002|Overall Study|Withdrawal by Subject|1|||
130607688|NCT01095250|470184222|FG003|Overall Study|Withdrawal by Subject|0|||
130607689|NCT00705224|470184223|FG000|Overall Study|Adverse Event|1|||
130607690|NCT00705224|470184223|FG000|Overall Study|Lack of Efficacy|2|||
130607691|NCT00705224|470184223|FG000|Overall Study|Withdrawal by Subject|3|||
130607692|NCT00705224|470184223|FG000|Overall Study|Lost to Follow-up|5|||
130607693|NCT03596177|470184224|FG000|Single Blind Period|Withdrawal by Subject|1|||
130607694|NCT03596177|470184225|FG001|Single Blind Period|Withdrawal by Subject|1|||
130607695|NCT03596177|470184224|FG000|Single Blind Period|Other|1|||
130607696|NCT03596177|470184225|FG001|Single Blind Period|Other|0|||
130607697|NCT03596177|470184224|FG000|Double Blind Period|Withdrawal by Subject|0|||
130607698|NCT03596177|470184225|FG001|Double Blind Period|Withdrawal by Subject|1|||
130607699|NCT03596177|470184224|FG000|Double Blind Period|Other|0|||
130607700|NCT03596177|470184225|FG001|Double Blind Period|Other|4|||
130607701|NCT03596177|470184224|FG000|Double Blind Period|Death during safety follow-up|0|||
130607702|NCT03596177|470184225|FG001|Double Blind Period|Death during safety follow-up|1|||
130607703|NCT03860844|470184230|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
130607704|NCT03860844|470184231|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
130607705|NCT03860844|470184232|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
130607706|NCT03860844|470184230|FG000|Overall Study|Progressive disease|5|||
130607707|NCT03860844|470184231|FG001|Overall Study|Progressive disease|3|||
130607708|NCT03860844|470184232|FG002|Overall Study|Progressive disease|4|||
130607709|NCT03860844|470184230|FG000|Overall Study|Other, Not related to COVID-19|0|||
130607710|NCT03860844|470184231|FG001|Overall Study|Other, Not related to COVID-19|1|||
130607711|NCT03860844|470184232|FG002|Overall Study|Other, Not related to COVID-19|0|||
130607712|NCT00953043|470185793|FG000|Overall Study|Withdrawal by Subject|4|||
130607713|NCT00953043|470185794|FG001|Overall Study|Withdrawal by Subject|0|||
130607714|NCT00953043|470185793|FG000|Overall Study|Physician Decision|0|||
130607715|NCT00953043|470185794|FG001|Overall Study|Physician Decision|2|||
130607716|NCT01043185|470185796|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
130607717|NCT01043185|470185797|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
130607718|NCT01043185|470185798|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
130607719|NCT01043185|470185799|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
130607720|NCT01043185|470185800|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
130607721|NCT01043185|470185801|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
130607722|NCT01043185|470185802|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
130607723|NCT01043185|470185803|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
130607724|NCT01043185|470185804|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
130607725|NCT01043185|470185805|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
130607726|NCT01432262|470185806|FG000|Overall Study|Withdrawal by Subject|2|||
130607727|NCT01432262|470185807|FG001|Overall Study|Withdrawal by Subject|1|||
130607728|NCT00165646|470185808|FG000|Overall Study|Adverse Event|1|||
130607729|NCT00165646|470185809|FG001|Overall Study|Adverse Event|1|||
130607730|NCT00165646|470185810|FG002|Overall Study|Adverse Event|1|||
130607731|NCT00165646|470185808|FG000|Overall Study|Lack of Efficacy|1|||
130607732|NCT00165646|470185809|FG001|Overall Study|Lack of Efficacy|2|||
130607733|NCT00165646|470185810|FG002|Overall Study|Lack of Efficacy|0|||
130607734|NCT00165646|470185808|FG000|Overall Study|Withdrawal by Subject|0|||
130607735|NCT00165646|470185809|FG001|Overall Study|Withdrawal by Subject|2|||
130607736|NCT00165646|470185810|FG002|Overall Study|Withdrawal by Subject|1|||
130607737|NCT00165646|470185808|FG000|Overall Study|Physician Decision|2|||
130607738|NCT00165646|470185809|FG001|Overall Study|Physician Decision|0|||
130607739|NCT00165646|470185810|FG002|Overall Study|Physician Decision|2|||
130607740|NCT00165646|470185808|FG000|Overall Study|Protocol Violation|1|||
130607741|NCT00165646|470185809|FG001|Overall Study|Protocol Violation|0|||
130607742|NCT00165646|470185810|FG002|Overall Study|Protocol Violation|0|||
130607743|NCT00523341|470185813|FG000|Overall Study|Withdrawal by Subject|399|||
130607744|NCT00523341|470185814|FG001|Overall Study|Withdrawal by Subject|427|||
130607745|NCT00523341|470185813|FG000|Overall Study|Other|181|||
130607746|NCT00523341|470185814|FG001|Overall Study|Other|198|||
130607747|NCT00523341|470185813|FG000|Overall Study|Adverse Event|122|||
130607748|NCT00523341|470185814|FG001|Overall Study|Adverse Event|155|||
130607749|NCT00523341|470185813|FG000|Overall Study|Death|101|||
130607750|NCT00523341|470185814|FG001|Overall Study|Death|110|||
130607751|NCT00523341|470185813|FG000|Overall Study|Lost to Follow-up|73|||
130607752|NCT00523341|470185814|FG001|Overall Study|Lost to Follow-up|61|||
130607753|NCT00523341|470185813|FG000|Overall Study|Non-compliance|20|||
130607754|NCT00523341|470185814|FG001|Overall Study|Non-compliance|13|||
130607755|NCT00523341|470185813|FG000|Overall Study|Physician Decision|14|||
130607756|NCT00523341|470185814|FG001|Overall Study|Physician Decision|13|||
130607757|NCT00523341|470185813|FG000|Overall Study|Requirement for Alternative Therapy|4|||
130607758|NCT00523341|470185814|FG001|Overall Study|Requirement for Alternative Therapy|14|||
130607759|NCT00523341|470185813|FG000|Overall Study|Protocol Deviation|6|||
130607760|NCT00523341|470185814|FG001|Overall Study|Protocol Deviation|5|||
130607761|NCT00523341|470185813|FG000|Overall Study|Ineligibility Determined|3|||
130607762|NCT00523341|470185814|FG001|Overall Study|Ineligibility Determined|4|||
130607763|NCT00523341|470185813|FG000|Overall Study|Disease Progression|1|||
130607764|NCT00523341|470185814|FG001|Overall Study|Disease Progression|0|||
130607765|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130607766|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130607767|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130607768|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
130607769|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130607770|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130607771|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130607772|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130607773|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
130607774|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
130607775|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130607776|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130607777|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130607778|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130607779|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
130607780|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130607781|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130607782|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130607783|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130607784|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130607785|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
130607786|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
130607787|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130607788|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130607789|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130607790|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130607791|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
130607792|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
130607793|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130607794|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130607795|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
130607796|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
130607797|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
130607798|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
130607799|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
130607800|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
130607801|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
130607802|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
130607803|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
130607804|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
130607805|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
130607806|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
130607807|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130607808|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
130607809|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
130607810|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
130607811|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130607812|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130607813|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
130607814|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130607815|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
130607816|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
130607817|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130607818|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130607819|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
130607820|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
130607821|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
130607822|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
130607823|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
130607824|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
130607825|NCT03395197|470185817|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
130607826|NCT03395197|470185818|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130607827|NCT03395197|470185819|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
130607828|NCT03395197|470185820|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
130607829|NCT03395197|470185821|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130607830|NCT03395197|470185822|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130607831|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Death|0|||
130607832|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Death|0|||
130607833|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Death|0|||
130607834|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Death|0|||
130607835|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Death|1|||
130607836|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Death|4|||
130607837|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130607838|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130607839|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130607840|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130607841|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
130607842|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
130607843|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130607844|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130607845|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130607846|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130607847|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
130607848|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130607849|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130607850|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130607851|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130607852|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130607853|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
130607854|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
130607855|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130607856|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130607857|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130607858|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130607859|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
130607860|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
130607861|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130607862|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130607863|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130607864|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130607865|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
130607866|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
130607867|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130607868|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130607869|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130607870|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130607871|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
130607872|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
130607873|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Other|0|||
130607874|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Other|0|||
130607875|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Other|0|||
130607876|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Other|0|||
130607877|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Other|3|||
130607878|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Other|3|||
130607879|NCT03395197|470185817|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
130607880|NCT03395197|470185818|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
130607881|NCT03395197|470185819|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
130607882|NCT03395197|470185820|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
130607883|NCT03395197|470185821|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
130607884|NCT03395197|470185822|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
130607885|NCT05137041|470185823|FG000|Overall Study|Lost to Follow-up|1|||
130607886|NCT05137041|470185824|FG001|Overall Study|Lost to Follow-up|1|||
130607887|NCT05137041|470185823|FG000|Overall Study|Withdrawal by Subject|0|||
130607888|NCT05137041|470185824|FG001|Overall Study|Withdrawal by Subject|2|||
130607889|NCT05137041|470185823|FG000|Overall Study|Reason not Specified|0|||
130607890|NCT05137041|470185824|FG001|Overall Study|Reason not Specified|1|||
130607891|NCT00392171|470185825|FG000|Overall Study|Did not meet inclusion criteria|4|||
130607892|NCT00392171|470185825|FG000|Overall Study|Disease progression|101|||
130607893|NCT01605071|470185826|FG000|Overall Study|Withdrawal by Subject|3|||
130607894|NCT01605071|470185827|FG001|Overall Study|Withdrawal by Subject|2|||
130607895|NCT03470922|470185829|FG000|Overall Study|Death|107|||
130607896|NCT03470922|470185830|FG001|Overall Study|Death|118|||
130607897|NCT03470922|470185829|FG000|Overall Study|Lost to Follow-up|5|||
130607898|NCT03470922|470185830|FG001|Overall Study|Lost to Follow-up|5|||
130607899|NCT03470922|470185829|FG000|Overall Study|Participant Withdrew Consent|4|||
130607900|NCT03470922|470185830|FG001|Overall Study|Participant Withdrew Consent|9|||
130607901|NCT03470922|470185829|FG000|Overall Study|Other reasons|1|||
130607902|NCT03470922|470185830|FG001|Overall Study|Other reasons|0|||
130607903|NCT03470922|470185829|FG000|Overall Study|Not reported|1|||
130607904|NCT03470922|470185830|FG001|Overall Study|Not reported|0|||
130607905|NCT02340819|470185831|FG000|Overall Study|Adverse Event|1|||
130607906|NCT02340819|470185831|FG000|Overall Study|Withdrawal by Subject|2|||
130607907|NCT02340819|470185831|FG000|Overall Study|Discontinued with other reason|1|||
130607908|NCT00028002|470185834|FG000|Overall Study|Withdrawal by Subject|3|||
130607909|NCT00028002|470185834|FG000|Overall Study|Ineligible|8|||
130607910|NCT01793051|470185835|FG000|Overall Study|Withdrawal by Subject|6|||
130607911|NCT01793051|470185836|FG001|Overall Study|Withdrawal by Subject|4|||
130607912|NCT01793051|470185835|FG000|Overall Study|Adverse Event|0|||
130607913|NCT01793051|470185836|FG001|Overall Study|Adverse Event|2|||
130607914|NCT01793051|470185835|FG000|Overall Study|Too ill to continue|1|||
130607915|NCT01793051|470185836|FG001|Overall Study|Too ill to continue|0|||
130607916|NCT01793051|470185835|FG000|Overall Study|Switched chemo|1|||
130607917|NCT01793051|470185836|FG001|Overall Study|Switched chemo|1|||
130607918|NCT01793051|470185835|FG000|Overall Study|Lack of compliance|1|||
130607919|NCT01793051|470185836|FG001|Overall Study|Lack of compliance|0|||
130607920|NCT01793051|470185835|FG000|Overall Study|Requested to be removed from the study|1|||
130607921|NCT01793051|470185836|FG001|Overall Study|Requested to be removed from the study|1|||
130607922|NCT04907539|470185839|FG000|Overall Study|Consent withdrawn|1|||
130607923|NCT04907539|470185840|FG001|Overall Study|Consent withdrawn|0|||
130607924|NCT04907539|470185839|FG000|Overall Study|Death|14|||
130607925|NCT04907539|470185840|FG001|Overall Study|Death|3|||
130607926|NCT00051558|470185842|FG000|Overall Study|Adverse Event|30|||
130607927|NCT00051558|470185843|FG001|Overall Study|Adverse Event|18|||
130607928|NCT00051558|470185842|FG000|Overall Study|Withdrawal by Subject|29|||
130607929|NCT00051558|470185843|FG001|Overall Study|Withdrawal by Subject|42|||
130607930|NCT00051558|470185842|FG000|Overall Study|Death|9|||
130607931|NCT00051558|470185843|FG001|Overall Study|Death|15|||
130607932|NCT00051558|470185842|FG000|Overall Study|Lost to Follow-up|4|||
130607933|NCT00051558|470185843|FG001|Overall Study|Lost to Follow-up|13|||
130607934|NCT00051558|470185842|FG000|Overall Study|Protocol Violation|3|||
130607935|NCT00051558|470185843|FG001|Overall Study|Protocol Violation|4|||
130607936|NCT00051558|470185842|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
130607937|NCT00051558|470185843|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
130607938|NCT00051558|470185842|FG000|Overall Study|Sponsor Decision|6|||
130607939|NCT00051558|470185843|FG001|Overall Study|Sponsor Decision|1|||
130607940|NCT00051558|470185842|FG000|Overall Study|Other|2|||
130607941|NCT00051558|470185843|FG001|Overall Study|Other|1|||
130607942|NCT00051558|470185842|FG000|Overall Study|Significant Lab Value|2|||
130607943|NCT00051558|470185843|FG001|Overall Study|Significant Lab Value|0|||
130607944|NCT00051558|470185842|FG000|Overall Study|Physician Decision|5|||
130607945|NCT00051558|470185843|FG001|Overall Study|Physician Decision|0|||
130607946|NCT01808118|470185846|FG000|Period 1|Adverse Event|15|||
130607947|NCT01808118|470185847|FG001|Period 1|Adverse Event|0|||
130607948|NCT01808118|470185848|FG002|Period 1|Adverse Event|0|||
130607949|NCT01808118|470185846|FG000|Period 1|Withdrew consent|24|||
130607950|NCT01808118|470185847|FG001|Period 1|Withdrew consent|0|||
130607951|NCT01808118|470185848|FG002|Period 1|Withdrew consent|0|||
130607952|NCT01808118|470185846|FG000|Period 1|Lost to Follow-up|9|||
130607953|NCT01808118|470185847|FG001|Period 1|Lost to Follow-up|0|||
130607954|NCT01808118|470185848|FG002|Period 1|Lost to Follow-up|0|||
130607955|NCT01808118|470185846|FG000|Period 1|Did not meet criteria for remission|303|||
130607956|NCT01808118|470185847|FG001|Period 1|Did not meet criteria for remission|0|||
130607957|NCT01808118|470185848|FG002|Period 1|Did not meet criteria for remission|0|||
130607958|NCT01808118|470185846|FG000|Period 1|Enrolled in error|7|||
130607959|NCT01808118|470185847|FG001|Period 1|Enrolled in error|0|||
130607960|NCT01808118|470185848|FG002|Period 1|Enrolled in error|0|||
130607961|NCT01808118|470185846|FG000|Period 1|Did not meet inclusion criteria|3|||
130607962|NCT01808118|470185847|FG001|Period 1|Did not meet inclusion criteria|0|||
130607963|NCT01808118|470185848|FG002|Period 1|Did not meet inclusion criteria|0|||
130607964|NCT01808118|470185846|FG000|Period 1|Non-conformance with inclusion criteria|3|||
130607965|NCT01808118|470185847|FG001|Period 1|Non-conformance with inclusion criteria|0|||
130607966|NCT01808118|470185848|FG002|Period 1|Non-conformance with inclusion criteria|0|||
130607967|NCT01808118|470185846|FG000|Period 1|Investigator decision: site closure|2|||
130607968|NCT01808118|470185847|FG001|Period 1|Investigator decision: site closure|0|||
130607969|NCT01808118|470185848|FG002|Period 1|Investigator decision: site closure|0|||
130607970|NCT01808118|470185846|FG000|Period 1|Non-compliance per sponsor|1|||
130607971|NCT01808118|470185847|FG001|Period 1|Non-compliance per sponsor|0|||
130607972|NCT01808118|470185848|FG002|Period 1|Non-compliance per sponsor|0|||
130607973|NCT01808118|470185846|FG000|Period 1|Lack of Efficacy|1|||
130607974|NCT01808118|470185847|FG001|Period 1|Lack of Efficacy|0|||
130607975|NCT01808118|470185848|FG002|Period 1|Lack of Efficacy|0|||
130607976|NCT01808118|470185846|FG000|Period 2|Adverse Event|0|||
130607977|NCT01808118|470185847|FG001|Period 2|Adverse Event|4|||
130607978|NCT01808118|470185848|FG002|Period 2|Adverse Event|0|||
130607979|NCT01808118|470185846|FG000|Period 2|Withdrew consent|0|||
130607980|NCT01808118|470185847|FG001|Period 2|Withdrew consent|7|||
130607981|NCT01808118|470185848|FG002|Period 2|Withdrew consent|6|||
130607982|NCT01808118|470185846|FG000|Period 2|Lost to Follow-up|0|||
130607983|NCT01808118|470185847|FG001|Period 2|Lost to Follow-up|0|||
130607984|NCT01808118|470185848|FG002|Period 2|Lost to Follow-up|2|||
130607985|NCT01808118|470185846|FG000|Period 2|Investigator no longer conducting trials|0|||
130607986|NCT01808118|470185847|FG001|Period 2|Investigator no longer conducting trials|1|||
130607987|NCT01808118|470185848|FG002|Period 2|Investigator no longer conducting trials|0|||
130607988|NCT01808118|470185846|FG000|Period 2|Switched to other therapy|0|||
130607989|NCT01808118|470185847|FG001|Period 2|Switched to other therapy|1|||
130607990|NCT01808118|470185848|FG002|Period 2|Switched to other therapy|0|||
130607991|NCT00718419|470185853|FG000|Overall Study|Adverse Event|2|||
130607992|NCT00718419|470185854|FG001|Overall Study|Adverse Event|1|||
130607993|NCT00718419|470185853|FG000|Overall Study|Physician Decision|1|||
130607994|NCT00718419|470185854|FG001|Overall Study|Physician Decision|6|||
130607995|NCT00718419|470185853|FG000|Overall Study|Sponsor decision|0|||
130607996|NCT00718419|470185854|FG001|Overall Study|Sponsor decision|1|||
130607997|NCT00718419|470185853|FG000|Overall Study|Withdrawal by Subject|0|||
130607998|NCT00718419|470185854|FG001|Overall Study|Withdrawal by Subject|5|||
130607999|NCT00718419|470185853|FG000|Overall Study|Progressive Disease|7|||
130608000|NCT00718419|470185854|FG001|Overall Study|Progressive Disease|25|||
130608001|NCT00718419|470185853|FG000|Overall Study|Death Due to Progressive Disease|2|||
130608002|NCT00718419|470185854|FG001|Overall Study|Death Due to Progressive Disease|0|||
130608003|NCT00718419|470185853|FG000|Overall Study|Death Due to Study Drug Related|0|||
130608004|NCT00718419|470185854|FG001|Overall Study|Death Due to Study Drug Related|1|||
130608005|NCT00718419|470185853|FG000|Overall Study|Death Due to Adverse Events|1|||
130608006|NCT00718419|470185854|FG001|Overall Study|Death Due to Adverse Events|0|||
130608007|NCT03952468|470185862|FG000|Overall Study|Death|0|||
130608008|NCT03952468|470185863|FG001|Overall Study|Death|1|||
130608009|NCT03952468|470185862|FG000|Overall Study|Adverse Event|0|||
130608010|NCT03952468|470185863|FG001|Overall Study|Adverse Event|1|||
130608011|NCT03952468|470185862|FG000|Overall Study|Physician Decision|1|||
130608012|NCT03952468|470185863|FG001|Overall Study|Physician Decision|0|||
130608013|NCT03952468|470185862|FG000|Overall Study|Lost to Follow-up|3|||
130608014|NCT03952468|470185863|FG001|Overall Study|Lost to Follow-up|4|||
130608015|NCT03952468|470185862|FG000|Overall Study|Withdrawal by Subject|2|||
130608016|NCT03952468|470185863|FG001|Overall Study|Withdrawal by Subject|1|||
130608017|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
130608018|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
130608019|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130608020|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130608021|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130608022|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130608023|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130608024|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130608025|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
130608026|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130608027|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130608028|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
130608029|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130608030|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130608031|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
130608032|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
130608033|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
130608034|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
130608035|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130608036|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130608037|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130608038|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Other|0|||
130608039|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Other|1|||
130608040|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Other|0|||
130608041|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Other|0|||
130608042|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Other|0|||
130608043|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Other|0|||
130608044|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Other|0|||
130608045|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
130608046|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
130608047|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
130608048|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
130608049|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
130608050|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
130608051|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
130608052|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
130608053|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
130608054|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130608055|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
130608056|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
130608057|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130608058|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130608059|NCT00365716|470185864|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
130608060|NCT00365716|470185865|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
130608061|NCT00365716|470185866|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
130608062|NCT00365716|470185867|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
130608063|NCT00365716|470185868|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
130608064|NCT00365716|470185869|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
130608065|NCT00365716|470185870|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
130608066|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
130608067|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130608068|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130608069|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
130608070|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
130608071|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130608072|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130608073|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
130608074|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
130608075|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
130608076|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
130608077|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
130608078|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
130608079|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
130608080|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
130608081|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
130608082|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
130608083|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
130608084|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130608085|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130608086|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130608087|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
130608088|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130608089|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130608090|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130608091|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
130608092|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130608093|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130608094|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130608095|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
130608096|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
130608097|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130608098|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130608099|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130608100|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130608101|NCT00365716|470185864|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
130608102|NCT00365716|470185865|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
130608103|NCT00365716|470185866|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
130608104|NCT00365716|470185867|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
130608105|NCT00365716|470185868|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
130608106|NCT00365716|470185869|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
130608107|NCT00365716|470185870|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
130608108|NCT00365716|470185864|FG000|Extension 1|Lost to Follow-up|0|||
130608109|NCT00365716|470185865|FG001|Extension 1|Lost to Follow-up|0|||
130608110|NCT00365716|470185866|FG002|Extension 1|Lost to Follow-up|0|||
130608111|NCT00365716|470185867|FG003|Extension 1|Lost to Follow-up|0|||
130608112|NCT00365716|470185868|FG004|Extension 1|Lost to Follow-up|0|||
130608113|NCT00365716|470185869|FG005|Extension 1|Lost to Follow-up|1|||
130608114|NCT00365716|470185870|FG006|Extension 1|Lost to Follow-up|0|||
130608115|NCT00365716|470185864|FG000|Extension 1|Other|0|||
130608116|NCT00365716|470185865|FG001|Extension 1|Other|0|||
130608117|NCT00365716|470185866|FG002|Extension 1|Other|0|||
130608118|NCT00365716|470185867|FG003|Extension 1|Other|0|||
130608119|NCT00365716|470185868|FG004|Extension 1|Other|0|||
130608120|NCT00365716|470185869|FG005|Extension 1|Other|9|||
130608121|NCT00365716|470185870|FG006|Extension 1|Other|0|||
130608122|NCT00365716|470185864|FG000|Extension 1|Moved|0|||
130608123|NCT00365716|470185865|FG001|Extension 1|Moved|0|||
130608124|NCT00365716|470185866|FG002|Extension 1|Moved|0|||
130608125|NCT00365716|470185867|FG003|Extension 1|Moved|0|||
130608126|NCT00365716|470185868|FG004|Extension 1|Moved|0|||
130608127|NCT00365716|470185869|FG005|Extension 1|Moved|4|||
130608128|NCT00365716|470185870|FG006|Extension 1|Moved|0|||
130608129|NCT00365716|470185864|FG000|Extension 1|Withdrawal by Subject|0|||
130608130|NCT00365716|470185865|FG001|Extension 1|Withdrawal by Subject|0|||
130608131|NCT00365716|470185866|FG002|Extension 1|Withdrawal by Subject|0|||
130608132|NCT00365716|470185867|FG003|Extension 1|Withdrawal by Subject|0|||
130608133|NCT00365716|470185868|FG004|Extension 1|Withdrawal by Subject|0|||
130608134|NCT00365716|470185869|FG005|Extension 1|Withdrawal by Subject|3|||
130608135|NCT00365716|470185870|FG006|Extension 1|Withdrawal by Subject|0|||
130608136|NCT00365716|470185864|FG000|Extension 1|Pregnancy|0|||
130608137|NCT00365716|470185865|FG001|Extension 1|Pregnancy|0|||
130608138|NCT00365716|470185866|FG002|Extension 1|Pregnancy|0|||
130608139|NCT00365716|470185867|FG003|Extension 1|Pregnancy|0|||
130608140|NCT00365716|470185868|FG004|Extension 1|Pregnancy|0|||
130608141|NCT00365716|470185869|FG005|Extension 1|Pregnancy|4|||
130608142|NCT00365716|470185870|FG006|Extension 1|Pregnancy|0|||
130608143|NCT00365716|470185864|FG000|Extension 1|Protocol Violation|0|||
130608144|NCT00365716|470185865|FG001|Extension 1|Protocol Violation|0|||
130608145|NCT00365716|470185866|FG002|Extension 1|Protocol Violation|0|||
130608146|NCT00365716|470185867|FG003|Extension 1|Protocol Violation|0|||
130608147|NCT00365716|470185868|FG004|Extension 1|Protocol Violation|0|||
130608148|NCT00365716|470185869|FG005|Extension 1|Protocol Violation|1|||
130608149|NCT00365716|470185870|FG006|Extension 1|Protocol Violation|0|||
130608150|NCT00365716|470185864|FG000|Extension 2|Lost to Follow-up|0|||
130608151|NCT00365716|470185865|FG001|Extension 2|Lost to Follow-up|0|||
130608152|NCT00365716|470185866|FG002|Extension 2|Lost to Follow-up|0|||
130608153|NCT00365716|470185867|FG003|Extension 2|Lost to Follow-up|0|||
130608154|NCT00365716|470185868|FG004|Extension 2|Lost to Follow-up|0|||
130608155|NCT00365716|470185869|FG005|Extension 2|Lost to Follow-up|0|||
130608156|NCT00365716|470185870|FG006|Extension 2|Lost to Follow-up|2|||
130608157|NCT00365716|470185864|FG000|Extension 2|Other|0|||
130608158|NCT00365716|470185865|FG001|Extension 2|Other|0|||
130608159|NCT00365716|470185866|FG002|Extension 2|Other|0|||
130608160|NCT00365716|470185867|FG003|Extension 2|Other|0|||
130608161|NCT00365716|470185868|FG004|Extension 2|Other|0|||
130608162|NCT00365716|470185869|FG005|Extension 2|Other|0|||
130608163|NCT00365716|470185870|FG006|Extension 2|Other|3|||
130608164|NCT00365716|470185864|FG000|Extension 2|Withdrawal by Subject|0|||
130608165|NCT00365716|470185865|FG001|Extension 2|Withdrawal by Subject|0|||
130608166|NCT00365716|470185866|FG002|Extension 2|Withdrawal by Subject|0|||
130608167|NCT00365716|470185867|FG003|Extension 2|Withdrawal by Subject|0|||
130608168|NCT00365716|470185868|FG004|Extension 2|Withdrawal by Subject|0|||
130608169|NCT00365716|470185869|FG005|Extension 2|Withdrawal by Subject|0|||
130608170|NCT00365716|470185870|FG006|Extension 2|Withdrawal by Subject|5|||
130608171|NCT05761444|470185871|FG000|Overall Study|Protocol Violation|2|||
130608172|NCT05761444|470185872|FG001|Overall Study|Protocol Violation|1|||
130608173|NCT05761444|470185871|FG000|Overall Study|Adverse Event|2|||
130608174|NCT05761444|470185872|FG001|Overall Study|Adverse Event|2|||
130608175|NCT05761444|470185871|FG000|Overall Study|Withdrawal by Subject|3|||
130608176|NCT05761444|470185872|FG001|Overall Study|Withdrawal by Subject|2|||
130608177|NCT05761444|470185871|FG000|Overall Study|Other|1|||
130608178|NCT05761444|470185872|FG001|Overall Study|Other|0|||
130608179|NCT01106534|470185873|FG000|Overall Study|Withdrawal by Subject|18|||
130608180|NCT01106534|470185873|FG000|Overall Study|Lost to Follow-up|2|||
130608181|NCT01106534|470185873|FG000|Overall Study|Death|16|||
130608182|NCT01106534|470185873|FG000|Overall Study|Physician Decision|1|||
130608183|NCT00069576|470185877|FG000|Original Trial|Lost to Follow-up|25|||
130608184|NCT00069576|470185878|FG001|Original Trial|Lost to Follow-up|33|||
130608185|NCT00069576|470185877|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
130608186|NCT00069576|470185878|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
130608187|NCT04430738|470185879|FG000|Phase 1: Dose Escalation|Death|1|||
130608188|NCT04430738|470185880|FG001|Phase 1: Dose Escalation|Death|4|||
130608189|NCT04430738|470185881|FG002|Phase 1: Dose Escalation|Death|4|||
130608190|NCT04430738|470185882|FG003|Phase 1: Dose Escalation|Death|1|||
130608191|NCT04430738|470185883|FG004|Phase 1: Dose Escalation|Death|6|||
130608192|NCT04430738|470185884|FG005|Phase 1: Dose Escalation|Death|0|||
130608193|NCT04430738|470185879|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
130608194|NCT04430738|470185880|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130608195|NCT04430738|470185881|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
130608196|NCT04430738|470185882|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130608197|NCT04430738|470185883|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130608198|NCT04430738|470185884|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
130608199|NCT04430738|470185879|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130608200|NCT04430738|470185880|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
130608201|NCT04430738|470185881|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130608202|NCT04430738|470185882|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
130608203|NCT04430738|470185883|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130608204|NCT04430738|470185884|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130608205|NCT04430738|470185879|FG000|Phase 1: Dose Escalation|Other|1|||
130608206|NCT04430738|470185880|FG001|Phase 1: Dose Escalation|Other|0|||
130608207|NCT04430738|470185881|FG002|Phase 1: Dose Escalation|Other|0|||
130608208|NCT04430738|470185882|FG003|Phase 1: Dose Escalation|Other|0|||
130608209|NCT04430738|470185883|FG004|Phase 1: Dose Escalation|Other|0|||
130608210|NCT04430738|470185884|FG005|Phase 1: Dose Escalation|Other|0|||
130608211|NCT04430738|470185879|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130608212|NCT04430738|470185880|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130608213|NCT04430738|470185881|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130608214|NCT04430738|470185882|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130608215|NCT04430738|470185883|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130608216|NCT04430738|470185884|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
130608217|NCT04430738|470185879|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130608218|NCT04430738|470185880|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130608219|NCT04430738|470185881|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130608220|NCT04430738|470185882|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130608221|NCT04430738|470185883|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130608222|NCT04430738|470185884|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
130608223|NCT05590793|470185885|FG000|Overall Study|Withdrawal by Subject|6|||
130608224|NCT05590793|470185885|FG000|Overall Study|Physician Decision|1|||
130608225|NCT02499146|470185893|FG000|Overall Study|Lost to Follow-up|1|||
130608226|NCT02499146|470185893|FG000|Overall Study|Withdrawal by Subject|1|||
130608227|NCT02499146|470185893|FG000|Overall Study|Other|2|||
130608228|NCT02499146|470185893|FG000|Overall Study|Ongoing at date of cut-off|9|||
130608229|NCT02499146|470185893|FG000|Overall Study|Began other treatment/therapy|13|||
130608230|NCT02275026|470185894|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
130608231|NCT02275026|470185894|FG000|Overall Study|Withdrawal by Subject|4|||
130608232|NCT02275026|470185894|FG000|Overall Study|Ineligible due to medical history|13|||
130608233|NCT02275026|470185894|FG000|Overall Study|MRI malfunction precluded testing|1|||
130608234|NCT02275026|470185894|FG000|Overall Study|Ineligible after MRI findings|1|||
130608235|NCT02275026|470185894|FG000|Overall Study|Lost to Follow-up|2|||
130608236|NCT02275026|470185894|FG000|Overall Study|Scanner failure|1|||
130608237|NCT05468086|470185897|FG000|Overall Study|Withdrawal by Subject|3|||
130608238|NCT05468086|470185897|FG000|Overall Study|Subject was found ineligible after consent|1|||
130608239|NCT01108809|470185898|FG000|Overall Study|Adverse Event|3|||
130608240|NCT01108809|470185898|FG000|Overall Study|Lost to Follow-up|1|||
130608241|NCT00783705|470185901|FG000|Overall Study|Adverse Event|2|||
130608242|NCT00783705|470185902|FG001|Overall Study|Adverse Event|0|||
130608243|NCT00783705|470185901|FG000|Overall Study|Withdrawal by Subject|3|||
130608244|NCT00783705|470185902|FG001|Overall Study|Withdrawal by Subject|2|||
130608245|NCT00783705|470185901|FG000|Overall Study|Lost to Follow-up|1|||
130608246|NCT00783705|470185902|FG001|Overall Study|Lost to Follow-up|3|||
130608247|NCT03643432|470185903|FG000|Overall Study|Lost to Follow-up|1|||
130608248|NCT03643432|470185904|FG001|Overall Study|Lost to Follow-up|0|||
130608249|NCT01617434|470185907|FG000|Overall Study|Adverse Event|12|||
130608250|NCT01617434|470185908|FG001|Overall Study|Adverse Event|3|||
130608251|NCT01617434|470185907|FG000|Overall Study|Protocol Violation|8|||
130608252|NCT01617434|470185908|FG001|Overall Study|Protocol Violation|7|||
130608253|NCT01617434|470185907|FG000|Overall Study|Withdrawal Criteria|12|||
130608254|NCT01617434|470185908|FG001|Overall Study|Withdrawal Criteria|37|||
130608255|NCT01617434|470185907|FG000|Overall Study|Unclassified|3|||
130608256|NCT01617434|470185908|FG001|Overall Study|Unclassified|4|||
130608257|NCT03283163|470185909|FG000|Overall Study|Lost to Follow-up|1|||
130608258|NCT03283163|470185909|FG000|Overall Study|other life commitments|6|||
130608259|NCT03283163|470185909|FG000|Overall Study|COVID-19 institution wide halting|1|||
130608260|NCT03283163|470185909|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
130608261|NCT03283163|470185909|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
130608262|NCT00237796|470185910|FG000|Overall Study|Baseline and one other ILSS required|10|||
130608263|NCT00237796|470185911|FG001|Overall Study|Baseline and one other ILSS required|5|||
130608264|NCT04238663|470185912|FG000|Overall Study|Lost to Follow-up|0|||
130608265|NCT04238663|470185913|FG001|Overall Study|Lost to Follow-up|1|||
130608266|NCT04238663|470185914|FG002|Overall Study|Lost to Follow-up|0|||
130608267|NCT01193348|470185915|FG000|Screening Period|Screen Failure|5|||
130608268|NCT01193348|470185915|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
130608269|NCT01193348|470185915|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
130608270|NCT01193348|470185915|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
130608271|NCT01193348|470185915|FG000|Extension Treatment Period|Physician Decision|1|||
130608272|NCT01193348|470185915|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
130608273|NCT04070378|470185916|FG000|Overall Study|Withdrawal by Subject|2|||
130608274|NCT04070378|470185916|FG000|Overall Study|Screen Failure|6|||
130608275|NCT04070378|470185916|FG000|Overall Study|Physician Decision|1|||
130608276|NCT04070378|470185916|FG000|Overall Study|Adverse Event|1|||
130608277|NCT03259334|470185917|FG000|Overall Study|Adverse Event|3|||
130608278|NCT03259334|470185918|FG001|Overall Study|Adverse Event|8|||
130608279|NCT03259334|470185919|FG002|Overall Study|Adverse Event|5|||
130608280|NCT03259334|470185917|FG000|Overall Study|Withdrawal by Subject|4|||
130608281|NCT03259334|470185918|FG001|Overall Study|Withdrawal by Subject|2|||
130608282|NCT03259334|470185919|FG002|Overall Study|Withdrawal by Subject|4|||
130608283|NCT03259334|470185917|FG000|Overall Study|Physician Decision|1|||
130608284|NCT03259334|470185918|FG001|Overall Study|Physician Decision|0|||
130608285|NCT03259334|470185919|FG002|Overall Study|Physician Decision|0|||
130608286|NCT03259334|470185917|FG000|Overall Study|Lost to Follow-up|0|||
130608287|NCT03259334|470185918|FG001|Overall Study|Lost to Follow-up|2|||
130608288|NCT03259334|470185919|FG002|Overall Study|Lost to Follow-up|1|||
130608289|NCT03259334|470185917|FG000|Overall Study|Protocol Deviation|0|||
130608290|NCT03259334|470185918|FG001|Overall Study|Protocol Deviation|3|||
130608291|NCT03259334|470185919|FG002|Overall Study|Protocol Deviation|2|||
130608292|NCT03259334|470185917|FG000|Overall Study|Lack of Efficacy|2|||
130608293|NCT03259334|470185918|FG001|Overall Study|Lack of Efficacy|0|||
130608294|NCT03259334|470185919|FG002|Overall Study|Lack of Efficacy|1|||
130608295|NCT03259334|470185917|FG000|Overall Study|Randomized but never treated|0|||
130608296|NCT03259334|470185918|FG001|Overall Study|Randomized but never treated|2|||
130608297|NCT03259334|470185919|FG002|Overall Study|Randomized but never treated|0|||
130608298|NCT01678807|470185920|FG000|Overall Study|Adverse Event|4|||
130608299|NCT01678807|470185921|FG001|Overall Study|Adverse Event|4|||
130608300|NCT01678807|470185922|FG002|Overall Study|Adverse Event|0|||
130608301|NCT01678807|470185920|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
130608302|NCT01678807|470185921|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
130608303|NCT01678807|470185922|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130608304|NCT00370149|470185923|FG000|Overall Study|Physician Decision|16|||
130608305|NCT00370149|470185924|FG001|Overall Study|Physician Decision|16|||
130608306|NCT00370149|470185923|FG000|Overall Study|Protocol Violation|1|||
130608307|NCT00370149|470185924|FG001|Overall Study|Protocol Violation|0|||
130608308|NCT00370149|470185923|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
130608309|NCT00370149|470185924|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
130608310|NCT00370149|470185923|FG000|Overall Study|Pre-existing infection|0|||
130608311|NCT00370149|470185924|FG001|Overall Study|Pre-existing infection|1|||
130608312|NCT00370149|470185923|FG000|Overall Study|Antibiotic coated dressing placed|0|||
130608313|NCT00370149|470185924|FG001|Overall Study|Antibiotic coated dressing placed|1|||
130608314|NCT00701727|470186926|FG000|First Treatment Period|Adverse Event|0|||
130608315|NCT00701727|470186927|FG001|First Treatment Period|Adverse Event|0|||
130608316|NCT00701727|470186926|FG000|First Treatment Period|Withdrawal by Subject|1|||
130608317|NCT00701727|470186927|FG001|First Treatment Period|Withdrawal by Subject|0|||
130608318|NCT00701727|470186926|FG000|First Treatment Period|sponsor decision|0|||
130608319|NCT00701727|470186927|FG001|First Treatment Period|sponsor decision|1|||
130608320|NCT00701727|470186926|FG000|First Treatment Period|Lost to Follow-up|0|||
130608321|NCT00701727|470186927|FG001|First Treatment Period|Lost to Follow-up|1|||
130608322|NCT00701727|470186926|FG000|Second Treatment Period|Withdrawal by Subject|2|||
130608323|NCT00701727|470186927|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130608324|NCT05113953|470186928|FG000|Overall Study|Adverse Event|5|||
130608325|NCT05113953|470186929|FG001|Overall Study|Adverse Event|0|||
130608326|NCT05113953|470186930|FG002|Overall Study|Adverse Event|3|||
130608327|NCT05113953|470186928|FG000|Overall Study|Lost to Follow-up|3|||
130608328|NCT05113953|470186929|FG001|Overall Study|Lost to Follow-up|4|||
130608329|NCT05113953|470186930|FG002|Overall Study|Lost to Follow-up|2|||
130608330|NCT05113953|470186928|FG000|Overall Study|Non-compliance with Study Drug|1|||
130608331|NCT05113953|470186929|FG001|Overall Study|Non-compliance with Study Drug|0|||
130608332|NCT05113953|470186930|FG002|Overall Study|Non-compliance with Study Drug|0|||
130608333|NCT05113953|470186928|FG000|Overall Study|Withdrawal by Subject|2|||
130608334|NCT05113953|470186929|FG001|Overall Study|Withdrawal by Subject|6|||
130608335|NCT05113953|470186930|FG002|Overall Study|Withdrawal by Subject|4|||
130608336|NCT05113953|470186928|FG000|Overall Study|Reason not Specified|2|||
130608337|NCT05113953|470186929|FG001|Overall Study|Reason not Specified|0|||
130608338|NCT05113953|470186930|FG002|Overall Study|Reason not Specified|0|||
130608339|NCT00502307|470186933|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
130608340|NCT00502307|470186934|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
130608341|NCT00502307|470186935|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
130608342|NCT00502307|470186933|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
130608343|NCT00502307|470186934|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
130608344|NCT00502307|470186935|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
130608345|NCT00502307|470186933|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
130608346|NCT00502307|470186934|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
130608347|NCT00502307|470186935|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
130608348|NCT00502307|470186933|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
130608349|NCT00502307|470186934|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
130608350|NCT00502307|470186935|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
130608351|NCT00502307|470186933|FG000|Maintenance Period|Progressive disease|80|||
130608352|NCT00502307|470186934|FG001|Maintenance Period|Progressive disease|0|||
130608353|NCT00502307|470186935|FG002|Maintenance Period|Progressive disease|0|||
130608354|NCT00502307|470186933|FG000|Maintenance Period|Discontinued due to other reasons|68|||
130608355|NCT00502307|470186934|FG001|Maintenance Period|Discontinued due to other reasons|0|||
130608356|NCT00502307|470186935|FG002|Maintenance Period|Discontinued due to other reasons|0|||
130608357|NCT05132569|470186939|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
130608358|NCT05132569|470186940|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
130608359|NCT05132569|470186939|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
130608360|NCT05132569|470186940|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
130608361|NCT05132569|470186939|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
130608362|NCT05132569|470186940|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
130608363|NCT04102098|470186941|FG000|Main Study Period|Ongoing in study|302|||
130608364|NCT04102098|470186942|FG001|Main Study Period|Ongoing in study|291|||
130608365|NCT04102098|470186941|FG000|Main Study Period|Death|20|||
130608366|NCT04102098|470186942|FG001|Main Study Period|Death|27|||
130608367|NCT04102098|470186941|FG000|Main Study Period|Lost to Follow-up|1|||
130608368|NCT04102098|470186942|FG001|Main Study Period|Lost to Follow-up|1|||
130608369|NCT04102098|470186941|FG000|Main Study Period|Physician Decision|0|||
130608370|NCT04102098|470186942|FG001|Main Study Period|Physician Decision|1|||
130608371|NCT04102098|470186941|FG000|Main Study Period|Withdrawal by Subject|11|||
130608372|NCT04102098|470186942|FG001|Main Study Period|Withdrawal by Subject|14|||
130608373|NCT04102098|470186941|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
130608374|NCT04102098|470186942|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
130608375|NCT04102098|470186941|FG000|Crossover: AS Who Crossed Over|Death|11|||
130608376|NCT04102098|470186942|FG001|Crossover: AS Who Crossed Over|Death|0|||
130608377|NCT04102098|470186941|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
130608378|NCT04102098|470186942|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
130608379|NCT04742907|470186943|FG000|Overall Study|Adverse Event|1|||
130608380|NCT04742907|470186944|FG001|Overall Study|Adverse Event|0|||
130608381|NCT04742907|470186945|FG002|Overall Study|Adverse Event|1|||
130608382|NCT04742907|470186943|FG000|Overall Study|Lost to Follow-up|3|||
130608383|NCT04742907|470186944|FG001|Overall Study|Lost to Follow-up|3|||
130608384|NCT04742907|470186945|FG002|Overall Study|Lost to Follow-up|2|||
130608385|NCT04742907|470186943|FG000|Overall Study|Physician Decision|0|||
130608386|NCT04742907|470186944|FG001|Overall Study|Physician Decision|1|||
130608387|NCT04742907|470186945|FG002|Overall Study|Physician Decision|0|||
130608388|NCT04742907|470186943|FG000|Overall Study|Protocol Violation|1|||
130608389|NCT04742907|470186944|FG001|Overall Study|Protocol Violation|1|||
130608390|NCT04742907|470186945|FG002|Overall Study|Protocol Violation|1|||
130608391|NCT04742907|470186943|FG000|Overall Study|Withdrawal by Subject|5|||
130608392|NCT04742907|470186944|FG001|Overall Study|Withdrawal by Subject|6|||
130608393|NCT04742907|470186945|FG002|Overall Study|Withdrawal by Subject|4|||
130608394|NCT04742907|470186943|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
130608395|NCT04742907|470186944|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
130608396|NCT04742907|470186945|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
130608397|NCT04742907|470186943|FG000|Overall Study|Did Not Receive the Study Drug|2|||
130608398|NCT04742907|470186944|FG001|Overall Study|Did Not Receive the Study Drug|4|||
130608399|NCT04742907|470186945|FG002|Overall Study|Did Not Receive the Study Drug|4|||
130608400|NCT02280291|470186946|FG000|Overall Study|Lost to Follow-up|2|||
130608401|NCT02280291|470186947|FG001|Overall Study|Lost to Follow-up|1|||
130608402|NCT02280291|470186948|FG002|Overall Study|Lost to Follow-up|3|||
130608403|NCT02280291|470186949|FG003|Overall Study|Lost to Follow-up|8|||
130608404|NCT02280291|470186946|FG000|Overall Study|Protocol Violation|1|||
130608405|NCT02280291|470186947|FG001|Overall Study|Protocol Violation|0|||
130608406|NCT02280291|470186948|FG002|Overall Study|Protocol Violation|0|||
130608407|NCT02280291|470186949|FG003|Overall Study|Protocol Violation|0|||
130608408|NCT02280291|470186946|FG000|Overall Study|Other|1|||
130608409|NCT02280291|470186947|FG001|Overall Study|Other|1|||
130608410|NCT02280291|470186948|FG002|Overall Study|Other|0|||
130608411|NCT02280291|470186949|FG003|Overall Study|Other|0|||
130608412|NCT00210158|470186951|FG000|Overall Study|Protocol Violation|0|||
130608413|NCT00210158|470186952|FG001|Overall Study|Protocol Violation|2|||
130608414|NCT04716933|470186953|FG000|Overall Study|Sponsor Decision|36|||
130608415|NCT04716933|470186954|FG001|Overall Study|Sponsor Decision|33|||
130608416|NCT04716933|470186953|FG000|Overall Study|Death|65|||
130608417|NCT04716933|470186954|FG001|Overall Study|Death|67|||
130608418|NCT03196505|470186957|FG000|Overall Study|Physician Decision|26|||
130608419|NCT03196505|470186958|FG001|Overall Study|Physician Decision|26|||
130608420|NCT01005719|470186959|FG000|Period 1|Adverse Event|0|||
130608421|NCT01005719|470186960|FG001|Period 1|Adverse Event|0|||
130608422|NCT01005719|470186961|FG002|Period 1|Adverse Event|0|||
130608423|NCT01005719|470186962|FG003|Period 1|Adverse Event|1|||
130608424|NCT01005719|470186963|FG004|Period 1|Adverse Event|0|||
130608425|NCT01005719|470186964|FG005|Period 1|Adverse Event|0|||
130608426|NCT01005719|470186959|FG000|Period 1|Delay in completing study procedures|0|||
130608427|NCT01005719|470186960|FG001|Period 1|Delay in completing study procedures|0|||
130608428|NCT01005719|470186961|FG002|Period 1|Delay in completing study procedures|0|||
130608429|NCT01005719|470186962|FG003|Period 1|Delay in completing study procedures|0|||
130608430|NCT01005719|470186963|FG004|Period 1|Delay in completing study procedures|0|||
130608431|NCT01005719|470186964|FG005|Period 1|Delay in completing study procedures|1|||
130608432|NCT01005719|470186959|FG000|Period 2|Adverse Event|0|||
130608433|NCT01005719|470186960|FG001|Period 2|Adverse Event|0|||
130608434|NCT01005719|470186961|FG002|Period 2|Adverse Event|0|||
130608435|NCT01005719|470186962|FG003|Period 2|Adverse Event|0|||
130608436|NCT01005719|470186963|FG004|Period 2|Adverse Event|1|||
130608437|NCT01005719|470186964|FG005|Period 2|Adverse Event|1|||
130608438|NCT05187013|470186965|FG000|Overall Study|Withdrawal by Subject|1|||
130608439|NCT05187013|470186966|FG001|Overall Study|Withdrawal by Subject|1|||
130608440|NCT05187013|470186967|FG002|Overall Study|Withdrawal by Subject|0|||
130608441|NCT05187013|470186965|FG000|Overall Study|Death|0|||
130608442|NCT05187013|470186966|FG001|Overall Study|Death|1|||
130608443|NCT05187013|470186967|FG002|Overall Study|Death|0|||
130608444|NCT05187013|470186965|FG000|Overall Study|Lost to Follow-up|20|||
130608445|NCT05187013|470186966|FG001|Overall Study|Lost to Follow-up|17|||
130608446|NCT05187013|470186967|FG002|Overall Study|Lost to Follow-up|0|||
130608447|NCT05187013|470186965|FG000|Overall Study|Ongoing Participants|3|||
130608448|NCT05187013|470186966|FG001|Overall Study|Ongoing Participants|5|||
130608449|NCT05187013|470186967|FG002|Overall Study|Ongoing Participants|0|||
130608450|NCT04488822|470186968|FG000|Overall Study|Adverse Event|8|||
130608451|NCT04488822|470186968|FG000|Overall Study|Withdrawal by Subject|1|||
130608452|NCT03838367|470186969|FG000|Overall Study|Early termination of study|3|||
130608453|NCT03838367|470186970|FG001|Overall Study|Early termination of study|4|||
130608454|NCT03838367|470186971|FG002|Overall Study|Early termination of study|3|||
130608455|NCT03838367|470186972|FG003|Overall Study|Early termination of study|0|||
130608456|NCT03406104|470186973|FG000|Overall Study|Lost to Follow-up|2|||
130608457|NCT03406104|470186973|FG000|Overall Study|Withdrawal by Subject|2|||
130608458|NCT03406104|470186973|FG000|Overall Study|due to Covid patient did not want to travel|1|||
130608459|NCT03406104|470186973|FG000|Overall Study|Death|2|||
130608460|NCT03015610|470186979|FG000|Overall Study|Lost to Follow-up|1|||
130608461|NCT03015610|470186980|FG001|Overall Study|Lost to Follow-up|5|||
130608462|NCT05100199|470186982|FG000|Overall Study|Lost to Follow-up|5|||
130608463|NCT05100199|470186983|FG001|Overall Study|Lost to Follow-up|8|||
130608464|NCT05100199|470186984|FG002|Overall Study|Lost to Follow-up|3|||
130608465|NCT05100199|470186985|FG003|Overall Study|Lost to Follow-up|6|||
130608466|NCT05100199|470186982|FG000|Overall Study|Withdrawal by Subject|3|||
130608467|NCT05100199|470186983|FG001|Overall Study|Withdrawal by Subject|3|||
130608468|NCT05100199|470186984|FG002|Overall Study|Withdrawal by Subject|9|||
130608469|NCT05100199|470186985|FG003|Overall Study|Withdrawal by Subject|7|||
130608470|NCT05100199|470186982|FG000|Overall Study|Other|0|||
130608471|NCT05100199|470186983|FG001|Overall Study|Other|0|||
130608472|NCT05100199|470186984|FG002|Overall Study|Other|1|||
130608473|NCT05100199|470186985|FG003|Overall Study|Other|1|||
130608474|NCT00752609|470186986|FG000|Overall Study|Adverse Event|2|||
130608475|NCT00752609|470186987|FG001|Overall Study|Adverse Event|2|||
130608476|NCT00752609|470186986|FG000|Overall Study|Withdrawal by Subject|3|||
130608477|NCT00752609|470186987|FG001|Overall Study|Withdrawal by Subject|0|||
130608478|NCT00752609|470186986|FG000|Overall Study|Physician Decision|1|||
130608479|NCT00752609|470186987|FG001|Overall Study|Physician Decision|0|||
130608480|NCT00752609|470186986|FG000|Overall Study|Death|1|||
130608481|NCT00752609|470186987|FG001|Overall Study|Death|0|||
130608482|NCT00752609|470186986|FG000|Overall Study|Met exclusion criteria|1|||
130608483|NCT00752609|470186987|FG001|Overall Study|Met exclusion criteria|0|||
130608484|NCT00752609|470186986|FG000|Overall Study|Received Aranesp in error|1|||
130608485|NCT00752609|470186987|FG001|Overall Study|Received Aranesp in error|0|||
130608486|NCT05692154|470186988|FG000|Overall Study|Adverse Event|0|||
130608487|NCT05692154|470186989|FG001|Overall Study|Adverse Event|1|||
130608488|NCT01379534|470186990|FG000|Treatment Phase|Withdrawal by Subject|2|||
130608489|NCT01379534|470186991|FG001|Treatment Phase|Withdrawal by Subject|2|||
130608490|NCT01379534|470186990|FG000|Treatment Phase|Progressive disease|13|||
130608491|NCT01379534|470186991|FG001|Treatment Phase|Progressive disease|22|||
130608492|NCT01379534|470186990|FG000|Treatment Phase|Adverse Event|7|||
130608493|NCT01379534|470186991|FG001|Treatment Phase|Adverse Event|7|||
130608494|NCT01379534|470186990|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
130608495|NCT01379534|470186991|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
130608496|NCT01379534|470186990|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
130608497|NCT01379534|470186991|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
130608498|NCT01379534|470186990|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
130608499|NCT01379534|470186991|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
130608500|NCT01379534|470186990|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
130608501|NCT01379534|470186991|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
130608502|NCT05372575|470186992|FG000|Overall Study|Protocol Violation|7|||
130608503|NCT05372575|470186993|FG001|Overall Study|Protocol Violation|16|||
130608504|NCT00001262|470186996|FG000|Overall Study|Death|10|||
130608505|NCT00001262|470186997|FG001|Overall Study|Death|11|||
130608506|NCT00001262|470186998|FG002|Overall Study|Death|0|||
130608507|NCT00001262|470186996|FG000|Overall Study|Withdrawal by Subject|0|||
130608508|NCT00001262|470186997|FG001|Overall Study|Withdrawal by Subject|3|||
130608509|NCT00001262|470186998|FG002|Overall Study|Withdrawal by Subject|0|||
130608510|NCT00878072|470187000|FG000|Overall Study|Withdrew consent|2|||
130608511|NCT01954121|470187005|FG000|Overall Study|Lack of Efficacy|94|||
130608512|NCT01954121|470187006|FG001|Overall Study|Lack of Efficacy|41|||
130608513|NCT01954121|470187005|FG000|Overall Study|Protocol Violation|0|||
130608514|NCT01954121|470187006|FG001|Overall Study|Protocol Violation|2|||
130608515|NCT01954121|470187005|FG000|Overall Study|Lost to Follow-up|5|||
130608516|NCT01954121|470187006|FG001|Overall Study|Lost to Follow-up|6|||
130608517|NCT01954121|470187005|FG000|Overall Study|Withdrawal by Subject|18|||
130608518|NCT01954121|470187006|FG001|Overall Study|Withdrawal by Subject|12|||
130608519|NCT01954121|470187005|FG000|Overall Study|Pregnancy|1|||
130608520|NCT01954121|470187006|FG001|Overall Study|Pregnancy|1|||
130608521|NCT01954121|470187005|FG000|Overall Study|AE, serious fatal|1|||
130608522|NCT01954121|470187006|FG001|Overall Study|AE, serious fatal|0|||
130608523|NCT01954121|470187005|FG000|Overall Study|AE, non-serious non-fatal|5|||
130608524|NCT01954121|470187006|FG001|Overall Study|AE, non-serious non-fatal|22|||
130608525|NCT01954121|470187005|FG000|Overall Study|SAE, non-fatal|1|||
130608526|NCT01954121|470187006|FG001|Overall Study|SAE, non-fatal|4|||
130608527|NCT01954121|470187005|FG000|Overall Study|Non-compliant with study procedures|1|||
130608528|NCT01954121|470187006|FG001|Overall Study|Non-compliant with study procedures|0|||
130608529|NCT01954121|470187005|FG000|Overall Study|Non-compliant patient|1|||
130608530|NCT01954121|470187006|FG001|Overall Study|Non-compliant patient|1|||
130608531|NCT01954121|470187005|FG000|Overall Study|Subject did not follow instructions|0|||
130608532|NCT01954121|470187006|FG001|Overall Study|Subject did not follow instructions|2|||
130608533|NCT02588248|470187013|FG000|Overall Study|Physician Decision|4|||
130608534|NCT02588248|470187014|FG001|Overall Study|Physician Decision|3|||
130608535|NCT01355068|470187017|FG000|First Intervention Period|Adverse Event|0|||
130608536|NCT01355068|470187018|FG001|First Intervention Period|Adverse Event|1|||
130608537|NCT01355068|470187017|FG000|First Intervention Period|Withdrawal by Subject|0|||
130608538|NCT01355068|470187018|FG001|First Intervention Period|Withdrawal by Subject|1|||
130608539|NCT02504892|470187019|FG000|Overall Study|Adverse event-pneumonitis|2|||
130608540|NCT00524745|470187020|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
130608541|NCT00524745|470187021|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
130608542|NCT00524745|470187022|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
130608543|NCT00524745|470187023|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
130608544|NCT01413178|470187024|FG000|Overall Study|Toxicity|1|||
130608545|NCT01413178|470187025|FG001|Overall Study|Toxicity|0|||
130608546|NCT01413178|470187024|FG000|Overall Study|Ineligible|0|||
130608547|NCT01413178|470187025|FG001|Overall Study|Ineligible|2|||
130608548|NCT00576693|470187026|FG000|Overall Study|Lost to Follow-up|7|||
130608549|NCT00576693|470187027|FG001|Overall Study|Lost to Follow-up|11|||
130608550|NCT00576693|470187026|FG000|Overall Study|Withdrawal by Subject|3|||
130608551|NCT00576693|470187027|FG001|Overall Study|Withdrawal by Subject|13|||
130608552|NCT00804193|470187028|FG000|Overall Study|Lack of baseline fungus|32|||
130608553|NCT00804193|470187029|FG001|Overall Study|Lack of baseline fungus|31|||
130608554|NCT00804193|470187030|FG002|Overall Study|Lack of baseline fungus|19|||
130608555|NCT00804193|470187028|FG000|Overall Study|Adverse Event|0|||
130608556|NCT00804193|470187029|FG001|Overall Study|Adverse Event|0|||
130608557|NCT00804193|470187030|FG002|Overall Study|Adverse Event|2|||
130608558|NCT00804193|470187028|FG000|Overall Study|Lack of Efficacy|1|||
130608559|NCT00804193|470187029|FG001|Overall Study|Lack of Efficacy|1|||
130608560|NCT00804193|470187030|FG002|Overall Study|Lack of Efficacy|3|||
130608561|NCT00804193|470187028|FG000|Overall Study|Protocol Violation|0|||
130608562|NCT00804193|470187029|FG001|Overall Study|Protocol Violation|8|||
130608563|NCT00804193|470187030|FG002|Overall Study|Protocol Violation|2|||
130608564|NCT00804193|470187028|FG000|Overall Study|Lost to Follow-up|3|||
130608565|NCT00804193|470187029|FG001|Overall Study|Lost to Follow-up|3|||
130608566|NCT00804193|470187030|FG002|Overall Study|Lost to Follow-up|4|||
130608567|NCT00804193|470187028|FG000|Overall Study|Withdrawal by Subject|3|||
130608568|NCT00804193|470187029|FG001|Overall Study|Withdrawal by Subject|1|||
130608569|NCT00804193|470187030|FG002|Overall Study|Withdrawal by Subject|2|||
130608570|NCT04072146|470187031|FG000|Overall Study|Adverse Event|0|||
130608571|NCT04072146|470187032|FG001|Overall Study|Adverse Event|1|||
130608572|NCT01987986|470187033|FG000|Overall Study|Lost to Follow-up|1|||
130608573|NCT01987986|470187034|FG001|Overall Study|Lost to Follow-up|0|||
130608574|NCT01987986|470187035|FG002|Overall Study|Lost to Follow-up|0|||
130608575|NCT01987986|470187036|FG003|Overall Study|Lost to Follow-up|0|||
130608576|NCT01987986|470187033|FG000|Overall Study|Adverse Event|1|||
130608577|NCT01987986|470187034|FG001|Overall Study|Adverse Event|0|||
130608578|NCT01987986|470187035|FG002|Overall Study|Adverse Event|2|||
130608579|NCT01987986|470187036|FG003|Overall Study|Adverse Event|0|||
130608580|NCT01721408|470187042|FG000|Overall Study|Adverse Event|6|||
130608581|NCT01721408|470187043|FG001|Overall Study|Adverse Event|1|||
130608582|NCT01721408|470187042|FG000|Overall Study|Death|1|||
130608583|NCT01721408|470187043|FG001|Overall Study|Death|0|||
130608584|NCT01721408|470187042|FG000|Overall Study|Insufficient clinical response|15|||
130608585|NCT01721408|470187043|FG001|Overall Study|Insufficient clinical response|6|||
130608586|NCT01721408|470187042|FG000|Overall Study|No longer willing to participate study|9|||
130608587|NCT01721408|470187043|FG001|Overall Study|No longer willing to participate study|10|||
130608588|NCT01721408|470187042|FG000|Overall Study|Protocol Violation|0|||
130608589|NCT01721408|470187043|FG001|Overall Study|Protocol Violation|2|||
130608590|NCT01721408|470187042|FG000|Overall Study|Other|3|||
130608591|NCT01721408|470187043|FG001|Overall Study|Other|3|||
130608592|NCT01721408|470187042|FG000|Overall Study|Lost to Follow-up|1|||
130608593|NCT01721408|470187043|FG001|Overall Study|Lost to Follow-up|2|||
130608594|NCT01721408|470187042|FG000|Overall Study|Does not meet entrance criteria|1|||
130608595|NCT01721408|470187043|FG001|Overall Study|Does not meet entrance criteria|0|||
130608596|NCT03987620|470187046|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
130608597|NCT03987620|470187047|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
130608598|NCT03987620|470187046|FG000|Overall Study|Adverse Event|3|||
130608599|NCT03987620|470187047|FG001|Overall Study|Adverse Event|0|||
130608600|NCT03987620|470187046|FG000|Overall Study|Lost to Follow-up|1|||
130608601|NCT03987620|470187047|FG001|Overall Study|Lost to Follow-up|2|||
130608602|NCT03987620|470187046|FG000|Overall Study|Physician Decision|0|||
130608603|NCT03987620|470187047|FG001|Overall Study|Physician Decision|1|||
130608604|NCT03987620|470187046|FG000|Overall Study|Pregnancy|1|||
130608605|NCT03987620|470187047|FG001|Overall Study|Pregnancy|0|||
130608606|NCT03987620|470187046|FG000|Overall Study|Withdrawal by Subject|7|||
130608607|NCT03987620|470187047|FG001|Overall Study|Withdrawal by Subject|1|||
130608608|NCT03987620|470187046|FG000|Overall Study|Other|2|||
130608609|NCT03987620|470187047|FG001|Overall Study|Other|5|||
130608610|NCT05128162|470187050|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
130608611|NCT05128162|470187050|FG000|Overall Study|Physician Decision|1|||
130608612|NCT05306873|470188581|FG000|Stage 2|Study stopped|1|||
130608613|NCT05306873|470188582|FG001|Stage 2|Study stopped|1|||
130608614|NCT05306873|470188583|FG002|Stage 2|Study stopped|0|||
130608615|NCT05306873|470188584|FG003|Stage 2|Study stopped|0|||
130608616|NCT05306873|470188581|FG000|Stage 2|Stage 2 Treatment Failure|2|||
130608617|NCT05306873|470188582|FG001|Stage 2|Stage 2 Treatment Failure|3|||
130608618|NCT05306873|470188583|FG002|Stage 2|Stage 2 Treatment Failure|0|||
130608619|NCT05306873|470188584|FG003|Stage 2|Stage 2 Treatment Failure|0|||
130608620|NCT05306873|470188581|FG000|Stage 2|Logistical issues due to participant moving|1|||
130608621|NCT05306873|470188582|FG001|Stage 2|Logistical issues due to participant moving|0|||
130608622|NCT05306873|470188583|FG002|Stage 2|Logistical issues due to participant moving|0|||
130608623|NCT05306873|470188584|FG003|Stage 2|Logistical issues due to participant moving|0|||
130608624|NCT05306873|470188581|FG000|Stage 3|Stage 3 Treatment Failure|0|||
130608625|NCT05306873|470188582|FG001|Stage 3|Stage 3 Treatment Failure|0|||
130608626|NCT05306873|470188583|FG002|Stage 3|Stage 3 Treatment Failure|0|||
130608627|NCT05306873|470188584|FG003|Stage 3|Stage 3 Treatment Failure|1|||
130608628|NCT05306873|470188581|FG000|Stage 3|Study Stopped|0|||
130608629|NCT05306873|470188582|FG001|Stage 3|Study Stopped|0|||
130608630|NCT05306873|470188583|FG002|Stage 3|Study Stopped|1|||
130608631|NCT05306873|470188584|FG003|Stage 3|Study Stopped|0|||
130608632|NCT02626819|470188587|FG000|Overall Study|Lost to Follow-up|3|||
130608633|NCT02626819|470188588|FG001|Overall Study|Lost to Follow-up|2|||
130608634|NCT02626819|470188587|FG000|Overall Study|Withdrawal by Subject|1|||
130608635|NCT02626819|470188588|FG001|Overall Study|Withdrawal by Subject|0|||
130608636|NCT02626819|470188587|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
130608637|NCT02626819|470188588|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
130608638|NCT00366548|470188592|FG000|Infant Series|Adverse Event|1|||
130608639|NCT00366548|470188593|FG001|Infant Series|Adverse Event|3|||
130608640|NCT00366548|470188592|FG000|Infant Series|Protocol Violation|0|||
130608641|NCT00366548|470188593|FG001|Infant Series|Protocol Violation|1|||
130608642|NCT00366548|470188592|FG000|Infant Series|Withdrawal by Subject|3|||
130608643|NCT00366548|470188593|FG001|Infant Series|Withdrawal by Subject|1|||
130608644|NCT00366548|470188592|FG000|After Infant Series|Withdrawal by Subject|3|||
130608645|NCT00366548|470188593|FG001|After Infant Series|Withdrawal by Subject|1|||
130608646|NCT00366548|470188592|FG000|After Infant Series|Adverse Event|2|||
130608647|NCT00366548|470188593|FG001|After Infant Series|Adverse Event|0|||
130608648|NCT00366548|470188592|FG000|After Infant Series|Lost to Follow-up|1|||
130608649|NCT00366548|470188593|FG001|After Infant Series|Lost to Follow-up|0|||
130608650|NCT02849990|470188594|FG000|Overall Study|Adverse Event|1|||
130608651|NCT02849990|470188594|FG000|Overall Study|Withdrawal by Subject|1|||
130608652|NCT01051986|470188596|FG000|Overall Study|Death|1|||
130608653|NCT01051986|470188597|FG001|Overall Study|Death|0|||
130608654|NCT01051986|470188596|FG000|Overall Study|Withdrawal by Subject|2|||
130608655|NCT01051986|470188597|FG001|Overall Study|Withdrawal by Subject|1|||
130608656|NCT01051986|470188596|FG000|Overall Study|Protocol Violation|2|||
130608657|NCT01051986|470188597|FG001|Overall Study|Protocol Violation|3|||
130608658|NCT02273752|470188599|FG000|Overall Study|Trial was terminated early|2|||
130608659|NCT03628417|470188600|FG000|Overall Study|Death|1|||
130608660|NCT03628417|470188601|FG001|Overall Study|Death|1|||
130608661|NCT02297438|470188602|FG000|Overall Study|Death|79|||
130608662|NCT02297438|470188603|FG001|Overall Study|Death|86|||
130608663|NCT02297438|470188602|FG000|Overall Study|Lost to Follow-up|9|||
130608664|NCT02297438|470188603|FG001|Overall Study|Lost to Follow-up|7|||
130608665|NCT02297438|470188602|FG000|Overall Study|Withdrawal by Subject|7|||
130608666|NCT02297438|470188603|FG001|Overall Study|Withdrawal by Subject|0|||
130608667|NCT02297438|470188602|FG000|Overall Study|Other|9|||
130608668|NCT02297438|470188603|FG001|Overall Study|Other|5|||
130608669|NCT02297438|470188602|FG000|Overall Study|Ongoing|65|||
130608670|NCT02297438|470188603|FG001|Overall Study|Ongoing|73|||
130608671|NCT02042404|470188609|FG000|Overall Study|Death|1|||
130608672|NCT02042404|470188610|FG001|Overall Study|Death|0|||
130608673|NCT02042404|470188609|FG000|Overall Study|Unrelated Adverse Event|3|||
130608674|NCT02042404|470188610|FG001|Overall Study|Unrelated Adverse Event|0|||
130608675|NCT02042404|470188609|FG000|Overall Study|Inability to meet time requirements|1|||
130608676|NCT02042404|470188610|FG001|Overall Study|Inability to meet time requirements|0|||
130608677|NCT01623531|470188611|FG000|Overall Study|Death|1|||
130608678|NCT01623531|470188612|FG001|Overall Study|Death|0|||
130608679|NCT01623531|470188611|FG000|Overall Study|Protocol Violation|2|||
130608680|NCT01623531|470188612|FG001|Overall Study|Protocol Violation|1|||
130608681|NCT01623531|470188611|FG000|Overall Study|Missing data at primary outcome time poi|1|||
130608682|NCT01623531|470188612|FG001|Overall Study|Missing data at primary outcome time poi|1|||
130608683|NCT00726323|470188613|FG000|Overall Study|Withdrawal by Subject|3|||
130608684|NCT00726323|470188614|FG001|Overall Study|Withdrawal by Subject|1|||
130608685|NCT00726323|470188613|FG000|Overall Study|Physician Decision|1|||
130608686|NCT00726323|470188614|FG001|Overall Study|Physician Decision|0|||
130608687|NCT00726323|470188613|FG000|Overall Study|Progressive disease|23|||
130608688|NCT00726323|470188614|FG001|Overall Study|Progressive disease|16|||
130608689|NCT00726323|470188613|FG000|Overall Study|Clinical progression|0|||
130608690|NCT00726323|470188614|FG001|Overall Study|Clinical progression|3|||
130608691|NCT00726323|470188613|FG000|Overall Study|Adverse Event|9|||
130608692|NCT00726323|470188614|FG001|Overall Study|Adverse Event|9|||
130608693|NCT00726323|470188613|FG000|Overall Study|Death|1|||
130608694|NCT00726323|470188614|FG001|Overall Study|Death|0|||
130608695|NCT00726323|470188613|FG000|Overall Study|Participant wished to discontinue|0|||
130608696|NCT00726323|470188614|FG001|Overall Study|Participant wished to discontinue|1|||
130608697|NCT00726323|470188613|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
130608698|NCT00726323|470188614|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
130608699|NCT01617681|470188615|FG000|Period 1 Double Blind|Adverse Event|2|||
130608700|NCT01617681|470188616|FG001|Period 1 Double Blind|Adverse Event|0|||
130608701|NCT01617681|470188617|FG002|Period 1 Double Blind|Adverse Event|0|||
130608702|NCT01617681|470188618|FG003|Period 1 Double Blind|Adverse Event|2|||
130608703|NCT01617681|470188619|FG004|Period 1 Double Blind|Adverse Event|0|||
130608704|NCT01617681|470188615|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
130608705|NCT01617681|470188616|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
130608706|NCT01617681|470188617|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
130608707|NCT01617681|470188618|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
130608708|NCT01617681|470188619|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
130608709|NCT01617681|470188615|FG000|Period 2 Open Label|Adverse Event|0|||
130608710|NCT01617681|470188616|FG001|Period 2 Open Label|Adverse Event|0|||
130608711|NCT01617681|470188617|FG002|Period 2 Open Label|Adverse Event|0|||
130608712|NCT01617681|470188618|FG003|Period 2 Open Label|Adverse Event|0|||
130608713|NCT01617681|470188619|FG004|Period 2 Open Label|Adverse Event|3|||
130608714|NCT01617681|470188615|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
130608715|NCT01617681|470188616|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
130608716|NCT01617681|470188617|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
130608717|NCT01617681|470188618|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
130608718|NCT01617681|470188619|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
130608719|NCT01856595|470188627|FG000|Overall Study|Withdrawal by Subject|0|||
130608720|NCT01856595|470188628|FG001|Overall Study|Withdrawal by Subject|1|||
130608721|NCT01856595|470188629|FG002|Overall Study|Withdrawal by Subject|0|||
130608722|NCT01856595|470188630|FG003|Overall Study|Withdrawal by Subject|0|||
130608723|NCT01856595|470188631|FG004|Overall Study|Withdrawal by Subject|0|||
130608724|NCT01856595|470188632|FG005|Overall Study|Withdrawal by Subject|0|||
130608725|NCT01856595|470188633|FG006|Overall Study|Withdrawal by Subject|1|||
130608726|NCT01856595|470188634|FG007|Overall Study|Withdrawal by Subject|0|||
130608727|NCT01856595|470188635|FG008|Overall Study|Withdrawal by Subject|0|||
130608728|NCT03521154|470188640|FG000|Overall Study|Ongoing study at data cut-off|111|||
130608729|NCT03521154|470188641|FG001|Overall Study|Ongoing study at data cut-off|52|||
130608730|NCT00972478|470188645|FG000|Overall Study|Adverse Event|3|||
130608731|NCT00972478|470188646|FG001|Overall Study|Adverse Event|16|||
130608732|NCT00972478|470188645|FG000|Overall Study|Withdrawal by Subject|1|||
130608733|NCT00972478|470188646|FG001|Overall Study|Withdrawal by Subject|8|||
130608734|NCT00972478|470188645|FG000|Overall Study|Progression/Relapse|0|||
130608735|NCT00972478|470188646|FG001|Overall Study|Progression/Relapse|2|||
130608736|NCT00972478|470188645|FG000|Overall Study|Death|0|||
130608737|NCT00972478|470188646|FG001|Overall Study|Death|2|||
130608738|NCT00972478|470188645|FG000|Overall Study|Not protocol specified|1|||
130608739|NCT00972478|470188646|FG001|Overall Study|Not protocol specified|1|||
130608740|NCT00972478|470188645|FG000|Overall Study|Ineligible|1|||
130608741|NCT00972478|470188646|FG001|Overall Study|Ineligible|7|||
130608742|NCT00972478|470188645|FG000|Overall Study|Not start protocol treatment|1|||
130608743|NCT00972478|470188646|FG001|Overall Study|Not start protocol treatment|2|||
130608744|NCT02561000|470188647|FG000|Overall Study|Withdrawal by Subject|2|||
130608745|NCT02561000|470188648|FG001|Overall Study|Withdrawal by Subject|3|||
130608746|NCT02561000|470188649|FG002|Overall Study|Withdrawal by Subject|0|||
130608747|NCT02561000|470188647|FG000|Overall Study|Adverse Event|0|||
130608748|NCT02561000|470188648|FG001|Overall Study|Adverse Event|1|||
130608749|NCT02561000|470188649|FG002|Overall Study|Adverse Event|0|||
130608750|NCT01522976|470188650|FG000|Overall Study|Ineligible|4|||
130608751|NCT01522976|470188651|FG001|Overall Study|Ineligible|0|||
130608752|NCT01522976|470188652|FG002|Overall Study|Ineligible|1|||
130608753|NCT01522976|470188650|FG000|Overall Study|Death|7|||
130608754|NCT01522976|470188651|FG001|Overall Study|Death|6|||
130608755|NCT01522976|470188652|FG002|Overall Study|Death|2|||
130608756|NCT01522976|470188650|FG000|Overall Study|Still on treatment|9|||
130608757|NCT01522976|470188651|FG001|Overall Study|Still on treatment|9|||
130608758|NCT01522976|470188652|FG002|Overall Study|Still on treatment|6|||
130608759|NCT01522976|470188650|FG000|Overall Study|Disease progression|28|||
130608760|NCT01522976|470188651|FG001|Overall Study|Disease progression|30|||
130608761|NCT01522976|470188652|FG002|Overall Study|Disease progression|25|||
130608762|NCT01522976|470188650|FG000|Overall Study|Adverse Event|17|||
130608763|NCT01522976|470188651|FG001|Overall Study|Adverse Event|7|||
130608764|NCT01522976|470188652|FG002|Overall Study|Adverse Event|18|||
130608765|NCT01522976|470188650|FG000|Overall Study|Refusal unrelated to adverse event|10|||
130608766|NCT01522976|470188651|FG001|Overall Study|Refusal unrelated to adverse event|13|||
130608767|NCT01522976|470188652|FG002|Overall Study|Refusal unrelated to adverse event|14|||
130608768|NCT01522976|470188650|FG000|Overall Study|Not protocol specified|22|||
130608769|NCT01522976|470188651|FG001|Overall Study|Not protocol specified|27|||
130608770|NCT01522976|470188652|FG002|Overall Study|Not protocol specified|27|||
130608771|NCT04075266|470188655|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
130608772|NCT04075266|470188656|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
130608773|NCT04075266|470188655|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
130608774|NCT04075266|470188656|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
130608775|NCT06150573|470188657|FG000|Overall Study|Did not meet study criteria|1|||
130608776|NCT06150573|470188658|FG001|Overall Study|Did not meet study criteria|0|||
130608777|NCT06150573|470188657|FG000|Overall Study|Adverse Event|1|||
130608778|NCT06150573|470188658|FG001|Overall Study|Adverse Event|0|||
130608779|NCT06150573|470188657|FG000|Overall Study|Lost to Follow-up|0|||
130608780|NCT06150573|470188658|FG001|Overall Study|Lost to Follow-up|1|||
130608781|NCT06150573|470188657|FG000|Overall Study|Protocol Violation|0|||
130608782|NCT06150573|470188658|FG001|Overall Study|Protocol Violation|1|||
130608783|NCT06150573|470188657|FG000|Overall Study|Withdrawal by Subject|2|||
130608784|NCT06150573|470188658|FG001|Overall Study|Withdrawal by Subject|0|||
130608785|NCT00069095|470188659|FG000|Primary Treatment Phase|Ongoing|0|||
130608786|NCT00069095|470188660|FG001|Primary Treatment Phase|Ongoing|0|||
130608787|NCT00069095|470188661|FG002|Primary Treatment Phase|Ongoing|5|||
130608788|NCT00069095|470188662|FG003|Primary Treatment Phase|Ongoing|7|||
130608789|NCT00069095|470188663|FG004|Primary Treatment Phase|Ongoing|7|||
130608790|NCT00069095|470188664|FG005|Primary Treatment Phase|Ongoing|4|||
130608791|NCT00069095|470188659|FG000|Primary Treatment Phase|Admin/Other|29|||
130608792|NCT00069095|470188660|FG001|Primary Treatment Phase|Admin/Other|38|||
130608793|NCT00069095|470188661|FG002|Primary Treatment Phase|Admin/Other|31|||
130608794|NCT00069095|470188662|FG003|Primary Treatment Phase|Admin/Other|45|||
130608795|NCT00069095|470188663|FG004|Primary Treatment Phase|Admin/Other|48|||
130608796|NCT00069095|470188664|FG005|Primary Treatment Phase|Admin/Other|42|||
130608797|NCT00069095|470188659|FG000|Primary Treatment Phase|Adverse Event|99|||
130608798|NCT00069095|470188660|FG001|Primary Treatment Phase|Adverse Event|92|||
130608799|NCT00069095|470188661|FG002|Primary Treatment Phase|Adverse Event|71|||
130608800|NCT00069095|470188662|FG003|Primary Treatment Phase|Adverse Event|72|||
130608801|NCT00069095|470188663|FG004|Primary Treatment Phase|Adverse Event|109|||
130608802|NCT00069095|470188664|FG005|Primary Treatment Phase|Adverse Event|101|||
130608803|NCT00069095|470188659|FG000|Primary Treatment Phase|Death|14|||
130608804|NCT00069095|470188660|FG001|Primary Treatment Phase|Death|8|||
130608805|NCT00069095|470188661|FG002|Primary Treatment Phase|Death|2|||
130608806|NCT00069095|470188662|FG003|Primary Treatment Phase|Death|5|||
130608807|NCT00069095|470188663|FG004|Primary Treatment Phase|Death|8|||
130608808|NCT00069095|470188664|FG005|Primary Treatment Phase|Death|8|||
130608809|NCT00069095|470188659|FG000|Primary Treatment Phase|Failure to return|5|||
130608810|NCT00069095|470188660|FG001|Primary Treatment Phase|Failure to return|5|||
130608811|NCT00069095|470188661|FG002|Primary Treatment Phase|Failure to return|0|||
130608812|NCT00069095|470188662|FG003|Primary Treatment Phase|Failure to return|0|||
130608813|NCT00069095|470188663|FG004|Primary Treatment Phase|Failure to return|0|||
130608814|NCT00069095|470188664|FG005|Primary Treatment Phase|Failure to return|2|||
130608815|NCT00069095|470188659|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
130608816|NCT00069095|470188660|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
130608817|NCT00069095|470188661|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
130608818|NCT00069095|470188662|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
130608819|NCT00069095|470188663|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
130608820|NCT00069095|470188664|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
130608821|NCT00069095|470188659|FG000|Primary Treatment Phase|Refused treatment|15|||
130608822|NCT00069095|470188660|FG001|Primary Treatment Phase|Refused treatment|26|||
130608823|NCT00069095|470188661|FG002|Primary Treatment Phase|Refused treatment|17|||
130608824|NCT00069095|470188662|FG003|Primary Treatment Phase|Refused treatment|31|||
130608825|NCT00069095|470188663|FG004|Primary Treatment Phase|Refused treatment|24|||
130608826|NCT00069095|470188664|FG005|Primary Treatment Phase|Refused treatment|27|||
130608827|NCT00069095|470188659|FG000|Primary Treatment Phase|Withdrew|2|||
130608828|NCT00069095|470188660|FG001|Primary Treatment Phase|Withdrew|3|||
130608829|NCT00069095|470188661|FG002|Primary Treatment Phase|Withdrew|8|||
130608830|NCT00069095|470188662|FG003|Primary Treatment Phase|Withdrew|2|||
130608831|NCT00069095|470188663|FG004|Primary Treatment Phase|Withdrew|4|||
130608832|NCT00069095|470188664|FG005|Primary Treatment Phase|Withdrew|9|||
130608833|NCT00069095|470188659|FG000|Primary Treatment Phase|Other Violation|0|||
130608834|NCT00069095|470188660|FG001|Primary Treatment Phase|Other Violation|1|||
130608835|NCT00069095|470188661|FG002|Primary Treatment Phase|Other Violation|1|||
130608836|NCT00069095|470188662|FG003|Primary Treatment Phase|Other Violation|1|||
130608837|NCT00069095|470188663|FG004|Primary Treatment Phase|Other Violation|0|||
130608838|NCT00069095|470188664|FG005|Primary Treatment Phase|Other Violation|1|||
130608839|NCT00069095|470188659|FG000|Primary Treatment Phase|Violation criteria|0|||
130608840|NCT00069095|470188660|FG001|Primary Treatment Phase|Violation criteria|2|||
130608841|NCT00069095|470188661|FG002|Primary Treatment Phase|Violation criteria|4|||
130608842|NCT00069095|470188662|FG003|Primary Treatment Phase|Violation criteria|3|||
130608843|NCT00069095|470188663|FG004|Primary Treatment Phase|Violation criteria|1|||
130608844|NCT00069095|470188664|FG005|Primary Treatment Phase|Violation criteria|5|||
130608845|NCT00069095|470188659|FG000|Post-study Treatment Phase|Missing reason|1|||
130608846|NCT00069095|470188660|FG001|Post-study Treatment Phase|Missing reason|3|||
130608847|NCT00069095|470188661|FG002|Post-study Treatment Phase|Missing reason|12|||
130608848|NCT00069095|470188662|FG003|Post-study Treatment Phase|Missing reason|8|||
130608849|NCT00069095|470188663|FG004|Post-study Treatment Phase|Missing reason|18|||
130608850|NCT00069095|470188664|FG005|Post-study Treatment Phase|Missing reason|17|||
130608851|NCT00069095|470188659|FG000|Post-study Treatment Phase|Adverse Event|2|||
130608852|NCT00069095|470188660|FG001|Post-study Treatment Phase|Adverse Event|3|||
130608853|NCT00069095|470188661|FG002|Post-study Treatment Phase|Adverse Event|1|||
130608854|NCT00069095|470188662|FG003|Post-study Treatment Phase|Adverse Event|0|||
130608855|NCT00069095|470188663|FG004|Post-study Treatment Phase|Adverse Event|5|||
130608856|NCT00069095|470188664|FG005|Post-study Treatment Phase|Adverse Event|1|||
130608857|NCT00069095|470188659|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
130608858|NCT00069095|470188660|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
130608859|NCT00069095|470188661|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
130608860|NCT00069095|470188662|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
130608861|NCT00069095|470188663|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
130608862|NCT00069095|470188664|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
130608863|NCT00069095|470188659|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
130608864|NCT00069095|470188660|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
130608865|NCT00069095|470188661|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
130608866|NCT00069095|470188662|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
130608867|NCT00069095|470188663|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
130608868|NCT00069095|470188664|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
130608869|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
130608870|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130608871|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130608872|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130608873|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130608874|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
130608875|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant had complete response|1|||
130608876|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant had complete response|1|||
130608877|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant had complete response|0|||
130608878|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant had complete response|0|||
130608879|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant had complete response|0|||
130608880|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant had complete response|0|||
130608881|NCT00069095|470188659|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130608882|NCT00069095|470188660|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
130608883|NCT00069095|470188661|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130608884|NCT00069095|470188662|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130608885|NCT00069095|470188663|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130608886|NCT00069095|470188664|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130608887|NCT00069095|470188659|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130608888|NCT00069095|470188660|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130608889|NCT00069095|470188661|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130608890|NCT00069095|470188662|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130608891|NCT00069095|470188663|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130608892|NCT00069095|470188664|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130608893|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
130608894|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
130608895|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
130608896|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
130608897|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
130608898|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
130608899|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
130608900|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
130608901|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
130608902|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
130608903|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
130608904|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
130608905|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130608906|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130608907|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130608908|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
130608909|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130608910|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130608911|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
130608912|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
130608913|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
130608914|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
130608915|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
130608916|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
130608917|NCT00069095|470188659|FG000|Post-study Treatment Phase|Surgery|0|||
130608918|NCT00069095|470188660|FG001|Post-study Treatment Phase|Surgery|0|||
130608919|NCT00069095|470188661|FG002|Post-study Treatment Phase|Surgery|0|||
130608920|NCT00069095|470188662|FG003|Post-study Treatment Phase|Surgery|1|||
130608921|NCT00069095|470188663|FG004|Post-study Treatment Phase|Surgery|1|||
130608922|NCT00069095|470188664|FG005|Post-study Treatment Phase|Surgery|0|||
130608923|NCT00069095|470188659|FG000|Post-study Treatment Phase|Death|0|||
130608924|NCT00069095|470188660|FG001|Post-study Treatment Phase|Death|0|||
130608925|NCT00069095|470188661|FG002|Post-study Treatment Phase|Death|0|||
130608926|NCT00069095|470188662|FG003|Post-study Treatment Phase|Death|0|||
130608927|NCT00069095|470188663|FG004|Post-study Treatment Phase|Death|1|||
130608928|NCT00069095|470188664|FG005|Post-study Treatment Phase|Death|0|||
130608929|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
130608930|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
130608931|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
130608932|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
130608933|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
130608934|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
130608935|NCT00069095|470188659|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130608936|NCT00069095|470188660|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130608937|NCT00069095|470188661|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130608938|NCT00069095|470188662|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130608939|NCT00069095|470188663|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
130608940|NCT00069095|470188664|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130608941|NCT00069095|470188659|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130608942|NCT00069095|470188660|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130608943|NCT00069095|470188661|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130608944|NCT00069095|470188662|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130608945|NCT00069095|470188663|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
130608946|NCT00069095|470188664|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130608947|NCT00069095|470188659|FG000|Post-study Treatment Phase|Investigator decision|0|||
130608948|NCT00069095|470188660|FG001|Post-study Treatment Phase|Investigator decision|0|||
130608949|NCT00069095|470188661|FG002|Post-study Treatment Phase|Investigator decision|0|||
130608950|NCT00069095|470188662|FG003|Post-study Treatment Phase|Investigator decision|0|||
130608951|NCT00069095|470188663|FG004|Post-study Treatment Phase|Investigator decision|0|||
130608952|NCT00069095|470188664|FG005|Post-study Treatment Phase|Investigator decision|1|||
130608953|NCT00069095|470188659|FG000|Follow-up Phase|Death|174|||
130608954|NCT00069095|470188660|FG001|Follow-up Phase|Death|206|||
130608955|NCT00069095|470188661|FG002|Follow-up Phase|Death|120|||
130608956|NCT00069095|470188662|FG003|Follow-up Phase|Death|112|||
130608957|NCT00069095|470188663|FG004|Follow-up Phase|Death|92|||
130608958|NCT00069095|470188664|FG005|Follow-up Phase|Death|101|||
130608959|NCT03508622|470188665|FG000|Overall Study|Protocol Violation|1|||
130608960|NCT03508622|470188666|FG001|Overall Study|Protocol Violation|0|||
130608961|NCT03508622|470188665|FG000|Overall Study|Withdrawal by Subject|1|||
130608962|NCT03508622|470188666|FG001|Overall Study|Withdrawal by Subject|0|||
130608963|NCT03508622|470188665|FG000|Overall Study|Lost to Follow-up|16|||
130608964|NCT03508622|470188666|FG001|Overall Study|Lost to Follow-up|0|||
130608965|NCT03508622|470188665|FG000|Overall Study|Incomplete data|0|||
130608966|NCT03508622|470188666|FG001|Overall Study|Incomplete data|24|||
130608967|NCT05114590|470188667|FG000|Overall Study|Adverse Event|1|||
130608968|NCT05114590|470188667|FG000|Overall Study|Investigator decision|1|||
130608969|NCT05114590|470188667|FG000|Overall Study|Lost to Follow-up|5|||
130608970|NCT05114590|470188667|FG000|Overall Study|Withdrawal by Subject|5|||
130608971|NCT05114590|470188667|FG000|Overall Study|Other|2|||
130608972|NCT00358917|470188670|FG000|Overall Study|Adverse Event|14|||
130608973|NCT00358917|470188671|FG001|Overall Study|Adverse Event|21|||
130608974|NCT00358917|470188670|FG000|Overall Study|Withdrawal by Subject|5|||
130608975|NCT00358917|470188671|FG001|Overall Study|Withdrawal by Subject|7|||
130608976|NCT00358917|470188670|FG000|Overall Study|Lost to Follow-up|20|||
130608977|NCT00358917|470188671|FG001|Overall Study|Lost to Follow-up|17|||
130608978|NCT00358917|470188670|FG000|Overall Study|Noncompliance|12|||
130608979|NCT00358917|470188671|FG001|Overall Study|Noncompliance|11|||
130608980|NCT00358917|470188670|FG000|Overall Study|Death|2|||
130608981|NCT00358917|470188671|FG001|Overall Study|Death|3|||
130608982|NCT00358917|470188670|FG000|Overall Study|Virologic failure|11|||
130608983|NCT00358917|470188671|FG001|Overall Study|Virologic failure|8|||
130608984|NCT00358917|470188670|FG000|Overall Study|Unable to Continue Participation|2|||
130608985|NCT00358917|470188671|FG001|Overall Study|Unable to Continue Participation|2|||
130608986|NCT01096550|470188688|FG000|Overall Study|discontinued site|10|||
130608987|NCT01096550|470188689|FG001|Overall Study|discontinued site|11|||
130608988|NCT01096550|470188688|FG000|Overall Study|non-regular treatment track at clinic|1|||
130608989|NCT01096550|470188689|FG001|Overall Study|non-regular treatment track at clinic|1|||
130608990|NCT01096550|470188688|FG000|Overall Study|clinic readmission|1|||
130608991|NCT01096550|470188689|FG001|Overall Study|clinic readmission|1|||
130608992|NCT01096550|470188688|FG000|Overall Study|Withdrawal by Subject|0|||
130608993|NCT01096550|470188689|FG001|Overall Study|Withdrawal by Subject|1|||
130608994|NCT01096550|470188688|FG000|Overall Study|non-African American participant|13|||
130608995|NCT01096550|470188689|FG001|Overall Study|non-African American participant|6|||
130608996|NCT01096550|470188688|FG000|Overall Study|Lost to Follow-up|12|||
130608997|NCT01096550|470188689|FG001|Overall Study|Lost to Follow-up|9|||
130608998|NCT02538666|470188690|FG000|Pre-Treatment|Disease progression|1|||
130608999|NCT02538666|470188691|FG001|Pre-Treatment|Disease progression|0|||
130609000|NCT02538666|470188692|FG002|Pre-Treatment|Disease progression|0|||
130609001|NCT02538666|470188690|FG000|Pre-Treatment|no longer meets study criteria|1|||
130609002|NCT02538666|470188691|FG001|Pre-Treatment|no longer meets study criteria|0|||
130609003|NCT02538666|470188692|FG002|Pre-Treatment|no longer meets study criteria|0|||
130609004|NCT02538666|470188690|FG000|Pre-Treatment|Withdrew Consent|0|||
130609005|NCT02538666|470188691|FG001|Pre-Treatment|Withdrew Consent|1|||
130609006|NCT02538666|470188692|FG002|Pre-Treatment|Withdrew Consent|1|||
130609007|NCT02538666|470188690|FG000|Treatment|Disease progression|270|||
130609008|NCT02538666|470188691|FG001|Treatment|Disease progression|227|||
130609009|NCT02538666|470188692|FG002|Treatment|Disease progression|165|||
130609010|NCT02538666|470188690|FG000|Treatment|Study drug toxicity|1|||
130609011|NCT02538666|470188691|FG001|Treatment|Study drug toxicity|29|||
130609012|NCT02538666|470188692|FG002|Treatment|Study drug toxicity|92|||
130609013|NCT02538666|470188690|FG000|Treatment|Death|0|||
130609014|NCT02538666|470188691|FG001|Treatment|Death|2|||
130609015|NCT02538666|470188692|FG002|Treatment|Death|3|||
130609016|NCT02538666|470188690|FG000|Treatment|Adverse event unrelated to study drug|8|||
130609017|NCT02538666|470188691|FG001|Treatment|Adverse event unrelated to study drug|10|||
130609018|NCT02538666|470188692|FG002|Treatment|Adverse event unrelated to study drug|15|||
130609019|NCT02538666|470188690|FG000|Treatment|Participant request to discontinue study treatment|3|||
130609020|NCT02538666|470188691|FG001|Treatment|Participant request to discontinue study treatment|6|||
130609021|NCT02538666|470188692|FG002|Treatment|Participant request to discontinue study treatment|11|||
130609022|NCT02538666|470188690|FG000|Treatment|Participant withdrew consent|2|||
130609023|NCT02538666|470188691|FG001|Treatment|Participant withdrew consent|5|||
130609024|NCT02538666|470188692|FG002|Treatment|Participant withdrew consent|3|||
130609025|NCT02538666|470188690|FG000|Treatment|Lost to Follow-up|0|||
130609026|NCT02538666|470188691|FG001|Treatment|Lost to Follow-up|1|||
130609027|NCT02538666|470188692|FG002|Treatment|Lost to Follow-up|1|||
130609028|NCT02538666|470188690|FG000|Treatment|Maximum clinical benefit|4|||
130609029|NCT02538666|470188691|FG001|Treatment|Maximum clinical benefit|3|||
130609030|NCT02538666|470188692|FG002|Treatment|Maximum clinical benefit|4|||
130609031|NCT02538666|470188690|FG000|Treatment|Poor/non-compliance|0|||
130609032|NCT02538666|470188691|FG001|Treatment|Poor/non-compliance|1|||
130609033|NCT02538666|470188692|FG002|Treatment|Poor/non-compliance|0|||
130609034|NCT02538666|470188690|FG000|Treatment|Participant no longer meets study criteria|0|||
130609035|NCT02538666|470188691|FG001|Treatment|Participant no longer meets study criteria|2|||
130609036|NCT02538666|470188692|FG002|Treatment|Participant no longer meets study criteria|0|||
130609037|NCT02538666|470188690|FG000|Treatment|Administrative reason by sponsor|0|||
130609038|NCT02538666|470188691|FG001|Treatment|Administrative reason by sponsor|0|||
130609039|NCT02538666|470188692|FG002|Treatment|Administrative reason by sponsor|1|||
130609040|NCT02538666|470188690|FG000|Treatment|Other reasons|8|||
130609041|NCT02538666|470188691|FG001|Treatment|Other reasons|15|||
130609042|NCT02538666|470188692|FG002|Treatment|Other reasons|5|||
130609043|NCT02538666|470188690|FG000|Treatment|Not reported|2|||
130609044|NCT02538666|470188691|FG001|Treatment|Not reported|2|||
130609045|NCT02538666|470188692|FG002|Treatment|Not reported|2|||
130609046|NCT04590937|470188693|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
130609047|NCT01544595|470188694|FG000|Status at Week 68|Adverse Event|3|||
130609048|NCT01544595|470188695|FG001|Status at Week 68|Adverse Event|2|||
130609049|NCT01544595|470188696|FG002|Status at Week 68|Adverse Event|1|||
130609050|NCT01544595|470188697|FG003|Status at Week 68|Adverse Event|0|||
130609051|NCT01544595|470188698|FG004|Status at Week 68|Adverse Event|0|||
130609052|NCT01544595|470188699|FG005|Status at Week 68|Adverse Event|0|||
130609053|NCT01544595|470188694|FG000|Status at Week 68|Lack of Efficacy|1|||
130609054|NCT01544595|470188695|FG001|Status at Week 68|Lack of Efficacy|0|||
130609055|NCT01544595|470188696|FG002|Status at Week 68|Lack of Efficacy|0|||
130609056|NCT01544595|470188697|FG003|Status at Week 68|Lack of Efficacy|0|||
130609057|NCT01544595|470188698|FG004|Status at Week 68|Lack of Efficacy|0|||
130609058|NCT01544595|470188699|FG005|Status at Week 68|Lack of Efficacy|0|||
130609059|NCT01544595|470188694|FG000|Status at Week 68|Lost to Follow-up|1|||
130609060|NCT01544595|470188695|FG001|Status at Week 68|Lost to Follow-up|1|||
130609061|NCT01544595|470188696|FG002|Status at Week 68|Lost to Follow-up|0|||
130609062|NCT01544595|470188697|FG003|Status at Week 68|Lost to Follow-up|0|||
130609063|NCT01544595|470188698|FG004|Status at Week 68|Lost to Follow-up|0|||
130609064|NCT01544595|470188699|FG005|Status at Week 68|Lost to Follow-up|0|||
130609065|NCT01544595|470188694|FG000|Status at Week 68|Non-compliance with study treatment|1|||
130609066|NCT01544595|470188695|FG001|Status at Week 68|Non-compliance with study treatment|0|||
130609067|NCT01544595|470188696|FG002|Status at Week 68|Non-compliance with study treatment|0|||
130609068|NCT01544595|470188697|FG003|Status at Week 68|Non-compliance with study treatment|1|||
130609069|NCT01544595|470188698|FG004|Status at Week 68|Non-compliance with study treatment|0|||
130609070|NCT01544595|470188699|FG005|Status at Week 68|Non-compliance with study treatment|0|||
130609071|NCT01544595|470188694|FG000|Status at Week 68|Protocol Violation|2|||
130609072|NCT01544595|470188695|FG001|Status at Week 68|Protocol Violation|0|||
130609073|NCT01544595|470188696|FG002|Status at Week 68|Protocol Violation|1|||
130609074|NCT01544595|470188697|FG003|Status at Week 68|Protocol Violation|1|||
130609075|NCT01544595|470188698|FG004|Status at Week 68|Protocol Violation|0|||
130609076|NCT01544595|470188699|FG005|Status at Week 68|Protocol Violation|0|||
130609077|NCT01544595|470188694|FG000|Status at Week 68|Technical problems|1|||
130609078|NCT01544595|470188695|FG001|Status at Week 68|Technical problems|0|||
130609079|NCT01544595|470188696|FG002|Status at Week 68|Technical problems|0|||
130609080|NCT01544595|470188697|FG003|Status at Week 68|Technical problems|1|||
130609081|NCT01544595|470188698|FG004|Status at Week 68|Technical problems|0|||
130609082|NCT01544595|470188699|FG005|Status at Week 68|Technical problems|0|||
130609083|NCT01544595|470188694|FG000|Status at Week 68|Withdrawal by Subject|0|||
130609084|NCT01544595|470188695|FG001|Status at Week 68|Withdrawal by Subject|1|||
130609085|NCT01544595|470188696|FG002|Status at Week 68|Withdrawal by Subject|1|||
130609086|NCT01544595|470188697|FG003|Status at Week 68|Withdrawal by Subject|2|||
130609087|NCT01544595|470188698|FG004|Status at Week 68|Withdrawal by Subject|0|||
130609088|NCT01544595|470188699|FG005|Status at Week 68|Withdrawal by Subject|0|||
130609089|NCT01544595|470188694|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
130609090|NCT01544595|470188695|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
130609091|NCT01544595|470188696|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
130609092|NCT01544595|470188697|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
130609093|NCT01544595|470188698|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
130609094|NCT01544595|470188699|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
130609095|NCT01544595|470188694|FG000|Status at Week 156|Withdrawal by Subject|9|||
130609096|NCT01544595|470188695|FG001|Status at Week 156|Withdrawal by Subject|10|||
130609097|NCT01544595|470188696|FG002|Status at Week 156|Withdrawal by Subject|4|||
130609098|NCT01544595|470188697|FG003|Status at Week 156|Withdrawal by Subject|9|||
130609099|NCT01544595|470188698|FG004|Status at Week 156|Withdrawal by Subject|20|||
130609100|NCT01544595|470188699|FG005|Status at Week 156|Withdrawal by Subject|6|||
130609101|NCT01544595|470188694|FG000|Status at Week 156|Adverse Event|9|||
130609102|NCT01544595|470188695|FG001|Status at Week 156|Adverse Event|11|||
130609103|NCT01544595|470188696|FG002|Status at Week 156|Adverse Event|1|||
130609104|NCT01544595|470188697|FG003|Status at Week 156|Adverse Event|3|||
130609105|NCT01544595|470188698|FG004|Status at Week 156|Adverse Event|4|||
130609106|NCT01544595|470188699|FG005|Status at Week 156|Adverse Event|2|||
130609107|NCT01544595|470188694|FG000|Status at Week 156|Lost to Follow-up|4|||
130609108|NCT01544595|470188695|FG001|Status at Week 156|Lost to Follow-up|4|||
130609109|NCT01544595|470188696|FG002|Status at Week 156|Lost to Follow-up|0|||
130609110|NCT01544595|470188697|FG003|Status at Week 156|Lost to Follow-up|1|||
130609111|NCT01544595|470188698|FG004|Status at Week 156|Lost to Follow-up|4|||
130609112|NCT01544595|470188699|FG005|Status at Week 156|Lost to Follow-up|1|||
130609113|NCT01544595|470188694|FG000|Status at Week 156|Non-compliance with study treatement|0|||
130609114|NCT01544595|470188695|FG001|Status at Week 156|Non-compliance with study treatement|1|||
130609115|NCT01544595|470188696|FG002|Status at Week 156|Non-compliance with study treatement|0|||
130609116|NCT01544595|470188697|FG003|Status at Week 156|Non-compliance with study treatement|1|||
130609117|NCT01544595|470188698|FG004|Status at Week 156|Non-compliance with study treatement|0|||
130609118|NCT01544595|470188699|FG005|Status at Week 156|Non-compliance with study treatement|1|||
130609119|NCT01544595|470188694|FG000|Status at Week 156|Physician Decision|0|||
130609120|NCT01544595|470188695|FG001|Status at Week 156|Physician Decision|3|||
130609121|NCT01544595|470188696|FG002|Status at Week 156|Physician Decision|1|||
130609122|NCT01544595|470188697|FG003|Status at Week 156|Physician Decision|0|||
130609123|NCT01544595|470188698|FG004|Status at Week 156|Physician Decision|0|||
130609124|NCT01544595|470188699|FG005|Status at Week 156|Physician Decision|0|||
130609125|NCT01544595|470188694|FG000|Status at Week 156|Pregnancy|2|||
130609126|NCT01544595|470188695|FG001|Status at Week 156|Pregnancy|3|||
130609127|NCT01544595|470188696|FG002|Status at Week 156|Pregnancy|0|||
130609128|NCT01544595|470188697|FG003|Status at Week 156|Pregnancy|0|||
130609129|NCT01544595|470188698|FG004|Status at Week 156|Pregnancy|0|||
130609130|NCT01544595|470188699|FG005|Status at Week 156|Pregnancy|0|||
130609131|NCT01544595|470188694|FG000|Status at Week 156|Protocol Violation|3|||
130609132|NCT01544595|470188695|FG001|Status at Week 156|Protocol Violation|1|||
130609133|NCT01544595|470188696|FG002|Status at Week 156|Protocol Violation|2|||
130609134|NCT01544595|470188697|FG003|Status at Week 156|Protocol Violation|2|||
130609135|NCT01544595|470188698|FG004|Status at Week 156|Protocol Violation|0|||
130609136|NCT01544595|470188699|FG005|Status at Week 156|Protocol Violation|0|||
130609137|NCT01544595|470188694|FG000|Status at Week 156|Technical problems|3|||
130609138|NCT01544595|470188695|FG001|Status at Week 156|Technical problems|1|||
130609139|NCT01544595|470188696|FG002|Status at Week 156|Technical problems|0|||
130609140|NCT01544595|470188697|FG003|Status at Week 156|Technical problems|1|||
130609141|NCT01544595|470188698|FG004|Status at Week 156|Technical problems|0|||
130609142|NCT01544595|470188699|FG005|Status at Week 156|Technical problems|0|||
130609143|NCT01544595|470188694|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
130609144|NCT01544595|470188695|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
130609145|NCT01544595|470188696|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
130609146|NCT01544595|470188697|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
130609147|NCT01544595|470188698|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
130609148|NCT01544595|470188699|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
130609149|NCT01544595|470188694|FG000|Status at Week 156|Lack of Efficacy|1|||
130609150|NCT01544595|470188695|FG001|Status at Week 156|Lack of Efficacy|0|||
130609151|NCT01544595|470188696|FG002|Status at Week 156|Lack of Efficacy|1|||
130609152|NCT01544595|470188697|FG003|Status at Week 156|Lack of Efficacy|4|||
130609153|NCT01544595|470188698|FG004|Status at Week 156|Lack of Efficacy|10|||
130609154|NCT01544595|470188699|FG005|Status at Week 156|Lack of Efficacy|5|||
130609155|NCT04333433|470188708|FG000|Overall Study|Withdrawal by Subject|6|||
130609156|NCT04333433|470188709|FG001|Overall Study|Withdrawal by Subject|3|||
130609157|NCT04333433|470188708|FG000|Overall Study|Death|3|||
130609158|NCT04333433|470188709|FG001|Overall Study|Death|0|||
130609159|NCT04333433|470188708|FG000|Overall Study|Lost to Follow-up|6|||
130609160|NCT04333433|470188709|FG001|Overall Study|Lost to Follow-up|1|||
130609161|NCT04333433|470188708|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
130609162|NCT04333433|470188709|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
130609163|NCT00320385|470188710|FG000|Overall Study|Lost to Follow-up|7|||
130609164|NCT00320385|470188711|FG001|Overall Study|Lost to Follow-up|10|||
130609165|NCT00320385|470188710|FG000|Overall Study|Withdrawal by Subject|6|||
130609166|NCT00320385|470188711|FG001|Overall Study|Withdrawal by Subject|7|||
130609167|NCT00320385|470188710|FG000|Overall Study|Sponsor Terminated Study|2|||
130609168|NCT00320385|470188711|FG001|Overall Study|Sponsor Terminated Study|1|||
130609169|NCT00320385|470188710|FG000|Overall Study|Investigator Decision|0|||
130609170|NCT00320385|470188711|FG001|Overall Study|Investigator Decision|1|||
130609171|NCT00320385|470188710|FG000|Overall Study|Death|1|||
130609172|NCT00320385|470188711|FG001|Overall Study|Death|2|||
130609173|NCT00320385|470188710|FG000|Overall Study|Serious Adverse Event|1|||
130609174|NCT00320385|470188711|FG001|Overall Study|Serious Adverse Event|0|||
130609175|NCT00320385|470188710|FG000|Overall Study|Withdrew Consent|1|||
130609176|NCT00320385|470188711|FG001|Overall Study|Withdrew Consent|0|||
130609177|NCT00320385|470188710|FG000|Overall Study|Adverse Event|0|||
130609178|NCT00320385|470188711|FG001|Overall Study|Adverse Event|1|||
130609179|NCT03844633|470188720|FG000|1 Week FU|Lost to Follow-up|0|||
130609180|NCT03844633|470188721|FG001|1 Week FU|Lost to Follow-up|1|||
130609181|NCT03844633|470188722|FG002|1 Week FU|Lost to Follow-up|4|||
130609182|NCT03844633|470188720|FG000|12-month Follow-up|Lost to Follow-up|7|||
130609183|NCT03844633|470188721|FG001|12-month Follow-up|Lost to Follow-up|5|||
130609184|NCT03844633|470188722|FG002|12-month Follow-up|Lost to Follow-up|8|||
130609185|NCT03288779|470188723|FG000|Overall Study|Withdrawal by Subject|3|||
130609186|NCT00872170|470188724|FG000|Overall Study|Adverse Event|1|||
130609187|NCT00872170|470188725|FG001|Overall Study|Adverse Event|0|||
130609188|NCT00601523|470188726|FG000|Overall Study|Adverse Event|42|||
130609189|NCT00601523|470188727|FG001|Overall Study|Adverse Event|14|||
130609190|NCT00601523|470188726|FG000|Overall Study|Lack of Efficacy|3|||
130609191|NCT00601523|470188727|FG001|Overall Study|Lack of Efficacy|0|||
130609192|NCT00601523|470188726|FG000|Overall Study|Protocol Violation|5|||
130609193|NCT00601523|470188727|FG001|Overall Study|Protocol Violation|1|||
130609194|NCT00601523|470188726|FG000|Overall Study|Lost to Follow-up|0|||
130609195|NCT00601523|470188727|FG001|Overall Study|Lost to Follow-up|1|||
130609196|NCT00601523|470188726|FG000|Overall Study|Withdrawal by Subject|18|||
130609197|NCT00601523|470188727|FG001|Overall Study|Withdrawal by Subject|9|||
130609198|NCT00601523|470188726|FG000|Overall Study|Other|9|||
130609199|NCT00601523|470188727|FG001|Overall Study|Other|1|||
130609200|NCT01064648|470188728|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
130609201|NCT01064648|470188729|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
130609202|NCT01064648|470188730|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
130609203|NCT01064648|470188731|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
130609204|NCT01064648|470188728|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
130609205|NCT01064648|470188729|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130609206|NCT01064648|470188730|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130609207|NCT01064648|470188731|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130609208|NCT01064648|470188728|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
130609209|NCT01064648|470188729|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
130609210|NCT01064648|470188730|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
130609211|NCT01064648|470188731|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
130609212|NCT01064648|470188728|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130609213|NCT01064648|470188729|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
130609214|NCT01064648|470188730|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130609215|NCT01064648|470188731|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130609216|NCT01064648|470188728|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
130609217|NCT01064648|470188729|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
130609218|NCT01064648|470188730|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
130609219|NCT01064648|470188731|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
130609220|NCT01064648|470188728|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
130609221|NCT01064648|470188729|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
130609222|NCT01064648|470188730|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
130609223|NCT01064648|470188731|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
130609224|NCT01064648|470188728|FG000|Phase II|Adverse Event|0|||
130609225|NCT01064648|470188729|FG001|Phase II|Adverse Event|0|||
130609226|NCT01064648|470188730|FG002|Phase II|Adverse Event|15|||
130609227|NCT01064648|470188731|FG003|Phase II|Adverse Event|8|||
130609228|NCT01064648|470188728|FG000|Phase II|Death|0|||
130609229|NCT01064648|470188729|FG001|Phase II|Death|0|||
130609230|NCT01064648|470188730|FG002|Phase II|Death|4|||
130609231|NCT01064648|470188731|FG003|Phase II|Death|5|||
130609232|NCT01064648|470188728|FG000|Phase II|Withdrawal by Subject|0|||
130609233|NCT01064648|470188729|FG001|Phase II|Withdrawal by Subject|0|||
130609234|NCT01064648|470188730|FG002|Phase II|Withdrawal by Subject|2|||
130609235|NCT01064648|470188731|FG003|Phase II|Withdrawal by Subject|5|||
130609236|NCT01064648|470188728|FG000|Phase II|Progression|0|||
130609237|NCT01064648|470188729|FG001|Phase II|Progression|0|||
130609238|NCT01064648|470188730|FG002|Phase II|Progression|21|||
130609239|NCT01064648|470188731|FG003|Phase II|Progression|27|||
130609240|NCT01064648|470188728|FG000|Phase II|Non-protocol specified|0|||
130609241|NCT01064648|470188729|FG001|Phase II|Non-protocol specified|0|||
130609242|NCT01064648|470188730|FG002|Phase II|Non-protocol specified|5|||
130609243|NCT01064648|470188731|FG003|Phase II|Non-protocol specified|3|||
130609244|NCT01064648|470188728|FG000|Phase II|Under Review|0|||
130609245|NCT01064648|470188729|FG001|Phase II|Under Review|0|||
130609246|NCT01064648|470188730|FG002|Phase II|Under Review|2|||
130609247|NCT01064648|470188731|FG003|Phase II|Under Review|0|||
130609248|NCT00977574|470188732|FG000|Overall Study|Never Treated|4|||
130609249|NCT00977574|470188733|FG001|Overall Study|Never Treated|2|||
130609250|NCT00977574|470188734|FG002|Overall Study|Never Treated|4|||
130609251|NCT05281523|470188735|FG000|Overall Study|Adverse Event|1|||
130609252|NCT05281523|470188736|FG001|Overall Study|Adverse Event|1|||
130609253|NCT05281523|470188735|FG000|Overall Study|Physician Decision|1|||
130609254|NCT05281523|470188736|FG001|Overall Study|Physician Decision|1|||
130609255|NCT05281523|470188735|FG000|Overall Study|Withdrawal by Subject|5|||
130609256|NCT05281523|470188736|FG001|Overall Study|Withdrawal by Subject|15|||
130609257|NCT05281523|470188735|FG000|Overall Study|GCP violations|3|||
130609258|NCT05281523|470188736|FG001|Overall Study|GCP violations|4|||
130609259|NCT04491877|470191060|FG000|Overall Study|Protocol Deviation|1|||
130609260|NCT04491877|470191061|FG001|Overall Study|Protocol Deviation|0|||
130609261|NCT04491877|470191062|FG002|Overall Study|Protocol Deviation|2|||
130609262|NCT04491877|470191063|FG003|Overall Study|Protocol Deviation|0|||
130609263|NCT04491877|470191064|FG004|Overall Study|Protocol Deviation|0|||
130609264|NCT04491877|470191065|FG005|Overall Study|Protocol Deviation|0|||
130609265|NCT04491877|470191066|FG006|Overall Study|Protocol Deviation|1|||
130609266|NCT04491877|470191067|FG007|Overall Study|Protocol Deviation|1|||
130609267|NCT04491877|470191068|FG008|Overall Study|Protocol Deviation|0|||
130609268|NCT04491877|470191060|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130609269|NCT04491877|470191061|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130609270|NCT04491877|470191062|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130609271|NCT04491877|470191063|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
130609272|NCT04491877|470191064|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130609273|NCT04491877|470191065|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
130609274|NCT04491877|470191066|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
130609275|NCT04491877|470191067|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
130609276|NCT04491877|470191068|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
130609277|NCT04491877|470191060|FG000|Overall Study|Lost to Follow-up|0|||
130609278|NCT04491877|470191061|FG001|Overall Study|Lost to Follow-up|2|||
130609279|NCT04491877|470191062|FG002|Overall Study|Lost to Follow-up|0|||
130609280|NCT04491877|470191063|FG003|Overall Study|Lost to Follow-up|0|||
130609281|NCT04491877|470191064|FG004|Overall Study|Lost to Follow-up|0|||
130609282|NCT04491877|470191065|FG005|Overall Study|Lost to Follow-up|0|||
130609283|NCT04491877|470191066|FG006|Overall Study|Lost to Follow-up|2|||
130609284|NCT04491877|470191067|FG007|Overall Study|Lost to Follow-up|1|||
130609285|NCT04491877|470191068|FG008|Overall Study|Lost to Follow-up|1|||
130609286|NCT00074412|470191073|FG000|Overall Study|Death|30|||
130609287|NCT00074412|470191074|FG001|Overall Study|Death|26|||
130609288|NCT00074412|470191073|FG000|Overall Study|Lost to Follow-up|52|||
130609289|NCT00074412|470191074|FG001|Overall Study|Lost to Follow-up|58|||
130609290|NCT00418834|470191079|FG000|Overall Study|Adverse Event|16|||
130609291|NCT00418834|470191080|FG001|Overall Study|Adverse Event|9|||
130609292|NCT00418834|470191079|FG000|Overall Study|Lost to Follow-up|0|||
130609293|NCT00418834|470191080|FG001|Overall Study|Lost to Follow-up|1|||
130609294|NCT00418834|470191079|FG000|Overall Study|Protocol Violation|4|||
130609295|NCT00418834|470191080|FG001|Overall Study|Protocol Violation|3|||
130609296|NCT00418834|470191079|FG000|Overall Study|Withdrawal by Subject|3|||
130609297|NCT00418834|470191080|FG001|Overall Study|Withdrawal by Subject|7|||
130609298|NCT01953328|470191081|FG000|Overall Study|Withdrawal by Subject|0|||
130609299|NCT01953328|470191082|FG001|Overall Study|Withdrawal by Subject|0|||
130609300|NCT01953328|470191083|FG002|Overall Study|Withdrawal by Subject|0|||
130609301|NCT01953328|470191084|FG003|Overall Study|Withdrawal by Subject|0|||
130609302|NCT01953328|470191085|FG004|Overall Study|Withdrawal by Subject|1|||
130609303|NCT01953328|470191086|FG005|Overall Study|Withdrawal by Subject|0|||
130609304|NCT01953328|470191087|FG006|Overall Study|Withdrawal by Subject|0|||
130609305|NCT01953328|470191088|FG007|Overall Study|Withdrawal by Subject|0|||
130609306|NCT01953328|470191081|FG000|Overall Study|Lost to Follow-up|0|||
130609307|NCT01953328|470191082|FG001|Overall Study|Lost to Follow-up|0|||
130609308|NCT01953328|470191083|FG002|Overall Study|Lost to Follow-up|0|||
130609309|NCT01953328|470191084|FG003|Overall Study|Lost to Follow-up|0|||
130609310|NCT01953328|470191085|FG004|Overall Study|Lost to Follow-up|1|||
130609311|NCT01953328|470191086|FG005|Overall Study|Lost to Follow-up|0|||
130609312|NCT01953328|470191087|FG006|Overall Study|Lost to Follow-up|0|||
130609313|NCT01953328|470191088|FG007|Overall Study|Lost to Follow-up|0|||
130609314|NCT02364947|470191090|FG000|Overall Study|Withdrawal by Subject|10|||
130609315|NCT02364947|470191091|FG001|Overall Study|Withdrawal by Subject|8|||
130609316|NCT02364947|470191092|FG002|Overall Study|Withdrawal by Subject|9|||
130609317|NCT02364947|470191090|FG000|Overall Study|Adverse Event|45|||
130609318|NCT02364947|470191091|FG001|Overall Study|Adverse Event|33|||
130609319|NCT02364947|470191092|FG002|Overall Study|Adverse Event|11|||
130609320|NCT02364947|470191090|FG000|Overall Study|Protocol Violation|1|||
130609321|NCT02364947|470191091|FG001|Overall Study|Protocol Violation|1|||
130609322|NCT02364947|470191092|FG002|Overall Study|Protocol Violation|1|||
130609323|NCT02364947|470191090|FG000|Overall Study|Physician Decision|3|||
130609324|NCT02364947|470191091|FG001|Overall Study|Physician Decision|2|||
130609325|NCT02364947|470191092|FG002|Overall Study|Physician Decision|5|||
130609326|NCT02364947|470191090|FG000|Overall Study|Death|0|||
130609327|NCT02364947|470191091|FG001|Overall Study|Death|1|||
130609328|NCT02364947|470191092|FG002|Overall Study|Death|0|||
130609329|NCT02163993|470191093|FG000|Treatment Period|Adverse Event|0|||
130609330|NCT02163993|470191094|FG001|Treatment Period|Adverse Event|1|||
130609331|NCT02163993|470191095|FG002|Treatment Period|Adverse Event|0|||
130609332|NCT02163993|470191096|FG003|Treatment Period|Adverse Event|0|||
130609333|NCT02163993|470191097|FG004|Treatment Period|Adverse Event|1|||
130609334|NCT02163993|470191093|FG000|Treatment Period|Lost to Follow-up|2|||
130609335|NCT02163993|470191094|FG001|Treatment Period|Lost to Follow-up|3|||
130609336|NCT02163993|470191095|FG002|Treatment Period|Lost to Follow-up|1|||
130609337|NCT02163993|470191096|FG003|Treatment Period|Lost to Follow-up|3|||
130609338|NCT02163993|470191097|FG004|Treatment Period|Lost to Follow-up|1|||
130609339|NCT02163993|470191093|FG000|Treatment Period|Physician Decision|1|||
130609340|NCT02163993|470191094|FG001|Treatment Period|Physician Decision|0|||
130609341|NCT02163993|470191095|FG002|Treatment Period|Physician Decision|0|||
130609342|NCT02163993|470191096|FG003|Treatment Period|Physician Decision|0|||
130609343|NCT02163993|470191097|FG004|Treatment Period|Physician Decision|0|||
130609344|NCT02163993|470191093|FG000|Treatment Period|Protocol Violation|2|||
130609345|NCT02163993|470191094|FG001|Treatment Period|Protocol Violation|1|||
130609346|NCT02163993|470191095|FG002|Treatment Period|Protocol Violation|0|||
130609347|NCT02163993|470191096|FG003|Treatment Period|Protocol Violation|1|||
130609348|NCT02163993|470191097|FG004|Treatment Period|Protocol Violation|2|||
130609349|NCT02163993|470191093|FG000|Treatment Period|Withdrawal by Subject|6|||
130609350|NCT02163993|470191094|FG001|Treatment Period|Withdrawal by Subject|4|||
130609351|NCT02163993|470191095|FG002|Treatment Period|Withdrawal by Subject|1|||
130609352|NCT02163993|470191096|FG003|Treatment Period|Withdrawal by Subject|4|||
130609353|NCT02163993|470191097|FG004|Treatment Period|Withdrawal by Subject|1|||
130609354|NCT02163993|470191093|FG000|Treatment Period|Not treated|1|||
130609355|NCT02163993|470191094|FG001|Treatment Period|Not treated|0|||
130609356|NCT02163993|470191095|FG002|Treatment Period|Not treated|0|||
130609357|NCT02163993|470191096|FG003|Treatment Period|Not treated|1|||
130609358|NCT02163993|470191097|FG004|Treatment Period|Not treated|2|||
130609359|NCT02163993|470191093|FG000|Post-treatment Period|Adverse Event|0|||
130609360|NCT02163993|470191094|FG001|Post-treatment Period|Adverse Event|0|||
130609361|NCT02163993|470191095|FG002|Post-treatment Period|Adverse Event|1|||
130609362|NCT02163993|470191096|FG003|Post-treatment Period|Adverse Event|0|||
130609363|NCT02163993|470191097|FG004|Post-treatment Period|Adverse Event|0|||
130609364|NCT02163993|470191093|FG000|Post-treatment Period|Lost to Follow-up|2|||
130609365|NCT02163993|470191094|FG001|Post-treatment Period|Lost to Follow-up|2|||
130609366|NCT02163993|470191095|FG002|Post-treatment Period|Lost to Follow-up|3|||
130609367|NCT02163993|470191096|FG003|Post-treatment Period|Lost to Follow-up|1|||
130609368|NCT02163993|470191097|FG004|Post-treatment Period|Lost to Follow-up|0|||
130609369|NCT02163993|470191093|FG000|Post-treatment Period|Protocol Violation|0|||
130609370|NCT02163993|470191094|FG001|Post-treatment Period|Protocol Violation|0|||
130609371|NCT02163993|470191095|FG002|Post-treatment Period|Protocol Violation|0|||
130609372|NCT02163993|470191096|FG003|Post-treatment Period|Protocol Violation|0|||
130609373|NCT02163993|470191097|FG004|Post-treatment Period|Protocol Violation|1|||
130609374|NCT02163993|470191093|FG000|Post-treatment Period|Withdrawal by Subject|2|||
130609375|NCT02163993|470191094|FG001|Post-treatment Period|Withdrawal by Subject|4|||
130609376|NCT02163993|470191095|FG002|Post-treatment Period|Withdrawal by Subject|0|||
130609377|NCT02163993|470191096|FG003|Post-treatment Period|Withdrawal by Subject|1|||
130609378|NCT02163993|470191097|FG004|Post-treatment Period|Withdrawal by Subject|2|||
130609379|NCT00853489|470191098|FG000|Overall Study|Lost to Follow-up|5|||
130609380|NCT00853489|470191099|FG001|Overall Study|Lost to Follow-up|2|||
130609381|NCT05525975|470191100|FG000|Overall Study|Surgery cancellation|4|||
130609382|NCT05525975|470191101|FG001|Overall Study|Surgery cancellation|5|||
130609383|NCT05525975|470191100|FG000|Overall Study|didn't fill prescription|1|||
130609384|NCT05525975|470191101|FG001|Overall Study|didn't fill prescription|0|||
130609385|NCT05525975|470191100|FG000|Overall Study|Withdrawal by Subject|0|||
130609386|NCT05525975|470191101|FG001|Overall Study|Withdrawal by Subject|3|||
130609387|NCT01701583|470191103|FG000|Overall Study|Withdrawal by Subject|2|||
130609388|NCT01701583|470191104|FG001|Overall Study|Withdrawal by Subject|0|||
130609389|NCT01441440|470191105|FG000|Overall Study|Death|1|||
130609390|NCT01441440|470191106|FG001|Overall Study|Death|0|||
130609391|NCT01441440|470191107|FG002|Overall Study|Death|1|||
130609392|NCT01441440|470191105|FG000|Overall Study|Adverse Event|2|||
130609393|NCT01441440|470191106|FG001|Overall Study|Adverse Event|9|||
130609394|NCT01441440|470191107|FG002|Overall Study|Adverse Event|9|||
130609395|NCT01441440|470191105|FG000|Overall Study|Lost to Follow-up|0|||
130609396|NCT01441440|470191106|FG001|Overall Study|Lost to Follow-up|2|||
130609397|NCT01441440|470191107|FG002|Overall Study|Lost to Follow-up|1|||
130609398|NCT01441440|470191105|FG000|Overall Study|Withdrawal by Subject|11|||
130609399|NCT01441440|470191106|FG001|Overall Study|Withdrawal by Subject|9|||
130609400|NCT01441440|470191107|FG002|Overall Study|Withdrawal by Subject|9|||
130609401|NCT01441440|470191105|FG000|Overall Study|Pregnancy|1|||
130609402|NCT01441440|470191106|FG001|Overall Study|Pregnancy|0|||
130609403|NCT01441440|470191107|FG002|Overall Study|Pregnancy|0|||
130609404|NCT01441440|470191105|FG000|Overall Study|Lack of Efficacy|1|||
130609405|NCT01441440|470191106|FG001|Overall Study|Lack of Efficacy|0|||
130609406|NCT01441440|470191107|FG002|Overall Study|Lack of Efficacy|1|||
130609407|NCT01441440|470191105|FG000|Overall Study|Moving|0|||
130609408|NCT01441440|470191106|FG001|Overall Study|Moving|1|||
130609409|NCT01441440|470191107|FG002|Overall Study|Moving|1|||
130609410|NCT01441440|470191105|FG000|Overall Study|Work-related matter|0|||
130609411|NCT01441440|470191106|FG001|Overall Study|Work-related matter|1|||
130609412|NCT01441440|470191107|FG002|Overall Study|Work-related matter|0|||
130609413|NCT01441440|470191105|FG000|Overall Study|Difficllty in keeping the schedule|1|||
130609414|NCT01441440|470191106|FG001|Overall Study|Difficllty in keeping the schedule|1|||
130609415|NCT01441440|470191107|FG002|Overall Study|Difficllty in keeping the schedule|0|||
130609416|NCT02750813|470191108|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
130609417|NCT02750813|470191109|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
130609418|NCT02750813|470191108|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
130609419|NCT02750813|470191109|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
130609420|NCT01998581|470191110|FG000|Overall Study|Refused repeat treatment|20|||
130609421|NCT01998581|470191111|FG001|Overall Study|Refused repeat treatment|4|||
130609422|NCT01998581|470191110|FG000|Overall Study|Protocol Violation|1|||
130609423|NCT01998581|470191111|FG001|Overall Study|Protocol Violation|0|||
130609424|NCT01998581|470191110|FG000|Overall Study|Withdrawal by Subject|8|||
130609425|NCT01998581|470191111|FG001|Overall Study|Withdrawal by Subject|1|||
130609426|NCT01998581|470191110|FG000|Overall Study|Lost to Follow-up|12|||
130609427|NCT01998581|470191111|FG001|Overall Study|Lost to Follow-up|4|||
130609428|NCT01998581|470191110|FG000|Overall Study|Adverse Event|1|||
130609429|NCT01998581|470191111|FG001|Overall Study|Adverse Event|1|||
130609430|NCT01998581|470191110|FG000|Overall Study|Other reasons|3|||
130609431|NCT01998581|470191111|FG001|Overall Study|Other reasons|2|||
130609432|NCT01998581|470191110|FG000|Overall Study|Randomized but withdrew before treatment|1|||
130609433|NCT01998581|470191111|FG001|Overall Study|Randomized but withdrew before treatment|0|||
130609434|NCT01251276|470191112|FG000|Overall Study|Protocol Violation|1|||
130609435|NCT01251276|470191113|FG001|Overall Study|Protocol Violation|0|||
130609436|NCT01251276|470191112|FG000|Overall Study|Lost to Follow-up|0|||
130609437|NCT01251276|470191113|FG001|Overall Study|Lost to Follow-up|1|||
130609438|NCT01345123|470191114|FG000|Overall Study|participants no longer with health plan|79|||
130609439|NCT01345123|470191115|FG001|Overall Study|participants no longer with health plan|85|||
130609440|NCT01345123|470191116|FG002|Overall Study|participants no longer with health plan|88|||
130609441|NCT02245568|470191117|FG000|Overall Study|Study terminated by Sponsor|346|||
130609442|NCT02245568|470191117|FG000|Overall Study|Adverse Event|144|||
130609443|NCT02245568|470191117|FG000|Overall Study|Lack of Efficacy|98|||
130609444|NCT02245568|470191117|FG000|Overall Study|Withdrawal by Caregiver|85|||
130609445|NCT02245568|470191117|FG000|Overall Study|Withdrawal by Subject|77|||
130609446|NCT02245568|470191117|FG000|Overall Study|Withdrawal by Legal Representative|31|||
130609447|NCT02245568|470191117|FG000|Overall Study|Missing (Site closure)|16|||
130609448|NCT02245568|470191117|FG000|Overall Study|Physician Decision|14|||
130609449|NCT02245568|470191117|FG000|Overall Study|Non-compliance with study drug|11|||
130609450|NCT02245568|470191117|FG000|Overall Study|Death|9|||
130609451|NCT02245568|470191117|FG000|Overall Study|Blue staining|6|||
130609452|NCT02245568|470191117|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
130609453|NCT02245568|470191117|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
130609454|NCT02245568|470191117|FG000|Overall Study|Lost to Follow-up|5|||
130609455|NCT01725152|470191118|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
130609456|NCT01725152|470191119|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
130609457|NCT01725152|470191118|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
130609458|NCT01725152|470191119|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
130609459|NCT01725152|470191118|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
130609460|NCT01725152|470191119|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
130609461|NCT01725152|470191118|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
130609462|NCT01725152|470191119|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
130609463|NCT02044159|470191120|FG000|Overall Study|Consent declined (deferred consent)|2|||
130609464|NCT02044159|470191121|FG001|Overall Study|Consent declined (deferred consent)|4|||
130609465|NCT02044159|470191120|FG000|Overall Study|No longer eligible, drug not given|1|||
130609466|NCT02044159|470191121|FG001|Overall Study|No longer eligible, drug not given|0|||
130609467|NCT02044159|470191120|FG000|Overall Study|Nurse declined to give study drug|1|||
130609468|NCT02044159|470191121|FG001|Overall Study|Nurse declined to give study drug|0|||
130609469|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
130609470|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130609471|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130609472|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130609473|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130609474|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
130609475|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130609476|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130609477|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130609478|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130609479|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
130609480|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130609481|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130609482|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130609483|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130609484|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
130609485|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130609486|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130609487|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130609488|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130609489|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
130609490|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130609491|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130609492|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130609493|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130609494|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
130609495|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130609496|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130609497|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130609498|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130609499|NCT01111539|470191122|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
130609500|NCT01111539|470191123|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130609501|NCT01111539|470191124|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130609502|NCT01111539|470191125|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130609503|NCT01111539|470191126|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130609504|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130609505|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130609506|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130609507|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130609508|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130609509|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130609510|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130609511|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
130609512|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130609513|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
130609514|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130609515|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
130609516|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
130609517|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130609518|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130609519|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130609520|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130609521|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130609522|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130609523|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
130609524|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130609525|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130609526|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130609527|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
130609528|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130609529|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130609530|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130609531|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130609532|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
130609533|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130609534|NCT01111539|470191122|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130609535|NCT01111539|470191123|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130609536|NCT01111539|470191124|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130609537|NCT01111539|470191125|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130609538|NCT01111539|470191126|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
130609539|NCT02808312|470191127|FG000|Overall Study|Enrolled but Never Treated|0|||
130609540|NCT02808312|470191128|FG001|Overall Study|Enrolled but Never Treated|0|||
130609541|NCT02808312|470191129|FG002|Overall Study|Enrolled but Never Treated|1|||
130609542|NCT02808312|470191130|FG003|Overall Study|Enrolled but Never Treated|0|||
130609543|NCT02808312|470191131|FG004|Overall Study|Enrolled but Never Treated|0|||
130609544|NCT03100942|470191132|FG000|Randomized Treatment Period|Withdrew Consent|4|||
130609545|NCT03100942|470191133|FG001|Randomized Treatment Period|Withdrew Consent|5|||
130609546|NCT03100942|470191134|FG002|Randomized Treatment Period|Withdrew Consent|3|||
130609547|NCT03100942|470191135|FG003|Randomized Treatment Period|Withdrew Consent|3|||
130609548|NCT03100942|470191136|FG004|Randomized Treatment Period|Withdrew Consent|0|||
130609549|NCT03100942|470191137|FG005|Randomized Treatment Period|Withdrew Consent|0|||
130609550|NCT03100942|470191138|FG006|Randomized Treatment Period|Withdrew Consent|0|||
130609551|NCT03100942|470191132|FG000|Randomized Treatment Period|Adverse Event|5|||
130609552|NCT03100942|470191133|FG001|Randomized Treatment Period|Adverse Event|2|||
130609553|NCT03100942|470191134|FG002|Randomized Treatment Period|Adverse Event|1|||
130609554|NCT03100942|470191135|FG003|Randomized Treatment Period|Adverse Event|0|||
130609555|NCT03100942|470191136|FG004|Randomized Treatment Period|Adverse Event|0|||
130609556|NCT03100942|470191137|FG005|Randomized Treatment Period|Adverse Event|0|||
130609557|NCT03100942|470191138|FG006|Randomized Treatment Period|Adverse Event|0|||
130609558|NCT03100942|470191132|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
130609559|NCT03100942|470191133|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
130609560|NCT03100942|470191134|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
130609561|NCT03100942|470191135|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
130609562|NCT03100942|470191136|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
130609563|NCT03100942|470191137|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
130609564|NCT03100942|470191138|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
130609565|NCT03100942|470191132|FG000|Randomized Treatment Period|Protocol Violation|0|||
130609566|NCT03100942|470191133|FG001|Randomized Treatment Period|Protocol Violation|1|||
130609567|NCT03100942|470191134|FG002|Randomized Treatment Period|Protocol Violation|1|||
130609568|NCT03100942|470191135|FG003|Randomized Treatment Period|Protocol Violation|1|||
130609569|NCT03100942|470191136|FG004|Randomized Treatment Period|Protocol Violation|0|||
130609570|NCT03100942|470191137|FG005|Randomized Treatment Period|Protocol Violation|0|||
130609571|NCT03100942|470191138|FG006|Randomized Treatment Period|Protocol Violation|0|||
130609572|NCT03100942|470191132|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
130609573|NCT03100942|470191133|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
130609574|NCT03100942|470191134|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
130609575|NCT03100942|470191135|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
130609576|NCT03100942|470191136|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
130609577|NCT03100942|470191137|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
130609578|NCT03100942|470191138|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
130609579|NCT03100942|470191132|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
130609580|NCT03100942|470191133|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130609581|NCT03100942|470191134|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130609582|NCT03100942|470191135|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
130609583|NCT03100942|470191136|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130609584|NCT03100942|470191137|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130609585|NCT03100942|470191138|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130609586|NCT03100942|470191132|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609587|NCT03100942|470191133|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609588|NCT03100942|470191134|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609589|NCT03100942|470191135|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609590|NCT03100942|470191136|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609591|NCT03100942|470191137|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130609592|NCT03100942|470191138|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
130609593|NCT00372190|470191139|FG000|Overall Study|Lost to Follow-up|3|||
130609594|NCT00372190|470191140|FG001|Overall Study|Lost to Follow-up|1|||
130609595|NCT01429792|470191141|FG000|Overall Study|Other Reasons|67|||
130609596|NCT01429792|470191141|FG000|Overall Study|Unknown Disposition|94|||
130609597|NCT01429792|470191141|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
130609598|NCT01429792|470191141|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
130609599|NCT01429792|470191141|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
130609600|NCT01429792|470191141|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
130609601|NCT01429792|470191141|FG000|Overall Study|Withdrawal by Subject|70|||
130609602|NCT01429792|470191141|FG000|Overall Study|Lost to Follow-up|88|||
130609603|NCT04184622|470191143|FG000|Primary Treatment Period|Adverse Event|6|||
130609604|NCT04184622|470191144|FG001|Primary Treatment Period|Adverse Event|4|||
130609605|NCT04184622|470191145|FG002|Primary Treatment Period|Adverse Event|8|||
130609606|NCT04184622|470191146|FG003|Primary Treatment Period|Adverse Event|6|||
130609607|NCT04184622|470191143|FG000|Primary Treatment Period|Death|4|||
130609608|NCT04184622|470191144|FG001|Primary Treatment Period|Death|4|||
130609609|NCT04184622|470191145|FG002|Primary Treatment Period|Death|2|||
130609610|NCT04184622|470191146|FG003|Primary Treatment Period|Death|1|||
130609611|NCT04184622|470191143|FG000|Primary Treatment Period|Lost to Follow-up|41|||
130609612|NCT04184622|470191144|FG001|Primary Treatment Period|Lost to Follow-up|17|||
130609613|NCT04184622|470191145|FG002|Primary Treatment Period|Lost to Follow-up|15|||
130609614|NCT04184622|470191146|FG003|Primary Treatment Period|Lost to Follow-up|13|||
130609615|NCT04184622|470191143|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
130609616|NCT04184622|470191144|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
130609617|NCT04184622|470191145|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
130609618|NCT04184622|470191146|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
130609619|NCT04184622|470191143|FG000|Primary Treatment Period|Physician Decision|0|||
130609620|NCT04184622|470191144|FG001|Primary Treatment Period|Physician Decision|0|||
130609621|NCT04184622|470191145|FG002|Primary Treatment Period|Physician Decision|3|||
130609622|NCT04184622|470191146|FG003|Primary Treatment Period|Physician Decision|1|||
130609623|NCT04184622|470191143|FG000|Primary Treatment Period|Pregnancy|4|||
130609624|NCT04184622|470191144|FG001|Primary Treatment Period|Pregnancy|3|||
130609625|NCT04184622|470191145|FG002|Primary Treatment Period|Pregnancy|4|||
130609626|NCT04184622|470191146|FG003|Primary Treatment Period|Pregnancy|1|||
130609627|NCT04184622|470191143|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
130609628|NCT04184622|470191144|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
130609629|NCT04184622|470191145|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
130609630|NCT04184622|470191146|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
130609631|NCT04184622|470191143|FG000|Additional Treatment Period|Adverse Event|1|||
130609632|NCT04184622|470191144|FG001|Additional Treatment Period|Adverse Event|2|||
130609633|NCT04184622|470191145|FG002|Additional Treatment Period|Adverse Event|1|||
130609634|NCT04184622|470191146|FG003|Additional Treatment Period|Adverse Event|0|||
130609635|NCT04184622|470191143|FG000|Additional Treatment Period|Death|0|||
130609636|NCT04184622|470191144|FG001|Additional Treatment Period|Death|0|||
130609637|NCT04184622|470191145|FG002|Additional Treatment Period|Death|1|||
130609638|NCT04184622|470191146|FG003|Additional Treatment Period|Death|1|||
130609639|NCT04184622|470191143|FG000|Additional Treatment Period|Lost to Follow-up|6|||
130609640|NCT04184622|470191144|FG001|Additional Treatment Period|Lost to Follow-up|4|||
130609641|NCT04184622|470191145|FG002|Additional Treatment Period|Lost to Follow-up|8|||
130609642|NCT04184622|470191146|FG003|Additional Treatment Period|Lost to Follow-up|6|||
130609643|NCT04184622|470191143|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
130609644|NCT04184622|470191144|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
130609645|NCT04184622|470191145|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
130609646|NCT04184622|470191146|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
130609647|NCT04184622|470191143|FG000|Additional Treatment Period|Physician Decision|0|||
130609648|NCT04184622|470191144|FG001|Additional Treatment Period|Physician Decision|0|||
130609649|NCT04184622|470191145|FG002|Additional Treatment Period|Physician Decision|1|||
130609650|NCT04184622|470191146|FG003|Additional Treatment Period|Physician Decision|0|||
130609651|NCT04184622|470191143|FG000|Additional Treatment Period|Pregnancy|0|||
130609652|NCT04184622|470191144|FG001|Additional Treatment Period|Pregnancy|0|||
130609653|NCT04184622|470191145|FG002|Additional Treatment Period|Pregnancy|0|||
130609654|NCT04184622|470191146|FG003|Additional Treatment Period|Pregnancy|1|||
130609655|NCT04184622|470191143|FG000|Additional Treatment Period|Protocol deviation|0|||
130609656|NCT04184622|470191144|FG001|Additional Treatment Period|Protocol deviation|0|||
130609657|NCT04184622|470191145|FG002|Additional Treatment Period|Protocol deviation|1|||
130609658|NCT04184622|470191146|FG003|Additional Treatment Period|Protocol deviation|0|||
130609659|NCT04184622|470191143|FG000|Additional Treatment Period|Site closed|1|||
130609660|NCT04184622|470191144|FG001|Additional Treatment Period|Site closed|0|||
130609661|NCT04184622|470191145|FG002|Additional Treatment Period|Site closed|1|||
130609662|NCT04184622|470191146|FG003|Additional Treatment Period|Site closed|0|||
130609663|NCT04184622|470191143|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
130609664|NCT04184622|470191144|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
130609665|NCT04184622|470191145|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
130609666|NCT04184622|470191146|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
130609667|NCT04184622|470191143|FG000|Safety Follow-up Period|Adverse Event|6|||
130609668|NCT04184622|470191144|FG001|Safety Follow-up Period|Adverse Event|8|||
130609669|NCT04184622|470191145|FG002|Safety Follow-up Period|Adverse Event|9|||
130609670|NCT04184622|470191146|FG003|Safety Follow-up Period|Adverse Event|16|||
130609671|NCT04184622|470191143|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
130609672|NCT04184622|470191144|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
130609673|NCT04184622|470191145|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
130609674|NCT04184622|470191146|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
130609675|NCT04184622|470191143|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
130609676|NCT04184622|470191144|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
130609677|NCT04184622|470191145|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
130609678|NCT04184622|470191146|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
130609679|NCT04184622|470191143|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
130609680|NCT04184622|470191144|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
130609681|NCT04184622|470191145|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
130609682|NCT04184622|470191146|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
130609683|NCT04184622|470191143|FG000|Safety Follow-up Period|Physician Decision|1|||
130609684|NCT04184622|470191144|FG001|Safety Follow-up Period|Physician Decision|0|||
130609685|NCT04184622|470191145|FG002|Safety Follow-up Period|Physician Decision|0|||
130609686|NCT04184622|470191146|FG003|Safety Follow-up Period|Physician Decision|1|||
130609687|NCT04184622|470191143|FG000|Safety Follow-up Period|Pregnancy|1|||
130609688|NCT04184622|470191144|FG001|Safety Follow-up Period|Pregnancy|3|||
130609689|NCT04184622|470191145|FG002|Safety Follow-up Period|Pregnancy|0|||
130609690|NCT04184622|470191146|FG003|Safety Follow-up Period|Pregnancy|6|||
130609691|NCT04184622|470191143|FG000|Safety Follow-up Period|Protocol deviation|1|||
130609692|NCT04184622|470191144|FG001|Safety Follow-up Period|Protocol deviation|0|||
130609693|NCT04184622|470191145|FG002|Safety Follow-up Period|Protocol deviation|0|||
130609694|NCT04184622|470191146|FG003|Safety Follow-up Period|Protocol deviation|0|||
130609695|NCT04184622|470191143|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
130609696|NCT04184622|470191144|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
130609697|NCT04184622|470191145|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
130609698|NCT04184622|470191146|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
130609699|NCT04426825|470191147|FG000|Overall Study|Death|17|||
130609700|NCT04426825|470191147|FG000|Overall Study|Lost to Follow-up|1|||
130609701|NCT04426825|470191147|FG000|Overall Study|Study terminated by sponsor|5|||
130609702|NCT01763905|470191150|FG000|Overall Study|Withdrawal by Subject|1|||
130609703|NCT01763905|470191151|FG001|Overall Study|Withdrawal by Subject|1|||
130609704|NCT01763905|470191152|FG002|Overall Study|Withdrawal by Subject|0|||
130609705|NCT01763905|470191153|FG003|Overall Study|Withdrawal by Subject|1|||
130609706|NCT01763905|470191150|FG000|Overall Study|Decision by sponsor|5|||
130609707|NCT01763905|470191151|FG001|Overall Study|Decision by sponsor|0|||
130609708|NCT01763905|470191152|FG002|Overall Study|Decision by sponsor|8|||
130609709|NCT01763905|470191153|FG003|Overall Study|Decision by sponsor|0|||
130609710|NCT01763905|470191150|FG000|Overall Study|Lost to Follow-up|0|||
130609711|NCT01763905|470191151|FG001|Overall Study|Lost to Follow-up|0|||
130609712|NCT01763905|470191152|FG002|Overall Study|Lost to Follow-up|1|||
130609713|NCT01763905|470191153|FG003|Overall Study|Lost to Follow-up|0|||
130609714|NCT03456713|470191155|FG000|Overall Study|Lost to Follow-up|1|||
130609715|NCT03456713|470191156|FG001|Overall Study|Lost to Follow-up|0|||
130609716|NCT03456713|470191157|FG002|Overall Study|Lost to Follow-up|0|||
130609717|NCT03456713|470191158|FG003|Overall Study|Lost to Follow-up|0|||
130609718|NCT01263691|470191162|FG000|Overall Study|Lost to Follow-up|1|||
130609719|NCT01263691|470191163|FG001|Overall Study|Lost to Follow-up|0|||
130609720|NCT01263691|470191164|FG002|Overall Study|Lost to Follow-up|1|||
130609721|NCT01263691|470191165|FG003|Overall Study|Lost to Follow-up|1|||
130609722|NCT01263691|470191166|FG004|Overall Study|Lost to Follow-up|0|||
130609723|NCT01263691|470191167|FG005|Overall Study|Lost to Follow-up|0|||
130609724|NCT01263691|470191162|FG000|Overall Study|Withdrawal by Subject|1|||
130609725|NCT01263691|470191163|FG001|Overall Study|Withdrawal by Subject|0|||
130609726|NCT01263691|470191164|FG002|Overall Study|Withdrawal by Subject|0|||
130609727|NCT01263691|470191165|FG003|Overall Study|Withdrawal by Subject|0|||
130609728|NCT01263691|470191166|FG004|Overall Study|Withdrawal by Subject|0|||
130609729|NCT01263691|470191167|FG005|Overall Study|Withdrawal by Subject|0|||
130609730|NCT01263691|470191162|FG000|Overall Study|Adverse Event|1|||
130609731|NCT01263691|470191163|FG001|Overall Study|Adverse Event|0|||
130609732|NCT01263691|470191164|FG002|Overall Study|Adverse Event|0|||
130609733|NCT01263691|470191165|FG003|Overall Study|Adverse Event|0|||
130609734|NCT01263691|470191166|FG004|Overall Study|Adverse Event|0|||
130609735|NCT01263691|470191167|FG005|Overall Study|Adverse Event|0|||
130609736|NCT01028651|470191168|FG000|Overall Study|Death|2|||
130609737|NCT01028651|470191168|FG000|Overall Study|Adverse Event|1|||
130609738|NCT01554956|470191169|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
130609739|NCT01554956|470191170|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
130609740|NCT01554956|470191171|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
130609741|NCT01554956|470191169|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
130609742|NCT01554956|470191170|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
130609743|NCT01554956|470191171|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
130609744|NCT01554956|470191169|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
130609745|NCT01554956|470191170|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
130609746|NCT01554956|470191171|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
130609747|NCT00913978|470191173|FG000|Overall Study|Surgeon choice|1|||
130609748|NCT00913978|470191174|FG001|Overall Study|Surgeon choice|3|||
130609749|NCT01327651|470191178|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
130609750|NCT01327651|470191179|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
130609751|NCT01327651|470191180|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
130609752|NCT01327651|470191181|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
130609753|NCT01327651|470191182|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
130609754|NCT01327651|470191183|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
130609755|NCT01327651|470191184|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
130609756|NCT01327651|470191185|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
130609757|NCT01327651|470191186|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
130609758|NCT01327651|470191178|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
130609759|NCT01327651|470191179|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609760|NCT01327651|470191180|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609761|NCT01327651|470191181|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609762|NCT01327651|470191182|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609763|NCT01327651|470191183|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609764|NCT01327651|470191184|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609765|NCT01327651|470191185|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609766|NCT01327651|470191186|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130609767|NCT01327651|470191178|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
130609768|NCT01327651|470191179|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
130609769|NCT01327651|470191180|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
130609770|NCT01327651|470191181|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
130609771|NCT01327651|470191182|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
130609772|NCT01327651|470191183|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
130609773|NCT01327651|470191184|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
130609774|NCT01327651|470191185|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
130609775|NCT01327651|470191186|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
130609776|NCT01327651|470191178|FG000|Post Study Follow-up|Lost to Follow-up|0|||
130609777|NCT01327651|470191179|FG001|Post Study Follow-up|Lost to Follow-up|1|||
130609778|NCT01327651|470191180|FG002|Post Study Follow-up|Lost to Follow-up|1|||
130609779|NCT01327651|470191181|FG003|Post Study Follow-up|Lost to Follow-up|0|||
130609780|NCT01327651|470191182|FG004|Post Study Follow-up|Lost to Follow-up|0|||
130609781|NCT01327651|470191183|FG005|Post Study Follow-up|Lost to Follow-up|0|||
130609782|NCT01327651|470191184|FG006|Post Study Follow-up|Lost to Follow-up|4|||
130609783|NCT01327651|470191185|FG007|Post Study Follow-up|Lost to Follow-up|1|||
130609784|NCT01327651|470191186|FG008|Post Study Follow-up|Lost to Follow-up|2|||
130609785|NCT03249792|470191191|FG000|Arms 1, 2, and 4|Death|1|||
130609786|NCT03249792|470191192|FG001|Arms 1, 2, and 4|Death|1|||
130609787|NCT03249792|470191193|FG002|Arms 1, 2, and 4|Death|0|||
130609788|NCT03249792|470191194|FG003|Arms 1, 2, and 4|Death|2|||
130609789|NCT03249792|470191195|FG004|Arms 1, 2, and 4|Death|3|||
130609790|NCT03249792|470191196|FG005|Arms 1, 2, and 4|Death|2|||
130609791|NCT03249792|470191197|FG006|Arms 1, 2, and 4|Death|2|||
130609792|NCT03249792|470191198|FG007|Arms 1, 2, and 4|Death|4|||
130609793|NCT03249792|470191199|FG008|Arms 1, 2, and 4|Death|2|||
130609794|NCT03249792|470191200|FG009|Arms 1, 2, and 4|Death|1|||
130609795|NCT03249792|470191201|FG010|Arms 1, 2, and 4|Death|7|||
130609796|NCT03249792|470191202|FG011|Arms 1, 2, and 4|Death|7|||
130609797|NCT03249792|470191203|FG012|Arms 1, 2, and 4|Death|12|||
130609798|NCT03249792|470191204|FG013|Arms 1, 2, and 4|Death|7|||
130609799|NCT03249792|470191205|FG014|Arms 1, 2, and 4|Death|0|||
130609800|NCT03249792|470191206|FG015|Arms 1, 2, and 4|Death|4|||
130609801|NCT03249792|470191207|FG016|Arms 1, 2, and 4|Death|4|||
130609802|NCT03249792|470191208|FG017|Arms 1, 2, and 4|Death|12|||
130609803|NCT03249792|470191209|FG018|Arms 1, 2, and 4|Death|6|||
130609804|NCT03249792|470191210|FG019|Arms 1, 2, and 4|Death|4|||
130609805|NCT03249792|470191211|FG020|Arms 1, 2, and 4|Death|2|||
130609806|NCT03249792|470191212|FG021|Arms 1, 2, and 4|Death|3|||
130609807|NCT03249792|470191213|FG022|Arms 1, 2, and 4|Death|1|||
130609808|NCT03249792|470191214|FG023|Arms 1, 2, and 4|Death|1|||
130609809|NCT03249792|470191215|FG024|Arms 1, 2, and 4|Death|4|||
130609810|NCT03249792|470191216|FG025|Arms 1, 2, and 4|Death|0|||
130609811|NCT03249792|470191217|FG026|Arms 1, 2, and 4|Death|0|||
130609812|NCT03249792|470191218|FG027|Arms 1, 2, and 4|Death|0|||
130609813|NCT03249792|470191219|FG028|Arms 1, 2, and 4|Death|0|||
130609814|NCT03249792|470191220|FG029|Arms 1, 2, and 4|Death|0|||
130609815|NCT03249792|470191221|FG030|Arms 1, 2, and 4|Death|0|||
130609816|NCT03249792|470191222|FG031|Arms 1, 2, and 4|Death|0|||
130609817|NCT03249792|470191223|FG032|Arms 1, 2, and 4|Death|0|||
130609818|NCT03249792|470191191|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609819|NCT03249792|470191192|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609820|NCT03249792|470191193|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609821|NCT03249792|470191194|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609822|NCT03249792|470191195|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609823|NCT03249792|470191196|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609824|NCT03249792|470191197|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
130609825|NCT03249792|470191198|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609826|NCT03249792|470191199|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
130609827|NCT03249792|470191200|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609828|NCT03249792|470191201|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
130609829|NCT03249792|470191202|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
130609830|NCT03249792|470191203|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
130609831|NCT03249792|470191204|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
130609832|NCT03249792|470191205|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609833|NCT03249792|470191206|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609834|NCT03249792|470191207|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
130609835|NCT03249792|470191208|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609836|NCT03249792|470191209|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609837|NCT03249792|470191210|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609838|NCT03249792|470191211|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609839|NCT03249792|470191212|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609840|NCT03249792|470191213|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609841|NCT03249792|470191214|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130609842|NCT03249792|470191215|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609843|NCT03249792|470191216|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609844|NCT03249792|470191217|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609845|NCT03249792|470191218|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609846|NCT03249792|470191219|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609847|NCT03249792|470191220|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609848|NCT03249792|470191221|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609849|NCT03249792|470191222|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609850|NCT03249792|470191223|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130609851|NCT03249792|470191191|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
130609852|NCT03249792|470191192|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
130609853|NCT03249792|470191193|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
130609854|NCT03249792|470191194|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
130609855|NCT03249792|470191195|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
130609856|NCT03249792|470191196|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
130609857|NCT03249792|470191197|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
130609858|NCT03249792|470191198|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
130609859|NCT03249792|470191199|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
130609860|NCT03249792|470191200|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
130609861|NCT03249792|470191201|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
130609862|NCT03249792|470191202|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
130609863|NCT03249792|470191203|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
130609864|NCT03249792|470191204|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
130609865|NCT03249792|470191205|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
130609866|NCT03249792|470191206|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
130609867|NCT03249792|470191207|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
130609868|NCT03249792|470191208|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
130609869|NCT03249792|470191209|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
130609870|NCT03249792|470191210|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
130609871|NCT03249792|470191211|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
130609872|NCT03249792|470191212|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
130609873|NCT03249792|470191213|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
130609874|NCT03249792|470191214|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
130609875|NCT03249792|470191215|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
130609876|NCT03249792|470191216|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
130609877|NCT03249792|470191217|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
130609878|NCT03249792|470191218|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
130609879|NCT03249792|470191219|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
130609880|NCT03249792|470191220|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
130609881|NCT03249792|470191221|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
130609882|NCT03249792|470191222|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
130609883|NCT03249792|470191223|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
130609884|NCT03249792|470191191|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609885|NCT03249792|470191192|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609886|NCT03249792|470191193|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609887|NCT03249792|470191194|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609888|NCT03249792|470191195|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609889|NCT03249792|470191196|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609890|NCT03249792|470191197|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609891|NCT03249792|470191198|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609892|NCT03249792|470191199|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
130609893|NCT03249792|470191200|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609894|NCT03249792|470191201|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609895|NCT03249792|470191202|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609896|NCT03249792|470191203|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609897|NCT03249792|470191204|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609898|NCT03249792|470191205|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609899|NCT03249792|470191206|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609900|NCT03249792|470191207|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
130609901|NCT03249792|470191208|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
130609902|NCT03249792|470191209|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609903|NCT03249792|470191210|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
130609904|NCT03249792|470191211|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609905|NCT03249792|470191212|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609906|NCT03249792|470191213|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609907|NCT03249792|470191214|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609908|NCT03249792|470191215|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609909|NCT03249792|470191216|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609910|NCT03249792|470191217|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609911|NCT03249792|470191218|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609912|NCT03249792|470191219|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609913|NCT03249792|470191220|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609914|NCT03249792|470191221|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609915|NCT03249792|470191222|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609916|NCT03249792|470191223|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
130609917|NCT03249792|470191191|FG000|Switch Over Period|Withdrawal by Subject|0|||
130609918|NCT03249792|470191192|FG001|Switch Over Period|Withdrawal by Subject|0|||
130609919|NCT03249792|470191193|FG002|Switch Over Period|Withdrawal by Subject|0|||
130609920|NCT03249792|470191194|FG003|Switch Over Period|Withdrawal by Subject|0|||
130609921|NCT03249792|470191195|FG004|Switch Over Period|Withdrawal by Subject|0|||
130609922|NCT03249792|470191196|FG005|Switch Over Period|Withdrawal by Subject|0|||
130609923|NCT03249792|470191197|FG006|Switch Over Period|Withdrawal by Subject|0|||
130609924|NCT03249792|470191198|FG007|Switch Over Period|Withdrawal by Subject|0|||
130609925|NCT03249792|470191199|FG008|Switch Over Period|Withdrawal by Subject|0|||
130609926|NCT03249792|470191200|FG009|Switch Over Period|Withdrawal by Subject|0|||
130609927|NCT03249792|470191201|FG010|Switch Over Period|Withdrawal by Subject|0|||
130609928|NCT03249792|470191202|FG011|Switch Over Period|Withdrawal by Subject|0|||
130609929|NCT03249792|470191203|FG012|Switch Over Period|Withdrawal by Subject|0|||
130609930|NCT03249792|470191204|FG013|Switch Over Period|Withdrawal by Subject|0|||
130609931|NCT03249792|470191205|FG014|Switch Over Period|Withdrawal by Subject|0|||
130609932|NCT03249792|470191206|FG015|Switch Over Period|Withdrawal by Subject|0|||
130609933|NCT03249792|470191207|FG016|Switch Over Period|Withdrawal by Subject|0|||
130609934|NCT03249792|470191208|FG017|Switch Over Period|Withdrawal by Subject|0|||
130609935|NCT03249792|470191209|FG018|Switch Over Period|Withdrawal by Subject|0|||
130609936|NCT03249792|470191210|FG019|Switch Over Period|Withdrawal by Subject|0|||
130609937|NCT03249792|470191211|FG020|Switch Over Period|Withdrawal by Subject|0|||
130609938|NCT03249792|470191212|FG021|Switch Over Period|Withdrawal by Subject|0|||
130609939|NCT03249792|470191213|FG022|Switch Over Period|Withdrawal by Subject|0|||
130609940|NCT03249792|470191214|FG023|Switch Over Period|Withdrawal by Subject|0|||
130609941|NCT03249792|470191215|FG024|Switch Over Period|Withdrawal by Subject|0|||
130609942|NCT03249792|470191216|FG025|Switch Over Period|Withdrawal by Subject|0|||
130609943|NCT03249792|470191217|FG026|Switch Over Period|Withdrawal by Subject|0|||
130609944|NCT03249792|470191218|FG027|Switch Over Period|Withdrawal by Subject|0|||
130609945|NCT03249792|470191219|FG028|Switch Over Period|Withdrawal by Subject|0|||
130609946|NCT03249792|470191220|FG029|Switch Over Period|Withdrawal by Subject|0|||
130609947|NCT03249792|470191221|FG030|Switch Over Period|Withdrawal by Subject|0|||
130609948|NCT03249792|470191222|FG031|Switch Over Period|Withdrawal by Subject|1|||
130609949|NCT03249792|470191223|FG032|Switch Over Period|Withdrawal by Subject|0|||
130609950|NCT03249792|470191191|FG000|Switch Over Period|Progressive Disease|0|||
130609951|NCT03249792|470191192|FG001|Switch Over Period|Progressive Disease|0|||
130609952|NCT03249792|470191193|FG002|Switch Over Period|Progressive Disease|0|||
130609953|NCT03249792|470191194|FG003|Switch Over Period|Progressive Disease|0|||
130609954|NCT03249792|470191195|FG004|Switch Over Period|Progressive Disease|0|||
130609955|NCT03249792|470191196|FG005|Switch Over Period|Progressive Disease|0|||
130609956|NCT03249792|470191197|FG006|Switch Over Period|Progressive Disease|0|||
130609957|NCT03249792|470191198|FG007|Switch Over Period|Progressive Disease|0|||
130609958|NCT03249792|470191199|FG008|Switch Over Period|Progressive Disease|0|||
130609959|NCT03249792|470191200|FG009|Switch Over Period|Progressive Disease|0|||
130609960|NCT03249792|470191201|FG010|Switch Over Period|Progressive Disease|0|||
130609961|NCT03249792|470191202|FG011|Switch Over Period|Progressive Disease|0|||
130609962|NCT03249792|470191203|FG012|Switch Over Period|Progressive Disease|0|||
130609963|NCT03249792|470191204|FG013|Switch Over Period|Progressive Disease|0|||
130609964|NCT03249792|470191205|FG014|Switch Over Period|Progressive Disease|0|||
130609965|NCT03249792|470191206|FG015|Switch Over Period|Progressive Disease|0|||
130609966|NCT03249792|470191207|FG016|Switch Over Period|Progressive Disease|0|||
130609967|NCT03249792|470191208|FG017|Switch Over Period|Progressive Disease|0|||
130609968|NCT03249792|470191209|FG018|Switch Over Period|Progressive Disease|0|||
130609969|NCT03249792|470191210|FG019|Switch Over Period|Progressive Disease|0|||
130609970|NCT03249792|470191211|FG020|Switch Over Period|Progressive Disease|0|||
130609971|NCT03249792|470191212|FG021|Switch Over Period|Progressive Disease|0|||
130609972|NCT03249792|470191213|FG022|Switch Over Period|Progressive Disease|0|||
130609973|NCT03249792|470191214|FG023|Switch Over Period|Progressive Disease|0|||
130609974|NCT03249792|470191215|FG024|Switch Over Period|Progressive Disease|0|||
130609975|NCT03249792|470191216|FG025|Switch Over Period|Progressive Disease|0|||
130609976|NCT03249792|470191217|FG026|Switch Over Period|Progressive Disease|1|||
130609977|NCT03249792|470191218|FG027|Switch Over Period|Progressive Disease|0|||
130609978|NCT03249792|470191219|FG028|Switch Over Period|Progressive Disease|1|||
130609979|NCT03249792|470191220|FG029|Switch Over Period|Progressive Disease|2|||
130609980|NCT03249792|470191221|FG030|Switch Over Period|Progressive Disease|1|||
130609981|NCT03249792|470191222|FG031|Switch Over Period|Progressive Disease|0|||
130609982|NCT03249792|470191223|FG032|Switch Over Period|Progressive Disease|1|||
130609983|NCT03249792|470191191|FG000|Switch Over Period|Adverse Event|0|||
130609984|NCT03249792|470191192|FG001|Switch Over Period|Adverse Event|0|||
130609985|NCT03249792|470191193|FG002|Switch Over Period|Adverse Event|0|||
130609986|NCT03249792|470191194|FG003|Switch Over Period|Adverse Event|0|||
130609987|NCT03249792|470191195|FG004|Switch Over Period|Adverse Event|0|||
130609988|NCT03249792|470191196|FG005|Switch Over Period|Adverse Event|0|||
130609989|NCT03249792|470191197|FG006|Switch Over Period|Adverse Event|0|||
130609990|NCT03249792|470191198|FG007|Switch Over Period|Adverse Event|0|||
130609991|NCT03249792|470191199|FG008|Switch Over Period|Adverse Event|0|||
130609992|NCT03249792|470191200|FG009|Switch Over Period|Adverse Event|0|||
130609993|NCT03249792|470191201|FG010|Switch Over Period|Adverse Event|0|||
130609994|NCT03249792|470191202|FG011|Switch Over Period|Adverse Event|0|||
130609995|NCT03249792|470191203|FG012|Switch Over Period|Adverse Event|0|||
130609996|NCT03249792|470191204|FG013|Switch Over Period|Adverse Event|0|||
130609997|NCT03249792|470191205|FG014|Switch Over Period|Adverse Event|0|||
130609998|NCT03249792|470191206|FG015|Switch Over Period|Adverse Event|0|||
130609999|NCT03249792|470191207|FG016|Switch Over Period|Adverse Event|0|||
130610000|NCT03249792|470191208|FG017|Switch Over Period|Adverse Event|0|||
130610001|NCT03249792|470191209|FG018|Switch Over Period|Adverse Event|0|||
130610002|NCT03249792|470191210|FG019|Switch Over Period|Adverse Event|0|||
130610003|NCT03249792|470191211|FG020|Switch Over Period|Adverse Event|0|||
130610004|NCT03249792|470191212|FG021|Switch Over Period|Adverse Event|0|||
130610005|NCT03249792|470191213|FG022|Switch Over Period|Adverse Event|0|||
130610006|NCT03249792|470191214|FG023|Switch Over Period|Adverse Event|0|||
130610007|NCT03249792|470191215|FG024|Switch Over Period|Adverse Event|0|||
130610008|NCT03249792|470191216|FG025|Switch Over Period|Adverse Event|1|||
130610009|NCT03249792|470191217|FG026|Switch Over Period|Adverse Event|0|||
130610010|NCT03249792|470191218|FG027|Switch Over Period|Adverse Event|1|||
130610011|NCT03249792|470191219|FG028|Switch Over Period|Adverse Event|0|||
130610012|NCT03249792|470191220|FG029|Switch Over Period|Adverse Event|0|||
130610013|NCT03249792|470191221|FG030|Switch Over Period|Adverse Event|0|||
130610014|NCT03249792|470191222|FG031|Switch Over Period|Adverse Event|0|||
130610015|NCT03249792|470191223|FG032|Switch Over Period|Adverse Event|0|||
130610016|NCT01201798|470191230|FG000|Overall Study|Adverse Event|2|||
130610017|NCT01201798|470191231|FG001|Overall Study|Adverse Event|0|||
130610018|NCT01201798|470191230|FG000|Overall Study|Lost to Follow-up|3|||
130610019|NCT01201798|470191231|FG001|Overall Study|Lost to Follow-up|5|||
130610020|NCT01201798|470191230|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
130610021|NCT01201798|470191231|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
130610022|NCT01201798|470191230|FG000|Overall Study|Noncompliance|1|||
130610023|NCT01201798|470191231|FG001|Overall Study|Noncompliance|0|||
130610024|NCT01201798|470191230|FG000|Overall Study|Protocol Violation|1|||
130610025|NCT01201798|470191231|FG001|Overall Study|Protocol Violation|1|||
130610026|NCT01201798|470191230|FG000|Overall Study|Treatment Failure|1|||
130610027|NCT01201798|470191231|FG001|Overall Study|Treatment Failure|8|||
130610028|NCT00525148|470191237|FG000|Overall Study|Other Adverse Event|3|||
130610029|NCT00525148|470191238|FG001|Overall Study|Other Adverse Event|5|||
130610030|NCT00525148|470191239|FG002|Overall Study|Other Adverse Event|1|||
130610031|NCT00525148|470191240|FG003|Overall Study|Other Adverse Event|8|||
130610032|NCT00525148|470191237|FG000|Overall Study|Progressive disease|18|||
130610033|NCT00525148|470191238|FG001|Overall Study|Progressive disease|30|||
130610034|NCT00525148|470191239|FG002|Overall Study|Progressive disease|6|||
130610035|NCT00525148|470191240|FG003|Overall Study|Progressive disease|49|||
130610036|NCT00525148|470191237|FG000|Overall Study|Refused continuation of study medication|0|||
130610037|NCT00525148|470191238|FG001|Overall Study|Refused continuation of study medication|2|||
130610038|NCT00525148|470191239|FG002|Overall Study|Refused continuation of study medication|0|||
130610039|NCT00525148|470191240|FG003|Overall Study|Refused continuation of study medication|1|||
130610040|NCT00525148|470191237|FG000|Overall Study|Other than stated|2|||
130610041|NCT00525148|470191238|FG001|Overall Study|Other than stated|1|||
130610042|NCT00525148|470191239|FG002|Overall Study|Other than stated|0|||
130610043|NCT00525148|470191240|FG003|Overall Study|Other than stated|3|||
130610044|NCT00114972|470191243|FG000|Overall Study|Withdrawal by Subject|40|||
130610045|NCT00114972|470191244|FG001|Overall Study|Withdrawal by Subject|7|||
130610046|NCT00114972|470191243|FG000|Overall Study|Lost to Follow-up|8|||
130610047|NCT00114972|470191244|FG001|Overall Study|Lost to Follow-up|5|||
130610048|NCT00830037|470191245|FG000|Overall Study|Withdrawal by Subject|2|||
130610049|NCT00830037|470191246|FG001|Overall Study|Withdrawal by Subject|3|||
130610050|NCT00830037|470191245|FG000|Overall Study|Lost to Follow-up|1|||
130610051|NCT00830037|470191246|FG001|Overall Study|Lost to Follow-up|2|||
130610052|NCT00830037|470191245|FG000|Overall Study|Active when terminated by DSMB|15|||
130610053|NCT00830037|470191246|FG001|Overall Study|Active when terminated by DSMB|14|||
130610054|NCT01425190|470191247|FG000|Overall Study|Full dose not consumed.|1|||
130610055|NCT01425190|470191248|FG001|Overall Study|Full dose not consumed.|0|||
130610056|NCT01425190|470191249|FG002|Overall Study|Full dose not consumed.|0|||
130610057|NCT01555463|470191251|FG000|Treatment|Adverse Event|6|||
130610058|NCT01555463|470191252|FG001|Treatment|Adverse Event|12|||
130610059|NCT01555463|470191251|FG000|Treatment|Withdrawal by Subject|24|||
130610060|NCT01555463|470191252|FG001|Treatment|Withdrawal by Subject|36|||
130610061|NCT01555463|470191251|FG000|Treatment|Lost to Follow-up|28|||
130610062|NCT01555463|470191252|FG001|Treatment|Lost to Follow-up|23|||
130610063|NCT01555463|470191251|FG000|Treatment|Protocol Violation|4|||
130610064|NCT01555463|470191252|FG001|Treatment|Protocol Violation|5|||
130610065|NCT01555463|470191251|FG000|Treatment|Other reason|2|||
130610066|NCT01555463|470191252|FG001|Treatment|Other reason|3|||
130610067|NCT01555463|470191251|FG000|Follow up|Adverse Event|2|||
130610068|NCT01555463|470191252|FG001|Follow up|Adverse Event|5|||
130610069|NCT01555463|470191251|FG000|Follow up|Death|0|||
130610070|NCT01555463|470191252|FG001|Follow up|Death|1|||
130610071|NCT01555463|470191251|FG000|Follow up|Withdrawal by Subject|22|||
130610072|NCT01555463|470191252|FG001|Follow up|Withdrawal by Subject|22|||
130610073|NCT01555463|470191251|FG000|Follow up|Lost to Follow-up|9|||
130610074|NCT01555463|470191252|FG001|Follow up|Lost to Follow-up|10|||
130610075|NCT01555463|470191251|FG000|Follow up|Protocol Violation|2|||
130610076|NCT01555463|470191252|FG001|Follow up|Protocol Violation|4|||
130610077|NCT01555463|470191251|FG000|Follow up|Other reason|3|||
130610078|NCT01555463|470191252|FG001|Follow up|Other reason|3|||
130610079|NCT02026271|470191253|FG000|Overall Study|Adverse Event|2|||
130610080|NCT02026271|470191254|FG001|Overall Study|Adverse Event|3|||
130610081|NCT02026271|470191255|FG002|Overall Study|Adverse Event|2|||
130610082|NCT02026271|470191256|FG003|Overall Study|Adverse Event|3|||
130610083|NCT02026271|470191257|FG004|Overall Study|Adverse Event|0|||
130610084|NCT02026271|470191253|FG000|Overall Study|Withdrawal by Subject|0|||
130610085|NCT02026271|470191254|FG001|Overall Study|Withdrawal by Subject|0|||
130610086|NCT02026271|470191255|FG002|Overall Study|Withdrawal by Subject|0|||
130610087|NCT02026271|470191256|FG003|Overall Study|Withdrawal by Subject|0|||
130610088|NCT02026271|470191257|FG004|Overall Study|Withdrawal by Subject|1|||
130610089|NCT04370028|470191258|FG000|Overall Study|Withdrawal by Subject|695|||
130610090|NCT04370028|470191258|FG000|Overall Study|Protocol Violation|9|||
130610091|NCT04370028|470191258|FG000|Overall Study|Adverse Event|3|||
130610092|NCT00540449|470191259|FG000|Overall Study|Adverse Event|12|||
130610093|NCT00540449|470191260|FG001|Overall Study|Adverse Event|32|||
130610094|NCT00540449|470191259|FG000|Overall Study|Sponsor's Decision|1|||
130610095|NCT00540449|470191260|FG001|Overall Study|Sponsor's Decision|1|||
130610096|NCT00540449|470191259|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
130610097|NCT00540449|470191260|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
130610098|NCT00540449|470191259|FG000|Overall Study|Lost to Follow-up|19|||
130610099|NCT00540449|470191260|FG001|Overall Study|Lost to Follow-up|17|||
130610100|NCT00540449|470191259|FG000|Overall Study|Subject Non-Compliant|7|||
130610101|NCT00540449|470191260|FG001|Overall Study|Subject Non-Compliant|5|||
130610102|NCT00540449|470191259|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
130610103|NCT00540449|470191260|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
130610104|NCT00540449|470191259|FG000|Overall Study|Withdrawal by Subject|10|||
130610105|NCT00540449|470191260|FG001|Overall Study|Withdrawal by Subject|10|||
130610106|NCT00540449|470191259|FG000|Overall Study|Other|1|||
130610107|NCT00540449|470191260|FG001|Overall Study|Other|4|||
130610108|NCT02149836|470191263|FG000|Overall Study|Withdrawal by Subject|1|||
130610109|NCT01204658|470191264|FG000|Primary Phase|Adverse Event|0|||
130610110|NCT01204658|470191265|FG001|Primary Phase|Adverse Event|0|||
130610111|NCT01204658|470191266|FG002|Primary Phase|Adverse Event|1|||
130610112|NCT01204658|470191267|FG003|Primary Phase|Adverse Event|0|||
130610113|NCT04038255|470192884|FG000|Overall Study|Lost to Follow-up|0|||
130610114|NCT04038255|470192885|FG001|Overall Study|Lost to Follow-up|9|||
130610115|NCT04038255|470192886|FG002|Overall Study|Lost to Follow-up|5|||
130610116|NCT04038255|470192884|FG000|Overall Study|Withdrawal by Subject|0|||
130610117|NCT04038255|470192885|FG001|Overall Study|Withdrawal by Subject|0|||
130610118|NCT04038255|470192886|FG002|Overall Study|Withdrawal by Subject|1|||
130610119|NCT05183867|470192889|FG000|Overall Study|Withdrawal by Subject|3|||
130610120|NCT05183867|470192890|FG001|Overall Study|Withdrawal by Subject|2|||
130610121|NCT05183867|470192891|FG002|Overall Study|Withdrawal by Subject|0|||
130610122|NCT01286272|470192892|FG000|Overall Study|Ineligible after beginning treatment|1|||
130610123|NCT01286272|470192893|FG001|Overall Study|Ineligible after beginning treatment|3|||
130610124|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
130610125|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
130610126|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
130610127|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
130610128|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
130610129|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
130610130|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
130610131|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130610132|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
130610133|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
130610134|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
130610135|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
130610136|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
130610137|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
130610138|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
130610139|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
130610140|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
130610141|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
130610142|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
130610143|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
130610144|NCT00423085|470192901|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
130610145|NCT00423085|470192902|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
130610146|NCT00423085|470192903|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
130610147|NCT00423085|470192904|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
130610148|NCT00423085|470192901|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
130610149|NCT00423085|470192902|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
130610150|NCT00423085|470192903|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
130610151|NCT00423085|470192904|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
130610152|NCT00423085|470192901|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
130610153|NCT00423085|470192902|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
130610154|NCT00423085|470192903|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
130610155|NCT00423085|470192904|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
130610156|NCT00423085|470192901|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
130610157|NCT00423085|470192902|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
130610158|NCT00423085|470192903|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
130610159|NCT00423085|470192904|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
130610160|NCT00423085|470192901|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130610161|NCT00423085|470192902|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130610162|NCT00423085|470192903|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130610163|NCT00423085|470192904|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
130610164|NCT00423085|470192901|FG000|52-Week Open-Label Extension Phase|Death|0|||
130610165|NCT00423085|470192902|FG001|52-Week Open-Label Extension Phase|Death|0|||
130610166|NCT00423085|470192903|FG002|52-Week Open-Label Extension Phase|Death|0|||
130610167|NCT00423085|470192904|FG003|52-Week Open-Label Extension Phase|Death|2|||
130610168|NCT00769704|470192905|FG000|Overall Study|Lost to Follow-up|3|||
130610169|NCT00769704|470192906|FG001|Overall Study|Lost to Follow-up|2|||
130610170|NCT00769704|470192905|FG000|Overall Study|Death|95|||
130610171|NCT00769704|470192906|FG001|Overall Study|Death|190|||
130610172|NCT00769704|470192905|FG000|Overall Study|Withdrawal by Subject|12|||
130610173|NCT00769704|470192906|FG001|Overall Study|Withdrawal by Subject|5|||
130610174|NCT00769704|470192905|FG000|Overall Study|Other|1|||
130610175|NCT00769704|470192906|FG001|Overall Study|Other|2|||
130610176|NCT04346628|470192911|FG000|Overall Study|Lost to Follow-up|4|||
130610177|NCT04346628|470192912|FG001|Overall Study|Lost to Follow-up|4|||
130610178|NCT04346628|470192911|FG000|Overall Study|Withdrew (had personal reasons)|2|||
130610179|NCT04346628|470192912|FG001|Overall Study|Withdrew (had personal reasons)|5|||
130610180|NCT04346628|470192911|FG000|Overall Study|Withdrew (medication intolerant)|0|||
130610181|NCT04346628|470192912|FG001|Overall Study|Withdrew (medication intolerant)|3|||
130610182|NCT04346628|470192911|FG000|Overall Study|Withdrew (declined intervention)|0|||
130610183|NCT04346628|470192912|FG001|Overall Study|Withdrew (declined intervention)|1|||
130610184|NCT01202227|470192917|FG000|Overall Study|Adverse Event|16|||
130610185|NCT01202227|470192917|FG000|Overall Study|Withdrawal by Subject|2|||
130610186|NCT01202227|470192917|FG000|Overall Study|Lack of Efficacy|1|||
130610187|NCT00643487|470192918|FG000|Overall Study|Technical difficulty|3|||
130610188|NCT04402008|470192919|FG000|Overall Study|Adverse Event|0|||
130610189|NCT04402008|470192920|FG001|Overall Study|Adverse Event|0|||
130610190|NCT04402008|470192921|FG002|Overall Study|Adverse Event|0|||
130610191|NCT04402008|470192922|FG003|Overall Study|Adverse Event|1|||
130610192|NCT04402008|470192923|FG004|Overall Study|Adverse Event|0|||
130610193|NCT04402008|470192924|FG005|Overall Study|Adverse Event|0|||
130610194|NCT04402008|470192925|FG006|Overall Study|Adverse Event|0|||
130610195|NCT04402008|470192919|FG000|Overall Study|Disease Progression|3|||
130610196|NCT04402008|470192920|FG001|Overall Study|Disease Progression|2|||
130610197|NCT04402008|470192921|FG002|Overall Study|Disease Progression|3|||
130610198|NCT04402008|470192922|FG003|Overall Study|Disease Progression|3|||
130610199|NCT04402008|470192923|FG004|Overall Study|Disease Progression|4|||
130610200|NCT04402008|470192924|FG005|Overall Study|Disease Progression|3|||
130610201|NCT04402008|470192925|FG006|Overall Study|Disease Progression|10|||
130610202|NCT04402008|470192919|FG000|Overall Study|Withdrawal by Subject|0|||
130610203|NCT04402008|470192920|FG001|Overall Study|Withdrawal by Subject|1|||
130610204|NCT04402008|470192921|FG002|Overall Study|Withdrawal by Subject|0|||
130610205|NCT04402008|470192922|FG003|Overall Study|Withdrawal by Subject|0|||
130610206|NCT04402008|470192923|FG004|Overall Study|Withdrawal by Subject|1|||
130610207|NCT04402008|470192924|FG005|Overall Study|Withdrawal by Subject|0|||
130610208|NCT04402008|470192925|FG006|Overall Study|Withdrawal by Subject|0|||
130610209|NCT04402008|470192919|FG000|Overall Study|Sponsor Decision|0|||
130610210|NCT04402008|470192920|FG001|Overall Study|Sponsor Decision|0|||
130610211|NCT04402008|470192921|FG002|Overall Study|Sponsor Decision|0|||
130610212|NCT04402008|470192922|FG003|Overall Study|Sponsor Decision|0|||
130610213|NCT04402008|470192923|FG004|Overall Study|Sponsor Decision|0|||
130610214|NCT04402008|470192924|FG005|Overall Study|Sponsor Decision|0|||
130610215|NCT04402008|470192925|FG006|Overall Study|Sponsor Decision|3|||
130610216|NCT04402008|470192919|FG000|Overall Study|Death|0|||
130610217|NCT04402008|470192920|FG001|Overall Study|Death|0|||
130610218|NCT04402008|470192921|FG002|Overall Study|Death|0|||
130610219|NCT04402008|470192922|FG003|Overall Study|Death|0|||
130610220|NCT04402008|470192923|FG004|Overall Study|Death|1|||
130610221|NCT04402008|470192924|FG005|Overall Study|Death|0|||
130610222|NCT04402008|470192925|FG006|Overall Study|Death|2|||
130610223|NCT04402008|470192919|FG000|Overall Study|Other|0|||
130610224|NCT04402008|470192920|FG001|Overall Study|Other|0|||
130610225|NCT04402008|470192921|FG002|Overall Study|Other|0|||
130610226|NCT04402008|470192922|FG003|Overall Study|Other|0|||
130610227|NCT04402008|470192923|FG004|Overall Study|Other|0|||
130610228|NCT04402008|470192924|FG005|Overall Study|Other|0|||
130610229|NCT04402008|470192925|FG006|Overall Study|Other|5|||
130610230|NCT01533935|470192926|FG000|Overall Study|Adverse Event|5|||
130610231|NCT01533935|470192927|FG001|Overall Study|Adverse Event|7|||
130610232|NCT01533935|470192928|FG002|Overall Study|Adverse Event|1|||
130610233|NCT01533935|470192929|FG003|Overall Study|Adverse Event|5|||
130610234|NCT01533935|470192930|FG004|Overall Study|Adverse Event|3|||
130610235|NCT01533935|470192926|FG000|Overall Study|Protocol Violation|0|||
130610236|NCT01533935|470192927|FG001|Overall Study|Protocol Violation|2|||
130610237|NCT01533935|470192928|FG002|Overall Study|Protocol Violation|0|||
130610238|NCT01533935|470192929|FG003|Overall Study|Protocol Violation|0|||
130610239|NCT01533935|470192930|FG004|Overall Study|Protocol Violation|0|||
130610240|NCT01533935|470192926|FG000|Overall Study|Lost to Follow-up|0|||
130610241|NCT01533935|470192927|FG001|Overall Study|Lost to Follow-up|0|||
130610242|NCT01533935|470192928|FG002|Overall Study|Lost to Follow-up|1|||
130610243|NCT01533935|470192929|FG003|Overall Study|Lost to Follow-up|0|||
130610244|NCT01533935|470192930|FG004|Overall Study|Lost to Follow-up|0|||
130610245|NCT01533935|470192926|FG000|Overall Study|Withdrawal by Subject|0|||
130610246|NCT01533935|470192927|FG001|Overall Study|Withdrawal by Subject|4|||
130610247|NCT01533935|470192928|FG002|Overall Study|Withdrawal by Subject|5|||
130610248|NCT01533935|470192929|FG003|Overall Study|Withdrawal by Subject|2|||
130610249|NCT01533935|470192930|FG004|Overall Study|Withdrawal by Subject|4|||
130610250|NCT01533935|470192926|FG000|Overall Study|Other reason not defined above|1|||
130610251|NCT01533935|470192927|FG001|Overall Study|Other reason not defined above|0|||
130610252|NCT01533935|470192928|FG002|Overall Study|Other reason not defined above|1|||
130610253|NCT01533935|470192929|FG003|Overall Study|Other reason not defined above|0|||
130610254|NCT01533935|470192930|FG004|Overall Study|Other reason not defined above|1|||
130610255|NCT03430245|470192931|FG000|Overall Study|Withdrawal by Subject|6|||
130610256|NCT03430245|470192931|FG000|Overall Study|Lost to Follow-up|1|||
130610257|NCT05628181|470192932|FG000|Overall Study|Death|2|||
130610258|NCT05628181|470192933|FG001|Overall Study|Death|4|||
130610259|NCT05628181|470192934|FG002|Overall Study|Death|0|||
130610260|NCT01428063|470192935|FG000|Overall Study|Lack of Efficacy|8|||
130610261|NCT01428063|470192936|FG001|Overall Study|Lack of Efficacy|4|||
130610262|NCT01428063|470192937|FG002|Overall Study|Lack of Efficacy|1|||
130610263|NCT01428063|470192935|FG000|Overall Study|Adverse Event|2|||
130610264|NCT01428063|470192936|FG001|Overall Study|Adverse Event|3|||
130610265|NCT01428063|470192937|FG002|Overall Study|Adverse Event|0|||
130610266|NCT01428063|470192935|FG000|Overall Study|Lost to Follow-up|0|||
130610267|NCT01428063|470192936|FG001|Overall Study|Lost to Follow-up|2|||
130610268|NCT01428063|470192937|FG002|Overall Study|Lost to Follow-up|0|||
130610269|NCT01428063|470192935|FG000|Overall Study|No longer meets study criteria|0|||
130610270|NCT01428063|470192936|FG001|Overall Study|No longer meets study criteria|1|||
130610271|NCT01428063|470192937|FG002|Overall Study|No longer meets study criteria|0|||
130610272|NCT02284906|470192938|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130610273|NCT02284906|470192939|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130610274|NCT02284906|470192940|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130610275|NCT02284906|470192938|FG000|Overall Study|Major Protocol Deviation|0|||
130610276|NCT02284906|470192939|FG001|Overall Study|Major Protocol Deviation|1|||
130610277|NCT02284906|470192940|FG002|Overall Study|Major Protocol Deviation|0|||
130610278|NCT02284906|470192938|FG000|Overall Study|Voluntary Withdrawal|2|||
130610279|NCT02284906|470192939|FG001|Overall Study|Voluntary Withdrawal|4|||
130610280|NCT02284906|470192940|FG002|Overall Study|Voluntary Withdrawal|5|||
130610281|NCT02284906|470192938|FG000|Overall Study|Study Termination|0|||
130610282|NCT02284906|470192939|FG001|Overall Study|Study Termination|11|||
130610283|NCT02284906|470192940|FG002|Overall Study|Study Termination|14|||
130610284|NCT02284906|470192938|FG000|Overall Study|Reason not Specified|1|||
130610285|NCT02284906|470192939|FG001|Overall Study|Reason not Specified|1|||
130610286|NCT02284906|470192940|FG002|Overall Study|Reason not Specified|0|||
130610287|NCT00850759|470192942|FG000|Overall Study|Lost to Follow-up|7|||
130610288|NCT00850759|470192943|FG001|Overall Study|Lost to Follow-up|5|||
130610289|NCT00850759|470192944|FG002|Overall Study|Lost to Follow-up|5|||
130610290|NCT00850759|470192945|FG003|Overall Study|Lost to Follow-up|3|||
130610291|NCT00532948|470192946|FG000|Overall Study|Protocol Violation|1|||
130610292|NCT00532948|470192947|FG001|Overall Study|Protocol Violation|0|||
130610293|NCT00532948|470192948|FG002|Overall Study|Protocol Violation|0|||
130610294|NCT00532948|470192946|FG000|Overall Study|Death|3|||
130610295|NCT00532948|470192947|FG001|Overall Study|Death|3|||
130610296|NCT00532948|470192948|FG002|Overall Study|Death|4|||
130610297|NCT00532948|470192946|FG000|Overall Study|Violation of selection criteria at entry|0|||
130610298|NCT00532948|470192947|FG001|Overall Study|Violation of selection criteria at entry|1|||
130610299|NCT00532948|470192948|FG002|Overall Study|Violation of selection criteria at entry|0|||
130610300|NCT00532948|470192946|FG000|Overall Study|Failure to return|0|||
130610301|NCT00532948|470192947|FG001|Overall Study|Failure to return|1|||
130610302|NCT00532948|470192948|FG002|Overall Study|Failure to return|0|||
130610303|NCT02575079|470192949|FG000|Overall Study|Death|3|||
130610304|NCT02575079|470192950|FG001|Overall Study|Death|0|||
130610305|NCT02575079|470192949|FG000|Overall Study|Withdrawal by Subject|3|||
130610306|NCT02575079|470192950|FG001|Overall Study|Withdrawal by Subject|0|||
130610307|NCT02918266|470192951|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
130610308|NCT02918266|470192952|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610309|NCT02918266|470192953|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610310|NCT02918266|470192954|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610311|NCT02918266|470192955|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610312|NCT02918266|470192956|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610313|NCT02918266|470192957|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
130610314|NCT02918266|470192958|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610315|NCT02918266|470192959|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
130610316|NCT02918266|470192960|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610317|NCT02918266|470192961|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130610318|NCT01259856|470192968|FG000|Overall Study|Adverse Event|12|||
130610319|NCT01259856|470192969|FG001|Overall Study|Adverse Event|9|||
130610320|NCT01259856|470192968|FG000|Overall Study|Death|0|||
130610321|NCT01259856|470192969|FG001|Overall Study|Death|1|||
130610322|NCT01259856|470192968|FG000|Overall Study|Lack of Efficacy|3|||
130610323|NCT01259856|470192969|FG001|Overall Study|Lack of Efficacy|1|||
130610324|NCT01259856|470192968|FG000|Overall Study|Lost to Follow-up|1|||
130610325|NCT01259856|470192969|FG001|Overall Study|Lost to Follow-up|1|||
130610326|NCT01259856|470192968|FG000|Overall Study|Physician Decision|2|||
130610327|NCT01259856|470192969|FG001|Overall Study|Physician Decision|1|||
130610328|NCT01259856|470192968|FG000|Overall Study|Withdrawal by Subject|9|||
130610329|NCT01259856|470192969|FG001|Overall Study|Withdrawal by Subject|10|||
130610330|NCT01259856|470192968|FG000|Overall Study|Treatment never started|0|||
130610331|NCT01259856|470192969|FG001|Overall Study|Treatment never started|6|||
130610332|NCT01259856|470192968|FG000|Overall Study|Study closure by sponsor|40|||
130610333|NCT01259856|470192969|FG001|Overall Study|Study closure by sponsor|41|||
130610334|NCT01259856|470192968|FG000|Overall Study|Patient developed other disease|0|||
130610335|NCT01259856|470192969|FG001|Overall Study|Patient developed other disease|1|||
130610336|NCT01259856|470192968|FG000|Overall Study|Transfer to another study|0|||
130610337|NCT01259856|470192969|FG001|Overall Study|Transfer to another study|1|||
130610338|NCT01259856|470192968|FG000|Overall Study|Unknown/missing|2|||
130610339|NCT01259856|470192969|FG001|Overall Study|Unknown/missing|2|||
130610340|NCT00788775|470192970|FG000|Overall Study|Progressive Disease|8|||
130610341|NCT00788775|470192971|FG001|Overall Study|Progressive Disease|6|||
130610342|NCT00788775|470192970|FG000|Overall Study|Withdrawal by Subject|0|||
130610343|NCT00788775|470192971|FG001|Overall Study|Withdrawal by Subject|2|||
130610344|NCT00788775|470192970|FG000|Overall Study|Patient Non-Compliance|1|||
130610345|NCT00788775|470192971|FG001|Overall Study|Patient Non-Compliance|0|||
130610346|NCT00788775|470192970|FG000|Overall Study|Patient's measurable disease resected.|1|||
130610347|NCT00788775|470192971|FG001|Overall Study|Patient's measurable disease resected.|0|||
130610348|NCT00578864|470192972|FG000|Overall Study|Death|1|||
130610349|NCT00578864|470192973|FG001|Overall Study|Death|0|||
130610350|NCT01253044|470192977|FG000|Overall Study|Lost to Follow-up|38|||
130610351|NCT01253044|470192978|FG001|Overall Study|Lost to Follow-up|29|||
130610352|NCT01087528|470192979|FG000|Overall Study|Withdrawal by Subject|1|||
130610353|NCT01087528|470192979|FG000|Overall Study|Incomplete CE procedure|6|||
130610354|NCT00905307|470192984|FG000|Overall Study|Switched to Open Label Rescue|7|||
130610355|NCT00905307|470192985|FG001|Overall Study|Switched to Open Label Rescue|17|||
130610356|NCT00905307|470192986|FG002|Overall Study|Switched to Open Label Rescue|11|||
130610357|NCT00905307|470192987|FG003|Overall Study|Switched to Open Label Rescue|11|||
130610358|NCT00905307|470192988|FG004|Overall Study|Switched to Open Label Rescue|4|||
130610359|NCT00905307|470192989|FG005|Overall Study|Switched to Open Label Rescue|15|||
130610360|NCT00905307|470192984|FG000|Overall Study|Lost to Follow-up|0|||
130610361|NCT00905307|470192985|FG001|Overall Study|Lost to Follow-up|0|||
130610362|NCT00905307|470192986|FG002|Overall Study|Lost to Follow-up|0|||
130610363|NCT00905307|470192987|FG003|Overall Study|Lost to Follow-up|0|||
130610364|NCT00905307|470192988|FG004|Overall Study|Lost to Follow-up|1|||
130610365|NCT00905307|470192989|FG005|Overall Study|Lost to Follow-up|1|||
130610366|NCT00905307|470192984|FG000|Overall Study|Adverse Event|3|||
130610367|NCT00905307|470192985|FG001|Overall Study|Adverse Event|4|||
130610368|NCT00905307|470192986|FG002|Overall Study|Adverse Event|5|||
130610369|NCT00905307|470192987|FG003|Overall Study|Adverse Event|11|||
130610370|NCT00905307|470192988|FG004|Overall Study|Adverse Event|3|||
130610371|NCT00905307|470192989|FG005|Overall Study|Adverse Event|5|||
130610372|NCT00905307|470192984|FG000|Overall Study|Withdrawal by Subject|5|||
130610373|NCT00905307|470192985|FG001|Overall Study|Withdrawal by Subject|13|||
130610374|NCT00905307|470192986|FG002|Overall Study|Withdrawal by Subject|15|||
130610375|NCT00905307|470192987|FG003|Overall Study|Withdrawal by Subject|11|||
130610376|NCT00905307|470192988|FG004|Overall Study|Withdrawal by Subject|4|||
130610377|NCT00905307|470192989|FG005|Overall Study|Withdrawal by Subject|13|||
130610378|NCT00905307|470192984|FG000|Overall Study|Protocol Violation|1|||
130610379|NCT00905307|470192985|FG001|Overall Study|Protocol Violation|0|||
130610380|NCT00905307|470192986|FG002|Overall Study|Protocol Violation|1|||
130610381|NCT00905307|470192987|FG003|Overall Study|Protocol Violation|0|||
130610382|NCT00905307|470192988|FG004|Overall Study|Protocol Violation|0|||
130610383|NCT00905307|470192989|FG005|Overall Study|Protocol Violation|0|||
130610384|NCT00905307|470192984|FG000|Overall Study|Lack of Efficacy|6|||
130610385|NCT00905307|470192985|FG001|Overall Study|Lack of Efficacy|3|||
130610386|NCT00905307|470192986|FG002|Overall Study|Lack of Efficacy|5|||
130610387|NCT00905307|470192987|FG003|Overall Study|Lack of Efficacy|4|||
130610388|NCT00905307|470192988|FG004|Overall Study|Lack of Efficacy|4|||
130610389|NCT00905307|470192989|FG005|Overall Study|Lack of Efficacy|8|||
130610390|NCT04060667|470192990|FG000|Overall Study|Lost to Follow-up|75|||
130610391|NCT04060667|470192991|FG001|Overall Study|Lost to Follow-up|10|||
130610392|NCT03007953|470192992|FG000|Overall Study|Withdrawal by Subject|5|||
130610393|NCT03007953|470192993|FG001|Overall Study|Withdrawal by Subject|2|||
130610394|NCT03007953|470192992|FG000|Overall Study|Death|5|||
130610395|NCT03007953|470192993|FG001|Overall Study|Death|7|||
130610396|NCT03007953|470192992|FG000|Overall Study|Lost to Follow-up|3|||
130610397|NCT03007953|470192993|FG001|Overall Study|Lost to Follow-up|2|||
130610398|NCT03007953|470192992|FG000|Overall Study|Enrolled in Hospice|3|||
130610399|NCT03007953|470192993|FG001|Overall Study|Enrolled in Hospice|2|||
130610400|NCT03196297|470192994|FG000|Main Period|Withdrawal by Subject|4|||
130610401|NCT03196297|470192994|FG000|Extension Period|Withdrawal by Subject|1|||
130610402|NCT03196297|470192994|FG000|Extension Period|Lack of Efficacy|2|||
130610403|NCT00829166|470192995|FG000|Overall Study|Death|305|||
130610404|NCT00829166|470192996|FG001|Overall Study|Death|333|||
130610405|NCT00829166|470192995|FG000|Overall Study|Lost to Follow-up|5|||
130610406|NCT00829166|470192996|FG001|Overall Study|Lost to Follow-up|4|||
130610407|NCT00829166|470192995|FG000|Overall Study|Physician's Decision|4|||
130610408|NCT00829166|470192996|FG001|Overall Study|Physician's Decision|3|||
130610409|NCT00829166|470192995|FG000|Overall Study|Subject's Decision|41|||
130610410|NCT00829166|470192996|FG001|Overall Study|Subject's Decision|55|||
130610411|NCT00829166|470192995|FG000|Overall Study|Sponsor's Decision|137|||
130610412|NCT00829166|470192996|FG001|Overall Study|Sponsor's Decision|98|||
130610413|NCT00829166|470192995|FG000|Overall Study|Reason Not Specified|3|||
130610414|NCT00829166|470192996|FG001|Overall Study|Reason Not Specified|3|||
130610415|NCT01635933|470192997|FG000|Overall Study|Adverse Event|1|||
130610416|NCT01635933|470192998|FG001|Overall Study|Adverse Event|0|||
130610417|NCT01635933|470192997|FG000|Overall Study|Lost to Follow-up|0|||
130610418|NCT01635933|470192998|FG001|Overall Study|Lost to Follow-up|5|||
130610419|NCT01635933|470192997|FG000|Overall Study|Subject decision|1|||
130610420|NCT01635933|470192998|FG001|Overall Study|Subject decision|1|||
130610421|NCT01635933|470192997|FG000|Overall Study|Noncompliance|0|||
130610422|NCT01635933|470192998|FG001|Overall Study|Noncompliance|1|||
130610423|NCT01635933|470192997|FG000|Overall Study|No longer had transportation|0|||
130610424|NCT01635933|470192998|FG001|Overall Study|No longer had transportation|1|||
130610425|NCT03510663|470192999|FG000|Overall Study|Withdrawal by Subject|0|||
130610426|NCT03510663|470193000|FG001|Overall Study|Withdrawal by Subject|1|||
130610427|NCT03510663|470193001|FG002|Overall Study|Withdrawal by Subject|0|||
130610428|NCT03510663|470193002|FG003|Overall Study|Withdrawal by Subject|0|||
130610429|NCT03510663|470193003|FG004|Overall Study|Withdrawal by Subject|0|||
130610430|NCT03510663|470193004|FG005|Overall Study|Withdrawal by Subject|0|||
130610431|NCT03510663|470193005|FG006|Overall Study|Withdrawal by Subject|0|||
130610432|NCT03510663|470193006|FG007|Overall Study|Withdrawal by Subject|0|||
130610433|NCT02213198|470193010|FG000|Baseline|No show for intake|7|||
130610434|NCT02213198|470193011|FG001|Baseline|No show for intake|9|||
130610435|NCT02213198|470193010|FG000|Baseline|Withdrawal by Subject|34|||
130610436|NCT02213198|470193011|FG001|Baseline|Withdrawal by Subject|11|||
130610437|NCT02213198|470193010|FG000|Baseline|transferred out of clinic|7|||
130610438|NCT02213198|470193011|FG001|Baseline|transferred out of clinic|9|||
130610439|NCT02213198|470193010|FG000|Baseline|Lost to Follow-up|40|||
130610440|NCT02213198|470193011|FG001|Baseline|Lost to Follow-up|21|||
130610441|NCT02213198|470193010|FG000|Baseline|incarcerated,violent|0|||
130610442|NCT02213198|470193011|FG001|Baseline|incarcerated,violent|1|||
130610443|NCT02213198|470193010|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
130610444|NCT02213198|470193011|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
130610445|NCT02213198|470193010|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
130610446|NCT02213198|470193011|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
130610447|NCT02213198|470193010|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
130610448|NCT02213198|470193011|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
130610449|NCT02213198|470193010|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
130610450|NCT02213198|470193011|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
130610451|NCT02213198|470193010|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
130610452|NCT02213198|470193011|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
130610453|NCT02213198|470193010|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
130610454|NCT02213198|470193011|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
130610455|NCT04743635|470193012|FG000|Overall Study|Lost to Follow-up|2|||
130610456|NCT04743635|470193013|FG001|Overall Study|Lost to Follow-up|0|||
130610457|NCT03382899|470193014|FG000|Overall Study|Ineligibility Determined|0|||
130610458|NCT03382899|470193015|FG001|Overall Study|Ineligibility Determined|1|||
130610459|NCT03382899|470193014|FG000|Overall Study|Lost to Follow-up|0|||
130610460|NCT03382899|470193015|FG001|Overall Study|Lost to Follow-up|1|||
130610461|NCT03382899|470193014|FG000|Overall Study|Sponsor's decision|31|||
130610462|NCT03382899|470193015|FG001|Overall Study|Sponsor's decision|28|||
130610463|NCT03382899|470193014|FG000|Overall Study|Withdrawal by Subject|0|||
130610464|NCT03382899|470193015|FG001|Overall Study|Withdrawal by Subject|5|||
130610465|NCT02426658|470193018|FG000|Overall Study|Withdrawal by Subject|1|||
130610466|NCT02426658|470193018|FG000|Overall Study|Patient expired before treatment|2|||
130610467|NCT00524316|470193019|FG000|Overall Study|Withdrawal by Subject|2|||
130610468|NCT00524316|470193019|FG000|Overall Study|Adverse Event|7|||
130610469|NCT00524316|470193019|FG000|Overall Study|Disease Progression|7|||
130610470|NCT01402284|470193020|FG000|Overall Study|Withdrawal consent|2|||
130610471|NCT01402284|470193020|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
130610472|NCT01402284|470193020|FG000|Overall Study|Physician Decision|1|||
130610473|NCT01402284|470193020|FG000|Overall Study|Disease progression on study|10|||
130610474|NCT01199263|470193021|FG000|Overall Study|Ineligible|0|||
130610475|NCT01199263|470193022|FG001|Overall Study|Ineligible|2|||
130610476|NCT01199263|470193021|FG000|Overall Study|Never Treated|6|||
130610477|NCT01199263|470193022|FG001|Overall Study|Never Treated|0|||
130610478|NCT02928406|470193023|FG000|Overall Study|Death|780|||
130610479|NCT02928406|470193023|FG000|Overall Study|Progressive disease|3|||
130610480|NCT02928406|470193023|FG000|Overall Study|Lost to Follow-up|49|||
130610481|NCT02928406|470193023|FG000|Overall Study|Non-compliance|2|||
130610482|NCT02928406|470193023|FG000|Overall Study|Withdrawal by Subject|40|||
130610483|NCT02928406|470193023|FG000|Overall Study|Study terminated by sponsor|57|||
130610484|NCT02928406|470193023|FG000|Overall Study|Physician Decision|1|||
130610485|NCT02928406|470193023|FG000|Overall Study|Various reasons|72|||
130610486|NCT00905021|470193028|FG000|Overall Study|Adverse Event|2|||
130610487|NCT00786838|470193029|FG000|Overall Study|Physician Decision|4|||
130610488|NCT00786838|470193029|FG000|Overall Study|Death|4|||
130610489|NCT00786838|470193029|FG000|Overall Study|Adverse Event|6|||
130610490|NCT00786838|470193029|FG000|Overall Study|Progressive disease|31|||
130610491|NCT00786838|470193029|FG000|Overall Study|Withdrawal by Subject|4|||
130610492|NCT04937816|470193030|FG000|Overall Study|Study drug stopped, reason missing|5|||
130610493|NCT04937816|470193031|FG001|Overall Study|Study drug stopped, reason missing|3|||
130610494|NCT04937816|470193032|FG002|Overall Study|Study drug stopped, reason missing|4|||
130610495|NCT04937816|470193033|FG003|Overall Study|Study drug stopped, reason missing|6|||
130610496|NCT04937816|470193034|FG004|Overall Study|Study drug stopped, reason missing|1|||
130610497|NCT04937816|470193035|FG005|Overall Study|Study drug stopped, reason missing|0|||
130610498|NCT04937816|470193036|FG006|Overall Study|Study drug stopped, reason missing|0|||
130610499|NCT04937816|470193030|FG000|Overall Study|Other than stated below|173|||
130610500|NCT04937816|470193031|FG001|Overall Study|Other than stated below|143|||
130610501|NCT04937816|470193032|FG002|Overall Study|Other than stated below|125|||
130610502|NCT04937816|470193033|FG003|Overall Study|Other than stated below|44|||
130610503|NCT04937816|470193034|FG004|Overall Study|Other than stated below|45|||
130610504|NCT04937816|470193035|FG005|Overall Study|Other than stated below|28|||
130610505|NCT04937816|470193036|FG006|Overall Study|Other than stated below|31|||
130610506|NCT04937816|470193030|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
130610507|NCT04937816|470193031|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
130610508|NCT04937816|470193032|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
130610509|NCT04937816|470193033|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
130610510|NCT04937816|470193034|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
130610511|NCT04937816|470193035|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
130610512|NCT04937816|470193036|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
130610513|NCT04937816|470193030|FG000|Overall Study|Lost to Follow-up|15|||
130610514|NCT04937816|470193031|FG001|Overall Study|Lost to Follow-up|9|||
130610515|NCT04937816|470193032|FG002|Overall Study|Lost to Follow-up|6|||
130610516|NCT04937816|470193033|FG003|Overall Study|Lost to Follow-up|6|||
130610517|NCT04937816|470193034|FG004|Overall Study|Lost to Follow-up|16|||
130610518|NCT04937816|470193035|FG005|Overall Study|Lost to Follow-up|11|||
130610519|NCT04937816|470193036|FG006|Overall Study|Lost to Follow-up|17|||
130610520|NCT04937816|470193030|FG000|Overall Study|Protocol Violation|15|||
130610521|NCT04937816|470193031|FG001|Overall Study|Protocol Violation|15|||
130610522|NCT04937816|470193032|FG002|Overall Study|Protocol Violation|12|||
130610523|NCT04937816|470193033|FG003|Overall Study|Protocol Violation|30|||
130610524|NCT04937816|470193034|FG004|Overall Study|Protocol Violation|24|||
130610525|NCT04937816|470193035|FG005|Overall Study|Protocol Violation|5|||
130610526|NCT04937816|470193036|FG006|Overall Study|Protocol Violation|5|||
130610527|NCT04937816|470193030|FG000|Overall Study|Adverse Event|303|||
130610528|NCT04937816|470193031|FG001|Overall Study|Adverse Event|267|||
130610529|NCT04937816|470193032|FG002|Overall Study|Adverse Event|273|||
130610530|NCT04937816|470193033|FG003|Overall Study|Adverse Event|553|||
130610531|NCT04937816|470193034|FG004|Overall Study|Adverse Event|575|||
130610532|NCT04937816|470193035|FG005|Overall Study|Adverse Event|343|||
130610533|NCT04937816|470193036|FG006|Overall Study|Adverse Event|337|||
130610534|NCT04937816|470193030|FG000|Overall Study|Not treated|4|||
130610535|NCT04937816|470193031|FG001|Overall Study|Not treated|2|||
130610536|NCT04937816|470193032|FG002|Overall Study|Not treated|2|||
130610537|NCT04937816|470193033|FG003|Overall Study|Not treated|2|||
130610538|NCT04937816|470193034|FG004|Overall Study|Not treated|1|||
130610539|NCT04937816|470193035|FG005|Overall Study|Not treated|4|||
130610540|NCT04937816|470193036|FG006|Overall Study|Not treated|0|||
130610541|NCT05513391|470193037|FG000|Overall Study|Adverse Event|1|||
130610542|NCT05513391|470193038|FG001|Overall Study|Adverse Event|0|||
130610543|NCT05513391|470193037|FG000|Overall Study|Protocol Deviation|0|||
130610544|NCT05513391|470193038|FG001|Overall Study|Protocol Deviation|1|||
130610545|NCT05513391|470193037|FG000|Overall Study|Withdrawal by Subject|3|||
130610546|NCT05513391|470193038|FG001|Overall Study|Withdrawal by Subject|1|||
130610547|NCT05513391|470193037|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130610548|NCT05513391|470193038|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130610549|NCT05513391|470193037|FG000|Overall Study|Lost to Follow-up|0|||
130610550|NCT05513391|470193038|FG001|Overall Study|Lost to Follow-up|2|||
130610551|NCT00436215|470193039|FG000|Overall Study|Refused further treatment|3|||
130610552|NCT00436215|470193039|FG000|Overall Study|Small bowel obstruction|1|||
130610553|NCT00309777|470193040|FG000|Overall Study|Adverse Event|13|||
130610554|NCT00309777|470193041|FG001|Overall Study|Adverse Event|2|||
130610555|NCT00309777|470193042|FG002|Overall Study|Adverse Event|8|||
130610556|NCT00309777|470193043|FG003|Overall Study|Adverse Event|1|||
130610557|NCT00309777|470193040|FG000|Overall Study|Protocol Violation|4|||
130610558|NCT00309777|470193041|FG001|Overall Study|Protocol Violation|1|||
130610559|NCT00309777|470193042|FG002|Overall Study|Protocol Violation|3|||
130610560|NCT00309777|470193043|FG003|Overall Study|Protocol Violation|1|||
130610561|NCT00309777|470193040|FG000|Overall Study|Withdrawal by Subject|6|||
130610562|NCT00309777|470193041|FG001|Overall Study|Withdrawal by Subject|5|||
130610563|NCT00309777|470193042|FG002|Overall Study|Withdrawal by Subject|7|||
130610564|NCT00309777|470193043|FG003|Overall Study|Withdrawal by Subject|2|||
130610565|NCT00309777|470193040|FG000|Overall Study|Lost to Follow-up|0|||
130610566|NCT00309777|470193041|FG001|Overall Study|Lost to Follow-up|0|||
130610567|NCT00309777|470193042|FG002|Overall Study|Lost to Follow-up|1|||
130610568|NCT00309777|470193043|FG003|Overall Study|Lost to Follow-up|0|||
130610569|NCT00309777|470193040|FG000|Overall Study|Death|0|||
130610570|NCT00309777|470193041|FG001|Overall Study|Death|1|||
130610571|NCT00309777|470193042|FG002|Overall Study|Death|0|||
130610572|NCT00309777|470193043|FG003|Overall Study|Death|0|||
130610573|NCT05513053|470193044|FG000|Overall Study|Lost to Follow-up|9|||
130610574|NCT05513053|470193045|FG001|Overall Study|Lost to Follow-up|11|||
130610575|NCT05513053|470193044|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130610576|NCT05513053|470193045|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130610577|NCT05513053|470193044|FG000|Overall Study|Withdrawal by Subject|2|||
130610578|NCT05513053|470193045|FG001|Overall Study|Withdrawal by Subject|9|||
130610579|NCT05513053|470193044|FG000|Overall Study|Protocol Violation|6|||
130610580|NCT05513053|470193045|FG001|Overall Study|Protocol Violation|3|||
130610581|NCT05513053|470193044|FG000|Overall Study|Adverse Event|0|||
130610582|NCT05513053|470193045|FG001|Overall Study|Adverse Event|2|||
130610583|NCT03050359|470194643|FG000|Overall Study|Randomized But Not Treated|2|||
130610584|NCT03050359|470194644|FG001|Overall Study|Randomized But Not Treated|0|||
130610585|NCT03050359|470194643|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
130610586|NCT03050359|470194644|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130610587|NCT03050359|470194643|FG000|Overall Study|Significant Protocol Deviation|2|||
130610588|NCT03050359|470194644|FG001|Overall Study|Significant Protocol Deviation|3|||
130610589|NCT03050359|470194643|FG000|Overall Study|Lost to Follow-up|2|||
130610590|NCT03050359|470194644|FG001|Overall Study|Lost to Follow-up|1|||
130610591|NCT03050359|470194643|FG000|Overall Study|Voluntary Withdrawal|4|||
130610592|NCT03050359|470194644|FG001|Overall Study|Voluntary Withdrawal|6|||
130610593|NCT03050359|470194643|FG000|Overall Study|Pregnancy|1|||
130610594|NCT03050359|470194644|FG001|Overall Study|Pregnancy|0|||
130610595|NCT03050359|470194643|FG000|Overall Study|Reason Not Specified|1|||
130610596|NCT03050359|470194644|FG001|Overall Study|Reason Not Specified|0|||
130610597|NCT02614287|470194645|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
130610598|NCT02614287|470194646|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
130610599|NCT02614287|470194645|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
130610600|NCT02614287|470194646|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
130610601|NCT02614287|470194645|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
130610602|NCT02614287|470194646|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
130610603|NCT02614287|470194645|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
130610604|NCT02614287|470194646|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
130610605|NCT02614287|470194645|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
130610606|NCT02614287|470194646|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
130610607|NCT02614287|470194645|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
130610608|NCT02614287|470194646|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
130610609|NCT02614287|470194645|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
130610610|NCT02614287|470194646|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
130610611|NCT02614287|470194645|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
130610612|NCT02614287|470194646|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
130610613|NCT00492856|470194647|FG000|Induction|Adverse Event|2|||
130610614|NCT00492856|470194648|FG001|Induction|Adverse Event|0|||
130610615|NCT00492856|470194649|FG002|Induction|Adverse Event|0|||
130610616|NCT00492856|470194650|FG003|Induction|Adverse Event|0|||
130610617|NCT00492856|470194647|FG000|Induction|Withdrawal by Subject|1|||
130610618|NCT00492856|470194648|FG001|Induction|Withdrawal by Subject|0|||
130610619|NCT00492856|470194649|FG002|Induction|Withdrawal by Subject|0|||
130610620|NCT00492856|470194650|FG003|Induction|Withdrawal by Subject|0|||
130610621|NCT00492856|470194647|FG000|Induction|Death|3|||
130610622|NCT00492856|470194648|FG001|Induction|Death|0|||
130610623|NCT00492856|470194649|FG002|Induction|Death|0|||
130610624|NCT00492856|470194650|FG003|Induction|Death|0|||
130610625|NCT00492856|470194647|FG000|Consolidation|Adverse Event|6|||
130610626|NCT00492856|470194648|FG001|Consolidation|Adverse Event|0|||
130610627|NCT00492856|470194649|FG002|Consolidation|Adverse Event|0|||
130610628|NCT00492856|470194650|FG003|Consolidation|Adverse Event|0|||
130610629|NCT00492856|470194647|FG000|Consolidation|Not protocol specified|2|||
130610630|NCT00492856|470194648|FG001|Consolidation|Not protocol specified|0|||
130610631|NCT00492856|470194649|FG002|Consolidation|Not protocol specified|0|||
130610632|NCT00492856|470194650|FG003|Consolidation|Not protocol specified|0|||
130610633|NCT00492856|470194647|FG000|Consolidation|Lost to Follow-up|1|||
130610634|NCT00492856|470194648|FG001|Consolidation|Lost to Follow-up|0|||
130610635|NCT00492856|470194649|FG002|Consolidation|Lost to Follow-up|0|||
130610636|NCT00492856|470194650|FG003|Consolidation|Lost to Follow-up|0|||
130610637|NCT00492856|470194647|FG000|Post-consolidation|Adverse Event|0|||
130610638|NCT00492856|470194648|FG001|Post-consolidation|Adverse Event|4|||
130610639|NCT00492856|470194649|FG002|Post-consolidation|Adverse Event|0|||
130610640|NCT00492856|470194650|FG003|Post-consolidation|Adverse Event|1|||
130610641|NCT00492856|470194647|FG000|Post-consolidation|Withdrawal by Subject|0|||
130610642|NCT00492856|470194648|FG001|Post-consolidation|Withdrawal by Subject|4|||
130610643|NCT00492856|470194649|FG002|Post-consolidation|Withdrawal by Subject|0|||
130610644|NCT00492856|470194650|FG003|Post-consolidation|Withdrawal by Subject|0|||
130610645|NCT00492856|470194647|FG000|Post-consolidation|Death|0|||
130610646|NCT00492856|470194648|FG001|Post-consolidation|Death|1|||
130610647|NCT00492856|470194649|FG002|Post-consolidation|Death|0|||
130610648|NCT00492856|470194650|FG003|Post-consolidation|Death|0|||
130610649|NCT00492856|470194647|FG000|Post-consolidation|Not protocol specified|0|||
130610650|NCT00492856|470194648|FG001|Post-consolidation|Not protocol specified|1|||
130610651|NCT00492856|470194649|FG002|Post-consolidation|Not protocol specified|0|||
130610652|NCT00492856|470194650|FG003|Post-consolidation|Not protocol specified|0|||
130610653|NCT00492856|470194647|FG000|Post-consolidation|Lost to Follow-up|0|||
130610654|NCT00492856|470194648|FG001|Post-consolidation|Lost to Follow-up|2|||
130610655|NCT00492856|470194649|FG002|Post-consolidation|Lost to Follow-up|0|||
130610656|NCT00492856|470194650|FG003|Post-consolidation|Lost to Follow-up|0|||
130610657|NCT00492856|470194647|FG000|Post-consolidation|Observation Arm|0|||
130610658|NCT00492856|470194648|FG001|Post-consolidation|Observation Arm|0|||
130610659|NCT00492856|470194649|FG002|Post-consolidation|Observation Arm|27|||
130610660|NCT00492856|470194650|FG003|Post-consolidation|Observation Arm|0|||
130610661|NCT01520324|470194651|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
130610662|NCT03488472|470194652|FG000|Overall Study|disease progression additional mets|1|||
130610663|NCT00441441|470194656|FG000|Overall Study|Adverse Event|2|||
130610664|NCT00441441|470194657|FG001|Overall Study|Adverse Event|1|||
130610665|NCT00441441|470194656|FG000|Overall Study|Protocol Violation|4|||
130610666|NCT00441441|470194657|FG001|Overall Study|Protocol Violation|6|||
130610667|NCT00441441|470194656|FG000|Overall Study|Exacerbation of asthma|1|||
130610668|NCT00441441|470194657|FG001|Overall Study|Exacerbation of asthma|2|||
130610669|NCT00441441|470194656|FG000|Overall Study|Withdrawal by Subject|1|||
130610670|NCT00441441|470194657|FG001|Overall Study|Withdrawal by Subject|2|||
130610671|NCT00441441|470194656|FG000|Overall Study|Other|3|||
130610672|NCT00441441|470194657|FG001|Overall Study|Other|3|||
130610673|NCT00262080|470194658|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
130610674|NCT00262080|470194659|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130610675|NCT00262080|470194660|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
130610676|NCT00262080|470194658|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
130610677|NCT00262080|470194659|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
130610678|NCT00262080|470194660|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
130610679|NCT00262080|470194658|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
130610680|NCT00262080|470194659|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
130610681|NCT00262080|470194660|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
130610682|NCT00262080|470194658|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
130610683|NCT00262080|470194659|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
130610684|NCT00262080|470194660|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
130610685|NCT00262080|470194658|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
130610686|NCT00262080|470194659|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
130610687|NCT00262080|470194660|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
130610688|NCT00262080|470194658|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
130610689|NCT00262080|470194659|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
130610690|NCT00262080|470194660|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
130610691|NCT03580382|470194661|FG000|Overall Study|Early Termination of Study|0|||
130610692|NCT03580382|470194662|FG001|Overall Study|Early Termination of Study|3|||
130610693|NCT05619172|470194663|FG000|Safety Cohort 1|Death|7|||
130610694|NCT05619172|470194664|FG001|Safety Cohort 1|Death|0|||
130610695|NCT05619172|470194663|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
130610696|NCT05619172|470194664|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
130610697|NCT05619172|470194663|FG000|Safety Cohort 2|Death|0|||
130610698|NCT05619172|470194664|FG001|Safety Cohort 2|Death|1|||
130610699|NCT05619172|470194663|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
130610700|NCT05619172|470194664|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
130610701|NCT04009096|470194665|FG000|Overall Study|Withdrawal by Subject|0|||
130610702|NCT04009096|470194666|FG001|Overall Study|Withdrawal by Subject|7|||
130610703|NCT04009096|470194667|FG002|Overall Study|Withdrawal by Subject|0|||
130610704|NCT04009096|470194665|FG000|Overall Study|Physician Decision|0|||
130610705|NCT04009096|470194666|FG001|Overall Study|Physician Decision|1|||
130610706|NCT04009096|470194667|FG002|Overall Study|Physician Decision|0|||
130610707|NCT05151471|470194668|FG000|Overall Study|Adverse Event|21|||
130610708|NCT05151471|470194669|FG001|Overall Study|Adverse Event|16|||
130610709|NCT05151471|470194668|FG000|Overall Study|Death|1|||
130610710|NCT05151471|470194669|FG001|Overall Study|Death|0|||
130610711|NCT05151471|470194668|FG000|Overall Study|Lost to Follow-up|0|||
130610712|NCT05151471|470194669|FG001|Overall Study|Lost to Follow-up|1|||
130610713|NCT05151471|470194668|FG000|Overall Study|Withdrawal by Subject|7|||
130610714|NCT05151471|470194669|FG001|Overall Study|Withdrawal by Subject|9|||
130610715|NCT05151471|470194668|FG000|Overall Study|Study terminated by sponsor|49|||
130610716|NCT05151471|470194669|FG001|Overall Study|Study terminated by sponsor|47|||
130610717|NCT05151471|470194668|FG000|Overall Study|Other|2|||
130610718|NCT05151471|470194669|FG001|Overall Study|Other|1|||
130610719|NCT04263142|470194670|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130610720|NCT04263142|470194671|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130610721|NCT04263142|470194672|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130610722|NCT04263142|470194673|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130610723|NCT04263142|470194674|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
130610724|NCT04263142|470194670|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130610725|NCT04263142|470194671|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130610726|NCT04263142|470194672|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130610727|NCT04263142|470194673|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130610728|NCT04263142|470194674|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
130610729|NCT00450372|470194676|FG000|Overall Study|Physician Decision|1|||
130610730|NCT03010423|470194677|FG000|Overall Study|Study termination|8|||
130610731|NCT00879814|470194680|FG000|Overall Study|Adverse Event|0|||
130610732|NCT00879814|470194681|FG001|Overall Study|Adverse Event|1|||
130610733|NCT00879814|470194682|FG002|Overall Study|Adverse Event|0|||
130610734|NCT00879814|470194683|FG003|Overall Study|Adverse Event|0|||
130610735|NCT00879814|470194680|FG000|Overall Study|Lost to Follow-up|1|||
130610736|NCT00879814|470194681|FG001|Overall Study|Lost to Follow-up|0|||
130610737|NCT00879814|470194682|FG002|Overall Study|Lost to Follow-up|0|||
130610738|NCT00879814|470194683|FG003|Overall Study|Lost to Follow-up|2|||
130610739|NCT00879814|470194680|FG000|Overall Study|Participant Failed to Return|0|||
130610740|NCT00879814|470194681|FG001|Overall Study|Participant Failed to Return|0|||
130610741|NCT00879814|470194682|FG002|Overall Study|Participant Failed to Return|0|||
130610742|NCT00879814|470194683|FG003|Overall Study|Participant Failed to Return|1|||
130610743|NCT00879814|470194680|FG000|Overall Study|Withdrawal by Subject|3|||
130610744|NCT00879814|470194681|FG001|Overall Study|Withdrawal by Subject|1|||
130610745|NCT00879814|470194682|FG002|Overall Study|Withdrawal by Subject|1|||
130610746|NCT00879814|470194683|FG003|Overall Study|Withdrawal by Subject|2|||
130610747|NCT00879814|470194680|FG000|Overall Study|Physician Decision|0|||
130610748|NCT00879814|470194681|FG001|Overall Study|Physician Decision|0|||
130610749|NCT00879814|470194682|FG002|Overall Study|Physician Decision|1|||
130610750|NCT00879814|470194683|FG003|Overall Study|Physician Decision|0|||
130610751|NCT00879814|470194680|FG000|Overall Study|Other|0|||
130610752|NCT00879814|470194681|FG001|Overall Study|Other|0|||
130610753|NCT00879814|470194682|FG002|Overall Study|Other|1|||
130610754|NCT00879814|470194683|FG003|Overall Study|Other|0|||
130610755|NCT00630812|470194696|FG000|Randomisation to First Dose|Adverse Event|1|||
130610756|NCT00630812|470194697|FG001|Randomisation to First Dose|Adverse Event|1|||
130610757|NCT00630812|470194696|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
130610758|NCT00630812|470194697|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
130610759|NCT00630812|470194696|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
130610760|NCT00630812|470194697|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
130610761|NCT00630812|470194696|FG000|Randomisation to First Dose|Protocol Violation|4|||
130610762|NCT00630812|470194697|FG001|Randomisation to First Dose|Protocol Violation|1|||
130610763|NCT00630812|470194696|FG000|Double Blind Treatment Period|Adverse Event|13|||
130610764|NCT00630812|470194697|FG001|Double Blind Treatment Period|Adverse Event|5|||
130610765|NCT00630812|470194696|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
130610766|NCT00630812|470194697|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130610767|NCT00630812|470194696|FG000|Double Blind Treatment Period|Physician Decision|2|||
130610768|NCT00630812|470194697|FG001|Double Blind Treatment Period|Physician Decision|1|||
130610769|NCT00630812|470194696|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130610770|NCT00630812|470194697|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130610771|NCT00630812|470194696|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
130610772|NCT00630812|470194697|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
130610773|NCT00630812|470194696|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
130610774|NCT00630812|470194697|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
130610775|NCT00630812|470194696|FG000|Double Blind Treatment Period|Non-compliance|0|||
130610776|NCT00630812|470194697|FG001|Double Blind Treatment Period|Non-compliance|1|||
130610777|NCT03656926|470194704|FG000|Overall Study|Adverse Event|5|||
130610778|NCT03656926|470194705|FG001|Overall Study|Adverse Event|4|||
130610779|NCT03656926|470194704|FG000|Overall Study|Withdrawal by Subject|7|||
130610780|NCT03656926|470194705|FG001|Overall Study|Withdrawal by Subject|2|||
130610781|NCT03656926|470194704|FG000|Overall Study|Screen fail after randomization|1|||
130610782|NCT03656926|470194705|FG001|Overall Study|Screen fail after randomization|0|||
130610783|NCT03656926|470194704|FG000|Overall Study|PI decision due to patient condition|1|||
130610784|NCT03656926|470194705|FG001|Overall Study|PI decision due to patient condition|0|||
130610785|NCT03656926|470194704|FG000|Overall Study|Patient unresponsiveness|1|||
130610786|NCT03656926|470194705|FG001|Overall Study|Patient unresponsiveness|0|||
130610787|NCT05610176|470194706|FG000|Overall Study|Death|6|||
130610788|NCT00506077|470194707|FG000|Treatment Period 1|Adverse Event|2|||
130610789|NCT00506077|470194708|FG001|Treatment Period 1|Adverse Event|1|||
130610790|NCT00506077|470194707|FG000|Treatment Period 1|Lost to Follow-up|0|||
130610791|NCT00506077|470194708|FG001|Treatment Period 1|Lost to Follow-up|2|||
130610792|NCT00506077|470194707|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130610793|NCT00506077|470194708|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130610794|NCT00506077|470194707|FG000|Treatment Period 2|Adverse Event|0|||
130610795|NCT00506077|470194708|FG001|Treatment Period 2|Adverse Event|1|||
130610796|NCT00506077|470194707|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130610797|NCT00506077|470194708|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130610798|NCT00316303|470194709|FG000|Overall Study|Lost to Follow-up|11|||
130610799|NCT00316303|470194710|FG001|Overall Study|Lost to Follow-up|16|||
130610800|NCT01753076|470194711|FG000|Overall Study|Adverse Event|17|||
130610801|NCT01753076|470194712|FG001|Overall Study|Adverse Event|18|||
130610802|NCT01753076|470194711|FG000|Overall Study|Lack of Efficacy|3|||
130610803|NCT01753076|470194712|FG001|Overall Study|Lack of Efficacy|1|||
130610804|NCT01753076|470194711|FG000|Overall Study|Lost to Follow-up|2|||
130610805|NCT01753076|470194712|FG001|Overall Study|Lost to Follow-up|1|||
130610806|NCT01753076|470194711|FG000|Overall Study|Physician Decision|4|||
130610807|NCT01753076|470194712|FG001|Overall Study|Physician Decision|2|||
130610808|NCT01753076|470194711|FG000|Overall Study|Withdrawal by Subject|14|||
130610809|NCT01753076|470194712|FG001|Overall Study|Withdrawal by Subject|24|||
130610810|NCT01753076|470194711|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
130610811|NCT01753076|470194712|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
130610812|NCT03885726|470194716|FG000|Overall Study|Staffing issues/lost interest|1|||
130610813|NCT03885726|470194716|FG000|Overall Study|Early discharge from hospital|3|||
130610814|NCT01217190|470194717|FG000|Second Dosing|Withdrawal by Subject|0|||
130610815|NCT01217190|470194718|FG001|Second Dosing|Withdrawal by Subject|2|||
130610816|NCT03116399|470194719|FG000|Overall Study|Death|8|||
130610817|NCT03116399|470194720|FG001|Overall Study|Death|3|||
130610818|NCT03116399|470194719|FG000|Overall Study|Lost to Follow-up|7|||
130610819|NCT03116399|470194720|FG001|Overall Study|Lost to Follow-up|11|||
130610820|NCT03116399|470194719|FG000|Overall Study|Investigator Decision|1|||
130610821|NCT03116399|470194720|FG001|Overall Study|Investigator Decision|1|||
130610822|NCT03116399|470194719|FG000|Overall Study|Withdrawal by Subject|24|||
130610823|NCT03116399|470194720|FG001|Overall Study|Withdrawal by Subject|9|||
130610824|NCT02868216|470194723|FG000|Overall Study|Death|0|||
130610825|NCT02868216|470194724|FG001|Overall Study|Death|1|||
130610826|NCT02868216|470194723|FG000|Overall Study|coronary artery bypass|1|||
130610827|NCT02868216|470194724|FG001|Overall Study|coronary artery bypass|0|||
130610828|NCT02868216|470194723|FG000|Overall Study|Withdrawal by Subject|7|||
130610829|NCT02868216|470194724|FG001|Overall Study|Withdrawal by Subject|5|||
130610830|NCT02702193|470194725|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
130610831|NCT02702193|470194726|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
130610832|NCT02702193|470194725|FG000|4 Month Follow up|Withdrawal by Subject|1|||
130610833|NCT02702193|470194726|FG001|4 Month Follow up|Withdrawal by Subject|0|||
130610834|NCT02702193|470194725|FG000|4 Month Follow up|Lost to Follow-up|17|||
130610835|NCT02702193|470194726|FG001|4 Month Follow up|Lost to Follow-up|18|||
130610836|NCT02702193|470194725|FG000|8 Month Follow up|Withdrawal by Subject|1|||
130610837|NCT02702193|470194726|FG001|8 Month Follow up|Withdrawal by Subject|0|||
130610838|NCT02702193|470194725|FG000|8 Month Follow up|Lost to Follow-up|14|||
130610839|NCT02702193|470194726|FG001|8 Month Follow up|Lost to Follow-up|18|||
130610840|NCT02702193|470194725|FG000|12 Month Follow up|Withdrawal by Subject|1|||
130610841|NCT02702193|470194726|FG001|12 Month Follow up|Withdrawal by Subject|0|||
130610842|NCT02702193|470194725|FG000|12 Month Follow up|Lost to Follow-up|16|||
130610843|NCT02702193|470194726|FG001|12 Month Follow up|Lost to Follow-up|18|||
130610844|NCT01035255|470194730|FG000|Overall Study|Death|724|||
130610845|NCT01035255|470194731|FG001|Overall Study|Death|844|||
130610846|NCT01035255|470194730|FG000|Overall Study|Lost to Follow-up|2|||
130610847|NCT01035255|470194731|FG001|Overall Study|Lost to Follow-up|5|||
130610848|NCT01035255|470194730|FG000|Overall Study|patient's request|15|||
130610849|NCT01035255|470194731|FG001|Overall Study|patient's request|13|||
130610850|NCT01912729|470194732|FG000|Overall Study|Withdrawal by Subject|0|||
130610851|NCT01912729|470194733|FG001|Overall Study|Withdrawal by Subject|1|||
130610852|NCT00195260|470194735|FG000|Part 1: Dose Escalation|Adverse Event|0|||
130610853|NCT00195260|470194736|FG001|Part 1: Dose Escalation|Adverse Event|1|||
130610854|NCT00195260|470194737|FG002|Part 1: Dose Escalation|Adverse Event|0|||
130610855|NCT00195260|470194738|FG003|Part 1: Dose Escalation|Adverse Event|1|||
130610856|NCT00195260|470194739|FG004|Part 1: Dose Escalation|Adverse Event|1|||
130610857|NCT00195260|470194740|FG005|Part 1: Dose Escalation|Adverse Event|0|||
130610858|NCT00195260|470194741|FG006|Part 1: Dose Escalation|Adverse Event|3|||
130610859|NCT00195260|470194742|FG007|Part 1: Dose Escalation|Adverse Event|0|||
130610860|NCT00195260|470194743|FG008|Part 1: Dose Escalation|Adverse Event|0|||
130610861|NCT00195260|470194744|FG009|Part 1: Dose Escalation|Adverse Event|0|||
130610862|NCT00195260|470194745|FG010|Part 1: Dose Escalation|Adverse Event|0|||
130610863|NCT00195260|470194735|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610864|NCT00195260|470194736|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610865|NCT00195260|470194737|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610866|NCT00195260|470194738|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610867|NCT00195260|470194739|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
130610868|NCT00195260|470194740|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610869|NCT00195260|470194741|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610870|NCT00195260|470194742|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130610871|NCT00195260|470194743|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610872|NCT00195260|470194744|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610873|NCT00195260|470194745|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130610874|NCT00195260|470194735|FG000|Part 1: Dose Escalation|Death|0|||
130610875|NCT00195260|470194736|FG001|Part 1: Dose Escalation|Death|0|||
130610876|NCT00195260|470194737|FG002|Part 1: Dose Escalation|Death|0|||
130610877|NCT00195260|470194738|FG003|Part 1: Dose Escalation|Death|0|||
130610878|NCT00195260|470194739|FG004|Part 1: Dose Escalation|Death|0|||
130610879|NCT00195260|470194740|FG005|Part 1: Dose Escalation|Death|0|||
130610880|NCT00195260|470194741|FG006|Part 1: Dose Escalation|Death|0|||
130610881|NCT00195260|470194742|FG007|Part 1: Dose Escalation|Death|1|||
130610882|NCT00195260|470194743|FG008|Part 1: Dose Escalation|Death|0|||
130610883|NCT00195260|470194744|FG009|Part 1: Dose Escalation|Death|0|||
130610884|NCT00195260|470194745|FG010|Part 1: Dose Escalation|Death|0|||
130610885|NCT00195260|470194735|FG000|Part 1: Dose Escalation|Disease Progression|3|||
130610886|NCT00195260|470194736|FG001|Part 1: Dose Escalation|Disease Progression|2|||
130610887|NCT00195260|470194737|FG002|Part 1: Dose Escalation|Disease Progression|5|||
130610888|NCT00195260|470194738|FG003|Part 1: Dose Escalation|Disease Progression|6|||
130610889|NCT00195260|470194739|FG004|Part 1: Dose Escalation|Disease Progression|4|||
130610890|NCT00195260|470194740|FG005|Part 1: Dose Escalation|Disease Progression|6|||
130610891|NCT00195260|470194741|FG006|Part 1: Dose Escalation|Disease Progression|7|||
130610892|NCT00195260|470194742|FG007|Part 1: Dose Escalation|Disease Progression|4|||
130610893|NCT00195260|470194743|FG008|Part 1: Dose Escalation|Disease Progression|0|||
130610894|NCT00195260|470194744|FG009|Part 1: Dose Escalation|Disease Progression|0|||
130610895|NCT00195260|470194745|FG010|Part 1: Dose Escalation|Disease Progression|0|||
130610896|NCT00195260|470194735|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130610897|NCT00195260|470194736|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130610898|NCT00195260|470194737|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130610899|NCT00195260|470194738|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610900|NCT00195260|470194739|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610901|NCT00195260|470194740|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130610902|NCT00195260|470194741|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610903|NCT00195260|470194742|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610904|NCT00195260|470194743|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610905|NCT00195260|470194744|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610906|NCT00195260|470194745|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130610907|NCT00195260|470194735|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610908|NCT00195260|470194736|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610909|NCT00195260|470194737|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610910|NCT00195260|470194738|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610911|NCT00195260|470194739|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610912|NCT00195260|470194740|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610913|NCT00195260|470194741|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610914|NCT00195260|470194742|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130610915|NCT00195260|470194743|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
130610916|NCT00195260|470194744|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
130610917|NCT00195260|470194745|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
130610918|NCT00195260|470194735|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610919|NCT00195260|470194736|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610920|NCT00195260|470194737|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610921|NCT00195260|470194738|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610922|NCT00195260|470194739|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610923|NCT00195260|470194740|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610924|NCT00195260|470194741|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610925|NCT00195260|470194742|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130610926|NCT00195260|470194743|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
130610927|NCT00195260|470194744|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
130610928|NCT00195260|470194745|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
130610929|NCT00195260|470194735|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610930|NCT00195260|470194736|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610931|NCT00195260|470194737|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610932|NCT00195260|470194738|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610933|NCT00195260|470194739|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610934|NCT00195260|470194740|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610935|NCT00195260|470194741|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610936|NCT00195260|470194742|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130610937|NCT00195260|470194743|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
130610938|NCT00195260|470194744|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
130610939|NCT00195260|470194745|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
130610940|NCT00195260|470194735|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610941|NCT00195260|470194736|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610942|NCT00195260|470194737|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610943|NCT00195260|470194738|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610944|NCT00195260|470194739|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610945|NCT00195260|470194740|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610946|NCT00195260|470194741|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610947|NCT00195260|470194742|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130610948|NCT00195260|470194743|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
130610949|NCT00195260|470194744|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
130610950|NCT00195260|470194745|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
130610951|NCT01952834|470194748|FG000|Overall Study|Adverse Event|1|||
130610952|NCT00610935|470194751|FG000|Overall Study|Lost to Follow-up|0|||
130610953|NCT00610935|470194752|FG001|Overall Study|Lost to Follow-up|1|||
130610954|NCT00610935|470194751|FG000|Overall Study|Withdrawal by Subject|0|||
130610955|NCT00610935|470194752|FG001|Overall Study|Withdrawal by Subject|2|||
130610956|NCT00610935|470194751|FG000|Overall Study|Sponsor Discontinuation|1|||
130610957|NCT00610935|470194752|FG001|Overall Study|Sponsor Discontinuation|0|||
130610958|NCT00740779|470194753|FG000|Overall Study|Adverse Event|4|||
130610959|NCT00740779|470194754|FG001|Overall Study|Adverse Event|6|||
130610960|NCT00740779|470194755|FG002|Overall Study|Adverse Event|3|||
130610961|NCT00740779|470194753|FG000|Overall Study|Protocol Violation|1|||
130610962|NCT00740779|470194754|FG001|Overall Study|Protocol Violation|1|||
130610963|NCT00740779|470194755|FG002|Overall Study|Protocol Violation|1|||
130610964|NCT00740779|470194753|FG000|Overall Study|Lack of Efficacy|0|||
130610965|NCT00740779|470194754|FG001|Overall Study|Lack of Efficacy|0|||
130610966|NCT00740779|470194755|FG002|Overall Study|Lack of Efficacy|2|||
130610967|NCT00740779|470194753|FG000|Overall Study|Withdrawal by Subject|2|||
130610968|NCT00740779|470194754|FG001|Overall Study|Withdrawal by Subject|4|||
130610969|NCT00740779|470194755|FG002|Overall Study|Withdrawal by Subject|2|||
130610970|NCT00740779|470194753|FG000|Overall Study|Lost to Follow-up|2|||
130610971|NCT00740779|470194754|FG001|Overall Study|Lost to Follow-up|3|||
130610972|NCT00740779|470194755|FG002|Overall Study|Lost to Follow-up|5|||
130610973|NCT00850460|470194758|FG000|Overall Study|Lost to Follow-up|4|||
130610974|NCT00850460|470194759|FG001|Overall Study|Lost to Follow-up|4|||
130610975|NCT02399813|470194762|FG000|Overall Study|Progressive Disease-Radiographic|2|||
130610976|NCT02399813|470194762|FG000|Overall Study|Death|20|||
130610977|NCT02399813|470194762|FG000|Overall Study|Withdrawal by Subject|3|||
130610978|NCT02399813|470194762|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
130610979|NCT02399813|470194762|FG000|Overall Study|Lost to Follow-up|2|||
130610980|NCT02399813|470194762|FG000|Overall Study|Other than specified|5|||
130610981|NCT00988559|470194763|FG000|Overall Study|Withdrawal by Subject|1|||
130610982|NCT00988559|470194764|FG001|Overall Study|Withdrawal by Subject|1|||
130610983|NCT00988559|470194765|FG002|Overall Study|Withdrawal by Subject|0|||
130610984|NCT00988559|470194766|FG003|Overall Study|Withdrawal by Subject|1|||
130610985|NCT00988559|470194763|FG000|Overall Study|Pregnancy|0|||
130610986|NCT00988559|470194764|FG001|Overall Study|Pregnancy|1|||
130610987|NCT00988559|470194765|FG002|Overall Study|Pregnancy|1|||
130610988|NCT00988559|470194766|FG003|Overall Study|Pregnancy|0|||
130610989|NCT00988559|470194763|FG000|Overall Study|Lost to Follow-up|0|||
130610990|NCT00988559|470194764|FG001|Overall Study|Lost to Follow-up|0|||
130610991|NCT00988559|470194765|FG002|Overall Study|Lost to Follow-up|1|||
130610992|NCT00988559|470194766|FG003|Overall Study|Lost to Follow-up|0|||
130610993|NCT02203838|470194767|FG000|Overall Study|Lack of Efficacy|7|||
130610994|NCT02203838|470194768|FG001|Overall Study|Lack of Efficacy|0|||
130610995|NCT02203838|470194769|FG002|Overall Study|Lack of Efficacy|1|||
130610996|NCT02203838|470194770|FG003|Overall Study|Lack of Efficacy|1|||
130610997|NCT02203838|470194767|FG000|Overall Study|Adverse Event|46|||
130610998|NCT02203838|470194768|FG001|Overall Study|Adverse Event|6|||
130610999|NCT02203838|470194769|FG002|Overall Study|Adverse Event|3|||
130611000|NCT02203838|470194770|FG003|Overall Study|Adverse Event|2|||
130611001|NCT02203838|470194767|FG000|Overall Study|Lost to Follow-up|39|||
130611002|NCT02203838|470194768|FG001|Overall Study|Lost to Follow-up|3|||
130611003|NCT02203838|470194769|FG002|Overall Study|Lost to Follow-up|2|||
130611004|NCT02203838|470194770|FG003|Overall Study|Lost to Follow-up|1|||
130611005|NCT02203838|470194767|FG000|Overall Study|Protocol Violation|7|||
130611006|NCT02203838|470194768|FG001|Overall Study|Protocol Violation|3|||
130611007|NCT02203838|470194769|FG002|Overall Study|Protocol Violation|0|||
130611008|NCT02203838|470194770|FG003|Overall Study|Protocol Violation|0|||
130611009|NCT02203838|470194767|FG000|Overall Study|Withdrawal by Subject|83|||
130611010|NCT02203838|470194768|FG001|Overall Study|Withdrawal by Subject|10|||
130611011|NCT02203838|470194769|FG002|Overall Study|Withdrawal by Subject|8|||
130611012|NCT02203838|470194770|FG003|Overall Study|Withdrawal by Subject|11|||
130611013|NCT02203838|470194767|FG000|Overall Study|Physician Decision|27|||
130611014|NCT02203838|470194768|FG001|Overall Study|Physician Decision|0|||
130611015|NCT02203838|470194769|FG002|Overall Study|Physician Decision|2|||
130611016|NCT02203838|470194770|FG003|Overall Study|Physician Decision|3|||
130611017|NCT02203838|470194767|FG000|Overall Study|Other|1|||
130611018|NCT02203838|470194768|FG001|Overall Study|Other|0|||
130611019|NCT02203838|470194769|FG002|Overall Study|Other|0|||
130611020|NCT02203838|470194770|FG003|Overall Study|Other|0|||
130611021|NCT03345836|470194773|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
130611022|NCT03345836|470194774|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
130611023|NCT03345836|470194775|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
130611024|NCT03345836|470194776|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130611025|NCT03345836|470194777|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130611026|NCT03345836|470194778|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130611027|NCT03345836|470194773|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
130611028|NCT03345836|470194774|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
130611029|NCT03345836|470194775|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
130611030|NCT03345836|470194776|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130611031|NCT03345836|470194777|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130611032|NCT03345836|470194778|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130611033|NCT03345836|470194773|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130611034|NCT03345836|470194774|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
130611035|NCT03345836|470194775|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130611036|NCT03345836|470194776|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130611037|NCT03345836|470194777|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130611038|NCT03345836|470194778|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130611039|NCT03345836|470194773|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
130611040|NCT03345836|470194774|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
130611041|NCT03345836|470194775|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130611042|NCT03345836|470194776|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130611043|NCT03345836|470194777|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130611044|NCT03345836|470194778|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130611045|NCT03345836|470194773|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
130611046|NCT03345836|470194774|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
130611047|NCT03345836|470194775|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
130611048|NCT03345836|470194776|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130611049|NCT03345836|470194777|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130611050|NCT03345836|470194778|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130611051|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130611052|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130611053|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130611054|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
130611055|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
130611056|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130611057|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130611058|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130611059|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130611060|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130611061|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
130611062|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
130611063|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130611064|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130611065|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130611066|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130611067|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130611068|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
130611069|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130611070|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130611071|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130611072|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
130611073|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
130611074|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
130611075|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130611076|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130611077|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130611078|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130611079|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
130611080|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130611081|NCT03345836|470194773|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130611082|NCT03345836|470194774|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130611083|NCT03345836|470194775|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130611084|NCT03345836|470194776|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130611085|NCT03345836|470194777|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130611086|NCT03345836|470194778|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130611087|NCT02689219|470194780|FG000|Overall Study|Death|1|||
130611088|NCT02689219|470194781|FG001|Overall Study|Death|1|||
130611089|NCT02689219|470194780|FG000|Overall Study|Disease Progression|10|||
130611090|NCT02689219|470194781|FG001|Overall Study|Disease Progression|6|||
130611091|NCT00520676|470196217|FG000|Overall Study|Death|84|||
130611092|NCT00520676|470196218|FG001|Overall Study|Death|81|||
130611093|NCT00520676|470196217|FG000|Overall Study|Lost to Follow-up|6|||
130611094|NCT00520676|470196218|FG001|Overall Study|Lost to Follow-up|10|||
130611095|NCT00520676|470196217|FG000|Overall Study|Physician Decision|4|||
130611096|NCT00520676|470196218|FG001|Overall Study|Physician Decision|1|||
130611097|NCT00520676|470196217|FG000|Overall Study|Withdrawal by Subject|7|||
130611098|NCT00520676|470196218|FG001|Overall Study|Withdrawal by Subject|11|||
130611099|NCT02179515|470196219|FG000|Overall Study|switched to alternative treatment|0|||
130611100|NCT02179515|470196220|FG001|Overall Study|switched to alternative treatment|1|||
130611101|NCT02179515|470196221|FG002|Overall Study|switched to alternative treatment|1|||
130611102|NCT02179515|470196219|FG000|Overall Study|Death|0|||
130611103|NCT02179515|470196220|FG001|Overall Study|Death|1|||
130611104|NCT02179515|470196221|FG002|Overall Study|Death|1|||
130611105|NCT02179515|470196219|FG000|Overall Study|refused further treatment|0|||
130611106|NCT02179515|470196220|FG001|Overall Study|refused further treatment|3|||
130611107|NCT02179515|470196221|FG002|Overall Study|refused further treatment|4|||
130611108|NCT02179515|470196219|FG000|Overall Study|Disease progression on study|2|||
130611109|NCT02179515|470196220|FG001|Overall Study|Disease progression on study|11|||
130611110|NCT02179515|470196221|FG002|Overall Study|Disease progression on study|8|||
130611111|NCT03484923|470196222|FG000|Overall Study|Adverse Event|3|||
130611112|NCT03484923|470196223|FG001|Overall Study|Adverse Event|3|||
130611113|NCT03484923|470196224|FG002|Overall Study|Adverse Event|5|||
130611114|NCT03484923|470196225|FG003|Overall Study|Adverse Event|11|||
130611115|NCT03484923|470196226|FG004|Overall Study|Adverse Event|1|||
130611116|NCT03484923|470196222|FG000|Overall Study|Death|2|||
130611117|NCT03484923|470196223|FG001|Overall Study|Death|2|||
130611118|NCT03484923|470196224|FG002|Overall Study|Death|3|||
130611119|NCT03484923|470196225|FG003|Overall Study|Death|0|||
130611120|NCT03484923|470196226|FG004|Overall Study|Death|1|||
130611121|NCT03484923|470196222|FG000|Overall Study|Physician Decision|6|||
130611122|NCT03484923|470196223|FG001|Overall Study|Physician Decision|7|||
130611123|NCT03484923|470196224|FG002|Overall Study|Physician Decision|6|||
130611124|NCT03484923|470196225|FG003|Overall Study|Physician Decision|3|||
130611125|NCT03484923|470196226|FG004|Overall Study|Physician Decision|2|||
130611126|NCT03484923|470196222|FG000|Overall Study|Progressive disease|33|||
130611127|NCT03484923|470196223|FG001|Overall Study|Progressive disease|28|||
130611128|NCT03484923|470196224|FG002|Overall Study|Progressive disease|26|||
130611129|NCT03484923|470196225|FG003|Overall Study|Progressive disease|30|||
130611130|NCT03484923|470196226|FG004|Overall Study|Progressive disease|16|||
130611131|NCT03484923|470196222|FG000|Overall Study|Subject Decision|1|||
130611132|NCT03484923|470196223|FG001|Overall Study|Subject Decision|3|||
130611133|NCT03484923|470196224|FG002|Overall Study|Subject Decision|3|||
130611134|NCT03484923|470196225|FG003|Overall Study|Subject Decision|0|||
130611135|NCT03484923|470196226|FG004|Overall Study|Subject Decision|1|||
130611136|NCT03165721|470196231|FG000|Overall Study|Refused further treatment|3|||
130611137|NCT03165721|470196232|FG001|Overall Study|Refused further treatment|0|||
130611138|NCT03165721|470196233|FG002|Overall Study|Refused further treatment|0|||
130611139|NCT03165721|470196231|FG000|Overall Study|Physician Decision|1|||
130611140|NCT03165721|470196232|FG001|Overall Study|Physician Decision|0|||
130611141|NCT03165721|470196233|FG002|Overall Study|Physician Decision|0|||
130611142|NCT01863849|470196234|FG000|Overall Study|Lost to Follow-up|1|||
130611143|NCT01863849|470196235|FG001|Overall Study|Lost to Follow-up|0|||
130611144|NCT01457118|470196236|FG000|Overall Study|Adverse Event|1|||
130611145|NCT01457118|470196237|FG001|Overall Study|Adverse Event|0|||
130611146|NCT01457118|470196238|FG002|Overall Study|Adverse Event|0|||
130611147|NCT01457118|470196239|FG003|Overall Study|Adverse Event|1|||
130611148|NCT01457118|470196236|FG000|Overall Study|Clinical Progression|0|||
130611149|NCT01457118|470196237|FG001|Overall Study|Clinical Progression|1|||
130611150|NCT01457118|470196238|FG002|Overall Study|Clinical Progression|0|||
130611151|NCT01457118|470196239|FG003|Overall Study|Clinical Progression|1|||
130611152|NCT01457118|470196236|FG000|Overall Study|Physician Decision|2|||
130611153|NCT01457118|470196237|FG001|Overall Study|Physician Decision|0|||
130611154|NCT01457118|470196238|FG002|Overall Study|Physician Decision|0|||
130611155|NCT01457118|470196239|FG003|Overall Study|Physician Decision|0|||
130611156|NCT01457118|470196236|FG000|Overall Study|Progressive Disease by RECIST|12|||
130611157|NCT01457118|470196237|FG001|Overall Study|Progressive Disease by RECIST|3|||
130611158|NCT01457118|470196238|FG002|Overall Study|Progressive Disease by RECIST|1|||
130611159|NCT01457118|470196239|FG003|Overall Study|Progressive Disease by RECIST|0|||
130611160|NCT01457118|470196236|FG000|Overall Study|Withdrawal by Subject|5|||
130611161|NCT01457118|470196237|FG001|Overall Study|Withdrawal by Subject|0|||
130611162|NCT01457118|470196238|FG002|Overall Study|Withdrawal by Subject|0|||
130611163|NCT01457118|470196239|FG003|Overall Study|Withdrawal by Subject|0|||
130611164|NCT00115349|470196240|FG000|Overall Study|Study closed due to low enrollment.|11|||
130611165|NCT00115349|470196241|FG001|Overall Study|Study closed due to low enrollment.|9|||
130611166|NCT01718509|470196244|FG000|Overall Study|Lost to Follow-up|18|||
130611167|NCT01718509|470196245|FG001|Overall Study|Lost to Follow-up|15|||
130611168|NCT01718509|470196244|FG000|Overall Study|Withdrawal by Subject|7|||
130611169|NCT01718509|470196245|FG001|Overall Study|Withdrawal by Subject|13|||
130611170|NCT01718509|470196244|FG000|Overall Study|Adverse Event|5|||
130611171|NCT01718509|470196245|FG001|Overall Study|Adverse Event|7|||
130611172|NCT01718509|470196244|FG000|Overall Study|Other|13|||
130611173|NCT01718509|470196245|FG001|Overall Study|Other|11|||
130611174|NCT01718509|470196244|FG000|Overall Study|Protocol Violation|4|||
130611175|NCT01718509|470196245|FG001|Overall Study|Protocol Violation|2|||
130611176|NCT01718509|470196244|FG000|Overall Study|Lack of Efficacy|1|||
130611177|NCT01718509|470196245|FG001|Overall Study|Lack of Efficacy|0|||
130611178|NCT00390416|470196251|FG000|Overall Study|Withdrawal by Subject|1|||
130611179|NCT00390416|470196251|FG000|Overall Study|Not treated|3|||
130611180|NCT01219959|470196252|FG000|Overall Study|Adverse Event|6|||
130611181|NCT01219959|470196253|FG001|Overall Study|Adverse Event|14|||
130611182|NCT01219959|470196252|FG000|Overall Study|Physician Decision|0|||
130611183|NCT01219959|470196253|FG001|Overall Study|Physician Decision|4|||
130611184|NCT01219959|470196252|FG000|Overall Study|Withdrawal by Subject|0|||
130611185|NCT01219959|470196253|FG001|Overall Study|Withdrawal by Subject|2|||
130611186|NCT01219959|470196252|FG000|Overall Study|Renal Transplantation|0|||
130611187|NCT01219959|470196253|FG001|Overall Study|Renal Transplantation|3|||
130611188|NCT01219959|470196252|FG000|Overall Study|Other|1|||
130611189|NCT01219959|470196253|FG001|Overall Study|Other|0|||
130611190|NCT01728584|470196254|FG000|Overall Study|Adverse Event|1|||
130611191|NCT01728584|470196255|FG001|Overall Study|Adverse Event|0|||
130611192|NCT01728584|470196256|FG002|Overall Study|Adverse Event|0|||
130611193|NCT01728584|470196257|FG003|Overall Study|Adverse Event|0|||
130611194|NCT01728584|470196254|FG000|Overall Study|Physician Decision|4|||
130611195|NCT01728584|470196255|FG001|Overall Study|Physician Decision|0|||
130611196|NCT01728584|470196256|FG002|Overall Study|Physician Decision|1|||
130611197|NCT01728584|470196257|FG003|Overall Study|Physician Decision|0|||
130611198|NCT01728584|470196254|FG000|Overall Study|Withdrawal by Subject|1|||
130611199|NCT01728584|470196255|FG001|Overall Study|Withdrawal by Subject|0|||
130611200|NCT01728584|470196256|FG002|Overall Study|Withdrawal by Subject|0|||
130611201|NCT01728584|470196257|FG003|Overall Study|Withdrawal by Subject|0|||
130611202|NCT01728584|470196254|FG000|Overall Study|Screen failure|1|||
130611203|NCT01728584|470196255|FG001|Overall Study|Screen failure|0|||
130611204|NCT01728584|470196256|FG002|Overall Study|Screen failure|0|||
130611205|NCT01728584|470196257|FG003|Overall Study|Screen failure|0|||
130611206|NCT01728584|470196254|FG000|Overall Study|Other reason (not specified)|1|||
130611207|NCT01728584|470196255|FG001|Overall Study|Other reason (not specified)|0|||
130611208|NCT01728584|470196256|FG002|Overall Study|Other reason (not specified)|0|||
130611209|NCT01728584|470196257|FG003|Overall Study|Other reason (not specified)|1|||
130611210|NCT02935634|470196258|FG000|Randomization|Participant withdrew consent|0|||
130611211|NCT02935634|470196259|FG001|Randomization|Participant withdrew consent|1|||
130611212|NCT02935634|470196260|FG002|Randomization|Participant withdrew consent|0|||
130611213|NCT02935634|470196261|FG003|Randomization|Participant withdrew consent|0|||
130611214|NCT02935634|470196262|FG004|Randomization|Participant withdrew consent|0|||
130611215|NCT02935634|470196263|FG005|Randomization|Participant withdrew consent|0|||
130611216|NCT02935634|470196258|FG000|Randomization|Death|2|||
130611217|NCT02935634|470196259|FG001|Randomization|Death|1|||
130611218|NCT02935634|470196260|FG002|Randomization|Death|1|||
130611219|NCT02935634|470196261|FG003|Randomization|Death|0|||
130611220|NCT02935634|470196262|FG004|Randomization|Death|0|||
130611221|NCT02935634|470196263|FG005|Randomization|Death|0|||
130611222|NCT02935634|470196258|FG000|Randomization|Other reasons|0|||
130611223|NCT02935634|470196259|FG001|Randomization|Other reasons|2|||
130611224|NCT02935634|470196260|FG002|Randomization|Other reasons|2|||
130611225|NCT02935634|470196261|FG003|Randomization|Other reasons|0|||
130611226|NCT02935634|470196262|FG004|Randomization|Other reasons|0|||
130611227|NCT02935634|470196263|FG005|Randomization|Other reasons|0|||
130611228|NCT02935634|470196258|FG000|Treatment: Track 1|Disease progression|15|||
130611229|NCT02935634|470196259|FG001|Treatment: Track 1|Disease progression|17|||
130611230|NCT02935634|470196260|FG002|Treatment: Track 1|Disease progression|28|||
130611231|NCT02935634|470196261|FG003|Treatment: Track 1|Disease progression|4|||
130611232|NCT02935634|470196262|FG004|Treatment: Track 1|Disease progression|6|||
130611233|NCT02935634|470196263|FG005|Treatment: Track 1|Disease progression|2|||
130611234|NCT02935634|470196258|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
130611235|NCT02935634|470196259|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
130611236|NCT02935634|470196260|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
130611237|NCT02935634|470196261|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
130611238|NCT02935634|470196262|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
130611239|NCT02935634|470196263|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
130611240|NCT02935634|470196258|FG000|Treatment: Track 1|Lost to Follow-up|1|||
130611241|NCT02935634|470196259|FG001|Treatment: Track 1|Lost to Follow-up|0|||
130611242|NCT02935634|470196260|FG002|Treatment: Track 1|Lost to Follow-up|0|||
130611243|NCT02935634|470196261|FG003|Treatment: Track 1|Lost to Follow-up|0|||
130611244|NCT02935634|470196262|FG004|Treatment: Track 1|Lost to Follow-up|0|||
130611245|NCT02935634|470196263|FG005|Treatment: Track 1|Lost to Follow-up|0|||
130611246|NCT02935634|470196258|FG000|Treatment: Track 1|Study drug toxicity|2|||
130611247|NCT02935634|470196259|FG001|Treatment: Track 1|Study drug toxicity|1|||
130611248|NCT02935634|470196260|FG002|Treatment: Track 1|Study drug toxicity|3|||
130611249|NCT02935634|470196261|FG003|Treatment: Track 1|Study drug toxicity|0|||
130611250|NCT02935634|470196262|FG004|Treatment: Track 1|Study drug toxicity|0|||
130611251|NCT02935634|470196263|FG005|Treatment: Track 1|Study drug toxicity|1|||
130611252|NCT02935634|470196258|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
130611253|NCT02935634|470196259|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
130611254|NCT02935634|470196260|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
130611255|NCT02935634|470196261|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
130611256|NCT02935634|470196262|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
130611257|NCT02935634|470196263|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
130611258|NCT02935634|470196258|FG000|Treatment: Track 1|Participant withdrew consent|2|||
130611259|NCT02935634|470196259|FG001|Treatment: Track 1|Participant withdrew consent|0|||
130611260|NCT02935634|470196260|FG002|Treatment: Track 1|Participant withdrew consent|1|||
130611261|NCT02935634|470196261|FG003|Treatment: Track 1|Participant withdrew consent|0|||
130611262|NCT02935634|470196262|FG004|Treatment: Track 1|Participant withdrew consent|1|||
130611263|NCT02935634|470196263|FG005|Treatment: Track 1|Participant withdrew consent|0|||
130611264|NCT02935634|470196258|FG000|Treatment: Track 1|Other reasons|0|||
130611265|NCT02935634|470196259|FG001|Treatment: Track 1|Other reasons|0|||
130611266|NCT02935634|470196260|FG002|Treatment: Track 1|Other reasons|2|||
130611267|NCT02935634|470196261|FG003|Treatment: Track 1|Other reasons|0|||
130611268|NCT02935634|470196262|FG004|Treatment: Track 1|Other reasons|0|||
130611269|NCT02935634|470196263|FG005|Treatment: Track 1|Other reasons|0|||
130611270|NCT02935634|470196258|FG000|Treatment: Track 2|Disease progression|13|||
130611271|NCT02935634|470196259|FG001|Treatment: Track 2|Disease progression|26|||
130611272|NCT02935634|470196260|FG002|Treatment: Track 2|Disease progression|20|||
130611273|NCT02935634|470196261|FG003|Treatment: Track 2|Disease progression|5|||
130611274|NCT02935634|470196262|FG004|Treatment: Track 2|Disease progression|1|||
130611275|NCT02935634|470196263|FG005|Treatment: Track 2|Disease progression|4|||
130611276|NCT02935634|470196258|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
130611277|NCT02935634|470196259|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
130611278|NCT02935634|470196260|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130611279|NCT02935634|470196261|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130611280|NCT02935634|470196262|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130611281|NCT02935634|470196263|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130611282|NCT02935634|470196258|FG000|Treatment: Track 2|Study drug toxicity|7|||
130611283|NCT02935634|470196259|FG001|Treatment: Track 2|Study drug toxicity|3|||
130611284|NCT02935634|470196260|FG002|Treatment: Track 2|Study drug toxicity|0|||
130611285|NCT02935634|470196261|FG003|Treatment: Track 2|Study drug toxicity|0|||
130611286|NCT02935634|470196262|FG004|Treatment: Track 2|Study drug toxicity|0|||
130611287|NCT02935634|470196263|FG005|Treatment: Track 2|Study drug toxicity|0|||
130611288|NCT02935634|470196258|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
130611289|NCT02935634|470196259|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
130611290|NCT02935634|470196260|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
130611291|NCT02935634|470196261|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
130611292|NCT02935634|470196262|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
130611293|NCT02935634|470196263|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
130611294|NCT02935634|470196258|FG000|Treatment: Track 2|Participant withdrew consent|0|||
130611295|NCT02935634|470196259|FG001|Treatment: Track 2|Participant withdrew consent|1|||
130611296|NCT02935634|470196260|FG002|Treatment: Track 2|Participant withdrew consent|1|||
130611297|NCT02935634|470196261|FG003|Treatment: Track 2|Participant withdrew consent|0|||
130611298|NCT02935634|470196262|FG004|Treatment: Track 2|Participant withdrew consent|1|||
130611299|NCT02935634|470196263|FG005|Treatment: Track 2|Participant withdrew consent|0|||
130611300|NCT05906732|470196264|FG000|Overall Study|Withdrawal by Subject|1|||
130611301|NCT05906732|470196265|FG001|Overall Study|Withdrawal by Subject|0|||
130611302|NCT05906732|470196266|FG002|Overall Study|Withdrawal by Subject|0|||
130611303|NCT05906732|470196267|FG003|Overall Study|Withdrawal by Subject|0|||
130611304|NCT05906732|470196264|FG000|Overall Study|Physician Decision|2|||
130611305|NCT05906732|470196265|FG001|Overall Study|Physician Decision|4|||
130611306|NCT05906732|470196266|FG002|Overall Study|Physician Decision|0|||
130611307|NCT05906732|470196267|FG003|Overall Study|Physician Decision|0|||
130611308|NCT00471536|470196274|FG000|Overall Study|Withdrawal by Subject|1|||
130611309|NCT02651194|470196275|FG000|Overall Study|Lost to Follow-up|3|||
130611310|NCT02651194|470196275|FG000|Overall Study|Other|2|||
130611311|NCT02496585|470196276|FG000|Overall Study|Death|3|||
130611312|NCT02496585|470196277|FG001|Overall Study|Death|0|||
130611313|NCT02496585|470196276|FG000|Overall Study|Lost to Follow-up|2|||
130611314|NCT02496585|470196277|FG001|Overall Study|Lost to Follow-up|0|||
130611315|NCT02496585|470196276|FG000|Overall Study|Withdrawal by Subject|1|||
130611316|NCT02496585|470196277|FG001|Overall Study|Withdrawal by Subject|2|||
130611317|NCT02496585|470196276|FG000|Overall Study|Progression of Malignancy|4|||
130611318|NCT02496585|470196277|FG001|Overall Study|Progression of Malignancy|1|||
130611319|NCT01864018|470196280|FG000|Overall Study|Ineligible|3|||
130611320|NCT01864018|470196281|FG001|Overall Study|Ineligible|1|||
130611321|NCT03609359|470196284|FG000|Overall Study|Progression of primary disease (PD)|25|||
130611322|NCT03609359|470196284|FG000|Overall Study|Patient's refusal|1|||
130611323|NCT03609359|470196284|FG000|Overall Study|Physician Decision|1|||
130611324|NCT03609359|470196284|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
130611325|NCT04285346|470196285|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
130611326|NCT04285346|470196286|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
130611327|NCT04285346|470196285|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
130611328|NCT04285346|470196286|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130611329|NCT04285346|470196285|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
130611330|NCT04285346|470196286|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130611331|NCT01975272|470196287|FG000|Overall Study|Excluded after protocol amendment|1|||
130611332|NCT01975272|470196288|FG001|Overall Study|Excluded after protocol amendment|1|||
130611333|NCT01975272|470196289|FG002|Overall Study|Excluded after protocol amendment|2|||
130611334|NCT02224846|470196293|FG000|Period 1 (Month 3)|Adverse Event|2|||
130611335|NCT02224846|470196294|FG001|Period 1 (Month 3)|Adverse Event|1|||
130611336|NCT02224846|470196293|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
130611337|NCT02224846|470196294|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
130611338|NCT02224846|470196293|FG000|Period 1 (Month 3)|Protocol Violation|4|||
130611339|NCT02224846|470196294|FG001|Period 1 (Month 3)|Protocol Violation|8|||
130611340|NCT02224846|470196293|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
130611341|NCT02224846|470196294|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
130611342|NCT02224846|470196293|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
130611343|NCT02224846|470196294|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
130611344|NCT02224846|470196293|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
130611345|NCT02224846|470196294|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
130611346|NCT02224846|470196293|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
130611347|NCT02224846|470196294|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
130611348|NCT02224846|470196293|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
130611349|NCT02224846|470196294|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
130611350|NCT02224846|470196293|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
130611351|NCT02224846|470196294|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
130611352|NCT02224846|470196293|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
130611353|NCT02224846|470196294|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
130611354|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
130611355|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
130611356|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
130611357|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
130611358|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
130611359|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
130611360|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
130611361|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
130611362|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
130611363|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
130611364|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
130611365|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
130611366|NCT02224846|470196293|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
130611367|NCT02224846|470196294|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
130611368|NCT03280550|470196295|FG000|Overall Study|Withdrawal by Subject|2|||
130611369|NCT03280550|470196296|FG001|Overall Study|Withdrawal by Subject|2|||
130611370|NCT03280550|470196295|FG000|Overall Study|Physician Decision|0|||
130611371|NCT03280550|470196296|FG001|Overall Study|Physician Decision|1|||
130611372|NCT01915849|470196301|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
130611373|NCT01915849|470196302|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130611374|NCT01915849|470196303|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130611375|NCT01915849|470196304|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130611376|NCT01915849|470196301|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
130611377|NCT01915849|470196302|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130611378|NCT01915849|470196303|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130611379|NCT01915849|470196304|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130611380|NCT05091060|470196305|FG000|Overall Study|Lost to Follow-up|1|||
130611381|NCT02775864|470196306|FG000|Overall Study|Data ended end of 2010|1764|||
130611382|NCT02775864|470196307|FG001|Overall Study|Data ended end of 2010|2880|||
130611383|NCT02775864|470196308|FG002|Overall Study|Data ended end of 2010|1140|||
130611384|NCT02775864|470196309|FG003|Overall Study|Data ended end of 2010|1194|||
130611385|NCT02775864|470196306|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
130611386|NCT02775864|470196307|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
130611387|NCT02775864|470196308|FG002|Overall Study|Medicaid eligibility discontinued|720|||
130611388|NCT02775864|470196309|FG003|Overall Study|Medicaid eligibility discontinued|890|||
130611389|NCT03552549|470196311|FG000|Overall Study|Disease progression|25|||
130611390|NCT03552549|470196312|FG001|Overall Study|Disease progression|17|||
130611391|NCT03552549|470196311|FG000|Overall Study|Adverse event in first 12 months|12|||
130611392|NCT03552549|470196312|FG001|Overall Study|Adverse event in first 12 months|8|||
130611393|NCT03552549|470196311|FG000|Overall Study|Withdrawal by Subject|7|||
130611394|NCT03552549|470196312|FG001|Overall Study|Withdrawal by Subject|7|||
130611395|NCT03552549|470196311|FG000|Overall Study|Unknown (no reason provided)|4|||
130611396|NCT03552549|470196312|FG001|Overall Study|Unknown (no reason provided)|2|||
130611397|NCT03552549|470196311|FG000|Overall Study|Not in participant's best interest|2|||
130611398|NCT03552549|470196312|FG001|Overall Study|Not in participant's best interest|1|||
130611399|NCT03552549|470196311|FG000|Overall Study|Did not complete study treatment|2|||
130611400|NCT03552549|470196312|FG001|Overall Study|Did not complete study treatment|3|||
130611401|NCT03552549|470196311|FG000|Overall Study|Did not meet eligibility criteria|1|||
130611402|NCT03552549|470196312|FG001|Overall Study|Did not meet eligibility criteria|0|||
130611403|NCT03552549|470196311|FG000|Overall Study|Administrative|0|||
130611404|NCT03552549|470196312|FG001|Overall Study|Administrative|14|||
130611405|NCT02761993|470196319|FG000|Overall Study|Adverse Event|0|||
130611406|NCT02761993|470196320|FG001|Overall Study|Adverse Event|2|||
130611407|NCT02761993|470196321|FG002|Overall Study|Adverse Event|0|||
130611408|NCT02761993|470196319|FG000|Overall Study|Lost to Follow-up|1|||
130611409|NCT02761993|470196320|FG001|Overall Study|Lost to Follow-up|3|||
130611410|NCT02761993|470196321|FG002|Overall Study|Lost to Follow-up|2|||
130611411|NCT02761993|470196319|FG000|Overall Study|Withdrawal by Subject|1|||
130611412|NCT02761993|470196320|FG001|Overall Study|Withdrawal by Subject|1|||
130611413|NCT02761993|470196321|FG002|Overall Study|Withdrawal by Subject|2|||
130611414|NCT01465178|470196324|FG000|Overall Study|Withdrawal by Subject|1|||
130611415|NCT01465178|470196325|FG001|Overall Study|Withdrawal by Subject|0|||
130611416|NCT03827473|470196328|FG000|Overall Study|Withdrawal by Subject|1|||
130611417|NCT03827473|470196329|FG001|Overall Study|Withdrawal by Subject|0|||
130611418|NCT00875017|470196330|FG000|First Intervention|Withdrawal by Subject|1|||
130611419|NCT00875017|470196331|FG001|First Intervention|Withdrawal by Subject|0|||
130611420|NCT00875017|470196332|FG002|First Intervention|Withdrawal by Subject|1|||
130611421|NCT00875017|470196333|FG003|First Intervention|Withdrawal by Subject|0|||
130611422|NCT00875017|470196334|FG004|First Intervention|Withdrawal by Subject|0|||
130611423|NCT00875017|470196335|FG005|First Intervention|Withdrawal by Subject|0|||
130611424|NCT00875017|470196330|FG000|First Intervention|Adverse Event|0|||
130611425|NCT00875017|470196331|FG001|First Intervention|Adverse Event|0|||
130611426|NCT00875017|470196332|FG002|First Intervention|Adverse Event|0|||
130611427|NCT00875017|470196333|FG003|First Intervention|Adverse Event|1|||
130611428|NCT00875017|470196334|FG004|First Intervention|Adverse Event|0|||
130611429|NCT00875017|470196335|FG005|First Intervention|Adverse Event|0|||
130611430|NCT00875017|470196330|FG000|First Intervention|Problems collecting rectal effluent|1|||
130611431|NCT00875017|470196331|FG001|First Intervention|Problems collecting rectal effluent|0|||
130611432|NCT00875017|470196332|FG002|First Intervention|Problems collecting rectal effluent|0|||
130611433|NCT00875017|470196333|FG003|First Intervention|Problems collecting rectal effluent|0|||
130611434|NCT00875017|470196334|FG004|First Intervention|Problems collecting rectal effluent|0|||
130611435|NCT00875017|470196335|FG005|First Intervention|Problems collecting rectal effluent|0|||
130611436|NCT00875017|470196330|FG000|First Intervention|Intolerance to nasogastric tube|0|||
130611437|NCT00875017|470196331|FG001|First Intervention|Intolerance to nasogastric tube|0|||
130611438|NCT00875017|470196332|FG002|First Intervention|Intolerance to nasogastric tube|0|||
130611439|NCT00875017|470196333|FG003|First Intervention|Intolerance to nasogastric tube|0|||
130611440|NCT00875017|470196334|FG004|First Intervention|Intolerance to nasogastric tube|1|||
130611441|NCT00875017|470196335|FG005|First Intervention|Intolerance to nasogastric tube|0|||
130611442|NCT00875017|470196330|FG000|Washout|Problem collecting rectal effluent|0|||
130611443|NCT00875017|470196331|FG001|Washout|Problem collecting rectal effluent|0|||
130611444|NCT00875017|470196332|FG002|Washout|Problem collecting rectal effluent|1|||
130611445|NCT00875017|470196333|FG003|Washout|Problem collecting rectal effluent|0|||
130611446|NCT00875017|470196334|FG004|Washout|Problem collecting rectal effluent|0|||
130611447|NCT00875017|470196335|FG005|Washout|Problem collecting rectal effluent|0|||
130611448|NCT00875017|470196330|FG000|Second Intervention|Adverse Event|0|||
130611449|NCT00875017|470196331|FG001|Second Intervention|Adverse Event|0|||
130611450|NCT00875017|470196332|FG002|Second Intervention|Adverse Event|0|||
130611451|NCT00875017|470196333|FG003|Second Intervention|Adverse Event|1|||
130611452|NCT00875017|470196334|FG004|Second Intervention|Adverse Event|0|||
130611453|NCT00875017|470196335|FG005|Second Intervention|Adverse Event|0|||
130611454|NCT00875017|470196330|FG000|Washout|Problems collecting rectal effluent|0|||
130611455|NCT00875017|470196331|FG001|Washout|Problems collecting rectal effluent|1|||
130611456|NCT00875017|470196332|FG002|Washout|Problems collecting rectal effluent|0|||
130611457|NCT00875017|470196333|FG003|Washout|Problems collecting rectal effluent|0|||
130611458|NCT00875017|470196334|FG004|Washout|Problems collecting rectal effluent|0|||
130611459|NCT00875017|470196335|FG005|Washout|Problems collecting rectal effluent|0|||
130611460|NCT00875017|470196330|FG000|Third Intervention|Adverse Event|0|||
130611461|NCT00875017|470196331|FG001|Third Intervention|Adverse Event|1|||
130611462|NCT00875017|470196332|FG002|Third Intervention|Adverse Event|1|||
130611463|NCT00875017|470196333|FG003|Third Intervention|Adverse Event|0|||
130611464|NCT00875017|470196334|FG004|Third Intervention|Adverse Event|0|||
130611465|NCT00875017|470196335|FG005|Third Intervention|Adverse Event|0|||
130611466|NCT00875017|470196330|FG000|Washout|Withdrawal by Subject|0|||
130611467|NCT00875017|470196331|FG001|Washout|Withdrawal by Subject|0|||
130611468|NCT00875017|470196332|FG002|Washout|Withdrawal by Subject|0|||
130611469|NCT00875017|470196333|FG003|Washout|Withdrawal by Subject|0|||
130611470|NCT00875017|470196334|FG004|Washout|Withdrawal by Subject|1|||
130611471|NCT00875017|470196335|FG005|Washout|Withdrawal by Subject|0|||
130611472|NCT00875017|470196330|FG000|Fourth Intervention|Inability to comply with fasting|0|||
130611473|NCT00875017|470196331|FG001|Fourth Intervention|Inability to comply with fasting|0|||
130611474|NCT00875017|470196332|FG002|Fourth Intervention|Inability to comply with fasting|0|||
130611475|NCT00875017|470196333|FG003|Fourth Intervention|Inability to comply with fasting|0|||
130611476|NCT00875017|470196334|FG004|Fourth Intervention|Inability to comply with fasting|0|||
130611477|NCT00875017|470196335|FG005|Fourth Intervention|Inability to comply with fasting|1|||
130611478|NCT03342469|470196336|FG000|Overall Study|Withdrawal by Subject|0|||
130611479|NCT03342469|470196337|FG001|Overall Study|Withdrawal by Subject|1|||
130611480|NCT03342469|470196338|FG002|Overall Study|Withdrawal by Subject|0|||
130611481|NCT03342469|470196339|FG003|Overall Study|Withdrawal by Subject|0|||
130611482|NCT01477892|470196340|FG000|Overall Study|Withdrawal by Subject|0|||
130611483|NCT01477892|470196341|FG001|Overall Study|Withdrawal by Subject|2|||
130611484|NCT05515601|470196344|FG000|Overall Study|Withdrawal by Subject|1|||
130611485|NCT05515601|470196345|FG001|Overall Study|Withdrawal by Subject|3|||
130611486|NCT05515601|470196346|FG002|Overall Study|Withdrawal by Subject|2|||
130611487|NCT05515601|470196347|FG003|Overall Study|Withdrawal by Subject|1|||
130611488|NCT05515601|470196348|FG004|Overall Study|Withdrawal by Subject|1|||
130611489|NCT05515601|470196349|FG005|Overall Study|Withdrawal by Subject|1|||
130611490|NCT05515601|470196344|FG000|Overall Study|Lost to Follow-up|0|||
130611491|NCT05515601|470196345|FG001|Overall Study|Lost to Follow-up|0|||
130611492|NCT05515601|470196346|FG002|Overall Study|Lost to Follow-up|0|||
130611493|NCT05515601|470196347|FG003|Overall Study|Lost to Follow-up|0|||
130611494|NCT05515601|470196348|FG004|Overall Study|Lost to Follow-up|1|||
130611495|NCT05515601|470196349|FG005|Overall Study|Lost to Follow-up|0|||
130611496|NCT00777491|470196350|FG000|Overall Study|Protocol Violation|0|||
130611497|NCT00777491|470196351|FG001|Overall Study|Protocol Violation|2|||
130611498|NCT00777491|470196350|FG000|Overall Study|Did not receive any protocol treatment|2|||
130611499|NCT00777491|470196351|FG001|Overall Study|Did not receive any protocol treatment|0|||
130611500|NCT00540436|470196354|FG000|First 12-Week Treatment Period|Adverse Event|1|||
130611501|NCT00540436|470196354|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
130611502|NCT00540436|470196354|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
130611503|NCT00540436|470196354|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
130611504|NCT03255291|470196355|FG000|Overall Study|Determined to be ineligible|10|||
130611505|NCT03255291|470196356|FG001|Overall Study|Determined to be ineligible|12|||
130611506|NCT03255291|470196357|FG002|Overall Study|Determined to be ineligible|6|||
130611507|NCT03255291|470196358|FG003|Overall Study|Determined to be ineligible|6|||
130611508|NCT03255291|470196359|FG004|Overall Study|Determined to be ineligible|5|||
130611509|NCT03255291|470196360|FG005|Overall Study|Determined to be ineligible|10|||
130611510|NCT03255291|470196355|FG000|Overall Study|Baseline data collection issues|3|||
130611511|NCT03255291|470196356|FG001|Overall Study|Baseline data collection issues|0|||
130611512|NCT03255291|470196357|FG002|Overall Study|Baseline data collection issues|0|||
130611513|NCT03255291|470196358|FG003|Overall Study|Baseline data collection issues|0|||
130611514|NCT03255291|470196359|FG004|Overall Study|Baseline data collection issues|2|||
130611515|NCT03255291|470196360|FG005|Overall Study|Baseline data collection issues|0|||
130611516|NCT00471445|470196361|FG000|Overall Study|Withdrawal by Subject|1|||
130611517|NCT00471445|470196362|FG001|Overall Study|Withdrawal by Subject|1|||
130611518|NCT00471445|470196361|FG000|Overall Study|Ineligible|1|||
130611519|NCT00471445|470196362|FG001|Overall Study|Ineligible|0|||
130611520|NCT00471445|470196361|FG000|Overall Study|Protocol Violation|0|||
130611521|NCT00471445|470196362|FG001|Overall Study|Protocol Violation|1|||
130611522|NCT01067508|470196365|FG000|Overall Study|Physician Decision|0|||
130611523|NCT01067508|470196366|FG001|Overall Study|Physician Decision|1|||
130611524|NCT01067508|470196365|FG000|Overall Study|Withdrawal by Subject|0|||
130611525|NCT01067508|470196366|FG001|Overall Study|Withdrawal by Subject|1|||
130611526|NCT00444626|470196369|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
130611527|NCT00444626|470196369|FG000|Initial Treatment Period|Adverse Event|1|||
130611528|NCT00444626|470196369|FG000|Initial Treatment Period|Lost to Follow-up|9|||
130611529|NCT04594239|470196370|FG000|Overall Study|Withdrawal by Subject|3|||
130611530|NCT04594239|470196371|FG001|Overall Study|Withdrawal by Subject|4|||
130611531|NCT04594239|470196372|FG002|Overall Study|Withdrawal by Subject|2|||
130611532|NCT04594239|470196373|FG003|Overall Study|Withdrawal by Subject|4|||
130611533|NCT04594239|470196370|FG000|Overall Study|Lost to Follow-up|8|||
130611534|NCT04594239|470196371|FG001|Overall Study|Lost to Follow-up|5|||
130611535|NCT04594239|470196372|FG002|Overall Study|Lost to Follow-up|4|||
130611536|NCT04594239|470196373|FG003|Overall Study|Lost to Follow-up|6|||
130611537|NCT04594239|470196370|FG000|Overall Study|Subject relocated|0|||
130611538|NCT04594239|470196371|FG001|Overall Study|Subject relocated|0|||
130611539|NCT04594239|470196372|FG002|Overall Study|Subject relocated|0|||
130611540|NCT04594239|470196373|FG003|Overall Study|Subject relocated|1|||
130611541|NCT00091390|470196374|FG000|Overall Study|Protocol Violation|1|||
130611542|NCT00091390|470196374|FG000|Overall Study|No protocol treatment|3|||
130611543|NCT03229759|470196375|FG000|Overall Study|Screen Failure|30|||
130611544|NCT02326467|470197766|FG000|Overall Study|Withdrawal by Subject|1|||
130611545|NCT00434512|470197767|FG000|Overall Study|Migrated/moved from study area|0|||
130611546|NCT00434512|470197768|FG001|Overall Study|Migrated/moved from study area|0|||
130611547|NCT00434512|470197769|FG002|Overall Study|Migrated/moved from study area|0|||
130611548|NCT00434512|470197770|FG003|Overall Study|Migrated/moved from study area|1|||
130611549|NCT00434512|470197771|FG004|Overall Study|Migrated/moved from study area|1|||
130611550|NCT00434512|470197772|FG005|Overall Study|Migrated/moved from study area|1|||
130611551|NCT00434512|470197767|FG000|Overall Study|Other|0|||
130611552|NCT00434512|470197768|FG001|Overall Study|Other|1|||
130611553|NCT00434512|470197769|FG002|Overall Study|Other|0|||
130611554|NCT00434512|470197770|FG003|Overall Study|Other|0|||
130611555|NCT00434512|470197771|FG004|Overall Study|Other|0|||
130611556|NCT00434512|470197772|FG005|Overall Study|Other|0|||
130611557|NCT01575197|470197775|FG000|Overall Study|Migration out of study area|1|||
130611558|NCT01575197|470197776|FG001|Overall Study|Migration out of study area|5|||
130611559|NCT01575197|470197777|FG002|Overall Study|Migration out of study area|4|||
130611560|NCT01575197|470197775|FG000|Overall Study|SAE|0|||
130611561|NCT01575197|470197776|FG001|Overall Study|SAE|1|||
130611562|NCT01575197|470197777|FG002|Overall Study|SAE|0|||
130611563|NCT01575197|470197775|FG000|Overall Study|Lost to Follow-up|0|||
130611564|NCT01575197|470197776|FG001|Overall Study|Lost to Follow-up|1|||
130611565|NCT01575197|470197777|FG002|Overall Study|Lost to Follow-up|0|||
130611566|NCT01575197|470197775|FG000|Overall Study|Withdrawal by Subject|0|||
130611567|NCT01575197|470197776|FG001|Overall Study|Withdrawal by Subject|1|||
130611568|NCT01575197|470197777|FG002|Overall Study|Withdrawal by Subject|1|||
130611569|NCT01575197|470197775|FG000|Overall Study|Protocol Violation|2|||
130611570|NCT01575197|470197776|FG001|Overall Study|Protocol Violation|1|||
130611571|NCT01575197|470197777|FG002|Overall Study|Protocol Violation|1|||
130611572|NCT04281030|470197789|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
130611573|NCT04281030|470197790|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
130611574|NCT04281030|470197789|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
130611575|NCT04281030|470197790|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
130611576|NCT01361009|470197791|FG000|Overall Study|Protocol Violation|116|||
130611577|NCT02116660|470197793|FG000|Overall Study|Deteriorating renal function|0|||
130611578|NCT02116660|470197794|FG001|Overall Study|Deteriorating renal function|1|||
130611579|NCT02116660|470197793|FG000|Overall Study|Adverse Event|1|||
130611580|NCT02116660|470197794|FG001|Overall Study|Adverse Event|1|||
130611581|NCT02116660|470197793|FG000|Overall Study|Withdrawal by Subject|0|||
130611582|NCT02116660|470197794|FG001|Overall Study|Withdrawal by Subject|2|||
130611583|NCT02116660|470197793|FG000|Overall Study|Organization reason|1|||
130611584|NCT02116660|470197794|FG001|Overall Study|Organization reason|0|||
130611585|NCT00411788|470197795|FG000|Overall Study|Protocol Violation|1|||
130611586|NCT00411788|470197795|FG000|Overall Study|Adverse Event|1|||
130611587|NCT01727713|470197800|FG000|Overall Study|Lost to Follow-up|5|||
130611588|NCT01727713|470197800|FG000|Overall Study|Adverse Event|10|||
130611589|NCT01727713|470197800|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
130611590|NCT01727713|470197800|FG000|Overall Study|Withdrawal by Subject|13|||
130611591|NCT01727713|470197800|FG000|Overall Study|Protocol Deviation|2|||
130611592|NCT04891770|470197803|FG000|Overall Study|Withdrew consent|1|||
130611593|NCT04891770|470197804|FG001|Overall Study|Withdrew consent|3|||
130611594|NCT04891770|470197805|FG002|Overall Study|Withdrew consent|0|||
130611595|NCT04891770|470197803|FG000|Overall Study|Enrolled but never treated|0|||
130611596|NCT04891770|470197804|FG001|Overall Study|Enrolled but never treated|0|||
130611597|NCT04891770|470197805|FG002|Overall Study|Enrolled but never treated|1|||
130611598|NCT04891770|470197803|FG000|Overall Study|Investigator's discretion|0|||
130611599|NCT04891770|470197804|FG001|Overall Study|Investigator's discretion|1|||
130611600|NCT04891770|470197805|FG002|Overall Study|Investigator's discretion|0|||
130611601|NCT00222729|470197814|FG000|Overall Study|Adverse Event|3|||
130611602|NCT00515008|470197815|FG000|Overall Study|Lost to Follow-up|1|||
130611603|NCT00515008|470197816|FG001|Overall Study|Lost to Follow-up|0|||
130611604|NCT00515008|470197815|FG000|Overall Study|Declined|0|||
130611605|NCT00515008|470197816|FG001|Overall Study|Declined|3|||
130611606|NCT00515008|470197815|FG000|Overall Study|Left the Boston Area|1|||
130611607|NCT00515008|470197816|FG001|Overall Study|Left the Boston Area|1|||
130611608|NCT00515008|470197815|FG000|Overall Study|Scheduling conflict|1|||
130611609|NCT00515008|470197816|FG001|Overall Study|Scheduling conflict|0|||
130611610|NCT01798706|470197817|FG000|Overall Study|Adverse Event|15|||
130611611|NCT01798706|470197818|FG001|Overall Study|Adverse Event|10|||
130611612|NCT01798706|470197817|FG000|Overall Study|Lack of Efficacy|0|||
130611613|NCT01798706|470197818|FG001|Overall Study|Lack of Efficacy|2|||
130611614|NCT01798706|470197817|FG000|Overall Study|Poor compliance to protocol|1|||
130611615|NCT01798706|470197818|FG001|Overall Study|Poor compliance to protocol|0|||
130611616|NCT01798706|470197817|FG000|Overall Study|Other than specified above|5|||
130611617|NCT01798706|470197818|FG001|Overall Study|Other than specified above|9|||
130611618|NCT00496873|470197819|FG000|Overall Study|Ineligible|2|||
130611619|NCT00496873|470197819|FG000|Overall Study|Death|2|||
130611620|NCT00496873|470197819|FG000|Overall Study|Withdrawal by Subject|3|||
130611621|NCT03238235|470197820|FG000|Overall Study|Adverse Event|2|||
130611622|NCT03238235|470197821|FG001|Overall Study|Adverse Event|0|||
130611623|NCT03238235|470197820|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
130611624|NCT03238235|470197821|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
130611625|NCT01318083|470197824|FG000|Overall Study|Adverse Event|4|||
130611626|NCT01318083|470197825|FG001|Overall Study|Adverse Event|1|||
130611627|NCT01318083|470197826|FG002|Overall Study|Adverse Event|2|||
130611628|NCT01318083|470197824|FG000|Overall Study|Withdrawal by Subject|1|||
130611629|NCT01318083|470197825|FG001|Overall Study|Withdrawal by Subject|0|||
130611630|NCT01318083|470197826|FG002|Overall Study|Withdrawal by Subject|2|||
130611631|NCT01318083|470197824|FG000|Overall Study|Lack of Efficacy|0|||
130611632|NCT01318083|470197825|FG001|Overall Study|Lack of Efficacy|0|||
130611633|NCT01318083|470197826|FG002|Overall Study|Lack of Efficacy|1|||
130611634|NCT01318083|470197824|FG000|Overall Study|Treatment Complications|1|||
130611635|NCT01318083|470197825|FG001|Overall Study|Treatment Complications|0|||
130611636|NCT01318083|470197826|FG002|Overall Study|Treatment Complications|0|||
130611637|NCT01318083|470197824|FG000|Overall Study|Lack of Study Medication Compliance|0|||
130611638|NCT01318083|470197825|FG001|Overall Study|Lack of Study Medication Compliance|1|||
130611639|NCT01318083|470197826|FG002|Overall Study|Lack of Study Medication Compliance|0|||
130611640|NCT05896761|470197827|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
130611641|NCT05896761|470197828|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
130611642|NCT05896761|470197827|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
130611643|NCT05896761|470197828|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
130611644|NCT02028338|470197829|FG000|Overall Study|Withdrawal by Subject|3|||
130611645|NCT02028338|470197830|FG001|Overall Study|Withdrawal by Subject|1|||
130611646|NCT02028338|470197829|FG000|Overall Study|Unable to contact participant|1|||
130611647|NCT02028338|470197830|FG001|Overall Study|Unable to contact participant|0|||
130611648|NCT01842620|470197835|FG000|Period 1|Withdrawal by Subject|1|||
130611649|NCT01842620|470197836|FG001|Period 1|Withdrawal by Subject|0|||
130611650|NCT02739594|470197837|FG000|Overall Study|Undesired Event|3|||
130611651|NCT02739594|470197838|FG001|Overall Study|Undesired Event|4|||
130611652|NCT02739594|470197837|FG000|Overall Study|Violation of Eligibility Criteria|1|||
130611653|NCT02739594|470197838|FG001|Overall Study|Violation of Eligibility Criteria|2|||
130611654|NCT02739594|470197837|FG000|Overall Study|Protocol Violation|5|||
130611655|NCT02739594|470197838|FG001|Overall Study|Protocol Violation|6|||
130611656|NCT02739594|470197837|FG000|Overall Study|Death|4|||
130611657|NCT02739594|470197838|FG001|Overall Study|Death|2|||
130611658|NCT02739594|470197837|FG000|Overall Study|Renal Insufficiency|4|||
130611659|NCT02739594|470197838|FG001|Overall Study|Renal Insufficiency|6|||
130611660|NCT02739594|470197837|FG000|Overall Study|Administrative Reasons|1|||
130611661|NCT02739594|470197838|FG001|Overall Study|Administrative Reasons|3|||
130611662|NCT02739594|470197837|FG000|Overall Study|Withdrawal by Subject|1|||
130611663|NCT02739594|470197838|FG001|Overall Study|Withdrawal by Subject|1|||
130611664|NCT02739594|470197837|FG000|Overall Study|Lost to Follow-up|0|||
130611665|NCT02739594|470197838|FG001|Overall Study|Lost to Follow-up|1|||
130611666|NCT02739594|470197837|FG000|Overall Study|Elevated Serum Creatinine|0|||
130611667|NCT02739594|470197838|FG001|Overall Study|Elevated Serum Creatinine|1|||
130611668|NCT02739594|470197837|FG000|Overall Study|Other|6|||
130611669|NCT02739594|470197838|FG001|Overall Study|Other|2|||
130611670|NCT00527111|470197841|FG000|Overall Study|Adverse Event|14|||
130611671|NCT00527111|470197842|FG001|Overall Study|Adverse Event|13|||
130611672|NCT00527111|470197841|FG000|Overall Study|Death|0|||
130611673|NCT00527111|470197842|FG001|Overall Study|Death|1|||
130611674|NCT00527111|470197841|FG000|Overall Study|Investigator Request|2|||
130611675|NCT00527111|470197842|FG001|Overall Study|Investigator Request|1|||
130611676|NCT00527111|470197841|FG000|Overall Study|Patient Request|2|||
130611677|NCT00527111|470197842|FG001|Overall Study|Patient Request|5|||
130611678|NCT00527111|470197841|FG000|Overall Study|Other|2|||
130611679|NCT00527111|470197842|FG001|Overall Study|Other|2|||
130611680|NCT01930799|470197845|FG000|Overall Study|Withdrawal by Subject|3|||
130611681|NCT01930799|470197845|FG000|Overall Study|Lost to Follow-up|5|||
130611682|NCT00952289|470197847|FG000|All Participants|Death|9|||
130611683|NCT00952289|470197848|FG001|All Participants|Death|9|||
130611684|NCT00952289|470197847|FG000|All Participants|Adverse Event|8|||
130611685|NCT00952289|470197848|FG001|All Participants|Adverse Event|8|||
130611686|NCT00952289|470197847|FG000|All Participants|Disease progression|3|||
130611687|NCT00952289|470197848|FG001|All Participants|Disease progression|12|||
130611688|NCT00952289|470197847|FG000|All Participants|Withdrawal by Subject|1|||
130611689|NCT00952289|470197848|FG001|All Participants|Withdrawal by Subject|10|||
130611690|NCT00952289|470197847|FG000|All Participants|Data lost during site relocation|0|||
130611691|NCT00952289|470197848|FG001|All Participants|Data lost during site relocation|1|||
130611692|NCT00952289|470197847|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
130611693|NCT00952289|470197848|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
130611694|NCT00952289|470197847|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
130611695|NCT00952289|470197848|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
130611696|NCT00952289|470197847|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
130611697|NCT00952289|470197848|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
130611698|NCT00952289|470197847|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
130611699|NCT00952289|470197848|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
130611700|NCT00952289|470197847|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
130611701|NCT00952289|470197848|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
130611702|NCT01921257|470197851|FG000|Overall Study|Adverse Event|1|||
130611703|NCT01921257|470197851|FG000|Overall Study|Protocol Violation|1|||
130611704|NCT01921257|470197851|FG000|Overall Study|Withdrawal by Subject|1|||
130611705|NCT00364845|470197855|FG000|Overall Study|Adverse Event|1|||
130611706|NCT00364845|470197856|FG001|Overall Study|Adverse Event|0|||
130611707|NCT00364845|470197855|FG000|Overall Study|Withdrawal by Subject|2|||
130611708|NCT00364845|470197856|FG001|Overall Study|Withdrawal by Subject|1|||
130611709|NCT00364845|470197855|FG000|Overall Study|Physician Decision|8|||
130611710|NCT00364845|470197856|FG001|Overall Study|Physician Decision|8|||
130611711|NCT00364845|470197855|FG000|Overall Study|Lost to Follow-up|0|||
130611712|NCT00364845|470197856|FG001|Overall Study|Lost to Follow-up|1|||
130611713|NCT00364845|470197855|FG000|Overall Study|Death|0|||
130611714|NCT00364845|470197856|FG001|Overall Study|Death|1|||
130611715|NCT04160468|470197857|FG000|Overall Study|Lost to Follow-up|19|||
130611716|NCT04160468|470197858|FG001|Overall Study|Lost to Follow-up|4|||
130611717|NCT04160468|470197857|FG000|Overall Study|Randomized but not dosed|6|||
130611718|NCT04160468|470197858|FG001|Overall Study|Randomized but not dosed|0|||
130611719|NCT04160468|470197857|FG000|Overall Study|Withdrawal by Subject|4|||
130611720|NCT04160468|470197858|FG001|Overall Study|Withdrawal by Subject|1|||
130611721|NCT04160468|470197857|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
130611722|NCT04160468|470197858|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
130611723|NCT04160468|470197857|FG000|Overall Study|Participant incarcerated|1|||
130611724|NCT04160468|470197858|FG001|Overall Study|Participant incarcerated|0|||
130611725|NCT01187901|470197859|FG000|Overall Study|Protocol Violation|1|||
130611726|NCT01187901|470197860|FG001|Overall Study|Protocol Violation|0|||
130611727|NCT01187901|470197859|FG000|Overall Study|Lost to Follow-up|1|||
130611728|NCT01187901|470197860|FG001|Overall Study|Lost to Follow-up|2|||
130611729|NCT01187901|470197859|FG000|Overall Study|Unrelated Health Reasons|1|||
130611730|NCT01187901|470197860|FG001|Overall Study|Unrelated Health Reasons|2|||
130611731|NCT01187901|470197859|FG000|Overall Study|Suspected Allergic Reaction|1|||
130611732|NCT01187901|470197860|FG001|Overall Study|Suspected Allergic Reaction|1|||
130611733|NCT01187901|470197859|FG000|Overall Study|Adverse Event|3|||
130611734|NCT01187901|470197860|FG001|Overall Study|Adverse Event|0|||
130611735|NCT01187901|470197859|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
130611736|NCT01187901|470197860|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
130611737|NCT01187901|470197859|FG000|Overall Study|Pregnancy|0|||
130611738|NCT01187901|470197860|FG001|Overall Study|Pregnancy|2|||
130611739|NCT01912768|470197861|FG000|Overall Study|Adverse Event|2|||
130611740|NCT01912768|470197862|FG001|Overall Study|Adverse Event|0|||
130611741|NCT01912768|470197861|FG000|Overall Study|Lost to Follow-up|2|||
130611742|NCT01912768|470197862|FG001|Overall Study|Lost to Follow-up|1|||
130611743|NCT01912768|470197861|FG000|Overall Study|Withdrawal by Subject|5|||
130611744|NCT01912768|470197862|FG001|Overall Study|Withdrawal by Subject|3|||
130611745|NCT01912768|470197861|FG000|Overall Study|Randomized in error|1|||
130611746|NCT01912768|470197862|FG001|Overall Study|Randomized in error|0|||
130611747|NCT01745393|470197864|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
130611748|NCT01745393|470197865|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
130611749|NCT01745393|470197864|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
130611750|NCT01745393|470197865|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
130611751|NCT01745393|470197864|FG000|12-month Follow-up|Lost to Follow-up|6|||
130611752|NCT01745393|470197865|FG001|12-month Follow-up|Lost to Follow-up|5|||
130611753|NCT03591146|470197866|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130611754|NCT03591146|470197867|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130611755|NCT03591146|470197868|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130611756|NCT03591146|470197869|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130611757|NCT03591146|470197870|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
130611758|NCT03591146|470197866|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130611759|NCT03591146|470197867|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
130611760|NCT03591146|470197868|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130611761|NCT03591146|470197869|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130611762|NCT03591146|470197870|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130611763|NCT03591146|470197866|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130611764|NCT03591146|470197867|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130611765|NCT03591146|470197868|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130611766|NCT03591146|470197869|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130611767|NCT03591146|470197870|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
130611768|NCT03591146|470197866|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130611769|NCT03591146|470197867|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130611770|NCT03591146|470197868|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
130611771|NCT03591146|470197869|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130611772|NCT03591146|470197870|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
130611773|NCT04737031|470197871|FG000|Overall Study|Patients who did not have a treatment visit|0|||
130611774|NCT04737031|470197872|FG001|Overall Study|Patients who did not have a treatment visit|31|||
130611775|NCT04737031|470197873|FG002|Overall Study|Patients who did not have a treatment visit|93|||
130611776|NCT04737031|470197874|FG003|Overall Study|Patients who did not have a treatment visit|227|||
130611777|NCT04715230|470197879|FG000|Overall Study|Withdrawal by Subject|1|||
130611778|NCT04715230|470197880|FG001|Overall Study|Withdrawal by Subject|0|||
130611779|NCT04715230|470197881|FG002|Overall Study|Withdrawal by Subject|0|||
130611780|NCT04715230|470197879|FG000|Overall Study|Lost to Follow-up|0|||
130611781|NCT04715230|470197880|FG001|Overall Study|Lost to Follow-up|5|||
130611782|NCT04715230|470197881|FG002|Overall Study|Lost to Follow-up|1|||
130611783|NCT03453151|470197882|FG000|Overall Study|Withdrawal by Subject|1|||
130611784|NCT03453151|470197882|FG000|Overall Study|Physician Decision|3|||
130611785|NCT01468909|470197886|FG000|Overall Study|Never Treated|2|||
130611786|NCT01468909|470197887|FG001|Overall Study|Never Treated|2|||
130611787|NCT01511419|470197890|FG000|Dose 2|Physician Decision|1|||
130611788|NCT01511419|470197891|FG001|Dose 2|Physician Decision|0|||
130611789|NCT00488618|470197899|FG000|Overall Study|Adverse Event|13|||
130611790|NCT00488618|470197900|FG001|Overall Study|Adverse Event|17|||
130611791|NCT00488618|470197899|FG000|Overall Study|Insufficient Therapeutic Response|18|||
130611792|NCT00488618|470197900|FG001|Overall Study|Insufficient Therapeutic Response|11|||
130611793|NCT00488618|470197899|FG000|Overall Study|Protocol Violation|0|||
130611794|NCT00488618|470197900|FG001|Overall Study|Protocol Violation|2|||
130611795|NCT00488618|470197899|FG000|Overall Study|Withdrawal of Consent|15|||
130611796|NCT00488618|470197900|FG001|Overall Study|Withdrawal of Consent|13|||
130611797|NCT00488618|470197899|FG000|Overall Study|Lost to Follow-up|1|||
130611798|NCT00488618|470197900|FG001|Overall Study|Lost to Follow-up|0|||
130611799|NCT00111475|470199396|FG000|Overall Study|Lost to Follow-up|0|||
130611800|NCT00111475|470199397|FG001|Overall Study|Lost to Follow-up|0|||
130611801|NCT00111475|470199398|FG002|Overall Study|Lost to Follow-up|0|||
130611802|NCT00111475|470199399|FG003|Overall Study|Lost to Follow-up|0|||
130611803|NCT00111475|470199400|FG004|Overall Study|Lost to Follow-up|0|||
130611804|NCT00111475|470199401|FG005|Overall Study|Lost to Follow-up|1|||
130611805|NCT00111475|470199402|FG006|Overall Study|Lost to Follow-up|0|||
130611806|NCT00111475|470199403|FG007|Overall Study|Lost to Follow-up|0|||
130611807|NCT00111475|470199404|FG008|Overall Study|Lost to Follow-up|0|||
130611808|NCT00111475|470199405|FG009|Overall Study|Lost to Follow-up|0|||
130611809|NCT03303092|470199406|FG000|Overall Study|Adverse Event|1|||
130611810|NCT03303092|470199407|FG001|Overall Study|Adverse Event|0|||
130611811|NCT03303092|470199408|FG002|Overall Study|Adverse Event|1|||
130611812|NCT03303092|470199406|FG000|Overall Study|Protocol Violation|1|||
130611813|NCT03303092|470199407|FG001|Overall Study|Protocol Violation|5|||
130611814|NCT03303092|470199408|FG002|Overall Study|Protocol Violation|1|||
130611815|NCT03303092|470199406|FG000|Overall Study|Withdrawal by Subject|1|||
130611816|NCT03303092|470199407|FG001|Overall Study|Withdrawal by Subject|1|||
130611817|NCT03303092|470199408|FG002|Overall Study|Withdrawal by Subject|3|||
130611818|NCT00833248|470199414|FG000|Overall Study|Adverse Event|3|||
130611819|NCT00833248|470199415|FG001|Overall Study|Adverse Event|0|||
130611820|NCT00833248|470199414|FG000|Overall Study|Protocol Violation|1|||
130611821|NCT00833248|470199415|FG001|Overall Study|Protocol Violation|2|||
130611822|NCT00833248|470199414|FG000|Overall Study|Withdrawal by Subject|0|||
130611823|NCT00833248|470199415|FG001|Overall Study|Withdrawal by Subject|1|||
130611824|NCT02006667|470199416|FG000|Overall Study|Adverse Event|3|||
130611825|NCT02006667|470199416|FG000|Overall Study|Death|2|||
130611826|NCT02006667|470199416|FG000|Overall Study|Withdrawal by Subject|1|||
130611827|NCT02939937|470199417|FG000|Overall Study|Adverse Event|5|||
130611828|NCT02939937|470199418|FG001|Overall Study|Adverse Event|0|||
130611829|NCT02939937|470199417|FG000|Overall Study|Lost to Follow-up|1|||
130611830|NCT02939937|470199418|FG001|Overall Study|Lost to Follow-up|3|||
130611831|NCT01826422|470199419|FG000|Overall Study|Withdrawal by Subject|1|||
130611832|NCT01826422|470199420|FG001|Overall Study|Withdrawal by Subject|3|||
130611833|NCT03439748|470199426|FG000|Overall Study|Withdrawal by Subject|11|||
130611834|NCT03439748|470199427|FG001|Overall Study|Withdrawal by Subject|17|||
130611835|NCT05131451|470199428|FG000|Overall Study|Protocol Violation|1|||
130611836|NCT05131451|470199429|FG001|Overall Study|Protocol Violation|0|||
130611837|NCT00782418|470199436|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
130611838|NCT00782418|470199437|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611839|NCT00782418|470199438|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611840|NCT00782418|470199439|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611841|NCT00782418|470199440|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611842|NCT00782418|470199441|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611843|NCT00782418|470199442|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130611844|NCT00782418|470199436|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130611845|NCT00782418|470199437|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130611846|NCT00782418|470199438|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130611847|NCT00782418|470199439|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130611848|NCT00782418|470199440|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130611849|NCT00782418|470199441|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130611850|NCT00782418|470199442|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130611851|NCT02324842|470199443|FG000|Overall Study|Lost to Follow-up|1|||
130611852|NCT02324842|470199444|FG001|Overall Study|Lost to Follow-up|1|||
130611853|NCT02324842|470199445|FG002|Overall Study|Lost to Follow-up|2|||
130611854|NCT02750800|470199446|FG000|Overall Study|Adverse Event|18|||
130611855|NCT02750800|470199446|FG000|Overall Study|Lost to Follow-up|12|||
130611856|NCT02750800|470199446|FG000|Overall Study|Investigator decision|53|||
130611857|NCT02750800|470199446|FG000|Overall Study|Patient request|12|||
130611858|NCT02750800|470199446|FG000|Overall Study|Other, not specified|3|||
130611859|NCT03298412|470199447|FG000|Run-in Period|Other, Not Specified|1|||
130611860|NCT03298412|470199447|FG000|Run-in Period|Disease Progression|1|||
130611861|NCT03298412|470199447|FG000|Run-in Period|Ineligibility Determined|1|||
130611862|NCT03298412|470199447|FG000|Run-in Period|Decision by Sponsor|6|||
130611863|NCT05631548|470199449|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
130611864|NCT05631548|470199450|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
130611865|NCT01592409|470199451|FG000|Overall Study|Withdrawal by Subject|0|||
130611866|NCT01592409|470199452|FG001|Overall Study|Withdrawal by Subject|1|||
130611867|NCT01409031|470199457|FG000|Overall Study|transferred to other hosp|1|||
130611868|NCT01409031|470199458|FG001|Overall Study|transferred to other hosp|0|||
130611869|NCT00995345|470199460|FG000|Overall Study|Withdrawal by Subject|4|||
130611870|NCT00995345|470199461|FG001|Overall Study|Withdrawal by Subject|2|||
130611871|NCT00995345|470199462|FG002|Overall Study|Withdrawal by Subject|1|||
130611872|NCT00995345|470199463|FG003|Overall Study|Withdrawal by Subject|3|||
130611873|NCT00995345|470199464|FG004|Overall Study|Withdrawal by Subject|1|||
130611874|NCT00995345|470199460|FG000|Overall Study|Adverse Event|3|||
130611875|NCT00995345|470199461|FG001|Overall Study|Adverse Event|1|||
130611876|NCT00995345|470199462|FG002|Overall Study|Adverse Event|2|||
130611877|NCT00995345|470199463|FG003|Overall Study|Adverse Event|0|||
130611878|NCT00995345|470199464|FG004|Overall Study|Adverse Event|1|||
130611879|NCT00995345|470199460|FG000|Overall Study|Lost to Follow-up|2|||
130611880|NCT00995345|470199461|FG001|Overall Study|Lost to Follow-up|2|||
130611881|NCT00995345|470199462|FG002|Overall Study|Lost to Follow-up|2|||
130611882|NCT00995345|470199463|FG003|Overall Study|Lost to Follow-up|1|||
130611883|NCT00995345|470199464|FG004|Overall Study|Lost to Follow-up|0|||
130611884|NCT00995345|470199460|FG000|Overall Study|all other reasons combined|2|||
130611885|NCT00995345|470199461|FG001|Overall Study|all other reasons combined|2|||
130611886|NCT00995345|470199462|FG002|Overall Study|all other reasons combined|2|||
130611887|NCT00995345|470199463|FG003|Overall Study|all other reasons combined|1|||
130611888|NCT00995345|470199464|FG004|Overall Study|all other reasons combined|3|||
130611889|NCT01860534|470199465|FG000|ROP #1|Needed treatment for ROP|0|||
130611890|NCT01860534|470199466|FG001|ROP #1|Needed treatment for ROP|1|||
130611891|NCT01860534|470199465|FG000|ROP #2|discharged prior to ROP #2|1|||
130611892|NCT01860534|470199466|FG001|ROP #2|discharged prior to ROP #2|0|||
130611893|NCT01934894|470199469|FG000|Overall Study|Adverse Event|1|||
130611894|NCT01934894|470199470|FG001|Overall Study|Adverse Event|2|||
130611895|NCT01934894|470199469|FG000|Overall Study|Death|2|||
130611896|NCT01934894|470199470|FG001|Overall Study|Death|0|||
130611897|NCT01934894|470199469|FG000|Overall Study|Withdrawal by Subject|0|||
130611898|NCT01934894|470199470|FG001|Overall Study|Withdrawal by Subject|1|||
130611899|NCT01934894|470199469|FG000|Overall Study|Progressive Disease|3|||
130611900|NCT01934894|470199470|FG001|Overall Study|Progressive Disease|2|||
130611901|NCT01100307|470199474|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
130611902|NCT01100307|470199475|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
130611903|NCT01100307|470199474|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
130611904|NCT01100307|470199475|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
130611905|NCT01100307|470199474|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
130611906|NCT01100307|470199475|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
130611907|NCT01100307|470199474|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
130611908|NCT01100307|470199475|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
130611909|NCT01100307|470199474|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
130611910|NCT01100307|470199475|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
130611911|NCT01100307|470199474|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
130611912|NCT01100307|470199475|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
130611913|NCT05122650|470199476|FG000|Overall Study|Adverse Event|4|||
130611914|NCT05122650|470199477|FG001|Overall Study|Adverse Event|16|||
130611915|NCT05122650|470199478|FG002|Overall Study|Adverse Event|11|||
130611916|NCT05122650|470199479|FG003|Overall Study|Adverse Event|12|||
130611917|NCT05122650|470199476|FG000|Overall Study|Lack of Efficacy|0|||
130611918|NCT05122650|470199477|FG001|Overall Study|Lack of Efficacy|1|||
130611919|NCT05122650|470199478|FG002|Overall Study|Lack of Efficacy|1|||
130611920|NCT05122650|470199479|FG003|Overall Study|Lack of Efficacy|2|||
130611921|NCT05122650|470199476|FG000|Overall Study|Lost to Follow-up|1|||
130611922|NCT05122650|470199477|FG001|Overall Study|Lost to Follow-up|1|||
130611923|NCT05122650|470199478|FG002|Overall Study|Lost to Follow-up|3|||
130611924|NCT05122650|470199479|FG003|Overall Study|Lost to Follow-up|0|||
130611925|NCT05122650|470199476|FG000|Overall Study|Non-compliance with study intervention|0|||
130611926|NCT05122650|470199477|FG001|Overall Study|Non-compliance with study intervention|0|||
130611927|NCT05122650|470199478|FG002|Overall Study|Non-compliance with study intervention|0|||
130611928|NCT05122650|470199479|FG003|Overall Study|Non-compliance with study intervention|2|||
130611929|NCT05122650|470199476|FG000|Overall Study|Protocol Violation|0|||
130611930|NCT05122650|470199477|FG001|Overall Study|Protocol Violation|1|||
130611931|NCT05122650|470199478|FG002|Overall Study|Protocol Violation|0|||
130611932|NCT05122650|470199479|FG003|Overall Study|Protocol Violation|1|||
130611933|NCT05122650|470199476|FG000|Overall Study|Randomized by mistake|0|||
130611934|NCT05122650|470199477|FG001|Overall Study|Randomized by mistake|0|||
130611935|NCT05122650|470199478|FG002|Overall Study|Randomized by mistake|3|||
130611936|NCT05122650|470199479|FG003|Overall Study|Randomized by mistake|2|||
130611937|NCT05122650|470199476|FG000|Overall Study|Sponsor request|0|||
130611938|NCT05122650|470199477|FG001|Overall Study|Sponsor request|1|||
130611939|NCT05122650|470199478|FG002|Overall Study|Sponsor request|1|||
130611940|NCT05122650|470199479|FG003|Overall Study|Sponsor request|2|||
130611941|NCT05122650|470199476|FG000|Overall Study|Withdrawal by Subject|3|||
130611942|NCT05122650|470199477|FG001|Overall Study|Withdrawal by Subject|7|||
130611943|NCT05122650|470199478|FG002|Overall Study|Withdrawal by Subject|4|||
130611944|NCT05122650|470199479|FG003|Overall Study|Withdrawal by Subject|8|||
130611945|NCT05122650|470199476|FG000|Overall Study|Other|5|||
130611946|NCT05122650|470199477|FG001|Overall Study|Other|0|||
130611947|NCT05122650|470199478|FG002|Overall Study|Other|0|||
130611948|NCT05122650|470199479|FG003|Overall Study|Other|0|||
130611949|NCT04360187|470199487|FG000|Double-Blind Treatment|Adverse Event|9|||
130611950|NCT04360187|470199488|FG001|Double-Blind Treatment|Adverse Event|11|||
130611951|NCT04360187|470199487|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
130611952|NCT04360187|470199488|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
130611953|NCT04360187|470199487|FG000|Double-Blind Treatment|Physician Decision|1|||
130611954|NCT04360187|470199488|FG001|Double-Blind Treatment|Physician Decision|0|||
130611955|NCT04360187|470199487|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
130611956|NCT04360187|470199488|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
130611957|NCT04360187|470199487|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
130611958|NCT04360187|470199488|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
130611959|NCT04360187|470199487|FG000|Follow-Up|Lost to Follow-up|1|||
130611960|NCT04360187|470199488|FG001|Follow-Up|Lost to Follow-up|0|||
130611961|NCT00256867|470199489|FG000|Overall Study|Adverse Event|0|||
130611962|NCT00256867|470199490|FG001|Overall Study|Adverse Event|1|||
130611963|NCT00256867|470199491|FG002|Overall Study|Adverse Event|1|||
130611964|NCT00256867|470199492|FG003|Overall Study|Adverse Event|1|||
130611965|NCT00256867|470199493|FG004|Overall Study|Adverse Event|2|||
130611966|NCT00256867|470199494|FG005|Overall Study|Adverse Event|2|||
130611967|NCT00256867|470199495|FG006|Overall Study|Adverse Event|1|||
130611968|NCT00256867|470199496|FG007|Overall Study|Adverse Event|4|||
130611969|NCT00256867|470199489|FG000|Overall Study|Lost to Follow-up|2|||
130611970|NCT00256867|470199490|FG001|Overall Study|Lost to Follow-up|2|||
130611971|NCT00256867|470199491|FG002|Overall Study|Lost to Follow-up|2|||
130611972|NCT00256867|470199492|FG003|Overall Study|Lost to Follow-up|3|||
130611973|NCT00256867|470199493|FG004|Overall Study|Lost to Follow-up|2|||
130611974|NCT00256867|470199494|FG005|Overall Study|Lost to Follow-up|0|||
130611975|NCT00256867|470199495|FG006|Overall Study|Lost to Follow-up|1|||
130611976|NCT00256867|470199496|FG007|Overall Study|Lost to Follow-up|2|||
130611977|NCT00256867|470199489|FG000|Overall Study|Protocol Violation|0|||
130611978|NCT00256867|470199490|FG001|Overall Study|Protocol Violation|0|||
130611979|NCT00256867|470199491|FG002|Overall Study|Protocol Violation|0|||
130611980|NCT00256867|470199492|FG003|Overall Study|Protocol Violation|1|||
130611981|NCT00256867|470199493|FG004|Overall Study|Protocol Violation|0|||
130611982|NCT00256867|470199494|FG005|Overall Study|Protocol Violation|1|||
130611983|NCT00256867|470199495|FG006|Overall Study|Protocol Violation|0|||
130611984|NCT00256867|470199496|FG007|Overall Study|Protocol Violation|1|||
130611985|NCT00256867|470199489|FG000|Overall Study|Withdrawal by Subject|0|||
130611986|NCT00256867|470199490|FG001|Overall Study|Withdrawal by Subject|0|||
130611987|NCT00256867|470199491|FG002|Overall Study|Withdrawal by Subject|1|||
130611988|NCT00256867|470199492|FG003|Overall Study|Withdrawal by Subject|1|||
130611989|NCT00256867|470199493|FG004|Overall Study|Withdrawal by Subject|2|||
130611990|NCT00256867|470199494|FG005|Overall Study|Withdrawal by Subject|2|||
130611991|NCT00256867|470199495|FG006|Overall Study|Withdrawal by Subject|3|||
130611992|NCT00256867|470199496|FG007|Overall Study|Withdrawal by Subject|2|||
130611993|NCT00256867|470199489|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130611994|NCT00256867|470199490|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
130611995|NCT00256867|470199491|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130611996|NCT00256867|470199492|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130611997|NCT00256867|470199493|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130611998|NCT00256867|470199494|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130611999|NCT00256867|470199495|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130612000|NCT00256867|470199496|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130612001|NCT00256867|470199489|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612002|NCT00256867|470199490|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612003|NCT00256867|470199491|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612004|NCT00256867|470199492|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612005|NCT00256867|470199493|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612006|NCT00256867|470199494|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612007|NCT00256867|470199495|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130612008|NCT00256867|470199496|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
130612009|NCT00256867|470199489|FG000|Overall Study|Investigator's Decision|0|||
130612010|NCT00256867|470199490|FG001|Overall Study|Investigator's Decision|0|||
130612011|NCT00256867|470199491|FG002|Overall Study|Investigator's Decision|0|||
130612012|NCT00256867|470199492|FG003|Overall Study|Investigator's Decision|0|||
130612013|NCT00256867|470199493|FG004|Overall Study|Investigator's Decision|1|||
130612014|NCT00256867|470199494|FG005|Overall Study|Investigator's Decision|0|||
130612015|NCT00256867|470199495|FG006|Overall Study|Investigator's Decision|0|||
130612016|NCT00256867|470199496|FG007|Overall Study|Investigator's Decision|0|||
130612017|NCT00256867|470199489|FG000|Overall Study|Non-compliance with study medication|0|||
130612018|NCT00256867|470199490|FG001|Overall Study|Non-compliance with study medication|0|||
130612019|NCT00256867|470199491|FG002|Overall Study|Non-compliance with study medication|0|||
130612020|NCT00256867|470199492|FG003|Overall Study|Non-compliance with study medication|0|||
130612021|NCT00256867|470199493|FG004|Overall Study|Non-compliance with study medication|0|||
130612022|NCT00256867|470199494|FG005|Overall Study|Non-compliance with study medication|0|||
130612023|NCT00256867|470199495|FG006|Overall Study|Non-compliance with study medication|0|||
130612024|NCT00256867|470199496|FG007|Overall Study|Non-compliance with study medication|1|||
130612025|NCT00256867|470199489|FG000|Overall Study|Participant travelled Overseas|0|||
130612026|NCT00256867|470199490|FG001|Overall Study|Participant travelled Overseas|1|||
130612027|NCT00256867|470199491|FG002|Overall Study|Participant travelled Overseas|0|||
130612028|NCT00256867|470199492|FG003|Overall Study|Participant travelled Overseas|0|||
130612029|NCT00256867|470199493|FG004|Overall Study|Participant travelled Overseas|0|||
130612030|NCT00256867|470199494|FG005|Overall Study|Participant travelled Overseas|0|||
130612031|NCT00256867|470199495|FG006|Overall Study|Participant travelled Overseas|0|||
130612032|NCT00256867|470199496|FG007|Overall Study|Participant travelled Overseas|0|||
130612033|NCT00256867|470199489|FG000|Overall Study|Participant out of assessment window|0|||
130612034|NCT00256867|470199490|FG001|Overall Study|Participant out of assessment window|0|||
130612035|NCT00256867|470199491|FG002|Overall Study|Participant out of assessment window|1|||
130612036|NCT00256867|470199492|FG003|Overall Study|Participant out of assessment window|0|||
130612037|NCT00256867|470199493|FG004|Overall Study|Participant out of assessment window|0|||
130612038|NCT00256867|470199494|FG005|Overall Study|Participant out of assessment window|0|||
130612039|NCT00256867|470199495|FG006|Overall Study|Participant out of assessment window|0|||
130612040|NCT00256867|470199496|FG007|Overall Study|Participant out of assessment window|0|||
130612041|NCT00256867|470199489|FG000|Overall Study|Withdrawal by participant|0|||
130612042|NCT00256867|470199490|FG001|Overall Study|Withdrawal by participant|0|||
130612043|NCT00256867|470199491|FG002|Overall Study|Withdrawal by participant|0|||
130612044|NCT00256867|470199492|FG003|Overall Study|Withdrawal by participant|0|||
130612045|NCT00256867|470199493|FG004|Overall Study|Withdrawal by participant|0|||
130612046|NCT00256867|470199494|FG005|Overall Study|Withdrawal by participant|1|||
130612047|NCT00256867|470199495|FG006|Overall Study|Withdrawal by participant|0|||
130612048|NCT00256867|470199496|FG007|Overall Study|Withdrawal by participant|0|||
130612049|NCT02993224|470199497|FG000|Core Phase - Period 1|Adverse Event|4|||
130612050|NCT02993224|470199497|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
130612051|NCT02993224|470199497|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
130612052|NCT02993224|470199497|FG000|Core Phase- Period 2|Adverse Event|1|||
130612053|NCT02993224|470199497|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
130612054|NCT02993224|470199497|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
130612055|NCT02993224|470199497|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
130612056|NCT02993224|470199497|FG000|Extension Phase|Adverse Event|3|||
130612057|NCT02993224|470199497|FG000|Extension Phase|Withdrawal by Subject|3|||
130612058|NCT02993224|470199497|FG000|Extension Phase|Lost to Follow-up|2|||
130612059|NCT02993224|470199497|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
130612060|NCT03136185|470199504|FG000|Overall Study|Adverse Event|0|||
130612061|NCT03136185|470199505|FG001|Overall Study|Adverse Event|1|||
130612062|NCT03136185|470199506|FG002|Overall Study|Adverse Event|3|||
130612063|NCT03136185|470199507|FG003|Overall Study|Adverse Event|1|||
130612064|NCT03136185|470199508|FG004|Overall Study|Adverse Event|2|||
130612065|NCT03136185|470199509|FG005|Overall Study|Adverse Event|2|||
130612066|NCT03136185|470199510|FG006|Overall Study|Adverse Event|5|||
130612067|NCT03136185|470199511|FG007|Overall Study|Adverse Event|1|||
130612068|NCT03136185|470199512|FG008|Overall Study|Adverse Event|1|||
130612069|NCT03136185|470199504|FG000|Overall Study|Death|0|||
130612070|NCT03136185|470199505|FG001|Overall Study|Death|0|||
130612071|NCT03136185|470199506|FG002|Overall Study|Death|0|||
130612072|NCT03136185|470199507|FG003|Overall Study|Death|1|||
130612073|NCT03136185|470199508|FG004|Overall Study|Death|1|||
130612074|NCT03136185|470199509|FG005|Overall Study|Death|0|||
130612075|NCT03136185|470199510|FG006|Overall Study|Death|1|||
130612076|NCT03136185|470199511|FG007|Overall Study|Death|0|||
130612077|NCT03136185|470199512|FG008|Overall Study|Death|0|||
130612078|NCT03136185|470199504|FG000|Overall Study|Physician Decision|3|||
130612079|NCT03136185|470199505|FG001|Overall Study|Physician Decision|1|||
130612080|NCT03136185|470199506|FG002|Overall Study|Physician Decision|1|||
130612081|NCT03136185|470199507|FG003|Overall Study|Physician Decision|2|||
130612082|NCT03136185|470199508|FG004|Overall Study|Physician Decision|1|||
130612083|NCT03136185|470199509|FG005|Overall Study|Physician Decision|2|||
130612084|NCT03136185|470199510|FG006|Overall Study|Physician Decision|1|||
130612085|NCT03136185|470199511|FG007|Overall Study|Physician Decision|0|||
130612086|NCT03136185|470199512|FG008|Overall Study|Physician Decision|1|||
130612087|NCT03136185|470199504|FG000|Overall Study|Protocol Defined Disease Progression|0|||
130612088|NCT03136185|470199505|FG001|Overall Study|Protocol Defined Disease Progression|0|||
130612089|NCT03136185|470199506|FG002|Overall Study|Protocol Defined Disease Progression|1|||
130612090|NCT03136185|470199507|FG003|Overall Study|Protocol Defined Disease Progression|0|||
130612091|NCT03136185|470199508|FG004|Overall Study|Protocol Defined Disease Progression|0|||
130612092|NCT03136185|470199509|FG005|Overall Study|Protocol Defined Disease Progression|1|||
130612093|NCT03136185|470199510|FG006|Overall Study|Protocol Defined Disease Progression|0|||
130612094|NCT03136185|470199511|FG007|Overall Study|Protocol Defined Disease Progression|1|||
130612095|NCT03136185|470199512|FG008|Overall Study|Protocol Defined Disease Progression|1|||
130612096|NCT03136185|470199504|FG000|Overall Study|Withdrawal by Subject|1|||
130612097|NCT03136185|470199505|FG001|Overall Study|Withdrawal by Subject|0|||
130612098|NCT03136185|470199506|FG002|Overall Study|Withdrawal by Subject|1|||
130612099|NCT03136185|470199507|FG003|Overall Study|Withdrawal by Subject|1|||
130612100|NCT03136185|470199508|FG004|Overall Study|Withdrawal by Subject|1|||
130612101|NCT03136185|470199509|FG005|Overall Study|Withdrawal by Subject|1|||
130612102|NCT03136185|470199510|FG006|Overall Study|Withdrawal by Subject|2|||
130612103|NCT03136185|470199511|FG007|Overall Study|Withdrawal by Subject|3|||
130612104|NCT03136185|470199512|FG008|Overall Study|Withdrawal by Subject|3|||
130612105|NCT03136185|470199504|FG000|Overall Study|Not Reported|4|||
130612106|NCT03136185|470199505|FG001|Overall Study|Not Reported|1|||
130612107|NCT03136185|470199506|FG002|Overall Study|Not Reported|0|||
130612108|NCT03136185|470199507|FG003|Overall Study|Not Reported|1|||
130612109|NCT03136185|470199508|FG004|Overall Study|Not Reported|0|||
130612110|NCT03136185|470199509|FG005|Overall Study|Not Reported|2|||
130612111|NCT03136185|470199510|FG006|Overall Study|Not Reported|1|||
130612112|NCT03136185|470199511|FG007|Overall Study|Not Reported|1|||
130612113|NCT03136185|470199512|FG008|Overall Study|Not Reported|0|||
130612114|NCT00488033|470199520|FG000|Overall Study|Withdrawal by Subject|1|||
130612115|NCT00488033|470199521|FG001|Overall Study|Withdrawal by Subject|0|||
130612116|NCT01423617|470199522|FG000|Overall Study|Lost to Follow-up|0|||
130612117|NCT01423617|470199523|FG001|Overall Study|Lost to Follow-up|1|||
130612118|NCT01515306|470199524|FG000|Overall Study|Adverse Event|3|||
130612119|NCT01515306|470199525|FG001|Overall Study|Adverse Event|2|||
130612120|NCT01515306|470199524|FG000|Overall Study|Progressive Disease|19|||
130612121|NCT01515306|470199525|FG001|Overall Study|Progressive Disease|9|||
130612122|NCT01515306|470199524|FG000|Overall Study|Withdrawal by Subject|1|||
130612123|NCT01515306|470199525|FG001|Overall Study|Withdrawal by Subject|2|||
130612124|NCT01515306|470199524|FG000|Overall Study|Physician Decision|1|||
130612125|NCT01515306|470199525|FG001|Overall Study|Physician Decision|1|||
130612126|NCT00634244|470199529|FG000|Overall Study|Never started treatment|0|||
130612127|NCT00634244|470199530|FG001|Overall Study|Never started treatment|1|||
130612128|NCT00634244|470199531|FG002|Overall Study|Never started treatment|0|||
130612129|NCT00634244|470199529|FG000|Overall Study|Death|1|||
130612130|NCT00634244|470199530|FG001|Overall Study|Death|6|||
130612131|NCT00634244|470199531|FG002|Overall Study|Death|0|||
130612132|NCT00634244|470199529|FG000|Overall Study|Adverse Event|0|||
130612133|NCT00634244|470199530|FG001|Overall Study|Adverse Event|2|||
130612134|NCT00634244|470199531|FG002|Overall Study|Adverse Event|0|||
130612135|NCT00634244|470199529|FG000|Overall Study|Withdrawal by Subject|0|||
130612136|NCT00634244|470199530|FG001|Overall Study|Withdrawal by Subject|1|||
130612137|NCT00634244|470199531|FG002|Overall Study|Withdrawal by Subject|0|||
130612138|NCT00634244|470199529|FG000|Overall Study|Physician Decision|0|||
130612139|NCT00634244|470199530|FG001|Overall Study|Physician Decision|1|||
130612140|NCT00634244|470199531|FG002|Overall Study|Physician Decision|0|||
130612141|NCT00634244|470199529|FG000|Overall Study|Disease progression/relapse|0|||
130612142|NCT00634244|470199530|FG001|Overall Study|Disease progression/relapse|1|||
130612143|NCT00634244|470199531|FG002|Overall Study|Disease progression/relapse|0|||
130612144|NCT00634244|470199529|FG000|Overall Study|Other complicating disease|0|||
130612145|NCT00634244|470199530|FG001|Overall Study|Other complicating disease|1|||
130612146|NCT00634244|470199531|FG002|Overall Study|Other complicating disease|0|||
130612147|NCT04369430|470199538|FG000|Overall Study|Adverse Event|2|||
130612148|NCT04369430|470199539|FG001|Overall Study|Adverse Event|3|||
130612149|NCT04369430|470199538|FG000|Overall Study|Death|1|||
130612150|NCT04369430|470199539|FG001|Overall Study|Death|0|||
130612151|NCT04369430|470199538|FG000|Overall Study|Withdrawal by Subject|4|||
130612152|NCT04369430|470199539|FG001|Overall Study|Withdrawal by Subject|3|||
130612153|NCT04369430|470199538|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
130612154|NCT04369430|470199539|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
130612155|NCT04369430|470199538|FG000|Overall Study|Lost to Follow-up|0|||
130612156|NCT04369430|470199539|FG001|Overall Study|Lost to Follow-up|1|||
130612157|NCT02435277|470199540|FG000|Overall Study|Adverse Event|1|||
130612158|NCT02435277|470199541|FG001|Overall Study|Adverse Event|1|||
130612159|NCT02435277|470199542|FG002|Overall Study|Adverse Event|0|||
130612160|NCT02435277|470199543|FG003|Overall Study|Adverse Event|0|||
130612161|NCT02435277|470199540|FG000|Overall Study|Withdrawal by Subject|1|||
130612162|NCT02435277|470199541|FG001|Overall Study|Withdrawal by Subject|0|||
130612163|NCT02435277|470199542|FG002|Overall Study|Withdrawal by Subject|0|||
130612164|NCT02435277|470199543|FG003|Overall Study|Withdrawal by Subject|0|||
130612165|NCT00008138|470199544|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
130612166|NCT00008138|470199544|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
130612167|NCT00008138|470199544|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
130612168|NCT00008138|470199544|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
130612169|NCT00008138|470199544|FG000|Interval Debulking|Withdrawal by Subject|2|||
130612170|NCT00008138|470199544|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
130612171|NCT00008138|470199544|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
130612172|NCT00008138|470199544|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
130612173|NCT00937768|470199549|FG000|Overall Study|Refused Further Treatment|3|||
130612174|NCT00937768|470199550|FG001|Overall Study|Refused Further Treatment|2|||
130612175|NCT00937768|470199549|FG000|Overall Study|Disease Progression|1|||
130612176|NCT00937768|470199550|FG001|Overall Study|Disease Progression|1|||
130612177|NCT00937768|470199549|FG000|Overall Study|Alternate Treatment|0|||
130612178|NCT00937768|470199550|FG001|Overall Study|Alternate Treatment|1|||
130612179|NCT00937768|470199549|FG000|Overall Study|No Further Funding|4|||
130612180|NCT00937768|470199550|FG001|Overall Study|No Further Funding|4|||
130612181|NCT02678780|470199553|FG000|Overall Study|Adverse Event|11|||
130612182|NCT02678780|470199554|FG001|Overall Study|Adverse Event|14|||
130612183|NCT02678780|470199553|FG000|Overall Study|Withdrawal by Subject|2|||
130612184|NCT02678780|470199554|FG001|Overall Study|Withdrawal by Subject|1|||
130612185|NCT02678780|470199553|FG000|Overall Study|Sponsor discontinuation|7|||
130612186|NCT02678780|470199554|FG001|Overall Study|Sponsor discontinuation|4|||
130612187|NCT02678780|470199553|FG000|Overall Study|Death|1|||
130612188|NCT02678780|470199554|FG001|Overall Study|Death|1|||
130612189|NCT02678780|470199553|FG000|Overall Study|Other|6|||
130612190|NCT02678780|470199554|FG001|Overall Study|Other|8|||
130612191|NCT00992446|470199555|FG000|Overall Study|Disease Progression|1|||
130612192|NCT00992446|470199555|FG000|Overall Study|Withdrawal by Subject|2|||
130612193|NCT00992446|470199555|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
130612194|NCT03675737|470199557|FG000|Overall Study|Death|593|||
130612195|NCT03675737|470199558|FG001|Overall Study|Death|660|||
130612196|NCT03675737|470199557|FG000|Overall Study|Lost to Follow-up|1|||
130612197|NCT03675737|470199558|FG001|Overall Study|Lost to Follow-up|5|||
130612198|NCT03675737|470199557|FG000|Overall Study|Physician Decision|1|||
130612199|NCT03675737|470199558|FG001|Overall Study|Physician Decision|0|||
130612200|NCT03675737|470199557|FG000|Overall Study|Withdrawal by Subject|14|||
130612201|NCT03675737|470199558|FG001|Overall Study|Withdrawal by Subject|12|||
130612202|NCT03675737|470199557|FG000|Overall Study|Ongoing in Study|181|||
130612203|NCT03675737|470199558|FG001|Overall Study|Ongoing in Study|112|||
130612204|NCT02349789|470200874|FG000|Overall Study|Withdrawal by Subject|2|||
130612205|NCT00683475|470200875|FG000|Overall Study|Withdrawal by Subject|1|||
130612206|NCT00683475|470200876|FG001|Overall Study|Withdrawal by Subject|0|||
130612207|NCT00683475|470200875|FG000|Overall Study|Never Treated: Adverse Event|2|||
130612208|NCT00683475|470200876|FG001|Overall Study|Never Treated: Adverse Event|3|||
130612209|NCT00683475|470200875|FG000|Overall Study|Never Treated: Progressive Disease|1|||
130612210|NCT00683475|470200876|FG001|Overall Study|Never Treated: Progressive Disease|0|||
130612211|NCT02922634|470200877|FG000|Overall Study|Withdrawal by Subject|5|||
130612212|NCT02922634|470200877|FG000|Overall Study|Did not have their surgery|5|||
130612213|NCT02723604|470200878|FG000|Overall Study|ineligible|1|||
130612214|NCT02723604|470200878|FG000|Overall Study|never received treatment|1|||
130612215|NCT00762372|470200879|FG000|Overall Study|Adverse Event|1|||
130612216|NCT00762372|470200880|FG001|Overall Study|Adverse Event|0|||
130612217|NCT00762372|470200881|FG002|Overall Study|Adverse Event|0|||
130612218|NCT03364335|470200882|FG000|Overall Study|Adverse Event|3|||
130612219|NCT03364335|470200883|FG001|Overall Study|Adverse Event|4|||
130612220|NCT03364335|470200884|FG002|Overall Study|Adverse Event|1|||
130612221|NCT03364335|470200885|FG003|Overall Study|Adverse Event|2|||
130612222|NCT03364335|470200886|FG004|Overall Study|Adverse Event|0|||
130612223|NCT03364335|470200882|FG000|Overall Study|Lost to Follow-up|7|||
130612224|NCT03364335|470200883|FG001|Overall Study|Lost to Follow-up|7|||
130612225|NCT03364335|470200884|FG002|Overall Study|Lost to Follow-up|10|||
130612226|NCT03364335|470200885|FG003|Overall Study|Lost to Follow-up|11|||
130612227|NCT03364335|470200886|FG004|Overall Study|Lost to Follow-up|11|||
130612228|NCT03987919|470200887|FG000|Overall Study|Adverse Event|1|||
130612229|NCT03987919|470200888|FG001|Overall Study|Adverse Event|4|||
130612230|NCT03987919|470200889|FG002|Overall Study|Adverse Event|1|||
130612231|NCT03987919|470200890|FG003|Overall Study|Adverse Event|3|||
130612232|NCT03987919|470200887|FG000|Overall Study|Death|4|||
130612233|NCT03987919|470200888|FG001|Overall Study|Death|4|||
130612234|NCT03987919|470200889|FG002|Overall Study|Death|4|||
130612235|NCT03987919|470200890|FG003|Overall Study|Death|1|||
130612236|NCT03987919|470200887|FG000|Overall Study|Lost to Follow-up|5|||
130612237|NCT03987919|470200888|FG001|Overall Study|Lost to Follow-up|6|||
130612238|NCT03987919|470200889|FG002|Overall Study|Lost to Follow-up|8|||
130612239|NCT03987919|470200890|FG003|Overall Study|Lost to Follow-up|12|||
130612240|NCT03987919|470200887|FG000|Overall Study|Physician Decision|0|||
130612241|NCT03987919|470200888|FG001|Overall Study|Physician Decision|2|||
130612242|NCT03987919|470200889|FG002|Overall Study|Physician Decision|0|||
130612243|NCT03987919|470200890|FG003|Overall Study|Physician Decision|4|||
130612244|NCT03987919|470200887|FG000|Overall Study|Pregnancy|1|||
130612245|NCT03987919|470200888|FG001|Overall Study|Pregnancy|0|||
130612246|NCT03987919|470200889|FG002|Overall Study|Pregnancy|1|||
130612247|NCT03987919|470200890|FG003|Overall Study|Pregnancy|1|||
130612248|NCT03987919|470200887|FG000|Overall Study|Protocol Violation|0|||
130612249|NCT03987919|470200888|FG001|Overall Study|Protocol Violation|1|||
130612250|NCT03987919|470200889|FG002|Overall Study|Protocol Violation|0|||
130612251|NCT03987919|470200890|FG003|Overall Study|Protocol Violation|0|||
130612252|NCT03987919|470200887|FG000|Overall Study|Site terminated by Sponsor|0|||
130612253|NCT03987919|470200888|FG001|Overall Study|Site terminated by Sponsor|0|||
130612254|NCT03987919|470200889|FG002|Overall Study|Site terminated by Sponsor|0|||
130612255|NCT03987919|470200890|FG003|Overall Study|Site terminated by Sponsor|1|||
130612256|NCT03987919|470200887|FG000|Overall Study|Withdrawal by Subject|7|||
130612257|NCT03987919|470200888|FG001|Overall Study|Withdrawal by Subject|7|||
130612258|NCT03987919|470200889|FG002|Overall Study|Withdrawal by Subject|8|||
130612259|NCT03987919|470200890|FG003|Overall Study|Withdrawal by Subject|4|||
130612260|NCT03987919|470200887|FG000|Overall Study|Other - as reported by the investigator|1|||
130612261|NCT03987919|470200888|FG001|Overall Study|Other - as reported by the investigator|3|||
130612262|NCT03987919|470200889|FG002|Overall Study|Other - as reported by the investigator|2|||
130612263|NCT03987919|470200890|FG003|Overall Study|Other - as reported by the investigator|0|||
130612264|NCT01194804|470200891|FG000|Overall Study|Withdrawal by Subject|1|||
130612265|NCT01303380|470200892|FG000|Overall Study|Lack of compliance to study procedures|1|||
130612266|NCT03621943|470200893|FG000|First Randomized Intervention|Lost to Follow-up|51|||
130612267|NCT03621943|470200894|FG001|First Randomized Intervention|Lost to Follow-up|54|||
130612268|NCT03621943|470200893|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
130612269|NCT03621943|470200894|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
130612270|NCT03621943|470200893|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
130612271|NCT03621943|470200894|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
130612272|NCT03621943|470200893|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
130612273|NCT03621943|470200894|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
130612274|NCT00748553|470200895|FG000|Overall Study|Adverse Event|0|||
130612275|NCT00748553|470200896|FG001|Overall Study|Adverse Event|1|||
130612276|NCT00748553|470200895|FG000|Overall Study|disease progression|2|||
130612277|NCT00748553|470200896|FG001|Overall Study|disease progression|0|||
130612278|NCT00748553|470200895|FG000|Overall Study|noncompliance|1|||
130612279|NCT00748553|470200896|FG001|Overall Study|noncompliance|0|||
130612280|NCT00315705|470200897|FG000|Phase 1|Refused further treatment|1|||
130612281|NCT00315705|470200897|FG000|Phase 1|Failure to achieve response|8|||
130612282|NCT00315705|470200897|FG000|Phase 1|Disease relapse|4|||
130612283|NCT00315705|470200897|FG000|Phase 1|Scheduled for transplant|9|||
130612284|NCT00315705|470200897|FG000|Phase 1|Death|3|||
130612285|NCT00315705|470200897|FG000|Phase 2|Physician Decision|4|||
130612286|NCT00315705|470200897|FG000|Phase 2|Adverse Event|1|||
130612287|NCT00315705|470200897|FG000|Phase 2|Failure to achieve response|3|||
130612288|NCT00315705|470200897|FG000|Phase 2|Disease relapse|1|||
130612289|NCT00315705|470200897|FG000|Phase 2|Scheduled for transplant|8|||
130612290|NCT00315705|470200897|FG000|Phase 2|Other|1|||
130612291|NCT00315705|470200897|FG000|Phase 2|Death|7|||
130612292|NCT00948818|470200899|FG000|Overall Study|Adverse Event|10|||
130612293|NCT00948818|470200900|FG001|Overall Study|Adverse Event|32|||
130612294|NCT00948818|470200899|FG000|Overall Study|Protocol Violation|9|||
130612295|NCT00948818|470200900|FG001|Overall Study|Protocol Violation|10|||
130612296|NCT00948818|470200899|FG000|Overall Study|Withdrawal by Subject|25|||
130612297|NCT00948818|470200900|FG001|Overall Study|Withdrawal by Subject|25|||
130612298|NCT00948818|470200899|FG000|Overall Study|Lost to Follow-up|10|||
130612299|NCT00948818|470200900|FG001|Overall Study|Lost to Follow-up|17|||
130612300|NCT00948818|470200899|FG000|Overall Study|Lack of Efficacy|4|||
130612301|NCT00948818|470200900|FG001|Overall Study|Lack of Efficacy|5|||
130612302|NCT00948818|470200899|FG000|Overall Study|Other Reason|4|||
130612303|NCT00948818|470200900|FG001|Overall Study|Other Reason|5|||
130612304|NCT01716533|470200901|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
130612305|NCT01716533|470200902|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
130612306|NCT01716533|470200903|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
130612307|NCT01716533|470200904|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
130612308|NCT01716533|470200901|FG000|Overall Study|Withdrawal by Subject|0|||
130612309|NCT01716533|470200902|FG001|Overall Study|Withdrawal by Subject|0|||
130612310|NCT01716533|470200903|FG002|Overall Study|Withdrawal by Subject|0|||
130612311|NCT01716533|470200904|FG003|Overall Study|Withdrawal by Subject|5|||
130612312|NCT01716533|470200901|FG000|Overall Study|Death|0|||
130612313|NCT01716533|470200902|FG001|Overall Study|Death|0|||
130612314|NCT01716533|470200903|FG002|Overall Study|Death|0|||
130612315|NCT01716533|470200904|FG003|Overall Study|Death|2|||
130612316|NCT01716533|470200901|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
130612317|NCT01716533|470200902|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
130612318|NCT01716533|470200903|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
130612319|NCT01716533|470200904|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
130612320|NCT00745368|470200905|FG000|Overall Study|Unable to provide sample|3|||
130612321|NCT03446651|470200909|FG000|Overall Study|Lost to Follow-up|4|||
130612322|NCT03446651|470200910|FG001|Overall Study|Lost to Follow-up|0|||
130612323|NCT03446651|470200909|FG000|Overall Study|Open Label Participants|5|||
130612324|NCT03446651|470200910|FG001|Overall Study|Open Label Participants|0|||
130612325|NCT05142332|470200911|FG000|Overall Study|Withdrawal by Subject|0|||
130612326|NCT05142332|470200912|FG001|Overall Study|Withdrawal by Subject|1|||
130612327|NCT05142332|470200913|FG002|Overall Study|Withdrawal by Subject|2|||
130612328|NCT05142332|470200914|FG003|Overall Study|Withdrawal by Subject|0|||
130612329|NCT05142332|470200915|FG004|Overall Study|Withdrawal by Subject|0|||
130612330|NCT05142332|470200916|FG005|Overall Study|Withdrawal by Subject|2|||
130612331|NCT05142332|470200917|FG006|Overall Study|Withdrawal by Subject|6|||
130612332|NCT05142332|470200911|FG000|Overall Study|Left ED|3|||
130612333|NCT05142332|470200912|FG001|Overall Study|Left ED|0|||
130612334|NCT05142332|470200913|FG002|Overall Study|Left ED|4|||
130612335|NCT05142332|470200914|FG003|Overall Study|Left ED|6|||
130612336|NCT05142332|470200915|FG004|Overall Study|Left ED|1|||
130612337|NCT05142332|470200916|FG005|Overall Study|Left ED|2|||
130612338|NCT05142332|470200917|FG006|Overall Study|Left ED|6|||
130612339|NCT05142332|470200911|FG000|Overall Study|Physician Decision|0|||
130612340|NCT05142332|470200912|FG001|Overall Study|Physician Decision|0|||
130612341|NCT05142332|470200913|FG002|Overall Study|Physician Decision|2|||
130612342|NCT05142332|470200914|FG003|Overall Study|Physician Decision|1|||
130612343|NCT05142332|470200915|FG004|Overall Study|Physician Decision|0|||
130612344|NCT05142332|470200916|FG005|Overall Study|Physician Decision|0|||
130612345|NCT05142332|470200917|FG006|Overall Study|Physician Decision|3|||
130612346|NCT05142332|470200911|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
130612347|NCT05142332|470200912|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130612348|NCT05142332|470200913|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
130612349|NCT05142332|470200914|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
130612350|NCT05142332|470200915|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130612351|NCT05142332|470200916|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
130612352|NCT05142332|470200917|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130612353|NCT01894477|470200920|FG000|Overall Study|Protocol Violation|0|||
130612354|NCT01894477|470200921|FG001|Overall Study|Protocol Violation|1|||
130612355|NCT01894477|470200920|FG000|Overall Study|protocol changed due SC changed to cord|0|||
130612356|NCT01894477|470200921|FG001|Overall Study|protocol changed due SC changed to cord|1|||
130612357|NCT04171037|470200922|FG000|Overall Study|Lost to Follow-up|1|||
130612358|NCT04171037|470200923|FG001|Overall Study|Lost to Follow-up|0|||
130612359|NCT04171037|470200922|FG000|Overall Study|Physician Decision|3|||
130612360|NCT04171037|470200923|FG001|Overall Study|Physician Decision|3|||
130612361|NCT01401010|470200925|FG000|Overall Study|Could not interpret assay results|1|||
130612362|NCT01401010|470200926|FG001|Overall Study|Could not interpret assay results|0|||
130612363|NCT03135028|470200927|FG000|Overall Study|Death|6|||
130612364|NCT03135028|470200927|FG000|Overall Study|Study Terminated by Sponsor|2|||
130612365|NCT03135028|470200927|FG000|Overall Study|Withdrew Consent|1|||
130612366|NCT00748540|470200928|FG000|Overall Study|Physician Decision|1|||
130612367|NCT01814800|470200930|FG000|Overall Study|Adverse Event|2|||
130612368|NCT01814800|470200930|FG000|Overall Study|Pregnancy|1|||
130612369|NCT01814800|470200930|FG000|Overall Study|Sponsor decision|1|||
130612370|NCT01814800|470200930|FG000|Overall Study|Subject relocation|1|||
130612371|NCT04436822|470200931|FG000|Overall Study|Physician Decision|2|||
130612372|NCT04436822|470200932|FG001|Overall Study|Physician Decision|0|||
130612373|NCT04436822|470200931|FG000|Overall Study|Sponsor request|1|||
130612374|NCT04436822|470200932|FG001|Overall Study|Sponsor request|0|||
130612375|NCT04436822|470200931|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130612376|NCT04436822|470200932|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130612377|NCT04436822|470200931|FG000|Overall Study|Unsuccessful procedure|0|||
130612378|NCT04436822|470200932|FG001|Overall Study|Unsuccessful procedure|1|||
130612379|NCT04436822|470200931|FG000|Overall Study|Withdrawal due to Covid-19|8|||
130612380|NCT04436822|470200932|FG001|Overall Study|Withdrawal due to Covid-19|1|||
130612381|NCT04436822|470200931|FG000|Overall Study|Withdrawal by Subject|1|||
130612382|NCT04436822|470200932|FG001|Overall Study|Withdrawal by Subject|0|||
130612383|NCT04436822|470200931|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
130612384|NCT04436822|470200932|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
130612385|NCT01689207|470200933|FG000|Overall Study|Adverse Event|0|||
130612386|NCT01689207|470200934|FG001|Overall Study|Adverse Event|1|||
130612387|NCT01689207|470200935|FG002|Overall Study|Adverse Event|0|||
130612388|NCT01689207|470200936|FG003|Overall Study|Adverse Event|0|||
130612389|NCT01689207|470200937|FG004|Overall Study|Adverse Event|2|||
130612390|NCT01689207|470200938|FG005|Overall Study|Adverse Event|1|||
130612391|NCT01689207|470200939|FG006|Overall Study|Adverse Event|0|||
130612392|NCT01689207|470200940|FG007|Overall Study|Adverse Event|0|||
130612393|NCT01689207|470200941|FG008|Overall Study|Adverse Event|1|||
130612394|NCT01689207|470200942|FG009|Overall Study|Adverse Event|0|||
130612395|NCT01689207|470200943|FG010|Overall Study|Adverse Event|0|||
130612396|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
130612397|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
130612398|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
130612399|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
130612400|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
130612401|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
130612402|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
130612403|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
130612404|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
130612405|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
130612406|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
130612407|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
130612408|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
130612409|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
130612410|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
130612411|NCT03855137|470200945|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
130612412|NCT03855137|470200946|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
130612413|NCT03855137|470200947|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
130612414|NCT03855137|470200945|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
130612415|NCT03855137|470200946|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
130612416|NCT03855137|470200947|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
130612417|NCT03855137|470200945|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
130612418|NCT03855137|470200946|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
130612419|NCT03855137|470200947|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
130612420|NCT03855137|470200945|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
130612421|NCT03855137|470200946|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
130612422|NCT03855137|470200947|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
130612423|NCT03855137|470200945|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
130612424|NCT03855137|470200946|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
130612425|NCT03855137|470200947|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
130612426|NCT02635737|470200952|FG000|Overall Study|Protocol Violation|1|||
130612427|NCT02065622|470200953|FG000|Induction Study|Adverse Event|13|||
130612428|NCT02065622|470200954|FG001|Induction Study|Adverse Event|19|||
130612429|NCT02065622|470200955|FG002|Induction Study|Adverse Event|0|||
130612430|NCT02065622|470200956|FG003|Induction Study|Adverse Event|0|||
130612431|NCT02065622|470200957|FG004|Induction Study|Adverse Event|0|||
130612432|NCT02065622|470200953|FG000|Induction Study|Withdrawal by Subject|3|||
130612433|NCT02065622|470200954|FG001|Induction Study|Withdrawal by Subject|5|||
130612434|NCT02065622|470200955|FG002|Induction Study|Withdrawal by Subject|0|||
130612435|NCT02065622|470200956|FG003|Induction Study|Withdrawal by Subject|0|||
130612436|NCT02065622|470200957|FG004|Induction Study|Withdrawal by Subject|0|||
130612437|NCT02065622|470200953|FG000|Induction Study|Lost to Follow-up|1|||
130612438|NCT02065622|470200954|FG001|Induction Study|Lost to Follow-up|0|||
130612439|NCT02065622|470200955|FG002|Induction Study|Lost to Follow-up|0|||
130612440|NCT02065622|470200956|FG003|Induction Study|Lost to Follow-up|0|||
130612441|NCT02065622|470200957|FG004|Induction Study|Lost to Follow-up|0|||
130612442|NCT02065622|470200953|FG000|Induction Study|Lack of Efficacy|22|||
130612443|NCT02065622|470200954|FG001|Induction Study|Lack of Efficacy|27|||
130612444|NCT02065622|470200955|FG002|Induction Study|Lack of Efficacy|0|||
130612445|NCT02065622|470200956|FG003|Induction Study|Lack of Efficacy|0|||
130612446|NCT02065622|470200957|FG004|Induction Study|Lack of Efficacy|0|||
130612447|NCT02065622|470200953|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
130612448|NCT02065622|470200954|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
130612449|NCT02065622|470200955|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130612450|NCT02065622|470200956|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130612451|NCT02065622|470200957|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130612452|NCT02065622|470200953|FG000|Induction Study|Subject Noncompliance|1|||
130612453|NCT02065622|470200954|FG001|Induction Study|Subject Noncompliance|1|||
130612454|NCT02065622|470200955|FG002|Induction Study|Subject Noncompliance|0|||
130612455|NCT02065622|470200956|FG003|Induction Study|Subject Noncompliance|0|||
130612456|NCT02065622|470200957|FG004|Induction Study|Subject Noncompliance|0|||
130612457|NCT02065622|470200953|FG000|Induction Study|Other, Not Specified|3|||
130612458|NCT02065622|470200954|FG001|Induction Study|Other, Not Specified|2|||
130612459|NCT02065622|470200955|FG002|Induction Study|Other, Not Specified|0|||
130612460|NCT02065622|470200956|FG003|Induction Study|Other, Not Specified|0|||
130612461|NCT02065622|470200957|FG004|Induction Study|Other, Not Specified|0|||
130612462|NCT02065622|470200953|FG000|Maintenance Study|Adverse Event|0|||
130612463|NCT02065622|470200954|FG001|Maintenance Study|Adverse Event|0|||
130612464|NCT02065622|470200955|FG002|Maintenance Study|Adverse Event|25|||
130612465|NCT02065622|470200956|FG003|Maintenance Study|Adverse Event|22|||
130612466|NCT02065622|470200957|FG004|Maintenance Study|Adverse Event|11|||
130612467|NCT02065622|470200953|FG000|Maintenance Study|Withdrawal by Subject|0|||
130612468|NCT02065622|470200954|FG001|Maintenance Study|Withdrawal by Subject|0|||
130612469|NCT02065622|470200955|FG002|Maintenance Study|Withdrawal by Subject|11|||
130612470|NCT02065622|470200956|FG003|Maintenance Study|Withdrawal by Subject|5|||
130612471|NCT02065622|470200957|FG004|Maintenance Study|Withdrawal by Subject|7|||
130612472|NCT02065622|470200953|FG000|Maintenance Study|Lost to Follow-up|0|||
130612473|NCT02065622|470200954|FG001|Maintenance Study|Lost to Follow-up|0|||
130612474|NCT02065622|470200955|FG002|Maintenance Study|Lost to Follow-up|4|||
130612475|NCT02065622|470200956|FG003|Maintenance Study|Lost to Follow-up|1|||
130612476|NCT02065622|470200957|FG004|Maintenance Study|Lost to Follow-up|1|||
130612477|NCT02065622|470200953|FG000|Maintenance Study|Lack of Efficacy|0|||
130612478|NCT02065622|470200954|FG001|Maintenance Study|Lack of Efficacy|0|||
130612479|NCT02065622|470200955|FG002|Maintenance Study|Lack of Efficacy|70|||
130612480|NCT02065622|470200956|FG003|Maintenance Study|Lack of Efficacy|55|||
130612481|NCT02065622|470200957|FG004|Maintenance Study|Lack of Efficacy|19|||
130612482|NCT02065622|470200953|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
130612483|NCT02065622|470200954|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
130612484|NCT02065622|470200955|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
130612485|NCT02065622|470200956|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
130612486|NCT02065622|470200957|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
130612487|NCT02065622|470200953|FG000|Maintenance Study|Subject Non-Compliance|0|||
130612488|NCT02065622|470200954|FG001|Maintenance Study|Subject Non-Compliance|0|||
130612489|NCT02065622|470200955|FG002|Maintenance Study|Subject Non-Compliance|1|||
130612490|NCT02065622|470200956|FG003|Maintenance Study|Subject Non-Compliance|3|||
130612491|NCT02065622|470200957|FG004|Maintenance Study|Subject Non-Compliance|2|||
130612492|NCT02065622|470200953|FG000|Maintenance Study|Other, Not Specified|0|||
130612493|NCT02065622|470200954|FG001|Maintenance Study|Other, Not Specified|0|||
130612494|NCT02065622|470200955|FG002|Maintenance Study|Other, Not Specified|6|||
130612495|NCT02065622|470200956|FG003|Maintenance Study|Other, Not Specified|14|||
130612496|NCT02065622|470200957|FG004|Maintenance Study|Other, Not Specified|2|||
130612497|NCT02065622|470200953|FG000|Maintenance Study|Unknown Reason|0|||
130612498|NCT02065622|470200954|FG001|Maintenance Study|Unknown Reason|0|||
130612499|NCT02065622|470200955|FG002|Maintenance Study|Unknown Reason|0|||
130612500|NCT02065622|470200956|FG003|Maintenance Study|Unknown Reason|1|||
130612501|NCT02065622|470200957|FG004|Maintenance Study|Unknown Reason|0|||
130612502|NCT01687413|470200958|FG000|Overall Study|Withdrawal by Subject|0|||
130612503|NCT01687413|470200959|FG001|Overall Study|Withdrawal by Subject|2|||
130612504|NCT01687413|470200958|FG000|Overall Study|Not eligible|0|||
130612505|NCT01687413|470200959|FG001|Overall Study|Not eligible|2|||
130612506|NCT01687413|470200958|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
130612507|NCT01687413|470200959|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
130612508|NCT04973228|470200962|FG000|Overall Study|Adverse Event|2|||
130612509|NCT04973228|470200963|FG001|Overall Study|Adverse Event|3|||
130612510|NCT04973228|470200962|FG000|Overall Study|Lack of Efficacy|1|||
130612511|NCT04973228|470200963|FG001|Overall Study|Lack of Efficacy|3|||
130612512|NCT04973228|470200962|FG000|Overall Study|Lost to Follow-up|12|||
130612513|NCT04973228|470200963|FG001|Overall Study|Lost to Follow-up|4|||
130612514|NCT04973228|470200962|FG000|Overall Study|Withdrawal by Subject|11|||
130612515|NCT04973228|470200963|FG001|Overall Study|Withdrawal by Subject|4|||
130612516|NCT04973228|470200962|FG000|Overall Study|Did not tolerate application|1|||
130612517|NCT04973228|470200963|FG001|Overall Study|Did not tolerate application|0|||
130612518|NCT04973228|470200962|FG000|Overall Study|Wanted to early terminate and use own product|0|||
130612519|NCT04973228|470200963|FG001|Overall Study|Wanted to early terminate and use own product|1|||
130612520|NCT04973228|470200962|FG000|Overall Study|Missed visits due to new work schedule|1|||
130612521|NCT04973228|470200963|FG001|Overall Study|Missed visits due to new work schedule|0|||
130612522|NCT00406640|470200979|FG000|Acute Phase|Adverse Event|18|||
130612523|NCT00406640|470200980|FG001|Acute Phase|Adverse Event|13|||
130612524|NCT00406640|470200979|FG000|Acute Phase|Failed to Return|5|||
130612525|NCT00406640|470200980|FG001|Acute Phase|Failed to Return|1|||
130612526|NCT00406640|470200979|FG000|Acute Phase|Physician Decision|0|||
130612527|NCT00406640|470200980|FG001|Acute Phase|Physician Decision|1|||
130612528|NCT00406640|470200979|FG000|Acute Phase|Lost to Follow-up|7|||
130612529|NCT00406640|470200980|FG001|Acute Phase|Lost to Follow-up|4|||
130612530|NCT00406640|470200979|FG000|Acute Phase|Protocol deviation|4|||
130612531|NCT00406640|470200980|FG001|Acute Phase|Protocol deviation|10|||
130612532|NCT00406640|470200979|FG000|Acute Phase|Protocol Violation|3|||
130612533|NCT00406640|470200980|FG001|Acute Phase|Protocol Violation|2|||
130612534|NCT00406640|470200979|FG000|Acute Phase|Withdrawal by Subject|11|||
130612535|NCT00406640|470200980|FG001|Acute Phase|Withdrawal by Subject|9|||
130612536|NCT00406640|470200979|FG000|Acute Phase|Lack of Efficacy|3|||
130612537|NCT00406640|470200980|FG001|Acute Phase|Lack of Efficacy|3|||
130612538|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
130612539|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
130612540|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Death|1|||
130612541|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Death|0|||
130612542|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
130612543|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
130612544|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
130612545|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
130612546|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
130612547|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
130612548|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|non-compliance|7|||
130612549|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|non-compliance|5|||
130612550|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
130612551|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
130612552|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
130612553|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
130612554|NCT00406640|470200979|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
130612555|NCT00406640|470200980|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
130612556|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
130612557|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
130612558|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
130612559|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
130612560|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
130612561|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
130612562|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
130612563|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
130612564|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
130612565|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
130612566|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
130612567|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
130612568|NCT00406640|470200979|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
130612569|NCT00406640|470200980|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
130612570|NCT01454401|470200983|FG000|Overall Study|Death|1|||
130612571|NCT01454401|470200983|FG000|Overall Study|hospitalised|1|||
130612572|NCT01454401|470200983|FG000|Overall Study|osteomyelitis|2|||
130612573|NCT01454401|470200983|FG000|Overall Study|non-adherence|1|||
130612574|NCT00755846|470202756|FG000|Overall Study|Adverse Event|0|||
130612575|NCT00755846|470202757|FG001|Overall Study|Adverse Event|0|||
130612576|NCT00755846|470202758|FG002|Overall Study|Adverse Event|0|||
130612577|NCT00755846|470202759|FG003|Overall Study|Adverse Event|1|||
130612578|NCT00755846|470202760|FG004|Overall Study|Adverse Event|3|||
130612579|NCT00755846|470202761|FG005|Overall Study|Adverse Event|2|||
130612580|NCT00755846|470202756|FG000|Overall Study|Protocol Violation|1|||
130612581|NCT00755846|470202757|FG001|Overall Study|Protocol Violation|1|||
130612582|NCT00755846|470202758|FG002|Overall Study|Protocol Violation|1|||
130612583|NCT00755846|470202759|FG003|Overall Study|Protocol Violation|1|||
130612584|NCT00755846|470202760|FG004|Overall Study|Protocol Violation|1|||
130612585|NCT00755846|470202761|FG005|Overall Study|Protocol Violation|1|||
130612586|NCT00755846|470202756|FG000|Overall Study|Lost to Follow-up|0|||
130612587|NCT00755846|470202757|FG001|Overall Study|Lost to Follow-up|2|||
130612588|NCT00755846|470202758|FG002|Overall Study|Lost to Follow-up|1|||
130612589|NCT00755846|470202759|FG003|Overall Study|Lost to Follow-up|0|||
130612590|NCT00755846|470202760|FG004|Overall Study|Lost to Follow-up|4|||
130612591|NCT00755846|470202761|FG005|Overall Study|Lost to Follow-up|2|||
130612592|NCT00755846|470202756|FG000|Overall Study|Withdrawal by Subject|2|||
130612593|NCT00755846|470202757|FG001|Overall Study|Withdrawal by Subject|3|||
130612594|NCT00755846|470202758|FG002|Overall Study|Withdrawal by Subject|5|||
130612595|NCT00755846|470202759|FG003|Overall Study|Withdrawal by Subject|2|||
130612596|NCT00755846|470202760|FG004|Overall Study|Withdrawal by Subject|0|||
130612597|NCT00755846|470202761|FG005|Overall Study|Withdrawal by Subject|1|||
130612598|NCT00755846|470202756|FG000|Overall Study|Hyperglycemic Rescue|21|||
130612599|NCT00755846|470202757|FG001|Overall Study|Hyperglycemic Rescue|7|||
130612600|NCT00755846|470202758|FG002|Overall Study|Hyperglycemic Rescue|5|||
130612601|NCT00755846|470202759|FG003|Overall Study|Hyperglycemic Rescue|8|||
130612602|NCT00755846|470202760|FG004|Overall Study|Hyperglycemic Rescue|8|||
130612603|NCT00755846|470202761|FG005|Overall Study|Hyperglycemic Rescue|7|||
130612604|NCT00755846|470202756|FG000|Overall Study|Physician Decision|1|||
130612605|NCT00755846|470202757|FG001|Overall Study|Physician Decision|3|||
130612606|NCT00755846|470202758|FG002|Overall Study|Physician Decision|0|||
130612607|NCT00755846|470202759|FG003|Overall Study|Physician Decision|1|||
130612608|NCT00755846|470202760|FG004|Overall Study|Physician Decision|0|||
130612609|NCT00755846|470202761|FG005|Overall Study|Physician Decision|1|||
130612610|NCT00755846|470202756|FG000|Overall Study|Administrative Error|0|||
130612611|NCT00755846|470202757|FG001|Overall Study|Administrative Error|1|||
130612612|NCT00755846|470202758|FG002|Overall Study|Administrative Error|0|||
130612613|NCT00755846|470202759|FG003|Overall Study|Administrative Error|0|||
130612614|NCT00755846|470202760|FG004|Overall Study|Administrative Error|0|||
130612615|NCT00755846|470202761|FG005|Overall Study|Administrative Error|0|||
130612616|NCT00755846|470202756|FG000|Overall Study|Participant Non-compliance|0|||
130612617|NCT00755846|470202757|FG001|Overall Study|Participant Non-compliance|0|||
130612618|NCT00755846|470202758|FG002|Overall Study|Participant Non-compliance|0|||
130612619|NCT00755846|470202759|FG003|Overall Study|Participant Non-compliance|0|||
130612620|NCT00755846|470202760|FG004|Overall Study|Participant Non-compliance|1|||
130612621|NCT00755846|470202761|FG005|Overall Study|Participant Non-compliance|0|||
130612622|NCT00352755|470202762|FG000|Overall Study|Physician Decision|1|||
130612623|NCT00352755|470202762|FG000|Overall Study|Adverse Event|1|||
130612624|NCT02429258|470202763|FG000|Overall Study|Withdrawal by Subject|2|||
130612625|NCT02429258|470202764|FG001|Overall Study|Withdrawal by Subject|0|||
130612626|NCT02429258|470202763|FG000|Overall Study|Protocol Violation|0|||
130612627|NCT02429258|470202764|FG001|Overall Study|Protocol Violation|1|||
130612628|NCT02397694|470202765|FG000|Double-Blinded Phase|Adverse Event|1|||
130612629|NCT02397694|470202766|FG001|Double-Blinded Phase|Adverse Event|0|||
130612630|NCT02397694|470202765|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
130612631|NCT02397694|470202766|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
130612632|NCT02397694|470202765|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
130612633|NCT02397694|470202766|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
130612634|NCT02397694|470202765|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
130612635|NCT02397694|470202766|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
130612636|NCT02397694|470202765|FG000|Open Label Extension Phase|Protocol Violation|1|||
130612637|NCT02397694|470202766|FG001|Open Label Extension Phase|Protocol Violation|0|||
130612638|NCT02397694|470202765|FG000|Open Label Extension Phase|Withdrew Consent|3|||
130612639|NCT02397694|470202766|FG001|Open Label Extension Phase|Withdrew Consent|1|||
130612640|NCT02397694|470202765|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
130612641|NCT02397694|470202766|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
130612642|NCT01694420|470202768|FG000|Overall Study|Lost to Follow-up|3|||
130612643|NCT02670915|470202771|FG000|Overall Study|Withdrawal by Subject|0|||
130612644|NCT02670915|470202772|FG001|Overall Study|Withdrawal by Subject|1|||
130612645|NCT02670915|470202773|FG002|Overall Study|Withdrawal by Subject|4|||
130612646|NCT02670915|470202771|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130612647|NCT02670915|470202772|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130612648|NCT02670915|470202773|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130612649|NCT02670915|470202771|FG000|Overall Study|Unclassified|0|||
130612650|NCT02670915|470202772|FG001|Overall Study|Unclassified|3|||
130612651|NCT02670915|470202773|FG002|Overall Study|Unclassified|0|||
130612652|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
130612653|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
130612654|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
130612655|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130612656|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130612657|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130612658|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130612659|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130612660|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
130612661|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
130612662|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
130612663|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130612664|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130612665|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130612666|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130612667|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130612668|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
130612669|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612670|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612671|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612672|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612673|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612674|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612675|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130612676|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
130612677|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612678|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612679|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612680|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612681|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612682|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612683|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130612684|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130612685|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130612686|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130612687|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130612688|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130612689|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130612690|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130612691|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130612692|NCT03725202|470202774|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612693|NCT03725202|470202775|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612694|NCT03725202|470202776|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
130612695|NCT03725202|470202777|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612696|NCT03725202|470202778|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612697|NCT03725202|470202779|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612698|NCT03725202|470202780|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612699|NCT03725202|470202781|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130612700|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130612701|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130612702|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130612703|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
130612704|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
130612705|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
130612706|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
130612707|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
130612708|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130612709|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130612710|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130612711|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
130612712|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
130612713|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
130612714|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
130612715|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
130612716|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130612717|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130612718|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130612719|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
130612720|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130612721|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130612722|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
130612723|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
130612724|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612725|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612726|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612727|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612728|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612729|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612730|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
130612731|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130612732|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612733|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612734|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612735|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612736|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612737|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
130612738|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612739|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130612740|NCT03725202|470202774|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130612741|NCT03725202|470202775|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130612742|NCT03725202|470202776|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130612743|NCT03725202|470202777|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
130612744|NCT03725202|470202778|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130612745|NCT03725202|470202779|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130612746|NCT03725202|470202780|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
130612747|NCT03725202|470202781|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
130612748|NCT01328249|470202784|FG000|Overall Study|Adverse Event|3|||
130612749|NCT01328249|470202785|FG001|Overall Study|Adverse Event|0|||
130612750|NCT01328249|470202784|FG000|Overall Study|Disease progression|1|||
130612751|NCT01328249|470202785|FG001|Overall Study|Disease progression|0|||
130612752|NCT01328249|470202784|FG000|Overall Study|Withdrawal by Subject|1|||
130612753|NCT01328249|470202785|FG001|Overall Study|Withdrawal by Subject|1|||
130612754|NCT01328249|470202784|FG000|Overall Study|Moved before end of treatment visit|1|||
130612755|NCT01328249|470202785|FG001|Overall Study|Moved before end of treatment visit|0|||
130612756|NCT01328249|470202784|FG000|Overall Study|Subject choice|1|||
130612757|NCT01328249|470202785|FG001|Overall Study|Subject choice|1|||
130612758|NCT01328249|470202784|FG000|Overall Study|Protocol Violation|0|||
130612759|NCT01328249|470202785|FG001|Overall Study|Protocol Violation|1|||
130612760|NCT01215734|470202786|FG000|Overall Study|Death|0|||
130612761|NCT01215734|470202787|FG001|Overall Study|Death|1|||
130612762|NCT01346371|470202788|FG000|Overall Study|Lost to Follow-up|2|||
130612763|NCT01346371|470202789|FG001|Overall Study|Lost to Follow-up|0|||
130612764|NCT02330549|470202790|FG000|Overall Study|Adverse Event|1|||
130612765|NCT02330549|470202791|FG001|Overall Study|Adverse Event|0|||
130612766|NCT02330549|470202790|FG000|Overall Study|Subject withdrew consent|2|||
130612767|NCT02330549|470202791|FG001|Overall Study|Subject withdrew consent|1|||
130612768|NCT02330549|470202790|FG000|Overall Study|Failure to meet randomization criteria|1|||
130612769|NCT02330549|470202791|FG001|Overall Study|Failure to meet randomization criteria|0|||
130612770|NCT00495495|470202797|FG000|Overall Study|Protocol Violation|99|||
130612771|NCT01670656|470202801|FG000|Overall Study|Non-compliance with study drug|0|||
130612772|NCT01670656|470202802|FG001|Overall Study|Non-compliance with study drug|0|||
130612773|NCT01670656|470202803|FG002|Overall Study|Non-compliance with study drug|3|||
130612774|NCT01670656|470202804|FG003|Overall Study|Non-compliance with study drug|0|||
130612775|NCT01670656|470202805|FG004|Overall Study|Non-compliance with study drug|1|||
130612776|NCT01670656|470202801|FG000|Overall Study|Pregnancy|0|||
130612777|NCT01670656|470202802|FG001|Overall Study|Pregnancy|0|||
130612778|NCT01670656|470202803|FG002|Overall Study|Pregnancy|0|||
130612779|NCT01670656|470202804|FG003|Overall Study|Pregnancy|0|||
130612780|NCT01670656|470202805|FG004|Overall Study|Pregnancy|1|||
130612781|NCT01670656|470202801|FG000|Overall Study|Withdrawal by Subject|1|||
130612782|NCT01670656|470202802|FG001|Overall Study|Withdrawal by Subject|1|||
130612783|NCT01670656|470202803|FG002|Overall Study|Withdrawal by Subject|0|||
130612784|NCT01670656|470202804|FG003|Overall Study|Withdrawal by Subject|0|||
130612785|NCT01670656|470202805|FG004|Overall Study|Withdrawal by Subject|0|||
130612786|NCT01670656|470202801|FG000|Overall Study|Non-compliance with protocol|0|||
130612787|NCT01670656|470202802|FG001|Overall Study|Non-compliance with protocol|3|||
130612788|NCT01670656|470202803|FG002|Overall Study|Non-compliance with protocol|1|||
130612789|NCT01670656|470202804|FG003|Overall Study|Non-compliance with protocol|1|||
130612790|NCT01670656|470202805|FG004|Overall Study|Non-compliance with protocol|2|||
130612791|NCT01670656|470202801|FG000|Overall Study|Adverse Event|2|||
130612792|NCT01670656|470202802|FG001|Overall Study|Adverse Event|2|||
130612793|NCT01670656|470202803|FG002|Overall Study|Adverse Event|2|||
130612794|NCT01670656|470202804|FG003|Overall Study|Adverse Event|3|||
130612795|NCT01670656|470202805|FG004|Overall Study|Adverse Event|3|||
130612796|NCT01670656|470202801|FG000|Overall Study|Subject withdrew consent|0|||
130612797|NCT01670656|470202802|FG001|Overall Study|Subject withdrew consent|1|||
130612798|NCT01670656|470202803|FG002|Overall Study|Subject withdrew consent|2|||
130612799|NCT01670656|470202804|FG003|Overall Study|Subject withdrew consent|1|||
130612800|NCT01670656|470202805|FG004|Overall Study|Subject withdrew consent|1|||
130612801|NCT01670656|470202801|FG000|Overall Study|Lost to Follow-up|0|||
130612802|NCT01670656|470202802|FG001|Overall Study|Lost to Follow-up|0|||
130612803|NCT01670656|470202803|FG002|Overall Study|Lost to Follow-up|0|||
130612804|NCT01670656|470202804|FG003|Overall Study|Lost to Follow-up|0|||
130612805|NCT01670656|470202805|FG004|Overall Study|Lost to Follow-up|3|||
130612806|NCT01670656|470202801|FG000|Overall Study|Subject moved|0|||
130612807|NCT01670656|470202802|FG001|Overall Study|Subject moved|0|||
130612808|NCT01670656|470202803|FG002|Overall Study|Subject moved|0|||
130612809|NCT01670656|470202804|FG003|Overall Study|Subject moved|1|||
130612810|NCT01670656|470202805|FG004|Overall Study|Subject moved|0|||
130612811|NCT00789958|470202806|FG000|Overall Study|Adverse Event|3|||
130612812|NCT00789958|470202806|FG000|Overall Study|Withdrawal by Subject|4|||
130612813|NCT00789958|470202806|FG000|Overall Study|Progression|3|||
130612814|NCT00789958|470202806|FG000|Overall Study|not protocol specified|1|||
130612815|NCT00789958|470202806|FG000|Overall Study|Not eligible/not analyzable|26|||
130612816|NCT03331666|470202807|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
130612817|NCT03331666|470202808|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
130612818|NCT03583372|470202809|FG000|Overall Study|Withdrawal by Subject|6|||
130612819|NCT03583372|470202810|FG001|Overall Study|Withdrawal by Subject|11|||
130612820|NCT03583372|470202811|FG002|Overall Study|Withdrawal by Subject|7|||
130612821|NCT03583372|470202812|FG003|Overall Study|Withdrawal by Subject|8|||
130612822|NCT03583372|470202809|FG000|Overall Study|Lost to Follow-up|4|||
130612823|NCT03583372|470202810|FG001|Overall Study|Lost to Follow-up|6|||
130612824|NCT03583372|470202811|FG002|Overall Study|Lost to Follow-up|3|||
130612825|NCT03583372|470202812|FG003|Overall Study|Lost to Follow-up|2|||
130612826|NCT03583372|470202809|FG000|Overall Study|Adverse Event|1|||
130612827|NCT03583372|470202810|FG001|Overall Study|Adverse Event|3|||
130612828|NCT03583372|470202811|FG002|Overall Study|Adverse Event|4|||
130612829|NCT03583372|470202812|FG003|Overall Study|Adverse Event|4|||
130612830|NCT03583372|470202809|FG000|Overall Study|Physician Decision|0|||
130612831|NCT03583372|470202810|FG001|Overall Study|Physician Decision|1|||
130612832|NCT03583372|470202811|FG002|Overall Study|Physician Decision|1|||
130612833|NCT03583372|470202812|FG003|Overall Study|Physician Decision|1|||
130612834|NCT03583372|470202809|FG000|Overall Study|Lack of Efficacy|0|||
130612835|NCT03583372|470202810|FG001|Overall Study|Lack of Efficacy|1|||
130612836|NCT03583372|470202811|FG002|Overall Study|Lack of Efficacy|0|||
130612837|NCT03583372|470202812|FG003|Overall Study|Lack of Efficacy|1|||
130612838|NCT03583372|470202809|FG000|Overall Study|Death|1|||
130612839|NCT03583372|470202810|FG001|Overall Study|Death|0|||
130612840|NCT03583372|470202811|FG002|Overall Study|Death|0|||
130612841|NCT03583372|470202812|FG003|Overall Study|Death|0|||
130612842|NCT03583372|470202809|FG000|Overall Study|Protocol Violation|0|||
130612843|NCT03583372|470202810|FG001|Overall Study|Protocol Violation|1|||
130612844|NCT03583372|470202811|FG002|Overall Study|Protocol Violation|0|||
130612845|NCT03583372|470202812|FG003|Overall Study|Protocol Violation|0|||
130612846|NCT03583372|470202809|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
130612847|NCT03583372|470202810|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
130612848|NCT03583372|470202811|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
130612849|NCT03583372|470202812|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
130612850|NCT03583372|470202809|FG000|Overall Study|Did Not Receive Study Drug|0|||
130612851|NCT03583372|470202810|FG001|Overall Study|Did Not Receive Study Drug|1|||
130612852|NCT03583372|470202811|FG002|Overall Study|Did Not Receive Study Drug|0|||
130612853|NCT03583372|470202812|FG003|Overall Study|Did Not Receive Study Drug|0|||
130612854|NCT03583372|470202809|FG000|Overall Study|Captured as Other in the Database|1|||
130612855|NCT03583372|470202810|FG001|Overall Study|Captured as Other in the Database|2|||
130612856|NCT03583372|470202811|FG002|Overall Study|Captured as Other in the Database|4|||
130612857|NCT03583372|470202812|FG003|Overall Study|Captured as Other in the Database|1|||
130612858|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130612859|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130612860|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130612861|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
130612862|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130612863|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
130612864|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612865|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
130612866|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
130612867|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130612868|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
130612869|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
130612870|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130612871|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
130612872|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612873|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612874|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612875|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612876|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612877|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612878|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612879|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612880|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130612881|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130612882|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130612883|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130612884|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130612885|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130612886|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130612887|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
130612888|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130612889|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130612890|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612891|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612892|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130612893|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130612894|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
130612895|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612896|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612897|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612898|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612899|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612900|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612901|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612902|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612903|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130612904|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612905|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612906|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612907|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612908|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612909|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612910|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612911|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612912|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612913|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612914|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612915|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612916|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612917|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
130612918|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612919|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612920|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612921|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612922|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612923|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612924|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612925|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612926|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130612927|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
130612928|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
130612929|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
130612930|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
130612931|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
130612932|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
130612933|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
130612934|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
130612935|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
130612936|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
130612937|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
130612938|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
130612939|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
130612940|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
130612941|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
130612942|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
130612943|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
130612944|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
130612945|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
130612946|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
130612947|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
130612948|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
130612949|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
130612950|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612951|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612952|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612953|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612954|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612955|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612956|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612957|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612958|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
130612959|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612960|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612961|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612962|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612963|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
130612964|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612965|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612966|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612967|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612968|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612969|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612970|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612971|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612972|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130612973|NCT02052778|470202824|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612974|NCT02052778|470202825|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612975|NCT02052778|470202826|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612976|NCT02052778|470202827|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612977|NCT02052778|470202828|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612978|NCT02052778|470202829|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
130612979|NCT02052778|470202830|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612980|NCT02052778|470202831|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612981|NCT02052778|470202832|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612982|NCT02052778|470202833|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612983|NCT02052778|470202834|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612984|NCT02052778|470202835|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612985|NCT02052778|470202836|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
130612986|NCT02052778|470202837|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612987|NCT02052778|470202838|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612988|NCT02052778|470202839|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612989|NCT02052778|470202840|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612990|NCT02052778|470202841|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612991|NCT02052778|470202842|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612992|NCT02052778|470202843|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612993|NCT02052778|470202844|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612994|NCT02052778|470202845|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612995|NCT02052778|470202846|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130612996|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130612997|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130612998|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130612999|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613000|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613001|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613002|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613003|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613004|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613005|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613006|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613007|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613008|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613009|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613010|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
130613011|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
130613012|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
130613013|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
130613014|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
130613015|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
130613016|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
130613017|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
130613018|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130613019|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613020|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613021|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613022|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613023|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613024|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613025|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613026|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613027|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613028|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613029|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613030|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613031|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613032|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613033|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
130613034|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
130613035|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613036|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
130613037|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
130613038|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
130613039|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
130613040|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
130613041|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130613042|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613043|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613044|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613045|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613046|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613047|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613048|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613049|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613050|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613051|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613052|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613053|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613054|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613055|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613056|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
130613057|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
130613058|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
130613059|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613060|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
130613061|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
130613062|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613063|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613064|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130613065|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613066|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613067|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613068|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613069|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613070|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613071|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613072|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613073|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613074|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613075|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613076|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613077|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613078|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613079|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
130613080|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
130613081|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613082|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613083|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613084|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613085|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613086|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613087|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130613088|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613089|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613090|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613091|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613092|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613093|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613094|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613095|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613096|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613097|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613098|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613099|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613100|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613101|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613102|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
130613103|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
130613104|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613105|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613106|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613107|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
130613108|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613109|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613110|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130613111|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
130613112|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
130613113|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
130613114|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
130613115|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
130613116|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
130613117|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
130613118|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
130613119|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
130613120|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
130613121|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
130613122|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
130613123|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
130613124|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
130613125|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
130613126|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
130613127|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
130613128|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
130613129|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
130613130|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
130613131|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
130613132|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
130613133|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
130613134|NCT02052778|470202824|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613135|NCT02052778|470202825|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613136|NCT02052778|470202826|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613137|NCT02052778|470202827|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613138|NCT02052778|470202828|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613139|NCT02052778|470202829|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613140|NCT02052778|470202830|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613141|NCT02052778|470202831|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613142|NCT02052778|470202832|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613143|NCT02052778|470202833|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613144|NCT02052778|470202834|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613145|NCT02052778|470202835|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613146|NCT02052778|470202836|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613147|NCT02052778|470202837|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613148|NCT02052778|470202838|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130613149|NCT02052778|470202839|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130613150|NCT02052778|470202840|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130613151|NCT02052778|470202841|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613152|NCT02052778|470202842|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130613153|NCT02052778|470202843|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613154|NCT02052778|470202844|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613155|NCT02052778|470202845|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613156|NCT02052778|470202846|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130613157|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613158|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613159|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613160|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613161|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613162|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613163|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613164|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613165|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613166|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613167|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613168|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613169|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613170|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613171|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613172|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613173|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613174|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613175|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613176|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613177|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613178|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130613179|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
130613180|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613181|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613182|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613183|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613184|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613185|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613186|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613187|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613188|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613189|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613190|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613191|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613192|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613193|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613194|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613195|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613196|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613197|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613198|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613199|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613200|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613201|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130613202|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
130613203|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613204|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613205|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613206|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613207|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613208|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613209|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613210|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613211|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613212|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613213|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613214|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613215|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613216|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613217|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613218|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613219|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613220|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613221|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613222|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613223|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613224|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130613225|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
130613226|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613227|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613228|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613229|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613230|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613231|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613232|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613233|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613234|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613235|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613236|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613237|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613238|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613239|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613240|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613241|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613242|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613243|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613244|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613245|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613246|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613247|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130613248|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
130613249|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613250|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613251|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613252|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613253|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613254|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613255|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613256|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613257|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613258|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613259|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613260|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613261|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613262|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613263|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613264|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613265|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613266|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613267|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613268|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613269|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613270|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130613271|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
130613272|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
130613273|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
130613274|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
130613275|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
130613276|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
130613277|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
130613278|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
130613279|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
130613280|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
130613281|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
130613282|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
130613283|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
130613284|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
130613285|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
130613286|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
130613287|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
130613288|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
130613289|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
130613290|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
130613291|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
130613292|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
130613293|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
130613294|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
130613295|NCT02052778|470202824|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613296|NCT02052778|470202825|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613297|NCT02052778|470202826|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613298|NCT02052778|470202827|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613299|NCT02052778|470202828|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613300|NCT02052778|470202829|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613301|NCT02052778|470202830|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613302|NCT02052778|470202831|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613303|NCT02052778|470202832|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613304|NCT02052778|470202833|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613305|NCT02052778|470202834|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613306|NCT02052778|470202835|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613307|NCT02052778|470202836|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613308|NCT02052778|470202837|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613309|NCT02052778|470202838|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613310|NCT02052778|470202839|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613311|NCT02052778|470202840|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613312|NCT02052778|470202841|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613313|NCT02052778|470202842|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613314|NCT02052778|470202843|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613315|NCT02052778|470202844|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613316|NCT02052778|470202845|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
130613317|NCT02052778|470202846|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
130613318|NCT01980706|470202851|FG000|Overall Study|Withdrawal by Subject|9|||
130613319|NCT01980706|470202852|FG001|Overall Study|Withdrawal by Subject|6|||
130613320|NCT01980706|470202853|FG002|Overall Study|Withdrawal by Subject|2|||
130613321|NCT01980706|470202851|FG000|Overall Study|Adverse Event|1|||
130613322|NCT01980706|470202852|FG001|Overall Study|Adverse Event|2|||
130613323|NCT01980706|470202853|FG002|Overall Study|Adverse Event|5|||
130613324|NCT01980706|470202851|FG000|Overall Study|Lost to Follow-up|3|||
130613325|NCT01980706|470202852|FG001|Overall Study|Lost to Follow-up|4|||
130613326|NCT01980706|470202853|FG002|Overall Study|Lost to Follow-up|3|||
130613327|NCT01980706|470202851|FG000|Overall Study|miscellaneous|4|||
130613328|NCT01980706|470202852|FG001|Overall Study|miscellaneous|5|||
130613329|NCT01980706|470202853|FG002|Overall Study|miscellaneous|3|||
130613330|NCT01094730|470202856|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
130613331|NCT01094730|470202857|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
130613332|NCT01094730|470202856|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
130613333|NCT01094730|470202857|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
130613334|NCT01094730|470202856|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
130613335|NCT01094730|470202857|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
130613336|NCT01094730|470202856|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
130613337|NCT01094730|470202857|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
130613338|NCT01094730|470202856|FG000|Period 2 (14 Days)|Protocol Violation|2|||
130613339|NCT01094730|470202857|FG001|Period 2 (14 Days)|Protocol Violation|0|||
130613340|NCT01094730|470202856|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
130613341|NCT01094730|470202857|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
130613342|NCT01094730|470202856|FG000|Period 2 (14 Days)|Adverse Event|0|||
130613343|NCT01094730|470202857|FG001|Period 2 (14 Days)|Adverse Event|1|||
130613344|NCT01094730|470202856|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
130613345|NCT01094730|470202857|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
130613346|NCT01842308|470202858|FG000|Overall Study|Withdrawal by Subject|0|||
130613347|NCT01842308|470202859|FG001|Overall Study|Withdrawal by Subject|0|||
130613348|NCT01842308|470202860|FG002|Overall Study|Withdrawal by Subject|0|||
130613349|NCT01842308|470202861|FG003|Overall Study|Withdrawal by Subject|0|||
130613350|NCT01842308|470202862|FG004|Overall Study|Withdrawal by Subject|1|||
130613351|NCT00987623|470202863|FG000|Overall Study|Lost to Follow-up|2|||
130613352|NCT00987623|470202864|FG001|Overall Study|Lost to Follow-up|1|||
130613353|NCT00987623|470202863|FG000|Overall Study|Time/job conflict|2|||
130613354|NCT00987623|470202864|FG001|Overall Study|Time/job conflict|0|||
130613355|NCT00987623|470202863|FG000|Overall Study|Discomfort|1|||
130613356|NCT00987623|470202864|FG001|Overall Study|Discomfort|0|||
130613357|NCT00987623|470202863|FG000|Overall Study|Biomicroscopy|0|||
130613358|NCT00987623|470202864|FG001|Overall Study|Biomicroscopy|1|||
130613359|NCT00987623|470202863|FG000|Overall Study|Influenza|0|||
130613360|NCT00987623|470202864|FG001|Overall Study|Influenza|1|||
130613361|NCT04056455|470202865|FG000|Overall Study|Adverse Event|1|||
130613362|NCT04056455|470202866|FG001|Overall Study|Adverse Event|0|||
130613363|NCT03521687|470202867|FG000|Overall Study|Adverse Event|4|||
130613364|NCT03521687|470202867|FG000|Overall Study|Physician Decision|1|||
130613365|NCT01151579|470202868|FG000|Overall Study|Physician Decision|3|||
130613366|NCT01151579|470202869|FG001|Overall Study|Physician Decision|1|||
130613367|NCT01151579|470202868|FG000|Overall Study|Withdrawal by Subject|3|||
130613368|NCT01151579|470202869|FG001|Overall Study|Withdrawal by Subject|2|||
130613369|NCT01151579|470202868|FG000|Overall Study|Not meet inclusion criteria|6|||
130613370|NCT01151579|470202869|FG001|Overall Study|Not meet inclusion criteria|4|||
130613371|NCT01276457|470202872|FG000|Core Study|Adverse Event|6|||
130613372|NCT01276457|470202873|FG001|Core Study|Adverse Event|3|||
130613373|NCT01276457|470202872|FG000|Core Study|Lost to Follow-up|1|||
130613374|NCT01276457|470202873|FG001|Core Study|Lost to Follow-up|2|||
130613375|NCT01276457|470202872|FG000|Core Study|Administrative problems|1|||
130613376|NCT01276457|470202873|FG001|Core Study|Administrative problems|1|||
130613377|NCT01276457|470202872|FG000|Core Study|Death|2|||
130613378|NCT01276457|470202873|FG001|Core Study|Death|2|||
130613379|NCT01276457|470202872|FG000|Core Study|Lack of Efficacy|3|||
130613380|NCT01276457|470202873|FG001|Core Study|Lack of Efficacy|12|||
130613381|NCT01276457|470202872|FG000|Extension Study|Lost to Follow-up|3|||
130613382|NCT01276457|470202873|FG001|Extension Study|Lost to Follow-up|0|||
130613383|NCT01276457|470202872|FG000|Extension Study|Death|0|||
130613384|NCT01276457|470202873|FG001|Extension Study|Death|1|||
130613385|NCT01276457|470202872|FG000|Extension Study|Lack of Efficacy|3|||
130613386|NCT01276457|470202873|FG001|Extension Study|Lack of Efficacy|1|||
130613387|NCT02065869|470202879|FG000|Overall Study|Death|7|||
130613388|NCT02065869|470202879|FG000|Overall Study|Disease relapse|16|||
130613389|NCT02065869|470202879|FG000|Overall Study|Lost to Follow-up|4|||
130613390|NCT02065869|470202879|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
130613391|NCT02065869|470202879|FG000|Overall Study|Withdrawal by Subject|1|||
130613392|NCT03807739|470202880|FG000|Overall Study|Adverse Event|1|||
130613393|NCT03807739|470202881|FG001|Overall Study|Adverse Event|0|||
130613394|NCT03807739|470202882|FG002|Overall Study|Adverse Event|0|||
130613395|NCT03807739|470202883|FG003|Overall Study|Adverse Event|0|||
130613396|NCT03807739|470202880|FG000|Overall Study|Withdrawal by Subject|1|||
130613397|NCT03807739|470202881|FG001|Overall Study|Withdrawal by Subject|0|||
130613398|NCT03807739|470202882|FG002|Overall Study|Withdrawal by Subject|0|||
130613399|NCT03807739|470202883|FG003|Overall Study|Withdrawal by Subject|0|||
130613400|NCT02371759|470202886|FG000|Overall Study|Protocol Violation|3|||
130613401|NCT02371759|470202887|FG001|Overall Study|Protocol Violation|1|||
130613402|NCT02371759|470202888|FG002|Overall Study|Protocol Violation|1|||
130613403|NCT02371759|470202889|FG003|Overall Study|Protocol Violation|0|||
130613404|NCT02371759|470202890|FG004|Overall Study|Protocol Violation|3|||
130613405|NCT02371759|470202891|FG005|Overall Study|Protocol Violation|1|||
130613406|NCT02371759|470202892|FG006|Overall Study|Protocol Violation|0|||
130613407|NCT02371759|470202893|FG007|Overall Study|Protocol Violation|3|||
130613408|NCT02371759|470202886|FG000|Overall Study|Withdrawal by Subject|0|||
130613409|NCT02371759|470202887|FG001|Overall Study|Withdrawal by Subject|0|||
130613410|NCT02371759|470202888|FG002|Overall Study|Withdrawal by Subject|0|||
130613411|NCT02371759|470202889|FG003|Overall Study|Withdrawal by Subject|0|||
130613412|NCT02371759|470202890|FG004|Overall Study|Withdrawal by Subject|0|||
130613413|NCT02371759|470202891|FG005|Overall Study|Withdrawal by Subject|0|||
130613414|NCT02371759|470202892|FG006|Overall Study|Withdrawal by Subject|0|||
130613415|NCT02371759|470202893|FG007|Overall Study|Withdrawal by Subject|1|||
130613416|NCT03375112|470202896|FG000|Overall Study|Withdrawal by Subject|3|||
130613417|NCT03375112|470202897|FG001|Overall Study|Withdrawal by Subject|0|||
130613418|NCT00243230|470202898|FG000|Double-Blind Period|Adverse Event|0|||
130613419|NCT00243230|470202899|FG001|Double-Blind Period|Adverse Event|2|||
130613420|NCT00243230|470202900|FG002|Double-Blind Period|Adverse Event|2|||
130613421|NCT00243230|470202901|FG003|Double-Blind Period|Adverse Event|0|||
130613422|NCT00243230|470202898|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130613423|NCT00243230|470202899|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130613424|NCT00243230|470202900|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130613425|NCT00243230|470202901|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130613426|NCT00243230|470202898|FG000|Double-Blind Period|Protocol Violation|0|||
130613427|NCT00243230|470202899|FG001|Double-Blind Period|Protocol Violation|0|||
130613428|NCT00243230|470202900|FG002|Double-Blind Period|Protocol Violation|1|||
130613429|NCT00243230|470202901|FG003|Double-Blind Period|Protocol Violation|0|||
130613430|NCT00243230|470202898|FG000|Double-Blind Period|Randomized but Not Treated|0|||
130613431|NCT00243230|470202899|FG001|Double-Blind Period|Randomized but Not Treated|0|||
130613432|NCT00243230|470202900|FG002|Double-Blind Period|Randomized but Not Treated|2|||
130613433|NCT00243230|470202901|FG003|Double-Blind Period|Randomized but Not Treated|0|||
130613434|NCT00243230|470202898|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
130613435|NCT00243230|470202899|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
130648353|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130613436|NCT00243230|470202900|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
130613437|NCT00243230|470202901|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
130613438|NCT00243230|470202898|FG000|Open Label Period|Adverse Event|0|||
130613439|NCT00243230|470202899|FG001|Open Label Period|Adverse Event|0|||
130613440|NCT00243230|470202900|FG002|Open Label Period|Adverse Event|0|||
130613441|NCT00243230|470202901|FG003|Open Label Period|Adverse Event|2|||
130613442|NCT00243230|470202898|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
130613443|NCT00243230|470202899|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
130613444|NCT00243230|470202900|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
130613445|NCT00243230|470202901|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
130613446|NCT00243230|470202898|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130613447|NCT00243230|470202899|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130613448|NCT00243230|470202900|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130613449|NCT00243230|470202901|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
130613450|NCT00243230|470202898|FG000|Open Label Period|Lost to Follow-up|0|||
130613451|NCT00243230|470202899|FG001|Open Label Period|Lost to Follow-up|0|||
130613452|NCT00243230|470202900|FG002|Open Label Period|Lost to Follow-up|0|||
130613453|NCT00243230|470202901|FG003|Open Label Period|Lost to Follow-up|2|||
130613454|NCT00243230|470202898|FG000|Open Label Period|Withdrawal by Subject|0|||
130613455|NCT00243230|470202899|FG001|Open Label Period|Withdrawal by Subject|0|||
130613456|NCT00243230|470202900|FG002|Open Label Period|Withdrawal by Subject|0|||
130613457|NCT00243230|470202901|FG003|Open Label Period|Withdrawal by Subject|2|||
130613458|NCT00243230|470202898|FG000|Open Label Period|Protocol Violation|0|||
130613459|NCT00243230|470202899|FG001|Open Label Period|Protocol Violation|0|||
130613460|NCT00243230|470202900|FG002|Open Label Period|Protocol Violation|0|||
130613461|NCT00243230|470202901|FG003|Open Label Period|Protocol Violation|2|||
130613462|NCT00243230|470202898|FG000|Open Label Period|Administrative Reason|0|||
130613463|NCT00243230|470202899|FG001|Open Label Period|Administrative Reason|0|||
130613464|NCT00243230|470202900|FG002|Open Label Period|Administrative Reason|0|||
130613465|NCT00243230|470202901|FG003|Open Label Period|Administrative Reason|63|||
130613466|NCT05118386|470202904|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130613467|NCT05118386|470202905|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130613468|NCT05118386|470202906|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130613469|NCT05118386|470202907|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
130613470|NCT05118386|470202908|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130613471|NCT05118386|470202909|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130613472|NCT05118386|470202904|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130613473|NCT05118386|470202905|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130613474|NCT05118386|470202906|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130613475|NCT05118386|470202907|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130613476|NCT05118386|470202908|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
130613477|NCT05118386|470202909|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130613478|NCT00303108|470202910|FG000|Overall Study|Adverse Event|5|||
130613479|NCT00303108|470202911|FG001|Overall Study|Adverse Event|6|||
130613480|NCT00303108|470202912|FG002|Overall Study|Adverse Event|7|||
130613481|NCT00303108|470202910|FG000|Overall Study|Patient Request|4|||
130613482|NCT00303108|470202911|FG001|Overall Study|Patient Request|2|||
130613483|NCT00303108|470202912|FG002|Overall Study|Patient Request|8|||
130613484|NCT00303108|470202910|FG000|Overall Study|Failed Entry|1|||
130613485|NCT00303108|470202911|FG001|Overall Study|Failed Entry|0|||
130613486|NCT00303108|470202912|FG002|Overall Study|Failed Entry|1|||
130613487|NCT00303108|470202910|FG000|Overall Study|ineligible|2|||
130613488|NCT00303108|470202911|FG001|Overall Study|ineligible|1|||
130613489|NCT00303108|470202912|FG002|Overall Study|ineligible|0|||
130613490|NCT00894413|470202915|FG000|Overall Study|Physician Decision|0|||
130613491|NCT00894413|470202916|FG001|Overall Study|Physician Decision|2|||
130613492|NCT00894413|470202915|FG000|Overall Study|Adverse Event|0|||
130613493|NCT00894413|470202916|FG001|Overall Study|Adverse Event|2|||
130613494|NCT00894413|470202915|FG000|Overall Study|Withdrawal by Subject|0|||
130613495|NCT00894413|470202916|FG001|Overall Study|Withdrawal by Subject|4|||
130613496|NCT03201198|470202917|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
130613497|NCT03201198|470202918|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
130613498|NCT03201198|470202917|FG000|Overall Study|Withdrawal by Subject|2|||
130613499|NCT03201198|470202918|FG001|Overall Study|Withdrawal by Subject|3|||
130613500|NCT02427477|470202923|FG000|Period 1|Adverse Event|1|||
130613501|NCT02427477|470202924|FG001|Period 1|Adverse Event|0|||
130613502|NCT01767194|470202925|FG000|Overall Study|Adverse Event|1|||
130613503|NCT01767194|470202926|FG001|Overall Study|Adverse Event|1|||
130613504|NCT01767194|470202925|FG000|Overall Study|Death|0|||
130613505|NCT01767194|470202926|FG001|Overall Study|Death|1|||
130613506|NCT01767194|470202925|FG000|Overall Study|Lack of Efficacy|12|||
130613507|NCT01767194|470202926|FG001|Overall Study|Lack of Efficacy|11|||
130613508|NCT01767194|470202925|FG000|Overall Study|Physician Decision|2|||
130613509|NCT01767194|470202926|FG001|Overall Study|Physician Decision|23|||
130613510|NCT01767194|470202925|FG000|Overall Study|Withdrawal by Subject|0|||
130613511|NCT01767194|470202926|FG001|Overall Study|Withdrawal by Subject|1|||
130613512|NCT01767194|470202925|FG000|Overall Study|Ineligible|1|||
130613513|NCT01767194|470202926|FG001|Overall Study|Ineligible|1|||
130613514|NCT01767194|470202925|FG000|Overall Study|Refusal by patient/parent|2|||
130613515|NCT01767194|470202926|FG001|Overall Study|Refusal by patient/parent|4|||
130613516|NCT01767194|470202925|FG000|Overall Study|Criteria not met on time for next cycle|0|||
130613517|NCT01767194|470202926|FG001|Overall Study|Criteria not met on time for next cycle|1|||
130613518|NCT00311181|470204372|FG000|Overall Study|Final DFTs were not obtained|96|||
130613519|NCT02669862|470204373|FG000|Overall Study|Lost to Follow-up|0|||
130613520|NCT02669862|470204374|FG001|Overall Study|Lost to Follow-up|2|||
130613521|NCT02669862|470204375|FG002|Overall Study|Lost to Follow-up|1|||
130613522|NCT02669862|470204373|FG000|Overall Study|Withdrawal by Subject|2|||
130613523|NCT02669862|470204374|FG001|Overall Study|Withdrawal by Subject|2|||
130613524|NCT02669862|470204375|FG002|Overall Study|Withdrawal by Subject|3|||
130613525|NCT02669862|470204373|FG000|Overall Study|moved|0|||
130613526|NCT02669862|470204374|FG001|Overall Study|moved|1|||
130613527|NCT02669862|470204375|FG002|Overall Study|moved|0|||
130613528|NCT02669862|470204373|FG000|Overall Study|Protocol Violation|0|||
130613529|NCT02669862|470204374|FG001|Overall Study|Protocol Violation|0|||
130613530|NCT02669862|470204375|FG002|Overall Study|Protocol Violation|1|||
130613531|NCT00818207|470204378|FG000|Overall Study|Adverse Event|6|||
130613532|NCT00818207|470204379|FG001|Overall Study|Adverse Event|0|||
130613533|NCT00818207|470204378|FG000|Overall Study|Lost to Follow-up|160|||
130613534|NCT00818207|470204379|FG001|Overall Study|Lost to Follow-up|146|||
130613535|NCT00818207|470204378|FG000|Overall Study|Multiple reasons|11|||
130613536|NCT00818207|470204379|FG001|Overall Study|Multiple reasons|12|||
130613537|NCT00818207|470204378|FG000|Overall Study|Withdrawal by Subject|42|||
130613538|NCT00818207|470204379|FG001|Overall Study|Withdrawal by Subject|104|||
130613539|NCT00818207|470204378|FG000|Overall Study|Death|3|||
130613540|NCT00818207|470204379|FG001|Overall Study|Death|5|||
130613541|NCT02616185|470204380|FG000|Overall Study|Death|0|||
130613542|NCT02616185|470204381|FG001|Overall Study|Death|0|||
130613543|NCT02616185|470204382|FG002|Overall Study|Death|0|||
130613544|NCT02616185|470204383|FG003|Overall Study|Death|1|||
130613545|NCT02616185|470204384|FG004|Overall Study|Death|2|||
130613546|NCT02616185|470204385|FG005|Overall Study|Death|0|||
130613547|NCT02616185|470204386|FG006|Overall Study|Death|0|||
130613548|NCT02616185|470204387|FG007|Overall Study|Death|2|||
130613549|NCT02616185|470204388|FG008|Overall Study|Death|1|||
130613550|NCT02616185|470204380|FG000|Overall Study|Study terminated by sponsor|0|||
130613551|NCT02616185|470204381|FG001|Overall Study|Study terminated by sponsor|0|||
130613552|NCT02616185|470204382|FG002|Overall Study|Study terminated by sponsor|1|||
130613553|NCT02616185|470204383|FG003|Overall Study|Study terminated by sponsor|0|||
130613554|NCT02616185|470204384|FG004|Overall Study|Study terminated by sponsor|0|||
130613555|NCT02616185|470204385|FG005|Overall Study|Study terminated by sponsor|0|||
130613556|NCT02616185|470204386|FG006|Overall Study|Study terminated by sponsor|5|||
130613557|NCT02616185|470204387|FG007|Overall Study|Study terminated by sponsor|2|||
130613558|NCT02616185|470204388|FG008|Overall Study|Study terminated by sponsor|0|||
130613559|NCT02616185|470204380|FG000|Overall Study|Participant refused further follow-up|1|||
130613560|NCT02616185|470204381|FG001|Overall Study|Participant refused further follow-up|1|||
130613561|NCT02616185|470204382|FG002|Overall Study|Participant refused further follow-up|2|||
130613562|NCT02616185|470204383|FG003|Overall Study|Participant refused further follow-up|3|||
130613563|NCT02616185|470204384|FG004|Overall Study|Participant refused further follow-up|4|||
130613564|NCT02616185|470204385|FG005|Overall Study|Participant refused further follow-up|0|||
130613565|NCT02616185|470204386|FG006|Overall Study|Participant refused further follow-up|3|||
130613566|NCT02616185|470204387|FG007|Overall Study|Participant refused further follow-up|4|||
130613567|NCT02616185|470204388|FG008|Overall Study|Participant refused further follow-up|3|||
130613568|NCT02616185|470204380|FG000|Overall Study|Not reported|0|||
130613569|NCT02616185|470204381|FG001|Overall Study|Not reported|0|||
130613570|NCT02616185|470204382|FG002|Overall Study|Not reported|0|||
130613571|NCT02616185|470204383|FG003|Overall Study|Not reported|1|||
130613572|NCT02616185|470204384|FG004|Overall Study|Not reported|3|||
130613573|NCT02616185|470204385|FG005|Overall Study|Not reported|1|||
130613574|NCT02616185|470204386|FG006|Overall Study|Not reported|0|||
130613575|NCT02616185|470204387|FG007|Overall Study|Not reported|5|||
130613576|NCT02616185|470204388|FG008|Overall Study|Not reported|2|||
130613577|NCT02494778|470204389|FG000|Overall Study|Death|3|||
130613578|NCT02494778|470204389|FG000|Overall Study|Other|173|||
130613579|NCT02494778|470204389|FG000|Overall Study|Lack of Efficacy|4|||
130613580|NCT02494778|470204389|FG000|Overall Study|Adverse Event|18|||
130613581|NCT02494778|470204389|FG000|Overall Study|Withdrawal by Subject|20|||
130613582|NCT02494778|470204389|FG000|Overall Study|Lost to Follow-up|2|||
130613583|NCT02494778|470204389|FG000|Overall Study|Noncompliant with study drug admin.|1|||
130613584|NCT02702518|470204395|FG000|Overall Study|Lost to Follow-up|3|||
130613585|NCT02702518|470204396|FG001|Overall Study|Lost to Follow-up|4|||
130613586|NCT01000727|470204400|FG000|Overall Study|Lost to Follow-up|41|||
130613587|NCT01000727|470204401|FG001|Overall Study|Lost to Follow-up|43|||
130613588|NCT01000727|470204400|FG000|Overall Study|Withdrawal by Subject|111|||
130613589|NCT01000727|470204401|FG001|Overall Study|Withdrawal by Subject|109|||
130613590|NCT01000727|470204400|FG000|Overall Study|Study closed/terminated|23|||
130613591|NCT01000727|470204401|FG001|Overall Study|Study closed/terminated|24|||
130613592|NCT03137121|470204402|FG000|Overall Study|Withdrawal by Subject|0|||
130613593|NCT03137121|470204403|FG001|Overall Study|Withdrawal by Subject|1|||
130613594|NCT01026389|470204408|FG000|Overall Study|Withdrawal by Subject|1|||
130613595|NCT01026389|470204409|FG001|Overall Study|Withdrawal by Subject|3|||
130613596|NCT01026389|470204408|FG000|Overall Study|change of treatment, patient moved|4|||
130613597|NCT01026389|470204409|FG001|Overall Study|change of treatment, patient moved|2|||
130613598|NCT00836277|470204410|FG000|Overall Study|Not evaluable for response|6|||
130613599|NCT01995136|470204411|FG000|Overall Study|Change in residence|1|||
130613600|NCT03544268|470204412|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
130613601|NCT03544268|470204413|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
130613602|NCT04410198|470204414|FG000|Overall Study|Death|10|||
130613603|NCT04410198|470204414|FG000|Overall Study|Withdrawal by Subject|7|||
130613604|NCT04410198|470204414|FG000|Overall Study|Transferred/Relocation|4|||
130613605|NCT04410198|470204414|FG000|Overall Study|Kidney Transplant|9|||
130613606|NCT04410198|470204414|FG000|Overall Study|Adverse Event|4|||
130613607|NCT04410198|470204414|FG000|Overall Study|Physician Decision|2|||
130613608|NCT04410198|470204414|FG000|Overall Study|Other than specified|1|||
130613609|NCT01830543|470204417|FG000|Overall Study|Subject Decision|19|||
130613610|NCT01830543|470204418|FG001|Overall Study|Subject Decision|21|||
130613611|NCT01830543|470204419|FG002|Overall Study|Subject Decision|57|||
130613612|NCT01830543|470204417|FG000|Overall Study|Adverse Event|91|||
130613613|NCT01830543|470204418|FG001|Overall Study|Adverse Event|77|||
130613614|NCT01830543|470204419|FG002|Overall Study|Adverse Event|76|||
130613615|NCT01830543|470204417|FG000|Overall Study|Death|20|||
130613616|NCT01830543|470204418|FG001|Overall Study|Death|22|||
130613617|NCT01830543|470204419|FG002|Overall Study|Death|22|||
130613618|NCT01830543|470204417|FG000|Overall Study|Protocol Violation|3|||
130613619|NCT01830543|470204418|FG001|Overall Study|Protocol Violation|7|||
130613620|NCT01830543|470204419|FG002|Overall Study|Protocol Violation|7|||
130613621|NCT01830543|470204417|FG000|Overall Study|Physician Decision|11|||
130613622|NCT01830543|470204418|FG001|Overall Study|Physician Decision|5|||
130613623|NCT01830543|470204419|FG002|Overall Study|Physician Decision|12|||
130613624|NCT01830543|470204417|FG000|Overall Study|Withdrawal by consent|3|||
130613625|NCT01830543|470204418|FG001|Overall Study|Withdrawal by consent|3|||
130613626|NCT01830543|470204419|FG002|Overall Study|Withdrawal by consent|3|||
130613627|NCT01830543|470204417|FG000|Overall Study|Other|12|||
130613628|NCT01830543|470204418|FG001|Overall Study|Other|17|||
130613629|NCT01830543|470204419|FG002|Overall Study|Other|37|||
130613630|NCT00377611|470204422|FG000|Overall Study|Adverse Event|2|||
130613631|NCT00377611|470204423|FG001|Overall Study|Adverse Event|9|||
130613632|NCT00377611|470204422|FG000|Overall Study|Protocol Violation|2|||
130613633|NCT00377611|470204423|FG001|Overall Study|Protocol Violation|0|||
130613634|NCT00377611|470204422|FG000|Overall Study|Withdrawal by Subject|0|||
130613635|NCT00377611|470204423|FG001|Overall Study|Withdrawal by Subject|5|||
130613636|NCT00377611|470204422|FG000|Overall Study|Lost to Follow-up|18|||
130613637|NCT00377611|470204423|FG001|Overall Study|Lost to Follow-up|16|||
130613638|NCT00377611|470204422|FG000|Overall Study|Other|0|||
130613639|NCT00377611|470204423|FG001|Overall Study|Other|3|||
130613640|NCT04831515|470204424|FG000|First Intervention|Adverse Event|0|||
130613641|NCT04831515|470204425|FG001|First Intervention|Adverse Event|1|||
130613642|NCT01640925|470204428|FG000|Overall Study|Withdrawal by Subject|1|||
130613643|NCT01640925|470204429|FG001|Overall Study|Withdrawal by Subject|0|||
130613644|NCT01640925|470204428|FG000|Overall Study|Previously enrolled in this trial|13|||
130613645|NCT01640925|470204429|FG001|Overall Study|Previously enrolled in this trial|11|||
130613646|NCT01030458|470204441|FG000|Overall Study|Lost to Follow-up|9|||
130613647|NCT01030458|470204442|FG001|Overall Study|Lost to Follow-up|10|||
130613648|NCT01030458|470204441|FG000|Overall Study|Withdrawal by Subject|2|||
130613649|NCT01030458|470204442|FG001|Overall Study|Withdrawal by Subject|3|||
130613650|NCT01030458|470204441|FG000|Overall Study|Logistical reasons|9|||
130613651|NCT01030458|470204442|FG001|Overall Study|Logistical reasons|5|||
130613652|NCT01030458|470204441|FG000|Overall Study|Moved or changed job|6|||
130613653|NCT01030458|470204442|FG001|Overall Study|Moved or changed job|13|||
130613654|NCT01030458|470204441|FG000|Overall Study|Side effect of medication|1|||
130613655|NCT01030458|470204442|FG001|Overall Study|Side effect of medication|1|||
130613656|NCT02420223|470204443|FG000|Overall Study|Adverse Event|1|||
130613657|NCT02420223|470204444|FG001|Overall Study|Adverse Event|0|||
130613658|NCT02420223|470204443|FG000|Overall Study|Physician Decision|0|||
130613659|NCT02420223|470204444|FG001|Overall Study|Physician Decision|2|||
130613660|NCT00288860|470204453|FG000|Overall Study|Did not complete intake|4|||
130613661|NCT00288860|470204454|FG001|Overall Study|Did not complete intake|8|||
130613662|NCT00288860|470204453|FG000|Overall Study|Death|4|||
130613663|NCT00288860|470204454|FG001|Overall Study|Death|3|||
130613664|NCT00288860|470204453|FG000|Overall Study|Withdrawal by Subject|20|||
130613665|NCT00288860|470204454|FG001|Overall Study|Withdrawal by Subject|15|||
130613666|NCT00288860|470204453|FG000|Overall Study|Lost to Follow-up|74|||
130613667|NCT00288860|470204454|FG001|Overall Study|Lost to Follow-up|71|||
130613668|NCT04017442|470204455|FG000|Overall Study|Withdrawal by Subject|0|||
130613669|NCT04017442|470204456|FG001|Overall Study|Withdrawal by Subject|3|||
130613670|NCT04017442|470204455|FG000|Overall Study|Lost to Follow-up|21|||
130613671|NCT04017442|470204456|FG001|Overall Study|Lost to Follow-up|19|||
130613672|NCT02586233|470204457|FG000|Overall Study|Randomized but did not receive treatment|0|||
130613673|NCT02586233|470204458|FG001|Overall Study|Randomized but did not receive treatment|1|||
130613674|NCT02586233|470204459|FG002|Overall Study|Randomized but did not receive treatment|0|||
130613675|NCT02586233|470204460|FG003|Overall Study|Randomized but did not receive treatment|0|||
130613676|NCT02586233|470204461|FG004|Overall Study|Randomized but did not receive treatment|0|||
130613677|NCT02586233|470204462|FG005|Overall Study|Randomized but did not receive treatment|2|||
130613678|NCT02586233|470204463|FG006|Overall Study|Randomized but did not receive treatment|2|||
130613679|NCT02586233|470204457|FG000|Overall Study|Death|0|||
130613680|NCT02586233|470204458|FG001|Overall Study|Death|1|||
130613681|NCT02586233|470204459|FG002|Overall Study|Death|0|||
130613682|NCT02586233|470204460|FG003|Overall Study|Death|0|||
130613683|NCT02586233|470204461|FG004|Overall Study|Death|2|||
130613684|NCT02586233|470204462|FG005|Overall Study|Death|0|||
130613685|NCT02586233|470204463|FG006|Overall Study|Death|0|||
130613686|NCT01757405|470204464|FG000|Overall Study|Lost to Follow-up|1|||
130613687|NCT01757405|470204465|FG001|Overall Study|Lost to Follow-up|1|||
130613688|NCT01757405|470204464|FG000|Overall Study|Withdrawal by Subject|0|||
130613689|NCT01757405|470204465|FG001|Overall Study|Withdrawal by Subject|1|||
130613690|NCT00082758|470204467|FG000|Overall Study|Adverse Event|0|||
130613691|NCT00082758|470204468|FG001|Overall Study|Adverse Event|2|||
130613692|NCT00082758|470204469|FG002|Overall Study|Adverse Event|0|||
130613693|NCT00082758|470204467|FG000|Overall Study|Lack of Efficacy|12|||
130613694|NCT00082758|470204468|FG001|Overall Study|Lack of Efficacy|13|||
130613695|NCT00082758|470204469|FG002|Overall Study|Lack of Efficacy|0|||
130613696|NCT00082758|470204467|FG000|Overall Study|Physician Decision|0|||
130613697|NCT00082758|470204468|FG001|Overall Study|Physician Decision|1|||
130613698|NCT00082758|470204469|FG002|Overall Study|Physician Decision|0|||
130613699|NCT00082758|470204467|FG000|Overall Study|Withdrawal by Subject|3|||
130613700|NCT00082758|470204468|FG001|Overall Study|Withdrawal by Subject|0|||
130613701|NCT00082758|470204469|FG002|Overall Study|Withdrawal by Subject|0|||
130613702|NCT00082758|470204467|FG000|Overall Study|Protocol Violation|0|||
130613703|NCT00082758|470204468|FG001|Overall Study|Protocol Violation|1|||
130613704|NCT00082758|470204469|FG002|Overall Study|Protocol Violation|0|||
130613705|NCT00238303|470204470|FG000|Overall Study|Withdrawal by Subject|11|||
130613706|NCT00238303|470204471|FG001|Overall Study|Withdrawal by Subject|1|||
130613707|NCT00238303|470204472|FG002|Overall Study|Withdrawal by Subject|2|||
130613708|NCT00238303|470204470|FG000|Overall Study|Death|1|||
130613709|NCT00238303|470204471|FG001|Overall Study|Death|0|||
130613710|NCT00238303|470204472|FG002|Overall Study|Death|1|||
130613711|NCT00238303|470204470|FG000|Overall Study|Other Medical Problems|2|||
130613712|NCT00238303|470204471|FG001|Overall Study|Other Medical Problems|0|||
130613713|NCT00238303|470204472|FG002|Overall Study|Other Medical Problems|2|||
130613714|NCT00238303|470204470|FG000|Overall Study|Poor tolerance of study treatment|1|||
130613715|NCT00238303|470204471|FG001|Overall Study|Poor tolerance of study treatment|0|||
130613716|NCT00238303|470204472|FG002|Overall Study|Poor tolerance of study treatment|1|||
130613717|NCT00238303|470204470|FG000|Overall Study|Adverse Event|0|||
130613718|NCT00238303|470204471|FG001|Overall Study|Adverse Event|1|||
130613719|NCT00238303|470204472|FG002|Overall Study|Adverse Event|3|||
130613720|NCT01358877|470204476|FG000|Overall Study|Death|80|||
130613721|NCT01358877|470204477|FG001|Overall Study|Death|89|||
130613722|NCT01358877|470204476|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
130613723|NCT01358877|470204477|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
130613724|NCT01358877|470204476|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
130613725|NCT01358877|470204477|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
130613726|NCT01358877|470204476|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
130613727|NCT01358877|470204477|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
130613728|NCT01358877|470204476|FG000|Overall Study|Other|142|||
130613729|NCT01358877|470204477|FG001|Overall Study|Other|129|||
130613730|NCT01911845|470204482|FG000|Overall Study|Adverse Event|2|||
130613731|NCT01911845|470204482|FG000|Overall Study|Lost to Follow-up|1|||
130613732|NCT01911845|470204482|FG000|Overall Study|Other (not specified)|3|||
130613733|NCT01994226|470204483|FG000|Overall Study|Protocol Violation|13|||
130613734|NCT01994226|470204484|FG001|Overall Study|Protocol Violation|10|||
130613735|NCT01994226|470204483|FG000|Overall Study|Early Cessation of treatment|6|||
130613736|NCT01994226|470204484|FG001|Overall Study|Early Cessation of treatment|11|||
130613737|NCT02345252|470204490|FG000|Double-Blind Phase|Adverse Event|2|||
130613738|NCT02345252|470204491|FG001|Double-Blind Phase|Adverse Event|3|||
130613739|NCT02345252|470204490|FG000|Double-Blind Phase|Death|1|||
130613740|NCT02345252|470204491|FG001|Double-Blind Phase|Death|2|||
130613741|NCT02345252|470204490|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130613742|NCT02345252|470204491|FG001|Double-Blind Phase|Lack of Efficacy|0|||
130613743|NCT02345252|470204490|FG000|Double-Blind Phase|Investigator's Discretion|4|||
130613744|NCT02345252|470204491|FG001|Double-Blind Phase|Investigator's Discretion|6|||
130613745|NCT02345252|470204490|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130613746|NCT02345252|470204491|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
130613747|NCT02345252|470204490|FG000|Double-Blind Phase|Protocol Violation|2|||
130613748|NCT02345252|470204491|FG001|Double-Blind Phase|Protocol Violation|1|||
130613749|NCT02345252|470204490|FG000|Double-Blind Phase|Withdrew Consent|21|||
130613750|NCT02345252|470204491|FG001|Double-Blind Phase|Withdrew Consent|23|||
130613751|NCT02345252|470204490|FG000|Double-Blind Phase|Lost to Follow-up|8|||
130613752|NCT02345252|470204491|FG001|Double-Blind Phase|Lost to Follow-up|10|||
130613753|NCT02345252|470204490|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
130613754|NCT02345252|470204491|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
130613755|NCT04507867|470204492|FG000|Overall Study|Death|7|||
130613756|NCT04507867|470204493|FG001|Overall Study|Death|1|||
130613757|NCT01954251|470204497|FG000|Overall Study|Adverse Event|5|||
130613758|NCT01954251|470204498|FG001|Overall Study|Adverse Event|7|||
130613759|NCT01954251|470204497|FG000|Overall Study|Lost to Follow-up|6|||
130613760|NCT01954251|470204498|FG001|Overall Study|Lost to Follow-up|6|||
130613761|NCT01954251|470204497|FG000|Overall Study|Withdrawal by Subject|2|||
130613762|NCT01954251|470204498|FG001|Overall Study|Withdrawal by Subject|6|||
130613763|NCT00779324|470204499|FG000|Overall Study|Lost to Follow-up|2|||
130613764|NCT00779324|470204500|FG001|Overall Study|Lost to Follow-up|1|||
130613765|NCT00779324|470204499|FG000|Overall Study|Withdrawal by Subject|4|||
130613766|NCT00779324|470204500|FG001|Overall Study|Withdrawal by Subject|2|||
130613767|NCT00779324|470204499|FG000|Overall Study|Missed visit|1|||
130613768|NCT00779324|470204500|FG001|Overall Study|Missed visit|1|||
130613769|NCT02207556|470204501|FG000|Overall Study|Physician Decision|1|||
130613770|NCT02207556|470204502|FG001|Overall Study|Physician Decision|0|||
130613771|NCT02207556|470204501|FG000|Overall Study|Withdrawal by Subject|1|||
130613772|NCT02207556|470204502|FG001|Overall Study|Withdrawal by Subject|0|||
130613773|NCT02207556|470204501|FG000|Overall Study|Death|0|||
130613774|NCT02207556|470204502|FG001|Overall Study|Death|5|||
130613775|NCT03558555|470204503|FG000|Overall Study|Lost to Follow-up|2|||
130613776|NCT03558555|470204504|FG001|Overall Study|Lost to Follow-up|1|||
130613777|NCT01958125|470204505|FG000|Overall Study|Missing diary data|2|||
130613778|NCT01958125|470204506|FG001|Overall Study|Missing diary data|6|||
130613779|NCT01958125|470204505|FG000|Overall Study|No headache attacks|0|||
130613780|NCT01958125|470204506|FG001|Overall Study|No headache attacks|2|||
130613781|NCT00781599|470204509|FG000|Overall Study|Lost to Follow-up|7|||
130613782|NCT00781599|470204510|FG001|Overall Study|Lost to Follow-up|4|||
130613783|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
130613784|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
130613785|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
130613786|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
130613787|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130613788|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
130613789|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
130613790|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
130613791|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
130613792|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
130613793|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
130613794|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
130613795|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
130613796|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
130613797|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
130613798|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
130613799|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130613800|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130613801|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
130613802|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
130613803|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
130613804|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130613805|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130613806|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130613807|NCT01106625|470204511|FG000|Core Period: Baseline to Week 26|Other|8|||
130613808|NCT01106625|470204512|FG001|Core Period: Baseline to Week 26|Other|7|||
130613809|NCT01106625|470204513|FG002|Core Period: Baseline to Week 26|Other|4|||
130613810|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130613811|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130613812|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
130613813|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130613814|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
130613815|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130613816|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130613817|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130613818|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130613819|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130613820|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130613821|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130613822|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
130613823|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130613824|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130613825|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
130613826|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
130613827|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
130613828|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130613829|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130613830|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130613831|NCT01106625|470204511|FG000|Extension Period: Week 26 to Week 52|Other|5|||
130613832|NCT01106625|470204512|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130613833|NCT01106625|470204513|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130613834|NCT02509598|470204514|FG000|Overall Study|Withdrawal by Subject|1|||
130613835|NCT02196038|470204515|FG000|Overall Study|Death|16|||
130613836|NCT02196038|470204516|FG001|Overall Study|Death|21|||
130613837|NCT02196038|470204515|FG000|Overall Study|Withdrawal by Subject|0|||
130613838|NCT02196038|470204516|FG001|Overall Study|Withdrawal by Subject|1|||
130613839|NCT02196038|470204515|FG000|Overall Study|Lost to Follow-up|1|||
130613840|NCT02196038|470204516|FG001|Overall Study|Lost to Follow-up|0|||
130613841|NCT03213626|470204519|FG000|Overall Study|Adverse Event|1|||
130613842|NCT03213626|470204519|FG000|Overall Study|Progressive Disease|6|||
130613843|NCT00786032|470206021|FG000|Overall Study|Death|4|||
130613844|NCT00786032|470206021|FG000|Overall Study|Withdrawal by Subject|14|||
130613845|NCT00786032|470206021|FG000|Overall Study|Did not complete in the timeframe|6|||
130613846|NCT02457182|470206022|FG000|Overall Study|Lost to Follow-up|1|||
130613847|NCT02457182|470206023|FG001|Overall Study|Lost to Follow-up|0|||
130613848|NCT02294318|470206026|FG000|Overall Study|Worsening of drinking|3|||
130613849|NCT02294318|470206027|FG001|Overall Study|Worsening of drinking|0|||
130613850|NCT02294318|470206026|FG000|Overall Study|Not exposed to intervention|0|||
130613851|NCT02294318|470206027|FG001|Overall Study|Not exposed to intervention|2|||
130613852|NCT01116687|470206028|FG000|Overall Study|Withdrawal by Subject|4|||
130613853|NCT00789191|470206031|FG000|Overall Study|Adverse Event|2|||
130613854|NCT00789191|470206032|FG001|Overall Study|Adverse Event|4|||
130613855|NCT00789191|470206031|FG000|Overall Study|Lack of Efficacy|0|||
130613856|NCT00789191|470206032|FG001|Overall Study|Lack of Efficacy|5|||
130613857|NCT00789191|470206031|FG000|Overall Study|Protocol Violation|5|||
130613858|NCT00789191|470206032|FG001|Overall Study|Protocol Violation|3|||
130613859|NCT00789191|470206031|FG000|Overall Study|Withdrawal Criteria|2|||
130613860|NCT00789191|470206032|FG001|Overall Study|Withdrawal Criteria|4|||
130613861|NCT00789191|470206031|FG000|Overall Study|Unclassified|5|||
130613862|NCT00789191|470206032|FG001|Overall Study|Unclassified|3|||
130613863|NCT03497429|470206033|FG000|Overall Study|Progressive disease|3|||
130613864|NCT03497429|470206034|FG001|Overall Study|Progressive disease|4|||
130613865|NCT03497429|470206033|FG000|Overall Study|Adverse Event|0|||
130613866|NCT03497429|470206034|FG001|Overall Study|Adverse Event|2|||
130613867|NCT01009983|470206035|FG000|Overall Study|necessary scans not completed|1|||
130613868|NCT00506948|470206036|FG000|Overall Study|Death|4|||
130613869|NCT00506948|470206036|FG000|Overall Study|Adverse Event|5|||
130613870|NCT00506948|470206036|FG000|Overall Study|Physician Decision|1|||
130613871|NCT00568958|470206049|FG000|Allocation|Withdrawal by Subject|7|||
130613872|NCT00568958|470206050|FG001|Allocation|Withdrawal by Subject|3|||
130613873|NCT00568958|470206049|FG000|Allocation|Physician Decision|2|||
130613874|NCT00568958|470206050|FG001|Allocation|Physician Decision|0|||
130613875|NCT00568958|470206049|FG000|Follow-Up|Withdrawal by Subject|6|||
130613876|NCT00568958|470206050|FG001|Follow-Up|Withdrawal by Subject|6|||
130613877|NCT00568958|470206049|FG000|Follow-Up|Physician Decision|1|||
130613878|NCT00568958|470206050|FG001|Follow-Up|Physician Decision|1|||
130613879|NCT00568958|470206049|FG000|Follow-Up|Family Emergency|1|||
130613880|NCT00568958|470206050|FG001|Follow-Up|Family Emergency|0|||
130613881|NCT00568958|470206049|FG000|Follow-Up|Adverse Event|1|||
130613882|NCT00568958|470206050|FG001|Follow-Up|Adverse Event|0|||
130613883|NCT01354353|470206054|FG000|Overall Study|Adverse Event|1|||
130613884|NCT01354353|470206055|FG001|Overall Study|Adverse Event|0|||
130613885|NCT01354353|470206056|FG002|Overall Study|Adverse Event|0|||
130613886|NCT01354353|470206057|FG003|Overall Study|Adverse Event|4|||
130613887|NCT01354353|470206058|FG004|Overall Study|Adverse Event|0|||
130613888|NCT01354353|470206059|FG005|Overall Study|Adverse Event|5|||
130613889|NCT01354353|470206054|FG000|Overall Study|Entry Criteria Not Met|0|||
130613890|NCT01354353|470206055|FG001|Overall Study|Entry Criteria Not Met|0|||
130613891|NCT01354353|470206056|FG002|Overall Study|Entry Criteria Not Met|0|||
130613892|NCT01354353|470206057|FG003|Overall Study|Entry Criteria Not Met|1|||
130613893|NCT01354353|470206058|FG004|Overall Study|Entry Criteria Not Met|1|||
130613894|NCT01354353|470206059|FG005|Overall Study|Entry Criteria Not Met|0|||
130613895|NCT01354353|470206054|FG000|Overall Study|Physician Decision|0|||
130613896|NCT01354353|470206055|FG001|Overall Study|Physician Decision|1|||
130613897|NCT01354353|470206056|FG002|Overall Study|Physician Decision|1|||
130613898|NCT01354353|470206057|FG003|Overall Study|Physician Decision|0|||
130613899|NCT01354353|470206058|FG004|Overall Study|Physician Decision|0|||
130613900|NCT01354353|470206059|FG005|Overall Study|Physician Decision|0|||
130613901|NCT01354353|470206054|FG000|Overall Study|Withdrawal by Subject|2|||
130613902|NCT01354353|470206055|FG001|Overall Study|Withdrawal by Subject|0|||
130613903|NCT01354353|470206056|FG002|Overall Study|Withdrawal by Subject|1|||
130613904|NCT01354353|470206057|FG003|Overall Study|Withdrawal by Subject|0|||
130613905|NCT01354353|470206058|FG004|Overall Study|Withdrawal by Subject|0|||
130613906|NCT01354353|470206059|FG005|Overall Study|Withdrawal by Subject|1|||
130613907|NCT02681055|470206060|FG000|Weeks 5-12|Adverse Event|1|||
130613908|NCT02695524|470206061|FG000|Overall Study|Lost to Follow-up|3|||
130613909|NCT02695524|470206062|FG001|Overall Study|Lost to Follow-up|2|||
130613910|NCT02695524|470206061|FG000|Overall Study|Death|0|||
130613911|NCT02695524|470206062|FG001|Overall Study|Death|1|||
130613912|NCT02156492|470206067|FG000|Period 1|No Reason Given|0|||
130613913|NCT02156492|470206068|FG001|Period 1|No Reason Given|1|||
130613914|NCT02156492|470206069|FG002|Period 1|No Reason Given|0|||
130613915|NCT02156492|470206067|FG000|Period 3|Adverse Event|0|||
130613916|NCT02156492|470206068|FG001|Period 3|Adverse Event|1|||
130613917|NCT02156492|470206069|FG002|Period 3|Adverse Event|0|||
130613918|NCT01332019|470206074|FG000|Overall Study|Was Not Dosed|1|||
130613919|NCT01332019|470206075|FG001|Overall Study|Was Not Dosed|0|||
130613920|NCT01332019|470206074|FG000|Overall Study|Other|16|||
130613921|NCT01332019|470206075|FG001|Overall Study|Other|18|||
130613922|NCT01332019|470206074|FG000|Overall Study|Death|2|||
130613923|NCT01332019|470206075|FG001|Overall Study|Death|1|||
130613924|NCT01332019|470206074|FG000|Overall Study|Physician Decision|4|||
130613925|NCT01332019|470206075|FG001|Overall Study|Physician Decision|3|||
130613926|NCT01332019|470206074|FG000|Overall Study|Withdrawal by Subject|73|||
130613927|NCT01332019|470206075|FG001|Overall Study|Withdrawal by Subject|71|||
130613928|NCT01332019|470206074|FG000|Overall Study|Lost to Follow-up|4|||
130613929|NCT01332019|470206075|FG001|Overall Study|Lost to Follow-up|7|||
130613930|NCT01332019|470206074|FG000|Overall Study|Adverse Event|13|||
130613931|NCT01332019|470206075|FG001|Overall Study|Adverse Event|22|||
130613932|NCT00871377|470206076|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130613933|NCT00871377|470206077|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130613934|NCT00871377|470206078|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
130613935|NCT00871377|470206079|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130613936|NCT00871377|470206080|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130613937|NCT00871377|470206081|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130613938|NCT00871377|470206076|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130613939|NCT00871377|470206077|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130613940|NCT00871377|470206078|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130613941|NCT00871377|470206079|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130613942|NCT00871377|470206080|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130613943|NCT00871377|470206081|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
130613944|NCT00871377|470206076|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
130613945|NCT00871377|470206077|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613946|NCT00871377|470206078|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613947|NCT00871377|470206079|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613948|NCT00871377|470206080|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613949|NCT00871377|470206081|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613950|NCT00871377|470206076|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613951|NCT00871377|470206077|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613952|NCT00871377|470206078|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613953|NCT00871377|470206079|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613954|NCT00871377|470206080|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
130613955|NCT00871377|470206081|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
130613956|NCT00871377|470206076|FG000|Third Intervention (10 Weeks)|Death|0|||
130613957|NCT00871377|470206077|FG001|Third Intervention (10 Weeks)|Death|0|||
130613958|NCT00871377|470206078|FG002|Third Intervention (10 Weeks)|Death|0|||
130613959|NCT00871377|470206079|FG003|Third Intervention (10 Weeks)|Death|1|||
130613960|NCT00871377|470206080|FG004|Third Intervention (10 Weeks)|Death|0|||
130613961|NCT00871377|470206081|FG005|Third Intervention (10 Weeks)|Death|0|||
130613962|NCT01395368|470206083|FG000|Overall Study|Physician Decision|14|||
130613963|NCT01395368|470206083|FG000|Overall Study|Withdrawal by Subject|2|||
130613964|NCT01104584|470206089|FG000|Overall Study|Study drug never administered|21|||
130613965|NCT01104584|470206089|FG000|Overall Study|Study prematurely discontinued|2|||
130613966|NCT02561299|470206090|FG000|Overall Study|Death|2|||
130613967|NCT02561299|470206091|FG001|Overall Study|Death|4|||
130613968|NCT02561299|470206090|FG000|Overall Study|Lost to Follow-up|1|||
130613969|NCT02561299|470206091|FG001|Overall Study|Lost to Follow-up|0|||
130613970|NCT02561299|470206090|FG000|Overall Study|Withdrawal by Subject|2|||
130613971|NCT02561299|470206091|FG001|Overall Study|Withdrawal by Subject|2|||
130613972|NCT01248130|470206092|FG000|Overall Study|Protocol Violation|1|||
130613973|NCT01248130|470206093|FG001|Overall Study|Protocol Violation|0|||
130613974|NCT01248130|470206092|FG000|Overall Study|Ineligible|1|||
130613975|NCT01248130|470206093|FG001|Overall Study|Ineligible|0|||
130613976|NCT00501046|470206098|FG000|Overall Study|Adverse Event|21|||
130613977|NCT00501046|470206099|FG001|Overall Study|Adverse Event|25|||
130613978|NCT00501046|470206098|FG000|Overall Study|Death|23|||
130613979|NCT00501046|470206099|FG001|Overall Study|Death|30|||
130613980|NCT00501046|470206098|FG000|Overall Study|Lost to Follow-up|14|||
130613981|NCT00501046|470206099|FG001|Overall Study|Lost to Follow-up|13|||
130613982|NCT00501046|470206098|FG000|Overall Study|Physician Decision|7|||
130613983|NCT00501046|470206099|FG001|Overall Study|Physician Decision|2|||
130613984|NCT00501046|470206098|FG000|Overall Study|Pregnancy|0|||
130613985|NCT00501046|470206099|FG001|Overall Study|Pregnancy|3|||
130613986|NCT00501046|470206098|FG000|Overall Study|Protocol Violation|2|||
130613987|NCT00501046|470206099|FG001|Overall Study|Protocol Violation|1|||
130613988|NCT00501046|470206098|FG000|Overall Study|Withdrawal by Subject|84|||
130613989|NCT00501046|470206099|FG001|Overall Study|Withdrawal by Subject|83|||
130613990|NCT00501046|470206098|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
130613991|NCT00501046|470206099|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
130613992|NCT00436566|470206103|FG000|Overall Study|Withdrawal by Subject|2|||
130613993|NCT00436566|470206103|FG000|Overall Study|Protocol Violation|1|||
130613994|NCT01188564|470206104|FG000|Double-blind Phase|randomized not treated|1|||
130613995|NCT01188564|470206105|FG001|Double-blind Phase|randomized not treated|0|||
130613996|NCT00617409|470206106|FG000|Overall Study|Withdrawal by Subject|4|||
130613997|NCT00617409|470206107|FG001|Overall Study|Withdrawal by Subject|1|||
130613998|NCT00617409|470206108|FG002|Overall Study|Withdrawal by Subject|2|||
130613999|NCT00617409|470206106|FG000|Overall Study|Adverse Event|0|||
130614000|NCT00617409|470206107|FG001|Overall Study|Adverse Event|2|||
130614001|NCT00617409|470206108|FG002|Overall Study|Adverse Event|3|||
130614002|NCT00617409|470206106|FG000|Overall Study|Disease Progression|8|||
130614003|NCT00617409|470206107|FG001|Overall Study|Disease Progression|8|||
130614004|NCT00617409|470206108|FG002|Overall Study|Disease Progression|18|||
130614005|NCT00617409|470206106|FG000|Overall Study|Death|3|||
130614006|NCT00617409|470206107|FG001|Overall Study|Death|5|||
130614007|NCT00617409|470206108|FG002|Overall Study|Death|4|||
130614008|NCT00617409|470206106|FG000|Overall Study|Alternative Therapy|1|||
130614009|NCT00617409|470206107|FG001|Overall Study|Alternative Therapy|2|||
130614010|NCT00617409|470206108|FG002|Overall Study|Alternative Therapy|0|||
130614011|NCT00668200|470206127|FG000|Overall Study|Withdrawal by Subject|2|||
130614012|NCT00668200|470206127|FG000|Overall Study|Lost to Follow-up|1|||
130614013|NCT01496430|470206128|FG000|Overall Study|Adverse Event|0|||
130614014|NCT01496430|470206129|FG001|Overall Study|Adverse Event|0|||
130614015|NCT01496430|470206130|FG002|Overall Study|Adverse Event|1|||
130614016|NCT01496430|470206128|FG000|Overall Study|Major Protocol Deviation|0|||
130614017|NCT01496430|470206129|FG001|Overall Study|Major Protocol Deviation|0|||
130614018|NCT01496430|470206130|FG002|Overall Study|Major Protocol Deviation|1|||
130614019|NCT01496430|470206128|FG000|Overall Study|Lost to Follow-up|2|||
130614020|NCT01496430|470206129|FG001|Overall Study|Lost to Follow-up|3|||
130614021|NCT01496430|470206130|FG002|Overall Study|Lost to Follow-up|1|||
130614022|NCT01496430|470206128|FG000|Overall Study|Voluntary Withdrawal|2|||
130614023|NCT01496430|470206129|FG001|Overall Study|Voluntary Withdrawal|1|||
130614024|NCT01496430|470206130|FG002|Overall Study|Voluntary Withdrawal|6|||
130614025|NCT01496430|470206128|FG000|Overall Study|Principal Investigator Discretion|0|||
130614026|NCT01496430|470206129|FG001|Overall Study|Principal Investigator Discretion|1|||
130614027|NCT01496430|470206130|FG002|Overall Study|Principal Investigator Discretion|1|||
130614028|NCT01496430|470206128|FG000|Overall Study|Other|2|||
130614029|NCT01496430|470206129|FG001|Overall Study|Other|0|||
130614030|NCT01496430|470206130|FG002|Overall Study|Other|0|||
130614031|NCT00997321|470206131|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
130614032|NCT00997321|470206132|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
130614033|NCT02512068|470206137|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
130614034|NCT02512068|470206138|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130614035|NCT02512068|470206137|FG000|Overall Study|Major Protocol Deviation|1|||
130614036|NCT02512068|470206138|FG001|Overall Study|Major Protocol Deviation|0|||
130614037|NCT02512068|470206137|FG000|Overall Study|Voluntary Withdrawal|0|||
130614038|NCT02512068|470206138|FG001|Overall Study|Voluntary Withdrawal|1|||
130614039|NCT02512068|470206137|FG000|Overall Study|Lack of Efficacy|0|||
130614040|NCT02512068|470206138|FG001|Overall Study|Lack of Efficacy|1|||
130614041|NCT02512068|470206137|FG000|Overall Study|Reason Not Specified|3|||
130614042|NCT02512068|470206138|FG001|Overall Study|Reason Not Specified|5|||
130614043|NCT01098461|470206148|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
130614044|NCT01098461|470206149|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
130614045|NCT01098461|470206150|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
130614046|NCT01098461|470206151|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
130614047|NCT01098461|470206148|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
130614048|NCT01098461|470206149|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
130614049|NCT01098461|470206150|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
130614050|NCT01098461|470206151|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
130614051|NCT01098461|470206148|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
130614052|NCT01098461|470206149|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
130614053|NCT01098461|470206150|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
130614054|NCT01098461|470206151|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
130614055|NCT01098461|470206148|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
130614056|NCT01098461|470206149|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
130614057|NCT01098461|470206150|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
130614058|NCT01098461|470206151|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
130614059|NCT01098461|470206148|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130614060|NCT01098461|470206149|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
130614061|NCT01098461|470206150|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130614062|NCT01098461|470206151|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130614063|NCT01098461|470206148|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130614064|NCT01098461|470206149|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
130614065|NCT01098461|470206150|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130614066|NCT01098461|470206151|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130614067|NCT01098461|470206148|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
130614068|NCT01098461|470206149|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
130614069|NCT01098461|470206150|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
130614070|NCT01098461|470206151|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
130614071|NCT01153763|470206154|FG000|Overall Study|Study Closed|16|||
130614072|NCT01153763|470206154|FG000|Overall Study|Lost to Follow-up|1|||
130614073|NCT01153763|470206154|FG000|Overall Study|Physician Decision|2|||
130614074|NCT01153763|470206154|FG000|Overall Study|Withdrawal by Subject|2|||
130614075|NCT01474746|470206155|FG000|Overall Study|Lost to Follow-up|1|||
130614076|NCT01474746|470206156|FG001|Overall Study|Lost to Follow-up|1|||
130614077|NCT01474746|470206155|FG000|Overall Study|Withdrawal by Subject|2|||
130614078|NCT01474746|470206156|FG001|Overall Study|Withdrawal by Subject|1|||
130614079|NCT01766336|470206158|FG000|Overall Study|Adverse Event|11|||
130614080|NCT01766336|470206159|FG001|Overall Study|Adverse Event|8|||
130614081|NCT01766336|470206158|FG000|Overall Study|Death|4|||
130614082|NCT01766336|470206159|FG001|Overall Study|Death|3|||
130614083|NCT01766336|470206158|FG000|Overall Study|Lost to Follow-up|1|||
130614084|NCT01766336|470206159|FG001|Overall Study|Lost to Follow-up|3|||
130614085|NCT01766336|470206158|FG000|Overall Study|Physician Decision|4|||
130614086|NCT01766336|470206159|FG001|Overall Study|Physician Decision|2|||
130614087|NCT01766336|470206158|FG000|Overall Study|Protocol Violation|0|||
130614088|NCT01766336|470206159|FG001|Overall Study|Protocol Violation|1|||
130614089|NCT01766336|470206158|FG000|Overall Study|Sponsor Decision|52|||
130614090|NCT01766336|470206159|FG001|Overall Study|Sponsor Decision|43|||
130614091|NCT01766336|470206158|FG000|Overall Study|Withdrawal by Subject|18|||
130614092|NCT01766336|470206159|FG001|Overall Study|Withdrawal by Subject|15|||
130614093|NCT02605447|470206160|FG000|Overall Study|Death|66|||
130614094|NCT02605447|470206160|FG000|Overall Study|Physician Decision|1|||
130614095|NCT02605447|470206160|FG000|Overall Study|Lost to Follow-up|24|||
130614096|NCT02605447|470206160|FG000|Overall Study|Withdrawal by Subject|10|||
130614097|NCT02605447|470206160|FG000|Overall Study|Not disclosed|1|||
130614098|NCT04544709|470206164|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
130614099|NCT02045212|470206165|FG000|Overall Study|Adverse Event|0|||
130614100|NCT02045212|470206166|FG001|Overall Study|Adverse Event|1|||
130614101|NCT02045212|470206165|FG000|Overall Study|Withdrawal by Subject|1|||
130614102|NCT02045212|470206166|FG001|Overall Study|Withdrawal by Subject|0|||
130614103|NCT02045212|470206165|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
130614104|NCT02045212|470206166|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
130614105|NCT00369668|470206170|FG000|Overall Study|Lack of Efficacy|4|||
130614106|NCT00369668|470206171|FG001|Overall Study|Lack of Efficacy|5|||
130614107|NCT00369668|470206172|FG002|Overall Study|Lack of Efficacy|7|||
130614108|NCT00142519|470206176|FG000|Overall Study|Not Treated|7|||
130614109|NCT00142519|470206177|FG001|Overall Study|Not Treated|9|||
130614110|NCT00142519|470206176|FG000|Overall Study|Protocol Violation|1|||
130614111|NCT00142519|470206177|FG001|Overall Study|Protocol Violation|0|||
130614112|NCT00142519|470206176|FG000|Overall Study|Withdrawal by Subject|10|||
130614113|NCT00142519|470206177|FG001|Overall Study|Withdrawal by Subject|7|||
130614114|NCT01005732|470206178|FG000|Overall Study|Lost to Follow-up|10|||
130614115|NCT01005732|470206178|FG000|Overall Study|Death|1|||
130614116|NCT02596711|470206179|FG000|Overall Study|Lost to Follow-up|1|||
130614117|NCT02596711|470206180|FG001|Overall Study|Lost to Follow-up|2|||
130614118|NCT02596711|470206181|FG002|Overall Study|Lost to Follow-up|3|||
130614119|NCT01552928|470206182|FG000|Period 3|Adverse Event|0|||
130614120|NCT01552928|470206183|FG001|Period 3|Adverse Event|0|||
130614121|NCT01552928|470206184|FG002|Period 3|Adverse Event|1|||
130614122|NCT01552928|470206185|FG003|Period 3|Adverse Event|0|||
130614123|NCT04570657|470206187|FG000|Overall Study|Adverse Event|0|||
130614124|NCT04570657|470206188|FG001|Overall Study|Adverse Event|0|||
130614125|NCT04570657|470206189|FG002|Overall Study|Adverse Event|1|||
130614126|NCT04570657|470206187|FG000|Overall Study|Lost to Follow-up|0|||
130614127|NCT04570657|470206188|FG001|Overall Study|Lost to Follow-up|0|||
130614128|NCT04570657|470206189|FG002|Overall Study|Lost to Follow-up|1|||
130614129|NCT04570657|470206187|FG000|Overall Study|Physician Decision|0|||
130614130|NCT04570657|470206188|FG001|Overall Study|Physician Decision|1|||
130614131|NCT04570657|470206189|FG002|Overall Study|Physician Decision|0|||
130614132|NCT04570657|470206187|FG000|Overall Study|Withdrawal by Subject|1|||
130614133|NCT04570657|470206188|FG001|Overall Study|Withdrawal by Subject|2|||
130614134|NCT04570657|470206189|FG002|Overall Study|Withdrawal by Subject|2|||
130614135|NCT02625324|470208874|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
130614136|NCT02625324|470208874|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
130614137|NCT02625324|470208874|FG000|6-Month Follow-up Subject Accountability|Death|5|||
130614138|NCT02625324|470208874|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
130614139|NCT02625324|470208874|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
130614140|NCT02625324|470208874|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
130614141|NCT02625324|470208874|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130614142|NCT02625324|470208874|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
130614143|NCT02625324|470208874|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
130614144|NCT02625324|470208874|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
130614145|NCT02625324|470208874|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
130614146|NCT02625324|470208874|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130614147|NCT02625324|470208874|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
130614148|NCT02625324|470208874|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130614149|NCT02625324|470208874|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130614150|NCT02625324|470208874|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
130614151|NCT02625324|470208874|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130614152|NCT00424528|470208877|FG000|Overall Study|Adverse Event|2|||
130614153|NCT00424528|470208878|FG001|Overall Study|Adverse Event|1|||
130614154|NCT00424528|470208879|FG002|Overall Study|Adverse Event|2|||
130614155|NCT00424528|470208877|FG000|Overall Study|Protocol Violation|1|||
130614156|NCT00424528|470208878|FG001|Overall Study|Protocol Violation|1|||
130614157|NCT00424528|470208879|FG002|Overall Study|Protocol Violation|0|||
130614158|NCT00424528|470208877|FG000|Overall Study|Lost to Follow-up|0|||
130614159|NCT00424528|470208878|FG001|Overall Study|Lost to Follow-up|1|||
130614160|NCT00424528|470208879|FG002|Overall Study|Lost to Follow-up|0|||
130614161|NCT00424528|470208877|FG000|Overall Study|noncompliance with study requirements|2|||
130614162|NCT00424528|470208878|FG001|Overall Study|noncompliance with study requirements|1|||
130614163|NCT00424528|470208879|FG002|Overall Study|noncompliance with study requirements|2|||
130614164|NCT00967226|470208881|FG000|Overall Study|Adverse Event|0|||
130614165|NCT00967226|470208882|FG001|Overall Study|Adverse Event|5|||
130614166|NCT00967226|470208881|FG000|Overall Study|Protocol Violation|2|||
130614167|NCT00967226|470208882|FG001|Overall Study|Protocol Violation|0|||
130614168|NCT00967226|470208881|FG000|Overall Study|Physician Decision|0|||
130614169|NCT00967226|470208882|FG001|Overall Study|Physician Decision|1|||
130614170|NCT02174861|470208883|FG000|Overall Study|Decision by sponsor|8|||
130614171|NCT02174861|470208883|FG000|Overall Study|Withdrawal by Subject|124|||
130614172|NCT02174861|470208883|FG000|Overall Study|Lost to Follow-up|26|||
130614173|NCT00165841|470208884|FG000|Overall Study|Adverse Event|2|||
130614174|NCT00165841|470208885|FG001|Overall Study|Adverse Event|3|||
130614175|NCT00165841|470208884|FG000|Overall Study|Lack of Efficacy|6|||
130614176|NCT00165841|470208885|FG001|Overall Study|Lack of Efficacy|33|||
130614177|NCT00165841|470208884|FG000|Overall Study|Lost to Follow-up|4|||
130614178|NCT00165841|470208885|FG001|Overall Study|Lost to Follow-up|4|||
130614179|NCT00165841|470208884|FG000|Overall Study|Withdrawal by Subject|7|||
130614180|NCT00165841|470208885|FG001|Overall Study|Withdrawal by Subject|8|||
130614181|NCT00165841|470208884|FG000|Overall Study|Physician Decision|1|||
130614182|NCT00165841|470208885|FG001|Overall Study|Physician Decision|0|||
130614183|NCT00165841|470208884|FG000|Overall Study|Protocol Violation|6|||
130614184|NCT00165841|470208885|FG001|Overall Study|Protocol Violation|8|||
130614185|NCT00165841|470208884|FG000|Overall Study|Other|3|||
130614186|NCT00165841|470208885|FG001|Overall Study|Other|5|||
130614187|NCT00165841|470208884|FG000|Overall Study|Medication Noncompliance|1|||
130614188|NCT00165841|470208885|FG001|Overall Study|Medication Noncompliance|1|||
130614189|NCT00254293|470208886|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130614190|NCT00254293|470208887|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
130614191|NCT00254293|470208888|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130614192|NCT00254293|470208889|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
130614193|NCT00254293|470208890|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130614194|NCT00254293|470208891|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130614195|NCT00254293|470208892|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130614196|NCT00254293|470208886|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614197|NCT00254293|470208887|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614198|NCT00254293|470208888|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
130614199|NCT00254293|470208889|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614200|NCT00254293|470208890|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614201|NCT00254293|470208891|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614202|NCT00254293|470208892|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130614203|NCT00254293|470208886|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614204|NCT00254293|470208887|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614205|NCT00254293|470208888|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
130614206|NCT00254293|470208889|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614207|NCT00254293|470208890|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614208|NCT00254293|470208891|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614209|NCT00254293|470208892|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130614210|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Death|0|||
130614211|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Death|0|||
130614212|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Death|1|||
130614213|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Death|0|||
130614214|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Death|0|||
130614215|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Death|0|||
130614216|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Death|0|||
130614217|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
130614218|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130614219|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
130614220|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130614221|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
130614222|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130614223|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130614224|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
130614225|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130614226|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
130614227|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130614228|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
130614229|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130614230|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130614231|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614232|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614233|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
130614234|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614235|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614236|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614237|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130614238|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614239|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614240|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
130614241|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614242|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614243|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614244|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130614245|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614246|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614247|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
130614248|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614249|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614250|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614251|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130614252|NCT00254293|470208886|FG000|LTE Open Label Variable SC Dosing|Other|0|||
130614253|NCT00254293|470208887|FG001|LTE Open Label Variable SC Dosing|Other|0|||
130614254|NCT00254293|470208888|FG002|LTE Open Label Variable SC Dosing|Other|2|||
130614255|NCT00254293|470208889|FG003|LTE Open Label Variable SC Dosing|Other|0|||
130614256|NCT00254293|470208890|FG004|LTE Open Label Variable SC Dosing|Other|0|||
130614257|NCT00254293|470208891|FG005|LTE Open Label Variable SC Dosing|Other|0|||
130614258|NCT00254293|470208892|FG006|LTE Open Label Variable SC Dosing|Other|0|||
130614259|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Death|0|||
130614260|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Death|0|||
130614261|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Death|0|||
130614262|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Death|0|||
130614263|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Death|0|||
130614264|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Death|0|||
130614265|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Death|3|||
130614266|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614267|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614268|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614269|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614270|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614271|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
130614272|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
130614273|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614274|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614275|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614276|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614277|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614278|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130614279|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
130614280|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614281|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614282|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614283|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614284|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614285|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130614286|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
130614287|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614288|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614289|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614290|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614291|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614292|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130614293|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
130614294|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614295|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614296|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614297|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614298|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614299|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130614300|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
130614301|NCT00254293|470208886|FG000|LTE Open Label Fixed Dosing|Other|0|||
130614302|NCT00254293|470208887|FG001|LTE Open Label Fixed Dosing|Other|0|||
130614303|NCT00254293|470208888|FG002|LTE Open Label Fixed Dosing|Other|0|||
130614304|NCT00254293|470208889|FG003|LTE Open Label Fixed Dosing|Other|0|||
130614305|NCT00254293|470208890|FG004|LTE Open Label Fixed Dosing|Other|0|||
130614306|NCT00254293|470208891|FG005|LTE Open Label Fixed Dosing|Other|0|||
130614307|NCT00254293|470208892|FG006|LTE Open Label Fixed Dosing|Other|1|||
130614308|NCT03196193|470208899|FG000|Overall Study|Adverse Event|1|||
130614309|NCT03196193|470208900|FG001|Overall Study|Adverse Event|0|||
130614310|NCT03196193|470208899|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
130614311|NCT03196193|470208900|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
130614312|NCT02709083|470208901|FG000|Overall Study|Original PI left institution|7|||
130614313|NCT01697267|470208903|FG000|Overall Study|Death|3|||
130614314|NCT01697267|470208904|FG001|Overall Study|Death|1|||
130614315|NCT01697267|470208903|FG000|Overall Study|Withdrawal by Subject|5|||
130614316|NCT01697267|470208904|FG001|Overall Study|Withdrawal by Subject|5|||
130614317|NCT01697267|470208903|FG000|Overall Study|Adverse Event|2|||
130614318|NCT01697267|470208904|FG001|Overall Study|Adverse Event|1|||
130614319|NCT01697267|470208903|FG000|Overall Study|Lost to Follow-up|2|||
130614320|NCT01697267|470208904|FG001|Overall Study|Lost to Follow-up|4|||
130614321|NCT01697267|470208903|FG000|Overall Study|Physician Decision|2|||
130614322|NCT01697267|470208904|FG001|Overall Study|Physician Decision|4|||
130614323|NCT04031404|470208905|FG000|Baseline|Lost to Follow-up|0|||
130614324|NCT04031404|470208906|FG001|Baseline|Lost to Follow-up|1|||
130614325|NCT04031404|470208905|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
130614326|NCT04031404|470208906|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
130614327|NCT04031404|470208905|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
130614328|NCT04031404|470208906|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
130614329|NCT04031404|470208905|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
130614330|NCT04031404|470208906|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
130614331|NCT04031404|470208905|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
130614332|NCT04031404|470208906|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
130614333|NCT02796391|470208909|FG000|Overall Study|Lost to Follow-up|2|||
130614334|NCT02796391|470208910|FG001|Overall Study|Lost to Follow-up|2|||
130614335|NCT02796391|470208911|FG002|Overall Study|Lost to Follow-up|13|||
130614336|NCT02796391|470208912|FG003|Overall Study|Lost to Follow-up|8|||
130614337|NCT02796391|470208913|FG004|Overall Study|Lost to Follow-up|14|||
130614338|NCT02796391|470208914|FG005|Overall Study|Lost to Follow-up|13|||
130614339|NCT02796391|470208909|FG000|Overall Study|COVID|0|||
130614340|NCT02796391|470208910|FG001|Overall Study|COVID|0|||
130614341|NCT02796391|470208911|FG002|Overall Study|COVID|5|||
130614342|NCT02796391|470208912|FG003|Overall Study|COVID|5|||
130614343|NCT02796391|470208913|FG004|Overall Study|COVID|2|||
130614344|NCT02796391|470208914|FG005|Overall Study|COVID|4|||
130614345|NCT02796391|470208909|FG000|Overall Study|Participant did not like study cigarettes|0|||
130614346|NCT02796391|470208910|FG001|Overall Study|Participant did not like study cigarettes|0|||
130614347|NCT02796391|470208911|FG002|Overall Study|Participant did not like study cigarettes|3|||
130614348|NCT02796391|470208912|FG003|Overall Study|Participant did not like study cigarettes|0|||
130614349|NCT02796391|470208913|FG004|Overall Study|Participant did not like study cigarettes|0|||
130614350|NCT02796391|470208914|FG005|Overall Study|Participant did not like study cigarettes|0|||
130614351|NCT02796391|470208909|FG000|Overall Study|Withdrawal by Subject|1|||
130614352|NCT02796391|470208910|FG001|Overall Study|Withdrawal by Subject|1|||
130614353|NCT02796391|470208911|FG002|Overall Study|Withdrawal by Subject|4|||
130614354|NCT02796391|470208912|FG003|Overall Study|Withdrawal by Subject|3|||
130614355|NCT02796391|470208913|FG004|Overall Study|Withdrawal by Subject|4|||
130614356|NCT02796391|470208914|FG005|Overall Study|Withdrawal by Subject|3|||
130614357|NCT02796391|470208909|FG000|Overall Study|Adverse Event|0|||
130614358|NCT02796391|470208910|FG001|Overall Study|Adverse Event|0|||
130614359|NCT02796391|470208911|FG002|Overall Study|Adverse Event|0|||
130614360|NCT02796391|470208912|FG003|Overall Study|Adverse Event|1|||
130614361|NCT02796391|470208913|FG004|Overall Study|Adverse Event|0|||
130614362|NCT02796391|470208914|FG005|Overall Study|Adverse Event|0|||
130614363|NCT02796391|470208909|FG000|Overall Study|Protocol Violation|0|||
130614364|NCT02796391|470208910|FG001|Overall Study|Protocol Violation|0|||
130614365|NCT02796391|470208911|FG002|Overall Study|Protocol Violation|0|||
130614366|NCT02796391|470208912|FG003|Overall Study|Protocol Violation|1|||
130614367|NCT02796391|470208913|FG004|Overall Study|Protocol Violation|0|||
130614368|NCT02796391|470208914|FG005|Overall Study|Protocol Violation|0|||
130614369|NCT00831441|470208915|FG000|Randomized|Death|82|||
130614370|NCT00831441|470208916|FG001|Randomized|Death|81|||
130614371|NCT00831441|470208915|FG000|Randomized|Adverse Event|248|||
130614372|NCT00831441|470208916|FG001|Randomized|Adverse Event|321|||
130614373|NCT00831441|470208915|FG000|Randomized|Emergency procedure|2|||
130614374|NCT00831441|470208916|FG001|Randomized|Emergency procedure|2|||
130614375|NCT00831441|470208915|FG000|Randomized|Elective procedure|26|||
130614376|NCT00831441|470208916|FG001|Randomized|Elective procedure|25|||
130614377|NCT00831441|470208915|FG000|Randomized|Physician Decision|26|||
130614378|NCT00831441|470208916|FG001|Randomized|Physician Decision|35|||
130614379|NCT00831441|470208915|FG000|Randomized|No longer met criteria|13|||
130614380|NCT00831441|470208916|FG001|Randomized|No longer met criteria|19|||
130614381|NCT00831441|470208915|FG000|Randomized|Withdrawal by Subject|178|||
130614382|NCT00831441|470208916|FG001|Randomized|Withdrawal by Subject|212|||
130614383|NCT00831441|470208915|FG000|Randomized|Lost to Follow-up|26|||
130614384|NCT00831441|470208916|FG001|Randomized|Lost to Follow-up|35|||
130614385|NCT00831441|470208915|FG000|Randomized|Administrative reason by sponsor|2780|||
130614386|NCT00831441|470208916|FG001|Randomized|Administrative reason by sponsor|2671|||
130614387|NCT00831441|470208915|FG000|Randomized|poor/non-compliance|30|||
130614388|NCT00831441|470208916|FG001|Randomized|poor/non-compliance|38|||
130614389|NCT00831441|470208915|FG000|Randomized|non-specified|276|||
130614390|NCT00831441|470208916|FG001|Randomized|non-specified|266|||
130614391|NCT00831441|470208915|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
130614392|NCT00831441|470208916|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
130614393|NCT00831441|470208915|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
130614394|NCT00831441|470208916|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
130614395|NCT00831441|470208915|FG000|Follow Up (30 Days)|Death|63|||
130614396|NCT00831441|470208916|FG001|Follow Up (30 Days)|Death|86|||
130614397|NCT00831441|470208915|FG000|Follow Up (30 Days)|non-specified|16|||
130614398|NCT00831441|470208916|FG001|Follow Up (30 Days)|non-specified|26|||
130614399|NCT00831441|470208915|FG000|Follow Up (30 Days)|missing end of study status|0|||
130614400|NCT00831441|470208916|FG001|Follow Up (30 Days)|missing end of study status|1|||
130614401|NCT05674344|470208917|FG000|Overall Study|Screen Fail|21|||
130614402|NCT05674344|470208917|FG000|Overall Study|Incomplete study procedures|3|||
130614403|NCT00798655|470208918|FG000|Overall Study|Did not receive at least one dose of pan|2|||
130614404|NCT00343291|470208919|FG000|Overall Study|Adverse Event|13|||
130614405|NCT00343291|470208920|FG001|Overall Study|Adverse Event|13|||
130614406|NCT00343291|470208919|FG000|Overall Study|Death|3|||
130614407|NCT00343291|470208920|FG001|Overall Study|Death|2|||
130614408|NCT00343291|470208919|FG000|Overall Study|Progressive disease|33|||
130614409|NCT00343291|470208920|FG001|Overall Study|Progressive disease|34|||
130614410|NCT00343291|470208919|FG000|Overall Study|Withdrawal by Subject|0|||
130614411|NCT00343291|470208920|FG001|Overall Study|Withdrawal by Subject|2|||
130614412|NCT00343291|470208919|FG000|Overall Study|Other|8|||
130614413|NCT00343291|470208920|FG001|Overall Study|Other|5|||
130614414|NCT00960934|470208921|FG000|Overall Study|Adverse Event|2|||
130614415|NCT00960934|470208922|FG001|Overall Study|Adverse Event|3|||
130614416|NCT00960934|470208923|FG002|Overall Study|Adverse Event|3|||
130614417|NCT00960934|470208924|FG003|Overall Study|Adverse Event|2|||
130614418|NCT00960934|470208925|FG004|Overall Study|Adverse Event|4|||
130614419|NCT00960934|470208926|FG005|Overall Study|Adverse Event|3|||
130614420|NCT00960934|470208921|FG000|Overall Study|Lack of Efficacy|1|||
130614421|NCT00960934|470208922|FG001|Overall Study|Lack of Efficacy|0|||
130614422|NCT00960934|470208923|FG002|Overall Study|Lack of Efficacy|0|||
130614423|NCT00960934|470208924|FG003|Overall Study|Lack of Efficacy|0|||
130614424|NCT00960934|470208925|FG004|Overall Study|Lack of Efficacy|0|||
130614425|NCT00960934|470208926|FG005|Overall Study|Lack of Efficacy|0|||
130614426|NCT00960934|470208921|FG000|Overall Study|Lost to Follow-up|0|||
130614427|NCT00960934|470208922|FG001|Overall Study|Lost to Follow-up|1|||
130614428|NCT00960934|470208923|FG002|Overall Study|Lost to Follow-up|0|||
130614429|NCT00960934|470208924|FG003|Overall Study|Lost to Follow-up|0|||
130614430|NCT00960934|470208925|FG004|Overall Study|Lost to Follow-up|0|||
130614431|NCT00960934|470208926|FG005|Overall Study|Lost to Follow-up|0|||
130614432|NCT00960934|470208921|FG000|Overall Study|Other|2|||
130614433|NCT00960934|470208922|FG001|Overall Study|Other|1|||
130614434|NCT00960934|470208923|FG002|Overall Study|Other|5|||
130614435|NCT00960934|470208924|FG003|Overall Study|Other|4|||
130614436|NCT00960934|470208925|FG004|Overall Study|Other|2|||
130614437|NCT00960934|470208926|FG005|Overall Study|Other|2|||
130614438|NCT00960934|470208921|FG000|Overall Study|Physician Decision|0|||
130614439|NCT00960934|470208922|FG001|Overall Study|Physician Decision|1|||
130614440|NCT00960934|470208923|FG002|Overall Study|Physician Decision|0|||
130614441|NCT00960934|470208924|FG003|Overall Study|Physician Decision|0|||
130614442|NCT00960934|470208925|FG004|Overall Study|Physician Decision|0|||
130614443|NCT00960934|470208926|FG005|Overall Study|Physician Decision|0|||
130614444|NCT00960934|470208921|FG000|Overall Study|Progressive Disease|1|||
130614445|NCT00960934|470208922|FG001|Overall Study|Progressive Disease|1|||
130614446|NCT00960934|470208923|FG002|Overall Study|Progressive Disease|0|||
130614447|NCT00960934|470208924|FG003|Overall Study|Progressive Disease|0|||
130614448|NCT00960934|470208925|FG004|Overall Study|Progressive Disease|1|||
130614449|NCT00960934|470208926|FG005|Overall Study|Progressive Disease|1|||
130614450|NCT00960934|470208921|FG000|Overall Study|Protocol Violation|3|||
130614451|NCT00960934|470208922|FG001|Overall Study|Protocol Violation|4|||
130614452|NCT00960934|470208923|FG002|Overall Study|Protocol Violation|0|||
130614453|NCT00960934|470208924|FG003|Overall Study|Protocol Violation|3|||
130614454|NCT00960934|470208925|FG004|Overall Study|Protocol Violation|3|||
130614455|NCT00960934|470208926|FG005|Overall Study|Protocol Violation|2|||
130614456|NCT00960934|470208921|FG000|Overall Study|Withdrawal by Subject|5|||
130614457|NCT00960934|470208922|FG001|Overall Study|Withdrawal by Subject|6|||
130614458|NCT00960934|470208923|FG002|Overall Study|Withdrawal by Subject|4|||
130614459|NCT00960934|470208924|FG003|Overall Study|Withdrawal by Subject|5|||
130614460|NCT00960934|470208925|FG004|Overall Study|Withdrawal by Subject|5|||
130614461|NCT00960934|470208926|FG005|Overall Study|Withdrawal by Subject|7|||
130614462|NCT00960934|470208921|FG000|Overall Study|Study Terminated by Sponsor|50|||
130614463|NCT00960934|470208922|FG001|Overall Study|Study Terminated by Sponsor|46|||
130614464|NCT00960934|470208923|FG002|Overall Study|Study Terminated by Sponsor|52|||
130614465|NCT00960934|470208924|FG003|Overall Study|Study Terminated by Sponsor|50|||
130614466|NCT00960934|470208925|FG004|Overall Study|Study Terminated by Sponsor|49|||
130614467|NCT00960934|470208926|FG005|Overall Study|Study Terminated by Sponsor|49|||
130614468|NCT05254613|470208932|FG000|Overall Study|Lost to Follow-up|0|||
130614469|NCT05254613|470208933|FG001|Overall Study|Lost to Follow-up|0|||
130614470|NCT05254613|470208934|FG002|Overall Study|Lost to Follow-up|1|||
130614471|NCT00839423|470208937|FG000|Overall Study|Adverse Event|4|||
130614472|NCT00839423|470208938|FG001|Overall Study|Adverse Event|3|||
130614473|NCT00839423|470208939|FG002|Overall Study|Adverse Event|7|||
130614474|NCT00839423|470208940|FG003|Overall Study|Adverse Event|16|||
130614475|NCT00839423|470208937|FG000|Overall Study|Lack of Efficacy|6|||
130614476|NCT00839423|470208938|FG001|Overall Study|Lack of Efficacy|6|||
130614477|NCT00839423|470208939|FG002|Overall Study|Lack of Efficacy|3|||
130614478|NCT00839423|470208940|FG003|Overall Study|Lack of Efficacy|2|||
130614479|NCT00839423|470208937|FG000|Overall Study|Non-compliance|0|||
130614480|NCT00839423|470208938|FG001|Overall Study|Non-compliance|0|||
130614481|NCT00839423|470208939|FG002|Overall Study|Non-compliance|0|||
130614482|NCT00839423|470208940|FG003|Overall Study|Non-compliance|1|||
130614483|NCT00839423|470208937|FG000|Overall Study|Protocol Violation|0|||
130614484|NCT00839423|470208938|FG001|Overall Study|Protocol Violation|1|||
130614485|NCT00839423|470208939|FG002|Overall Study|Protocol Violation|2|||
130614486|NCT00839423|470208940|FG003|Overall Study|Protocol Violation|0|||
130614487|NCT00839423|470208937|FG000|Overall Study|Withdrawal of consent|4|||
130614488|NCT00839423|470208938|FG001|Overall Study|Withdrawal of consent|0|||
130614489|NCT00839423|470208939|FG002|Overall Study|Withdrawal of consent|4|||
130614490|NCT00839423|470208940|FG003|Overall Study|Withdrawal of consent|1|||
130614491|NCT00839423|470208937|FG000|Overall Study|Lost to Follow-up|1|||
130614492|NCT00839423|470208938|FG001|Overall Study|Lost to Follow-up|0|||
130614493|NCT00839423|470208939|FG002|Overall Study|Lost to Follow-up|1|||
130614494|NCT00839423|470208940|FG003|Overall Study|Lost to Follow-up|0|||
130614495|NCT00839423|470208937|FG000|Overall Study|Administrative or other reasons|3|||
130614496|NCT00839423|470208938|FG001|Overall Study|Administrative or other reasons|0|||
130614497|NCT00839423|470208939|FG002|Overall Study|Administrative or other reasons|1|||
130614498|NCT00839423|470208940|FG003|Overall Study|Administrative or other reasons|0|||
130614499|NCT04348656|470208941|FG000|Overall Study|Withdrawal by Subject|2|||
130614500|NCT04348656|470208942|FG001|Overall Study|Withdrawal by Subject|0|||
130614501|NCT04348656|470208941|FG000|Overall Study|Lost to Follow-up|11|||
130614502|NCT04348656|470208942|FG001|Overall Study|Lost to Follow-up|6|||
130614503|NCT03072719|470208943|FG000|Overall Study|Adverse Event|1|||
130614504|NCT03072719|470208944|FG001|Overall Study|Adverse Event|1|||
130614505|NCT00882999|470208945|FG000|Overall Study|Adverse Event|0|||
130614506|NCT00882999|470208946|FG001|Overall Study|Adverse Event|0|||
130614507|NCT00882999|470208947|FG002|Overall Study|Adverse Event|0|||
130614508|NCT00882999|470208948|FG003|Overall Study|Adverse Event|0|||
130614509|NCT00882999|470208949|FG004|Overall Study|Adverse Event|1|||
130614510|NCT00882999|470208950|FG005|Overall Study|Adverse Event|0|||
130614511|NCT00882999|470208951|FG006|Overall Study|Adverse Event|0|||
130614512|NCT00882999|470208945|FG000|Overall Study|Death|0|||
130614513|NCT00882999|470208946|FG001|Overall Study|Death|1|||
130614514|NCT00882999|470208947|FG002|Overall Study|Death|0|||
130614515|NCT00882999|470208948|FG003|Overall Study|Death|0|||
130614516|NCT00882999|470208949|FG004|Overall Study|Death|0|||
130614517|NCT00882999|470208950|FG005|Overall Study|Death|0|||
130614518|NCT00882999|470208951|FG006|Overall Study|Death|0|||
130614519|NCT00882999|470208945|FG000|Overall Study|Withdrawal by Subject|7|||
130614520|NCT00882999|470208946|FG001|Overall Study|Withdrawal by Subject|6|||
130614521|NCT00882999|470208947|FG002|Overall Study|Withdrawal by Subject|3|||
130614522|NCT00882999|470208948|FG003|Overall Study|Withdrawal by Subject|3|||
130614523|NCT00882999|470208949|FG004|Overall Study|Withdrawal by Subject|6|||
130614524|NCT00882999|470208950|FG005|Overall Study|Withdrawal by Subject|5|||
130614525|NCT00882999|470208951|FG006|Overall Study|Withdrawal by Subject|5|||
130614526|NCT00882999|470208945|FG000|Overall Study|Lost to Follow-up|0|||
130614527|NCT00882999|470208946|FG001|Overall Study|Lost to Follow-up|1|||
130614528|NCT00882999|470208947|FG002|Overall Study|Lost to Follow-up|1|||
130614529|NCT00882999|470208948|FG003|Overall Study|Lost to Follow-up|2|||
130614530|NCT00882999|470208949|FG004|Overall Study|Lost to Follow-up|1|||
130614531|NCT00882999|470208950|FG005|Overall Study|Lost to Follow-up|1|||
130614532|NCT00882999|470208951|FG006|Overall Study|Lost to Follow-up|2|||
130614533|NCT00882999|470208945|FG000|Overall Study|Physician Decision|1|||
130614534|NCT00882999|470208946|FG001|Overall Study|Physician Decision|0|||
130614535|NCT00882999|470208947|FG002|Overall Study|Physician Decision|0|||
130614536|NCT00882999|470208948|FG003|Overall Study|Physician Decision|0|||
130614537|NCT00882999|470208949|FG004|Overall Study|Physician Decision|0|||
130614538|NCT00882999|470208950|FG005|Overall Study|Physician Decision|1|||
130614539|NCT00882999|470208951|FG006|Overall Study|Physician Decision|1|||
130614540|NCT02387372|470208954|FG000|Overall Study|Not Treated|1|||
130614541|NCT02387372|470208955|FG001|Overall Study|Not Treated|0|||
130614542|NCT00937560|470208956|FG000|Initial Treatment|Death|6|||
130614543|NCT00937560|470208956|FG000|Initial Treatment|Withdraw consent|3|||
130614544|NCT00937560|470208956|FG000|Initial Treatment|Adverse Event|1|||
130614545|NCT00937560|470208956|FG000|Initial Treatment|Lost to Follow-up|1|||
130614546|NCT00937560|470208956|FG000|Initial Treatment|No end of study page|10|||
130614547|NCT00937560|470208956|FG000|Maintenance Treatment|Death|12|||
130614548|NCT00937560|470208956|FG000|Maintenance Treatment|Withdraw consent|5|||
130614549|NCT00937560|470208956|FG000|Maintenance Treatment|According to protocol|1|||
130614550|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
130614551|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
130614552|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
130614553|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
130614554|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
130614555|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
130614556|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
130614557|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
130614558|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
130614559|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
130614560|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
130614561|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
130614562|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
130614563|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
130614564|NCT00848549|470208957|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
130614565|NCT00848549|470208958|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
130614566|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
130614567|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
130614568|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
130614569|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
130614570|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
130614571|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
130614572|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
130614573|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
130614574|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
130614575|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
130614576|NCT00848549|470208957|FG000|E2090-E044-314 (Extension Study)|Other|5|||
130614577|NCT00848549|470208958|FG001|E2090-E044-314 (Extension Study)|Other|6|||
130614578|NCT02106455|470208965|FG000|Overall Study|Case Report Form Uncollected|6|||
130614579|NCT02106455|470208965|FG000|Overall Study|Protocol Deviation|2|||
130614580|NCT01576016|470208966|FG000|Lead Safety|Death|132|||
130614581|NCT01576016|470208967|FG001|Lead Safety|Death|0|||
130614582|NCT01576016|470208966|FG000|Lead Safety|Withdrawal by Subject|81|||
130614583|NCT01576016|470208967|FG001|Lead Safety|Withdrawal by Subject|0|||
130614584|NCT01576016|470208966|FG000|Lead Safety|System Explanted without Replacement|24|||
130614585|NCT01576016|470208967|FG001|Lead Safety|System Explanted without Replacement|0|||
130614586|NCT01576016|470208966|FG000|Lead Safety|Physician Decision|14|||
130614587|NCT01576016|470208967|FG001|Lead Safety|Physician Decision|0|||
130614588|NCT01576016|470208966|FG000|Lead Safety|Lost to Follow-up|13|||
130614589|NCT01576016|470208967|FG001|Lead Safety|Lost to Follow-up|0|||
130614590|NCT01576016|470208966|FG000|Lead Safety|Unsuccessful implant|2|||
130614591|NCT01576016|470208967|FG001|Lead Safety|Unsuccessful implant|0|||
130614592|NCT01576016|470208966|FG000|Lead Safety|Sponsor request|1|||
130614593|NCT01576016|470208967|FG001|Lead Safety|Sponsor request|0|||
130614594|NCT01576016|470208966|FG000|Lead Safety|Device replaced with CRT-D|1|||
130614595|NCT01576016|470208967|FG001|Lead Safety|Device replaced with CRT-D|0|||
130614596|NCT01576016|470208966|FG000|Lead Safety|Patient on Palliative Care|1|||
130614597|NCT01576016|470208967|FG001|Lead Safety|Patient on Palliative Care|0|||
130614598|NCT01576016|470208966|FG000|Lead Safety|Patient noncompliance|1|||
130614599|NCT01576016|470208967|FG001|Lead Safety|Patient noncompliance|0|||
130614600|NCT01576016|470208966|FG000|Lead Safety|Too far from study site|1|||
130614601|NCT01576016|470208967|FG001|Lead Safety|Too far from study site|0|||
130614602|NCT01576016|470208966|FG000|Lead Safety|System deactivated|1|||
130614603|NCT01576016|470208967|FG001|Lead Safety|System deactivated|0|||
130614604|NCT01576016|470208966|FG000|Lead Safety|Patient no longer followed by study PI|1|||
130614605|NCT01576016|470208967|FG001|Lead Safety|Patient no longer followed by study PI|0|||
130614606|NCT01576016|470208966|FG000|MRI Safety|Withdrawal by Subject|0|||
130614607|NCT01576016|470208967|FG001|MRI Safety|Withdrawal by Subject|10|||
130614608|NCT01576016|470208966|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
130614609|NCT01576016|470208967|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
130614610|NCT01576016|470208966|FG000|MRI Safety|Has not yet completed MRI scan|0|||
130614611|NCT01576016|470208967|FG001|MRI Safety|Has not yet completed MRI scan|56|||
130614612|NCT01576016|470208966|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
130614613|NCT01576016|470208967|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
130614614|NCT02488551|470208970|FG000|Overall Study|Lost to Follow-up|4|||
130614615|NCT02488551|470208971|FG001|Overall Study|Lost to Follow-up|7|||
130614616|NCT02488551|470208972|FG002|Overall Study|Lost to Follow-up|0|||
130614617|NCT02488551|470208973|FG003|Overall Study|Lost to Follow-up|0|||
130614618|NCT02488551|470208970|FG000|Overall Study|Military Deployment|1|||
130614619|NCT02488551|470208971|FG001|Overall Study|Military Deployment|1|||
130614620|NCT02488551|470208972|FG002|Overall Study|Military Deployment|0|||
130614621|NCT02488551|470208973|FG003|Overall Study|Military Deployment|0|||
130614622|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
130614623|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614624|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614625|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614626|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614627|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614628|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614629|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614630|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130614631|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
130614632|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614633|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614634|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614635|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614636|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614637|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614638|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614639|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130614640|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
130614641|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614642|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614643|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614644|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614645|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614646|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614647|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614648|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130614649|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
130614650|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614651|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614652|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614653|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614654|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614655|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614656|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614657|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
130614658|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
130614659|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614660|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614661|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614662|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614663|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614664|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614665|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614666|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130614667|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
130614668|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614669|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614670|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614671|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614672|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614673|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614674|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614675|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130614676|NCT02175771|470208986|FG000|Run-In Period (Pre-assignment)|Other|8|||
130614677|NCT02175771|470208987|FG001|Run-In Period (Pre-assignment)|Other|0|||
130614678|NCT02175771|470208988|FG002|Run-In Period (Pre-assignment)|Other|0|||
130614679|NCT02175771|470208989|FG003|Run-In Period (Pre-assignment)|Other|0|||
130614680|NCT02175771|470208990|FG004|Run-In Period (Pre-assignment)|Other|0|||
130614681|NCT02175771|470208991|FG005|Run-In Period (Pre-assignment)|Other|0|||
130614682|NCT02175771|470208992|FG006|Run-In Period (Pre-assignment)|Other|0|||
130614683|NCT02175771|470208993|FG007|Run-In Period (Pre-assignment)|Other|0|||
130614684|NCT02175771|470208994|FG008|Run-In Period (Pre-assignment)|Other|0|||
130614685|NCT02175771|470208986|FG000|Treatment Period|Adverse Event|0|||
130614686|NCT02175771|470208987|FG001|Treatment Period|Adverse Event|2|||
130614687|NCT02175771|470208988|FG002|Treatment Period|Adverse Event|1|||
130614688|NCT02175771|470208989|FG003|Treatment Period|Adverse Event|1|||
130614689|NCT02175771|470208990|FG004|Treatment Period|Adverse Event|1|||
130614690|NCT02175771|470208991|FG005|Treatment Period|Adverse Event|3|||
130614691|NCT02175771|470208992|FG006|Treatment Period|Adverse Event|2|||
130614692|NCT02175771|470208993|FG007|Treatment Period|Adverse Event|0|||
130614693|NCT02175771|470208994|FG008|Treatment Period|Adverse Event|1|||
130614694|NCT02175771|470208986|FG000|Treatment Period|Withdrawal by Subject|0|||
130614695|NCT02175771|470208987|FG001|Treatment Period|Withdrawal by Subject|9|||
130614696|NCT02175771|470208988|FG002|Treatment Period|Withdrawal by Subject|3|||
130614697|NCT02175771|470208989|FG003|Treatment Period|Withdrawal by Subject|6|||
130614698|NCT02175771|470208990|FG004|Treatment Period|Withdrawal by Subject|2|||
130614699|NCT02175771|470208991|FG005|Treatment Period|Withdrawal by Subject|4|||
130614700|NCT02175771|470208992|FG006|Treatment Period|Withdrawal by Subject|2|||
130614701|NCT02175771|470208993|FG007|Treatment Period|Withdrawal by Subject|9|||
130614702|NCT02175771|470208994|FG008|Treatment Period|Withdrawal by Subject|2|||
130614703|NCT02175771|470208986|FG000|Treatment Period|Noncompliance|0|||
130614704|NCT02175771|470208987|FG001|Treatment Period|Noncompliance|1|||
130614705|NCT02175771|470208988|FG002|Treatment Period|Noncompliance|2|||
130614706|NCT02175771|470208989|FG003|Treatment Period|Noncompliance|0|||
130614707|NCT02175771|470208990|FG004|Treatment Period|Noncompliance|0|||
130614708|NCT02175771|470208991|FG005|Treatment Period|Noncompliance|0|||
130614709|NCT02175771|470208992|FG006|Treatment Period|Noncompliance|0|||
130614710|NCT02175771|470208993|FG007|Treatment Period|Noncompliance|0|||
130614711|NCT02175771|470208994|FG008|Treatment Period|Noncompliance|1|||
130614712|NCT02175771|470208986|FG000|Treatment Period|Protocol Violation|0|||
130614713|NCT02175771|470208987|FG001|Treatment Period|Protocol Violation|0|||
130614714|NCT02175771|470208988|FG002|Treatment Period|Protocol Violation|0|||
130614715|NCT02175771|470208989|FG003|Treatment Period|Protocol Violation|0|||
130614716|NCT02175771|470208990|FG004|Treatment Period|Protocol Violation|0|||
130614717|NCT02175771|470208991|FG005|Treatment Period|Protocol Violation|0|||
130614718|NCT02175771|470208992|FG006|Treatment Period|Protocol Violation|0|||
130614719|NCT02175771|470208993|FG007|Treatment Period|Protocol Violation|1|||
130614720|NCT02175771|470208994|FG008|Treatment Period|Protocol Violation|0|||
130614721|NCT02175771|470208986|FG000|Treatment Period|Disease progression|0|||
130614722|NCT02175771|470208987|FG001|Treatment Period|Disease progression|0|||
130614723|NCT02175771|470208988|FG002|Treatment Period|Disease progression|0|||
130614724|NCT02175771|470208989|FG003|Treatment Period|Disease progression|0|||
130614725|NCT02175771|470208990|FG004|Treatment Period|Disease progression|0|||
130614726|NCT02175771|470208991|FG005|Treatment Period|Disease progression|0|||
130614727|NCT02175771|470208992|FG006|Treatment Period|Disease progression|0|||
130614728|NCT02175771|470208993|FG007|Treatment Period|Disease progression|2|||
130614729|NCT02175771|470208994|FG008|Treatment Period|Disease progression|0|||
130614730|NCT02175771|470208986|FG000|Treatment Period|Lost to Follow-up|0|||
130614731|NCT02175771|470208987|FG001|Treatment Period|Lost to Follow-up|3|||
130614732|NCT02175771|470208988|FG002|Treatment Period|Lost to Follow-up|1|||
130614733|NCT02175771|470208989|FG003|Treatment Period|Lost to Follow-up|3|||
130614734|NCT02175771|470208990|FG004|Treatment Period|Lost to Follow-up|1|||
130614735|NCT02175771|470208991|FG005|Treatment Period|Lost to Follow-up|2|||
130614736|NCT02175771|470208992|FG006|Treatment Period|Lost to Follow-up|1|||
130614737|NCT02175771|470208993|FG007|Treatment Period|Lost to Follow-up|2|||
130614738|NCT02175771|470208994|FG008|Treatment Period|Lost to Follow-up|2|||
130614739|NCT02175771|470208986|FG000|Treatment Period|Lack of Efficacy|0|||
130614740|NCT02175771|470208987|FG001|Treatment Period|Lack of Efficacy|0|||
130614741|NCT02175771|470208988|FG002|Treatment Period|Lack of Efficacy|0|||
130614742|NCT02175771|470208989|FG003|Treatment Period|Lack of Efficacy|0|||
130614743|NCT02175771|470208990|FG004|Treatment Period|Lack of Efficacy|0|||
130614744|NCT02175771|470208991|FG005|Treatment Period|Lack of Efficacy|1|||
130614745|NCT02175771|470208992|FG006|Treatment Period|Lack of Efficacy|0|||
130614746|NCT02175771|470208993|FG007|Treatment Period|Lack of Efficacy|1|||
130614747|NCT02175771|470208994|FG008|Treatment Period|Lack of Efficacy|0|||
130614748|NCT02175771|470208986|FG000|Treatment Period|Other|0|||
130614749|NCT02175771|470208987|FG001|Treatment Period|Other|1|||
130614750|NCT02175771|470208988|FG002|Treatment Period|Other|0|||
130614751|NCT02175771|470208989|FG003|Treatment Period|Other|3|||
130614752|NCT02175771|470208990|FG004|Treatment Period|Other|1|||
130614753|NCT02175771|470208991|FG005|Treatment Period|Other|0|||
130614754|NCT02175771|470208992|FG006|Treatment Period|Other|0|||
130614755|NCT02175771|470208993|FG007|Treatment Period|Other|2|||
130614756|NCT02175771|470208994|FG008|Treatment Period|Other|0|||
130614757|NCT04096326|470208995|FG000|Overall Study|Withdrawal by Subject|0|||
130614758|NCT04096326|470208996|FG001|Overall Study|Withdrawal by Subject|0|||
130614759|NCT04096326|470208997|FG002|Overall Study|Withdrawal by Subject|0|||
130614760|NCT04096326|470208998|FG003|Overall Study|Withdrawal by Subject|0|||
130614761|NCT04096326|470208999|FG004|Overall Study|Withdrawal by Subject|0|||
130614762|NCT04096326|470209000|FG005|Overall Study|Withdrawal by Subject|0|||
130614763|NCT04096326|470209001|FG006|Overall Study|Withdrawal by Subject|1|||
130614764|NCT04096326|470209002|FG007|Overall Study|Withdrawal by Subject|0|||
130614765|NCT04096326|470209003|FG008|Overall Study|Withdrawal by Subject|0|||
130614766|NCT04096326|470209004|FG009|Overall Study|Withdrawal by Subject|0|||
130614767|NCT04096326|470208995|FG000|Overall Study|Lost to Follow-up|0|||
130614768|NCT04096326|470208996|FG001|Overall Study|Lost to Follow-up|1|||
130614769|NCT04096326|470208997|FG002|Overall Study|Lost to Follow-up|0|||
130614770|NCT04096326|470208998|FG003|Overall Study|Lost to Follow-up|0|||
130614771|NCT04096326|470208999|FG004|Overall Study|Lost to Follow-up|0|||
130614772|NCT04096326|470209000|FG005|Overall Study|Lost to Follow-up|0|||
130614773|NCT04096326|470209001|FG006|Overall Study|Lost to Follow-up|0|||
130614774|NCT04096326|470209002|FG007|Overall Study|Lost to Follow-up|0|||
130614775|NCT04096326|470209003|FG008|Overall Study|Lost to Follow-up|0|||
130614776|NCT04096326|470209004|FG009|Overall Study|Lost to Follow-up|0|||
130614777|NCT04096326|470208995|FG000|Overall Study|COVID-19-related reasons|0|||
130614778|NCT04096326|470208996|FG001|Overall Study|COVID-19-related reasons|0|||
130614779|NCT04096326|470208997|FG002|Overall Study|COVID-19-related reasons|0|||
130614780|NCT04096326|470208998|FG003|Overall Study|COVID-19-related reasons|0|||
130614781|NCT04096326|470208999|FG004|Overall Study|COVID-19-related reasons|1|||
130614782|NCT04096326|470209000|FG005|Overall Study|COVID-19-related reasons|5|||
130614783|NCT04096326|470209001|FG006|Overall Study|COVID-19-related reasons|0|||
130614784|NCT04096326|470209002|FG007|Overall Study|COVID-19-related reasons|0|||
130614785|NCT04096326|470209003|FG008|Overall Study|COVID-19-related reasons|0|||
130614786|NCT04096326|470209004|FG009|Overall Study|COVID-19-related reasons|0|||
130614787|NCT00194025|470209005|FG000|Overall Study|Adverse Event|1|||
130614788|NCT00194025|470209005|FG000|Overall Study|non-adherence with study medication|4|||
130614789|NCT05373706|470209008|FG000|Overall Study|Lost to Follow-up|2|||
130614790|NCT05373706|470209009|FG001|Overall Study|Lost to Follow-up|2|||
130614791|NCT03628508|470209013|FG000|Overall Study|Lost to Follow-up|1|||
130614792|NCT02402218|470209014|FG000|Overall Study|Did not pickup study medication|12|||
130614793|NCT02402218|470209015|FG001|Overall Study|Did not pickup study medication|9|||
130614794|NCT02402218|470209016|FG002|Overall Study|Did not pickup study medication|13|||
130614795|NCT02402218|470209014|FG000|Overall Study|Lack of Efficacy|0|||
130614796|NCT02402218|470209015|FG001|Overall Study|Lack of Efficacy|1|||
130614797|NCT02402218|470209016|FG002|Overall Study|Lack of Efficacy|1|||
130614798|NCT02402218|470209014|FG000|Overall Study|Death|1|||
130614799|NCT02402218|470209015|FG001|Overall Study|Death|0|||
130614800|NCT02402218|470209016|FG002|Overall Study|Death|0|||
130614801|NCT02402218|470209014|FG000|Overall Study|Reinfection|0|||
130614802|NCT02402218|470209015|FG001|Overall Study|Reinfection|0|||
130614803|NCT02402218|470209016|FG002|Overall Study|Reinfection|1|||
130614804|NCT02402218|470209014|FG000|Overall Study|Adverse Event|0|||
130614805|NCT02402218|470209015|FG001|Overall Study|Adverse Event|2|||
130614806|NCT02402218|470209016|FG002|Overall Study|Adverse Event|1|||
130614807|NCT02402218|470209014|FG000|Overall Study|Withdrawal by Subject|1|||
130614808|NCT02402218|470209015|FG001|Overall Study|Withdrawal by Subject|1|||
130614809|NCT02402218|470209016|FG002|Overall Study|Withdrawal by Subject|1|||
130614810|NCT00807846|470209018|FG000|Overall Study|Adverse Event|5|||
130614811|NCT00807846|470209019|FG001|Overall Study|Adverse Event|0|||
130614812|NCT00807846|470209018|FG000|Overall Study|Lack of Efficacy|2|||
130614813|NCT00807846|470209019|FG001|Overall Study|Lack of Efficacy|0|||
130614814|NCT00807846|470209018|FG000|Overall Study|Protocol Violation|2|||
130614815|NCT00807846|470209019|FG001|Overall Study|Protocol Violation|1|||
130614816|NCT00807846|470209018|FG000|Overall Study|Withdrawal by Subject|2|||
130614817|NCT00807846|470209019|FG001|Overall Study|Withdrawal by Subject|1|||
130614818|NCT00807846|470209018|FG000|Overall Study|Other|1|||
130614819|NCT00807846|470209019|FG001|Overall Study|Other|2|||
130614820|NCT01081873|470209020|FG000|Overall Study|Death|86|||
130614821|NCT01081873|470209020|FG000|Overall Study|Withdrawal by Subject|10|||
130614822|NCT01081873|470209020|FG000|Overall Study|Lost to Follow-up|142|||
130614823|NCT01081873|470209020|FG000|Overall Study|Progression of prostate cancer|13|||
130614824|NCT01081873|470209020|FG000|Overall Study|Other|47|||
130614825|NCT03011840|470209021|FG000|Overall Study|Not received PIL in post PIL phase|0|||
130614826|NCT03011840|470209022|FG001|Overall Study|Not received PIL in post PIL phase|21|||
130614827|NCT02491073|470209024|FG000|Overall Study|screen failure|1|||
130614828|NCT02491073|470209025|FG001|Overall Study|screen failure|0|||
130614829|NCT03738566|470209026|FG000|Initial Study Phase|Withdrawal by Subject|1|||
130614830|NCT03738566|470209027|FG001|Initial Study Phase|Withdrawal by Subject|1|||
130614831|NCT03738566|470209028|FG002|Initial Study Phase|Withdrawal by Subject|2|||
130614832|NCT03738566|470209029|FG003|Initial Study Phase|Withdrawal by Subject|0|||
130614833|NCT03738566|470209026|FG000|Initial Study Phase|Death|0|||
130614834|NCT03738566|470209027|FG001|Initial Study Phase|Death|1|||
130614835|NCT03738566|470209028|FG002|Initial Study Phase|Death|0|||
130614836|NCT03738566|470209029|FG003|Initial Study Phase|Death|0|||
130614837|NCT03738566|470209026|FG000|Initial Study Phase|Treatment failure|5|||
130614838|NCT03738566|470209027|FG001|Initial Study Phase|Treatment failure|0|||
130614839|NCT03738566|470209028|FG002|Initial Study Phase|Treatment failure|0|||
130614840|NCT03738566|470209029|FG003|Initial Study Phase|Treatment failure|0|||
130614841|NCT03738566|470209026|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
130614842|NCT03738566|470209027|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
130614843|NCT03738566|470209028|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
130614844|NCT03738566|470209029|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
130614845|NCT03126539|470209035|FG000|Overall Study|Lost to Follow-up|1|||
130614846|NCT03126539|470209036|FG001|Overall Study|Lost to Follow-up|1|||
130614847|NCT03126539|470209037|FG002|Overall Study|Lost to Follow-up|1|||
130614848|NCT03126539|470209038|FG003|Overall Study|Lost to Follow-up|0|||
130614849|NCT03126539|470209039|FG004|Overall Study|Lost to Follow-up|0|||
130614850|NCT03352414|470209040|FG000|Overall Study|Ineligible by operative criteria|12|||
130614851|NCT03352414|470209041|FG001|Overall Study|Ineligible by operative criteria|10|||
130614852|NCT02632110|470209042|FG000|Overall Study|Withdrawal by Subject|1|||
130614853|NCT02632110|470209043|FG001|Overall Study|Withdrawal by Subject|1|||
130614854|NCT02632110|470209044|FG002|Overall Study|Withdrawal by Subject|0|||
130614855|NCT02632110|470209045|FG003|Overall Study|Withdrawal by Subject|0|||
130614856|NCT02632110|470209046|FG004|Overall Study|Withdrawal by Subject|1|||
130614857|NCT02632110|470209047|FG005|Overall Study|Withdrawal by Subject|1|||
130614858|NCT02632110|470209048|FG006|Overall Study|Withdrawal by Subject|3|||
130614859|NCT02632110|470209049|FG007|Overall Study|Withdrawal by Subject|3|||
130614860|NCT02632110|470209050|FG008|Overall Study|Withdrawal by Subject|1|||
130614861|NCT02632110|470209051|FG009|Overall Study|Withdrawal by Subject|1|||
130614862|NCT00516269|470209054|FG000|Overall Study|Adverse Event|2|||
130614863|NCT00516269|470209055|FG001|Overall Study|Adverse Event|1|||
130614864|NCT00516269|470209054|FG000|Overall Study|Lost to Follow-up|0|||
130614865|NCT00516269|470209055|FG001|Overall Study|Lost to Follow-up|1|||
130614866|NCT00516269|470209054|FG000|Overall Study|Protocol Violation|0|||
130614867|NCT00516269|470209055|FG001|Overall Study|Protocol Violation|1|||
130614868|NCT01079962|470209056|FG000|Overall Study|Adverse Event|2|||
130614869|NCT01079962|470209057|FG001|Overall Study|Adverse Event|2|||
130614870|NCT01079962|470209056|FG000|Overall Study|Withdrawal by Subject|5|||
130614871|NCT01079962|470209057|FG001|Overall Study|Withdrawal by Subject|7|||
130614872|NCT01079962|470209056|FG000|Overall Study|Protocol Violation|2|||
130614873|NCT01079962|470209057|FG001|Overall Study|Protocol Violation|2|||
130614874|NCT01079962|470209056|FG000|Overall Study|No blood pressure (BP) control|3|||
130614875|NCT01079962|470209057|FG001|Overall Study|No blood pressure (BP) control|0|||
130614876|NCT01079962|470209056|FG000|Overall Study|Inclusion/exclusion criteria|1|||
130614877|NCT01079962|470209057|FG001|Overall Study|Inclusion/exclusion criteria|3|||
130614878|NCT01079962|470209056|FG000|Overall Study|Participant not returning for next visit|1|||
130614879|NCT01079962|470209057|FG001|Overall Study|Participant not returning for next visit|0|||
130614880|NCT01079962|470209056|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
130614881|NCT01079962|470209057|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
130614882|NCT01072539|470209058|FG000|Overall Study|Treated prior to the Site Initiation|1|||
130614883|NCT01072539|470209058|FG000|Overall Study|Protocol Violation|2|||
130614884|NCT01331239|470209059|FG000|Part II: Core Study|Adverse Event|0|||
130614885|NCT01331239|470209060|FG001|Part II: Core Study|Adverse Event|3|||
130614886|NCT01331239|470209061|FG002|Part II: Core Study|Adverse Event|0|||
130614887|NCT01331239|470209059|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
130614888|NCT01331239|470209060|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
130614889|NCT01331239|470209061|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
130614890|NCT01331239|470209059|FG000|Part II: Core Study|Withdrawal by Subject|0|||
130614891|NCT01331239|470209060|FG001|Part II: Core Study|Withdrawal by Subject|2|||
130614892|NCT01331239|470209061|FG002|Part II: Core Study|Withdrawal by Subject|0|||
130614893|NCT01331239|470209059|FG000|Part II: Core Study|Administrative problems|0|||
130614894|NCT01331239|470209060|FG001|Part II: Core Study|Administrative problems|1|||
130614895|NCT01331239|470209061|FG002|Part II: Core Study|Administrative problems|0|||
130614896|NCT00946530|470209062|FG000|Overall Study|Withdrawal by Subject|0|||
130614897|NCT00946530|470209063|FG001|Overall Study|Withdrawal by Subject|3|||
130614898|NCT00946530|470209064|FG002|Overall Study|Withdrawal by Subject|0|||
130614899|NCT00946530|470209065|FG003|Overall Study|Withdrawal by Subject|3|||
130614900|NCT00946530|470209062|FG000|Overall Study|Physician Decision|1|||
130614901|NCT00946530|470209063|FG001|Overall Study|Physician Decision|1|||
130614902|NCT00946530|470209064|FG002|Overall Study|Physician Decision|1|||
130614903|NCT00946530|470209065|FG003|Overall Study|Physician Decision|1|||
130614904|NCT01008995|470209066|FG000|Controlled Period|Adverse Event|1|||
130614905|NCT01008995|470209067|FG001|Controlled Period|Adverse Event|2|||
130614906|NCT01008995|470209068|FG002|Controlled Period|Adverse Event|0|||
130614907|NCT01008995|470209069|FG003|Controlled Period|Adverse Event|0|||
130614908|NCT01008995|470209066|FG000|Controlled Period|Other|2|||
130614909|NCT01008995|470209067|FG001|Controlled Period|Other|1|||
130614910|NCT01008995|470209068|FG002|Controlled Period|Other|0|||
130614911|NCT01008995|470209069|FG003|Controlled Period|Other|0|||
130614912|NCT01008995|470209066|FG000|After Controlled Period|Adverse Event|0|||
130614913|NCT01008995|470209067|FG001|After Controlled Period|Adverse Event|0|||
130614914|NCT01008995|470209068|FG002|After Controlled Period|Adverse Event|1|||
130614915|NCT01008995|470209069|FG003|After Controlled Period|Adverse Event|1|||
130614916|NCT01008995|470209066|FG000|After Controlled Period|Other|0|||
130614917|NCT01008995|470209067|FG001|After Controlled Period|Other|0|||
130614918|NCT01008995|470209068|FG002|After Controlled Period|Other|1|||
130614919|NCT01008995|470209069|FG003|After Controlled Period|Other|0|||
130614920|NCT00115804|470209072|FG000|Overall Study|Adverse Event|2|||
130614921|NCT01877382|470209075|FG000|Dose Escalation|Progressive disease|2|||
130614922|NCT01877382|470209076|FG001|Dose Escalation|Progressive disease|0|||
130614923|NCT01877382|470209077|FG002|Dose Escalation|Progressive disease|1|||
130614924|NCT01877382|470209078|FG003|Dose Escalation|Progressive disease|6|||
130614925|NCT01877382|470209079|FG004|Dose Escalation|Progressive disease|1|||
130614926|NCT01877382|470209080|FG005|Dose Escalation|Progressive disease|0|||
130614927|NCT01877382|470209081|FG006|Dose Escalation|Progressive disease|3|||
130614928|NCT01877382|470209082|FG007|Dose Escalation|Progressive disease|10|||
130614929|NCT01877382|470209083|FG008|Dose Escalation|Progressive disease|4|||
130614930|NCT01877382|470209084|FG009|Dose Escalation|Progressive disease|2|||
130614931|NCT01877382|470209085|FG010|Dose Escalation|Progressive disease|3|||
130614932|NCT01877382|470209086|FG011|Dose Escalation|Progressive disease|3|||
130614933|NCT01877382|470209087|FG012|Dose Escalation|Progressive disease|13|||
130614934|NCT01877382|470209088|FG013|Dose Escalation|Progressive disease|1|||
130614935|NCT01877382|470209089|FG014|Dose Escalation|Progressive disease|0|||
130614936|NCT01877382|470209075|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130614937|NCT01877382|470209076|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614938|NCT01877382|470209077|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614939|NCT01877382|470209078|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130614940|NCT01877382|470209079|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614941|NCT01877382|470209080|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614942|NCT01877382|470209081|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130614943|NCT01877382|470209082|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614944|NCT01877382|470209083|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614945|NCT01877382|470209084|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614946|NCT01877382|470209085|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614947|NCT01877382|470209086|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614948|NCT01877382|470209087|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614949|NCT01877382|470209088|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614950|NCT01877382|470209089|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130614951|NCT01877382|470209075|FG000|Dose Escalation|Clinical progression|0|||
130614952|NCT01877382|470209076|FG001|Dose Escalation|Clinical progression|1|||
130614953|NCT01877382|470209077|FG002|Dose Escalation|Clinical progression|0|||
130614954|NCT01877382|470209078|FG003|Dose Escalation|Clinical progression|2|||
130614955|NCT01877382|470209079|FG004|Dose Escalation|Clinical progression|0|||
130614956|NCT01877382|470209080|FG005|Dose Escalation|Clinical progression|0|||
130614957|NCT01877382|470209081|FG006|Dose Escalation|Clinical progression|1|||
130614958|NCT01877382|470209082|FG007|Dose Escalation|Clinical progression|0|||
130614959|NCT01877382|470209083|FG008|Dose Escalation|Clinical progression|0|||
130614960|NCT01877382|470209084|FG009|Dose Escalation|Clinical progression|1|||
130614961|NCT01877382|470209085|FG010|Dose Escalation|Clinical progression|0|||
130614962|NCT01877382|470209086|FG011|Dose Escalation|Clinical progression|0|||
130614963|NCT01877382|470209087|FG012|Dose Escalation|Clinical progression|2|||
130614964|NCT01877382|470209088|FG013|Dose Escalation|Clinical progression|1|||
130614965|NCT01877382|470209089|FG014|Dose Escalation|Clinical progression|0|||
130614966|NCT01877382|470209075|FG000|Dose Escalation|Adverse Event|0|||
130614967|NCT01877382|470209076|FG001|Dose Escalation|Adverse Event|0|||
130614968|NCT01877382|470209077|FG002|Dose Escalation|Adverse Event|0|||
130614969|NCT01877382|470209078|FG003|Dose Escalation|Adverse Event|4|||
130614970|NCT01877382|470209079|FG004|Dose Escalation|Adverse Event|1|||
130614971|NCT01877382|470209080|FG005|Dose Escalation|Adverse Event|2|||
130614972|NCT01877382|470209081|FG006|Dose Escalation|Adverse Event|1|||
130614973|NCT01877382|470209082|FG007|Dose Escalation|Adverse Event|2|||
130614974|NCT01877382|470209083|FG008|Dose Escalation|Adverse Event|0|||
130614975|NCT01877382|470209084|FG009|Dose Escalation|Adverse Event|0|||
130614976|NCT01877382|470209085|FG010|Dose Escalation|Adverse Event|0|||
130614977|NCT01877382|470209086|FG011|Dose Escalation|Adverse Event|0|||
130614978|NCT01877382|470209087|FG012|Dose Escalation|Adverse Event|1|||
130614979|NCT01877382|470209088|FG013|Dose Escalation|Adverse Event|0|||
130614980|NCT01877382|470209089|FG014|Dose Escalation|Adverse Event|0|||
130614981|NCT01877382|470209075|FG000|Dose Escalation|Withdrawal by Subject|0|||
130614982|NCT01877382|470209076|FG001|Dose Escalation|Withdrawal by Subject|0|||
130614983|NCT01877382|470209077|FG002|Dose Escalation|Withdrawal by Subject|0|||
130614984|NCT01877382|470209078|FG003|Dose Escalation|Withdrawal by Subject|0|||
130614985|NCT01877382|470209079|FG004|Dose Escalation|Withdrawal by Subject|0|||
130614986|NCT01877382|470209080|FG005|Dose Escalation|Withdrawal by Subject|3|||
130614987|NCT01877382|470209081|FG006|Dose Escalation|Withdrawal by Subject|2|||
130614988|NCT01877382|470209082|FG007|Dose Escalation|Withdrawal by Subject|1|||
130614989|NCT01877382|470209083|FG008|Dose Escalation|Withdrawal by Subject|1|||
130614990|NCT01877382|470209084|FG009|Dose Escalation|Withdrawal by Subject|0|||
130614991|NCT01877382|470209085|FG010|Dose Escalation|Withdrawal by Subject|0|||
130614992|NCT01877382|470209086|FG011|Dose Escalation|Withdrawal by Subject|0|||
130614993|NCT01877382|470209087|FG012|Dose Escalation|Withdrawal by Subject|0|||
130614994|NCT01877382|470209088|FG013|Dose Escalation|Withdrawal by Subject|0|||
130614995|NCT01877382|470209089|FG014|Dose Escalation|Withdrawal by Subject|0|||
130614996|NCT01877382|470209075|FG000|Dose Escalation|Protocol Violation|0|||
130614997|NCT01877382|470209076|FG001|Dose Escalation|Protocol Violation|0|||
130614998|NCT01877382|470209077|FG002|Dose Escalation|Protocol Violation|0|||
130614999|NCT01877382|470209078|FG003|Dose Escalation|Protocol Violation|0|||
130615000|NCT01877382|470209079|FG004|Dose Escalation|Protocol Violation|0|||
130615001|NCT01877382|470209080|FG005|Dose Escalation|Protocol Violation|0|||
130615002|NCT01877382|470209081|FG006|Dose Escalation|Protocol Violation|1|||
130615003|NCT01877382|470209082|FG007|Dose Escalation|Protocol Violation|0|||
130615004|NCT01877382|470209083|FG008|Dose Escalation|Protocol Violation|0|||
130615005|NCT01877382|470209084|FG009|Dose Escalation|Protocol Violation|0|||
130615006|NCT01877382|470209085|FG010|Dose Escalation|Protocol Violation|0|||
130615007|NCT01877382|470209086|FG011|Dose Escalation|Protocol Violation|0|||
130615008|NCT01877382|470209087|FG012|Dose Escalation|Protocol Violation|0|||
130615009|NCT01877382|470209088|FG013|Dose Escalation|Protocol Violation|0|||
130615010|NCT01877382|470209089|FG014|Dose Escalation|Protocol Violation|0|||
130615011|NCT01877382|470209075|FG000|Dose Escalation|Study terminated by sponsor|0|||
130615012|NCT01877382|470209076|FG001|Dose Escalation|Study terminated by sponsor|0|||
130615013|NCT01877382|470209077|FG002|Dose Escalation|Study terminated by sponsor|0|||
130615014|NCT01877382|470209078|FG003|Dose Escalation|Study terminated by sponsor|0|||
130615015|NCT01877382|470209079|FG004|Dose Escalation|Study terminated by sponsor|0|||
130615016|NCT01877382|470209080|FG005|Dose Escalation|Study terminated by sponsor|0|||
130615017|NCT01877382|470209081|FG006|Dose Escalation|Study terminated by sponsor|0|||
130615018|NCT01877382|470209082|FG007|Dose Escalation|Study terminated by sponsor|1|||
130615019|NCT01877382|470209083|FG008|Dose Escalation|Study terminated by sponsor|1|||
130615020|NCT01877382|470209084|FG009|Dose Escalation|Study terminated by sponsor|0|||
130615021|NCT01877382|470209085|FG010|Dose Escalation|Study terminated by sponsor|0|||
130615022|NCT01877382|470209086|FG011|Dose Escalation|Study terminated by sponsor|0|||
130615023|NCT01877382|470209087|FG012|Dose Escalation|Study terminated by sponsor|3|||
130615024|NCT01877382|470209088|FG013|Dose Escalation|Study terminated by sponsor|0|||
130615025|NCT01877382|470209089|FG014|Dose Escalation|Study terminated by sponsor|0|||
130615026|NCT01877382|470209075|FG000|Dose Escalation|Death|0|||
130615027|NCT01877382|470209076|FG001|Dose Escalation|Death|0|||
130615028|NCT01877382|470209077|FG002|Dose Escalation|Death|0|||
130615029|NCT01877382|470209078|FG003|Dose Escalation|Death|0|||
130615030|NCT01877382|470209079|FG004|Dose Escalation|Death|0|||
130615031|NCT01877382|470209080|FG005|Dose Escalation|Death|0|||
130615032|NCT01877382|470209081|FG006|Dose Escalation|Death|0|||
130615033|NCT01877382|470209082|FG007|Dose Escalation|Death|1|||
130615034|NCT01877382|470209083|FG008|Dose Escalation|Death|0|||
130615035|NCT01877382|470209084|FG009|Dose Escalation|Death|0|||
130615036|NCT01877382|470209085|FG010|Dose Escalation|Death|0|||
130615037|NCT01877382|470209086|FG011|Dose Escalation|Death|0|||
130615038|NCT01877382|470209087|FG012|Dose Escalation|Death|1|||
130615039|NCT01877382|470209088|FG013|Dose Escalation|Death|1|||
130615040|NCT01877382|470209089|FG014|Dose Escalation|Death|0|||
130615041|NCT01877382|470209075|FG000|Dose Expansion|Progressive disease|0|||
130615042|NCT01877382|470209076|FG001|Dose Expansion|Progressive disease|0|||
130615043|NCT01877382|470209077|FG002|Dose Expansion|Progressive disease|0|||
130615044|NCT01877382|470209078|FG003|Dose Expansion|Progressive disease|0|||
130615045|NCT01877382|470209079|FG004|Dose Expansion|Progressive disease|0|||
130615046|NCT01877382|470209080|FG005|Dose Expansion|Progressive disease|0|||
130615047|NCT01877382|470209081|FG006|Dose Expansion|Progressive disease|0|||
130615048|NCT01877382|470209082|FG007|Dose Expansion|Progressive disease|0|||
130615049|NCT01877382|470209083|FG008|Dose Expansion|Progressive disease|0|||
130615050|NCT01877382|470209084|FG009|Dose Expansion|Progressive disease|0|||
130615051|NCT01877382|470209085|FG010|Dose Expansion|Progressive disease|0|||
130615052|NCT01877382|470209086|FG011|Dose Expansion|Progressive disease|0|||
130615053|NCT01877382|470209087|FG012|Dose Expansion|Progressive disease|0|||
130615054|NCT01877382|470209088|FG013|Dose Expansion|Progressive disease|0|||
130615055|NCT01877382|470209089|FG014|Dose Expansion|Progressive disease|11|||
130615056|NCT01877382|470209075|FG000|Dose Expansion|Clinical progression|0|||
130615057|NCT01877382|470209076|FG001|Dose Expansion|Clinical progression|0|||
130615058|NCT01877382|470209077|FG002|Dose Expansion|Clinical progression|0|||
130615059|NCT01877382|470209078|FG003|Dose Expansion|Clinical progression|0|||
130615060|NCT01877382|470209079|FG004|Dose Expansion|Clinical progression|0|||
130615061|NCT01877382|470209080|FG005|Dose Expansion|Clinical progression|0|||
130615062|NCT01877382|470209081|FG006|Dose Expansion|Clinical progression|0|||
130615063|NCT01877382|470209082|FG007|Dose Expansion|Clinical progression|0|||
130615064|NCT01877382|470209083|FG008|Dose Expansion|Clinical progression|0|||
130615065|NCT01877382|470209084|FG009|Dose Expansion|Clinical progression|0|||
130615066|NCT01877382|470209085|FG010|Dose Expansion|Clinical progression|0|||
130615067|NCT01877382|470209086|FG011|Dose Expansion|Clinical progression|0|||
130615068|NCT01877382|470209087|FG012|Dose Expansion|Clinical progression|0|||
130615069|NCT01877382|470209088|FG013|Dose Expansion|Clinical progression|0|||
130615070|NCT01877382|470209089|FG014|Dose Expansion|Clinical progression|6|||
130615071|NCT01877382|470209075|FG000|Dose Expansion|Adverse Event|0|||
130615072|NCT01877382|470209076|FG001|Dose Expansion|Adverse Event|0|||
130615073|NCT01877382|470209077|FG002|Dose Expansion|Adverse Event|0|||
130615074|NCT01877382|470209078|FG003|Dose Expansion|Adverse Event|0|||
130615075|NCT01877382|470209079|FG004|Dose Expansion|Adverse Event|0|||
130615076|NCT01877382|470209080|FG005|Dose Expansion|Adverse Event|0|||
130615077|NCT01877382|470209081|FG006|Dose Expansion|Adverse Event|0|||
130615078|NCT01877382|470209082|FG007|Dose Expansion|Adverse Event|0|||
130615079|NCT01877382|470209083|FG008|Dose Expansion|Adverse Event|0|||
130615080|NCT01877382|470209084|FG009|Dose Expansion|Adverse Event|0|||
130615081|NCT01877382|470209085|FG010|Dose Expansion|Adverse Event|0|||
130615082|NCT01877382|470209086|FG011|Dose Expansion|Adverse Event|0|||
130615083|NCT01877382|470209087|FG012|Dose Expansion|Adverse Event|0|||
130615084|NCT01877382|470209088|FG013|Dose Expansion|Adverse Event|0|||
130615085|NCT01877382|470209089|FG014|Dose Expansion|Adverse Event|1|||
130615086|NCT01877382|470209075|FG000|Dose Expansion|Death|0|||
130615087|NCT01877382|470209076|FG001|Dose Expansion|Death|0|||
130615088|NCT01877382|470209077|FG002|Dose Expansion|Death|0|||
130615089|NCT01877382|470209078|FG003|Dose Expansion|Death|0|||
130615090|NCT01877382|470209079|FG004|Dose Expansion|Death|0|||
130615091|NCT01877382|470209080|FG005|Dose Expansion|Death|0|||
130615092|NCT01877382|470209081|FG006|Dose Expansion|Death|0|||
130615093|NCT01877382|470209082|FG007|Dose Expansion|Death|0|||
130615094|NCT01877382|470209083|FG008|Dose Expansion|Death|0|||
130615095|NCT01877382|470209084|FG009|Dose Expansion|Death|0|||
130615096|NCT01877382|470209085|FG010|Dose Expansion|Death|0|||
130615097|NCT01877382|470209086|FG011|Dose Expansion|Death|0|||
130615098|NCT01877382|470209087|FG012|Dose Expansion|Death|0|||
130615099|NCT01877382|470209088|FG013|Dose Expansion|Death|0|||
130615100|NCT01877382|470209089|FG014|Dose Expansion|Death|1|||
130615101|NCT01877382|470209075|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615102|NCT01877382|470209076|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615103|NCT01877382|470209077|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615104|NCT01877382|470209078|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615105|NCT01877382|470209079|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615106|NCT01877382|470209080|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615107|NCT01877382|470209081|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615108|NCT01877382|470209082|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615109|NCT01877382|470209083|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615110|NCT01877382|470209084|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615111|NCT01877382|470209085|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615112|NCT01877382|470209086|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615113|NCT01877382|470209087|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615114|NCT01877382|470209088|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130615115|NCT01877382|470209089|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130615116|NCT02020031|470210687|FG000|Overall Study|Physician Decision|1|||
130615117|NCT02020031|470210688|FG001|Overall Study|Physician Decision|1|||
130615118|NCT00605722|470210691|FG000|Overall Study|Adverse Event|6|||
130615119|NCT00605722|470210691|FG000|Overall Study|Insufficient therapeutic response|44|||
130615120|NCT00605722|470210691|FG000|Overall Study|Failure to return|1|||
130615121|NCT01626352|470210694|FG000|Overall Study|Disease Progression|3|||
130615122|NCT01626352|470210694|FG000|Overall Study|Intercurrent Illness|2|||
130615123|NCT01626352|470210694|FG000|Overall Study|Death|2|||
130615124|NCT01626352|470210694|FG000|Overall Study|Withdrawal by Subject|1|||
130615125|NCT01626352|470210694|FG000|Overall Study|Non-Compliance|1|||
130615126|NCT01626352|470210694|FG000|Overall Study|Never Treated|1|||
130615127|NCT00111917|470210695|FG000|Overall Study|Withdrawal by Subject|1|||
130615128|NCT00111917|470210696|FG001|Overall Study|Withdrawal by Subject|1|||
130615129|NCT02338492|470210703|FG000|Overall Study|Death|32|||
130615130|NCT02338492|470210703|FG000|Overall Study|Adverse Event|3|||
130615131|NCT02338492|470210703|FG000|Overall Study|Lost to Follow-up|4|||
130615132|NCT02338492|470210703|FG000|Overall Study|Reason not captured above|6|||
130615133|NCT01071096|470210704|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
130615134|NCT01071096|470210705|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
130615135|NCT03421964|470210711|FG000|Overall Study|Lost to Follow-up|11|||
130615136|NCT03421964|470210712|FG001|Overall Study|Lost to Follow-up|21|||
130615137|NCT03421964|470210711|FG000|Overall Study|Withdrawal by Subject|9|||
130615138|NCT03421964|470210712|FG001|Overall Study|Withdrawal by Subject|3|||
130615139|NCT03421964|470210711|FG000|Overall Study|Incarcerated|1|||
130615140|NCT03421964|470210712|FG001|Overall Study|Incarcerated|0|||
130615141|NCT03421964|470210711|FG000|Overall Study|Inpt Treatment Facility|1|||
130615142|NCT03421964|470210712|FG001|Overall Study|Inpt Treatment Facility|1|||
130615143|NCT03421964|470210711|FG000|Overall Study|Virtual Platform Issues|1|||
130615144|NCT03421964|470210712|FG001|Overall Study|Virtual Platform Issues|1|||
130615145|NCT00229203|470210713|FG000|Overall Study|Progressive disease|18|||
130615146|NCT00229203|470210714|FG001|Overall Study|Progressive disease|9|||
130615147|NCT00229203|470210713|FG000|Overall Study|Toxicity|6|||
130615148|NCT00229203|470210714|FG001|Overall Study|Toxicity|1|||
130615149|NCT00229203|470210713|FG000|Overall Study|Death|4|||
130615150|NCT00229203|470210714|FG001|Overall Study|Death|2|||
130615151|NCT00229203|470210713|FG000|Overall Study|Other|3|||
130615152|NCT00229203|470210714|FG001|Overall Study|Other|3|||
130615153|NCT00229203|470210713|FG000|Overall Study|Withdrawal by Subject|1|||
130615154|NCT00229203|470210714|FG001|Overall Study|Withdrawal by Subject|4|||
130615155|NCT03607838|470210715|FG000|Overall Study|Lack of Efficacy|14|||
130615156|NCT03607838|470210716|FG001|Overall Study|Lack of Efficacy|20|||
130615157|NCT03607838|470210715|FG000|Overall Study|Withdrawal by Subject|13|||
130615158|NCT03607838|470210716|FG001|Overall Study|Withdrawal by Subject|8|||
130615159|NCT03607838|470210715|FG000|Overall Study|Lost to Follow-up|6|||
130615160|NCT03607838|470210716|FG001|Overall Study|Lost to Follow-up|11|||
130615161|NCT03607838|470210715|FG000|Overall Study|Adverse Event|2|||
130615162|NCT03607838|470210716|FG001|Overall Study|Adverse Event|2|||
130615163|NCT03607838|470210715|FG000|Overall Study|Physician Decision|2|||
130615164|NCT03607838|470210716|FG001|Overall Study|Physician Decision|0|||
130615165|NCT03607838|470210715|FG000|Overall Study|Failure to meet randomization criteria|1|||
130615166|NCT03607838|470210716|FG001|Overall Study|Failure to meet randomization criteria|2|||
130615167|NCT03607838|470210715|FG000|Overall Study|Pregnancy|1|||
130615168|NCT03607838|470210716|FG001|Overall Study|Pregnancy|0|||
130615169|NCT03607838|470210715|FG000|Overall Study|Protocol Violation|1|||
130615170|NCT03607838|470210716|FG001|Overall Study|Protocol Violation|0|||
130615171|NCT03607838|470210715|FG000|Overall Study|Due to work|1|||
130615172|NCT03607838|470210716|FG001|Overall Study|Due to work|0|||
130615173|NCT03607838|470210715|FG000|Overall Study|Litigation|0|||
130615174|NCT03607838|470210716|FG001|Overall Study|Litigation|1|||
130615175|NCT03607838|470210715|FG000|Overall Study|Temperature excursion for study drug|0|||
130615176|NCT03607838|470210716|FG001|Overall Study|Temperature excursion for study drug|1|||
130615177|NCT03607838|470210715|FG000|Overall Study|Change of mind|0|||
130615178|NCT03607838|470210716|FG001|Overall Study|Change of mind|1|||
130615179|NCT02411201|470210717|FG000|Overall Study|Adverse Event|2|||
130615180|NCT02411201|470210717|FG000|Overall Study|Withdrawal by Subject|2|||
130615181|NCT02411201|470210717|FG000|Overall Study|Age group completed|2|||
130615182|NCT01260467|470210718|FG000|Overall Study|Withdrawal by Subject|2|||
130615183|NCT03364608|470210727|FG000|Overall Study|Withdrawal by Subject|4|||
130615184|NCT03364608|470210727|FG000|Overall Study|Protocol Violation|2|||
130615185|NCT03364608|470210727|FG000|Overall Study|Lost to Follow-up|2|||
130615186|NCT02546674|470210730|FG000|Overall Study|Adverse Event|19|||
130615187|NCT02546674|470210730|FG000|Overall Study|Death|1|||
130615188|NCT02546674|470210730|FG000|Overall Study|Lost to Follow-up|1|||
130615189|NCT02546674|470210730|FG000|Overall Study|Physician Decision|13|||
130615190|NCT02546674|470210730|FG000|Overall Study|Pregnancy|1|||
130615191|NCT02546674|470210730|FG000|Overall Study|Progressive Disease|2|||
130615192|NCT02546674|470210730|FG000|Overall Study|Protocol Deviation|2|||
130615193|NCT02546674|470210730|FG000|Overall Study|Subject/Guardian Decision|6|||
130615194|NCT02546674|470210730|FG000|Overall Study|Withdrawal of Informed Consent|3|||
130615195|NCT03888391|470210733|FG000|Overall Study|Lost to Follow-up|15|||
130615196|NCT00423735|470210734|FG000|Overall Study|Ineligible / No protocol treatment|8|||
130615197|NCT00423735|470210735|FG001|Overall Study|Ineligible / No protocol treatment|6|||
130615198|NCT00423735|470210736|FG002|Overall Study|Ineligible / No protocol treatment|0|||
130615199|NCT02864940|470210739|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
130615200|NCT02864940|470210740|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
130615201|NCT00579501|470210745|FG000|Overall Study|Death|1|||
130615202|NCT00579501|470210745|FG000|Overall Study|End of neoadjuvant therapy|25|||
130615203|NCT00579501|470210745|FG000|Overall Study|toxicity|1|||
130615204|NCT00579501|470210745|FG000|Overall Study|Secondary lesion|1|||
130615205|NCT00579501|470210745|FG000|Overall Study|Radiation therapy before surgery|1|||
130615206|NCT03364673|470210746|FG000|Overall Study|Withdrawal by Subject|2|||
130615207|NCT03364673|470210746|FG000|Overall Study|Injury unrelated to study|3|||
130615208|NCT02232087|470210747|FG000|Overall Study|Withdrawal by Subject|2|||
130615209|NCT02232087|470210748|FG001|Overall Study|Withdrawal by Subject|0|||
130615210|NCT02232087|470210749|FG002|Overall Study|Withdrawal by Subject|0|||
130615211|NCT02232087|470210750|FG003|Overall Study|Withdrawal by Subject|0|||
130615212|NCT02232087|470210751|FG004|Overall Study|Withdrawal by Subject|0|||
130615213|NCT02232087|470210752|FG005|Overall Study|Withdrawal by Subject|1|||
130615214|NCT02232087|470210747|FG000|Overall Study|poor inhalation technique|0|||
130615215|NCT02232087|470210748|FG001|Overall Study|poor inhalation technique|1|||
130615216|NCT02232087|470210749|FG002|Overall Study|poor inhalation technique|0|||
130615217|NCT02232087|470210750|FG003|Overall Study|poor inhalation technique|0|||
130615218|NCT02232087|470210751|FG004|Overall Study|poor inhalation technique|0|||
130615219|NCT02232087|470210752|FG005|Overall Study|poor inhalation technique|2|||
130615220|NCT02232087|470210747|FG000|Overall Study|protocol stop criteria|0|||
130615221|NCT02232087|470210748|FG001|Overall Study|protocol stop criteria|1|||
130615222|NCT02232087|470210749|FG002|Overall Study|protocol stop criteria|0|||
130615223|NCT02232087|470210750|FG003|Overall Study|protocol stop criteria|1|||
130615224|NCT02232087|470210751|FG004|Overall Study|protocol stop criteria|0|||
130615225|NCT02232087|470210752|FG005|Overall Study|protocol stop criteria|0|||
130615226|NCT02232087|470210747|FG000|Overall Study|Adverse Event|0|||
130615227|NCT02232087|470210748|FG001|Overall Study|Adverse Event|0|||
130615228|NCT02232087|470210749|FG002|Overall Study|Adverse Event|0|||
130615229|NCT02232087|470210750|FG003|Overall Study|Adverse Event|0|||
130615230|NCT02232087|470210751|FG004|Overall Study|Adverse Event|1|||
130615231|NCT02232087|470210752|FG005|Overall Study|Adverse Event|0|||
130615232|NCT03025217|470210753|FG000|Overall Study|Pregnancy|1|||
130615233|NCT03025217|470210753|FG000|Overall Study|Lost to Follow-up|1|||
130615234|NCT03025217|470210753|FG000|Overall Study|Not eligible, poor English|2|||
130615235|NCT04069156|470210754|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
130615236|NCT04069156|470210755|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
130615237|NCT04069156|470210754|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
130615238|NCT04069156|470210755|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
130615239|NCT04069156|470210754|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
130615240|NCT04069156|470210755|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
130615241|NCT04069156|470210754|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
130615242|NCT04069156|470210755|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
130615243|NCT02208024|470210756|FG000|Overall Study|Withdrawal by Subject|1|||
130615244|NCT04804033|470210759|FG000|Period 1: DBT Phase|Adverse Event|1|||
130615245|NCT04804033|470210760|FG001|Period 1: DBT Phase|Adverse Event|5|||
130615246|NCT04804033|470210761|FG002|Period 1: DBT Phase|Adverse Event|3|||
130615247|NCT04804033|470210762|FG003|Period 1: DBT Phase|Adverse Event|4|||
130615248|NCT04804033|470210759|FG000|Period 1: DBT Phase|Death|1|||
130615249|NCT04804033|470210760|FG001|Period 1: DBT Phase|Death|0|||
130615250|NCT04804033|470210761|FG002|Period 1: DBT Phase|Death|0|||
130615251|NCT04804033|470210762|FG003|Period 1: DBT Phase|Death|0|||
130615252|NCT04804033|470210759|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
130615253|NCT04804033|470210760|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
130615254|NCT04804033|470210761|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
130615255|NCT04804033|470210762|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
130615256|NCT04804033|470210759|FG000|Period 1: DBT Phase|Non-compliance|1|||
130615257|NCT04804033|470210760|FG001|Period 1: DBT Phase|Non-compliance|0|||
130615258|NCT04804033|470210761|FG002|Period 1: DBT Phase|Non-compliance|1|||
130615259|NCT04804033|470210762|FG003|Period 1: DBT Phase|Non-compliance|2|||
130615260|NCT04804033|470210759|FG000|Period 1: DBT Phase|Other|0|||
130615261|NCT04804033|470210760|FG001|Period 1: DBT Phase|Other|1|||
130615262|NCT04804033|470210761|FG002|Period 1: DBT Phase|Other|0|||
130615263|NCT04804033|470210762|FG003|Period 1: DBT Phase|Other|0|||
130615264|NCT04804033|470210759|FG000|Period 1: DBT Phase|Pregnancy|2|||
130615265|NCT04804033|470210760|FG001|Period 1: DBT Phase|Pregnancy|0|||
130615266|NCT04804033|470210761|FG002|Period 1: DBT Phase|Pregnancy|0|||
130615267|NCT04804033|470210762|FG003|Period 1: DBT Phase|Pregnancy|0|||
130615268|NCT04804033|470210759|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
130615269|NCT04804033|470210760|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
130615270|NCT04804033|470210761|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
130615271|NCT04804033|470210762|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
130615272|NCT04804033|470210759|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
130615273|NCT04804033|470210760|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
130615274|NCT04804033|470210761|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
130615275|NCT04804033|470210762|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
130615276|NCT04804033|470210759|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
130615277|NCT04804033|470210760|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
130615278|NCT04804033|470210761|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
130615279|NCT04804033|470210762|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
130615280|NCT04804033|470210759|FG000|Period 2: OLE Phase|Adverse Event|3|||
130615281|NCT04804033|470210760|FG001|Period 2: OLE Phase|Adverse Event|4|||
130615282|NCT04804033|470210761|FG002|Period 2: OLE Phase|Adverse Event|2|||
130615283|NCT04804033|470210762|FG003|Period 2: OLE Phase|Adverse Event|0|||
130615284|NCT04804033|470210759|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
130615285|NCT04804033|470210760|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
130615286|NCT04804033|470210761|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
130615287|NCT04804033|470210762|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
130615288|NCT04804033|470210759|FG000|Period 2: OLE Phase|Non-compliance|2|||
130615289|NCT04804033|470210760|FG001|Period 2: OLE Phase|Non-compliance|2|||
130615290|NCT04804033|470210761|FG002|Period 2: OLE Phase|Non-compliance|0|||
130615291|NCT04804033|470210762|FG003|Period 2: OLE Phase|Non-compliance|1|||
130615292|NCT04804033|470210759|FG000|Period 2: OLE Phase|Other|0|||
130615293|NCT04804033|470210760|FG001|Period 2: OLE Phase|Other|2|||
130615294|NCT04804033|470210761|FG002|Period 2: OLE Phase|Other|0|||
130615295|NCT04804033|470210762|FG003|Period 2: OLE Phase|Other|0|||
130615296|NCT04804033|470210759|FG000|Period 2: OLE Phase|Physician Decision|1|||
130615297|NCT04804033|470210760|FG001|Period 2: OLE Phase|Physician Decision|1|||
130615298|NCT04804033|470210761|FG002|Period 2: OLE Phase|Physician Decision|0|||
130615299|NCT04804033|470210762|FG003|Period 2: OLE Phase|Physician Decision|0|||
130615300|NCT04804033|470210759|FG000|Period 2: OLE Phase|Pregnancy|0|||
130615301|NCT04804033|470210760|FG001|Period 2: OLE Phase|Pregnancy|0|||
130615302|NCT04804033|470210761|FG002|Period 2: OLE Phase|Pregnancy|2|||
130615303|NCT04804033|470210762|FG003|Period 2: OLE Phase|Pregnancy|0|||
130615304|NCT04804033|470210759|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
130615305|NCT04804033|470210760|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
130615306|NCT04804033|470210761|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
130615307|NCT04804033|470210762|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
130615308|NCT04804033|470210759|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
130615309|NCT04804033|470210760|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
130615310|NCT04804033|470210761|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
130615311|NCT04804033|470210762|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
130615312|NCT04804033|470210759|FG000|Period 2: OLE Phase|Not reported|0|||
130615313|NCT04804033|470210760|FG001|Period 2: OLE Phase|Not reported|2|||
130615314|NCT04804033|470210761|FG002|Period 2: OLE Phase|Not reported|0|||
130615315|NCT04804033|470210762|FG003|Period 2: OLE Phase|Not reported|0|||
130615316|NCT04804033|470210759|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
130615317|NCT04804033|470210760|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
130615318|NCT04804033|470210761|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
130615319|NCT04804033|470210762|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
130615320|NCT04804033|470210759|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
130615321|NCT04804033|470210760|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
130615322|NCT04804033|470210761|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
130615323|NCT04804033|470210762|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
130615324|NCT04804033|470210759|FG000|Period 3: Follow-up Phase|Other|0|||
130615325|NCT04804033|470210760|FG001|Period 3: Follow-up Phase|Other|1|||
130615326|NCT04804033|470210761|FG002|Period 3: Follow-up Phase|Other|2|||
130615327|NCT04804033|470210762|FG003|Period 3: Follow-up Phase|Other|1|||
130615328|NCT04804033|470210759|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
130615329|NCT04804033|470210760|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
130615330|NCT04804033|470210761|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
130615331|NCT04804033|470210762|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
130615332|NCT04804033|470210759|FG000|Period 3: Follow-up Phase|Not reported|18|||
130615333|NCT04804033|470210760|FG001|Period 3: Follow-up Phase|Not reported|15|||
130615334|NCT04804033|470210761|FG002|Period 3: Follow-up Phase|Not reported|1|||
130615335|NCT04804033|470210762|FG003|Period 3: Follow-up Phase|Not reported|4|||
130615336|NCT00209170|470210763|FG000|Overall Study|Adverse Event|0|||
130615337|NCT00209170|470210764|FG001|Overall Study|Adverse Event|1|||
130615338|NCT00209170|470210763|FG000|Overall Study|Withdrawal by Subject|2|||
130615339|NCT00209170|470210764|FG001|Overall Study|Withdrawal by Subject|1|||
130615340|NCT00209170|470210763|FG000|Overall Study|Lack of Efficacy|0|||
130615341|NCT00209170|470210764|FG001|Overall Study|Lack of Efficacy|1|||
130615342|NCT00543569|470210765|FG000|Overall Study|Death|2|||
130615343|NCT00543569|470210766|FG001|Overall Study|Death|2|||
130615344|NCT00543569|470210767|FG002|Overall Study|Death|3|||
130615345|NCT00543569|470210768|FG003|Overall Study|Death|1|||
130615346|NCT00543569|470210765|FG000|Overall Study|Lost to Follow-up|0|||
130615347|NCT00543569|470210766|FG001|Overall Study|Lost to Follow-up|0|||
130615348|NCT00543569|470210767|FG002|Overall Study|Lost to Follow-up|1|||
130615349|NCT00543569|470210768|FG003|Overall Study|Lost to Follow-up|1|||
130615350|NCT00543569|470210765|FG000|Overall Study|Miscellaneous Reasons|7|||
130615351|NCT00543569|470210766|FG001|Overall Study|Miscellaneous Reasons|3|||
130615352|NCT00543569|470210767|FG002|Overall Study|Miscellaneous Reasons|11|||
130615353|NCT00543569|470210768|FG003|Overall Study|Miscellaneous Reasons|4|||
130615354|NCT00543569|470210765|FG000|Overall Study|Randomized but never received study drug|3|||
130615355|NCT00543569|470210766|FG001|Overall Study|Randomized but never received study drug|3|||
130615356|NCT00543569|470210767|FG002|Overall Study|Randomized but never received study drug|5|||
130615357|NCT00543569|470210768|FG003|Overall Study|Randomized but never received study drug|3|||
130615358|NCT03150095|470210770|FG000|Overall Study|Death|0|||
130615359|NCT03150095|470210771|FG001|Overall Study|Death|1|||
130615360|NCT03150095|470210770|FG000|Overall Study|Lost to Follow-up|1|||
130615361|NCT03150095|470210771|FG001|Overall Study|Lost to Follow-up|1|||
130615362|NCT03150095|470210770|FG000|Overall Study|Withdrawal by Subject|4|||
130615363|NCT03150095|470210771|FG001|Overall Study|Withdrawal by Subject|0|||
130615364|NCT03150095|470210770|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
130615365|NCT03150095|470210771|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
130615366|NCT02124707|470210772|FG000|Overall Study|Adverse Event|5|||
130615367|NCT02124707|470210772|FG000|Overall Study|Physician Decision|1|||
130615368|NCT02124707|470210772|FG000|Overall Study|Death|1|||
130615369|NCT01088438|470210781|FG000|Overall Study|Withdrawal by Subject|11|||
130615370|NCT01088438|470210782|FG001|Overall Study|Withdrawal by Subject|6|||
130615371|NCT01088438|470210781|FG000|Overall Study|Lost to Follow-up|18|||
130615372|NCT01088438|470210782|FG001|Overall Study|Lost to Follow-up|30|||
130615373|NCT00511342|470210783|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
130615374|NCT00511342|470210784|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
130615375|NCT00511342|470210783|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
130615376|NCT00511342|470210784|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
130615377|NCT00511342|470210783|FG000|Overall Study|Pregnancy|0|||
130615378|NCT00511342|470210784|FG001|Overall Study|Pregnancy|1|||
130615379|NCT00511342|470210783|FG000|Overall Study|Pregnancy wish|0|||
130615380|NCT00511342|470210784|FG001|Overall Study|Pregnancy wish|1|||
130615381|NCT00511342|470210783|FG000|Overall Study|Lost to Follow-up|1|||
130615382|NCT00511342|470210784|FG001|Overall Study|Lost to Follow-up|5|||
130615383|NCT00511342|470210783|FG000|Overall Study|Other Reason|2|||
130615384|NCT00511342|470210784|FG001|Overall Study|Other Reason|2|||
130615385|NCT03198754|470210786|FG000|Overall Study|Withdrawal by Subject|5|||
130615386|NCT03198754|470210787|FG001|Overall Study|Withdrawal by Subject|4|||
130615387|NCT03198754|470210786|FG000|Overall Study|Lost to Follow-up|4|||
130615388|NCT03198754|470210787|FG001|Overall Study|Lost to Follow-up|3|||
130615389|NCT03198754|470210786|FG000|Overall Study|Ineligible|2|||
130615390|NCT03198754|470210787|FG001|Overall Study|Ineligible|1|||
130615391|NCT00421343|470210792|FG000|Overall Study|Death|1|||
130615392|NCT00421343|470210792|FG000|Overall Study|Withdrawal by Subject|2|||
130615393|NCT00421343|470210792|FG000|Overall Study|Lost to Follow-up|3|||
130615394|NCT01479374|470210797|FG000|Overall Study|Adverse Event|2|||
130615395|NCT01479374|470210798|FG001|Overall Study|Adverse Event|1|||
130615396|NCT01479374|470210799|FG002|Overall Study|Adverse Event|0|||
130615397|NCT01479374|470210797|FG000|Overall Study|Lost to Follow-up|1|||
130615398|NCT01479374|470210798|FG001|Overall Study|Lost to Follow-up|2|||
130615399|NCT01479374|470210799|FG002|Overall Study|Lost to Follow-up|0|||
130615400|NCT01479374|470210797|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
130615401|NCT01479374|470210798|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
130615402|NCT01479374|470210799|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
130615403|NCT01479374|470210797|FG000|Overall Study|Other|0|||
130615404|NCT01479374|470210798|FG001|Overall Study|Other|4|||
130615405|NCT01479374|470210799|FG002|Overall Study|Other|5|||
130615406|NCT01606761|470210800|FG000|Prior to Week 24|Lost to Follow-up|0|||
130615407|NCT01606761|470210801|FG001|Prior to Week 24|Lost to Follow-up|3|||
130615408|NCT01606761|470210802|FG002|Prior to Week 24|Lost to Follow-up|2|||
130615409|NCT01606761|470210803|FG003|Prior to Week 24|Lost to Follow-up|0|||
130615410|NCT01606761|470210804|FG004|Prior to Week 24|Lost to Follow-up|0|||
130615411|NCT01606761|470210800|FG000|Prior to Week 24|Withdrawal by Subject|12|||
130615412|NCT01606761|470210801|FG001|Prior to Week 24|Withdrawal by Subject|10|||
130615413|NCT01606761|470210802|FG002|Prior to Week 24|Withdrawal by Subject|9|||
130615414|NCT01606761|470210803|FG003|Prior to Week 24|Withdrawal by Subject|0|||
130615415|NCT01606761|470210804|FG004|Prior to Week 24|Withdrawal by Subject|0|||
130615416|NCT01606761|470210800|FG000|Prior to Week 24|Adverse Event|11|||
130615417|NCT01606761|470210801|FG001|Prior to Week 24|Adverse Event|18|||
130615418|NCT01606761|470210802|FG002|Prior to Week 24|Adverse Event|22|||
130615419|NCT01606761|470210803|FG003|Prior to Week 24|Adverse Event|0|||
130615420|NCT01606761|470210804|FG004|Prior to Week 24|Adverse Event|0|||
130615421|NCT01606761|470210800|FG000|Prior to Week 24|Lack of Efficacy|15|||
130615422|NCT01606761|470210801|FG001|Prior to Week 24|Lack of Efficacy|14|||
130615423|NCT01606761|470210802|FG002|Prior to Week 24|Lack of Efficacy|8|||
130615424|NCT01606761|470210803|FG003|Prior to Week 24|Lack of Efficacy|0|||
130615425|NCT01606761|470210804|FG004|Prior to Week 24|Lack of Efficacy|0|||
130615426|NCT01606761|470210800|FG000|Prior to Week 24|Physician Decision|0|||
130615427|NCT01606761|470210801|FG001|Prior to Week 24|Physician Decision|3|||
130615428|NCT01606761|470210802|FG002|Prior to Week 24|Physician Decision|1|||
130615429|NCT01606761|470210803|FG003|Prior to Week 24|Physician Decision|0|||
130615430|NCT01606761|470210804|FG004|Prior to Week 24|Physician Decision|0|||
130615431|NCT01606761|470210800|FG000|Prior to Week 24|Other|4|||
130615432|NCT01606761|470210801|FG001|Prior to Week 24|Other|7|||
130615433|NCT01606761|470210802|FG002|Prior to Week 24|Other|5|||
130615434|NCT01606761|470210803|FG003|Prior to Week 24|Other|0|||
130615435|NCT01606761|470210804|FG004|Prior to Week 24|Other|0|||
130615436|NCT01606761|470210800|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
130615437|NCT01606761|470210801|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
130615438|NCT01606761|470210802|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
130615439|NCT01606761|470210803|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
130615440|NCT01606761|470210804|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
130615441|NCT01606761|470210800|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
130615442|NCT01606761|470210801|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
130615443|NCT01606761|470210802|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
130615444|NCT01606761|470210803|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
130615445|NCT01606761|470210804|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
130615446|NCT01606761|470210800|FG000|Week 24 to Week 52|Adverse Event|0|||
130615447|NCT01606761|470210801|FG001|Week 24 to Week 52|Adverse Event|11|||
130615448|NCT01606761|470210802|FG002|Week 24 to Week 52|Adverse Event|14|||
130615449|NCT01606761|470210803|FG003|Week 24 to Week 52|Adverse Event|3|||
130615450|NCT01606761|470210804|FG004|Week 24 to Week 52|Adverse Event|15|||
130615451|NCT01606761|470210800|FG000|Week 24 to Week 52|Death|0|||
130615452|NCT01606761|470210801|FG001|Week 24 to Week 52|Death|0|||
130615453|NCT01606761|470210802|FG002|Week 24 to Week 52|Death|2|||
130615454|NCT01606761|470210803|FG003|Week 24 to Week 52|Death|1|||
130615455|NCT01606761|470210804|FG004|Week 24 to Week 52|Death|0|||
130615456|NCT01606761|470210800|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
130615457|NCT01606761|470210801|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
130615458|NCT01606761|470210802|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
130615459|NCT01606761|470210803|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
130615460|NCT01606761|470210804|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
130615461|NCT01606761|470210800|FG000|Week 24 to Week 52|Physician Decision|0|||
130615462|NCT01606761|470210801|FG001|Week 24 to Week 52|Physician Decision|1|||
130615463|NCT01606761|470210802|FG002|Week 24 to Week 52|Physician Decision|1|||
130615464|NCT01606761|470210803|FG003|Week 24 to Week 52|Physician Decision|0|||
130615465|NCT01606761|470210804|FG004|Week 24 to Week 52|Physician Decision|0|||
130615466|NCT01606761|470210800|FG000|Week 24 to Week 52|Other|0|||
130615467|NCT01606761|470210801|FG001|Week 24 to Week 52|Other|1|||
130615468|NCT01606761|470210802|FG002|Week 24 to Week 52|Other|5|||
130615469|NCT01606761|470210803|FG003|Week 24 to Week 52|Other|2|||
130615470|NCT01606761|470210804|FG004|Week 24 to Week 52|Other|2|||
130615471|NCT01606761|470210800|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
130615472|NCT01606761|470210801|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
130615473|NCT01606761|470210802|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
130615474|NCT01606761|470210803|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
130615475|NCT01606761|470210804|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
130615476|NCT01606761|470210800|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
130615477|NCT01606761|470210801|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
130615478|NCT01606761|470210802|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
130615479|NCT01606761|470210803|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
130615480|NCT01606761|470210804|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
130615481|NCT01606761|470210800|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
130615482|NCT01606761|470210801|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
130615483|NCT01606761|470210802|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
130615484|NCT01606761|470210803|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
130615485|NCT01606761|470210804|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
130615486|NCT01606761|470210800|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
130615487|NCT01606761|470210801|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
130615488|NCT01606761|470210802|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
130615489|NCT01606761|470210803|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
130615490|NCT01606761|470210804|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
130615491|NCT05086289|470210805|FG000|Overall Study|Adverse Event|4|||
130615492|NCT05086289|470210806|FG001|Overall Study|Adverse Event|2|||
130615493|NCT05086289|470210805|FG000|Overall Study|Lost to Follow-up|2|||
130615494|NCT05086289|470210806|FG001|Overall Study|Lost to Follow-up|0|||
130615495|NCT05086289|470210805|FG000|Overall Study|Non-compliance with study drug|2|||
130615496|NCT05086289|470210806|FG001|Overall Study|Non-compliance with study drug|1|||
130615497|NCT05086289|470210805|FG000|Overall Study|Physician Decision|2|||
130615498|NCT05086289|470210806|FG001|Overall Study|Physician Decision|0|||
130615499|NCT05086289|470210805|FG000|Overall Study|Withdrawal by Subject|5|||
130615500|NCT05086289|470210806|FG001|Overall Study|Withdrawal by Subject|2|||
130615501|NCT01996748|470210807|FG000|Overall Study|Personal reason|1|||
130615502|NCT01996748|470210808|FG001|Overall Study|Personal reason|0|||
130615503|NCT01996748|470210807|FG000|Overall Study|Physician Decision|2|||
130615504|NCT01996748|470210808|FG001|Overall Study|Physician Decision|0|||
130615505|NCT01996748|470210807|FG000|Overall Study|Adverse Event|1|||
130615506|NCT01996748|470210808|FG001|Overall Study|Adverse Event|4|||
130615507|NCT01996748|470210807|FG000|Overall Study|Withdrawal by Subject|0|||
130615508|NCT01996748|470210808|FG001|Overall Study|Withdrawal by Subject|1|||
130615509|NCT01996748|470210807|FG000|Overall Study|Lost to Follow-up|4|||
130615510|NCT01996748|470210808|FG001|Overall Study|Lost to Follow-up|1|||
130615511|NCT03599141|470210814|FG000|Overall Study|Lost to Follow-up|3|||
130615512|NCT03599141|470210815|FG001|Overall Study|Lost to Follow-up|1|||
130615513|NCT01165021|470210816|FG000|Overall Study|Death|1|||
130615514|NCT01419665|470210817|FG000|Combination Treatment|Adverse Event|7|||
130615515|NCT01419665|470210818|FG001|Combination Treatment|Adverse Event|10|||
130615516|NCT01419665|470210817|FG000|Combination Treatment|Physician Decision|5|||
130615517|NCT01419665|470210818|FG001|Combination Treatment|Physician Decision|8|||
130615518|NCT01419665|470210817|FG000|Combination Treatment|Protocol Violation|6|||
130615519|NCT01419665|470210818|FG001|Combination Treatment|Protocol Violation|2|||
130615520|NCT01419665|470210817|FG000|Combination Treatment|disease progression|10|||
130615521|NCT01419665|470210818|FG001|Combination Treatment|disease progression|9|||
130615522|NCT01419665|470210817|FG000|Combination Treatment|Death|5|||
130615523|NCT01419665|470210818|FG001|Combination Treatment|Death|7|||
130615524|NCT01419665|470210817|FG000|Combination Treatment|administrative problems|0|||
130615525|NCT01419665|470210818|FG001|Combination Treatment|administrative problems|1|||
130615526|NCT01419665|470210817|FG000|Combination Treatment|Withdrawal by Subject|5|||
130615527|NCT01419665|470210818|FG001|Combination Treatment|Withdrawal by Subject|4|||
130615528|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
130615529|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
130615530|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
130615531|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
130615532|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
130615533|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
130615534|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
130615535|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
130615536|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
130615537|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
130615538|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
130615539|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
130615540|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Death|1|||
130615541|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Death|2|||
130615542|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
130615543|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
130615544|NCT01419665|470210817|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
130615545|NCT01419665|470210818|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
130615546|NCT01419665|470210817|FG000|Open Label Phase|Death|1|||
130615547|NCT01419665|470210818|FG001|Open Label Phase|Death|0|||
130615548|NCT01419665|470210817|FG000|Open Label Phase|disease progression|0|||
130615549|NCT01419665|470210818|FG001|Open Label Phase|disease progression|1|||
130615550|NCT02998554|470210824|FG000|Overall Study|Adverse Event|8|||
130615551|NCT02998554|470210825|FG001|Overall Study|Adverse Event|3|||
130615552|NCT02998554|470210824|FG000|Overall Study|Protocol deviation|1|||
130615553|NCT02998554|470210825|FG001|Overall Study|Protocol deviation|0|||
130615554|NCT02998554|470210824|FG000|Overall Study|Withdrawal by Subject|2|||
130615555|NCT02998554|470210825|FG001|Overall Study|Withdrawal by Subject|6|||
130615556|NCT02998554|470210824|FG000|Overall Study|Lost to Follow-up|0|||
130615557|NCT02998554|470210825|FG001|Overall Study|Lost to Follow-up|1|||
130615558|NCT02998554|470210824|FG000|Overall Study|Lack of Efficacy|0|||
130615559|NCT02998554|470210825|FG001|Overall Study|Lack of Efficacy|1|||
130615560|NCT01752842|470210826|FG000|Overall Study|Adverse Event|3|||
130615561|NCT01752842|470210827|FG001|Overall Study|Adverse Event|0|||
130615562|NCT01752842|470210826|FG000|Overall Study|Withdrawal by Subject|0|||
130615563|NCT01752842|470210827|FG001|Overall Study|Withdrawal by Subject|2|||
130615564|NCT01683071|470210828|FG000|Part 1|Lack of Efficacy|1|||
130615565|NCT01683071|470210829|FG001|Part 1|Lack of Efficacy|0|||
130615566|NCT01683071|470210830|FG002|Part 1|Lack of Efficacy|0|||
130615567|NCT01683071|470210831|FG003|Part 1|Lack of Efficacy|3|||
130615568|NCT01683071|470210832|FG004|Part 1|Lack of Efficacy|0|||
130615569|NCT01683071|470210833|FG005|Part 1|Lack of Efficacy|0|||
130615570|NCT01683071|470210828|FG000|Part 1|Withdrawal by Subject|1|||
130615571|NCT01683071|470210829|FG001|Part 1|Withdrawal by Subject|2|||
130615572|NCT01683071|470210830|FG002|Part 1|Withdrawal by Subject|2|||
130615573|NCT01683071|470210831|FG003|Part 1|Withdrawal by Subject|1|||
130615574|NCT01683071|470210832|FG004|Part 1|Withdrawal by Subject|0|||
130615575|NCT01683071|470210833|FG005|Part 1|Withdrawal by Subject|0|||
130615576|NCT01683071|470210828|FG000|Part 1|Surgery Cancelled|1|||
130615577|NCT01683071|470210829|FG001|Part 1|Surgery Cancelled|0|||
130615578|NCT01683071|470210830|FG002|Part 1|Surgery Cancelled|0|||
130615579|NCT01683071|470210831|FG003|Part 1|Surgery Cancelled|0|||
130615580|NCT01683071|470210832|FG004|Part 1|Surgery Cancelled|0|||
130615581|NCT01683071|470210833|FG005|Part 1|Surgery Cancelled|0|||
130615582|NCT01683071|470210828|FG000|Part 1|Did not receive study drug|1|||
130615583|NCT01683071|470210829|FG001|Part 1|Did not receive study drug|0|||
130615584|NCT01683071|470210830|FG002|Part 1|Did not receive study drug|0|||
130615585|NCT01683071|470210831|FG003|Part 1|Did not receive study drug|1|||
130615586|NCT01683071|470210832|FG004|Part 1|Did not receive study drug|0|||
130615587|NCT01683071|470210833|FG005|Part 1|Did not receive study drug|0|||
130615588|NCT01683071|470210828|FG000|Part 1|Early termination; met exclusion criteria|0|||
130615589|NCT01683071|470210829|FG001|Part 1|Early termination; met exclusion criteria|2|||
130615590|NCT01683071|470210830|FG002|Part 1|Early termination; met exclusion criteria|1|||
130615591|NCT01683071|470210831|FG003|Part 1|Early termination; met exclusion criteria|0|||
130615592|NCT01683071|470210832|FG004|Part 1|Early termination; met exclusion criteria|0|||
130615593|NCT01683071|470210833|FG005|Part 1|Early termination; met exclusion criteria|0|||
130615594|NCT01683071|470210828|FG000|Part 2|Lack of Efficacy|0|||
130615595|NCT01683071|470210829|FG001|Part 2|Lack of Efficacy|0|||
130615596|NCT01683071|470210830|FG002|Part 2|Lack of Efficacy|0|||
130615597|NCT01683071|470210831|FG003|Part 2|Lack of Efficacy|0|||
130615598|NCT01683071|470210832|FG004|Part 2|Lack of Efficacy|3|||
130615599|NCT01683071|470210833|FG005|Part 2|Lack of Efficacy|4|||
130615600|NCT01683071|470210828|FG000|Part 2|Lost to Follow-up|0|||
130615601|NCT01683071|470210829|FG001|Part 2|Lost to Follow-up|0|||
130615602|NCT01683071|470210830|FG002|Part 2|Lost to Follow-up|0|||
130615603|NCT01683071|470210831|FG003|Part 2|Lost to Follow-up|0|||
130615604|NCT01683071|470210832|FG004|Part 2|Lost to Follow-up|2|||
130615605|NCT01683071|470210833|FG005|Part 2|Lost to Follow-up|0|||
130615606|NCT01683071|470210828|FG000|Part 2|Withdrawal by Subject|0|||
130615607|NCT01683071|470210829|FG001|Part 2|Withdrawal by Subject|0|||
130615608|NCT01683071|470210830|FG002|Part 2|Withdrawal by Subject|0|||
130615609|NCT01683071|470210831|FG003|Part 2|Withdrawal by Subject|0|||
130615610|NCT01683071|470210832|FG004|Part 2|Withdrawal by Subject|3|||
130615611|NCT01683071|470210833|FG005|Part 2|Withdrawal by Subject|3|||
130615612|NCT01683071|470210828|FG000|Part 2|Surgery cancelled|0|||
130615613|NCT01683071|470210829|FG001|Part 2|Surgery cancelled|0|||
130615614|NCT01683071|470210830|FG002|Part 2|Surgery cancelled|0|||
130615615|NCT01683071|470210831|FG003|Part 2|Surgery cancelled|0|||
130615616|NCT01683071|470210832|FG004|Part 2|Surgery cancelled|4|||
130615617|NCT01683071|470210833|FG005|Part 2|Surgery cancelled|2|||
130615618|NCT01683071|470210828|FG000|Part 2|Did not receive study drug|0|||
130615619|NCT01683071|470210829|FG001|Part 2|Did not receive study drug|0|||
130615620|NCT01683071|470210830|FG002|Part 2|Did not receive study drug|0|||
130615621|NCT01683071|470210831|FG003|Part 2|Did not receive study drug|0|||
130615622|NCT01683071|470210832|FG004|Part 2|Did not receive study drug|2|||
130615623|NCT01683071|470210833|FG005|Part 2|Did not receive study drug|1|||
130615624|NCT01683071|470210828|FG000|Part 2|Met exclusion criterion|0|||
130615625|NCT01683071|470210829|FG001|Part 2|Met exclusion criterion|0|||
130615626|NCT01683071|470210830|FG002|Part 2|Met exclusion criterion|0|||
130615627|NCT01683071|470210831|FG003|Part 2|Met exclusion criterion|0|||
130615628|NCT01683071|470210832|FG004|Part 2|Met exclusion criterion|1|||
130615629|NCT01683071|470210833|FG005|Part 2|Met exclusion criterion|1|||
130615630|NCT01683071|470210828|FG000|Part 2|Protocol deviation|0|||
130615631|NCT01683071|470210829|FG001|Part 2|Protocol deviation|0|||
130615632|NCT01683071|470210830|FG002|Part 2|Protocol deviation|0|||
130615633|NCT01683071|470210831|FG003|Part 2|Protocol deviation|0|||
130615634|NCT01683071|470210832|FG004|Part 2|Protocol deviation|1|||
130615635|NCT01683071|470210833|FG005|Part 2|Protocol deviation|2|||
130615636|NCT01683071|470210828|FG000|Part 2|Withdrawal by investigator decision|0|||
130615637|NCT01683071|470210829|FG001|Part 2|Withdrawal by investigator decision|0|||
130615638|NCT01683071|470210830|FG002|Part 2|Withdrawal by investigator decision|0|||
130615639|NCT01683071|470210831|FG003|Part 2|Withdrawal by investigator decision|0|||
130615640|NCT01683071|470210832|FG004|Part 2|Withdrawal by investigator decision|1|||
130615641|NCT01683071|470210833|FG005|Part 2|Withdrawal by investigator decision|2|||
130615642|NCT01968187|470210837|FG000|Overall Study|Adverse Event|0|||
130615643|NCT01968187|470210838|FG001|Overall Study|Adverse Event|1|||
130615644|NCT01968187|470210837|FG000|Overall Study|Randomized but not treated|1|||
130615645|NCT01968187|470210838|FG001|Overall Study|Randomized but not treated|0|||
130615646|NCT04095286|470210841|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615647|NCT04095286|470210842|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
130615648|NCT04095286|470210843|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615649|NCT04095286|470210844|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615650|NCT04095286|470210845|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615651|NCT04095286|470210846|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615652|NCT04095286|470210841|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
130615653|NCT04095286|470210842|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130615654|NCT04095286|470210843|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130615655|NCT04095286|470210844|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130615656|NCT04095286|470210845|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130615657|NCT04095286|470210846|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130615658|NCT04095286|470210841|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130615659|NCT04095286|470210842|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130615660|NCT04095286|470210843|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
130615661|NCT04095286|470210844|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130615662|NCT04095286|470210845|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130615663|NCT04095286|470210846|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130615664|NCT04095286|470210841|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615665|NCT04095286|470210842|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615666|NCT04095286|470210843|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
130615667|NCT04095286|470210844|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615668|NCT04095286|470210845|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615669|NCT04095286|470210846|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130615670|NCT04095286|470210841|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130615671|NCT04095286|470210842|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130615672|NCT04095286|470210843|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130615673|NCT04095286|470210844|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130615674|NCT04095286|470210845|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
130615675|NCT04095286|470210846|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130615676|NCT04092816|470212911|FG000|Overall Study|Lost to Follow-up|1|||
130615677|NCT04092816|470212912|FG001|Overall Study|Lost to Follow-up|2|||
130615678|NCT02115113|470212913|FG000|Participants in Run-in Period|Death|0|||
130615679|NCT02115113|470212914|FG001|Participants in Run-in Period|Death|0|||
130615680|NCT02115113|470212915|FG002|Participants in Run-in Period|Death|1|||
130615681|NCT02115113|470212913|FG000|Participants in Run-in Period|Administrative problems|0|||
130615682|NCT02115113|470212914|FG001|Participants in Run-in Period|Administrative problems|0|||
130615683|NCT02115113|470212915|FG002|Participants in Run-in Period|Administrative problems|1|||
130615684|NCT02115113|470212913|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
130615685|NCT02115113|470212914|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
130615686|NCT02115113|470212915|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
130615687|NCT02115113|470212913|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
130615688|NCT02115113|470212914|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
130615689|NCT02115113|470212915|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
130615690|NCT02115113|470212913|FG000|Participants Randomized|Lost to Follow-up|1|||
130615691|NCT02115113|470212914|FG001|Participants Randomized|Lost to Follow-up|0|||
130615692|NCT02115113|470212915|FG002|Participants Randomized|Lost to Follow-up|0|||
130615693|NCT02115113|470212913|FG000|Participants Randomized|Death|1|||
130615694|NCT02115113|470212914|FG001|Participants Randomized|Death|0|||
130615695|NCT02115113|470212915|FG002|Participants Randomized|Death|0|||
130615696|NCT02395653|470212916|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
130615697|NCT02395653|470212916|FG000|Overall Study|Consent Withdrawn at Screening|1|||
130615698|NCT02395653|470212916|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
130615699|NCT02395653|470212916|FG000|Overall Study|Investigator Decision at Screening|1|||
130615700|NCT02395653|470212916|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
130615701|NCT02395653|470212916|FG000|Overall Study|Withdrawal by Subject|1|||
130615702|NCT02395653|470212916|FG000|Overall Study|Lost to Follow-up|1|||
130615703|NCT00296725|470212920|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
130615704|NCT00296725|470212920|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
130615705|NCT00296725|470212920|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
130615706|NCT02622724|470212921|FG000|Overall Study|Death|51|||
130615707|NCT02622724|470212922|FG001|Overall Study|Death|53|||
130615708|NCT02622724|470212921|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
130615709|NCT02622724|470212922|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
130615710|NCT02622724|470212921|FG000|Overall Study|Early termination of study|38|||
130615711|NCT02622724|470212922|FG001|Overall Study|Early termination of study|43|||
130615712|NCT00487084|470212923|FG000|Overall Study|Did not receive intervention|4|||
130615713|NCT00487084|470212924|FG001|Overall Study|Did not receive intervention|3|||
130615714|NCT00487084|470212925|FG002|Overall Study|Did not receive intervention|5|||
130615715|NCT00356863|470212926|FG000|Overall Study|Death|16|||
130615716|NCT00356863|470212927|FG001|Overall Study|Death|32|||
130615717|NCT00356863|470212926|FG000|Overall Study|Lost to Follow-up|76|||
130615718|NCT00356863|470212927|FG001|Overall Study|Lost to Follow-up|43|||
130615719|NCT00333619|470212928|FG000|Overall Study|Death|12|||
130615720|NCT00333619|470212929|FG001|Overall Study|Death|6|||
130615721|NCT00333619|470212928|FG000|Overall Study|Withdrawal by Subject|6|||
130615722|NCT00333619|470212929|FG001|Overall Study|Withdrawal by Subject|1|||
130615723|NCT00333619|470212928|FG000|Overall Study|Lost to Follow-up|3|||
130615724|NCT00333619|470212929|FG001|Overall Study|Lost to Follow-up|3|||
130615725|NCT02690207|470212936|FG000|Overall Study|Lost to Follow-up|48|||
130615726|NCT02690207|470212936|FG000|Overall Study|Withdrawal by Subject|46|||
130615727|NCT02690207|470212936|FG000|Overall Study|Protocol Violation|2|||
130615728|NCT02690207|470212936|FG000|Overall Study|Serious adverse event|110|||
130615729|NCT02690207|470212936|FG000|Overall Study|Non-serious Adverse Event|18|||
130615730|NCT02690207|470212936|FG000|Overall Study|Migrated/moved from study area|5|||
130615731|NCT02690207|470212936|FG000|Overall Study|Suspected HZ Episode|1|||
130615732|NCT02690207|470212936|FG000|Overall Study|Other reasons for withdrawal|23|||
130615733|NCT03712345|470212939|FG000|Overall Study|Failure to meet randomization criteria|0|||
130615734|NCT03712345|470212940|FG001|Overall Study|Failure to meet randomization criteria|0|||
130615735|NCT03712345|470212941|FG002|Overall Study|Failure to meet randomization criteria|1|||
130615736|NCT02585999|470212942|FG000|Overall Study|Lost to Follow-up|1|||
130615737|NCT02585999|470212942|FG000|Overall Study|Protocol Violation|1|||
130615738|NCT00485589|470212943|FG000|Overall Study|Death|2|||
130615739|NCT00485589|470212944|FG001|Overall Study|Death|2|||
130615740|NCT00485589|470212945|FG002|Overall Study|Death|0|||
130615741|NCT00485589|470212943|FG000|Overall Study|Failure to return|6|||
130615742|NCT00485589|470212944|FG001|Overall Study|Failure to return|5|||
130615743|NCT00485589|470212945|FG002|Overall Study|Failure to return|1|||
130615744|NCT00485589|470212943|FG000|Overall Study|Protocol Violation|1|||
130615745|NCT00485589|470212944|FG001|Overall Study|Protocol Violation|0|||
130615746|NCT00485589|470212945|FG002|Overall Study|Protocol Violation|0|||
130615747|NCT00485589|470212943|FG000|Overall Study|Violation of selection criteria at entry|0|||
130615748|NCT00485589|470212944|FG001|Overall Study|Violation of selection criteria at entry|3|||
130615749|NCT00485589|470212945|FG002|Overall Study|Violation of selection criteria at entry|1|||
130615750|NCT00485589|470212943|FG000|Overall Study|Administrative/Other|1|||
130615751|NCT00485589|470212944|FG001|Overall Study|Administrative/Other|2|||
130615752|NCT00485589|470212945|FG002|Overall Study|Administrative/Other|1|||
130615753|NCT00485589|470212943|FG000|Overall Study|Insufficient therapeutic response|10|||
130615754|NCT00485589|470212944|FG001|Overall Study|Insufficient therapeutic response|3|||
130615755|NCT00485589|470212945|FG002|Overall Study|Insufficient therapeutic response|1|||
130615756|NCT00485589|470212943|FG000|Overall Study|Refused treatment/did not cooperate|1|||
130615757|NCT00485589|470212944|FG001|Overall Study|Refused treatment/did not cooperate|0|||
130615758|NCT00485589|470212945|FG002|Overall Study|Refused treatment/did not cooperate|2|||
130615759|NCT00485589|470212943|FG000|Overall Study|Withdrawal by Subject|3|||
130615760|NCT00485589|470212944|FG001|Overall Study|Withdrawal by Subject|2|||
130615761|NCT00485589|470212945|FG002|Overall Study|Withdrawal by Subject|2|||
130615762|NCT00485589|470212943|FG000|Overall Study|Adverse Event|3|||
130615763|NCT00485589|470212944|FG001|Overall Study|Adverse Event|3|||
130615764|NCT00485589|470212945|FG002|Overall Study|Adverse Event|10|||
130615765|NCT01369849|470212946|FG000|Overall Study|Ineligible prior to treatment|0|||
130615766|NCT01369849|470212947|FG001|Overall Study|Ineligible prior to treatment|0|||
130615767|NCT01369849|470212948|FG002|Overall Study|Ineligible prior to treatment|1|||
130615768|NCT01369849|470212946|FG000|Overall Study|Ineligible after receiving treatment|0|||
130615769|NCT01369849|470212947|FG001|Overall Study|Ineligible after receiving treatment|1|||
130615770|NCT01369849|470212948|FG002|Overall Study|Ineligible after receiving treatment|0|||
130615771|NCT00756886|470212952|FG000|Overall Study|Lost to Follow-up|1|||
130615772|NCT00756886|470212953|FG001|Overall Study|Lost to Follow-up|0|||
130615773|NCT00756886|470212952|FG000|Overall Study|Adverse Event|0|||
130615774|NCT00756886|470212953|FG001|Overall Study|Adverse Event|3|||
130615775|NCT00756886|470212952|FG000|Overall Study|Lack of Efficacy|1|||
130615776|NCT00756886|470212953|FG001|Overall Study|Lack of Efficacy|0|||
130615777|NCT00756886|470212952|FG000|Overall Study|Ineligible|9|||
130615778|NCT00756886|470212953|FG001|Overall Study|Ineligible|4|||
130615779|NCT00174785|470212954|FG000|Overall Study|Adverse Event|293|||
130615780|NCT00174785|470212955|FG001|Overall Study|Adverse Event|191|||
130615781|NCT00174785|470212954|FG000|Overall Study|Protocol Violation|14|||
130615782|NCT00174785|470212955|FG001|Overall Study|Protocol Violation|14|||
130615783|NCT00174785|470212954|FG000|Overall Study|Withdrawal by Subject|173|||
130615784|NCT00174785|470212955|FG001|Overall Study|Withdrawal by Subject|175|||
130615785|NCT00174785|470212954|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
130615786|NCT00174785|470212955|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
130615787|NCT00174785|470212954|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
130615788|NCT00174785|470212955|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
130615789|NCT00174785|470212954|FG000|Overall Study|Other prohibited medication|5|||
130615790|NCT00174785|470212955|FG001|Overall Study|Other prohibited medication|3|||
130615791|NCT00174785|470212954|FG000|Overall Study|Family request|6|||
130615792|NCT00174785|470212955|FG001|Overall Study|Family request|8|||
130615793|NCT00174785|470212954|FG000|Overall Study|Not pre-specified/Not coded|56|||
130615794|NCT00174785|470212955|FG001|Overall Study|Not pre-specified/Not coded|70|||
130615795|NCT00120289|470212957|FG000|Overall Study|Death|96|||
130615796|NCT00120289|470212958|FG001|Overall Study|Death|82|||
130615797|NCT00120289|470212957|FG000|Overall Study|Lost to Follow-up|11|||
130615798|NCT00120289|470212958|FG001|Overall Study|Lost to Follow-up|14|||
130615799|NCT00120289|470212957|FG000|Overall Study|Withdrawal by Subject|14|||
130615800|NCT00120289|470212958|FG001|Overall Study|Withdrawal by Subject|13|||
130615801|NCT01944969|470212959|FG000|Overall Study|Adverse Event|1|||
130615802|NCT01944969|470212959|FG000|Overall Study|Lack of Efficacy|1|||
130615803|NCT01944969|470212959|FG000|Overall Study|Non-compliance with IMP|1|||
130615804|NCT01944969|470212959|FG000|Overall Study|Administrative or other reasons|23|||
130615805|NCT02938585|470212968|FG000|Overall Study|Withdrawal by parent or guardian|0|||
130615806|NCT02938585|470212969|FG001|Overall Study|Withdrawal by parent or guardian|1|||
130615807|NCT02938585|470212970|FG002|Overall Study|Withdrawal by parent or guardian|0|||
130615808|NCT02938585|470212971|FG003|Overall Study|Withdrawal by parent or guardian|0|||
130615809|NCT02938585|470212968|FG000|Overall Study|Withdrawal by Subject|0|||
130615810|NCT02938585|470212969|FG001|Overall Study|Withdrawal by Subject|0|||
130615811|NCT02938585|470212970|FG002|Overall Study|Withdrawal by Subject|0|||
130615812|NCT02938585|470212971|FG003|Overall Study|Withdrawal by Subject|5|||
130615813|NCT00213980|470212972|FG000|Overall Study|Withdrawal by Subject|3|||
130615814|NCT00213980|470212973|FG001|Overall Study|Withdrawal by Subject|1|||
130615815|NCT00213980|470212972|FG000|Overall Study|Adverse Event|1|||
130615816|NCT00213980|470212973|FG001|Overall Study|Adverse Event|1|||
130615817|NCT00213980|470212972|FG000|Overall Study|Disease progression|0|||
130615818|NCT00213980|470212973|FG001|Overall Study|Disease progression|2|||
130615819|NCT00213980|470212972|FG000|Overall Study|Developed ovarian cancer|1|||
130615820|NCT00213980|470212973|FG001|Overall Study|Developed ovarian cancer|0|||
130615821|NCT00213980|470212972|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
130615822|NCT00213980|470212973|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
130615823|NCT01163253|470212976|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
130615824|NCT01163253|470212977|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
130615825|NCT01163253|470212976|FG000|Overall Study|Study Terminated by Sponsor|978|||
130615826|NCT01163253|470212977|FG001|Overall Study|Study Terminated by Sponsor|349|||
130615827|NCT01163253|470212976|FG000|Overall Study|Protocol Violation|43|||
130615828|NCT01163253|470212977|FG001|Overall Study|Protocol Violation|12|||
130615829|NCT01163253|470212976|FG000|Overall Study|Withdrawal by Subject|199|||
130615830|NCT01163253|470212977|FG001|Overall Study|Withdrawal by Subject|50|||
130615831|NCT01163253|470212976|FG000|Overall Study|Medication Error|1|||
130615832|NCT01163253|470212977|FG001|Overall Study|Medication Error|0|||
130615833|NCT01163253|470212976|FG000|Overall Study|Lost to Follow-up|125|||
130615834|NCT01163253|470212977|FG001|Overall Study|Lost to Follow-up|23|||
130615835|NCT01163253|470212976|FG000|Overall Study|Insufficient Clinical Response|423|||
130615836|NCT01163253|470212977|FG001|Overall Study|Insufficient Clinical Response|29|||
130615837|NCT01163253|470212976|FG000|Overall Study|Adverse Event|300|||
130615838|NCT01163253|470212977|FG001|Overall Study|Adverse Event|78|||
130615839|NCT01163253|470212976|FG000|Overall Study|Death|17|||
130615840|NCT01163253|470212977|FG001|Overall Study|Death|5|||
130615841|NCT01163253|470212976|FG000|Overall Study|Ongoing|13|||
130615842|NCT01163253|470212977|FG001|Overall Study|Ongoing|4|||
130615843|NCT01163253|470212976|FG000|Overall Study|Other Unspecified|170|||
130615844|NCT01163253|470212977|FG001|Overall Study|Other Unspecified|34|||
130615845|NCT02492997|470212978|FG000|Overall Study|Withdrawal by Subject|1|||
130615846|NCT02492997|470212979|FG001|Overall Study|Withdrawal by Subject|0|||
130615847|NCT02492997|470212978|FG000|Overall Study|Gained Weight|1|||
130615848|NCT02492997|470212979|FG001|Overall Study|Gained Weight|0|||
130615849|NCT02492997|470212978|FG000|Overall Study|Lost to Follow-up|0|||
130615850|NCT02492997|470212979|FG001|Overall Study|Lost to Follow-up|1|||
130615851|NCT01397552|470212980|FG000|Overall Study|Adverse Event|1|||
130615852|NCT01397552|470212981|FG001|Overall Study|Adverse Event|0|||
130615853|NCT01397552|470212980|FG000|Overall Study|Withdrawal by Subject|2|||
130615854|NCT01397552|470212981|FG001|Overall Study|Withdrawal by Subject|1|||
130615855|NCT02504268|470212983|FG000|Overall Study|Adverse Event|18|||
130615856|NCT02504268|470212984|FG001|Overall Study|Adverse Event|8|||
130615857|NCT02504268|470212985|FG002|Overall Study|Adverse Event|14|||
130615858|NCT02504268|470212986|FG003|Overall Study|Adverse Event|0|||
130615859|NCT02504268|470212987|FG004|Overall Study|Adverse Event|0|||
130615860|NCT02504268|470212988|FG005|Overall Study|Adverse Event|0|||
130615861|NCT02504268|470212989|FG006|Overall Study|Adverse Event|0|||
130615862|NCT02504268|470212990|FG007|Overall Study|Adverse Event|0|||
130615863|NCT02504268|470212991|FG008|Overall Study|Adverse Event|0|||
130615864|NCT02504268|470212983|FG000|Overall Study|Withdrawal of Consent|11|||
130615865|NCT02504268|470212984|FG001|Overall Study|Withdrawal of Consent|10|||
130615866|NCT02504268|470212985|FG002|Overall Study|Withdrawal of Consent|3|||
130615867|NCT02504268|470212986|FG003|Overall Study|Withdrawal of Consent|0|||
130615868|NCT02504268|470212987|FG004|Overall Study|Withdrawal of Consent|0|||
130615869|NCT02504268|470212988|FG005|Overall Study|Withdrawal of Consent|0|||
130615870|NCT02504268|470212989|FG006|Overall Study|Withdrawal of Consent|0|||
130615871|NCT02504268|470212990|FG007|Overall Study|Withdrawal of Consent|0|||
130615872|NCT02504268|470212991|FG008|Overall Study|Withdrawal of Consent|0|||
130615873|NCT02504268|470212983|FG000|Overall Study|Pregnancy|2|||
130615874|NCT02504268|470212984|FG001|Overall Study|Pregnancy|0|||
130615875|NCT02504268|470212985|FG002|Overall Study|Pregnancy|0|||
130615876|NCT02504268|470212986|FG003|Overall Study|Pregnancy|0|||
130615877|NCT02504268|470212987|FG004|Overall Study|Pregnancy|0|||
130615878|NCT02504268|470212988|FG005|Overall Study|Pregnancy|0|||
130615879|NCT02504268|470212989|FG006|Overall Study|Pregnancy|0|||
130615880|NCT02504268|470212990|FG007|Overall Study|Pregnancy|0|||
130615881|NCT02504268|470212991|FG008|Overall Study|Pregnancy|0|||
130615882|NCT02504268|470212983|FG000|Overall Study|Lost to Follow-up|3|||
130615883|NCT02504268|470212984|FG001|Overall Study|Lost to Follow-up|6|||
130615884|NCT02504268|470212985|FG002|Overall Study|Lost to Follow-up|4|||
130615885|NCT02504268|470212986|FG003|Overall Study|Lost to Follow-up|0|||
130615886|NCT02504268|470212987|FG004|Overall Study|Lost to Follow-up|0|||
130615887|NCT02504268|470212988|FG005|Overall Study|Lost to Follow-up|0|||
130615888|NCT02504268|470212989|FG006|Overall Study|Lost to Follow-up|0|||
130615889|NCT02504268|470212990|FG007|Overall Study|Lost to Follow-up|0|||
130615890|NCT02504268|470212991|FG008|Overall Study|Lost to Follow-up|0|||
130615891|NCT02504268|470212983|FG000|Overall Study|Death|1|||
130615892|NCT02504268|470212984|FG001|Overall Study|Death|1|||
130615893|NCT02504268|470212985|FG002|Overall Study|Death|0|||
130615894|NCT02504268|470212986|FG003|Overall Study|Death|0|||
130615895|NCT02504268|470212987|FG004|Overall Study|Death|0|||
130615896|NCT02504268|470212988|FG005|Overall Study|Death|0|||
130615897|NCT02504268|470212989|FG006|Overall Study|Death|0|||
130615898|NCT02504268|470212990|FG007|Overall Study|Death|0|||
130615899|NCT02504268|470212991|FG008|Overall Study|Death|0|||
130615900|NCT02504268|470212983|FG000|Overall Study|Subject Request to Discontinue|11|||
130615901|NCT02504268|470212984|FG001|Overall Study|Subject Request to Discontinue|3|||
130615902|NCT02504268|470212985|FG002|Overall Study|Subject Request to Discontinue|6|||
130615903|NCT02504268|470212986|FG003|Overall Study|Subject Request to Discontinue|0|||
130615904|NCT02504268|470212987|FG004|Overall Study|Subject Request to Discontinue|0|||
130615905|NCT02504268|470212988|FG005|Overall Study|Subject Request to Discontinue|0|||
130615906|NCT02504268|470212989|FG006|Overall Study|Subject Request to Discontinue|0|||
130615907|NCT02504268|470212990|FG007|Overall Study|Subject Request to Discontinue|0|||
130615908|NCT02504268|470212991|FG008|Overall Study|Subject Request to Discontinue|0|||
130615909|NCT02504268|470212983|FG000|Overall Study|No Longer Meets Study Criteria|2|||
130615910|NCT02504268|470212984|FG001|Overall Study|No Longer Meets Study Criteria|3|||
130615911|NCT02504268|470212985|FG002|Overall Study|No Longer Meets Study Criteria|0|||
130615912|NCT02504268|470212986|FG003|Overall Study|No Longer Meets Study Criteria|0|||
130615913|NCT02504268|470212987|FG004|Overall Study|No Longer Meets Study Criteria|0|||
130615914|NCT02504268|470212988|FG005|Overall Study|No Longer Meets Study Criteria|0|||
130615915|NCT02504268|470212989|FG006|Overall Study|No Longer Meets Study Criteria|0|||
130615916|NCT02504268|470212990|FG007|Overall Study|No Longer Meets Study Criteria|0|||
130615917|NCT02504268|470212991|FG008|Overall Study|No Longer Meets Study Criteria|0|||
130615918|NCT02504268|470212983|FG000|Overall Study|Lack of Efficacy|11|||
130615919|NCT02504268|470212984|FG001|Overall Study|Lack of Efficacy|35|||
130615920|NCT02504268|470212985|FG002|Overall Study|Lack of Efficacy|9|||
130615921|NCT02504268|470212986|FG003|Overall Study|Lack of Efficacy|0|||
130615922|NCT02504268|470212987|FG004|Overall Study|Lack of Efficacy|0|||
130615923|NCT02504268|470212988|FG005|Overall Study|Lack of Efficacy|0|||
130615924|NCT02504268|470212989|FG006|Overall Study|Lack of Efficacy|0|||
130615925|NCT02504268|470212990|FG007|Overall Study|Lack of Efficacy|0|||
130615926|NCT02504268|470212991|FG008|Overall Study|Lack of Efficacy|0|||
130615927|NCT02504268|470212983|FG000|Overall Study|Poor/Non-Compliance|3|||
130615928|NCT02504268|470212984|FG001|Overall Study|Poor/Non-Compliance|2|||
130615929|NCT02504268|470212985|FG002|Overall Study|Poor/Non-Compliance|3|||
130615930|NCT02504268|470212986|FG003|Overall Study|Poor/Non-Compliance|0|||
130615931|NCT02504268|470212987|FG004|Overall Study|Poor/Non-Compliance|0|||
130615932|NCT02504268|470212988|FG005|Overall Study|Poor/Non-Compliance|0|||
130615933|NCT02504268|470212989|FG006|Overall Study|Poor/Non-Compliance|0|||
130615934|NCT02504268|470212990|FG007|Overall Study|Poor/Non-Compliance|0|||
130615935|NCT02504268|470212991|FG008|Overall Study|Poor/Non-Compliance|0|||
130615936|NCT02504268|470212983|FG000|Overall Study|Not Disclosed|1|||
130615937|NCT02504268|470212984|FG001|Overall Study|Not Disclosed|0|||
130615938|NCT02504268|470212985|FG002|Overall Study|Not Disclosed|2|||
130615939|NCT02504268|470212986|FG003|Overall Study|Not Disclosed|0|||
130615940|NCT02504268|470212987|FG004|Overall Study|Not Disclosed|0|||
130615941|NCT02504268|470212988|FG005|Overall Study|Not Disclosed|0|||
130615942|NCT02504268|470212989|FG006|Overall Study|Not Disclosed|0|||
130615943|NCT02504268|470212990|FG007|Overall Study|Not Disclosed|0|||
130615944|NCT02504268|470212991|FG008|Overall Study|Not Disclosed|0|||
130615945|NCT02130427|470212992|FG000|Overall Study|Imaging results not interpretable|30|||
130615946|NCT00862849|470212997|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130615947|NCT00862849|470212998|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
130615948|NCT00862849|470212999|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130615949|NCT00862849|470213000|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130615950|NCT00862849|470213001|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130615951|NCT00862849|470213002|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130615952|NCT00862849|470212997|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130615953|NCT00862849|470212998|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
130615954|NCT00862849|470212999|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130615955|NCT00862849|470213000|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130615956|NCT00862849|470213001|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130615957|NCT00862849|470213002|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130615958|NCT00089479|470213013|FG000|Overall Study|Death|108|||
130615959|NCT00089479|470213014|FG001|Overall Study|Death|75|||
130615960|NCT00089479|470213013|FG000|Overall Study|Withdrawal by Subject|86|||
130615961|NCT00089479|470213014|FG001|Overall Study|Withdrawal by Subject|107|||
130615962|NCT00089479|470213013|FG000|Overall Study|Lost to Follow-up|137|||
130615963|NCT00089479|470213014|FG001|Overall Study|Lost to Follow-up|107|||
130615964|NCT01124448|470213017|FG000|Overall Study|Lost to Follow-up|0|||
130615965|NCT01124448|470213018|FG001|Overall Study|Lost to Follow-up|3|||
130615966|NCT01124448|470213017|FG000|Overall Study|Protocol Violation|2|||
130615967|NCT01124448|470213018|FG001|Overall Study|Protocol Violation|0|||
130615968|NCT00718666|470213019|FG000|Booster Phase Year 5|No active participation request|0|||
130615969|NCT00718666|470213020|FG001|Booster Phase Year 5|No active participation request|0|||
130615970|NCT00718666|470213021|FG002|Booster Phase Year 5|No active participation request|1|||
130615971|NCT00718666|470213019|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
130615972|NCT00718666|470213020|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
130615973|NCT00718666|470213021|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
130615974|NCT00718666|470213019|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
130615975|NCT00718666|470213020|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
130615976|NCT00718666|470213021|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
130615977|NCT00718666|470213019|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
130615978|NCT00718666|470213020|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
130615979|NCT00718666|470213021|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
130615980|NCT03471767|470213027|FG000|Overall Study|Withdrawal by Subject|3|||
130615981|NCT03471767|470213028|FG001|Overall Study|Withdrawal by Subject|1|||
130615982|NCT03471767|470213027|FG000|Overall Study|Adverse Event|1|||
130615983|NCT03471767|470213028|FG001|Overall Study|Adverse Event|0|||
130615984|NCT03471767|470213027|FG000|Overall Study|Lost to Follow-up|1|||
130615985|NCT03471767|470213028|FG001|Overall Study|Lost to Follow-up|0|||
130615986|NCT03471767|470213027|FG000|Overall Study|PI Withdrawal|1|||
130615987|NCT03471767|470213028|FG001|Overall Study|PI Withdrawal|3|||
130615988|NCT00678587|470213029|FG000|Overall Study|Adverse Event|3|||
130615989|NCT00678587|470213030|FG001|Overall Study|Adverse Event|3|||
130615990|NCT00678587|470213029|FG000|Overall Study|Lack of Efficacy|1|||
130615991|NCT00678587|470213030|FG001|Overall Study|Lack of Efficacy|0|||
130615992|NCT00678587|470213029|FG000|Overall Study|Protocol Violation|2|||
130615993|NCT00678587|470213030|FG001|Overall Study|Protocol Violation|1|||
130615994|NCT00678587|470213029|FG000|Overall Study|Study Closed/Terminated|1|||
130615995|NCT00678587|470213030|FG001|Overall Study|Study Closed/Terminated|0|||
130615996|NCT00678587|470213029|FG000|Overall Study|Lost to Follow-up|3|||
130615997|NCT00678587|470213030|FG001|Overall Study|Lost to Follow-up|5|||
130615998|NCT00678587|470213029|FG000|Overall Study|Investigator Discretion|2|||
130615999|NCT00678587|470213030|FG001|Overall Study|Investigator Discretion|6|||
130616000|NCT00678587|470213029|FG000|Overall Study|Withdrew Consent|8|||
130616001|NCT00678587|470213030|FG001|Overall Study|Withdrew Consent|3|||
130616002|NCT01952730|470213031|FG000|Overall Study|FDA shut down core lab used by study|1|||
130616003|NCT00305253|470213034|FG000|Overall Study|Withdrawal by Subject|0|||
130616004|NCT00305253|470213035|FG001|Overall Study|Withdrawal by Subject|1|||
130616005|NCT01019486|470213038|FG000|Overall Study|Withdrawal by Subject|1|||
130616006|NCT01019486|470213039|FG001|Overall Study|Withdrawal by Subject|1|||
130616007|NCT01019486|470213040|FG002|Overall Study|Withdrawal by Subject|1|||
130616008|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
130616009|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
130616010|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Death|2|||
130616011|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Death|1|||
130616012|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
130616013|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
130616014|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
130616015|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
130616016|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
130616017|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
130616018|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
130616019|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
130616020|NCT03633227|470213041|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
130616021|NCT03633227|470213042|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
130616022|NCT03633227|470213041|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
130616023|NCT03633227|470213042|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
130616024|NCT03633227|470213041|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
130616025|NCT03633227|470213042|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
130616026|NCT03633227|470213041|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
130616027|NCT03633227|470213042|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
130616028|NCT03633227|470213041|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
130616029|NCT03633227|470213042|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
130616030|NCT03633227|470213041|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
130616031|NCT03633227|470213042|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
130616032|NCT01655823|470213043|FG000|Overall Study|Lost to Follow-up|0|||
130616033|NCT01655823|470213044|FG001|Overall Study|Lost to Follow-up|1|||
130616034|NCT01655823|470213045|FG002|Overall Study|Lost to Follow-up|0|||
130616035|NCT01655823|470213046|FG003|Overall Study|Lost to Follow-up|0|||
130616036|NCT01655823|470213047|FG004|Overall Study|Lost to Follow-up|1|||
130616037|NCT01655823|470213043|FG000|Overall Study|Withdrawal by Subject|0|||
130616038|NCT01655823|470213044|FG001|Overall Study|Withdrawal by Subject|1|||
130616039|NCT01655823|470213045|FG002|Overall Study|Withdrawal by Subject|0|||
130616040|NCT01655823|470213046|FG003|Overall Study|Withdrawal by Subject|1|||
130616041|NCT01655823|470213047|FG004|Overall Study|Withdrawal by Subject|0|||
130616042|NCT04799405|470213050|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
130616043|NCT01934192|470213053|FG000|Overall Study|Protocol Violation|0|||
130616044|NCT01934192|470213054|FG001|Overall Study|Protocol Violation|0|||
130616045|NCT01934192|470213055|FG002|Overall Study|Protocol Violation|0|||
130616046|NCT01934192|470213056|FG003|Overall Study|Protocol Violation|1|||
130616047|NCT01934192|470213053|FG000|Overall Study|Other: reached stopping criteria|6|||
130616048|NCT01934192|470213054|FG001|Overall Study|Other: reached stopping criteria|5|||
130616049|NCT01934192|470213055|FG002|Overall Study|Other: reached stopping criteria|1|||
130616050|NCT01934192|470213056|FG003|Overall Study|Other: reached stopping criteria|0|||
130616051|NCT01934192|470213053|FG000|Overall Study|Physician Decision|3|||
130616052|NCT01934192|470213054|FG001|Overall Study|Physician Decision|2|||
130616053|NCT01934192|470213055|FG002|Overall Study|Physician Decision|0|||
130616054|NCT01934192|470213056|FG003|Overall Study|Physician Decision|0|||
130616055|NCT01189435|470213057|FG000|Overall Study|Withdrawal by Subject|1|||
130616056|NCT01189435|470213057|FG000|Overall Study|Physician Decision|1|||
130616057|NCT03095521|470213063|FG000|Overall Study|Withdrawal by Subject|0|||
130616058|NCT03095521|470213064|FG001|Overall Study|Withdrawal by Subject|1|||
130616059|NCT03095521|470213063|FG000|Overall Study|Lost to Follow-up|0|||
130616060|NCT03095521|470213064|FG001|Overall Study|Lost to Follow-up|1|||
130616061|NCT01536119|470213065|FG000|Overall Study|Lost to Follow-up|17|||
130616062|NCT01536119|470213066|FG001|Overall Study|Lost to Follow-up|14|||
130616063|NCT01810042|470213067|FG000|Overall Study|Lost to Follow-up|10|||
130616064|NCT02773238|470213069|FG000|Overall Study|Lack of Efficacy|4|||
130616065|NCT00280150|470215142|FG000|Overall Study|Adverse Event|0|||
130616066|NCT00280150|470215143|FG001|Overall Study|Adverse Event|1|||
130616067|NCT00280150|470215144|FG002|Overall Study|Adverse Event|2|||
130616068|NCT00280150|470215145|FG003|Overall Study|Adverse Event|3|||
130616069|NCT00280150|470215142|FG000|Overall Study|Lack of Efficacy|0|||
130616070|NCT00280150|470215143|FG001|Overall Study|Lack of Efficacy|0|||
130616071|NCT00280150|470215144|FG002|Overall Study|Lack of Efficacy|0|||
130616072|NCT00280150|470215145|FG003|Overall Study|Lack of Efficacy|3|||
130616073|NCT00280150|470215142|FG000|Overall Study|Physician Decision|0|||
130616074|NCT00280150|470215143|FG001|Overall Study|Physician Decision|0|||
130616075|NCT00280150|470215144|FG002|Overall Study|Physician Decision|0|||
130616076|NCT00280150|470215145|FG003|Overall Study|Physician Decision|1|||
130616077|NCT00280150|470215142|FG000|Overall Study|Protocol Violation|0|||
130616078|NCT00280150|470215143|FG001|Overall Study|Protocol Violation|0|||
130616079|NCT00280150|470215144|FG002|Overall Study|Protocol Violation|0|||
130616080|NCT00280150|470215145|FG003|Overall Study|Protocol Violation|1|||
130616081|NCT00280150|470215142|FG000|Overall Study|Withdrawal by Subject|0|||
130616082|NCT00280150|470215143|FG001|Overall Study|Withdrawal by Subject|0|||
130616083|NCT00280150|470215144|FG002|Overall Study|Withdrawal by Subject|0|||
130616084|NCT00280150|470215145|FG003|Overall Study|Withdrawal by Subject|1|||
130616085|NCT00280150|470215142|FG000|Overall Study|Did not get consolidation therapy|3|||
130616086|NCT00280150|470215143|FG001|Overall Study|Did not get consolidation therapy|0|||
130616087|NCT00280150|470215144|FG002|Overall Study|Did not get consolidation therapy|3|||
130616088|NCT00280150|470215145|FG003|Overall Study|Did not get consolidation therapy|0|||
130616089|NCT00280150|470215142|FG000|Overall Study|Declining Performance Status|0|||
130616090|NCT00280150|470215143|FG001|Overall Study|Declining Performance Status|0|||
130616091|NCT00280150|470215144|FG002|Overall Study|Declining Performance Status|0|||
130616092|NCT00280150|470215145|FG003|Overall Study|Declining Performance Status|1|||
130616093|NCT03162055|470215147|FG000|Overall Study|Adverse Event|6|||
130616094|NCT03162055|470215148|FG001|Overall Study|Adverse Event|5|||
130616095|NCT03162055|470215147|FG000|Overall Study|Death|3|||
130616096|NCT03162055|470215148|FG001|Overall Study|Death|3|||
130616097|NCT03162055|470215147|FG000|Overall Study|Lost to Follow-up|0|||
130616098|NCT03162055|470215148|FG001|Overall Study|Lost to Follow-up|1|||
130616099|NCT03162055|470215147|FG000|Overall Study|Study-specific withdrawal criteria|22|||
130616100|NCT03162055|470215148|FG001|Overall Study|Study-specific withdrawal criteria|14|||
130616101|NCT03162055|470215147|FG000|Overall Study|Withdrawal by Subject|17|||
130616102|NCT03162055|470215148|FG001|Overall Study|Withdrawal by Subject|2|||
130616103|NCT03162055|470215147|FG000|Overall Study|Did not receive treatment|2|||
130616104|NCT03162055|470215148|FG001|Overall Study|Did not receive treatment|0|||
130616105|NCT03162055|470215147|FG000|Overall Study|Incorrect randomization|4|||
130616106|NCT03162055|470215148|FG001|Overall Study|Incorrect randomization|3|||
130616107|NCT03162055|470215147|FG000|Overall Study|Other|8|||
130616108|NCT03162055|470215148|FG001|Overall Study|Other|15|||
130616109|NCT01993615|470215152|FG000|Overall Study|Death|1|||
130616110|NCT01993615|470215153|FG001|Overall Study|Death|0|||
130616111|NCT00310388|470215155|FG000|Primary Reporting Phase|Adverse Event|101|||
130616112|NCT00310388|470215156|FG001|Primary Reporting Phase|Adverse Event|0|||
130616113|NCT00310388|470215155|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
130616114|NCT00310388|470215156|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
130616115|NCT00310388|470215155|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
130616116|NCT00310388|470215156|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
130616117|NCT00310388|470215155|FG000|Primary Reporting Phase|Protocol Violation|10|||
130616118|NCT00310388|470215156|FG001|Primary Reporting Phase|Protocol Violation|0|||
130616119|NCT00310388|470215155|FG000|Primary Reporting Phase|Pregnancy|3|||
130616120|NCT00310388|470215156|FG001|Primary Reporting Phase|Pregnancy|0|||
130616121|NCT00310388|470215155|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
130616122|NCT00310388|470215156|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
130616123|NCT00310388|470215155|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
130616124|NCT00310388|470215156|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
130616125|NCT00310388|470215155|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
130616126|NCT00310388|470215156|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
130616127|NCT00310388|470215155|FG000|Primary Reporting Phase|Physician Decision|2|||
130616128|NCT00310388|470215156|FG001|Primary Reporting Phase|Physician Decision|0|||
130616129|NCT00310388|470215155|FG000|Primary Reporting Phase|Request of the sponsor|19|||
130616130|NCT00310388|470215156|FG001|Primary Reporting Phase|Request of the sponsor|0|||
130616131|NCT00310388|470215155|FG000|Primary Reporting Phase|Failed to return|8|||
130616132|NCT00310388|470215156|FG001|Primary Reporting Phase|Failed to return|0|||
130616133|NCT00310388|470215155|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
130616134|NCT00310388|470215156|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
130616135|NCT00310388|470215155|FG000|Primary Reporting Phase|Participant request|2|||
130616136|NCT00310388|470215156|FG001|Primary Reporting Phase|Participant request|0|||
130616137|NCT00310388|470215155|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
130616138|NCT00310388|470215156|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
130616139|NCT00310388|470215155|FG000|Primary Reporting Phase|Discontinuation of study|1|||
130616140|NCT00310388|470215156|FG001|Primary Reporting Phase|Discontinuation of study|0|||
130616141|NCT00310388|470215155|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
130616142|NCT00310388|470215156|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
130616143|NCT00310388|470215155|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
130616144|NCT00310388|470215156|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
130616145|NCT00310388|470215155|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
130616146|NCT00310388|470215156|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
130616147|NCT00310388|470215155|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
130616148|NCT00310388|470215156|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
130616149|NCT00310388|470215155|FG000|Primary Reporting Phase|Participant passed away|1|||
130616150|NCT00310388|470215156|FG001|Primary Reporting Phase|Participant passed away|0|||
130616151|NCT00310388|470215155|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
130616152|NCT00310388|470215156|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
130616153|NCT00310388|470215155|FG000|Primary Reporting Phase|Missing|1|||
130616154|NCT00310388|470215156|FG001|Primary Reporting Phase|Missing|0|||
130616155|NCT00310388|470215155|FG000|Primary Reporting Phase|Other|1|||
130616156|NCT00310388|470215156|FG001|Primary Reporting Phase|Other|0|||
130616157|NCT00310388|470215155|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
130616158|NCT00310388|470215156|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
130616159|NCT00310388|470215155|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
130616160|NCT00310388|470215156|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
130616161|NCT00310388|470215155|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
130616162|NCT00310388|470215156|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
130616163|NCT00310388|470215155|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
130616164|NCT00310388|470215156|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
130616165|NCT00798694|470215160|FG000|Overall Study|Lost to Follow-up|1|||
130616166|NCT00798694|470215161|FG001|Overall Study|Lost to Follow-up|1|||
130616167|NCT00798694|470215160|FG000|Overall Study|Physician Decision|1|||
130616168|NCT00798694|470215161|FG001|Overall Study|Physician Decision|0|||
130616169|NCT01774344|470215163|FG000|Overall Study|Withdrawal by Subject|3|||
130616170|NCT01774344|470215164|FG001|Overall Study|Withdrawal by Subject|10|||
130616171|NCT01774344|470215163|FG000|Overall Study|Protocol Violation|0|||
130616172|NCT01774344|470215164|FG001|Overall Study|Protocol Violation|1|||
130616173|NCT01774344|470215163|FG000|Overall Study|Lost to Follow-up|4|||
130616174|NCT01774344|470215164|FG001|Overall Study|Lost to Follow-up|10|||
130616175|NCT01774344|470215163|FG000|Overall Study|End of survival follow-up not available|2|||
130616176|NCT01774344|470215164|FG001|Overall Study|End of survival follow-up not available|2|||
130616177|NCT01774344|470215163|FG000|Overall Study|Data collection finished|4|||
130616178|NCT01774344|470215164|FG001|Overall Study|Data collection finished|14|||
130616179|NCT01774344|470215163|FG000|Overall Study|Other|0|||
130616180|NCT01774344|470215164|FG001|Overall Study|Other|1|||
130616181|NCT01774344|470215163|FG000|Overall Study|Did not enter Survival Follow up|49|||
130616182|NCT01774344|470215164|FG001|Overall Study|Did not enter Survival Follow up|83|||
130616183|NCT04032171|470215172|FG000|Overall Study|Study Termination|1|||
130616184|NCT04032171|470215173|FG001|Overall Study|Study Termination|0|||
130616185|NCT00992784|470215174|FG000|Overall Study|Adverse Event|2|||
130616186|NCT00992784|470215175|FG001|Overall Study|Adverse Event|1|||
130616187|NCT00992784|470215176|FG002|Overall Study|Adverse Event|0|||
130616188|NCT00992784|470215174|FG000|Overall Study|Withdrawal by Subject|1|||
130616189|NCT00992784|470215175|FG001|Overall Study|Withdrawal by Subject|1|||
130616190|NCT00992784|470215176|FG002|Overall Study|Withdrawal by Subject|1|||
130616191|NCT01363713|470215177|FG000|Overall Study|Adverse Event|1|||
130616192|NCT01363713|470215177|FG000|Overall Study|Protocol Violation|3|||
130616193|NCT01363713|470215177|FG000|Overall Study|Withdrawal by Subject|2|||
130616194|NCT01658579|470215182|FG000|Treatment Period A|Other|0|||
130616195|NCT01658579|470215183|FG001|Treatment Period A|Other|0|||
130616196|NCT01658579|470215184|FG002|Treatment Period A|Other|1|||
130616197|NCT01658579|470215185|FG003|Treatment Period A|Other|1|||
130616198|NCT01658579|470215182|FG000|Treatment Period A|Adverse Event|1|||
130616199|NCT01658579|470215183|FG001|Treatment Period A|Adverse Event|0|||
130616200|NCT01658579|470215184|FG002|Treatment Period A|Adverse Event|0|||
130616201|NCT01658579|470215185|FG003|Treatment Period A|Adverse Event|0|||
130616202|NCT01658579|470215182|FG000|Treatment Period B|Other|0|||
130616203|NCT01658579|470215183|FG001|Treatment Period B|Other|0|||
130616204|NCT01658579|470215184|FG002|Treatment Period B|Other|0|||
130616205|NCT01658579|470215185|FG003|Treatment Period B|Other|1|||
130616206|NCT02108951|470215189|FG000|Overall Study|Lost to Follow-up|1|||
130616207|NCT02108951|470215189|FG000|Overall Study|Patient's/guardian's decision|1|||
130616208|NCT02108951|470215189|FG000|Overall Study|Study Terminated by Sponsor|14|||
130616209|NCT03806179|470215190|FG000|Overall Study|Progressive disease|0|||
130616210|NCT03806179|470215191|FG001|Overall Study|Progressive disease|2|||
130616211|NCT00608530|470215194|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
130616212|NCT00608530|470215195|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
130616213|NCT00608530|470215196|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
130616214|NCT00608530|470215197|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
130616215|NCT00608530|470215194|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
130616216|NCT00608530|470215195|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
130616217|NCT00608530|470215196|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
130616218|NCT00608530|470215197|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
130616219|NCT00608530|470215194|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
130616220|NCT00608530|470215195|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
130616221|NCT00608530|470215196|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
130616222|NCT00608530|470215197|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
130616223|NCT00608530|470215194|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
130616224|NCT00608530|470215195|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
130616225|NCT00608530|470215196|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
130616226|NCT00608530|470215197|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
130616227|NCT00608530|470215194|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
130616228|NCT00608530|470215195|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
130616229|NCT00608530|470215196|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
130616230|NCT00608530|470215197|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
130616231|NCT00608530|470215194|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
130616232|NCT00608530|470215195|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
130616233|NCT00608530|470215196|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
130616234|NCT00608530|470215197|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
130616235|NCT01357915|470215198|FG000|Overall Study|Lost to Follow-up|3|||
130616236|NCT01357915|470215199|FG001|Overall Study|Lost to Follow-up|0|||
130616237|NCT02841787|470215200|FG000|Overall Study|Lost to Follow-up|1|||
130616238|NCT02841787|470215201|FG001|Overall Study|Lost to Follow-up|0|||
130616239|NCT02841787|470215202|FG002|Overall Study|Lost to Follow-up|0|||
130616240|NCT02841787|470215200|FG000|Overall Study|Symptoms dropped below threshold|1|||
130616241|NCT02841787|470215201|FG001|Overall Study|Symptoms dropped below threshold|0|||
130616242|NCT02841787|470215202|FG002|Overall Study|Symptoms dropped below threshold|0|||
130616243|NCT02841787|470215200|FG000|Overall Study|Withdrawal by Subject|1|||
130616244|NCT02841787|470215201|FG001|Overall Study|Withdrawal by Subject|4|||
130616245|NCT02841787|470215202|FG002|Overall Study|Withdrawal by Subject|0|||
130616246|NCT03029650|470215207|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
130616247|NCT03029650|470215208|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
130616248|NCT03029650|470215207|FG000|Washout (1 Week)|Physician Decision|0|||
130616249|NCT03029650|470215208|FG001|Washout (1 Week)|Physician Decision|1|||
130616250|NCT01875367|470215209|FG000|Overall Study|Not complete at least 2 questionaries|4|||
130616251|NCT01875367|470215210|FG001|Overall Study|Not complete at least 2 questionaries|2|||
130616252|NCT01875367|470215209|FG000|Overall Study|Not receive study treatment|1|||
130616253|NCT01875367|470215210|FG001|Overall Study|Not receive study treatment|0|||
130616254|NCT02237157|470215213|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
130616255|NCT02237157|470215214|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130616256|NCT02237157|470215215|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130616257|NCT02237157|470215216|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130616258|NCT02237157|470215213|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
130616259|NCT02237157|470215214|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130616260|NCT02237157|470215215|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130616261|NCT02237157|470215216|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130616262|NCT02951988|470215217|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
130616263|NCT02951988|470215218|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
130616264|NCT02951988|470215219|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
130616265|NCT02951988|470215220|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
130616266|NCT02951988|470215217|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
130616267|NCT02951988|470215218|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
130616268|NCT02951988|470215219|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
130616269|NCT02951988|470215220|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
130616270|NCT02951988|470215217|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
130616271|NCT02951988|470215218|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130616272|NCT02951988|470215219|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130616273|NCT02951988|470215220|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130616274|NCT02951988|470215217|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
130616275|NCT02951988|470215218|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
130616276|NCT02951988|470215219|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
130616277|NCT02951988|470215220|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
130616278|NCT02951988|470215217|FG000|Open-Label Treatment Period|Protocol Violation|22|||
130616279|NCT02951988|470215218|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130616280|NCT02951988|470215219|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130616281|NCT02951988|470215220|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130616282|NCT02951988|470215217|FG000|Open-Label Treatment Period|Pregnancy|2|||
130616283|NCT02951988|470215218|FG001|Open-Label Treatment Period|Pregnancy|0|||
130616284|NCT02951988|470215219|FG002|Open-Label Treatment Period|Pregnancy|0|||
130616285|NCT02951988|470215220|FG003|Open-Label Treatment Period|Pregnancy|0|||
130616286|NCT02951988|470215217|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
130616287|NCT02951988|470215218|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130616288|NCT02951988|470215219|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130616289|NCT02951988|470215220|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130616290|NCT02951988|470215217|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
130616291|NCT02951988|470215218|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130616292|NCT02951988|470215219|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130616293|NCT02951988|470215220|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130616294|NCT02951988|470215217|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
130616295|NCT02951988|470215218|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130616296|NCT02951988|470215219|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130616297|NCT02951988|470215220|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130616298|NCT02951988|470215217|FG000|Open-Label Treatment Period|Adverse Event|45|||
130616299|NCT02951988|470215218|FG001|Open-Label Treatment Period|Adverse Event|0|||
130616300|NCT02951988|470215219|FG002|Open-Label Treatment Period|Adverse Event|0|||
130616301|NCT02951988|470215220|FG003|Open-Label Treatment Period|Adverse Event|0|||
130616302|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
130616303|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
130616304|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
130616305|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
130616306|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
130616307|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
130616308|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
130616309|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
130616310|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
130616311|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
130616312|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
130616313|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
130616314|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130616315|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
130616316|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
130616317|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
130616318|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Pregnancy|0|||
130616319|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Pregnancy|1|||
130616320|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Pregnancy|1|||
130616321|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Pregnancy|0|||
130616322|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130616323|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
130616324|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
130616325|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
130616326|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130616327|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
130616328|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
130616329|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
130616330|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130616331|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Adverse Event|8|||
130616332|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Adverse Event|3|||
130616333|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Adverse Event|6|||
130616334|NCT02951988|470215217|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
130616335|NCT02951988|470215218|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
130616336|NCT02951988|470215219|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
130616337|NCT02951988|470215220|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
130616338|NCT00603980|470215222|FG000|Study Qualification|Protocol Violation|3|||
130616339|NCT00603980|470215222|FG000|Study Qualification|Inconsistent data reporting|13|||
130616340|NCT00603980|470215222|FG000|Main Study|14th subject completed trial|1|||
130616341|NCT02683525|470215223|FG000|Overall Study|Lost to Follow-up|1|||
130616342|NCT02683525|470215223|FG000|Overall Study|Physician Decision|1|||
130616343|NCT02683525|470215223|FG000|Overall Study|Disease Progression|6|||
130616344|NCT01627067|470215224|FG000|Overall Study|Screen Failure|1|||
130616345|NCT00926796|470215228|FG000|Overall Study|Did not receive randomized treatment|4|||
130616346|NCT00926796|470215229|FG001|Overall Study|Did not receive randomized treatment|7|||
130616347|NCT00926796|470215228|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
130616348|NCT00926796|470215229|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
130616349|NCT00926796|470215228|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
130616350|NCT00926796|470215229|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
130616351|NCT00926796|470215228|FG000|Overall Study|Adverse Event|7|||
130616352|NCT00926796|470215229|FG001|Overall Study|Adverse Event|14|||
130616353|NCT00926796|470215228|FG000|Overall Study|Lost to Follow-up|22|||
130616354|NCT00926796|470215229|FG001|Overall Study|Lost to Follow-up|13|||
130616355|NCT00926796|470215228|FG000|Overall Study|Protocol Violation|15|||
130616356|NCT00926796|470215229|FG001|Overall Study|Protocol Violation|11|||
130616357|NCT00926796|470215228|FG000|Overall Study|Withdrawal by Subject|1|||
130616358|NCT00926796|470215229|FG001|Overall Study|Withdrawal by Subject|0|||
130616359|NCT01341652|470215233|FG000|Overall Study|Incorrect Random Assignment|0|||
130616360|NCT01341652|470215234|FG001|Overall Study|Incorrect Random Assignment|1|||
130616361|NCT01341652|470215233|FG000|Overall Study|ineligible; presence metastatic disease|0|||
130616362|NCT01341652|470215234|FG001|Overall Study|ineligible; presence metastatic disease|1|||
130616363|NCT00632463|470215235|FG000|Overall Study|Adverse Event|0|||
130616364|NCT00632463|470215236|FG001|Overall Study|Adverse Event|1|||
130616365|NCT00632463|470215237|FG002|Overall Study|Adverse Event|0|||
130616366|NCT00586924|470215238|FG000|Overall Study|Adverse event/serious adverse event|0|||
130616367|NCT00586924|470215239|FG001|Overall Study|Adverse event/serious adverse event|0|||
130616368|NCT00586924|470215240|FG002|Overall Study|Adverse event/serious adverse event|0|||
130616369|NCT00586924|470215241|FG003|Overall Study|Adverse event/serious adverse event|1|||
130616370|NCT00586924|470215242|FG004|Overall Study|Adverse event/serious adverse event|0|||
130616371|NCT00586924|470215243|FG005|Overall Study|Adverse event/serious adverse event|2|||
130616372|NCT00586924|470215238|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
130616373|NCT00586924|470215239|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
130616374|NCT00586924|470215240|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
130616375|NCT00586924|470215241|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
130616376|NCT00586924|470215242|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
130616377|NCT00586924|470215243|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
130616378|NCT00586924|470215238|FG000|Overall Study|Disease progression|0|||
130616379|NCT00586924|470215239|FG001|Overall Study|Disease progression|0|||
130616380|NCT00586924|470215240|FG002|Overall Study|Disease progression|0|||
130616381|NCT00586924|470215241|FG003|Overall Study|Disease progression|1|||
130616382|NCT00586924|470215242|FG004|Overall Study|Disease progression|1|||
130616383|NCT00586924|470215243|FG005|Overall Study|Disease progression|0|||
130616384|NCT00586924|470215238|FG000|Overall Study|Development of neutralizing antibodies|2|||
130616385|NCT00586924|470215239|FG001|Overall Study|Development of neutralizing antibodies|2|||
130616386|NCT00586924|470215240|FG002|Overall Study|Development of neutralizing antibodies|2|||
130616387|NCT00586924|470215241|FG003|Overall Study|Development of neutralizing antibodies|0|||
130616388|NCT00586924|470215242|FG004|Overall Study|Development of neutralizing antibodies|0|||
130616389|NCT00586924|470215243|FG005|Overall Study|Development of neutralizing antibodies|22|||
130616390|NCT00586924|470215238|FG000|Overall Study|Complete response|0|||
130616391|NCT00586924|470215239|FG001|Overall Study|Complete response|1|||
130616392|NCT00586924|470215240|FG002|Overall Study|Complete response|0|||
130616393|NCT00586924|470215241|FG003|Overall Study|Complete response|0|||
130616394|NCT00586924|470215242|FG004|Overall Study|Complete response|2|||
130616395|NCT00586924|470215243|FG005|Overall Study|Complete response|2|||
130616396|NCT00586924|470215238|FG000|Overall Study|Other|1|||
130616397|NCT00586924|470215239|FG001|Overall Study|Other|0|||
130616398|NCT00586924|470215240|FG002|Overall Study|Other|1|||
130616399|NCT00586924|470215241|FG003|Overall Study|Other|1|||
130616400|NCT00586924|470215242|FG004|Overall Study|Other|1|||
130616401|NCT00586924|470215243|FG005|Overall Study|Other|6|||
130616402|NCT04167306|470215244|FG000|Overall Study|Lost to Follow-up|2|||
130616403|NCT04167306|470215245|FG001|Overall Study|Lost to Follow-up|2|||
130616404|NCT04167306|470215246|FG002|Overall Study|Lost to Follow-up|5|||
130616405|NCT04167306|470215247|FG003|Overall Study|Lost to Follow-up|5|||
130616406|NCT04167306|470215244|FG000|Overall Study|Adverse Event|13|||
130616407|NCT04167306|470215245|FG001|Overall Study|Adverse Event|14|||
130616408|NCT04167306|470215246|FG002|Overall Study|Adverse Event|5|||
130616409|NCT04167306|470215247|FG003|Overall Study|Adverse Event|4|||
130616410|NCT04167306|470215244|FG000|Overall Study|Withdrawal by Subject|4|||
130616411|NCT04167306|470215245|FG001|Overall Study|Withdrawal by Subject|6|||
130616412|NCT04167306|470215246|FG002|Overall Study|Withdrawal by Subject|8|||
130616413|NCT04167306|470215247|FG003|Overall Study|Withdrawal by Subject|3|||
130616414|NCT04167306|470215244|FG000|Overall Study|covid|1|||
130616415|NCT04167306|470215245|FG001|Overall Study|covid|1|||
130616416|NCT04167306|470215246|FG002|Overall Study|covid|2|||
130616417|NCT04167306|470215247|FG003|Overall Study|covid|1|||
130616418|NCT04167306|470215244|FG000|Overall Study|concomitant medication|0|||
130616419|NCT04167306|470215245|FG001|Overall Study|concomitant medication|0|||
130616420|NCT04167306|470215246|FG002|Overall Study|concomitant medication|0|||
130616421|NCT04167306|470215247|FG003|Overall Study|concomitant medication|1|||
130616422|NCT04167306|470215244|FG000|Overall Study|Alcohol treatment|0|||
130616423|NCT04167306|470215245|FG001|Overall Study|Alcohol treatment|4|||
130616424|NCT04167306|470215246|FG002|Overall Study|Alcohol treatment|3|||
130616425|NCT04167306|470215247|FG003|Overall Study|Alcohol treatment|2|||
130616426|NCT04167306|470215244|FG000|Overall Study|non-compliance|0|||
130616427|NCT04167306|470215245|FG001|Overall Study|non-compliance|0|||
130616428|NCT04167306|470215246|FG002|Overall Study|non-compliance|1|||
130616429|NCT04167306|470215247|FG003|Overall Study|non-compliance|0|||
130616430|NCT04167306|470215244|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
130616431|NCT04167306|470215245|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
130616432|NCT04167306|470215246|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
130616433|NCT04167306|470215247|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
130616434|NCT04146467|470215251|FG000|Overall Study|Adverse Event|0|||
130616435|NCT04146467|470215252|FG001|Overall Study|Adverse Event|1|||
130616436|NCT04146467|470215251|FG000|Overall Study|Lost to Follow-up|0|||
130616437|NCT04146467|470215252|FG001|Overall Study|Lost to Follow-up|2|||
130616438|NCT03731364|470215255|FG000|Overall Study|Adverse Event|0|||
130616439|NCT03731364|470215256|FG001|Overall Study|Adverse Event|0|||
130616440|NCT03731364|470215257|FG002|Overall Study|Adverse Event|1|||
130616441|NCT03731364|470215258|FG003|Overall Study|Adverse Event|2|||
130616442|NCT03731364|470215259|FG004|Overall Study|Adverse Event|1|||
130616443|NCT02357849|470215260|FG000|Overall Study|Withdrawal by Subject|2|||
130616444|NCT02357849|470215261|FG001|Overall Study|Withdrawal by Subject|3|||
130616445|NCT01982773|470215265|FG000|Overall Study|Withdrawal by Subject|1|||
130616446|NCT01982773|470215266|FG001|Overall Study|Withdrawal by Subject|3|||
130616447|NCT01982773|470215265|FG000|Overall Study|Lost to Follow-up|7|||
130616448|NCT01982773|470215266|FG001|Overall Study|Lost to Follow-up|1|||
130616449|NCT01029886|470215267|FG000|Overall Study|Adverse Event|12|||
130616450|NCT01029886|470215268|FG001|Overall Study|Adverse Event|25|||
130616451|NCT01029886|470215267|FG000|Overall Study|Lost to Follow-up|1|||
130616452|NCT01029886|470215268|FG001|Overall Study|Lost to Follow-up|0|||
130616453|NCT01029886|470215267|FG000|Overall Study|Physician Decision|2|||
130616454|NCT01029886|470215268|FG001|Overall Study|Physician Decision|6|||
130616455|NCT01029886|470215267|FG000|Overall Study|Protocol Violation|17|||
130616456|NCT01029886|470215268|FG001|Overall Study|Protocol Violation|5|||
130616457|NCT01029886|470215267|FG000|Overall Study|Withdrawal by Subject|8|||
130616458|NCT01029886|470215268|FG001|Overall Study|Withdrawal by Subject|18|||
130616459|NCT01029886|470215267|FG000|Overall Study|Entry Criteria Not Met|13|||
130616460|NCT01029886|470215268|FG001|Overall Study|Entry Criteria Not Met|5|||
130616461|NCT01029886|470215267|FG000|Overall Study|Sponsor Decision|1|||
130616462|NCT01029886|470215268|FG001|Overall Study|Sponsor Decision|0|||
130616463|NCT01029886|470215267|FG000|Overall Study|Loss Glucose Control|7|||
130616464|NCT01029886|470215268|FG001|Overall Study|Loss Glucose Control|1|||
130616465|NCT03294681|470215269|FG000|Overall Study|Withdrawal by Subject|1|||
130616466|NCT01778127|470215270|FG000|Overall Study|Lost to Follow-up|5|||
130616467|NCT01778127|470215271|FG001|Overall Study|Lost to Follow-up|1|||
130616468|NCT01778127|470215272|FG002|Overall Study|Lost to Follow-up|2|||
130616469|NCT01778127|470215270|FG000|Overall Study|Withdrawal by Subject|3|||
130616470|NCT01778127|470215271|FG001|Overall Study|Withdrawal by Subject|1|||
130616471|NCT01778127|470215272|FG002|Overall Study|Withdrawal by Subject|4|||
130616472|NCT01348425|470215273|FG000|Overall Study|Imaging was not taken.|1|||
130616473|NCT01348425|470215274|FG001|Overall Study|Imaging was not taken.|1|||
130616474|NCT03722784|470215275|FG000|Overall Study|Withdrawal by Subject|1|||
130616475|NCT03722784|470215276|FG001|Overall Study|Withdrawal by Subject|0|||
130616476|NCT03722784|470215275|FG000|Overall Study|Physician Decision|1|||
130616477|NCT03722784|470215276|FG001|Overall Study|Physician Decision|1|||
130616478|NCT03722784|470215275|FG000|Overall Study|Protocol Violation|0|||
130616479|NCT03722784|470215276|FG001|Overall Study|Protocol Violation|1|||
130616480|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
130616481|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
130616482|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
130616483|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
130616484|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
130616485|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
130616486|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130616487|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
130616488|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
130616489|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
130616490|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130616491|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130616492|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130616493|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130616494|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
130616495|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130616496|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130616497|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130616498|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130616499|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130616500|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
130616501|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
130616502|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130616503|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130616504|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
130616505|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
130616506|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
130616507|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
130616508|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
130616509|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
130616510|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130616511|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130616512|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130616513|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
130616514|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130616515|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130616516|NCT01963208|470215277|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130616517|NCT01963208|470215278|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130616518|NCT01963208|470215279|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130616519|NCT01963208|470215280|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
130616520|NCT01963208|470215281|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130616521|NCT01963208|470215282|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130616522|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130616523|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130616524|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130616525|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130616526|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
130616527|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
130616528|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130616529|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130616530|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130616531|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130616532|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
130616533|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
130616534|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130616535|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130616536|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130616537|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130616538|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130616539|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
130616540|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130616541|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130616542|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130616543|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130616544|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130616545|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
130616546|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
130616547|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
130616548|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
130616549|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
130616550|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
130616551|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
130616552|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130616553|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130616554|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130616555|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130616556|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
130616557|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
130616558|NCT01963208|470215277|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
130616559|NCT01963208|470215278|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
130616560|NCT01963208|470215279|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
130616561|NCT01963208|470215280|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
130616562|NCT01963208|470215281|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
130616563|NCT01963208|470215282|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
130616564|NCT00448916|470215283|FG000|Overall Study|Adverse Event|2|||
130616565|NCT00448916|470215284|FG001|Overall Study|Adverse Event|2|||
130616566|NCT00448916|470215285|FG002|Overall Study|Adverse Event|3|||
130616567|NCT00448916|470215286|FG003|Overall Study|Adverse Event|2|||
130616568|NCT00448916|470215283|FG000|Overall Study|Lack of Efficacy|1|||
130616569|NCT00448916|470215284|FG001|Overall Study|Lack of Efficacy|0|||
130616570|NCT00448916|470215285|FG002|Overall Study|Lack of Efficacy|2|||
130616571|NCT00448916|470215286|FG003|Overall Study|Lack of Efficacy|1|||
130616572|NCT00448916|470215283|FG000|Overall Study|Withdrawal by Subject|3|||
130616573|NCT00448916|470215284|FG001|Overall Study|Withdrawal by Subject|3|||
130616574|NCT00448916|470215285|FG002|Overall Study|Withdrawal by Subject|1|||
130616575|NCT00448916|470215286|FG003|Overall Study|Withdrawal by Subject|1|||
130616576|NCT00448916|470215283|FG000|Overall Study|Other|1|||
130616577|NCT00448916|470215284|FG001|Overall Study|Other|0|||
130616578|NCT00448916|470215285|FG002|Overall Study|Other|0|||
130616579|NCT00448916|470215286|FG003|Overall Study|Other|0|||
130616580|NCT00448916|470215283|FG000|Overall Study|Lost to Follow-up|0|||
130616581|NCT00448916|470215284|FG001|Overall Study|Lost to Follow-up|1|||
130616582|NCT00448916|470215285|FG002|Overall Study|Lost to Follow-up|0|||
130616583|NCT00448916|470215286|FG003|Overall Study|Lost to Follow-up|1|||
130616584|NCT00448916|470215283|FG000|Overall Study|Protocol Violation|0|||
130616585|NCT00448916|470215284|FG001|Overall Study|Protocol Violation|0|||
130616586|NCT00448916|470215285|FG002|Overall Study|Protocol Violation|0|||
130616587|NCT00448916|470215286|FG003|Overall Study|Protocol Violation|1|||
130616588|NCT03707158|470215289|FG000|Midtreatment|Lost to Follow-up|16|||
130616589|NCT03707158|470215290|FG001|Midtreatment|Lost to Follow-up|7|||
130616590|NCT03707158|470215289|FG000|Midtreatment|Withdrawal by Subject|28|||
130616591|NCT03707158|470215290|FG001|Midtreatment|Withdrawal by Subject|19|||
130616592|NCT03707158|470215289|FG000|Posttreatment|Lost to Follow-up|0|||
130616593|NCT03707158|470215290|FG001|Posttreatment|Lost to Follow-up|5|||
130616594|NCT03707158|470215289|FG000|Follow-up|Lost to Follow-up|19|||
130616595|NCT03707158|470215290|FG001|Follow-up|Lost to Follow-up|18|||
130616596|NCT03707158|470215289|FG000|Follow-up|Withdrawal by Subject|13|||
130616597|NCT03707158|470215290|FG001|Follow-up|Withdrawal by Subject|6|||
130616598|NCT01208038|470215291|FG000|Overall Study|Withdrawal by Subject|1|||
130616599|NCT03260205|470215292|FG000|Overall Study|Adverse Event|2|||
130616600|NCT03260205|470215293|FG001|Overall Study|Adverse Event|0|||
130616601|NCT03260205|470215294|FG002|Overall Study|Adverse Event|2|||
130616602|NCT03260205|470215295|FG003|Overall Study|Adverse Event|2|||
130616603|NCT03260205|470215296|FG004|Overall Study|Adverse Event|4|||
130616604|NCT03260205|470215292|FG000|Overall Study|Lost to Follow-up|2|||
130616605|NCT03260205|470215293|FG001|Overall Study|Lost to Follow-up|2|||
130616606|NCT03260205|470215294|FG002|Overall Study|Lost to Follow-up|1|||
130616607|NCT03260205|470215295|FG003|Overall Study|Lost to Follow-up|1|||
130616608|NCT03260205|470215296|FG004|Overall Study|Lost to Follow-up|5|||
130616609|NCT03260205|470215292|FG000|Overall Study|Protocol Violation|0|||
130616610|NCT03260205|470215293|FG001|Overall Study|Protocol Violation|0|||
130616611|NCT03260205|470215294|FG002|Overall Study|Protocol Violation|2|||
130616612|NCT03260205|470215295|FG003|Overall Study|Protocol Violation|0|||
130616613|NCT03260205|470215296|FG004|Overall Study|Protocol Violation|1|||
130616614|NCT03260205|470215292|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
130616615|NCT03260205|470215293|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
130616616|NCT03260205|470215294|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
130616617|NCT03260205|470215295|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
130616618|NCT03260205|470215296|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
130616619|NCT03260205|470215292|FG000|Overall Study|Other: Unspecified|0|||
130616620|NCT03260205|470215293|FG001|Overall Study|Other: Unspecified|0|||
130616621|NCT03260205|470215294|FG002|Overall Study|Other: Unspecified|3|||
130616622|NCT03260205|470215295|FG003|Overall Study|Other: Unspecified|1|||
130616623|NCT03260205|470215296|FG004|Overall Study|Other: Unspecified|1|||
130616624|NCT03260205|470215292|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
130616625|NCT03260205|470215293|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
130616626|NCT03260205|470215294|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
130616627|NCT03260205|470215295|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
130616628|NCT03260205|470215296|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
130616629|NCT05301322|470215297|FG000|Overall Study|Adverse Event|7|||
130616630|NCT05301322|470215298|FG001|Overall Study|Adverse Event|3|||
130616631|NCT05301322|470215297|FG000|Overall Study|Death|0|||
130616632|NCT05301322|470215298|FG001|Overall Study|Death|1|||
130616633|NCT05301322|470215297|FG000|Overall Study|Lost to Follow-up|2|||
130616634|NCT05301322|470215298|FG001|Overall Study|Lost to Follow-up|1|||
130616635|NCT05301322|470215297|FG000|Overall Study|Protocol Violation|3|||
130616636|NCT05301322|470215298|FG001|Overall Study|Protocol Violation|1|||
130616637|NCT05301322|470215297|FG000|Overall Study|Withdrawal by Subject|3|||
130616638|NCT05301322|470215298|FG001|Overall Study|Withdrawal by Subject|0|||
130616639|NCT05301322|470215297|FG000|Overall Study|Other|4|||
130616640|NCT05301322|470215298|FG001|Overall Study|Other|0|||
130616641|NCT00808249|470215301|FG000|Overall Study|Adverse Event|4|||
130616642|NCT00808249|470215302|FG001|Overall Study|Adverse Event|7|||
130616643|NCT00808249|470215303|FG002|Overall Study|Adverse Event|10|||
130616644|NCT00808249|470215304|FG003|Overall Study|Adverse Event|6|||
130616645|NCT00808249|470215301|FG000|Overall Study|Lost to Follow-up|2|||
130616646|NCT00808249|470215302|FG001|Overall Study|Lost to Follow-up|3|||
130616647|NCT00808249|470215303|FG002|Overall Study|Lost to Follow-up|3|||
130616648|NCT00808249|470215304|FG003|Overall Study|Lost to Follow-up|5|||
130616649|NCT00808249|470215301|FG000|Overall Study|Withdrawal by Subject|4|||
130616650|NCT00808249|470215302|FG001|Overall Study|Withdrawal by Subject|0|||
130616651|NCT00808249|470215303|FG002|Overall Study|Withdrawal by Subject|2|||
130616652|NCT00808249|470215304|FG003|Overall Study|Withdrawal by Subject|4|||
130616653|NCT00808249|470215301|FG000|Overall Study|Protocol Violation|3|||
130616654|NCT00808249|470215302|FG001|Overall Study|Protocol Violation|3|||
130616655|NCT00808249|470215303|FG002|Overall Study|Protocol Violation|3|||
130616656|NCT00808249|470215304|FG003|Overall Study|Protocol Violation|0|||
130616657|NCT00808249|470215301|FG000|Overall Study|Lack of Efficacy|1|||
130616658|NCT00808249|470215302|FG001|Overall Study|Lack of Efficacy|1|||
130616659|NCT00808249|470215303|FG002|Overall Study|Lack of Efficacy|0|||
130616660|NCT00808249|470215304|FG003|Overall Study|Lack of Efficacy|0|||
130616661|NCT00808249|470215301|FG000|Overall Study|study specific discontinuation criteria|1|||
130616662|NCT00808249|470215302|FG001|Overall Study|study specific discontinuation criteria|0|||
130616663|NCT00808249|470215303|FG002|Overall Study|study specific discontinuation criteria|1|||
130616664|NCT00808249|470215304|FG003|Overall Study|study specific discontinuation criteria|0|||
130616665|NCT00808249|470215301|FG000|Overall Study|All other reasons|2|||
130616666|NCT00808249|470215302|FG001|Overall Study|All other reasons|1|||
130616667|NCT00808249|470215303|FG002|Overall Study|All other reasons|3|||
130616668|NCT00808249|470215304|FG003|Overall Study|All other reasons|1|||
130616669|NCT03829332|470215305|FG000|Overall Study|Death|225|||
130616670|NCT03829332|470215306|FG001|Overall Study|Death|230|||
130616671|NCT03829332|470215305|FG000|Overall Study|Lost to Follow-up|1|||
130616672|NCT03829332|470215306|FG001|Overall Study|Lost to Follow-up|3|||
130616673|NCT03829332|470215305|FG000|Overall Study|Physician Decision|1|||
130616674|NCT03829332|470215306|FG001|Overall Study|Physician Decision|0|||
130616675|NCT03829332|470215305|FG000|Overall Study|Sponsor Decision|71|||
130616676|NCT03829332|470215306|FG001|Overall Study|Sponsor Decision|72|||
130616677|NCT03829332|470215305|FG000|Overall Study|Withdrawal by Subject|11|||
130616678|NCT03829332|470215306|FG001|Overall Study|Withdrawal by Subject|9|||
130616679|NCT00430521|470215307|FG000|Overall Study|Adverse Event|0|||
130616680|NCT00430521|470215308|FG001|Overall Study|Adverse Event|0|||
130616681|NCT00430521|470215309|FG002|Overall Study|Adverse Event|0|||
130616682|NCT00430521|470215310|FG003|Overall Study|Adverse Event|0|||
130616683|NCT00430521|470215311|FG004|Overall Study|Adverse Event|0|||
130616684|NCT00430521|470215312|FG005|Overall Study|Adverse Event|2|||
130616685|NCT00430521|470215313|FG006|Overall Study|Adverse Event|1|||
130616686|NCT00430521|470215314|FG007|Overall Study|Adverse Event|0|||
130616687|NCT00430521|470215307|FG000|Overall Study|Lost to Follow-up|7|||
130616688|NCT00430521|470215308|FG001|Overall Study|Lost to Follow-up|8|||
130616689|NCT00430521|470215309|FG002|Overall Study|Lost to Follow-up|3|||
130616690|NCT00430521|470215310|FG003|Overall Study|Lost to Follow-up|5|||
130616691|NCT00430521|470215311|FG004|Overall Study|Lost to Follow-up|5|||
130616692|NCT00430521|470215312|FG005|Overall Study|Lost to Follow-up|2|||
130616693|NCT00430521|470215313|FG006|Overall Study|Lost to Follow-up|8|||
130616694|NCT00430521|470215314|FG007|Overall Study|Lost to Follow-up|10|||
130616695|NCT00430521|470215307|FG000|Overall Study|Pregnancy|0|||
130616696|NCT00430521|470215308|FG001|Overall Study|Pregnancy|0|||
130616697|NCT00430521|470215309|FG002|Overall Study|Pregnancy|0|||
130616698|NCT00430521|470215310|FG003|Overall Study|Pregnancy|0|||
130616699|NCT00430521|470215311|FG004|Overall Study|Pregnancy|0|||
130616700|NCT00430521|470215312|FG005|Overall Study|Pregnancy|0|||
130616701|NCT00430521|470215313|FG006|Overall Study|Pregnancy|1|||
130616702|NCT00430521|470215314|FG007|Overall Study|Pregnancy|0|||
130616703|NCT00430521|470215307|FG000|Overall Study|Vaccine Expired|0|||
130616704|NCT00430521|470215308|FG001|Overall Study|Vaccine Expired|0|||
130616705|NCT00430521|470215309|FG002|Overall Study|Vaccine Expired|0|||
130616706|NCT00430521|470215310|FG003|Overall Study|Vaccine Expired|0|||
130616707|NCT00430521|470215311|FG004|Overall Study|Vaccine Expired|0|||
130616708|NCT00430521|470215312|FG005|Overall Study|Vaccine Expired|1|||
130616709|NCT00430521|470215313|FG006|Overall Study|Vaccine Expired|0|||
130616710|NCT00430521|470215314|FG007|Overall Study|Vaccine Expired|0|||
130616711|NCT00430521|470215307|FG000|Overall Study|Protocol Violation|1|||
130616712|NCT00430521|470215308|FG001|Overall Study|Protocol Violation|0|||
130616713|NCT00430521|470215309|FG002|Overall Study|Protocol Violation|0|||
130616714|NCT00430521|470215310|FG003|Overall Study|Protocol Violation|0|||
130616715|NCT00430521|470215311|FG004|Overall Study|Protocol Violation|0|||
130616716|NCT00430521|470215312|FG005|Overall Study|Protocol Violation|0|||
130616717|NCT00430521|470215313|FG006|Overall Study|Protocol Violation|0|||
130616718|NCT00430521|470215314|FG007|Overall Study|Protocol Violation|0|||
130616719|NCT00430521|470215307|FG000|Overall Study|Withdrawal by Subject|3|||
130616720|NCT00430521|470215308|FG001|Overall Study|Withdrawal by Subject|1|||
130616721|NCT00430521|470215309|FG002|Overall Study|Withdrawal by Subject|0|||
130616722|NCT00430521|470215310|FG003|Overall Study|Withdrawal by Subject|3|||
130616723|NCT00430521|470215311|FG004|Overall Study|Withdrawal by Subject|0|||
130616724|NCT00430521|470215312|FG005|Overall Study|Withdrawal by Subject|0|||
130616725|NCT00430521|470215313|FG006|Overall Study|Withdrawal by Subject|0|||
130616726|NCT00430521|470215314|FG007|Overall Study|Withdrawal by Subject|2|||
130616727|NCT05108805|470215315|FG000|Overall Study|T-cell expansion was not successful.|5|||
130616728|NCT04752189|470215316|FG000|Overall Study|Withdrawal by Subject|0|||
130616729|NCT04752189|470215317|FG001|Overall Study|Withdrawal by Subject|150|||
130616730|NCT04752189|470215316|FG000|Overall Study|Lost to Follow-up|261|||
130616731|NCT04752189|470215317|FG001|Overall Study|Lost to Follow-up|126|||
130616732|NCT03422133|470215318|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
130616733|NCT03422133|470215319|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
130616734|NCT03003403|470215320|FG000|Overall Study|Ineligible|8|||
130616735|NCT03003403|470215321|FG001|Overall Study|Ineligible|7|||
130616736|NCT03003403|470215320|FG000|Overall Study|Withdrawal by Subject|3|||
130616737|NCT03003403|470215321|FG001|Overall Study|Withdrawal by Subject|1|||
130616738|NCT02198651|470216908|FG000|Lead-in Period|Withdrew consent|13|||
130616739|NCT02198651|470216909|FG001|Lead-in Period|Withdrew consent|0|||
130616740|NCT02198651|470216910|FG002|Lead-in Period|Withdrew consent|0|||
130616741|NCT02198651|470216911|FG003|Lead-in Period|Withdrew consent|0|||
130616742|NCT02198651|470216912|FG004|Lead-in Period|Withdrew consent|0|||
130616743|NCT02198651|470216908|FG000|Lead-in Period|Adverse Event|2|||
130616744|NCT02198651|470216909|FG001|Lead-in Period|Adverse Event|0|||
130616745|NCT02198651|470216910|FG002|Lead-in Period|Adverse Event|0|||
130616746|NCT02198651|470216911|FG003|Lead-in Period|Adverse Event|0|||
130616747|NCT02198651|470216912|FG004|Lead-in Period|Adverse Event|0|||
130616748|NCT02198651|470216908|FG000|Lead-in Period|Other, not specified|22|||
130616749|NCT02198651|470216909|FG001|Lead-in Period|Other, not specified|0|||
130616750|NCT02198651|470216910|FG002|Lead-in Period|Other, not specified|0|||
130616751|NCT02198651|470216911|FG003|Lead-in Period|Other, not specified|0|||
130616752|NCT02198651|470216912|FG004|Lead-in Period|Other, not specified|0|||
130616753|NCT02198651|470216908|FG000|Double-blind Period|Withdrew consent|0|||
130616754|NCT02198651|470216909|FG001|Double-blind Period|Withdrew consent|4|||
130616755|NCT02198651|470216910|FG002|Double-blind Period|Withdrew consent|0|||
130616756|NCT02198651|470216911|FG003|Double-blind Period|Withdrew consent|0|||
130616757|NCT02198651|470216912|FG004|Double-blind Period|Withdrew consent|0|||
130616758|NCT02198651|470216908|FG000|Double-blind Period|Adverse Event|0|||
130616759|NCT02198651|470216909|FG001|Double-blind Period|Adverse Event|1|||
130616760|NCT02198651|470216910|FG002|Double-blind Period|Adverse Event|0|||
130616761|NCT02198651|470216911|FG003|Double-blind Period|Adverse Event|0|||
130616762|NCT02198651|470216912|FG004|Double-blind Period|Adverse Event|0|||
130616763|NCT02198651|470216908|FG000|Double-blind Period|Other, not specified|0|||
130616764|NCT02198651|470216909|FG001|Double-blind Period|Other, not specified|4|||
130616765|NCT02198651|470216910|FG002|Double-blind Period|Other, not specified|1|||
130616766|NCT02198651|470216911|FG003|Double-blind Period|Other, not specified|0|||
130616767|NCT02198651|470216912|FG004|Double-blind Period|Other, not specified|0|||
130616768|NCT02198651|470216908|FG000|Open-label Rescue Period|Withdrew consent|0|||
130616769|NCT02198651|470216909|FG001|Open-label Rescue Period|Withdrew consent|0|||
130616770|NCT02198651|470216910|FG002|Open-label Rescue Period|Withdrew consent|0|||
130616771|NCT02198651|470216911|FG003|Open-label Rescue Period|Withdrew consent|2|||
130616772|NCT02198651|470216912|FG004|Open-label Rescue Period|Withdrew consent|0|||
130616773|NCT02198651|470216908|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130616774|NCT02198651|470216909|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130616775|NCT02198651|470216910|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130616776|NCT02198651|470216911|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
130616777|NCT02198651|470216912|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130616778|NCT02871401|470216919|FG000|Overall Study|Adverse Event|1|||
130616779|NCT02871401|470216920|FG001|Overall Study|Adverse Event|0|||
130616780|NCT01120379|470216921|FG000|One Year Timepoint|Withdrawal by Subject|41|||
130616781|NCT01120379|470216921|FG000|One Year Timepoint|Lost to Follow-up|115|||
130616782|NCT01120379|470216921|FG000|One Year Timepoint|Death|108|||
130616783|NCT01120379|470216921|FG000|One Year Timepoint|Physician Decision|9|||
130616784|NCT01120379|470216921|FG000|One Year Timepoint|Any other reason for early termination|5|||
130616785|NCT01120379|470216921|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
130616786|NCT01120379|470216921|FG000|Two Year Timepoint|Lost to Follow-up|87|||
130616787|NCT01120379|470216921|FG000|Two Year Timepoint|Death|123|||
130616788|NCT01120379|470216921|FG000|Two Year Timepoint|Physician Decision|12|||
130616789|NCT01120379|470216921|FG000|Two Year Timepoint|Any other reason for early termination|4|||
130616790|NCT01120379|470216921|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
130616791|NCT01120379|470216921|FG000|Three Year Timepoint|Lost to Follow-up|43|||
130616792|NCT01120379|470216921|FG000|Three Year Timepoint|Death|120|||
130616793|NCT01120379|470216921|FG000|Three Year Timepoint|Physician Decision|9|||
130616794|NCT01120379|470216921|FG000|Three Year Timepoint|Any other reason for early termination|17|||
130616795|NCT01120379|470216921|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
130616796|NCT01120379|470216921|FG000|Four Year Timepoint|Lost to Follow-up|10|||
130616797|NCT01120379|470216921|FG000|Four Year Timepoint|Death|131|||
130616798|NCT01120379|470216921|FG000|Four Year Timepoint|Physician Decision|5|||
130616799|NCT01120379|470216921|FG000|Four Year Timepoint|Any other reason for early termination|217|||
130616800|NCT02370498|470216927|FG000|Overall Study|Adverse Event|10|||
130616801|NCT02370498|470216928|FG001|Overall Study|Adverse Event|8|||
130616802|NCT02370498|470216927|FG000|Overall Study|Death|263|||
130616803|NCT02370498|470216928|FG001|Overall Study|Death|265|||
130616804|NCT02370498|470216927|FG000|Overall Study|Protocol Violation|1|||
130616805|NCT02370498|470216928|FG001|Overall Study|Protocol Violation|2|||
130616806|NCT02370498|470216927|FG000|Overall Study|Withdrawal by Subject|7|||
130616807|NCT02370498|470216928|FG001|Overall Study|Withdrawal by Subject|12|||
130616808|NCT02370498|470216927|FG000|Overall Study|Sponsor's decision|15|||
130616809|NCT02370498|470216928|FG001|Overall Study|Sponsor's decision|9|||
130616810|NCT01089582|470216930|FG000|Overall Study|Death|2|||
130616811|NCT01089582|470216930|FG000|Overall Study|Adverse Event|15|||
130616812|NCT01089582|470216930|FG000|Overall Study|Lost to Follow-up|8|||
130616813|NCT01089582|470216930|FG000|Overall Study|Other|4|||
130616814|NCT01089582|470216930|FG000|Overall Study|Withdrawal by Subject|1|||
130616815|NCT02108600|470216931|FG000|Overall Study|Withdrawal by Subject|2|||
130616816|NCT02108600|470216932|FG001|Overall Study|Withdrawal by Subject|0|||
130616817|NCT02108600|470216931|FG000|Overall Study|Lost to Follow-up|1|||
130616818|NCT02108600|470216932|FG001|Overall Study|Lost to Follow-up|1|||
130616819|NCT02432040|470216935|FG000|Overall Study|Lack of Efficacy|3|||
130616820|NCT02432040|470216936|FG001|Overall Study|Lack of Efficacy|0|||
130616821|NCT02432040|470216935|FG000|Overall Study|Lost to Follow-up|4|||
130616822|NCT02432040|470216936|FG001|Overall Study|Lost to Follow-up|5|||
130616823|NCT02432040|470216935|FG000|Overall Study|Physician Decision|1|||
130616824|NCT02432040|470216936|FG001|Overall Study|Physician Decision|1|||
130616825|NCT01514188|470216937|FG000|Overall Study|Adverse Event|3|||
130616826|NCT01514188|470216938|FG001|Overall Study|Adverse Event|5|||
130616827|NCT01514188|470216937|FG000|Overall Study|Withdrawal by Subject|2|||
130616828|NCT01514188|470216938|FG001|Overall Study|Withdrawal by Subject|4|||
130616829|NCT01514188|470216937|FG000|Overall Study|Protocol Violation|2|||
130616830|NCT01514188|470216938|FG001|Overall Study|Protocol Violation|4|||
130616831|NCT01514188|470216937|FG000|Overall Study|Physician Decision|0|||
130616832|NCT01514188|470216938|FG001|Overall Study|Physician Decision|2|||
130616833|NCT01514188|470216937|FG000|Overall Study|Disease Progression|13|||
130616834|NCT01514188|470216938|FG001|Overall Study|Disease Progression|14|||
130616835|NCT01514188|470216937|FG000|Overall Study|Death|1|||
130616836|NCT01514188|470216938|FG001|Overall Study|Death|3|||
130616837|NCT01514188|470216937|FG000|Overall Study|Other|2|||
130616838|NCT01514188|470216938|FG001|Overall Study|Other|1|||
130616839|NCT02932332|470216943|FG000|Overall Study|Withdrawal by Subject|1|||
130616840|NCT02932332|470216944|FG001|Overall Study|Withdrawal by Subject|1|||
130616841|NCT02932332|470216945|FG002|Overall Study|Withdrawal by Subject|0|||
130616842|NCT02932332|470216946|FG003|Overall Study|Withdrawal by Subject|1|||
130616843|NCT02932332|470216943|FG000|Overall Study|Chest pain|0|||
130616844|NCT02932332|470216944|FG001|Overall Study|Chest pain|0|||
130616845|NCT02932332|470216945|FG002|Overall Study|Chest pain|0|||
130616846|NCT02932332|470216946|FG003|Overall Study|Chest pain|1|||
130616847|NCT02932332|470216943|FG000|Overall Study|Not Dyspneic cough|1|||
130616848|NCT02932332|470216944|FG001|Overall Study|Not Dyspneic cough|2|||
130616849|NCT02932332|470216945|FG002|Overall Study|Not Dyspneic cough|1|||
130616850|NCT02932332|470216946|FG003|Overall Study|Not Dyspneic cough|0|||
130616851|NCT04533815|470216949|FG000|Overall Study|Adverse Event|2|||
130616852|NCT04533815|470216949|FG000|Overall Study|Site withdrew|5|||
130616853|NCT00488592|470216952|FG000|Overall Study|Withdrawal by Subject|1|||
130616854|NCT00488592|470216952|FG000|Overall Study|Disease progression|1|||
130616855|NCT00488592|470216952|FG000|Overall Study|Enrolled but not treated|1|||
130616856|NCT05836818|470216953|FG000|Overall Study|Physician Decision|1|||
130616857|NCT05836818|470216954|FG001|Overall Study|Physician Decision|1|||
130616858|NCT05836818|470216955|FG002|Overall Study|Physician Decision|0|||
130616859|NCT05836818|470216953|FG000|Overall Study|Withdrawal by Subject|0|||
130616860|NCT05836818|470216954|FG001|Overall Study|Withdrawal by Subject|0|||
130616861|NCT05836818|470216955|FG002|Overall Study|Withdrawal by Subject|1|||
130616862|NCT05836818|470216953|FG000|Overall Study|Later found to be previously vaccinated|0|||
130616863|NCT05836818|470216954|FG001|Overall Study|Later found to be previously vaccinated|1|||
130616864|NCT05836818|470216955|FG002|Overall Study|Later found to be previously vaccinated|3|||
130616865|NCT05836818|470216953|FG000|Overall Study|Pregnancy|0|||
130616866|NCT05836818|470216954|FG001|Overall Study|Pregnancy|1|||
130616867|NCT05836818|470216955|FG002|Overall Study|Pregnancy|0|||
130616868|NCT05836818|470216953|FG000|Overall Study|Allergic to vaccines|0|||
130616869|NCT05836818|470216954|FG001|Overall Study|Allergic to vaccines|1|||
130616870|NCT05836818|470216955|FG002|Overall Study|Allergic to vaccines|0|||
130616871|NCT03977727|470216956|FG000|Second Treatment|Lost to Follow-up|0|||
130616872|NCT03977727|470216957|FG001|Second Treatment|Lost to Follow-up|3|||
130616873|NCT00621855|470216958|FG000|Overall Study|Adverse Event|32|||
130616874|NCT00621855|470216959|FG001|Overall Study|Adverse Event|31|||
130616875|NCT00621855|470216960|FG002|Overall Study|Adverse Event|48|||
130616876|NCT00621855|470216961|FG003|Overall Study|Adverse Event|34|||
130616877|NCT00621855|470216962|FG004|Overall Study|Adverse Event|31|||
130616878|NCT00621855|470216958|FG000|Overall Study|Lost to Follow-up|0|||
130616879|NCT00621855|470216959|FG001|Overall Study|Lost to Follow-up|1|||
130616880|NCT00621855|470216960|FG002|Overall Study|Lost to Follow-up|3|||
130616881|NCT00621855|470216961|FG003|Overall Study|Lost to Follow-up|4|||
130616882|NCT00621855|470216962|FG004|Overall Study|Lost to Follow-up|1|||
130616883|NCT00621855|470216958|FG000|Overall Study|Protocol Violation|16|||
130616884|NCT00621855|470216959|FG001|Overall Study|Protocol Violation|8|||
130616885|NCT00621855|470216960|FG002|Overall Study|Protocol Violation|6|||
130616886|NCT00621855|470216961|FG003|Overall Study|Protocol Violation|7|||
130616887|NCT00621855|470216962|FG004|Overall Study|Protocol Violation|8|||
130616888|NCT00621855|470216958|FG000|Overall Study|Withdrawal by Subject|16|||
130616889|NCT00621855|470216959|FG001|Overall Study|Withdrawal by Subject|11|||
130616890|NCT00621855|470216960|FG002|Overall Study|Withdrawal by Subject|13|||
130616891|NCT00621855|470216961|FG003|Overall Study|Withdrawal by Subject|13|||
130616892|NCT00621855|470216962|FG004|Overall Study|Withdrawal by Subject|9|||
130616893|NCT00621855|470216958|FG000|Overall Study|Other|9|||
130616894|NCT00621855|470216959|FG001|Overall Study|Other|7|||
130616895|NCT00621855|470216960|FG002|Overall Study|Other|6|||
130616896|NCT00621855|470216961|FG003|Overall Study|Other|5|||
130616897|NCT00621855|470216962|FG004|Overall Study|Other|4|||
130616898|NCT00621855|470216958|FG000|Overall Study|Patients did not receive study drug|3|||
130616899|NCT00621855|470216959|FG001|Overall Study|Patients did not receive study drug|3|||
130616900|NCT00621855|470216960|FG002|Overall Study|Patients did not receive study drug|5|||
130616901|NCT00621855|470216961|FG003|Overall Study|Patients did not receive study drug|4|||
130616902|NCT00621855|470216962|FG004|Overall Study|Patients did not receive study drug|2|||
130616903|NCT02953782|470216963|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
130616904|NCT02953782|470216964|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
130616905|NCT02953782|470216965|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
130616906|NCT02953782|470216966|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
130616907|NCT02953782|470216967|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
130616908|NCT02953782|470216968|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130616909|NCT02953782|470216969|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130616910|NCT02953782|470216970|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130616911|NCT02953782|470216963|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
130616912|NCT02953782|470216964|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130616913|NCT02953782|470216965|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
130616914|NCT02953782|470216966|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130616915|NCT02953782|470216967|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
130616916|NCT02953782|470216968|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130616917|NCT02953782|470216969|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130616918|NCT02953782|470216970|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130616919|NCT02953782|470216963|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130616920|NCT02953782|470216964|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130616921|NCT02953782|470216965|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130616922|NCT02953782|470216966|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130616923|NCT02953782|470216967|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130616924|NCT02953782|470216968|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130616925|NCT02953782|470216969|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130616926|NCT02953782|470216970|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130616927|NCT02953782|470216963|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616928|NCT02953782|470216964|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616929|NCT02953782|470216965|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
130616930|NCT02953782|470216966|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
130616931|NCT02953782|470216967|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616932|NCT02953782|470216968|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616933|NCT02953782|470216969|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616934|NCT02953782|470216970|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130616935|NCT02953782|470216963|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130616936|NCT02953782|470216964|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130616937|NCT02953782|470216965|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130616938|NCT02953782|470216966|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130616939|NCT02953782|470216967|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130616940|NCT02953782|470216968|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
130616941|NCT02953782|470216969|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
130616942|NCT02953782|470216970|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
130616943|NCT02953782|470216963|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130616944|NCT02953782|470216964|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130616945|NCT02953782|470216965|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130616946|NCT02953782|470216966|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130616947|NCT02953782|470216967|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130616948|NCT02953782|470216968|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
130616949|NCT02953782|470216969|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
130616950|NCT02953782|470216970|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
130616951|NCT02953782|470216963|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130616952|NCT02953782|470216964|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130616953|NCT02953782|470216965|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130616954|NCT02953782|470216966|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130616955|NCT02953782|470216967|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130616956|NCT02953782|470216968|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
130616957|NCT02953782|470216969|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
130616958|NCT02953782|470216970|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
130616959|NCT02953782|470216963|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616960|NCT02953782|470216964|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616961|NCT02953782|470216965|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616962|NCT02953782|470216966|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616963|NCT02953782|470216967|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616964|NCT02953782|470216968|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616965|NCT02953782|470216969|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
130616966|NCT02953782|470216970|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130616967|NCT01737840|470216971|FG000|Overall Study|Diagnosed with an other pathology|2|||
130616968|NCT01737840|470216972|FG001|Overall Study|Diagnosed with an other pathology|2|||
130616969|NCT03105700|470216973|FG000|Overall Study|screen fail|3|||
130616970|NCT03105700|470216973|FG000|Overall Study|Lost to Follow-up|4|||
130616971|NCT00403559|470216974|FG000|Overall Study|Adverse Event|0|||
130616972|NCT00403559|470216975|FG001|Overall Study|Adverse Event|1|||
130616973|NCT00403559|470216974|FG000|Overall Study|Lost to Follow-up|3|||
130616974|NCT00403559|470216975|FG001|Overall Study|Lost to Follow-up|3|||
130616975|NCT00403559|470216974|FG000|Overall Study|Withdrawal by Subject|1|||
130616976|NCT00403559|470216975|FG001|Overall Study|Withdrawal by Subject|0|||
130616977|NCT01253421|470216978|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
130616978|NCT01253421|470216979|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
130616979|NCT01253421|470216980|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
130616980|NCT01253421|470216981|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
130616981|NCT01253421|470216982|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
130616982|NCT01253421|470216978|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
130616983|NCT01253421|470216979|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
130616984|NCT01253421|470216980|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
130616985|NCT01253421|470216981|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
130616986|NCT01253421|470216982|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
130616987|NCT01253421|470216978|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
130616988|NCT01253421|470216979|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
130616989|NCT01253421|470216980|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
130616990|NCT01253421|470216981|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
130616991|NCT01253421|470216982|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
130616992|NCT01253421|470216978|FG000|Assessment and Scheduling|Physician Decision|1|||
130616993|NCT01253421|470216979|FG001|Assessment and Scheduling|Physician Decision|0|||
130616994|NCT01253421|470216980|FG002|Assessment and Scheduling|Physician Decision|0|||
130616995|NCT01253421|470216981|FG003|Assessment and Scheduling|Physician Decision|0|||
130616996|NCT01253421|470216982|FG004|Assessment and Scheduling|Physician Decision|0|||
130616997|NCT01253421|470216978|FG000|Drug+Scanning Visit|Physician Decision|0|||
130616998|NCT01253421|470216979|FG001|Drug+Scanning Visit|Physician Decision|0|||
130616999|NCT01253421|470216980|FG002|Drug+Scanning Visit|Physician Decision|0|||
130617000|NCT01253421|470216981|FG003|Drug+Scanning Visit|Physician Decision|0|||
130617001|NCT01253421|470216982|FG004|Drug+Scanning Visit|Physician Decision|1|||
130617002|NCT01449682|470216983|FG000|Overall Study|Death|0|||
130617003|NCT01449682|470216984|FG001|Overall Study|Death|1|||
130617004|NCT01449682|470216983|FG000|Overall Study|Adverse Event|1|||
130617005|NCT01449682|470216984|FG001|Overall Study|Adverse Event|0|||
130617006|NCT04863014|470216985|FG000|Overall Study|Lost to Follow-up|3|||
130617007|NCT04863014|470216986|FG001|Overall Study|Lost to Follow-up|2|||
130617008|NCT04863014|470216985|FG000|Overall Study|Subject Decision|0|||
130617009|NCT04863014|470216986|FG001|Overall Study|Subject Decision|4|||
130617010|NCT04633473|470216987|FG000|Overall Study|Withdrawal by Subject|6|||
130617011|NCT03089216|470216992|FG000|Overall Study|Adverse Event|0|||
130617012|NCT03089216|470216993|FG001|Overall Study|Adverse Event|0|||
130617013|NCT03089216|470216994|FG002|Overall Study|Adverse Event|0|||
130617014|NCT03089216|470216995|FG003|Overall Study|Adverse Event|1|||
130617015|NCT00417976|470216996|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
130617016|NCT00417976|470216996|FG000|Overall Study|Treatment -related toxicity|2|||
130617017|NCT04348591|470216997|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
130617018|NCT04348591|470216998|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
130617019|NCT04348591|470216997|FG000|Imaging Session (120 Min)|Physician Decision|0|||
130617020|NCT04348591|470216998|FG001|Imaging Session (120 Min)|Physician Decision|1|||
130617021|NCT04348591|470216997|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
130617022|NCT04348591|470216998|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
130617023|NCT02104804|470217007|FG000|Overall Study|Did not take study medication|0|||
130617024|NCT02104804|470217008|FG001|Overall Study|Did not take study medication|1|||
130617025|NCT02104804|470217007|FG000|Overall Study|Study specific discontinuation criteria|6|||
130617026|NCT02104804|470217008|FG001|Overall Study|Study specific discontinuation criteria|1|||
130617027|NCT02104804|470217007|FG000|Overall Study|Other listed|2|||
130617028|NCT02104804|470217008|FG001|Overall Study|Other listed|1|||
130617029|NCT02104804|470217007|FG000|Overall Study|Protocol Violation|0|||
130617030|NCT02104804|470217008|FG001|Overall Study|Protocol Violation|1|||
130617031|NCT02104804|470217007|FG000|Overall Study|Adverse Event|4|||
130617032|NCT02104804|470217008|FG001|Overall Study|Adverse Event|3|||
130617033|NCT02104804|470217007|FG000|Overall Study|Withdrawal by Subject|4|||
130617034|NCT02104804|470217008|FG001|Overall Study|Withdrawal by Subject|12|||
130617035|NCT02720016|470217009|FG000|Overall Study|Separation of couple|6|||
130617036|NCT02720016|470217010|FG001|Overall Study|Separation of couple|8|||
130617037|NCT02720016|470217011|FG002|Overall Study|Separation of couple|2|||
130617038|NCT02720016|470217009|FG000|Overall Study|Withdrawal by Subject|6|||
130617039|NCT02720016|470217010|FG001|Overall Study|Withdrawal by Subject|6|||
130617040|NCT02720016|470217011|FG002|Overall Study|Withdrawal by Subject|4|||
130617041|NCT02720016|470217009|FG000|Overall Study|Scheduling issues|2|||
130617042|NCT02720016|470217010|FG001|Overall Study|Scheduling issues|4|||
130617043|NCT02720016|470217011|FG002|Overall Study|Scheduling issues|7|||
130617044|NCT02720016|470217009|FG000|Overall Study|Childcare|2|||
130617045|NCT02720016|470217010|FG001|Overall Study|Childcare|0|||
130617046|NCT02720016|470217011|FG002|Overall Study|Childcare|2|||
130617047|NCT02720016|470217009|FG000|Overall Study|Withdrawal by PI|2|||
130617048|NCT02720016|470217010|FG001|Overall Study|Withdrawal by PI|2|||
130617049|NCT02720016|470217011|FG002|Overall Study|Withdrawal by PI|0|||
130617050|NCT02720016|470217009|FG000|Overall Study|Moved away|2|||
130617051|NCT02720016|470217010|FG001|Overall Study|Moved away|0|||
130617052|NCT02720016|470217011|FG002|Overall Study|Moved away|0|||
130617053|NCT02720016|470217009|FG000|Overall Study|Not Primary Health Concern|0|||
130617054|NCT02720016|470217010|FG001|Overall Study|Not Primary Health Concern|0|||
130617055|NCT02720016|470217011|FG002|Overall Study|Not Primary Health Concern|2|||
130617056|NCT02720016|470217009|FG000|Overall Study|Transportation issues|0|||
130617057|NCT02720016|470217010|FG001|Overall Study|Transportation issues|0|||
130617058|NCT02720016|470217011|FG002|Overall Study|Transportation issues|1|||
130617059|NCT02720016|470217009|FG000|Overall Study|Other|0|||
130617060|NCT02720016|470217010|FG001|Overall Study|Other|0|||
130617061|NCT02720016|470217011|FG002|Overall Study|Other|2|||
130617062|NCT04501679|470217016|FG000|Overall Study|Pregnancy|0|||
130617063|NCT04501679|470217017|FG001|Overall Study|Pregnancy|1|||
130617064|NCT04501679|470217016|FG000|Overall Study|Adverse Event|4|||
130617065|NCT04501679|470217017|FG001|Overall Study|Adverse Event|2|||
130617066|NCT04501679|470217016|FG000|Overall Study|Withdrawal by Subject|2|||
130617067|NCT04501679|470217017|FG001|Overall Study|Withdrawal by Subject|0|||
130617068|NCT04501679|470217016|FG000|Overall Study|Physician Decision|1|||
130617069|NCT04501679|470217017|FG001|Overall Study|Physician Decision|0|||
130617070|NCT04501679|470217016|FG000|Overall Study|Lost to Follow-up|2|||
130617071|NCT04501679|470217017|FG001|Overall Study|Lost to Follow-up|0|||
130617072|NCT01968954|470217023|FG000|Overall Study|Adverse Event|6|||
130617073|NCT01968954|470217024|FG001|Overall Study|Adverse Event|3|||
130617074|NCT01968954|470217023|FG000|Overall Study|Death|1|||
130617075|NCT01968954|470217024|FG001|Overall Study|Death|2|||
130617076|NCT01968954|470217023|FG000|Overall Study|Lost to Follow-up|6|||
130617077|NCT01968954|470217024|FG001|Overall Study|Lost to Follow-up|4|||
130617078|NCT01968954|470217023|FG000|Overall Study|Withdrawal by Subject|20|||
130617079|NCT01968954|470217024|FG001|Overall Study|Withdrawal by Subject|23|||
130617080|NCT01968954|470217023|FG000|Overall Study|Other|7|||
130617081|NCT01968954|470217024|FG001|Overall Study|Other|8|||
130617082|NCT01968954|470217023|FG000|Overall Study|Protocol Violation|0|||
130617083|NCT01968954|470217024|FG001|Overall Study|Protocol Violation|1|||
130617084|NCT01968954|470217023|FG000|Overall Study|Did not met inclusion criteria|0|||
130617085|NCT01968954|470217024|FG001|Overall Study|Did not met inclusion criteria|2|||
130617086|NCT00751114|470217026|FG000|Overall Study|Adverse Event|2|||
130617087|NCT00751114|470217027|FG001|Overall Study|Adverse Event|4|||
130617088|NCT00751114|470217026|FG000|Overall Study|Protocol Violation|8|||
130617089|NCT00751114|470217027|FG001|Overall Study|Protocol Violation|9|||
130617090|NCT00751114|470217026|FG000|Overall Study|Withdrawal by Subject|9|||
130617091|NCT00751114|470217027|FG001|Overall Study|Withdrawal by Subject|4|||
130617092|NCT00751114|470217026|FG000|Overall Study|Lost to Follow-up|4|||
130617093|NCT00751114|470217027|FG001|Overall Study|Lost to Follow-up|7|||
130617094|NCT00751114|470217026|FG000|Overall Study|Lack of Efficacy|0|||
130617095|NCT00751114|470217027|FG001|Overall Study|Lack of Efficacy|7|||
130617096|NCT00751114|470217026|FG000|Overall Study|Not Treated|13|||
130617097|NCT00751114|470217027|FG001|Overall Study|Not Treated|1|||
130617098|NCT00751114|470217026|FG000|Overall Study|Out of country for 2 months|1|||
130617099|NCT00751114|470217027|FG001|Overall Study|Out of country for 2 months|0|||
130617100|NCT00751114|470217026|FG000|Overall Study|Move to another city|1|||
130617101|NCT00751114|470217027|FG001|Overall Study|Move to another city|0|||
130617102|NCT05319080|470217028|FG000|Overall Study|Withdrawal by Subject|2|||
130617103|NCT05319080|470217028|FG000|Overall Study|Physician Decision|4|||
130617104|NCT02358369|470217031|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
130617105|NCT02358369|470217032|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130617106|NCT02358369|470217033|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130617107|NCT02358369|470217034|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130617108|NCT02358369|470217035|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130617109|NCT02358369|470217031|FG000|Treatment Period A/B|Adverse Event|0|||
130617110|NCT02358369|470217032|FG001|Treatment Period A/B|Adverse Event|0|||
130617111|NCT02358369|470217033|FG002|Treatment Period A/B|Adverse Event|1|||
130617112|NCT02358369|470217034|FG003|Treatment Period A/B|Adverse Event|2|||
130617113|NCT02358369|470217035|FG004|Treatment Period A/B|Adverse Event|0|||
130617114|NCT02358369|470217031|FG000|Treatment Period A/B|Death|0|||
130617115|NCT02358369|470217032|FG001|Treatment Period A/B|Death|0|||
130617116|NCT02358369|470217033|FG002|Treatment Period A/B|Death|1|||
130617117|NCT02358369|470217034|FG003|Treatment Period A/B|Death|0|||
130617118|NCT02358369|470217035|FG004|Treatment Period A/B|Death|0|||
130617119|NCT02358369|470217031|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
130617120|NCT02358369|470217032|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
130617121|NCT02358369|470217033|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
130617122|NCT02358369|470217034|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
130617123|NCT02358369|470217035|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
130617124|NCT02358369|470217031|FG000|Treatment Period C|Adverse Event|0|||
130617125|NCT02358369|470217032|FG001|Treatment Period C|Adverse Event|0|||
130617126|NCT02358369|470217033|FG002|Treatment Period C|Adverse Event|0|||
130617127|NCT02358369|470217034|FG003|Treatment Period C|Adverse Event|0|||
130617128|NCT02358369|470217035|FG004|Treatment Period C|Adverse Event|7|||
130617129|NCT03259490|470217036|FG000|Period 1|Withdrawal by Subject|0|||
130617130|NCT03259490|470217037|FG001|Period 1|Withdrawal by Subject|1|||
130617131|NCT03259490|470217036|FG000|Period 2|Protocol Violation|1|||
130617132|NCT03259490|470217037|FG001|Period 2|Protocol Violation|0|||
130617133|NCT04191577|470217041|FG000|Overall Study|Withdrawal by Subject|2|||
130617134|NCT04191577|470217042|FG001|Overall Study|Withdrawal by Subject|2|||
130617135|NCT04191577|470217043|FG002|Overall Study|Withdrawal by Subject|1|||
130617136|NCT04191577|470217041|FG000|Overall Study|Physician Decision|1|||
130617137|NCT04191577|470217042|FG001|Overall Study|Physician Decision|1|||
130617138|NCT04191577|470217043|FG002|Overall Study|Physician Decision|0|||
130617139|NCT04191577|470217041|FG000|Overall Study|Adverse Event|0|||
130617140|NCT04191577|470217042|FG001|Overall Study|Adverse Event|0|||
130617141|NCT04191577|470217043|FG002|Overall Study|Adverse Event|1|||
130617142|NCT04191577|470217041|FG000|Overall Study|Death|0|||
130617143|NCT04191577|470217042|FG001|Overall Study|Death|0|||
130617144|NCT04191577|470217043|FG002|Overall Study|Death|1|||
130617145|NCT03655717|470217044|FG000|Overall Study|Withdrawal by Subject|4|||
130617146|NCT03655717|470217045|FG001|Overall Study|Withdrawal by Subject|8|||
130617147|NCT03655717|470217046|FG002|Overall Study|Withdrawal by Subject|1|||
130617148|NCT03655717|470217047|FG003|Overall Study|Withdrawal by Subject|0|||
130617149|NCT03655717|470217048|FG004|Overall Study|Withdrawal by Subject|0|||
130617150|NCT03655717|470217049|FG005|Overall Study|Withdrawal by Subject|1|||
130617151|NCT03655717|470217050|FG006|Overall Study|Withdrawal by Subject|3|||
130617152|NCT03655717|470217051|FG007|Overall Study|Withdrawal by Subject|1|||
130617153|NCT03655717|470217052|FG008|Overall Study|Withdrawal by Subject|2|||
130617154|NCT03655717|470217053|FG009|Overall Study|Withdrawal by Subject|0|||
130617155|NCT03655717|470217054|FG010|Overall Study|Withdrawal by Subject|0|||
130617156|NCT03655717|470217055|FG011|Overall Study|Withdrawal by Subject|1|||
130617157|NCT03655717|470217056|FG012|Overall Study|Withdrawal by Subject|0|||
130617158|NCT03655717|470217057|FG013|Overall Study|Withdrawal by Subject|3|||
130617159|NCT03655717|470217058|FG014|Overall Study|Withdrawal by Subject|0|||
130617160|NCT03655717|470217059|FG015|Overall Study|Withdrawal by Subject|1|||
130617161|NCT03655717|470217060|FG016|Overall Study|Withdrawal by Subject|0|||
130617162|NCT03655717|470217061|FG017|Overall Study|Withdrawal by Subject|0|||
130617163|NCT03655717|470217062|FG018|Overall Study|Withdrawal by Subject|1|||
130617164|NCT03655717|470217063|FG019|Overall Study|Withdrawal by Subject|0|||
130617165|NCT03655717|470217064|FG020|Overall Study|Withdrawal by Subject|0|||
130617166|NCT03655717|470217065|FG021|Overall Study|Withdrawal by Subject|1|||
130617167|NCT03655717|470217066|FG022|Overall Study|Withdrawal by Subject|2|||
130617168|NCT03655717|470217067|FG023|Overall Study|Withdrawal by Subject|1|||
130617169|NCT03655717|470217068|FG024|Overall Study|Withdrawal by Subject|1|||
130617170|NCT03655717|470217069|FG025|Overall Study|Withdrawal by Subject|0|||
130617171|NCT03655717|470217044|FG000|Overall Study|Physician Decision|3|||
130617172|NCT03655717|470217045|FG001|Overall Study|Physician Decision|3|||
130617173|NCT03655717|470217046|FG002|Overall Study|Physician Decision|0|||
130617174|NCT03655717|470217047|FG003|Overall Study|Physician Decision|0|||
130617175|NCT03655717|470217048|FG004|Overall Study|Physician Decision|0|||
130617176|NCT03655717|470217049|FG005|Overall Study|Physician Decision|0|||
130617177|NCT03655717|470217050|FG006|Overall Study|Physician Decision|0|||
130617178|NCT03655717|470217051|FG007|Overall Study|Physician Decision|0|||
130617179|NCT03655717|470217052|FG008|Overall Study|Physician Decision|0|||
130617180|NCT03655717|470217053|FG009|Overall Study|Physician Decision|1|||
130617181|NCT03655717|470217054|FG010|Overall Study|Physician Decision|0|||
130617182|NCT03655717|470217055|FG011|Overall Study|Physician Decision|0|||
130617183|NCT03655717|470217056|FG012|Overall Study|Physician Decision|0|||
130617184|NCT03655717|470217057|FG013|Overall Study|Physician Decision|0|||
130617185|NCT03655717|470217058|FG014|Overall Study|Physician Decision|0|||
130617186|NCT03655717|470217059|FG015|Overall Study|Physician Decision|0|||
130617187|NCT03655717|470217060|FG016|Overall Study|Physician Decision|0|||
130617188|NCT03655717|470217061|FG017|Overall Study|Physician Decision|0|||
130617189|NCT03655717|470217062|FG018|Overall Study|Physician Decision|0|||
130617190|NCT03655717|470217063|FG019|Overall Study|Physician Decision|1|||
130617191|NCT03655717|470217064|FG020|Overall Study|Physician Decision|0|||
130617192|NCT03655717|470217065|FG021|Overall Study|Physician Decision|0|||
130617193|NCT03655717|470217066|FG022|Overall Study|Physician Decision|0|||
130617194|NCT03655717|470217067|FG023|Overall Study|Physician Decision|1|||
130617195|NCT03655717|470217068|FG024|Overall Study|Physician Decision|0|||
130617196|NCT03655717|470217069|FG025|Overall Study|Physician Decision|0|||
130617197|NCT03655717|470217044|FG000|Overall Study|Lost to Follow-up|3|||
130617198|NCT03655717|470217045|FG001|Overall Study|Lost to Follow-up|1|||
130617199|NCT03655717|470217046|FG002|Overall Study|Lost to Follow-up|0|||
130617200|NCT03655717|470217047|FG003|Overall Study|Lost to Follow-up|1|||
130617201|NCT03655717|470217048|FG004|Overall Study|Lost to Follow-up|0|||
130617202|NCT03655717|470217049|FG005|Overall Study|Lost to Follow-up|1|||
130617203|NCT03655717|470217050|FG006|Overall Study|Lost to Follow-up|0|||
130617204|NCT03655717|470217051|FG007|Overall Study|Lost to Follow-up|0|||
130617205|NCT03655717|470217052|FG008|Overall Study|Lost to Follow-up|0|||
130617206|NCT03655717|470217053|FG009|Overall Study|Lost to Follow-up|0|||
130617207|NCT03655717|470217054|FG010|Overall Study|Lost to Follow-up|0|||
130617208|NCT03655717|470217055|FG011|Overall Study|Lost to Follow-up|1|||
130617209|NCT03655717|470217056|FG012|Overall Study|Lost to Follow-up|0|||
130617210|NCT03655717|470217057|FG013|Overall Study|Lost to Follow-up|0|||
130617211|NCT03655717|470217058|FG014|Overall Study|Lost to Follow-up|0|||
130617212|NCT03655717|470217059|FG015|Overall Study|Lost to Follow-up|0|||
130617213|NCT03655717|470217060|FG016|Overall Study|Lost to Follow-up|0|||
130617214|NCT03655717|470217061|FG017|Overall Study|Lost to Follow-up|0|||
130617215|NCT03655717|470217062|FG018|Overall Study|Lost to Follow-up|0|||
130617216|NCT03655717|470217063|FG019|Overall Study|Lost to Follow-up|0|||
130617217|NCT03655717|470217064|FG020|Overall Study|Lost to Follow-up|0|||
130617218|NCT03655717|470217065|FG021|Overall Study|Lost to Follow-up|0|||
130617219|NCT03655717|470217066|FG022|Overall Study|Lost to Follow-up|0|||
130617220|NCT03655717|470217067|FG023|Overall Study|Lost to Follow-up|0|||
130617221|NCT03655717|470217068|FG024|Overall Study|Lost to Follow-up|0|||
130617222|NCT03655717|470217069|FG025|Overall Study|Lost to Follow-up|0|||
130617223|NCT01185249|470217070|FG000|Overall Study|Patients discharged or change in status|42|||
130617224|NCT03521193|470217071|FG000|Overall Study|Withdrawal by Subject|8|||
130617225|NCT03521193|470217072|FG001|Overall Study|Withdrawal by Subject|0|||
130617226|NCT03521193|470217071|FG000|Overall Study|non compliant to ASA treatment|8|||
130617227|NCT03521193|470217072|FG001|Overall Study|non compliant to ASA treatment|0|||
130617228|NCT00406783|470217075|FG000|Overall Study|Adverse Event|4|||
130617229|NCT00406783|470217076|FG001|Overall Study|Adverse Event|4|||
130617230|NCT00406783|470217075|FG000|Overall Study|Treatment Failure|2|||
130617231|NCT00406783|470217076|FG001|Overall Study|Treatment Failure|3|||
130617232|NCT00406783|470217075|FG000|Overall Study|Lost to Follow-up|3|||
130617233|NCT00406783|470217076|FG001|Overall Study|Lost to Follow-up|0|||
130617234|NCT00406783|470217075|FG000|Overall Study|Withdrawal by Subject|1|||
130617235|NCT00406783|470217076|FG001|Overall Study|Withdrawal by Subject|4|||
130617236|NCT00406783|470217075|FG000|Overall Study|Protocol Violation|4|||
130617237|NCT00406783|470217076|FG001|Overall Study|Protocol Violation|4|||
130617238|NCT00012012|470217077|FG000|Overall Study|Protocol Violation|1|||
130617239|NCT00012012|470217078|FG001|Overall Study|Protocol Violation|1|||
130617240|NCT00012012|470217077|FG000|Overall Study|Withdrawal by Subject|0|||
130617241|NCT00012012|470217078|FG001|Overall Study|Withdrawal by Subject|2|||
130617242|NCT01391819|470217079|FG000|Overall Study|Withdrawal by Subject|56|||
130617243|NCT01391819|470217079|FG000|Overall Study|Migrated/moved from study area|82|||
130617244|NCT01391819|470217079|FG000|Overall Study|Lost to Follow-up|252|||
130617245|NCT01391819|470217079|FG000|Overall Study|Death|3|||
130617246|NCT01391819|470217079|FG000|Overall Study|Other|9|||
130617247|NCT00479557|470217085|FG000|Overall Study|Death|0|||
130617248|NCT00479557|470217086|FG001|Overall Study|Death|0|||
130617249|NCT00479557|470217087|FG002|Overall Study|Death|0|||
130617250|NCT00479557|470217088|FG003|Overall Study|Death|0|||
130617251|NCT00479557|470217089|FG004|Overall Study|Death|0|||
130617252|NCT00479557|470217090|FG005|Overall Study|Death|1|||
130617253|NCT00479557|470217091|FG006|Overall Study|Death|0|||
130617254|NCT00479557|470217085|FG000|Overall Study|Lack of Efficacy|1|||
130617255|NCT00479557|470217086|FG001|Overall Study|Lack of Efficacy|0|||
130617256|NCT00479557|470217087|FG002|Overall Study|Lack of Efficacy|0|||
130617257|NCT00479557|470217088|FG003|Overall Study|Lack of Efficacy|0|||
130617258|NCT00479557|470217089|FG004|Overall Study|Lack of Efficacy|0|||
130617259|NCT00479557|470217090|FG005|Overall Study|Lack of Efficacy|0|||
130617260|NCT00479557|470217091|FG006|Overall Study|Lack of Efficacy|0|||
130617261|NCT00479557|470217085|FG000|Overall Study|Lost to Follow-up|0|||
130617262|NCT00479557|470217086|FG001|Overall Study|Lost to Follow-up|2|||
130617263|NCT00479557|470217087|FG002|Overall Study|Lost to Follow-up|0|||
130617264|NCT00479557|470217088|FG003|Overall Study|Lost to Follow-up|2|||
130617265|NCT00479557|470217089|FG004|Overall Study|Lost to Follow-up|0|||
130617266|NCT00479557|470217090|FG005|Overall Study|Lost to Follow-up|0|||
130617267|NCT00479557|470217091|FG006|Overall Study|Lost to Follow-up|0|||
130617268|NCT00479557|470217085|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130617269|NCT00479557|470217086|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130617270|NCT00479557|470217087|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
130617271|NCT00479557|470217088|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
130617272|NCT00479557|470217089|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130617273|NCT00479557|470217090|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130617274|NCT00479557|470217091|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130617275|NCT00479557|470217085|FG000|Overall Study|AE not related to Study Drug|1|||
130617276|NCT00479557|470217086|FG001|Overall Study|AE not related to Study Drug|3|||
130617277|NCT00479557|470217087|FG002|Overall Study|AE not related to Study Drug|0|||
130617278|NCT00479557|470217088|FG003|Overall Study|AE not related to Study Drug|0|||
130617279|NCT00479557|470217089|FG004|Overall Study|AE not related to Study Drug|2|||
130617280|NCT00479557|470217090|FG005|Overall Study|AE not related to Study Drug|2|||
130617281|NCT00479557|470217091|FG006|Overall Study|AE not related to Study Drug|1|||
130617282|NCT00479557|470217085|FG000|Overall Study|Caregiver Request|2|||
130617283|NCT00479557|470217086|FG001|Overall Study|Caregiver Request|2|||
130617284|NCT00479557|470217087|FG002|Overall Study|Caregiver Request|2|||
130617285|NCT00479557|470217088|FG003|Overall Study|Caregiver Request|0|||
130617286|NCT00479557|470217089|FG004|Overall Study|Caregiver Request|1|||
130617287|NCT00479557|470217090|FG005|Overall Study|Caregiver Request|2|||
130617288|NCT00479557|470217091|FG006|Overall Study|Caregiver Request|0|||
130617289|NCT00479557|470217085|FG000|Overall Study|Investigator Request|0|||
130617290|NCT00479557|470217086|FG001|Overall Study|Investigator Request|0|||
130617291|NCT00479557|470217087|FG002|Overall Study|Investigator Request|1|||
130617292|NCT00479557|470217088|FG003|Overall Study|Investigator Request|0|||
130617293|NCT00479557|470217089|FG004|Overall Study|Investigator Request|0|||
130617294|NCT00479557|470217090|FG005|Overall Study|Investigator Request|0|||
130617295|NCT00479557|470217091|FG006|Overall Study|Investigator Request|0|||
130617296|NCT00479557|470217085|FG000|Overall Study|Subject Request|3|||
130617297|NCT00479557|470217086|FG001|Overall Study|Subject Request|0|||
130617298|NCT00479557|470217087|FG002|Overall Study|Subject Request|1|||
130617299|NCT00479557|470217088|FG003|Overall Study|Subject Request|1|||
130617300|NCT00479557|470217089|FG004|Overall Study|Subject Request|1|||
130617301|NCT00479557|470217090|FG005|Overall Study|Subject Request|4|||
130617302|NCT00479557|470217091|FG006|Overall Study|Subject Request|1|||
130617303|NCT00479557|470217085|FG000|Overall Study|Other|2|||
130617304|NCT00479557|470217086|FG001|Overall Study|Other|3|||
130617305|NCT00479557|470217087|FG002|Overall Study|Other|1|||
130617306|NCT00479557|470217088|FG003|Overall Study|Other|0|||
130617307|NCT00479557|470217089|FG004|Overall Study|Other|0|||
130617308|NCT00479557|470217090|FG005|Overall Study|Other|3|||
130617309|NCT00479557|470217091|FG006|Overall Study|Other|0|||
130617310|NCT03073213|470218865|FG000|Multiple Dose Period|Protocol Violation|0|||
130617311|NCT03073213|470218866|FG001|Multiple Dose Period|Protocol Violation|0|||
130617312|NCT03073213|470218867|FG002|Multiple Dose Period|Protocol Violation|1|||
130617313|NCT01617655|470218871|FG000|Overall Study|Adverse Event|2|||
130617314|NCT01617655|470218872|FG001|Overall Study|Adverse Event|3|||
130617315|NCT01617655|470218871|FG000|Overall Study|Poor compliance to protocol|1|||
130617316|NCT01617655|470218872|FG001|Overall Study|Poor compliance to protocol|4|||
130617317|NCT01617655|470218871|FG000|Overall Study|Participants moved|0|||
130617318|NCT01617655|470218872|FG001|Overall Study|Participants moved|4|||
130617319|NCT01617655|470218871|FG000|Overall Study|Consent withdrawn by participant|1|||
130617320|NCT01617655|470218872|FG001|Overall Study|Consent withdrawn by participant|1|||
130617321|NCT01617655|470218871|FG000|Overall Study|Last visit outside protocol visit window|1|||
130617322|NCT01617655|470218872|FG001|Overall Study|Last visit outside protocol visit window|10|||
130617323|NCT01617655|470218871|FG000|Overall Study|Site closure|3|||
130617324|NCT01617655|470218872|FG001|Overall Study|Site closure|5|||
130617325|NCT01617655|470218871|FG000|Overall Study|Other than specified above|1|||
130617326|NCT01617655|470218872|FG001|Overall Study|Other than specified above|2|||
130617327|NCT01175213|470218873|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
130617328|NCT01175213|470218874|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
130617329|NCT01175213|470218873|FG000|IGSC, 10%/rHuPH20|Death|1|||
130617330|NCT01175213|470218874|FG001|IGSC, 10%/rHuPH20|Death|0|||
130617331|NCT01175213|470218873|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
130617332|NCT01175213|470218874|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
130617333|NCT01175213|470218873|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
130617334|NCT01175213|470218874|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
130617335|NCT01175213|470218873|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
130617336|NCT01175213|470218874|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
130617337|NCT01175213|470218873|FG000|Safety Follow-up|Adverse Event|1|||
130617338|NCT01175213|470218874|FG001|Safety Follow-up|Adverse Event|0|||
130617339|NCT00003476|470218878|FG000|Overall Study|Not evaluable|1|||
130617340|NCT03057951|470218879|FG000|Overall Study|Adverse Event|553|||
130617341|NCT03057951|470218880|FG001|Overall Study|Adverse Event|575|||
130617342|NCT03057951|470218879|FG000|Overall Study|Protocol Violation|30|||
130617343|NCT03057951|470218880|FG001|Overall Study|Protocol Violation|24|||
130617344|NCT03057951|470218879|FG000|Overall Study|Lost to Follow-up|6|||
130617345|NCT03057951|470218880|FG001|Overall Study|Lost to Follow-up|16|||
130617346|NCT03057951|470218879|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
130617347|NCT03057951|470218880|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
130617348|NCT03057951|470218879|FG000|Overall Study|Study drug stopped, reason missing|6|||
130617349|NCT03057951|470218880|FG001|Overall Study|Study drug stopped, reason missing|1|||
130617350|NCT03057951|470218879|FG000|Overall Study|Medical advice|6|||
130617351|NCT03057951|470218880|FG001|Overall Study|Medical advice|2|||
130617352|NCT03057951|470218879|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
130617353|NCT03057951|470218880|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
130617354|NCT03057951|470218879|FG000|Overall Study|Investigator decision|2|||
130617355|NCT03057951|470218880|FG001|Overall Study|Investigator decision|0|||
130617356|NCT03057951|470218879|FG000|Overall Study|Patient decision|5|||
130617357|NCT03057951|470218880|FG001|Overall Study|Patient decision|2|||
130617358|NCT03057951|470218879|FG000|Overall Study|Not attending study visits|3|||
130617359|NCT03057951|470218880|FG001|Overall Study|Not attending study visits|0|||
130617360|NCT03057951|470218879|FG000|Overall Study|Patient moved away|3|||
130617361|NCT03057951|470218880|FG001|Overall Study|Patient moved away|4|||
130617362|NCT03057951|470218879|FG000|Overall Study|Other reason than stated above|23|||
130617363|NCT03057951|470218880|FG001|Overall Study|Other reason than stated above|29|||
130617364|NCT03057951|470218879|FG000|Overall Study|Not treated|2|||
130617365|NCT03057951|470218880|FG001|Overall Study|Not treated|1|||
130617366|NCT00696436|470218881|FG000|Overall Study|Adverse Event|7|||
130617367|NCT00696436|470218882|FG001|Overall Study|Adverse Event|9|||
130617368|NCT00696436|470218883|FG002|Overall Study|Adverse Event|8|||
130617369|NCT00696436|470218884|FG003|Overall Study|Adverse Event|6|||
130617370|NCT00696436|470218885|FG004|Overall Study|Adverse Event|4|||
130617371|NCT00696436|470218881|FG000|Overall Study|Protocol Violation|3|||
130617372|NCT00696436|470218882|FG001|Overall Study|Protocol Violation|2|||
130617373|NCT00696436|470218883|FG002|Overall Study|Protocol Violation|2|||
130617374|NCT00696436|470218884|FG003|Overall Study|Protocol Violation|0|||
130617375|NCT00696436|470218885|FG004|Overall Study|Protocol Violation|1|||
130617376|NCT00696436|470218881|FG000|Overall Study|Lost to Follow-up|1|||
130617377|NCT00696436|470218882|FG001|Overall Study|Lost to Follow-up|6|||
130617378|NCT00696436|470218883|FG002|Overall Study|Lost to Follow-up|2|||
130617379|NCT00696436|470218884|FG003|Overall Study|Lost to Follow-up|4|||
130617380|NCT00696436|470218885|FG004|Overall Study|Lost to Follow-up|3|||
130617381|NCT00696436|470218881|FG000|Overall Study|Withdrawal by Subject|4|||
130617382|NCT00696436|470218882|FG001|Overall Study|Withdrawal by Subject|11|||
130617383|NCT00696436|470218883|FG002|Overall Study|Withdrawal by Subject|5|||
130617384|NCT00696436|470218884|FG003|Overall Study|Withdrawal by Subject|7|||
130617385|NCT00696436|470218885|FG004|Overall Study|Withdrawal by Subject|1|||
130617386|NCT00696436|470218881|FG000|Overall Study|Lack of Efficacy|3|||
130617387|NCT00696436|470218882|FG001|Overall Study|Lack of Efficacy|1|||
130617388|NCT00696436|470218883|FG002|Overall Study|Lack of Efficacy|5|||
130617389|NCT00696436|470218884|FG003|Overall Study|Lack of Efficacy|2|||
130617390|NCT00696436|470218885|FG004|Overall Study|Lack of Efficacy|4|||
130617391|NCT00696436|470218881|FG000|Overall Study|Participant Unavailability|2|||
130617392|NCT00696436|470218882|FG001|Overall Study|Participant Unavailability|0|||
130617393|NCT00696436|470218883|FG002|Overall Study|Participant Unavailability|2|||
130617394|NCT00696436|470218884|FG003|Overall Study|Participant Unavailability|1|||
130617395|NCT00696436|470218885|FG004|Overall Study|Participant Unavailability|0|||
130617396|NCT00696436|470218881|FG000|Overall Study|Administrative Error|2|||
130617397|NCT00696436|470218882|FG001|Overall Study|Administrative Error|0|||
130617398|NCT00696436|470218883|FG002|Overall Study|Administrative Error|2|||
130617399|NCT00696436|470218884|FG003|Overall Study|Administrative Error|0|||
130617400|NCT00696436|470218885|FG004|Overall Study|Administrative Error|0|||
130617401|NCT00696436|470218881|FG000|Overall Study|Participant Non-compliance|0|||
130617402|NCT00696436|470218882|FG001|Overall Study|Participant Non-compliance|0|||
130617403|NCT00696436|470218883|FG002|Overall Study|Participant Non-compliance|1|||
130617404|NCT00696436|470218884|FG003|Overall Study|Participant Non-compliance|2|||
130617405|NCT00696436|470218885|FG004|Overall Study|Participant Non-compliance|0|||
130617406|NCT00696436|470218881|FG000|Overall Study|Administrative Decision|1|||
130617407|NCT00696436|470218882|FG001|Overall Study|Administrative Decision|0|||
130617408|NCT00696436|470218883|FG002|Overall Study|Administrative Decision|0|||
130617409|NCT00696436|470218884|FG003|Overall Study|Administrative Decision|0|||
130617410|NCT00696436|470218885|FG004|Overall Study|Administrative Decision|0|||
130617411|NCT00696436|470218881|FG000|Overall Study|Missing|0|||
130617412|NCT00696436|470218882|FG001|Overall Study|Missing|1|||
130617413|NCT00696436|470218883|FG002|Overall Study|Missing|1|||
130617414|NCT00696436|470218884|FG003|Overall Study|Missing|0|||
130617415|NCT00696436|470218885|FG004|Overall Study|Missing|0|||
130617416|NCT02282982|470218886|FG000|Overall Study|Lost to Follow-up|15|||
130617417|NCT02282982|470218886|FG000|Overall Study|Withdrew consent|2|||
130617418|NCT02282982|470218886|FG000|Overall Study|Death|4|||
130617419|NCT02282982|470218886|FG000|Overall Study|Lack of product|156|||
130617420|NCT02282982|470218886|FG000|Overall Study|Palivizumab is ended|11|||
130617421|NCT02282982|470218886|FG000|Overall Study|Other, not specified|18|||
130617422|NCT02924688|470218887|FG000|Overall Study|Adverse Event|9|||
130617423|NCT02924688|470218888|FG001|Overall Study|Adverse Event|3|||
130617424|NCT02924688|470218889|FG002|Overall Study|Adverse Event|2|||
130617425|NCT02924688|470218890|FG003|Overall Study|Adverse Event|2|||
130617426|NCT02924688|470218891|FG004|Overall Study|Adverse Event|3|||
130617427|NCT02924688|470218892|FG005|Overall Study|Adverse Event|2|||
130617428|NCT02924688|470218887|FG000|Overall Study|Lack of Efficacy|2|||
130617429|NCT02924688|470218888|FG001|Overall Study|Lack of Efficacy|3|||
130617430|NCT02924688|470218889|FG002|Overall Study|Lack of Efficacy|4|||
130617431|NCT02924688|470218890|FG003|Overall Study|Lack of Efficacy|2|||
130617432|NCT02924688|470218891|FG004|Overall Study|Lack of Efficacy|1|||
130617433|NCT02924688|470218892|FG005|Overall Study|Lack of Efficacy|1|||
130617434|NCT02924688|470218887|FG000|Overall Study|Protocol Violation|3|||
130617435|NCT02924688|470218888|FG001|Overall Study|Protocol Violation|7|||
130617436|NCT02924688|470218889|FG002|Overall Study|Protocol Violation|5|||
130617437|NCT02924688|470218890|FG003|Overall Study|Protocol Violation|6|||
130617438|NCT02924688|470218891|FG004|Overall Study|Protocol Violation|2|||
130617439|NCT02924688|470218892|FG005|Overall Study|Protocol Violation|2|||
130617440|NCT02924688|470218887|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
130617441|NCT02924688|470218888|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
130617442|NCT02924688|470218889|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
130617443|NCT02924688|470218890|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
130617444|NCT02924688|470218891|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
130617445|NCT02924688|470218892|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
130617446|NCT02924688|470218887|FG000|Overall Study|Lost to Follow-up|2|||
130617447|NCT02924688|470218888|FG001|Overall Study|Lost to Follow-up|4|||
130617448|NCT02924688|470218889|FG002|Overall Study|Lost to Follow-up|2|||
130617449|NCT02924688|470218890|FG003|Overall Study|Lost to Follow-up|4|||
130617450|NCT02924688|470218891|FG004|Overall Study|Lost to Follow-up|2|||
130617451|NCT02924688|470218892|FG005|Overall Study|Lost to Follow-up|4|||
130617452|NCT02924688|470218887|FG000|Overall Study|Physician Decision|2|||
130617453|NCT02924688|470218888|FG001|Overall Study|Physician Decision|1|||
130617454|NCT02924688|470218889|FG002|Overall Study|Physician Decision|0|||
130617455|NCT02924688|470218890|FG003|Overall Study|Physician Decision|1|||
130617456|NCT02924688|470218891|FG004|Overall Study|Physician Decision|1|||
130617457|NCT02924688|470218892|FG005|Overall Study|Physician Decision|1|||
130617458|NCT02924688|470218887|FG000|Overall Study|Withdrawal by Subject|14|||
130617459|NCT02924688|470218888|FG001|Overall Study|Withdrawal by Subject|13|||
130617460|NCT02924688|470218889|FG002|Overall Study|Withdrawal by Subject|9|||
130617461|NCT02924688|470218890|FG003|Overall Study|Withdrawal by Subject|12|||
130617462|NCT02924688|470218891|FG004|Overall Study|Withdrawal by Subject|13|||
130617463|NCT02924688|470218892|FG005|Overall Study|Withdrawal by Subject|14|||
130617464|NCT00848250|470218895|FG000|Overall Study|surgery was completed without cardiopulm|0|||
130617465|NCT00848250|470218896|FG001|Overall Study|surgery was completed without cardiopulm|1|||
130617466|NCT00571688|470218900|FG000|Overall Study|Lost to Follow-up|3|||
130617467|NCT00571688|470218901|FG001|Overall Study|Lost to Follow-up|6|||
130617468|NCT00571688|470218900|FG000|Overall Study|subject did not tolerate Consta|1|||
130617469|NCT00571688|470218901|FG001|Overall Study|subject did not tolerate Consta|0|||
130617470|NCT00571688|470218900|FG000|Overall Study|subject moved out of the area|1|||
130617471|NCT00571688|470218901|FG001|Overall Study|subject moved out of the area|0|||
130617472|NCT03457103|470218902|FG000|Overall Study|illness/hospitalization|4|||
130617473|NCT03457103|470218903|FG001|Overall Study|illness/hospitalization|2|||
130617474|NCT03457103|470218902|FG000|Overall Study|Lost to Follow-up|2|||
130617475|NCT03457103|470218903|FG001|Overall Study|Lost to Follow-up|1|||
130617476|NCT03457103|470218902|FG000|Overall Study|Withdrawal by Subject|1|||
130617477|NCT03457103|470218903|FG001|Overall Study|Withdrawal by Subject|2|||
130617478|NCT03457103|470218902|FG000|Overall Study|financial/ insurance issues|1|||
130617479|NCT03457103|470218903|FG001|Overall Study|financial/ insurance issues|1|||
130617480|NCT00502320|470218904|FG000|Overall Study|Lost to Follow-up|1|||
130617481|NCT00502320|470218905|FG001|Overall Study|Lost to Follow-up|1|||
130617482|NCT00502320|470218904|FG000|Overall Study|Withdrew Consent|1|||
130617483|NCT00502320|470218905|FG001|Overall Study|Withdrew Consent|0|||
130617484|NCT00502320|470218904|FG000|Overall Study|No longer met criteria|1|||
130617485|NCT00502320|470218905|FG001|Overall Study|No longer met criteria|0|||
130617486|NCT00502320|470218904|FG000|Overall Study|Screen Failure|0|||
130617487|NCT00502320|470218905|FG001|Overall Study|Screen Failure|1|||
130617488|NCT00502320|470218904|FG000|Overall Study|Adverse Event|3|||
130617489|NCT00502320|470218905|FG001|Overall Study|Adverse Event|5|||
130617490|NCT03654755|470218911|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
130617491|NCT03654755|470218912|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
130617492|NCT03654755|470218913|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
130617493|NCT03654755|470218911|FG000|Overall Study|Withdrawal by Subject|2|||
130617494|NCT03654755|470218912|FG001|Overall Study|Withdrawal by Subject|4|||
130617495|NCT03654755|470218913|FG002|Overall Study|Withdrawal by Subject|8|||
130617496|NCT03654755|470218911|FG000|Overall Study|Lost to Follow-up|1|||
130617497|NCT03654755|470218912|FG001|Overall Study|Lost to Follow-up|3|||
130617498|NCT03654755|470218913|FG002|Overall Study|Lost to Follow-up|7|||
130617499|NCT03654755|470218911|FG000|Overall Study|Physician Decision|0|||
130617500|NCT03654755|470218912|FG001|Overall Study|Physician Decision|1|||
130617501|NCT03654755|470218913|FG002|Overall Study|Physician Decision|0|||
130617502|NCT03654755|470218911|FG000|Overall Study|Adverse Event|0|||
130617503|NCT03654755|470218912|FG001|Overall Study|Adverse Event|0|||
130617504|NCT03654755|470218913|FG002|Overall Study|Adverse Event|4|||
130617505|NCT03654755|470218911|FG000|Overall Study|Lack of Efficacy|0|||
130617506|NCT03654755|470218912|FG001|Overall Study|Lack of Efficacy|0|||
130617507|NCT03654755|470218913|FG002|Overall Study|Lack of Efficacy|1|||
130617508|NCT02394808|470218914|FG000|Period 1|Unsatisfactory lens fitting|0|||
130617509|NCT02394808|470218915|FG001|Period 1|Unsatisfactory lens fitting|1|||
130617510|NCT02394808|470218914|FG000|Period 2|Lost to Follow-up|1|||
130617511|NCT02394808|470218915|FG001|Period 2|Lost to Follow-up|0|||
130617512|NCT03943953|470218917|FG000|Trial of ITG 1|Lost to Follow-up|19|||
130617513|NCT03943953|470218918|FG001|Trial of ITG 1|Lost to Follow-up|1|||
130617514|NCT03943953|470218917|FG000|Trial of ITG 2|Lost to Follow-up|8|||
130617515|NCT03943953|470218918|FG001|Trial of ITG 2|Lost to Follow-up|0|||
130617516|NCT03943953|470218917|FG000|Trial of ITG 3|Lost to Follow-up|2|||
130617517|NCT03943953|470218918|FG001|Trial of ITG 3|Lost to Follow-up|0|||
130617518|NCT03943953|470218917|FG000|Trial of ITG 4|Lost to Follow-up|2|||
130617519|NCT03943953|470218918|FG001|Trial of ITG 4|Lost to Follow-up|0|||
130617520|NCT00289185|470218919|FG000|Overall Study|Withdrawal by Subject|4|||
130617521|NCT00289185|470218920|FG001|Overall Study|Withdrawal by Subject|8|||
130617522|NCT00289185|470218919|FG000|Overall Study|Lost to Follow-up|23|||
130617523|NCT00289185|470218920|FG001|Overall Study|Lost to Follow-up|17|||
130617524|NCT00289185|470218919|FG000|Overall Study|Death|1|||
130617525|NCT00289185|470218920|FG001|Overall Study|Death|1|||
130617526|NCT04580394|470218921|FG000|First Intervention|Incorrectly Randomized|1|||
130617527|NCT04580394|470218921|FG000|First Intervention|Physician Decision|1|||
130617528|NCT04580394|470218921|FG000|First Intervention|Lost to Follow-up|1|||
130617529|NCT04580394|470218921|FG000|Washout (One Week)|Withdrawal by Subject|1|||
130617530|NCT04580394|470218921|FG000|Washout (One Week)|Adverse Event|1|||
130617531|NCT04580394|470218921|FG000|Washout (One Week)|Withdrawal by Subject|2|||
130617532|NCT04580394|470218921|FG000|Third Intervention|Adverse Event|1|||
130617533|NCT04580394|470218921|FG000|Third Intervention|Withdrawal by Subject|1|||
130617534|NCT04580394|470218921|FG000|Washout (One Week)|Withdrawal by Subject|2|||
130617535|NCT00642746|470218923|FG000|Overall Study|Patient unevaluable|1|||
130617536|NCT00642746|470218924|FG001|Overall Study|Patient unevaluable|0|||
130617537|NCT03337152|470218927|FG000|Overall Study|Physician Decision|1|||
130617538|NCT03337152|470218928|FG001|Overall Study|Physician Decision|0|||
130617539|NCT03337152|470218927|FG000|Overall Study|Lost to Follow-up|1|||
130617540|NCT03337152|470218928|FG001|Overall Study|Lost to Follow-up|3|||
130617541|NCT03337152|470218927|FG000|Overall Study|Adverse Event|3|||
130617542|NCT03337152|470218928|FG001|Overall Study|Adverse Event|1|||
130617543|NCT03337152|470218927|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
130617544|NCT03337152|470218928|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
130617545|NCT01069523|470218929|FG000|Overall Study|Withdrawal by Subject|4|||
130617546|NCT01069523|470218930|FG001|Overall Study|Withdrawal by Subject|7|||
130617547|NCT01551758|470218949|FG000|Overall Study|Adverse Event|29|||
130617548|NCT01551758|470218950|FG001|Overall Study|Adverse Event|43|||
130617549|NCT01551758|470218949|FG000|Overall Study|Lack of Efficacy|0|||
130617550|NCT01551758|470218950|FG001|Overall Study|Lack of Efficacy|1|||
130617551|NCT01551758|470218949|FG000|Overall Study|Protocol Violation|5|||
130617552|NCT01551758|470218950|FG001|Overall Study|Protocol Violation|6|||
130617553|NCT01551758|470218949|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
130617554|NCT01551758|470218950|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
130617555|NCT01551758|470218949|FG000|Overall Study|Lost to Follow-up|29|||
130617556|NCT01551758|470218950|FG001|Overall Study|Lost to Follow-up|25|||
130617557|NCT01551758|470218949|FG000|Overall Study|Physician Decision|9|||
130617558|NCT01551758|470218950|FG001|Overall Study|Physician Decision|3|||
130617559|NCT01551758|470218949|FG000|Overall Study|Withdrawal by Subject|14|||
130617560|NCT01551758|470218950|FG001|Overall Study|Withdrawal by Subject|17|||
130617561|NCT03670641|470218955|FG000|Overall Study|Lost to Follow-up|3|||
130617562|NCT01096849|470218956|FG000|Overall Study|Consent Withdrawn|1|||
130617563|NCT01096849|470218957|FG001|Overall Study|Consent Withdrawn|4|||
130617564|NCT01096849|470218958|FG002|Overall Study|Consent Withdrawn|2|||
130617565|NCT01096849|470218956|FG000|Overall Study|Lack of Efficacy|0|||
130617566|NCT01096849|470218957|FG001|Overall Study|Lack of Efficacy|2|||
130617567|NCT01096849|470218958|FG002|Overall Study|Lack of Efficacy|0|||
130617568|NCT01096849|470218956|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
130617569|NCT01096849|470218957|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
130617570|NCT01096849|470218958|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
130617571|NCT01096849|470218956|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
130617572|NCT01096849|470218957|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
130617573|NCT01096849|470218958|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
130617574|NCT01096849|470218956|FG000|Overall Study|Administrative Reasons|0|||
130617575|NCT01096849|470218957|FG001|Overall Study|Administrative Reasons|1|||
130617576|NCT01096849|470218958|FG002|Overall Study|Administrative Reasons|2|||
130617577|NCT01096849|470218956|FG000|Overall Study|Lost to Follow-up|1|||
130617578|NCT01096849|470218957|FG001|Overall Study|Lost to Follow-up|3|||
130617579|NCT01096849|470218958|FG002|Overall Study|Lost to Follow-up|1|||
130617580|NCT00118482|470218960|FG000|Overall Study|Lost to Follow-up|7|||
130617581|NCT00118482|470218961|FG001|Overall Study|Lost to Follow-up|7|||
130617582|NCT00118482|470218960|FG000|Overall Study|Withdrawal by Subject|23|||
130617583|NCT00118482|470218961|FG001|Overall Study|Withdrawal by Subject|22|||
130617584|NCT00242580|470218962|FG000|Overall Study|Adverse Event|3|||
130617585|NCT00242580|470218963|FG001|Overall Study|Adverse Event|0|||
130617586|NCT00242580|470218964|FG002|Overall Study|Adverse Event|2|||
130617587|NCT00242580|470218962|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130617588|NCT00242580|470218963|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130617589|NCT00242580|470218964|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130617590|NCT00242580|470218962|FG000|Overall Study|Protocol Violation|0|||
130617591|NCT00242580|470218963|FG001|Overall Study|Protocol Violation|0|||
130617592|NCT00242580|470218964|FG002|Overall Study|Protocol Violation|1|||
130617593|NCT00242580|470218962|FG000|Overall Study|Subject withdrew consent|2|||
130617594|NCT00242580|470218963|FG001|Overall Study|Subject withdrew consent|2|||
130617595|NCT00242580|470218964|FG002|Overall Study|Subject withdrew consent|5|||
130617596|NCT00242580|470218962|FG000|Overall Study|Lost to Follow-up|0|||
130617597|NCT00242580|470218963|FG001|Overall Study|Lost to Follow-up|3|||
130617598|NCT00242580|470218964|FG002|Overall Study|Lost to Follow-up|0|||
130617599|NCT00242580|470218962|FG000|Overall Study|Death|1|||
130617600|NCT00242580|470218963|FG001|Overall Study|Death|2|||
130617601|NCT00242580|470218964|FG002|Overall Study|Death|1|||
130617602|NCT01232894|470218965|FG000|Overall Study|Lost to Follow-up|0|||
130617603|NCT01232894|470218966|FG001|Overall Study|Lost to Follow-up|1|||
130617604|NCT01232894|470218965|FG000|Overall Study|Death|1|||
130617605|NCT01232894|470218966|FG001|Overall Study|Death|0|||
130617606|NCT01232894|470218965|FG000|Overall Study|Protocol Violation|1|||
130617607|NCT01232894|470218966|FG001|Overall Study|Protocol Violation|1|||
130617608|NCT01232894|470218965|FG000|Overall Study|Withdrawal by Subject|8|||
130617609|NCT01232894|470218966|FG001|Overall Study|Withdrawal by Subject|5|||
130617610|NCT01232894|470218965|FG000|Overall Study|Physician Decision|2|||
130617611|NCT01232894|470218966|FG001|Overall Study|Physician Decision|1|||
130617612|NCT03970395|470218969|FG000|Overall Study|Withdrawal by Subject|3|||
130617613|NCT03970395|470218970|FG001|Overall Study|Withdrawal by Subject|4|||
130617614|NCT03970395|470218969|FG000|Overall Study|Lost to Follow-up|4|||
130617615|NCT03970395|470218970|FG001|Overall Study|Lost to Follow-up|8|||
130617616|NCT00125190|470218971|FG000|Overall Study|Subject/Parent Decision|7|||
130617617|NCT00125190|470218971|FG000|Overall Study|Non-compliance|2|||
130617618|NCT00125190|470218971|FG000|Overall Study|Adverse Event|1|||
130617619|NCT00125190|470218971|FG000|Overall Study|Other|1|||
130617620|NCT00125190|470218971|FG000|Overall Study|Lost to Follow-up|4|||
130617621|NCT00929734|470218974|FG000|Overall Study|Lost to Follow-up|2|||
130617622|NCT00929734|470218975|FG001|Overall Study|Lost to Follow-up|1|||
130617623|NCT00929734|470218974|FG000|Overall Study|Withdrawal by Subject|0|||
130617624|NCT00929734|470218975|FG001|Overall Study|Withdrawal by Subject|2|||
130617625|NCT02921919|470218976|FG000|Overall Study|Other|5|||
130617626|NCT02921919|470218977|FG001|Overall Study|Other|6|||
130617627|NCT02921919|470218976|FG000|Overall Study|Lost to Follow-up|0|||
130617628|NCT02921919|470218977|FG001|Overall Study|Lost to Follow-up|1|||
130617629|NCT02921919|470218976|FG000|Overall Study|Withdrawal by Subject|5|||
130617630|NCT02921919|470218977|FG001|Overall Study|Withdrawal by Subject|1|||
130617631|NCT02921919|470218976|FG000|Overall Study|Disease Progression|47|||
130617632|NCT02921919|470218977|FG001|Overall Study|Disease Progression|38|||
130617633|NCT02921919|470218976|FG000|Overall Study|Physician Decision|3|||
130617634|NCT02921919|470218977|FG001|Overall Study|Physician Decision|2|||
130617635|NCT02921919|470218976|FG000|Overall Study|Adverse Event|6|||
130617636|NCT02921919|470218977|FG001|Overall Study|Adverse Event|4|||
130617637|NCT00980980|470218978|FG000|Overall Study|Withdrawal by Hospital|0|||
130617638|NCT00980980|470218979|FG001|Overall Study|Withdrawal by Hospital|1|||
130617639|NCT00980980|470218980|FG002|Overall Study|Withdrawal by Hospital|0|||
130617640|NCT03666858|470218981|FG000|Cohort 1|Adverse Event|1|||
130617641|NCT03666858|470218982|FG001|Cohort 1|Adverse Event|0|||
130617642|NCT03666858|470218981|FG000|Cohort 2|Adverse Event|0|||
130617643|NCT03666858|470218982|FG001|Cohort 2|Adverse Event|1|||
130617644|NCT00121992|470218984|FG000|Overall Study|Treatment not received|2|||
130617645|NCT00121992|470218985|FG001|Overall Study|Treatment not received|11|||
130617646|NCT03282357|470218986|FG000|Overall Study|Lost to Follow-up|3|||
130617647|NCT03282357|470218986|FG000|Overall Study|Withdrawal by Subject|4|||
130617648|NCT03282357|470218986|FG000|Overall Study|Adverse Event|1|||
130617649|NCT03282357|470218986|FG000|Overall Study|Other|9|||
130617650|NCT01586156|470218987|FG000|Overall Study|Pregnancy|0|||
130617651|NCT01586156|470218988|FG001|Overall Study|Pregnancy|1|||
130617652|NCT01586156|470218989|FG002|Overall Study|Pregnancy|0|||
130617653|NCT00547378|470218990|FG000|Randomized Cohort|Withdrawal by Subject|7|||
130617654|NCT00547378|470218991|FG001|Randomized Cohort|Withdrawal by Subject|5|||
130617655|NCT00547378|470218992|FG002|Randomized Cohort|Withdrawal by Subject|0|||
130617656|NCT00547378|470218990|FG000|Randomized Cohort|Death|0|||
130617657|NCT00547378|470218991|FG001|Randomized Cohort|Death|1|||
130617658|NCT00547378|470218992|FG002|Randomized Cohort|Death|0|||
130617659|NCT00547378|470218990|FG000|Randomized Cohort|Lost to Follow-up|1|||
130617660|NCT00547378|470218991|FG001|Randomized Cohort|Lost to Follow-up|0|||
130617661|NCT00547378|470218992|FG002|Randomized Cohort|Lost to Follow-up|0|||
130617662|NCT00547378|470218990|FG000|Randomized Cohort|Adverse Event|1|||
130617663|NCT00547378|470218991|FG001|Randomized Cohort|Adverse Event|0|||
130617664|NCT00547378|470218992|FG002|Randomized Cohort|Adverse Event|0|||
130617665|NCT00547378|470218990|FG000|Randomized Cohort|Other reasons|2|||
130617666|NCT00547378|470218991|FG001|Randomized Cohort|Other reasons|0|||
130617667|NCT00547378|470218992|FG002|Randomized Cohort|Other reasons|0|||
130617668|NCT00547378|470218990|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
130617669|NCT00547378|470218991|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
130617670|NCT00547378|470218992|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
130617671|NCT00547378|470218990|FG000|All Implanted Cohort|Adverse Event|4|||
130617672|NCT00547378|470218991|FG001|All Implanted Cohort|Adverse Event|10|||
130617673|NCT00547378|470218992|FG002|All Implanted Cohort|Adverse Event|17|||
130617674|NCT00547378|470218990|FG000|All Implanted Cohort|Lost to Follow-up|0|||
130617675|NCT00547378|470218991|FG001|All Implanted Cohort|Lost to Follow-up|1|||
130617676|NCT00547378|470218992|FG002|All Implanted Cohort|Lost to Follow-up|14|||
130617677|NCT00547378|470218990|FG000|All Implanted Cohort|Death|3|||
130617678|NCT00547378|470218991|FG001|All Implanted Cohort|Death|1|||
130617679|NCT00547378|470218992|FG002|All Implanted Cohort|Death|4|||
130617680|NCT00547378|470218990|FG000|All Implanted Cohort|Physician Decision|0|||
130617681|NCT00547378|470218991|FG001|All Implanted Cohort|Physician Decision|2|||
130617682|NCT00547378|470218992|FG002|All Implanted Cohort|Physician Decision|6|||
130617683|NCT00547378|470218990|FG000|All Implanted Cohort|Site closure|2|||
130617684|NCT00547378|470218991|FG001|All Implanted Cohort|Site closure|0|||
130617685|NCT00547378|470218992|FG002|All Implanted Cohort|Site closure|1|||
130617686|NCT00547378|470218990|FG000|All Implanted Cohort|Other reasons|1|||
130617687|NCT00547378|470218991|FG001|All Implanted Cohort|Other reasons|0|||
130617688|NCT00547378|470218992|FG002|All Implanted Cohort|Other reasons|1|||
130617689|NCT00414960|470218993|FG000|Overall Study|Adverse Event|4|||
130617690|NCT00414960|470218994|FG001|Overall Study|Adverse Event|0|||
130617691|NCT00414960|470218993|FG000|Overall Study|Withdrawal by Subject|3|||
130617692|NCT00414960|470218994|FG001|Overall Study|Withdrawal by Subject|0|||
130617693|NCT00414960|470218993|FG000|Overall Study|Physician Decision|0|||
130617694|NCT00414960|470218994|FG001|Overall Study|Physician Decision|1|||
130617695|NCT04105244|470218995|FG000|Overall Study|Withdrawal by Subject|10|||
130617696|NCT04105244|470218996|FG001|Overall Study|Withdrawal by Subject|12|||
130617697|NCT04105244|470218995|FG000|Overall Study|Lost to Follow-up|20|||
130617698|NCT04105244|470218996|FG001|Overall Study|Lost to Follow-up|15|||
130617699|NCT04105244|470218995|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
130617700|NCT04105244|470218996|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
130617701|NCT04105244|470218995|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
130617702|NCT04105244|470218996|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
130617703|NCT02112994|470218997|FG000|Overall Study|Progressive Disease|0|||
130617704|NCT02112994|470218998|FG001|Overall Study|Progressive Disease|0|||
130617705|NCT02112994|470218999|FG002|Overall Study|Progressive Disease|1|||
130617706|NCT02112994|470218997|FG000|Overall Study|Pregnancy|0|||
130617707|NCT02112994|470218998|FG001|Overall Study|Pregnancy|1|||
130617708|NCT02112994|470218999|FG002|Overall Study|Pregnancy|1|||
130617709|NCT02112994|470218997|FG000|Overall Study|Liver Transplant|0|||
130617710|NCT02112994|470218998|FG001|Overall Study|Liver Transplant|1|||
130617711|NCT02112994|470218999|FG002|Overall Study|Liver Transplant|0|||
130617712|NCT02112994|470218997|FG000|Overall Study|Withdrawal by Subject|0|||
130617713|NCT02112994|470218998|FG001|Overall Study|Withdrawal by Subject|0|||
130617714|NCT02112994|470218999|FG002|Overall Study|Withdrawal by Subject|1|||
130617715|NCT02768194|470219001|FG000|Period 1|Adverse Event|0|||
130617716|NCT02768194|470219002|FG001|Period 1|Adverse Event|0|||
130617717|NCT02768194|470219003|FG002|Period 1|Adverse Event|0|||
130617718|NCT02768194|470219004|FG003|Period 1|Adverse Event|1|||
130617719|NCT02768194|470219005|FG004|Period 1|Adverse Event|0|||
130617720|NCT02768194|470219006|FG005|Period 1|Adverse Event|0|||
130617721|NCT02768194|470219001|FG000|Period 2|Other (Reason not specified)|1|||
130617722|NCT02768194|470219002|FG001|Period 2|Other (Reason not specified)|0|||
130617723|NCT02768194|470219003|FG002|Period 2|Other (Reason not specified)|0|||
130617724|NCT02768194|470219004|FG003|Period 2|Other (Reason not specified)|0|||
130617725|NCT02768194|470219005|FG004|Period 2|Other (Reason not specified)|0|||
130617726|NCT02768194|470219006|FG005|Period 2|Other (Reason not specified)|0|||
130617727|NCT02768194|470219001|FG000|Period 3|Other (Reason not specified)|0|||
130617728|NCT02768194|470219002|FG001|Period 3|Other (Reason not specified)|1|||
130617729|NCT02768194|470219003|FG002|Period 3|Other (Reason not specified)|0|||
130617730|NCT02768194|470219004|FG003|Period 3|Other (Reason not specified)|0|||
130617731|NCT02768194|470219005|FG004|Period 3|Other (Reason not specified)|0|||
130617732|NCT02768194|470219006|FG005|Period 3|Other (Reason not specified)|0|||
130617733|NCT00264849|470219007|FG000|Overall Study|Adverse Event|7|||
130617734|NCT00264849|470219008|FG001|Overall Study|Adverse Event|2|||
130617735|NCT00264849|470219007|FG000|Overall Study|Withdrawal by Subject|7|||
130617736|NCT00264849|470219008|FG001|Overall Study|Withdrawal by Subject|11|||
130617737|NCT00264849|470219007|FG000|Overall Study|Protocol Violation|5|||
130617738|NCT00264849|470219008|FG001|Overall Study|Protocol Violation|3|||
130617739|NCT00264849|470219007|FG000|Overall Study|Lack of Efficacy|1|||
130617740|NCT00264849|470219008|FG001|Overall Study|Lack of Efficacy|6|||
130617741|NCT00264849|470219007|FG000|Overall Study|Lost to Follow-up|0|||
130617742|NCT00264849|470219008|FG001|Overall Study|Lost to Follow-up|2|||
130617743|NCT00264849|470219007|FG000|Overall Study|Death|0|||
130617744|NCT00264849|470219008|FG001|Overall Study|Death|1|||
130617745|NCT00264849|470219007|FG000|Overall Study|Administrative Problems|2|||
130617746|NCT00264849|470219008|FG001|Overall Study|Administrative Problems|0|||
130617747|NCT00099359|470219011|FG000|Overall Study|Death|11|||
130617748|NCT00099359|470219012|FG001|Overall Study|Death|15|||
130617749|NCT00099359|470219013|FG002|Overall Study|Death|17|||
130617750|NCT00099359|470219011|FG000|Overall Study|Withdrawal by Subject|19|||
130617751|NCT00099359|470219012|FG001|Overall Study|Withdrawal by Subject|19|||
130617752|NCT00099359|470219013|FG002|Overall Study|Withdrawal by Subject|23|||
130617753|NCT00099359|470219011|FG000|Overall Study|Lost to Follow-up|15|||
130617754|NCT00099359|470219012|FG001|Overall Study|Lost to Follow-up|24|||
130617755|NCT00099359|470219013|FG002|Overall Study|Lost to Follow-up|24|||
130617756|NCT00099359|470219011|FG000|Overall Study|moved out of area|9|||
130617757|NCT00099359|470219012|FG001|Overall Study|moved out of area|7|||
130617758|NCT00099359|470219013|FG002|Overall Study|moved out of area|4|||
130617759|NCT02756650|470219014|FG000|Overall Study|Physician Decision|1|||
130617760|NCT02756650|470219014|FG000|Overall Study|Adverse Event|1|||
130617761|NCT01822691|470219015|FG000|Overall Study|Withdrawal by Subject|2|||
130617762|NCT01553916|470219016|FG000|Overall Study|Withdrawal by Subject|2|||
130617763|NCT01553916|470219016|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
130617764|NCT04465396|470219021|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
130617765|NCT04465396|470219022|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
130617766|NCT04465396|470219023|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
130617767|NCT04465396|470219024|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
130617768|NCT02648724|470219025|FG000|Overall Study|Withdrawal by Subject|0|||
130617769|NCT02648724|470219026|FG001|Overall Study|Withdrawal by Subject|1|||
130617770|NCT02648724|470219027|FG002|Overall Study|Withdrawal by Subject|1|||
130617771|NCT02648724|470219028|FG003|Overall Study|Withdrawal by Subject|0|||
130617772|NCT02648724|470219029|FG004|Overall Study|Withdrawal by Subject|1|||
130617773|NCT02648724|470219030|FG005|Overall Study|Withdrawal by Subject|0|||
130617774|NCT02648724|470219031|FG006|Overall Study|Withdrawal by Subject|0|||
130617775|NCT02648724|470219025|FG000|Overall Study|Progressive disease|2|||
130617776|NCT02648724|470219026|FG001|Overall Study|Progressive disease|2|||
130617777|NCT02648724|470219027|FG002|Overall Study|Progressive disease|2|||
130617778|NCT02648724|470219028|FG003|Overall Study|Progressive disease|3|||
130617779|NCT02648724|470219029|FG004|Overall Study|Progressive disease|22|||
130617780|NCT02648724|470219030|FG005|Overall Study|Progressive disease|7|||
130617781|NCT02648724|470219031|FG006|Overall Study|Progressive disease|8|||
130617782|NCT02648724|470219025|FG000|Overall Study|Other reason (unknown)|1|||
130617783|NCT02648724|470219026|FG001|Overall Study|Other reason (unknown)|0|||
130617784|NCT02648724|470219027|FG002|Overall Study|Other reason (unknown)|0|||
130617785|NCT02648724|470219028|FG003|Overall Study|Other reason (unknown)|0|||
130617786|NCT02648724|470219029|FG004|Overall Study|Other reason (unknown)|0|||
130617787|NCT02648724|470219030|FG005|Overall Study|Other reason (unknown)|0|||
130617788|NCT02648724|470219031|FG006|Overall Study|Other reason (unknown)|0|||
130617789|NCT02648724|470219025|FG000|Overall Study|Protocol Violation|0|||
130617790|NCT02648724|470219026|FG001|Overall Study|Protocol Violation|0|||
130617791|NCT02648724|470219027|FG002|Overall Study|Protocol Violation|0|||
130617792|NCT02648724|470219028|FG003|Overall Study|Protocol Violation|0|||
130617793|NCT02648724|470219029|FG004|Overall Study|Protocol Violation|1|||
130617794|NCT02648724|470219030|FG005|Overall Study|Protocol Violation|0|||
130617795|NCT02648724|470219031|FG006|Overall Study|Protocol Violation|0|||
130617796|NCT02648724|470219025|FG000|Overall Study|Death|0|||
130617797|NCT02648724|470219026|FG001|Overall Study|Death|0|||
130617798|NCT02648724|470219027|FG002|Overall Study|Death|0|||
130617799|NCT02648724|470219028|FG003|Overall Study|Death|0|||
130617800|NCT02648724|470219029|FG004|Overall Study|Death|0|||
130617801|NCT02648724|470219030|FG005|Overall Study|Death|0|||
130617802|NCT02648724|470219031|FG006|Overall Study|Death|3|||
130617803|NCT02648724|470219025|FG000|Overall Study|Physician Decision|0|||
130617804|NCT02648724|470219026|FG001|Overall Study|Physician Decision|0|||
130617805|NCT02648724|470219027|FG002|Overall Study|Physician Decision|0|||
130617806|NCT02648724|470219028|FG003|Overall Study|Physician Decision|0|||
130617807|NCT02648724|470219029|FG004|Overall Study|Physician Decision|1|||
130617808|NCT02648724|470219030|FG005|Overall Study|Physician Decision|0|||
130617809|NCT02648724|470219031|FG006|Overall Study|Physician Decision|1|||
130617810|NCT02648724|470219025|FG000|Overall Study|Transferred to named patient program|0|||
130617811|NCT02648724|470219026|FG001|Overall Study|Transferred to named patient program|0|||
130617812|NCT02648724|470219027|FG002|Overall Study|Transferred to named patient program|0|||
130617813|NCT02648724|470219028|FG003|Overall Study|Transferred to named patient program|0|||
130617814|NCT02648724|470219029|FG004|Overall Study|Transferred to named patient program|0|||
130617815|NCT02648724|470219030|FG005|Overall Study|Transferred to named patient program|1|||
130617816|NCT02648724|470219031|FG006|Overall Study|Transferred to named patient program|0|||
130617817|NCT03076190|470219035|FG000|Overall Study|Lost to Follow-up|9|||
130617818|NCT03076190|470219036|FG001|Overall Study|Lost to Follow-up|34|||
130617819|NCT03076190|470219035|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
130617820|NCT03076190|470219036|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
130617821|NCT00434122|470219037|FG000|Overall Study|Non-compliance with protocol|0|||
130617822|NCT00434122|470219038|FG001|Overall Study|Non-compliance with protocol|1|||
130617823|NCT00434122|470219037|FG000|Overall Study|loss of subject contact|1|||
130617824|NCT00434122|470219038|FG001|Overall Study|loss of subject contact|1|||
130617825|NCT00434122|470219037|FG000|Overall Study|Personal reasons|1|||
130617826|NCT00434122|470219038|FG001|Overall Study|Personal reasons|1|||
130617827|NCT00434122|470219037|FG000|Overall Study|Large follicle size|2|||
130617828|NCT00434122|470219038|FG001|Overall Study|Large follicle size|2|||
130617829|NCT00434122|470219037|FG000|Overall Study|Low follicular response.|1|||
130617830|NCT00434122|470219038|FG001|Overall Study|Low follicular response.|2|||
130617831|NCT00434122|470219037|FG000|Overall Study|Travelling of subject.|1|||
130617832|NCT00434122|470219038|FG001|Overall Study|Travelling of subject.|0|||
130617833|NCT00975195|470219039|FG000|Overall Study|Adverse Event|108|||
130617834|NCT00975195|470219040|FG001|Overall Study|Adverse Event|101|||
130617835|NCT00975195|470219039|FG000|Overall Study|Lack of Efficacy|6|||
130617836|NCT00975195|470219040|FG001|Overall Study|Lack of Efficacy|6|||
130617837|NCT00975195|470219039|FG000|Overall Study|Protocol Violation|27|||
130617838|NCT00975195|470219040|FG001|Overall Study|Protocol Violation|23|||
130617839|NCT00975195|470219039|FG000|Overall Study|Lost to Follow-up|9|||
130617840|NCT00975195|470219040|FG001|Overall Study|Lost to Follow-up|7|||
130617841|NCT00975195|470219039|FG000|Overall Study|Withdrawal by Subject|48|||
130617842|NCT00975195|470219040|FG001|Overall Study|Withdrawal by Subject|61|||
130617843|NCT00975195|470219039|FG000|Overall Study|Other reason not defined above|29|||
130617844|NCT00975195|470219040|FG001|Overall Study|Other reason not defined above|33|||
130617845|NCT00975195|470219039|FG000|Overall Study|Not treated|1|||
130617846|NCT00975195|470219040|FG001|Overall Study|Not treated|2|||
130617847|NCT01179347|470220429|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
130617848|NCT01179347|470220430|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
130617849|NCT01179347|470220429|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
130617850|NCT01179347|470220430|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
130617851|NCT01179347|470220429|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130617852|NCT01179347|470220430|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130617853|NCT01179347|470220429|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
130617854|NCT01179347|470220430|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
130617855|NCT01179347|470220429|FG000|Double-blind Period (12 Weeks)|Other|2|||
130617856|NCT01179347|470220430|FG001|Double-blind Period (12 Weeks)|Other|4|||
130617857|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
130617858|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
130617859|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
130617860|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
130617861|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
130617862|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
130617863|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
130617864|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
130617865|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
130617866|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
130617867|NCT01179347|470220429|FG000|Open-label Period (12 Weeks)|Other|7|||
130617868|NCT01179347|470220430|FG001|Open-label Period (12 Weeks)|Other|4|||
130617869|NCT02586077|470220431|FG000|Overall Study|Withdrawal by Subject|1|||
130617870|NCT02586077|470220431|FG000|Overall Study|Physician Decision|4|||
130617871|NCT02586077|470220431|FG000|Overall Study|Lost to Follow-up|3|||
130617872|NCT01245764|470220432|FG000|Study Phase A|Other|3|||
130617873|NCT01245764|470220433|FG001|Study Phase A|Other|2|||
130617874|NCT01245764|470220434|FG002|Study Phase A|Other|3|||
130617875|NCT01245764|470220435|FG003|Study Phase A|Other|1|||
130617876|NCT01245764|470220432|FG000|Study Phase A|Protocol Violation|6|||
130617877|NCT01245764|470220433|FG001|Study Phase A|Protocol Violation|3|||
130617878|NCT01245764|470220434|FG002|Study Phase A|Protocol Violation|2|||
130617879|NCT01245764|470220435|FG003|Study Phase A|Protocol Violation|2|||
130617880|NCT01245764|470220432|FG000|Study Phase A|Lost to Follow-up|0|||
130617881|NCT01245764|470220433|FG001|Study Phase A|Lost to Follow-up|0|||
130617882|NCT01245764|470220434|FG002|Study Phase A|Lost to Follow-up|5|||
130617883|NCT01245764|470220435|FG003|Study Phase A|Lost to Follow-up|0|||
130617884|NCT00781963|470220438|FG000|Overall Study|Death|3|||
130617885|NCT00781963|470220439|FG001|Overall Study|Death|0|||
130617886|NCT00781963|470220438|FG000|Overall Study|Lost to Follow-up|2|||
130617887|NCT00781963|470220439|FG001|Overall Study|Lost to Follow-up|1|||
130617888|NCT00781963|470220438|FG000|Overall Study|Withdrawal by Subject|3|||
130617889|NCT00781963|470220439|FG001|Overall Study|Withdrawal by Subject|1|||
130617890|NCT00781963|470220438|FG000|Overall Study|Refused follow-up|9|||
130617891|NCT00781963|470220439|FG001|Overall Study|Refused follow-up|0|||
130617892|NCT02064205|470220440|FG000|Overall Study|Withdrawal by Subject|1|||
130617893|NCT02062463|470220444|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
130617894|NCT02062463|470220445|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
130617895|NCT02062463|470220446|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
130617896|NCT02062463|470220447|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
130617897|NCT02062463|470220444|FG000|Stage 2|Adverse Event|0|||
130617898|NCT02062463|470220445|FG001|Stage 2|Adverse Event|0|||
130617899|NCT02062463|470220446|FG002|Stage 2|Adverse Event|12|||
130617900|NCT02062463|470220447|FG003|Stage 2|Adverse Event|20|||
130617901|NCT02062463|470220444|FG000|Stage 2|Lack of Efficacy|0|||
130617902|NCT02062463|470220445|FG001|Stage 2|Lack of Efficacy|0|||
130617903|NCT02062463|470220446|FG002|Stage 2|Lack of Efficacy|3|||
130617904|NCT02062463|470220447|FG003|Stage 2|Lack of Efficacy|4|||
130617905|NCT02062463|470220444|FG000|Stage 2|Lost to Follow-up|0|||
130617906|NCT02062463|470220445|FG001|Stage 2|Lost to Follow-up|0|||
130617907|NCT02062463|470220446|FG002|Stage 2|Lost to Follow-up|20|||
130617908|NCT02062463|470220447|FG003|Stage 2|Lost to Follow-up|20|||
130617909|NCT02062463|470220444|FG000|Stage 2|Non-Compliance|0|||
130617910|NCT02062463|470220445|FG001|Stage 2|Non-Compliance|0|||
130617911|NCT02062463|470220446|FG002|Stage 2|Non-Compliance|0|||
130617912|NCT02062463|470220447|FG003|Stage 2|Non-Compliance|1|||
130617913|NCT02062463|470220444|FG000|Stage 2|Other than specified|0|||
130617914|NCT02062463|470220445|FG001|Stage 2|Other than specified|0|||
130617915|NCT02062463|470220446|FG002|Stage 2|Other than specified|3|||
130617916|NCT02062463|470220447|FG003|Stage 2|Other than specified|1|||
130617917|NCT02062463|470220444|FG000|Stage 2|Withdrawal by Subject|0|||
130617918|NCT02062463|470220445|FG001|Stage 2|Withdrawal by Subject|0|||
130617919|NCT02062463|470220446|FG002|Stage 2|Withdrawal by Subject|15|||
130617920|NCT02062463|470220447|FG003|Stage 2|Withdrawal by Subject|10|||
130617921|NCT04124692|470220450|FG000|Overall Study|Medical reason|0|||
130617922|NCT04124692|470220451|FG001|Overall Study|Medical reason|1|||
130617923|NCT04124692|470220450|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
130617924|NCT04124692|470220451|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
130617925|NCT04124692|470220450|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
130617926|NCT04124692|470220451|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
130617927|NCT04124692|470220450|FG000|Overall Study|Lost to Follow-up|2|||
130617928|NCT04124692|470220451|FG001|Overall Study|Lost to Follow-up|4|||
130617929|NCT04124692|470220450|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
130617930|NCT04124692|470220451|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
130617931|NCT00205699|470220452|FG000|Overall Study|Lost to Follow-up|1|||
130617932|NCT00205699|470220453|FG001|Overall Study|Lost to Follow-up|3|||
130617933|NCT00205699|470220454|FG002|Overall Study|Lost to Follow-up|5|||
130617934|NCT00205699|470220452|FG000|Overall Study|Adverse Event|1|||
130617935|NCT00205699|470220453|FG001|Overall Study|Adverse Event|0|||
130617936|NCT00205699|470220454|FG002|Overall Study|Adverse Event|0|||
130617937|NCT00205699|470220452|FG000|Overall Study|Withdrawal by Subject|1|||
130617938|NCT00205699|470220453|FG001|Overall Study|Withdrawal by Subject|2|||
130617939|NCT00205699|470220454|FG002|Overall Study|Withdrawal by Subject|1|||
130617940|NCT00205699|470220452|FG000|Overall Study|Lack of Efficacy|0|||
130617941|NCT00205699|470220453|FG001|Overall Study|Lack of Efficacy|1|||
130617942|NCT00205699|470220454|FG002|Overall Study|Lack of Efficacy|0|||
130617943|NCT01754922|470220457|FG000|Overall Study|Adverse Event|0|||
130617944|NCT01754922|470220458|FG001|Overall Study|Adverse Event|1|||
130617945|NCT01199055|470220467|FG000|Overall Study|Death|0|||
130617946|NCT01199055|470220468|FG001|Overall Study|Death|1|||
130617947|NCT01199055|470220469|FG002|Overall Study|Death|0|||
130617948|NCT01199055|470220467|FG000|Overall Study|Physician Decision|0|||
130617949|NCT01199055|470220468|FG001|Overall Study|Physician Decision|1|||
130617950|NCT01199055|470220469|FG002|Overall Study|Physician Decision|1|||
130617951|NCT01199055|470220467|FG000|Overall Study|Progressive disease|2|||
130617952|NCT01199055|470220468|FG001|Overall Study|Progressive disease|1|||
130617953|NCT01199055|470220469|FG002|Overall Study|Progressive disease|2|||
130617954|NCT01199055|470220467|FG000|Overall Study|Withdrawal by Subject|0|||
130617955|NCT01199055|470220468|FG001|Overall Study|Withdrawal by Subject|0|||
130617956|NCT01199055|470220469|FG002|Overall Study|Withdrawal by Subject|1|||
130617957|NCT00077610|470220470|FG000|Overall Study|Adverse Event|9|||
130617958|NCT00077610|470220471|FG001|Overall Study|Adverse Event|7|||
130617959|NCT00077610|470220472|FG002|Overall Study|Adverse Event|1|||
130617960|NCT00077610|470220470|FG000|Overall Study|Lost to Follow-up|0|||
130617961|NCT00077610|470220471|FG001|Overall Study|Lost to Follow-up|1|||
130617962|NCT00077610|470220472|FG002|Overall Study|Lost to Follow-up|2|||
130617963|NCT00077610|470220470|FG000|Overall Study|Withdrawal by Subject|4|||
130617964|NCT00077610|470220471|FG001|Overall Study|Withdrawal by Subject|10|||
130617965|NCT00077610|470220472|FG002|Overall Study|Withdrawal by Subject|6|||
130617966|NCT00077610|470220470|FG000|Overall Study|Death|17|||
130617967|NCT00077610|470220471|FG001|Overall Study|Death|13|||
130617968|NCT00077610|470220472|FG002|Overall Study|Death|13|||
130617969|NCT00077610|470220470|FG000|Overall Study|Renal transplant|12|||
130617970|NCT00077610|470220471|FG001|Overall Study|Renal transplant|15|||
130617971|NCT00077610|470220472|FG002|Overall Study|Renal transplant|11|||
130617972|NCT00077610|470220470|FG000|Overall Study|Withdrew from dialysis care|5|||
130617973|NCT00077610|470220471|FG001|Overall Study|Withdrew from dialysis care|0|||
130617974|NCT00077610|470220472|FG002|Overall Study|Withdrew from dialysis care|3|||
130617975|NCT00077610|470220470|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130617976|NCT00077610|470220471|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130617977|NCT00077610|470220472|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130617978|NCT00077610|470220470|FG000|Overall Study|Multiple blood transfusions|0|||
130617979|NCT00077610|470220471|FG001|Overall Study|Multiple blood transfusions|0|||
130617980|NCT00077610|470220472|FG002|Overall Study|Multiple blood transfusions|1|||
130617981|NCT00077610|470220470|FG000|Overall Study|Principal Investigator's decision|1|||
130617982|NCT00077610|470220471|FG001|Overall Study|Principal Investigator's decision|0|||
130617983|NCT00077610|470220472|FG002|Overall Study|Principal Investigator's decision|1|||
130617984|NCT00077610|470220470|FG000|Overall Study|Worsening of health condition|1|||
130617985|NCT00077610|470220471|FG001|Overall Study|Worsening of health condition|1|||
130617986|NCT00077610|470220472|FG002|Overall Study|Worsening of health condition|0|||
130617987|NCT00077610|470220470|FG000|Overall Study|Given Epogen in hospital|1|||
130617988|NCT00077610|470220471|FG001|Overall Study|Given Epogen in hospital|0|||
130617989|NCT00077610|470220472|FG002|Overall Study|Given Epogen in hospital|0|||
130617990|NCT00077610|470220470|FG000|Overall Study|Transferred to other unit|0|||
130617991|NCT00077610|470220471|FG001|Overall Study|Transferred to other unit|0|||
130617992|NCT00077610|470220472|FG002|Overall Study|Transferred to other unit|1|||
130617993|NCT00077610|470220470|FG000|Overall Study|Transferred to nursing home|0|||
130617994|NCT00077610|470220471|FG001|Overall Study|Transferred to nursing home|0|||
130617995|NCT00077610|470220472|FG002|Overall Study|Transferred to nursing home|1|||
130617996|NCT00077610|470220470|FG000|Overall Study|Transfer to satellite unit|1|||
130617997|NCT00077610|470220471|FG001|Overall Study|Transfer to satellite unit|0|||
130617998|NCT00077610|470220472|FG002|Overall Study|Transfer to satellite unit|0|||
130617999|NCT00077610|470220470|FG000|Overall Study|Transfer to other center for surgery|1|||
130618000|NCT00077610|470220471|FG001|Overall Study|Transfer to other center for surgery|0|||
130618001|NCT00077610|470220472|FG002|Overall Study|Transfer to other center for surgery|0|||
130618002|NCT00077610|470220470|FG000|Overall Study|Change in dialysis modality|1|||
130618003|NCT00077610|470220471|FG001|Overall Study|Change in dialysis modality|0|||
130618004|NCT00077610|470220472|FG002|Overall Study|Change in dialysis modality|0|||
130618005|NCT00077610|470220470|FG000|Overall Study|Relocation|0|||
130618006|NCT00077610|470220471|FG001|Overall Study|Relocation|8|||
130618007|NCT00077610|470220472|FG002|Overall Study|Relocation|5|||
130618008|NCT00077610|470220470|FG000|Overall Study|Financial issues|0|||
130618009|NCT00077610|470220471|FG001|Overall Study|Financial issues|1|||
130618010|NCT00077610|470220472|FG002|Overall Study|Financial issues|0|||
130618011|NCT00077610|470220470|FG000|Overall Study|Sponsors decision to withdraw|0|||
130618012|NCT00077610|470220471|FG001|Overall Study|Sponsors decision to withdraw|0|||
130618013|NCT00077610|470220472|FG002|Overall Study|Sponsors decision to withdraw|1|||
130618014|NCT00976950|470220473|FG000|Overall Study|Adverse Event|3|||
130618015|NCT00976950|470220473|FG000|Overall Study|Events with no relationship to Aptivus|3|||
130618016|NCT00304915|470220474|FG000|Overall Study|Lost to Follow-up|11|||
130618017|NCT00304915|470220475|FG001|Overall Study|Lost to Follow-up|11|||
130618018|NCT00304915|470220474|FG000|Overall Study|Death|4|||
130618019|NCT00304915|470220475|FG001|Overall Study|Death|5|||
130618020|NCT00304915|470220474|FG000|Overall Study|Withdrawal by Subject|3|||
130618021|NCT00304915|470220475|FG001|Overall Study|Withdrawal by Subject|0|||
130618022|NCT02662985|470220484|FG000|Treatment Period 1|Adverse Event|0|||
130618023|NCT02662985|470220485|FG001|Treatment Period 1|Adverse Event|2|||
130618024|NCT02662985|470220484|FG000|Treatment Period 1|Protocol Violation|0|||
130618025|NCT02662985|470220485|FG001|Treatment Period 1|Protocol Violation|1|||
130618026|NCT02662985|470220484|FG000|Treatment Period 1|Physician Decision|1|||
130618027|NCT02662985|470220485|FG001|Treatment Period 1|Physician Decision|0|||
130618028|NCT02662985|470220484|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130618029|NCT02662985|470220485|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130618030|NCT02662985|470220484|FG000|Treatment Period 2|Lack of Efficacy|0|||
130618031|NCT02662985|470220485|FG001|Treatment Period 2|Lack of Efficacy|1|||
130618032|NCT02662985|470220484|FG000|Treatment Period 2|Lost to Follow-up|1|||
130618033|NCT02662985|470220485|FG001|Treatment Period 2|Lost to Follow-up|0|||
130618034|NCT02662985|470220484|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
130618035|NCT02662985|470220485|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
130618036|NCT02662985|470220484|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
130618037|NCT02662985|470220485|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
130618038|NCT02662985|470220484|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
130618039|NCT02662985|470220485|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
130618040|NCT02662985|470220484|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
130618041|NCT02662985|470220485|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
130618042|NCT02662985|470220484|FG000|Treatment Period 3 (Extension Period)|Death|0|||
130618043|NCT02662985|470220485|FG001|Treatment Period 3 (Extension Period)|Death|1|||
130618044|NCT03442829|470220486|FG000|Overall Study|Scheduling clash|3|||
130618045|NCT03442829|470220487|FG001|Overall Study|Scheduling clash|1|||
130618046|NCT03442829|470220486|FG000|Overall Study|Illness unrelated to study|1|||
130618047|NCT03442829|470220487|FG001|Overall Study|Illness unrelated to study|1|||
130618048|NCT01486784|470220488|FG000|Overall Study|Withdrawal by Subject|0|||
130618049|NCT01486784|470220489|FG001|Overall Study|Withdrawal by Subject|0|||
130618050|NCT01486784|470220490|FG002|Overall Study|Withdrawal by Subject|1|||
130618051|NCT01486784|470220491|FG003|Overall Study|Withdrawal by Subject|0|||
130618052|NCT01486784|470220492|FG004|Overall Study|Withdrawal by Subject|1|||
130618053|NCT01486784|470220493|FG005|Overall Study|Withdrawal by Subject|2|||
130618054|NCT01486784|470220488|FG000|Overall Study|Subject did not meet entry criteria|0|||
130618055|NCT01486784|470220489|FG001|Overall Study|Subject did not meet entry criteria|0|||
130618056|NCT01486784|470220490|FG002|Overall Study|Subject did not meet entry criteria|0|||
130618057|NCT01486784|470220491|FG003|Overall Study|Subject did not meet entry criteria|0|||
130618058|NCT01486784|470220492|FG004|Overall Study|Subject did not meet entry criteria|1|||
130618059|NCT01486784|470220493|FG005|Overall Study|Subject did not meet entry criteria|0|||
130618060|NCT01486784|470220488|FG000|Overall Study|Death|0|||
130618061|NCT01486784|470220489|FG001|Overall Study|Death|0|||
130618062|NCT01486784|470220490|FG002|Overall Study|Death|0|||
130618063|NCT01486784|470220491|FG003|Overall Study|Death|0|||
130618064|NCT01486784|470220492|FG004|Overall Study|Death|0|||
130618065|NCT01486784|470220493|FG005|Overall Study|Death|1|||
130618066|NCT01021852|470220496|FG000|Treatment Period 1|Adverse Event|3|||
130618067|NCT01021852|470220497|FG001|Treatment Period 1|Adverse Event|1|||
130618068|NCT01021852|470220498|FG002|Treatment Period 1|Adverse Event|1|||
130618069|NCT01021852|470220499|FG003|Treatment Period 1|Adverse Event|0|||
130618070|NCT01021852|470220500|FG004|Treatment Period 1|Adverse Event|2|||
130618071|NCT01021852|470220501|FG005|Treatment Period 1|Adverse Event|2|||
130618072|NCT01021852|470220502|FG006|Treatment Period 1|Adverse Event|0|||
130618073|NCT01021852|470220503|FG007|Treatment Period 1|Adverse Event|0|||
130618074|NCT01021852|470220496|FG000|Treatment Period 1|Pregnancy|0|||
130618075|NCT01021852|470220497|FG001|Treatment Period 1|Pregnancy|0|||
130618076|NCT01021852|470220498|FG002|Treatment Period 1|Pregnancy|1|||
130618077|NCT01021852|470220499|FG003|Treatment Period 1|Pregnancy|0|||
130618078|NCT01021852|470220500|FG004|Treatment Period 1|Pregnancy|0|||
130618079|NCT01021852|470220501|FG005|Treatment Period 1|Pregnancy|0|||
130618080|NCT01021852|470220502|FG006|Treatment Period 1|Pregnancy|0|||
130618081|NCT01021852|470220503|FG007|Treatment Period 1|Pregnancy|0|||
130618082|NCT01021852|470220496|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130618083|NCT01021852|470220497|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130618084|NCT01021852|470220498|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130618085|NCT01021852|470220499|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130618086|NCT01021852|470220500|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130618087|NCT01021852|470220501|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130618088|NCT01021852|470220502|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130618089|NCT01021852|470220503|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130618090|NCT01021852|470220496|FG000|Treatment Period 1|Not Treated|0|||
130618091|NCT01021852|470220497|FG001|Treatment Period 1|Not Treated|0|||
130618092|NCT01021852|470220498|FG002|Treatment Period 1|Not Treated|0|||
130618093|NCT01021852|470220499|FG003|Treatment Period 1|Not Treated|2|||
130618094|NCT01021852|470220500|FG004|Treatment Period 1|Not Treated|0|||
130618095|NCT01021852|470220501|FG005|Treatment Period 1|Not Treated|0|||
130618096|NCT01021852|470220502|FG006|Treatment Period 1|Not Treated|0|||
130618097|NCT01021852|470220503|FG007|Treatment Period 1|Not Treated|0|||
130618098|NCT01021852|470220496|FG000|Washout Period-Placebo|Adverse Event|0|||
130618099|NCT01021852|470220497|FG001|Washout Period-Placebo|Adverse Event|0|||
130618100|NCT01021852|470220498|FG002|Washout Period-Placebo|Adverse Event|0|||
130618101|NCT01021852|470220499|FG003|Washout Period-Placebo|Adverse Event|1|||
130618102|NCT01021852|470220500|FG004|Washout Period-Placebo|Adverse Event|0|||
130618103|NCT01021852|470220501|FG005|Washout Period-Placebo|Adverse Event|1|||
130618104|NCT01021852|470220502|FG006|Washout Period-Placebo|Adverse Event|0|||
130618105|NCT01021852|470220503|FG007|Washout Period-Placebo|Adverse Event|0|||
130618106|NCT01021852|470220496|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
130618107|NCT01021852|470220497|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
130618108|NCT01021852|470220498|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
130618109|NCT01021852|470220499|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
130618110|NCT01021852|470220500|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
130618111|NCT01021852|470220501|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
130618112|NCT01021852|470220502|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
130618113|NCT01021852|470220503|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
130618114|NCT01021852|470220496|FG000|Washout Period-Placebo|Protocol Violation|0|||
130618115|NCT01021852|470220497|FG001|Washout Period-Placebo|Protocol Violation|0|||
130618116|NCT01021852|470220498|FG002|Washout Period-Placebo|Protocol Violation|0|||
130618117|NCT01021852|470220499|FG003|Washout Period-Placebo|Protocol Violation|0|||
130618118|NCT01021852|470220500|FG004|Washout Period-Placebo|Protocol Violation|0|||
130618119|NCT01021852|470220501|FG005|Washout Period-Placebo|Protocol Violation|0|||
130618120|NCT01021852|470220502|FG006|Washout Period-Placebo|Protocol Violation|1|||
130618121|NCT01021852|470220503|FG007|Washout Period-Placebo|Protocol Violation|0|||
130618122|NCT01021852|470220496|FG000|Washout Period-No Drug|Adverse Event|1|||
130618123|NCT01021852|470220497|FG001|Washout Period-No Drug|Adverse Event|0|||
130618124|NCT01021852|470220498|FG002|Washout Period-No Drug|Adverse Event|0|||
130618125|NCT01021852|470220499|FG003|Washout Period-No Drug|Adverse Event|0|||
130618126|NCT01021852|470220500|FG004|Washout Period-No Drug|Adverse Event|0|||
130618127|NCT01021852|470220501|FG005|Washout Period-No Drug|Adverse Event|1|||
130618128|NCT01021852|470220502|FG006|Washout Period-No Drug|Adverse Event|0|||
130618129|NCT01021852|470220503|FG007|Washout Period-No Drug|Adverse Event|0|||
130618130|NCT01021852|470220496|FG000|Treatment Period 2|Adverse Event|0|||
130618131|NCT01021852|470220497|FG001|Treatment Period 2|Adverse Event|1|||
130618132|NCT01021852|470220498|FG002|Treatment Period 2|Adverse Event|0|||
130618133|NCT01021852|470220499|FG003|Treatment Period 2|Adverse Event|0|||
130618134|NCT01021852|470220500|FG004|Treatment Period 2|Adverse Event|1|||
130618135|NCT01021852|470220501|FG005|Treatment Period 2|Adverse Event|0|||
130618136|NCT01021852|470220502|FG006|Treatment Period 2|Adverse Event|1|||
130618137|NCT01021852|470220503|FG007|Treatment Period 2|Adverse Event|0|||
130618138|NCT01021852|470220496|FG000|Treatment Period 2|Lack of Efficacy|0|||
130618139|NCT01021852|470220497|FG001|Treatment Period 2|Lack of Efficacy|0|||
130618140|NCT01021852|470220498|FG002|Treatment Period 2|Lack of Efficacy|0|||
130618141|NCT01021852|470220499|FG003|Treatment Period 2|Lack of Efficacy|0|||
130618142|NCT01021852|470220500|FG004|Treatment Period 2|Lack of Efficacy|0|||
130618143|NCT01021852|470220501|FG005|Treatment Period 2|Lack of Efficacy|1|||
130618144|NCT01021852|470220502|FG006|Treatment Period 2|Lack of Efficacy|0|||
130618145|NCT01021852|470220503|FG007|Treatment Period 2|Lack of Efficacy|0|||
130618146|NCT01021852|470220496|FG000|Treatment Period 2|Physician Decision|0|||
130618147|NCT01021852|470220497|FG001|Treatment Period 2|Physician Decision|0|||
130618148|NCT01021852|470220498|FG002|Treatment Period 2|Physician Decision|1|||
130618149|NCT01021852|470220499|FG003|Treatment Period 2|Physician Decision|0|||
130618150|NCT01021852|470220500|FG004|Treatment Period 2|Physician Decision|0|||
130618151|NCT01021852|470220501|FG005|Treatment Period 2|Physician Decision|0|||
130618152|NCT01021852|470220502|FG006|Treatment Period 2|Physician Decision|0|||
130618153|NCT01021852|470220503|FG007|Treatment Period 2|Physician Decision|0|||
130618154|NCT01021852|470220496|FG000|Treatment Period 2|Protocol Violation|0|||
130618155|NCT01021852|470220497|FG001|Treatment Period 2|Protocol Violation|0|||
130618156|NCT01021852|470220498|FG002|Treatment Period 2|Protocol Violation|0|||
130618157|NCT01021852|470220499|FG003|Treatment Period 2|Protocol Violation|0|||
130618158|NCT01021852|470220500|FG004|Treatment Period 2|Protocol Violation|1|||
130618159|NCT01021852|470220501|FG005|Treatment Period 2|Protocol Violation|0|||
130618160|NCT01021852|470220502|FG006|Treatment Period 2|Protocol Violation|1|||
130618161|NCT01021852|470220503|FG007|Treatment Period 2|Protocol Violation|0|||
130618162|NCT01021852|470220496|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130618163|NCT01021852|470220497|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130618164|NCT01021852|470220498|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130618165|NCT01021852|470220499|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130618166|NCT01021852|470220500|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130618167|NCT01021852|470220501|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130618168|NCT01021852|470220502|FG006|Treatment Period 2|Withdrawal by Subject|1|||
130618169|NCT01021852|470220503|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130618170|NCT02493426|470220504|FG000|Overall Study|Withdrawal by Subject|0|||
130618171|NCT02493426|470220505|FG001|Overall Study|Withdrawal by Subject|1|||
130618172|NCT03491553|470220506|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
130618173|NCT03491553|470220507|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
130618174|NCT03491553|470220508|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
130618175|NCT03491553|470220509|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
130618176|NCT03491553|470220510|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
130618177|NCT03491553|470220511|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
130618178|NCT03491553|470220506|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
130618179|NCT03491553|470220507|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
130618180|NCT03491553|470220508|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
130618181|NCT03491553|470220509|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
130618182|NCT03491553|470220510|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
130618183|NCT03491553|470220511|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
130618184|NCT02128763|470220516|FG000|Overall Study|Death|1|||
130618185|NCT02128763|470220517|FG001|Overall Study|Death|0|||
130618186|NCT02128763|470220516|FG000|Overall Study|Lost to Follow-up|19|||
130618187|NCT02128763|470220517|FG001|Overall Study|Lost to Follow-up|16|||
130618188|NCT00363246|470220518|FG000|Overall Study|Death|40|||
130618189|NCT00363246|470220518|FG000|Overall Study|Withdrawal by Subject|19|||
130618190|NCT00363246|470220518|FG000|Overall Study|Lost to Follow-up|14|||
130618191|NCT00363246|470220518|FG000|Overall Study|Bad health|6|||
130618192|NCT00363246|470220518|FG000|Overall Study|Stopped using wheelchair|11|||
130618193|NCT00363246|470220518|FG000|Overall Study|Subject expressed security concerns|2|||
130618194|NCT00363246|470220518|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
130618195|NCT01608724|470220523|FG000|Overall Study|Withdrawal by Subject|131|||
130618196|NCT01608724|470220523|FG000|Overall Study|Lost to Follow-up|41|||
130618197|NCT01608724|470220523|FG000|Overall Study|Study-specific discontinuation criteria|32|||
130618198|NCT01608724|470220523|FG000|Overall Study|Adverse Event|29|||
130618199|NCT01608724|470220523|FG000|Overall Study|Protocol Violation|6|||
130618200|NCT01608724|470220523|FG000|Overall Study|bood sugar too high, etc.|3|||
130618201|NCT01608724|470220523|FG000|Overall Study|Safety reasons|1|||
130618202|NCT04387136|470220524|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
130618203|NCT04387136|470220525|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
130618204|NCT00717366|470220526|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
130618205|NCT00717366|470220527|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
130618206|NCT00717366|470220526|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
130618207|NCT00717366|470220527|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
130618208|NCT00717366|470220526|FG000|Core Study Period (20 Weeks)|Death|0|||
130618209|NCT00717366|470220527|FG001|Core Study Period (20 Weeks)|Death|1|||
130618210|NCT00717366|470220526|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
130618211|NCT00717366|470220527|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
130618212|NCT00717366|470220526|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
130618213|NCT00717366|470220527|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
130618214|NCT00717366|470220526|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
130618215|NCT00717366|470220527|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
130618216|NCT00717366|470220526|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
130618217|NCT00717366|470220527|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
130618218|NCT00910429|470220528|FG000|Overall Study|Death|18|||
130618219|NCT00910429|470220529|FG001|Overall Study|Death|12|||
130618220|NCT00910429|470220528|FG000|Overall Study|Withdrawal by Subject|3|||
130618221|NCT00910429|470220529|FG001|Overall Study|Withdrawal by Subject|2|||
130618222|NCT00910429|470220528|FG000|Overall Study|Protocol Violation|1|||
130618223|NCT00910429|470220529|FG001|Overall Study|Protocol Violation|0|||
130618224|NCT00910429|470220528|FG000|Overall Study|Lost to Follow-up|2|||
130618225|NCT00910429|470220529|FG001|Overall Study|Lost to Follow-up|1|||
130618226|NCT00910429|470220528|FG000|Overall Study|Adverse Event|10|||
130618227|NCT00910429|470220529|FG001|Overall Study|Adverse Event|5|||
130618228|NCT00910429|470220528|FG000|Overall Study|Drug non-compliance|1|||
130618229|NCT00910429|470220529|FG001|Overall Study|Drug non-compliance|0|||
130618230|NCT00910429|470220528|FG000|Overall Study|Lack of Efficacy|4|||
130618231|NCT00910429|470220529|FG001|Overall Study|Lack of Efficacy|1|||
130618232|NCT02121756|470220531|FG000|Overall Study|Adverse Event|3|||
130618233|NCT02121756|470220532|FG001|Overall Study|Adverse Event|0|||
130618234|NCT02121756|470220531|FG000|Overall Study|Protocol Violation|1|||
130618235|NCT02121756|470220532|FG001|Overall Study|Protocol Violation|1|||
130618236|NCT02121756|470220531|FG000|Overall Study|Physician Decision|2|||
130618237|NCT02121756|470220532|FG001|Overall Study|Physician Decision|1|||
130618238|NCT00255086|470220535|FG000|Overall Study|Adverse Event|1|||
130618239|NCT00255086|470220536|FG001|Overall Study|Adverse Event|1|||
130618240|NCT00255086|470220535|FG000|Overall Study|Protocol Violation|1|||
130618241|NCT00255086|470220536|FG001|Overall Study|Protocol Violation|1|||
130618242|NCT05294211|470220537|FG000|Overall Study|Withdrawal by Subject|3|||
130618243|NCT05294211|470220537|FG000|Overall Study|Physician Decision|2|||
130618244|NCT05294211|470220537|FG000|Overall Study|Progressed to active labor|1|||
130618245|NCT05294211|470220537|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
130618246|NCT05294211|470220537|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
130618247|NCT00064350|470220538|FG000|Induction Treatment|Disease Progression|5|||
130618248|NCT00064350|470220539|FG001|Induction Treatment|Disease Progression|1|||
130618249|NCT00064350|470220540|FG002|Induction Treatment|Disease Progression|110|||
130618250|NCT00064350|470220538|FG000|Induction Treatment|Adverse Event|0|||
130618251|NCT00064350|470220539|FG001|Induction Treatment|Adverse Event|2|||
130618252|NCT00064350|470220540|FG002|Induction Treatment|Adverse Event|49|||
130618253|NCT00064350|470220538|FG000|Induction Treatment|Death|0|||
130618254|NCT00064350|470220539|FG001|Induction Treatment|Death|0|||
130618255|NCT00064350|470220540|FG002|Induction Treatment|Death|9|||
130618256|NCT00064350|470220538|FG000|Induction Treatment|Withdrawal by Subject|0|||
130618257|NCT00064350|470220539|FG001|Induction Treatment|Withdrawal by Subject|0|||
130618258|NCT00064350|470220540|FG002|Induction Treatment|Withdrawal by Subject|21|||
130618259|NCT00064350|470220538|FG000|Induction Treatment|Ineligible or never started treatment|3|||
130618260|NCT00064350|470220539|FG001|Induction Treatment|Ineligible or never started treatment|6|||
130618261|NCT00064350|470220540|FG002|Induction Treatment|Ineligible or never started treatment|34|||
130618262|NCT00064350|470220538|FG000|Induction Treatment|Other|0|||
130618263|NCT00064350|470220539|FG001|Induction Treatment|Other|0|||
130618264|NCT00064350|470220540|FG002|Induction Treatment|Other|13|||
130618265|NCT00064350|470220538|FG000|Randomization|Adverse Event|8|||
130618266|NCT00064350|470220539|FG001|Randomization|Adverse Event|3|||
130618267|NCT00064350|470220540|FG002|Randomization|Adverse Event|0|||
130618268|NCT00064350|470220538|FG000|Randomization|Death|3|||
130618269|NCT00064350|470220539|FG001|Randomization|Death|0|||
130618270|NCT00064350|470220540|FG002|Randomization|Death|0|||
130618271|NCT00064350|470220538|FG000|Randomization|Withdrawal by Subject|1|||
130618272|NCT00064350|470220539|FG001|Randomization|Withdrawal by Subject|0|||
130618273|NCT00064350|470220540|FG002|Randomization|Withdrawal by Subject|0|||
130618274|NCT00064350|470220538|FG000|Randomization|Ineligible or never started treatment|9|||
130618275|NCT00064350|470220539|FG001|Randomization|Ineligible or never started treatment|15|||
130618276|NCT00064350|470220540|FG002|Randomization|Ineligible or never started treatment|0|||
130618277|NCT00064350|470220538|FG000|Randomization|Other|5|||
130618278|NCT00064350|470220539|FG001|Randomization|Other|0|||
130618279|NCT00064350|470220540|FG002|Randomization|Other|0|||
130618280|NCT00064350|470220538|FG000|Cross-Over|Adverse Event|0|||
130618281|NCT00064350|470220539|FG001|Cross-Over|Adverse Event|1|||
130618282|NCT00064350|470220540|FG002|Cross-Over|Adverse Event|0|||
130618283|NCT00064350|470220538|FG000|Cross-Over|Death|1|||
130618284|NCT00064350|470220539|FG001|Cross-Over|Death|3|||
130618285|NCT00064350|470220540|FG002|Cross-Over|Death|0|||
130618286|NCT00064350|470220538|FG000|Cross-Over|Withdrawal by Subject|2|||
130618287|NCT00064350|470220539|FG001|Cross-Over|Withdrawal by Subject|2|||
130618288|NCT00064350|470220540|FG002|Cross-Over|Withdrawal by Subject|0|||
130618289|NCT00064350|470220538|FG000|Cross-Over|Ineligible or never started treatment|3|||
130618290|NCT00064350|470220539|FG001|Cross-Over|Ineligible or never started treatment|6|||
130618291|NCT00064350|470220540|FG002|Cross-Over|Ineligible or never started treatment|0|||
130618292|NCT00064350|470220538|FG000|Cross-Over|Other|0|||
130618293|NCT00064350|470220539|FG001|Cross-Over|Other|2|||
130618294|NCT00064350|470220540|FG002|Cross-Over|Other|0|||
130618295|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
130618296|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
130618297|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
130618298|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
130618299|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
130618300|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
130618301|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
130618302|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130618303|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
130618304|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
130618305|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
130618306|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
130618307|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
130618308|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
130618309|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
130618310|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
130618311|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Missing|3|||
130618312|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Missing|1|||
130618313|NCT00838916|470220541|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
130618314|NCT00838916|470220542|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130618315|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
130618316|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
130618317|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
130618318|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
130618319|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
130618320|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
130618321|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
130618322|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
130618323|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
130618324|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
130618325|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
130618326|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
130618327|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
130618328|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
130618329|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130618330|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
130618331|NCT00838916|470220541|FG000|Follow-up Period (8 Weeks)|Missing|3|||
130618332|NCT00838916|470220542|FG001|Follow-up Period (8 Weeks)|Missing|0|||
130618333|NCT01842607|470220543|FG000|Overall Study|Adverse Event|11|||
130618334|NCT01842607|470220543|FG000|Overall Study|Lack of Efficacy|19|||
130618335|NCT01842607|470220543|FG000|Overall Study|Protocol Violation|8|||
130618336|NCT01842607|470220543|FG000|Overall Study|Protocol defined stopping criteria|2|||
130618337|NCT01842607|470220543|FG000|Overall Study|Lost to Follow-up|3|||
130618338|NCT01842607|470220543|FG000|Overall Study|Physician Decision|9|||
130618339|NCT01842607|470220543|FG000|Overall Study|Withdrawal by Subject|14|||
130618340|NCT02034474|470220544|FG000|Overall Study|Adverse Event|3|||
130618341|NCT02034474|470220545|FG001|Overall Study|Adverse Event|2|||
130618342|NCT02034474|470220544|FG000|Overall Study|Withdrawal by Subject|1|||
130618343|NCT02034474|470220545|FG001|Overall Study|Withdrawal by Subject|2|||
130618344|NCT03600714|470220546|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
130618345|NCT00675103|470220547|FG000|Overall Study|Lack of Efficacy|2|||
130618346|NCT00675103|470220547|FG000|Overall Study|Adverse Event|1|||
130618347|NCT01244191|470220550|FG000|Overall Study|Progressive disease|295|||
130618348|NCT01244191|470220551|FG001|Overall Study|Progressive disease|350|||
130618349|NCT01244191|470220550|FG000|Overall Study|Clinical disease progression|54|||
130618350|NCT01244191|470220551|FG001|Overall Study|Clinical disease progression|36|||
130618351|NCT01244191|470220550|FG000|Overall Study|Adverse Event|65|||
130618352|NCT01244191|470220551|FG001|Overall Study|Adverse Event|48|||
130618353|NCT01244191|470220550|FG000|Overall Study|Death|22|||
130618354|NCT01244191|470220551|FG001|Overall Study|Death|29|||
130618355|NCT01244191|470220550|FG000|Overall Study|Lost to Follow-up|0|||
130618356|NCT01244191|470220551|FG001|Overall Study|Lost to Follow-up|2|||
130618357|NCT01244191|470220550|FG000|Overall Study|Protocol Violation|1|||
130618358|NCT01244191|470220551|FG001|Overall Study|Protocol Violation|2|||
130618359|NCT01244191|470220550|FG000|Overall Study|Withdrawal by Subject|31|||
130618360|NCT01244191|470220551|FG001|Overall Study|Withdrawal by Subject|23|||
130618361|NCT01244191|470220550|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
130618362|NCT01244191|470220551|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
130618363|NCT02164513|470220552|FG000|Overall Study|Adverse Event|162|||
130618364|NCT02164513|470220553|FG001|Overall Study|Adverse Event|180|||
130618365|NCT02164513|470220554|FG002|Overall Study|Adverse Event|111|||
130618366|NCT02164513|470220552|FG000|Overall Study|Other: Study Closed or terminated|5|||
130618367|NCT02164513|470220553|FG001|Overall Study|Other: Study Closed or terminated|2|||
130618368|NCT02164513|470220554|FG002|Overall Study|Other: Study Closed or terminated|4|||
130618369|NCT02164513|470220552|FG000|Overall Study|Lost to Follow-up|30|||
130618370|NCT02164513|470220553|FG001|Overall Study|Lost to Follow-up|36|||
130618371|NCT02164513|470220554|FG002|Overall Study|Lost to Follow-up|22|||
130618372|NCT02164513|470220552|FG000|Overall Study|Physician Decision|47|||
130618373|NCT02164513|470220553|FG001|Overall Study|Physician Decision|57|||
130618374|NCT02164513|470220554|FG002|Overall Study|Physician Decision|28|||
130618375|NCT02164513|470220552|FG000|Overall Study|Withdrawal by Subject|192|||
130618376|NCT02164513|470220553|FG001|Overall Study|Withdrawal by Subject|261|||
130618377|NCT02164513|470220554|FG002|Overall Study|Withdrawal by Subject|130|||
130618378|NCT02164513|470220552|FG000|Overall Study|Other: Reason not provided by site|1|||
130618379|NCT02164513|470220553|FG001|Overall Study|Other: Reason not provided by site|0|||
130618380|NCT02164513|470220554|FG002|Overall Study|Other: Reason not provided by site|0|||
130618381|NCT00369967|470222361|FG000|Overall Study|Lost to Follow-up|23|||
130618382|NCT00369967|470222362|FG001|Overall Study|Lost to Follow-up|12|||
130618383|NCT01830816|470222370|FG000|Overall Study|Progressive Disease|12|||
130618384|NCT01830816|470222371|FG001|Overall Study|Progressive Disease|7|||
130618385|NCT01830816|470222372|FG002|Overall Study|Progressive Disease|7|||
130618386|NCT01830816|470222370|FG000|Overall Study|Adverse Event|3|||
130618387|NCT01830816|470222371|FG001|Overall Study|Adverse Event|4|||
130618388|NCT01830816|470222372|FG002|Overall Study|Adverse Event|0|||
130618389|NCT01830816|470222370|FG000|Overall Study|Study Terminated by Sponsor|1|||
130618390|NCT01830816|470222371|FG001|Overall Study|Study Terminated by Sponsor|1|||
130618391|NCT01830816|470222372|FG002|Overall Study|Study Terminated by Sponsor|0|||
130618392|NCT01830816|470222370|FG000|Overall Study|Withdrawal by Subject|1|||
130618393|NCT01830816|470222371|FG001|Overall Study|Withdrawal by Subject|1|||
130618394|NCT01830816|470222372|FG002|Overall Study|Withdrawal by Subject|0|||
130618395|NCT01830816|470222370|FG000|Overall Study|Lost to Follow-up|0|||
130618396|NCT01830816|470222371|FG001|Overall Study|Lost to Follow-up|1|||
130618397|NCT01830816|470222372|FG002|Overall Study|Lost to Follow-up|0|||
130618398|NCT01830816|470222370|FG000|Overall Study|Symptomatic Deterioration|1|||
130618399|NCT01830816|470222371|FG001|Overall Study|Symptomatic Deterioration|0|||
130618400|NCT01830816|470222372|FG002|Overall Study|Symptomatic Deterioration|0|||
130618401|NCT01830816|470222370|FG000|Overall Study|Reason not Specified|2|||
130618402|NCT01830816|470222371|FG001|Overall Study|Reason not Specified|0|||
130618403|NCT01830816|470222372|FG002|Overall Study|Reason not Specified|0|||
130618404|NCT03225716|470222378|FG000|Overall Study|Withdrawal by Subject|2|||
130618405|NCT03225716|470222379|FG001|Overall Study|Withdrawal by Subject|2|||
130618406|NCT03225716|470222380|FG002|Overall Study|Withdrawal by Subject|0|||
130618407|NCT03225716|470222378|FG000|Overall Study|Lack of Efficacy|1|||
130618408|NCT03225716|470222379|FG001|Overall Study|Lack of Efficacy|0|||
130618409|NCT03225716|470222380|FG002|Overall Study|Lack of Efficacy|0|||
130618410|NCT03225716|470222378|FG000|Overall Study|Adverse Event|2|||
130618411|NCT03225716|470222379|FG001|Overall Study|Adverse Event|0|||
130618412|NCT03225716|470222380|FG002|Overall Study|Adverse Event|1|||
130618413|NCT03225716|470222378|FG000|Overall Study|Study early termination by Sponsor|0|||
130618414|NCT03225716|470222379|FG001|Overall Study|Study early termination by Sponsor|0|||
130618415|NCT03225716|470222380|FG002|Overall Study|Study early termination by Sponsor|2|||
130618416|NCT01107405|470222381|FG000|Overall Study|Adverse Event|1|||
130618417|NCT01107405|470222382|FG001|Overall Study|Adverse Event|1|||
130618418|NCT01107405|470222383|FG002|Overall Study|Adverse Event|0|||
130618419|NCT01107405|470222384|FG003|Overall Study|Adverse Event|0|||
130618420|NCT01107405|470222385|FG004|Overall Study|Adverse Event|2|||
130618421|NCT01107405|470222381|FG000|Overall Study|Withdrawal by Subject|1|||
130618422|NCT01107405|470222382|FG001|Overall Study|Withdrawal by Subject|0|||
130618423|NCT01107405|470222383|FG002|Overall Study|Withdrawal by Subject|1|||
130618424|NCT01107405|470222384|FG003|Overall Study|Withdrawal by Subject|2|||
130618425|NCT01107405|470222385|FG004|Overall Study|Withdrawal by Subject|1|||
130618426|NCT01107405|470222381|FG000|Overall Study|Protocol Violation|0|||
130618427|NCT01107405|470222382|FG001|Overall Study|Protocol Violation|0|||
130618428|NCT01107405|470222383|FG002|Overall Study|Protocol Violation|1|||
130618429|NCT01107405|470222384|FG003|Overall Study|Protocol Violation|1|||
130618430|NCT01107405|470222385|FG004|Overall Study|Protocol Violation|0|||
130618431|NCT01895452|470222389|FG000|Overall Study|Adverse Event|1|||
130618432|NCT01895452|470222390|FG001|Overall Study|Adverse Event|4|||
130618433|NCT01895452|470222389|FG000|Overall Study|Lost to Follow-up|1|||
130618434|NCT01895452|470222390|FG001|Overall Study|Lost to Follow-up|5|||
130618435|NCT01895452|470222389|FG000|Overall Study|Pregnancy|0|||
130618436|NCT01895452|470222390|FG001|Overall Study|Pregnancy|1|||
130618437|NCT01895452|470222389|FG000|Overall Study|Withdrawal by Subject|2|||
130618438|NCT01895452|470222390|FG001|Overall Study|Withdrawal by Subject|14|||
130618439|NCT01895452|470222389|FG000|Overall Study|Underlying disease|0|||
130618440|NCT01895452|470222390|FG001|Overall Study|Underlying disease|3|||
130618441|NCT01895452|470222389|FG000|Overall Study|Noncompliance with study drug|0|||
130618442|NCT01895452|470222390|FG001|Overall Study|Noncompliance with study drug|1|||
130618443|NCT01653158|470222391|FG000|Overall Study|Death|0|||
130618444|NCT01653158|470222392|FG001|Overall Study|Death|0|||
130618445|NCT01653158|470222393|FG002|Overall Study|Death|0|||
130618446|NCT01653158|470222394|FG003|Overall Study|Death|1|||
130618447|NCT01653158|470222395|FG004|Overall Study|Death|0|||
130618448|NCT01653158|470222396|FG005|Overall Study|Death|0|||
130618449|NCT01653158|470222397|FG006|Overall Study|Death|0|||
130618450|NCT01653158|470222398|FG007|Overall Study|Death|2|||
130618451|NCT01653158|470222391|FG000|Overall Study|Adverse Event|0|||
130618452|NCT01653158|470222392|FG001|Overall Study|Adverse Event|0|||
130618453|NCT01653158|470222393|FG002|Overall Study|Adverse Event|0|||
130618454|NCT01653158|470222394|FG003|Overall Study|Adverse Event|1|||
130618455|NCT01653158|470222395|FG004|Overall Study|Adverse Event|0|||
130618456|NCT01653158|470222396|FG005|Overall Study|Adverse Event|0|||
130618457|NCT01653158|470222397|FG006|Overall Study|Adverse Event|0|||
130618458|NCT01653158|470222398|FG007|Overall Study|Adverse Event|3|||
130618459|NCT01653158|470222391|FG000|Overall Study|Other|0|||
130618460|NCT01653158|470222392|FG001|Overall Study|Other|0|||
130618461|NCT01653158|470222393|FG002|Overall Study|Other|0|||
130618462|NCT01653158|470222394|FG003|Overall Study|Other|0|||
130618463|NCT01653158|470222395|FG004|Overall Study|Other|0|||
130618464|NCT01653158|470222396|FG005|Overall Study|Other|0|||
130618465|NCT01653158|470222397|FG006|Overall Study|Other|0|||
130618466|NCT01653158|470222398|FG007|Overall Study|Other|1|||
130618467|NCT01653158|470222391|FG000|Overall Study|Progressive disease|0|||
130618468|NCT01653158|470222392|FG001|Overall Study|Progressive disease|0|||
130618469|NCT01653158|470222393|FG002|Overall Study|Progressive disease|0|||
130618470|NCT01653158|470222394|FG003|Overall Study|Progressive disease|0|||
130618471|NCT01653158|470222395|FG004|Overall Study|Progressive disease|1|||
130618472|NCT01653158|470222396|FG005|Overall Study|Progressive disease|1|||
130618473|NCT01653158|470222397|FG006|Overall Study|Progressive disease|2|||
130618474|NCT01653158|470222398|FG007|Overall Study|Progressive disease|9|||
130618475|NCT01653158|470222391|FG000|Overall Study|Withdrawal by Subject|1|||
130618476|NCT01653158|470222392|FG001|Overall Study|Withdrawal by Subject|0|||
130618477|NCT01653158|470222393|FG002|Overall Study|Withdrawal by Subject|0|||
130618478|NCT01653158|470222394|FG003|Overall Study|Withdrawal by Subject|0|||
130618479|NCT01653158|470222395|FG004|Overall Study|Withdrawal by Subject|0|||
130618480|NCT01653158|470222396|FG005|Overall Study|Withdrawal by Subject|0|||
130618481|NCT01653158|470222397|FG006|Overall Study|Withdrawal by Subject|0|||
130618482|NCT01653158|470222398|FG007|Overall Study|Withdrawal by Subject|0|||
130618483|NCT00980343|470222399|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
130618484|NCT00980343|470222400|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
130618485|NCT01194869|470222407|FG000|Overall Study|Disease Progression|2|||
130618486|NCT01194869|470222407|FG000|Overall Study|Toxicity|2|||
130618487|NCT04321252|470222408|FG000|Overall Study|Withdrawal by Subject|0|||
130618488|NCT04321252|470222409|FG001|Overall Study|Withdrawal by Subject|0|||
130618489|NCT04321252|470222410|FG002|Overall Study|Withdrawal by Subject|0|||
130618490|NCT04321252|470222411|FG003|Overall Study|Withdrawal by Subject|0|||
130618491|NCT04321252|470222412|FG004|Overall Study|Withdrawal by Subject|0|||
130618492|NCT04321252|470222413|FG005|Overall Study|Withdrawal by Subject|1|||
130618493|NCT04321252|470222414|FG006|Overall Study|Withdrawal by Subject|0|||
130618494|NCT04321252|470222415|FG007|Overall Study|Withdrawal by Subject|0|||
130618495|NCT04321252|470222416|FG008|Overall Study|Withdrawal by Subject|0|||
130618496|NCT03004469|470222417|FG000|Overall Study|Adverse Event|6|||
130618497|NCT03004469|470222418|FG001|Overall Study|Adverse Event|4|||
130618498|NCT03004469|470222419|FG002|Overall Study|Adverse Event|6|||
130618499|NCT03004469|470222417|FG000|Overall Study|Lack of Efficacy|1|||
130618500|NCT03004469|470222418|FG001|Overall Study|Lack of Efficacy|0|||
130618501|NCT03004469|470222419|FG002|Overall Study|Lack of Efficacy|1|||
130618502|NCT03004469|470222417|FG000|Overall Study|Lost to Follow-up|23|||
130618503|NCT03004469|470222418|FG001|Overall Study|Lost to Follow-up|14|||
130618504|NCT03004469|470222419|FG002|Overall Study|Lost to Follow-up|6|||
130618505|NCT03004469|470222417|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130618506|NCT03004469|470222418|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130618507|NCT03004469|470222419|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130618508|NCT03004469|470222417|FG000|Overall Study|Protocol Violation|0|||
130618509|NCT03004469|470222418|FG001|Overall Study|Protocol Violation|0|||
130618510|NCT03004469|470222419|FG002|Overall Study|Protocol Violation|1|||
130618511|NCT03004469|470222417|FG000|Overall Study|Withdrawal by Subject|29|||
130618512|NCT03004469|470222418|FG001|Overall Study|Withdrawal by Subject|27|||
130618513|NCT03004469|470222419|FG002|Overall Study|Withdrawal by Subject|10|||
130618514|NCT03004469|470222417|FG000|Overall Study|Other unspecified reason|0|||
130618515|NCT03004469|470222418|FG001|Overall Study|Other unspecified reason|4|||
130618516|NCT03004469|470222419|FG002|Overall Study|Other unspecified reason|1|||
130618517|NCT00259740|470222420|FG000|Overall Study|Physician Decision|1|||
130618518|NCT00259740|470222421|FG001|Overall Study|Physician Decision|1|||
130618519|NCT00259740|470222420|FG000|Overall Study|Adverse Event|0|||
130618520|NCT00259740|470222421|FG001|Overall Study|Adverse Event|2|||
130618521|NCT00259740|470222420|FG000|Overall Study|Withdrawal by Subject|2|||
130618522|NCT00259740|470222421|FG001|Overall Study|Withdrawal by Subject|6|||
130618523|NCT00259740|470222420|FG000|Overall Study|Death|1|||
130618524|NCT00259740|470222421|FG001|Overall Study|Death|1|||
130618525|NCT00259740|470222420|FG000|Overall Study|Disease progression|19|||
130618526|NCT00259740|470222421|FG001|Overall Study|Disease progression|36|||
130618527|NCT00259740|470222420|FG000|Overall Study|Ongoing|17|||
130618528|NCT00259740|470222421|FG001|Overall Study|Ongoing|3|||
130618529|NCT00259740|470222420|FG000|Overall Study|Other|3|||
130618530|NCT00259740|470222421|FG001|Overall Study|Other|0|||
130618531|NCT00259740|470222420|FG000|Overall Study|Requirement for alternative therapy|0|||
130618532|NCT00259740|470222421|FG001|Overall Study|Requirement for alternative therapy|4|||
130618533|NCT00190983|470222422|FG000|Overall Study|Inevaluable (never treated)|2|||
130618534|NCT02287402|470222423|FG000|Treatment Period|Adverse Event|17|||
130618535|NCT02287402|470222423|FG000|Treatment Period|Voluntary Withdrawal|10|||
130618536|NCT02287402|470222423|FG000|Follow-up|Lost to Follow-up|1|||
130618537|NCT02287402|470222423|FG000|Follow-up|Voluntary Withdrawal|2|||
130618538|NCT01844830|470222424|FG000|Overall Study|Withdrawal by Subject|1|||
130618539|NCT01844830|470222425|FG001|Overall Study|Withdrawal by Subject|0|||
130618540|NCT04247815|470222426|FG000|Overall Study|Adverse Event|1|||
130618541|NCT04247815|470222427|FG001|Overall Study|Adverse Event|0|||
130618542|NCT04247815|470222426|FG000|Overall Study|Withdrawal by Subject|1|||
130618543|NCT04247815|470222427|FG001|Overall Study|Withdrawal by Subject|0|||
130618544|NCT04247815|470222426|FG000|Overall Study|Protocol Violation|0|||
130618545|NCT04247815|470222427|FG001|Overall Study|Protocol Violation|1|||
130618546|NCT01453998|470222429|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
130618547|NCT01453998|470222430|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
130618548|NCT01453998|470222431|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
130618549|NCT03495453|470222438|FG000|Overall Study|Withdrawal by Subject|0|||
130618550|NCT03495453|470222439|FG001|Overall Study|Withdrawal by Subject|1|||
130618551|NCT03247413|470222442|FG000|Overall Study|Lost to Follow-up|28|||
130618552|NCT00091026|470222445|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
130618553|NCT00091026|470222446|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
130618554|NCT00091026|470222445|FG000|Overall Study|Patient withdrew and never received trea|0|||
130618555|NCT00091026|470222446|FG001|Overall Study|Patient withdrew and never received trea|2|||
130618556|NCT00091026|470222445|FG000|Overall Study|Unknown-never received treatment|0|||
130618557|NCT00091026|470222446|FG001|Overall Study|Unknown-never received treatment|1|||
130618558|NCT01025817|470222448|FG000|Completed Study Medication|Adverse Event|66|||
130618559|NCT01025817|470222449|FG001|Completed Study Medication|Adverse Event|39|||
130618560|NCT01025817|470222448|FG000|Completed Study Medication|Protocol Deviation|9|||
130618561|NCT01025817|470222449|FG001|Completed Study Medication|Protocol Deviation|8|||
130618562|NCT01025817|470222448|FG000|Completed Study Medication|Withdrawal by Subject|8|||
130618563|NCT01025817|470222449|FG001|Completed Study Medication|Withdrawal by Subject|9|||
130618564|NCT01025817|470222448|FG000|Completed Study Medication|Administrative problems|7|||
130618565|NCT01025817|470222449|FG001|Completed Study Medication|Administrative problems|5|||
130618566|NCT01025817|470222448|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
130618567|NCT01025817|470222449|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
130618568|NCT01025817|470222448|FG000|Completed Study Medication|Abnormal test procedure|4|||
130618569|NCT01025817|470222449|FG001|Completed Study Medication|Abnormal test procedure|0|||
130618570|NCT01025817|470222448|FG000|Completed Study Medication|Graft loss|2|||
130618571|NCT01025817|470222449|FG001|Completed Study Medication|Graft loss|5|||
130618572|NCT01025817|470222448|FG000|Completed Study Medication|Death|2|||
130618573|NCT01025817|470222449|FG001|Completed Study Medication|Death|2|||
130618574|NCT01025817|470222448|FG000|Completed Study Medication|Abnormal lab values|0|||
130618575|NCT01025817|470222449|FG001|Completed Study Medication|Abnormal lab values|2|||
130618576|NCT01025817|470222448|FG000|Completed Study Medication|Subject no longer required study drug|0|||
130618577|NCT01025817|470222449|FG001|Completed Study Medication|Subject no longer required study drug|1|||
130618578|NCT01025817|470222448|FG000|Completed Study Medication|Lost to Follow-up|0|||
130618579|NCT01025817|470222449|FG001|Completed Study Medication|Lost to Follow-up|1|||
130618580|NCT01025817|470222448|FG000|Completed Study|Withdrawal by Subject|8|||
130618581|NCT01025817|470222449|FG001|Completed Study|Withdrawal by Subject|16|||
130618582|NCT01025817|470222448|FG000|Completed Study|Death|6|||
130618583|NCT01025817|470222449|FG001|Completed Study|Death|5|||
130618584|NCT01025817|470222448|FG000|Completed Study|Missing|2|||
130618585|NCT01025817|470222449|FG001|Completed Study|Missing|0|||
130618586|NCT01025817|470222448|FG000|Completed Study|Lost to Follow-up|0|||
130618587|NCT01025817|470222449|FG001|Completed Study|Lost to Follow-up|1|||
130618588|NCT00441103|470222450|FG000|Overall Study|Adverse Event|2|||
130618589|NCT00441103|470222451|FG001|Overall Study|Adverse Event|1|||
130618590|NCT00441103|470222450|FG000|Overall Study|Death|1|||
130618591|NCT00441103|470222451|FG001|Overall Study|Death|0|||
130618592|NCT00441103|470222450|FG000|Overall Study|Disease Progression|2|||
130618593|NCT00441103|470222451|FG001|Overall Study|Disease Progression|0|||
130618594|NCT00441103|470222450|FG000|Overall Study|Lost to Follow-up|1|||
130618595|NCT00441103|470222451|FG001|Overall Study|Lost to Follow-up|0|||
130618596|NCT00441103|470222450|FG000|Overall Study|Protocol Violation|1|||
130618597|NCT00441103|470222451|FG001|Overall Study|Protocol Violation|0|||
130618598|NCT00441103|470222450|FG000|Overall Study|Participant unable to use Rebiject II|1|||
130618599|NCT00441103|470222451|FG001|Overall Study|Participant unable to use Rebiject II|0|||
130618600|NCT00441103|470222450|FG000|Overall Study|Participant refused MRI|1|||
130618601|NCT00441103|470222451|FG001|Overall Study|Participant refused MRI|0|||
130618602|NCT00441103|470222450|FG000|Overall Study|Inclusion criteria absent|1|||
130618603|NCT00441103|470222451|FG001|Overall Study|Inclusion criteria absent|0|||
130618604|NCT00441103|470222450|FG000|Overall Study|Non-compliant|0|||
130618605|NCT00441103|470222451|FG001|Overall Study|Non-compliant|1|||
130618606|NCT00441103|470222450|FG000|Overall Study|Participant decided to withdraw|1|||
130618607|NCT00441103|470222451|FG001|Overall Study|Participant decided to withdraw|0|||
130618608|NCT00441103|470222450|FG000|Overall Study|Participant's reason|0|||
130618609|NCT00441103|470222451|FG001|Overall Study|Participant's reason|1|||
130618610|NCT00441103|470222450|FG000|Overall Study|Participant decided to stop|0|||
130618611|NCT00441103|470222451|FG001|Overall Study|Participant decided to stop|1|||
130618612|NCT01354431|470222454|FG000|Pre-Treatment Period|Not reported|1|||
130618613|NCT01354431|470222455|FG001|Pre-Treatment Period|Not reported|0|||
130618614|NCT01354431|470222456|FG002|Pre-Treatment Period|Not reported|0|||
130618615|NCT01354431|470222454|FG000|Treatment Period|Disease Progression|50|||
130618616|NCT01354431|470222455|FG001|Treatment Period|Disease Progression|40|||
130618617|NCT01354431|470222456|FG002|Treatment Period|Disease Progression|44|||
130618618|NCT01354431|470222454|FG000|Treatment Period|Study Drug Toxicity|5|||
130618619|NCT01354431|470222455|FG001|Treatment Period|Study Drug Toxicity|8|||
130618620|NCT01354431|470222456|FG002|Treatment Period|Study Drug Toxicity|4|||
130618621|NCT01354431|470222454|FG000|Treatment Period|Death|0|||
130618622|NCT01354431|470222455|FG001|Treatment Period|Death|1|||
130618623|NCT01354431|470222456|FG002|Treatment Period|Death|0|||
130618624|NCT01354431|470222454|FG000|Treatment Period|AE unrelated to study drug|1|||
130618625|NCT01354431|470222455|FG001|Treatment Period|AE unrelated to study drug|2|||
130618626|NCT01354431|470222456|FG002|Treatment Period|AE unrelated to study drug|5|||
130618627|NCT01354431|470222454|FG000|Treatment Period|Participant request to discontinue|2|||
130618628|NCT01354431|470222455|FG001|Treatment Period|Participant request to discontinue|2|||
130618629|NCT01354431|470222456|FG002|Treatment Period|Participant request to discontinue|1|||
130618630|NCT01354431|470222454|FG000|Treatment Period|Participant withdrew consent|0|||
130618631|NCT01354431|470222455|FG001|Treatment Period|Participant withdrew consent|1|||
130618632|NCT01354431|470222456|FG002|Treatment Period|Participant withdrew consent|0|||
130618633|NCT01354431|470222454|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
130618634|NCT01354431|470222455|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
130618635|NCT01354431|470222456|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
130618636|NCT02802878|470222457|FG000|Overall Study|Withdrawal by Subject|3|||
130618637|NCT02802878|470222458|FG001|Overall Study|Withdrawal by Subject|3|||
130618638|NCT02802878|470222457|FG000|Overall Study|Protocol Violation|1|||
130618639|NCT02802878|470222458|FG001|Overall Study|Protocol Violation|0|||
130618640|NCT01599754|470222459|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
130618641|NCT01599754|470222460|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
130618642|NCT01599754|470222459|FG000|Overall Study|Participant noncompliance|4|||
130618643|NCT01599754|470222460|FG001|Overall Study|Participant noncompliance|4|||
130618644|NCT01599754|470222459|FG000|Overall Study|Lost to Follow-up|13|||
130618645|NCT01599754|470222460|FG001|Overall Study|Lost to Follow-up|6|||
130618646|NCT01599754|470222459|FG000|Overall Study|Death|31|||
130618647|NCT01599754|470222460|FG001|Overall Study|Death|33|||
130618648|NCT01599754|470222459|FG000|Overall Study|Adverse Event|3|||
130618649|NCT01599754|470222460|FG001|Overall Study|Adverse Event|2|||
130618650|NCT01599754|470222459|FG000|Overall Study|Investigator decision|1|||
130618651|NCT01599754|470222460|FG001|Overall Study|Investigator decision|3|||
130618652|NCT01599754|470222459|FG000|Overall Study|Withdrawal by Subject|24|||
130618653|NCT01599754|470222460|FG001|Overall Study|Withdrawal by Subject|25|||
130618654|NCT01599754|470222459|FG000|Overall Study|Study terminated by sponsor|282|||
130618655|NCT01599754|470222460|FG001|Overall Study|Study terminated by sponsor|285|||
130618656|NCT01029002|470222461|FG000|Overall Study|Lost to Follow-up|2|||
130618657|NCT01029002|470222462|FG001|Overall Study|Lost to Follow-up|4|||
130618658|NCT00702052|470222463|FG000|Overall Study|Adverse Event|23|||
130618659|NCT00702052|470222463|FG000|Overall Study|Disease Progression|30|||
130618660|NCT00702052|470222463|FG000|Overall Study|Withdrawal by Subject|5|||
130618661|NCT01577160|470222464|FG000|Overall Study|Adverse Event|9|||
130618662|NCT01577160|470222464|FG000|Overall Study|Lack of Efficacy|15|||
130618663|NCT01577160|470222464|FG000|Overall Study|Lost to Follow-up|40|||
130618664|NCT01577160|470222464|FG000|Overall Study|Withdrawal by Subject|18|||
130618665|NCT01577160|470222464|FG000|Overall Study|Subject Uncooperative|7|||
130618666|NCT01577160|470222464|FG000|Overall Study|Other|9|||
130618667|NCT00101192|470222465|FG000|Overall Study|Ineligible|6|||
130618668|NCT00101192|470222465|FG000|Overall Study|Inevaluable|1|||
130618669|NCT02618928|470222466|FG000|Overall Study|Failure to Return|28|||
130618670|NCT02618928|470222466|FG000|Overall Study|Insufficient Virological Response|1|||
130618671|NCT02618928|470222466|FG000|Overall Study|Withdrawal by Subject|2|||
130618672|NCT02618928|470222466|FG000|Overall Study|Death|3|||
130618673|NCT02618928|470222466|FG000|Overall Study|Other|11|||
130618674|NCT02618928|470222466|FG000|Overall Study|Missing|6|||
130618675|NCT02618928|470222466|FG000|Overall Study|Treatment Never Started|7|||
130618676|NCT00916370|470222469|FG000|Overall Study|Death|3|||
130618677|NCT00916370|470222470|FG001|Overall Study|Death|1|||
130618678|NCT00916370|470222469|FG000|Overall Study|Withdrawal by Subject|2|||
130618679|NCT00916370|470222470|FG001|Overall Study|Withdrawal by Subject|0|||
130618680|NCT00916370|470222469|FG000|Overall Study|Physician Decision|0|||
130618681|NCT00916370|470222470|FG001|Overall Study|Physician Decision|1|||
130618682|NCT01317615|470222471|FG000|Overall Study|Disease progression|25|||
130618683|NCT01317615|470222471|FG000|Overall Study|New cancer therapy|5|||
130618684|NCT01317615|470222471|FG000|Overall Study|Death|6|||
130618685|NCT01317615|470222471|FG000|Overall Study|Withdrawal by Subject|5|||
130618686|NCT01317615|470222471|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130618687|NCT01317615|470222471|FG000|Overall Study|Adverse Event|7|||
130618688|NCT00438399|470222472|FG000|Overall Study|Lost to Follow-up|2|||
130618689|NCT00438399|470222473|FG001|Overall Study|Lost to Follow-up|2|||
130618690|NCT00438399|470222474|FG002|Overall Study|Lost to Follow-up|1|||
130618691|NCT00438399|470222475|FG003|Overall Study|Lost to Follow-up|1|||
130618692|NCT00438399|470222476|FG004|Overall Study|Lost to Follow-up|1|||
130618693|NCT00438399|470222477|FG005|Overall Study|Lost to Follow-up|1|||
130618694|NCT00438399|470222472|FG000|Overall Study|Adverse Event|0|||
130618695|NCT00438399|470222473|FG001|Overall Study|Adverse Event|0|||
130618696|NCT00438399|470222474|FG002|Overall Study|Adverse Event|1|||
130618697|NCT00438399|470222475|FG003|Overall Study|Adverse Event|1|||
130618698|NCT00438399|470222476|FG004|Overall Study|Adverse Event|0|||
130618699|NCT00438399|470222477|FG005|Overall Study|Adverse Event|1|||
130618700|NCT00438399|470222472|FG000|Overall Study|Withdrawal by Subject|5|||
130618701|NCT00438399|470222473|FG001|Overall Study|Withdrawal by Subject|6|||
130618702|NCT00438399|470222474|FG002|Overall Study|Withdrawal by Subject|3|||
130618703|NCT00438399|470222475|FG003|Overall Study|Withdrawal by Subject|2|||
130618704|NCT00438399|470222476|FG004|Overall Study|Withdrawal by Subject|2|||
130618705|NCT00438399|470222477|FG005|Overall Study|Withdrawal by Subject|2|||
130618706|NCT00438399|470222472|FG000|Overall Study|Protocol Violation|0|||
130618707|NCT00438399|470222473|FG001|Overall Study|Protocol Violation|0|||
130618708|NCT00438399|470222474|FG002|Overall Study|Protocol Violation|1|||
130618709|NCT00438399|470222475|FG003|Overall Study|Protocol Violation|0|||
130618710|NCT00438399|470222476|FG004|Overall Study|Protocol Violation|0|||
130618711|NCT00438399|470222477|FG005|Overall Study|Protocol Violation|1|||
130618712|NCT00438399|470222472|FG000|Overall Study|Subje stopped study|0|||
130618713|NCT00438399|470222473|FG001|Overall Study|Subje stopped study|0|||
130618714|NCT00438399|470222474|FG002|Overall Study|Subje stopped study|1|||
130618715|NCT00438399|470222475|FG003|Overall Study|Subje stopped study|0|||
130618716|NCT00438399|470222476|FG004|Overall Study|Subje stopped study|0|||
130618717|NCT00438399|470222477|FG005|Overall Study|Subje stopped study|0|||
130618718|NCT00438399|470222472|FG000|Overall Study|Pregnancy|0|||
130618719|NCT00438399|470222473|FG001|Overall Study|Pregnancy|0|||
130618720|NCT00438399|470222474|FG002|Overall Study|Pregnancy|0|||
130618721|NCT00438399|470222475|FG003|Overall Study|Pregnancy|0|||
130618722|NCT00438399|470222476|FG004|Overall Study|Pregnancy|0|||
130618723|NCT00438399|470222477|FG005|Overall Study|Pregnancy|1|||
130618724|NCT00438399|470222472|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
130618725|NCT00438399|470222473|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
130618726|NCT00438399|470222474|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
130618727|NCT00438399|470222475|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
130618728|NCT00438399|470222476|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
130618729|NCT00438399|470222477|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
130618730|NCT02365584|470222479|FG000|Overall Study|Adverse Event|2|||
130618731|NCT02365584|470222480|FG001|Overall Study|Adverse Event|2|||
130618732|NCT02365584|470222479|FG000|Overall Study|Withdrawal by Subject|1|||
130618733|NCT02365584|470222480|FG001|Overall Study|Withdrawal by Subject|0|||
130618734|NCT02365584|470222479|FG000|Overall Study|Disease Progression|9|||
130618735|NCT02365584|470222480|FG001|Overall Study|Disease Progression|12|||
130618736|NCT01973452|470222481|FG000|Overall Study|Lack of Efficacy|0|||
130618737|NCT01973452|470222482|FG001|Overall Study|Lack of Efficacy|1|||
130618738|NCT01973452|470222481|FG000|Overall Study|Lost to Follow-up|1|||
130618739|NCT01973452|470222482|FG001|Overall Study|Lost to Follow-up|0|||
130618740|NCT01973452|470222481|FG000|Overall Study|Withdrawal by Subject|10|||
130618741|NCT01973452|470222482|FG001|Overall Study|Withdrawal by Subject|9|||
130618742|NCT01973452|470222481|FG000|Overall Study|Ineligible|1|||
130618743|NCT01973452|470222482|FG001|Overall Study|Ineligible|1|||
130618744|NCT01973452|470222481|FG000|Overall Study|Surgery canceled by participant|5|||
130618745|NCT01973452|470222482|FG001|Overall Study|Surgery canceled by participant|3|||
130618746|NCT00349752|470222483|FG000|Overall Study|Adverse Event|8|||
130618747|NCT00349752|470222484|FG001|Overall Study|Adverse Event|12|||
130618748|NCT00349752|470222483|FG000|Overall Study|Lack of Efficacy|37|||
130618749|NCT00349752|470222484|FG001|Overall Study|Lack of Efficacy|42|||
130618750|NCT00349752|470222483|FG000|Overall Study|Lost to Follow-up|4|||
130618751|NCT00349752|470222484|FG001|Overall Study|Lost to Follow-up|2|||
130618752|NCT00349752|470222483|FG000|Overall Study|Personal reasons|6|||
130618753|NCT00349752|470222484|FG001|Overall Study|Personal reasons|5|||
130618754|NCT00349752|470222483|FG000|Overall Study|Other: Required exclusionary medication|0|||
130618755|NCT00349752|470222484|FG001|Overall Study|Other: Required exclusionary medication|1|||
130618756|NCT00349752|470222483|FG000|Overall Study|Other: Non compliance|0|||
130618757|NCT00349752|470222484|FG001|Overall Study|Other: Non compliance|1|||
130618758|NCT00349752|470222483|FG000|Overall Study|Other: Patient stopped steroids|0|||
130618759|NCT00349752|470222484|FG001|Overall Study|Other: Patient stopped steroids|1|||
130618760|NCT00349752|470222483|FG000|Overall Study|Other: Patient's steroid use|1|||
130618761|NCT00349752|470222484|FG001|Overall Study|Other: Patient's steroid use|0|||
130618762|NCT00349752|470222483|FG000|Overall Study|Other: Ineligible|1|||
130618763|NCT00349752|470222484|FG001|Overall Study|Other: Ineligible|0|||
130618764|NCT00349752|470222483|FG000|Overall Study|Other: Inadvertently unblinded|1|||
130618765|NCT00349752|470222484|FG001|Overall Study|Other: Inadvertently unblinded|0|||
130618766|NCT00349752|470222483|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
130618767|NCT00349752|470222484|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
130618768|NCT01927419|470222490|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130618769|NCT01927419|470222491|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130618770|NCT01927419|470222490|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
130618771|NCT01927419|470222491|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
130618772|NCT01927419|470222490|FG000|Treatment Period|Disease progression|17|||
130618773|NCT01927419|470222491|FG001|Treatment Period|Disease progression|20|||
130618774|NCT01927419|470222490|FG000|Treatment Period|Study drug toxicity|48|||
130618775|NCT01927419|470222491|FG001|Treatment Period|Study drug toxicity|10|||
130618776|NCT01927419|470222490|FG000|Treatment Period|Death|0|||
130618777|NCT01927419|470222491|FG001|Treatment Period|Death|1|||
130618778|NCT01927419|470222490|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
130618779|NCT01927419|470222491|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
130618780|NCT01927419|470222490|FG000|Treatment Period|Participant request to discontinue|12|||
130618781|NCT01927419|470222491|FG001|Treatment Period|Participant request to discontinue|4|||
130618782|NCT01927419|470222490|FG000|Treatment Period|Withdrawal by Subject|1|||
130618783|NCT01927419|470222491|FG001|Treatment Period|Withdrawal by Subject|1|||
130618784|NCT01927419|470222490|FG000|Treatment Period|Maximum Clinical Benefit|6|||
130618785|NCT01927419|470222491|FG001|Treatment Period|Maximum Clinical Benefit|2|||
130618786|NCT01927419|470222490|FG000|Treatment Period|Other reasons|3|||
130618787|NCT01927419|470222491|FG001|Treatment Period|Other reasons|4|||
130618788|NCT01927419|470222490|FG000|Treatment Period|Not Reported|1|||
130618789|NCT01927419|470222491|FG001|Treatment Period|Not Reported|1|||
130618790|NCT03488251|470222492|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
130618791|NCT03488251|470222493|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130618792|NCT03488251|470222494|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130618793|NCT03488251|470222495|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130618794|NCT03488251|470222492|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
130618795|NCT03488251|470222493|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130618796|NCT03488251|470222494|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130618797|NCT03488251|470222495|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130618798|NCT03488251|470222492|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
130618799|NCT03488251|470222493|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130618800|NCT03488251|470222494|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130618801|NCT03488251|470222495|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130618802|NCT03488251|470222492|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
130618803|NCT03488251|470222493|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130618804|NCT03488251|470222494|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130618805|NCT03488251|470222495|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130618806|NCT03488251|470222492|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
130618807|NCT03488251|470222493|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130618808|NCT03488251|470222494|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130618809|NCT03488251|470222495|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130618810|NCT02379390|470222496|FG000|Overall Study|Adverse Event|1|||
130618811|NCT02379390|470222497|FG001|Overall Study|Adverse Event|1|||
130618812|NCT02379390|470222496|FG000|Overall Study|Investigator's decision|1|||
130618813|NCT02379390|470222497|FG001|Overall Study|Investigator's decision|0|||
130618814|NCT02379390|470222496|FG000|Overall Study|Study Termination|0|||
130618815|NCT02379390|470222497|FG001|Overall Study|Study Termination|1|||
130618816|NCT02509494|470222502|FG000|Overall Study|Lost to Follow-up|8|||
130618817|NCT02509494|470222503|FG001|Overall Study|Lost to Follow-up|47|||
130618818|NCT02509494|470222504|FG002|Overall Study|Lost to Follow-up|19|||
130618819|NCT02509494|470222505|FG003|Overall Study|Lost to Follow-up|6|||
130618820|NCT02509494|470222506|FG004|Overall Study|Lost to Follow-up|3|||
130618821|NCT02509494|470222507|FG005|Overall Study|Lost to Follow-up|3|||
130618822|NCT02509494|470222508|FG006|Overall Study|Lost to Follow-up|1|||
130618823|NCT02509494|470222509|FG007|Overall Study|Lost to Follow-up|3|||
130618824|NCT02509494|470222510|FG008|Overall Study|Lost to Follow-up|1|||
130618825|NCT02509494|470222502|FG000|Overall Study|Physician Decision|2|||
130618826|NCT02509494|470222503|FG001|Overall Study|Physician Decision|1|||
130618827|NCT02509494|470222504|FG002|Overall Study|Physician Decision|0|||
130618828|NCT02509494|470222505|FG003|Overall Study|Physician Decision|0|||
130618829|NCT02509494|470222506|FG004|Overall Study|Physician Decision|0|||
130618830|NCT02509494|470222507|FG005|Overall Study|Physician Decision|0|||
130618831|NCT02509494|470222508|FG006|Overall Study|Physician Decision|0|||
130618832|NCT02509494|470222509|FG007|Overall Study|Physician Decision|0|||
130618833|NCT02509494|470222510|FG008|Overall Study|Physician Decision|0|||
130618834|NCT02509494|470222502|FG000|Overall Study|Withdrawal by Subject|4|||
130618835|NCT02509494|470222503|FG001|Overall Study|Withdrawal by Subject|17|||
130618836|NCT02509494|470222504|FG002|Overall Study|Withdrawal by Subject|7|||
130618837|NCT02509494|470222505|FG003|Overall Study|Withdrawal by Subject|5|||
130618838|NCT02509494|470222506|FG004|Overall Study|Withdrawal by Subject|0|||
130618839|NCT02509494|470222507|FG005|Overall Study|Withdrawal by Subject|6|||
130618840|NCT02509494|470222508|FG006|Overall Study|Withdrawal by Subject|1|||
130618841|NCT02509494|470222509|FG007|Overall Study|Withdrawal by Subject|2|||
130618842|NCT02509494|470222510|FG008|Overall Study|Withdrawal by Subject|1|||
130618843|NCT02509494|470222502|FG000|Overall Study|Death|0|||
130618844|NCT02509494|470222503|FG001|Overall Study|Death|1|||
130618845|NCT02509494|470222504|FG002|Overall Study|Death|0|||
130618846|NCT02509494|470222505|FG003|Overall Study|Death|0|||
130618847|NCT02509494|470222506|FG004|Overall Study|Death|1|||
130618848|NCT02509494|470222507|FG005|Overall Study|Death|0|||
130618849|NCT02509494|470222508|FG006|Overall Study|Death|0|||
130618850|NCT02509494|470222509|FG007|Overall Study|Death|1|||
130618851|NCT02509494|470222510|FG008|Overall Study|Death|0|||
130618852|NCT02509494|470222502|FG000|Overall Study|Other|0|||
130618853|NCT02509494|470222503|FG001|Overall Study|Other|4|||
130618854|NCT02509494|470222504|FG002|Overall Study|Other|5|||
130618855|NCT02509494|470222505|FG003|Overall Study|Other|0|||
130618856|NCT02509494|470222506|FG004|Overall Study|Other|0|||
130618857|NCT02509494|470222507|FG005|Overall Study|Other|0|||
130618858|NCT02509494|470222508|FG006|Overall Study|Other|0|||
130618859|NCT02509494|470222509|FG007|Overall Study|Other|0|||
130618860|NCT02509494|470222510|FG008|Overall Study|Other|0|||
130618861|NCT02509494|470222502|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130618862|NCT02509494|470222503|FG001|Overall Study|Non-Compliance With Study Drug|11|||
130618863|NCT02509494|470222504|FG002|Overall Study|Non-Compliance With Study Drug|7|||
130618864|NCT02509494|470222505|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130618865|NCT02509494|470222506|FG004|Overall Study|Non-Compliance With Study Drug|1|||
130618866|NCT02509494|470222507|FG005|Overall Study|Non-Compliance With Study Drug|2|||
130618867|NCT02509494|470222508|FG006|Overall Study|Non-Compliance With Study Drug|1|||
130618868|NCT02509494|470222509|FG007|Overall Study|Non-Compliance With Study Drug|1|||
130618869|NCT02509494|470222510|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130618870|NCT01511107|470222511|FG000|Overall Study|Ineligible|3|||
130618871|NCT01511107|470222512|FG001|Overall Study|Ineligible|2|||
130618872|NCT01511107|470222511|FG000|Overall Study|Lost to Follow-up|10|||
130618873|NCT01511107|470222512|FG001|Overall Study|Lost to Follow-up|19|||
130618874|NCT01511107|470222511|FG000|Overall Study|Withdrawal by Subject|9|||
130618875|NCT01511107|470222512|FG001|Overall Study|Withdrawal by Subject|20|||
130618876|NCT00363051|470224709|FG000|Overall Study|Adminstrative problems|1|||
130618877|NCT00363051|470224710|FG001|Overall Study|Adminstrative problems|1|||
130618878|NCT00363051|470224709|FG000|Overall Study|Adverse Event|21|||
130618879|NCT00363051|470224710|FG001|Overall Study|Adverse Event|12|||
130618880|NCT00363051|470224709|FG000|Overall Study|New Cancer Therapy|2|||
130618881|NCT00363051|470224710|FG001|Overall Study|New Cancer Therapy|1|||
130618882|NCT00363051|470224709|FG000|Overall Study|Withdrawal by Subject|11|||
130618883|NCT00363051|470224710|FG001|Overall Study|Withdrawal by Subject|3|||
130618884|NCT00363051|470224709|FG000|Overall Study|Lost to Follow-up|0|||
130618885|NCT00363051|470224710|FG001|Overall Study|Lost to Follow-up|1|||
130618886|NCT00363051|470224709|FG000|Overall Study|Protocol Violation|0|||
130618887|NCT00363051|470224710|FG001|Overall Study|Protocol Violation|2|||
130618888|NCT00363051|470224709|FG000|Overall Study|Death|3|||
130618889|NCT00363051|470224710|FG001|Overall Study|Death|2|||
130618890|NCT00830115|470224713|FG000|Overall Study|Adverse Event|2|||
130618891|NCT00830115|470224713|FG000|Overall Study|Improvement/recovery|1|||
130618892|NCT01207388|470224721|FG000|Overall Study|Death|67|||
130618893|NCT01207388|470224721|FG000|Overall Study|Withdrawal by Subject|1|||
130618894|NCT01885078|470224722|FG000|Treatment Period|Adverse Event|52|||
130618895|NCT01885078|470224723|FG001|Treatment Period|Adverse Event|136|||
130618896|NCT01885078|470224724|FG002|Treatment Period|Adverse Event|30|||
130618897|NCT01885078|470224725|FG003|Treatment Period|Adverse Event|73|||
130618898|NCT01885078|470224726|FG004|Treatment Period|Adverse Event|17|||
130618899|NCT01885078|470224727|FG005|Treatment Period|Adverse Event|72|||
130618900|NCT01885078|470224728|FG006|Treatment Period|Adverse Event|24|||
130618901|NCT01885078|470224729|FG007|Treatment Period|Adverse Event|5|||
130618902|NCT01885078|470224730|FG008|Treatment Period|Adverse Event|0|||
130618903|NCT01885078|470224731|FG009|Treatment Period|Adverse Event|0|||
130618904|NCT01885078|470224722|FG000|Treatment Period|Death|13|||
130618905|NCT01885078|470224723|FG001|Treatment Period|Death|33|||
130618906|NCT01885078|470224724|FG002|Treatment Period|Death|5|||
130618907|NCT01885078|470224725|FG003|Treatment Period|Death|9|||
130618908|NCT01885078|470224726|FG004|Treatment Period|Death|2|||
130618909|NCT01885078|470224727|FG005|Treatment Period|Death|10|||
130618910|NCT01885078|470224728|FG006|Treatment Period|Death|3|||
130618911|NCT01885078|470224729|FG007|Treatment Period|Death|2|||
130618912|NCT01885078|470224730|FG008|Treatment Period|Death|0|||
130618913|NCT01885078|470224731|FG009|Treatment Period|Death|0|||
130618914|NCT01885078|470224722|FG000|Treatment Period|Lack of Efficacy|12|||
130618915|NCT01885078|470224723|FG001|Treatment Period|Lack of Efficacy|33|||
130618916|NCT01885078|470224724|FG002|Treatment Period|Lack of Efficacy|10|||
130618917|NCT01885078|470224725|FG003|Treatment Period|Lack of Efficacy|23|||
130618918|NCT01885078|470224726|FG004|Treatment Period|Lack of Efficacy|24|||
130618919|NCT01885078|470224727|FG005|Treatment Period|Lack of Efficacy|58|||
130618920|NCT01885078|470224728|FG006|Treatment Period|Lack of Efficacy|9|||
130618921|NCT01885078|470224729|FG007|Treatment Period|Lack of Efficacy|5|||
130618922|NCT01885078|470224730|FG008|Treatment Period|Lack of Efficacy|0|||
130618923|NCT01885078|470224731|FG009|Treatment Period|Lack of Efficacy|0|||
130618924|NCT01885078|470224722|FG000|Treatment Period|Lost to Follow-up|16|||
130618925|NCT01885078|470224723|FG001|Treatment Period|Lost to Follow-up|19|||
130618926|NCT01885078|470224724|FG002|Treatment Period|Lost to Follow-up|7|||
130618927|NCT01885078|470224725|FG003|Treatment Period|Lost to Follow-up|9|||
130618928|NCT01885078|470224726|FG004|Treatment Period|Lost to Follow-up|2|||
130618929|NCT01885078|470224727|FG005|Treatment Period|Lost to Follow-up|8|||
130618930|NCT01885078|470224728|FG006|Treatment Period|Lost to Follow-up|2|||
130618931|NCT01885078|470224729|FG007|Treatment Period|Lost to Follow-up|0|||
130618932|NCT01885078|470224730|FG008|Treatment Period|Lost to Follow-up|0|||
130618933|NCT01885078|470224731|FG009|Treatment Period|Lost to Follow-up|0|||
130618934|NCT01885078|470224722|FG000|Treatment Period|Physician Decision|19|||
130618935|NCT01885078|470224723|FG001|Treatment Period|Physician Decision|21|||
130618936|NCT01885078|470224724|FG002|Treatment Period|Physician Decision|5|||
130618937|NCT01885078|470224725|FG003|Treatment Period|Physician Decision|12|||
130618938|NCT01885078|470224726|FG004|Treatment Period|Physician Decision|9|||
130618939|NCT01885078|470224727|FG005|Treatment Period|Physician Decision|24|||
130618940|NCT01885078|470224728|FG006|Treatment Period|Physician Decision|4|||
130618941|NCT01885078|470224729|FG007|Treatment Period|Physician Decision|3|||
130618942|NCT01885078|470224730|FG008|Treatment Period|Physician Decision|0|||
130618943|NCT01885078|470224731|FG009|Treatment Period|Physician Decision|0|||
130618944|NCT01885078|470224722|FG000|Treatment Period|Protocol Violation|3|||
130618945|NCT01885078|470224723|FG001|Treatment Period|Protocol Violation|5|||
130618946|NCT01885078|470224724|FG002|Treatment Period|Protocol Violation|0|||
130618947|NCT01885078|470224725|FG003|Treatment Period|Protocol Violation|3|||
130618948|NCT01885078|470224726|FG004|Treatment Period|Protocol Violation|1|||
130618949|NCT01885078|470224727|FG005|Treatment Period|Protocol Violation|6|||
130618950|NCT01885078|470224728|FG006|Treatment Period|Protocol Violation|0|||
130618951|NCT01885078|470224729|FG007|Treatment Period|Protocol Violation|0|||
130618952|NCT01885078|470224730|FG008|Treatment Period|Protocol Violation|0|||
130618953|NCT01885078|470224731|FG009|Treatment Period|Protocol Violation|0|||
130618954|NCT01885078|470224722|FG000|Treatment Period|Sponsor Decision|245|||
130618955|NCT01885078|470224723|FG001|Treatment Period|Sponsor Decision|648|||
130618956|NCT01885078|470224724|FG002|Treatment Period|Sponsor Decision|49|||
130618957|NCT01885078|470224725|FG003|Treatment Period|Sponsor Decision|90|||
130618958|NCT01885078|470224726|FG004|Treatment Period|Sponsor Decision|20|||
130618959|NCT01885078|470224727|FG005|Treatment Period|Sponsor Decision|38|||
130618960|NCT01885078|470224728|FG006|Treatment Period|Sponsor Decision|162|||
130618961|NCT01885078|470224729|FG007|Treatment Period|Sponsor Decision|3|||
130618962|NCT01885078|470224730|FG008|Treatment Period|Sponsor Decision|0|||
130618963|NCT01885078|470224731|FG009|Treatment Period|Sponsor Decision|0|||
130618964|NCT01885078|470224722|FG000|Treatment Period|Withdrawal by Subject|72|||
130618965|NCT01885078|470224723|FG001|Treatment Period|Withdrawal by Subject|132|||
130618966|NCT01885078|470224724|FG002|Treatment Period|Withdrawal by Subject|25|||
130618967|NCT01885078|470224725|FG003|Treatment Period|Withdrawal by Subject|63|||
130618968|NCT01885078|470224726|FG004|Treatment Period|Withdrawal by Subject|15|||
130618969|NCT01885078|470224727|FG005|Treatment Period|Withdrawal by Subject|34|||
130618970|NCT01885078|470224728|FG006|Treatment Period|Withdrawal by Subject|17|||
130618971|NCT01885078|470224729|FG007|Treatment Period|Withdrawal by Subject|10|||
130618972|NCT01885078|470224730|FG008|Treatment Period|Withdrawal by Subject|0|||
130618973|NCT01885078|470224731|FG009|Treatment Period|Withdrawal by Subject|0|||
130618974|NCT01885078|470224722|FG000|Treatment Period|Other|0|||
130618975|NCT01885078|470224723|FG001|Treatment Period|Other|0|||
130618976|NCT01885078|470224724|FG002|Treatment Period|Other|0|||
130618977|NCT01885078|470224725|FG003|Treatment Period|Other|1|||
130618978|NCT01885078|470224726|FG004|Treatment Period|Other|0|||
130618979|NCT01885078|470224727|FG005|Treatment Period|Other|0|||
130618980|NCT01885078|470224728|FG006|Treatment Period|Other|0|||
130618981|NCT01885078|470224729|FG007|Treatment Period|Other|0|||
130618982|NCT01885078|470224730|FG008|Treatment Period|Other|0|||
130618983|NCT01885078|470224731|FG009|Treatment Period|Other|0|||
130618984|NCT01885078|470224722|FG000|Step-down Period|Sponsor Decision|0|||
130618985|NCT01885078|470224723|FG001|Step-down Period|Sponsor Decision|0|||
130618986|NCT01885078|470224724|FG002|Step-down Period|Sponsor Decision|0|||
130618987|NCT01885078|470224725|FG003|Step-down Period|Sponsor Decision|0|||
130618988|NCT01885078|470224726|FG004|Step-down Period|Sponsor Decision|0|||
130618989|NCT01885078|470224727|FG005|Step-down Period|Sponsor Decision|0|||
130618990|NCT01885078|470224728|FG006|Step-down Period|Sponsor Decision|0|||
130618991|NCT01885078|470224729|FG007|Step-down Period|Sponsor Decision|0|||
130618992|NCT01885078|470224730|FG008|Step-down Period|Sponsor Decision|1|||
130618993|NCT01885078|470224731|FG009|Step-down Period|Sponsor Decision|1|||
130618994|NCT01885078|470224722|FG000|Step-down Period|Adverse Event|0|||
130618995|NCT01885078|470224723|FG001|Step-down Period|Adverse Event|0|||
130618996|NCT01885078|470224724|FG002|Step-down Period|Adverse Event|0|||
130618997|NCT01885078|470224725|FG003|Step-down Period|Adverse Event|0|||
130618998|NCT01885078|470224726|FG004|Step-down Period|Adverse Event|0|||
130618999|NCT01885078|470224727|FG005|Step-down Period|Adverse Event|0|||
130619000|NCT01885078|470224728|FG006|Step-down Period|Adverse Event|0|||
130619001|NCT01885078|470224729|FG007|Step-down Period|Adverse Event|0|||
130619002|NCT01885078|470224730|FG008|Step-down Period|Adverse Event|29|||
130619003|NCT01885078|470224731|FG009|Step-down Period|Adverse Event|38|||
130619004|NCT01885078|470224722|FG000|Step-down Period|Withdrawal by Subject|0|||
130619005|NCT01885078|470224723|FG001|Step-down Period|Withdrawal by Subject|0|||
130619006|NCT01885078|470224724|FG002|Step-down Period|Withdrawal by Subject|0|||
130619007|NCT01885078|470224725|FG003|Step-down Period|Withdrawal by Subject|0|||
130619008|NCT01885078|470224726|FG004|Step-down Period|Withdrawal by Subject|0|||
130619009|NCT01885078|470224727|FG005|Step-down Period|Withdrawal by Subject|0|||
130619010|NCT01885078|470224728|FG006|Step-down Period|Withdrawal by Subject|0|||
130619011|NCT01885078|470224729|FG007|Step-down Period|Withdrawal by Subject|0|||
130619012|NCT01885078|470224730|FG008|Step-down Period|Withdrawal by Subject|25|||
130619013|NCT01885078|470224731|FG009|Step-down Period|Withdrawal by Subject|15|||
130619014|NCT01885078|470224722|FG000|Step-down Period|Physician Decision|0|||
130619015|NCT01885078|470224723|FG001|Step-down Period|Physician Decision|0|||
130619016|NCT01885078|470224724|FG002|Step-down Period|Physician Decision|0|||
130619017|NCT01885078|470224725|FG003|Step-down Period|Physician Decision|0|||
130619018|NCT01885078|470224726|FG004|Step-down Period|Physician Decision|0|||
130619019|NCT01885078|470224727|FG005|Step-down Period|Physician Decision|0|||
130619020|NCT01885078|470224728|FG006|Step-down Period|Physician Decision|0|||
130619021|NCT01885078|470224729|FG007|Step-down Period|Physician Decision|0|||
130619022|NCT01885078|470224730|FG008|Step-down Period|Physician Decision|7|||
130619023|NCT01885078|470224731|FG009|Step-down Period|Physician Decision|2|||
130619024|NCT01885078|470224722|FG000|Step-down Period|Death|0|||
130619025|NCT01885078|470224723|FG001|Step-down Period|Death|0|||
130619026|NCT01885078|470224724|FG002|Step-down Period|Death|0|||
130619027|NCT01885078|470224725|FG003|Step-down Period|Death|0|||
130619028|NCT01885078|470224726|FG004|Step-down Period|Death|0|||
130619029|NCT01885078|470224727|FG005|Step-down Period|Death|0|||
130619030|NCT01885078|470224728|FG006|Step-down Period|Death|0|||
130619031|NCT01885078|470224729|FG007|Step-down Period|Death|0|||
130619032|NCT01885078|470224730|FG008|Step-down Period|Death|4|||
130619033|NCT01885078|470224731|FG009|Step-down Period|Death|3|||
130619034|NCT01885078|470224722|FG000|Step-down Period|Lost to Follow-up|0|||
130619035|NCT01885078|470224723|FG001|Step-down Period|Lost to Follow-up|0|||
130619036|NCT01885078|470224724|FG002|Step-down Period|Lost to Follow-up|0|||
130619037|NCT01885078|470224725|FG003|Step-down Period|Lost to Follow-up|0|||
130619038|NCT01885078|470224726|FG004|Step-down Period|Lost to Follow-up|0|||
130619039|NCT01885078|470224727|FG005|Step-down Period|Lost to Follow-up|0|||
130619040|NCT01885078|470224728|FG006|Step-down Period|Lost to Follow-up|0|||
130619041|NCT01885078|470224729|FG007|Step-down Period|Lost to Follow-up|0|||
130619042|NCT01885078|470224730|FG008|Step-down Period|Lost to Follow-up|1|||
130619043|NCT01885078|470224731|FG009|Step-down Period|Lost to Follow-up|1|||
130619044|NCT01885078|470224722|FG000|Step-down Period|Lack of Efficacy|0|||
130619045|NCT01885078|470224723|FG001|Step-down Period|Lack of Efficacy|0|||
130619046|NCT01885078|470224724|FG002|Step-down Period|Lack of Efficacy|0|||
130619047|NCT01885078|470224725|FG003|Step-down Period|Lack of Efficacy|0|||
130619048|NCT01885078|470224726|FG004|Step-down Period|Lack of Efficacy|0|||
130619049|NCT01885078|470224727|FG005|Step-down Period|Lack of Efficacy|0|||
130619050|NCT01885078|470224728|FG006|Step-down Period|Lack of Efficacy|0|||
130619051|NCT01885078|470224729|FG007|Step-down Period|Lack of Efficacy|0|||
130619052|NCT01885078|470224730|FG008|Step-down Period|Lack of Efficacy|1|||
130619053|NCT01885078|470224731|FG009|Step-down Period|Lack of Efficacy|0|||
130619054|NCT01885078|470224722|FG000|Step-down Period|Protocol Violation|0|||
130619055|NCT01885078|470224723|FG001|Step-down Period|Protocol Violation|0|||
130619056|NCT01885078|470224724|FG002|Step-down Period|Protocol Violation|0|||
130619057|NCT01885078|470224725|FG003|Step-down Period|Protocol Violation|0|||
130619058|NCT01885078|470224726|FG004|Step-down Period|Protocol Violation|0|||
130619059|NCT01885078|470224727|FG005|Step-down Period|Protocol Violation|0|||
130619060|NCT01885078|470224728|FG006|Step-down Period|Protocol Violation|0|||
130619061|NCT01885078|470224729|FG007|Step-down Period|Protocol Violation|0|||
130619062|NCT01885078|470224730|FG008|Step-down Period|Protocol Violation|1|||
130619063|NCT01885078|470224731|FG009|Step-down Period|Protocol Violation|1|||
130619064|NCT03115112|470224732|FG000|Overall Study|Adverse Event|5|||
130619065|NCT03115112|470224733|FG001|Overall Study|Adverse Event|1|||
130619066|NCT03115112|470224732|FG000|Overall Study|Withdrawal by Subject|4|||
130619067|NCT03115112|470224733|FG001|Overall Study|Withdrawal by Subject|2|||
130619068|NCT03115112|470224732|FG000|Overall Study|Lost to Follow-up|0|||
130619069|NCT03115112|470224733|FG001|Overall Study|Lost to Follow-up|1|||
130619070|NCT03115112|470224732|FG000|Overall Study|Death|1|||
130619071|NCT03115112|470224733|FG001|Overall Study|Death|0|||
130619072|NCT03115112|470224732|FG000|Overall Study|Pregnancy|1|||
130619073|NCT03115112|470224733|FG001|Overall Study|Pregnancy|0|||
130619074|NCT03115112|470224732|FG000|Overall Study|Site closure|1|||
130619075|NCT03115112|470224733|FG001|Overall Study|Site closure|1|||
130619076|NCT04019795|470224735|FG000|Overall Study|Withdrawal by Subject|1|||
130619077|NCT04019795|470224736|FG001|Overall Study|Withdrawal by Subject|2|||
130619078|NCT04019795|470224737|FG002|Overall Study|Withdrawal by Subject|2|||
130619079|NCT04019795|470224738|FG003|Overall Study|Withdrawal by Subject|1|||
130619080|NCT04019795|470224735|FG000|Overall Study|Lost to Follow-up|0|||
130619081|NCT04019795|470224736|FG001|Overall Study|Lost to Follow-up|1|||
130619082|NCT04019795|470224737|FG002|Overall Study|Lost to Follow-up|1|||
130619083|NCT04019795|470224738|FG003|Overall Study|Lost to Follow-up|2|||
130619084|NCT04019795|470224735|FG000|Overall Study|Treatment non-compliance|3|||
130619085|NCT04019795|470224736|FG001|Overall Study|Treatment non-compliance|1|||
130619086|NCT04019795|470224737|FG002|Overall Study|Treatment non-compliance|2|||
130619087|NCT04019795|470224738|FG003|Overall Study|Treatment non-compliance|0|||
130619088|NCT04019795|470224735|FG000|Overall Study|Physician Decision|0|||
130619089|NCT04019795|470224736|FG001|Overall Study|Physician Decision|0|||
130619090|NCT04019795|470224737|FG002|Overall Study|Physician Decision|1|||
130619091|NCT04019795|470224738|FG003|Overall Study|Physician Decision|0|||
130619092|NCT04019795|470224735|FG000|Overall Study|Adverse Event|1|||
130619093|NCT04019795|470224736|FG001|Overall Study|Adverse Event|0|||
130619094|NCT04019795|470224737|FG002|Overall Study|Adverse Event|0|||
130619095|NCT04019795|470224738|FG003|Overall Study|Adverse Event|0|||
130619096|NCT01204697|470224739|FG000|Overall Study|Death|26|||
130619097|NCT01204697|470224740|FG001|Overall Study|Death|27|||
130619098|NCT01204697|470224739|FG000|Overall Study|Lost to Follow-up|3|||
130619099|NCT01204697|470224740|FG001|Overall Study|Lost to Follow-up|4|||
130619100|NCT01204697|470224739|FG000|Overall Study|Withdrawal by Subject|2|||
130619101|NCT01204697|470224740|FG001|Overall Study|Withdrawal by Subject|4|||
130619102|NCT01204697|470224739|FG000|Overall Study|Randomized, but not treated|0|||
130619103|NCT01204697|470224740|FG001|Overall Study|Randomized, but not treated|1|||
130619104|NCT01205451|470224741|FG000|Overall Study|Lost to Follow-up|1|||
130619105|NCT01205451|470224742|FG001|Overall Study|Lost to Follow-up|1|||
130619106|NCT01205451|470224741|FG000|Overall Study|Withdrawal by Subject|5|||
130619107|NCT01205451|470224742|FG001|Overall Study|Withdrawal by Subject|9|||
130619108|NCT01170702|470224743|FG000|Overall Study|Exclusion criteria met after consent|1|||
130619109|NCT01170702|470224744|FG001|Overall Study|Exclusion criteria met after consent|2|||
130619110|NCT01170702|470224745|FG002|Overall Study|Exclusion criteria met after consent|0|||
130619111|NCT01170702|470224746|FG003|Overall Study|Exclusion criteria met after consent|2|||
130619112|NCT01677507|470224747|FG000|Initial Assignment|Adverse Event|0|||
130619113|NCT01677507|470224748|FG001|Initial Assignment|Adverse Event|1|||
130619114|NCT01677507|470224747|FG000|Initial Assignment|Protocol Violation|0|||
130619115|NCT01677507|470224748|FG001|Initial Assignment|Protocol Violation|1|||
130619116|NCT01677507|470224747|FG000|Second Assigment|Withdrawal by Subject|2|||
130619117|NCT01677507|470224748|FG001|Second Assigment|Withdrawal by Subject|2|||
130619118|NCT01677507|470224747|FG000|Second Assigment|Adverse Event|1|||
130619119|NCT01677507|470224748|FG001|Second Assigment|Adverse Event|3|||
130619120|NCT00712933|470224755|FG000|Overall Study|Adverse Event|69|||
130619121|NCT00712933|470224755|FG000|Overall Study|Lack of Efficacy|6|||
130619122|NCT00712933|470224755|FG000|Overall Study|Lost to Follow-up|22|||
130619123|NCT00712933|470224755|FG000|Overall Study|Non-compliance with study drug|13|||
130619124|NCT00712933|470224755|FG000|Overall Study|Other Pregnancy|37|||
130619125|NCT00712933|470224755|FG000|Overall Study|Sponsor decision|14|||
130619126|NCT00712933|470224755|FG000|Overall Study|Withdrew consent|4|||
130619127|NCT00712933|470224755|FG000|Overall Study|Hip replacement surgery|1|||
130619128|NCT00712933|470224755|FG000|Overall Study|Involved in Clinical research|3|||
130619129|NCT00712933|470224755|FG000|Overall Study|Participant hospitalized|1|||
130619130|NCT00712933|470224755|FG000|Overall Study|Participant travelled overseas|2|||
130619131|NCT00712933|470224755|FG000|Overall Study|Death of patient|1|||
130619132|NCT00712933|470224755|FG000|Overall Study|Other Physician decision|1|||
130619133|NCT00712933|470224755|FG000|Overall Study|Not committed to contraception|1|||
130619134|NCT00712933|470224755|FG000|Overall Study|Participant received medication|1|||
130619135|NCT00712933|470224755|FG000|Overall Study|Physician Decision|36|||
130619136|NCT00712933|470224755|FG000|Overall Study|Protocol Violation|4|||
130619137|NCT00712933|470224755|FG000|Overall Study|Withdrawal by Subject|151|||
130619138|NCT03084718|470224761|FG000|Overall Study|Withdrawal by Subject|4|||
130619139|NCT03084718|470224762|FG001|Overall Study|Withdrawal by Subject|3|||
130619140|NCT03084718|470224763|FG002|Overall Study|Withdrawal by Subject|4|||
130619141|NCT03084718|470224764|FG003|Overall Study|Withdrawal by Subject|0|||
130619142|NCT03084718|470224765|FG004|Overall Study|Withdrawal by Subject|0|||
130619143|NCT03084718|470224761|FG000|Overall Study|Physician Decision|1|||
130619144|NCT03084718|470224762|FG001|Overall Study|Physician Decision|0|||
130619145|NCT03084718|470224763|FG002|Overall Study|Physician Decision|0|||
130619146|NCT03084718|470224764|FG003|Overall Study|Physician Decision|0|||
130619147|NCT03084718|470224765|FG004|Overall Study|Physician Decision|0|||
130619148|NCT03084718|470224761|FG000|Overall Study|Adverse Event|3|||
130619149|NCT03084718|470224762|FG001|Overall Study|Adverse Event|5|||
130619150|NCT03084718|470224763|FG002|Overall Study|Adverse Event|5|||
130619151|NCT03084718|470224764|FG003|Overall Study|Adverse Event|8|||
130619152|NCT03084718|470224765|FG004|Overall Study|Adverse Event|2|||
130619153|NCT03084718|470224761|FG000|Overall Study|Lack of Efficacy|2|||
130619154|NCT03084718|470224762|FG001|Overall Study|Lack of Efficacy|0|||
130619155|NCT03084718|470224763|FG002|Overall Study|Lack of Efficacy|1|||
130619156|NCT03084718|470224764|FG003|Overall Study|Lack of Efficacy|4|||
130619157|NCT03084718|470224765|FG004|Overall Study|Lack of Efficacy|0|||
130619158|NCT03084718|470224761|FG000|Overall Study|Lost to Follow-up|0|||
130619159|NCT03084718|470224762|FG001|Overall Study|Lost to Follow-up|1|||
130619160|NCT03084718|470224763|FG002|Overall Study|Lost to Follow-up|0|||
130619161|NCT03084718|470224764|FG003|Overall Study|Lost to Follow-up|0|||
130619162|NCT03084718|470224765|FG004|Overall Study|Lost to Follow-up|2|||
130619163|NCT03084718|470224761|FG000|Overall Study|Protocol Violation|0|||
130619164|NCT03084718|470224762|FG001|Overall Study|Protocol Violation|0|||
130619165|NCT03084718|470224763|FG002|Overall Study|Protocol Violation|1|||
130619166|NCT03084718|470224764|FG003|Overall Study|Protocol Violation|0|||
130619167|NCT03084718|470224765|FG004|Overall Study|Protocol Violation|0|||
130619168|NCT03084718|470224761|FG000|Overall Study|Death|0|||
130619169|NCT03084718|470224762|FG001|Overall Study|Death|1|||
130619170|NCT03084718|470224763|FG002|Overall Study|Death|0|||
130619171|NCT03084718|470224764|FG003|Overall Study|Death|0|||
130619172|NCT03084718|470224765|FG004|Overall Study|Death|0|||
130619173|NCT03084718|470224761|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
130619174|NCT03084718|470224762|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
130619175|NCT03084718|470224763|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
130619176|NCT03084718|470224764|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
130619177|NCT03084718|470224765|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
130619178|NCT03341923|470224766|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
130619179|NCT03341923|470224767|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
130619180|NCT04929613|470224768|FG000|Overall Study|Withdrawal by Subject|12|||
130619181|NCT01742078|470224769|FG000|Overall Study|Withdrawal by Subject|0|||
130619182|NCT01742078|470224770|FG001|Overall Study|Withdrawal by Subject|0|||
130619183|NCT01742078|470224771|FG002|Overall Study|Withdrawal by Subject|0|||
130619184|NCT01742078|470224772|FG003|Overall Study|Withdrawal by Subject|1|||
130619185|NCT01742078|470224773|FG004|Overall Study|Withdrawal by Subject|0|||
130619186|NCT01742078|470224774|FG005|Overall Study|Withdrawal by Subject|0|||
130619187|NCT01742078|470224775|FG006|Overall Study|Withdrawal by Subject|0|||
130619188|NCT01742078|470224776|FG007|Overall Study|Withdrawal by Subject|0|||
130619189|NCT01742078|470224777|FG008|Overall Study|Withdrawal by Subject|0|||
130619190|NCT02767856|470224779|FG000|Overall Study|Lost to Follow-up|9|||
130619191|NCT02767856|470224780|FG001|Overall Study|Lost to Follow-up|1|||
130619192|NCT02767856|470224779|FG000|Overall Study|Withdrawal by Subject|2|||
130619193|NCT02767856|470224780|FG001|Overall Study|Withdrawal by Subject|1|||
130619194|NCT00424294|470224781|FG000|Overall Study|Adverse Event|4|||
130619195|NCT00424294|470224782|FG001|Overall Study|Adverse Event|10|||
130619196|NCT00424294|470224781|FG000|Overall Study|Lack of Efficacy|2|||
130619197|NCT00424294|470224782|FG001|Overall Study|Lack of Efficacy|1|||
130619198|NCT00424294|470224781|FG000|Overall Study|Withdrawal by Subject|1|||
130619199|NCT00424294|470224782|FG001|Overall Study|Withdrawal by Subject|2|||
130619200|NCT00424294|470224781|FG000|Overall Study|Other|0|||
130619201|NCT00424294|470224782|FG001|Overall Study|Other|2|||
130619202|NCT00424294|470224781|FG000|Overall Study|Randomized but not Treated|1|||
130619203|NCT00424294|470224782|FG001|Overall Study|Randomized but not Treated|0|||
130619204|NCT01464788|470224783|FG000|Overall Study|Lost to Follow-up|0|||
130619205|NCT01464788|470224784|FG001|Overall Study|Lost to Follow-up|1|||
130619206|NCT01464788|470224785|FG002|Overall Study|Lost to Follow-up|0|||
130619207|NCT01464788|470224783|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
130619208|NCT01464788|470224784|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
130619209|NCT01464788|470224785|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
130619210|NCT04397718|470224786|FG000|Overall Study|Death|7|||
130619211|NCT04397718|470224787|FG001|Overall Study|Death|11|||
130619212|NCT04397718|470224786|FG000|Overall Study|Lost to Follow-up|0|||
130619213|NCT04397718|470224787|FG001|Overall Study|Lost to Follow-up|4|||
130619214|NCT01797965|470224788|FG000|Overall Study|Adverse Event|104|||
130619215|NCT01797965|470224789|FG001|Overall Study|Adverse Event|129|||
130619216|NCT01797965|470224790|FG002|Overall Study|Adverse Event|4|||
130619217|NCT01797965|470224791|FG003|Overall Study|Adverse Event|21|||
130619218|NCT01797965|470224788|FG000|Overall Study|Lost to Follow-up|9|||
130619219|NCT01797965|470224789|FG001|Overall Study|Lost to Follow-up|8|||
130619220|NCT01797965|470224790|FG002|Overall Study|Lost to Follow-up|1|||
130619221|NCT01797965|470224791|FG003|Overall Study|Lost to Follow-up|2|||
130619222|NCT01797965|470224788|FG000|Overall Study|Consent withdrawn|130|||
130619223|NCT01797965|470224789|FG001|Overall Study|Consent withdrawn|117|||
130619224|NCT01797965|470224790|FG002|Overall Study|Consent withdrawn|3|||
130619225|NCT01797965|470224791|FG003|Overall Study|Consent withdrawn|35|||
130619226|NCT01797965|470224788|FG000|Overall Study|Investigator decision|21|||
130619227|NCT01797965|470224789|FG001|Overall Study|Investigator decision|15|||
130619228|NCT01797965|470224790|FG002|Overall Study|Investigator decision|0|||
130619229|NCT01797965|470224791|FG003|Overall Study|Investigator decision|0|||
130619230|NCT01797965|470224788|FG000|Overall Study|Death|2|||
130619231|NCT01797965|470224789|FG001|Overall Study|Death|4|||
130619232|NCT01797965|470224790|FG002|Overall Study|Death|0|||
130619233|NCT01797965|470224791|FG003|Overall Study|Death|0|||
130619234|NCT01797965|470224788|FG000|Overall Study|Disease progression, defined by protocol|3|||
130619235|NCT01797965|470224789|FG001|Overall Study|Disease progression, defined by protocol|1|||
130619236|NCT01797965|470224790|FG002|Overall Study|Disease progression, defined by protocol|0|||
130619237|NCT01797965|470224791|FG003|Overall Study|Disease progression, defined by protocol|0|||
130619238|NCT01797965|470224788|FG000|Overall Study|Reason Not Specified|280|||
130619239|NCT01797965|470224789|FG001|Overall Study|Reason Not Specified|295|||
130619240|NCT01797965|470224790|FG002|Overall Study|Reason Not Specified|0|||
130619241|NCT01797965|470224791|FG003|Overall Study|Reason Not Specified|15|||
130619242|NCT00973921|470224792|FG000|Overall Study|IVUS results were not available|9|||
130619243|NCT04404010|470224796|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
130619244|NCT04404010|470224797|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
130619245|NCT02120157|470224798|FG000|Overall Study|Death|8|||
130619246|NCT00239837|470224803|FG000|Overall Study|Lost to Follow-up|3|||
130619247|NCT00239837|470224804|FG001|Overall Study|Lost to Follow-up|7|||
130619248|NCT01153893|470224805|FG000|Overall Study|Adverse Event|1|||
130619249|NCT01153893|470224806|FG001|Overall Study|Adverse Event|0|||
130619250|NCT01838590|470224807|FG000|Overall Study|Lack of Efficacy|12|||
130619251|NCT01838590|470224808|FG001|Overall Study|Lack of Efficacy|4|||
130619252|NCT01838590|470224807|FG000|Overall Study|Lost to Follow-up|0|||
130619253|NCT01838590|470224808|FG001|Overall Study|Lost to Follow-up|1|||
130619254|NCT00536978|470224809|FG000|Overall Study|Not eligible for Adback Infusion|22|||
130619255|NCT03550131|470224811|FG000|Overall Study|Lost to Follow-up|16|||
130619256|NCT03550131|470224812|FG001|Overall Study|Lost to Follow-up|24|||
130619257|NCT03550131|470224811|FG000|Overall Study|Withdrawal by Subject|36|||
130619258|NCT03550131|470224812|FG001|Overall Study|Withdrawal by Subject|28|||
130619259|NCT03550131|470224811|FG000|Overall Study|Illness of dyad member|10|||
130619260|NCT03550131|470224812|FG001|Overall Study|Illness of dyad member|2|||
130619261|NCT03550131|470224811|FG000|Overall Study|Death of person with dementia|4|||
130619262|NCT03550131|470224812|FG001|Overall Study|Death of person with dementia|8|||
130619263|NCT01318512|470224813|FG000|Maintenance Period (6 Months)|Death|2|||
130619264|NCT01318512|470224813|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
130619265|NCT01364233|470224817|FG000|Overall Study|Lost to Follow-up|1|||
130619266|NCT00302718|470224821|FG000|Overall Study|Participant left the hospital|1|||
130619267|NCT00302718|470224822|FG001|Overall Study|Participant left the hospital|0|||
130619268|NCT00302718|470224823|FG002|Overall Study|Participant left the hospital|0|||
130619269|NCT00302718|470224824|FG003|Overall Study|Participant left the hospital|1|||
130619270|NCT00302718|470224821|FG000|Overall Study|Withdrawal by Subject|0|||
130619271|NCT00302718|470224822|FG001|Overall Study|Withdrawal by Subject|1|||
130619272|NCT00302718|470224823|FG002|Overall Study|Withdrawal by Subject|0|||
130619273|NCT00302718|470224824|FG003|Overall Study|Withdrawal by Subject|0|||
130619274|NCT00302718|470224821|FG000|Overall Study|Participant left primary care setting|0|||
130619275|NCT00302718|470224822|FG001|Overall Study|Participant left primary care setting|0|||
130619276|NCT00302718|470224823|FG002|Overall Study|Participant left primary care setting|2|||
130619277|NCT00302718|470224824|FG003|Overall Study|Participant left primary care setting|1|||
130619278|NCT00819585|470224825|FG000|Core Study|Adverse Event|2|||
130619279|NCT00819585|470224826|FG001|Core Study|Adverse Event|1|||
130619280|NCT00819585|470224827|FG002|Core Study|Adverse Event|1|||
130619281|NCT00819585|470224828|FG003|Core Study|Adverse Event|4|||
130619282|NCT00819585|470224829|FG004|Core Study|Adverse Event|1|||
130619283|NCT00819585|470224830|FG005|Core Study|Adverse Event|0|||
130619284|NCT00819585|470224831|FG006|Core Study|Adverse Event|2|||
130619285|NCT00819585|470224832|FG007|Core Study|Adverse Event|0|||
130619286|NCT00819585|470224833|FG008|Core Study|Adverse Event|0|||
130619287|NCT00819585|470224834|FG009|Core Study|Adverse Event|0|||
130619288|NCT00819585|470224835|FG010|Core Study|Adverse Event|0|||
130619289|NCT00819585|470224825|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
130619290|NCT00819585|470224826|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
130619291|NCT00819585|470224827|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
130619292|NCT00819585|470224828|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
130619293|NCT00819585|470224829|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
130619294|NCT00819585|470224830|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
130619295|NCT00819585|470224831|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
130619296|NCT00819585|470224832|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
130619297|NCT00819585|470224833|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
130619298|NCT00819585|470224834|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
130619299|NCT00819585|470224835|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
130619300|NCT00819585|470224825|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619301|NCT00819585|470224826|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
130619302|NCT00819585|470224827|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619303|NCT00819585|470224828|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619304|NCT00819585|470224829|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619305|NCT00819585|470224830|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619306|NCT00819585|470224831|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
130619307|NCT00819585|470224832|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619308|NCT00819585|470224833|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619309|NCT00819585|470224834|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619310|NCT00819585|470224835|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
130619311|NCT00819585|470224825|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
130619312|NCT00819585|470224826|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
130619313|NCT00819585|470224827|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
130619314|NCT00819585|470224828|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
130619315|NCT00819585|470224829|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
130619316|NCT00819585|470224830|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
130619317|NCT00819585|470224831|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
130619318|NCT00819585|470224832|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
130619319|NCT00819585|470224833|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
130619320|NCT00819585|470224834|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
130619321|NCT00819585|470224835|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
130619322|NCT00819585|470224825|FG000|Core Study|Subject Withdrew Consent|0|||
130619323|NCT00819585|470224826|FG001|Core Study|Subject Withdrew Consent|3|||
130619324|NCT00819585|470224827|FG002|Core Study|Subject Withdrew Consent|2|||
130619325|NCT00819585|470224828|FG003|Core Study|Subject Withdrew Consent|1|||
130619326|NCT00819585|470224829|FG004|Core Study|Subject Withdrew Consent|0|||
130619327|NCT00819585|470224830|FG005|Core Study|Subject Withdrew Consent|0|||
130619328|NCT00819585|470224831|FG006|Core Study|Subject Withdrew Consent|3|||
130619329|NCT00819585|470224832|FG007|Core Study|Subject Withdrew Consent|0|||
130619330|NCT00819585|470224833|FG008|Core Study|Subject Withdrew Consent|0|||
130619331|NCT00819585|470224834|FG009|Core Study|Subject Withdrew Consent|0|||
130619332|NCT00819585|470224835|FG010|Core Study|Subject Withdrew Consent|0|||
130619333|NCT00819585|470224825|FG000|Core Study|Lost to Follow-up|2|||
130619334|NCT00819585|470224826|FG001|Core Study|Lost to Follow-up|1|||
130619335|NCT00819585|470224827|FG002|Core Study|Lost to Follow-up|2|||
130619336|NCT00819585|470224828|FG003|Core Study|Lost to Follow-up|0|||
130619337|NCT00819585|470224829|FG004|Core Study|Lost to Follow-up|1|||
130619338|NCT00819585|470224830|FG005|Core Study|Lost to Follow-up|1|||
130619339|NCT00819585|470224831|FG006|Core Study|Lost to Follow-up|1|||
130619340|NCT00819585|470224832|FG007|Core Study|Lost to Follow-up|0|||
130619341|NCT00819585|470224833|FG008|Core Study|Lost to Follow-up|0|||
130619342|NCT00819585|470224834|FG009|Core Study|Lost to Follow-up|0|||
130619343|NCT00819585|470224835|FG010|Core Study|Lost to Follow-up|0|||
130619344|NCT00819585|470224825|FG000|Core Study|Administrative Problems|0|||
130619345|NCT00819585|470224826|FG001|Core Study|Administrative Problems|0|||
130619346|NCT00819585|470224827|FG002|Core Study|Administrative Problems|0|||
130619347|NCT00819585|470224828|FG003|Core Study|Administrative Problems|0|||
130619348|NCT00819585|470224829|FG004|Core Study|Administrative Problems|0|||
130619349|NCT00819585|470224830|FG005|Core Study|Administrative Problems|0|||
130619350|NCT00819585|470224831|FG006|Core Study|Administrative Problems|2|||
130619351|NCT00819585|470224832|FG007|Core Study|Administrative Problems|0|||
130619352|NCT00819585|470224833|FG008|Core Study|Administrative Problems|0|||
130619353|NCT00819585|470224834|FG009|Core Study|Administrative Problems|0|||
130619354|NCT00819585|470224835|FG010|Core Study|Administrative Problems|0|||
130619355|NCT00819585|470224825|FG000|Core Study|Death|0|||
130619356|NCT00819585|470224826|FG001|Core Study|Death|0|||
130619357|NCT00819585|470224827|FG002|Core Study|Death|0|||
130619358|NCT00819585|470224828|FG003|Core Study|Death|0|||
130619359|NCT00819585|470224829|FG004|Core Study|Death|0|||
130619360|NCT00819585|470224830|FG005|Core Study|Death|0|||
130619361|NCT00819585|470224831|FG006|Core Study|Death|1|||
130619362|NCT00819585|470224832|FG007|Core Study|Death|0|||
130619363|NCT00819585|470224833|FG008|Core Study|Death|0|||
130619364|NCT00819585|470224834|FG009|Core Study|Death|0|||
130619365|NCT00819585|470224835|FG010|Core Study|Death|0|||
130619366|NCT00819585|470224825|FG000|Core Study|Protocol Violation|0|||
130619367|NCT00819585|470224826|FG001|Core Study|Protocol Violation|0|||
130619368|NCT00819585|470224827|FG002|Core Study|Protocol Violation|1|||
130619369|NCT00819585|470224828|FG003|Core Study|Protocol Violation|0|||
130619370|NCT00819585|470224829|FG004|Core Study|Protocol Violation|0|||
130619371|NCT00819585|470224830|FG005|Core Study|Protocol Violation|1|||
130619372|NCT00819585|470224831|FG006|Core Study|Protocol Violation|3|||
130619373|NCT00819585|470224832|FG007|Core Study|Protocol Violation|0|||
130619374|NCT00819585|470224833|FG008|Core Study|Protocol Violation|0|||
130619375|NCT00819585|470224834|FG009|Core Study|Protocol Violation|0|||
130619376|NCT00819585|470224835|FG010|Core Study|Protocol Violation|0|||
130619377|NCT00819585|470224825|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
130619378|NCT00819585|470224826|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
130619379|NCT00819585|470224827|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
130619380|NCT00819585|470224828|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
130619381|NCT00819585|470224829|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
130619382|NCT00819585|470224830|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
130619383|NCT00819585|470224831|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
130619384|NCT00819585|470224832|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
130619385|NCT00819585|470224833|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
130619386|NCT00819585|470224834|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
130619387|NCT00819585|470224835|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
130619388|NCT00819585|470224825|FG000|Extension Study|Subject Withdrew Consent|0|||
130619389|NCT00819585|470224826|FG001|Extension Study|Subject Withdrew Consent|0|||
130619390|NCT00819585|470224827|FG002|Extension Study|Subject Withdrew Consent|0|||
130619391|NCT00819585|470224828|FG003|Extension Study|Subject Withdrew Consent|0|||
130619392|NCT00819585|470224829|FG004|Extension Study|Subject Withdrew Consent|0|||
130619393|NCT00819585|470224830|FG005|Extension Study|Subject Withdrew Consent|0|||
130619394|NCT00819585|470224831|FG006|Extension Study|Subject Withdrew Consent|0|||
130619395|NCT00819585|470224832|FG007|Extension Study|Subject Withdrew Consent|0|||
130619396|NCT00819585|470224833|FG008|Extension Study|Subject Withdrew Consent|3|||
130619397|NCT00819585|470224834|FG009|Extension Study|Subject Withdrew Consent|0|||
130619398|NCT00819585|470224835|FG010|Extension Study|Subject Withdrew Consent|1|||
130619399|NCT00819585|470224825|FG000|Extension Study|Lost to Follow-up|0|||
130619400|NCT00819585|470224826|FG001|Extension Study|Lost to Follow-up|0|||
130619401|NCT00819585|470224827|FG002|Extension Study|Lost to Follow-up|0|||
130619402|NCT00819585|470224828|FG003|Extension Study|Lost to Follow-up|0|||
130619403|NCT00819585|470224829|FG004|Extension Study|Lost to Follow-up|0|||
130619404|NCT00819585|470224830|FG005|Extension Study|Lost to Follow-up|0|||
130619405|NCT00819585|470224831|FG006|Extension Study|Lost to Follow-up|0|||
130619406|NCT00819585|470224832|FG007|Extension Study|Lost to Follow-up|0|||
130619407|NCT00819585|470224833|FG008|Extension Study|Lost to Follow-up|2|||
130619408|NCT00819585|470224834|FG009|Extension Study|Lost to Follow-up|1|||
130619409|NCT00819585|470224835|FG010|Extension Study|Lost to Follow-up|1|||
130619410|NCT00819585|470224825|FG000|Extension Study|Death|0|||
130619411|NCT00819585|470224826|FG001|Extension Study|Death|0|||
130619412|NCT00819585|470224827|FG002|Extension Study|Death|0|||
130619413|NCT00819585|470224828|FG003|Extension Study|Death|0|||
130619414|NCT00819585|470224829|FG004|Extension Study|Death|0|||
130619415|NCT00819585|470224830|FG005|Extension Study|Death|0|||
130619416|NCT00819585|470224831|FG006|Extension Study|Death|0|||
130619417|NCT00819585|470224832|FG007|Extension Study|Death|0|||
130619418|NCT00819585|470224833|FG008|Extension Study|Death|2|||
130619419|NCT00819585|470224834|FG009|Extension Study|Death|0|||
130619420|NCT00819585|470224835|FG010|Extension Study|Death|0|||
130619421|NCT00632541|470224836|FG000|Overall Study|Adverse Event|7|||
130619422|NCT02159469|470224840|FG000|Overall Study|Missing Completion status|1|||
130619423|NCT02159469|470224840|FG000|Overall Study|Adverse Event|5|||
130619424|NCT02159469|470224840|FG000|Overall Study|Non-compliance|2|||
130619425|NCT02159469|470224840|FG000|Overall Study|Withdrawal by Subject|9|||
130619426|NCT02159469|470224840|FG000|Overall Study|Lost to Follow-up|1|||
130619427|NCT02159469|470224840|FG000|Overall Study|Sponsor's request|2|||
130619428|NCT02159469|470224840|FG000|Overall Study|Met Stopping Criteria|3|||
130619429|NCT02159469|470224840|FG000|Overall Study|Other|1|||
130619430|NCT02159469|470224840|FG000|Overall Study|Multiple|29|||
130619431|NCT02927873|470224841|FG000|Overall Study|Lost to Follow-up|0|||
130619432|NCT02927873|470224842|FG001|Overall Study|Lost to Follow-up|1|||
130619433|NCT02927873|470224843|FG002|Overall Study|Lost to Follow-up|0|||
130619434|NCT02927873|470224844|FG003|Overall Study|Lost to Follow-up|0|||
130619435|NCT02927873|470224845|FG004|Overall Study|Lost to Follow-up|0|||
130619436|NCT02927873|470224846|FG005|Overall Study|Lost to Follow-up|0|||
130619437|NCT02927873|470224841|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130619438|NCT02927873|470224842|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130619439|NCT02927873|470224843|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130619440|NCT02927873|470224844|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130619441|NCT02927873|470224845|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130619442|NCT02927873|470224846|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130619443|NCT02927873|470224841|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130619444|NCT02927873|470224842|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130619445|NCT02927873|470224843|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130619446|NCT02927873|470224844|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130619447|NCT02927873|470224845|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130619448|NCT02927873|470224846|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130619449|NCT02927873|470224841|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130619450|NCT02927873|470224842|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
130619451|NCT02927873|470224843|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130619452|NCT02927873|470224844|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130619453|NCT02927873|470224845|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130619454|NCT02927873|470224846|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130619455|NCT02927873|470224841|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
130619456|NCT02927873|470224842|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130619457|NCT02927873|470224843|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130619458|NCT02927873|470224844|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130619459|NCT02927873|470224845|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130619460|NCT02927873|470224846|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130619461|NCT02927873|470224841|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
130619462|NCT02927873|470224842|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130619463|NCT02927873|470224843|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130619464|NCT02927873|470224844|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130619465|NCT02927873|470224845|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130619466|NCT02927873|470224846|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130619467|NCT03629041|470224852|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
130619468|NCT03629041|470224853|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
130619469|NCT03629041|470224854|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
130619470|NCT03629041|470224855|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
130619471|NCT00393913|470224857|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
130619472|NCT00393913|470224857|FG000|Initial Assessment|Withdrawal by Subject|16|||
130619473|NCT00393913|470224857|FG000|CPAP|Withdrawal by Subject|3|||
130619474|NCT00393913|470224857|FG000|CPAP|Physician Decision|1|||
130619475|NCT00393913|470224857|FG000|CPAP|TEchnical problem with CPAP|3|||
130619476|NCT00995670|470224860|FG000|Overall Study|Failed arterial cannulation|1|||
130619477|NCT00995670|470224861|FG001|Overall Study|Failed arterial cannulation|0|||
130619478|NCT00995670|470224862|FG002|Overall Study|Failed arterial cannulation|3|||
130619479|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
130619480|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
130619481|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
130619482|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
130619483|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
130619484|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
130619485|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130619486|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130619487|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
130619488|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
130619489|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
130619490|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
130619491|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130619492|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
130619493|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
130619494|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
130619495|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
130619496|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
130619497|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
130619498|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
130619499|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
130619500|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130619501|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
130619502|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
130619503|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
130619504|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
130619505|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130619506|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
130619507|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
130619508|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
130619509|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130619510|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
130619511|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
130619512|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
130619513|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
130619514|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
130619515|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
130619516|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
130619517|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
130619518|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
130619519|NCT00383721|470224866|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
130619520|NCT00383721|470224867|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
130619521|NCT00383721|470224868|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
130619522|NCT00383721|470224869|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
130619523|NCT00383721|470224870|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
130619524|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
130619525|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
130619526|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
130619527|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
130619528|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
130619529|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130619530|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
130619531|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
130619532|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130619533|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130619534|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
130619535|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130619536|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130619537|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130619538|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130619539|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130619540|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
130619541|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130619542|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
130619543|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
130619544|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130619545|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130619546|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130619547|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130619548|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130619549|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
130619550|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130619551|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130619552|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
130619553|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
130619554|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130619555|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130619556|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130619557|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130619558|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130619559|NCT00383721|470224866|FG000|26-Week Treatment Safety Extension|Administrative|1|||
130619560|NCT00383721|470224867|FG001|26-Week Treatment Safety Extension|Administrative|2|||
130619561|NCT00383721|470224868|FG002|26-Week Treatment Safety Extension|Administrative|3|||
130619562|NCT00383721|470224869|FG003|26-Week Treatment Safety Extension|Administrative|1|||
130619563|NCT00383721|470224870|FG004|26-Week Treatment Safety Extension|Administrative|0|||
130619564|NCT03519516|470224872|FG000|Overall Study|Adverse Event|0|||
130619565|NCT03519516|470224873|FG001|Overall Study|Adverse Event|1|||
130619566|NCT01935336|470224874|FG000|Overall Study|Adverse Event|1|||
130619567|NCT01935336|470224875|FG001|Overall Study|Adverse Event|0|||
130619568|NCT01935336|470224876|FG002|Overall Study|Adverse Event|0|||
130619569|NCT01935336|470224877|FG003|Overall Study|Adverse Event|0|||
130619570|NCT01935336|470224874|FG000|Overall Study|Progressive disease|5|||
130619571|NCT01935336|470224875|FG001|Overall Study|Progressive disease|3|||
130619572|NCT01935336|470224876|FG002|Overall Study|Progressive disease|47|||
130619573|NCT01935336|470224877|FG003|Overall Study|Progressive disease|66|||
130619574|NCT00592553|470224878|FG000|Overall Study|Protocol Noncompliance|1|||
130619575|NCT00592553|470224879|FG001|Overall Study|Protocol Noncompliance|0|||
130619576|NCT00592553|470224880|FG002|Overall Study|Protocol Noncompliance|0|||
130619577|NCT01146951|470226333|FG000|Overall Study|Adverse Event|4|||
130619578|NCT01146951|470226334|FG001|Overall Study|Adverse Event|1|||
130619579|NCT01747811|470226335|FG000|Overall Study|Lack of Efficacy|2|||
130619580|NCT01747811|470226336|FG001|Overall Study|Lack of Efficacy|4|||
130619581|NCT01337167|470226340|FG000|Infant Series|Adverse Event|1|||
130619582|NCT01337167|470226341|FG001|Infant Series|Adverse Event|1|||
130619583|NCT01337167|470226340|FG000|Infant Series|Death|1|||
130619584|NCT01337167|470226341|FG001|Infant Series|Death|1|||
130619585|NCT01337167|470226340|FG000|Infant Series|Lost to Follow-up|13|||
130619586|NCT01337167|470226341|FG001|Infant Series|Lost to Follow-up|7|||
130619587|NCT01337167|470226340|FG000|Infant Series|Non-compliance with study drug|2|||
130619588|NCT01337167|470226341|FG001|Infant Series|Non-compliance with study drug|1|||
130619589|NCT01337167|470226340|FG000|Infant Series|Physician Decision|3|||
130619590|NCT01337167|470226341|FG001|Infant Series|Physician Decision|1|||
130619591|NCT01337167|470226340|FG000|Infant Series|Protocol Violation|22|||
130619592|NCT01337167|470226341|FG001|Infant Series|Protocol Violation|9|||
130619593|NCT01337167|470226340|FG000|Infant Series|Withdrawal by Subject|15|||
130619594|NCT01337167|470226341|FG001|Infant Series|Withdrawal by Subject|4|||
130619595|NCT01337167|470226340|FG000|Infant Series|Randomized but not vaccinated|5|||
130619596|NCT01337167|470226341|FG001|Infant Series|Randomized but not vaccinated|3|||
130619597|NCT01337167|470226340|FG000|Interim Period|Lost to Follow-up|51|||
130619598|NCT01337167|470226341|FG001|Interim Period|Lost to Follow-up|23|||
130619599|NCT01337167|470226340|FG000|Interim Period|Non-compliance with study drug|1|||
130619600|NCT01337167|470226341|FG001|Interim Period|Non-compliance with study drug|0|||
130619601|NCT01337167|470226340|FG000|Interim Period|Physician Decision|6|||
130619602|NCT01337167|470226341|FG001|Interim Period|Physician Decision|3|||
130619603|NCT01337167|470226340|FG000|Interim Period|Protocol Violation|5|||
130619604|NCT01337167|470226341|FG001|Interim Period|Protocol Violation|3|||
130619605|NCT01337167|470226340|FG000|Interim Period|Withdrawal by Subject|18|||
130619606|NCT01337167|470226341|FG001|Interim Period|Withdrawal by Subject|10|||
130619607|NCT01337167|470226340|FG000|Interim Period|Other protocol criterion not met|0|||
130619608|NCT01337167|470226341|FG001|Interim Period|Other protocol criterion not met|1|||
130619609|NCT01337167|470226340|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
130619610|NCT01337167|470226341|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
130619611|NCT01337167|470226340|FG000|Toddler Vaccinations|Protocol Violation|0|||
130619612|NCT01337167|470226341|FG001|Toddler Vaccinations|Protocol Violation|1|||
130619613|NCT01337167|470226340|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
130619614|NCT01337167|470226341|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
130619615|NCT03833817|470226342|FG000|Overall Study|Withdrawal by Subject|3|||
130619616|NCT03833817|470226343|FG001|Overall Study|Withdrawal by Subject|3|||
130619617|NCT03833817|470226342|FG000|Overall Study|Lost to Follow-up|3|||
130619618|NCT03833817|470226343|FG001|Overall Study|Lost to Follow-up|3|||
130619619|NCT02126670|470226348|FG000|Overall Study|Withdrawal by Subject|1|||
130619620|NCT02126670|470226349|FG001|Overall Study|Withdrawal by Subject|0|||
130619621|NCT02126670|470226350|FG002|Overall Study|Withdrawal by Subject|0|||
130619622|NCT02126670|470226351|FG003|Overall Study|Withdrawal by Subject|1|||
130619623|NCT03363919|470226354|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
130619624|NCT03363919|470226355|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
130619625|NCT03363919|470226354|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
130619626|NCT03363919|470226355|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
130619627|NCT01646398|470226356|FG000|Overall Study|Withdrawal by Subject|1|||
130619628|NCT01646398|470226357|FG001|Overall Study|Withdrawal by Subject|0|||
130619629|NCT00255034|470226358|FG000|Overall Study|Withdrawal by Subject|15|||
130619630|NCT00255034|470226359|FG001|Overall Study|Withdrawal by Subject|38|||
130619631|NCT01827319|470226360|FG000|Overall Study|Lost to Follow-up|3|||
130619632|NCT03947255|470226364|FG000|Overall Study|Study Closure by Sponsor|2|||
130619633|NCT03947255|470226365|FG001|Overall Study|Study Closure by Sponsor|2|||
130619634|NCT03947255|470226364|FG000|Overall Study|Withdrawal by Subject|2|||
130619635|NCT03947255|470226365|FG001|Overall Study|Withdrawal by Subject|2|||
130619636|NCT03947255|470226364|FG000|Overall Study|Lost to Follow-up|2|||
130619637|NCT03947255|470226365|FG001|Overall Study|Lost to Follow-up|0|||
130619638|NCT03947255|470226364|FG000|Overall Study|Death|0|||
130619639|NCT03947255|470226365|FG001|Overall Study|Death|2|||
130619640|NCT01061736|470226375|FG000|Overall Study|Dose regimen not selected|0|||
130619641|NCT01061736|470226376|FG001|Overall Study|Dose regimen not selected|0|||
130619642|NCT01061736|470226377|FG002|Overall Study|Dose regimen not selected|0|||
130619643|NCT01061736|470226378|FG003|Overall Study|Dose regimen not selected|0|||
130619644|NCT01061736|470226379|FG004|Overall Study|Dose regimen not selected|0|||
130619645|NCT01061736|470226380|FG005|Overall Study|Dose regimen not selected|0|||
130619646|NCT01061736|470226381|FG006|Overall Study|Dose regimen not selected|79|||
130619647|NCT01061736|470226382|FG007|Overall Study|Dose regimen not selected|0|||
130619648|NCT01061736|470226383|FG008|Overall Study|Dose regimen not selected|0|||
130619649|NCT01061736|470226384|FG009|Overall Study|Dose regimen not selected|0|||
130619650|NCT01061736|470226375|FG000|Overall Study|Adverse Event|13|||
130619651|NCT01061736|470226376|FG001|Overall Study|Adverse Event|1|||
130619652|NCT01061736|470226377|FG002|Overall Study|Adverse Event|3|||
130619653|NCT01061736|470226378|FG003|Overall Study|Adverse Event|2|||
130619654|NCT01061736|470226379|FG004|Overall Study|Adverse Event|4|||
130619655|NCT01061736|470226380|FG005|Overall Study|Adverse Event|1|||
130619656|NCT01061736|470226381|FG006|Overall Study|Adverse Event|4|||
130619657|NCT01061736|470226382|FG007|Overall Study|Adverse Event|63|||
130619658|NCT01061736|470226383|FG008|Overall Study|Adverse Event|67|||
130619659|NCT01061736|470226384|FG009|Overall Study|Adverse Event|34|||
130619660|NCT01061736|470226375|FG000|Overall Study|Lack of Efficacy|0|||
130619661|NCT01061736|470226376|FG001|Overall Study|Lack of Efficacy|2|||
130619662|NCT01061736|470226377|FG002|Overall Study|Lack of Efficacy|1|||
130619663|NCT01061736|470226378|FG003|Overall Study|Lack of Efficacy|1|||
130619664|NCT01061736|470226379|FG004|Overall Study|Lack of Efficacy|1|||
130619665|NCT01061736|470226380|FG005|Overall Study|Lack of Efficacy|2|||
130619666|NCT01061736|470226381|FG006|Overall Study|Lack of Efficacy|1|||
130619667|NCT01061736|470226382|FG007|Overall Study|Lack of Efficacy|9|||
130619668|NCT01061736|470226383|FG008|Overall Study|Lack of Efficacy|9|||
130619669|NCT01061736|470226384|FG009|Overall Study|Lack of Efficacy|10|||
130619670|NCT01061736|470226375|FG000|Overall Study|Poor compliance to protocol|0|||
130619671|NCT01061736|470226376|FG001|Overall Study|Poor compliance to protocol|0|||
130619672|NCT01061736|470226377|FG002|Overall Study|Poor compliance to protocol|0|||
130619673|NCT01061736|470226378|FG003|Overall Study|Poor compliance to protocol|0|||
130619674|NCT01061736|470226379|FG004|Overall Study|Poor compliance to protocol|0|||
130619675|NCT01061736|470226380|FG005|Overall Study|Poor compliance to protocol|0|||
130619676|NCT01061736|470226381|FG006|Overall Study|Poor compliance to protocol|0|||
130619677|NCT01061736|470226382|FG007|Overall Study|Poor compliance to protocol|2|||
130619678|NCT01061736|470226383|FG008|Overall Study|Poor compliance to protocol|5|||
130619679|NCT01061736|470226384|FG009|Overall Study|Poor compliance to protocol|9|||
130619680|NCT01061736|470226375|FG000|Overall Study|Not treated|0|||
130619681|NCT01061736|470226376|FG001|Overall Study|Not treated|0|||
130619682|NCT01061736|470226377|FG002|Overall Study|Not treated|0|||
130619683|NCT01061736|470226378|FG003|Overall Study|Not treated|0|||
130619684|NCT01061736|470226379|FG004|Overall Study|Not treated|1|||
130619685|NCT01061736|470226380|FG005|Overall Study|Not treated|0|||
130619686|NCT01061736|470226381|FG006|Overall Study|Not treated|0|||
130619687|NCT01061736|470226382|FG007|Overall Study|Not treated|2|||
130619688|NCT01061736|470226383|FG008|Overall Study|Not treated|1|||
130619689|NCT01061736|470226384|FG009|Overall Study|Not treated|0|||
130619690|NCT01061736|470226375|FG000|Overall Study|Other than specified above|0|||
130619691|NCT01061736|470226376|FG001|Overall Study|Other than specified above|1|||
130619692|NCT01061736|470226377|FG002|Overall Study|Other than specified above|2|||
130619693|NCT01061736|470226378|FG003|Overall Study|Other than specified above|0|||
130619694|NCT01061736|470226379|FG004|Overall Study|Other than specified above|1|||
130619695|NCT01061736|470226380|FG005|Overall Study|Other than specified above|0|||
130619696|NCT01061736|470226381|FG006|Overall Study|Other than specified above|0|||
130619697|NCT01061736|470226382|FG007|Overall Study|Other than specified above|18|||
130619698|NCT01061736|470226383|FG008|Overall Study|Other than specified above|15|||
130619699|NCT01061736|470226384|FG009|Overall Study|Other than specified above|21|||
130619700|NCT02168803|470226385|FG000|Overall Study|Lost to Follow-up|1|||
130619701|NCT02168803|470226386|FG001|Overall Study|Lost to Follow-up|0|||
130619702|NCT02168803|470226387|FG002|Overall Study|Lost to Follow-up|1|||
130619703|NCT02168803|470226385|FG000|Overall Study|Withdrawal by Subject|1|||
130619704|NCT02168803|470226386|FG001|Overall Study|Withdrawal by Subject|1|||
130619705|NCT02168803|470226387|FG002|Overall Study|Withdrawal by Subject|2|||
130619706|NCT02168803|470226385|FG000|Overall Study|Physician Decision|0|||
130619707|NCT02168803|470226386|FG001|Overall Study|Physician Decision|1|||
130619708|NCT02168803|470226387|FG002|Overall Study|Physician Decision|0|||
130619709|NCT02168803|470226385|FG000|Overall Study|Adverse Event|0|||
130619710|NCT02168803|470226386|FG001|Overall Study|Adverse Event|1|||
130619711|NCT02168803|470226387|FG002|Overall Study|Adverse Event|1|||
130619712|NCT02168803|470226385|FG000|Overall Study|Death|0|||
130619713|NCT02168803|470226386|FG001|Overall Study|Death|0|||
130619714|NCT02168803|470226387|FG002|Overall Study|Death|1|||
130619715|NCT02168803|470226385|FG000|Overall Study|Sponsor Decision|0|||
130619716|NCT02168803|470226386|FG001|Overall Study|Sponsor Decision|0|||
130619717|NCT02168803|470226387|FG002|Overall Study|Sponsor Decision|1|||
130619718|NCT01114373|470226388|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
130619719|NCT01114373|470226389|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
130619720|NCT01114373|470226388|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
130619721|NCT01114373|470226389|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
130619722|NCT01114373|470226388|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
130619723|NCT01114373|470226389|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
130619724|NCT01114373|470226388|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
130619725|NCT01114373|470226389|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
130619726|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130619727|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130619728|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
130619729|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
130619730|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130619731|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130619732|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
130619733|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
130619734|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
130619735|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130619736|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130619737|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130619738|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
130619739|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
130619740|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
130619741|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130619742|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130619743|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130619744|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
130619745|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
130619746|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130619747|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130619748|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130619749|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130619750|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
130619751|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
130619752|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130619753|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130619754|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130619755|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130619756|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
130619757|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130619758|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130619759|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130619760|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130619761|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130619762|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
130619763|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
130619764|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
130619765|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
130619766|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
130619767|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
130619768|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
130619769|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
130619770|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130619771|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130619772|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130619773|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130619774|NCT03444870|470226396|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
130619775|NCT03444870|470226397|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130619776|NCT03444870|470226398|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130619777|NCT03444870|470226399|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130619778|NCT03444870|470226400|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130619779|NCT03444870|470226401|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130619780|NCT03444870|470226396|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130619781|NCT03444870|470226397|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130619782|NCT03444870|470226398|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130619783|NCT03444870|470226399|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130619784|NCT03444870|470226400|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
130619785|NCT03444870|470226401|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130619786|NCT03444870|470226396|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130619787|NCT03444870|470226397|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130619788|NCT03444870|470226398|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
130619789|NCT03444870|470226399|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
130619790|NCT03444870|470226400|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
130619791|NCT03444870|470226401|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
130619792|NCT03444870|470226396|FG000|Open-Label Extension (OLE) Period|Death|0|||
130619793|NCT03444870|470226397|FG001|Open-Label Extension (OLE) Period|Death|0|||
130619794|NCT03444870|470226398|FG002|Open-Label Extension (OLE) Period|Death|0|||
130619795|NCT03444870|470226399|FG003|Open-Label Extension (OLE) Period|Death|0|||
130619796|NCT03444870|470226400|FG004|Open-Label Extension (OLE) Period|Death|1|||
130619797|NCT03444870|470226401|FG005|Open-Label Extension (OLE) Period|Death|0|||
130619798|NCT02310906|470226404|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130619799|NCT02310906|470226405|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130619800|NCT02310906|470226406|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130619801|NCT02310906|470226407|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
130619802|NCT02310906|470226404|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
130619803|NCT02310906|470226405|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
130619804|NCT02310906|470226406|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
130619805|NCT02310906|470226407|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
130619806|NCT02310906|470226404|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130619807|NCT02310906|470226405|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130619808|NCT02310906|470226406|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130619809|NCT02310906|470226407|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
130619810|NCT02310906|470226404|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130619811|NCT02310906|470226405|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130619812|NCT02310906|470226406|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130619813|NCT02310906|470226407|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
130619814|NCT02680587|470226408|FG000|Overall Study|Withdrawal by Subject|1|||
130619815|NCT02680587|470226409|FG001|Overall Study|Withdrawal by Subject|0|||
130619816|NCT00098020|470226413|FG000|Overall Study|Adverse Event|2|||
130619817|NCT00098020|470226413|FG000|Overall Study|Lost to Follow-up|1|||
130619818|NCT00098020|470226413|FG000|Overall Study|elevated liver enzymes|1|||
130619819|NCT00098020|470226413|FG000|Overall Study|Low urine PCR|1|||
130619820|NCT00098020|470226413|FG000|Overall Study|Low epidermal growth factor receptor|1|||
130619821|NCT01840228|470226415|FG000|Overall Study|Lost to Follow-up|1|||
130619822|NCT01840228|470226416|FG001|Overall Study|Lost to Follow-up|1|||
130619823|NCT01295580|470226419|FG000|Overall Study|Protocol Violation|4|||
130619824|NCT01295580|470226420|FG001|Overall Study|Protocol Violation|2|||
130619825|NCT01295580|470226419|FG000|Overall Study|Withdrawal by Subject|1|||
130619826|NCT01295580|470226420|FG001|Overall Study|Withdrawal by Subject|4|||
130619827|NCT01295580|470226419|FG000|Overall Study|Adverse Event|2|||
130619828|NCT01295580|470226420|FG001|Overall Study|Adverse Event|1|||
130619829|NCT01295580|470226419|FG000|Overall Study|Lost to Follow-up|1|||
130619830|NCT01295580|470226420|FG001|Overall Study|Lost to Follow-up|0|||
130619831|NCT01295580|470226419|FG000|Overall Study|Lack of Efficacy|1|||
130619832|NCT01295580|470226420|FG001|Overall Study|Lack of Efficacy|0|||
130619833|NCT01295580|470226419|FG000|Overall Study|Other: inconvenience|1|||
130619834|NCT01295580|470226420|FG001|Overall Study|Other: inconvenience|0|||
130619835|NCT01295580|470226419|FG000|Overall Study|Other: family objection|0|||
130619836|NCT01295580|470226420|FG001|Overall Study|Other: family objection|1|||
130619837|NCT02022033|470226426|FG000|Overall Study|Physician Decision|1|||
130619838|NCT01879319|470226429|FG000|Overall Study|Withdrawal by Subject|1|||
130619839|NCT01879319|470226430|FG001|Overall Study|Withdrawal by Subject|0|||
130619840|NCT01879319|470226429|FG000|Overall Study|Lost to Follow-up|1|||
130619841|NCT01879319|470226430|FG001|Overall Study|Lost to Follow-up|5|||
130619842|NCT01360762|470226431|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
130619843|NCT01360762|470226431|FG000|Main Study Period (12-month Treatment)|Death|5|||
130619844|NCT01360762|470226431|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
130619845|NCT01360762|470226431|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
130619846|NCT01360762|470226431|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
130619847|NCT01360762|470226431|FG000|Whole Study Period|Lost to Follow-up|10|||
130619848|NCT01360762|470226431|FG000|Whole Study Period|Death|7|||
130619849|NCT01360762|470226431|FG000|Whole Study Period|Patient relapsed|18|||
130619850|NCT01360762|470226431|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
130619851|NCT01103778|470226432|FG000|Overall Study|Lost to Follow-up|1|||
130619852|NCT01103778|470226432|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
130619853|NCT01103778|470226432|FG000|Overall Study|Screen failure|1|||
130619854|NCT04724733|470226433|FG000|Overall Study|Lost to Follow-up|1|||
130619855|NCT04724733|470226434|FG001|Overall Study|Lost to Follow-up|1|||
130619856|NCT04724733|470226435|FG002|Overall Study|Lost to Follow-up|1|||
130619857|NCT03986190|470226436|FG000|Overall Study|Withdrawal by Subject|12|||
130619858|NCT03986190|470226437|FG001|Overall Study|Withdrawal by Subject|0|||
130619859|NCT04511819|470226438|FG000|Overall Study|Non-compliance with study drug|5|||
130619860|NCT04511819|470226439|FG001|Overall Study|Non-compliance with study drug|1|||
130619861|NCT04511819|470226438|FG000|Overall Study|Withdrawal by Subject|0|||
130619862|NCT04511819|470226439|FG001|Overall Study|Withdrawal by Subject|3|||
130619863|NCT04511819|470226438|FG000|Overall Study|Adverse Event|0|||
130619864|NCT04511819|470226439|FG001|Overall Study|Adverse Event|1|||
130619865|NCT04511819|470226438|FG000|Overall Study|Protocol deviation|1|||
130619866|NCT04511819|470226439|FG001|Overall Study|Protocol deviation|0|||
130619867|NCT00084929|470226440|FG000|Overall Study|ineligible - medical contraindication|1|||
130619868|NCT00084929|470226440|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
130619869|NCT00084929|470226440|FG000|Overall Study|Ineligible - Medical history|6|||
130619870|NCT00084929|470226440|FG000|Overall Study|Withdrawal by Subject|10|||
130619871|NCT00084929|470226440|FG000|Overall Study|Missing/incomplete CTC exam|9|||
130619872|NCT00084929|470226440|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
130619873|NCT00844649|470226441|FG000|Overall Study|Progressive Disease|196|||
130619874|NCT00844649|470226442|FG001|Overall Study|Progressive Disease|245|||
130619875|NCT00844649|470226441|FG000|Overall Study|Adverse Event|128|||
130619876|NCT00844649|470226442|FG001|Overall Study|Adverse Event|73|||
130619877|NCT00844649|470226441|FG000|Overall Study|Physician Decision|25|||
130619878|NCT00844649|470226442|FG001|Overall Study|Physician Decision|18|||
130619879|NCT00844649|470226441|FG000|Overall Study|Protocol Violation|10|||
130619880|NCT00844649|470226442|FG001|Overall Study|Protocol Violation|6|||
130619881|NCT00844649|470226441|FG000|Overall Study|Withdrawal by Subject|28|||
130619882|NCT00844649|470226442|FG001|Overall Study|Withdrawal by Subject|39|||
130619883|NCT00844649|470226441|FG000|Overall Study|Other|7|||
130619884|NCT00844649|470226442|FG001|Overall Study|Other|10|||
130619885|NCT00844649|470226441|FG000|Overall Study|Withdrew prior to starting treatment|11|||
130619886|NCT00844649|470226442|FG001|Overall Study|Withdrew prior to starting treatment|27|||
130619887|NCT00664209|470226443|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
130619888|NCT00664209|470226443|FG000|Study Treatment Period|Physician Decision|4|||
130619889|NCT00664209|470226443|FG000|Study Treatment Period|Withdrawal by Subject|2|||
130619890|NCT00065442|470226454|FG000|Overall Study|Lost to Follow-up|1|||
130619891|NCT00065442|470226455|FG001|Overall Study|Lost to Follow-up|1|||
130619892|NCT00065442|470226454|FG000|Overall Study|Death|121|||
130619893|NCT00065442|470226455|FG001|Overall Study|Death|210|||
130619894|NCT00065442|470226454|FG000|Overall Study|Withdrawal by Subject|3|||
130619895|NCT00065442|470226455|FG001|Overall Study|Withdrawal by Subject|9|||
130619896|NCT01594333|470226456|FG000|Overall Study|Death|96|||
130619897|NCT01594333|470226457|FG001|Overall Study|Death|83|||
130619898|NCT01594333|470226456|FG000|Overall Study|Lost to Follow-up|5|||
130619899|NCT01594333|470226457|FG001|Overall Study|Lost to Follow-up|5|||
130619900|NCT01594333|470226456|FG000|Overall Study|Withdrawal by Subject|60|||
130619901|NCT01594333|470226457|FG001|Overall Study|Withdrawal by Subject|63|||
130619902|NCT00589979|470226458|FG000|Run-In Period|Adverse Event|5|||
130619903|NCT00589979|470226459|FG001|Run-In Period|Adverse Event|0|||
130619904|NCT00589979|470226460|FG002|Run-In Period|Adverse Event|0|||
130619905|NCT00589979|470226458|FG000|Run-In Period|Protocol Violation|3|||
130619906|NCT00589979|470226459|FG001|Run-In Period|Protocol Violation|0|||
130619907|NCT00589979|470226460|FG002|Run-In Period|Protocol Violation|0|||
130619908|NCT00589979|470226458|FG000|Run-In Period|Did not qualify for randomization|54|||
130619909|NCT00589979|470226459|FG001|Run-In Period|Did not qualify for randomization|0|||
130619910|NCT00589979|470226460|FG002|Run-In Period|Did not qualify for randomization|0|||
130619911|NCT00589979|470226458|FG000|Run-In Period|Withdrawal by Subject|10|||
130619912|NCT00589979|470226459|FG001|Run-In Period|Withdrawal by Subject|0|||
130619913|NCT00589979|470226460|FG002|Run-In Period|Withdrawal by Subject|0|||
130619914|NCT00589979|470226458|FG000|Run-In Period|Informed Consent Withdrawn|4|||
130619915|NCT00589979|470226459|FG001|Run-In Period|Informed Consent Withdrawn|0|||
130619916|NCT00589979|470226460|FG002|Run-In Period|Informed Consent Withdrawn|0|||
130619917|NCT00589979|470226458|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
130619918|NCT00589979|470226459|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
130619919|NCT00589979|470226460|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
130619920|NCT00589979|470226458|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
130619921|NCT00589979|470226459|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
130619922|NCT00589979|470226460|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
130619923|NCT00589979|470226458|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130619924|NCT00589979|470226459|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130619925|NCT00589979|470226460|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
130619926|NCT00589979|470226458|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
130619927|NCT00589979|470226459|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
130619928|NCT00589979|470226460|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
130619929|NCT00589979|470226458|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130619930|NCT00589979|470226459|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130619931|NCT00589979|470226460|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
130619932|NCT00589979|470226458|FG000|Double-Blind Treatment Period 2|Other|0|||
130619933|NCT00589979|470226459|FG001|Double-Blind Treatment Period 2|Other|0|||
130619934|NCT00589979|470226460|FG002|Double-Blind Treatment Period 2|Other|1|||
130619935|NCT00589979|470226458|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
130619936|NCT00589979|470226459|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
130619937|NCT00589979|470226460|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
130619938|NCT00589979|470226458|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
130619939|NCT00589979|470226459|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
130619940|NCT00589979|470226460|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
130619941|NCT00712322|470226461|FG000|Overall Study|Protocol deviation|0|||
130619942|NCT00712322|470226462|FG001|Overall Study|Protocol deviation|1|||
130619943|NCT00712322|470226463|FG002|Overall Study|Protocol deviation|0|||
130619944|NCT02670330|470226465|FG000|Overall Study|Protocol Deviation|1|||
130619945|NCT02670330|470226466|FG001|Overall Study|Protocol Deviation|0|||
130619946|NCT02670330|470226465|FG000|Overall Study|Study Terminated By Sponsor|36|||
130619947|NCT02670330|470226466|FG001|Overall Study|Study Terminated By Sponsor|43|||
130619948|NCT02670330|470226465|FG000|Overall Study|Adverse Event|1|||
130619949|NCT02670330|470226466|FG001|Overall Study|Adverse Event|3|||
130619950|NCT02670330|470226465|FG000|Overall Study|Withdrawal by Subject|34|||
130619951|NCT02670330|470226466|FG001|Overall Study|Withdrawal by Subject|29|||
130619952|NCT02670330|470226465|FG000|Overall Study|Lost to Follow-up|3|||
130619953|NCT02670330|470226466|FG001|Overall Study|Lost to Follow-up|2|||
130619954|NCT02180217|470226469|FG000|Overall Study|Adverse Event|3|||
130619955|NCT02180217|470226470|FG001|Overall Study|Adverse Event|2|||
130619956|NCT02180217|470226471|FG002|Overall Study|Adverse Event|22|||
130619957|NCT02180217|470226469|FG000|Overall Study|Death|1|||
130619958|NCT02180217|470226470|FG001|Overall Study|Death|1|||
130619959|NCT02180217|470226471|FG002|Overall Study|Death|0|||
130619960|NCT02180217|470226469|FG000|Overall Study|Withdrawal by Subject|1|||
130619961|NCT02180217|470226470|FG001|Overall Study|Withdrawal by Subject|1|||
130619962|NCT02180217|470226471|FG002|Overall Study|Withdrawal by Subject|4|||
130619963|NCT02180217|470226469|FG000|Overall Study|Subject/Guardian decision|5|||
130619964|NCT02180217|470226470|FG001|Overall Study|Subject/Guardian decision|3|||
130619965|NCT02180217|470226471|FG002|Overall Study|Subject/Guardian decision|6|||
130619966|NCT02180217|470226469|FG000|Overall Study|Physician Decision|1|||
130619967|NCT02180217|470226470|FG001|Overall Study|Physician Decision|1|||
130619968|NCT02180217|470226471|FG002|Overall Study|Physician Decision|6|||
130619969|NCT02180217|470226469|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130619970|NCT02180217|470226470|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130619971|NCT02180217|470226471|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130619972|NCT00878215|470226472|FG000|Overall Study|Determined to be ineligible|0|||
130619973|NCT00878215|470226473|FG001|Overall Study|Determined to be ineligible|10|||
130619974|NCT00878215|470226474|FG002|Overall Study|Determined to be ineligible|0|||
130619975|NCT00878215|470226475|FG003|Overall Study|Determined to be ineligible|0|||
130619976|NCT00738374|470226476|FG000|Induction Treatment Phase|Adverse Event|14|||
130619977|NCT00738374|470226477|FG001|Induction Treatment Phase|Adverse Event|0|||
130619978|NCT00738374|470226478|FG002|Induction Treatment Phase|Adverse Event|0|||
130619979|NCT00738374|470226479|FG003|Induction Treatment Phase|Adverse Event|0|||
130619980|NCT00738374|470226476|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
130619981|NCT00738374|470226477|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
130619982|NCT00738374|470226478|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
130619983|NCT00738374|470226479|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
130619984|NCT00738374|470226476|FG000|Induction Treatment Phase|Physician Decision|2|||
130619985|NCT00738374|470226477|FG001|Induction Treatment Phase|Physician Decision|0|||
130619986|NCT00738374|470226478|FG002|Induction Treatment Phase|Physician Decision|0|||
130619987|NCT00738374|470226479|FG003|Induction Treatment Phase|Physician Decision|0|||
130619988|NCT00738374|470226476|FG000|Induction Treatment Phase|Protocol Violation|2|||
130619989|NCT00738374|470226477|FG001|Induction Treatment Phase|Protocol Violation|0|||
130619990|NCT00738374|470226478|FG002|Induction Treatment Phase|Protocol Violation|0|||
130619991|NCT00738374|470226479|FG003|Induction Treatment Phase|Protocol Violation|0|||
130619992|NCT00738374|470226476|FG000|Induction Treatment Phase|Non-compliance|1|||
130619993|NCT00738374|470226477|FG001|Induction Treatment Phase|Non-compliance|0|||
130619994|NCT00738374|470226478|FG002|Induction Treatment Phase|Non-compliance|0|||
130619995|NCT00738374|470226479|FG003|Induction Treatment Phase|Non-compliance|0|||
130619996|NCT00738374|470226476|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
130619997|NCT00738374|470226477|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130619998|NCT00738374|470226478|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
130619999|NCT00738374|470226479|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
130620000|NCT00738374|470226476|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
130620001|NCT00738374|470226477|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
130620002|NCT00738374|470226478|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
130620003|NCT00738374|470226479|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
130620004|NCT00738374|470226476|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
130620005|NCT00738374|470226477|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
130620006|NCT00738374|470226478|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
130620007|NCT00738374|470226479|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
130620008|NCT00738374|470226476|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130620009|NCT00738374|470226477|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130620010|NCT00738374|470226478|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130620011|NCT00738374|470226479|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
130620012|NCT00738374|470226476|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130620013|NCT00738374|470226477|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
130620014|NCT00738374|470226478|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130620015|NCT00738374|470226479|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130620016|NCT00738374|470226476|FG000|Maintenance Treatment/Observation Phase|Other|0|||
130620017|NCT00738374|470226477|FG001|Maintenance Treatment/Observation Phase|Other|1|||
130620018|NCT00738374|470226478|FG002|Maintenance Treatment/Observation Phase|Other|0|||
130620019|NCT00738374|470226479|FG003|Maintenance Treatment/Observation Phase|Other|0|||
130620020|NCT03334396|470226480|FG000|Overall Study|Adverse Event|1|||
130620021|NCT03334396|470226481|FG001|Overall Study|Adverse Event|0|||
130620022|NCT03334396|470226482|FG002|Overall Study|Adverse Event|1|||
130620023|NCT03334396|470226483|FG003|Overall Study|Adverse Event|0|||
130620024|NCT03334396|470226484|FG004|Overall Study|Adverse Event|0|||
130620025|NCT03334396|470226485|FG005|Overall Study|Adverse Event|0|||
130620026|NCT03334396|470226486|FG006|Overall Study|Adverse Event|0|||
130620027|NCT03334396|470226487|FG007|Overall Study|Adverse Event|0|||
130620028|NCT03334396|470226480|FG000|Overall Study|Lack of Efficacy|10|||
130620029|NCT03334396|470226481|FG001|Overall Study|Lack of Efficacy|4|||
130620030|NCT03334396|470226482|FG002|Overall Study|Lack of Efficacy|1|||
130620031|NCT03334396|470226483|FG003|Overall Study|Lack of Efficacy|3|||
130620032|NCT03334396|470226484|FG004|Overall Study|Lack of Efficacy|1|||
130620033|NCT03334396|470226485|FG005|Overall Study|Lack of Efficacy|0|||
130620034|NCT03334396|470226486|FG006|Overall Study|Lack of Efficacy|0|||
130620035|NCT03334396|470226487|FG007|Overall Study|Lack of Efficacy|1|||
130620036|NCT03334396|470226480|FG000|Overall Study|Lost to Follow-up|0|||
130620037|NCT03334396|470226481|FG001|Overall Study|Lost to Follow-up|0|||
130620038|NCT03334396|470226482|FG002|Overall Study|Lost to Follow-up|1|||
130620039|NCT03334396|470226483|FG003|Overall Study|Lost to Follow-up|0|||
130620040|NCT03334396|470226484|FG004|Overall Study|Lost to Follow-up|0|||
130620041|NCT03334396|470226485|FG005|Overall Study|Lost to Follow-up|0|||
130620042|NCT03334396|470226486|FG006|Overall Study|Lost to Follow-up|1|||
130620043|NCT03334396|470226487|FG007|Overall Study|Lost to Follow-up|0|||
130620044|NCT03334396|470226480|FG000|Overall Study|Physician Decision|1|||
130620045|NCT03334396|470226481|FG001|Overall Study|Physician Decision|0|||
130620046|NCT03334396|470226482|FG002|Overall Study|Physician Decision|0|||
130620047|NCT03334396|470226483|FG003|Overall Study|Physician Decision|0|||
130620048|NCT03334396|470226484|FG004|Overall Study|Physician Decision|0|||
130620049|NCT03334396|470226485|FG005|Overall Study|Physician Decision|0|||
130620050|NCT03334396|470226486|FG006|Overall Study|Physician Decision|0|||
130620051|NCT03334396|470226487|FG007|Overall Study|Physician Decision|0|||
130620052|NCT03334396|470226480|FG000|Overall Study|Withdrawal by Subject|10|||
130620053|NCT03334396|470226481|FG001|Overall Study|Withdrawal by Subject|5|||
130620054|NCT03334396|470226482|FG002|Overall Study|Withdrawal by Subject|7|||
130620055|NCT03334396|470226483|FG003|Overall Study|Withdrawal by Subject|2|||
130620056|NCT03334396|470226484|FG004|Overall Study|Withdrawal by Subject|2|||
130620057|NCT03334396|470226485|FG005|Overall Study|Withdrawal by Subject|1|||
130620058|NCT03334396|470226486|FG006|Overall Study|Withdrawal by Subject|2|||
130620059|NCT03334396|470226487|FG007|Overall Study|Withdrawal by Subject|0|||
130620060|NCT03334396|470226480|FG000|Overall Study|Pregnancy|0|||
130620061|NCT03334396|470226481|FG001|Overall Study|Pregnancy|1|||
130620062|NCT03334396|470226482|FG002|Overall Study|Pregnancy|0|||
130620063|NCT03334396|470226483|FG003|Overall Study|Pregnancy|0|||
130620064|NCT03334396|470226484|FG004|Overall Study|Pregnancy|0|||
130620065|NCT03334396|470226485|FG005|Overall Study|Pregnancy|0|||
130620066|NCT03334396|470226486|FG006|Overall Study|Pregnancy|0|||
130620067|NCT03334396|470226487|FG007|Overall Study|Pregnancy|0|||
130620068|NCT03334396|470226480|FG000|Overall Study|Ineligible|0|||
130620069|NCT03334396|470226481|FG001|Overall Study|Ineligible|1|||
130620070|NCT03334396|470226482|FG002|Overall Study|Ineligible|0|||
130620071|NCT03334396|470226483|FG003|Overall Study|Ineligible|0|||
130620072|NCT03334396|470226484|FG004|Overall Study|Ineligible|0|||
130620073|NCT03334396|470226485|FG005|Overall Study|Ineligible|0|||
130620074|NCT03334396|470226486|FG006|Overall Study|Ineligible|0|||
130620075|NCT03334396|470226487|FG007|Overall Study|Ineligible|0|||
130620076|NCT03334396|470226480|FG000|Overall Study|Started New Job|1|||
130620077|NCT03334396|470226481|FG001|Overall Study|Started New Job|0|||
130620078|NCT03334396|470226482|FG002|Overall Study|Started New Job|0|||
130620079|NCT03334396|470226483|FG003|Overall Study|Started New Job|0|||
130620080|NCT03334396|470226484|FG004|Overall Study|Started New Job|0|||
130620081|NCT03334396|470226485|FG005|Overall Study|Started New Job|0|||
130620082|NCT03334396|470226486|FG006|Overall Study|Started New Job|0|||
130620083|NCT03334396|470226487|FG007|Overall Study|Started New Job|0|||
130620084|NCT01255306|470228167|FG000|Overall Study|Physician Decision|1|||
130620085|NCT01255306|470228168|FG001|Overall Study|Physician Decision|1|||
130620086|NCT01283997|470228169|FG000|Overall Study|Physician Decision|8|||
130620087|NCT01283997|470228170|FG001|Overall Study|Physician Decision|10|||
130620088|NCT01283997|470228169|FG000|Overall Study|Withdrawal by Subject|3|||
130620089|NCT01283997|470228170|FG001|Overall Study|Withdrawal by Subject|2|||
130620090|NCT01283997|470228169|FG000|Overall Study|Physically unable to continue|0|||
130620091|NCT01283997|470228170|FG001|Overall Study|Physically unable to continue|1|||
130620092|NCT01283997|470228169|FG000|Overall Study|Progressive disease|1|||
130620093|NCT01283997|470228170|FG001|Overall Study|Progressive disease|0|||
130620094|NCT01283997|470228169|FG000|Overall Study|Other|4|||
130620095|NCT01283997|470228170|FG001|Overall Study|Other|4|||
130620096|NCT02017899|470228171|FG000|Overall Study|Withdrawal by Subject|0|||
130620097|NCT02017899|470228172|FG001|Overall Study|Withdrawal by Subject|0|||
130620098|NCT02017899|470228173|FG002|Overall Study|Withdrawal by Subject|0|||
130620099|NCT02017899|470228174|FG003|Overall Study|Withdrawal by Subject|1|||
130620100|NCT02017899|470228175|FG004|Overall Study|Withdrawal by Subject|1|||
130620101|NCT02017899|470228176|FG005|Overall Study|Withdrawal by Subject|0|||
130620102|NCT01677624|470228180|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
130620103|NCT00804843|470228181|FG000|Overall Study|Protocol Violation|1|||
130620104|NCT00804843|470228182|FG001|Overall Study|Protocol Violation|0|||
130620105|NCT00804843|470228181|FG000|Overall Study|Adverse Event|8|||
130620106|NCT00804843|470228182|FG001|Overall Study|Adverse Event|5|||
130620107|NCT00804843|470228181|FG000|Overall Study|Withdrawal by Subject|1|||
130620108|NCT00804843|470228182|FG001|Overall Study|Withdrawal by Subject|2|||
130620109|NCT00884221|470228187|FG000|Overall Study|Withdrawal by Subject|0|||
130620110|NCT00884221|470228188|FG001|Overall Study|Withdrawal by Subject|3|||
130620111|NCT00884221|470228187|FG000|Overall Study|Adverse Event|6|||
130620112|NCT00884221|470228188|FG001|Overall Study|Adverse Event|3|||
130620113|NCT00884221|470228187|FG000|Overall Study|Protocol Violation|16|||
130620114|NCT00884221|470228188|FG001|Overall Study|Protocol Violation|13|||
130620115|NCT00884221|470228187|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
130620116|NCT00884221|470228188|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
130620117|NCT01975246|470228191|FG000|Overall Study|Adverse Event|2|||
130620118|NCT01975246|470228192|FG001|Overall Study|Adverse Event|1|||
130620119|NCT01975246|470228191|FG000|Overall Study|Lack of Efficacy|1|||
130620120|NCT01975246|470228192|FG001|Overall Study|Lack of Efficacy|0|||
130620121|NCT01975246|470228191|FG000|Overall Study|Protocol Violation|1|||
130620122|NCT01975246|470228192|FG001|Overall Study|Protocol Violation|0|||
130620123|NCT01975246|470228191|FG000|Overall Study|Other than stated|0|||
130620124|NCT01975246|470228192|FG001|Overall Study|Other than stated|1|||
130620125|NCT01263093|470228193|FG000|Washout|Physician Decision|1|||
130620126|NCT01263093|470228194|FG001|Washout|Physician Decision|0|||
130620127|NCT01263093|470228193|FG000|Period 2|Adverse Event|1|||
130620128|NCT01263093|470228194|FG001|Period 2|Adverse Event|0|||
130620129|NCT00424346|470228195|FG000|Core Study|Adverse Event|5|||
130620130|NCT00424346|470228196|FG001|Core Study|Adverse Event|3|||
130620131|NCT00424346|470228197|FG002|Core Study|Adverse Event|1|||
130620132|NCT00424346|470228198|FG003|Core Study|Adverse Event|1|||
130620133|NCT00424346|470228195|FG000|Core Study|Abnormal Laboratory Values|0|||
130620134|NCT00424346|470228196|FG001|Core Study|Abnormal Laboratory Values|1|||
130620135|NCT00424346|470228197|FG002|Core Study|Abnormal Laboratory Values|0|||
130620136|NCT00424346|470228198|FG003|Core Study|Abnormal Laboratory Values|0|||
130620137|NCT00424346|470228195|FG000|Core Study|Lack of Efficacy|1|||
130620138|NCT00424346|470228196|FG001|Core Study|Lack of Efficacy|3|||
130620139|NCT00424346|470228197|FG002|Core Study|Lack of Efficacy|0|||
130620140|NCT00424346|470228198|FG003|Core Study|Lack of Efficacy|4|||
130620141|NCT00424346|470228195|FG000|Core Study|Withdrawal by Subject|1|||
130620142|NCT00424346|470228196|FG001|Core Study|Withdrawal by Subject|0|||
130620143|NCT00424346|470228197|FG002|Core Study|Withdrawal by Subject|0|||
130620144|NCT00424346|470228198|FG003|Core Study|Withdrawal by Subject|2|||
130620145|NCT00424346|470228195|FG000|Core Study|Lost to Follow-up|1|||
130620146|NCT00424346|470228196|FG001|Core Study|Lost to Follow-up|1|||
130620147|NCT00424346|470228197|FG002|Core Study|Lost to Follow-up|0|||
130620148|NCT00424346|470228198|FG003|Core Study|Lost to Follow-up|0|||
130620149|NCT00424346|470228195|FG000|Core Study|Administrative Problems|1|||
130620150|NCT00424346|470228196|FG001|Core Study|Administrative Problems|0|||
130620151|NCT00424346|470228197|FG002|Core Study|Administrative Problems|1|||
130620152|NCT00424346|470228198|FG003|Core Study|Administrative Problems|0|||
130620153|NCT00424346|470228195|FG000|Core Study|Protocol Violation|0|||
130620154|NCT00424346|470228196|FG001|Core Study|Protocol Violation|0|||
130620155|NCT00424346|470228197|FG002|Core Study|Protocol Violation|2|||
130620156|NCT00424346|470228198|FG003|Core Study|Protocol Violation|0|||
130620157|NCT00424346|470228195|FG000|Extension Phase|Adverse Event|0|||
130620158|NCT00424346|470228196|FG001|Extension Phase|Adverse Event|9|||
130620159|NCT00424346|470228197|FG002|Extension Phase|Adverse Event|5|||
130620160|NCT00424346|470228198|FG003|Extension Phase|Adverse Event|4|||
130620161|NCT00424346|470228195|FG000|Extension Phase|Lack of Efficacy|0|||
130620162|NCT00424346|470228196|FG001|Extension Phase|Lack of Efficacy|16|||
130620163|NCT00424346|470228197|FG002|Extension Phase|Lack of Efficacy|14|||
130620164|NCT00424346|470228198|FG003|Extension Phase|Lack of Efficacy|11|||
130620165|NCT00424346|470228195|FG000|Extension Phase|Withdrawal by Subject|0|||
130620166|NCT00424346|470228196|FG001|Extension Phase|Withdrawal by Subject|5|||
130620167|NCT00424346|470228197|FG002|Extension Phase|Withdrawal by Subject|3|||
130620168|NCT00424346|470228198|FG003|Extension Phase|Withdrawal by Subject|4|||
130620169|NCT00424346|470228195|FG000|Extension Phase|Lost to Follow-up|0|||
130620170|NCT00424346|470228196|FG001|Extension Phase|Lost to Follow-up|2|||
130620171|NCT00424346|470228197|FG002|Extension Phase|Lost to Follow-up|0|||
130620172|NCT00424346|470228198|FG003|Extension Phase|Lost to Follow-up|0|||
130620173|NCT00424346|470228195|FG000|Extension Phase|Administrative Problems|0|||
130620174|NCT00424346|470228196|FG001|Extension Phase|Administrative Problems|69|||
130620175|NCT00424346|470228197|FG002|Extension Phase|Administrative Problems|32|||
130620176|NCT00424346|470228198|FG003|Extension Phase|Administrative Problems|35|||
130620177|NCT00424346|470228195|FG000|Extension Phase|Death|0|||
130620178|NCT00424346|470228196|FG001|Extension Phase|Death|0|||
130620179|NCT00424346|470228197|FG002|Extension Phase|Death|0|||
130620180|NCT00424346|470228198|FG003|Extension Phase|Death|1|||
130620181|NCT00424346|470228195|FG000|Extension Phase|Protocol Violation|0|||
130620182|NCT00424346|470228196|FG001|Extension Phase|Protocol Violation|1|||
130620183|NCT00424346|470228197|FG002|Extension Phase|Protocol Violation|1|||
130620184|NCT00424346|470228198|FG003|Extension Phase|Protocol Violation|0|||
130620185|NCT00571519|470228199|FG000|Overall Study|Subject withdrew consent|0|||
130620186|NCT00571519|470228200|FG001|Overall Study|Subject withdrew consent|1|||
130620187|NCT00571519|470228201|FG002|Overall Study|Subject withdrew consent|0|||
130620188|NCT00571519|470228202|FG003|Overall Study|Subject withdrew consent|2|||
130620189|NCT00571519|470228203|FG004|Overall Study|Subject withdrew consent|1|||
130620190|NCT00571519|470228204|FG005|Overall Study|Subject withdrew consent|1|||
130620191|NCT00571519|470228205|FG006|Overall Study|Subject withdrew consent|2|||
130620192|NCT00571519|470228199|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130620193|NCT00571519|470228200|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130620194|NCT00571519|470228201|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130620195|NCT00571519|470228202|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130620196|NCT00571519|470228203|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130620197|NCT00571519|470228204|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130620198|NCT00571519|470228205|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130620199|NCT00571519|470228199|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620200|NCT00571519|470228200|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
130620201|NCT00571519|470228201|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620202|NCT00571519|470228202|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620203|NCT00571519|470228203|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620204|NCT00571519|470228204|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620205|NCT00571519|470228205|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
130620206|NCT00571519|470228199|FG000|Overall Study|Termination of study by Sponsor|2|||
130620207|NCT00571519|470228200|FG001|Overall Study|Termination of study by Sponsor|7|||
130620208|NCT00571519|470228201|FG002|Overall Study|Termination of study by Sponsor|10|||
130620209|NCT00571519|470228202|FG003|Overall Study|Termination of study by Sponsor|24|||
130620210|NCT00571519|470228203|FG004|Overall Study|Termination of study by Sponsor|8|||
130620211|NCT00571519|470228204|FG005|Overall Study|Termination of study by Sponsor|9|||
130620212|NCT00571519|470228205|FG006|Overall Study|Termination of study by Sponsor|22|||
130620213|NCT00571519|470228199|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620214|NCT00571519|470228200|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620215|NCT00571519|470228201|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
130620216|NCT00571519|470228202|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620217|NCT00571519|470228203|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620218|NCT00571519|470228204|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620219|NCT00571519|470228205|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130620220|NCT02499575|470228206|FG000|Overall Study|Protocol Violation|0|||
130620221|NCT02499575|470228207|FG001|Overall Study|Protocol Violation|1|||
130620222|NCT02658968|470228208|FG000|Received Rituximab|Adverse Event|0|||
130620223|NCT02658968|470228209|FG001|Received Rituximab|Adverse Event|0|||
130620224|NCT02658968|470228210|FG002|Received Rituximab|Adverse Event|0|||
130620225|NCT02658968|470228211|FG003|Received Rituximab|Adverse Event|0|||
130620226|NCT02658968|470228212|FG004|Received Rituximab|Adverse Event|1|||
130620227|NCT02658968|470228208|FG000|Received Rituximab|Progressive disease|0|||
130620228|NCT02658968|470228209|FG001|Received Rituximab|Progressive disease|0|||
130620229|NCT02658968|470228210|FG002|Received Rituximab|Progressive disease|0|||
130620230|NCT02658968|470228211|FG003|Received Rituximab|Progressive disease|0|||
130620231|NCT02658968|470228212|FG004|Received Rituximab|Progressive disease|1|||
130620232|NCT02658968|470228208|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
130620233|NCT02658968|470228209|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
130620234|NCT02658968|470228210|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
130620235|NCT02658968|470228211|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
130620236|NCT02658968|470228212|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
130620237|NCT02658968|470228208|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
130620238|NCT02658968|470228209|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
130620239|NCT02658968|470228210|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
130620240|NCT02658968|470228211|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
130620241|NCT02658968|470228212|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
130620242|NCT02658968|470228208|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130620243|NCT02658968|470228209|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
130620244|NCT02658968|470228210|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130620245|NCT02658968|470228211|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
130620246|NCT02658968|470228212|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130620247|NCT02658968|470228208|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130620248|NCT02658968|470228209|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
130620249|NCT02658968|470228210|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130620250|NCT02658968|470228211|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130620251|NCT02658968|470228212|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130620252|NCT02658968|470228208|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
130620253|NCT02658968|470228209|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
130620254|NCT02658968|470228210|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
130620255|NCT02658968|470228211|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
130620256|NCT02658968|470228212|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
130620257|NCT00574119|470228213|FG000|Overall Study|Adverse Event|1|||
130620258|NCT00574119|470228213|FG000|Overall Study|Protocol Violation|1|||
130620259|NCT00574119|470228213|FG000|Overall Study|Withdrawal by Subject|1|||
130620260|NCT00574119|470228213|FG000|Overall Study|Physician Decision|1|||
130620261|NCT02667457|470228221|FG000|Overall Study|Withdrawal by Subject|1|||
130620262|NCT02667457|470228222|FG001|Overall Study|Withdrawal by Subject|0|||
130620263|NCT02667457|470228221|FG000|Overall Study|Other Reason|0|||
130620264|NCT02667457|470228222|FG001|Overall Study|Other Reason|2|||
130620265|NCT02475850|470228223|FG000|Overall Study|Death|155|||
130620266|NCT02475850|470228224|FG001|Overall Study|Death|141|||
130620267|NCT02475850|470228223|FG000|Overall Study|Lost to Follow-up|217|||
130620268|NCT02475850|470228224|FG001|Overall Study|Lost to Follow-up|188|||
130620269|NCT02475850|470228223|FG000|Overall Study|Withdrawal by Subject|221|||
130620270|NCT02475850|470228224|FG001|Overall Study|Withdrawal by Subject|155|||
130620271|NCT03297216|470228229|FG000|Overall Study|Death|0|||
130620272|NCT03297216|470228230|FG001|Overall Study|Death|1|||
130620273|NCT03297216|470228229|FG000|Overall Study|Miscarriage|0|||
130620274|NCT03297216|470228230|FG001|Overall Study|Miscarriage|2|||
130620275|NCT03297216|470228229|FG000|Overall Study|Lost to Follow-up|3|||
130620276|NCT03297216|470228230|FG001|Overall Study|Lost to Follow-up|2|||
130620277|NCT02700919|470228231|FG000|Overall Study|Physician Decision|1|||
130620278|NCT02700919|470228232|FG001|Overall Study|Physician Decision|0|||
130620279|NCT02700919|470228233|FG002|Overall Study|Physician Decision|0|||
130620280|NCT02700919|470228231|FG000|Overall Study|Protocol Violation|1|||
130620281|NCT02700919|470228232|FG001|Overall Study|Protocol Violation|0|||
130620282|NCT02700919|470228233|FG002|Overall Study|Protocol Violation|0|||
130620283|NCT02700919|470228231|FG000|Overall Study|Adverse Event|1|||
130620284|NCT02700919|470228232|FG001|Overall Study|Adverse Event|3|||
130620285|NCT02700919|470228233|FG002|Overall Study|Adverse Event|1|||
130620286|NCT02700919|470228231|FG000|Overall Study|Withdrawal by Subject|5|||
130620287|NCT02700919|470228232|FG001|Overall Study|Withdrawal by Subject|8|||
130620288|NCT02700919|470228233|FG002|Overall Study|Withdrawal by Subject|2|||
130620289|NCT02700919|470228231|FG000|Overall Study|Lost to Follow-up|2|||
130620290|NCT02700919|470228232|FG001|Overall Study|Lost to Follow-up|0|||
130620291|NCT02700919|470228233|FG002|Overall Study|Lost to Follow-up|0|||
130620292|NCT02700919|470228231|FG000|Overall Study|Other|2|||
130620293|NCT02700919|470228232|FG001|Overall Study|Other|1|||
130620294|NCT02700919|470228233|FG002|Overall Study|Other|1|||
130620295|NCT03434418|470228234|FG000|Overall Study|Disease Progression|11|||
130620296|NCT03434418|470228234|FG000|Overall Study|Adverse Event|2|||
130620297|NCT03434418|470228234|FG000|Overall Study|Physician Decision|1|||
130620298|NCT03434418|470228234|FG000|Overall Study|Decline in Performance Status (PS)|1|||
130620299|NCT03039738|470228239|FG000|Overall Study|Incomplete data sets|54|||
130620300|NCT03039738|470228240|FG001|Overall Study|Incomplete data sets|0|||
130620301|NCT00912340|470228242|FG000|Overall Study|Adverse Event|2|||
130620302|NCT00912340|470228243|FG001|Overall Study|Adverse Event|4|||
130620303|NCT00912340|470228244|FG002|Overall Study|Adverse Event|0|||
130620304|NCT00912340|470228242|FG000|Overall Study|Protocol revised to remove arm|0|||
130620305|NCT00912340|470228243|FG001|Overall Study|Protocol revised to remove arm|0|||
130620306|NCT00912340|470228244|FG002|Overall Study|Protocol revised to remove arm|4|||
130620307|NCT01517412|470228247|FG000|Overall Study|Adverse Event|10|||
130620308|NCT01517412|470228248|FG001|Overall Study|Adverse Event|11|||
130620309|NCT01517412|470228247|FG000|Overall Study|Lack of Efficacy|10|||
130620310|NCT01517412|470228248|FG001|Overall Study|Lack of Efficacy|5|||
130620311|NCT01517412|470228247|FG000|Overall Study|Poor compliance to protocol|8|||
130620312|NCT01517412|470228248|FG001|Overall Study|Poor compliance to protocol|3|||
130620313|NCT01517412|470228247|FG000|Overall Study|Other than specified above|8|||
130620314|NCT01517412|470228248|FG001|Overall Study|Other than specified above|5|||
130620315|NCT01253187|470228249|FG000|Period 2|Withdrawal by Subject|0|||
130620316|NCT01253187|470228250|FG001|Period 2|Withdrawal by Subject|0|||
130620317|NCT01253187|470228251|FG002|Period 2|Withdrawal by Subject|0|||
130620318|NCT01253187|470228252|FG003|Period 2|Withdrawal by Subject|0|||
130620319|NCT01253187|470228253|FG004|Period 2|Withdrawal by Subject|1|||
130620320|NCT01253187|470228254|FG005|Period 2|Withdrawal by Subject|0|||
130620321|NCT01253187|470228249|FG000|Period 3|Pregnancy|1|||
130620322|NCT01253187|470228250|FG001|Period 3|Pregnancy|0|||
130620323|NCT01253187|470228251|FG002|Period 3|Pregnancy|0|||
130620324|NCT01253187|470228252|FG003|Period 3|Pregnancy|0|||
130620325|NCT01253187|470228253|FG004|Period 3|Pregnancy|0|||
130620326|NCT01253187|470228254|FG005|Period 3|Pregnancy|0|||
130620327|NCT01253187|470228249|FG000|Period 3|difficulty with blood sampling|0|||
130620328|NCT01253187|470228250|FG001|Period 3|difficulty with blood sampling|1|||
130620329|NCT01253187|470228251|FG002|Period 3|difficulty with blood sampling|0|||
130620330|NCT01253187|470228252|FG003|Period 3|difficulty with blood sampling|0|||
130620331|NCT01253187|470228253|FG004|Period 3|difficulty with blood sampling|0|||
130620332|NCT01253187|470228254|FG005|Period 3|difficulty with blood sampling|0|||
130620333|NCT01253187|470228249|FG000|Period 3|non-compliance|0|||
130620334|NCT01253187|470228250|FG001|Period 3|non-compliance|0|||
130620335|NCT01253187|470228251|FG002|Period 3|non-compliance|0|||
130620336|NCT01253187|470228252|FG003|Period 3|non-compliance|0|||
130620337|NCT01253187|470228253|FG004|Period 3|non-compliance|1|||
130620338|NCT01253187|470228254|FG005|Period 3|non-compliance|0|||
130620339|NCT01956240|470228260|FG000|Overall Study|Lost to Follow-up|6|||
130620340|NCT01956240|470228261|FG001|Overall Study|Lost to Follow-up|20|||
130620341|NCT01956240|470228260|FG000|Overall Study|Adverse Event|17|||
130620342|NCT01956240|470228261|FG001|Overall Study|Adverse Event|4|||
130620343|NCT00600028|470228264|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130620344|NCT00600028|470228265|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
130620345|NCT00600028|470228264|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
130620346|NCT00600028|470228265|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
130620347|NCT00600028|470228264|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
130620348|NCT00600028|470228265|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
130620349|NCT03172481|470228266|FG000|Double-blind|Withdrawal by Subject|1|||
130620350|NCT03172481|470228267|FG001|Double-blind|Withdrawal by Subject|0|||
130620351|NCT02716194|470228268|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
130620352|NCT02716194|470228269|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
130620353|NCT02716194|470228270|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
130620354|NCT01957709|470228274|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
130620355|NCT01610076|470228275|FG000|Overall Study|Technical issue with video|0|||
130620356|NCT01610076|470228276|FG001|Overall Study|Technical issue with video|1|||
130620357|NCT01610076|470228275|FG000|Overall Study|Lost to Follow-up|3|||
130620358|NCT01610076|470228276|FG001|Overall Study|Lost to Follow-up|4|||
130620359|NCT02899377|470228279|FG000|Overall Study|Adverse Event|1|||
130620360|NCT02899377|470228280|FG001|Overall Study|Adverse Event|0|||
130620361|NCT00469209|470228282|FG000|Overall Study|Adverse Event|1|||
130620362|NCT00469209|470228283|FG001|Overall Study|Adverse Event|0|||
130620363|NCT00469209|470228284|FG002|Overall Study|Adverse Event|1|||
130620364|NCT00865189|470228288|FG000|Overall Study|Other|1|||
130620365|NCT00865189|470228289|FG001|Overall Study|Other|2|||
130620366|NCT00865189|470228288|FG000|Overall Study|Death|4|||
130620367|NCT00865189|470228289|FG001|Overall Study|Death|11|||
130620368|NCT00865189|470228288|FG000|Overall Study|Lost to Follow-up|6|||
130620369|NCT00865189|470228289|FG001|Overall Study|Lost to Follow-up|6|||
130620370|NCT00865189|470228288|FG000|Overall Study|Withdrawal by Subject|1|||
130620371|NCT00865189|470228289|FG001|Overall Study|Withdrawal by Subject|0|||
130620372|NCT00843843|470228295|FG000|Overall Study|Physician Decision|1|||
130620373|NCT00843843|470228296|FG001|Overall Study|Physician Decision|1|||
130620374|NCT00843843|470228295|FG000|Overall Study|Protocol Violation|1|||
130620375|NCT00843843|470228296|FG001|Overall Study|Protocol Violation|1|||
130620376|NCT00418379|470228297|FG000|Year 1|Adverse Event|9|||
130620377|NCT00418379|470228298|FG001|Year 1|Adverse Event|15|||
130620378|NCT00418379|470228299|FG002|Year 1|Adverse Event|3|||
130620379|NCT00418379|470228297|FG000|Year 1|Withdrawal by Subject|7|||
130620380|NCT00418379|470228298|FG001|Year 1|Withdrawal by Subject|8|||
130620381|NCT00418379|470228299|FG002|Year 1|Withdrawal by Subject|5|||
130620382|NCT00418379|470228297|FG000|Year 1|Any other reason not above-mentioned|2|||
130620383|NCT00418379|470228298|FG001|Year 1|Any other reason not above-mentioned|5|||
130620384|NCT00418379|470228299|FG002|Year 1|Any other reason not above-mentioned|7|||
130620385|NCT00418379|470228297|FG000|Year 2|Adverse Event|5|||
130620386|NCT00418379|470228298|FG001|Year 2|Adverse Event|2|||
130620387|NCT00418379|470228299|FG002|Year 2|Adverse Event|1|||
130620388|NCT00418379|470228297|FG000|Year 2|Withdrawal by Subject|1|||
130620389|NCT00418379|470228298|FG001|Year 2|Withdrawal by Subject|1|||
130620390|NCT00418379|470228299|FG002|Year 2|Withdrawal by Subject|3|||
130620391|NCT00418379|470228297|FG000|Year 2|Any other reason not above-mentioned|2|||
130620392|NCT00418379|470228298|FG001|Year 2|Any other reason not above-mentioned|1|||
130620393|NCT00418379|470228299|FG002|Year 2|Any other reason not above-mentioned|6|||
130620394|NCT00418379|470228297|FG000|Year 3|Withdrawal by Subject|1|||
130620395|NCT00418379|470228298|FG001|Year 3|Withdrawal by Subject|1|||
130620396|NCT00418379|470228299|FG002|Year 3|Withdrawal by Subject|2|||
130620397|NCT00418379|470228297|FG000|Year 3|Any other reason not above-mentioned|2|||
130620398|NCT00418379|470228298|FG001|Year 3|Any other reason not above-mentioned|1|||
130620399|NCT00418379|470228299|FG002|Year 3|Any other reason not above-mentioned|1|||
130620400|NCT00418379|470228297|FG000|Year 4|Adverse Event|0|||
130620401|NCT00418379|470228298|FG001|Year 4|Adverse Event|1|||
130620402|NCT00418379|470228299|FG002|Year 4|Adverse Event|0|||
130620403|NCT00418379|470228297|FG000|Year 4|Withdrawal by Subject|2|||
130620404|NCT00418379|470228298|FG001|Year 4|Withdrawal by Subject|3|||
130620405|NCT00418379|470228299|FG002|Year 4|Withdrawal by Subject|2|||
130620406|NCT00418379|470228297|FG000|Year 4|Any other reason not above-mentioned|1|||
130620407|NCT00418379|470228298|FG001|Year 4|Any other reason not above-mentioned|1|||
130620408|NCT00418379|470228299|FG002|Year 4|Any other reason not above-mentioned|0|||
130620409|NCT00418379|470228297|FG000|Year 5|Adverse Event|0|||
130620410|NCT00418379|470228298|FG001|Year 5|Adverse Event|1|||
130620411|NCT00418379|470228299|FG002|Year 5|Adverse Event|0|||
130620412|NCT00418379|470228297|FG000|Year 5|Any other reason not above-mentioned|2|||
130620413|NCT00418379|470228298|FG001|Year 5|Any other reason not above-mentioned|4|||
130620414|NCT00418379|470228299|FG002|Year 5|Any other reason not above-mentioned|3|||
130620415|NCT00565058|470228300|FG000|Overall Study|Adverse Event|1|||
130620416|NCT00565058|470228301|FG001|Overall Study|Adverse Event|0|||
130620417|NCT00830804|470228304|FG000|Overall Study|Lost to Follow-up|4|||
130620418|NCT00830804|470228304|FG000|Overall Study|Death|1|||
130620419|NCT00830804|470228304|FG000|Overall Study|Unable to get to clinic|7|||
130620420|NCT00830804|470228304|FG000|Overall Study|Consent withdrawn|2|||
130620421|NCT00830804|470228304|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130620422|NCT03428997|470228312|FG000|Overall Study|Sponsor decision.|1|||
130620423|NCT03428997|470228312|FG000|Overall Study|Withdrawal by Subject|3|||
130620424|NCT03428997|470228312|FG000|Overall Study|Lost to Follow-up|4|||
130620425|NCT00510068|470228317|FG000|Double-blind Period|Disease progression|98|||
130620426|NCT00510068|470228318|FG001|Double-blind Period|Disease progression|169|||
130620427|NCT00510068|470228317|FG000|Double-blind Period|Final primary analysis|52|||
130620428|NCT00510068|470228318|FG001|Double-blind Period|Final primary analysis|18|||
130620429|NCT00510068|470228317|FG000|Double-blind Period|Adverse Event|37|||
130620430|NCT00510068|470228318|FG001|Double-blind Period|Adverse Event|7|||
130620431|NCT00510068|470228317|FG000|Double-blind Period|Withdrawal by Subject|8|||
130620432|NCT00510068|470228318|FG001|Double-blind Period|Withdrawal by Subject|6|||
130620433|NCT00510068|470228317|FG000|Double-blind Period|Death|4|||
130620434|NCT00510068|470228318|FG001|Double-blind Period|Death|3|||
130620435|NCT00510068|470228317|FG000|Double-blind Period|Abnormal test result (s)|1|||
130620436|NCT00510068|470228318|FG001|Double-blind Period|Abnormal test result (s)|0|||
130620437|NCT00510068|470228317|FG000|Double-blind Period|Lost to Follow-up|1|||
130620438|NCT00510068|470228318|FG001|Double-blind Period|Lost to Follow-up|0|||
130620439|NCT00510068|470228317|FG000|Double-blind Period|Protocol Violation|6|||
130620440|NCT00510068|470228318|FG001|Double-blind Period|Protocol Violation|0|||
130620441|NCT00510068|470228317|FG000|Open-label Period|Disease Progression|124|||
130620442|NCT00510068|470228318|FG001|Open-label Period|Disease Progression|0|||
130620443|NCT00510068|470228317|FG000|Open-label Period|Adverse Event|46|||
130620444|NCT00510068|470228318|FG001|Open-label Period|Adverse Event|0|||
130620445|NCT00510068|470228317|FG000|Open-label Period|Withdrawal by Subject|21|||
130620446|NCT00510068|470228318|FG001|Open-label Period|Withdrawal by Subject|0|||
130620447|NCT00510068|470228317|FG000|Open-label Period|Administrative problems|17|||
130620448|NCT00510068|470228318|FG001|Open-label Period|Administrative problems|0|||
130620449|NCT00510068|470228317|FG000|Open-label Period|Death|7|||
130620450|NCT00510068|470228318|FG001|Open-label Period|Death|0|||
130620451|NCT00510068|470228317|FG000|Open-label Period|New cancer therapy|7|||
130620452|NCT00510068|470228318|FG001|Open-label Period|New cancer therapy|0|||
130620453|NCT00510068|470228317|FG000|Open-label Period|Protocol Violation|2|||
130620454|NCT00510068|470228318|FG001|Open-label Period|Protocol Violation|0|||
130620455|NCT00510068|470228317|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
130620456|NCT00510068|470228318|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
130620457|NCT01397448|470228320|FG000|Overall Study|Adverse Event|4|||
130620458|NCT01397448|470228321|FG001|Overall Study|Adverse Event|4|||
130620459|NCT01397448|470228322|FG002|Overall Study|Adverse Event|6|||
130620460|NCT01397448|470228320|FG000|Overall Study|Withdrawal by Subject|4|||
130620461|NCT01397448|470228321|FG001|Overall Study|Withdrawal by Subject|4|||
130620462|NCT01397448|470228322|FG002|Overall Study|Withdrawal by Subject|3|||
130620463|NCT01397448|470228320|FG000|Overall Study|Lack of Efficacy|2|||
130620464|NCT01397448|470228321|FG001|Overall Study|Lack of Efficacy|0|||
130620465|NCT01397448|470228322|FG002|Overall Study|Lack of Efficacy|5|||
130620466|NCT01397448|470228320|FG000|Overall Study|Other|8|||
130620467|NCT01397448|470228321|FG001|Overall Study|Other|7|||
130620468|NCT01397448|470228322|FG002|Overall Study|Other|4|||
130620469|NCT03691610|470228324|FG000|Overall Study|Adverse Event|0|||
130620470|NCT03691610|470228325|FG001|Overall Study|Adverse Event|1|||
130620471|NCT03691610|470228326|FG002|Overall Study|Adverse Event|0|||
130620472|NCT03691610|470228327|FG003|Overall Study|Adverse Event|0|||
130620473|NCT03691610|470228324|FG000|Overall Study|Protocol Deviation|15|||
130620474|NCT03691610|470228325|FG001|Overall Study|Protocol Deviation|8|||
130620475|NCT03691610|470228326|FG002|Overall Study|Protocol Deviation|1|||
130620476|NCT03691610|470228327|FG003|Overall Study|Protocol Deviation|2|||
130620477|NCT03691610|470228324|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
130620478|NCT03691610|470228325|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
130620479|NCT03691610|470228326|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
130620480|NCT03691610|470228327|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
130620481|NCT03691610|470228324|FG000|Overall Study|Lost to Follow-up|20|||
130620482|NCT03691610|470228325|FG001|Overall Study|Lost to Follow-up|11|||
130620483|NCT03691610|470228326|FG002|Overall Study|Lost to Follow-up|5|||
130620484|NCT03691610|470228327|FG003|Overall Study|Lost to Follow-up|2|||
130620485|NCT01969799|470228335|FG000|Overall Study|Adverse Event|0|||
130620486|NCT01969799|470228336|FG001|Overall Study|Adverse Event|1|||
130620487|NCT01969799|470228335|FG000|Overall Study|Death|16|||
130620488|NCT01969799|470228336|FG001|Overall Study|Death|11|||
130620489|NCT01969799|470228335|FG000|Overall Study|Lost to Follow-up|0|||
130620490|NCT01969799|470228336|FG001|Overall Study|Lost to Follow-up|2|||
130620491|NCT01969799|470228335|FG000|Overall Study|Physician Decision|1|||
130620492|NCT01969799|470228336|FG001|Overall Study|Physician Decision|0|||
130620493|NCT03337139|470228339|FG000|Phase I|Withdrawal by Subject|10|||
130620494|NCT03337139|470228340|FG001|Phase I|Withdrawal by Subject|0|||
130620495|NCT00077376|470228341|FG000|Overall Study|Adverse Event|8|||
130620496|NCT00077376|470228341|FG000|Overall Study|Withdrawal by Subject|2|||
130620497|NCT00077376|470228341|FG000|Overall Study|Death|1|||
130620498|NCT00077376|470228341|FG000|Overall Study|Physician Decision|1|||
130620499|NCT00077376|470228341|FG000|Overall Study|Alternative therapy|5|||
130620500|NCT00077376|470228341|FG000|Overall Study|Complicating disease|1|||
130620501|NCT00077376|470228341|FG000|Overall Study|Still on treatment|1|||
130620502|NCT00077376|470228341|FG000|Overall Study|Symptomatic deterioration|1|||
130620503|NCT00077376|470228341|FG000|Overall Study|Surgery|1|||
130620504|NCT00077376|470228341|FG000|Overall Study|Insurance ran out|1|||
130620505|NCT03288493|470228342|FG000|Overall Study|Withdrawal by Subject|4|||
130620506|NCT03288493|470228343|FG001|Overall Study|Withdrawal by Subject|0|||
130620507|NCT03288493|470228344|FG002|Overall Study|Withdrawal by Subject|0|||
130620508|NCT03288493|470228345|FG003|Overall Study|Withdrawal by Subject|0|||
130620509|NCT03288493|470228346|FG004|Overall Study|Withdrawal by Subject|0|||
130620510|NCT03288493|470228347|FG005|Overall Study|Withdrawal by Subject|2|||
130620511|NCT03288493|470228348|FG006|Overall Study|Withdrawal by Subject|0|||
130620512|NCT03288493|470228342|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
130620513|NCT03288493|470228343|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
130620514|NCT03288493|470228344|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
130620515|NCT03288493|470228345|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
130620516|NCT03288493|470228346|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
130620517|NCT03288493|470228347|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
130620518|NCT03288493|470228348|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
130620519|NCT03288493|470228342|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
130620520|NCT03288493|470228343|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130620521|NCT03288493|470228344|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130620522|NCT03288493|470228345|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
130620523|NCT03288493|470228346|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130620524|NCT03288493|470228347|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
130620525|NCT03288493|470228348|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130620526|NCT03288493|470228342|FG000|Overall Study|Death|2|||
130620527|NCT03288493|470228343|FG001|Overall Study|Death|0|||
130620528|NCT03288493|470228344|FG002|Overall Study|Death|0|||
130620529|NCT03288493|470228345|FG003|Overall Study|Death|0|||
130620530|NCT03288493|470228346|FG004|Overall Study|Death|0|||
130620531|NCT03288493|470228347|FG005|Overall Study|Death|0|||
130620532|NCT03288493|470228348|FG006|Overall Study|Death|0|||
130620533|NCT03288493|470228342|FG000|Overall Study|other reason not listed above|2|||
130620534|NCT03288493|470228343|FG001|Overall Study|other reason not listed above|0|||
130620535|NCT03288493|470228344|FG002|Overall Study|other reason not listed above|0|||
130620536|NCT03288493|470228345|FG003|Overall Study|other reason not listed above|0|||
130620537|NCT03288493|470228346|FG004|Overall Study|other reason not listed above|0|||
130620538|NCT03288493|470228347|FG005|Overall Study|other reason not listed above|0|||
130620539|NCT03288493|470228348|FG006|Overall Study|other reason not listed above|0|||
130620540|NCT03784027|470228349|FG000|Period 1|Withdrawal by Subject|0|||
130620541|NCT03784027|470228350|FG001|Period 1|Withdrawal by Subject|1|||
130620542|NCT00562640|470230742|FG000|Overall Study|Death|0|||
130620543|NCT00562640|470230743|FG001|Overall Study|Death|1|||
130620544|NCT00562640|470230744|FG002|Overall Study|Death|1|||
130620545|NCT00562640|470230745|FG003|Overall Study|Death|0|||
130620546|NCT05263921|470230746|FG000|Overall Study|Other: family emergency.|0|||
130620547|NCT05263921|470230747|FG001|Overall Study|Other: family emergency.|0|||
130620548|NCT05263921|470230748|FG002|Overall Study|Other: family emergency.|1|||
130620549|NCT05263921|470230749|FG003|Overall Study|Other: family emergency.|0|||
130620550|NCT02254551|470230757|FG000|Dose Escalation|Physician Decision|1|||
130620551|NCT02254551|470230757|FG000|Dose Escalation|Dose-limiting toxicity|2|||
130620552|NCT03587584|470230761|FG000|Overall Study|SOC deviations|4|||
130620553|NCT03587584|470230762|FG001|Overall Study|SOC deviations|6|||
130620554|NCT03587584|470230761|FG000|Overall Study|Incomplete data|0|||
130620555|NCT03587584|470230762|FG001|Overall Study|Incomplete data|3|||
130620556|NCT00387348|470230763|FG000|Overall Study|Death|1|||
130620557|NCT00387348|470230764|FG001|Overall Study|Death|1|||
130620558|NCT00387348|470230765|FG002|Overall Study|Death|0|||
130620559|NCT00387348|470230763|FG000|Overall Study|Physician Decision|1|||
130620560|NCT00387348|470230764|FG001|Overall Study|Physician Decision|0|||
130620561|NCT00387348|470230765|FG002|Overall Study|Physician Decision|1|||
130620562|NCT00387348|470230763|FG000|Overall Study|Withdrawal by Subject|0|||
130620563|NCT00387348|470230764|FG001|Overall Study|Withdrawal by Subject|2|||
130620564|NCT00387348|470230765|FG002|Overall Study|Withdrawal by Subject|2|||
130620565|NCT00387348|470230763|FG000|Overall Study|Adverse Event|1|||
130620566|NCT00387348|470230764|FG001|Overall Study|Adverse Event|0|||
130620567|NCT00387348|470230765|FG002|Overall Study|Adverse Event|1|||
130620568|NCT00505752|470230766|FG000|Overall Study|Adverse Event|1|||
130620569|NCT00505752|470230767|FG001|Overall Study|Adverse Event|0|||
130620570|NCT00505752|470230768|FG002|Overall Study|Adverse Event|1|||
130620571|NCT00505752|470230769|FG003|Overall Study|Adverse Event|0|||
130620572|NCT00505752|470230766|FG000|Overall Study|Lost to Follow-up|1|||
130620573|NCT00505752|470230767|FG001|Overall Study|Lost to Follow-up|0|||
130620574|NCT00505752|470230768|FG002|Overall Study|Lost to Follow-up|0|||
130620575|NCT00505752|470230769|FG003|Overall Study|Lost to Follow-up|0|||
130620576|NCT00505752|470230766|FG000|Overall Study|Lack of ovarian response|1|||
130620577|NCT00505752|470230767|FG001|Overall Study|Lack of ovarian response|3|||
130620578|NCT00505752|470230768|FG002|Overall Study|Lack of ovarian response|0|||
130620579|NCT00505752|470230769|FG003|Overall Study|Lack of ovarian response|0|||
130620580|NCT00505752|470230766|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130620581|NCT00505752|470230767|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130620582|NCT00505752|470230768|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130620583|NCT00505752|470230769|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130620584|NCT00505752|470230766|FG000|Overall Study|No oocytes retrieved|0|||
130620585|NCT00505752|470230767|FG001|Overall Study|No oocytes retrieved|2|||
130620586|NCT00505752|470230768|FG002|Overall Study|No oocytes retrieved|0|||
130620587|NCT00505752|470230769|FG003|Overall Study|No oocytes retrieved|1|||
130620588|NCT00505752|470230766|FG000|Overall Study|No Fertilization|1|||
130620589|NCT00505752|470230767|FG001|Overall Study|No Fertilization|1|||
130620590|NCT00505752|470230768|FG002|Overall Study|No Fertilization|2|||
130620591|NCT00505752|470230769|FG003|Overall Study|No Fertilization|1|||
130620592|NCT00505752|470230766|FG000|Overall Study|All embryos/blastocysts discarded|0|||
130620593|NCT00505752|470230767|FG001|Overall Study|All embryos/blastocysts discarded|0|||
130620594|NCT00505752|470230768|FG002|Overall Study|All embryos/blastocysts discarded|1|||
130620595|NCT00505752|470230769|FG003|Overall Study|All embryos/blastocysts discarded|1|||
130620596|NCT00505752|470230766|FG000|Overall Study|Other|1|||
130620597|NCT00505752|470230767|FG001|Overall Study|Other|2|||
130620598|NCT00505752|470230768|FG002|Overall Study|Other|1|||
130620599|NCT00505752|470230769|FG003|Overall Study|Other|2|||
130620600|NCT01149343|470230770|FG000|Overall Study|Withdrawal by Subject|1|||
130620601|NCT01149343|470230771|FG001|Overall Study|Withdrawal by Subject|1|||
130620602|NCT01149343|470230772|FG002|Overall Study|Withdrawal by Subject|1|||
130620603|NCT01149343|470230773|FG003|Overall Study|Withdrawal by Subject|5|||
130620604|NCT01149343|470230770|FG000|Overall Study|Death|10|||
130620605|NCT01149343|470230771|FG001|Overall Study|Death|13|||
130620606|NCT01149343|470230772|FG002|Overall Study|Death|18|||
130620607|NCT01149343|470230773|FG003|Overall Study|Death|18|||
130620608|NCT01149343|470230770|FG000|Overall Study|Lost to Follow-up|1|||
130620609|NCT01149343|470230771|FG001|Overall Study|Lost to Follow-up|0|||
130620610|NCT01149343|470230772|FG002|Overall Study|Lost to Follow-up|0|||
130620611|NCT01149343|470230773|FG003|Overall Study|Lost to Follow-up|1|||
130620612|NCT01149343|470230770|FG000|Overall Study|Other|8|||
130620613|NCT01149343|470230771|FG001|Overall Study|Other|10|||
130620614|NCT01149343|470230772|FG002|Overall Study|Other|2|||
130620615|NCT01149343|470230773|FG003|Overall Study|Other|14|||
130620616|NCT01149343|470230770|FG000|Overall Study|Sponsor study termination|0|||
130620617|NCT01149343|470230771|FG001|Overall Study|Sponsor study termination|0|||
130620618|NCT01149343|470230772|FG002|Overall Study|Sponsor study termination|0|||
130620619|NCT01149343|470230773|FG003|Overall Study|Sponsor study termination|2|||
130620620|NCT01149343|470230770|FG000|Overall Study|Recurrence / Progressive disease|0|||
130620621|NCT01149343|470230771|FG001|Overall Study|Recurrence / Progressive disease|0|||
130620622|NCT01149343|470230772|FG002|Overall Study|Recurrence / Progressive disease|1|||
130620623|NCT01149343|470230773|FG003|Overall Study|Recurrence / Progressive disease|0|||
130620624|NCT01925612|470230774|FG000|Overall Study|Progressive Disease|1|||
130620625|NCT01925612|470230775|FG001|Overall Study|Progressive Disease|1|||
130620626|NCT01925612|470230776|FG002|Overall Study|Progressive Disease|1|||
130620627|NCT01925612|470230777|FG003|Overall Study|Progressive Disease|0|||
130620628|NCT01925612|470230778|FG004|Overall Study|Progressive Disease|0|||
130620629|NCT01925612|470230774|FG000|Overall Study|Adverse Event|3|||
130620630|NCT01925612|470230775|FG001|Overall Study|Adverse Event|3|||
130620631|NCT01925612|470230776|FG002|Overall Study|Adverse Event|0|||
130620632|NCT01925612|470230777|FG003|Overall Study|Adverse Event|1|||
130620633|NCT01925612|470230778|FG004|Overall Study|Adverse Event|2|||
130620634|NCT01093755|470230782|FG000|Overall Study|Withdrawal by Subject|3|||
130620635|NCT01093755|470230783|FG001|Overall Study|Withdrawal by Subject|4|||
130620636|NCT00868166|470230784|FG000|Overall Study|Death|58|||
130620637|NCT00868166|470230785|FG001|Overall Study|Death|65|||
130620638|NCT00868166|470230784|FG000|Overall Study|Withdrawal by Subject|33|||
130620639|NCT00868166|470230785|FG001|Overall Study|Withdrawal by Subject|25|||
130620640|NCT00868166|470230784|FG000|Overall Study|Protocol Violation|1|||
130620641|NCT00868166|470230785|FG001|Overall Study|Protocol Violation|0|||
130620642|NCT00868166|470230784|FG000|Overall Study|Lost to Follow-up|1|||
130620643|NCT00868166|470230785|FG001|Overall Study|Lost to Follow-up|3|||
130620644|NCT00868166|470230784|FG000|Overall Study|Adverse Event|9|||
130620645|NCT00868166|470230785|FG001|Overall Study|Adverse Event|10|||
130620646|NCT00868166|470230784|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
130620647|NCT00868166|470230785|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
130620648|NCT00868166|470230784|FG000|Overall Study|Non-compliance with IMP|1|||
130620649|NCT00868166|470230785|FG001|Overall Study|Non-compliance with IMP|1|||
130620650|NCT01231607|470230795|FG000|Overall Study|Adverse Event|0|||
130620651|NCT01231607|470230796|FG001|Overall Study|Adverse Event|8|||
130620652|NCT01231607|470230797|FG002|Overall Study|Adverse Event|4|||
130620653|NCT01231607|470230798|FG003|Overall Study|Adverse Event|4|||
130620654|NCT01231607|470230799|FG004|Overall Study|Adverse Event|5|||
130620655|NCT01231607|470230795|FG000|Overall Study|Lost to Follow-up|13|||
130620656|NCT01231607|470230796|FG001|Overall Study|Lost to Follow-up|11|||
130620657|NCT01231607|470230797|FG002|Overall Study|Lost to Follow-up|10|||
130620658|NCT01231607|470230798|FG003|Overall Study|Lost to Follow-up|10|||
130620659|NCT01231607|470230799|FG004|Overall Study|Lost to Follow-up|4|||
130620660|NCT01231607|470230795|FG000|Overall Study|Physician Decision|4|||
130620661|NCT01231607|470230796|FG001|Overall Study|Physician Decision|4|||
130620662|NCT01231607|470230797|FG002|Overall Study|Physician Decision|3|||
130620663|NCT01231607|470230798|FG003|Overall Study|Physician Decision|5|||
130620664|NCT01231607|470230799|FG004|Overall Study|Physician Decision|4|||
130620665|NCT01231607|470230795|FG000|Overall Study|Protocol Violation|3|||
130620666|NCT01231607|470230796|FG001|Overall Study|Protocol Violation|2|||
130620667|NCT01231607|470230797|FG002|Overall Study|Protocol Violation|0|||
130620668|NCT01231607|470230798|FG003|Overall Study|Protocol Violation|2|||
130620669|NCT01231607|470230799|FG004|Overall Study|Protocol Violation|2|||
130620670|NCT01231607|470230795|FG000|Overall Study|Withdrawal by Subject|9|||
130620671|NCT01231607|470230796|FG001|Overall Study|Withdrawal by Subject|9|||
130620672|NCT01231607|470230797|FG002|Overall Study|Withdrawal by Subject|14|||
130620673|NCT01231607|470230798|FG003|Overall Study|Withdrawal by Subject|17|||
130620674|NCT01231607|470230799|FG004|Overall Study|Withdrawal by Subject|9|||
130620675|NCT02267278|470230800|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
130620676|NCT02267278|470230800|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
130620677|NCT02267278|470230800|FG000|Overall Study|Developed new cancer diagnoses|2|||
130620678|NCT02267278|470230800|FG000|Overall Study|prescribed prohibited medication|1|||
130620679|NCT00085917|470230808|FG000|Overall Study|Adverse Event|4|||
130620680|NCT00085917|470230809|FG001|Overall Study|Adverse Event|3|||
130620681|NCT03372603|470230811|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
130620682|NCT03372603|470230812|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
130620683|NCT03372603|470230811|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
130620684|NCT03372603|470230812|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
130620685|NCT01153841|470230813|FG000|Overall Study|Adverse Event|1|||
130620686|NCT01153841|470230814|FG001|Overall Study|Adverse Event|0|||
130620687|NCT01153841|470230813|FG000|Overall Study|Withdrawal by Subject|1|||
130620688|NCT01153841|470230814|FG001|Overall Study|Withdrawal by Subject|0|||
130620689|NCT01153841|470230813|FG000|Overall Study|Protocol Violation|2|||
130620690|NCT01153841|470230814|FG001|Overall Study|Protocol Violation|0|||
130620691|NCT01153841|470230813|FG000|Overall Study|Lost to Follow-up|2|||
130620692|NCT01153841|470230814|FG001|Overall Study|Lost to Follow-up|0|||
130620693|NCT00622869|470230816|FG000|Overall Study|Subject Withdrew Consent|13|||
130620694|NCT00622869|470230817|FG001|Overall Study|Subject Withdrew Consent|17|||
130620695|NCT00622869|470230818|FG002|Overall Study|Subject Withdrew Consent|11|||
130620696|NCT00622869|470230816|FG000|Overall Study|Administrative Problems|11|||
130620697|NCT00622869|470230817|FG001|Overall Study|Administrative Problems|17|||
130620698|NCT00622869|470230818|FG002|Overall Study|Administrative Problems|13|||
130620699|NCT00622869|470230816|FG000|Overall Study|Death|12|||
130620700|NCT00622869|470230817|FG001|Overall Study|Death|15|||
130620701|NCT00622869|470230818|FG002|Overall Study|Death|10|||
130620702|NCT00622869|470230816|FG000|Overall Study|Lost to Follow-up|2|||
130620703|NCT00622869|470230817|FG001|Overall Study|Lost to Follow-up|4|||
130620704|NCT00622869|470230818|FG002|Overall Study|Lost to Follow-up|2|||
130620705|NCT00622869|470230816|FG000|Overall Study|Graft Loss|5|||
130620706|NCT00622869|470230817|FG001|Overall Study|Graft Loss|3|||
130620707|NCT00622869|470230818|FG002|Overall Study|Graft Loss|2|||
130620708|NCT00622869|470230816|FG000|Overall Study|Missing|0|||
130620709|NCT00622869|470230817|FG001|Overall Study|Missing|1|||
130620710|NCT00622869|470230818|FG002|Overall Study|Missing|1|||
130620711|NCT00645567|470230819|FG000|Overall Study|Adverse Event|1|||
130620712|NCT02475395|470230823|FG000|Overall Study|Protocol Violation|30|||
130620713|NCT02475395|470230824|FG001|Overall Study|Protocol Violation|3|||
130620714|NCT03730194|470230825|FG000|First Stage Treatment|Withdrawal by Subject|1|||
130620715|NCT03730194|470230826|FG001|First Stage Treatment|Withdrawal by Subject|1|||
130620716|NCT03730194|470230827|FG002|First Stage Treatment|Withdrawal by Subject|0|||
130620717|NCT03730194|470230828|FG003|First Stage Treatment|Withdrawal by Subject|0|||
130620718|NCT03730194|470230829|FG004|First Stage Treatment|Withdrawal by Subject|0|||
130620719|NCT03730194|470230830|FG005|First Stage Treatment|Withdrawal by Subject|0|||
130620720|NCT03730194|470230825|FG000|First Stage Treatment|Protocol Violation|3|||
130620721|NCT03730194|470230826|FG001|First Stage Treatment|Protocol Violation|3|||
130620722|NCT03730194|470230827|FG002|First Stage Treatment|Protocol Violation|0|||
130620723|NCT03730194|470230828|FG003|First Stage Treatment|Protocol Violation|0|||
130620724|NCT03730194|470230829|FG004|First Stage Treatment|Protocol Violation|0|||
130620725|NCT03730194|470230830|FG005|First Stage Treatment|Protocol Violation|0|||
130620726|NCT00115765|470230831|FG000|Overall Study|Withdrawal by Subject|22|||
130620727|NCT00115765|470230832|FG001|Overall Study|Withdrawal by Subject|53|||
130620728|NCT00115765|470230833|FG002|Overall Study|Withdrawal by Subject|76|||
130620729|NCT00115765|470230834|FG003|Overall Study|Withdrawal by Subject|15|||
130620730|NCT00115765|470230831|FG000|Overall Study|Physician Decision|4|||
130620731|NCT00115765|470230832|FG001|Overall Study|Physician Decision|15|||
130620732|NCT00115765|470230833|FG002|Overall Study|Physician Decision|18|||
130620733|NCT00115765|470230834|FG003|Overall Study|Physician Decision|13|||
130620734|NCT00115765|470230831|FG000|Overall Study|Lost to Follow-up|3|||
130620735|NCT00115765|470230832|FG001|Overall Study|Lost to Follow-up|20|||
130620736|NCT00115765|470230833|FG002|Overall Study|Lost to Follow-up|18|||
130620737|NCT00115765|470230834|FG003|Overall Study|Lost to Follow-up|1|||
130620738|NCT00115765|470230831|FG000|Overall Study|Other|6|||
130620739|NCT00115765|470230832|FG001|Overall Study|Other|12|||
130620740|NCT00115765|470230833|FG002|Overall Study|Other|9|||
130620741|NCT00115765|470230834|FG003|Overall Study|Other|2|||
130620742|NCT03814590|470230837|FG000|Overall Study|Adverse Event|0|||
130620743|NCT03814590|470230838|FG001|Overall Study|Adverse Event|0|||
130620744|NCT03814590|470230839|FG002|Overall Study|Adverse Event|0|||
130620745|NCT03814590|470230840|FG003|Overall Study|Adverse Event|0|||
130620746|NCT03814590|470230841|FG004|Overall Study|Adverse Event|0|||
130620747|NCT03814590|470230842|FG005|Overall Study|Adverse Event|1|||
130620748|NCT03814590|470230843|FG006|Overall Study|Adverse Event|1|||
130620749|NCT03814590|470230844|FG007|Overall Study|Adverse Event|1|||
130620750|NCT03814590|470230845|FG008|Overall Study|Adverse Event|0|||
130620751|NCT03814590|470230846|FG009|Overall Study|Adverse Event|0|||
130620752|NCT03814590|470230847|FG010|Overall Study|Adverse Event|1|||
130620753|NCT03814590|470230848|FG011|Overall Study|Adverse Event|0|||
130620754|NCT03814590|470230849|FG012|Overall Study|Adverse Event|3|||
130620755|NCT03814590|470230850|FG013|Overall Study|Adverse Event|0|||
130620756|NCT03814590|470230837|FG000|Overall Study|Lost to Follow-up|0|||
130620757|NCT03814590|470230838|FG001|Overall Study|Lost to Follow-up|2|||
130620758|NCT03814590|470230839|FG002|Overall Study|Lost to Follow-up|1|||
130620759|NCT03814590|470230840|FG003|Overall Study|Lost to Follow-up|0|||
130620760|NCT03814590|470230841|FG004|Overall Study|Lost to Follow-up|1|||
130620761|NCT03814590|470230842|FG005|Overall Study|Lost to Follow-up|1|||
130620762|NCT03814590|470230843|FG006|Overall Study|Lost to Follow-up|1|||
130620763|NCT03814590|470230844|FG007|Overall Study|Lost to Follow-up|1|||
130620764|NCT03814590|470230845|FG008|Overall Study|Lost to Follow-up|0|||
130620765|NCT03814590|470230846|FG009|Overall Study|Lost to Follow-up|0|||
130620766|NCT03814590|470230847|FG010|Overall Study|Lost to Follow-up|1|||
130620767|NCT03814590|470230848|FG011|Overall Study|Lost to Follow-up|0|||
130620768|NCT03814590|470230849|FG012|Overall Study|Lost to Follow-up|0|||
130620769|NCT03814590|470230850|FG013|Overall Study|Lost to Follow-up|1|||
130620770|NCT03814590|470230837|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620771|NCT03814590|470230838|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620772|NCT03814590|470230839|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620773|NCT03814590|470230840|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620774|NCT03814590|470230841|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620775|NCT03814590|470230842|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620776|NCT03814590|470230843|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620777|NCT03814590|470230844|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620778|NCT03814590|470230845|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620779|NCT03814590|470230846|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
130620780|NCT03814590|470230847|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620781|NCT03814590|470230848|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620782|NCT03814590|470230849|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620783|NCT03814590|470230850|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130620784|NCT03814590|470230837|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620785|NCT03814590|470230838|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620786|NCT03814590|470230839|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620787|NCT03814590|470230840|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620788|NCT03814590|470230841|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620789|NCT03814590|470230842|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
130620790|NCT03814590|470230843|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
130620791|NCT03814590|470230844|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
130620792|NCT03814590|470230845|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620793|NCT03814590|470230846|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
130620794|NCT03814590|470230847|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
130620795|NCT03814590|470230848|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130620796|NCT03814590|470230849|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
130620797|NCT03814590|470230850|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
130620798|NCT03814590|470230837|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620799|NCT03814590|470230838|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620800|NCT03814590|470230839|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620801|NCT03814590|470230840|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620802|NCT03814590|470230841|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620803|NCT03814590|470230842|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620804|NCT03814590|470230843|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620805|NCT03814590|470230844|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130620806|NCT03814590|470230845|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620807|NCT03814590|470230846|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130620808|NCT03814590|470230847|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620809|NCT03814590|470230848|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620810|NCT03814590|470230849|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620811|NCT03814590|470230850|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130620812|NCT03814590|470230837|FG000|Overall Study|UNKNOWN REASON|0|||
130620813|NCT03814590|470230838|FG001|Overall Study|UNKNOWN REASON|0|||
130620814|NCT03814590|470230839|FG002|Overall Study|UNKNOWN REASON|0|||
130620815|NCT03814590|470230840|FG003|Overall Study|UNKNOWN REASON|0|||
130620816|NCT03814590|470230841|FG004|Overall Study|UNKNOWN REASON|0|||
130620817|NCT03814590|470230842|FG005|Overall Study|UNKNOWN REASON|0|||
130620818|NCT03814590|470230843|FG006|Overall Study|UNKNOWN REASON|0|||
130620819|NCT03814590|470230844|FG007|Overall Study|UNKNOWN REASON|1|||
130620820|NCT03814590|470230845|FG008|Overall Study|UNKNOWN REASON|0|||
130620821|NCT03814590|470230846|FG009|Overall Study|UNKNOWN REASON|0|||
130620822|NCT03814590|470230847|FG010|Overall Study|UNKNOWN REASON|0|||
130620823|NCT03814590|470230848|FG011|Overall Study|UNKNOWN REASON|0|||
130620824|NCT03814590|470230849|FG012|Overall Study|UNKNOWN REASON|0|||
130620825|NCT03814590|470230850|FG013|Overall Study|UNKNOWN REASON|0|||
130620826|NCT02260648|470230853|FG000|Overall Study|Adverse Event|3|||
130620827|NCT02260648|470230854|FG001|Overall Study|Adverse Event|0|||
130620828|NCT02260648|470230855|FG002|Overall Study|Adverse Event|1|||
130620829|NCT02260648|470230853|FG000|Overall Study|Withdrawal by Subject|1|||
130620830|NCT02260648|470230854|FG001|Overall Study|Withdrawal by Subject|1|||
130620831|NCT02260648|470230855|FG002|Overall Study|Withdrawal by Subject|0|||
130620832|NCT02260648|470230853|FG000|Overall Study|Protocol Violation|1|||
130620833|NCT02260648|470230854|FG001|Overall Study|Protocol Violation|0|||
130620834|NCT02260648|470230855|FG002|Overall Study|Protocol Violation|0|||
130620835|NCT02260648|470230853|FG000|Overall Study|Discontinue Due to Study Termination|13|||
130620836|NCT02260648|470230854|FG001|Overall Study|Discontinue Due to Study Termination|12|||
130620837|NCT02260648|470230855|FG002|Overall Study|Discontinue Due to Study Termination|7|||
130620838|NCT03956225|470230856|FG000|Overall Study|Lack of Efficacy|1|||
130620839|NCT03956225|470230857|FG001|Overall Study|Lack of Efficacy|1|||
130620840|NCT03956225|470230856|FG000|Overall Study|Lost to Follow-up|0|||
130620841|NCT03956225|470230857|FG001|Overall Study|Lost to Follow-up|1|||
130620842|NCT03956225|470230856|FG000|Overall Study|Withdrawal by Subject|2|||
130620843|NCT03956225|470230857|FG001|Overall Study|Withdrawal by Subject|1|||
130620844|NCT03956225|470230856|FG000|Overall Study|Other Reasons|2|||
130620845|NCT03956225|470230857|FG001|Overall Study|Other Reasons|1|||
130620846|NCT04093258|470230858|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
130620847|NCT04093258|470230859|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
130620848|NCT00594204|470230860|FG000|Overall Study|Adverse Event|15|||
130620849|NCT00594204|470230861|FG001|Overall Study|Adverse Event|3|||
130620850|NCT00594204|470230860|FG000|Overall Study|Lost to Follow-up|9|||
130620851|NCT00594204|470230861|FG001|Overall Study|Lost to Follow-up|5|||
130620852|NCT00594204|470230860|FG000|Overall Study|Withdrawal by Subject|23|||
130620853|NCT00594204|470230861|FG001|Overall Study|Withdrawal by Subject|29|||
130620854|NCT00594204|470230860|FG000|Overall Study|Other|4|||
130620855|NCT00594204|470230861|FG001|Overall Study|Other|3|||
130620856|NCT00594204|470230860|FG000|Overall Study|Lack of Efficacy|3|||
130620857|NCT00594204|470230861|FG001|Overall Study|Lack of Efficacy|4|||
130620858|NCT00594204|470230860|FG000|Overall Study|Randomized but not treated|4|||
130620859|NCT00594204|470230861|FG001|Overall Study|Randomized but not treated|1|||
130620860|NCT00567541|470230864|FG000|Overall Study|Adverse Event|0|||
130620861|NCT00567541|470230865|FG001|Overall Study|Adverse Event|1|||
130620862|NCT01890512|470230866|FG000|Overall Study|Physician Decision|1|||
130620863|NCT01890512|470230866|FG000|Overall Study|Withdrawal by Subject|1|||
130620864|NCT01890512|470230866|FG000|Overall Study|Protocol Violation|1|||
130620865|NCT01529385|470230867|FG000|Overall Study|Lost to Follow-up|2|||
130620866|NCT01529385|470230868|FG001|Overall Study|Lost to Follow-up|1|||
130620867|NCT00964158|470230871|FG000|Overall Study|Lost to Follow-up|0|||
130620868|NCT00964158|470230872|FG001|Overall Study|Lost to Follow-up|1|||
130620869|NCT00964158|470230873|FG002|Overall Study|Lost to Follow-up|2|||
130620870|NCT00964158|470230871|FG000|Overall Study|Withdrawal by Subject|0|||
130620871|NCT00964158|470230872|FG001|Overall Study|Withdrawal by Subject|0|||
130620872|NCT00964158|470230873|FG002|Overall Study|Withdrawal by Subject|6|||
130620873|NCT00986427|470230874|FG000|Overall Study|Lost to Follow-up|2|||
130620874|NCT00986427|470230875|FG001|Overall Study|Lost to Follow-up|0|||
130620875|NCT00986427|470230874|FG000|Overall Study|Lack of Efficacy|1|||
130620876|NCT00986427|470230875|FG001|Overall Study|Lack of Efficacy|0|||
130620877|NCT00986427|470230874|FG000|Overall Study|Withdrawal by Subject|1|||
130620878|NCT00986427|470230875|FG001|Overall Study|Withdrawal by Subject|0|||
130620879|NCT01401465|470230876|FG000|Treatment Period 1|Adverse Event|4|||
130620880|NCT01401465|470230877|FG001|Treatment Period 1|Adverse Event|1|||
130620881|NCT01401465|470230876|FG000|Treatment Period 1|Pregnancy|0|||
130620882|NCT01401465|470230877|FG001|Treatment Period 1|Pregnancy|1|||
130620883|NCT01401465|470230876|FG000|Treatment Period 1|Protocol Violation|5|||
130620884|NCT01401465|470230877|FG001|Treatment Period 1|Protocol Violation|0|||
130620885|NCT01401465|470230876|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130620886|NCT01401465|470230877|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130620887|NCT01401465|470230876|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
130620888|NCT01401465|470230877|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
130620889|NCT01401465|470230876|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
130620890|NCT01401465|470230877|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
130620891|NCT01401465|470230876|FG000|Treatment Period 1|Scheduling Difficulties|1|||
130620892|NCT01401465|470230877|FG001|Treatment Period 1|Scheduling Difficulties|1|||
130620893|NCT01401465|470230876|FG000|Treatment Period 2|Lost to Follow-up|0|||
130620894|NCT01401465|470230877|FG001|Treatment Period 2|Lost to Follow-up|1|||
130620895|NCT01401465|470230876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130620896|NCT01401465|470230877|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130620897|NCT01115738|470230878|FG000|Overall Study|Death|1|||
130620898|NCT01115738|470230879|FG001|Overall Study|Death|0|||
130620899|NCT01115738|470230880|FG002|Overall Study|Death|0|||
130620900|NCT01115738|470230878|FG000|Overall Study|Lost to Follow-up|0|||
130620901|NCT01115738|470230879|FG001|Overall Study|Lost to Follow-up|0|||
130620902|NCT01115738|470230880|FG002|Overall Study|Lost to Follow-up|1|||
130620903|NCT01115738|470230878|FG000|Overall Study|Physician Decision|18|||
130620904|NCT01115738|470230879|FG001|Overall Study|Physician Decision|15|||
130620905|NCT01115738|470230880|FG002|Overall Study|Physician Decision|17|||
130620906|NCT01115738|470230878|FG000|Overall Study|Withdrawal by Subject|6|||
130620907|NCT01115738|470230879|FG001|Overall Study|Withdrawal by Subject|6|||
130620908|NCT01115738|470230880|FG002|Overall Study|Withdrawal by Subject|9|||
130620909|NCT01054976|470230892|FG000|Overall Study|Adverse Event|16|||
130620910|NCT01054976|470230892|FG000|Overall Study|Uncooperative participations to study|7|||
130620911|NCT01054976|470230892|FG000|Overall Study|Withdrawal by Subject|4|||
130620912|NCT01054976|470230892|FG000|Overall Study|Other|8|||
130620913|NCT01763866|470230893|FG000|Overall Study|Withdrawal by Subject|2|||
130620914|NCT01763866|470230894|FG001|Overall Study|Withdrawal by Subject|1|||
130620915|NCT01763866|470230895|FG002|Overall Study|Withdrawal by Subject|4|||
130620916|NCT01763866|470230896|FG003|Overall Study|Withdrawal by Subject|0|||
130620917|NCT01763866|470230897|FG004|Overall Study|Withdrawal by Subject|0|||
130620918|NCT01763866|470230898|FG005|Overall Study|Withdrawal by Subject|3|||
130620919|NCT01763866|470230899|FG006|Overall Study|Withdrawal by Subject|4|||
130620920|NCT01763866|470230900|FG007|Overall Study|Withdrawal by Subject|0|||
130620921|NCT01763866|470230901|FG008|Overall Study|Withdrawal by Subject|1|||
130620922|NCT01763866|470230902|FG009|Overall Study|Withdrawal by Subject|1|||
130620923|NCT01763866|470230903|FG010|Overall Study|Withdrawal by Subject|2|||
130620924|NCT01763866|470230904|FG011|Overall Study|Withdrawal by Subject|2|||
130620925|NCT01763866|470230905|FG012|Overall Study|Withdrawal by Subject|2|||
130620926|NCT01763866|470230906|FG013|Overall Study|Withdrawal by Subject|0|||
130620927|NCT01763866|470230907|FG014|Overall Study|Withdrawal by Subject|6|||
130620928|NCT01763866|470230908|FG015|Overall Study|Withdrawal by Subject|3|||
130620929|NCT01763866|470230909|FG016|Overall Study|Withdrawal by Subject|0|||
130620930|NCT01763866|470230910|FG017|Overall Study|Withdrawal by Subject|1|||
130620931|NCT01763866|470230911|FG018|Overall Study|Withdrawal by Subject|1|||
130620932|NCT01763866|470230912|FG019|Overall Study|Withdrawal by Subject|1|||
130620933|NCT01763866|470230913|FG020|Overall Study|Withdrawal by Subject|2|||
130620934|NCT01763866|470230914|FG021|Overall Study|Withdrawal by Subject|1|||
130620935|NCT01763866|470230915|FG022|Overall Study|Withdrawal by Subject|2|||
130620936|NCT01763866|470230916|FG023|Overall Study|Withdrawal by Subject|1|||
130620937|NCT01763866|470230893|FG000|Overall Study|Decision by sponsor|0|||
130620938|NCT01763866|470230894|FG001|Overall Study|Decision by sponsor|0|||
130620939|NCT01763866|470230895|FG002|Overall Study|Decision by sponsor|1|||
130620940|NCT01763866|470230896|FG003|Overall Study|Decision by sponsor|0|||
130620941|NCT01763866|470230897|FG004|Overall Study|Decision by sponsor|2|||
130620942|NCT01763866|470230898|FG005|Overall Study|Decision by sponsor|0|||
130620943|NCT01763866|470230899|FG006|Overall Study|Decision by sponsor|2|||
130620944|NCT01763866|470230900|FG007|Overall Study|Decision by sponsor|0|||
130620945|NCT01763866|470230901|FG008|Overall Study|Decision by sponsor|2|||
130620946|NCT01763866|470230902|FG009|Overall Study|Decision by sponsor|0|||
130620947|NCT01763866|470230903|FG010|Overall Study|Decision by sponsor|6|||
130620948|NCT01763866|470230904|FG011|Overall Study|Decision by sponsor|0|||
130620949|NCT01763866|470230905|FG012|Overall Study|Decision by sponsor|1|||
130620950|NCT01763866|470230906|FG013|Overall Study|Decision by sponsor|0|||
130620951|NCT01763866|470230907|FG014|Overall Study|Decision by sponsor|5|||
130620952|NCT01763866|470230908|FG015|Overall Study|Decision by sponsor|0|||
130620953|NCT01763866|470230909|FG016|Overall Study|Decision by sponsor|0|||
130620954|NCT01763866|470230910|FG017|Overall Study|Decision by sponsor|0|||
130620955|NCT01763866|470230911|FG018|Overall Study|Decision by sponsor|4|||
130620956|NCT01763866|470230912|FG019|Overall Study|Decision by sponsor|0|||
130620957|NCT01763866|470230913|FG020|Overall Study|Decision by sponsor|2|||
130620958|NCT01763866|470230914|FG021|Overall Study|Decision by sponsor|0|||
130620959|NCT01763866|470230915|FG022|Overall Study|Decision by sponsor|1|||
130620960|NCT01763866|470230916|FG023|Overall Study|Decision by sponsor|0|||
130620961|NCT01763866|470230893|FG000|Overall Study|Lost to Follow-up|0|||
130620962|NCT01763866|470230894|FG001|Overall Study|Lost to Follow-up|0|||
130620963|NCT01763866|470230895|FG002|Overall Study|Lost to Follow-up|0|||
130620964|NCT01763866|470230896|FG003|Overall Study|Lost to Follow-up|0|||
130620965|NCT01763866|470230897|FG004|Overall Study|Lost to Follow-up|0|||
130620966|NCT01763866|470230898|FG005|Overall Study|Lost to Follow-up|0|||
130620967|NCT01763866|470230899|FG006|Overall Study|Lost to Follow-up|1|||
130620968|NCT01763866|470230900|FG007|Overall Study|Lost to Follow-up|0|||
130620969|NCT01763866|470230901|FG008|Overall Study|Lost to Follow-up|0|||
130620970|NCT01763866|470230902|FG009|Overall Study|Lost to Follow-up|0|||
130620971|NCT01763866|470230903|FG010|Overall Study|Lost to Follow-up|0|||
130620972|NCT01763866|470230904|FG011|Overall Study|Lost to Follow-up|0|||
130620973|NCT01763866|470230905|FG012|Overall Study|Lost to Follow-up|1|||
130620974|NCT01763866|470230906|FG013|Overall Study|Lost to Follow-up|0|||
130620975|NCT01763866|470230907|FG014|Overall Study|Lost to Follow-up|1|||
130620976|NCT01763866|470230908|FG015|Overall Study|Lost to Follow-up|0|||
130620977|NCT01763866|470230909|FG016|Overall Study|Lost to Follow-up|0|||
130620978|NCT01763866|470230910|FG017|Overall Study|Lost to Follow-up|0|||
130620979|NCT01763866|470230911|FG018|Overall Study|Lost to Follow-up|1|||
130620980|NCT01763866|470230912|FG019|Overall Study|Lost to Follow-up|1|||
130620981|NCT01763866|470230913|FG020|Overall Study|Lost to Follow-up|0|||
130620982|NCT01763866|470230914|FG021|Overall Study|Lost to Follow-up|0|||
130620983|NCT01763866|470230915|FG022|Overall Study|Lost to Follow-up|0|||
130620984|NCT01763866|470230916|FG023|Overall Study|Lost to Follow-up|1|||
130620985|NCT01763866|470230893|FG000|Overall Study|Death|0|||
130620986|NCT01763866|470230894|FG001|Overall Study|Death|0|||
130620987|NCT01763866|470230895|FG002|Overall Study|Death|0|||
130620988|NCT01763866|470230896|FG003|Overall Study|Death|0|||
130620989|NCT01763866|470230897|FG004|Overall Study|Death|0|||
130620990|NCT01763866|470230898|FG005|Overall Study|Death|0|||
130620991|NCT01763866|470230899|FG006|Overall Study|Death|0|||
130620992|NCT01763866|470230900|FG007|Overall Study|Death|0|||
130620993|NCT01763866|470230901|FG008|Overall Study|Death|0|||
130620994|NCT01763866|470230902|FG009|Overall Study|Death|0|||
130620995|NCT01763866|470230903|FG010|Overall Study|Death|0|||
130620996|NCT01763866|470230904|FG011|Overall Study|Death|0|||
130620997|NCT01763866|470230905|FG012|Overall Study|Death|0|||
130620998|NCT01763866|470230906|FG013|Overall Study|Death|0|||
130620999|NCT01763866|470230907|FG014|Overall Study|Death|0|||
130621000|NCT01763866|470230908|FG015|Overall Study|Death|0|||
130621001|NCT01763866|470230909|FG016|Overall Study|Death|1|||
130621002|NCT01763866|470230910|FG017|Overall Study|Death|0|||
130621003|NCT01763866|470230911|FG018|Overall Study|Death|0|||
130621004|NCT01763866|470230912|FG019|Overall Study|Death|0|||
130621005|NCT01763866|470230913|FG020|Overall Study|Death|0|||
130621006|NCT01763866|470230914|FG021|Overall Study|Death|0|||
130621007|NCT01763866|470230915|FG022|Overall Study|Death|0|||
130621008|NCT01763866|470230916|FG023|Overall Study|Death|0|||
130621009|NCT01669811|470230923|FG000|Overall Study|Investigator decision|0|||
130621010|NCT01669811|470230924|FG001|Overall Study|Investigator decision|1|||
130621011|NCT01669811|470230923|FG000|Overall Study|Withdrawal by Subject|1|||
130621012|NCT01669811|470230924|FG001|Overall Study|Withdrawal by Subject|2|||
130621013|NCT01669811|470230923|FG000|Overall Study|Adverse Event|2|||
130621014|NCT01669811|470230924|FG001|Overall Study|Adverse Event|6|||
130621015|NCT01669811|470230923|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130621016|NCT01669811|470230924|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130621017|NCT03245723|470230930|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
130621018|NCT03245723|470230931|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
130621019|NCT03245723|470230930|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
130621020|NCT03245723|470230931|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
130621021|NCT03245723|470230930|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
130621022|NCT03245723|470230931|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
130621023|NCT03245723|470230930|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
130621024|NCT03245723|470230931|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
130621025|NCT06025396|470233118|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
130621026|NCT06025396|470233119|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
130621027|NCT06025396|470233120|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
130621028|NCT06025396|470233121|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
130621029|NCT06025396|470233122|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
130621030|NCT06025396|470233118|FG000|Overall Study|Withdrawal by Subject|0|||
130621031|NCT06025396|470233119|FG001|Overall Study|Withdrawal by Subject|1|||
130621032|NCT06025396|470233120|FG002|Overall Study|Withdrawal by Subject|1|||
130621033|NCT06025396|470233121|FG003|Overall Study|Withdrawal by Subject|0|||
130621034|NCT06025396|470233122|FG004|Overall Study|Withdrawal by Subject|0|||
130621035|NCT00646113|470233123|FG000|Overall Study|Lost to Follow-up|5|||
130621036|NCT00646113|470233123|FG000|Overall Study|Adverse Event|3|||
130621037|NCT02109744|470233124|FG000|Overall Study|Death|1|||
130621038|NCT02109744|470233125|FG001|Overall Study|Death|1|||
130621039|NCT02109744|470233124|FG000|Overall Study|no marrow exam|1|||
130621040|NCT02109744|470233125|FG001|Overall Study|no marrow exam|0|||
130621041|NCT04095442|470233126|FG000|Overall Study|Lost to Follow-up|0|||
130621042|NCT04095442|470233127|FG001|Overall Study|Lost to Follow-up|1|||
130621043|NCT04095442|470233126|FG000|Overall Study|Screen failure|1|||
130621044|NCT04095442|470233127|FG001|Overall Study|Screen failure|0|||
130621045|NCT04656418|470233131|FG000|Overall Study|Withdrawal by Subject|1|||
130621046|NCT04656418|470233132|FG001|Overall Study|Withdrawal by Subject|3|||
130621047|NCT03097614|470233135|FG000|Overall Study|Adverse Event|3|||
130621048|NCT00603733|470233137|FG000|Active Phase ITT|Adverse Event|8|||
130621049|NCT00603733|470233138|FG001|Active Phase ITT|Adverse Event|7|||
130621050|NCT00603733|470233137|FG000|Active Phase ITT|Withdrawal by Subject|0|||
130621051|NCT00603733|470233138|FG001|Active Phase ITT|Withdrawal by Subject|3|||
130621052|NCT00603733|470233137|FG000|Active Phase ITT|Lost to Follow-up|0|||
130621053|NCT00603733|470233138|FG001|Active Phase ITT|Lost to Follow-up|1|||
130621054|NCT00603733|470233137|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
130621055|NCT00603733|470233138|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
130621056|NCT00603733|470233137|FG000|Active Phase ITT|Lack of Efficacy|1|||
130621057|NCT00603733|470233138|FG001|Active Phase ITT|Lack of Efficacy|2|||
130621058|NCT00603733|470233137|FG000|Active Phase ITT|Subject moved, site closed|1|||
130621059|NCT00603733|470233138|FG001|Active Phase ITT|Subject moved, site closed|1|||
130621060|NCT00603733|470233137|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
130621061|NCT00603733|470233138|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
130621062|NCT00603733|470233137|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
130621063|NCT00603733|470233138|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
130621064|NCT00603733|470233137|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
130621065|NCT00603733|470233138|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
130621066|NCT00603733|470233137|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
130621067|NCT00603733|470233138|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
130621068|NCT00603733|470233137|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
130621069|NCT00603733|470233138|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
130621070|NCT00603733|470233137|FG000|Maintenance Phase ITT|Adverse Event|3|||
130621071|NCT00603733|470233138|FG001|Maintenance Phase ITT|Adverse Event|6|||
130621072|NCT00603733|470233137|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
130621073|NCT00603733|470233138|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
130621074|NCT00603733|470233137|FG000|Maintenance Phase ITT|Protocol Violation|1|||
130621075|NCT00603733|470233138|FG001|Maintenance Phase ITT|Protocol Violation|1|||
130621076|NCT00603733|470233137|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
130621077|NCT00603733|470233138|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
130621078|NCT00603733|470233137|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
130621079|NCT00603733|470233138|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
130621080|NCT00603733|470233137|FG000|Maintenance Phase ITT|Physician Decision|0|||
130621081|NCT00603733|470233138|FG001|Maintenance Phase ITT|Physician Decision|1|||
130621082|NCT00603733|470233137|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
130621083|NCT00603733|470233138|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
130621084|NCT01297309|470233143|FG000|Overall Study|Eligibility failure|2|||
130621085|NCT01297309|470233143|FG000|Overall Study|Screen failure|2|||
130621086|NCT01297309|470233143|FG000|Overall Study|Withdrawal by Subject|5|||
130621087|NCT01297309|470233143|FG000|Overall Study|Adverse Event|1|||
130621088|NCT01297309|470233143|FG000|Overall Study|Investigator Decision|2|||
130621089|NCT01297309|470233143|FG000|Overall Study|Death|1|||
130621090|NCT01297309|470233143|FG000|Overall Study|Participant not entering extensionperiod|1|||
130621091|NCT02759562|470233144|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
130621092|NCT02759562|470233145|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
130621093|NCT02759562|470233144|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
130621094|NCT02759562|470233145|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
130621095|NCT00225147|470233150|FG000|Open-label Phase|Lost to Follow-up|0|||
130621096|NCT00225147|470233151|FG001|Open-label Phase|Lost to Follow-up|0|||
130621097|NCT00225147|470233152|FG002|Open-label Phase|Lost to Follow-up|0|||
130621098|NCT00225147|470233153|FG003|Open-label Phase|Lost to Follow-up|4|||
130621099|NCT00225147|470233150|FG000|Open-label Phase|Withdrawal by Subject|0|||
130621100|NCT00225147|470233151|FG001|Open-label Phase|Withdrawal by Subject|0|||
130621101|NCT00225147|470233152|FG002|Open-label Phase|Withdrawal by Subject|0|||
130621102|NCT00225147|470233153|FG003|Open-label Phase|Withdrawal by Subject|6|||
130621103|NCT02501902|470233157|FG000|Overall Study|Subject Refused Further Follow-up|0|||
130621104|NCT02501902|470233158|FG001|Overall Study|Subject Refused Further Follow-up|0|||
130621105|NCT02501902|470233159|FG002|Overall Study|Subject Refused Further Follow-up|0|||
130621106|NCT02501902|470233160|FG003|Overall Study|Subject Refused Further Follow-up|0|||
130621107|NCT02501902|470233161|FG004|Overall Study|Subject Refused Further Follow-up|0|||
130621108|NCT02501902|470233162|FG005|Overall Study|Subject Refused Further Follow-up|0|||
130621109|NCT02501902|470233163|FG006|Overall Study|Subject Refused Further Follow-up|0|||
130621110|NCT02501902|470233164|FG007|Overall Study|Subject Refused Further Follow-up|1|||
130621111|NCT02501902|470233157|FG000|Overall Study|Study Terminated by Sponsor|0|||
130621112|NCT02501902|470233158|FG001|Overall Study|Study Terminated by Sponsor|3|||
130621113|NCT02501902|470233159|FG002|Overall Study|Study Terminated by Sponsor|0|||
130621114|NCT02501902|470233160|FG003|Overall Study|Study Terminated by Sponsor|1|||
130621115|NCT02501902|470233161|FG004|Overall Study|Study Terminated by Sponsor|1|||
130621116|NCT02501902|470233162|FG005|Overall Study|Study Terminated by Sponsor|0|||
130621117|NCT02501902|470233163|FG006|Overall Study|Study Terminated by Sponsor|2|||
130621118|NCT02501902|470233164|FG007|Overall Study|Study Terminated by Sponsor|4|||
130621119|NCT02501902|470233157|FG000|Overall Study|Death|3|||
130621120|NCT02501902|470233158|FG001|Overall Study|Death|4|||
130621121|NCT02501902|470233159|FG002|Overall Study|Death|4|||
130621122|NCT02501902|470233160|FG003|Overall Study|Death|10|||
130621123|NCT02501902|470233161|FG004|Overall Study|Death|10|||
130621124|NCT02501902|470233162|FG005|Overall Study|Death|11|||
130621125|NCT02501902|470233163|FG006|Overall Study|Death|7|||
130621126|NCT02501902|470233164|FG007|Overall Study|Death|15|||
130621127|NCT02513771|470233165|FG000|Overall Study|Lost to Follow-up|1|||
130621128|NCT02513771|470233166|FG001|Overall Study|Lost to Follow-up|1|||
130621129|NCT02513771|470233165|FG000|Overall Study|Not being able to get to clinic|1|||
130621130|NCT02513771|470233166|FG001|Overall Study|Not being able to get to clinic|0|||
130621131|NCT01797445|470233167|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
130621132|NCT01797445|470233168|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
130621133|NCT01797445|470233167|FG000|Double-Blind Phase|Adverse Event|3|||
130621134|NCT01797445|470233168|FG001|Double-Blind Phase|Adverse Event|0|||
130621135|NCT01797445|470233167|FG000|Double-Blind Phase|Death|5|||
130621136|NCT01797445|470233168|FG001|Double-Blind Phase|Death|4|||
130621137|NCT01797445|470233167|FG000|Double-Blind Phase|Pregnancy|0|||
130621138|NCT01797445|470233168|FG001|Double-Blind Phase|Pregnancy|1|||
130621139|NCT01797445|470233167|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130621140|NCT01797445|470233168|FG001|Double-Blind Phase|Lack of Efficacy|2|||
130621141|NCT01797445|470233167|FG000|Double-Blind Phase|Investigator's Discretion|15|||
130621142|NCT01797445|470233168|FG001|Double-Blind Phase|Investigator's Discretion|17|||
130621143|NCT01797445|470233167|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
130621144|NCT01797445|470233168|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
130621145|NCT01797445|470233167|FG000|Double-Blind Phase|Protocol Violation|0|||
130621146|NCT01797445|470233168|FG001|Double-Blind Phase|Protocol Violation|1|||
130621147|NCT01797445|470233167|FG000|Double-Blind Phase|Withdrew Consent|20|||
130621148|NCT01797445|470233168|FG001|Double-Blind Phase|Withdrew Consent|35|||
130621149|NCT01797445|470233167|FG000|Double-Blind Phase|Lost to Follow-up|34|||
130621150|NCT01797445|470233168|FG001|Double-Blind Phase|Lost to Follow-up|26|||
130621151|NCT01797445|470233167|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
130621152|NCT01797445|470233168|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
130621153|NCT01595438|470233169|FG000|Overall Study|Lost to Follow-up|20|||
130621154|NCT01595438|470233170|FG001|Overall Study|Lost to Follow-up|20|||
130621155|NCT01595438|470233169|FG000|Overall Study|Withdrawal by Subject|12|||
130621156|NCT01595438|470233170|FG001|Overall Study|Withdrawal by Subject|12|||
130621157|NCT01595438|470233169|FG000|Overall Study|Other Eligibility criteria|11|||
130621158|NCT01595438|470233170|FG001|Overall Study|Other Eligibility criteria|9|||
130621159|NCT00650091|470233171|FG000|Amended Study Design|Withdrawal by Subject|12|||
130621160|NCT00650091|470233172|FG001|Amended Study Design|Withdrawal by Subject|11|||
130621161|NCT00650091|470233173|FG002|Amended Study Design|Withdrawal by Subject|0|||
130621162|NCT00650091|470233171|FG000|Amended Study Design|Physician Decision|5|||
130621163|NCT00650091|470233172|FG001|Amended Study Design|Physician Decision|0|||
130621164|NCT00650091|470233173|FG002|Amended Study Design|Physician Decision|0|||
130621165|NCT00650091|470233171|FG000|Amended Study Design|Adverse Event|1|||
130621166|NCT00650091|470233172|FG001|Amended Study Design|Adverse Event|4|||
130621167|NCT00650091|470233173|FG002|Amended Study Design|Adverse Event|0|||
130621168|NCT00650091|470233171|FG000|Amended Study Design|Lung transplantation|4|||
130621169|NCT00650091|470233172|FG001|Amended Study Design|Lung transplantation|2|||
130621170|NCT00650091|470233173|FG002|Amended Study Design|Lung transplantation|0|||
130621171|NCT00650091|470233171|FG000|Amended Study Design|Other|1|||
130621172|NCT00650091|470233172|FG001|Amended Study Design|Other|3|||
130621173|NCT00650091|470233173|FG002|Amended Study Design|Other|0|||
130621174|NCT04116073|470233182|FG000|Overall Study|Withdrawal by Subject|2|||
130621175|NCT04116073|470233182|FG000|Overall Study|failed to maintained eligibility|1|||
130621176|NCT01429077|470233187|FG000|Overall Study|Lost to Follow-up|0|||
130621177|NCT01429077|470233188|FG001|Overall Study|Lost to Follow-up|3|||
130621178|NCT03067129|470233189|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130621179|NCT03067129|470233190|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130621180|NCT03067129|470233191|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130621181|NCT03067129|470233192|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
130621182|NCT03067129|470233189|FG000|Overall Study|Withdrawal by Subject|0|||
130621183|NCT03067129|470233190|FG001|Overall Study|Withdrawal by Subject|0|||
130621184|NCT03067129|470233191|FG002|Overall Study|Withdrawal by Subject|1|||
130621185|NCT03067129|470233192|FG003|Overall Study|Withdrawal by Subject|2|||
130621186|NCT03067129|470233189|FG000|Overall Study|Lost to Follow-up|5|||
130621187|NCT03067129|470233190|FG001|Overall Study|Lost to Follow-up|5|||
130621188|NCT03067129|470233191|FG002|Overall Study|Lost to Follow-up|4|||
130621189|NCT03067129|470233192|FG003|Overall Study|Lost to Follow-up|3|||
130621190|NCT02806947|470233193|FG000|Overall Study|Withdrawal by Subject|5|||
130621191|NCT02806947|470233194|FG001|Overall Study|Withdrawal by Subject|1|||
130621192|NCT02029638|470233196|FG000|Overall Study|Death|0|||
130621193|NCT02029638|470233197|FG001|Overall Study|Death|0|||
130621194|NCT02029638|470233198|FG002|Overall Study|Death|1|||
130621195|NCT02029638|470233196|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
130621196|NCT02029638|470233197|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
130621197|NCT02029638|470233198|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
130621198|NCT02563925|470233199|FG000|Overall Study|Withdrawal by Subject|2|||
130621199|NCT00400712|470233200|FG000|Overall Study|Death|1|||
130621200|NCT00400712|470233201|FG001|Overall Study|Death|0|||
130621201|NCT00400712|470233200|FG000|Overall Study|Withdrawal by Subject|11|||
130621202|NCT00400712|470233201|FG001|Overall Study|Withdrawal by Subject|12|||
130621203|NCT00400712|470233200|FG000|Overall Study|Physician Decision|5|||
130621204|NCT00400712|470233201|FG001|Overall Study|Physician Decision|4|||
130621205|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
130621206|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
130621207|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
130621208|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
130621209|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
130621210|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
130621211|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Death|1|||
130621212|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Death|3|||
130621213|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
130621214|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
130621215|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
130621216|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
130621217|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
130621218|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
130621219|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
130621220|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
130621221|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
130621222|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
130621223|NCT02553317|470233204|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
130621224|NCT02553317|470233205|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
130621225|NCT03483116|470233206|FG000|Overall Study|Adverse Event|0|||
130621226|NCT03483116|470233207|FG001|Overall Study|Adverse Event|1|||
130621227|NCT03483116|470233208|FG002|Overall Study|Adverse Event|0|||
130621228|NCT03483116|470233209|FG003|Overall Study|Adverse Event|1|||
130621229|NCT03483116|470233206|FG000|Overall Study|Protocol Violation|1|||
130621230|NCT03483116|470233207|FG001|Overall Study|Protocol Violation|0|||
130621231|NCT03483116|470233208|FG002|Overall Study|Protocol Violation|0|||
130621232|NCT03483116|470233209|FG003|Overall Study|Protocol Violation|7|||
130621233|NCT03483116|470233206|FG000|Overall Study|Lost to Follow-up|9|||
130621234|NCT03483116|470233207|FG001|Overall Study|Lost to Follow-up|4|||
130621235|NCT03483116|470233208|FG002|Overall Study|Lost to Follow-up|9|||
130621236|NCT03483116|470233209|FG003|Overall Study|Lost to Follow-up|5|||
130621237|NCT03483116|470233206|FG000|Overall Study|Death|1|||
130621238|NCT03483116|470233207|FG001|Overall Study|Death|0|||
130621239|NCT03483116|470233208|FG002|Overall Study|Death|2|||
130621240|NCT03483116|470233209|FG003|Overall Study|Death|1|||
130621241|NCT03483116|470233206|FG000|Overall Study|Withdrawal by Subject|14|||
130621242|NCT03483116|470233207|FG001|Overall Study|Withdrawal by Subject|16|||
130621243|NCT03483116|470233208|FG002|Overall Study|Withdrawal by Subject|14|||
130621244|NCT03483116|470233209|FG003|Overall Study|Withdrawal by Subject|16|||
130621245|NCT03483116|470233206|FG000|Overall Study|Unknown other reason|3|||
130621246|NCT03483116|470233207|FG001|Overall Study|Unknown other reason|2|||
130621247|NCT03483116|470233208|FG002|Overall Study|Unknown other reason|1|||
130621248|NCT03483116|470233209|FG003|Overall Study|Unknown other reason|1|||
130621249|NCT01181102|470233210|FG000|Overall Study|Adverse Event|28|||
130621250|NCT01181102|470233211|FG001|Overall Study|Adverse Event|26|||
130621251|NCT01181102|470233210|FG000|Overall Study|Lack of Efficacy|3|||
130621252|NCT01181102|470233211|FG001|Overall Study|Lack of Efficacy|1|||
130621253|NCT01181102|470233210|FG000|Overall Study|Lost to Follow-up|2|||
130621254|NCT01181102|470233211|FG001|Overall Study|Lost to Follow-up|0|||
130621255|NCT01181102|470233210|FG000|Overall Study|Physician Decision|3|||
130621256|NCT01181102|470233211|FG001|Overall Study|Physician Decision|1|||
130621257|NCT01181102|470233210|FG000|Overall Study|Protocol Violation|5|||
130621258|NCT01181102|470233211|FG001|Overall Study|Protocol Violation|6|||
130621259|NCT01181102|470233210|FG000|Overall Study|Withdrawal by Subject|10|||
130621260|NCT01181102|470233211|FG001|Overall Study|Withdrawal by Subject|12|||
130621261|NCT04685499|470233217|FG000|Overall Study|Study Terminated Early|1|||
130621262|NCT03176277|470233218|FG000|Part A Dose Escalation Study|Adverse Event|1|||
130621263|NCT03176277|470233219|FG001|Part A Dose Escalation Study|Adverse Event|0|||
130621264|NCT03176277|470233220|FG002|Part A Dose Escalation Study|Adverse Event|1|||
130621265|NCT03176277|470233221|FG003|Part A Dose Escalation Study|Adverse Event|0|||
130621266|NCT03176277|470233218|FG000|Part A Dose Escalation Study|Physician Decision|1|||
130621267|NCT03176277|470233219|FG001|Part A Dose Escalation Study|Physician Decision|1|||
130621268|NCT03176277|470233220|FG002|Part A Dose Escalation Study|Physician Decision|2|||
130621269|NCT03176277|470233221|FG003|Part A Dose Escalation Study|Physician Decision|0|||
130621270|NCT03176277|470233218|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
130621271|NCT03176277|470233219|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
130621272|NCT03176277|470233220|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
130621273|NCT03176277|470233221|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
130621274|NCT03176277|470233218|FG000|Part A Dose Escalation Study|Progressive disease|3|||
130621275|NCT03176277|470233219|FG001|Part A Dose Escalation Study|Progressive disease|1|||
130621276|NCT03176277|470233220|FG002|Part A Dose Escalation Study|Progressive disease|3|||
130621277|NCT03176277|470233221|FG003|Part A Dose Escalation Study|Progressive disease|0|||
130621278|NCT00634114|470233222|FG000|Overall Study|Adverse Event|6|||
130621279|NCT00634114|470233223|FG001|Overall Study|Adverse Event|8|||
130621280|NCT00634114|470233224|FG002|Overall Study|Adverse Event|3|||
130621281|NCT00634114|470233222|FG000|Overall Study|Withdrawal by Subject|9|||
130621282|NCT00634114|470233223|FG001|Overall Study|Withdrawal by Subject|6|||
130621283|NCT00634114|470233224|FG002|Overall Study|Withdrawal by Subject|11|||
130621284|NCT00634114|470233222|FG000|Overall Study|Lost to Follow-up|0|||
130621285|NCT00634114|470233223|FG001|Overall Study|Lost to Follow-up|0|||
130621286|NCT00634114|470233224|FG002|Overall Study|Lost to Follow-up|1|||
130621287|NCT00634114|470233222|FG000|Overall Study|Protocol Violation|3|||
130621288|NCT00634114|470233223|FG001|Overall Study|Protocol Violation|3|||
130621289|NCT00634114|470233224|FG002|Overall Study|Protocol Violation|1|||
130621290|NCT00634114|470233222|FG000|Overall Study|Pregnancy|1|||
130621291|NCT00634114|470233223|FG001|Overall Study|Pregnancy|0|||
130621292|NCT00634114|470233224|FG002|Overall Study|Pregnancy|0|||
130621293|NCT00634114|470233222|FG000|Overall Study|Incorrect enrolment|0|||
130621294|NCT00634114|470233223|FG001|Overall Study|Incorrect enrolment|1|||
130621295|NCT00634114|470233224|FG002|Overall Study|Incorrect enrolment|0|||
130621296|NCT00634114|470233222|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
130621297|NCT00634114|470233223|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
130621298|NCT00634114|470233224|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
130621299|NCT00634114|470233222|FG000|Overall Study|Difficult to continue|3|||
130621300|NCT00634114|470233223|FG001|Overall Study|Difficult to continue|1|||
130621301|NCT00634114|470233224|FG002|Overall Study|Difficult to continue|1|||
130621302|NCT00634114|470233222|FG000|Overall Study|Other reason|1|||
130621303|NCT00634114|470233223|FG001|Overall Study|Other reason|1|||
130621304|NCT00634114|470233224|FG002|Overall Study|Other reason|1|||
130621305|NCT01996904|470233225|FG000|Overall Study|Lost to Follow-up|38|||
130621306|NCT01996904|470233226|FG001|Overall Study|Lost to Follow-up|27|||
130621307|NCT04664855|470233227|FG000|Overall Study|Withdrawal by Subject|0|||
130621308|NCT04664855|470233228|FG001|Overall Study|Withdrawal by Subject|2|||
130621309|NCT05127421|470233229|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
130621310|NCT05127421|470233230|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
130621311|NCT05127421|470233231|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
130621312|NCT05127421|470233232|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
130621313|NCT05127421|470233229|FG000|4-Week Double-Blind Period|Physician Decision|1|||
130621314|NCT05127421|470233230|FG001|4-Week Double-Blind Period|Physician Decision|0|||
130621315|NCT05127421|470233231|FG002|4-Week Double-Blind Period|Physician Decision|0|||
130621316|NCT05127421|470233232|FG003|4-Week Double-Blind Period|Physician Decision|0|||
130621317|NCT05127421|470233229|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
130621318|NCT05127421|470233230|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
130621319|NCT05127421|470233231|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
130621320|NCT05127421|470233232|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
130621321|NCT05127421|470233229|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130621322|NCT05127421|470233230|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
130621323|NCT05127421|470233231|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130621324|NCT05127421|470233232|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130621325|NCT05127421|470233229|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130621326|NCT05127421|470233230|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
130621327|NCT05127421|470233231|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130621328|NCT05127421|470233232|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130621329|NCT05127421|470233229|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
130621330|NCT05127421|470233230|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
130621331|NCT05127421|470233231|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
130621332|NCT05127421|470233232|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
130621333|NCT05127421|470233229|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
130621334|NCT05127421|470233230|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
130621335|NCT05127421|470233231|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
130621336|NCT05127421|470233232|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
130621337|NCT05127421|470233229|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130621338|NCT05127421|470233230|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130621339|NCT05127421|470233231|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130621340|NCT05127421|470233232|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
130621341|NCT02219087|470233233|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
130621342|NCT02219087|470233234|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
130621343|NCT00574496|470233235|FG000|Overall Study|Withdrawal by Subject|1|||
130621344|NCT03543358|470233236|FG000|Overall Study|Death|1|||
130621345|NCT03543358|470233237|FG001|Overall Study|Death|0|||
130621346|NCT03543358|470233236|FG000|Overall Study|Disease Progression|1|||
130621347|NCT03543358|470233237|FG001|Overall Study|Disease Progression|0|||
130621348|NCT03543358|470233236|FG000|Overall Study|Parent Study Closure|1|||
130621349|NCT03543358|470233237|FG001|Overall Study|Parent Study Closure|0|||
130621350|NCT00870818|470233238|FG000|Overall Study|Lost to Follow-up|3|||
130621351|NCT00870818|470233239|FG001|Overall Study|Lost to Follow-up|2|||
130621352|NCT00870818|470233240|FG002|Overall Study|Lost to Follow-up|1|||
130621353|NCT00870818|470233241|FG003|Overall Study|Lost to Follow-up|0|||
130621354|NCT00870818|470233242|FG004|Overall Study|Lost to Follow-up|0|||
130621355|NCT00870818|470233238|FG000|Overall Study|Withdrawal by Subject|0|||
130621356|NCT00870818|470233239|FG001|Overall Study|Withdrawal by Subject|0|||
130621357|NCT00870818|470233240|FG002|Overall Study|Withdrawal by Subject|1|||
130621358|NCT00870818|470233241|FG003|Overall Study|Withdrawal by Subject|2|||
130621359|NCT00870818|470233242|FG004|Overall Study|Withdrawal by Subject|0|||
130621360|NCT00870818|470233238|FG000|Overall Study|Terminated by sponsor|29|||
130621361|NCT00870818|470233239|FG001|Overall Study|Terminated by sponsor|70|||
130621362|NCT00870818|470233240|FG002|Overall Study|Terminated by sponsor|36|||
130621363|NCT00870818|470233241|FG003|Overall Study|Terminated by sponsor|36|||
130621364|NCT00870818|470233242|FG004|Overall Study|Terminated by sponsor|38|||
130621365|NCT00870818|470233238|FG000|Overall Study|Other|0|||
130621366|NCT00870818|470233239|FG001|Overall Study|Other|1|||
130621367|NCT00870818|470233240|FG002|Overall Study|Other|0|||
130621368|NCT00870818|470233241|FG003|Overall Study|Other|0|||
130621369|NCT00870818|470233242|FG004|Overall Study|Other|0|||
130621370|NCT00178464|470233244|FG000|Overall Study|Withdrawal by Subject|1|||
130621371|NCT00178464|470233244|FG000|Overall Study|Physician Decision|1|||
130621372|NCT01766817|470233245|FG000|Overall Study|Drug-related adverse event|1|||
130621373|NCT01766817|470233246|FG001|Overall Study|Drug-related adverse event|2|||
130621374|NCT01766817|470233247|FG002|Overall Study|Drug-related adverse event|1|||
130621375|NCT01766817|470233245|FG000|Overall Study|Drug-unrelated adverse event|3|||
130621376|NCT01766817|470233246|FG001|Overall Study|Drug-unrelated adverse event|3|||
130621377|NCT01766817|470233247|FG002|Overall Study|Drug-unrelated adverse event|3|||
130621378|NCT01766817|470233245|FG000|Overall Study|Death|1|||
130621379|NCT01766817|470233246|FG001|Overall Study|Death|1|||
130621380|NCT01766817|470233247|FG002|Overall Study|Death|0|||
130621381|NCT01766817|470233245|FG000|Overall Study|Unable to take study drug|0|||
130621382|NCT01766817|470233246|FG001|Overall Study|Unable to take study drug|1|||
130621383|NCT01766817|470233247|FG002|Overall Study|Unable to take study drug|0|||
130621384|NCT01766817|470233245|FG000|Overall Study|Withdrawal by Subject|2|||
130621385|NCT01766817|470233246|FG001|Overall Study|Withdrawal by Subject|0|||
130621386|NCT01766817|470233247|FG002|Overall Study|Withdrawal by Subject|3|||
130621387|NCT01766817|470233245|FG000|Overall Study|Subject non-compliance|0|||
130621388|NCT01766817|470233246|FG001|Overall Study|Subject non-compliance|1|||
130621389|NCT01766817|470233247|FG002|Overall Study|Subject non-compliance|2|||
130621390|NCT01766817|470233245|FG000|Overall Study|Physician Decision|3|||
130621391|NCT01766817|470233246|FG001|Overall Study|Physician Decision|3|||
130621392|NCT01766817|470233247|FG002|Overall Study|Physician Decision|4|||
130621393|NCT01766817|470233245|FG000|Overall Study|Other|1|||
130621394|NCT01766817|470233246|FG001|Overall Study|Other|0|||
130621395|NCT01766817|470233247|FG002|Overall Study|Other|0|||
130621396|NCT04900038|470233248|FG000|Overall Study|Adverse Event|1|||
130621397|NCT04900038|470233249|FG001|Overall Study|Adverse Event|0|||
130621398|NCT04900038|470233250|FG002|Overall Study|Adverse Event|1|||
130621399|NCT04900038|470233251|FG003|Overall Study|Adverse Event|1|||
130621400|NCT04900038|470233248|FG000|Overall Study|Withdrawal by Subject|0|||
130621401|NCT04900038|470233249|FG001|Overall Study|Withdrawal by Subject|1|||
130621402|NCT04900038|470233250|FG002|Overall Study|Withdrawal by Subject|0|||
130621403|NCT04900038|470233251|FG003|Overall Study|Withdrawal by Subject|0|||
130621404|NCT04900038|470233248|FG000|Overall Study|Study terminated by sponsor|18|||
130621405|NCT04900038|470233249|FG001|Overall Study|Study terminated by sponsor|15|||
130621406|NCT04900038|470233250|FG002|Overall Study|Study terminated by sponsor|17|||
130621407|NCT04900038|470233251|FG003|Overall Study|Study terminated by sponsor|14|||
130621408|NCT04900038|470233248|FG000|Overall Study|Protocol Deviation|1|||
130621409|NCT04900038|470233249|FG001|Overall Study|Protocol Deviation|1|||
130621410|NCT04900038|470233250|FG002|Overall Study|Protocol Deviation|0|||
130621411|NCT04900038|470233251|FG003|Overall Study|Protocol Deviation|0|||
130621412|NCT04900038|470233248|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
130621413|NCT04900038|470233249|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
130621414|NCT04900038|470233250|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
130621415|NCT04900038|470233251|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
130621416|NCT04900038|470233248|FG000|Overall Study|Lost to Follow-up|0|||
130621417|NCT04900038|470233249|FG001|Overall Study|Lost to Follow-up|0|||
130621418|NCT04900038|470233250|FG002|Overall Study|Lost to Follow-up|0|||
130621419|NCT04900038|470233251|FG003|Overall Study|Lost to Follow-up|1|||
130621420|NCT02227108|470233252|FG000|Overall Study|Did not receive treatment|2|||
130621421|NCT02227108|470233252|FG000|Overall Study|Other|3|||
130621422|NCT02227108|470233252|FG000|Overall Study|Progressive disease|17|||
130621423|NCT02227108|470233252|FG000|Overall Study|Initiation of alternative therapy|2|||
130621424|NCT02227108|470233252|FG000|Overall Study|Investigator discretion|1|||
130621425|NCT02227108|470233252|FG000|Overall Study|Adverse Event|6|||
130621426|NCT02486952|470233255|FG000|Overall Study|Not Started Induction Therapy|3|||
130621427|NCT02486952|470233255|FG000|Overall Study|Adverse Event|1|||
130621428|NCT02486952|470233255|FG000|Overall Study|Death|15|||
130621429|NCT02486952|470233255|FG000|Overall Study|Lack of Efficacy|3|||
130621430|NCT02486952|470233255|FG000|Overall Study|Lost to Follow-up|26|||
130621431|NCT02486952|470233255|FG000|Overall Study|Other|2|||
130621432|NCT01928485|470233257|FG000|Overall Study|Physician Decision|0|||
130621433|NCT01928485|470233258|FG001|Overall Study|Physician Decision|1|||
130621434|NCT04111107|470233259|FG000|Overall Study|Withdrawal by Subject|6|||
130621435|NCT04111107|470233259|FG000|Overall Study|Declining Health|5|||
130621436|NCT02721251|470233260|FG000|Overall Study|Withdrawal by Subject|8|||
130621437|NCT02721251|470233261|FG001|Overall Study|Withdrawal by Subject|7|||
130621438|NCT02721251|470233262|FG002|Overall Study|Withdrawal by Subject|9|||
130621439|NCT02721251|470233260|FG000|Overall Study|poor adherence|2|||
130621440|NCT02721251|470233261|FG001|Overall Study|poor adherence|2|||
130621441|NCT02721251|470233262|FG002|Overall Study|poor adherence|2|||
130621442|NCT01714817|470233263|FG000|Year 1 Period|Lack of Efficacy|11|||
130621443|NCT01714817|470233264|FG001|Year 1 Period|Lack of Efficacy|9|||
130621444|NCT01714817|470233263|FG000|Year 1 Period|Adverse Event|20|||
130621445|NCT01714817|470233264|FG001|Year 1 Period|Adverse Event|17|||
130621446|NCT01714817|470233263|FG000|Year 1 Period|Withdrawal by Subject|6|||
130621447|NCT01714817|470233264|FG001|Year 1 Period|Withdrawal by Subject|7|||
130621448|NCT01714817|470233263|FG000|Year 1 Period|Death|1|||
130621449|NCT01714817|470233264|FG001|Year 1 Period|Death|1|||
130621450|NCT01714817|470233263|FG000|Year 1 Period|Lost to Follow-up|0|||
130621451|NCT01714817|470233264|FG001|Year 1 Period|Lost to Follow-up|2|||
130621452|NCT01714817|470233263|FG000|Year 1 Period|Poor / non-compliance|0|||
130621453|NCT01714817|470233264|FG001|Year 1 Period|Poor / non-compliance|1|||
130621454|NCT01714817|470233263|FG000|Year 1 Period|Pregnancy|2|||
130621455|NCT01714817|470233264|FG001|Year 1 Period|Pregnancy|0|||
130621456|NCT01714817|470233263|FG000|Year 1 Period|Participant no longer meets criteria|6|||
130621457|NCT01714817|470233264|FG001|Year 1 Period|Participant no longer meets criteria|2|||
130621458|NCT01714817|470233263|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
130621459|NCT01714817|470233264|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
130621460|NCT01714817|470233263|FG000|Year 1 Period|Change in Concomitant Medication|0|||
130621461|NCT01714817|470233264|FG001|Year 1 Period|Change in Concomitant Medication|1|||
130621462|NCT01714817|470233263|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
130621463|NCT01714817|470233264|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
130621464|NCT01714817|470233263|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
130621465|NCT01714817|470233264|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
130621466|NCT01714817|470233263|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
130621467|NCT01714817|470233264|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
130621468|NCT01714817|470233263|FG000|Year 2 Period|Lack of Efficacy|4|||
130621469|NCT01714817|470233264|FG001|Year 2 Period|Lack of Efficacy|12|||
130621470|NCT01714817|470233263|FG000|Year 2 Period|Adverse Event|7|||
130621471|NCT01714817|470233264|FG001|Year 2 Period|Adverse Event|6|||
130621472|NCT01714817|470233263|FG000|Year 2 Period|Participant request to stop treatment|4|||
130621473|NCT01714817|470233264|FG001|Year 2 Period|Participant request to stop treatment|4|||
130621474|NCT01714817|470233263|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
130621475|NCT01714817|470233264|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
130621476|NCT01714817|470233263|FG000|Year 2 Period|Participant withdrew consent|1|||
130621477|NCT01714817|470233264|FG001|Year 2 Period|Participant withdrew consent|5|||
130621478|NCT01714817|470233263|FG000|Year 2 Period|Participant no longer meets criteria|1|||
130621479|NCT01714817|470233264|FG001|Year 2 Period|Participant no longer meets criteria|4|||
130621480|NCT01714817|470233263|FG000|Year 2 Period|Lost to Follow-up|2|||
130621481|NCT01714817|470233264|FG001|Year 2 Period|Lost to Follow-up|0|||
130621482|NCT01714817|470233263|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
130621483|NCT01714817|470233264|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
130621484|NCT01714817|470233263|FG000|Year 2 Period|Pregnancy|1|||
130621485|NCT01714817|470233264|FG001|Year 2 Period|Pregnancy|1|||
130621486|NCT01714817|470233263|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
130621487|NCT01714817|470233264|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
130621488|NCT01714817|470233263|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
130621489|NCT01714817|470233264|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
130621490|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
130621491|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
130621492|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
130621493|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
130621494|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
130621495|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
130621496|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
130621497|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
130621498|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
130621499|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
130621500|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
130621501|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
130621502|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130621503|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
130621504|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
130621505|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
130621506|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
130621507|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
130621508|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
130621509|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
130621510|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
130621511|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
130621512|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
130621513|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
130621514|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
130621515|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
130621516|NCT01714817|470233263|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
130621517|NCT01714817|470233264|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
130621518|NCT02921763|470233265|FG000|Overall Study|Adverse Event|4|||
130621519|NCT02921763|470233265|FG000|Overall Study|Lost to Follow-up|4|||
130621520|NCT02921763|470233265|FG000|Overall Study|Lack of Efficacy|3|||
130621521|NCT02921763|470233265|FG000|Overall Study|Protocol Violation|2|||
130621522|NCT02921763|470233265|FG000|Overall Study|Withdrawal by Subject|2|||
130621523|NCT02921763|470233265|FG000|Overall Study|Physician Decision|1|||
130621524|NCT02921763|470233265|FG000|Overall Study|No data obtained|2|||
130621525|NCT01582971|470233266|FG000|Overall Study|Death|2|||
130621526|NCT01582971|470233267|FG001|Overall Study|Death|1|||
130621527|NCT01582971|470233266|FG000|Overall Study|Lost to Follow-up|18|||
130621528|NCT01582971|470233267|FG001|Overall Study|Lost to Follow-up|21|||
130621529|NCT01582971|470233266|FG000|Overall Study|Withdrawal by Subject|4|||
130621530|NCT01582971|470233267|FG001|Overall Study|Withdrawal by Subject|2|||
130621531|NCT01582971|470233266|FG000|Overall Study|Other|15|||
130621532|NCT01582971|470233267|FG001|Overall Study|Other|13|||
130621533|NCT02554253|470233275|FG000|Overall Study|ineligible after enrollment|1|||
130621534|NCT02554253|470233276|FG001|Overall Study|ineligible after enrollment|0|||
130621535|NCT02554253|470233275|FG000|Overall Study|converted to transcatheter procedure|0|||
130621536|NCT02554253|470233276|FG001|Overall Study|converted to transcatheter procedure|1|||
130621537|NCT02554253|470233275|FG000|Overall Study|received both drugs|0|||
130621538|NCT02554253|470233276|FG001|Overall Study|received both drugs|1|||
130621539|NCT01736254|470233279|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
130621540|NCT01736254|470233279|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
130621541|NCT02559206|470233280|FG000|Overall Study|Adverse Event|0|||
130621542|NCT02559206|470233281|FG001|Overall Study|Adverse Event|4|||
130621543|NCT02559206|470233282|FG002|Overall Study|Adverse Event|1|||
130621544|NCT02559206|470233283|FG003|Overall Study|Adverse Event|5|||
130621545|NCT02559206|470233284|FG004|Overall Study|Adverse Event|3|||
130621546|NCT02559206|470233285|FG005|Overall Study|Adverse Event|0|||
130621547|NCT02559206|470233286|FG006|Overall Study|Adverse Event|1|||
130621548|NCT02559206|470233287|FG007|Overall Study|Adverse Event|0|||
130621549|NCT02559206|470233280|FG000|Overall Study|Protocol Violation|1|||
130621550|NCT02559206|470233281|FG001|Overall Study|Protocol Violation|0|||
130621551|NCT02559206|470233282|FG002|Overall Study|Protocol Violation|1|||
130621552|NCT02559206|470233283|FG003|Overall Study|Protocol Violation|0|||
130621553|NCT02559206|470233284|FG004|Overall Study|Protocol Violation|0|||
130621554|NCT02559206|470233285|FG005|Overall Study|Protocol Violation|2|||
130621555|NCT02559206|470233286|FG006|Overall Study|Protocol Violation|0|||
130621556|NCT02559206|470233287|FG007|Overall Study|Protocol Violation|0|||
130621557|NCT02559206|470233280|FG000|Overall Study|Withdrawal by Subject|3|||
130621558|NCT02559206|470233281|FG001|Overall Study|Withdrawal by Subject|3|||
130621559|NCT02559206|470233282|FG002|Overall Study|Withdrawal by Subject|1|||
130621560|NCT02559206|470233283|FG003|Overall Study|Withdrawal by Subject|3|||
130621561|NCT02559206|470233284|FG004|Overall Study|Withdrawal by Subject|5|||
130621562|NCT02559206|470233285|FG005|Overall Study|Withdrawal by Subject|4|||
130621563|NCT02559206|470233286|FG006|Overall Study|Withdrawal by Subject|1|||
130621564|NCT02559206|470233287|FG007|Overall Study|Withdrawal by Subject|2|||
130621565|NCT02559206|470233280|FG000|Overall Study|Lost to Follow-up|3|||
130621566|NCT02559206|470233281|FG001|Overall Study|Lost to Follow-up|5|||
130621567|NCT02559206|470233282|FG002|Overall Study|Lost to Follow-up|3|||
130621568|NCT02559206|470233283|FG003|Overall Study|Lost to Follow-up|3|||
130621569|NCT02559206|470233284|FG004|Overall Study|Lost to Follow-up|2|||
130621570|NCT02559206|470233285|FG005|Overall Study|Lost to Follow-up|5|||
130621571|NCT02559206|470233286|FG006|Overall Study|Lost to Follow-up|1|||
130621572|NCT02559206|470233287|FG007|Overall Study|Lost to Follow-up|4|||
130621573|NCT02559206|470233280|FG000|Overall Study|Lack of Efficacy|1|||
130621574|NCT02559206|470233281|FG001|Overall Study|Lack of Efficacy|0|||
130621575|NCT02559206|470233282|FG002|Overall Study|Lack of Efficacy|3|||
130621576|NCT02559206|470233283|FG003|Overall Study|Lack of Efficacy|2|||
130621577|NCT02559206|470233284|FG004|Overall Study|Lack of Efficacy|2|||
130621578|NCT02559206|470233285|FG005|Overall Study|Lack of Efficacy|3|||
130621579|NCT02559206|470233286|FG006|Overall Study|Lack of Efficacy|3|||
130621580|NCT02559206|470233287|FG007|Overall Study|Lack of Efficacy|3|||
130621581|NCT02559206|470233280|FG000|Overall Study|Other Not Specified|0|||
130621582|NCT02559206|470233281|FG001|Overall Study|Other Not Specified|0|||
130621583|NCT02559206|470233282|FG002|Overall Study|Other Not Specified|0|||
130621584|NCT02559206|470233283|FG003|Overall Study|Other Not Specified|1|||
130621585|NCT02559206|470233284|FG004|Overall Study|Other Not Specified|0|||
130621586|NCT02559206|470233285|FG005|Overall Study|Other Not Specified|0|||
130621587|NCT02559206|470233286|FG006|Overall Study|Other Not Specified|0|||
130621588|NCT02559206|470233287|FG007|Overall Study|Other Not Specified|0|||
130621589|NCT01561560|470233288|FG000|First Two Weeks of Wear|Time/job conflict|0|||
130621590|NCT01561560|470233289|FG001|First Two Weeks of Wear|Time/job conflict|1|||
130621591|NCT01561560|470233288|FG000|First Two Weeks of Wear|Adverse Event|0|||
130621592|NCT01561560|470233289|FG001|First Two Weeks of Wear|Adverse Event|1|||
130621593|NCT01561560|470233288|FG000|Second Two Weeks of Wear|Adverse Event|0|||
130621594|NCT01561560|470233289|FG001|Second Two Weeks of Wear|Adverse Event|1|||
130621595|NCT01871896|470233292|FG000|Overall Study|Lost to Follow-up|1|||
130621596|NCT01512108|470234465|FG000|Overall Study|Adverse Event|9|||
130621597|NCT01512108|470234466|FG001|Overall Study|Adverse Event|4|||
130621598|NCT01512108|470234465|FG000|Overall Study|Protocol Violation|1|||
130621599|NCT01512108|470234466|FG001|Overall Study|Protocol Violation|2|||
130621600|NCT01512108|470234465|FG000|Overall Study|Withdrawal Criteria|1|||
130621601|NCT01512108|470234466|FG001|Overall Study|Withdrawal Criteria|0|||
130621602|NCT01512108|470234465|FG000|Overall Study|Unclassified|11|||
130621603|NCT01512108|470234466|FG001|Overall Study|Unclassified|3|||
130621604|NCT06422377|470234471|FG000|Overall Study|Study Terminated by Sponsor|1|||
130621605|NCT02843178|470234474|FG000|Overall Study|Lost to Follow-up|8|||
130621606|NCT02843178|470234475|FG001|Overall Study|Lost to Follow-up|8|||
130621607|NCT02843178|470234476|FG002|Overall Study|Lost to Follow-up|6|||
130621608|NCT02843178|470234477|FG003|Overall Study|Lost to Follow-up|3|||
130621609|NCT02843178|470234474|FG000|Overall Study|Withdrawal by Subject|0|||
130621610|NCT02843178|470234475|FG001|Overall Study|Withdrawal by Subject|0|||
130621611|NCT02843178|470234476|FG002|Overall Study|Withdrawal by Subject|1|||
130621612|NCT02843178|470234477|FG003|Overall Study|Withdrawal by Subject|1|||
130621613|NCT03287245|470234481|FG000|Overall Study|Study terminated by sponsor|3|||
130621614|NCT03287245|470234482|FG001|Overall Study|Study terminated by sponsor|0|||
130621615|NCT03287245|470234483|FG002|Overall Study|Study terminated by sponsor|3|||
130621616|NCT03287245|470234484|FG003|Overall Study|Study terminated by sponsor|1|||
130621617|NCT03287245|470234481|FG000|Overall Study|Adverse Event|1|||
130621618|NCT03287245|470234482|FG001|Overall Study|Adverse Event|0|||
130621619|NCT03287245|470234483|FG002|Overall Study|Adverse Event|0|||
130621620|NCT03287245|470234484|FG003|Overall Study|Adverse Event|0|||
130621621|NCT03287245|470234481|FG000|Overall Study|Withdrawal by Subject|8|||
130621622|NCT03287245|470234482|FG001|Overall Study|Withdrawal by Subject|3|||
130621623|NCT03287245|470234483|FG002|Overall Study|Withdrawal by Subject|3|||
130621624|NCT03287245|470234484|FG003|Overall Study|Withdrawal by Subject|0|||
130621625|NCT03287245|470234481|FG000|Overall Study|Physician Decision|3|||
130621626|NCT03287245|470234482|FG001|Overall Study|Physician Decision|2|||
130621627|NCT03287245|470234483|FG002|Overall Study|Physician Decision|0|||
130621628|NCT03287245|470234484|FG003|Overall Study|Physician Decision|0|||
130621629|NCT02701192|470234485|FG000|Overall Study|Protocol Violation|2|||
130621630|NCT02701192|470234485|FG000|Overall Study|Lost to Follow-up|4|||
130621631|NCT00949910|470234486|FG000|Overall Study|Progressive Disease|3750|||
130621632|NCT00949910|470234486|FG000|Overall Study|Symptomatic Deterioration|1088|||
130621633|NCT00949910|470234486|FG000|Overall Study|Lost to Follow-up|100|||
130621634|NCT00949910|470234486|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
130621635|NCT00949910|470234486|FG000|Overall Study|Participant Refusal|390|||
130621636|NCT00949910|470234486|FG000|Overall Study|Death Due to Malignant Disease|456|||
130621637|NCT00949910|470234486|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
130621638|NCT00949910|470234486|FG000|Overall Study|Death Due to Adverse Event|115|||
130621639|NCT00949910|470234486|FG000|Overall Study|Death Due to Toxicity|3|||
130621640|NCT00949910|470234486|FG000|Overall Study|Death from Unknown Cause|5|||
130621641|NCT00949910|470234486|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
130621642|NCT00949910|470234486|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
130621643|NCT00949910|470234486|FG000|Overall Study|Switched to Commercial Treatment|4|||
130621644|NCT00949910|470234486|FG000|Overall Study|Violation of Eligibility|23|||
130621645|NCT00949910|470234486|FG000|Overall Study|Logistical Reasons|13|||
130621646|NCT00949910|470234486|FG000|Overall Study|Non-Compliance|10|||
130621647|NCT00949910|470234486|FG000|Overall Study|Prolonged Dosing Interruption|4|||
130621648|NCT00949910|470234486|FG000|Overall Study|Adverse Event|83|||
130621649|NCT00949910|470234486|FG000|Overall Study|Serious Adverse Event|6|||
130621650|NCT00949910|470234486|FG000|Overall Study|Physician/Participant Decision|7|||
130621651|NCT00949910|470234486|FG000|Overall Study|Other|4|||
130621652|NCT00949910|470234486|FG000|Overall Study|No Data|9|||
130621653|NCT02150213|470234487|FG000|Overall Study|Lost to Follow-up|1|||
130621654|NCT02150213|470234487|FG000|Overall Study|Withdrawal by Subject|1|||
130621655|NCT02678312|470234488|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
130621656|NCT02678312|470234489|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130621657|NCT02678312|470234490|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130621658|NCT02678312|470234491|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130621659|NCT02678312|470234492|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130621660|NCT02678312|470234488|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
130621661|NCT02678312|470234489|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130621662|NCT02678312|470234490|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130621663|NCT02678312|470234491|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130621664|NCT02678312|470234492|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130621665|NCT02678312|470234488|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
130621666|NCT02678312|470234489|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130621667|NCT02678312|470234490|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130621668|NCT02678312|470234491|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130621669|NCT02678312|470234492|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130621670|NCT02678312|470234488|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
130621671|NCT02678312|470234489|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
130621672|NCT02678312|470234490|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
130621673|NCT02678312|470234491|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
130621674|NCT02678312|470234492|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
130621675|NCT02678312|470234488|FG000|Part 2 Double Blind Epoch|Death|0|||
130621676|NCT02678312|470234489|FG001|Part 2 Double Blind Epoch|Death|0|||
130621677|NCT02678312|470234490|FG002|Part 2 Double Blind Epoch|Death|0|||
130621678|NCT02678312|470234491|FG003|Part 2 Double Blind Epoch|Death|8|||
130621679|NCT02678312|470234492|FG004|Part 2 Double Blind Epoch|Death|12|||
130621680|NCT02678312|470234488|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
130621681|NCT02678312|470234489|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
130621682|NCT02678312|470234490|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
130621683|NCT02678312|470234491|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
130621684|NCT02678312|470234492|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
130621685|NCT02678312|470234488|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130621686|NCT02678312|470234489|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130621687|NCT02678312|470234490|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130621688|NCT02678312|470234491|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130621689|NCT02678312|470234492|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
130621690|NCT02678312|470234488|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
130621691|NCT02678312|470234489|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
130621692|NCT02678312|470234490|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
130621693|NCT02678312|470234491|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
130621694|NCT02678312|470234492|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
130621695|NCT00971425|470234493|FG000|Overall Study|Adverse Event|1|||
130621696|NCT00971425|470234494|FG001|Overall Study|Adverse Event|1|||
130621697|NCT00971425|470234493|FG000|Overall Study|Withdrawal by Subject|0|||
130621698|NCT00971425|470234494|FG001|Overall Study|Withdrawal by Subject|1|||
130621699|NCT02293993|470234497|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
130621700|NCT02293993|470234498|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
130621701|NCT02293993|470234499|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
130621702|NCT02293993|470234500|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
130621703|NCT02293993|470234497|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
130621704|NCT02293993|470234498|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
130621705|NCT02293993|470234499|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
130621706|NCT02293993|470234500|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
130621707|NCT02293993|470234497|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130621708|NCT02293993|470234498|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130621709|NCT02293993|470234499|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
130621710|NCT02293993|470234500|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130621711|NCT02293993|470234497|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
130621712|NCT02293993|470234498|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
130621713|NCT02293993|470234499|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
130621714|NCT02293993|470234500|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
130621715|NCT02293993|470234497|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
130621716|NCT02293993|470234498|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
130621717|NCT02293993|470234499|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
130621718|NCT02293993|470234500|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
130621719|NCT04624672|470234503|FG000|Overall Study|Early Study Closure|2|||
130621720|NCT04624672|470234504|FG001|Overall Study|Early Study Closure|1|||
130621721|NCT03472040|470234505|FG000|Overall Study|Physician Decision|0|||
130621722|NCT03472040|470234506|FG001|Overall Study|Physician Decision|3|||
130621723|NCT03472040|470234505|FG000|Overall Study|Withdrawal by Subject|10|||
130621724|NCT03472040|470234506|FG001|Overall Study|Withdrawal by Subject|23|||
130621725|NCT03472040|470234505|FG000|Overall Study|Perceived Lack of Efficacy|29|||
130621726|NCT03472040|470234506|FG001|Overall Study|Perceived Lack of Efficacy|30|||
130621727|NCT03472040|470234505|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
130621728|NCT03472040|470234506|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
130621729|NCT03472040|470234505|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
130621730|NCT03472040|470234506|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
130621731|NCT03472040|470234505|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
130621732|NCT03472040|470234506|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
130621733|NCT03472040|470234505|FG000|Overall Study|Subject Non-compliance|2|||
130621734|NCT03472040|470234506|FG001|Overall Study|Subject Non-compliance|5|||
130621735|NCT03472040|470234505|FG000|Overall Study|Discontinuation due to Rash|0|||
130621736|NCT03472040|470234506|FG001|Overall Study|Discontinuation due to Rash|1|||
130621737|NCT03472040|470234505|FG000|Overall Study|Subsequent Ineligibility|0|||
130621738|NCT03472040|470234506|FG001|Overall Study|Subsequent Ineligibility|2|||
130621739|NCT03472040|470234505|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
130621740|NCT03472040|470234506|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
130621741|NCT02769832|470234507|FG000|Overall Study|Death|30|||
130621742|NCT02685995|470234517|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
130621743|NCT02685995|470234518|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
130621744|NCT03625141|470234519|FG000|Overall Study|Adverse Event|0|||
130621745|NCT03625141|470234520|FG001|Overall Study|Adverse Event|2|||
130621746|NCT03625141|470234519|FG000|Overall Study|Study Terminated By Sponsor|1|||
130621747|NCT03625141|470234520|FG001|Overall Study|Study Terminated By Sponsor|13|||
130621748|NCT03625141|470234519|FG000|Overall Study|Withdrawal by Subject|3|||
130621749|NCT03625141|470234520|FG001|Overall Study|Withdrawal by Subject|0|||
130621750|NCT03625141|470234519|FG000|Overall Study|Withdrawal Of Consent|0|||
130621751|NCT03625141|470234520|FG001|Overall Study|Withdrawal Of Consent|1|||
130621752|NCT03625141|470234519|FG000|Overall Study|Death|11|||
130621753|NCT03625141|470234520|FG001|Overall Study|Death|47|||
130621754|NCT03625141|470234519|FG000|Overall Study|Progressive Disease|0|||
130621755|NCT03625141|470234520|FG001|Overall Study|Progressive Disease|2|||
130621756|NCT03819218|470234521|FG000|Overall Study|Protocol Violation|1|||
130621757|NCT00433446|470234522|FG000|Overall Study|Adverse Event|4|||
130621758|NCT00433446|470234522|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130621759|NCT00433446|470234522|FG000|Overall Study|Progression|44|||
130621760|NCT00433446|470234522|FG000|Overall Study|Other - Not Protocol specified|3|||
130621761|NCT00433446|470234522|FG000|Overall Study|Ineligible|9|||
130621762|NCT01188538|470234523|FG000|Overall Study|Lost to Follow-up|0|||
130621763|NCT01188538|470234524|FG001|Overall Study|Lost to Follow-up|1|||
130621764|NCT01280266|470234529|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
130621765|NCT01280266|470234530|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
130621766|NCT01280266|470234529|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
130621767|NCT01280266|470234530|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
130621768|NCT01381718|470234531|FG000|Overall Study|Withdrawal by Subject|2|||
130621769|NCT01381718|470234532|FG001|Overall Study|Withdrawal by Subject|5|||
130621770|NCT01381718|470234531|FG000|Overall Study|Lost to Follow-up|3|||
130621771|NCT01381718|470234532|FG001|Overall Study|Lost to Follow-up|5|||
130621772|NCT01381718|470234531|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
130621773|NCT01381718|470234532|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
130621774|NCT01522443|470234535|FG000|Overall Study|No longer receiving clinical benefit|36|||
130621775|NCT01522443|470234536|FG001|Overall Study|No longer receiving clinical benefit|28|||
130621776|NCT01522443|470234535|FG000|Overall Study|Adverse Event|10|||
130621777|NCT01522443|470234536|FG001|Overall Study|Adverse Event|15|||
130621778|NCT01522443|470234535|FG000|Overall Study|Withdrawal by Subject|5|||
130621779|NCT01522443|470234536|FG001|Overall Study|Withdrawal by Subject|8|||
130621780|NCT01522443|470234535|FG000|Overall Study|No study treatment given|1|||
130621781|NCT01522443|470234536|FG001|Overall Study|No study treatment given|1|||
130621782|NCT01522443|470234535|FG000|Overall Study|Other|1|||
130621783|NCT01522443|470234536|FG001|Overall Study|Other|3|||
130621784|NCT05590767|470234539|FG000|Overall Study|Protocol Violation|1|||
130621785|NCT05590767|470234539|FG000|Overall Study|surgery canceled|1|||
130621786|NCT05590767|470234539|FG000|Overall Study|interscalene brachial block not performed|1|||
130621787|NCT01764256|470234540|FG000|Received All Vaccinations|Adverse Event|1|||
130621788|NCT01764256|470234541|FG001|Received All Vaccinations|Adverse Event|1|||
130621789|NCT01764256|470234542|FG002|Received All Vaccinations|Adverse Event|0|||
130621790|NCT01764256|470234543|FG003|Received All Vaccinations|Adverse Event|0|||
130621791|NCT01764256|470234540|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
130621792|NCT01764256|470234541|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
130621793|NCT01764256|470234542|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
130621794|NCT01764256|470234543|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
130621795|NCT01764256|470234540|FG000|Received All Vaccinations|Lost to Follow-up|1|||
130621796|NCT01764256|470234541|FG001|Received All Vaccinations|Lost to Follow-up|0|||
130621797|NCT01764256|470234542|FG002|Received All Vaccinations|Lost to Follow-up|0|||
130621798|NCT01764256|470234543|FG003|Received All Vaccinations|Lost to Follow-up|0|||
130621799|NCT01764256|470234540|FG000|Completed Study|Lost to Follow-up|0|||
130621800|NCT01764256|470234541|FG001|Completed Study|Lost to Follow-up|0|||
130621801|NCT01764256|470234542|FG002|Completed Study|Lost to Follow-up|0|||
130621802|NCT01764256|470234543|FG003|Completed Study|Lost to Follow-up|1|||
130621803|NCT00776555|470234555|FG000|Overall Study|Study terminated|3|||
130621804|NCT00776555|470234556|FG001|Overall Study|Study terminated|0|||
130621805|NCT02940626|470234557|FG000|Overall Study|Death|40|||
130621806|NCT02940626|470234558|FG001|Overall Study|Death|32|||
130621807|NCT02940626|470234557|FG000|Overall Study|Lost to Follow-up|5|||
130621808|NCT02940626|470234558|FG001|Overall Study|Lost to Follow-up|2|||
130621809|NCT02940626|470234557|FG000|Overall Study|Withdrawal by Subject|1|||
130621810|NCT02940626|470234558|FG001|Overall Study|Withdrawal by Subject|0|||
130621811|NCT02940626|470234557|FG000|Overall Study|Transfer to Hospice Care|1|||
130621812|NCT02940626|470234558|FG001|Overall Study|Transfer to Hospice Care|0|||
130621813|NCT02940626|470234557|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130621814|NCT02940626|470234558|FG001|Overall Study|Prohibited Concomitant Medication|1|||
130621815|NCT00585923|470234560|FG000|Overall Study|Physician decided not to continue|31|||
130621816|NCT00585923|470234561|FG001|Overall Study|Physician decided not to continue|33|||
130621817|NCT00618449|470234562|FG000|Overall Study|Lost to Follow-up|98|||
130621818|NCT00618449|470234563|FG001|Overall Study|Lost to Follow-up|110|||
130621819|NCT01441115|470234564|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
130621820|NCT04311177|470234567|FG000|Overall Study|Adverse Event|3|||
130621821|NCT04311177|470234568|FG001|Overall Study|Adverse Event|1|||
130621822|NCT04311177|470234567|FG000|Overall Study|Physician Decision|4|||
130621823|NCT04311177|470234568|FG001|Overall Study|Physician Decision|3|||
130621824|NCT04311177|470234567|FG000|Overall Study|Withdrawal by Subject|1|||
130621825|NCT04311177|470234568|FG001|Overall Study|Withdrawal by Subject|0|||
130621826|NCT03454412|470234575|FG000|Baseline Assesment|Physician Decision|12|||
130621827|NCT01681576|470234578|FG000|Period 1|Adverse Event|1|||
130621828|NCT01681576|470234579|FG001|Period 1|Adverse Event|0|||
130621829|NCT01681576|470234578|FG000|Period 1|Protocol Deviation|1|||
130621830|NCT01681576|470234579|FG001|Period 1|Protocol Deviation|0|||
130621831|NCT01681576|470234578|FG000|Period 2|subject/guardian decision|3|||
130621832|NCT01681576|470234579|FG001|Period 2|subject/guardian decision|1|||
130621833|NCT01681576|470234578|FG000|Period 2|Non-compliance with study treatment|1|||
130621834|NCT01681576|470234579|FG001|Period 2|Non-compliance with study treatment|0|||
130621835|NCT01518244|470234580|FG000|Overall Study|Adverse Event|3|||
130621836|NCT04142216|470234583|FG000|Overall Study|Hospitalization|0|||
130621837|NCT04142216|470234584|FG001|Overall Study|Hospitalization|2|||
130621838|NCT04142216|470234583|FG000|Overall Study|Death|3|||
130621839|NCT04142216|470234584|FG001|Overall Study|Death|1|||
130621840|NCT04142216|470234583|FG000|Overall Study|Referral to another hemodialysis unit|3|||
130621841|NCT04142216|470234584|FG001|Overall Study|Referral to another hemodialysis unit|2|||
130621842|NCT04142216|470234583|FG000|Overall Study|Use of clove|0|||
130621843|NCT04142216|470234584|FG001|Overall Study|Use of clove|1|||
130621844|NCT00377429|470234586|FG000|Overall Study|Withdrawal by Subject|5|||
130621845|NCT00377429|470234586|FG000|Overall Study|Adverse Event|8|||
130621846|NCT00377429|470234586|FG000|Overall Study|Physician Decision|1|||
130621847|NCT00377429|470234586|FG000|Overall Study|Patient non-compliance|1|||
130621848|NCT00453180|470236232|FG000|Overall Study|Lost to Follow-up|2|||
130621849|NCT00453180|470236233|FG001|Overall Study|Lost to Follow-up|1|||
130621850|NCT00453180|470236232|FG000|Overall Study|Adverse Event|1|||
130621851|NCT00453180|470236233|FG001|Overall Study|Adverse Event|2|||
130621852|NCT02420795|470236240|FG000|Overall Study|Withdrawal by Subject|1|||
130621853|NCT02420795|470236241|FG001|Overall Study|Withdrawal by Subject|0|||
130621854|NCT02420795|470236242|FG002|Overall Study|Withdrawal by Subject|0|||
130621855|NCT02420795|470236240|FG000|Overall Study|Adverse Event|1|||
130621856|NCT02420795|470236241|FG001|Overall Study|Adverse Event|0|||
130621857|NCT02420795|470236242|FG002|Overall Study|Adverse Event|0|||
130621858|NCT02420795|470236240|FG000|Overall Study|Progressive disease|2|||
130621859|NCT02420795|470236241|FG001|Overall Study|Progressive disease|2|||
130621860|NCT02420795|470236242|FG002|Overall Study|Progressive disease|4|||
130621861|NCT02420795|470236240|FG000|Overall Study|Death|0|||
130621862|NCT02420795|470236241|FG001|Overall Study|Death|0|||
130621863|NCT02420795|470236242|FG002|Overall Study|Death|1|||
130621864|NCT01002742|470236245|FG000|Overall Study|Determined to be ineligible|0|||
130621865|NCT01002742|470236246|FG001|Overall Study|Determined to be ineligible|1|||
130621866|NCT02862548|470236258|FG000|Randomized Phase (Up to Week 48)|Death|0|||
130621867|NCT02862548|470236259|FG001|Randomized Phase (Up to Week 48)|Death|1|||
130621868|NCT02862548|470236258|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
130621869|NCT02862548|470236259|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
130621870|NCT02862548|470236258|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
130621871|NCT02862548|470236259|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
130621872|NCT02862548|470236258|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
130621873|NCT02862548|470236259|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
130621874|NCT00880763|470236260|FG000|Extension Period (Part 2)|Adverse Event|0|||
130621875|NCT00880763|470236261|FG001|Extension Period (Part 2)|Adverse Event|0|||
130621876|NCT00880763|470236262|FG002|Extension Period (Part 2)|Adverse Event|1|||
130621877|NCT00880763|470236263|FG003|Extension Period (Part 2)|Adverse Event|1|||
130621878|NCT00880763|470236260|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
130621879|NCT00880763|470236261|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
130621880|NCT00880763|470236262|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
130621881|NCT00880763|470236263|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
130621882|NCT00880763|470236260|FG000|Extension Period (Part 2)|Physician Decision|0|||
130621883|NCT00880763|470236261|FG001|Extension Period (Part 2)|Physician Decision|1|||
130621884|NCT00880763|470236262|FG002|Extension Period (Part 2)|Physician Decision|1|||
130621885|NCT00880763|470236263|FG003|Extension Period (Part 2)|Physician Decision|0|||
130621886|NCT00880763|470236260|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
130621887|NCT00880763|470236261|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
130621888|NCT00880763|470236262|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
130621889|NCT00880763|470236263|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
130621890|NCT00656084|470236264|FG000|Overall Study|Adverse Event|4|||
130621891|NCT00656084|470236264|FG000|Overall Study|Withdrawal by Subject|1|||
130621892|NCT00656084|470236264|FG000|Overall Study|Patient Request|1|||
130621893|NCT00656084|470236264|FG000|Overall Study|Investigator Request|1|||
130621894|NCT01293006|470236265|FG000|Period 2|Lost to Follow-up|1|||
130621895|NCT01293006|470236266|FG001|Period 2|Lost to Follow-up|0|||
130621896|NCT01293006|470236267|FG002|Period 2|Lost to Follow-up|0|||
130621897|NCT01293006|470236268|FG003|Period 2|Lost to Follow-up|0|||
130621898|NCT01494987|470236269|FG000|Overall Study|Adverse Event|6|||
130621899|NCT01494987|470236270|FG001|Overall Study|Adverse Event|5|||
130621900|NCT01494987|470236269|FG000|Overall Study|Hyperglycemia|6|||
130621901|NCT01494987|470236270|FG001|Overall Study|Hyperglycemia|4|||
130621902|NCT01494987|470236269|FG000|Overall Study|Investigator's Discretion|1|||
130621903|NCT01494987|470236270|FG001|Overall Study|Investigator's Discretion|2|||
130621904|NCT01494987|470236269|FG000|Overall Study|Lost to Follow-up|1|||
130621905|NCT01494987|470236270|FG001|Overall Study|Lost to Follow-up|1|||
130621906|NCT01494987|470236269|FG000|Overall Study|Protocol Violation|3|||
130621907|NCT01494987|470236270|FG001|Overall Study|Protocol Violation|3|||
130621908|NCT01494987|470236269|FG000|Overall Study|Subject Non-Compliance|9|||
130621909|NCT01494987|470236270|FG001|Overall Study|Subject Non-Compliance|10|||
130621910|NCT01494987|470236269|FG000|Overall Study|Subject Withdrew Consent|2|||
130621911|NCT01494987|470236270|FG001|Overall Study|Subject Withdrew Consent|3|||
130621912|NCT00436982|470236271|FG000|Overall Study|Withdrawal by Subject|3|||
130621913|NCT00436982|470236272|FG001|Overall Study|Withdrawal by Subject|1|||
130621914|NCT00436982|470236271|FG000|Overall Study|Did not receive allocated intervention|0|||
130621915|NCT00436982|470236272|FG001|Overall Study|Did not receive allocated intervention|1|||
130621916|NCT00436982|470236271|FG000|Overall Study|no RSA data|1|||
130621917|NCT00436982|470236272|FG001|Overall Study|no RSA data|2|||
130621918|NCT00953225|470236273|FG000|Overall Study|Withdrawal by Subject|2|||
130621919|NCT00953225|470236274|FG001|Overall Study|Withdrawal by Subject|0|||
130621920|NCT04295356|470236278|FG000|Overall Study|Physician Decision|1|||
130621921|NCT04295356|470236279|FG001|Overall Study|Physician Decision|0|||
130621922|NCT04295356|470236278|FG000|Overall Study|Lost to Follow-up|0|||
130621923|NCT04295356|470236279|FG001|Overall Study|Lost to Follow-up|3|||
130621924|NCT04295356|470236278|FG000|Overall Study|Protocol Violation|0|||
130621925|NCT04295356|470236279|FG001|Overall Study|Protocol Violation|1|||
130621926|NCT01106391|470236282|FG000|Overall Study|Death|12|||
130621927|NCT01106391|470236282|FG000|Overall Study|Withdrawal by Subject|7|||
130621928|NCT04268004|470236289|FG000|Overall Study|Excluded from analyses|0|||
130621929|NCT04268004|470236290|FG001|Overall Study|Excluded from analyses|1|||
130621930|NCT03783442|470236291|FG000|Overall Study|Death|252|||
130621931|NCT03783442|470236292|FG001|Overall Study|Death|268|||
130621932|NCT03783442|470236291|FG000|Overall Study|Withdrawal by Subject|19|||
130621933|NCT03783442|470236292|FG001|Overall Study|Withdrawal by Subject|21|||
130621934|NCT03783442|470236291|FG000|Overall Study|Lost to Follow-up|7|||
130621935|NCT03783442|470236292|FG001|Overall Study|Lost to Follow-up|6|||
130621936|NCT03783442|470236291|FG000|Overall Study|Sponsor Ended Study|48|||
130621937|NCT03783442|470236292|FG001|Overall Study|Sponsor Ended Study|28|||
130621938|NCT00881361|470236293|FG000|Overall Study|Terminated prior to surgery|27|||
130621939|NCT00881361|470236294|FG001|Overall Study|Terminated prior to surgery|7|||
130621940|NCT00881361|470236295|FG002|Overall Study|Terminated prior to surgery|0|||
130621941|NCT00881361|470236293|FG000|Overall Study|Ineligible|17|||
130621942|NCT00881361|470236294|FG001|Overall Study|Ineligible|2|||
130621943|NCT00881361|470236295|FG002|Overall Study|Ineligible|2|||
130621944|NCT01413542|470236300|FG000|Overall Study|Physician Decision|1|||
130621945|NCT01413542|470236301|FG001|Overall Study|Physician Decision|0|||
130621946|NCT01413542|470236302|FG002|Overall Study|Physician Decision|3|||
130621947|NCT01413542|470236303|FG003|Overall Study|Physician Decision|0|||
130621948|NCT01413542|470236300|FG000|Overall Study|Adverse Event|0|||
130621949|NCT01413542|470236301|FG001|Overall Study|Adverse Event|0|||
130621950|NCT01413542|470236302|FG002|Overall Study|Adverse Event|0|||
130621951|NCT01413542|470236303|FG003|Overall Study|Adverse Event|1|||
130621952|NCT02505542|470236304|FG000|Part A: Open-Label Period|Adverse Event|31|||
130621953|NCT02505542|470236305|FG001|Part A: Open-Label Period|Adverse Event|0|||
130621954|NCT02505542|470236306|FG002|Part A: Open-Label Period|Adverse Event|0|||
130621955|NCT02505542|470236307|FG003|Part A: Open-Label Period|Adverse Event|0|||
130621956|NCT02505542|470236304|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
130621957|NCT02505542|470236305|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
130621958|NCT02505542|470236306|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
130621959|NCT02505542|470236307|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
130621960|NCT02505542|470236304|FG000|Part A: Open-Label Period|Protocol Violation|1|||
130621961|NCT02505542|470236305|FG001|Part A: Open-Label Period|Protocol Violation|0|||
130621962|NCT02505542|470236306|FG002|Part A: Open-Label Period|Protocol Violation|0|||
130621963|NCT02505542|470236307|FG003|Part A: Open-Label Period|Protocol Violation|0|||
130621964|NCT02505542|470236304|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
130621965|NCT02505542|470236305|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
130621966|NCT02505542|470236306|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
130621967|NCT02505542|470236307|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
130621968|NCT02505542|470236304|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
130621969|NCT02505542|470236305|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
130621970|NCT02505542|470236306|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
130621971|NCT02505542|470236307|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
130621972|NCT02505542|470236304|FG000|Part A: Open-Label Period|New medical history available|1|||
130621973|NCT02505542|470236305|FG001|Part A: Open-Label Period|New medical history available|0|||
130621974|NCT02505542|470236306|FG002|Part A: Open-Label Period|New medical history available|0|||
130621975|NCT02505542|470236307|FG003|Part A: Open-Label Period|New medical history available|0|||
130621976|NCT02505542|470236304|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
130621977|NCT02505542|470236305|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130621978|NCT02505542|470236306|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130621979|NCT02505542|470236307|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130621980|NCT02505542|470236304|FG000|Part A: Open-Label Period|Pregnancy|2|||
130621981|NCT02505542|470236305|FG001|Part A: Open-Label Period|Pregnancy|0|||
130621982|NCT02505542|470236306|FG002|Part A: Open-Label Period|Pregnancy|0|||
130621983|NCT02505542|470236307|FG003|Part A: Open-Label Period|Pregnancy|0|||
130621984|NCT02505542|470236304|FG000|Part A: Open-Label Period|Sponsor directive|1|||
130621985|NCT02505542|470236305|FG001|Part A: Open-Label Period|Sponsor directive|0|||
130621986|NCT02505542|470236306|FG002|Part A: Open-Label Period|Sponsor directive|0|||
130621987|NCT02505542|470236307|FG003|Part A: Open-Label Period|Sponsor directive|0|||
130621988|NCT02505542|470236304|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
130621989|NCT02505542|470236305|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
130621990|NCT02505542|470236306|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
130621991|NCT02505542|470236307|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
130621992|NCT02505542|470236304|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
130621993|NCT02505542|470236305|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130621994|NCT02505542|470236306|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130621995|NCT02505542|470236307|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130621996|NCT02505542|470236304|FG000|Part A: Open-Label Period|Non-compliance|1|||
130621997|NCT02505542|470236305|FG001|Part A: Open-Label Period|Non-compliance|0|||
130621998|NCT02505542|470236306|FG002|Part A: Open-Label Period|Non-compliance|0|||
130621999|NCT02505542|470236307|FG003|Part A: Open-Label Period|Non-compliance|0|||
130622000|NCT02505542|470236304|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
130622001|NCT02505542|470236305|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
130622002|NCT02505542|470236306|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
130622003|NCT02505542|470236307|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
130622004|NCT02505542|470236304|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
130622005|NCT02505542|470236305|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
130622006|NCT02505542|470236306|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
130622007|NCT02505542|470236307|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
130622008|NCT02505542|470236304|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
130622009|NCT02505542|470236305|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
130622010|NCT02505542|470236306|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
130622011|NCT02505542|470236307|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
130622012|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Adverse Event|0|||
130622013|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Adverse Event|0|||
130622014|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Adverse Event|1|||
130622015|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Adverse Event|3|||
130622016|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
130622017|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
130622018|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
130622019|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
130622020|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
130622021|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
130622022|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
130622023|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
130622024|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
130622025|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
130622026|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
130622027|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
130622028|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
130622029|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
130622030|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
130622031|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
130622032|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
130622033|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
130622034|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
130622035|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
130622036|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
130622037|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
130622038|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
130622039|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
130622040|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Miscalculation|0|||
130622041|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Miscalculation|1|||
130622042|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Miscalculation|0|||
130622043|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Miscalculation|0|||
130622044|NCT02505542|470236304|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130622045|NCT02505542|470236305|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
130622046|NCT02505542|470236306|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130622047|NCT02505542|470236307|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130622048|NCT02759861|470236308|FG000|Overall Study|Death|1|||
130622049|NCT00225212|470236309|FG000|Overall Study|Disease progression|2|||
130622050|NCT00225212|470236309|FG000|Overall Study|Death|1|||
130622051|NCT00225212|470236309|FG000|Overall Study|Adverse Event|2|||
130622052|NCT00225212|470236309|FG000|Overall Study|Intercurrent illness|1|||
130622053|NCT01309841|470236312|FG000|Overall Study|Other|0|||
130622054|NCT01309841|470236313|FG001|Overall Study|Other|1|||
130622055|NCT01309841|470236314|FG002|Overall Study|Other|1|||
130622056|NCT01309841|470236312|FG000|Overall Study|Lost to Follow-up|7|||
130622057|NCT01309841|470236313|FG001|Overall Study|Lost to Follow-up|6|||
130622058|NCT01309841|470236314|FG002|Overall Study|Lost to Follow-up|4|||
130622059|NCT01309841|470236312|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
130622060|NCT01309841|470236313|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130622061|NCT01309841|470236314|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
130622062|NCT01309841|470236312|FG000|Overall Study|Lack of Efficacy|0|||
130622063|NCT01309841|470236313|FG001|Overall Study|Lack of Efficacy|0|||
130622064|NCT01309841|470236314|FG002|Overall Study|Lack of Efficacy|2|||
130622065|NCT01309841|470236312|FG000|Overall Study|Adverse Event|9|||
130622066|NCT01309841|470236313|FG001|Overall Study|Adverse Event|22|||
130622067|NCT01309841|470236314|FG002|Overall Study|Adverse Event|11|||
130622068|NCT01309841|470236312|FG000|Overall Study|Death|1|||
130622069|NCT01309841|470236313|FG001|Overall Study|Death|0|||
130622070|NCT01309841|470236314|FG002|Overall Study|Death|0|||
130622071|NCT01309841|470236312|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130622072|NCT01309841|470236313|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130622073|NCT01309841|470236314|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
130622074|NCT01309841|470236312|FG000|Overall Study|Withdrawal by Subject|17|||
130622075|NCT01309841|470236313|FG001|Overall Study|Withdrawal by Subject|6|||
130622076|NCT01309841|470236314|FG002|Overall Study|Withdrawal by Subject|13|||
130622077|NCT01309841|470236312|FG000|Overall Study|Did Not Receive Treatment|2|||
130622078|NCT01309841|470236313|FG001|Overall Study|Did Not Receive Treatment|0|||
130622079|NCT01309841|470236314|FG002|Overall Study|Did Not Receive Treatment|1|||
130622080|NCT01309841|470236312|FG000|Overall Study|Severe non-compliance with protocol|0|||
130622081|NCT01309841|470236313|FG001|Overall Study|Severe non-compliance with protocol|5|||
130622082|NCT01309841|470236314|FG002|Overall Study|Severe non-compliance with protocol|2|||
130622083|NCT03699631|470236315|FG000|Overall Study|Adverse Event|3|||
130622084|NCT01324622|470236316|FG000|Overall Study|Lost to Follow-up|7|||
130622085|NCT01324622|470236317|FG001|Overall Study|Lost to Follow-up|7|||
130622086|NCT01324622|470236316|FG000|Overall Study|Death|1|||
130622087|NCT01324622|470236317|FG001|Overall Study|Death|0|||
130622088|NCT01324622|470236316|FG000|Overall Study|Lack of Efficacy|1|||
130622089|NCT01324622|470236317|FG001|Overall Study|Lack of Efficacy|0|||
130622090|NCT00138424|470236318|FG000|Overall Study|Physician Decision|0|||
130622091|NCT00138424|470236319|FG001|Overall Study|Physician Decision|1|||
130622092|NCT00138424|470236320|FG002|Overall Study|Physician Decision|0|||
130622093|NCT00138424|470236321|FG003|Overall Study|Physician Decision|0|||
130622094|NCT00413062|470236322|FG000|Overall Study|Adverse event/serious adverse event|289|||
130622095|NCT00413062|470236323|FG001|Overall Study|Adverse event/serious adverse event|56|||
130622096|NCT00413062|470236322|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
130622097|NCT00413062|470236323|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
130622098|NCT00413062|470236322|FG000|Overall Study|Withdrawal of informed consent|111|||
130622099|NCT00413062|470236323|FG001|Overall Study|Withdrawal of informed consent|36|||
130622100|NCT00413062|470236322|FG000|Overall Study|Pregnancy|15|||
130622101|NCT00413062|470236323|FG001|Overall Study|Pregnancy|5|||
130622102|NCT00413062|470236322|FG000|Overall Study|Pregnancy wish|17|||
130622103|NCT00413062|470236323|FG001|Overall Study|Pregnancy wish|6|||
130622104|NCT00413062|470236322|FG000|Overall Study|Lost to Follow-up|175|||
130622105|NCT00413062|470236323|FG001|Overall Study|Lost to Follow-up|73|||
130622106|NCT00413062|470236322|FG000|Overall Study|Other reason|70|||
130622107|NCT00413062|470236323|FG001|Overall Study|Other reason|34|||
130622108|NCT02815293|470236326|FG000|Overall Study|Study termination by sponsor|10|||
130622109|NCT02815293|470236327|FG001|Overall Study|Study termination by sponsor|7|||
130622110|NCT02815293|470236328|FG002|Overall Study|Study termination by sponsor|0|||
130622111|NCT02815293|470236326|FG000|Overall Study|Participants not randomized|0|||
130622112|NCT02815293|470236327|FG001|Overall Study|Participants not randomized|0|||
130622113|NCT02815293|470236328|FG002|Overall Study|Participants not randomized|18|||
130622114|NCT02815293|470236326|FG000|Overall Study|Adverse Event|0|||
130622115|NCT02815293|470236327|FG001|Overall Study|Adverse Event|1|||
130622116|NCT02815293|470236328|FG002|Overall Study|Adverse Event|0|||
130622117|NCT00006604|470236329|FG000|Overall Study|Met study objective - no further FU|1|||
130622118|NCT00006604|470236330|FG001|Overall Study|Met study objective - no further FU|0|||
130622119|NCT00006604|470236331|FG002|Overall Study|Met study objective - no further FU|0|||
130622120|NCT00006604|470236332|FG003|Overall Study|Met study objective - no further FU|0|||
130622121|NCT00006604|470236333|FG004|Overall Study|Met study objective - no further FU|0|||
130622122|NCT00006604|470236334|FG005|Overall Study|Met study objective - no further FU|0|||
130622123|NCT00006604|470236335|FG006|Overall Study|Met study objective - no further FU|0|||
130622124|NCT00006604|470236336|FG007|Overall Study|Met study objective - no further FU|0|||
130622125|NCT00006604|470236337|FG008|Overall Study|Met study objective - no further FU|0|||
130622126|NCT00006604|470236338|FG009|Overall Study|Met study objective - no further FU|0|||
130622127|NCT00006604|470236339|FG010|Overall Study|Met study objective - no further FU|0|||
130622128|NCT00006604|470236340|FG011|Overall Study|Met study objective - no further FU|0|||
130622129|NCT00006604|470236341|FG012|Overall Study|Met study objective - no further FU|0|||
130622130|NCT00006604|470236342|FG013|Overall Study|Met study objective - no further FU|0|||
130622131|NCT00006604|470236343|FG014|Overall Study|Met study objective - no further FU|1|||
130622132|NCT00006604|470236344|FG015|Overall Study|Met study objective - no further FU|1|||
130622133|NCT00006604|470236345|FG016|Overall Study|Met study objective - no further FU|0|||
130622134|NCT00006604|470236329|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
130622135|NCT00006604|470236330|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
130622136|NCT00006604|470236331|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
130622137|NCT00006604|470236332|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
130622138|NCT00006604|470236333|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
130622139|NCT00006604|470236334|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
130622140|NCT00006604|470236335|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
130622141|NCT00006604|470236336|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
130622142|NCT00006604|470236337|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
130622143|NCT00006604|470236338|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
130622144|NCT00006604|470236339|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
130622145|NCT00006604|470236340|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
130622146|NCT00006604|470236341|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
130622147|NCT00006604|470236342|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
130622148|NCT00006604|470236343|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
130622149|NCT00006604|470236344|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
130622150|NCT00006604|470236345|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
130622151|NCT00006604|470236329|FG000|Overall Study|Death|0|||
130622152|NCT00006604|470236330|FG001|Overall Study|Death|0|||
130622153|NCT00006604|470236331|FG002|Overall Study|Death|0|||
130622154|NCT00006604|470236332|FG003|Overall Study|Death|0|||
130622155|NCT00006604|470236333|FG004|Overall Study|Death|0|||
130622156|NCT00006604|470236334|FG005|Overall Study|Death|0|||
130622157|NCT00006604|470236335|FG006|Overall Study|Death|0|||
130622158|NCT00006604|470236336|FG007|Overall Study|Death|0|||
130622159|NCT00006604|470236337|FG008|Overall Study|Death|0|||
130622160|NCT00006604|470236338|FG009|Overall Study|Death|1|||
130622161|NCT00006604|470236339|FG010|Overall Study|Death|1|||
130622162|NCT00006604|470236340|FG011|Overall Study|Death|1|||
130622163|NCT00006604|470236341|FG012|Overall Study|Death|0|||
130622164|NCT00006604|470236342|FG013|Overall Study|Death|0|||
130622165|NCT00006604|470236343|FG014|Overall Study|Death|0|||
130622166|NCT00006604|470236344|FG015|Overall Study|Death|0|||
130622167|NCT00006604|470236345|FG016|Overall Study|Death|0|||
130622168|NCT00006604|470236329|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130622169|NCT00006604|470236330|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130622170|NCT00006604|470236331|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130622171|NCT00006604|470236332|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130622172|NCT00006604|470236333|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130622173|NCT00006604|470236334|FG005|Overall Study|Severe debilitation, unable to continue|0|||
130622174|NCT00006604|470236335|FG006|Overall Study|Severe debilitation, unable to continue|3|||
130622175|NCT00006604|470236336|FG007|Overall Study|Severe debilitation, unable to continue|0|||
130622176|NCT00006604|470236337|FG008|Overall Study|Severe debilitation, unable to continue|0|||
130622177|NCT00006604|470236338|FG009|Overall Study|Severe debilitation, unable to continue|5|||
130622178|NCT00006604|470236339|FG010|Overall Study|Severe debilitation, unable to continue|0|||
130622179|NCT00006604|470236340|FG011|Overall Study|Severe debilitation, unable to continue|2|||
130622180|NCT00006604|470236341|FG012|Overall Study|Severe debilitation, unable to continue|1|||
130622181|NCT00006604|470236342|FG013|Overall Study|Severe debilitation, unable to continue|0|||
130622182|NCT00006604|470236343|FG014|Overall Study|Severe debilitation, unable to continue|2|||
130622183|NCT00006604|470236344|FG015|Overall Study|Severe debilitation, unable to continue|0|||
130622184|NCT00006604|470236345|FG016|Overall Study|Severe debilitation, unable to continue|0|||
130622185|NCT00006604|470236329|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
130622186|NCT00006604|470236330|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
130622187|NCT00006604|470236331|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
130622188|NCT00006604|470236332|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
130622189|NCT00006604|470236333|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
130622190|NCT00006604|470236334|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
130622191|NCT00006604|470236335|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
130622192|NCT00006604|470236336|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
130622193|NCT00006604|470236337|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
130622194|NCT00006604|470236338|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
130622195|NCT00006604|470236339|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
130622196|NCT00006604|470236340|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
130622197|NCT00006604|470236341|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
130622198|NCT00006604|470236342|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
130622199|NCT00006604|470236343|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
130622200|NCT00006604|470236344|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
130622201|NCT00006604|470236345|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
130622202|NCT00006604|470236329|FG000|Overall Study|Site closing|0|||
130622203|NCT00006604|470236330|FG001|Overall Study|Site closing|0|||
130622204|NCT00006604|470236331|FG002|Overall Study|Site closing|1|||
130622205|NCT00006604|470236332|FG003|Overall Study|Site closing|1|||
130622206|NCT00006604|470236333|FG004|Overall Study|Site closing|0|||
130622207|NCT00006604|470236334|FG005|Overall Study|Site closing|0|||
130622208|NCT00006604|470236335|FG006|Overall Study|Site closing|0|||
130622209|NCT00006604|470236336|FG007|Overall Study|Site closing|1|||
130622210|NCT00006604|470236337|FG008|Overall Study|Site closing|0|||
130622211|NCT00006604|470236338|FG009|Overall Study|Site closing|0|||
130622212|NCT00006604|470236339|FG010|Overall Study|Site closing|0|||
130622213|NCT00006604|470236340|FG011|Overall Study|Site closing|1|||
130622214|NCT00006604|470236341|FG012|Overall Study|Site closing|1|||
130622215|NCT00006604|470236342|FG013|Overall Study|Site closing|1|||
130622216|NCT00006604|470236343|FG014|Overall Study|Site closing|0|||
130622217|NCT00006604|470236344|FG015|Overall Study|Site closing|0|||
130622218|NCT00006604|470236345|FG016|Overall Study|Site closing|1|||
130622219|NCT00006604|470236329|FG000|Overall Study|Withdrawal by Subject|1|||
130622220|NCT00006604|470236330|FG001|Overall Study|Withdrawal by Subject|0|||
130622221|NCT00006604|470236331|FG002|Overall Study|Withdrawal by Subject|2|||
130622222|NCT00006604|470236332|FG003|Overall Study|Withdrawal by Subject|0|||
130622223|NCT00006604|470236333|FG004|Overall Study|Withdrawal by Subject|1|||
130622224|NCT00006604|470236334|FG005|Overall Study|Withdrawal by Subject|2|||
130622225|NCT00006604|470236335|FG006|Overall Study|Withdrawal by Subject|2|||
130622226|NCT00006604|470236336|FG007|Overall Study|Withdrawal by Subject|0|||
130622227|NCT00006604|470236337|FG008|Overall Study|Withdrawal by Subject|1|||
130622228|NCT00006604|470236338|FG009|Overall Study|Withdrawal by Subject|3|||
130622229|NCT00006604|470236339|FG010|Overall Study|Withdrawal by Subject|2|||
130622230|NCT00006604|470236340|FG011|Overall Study|Withdrawal by Subject|0|||
130622231|NCT00006604|470236341|FG012|Overall Study|Withdrawal by Subject|1|||
130622232|NCT00006604|470236342|FG013|Overall Study|Withdrawal by Subject|2|||
130622233|NCT00006604|470236343|FG014|Overall Study|Withdrawal by Subject|1|||
130622234|NCT00006604|470236344|FG015|Overall Study|Withdrawal by Subject|0|||
130622235|NCT00006604|470236345|FG016|Overall Study|Withdrawal by Subject|1|||
130622236|NCT00006604|470236329|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
130622237|NCT00006604|470236330|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
130622238|NCT00006604|470236331|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
130622239|NCT00006604|470236332|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
130622240|NCT00006604|470236333|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
130622241|NCT00006604|470236334|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
130622242|NCT00006604|470236335|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
130622243|NCT00006604|470236336|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
130622244|NCT00006604|470236337|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
130622245|NCT00006604|470236338|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
130622246|NCT00006604|470236339|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
130622247|NCT00006604|470236340|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
130622248|NCT00006604|470236341|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
130622249|NCT00006604|470236342|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
130622250|NCT00006604|470236343|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
130622251|NCT00006604|470236344|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
130622252|NCT00006604|470236345|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
130622253|NCT00006604|470236329|FG000|Overall Study|Lost to Follow-up|0|||
130622254|NCT00006604|470236330|FG001|Overall Study|Lost to Follow-up|0|||
130622255|NCT00006604|470236331|FG002|Overall Study|Lost to Follow-up|0|||
130622256|NCT00006604|470236332|FG003|Overall Study|Lost to Follow-up|0|||
130622257|NCT00006604|470236333|FG004|Overall Study|Lost to Follow-up|0|||
130622258|NCT00006604|470236334|FG005|Overall Study|Lost to Follow-up|0|||
130622259|NCT00006604|470236335|FG006|Overall Study|Lost to Follow-up|0|||
130622260|NCT00006604|470236336|FG007|Overall Study|Lost to Follow-up|1|||
130622261|NCT00006604|470236337|FG008|Overall Study|Lost to Follow-up|0|||
130622262|NCT00006604|470236338|FG009|Overall Study|Lost to Follow-up|2|||
130622263|NCT00006604|470236339|FG010|Overall Study|Lost to Follow-up|0|||
130622264|NCT00006604|470236340|FG011|Overall Study|Lost to Follow-up|0|||
130622265|NCT00006604|470236341|FG012|Overall Study|Lost to Follow-up|0|||
130622266|NCT00006604|470236342|FG013|Overall Study|Lost to Follow-up|0|||
130622267|NCT00006604|470236343|FG014|Overall Study|Lost to Follow-up|0|||
130622268|NCT00006604|470236344|FG015|Overall Study|Lost to Follow-up|1|||
130622269|NCT00006604|470236345|FG016|Overall Study|Lost to Follow-up|3|||
130622270|NCT00006604|470236329|FG000|Overall Study|Other Reason|0|||
130622271|NCT00006604|470236330|FG001|Overall Study|Other Reason|0|||
130622272|NCT00006604|470236331|FG002|Overall Study|Other Reason|0|||
130622273|NCT00006604|470236332|FG003|Overall Study|Other Reason|0|||
130622274|NCT00006604|470236333|FG004|Overall Study|Other Reason|0|||
130622275|NCT00006604|470236334|FG005|Overall Study|Other Reason|1|||
130622276|NCT00006604|470236335|FG006|Overall Study|Other Reason|0|||
130622277|NCT00006604|470236336|FG007|Overall Study|Other Reason|0|||
130622278|NCT00006604|470236337|FG008|Overall Study|Other Reason|0|||
130622279|NCT00006604|470236338|FG009|Overall Study|Other Reason|1|||
130622280|NCT00006604|470236339|FG010|Overall Study|Other Reason|0|||
130622281|NCT00006604|470236340|FG011|Overall Study|Other Reason|0|||
130622282|NCT00006604|470236341|FG012|Overall Study|Other Reason|0|||
130622283|NCT00006604|470236342|FG013|Overall Study|Other Reason|0|||
130622284|NCT00006604|470236343|FG014|Overall Study|Other Reason|0|||
130622285|NCT00006604|470236344|FG015|Overall Study|Other Reason|0|||
130622286|NCT00006604|470236345|FG016|Overall Study|Other Reason|0|||
130622287|NCT01056341|470236348|FG000|Overall Study|Treatment Intolerance|0|||
130622288|NCT01056341|470236349|FG001|Overall Study|Treatment Intolerance|2|||
130622289|NCT01056341|470236350|FG002|Overall Study|Treatment Intolerance|0|||
130622290|NCT01056341|470236351|FG003|Overall Study|Treatment Intolerance|2|||
130622291|NCT01056341|470236352|FG004|Overall Study|Treatment Intolerance|0|||
130622292|NCT01056341|470236348|FG000|Overall Study|Lack of Efficacy|32|||
130622293|NCT01056341|470236349|FG001|Overall Study|Lack of Efficacy|30|||
130622294|NCT01056341|470236350|FG002|Overall Study|Lack of Efficacy|7|||
130622295|NCT01056341|470236351|FG003|Overall Study|Lack of Efficacy|25|||
130622296|NCT01056341|470236352|FG004|Overall Study|Lack of Efficacy|9|||
130622297|NCT01056341|470236348|FG000|Overall Study|Other reasons|4|||
130622298|NCT01056341|470236349|FG001|Overall Study|Other reasons|4|||
130622299|NCT01056341|470236350|FG002|Overall Study|Other reasons|8|||
130622300|NCT01056341|470236351|FG003|Overall Study|Other reasons|9|||
130622301|NCT01056341|470236352|FG004|Overall Study|Other reasons|5|||
130622302|NCT01167582|470236353|FG000|Overall Study|Lost to Follow-up|0|||
130622303|NCT01167582|470236354|FG001|Overall Study|Lost to Follow-up|1|||
130622304|NCT01182337|470236355|FG000|Overall Study|Withdrawal by Subject|3|||
130622305|NCT01182337|470236356|FG001|Overall Study|Withdrawal by Subject|1|||
130622306|NCT01182337|470236355|FG000|Overall Study|Lost to Follow-up|0|||
130622307|NCT01182337|470236356|FG001|Overall Study|Lost to Follow-up|1|||
130622308|NCT03103906|470236357|FG000|Overall Study|Adverse Event|2|||
130622309|NCT03103906|470236358|FG001|Overall Study|Adverse Event|3|||
130622310|NCT03103906|470236357|FG000|Overall Study|Other|2|||
130622311|NCT03103906|470236358|FG001|Overall Study|Other|0|||
130622312|NCT03571256|470236359|FG000|Overall Study|Adverse Event|3|||
130622313|NCT03571256|470236360|FG001|Overall Study|Adverse Event|0|||
130622314|NCT03571256|470236361|FG002|Overall Study|Adverse Event|1|||
130622315|NCT03571256|470236359|FG000|Overall Study|Withdrawal by Subject|3|||
130622316|NCT03571256|470236360|FG001|Overall Study|Withdrawal by Subject|1|||
130622317|NCT03571256|470236361|FG002|Overall Study|Withdrawal by Subject|1|||
130622318|NCT03571256|470236359|FG000|Overall Study|Other than specified|0|||
130622319|NCT03571256|470236360|FG001|Overall Study|Other than specified|1|||
130622320|NCT03571256|470236361|FG002|Overall Study|Other than specified|1|||
130622321|NCT03571256|470236359|FG000|Overall Study|Protocol Violation|0|||
130622322|NCT03571256|470236360|FG001|Overall Study|Protocol Violation|1|||
130622323|NCT03571256|470236361|FG002|Overall Study|Protocol Violation|1|||
130622324|NCT00575094|470236362|FG000|Overall Study|Adverse Event|2|||
130622325|NCT00575094|470236362|FG000|Overall Study|Withdrawal by Subject|1|||
130622326|NCT00772382|470236368|FG000|Overall Study|Adverse Event|19|||
130622327|NCT00772382|470236368|FG000|Overall Study|Death|6|||
130622328|NCT00772382|470236368|FG000|Overall Study|Lack of Efficacy|4|||
130622329|NCT00772382|470236368|FG000|Overall Study|Physician Decision|5|||
130622330|NCT00772382|470236368|FG000|Overall Study|Protocol Violation|1|||
130622331|NCT00772382|470236368|FG000|Overall Study|Withdrawal by Subject|10|||
130622332|NCT00772382|470236368|FG000|Overall Study|Other Reasons|10|||
130622333|NCT00643604|470236369|FG000|Overall Study|Death|1|||
130622334|NCT02702011|470236372|FG000|Overall Study|Withdrawal by Subject|0|||
130622335|NCT02702011|470236373|FG001|Overall Study|Withdrawal by Subject|1|||
130622336|NCT02702011|470236374|FG002|Overall Study|Withdrawal by Subject|0|||
130622337|NCT02702011|470236375|FG003|Overall Study|Withdrawal by Subject|0|||
130622338|NCT02007954|470236377|FG000|Overall Study|Received liver transplant|3|||
130622339|NCT02007954|470236377|FG000|Overall Study|Switch in treatment modality|2|||
130622340|NCT02007954|470236377|FG000|Overall Study|Disease progression and unrelated AE|1|||
130622341|NCT02007954|470236377|FG000|Overall Study|Death|1|||
130622342|NCT01195363|470236380|FG000|Overall Study|Lost to Follow-up|7|||
130622343|NCT01195363|470236381|FG001|Overall Study|Lost to Follow-up|4|||
130622344|NCT01195363|470236380|FG000|Overall Study|Adverse Event|3|||
130622345|NCT01195363|470236381|FG001|Overall Study|Adverse Event|1|||
130622346|NCT01195363|470236380|FG000|Overall Study|Lack of Efficacy|0|||
130622347|NCT01195363|470236381|FG001|Overall Study|Lack of Efficacy|4|||
130622348|NCT01195363|470236380|FG000|Overall Study|incarceration|1|||
130622349|NCT01195363|470236381|FG001|Overall Study|incarceration|0|||
130622350|NCT00475540|470236382|FG000|36 Months|Lost to Follow-up|4|||
130622351|NCT00475540|470236383|FG001|36 Months|Lost to Follow-up|4|||
130622352|NCT00475540|470236382|FG000|36 Months|Death|1|||
130622353|NCT00475540|470236383|FG001|36 Months|Death|2|||
130622354|NCT00475540|470236382|FG000|36 Months|Censored due to reoperation|3|||
130622355|NCT00475540|470236383|FG001|36 Months|Censored due to reoperation|0|||
130622356|NCT02726113|470236386|FG000|Total Enrollment|Physician Decision|0|||
130622357|NCT02726113|470236387|FG001|Total Enrollment|Physician Decision|1|||
130622358|NCT02726113|470236386|FG000|Total Enrollment|Protocol Violation|1|||
130622359|NCT02726113|470236387|FG001|Total Enrollment|Protocol Violation|0|||
130622360|NCT02726113|470236386|FG000|Total Enrollment|Withdrawal by Subject|2|||
130622361|NCT02726113|470236387|FG001|Total Enrollment|Withdrawal by Subject|1|||
130622362|NCT02726113|470236386|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
130622363|NCT02726113|470236387|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
130622364|NCT02726113|470236386|FG000|Genomic Analysis|Protocol Violation|1|||
130622365|NCT02726113|470236387|FG001|Genomic Analysis|Protocol Violation|0|||
130622366|NCT02726113|470236386|FG000|Genomic Analysis|Withdrawal by Subject|2|||
130622367|NCT02726113|470236387|FG001|Genomic Analysis|Withdrawal by Subject|1|||
130622368|NCT02726113|470236386|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
130622369|NCT02726113|470236387|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
130622370|NCT05691829|470238023|FG000|Overall Study|Physician Decision|2|||
130622371|NCT05691829|470238023|FG000|Overall Study|Eligibility criteria not met|3|||
130622372|NCT00640146|470238027|FG000|Overall Study|Adverse Event|2|||
130622373|NCT00640146|470238028|FG001|Overall Study|Adverse Event|0|||
130622374|NCT00640146|470238027|FG000|Overall Study|Lost to Follow-up|0|||
130622375|NCT00640146|470238028|FG001|Overall Study|Lost to Follow-up|1|||
130622376|NCT00640146|470238027|FG000|Overall Study|Lack of Efficacy|0|||
130622377|NCT00640146|470238028|FG001|Overall Study|Lack of Efficacy|1|||
130622378|NCT00640146|470238027|FG000|Overall Study|Withdrawal by Subject|1|||
130622379|NCT00640146|470238028|FG001|Overall Study|Withdrawal by Subject|1|||
130622380|NCT00640146|470238027|FG000|Overall Study|Randomized but not treated|1|||
130622381|NCT00640146|470238028|FG001|Overall Study|Randomized but not treated|3|||
130622382|NCT04058158|470238031|FG000|Period 1|Death|1|||
130622383|NCT04058158|470238032|FG001|Period 1|Death|0|||
130622384|NCT04058158|470238031|FG000|Period 1|Adverse Event|1|||
130622385|NCT04058158|470238032|FG001|Period 1|Adverse Event|1|||
130622386|NCT04058158|470238031|FG000|Period 1|Pregnancy|0|||
130622387|NCT04058158|470238032|FG001|Period 1|Pregnancy|1|||
130622388|NCT04847141|470238033|FG000|Overall Study|Adverse Event|1|||
130622389|NCT04847141|470238034|FG001|Overall Study|Adverse Event|0|||
130622390|NCT04847141|470238035|FG002|Overall Study|Adverse Event|1|||
130622391|NCT04847141|470238033|FG000|Overall Study|Withdrawal by Subject|2|||
130622392|NCT04847141|470238034|FG001|Overall Study|Withdrawal by Subject|4|||
130622393|NCT04847141|470238035|FG002|Overall Study|Withdrawal by Subject|3|||
130622394|NCT04847141|470238033|FG000|Overall Study|Lost to Follow-up|7|||
130622395|NCT04847141|470238034|FG001|Overall Study|Lost to Follow-up|5|||
130622396|NCT04847141|470238035|FG002|Overall Study|Lost to Follow-up|7|||
130622397|NCT04847141|470238033|FG000|Overall Study|Reason not Specified|0|||
130622398|NCT04847141|470238034|FG001|Overall Study|Reason not Specified|1|||
130622399|NCT04847141|470238035|FG002|Overall Study|Reason not Specified|0|||
130622400|NCT02215616|470238036|FG000|Overall Study|Sponsor requested to stop study drug|0|||
130622401|NCT02215616|470238037|FG001|Overall Study|Sponsor requested to stop study drug|0|||
130622402|NCT02215616|470238038|FG002|Overall Study|Sponsor requested to stop study drug|1|||
130622403|NCT02215616|470238039|FG003|Overall Study|Sponsor requested to stop study drug|4|||
130622404|NCT02215616|470238036|FG000|Overall Study|Death|1|||
130622405|NCT02215616|470238037|FG001|Overall Study|Death|0|||
130622406|NCT02215616|470238038|FG002|Overall Study|Death|0|||
130622407|NCT02215616|470238039|FG003|Overall Study|Death|0|||
130622408|NCT02215616|470238036|FG000|Overall Study|Adverse Event|7|||
130622409|NCT02215616|470238037|FG001|Overall Study|Adverse Event|4|||
130622410|NCT02215616|470238038|FG002|Overall Study|Adverse Event|9|||
130622411|NCT02215616|470238039|FG003|Overall Study|Adverse Event|2|||
130622412|NCT02215616|470238036|FG000|Overall Study|Withdrawal by Subject|1|||
130622413|NCT02215616|470238037|FG001|Overall Study|Withdrawal by Subject|8|||
130622414|NCT02215616|470238038|FG002|Overall Study|Withdrawal by Subject|2|||
130622415|NCT02215616|470238039|FG003|Overall Study|Withdrawal by Subject|5|||
130622416|NCT02215616|470238036|FG000|Overall Study|Non-compliance|0|||
130622417|NCT02215616|470238037|FG001|Overall Study|Non-compliance|2|||
130622418|NCT02215616|470238038|FG002|Overall Study|Non-compliance|1|||
130622419|NCT02215616|470238039|FG003|Overall Study|Non-compliance|0|||
130622420|NCT02215616|470238036|FG000|Overall Study|Protocol Violation|0|||
130622421|NCT02215616|470238037|FG001|Overall Study|Protocol Violation|2|||
130622422|NCT02215616|470238038|FG002|Overall Study|Protocol Violation|0|||
130622423|NCT02215616|470238039|FG003|Overall Study|Protocol Violation|0|||
130622424|NCT02215616|470238036|FG000|Overall Study|Lost to Follow-up|1|||
130622425|NCT02215616|470238037|FG001|Overall Study|Lost to Follow-up|1|||
130622426|NCT02215616|470238038|FG002|Overall Study|Lost to Follow-up|0|||
130622427|NCT02215616|470238039|FG003|Overall Study|Lost to Follow-up|1|||
130622428|NCT02215616|470238036|FG000|Overall Study|Other than specified|1|||
130622429|NCT02215616|470238037|FG001|Overall Study|Other than specified|0|||
130622430|NCT02215616|470238038|FG002|Overall Study|Other than specified|1|||
130622431|NCT02215616|470238039|FG003|Overall Study|Other than specified|1|||
130622432|NCT02528253|470238042|FG000|Overall Study|Adverse Event|3|||
130622433|NCT02528253|470238043|FG001|Overall Study|Adverse Event|4|||
130622434|NCT02528253|470238044|FG002|Overall Study|Adverse Event|4|||
130622435|NCT02528253|470238045|FG003|Overall Study|Adverse Event|8|||
130622436|NCT02528253|470238046|FG004|Overall Study|Adverse Event|18|||
130622437|NCT02528253|470238042|FG000|Overall Study|Death|2|||
130622438|NCT02528253|470238043|FG001|Overall Study|Death|2|||
130622439|NCT02528253|470238044|FG002|Overall Study|Death|1|||
130622440|NCT02528253|470238045|FG003|Overall Study|Death|0|||
130622441|NCT02528253|470238046|FG004|Overall Study|Death|1|||
130622442|NCT02528253|470238042|FG000|Overall Study|Insufficient clinical response|7|||
130622443|NCT02528253|470238043|FG001|Overall Study|Insufficient clinical response|10|||
130622444|NCT02528253|470238044|FG002|Overall Study|Insufficient clinical response|13|||
130622445|NCT02528253|470238045|FG003|Overall Study|Insufficient clinical response|12|||
130622446|NCT02528253|470238046|FG004|Overall Study|Insufficient clinical response|16|||
130622447|NCT02528253|470238042|FG000|Overall Study|Lost to Follow-up|16|||
130622448|NCT02528253|470238043|FG001|Overall Study|Lost to Follow-up|9|||
130622449|NCT02528253|470238044|FG002|Overall Study|Lost to Follow-up|31|||
130622450|NCT02528253|470238045|FG003|Overall Study|Lost to Follow-up|16|||
130622451|NCT02528253|470238046|FG004|Overall Study|Lost to Follow-up|34|||
130622452|NCT02528253|470238042|FG000|Overall Study|Other|21|||
130622453|NCT02528253|470238043|FG001|Overall Study|Other|22|||
130622454|NCT02528253|470238044|FG002|Overall Study|Other|58|||
130622455|NCT02528253|470238045|FG003|Overall Study|Other|52|||
130622456|NCT02528253|470238046|FG004|Overall Study|Other|76|||
130622457|NCT02528253|470238042|FG000|Overall Study|Withdrawal by Subject|25|||
130622458|NCT02528253|470238043|FG001|Overall Study|Withdrawal by Subject|20|||
130622459|NCT02528253|470238044|FG002|Overall Study|Withdrawal by Subject|29|||
130622460|NCT02528253|470238045|FG003|Overall Study|Withdrawal by Subject|48|||
130622461|NCT02528253|470238046|FG004|Overall Study|Withdrawal by Subject|73|||
130622462|NCT02528253|470238042|FG000|Overall Study|Protocol Violation|1|||
130622463|NCT02528253|470238043|FG001|Overall Study|Protocol Violation|2|||
130622464|NCT02528253|470238044|FG002|Overall Study|Protocol Violation|4|||
130622465|NCT02528253|470238045|FG003|Overall Study|Protocol Violation|0|||
130622466|NCT02528253|470238046|FG004|Overall Study|Protocol Violation|4|||
130622467|NCT02528253|470238042|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
130622468|NCT02528253|470238043|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
130622469|NCT02528253|470238044|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
130622470|NCT02528253|470238045|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
130622471|NCT02528253|470238046|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
130622472|NCT00094835|470238047|FG000|Overall Study|Physician Decision|1|||
130622473|NCT00094835|470238048|FG001|Overall Study|Physician Decision|0|||
130622474|NCT00094835|470238049|FG002|Overall Study|Physician Decision|0|||
130622475|NCT00094835|470238050|FG003|Overall Study|Physician Decision|0|||
130622476|NCT00094835|470238051|FG004|Overall Study|Physician Decision|0|||
130622477|NCT00094835|470238052|FG005|Overall Study|Physician Decision|1|||
130622478|NCT00094835|470238053|FG006|Overall Study|Physician Decision|0|||
130622479|NCT00094835|470238047|FG000|Overall Study|Withdrawal by Subject|0|||
130622480|NCT00094835|470238048|FG001|Overall Study|Withdrawal by Subject|0|||
130622481|NCT00094835|470238049|FG002|Overall Study|Withdrawal by Subject|0|||
130622482|NCT00094835|470238050|FG003|Overall Study|Withdrawal by Subject|0|||
130622483|NCT00094835|470238051|FG004|Overall Study|Withdrawal by Subject|0|||
130622484|NCT00094835|470238052|FG005|Overall Study|Withdrawal by Subject|0|||
130622485|NCT00094835|470238053|FG006|Overall Study|Withdrawal by Subject|1|||
130622486|NCT00094835|470238047|FG000|Overall Study|Lost to Follow-up|0|||
130622487|NCT00094835|470238048|FG001|Overall Study|Lost to Follow-up|0|||
130622488|NCT00094835|470238049|FG002|Overall Study|Lost to Follow-up|0|||
130622489|NCT00094835|470238050|FG003|Overall Study|Lost to Follow-up|0|||
130622490|NCT00094835|470238051|FG004|Overall Study|Lost to Follow-up|1|||
130622491|NCT00094835|470238052|FG005|Overall Study|Lost to Follow-up|0|||
130622492|NCT00094835|470238053|FG006|Overall Study|Lost to Follow-up|0|||
130622493|NCT00094835|470238047|FG000|Overall Study|Death|1|||
130622494|NCT00094835|470238048|FG001|Overall Study|Death|0|||
130622495|NCT00094835|470238049|FG002|Overall Study|Death|0|||
130622496|NCT00094835|470238050|FG003|Overall Study|Death|0|||
130622497|NCT00094835|470238051|FG004|Overall Study|Death|1|||
130622498|NCT00094835|470238052|FG005|Overall Study|Death|0|||
130622499|NCT00094835|470238053|FG006|Overall Study|Death|0|||
130622500|NCT00094835|470238047|FG000|Overall Study|Non-compliance|1|||
130622501|NCT00094835|470238048|FG001|Overall Study|Non-compliance|2|||
130622502|NCT00094835|470238049|FG002|Overall Study|Non-compliance|2|||
130622503|NCT00094835|470238050|FG003|Overall Study|Non-compliance|0|||
130622504|NCT00094835|470238051|FG004|Overall Study|Non-compliance|2|||
130622505|NCT00094835|470238052|FG005|Overall Study|Non-compliance|2|||
130622506|NCT00094835|470238053|FG006|Overall Study|Non-compliance|1|||
130622507|NCT00094835|470238047|FG000|Overall Study|Other|1|||
130622508|NCT00094835|470238048|FG001|Overall Study|Other|1|||
130622509|NCT00094835|470238049|FG002|Overall Study|Other|1|||
130622510|NCT00094835|470238050|FG003|Overall Study|Other|1|||
130622511|NCT00094835|470238051|FG004|Overall Study|Other|0|||
130622512|NCT00094835|470238052|FG005|Overall Study|Other|0|||
130622513|NCT00094835|470238053|FG006|Overall Study|Other|0|||
130622514|NCT03583606|470238056|FG000|Overall Study|Lost to Follow-up|0|||
130622515|NCT03583606|470238057|FG001|Overall Study|Lost to Follow-up|1|||
130622516|NCT03583606|470238058|FG002|Overall Study|Lost to Follow-up|0|||
130622517|NCT03583606|470238056|FG000|Overall Study|Ineligible at baseline|1|||
130622518|NCT03583606|470238057|FG001|Overall Study|Ineligible at baseline|0|||
130622519|NCT03583606|470238058|FG002|Overall Study|Ineligible at baseline|0|||
130622520|NCT00817206|470238063|FG000|Overall Study|Adverse Event|10|||
130622521|NCT00817206|470238064|FG001|Overall Study|Adverse Event|3|||
130622522|NCT00817206|470238063|FG000|Overall Study|Protocol Violation|0|||
130622523|NCT00817206|470238064|FG001|Overall Study|Protocol Violation|2|||
130622524|NCT00817206|470238063|FG000|Overall Study|Lost to Follow-up|0|||
130622525|NCT00817206|470238064|FG001|Overall Study|Lost to Follow-up|1|||
130622526|NCT00817206|470238063|FG000|Overall Study|Death|2|||
130622527|NCT00817206|470238064|FG001|Overall Study|Death|0|||
130622528|NCT00817206|470238063|FG000|Overall Study|Withdrawal by Subject|7|||
130622529|NCT00817206|470238064|FG001|Overall Study|Withdrawal by Subject|3|||
130622530|NCT00817206|470238063|FG000|Overall Study|Physician Decision|2|||
130622531|NCT00817206|470238064|FG001|Overall Study|Physician Decision|0|||
130622532|NCT00126581|470238065|FG000|Overall Study|Adverse Event|3|||
130622533|NCT00126581|470238066|FG001|Overall Study|Adverse Event|7|||
130622534|NCT00126581|470238065|FG000|Overall Study|Death|3|||
130622535|NCT00126581|470238066|FG001|Overall Study|Death|2|||
130622536|NCT00126581|470238065|FG000|Overall Study|Withdrawal by Subject|1|||
130622537|NCT00126581|470238066|FG001|Overall Study|Withdrawal by Subject|4|||
130622538|NCT00126581|470238065|FG000|Overall Study|Alternative therapy|3|||
130622539|NCT00126581|470238066|FG001|Overall Study|Alternative therapy|3|||
130622540|NCT00126581|470238065|FG000|Overall Study|Other illness/MD discretion|3|||
130622541|NCT00126581|470238066|FG001|Overall Study|Other illness/MD discretion|4|||
130622542|NCT03728140|470238068|FG000|Overall Study|Abnormal embryo transfer operation|10|||
130622543|NCT03728140|470238069|FG001|Overall Study|Abnormal embryo transfer operation|7|||
130622544|NCT02034552|470238070|FG000|Overall Study|Never treated|3|||
130622545|NCT02034552|470238071|FG001|Overall Study|Never treated|2|||
130622546|NCT02034552|470238072|FG002|Overall Study|Never treated|0|||
130622547|NCT02034552|470238070|FG000|Overall Study|Radiological progression|3|||
130622548|NCT02034552|470238071|FG001|Overall Study|Radiological progression|5|||
130622549|NCT02034552|470238072|FG002|Overall Study|Radiological progression|4|||
130622550|NCT02034552|470238070|FG000|Overall Study|AE not assoc. with disease progression|1|||
130622551|NCT02034552|470238071|FG001|Overall Study|AE not assoc. with disease progression|4|||
130622552|NCT02034552|470238072|FG002|Overall Study|AE not assoc. with disease progression|2|||
130622553|NCT02034552|470238070|FG000|Overall Study|AE associated with disease progression|0|||
130622554|NCT02034552|470238071|FG001|Overall Study|AE associated with disease progression|1|||
130622555|NCT02034552|470238072|FG002|Overall Study|AE associated with disease progression|0|||
130622556|NCT02034552|470238070|FG000|Overall Study|Withdrawal by Subject|2|||
130622557|NCT02034552|470238071|FG001|Overall Study|Withdrawal by Subject|1|||
130622558|NCT02034552|470238072|FG002|Overall Study|Withdrawal by Subject|1|||
130622559|NCT02034552|470238070|FG000|Overall Study|Non-compliance with study drug|0|||
130622560|NCT02034552|470238071|FG001|Overall Study|Non-compliance with study drug|0|||
130622561|NCT02034552|470238072|FG002|Overall Study|Non-compliance with study drug|1|||
130622562|NCT02034552|470238070|FG000|Overall Study|Clinical progression|5|||
130622563|NCT02034552|470238071|FG001|Overall Study|Clinical progression|7|||
130622564|NCT02034552|470238072|FG002|Overall Study|Clinical progression|9|||
130622565|NCT02384395|470238073|FG000|Overall Study|Physician Decision|4|||
130622566|NCT02384395|470238073|FG000|Overall Study|Withdrawal by Subject|3|||
130622567|NCT02384395|470238073|FG000|Overall Study|Lost to Follow-up|3|||
130622568|NCT00291499|470238077|FG000|Overall Study|Adverse Event|3|||
130622569|NCT00291499|470238078|FG001|Overall Study|Adverse Event|8|||
130622570|NCT00291499|470238077|FG000|Overall Study|Change to other therapy|2|||
130622571|NCT00291499|470238078|FG001|Overall Study|Change to other therapy|1|||
130622572|NCT00291499|470238077|FG000|Overall Study|Intercurrent illness|1|||
130622573|NCT00291499|470238078|FG001|Overall Study|Intercurrent illness|0|||
130622574|NCT00291499|470238077|FG000|Overall Study|Protocol Violation|2|||
130622575|NCT00291499|470238078|FG001|Overall Study|Protocol Violation|2|||
130622576|NCT00291499|470238077|FG000|Overall Study|Other reasons|1|||
130622577|NCT00291499|470238078|FG001|Overall Study|Other reasons|4|||
130622578|NCT03939637|470238079|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
130622579|NCT03939637|470238080|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
130622580|NCT03939637|470238079|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
130622581|NCT03939637|470238080|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
130622582|NCT05224076|470238081|FG000|Overall Study|Lost to Follow-up|24|||
130622583|NCT01082367|470238082|FG000|Double-blind Period|Administrative problems|0|||
130622584|NCT01082367|470238083|FG001|Double-blind Period|Administrative problems|1|||
130622585|NCT01082367|470238082|FG000|Double-blind Period|Lack of Efficacy|5|||
130622586|NCT01082367|470238083|FG001|Double-blind Period|Lack of Efficacy|11|||
130622587|NCT01082367|470238082|FG000|Double-blind Period|Adverse Event|0|||
130622588|NCT01082367|470238083|FG001|Double-blind Period|Adverse Event|1|||
130622589|NCT01082367|470238082|FG000|Follow-up (F-U) Period|Administrative problems|1|||
130622590|NCT01082367|470238083|FG001|Follow-up (F-U) Period|Administrative problems|0|||
130622591|NCT01082367|470238082|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
130622592|NCT01082367|470238083|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
130622593|NCT01082367|470238082|FG000|Follow-up (F-U) Period|Adverse Event|0|||
130622594|NCT01082367|470238083|FG001|Follow-up (F-U) Period|Adverse Event|1|||
130622595|NCT04325906|470238084|FG000|Overall Study|Withdrawal by Subject|2|||
130622596|NCT04325906|470238085|FG001|Overall Study|Withdrawal by Subject|0|||
130622597|NCT04190186|470238086|FG000|Overall Study|ILR is no longer functioning|0|||
130622598|NCT04190186|470238087|FG001|Overall Study|ILR is no longer functioning|1|||
130622599|NCT04190186|470238086|FG000|Overall Study|Lost to Follow-up|0|||
130622600|NCT04190186|470238087|FG001|Overall Study|Lost to Follow-up|1|||
130622601|NCT04190186|470238086|FG000|Overall Study|Withdrawal by Subject|2|||
130622602|NCT04190186|470238087|FG001|Overall Study|Withdrawal by Subject|0|||
130622603|NCT04190186|470238086|FG000|Overall Study|Subject choice to explant|1|||
130622604|NCT04190186|470238087|FG001|Overall Study|Subject choice to explant|0|||
130622605|NCT04190186|470238086|FG000|Overall Study|Physician Decision|0|||
130622606|NCT04190186|470238087|FG001|Overall Study|Physician Decision|1|||
130622607|NCT04190186|470238086|FG000|Overall Study|Study was stopped|4|||
130622608|NCT04190186|470238087|FG001|Overall Study|Study was stopped|5|||
130622609|NCT02016898|470238088|FG000|Overall Study|Death|1|||
130622610|NCT02016898|470238089|FG001|Overall Study|Death|1|||
130622611|NCT02016898|470238088|FG000|Overall Study|Lost to Follow-up|4|||
130622612|NCT02016898|470238089|FG001|Overall Study|Lost to Follow-up|4|||
130622613|NCT01665768|470238090|FG000|Overall Study|Adverse Event|3|||
130622614|NCT01665768|470238090|FG000|Overall Study|Lack of Efficacy|19|||
130622615|NCT01665768|470238090|FG000|Overall Study|Withdrawal by Subject|1|||
130622616|NCT00618995|470238091|FG000|Period 1|Adverse Event|0|||
130622617|NCT00618995|470238092|FG001|Period 1|Adverse Event|0|||
130622618|NCT00618995|470238093|FG002|Period 1|Adverse Event|1|||
130622619|NCT00618995|470238094|FG003|Period 1|Adverse Event|0|||
130622620|NCT00618995|470238091|FG000|Period 1|Protocol Violation|0|||
130622621|NCT00618995|470238092|FG001|Period 1|Protocol Violation|1|||
130622622|NCT00618995|470238093|FG002|Period 1|Protocol Violation|1|||
130622623|NCT00618995|470238094|FG003|Period 1|Protocol Violation|0|||
130622624|NCT00618995|470238091|FG000|Period 2|Protocol Violation|0|||
130622625|NCT00618995|470238092|FG001|Period 2|Protocol Violation|0|||
130622626|NCT00618995|470238093|FG002|Period 2|Protocol Violation|1|||
130622627|NCT00618995|470238094|FG003|Period 2|Protocol Violation|0|||
130622628|NCT00618995|470238091|FG000|Period 4|Adverse Event|1|||
130622629|NCT00618995|470238092|FG001|Period 4|Adverse Event|0|||
130622630|NCT00618995|470238093|FG002|Period 4|Adverse Event|0|||
130622631|NCT00618995|470238094|FG003|Period 4|Adverse Event|0|||
130622632|NCT02988219|470238097|FG000|Overall Study|Lack of Efficacy|1|||
130622633|NCT02988219|470238098|FG001|Overall Study|Lack of Efficacy|1|||
130622634|NCT02988219|470238097|FG000|Overall Study|Withdrawal by Subject|0|||
130622635|NCT02988219|470238098|FG001|Overall Study|Withdrawal by Subject|2|||
130622636|NCT00992186|470238099|FG000|Overall Study|Withdrawal by Subject|2|||
130622637|NCT00992186|470238099|FG000|Overall Study|Protocol Violation|1|||
130622638|NCT00992186|470238099|FG000|Overall Study|Physician Decision|1|||
130622639|NCT00992186|470238099|FG000|Overall Study|Adverse Event|9|||
130622640|NCT00992186|470238099|FG000|Overall Study|Progressive Disease|30|||
130622641|NCT00992186|470238099|FG000|Overall Study|Refusal To Receive Study Agent|3|||
130622642|NCT01896856|470238100|FG000|Overall Study|Transportation issues / Non-compliance|0|||
130622643|NCT01896856|470238101|FG001|Overall Study|Transportation issues / Non-compliance|0|||
130622644|NCT01896856|470238102|FG002|Overall Study|Transportation issues / Non-compliance|1|||
130622645|NCT01896856|470238103|FG003|Overall Study|Transportation issues / Non-compliance|0|||
130622646|NCT01896856|470238104|FG004|Overall Study|Transportation issues / Non-compliance|0|||
130622647|NCT01896856|470238105|FG005|Overall Study|Transportation issues / Non-compliance|0|||
130622648|NCT00282867|470238106|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
130622649|NCT00282867|470238107|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
130622650|NCT00282867|470238108|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
130622651|NCT02677220|470238109|FG000|Overall Study|Adverse Event|1|||
130622652|NCT00965146|470238110|FG000|Overall Study|Death|7|||
130622653|NCT00965146|470238110|FG000|Overall Study|Lost to Follow-up|22|||
130622654|NCT00965146|470238110|FG000|Overall Study|Withdrawal by Subject|17|||
130622655|NCT00965146|470238110|FG000|Overall Study|Unable to return|1|||
130622656|NCT00965146|470238110|FG000|Overall Study|Unwilling to return|11|||
130622657|NCT00965146|470238110|FG000|Overall Study|Intercurrent illness|1|||
130622658|NCT00965146|470238110|FG000|Overall Study|Revision / Removal of Study Implant|6|||
130622659|NCT00965146|470238110|FG000|Overall Study|Overall Study Termination|145|||
130622660|NCT02855450|470238111|FG000|Overall Study|Adverse Event|1|||
130622661|NCT02855450|470238112|FG001|Overall Study|Adverse Event|0|||
130622662|NCT02855450|470238111|FG000|Overall Study|Lost to Follow-up|4|||
130622663|NCT02855450|470238112|FG001|Overall Study|Lost to Follow-up|0|||
130622664|NCT01504971|470238113|FG000|Overall Study|Physician Decision|13|||
130622665|NCT00936117|470238114|FG000|Overall Study|Adverse Event|7|||
130622666|NCT00936117|470238114|FG000|Overall Study|Unable to continue oral medication|3|||
130622667|NCT05159362|470238121|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
130622668|NCT05159362|470238122|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
130622669|NCT05159362|470238123|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
130622670|NCT01376245|470238124|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
130622671|NCT01376245|470238125|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130622672|NCT01376245|470238126|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130622673|NCT01376245|470238127|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130622674|NCT01376245|470238128|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130622675|NCT01376245|470238124|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
130622676|NCT01376245|470238125|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130622677|NCT01376245|470238126|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130622678|NCT01376245|470238127|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130622679|NCT01376245|470238128|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130622680|NCT01376245|470238124|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
130622681|NCT01376245|470238125|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130622682|NCT01376245|470238126|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130622683|NCT01376245|470238127|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130622684|NCT01376245|470238128|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130622685|NCT01376245|470238124|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
130622686|NCT01376245|470238125|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130622687|NCT01376245|470238126|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130622688|NCT01376245|470238127|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130622689|NCT01376245|470238128|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130622690|NCT01376245|470238124|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
130622691|NCT01376245|470238125|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130622692|NCT01376245|470238126|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130622693|NCT01376245|470238127|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130622694|NCT01376245|470238128|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130622695|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130622696|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
130622697|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
130622698|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
130622699|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
130622700|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130622701|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
130622702|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
130622703|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
130622704|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
130622705|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130622706|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130622707|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130622708|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130622709|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
130622710|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130622711|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
130622712|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
130622713|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
130622714|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130622715|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130622716|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130622717|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130622718|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130622719|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130622720|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130622721|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
130622722|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130622723|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
130622724|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
130622725|NCT01376245|470238124|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130622726|NCT01376245|470238125|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
130622727|NCT01376245|470238126|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130622728|NCT01376245|470238127|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
130622729|NCT01376245|470238128|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
130622730|NCT01357889|470238129|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
130622731|NCT01357889|470238130|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
130622732|NCT01357889|470238129|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
130622733|NCT01357889|470238130|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
130622734|NCT01357889|470238129|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
130622735|NCT01357889|470238130|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
130622736|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
130622737|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
130622738|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
130622739|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
130622740|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
130622741|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
130622742|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
130622743|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
130622744|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
130622745|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
130622746|NCT01357889|470238129|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
130622747|NCT01357889|470238130|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
130622748|NCT01357889|470238129|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
130622749|NCT01357889|470238130|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
130622750|NCT01357889|470238129|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
130622751|NCT01357889|470238130|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
130622752|NCT01357889|470238129|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
130622753|NCT01357889|470238130|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
130622754|NCT01357889|470238129|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
130622755|NCT01357889|470238130|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
130622756|NCT01335698|470238131|FG000|Treatment Stage 1|Lack of Efficacy|3|||
130622757|NCT01335698|470238132|FG001|Treatment Stage 1|Lack of Efficacy|1|||
130622758|NCT01335698|470238133|FG002|Treatment Stage 1|Lack of Efficacy|3|||
130622759|NCT01335698|470238134|FG003|Treatment Stage 1|Lack of Efficacy|3|||
130622760|NCT01335698|470238135|FG004|Treatment Stage 1|Lack of Efficacy|1|||
130622761|NCT01335698|470238131|FG000|Treatment Stage 1|Adverse Event|1|||
130622762|NCT01335698|470238132|FG001|Treatment Stage 1|Adverse Event|2|||
130622763|NCT01335698|470238133|FG002|Treatment Stage 1|Adverse Event|2|||
130622764|NCT01335698|470238134|FG003|Treatment Stage 1|Adverse Event|1|||
130622765|NCT01335698|470238135|FG004|Treatment Stage 1|Adverse Event|1|||
130622766|NCT01335698|470238131|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
130622767|NCT01335698|470238132|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
130622768|NCT01335698|470238133|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
130622769|NCT01335698|470238134|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
130622770|NCT01335698|470238135|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
130622771|NCT01335698|470238131|FG000|Treatment Stage 1|Lost to Follow-up|1|||
130622772|NCT01335698|470238132|FG001|Treatment Stage 1|Lost to Follow-up|1|||
130622773|NCT01335698|470238133|FG002|Treatment Stage 1|Lost to Follow-up|0|||
130622774|NCT01335698|470238134|FG003|Treatment Stage 1|Lost to Follow-up|0|||
130622775|NCT01335698|470238135|FG004|Treatment Stage 1|Lost to Follow-up|0|||
130622776|NCT01335698|470238131|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
130622777|NCT01335698|470238132|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
130622778|NCT01335698|470238133|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
130622779|NCT01335698|470238134|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
130622780|NCT01335698|470238135|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
130622781|NCT01335698|470238131|FG000|Treatment Stage 1|No longer meets study criteria|1|||
130622782|NCT01335698|470238132|FG001|Treatment Stage 1|No longer meets study criteria|1|||
130622783|NCT01335698|470238133|FG002|Treatment Stage 1|No longer meets study criteria|0|||
130622784|NCT01335698|470238134|FG003|Treatment Stage 1|No longer meets study criteria|1|||
130622785|NCT01335698|470238135|FG004|Treatment Stage 1|No longer meets study criteria|0|||
130622786|NCT01335698|470238131|FG000|Treatment Stage 1|Other|1|||
130622787|NCT01335698|470238132|FG001|Treatment Stage 1|Other|0|||
130622788|NCT01335698|470238133|FG002|Treatment Stage 1|Other|0|||
130622789|NCT01335698|470238134|FG003|Treatment Stage 1|Other|1|||
130622790|NCT01335698|470238135|FG004|Treatment Stage 1|Other|0|||
130622791|NCT01335698|470238131|FG000|Treatment Stage 2|Lack of Efficacy|2|||
130622792|NCT01335698|470238132|FG001|Treatment Stage 2|Lack of Efficacy|1|||
130622793|NCT01335698|470238133|FG002|Treatment Stage 2|Lack of Efficacy|3|||
130622794|NCT01335698|470238134|FG003|Treatment Stage 2|Lack of Efficacy|1|||
130622795|NCT01335698|470238135|FG004|Treatment Stage 2|Lack of Efficacy|0|||
130622796|NCT01335698|470238131|FG000|Treatment Stage 2|Adverse Event|2|||
130622797|NCT01335698|470238132|FG001|Treatment Stage 2|Adverse Event|0|||
130622798|NCT01335698|470238133|FG002|Treatment Stage 2|Adverse Event|0|||
130622799|NCT01335698|470238134|FG003|Treatment Stage 2|Adverse Event|3|||
130622800|NCT01335698|470238135|FG004|Treatment Stage 2|Adverse Event|0|||
130622801|NCT01335698|470238131|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
130622802|NCT01335698|470238132|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
130622803|NCT01335698|470238133|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
130622804|NCT01335698|470238134|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
130622805|NCT01335698|470238135|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
130622806|NCT01335698|470238131|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
130622807|NCT01335698|470238132|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
130622808|NCT01335698|470238133|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
130622809|NCT01335698|470238134|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
130622810|NCT01335698|470238135|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
130622811|NCT01335698|470238131|FG000|Treatment Stage 2|Lost to Follow-up|1|||
130622812|NCT01335698|470238132|FG001|Treatment Stage 2|Lost to Follow-up|0|||
130622813|NCT01335698|470238133|FG002|Treatment Stage 2|Lost to Follow-up|0|||
130622814|NCT01335698|470238134|FG003|Treatment Stage 2|Lost to Follow-up|0|||
130622815|NCT01335698|470238135|FG004|Treatment Stage 2|Lost to Follow-up|0|||
130622816|NCT01335698|470238131|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
130622817|NCT01335698|470238132|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
130622818|NCT01335698|470238133|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
130622819|NCT01335698|470238134|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
130622820|NCT01335698|470238135|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
130622821|NCT01335698|470238131|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
130622822|NCT01335698|470238132|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
130622823|NCT01335698|470238133|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
130622824|NCT01335698|470238134|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
130622825|NCT01335698|470238135|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
130622826|NCT01335698|470238131|FG000|Treatment Stage 2|Switched to another formulation|1|||
130622827|NCT01335698|470238132|FG001|Treatment Stage 2|Switched to another formulation|1|||
130622828|NCT01335698|470238133|FG002|Treatment Stage 2|Switched to another formulation|0|||
130622829|NCT01335698|470238134|FG003|Treatment Stage 2|Switched to another formulation|0|||
130622830|NCT01335698|470238135|FG004|Treatment Stage 2|Switched to another formulation|0|||
130622831|NCT00105560|470238136|FG000|Overall Study|Lost to Follow-up|1|||
130622832|NCT02176291|470238139|FG000|Overall Study|Death|1|||
130622833|NCT02176291|470238140|FG001|Overall Study|Death|0|||
130622834|NCT02176291|470238139|FG000|Overall Study|non compliance with protocol|2|||
130622835|NCT02176291|470238140|FG001|Overall Study|non compliance with protocol|0|||
130622836|NCT02176291|470238139|FG000|Overall Study|Withdrawal by Subject|2|||
130622837|NCT02176291|470238140|FG001|Overall Study|Withdrawal by Subject|0|||
130622838|NCT01086150|470238141|FG000|Overall Study|Withdrawal by Subject|0|||
130622839|NCT01086150|470238142|FG001|Overall Study|Withdrawal by Subject|4|||
130622840|NCT01086150|470238143|FG002|Overall Study|Withdrawal by Subject|1|||
130622841|NCT01086150|470238141|FG000|Overall Study|Lost to Follow-up|0|||
130622842|NCT01086150|470238142|FG001|Overall Study|Lost to Follow-up|1|||
130622843|NCT01086150|470238143|FG002|Overall Study|Lost to Follow-up|0|||
130622844|NCT01086150|470238141|FG000|Overall Study|Screen Failure|0|||
130622845|NCT01086150|470238142|FG001|Overall Study|Screen Failure|1|||
130622846|NCT01086150|470238143|FG002|Overall Study|Screen Failure|0|||
130622847|NCT00805545|470238144|FG000|Overall Study|Protocol Violation|3|||
130622848|NCT00805545|470238145|FG001|Overall Study|Protocol Violation|2|||
130622849|NCT00805545|470238144|FG000|Overall Study|Protocol Violation|3|||
130622850|NCT00805545|470238145|FG001|Overall Study|Protocol Violation|1|||
130622851|NCT03448224|470238146|FG000|Overall Study|Provided same answer to every question|1|||
130622852|NCT03448224|470238147|FG001|Overall Study|Provided same answer to every question|0|||
130622853|NCT01021813|470238148|FG000|DB Treatment Phase|Adverse Event|60|||
130622854|NCT01021813|470238149|FG001|DB Treatment Phase|Adverse Event|22|||
130622855|NCT01021813|470238150|FG002|DB Treatment Phase|Adverse Event|0|||
130622856|NCT01021813|470238151|FG003|DB Treatment Phase|Adverse Event|0|||
130622857|NCT01021813|470238152|FG004|DB Treatment Phase|Adverse Event|0|||
130622858|NCT01021813|470238148|FG000|DB Treatment Phase|Lack of Efficacy|44|||
130622859|NCT01021813|470238149|FG001|DB Treatment Phase|Lack of Efficacy|28|||
130622860|NCT01021813|470238150|FG002|DB Treatment Phase|Lack of Efficacy|0|||
130622861|NCT01021813|470238151|FG003|DB Treatment Phase|Lack of Efficacy|0|||
130622862|NCT01021813|470238152|FG004|DB Treatment Phase|Lack of Efficacy|0|||
130622863|NCT01021813|470238148|FG000|DB Treatment Phase|Lost to Follow-up|14|||
130622864|NCT01021813|470238149|FG001|DB Treatment Phase|Lost to Follow-up|12|||
130622865|NCT01021813|470238150|FG002|DB Treatment Phase|Lost to Follow-up|0|||
130622866|NCT01021813|470238151|FG003|DB Treatment Phase|Lost to Follow-up|0|||
130622867|NCT01021813|470238152|FG004|DB Treatment Phase|Lost to Follow-up|0|||
130622868|NCT01021813|470238148|FG000|DB Treatment Phase|Physician Decision|17|||
130622869|NCT01021813|470238149|FG001|DB Treatment Phase|Physician Decision|8|||
130622870|NCT01021813|470238150|FG002|DB Treatment Phase|Physician Decision|0|||
130622871|NCT01021813|470238151|FG003|DB Treatment Phase|Physician Decision|0|||
130622872|NCT01021813|470238152|FG004|DB Treatment Phase|Physician Decision|0|||
130622873|NCT01021813|470238148|FG000|DB Treatment Phase|Pregnancy|1|||
130622874|NCT01021813|470238149|FG001|DB Treatment Phase|Pregnancy|0|||
130622875|NCT01021813|470238150|FG002|DB Treatment Phase|Pregnancy|0|||
130622876|NCT01021813|470238151|FG003|DB Treatment Phase|Pregnancy|0|||
130622877|NCT01021813|470238152|FG004|DB Treatment Phase|Pregnancy|0|||
130622878|NCT01021813|470238148|FG000|DB Treatment Phase|Protocol Violation|4|||
130622879|NCT01021813|470238149|FG001|DB Treatment Phase|Protocol Violation|3|||
130622880|NCT01021813|470238150|FG002|DB Treatment Phase|Protocol Violation|0|||
130622881|NCT01021813|470238151|FG003|DB Treatment Phase|Protocol Violation|0|||
130622882|NCT01021813|470238152|FG004|DB Treatment Phase|Protocol Violation|0|||
130622883|NCT01021813|470238148|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
130622884|NCT01021813|470238149|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
130622885|NCT01021813|470238150|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
130622886|NCT01021813|470238151|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
130622887|NCT01021813|470238152|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
130622888|NCT01021813|470238148|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
130622889|NCT01021813|470238149|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
130622890|NCT01021813|470238150|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
130622891|NCT01021813|470238151|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
130622892|NCT01021813|470238152|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
130622893|NCT01021813|470238148|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130622894|NCT01021813|470238149|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130622895|NCT01021813|470238150|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130622896|NCT01021813|470238151|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
130622897|NCT01021813|470238152|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130622898|NCT01021813|470238148|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130622899|NCT01021813|470238149|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130622900|NCT01021813|470238150|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130622901|NCT01021813|470238151|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130622902|NCT01021813|470238152|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
130622903|NCT01021813|470238148|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130622904|NCT01021813|470238149|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130622905|NCT01021813|470238150|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
130622906|NCT01021813|470238151|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130622907|NCT01021813|470238152|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130622908|NCT01021813|470238148|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
130622909|NCT01021813|470238149|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
130622910|NCT01021813|470238150|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
130622911|NCT01021813|470238151|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
130622912|NCT01021813|470238152|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
130622913|NCT00764478|470238153|FG000|Overall Study|Adverse Event|1|||
130622914|NCT00764478|470238154|FG001|Overall Study|Adverse Event|1|||
130622915|NCT00764478|470238155|FG002|Overall Study|Adverse Event|1|||
130622916|NCT00764478|470238153|FG000|Overall Study|Withdrawal by Subject|7|||
130622917|NCT00764478|470238154|FG001|Overall Study|Withdrawal by Subject|12|||
130622918|NCT00764478|470238155|FG002|Overall Study|Withdrawal by Subject|1|||
130622919|NCT00764478|470238153|FG000|Overall Study|Lost to Follow-up|7|||
130622920|NCT00764478|470238154|FG001|Overall Study|Lost to Follow-up|8|||
130622921|NCT00764478|470238155|FG002|Overall Study|Lost to Follow-up|5|||
130622922|NCT00764478|470238153|FG000|Overall Study|Protocol Violation|0|||
130622923|NCT00764478|470238154|FG001|Overall Study|Protocol Violation|1|||
130622924|NCT00764478|470238155|FG002|Overall Study|Protocol Violation|1|||
130622925|NCT02270684|470238156|FG000|Overall Study|Lost to Follow-up|0|||
130622926|NCT02270684|470238157|FG001|Overall Study|Lost to Follow-up|3|||
130622927|NCT02270684|470238156|FG000|Overall Study|Study terminated|1|||
130622928|NCT02270684|470238157|FG001|Overall Study|Study terminated|0|||
130622929|NCT00862121|470238160|FG000|Overall Study|Adverse Event|1|||
130622930|NCT00862121|470238161|FG001|Overall Study|Adverse Event|2|||
130622931|NCT00862121|470238160|FG000|Overall Study|Lack of Efficacy|0|||
130622932|NCT00862121|470238161|FG001|Overall Study|Lack of Efficacy|3|||
130622933|NCT00862121|470238160|FG000|Overall Study|Protocol Violation|0|||
130622934|NCT00862121|470238161|FG001|Overall Study|Protocol Violation|1|||
130622935|NCT00862121|470238160|FG000|Overall Study|Exclusion criterion violation|0|||
130622936|NCT00862121|470238161|FG001|Overall Study|Exclusion criterion violation|1|||
130622937|NCT00862121|470238160|FG000|Overall Study|Incorrect randomisation|0|||
130622938|NCT00862121|470238161|FG001|Overall Study|Incorrect randomisation|1|||
130622939|NCT00171314|470238166|FG000|Overall Study|Adverse Event|44|||
130622940|NCT00171314|470238167|FG001|Overall Study|Adverse Event|41|||
130622941|NCT00171314|470238166|FG000|Overall Study|Lack of Efficacy|19|||
130622942|NCT00171314|470238167|FG001|Overall Study|Lack of Efficacy|14|||
130622943|NCT00171314|470238166|FG000|Overall Study|Withdrawal by Subject|9|||
130622944|NCT00171314|470238167|FG001|Overall Study|Withdrawal by Subject|6|||
130622945|NCT00171314|470238166|FG000|Overall Study|Abnormal Test Procedure Results|9|||
130622946|NCT00171314|470238167|FG001|Overall Study|Abnormal Test Procedure Results|3|||
130622947|NCT00171314|470238166|FG000|Overall Study|Protocol Violation|3|||
130622948|NCT00171314|470238167|FG001|Overall Study|Protocol Violation|7|||
130622949|NCT00171314|470238166|FG000|Overall Study|Administrative Problems|4|||
130622950|NCT00171314|470238167|FG001|Overall Study|Administrative Problems|3|||
130622951|NCT00171314|470238166|FG000|Overall Study|Lost to Follow-up|1|||
130622952|NCT00171314|470238167|FG001|Overall Study|Lost to Follow-up|3|||
130622953|NCT00171314|470238166|FG000|Overall Study|Death|2|||
130622954|NCT00171314|470238167|FG001|Overall Study|Death|1|||
130622955|NCT01033487|470238168|FG000|Fourth Intervention Period|Adverse Event|0|||
130622956|NCT01033487|470238169|FG001|Fourth Intervention Period|Adverse Event|0|||
130622957|NCT01033487|470238170|FG002|Fourth Intervention Period|Adverse Event|0|||
130622958|NCT01033487|470238171|FG003|Fourth Intervention Period|Adverse Event|0|||
130622959|NCT01033487|470238172|FG004|Fourth Intervention Period|Adverse Event|0|||
130622960|NCT01033487|470238173|FG005|Fourth Intervention Period|Adverse Event|0|||
130622961|NCT01033487|470238174|FG006|Fourth Intervention Period|Adverse Event|0|||
130622962|NCT01033487|470238175|FG007|Fourth Intervention Period|Adverse Event|0|||
130622963|NCT01033487|470238176|FG008|Fourth Intervention Period|Adverse Event|1|||
130622964|NCT01033487|470238177|FG009|Fourth Intervention Period|Adverse Event|0|||
130622965|NCT02939599|470238181|FG000|Overall Study|Adverse Event|1|||
130622966|NCT02939599|470238182|FG001|Overall Study|Adverse Event|0|||
130622967|NCT02939599|470238181|FG000|Overall Study|Study Terminated By Sponsor|2|||
130622968|NCT02939599|470238182|FG001|Overall Study|Study Terminated By Sponsor|2|||
130622969|NCT02148211|470238184|FG000|Overall Study|Lost to Follow-up|352|||
130622970|NCT03326869|470239822|FG000|Overall Study|Study data has been lost to natural disa|1|||
130622971|NCT03326869|470239823|FG001|Overall Study|Study data has been lost to natural disa|1|||
130622972|NCT03287869|470239827|FG000|Overall Study|Adverse Event|14|||
130622973|NCT03287869|470239828|FG001|Overall Study|Adverse Event|12|||
130622974|NCT03287869|470239827|FG000|Overall Study|Lack of Efficacy|1|||
130622975|NCT03287869|470239828|FG001|Overall Study|Lack of Efficacy|0|||
130622976|NCT03287869|470239827|FG000|Overall Study|Lost to Follow-up|13|||
130622977|NCT03287869|470239828|FG001|Overall Study|Lost to Follow-up|19|||
130622978|NCT03287869|470239827|FG000|Overall Study|Non-Compliance With Study Drug|5|||
130622979|NCT03287869|470239828|FG001|Overall Study|Non-Compliance With Study Drug|9|||
130622980|NCT03287869|470239827|FG000|Overall Study|Progressive Disease|1|||
130622981|NCT03287869|470239828|FG001|Overall Study|Progressive Disease|0|||
130622982|NCT03287869|470239827|FG000|Overall Study|Protocol Deviation|2|||
130622983|NCT03287869|470239828|FG001|Overall Study|Protocol Deviation|1|||
130622984|NCT03287869|470239827|FG000|Overall Study|Withdrawal by Subject|36|||
130622985|NCT03287869|470239828|FG001|Overall Study|Withdrawal by Subject|43|||
130622986|NCT03287869|470239827|FG000|Overall Study|Early Closure of the Site|0|||
130622987|NCT03287869|470239828|FG001|Overall Study|Early Closure of the Site|1|||
130622988|NCT03287869|470239827|FG000|Overall Study|Physician Decision|5|||
130622989|NCT03287869|470239828|FG001|Overall Study|Physician Decision|5|||
130622990|NCT03287869|470239827|FG000|Overall Study|Reason not Specified|6|||
130622991|NCT03287869|470239828|FG001|Overall Study|Reason not Specified|3|||
130622992|NCT03488238|470239829|FG000|Overall Study|Equipment malfunction|1|||
130622993|NCT03488238|470239829|FG000|Overall Study|Adverse Event|1|||
130622994|NCT02670928|470239830|FG000|Overall Study|Adverse Event|3|||
130622995|NCT02670928|470239831|FG001|Overall Study|Adverse Event|1|||
130622996|NCT02670928|470239830|FG000|Overall Study|Withdrawal by Subject|4|||
130622997|NCT02670928|470239831|FG001|Overall Study|Withdrawal by Subject|0|||
130622998|NCT02670928|470239830|FG000|Overall Study|Lost to Follow-up|1|||
130622999|NCT02670928|470239831|FG001|Overall Study|Lost to Follow-up|0|||
130623000|NCT02670928|470239830|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
130623001|NCT02670928|470239831|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
130623002|NCT02591238|470239832|FG000|Overall Study|Pregnancy|1|||
130623003|NCT02591238|470239833|FG001|Overall Study|Pregnancy|0|||
130623004|NCT02591238|470239834|FG002|Overall Study|Pregnancy|0|||
130623005|NCT02591238|470239835|FG003|Overall Study|Pregnancy|0|||
130623006|NCT02591238|470239832|FG000|Overall Study|Withdrawal by Subject|0|||
130623007|NCT02591238|470239833|FG001|Overall Study|Withdrawal by Subject|0|||
130623008|NCT02591238|470239834|FG002|Overall Study|Withdrawal by Subject|0|||
130623009|NCT02591238|470239835|FG003|Overall Study|Withdrawal by Subject|1|||
130623010|NCT02591238|470239832|FG000|Overall Study|influenza|0|||
130623011|NCT02591238|470239833|FG001|Overall Study|influenza|0|||
130623012|NCT02591238|470239834|FG002|Overall Study|influenza|0|||
130623013|NCT02591238|470239835|FG003|Overall Study|influenza|1|||
130623014|NCT02591238|470239832|FG000|Overall Study|personal circumstances|0|||
130623015|NCT02591238|470239833|FG001|Overall Study|personal circumstances|0|||
130623016|NCT02591238|470239834|FG002|Overall Study|personal circumstances|0|||
130623017|NCT02591238|470239835|FG003|Overall Study|personal circumstances|1|||
130623018|NCT02591238|470239832|FG000|Overall Study|personal circumstances|0|||
130623019|NCT02591238|470239833|FG001|Overall Study|personal circumstances|1|||
130623020|NCT02591238|470239834|FG002|Overall Study|personal circumstances|0|||
130623021|NCT02591238|470239835|FG003|Overall Study|personal circumstances|0|||
130623022|NCT00525785|470239837|FG000|Overall Study|Withdrawal by Subject|1|||
130623023|NCT00525785|470239837|FG000|Overall Study|Lack of Efficacy|1|||
130623024|NCT00525785|470239837|FG000|Overall Study|Physician Decision|1|||
130623025|NCT01316939|470239838|FG000|Overall Study|Study closed/terminated|26|||
130623026|NCT01316939|470239839|FG001|Overall Study|Study closed/terminated|25|||
130623027|NCT01316939|470239840|FG002|Overall Study|Study closed/terminated|23|||
130623028|NCT01316939|470239838|FG000|Overall Study|Lack of Efficacy|24|||
130623029|NCT01316939|470239839|FG001|Overall Study|Lack of Efficacy|25|||
130623030|NCT01316939|470239840|FG002|Overall Study|Lack of Efficacy|25|||
130623031|NCT01316939|470239838|FG000|Overall Study|Adverse Event|9|||
130623032|NCT01316939|470239839|FG001|Overall Study|Adverse Event|12|||
130623033|NCT01316939|470239840|FG002|Overall Study|Adverse Event|11|||
130623034|NCT01316939|470239838|FG000|Overall Study|Withdrawal by Subject|1|||
130623035|NCT01316939|470239839|FG001|Overall Study|Withdrawal by Subject|3|||
130623036|NCT01316939|470239840|FG002|Overall Study|Withdrawal by Subject|6|||
130623037|NCT01316939|470239838|FG000|Overall Study|Physician Decision|2|||
130623038|NCT01316939|470239839|FG001|Overall Study|Physician Decision|2|||
130623039|NCT01316939|470239840|FG002|Overall Study|Physician Decision|1|||
130623040|NCT01316939|470239838|FG000|Overall Study|Lost to Follow-up|0|||
130623041|NCT01316939|470239839|FG001|Overall Study|Lost to Follow-up|0|||
130623042|NCT01316939|470239840|FG002|Overall Study|Lost to Follow-up|2|||
130623043|NCT01316939|470239838|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
130623044|NCT01316939|470239839|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
130623045|NCT01316939|470239840|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
130623046|NCT01316939|470239838|FG000|Overall Study|Protocol Violation|0|||
130623047|NCT01316939|470239839|FG001|Overall Study|Protocol Violation|1|||
130623048|NCT01316939|470239840|FG002|Overall Study|Protocol Violation|0|||
130623049|NCT01634113|470239841|FG000|Overall Study|Not treated|0|||
130623050|NCT01634113|470239842|FG001|Overall Study|Not treated|0|||
130623051|NCT01634113|470239843|FG002|Overall Study|Not treated|1|||
130623052|NCT00324740|470239844|FG000|Overall Study|Withdrawal by Subject|1|||
130623053|NCT00324740|470239845|FG001|Overall Study|Withdrawal by Subject|0|||
130623054|NCT00324740|470239846|FG002|Overall Study|Withdrawal by Subject|1|||
130623055|NCT00520299|470239849|FG000|Overall Study|Withdrawal by Subject|0|||
130623056|NCT00520299|470239850|FG001|Overall Study|Withdrawal by Subject|0|||
130623057|NCT00520299|470239851|FG002|Overall Study|Withdrawal by Subject|2|||
130623058|NCT00520299|470239849|FG000|Overall Study|Progressive disease|0|||
130623059|NCT00520299|470239850|FG001|Overall Study|Progressive disease|3|||
130623060|NCT00520299|470239851|FG002|Overall Study|Progressive disease|4|||
130623061|NCT01352845|470239852|FG000|Overall Study|Lost to Follow-up|313|||
130623062|NCT01352845|470239853|FG001|Overall Study|Lost to Follow-up|92|||
130623063|NCT01352845|470239852|FG000|Overall Study|No Longer Willing to Participate|205|||
130623064|NCT01352845|470239853|FG001|Overall Study|No Longer Willing to Participate|58|||
130623065|NCT01352845|470239852|FG000|Overall Study|Withdrawal by Subject|48|||
130623066|NCT01352845|470239853|FG001|Overall Study|Withdrawal by Subject|16|||
130623067|NCT01352845|470239852|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
130623068|NCT01352845|470239853|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
130623069|NCT01352845|470239852|FG000|Overall Study|Pregnancy|27|||
130623070|NCT01352845|470239853|FG001|Overall Study|Pregnancy|7|||
130623071|NCT01352845|470239852|FG000|Overall Study|Adverse Event|22|||
130623072|NCT01352845|470239853|FG001|Overall Study|Adverse Event|6|||
130623073|NCT01352845|470239852|FG000|Overall Study|Other|17|||
130623074|NCT01352845|470239853|FG001|Overall Study|Other|7|||
130623075|NCT01352845|470239852|FG000|Overall Study|Protocol Violation|12|||
130623076|NCT01352845|470239853|FG001|Overall Study|Protocol Violation|6|||
130623077|NCT01352845|470239852|FG000|Overall Study|Death|3|||
130623078|NCT01352845|470239853|FG001|Overall Study|Death|0|||
130623079|NCT01357980|470239857|FG000|Overall Study|Lack of Efficacy|0|||
130623080|NCT01357980|470239858|FG001|Overall Study|Lack of Efficacy|1|||
130623081|NCT01357980|470239859|FG002|Overall Study|Lack of Efficacy|0|||
130623082|NCT01357980|470239860|FG003|Overall Study|Lack of Efficacy|0|||
130623083|NCT01357980|470239857|FG000|Overall Study|Consent withdrawn|0|||
130623084|NCT01357980|470239858|FG001|Overall Study|Consent withdrawn|0|||
130623085|NCT01357980|470239859|FG002|Overall Study|Consent withdrawn|1|||
130623086|NCT01357980|470239860|FG003|Overall Study|Consent withdrawn|0|||
130623087|NCT04507776|470239861|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
130623088|NCT01624506|470239862|FG000|Overall Study|Lost to Follow-up|29|||
130623089|NCT01624506|470239863|FG001|Overall Study|Lost to Follow-up|15|||
130623090|NCT01624506|470239862|FG000|Overall Study|Withdrawal by Subject|9|||
130623091|NCT01624506|470239863|FG001|Overall Study|Withdrawal by Subject|2|||
130623092|NCT01624506|470239862|FG000|Overall Study|Death|1|||
130623093|NCT01624506|470239863|FG001|Overall Study|Death|0|||
130623094|NCT01624506|470239862|FG000|Overall Study|LINX explants|23|||
130623095|NCT01624506|470239863|FG001|Overall Study|LINX explants|0|||
130623096|NCT01624506|470239862|FG000|Overall Study|Adverse Event|3|||
130623097|NCT01624506|470239863|FG001|Overall Study|Adverse Event|0|||
130623098|NCT00132314|470239867|FG000|Overall Study|Lost to Follow-up|70|||
130623099|NCT00132314|470239868|FG001|Overall Study|Lost to Follow-up|62|||
130623100|NCT00132314|470239867|FG000|Overall Study|Lacked SSN|1|||
130623101|NCT00132314|470239868|FG001|Overall Study|Lacked SSN|3|||
130623102|NCT00132314|470239867|FG000|Overall Study|Refused intervention at baseline|2|||
130623103|NCT00132314|470239868|FG001|Overall Study|Refused intervention at baseline|7|||
130623104|NCT02966353|470239871|FG000|Overall Study|Withdrawal by Subject|7|||
130623105|NCT02966353|470239871|FG000|Overall Study|Adverse Event|4|||
130623106|NCT02966353|470239871|FG000|Overall Study|Death|4|||
130623107|NCT02966353|470239871|FG000|Overall Study|Physician Decision|3|||
130623108|NCT02966353|470239871|FG000|Overall Study|Progressive disease|2|||
130623109|NCT02966353|470239871|FG000|Overall Study|Protocol deviation|2|||
130623110|NCT05905601|470239872|FG000|Overall Study|Lost to Follow-up|1|||
130623111|NCT05905601|470239873|FG001|Overall Study|Lost to Follow-up|3|||
130623112|NCT03024255|470239874|FG000|Overall Study|Adverse Event|1|||
130623113|NCT03024255|470239875|FG001|Overall Study|Adverse Event|4|||
130623114|NCT03024255|470239876|FG002|Overall Study|Adverse Event|8|||
130623115|NCT03024255|470239877|FG003|Overall Study|Adverse Event|0|||
130623116|NCT03024255|470239874|FG000|Overall Study|Withdrawal by Subject|3|||
130623117|NCT03024255|470239875|FG001|Overall Study|Withdrawal by Subject|1|||
130623118|NCT03024255|470239876|FG002|Overall Study|Withdrawal by Subject|0|||
130623119|NCT03024255|470239877|FG003|Overall Study|Withdrawal by Subject|3|||
130623120|NCT03024255|470239874|FG000|Overall Study|Protocol Violation|0|||
130623121|NCT03024255|470239875|FG001|Overall Study|Protocol Violation|0|||
130623122|NCT03024255|470239876|FG002|Overall Study|Protocol Violation|2|||
130623123|NCT03024255|470239877|FG003|Overall Study|Protocol Violation|0|||
130623124|NCT03024255|470239874|FG000|Overall Study|Lost to Follow-up|1|||
130623125|NCT03024255|470239875|FG001|Overall Study|Lost to Follow-up|2|||
130623126|NCT03024255|470239876|FG002|Overall Study|Lost to Follow-up|1|||
130623127|NCT03024255|470239877|FG003|Overall Study|Lost to Follow-up|1|||
130623128|NCT03024255|470239874|FG000|Overall Study|Lack of Efficacy|1|||
130623129|NCT03024255|470239875|FG001|Overall Study|Lack of Efficacy|0|||
130623130|NCT03024255|470239876|FG002|Overall Study|Lack of Efficacy|0|||
130623131|NCT03024255|470239877|FG003|Overall Study|Lack of Efficacy|0|||
130623132|NCT03024255|470239874|FG000|Overall Study|Protocol Noncompliance|1|||
130623133|NCT03024255|470239875|FG001|Overall Study|Protocol Noncompliance|1|||
130623134|NCT03024255|470239876|FG002|Overall Study|Protocol Noncompliance|0|||
130623135|NCT03024255|470239877|FG003|Overall Study|Protocol Noncompliance|1|||
130623136|NCT03250377|470239878|FG000|Overall Study|Adverse Event|2|||
130623137|NCT03250377|470239879|FG001|Overall Study|Adverse Event|4|||
130623138|NCT03250377|470239880|FG002|Overall Study|Adverse Event|0|||
130623139|NCT03250377|470239881|FG003|Overall Study|Adverse Event|4|||
130623140|NCT03250377|470239878|FG000|Overall Study|Lack of Efficacy|5|||
130623141|NCT03250377|470239879|FG001|Overall Study|Lack of Efficacy|14|||
130623142|NCT03250377|470239880|FG002|Overall Study|Lack of Efficacy|1|||
130623143|NCT03250377|470239881|FG003|Overall Study|Lack of Efficacy|3|||
130623144|NCT03250377|470239878|FG000|Overall Study|Protocol Violation|0|||
130623145|NCT03250377|470239879|FG001|Overall Study|Protocol Violation|2|||
130623146|NCT03250377|470239880|FG002|Overall Study|Protocol Violation|0|||
130623147|NCT03250377|470239881|FG003|Overall Study|Protocol Violation|1|||
130623148|NCT03250377|470239878|FG000|Overall Study|Lost to Follow-up|0|||
130623149|NCT03250377|470239879|FG001|Overall Study|Lost to Follow-up|1|||
130623150|NCT03250377|470239880|FG002|Overall Study|Lost to Follow-up|0|||
130623151|NCT03250377|470239881|FG003|Overall Study|Lost to Follow-up|0|||
130623152|NCT03250377|470239878|FG000|Overall Study|Withdrawal by Subject|7|||
130623153|NCT03250377|470239879|FG001|Overall Study|Withdrawal by Subject|7|||
130623154|NCT03250377|470239880|FG002|Overall Study|Withdrawal by Subject|0|||
130623155|NCT03250377|470239881|FG003|Overall Study|Withdrawal by Subject|4|||
130623156|NCT03250377|470239878|FG000|Overall Study|Investigator's Judgment|1|||
130623157|NCT03250377|470239879|FG001|Overall Study|Investigator's Judgment|0|||
130623158|NCT03250377|470239880|FG002|Overall Study|Investigator's Judgment|0|||
130623159|NCT03250377|470239881|FG003|Overall Study|Investigator's Judgment|0|||
130623160|NCT03250377|470239878|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
130623161|NCT03250377|470239879|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
130623162|NCT03250377|470239880|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
130623163|NCT03250377|470239881|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
130623164|NCT03250377|470239878|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
130623165|NCT03250377|470239879|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
130623166|NCT03250377|470239880|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
130623167|NCT03250377|470239881|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
130623168|NCT03250377|470239878|FG000|Overall Study|Epilepsy Surgery|0|||
130623169|NCT03250377|470239879|FG001|Overall Study|Epilepsy Surgery|1|||
130623170|NCT03250377|470239880|FG002|Overall Study|Epilepsy Surgery|2|||
130623171|NCT03250377|470239881|FG003|Overall Study|Epilepsy Surgery|0|||
130623172|NCT03250377|470239878|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130623173|NCT03250377|470239879|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
130623174|NCT03250377|470239880|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130623175|NCT03250377|470239881|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130623176|NCT03250377|470239878|FG000|Overall Study|Request From The Sponsor|0|||
130623177|NCT03250377|470239879|FG001|Overall Study|Request From The Sponsor|1|||
130623178|NCT03250377|470239880|FG002|Overall Study|Request From The Sponsor|0|||
130623179|NCT03250377|470239881|FG003|Overall Study|Request From The Sponsor|0|||
130623180|NCT03250377|470239878|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
130623181|NCT03250377|470239879|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
130623182|NCT03250377|470239880|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
130623183|NCT03250377|470239881|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
130623184|NCT03250377|470239878|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
130623185|NCT03250377|470239879|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
130623186|NCT03250377|470239880|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
130623187|NCT03250377|470239881|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
130623188|NCT03250377|470239878|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
130623189|NCT03250377|470239879|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
130623190|NCT03250377|470239880|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
130623191|NCT03250377|470239881|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
130623192|NCT03250377|470239878|FG000|Overall Study|Pregnancy Event|0|||
130623193|NCT03250377|470239879|FG001|Overall Study|Pregnancy Event|1|||
130623194|NCT03250377|470239880|FG002|Overall Study|Pregnancy Event|0|||
130623195|NCT03250377|470239881|FG003|Overall Study|Pregnancy Event|0|||
130623196|NCT03250377|470239878|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
130623197|NCT03250377|470239879|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
130623198|NCT03250377|470239880|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
130623199|NCT03250377|470239881|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
130623200|NCT03250377|470239878|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130623201|NCT03250377|470239879|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
130623202|NCT03250377|470239880|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130623203|NCT03250377|470239881|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130623204|NCT03250377|470239878|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130623205|NCT03250377|470239879|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
130623206|NCT03250377|470239880|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130623207|NCT03250377|470239881|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130623208|NCT03250377|470239878|FG000|Overall Study|Patient requested to change hospital|0|||
130623209|NCT03250377|470239879|FG001|Overall Study|Patient requested to change hospital|0|||
130623210|NCT03250377|470239880|FG002|Overall Study|Patient requested to change hospital|0|||
130623211|NCT03250377|470239881|FG003|Overall Study|Patient requested to change hospital|1|||
130623212|NCT03250377|470239878|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
130623213|NCT03250377|470239879|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
130623214|NCT03250377|470239880|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
130623215|NCT03250377|470239881|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
130623216|NCT00793182|470239882|FG000|Overall Study|Adverse Event|0|||
130623217|NCT00793182|470239883|FG001|Overall Study|Adverse Event|1|||
130623218|NCT02197897|470239889|FG000|Overall Study|not eligible|1|||
130623219|NCT01532570|470239891|FG000|Overall Study|Lack of Efficacy|1|||
130623220|NCT01532570|470239892|FG001|Overall Study|Lack of Efficacy|0|||
130623221|NCT01532570|470239893|FG002|Overall Study|Lack of Efficacy|0|||
130623222|NCT01532570|470239894|FG003|Overall Study|Lack of Efficacy|0|||
130623223|NCT01532570|470239891|FG000|Overall Study|Withdrawal by Subject|0|||
130623224|NCT01532570|470239892|FG001|Overall Study|Withdrawal by Subject|1|||
130623225|NCT01532570|470239893|FG002|Overall Study|Withdrawal by Subject|0|||
130623226|NCT01532570|470239894|FG003|Overall Study|Withdrawal by Subject|0|||
130623227|NCT01329341|470239898|FG000|Overall Study|Withdrawal by Subject|44|||
130623228|NCT03017846|470239899|FG000|Overall Study|Lost to Follow-up|3|||
130623229|NCT03017846|470239899|FG000|Overall Study|Adverse Event|2|||
130623230|NCT04603391|470239900|FG000|First Intervention (4 Days)|Adverse Event|1|||
130623231|NCT04603391|470239901|FG001|First Intervention (4 Days)|Adverse Event|0|||
130623232|NCT04603391|470239900|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
130623233|NCT04603391|470239901|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
130623234|NCT02151682|470239902|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130623235|NCT02151682|470239903|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
130623236|NCT02151682|470239904|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130623237|NCT02151682|470239905|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130623238|NCT02151682|470239906|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130623239|NCT02151682|470239907|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130623240|NCT02151682|470239902|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130623241|NCT02151682|470239903|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
130623242|NCT02151682|470239904|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130623243|NCT02151682|470239905|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130623244|NCT02151682|470239906|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130623245|NCT02151682|470239907|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130623246|NCT02151682|470239902|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130623247|NCT02151682|470239903|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
130623248|NCT02151682|470239904|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130623249|NCT02151682|470239905|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130623250|NCT02151682|470239906|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130623251|NCT02151682|470239907|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130623252|NCT02151682|470239902|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
130623253|NCT02151682|470239903|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
130623254|NCT02151682|470239904|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130623255|NCT02151682|470239905|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130623256|NCT02151682|470239906|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130623257|NCT02151682|470239907|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130623258|NCT02151682|470239902|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
130623259|NCT02151682|470239903|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130623260|NCT02151682|470239904|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130623261|NCT02151682|470239905|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130623262|NCT02151682|470239906|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130623263|NCT02151682|470239907|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130623264|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130623265|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130623266|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
130623267|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130623268|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130623269|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130623270|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
130623271|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
130623272|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
130623273|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
130623274|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
130623275|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
130623276|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130623277|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130623278|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
130623279|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
130623280|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130623281|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130623282|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130623283|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130623284|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
130623285|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130623286|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130623287|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130623288|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130623289|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130623290|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
130623291|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130623292|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130623293|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130623294|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130623295|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130623296|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
130623297|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130623298|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130623299|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130623300|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
130623301|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
130623302|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
130623303|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
130623304|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
130623305|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
130623306|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
130623307|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
130623308|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
130623309|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
130623310|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
130623311|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
130623312|NCT02151682|470239902|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130623313|NCT02151682|470239903|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130623314|NCT02151682|470239904|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
130623315|NCT02151682|470239905|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130623316|NCT02151682|470239906|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130623317|NCT02151682|470239907|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130623318|NCT02151682|470239902|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130623319|NCT02151682|470239903|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130623320|NCT02151682|470239904|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130623321|NCT02151682|470239905|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130623322|NCT02151682|470239906|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130623323|NCT02151682|470239907|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
130623324|NCT02151682|470239902|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130623325|NCT02151682|470239903|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130623326|NCT02151682|470239904|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130623327|NCT02151682|470239905|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130623328|NCT02151682|470239906|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130623329|NCT02151682|470239907|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
130623330|NCT02151682|470239902|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130623331|NCT02151682|470239903|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130623332|NCT02151682|470239904|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130623333|NCT02151682|470239905|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130623334|NCT02151682|470239906|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130623335|NCT02151682|470239907|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
130623336|NCT02151682|470239902|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130623337|NCT02151682|470239903|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130623338|NCT02151682|470239904|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130623339|NCT02151682|470239905|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130623340|NCT02151682|470239906|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130623341|NCT02151682|470239907|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
130623342|NCT00168064|470239908|FG000|Overall Study|Adverse Event|26|||
130623343|NCT00168064|470239909|FG001|Overall Study|Adverse Event|22|||
130623344|NCT00168064|470239908|FG000|Overall Study|Withdrawal by Subject|3|||
130623345|NCT00168064|470239909|FG001|Overall Study|Withdrawal by Subject|4|||
130623346|NCT00168064|470239908|FG000|Overall Study|Lack of Efficacy|4|||
130623347|NCT00168064|470239909|FG001|Overall Study|Lack of Efficacy|4|||
130623348|NCT00168064|470239908|FG000|Overall Study|Lost to Follow-up|4|||
130623349|NCT00168064|470239909|FG001|Overall Study|Lost to Follow-up|3|||
130623350|NCT00168064|470239908|FG000|Overall Study|Non-compliance|2|||
130623351|NCT00168064|470239909|FG001|Overall Study|Non-compliance|3|||
130623352|NCT00168064|470239908|FG000|Overall Study|Concurrent Illness|4|||
130623353|NCT00168064|470239909|FG001|Overall Study|Concurrent Illness|3|||
130623354|NCT00168064|470239908|FG000|Overall Study|Subject's Best interest|2|||
130623355|NCT00168064|470239909|FG001|Overall Study|Subject's Best interest|2|||
130623356|NCT00168064|470239908|FG000|Overall Study|Various|4|||
130623357|NCT00168064|470239909|FG001|Overall Study|Various|3|||
130623358|NCT00318565|470239910|FG000|Overall Study|Excluded per protocol|24|||
130623359|NCT00830960|470239911|FG000|Overall Study|Death|5|||
130623360|NCT00830960|470239912|FG001|Overall Study|Death|4|||
130623361|NCT00830960|470239913|FG002|Overall Study|Death|3|||
130623362|NCT00830960|470239914|FG003|Overall Study|Death|2|||
130623363|NCT00830960|470239915|FG004|Overall Study|Death|6|||
130623364|NCT00830960|470239916|FG005|Overall Study|Death|1|||
130623365|NCT00830960|470239911|FG000|Overall Study|Lost to Follow-up|1|||
130623366|NCT00830960|470239912|FG001|Overall Study|Lost to Follow-up|1|||
130623367|NCT00830960|470239913|FG002|Overall Study|Lost to Follow-up|1|||
130623368|NCT00830960|470239914|FG003|Overall Study|Lost to Follow-up|0|||
130623369|NCT00830960|470239915|FG004|Overall Study|Lost to Follow-up|0|||
130623370|NCT00830960|470239916|FG005|Overall Study|Lost to Follow-up|1|||
130623371|NCT00830960|470239911|FG000|Overall Study|Withdrawal by Subject|19|||
130623372|NCT00830960|470239912|FG001|Overall Study|Withdrawal by Subject|19|||
130623373|NCT00830960|470239913|FG002|Overall Study|Withdrawal by Subject|18|||
130623374|NCT00830960|470239914|FG003|Overall Study|Withdrawal by Subject|23|||
130623375|NCT00830960|470239915|FG004|Overall Study|Withdrawal by Subject|16|||
130623376|NCT00830960|470239916|FG005|Overall Study|Withdrawal by Subject|21|||
130623377|NCT00830960|470239911|FG000|Overall Study|Sponsor Decision|1|||
130623378|NCT00830960|470239912|FG001|Overall Study|Sponsor Decision|2|||
130623379|NCT00830960|470239913|FG002|Overall Study|Sponsor Decision|3|||
130623380|NCT00830960|470239914|FG003|Overall Study|Sponsor Decision|4|||
130623381|NCT00830960|470239915|FG004|Overall Study|Sponsor Decision|5|||
130623382|NCT00830960|470239916|FG005|Overall Study|Sponsor Decision|7|||
130623383|NCT00830960|470239911|FG000|Overall Study|No study drug received|7|||
130623384|NCT00830960|470239912|FG001|Overall Study|No study drug received|2|||
130623385|NCT00830960|470239913|FG002|Overall Study|No study drug received|4|||
130623386|NCT00830960|470239914|FG003|Overall Study|No study drug received|3|||
130623387|NCT00830960|470239915|FG004|Overall Study|No study drug received|5|||
130623388|NCT00830960|470239916|FG005|Overall Study|No study drug received|7|||
130623389|NCT00507416|470239924|FG000|Overall Study|Adverse Event|58|||
130623390|NCT00507416|470239925|FG001|Overall Study|Adverse Event|67|||
130623391|NCT00507416|470239926|FG002|Overall Study|Adverse Event|65|||
130623392|NCT00507416|470239924|FG000|Overall Study|Protocol Violation|1|||
130623393|NCT00507416|470239925|FG001|Overall Study|Protocol Violation|2|||
130623394|NCT00507416|470239926|FG002|Overall Study|Protocol Violation|0|||
130623395|NCT00507416|470239924|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
130623396|NCT00507416|470239925|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
130623397|NCT00507416|470239926|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
130623398|NCT00507416|470239924|FG000|Overall Study|Progressive Disease|20|||
130623399|NCT00507416|470239925|FG001|Overall Study|Progressive Disease|10|||
130623400|NCT00507416|470239926|FG002|Overall Study|Progressive Disease|13|||
130623401|NCT00507416|470239924|FG000|Overall Study|Patient declined further treatment|18|||
130623402|NCT00507416|470239925|FG001|Overall Study|Patient declined further treatment|14|||
130623403|NCT00507416|470239926|FG002|Overall Study|Patient declined further treatment|11|||
130623404|NCT00507416|470239924|FG000|Overall Study|Other|11|||
130623405|NCT00507416|470239925|FG001|Overall Study|Other|16|||
130623406|NCT00507416|470239926|FG002|Overall Study|Other|13|||
130623407|NCT00507416|470239924|FG000|Overall Study|Did not Receive Study Treatment|3|||
130623408|NCT00507416|470239925|FG001|Overall Study|Did not Receive Study Treatment|9|||
130623409|NCT00507416|470239926|FG002|Overall Study|Did not Receive Study Treatment|4|||
130623410|NCT02157506|470239929|FG000|Overall Study|Adverse Event|0|||
130623411|NCT02157506|470239930|FG001|Overall Study|Adverse Event|1|||
130623412|NCT02157506|470239931|FG002|Overall Study|Adverse Event|0|||
130623413|NCT02157506|470239932|FG003|Overall Study|Adverse Event|0|||
130623414|NCT02157506|470239933|FG004|Overall Study|Adverse Event|0|||
130623415|NCT02157506|470239929|FG000|Overall Study|Lost to Follow-up|0|||
130623416|NCT02157506|470239930|FG001|Overall Study|Lost to Follow-up|0|||
130623417|NCT02157506|470239931|FG002|Overall Study|Lost to Follow-up|1|||
130623418|NCT02157506|470239932|FG003|Overall Study|Lost to Follow-up|0|||
130623419|NCT02157506|470239933|FG004|Overall Study|Lost to Follow-up|0|||
130623420|NCT03101514|470239934|FG000|Overall Study|Withdrawal by Subject|4|||
130623421|NCT03101514|470239934|FG000|Overall Study|Protocol Violation|2|||
130623422|NCT03101514|470239934|FG000|Overall Study|patient's information was incomplete|1|||
130623423|NCT03498287|470239938|FG000|Overall Study|Withdrawal by Subject|3|||
130623424|NCT03498287|470239939|FG001|Overall Study|Withdrawal by Subject|0|||
130623425|NCT03498287|470239938|FG000|Overall Study|Protocol Violation|0|||
130623426|NCT03498287|470239939|FG001|Overall Study|Protocol Violation|4|||
130623427|NCT03498287|470239938|FG000|Overall Study|Adverse Event|0|||
130623428|NCT03498287|470239939|FG001|Overall Study|Adverse Event|1|||
130623429|NCT01374217|470239942|FG000|Overall Study|Lack of Efficacy|13|||
130623430|NCT01740388|470239943|FG000|Overall Study|Withdrawal by Subject|1|||
130623431|NCT01740388|470239944|FG001|Overall Study|Withdrawal by Subject|2|||
130623432|NCT01740388|470239943|FG000|Overall Study|Lost to Follow-up|2|||
130623433|NCT01740388|470239944|FG001|Overall Study|Lost to Follow-up|0|||
130623434|NCT01740388|470239943|FG000|Overall Study|Physician Decision|2|||
130623435|NCT01740388|470239944|FG001|Overall Study|Physician Decision|6|||
130623436|NCT01740388|470239943|FG000|Overall Study|Subjects missing data, completed|41|||
130623437|NCT01740388|470239944|FG001|Overall Study|Subjects missing data, completed|36|||
130623438|NCT01117012|470239945|FG000|Overall Study|Adverse Event|0|||
130623439|NCT01117012|470239946|FG001|Overall Study|Adverse Event|1|||
130623440|NCT01117012|470239945|FG000|Overall Study|Death|1|||
130623441|NCT01117012|470239946|FG001|Overall Study|Death|1|||
130623442|NCT01117012|470239945|FG000|Overall Study|Withdrawal by Subject|3|||
130623443|NCT01117012|470239946|FG001|Overall Study|Withdrawal by Subject|0|||
130623444|NCT01117012|470239945|FG000|Overall Study|Undefined|4|||
130623445|NCT01117012|470239946|FG001|Overall Study|Undefined|3|||
130623446|NCT03695393|470239947|FG000|Overall Study|Death|3|||
130623447|NCT03695393|470239948|FG001|Overall Study|Death|1|||
130623448|NCT03695393|470239947|FG000|Overall Study|Lost to Follow-up|0|||
130623449|NCT03695393|470239948|FG001|Overall Study|Lost to Follow-up|1|||
130623450|NCT00673894|470239951|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
130623451|NCT00673894|470239952|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
130623452|NCT00673894|470239951|FG000|First Intervention 4 Weeks|Adverse Event|1|||
130623453|NCT00673894|470239952|FG001|First Intervention 4 Weeks|Adverse Event|0|||
130623454|NCT01641991|470239953|FG000|Overall Study|Physician Decision|0|||
130623455|NCT01641991|470239954|FG001|Overall Study|Physician Decision|1|||
130623456|NCT01641991|470239955|FG002|Overall Study|Physician Decision|7|||
130623457|NCT01641991|470239956|FG003|Overall Study|Physician Decision|5|||
130623458|NCT01641991|470239953|FG000|Overall Study|Withdrawal by Subject|4|||
130623459|NCT01641991|470239954|FG001|Overall Study|Withdrawal by Subject|2|||
130623460|NCT01641991|470239955|FG002|Overall Study|Withdrawal by Subject|1|||
130623461|NCT01641991|470239956|FG003|Overall Study|Withdrawal by Subject|5|||
130623462|NCT01641991|470239953|FG000|Overall Study|Adverse Event|2|||
130623463|NCT01641991|470239954|FG001|Overall Study|Adverse Event|1|||
130623464|NCT01641991|470239955|FG002|Overall Study|Adverse Event|2|||
130623465|NCT01641991|470239956|FG003|Overall Study|Adverse Event|1|||
130623466|NCT01641991|470239953|FG000|Overall Study|Lost to Follow-up|0|||
130623467|NCT01641991|470239954|FG001|Overall Study|Lost to Follow-up|2|||
130623468|NCT01641991|470239955|FG002|Overall Study|Lost to Follow-up|3|||
130623469|NCT01641991|470239956|FG003|Overall Study|Lost to Follow-up|1|||
130623470|NCT01641991|470239953|FG000|Overall Study|Protocol Violation|1|||
130623471|NCT01641991|470239954|FG001|Overall Study|Protocol Violation|1|||
130623472|NCT01641991|470239955|FG002|Overall Study|Protocol Violation|3|||
130623473|NCT01641991|470239956|FG003|Overall Study|Protocol Violation|0|||
130623474|NCT01641991|470239953|FG000|Overall Study|Pregnancy|0|||
130623475|NCT01641991|470239954|FG001|Overall Study|Pregnancy|0|||
130623476|NCT01641991|470239955|FG002|Overall Study|Pregnancy|1|||
130623477|NCT01641991|470239956|FG003|Overall Study|Pregnancy|0|||
130623478|NCT01641991|470239953|FG000|Overall Study|no longer eligible|2|||
130623479|NCT01641991|470239954|FG001|Overall Study|no longer eligible|1|||
130623480|NCT01641991|470239955|FG002|Overall Study|no longer eligible|0|||
130623481|NCT01641991|470239956|FG003|Overall Study|no longer eligible|4|||
130623482|NCT00493974|470239957|FG000|Overall Study|Death|1|||
130623483|NCT00493974|470239958|FG001|Overall Study|Death|2|||
130623484|NCT00493974|470239957|FG000|Overall Study|Withdrawal by Subject|8|||
130623485|NCT00493974|470239958|FG001|Overall Study|Withdrawal by Subject|6|||
130623486|NCT00493974|470239957|FG000|Overall Study|Lost to Follow-up|4|||
130623487|NCT00493974|470239958|FG001|Overall Study|Lost to Follow-up|6|||
130623488|NCT02555657|470239959|FG000|Overall Study|Death|274|||
130623489|NCT02555657|470239960|FG001|Overall Study|Death|262|||
130623490|NCT02555657|470239959|FG000|Overall Study|Physician Decision|0|||
130623491|NCT02555657|470239960|FG001|Overall Study|Physician Decision|1|||
130623492|NCT02555657|470239959|FG000|Overall Study|Sponsor Decision|27|||
130623493|NCT02555657|470239960|FG001|Overall Study|Sponsor Decision|15|||
130623494|NCT02555657|470239959|FG000|Overall Study|Withdrawal by Subject|11|||
130623495|NCT02555657|470239960|FG001|Overall Study|Withdrawal by Subject|32|||
130623496|NCT02807363|470239961|FG000|Dosing Period|Adverse Event|0|||
130623497|NCT02807363|470239962|FG001|Dosing Period|Adverse Event|1|||
130623498|NCT02807363|470239963|FG002|Dosing Period|Adverse Event|0|||
130623499|NCT02807363|470239964|FG003|Dosing Period|Adverse Event|0|||
130623500|NCT00966693|470239965|FG000|Overall Study|Adverse Event|0|||
130623501|NCT00966693|470239966|FG001|Overall Study|Adverse Event|0|||
130623502|NCT00966693|470239967|FG002|Overall Study|Adverse Event|1|||
130623503|NCT00966693|470239968|FG003|Overall Study|Adverse Event|2|||
130623504|NCT00966693|470239965|FG000|Overall Study|Death|0|||
130623505|NCT00966693|470239966|FG001|Overall Study|Death|0|||
130623506|NCT00966693|470239967|FG002|Overall Study|Death|1|||
130623507|NCT00966693|470239968|FG003|Overall Study|Death|0|||
130623508|NCT00966693|470239965|FG000|Overall Study|Withdrawal by Subject|1|||
130623509|NCT00966693|470239966|FG001|Overall Study|Withdrawal by Subject|0|||
130623510|NCT00966693|470239967|FG002|Overall Study|Withdrawal by Subject|0|||
130623511|NCT00966693|470239968|FG003|Overall Study|Withdrawal by Subject|5|||
130623512|NCT00966693|470239965|FG000|Overall Study|Disease Progression|0|||
130623513|NCT00966693|470239966|FG001|Overall Study|Disease Progression|0|||
130623514|NCT00966693|470239967|FG002|Overall Study|Disease Progression|1|||
130623515|NCT00966693|470239968|FG003|Overall Study|Disease Progression|16|||
130623516|NCT01578785|470239969|FG000|Overall Study|Withdrawal by Subject|0|||
130623517|NCT01578785|470239970|FG001|Overall Study|Withdrawal by Subject|1|||
130623518|NCT01578785|470239969|FG000|Overall Study|Study terminated by sponsor|59|||
130623519|NCT01578785|470239970|FG001|Overall Study|Study terminated by sponsor|118|||
130623520|NCT03371732|470239971|FG000|Overall Study|Withdrawal by Subject|9|||
130623521|NCT03371732|470239972|FG001|Overall Study|Withdrawal by Subject|3|||
130623522|NCT03371732|470239971|FG000|Overall Study|Refusal to continue|3|||
130623523|NCT03371732|470239972|FG001|Overall Study|Refusal to continue|4|||
130623524|NCT02581982|470239975|FG000|Overall Study|Lack of Efficacy|12|||
130623525|NCT02581982|470239975|FG000|Overall Study|Adverse Event|3|||
130623526|NCT02581982|470239975|FG000|Overall Study|Physician Decision|1|||
130623527|NCT00599027|470239976|FG000|Overall Study|Withdrawal by Subject|1|||
130623528|NCT00599027|470239977|FG001|Overall Study|Withdrawal by Subject|1|||
130623529|NCT00599027|470239976|FG000|Overall Study|Adverse Event|0|||
130623530|NCT00599027|470239977|FG001|Overall Study|Adverse Event|1|||
130623531|NCT00599027|470239976|FG000|Overall Study|Treatment Failure|0|||
130623532|NCT00599027|470239977|FG001|Overall Study|Treatment Failure|1|||
130623533|NCT00405821|470239978|FG000|Overall Study|Death|5|||
130623534|NCT00405821|470239979|FG001|Overall Study|Death|7|||
130623535|NCT00405821|470239978|FG000|Overall Study|Lost to Follow-up|7|||
130623536|NCT00405821|470239979|FG001|Overall Study|Lost to Follow-up|7|||
130623537|NCT00405821|470239978|FG000|Overall Study|Protocol Violation|1|||
130623538|NCT00405821|470239979|FG001|Overall Study|Protocol Violation|0|||
130623539|NCT00405821|470239978|FG000|Overall Study|initiated ART|9|||
130623540|NCT00405821|470239979|FG001|Overall Study|initiated ART|8|||
130623541|NCT03479216|470239993|FG000|Overall Study|Withdrawal by Subject|3|||
130623542|NCT03479216|470239994|FG001|Overall Study|Withdrawal by Subject|2|||
130623543|NCT03479216|470239993|FG000|Overall Study|Physician Decision|2|||
130623544|NCT03479216|470239994|FG001|Overall Study|Physician Decision|3|||
130623545|NCT01181778|470239997|FG000|Overall Study|Physician Decision|48|||
130623546|NCT01265420|470239998|FG000|Overall Study|Lost to Follow-up|1|||
130623547|NCT03862131|470239999|FG000|Overall Study|Lost to Follow-up|1|||
130623548|NCT03862131|470240000|FG001|Overall Study|Lost to Follow-up|0|||
130623549|NCT03862131|470240001|FG002|Overall Study|Lost to Follow-up|1|||
130623550|NCT03862131|470239999|FG000|Overall Study|Determined to be ineligible|0|||
130623551|NCT03862131|470240000|FG001|Overall Study|Determined to be ineligible|0|||
130623552|NCT03862131|470240001|FG002|Overall Study|Determined to be ineligible|5|||
130623553|NCT03862131|470239999|FG000|Overall Study|Death|4|||
130623554|NCT03862131|470240000|FG001|Overall Study|Death|4|||
130623555|NCT03862131|470240001|FG002|Overall Study|Death|0|||
130623556|NCT03862131|470239999|FG000|Overall Study|Withdrawal by Subject|5|||
130623557|NCT03862131|470240000|FG001|Overall Study|Withdrawal by Subject|3|||
130623558|NCT03862131|470240001|FG002|Overall Study|Withdrawal by Subject|0|||
130623559|NCT03862131|470239999|FG000|Overall Study|Physician Decision|0|||
130623560|NCT03862131|470240000|FG001|Overall Study|Physician Decision|1|||
130623561|NCT03862131|470240001|FG002|Overall Study|Physician Decision|0|||
130623562|NCT03788967|470241700|FG000|Overall Study|Lost to Follow-up|14|||
130623563|NCT03788967|470241701|FG001|Overall Study|Lost to Follow-up|10|||
130623564|NCT03788967|470241700|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
130623565|NCT03788967|470241701|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
130623566|NCT03788967|470241700|FG000|Overall Study|Participant Withdrawal of Consent|13|||
130623567|NCT03788967|470241701|FG001|Overall Study|Participant Withdrawal of Consent|5|||
130623568|NCT03788967|470241700|FG000|Overall Study|Adverse Event|1|||
130623569|NCT03788967|470241701|FG001|Overall Study|Adverse Event|1|||
130623570|NCT03788967|470241700|FG000|Overall Study|COVID-19|1|||
130623571|NCT03788967|470241701|FG001|Overall Study|COVID-19|2|||
130623572|NCT04432376|470241702|FG000|Double-blind Treatment Period|Adverse Event|2|||
130623573|NCT04432376|470241703|FG001|Double-blind Treatment Period|Adverse Event|6|||
130623574|NCT04432376|470241704|FG002|Double-blind Treatment Period|Adverse Event|0|||
130623575|NCT04432376|470241702|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
130623576|NCT04432376|470241703|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130623577|NCT04432376|470241704|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130623578|NCT04432376|470241702|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130623579|NCT04432376|470241703|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130623580|NCT04432376|470241704|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130623581|NCT04432376|470241702|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130623582|NCT04432376|470241703|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130623583|NCT04432376|470241704|FG002|Double-blind Treatment Period|Protocol Violation|0|||
130623584|NCT04432376|470241702|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
130623585|NCT04432376|470241703|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
130623586|NCT04432376|470241704|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
130623587|NCT02455388|470241705|FG000|Overall Study|Protocol Violation|1|||
130623588|NCT02455388|470241706|FG001|Overall Study|Protocol Violation|0|||
130623589|NCT02455388|470241707|FG002|Overall Study|Protocol Violation|4|||
130623590|NCT02455388|470241705|FG000|Overall Study|Withdrawal by Subject|0|||
130623591|NCT02455388|470241706|FG001|Overall Study|Withdrawal by Subject|0|||
130623592|NCT02455388|470241707|FG002|Overall Study|Withdrawal by Subject|7|||
130623593|NCT03628599|470241709|FG000|Overall Study|Adverse Event|0|||
130623594|NCT03628599|470241710|FG001|Overall Study|Adverse Event|1|||
130623595|NCT00801892|470241711|FG000|Main Study Period|Withdrawal by Subject|0|||
130623596|NCT00801892|470241712|FG001|Main Study Period|Withdrawal by Subject|1|||
130623597|NCT00801892|470241711|FG000|Sham Crossover Period|Lost to Follow-up|0|||
130623598|NCT00801892|470241712|FG001|Sham Crossover Period|Lost to Follow-up|2|||
130623599|NCT00093470|470241720|FG000|Overall Study|Disease progression|39|||
130623600|NCT00093470|470241721|FG001|Overall Study|Disease progression|0|||
130623601|NCT00093470|470241720|FG000|Overall Study|Adverse Event|15|||
130623602|NCT00093470|470241721|FG001|Overall Study|Adverse Event|0|||
130623603|NCT00093470|470241720|FG000|Overall Study|Death|2|||
130623604|NCT00093470|470241721|FG001|Overall Study|Death|0|||
130623605|NCT00093470|470241720|FG000|Overall Study|Withdrawal by Subject|8|||
130623606|NCT00093470|470241721|FG001|Overall Study|Withdrawal by Subject|0|||
130623607|NCT00093470|470241720|FG000|Overall Study|Alternative therapy|2|||
130623608|NCT00093470|470241721|FG001|Overall Study|Alternative therapy|0|||
130623609|NCT00093470|470241720|FG000|Overall Study|Other complicating disease|3|||
130623610|NCT00093470|470241721|FG001|Overall Study|Other complicating disease|0|||
130623611|NCT00093470|470241720|FG000|Overall Study|Physician Decision|2|||
130623612|NCT00093470|470241721|FG001|Overall Study|Physician Decision|0|||
130623613|NCT00093470|470241720|FG000|Overall Study|Never started treatment|1|||
130623614|NCT00093470|470241721|FG001|Overall Study|Never started treatment|0|||
130623615|NCT00093470|470241720|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
130623616|NCT00093470|470241721|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
130623617|NCT02514772|470241722|FG000|Overall Study|Adverse Event|1|||
130623618|NCT02514772|470241723|FG001|Overall Study|Adverse Event|0|||
130623619|NCT02514772|470241722|FG000|Overall Study|Death|0|||
130623620|NCT02514772|470241723|FG001|Overall Study|Death|1|||
130623621|NCT02514772|470241722|FG000|Overall Study|Withdrawal by Subject|2|||
130623622|NCT02514772|470241723|FG001|Overall Study|Withdrawal by Subject|1|||
130623623|NCT01415908|470241724|FG000|Overall Study|Withdrawal by Subject|1|||
130623624|NCT01415908|470241725|FG001|Overall Study|Withdrawal by Subject|0|||
130623625|NCT00851253|470241727|FG000|Overall Study|Disease Progression|1|||
130623626|NCT00851253|470241728|FG001|Overall Study|Disease Progression|0|||
130623627|NCT01705587|470241733|FG000|Overall Study|Withdrawal by Subject|0|||
130623628|NCT01705587|470241734|FG001|Overall Study|Withdrawal by Subject|1|||
130623629|NCT01213264|470241740|FG000|Overall Study|Adverse Event|1|||
130623630|NCT01213264|470241741|FG001|Overall Study|Adverse Event|0|||
130623631|NCT01213264|470241742|FG002|Overall Study|Adverse Event|0|||
130623632|NCT01213264|470241740|FG000|Overall Study|Lost to Follow-up|1|||
130623633|NCT01213264|470241741|FG001|Overall Study|Lost to Follow-up|2|||
130623634|NCT01213264|470241742|FG002|Overall Study|Lost to Follow-up|6|||
130623635|NCT03260894|470241744|FG000|Overall Study|Death|6|||
130623636|NCT03260894|470241745|FG001|Overall Study|Death|8|||
130623637|NCT03260894|470241744|FG000|Overall Study|Withdrawal by Subject|4|||
130623638|NCT03260894|470241745|FG001|Overall Study|Withdrawal by Subject|11|||
130623639|NCT03260894|470241744|FG000|Overall Study|On-going at clinical cut off date|36|||
130623640|NCT03260894|470241745|FG001|Overall Study|On-going at clinical cut off date|31|||
130623641|NCT05507580|470241747|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130623642|NCT05507580|470241748|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130623643|NCT05507580|470241749|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130623644|NCT05507580|470241750|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
130623645|NCT05507580|470241751|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
130623646|NCT05507580|470241752|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
130623647|NCT05507580|470241747|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
130623648|NCT05507580|470241748|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130623649|NCT05507580|470241749|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130623650|NCT05507580|470241750|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130623651|NCT05507580|470241751|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130623652|NCT05507580|470241752|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130623653|NCT05507580|470241747|FG000|Double-Blind Treatment Period|Other, not specified|5|||
130623654|NCT05507580|470241748|FG001|Double-Blind Treatment Period|Other, not specified|4|||
130623655|NCT05507580|470241749|FG002|Double-Blind Treatment Period|Other, not specified|0|||
130623656|NCT05507580|470241750|FG003|Double-Blind Treatment Period|Other, not specified|0|||
130623657|NCT05507580|470241751|FG004|Double-Blind Treatment Period|Other, not specified|0|||
130623658|NCT05507580|470241752|FG005|Double-Blind Treatment Period|Other, not specified|0|||
130623659|NCT05507580|470241747|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
130623660|NCT05507580|470241748|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
130623661|NCT05507580|470241749|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
130623662|NCT05507580|470241750|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
130623663|NCT05507580|470241751|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
130623664|NCT05507580|470241752|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
130623665|NCT05507580|470241747|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
130623666|NCT05507580|470241748|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
130623667|NCT05507580|470241749|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
130623668|NCT05507580|470241750|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
130623669|NCT05507580|470241751|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
130623670|NCT05507580|470241752|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
130623671|NCT05507580|470241747|FG000|Single-Blind Treatment Period|Other, not specified|0|||
130623672|NCT05507580|470241748|FG001|Single-Blind Treatment Period|Other, not specified|0|||
130623673|NCT05507580|470241749|FG002|Single-Blind Treatment Period|Other, not specified|2|||
130623674|NCT05507580|470241750|FG003|Single-Blind Treatment Period|Other, not specified|7|||
130623675|NCT05507580|470241751|FG004|Single-Blind Treatment Period|Other, not specified|3|||
130623676|NCT05507580|470241752|FG005|Single-Blind Treatment Period|Other, not specified|5|||
130623677|NCT03496662|470241753|FG000|Overall Study|Adverse Event|0|||
130623678|NCT03496662|470241754|FG001|Overall Study|Adverse Event|0|||
130623679|NCT03496662|470241755|FG002|Overall Study|Adverse Event|4|||
130623680|NCT03496662|470241753|FG000|Overall Study|Withdrawal by Subject|1|||
130623681|NCT03496662|470241754|FG001|Overall Study|Withdrawal by Subject|0|||
130623682|NCT03496662|470241755|FG002|Overall Study|Withdrawal by Subject|2|||
130623683|NCT03496662|470241753|FG000|Overall Study|Death|0|||
130623684|NCT03496662|470241754|FG001|Overall Study|Death|0|||
130623685|NCT03496662|470241755|FG002|Overall Study|Death|2|||
130623686|NCT03496662|470241753|FG000|Overall Study|Noncompliance|0|||
130623687|NCT03496662|470241754|FG001|Overall Study|Noncompliance|0|||
130623688|NCT03496662|470241755|FG002|Overall Study|Noncompliance|1|||
130623689|NCT02378883|470241756|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
130623690|NCT02378883|470241756|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
130623691|NCT02378883|470241756|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
130623692|NCT02378883|470241756|FG000|30 Day Follow-Up|Physician Decision|2|||
130623693|NCT02378883|470241756|FG000|30 Day Follow-Up|Missed Visit|2|||
130623694|NCT02378883|470241756|FG000|30 Day Follow-Up|Death|1|||
130623695|NCT02378883|470241756|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
130623696|NCT02378883|470241756|FG000|12 Months Follow-Up|Death|2|||
130623697|NCT03037307|470241757|FG000|Period 1|Did Not Meet Study Criteria|0|||
130623698|NCT03037307|470241758|FG001|Period 1|Did Not Meet Study Criteria|0|||
130623699|NCT03037307|470241759|FG002|Period 1|Did Not Meet Study Criteria|0|||
130623700|NCT03037307|470241760|FG003|Period 1|Did Not Meet Study Criteria|1|||
130623701|NCT03037307|470241761|FG004|Period 1|Did Not Meet Study Criteria|0|||
130623702|NCT03037307|470241762|FG005|Period 1|Did Not Meet Study Criteria|0|||
130623703|NCT00691093|470241763|FG000|Overall Study|Adverse Event|1|||
130623704|NCT00691093|470241763|FG000|Overall Study|Lost to Follow-up|1|||
130623705|NCT00691093|470241763|FG000|Overall Study|Lack of Efficacy|1|||
130623706|NCT00691093|470241763|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
130623707|NCT00493467|470241765|FG000|Overall Study|Death|1|||
130623708|NCT05489081|470241766|FG000|Overall Study|student left classroom|0|||
130623709|NCT05489081|470241767|FG001|Overall Study|student left classroom|1|||
130623710|NCT05489081|470241766|FG000|Overall Study|teacher left school|0|||
130623711|NCT05489081|470241767|FG001|Overall Study|teacher left school|2|||
130623712|NCT00810810|470241768|FG000|Overall Study|Withdrawal by Subject|0|||
130623713|NCT00810810|470241769|FG001|Overall Study|Withdrawal by Subject|8|||
130623714|NCT00810810|470241770|FG002|Overall Study|Withdrawal by Subject|10|||
130623715|NCT00810810|470241771|FG003|Overall Study|Withdrawal by Subject|8|||
130623716|NCT00810810|470241768|FG000|Overall Study|Physician Decision|0|||
130623717|NCT00810810|470241769|FG001|Overall Study|Physician Decision|3|||
130623718|NCT00810810|470241770|FG002|Overall Study|Physician Decision|1|||
130623719|NCT00810810|470241771|FG003|Overall Study|Physician Decision|5|||
130623720|NCT01700985|470241772|FG000|Overall Study|Incarcerated|0|||
130623721|NCT01700985|470241773|FG001|Overall Study|Incarcerated|1|||
130623722|NCT01409993|470241774|FG000|Overall Study|Adverse Event|4|||
130623723|NCT01409993|470241775|FG001|Overall Study|Adverse Event|4|||
130623724|NCT01409993|470241776|FG002|Overall Study|Adverse Event|3|||
130623725|NCT01409993|470241777|FG003|Overall Study|Adverse Event|1|||
130623726|NCT01409993|470241774|FG000|Overall Study|Withdrawal by Subject|0|||
130623727|NCT01409993|470241775|FG001|Overall Study|Withdrawal by Subject|0|||
130623728|NCT01409993|470241776|FG002|Overall Study|Withdrawal by Subject|0|||
130623729|NCT01409993|470241777|FG003|Overall Study|Withdrawal by Subject|4|||
130623730|NCT01409993|470241774|FG000|Overall Study|Lost to Follow-up|0|||
130623731|NCT01409993|470241775|FG001|Overall Study|Lost to Follow-up|1|||
130623732|NCT01409993|470241776|FG002|Overall Study|Lost to Follow-up|0|||
130623733|NCT01409993|470241777|FG003|Overall Study|Lost to Follow-up|0|||
130623734|NCT00067470|470241778|FG000|Overall Study|Withdrawal by Subject|0|||
130623735|NCT00067470|470241779|FG001|Overall Study|Withdrawal by Subject|1|||
130623736|NCT03074149|470241780|FG000|Overall Study|Reason unknown|22|||
130623737|NCT03074149|470241781|FG001|Overall Study|Reason unknown|35|||
130623738|NCT03074149|470241780|FG000|Overall Study|Death|10|||
130623739|NCT03074149|470241781|FG001|Overall Study|Death|45|||
130623740|NCT00050622|470241784|FG000|Overall Study|Adverse Event|1|||
130623741|NCT00426556|470241787|FG000|Phase I - Core Phase|Disease Progression|0|||
130623742|NCT00426556|470241788|FG001|Phase I - Core Phase|Disease Progression|6|||
130623743|NCT00426556|470241789|FG002|Phase I - Core Phase|Disease Progression|2|||
130623744|NCT00426556|470241790|FG003|Phase I - Core Phase|Disease Progression|0|||
130623745|NCT00426556|470241787|FG000|Phase I - Core Phase|Adverse Event|1|||
130623746|NCT00426556|470241788|FG001|Phase I - Core Phase|Adverse Event|3|||
130623747|NCT00426556|470241789|FG002|Phase I - Core Phase|Adverse Event|1|||
130623748|NCT00426556|470241790|FG003|Phase I - Core Phase|Adverse Event|0|||
130623749|NCT00426556|470241787|FG000|Phase I - Core Phase|Death|0|||
130623750|NCT00426556|470241788|FG001|Phase I - Core Phase|Death|1|||
130623751|NCT00426556|470241789|FG002|Phase I - Core Phase|Death|0|||
130623752|NCT00426556|470241790|FG003|Phase I - Core Phase|Death|0|||
130623753|NCT00426556|470241787|FG000|Phase I - Extension Phase|Adverse Event|0|||
130623754|NCT00426556|470241788|FG001|Phase I - Extension Phase|Adverse Event|1|||
130623755|NCT00426556|470241789|FG002|Phase I - Extension Phase|Adverse Event|1|||
130623756|NCT00426556|470241790|FG003|Phase I - Extension Phase|Adverse Event|0|||
130623757|NCT00426556|470241787|FG000|Phase I - Extension Phase|Disease Progression|5|||
130623758|NCT00426556|470241788|FG001|Phase I - Extension Phase|Disease Progression|5|||
130623759|NCT00426556|470241789|FG002|Phase I - Extension Phase|Disease Progression|6|||
130623760|NCT00426556|470241790|FG003|Phase I - Extension Phase|Disease Progression|0|||
130623761|NCT00426556|470241787|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
130623762|NCT00426556|470241788|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
130623763|NCT00426556|470241789|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
130623764|NCT00426556|470241790|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
130623765|NCT00426556|470241787|FG000|Phase II - Core Phase|Disease Progression|0|||
130623766|NCT00426556|470241788|FG001|Phase II - Core Phase|Disease Progression|0|||
130623767|NCT00426556|470241789|FG002|Phase II - Core Phase|Disease Progression|0|||
130623768|NCT00426556|470241790|FG003|Phase II - Core Phase|Disease Progression|16|||
130623769|NCT00426556|470241787|FG000|Phase II - Core Phase|Adverse Event|0|||
130623770|NCT00426556|470241788|FG001|Phase II - Core Phase|Adverse Event|0|||
130623771|NCT00426556|470241789|FG002|Phase II - Core Phase|Adverse Event|0|||
130623772|NCT00426556|470241790|FG003|Phase II - Core Phase|Adverse Event|8|||
130623773|NCT00426556|470241787|FG000|Phase II - Extension Phase|Disease Progression|0|||
130623774|NCT00426556|470241788|FG001|Phase II - Extension Phase|Disease Progression|0|||
130623775|NCT00426556|470241789|FG002|Phase II - Extension Phase|Disease Progression|0|||
130623776|NCT00426556|470241790|FG003|Phase II - Extension Phase|Disease Progression|21|||
130623777|NCT00426556|470241787|FG000|Phase II - Extension Phase|Adverse Event|0|||
130623778|NCT00426556|470241788|FG001|Phase II - Extension Phase|Adverse Event|0|||
130623779|NCT00426556|470241789|FG002|Phase II - Extension Phase|Adverse Event|0|||
130623780|NCT00426556|470241790|FG003|Phase II - Extension Phase|Adverse Event|2|||
130623781|NCT03970824|470241792|FG000|Overall Study|Withdrawal by Subject|1|||
130623782|NCT03970824|470241793|FG001|Overall Study|Withdrawal by Subject|1|||
130623783|NCT03970824|470241794|FG002|Overall Study|Withdrawal by Subject|3|||
130623784|NCT03970824|470241792|FG000|Overall Study|Lost to Follow-up|0|||
130623785|NCT03970824|470241793|FG001|Overall Study|Lost to Follow-up|2|||
130623786|NCT03970824|470241794|FG002|Overall Study|Lost to Follow-up|1|||
130623787|NCT03970824|470241792|FG000|Overall Study|Adverse Event|1|||
130623788|NCT03970824|470241793|FG001|Overall Study|Adverse Event|0|||
130623789|NCT03970824|470241794|FG002|Overall Study|Adverse Event|0|||
130623790|NCT00416312|470241795|FG000|Overall Study|tumors not visible on imaging|2|||
130623791|NCT00050960|470241798|FG000|Overall Study|Progressive Disease|137|||
130623792|NCT00050960|470241799|FG001|Overall Study|Progressive Disease|93|||
130623793|NCT00050960|470241798|FG000|Overall Study|Stable Disease|19|||
130623794|NCT00050960|470241799|FG001|Overall Study|Stable Disease|48|||
130623795|NCT00050960|470241798|FG000|Overall Study|Partial Response|14|||
130623796|NCT00050960|470241799|FG001|Overall Study|Partial Response|19|||
130623797|NCT00050960|470241798|FG000|Overall Study|Complete Response|0|||
130623798|NCT00050960|470241799|FG001|Overall Study|Complete Response|2|||
130623799|NCT00050960|470241798|FG000|Overall Study|Adverse Event|62|||
130623800|NCT00050960|470241799|FG001|Overall Study|Adverse Event|61|||
130623801|NCT00050960|470241798|FG000|Overall Study|Lost to Follow-up|0|||
130623802|NCT00050960|470241799|FG001|Overall Study|Lost to Follow-up|1|||
130623803|NCT00050960|470241798|FG000|Overall Study|Withdrawal by Subject|23|||
130623804|NCT00050960|470241799|FG001|Overall Study|Withdrawal by Subject|18|||
130623805|NCT00050960|470241798|FG000|Overall Study|Administrative|31|||
130623806|NCT00050960|470241799|FG001|Overall Study|Administrative|46|||
130623807|NCT00050960|470241798|FG000|Overall Study|Non-compliance|3|||
130623808|NCT00050960|470241799|FG001|Overall Study|Non-compliance|1|||
130623809|NCT00050960|470241798|FG000|Overall Study|Death|13|||
130623810|NCT00050960|470241799|FG001|Overall Study|Death|15|||
130623811|NCT02727660|470241800|FG000|Overall Study|Lack of Efficacy|40|||
130623812|NCT02727660|470241801|FG001|Overall Study|Lack of Efficacy|40|||
130623813|NCT02727660|470241802|FG002|Overall Study|Lack of Efficacy|70|||
130623814|NCT02727660|470241800|FG000|Overall Study|Adverse Event|28|||
130623815|NCT02727660|470241801|FG001|Overall Study|Adverse Event|21|||
130623816|NCT02727660|470241802|FG002|Overall Study|Adverse Event|32|||
130623817|NCT02727660|470241800|FG000|Overall Study|Withdrawal by Subject|26|||
130623818|NCT02727660|470241801|FG001|Overall Study|Withdrawal by Subject|25|||
130623819|NCT02727660|470241802|FG002|Overall Study|Withdrawal by Subject|30|||
130623820|NCT02727660|470241800|FG000|Overall Study|Physician Decision|3|||
130623821|NCT02727660|470241801|FG001|Overall Study|Physician Decision|8|||
130623822|NCT02727660|470241802|FG002|Overall Study|Physician Decision|14|||
130623823|NCT02727660|470241800|FG000|Overall Study|Lost to Follow-up|5|||
130623824|NCT02727660|470241801|FG001|Overall Study|Lost to Follow-up|9|||
130623825|NCT02727660|470241802|FG002|Overall Study|Lost to Follow-up|8|||
130623826|NCT02727660|470241800|FG000|Overall Study|Protocol Violation|7|||
130623827|NCT02727660|470241801|FG001|Overall Study|Protocol Violation|5|||
130623828|NCT02727660|470241802|FG002|Overall Study|Protocol Violation|5|||
130623829|NCT02727660|470241800|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
130623830|NCT02727660|470241801|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
130623831|NCT02727660|470241802|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
130623832|NCT02727660|470241800|FG000|Overall Study|Administrative Reasons|2|||
130623833|NCT02727660|470241801|FG001|Overall Study|Administrative Reasons|3|||
130623834|NCT02727660|470241802|FG002|Overall Study|Administrative Reasons|4|||
130623835|NCT00305604|470241803|FG000|Overall Study|Adverse Event|6|||
130623836|NCT00305604|470241804|FG001|Overall Study|Adverse Event|3|||
130623837|NCT00305604|470241803|FG000|Overall Study|Lack of Efficacy|11|||
130623838|NCT00305604|470241804|FG001|Overall Study|Lack of Efficacy|18|||
130623839|NCT00305604|470241803|FG000|Overall Study|Lost to Follow-up|0|||
130623840|NCT00305604|470241804|FG001|Overall Study|Lost to Follow-up|4|||
130623841|NCT00305604|470241803|FG000|Overall Study|Protocol Violation|2|||
130623842|NCT00305604|470241804|FG001|Overall Study|Protocol Violation|1|||
130623843|NCT00305604|470241803|FG000|Overall Study|Withdrawal by Subject|12|||
130623844|NCT00305604|470241804|FG001|Overall Study|Withdrawal by Subject|21|||
130623845|NCT00305604|470241803|FG000|Overall Study|Patient moved|1|||
130623846|NCT00305604|470241804|FG001|Overall Study|Patient moved|0|||
130623847|NCT01248364|470241805|FG000|Overall Study|Adverse Event|0|||
130623848|NCT01248364|470241806|FG001|Overall Study|Adverse Event|1|||
130623849|NCT01248364|470241807|FG002|Overall Study|Adverse Event|0|||
130623850|NCT01248364|470241808|FG003|Overall Study|Adverse Event|0|||
130623851|NCT00764946|470241809|FG000|Overall Study|Lack of Efficacy|1|||
130623852|NCT00764946|470241810|FG001|Overall Study|Lack of Efficacy|0|||
130623853|NCT00764946|470241811|FG002|Overall Study|Lack of Efficacy|0|||
130623854|NCT00764946|470241809|FG000|Overall Study|Lost to Follow-up|3|||
130623855|NCT00764946|470241810|FG001|Overall Study|Lost to Follow-up|4|||
130623856|NCT00764946|470241811|FG002|Overall Study|Lost to Follow-up|0|||
130623857|NCT00764946|470241809|FG000|Overall Study|Physician Decision|2|||
130623858|NCT00764946|470241810|FG001|Overall Study|Physician Decision|4|||
130623859|NCT00764946|470241811|FG002|Overall Study|Physician Decision|0|||
130623860|NCT00764946|470241809|FG000|Overall Study|Adverse Event|3|||
130623861|NCT00764946|470241810|FG001|Overall Study|Adverse Event|2|||
130623862|NCT00764946|470241811|FG002|Overall Study|Adverse Event|1|||
130623863|NCT00764946|470241809|FG000|Overall Study|Withdrawal by Subject|3|||
130623864|NCT00764946|470241810|FG001|Overall Study|Withdrawal by Subject|6|||
130623865|NCT00764946|470241811|FG002|Overall Study|Withdrawal by Subject|2|||
130623866|NCT00764946|470241809|FG000|Overall Study|Never Treated|1|||
130623867|NCT00764946|470241810|FG001|Overall Study|Never Treated|1|||
130623868|NCT00764946|470241811|FG002|Overall Study|Never Treated|1|||
130623869|NCT01192204|470241813|FG000|Overall Study|could not keep recall appointments|1|||
130623870|NCT01192204|470241814|FG001|Overall Study|could not keep recall appointments|0|||
130623871|NCT02146248|470241815|FG000|Overall Study|Withdrawal by Subject|2|||
130623872|NCT02431468|470241817|FG000|Overall Study|Adverse Event|2|||
130623873|NCT02431468|470241818|FG001|Overall Study|Adverse Event|4|||
130623874|NCT02431468|470241819|FG002|Overall Study|Adverse Event|5|||
130623875|NCT02431468|470241817|FG000|Overall Study|Withdrawal by Subject|4|||
130623876|NCT02431468|470241818|FG001|Overall Study|Withdrawal by Subject|12|||
130623877|NCT02431468|470241819|FG002|Overall Study|Withdrawal by Subject|2|||
130623878|NCT02431468|470241817|FG000|Overall Study|noncompliance, investigator termination,|2|||
130623879|NCT02431468|470241818|FG001|Overall Study|noncompliance, investigator termination,|2|||
130623880|NCT02431468|470241819|FG002|Overall Study|noncompliance, investigator termination,|2|||
130623881|NCT01361919|470241820|FG000|Overall Study|technical issues|10|||
130623882|NCT01361919|470241821|FG001|Overall Study|technical issues|12|||
130623883|NCT01361919|470241822|FG002|Overall Study|technical issues|10|||
130623884|NCT03589885|470241824|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
130623885|NCT03589885|470241825|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
130623886|NCT03589885|470241826|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
130623887|NCT03589885|470241827|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
130623888|NCT03589885|470241828|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
130623889|NCT03589885|470241824|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130623890|NCT03589885|470241825|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130623891|NCT03589885|470241826|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
130623892|NCT03589885|470241827|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130623893|NCT03589885|470241828|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130623894|NCT03589885|470241824|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130623895|NCT03589885|470241825|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
130623896|NCT03589885|470241826|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130623897|NCT03589885|470241827|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130623898|NCT03589885|470241828|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130623899|NCT03589885|470241824|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130623900|NCT03589885|470241825|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130623901|NCT03589885|470241826|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
130623902|NCT03589885|470241827|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130623903|NCT03589885|470241828|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130623904|NCT03589885|470241824|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
130623905|NCT03589885|470241825|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
130623906|NCT03589885|470241826|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
130623907|NCT03589885|470241827|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
130623908|NCT03589885|470241828|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
130623909|NCT03589885|470241824|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
130623910|NCT03589885|470241825|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
130623911|NCT03589885|470241826|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
130623912|NCT03589885|470241827|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
130623913|NCT03589885|470241828|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
130623914|NCT03589885|470241824|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
130623915|NCT03589885|470241825|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
130623916|NCT03589885|470241826|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
130623917|NCT03589885|470241827|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
130623918|NCT03589885|470241828|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
130623919|NCT03589885|470241824|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130623920|NCT03589885|470241825|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
130623921|NCT03589885|470241826|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130623922|NCT03589885|470241827|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130623923|NCT03589885|470241828|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130623924|NCT01767519|470241829|FG000|Overall Study|Other Reasons|4|||
130623925|NCT01767519|470241830|FG001|Overall Study|Other Reasons|4|||
130623926|NCT01767519|470241831|FG002|Overall Study|Other Reasons|2|||
130623927|NCT01767519|470241829|FG000|Overall Study|Protocol Violation|0|||
130623928|NCT01767519|470241830|FG001|Overall Study|Protocol Violation|3|||
130623929|NCT01767519|470241831|FG002|Overall Study|Protocol Violation|0|||
130623930|NCT01767519|470241829|FG000|Overall Study|Personal Reasons|1|||
130623931|NCT01767519|470241830|FG001|Overall Study|Personal Reasons|0|||
130623932|NCT01767519|470241831|FG002|Overall Study|Personal Reasons|0|||
130623933|NCT01767519|470241829|FG000|Overall Study|Lost to Follow-up|3|||
130623934|NCT01767519|470241830|FG001|Overall Study|Lost to Follow-up|1|||
130623935|NCT01767519|470241831|FG002|Overall Study|Lost to Follow-up|2|||
130623936|NCT01767519|470241829|FG000|Overall Study|Lack of Efficacy|1|||
130623937|NCT01767519|470241830|FG001|Overall Study|Lack of Efficacy|0|||
130623938|NCT01767519|470241831|FG002|Overall Study|Lack of Efficacy|0|||
130623939|NCT01767519|470241829|FG000|Overall Study|Adverse Event|5|||
130623940|NCT01767519|470241830|FG001|Overall Study|Adverse Event|5|||
130623941|NCT01767519|470241831|FG002|Overall Study|Adverse Event|1|||
130623942|NCT00039741|470241832|FG000|Overall Study|Death|0|||
130623943|NCT00039741|470241833|FG001|Overall Study|Death|1|||
130623944|NCT00039741|470241834|FG002|Overall Study|Death|0|||
130623945|NCT00039741|470241835|FG003|Overall Study|Death|0|||
130623946|NCT00039741|470241832|FG000|Overall Study|Lost to Follow-up|3|||
130623947|NCT00039741|470241833|FG001|Overall Study|Lost to Follow-up|1|||
130623948|NCT00039741|470241834|FG002|Overall Study|Lost to Follow-up|5|||
130623949|NCT00039741|470241835|FG003|Overall Study|Lost to Follow-up|2|||
130623950|NCT00039741|470241832|FG000|Overall Study|Confounding medical condition|1|||
130623951|NCT00039741|470241833|FG001|Overall Study|Confounding medical condition|0|||
130623952|NCT00039741|470241834|FG002|Overall Study|Confounding medical condition|0|||
130623953|NCT00039741|470241835|FG003|Overall Study|Confounding medical condition|0|||
130623954|NCT00039741|470241832|FG000|Overall Study|Not able to get to clinic|5|||
130623955|NCT00039741|470241833|FG001|Overall Study|Not able to get to clinic|2|||
130623956|NCT00039741|470241834|FG002|Overall Study|Not able to get to clinic|0|||
130623957|NCT00039741|470241835|FG003|Overall Study|Not able to get to clinic|3|||
130623958|NCT00039741|470241832|FG000|Overall Study|Moved|3|||
130623959|NCT00039741|470241833|FG001|Overall Study|Moved|2|||
130623960|NCT00039741|470241834|FG002|Overall Study|Moved|3|||
130623961|NCT00039741|470241835|FG003|Overall Study|Moved|6|||
130623962|NCT00039741|470241832|FG000|Overall Study|Non-compliance with protocol|1|||
130623963|NCT00039741|470241833|FG001|Overall Study|Non-compliance with protocol|0|||
130623964|NCT00039741|470241834|FG002|Overall Study|Non-compliance with protocol|1|||
130623965|NCT00039741|470241835|FG003|Overall Study|Non-compliance with protocol|0|||
130623966|NCT00039741|470241832|FG000|Overall Study|Withdrew consent|0|||
130623967|NCT00039741|470241833|FG001|Overall Study|Withdrew consent|5|||
130623968|NCT00039741|470241834|FG002|Overall Study|Withdrew consent|0|||
130623969|NCT00039741|470241835|FG003|Overall Study|Withdrew consent|1|||
130623970|NCT00039741|470241832|FG000|Overall Study|Missed final visit|2|||
130623971|NCT00039741|470241833|FG001|Overall Study|Missed final visit|1|||
130623972|NCT00039741|470241834|FG002|Overall Study|Missed final visit|2|||
130623973|NCT00039741|470241835|FG003|Overall Study|Missed final visit|2|||
130623974|NCT00946881|470241836|FG000|First Treatment|Withdrawal by Subject|1|||
130623975|NCT00946881|470241836|FG000|First Treatment|Patient relocated to another state|1|||
130623976|NCT00946881|470241836|FG000|Retreatment|Withdrawal by Subject|1|||
130623977|NCT00293423|470241837|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
130623978|NCT00293423|470241838|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
130623979|NCT00293423|470241837|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
130623980|NCT00293423|470241838|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
130623981|NCT00293423|470241837|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
130623982|NCT00293423|470241838|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
130623983|NCT00293423|470241837|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
130623984|NCT00293423|470241838|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
130623985|NCT00293423|470241837|FG000|Surgical Resection|processing error during surgical resection|1|||
130623986|NCT00293423|470241838|FG001|Surgical Resection|processing error during surgical resection|0|||
130623987|NCT00293423|470241837|FG000|Surgical Resection|Withdrawal by Subject|4|||
130623988|NCT00293423|470241838|FG001|Surgical Resection|Withdrawal by Subject|0|||
130623989|NCT00293423|470241837|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
130623990|NCT00293423|470241838|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
130623991|NCT02247401|470241843|FG000|Overall Study|Adverse Event|1|||
130623992|NCT02247401|470241844|FG001|Overall Study|Adverse Event|0|||
130623993|NCT02247401|470241845|FG002|Overall Study|Adverse Event|0|||
130623994|NCT02247401|470241843|FG000|Overall Study|Withdrawal by Subject|4|||
130623995|NCT02247401|470241844|FG001|Overall Study|Withdrawal by Subject|1|||
130623996|NCT02247401|470241845|FG002|Overall Study|Withdrawal by Subject|1|||
130623997|NCT02247401|470241843|FG000|Overall Study|Lost to Follow-up|1|||
130623998|NCT02247401|470241844|FG001|Overall Study|Lost to Follow-up|1|||
130623999|NCT02247401|470241845|FG002|Overall Study|Lost to Follow-up|1|||
130624000|NCT02188719|470241850|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130624001|NCT02188719|470241851|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
130624002|NCT02188719|470241852|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130624003|NCT02188719|470241853|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130624004|NCT01164865|470241854|FG000|Overall Study|Lost to Follow-up|2|||
130624005|NCT01164865|470241855|FG001|Overall Study|Lost to Follow-up|1|||
130624006|NCT00192036|470241856|FG000|Overall Study|Protocol Violation|3|||
130624007|NCT00192036|470241856|FG000|Overall Study|Adverse Event|6|||
130624008|NCT00192036|470241856|FG000|Overall Study|Patient/Physician Perception|1|||
130624009|NCT00192036|470241856|FG000|Overall Study|Objective Tumor Progression|4|||
130624010|NCT00192036|470241856|FG000|Overall Study|Clinical Disease Progression|1|||
130624011|NCT00192036|470241856|FG000|Overall Study|Death|1|||
130624012|NCT00192036|470241856|FG000|Overall Study|Unknown or Not Specified|5|||
130624013|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
130624014|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
130624015|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
130624016|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
130624017|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
130624018|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
130624019|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
130624020|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
130624021|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
130624022|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
130624023|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
130624024|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
130624025|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
130624026|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
130624027|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
130624028|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
130624029|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
130624030|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
130624031|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
130624032|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
130624033|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
130624034|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
130624035|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
130624036|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
130624037|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
130624038|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
130624039|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
130624040|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
130624041|NCT00476996|470241858|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
130624042|NCT00476996|470241859|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
130624043|NCT00476996|470241860|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
130624044|NCT00476996|470241861|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
130624045|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130624046|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130624047|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130624048|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
130624049|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
130624050|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
130624051|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
130624052|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
130624053|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Death|0|||
130624054|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Death|0|||
130624055|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Death|0|||
130624056|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Death|7|||
130624057|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130624058|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130624059|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130624060|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
130624061|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130624062|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130624063|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130624064|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
130624065|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130624066|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130624067|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130624068|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
130624069|NCT00476996|470241858|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
130624070|NCT00476996|470241859|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
130624071|NCT00476996|470241860|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
130624072|NCT00476996|470241861|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
130624073|NCT01769469|470241864|FG000|Overall Study|Consent Withdrawn|5|||
130624074|NCT01769469|470241864|FG000|Overall Study|Moved Out Of Area|3|||
130624075|NCT01769469|470241864|FG000|Overall Study|Lost to Follow-up|17|||
130624076|NCT01769469|470241864|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
130624077|NCT01769469|470241864|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
130624078|NCT02394795|470241872|FG000|Overall Study|Adverse Event|92|||
130624079|NCT02394795|470241873|FG001|Overall Study|Adverse Event|70|||
130624080|NCT02394795|470241872|FG000|Overall Study|Lost to Follow-up|0|||
130624081|NCT02394795|470241873|FG001|Overall Study|Lost to Follow-up|1|||
130624082|NCT02394795|470241872|FG000|Overall Study|Withdrawal by Subject|17|||
130624083|NCT02394795|470241873|FG001|Overall Study|Withdrawal by Subject|26|||
130624084|NCT02394795|470241872|FG000|Overall Study|Lack of Efficacy|181|||
130624085|NCT02394795|470241873|FG001|Overall Study|Lack of Efficacy|211|||
130624086|NCT02394795|470241872|FG000|Overall Study|Death|4|||
130624087|NCT02394795|470241873|FG001|Overall Study|Death|5|||
130624088|NCT02394795|470241872|FG000|Overall Study|Physician Decision|109|||
130624089|NCT02394795|470241873|FG001|Overall Study|Physician Decision|93|||
130624090|NCT02031432|470241878|FG000|Overall Study|Protocol Violation|1|||
130624091|NCT02031432|470241878|FG000|Overall Study|Lack of Efficacy|5|||
130624092|NCT02031432|470241878|FG000|Overall Study|Cancer Progression|2|||
130624093|NCT02031432|470241878|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
130624094|NCT02031432|470241878|FG000|Overall Study|Adverse Event|8|||
130624095|NCT02031432|470241878|FG000|Overall Study|Withdrawal by Subject|5|||
130624096|NCT02031432|470241878|FG000|Overall Study|Lost to Follow-up|1|||
130624097|NCT02031432|470241878|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
130624098|NCT02031432|470241878|FG000|Overall Study|Death|10|||
130624099|NCT01617187|470241879|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
130624100|NCT01617187|470241880|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
130624101|NCT01617187|470241881|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
130624102|NCT01617187|470241882|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
130624103|NCT01617187|470241879|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
130624104|NCT01617187|470241880|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
130624105|NCT01617187|470241881|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
130624106|NCT01617187|470241882|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
130624107|NCT01617187|470241879|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
130624108|NCT01617187|470241880|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130624109|NCT01617187|470241881|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130624110|NCT01617187|470241882|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130624111|NCT01617187|470241879|FG000|Treatment Through Study Completion|Adverse Event|1|||
130624112|NCT01617187|470241880|FG001|Treatment Through Study Completion|Adverse Event|1|||
130624113|NCT01617187|470241881|FG002|Treatment Through Study Completion|Adverse Event|0|||
130624114|NCT01617187|470241882|FG003|Treatment Through Study Completion|Adverse Event|1|||
130624115|NCT01617187|470241879|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
130624116|NCT01617187|470241880|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
130624117|NCT01617187|470241881|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
130624118|NCT01617187|470241882|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
130624119|NCT01617187|470241879|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
130624120|NCT01617187|470241880|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
130624121|NCT01617187|470241881|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
130624122|NCT01617187|470241882|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
130624123|NCT01617187|470241879|FG000|Treatment Through Study Completion|Protocol Violation|1|||
130624124|NCT01617187|470241880|FG001|Treatment Through Study Completion|Protocol Violation|0|||
130624125|NCT01617187|470241881|FG002|Treatment Through Study Completion|Protocol Violation|0|||
130624126|NCT01617187|470241882|FG003|Treatment Through Study Completion|Protocol Violation|1|||
130624127|NCT01770145|470243776|FG000|Baseline|Adverse Event|20|||
130624128|NCT01770145|470243776|FG000|Baseline|Withdrawal by Subject|1|||
130624129|NCT01770145|470243776|FG000|Baseline|Lost to Follow-up|1|||
130624130|NCT01770145|470243776|FG000|Baseline|Unable to define optimal dose|4|||
130624131|NCT01770145|470243776|FG000|Treatment|Adverse Event|3|||
130624132|NCT01770145|470243776|FG000|Treatment|Withdrawal by Subject|1|||
130624133|NCT02332798|470243777|FG000|Overall Study|Unwilling to Participate in Study|0|||
130624134|NCT02332798|470243778|FG001|Overall Study|Unwilling to Participate in Study|1|||
130624135|NCT02332798|470243779|FG002|Overall Study|Unwilling to Participate in Study|1|||
130624136|NCT02332798|470243777|FG000|Overall Study|Positive Urine Drug Test|0|||
130624137|NCT02332798|470243778|FG001|Overall Study|Positive Urine Drug Test|1|||
130624138|NCT02332798|470243779|FG002|Overall Study|Positive Urine Drug Test|0|||
130624139|NCT02332798|470243777|FG000|Overall Study|Abnormal Laboratory Findings|1|||
130624140|NCT02332798|470243778|FG001|Overall Study|Abnormal Laboratory Findings|0|||
130624141|NCT02332798|470243779|FG002|Overall Study|Abnormal Laboratory Findings|0|||
130624142|NCT00595868|470243780|FG000|Overall Study|Lost to Follow-up|45|||
130624143|NCT00595868|470243781|FG001|Overall Study|Lost to Follow-up|50|||
130624144|NCT04268303|470243783|FG000|Overall Study|Lost to Follow-up|1|||
130624145|NCT04268303|470243784|FG001|Overall Study|Lost to Follow-up|1|||
130624146|NCT04268303|470243785|FG002|Overall Study|Lost to Follow-up|2|||
130624147|NCT04268303|470243783|FG000|Overall Study|Withdrawal by Subject|0|||
130624148|NCT04268303|470243784|FG001|Overall Study|Withdrawal by Subject|1|||
130624149|NCT04268303|470243785|FG002|Overall Study|Withdrawal by Subject|1|||
130624150|NCT04268303|470243783|FG000|Overall Study|Adverse Event|2|||
130624151|NCT04268303|470243784|FG001|Overall Study|Adverse Event|0|||
130624152|NCT04268303|470243785|FG002|Overall Study|Adverse Event|0|||
130624153|NCT03927911|470243786|FG000|Overall Study|problems with eDiary|0|||
130624154|NCT03927911|470243787|FG001|Overall Study|problems with eDiary|1|||
130624155|NCT03927911|470243788|FG002|Overall Study|problems with eDiary|0|||
130624156|NCT03927911|470243789|FG003|Overall Study|problems with eDiary|1|||
130624157|NCT03927911|470243790|FG004|Overall Study|problems with eDiary|0|||
130624158|NCT03927911|470243791|FG005|Overall Study|problems with eDiary|4|||
130624159|NCT03927911|470243786|FG000|Overall Study|Adverse Event|0|||
130624160|NCT03927911|470243787|FG001|Overall Study|Adverse Event|0|||
130624161|NCT03927911|470243788|FG002|Overall Study|Adverse Event|0|||
130624162|NCT03927911|470243789|FG003|Overall Study|Adverse Event|0|||
130624163|NCT03927911|470243790|FG004|Overall Study|Adverse Event|0|||
130624164|NCT03927911|470243791|FG005|Overall Study|Adverse Event|1|||
130624165|NCT03927911|470243786|FG000|Overall Study|not treated -study terminated by sponsor|0|||
130624166|NCT03927911|470243787|FG001|Overall Study|not treated -study terminated by sponsor|1|||
130624167|NCT03927911|470243788|FG002|Overall Study|not treated -study terminated by sponsor|0|||
130624168|NCT03927911|470243789|FG003|Overall Study|not treated -study terminated by sponsor|0|||
130624169|NCT03927911|470243790|FG004|Overall Study|not treated -study terminated by sponsor|0|||
130624170|NCT03927911|470243791|FG005|Overall Study|not treated -study terminated by sponsor|0|||
130624171|NCT03927911|470243786|FG000|Overall Study|Surgery cancelled|0|||
130624172|NCT03927911|470243787|FG001|Overall Study|Surgery cancelled|0|||
130624173|NCT03927911|470243788|FG002|Overall Study|Surgery cancelled|0|||
130624174|NCT03927911|470243789|FG003|Overall Study|Surgery cancelled|1|||
130624175|NCT03927911|470243790|FG004|Overall Study|Surgery cancelled|0|||
130624176|NCT03927911|470243791|FG005|Overall Study|Surgery cancelled|1|||
130624177|NCT03927911|470243786|FG000|Overall Study|Protocol Violation|0|||
130624178|NCT03927911|470243787|FG001|Overall Study|Protocol Violation|0|||
130624179|NCT03927911|470243788|FG002|Overall Study|Protocol Violation|0|||
130624180|NCT03927911|470243789|FG003|Overall Study|Protocol Violation|0|||
130624181|NCT03927911|470243790|FG004|Overall Study|Protocol Violation|0|||
130624182|NCT03927911|470243791|FG005|Overall Study|Protocol Violation|1|||
130624183|NCT01824693|470243792|FG000|Overall Study|Death|0|||
130624184|NCT01824693|470243793|FG001|Overall Study|Death|1|||
130624185|NCT01824693|470243794|FG002|Overall Study|Death|0|||
130624186|NCT01824693|470243792|FG000|Overall Study|Physician Decision|1|||
130624187|NCT01824693|470243793|FG001|Overall Study|Physician Decision|1|||
130624188|NCT01824693|470243794|FG002|Overall Study|Physician Decision|1|||
130624189|NCT01824693|470243792|FG000|Overall Study|Withdrawal by Subject|0|||
130624190|NCT01824693|470243793|FG001|Overall Study|Withdrawal by Subject|0|||
130624191|NCT01824693|470243794|FG002|Overall Study|Withdrawal by Subject|1|||
130624192|NCT01824693|470243792|FG000|Overall Study|Progressive Disease|0|||
130624193|NCT01824693|470243793|FG001|Overall Study|Progressive Disease|5|||
130624194|NCT01824693|470243794|FG002|Overall Study|Progressive Disease|0|||
130624195|NCT01824693|470243792|FG000|Overall Study|Ineligible|0|||
130624196|NCT01824693|470243793|FG001|Overall Study|Ineligible|0|||
130624197|NCT01824693|470243794|FG002|Overall Study|Ineligible|3|||
130624198|NCT01824693|470243792|FG000|Overall Study|No Transplant Planned|0|||
130624199|NCT01824693|470243793|FG001|Overall Study|No Transplant Planned|0|||
130624200|NCT01824693|470243794|FG002|Overall Study|No Transplant Planned|10|||
130624201|NCT01188096|470243808|FG000|Overall Study|progression of disease|4|||
130624202|NCT01188096|470243808|FG000|Overall Study|Withdrawal by Subject|2|||
130624203|NCT02062398|470243809|FG000|Overall Study|Implant removal|1|||
130624204|NCT01779648|470243810|FG000|Overall Study|Protocol Violation|1|||
130624205|NCT01779648|470243811|FG001|Overall Study|Protocol Violation|0|||
130624206|NCT00415519|470243812|FG000|Overall Study|Adverse Event|1|||
130624207|NCT00415519|470243813|FG001|Overall Study|Adverse Event|0|||
130624208|NCT00415519|470243812|FG000|Overall Study|Withdrawal by Subject|2|||
130624209|NCT00415519|470243813|FG001|Overall Study|Withdrawal by Subject|0|||
130624210|NCT00415519|470243812|FG000|Overall Study|Patient's convenience|1|||
130624211|NCT00415519|470243813|FG001|Overall Study|Patient's convenience|0|||
130624212|NCT03485222|470243816|FG000|Overall Study|Death|0|||
130624213|NCT03485222|470243817|FG001|Overall Study|Death|1|||
130624214|NCT03485222|470243816|FG000|Overall Study|Lost to Follow-up|2|||
130624215|NCT03485222|470243817|FG001|Overall Study|Lost to Follow-up|1|||
130624216|NCT03657810|470243818|FG000|Overall Study|Adverse Event|0|||
130624217|NCT03657810|470243819|FG001|Overall Study|Adverse Event|1|||
130624218|NCT03657810|470243820|FG002|Overall Study|Adverse Event|0|||
130624219|NCT03657810|470243818|FG000|Overall Study|Lack of Efficacy|4|||
130624220|NCT03657810|470243819|FG001|Overall Study|Lack of Efficacy|1|||
130624221|NCT03657810|470243820|FG002|Overall Study|Lack of Efficacy|3|||
130624222|NCT03657810|470243818|FG000|Overall Study|Protocol Violation|1|||
130624223|NCT03657810|470243819|FG001|Overall Study|Protocol Violation|0|||
130624224|NCT03657810|470243820|FG002|Overall Study|Protocol Violation|0|||
130624225|NCT03657810|470243818|FG000|Overall Study|Lost to Follow-up|0|||
130624226|NCT03657810|470243819|FG001|Overall Study|Lost to Follow-up|1|||
130624227|NCT03657810|470243820|FG002|Overall Study|Lost to Follow-up|0|||
130624228|NCT03657810|470243818|FG000|Overall Study|Not provided|0|||
130624229|NCT03657810|470243819|FG001|Overall Study|Not provided|1|||
130624230|NCT03657810|470243820|FG002|Overall Study|Not provided|0|||
130624231|NCT00688545|470243821|FG000|Overall Study|Lost to Follow-up|1|||
130624232|NCT00688545|470243822|FG001|Overall Study|Lost to Follow-up|4|||
130624233|NCT00688545|470243821|FG000|Overall Study|Insurance/cost of drug|0|||
130624234|NCT00688545|470243822|FG001|Overall Study|Insurance/cost of drug|1|||
130624235|NCT00688545|470243821|FG000|Overall Study|Withdrawal by Subject|2|||
130624236|NCT00688545|470243822|FG001|Overall Study|Withdrawal by Subject|3|||
130624237|NCT00688545|470243821|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
130624238|NCT00688545|470243822|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
130624239|NCT00367341|470243824|FG000|Overall Study|Physician Decision|1|||
130624240|NCT00367341|470243825|FG001|Overall Study|Physician Decision|0|||
130624241|NCT00367341|470243824|FG000|Overall Study|Protocol Violation|1|||
130624242|NCT00367341|470243825|FG001|Overall Study|Protocol Violation|0|||
130624243|NCT01373918|470243828|FG000|Overall Study|Physician Decision|0|||
130624244|NCT01373918|470243829|FG001|Overall Study|Physician Decision|1|||
130624245|NCT03004976|470243830|FG000|Overall Study|Lost to Follow-up|7|||
130624246|NCT03004976|470243831|FG001|Overall Study|Lost to Follow-up|5|||
130624247|NCT03004976|470243830|FG000|Overall Study|Physician Decision|1|||
130624248|NCT03004976|470243831|FG001|Overall Study|Physician Decision|0|||
130624249|NCT03004976|470243830|FG000|Overall Study|Withdrawal by Subject|1|||
130624250|NCT03004976|470243831|FG001|Overall Study|Withdrawal by Subject|0|||
130624251|NCT03004976|470243830|FG000|Overall Study|Death|4|||
130624252|NCT03004976|470243831|FG001|Overall Study|Death|1|||
130624253|NCT02786836|470243834|FG000|Overall Study|Death|1|||
130624254|NCT02786836|470243834|FG000|Overall Study|Lack of Efficacy|2|||
130624255|NCT02786836|470243834|FG000|Overall Study|Protocol Violation|3|||
130624256|NCT02786836|470243834|FG000|Overall Study|Withdrawal by Subject|3|||
130624257|NCT02786836|470243834|FG000|Overall Study|Liver Transplantation|2|||
130624258|NCT02786836|470243834|FG000|Overall Study|Device or Pharmacy Issues|3|||
130624259|NCT02137837|470243838|FG000|Overall Study|Adverse Event|0|||
130624260|NCT02137837|470243839|FG001|Overall Study|Adverse Event|2|||
130624261|NCT02137837|470243840|FG002|Overall Study|Adverse Event|1|||
130624262|NCT02137837|470243838|FG000|Overall Study|Refusal unrelated to adverse event|2|||
130624263|NCT02137837|470243839|FG001|Overall Study|Refusal unrelated to adverse event|2|||
130624264|NCT02137837|470243840|FG002|Overall Study|Refusal unrelated to adverse event|1|||
130624265|NCT02137837|470243838|FG000|Overall Study|Progression/relapse|9|||
130624266|NCT02137837|470243839|FG001|Overall Study|Progression/relapse|7|||
130624267|NCT02137837|470243840|FG002|Overall Study|Progression/relapse|7|||
130624268|NCT02137837|470243838|FG000|Overall Study|Not protocol specified|2|||
130624269|NCT02137837|470243839|FG001|Overall Study|Not protocol specified|1|||
130624270|NCT02137837|470243840|FG002|Overall Study|Not protocol specified|3|||
130624271|NCT02141217|470243841|FG000|Overall Study|Adverse Event|1|||
130624272|NCT02141217|470243842|FG001|Overall Study|Adverse Event|2|||
130624273|NCT02141217|470243841|FG000|Overall Study|Protocol Violation|1|||
130624274|NCT02141217|470243842|FG001|Overall Study|Protocol Violation|4|||
130624275|NCT02141217|470243841|FG000|Overall Study|Withdrawal by Subject|6|||
130624276|NCT02141217|470243842|FG001|Overall Study|Withdrawal by Subject|0|||
130624277|NCT02141217|470243841|FG000|Overall Study|Lost to Follow-up|1|||
130624278|NCT02141217|470243842|FG001|Overall Study|Lost to Follow-up|1|||
130624279|NCT02141217|470243841|FG000|Overall Study|Physician Decision|1|||
130624280|NCT02141217|470243842|FG001|Overall Study|Physician Decision|0|||
130624281|NCT02141217|470243841|FG000|Overall Study|Surgical Intervention|1|||
130624282|NCT02141217|470243842|FG001|Overall Study|Surgical Intervention|1|||
130624283|NCT00448760|470243845|FG000|Overall Study|Death|3|||
130624284|NCT01306032|470243849|FG000|First Intervention|Adverse Event|1|||
130624285|NCT01306032|470243850|FG001|First Intervention|Adverse Event|0|||
130624286|NCT01306032|470243851|FG002|First Intervention|Adverse Event|1|||
130624287|NCT01306032|470243852|FG003|First Intervention|Adverse Event|0|||
130624288|NCT01306032|470243853|FG004|First Intervention|Adverse Event|0|||
130624289|NCT01306032|470243854|FG005|First Intervention|Adverse Event|1|||
130624290|NCT01306032|470243849|FG000|First Intervention|Withdrawal by Subject|0|||
130624291|NCT01306032|470243850|FG001|First Intervention|Withdrawal by Subject|2|||
130624292|NCT01306032|470243851|FG002|First Intervention|Withdrawal by Subject|0|||
130624293|NCT01306032|470243852|FG003|First Intervention|Withdrawal by Subject|1|||
130624294|NCT01306032|470243853|FG004|First Intervention|Withdrawal by Subject|0|||
130624295|NCT01306032|470243854|FG005|First Intervention|Withdrawal by Subject|0|||
130624296|NCT01306032|470243849|FG000|First Intervention|Death|0|||
130624297|NCT01306032|470243850|FG001|First Intervention|Death|0|||
130624298|NCT01306032|470243851|FG002|First Intervention|Death|1|||
130624299|NCT01306032|470243852|FG003|First Intervention|Death|0|||
130624300|NCT01306032|470243853|FG004|First Intervention|Death|0|||
130624301|NCT01306032|470243854|FG005|First Intervention|Death|0|||
130624302|NCT01306032|470243849|FG000|First Intervention|Ineligible|0|||
130624303|NCT01306032|470243850|FG001|First Intervention|Ineligible|0|||
130624304|NCT01306032|470243851|FG002|First Intervention|Ineligible|0|||
130624305|NCT01306032|470243852|FG003|First Intervention|Ineligible|0|||
130624306|NCT01306032|470243853|FG004|First Intervention|Ineligible|0|||
130624307|NCT01306032|470243854|FG005|First Intervention|Ineligible|1|||
130624308|NCT01306032|470243849|FG000|First Intervention|Progressive disease|0|||
130624309|NCT01306032|470243850|FG001|First Intervention|Progressive disease|0|||
130624310|NCT01306032|470243851|FG002|First Intervention|Progressive disease|0|||
130624311|NCT01306032|470243852|FG003|First Intervention|Progressive disease|0|||
130624312|NCT01306032|470243853|FG004|First Intervention|Progressive disease|2|||
130624313|NCT01306032|470243854|FG005|First Intervention|Progressive disease|0|||
130624314|NCT01306032|470243849|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
130624315|NCT01306032|470243850|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
130624316|NCT01306032|470243851|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
130624317|NCT01306032|470243852|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
130624318|NCT01306032|470243853|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
130624319|NCT01306032|470243854|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
130624320|NCT01306032|470243849|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
130624321|NCT01306032|470243850|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
130624322|NCT01306032|470243851|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
130624323|NCT01306032|470243852|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
130624324|NCT01306032|470243853|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
130624325|NCT01306032|470243854|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
130624326|NCT05014542|470243855|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
130624327|NCT05014542|470243856|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
130624328|NCT05014542|470243855|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
130624329|NCT05014542|470243856|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
130624330|NCT05014542|470243855|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
130624331|NCT05014542|470243856|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
130624332|NCT05014542|470243855|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
130624333|NCT05014542|470243856|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
130624334|NCT00555568|470243857|FG000|Overall Study|Lost to Follow-up|26|||
130624335|NCT00555568|470243858|FG001|Overall Study|Lost to Follow-up|16|||
130624336|NCT00555568|470243859|FG002|Overall Study|Lost to Follow-up|16|||
130624337|NCT04702984|470243860|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
130624338|NCT06000501|470243863|FG000|Overall Study|Screen failure|3|||
130624339|NCT06000501|470243863|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
130624340|NCT06000501|470243863|FG000|Overall Study|Physician Decision|4|||
130624341|NCT06000501|470243863|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
130624342|NCT06000501|470243863|FG000|Overall Study|Scheduling issues|2|||
130624343|NCT01588353|470243864|FG000|Step2|Withdrawal by Subject|0|||
130624344|NCT01588353|470243865|FG001|Step2|Withdrawal by Subject|1|||
130624345|NCT01588353|470243866|FG002|Step2|Withdrawal by Subject|0|||
130624346|NCT01588353|470243864|FG000|Step3|Adverse Event|0|||
130624347|NCT01588353|470243865|FG001|Step3|Adverse Event|0|||
130624348|NCT01588353|470243866|FG002|Step3|Adverse Event|2|||
130624349|NCT05067452|470243868|FG000|Overall Study|Lost to Follow-up|0|||
130624350|NCT05067452|470243869|FG001|Overall Study|Lost to Follow-up|4|||
130624351|NCT02156804|470243870|FG000|Overall Study|Withdrawal by Subject|1|||
130624352|NCT03228394|470243871|FG000|Overall Study|Lost to Follow-up|0|||
130624353|NCT03228394|470243872|FG001|Overall Study|Lost to Follow-up|0|||
130624354|NCT03228394|470243873|FG002|Overall Study|Lost to Follow-up|1|||
130624355|NCT03228394|470243874|FG003|Overall Study|Lost to Follow-up|1|||
130624356|NCT03228394|470243875|FG004|Overall Study|Lost to Follow-up|0|||
130624357|NCT03228394|470243876|FG005|Overall Study|Lost to Follow-up|0|||
130624358|NCT03228394|470243877|FG006|Overall Study|Lost to Follow-up|2|||
130624359|NCT03228394|470243878|FG007|Overall Study|Lost to Follow-up|0|||
130624360|NCT03228394|470243871|FG000|Overall Study|Withdrawal by Subject|0|||
130624361|NCT03228394|470243872|FG001|Overall Study|Withdrawal by Subject|0|||
130624362|NCT03228394|470243873|FG002|Overall Study|Withdrawal by Subject|1|||
130624363|NCT03228394|470243874|FG003|Overall Study|Withdrawal by Subject|0|||
130624364|NCT03228394|470243875|FG004|Overall Study|Withdrawal by Subject|0|||
130624365|NCT03228394|470243876|FG005|Overall Study|Withdrawal by Subject|0|||
130624366|NCT03228394|470243877|FG006|Overall Study|Withdrawal by Subject|1|||
130624367|NCT03228394|470243878|FG007|Overall Study|Withdrawal by Subject|3|||
130624368|NCT03228394|470243871|FG000|Overall Study|Protocol Violation|0|||
130624369|NCT03228394|470243872|FG001|Overall Study|Protocol Violation|0|||
130624370|NCT03228394|470243873|FG002|Overall Study|Protocol Violation|0|||
130624371|NCT03228394|470243874|FG003|Overall Study|Protocol Violation|1|||
130624372|NCT03228394|470243875|FG004|Overall Study|Protocol Violation|0|||
130624373|NCT03228394|470243876|FG005|Overall Study|Protocol Violation|0|||
130624374|NCT03228394|470243877|FG006|Overall Study|Protocol Violation|0|||
130624375|NCT03228394|470243878|FG007|Overall Study|Protocol Violation|0|||
130624376|NCT03228394|470243871|FG000|Overall Study|Physician Decision|0|||
130624377|NCT03228394|470243872|FG001|Overall Study|Physician Decision|0|||
130624378|NCT03228394|470243873|FG002|Overall Study|Physician Decision|0|||
130624379|NCT03228394|470243874|FG003|Overall Study|Physician Decision|0|||
130624380|NCT03228394|470243875|FG004|Overall Study|Physician Decision|0|||
130624381|NCT03228394|470243876|FG005|Overall Study|Physician Decision|0|||
130624382|NCT03228394|470243877|FG006|Overall Study|Physician Decision|1|||
130624383|NCT03228394|470243878|FG007|Overall Study|Physician Decision|0|||
130624384|NCT03228394|470243871|FG000|Overall Study|Noncompliance|0|||
130624385|NCT03228394|470243872|FG001|Overall Study|Noncompliance|0|||
130624386|NCT03228394|470243873|FG002|Overall Study|Noncompliance|0|||
130624387|NCT03228394|470243874|FG003|Overall Study|Noncompliance|0|||
130624388|NCT03228394|470243875|FG004|Overall Study|Noncompliance|0|||
130624389|NCT03228394|470243876|FG005|Overall Study|Noncompliance|0|||
130624390|NCT03228394|470243877|FG006|Overall Study|Noncompliance|1|||
130624391|NCT03228394|470243878|FG007|Overall Study|Noncompliance|0|||
130624392|NCT04581863|470243879|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
130624393|NCT04581863|470243880|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
130624394|NCT01803711|470243883|FG000|Overall Study|Adverse Event|1|||
130624395|NCT01803711|470243884|FG001|Overall Study|Adverse Event|1|||
130624396|NCT01170221|470243888|FG000|Overall Study|Lost to Follow-up|22|||
130624397|NCT01170221|470243889|FG001|Overall Study|Lost to Follow-up|21|||
130624398|NCT01170221|470243888|FG000|Overall Study|Withdrawal by Subject|9|||
130624399|NCT01170221|470243889|FG001|Overall Study|Withdrawal by Subject|7|||
130624400|NCT01170221|470243888|FG000|Overall Study|Subject completed only screening and LFU|1|||
130624401|NCT01170221|470243889|FG001|Overall Study|Subject completed only screening and LFU|0|||
130624402|NCT01170221|470243888|FG000|Overall Study|Randomized but not treated|1|||
130624403|NCT01170221|470243889|FG001|Overall Study|Randomized but not treated|0|||
130624404|NCT00432562|470243890|FG000|Overall Study|Death|3|||
130624405|NCT00432562|470243891|FG001|Overall Study|Death|0|||
130624406|NCT02693691|470243892|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
130624407|NCT02693691|470243892|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
130624408|NCT02693691|470243892|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
130624409|NCT02693691|470243892|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
130624410|NCT02693691|470243892|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
130624411|NCT02693691|470243892|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
130624412|NCT02693691|470243892|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
130624413|NCT01315847|470243895|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
130624414|NCT01315847|470243896|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
130624415|NCT01315847|470243895|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
130624416|NCT01315847|470243896|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
130624417|NCT05425719|470243899|FG000|Overall Study|Lost to Follow-up|4|||
130624418|NCT05425719|470243900|FG001|Overall Study|Lost to Follow-up|0|||
130624419|NCT05425719|470243899|FG000|Overall Study|Withdrew consent|1|||
130624420|NCT05425719|470243900|FG001|Overall Study|Withdrew consent|1|||
130624421|NCT04682353|470243903|FG000|Overall Study|Lost to Follow-up|0|||
130624422|NCT04682353|470243904|FG001|Overall Study|Lost to Follow-up|1|||
130624423|NCT04682353|470243905|FG002|Overall Study|Lost to Follow-up|0|||
130624424|NCT04682353|470243906|FG003|Overall Study|Lost to Follow-up|1|||
130624425|NCT04682353|470243903|FG000|Overall Study|Personal reasons|0|||
130624426|NCT04682353|470243904|FG001|Overall Study|Personal reasons|1|||
130624427|NCT04682353|470243905|FG002|Overall Study|Personal reasons|0|||
130624428|NCT04682353|470243906|FG003|Overall Study|Personal reasons|0|||
130624429|NCT01586806|470243907|FG000|Overall Study|Protocol Violation|0|||
130624430|NCT01586806|470243908|FG001|Overall Study|Protocol Violation|1|||
130624431|NCT01586806|470243909|FG002|Overall Study|Protocol Violation|0|||
130624432|NCT01586806|470243907|FG000|Overall Study|Withdrawal by Subject|1|||
130624433|NCT01586806|470243908|FG001|Overall Study|Withdrawal by Subject|0|||
130624434|NCT01586806|470243909|FG002|Overall Study|Withdrawal by Subject|0|||
130624435|NCT01586806|470243907|FG000|Overall Study|Lost to Follow-up|2|||
130624436|NCT01586806|470243908|FG001|Overall Study|Lost to Follow-up|3|||
130624437|NCT01586806|470243909|FG002|Overall Study|Lost to Follow-up|2|||
130624438|NCT00862654|470243910|FG000|Overall Study|Lack of Efficacy|1|||
130624439|NCT00862654|470243911|FG001|Overall Study|Lack of Efficacy|0|||
130624440|NCT00862654|470243912|FG002|Overall Study|Lack of Efficacy|1|||
130624441|NCT00862654|470243913|FG003|Overall Study|Lack of Efficacy|0|||
130624442|NCT00862654|470243910|FG000|Overall Study|Lost to Follow-up|1|||
130624443|NCT00862654|470243911|FG001|Overall Study|Lost to Follow-up|2|||
130624444|NCT00862654|470243912|FG002|Overall Study|Lost to Follow-up|1|||
130624445|NCT00862654|470243913|FG003|Overall Study|Lost to Follow-up|3|||
130624446|NCT00862654|470243910|FG000|Overall Study|Adverse Event|0|||
130624447|NCT00862654|470243911|FG001|Overall Study|Adverse Event|1|||
130624448|NCT00862654|470243912|FG002|Overall Study|Adverse Event|1|||
130624449|NCT00862654|470243913|FG003|Overall Study|Adverse Event|0|||
130624450|NCT00862654|470243910|FG000|Overall Study|Pregnancy|1|||
130624451|NCT00862654|470243911|FG001|Overall Study|Pregnancy|1|||
130624452|NCT00862654|470243912|FG002|Overall Study|Pregnancy|0|||
130624453|NCT00862654|470243913|FG003|Overall Study|Pregnancy|0|||
130624454|NCT00862654|470243910|FG000|Overall Study|Withdrawal by Subject|2|||
130624455|NCT00862654|470243911|FG001|Overall Study|Withdrawal by Subject|2|||
130624456|NCT00862654|470243912|FG002|Overall Study|Withdrawal by Subject|2|||
130624457|NCT00862654|470243913|FG003|Overall Study|Withdrawal by Subject|3|||
130624458|NCT00862654|470243910|FG000|Overall Study|Subject mistake|0|||
130624459|NCT00862654|470243911|FG001|Overall Study|Subject mistake|1|||
130624460|NCT00862654|470243912|FG002|Overall Study|Subject mistake|0|||
130624461|NCT00862654|470243913|FG003|Overall Study|Subject mistake|0|||
130624462|NCT00862654|470243910|FG000|Overall Study|Familly constraint|0|||
130624463|NCT00862654|470243911|FG001|Overall Study|Familly constraint|1|||
130624464|NCT00862654|470243912|FG002|Overall Study|Familly constraint|0|||
130624465|NCT00862654|470243913|FG003|Overall Study|Familly constraint|0|||
130624466|NCT00862654|470243910|FG000|Overall Study|Never used study drugs|1|||
130624467|NCT00862654|470243911|FG001|Overall Study|Never used study drugs|0|||
130624468|NCT00862654|470243912|FG002|Overall Study|Never used study drugs|0|||
130624469|NCT00862654|470243913|FG003|Overall Study|Never used study drugs|0|||
130624470|NCT00862654|470243910|FG000|Overall Study|Included after end of inclusions|0|||
130624471|NCT00862654|470243911|FG001|Overall Study|Included after end of inclusions|0|||
130624472|NCT00862654|470243912|FG002|Overall Study|Included after end of inclusions|1|||
130624473|NCT00862654|470243913|FG003|Overall Study|Included after end of inclusions|0|||
130624474|NCT04377672|470243914|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
130624475|NCT03954444|470243915|FG000|Overall Study|Withdrawal by Subject|5|||
130624476|NCT03954444|470243916|FG001|Overall Study|Withdrawal by Subject|5|||
130624477|NCT03954444|470243917|FG002|Overall Study|Withdrawal by Subject|5|||
130624478|NCT03954444|470243915|FG000|Overall Study|Adverse Event|1|||
130624479|NCT03954444|470243916|FG001|Overall Study|Adverse Event|3|||
130624480|NCT03954444|470243917|FG002|Overall Study|Adverse Event|2|||
130624481|NCT03954444|470243915|FG000|Overall Study|Protocol Violation|0|||
130624482|NCT03954444|470243916|FG001|Overall Study|Protocol Violation|3|||
130624483|NCT03954444|470243917|FG002|Overall Study|Protocol Violation|5|||
130624484|NCT03954444|470243915|FG000|Overall Study|Use of prohibited therapy|1|||
130624485|NCT03954444|470243916|FG001|Overall Study|Use of prohibited therapy|1|||
130624486|NCT03954444|470243917|FG002|Overall Study|Use of prohibited therapy|2|||
130624487|NCT03954444|470243915|FG000|Overall Study|Lost to Follow-up|1|||
130624488|NCT03954444|470243916|FG001|Overall Study|Lost to Follow-up|0|||
130624489|NCT03954444|470243917|FG002|Overall Study|Lost to Follow-up|1|||
130624490|NCT03954444|470243915|FG000|Overall Study|Non-compliant with study drug application|2|||
130624491|NCT03954444|470243916|FG001|Overall Study|Non-compliant with study drug application|2|||
130624492|NCT03954444|470243917|FG002|Overall Study|Non-compliant with study drug application|0|||
130624493|NCT03954444|470243915|FG000|Overall Study|Administrative reasons|0|||
130624494|NCT03954444|470243916|FG001|Overall Study|Administrative reasons|0|||
130624495|NCT03954444|470243917|FG002|Overall Study|Administrative reasons|1|||
130624496|NCT03954444|470243915|FG000|Overall Study|Miscellaneous|3|||
130624497|NCT03954444|470243916|FG001|Overall Study|Miscellaneous|2|||
130624498|NCT03954444|470243917|FG002|Overall Study|Miscellaneous|1|||
130624499|NCT02447458|470243918|FG000|Overall Study|Other|0|||
130624500|NCT02447458|470243919|FG001|Overall Study|Other|0|||
130624501|NCT02447458|470243920|FG002|Overall Study|Other|1|||
130624502|NCT02447458|470243921|FG003|Overall Study|Other|0|||
130624503|NCT02447458|470243922|FG004|Overall Study|Other|0|||
130624504|NCT02447458|470243923|FG005|Overall Study|Other|0|||
130624505|NCT02133742|470243924|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
130624506|NCT02133742|470243924|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
130624507|NCT02133742|470243924|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
130624508|NCT02133742|470243924|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
130624509|NCT02133742|470243924|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
130624510|NCT01688635|470243926|FG000|Washout 1|Withdrawal by Subject|1|||
130624511|NCT01688635|470243927|FG001|Washout 1|Withdrawal by Subject|0|||
130624512|NCT01688635|470243926|FG000|Washout 1|Adverse Event|0|||
130624513|NCT01688635|470243927|FG001|Washout 1|Adverse Event|1|||
130624514|NCT01688635|470243926|FG000|Washout 1|Physician Decision|0|||
130624515|NCT01688635|470243927|FG001|Washout 1|Physician Decision|1|||
130624516|NCT01688635|470243926|FG000|Washout 2|Physician Decision|1|||
130624517|NCT01688635|470243927|FG001|Washout 2|Physician Decision|0|||
130624518|NCT01688635|470243926|FG000|Washout 2|Withdrawal by Subject|1|||
130624519|NCT01688635|470243927|FG001|Washout 2|Withdrawal by Subject|0|||
130624520|NCT01688635|470243926|FG000|Washout 2|Sponsor Decision|1|||
130624521|NCT01688635|470243927|FG001|Washout 2|Sponsor Decision|2|||
130624522|NCT01688635|470243926|FG000|Washout 3|Withdrawal by Subject|1|||
130624523|NCT01688635|470243927|FG001|Washout 3|Withdrawal by Subject|0|||
130624524|NCT02293902|470243932|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
130624525|NCT02293902|470243933|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
130624526|NCT02293902|470243934|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
130624527|NCT02293902|470243935|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
130624528|NCT02293902|470243936|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
130624529|NCT02293902|470243932|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
130624530|NCT02293902|470243933|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
130624531|NCT02293902|470243934|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
130624532|NCT02293902|470243935|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
130624533|NCT02293902|470243936|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
130624534|NCT02293902|470243932|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
130624535|NCT02293902|470243933|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130624536|NCT02293902|470243934|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130624537|NCT02293902|470243935|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130624538|NCT02293902|470243936|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130624539|NCT02293902|470243932|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
130624540|NCT02293902|470243933|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
130624541|NCT02293902|470243934|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
130624542|NCT02293902|470243935|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
130624543|NCT02293902|470243936|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
130624544|NCT02293902|470243932|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130624545|NCT02293902|470243933|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
130624546|NCT02293902|470243934|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
130624547|NCT02293902|470243935|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130624548|NCT02293902|470243936|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130624549|NCT05406440|470246238|FG000|Overall Study|Lost to Follow-up|0|||
130624550|NCT05406440|470246239|FG001|Overall Study|Lost to Follow-up|0|||
130624551|NCT05406440|470246240|FG002|Overall Study|Lost to Follow-up|0|||
130624552|NCT05406440|470246241|FG003|Overall Study|Lost to Follow-up|0|||
130624553|NCT05406440|470246242|FG004|Overall Study|Lost to Follow-up|2|||
130624554|NCT05406440|470246243|FG005|Overall Study|Lost to Follow-up|0|||
130624555|NCT05406440|470246244|FG006|Overall Study|Lost to Follow-up|0|||
130624556|NCT05406440|470246238|FG000|Overall Study|Physician Decision|0|||
130624557|NCT05406440|470246239|FG001|Overall Study|Physician Decision|0|||
130624558|NCT05406440|470246240|FG002|Overall Study|Physician Decision|0|||
130624559|NCT05406440|470246241|FG003|Overall Study|Physician Decision|0|||
130624560|NCT05406440|470246242|FG004|Overall Study|Physician Decision|1|||
130624561|NCT05406440|470246243|FG005|Overall Study|Physician Decision|0|||
130624562|NCT05406440|470246244|FG006|Overall Study|Physician Decision|0|||
130624563|NCT05406440|470246238|FG000|Overall Study|Withdrawal by Subject|0|||
130624564|NCT05406440|470246239|FG001|Overall Study|Withdrawal by Subject|0|||
130624565|NCT05406440|470246240|FG002|Overall Study|Withdrawal by Subject|0|||
130624566|NCT05406440|470246241|FG003|Overall Study|Withdrawal by Subject|0|||
130624567|NCT05406440|470246242|FG004|Overall Study|Withdrawal by Subject|0|||
130624568|NCT05406440|470246243|FG005|Overall Study|Withdrawal by Subject|2|||
130624569|NCT05406440|470246244|FG006|Overall Study|Withdrawal by Subject|0|||
130624570|NCT05742841|470246248|FG000|Overall Study|Withdrawal by Subject|1|||
130624571|NCT05742841|470246248|FG000|Overall Study|Lost to Follow-up|1|||
130624572|NCT04134728|470246249|FG000|Overall Study|Adverse Event|3|||
130624573|NCT04134728|470246250|FG001|Overall Study|Adverse Event|2|||
130624574|NCT04134728|470246251|FG002|Overall Study|Adverse Event|9|||
130624575|NCT04134728|470246252|FG003|Overall Study|Adverse Event|0|||
130624576|NCT04134728|470246253|FG004|Overall Study|Adverse Event|0|||
130624577|NCT04134728|470246254|FG005|Overall Study|Adverse Event|0|||
130624578|NCT04134728|470246249|FG000|Overall Study|Lack of Efficacy|3|||
130624579|NCT04134728|470246250|FG001|Overall Study|Lack of Efficacy|3|||
130624580|NCT04134728|470246251|FG002|Overall Study|Lack of Efficacy|1|||
130624581|NCT04134728|470246252|FG003|Overall Study|Lack of Efficacy|2|||
130624582|NCT04134728|470246253|FG004|Overall Study|Lack of Efficacy|0|||
130624583|NCT04134728|470246254|FG005|Overall Study|Lack of Efficacy|0|||
130624584|NCT04134728|470246249|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130624585|NCT04134728|470246250|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130624586|NCT04134728|470246251|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
130624587|NCT04134728|470246252|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130624588|NCT04134728|470246253|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130624589|NCT04134728|470246254|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130624590|NCT04134728|470246249|FG000|Overall Study|Protocol Deviation|0|||
130624591|NCT04134728|470246250|FG001|Overall Study|Protocol Deviation|0|||
130624592|NCT04134728|470246251|FG002|Overall Study|Protocol Deviation|1|||
130624593|NCT04134728|470246252|FG003|Overall Study|Protocol Deviation|0|||
130624594|NCT04134728|470246253|FG004|Overall Study|Protocol Deviation|0|||
130624595|NCT04134728|470246254|FG005|Overall Study|Protocol Deviation|0|||
130624596|NCT04134728|470246249|FG000|Overall Study|Informed Consent Withdrawn|3|||
130624597|NCT04134728|470246250|FG001|Overall Study|Informed Consent Withdrawn|6|||
130624598|NCT04134728|470246251|FG002|Overall Study|Informed Consent Withdrawn|8|||
130624599|NCT04134728|470246252|FG003|Overall Study|Informed Consent Withdrawn|1|||
130624600|NCT04134728|470246253|FG004|Overall Study|Informed Consent Withdrawn|1|||
130624601|NCT04134728|470246254|FG005|Overall Study|Informed Consent Withdrawn|0|||
130624602|NCT04134728|470246249|FG000|Overall Study|Physician Decision|2|||
130624603|NCT04134728|470246250|FG001|Overall Study|Physician Decision|0|||
130624604|NCT04134728|470246251|FG002|Overall Study|Physician Decision|0|||
130624605|NCT04134728|470246252|FG003|Overall Study|Physician Decision|0|||
130624606|NCT04134728|470246253|FG004|Overall Study|Physician Decision|0|||
130624607|NCT04134728|470246254|FG005|Overall Study|Physician Decision|0|||
130624608|NCT04134728|470246249|FG000|Overall Study|Lost to Follow-up|1|||
130624609|NCT04134728|470246250|FG001|Overall Study|Lost to Follow-up|2|||
130624610|NCT04134728|470246251|FG002|Overall Study|Lost to Follow-up|1|||
130624611|NCT04134728|470246252|FG003|Overall Study|Lost to Follow-up|0|||
130624612|NCT04134728|470246253|FG004|Overall Study|Lost to Follow-up|0|||
130624613|NCT04134728|470246254|FG005|Overall Study|Lost to Follow-up|1|||
130624614|NCT04134728|470246249|FG000|Overall Study|Investigator Site Closed|0|||
130624615|NCT04134728|470246250|FG001|Overall Study|Investigator Site Closed|1|||
130624616|NCT04134728|470246251|FG002|Overall Study|Investigator Site Closed|1|||
130624617|NCT04134728|470246252|FG003|Overall Study|Investigator Site Closed|0|||
130624618|NCT04134728|470246253|FG004|Overall Study|Investigator Site Closed|0|||
130624619|NCT04134728|470246254|FG005|Overall Study|Investigator Site Closed|0|||
130624620|NCT01711541|470246259|FG000|Overall Study|Cancel prior to treatment|0|||
130624621|NCT01711541|470246260|FG001|Overall Study|Cancel prior to treatment|0|||
130624622|NCT01711541|470246261|FG002|Overall Study|Cancel prior to treatment|0|||
130624623|NCT01711541|470246262|FG003|Overall Study|Cancel prior to treatment|1|||
130624624|NCT01711541|470246263|FG004|Overall Study|Cancel prior to treatment|0|||
130624625|NCT01711541|470246259|FG000|Overall Study|Ineligible|0|||
130624626|NCT01711541|470246260|FG001|Overall Study|Ineligible|1|||
130624627|NCT01711541|470246261|FG002|Overall Study|Ineligible|0|||
130624628|NCT01711541|470246262|FG003|Overall Study|Ineligible|0|||
130624629|NCT01711541|470246263|FG004|Overall Study|Ineligible|0|||
130624630|NCT00728936|470246264|FG000|Overall Study|Withdrawal by Subject|0|||
130624631|NCT00728936|470246265|FG001|Overall Study|Withdrawal by Subject|0|||
130624632|NCT00728936|470246266|FG002|Overall Study|Withdrawal by Subject|0|||
130624633|NCT00728936|470246267|FG003|Overall Study|Withdrawal by Subject|0|||
130624634|NCT00728936|470246268|FG004|Overall Study|Withdrawal by Subject|0|||
130624635|NCT00728936|470246269|FG005|Overall Study|Withdrawal by Subject|1|||
130624636|NCT00728936|470246270|FG006|Overall Study|Withdrawal by Subject|0|||
130624637|NCT05355818|470246276|FG000|Overall Study|Adverse Event|1|||
130624638|NCT05355818|470246277|FG001|Overall Study|Adverse Event|1|||
130624639|NCT05355818|470246276|FG000|Overall Study|Lack of Efficacy|2|||
130624640|NCT05355818|470246277|FG001|Overall Study|Lack of Efficacy|1|||
130624641|NCT05355818|470246276|FG000|Overall Study|Lost to Follow-up|0|||
130624642|NCT05355818|470246277|FG001|Overall Study|Lost to Follow-up|1|||
130624643|NCT01175590|470246286|FG000|Overall Study|Lost to Follow-up|1|||
130624644|NCT01175590|470246287|FG001|Overall Study|Lost to Follow-up|0|||
130624645|NCT01175590|470246286|FG000|Overall Study|Withdrawal by Subject|0|||
130624646|NCT01175590|470246287|FG001|Overall Study|Withdrawal by Subject|2|||
130624647|NCT01175590|470246286|FG000|Overall Study|Adverse Event|4|||
130624648|NCT01175590|470246287|FG001|Overall Study|Adverse Event|0|||
130624649|NCT01175590|470246286|FG000|Overall Study|Physician Decision|1|||
130624650|NCT01175590|470246287|FG001|Overall Study|Physician Decision|4|||
130624651|NCT01175590|470246286|FG000|Overall Study|Lack of Efficacy|1|||
130624652|NCT01175590|470246287|FG001|Overall Study|Lack of Efficacy|1|||
130624653|NCT01175590|470246286|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
130624654|NCT01175590|470246287|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
130624655|NCT01175590|470246286|FG000|Overall Study|Treated not as randomized|3|||
130624656|NCT01175590|470246287|FG001|Overall Study|Treated not as randomized|2|||
130624657|NCT01175590|470246286|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
130624658|NCT01175590|470246287|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
130624659|NCT01175590|470246286|FG000|Overall Study|Protocol Violation|0|||
130624660|NCT01175590|470246287|FG001|Overall Study|Protocol Violation|1|||
130624661|NCT00092677|470246288|FG000|Overall Study|Lost to Follow-up|0|||
130624662|NCT00092677|470246289|FG001|Overall Study|Lost to Follow-up|2|||
130624663|NCT00092677|470246288|FG000|Overall Study|Adminstrative|5|||
130624664|NCT00092677|470246289|FG001|Overall Study|Adminstrative|9|||
130624665|NCT01601704|470246290|FG000|Overall Study|Randomized but not dispensed study med|1|||
130624666|NCT01601704|470246291|FG001|Overall Study|Randomized but not dispensed study med|4|||
130624667|NCT00877006|470246294|FG000|Treatment Period|Death|2|||
130624668|NCT00877006|470246295|FG001|Treatment Period|Death|1|||
130624669|NCT00877006|470246294|FG000|Treatment Period|Adverse Event|10|||
130624670|NCT00877006|470246295|FG001|Treatment Period|Adverse Event|3|||
130624671|NCT00877006|470246294|FG000|Treatment Period|Withdrawal by Subject|2|||
130624672|NCT00877006|470246295|FG001|Treatment Period|Withdrawal by Subject|3|||
130624673|NCT00877006|470246294|FG000|Treatment Period|Protocol Violation|1|||
130624674|NCT00877006|470246295|FG001|Treatment Period|Protocol Violation|0|||
130624675|NCT00877006|470246294|FG000|Treatment Period|Lost to Follow-up|0|||
130624676|NCT00877006|470246295|FG001|Treatment Period|Lost to Follow-up|1|||
130624677|NCT00877006|470246294|FG000|Treatment Period|Disease Progression|1|||
130624678|NCT00877006|470246295|FG001|Treatment Period|Disease Progression|2|||
130624679|NCT00877006|470246294|FG000|Treatment Period|Started New Treatment Regimen|2|||
130624680|NCT00877006|470246295|FG001|Treatment Period|Started New Treatment Regimen|5|||
130624681|NCT00877006|470246294|FG000|Treatment Period|Other|4|||
130624682|NCT00877006|470246295|FG001|Treatment Period|Other|4|||
130624683|NCT00877006|470246294|FG000|Treatment Period|Randomized but Not Treated|3|||
130624684|NCT00877006|470246295|FG001|Treatment Period|Randomized but Not Treated|8|||
130624685|NCT00877006|470246294|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
130624686|NCT00877006|470246295|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
130624687|NCT00877006|470246294|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
130624688|NCT00877006|470246295|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
130624689|NCT00877006|470246294|FG000|Long-Term Follow-up Period|Death|26|||
130624690|NCT00877006|470246295|FG001|Long-Term Follow-up Period|Death|18|||
130624691|NCT00877006|470246294|FG000|Long-Term Follow-up Period|Other|7|||
130624692|NCT00877006|470246295|FG001|Long-Term Follow-up Period|Other|9|||
130624693|NCT04671342|470246296|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
130624694|NCT04671342|470246296|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
130624695|NCT04671342|470246296|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
130624696|NCT04671342|470246296|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
130624697|NCT04671342|470246296|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
130624698|NCT04671342|470246296|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
130624699|NCT03911869|470246297|FG000|Safety Lead-in Phase|Death|7|||
130624700|NCT03911869|470246298|FG001|Safety Lead-in Phase|Death|0|||
130624701|NCT03911869|470246299|FG002|Safety Lead-in Phase|Death|0|||
130624702|NCT03911869|470246297|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
130624703|NCT03911869|470246298|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
130624704|NCT03911869|470246299|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
130624705|NCT03911869|470246297|FG000|Safety Lead-in Phase|Other|1|||
130624706|NCT03911869|470246298|FG001|Safety Lead-in Phase|Other|0|||
130624707|NCT03911869|470246299|FG002|Safety Lead-in Phase|Other|0|||
130624708|NCT03911869|470246297|FG000|Phase 2|Death|0|||
130624709|NCT03911869|470246298|FG001|Phase 2|Death|3|||
130624710|NCT03911869|470246299|FG002|Phase 2|Death|0|||
130624711|NCT01878097|470246300|FG000|Baseline|Surveys not fully completed|2497|||
130624712|NCT01878097|470246301|FG001|Baseline|Surveys not fully completed|1800|||
130624713|NCT01878097|470246300|FG000|Implementation Year 1|Surveys not fully completed|3202|||
130624714|NCT01878097|470246301|FG001|Implementation Year 1|Surveys not fully completed|2549|||
130624715|NCT01878097|470246300|FG000|Implementation Year 2|Surveys not fully completed|3281|||
130624716|NCT01878097|470246301|FG001|Implementation Year 2|Surveys not fully completed|2841|||
130624717|NCT01878097|470246300|FG000|Implementation Year 3|Surveys not fully completed|3494|||
130624718|NCT01878097|470246301|FG001|Implementation Year 3|Surveys not fully completed|2980|||
130624719|NCT01878097|470246300|FG000|Implementation Year 4|Surveys not fully completed|3604|||
130624720|NCT01878097|470246301|FG001|Implementation Year 4|Surveys not fully completed|3007|||
130624721|NCT03325556|470246302|FG000|Open-label Period|Lack of Response in OL period|70|||
130624722|NCT03325556|470246303|FG001|Open-label Period|Lack of Response in OL period|0|||
130624723|NCT03325556|470246304|FG002|Open-label Period|Lack of Response in OL period|0|||
130624724|NCT03325556|470246302|FG000|Open-label Period|Adverse Event|27|||
130624725|NCT03325556|470246303|FG001|Open-label Period|Adverse Event|0|||
130624726|NCT03325556|470246304|FG002|Open-label Period|Adverse Event|0|||
130624727|NCT03325556|470246302|FG000|Open-label Period|Death|1|||
130624728|NCT03325556|470246303|FG001|Open-label Period|Death|0|||
130624729|NCT03325556|470246304|FG002|Open-label Period|Death|0|||
130624730|NCT03325556|470246302|FG000|Open-label Period|Lost to Follow-up|1|||
130624731|NCT03325556|470246303|FG001|Open-label Period|Lost to Follow-up|0|||
130624732|NCT03325556|470246304|FG002|Open-label Period|Lost to Follow-up|0|||
130624733|NCT03325556|470246302|FG000|Open-label Period|Non-compliance with study drug|5|||
130624734|NCT03325556|470246303|FG001|Open-label Period|Non-compliance with study drug|0|||
130624735|NCT03325556|470246304|FG002|Open-label Period|Non-compliance with study drug|0|||
130624736|NCT03325556|470246302|FG000|Open-label Period|Use of prohibited medication|1|||
130624737|NCT03325556|470246303|FG001|Open-label Period|Use of prohibited medication|0|||
130624738|NCT03325556|470246304|FG002|Open-label Period|Use of prohibited medication|0|||
130624739|NCT03325556|470246302|FG000|Open-label Period|Protocol Violation|4|||
130624740|NCT03325556|470246303|FG001|Open-label Period|Protocol Violation|0|||
130624741|NCT03325556|470246304|FG002|Open-label Period|Protocol Violation|0|||
130624742|NCT03325556|470246302|FG000|Open-label Period|Withdrawal by Subject|17|||
130624743|NCT03325556|470246303|FG001|Open-label Period|Withdrawal by Subject|0|||
130624744|NCT03325556|470246304|FG002|Open-label Period|Withdrawal by Subject|0|||
130624745|NCT03325556|470246302|FG000|Open-label Period|Not otherwise specified|8|||
130624746|NCT03325556|470246303|FG001|Open-label Period|Not otherwise specified|0|||
130624747|NCT03325556|470246304|FG002|Open-label Period|Not otherwise specified|0|||
130624748|NCT03325556|470246302|FG000|Open-label Period|Administrative discont. at study termination|41|||
130624749|NCT03325556|470246303|FG001|Open-label Period|Administrative discont. at study termination|0|||
130624750|NCT03325556|470246304|FG002|Open-label Period|Administrative discont. at study termination|0|||
130624751|NCT03325556|470246302|FG000|Double-blind Period|Relapse|0|||
130624752|NCT03325556|470246303|FG001|Double-blind Period|Relapse|15|||
130624753|NCT03325556|470246304|FG002|Double-blind Period|Relapse|34|||
130624754|NCT03325556|470246302|FG000|Double-blind Period|Adverse Event|0|||
130624755|NCT03325556|470246303|FG001|Double-blind Period|Adverse Event|3|||
130624756|NCT03325556|470246304|FG002|Double-blind Period|Adverse Event|1|||
130624757|NCT03325556|470246302|FG000|Double-blind Period|Noncompliance with study drug|0|||
130624758|NCT03325556|470246303|FG001|Double-blind Period|Noncompliance with study drug|0|||
130624759|NCT03325556|470246304|FG002|Double-blind Period|Noncompliance with study drug|1|||
130624760|NCT03325556|470246302|FG000|Double-blind Period|Use of prohibited medication|0|||
130624761|NCT03325556|470246303|FG001|Double-blind Period|Use of prohibited medication|1|||
130624762|NCT03325556|470246304|FG002|Double-blind Period|Use of prohibited medication|0|||
130624763|NCT03325556|470246302|FG000|Double-blind Period|Physician Decision|0|||
130624764|NCT03325556|470246303|FG001|Double-blind Period|Physician Decision|0|||
130624765|NCT03325556|470246304|FG002|Double-blind Period|Physician Decision|1|||
130624766|NCT03325556|470246302|FG000|Double-blind Period|Withdrawal by Subject|0|||
130624767|NCT03325556|470246303|FG001|Double-blind Period|Withdrawal by Subject|6|||
130624768|NCT03325556|470246304|FG002|Double-blind Period|Withdrawal by Subject|4|||
130624769|NCT03325556|470246302|FG000|Double-blind Period|Not otherwise specified|0|||
130624770|NCT03325556|470246303|FG001|Double-blind Period|Not otherwise specified|1|||
130624771|NCT03325556|470246304|FG002|Double-blind Period|Not otherwise specified|5|||
130624772|NCT03325556|470246302|FG000|Double-blind Period|Administrative discont. at study termination|0|||
130624773|NCT03325556|470246303|FG001|Double-blind Period|Administrative discont. at study termination|35|||
130624774|NCT03325556|470246304|FG002|Double-blind Period|Administrative discont. at study termination|31|||
130624775|NCT02119026|470246305|FG000|1st-line Treatment|Adverse Event|9|||
130624776|NCT02119026|470246306|FG001|1st-line Treatment|Adverse Event|14|||
130624777|NCT02119026|470246305|FG000|1st-line Treatment|Physician Decision|3|||
130624778|NCT02119026|470246306|FG001|1st-line Treatment|Physician Decision|8|||
130624779|NCT02119026|470246305|FG000|1st-line Treatment|Withdrawal by Subject|4|||
130624780|NCT02119026|470246306|FG001|1st-line Treatment|Withdrawal by Subject|10|||
130624781|NCT02119026|470246305|FG000|1st-line Treatment|Patient condition or compliance|6|||
130624782|NCT02119026|470246306|FG001|1st-line Treatment|Patient condition or compliance|4|||
130624783|NCT02119026|470246305|FG000|1st-line Treatment|Surgery of metastases|2|||
130624784|NCT02119026|470246306|FG001|1st-line Treatment|Surgery of metastases|1|||
130624785|NCT02119026|470246305|FG000|1st-line Treatment|Death|2|||
130624786|NCT02119026|470246306|FG001|1st-line Treatment|Death|1|||
130624787|NCT02119026|470246305|FG000|2nd-line Treatment|Lost to Follow-up|2|||
130624788|NCT02119026|470246306|FG001|2nd-line Treatment|Lost to Follow-up|0|||
130624789|NCT02119026|470246305|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
130624790|NCT02119026|470246306|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
130624791|NCT02119026|470246305|FG000|2nd-line Treatment|Adverse Event|4|||
130624792|NCT02119026|470246306|FG001|2nd-line Treatment|Adverse Event|1|||
130624793|NCT00510484|470246307|FG000|Wash-out Period|Adverse Event|0|||
130624794|NCT00510484|470246308|FG001|Wash-out Period|Adverse Event|1|||
130624795|NCT00340834|470246311|FG000|Core Phase of Study|Adverse Event|26|||
130624796|NCT00340834|470246312|FG001|Core Phase of Study|Adverse Event|9|||
130624797|NCT00340834|470246313|FG002|Core Phase of Study|Adverse Event|9|||
130624798|NCT00340834|470246314|FG003|Core Phase of Study|Adverse Event|0|||
130624799|NCT00340834|470246315|FG004|Core Phase of Study|Adverse Event|0|||
130624800|NCT00340834|470246311|FG000|Core Phase of Study|Withdrawal by Subject|11|||
130624801|NCT00340834|470246312|FG001|Core Phase of Study|Withdrawal by Subject|9|||
130624802|NCT00340834|470246313|FG002|Core Phase of Study|Withdrawal by Subject|16|||
130624803|NCT00340834|470246314|FG003|Core Phase of Study|Withdrawal by Subject|0|||
130624804|NCT00340834|470246315|FG004|Core Phase of Study|Withdrawal by Subject|0|||
130624805|NCT00340834|470246311|FG000|Core Phase of Study|Administrative Problems|6|||
130624806|NCT00340834|470246312|FG001|Core Phase of Study|Administrative Problems|2|||
130624807|NCT00340834|470246313|FG002|Core Phase of Study|Administrative Problems|7|||
130624808|NCT00340834|470246314|FG003|Core Phase of Study|Administrative Problems|0|||
130624809|NCT00340834|470246315|FG004|Core Phase of Study|Administrative Problems|0|||
130624810|NCT00340834|470246311|FG000|Core Phase of Study|Lack of Efficacy|3|||
130624811|NCT00340834|470246312|FG001|Core Phase of Study|Lack of Efficacy|3|||
130624812|NCT00340834|470246313|FG002|Core Phase of Study|Lack of Efficacy|7|||
130624813|NCT00340834|470246314|FG003|Core Phase of Study|Lack of Efficacy|0|||
130624814|NCT00340834|470246315|FG004|Core Phase of Study|Lack of Efficacy|0|||
130624815|NCT00340834|470246311|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
130624816|NCT00340834|470246312|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
130624817|NCT00340834|470246313|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
130624818|NCT00340834|470246314|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
130624819|NCT00340834|470246315|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
130624820|NCT00340834|470246311|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
130624821|NCT00340834|470246312|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
130624822|NCT00340834|470246313|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
130624823|NCT00340834|470246314|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
130624824|NCT00340834|470246315|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
130624825|NCT00340834|470246311|FG000|Core Phase of Study|Lost to Follow-up|1|||
130624826|NCT00340834|470246312|FG001|Core Phase of Study|Lost to Follow-up|1|||
130624827|NCT00340834|470246313|FG002|Core Phase of Study|Lost to Follow-up|4|||
130624828|NCT00340834|470246314|FG003|Core Phase of Study|Lost to Follow-up|0|||
130624829|NCT00340834|470246315|FG004|Core Phase of Study|Lost to Follow-up|0|||
130624830|NCT00340834|470246311|FG000|Core Phase of Study|Death|2|||
130624831|NCT00340834|470246312|FG001|Core Phase of Study|Death|0|||
130624832|NCT00340834|470246313|FG002|Core Phase of Study|Death|0|||
130624833|NCT00340834|470246314|FG003|Core Phase of Study|Death|0|||
130624834|NCT00340834|470246315|FG004|Core Phase of Study|Death|0|||
130624835|NCT00340834|470246311|FG000|Core Phase of Study|Protocol Violation|0|||
130624836|NCT00340834|470246312|FG001|Core Phase of Study|Protocol Violation|0|||
130624837|NCT00340834|470246313|FG002|Core Phase of Study|Protocol Violation|2|||
130624838|NCT00340834|470246314|FG003|Core Phase of Study|Protocol Violation|0|||
130624839|NCT00340834|470246315|FG004|Core Phase of Study|Protocol Violation|0|||
130624840|NCT00340834|470246311|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
130624841|NCT00340834|470246312|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
130624842|NCT00340834|470246313|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
130624843|NCT00340834|470246314|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
130624844|NCT00340834|470246315|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
130624845|NCT00340834|470246311|FG000|Extension Phase of Study|Subject withdrew consent|26|||
130624846|NCT00340834|470246312|FG001|Extension Phase of Study|Subject withdrew consent|31|||
130624847|NCT00340834|470246313|FG002|Extension Phase of Study|Subject withdrew consent|0|||
130624848|NCT00340834|470246314|FG003|Extension Phase of Study|Subject withdrew consent|12|||
130624849|NCT00340834|470246315|FG004|Extension Phase of Study|Subject withdrew consent|15|||
130624850|NCT00340834|470246311|FG000|Extension Phase of Study|Adverse Event|21|||
130624851|NCT00340834|470246312|FG001|Extension Phase of Study|Adverse Event|22|||
130624852|NCT00340834|470246313|FG002|Extension Phase of Study|Adverse Event|0|||
130624853|NCT00340834|470246314|FG003|Extension Phase of Study|Adverse Event|19|||
130624854|NCT00340834|470246315|FG004|Extension Phase of Study|Adverse Event|7|||
130624855|NCT00340834|470246311|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
130624856|NCT00340834|470246312|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
130624857|NCT00340834|470246313|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
130624858|NCT00340834|470246314|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
130624859|NCT00340834|470246315|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
130624860|NCT00340834|470246311|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
130624861|NCT00340834|470246312|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
130624862|NCT00340834|470246313|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
130624863|NCT00340834|470246314|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
130624864|NCT00340834|470246315|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
130624865|NCT00340834|470246311|FG000|Extension Phase of Study|Lost to Follow-up|1|||
130624866|NCT00340834|470246312|FG001|Extension Phase of Study|Lost to Follow-up|1|||
130624867|NCT00340834|470246313|FG002|Extension Phase of Study|Lost to Follow-up|0|||
130624868|NCT00340834|470246314|FG003|Extension Phase of Study|Lost to Follow-up|2|||
130624869|NCT00340834|470246315|FG004|Extension Phase of Study|Lost to Follow-up|3|||
130624870|NCT00340834|470246311|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
130624871|NCT00340834|470246312|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
130624872|NCT00340834|470246313|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
130624873|NCT00340834|470246314|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
130624874|NCT00340834|470246315|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
130624875|NCT00340834|470246311|FG000|Extension Phase of Study|Administrative problems|3|||
130624876|NCT00340834|470246312|FG001|Extension Phase of Study|Administrative problems|0|||
130624877|NCT00340834|470246313|FG002|Extension Phase of Study|Administrative problems|0|||
130624878|NCT00340834|470246314|FG003|Extension Phase of Study|Administrative problems|1|||
130624879|NCT00340834|470246315|FG004|Extension Phase of Study|Administrative problems|1|||
130624880|NCT00340834|470246311|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130624881|NCT00340834|470246312|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
130624882|NCT00340834|470246313|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130624883|NCT00340834|470246314|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130624884|NCT00340834|470246315|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
130624885|NCT00340834|470246311|FG000|Extension Phase of Study|Protocol Violation|3|||
130624886|NCT00340834|470246312|FG001|Extension Phase of Study|Protocol Violation|0|||
130624887|NCT00340834|470246313|FG002|Extension Phase of Study|Protocol Violation|0|||
130624888|NCT00340834|470246314|FG003|Extension Phase of Study|Protocol Violation|0|||
130624889|NCT00340834|470246315|FG004|Extension Phase of Study|Protocol Violation|0|||
130624890|NCT00340834|470246311|FG000|Extension Phase of Study|Death|0|||
130624891|NCT00340834|470246312|FG001|Extension Phase of Study|Death|0|||
130624892|NCT00340834|470246313|FG002|Extension Phase of Study|Death|0|||
130624893|NCT00340834|470246314|FG003|Extension Phase of Study|Death|0|||
130624894|NCT00340834|470246315|FG004|Extension Phase of Study|Death|1|||
130624895|NCT00762268|470246316|FG000|Overall Study|Withdrawal by Subject|3|||
130624896|NCT00762268|470246317|FG001|Overall Study|Withdrawal by Subject|3|||
130624897|NCT01143714|470246321|FG000|Overall Study|Adverse Event|4|||
130624898|NCT01143714|470246322|FG001|Overall Study|Adverse Event|2|||
130624899|NCT01143714|470246321|FG000|Overall Study|Withdrawal by Subject|1|||
130624900|NCT01143714|470246322|FG001|Overall Study|Withdrawal by Subject|0|||
130624901|NCT01143714|470246321|FG000|Overall Study|Subject non-compliance|0|||
130624902|NCT01143714|470246322|FG001|Overall Study|Subject non-compliance|1|||
130624903|NCT01143714|470246321|FG000|Overall Study|wound closed = deemed healed|1|||
130624904|NCT01143714|470246322|FG001|Overall Study|wound closed = deemed healed|0|||
130624905|NCT01143714|470246321|FG000|Overall Study|wound size increased|1|||
130624906|NCT01143714|470246322|FG001|Overall Study|wound size increased|0|||
130624907|NCT01387074|470246325|FG000|Overall Study|Lost to Follow-up|7|||
130624908|NCT01387074|470246325|FG000|Overall Study|Lack of Efficacy|1|||
130624909|NCT00150345|470246326|FG000|Overall Study|Death|5|||
130624910|NCT00150345|470246327|FG001|Overall Study|Death|2|||
130624911|NCT00150345|470246326|FG000|Overall Study|Adverse Event|8|||
130624912|NCT00150345|470246327|FG001|Overall Study|Adverse Event|6|||
130624913|NCT00150345|470246326|FG000|Overall Study|Lack of Efficacy|5|||
130624914|NCT00150345|470246327|FG001|Overall Study|Lack of Efficacy|4|||
130624915|NCT00150345|470246326|FG000|Overall Study|Withdrawal by Subject|3|||
130624916|NCT00150345|470246327|FG001|Overall Study|Withdrawal by Subject|4|||
130624917|NCT00150345|470246326|FG000|Overall Study|Laboratory abnormality|1|||
130624918|NCT00150345|470246327|FG001|Overall Study|Laboratory abnormality|2|||
130624919|NCT00150345|470246326|FG000|Overall Study|Other|12|||
130624920|NCT00150345|470246327|FG001|Overall Study|Other|14|||
130624921|NCT03892707|470246334|FG000|Overall Study|Screen failure|6|||
130624922|NCT03892707|470246335|FG001|Overall Study|Screen failure|0|||
130624923|NCT03892707|470246334|FG000|Overall Study|Pain resolution|0|||
130624924|NCT03892707|470246335|FG001|Overall Study|Pain resolution|4|||
130624925|NCT03892707|470246334|FG000|Overall Study|Withdrawal by Subject|0|||
130624926|NCT03892707|470246335|FG001|Overall Study|Withdrawal by Subject|1|||
130624927|NCT03892707|470246334|FG000|Overall Study|Other (long business trip)|0|||
130624928|NCT03892707|470246335|FG001|Overall Study|Other (long business trip)|1|||
130624929|NCT01807949|470246336|FG000|Overall Study|Adverse Event|1|||
130624930|NCT01807949|470246337|FG001|Overall Study|Adverse Event|2|||
130624931|NCT01807949|470246338|FG002|Overall Study|Adverse Event|2|||
130624932|NCT01807949|470246336|FG000|Overall Study|Withdrawal by Subject|1|||
130624933|NCT01807949|470246337|FG001|Overall Study|Withdrawal by Subject|2|||
130624934|NCT01807949|470246338|FG002|Overall Study|Withdrawal by Subject|2|||
130624935|NCT01807949|470246336|FG000|Overall Study|Non-Compliance|0|||
130624936|NCT01807949|470246337|FG001|Overall Study|Non-Compliance|0|||
130624937|NCT01807949|470246338|FG002|Overall Study|Non-Compliance|1|||
130624938|NCT01807949|470246336|FG000|Overall Study|Undefined|0|||
130624939|NCT01807949|470246337|FG001|Overall Study|Undefined|1|||
130624940|NCT01807949|470246338|FG002|Overall Study|Undefined|2|||
130624941|NCT01807949|470246336|FG000|Overall Study|Randomized But Not Treated|0|||
130624942|NCT01807949|470246337|FG001|Overall Study|Randomized But Not Treated|2|||
130624943|NCT01807949|470246338|FG002|Overall Study|Randomized But Not Treated|2|||
130624944|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
130624945|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
130624946|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
130624947|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
130624948|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
130624949|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130624950|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130624951|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130624952|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130624953|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
130624954|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
130624955|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130624956|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130624957|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130624958|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130624959|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
130624960|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130624961|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
130624962|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130624963|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130624964|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130624965|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130624966|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130624967|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
130624968|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
130624969|NCT01457924|470246339|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
130624970|NCT01457924|470246340|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
130624971|NCT01457924|470246341|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
130624972|NCT01457924|470246342|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
130624973|NCT01457924|470246343|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
130624974|NCT01457924|470246339|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
130624975|NCT01457924|470246340|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
130624976|NCT01457924|470246341|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
130624977|NCT01457924|470246342|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
130624978|NCT01457924|470246343|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
130624979|NCT01457924|470246339|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
130624980|NCT01457924|470246340|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
130624981|NCT01457924|470246341|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
130624982|NCT01457924|470246342|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
130624983|NCT01457924|470246343|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
130624984|NCT01457924|470246339|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130624985|NCT01457924|470246340|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130624986|NCT01457924|470246341|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130624987|NCT01457924|470246342|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
130624988|NCT01457924|470246343|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130624989|NCT01457924|470246339|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
130624990|NCT01457924|470246340|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
130624991|NCT01457924|470246341|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
130624992|NCT01457924|470246342|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
130624993|NCT01457924|470246343|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
130624994|NCT01457924|470246339|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
130624995|NCT01457924|470246340|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130624996|NCT01457924|470246341|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
130624997|NCT01457924|470246342|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130624998|NCT01457924|470246343|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130624999|NCT01457924|470246339|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
130625000|NCT01457924|470246340|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
130625001|NCT01457924|470246341|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
130625002|NCT01457924|470246342|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
130625003|NCT01457924|470246343|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
130625004|NCT01457924|470246339|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130625005|NCT01457924|470246340|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
130625006|NCT01457924|470246341|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130625007|NCT01457924|470246342|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
130625008|NCT01457924|470246343|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130625009|NCT01181141|470246344|FG000|Overall Study|Adverse Event|2|||
130625010|NCT01181141|470246345|FG001|Overall Study|Adverse Event|1|||
130625011|NCT01181141|470246344|FG000|Overall Study|Lack of Efficacy|1|||
130625012|NCT01181141|470246345|FG001|Overall Study|Lack of Efficacy|0|||
130625013|NCT01181141|470246344|FG000|Overall Study|Lost to Follow-up|1|||
130625014|NCT01181141|470246345|FG001|Overall Study|Lost to Follow-up|1|||
130625015|NCT01181141|470246344|FG000|Overall Study|Physician Decision|2|||
130625016|NCT01181141|470246345|FG001|Overall Study|Physician Decision|0|||
130625017|NCT01181141|470246344|FG000|Overall Study|Protocol Violation|3|||
130625018|NCT01181141|470246345|FG001|Overall Study|Protocol Violation|1|||
130625019|NCT01181141|470246344|FG000|Overall Study|Withdrawal by Subject|3|||
130625020|NCT01181141|470246345|FG001|Overall Study|Withdrawal by Subject|1|||
130625021|NCT00290589|470246346|FG000|Overall Study|Lost to Follow-up|2|||
130625022|NCT00290589|470246347|FG001|Overall Study|Lost to Follow-up|2|||
130625023|NCT00118911|470246348|FG000|Overall Study|Withdrawal by Subject|2|||
130625024|NCT00118911|470246349|FG001|Overall Study|Withdrawal by Subject|5|||
130625025|NCT01438307|470246350|FG000|Overall Study|Death|1|||
130625026|NCT01438307|470246351|FG001|Overall Study|Death|1|||
130625027|NCT00973622|470246353|FG000|Overall Study|did not attend MRI|14|||
130625028|NCT00973622|470246354|FG001|Overall Study|did not attend MRI|3|||
130625029|NCT00973622|470246353|FG000|Overall Study|did not pass MRI screen|6|||
130625030|NCT00973622|470246354|FG001|Overall Study|did not pass MRI screen|0|||
130625031|NCT00973622|470246353|FG000|Overall Study|did not complete rTMS sessions|11|||
130625032|NCT00973622|470246354|FG001|Overall Study|did not complete rTMS sessions|2|||
130625033|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
130625034|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
130625035|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
130625036|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
130625037|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
130625038|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
130625039|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
130625040|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
130625041|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
130625042|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
130625043|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
130625044|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
130625045|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
130625046|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
130625047|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
130625048|NCT03814005|470246358|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
130625049|NCT03814005|470246359|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
130625050|NCT03814005|470246360|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
130625051|NCT03395223|470246361|FG000|Overall Study|Lost to Follow-up|3|||
130625052|NCT03395223|470246361|FG000|Overall Study|Other|1|||
130625053|NCT01855945|470246367|FG000|Overall Study|Adverse Event|0|||
130625054|NCT01855945|470246368|FG001|Overall Study|Adverse Event|0|||
130625055|NCT01855945|470246369|FG002|Overall Study|Adverse Event|0|||
130625056|NCT01855945|470246370|FG003|Overall Study|Adverse Event|0|||
130625057|NCT01855945|470246371|FG004|Overall Study|Adverse Event|0|||
130625058|NCT01855945|470246372|FG005|Overall Study|Adverse Event|0|||
130625059|NCT01855945|470246373|FG006|Overall Study|Adverse Event|1|||
130625060|NCT01855945|470246374|FG007|Overall Study|Adverse Event|0|||
130625061|NCT01855945|470246375|FG008|Overall Study|Adverse Event|0|||
130625062|NCT01855945|470246376|FG009|Overall Study|Adverse Event|0|||
130625063|NCT01855945|470246377|FG010|Overall Study|Adverse Event|0|||
130625064|NCT01855945|470246378|FG011|Overall Study|Adverse Event|0|||
130625065|NCT01855945|470246367|FG000|Overall Study|Death|0|||
130625066|NCT01855945|470246368|FG001|Overall Study|Death|0|||
130625067|NCT01855945|470246369|FG002|Overall Study|Death|0|||
130625068|NCT01855945|470246370|FG003|Overall Study|Death|0|||
130625069|NCT01855945|470246371|FG004|Overall Study|Death|0|||
130625070|NCT01855945|470246372|FG005|Overall Study|Death|0|||
130625071|NCT01855945|470246373|FG006|Overall Study|Death|2|||
130625072|NCT01855945|470246374|FG007|Overall Study|Death|0|||
130625073|NCT01855945|470246375|FG008|Overall Study|Death|0|||
130625074|NCT01855945|470246376|FG009|Overall Study|Death|0|||
130625075|NCT01855945|470246377|FG010|Overall Study|Death|0|||
130625076|NCT01855945|470246378|FG011|Overall Study|Death|0|||
130625077|NCT01855945|470246367|FG000|Overall Study|Lost to Follow-up|11|||
130625078|NCT01855945|470246368|FG001|Overall Study|Lost to Follow-up|10|||
130625079|NCT01855945|470246369|FG002|Overall Study|Lost to Follow-up|7|||
130625080|NCT01855945|470246370|FG003|Overall Study|Lost to Follow-up|3|||
130625081|NCT01855945|470246371|FG004|Overall Study|Lost to Follow-up|0|||
130625082|NCT01855945|470246372|FG005|Overall Study|Lost to Follow-up|3|||
130625083|NCT01855945|470246373|FG006|Overall Study|Lost to Follow-up|4|||
130625084|NCT01855945|470246374|FG007|Overall Study|Lost to Follow-up|7|||
130625085|NCT01855945|470246375|FG008|Overall Study|Lost to Follow-up|2|||
130625086|NCT01855945|470246376|FG009|Overall Study|Lost to Follow-up|0|||
130625087|NCT01855945|470246377|FG010|Overall Study|Lost to Follow-up|0|||
130625088|NCT01855945|470246378|FG011|Overall Study|Lost to Follow-up|2|||
130625089|NCT01855945|470246367|FG000|Overall Study|Other - Unclassified|1|||
130625090|NCT01855945|470246368|FG001|Overall Study|Other - Unclassified|1|||
130625091|NCT01855945|470246369|FG002|Overall Study|Other - Unclassified|1|||
130625092|NCT01855945|470246370|FG003|Overall Study|Other - Unclassified|0|||
130625093|NCT01855945|470246371|FG004|Overall Study|Other - Unclassified|0|||
130625094|NCT01855945|470246372|FG005|Overall Study|Other - Unclassified|0|||
130625095|NCT01855945|470246373|FG006|Overall Study|Other - Unclassified|2|||
130625096|NCT01855945|470246374|FG007|Overall Study|Other - Unclassified|1|||
130625097|NCT01855945|470246375|FG008|Overall Study|Other - Unclassified|0|||
130625098|NCT01855945|470246376|FG009|Overall Study|Other - Unclassified|0|||
130625099|NCT01855945|470246377|FG010|Overall Study|Other - Unclassified|1|||
130625100|NCT01855945|470246378|FG011|Overall Study|Other - Unclassified|0|||
130625101|NCT01855945|470246367|FG000|Overall Study|Withdrawal by Subject|4|||
130625102|NCT01855945|470246368|FG001|Overall Study|Withdrawal by Subject|0|||
130625103|NCT01855945|470246369|FG002|Overall Study|Withdrawal by Subject|4|||
130625104|NCT01855945|470246370|FG003|Overall Study|Withdrawal by Subject|1|||
130625105|NCT01855945|470246371|FG004|Overall Study|Withdrawal by Subject|1|||
130625106|NCT01855945|470246372|FG005|Overall Study|Withdrawal by Subject|0|||
130625107|NCT01855945|470246373|FG006|Overall Study|Withdrawal by Subject|1|||
130625108|NCT01855945|470246374|FG007|Overall Study|Withdrawal by Subject|0|||
130625109|NCT01855945|470246375|FG008|Overall Study|Withdrawal by Subject|0|||
130625110|NCT01855945|470246376|FG009|Overall Study|Withdrawal by Subject|2|||
130625111|NCT01855945|470246377|FG010|Overall Study|Withdrawal by Subject|4|||
130625112|NCT01855945|470246378|FG011|Overall Study|Withdrawal by Subject|1|||
130625113|NCT01135017|470246379|FG000|Overall Study|Adverse Event|3|||
130625114|NCT01135017|470246380|FG001|Overall Study|Adverse Event|8|||
130625115|NCT01135017|470246379|FG000|Overall Study|Other than above|3|||
130625116|NCT01135017|470246380|FG001|Overall Study|Other than above|4|||
130625117|NCT01148693|470246381|FG000|Overall Study|Attempts for cannulation were failed|13|||
130625118|NCT01148693|470246382|FG001|Overall Study|Attempts for cannulation were failed|10|||
130625119|NCT01074658|470246384|FG000|Overall Study|No implant attempted|19|||
130625120|NCT01342952|470246385|FG000|Overall Study|Adverse Event|0|||
130625121|NCT01342952|470246386|FG001|Overall Study|Adverse Event|5|||
130625122|NCT01342952|470246387|FG002|Overall Study|Adverse Event|1|||
130625123|NCT01342952|470246388|FG003|Overall Study|Adverse Event|0|||
130625124|NCT01342952|470246385|FG000|Overall Study|Lost to Follow-up|0|||
130625125|NCT01342952|470246386|FG001|Overall Study|Lost to Follow-up|2|||
130625126|NCT01342952|470246387|FG002|Overall Study|Lost to Follow-up|0|||
130625127|NCT01342952|470246388|FG003|Overall Study|Lost to Follow-up|0|||
130625128|NCT01342952|470246385|FG000|Overall Study|Withdrawal by Subject|1|||
130625129|NCT01342952|470246386|FG001|Overall Study|Withdrawal by Subject|1|||
130625130|NCT01342952|470246387|FG002|Overall Study|Withdrawal by Subject|0|||
130625131|NCT01342952|470246388|FG003|Overall Study|Withdrawal by Subject|0|||
130625132|NCT01342952|470246385|FG000|Overall Study|Physician Decision|3|||
130625133|NCT01342952|470246386|FG001|Overall Study|Physician Decision|3|||
130625134|NCT01342952|470246387|FG002|Overall Study|Physician Decision|1|||
130625135|NCT01342952|470246388|FG003|Overall Study|Physician Decision|0|||
130625136|NCT01162304|470246391|FG000|Overall Study|Beck scale to high|11|||
130625137|NCT03505749|470246394|FG000|Overall Study|Lost to Follow-up|7|||
130625138|NCT03505749|470246395|FG001|Overall Study|Lost to Follow-up|11|||
130625139|NCT03505749|470246394|FG000|Overall Study|Withdrawal by Subject|6|||
130625140|NCT03505749|470246395|FG001|Overall Study|Withdrawal by Subject|0|||
130625141|NCT03505749|470246394|FG000|Overall Study|Discharged from treatment|3|||
130625142|NCT03505749|470246395|FG001|Overall Study|Discharged from treatment|6|||
130625143|NCT03549117|470246399|FG000|Overall Study|Withdrawal by Subject|1|||
130625144|NCT03549117|470246400|FG001|Overall Study|Withdrawal by Subject|0|||
130625145|NCT00888615|470246401|FG000|Overall Study|No treatment|2|||
130625146|NCT02091921|470246404|FG000|Overall Study|Adverse Event|3|||
130625147|NCT03307629|470246405|FG000|Overall Study|Withdrawal by Subject|0|||
130625148|NCT03307629|470246406|FG001|Overall Study|Withdrawal by Subject|0|||
130625149|NCT03307629|470246407|FG002|Overall Study|Withdrawal by Subject|0|||
130625150|NCT03307629|470246408|FG003|Overall Study|Withdrawal by Subject|2|||
130625151|NCT03307629|470246405|FG000|Overall Study|Disease Progression|0|||
130625152|NCT03307629|470246406|FG001|Overall Study|Disease Progression|0|||
130625153|NCT03307629|470246407|FG002|Overall Study|Disease Progression|0|||
130625154|NCT03307629|470246408|FG003|Overall Study|Disease Progression|3|||
130625155|NCT03307629|470246405|FG000|Overall Study|Death|0|||
130625156|NCT03307629|470246406|FG001|Overall Study|Death|3|||
130625157|NCT03307629|470246407|FG002|Overall Study|Death|0|||
130625158|NCT03307629|470246408|FG003|Overall Study|Death|1|||
130625159|NCT00719953|470246413|FG000|Overall Study|Adverse Event|4|||
130625160|NCT01626989|470246414|FG000|Screening Period|Screen Failure|15|||
130625161|NCT01626989|470246415|FG001|Screening Period|Screen Failure|0|||
130625162|NCT01626989|470246416|FG002|Screening Period|Screen Failure|0|||
130625163|NCT01626989|470246414|FG000|Screening Period|Withdrawal by Subject|2|||
130625164|NCT01626989|470246415|FG001|Screening Period|Withdrawal by Subject|0|||
130625165|NCT01626989|470246416|FG002|Screening Period|Withdrawal by Subject|0|||
130625166|NCT02947022|470246420|FG000|Overall Study|Study Stopped|1|||
130625167|NCT01230749|470246421|FG000|Overall Study|Adverse Event|0|||
130625168|NCT01230749|470246422|FG001|Overall Study|Adverse Event|0|||
130625169|NCT01230749|470246423|FG002|Overall Study|Adverse Event|0|||
130625170|NCT01230749|470246424|FG003|Overall Study|Adverse Event|1|||
130625171|NCT01230749|470246421|FG000|Overall Study|Physician Decision|0|||
130625172|NCT01230749|470246422|FG001|Overall Study|Physician Decision|0|||
130625173|NCT01230749|470246423|FG002|Overall Study|Physician Decision|1|||
130625174|NCT01230749|470246424|FG003|Overall Study|Physician Decision|0|||
130625175|NCT01230749|470246421|FG000|Overall Study|Withdrawal by Subject|0|||
130625176|NCT01230749|470246422|FG001|Overall Study|Withdrawal by Subject|1|||
130625177|NCT01230749|470246423|FG002|Overall Study|Withdrawal by Subject|0|||
130625178|NCT01230749|470246424|FG003|Overall Study|Withdrawal by Subject|0|||
130625179|NCT01230749|470246421|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
130625180|NCT01230749|470246422|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
130625181|NCT01230749|470246423|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
130625182|NCT01230749|470246424|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
130648354|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
130648355|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
130648356|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
130648357|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
130648358|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
130648359|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
130648360|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
130648361|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
130648362|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
130648363|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
130648364|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
130648365|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
130648366|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648367|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648368|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648369|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648370|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648371|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648372|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
130648373|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648374|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648375|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648376|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648377|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130648378|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648379|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648380|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
130648381|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648382|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648383|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648384|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648385|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648386|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648387|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648388|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648389|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130648390|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648391|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130625183|NCT04021706|470248140|FG000|Overall Study|Adverse Event|2|||
130625184|NCT04021706|470248141|FG001|Overall Study|Adverse Event|0|||
130625185|NCT04021706|470248140|FG000|Overall Study|Withdrawal by Subject|1|||
130625186|NCT04021706|470248141|FG001|Overall Study|Withdrawal by Subject|2|||
130625187|NCT04021706|470248140|FG000|Overall Study|Physician Decision|1|||
130625188|NCT04021706|470248141|FG001|Overall Study|Physician Decision|0|||
130625189|NCT01412151|470248142|FG000|Week 0 - 306 - Treatment Period|Death|1|||
130625190|NCT01412151|470248142|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
130625191|NCT01412151|470248142|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
130625192|NCT01412151|470248142|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
130625193|NCT03127852|470248144|FG000|Overall Study|Withdrawal by Subject|4|||
130625194|NCT03127852|470248145|FG001|Overall Study|Withdrawal by Subject|1|||
130625195|NCT03127852|470248144|FG000|Overall Study|Death|1|||
130625196|NCT03127852|470248145|FG001|Overall Study|Death|1|||
130625197|NCT00859573|470248147|FG000|Overall Study|Withdrawal by Subject|4|||
130625198|NCT00859573|470248148|FG001|Overall Study|Withdrawal by Subject|1|||
130625199|NCT00859573|470248147|FG000|Overall Study|Physician Decision|1|||
130625200|NCT00859573|470248148|FG001|Overall Study|Physician Decision|1|||
130625201|NCT01432457|470248149|FG000|Overall Study|Adverse Event|7|||
130625202|NCT01432457|470248150|FG001|Overall Study|Adverse Event|10|||
130625203|NCT01432457|470248151|FG002|Overall Study|Adverse Event|16|||
130625204|NCT01432457|470248149|FG000|Overall Study|Lack of Efficacy|2|||
130625205|NCT01432457|470248150|FG001|Overall Study|Lack of Efficacy|1|||
130625206|NCT01432457|470248151|FG002|Overall Study|Lack of Efficacy|1|||
130625207|NCT01432457|470248149|FG000|Overall Study|Lost to Follow-up|11|||
130625208|NCT01432457|470248150|FG001|Overall Study|Lost to Follow-up|15|||
130625209|NCT01432457|470248151|FG002|Overall Study|Lost to Follow-up|20|||
130625210|NCT01432457|470248149|FG000|Overall Study|Protocol Violation|3|||
130625211|NCT01432457|470248150|FG001|Overall Study|Protocol Violation|2|||
130625212|NCT01432457|470248151|FG002|Overall Study|Protocol Violation|6|||
130625213|NCT01432457|470248149|FG000|Overall Study|Withdrawal by Subject|6|||
130625214|NCT01432457|470248150|FG001|Overall Study|Withdrawal by Subject|11|||
130625215|NCT01432457|470248151|FG002|Overall Study|Withdrawal by Subject|9|||
130625216|NCT01432457|470248149|FG000|Overall Study|Reasons not defined|2|||
130625217|NCT01432457|470248150|FG001|Overall Study|Reasons not defined|3|||
130625218|NCT01432457|470248151|FG002|Overall Study|Reasons not defined|4|||
130625219|NCT01432457|470248149|FG000|Overall Study|Did not take study drug|6|||
130625220|NCT01432457|470248150|FG001|Overall Study|Did not take study drug|6|||
130625221|NCT01432457|470248151|FG002|Overall Study|Did not take study drug|3|||
130625222|NCT02574481|470248152|FG000|Overall Study|Withdrawal by Subject|29|||
130625223|NCT02574481|470248153|FG001|Overall Study|Withdrawal by Subject|15|||
130625224|NCT02574481|470248154|FG002|Overall Study|Withdrawal by Subject|4|||
130625225|NCT02574481|470248155|FG003|Overall Study|Withdrawal by Subject|1|||
130625226|NCT02574481|470248152|FG000|Overall Study|Adverse Event|5|||
130625227|NCT02574481|470248153|FG001|Overall Study|Adverse Event|1|||
130625228|NCT02574481|470248154|FG002|Overall Study|Adverse Event|1|||
130625229|NCT02574481|470248155|FG003|Overall Study|Adverse Event|0|||
130625230|NCT02574481|470248152|FG000|Overall Study|Visit Missed|15|||
130625231|NCT02574481|470248153|FG001|Overall Study|Visit Missed|7|||
130625232|NCT02574481|470248154|FG002|Overall Study|Visit Missed|5|||
130625233|NCT02574481|470248155|FG003|Overall Study|Visit Missed|0|||
130625234|NCT02574481|470248152|FG000|Overall Study|Other|7|||
130625235|NCT02574481|470248153|FG001|Overall Study|Other|2|||
130625236|NCT02574481|470248154|FG002|Overall Study|Other|0|||
130625237|NCT02574481|470248155|FG003|Overall Study|Other|0|||
130625238|NCT02574481|470248152|FG000|Overall Study|Death|48|||
130625239|NCT02574481|470248153|FG001|Overall Study|Death|26|||
130625240|NCT02574481|470248154|FG002|Overall Study|Death|12|||
130625241|NCT02574481|470248155|FG003|Overall Study|Death|4|||
130625242|NCT02574481|470248152|FG000|Overall Study|Physician Decision|5|||
130625243|NCT02574481|470248153|FG001|Overall Study|Physician Decision|2|||
130625244|NCT02574481|470248154|FG002|Overall Study|Physician Decision|0|||
130625245|NCT02574481|470248155|FG003|Overall Study|Physician Decision|0|||
130625246|NCT02574481|470248152|FG000|Overall Study|Lost to Follow-up|5|||
130625247|NCT02574481|470248153|FG001|Overall Study|Lost to Follow-up|1|||
130625248|NCT02574481|470248154|FG002|Overall Study|Lost to Follow-up|3|||
130625249|NCT02574481|470248155|FG003|Overall Study|Lost to Follow-up|0|||
130625250|NCT02905825|470248160|FG000|Overall Study|Protocol Violation|11|||
130625251|NCT02905825|470248160|FG000|Overall Study|Device Malfunction|1|||
130625252|NCT01281189|470248161|FG000|Overall Study|Adverse Event|7|||
130625253|NCT01281189|470248162|FG001|Overall Study|Adverse Event|9|||
130625254|NCT01281189|470248161|FG000|Overall Study|Lost to Follow-up|6|||
130625255|NCT01281189|470248162|FG001|Overall Study|Lost to Follow-up|4|||
130625256|NCT01281189|470248161|FG000|Overall Study|Withdrawal by Subject|21|||
130625257|NCT01281189|470248162|FG001|Overall Study|Withdrawal by Subject|24|||
130625258|NCT01281189|470248161|FG000|Overall Study|Physician Decision|2|||
130625259|NCT01281189|470248162|FG001|Overall Study|Physician Decision|3|||
130625260|NCT01281189|470248161|FG000|Overall Study|Death|103|||
130625261|NCT01281189|470248162|FG001|Overall Study|Death|91|||
130625262|NCT01281189|470248161|FG000|Overall Study|Other|8|||
130625263|NCT01281189|470248162|FG001|Overall Study|Other|12|||
130625264|NCT01136746|470248163|FG000|Overall Study|Lost to Follow-up|0|||
130625265|NCT01136746|470248164|FG001|Overall Study|Lost to Follow-up|2|||
130625266|NCT01136746|470248163|FG000|Overall Study|Protocol Violation|2|||
130625267|NCT01136746|470248164|FG001|Overall Study|Protocol Violation|1|||
130625268|NCT01136746|470248163|FG000|Overall Study|Death|1|||
130625269|NCT01136746|470248164|FG001|Overall Study|Death|0|||
130625270|NCT01090102|470248170|FG000|First 12 Weeks|Withdrawal by Subject|1|||
130625271|NCT01090102|470248171|FG001|First 12 Weeks|Withdrawal by Subject|1|||
130625272|NCT01090102|470248170|FG000|First 12 Weeks|Adverse Event|2|||
130625273|NCT01090102|470248171|FG001|First 12 Weeks|Adverse Event|0|||
130625274|NCT01090102|470248170|FG000|First 12 Weeks|Death|1|||
130625275|NCT01090102|470248171|FG001|First 12 Weeks|Death|1|||
130625276|NCT01090102|470248170|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
130625277|NCT01090102|470248171|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
130625278|NCT03518034|470248172|FG000|Overall Study|Not Treated|5|||
130625279|NCT03518034|470248173|FG001|Overall Study|Not Treated|1|||
130625280|NCT03518034|470248172|FG000|Overall Study|Withdrawal by Subject|309|||
130625281|NCT03518034|470248173|FG001|Overall Study|Withdrawal by Subject|351|||
130625282|NCT03518034|470248172|FG000|Overall Study|Lost to Follow-up|446|||
130625283|NCT03518034|470248173|FG001|Overall Study|Lost to Follow-up|458|||
130625284|NCT03518034|470248172|FG000|Overall Study|Adverse Event|138|||
130625285|NCT03518034|470248173|FG001|Overall Study|Adverse Event|130|||
130625286|NCT03518034|470248172|FG000|Overall Study|Lack of Efficacy|11|||
130625287|NCT03518034|470248173|FG001|Overall Study|Lack of Efficacy|23|||
130625288|NCT03518034|470248172|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
130625289|NCT03518034|470248173|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
130625290|NCT03518034|470248172|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
130625291|NCT03518034|470248173|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
130625292|NCT03518034|470248172|FG000|Overall Study|Other, Not Specified|84|||
130625293|NCT03518034|470248173|FG001|Overall Study|Other, Not Specified|53|||
130625294|NCT03518034|470248172|FG000|Overall Study|Reason Missing|2|||
130625295|NCT03518034|470248173|FG001|Overall Study|Reason Missing|3|||
130625296|NCT00010803|470248179|FG000|Overall Study|Withdrawal by Subject|97|||
130625297|NCT00010803|470248180|FG001|Overall Study|Withdrawal by Subject|98|||
130625298|NCT01019252|470248181|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
130625299|NCT01019252|470248182|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
130625300|NCT01019252|470248181|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
130625301|NCT01019252|470248182|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
130625302|NCT01019252|470248181|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
130625303|NCT01019252|470248182|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
130625304|NCT01019252|470248181|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
130625305|NCT01019252|470248182|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
130625306|NCT02273037|470248183|FG000|Overall Study|Lost to Follow-up|1|||
130625307|NCT02273037|470248184|FG001|Overall Study|Lost to Follow-up|0|||
130625308|NCT02273037|470248183|FG000|Overall Study|Delivered before monitoring initiated|1|||
130625309|NCT02273037|470248184|FG001|Overall Study|Delivered before monitoring initiated|3|||
130625310|NCT02273037|470248183|FG000|Overall Study|Breech delivery|2|||
130625311|NCT02273037|470248184|FG001|Overall Study|Breech delivery|3|||
130625312|NCT02273037|470248183|FG000|Overall Study|Multiple delivery|2|||
130625313|NCT02273037|470248184|FG001|Overall Study|Multiple delivery|2|||
130625314|NCT02273037|470248183|FG000|Overall Study|Other complication|2|||
130625315|NCT02273037|470248184|FG001|Overall Study|Other complication|0|||
130625316|NCT03351478|470248187|FG000|Overall Study|At the subject's own request|11|||
130625317|NCT03351478|470248188|FG001|Overall Study|At the subject's own request|12|||
130625318|NCT03351478|470248189|FG002|Overall Study|At the subject's own request|5|||
130625319|NCT03351478|470248187|FG000|Overall Study|Adverse Event|1|||
130625320|NCT03351478|470248188|FG001|Overall Study|Adverse Event|2|||
130625321|NCT03351478|470248189|FG002|Overall Study|Adverse Event|1|||
130625322|NCT03351478|470248187|FG000|Overall Study|Poor compliance to protocol|1|||
130625323|NCT03351478|470248188|FG001|Overall Study|Poor compliance to protocol|0|||
130625324|NCT03351478|470248189|FG002|Overall Study|Poor compliance to protocol|0|||
130625325|NCT03351478|470248187|FG000|Overall Study|Reason not Specified|1|||
130625326|NCT03351478|470248188|FG001|Overall Study|Reason not Specified|3|||
130625327|NCT03351478|470248189|FG002|Overall Study|Reason not Specified|0|||
130625328|NCT03351478|470248187|FG000|Overall Study|Lost to Follow-up|0|||
130625329|NCT03351478|470248188|FG001|Overall Study|Lost to Follow-up|0|||
130625330|NCT03351478|470248189|FG002|Overall Study|Lost to Follow-up|1|||
130625331|NCT00985738|470248191|FG000|Overall Study|Study closed prematurely|8|||
130625332|NCT00985738|470248192|FG001|Overall Study|Study closed prematurely|8|||
130625333|NCT02227849|470248196|FG000|Overall Study|Adverse Event|4|||
130625334|NCT02227849|470248196|FG000|Overall Study|Physician Decision|1|||
130625335|NCT02227849|470248196|FG000|Overall Study|Withdrawal by Subject|3|||
130625336|NCT01590212|470248199|FG000|Overall Study|Withdrawal by Subject|2|||
130625337|NCT01590212|470248200|FG001|Overall Study|Withdrawal by Subject|2|||
130625338|NCT01590212|470248201|FG002|Overall Study|Withdrawal by Subject|2|||
130625339|NCT01590212|470248199|FG000|Overall Study|Lost to Follow-up|1|||
130625340|NCT01590212|470248200|FG001|Overall Study|Lost to Follow-up|2|||
130625341|NCT01590212|470248201|FG002|Overall Study|Lost to Follow-up|3|||
130625342|NCT02533401|470248202|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
130625343|NCT02533401|470248202|FG000|Overall Study|Death|5|||
130625344|NCT02533401|470248202|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
130625345|NCT02533401|470248202|FG000|Overall Study|Lost to Follow-up|1|||
130625346|NCT02533401|470248202|FG000|Overall Study|Violation of Selection Criteria|1|||
130625347|NCT04897594|470248205|FG000|Overall Study|Lost to Follow-up|0|||
130625348|NCT04897594|470248206|FG001|Overall Study|Lost to Follow-up|1|||
130625349|NCT04897594|470248207|FG002|Overall Study|Lost to Follow-up|1|||
130625350|NCT04897594|470248205|FG000|Overall Study|Sponsor Decision|0|||
130625351|NCT04897594|470248206|FG001|Overall Study|Sponsor Decision|0|||
130625352|NCT04897594|470248207|FG002|Overall Study|Sponsor Decision|1|||
130625353|NCT04897594|470248205|FG000|Overall Study|Withdrawal by Subject|1|||
130625354|NCT04897594|470248206|FG001|Overall Study|Withdrawal by Subject|0|||
130625355|NCT04897594|470248207|FG002|Overall Study|Withdrawal by Subject|1|||
130625356|NCT00636441|470248222|FG000|Overall Study|Adverse Event|0|||
130625357|NCT00636441|470248223|FG001|Overall Study|Adverse Event|1|||
130625358|NCT00636441|470248224|FG002|Overall Study|Adverse Event|1|||
130625359|NCT00636441|470248225|FG003|Overall Study|Adverse Event|0|||
130625360|NCT00636441|470248226|FG004|Overall Study|Adverse Event|0|||
130625361|NCT00636441|470248227|FG005|Overall Study|Adverse Event|1|||
130625362|NCT00636441|470248228|FG006|Overall Study|Adverse Event|0|||
130625363|NCT00636441|470248222|FG000|Overall Study|Late, ineligible|0|||
130625364|NCT00636441|470248223|FG001|Overall Study|Late, ineligible|0|||
130625365|NCT00636441|470248224|FG002|Overall Study|Late, ineligible|0|||
130625366|NCT00636441|470248225|FG003|Overall Study|Late, ineligible|0|||
130625367|NCT00636441|470248226|FG004|Overall Study|Late, ineligible|0|||
130625368|NCT00636441|470248227|FG005|Overall Study|Late, ineligible|0|||
130625369|NCT00636441|470248228|FG006|Overall Study|Late, ineligible|1|||
130625370|NCT00636441|470248222|FG000|Overall Study|Screen Failure|0|||
130625371|NCT00636441|470248223|FG001|Overall Study|Screen Failure|0|||
130625372|NCT00636441|470248224|FG002|Overall Study|Screen Failure|0|||
130625373|NCT00636441|470248225|FG003|Overall Study|Screen Failure|0|||
130625374|NCT00636441|470248226|FG004|Overall Study|Screen Failure|0|||
130625375|NCT00636441|470248227|FG005|Overall Study|Screen Failure|0|||
130625376|NCT00636441|470248228|FG006|Overall Study|Screen Failure|17|||
130625377|NCT00425100|470248229|FG000|Overall Study|Adverse Event|36|||
130625378|NCT00425100|470248229|FG000|Overall Study|Lack of Efficacy|4|||
130625379|NCT00425100|470248229|FG000|Overall Study|Lost to Follow-up|2|||
130625380|NCT00425100|470248229|FG000|Overall Study|Protocol Violation|4|||
130625381|NCT00425100|470248229|FG000|Overall Study|Withdrawal by Subject|7|||
130625382|NCT03495817|470248230|FG000|26 Week Open Label|Adverse Event|3|||
130625383|NCT03495817|470248230|FG000|26 Week Open Label|Withdrawal by Subject|4|||
130625384|NCT03495817|470248230|FG000|26 Week Open Label|Lost to Follow-up|1|||
130625385|NCT03495817|470248230|FG000|26 Week Extension|Lost to Follow-up|2|||
130625386|NCT04169061|470248232|FG000|Overall Study|Adverse Event|2|||
130625387|NCT04169061|470248232|FG000|Overall Study|Death|1|||
130625388|NCT04169061|470248232|FG000|Overall Study|Withdrawal by Subject|1|||
130625389|NCT04169061|470248232|FG000|Overall Study|Protocol Violation|1|||
130625390|NCT04585451|470248236|FG000|Overall Study|Withdrawal by Subject|26|||
130625391|NCT04585451|470248237|FG001|Overall Study|Withdrawal by Subject|0|||
130625392|NCT00326417|470248238|FG000|Overall Study|Withdrawal by Subject|0|||
130625393|NCT00326417|470248239|FG001|Overall Study|Withdrawal by Subject|0|||
130625394|NCT00326417|470248240|FG002|Overall Study|Withdrawal by Subject|1|||
130625395|NCT00326417|470248241|FG003|Overall Study|Withdrawal by Subject|0|||
130625396|NCT00326417|470248238|FG000|Overall Study|Arm Closed|7|||
130625397|NCT00326417|470248239|FG001|Overall Study|Arm Closed|0|||
130625398|NCT00326417|470248240|FG002|Overall Study|Arm Closed|0|||
130625399|NCT00326417|470248241|FG003|Overall Study|Arm Closed|3|||
130625400|NCT00326417|470248238|FG000|Overall Study|Death|7|||
130625401|NCT00326417|470248239|FG001|Overall Study|Death|0|||
130625402|NCT00326417|470248240|FG002|Overall Study|Death|0|||
130625403|NCT00326417|470248241|FG003|Overall Study|Death|0|||
130625404|NCT00844285|470248242|FG000|Overall Study|Other|0|||
130625405|NCT00844285|470248243|FG001|Overall Study|Other|1|||
130625406|NCT00844285|470248244|FG002|Overall Study|Other|0|||
130625407|NCT00844285|470248242|FG000|Overall Study|Other than specified|95|||
130625408|NCT00844285|470248243|FG001|Overall Study|Other than specified|129|||
130625409|NCT00844285|470248244|FG002|Overall Study|Other than specified|12|||
130625410|NCT00844285|470248242|FG000|Overall Study|Site closure|256|||
130625411|NCT00844285|470248243|FG001|Overall Study|Site closure|450|||
130625412|NCT00844285|470248244|FG002|Overall Study|Site closure|50|||
130625413|NCT00844285|470248242|FG000|Overall Study|Follow-up < 8 years|16|||
130625414|NCT00844285|470248243|FG001|Overall Study|Follow-up < 8 years|23|||
130625415|NCT00844285|470248244|FG002|Overall Study|Follow-up < 8 years|4|||
130625416|NCT00844285|470248242|FG000|Overall Study|Protocol Violation|26|||
130625417|NCT00844285|470248243|FG001|Overall Study|Protocol Violation|28|||
130625418|NCT00844285|470248244|FG002|Overall Study|Protocol Violation|54|||
130625419|NCT00844285|470248242|FG000|Overall Study|Death|22|||
130625420|NCT00844285|470248243|FG001|Overall Study|Death|21|||
130625421|NCT00844285|470248244|FG002|Overall Study|Death|8|||
130625422|NCT00844285|470248242|FG000|Overall Study|Withdrew Consent|344|||
130625423|NCT00844285|470248243|FG001|Overall Study|Withdrew Consent|466|||
130625424|NCT00844285|470248244|FG002|Overall Study|Withdrew Consent|70|||
130625425|NCT00844285|470248242|FG000|Overall Study|Lost to Follow-up|330|||
130625426|NCT00844285|470248243|FG001|Overall Study|Lost to Follow-up|486|||
130625427|NCT00844285|470248244|FG002|Overall Study|Lost to Follow-up|74|||
130625428|NCT00555906|470248247|FG000|Phase 1|Objective Progression or Relapse|3|||
130625429|NCT00555906|470248248|FG001|Phase 1|Objective Progression or Relapse|5|||
130625430|NCT00555906|470248249|FG002|Phase 1|Objective Progression or Relapse|3|||
130625431|NCT00555906|470248250|FG003|Phase 1|Objective Progression or Relapse|1|||
130625432|NCT00555906|470248251|FG004|Phase 1|Objective Progression or Relapse|0|||
130625433|NCT00555906|470248247|FG000|Phase 1|Global Deterioration of Health Status|0|||
130625434|NCT00555906|470248248|FG001|Phase 1|Global Deterioration of Health Status|1|||
130625435|NCT00555906|470248249|FG002|Phase 1|Global Deterioration of Health Status|1|||
130625436|NCT00555906|470248250|FG003|Phase 1|Global Deterioration of Health Status|1|||
130625437|NCT00555906|470248251|FG004|Phase 1|Global Deterioration of Health Status|0|||
130625438|NCT00555906|470248247|FG000|Phase 1|Adverse Event|0|||
130625439|NCT00555906|470248248|FG001|Phase 1|Adverse Event|0|||
130625440|NCT00555906|470248249|FG002|Phase 1|Adverse Event|3|||
130625441|NCT00555906|470248250|FG003|Phase 1|Adverse Event|2|||
130625442|NCT00555906|470248251|FG004|Phase 1|Adverse Event|0|||
130625443|NCT00555906|470248247|FG000|Phase 1|Withdrawal by Subject|0|||
130625444|NCT00555906|470248248|FG001|Phase 1|Withdrawal by Subject|0|||
130625445|NCT00555906|470248249|FG002|Phase 1|Withdrawal by Subject|0|||
130625446|NCT00555906|470248250|FG003|Phase 1|Withdrawal by Subject|1|||
130625447|NCT00555906|470248251|FG004|Phase 1|Withdrawal by Subject|0|||
130625448|NCT00555906|470248247|FG000|Phase 2|Adverse Event|0|||
130625449|NCT00555906|470248248|FG001|Phase 2|Adverse Event|0|||
130625450|NCT00555906|470248249|FG002|Phase 2|Adverse Event|0|||
130625451|NCT00555906|470248250|FG003|Phase 2|Adverse Event|0|||
130625452|NCT00555906|470248251|FG004|Phase 2|Adverse Event|4|||
130625453|NCT00555906|470248247|FG000|Phase 2|Global Deterioration of Health Status|0|||
130625454|NCT00555906|470248248|FG001|Phase 2|Global Deterioration of Health Status|0|||
130625455|NCT00555906|470248249|FG002|Phase 2|Global Deterioration of Health Status|0|||
130625456|NCT00555906|470248250|FG003|Phase 2|Global Deterioration of Health Status|0|||
130625457|NCT00555906|470248251|FG004|Phase 2|Global Deterioration of Health Status|2|||
130625458|NCT00555906|470248247|FG000|Phase 2|Objective Progression or Relapse|0|||
130625459|NCT00555906|470248248|FG001|Phase 2|Objective Progression or Relapse|0|||
130625460|NCT00555906|470248249|FG002|Phase 2|Objective Progression or Relapse|0|||
130625461|NCT00555906|470248250|FG003|Phase 2|Objective Progression or Relapse|0|||
130625462|NCT00555906|470248251|FG004|Phase 2|Objective Progression or Relapse|16|||
130625463|NCT00555906|470248247|FG000|Phase 2|Withdrawal by Subject|0|||
130625464|NCT00555906|470248248|FG001|Phase 2|Withdrawal by Subject|0|||
130625465|NCT00555906|470248249|FG002|Phase 2|Withdrawal by Subject|0|||
130625466|NCT00555906|470248250|FG003|Phase 2|Withdrawal by Subject|0|||
130625467|NCT00555906|470248251|FG004|Phase 2|Withdrawal by Subject|2|||
130625468|NCT00555906|470248247|FG000|Phase 2|Other|0|||
130625469|NCT00555906|470248248|FG001|Phase 2|Other|0|||
130625470|NCT00555906|470248249|FG002|Phase 2|Other|0|||
130625471|NCT00555906|470248250|FG003|Phase 2|Other|0|||
130625472|NCT00555906|470248251|FG004|Phase 2|Other|6|||
130625473|NCT00555906|470248247|FG000|Phase 2|Randomized but not Treated|0|||
130625474|NCT00555906|470248248|FG001|Phase 2|Randomized but not Treated|0|||
130625475|NCT00555906|470248249|FG002|Phase 2|Randomized but not Treated|0|||
130625476|NCT00555906|470248250|FG003|Phase 2|Randomized but not Treated|0|||
130625477|NCT00555906|470248251|FG004|Phase 2|Randomized but not Treated|2|||
130625478|NCT03219567|470248252|FG000|Overall Study|Withdrawal by Subject|0|||
130625479|NCT03219567|470248253|FG001|Overall Study|Withdrawal by Subject|1|||
130625480|NCT02849626|470248254|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
130625481|NCT02849626|470248255|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
130625482|NCT02849626|470248256|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
130625483|NCT02849626|470248257|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
130625484|NCT02849626|470248254|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
130625485|NCT02849626|470248255|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
130625486|NCT02849626|470248256|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
130625487|NCT02849626|470248257|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
130625488|NCT02849626|470248254|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
130625489|NCT02849626|470248255|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
130625490|NCT02849626|470248256|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
130625491|NCT02849626|470248257|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
130625492|NCT02849626|470248254|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
130625493|NCT02849626|470248255|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
130625494|NCT02849626|470248256|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
130625495|NCT02849626|470248257|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
130625496|NCT02849626|470248254|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
130625497|NCT02849626|470248255|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
130625498|NCT02849626|470248256|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
130625499|NCT02849626|470248257|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
130625500|NCT02849626|470248254|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
130625501|NCT02849626|470248255|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130625502|NCT02849626|470248256|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130625503|NCT02849626|470248257|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130625504|NCT02849626|470248254|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
130625505|NCT02849626|470248255|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
130625506|NCT02849626|470248256|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
130625507|NCT02849626|470248257|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
130625508|NCT02849626|470248254|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
130625509|NCT02849626|470248255|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130625510|NCT02849626|470248256|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130625511|NCT02849626|470248257|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130625512|NCT02849626|470248254|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130625513|NCT02849626|470248255|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130625514|NCT02849626|470248256|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
130625515|NCT02849626|470248257|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130625516|NCT02849626|470248254|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
130625517|NCT02849626|470248255|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
130625518|NCT02849626|470248256|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
130625519|NCT02849626|470248257|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
130625520|NCT02849626|470248254|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
130625521|NCT02849626|470248255|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
130625522|NCT02849626|470248256|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
130625523|NCT02849626|470248257|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
130625524|NCT01654523|470248258|FG000|Overall Study|Withdrawal by Subject|1|||
130625525|NCT01313208|470248259|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
130625526|NCT01313208|470248260|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
130625527|NCT01313208|470248259|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
130625528|NCT01313208|470248260|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
130625529|NCT01313208|470248259|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
130625530|NCT01313208|470248260|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
130625531|NCT01313208|470248259|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
130625532|NCT01313208|470248260|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
130625533|NCT01313208|470248259|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
130625534|NCT01313208|470248260|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
130625535|NCT01313208|470248259|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
130625536|NCT01313208|470248260|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
130625537|NCT01313208|470248259|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
130625538|NCT01313208|470248260|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
130625539|NCT01313208|470248259|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
130625540|NCT01313208|470248260|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
130625541|NCT01313208|470248259|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
130625542|NCT01313208|470248260|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
130625543|NCT01957787|470248261|FG000|Overall Study|Death|18|||
130625544|NCT01957787|470248261|FG000|Overall Study|Lost to Follow-up|3|||
130625545|NCT01957787|470248261|FG000|Overall Study|Withdrawal by Subject|3|||
130625546|NCT01957787|470248261|FG000|Overall Study|Entered Hospice or Similar Program|2|||
130625547|NCT01957787|470248261|FG000|Overall Study|Index Tumor(s) Resected|2|||
130625548|NCT01957787|470248261|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
130625549|NCT01957787|470248261|FG000|Overall Study|Local therapy, not cryoablation|6|||
130625550|NCT04176445|470248262|FG000|Overall Study|Adverse Event|0|||
130625551|NCT04176445|470248263|FG001|Overall Study|Adverse Event|1|||
130625552|NCT04176445|470248262|FG000|Overall Study|change plans weaning after first intervention|0|||
130625553|NCT04176445|470248263|FG001|Overall Study|change plans weaning after first intervention|1|||
130625554|NCT04046341|470248265|FG000|Overall Study|Lost to Follow-up|2|||
130625555|NCT04046341|470248265|FG000|Overall Study|Withdrawal by Subject|1|||
130625556|NCT00405652|470248266|FG000|Overall Study|Adverse Event|4|||
130625557|NCT00435994|470248268|FG000|Overall Study|Lost to Follow-up|7|||
130625558|NCT00435994|470248269|FG001|Overall Study|Lost to Follow-up|0|||
130625559|NCT00435994|470248270|FG002|Overall Study|Lost to Follow-up|0|||
130625560|NCT03846219|470248274|FG000|Overall Study|Withdrawal by Subject|3|||
130625561|NCT03846219|470248275|FG001|Overall Study|Withdrawal by Subject|2|||
130625562|NCT03846219|470248276|FG002|Overall Study|Withdrawal by Subject|2|||
130625563|NCT03846219|470248274|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
130625564|NCT03846219|470248275|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
130625565|NCT03846219|470248276|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
130625566|NCT03846219|470248274|FG000|Overall Study|Physician Decision|0|||
130625567|NCT03846219|470248275|FG001|Overall Study|Physician Decision|0|||
130625568|NCT03846219|470248276|FG002|Overall Study|Physician Decision|2|||
130625569|NCT05109702|470248277|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
130625570|NCT05109702|470248278|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
130625571|NCT05109702|470248279|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
130625572|NCT05109702|470248277|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
130625573|NCT05109702|470248278|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
130625574|NCT05109702|470248279|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
130625575|NCT05109702|470248277|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
130625576|NCT05109702|470248278|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
130625577|NCT05109702|470248279|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
130625578|NCT05109702|470248277|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
130625579|NCT05109702|470248278|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
130625580|NCT05109702|470248279|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
130625581|NCT05109702|470248277|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
130625582|NCT05109702|470248278|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
130625583|NCT05109702|470248279|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
130625584|NCT02322411|470248288|FG000|Overall Study|Lost to Follow-up|4|||
130625585|NCT02322411|470248289|FG001|Overall Study|Lost to Follow-up|7|||
130625586|NCT02322411|470248288|FG000|Overall Study|Withdrawal by Subject|1|||
130625587|NCT02322411|470248289|FG001|Overall Study|Withdrawal by Subject|0|||
130625588|NCT01392378|470248290|FG000|Infant Series|Adverse Event|0|||
130625589|NCT01392378|470248291|FG001|Infant Series|Adverse Event|0|||
130625590|NCT01392378|470248292|FG002|Infant Series|Adverse Event|0|||
130625591|NCT01392378|470248293|FG003|Infant Series|Adverse Event|1|||
130625592|NCT01392378|470248294|FG004|Infant Series|Adverse Event|0|||
130625593|NCT01392378|470248290|FG000|Infant Series|Lost to Follow-up|0|||
130625594|NCT01392378|470248291|FG001|Infant Series|Lost to Follow-up|0|||
130625595|NCT01392378|470248292|FG002|Infant Series|Lost to Follow-up|0|||
130625596|NCT01392378|470248293|FG003|Infant Series|Lost to Follow-up|1|||
130625597|NCT01392378|470248294|FG004|Infant Series|Lost to Follow-up|0|||
130625598|NCT01392378|470248290|FG000|Infant Series|Protocol Violation|0|||
130625599|NCT01392378|470248291|FG001|Infant Series|Protocol Violation|1|||
130625600|NCT01392378|470248292|FG002|Infant Series|Protocol Violation|0|||
130625601|NCT01392378|470248293|FG003|Infant Series|Protocol Violation|0|||
130625602|NCT01392378|470248294|FG004|Infant Series|Protocol Violation|0|||
130625603|NCT01392378|470248290|FG000|Infant Series|Withdrawal by Parent|4|||
130625604|NCT01392378|470248291|FG001|Infant Series|Withdrawal by Parent|1|||
130625605|NCT01392378|470248292|FG002|Infant Series|Withdrawal by Parent|0|||
130625606|NCT01392378|470248293|FG003|Infant Series|Withdrawal by Parent|0|||
130625607|NCT01392378|470248294|FG004|Infant Series|Withdrawal by Parent|0|||
130625608|NCT01392378|470248290|FG000|After Infant Series|Lost to Follow-up|0|||
130625609|NCT01392378|470248291|FG001|After Infant Series|Lost to Follow-up|0|||
130625610|NCT01392378|470248292|FG002|After Infant Series|Lost to Follow-up|1|||
130625611|NCT01392378|470248293|FG003|After Infant Series|Lost to Follow-up|0|||
130625612|NCT01392378|470248294|FG004|After Infant Series|Lost to Follow-up|0|||
130625613|NCT01392378|470248290|FG000|After Infant Series|Withdrawal by Parent|0|||
130625614|NCT01392378|470248291|FG001|After Infant Series|Withdrawal by Parent|1|||
130625615|NCT01392378|470248292|FG002|After Infant Series|Withdrawal by Parent|1|||
130625616|NCT01392378|470248293|FG003|After Infant Series|Withdrawal by Parent|0|||
130625617|NCT01392378|470248294|FG004|After Infant Series|Withdrawal by Parent|1|||
130625618|NCT01392378|470248290|FG000|Toddler Dose|Lost to Follow-up|0|||
130625619|NCT01392378|470248291|FG001|Toddler Dose|Lost to Follow-up|0|||
130625620|NCT01392378|470248292|FG002|Toddler Dose|Lost to Follow-up|0|||
130625621|NCT01392378|470248293|FG003|Toddler Dose|Lost to Follow-up|1|||
130625622|NCT01392378|470248294|FG004|Toddler Dose|Lost to Follow-up|0|||
130625623|NCT01392378|470248290|FG000|Toddler Dose|Withdrawal by Parent|0|||
130625624|NCT01392378|470248291|FG001|Toddler Dose|Withdrawal by Parent|1|||
130625625|NCT01392378|470248292|FG002|Toddler Dose|Withdrawal by Parent|0|||
130625626|NCT01392378|470248293|FG003|Toddler Dose|Withdrawal by Parent|1|||
130625627|NCT01392378|470248294|FG004|Toddler Dose|Withdrawal by Parent|1|||
130625628|NCT02713789|470248295|FG000|Overall Study|Lost to Follow-up|0|||
130625629|NCT02713789|470248296|FG001|Overall Study|Lost to Follow-up|1|||
130625630|NCT02713789|470248297|FG002|Overall Study|Lost to Follow-up|1|||
130625631|NCT00014911|470248298|FG000|Overall Study|Adverse Event|1|||
130625632|NCT00014911|470248298|FG000|Overall Study|Lost to Follow-up|1|||
130625633|NCT00014911|470248298|FG000|Overall Study|Withdrawal by Subject|6|||
130625634|NCT00014911|470248298|FG000|Overall Study|Unknown Reasons|2|||
130625635|NCT00014911|470248298|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
130625636|NCT01924299|470248299|FG000|Period 2|Withdrawal by Subject|1|||
130625637|NCT01924299|470248300|FG001|Period 2|Withdrawal by Subject|0|||
130625638|NCT01924299|470248299|FG000|Period 2|Adverse Event|0|||
130625639|NCT01924299|470248300|FG001|Period 2|Adverse Event|1|||
130625640|NCT00355134|470249656|FG000|Core Phase|Withdrawal by Subject|35|||
130625641|NCT00355134|470249657|FG001|Core Phase|Withdrawal by Subject|24|||
130625642|NCT00355134|470249658|FG002|Core Phase|Withdrawal by Subject|35|||
130625643|NCT00355134|470249659|FG003|Core Phase|Withdrawal by Subject|0|||
130625644|NCT00355134|470249660|FG004|Core Phase|Withdrawal by Subject|0|||
130625645|NCT00355134|470249656|FG000|Core Phase|Adverse Event|28|||
130625646|NCT00355134|470249657|FG001|Core Phase|Adverse Event|22|||
130625647|NCT00355134|470249658|FG002|Core Phase|Adverse Event|16|||
130625648|NCT00355134|470249659|FG003|Core Phase|Adverse Event|0|||
130625649|NCT00355134|470249660|FG004|Core Phase|Adverse Event|0|||
130625650|NCT00355134|470249656|FG000|Core Phase|Lost to Follow-up|17|||
130625651|NCT00355134|470249657|FG001|Core Phase|Lost to Follow-up|13|||
130625652|NCT00355134|470249658|FG002|Core Phase|Lost to Follow-up|21|||
130625653|NCT00355134|470249659|FG003|Core Phase|Lost to Follow-up|0|||
130625654|NCT00355134|470249660|FG004|Core Phase|Lost to Follow-up|0|||
130625655|NCT00355134|470249656|FG000|Core Phase|Abnormal laboratory value(s)|19|||
130625656|NCT00355134|470249657|FG001|Core Phase|Abnormal laboratory value(s)|14|||
130625657|NCT00355134|470249658|FG002|Core Phase|Abnormal laboratory value(s)|2|||
130625658|NCT00355134|470249659|FG003|Core Phase|Abnormal laboratory value(s)|0|||
130625659|NCT00355134|470249660|FG004|Core Phase|Abnormal laboratory value(s)|0|||
130625660|NCT00355134|470249656|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
130625661|NCT00355134|470249657|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
130625662|NCT00355134|470249658|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
130625663|NCT00355134|470249659|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
130625664|NCT00355134|470249660|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
130625665|NCT00355134|470249656|FG000|Core Phase|Administrative problems|5|||
130625666|NCT00355134|470249657|FG001|Core Phase|Administrative problems|3|||
130625667|NCT00355134|470249658|FG002|Core Phase|Administrative problems|5|||
130625668|NCT00355134|470249659|FG003|Core Phase|Administrative problems|0|||
130625669|NCT00355134|470249660|FG004|Core Phase|Administrative problems|0|||
130625670|NCT00355134|470249656|FG000|Core Phase|Protocol Violation|3|||
130625671|NCT00355134|470249657|FG001|Core Phase|Protocol Violation|2|||
130625672|NCT00355134|470249658|FG002|Core Phase|Protocol Violation|2|||
130625673|NCT00355134|470249659|FG003|Core Phase|Protocol Violation|0|||
130625674|NCT00355134|470249660|FG004|Core Phase|Protocol Violation|0|||
130625675|NCT00355134|470249656|FG000|Core Phase|Abnormal test procedure result(s)|1|||
130625676|NCT00355134|470249657|FG001|Core Phase|Abnormal test procedure result(s)|2|||
130625677|NCT00355134|470249658|FG002|Core Phase|Abnormal test procedure result(s)|1|||
130625678|NCT00355134|470249659|FG003|Core Phase|Abnormal test procedure result(s)|0|||
130625679|NCT00355134|470249660|FG004|Core Phase|Abnormal test procedure result(s)|0|||
130625680|NCT00355134|470249656|FG000|Core Phase|Condition no longer requires study drug|1|||
130625681|NCT00355134|470249657|FG001|Core Phase|Condition no longer requires study drug|0|||
130625682|NCT00355134|470249658|FG002|Core Phase|Condition no longer requires study drug|1|||
130625683|NCT00355134|470249659|FG003|Core Phase|Condition no longer requires study drug|0|||
130625684|NCT00355134|470249660|FG004|Core Phase|Condition no longer requires study drug|0|||
130625685|NCT00355134|470249656|FG000|Extension Phase|Withdrawal by Subject|7|||
130625686|NCT00355134|470249657|FG001|Extension Phase|Withdrawal by Subject|11|||
130625687|NCT00355134|470249658|FG002|Extension Phase|Withdrawal by Subject|0|||
130625688|NCT00355134|470249659|FG003|Extension Phase|Withdrawal by Subject|7|||
130625689|NCT00355134|470249660|FG004|Extension Phase|Withdrawal by Subject|5|||
130625690|NCT00355134|470249656|FG000|Extension Phase|Adverse Event|13|||
130625691|NCT00355134|470249657|FG001|Extension Phase|Adverse Event|9|||
130625692|NCT00355134|470249658|FG002|Extension Phase|Adverse Event|0|||
130625693|NCT00355134|470249659|FG003|Extension Phase|Adverse Event|3|||
130625694|NCT00355134|470249660|FG004|Extension Phase|Adverse Event|5|||
130625695|NCT00355134|470249656|FG000|Extension Phase|Lost to Follow-up|2|||
130625696|NCT00355134|470249657|FG001|Extension Phase|Lost to Follow-up|6|||
130625697|NCT00355134|470249658|FG002|Extension Phase|Lost to Follow-up|0|||
130625698|NCT00355134|470249659|FG003|Extension Phase|Lost to Follow-up|2|||
130625699|NCT00355134|470249660|FG004|Extension Phase|Lost to Follow-up|4|||
130625700|NCT00355134|470249656|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
130625701|NCT00355134|470249657|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
130625702|NCT00355134|470249658|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
130625703|NCT00355134|470249659|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
130625704|NCT00355134|470249660|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
130625705|NCT00355134|470249656|FG000|Extension Phase|Administrative problems|2|||
130625706|NCT00355134|470249657|FG001|Extension Phase|Administrative problems|4|||
130625707|NCT00355134|470249658|FG002|Extension Phase|Administrative problems|0|||
130625708|NCT00355134|470249659|FG003|Extension Phase|Administrative problems|1|||
130625709|NCT00355134|470249660|FG004|Extension Phase|Administrative problems|1|||
130625710|NCT00355134|470249656|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
130625711|NCT00355134|470249657|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
130625712|NCT00355134|470249658|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130625713|NCT00355134|470249659|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
130625714|NCT00355134|470249660|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
130625715|NCT00355134|470249656|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
130625716|NCT00355134|470249657|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
130625717|NCT00355134|470249658|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
130625718|NCT00355134|470249659|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
130625719|NCT00355134|470249660|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
130625720|NCT00355134|470249656|FG000|Extension Phase|Protocol Violation|0|||
130625721|NCT00355134|470249657|FG001|Extension Phase|Protocol Violation|0|||
130625722|NCT00355134|470249658|FG002|Extension Phase|Protocol Violation|0|||
130625723|NCT00355134|470249659|FG003|Extension Phase|Protocol Violation|1|||
130625724|NCT00355134|470249660|FG004|Extension Phase|Protocol Violation|0|||
130625725|NCT02848313|470249661|FG000|Overall Study|Adverse Event|1|||
130625726|NCT02848313|470249662|FG001|Overall Study|Adverse Event|2|||
130625727|NCT02848313|470249661|FG000|Overall Study|Lack of Efficacy|0|||
130625728|NCT02848313|470249662|FG001|Overall Study|Lack of Efficacy|1|||
130625729|NCT02848313|470249661|FG000|Overall Study|Withdrawal by Subject|1|||
130625730|NCT02848313|470249662|FG001|Overall Study|Withdrawal by Subject|1|||
130625731|NCT02848313|470249661|FG000|Overall Study|Lost to follow up|1|||
130625732|NCT02848313|470249662|FG001|Overall Study|Lost to follow up|0|||
130625733|NCT01544478|470249663|FG000|Overall Study|Adverse Event|1|||
130625734|NCT01544478|470249663|FG000|Overall Study|Death|1|||
130625735|NCT01544478|470249663|FG000|Overall Study|Lost to Follow-up|48|||
130625736|NCT01544478|470249663|FG000|Overall Study|Physician Decision|15|||
130625737|NCT01544478|470249663|FG000|Overall Study|Pregnancy|1|||
130625738|NCT01544478|470249663|FG000|Overall Study|Withdrawal by Subject|52|||
130625739|NCT03382262|470249667|FG000|Overall Study|Physician Decision|0|||
130625740|NCT03382262|470249668|FG001|Overall Study|Physician Decision|0|||
130625741|NCT03382262|470249669|FG002|Overall Study|Physician Decision|1|||
130625742|NCT03382262|470249670|FG003|Overall Study|Physician Decision|0|||
130625743|NCT03382262|470249667|FG000|Overall Study|Withdrawal by Subject|0|||
130625744|NCT03382262|470249668|FG001|Overall Study|Withdrawal by Subject|0|||
130625745|NCT03382262|470249669|FG002|Overall Study|Withdrawal by Subject|0|||
130625746|NCT03382262|470249670|FG003|Overall Study|Withdrawal by Subject|1|||
130625747|NCT02038790|470249672|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
130625748|NCT02038790|470249673|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
130625749|NCT00438464|470249677|FG000|Overall Study|Terminated Early|14|||
130625750|NCT00438464|470249678|FG001|Overall Study|Terminated Early|5|||
130625751|NCT00438464|470249677|FG000|Overall Study|Incomplete data submission|0|||
130625752|NCT00438464|470249678|FG001|Overall Study|Incomplete data submission|2|||
130625753|NCT03943446|470249680|FG000|Overall Study|Lost to Follow-up|0|||
130625754|NCT03943446|470249681|FG001|Overall Study|Lost to Follow-up|0|||
130625755|NCT03943446|470249682|FG002|Overall Study|Lost to Follow-up|1|||
130625756|NCT03943446|470249680|FG000|Overall Study|Withdrawal by Subject|1|||
130625757|NCT03943446|470249681|FG001|Overall Study|Withdrawal by Subject|1|||
130625758|NCT03943446|470249682|FG002|Overall Study|Withdrawal by Subject|2|||
130625759|NCT03943446|470249680|FG000|Overall Study|Study Terminated by Sponsor|1|||
130625760|NCT03943446|470249681|FG001|Overall Study|Study Terminated by Sponsor|2|||
130625761|NCT03943446|470249682|FG002|Overall Study|Study Terminated by Sponsor|1|||
130625762|NCT03943446|470249680|FG000|Overall Study|Reason not Specified|5|||
130625763|NCT03943446|470249681|FG001|Overall Study|Reason not Specified|1|||
130625764|NCT03943446|470249682|FG002|Overall Study|Reason not Specified|3|||
130625765|NCT04209530|470249685|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
130625766|NCT04209530|470249686|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
130625767|NCT04209530|470249685|FG000|Overall Study|Withdrawal by Subject|0|||
130625768|NCT04209530|470249686|FG001|Overall Study|Withdrawal by Subject|1|||
130625769|NCT01467661|470249689|FG000|Overall Study|Adverse Event|16|||
130625770|NCT01467661|470249689|FG000|Overall Study|Withdrawal by Subject|1|||
130625771|NCT01467661|470249689|FG000|Overall Study|Lack of Efficacy|3|||
130625772|NCT01467661|470249689|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
130625773|NCT03673956|470249690|FG000|Overall Study|Lost to Follow-up|1|||
130625774|NCT03673956|470249691|FG001|Overall Study|Lost to Follow-up|0|||
130625775|NCT03673956|470249692|FG002|Overall Study|Lost to Follow-up|0|||
130625776|NCT03673956|470249693|FG003|Overall Study|Lost to Follow-up|0|||
130625777|NCT03673956|470249690|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
130625778|NCT03673956|470249691|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
130625779|NCT03673956|470249692|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
130625780|NCT03673956|470249693|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
130625781|NCT00270998|470249694|FG000|3 Month Follow-up|Adverse Event|1|||
130625782|NCT00270998|470249695|FG001|3 Month Follow-up|Adverse Event|0|||
130625783|NCT00270998|470249696|FG002|3 Month Follow-up|Adverse Event|0|||
130625784|NCT00270998|470249694|FG000|3 Month Follow-up|Lack of Efficacy|1|||
130625785|NCT00270998|470249695|FG001|3 Month Follow-up|Lack of Efficacy|2|||
130625786|NCT00270998|470249696|FG002|3 Month Follow-up|Lack of Efficacy|1|||
130625787|NCT00270998|470249694|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
130625788|NCT00270998|470249695|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
130625789|NCT00270998|470249696|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
130625790|NCT00270998|470249694|FG000|3 Month Follow-up|Pessary did not fit|12|||
130625791|NCT00270998|470249695|FG001|3 Month Follow-up|Pessary did not fit|0|||
130625792|NCT00270998|470249696|FG002|3 Month Follow-up|Pessary did not fit|0|||
130625793|NCT00270998|470249694|FG000|3 Month Follow-up|Personal/family health|1|||
130625794|NCT00270998|470249695|FG001|3 Month Follow-up|Personal/family health|1|||
130625795|NCT00270998|470249696|FG002|3 Month Follow-up|Personal/family health|0|||
130625796|NCT00270998|470249694|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
130625797|NCT00270998|470249695|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
130625798|NCT00270998|470249696|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
130625799|NCT00270998|470249694|FG000|12 Month Follow-up|Lack of Efficacy|5|||
130625800|NCT00270998|470249695|FG001|12 Month Follow-up|Lack of Efficacy|4|||
130625801|NCT00270998|470249696|FG002|12 Month Follow-up|Lack of Efficacy|3|||
130625802|NCT00270998|470249694|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
130625803|NCT00270998|470249695|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
130625804|NCT00270998|470249696|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
130625805|NCT00270998|470249694|FG000|12 Month Follow-up|Pessary did not fit|1|||
130625806|NCT00270998|470249695|FG001|12 Month Follow-up|Pessary did not fit|0|||
130625807|NCT00270998|470249696|FG002|12 Month Follow-up|Pessary did not fit|0|||
130625808|NCT00270998|470249694|FG000|12 Month Follow-up|Personal/family health|0|||
130625809|NCT00270998|470249695|FG001|12 Month Follow-up|Personal/family health|5|||
130625810|NCT00270998|470249696|FG002|12 Month Follow-up|Personal/family health|1|||
130625811|NCT00270998|470249694|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
130625812|NCT00270998|470249695|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
130625813|NCT00270998|470249696|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
130625814|NCT03094832|470249699|FG000|Overall Study|Lost to Follow-up|0|||
130625815|NCT03094832|470249700|FG001|Overall Study|Lost to Follow-up|0|||
130625816|NCT03094832|470249701|FG002|Overall Study|Lost to Follow-up|0|||
130625817|NCT03094832|470249702|FG003|Overall Study|Lost to Follow-up|1|||
130625818|NCT03094832|470249703|FG004|Overall Study|Lost to Follow-up|1|||
130625819|NCT03094832|470249699|FG000|Overall Study|Death|1|||
130625820|NCT03094832|470249700|FG001|Overall Study|Death|0|||
130625821|NCT03094832|470249701|FG002|Overall Study|Death|0|||
130625822|NCT03094832|470249702|FG003|Overall Study|Death|0|||
130625823|NCT03094832|470249703|FG004|Overall Study|Death|0|||
130625824|NCT03094832|470249699|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130625825|NCT03094832|470249700|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130625826|NCT03094832|470249701|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130625827|NCT03094832|470249702|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130625828|NCT03094832|470249703|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130625829|NCT03094832|470249699|FG000|Overall Study|Other|13|||
130625830|NCT03094832|470249700|FG001|Overall Study|Other|20|||
130625831|NCT03094832|470249701|FG002|Overall Study|Other|1|||
130625832|NCT03094832|470249702|FG003|Overall Study|Other|7|||
130625833|NCT03094832|470249703|FG004|Overall Study|Other|1|||
130625834|NCT00788697|470249708|FG000|Overall Study|No study drug administered|12|||
130625835|NCT00788697|470249708|FG000|Overall Study|Training Patients|74|||
130625836|NCT00788697|470249708|FG000|Overall Study|no truth standard procedure available|5|||
130625837|NCT00788697|470249708|FG000|Overall Study|Technically inadequate truth standard|1|||
130625838|NCT00788697|470249708|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
130625839|NCT01998880|470249709|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
130625840|NCT01998880|470249710|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
130625841|NCT01998880|470249709|FG000|Overall Study|Disease Progression|1|||
130625842|NCT01998880|470249710|FG001|Overall Study|Disease Progression|8|||
130625843|NCT01998880|470249709|FG000|Overall Study|Withdrew Consent|2|||
130625844|NCT01998880|470249710|FG001|Overall Study|Withdrew Consent|1|||
130625845|NCT01998880|470249709|FG000|Overall Study|Death|3|||
130625846|NCT01998880|470249710|FG001|Overall Study|Death|6|||
130625847|NCT01998880|470249709|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130625848|NCT01998880|470249710|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130625849|NCT01998880|470249709|FG000|Overall Study|Administrative/Other|1|||
130625850|NCT01998880|470249710|FG001|Overall Study|Administrative/Other|1|||
130625851|NCT01998880|470249709|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
130625852|NCT01998880|470249710|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130625853|NCT01998880|470249709|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130625854|NCT01998880|470249710|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130625855|NCT01998880|470249709|FG000|Overall Study|Did Not Receive Treatment|3|||
130625856|NCT01998880|470249710|FG001|Overall Study|Did Not Receive Treatment|2|||
130625857|NCT02671461|470249711|FG000|Treatment|Adverse Event|0|||
130625858|NCT02671461|470249712|FG001|Treatment|Adverse Event|0|||
130625859|NCT02671461|470249713|FG002|Treatment|Adverse Event|1|||
130625860|NCT02671461|470249711|FG000|Treatment|Administrative Reason by Sponsor|1|||
130625861|NCT02671461|470249712|FG001|Treatment|Administrative Reason by Sponsor|3|||
130625862|NCT02671461|470249713|FG002|Treatment|Administrative Reason by Sponsor|4|||
130625863|NCT02671461|470249711|FG000|Treatment|Randomized, not treated|1|||
130625864|NCT02671461|470249712|FG001|Treatment|Randomized, not treated|0|||
130625865|NCT02671461|470249713|FG002|Treatment|Randomized, not treated|0|||
130625866|NCT02671461|470249711|FG000|Follow-up|Withdrawal by Subject|1|||
130625867|NCT02671461|470249712|FG001|Follow-up|Withdrawal by Subject|0|||
130625868|NCT02671461|470249713|FG002|Follow-up|Withdrawal by Subject|0|||
130625869|NCT02671461|470249711|FG000|Follow-up|Lost to Follow-up|0|||
130625870|NCT02671461|470249712|FG001|Follow-up|Lost to Follow-up|0|||
130625871|NCT02671461|470249713|FG002|Follow-up|Lost to Follow-up|1|||
130625872|NCT02671461|470249711|FG000|Follow-up|Administrative Reason by Sponsor|0|||
130625873|NCT02671461|470249712|FG001|Follow-up|Administrative Reason by Sponsor|1|||
130625874|NCT02671461|470249713|FG002|Follow-up|Administrative Reason by Sponsor|0|||
130625875|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
130625876|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
130625877|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
130625878|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
130625879|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
130625880|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
130625881|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
130625882|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
130625883|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
130625884|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
130625885|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
130625886|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
130625887|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
130625888|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
130625889|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
130625890|NCT01412060|470249714|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
130625891|NCT01412060|470249715|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
130625892|NCT01412060|470249716|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
130625893|NCT01412060|470249714|FG000|Period Between RIP and SP|Adverse Event|4|||
130625894|NCT01412060|470249715|FG001|Period Between RIP and SP|Adverse Event|0|||
130625895|NCT01412060|470249716|FG002|Period Between RIP and SP|Adverse Event|0|||
130625896|NCT01412060|470249714|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
130625897|NCT01412060|470249715|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
130625898|NCT01412060|470249716|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
130625899|NCT01412060|470249714|FG000|Period Between RIP and SP|Protocol Violation|2|||
130625900|NCT01412060|470249715|FG001|Period Between RIP and SP|Protocol Violation|0|||
130625901|NCT01412060|470249716|FG002|Period Between RIP and SP|Protocol Violation|0|||
130625902|NCT01412060|470249714|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
130625903|NCT01412060|470249715|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
130625904|NCT01412060|470249716|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
130625905|NCT01412060|470249714|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
130625906|NCT01412060|470249715|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
130625907|NCT01412060|470249716|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
130625908|NCT01412060|470249714|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
130625909|NCT01412060|470249715|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
130625910|NCT01412060|470249716|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
130625911|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
130625912|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
130625913|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
130625914|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
130625915|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
130625916|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
130625917|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
130625918|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
130625919|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
130625920|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
130625921|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
130625922|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
130625923|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
130625924|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
130625925|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
130625926|NCT01412060|470249714|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
130625927|NCT01412060|470249715|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
130625928|NCT01412060|470249716|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
130625929|NCT01412060|470249714|FG000|Period Between SP and DBP|Protocol Violation|2|||
130625930|NCT01412060|470249715|FG001|Period Between SP and DBP|Protocol Violation|0|||
130625931|NCT01412060|470249716|FG002|Period Between SP and DBP|Protocol Violation|0|||
130625932|NCT01412060|470249714|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
130625933|NCT01412060|470249715|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
130625934|NCT01412060|470249716|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
130625935|NCT01412060|470249714|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
130625936|NCT01412060|470249715|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
130625937|NCT01412060|470249716|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
130625938|NCT01412060|470249714|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
130625939|NCT01412060|470249715|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
130625940|NCT01412060|470249716|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
130625941|NCT01412060|470249714|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
130625942|NCT01412060|470249715|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
130625943|NCT01412060|470249716|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
130625944|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
130625945|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
130625946|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
130625947|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
130625948|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
130625949|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
130625950|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
130625951|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
130625952|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
130625953|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
130625954|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
130625955|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
130625956|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
130625957|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
130625958|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
130625959|NCT01412060|470249714|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
130625960|NCT01412060|470249715|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
130625961|NCT01412060|470249716|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
130625962|NCT00004732|470249718|FG000|Overall Study|Withdrawal by Subject|36|||
130625963|NCT00004732|470249719|FG001|Overall Study|Withdrawal by Subject|64|||
130625964|NCT00004732|470249718|FG000|Overall Study|Lost to Follow-up|33|||
130625965|NCT00004732|470249719|FG001|Overall Study|Lost to Follow-up|47|||
130625966|NCT02674685|470249723|FG000|Overall Study|Withdrawal by Subject|4|||
130625967|NCT00367432|470249724|FG000|First Period (16 Weeks)|Adverse Event|6|||
130625968|NCT00367432|470249725|FG001|First Period (16 Weeks)|Adverse Event|0|||
130625969|NCT00367432|470249724|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
130625970|NCT00367432|470249725|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
130625971|NCT00367432|470249724|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
130625972|NCT00367432|470249725|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
130625973|NCT00367432|470249724|FG000|First Period (16 Weeks)|Other Reason|2|||
130625974|NCT00367432|470249725|FG001|First Period (16 Weeks)|Other Reason|0|||
130625975|NCT00367432|470249724|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
130625976|NCT00367432|470249725|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
130625977|NCT00367432|470249724|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
130625978|NCT00367432|470249725|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
130625979|NCT00367432|470249724|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
130625980|NCT00367432|470249725|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
130625981|NCT00367432|470249724|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
130625982|NCT00367432|470249725|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
130625983|NCT00367432|470249724|FG000|Second Period (up to 54 Months)|Other Reason|6|||
130625984|NCT00367432|470249725|FG001|Second Period (up to 54 Months)|Other Reason|2|||
130625985|NCT00903370|470249726|FG000|Overall Study|Death|13|||
130625986|NCT00903370|470249727|FG001|Overall Study|Death|10|||
130625987|NCT00903370|470249726|FG000|Overall Study|Withdrawal by Subject|9|||
130625988|NCT00903370|470249727|FG001|Overall Study|Withdrawal by Subject|6|||
130625989|NCT00903370|470249726|FG000|Overall Study|Lost to Follow-up|6|||
130625990|NCT00903370|470249727|FG001|Overall Study|Lost to Follow-up|8|||
130625991|NCT04199793|470249731|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
130625992|NCT04199793|470249732|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
130625993|NCT04199793|470249731|FG000|Overall Study|Withdrawal by Subject|1|||
130625994|NCT04199793|470249732|FG001|Overall Study|Withdrawal by Subject|1|||
130625995|NCT03820726|470249737|FG000|Overall Study|Other than listed|23|||
130625996|NCT03820726|470249737|FG000|Overall Study|Withdrawal by Subject|37|||
130625997|NCT03820726|470249737|FG000|Overall Study|Lost to Follow-up|3|||
130625998|NCT03820726|470249737|FG000|Overall Study|Protocol deviation|1|||
130625999|NCT03820726|470249737|FG000|Overall Study|Adverse Event|146|||
130626000|NCT03820726|470249737|FG000|Overall Study|Not treated|1|||
130626001|NCT00345540|470249741|FG000|Overall Study|Withdrawal by Subject|1|||
130626002|NCT01406652|470249742|FG000|Overall Study|Lost-to-follow-up|3|||
130626003|NCT01406652|470249743|FG001|Overall Study|Lost-to-follow-up|4|||
130626004|NCT01406652|470249742|FG000|Overall Study|Withdrawal by Subject|2|||
130626005|NCT01406652|470249743|FG001|Overall Study|Withdrawal by Subject|2|||
130626006|NCT01406652|470249742|FG000|Overall Study|Insufficient follow-up|5|||
130626007|NCT01406652|470249743|FG001|Overall Study|Insufficient follow-up|4|||
130626008|NCT01406652|470249742|FG000|Overall Study|Infection not sure|10|||
130626009|NCT01406652|470249743|FG001|Overall Study|Infection not sure|10|||
130626010|NCT00141037|470249744|FG000|Overall Study|Physician Decision|1|||
130626011|NCT00141037|470249745|FG001|Overall Study|Physician Decision|2|||
130626012|NCT00141037|470249744|FG000|Overall Study|Lost to Follow-up|3|||
130626013|NCT00141037|470249745|FG001|Overall Study|Lost to Follow-up|1|||
130626014|NCT00141037|470249744|FG000|Overall Study|Protocol Violation|0|||
130626015|NCT00141037|470249745|FG001|Overall Study|Protocol Violation|2|||
130626016|NCT00141037|470249744|FG000|Overall Study|Withdrawal by Subject|2|||
130626017|NCT00141037|470249745|FG001|Overall Study|Withdrawal by Subject|1|||
130626018|NCT00141037|470249744|FG000|Overall Study|Other|0|||
130626019|NCT00141037|470249745|FG001|Overall Study|Other|1|||
130626020|NCT00141037|470249744|FG000|Overall Study|Moved from area|1|||
130626021|NCT00141037|470249745|FG001|Overall Study|Moved from area|7|||
130626022|NCT00141037|470249744|FG000|Overall Study|Graft Failure|3|||
130626023|NCT00141037|470249745|FG001|Overall Study|Graft Failure|4|||
130626024|NCT04179786|470249746|FG000|Overall Study|Withdrawal by Subject|8|||
130626025|NCT01938001|470249747|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
130626026|NCT01938001|470249748|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
130626027|NCT01938001|470249747|FG000|Pre-Treatment|Death|1|||
130626028|NCT01938001|470249748|FG001|Pre-Treatment|Death|0|||
130626029|NCT01938001|470249747|FG000|Treatment|Death|2|||
130626030|NCT01938001|470249748|FG001|Treatment|Death|0|||
130626031|NCT01938001|470249747|FG000|Treatment|Adverse Event|14|||
130626032|NCT01938001|470249748|FG001|Treatment|Adverse Event|8|||
130626033|NCT01938001|470249747|FG000|Treatment|Progressive Disease|21|||
130626034|NCT01938001|470249748|FG001|Treatment|Progressive Disease|54|||
130626035|NCT01938001|470249747|FG000|Treatment|Withdrawal by Subject|13|||
130626036|NCT01938001|470249748|FG001|Treatment|Withdrawal by Subject|7|||
130626037|NCT01938001|470249747|FG000|Treatment|Other reasons|2|||
130626038|NCT01938001|470249748|FG001|Treatment|Other reasons|1|||
130626039|NCT03310580|470249749|FG000|Overall Study|Adverse Event|0|||
130626040|NCT03310580|470249750|FG001|Overall Study|Adverse Event|1|||
130626041|NCT03310580|470249751|FG002|Overall Study|Adverse Event|0|||
130626042|NCT04186663|470249756|FG000|Overall Study|Lost to Follow-up|1|||
130626043|NCT04186663|470249756|FG000|Overall Study|Unable to complete blood draw|3|||
130626044|NCT01184846|470249760|FG000|Overall Study|Adverse Event|2|||
130626045|NCT01184846|470249760|FG000|Overall Study|Insufficient response|1|||
130626046|NCT00892957|470249761|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
130626047|NCT00892957|470249762|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
130626048|NCT00892957|470249761|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
130626049|NCT00892957|470249762|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
130626050|NCT01999946|470249763|FG000|Overall Study|Participant not released from jail|2|||
130626051|NCT01999946|470249764|FG001|Overall Study|Participant not released from jail|2|||
130626052|NCT01999946|470249765|FG002|Overall Study|Participant not released from jail|0|||
130626053|NCT01999946|470249763|FG000|Overall Study|Not included in primary outcome analysis|0|||
130626054|NCT01999946|470249764|FG001|Overall Study|Not included in primary outcome analysis|0|||
130626055|NCT01999946|470249765|FG002|Overall Study|Not included in primary outcome analysis|79|||
130626056|NCT04876599|470249768|FG000|Overall Study|Missed|2|||
130626057|NCT04876599|470249769|FG001|Overall Study|Missed|0|||
130626058|NCT04876599|470249768|FG000|Overall Study|Declined|2|||
130626059|NCT04876599|470249769|FG001|Overall Study|Declined|3|||
130626060|NCT03175562|470249770|FG000|Overall Study|Adverse Event|1|||
130626061|NCT03175562|470249770|FG000|Overall Study|Lost to Follow-up|3|||
130626062|NCT03175562|470249770|FG000|Overall Study|Withdrawal by Subject|7|||
130626063|NCT03175562|470249770|FG000|Overall Study|Other (Not Specified)|5|||
130626064|NCT02146833|470249771|FG000|Overall Study|Death|10|||
130626065|NCT02146833|470249771|FG000|Overall Study|No longer consented to study treatment|1|||
130626066|NCT03700736|470249776|FG000|Overall Study|Pregnancy|1|||
130626067|NCT03700736|470249777|FG001|Overall Study|Pregnancy|1|||
130626068|NCT03700736|470249776|FG000|Overall Study|Withdrawal by Subject|2|||
130626069|NCT03700736|470249777|FG001|Overall Study|Withdrawal by Subject|6|||
130626070|NCT00642018|470249778|FG000|Overall Study|Adverse Event|11|||
130626071|NCT00642018|470249779|FG001|Overall Study|Adverse Event|36|||
130626072|NCT00642018|470249778|FG000|Overall Study|Withdrawal by Subject|4|||
130626073|NCT00642018|470249779|FG001|Overall Study|Withdrawal by Subject|10|||
130626074|NCT00642018|470249778|FG000|Overall Study|Progressive Disease|13|||
130626075|NCT00642018|470249779|FG001|Overall Study|Progressive Disease|18|||
130626076|NCT00642018|470249778|FG000|Overall Study|Physician Decision|0|||
130626077|NCT00642018|470249779|FG001|Overall Study|Physician Decision|10|||
130626078|NCT00642018|470249778|FG000|Overall Study|Protocol Violation|0|||
130626079|NCT00642018|470249779|FG001|Overall Study|Protocol Violation|1|||
130626080|NCT00642018|470249778|FG000|Overall Study|Death|0|||
130626081|NCT00642018|470249779|FG001|Overall Study|Death|3|||
130626082|NCT00642018|470249778|FG000|Overall Study|Entry Criteria Not Met|0|||
130626083|NCT00642018|470249779|FG001|Overall Study|Entry Criteria Not Met|1|||
130626084|NCT04126031|470249782|FG000|Part A|Withdrawal by Subject|0|||
130626085|NCT04126031|470249783|FG001|Part A|Withdrawal by Subject|0|||
130626086|NCT04126031|470249784|FG002|Part A|Withdrawal by Subject|1|||
130626087|NCT04126031|470249785|FG003|Part A|Withdrawal by Subject|0|||
130626088|NCT04126031|470249786|FG004|Part A|Withdrawal by Subject|0|||
130626089|NCT04126031|470249787|FG005|Part A|Withdrawal by Subject|0|||
130626090|NCT04126031|470249782|FG000|Part A|Other|1|||
130626091|NCT04126031|470249783|FG001|Part A|Other|0|||
130626092|NCT04126031|470249784|FG002|Part A|Other|0|||
130626093|NCT04126031|470249785|FG003|Part A|Other|0|||
130626094|NCT04126031|470249786|FG004|Part A|Other|0|||
130626095|NCT04126031|470249787|FG005|Part A|Other|0|||
130626096|NCT04126031|470249782|FG000|Part B|Adverse Event|0|||
130626097|NCT04126031|470249783|FG001|Part B|Adverse Event|0|||
130626098|NCT04126031|470249784|FG002|Part B|Adverse Event|0|||
130626099|NCT04126031|470249785|FG003|Part B|Adverse Event|0|||
130626100|NCT04126031|470249786|FG004|Part B|Adverse Event|0|||
130626101|NCT04126031|470249787|FG005|Part B|Adverse Event|2|||
130626102|NCT04126031|470249782|FG000|Part B|Pre-existing hypertransaminasemia|0|||
130626103|NCT04126031|470249783|FG001|Part B|Pre-existing hypertransaminasemia|0|||
130626104|NCT04126031|470249784|FG002|Part B|Pre-existing hypertransaminasemia|0|||
130626105|NCT04126031|470249785|FG003|Part B|Pre-existing hypertransaminasemia|0|||
130626106|NCT04126031|470249786|FG004|Part B|Pre-existing hypertransaminasemia|1|||
130626107|NCT04126031|470249787|FG005|Part B|Pre-existing hypertransaminasemia|0|||
130626108|NCT00617656|470249788|FG000|Overall Study|Inclusion error|4|||
130626109|NCT00617656|470249789|FG001|Overall Study|Inclusion error|4|||
130626110|NCT00617656|470249790|FG002|Overall Study|Inclusion error|0|||
130626111|NCT00617656|470249791|FG003|Overall Study|Inclusion error|0|||
130626112|NCT00617656|470249788|FG000|Overall Study|Missing data|44|||
130626113|NCT00617656|470249789|FG001|Overall Study|Missing data|30|||
130626114|NCT00617656|470249790|FG002|Overall Study|Missing data|13|||
130626115|NCT00617656|470249791|FG003|Overall Study|Missing data|6|||
130626116|NCT00617656|470249788|FG000|Overall Study|Withdrawal by Subject|0|||
130626117|NCT00617656|470249789|FG001|Overall Study|Withdrawal by Subject|2|||
130626118|NCT00617656|470249790|FG002|Overall Study|Withdrawal by Subject|0|||
130626119|NCT00617656|470249791|FG003|Overall Study|Withdrawal by Subject|0|||
130626120|NCT00131664|470249792|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
130626121|NCT00131664|470249793|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
130626122|NCT00131664|470249794|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
130626123|NCT00131664|470249795|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
130626124|NCT00131664|470249796|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
130626125|NCT00131664|470249797|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
130626126|NCT00131664|470249792|FG000|First Period (First 6 Months)|Death|0|||
130626127|NCT00131664|470249793|FG001|First Period (First 6 Months)|Death|1|||
130626128|NCT00131664|470249794|FG002|First Period (First 6 Months)|Death|0|||
130626129|NCT00131664|470249795|FG003|First Period (First 6 Months)|Death|0|||
130626130|NCT00131664|470249796|FG004|First Period (First 6 Months)|Death|0|||
130626131|NCT00131664|470249797|FG005|First Period (First 6 Months)|Death|0|||
130626132|NCT00131664|470249792|FG000|First Period (First 6 Months)|Protocol Violation|2|||
130626133|NCT00131664|470249793|FG001|First Period (First 6 Months)|Protocol Violation|2|||
130626134|NCT00131664|470249794|FG002|First Period (First 6 Months)|Protocol Violation|1|||
130626135|NCT00131664|470249795|FG003|First Period (First 6 Months)|Protocol Violation|0|||
130626136|NCT00131664|470249796|FG004|First Period (First 6 Months)|Protocol Violation|0|||
130626137|NCT00131664|470249797|FG005|First Period (First 6 Months)|Protocol Violation|0|||
130626138|NCT00131664|470249792|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
130626139|NCT00131664|470249793|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
130626140|NCT00131664|470249794|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
130626141|NCT00131664|470249795|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
130626142|NCT00131664|470249796|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
130626143|NCT00131664|470249797|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
130626144|NCT00131664|470249792|FG000|First Period (First 6 Months)|Adverse Event|9|||
130626145|NCT00131664|470249793|FG001|First Period (First 6 Months)|Adverse Event|4|||
130626146|NCT00131664|470249794|FG002|First Period (First 6 Months)|Adverse Event|5|||
130626147|NCT00131664|470249795|FG003|First Period (First 6 Months)|Adverse Event|0|||
130626148|NCT00131664|470249796|FG004|First Period (First 6 Months)|Adverse Event|0|||
130626149|NCT00131664|470249797|FG005|First Period (First 6 Months)|Adverse Event|0|||
130626150|NCT00131664|470249792|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
130626151|NCT00131664|470249793|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
130626152|NCT00131664|470249794|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130626153|NCT00131664|470249795|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130626154|NCT00131664|470249796|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130626155|NCT00131664|470249797|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130626156|NCT00131664|470249792|FG000|First Period (First 6 Months)|Administrative reasons|2|||
130626157|NCT00131664|470249793|FG001|First Period (First 6 Months)|Administrative reasons|0|||
130626158|NCT00131664|470249794|FG002|First Period (First 6 Months)|Administrative reasons|5|||
130626159|NCT00131664|470249795|FG003|First Period (First 6 Months)|Administrative reasons|0|||
130626160|NCT00131664|470249796|FG004|First Period (First 6 Months)|Administrative reasons|0|||
130626161|NCT00131664|470249797|FG005|First Period (First 6 Months)|Administrative reasons|0|||
130626162|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
130626163|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
130626164|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
130626165|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
130626166|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
130626167|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
130626168|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
130626169|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
130626170|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
130626171|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
130626172|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
130626173|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
130626174|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
130626175|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130626176|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130626177|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130626178|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130626179|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130626180|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
130626181|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
130626182|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
130626183|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
130626184|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
130626185|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
130626186|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130626187|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130626188|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130626189|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
130626190|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130626191|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130626192|NCT00131664|470249792|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
130626193|NCT00131664|470249793|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
130626194|NCT00131664|470249794|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
130626195|NCT00131664|470249795|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
130626196|NCT00131664|470249796|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
130626197|NCT00131664|470249797|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
130626198|NCT05441540|470251279|FG000|Overall Study|Withdrawal by Subject|2|||
130626199|NCT03862495|470251280|FG000|Overall Study|Lost to Follow-up|37|||
130626200|NCT03862495|470251281|FG001|Overall Study|Lost to Follow-up|35|||
130626201|NCT00615914|470251282|FG000|Overall Study|Adverse Event|274|||
130626202|NCT00615914|470251282|FG000|Overall Study|Death|20|||
130626203|NCT00615914|470251282|FG000|Overall Study|Lack of Efficacy|59|||
130626204|NCT00615914|470251282|FG000|Overall Study|Lost to Follow-up|187|||
130626205|NCT00615914|470251282|FG000|Overall Study|Withdrawal by Subject|16|||
130626206|NCT00615914|470251282|FG000|Overall Study|Physician Decision|4|||
130626207|NCT00615914|470251282|FG000|Overall Study|No data was collected.|65|||
130626208|NCT00615914|470251282|FG000|Overall Study|No treatment|2|||
130626209|NCT00615914|470251282|FG000|Overall Study|Irregularly enrolled patients|10|||
130626210|NCT00425113|470251283|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
130626211|NCT00425113|470251284|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
130626212|NCT00425113|470251283|FG000|Overall Study|diagnosis of abdominal TB|0|||
130626213|NCT00425113|470251284|FG001|Overall Study|diagnosis of abdominal TB|1|||
130626214|NCT00425113|470251283|FG000|Overall Study|missing study drug more than 14 days|0|||
130626215|NCT00425113|470251284|FG001|Overall Study|missing study drug more than 14 days|1|||
130626216|NCT00425113|470251283|FG000|Overall Study|Withdrawal by Subject|1|||
130626217|NCT00425113|470251284|FG001|Overall Study|Withdrawal by Subject|0|||
130626218|NCT00879437|470251285|FG000|Overall Study|Protocol Violation|0|||
130626219|NCT00879437|470251286|FG001|Overall Study|Protocol Violation|1|||
130626220|NCT00879437|470251285|FG000|Overall Study|Death|1|||
130626221|NCT00879437|470251286|FG001|Overall Study|Death|0|||
130626222|NCT03000686|470251287|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
130626223|NCT03000686|470251288|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
130626224|NCT03000686|470251289|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
130626225|NCT03000686|470251290|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
130626226|NCT01112982|470251293|FG000|Overall Study|Withdrawal by Subject|1|||
130626227|NCT01112982|470251293|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
130626228|NCT00294684|470251294|FG000|Overall Study|Lost to Follow-up|5|||
130626229|NCT00294684|470251295|FG001|Overall Study|Lost to Follow-up|8|||
130626230|NCT00389441|470251296|FG000|Overall Study|Adverse Event|7|||
130626231|NCT00389441|470251296|FG000|Overall Study|Death|4|||
130626232|NCT00389441|470251296|FG000|Overall Study|Lost to Follow-up|2|||
130626233|NCT00389441|470251296|FG000|Overall Study|Withdrawal by Subject|4|||
130626234|NCT00389441|470251296|FG000|Overall Study|Physician Decision|1|||
130626235|NCT00389441|470251296|FG000|Overall Study|Protocol Violation|1|||
130626236|NCT00389441|470251296|FG000|Overall Study|Global deterioration of health status|4|||
130626237|NCT00389441|470251296|FG000|Overall Study|Objective progression or relapse|26|||
130626238|NCT00389441|470251296|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
130626239|NCT00389441|470251296|FG000|Overall Study|Clinical progression|1|||
130626240|NCT01981109|470251297|FG000|Overall Study|Death|36|||
130626241|NCT01981109|470251297|FG000|Overall Study|Withdrawal by Subject|40|||
130626242|NCT01981109|470251297|FG000|Overall Study|Lost to Follow-up|9|||
130626243|NCT01981109|470251297|FG000|Overall Study|No Discontinuation Documentation|37|||
130626244|NCT01981109|470251297|FG000|Overall Study|Study Termination|100|||
130626245|NCT01981109|470251297|FG000|Overall Study|No data available|2|||
130626246|NCT00126672|470251300|FG000|Overall Study|Adverse Event|4|||
130626247|NCT00126672|470251300|FG000|Overall Study|Lost to Follow-up|4|||
130626248|NCT01001234|470251306|FG000|Overall Study|Withdrawal by Subject|2|||
130626249|NCT01001234|470251307|FG001|Overall Study|Withdrawal by Subject|0|||
130626250|NCT01001234|470251308|FG002|Overall Study|Withdrawal by Subject|3|||
130626251|NCT01001234|470251309|FG003|Overall Study|Withdrawal by Subject|0|||
130626252|NCT01001234|470251310|FG004|Overall Study|Withdrawal by Subject|0|||
130626253|NCT01001234|470251306|FG000|Overall Study|Protocol Violation|34|||
130626254|NCT01001234|470251307|FG001|Overall Study|Protocol Violation|3|||
130626255|NCT01001234|470251308|FG002|Overall Study|Protocol Violation|19|||
130626256|NCT01001234|470251309|FG003|Overall Study|Protocol Violation|18|||
130626257|NCT01001234|470251310|FG004|Overall Study|Protocol Violation|0|||
130626258|NCT01001234|470251306|FG000|Overall Study|Lost to Follow-up|0|||
130626259|NCT01001234|470251307|FG001|Overall Study|Lost to Follow-up|0|||
130626260|NCT01001234|470251308|FG002|Overall Study|Lost to Follow-up|1|||
130626261|NCT01001234|470251309|FG003|Overall Study|Lost to Follow-up|2|||
130626262|NCT01001234|470251310|FG004|Overall Study|Lost to Follow-up|0|||
130626263|NCT01001234|470251306|FG000|Overall Study|Physician Decision|1|||
130626264|NCT01001234|470251307|FG001|Overall Study|Physician Decision|0|||
130626265|NCT01001234|470251308|FG002|Overall Study|Physician Decision|0|||
130626266|NCT01001234|470251309|FG003|Overall Study|Physician Decision|0|||
130626267|NCT01001234|470251310|FG004|Overall Study|Physician Decision|0|||
130626268|NCT01001234|470251306|FG000|Overall Study|Not Treated: Adverse Event|1|||
130626269|NCT01001234|470251307|FG001|Overall Study|Not Treated: Adverse Event|0|||
130626270|NCT01001234|470251308|FG002|Overall Study|Not Treated: Adverse Event|0|||
130626271|NCT01001234|470251309|FG003|Overall Study|Not Treated: Adverse Event|0|||
130626272|NCT01001234|470251310|FG004|Overall Study|Not Treated: Adverse Event|0|||
130626273|NCT01001234|470251306|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
130626274|NCT01001234|470251307|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
130626275|NCT01001234|470251308|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
130626276|NCT01001234|470251309|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
130626277|NCT01001234|470251310|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
130626278|NCT01001234|470251306|FG000|Overall Study|Not Treated: Protocol Violation|3|||
130626279|NCT01001234|470251307|FG001|Overall Study|Not Treated: Protocol Violation|0|||
130626280|NCT01001234|470251308|FG002|Overall Study|Not Treated: Protocol Violation|0|||
130626281|NCT01001234|470251309|FG003|Overall Study|Not Treated: Protocol Violation|0|||
130626282|NCT01001234|470251310|FG004|Overall Study|Not Treated: Protocol Violation|0|||
130626283|NCT01001234|470251306|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
130626284|NCT01001234|470251307|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
130626285|NCT01001234|470251308|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
130626286|NCT01001234|470251309|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
130626287|NCT01001234|470251310|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
130626288|NCT01001234|470251306|FG000|Overall Study|Not Treated: Pregnancy|3|||
130626289|NCT01001234|470251307|FG001|Overall Study|Not Treated: Pregnancy|0|||
130626290|NCT01001234|470251308|FG002|Overall Study|Not Treated: Pregnancy|0|||
130626291|NCT01001234|470251309|FG003|Overall Study|Not Treated: Pregnancy|0|||
130626292|NCT01001234|470251310|FG004|Overall Study|Not Treated: Pregnancy|0|||
130626293|NCT01001234|470251306|FG000|Overall Study|Not Treated: Physician Decision|37|||
130626294|NCT01001234|470251307|FG001|Overall Study|Not Treated: Physician Decision|4|||
130626295|NCT01001234|470251308|FG002|Overall Study|Not Treated: Physician Decision|0|||
130626296|NCT01001234|470251309|FG003|Overall Study|Not Treated: Physician Decision|0|||
130626297|NCT01001234|470251310|FG004|Overall Study|Not Treated: Physician Decision|0|||
130626298|NCT01001234|470251306|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
130626299|NCT01001234|470251307|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
130626300|NCT01001234|470251308|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130626301|NCT01001234|470251309|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130626302|NCT01001234|470251310|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130626303|NCT02076334|470251312|FG000|Overall Study|Protocol Violation|1|||
130626304|NCT02076334|470251313|FG001|Overall Study|Protocol Violation|0|||
130626305|NCT02076334|470251314|FG002|Overall Study|Protocol Violation|0|||
130626306|NCT02076334|470251315|FG003|Overall Study|Protocol Violation|0|||
130626307|NCT02076334|470251312|FG000|Overall Study|Lost to Follow-up|0|||
130626308|NCT02076334|470251313|FG001|Overall Study|Lost to Follow-up|1|||
130626309|NCT02076334|470251314|FG002|Overall Study|Lost to Follow-up|1|||
130626310|NCT02076334|470251315|FG003|Overall Study|Lost to Follow-up|0|||
130626311|NCT02076334|470251312|FG000|Overall Study|muscle soreness|0|||
130626312|NCT02076334|470251313|FG001|Overall Study|muscle soreness|0|||
130626313|NCT02076334|470251314|FG002|Overall Study|muscle soreness|0|||
130626314|NCT02076334|470251315|FG003|Overall Study|muscle soreness|1|||
130626315|NCT03379376|470251316|FG000|Overall Study|Lost to Follow-up|2|||
130626316|NCT03379376|470251316|FG000|Overall Study|Did not wish to complete follow up|1|||
130626317|NCT03379376|470251316|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
130626318|NCT03379376|470251316|FG000|Overall Study|Death|1|||
130626319|NCT01611298|470251317|FG000|Overall Study|Relapsed|2|||
130626320|NCT00753623|470251318|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
130626321|NCT00753623|470251319|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
130626322|NCT00753623|470251318|FG000|Phase I (14 Days)|Physician Decision|1|||
130626323|NCT00753623|470251319|FG001|Phase I (14 Days)|Physician Decision|2|||
130626324|NCT00753623|470251318|FG000|Phase I (14 Days)|Adverse Event|0|||
130626325|NCT00753623|470251319|FG001|Phase I (14 Days)|Adverse Event|1|||
130626326|NCT00753623|470251318|FG000|Washout (7 Days)|Physician Decision|1|||
130626327|NCT00753623|470251319|FG001|Washout (7 Days)|Physician Decision|0|||
130626328|NCT00753623|470251318|FG000|Phase II (14 Days)|Physician Decision|0|||
130626329|NCT00753623|470251319|FG001|Phase II (14 Days)|Physician Decision|1|||
130626330|NCT03332303|470251320|FG000|Overall Study|Participant did not dose|1|||
130626331|NCT03332303|470251321|FG001|Overall Study|Participant did not dose|2|||
130626332|NCT03332303|470251322|FG002|Overall Study|Participant did not dose|0|||
130626333|NCT03332303|470251320|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
130626334|NCT03332303|470251321|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
130626335|NCT03332303|470251322|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
130626336|NCT03332303|470251320|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
130626337|NCT03332303|470251321|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
130626338|NCT03332303|470251322|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
130626339|NCT03332303|470251320|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
130626340|NCT03332303|470251321|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
130626341|NCT03332303|470251322|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
130626342|NCT03332303|470251320|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
130626343|NCT03332303|470251321|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
130626344|NCT03332303|470251322|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
130626345|NCT03332303|470251320|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
130626346|NCT03332303|470251321|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
130626347|NCT03332303|470251322|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
130626348|NCT03332303|470251320|FG000|Overall Study|Participant had a significant protocol deviation|0|||
130626349|NCT03332303|470251321|FG001|Overall Study|Participant had a significant protocol deviation|1|||
130626350|NCT03332303|470251322|FG002|Overall Study|Participant had a significant protocol deviation|0|||
130626351|NCT01296698|470251323|FG000|Overall Study|Adverse Event|1|||
130626352|NCT01296698|470251324|FG001|Overall Study|Adverse Event|0|||
130626353|NCT01296698|470251323|FG000|Overall Study|Death|1|||
130626354|NCT01296698|470251324|FG001|Overall Study|Death|0|||
130626355|NCT01296698|470251323|FG000|Overall Study|Lost to Follow-up|19|||
130626356|NCT01296698|470251324|FG001|Overall Study|Lost to Follow-up|1|||
130626357|NCT01296698|470251323|FG000|Overall Study|Withdrawal by Subject|12|||
130626358|NCT01296698|470251324|FG001|Overall Study|Withdrawal by Subject|0|||
130626359|NCT01296698|470251323|FG000|Overall Study|Difficulty Contacting Subject|2|||
130626360|NCT01296698|470251324|FG001|Overall Study|Difficulty Contacting Subject|0|||
130626361|NCT01296698|470251323|FG000|Overall Study|Study Terminated by Sponsor|209|||
130626362|NCT01296698|470251324|FG001|Overall Study|Study Terminated by Sponsor|12|||
130626363|NCT03639987|470251325|FG000|Overall Study|Study terminated by sponsor|26|||
130626364|NCT03639987|470251326|FG001|Overall Study|Study terminated by sponsor|25|||
130626365|NCT03639987|470251325|FG000|Overall Study|Lost to Follow-up|0|||
130626366|NCT03639987|470251326|FG001|Overall Study|Lost to Follow-up|1|||
130626367|NCT02559713|470251333|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
130626368|NCT02193828|470251338|FG000|Overall Study|Withdrawal by Subject|0|||
130626369|NCT02193828|470251339|FG001|Overall Study|Withdrawal by Subject|0|||
130626370|NCT02193828|470251340|FG002|Overall Study|Withdrawal by Subject|1|||
130626371|NCT02193828|470251341|FG003|Overall Study|Withdrawal by Subject|1|||
130626372|NCT00889681|470251342|FG000|Overall Study|Not meeting qualification Criteria|2|||
130626373|NCT00889681|470251342|FG000|Overall Study|Insurance disapproval|1|||
130626374|NCT01185704|470251343|FG000|Overall Study|Randomized but not treated|3|||
130626375|NCT01185704|470251344|FG001|Overall Study|Randomized but not treated|3|||
130626376|NCT01185704|470251343|FG000|Overall Study|Lack of ovarian response|5|||
130626377|NCT01185704|470251344|FG001|Overall Study|Lack of ovarian response|1|||
130626378|NCT01185704|470251343|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
130626379|NCT01185704|470251344|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130626380|NCT01185704|470251343|FG000|Overall Study|Ectopic pregnancy|0|||
130626381|NCT01185704|470251344|FG001|Overall Study|Ectopic pregnancy|1|||
130626382|NCT01686958|470251345|FG000|Overall Study|Withdrawal by Subject|1|||
130626383|NCT01151540|470251350|FG000|Overall Study|Other|2|||
130626384|NCT01151540|470251350|FG000|Overall Study|Adverse event, non-fatal|4|||
130626385|NCT01151540|470251350|FG000|Overall Study|Withdrawal by Subject|7|||
130626386|NCT02248857|470251351|FG000|3 Month|Withdrawal by Subject|9|||
130626387|NCT02248857|470251352|FG001|3 Month|Withdrawal by Subject|3|||
130626388|NCT02248857|470251353|FG002|3 Month|Withdrawal by Subject|4|||
130626389|NCT02248857|470251351|FG000|3 Month|Unable to reach for 3 month|35|||
130626390|NCT02248857|470251352|FG001|3 Month|Unable to reach for 3 month|29|||
130626391|NCT02248857|470251353|FG002|3 Month|Unable to reach for 3 month|26|||
130626392|NCT02248857|470251351|FG000|3 Month|Partially completed, unable to finish|2|||
130626393|NCT02248857|470251352|FG001|3 Month|Partially completed, unable to finish|2|||
130626394|NCT02248857|470251353|FG002|3 Month|Partially completed, unable to finish|1|||
130626395|NCT02248857|470251351|FG000|6 Month|Lost to Follow-up|27|||
130626396|NCT02248857|470251352|FG001|6 Month|Lost to Follow-up|26|||
130626397|NCT02248857|470251353|FG002|6 Month|Lost to Follow-up|15|||
130626398|NCT02248857|470251351|FG000|6 Month|Partially completed, unable to finish|0|||
130626399|NCT02248857|470251352|FG001|6 Month|Partially completed, unable to finish|1|||
130626400|NCT02248857|470251353|FG002|6 Month|Partially completed, unable to finish|0|||
130626401|NCT02248857|470251351|FG000|6 Month|Withdrawal by Subject|0|||
130626402|NCT02248857|470251352|FG001|6 Month|Withdrawal by Subject|2|||
130626403|NCT02248857|470251353|FG002|6 Month|Withdrawal by Subject|2|||
130626404|NCT02248857|470251351|FG000|6 Month|Death|1|||
130626405|NCT02248857|470251352|FG001|6 Month|Death|0|||
130626406|NCT02248857|470251353|FG002|6 Month|Death|0|||
130626407|NCT02261883|470251354|FG000|Overall Study|Death|3|||
130626408|NCT02261883|470251355|FG001|Overall Study|Death|2|||
130626409|NCT02261883|470251354|FG000|Overall Study|Physician Decision|1|||
130626410|NCT02261883|470251355|FG001|Overall Study|Physician Decision|0|||
130626411|NCT02261883|470251354|FG000|Overall Study|Protocol Violation|1|||
130626412|NCT02261883|470251355|FG001|Overall Study|Protocol Violation|0|||
130626413|NCT02261883|470251354|FG000|Overall Study|Withdrawal by Subject|0|||
130626414|NCT02261883|470251355|FG001|Overall Study|Withdrawal by Subject|1|||
130626415|NCT02261883|470251354|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
130626416|NCT02261883|470251355|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
130626417|NCT02661464|470251360|FG000|Overall Study|Lost to Follow-up|28|||
130626418|NCT02661464|470251361|FG001|Overall Study|Lost to Follow-up|0|||
130626419|NCT02661464|470251362|FG002|Overall Study|Lost to Follow-up|0|||
130626420|NCT02661464|470251363|FG003|Overall Study|Lost to Follow-up|0|||
130626421|NCT02661464|470251360|FG000|Overall Study|Withdrawal by Subject|3|||
130626422|NCT02661464|470251361|FG001|Overall Study|Withdrawal by Subject|1|||
130626423|NCT02661464|470251362|FG002|Overall Study|Withdrawal by Subject|0|||
130626424|NCT02661464|470251363|FG003|Overall Study|Withdrawal by Subject|0|||
130626425|NCT02661464|470251360|FG000|Overall Study|Participants terminated prematurely|288|||
130626426|NCT02661464|470251361|FG001|Overall Study|Participants terminated prematurely|52|||
130626427|NCT02661464|470251362|FG002|Overall Study|Participants terminated prematurely|1|||
130626428|NCT02661464|470251363|FG003|Overall Study|Participants terminated prematurely|1|||
130626429|NCT02661464|470251360|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
130626430|NCT02661464|470251361|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
130626431|NCT02661464|470251362|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
130626432|NCT02661464|470251363|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
130626433|NCT05567393|470251364|FG000|Overall Study|Voluntary Withdrawal|0|||
130626434|NCT05567393|470251365|FG001|Overall Study|Voluntary Withdrawal|0|||
130626435|NCT05567393|470251366|FG002|Overall Study|Voluntary Withdrawal|0|||
130626436|NCT05567393|470251367|FG003|Overall Study|Voluntary Withdrawal|0|||
130626437|NCT05567393|470251368|FG004|Overall Study|Voluntary Withdrawal|0|||
130626438|NCT05567393|470251369|FG005|Overall Study|Voluntary Withdrawal|0|||
130626439|NCT05567393|470251370|FG006|Overall Study|Voluntary Withdrawal|0|||
130626440|NCT05567393|470251371|FG007|Overall Study|Voluntary Withdrawal|0|||
130626441|NCT05567393|470251372|FG008|Overall Study|Voluntary Withdrawal|0|||
130626442|NCT05567393|470251373|FG009|Overall Study|Voluntary Withdrawal|0|||
130626443|NCT05567393|470251374|FG010|Overall Study|Voluntary Withdrawal|0|||
130626444|NCT05567393|470251375|FG011|Overall Study|Voluntary Withdrawal|0|||
130626445|NCT05567393|470251376|FG012|Overall Study|Voluntary Withdrawal|0|||
130626446|NCT05567393|470251377|FG013|Overall Study|Voluntary Withdrawal|1|||
130626447|NCT05567393|470251378|FG014|Overall Study|Voluntary Withdrawal|0|||
130626448|NCT05567393|470251379|FG015|Overall Study|Voluntary Withdrawal|0|||
130626449|NCT05567393|470251380|FG016|Overall Study|Voluntary Withdrawal|0|||
130626450|NCT05567393|470251381|FG017|Overall Study|Voluntary Withdrawal|0|||
130626451|NCT03148756|470251382|FG000|Overall Study|Study Terminated|0|||
130626452|NCT03148756|470251383|FG001|Overall Study|Study Terminated|1|||
130626453|NCT02177175|470251388|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
130626454|NCT02177175|470251389|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
130626455|NCT00260429|470251390|FG000|Overall Study|failure to follow appointments|1|||
130626456|NCT00260429|470251391|FG001|Overall Study|failure to follow appointments|0|||
130626457|NCT00260429|470251390|FG000|Overall Study|scheduled hand surgery|1|||
130626458|NCT00260429|470251391|FG001|Overall Study|scheduled hand surgery|0|||
130626459|NCT00861380|470251392|FG000|Overall Study|Withdrawal Information not recorded|8427|||
130626460|NCT00861380|470251393|FG001|Overall Study|Withdrawal Information not recorded|9112|||
130626461|NCT00861380|470251394|FG002|Overall Study|Withdrawal Information not recorded|8872|||
130626462|NCT00861380|470251395|FG003|Overall Study|Withdrawal Information not recorded|3689|||
130626463|NCT00861380|470251396|FG004|Overall Study|Withdrawal Information not recorded|1812|||
130626464|NCT00861380|470251397|FG005|Overall Study|Withdrawal Information not recorded|6249|||
130626465|NCT00861380|470251398|FG006|Overall Study|Withdrawal Information not recorded|3020|||
130626466|NCT00628758|470251399|FG000|Overall Study|Adverse Event|2|||
130626467|NCT00628758|470251400|FG001|Overall Study|Adverse Event|3|||
130626468|NCT00628758|470251399|FG000|Overall Study|Withdrawal by Subject|6|||
130626469|NCT00628758|470251400|FG001|Overall Study|Withdrawal by Subject|3|||
130626470|NCT00628758|470251399|FG000|Overall Study|Death|1|||
130626471|NCT00628758|470251400|FG001|Overall Study|Death|0|||
130626472|NCT00628758|470251399|FG000|Overall Study|Protocol Violation|5|||
130626473|NCT00628758|470251400|FG001|Overall Study|Protocol Violation|1|||
130626474|NCT00628758|470251399|FG000|Overall Study|Lost to Follow-up|25|||
130626475|NCT00628758|470251400|FG001|Overall Study|Lost to Follow-up|31|||
130626476|NCT00628758|470251399|FG000|Overall Study|Pregnancy|2|||
130626477|NCT00628758|470251400|FG001|Overall Study|Pregnancy|2|||
130626478|NCT00628758|470251399|FG000|Overall Study|Investigator Moved|3|||
130626479|NCT00628758|470251400|FG001|Overall Study|Investigator Moved|0|||
130626480|NCT00628758|470251399|FG000|Overall Study|Treatment Failure|0|||
130626481|NCT00628758|470251400|FG001|Overall Study|Treatment Failure|2|||
130626482|NCT00637377|470251401|FG000|Overall Study|Adverse Event|2|||
130626483|NCT00637377|470251402|FG001|Overall Study|Adverse Event|6|||
130626484|NCT00637377|470251403|FG002|Overall Study|Adverse Event|8|||
130626485|NCT00637377|470251404|FG003|Overall Study|Adverse Event|9|||
130626486|NCT00637377|470251401|FG000|Overall Study|Death|1|||
130626487|NCT00637377|470251402|FG001|Overall Study|Death|3|||
130626488|NCT00637377|470251403|FG002|Overall Study|Death|2|||
130626489|NCT00637377|470251404|FG003|Overall Study|Death|1|||
130626490|NCT00637377|470251401|FG000|Overall Study|Lack of Efficacy|0|||
130626491|NCT00637377|470251402|FG001|Overall Study|Lack of Efficacy|0|||
130626492|NCT00637377|470251403|FG002|Overall Study|Lack of Efficacy|1|||
130626493|NCT00637377|470251404|FG003|Overall Study|Lack of Efficacy|1|||
130626494|NCT00637377|470251401|FG000|Overall Study|Lost to Follow-up|4|||
130626495|NCT00637377|470251402|FG001|Overall Study|Lost to Follow-up|1|||
130626496|NCT00637377|470251403|FG002|Overall Study|Lost to Follow-up|2|||
130626497|NCT00637377|470251404|FG003|Overall Study|Lost to Follow-up|2|||
130626498|NCT00637377|470251401|FG000|Overall Study|Protocol Violation|2|||
130626499|NCT00637377|470251402|FG001|Overall Study|Protocol Violation|1|||
130626500|NCT00637377|470251403|FG002|Overall Study|Protocol Violation|1|||
130626501|NCT00637377|470251404|FG003|Overall Study|Protocol Violation|0|||
130626502|NCT00637377|470251401|FG000|Overall Study|Withdrawal by Subject|11|||
130626503|NCT00637377|470251402|FG001|Overall Study|Withdrawal by Subject|15|||
130626504|NCT00637377|470251403|FG002|Overall Study|Withdrawal by Subject|13|||
130626505|NCT00637377|470251404|FG003|Overall Study|Withdrawal by Subject|11|||
130626506|NCT00637377|470251401|FG000|Overall Study|Other (no further information available)|7|||
130626507|NCT00637377|470251402|FG001|Overall Study|Other (no further information available)|6|||
130626508|NCT00637377|470251403|FG002|Overall Study|Other (no further information available)|10|||
130626509|NCT00637377|470251404|FG003|Overall Study|Other (no further information available)|5|||
130626510|NCT02762708|470251406|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130626511|NCT02762708|470251407|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
130626512|NCT02762708|470251408|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130626513|NCT02762708|470251409|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130626514|NCT01468701|470251416|FG000|Overall Study|Not eligible|91|||
130626515|NCT01468701|470251417|FG001|Overall Study|Not eligible|140|||
130626516|NCT01468701|470251418|FG002|Overall Study|Not eligible|29|||
130626517|NCT01468701|470251419|FG003|Overall Study|Not eligible|12|||
130626518|NCT01468701|470251420|FG004|Overall Study|Not eligible|22|||
130626519|NCT01468701|470251421|FG005|Overall Study|Not eligible|2|||
130626520|NCT01468701|470251422|FG006|Overall Study|Not eligible|39|||
130626521|NCT01468701|470251423|FG007|Overall Study|Not eligible|1|||
130626522|NCT01468701|470251424|FG008|Overall Study|Not eligible|40|||
130626523|NCT01468701|470251425|FG009|Overall Study|Not eligible|126|||
130626524|NCT01468701|470251426|FG010|Overall Study|Not eligible|39|||
130626525|NCT01468701|470251427|FG011|Overall Study|Not eligible|33|||
130626526|NCT01468701|470251428|FG012|Overall Study|Not eligible|1|||
130626527|NCT01468701|470251429|FG013|Overall Study|Not eligible|19|||
130626528|NCT01468701|470251430|FG014|Overall Study|Not eligible|1|||
130626529|NCT01468701|470251431|FG015|Overall Study|Not eligible|32|||
130626530|NCT01468701|470251432|FG016|Overall Study|Not eligible|0|||
130626531|NCT01468701|470251416|FG000|Overall Study|Lost to Follow-up|306|||
130626532|NCT01468701|470251417|FG001|Overall Study|Lost to Follow-up|0|||
130626533|NCT01468701|470251418|FG002|Overall Study|Lost to Follow-up|0|||
130626534|NCT01468701|470251419|FG003|Overall Study|Lost to Follow-up|0|||
130626535|NCT01468701|470251420|FG004|Overall Study|Lost to Follow-up|0|||
130626536|NCT01468701|470251421|FG005|Overall Study|Lost to Follow-up|0|||
130626537|NCT01468701|470251422|FG006|Overall Study|Lost to Follow-up|0|||
130626538|NCT01468701|470251423|FG007|Overall Study|Lost to Follow-up|0|||
130626539|NCT01468701|470251424|FG008|Overall Study|Lost to Follow-up|215|||
130626540|NCT01468701|470251425|FG009|Overall Study|Lost to Follow-up|309|||
130626541|NCT01468701|470251426|FG010|Overall Study|Lost to Follow-up|224|||
130626542|NCT01468701|470251427|FG011|Overall Study|Lost to Follow-up|212|||
130626543|NCT01468701|470251428|FG012|Overall Study|Lost to Follow-up|11|||
130626544|NCT01468701|470251429|FG013|Overall Study|Lost to Follow-up|164|||
130626545|NCT01468701|470251430|FG014|Overall Study|Lost to Follow-up|17|||
130626546|NCT01468701|470251431|FG015|Overall Study|Lost to Follow-up|127|||
130626547|NCT01468701|470251432|FG016|Overall Study|Lost to Follow-up|1|||
130626548|NCT01468701|470251416|FG000|Overall Study|Withdrawal by Subject|165|||
130626549|NCT01468701|470251417|FG001|Overall Study|Withdrawal by Subject|0|||
130626550|NCT01468701|470251418|FG002|Overall Study|Withdrawal by Subject|0|||
130626551|NCT01468701|470251419|FG003|Overall Study|Withdrawal by Subject|0|||
130626552|NCT01468701|470251420|FG004|Overall Study|Withdrawal by Subject|0|||
130626553|NCT01468701|470251421|FG005|Overall Study|Withdrawal by Subject|0|||
130626554|NCT01468701|470251422|FG006|Overall Study|Withdrawal by Subject|0|||
130626555|NCT01468701|470251423|FG007|Overall Study|Withdrawal by Subject|0|||
130626556|NCT01468701|470251424|FG008|Overall Study|Withdrawal by Subject|83|||
130626557|NCT01468701|470251425|FG009|Overall Study|Withdrawal by Subject|88|||
130626558|NCT01468701|470251426|FG010|Overall Study|Withdrawal by Subject|100|||
130626559|NCT01468701|470251427|FG011|Overall Study|Withdrawal by Subject|114|||
130626560|NCT01468701|470251428|FG012|Overall Study|Withdrawal by Subject|9|||
130626561|NCT01468701|470251429|FG013|Overall Study|Withdrawal by Subject|47|||
130626562|NCT01468701|470251430|FG014|Overall Study|Withdrawal by Subject|6|||
130626563|NCT01468701|470251431|FG015|Overall Study|Withdrawal by Subject|31|||
130626564|NCT01468701|470251432|FG016|Overall Study|Withdrawal by Subject|0|||
130626565|NCT01468701|470251416|FG000|Overall Study|Other reasons than listed|437|||
130626566|NCT01468701|470251417|FG001|Overall Study|Other reasons than listed|0|||
130626567|NCT01468701|470251418|FG002|Overall Study|Other reasons than listed|0|||
130626568|NCT01468701|470251419|FG003|Overall Study|Other reasons than listed|0|||
130626569|NCT01468701|470251420|FG004|Overall Study|Other reasons than listed|0|||
130626570|NCT01468701|470251421|FG005|Overall Study|Other reasons than listed|0|||
130626571|NCT01468701|470251422|FG006|Overall Study|Other reasons than listed|0|||
130626572|NCT01468701|470251423|FG007|Overall Study|Other reasons than listed|0|||
130626573|NCT01468701|470251424|FG008|Overall Study|Other reasons than listed|318|||
130626574|NCT01468701|470251425|FG009|Overall Study|Other reasons than listed|658|||
130626575|NCT01468701|470251426|FG010|Overall Study|Other reasons than listed|433|||
130626576|NCT01468701|470251427|FG011|Overall Study|Other reasons than listed|504|||
130626577|NCT01468701|470251428|FG012|Overall Study|Other reasons than listed|28|||
130626578|NCT01468701|470251429|FG013|Overall Study|Other reasons than listed|239|||
130626579|NCT01468701|470251430|FG014|Overall Study|Other reasons than listed|39|||
130626580|NCT01468701|470251431|FG015|Overall Study|Other reasons than listed|172|||
130626581|NCT01468701|470251432|FG016|Overall Study|Other reasons than listed|0|||
130626582|NCT01468701|470251416|FG000|Overall Study|No end of study case report form|0|||
130626583|NCT01468701|470251417|FG001|Overall Study|No end of study case report form|0|||
130626584|NCT01468701|470251418|FG002|Overall Study|No end of study case report form|0|||
130626585|NCT01468701|470251419|FG003|Overall Study|No end of study case report form|0|||
130626586|NCT01468701|470251420|FG004|Overall Study|No end of study case report form|0|||
130626587|NCT01468701|470251421|FG005|Overall Study|No end of study case report form|0|||
130626588|NCT01468701|470251422|FG006|Overall Study|No end of study case report form|0|||
130626589|NCT01468701|470251423|FG007|Overall Study|No end of study case report form|0|||
130626590|NCT01468701|470251424|FG008|Overall Study|No end of study case report form|4|||
130626591|NCT01468701|470251425|FG009|Overall Study|No end of study case report form|1|||
130626592|NCT01468701|470251426|FG010|Overall Study|No end of study case report form|2|||
130626593|NCT01468701|470251427|FG011|Overall Study|No end of study case report form|3|||
130626594|NCT01468701|470251428|FG012|Overall Study|No end of study case report form|0|||
130626595|NCT01468701|470251429|FG013|Overall Study|No end of study case report form|1|||
130626596|NCT01468701|470251430|FG014|Overall Study|No end of study case report form|0|||
130626597|NCT01468701|470251431|FG015|Overall Study|No end of study case report form|0|||
130626598|NCT01468701|470251432|FG016|Overall Study|No end of study case report form|0|||
130626599|NCT01468701|470251416|FG000|Overall Study|Not being followed up|0|||
130626600|NCT01468701|470251417|FG001|Overall Study|Not being followed up|4963|||
130626601|NCT01468701|470251418|FG002|Overall Study|Not being followed up|1755|||
130626602|NCT01468701|470251419|FG003|Overall Study|Not being followed up|703|||
130626603|NCT01468701|470251420|FG004|Overall Study|Not being followed up|1714|||
130626604|NCT01468701|470251421|FG005|Overall Study|Not being followed up|126|||
130626605|NCT01468701|470251422|FG006|Overall Study|Not being followed up|1170|||
130626606|NCT01468701|470251423|FG007|Overall Study|Not being followed up|4|||
130626607|NCT01468701|470251424|FG008|Overall Study|Not being followed up|0|||
130626608|NCT01468701|470251425|FG009|Overall Study|Not being followed up|0|||
130626609|NCT01468701|470251426|FG010|Overall Study|Not being followed up|0|||
130626610|NCT01468701|470251427|FG011|Overall Study|Not being followed up|0|||
130626611|NCT01468701|470251428|FG012|Overall Study|Not being followed up|0|||
130626612|NCT01468701|470251429|FG013|Overall Study|Not being followed up|0|||
130626613|NCT01468701|470251430|FG014|Overall Study|Not being followed up|0|||
130626614|NCT01468701|470251431|FG015|Overall Study|Not being followed up|0|||
130626615|NCT01468701|470251432|FG016|Overall Study|Not being followed up|0|||
130626616|NCT01068717|470251433|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
130626617|NCT01068717|470251434|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130626618|NCT01068717|470251435|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130626619|NCT01068717|470251436|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130626620|NCT01822223|470251437|FG000|Overall Study|Death|0|||
130626621|NCT01822223|470251438|FG001|Overall Study|Death|1|||
130626622|NCT00719862|470251442|FG000|Overall Study|Adverse Event|1|||
130626623|NCT00719862|470251443|FG001|Overall Study|Adverse Event|2|||
130626624|NCT00719862|470251442|FG000|Overall Study|Lack of Efficacy|3|||
130626625|NCT00719862|470251443|FG001|Overall Study|Lack of Efficacy|0|||
130626626|NCT00719862|470251442|FG000|Overall Study|Non-Compliance|1|||
130626627|NCT00719862|470251443|FG001|Overall Study|Non-Compliance|0|||
130626628|NCT00719862|470251442|FG000|Overall Study|Withdrawal by Subject|1|||
130626629|NCT00719862|470251443|FG001|Overall Study|Withdrawal by Subject|0|||
130626630|NCT00719862|470251442|FG000|Overall Study|Lost to Follow-up|0|||
130626631|NCT00719862|470251443|FG001|Overall Study|Lost to Follow-up|1|||
130626632|NCT00719862|470251442|FG000|Overall Study|Other|2|||
130626633|NCT00719862|470251443|FG001|Overall Study|Other|3|||
130626634|NCT00107172|470253613|FG000|Overall Study|Withdrawal by Subject|1|||
130626635|NCT00107172|470253614|FG001|Overall Study|Withdrawal by Subject|0|||
130626636|NCT00107172|470253613|FG000|Overall Study|Death|0|||
130626637|NCT00107172|470253614|FG001|Overall Study|Death|2|||
130626638|NCT00107172|470253613|FG000|Overall Study|Other Reason|4|||
130626639|NCT00107172|470253614|FG001|Overall Study|Other Reason|3|||
130626640|NCT02688153|470253615|FG000|Overall Study|Death|7|||
130626641|NCT02688153|470253616|FG001|Overall Study|Death|5|||
130626642|NCT02688153|470253615|FG000|Overall Study|Withdrawal by Subject|4|||
130626643|NCT02688153|470253616|FG001|Overall Study|Withdrawal by Subject|2|||
130626644|NCT02688153|470253615|FG000|Overall Study|Valve Explant|1|||
130626645|NCT02688153|470253616|FG001|Overall Study|Valve Explant|0|||
130626646|NCT02688153|470253615|FG000|Overall Study|Conversion to Commercial Valve|3|||
130626647|NCT02688153|470253616|FG001|Overall Study|Conversion to Commercial Valve|0|||
130626648|NCT01102140|470253617|FG000|Overall Study|Lost to Follow-up|1|||
130626649|NCT01102140|470253618|FG001|Overall Study|Lost to Follow-up|0|||
130626650|NCT01102140|470253617|FG000|Overall Study|Investigator terminated study|2|||
130626651|NCT01102140|470253618|FG001|Overall Study|Investigator terminated study|2|||
130626652|NCT03682055|470253619|FG000|Overall Study|Lack of Efficacy|1|||
130626653|NCT03682055|470253620|FG001|Overall Study|Lack of Efficacy|2|||
130626654|NCT03682055|470253621|FG002|Overall Study|Lack of Efficacy|1|||
130626655|NCT03682055|470253622|FG003|Overall Study|Lack of Efficacy|2|||
130626656|NCT03682055|470253623|FG004|Overall Study|Lack of Efficacy|1|||
130626657|NCT03682055|470253624|FG005|Overall Study|Lack of Efficacy|3|||
130626658|NCT03682055|470253619|FG000|Overall Study|Withdrawal by Subject|0|||
130626659|NCT03682055|470253620|FG001|Overall Study|Withdrawal by Subject|0|||
130626660|NCT03682055|470253621|FG002|Overall Study|Withdrawal by Subject|0|||
130626661|NCT03682055|470253622|FG003|Overall Study|Withdrawal by Subject|0|||
130626662|NCT03682055|470253623|FG004|Overall Study|Withdrawal by Subject|0|||
130626663|NCT03682055|470253624|FG005|Overall Study|Withdrawal by Subject|1|||
130626664|NCT03682055|470253619|FG000|Overall Study|Termination of Study by Sponsor|0|||
130626665|NCT03682055|470253620|FG001|Overall Study|Termination of Study by Sponsor|0|||
130626666|NCT03682055|470253621|FG002|Overall Study|Termination of Study by Sponsor|0|||
130626667|NCT03682055|470253622|FG003|Overall Study|Termination of Study by Sponsor|0|||
130626668|NCT03682055|470253623|FG004|Overall Study|Termination of Study by Sponsor|0|||
130626669|NCT03682055|470253624|FG005|Overall Study|Termination of Study by Sponsor|3|||
130626670|NCT02687711|470253625|FG000|Overall Study|Adverse Event|89|||
130626671|NCT02687711|470253625|FG000|Overall Study|Lack of Efficacy|70|||
130626672|NCT02687711|470253625|FG000|Overall Study|Lost to Follow-up|20|||
130626673|NCT02687711|470253625|FG000|Overall Study|Consent withdrawn|15|||
130626674|NCT02687711|470253625|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
130626675|NCT02687711|470253625|FG000|Overall Study|Too expensive|4|||
130626676|NCT02687711|470253625|FG000|Overall Study|Participant moved abroad|1|||
130626677|NCT02687711|470253625|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
130626678|NCT02687711|470253625|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
130626679|NCT02687711|470253625|FG000|Overall Study|Disliked taste|1|||
130626680|NCT02687711|470253625|FG000|Overall Study|Low mood|1|||
130626681|NCT02687711|470253625|FG000|Overall Study|Side effects|1|||
130626682|NCT02687711|470253625|FG000|Overall Study|Change of Hospital|1|||
130626683|NCT02687711|470253625|FG000|Overall Study|Liver Encephalopathy|1|||
130626684|NCT02687711|470253625|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
130626685|NCT02687711|470253625|FG000|Overall Study|Withdrawn due to intake interruption|1|||
130626686|NCT02687711|470253625|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
130626687|NCT02687711|470253625|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
130626688|NCT02687711|470253625|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
130626689|NCT03621189|470253626|FG000|Overall Study|Withdrawal by Subject|0|||
130626690|NCT03621189|470253627|FG001|Overall Study|Withdrawal by Subject|3|||
130626691|NCT03621189|470253626|FG000|Overall Study|Physician Decision|0|||
130626692|NCT03621189|470253627|FG001|Overall Study|Physician Decision|2|||
130626693|NCT01135394|470253628|FG000|Screening|Lost to Follow-up|2|||
130626694|NCT01135394|470253628|FG000|Screening|Withdrawal by Subject|10|||
130626695|NCT01135394|470253628|FG000|Screening|Screening failure|16|||
130626696|NCT01135394|470253628|FG000|Screening|Physician Decision|5|||
130626697|NCT01135394|470253628|FG000|Baseline Assessment|Withdrawal by Subject|9|||
130626698|NCT01135394|470253628|FG000|Baseline Assessment|Physician Decision|3|||
130626699|NCT01135394|470253628|FG000|Baseline Assessment|Lost to Follow-up|2|||
130626700|NCT01135394|470253628|FG000|Baseline Assessment|Adverse Event|1|||
130626701|NCT01135394|470253628|FG000|Study Treatment|Withdrawal by Subject|1|||
130626702|NCT01135394|470253628|FG000|Study Treatment|Physician Decision|1|||
130626703|NCT01135394|470253628|FG000|Study Treatment|Adverse Event|2|||
130626704|NCT00191386|470253629|FG000|Overall Study|Adverse Event|16|||
130626705|NCT00191386|470253629|FG000|Overall Study|Lost to Follow-up|1|||
130626706|NCT00191386|470253629|FG000|Overall Study|Entry Criteria Exclusion|3|||
130626707|NCT00191386|470253629|FG000|Overall Study|Protocol Violation|18|||
130626708|NCT00191386|470253629|FG000|Overall Study|Withdrawal by Subject|96|||
130626709|NCT00191386|470253629|FG000|Overall Study|Physician Decision|11|||
130626710|NCT00191386|470253629|FG000|Overall Study|Lack of Efficacy|15|||
130626711|NCT00462488|470253630|FG000|Overall Study|Protocol Violation|1|||
130626712|NCT00462488|470253631|FG001|Overall Study|Protocol Violation|0|||
130626713|NCT00462488|470253630|FG000|Overall Study|Lack of Efficacy|19|||
130626714|NCT00462488|470253631|FG001|Overall Study|Lack of Efficacy|17|||
130626715|NCT01742091|470253636|FG000|Overall Study|Adverse Event|0|||
130626716|NCT01742091|470253637|FG001|Overall Study|Adverse Event|0|||
130626717|NCT01742091|470253638|FG002|Overall Study|Adverse Event|0|||
130626718|NCT01742091|470253639|FG003|Overall Study|Adverse Event|0|||
130626719|NCT01742091|470253640|FG004|Overall Study|Adverse Event|1|||
130626720|NCT01742091|470253641|FG005|Overall Study|Adverse Event|0|||
130626721|NCT01742091|470253636|FG000|Overall Study|Physician Decision|0|||
130626722|NCT01742091|470253637|FG001|Overall Study|Physician Decision|0|||
130626723|NCT01742091|470253638|FG002|Overall Study|Physician Decision|0|||
130626724|NCT01742091|470253639|FG003|Overall Study|Physician Decision|0|||
130626725|NCT01742091|470253640|FG004|Overall Study|Physician Decision|0|||
130626726|NCT01742091|470253641|FG005|Overall Study|Physician Decision|1|||
130626727|NCT01742091|470253636|FG000|Overall Study|Withdrawal by Subject|0|||
130626728|NCT01742091|470253637|FG001|Overall Study|Withdrawal by Subject|0|||
130626729|NCT01742091|470253638|FG002|Overall Study|Withdrawal by Subject|0|||
130626730|NCT01742091|470253639|FG003|Overall Study|Withdrawal by Subject|1|||
130626731|NCT01742091|470253640|FG004|Overall Study|Withdrawal by Subject|0|||
130626732|NCT01742091|470253641|FG005|Overall Study|Withdrawal by Subject|0|||
130626733|NCT01742091|470253636|FG000|Overall Study|Lost to Follow-up|0|||
130626734|NCT01742091|470253637|FG001|Overall Study|Lost to Follow-up|0|||
130626735|NCT01742091|470253638|FG002|Overall Study|Lost to Follow-up|0|||
130626736|NCT01742091|470253639|FG003|Overall Study|Lost to Follow-up|0|||
130626737|NCT01742091|470253640|FG004|Overall Study|Lost to Follow-up|0|||
130626738|NCT01742091|470253641|FG005|Overall Study|Lost to Follow-up|1|||
130626739|NCT03706040|470253642|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
130626740|NCT03706040|470253643|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
130626741|NCT03706040|470253644|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
130626742|NCT03706040|470253645|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
130626743|NCT03706040|470253646|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
130626744|NCT03706040|470253647|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
130626745|NCT03706040|470253648|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
130626746|NCT03706040|470253642|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
130626747|NCT03706040|470253643|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
130626748|NCT03706040|470253644|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
130626749|NCT03706040|470253645|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130626750|NCT03706040|470253646|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130626751|NCT03706040|470253647|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130626752|NCT03706040|470253648|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130626753|NCT03706040|470253642|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
130626754|NCT03706040|470253643|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
130626755|NCT03706040|470253644|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
130626756|NCT03706040|470253645|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130626757|NCT03706040|470253646|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130626758|NCT03706040|470253647|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130626759|NCT03706040|470253648|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130626760|NCT03706040|470253642|FG000|Period A (Week 0 to Week 16)|Other|2|||
130626761|NCT03706040|470253643|FG001|Period A (Week 0 to Week 16)|Other|0|||
130626762|NCT03706040|470253644|FG002|Period A (Week 0 to Week 16)|Other|2|||
130626763|NCT03706040|470253645|FG003|Period A (Week 0 to Week 16)|Other|0|||
130626764|NCT03706040|470253646|FG004|Period A (Week 0 to Week 16)|Other|0|||
130626765|NCT03706040|470253647|FG005|Period A (Week 0 to Week 16)|Other|0|||
130626766|NCT03706040|470253648|FG006|Period A (Week 0 to Week 16)|Other|0|||
130626767|NCT03706040|470253642|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
130626768|NCT03706040|470253643|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
130626769|NCT03706040|470253644|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
130626770|NCT03706040|470253645|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
130626771|NCT03706040|470253646|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
130626772|NCT03706040|470253647|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
130626773|NCT03706040|470253648|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
130626774|NCT03706040|470253642|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130626775|NCT03706040|470253643|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130626776|NCT03706040|470253644|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130626777|NCT03706040|470253645|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
130626778|NCT03706040|470253646|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
130626779|NCT03706040|470253647|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
130626780|NCT03706040|470253648|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
130626781|NCT03706040|470253642|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130626782|NCT03706040|470253643|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130626783|NCT03706040|470253644|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130626784|NCT03706040|470253645|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130626785|NCT03706040|470253646|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130626786|NCT03706040|470253647|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
130626787|NCT03706040|470253648|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
130626788|NCT03706040|470253642|FG000|Period B (Week 16 to Week 52)|Other|0|||
130626789|NCT03706040|470253643|FG001|Period B (Week 16 to Week 52)|Other|0|||
130626790|NCT03706040|470253644|FG002|Period B (Week 16 to Week 52)|Other|0|||
130626791|NCT03706040|470253645|FG003|Period B (Week 16 to Week 52)|Other|4|||
130626792|NCT03706040|470253646|FG004|Period B (Week 16 to Week 52)|Other|5|||
130626793|NCT03706040|470253647|FG005|Period B (Week 16 to Week 52)|Other|23|||
130626794|NCT03706040|470253648|FG006|Period B (Week 16 to Week 52)|Other|17|||
130626795|NCT03077243|470253649|FG000|Overall Study|Death|1|||
130626796|NCT03077243|470253650|FG001|Overall Study|Death|2|||
130626797|NCT03077243|470253651|FG002|Overall Study|Death|0|||
130626798|NCT03077243|470253652|FG003|Overall Study|Death|0|||
130626799|NCT03077243|470253649|FG000|Overall Study|Withdrawal by Subject|1|||
130626800|NCT03077243|470253650|FG001|Overall Study|Withdrawal by Subject|3|||
130626801|NCT03077243|470253651|FG002|Overall Study|Withdrawal by Subject|0|||
130626802|NCT03077243|470253652|FG003|Overall Study|Withdrawal by Subject|0|||
130626803|NCT03077243|470253649|FG000|Overall Study|Physician Decision|1|||
130626804|NCT03077243|470253650|FG001|Overall Study|Physician Decision|0|||
130626805|NCT03077243|470253651|FG002|Overall Study|Physician Decision|0|||
130626806|NCT03077243|470253652|FG003|Overall Study|Physician Decision|0|||
130626807|NCT03077243|470253649|FG000|Overall Study|Research at two study sites terminated early|0|||
130626808|NCT03077243|470253650|FG001|Overall Study|Research at two study sites terminated early|0|||
130626809|NCT03077243|470253651|FG002|Overall Study|Research at two study sites terminated early|0|||
130626810|NCT03077243|470253652|FG003|Overall Study|Research at two study sites terminated early|69|||
130626811|NCT00212758|470253656|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
130626812|NCT00212758|470253657|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
130626813|NCT00212758|470253656|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
130626814|NCT00212758|470253657|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
130626815|NCT03510910|470253658|FG000|Overall Study|Incomplete Survey|2|||
130626816|NCT03510910|470253659|FG001|Overall Study|Incomplete Survey|3|||
130626817|NCT01105936|470253660|FG000|Period 1|Adverse Event|0|||
130626818|NCT01105936|470253661|FG001|Period 1|Adverse Event|0|||
130626819|NCT01105936|470253662|FG002|Period 1|Adverse Event|0|||
130626820|NCT01105936|470253663|FG003|Period 1|Adverse Event|1|||
130626821|NCT01105936|470253660|FG000|Period 2|Adverse Event|1|||
130626822|NCT01105936|470253661|FG001|Period 2|Adverse Event|0|||
130626823|NCT01105936|470253662|FG002|Period 2|Adverse Event|0|||
130626824|NCT01105936|470253663|FG003|Period 2|Adverse Event|0|||
130626825|NCT01105936|470253660|FG000|Period 3|Protocol Violation|0|||
130626826|NCT01105936|470253661|FG001|Period 3|Protocol Violation|2|||
130626827|NCT01105936|470253662|FG002|Period 3|Protocol Violation|0|||
130626828|NCT01105936|470253663|FG003|Period 3|Protocol Violation|0|||
130626829|NCT01673490|470253664|FG000|Overall Study|Lost to Follow-up|1|||
130626830|NCT01673490|470253664|FG000|Overall Study|Adverse Event|3|||
130626831|NCT01673490|470253664|FG000|Overall Study|Withdrawal by Subject|3|||
130626832|NCT02940860|470253672|FG000|Overall Study|Non-serious AE|1|||
130626833|NCT02940860|470253673|FG001|Overall Study|Non-serious AE|2|||
130626834|NCT02940860|470253672|FG000|Overall Study|Serious AE|7|||
130626835|NCT02940860|470253673|FG001|Overall Study|Serious AE|3|||
130626836|NCT02940860|470253672|FG000|Overall Study|Withdrawal by Subject|19|||
130626837|NCT02940860|470253673|FG001|Overall Study|Withdrawal by Subject|9|||
130626838|NCT02940860|470253672|FG000|Overall Study|Lost to Follow-up|13|||
130626839|NCT02940860|470253673|FG001|Overall Study|Lost to Follow-up|7|||
130626840|NCT02940860|470253672|FG000|Overall Study|Physician Decision|5|||
130626841|NCT02940860|470253673|FG001|Overall Study|Physician Decision|3|||
130626842|NCT02940860|470253672|FG000|Overall Study|Sponsor Decision|0|||
130626843|NCT02940860|470253673|FG001|Overall Study|Sponsor Decision|1|||
130626844|NCT02940860|470253672|FG000|Overall Study|Protocol Violation|0|||
130626845|NCT02940860|470253673|FG001|Overall Study|Protocol Violation|2|||
130626846|NCT02940860|470253672|FG000|Overall Study|Death|3|||
130626847|NCT02940860|470253673|FG001|Overall Study|Death|2|||
130626848|NCT02940860|470253672|FG000|Overall Study|Moved, poor venous access, transport|6|||
130626849|NCT02940860|470253673|FG001|Overall Study|Moved, poor venous access, transport|4|||
130626850|NCT02940860|470253672|FG000|Overall Study|Not treated|2|||
130626851|NCT02940860|470253673|FG001|Overall Study|Not treated|2|||
130626852|NCT02715804|470253674|FG000|Overall Study|Death|222|||
130626853|NCT02715804|470253675|FG001|Overall Study|Death|106|||
130626854|NCT02715804|470253674|FG000|Overall Study|Withdrawal by Subject|5|||
130626855|NCT02715804|470253675|FG001|Overall Study|Withdrawal by Subject|4|||
130626856|NCT02715804|470253674|FG000|Overall Study|Other than specified|2|||
130626857|NCT02715804|470253675|FG001|Overall Study|Other than specified|3|||
130626858|NCT00948194|470253676|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
130626859|NCT00948194|470253677|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
130626860|NCT02431793|470253678|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
130626861|NCT02431793|470253679|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
130626862|NCT02431793|470253680|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
130626863|NCT02431793|470253678|FG000|Overall Study|Withdrawal by Subject|7|||
130626864|NCT02431793|470253679|FG001|Overall Study|Withdrawal by Subject|5|||
130626865|NCT02431793|470253680|FG002|Overall Study|Withdrawal by Subject|5|||
130626866|NCT02431793|470253678|FG000|Overall Study|Lost to Follow-up|101|||
130626867|NCT02431793|470253679|FG001|Overall Study|Lost to Follow-up|122|||
130626868|NCT02431793|470253680|FG002|Overall Study|Lost to Follow-up|104|||
130626869|NCT00233324|470253681|FG000|Main Study|Death|68|||
130626870|NCT00233324|470253682|FG001|Main Study|Death|60|||
130626871|NCT00233324|470253683|FG002|Main Study|Death|62|||
130626872|NCT00233324|470253684|FG003|Main Study|Death|47|||
130626873|NCT00233324|470253681|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
130626874|NCT00233324|470253682|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
130626875|NCT00233324|470253683|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
130626876|NCT00233324|470253684|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
130626877|NCT00233324|470253681|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
130626878|NCT00233324|470253682|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
130626879|NCT00233324|470253683|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
130626880|NCT00233324|470253684|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
130626881|NCT03170258|470253690|FG000|Overall Study|Physician Decision|4|||
130626882|NCT03170258|470253691|FG001|Overall Study|Physician Decision|0|||
130626883|NCT03170258|470253690|FG000|Overall Study|Equipment issues|1|||
130626884|NCT03170258|470253691|FG001|Overall Study|Equipment issues|0|||
130626885|NCT03170258|470253690|FG000|Overall Study|Medication|1|||
130626886|NCT03170258|470253691|FG001|Overall Study|Medication|0|||
130626887|NCT03170258|470253690|FG000|Overall Study|Sleep issues|1|||
130626888|NCT03170258|470253691|FG001|Overall Study|Sleep issues|0|||
130626889|NCT01563107|470253692|FG000|Overall Study|Physician Decision|0|||
130626890|NCT01563107|470253693|FG001|Overall Study|Physician Decision|1|||
130626891|NCT01563107|470253694|FG002|Overall Study|Physician Decision|1|||
130626892|NCT01563107|470253695|FG003|Overall Study|Physician Decision|3|||
130626893|NCT01563107|470253692|FG000|Overall Study|Withdrawal by Subject|1|||
130626894|NCT01563107|470253693|FG001|Overall Study|Withdrawal by Subject|2|||
130626895|NCT01563107|470253694|FG002|Overall Study|Withdrawal by Subject|1|||
130626896|NCT01563107|470253695|FG003|Overall Study|Withdrawal by Subject|2|||
130626897|NCT00247273|470253699|FG000|Overall Study|Adverse Event|85|||
130626898|NCT00247273|470253700|FG001|Overall Study|Adverse Event|80|||
130626899|NCT00247273|470253699|FG000|Overall Study|Physician Decision|6|||
130626900|NCT00247273|470253700|FG001|Overall Study|Physician Decision|3|||
130626901|NCT00247273|470253699|FG000|Overall Study|Lost to Follow-up|7|||
130626902|NCT00247273|470253700|FG001|Overall Study|Lost to Follow-up|7|||
130626903|NCT00247273|470253699|FG000|Overall Study|Withdrawal by Subject|46|||
130626904|NCT00247273|470253700|FG001|Overall Study|Withdrawal by Subject|47|||
130626905|NCT00247273|470253699|FG000|Overall Study|Did not take any study drug|2|||
130626906|NCT00247273|470253700|FG001|Overall Study|Did not take any study drug|0|||
130626907|NCT01419015|470253702|FG000|Overall Study|Death|2|||
130626908|NCT03276572|470253704|FG000|Overall Study|In follow-up|0|||
130626909|NCT03276572|470253705|FG001|Overall Study|In follow-up|0|||
130626910|NCT03276572|470253706|FG002|Overall Study|In follow-up|0|||
130626911|NCT03276572|470253707|FG003|Overall Study|In follow-up|0|||
130626912|NCT03276572|470253708|FG004|Overall Study|In follow-up|0|||
130626913|NCT03276572|470253709|FG005|Overall Study|In follow-up|1|||
130626914|NCT03276572|470253710|FG006|Overall Study|In follow-up|1|||
130626915|NCT03276572|470253704|FG000|Overall Study|Lost to Follow-up|0|||
130626916|NCT03276572|470253705|FG001|Overall Study|Lost to Follow-up|0|||
130626917|NCT03276572|470253706|FG002|Overall Study|Lost to Follow-up|0|||
130626918|NCT03276572|470253707|FG003|Overall Study|Lost to Follow-up|0|||
130626919|NCT03276572|470253708|FG004|Overall Study|Lost to Follow-up|0|||
130626920|NCT03276572|470253709|FG005|Overall Study|Lost to Follow-up|0|||
130626921|NCT03276572|470253710|FG006|Overall Study|Lost to Follow-up|1|||
130626922|NCT02580240|470253711|FG000|Overall Study|Physician Decision|2|||
130626923|NCT02580240|470253712|FG001|Overall Study|Physician Decision|0|||
130626924|NCT00607919|470253713|FG000|Acute Phase|Adverse Event|9|||
130626925|NCT00607919|470253714|FG001|Acute Phase|Adverse Event|2|||
130626926|NCT00607919|470253713|FG000|Acute Phase|Entry Criteria Not Met|1|||
130626927|NCT00607919|470253714|FG001|Acute Phase|Entry Criteria Not Met|1|||
130626928|NCT00607919|470253713|FG000|Acute Phase|Lack of Efficacy|1|||
130626929|NCT00607919|470253714|FG001|Acute Phase|Lack of Efficacy|2|||
130626930|NCT00607919|470253713|FG000|Acute Phase|Lost to Follow-up|9|||
130626931|NCT00607919|470253714|FG001|Acute Phase|Lost to Follow-up|3|||
130626932|NCT00607919|470253713|FG000|Acute Phase|Parent/Caregiver Decision|6|||
130626933|NCT00607919|470253714|FG001|Acute Phase|Parent/Caregiver Decision|4|||
130626934|NCT00607919|470253713|FG000|Acute Phase|Protocol Violation|5|||
130626935|NCT00607919|470253714|FG001|Acute Phase|Protocol Violation|1|||
130626936|NCT00607919|470253713|FG000|Acute Phase|Withdrawal by Subject|3|||
130626937|NCT00607919|470253714|FG001|Acute Phase|Withdrawal by Subject|3|||
130626938|NCT00607919|470253713|FG000|Open-Label Phase|Adverse Event|1|||
130626939|NCT00607919|470253714|FG001|Open-Label Phase|Adverse Event|5|||
130626940|NCT00607919|470253713|FG000|Open-Label Phase|Lost to Follow-up|4|||
130626941|NCT00607919|470253714|FG001|Open-Label Phase|Lost to Follow-up|1|||
130626942|NCT00607919|470253713|FG000|Open-Label Phase|Protocol Violation|2|||
130626943|NCT00607919|470253714|FG001|Open-Label Phase|Protocol Violation|2|||
130626944|NCT00607919|470253713|FG000|Open-Label Phase|Withdrawal by Subject|2|||
130626945|NCT00607919|470253714|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130626946|NCT00607919|470253713|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
130626947|NCT00607919|470253714|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
130626948|NCT00527072|470253729|FG000|Overall Study|Adverse Event|13|||
130626949|NCT00527072|470253729|FG000|Overall Study|Lack of Efficacy|11|||
130626950|NCT00527072|470253729|FG000|Overall Study|Lost to Follow-up|3|||
130626951|NCT00527072|470253729|FG000|Overall Study|Protocol Violation|2|||
130626952|NCT00527072|470253729|FG000|Overall Study|Withdrawal by Subject|7|||
130626953|NCT02007252|470253730|FG000|Overall Study|Administrative problems|3|||
130626954|NCT02007252|470253731|FG001|Overall Study|Administrative problems|7|||
130626955|NCT02007252|470253730|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130626956|NCT02007252|470253731|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130626957|NCT02007252|470253730|FG000|Overall Study|Adverse Event|7|||
130626958|NCT02007252|470253731|FG001|Overall Study|Adverse Event|4|||
130626959|NCT02657434|470253732|FG000|Overall Study|Study Terminated By Sponsor|64|||
130626960|NCT02657434|470253733|FG001|Overall Study|Study Terminated By Sponsor|82|||
130626961|NCT02657434|470253732|FG000|Overall Study|Death|189|||
130626962|NCT02657434|470253733|FG001|Overall Study|Death|190|||
130626963|NCT02657434|470253732|FG000|Overall Study|Lost to Follow-up|2|||
130626964|NCT02657434|470253733|FG001|Overall Study|Lost to Follow-up|2|||
130626965|NCT02657434|470253732|FG000|Overall Study|Randomization by Error|2|||
130626966|NCT02657434|470253733|FG001|Overall Study|Randomization by Error|0|||
130626967|NCT02657434|470253732|FG000|Overall Study|Withdrawal by Subject|28|||
130626968|NCT02657434|470253733|FG001|Overall Study|Withdrawal by Subject|17|||
130626969|NCT02657434|470253732|FG000|Overall Study|Protocol Violation|1|||
130626970|NCT02657434|470253733|FG001|Overall Study|Protocol Violation|0|||
130626971|NCT02657434|470253732|FG000|Overall Study|Physician Decision|0|||
130626972|NCT02657434|470253733|FG001|Overall Study|Physician Decision|1|||
130626973|NCT02001688|470253734|FG000|Overall Study|Withdrawal by Subject|0|||
130626974|NCT02001688|470253735|FG001|Overall Study|Withdrawal by Subject|0|||
130626975|NCT02001688|470253736|FG002|Overall Study|Withdrawal by Subject|1|||
130626976|NCT02001688|470253734|FG000|Overall Study|Adverse Event|0|||
130626977|NCT02001688|470253735|FG001|Overall Study|Adverse Event|1|||
130626978|NCT02001688|470253736|FG002|Overall Study|Adverse Event|0|||
130626979|NCT01989754|470253740|FG000|Overall Study|Withdrawal by Subject|10|||
130626980|NCT01989754|470253741|FG001|Overall Study|Withdrawal by Subject|14|||
130626981|NCT01989754|470253740|FG000|Overall Study|Lost to Follow-up|28|||
130626982|NCT01989754|470253741|FG001|Overall Study|Lost to Follow-up|20|||
130626983|NCT01989754|470253740|FG000|Overall Study|Closed Site|1|||
130626984|NCT01989754|470253741|FG001|Overall Study|Closed Site|1|||
130626985|NCT00813917|470253745|FG000|Overall Study|Adverse Event|0|||
130626986|NCT00813917|470253746|FG001|Overall Study|Adverse Event|1|||
130626987|NCT00813917|470253745|FG000|Overall Study|Withdrawal by Subject|3|||
130626988|NCT00813917|470253746|FG001|Overall Study|Withdrawal by Subject|4|||
130626989|NCT00813917|470253745|FG000|Overall Study|Lost to Follow-up|3|||
130626990|NCT00813917|470253746|FG001|Overall Study|Lost to Follow-up|1|||
130626991|NCT00105183|470253750|FG000|Overall Study|Death|19|||
130626992|NCT00105183|470253751|FG001|Overall Study|Death|13|||
130626993|NCT00105183|470253752|FG002|Overall Study|Death|15|||
130626994|NCT00105183|470253750|FG000|Overall Study|Withdrawal by Subject|1|||
130626995|NCT00105183|470253751|FG001|Overall Study|Withdrawal by Subject|1|||
130626996|NCT00105183|470253752|FG002|Overall Study|Withdrawal by Subject|4|||
130626997|NCT00105183|470253750|FG000|Overall Study|Physician Decision|1|||
130626998|NCT00105183|470253751|FG001|Overall Study|Physician Decision|2|||
130626999|NCT00105183|470253752|FG002|Overall Study|Physician Decision|3|||
130627000|NCT00105183|470253750|FG000|Overall Study|Lost to Follow-up|0|||
130627001|NCT00105183|470253751|FG001|Overall Study|Lost to Follow-up|1|||
130627002|NCT00105183|470253752|FG002|Overall Study|Lost to Follow-up|1|||
130627003|NCT00105183|470253750|FG000|Overall Study|Other reason|1|||
130627004|NCT00105183|470253751|FG001|Overall Study|Other reason|2|||
130627005|NCT00105183|470253752|FG002|Overall Study|Other reason|0|||
130627006|NCT00792701|470253753|FG000|Overall Study|Adverse Event|0|||
130627007|NCT00792701|470253754|FG001|Overall Study|Adverse Event|22|||
130627008|NCT00792701|470253753|FG000|Overall Study|Ineligible|1|||
130627009|NCT00792701|470253754|FG001|Overall Study|Ineligible|3|||
130627010|NCT00792701|470253753|FG000|Overall Study|Withdrawal by Subject|1|||
130627011|NCT00792701|470253754|FG001|Overall Study|Withdrawal by Subject|19|||
130627012|NCT00792701|470253753|FG000|Overall Study|Not protocol specified|17|||
130627013|NCT00792701|470253754|FG001|Overall Study|Not protocol specified|0|||
130627014|NCT02143141|470253761|FG000|Overall Study|pain scores at 24 hours not collected|1|||
130627015|NCT02143141|470253762|FG001|Overall Study|pain scores at 24 hours not collected|0|||
130627016|NCT00064077|470253763|FG000|Overall Study|Improper prior treatment|1|||
130627017|NCT00064077|470253764|FG001|Overall Study|Improper prior treatment|0|||
130627018|NCT00064077|470253765|FG002|Overall Study|Improper prior treatment|0|||
130627019|NCT00064077|470253766|FG003|Overall Study|Improper prior treatment|0|||
130627020|NCT00064077|470253763|FG000|Overall Study|Poor risk|2|||
130627021|NCT00064077|470253764|FG001|Overall Study|Poor risk|0|||
130627022|NCT00064077|470253765|FG002|Overall Study|Poor risk|1|||
130627023|NCT00064077|470253766|FG003|Overall Study|Poor risk|1|||
130627024|NCT00064077|470253763|FG000|Overall Study|Pathology|10|||
130627025|NCT00064077|470253764|FG001|Overall Study|Pathology|7|||
130627026|NCT00064077|470253765|FG002|Overall Study|Pathology|3|||
130627027|NCT00064077|470253766|FG003|Overall Study|Pathology|4|||
130627028|NCT00064077|470253763|FG000|Overall Study|No surgery|0|||
130627029|NCT00064077|470253764|FG001|Overall Study|No surgery|0|||
130627030|NCT00064077|470253765|FG002|Overall Study|No surgery|1|||
130627031|NCT00064077|470253766|FG003|Overall Study|No surgery|0|||
130627032|NCT00064077|470253763|FG000|Overall Study|No tumor|0|||
130627033|NCT00064077|470253764|FG001|Overall Study|No tumor|0|||
130627034|NCT00064077|470253765|FG002|Overall Study|No tumor|1|||
130627035|NCT00064077|470253766|FG003|Overall Study|No tumor|0|||
130627036|NCT00064077|470253763|FG000|Overall Study|Other reasons|2|||
130627037|NCT00064077|470253764|FG001|Overall Study|Other reasons|2|||
130627038|NCT00064077|470253765|FG002|Overall Study|Other reasons|1|||
130627039|NCT00064077|470253766|FG003|Overall Study|Other reasons|2|||
130627040|NCT00563368|470253767|FG000|Overall Study|Lost to Follow-up|14|||
130627041|NCT00563368|470253768|FG001|Overall Study|Lost to Follow-up|14|||
130627042|NCT00563368|470253769|FG002|Overall Study|Lost to Follow-up|12|||
130627043|NCT00563368|470253770|FG003|Overall Study|Lost to Follow-up|6|||
130627044|NCT00563368|470253771|FG004|Overall Study|Lost to Follow-up|9|||
130627045|NCT00563368|470253772|FG005|Overall Study|Lost to Follow-up|8|||
130627046|NCT00563368|470253773|FG006|Overall Study|Lost to Follow-up|9|||
130627047|NCT00563368|470253767|FG000|Overall Study|Adverse Event|3|||
130627048|NCT00563368|470253768|FG001|Overall Study|Adverse Event|4|||
130627049|NCT00563368|470253769|FG002|Overall Study|Adverse Event|5|||
130627050|NCT00563368|470253770|FG003|Overall Study|Adverse Event|9|||
130627051|NCT00563368|470253771|FG004|Overall Study|Adverse Event|6|||
130627052|NCT00563368|470253772|FG005|Overall Study|Adverse Event|10|||
130627053|NCT00563368|470253773|FG006|Overall Study|Adverse Event|17|||
130627054|NCT00563368|470253767|FG000|Overall Study|Withdrawal by Subject|11|||
130627055|NCT00563368|470253768|FG001|Overall Study|Withdrawal by Subject|6|||
130627056|NCT00563368|470253769|FG002|Overall Study|Withdrawal by Subject|5|||
130627057|NCT00563368|470253770|FG003|Overall Study|Withdrawal by Subject|7|||
130627058|NCT00563368|470253771|FG004|Overall Study|Withdrawal by Subject|8|||
130627059|NCT00563368|470253772|FG005|Overall Study|Withdrawal by Subject|5|||
130627060|NCT00563368|470253773|FG006|Overall Study|Withdrawal by Subject|4|||
130627061|NCT00563368|470253767|FG000|Overall Study|protocol non-compliance|1|||
130627062|NCT00563368|470253768|FG001|Overall Study|protocol non-compliance|1|||
130627063|NCT00563368|470253769|FG002|Overall Study|protocol non-compliance|2|||
130627064|NCT00563368|470253770|FG003|Overall Study|protocol non-compliance|1|||
130627065|NCT00563368|470253771|FG004|Overall Study|protocol non-compliance|0|||
130627066|NCT00563368|470253772|FG005|Overall Study|protocol non-compliance|1|||
130627067|NCT00563368|470253773|FG006|Overall Study|protocol non-compliance|3|||
130627068|NCT00563368|470253767|FG000|Overall Study|Pregnancy|1|||
130627069|NCT00563368|470253768|FG001|Overall Study|Pregnancy|0|||
130627070|NCT00563368|470253769|FG002|Overall Study|Pregnancy|1|||
130627071|NCT00563368|470253770|FG003|Overall Study|Pregnancy|2|||
130627072|NCT00563368|470253771|FG004|Overall Study|Pregnancy|1|||
130627073|NCT00563368|470253772|FG005|Overall Study|Pregnancy|2|||
130627074|NCT00563368|470253773|FG006|Overall Study|Pregnancy|0|||
130627075|NCT00563368|470253767|FG000|Overall Study|requirement for restricted medication|0|||
130627076|NCT00563368|470253768|FG001|Overall Study|requirement for restricted medication|0|||
130627077|NCT00563368|470253769|FG002|Overall Study|requirement for restricted medication|2|||
130627078|NCT00563368|470253770|FG003|Overall Study|requirement for restricted medication|0|||
130627079|NCT00563368|470253771|FG004|Overall Study|requirement for restricted medication|0|||
130627080|NCT00563368|470253772|FG005|Overall Study|requirement for restricted medication|0|||
130627081|NCT00563368|470253773|FG006|Overall Study|requirement for restricted medication|0|||
130627082|NCT00563368|470253767|FG000|Overall Study|Other|5|||
130627083|NCT00563368|470253768|FG001|Overall Study|Other|5|||
130627084|NCT00563368|470253769|FG002|Overall Study|Other|3|||
130627085|NCT00563368|470253770|FG003|Overall Study|Other|4|||
130627086|NCT00563368|470253771|FG004|Overall Study|Other|4|||
130627087|NCT00563368|470253772|FG005|Overall Study|Other|4|||
130627088|NCT00563368|470253773|FG006|Overall Study|Other|0|||
130627089|NCT01156532|470253774|FG000|Overall Study|Family Reasons|1|||
130627090|NCT01156532|470253774|FG000|Overall Study|Lost to Follow-up|1|||
130627091|NCT01235728|470253775|FG000|Overall Study|Protocol Violation|0|||
130627092|NCT01235728|470253776|FG001|Overall Study|Protocol Violation|0|||
130627093|NCT01235728|470253777|FG002|Overall Study|Protocol Violation|0|||
130627094|NCT01235728|470253778|FG003|Overall Study|Protocol Violation|1|||
130627095|NCT01235728|470253779|FG004|Overall Study|Protocol Violation|0|||
130627096|NCT01235728|470253780|FG005|Overall Study|Protocol Violation|0|||
130627097|NCT01235728|470253781|FG006|Overall Study|Protocol Violation|0|||
130627098|NCT01235728|470253782|FG007|Overall Study|Protocol Violation|0|||
130627099|NCT01419080|470253783|FG000|Overall Study|Withdrawal by Subject|75|||
130627100|NCT01419080|470253783|FG000|Overall Study|Death|30|||
130627101|NCT01419080|470253783|FG000|Overall Study|Lost to Follow-up|23|||
130627102|NCT01419080|470253783|FG000|Overall Study|Too Ill|3|||
130627103|NCT01575899|470253784|FG000|Overall Study|Lost to Follow-up|3|||
130627104|NCT01575899|470253785|FG001|Overall Study|Lost to Follow-up|4|||
130627105|NCT01575899|470253786|FG002|Overall Study|Lost to Follow-up|2|||
130627106|NCT01575899|470253784|FG000|Overall Study|Protocol Violation|2|||
130627107|NCT01575899|470253785|FG001|Overall Study|Protocol Violation|1|||
130627108|NCT01575899|470253786|FG002|Overall Study|Protocol Violation|0|||
130627109|NCT04294095|470253787|FG000|Overall Study|Adverse Event|1|||
130627110|NCT04294095|470253788|FG001|Overall Study|Adverse Event|0|||
130627111|NCT03205982|470253793|FG000|Overall Study|Lost to Follow-up|20|||
130627112|NCT03205982|470253794|FG001|Overall Study|Lost to Follow-up|19|||
130627113|NCT03205982|470253793|FG000|Overall Study|Withdrawal by Subject|4|||
130627114|NCT03205982|470253794|FG001|Overall Study|Withdrawal by Subject|3|||
130627115|NCT03205982|470253793|FG000|Overall Study|Withdrawal by PI|0|||
130627116|NCT03205982|470253794|FG001|Overall Study|Withdrawal by PI|1|||
130627117|NCT00994162|470253795|FG000|Overall Study|Withdrawal by Subject|1|||
130627118|NCT00994162|470253795|FG000|Overall Study|Lost to Follow-up|2|||
130627119|NCT00994162|470253795|FG000|Overall Study|Product Complaint|1|||
130627120|NCT00994162|470253795|FG000|Overall Study|Poor Compliance|5|||
130627121|NCT00994162|470253795|FG000|Overall Study|Lack of Response|3|||
130627122|NCT00994162|470253795|FG000|Overall Study|Discharged from Hospital|4|||
130627123|NCT00994162|470253795|FG000|Overall Study|Death|2|||
130627124|NCT00994162|470253795|FG000|Overall Study|Care Transferred to Another Physician|2|||
130627125|NCT00994162|470253795|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
130627126|NCT00994162|470253795|FG000|Overall Study|Physician Decision|2|||
130627127|NCT00994162|470253795|FG000|Overall Study|Surrounding Wound Erythematous|1|||
130627128|NCT00994162|470253795|FG000|Overall Study|Machine Losing Vaccum|1|||
130627129|NCT00994162|470253795|FG000|Overall Study|Patient Lived Too Far Away|1|||
130627130|NCT00994162|470253795|FG000|Overall Study|Above Knee Amputation|1|||
130627131|NCT00994162|470253795|FG000|Overall Study|Reason Not Reported By Site|1|||
130627132|NCT01425749|470253796|FG000|Overall Study|progression of melanoma|0|||
130627133|NCT01425749|470253797|FG001|Overall Study|progression of melanoma|1|||
130627134|NCT01293084|470253798|FG000|Overall Study|Physician Decision|3|||
130627135|NCT01293084|470253798|FG000|Overall Study|Withdrawal by Subject|2|||
130627136|NCT02983799|470253799|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
130627137|NCT02983799|470253800|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
130627138|NCT02983799|470253801|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
130627139|NCT02983799|470253802|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
130627140|NCT02983799|470253803|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
130627141|NCT02983799|470253799|FG000|Overall Study|Death|20|||
130627142|NCT02983799|470253800|FG001|Overall Study|Death|5|||
130627143|NCT02983799|470253801|FG002|Overall Study|Death|23|||
130627144|NCT02983799|470253802|FG003|Overall Study|Death|47|||
130627145|NCT02983799|470253803|FG004|Overall Study|Death|7|||
130627146|NCT02983799|470253799|FG000|Overall Study|Withdrawal by Subject|1|||
130627147|NCT02983799|470253800|FG001|Overall Study|Withdrawal by Subject|0|||
130627148|NCT02983799|470253801|FG002|Overall Study|Withdrawal by Subject|3|||
130627149|NCT02983799|470253802|FG003|Overall Study|Withdrawal by Subject|4|||
130627150|NCT02983799|470253803|FG004|Overall Study|Withdrawal by Subject|1|||
130627151|NCT02983799|470253799|FG000|Overall Study|Protocol Violation|0|||
130627152|NCT02983799|470253800|FG001|Overall Study|Protocol Violation|1|||
130627153|NCT02983799|470253801|FG002|Overall Study|Protocol Violation|0|||
130627154|NCT02983799|470253802|FG003|Overall Study|Protocol Violation|0|||
130627155|NCT02983799|470253803|FG004|Overall Study|Protocol Violation|1|||
130627156|NCT02983799|470253799|FG000|Overall Study|Lost to Follow-up|1|||
130627157|NCT02983799|470253800|FG001|Overall Study|Lost to Follow-up|0|||
130627158|NCT02983799|470253801|FG002|Overall Study|Lost to Follow-up|1|||
130627159|NCT02983799|470253802|FG003|Overall Study|Lost to Follow-up|0|||
130627160|NCT02983799|470253803|FG004|Overall Study|Lost to Follow-up|0|||
130627161|NCT02483078|470253818|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
130627162|NCT02483078|470253819|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
130627163|NCT02483078|470253818|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
130627164|NCT02483078|470253819|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
130627165|NCT02483078|470253818|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130627166|NCT02483078|470253819|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
130627167|NCT02483078|470253818|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
130627168|NCT02483078|470253819|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
130627169|NCT02483078|470253818|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
130627170|NCT02483078|470253819|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
130627171|NCT02483078|470253818|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
130627172|NCT02483078|470253819|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
130627173|NCT02853032|470253820|FG000|Overall Study|Adverse Event|4|||
130627174|NCT02853032|470253821|FG001|Overall Study|Adverse Event|0|||
130627175|NCT02853032|470253820|FG000|Overall Study|Withdrawal by Subject|3|||
130627176|NCT02853032|470253821|FG001|Overall Study|Withdrawal by Subject|1|||
130627177|NCT02853032|470253820|FG000|Overall Study|Requested to withdraw from all treatment|2|||
130627178|NCT02853032|470253821|FG001|Overall Study|Requested to withdraw from all treatment|2|||
130627179|NCT00676208|470253822|FG000|Overall Study|Lost to Follow-up|0|||
130627180|NCT00676208|470253823|FG001|Overall Study|Lost to Follow-up|2|||
130627181|NCT00676208|470253822|FG000|Overall Study|Incomplete data|2|||
130627182|NCT00676208|470253823|FG001|Overall Study|Incomplete data|4|||
130627183|NCT03726333|470253824|FG000|Overall Study|Progressive Disease|0|||
130627184|NCT03726333|470253825|FG001|Overall Study|Progressive Disease|0|||
130627185|NCT03726333|470253826|FG002|Overall Study|Progressive Disease|1|||
130627186|NCT03726333|470253827|FG003|Overall Study|Progressive Disease|0|||
130627187|NCT03726333|470253828|FG004|Overall Study|Progressive Disease|0|||
130627188|NCT01410799|470253829|FG000|Overall Study|PI decision|13|||
130627189|NCT01946412|470253830|FG000|Overall Study|Adverse Event|1|||
130627190|NCT01946412|470253830|FG000|Overall Study|Non-Compliance|1|||
130627191|NCT01946412|470253830|FG000|Overall Study|Continued with commercial Kalydeco|2|||
130627192|NCT01946412|470253830|FG000|Overall Study|Difficulty in swallowing|1|||
130627193|NCT03750240|470256632|FG000|Overall Study|Technical Difficulties|2|||
130627194|NCT00927758|470256633|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130627195|NCT00927758|470256634|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130627196|NCT00927758|470256635|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130627197|NCT00927758|470256636|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
130627198|NCT00927758|470256637|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130627199|NCT00927758|470256638|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
130627200|NCT00927758|470256633|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130627201|NCT00927758|470256634|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130627202|NCT00927758|470256635|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130627203|NCT00927758|470256636|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130627204|NCT00927758|470256637|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130627205|NCT00927758|470256638|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130627206|NCT00439725|470256640|FG000|Treatment Period|Withdrawal by Subject|22|||
130627207|NCT00439725|470256641|FG001|Treatment Period|Withdrawal by Subject|19|||
130627208|NCT00439725|470256640|FG000|Treatment Period|Study terminated by sponsor|156|||
130627209|NCT00439725|470256641|FG001|Treatment Period|Study terminated by sponsor|148|||
130627210|NCT00439725|470256640|FG000|Treatment Period|Site closed by investigator|1|||
130627211|NCT00439725|470256641|FG001|Treatment Period|Site closed by investigator|2|||
130627212|NCT00439725|470256640|FG000|Treatment Period|Adverse Event|39|||
130627213|NCT00439725|470256641|FG001|Treatment Period|Adverse Event|18|||
130627214|NCT00439725|470256640|FG000|Treatment Period|Physician Decision|1|||
130627215|NCT00439725|470256641|FG001|Treatment Period|Physician Decision|1|||
130627216|NCT00439725|470256640|FG000|Treatment Period|Protocol Violation|2|||
130627217|NCT00439725|470256641|FG001|Treatment Period|Protocol Violation|1|||
130627218|NCT00439725|470256640|FG000|Treatment Period|Clinical endpoint reached|6|||
130627219|NCT00439725|470256641|FG001|Treatment Period|Clinical endpoint reached|50|||
130627220|NCT00439725|470256640|FG000|Treatment Period|Technical problems|1|||
130627221|NCT00439725|470256641|FG001|Treatment Period|Technical problems|0|||
130627222|NCT00439725|470256640|FG000|Treatment Period|Lost to Follow-up|1|||
130627223|NCT00439725|470256641|FG001|Treatment Period|Lost to Follow-up|1|||
130627224|NCT00439725|470256640|FG000|Treatment Period|Participant convenience|1|||
130627225|NCT00439725|470256641|FG001|Treatment Period|Participant convenience|0|||
130627226|NCT00439725|470256640|FG000|Treatment Period|Protocol driven decision point|1|||
130627227|NCT00439725|470256641|FG001|Treatment Period|Protocol driven decision point|1|||
130627228|NCT00439725|470256640|FG000|Treatment Period|Death|1|||
130627229|NCT00439725|470256641|FG001|Treatment Period|Death|1|||
130627230|NCT00439725|470256640|FG000|Treatment Period|Participant did not receive treatment|4|||
130627231|NCT00439725|470256641|FG001|Treatment Period|Participant did not receive treatment|4|||
130627232|NCT00439725|470256640|FG000|Observational Period|Withdrawal by Subject|2|||
130627233|NCT00439725|470256641|FG001|Observational Period|Withdrawal by Subject|2|||
130627234|NCT00439725|470256640|FG000|Observational Period|Lost to Follow-up|0|||
130627235|NCT00439725|470256641|FG001|Observational Period|Lost to Follow-up|1|||
130627236|NCT00439725|470256640|FG000|Observational Period|Death|0|||
130627237|NCT00439725|470256641|FG001|Observational Period|Death|2|||
130627238|NCT00439725|470256640|FG000|Observational Period|Study termination by sponsor|1|||
130627239|NCT00439725|470256641|FG001|Observational Period|Study termination by sponsor|1|||
130627240|NCT00439725|470256640|FG000|Observational Period|Clinical endpoint reached|3|||
130627241|NCT00439725|470256641|FG001|Observational Period|Clinical endpoint reached|1|||
130627242|NCT00439725|470256640|FG000|Observational Period|Technical problems|1|||
130627243|NCT00439725|470256641|FG001|Observational Period|Technical problems|0|||
130627244|NCT00439725|470256640|FG000|Observational Period|Participant convenience|1|||
130627245|NCT00439725|470256641|FG001|Observational Period|Participant convenience|0|||
130627246|NCT00379236|470256642|FG000|Double-blind|Adverse Event|11|||
130627247|NCT00379236|470256643|FG001|Double-blind|Adverse Event|6|||
130627248|NCT00379236|470256644|FG002|Double-blind|Adverse Event|0|||
130627249|NCT00379236|470256642|FG000|Double-blind|Protocol Violation|3|||
130627250|NCT00379236|470256643|FG001|Double-blind|Protocol Violation|3|||
130627251|NCT00379236|470256644|FG002|Double-blind|Protocol Violation|0|||
130627252|NCT00379236|470256642|FG000|Double-blind|Withdrawal by Subject|12|||
130627253|NCT00379236|470256643|FG001|Double-blind|Withdrawal by Subject|13|||
130627254|NCT00379236|470256644|FG002|Double-blind|Withdrawal by Subject|0|||
130627255|NCT00379236|470256642|FG000|Double-blind|Lost to Follow-up|4|||
130627256|NCT00379236|470256643|FG001|Double-blind|Lost to Follow-up|3|||
130627257|NCT00379236|470256644|FG002|Double-blind|Lost to Follow-up|0|||
130627258|NCT00379236|470256642|FG000|Double-blind|Use of exclusionary medication|1|||
130627259|NCT00379236|470256643|FG001|Double-blind|Use of exclusionary medication|2|||
130627260|NCT00379236|470256644|FG002|Double-blind|Use of exclusionary medication|0|||
130627261|NCT00379236|470256642|FG000|Double-blind|Other|3|||
130627262|NCT00379236|470256643|FG001|Double-blind|Other|7|||
130627263|NCT00379236|470256644|FG002|Double-blind|Other|0|||
130627264|NCT00379236|470256642|FG000|Double-blind|Data could not be retrieved|2|||
130627265|NCT00379236|470256643|FG001|Double-blind|Data could not be retrieved|2|||
130627266|NCT00379236|470256644|FG002|Double-blind|Data could not be retrieved|0|||
130627267|NCT00379236|470256642|FG000|Open-label Extension|Adverse Event|0|||
130627268|NCT00379236|470256643|FG001|Open-label Extension|Adverse Event|0|||
130627269|NCT00379236|470256644|FG002|Open-label Extension|Adverse Event|13|||
130627270|NCT00379236|470256642|FG000|Open-label Extension|Protocol Violation|0|||
130627271|NCT00379236|470256643|FG001|Open-label Extension|Protocol Violation|0|||
130627272|NCT00379236|470256644|FG002|Open-label Extension|Protocol Violation|7|||
130627273|NCT00379236|470256642|FG000|Open-label Extension|Withdrawal by Subject|0|||
130627274|NCT00379236|470256643|FG001|Open-label Extension|Withdrawal by Subject|0|||
130627275|NCT00379236|470256644|FG002|Open-label Extension|Withdrawal by Subject|13|||
130627276|NCT00379236|470256642|FG000|Open-label Extension|Lost to Follow-up|0|||
130627277|NCT00379236|470256643|FG001|Open-label Extension|Lost to Follow-up|0|||
130627278|NCT00379236|470256644|FG002|Open-label Extension|Lost to Follow-up|12|||
130627279|NCT00379236|470256642|FG000|Open-label Extension|Use of exclusionary medication|0|||
130627280|NCT00379236|470256643|FG001|Open-label Extension|Use of exclusionary medication|0|||
130627281|NCT00379236|470256644|FG002|Open-label Extension|Use of exclusionary medication|3|||
130627282|NCT00379236|470256642|FG000|Open-label Extension|Other|0|||
130627283|NCT00379236|470256643|FG001|Open-label Extension|Other|0|||
130627284|NCT00379236|470256644|FG002|Open-label Extension|Other|7|||
130627285|NCT04914819|470256645|FG000|Overall Study|Pregnancy|3|||
130627286|NCT04914819|470256646|FG001|Overall Study|Pregnancy|1|||
130627287|NCT04914819|470256645|FG000|Overall Study|Discontinued study|4|||
130627288|NCT04914819|470256646|FG001|Overall Study|Discontinued study|1|||
130627289|NCT04914819|470256645|FG000|Overall Study|Lost to Follow-up|7|||
130627290|NCT04914819|470256646|FG001|Overall Study|Lost to Follow-up|0|||
130627291|NCT04038385|470256647|FG000|Overall Study|Completed baseline assessment only|7|||
130627292|NCT04038385|470256648|FG001|Overall Study|Completed baseline assessment only|4|||
130627293|NCT04038385|470256647|FG000|Overall Study|Moved out of area|4|||
130627294|NCT04038385|470256648|FG001|Overall Study|Moved out of area|2|||
130627295|NCT04038385|470256647|FG000|Overall Study|Discontinued study involvement|6|||
130627296|NCT04038385|470256648|FG001|Overall Study|Discontinued study involvement|1|||
130627297|NCT01625611|470256649|FG000|Overall Study|No adlib drinks Lab 1|3|||
130627298|NCT01625611|470256650|FG001|Overall Study|No adlib drinks Lab 1|0|||
130627299|NCT01625611|470256649|FG000|Overall Study|Technical issues with PET|1|||
130627300|NCT01625611|470256650|FG001|Overall Study|Technical issues with PET|0|||
130627301|NCT01625611|470256649|FG000|Overall Study|Unable to complete study procedures|1|||
130627302|NCT01625611|470256650|FG001|Overall Study|Unable to complete study procedures|0|||
130627303|NCT01625611|470256649|FG000|Overall Study|Withdrawal by Subject|3|||
130627304|NCT01625611|470256650|FG001|Overall Study|Withdrawal by Subject|0|||
130627305|NCT01527110|470256651|FG000|Overall Study|Adverse Event|1|||
130627306|NCT01709708|470256652|FG000|Overall Study|Protocol Violation|1|||
130627307|NCT01709708|470256653|FG001|Overall Study|Protocol Violation|2|||
130627308|NCT01998958|470256656|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627309|NCT01998958|470256657|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
130627310|NCT01998958|470256658|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627311|NCT01998958|470256659|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627312|NCT01998958|470256660|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627313|NCT01998958|470256661|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627314|NCT01998958|470256662|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627315|NCT01998958|470256663|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627316|NCT01998958|470256664|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627317|NCT01998958|470256665|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627318|NCT01998958|470256666|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627319|NCT01998958|470256667|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627320|NCT01998958|470256668|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627321|NCT01998958|470256669|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627322|NCT01998958|470256670|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627323|NCT01998958|470256671|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627324|NCT01998958|470256672|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627325|NCT01998958|470256673|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627326|NCT01998958|470256674|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627327|NCT01998958|470256675|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627328|NCT01998958|470256676|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627329|NCT01998958|470256677|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627330|NCT01998958|470256678|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627331|NCT01998958|470256679|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627332|NCT01998958|470256680|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627333|NCT01998958|470256681|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627334|NCT01998958|470256682|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627335|NCT01998958|470256683|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627336|NCT01998958|470256684|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627337|NCT01998958|470256685|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627338|NCT01998958|470256686|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627339|NCT01998958|470256687|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130627340|NCT01998958|470256656|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627341|NCT01998958|470256657|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
130627342|NCT01998958|470256658|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627343|NCT01998958|470256659|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627344|NCT01998958|470256660|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627345|NCT01998958|470256661|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627346|NCT01998958|470256662|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627347|NCT01998958|470256663|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627348|NCT01998958|470256664|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627349|NCT01998958|470256665|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627350|NCT01998958|470256666|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627351|NCT01998958|470256667|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627352|NCT01998958|470256668|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627353|NCT01998958|470256669|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627354|NCT01998958|470256670|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627355|NCT01998958|470256671|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627356|NCT01998958|470256672|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627357|NCT01998958|470256673|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627358|NCT01998958|470256674|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627359|NCT01998958|470256675|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627360|NCT01998958|470256676|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627361|NCT01998958|470256677|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627362|NCT01998958|470256678|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627363|NCT01998958|470256679|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627364|NCT01998958|470256680|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627365|NCT01998958|470256681|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627366|NCT01998958|470256682|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627367|NCT01998958|470256683|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627368|NCT01998958|470256684|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627369|NCT01998958|470256685|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627370|NCT01998958|470256686|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627371|NCT01998958|470256687|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130627372|NCT01998958|470256656|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
130627373|NCT01998958|470256657|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
130627374|NCT01998958|470256658|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
130627375|NCT01998958|470256659|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
130627376|NCT01998958|470256660|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
130627377|NCT01998958|470256661|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
130627378|NCT01998958|470256662|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
130627379|NCT01998958|470256663|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
130627380|NCT01998958|470256664|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
130627381|NCT01998958|470256665|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
130627382|NCT01998958|470256666|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
130627383|NCT01998958|470256667|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
130627384|NCT01998958|470256668|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
130627385|NCT01998958|470256669|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
130627386|NCT01998958|470256670|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
130627387|NCT01998958|470256671|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
130627388|NCT01998958|470256672|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
130627389|NCT01998958|470256673|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
130627390|NCT01998958|470256674|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
130627391|NCT01998958|470256675|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
130627392|NCT01998958|470256676|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
130627393|NCT01998958|470256677|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
130627394|NCT01998958|470256678|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
130627395|NCT01998958|470256679|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
130627396|NCT01998958|470256680|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
130627397|NCT01998958|470256681|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
130627398|NCT01998958|470256682|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
130627399|NCT01998958|470256683|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
130627400|NCT01998958|470256684|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
130627401|NCT01998958|470256685|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
130627402|NCT01998958|470256686|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
130627403|NCT01998958|470256687|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
130627404|NCT01998958|470256656|FG000|Period 1 (Panel A and B)|Other|1|||
130627405|NCT01998958|470256657|FG001|Period 1 (Panel A and B)|Other|0|||
130627406|NCT01998958|470256658|FG002|Period 1 (Panel A and B)|Other|0|||
130627407|NCT01998958|470256659|FG003|Period 1 (Panel A and B)|Other|0|||
130627408|NCT01998958|470256660|FG004|Period 1 (Panel A and B)|Other|0|||
130627409|NCT01998958|470256661|FG005|Period 1 (Panel A and B)|Other|0|||
130627410|NCT01998958|470256662|FG006|Period 1 (Panel A and B)|Other|0|||
130627411|NCT01998958|470256663|FG007|Period 1 (Panel A and B)|Other|0|||
130627412|NCT01998958|470256664|FG008|Period 1 (Panel A and B)|Other|0|||
130627413|NCT01998958|470256665|FG009|Period 1 (Panel A and B)|Other|0|||
130627414|NCT01998958|470256666|FG010|Period 1 (Panel A and B)|Other|0|||
130627415|NCT01998958|470256667|FG011|Period 1 (Panel A and B)|Other|0|||
130627416|NCT01998958|470256668|FG012|Period 1 (Panel A and B)|Other|0|||
130627417|NCT01998958|470256669|FG013|Period 1 (Panel A and B)|Other|0|||
130627418|NCT01998958|470256670|FG014|Period 1 (Panel A and B)|Other|0|||
130627419|NCT01998958|470256671|FG015|Period 1 (Panel A and B)|Other|0|||
130627420|NCT01998958|470256672|FG016|Period 1 (Panel A and B)|Other|0|||
130627421|NCT01998958|470256673|FG017|Period 1 (Panel A and B)|Other|0|||
130627422|NCT01998958|470256674|FG018|Period 1 (Panel A and B)|Other|0|||
130627423|NCT01998958|470256675|FG019|Period 1 (Panel A and B)|Other|0|||
130627424|NCT01998958|470256676|FG020|Period 1 (Panel A and B)|Other|0|||
130627425|NCT01998958|470256677|FG021|Period 1 (Panel A and B)|Other|0|||
130627426|NCT01998958|470256678|FG022|Period 1 (Panel A and B)|Other|0|||
130627427|NCT01998958|470256679|FG023|Period 1 (Panel A and B)|Other|0|||
130627428|NCT01998958|470256680|FG024|Period 1 (Panel A and B)|Other|0|||
130627429|NCT01998958|470256681|FG025|Period 1 (Panel A and B)|Other|0|||
130627430|NCT01998958|470256682|FG026|Period 1 (Panel A and B)|Other|0|||
130627431|NCT01998958|470256683|FG027|Period 1 (Panel A and B)|Other|0|||
130627432|NCT01998958|470256684|FG028|Period 1 (Panel A and B)|Other|0|||
130627433|NCT01998958|470256685|FG029|Period 1 (Panel A and B)|Other|0|||
130627434|NCT01998958|470256686|FG030|Period 1 (Panel A and B)|Other|0|||
130627435|NCT01998958|470256687|FG031|Period 1 (Panel A and B)|Other|0|||
130627436|NCT01998958|470256656|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
130627437|NCT01998958|470256657|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
130627438|NCT01998958|470256658|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
130627439|NCT01998958|470256659|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
130627440|NCT01998958|470256660|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
130627441|NCT01998958|470256661|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
130627442|NCT01998958|470256662|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
130627443|NCT01998958|470256663|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
130627444|NCT01998958|470256664|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
130627445|NCT01998958|470256665|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
130627446|NCT01998958|470256666|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
130627447|NCT01998958|470256667|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
130627448|NCT01998958|470256668|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
130627449|NCT01998958|470256669|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
130627450|NCT01998958|470256670|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
130627451|NCT01998958|470256671|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
130627452|NCT01998958|470256672|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
130627453|NCT01998958|470256673|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
130627454|NCT01998958|470256674|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
130627455|NCT01998958|470256675|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
130627456|NCT01998958|470256676|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
130627457|NCT01998958|470256677|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
130627458|NCT01998958|470256678|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
130627459|NCT01998958|470256679|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
130627460|NCT01998958|470256680|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
130627461|NCT01998958|470256681|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
130627462|NCT01998958|470256682|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
130627463|NCT01998958|470256683|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
130627464|NCT01998958|470256684|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
130627465|NCT01998958|470256685|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
130627466|NCT01998958|470256686|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
130627467|NCT01998958|470256687|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
130627468|NCT01998958|470256656|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627469|NCT01998958|470256657|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627470|NCT01998958|470256658|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627471|NCT01998958|470256659|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627472|NCT01998958|470256660|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627473|NCT01998958|470256661|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627474|NCT01998958|470256662|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627475|NCT01998958|470256663|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627476|NCT01998958|470256664|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627477|NCT01998958|470256665|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627478|NCT01998958|470256666|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627479|NCT01998958|470256667|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627480|NCT01998958|470256668|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627481|NCT01998958|470256669|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627482|NCT01998958|470256670|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
130627483|NCT01998958|470256671|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627484|NCT01998958|470256672|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627485|NCT01998958|470256673|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627486|NCT01998958|470256674|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
130627487|NCT01998958|470256675|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627488|NCT01998958|470256676|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627489|NCT01998958|470256677|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627490|NCT01998958|470256678|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627491|NCT01998958|470256679|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627492|NCT01998958|470256680|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627493|NCT01998958|470256681|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627494|NCT01998958|470256682|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627495|NCT01998958|470256683|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627496|NCT01998958|470256684|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627497|NCT01998958|470256685|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627498|NCT01998958|470256686|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627499|NCT01998958|470256687|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130627500|NCT01998958|470256656|FG000|Open Label Phase (Optional)|Adverse Event|0|||
130627501|NCT01998958|470256657|FG001|Open Label Phase (Optional)|Adverse Event|0|||
130627502|NCT01998958|470256658|FG002|Open Label Phase (Optional)|Adverse Event|0|||
130627503|NCT01998958|470256659|FG003|Open Label Phase (Optional)|Adverse Event|0|||
130627504|NCT01998958|470256660|FG004|Open Label Phase (Optional)|Adverse Event|0|||
130627505|NCT01998958|470256661|FG005|Open Label Phase (Optional)|Adverse Event|0|||
130627506|NCT01998958|470256662|FG006|Open Label Phase (Optional)|Adverse Event|0|||
130627507|NCT01998958|470256663|FG007|Open Label Phase (Optional)|Adverse Event|0|||
130627508|NCT01998958|470256664|FG008|Open Label Phase (Optional)|Adverse Event|0|||
130627509|NCT01998958|470256665|FG009|Open Label Phase (Optional)|Adverse Event|0|||
130627510|NCT01998958|470256666|FG010|Open Label Phase (Optional)|Adverse Event|0|||
130627511|NCT01998958|470256667|FG011|Open Label Phase (Optional)|Adverse Event|0|||
130627512|NCT01998958|470256668|FG012|Open Label Phase (Optional)|Adverse Event|0|||
130627513|NCT01998958|470256669|FG013|Open Label Phase (Optional)|Adverse Event|0|||
130627514|NCT01998958|470256670|FG014|Open Label Phase (Optional)|Adverse Event|0|||
130627515|NCT01998958|470256671|FG015|Open Label Phase (Optional)|Adverse Event|0|||
130627516|NCT01998958|470256672|FG016|Open Label Phase (Optional)|Adverse Event|0|||
130627517|NCT01998958|470256673|FG017|Open Label Phase (Optional)|Adverse Event|0|||
130627518|NCT01998958|470256674|FG018|Open Label Phase (Optional)|Adverse Event|0|||
130627519|NCT01998958|470256675|FG019|Open Label Phase (Optional)|Adverse Event|0|||
130627520|NCT01998958|470256676|FG020|Open Label Phase (Optional)|Adverse Event|0|||
130627521|NCT01998958|470256677|FG021|Open Label Phase (Optional)|Adverse Event|0|||
130627522|NCT01998958|470256678|FG022|Open Label Phase (Optional)|Adverse Event|0|||
130627523|NCT01998958|470256679|FG023|Open Label Phase (Optional)|Adverse Event|1|||
130627524|NCT01998958|470256680|FG024|Open Label Phase (Optional)|Adverse Event|0|||
130627525|NCT01998958|470256681|FG025|Open Label Phase (Optional)|Adverse Event|0|||
130627526|NCT01998958|470256682|FG026|Open Label Phase (Optional)|Adverse Event|0|||
130627527|NCT01998958|470256683|FG027|Open Label Phase (Optional)|Adverse Event|0|||
130627528|NCT01998958|470256684|FG028|Open Label Phase (Optional)|Adverse Event|0|||
130627529|NCT01998958|470256685|FG029|Open Label Phase (Optional)|Adverse Event|0|||
130627530|NCT01998958|470256686|FG030|Open Label Phase (Optional)|Adverse Event|0|||
130627531|NCT01998958|470256687|FG031|Open Label Phase (Optional)|Adverse Event|0|||
130627532|NCT01998958|470256656|FG000|Open Label Phase (Optional)|Other|0|||
130627533|NCT01998958|470256657|FG001|Open Label Phase (Optional)|Other|0|||
130627534|NCT01998958|470256658|FG002|Open Label Phase (Optional)|Other|0|||
130627535|NCT01998958|470256659|FG003|Open Label Phase (Optional)|Other|0|||
130627536|NCT01998958|470256660|FG004|Open Label Phase (Optional)|Other|0|||
130627537|NCT01998958|470256661|FG005|Open Label Phase (Optional)|Other|0|||
130627538|NCT01998958|470256662|FG006|Open Label Phase (Optional)|Other|0|||
130627539|NCT01998958|470256663|FG007|Open Label Phase (Optional)|Other|0|||
130627540|NCT01998958|470256664|FG008|Open Label Phase (Optional)|Other|0|||
130627541|NCT01998958|470256665|FG009|Open Label Phase (Optional)|Other|0|||
130627542|NCT01998958|470256666|FG010|Open Label Phase (Optional)|Other|0|||
130627543|NCT01998958|470256667|FG011|Open Label Phase (Optional)|Other|0|||
130627544|NCT01998958|470256668|FG012|Open Label Phase (Optional)|Other|0|||
130627545|NCT01998958|470256669|FG013|Open Label Phase (Optional)|Other|0|||
130627546|NCT01998958|470256670|FG014|Open Label Phase (Optional)|Other|0|||
130627547|NCT01998958|470256671|FG015|Open Label Phase (Optional)|Other|0|||
130627548|NCT01998958|470256672|FG016|Open Label Phase (Optional)|Other|0|||
130627549|NCT01998958|470256673|FG017|Open Label Phase (Optional)|Other|0|||
130627550|NCT01998958|470256674|FG018|Open Label Phase (Optional)|Other|0|||
130627551|NCT01998958|470256675|FG019|Open Label Phase (Optional)|Other|0|||
130627552|NCT01998958|470256676|FG020|Open Label Phase (Optional)|Other|0|||
130627553|NCT01998958|470256677|FG021|Open Label Phase (Optional)|Other|0|||
130627554|NCT01998958|470256678|FG022|Open Label Phase (Optional)|Other|5|||
130627555|NCT01998958|470256679|FG023|Open Label Phase (Optional)|Other|1|||
130627556|NCT01998958|470256680|FG024|Open Label Phase (Optional)|Other|0|||
130627557|NCT01998958|470256681|FG025|Open Label Phase (Optional)|Other|0|||
130627558|NCT01998958|470256682|FG026|Open Label Phase (Optional)|Other|0|||
130627559|NCT01998958|470256683|FG027|Open Label Phase (Optional)|Other|0|||
130627560|NCT01998958|470256684|FG028|Open Label Phase (Optional)|Other|0|||
130627561|NCT01998958|470256685|FG029|Open Label Phase (Optional)|Other|0|||
130627562|NCT01998958|470256686|FG030|Open Label Phase (Optional)|Other|0|||
130627563|NCT01998958|470256687|FG031|Open Label Phase (Optional)|Other|0|||
130627564|NCT01998958|470256656|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627565|NCT01998958|470256657|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627566|NCT01998958|470256658|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627567|NCT01998958|470256659|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627568|NCT01998958|470256660|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627569|NCT01998958|470256661|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627570|NCT01998958|470256662|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627571|NCT01998958|470256663|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627572|NCT01998958|470256664|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627573|NCT01998958|470256665|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627574|NCT01998958|470256666|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627575|NCT01998958|470256667|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627576|NCT01998958|470256668|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627577|NCT01998958|470256669|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627578|NCT01998958|470256670|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627579|NCT01998958|470256671|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627580|NCT01998958|470256672|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627581|NCT01998958|470256673|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627582|NCT01998958|470256674|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627583|NCT01998958|470256675|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627584|NCT01998958|470256676|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627585|NCT01998958|470256677|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627586|NCT01998958|470256678|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
130627587|NCT01998958|470256679|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627588|NCT01998958|470256680|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627589|NCT01998958|470256681|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627590|NCT01998958|470256682|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627591|NCT01998958|470256683|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627592|NCT01998958|470256684|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627593|NCT01998958|470256685|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627594|NCT01998958|470256686|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627595|NCT01998958|470256687|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
130627596|NCT01998958|470256656|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627597|NCT01998958|470256657|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627598|NCT01998958|470256658|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627599|NCT01998958|470256659|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627600|NCT01998958|470256660|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627601|NCT01998958|470256661|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627602|NCT01998958|470256662|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627603|NCT01998958|470256663|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627604|NCT01998958|470256664|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627605|NCT01998958|470256665|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627606|NCT01998958|470256666|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627607|NCT01998958|470256667|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627608|NCT01998958|470256668|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627609|NCT01998958|470256669|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627610|NCT01998958|470256670|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627611|NCT01998958|470256671|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627612|NCT01998958|470256672|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627613|NCT01998958|470256673|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627614|NCT01998958|470256674|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627615|NCT01998958|470256675|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627616|NCT01998958|470256676|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627617|NCT01998958|470256677|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
130627618|NCT01998958|470256678|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
130627619|NCT01998958|470256679|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627620|NCT01998958|470256680|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627621|NCT01998958|470256681|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627622|NCT01998958|470256682|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627623|NCT01998958|470256683|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627624|NCT01998958|470256684|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627625|NCT01998958|470256685|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627626|NCT01998958|470256686|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627627|NCT01998958|470256687|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
130627628|NCT01998958|470256656|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627629|NCT01998958|470256657|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627630|NCT01998958|470256658|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627631|NCT01998958|470256659|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627632|NCT01998958|470256660|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627633|NCT01998958|470256661|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627634|NCT01998958|470256662|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627635|NCT01998958|470256663|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627636|NCT01998958|470256664|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627637|NCT01998958|470256665|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627638|NCT01998958|470256666|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627639|NCT01998958|470256667|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627640|NCT01998958|470256668|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627641|NCT01998958|470256669|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627642|NCT01998958|470256670|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627643|NCT01998958|470256671|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627644|NCT01998958|470256672|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627645|NCT01998958|470256673|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627646|NCT01998958|470256674|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627647|NCT01998958|470256675|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627648|NCT01998958|470256676|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627649|NCT01998958|470256677|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
130627650|NCT01998958|470256678|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
130627651|NCT01998958|470256679|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
130627652|NCT01998958|470256680|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627653|NCT01998958|470256681|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627654|NCT01998958|470256682|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627655|NCT01998958|470256683|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627656|NCT01998958|470256684|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627657|NCT01998958|470256685|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627658|NCT01998958|470256686|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627659|NCT01998958|470256687|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130627660|NCT01628393|470256688|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
130627661|NCT01628393|470256689|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130627662|NCT01628393|470256690|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130627663|NCT01628393|470256691|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130627664|NCT01628393|470256692|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130627665|NCT01628393|470256688|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
130627666|NCT01628393|470256689|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
130627667|NCT01628393|470256690|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
130627668|NCT01628393|470256691|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
130627669|NCT01628393|470256692|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
130627670|NCT01628393|470256688|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
130627671|NCT01628393|470256689|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
130627672|NCT01628393|470256690|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
130627673|NCT01628393|470256691|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130627674|NCT01628393|470256692|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130627675|NCT01628393|470256688|FG000|Blinded Active Extension Period|Adverse Event|0|||
130627676|NCT01628393|470256689|FG001|Blinded Active Extension Period|Adverse Event|1|||
130627677|NCT01628393|470256690|FG002|Blinded Active Extension Period|Adverse Event|0|||
130627678|NCT01628393|470256691|FG003|Blinded Active Extension Period|Adverse Event|2|||
130627679|NCT01628393|470256692|FG004|Blinded Active Extension Period|Adverse Event|2|||
130627680|NCT01628393|470256688|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
130627681|NCT01628393|470256689|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
130627682|NCT01628393|470256690|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
130627683|NCT01628393|470256691|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
130627684|NCT01628393|470256692|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
130627685|NCT01628393|470256688|FG000|Blinded Active Extension Period|Physician Decision|0|||
130627686|NCT01628393|470256689|FG001|Blinded Active Extension Period|Physician Decision|3|||
130627687|NCT01628393|470256690|FG002|Blinded Active Extension Period|Physician Decision|0|||
130627688|NCT01628393|470256691|FG003|Blinded Active Extension Period|Physician Decision|1|||
130627689|NCT01628393|470256692|FG004|Blinded Active Extension Period|Physician Decision|0|||
130627690|NCT01628393|470256688|FG000|Blinded Active Extension Period|Protocol Violation|0|||
130627691|NCT01628393|470256689|FG001|Blinded Active Extension Period|Protocol Violation|0|||
130627692|NCT01628393|470256690|FG002|Blinded Active Extension Period|Protocol Violation|2|||
130627693|NCT01628393|470256691|FG003|Blinded Active Extension Period|Protocol Violation|1|||
130627694|NCT01628393|470256692|FG004|Blinded Active Extension Period|Protocol Violation|0|||
130627695|NCT01628393|470256688|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
130627696|NCT01628393|470256689|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
130627697|NCT01628393|470256690|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
130627698|NCT01628393|470256691|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
130627699|NCT01628393|470256692|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
130627700|NCT00445341|470256693|FG000|Overall Study|refused further treatment|1|||
130627701|NCT00445341|470256693|FG000|Overall Study|taken off treatment too early|1|||
130627702|NCT01369225|470256697|FG000|Overall Study|Withdrawal by Subject|1|||
130627703|NCT01369225|470256698|FG001|Overall Study|Withdrawal by Subject|0|||
130627704|NCT01369225|470256699|FG002|Overall Study|Withdrawal by Subject|2|||
130627705|NCT01369225|470256700|FG003|Overall Study|Withdrawal by Subject|1|||
130627706|NCT01369225|470256701|FG004|Overall Study|Withdrawal by Subject|0|||
130627707|NCT01369225|470256702|FG005|Overall Study|Withdrawal by Subject|0|||
130627708|NCT01369225|470256697|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
130627709|NCT01369225|470256698|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
130627710|NCT01369225|470256699|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
130627711|NCT01369225|470256700|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
130627712|NCT01369225|470256701|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
130627713|NCT01369225|470256702|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
130627714|NCT01369225|470256697|FG000|Overall Study|Other|1|||
130627715|NCT01369225|470256698|FG001|Overall Study|Other|0|||
130627716|NCT01369225|470256699|FG002|Overall Study|Other|0|||
130627717|NCT01369225|470256700|FG003|Overall Study|Other|0|||
130627718|NCT01369225|470256701|FG004|Overall Study|Other|1|||
130627719|NCT01369225|470256702|FG005|Overall Study|Other|0|||
130627720|NCT01369225|470256697|FG000|Overall Study|Adverse Event|0|||
130627721|NCT01369225|470256698|FG001|Overall Study|Adverse Event|0|||
130627722|NCT01369225|470256699|FG002|Overall Study|Adverse Event|0|||
130627723|NCT01369225|470256700|FG003|Overall Study|Adverse Event|1|||
130627724|NCT01369225|470256701|FG004|Overall Study|Adverse Event|1|||
130627725|NCT01369225|470256702|FG005|Overall Study|Adverse Event|0|||
130627726|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
130627727|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
130627728|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
130627729|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
130627730|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
130627731|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130627732|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
130627733|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130627734|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130627735|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
130627736|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130627737|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130627738|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130627739|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
130627740|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130627741|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
130627742|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
130627743|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
130627744|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
130627745|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
130627746|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
130627747|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130627748|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
130627749|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130627750|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130627751|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Other|1|||
130627752|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Other|0|||
130627753|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Other|0|||
130627754|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Other|0|||
130627755|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Other|1|||
130627756|NCT02980692|470256703|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
130627757|NCT02980692|470256704|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
130627758|NCT02980692|470256705|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
130627759|NCT02980692|470256706|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
130627760|NCT02980692|470256707|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
130627761|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Adverse Event|0|||
130627762|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Adverse Event|0|||
130627763|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Adverse Event|0|||
130627764|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Adverse Event|1|||
130627765|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Adverse Event|1|||
130627766|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130627767|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
130627768|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
130627769|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130627770|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130627771|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
130627772|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
130627773|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
130627774|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
130627775|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
130627776|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Pregnancy|0|||
130627777|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Pregnancy|0|||
130627778|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Pregnancy|1|||
130627779|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Pregnancy|1|||
130627780|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Pregnancy|0|||
130627781|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
130627782|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130627783|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
130627784|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130627785|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130627786|NCT02980692|470256703|FG000|Double-blind Follow-up Period|Other|0|||
130627787|NCT02980692|470256704|FG001|Double-blind Follow-up Period|Other|0|||
130627788|NCT02980692|470256705|FG002|Double-blind Follow-up Period|Other|1|||
130627789|NCT02980692|470256706|FG003|Double-blind Follow-up Period|Other|1|||
130627790|NCT02980692|470256707|FG004|Double-blind Follow-up Period|Other|3|||
130627791|NCT01819506|470256715|FG000|Overall Study|Physician Decision|5|||
130627792|NCT01819506|470256716|FG001|Overall Study|Physician Decision|2|||
130627793|NCT01819506|470256715|FG000|Overall Study|Withdrawal by Subject|3|||
130627794|NCT01819506|470256716|FG001|Overall Study|Withdrawal by Subject|3|||
130627795|NCT00968708|470256718|FG000|Overall Study|Adverse Event|169|||
130627796|NCT00968708|470256719|FG001|Overall Study|Adverse Event|150|||
130627797|NCT00968708|470256718|FG000|Overall Study|Major Protocol Deviation|0|||
130627798|NCT00968708|470256719|FG001|Overall Study|Major Protocol Deviation|1|||
130627799|NCT00968708|470256718|FG000|Overall Study|Lost to Follow-up|19|||
130627800|NCT00968708|470256719|FG001|Overall Study|Lost to Follow-up|11|||
130627801|NCT00968708|470256718|FG000|Overall Study|Voluntary Withdrawal|104|||
130627802|NCT00968708|470256719|FG001|Overall Study|Voluntary Withdrawal|101|||
130627803|NCT00968708|470256718|FG000|Overall Study|Investigator Discretion|0|||
130627804|NCT00968708|470256719|FG001|Overall Study|Investigator Discretion|1|||
130627805|NCT00968708|470256718|FG000|Overall Study|Other|26|||
130627806|NCT00968708|470256719|FG001|Overall Study|Other|34|||
130627807|NCT03407170|470256720|FG000|Overall Study|Adverse Event|1|||
130627808|NCT01851863|470256725|FG000|Overall Study|Did not receive study medication|2|||
130627809|NCT01851863|470256726|FG001|Overall Study|Did not receive study medication|5|||
130627810|NCT01851863|470256727|FG002|Overall Study|Did not receive study medication|3|||
130627811|NCT01851863|470256728|FG003|Overall Study|Did not receive study medication|0|||
130627812|NCT01851863|470256725|FG000|Overall Study|Lost to Follow-up|3|||
130627813|NCT01851863|470256726|FG001|Overall Study|Lost to Follow-up|4|||
130627814|NCT01851863|470256727|FG002|Overall Study|Lost to Follow-up|2|||
130627815|NCT01851863|470256728|FG003|Overall Study|Lost to Follow-up|3|||
130627816|NCT03238352|470256729|FG000|Overall Study|Lost to Follow-up|0|||
130627817|NCT03238352|470256730|FG001|Overall Study|Lost to Follow-up|2|||
130627818|NCT03238352|470256731|FG002|Overall Study|Lost to Follow-up|1|||
130627819|NCT03238352|470256729|FG000|Overall Study|Withdrawal by Subject|0|||
130627820|NCT03238352|470256730|FG001|Overall Study|Withdrawal by Subject|1|||
130627821|NCT03238352|470256731|FG002|Overall Study|Withdrawal by Subject|0|||
130627822|NCT00928512|470256732|FG000|Overall Study|Adverse Event|4|||
130627823|NCT00928512|470256733|FG001|Overall Study|Adverse Event|3|||
130627824|NCT00928512|470256734|FG002|Overall Study|Adverse Event|2|||
130627825|NCT00928512|470256735|FG003|Overall Study|Adverse Event|8|||
130627826|NCT00928512|470256736|FG004|Overall Study|Adverse Event|6|||
130627827|NCT00928512|470256732|FG000|Overall Study|Lack of Efficacy|2|||
130627828|NCT00928512|470256733|FG001|Overall Study|Lack of Efficacy|0|||
130627829|NCT00928512|470256734|FG002|Overall Study|Lack of Efficacy|4|||
130627830|NCT00928512|470256735|FG003|Overall Study|Lack of Efficacy|7|||
130627831|NCT00928512|470256736|FG004|Overall Study|Lack of Efficacy|3|||
130627832|NCT00928512|470256732|FG000|Overall Study|Protocol Violation|0|||
130627833|NCT00928512|470256733|FG001|Overall Study|Protocol Violation|1|||
130627834|NCT00928512|470256734|FG002|Overall Study|Protocol Violation|0|||
130627835|NCT00928512|470256735|FG003|Overall Study|Protocol Violation|1|||
130627836|NCT00928512|470256736|FG004|Overall Study|Protocol Violation|3|||
130627837|NCT00928512|470256732|FG000|Overall Study|Withdrawal by Subject|3|||
130627838|NCT00928512|470256733|FG001|Overall Study|Withdrawal by Subject|0|||
130627839|NCT00928512|470256734|FG002|Overall Study|Withdrawal by Subject|3|||
130627840|NCT00928512|470256735|FG003|Overall Study|Withdrawal by Subject|4|||
130627841|NCT00928512|470256736|FG004|Overall Study|Withdrawal by Subject|0|||
130627842|NCT00928512|470256732|FG000|Overall Study|Lost to Follow-up|1|||
130627843|NCT00928512|470256733|FG001|Overall Study|Lost to Follow-up|1|||
130627844|NCT00928512|470256734|FG002|Overall Study|Lost to Follow-up|2|||
130627845|NCT00928512|470256735|FG003|Overall Study|Lost to Follow-up|1|||
130627846|NCT00928512|470256736|FG004|Overall Study|Lost to Follow-up|3|||
130627847|NCT00928512|470256732|FG000|Overall Study|Administrative Problems|0|||
130627848|NCT00928512|470256733|FG001|Overall Study|Administrative Problems|1|||
130627849|NCT00928512|470256734|FG002|Overall Study|Administrative Problems|0|||
130627850|NCT00928512|470256735|FG003|Overall Study|Administrative Problems|0|||
130627851|NCT00928512|470256736|FG004|Overall Study|Administrative Problems|0|||
130627852|NCT04153929|470256737|FG000|Overall Study|Other than listed|2|||
130627853|NCT04153929|470256738|FG001|Overall Study|Other than listed|2|||
130627854|NCT04153929|470256739|FG002|Overall Study|Other than listed|0|||
130627855|NCT04153929|470256740|FG003|Overall Study|Other than listed|1|||
130627856|NCT04153929|470256741|FG004|Overall Study|Other than listed|0|||
130627857|NCT04153929|470256742|FG005|Overall Study|Other than listed|2|||
130627858|NCT04153929|470256743|FG006|Overall Study|Other than listed|2|||
130627859|NCT04153929|470256744|FG007|Overall Study|Other than listed|1|||
130627860|NCT04153929|470256737|FG000|Overall Study|Lost to Follow-up|2|||
130627861|NCT04153929|470256738|FG001|Overall Study|Lost to Follow-up|1|||
130627862|NCT04153929|470256739|FG002|Overall Study|Lost to Follow-up|0|||
130627863|NCT04153929|470256740|FG003|Overall Study|Lost to Follow-up|1|||
130627864|NCT04153929|470256741|FG004|Overall Study|Lost to Follow-up|1|||
130627865|NCT04153929|470256742|FG005|Overall Study|Lost to Follow-up|0|||
130627866|NCT04153929|470256743|FG006|Overall Study|Lost to Follow-up|0|||
130627867|NCT04153929|470256744|FG007|Overall Study|Lost to Follow-up|0|||
130627868|NCT04153929|470256737|FG000|Overall Study|Withdrawal by Subject|3|||
130627869|NCT04153929|470256738|FG001|Overall Study|Withdrawal by Subject|1|||
130627870|NCT04153929|470256739|FG002|Overall Study|Withdrawal by Subject|0|||
130627871|NCT04153929|470256740|FG003|Overall Study|Withdrawal by Subject|3|||
130627872|NCT04153929|470256741|FG004|Overall Study|Withdrawal by Subject|1|||
130627873|NCT04153929|470256742|FG005|Overall Study|Withdrawal by Subject|0|||
130627874|NCT04153929|470256743|FG006|Overall Study|Withdrawal by Subject|1|||
130627875|NCT04153929|470256744|FG007|Overall Study|Withdrawal by Subject|0|||
130627876|NCT04153929|470256737|FG000|Overall Study|Protocol Violation|0|||
130627877|NCT04153929|470256738|FG001|Overall Study|Protocol Violation|0|||
130627878|NCT04153929|470256739|FG002|Overall Study|Protocol Violation|0|||
130627879|NCT04153929|470256740|FG003|Overall Study|Protocol Violation|0|||
130627880|NCT04153929|470256741|FG004|Overall Study|Protocol Violation|0|||
130627881|NCT04153929|470256742|FG005|Overall Study|Protocol Violation|0|||
130627882|NCT04153929|470256743|FG006|Overall Study|Protocol Violation|1|||
130627883|NCT04153929|470256744|FG007|Overall Study|Protocol Violation|2|||
130627884|NCT04153929|470256737|FG000|Overall Study|Adverse Event|3|||
130627885|NCT04153929|470256738|FG001|Overall Study|Adverse Event|5|||
130627886|NCT04153929|470256739|FG002|Overall Study|Adverse Event|5|||
130627887|NCT04153929|470256740|FG003|Overall Study|Adverse Event|11|||
130627888|NCT04153929|470256741|FG004|Overall Study|Adverse Event|15|||
130627889|NCT04153929|470256742|FG005|Overall Study|Adverse Event|4|||
130627890|NCT04153929|470256743|FG006|Overall Study|Adverse Event|8|||
130627891|NCT04153929|470256744|FG007|Overall Study|Adverse Event|2|||
130627892|NCT04153929|470256737|FG000|Overall Study|Not treated|1|||
130627893|NCT04153929|470256738|FG001|Overall Study|Not treated|0|||
130627894|NCT04153929|470256739|FG002|Overall Study|Not treated|0|||
130627895|NCT04153929|470256740|FG003|Overall Study|Not treated|0|||
130627896|NCT04153929|470256741|FG004|Overall Study|Not treated|0|||
130627897|NCT04153929|470256742|FG005|Overall Study|Not treated|0|||
130627898|NCT04153929|470256743|FG006|Overall Study|Not treated|1|||
130627899|NCT04153929|470256744|FG007|Overall Study|Not treated|0|||
130627900|NCT01963780|470256745|FG000|Overall Study|Death|7|||
130627901|NCT04083794|470256746|FG000|Overall Study|Lost to Follow-up|9|||
130627902|NCT03383614|470256747|FG000|Overall Study|Withdrawal by Subject|0|||
130627903|NCT03383614|470256748|FG001|Overall Study|Withdrawal by Subject|1|||
130627904|NCT03383614|470256749|FG002|Overall Study|Withdrawal by Subject|0|||
130627905|NCT03383614|470256750|FG003|Overall Study|Withdrawal by Subject|0|||
130627906|NCT00729326|470256758|FG000|Overall Study|Lost to Follow-up|2|||
130627907|NCT00729326|470256759|FG001|Overall Study|Lost to Follow-up|0|||
130627908|NCT00729326|470256758|FG000|Overall Study|Physician Decision|0|||
130627909|NCT00729326|470256759|FG001|Overall Study|Physician Decision|1|||
130627910|NCT00729326|470256758|FG000|Overall Study|Protocol Violation|3|||
130627911|NCT00729326|470256759|FG001|Overall Study|Protocol Violation|2|||
130627912|NCT00729326|470256758|FG000|Overall Study|Subject Decision|4|||
130627913|NCT00729326|470256759|FG001|Overall Study|Subject Decision|4|||
130627914|NCT00729326|470256758|FG000|Overall Study|Sponsor Decision|1|||
130627915|NCT00729326|470256759|FG001|Overall Study|Sponsor Decision|2|||
130627916|NCT01202760|470256760|FG000|Overall Study|Entry Criteria Not Met|0|||
130627917|NCT01202760|470256761|FG001|Overall Study|Entry Criteria Not Met|3|||
130627918|NCT01202760|470256762|FG002|Overall Study|Entry Criteria Not Met|1|||
130627919|NCT01202760|470256760|FG000|Overall Study|Adverse Event|11|||
130627920|NCT01202760|470256761|FG001|Overall Study|Adverse Event|9|||
130627921|NCT01202760|470256762|FG002|Overall Study|Adverse Event|10|||
130627922|NCT01202760|470256760|FG000|Overall Study|Death|2|||
130627923|NCT01202760|470256761|FG001|Overall Study|Death|1|||
130627924|NCT01202760|470256762|FG002|Overall Study|Death|0|||
130627925|NCT01202760|470256760|FG000|Overall Study|Lack of Efficacy|6|||
130627926|NCT01202760|470256761|FG001|Overall Study|Lack of Efficacy|8|||
130627927|NCT01202760|470256762|FG002|Overall Study|Lack of Efficacy|7|||
130627928|NCT01202760|470256760|FG000|Overall Study|Lost to Follow-up|0|||
130627929|NCT01202760|470256761|FG001|Overall Study|Lost to Follow-up|2|||
130627930|NCT01202760|470256762|FG002|Overall Study|Lost to Follow-up|1|||
130627931|NCT01202760|470256760|FG000|Overall Study|Parent / Caregiver Decision|0|||
130627932|NCT01202760|470256761|FG001|Overall Study|Parent / Caregiver Decision|1|||
130627933|NCT01202760|470256762|FG002|Overall Study|Parent / Caregiver Decision|0|||
130627934|NCT01202760|470256760|FG000|Overall Study|Withdrawal by Subject|17|||
130627935|NCT01202760|470256761|FG001|Overall Study|Withdrawal by Subject|18|||
130627936|NCT01202760|470256762|FG002|Overall Study|Withdrawal by Subject|14|||
130627937|NCT01202760|470256760|FG000|Overall Study|Physician Decision|0|||
130627938|NCT01202760|470256761|FG001|Overall Study|Physician Decision|1|||
130627939|NCT01202760|470256762|FG002|Overall Study|Physician Decision|0|||
130627940|NCT01202760|470256760|FG000|Overall Study|Protocol Violation|7|||
130627941|NCT01202760|470256761|FG001|Overall Study|Protocol Violation|5|||
130627942|NCT01202760|470256762|FG002|Overall Study|Protocol Violation|2|||
130627943|NCT01202760|470256760|FG000|Overall Study|Sponsor Decision|4|||
130627944|NCT01202760|470256761|FG001|Overall Study|Sponsor Decision|4|||
130627945|NCT01202760|470256762|FG002|Overall Study|Sponsor Decision|0|||
130627946|NCT00871572|470256763|FG000|Overall Study|Adverse Event|0|||
130627947|NCT00871572|470256764|FG001|Overall Study|Adverse Event|2|||
130627948|NCT00871572|470256765|FG002|Overall Study|Adverse Event|0|||
130627949|NCT00871572|470256766|FG003|Overall Study|Adverse Event|3|||
130627950|NCT00871572|470256763|FG000|Overall Study|Investigator Decision|0|||
130627951|NCT00871572|470256764|FG001|Overall Study|Investigator Decision|1|||
130627952|NCT00871572|470256765|FG002|Overall Study|Investigator Decision|0|||
130627953|NCT00871572|470256766|FG003|Overall Study|Investigator Decision|1|||
130627954|NCT00871572|470256763|FG000|Overall Study|Lost to Follow-up|0|||
130627955|NCT00871572|470256764|FG001|Overall Study|Lost to Follow-up|1|||
130627956|NCT00871572|470256765|FG002|Overall Study|Lost to Follow-up|0|||
130627957|NCT00871572|470256766|FG003|Overall Study|Lost to Follow-up|1|||
130627958|NCT00871572|470256763|FG000|Overall Study|Protocol Violation|0|||
130627959|NCT00871572|470256764|FG001|Overall Study|Protocol Violation|0|||
130627960|NCT00871572|470256765|FG002|Overall Study|Protocol Violation|1|||
130627961|NCT00871572|470256766|FG003|Overall Study|Protocol Violation|1|||
130627962|NCT00871572|470256763|FG000|Overall Study|Sponsor Decision|1|||
130627963|NCT00871572|470256764|FG001|Overall Study|Sponsor Decision|0|||
130627964|NCT00871572|470256765|FG002|Overall Study|Sponsor Decision|0|||
130627965|NCT00871572|470256766|FG003|Overall Study|Sponsor Decision|0|||
130627966|NCT00871572|470256763|FG000|Overall Study|Withdrawal by Subject|1|||
130627967|NCT00871572|470256764|FG001|Overall Study|Withdrawal by Subject|2|||
130627968|NCT00871572|470256765|FG002|Overall Study|Withdrawal by Subject|3|||
130627969|NCT00871572|470256766|FG003|Overall Study|Withdrawal by Subject|1|||
130627970|NCT04354155|470256771|FG000|Overall Study|Withdrawal by Subject|1|||
130627971|NCT04354155|470256771|FG000|Overall Study|Did not meet criteria for study intervention|1|||
130627972|NCT00187889|470256772|FG000|Overall Study|Withdrawal by Subject|6|||
130627973|NCT00187889|470256773|FG001|Overall Study|Withdrawal by Subject|4|||
130627974|NCT03199638|470256781|FG000|Overall Study|inability to drink glutamine during regularly|0|||
130627975|NCT03199638|470256782|FG001|Overall Study|inability to drink glutamine during regularly|2|||
130627976|NCT03097029|470256783|FG000|Overall Study|Withdrawal by Subject|1|||
130627977|NCT02807844|470256784|FG000|Overall Study|Physician Decision|0|||
130627978|NCT02807844|470256785|FG001|Overall Study|Physician Decision|0|||
130627979|NCT02807844|470256786|FG002|Overall Study|Physician Decision|0|||
130627980|NCT02807844|470256787|FG003|Overall Study|Physician Decision|0|||
130627981|NCT02807844|470256788|FG004|Overall Study|Physician Decision|0|||
130627982|NCT02807844|470256789|FG005|Overall Study|Physician Decision|0|||
130627983|NCT02807844|470256790|FG006|Overall Study|Physician Decision|3|||
130627984|NCT02807844|470256791|FG007|Overall Study|Physician Decision|0|||
130627985|NCT02807844|470256792|FG008|Overall Study|Physician Decision|1|||
130627986|NCT02807844|470256793|FG009|Overall Study|Physician Decision|2|||
130627987|NCT02807844|470256784|FG000|Overall Study|Death|0|||
130627988|NCT02807844|470256785|FG001|Overall Study|Death|0|||
130627989|NCT02807844|470256786|FG002|Overall Study|Death|2|||
130627990|NCT02807844|470256787|FG003|Overall Study|Death|4|||
130627991|NCT02807844|470256788|FG004|Overall Study|Death|1|||
130627992|NCT02807844|470256789|FG005|Overall Study|Death|2|||
130627993|NCT02807844|470256790|FG006|Overall Study|Death|1|||
130627994|NCT02807844|470256791|FG007|Overall Study|Death|2|||
130627995|NCT02807844|470256792|FG008|Overall Study|Death|0|||
130627996|NCT02807844|470256793|FG009|Overall Study|Death|1|||
130627997|NCT02807844|470256784|FG000|Overall Study|Withdrawal by Subject|0|||
130627998|NCT02807844|470256785|FG001|Overall Study|Withdrawal by Subject|0|||
130627999|NCT02807844|470256786|FG002|Overall Study|Withdrawal by Subject|2|||
130628000|NCT02807844|470256787|FG003|Overall Study|Withdrawal by Subject|1|||
130628001|NCT02807844|470256788|FG004|Overall Study|Withdrawal by Subject|1|||
130628002|NCT02807844|470256789|FG005|Overall Study|Withdrawal by Subject|0|||
130628003|NCT02807844|470256790|FG006|Overall Study|Withdrawal by Subject|1|||
130628004|NCT02807844|470256791|FG007|Overall Study|Withdrawal by Subject|0|||
130628005|NCT02807844|470256792|FG008|Overall Study|Withdrawal by Subject|0|||
130628006|NCT02807844|470256793|FG009|Overall Study|Withdrawal by Subject|0|||
130628007|NCT02807844|470256784|FG000|Overall Study|Progressive disease|5|||
130628008|NCT02807844|470256785|FG001|Overall Study|Progressive disease|12|||
130628009|NCT02807844|470256786|FG002|Overall Study|Progressive disease|8|||
130628010|NCT02807844|470256787|FG003|Overall Study|Progressive disease|8|||
130628011|NCT02807844|470256788|FG004|Overall Study|Progressive disease|3|||
130628012|NCT02807844|470256789|FG005|Overall Study|Progressive disease|8|||
130628013|NCT02807844|470256790|FG006|Overall Study|Progressive disease|14|||
130628014|NCT02807844|470256791|FG007|Overall Study|Progressive disease|17|||
130628015|NCT02807844|470256792|FG008|Overall Study|Progressive disease|19|||
130628016|NCT02807844|470256793|FG009|Overall Study|Progressive disease|15|||
130628017|NCT02807844|470256784|FG000|Overall Study|Adverse Event|1|||
130628018|NCT02807844|470256785|FG001|Overall Study|Adverse Event|0|||
130628019|NCT02807844|470256786|FG002|Overall Study|Adverse Event|0|||
130628020|NCT02807844|470256787|FG003|Overall Study|Adverse Event|0|||
130628021|NCT02807844|470256788|FG004|Overall Study|Adverse Event|1|||
130628022|NCT02807844|470256789|FG005|Overall Study|Adverse Event|1|||
130628023|NCT02807844|470256790|FG006|Overall Study|Adverse Event|1|||
130628024|NCT02807844|470256791|FG007|Overall Study|Adverse Event|1|||
130628025|NCT02807844|470256792|FG008|Overall Study|Adverse Event|1|||
130628026|NCT02807844|470256793|FG009|Overall Study|Adverse Event|2|||
130628027|NCT00709124|470256795|FG000|Overall Study|Death|3|||
130628028|NCT00709124|470256796|FG001|Overall Study|Death|1|||
130628029|NCT00709124|470256795|FG000|Overall Study|encephalopathy; can't do assessment|1|||
130628030|NCT00709124|470256796|FG001|Overall Study|encephalopathy; can't do assessment|0|||
130628031|NCT00373490|470256797|FG000|Overall Study|Adverse Event|0|||
130628032|NCT00373490|470256798|FG001|Overall Study|Adverse Event|1|||
130628033|NCT00373490|470256797|FG000|Overall Study|Lack of Efficacy|9|||
130628034|NCT00373490|470256798|FG001|Overall Study|Lack of Efficacy|4|||
130628035|NCT00373490|470256797|FG000|Overall Study|Withdrawal by Subject|0|||
130628036|NCT00373490|470256798|FG001|Overall Study|Withdrawal by Subject|1|||
130628037|NCT00108953|470256805|FG000|Follow-up|Death|18|||
130628038|NCT00108953|470256806|FG001|Follow-up|Death|26|||
130628039|NCT00108953|470256805|FG000|Follow-up|Lost to Follow-up|1|||
130628040|NCT00108953|470256806|FG001|Follow-up|Lost to Follow-up|1|||
130628041|NCT00108953|470256805|FG000|Follow-up|Study terminated by sponsor|10|||
130628042|NCT00108953|470256806|FG001|Follow-up|Study terminated by sponsor|6|||
130628043|NCT02999100|470256812|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
130628044|NCT02999100|470256813|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
130628045|NCT02999100|470256814|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
130628046|NCT02999100|470256815|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
130628047|NCT02999100|470256816|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
130628048|NCT02999100|470256817|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
130628049|NCT02999100|470256812|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130628050|NCT02999100|470256813|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130628051|NCT02999100|470256814|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130628052|NCT02999100|470256815|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130628053|NCT02999100|470256816|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130628054|NCT02999100|470256817|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
130628055|NCT02999100|470256812|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130628056|NCT02999100|470256813|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130628057|NCT02999100|470256814|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
130628058|NCT02999100|470256815|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130628059|NCT02999100|470256816|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130628060|NCT02999100|470256817|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130628061|NCT01125293|470256818|FG000|Overall Study|Disease Progression|1|||
130628062|NCT01125293|470256819|FG001|Overall Study|Disease Progression|3|||
130628063|NCT01125293|470256820|FG002|Overall Study|Disease Progression|4|||
130628064|NCT01125293|470256821|FG003|Overall Study|Disease Progression|3|||
130628065|NCT01125293|470256822|FG004|Overall Study|Disease Progression|5|||
130628066|NCT01125293|470256823|FG005|Overall Study|Disease Progression|12|||
130628067|NCT01125293|470256818|FG000|Overall Study|Adverse Event|1|||
130628068|NCT01125293|470256819|FG001|Overall Study|Adverse Event|0|||
130628069|NCT01125293|470256820|FG002|Overall Study|Adverse Event|0|||
130628070|NCT01125293|470256821|FG003|Overall Study|Adverse Event|0|||
130628071|NCT01125293|470256822|FG004|Overall Study|Adverse Event|2|||
130628072|NCT01125293|470256823|FG005|Overall Study|Adverse Event|8|||
130628073|NCT01125293|470256818|FG000|Overall Study|Symptomatic Deterioration|1|||
130628074|NCT01125293|470256819|FG001|Overall Study|Symptomatic Deterioration|0|||
130628075|NCT01125293|470256820|FG002|Overall Study|Symptomatic Deterioration|0|||
130628076|NCT01125293|470256821|FG003|Overall Study|Symptomatic Deterioration|0|||
130628077|NCT01125293|470256822|FG004|Overall Study|Symptomatic Deterioration|0|||
130628078|NCT01125293|470256823|FG005|Overall Study|Symptomatic Deterioration|0|||
130628079|NCT01125293|470256818|FG000|Overall Study|Death|0|||
130628080|NCT01125293|470256819|FG001|Overall Study|Death|0|||
130628081|NCT01125293|470256820|FG002|Overall Study|Death|0|||
130628082|NCT01125293|470256821|FG003|Overall Study|Death|0|||
130628083|NCT01125293|470256822|FG004|Overall Study|Death|1|||
130628084|NCT01125293|470256823|FG005|Overall Study|Death|0|||
130628085|NCT01125293|470256818|FG000|Overall Study|Withdrawal by Subject|0|||
130628086|NCT01125293|470256819|FG001|Overall Study|Withdrawal by Subject|0|||
130628087|NCT01125293|470256820|FG002|Overall Study|Withdrawal by Subject|0|||
130628088|NCT01125293|470256821|FG003|Overall Study|Withdrawal by Subject|0|||
130628089|NCT01125293|470256822|FG004|Overall Study|Withdrawal by Subject|2|||
130628090|NCT01125293|470256823|FG005|Overall Study|Withdrawal by Subject|1|||
130628091|NCT01125293|470256818|FG000|Overall Study|Physician Decision|0|||
130628092|NCT01125293|470256819|FG001|Overall Study|Physician Decision|0|||
130628093|NCT01125293|470256820|FG002|Overall Study|Physician Decision|0|||
130628094|NCT01125293|470256821|FG003|Overall Study|Physician Decision|0|||
130628095|NCT01125293|470256822|FG004|Overall Study|Physician Decision|0|||
130628096|NCT01125293|470256823|FG005|Overall Study|Physician Decision|2|||
130628097|NCT02224638|470256824|FG000|Overall Study|Adverse Event|1|||
130628098|NCT02224638|470256825|FG001|Overall Study|Adverse Event|1|||
130628099|NCT01270958|470256828|FG000|Overall Study|Lost to Follow-up|2|||
130628100|NCT01270958|470256828|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
130628101|NCT02096042|470256833|FG000|Overall Study|Disease Progression|1|||
130628102|NCT02096042|470256834|FG001|Overall Study|Disease Progression|0|||
130628103|NCT02096042|470256835|FG002|Overall Study|Disease Progression|0|||
130628104|NCT00631540|470256848|FG000|Overall Study|Withdrawal by Subject|5|||
130628105|NCT00631540|470256848|FG000|Overall Study|Death|4|||
130628106|NCT00631540|470256848|FG000|Overall Study|Lost to Follow-up|2|||
130628107|NCT00631540|470256848|FG000|Overall Study|Core Lab Data Unavailable|3|||
130628108|NCT00970268|470256849|FG000|Overall Study|Withdrawal by Subject|12|||
130628109|NCT00970268|470256850|FG001|Overall Study|Withdrawal by Subject|19|||
130628110|NCT00970268|470256849|FG000|Overall Study|Adverse Event|15|||
130628111|NCT00970268|470256850|FG001|Overall Study|Adverse Event|12|||
130628112|NCT00970268|470256849|FG000|Overall Study|Lack of Efficacy|3|||
130628113|NCT00970268|470256850|FG001|Overall Study|Lack of Efficacy|6|||
130628114|NCT00970268|470256849|FG000|Overall Study|Protocol Violation|4|||
130628115|NCT00970268|470256850|FG001|Overall Study|Protocol Violation|7|||
130628116|NCT00970268|470256849|FG000|Overall Study|Other Reason|3|||
130628117|NCT00970268|470256850|FG001|Overall Study|Other Reason|1|||
130628118|NCT00970268|470256849|FG000|Overall Study|COPD Exacerbation|4|||
130628119|NCT00970268|470256850|FG001|Overall Study|COPD Exacerbation|2|||
130628120|NCT00970268|470256849|FG000|Overall Study|Lost to Follow-up|1|||
130628121|NCT00970268|470256850|FG001|Overall Study|Lost to Follow-up|2|||
130628122|NCT00970268|470256849|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
130628123|NCT00970268|470256850|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
130628124|NCT03136367|470256852|FG000|T1 Consultation|discontinued mistakenly included|2|||
130628125|NCT03136367|470256853|FG001|T1 Consultation|discontinued mistakenly included|6|||
130628126|NCT03136367|470256854|FG002|T1 Consultation|discontinued mistakenly included|1|||
130628127|NCT03136367|470256852|FG000|T1 Consultation|Discontinued other|0|||
130628128|NCT03136367|470256853|FG001|T1 Consultation|Discontinued other|1|||
130628129|NCT03136367|470256854|FG002|T1 Consultation|Discontinued other|0|||
130628130|NCT03136367|470256852|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
130628131|NCT03136367|470256853|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
130628132|NCT03136367|470256854|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
130628133|NCT03136367|470256852|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
130628134|NCT03136367|470256853|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
130628135|NCT03136367|470256854|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
130628136|NCT03136367|470256852|FG000|T2 Post-consultation|Discontinued other|0|||
130628137|NCT03136367|470256853|FG001|T2 Post-consultation|Discontinued other|2|||
130628138|NCT03136367|470256854|FG002|T2 Post-consultation|Discontinued other|6|||
130628139|NCT03136367|470256852|FG000|T2 Post-consultation|Discontinued transferred care|0|||
130628140|NCT03136367|470256853|FG001|T2 Post-consultation|Discontinued transferred care|0|||
130628141|NCT03136367|470256854|FG002|T2 Post-consultation|Discontinued transferred care|3|||
130628142|NCT03136367|470256852|FG000|T2 Post-consultation|Discontinued lost contact|0|||
130628143|NCT03136367|470256853|FG001|T2 Post-consultation|Discontinued lost contact|1|||
130628144|NCT03136367|470256854|FG002|T2 Post-consultation|Discontinued lost contact|0|||
130628145|NCT03136367|470256852|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
130628146|NCT03136367|470256853|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
130628147|NCT03136367|470256854|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
130628148|NCT03136367|470256852|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
130628149|NCT03136367|470256853|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
130628150|NCT03136367|470256854|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
130628151|NCT03136367|470256852|FG000|T3 1 Week After Surgery|other discontinued|2|||
130628152|NCT03136367|470256853|FG001|T3 1 Week After Surgery|other discontinued|4|||
130628153|NCT03136367|470256854|FG002|T3 1 Week After Surgery|other discontinued|3|||
130628154|NCT03136367|470256852|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
130628155|NCT03136367|470256853|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
130628156|NCT03136367|470256854|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
130628157|NCT03136367|470256852|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
130628158|NCT03136367|470256853|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
130628159|NCT03136367|470256854|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
130628160|NCT03136367|470256852|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
130628161|NCT03136367|470256853|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
130628162|NCT03136367|470256854|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
130628163|NCT03136367|470256852|FG000|T4 12 Weeks After Surgery|Death|0|||
130628164|NCT03136367|470256853|FG001|T4 12 Weeks After Surgery|Death|1|||
130628165|NCT03136367|470256854|FG002|T4 12 Weeks After Surgery|Death|3|||
130628166|NCT03136367|470256852|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
130628167|NCT03136367|470256853|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
130628168|NCT03136367|470256854|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
130628169|NCT03136367|470256852|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
130628170|NCT03136367|470256853|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
130628171|NCT03136367|470256854|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
130628172|NCT03136367|470256852|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
130628173|NCT03136367|470256853|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
130628174|NCT03136367|470256854|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
130628175|NCT03136367|470256852|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
130628176|NCT03136367|470256853|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
130628177|NCT03136367|470256854|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
130628178|NCT03136367|470256852|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
130628179|NCT03136367|470256853|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
130628180|NCT03136367|470256854|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
130628181|NCT03136367|470256852|FG000|T5 1 Year After Surgery|Death|0|||
130628182|NCT03136367|470256853|FG001|T5 1 Year After Surgery|Death|0|||
130628183|NCT03136367|470256854|FG002|T5 1 Year After Surgery|Death|1|||
130628184|NCT03136367|470256852|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
130628185|NCT03136367|470256853|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
130628186|NCT03136367|470256854|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
130628187|NCT03136367|470256852|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
130628188|NCT03136367|470256853|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
130628189|NCT03136367|470256854|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
130628190|NCT03136367|470256852|FG000|T5 1 Year After Surgery|study ended before due|31|||
130628191|NCT03136367|470256853|FG001|T5 1 Year After Surgery|study ended before due|103|||
130628192|NCT03136367|470256854|FG002|T5 1 Year After Surgery|study ended before due|110|||
130628193|NCT03136367|470256852|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
130628194|NCT03136367|470256853|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
130628195|NCT03136367|470256854|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
130628196|NCT05200455|470256857|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
130628197|NCT01602549|470256858|FG000|Overall Study|Protocol Violation|0|||
130628198|NCT01602549|470256859|FG001|Overall Study|Protocol Violation|1|||
130628199|NCT01602549|470256858|FG000|Overall Study|Withdrawal by Subject|1|||
130628200|NCT01602549|470256859|FG001|Overall Study|Withdrawal by Subject|0|||
130628201|NCT00511108|470258836|FG000|Overall Study|Adverse Event|2|||
130628202|NCT00511108|470258837|FG001|Overall Study|Adverse Event|0|||
130628203|NCT00511108|470258838|FG002|Overall Study|Adverse Event|1|||
130628204|NCT00511108|470258839|FG003|Overall Study|Adverse Event|2|||
130628205|NCT00511108|470258836|FG000|Overall Study|Lost to Follow-up|0|||
130628206|NCT00511108|470258837|FG001|Overall Study|Lost to Follow-up|2|||
130628207|NCT00511108|470258838|FG002|Overall Study|Lost to Follow-up|1|||
130628208|NCT00511108|470258839|FG003|Overall Study|Lost to Follow-up|0|||
130628209|NCT00511108|470258836|FG000|Overall Study|Physician Decision|0|||
130628210|NCT00511108|470258837|FG001|Overall Study|Physician Decision|0|||
130628211|NCT00511108|470258838|FG002|Overall Study|Physician Decision|0|||
130628212|NCT00511108|470258839|FG003|Overall Study|Physician Decision|1|||
130628213|NCT00511108|470258836|FG000|Overall Study|Withdrawal by Subject|4|||
130628214|NCT00511108|470258837|FG001|Overall Study|Withdrawal by Subject|0|||
130628215|NCT00511108|470258838|FG002|Overall Study|Withdrawal by Subject|3|||
130628216|NCT00511108|470258839|FG003|Overall Study|Withdrawal by Subject|2|||
130628217|NCT02147691|470258842|FG000|Overall Study|Withdrawal by Subject|2|||
130628218|NCT02147691|470258843|FG001|Overall Study|Withdrawal by Subject|0|||
130628219|NCT02147691|470258842|FG000|Overall Study|Adverse Event|2|||
130628220|NCT02147691|470258843|FG001|Overall Study|Adverse Event|0|||
130628221|NCT02147691|470258842|FG000|Overall Study|Lost to Follow-up|0|||
130628222|NCT02147691|470258843|FG001|Overall Study|Lost to Follow-up|1|||
130628223|NCT02954952|470258844|FG000|Overall Study|Withdrawal by Subject|1|||
130628224|NCT02954952|470258845|FG001|Overall Study|Withdrawal by Subject|0|||
130628225|NCT02954952|470258846|FG002|Overall Study|Withdrawal by Subject|0|||
130628226|NCT02954952|470258844|FG000|Overall Study|No data collected|0|||
130628227|NCT02954952|470258845|FG001|Overall Study|No data collected|1|||
130628228|NCT02954952|470258846|FG002|Overall Study|No data collected|0|||
130628229|NCT01392742|470258849|FG000|Overall Study|Premature study termination|42|||
130628230|NCT01392742|470258849|FG000|Overall Study|Failure to return|35|||
130628231|NCT01392742|470258849|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
130628232|NCT01392742|470258849|FG000|Overall Study|Lost to Follow-up|34|||
130628233|NCT01392742|470258849|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
130628234|NCT01392742|470258849|FG000|Overall Study|ITR and Protocol deviation|1|||
130628235|NCT01392742|470258849|FG000|Overall Study|Adverse event/intercurrent illness|17|||
130628236|NCT01392742|470258849|FG000|Overall Study|Protocol Violation|14|||
130628237|NCT01392742|470258849|FG000|Overall Study|Other|3|||
130628238|NCT01392742|470258849|FG000|Overall Study|Missing information|13|||
130628239|NCT04179032|470258850|FG000|Part B (Up to Week 52)|Adverse Event|1|||
130628240|NCT04179032|470258850|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
130628241|NCT04179032|470258850|FG000|Access Extension Phase|Ongoing|11|||
130628242|NCT02432703|470258851|FG000|Overall Study|Adverse Event|1|||
130628243|NCT02432703|470258852|FG001|Overall Study|Adverse Event|4|||
130628244|NCT02432703|470258851|FG000|Overall Study|Lack of Efficacy|1|||
130628245|NCT02432703|470258852|FG001|Overall Study|Lack of Efficacy|0|||
130628246|NCT02432703|470258851|FG000|Overall Study|Lost to Follow-up|5|||
130628247|NCT02432703|470258852|FG001|Overall Study|Lost to Follow-up|3|||
130628248|NCT02432703|470258851|FG000|Overall Study|Withdrawal by Subject|9|||
130628249|NCT02432703|470258852|FG001|Overall Study|Withdrawal by Subject|6|||
130628250|NCT02432703|470258851|FG000|Overall Study|Other|6|||
130628251|NCT02432703|470258852|FG001|Overall Study|Other|5|||
130628252|NCT00724815|470258853|FG000|Overall Study|Randomized, not treated|31|||
130628253|NCT00724815|470258854|FG001|Overall Study|Randomized, not treated|30|||
130628254|NCT00724815|470258853|FG000|Overall Study|Adverse Event|5|||
130628255|NCT00724815|470258854|FG001|Overall Study|Adverse Event|3|||
130628256|NCT00724815|470258853|FG000|Overall Study|Lost to Follow-up|4|||
130628257|NCT00724815|470258854|FG001|Overall Study|Lost to Follow-up|1|||
130628258|NCT00724815|470258853|FG000|Overall Study|Other Various|3|||
130628259|NCT00724815|470258854|FG001|Overall Study|Other Various|5|||
130628260|NCT00810043|470258855|FG000|Overall Study|Withdrawal by Subject|1|||
130628261|NCT00810043|470258856|FG001|Overall Study|Withdrawal by Subject|0|||
130628262|NCT00810043|470258857|FG002|Overall Study|Withdrawal by Subject|2|||
130628263|NCT00810043|470258855|FG000|Overall Study|Lost to Follow-up|1|||
130628264|NCT00810043|470258856|FG001|Overall Study|Lost to Follow-up|0|||
130628265|NCT00810043|470258857|FG002|Overall Study|Lost to Follow-up|0|||
130628266|NCT00810043|470258855|FG000|Overall Study|Physician Decision|0|||
130628267|NCT00810043|470258856|FG001|Overall Study|Physician Decision|0|||
130628268|NCT00810043|470258857|FG002|Overall Study|Physician Decision|2|||
130628269|NCT00810043|470258855|FG000|Overall Study|Death|2|||
130628270|NCT00810043|470258856|FG001|Overall Study|Death|0|||
130628271|NCT00810043|470258857|FG002|Overall Study|Death|0|||
130628272|NCT00810043|470258855|FG000|Overall Study|Unrelated medical problem|0|||
130628273|NCT00810043|470258856|FG001|Overall Study|Unrelated medical problem|1|||
130628274|NCT00810043|470258857|FG002|Overall Study|Unrelated medical problem|0|||
130628275|NCT00810043|470258855|FG000|Overall Study|Non-medical problem|0|||
130628276|NCT00810043|470258856|FG001|Overall Study|Non-medical problem|0|||
130628277|NCT00810043|470258857|FG002|Overall Study|Non-medical problem|1|||
130628278|NCT00810043|470258855|FG000|Overall Study|No longer met enrollment criteria|0|||
130628279|NCT00810043|470258856|FG001|Overall Study|No longer met enrollment criteria|0|||
130628280|NCT00810043|470258857|FG002|Overall Study|No longer met enrollment criteria|3|||
130628281|NCT01359046|470258858|FG000|Overall Study|Did not receive allocated intervention|6|||
130628282|NCT01359046|470258859|FG001|Overall Study|Did not receive allocated intervention|6|||
130628283|NCT01359046|470258858|FG000|Overall Study|Physician Decision|1|||
130628284|NCT01359046|470258859|FG001|Overall Study|Physician Decision|11|||
130628285|NCT04539262|470258863|FG000|Overall Study|Adverse Event|0|||
130628286|NCT04539262|470258864|FG001|Overall Study|Adverse Event|0|||
130628287|NCT04539262|470258865|FG002|Overall Study|Adverse Event|1|||
130628288|NCT04539262|470258866|FG003|Overall Study|Adverse Event|0|||
130628289|NCT04539262|470258867|FG004|Overall Study|Adverse Event|0|||
130628290|NCT04539262|470258868|FG005|Overall Study|Adverse Event|0|||
130628291|NCT04539262|470258869|FG006|Overall Study|Adverse Event|0|||
130628292|NCT04539262|470258870|FG007|Overall Study|Adverse Event|0|||
130628293|NCT04539262|470258863|FG000|Overall Study|Withdrew Consent|0|||
130628294|NCT04539262|470258864|FG001|Overall Study|Withdrew Consent|0|||
130628295|NCT04539262|470258865|FG002|Overall Study|Withdrew Consent|0|||
130628296|NCT04539262|470258866|FG003|Overall Study|Withdrew Consent|1|||
130628297|NCT04539262|470258867|FG004|Overall Study|Withdrew Consent|0|||
130628298|NCT04539262|470258868|FG005|Overall Study|Withdrew Consent|0|||
130628299|NCT04539262|470258869|FG006|Overall Study|Withdrew Consent|0|||
130628300|NCT04539262|470258870|FG007|Overall Study|Withdrew Consent|0|||
130628301|NCT04539262|470258863|FG000|Overall Study|Randomized, Not treated|0|||
130628302|NCT04539262|470258864|FG001|Overall Study|Randomized, Not treated|1|||
130628303|NCT04539262|470258865|FG002|Overall Study|Randomized, Not treated|0|||
130628304|NCT04539262|470258866|FG003|Overall Study|Randomized, Not treated|0|||
130628305|NCT04539262|470258867|FG004|Overall Study|Randomized, Not treated|0|||
130628306|NCT04539262|470258868|FG005|Overall Study|Randomized, Not treated|0|||
130628307|NCT04539262|470258869|FG006|Overall Study|Randomized, Not treated|1|||
130628308|NCT04539262|470258870|FG007|Overall Study|Randomized, Not treated|0|||
130628309|NCT01061567|470258877|FG000|Overall Study|Adverse Event|32|||
130628310|NCT01061567|470258877|FG000|Overall Study|Death|2|||
130628311|NCT01061567|470258877|FG000|Overall Study|Lack of Efficacy|3|||
130628312|NCT01061567|470258877|FG000|Overall Study|Lost to Follow-up|24|||
130628313|NCT01061567|470258877|FG000|Overall Study|Protocol Violation|1|||
130628314|NCT01061567|470258877|FG000|Overall Study|Withdrawal by Subject|11|||
130628315|NCT01061567|470258877|FG000|Overall Study|Other reason than stated above|3|||
130628316|NCT01831804|470258878|FG000|Overall Study|Adverse Event|0|||
130628317|NCT01831804|470258879|FG001|Overall Study|Adverse Event|0|||
130628318|NCT01831804|470258880|FG002|Overall Study|Adverse Event|0|||
130628319|NCT01831804|470258881|FG003|Overall Study|Adverse Event|0|||
130628320|NCT01831804|470258882|FG004|Overall Study|Adverse Event|0|||
130628321|NCT01831804|470258883|FG005|Overall Study|Adverse Event|0|||
130628322|NCT01831804|470258884|FG006|Overall Study|Adverse Event|1|||
130628323|NCT01831804|470258885|FG007|Overall Study|Adverse Event|0|||
130628324|NCT01831804|470258886|FG008|Overall Study|Adverse Event|1|||
130628325|NCT01831804|470258878|FG000|Overall Study|Protocol Violation|0|||
130628326|NCT01831804|470258879|FG001|Overall Study|Protocol Violation|0|||
130628327|NCT01831804|470258880|FG002|Overall Study|Protocol Violation|2|||
130628328|NCT01831804|470258881|FG003|Overall Study|Protocol Violation|0|||
130628329|NCT01831804|470258882|FG004|Overall Study|Protocol Violation|0|||
130628330|NCT01831804|470258883|FG005|Overall Study|Protocol Violation|0|||
130628331|NCT01831804|470258884|FG006|Overall Study|Protocol Violation|0|||
130628332|NCT01831804|470258885|FG007|Overall Study|Protocol Violation|0|||
130628333|NCT01831804|470258886|FG008|Overall Study|Protocol Violation|0|||
130628334|NCT01831804|470258878|FG000|Overall Study|Protocol defined stopping criteria|1|||
130628335|NCT01831804|470258879|FG001|Overall Study|Protocol defined stopping criteria|1|||
130628336|NCT01831804|470258880|FG002|Overall Study|Protocol defined stopping criteria|3|||
130628337|NCT01831804|470258881|FG003|Overall Study|Protocol defined stopping criteria|0|||
130628338|NCT01831804|470258882|FG004|Overall Study|Protocol defined stopping criteria|1|||
130628339|NCT01831804|470258883|FG005|Overall Study|Protocol defined stopping criteria|0|||
130628340|NCT01831804|470258884|FG006|Overall Study|Protocol defined stopping criteria|0|||
130628341|NCT01831804|470258885|FG007|Overall Study|Protocol defined stopping criteria|0|||
130628342|NCT01831804|470258886|FG008|Overall Study|Protocol defined stopping criteria|0|||
130628343|NCT01831804|470258878|FG000|Overall Study|Lost to Follow-up|0|||
130628344|NCT01831804|470258879|FG001|Overall Study|Lost to Follow-up|0|||
130628345|NCT01831804|470258880|FG002|Overall Study|Lost to Follow-up|1|||
130628346|NCT01831804|470258881|FG003|Overall Study|Lost to Follow-up|0|||
130628347|NCT01831804|470258882|FG004|Overall Study|Lost to Follow-up|0|||
130628348|NCT01831804|470258883|FG005|Overall Study|Lost to Follow-up|0|||
130628349|NCT01831804|470258884|FG006|Overall Study|Lost to Follow-up|0|||
130628350|NCT01831804|470258885|FG007|Overall Study|Lost to Follow-up|0|||
130628351|NCT01831804|470258886|FG008|Overall Study|Lost to Follow-up|1|||
130628352|NCT01831804|470258878|FG000|Overall Study|Investigator discretion|0|||
130628353|NCT01831804|470258879|FG001|Overall Study|Investigator discretion|0|||
130628354|NCT01831804|470258880|FG002|Overall Study|Investigator discretion|0|||
130628355|NCT01831804|470258881|FG003|Overall Study|Investigator discretion|0|||
130628356|NCT01831804|470258882|FG004|Overall Study|Investigator discretion|1|||
130628357|NCT01831804|470258883|FG005|Overall Study|Investigator discretion|0|||
130628358|NCT01831804|470258884|FG006|Overall Study|Investigator discretion|0|||
130628359|NCT01831804|470258885|FG007|Overall Study|Investigator discretion|1|||
130628360|NCT01831804|470258886|FG008|Overall Study|Investigator discretion|0|||
130628361|NCT01831804|470258878|FG000|Overall Study|Withdrew Consent|0|||
130628362|NCT01831804|470258879|FG001|Overall Study|Withdrew Consent|1|||
130628363|NCT01831804|470258880|FG002|Overall Study|Withdrew Consent|0|||
130628364|NCT01831804|470258881|FG003|Overall Study|Withdrew Consent|0|||
130628365|NCT01831804|470258882|FG004|Overall Study|Withdrew Consent|0|||
130628366|NCT01831804|470258883|FG005|Overall Study|Withdrew Consent|0|||
130628367|NCT01831804|470258884|FG006|Overall Study|Withdrew Consent|0|||
130628368|NCT01831804|470258885|FG007|Overall Study|Withdrew Consent|2|||
130628369|NCT01831804|470258886|FG008|Overall Study|Withdrew Consent|0|||
130628370|NCT00268463|470258889|FG000|Overall Study|study terminated due to low accrual|10|||
130628371|NCT00268463|470258890|FG001|Overall Study|study terminated due to low accrual|12|||
130628372|NCT02920450|470258891|FG000|Overall Study|Death|1|||
130628373|NCT02920450|470258892|FG001|Overall Study|Death|0|||
130628374|NCT02920450|470258893|FG002|Overall Study|Death|0|||
130628375|NCT02920450|470258894|FG003|Overall Study|Death|0|||
130628376|NCT02920450|470258891|FG000|Overall Study|Withdrawal by Subject|1|||
130628377|NCT02920450|470258892|FG001|Overall Study|Withdrawal by Subject|0|||
130628378|NCT02920450|470258893|FG002|Overall Study|Withdrawal by Subject|0|||
130628379|NCT02920450|470258894|FG003|Overall Study|Withdrawal by Subject|0|||
130628380|NCT00291187|470258895|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
130628381|NCT00291187|470258896|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
130628382|NCT00291187|470258897|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
130628383|NCT00291187|470258898|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
130628384|NCT02443805|470258904|FG000|Overall Study|Adverse Event|100|||
130628385|NCT02443805|470258905|FG001|Overall Study|Adverse Event|18|||
130628386|NCT02443805|470258904|FG000|Overall Study|Withdrawal by Subject|73|||
130628387|NCT02443805|470258905|FG001|Overall Study|Withdrawal by Subject|74|||
130628388|NCT02443805|470258904|FG000|Overall Study|Lost to Follow-up|19|||
130628389|NCT02443805|470258905|FG001|Overall Study|Lost to Follow-up|14|||
130628390|NCT02443805|470258904|FG000|Overall Study|Pregnancy|6|||
130628391|NCT02443805|470258905|FG001|Overall Study|Pregnancy|5|||
130628392|NCT02443805|470258904|FG000|Overall Study|Protocol Violation|2|||
130628393|NCT02443805|470258905|FG001|Overall Study|Protocol Violation|4|||
130628394|NCT02443805|470258904|FG000|Overall Study|Lack of Efficacy|1|||
130628395|NCT02443805|470258905|FG001|Overall Study|Lack of Efficacy|1|||
130628396|NCT02443805|470258904|FG000|Overall Study|Non-compliance with study drug|6|||
130628397|NCT02443805|470258905|FG001|Overall Study|Non-compliance with study drug|4|||
130628398|NCT02443805|470258904|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130628399|NCT02443805|470258905|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130628400|NCT02443805|470258904|FG000|Overall Study|Any other reason not above-mentioned|3|||
130628401|NCT02443805|470258905|FG001|Overall Study|Any other reason not above-mentioned|2|||
130628402|NCT04362813|470258906|FG000|Overall Study|Death|12|||
130628403|NCT04362813|470258907|FG001|Overall Study|Death|16|||
130628404|NCT04362813|470258906|FG000|Overall Study|Withdrawal by Subject|3|||
130628405|NCT04362813|470258907|FG001|Overall Study|Withdrawal by Subject|1|||
130628406|NCT04362813|470258906|FG000|Overall Study|Protocol Violation|0|||
130628407|NCT04362813|470258907|FG001|Overall Study|Protocol Violation|3|||
130628408|NCT04362813|470258906|FG000|Overall Study|Lost to Follow-up|1|||
130628409|NCT04362813|470258907|FG001|Overall Study|Lost to Follow-up|1|||
130628410|NCT04362813|470258906|FG000|Overall Study|Enrolled but did not receive treatment|2|||
130628411|NCT04362813|470258907|FG001|Overall Study|Enrolled but did not receive treatment|4|||
130628412|NCT00961116|470258908|FG000|Washout Period of 7 Days|Adverse Event|1|||
130628413|NCT00961116|470258909|FG001|Washout Period of 7 Days|Adverse Event|1|||
130628414|NCT00961116|470258908|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130628415|NCT00961116|470258909|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130628416|NCT00961116|470258908|FG000|Washout Period of 7 Days|Protocol Violation|0|||
130628417|NCT00961116|470258909|FG001|Washout Period of 7 Days|Protocol Violation|1|||
130628418|NCT02708966|470258910|FG000|Overall Study|Lost to Follow-up|2|||
130628419|NCT02708966|470258911|FG001|Overall Study|Lost to Follow-up|2|||
130628420|NCT01732107|470258914|FG000|Overall Study|Adverse Event|2|||
130628421|NCT01732107|470258914|FG000|Overall Study|Disease Progression|8|||
130628422|NCT01732107|470258914|FG000|Overall Study|Physician Decision|1|||
130628423|NCT01732107|470258914|FG000|Overall Study|Withdrawal by Subject|2|||
130628424|NCT02023268|470258915|FG000|Overall Study|Lack of Efficacy|0|||
130628425|NCT02023268|470258916|FG001|Overall Study|Lack of Efficacy|1|||
130628426|NCT02023268|470258915|FG000|Overall Study|Adverse Event|0|||
130628427|NCT02023268|470258916|FG001|Overall Study|Adverse Event|2|||
130628428|NCT02023268|470258915|FG000|Overall Study|Withdrawal by Subject|0|||
130628429|NCT02023268|470258916|FG001|Overall Study|Withdrawal by Subject|1|||
130628430|NCT00615459|470258917|FG000|Period I|Adverse Event|2|||
130628431|NCT00615459|470258918|FG001|Period I|Adverse Event|0|||
130628432|NCT00615459|470258919|FG002|Period I|Adverse Event|1|||
130628433|NCT00615459|470258920|FG003|Period I|Adverse Event|0|||
130628434|NCT00615459|470258917|FG000|Period I|Subject withdrew consent|1|||
130628435|NCT00615459|470258918|FG001|Period I|Subject withdrew consent|0|||
130628436|NCT00615459|470258919|FG002|Period I|Subject withdrew consent|0|||
130628437|NCT00615459|470258920|FG003|Period I|Subject withdrew consent|1|||
130628438|NCT00615459|470258917|FG000|Period I|Abnormal test procedure results|1|||
130628439|NCT00615459|470258918|FG001|Period I|Abnormal test procedure results|1|||
130628440|NCT00615459|470258919|FG002|Period I|Abnormal test procedure results|1|||
130628441|NCT00615459|470258920|FG003|Period I|Abnormal test procedure results|0|||
130628442|NCT00615459|470258917|FG000|Period II|Adverse Event|1|||
130628443|NCT00615459|470258918|FG001|Period II|Adverse Event|0|||
130628444|NCT00615459|470258919|FG002|Period II|Adverse Event|0|||
130628445|NCT00615459|470258920|FG003|Period II|Adverse Event|0|||
130628446|NCT00615459|470258917|FG000|Period II|Lost to Follow-up|0|||
130628447|NCT00615459|470258918|FG001|Period II|Lost to Follow-up|0|||
130628448|NCT00615459|470258919|FG002|Period II|Lost to Follow-up|0|||
130628449|NCT00615459|470258920|FG003|Period II|Lost to Follow-up|1|||
130628450|NCT00615459|470258917|FG000|Period III|Adverse Event|0|||
130628451|NCT00615459|470258918|FG001|Period III|Adverse Event|1|||
130628452|NCT00615459|470258919|FG002|Period III|Adverse Event|0|||
130628453|NCT00615459|470258920|FG003|Period III|Adverse Event|0|||
130628454|NCT00615459|470258917|FG000|Period III|Administrative problems|0|||
130628455|NCT00615459|470258918|FG001|Period III|Administrative problems|1|||
130628456|NCT00615459|470258919|FG002|Period III|Administrative problems|1|||
130628457|NCT00615459|470258920|FG003|Period III|Administrative problems|0|||
130628458|NCT00615459|470258917|FG000|Period III|Unsatisfactory therapeutic effect|0|||
130628459|NCT00615459|470258918|FG001|Period III|Unsatisfactory therapeutic effect|1|||
130628460|NCT00615459|470258919|FG002|Period III|Unsatisfactory therapeutic effect|0|||
130628461|NCT00615459|470258920|FG003|Period III|Unsatisfactory therapeutic effect|0|||
130628462|NCT01975675|470258921|FG000|Overall Study|Death|0|||
130628463|NCT01975675|470258922|FG001|Overall Study|Death|1|||
130628464|NCT01975675|470258923|FG002|Overall Study|Death|0|||
130628465|NCT01975675|470258924|FG003|Overall Study|Death|0|||
130628466|NCT00224003|470258925|FG000|Overall Study|Adverse Event|1|||
130628467|NCT00224003|470258925|FG000|Overall Study|Protocol Violation|2|||
130628468|NCT00224003|470258925|FG000|Overall Study|Withdrawal by Subject|1|||
130628469|NCT00224003|470258925|FG000|Overall Study|unk|3|||
130628470|NCT00753688|470258926|FG000|Overall Study|Death|102|||
130628471|NCT00753688|470258927|FG001|Overall Study|Death|203|||
130628472|NCT00753688|470258926|FG000|Overall Study|Missing|4|||
130628473|NCT00753688|470258927|FG001|Overall Study|Missing|9|||
130628474|NCT00753688|470258926|FG000|Overall Study|Participant Withdrew Consent|2|||
130628475|NCT00753688|470258927|FG001|Overall Study|Participant Withdrew Consent|2|||
130628476|NCT00753688|470258926|FG000|Overall Study|Ongoing - in Follow-up|15|||
130628477|NCT00753688|470258927|FG001|Overall Study|Ongoing - in Follow-up|31|||
130628478|NCT00753688|470258926|FG000|Overall Study|Adverse Event|0|||
130628479|NCT00753688|470258927|FG001|Overall Study|Adverse Event|1|||
130628480|NCT03803202|470258928|FG000|Overall Study|Other|0|||
130628481|NCT03803202|470258929|FG001|Overall Study|Other|1|||
130628482|NCT03803202|470258930|FG002|Overall Study|Other|0|||
130628483|NCT03803202|470258931|FG003|Overall Study|Other|0|||
130628484|NCT03803202|470258932|FG004|Overall Study|Other|0|||
130628485|NCT03803202|470258933|FG005|Overall Study|Other|0|||
130628486|NCT03803202|470258934|FG006|Overall Study|Other|0|||
130628487|NCT03803202|470258935|FG007|Overall Study|Other|0|||
130628488|NCT03803202|470258936|FG008|Overall Study|Other|0|||
130628489|NCT03803202|470258928|FG000|Overall Study|Death|0|||
130628490|NCT03803202|470258929|FG001|Overall Study|Death|0|||
130628491|NCT03803202|470258930|FG002|Overall Study|Death|0|||
130628492|NCT03803202|470258931|FG003|Overall Study|Death|0|||
130628493|NCT03803202|470258932|FG004|Overall Study|Death|0|||
130628494|NCT03803202|470258933|FG005|Overall Study|Death|1|||
130628495|NCT03803202|470258934|FG006|Overall Study|Death|0|||
130628496|NCT03803202|470258935|FG007|Overall Study|Death|0|||
130628497|NCT03803202|470258936|FG008|Overall Study|Death|0|||
130628498|NCT03803202|470258928|FG000|Overall Study|Withdrawal by Subject|0|||
130628499|NCT03803202|470258929|FG001|Overall Study|Withdrawal by Subject|0|||
130628500|NCT03803202|470258930|FG002|Overall Study|Withdrawal by Subject|1|||
130628501|NCT03803202|470258931|FG003|Overall Study|Withdrawal by Subject|0|||
130628502|NCT03803202|470258932|FG004|Overall Study|Withdrawal by Subject|0|||
130628503|NCT03803202|470258933|FG005|Overall Study|Withdrawal by Subject|0|||
130628504|NCT03803202|470258934|FG006|Overall Study|Withdrawal by Subject|0|||
130628505|NCT03803202|470258935|FG007|Overall Study|Withdrawal by Subject|1|||
130628506|NCT03803202|470258936|FG008|Overall Study|Withdrawal by Subject|0|||
130628507|NCT03803202|470258928|FG000|Overall Study|Lost to Follow-up|0|||
130628508|NCT03803202|470258929|FG001|Overall Study|Lost to Follow-up|0|||
130628509|NCT03803202|470258930|FG002|Overall Study|Lost to Follow-up|0|||
130628510|NCT03803202|470258931|FG003|Overall Study|Lost to Follow-up|1|||
130628511|NCT03803202|470258932|FG004|Overall Study|Lost to Follow-up|1|||
130628512|NCT03803202|470258933|FG005|Overall Study|Lost to Follow-up|0|||
130628513|NCT03803202|470258934|FG006|Overall Study|Lost to Follow-up|1|||
130628514|NCT03803202|470258935|FG007|Overall Study|Lost to Follow-up|0|||
130628515|NCT03803202|470258936|FG008|Overall Study|Lost to Follow-up|0|||
130628516|NCT00293241|470258937|FG000|Overall Study|Lost to Follow-up|9|||
130628517|NCT00293241|470258938|FG001|Overall Study|Lost to Follow-up|16|||
130628518|NCT00293241|470258937|FG000|Overall Study|Physician Decision|23|||
130628519|NCT00293241|470258938|FG001|Overall Study|Physician Decision|17|||
130628520|NCT00293241|470258937|FG000|Overall Study|Withdrawal by Subject|4|||
130628521|NCT00293241|470258938|FG001|Overall Study|Withdrawal by Subject|8|||
130628522|NCT03595384|470258939|FG000|Overall Study|Other time commitments|8|||
130628523|NCT03595384|470258939|FG000|Overall Study|Changes to session time|7|||
130628524|NCT03595384|470258939|FG000|Overall Study|Relocation out of country|1|||
130628525|NCT00659126|470258944|FG000|Overall Study|Adverse Event|2|||
130628526|NCT00659126|470258945|FG001|Overall Study|Adverse Event|2|||
130628527|NCT00659126|470258944|FG000|Overall Study|Screen failure|1|||
130628528|NCT00659126|470258945|FG001|Overall Study|Screen failure|1|||
130628529|NCT00659126|470258944|FG000|Overall Study|Technical problems with MRI|0|||
130628530|NCT00659126|470258945|FG001|Overall Study|Technical problems with MRI|1|||
130628531|NCT02633046|470258948|FG000|Overall Study|Adverse Event|8|||
130628532|NCT02633046|470258948|FG000|Overall Study|Physician Decision|7|||
130628533|NCT02633046|470258948|FG000|Overall Study|Withdrawal by Subject|8|||
130628534|NCT02633046|470258948|FG000|Overall Study|Increased proteinuria|2|||
130628535|NCT02633046|470258948|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
130628536|NCT02633046|470258948|FG000|Overall Study|Mutual decision patient and physician|1|||
130628537|NCT01455415|470258959|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
130628538|NCT01455415|470258960|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
130628539|NCT01455415|470258959|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
130628540|NCT01455415|470258960|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
130628541|NCT01455415|470258959|FG000|Period 1|Drug Error not Associated to AE|0|||
130628542|NCT01455415|470258960|FG001|Period 1|Drug Error not Associated to AE|1|||
130628543|NCT01455415|470258959|FG000|Period 1|AE Not Related to Study Drug|2|||
130628544|NCT01455415|470258960|FG001|Period 1|AE Not Related to Study Drug|6|||
130628545|NCT01455415|470258959|FG000|Period 1|Withdrawal by Subject|4|||
130628546|NCT01455415|470258960|FG001|Period 1|Withdrawal by Subject|5|||
130628547|NCT01455415|470258959|FG000|Period 1|Unspecified Reason|1|||
130628548|NCT01455415|470258960|FG001|Period 1|Unspecified Reason|1|||
130628549|NCT01455415|470258959|FG000|Period 1|Protocol Violation|0|||
130628550|NCT01455415|470258960|FG001|Period 1|Protocol Violation|2|||
130628551|NCT01455415|470258959|FG000|Washout|AE Related to Study Drug|2|||
130628552|NCT01455415|470258960|FG001|Washout|AE Related to Study Drug|0|||
130628553|NCT01455415|470258959|FG000|Washout|Lost to Follow-up|1|||
130628554|NCT01455415|470258960|FG001|Washout|Lost to Follow-up|0|||
130628555|NCT01455415|470258959|FG000|Washout|Drug Error not Associated to AE|2|||
130628556|NCT01455415|470258960|FG001|Washout|Drug Error not Associated to AE|1|||
130628557|NCT01455415|470258959|FG000|Washout|AE Not Related to Study Drug|2|||
130628558|NCT01455415|470258960|FG001|Washout|AE Not Related to Study Drug|3|||
130628559|NCT01455415|470258959|FG000|Washout|Unspecified Reason|1|||
130628560|NCT01455415|470258960|FG001|Washout|Unspecified Reason|2|||
130628561|NCT01455415|470258959|FG000|Washout|Protocol Violation|0|||
130628562|NCT01455415|470258960|FG001|Washout|Protocol Violation|1|||
130628563|NCT01455415|470258959|FG000|Period 2|AE Related to Study Drug|1|||
130628564|NCT01455415|470258960|FG001|Period 2|AE Related to Study Drug|2|||
130628565|NCT01455415|470258959|FG000|Period 2|Lost to Follow-up|2|||
130628566|NCT01455415|470258960|FG001|Period 2|Lost to Follow-up|1|||
130628567|NCT01455415|470258959|FG000|Period 2|AE Not Related to Study Drug|2|||
130628568|NCT01455415|470258960|FG001|Period 2|AE Not Related to Study Drug|1|||
130628569|NCT01455415|470258959|FG000|Period 2|Lack of Efficacy|2|||
130628570|NCT01455415|470258960|FG001|Period 2|Lack of Efficacy|0|||
130628571|NCT01455415|470258959|FG000|Period 2|Withdrawal by Subject|2|||
130628572|NCT01455415|470258960|FG001|Period 2|Withdrawal by Subject|3|||
130628573|NCT01455415|470258959|FG000|Period 2|Unspecified Reason|2|||
130628574|NCT01455415|470258960|FG001|Period 2|Unspecified Reason|3|||
130628575|NCT01455415|470258959|FG000|Period 2|Protocol Violation|2|||
130628576|NCT01455415|470258960|FG001|Period 2|Protocol Violation|0|||
130628577|NCT01455415|470258959|FG000|Follow-up|AE Related to Study Drug|0|||
130628578|NCT01455415|470258960|FG001|Follow-up|AE Related to Study Drug|1|||
130628579|NCT01455415|470258959|FG000|Follow-up|Lack of Efficacy|0|||
130628580|NCT01455415|470258960|FG001|Follow-up|Lack of Efficacy|1|||
130628581|NCT01455415|470258959|FG000|Follow-up|Withdrawal by Subject|2|||
130628582|NCT01455415|470258960|FG001|Follow-up|Withdrawal by Subject|0|||
130628583|NCT01455415|470258959|FG000|Follow-up|Unspecified Reason|1|||
130628584|NCT01455415|470258960|FG001|Follow-up|Unspecified Reason|0|||
130628585|NCT00587301|470258961|FG000|Overall Study|Screen Failure|9|||
130628586|NCT00587301|470258961|FG000|Overall Study|Lost to Follow-up|22|||
130628587|NCT00587301|470258961|FG000|Overall Study|Withdrawal by Subject|7|||
130628588|NCT00587301|470258961|FG000|Overall Study|Protocol Violation|7|||
130628589|NCT02758613|470258962|FG000|Treatment|Physician and Sponsor Decision|1|||
130628590|NCT02758613|470258963|FG001|Treatment|Physician and Sponsor Decision|0|||
130628591|NCT02758613|470258964|FG002|Treatment|Physician and Sponsor Decision|0|||
130628592|NCT02758613|470258965|FG003|Treatment|Physician and Sponsor Decision|0|||
130628593|NCT02758613|470258962|FG000|Treatment|Withdrawal by Subject|1|||
130628594|NCT02758613|470258963|FG001|Treatment|Withdrawal by Subject|0|||
130628595|NCT02758613|470258964|FG002|Treatment|Withdrawal by Subject|1|||
130628596|NCT02758613|470258965|FG003|Treatment|Withdrawal by Subject|0|||
130628597|NCT01496274|470258967|FG000|Overall Study|Protocol Violation|0|||
130628598|NCT01496274|470258968|FG001|Overall Study|Protocol Violation|1|||
130628599|NCT01496274|470258967|FG000|Overall Study|Adverse Event|1|||
130628600|NCT01496274|470258968|FG001|Overall Study|Adverse Event|1|||
130628601|NCT01496274|470258967|FG000|Overall Study|Withdrawal by Subject|2|||
130628602|NCT01496274|470258968|FG001|Overall Study|Withdrawal by Subject|0|||
130628603|NCT01496274|470258967|FG000|Overall Study|Lost to Follow-up|0|||
130628604|NCT01496274|470258968|FG001|Overall Study|Lost to Follow-up|3|||
130628605|NCT00351819|470258970|FG000|Overall Study|Lost to Follow-up|4|||
130628606|NCT00351819|470258971|FG001|Overall Study|Lost to Follow-up|4|||
130628607|NCT00351819|470258970|FG000|Overall Study|Withdrawal by Subject|0|||
130628608|NCT00351819|470258971|FG001|Overall Study|Withdrawal by Subject|4|||
130628609|NCT00351819|470258970|FG000|Overall Study|Elevated PSA|1|||
130628610|NCT00351819|470258971|FG001|Overall Study|Elevated PSA|1|||
130628611|NCT00351819|470258970|FG000|Overall Study|Traumatic ankle fracture|1|||
130628612|NCT00351819|470258971|FG001|Overall Study|Traumatic ankle fracture|0|||
130628613|NCT00351819|470258970|FG000|Overall Study|Unprofessional behavior|1|||
130628614|NCT00351819|470258971|FG001|Overall Study|Unprofessional behavior|0|||
130628615|NCT00351819|470258970|FG000|Overall Study|Non-compliance|0|||
130628616|NCT00351819|470258971|FG001|Overall Study|Non-compliance|1|||
130628617|NCT00351819|470258970|FG000|Overall Study|Incarcerated|0|||
130628618|NCT00351819|470258971|FG001|Overall Study|Incarcerated|1|||
130628619|NCT00351819|470258970|FG000|Overall Study|Enrolled in another trial|0|||
130628620|NCT00351819|470258971|FG001|Overall Study|Enrolled in another trial|1|||
130628621|NCT02910219|470258974|FG000|Overall Study|Withdrawal by Subject|1|||
130628622|NCT02910219|470258975|FG001|Overall Study|Withdrawal by Subject|1|||
130628623|NCT00701441|470258976|FG000|Overall Study|failure in cpap compliance|0|||
130628624|NCT00701441|470258977|FG001|Overall Study|failure in cpap compliance|4|||
130628625|NCT01015820|470258978|FG000|Overall Study|Suboptimal measurements|1|||
130628626|NCT01015820|470258979|FG001|Overall Study|Suboptimal measurements|0|||
130628627|NCT01313078|470258981|FG000|Overall Study|Death|1|||
130628628|NCT01313078|470258981|FG000|Overall Study|Discontinued study drug|1|||
130628629|NCT01313078|470258981|FG000|Overall Study|Withdrawal by Subject|1|||
130628630|NCT01225172|470258983|FG000|Overall Study|Subject decision to stop|1|||
130628631|NCT01225172|470258984|FG001|Overall Study|Subject decision to stop|0|||
130628632|NCT01225172|470258983|FG000|Overall Study|Subject request to discontinue treatment|3|||
130628633|NCT01225172|470258984|FG001|Overall Study|Subject request to discontinue treatment|1|||
130628634|NCT01225172|470258983|FG000|Overall Study|Subject no longer meets study criteria|1|||
130628635|NCT01225172|470258984|FG001|Overall Study|Subject no longer meets study criteria|0|||
130628636|NCT01225172|470258983|FG000|Overall Study|Withdrawal by Subject|1|||
130628637|NCT01225172|470258984|FG001|Overall Study|Withdrawal by Subject|0|||
130628638|NCT02679781|470258985|FG000|Overall Study|Lost to Follow-up|1|||
130628639|NCT02679781|470258986|FG001|Overall Study|Lost to Follow-up|2|||
130628640|NCT02679781|470258985|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
130628641|NCT02679781|470258986|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
130628642|NCT04209400|470258987|FG000|Overall Study|Withdrawal by Subject|0|||
130628643|NCT04209400|470258988|FG001|Overall Study|Withdrawal by Subject|1|||
130628644|NCT00795509|470258989|FG000|Overall Study|Protocol Violation|31|||
130628645|NCT00383708|470258993|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
130628646|NCT00383708|470258993|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
130628647|NCT00383708|470258993|FG000|Run-in Period|Protocol Violation|4|||
130628648|NCT00383708|470258993|FG000|Run-in Period|Adverse Event|2|||
130628649|NCT00383708|470258993|FG000|Run-in Period|Claustrophobia|1|||
130628650|NCT00383708|470258993|FG000|Co-administration Period|Adverse Event|5|||
130628651|NCT01576406|470258995|FG000|Overall Study|Lost to Follow-up|1|||
130628652|NCT01576406|470258996|FG001|Overall Study|Lost to Follow-up|2|||
130628653|NCT01576406|470258997|FG002|Overall Study|Lost to Follow-up|0|||
130628654|NCT01576406|470258998|FG003|Overall Study|Lost to Follow-up|0|||
130628655|NCT01576406|470258999|FG004|Overall Study|Lost to Follow-up|0|||
130628656|NCT01576406|470259000|FG005|Overall Study|Lost to Follow-up|0|||
130628657|NCT01576406|470258995|FG000|Overall Study|Death|3|||
130628658|NCT01576406|470258996|FG001|Overall Study|Death|4|||
130628659|NCT01576406|470258997|FG002|Overall Study|Death|8|||
130628660|NCT01576406|470258998|FG003|Overall Study|Death|5|||
130628661|NCT01576406|470258999|FG004|Overall Study|Death|7|||
130628662|NCT01576406|470259000|FG005|Overall Study|Death|9|||
130628663|NCT01576406|470258995|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130628664|NCT01576406|470258996|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130628665|NCT01576406|470258997|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
130628666|NCT01576406|470258998|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
130628667|NCT01576406|470258999|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130628668|NCT01576406|470259000|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130628669|NCT01576406|470258995|FG000|Overall Study|Withdrawal the consent|2|||
130628670|NCT01576406|470258996|FG001|Overall Study|Withdrawal the consent|2|||
130628671|NCT01576406|470258997|FG002|Overall Study|Withdrawal the consent|5|||
130628672|NCT01576406|470258998|FG003|Overall Study|Withdrawal the consent|1|||
130628673|NCT01576406|470258999|FG004|Overall Study|Withdrawal the consent|1|||
130628674|NCT01576406|470259000|FG005|Overall Study|Withdrawal the consent|3|||
130628675|NCT01576406|470258995|FG000|Overall Study|Other|0|||
130628676|NCT01576406|470258996|FG001|Overall Study|Other|0|||
130628677|NCT01576406|470258997|FG002|Overall Study|Other|2|||
130628678|NCT01576406|470258998|FG003|Overall Study|Other|2|||
130628679|NCT01576406|470258999|FG004|Overall Study|Other|0|||
130628680|NCT01576406|470259000|FG005|Overall Study|Other|0|||
130628681|NCT00669032|470259005|FG000|Overall Study|Lost to Follow-up|6|||
130628682|NCT00669032|470259006|FG001|Overall Study|Lost to Follow-up|5|||
130628683|NCT00669032|470259005|FG000|Overall Study|Lack of Efficacy|8|||
130628684|NCT00669032|470259006|FG001|Overall Study|Lack of Efficacy|19|||
130628685|NCT00669032|470259005|FG000|Overall Study|Withdrawal by Subject|12|||
130628686|NCT00669032|470259006|FG001|Overall Study|Withdrawal by Subject|13|||
130628687|NCT00669032|470259005|FG000|Overall Study|Adverse Event|12|||
130628688|NCT00669032|470259006|FG001|Overall Study|Adverse Event|16|||
130628689|NCT00669032|470259005|FG000|Overall Study|Physician Decision|1|||
130628690|NCT00669032|470259006|FG001|Overall Study|Physician Decision|1|||
130628691|NCT00669032|470259005|FG000|Overall Study|No fulfilment of the selection criteria|5|||
130628692|NCT00669032|470259006|FG001|Overall Study|No fulfilment of the selection criteria|5|||
130628693|NCT01607073|470259007|FG000|Overall Study|Adverse Event|1|||
130628694|NCT01375647|470261314|FG000|Overall Study|Lost to Follow-up|3|||
130628695|NCT01375647|470261315|FG001|Overall Study|Lost to Follow-up|3|||
130628696|NCT01375647|470261316|FG002|Overall Study|Lost to Follow-up|7|||
130628697|NCT01375647|470261317|FG003|Overall Study|Lost to Follow-up|10|||
130628698|NCT01375647|470261314|FG000|Overall Study|Death|1|||
130628699|NCT01375647|470261315|FG001|Overall Study|Death|2|||
130628700|NCT01375647|470261316|FG002|Overall Study|Death|1|||
130628701|NCT01375647|470261317|FG003|Overall Study|Death|0|||
130628702|NCT01375647|470261314|FG000|Overall Study|Withdrawal by Subject|17|||
130628703|NCT01375647|470261315|FG001|Overall Study|Withdrawal by Subject|20|||
130628704|NCT01375647|470261316|FG002|Overall Study|Withdrawal by Subject|26|||
130628705|NCT01375647|470261317|FG003|Overall Study|Withdrawal by Subject|14|||
130628706|NCT01375647|470261314|FG000|Overall Study|Physician Decision|1|||
130628707|NCT01375647|470261315|FG001|Overall Study|Physician Decision|0|||
130628708|NCT01375647|470261316|FG002|Overall Study|Physician Decision|0|||
130628709|NCT01375647|470261317|FG003|Overall Study|Physician Decision|0|||
130628710|NCT03366844|470261318|FG000|Overall Study|Physician Decision|1|||
130628711|NCT03366844|470261318|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
130628712|NCT02088541|470261323|FG000|Overall Study|Adverse Event|3|||
130628713|NCT02088541|470261324|FG001|Overall Study|Adverse Event|0|||
130628714|NCT02088541|470261325|FG002|Overall Study|Adverse Event|3|||
130628715|NCT02088541|470261326|FG003|Overall Study|Adverse Event|3|||
130628716|NCT02088541|470261327|FG004|Overall Study|Adverse Event|0|||
130628717|NCT02088541|470261323|FG000|Overall Study|Death|51|||
130628718|NCT02088541|470261324|FG001|Overall Study|Death|21|||
130628719|NCT02088541|470261325|FG002|Overall Study|Death|85|||
130628720|NCT02088541|470261326|FG003|Overall Study|Death|28|||
130628721|NCT02088541|470261327|FG004|Overall Study|Death|38|||
130628722|NCT02088541|470261323|FG000|Overall Study|Lost to Follow-up|2|||
130628723|NCT02088541|470261324|FG001|Overall Study|Lost to Follow-up|0|||
130628724|NCT02088541|470261325|FG002|Overall Study|Lost to Follow-up|1|||
130628725|NCT02088541|470261326|FG003|Overall Study|Lost to Follow-up|0|||
130628726|NCT02088541|470261327|FG004|Overall Study|Lost to Follow-up|0|||
130628727|NCT02088541|470261323|FG000|Overall Study|Physician Decision|2|||
130628728|NCT02088541|470261324|FG001|Overall Study|Physician Decision|1|||
130628729|NCT02088541|470261325|FG002|Overall Study|Physician Decision|2|||
130628730|NCT02088541|470261326|FG003|Overall Study|Physician Decision|0|||
130628731|NCT02088541|470261327|FG004|Overall Study|Physician Decision|2|||
130628732|NCT02088541|470261323|FG000|Overall Study|Disease progression|7|||
130628733|NCT02088541|470261324|FG001|Overall Study|Disease progression|1|||
130628734|NCT02088541|470261325|FG002|Overall Study|Disease progression|2|||
130628735|NCT02088541|470261326|FG003|Overall Study|Disease progression|3|||
130628736|NCT02088541|470261327|FG004|Overall Study|Disease progression|1|||
130628737|NCT02088541|470261323|FG000|Overall Study|Study terminated by sponsor|1|||
130628738|NCT02088541|470261324|FG001|Overall Study|Study terminated by sponsor|1|||
130628739|NCT02088541|470261325|FG002|Overall Study|Study terminated by sponsor|12|||
130628740|NCT02088541|470261326|FG003|Overall Study|Study terminated by sponsor|2|||
130628741|NCT02088541|470261327|FG004|Overall Study|Study terminated by sponsor|6|||
130628742|NCT02088541|470261323|FG000|Overall Study|Withdrawal by Subject|3|||
130628743|NCT02088541|470261324|FG001|Overall Study|Withdrawal by Subject|2|||
130628744|NCT02088541|470261325|FG002|Overall Study|Withdrawal by Subject|9|||
130628745|NCT02088541|470261326|FG003|Overall Study|Withdrawal by Subject|7|||
130628746|NCT02088541|470261327|FG004|Overall Study|Withdrawal by Subject|10|||
130628747|NCT02088541|470261323|FG000|Overall Study|Other|2|||
130628748|NCT02088541|470261324|FG001|Overall Study|Other|1|||
130628749|NCT02088541|470261325|FG002|Overall Study|Other|3|||
130628750|NCT02088541|470261326|FG003|Overall Study|Other|1|||
130628751|NCT02088541|470261327|FG004|Overall Study|Other|1|||
130628752|NCT00323310|470261329|FG000|Overall Study|Withdrawal by Subject|1|||
130628753|NCT00323310|470261329|FG000|Overall Study|a parent refused blood draw|1|||
130628754|NCT00323310|470261329|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
130628755|NCT03984812|470261330|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628756|NCT03984812|470261331|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628757|NCT03984812|470261332|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
130628758|NCT03984812|470261333|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628759|NCT03984812|470261334|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628760|NCT03984812|470261335|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628761|NCT03984812|470261336|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628762|NCT03984812|470261337|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628763|NCT03984812|470261338|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628764|NCT03984812|470261339|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628765|NCT03984812|470261340|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130628766|NCT00446641|470261341|FG000|Overall Study|Withdrawal by Subject|8|||
130628767|NCT00446641|470261342|FG001|Overall Study|Withdrawal by Subject|3|||
130628768|NCT00446641|470261341|FG000|Overall Study|poor compliance|8|||
130628769|NCT00446641|470261342|FG001|Overall Study|poor compliance|6|||
130628770|NCT00446641|470261341|FG000|Overall Study|Lost to Follow-up|1|||
130628771|NCT00446641|470261342|FG001|Overall Study|Lost to Follow-up|1|||
130628772|NCT02707601|470261345|FG000|Overall Study|Death|0|||
130628773|NCT02707601|470261346|FG001|Overall Study|Death|1|||
130628774|NCT02707601|470261345|FG000|Overall Study|Lack of Efficacy|0|||
130628775|NCT02707601|470261346|FG001|Overall Study|Lack of Efficacy|1|||
130628776|NCT02707601|470261345|FG000|Overall Study|Investigator's Discretion|1|||
130628777|NCT02707601|470261346|FG001|Overall Study|Investigator's Discretion|0|||
130628778|NCT02707601|470261345|FG000|Overall Study|Withdrew Consent|0|||
130628779|NCT02707601|470261346|FG001|Overall Study|Withdrew Consent|1|||
130628780|NCT02707601|470261345|FG000|Overall Study|Lost to Follow-up|1|||
130628781|NCT02707601|470261346|FG001|Overall Study|Lost to Follow-up|1|||
130628782|NCT02707601|470261345|FG000|Overall Study|Participants Randomized but Not Treated|2|||
130628783|NCT02707601|470261346|FG001|Overall Study|Participants Randomized but Not Treated|0|||
130628784|NCT03907969|470261348|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
130628785|NCT03907969|470261349|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
130628786|NCT03907969|470261350|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
130628787|NCT03907969|470261351|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
130628788|NCT03907969|470261352|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
130628789|NCT03907969|470261353|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
130628790|NCT03907969|470261354|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
130628791|NCT03907969|470261355|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
130628792|NCT03907969|470261356|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
130628793|NCT03907969|470261357|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
130628794|NCT03907969|470261358|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
130628795|NCT03907969|470261348|FG000|Monotherapy Part A|Progressive Disease|0|||
130628796|NCT03907969|470261349|FG001|Monotherapy Part A|Progressive Disease|1|||
130628797|NCT03907969|470261350|FG002|Monotherapy Part A|Progressive Disease|0|||
130628798|NCT03907969|470261351|FG003|Monotherapy Part A|Progressive Disease|0|||
130628799|NCT03907969|470261352|FG004|Monotherapy Part A|Progressive Disease|0|||
130628800|NCT03907969|470261353|FG005|Monotherapy Part A|Progressive Disease|1|||
130628801|NCT03907969|470261354|FG006|Monotherapy Part A|Progressive Disease|2|||
130628802|NCT03907969|470261355|FG007|Monotherapy Part A|Progressive Disease|0|||
130628803|NCT03907969|470261356|FG008|Monotherapy Part A|Progressive Disease|0|||
130628804|NCT03907969|470261357|FG009|Monotherapy Part A|Progressive Disease|0|||
130628805|NCT03907969|470261358|FG010|Monotherapy Part A|Progressive Disease|0|||
130628806|NCT03907969|470261348|FG000|Monotherapy Part A|Death|0|||
130628807|NCT03907969|470261349|FG001|Monotherapy Part A|Death|0|||
130628808|NCT03907969|470261350|FG002|Monotherapy Part A|Death|1|||
130628809|NCT03907969|470261351|FG003|Monotherapy Part A|Death|1|||
130628810|NCT03907969|470261352|FG004|Monotherapy Part A|Death|0|||
130628811|NCT03907969|470261353|FG005|Monotherapy Part A|Death|1|||
130628812|NCT03907969|470261354|FG006|Monotherapy Part A|Death|0|||
130628813|NCT03907969|470261355|FG007|Monotherapy Part A|Death|0|||
130628814|NCT03907969|470261356|FG008|Monotherapy Part A|Death|0|||
130628815|NCT03907969|470261357|FG009|Monotherapy Part A|Death|0|||
130628816|NCT03907969|470261358|FG010|Monotherapy Part A|Death|0|||
130628817|NCT03907969|470261348|FG000|Combination Therapy Part A|Adverse Event|0|||
130628818|NCT03907969|470261349|FG001|Combination Therapy Part A|Adverse Event|0|||
130628819|NCT03907969|470261350|FG002|Combination Therapy Part A|Adverse Event|0|||
130628820|NCT03907969|470261351|FG003|Combination Therapy Part A|Adverse Event|0|||
130628821|NCT03907969|470261352|FG004|Combination Therapy Part A|Adverse Event|0|||
130628822|NCT03907969|470261353|FG005|Combination Therapy Part A|Adverse Event|0|||
130628823|NCT03907969|470261354|FG006|Combination Therapy Part A|Adverse Event|0|||
130628824|NCT03907969|470261355|FG007|Combination Therapy Part A|Adverse Event|0|||
130628825|NCT03907969|470261356|FG008|Combination Therapy Part A|Adverse Event|0|||
130628826|NCT03907969|470261357|FG009|Combination Therapy Part A|Adverse Event|1|||
130628827|NCT03907969|470261358|FG010|Combination Therapy Part A|Adverse Event|1|||
130628828|NCT03907969|470261348|FG000|Combination Therapy Part A|Progressive disease|0|||
130628829|NCT03907969|470261349|FG001|Combination Therapy Part A|Progressive disease|0|||
130628830|NCT03907969|470261350|FG002|Combination Therapy Part A|Progressive disease|0|||
130628831|NCT03907969|470261351|FG003|Combination Therapy Part A|Progressive disease|0|||
130628832|NCT03907969|470261352|FG004|Combination Therapy Part A|Progressive disease|0|||
130628833|NCT03907969|470261353|FG005|Combination Therapy Part A|Progressive disease|0|||
130628834|NCT03907969|470261354|FG006|Combination Therapy Part A|Progressive disease|0|||
130628835|NCT03907969|470261355|FG007|Combination Therapy Part A|Progressive disease|1|||
130628836|NCT03907969|470261356|FG008|Combination Therapy Part A|Progressive disease|0|||
130628837|NCT03907969|470261357|FG009|Combination Therapy Part A|Progressive disease|2|||
130628838|NCT03907969|470261358|FG010|Combination Therapy Part A|Progressive disease|3|||
130628839|NCT03907969|470261348|FG000|Combination Therapy Part A|Death|0|||
130628840|NCT03907969|470261349|FG001|Combination Therapy Part A|Death|0|||
130628841|NCT03907969|470261350|FG002|Combination Therapy Part A|Death|0|||
130628842|NCT03907969|470261351|FG003|Combination Therapy Part A|Death|0|||
130628843|NCT03907969|470261352|FG004|Combination Therapy Part A|Death|0|||
130628844|NCT03907969|470261353|FG005|Combination Therapy Part A|Death|0|||
130628845|NCT03907969|470261354|FG006|Combination Therapy Part A|Death|0|||
130628846|NCT03907969|470261355|FG007|Combination Therapy Part A|Death|0|||
130628847|NCT03907969|470261356|FG008|Combination Therapy Part A|Death|1|||
130628848|NCT03907969|470261357|FG009|Combination Therapy Part A|Death|0|||
130628849|NCT03907969|470261358|FG010|Combination Therapy Part A|Death|1|||
130628850|NCT03907969|470261348|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
130628851|NCT03907969|470261349|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
130628852|NCT03907969|470261350|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
130628853|NCT03907969|470261351|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
130628854|NCT03907969|470261352|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
130628855|NCT03907969|470261353|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
130628856|NCT03907969|470261354|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
130628857|NCT03907969|470261355|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
130628858|NCT03907969|470261356|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
130628859|NCT03907969|470261357|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
130628860|NCT03907969|470261358|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
130628861|NCT03907969|470261348|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
130628862|NCT03907969|470261349|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
130628863|NCT03907969|470261350|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
130628864|NCT03907969|470261351|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
130628865|NCT03907969|470261352|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
130628866|NCT03907969|470261353|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
130628867|NCT03907969|470261354|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
130628868|NCT03907969|470261355|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
130628869|NCT03907969|470261356|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
130628870|NCT03907969|470261357|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
130628871|NCT03907969|470261358|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
130628872|NCT03907969|470261348|FG000|Combination Therapy Part A|Physician Decision|0|||
130628873|NCT03907969|470261349|FG001|Combination Therapy Part A|Physician Decision|0|||
130628874|NCT03907969|470261350|FG002|Combination Therapy Part A|Physician Decision|0|||
130628875|NCT03907969|470261351|FG003|Combination Therapy Part A|Physician Decision|0|||
130628876|NCT03907969|470261352|FG004|Combination Therapy Part A|Physician Decision|0|||
130628877|NCT03907969|470261353|FG005|Combination Therapy Part A|Physician Decision|0|||
130628878|NCT03907969|470261354|FG006|Combination Therapy Part A|Physician Decision|0|||
130628879|NCT03907969|470261355|FG007|Combination Therapy Part A|Physician Decision|1|||
130628880|NCT03907969|470261356|FG008|Combination Therapy Part A|Physician Decision|0|||
130628881|NCT03907969|470261357|FG009|Combination Therapy Part A|Physician Decision|0|||
130628882|NCT03907969|470261358|FG010|Combination Therapy Part A|Physician Decision|1|||
130628883|NCT00666536|470261359|FG000|Overall Study|Adverse Event|9|||
130628884|NCT00666536|470261360|FG001|Overall Study|Adverse Event|19|||
130628885|NCT00666536|470261359|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130628886|NCT00666536|470261360|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130628887|NCT00666536|470261359|FG000|Overall Study|Protocol deviation(s)|8|||
130628888|NCT00666536|470261360|FG001|Overall Study|Protocol deviation(s)|6|||
130628889|NCT00666536|470261359|FG000|Overall Study|Withdrawal by Subject|10|||
130628890|NCT00666536|470261360|FG001|Overall Study|Withdrawal by Subject|9|||
130628891|NCT00666536|470261359|FG000|Overall Study|Lost to Follow-up|4|||
130628892|NCT00666536|470261360|FG001|Overall Study|Lost to Follow-up|3|||
130628893|NCT00063986|470261364|FG000|Overall Study|Withdrawal by Subject|1|||
130628894|NCT00063986|470261364|FG000|Overall Study|Ineligible|1|||
130628895|NCT00063986|470261364|FG000|Overall Study|Intra-operatively ineligible|4|||
130628896|NCT04839393|470261365|FG000|Overall Study|Adverse Event|0|||
130628897|NCT04839393|470261366|FG001|Overall Study|Adverse Event|0|||
130628898|NCT04839393|470261367|FG002|Overall Study|Adverse Event|2|||
130628899|NCT04839393|470261365|FG000|Overall Study|Withdrawal by participant|0|||
130628900|NCT04839393|470261366|FG001|Overall Study|Withdrawal by participant|0|||
130628901|NCT04839393|470261367|FG002|Overall Study|Withdrawal by participant|1|||
130628902|NCT00608881|470261372|FG000|Overall Study|Death|22|||
130628903|NCT00608881|470261373|FG001|Overall Study|Death|13|||
130628904|NCT00608881|470261372|FG000|Overall Study|Adverse Event|5|||
130628905|NCT00608881|470261373|FG001|Overall Study|Adverse Event|3|||
130628906|NCT00608881|470261372|FG000|Overall Study|Lost to Follow-up|28|||
130628907|NCT00608881|470261373|FG001|Overall Study|Lost to Follow-up|14|||
130628908|NCT00608881|470261372|FG000|Overall Study|Withdrawal by Subject|18|||
130628909|NCT00608881|470261373|FG001|Overall Study|Withdrawal by Subject|29|||
130628910|NCT00608881|470261372|FG000|Overall Study|Physician Decision|5|||
130628911|NCT00608881|470261373|FG001|Overall Study|Physician Decision|5|||
130628912|NCT00608881|470261372|FG000|Overall Study|Institutionalized|1|||
130628913|NCT00608881|470261373|FG001|Overall Study|Institutionalized|2|||
130628914|NCT00633893|470261374|FG000|Overall Study|Death|1|||
130628915|NCT00633893|470261375|FG001|Overall Study|Death|3|||
130628916|NCT00633893|470261376|FG002|Overall Study|Death|9|||
130628917|NCT00633893|470261374|FG000|Overall Study|Adverse Event|65|||
130628918|NCT00633893|470261375|FG001|Overall Study|Adverse Event|58|||
130628919|NCT00633893|470261376|FG002|Overall Study|Adverse Event|126|||
130628920|NCT00633893|470261374|FG000|Overall Study|Withdrawal by Subject|7|||
130628921|NCT00633893|470261375|FG001|Overall Study|Withdrawal by Subject|12|||
130628922|NCT00633893|470261376|FG002|Overall Study|Withdrawal by Subject|6|||
130628923|NCT00633893|470261374|FG000|Overall Study|Lost to Follow-up|2|||
130628924|NCT00633893|470261375|FG001|Overall Study|Lost to Follow-up|4|||
130628925|NCT00633893|470261376|FG002|Overall Study|Lost to Follow-up|8|||
130628926|NCT00633893|470261374|FG000|Overall Study|Poor/non-compliance|5|||
130628927|NCT00633893|470261375|FG001|Overall Study|Poor/non-compliance|12|||
130628928|NCT00633893|470261376|FG002|Overall Study|Poor/non-compliance|3|||
130628929|NCT00633893|470261374|FG000|Overall Study|Pregnancy|2|||
130628930|NCT00633893|470261375|FG001|Overall Study|Pregnancy|1|||
130628931|NCT00633893|470261376|FG002|Overall Study|Pregnancy|1|||
130628932|NCT00633893|470261374|FG000|Overall Study|Not meet/no longer meets criteria|4|||
130628933|NCT00633893|470261375|FG001|Overall Study|Not meet/no longer meets criteria|6|||
130628934|NCT00633893|470261376|FG002|Overall Study|Not meet/no longer meets criteria|4|||
130628935|NCT00633893|470261374|FG000|Overall Study|Other|28|||
130628936|NCT00633893|470261375|FG001|Overall Study|Other|33|||
130628937|NCT00633893|470261376|FG002|Overall Study|Other|31|||
130628938|NCT05091918|470261377|FG000|Overall Study|Adverse Event|1|||
130628939|NCT05091918|470261377|FG000|Overall Study|Withdrawal by Subject|81|||
130628940|NCT03210220|470261379|FG000|Overall Study|Physician Decision|1|||
130628941|NCT03210220|470261380|FG001|Overall Study|Physician Decision|0|||
130628942|NCT02911519|470261381|FG000|Overall Study|Lost to Follow-up|2|||
130628943|NCT02911519|470261382|FG001|Overall Study|Lost to Follow-up|2|||
130628944|NCT02911519|470261381|FG000|Overall Study|Death|0|||
130628945|NCT02911519|470261382|FG001|Overall Study|Death|2|||
130628946|NCT00653328|470261383|FG000|Overall Study|Withdrawal by Subject|1|||
130628947|NCT00653328|470261383|FG000|Overall Study|Adverse Event|2|||
130628948|NCT00653328|470261383|FG000|Overall Study|Disease progression|10|||
130628949|NCT00653328|470261383|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
130628950|NCT00839436|470261386|FG000|Overall Study|Developed exclusionary condition|1|||
130628951|NCT00839436|470261387|FG001|Overall Study|Developed exclusionary condition|0|||
130628952|NCT00839436|470261388|FG002|Overall Study|Developed exclusionary condition|0|||
130628953|NCT00839436|470261386|FG000|Overall Study|Withdrawal by Subject|0|||
130628954|NCT00839436|470261387|FG001|Overall Study|Withdrawal by Subject|1|||
130628955|NCT00839436|470261388|FG002|Overall Study|Withdrawal by Subject|0|||
130628956|NCT00839436|470261386|FG000|Overall Study|Study drug no longer available|0|||
130628957|NCT00839436|470261387|FG001|Overall Study|Study drug no longer available|0|||
130628958|NCT00839436|470261388|FG002|Overall Study|Study drug no longer available|1|||
130628959|NCT00407550|470261389|FG000|Overall Study|Adverse Event|0|||
130628960|NCT00407550|470261390|FG001|Overall Study|Adverse Event|1|||
130628961|NCT00407550|470261389|FG000|Overall Study|Withdrawal by Subject|0|||
130628962|NCT00407550|470261390|FG001|Overall Study|Withdrawal by Subject|2|||
130628963|NCT00407550|470261389|FG000|Overall Study|Death|1|||
130628964|NCT00407550|470261390|FG001|Overall Study|Death|0|||
130628965|NCT00407550|470261389|FG000|Overall Study|Insurance or Other medical condition|2|||
130628966|NCT00407550|470261390|FG001|Overall Study|Insurance or Other medical condition|1|||
130628967|NCT01444898|470261392|FG000|Overall Study|Withdrawal by Subject|1|||
130628968|NCT02580591|470261394|FG000|Overall Study|Adverse Event|0|||
130628969|NCT02580591|470261395|FG001|Overall Study|Adverse Event|1|||
130628970|NCT02580591|470261396|FG002|Overall Study|Adverse Event|2|||
130628971|NCT02580591|470261397|FG003|Overall Study|Adverse Event|5|||
130628972|NCT02580591|470261394|FG000|Overall Study|Protocol Violation|3|||
130628973|NCT02580591|470261395|FG001|Overall Study|Protocol Violation|2|||
130628974|NCT02580591|470261396|FG002|Overall Study|Protocol Violation|1|||
130628975|NCT02580591|470261397|FG003|Overall Study|Protocol Violation|1|||
130628976|NCT02580591|470261394|FG000|Overall Study|Lost to Follow-up|5|||
130628977|NCT02580591|470261395|FG001|Overall Study|Lost to Follow-up|3|||
130628978|NCT02580591|470261396|FG002|Overall Study|Lost to Follow-up|3|||
130628979|NCT02580591|470261397|FG003|Overall Study|Lost to Follow-up|1|||
130628980|NCT02580591|470261394|FG000|Overall Study|Withdrawal by Subject|6|||
130628981|NCT02580591|470261395|FG001|Overall Study|Withdrawal by Subject|1|||
130628982|NCT02580591|470261396|FG002|Overall Study|Withdrawal by Subject|2|||
130628983|NCT02580591|470261397|FG003|Overall Study|Withdrawal by Subject|3|||
130628984|NCT02580591|470261394|FG000|Overall Study|Not treated|1|||
130628985|NCT02580591|470261395|FG001|Overall Study|Not treated|1|||
130628986|NCT02580591|470261396|FG002|Overall Study|Not treated|0|||
130628987|NCT02580591|470261397|FG003|Overall Study|Not treated|0|||
130628988|NCT02580591|470261394|FG000|Overall Study|Other than specified|3|||
130628989|NCT02580591|470261395|FG001|Overall Study|Other than specified|2|||
130628990|NCT02580591|470261396|FG002|Overall Study|Other than specified|5|||
130628991|NCT02580591|470261397|FG003|Overall Study|Other than specified|2|||
130628992|NCT00561340|470261401|FG000|Overall Study|refused to drink pediasure|6|||
130628993|NCT00561340|470261402|FG001|Overall Study|refused to drink pediasure|0|||
130628994|NCT03051217|470261403|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
130628995|NCT03051217|470261404|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130628996|NCT03051217|470261405|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130628997|NCT03051217|470261406|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130628998|NCT03051217|470261407|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130628999|NCT03051217|470261408|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130629000|NCT03051217|470261409|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130629001|NCT03051217|470261403|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629002|NCT03051217|470261404|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
130629003|NCT03051217|470261405|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629004|NCT03051217|470261406|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629005|NCT03051217|470261407|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629006|NCT03051217|470261408|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629007|NCT03051217|470261409|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130629008|NCT03051217|470261403|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130629009|NCT03051217|470261404|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130629010|NCT03051217|470261405|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130629011|NCT03051217|470261406|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130629012|NCT03051217|470261407|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130629013|NCT03051217|470261408|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130629014|NCT03051217|470261409|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130629015|NCT03051217|470261403|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130629016|NCT03051217|470261404|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130629017|NCT03051217|470261405|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130629018|NCT03051217|470261406|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130629019|NCT03051217|470261407|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
130629020|NCT03051217|470261408|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130629021|NCT03051217|470261409|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130629022|NCT03051217|470261403|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629023|NCT03051217|470261404|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629024|NCT03051217|470261405|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629025|NCT03051217|470261406|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
130629026|NCT03051217|470261407|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629027|NCT03051217|470261408|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629028|NCT03051217|470261409|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130629029|NCT03051217|470261403|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629030|NCT03051217|470261404|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629031|NCT03051217|470261405|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629032|NCT03051217|470261406|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
130629033|NCT03051217|470261407|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629034|NCT03051217|470261408|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629035|NCT03051217|470261409|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130629036|NCT03051217|470261403|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629037|NCT03051217|470261404|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629038|NCT03051217|470261405|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629039|NCT03051217|470261406|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629040|NCT03051217|470261407|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
130629041|NCT03051217|470261408|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629042|NCT03051217|470261409|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130629043|NCT03051217|470261403|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629044|NCT03051217|470261404|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629045|NCT03051217|470261405|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629046|NCT03051217|470261406|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629047|NCT03051217|470261407|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629048|NCT03051217|470261408|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
130629049|NCT03051217|470261409|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130629050|NCT00641706|470261410|FG000|Overall Study|Adverse Event|2|||
130629051|NCT00641706|470261411|FG001|Overall Study|Adverse Event|1|||
130629052|NCT00641706|470261410|FG000|Overall Study|Withdrawal by Subject|6|||
130629053|NCT00641706|470261411|FG001|Overall Study|Withdrawal by Subject|1|||
130629054|NCT00641706|470261410|FG000|Overall Study|Clinical Decline|1|||
130629055|NCT00641706|470261411|FG001|Overall Study|Clinical Decline|0|||
130629056|NCT00641706|470261410|FG000|Overall Study|Lead Investigator Decision|0|||
130629057|NCT00641706|470261411|FG001|Overall Study|Lead Investigator Decision|1|||
130629058|NCT00109772|470261412|FG000|Double-blind Treatment|Adverse Event|14|||
130629059|NCT00109772|470261413|FG001|Double-blind Treatment|Adverse Event|5|||
130629060|NCT00109772|470261412|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130629061|NCT00109772|470261413|FG001|Double-blind Treatment|Lack of Efficacy|0|||
130629062|NCT00109772|470261412|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
130629063|NCT00109772|470261413|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
130629064|NCT00109772|470261412|FG000|Double-blind Treatment|Lost to Follow-up|2|||
130629065|NCT00109772|470261413|FG001|Double-blind Treatment|Lost to Follow-up|3|||
130629066|NCT00109772|470261412|FG000|Double-blind Treatment|Protocol Violation|0|||
130629067|NCT00109772|470261413|FG001|Double-blind Treatment|Protocol Violation|1|||
130629068|NCT00109772|470261412|FG000|Double-blind Treatment|Other|0|||
130629069|NCT00109772|470261413|FG001|Double-blind Treatment|Other|4|||
130629070|NCT00109772|470261412|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
130629071|NCT00109772|470261413|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
130629072|NCT00109772|470261412|FG000|Open-label Extension|Adverse Event|10|||
130629073|NCT00109772|470261413|FG001|Open-label Extension|Adverse Event|19|||
130629074|NCT00109772|470261412|FG000|Open-label Extension|Lack of Efficacy|19|||
130629075|NCT00109772|470261413|FG001|Open-label Extension|Lack of Efficacy|11|||
130629076|NCT00109772|470261412|FG000|Open-label Extension|Withdrawal by Subject|9|||
130629077|NCT00109772|470261413|FG001|Open-label Extension|Withdrawal by Subject|6|||
130629078|NCT00109772|470261412|FG000|Open-label Extension|Lost to Follow-up|1|||
130629079|NCT00109772|470261413|FG001|Open-label Extension|Lost to Follow-up|0|||
130629080|NCT00109772|470261412|FG000|Open-label Extension|Death|0|||
130629081|NCT00109772|470261413|FG001|Open-label Extension|Death|1|||
130629082|NCT00109772|470261412|FG000|Open-label Extension|Protocol Violation|2|||
130629083|NCT00109772|470261413|FG001|Open-label Extension|Protocol Violation|2|||
130629084|NCT00109772|470261412|FG000|Open-label Extension|Other|4|||
130629085|NCT00109772|470261413|FG001|Open-label Extension|Other|10|||
130629086|NCT00282568|470261418|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
130629087|NCT00282568|470261418|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
130629088|NCT00282568|470261418|FG000|Extended Treatment Period|Adverse Event|17|||
130629089|NCT00282568|470261418|FG000|Extended Treatment Period|Non-compliance|4|||
130629090|NCT00282568|470261418|FG000|Extended Treatment Period|Physician Decision|1|||
130629091|NCT00282568|470261418|FG000|Extended Treatment Period|Lost to Follow-up|2|||
130629092|NCT03006926|470261419|FG000|Overall Study|Adverse Event|0|||
130629093|NCT03006926|470261420|FG001|Overall Study|Adverse Event|27|||
130629094|NCT03006926|470261419|FG000|Overall Study|Withdrawal by Subject|0|||
130629095|NCT03006926|470261420|FG001|Overall Study|Withdrawal by Subject|1|||
130629096|NCT03006926|470261419|FG000|Overall Study|Radiological Disease Progression|0|||
130629097|NCT03006926|470261420|FG001|Overall Study|Radiological Disease Progression|52|||
130629098|NCT03006926|470261419|FG000|Overall Study|Clinical Disease Progression|0|||
130629099|NCT03006926|470261420|FG001|Overall Study|Clinical Disease Progression|10|||
130629100|NCT03006926|470261419|FG000|Overall Study|Other|0|||
130629101|NCT03006926|470261420|FG001|Overall Study|Other|8|||
130629102|NCT03725293|470261425|FG000|Overall Study|Physician Decision|9|||
130629103|NCT03725293|470261426|FG001|Overall Study|Physician Decision|6|||
130629104|NCT03725293|470261425|FG000|Overall Study|alternative vascular access needs|1|||
130629105|NCT03725293|470261426|FG001|Overall Study|alternative vascular access needs|2|||
130629106|NCT03725293|470261425|FG000|Overall Study|venous anatomy screen failures|2|||
130629107|NCT03725293|470261426|FG001|Overall Study|venous anatomy screen failures|1|||
130629108|NCT01057862|470261429|FG000|Overall Study|Withdrawal by Subject|1|||
130629109|NCT01057862|470261430|FG001|Overall Study|Withdrawal by Subject|2|||
130629110|NCT00415584|470261431|FG000|Overall Study|Withdrawal by Subject|1|||
130629111|NCT00802867|470261432|FG000|Overall Study|Lost to Follow-up|6|||
130629112|NCT00802867|470261432|FG000|Overall Study|Protocol Violation|6|||
130629113|NCT00802867|470261432|FG000|Overall Study|Withdrawal by Subject|1|||
130629114|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130629115|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
130629116|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
130629117|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
130629118|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
130629119|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
130629120|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
130629121|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
130629122|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
130629123|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
130629124|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
130629125|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
130629126|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
130629127|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
130629128|NCT03434041|470261433|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
130629129|NCT03434041|470261434|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
130629130|NCT03434041|470261433|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
130629131|NCT03434041|470261434|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
130629132|NCT03434041|470261433|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
130629133|NCT03434041|470261434|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
130648392|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
130648393|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648394|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648395|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648396|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648397|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648398|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648399|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648400|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648401|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130648402|NCT00151775|470333052|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648403|NCT00151775|470333053|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648404|NCT00151775|470333054|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648405|NCT00151775|470333055|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648406|NCT00151775|470333056|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648407|NCT00151775|470333057|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648408|NCT00151775|470333058|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648409|NCT00151775|470333059|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648410|NCT00151775|470333060|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648411|NCT00151775|470333061|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648412|NCT00151775|470333062|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130648413|NCT00151775|470333063|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
130648414|NCT00151775|470333052|FG000|Period 4: Open Label|Increased blood pressure|0|||
130648415|NCT00151775|470333053|FG001|Period 4: Open Label|Increased blood pressure|0|||
130648416|NCT00151775|470333054|FG002|Period 4: Open Label|Increased blood pressure|0|||
130648417|NCT00151775|470333055|FG003|Period 4: Open Label|Increased blood pressure|0|||
130648418|NCT00151775|470333056|FG004|Period 4: Open Label|Increased blood pressure|1|||
130648419|NCT00151775|470333057|FG005|Period 4: Open Label|Increased blood pressure|0|||
130648420|NCT00151775|470333058|FG006|Period 4: Open Label|Increased blood pressure|0|||
130648421|NCT00151775|470333059|FG007|Period 4: Open Label|Increased blood pressure|0|||
130648422|NCT00151775|470333060|FG008|Period 4: Open Label|Increased blood pressure|0|||
130648423|NCT00151775|470333061|FG009|Period 4: Open Label|Increased blood pressure|1|||
130648424|NCT00151775|470333062|FG010|Period 4: Open Label|Increased blood pressure|0|||
130648425|NCT00151775|470333063|FG011|Period 4: Open Label|Increased blood pressure|0|||
130648426|NCT00151775|470333052|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
130648427|NCT00151775|470333053|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
130648428|NCT00151775|470333054|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
130648429|NCT00151775|470333055|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
130648430|NCT00151775|470333056|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
130648431|NCT00151775|470333057|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
130648432|NCT00151775|470333058|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
130648433|NCT00151775|470333059|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
130648434|NCT00151775|470333060|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
130648435|NCT00151775|470333061|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
130648436|NCT00151775|470333062|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
130648437|NCT00151775|470333063|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
130648438|NCT00151775|470333052|FG000|Period 4: Open Label|Adverse Event|0|||
130648439|NCT00151775|470333053|FG001|Period 4: Open Label|Adverse Event|0|||
130648440|NCT00151775|470333054|FG002|Period 4: Open Label|Adverse Event|0|||
130648441|NCT00151775|470333055|FG003|Period 4: Open Label|Adverse Event|0|||
130648442|NCT00151775|470333056|FG004|Period 4: Open Label|Adverse Event|1|||
130648443|NCT00151775|470333057|FG005|Period 4: Open Label|Adverse Event|0|||
130648444|NCT00151775|470333058|FG006|Period 4: Open Label|Adverse Event|0|||
130648445|NCT00151775|470333059|FG007|Period 4: Open Label|Adverse Event|0|||
130648446|NCT00151775|470333060|FG008|Period 4: Open Label|Adverse Event|0|||
130648447|NCT00151775|470333061|FG009|Period 4: Open Label|Adverse Event|2|||
130648448|NCT00151775|470333062|FG010|Period 4: Open Label|Adverse Event|0|||
130648449|NCT00151775|470333063|FG011|Period 4: Open Label|Adverse Event|0|||
130648450|NCT00151775|470333052|FG000|Period 4: Open Label|Lost to Follow-up|0|||
130648451|NCT00151775|470333053|FG001|Period 4: Open Label|Lost to Follow-up|0|||
130648452|NCT00151775|470333054|FG002|Period 4: Open Label|Lost to Follow-up|0|||
130648453|NCT00151775|470333055|FG003|Period 4: Open Label|Lost to Follow-up|0|||
130648454|NCT00151775|470333056|FG004|Period 4: Open Label|Lost to Follow-up|17|||
130648455|NCT00151775|470333057|FG005|Period 4: Open Label|Lost to Follow-up|0|||
130648456|NCT00151775|470333058|FG006|Period 4: Open Label|Lost to Follow-up|0|||
130648457|NCT00151775|470333059|FG007|Period 4: Open Label|Lost to Follow-up|0|||
130648458|NCT00151775|470333060|FG008|Period 4: Open Label|Lost to Follow-up|0|||
130629134|NCT03434041|470261433|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
130629135|NCT03434041|470261434|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
130629136|NCT04075396|470261435|FG000|Overall Study|Death|11|||
130629137|NCT04075396|470261436|FG001|Overall Study|Death|9|||
130629138|NCT04075396|470261435|FG000|Overall Study|Withdrawal by Subject|1|||
130629139|NCT04075396|470261436|FG001|Overall Study|Withdrawal by Subject|2|||
130629140|NCT04075396|470261435|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
130629141|NCT04075396|470261436|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
130629142|NCT04075396|470261435|FG000|Overall Study|Enrolled but not-treated|0|||
130629143|NCT04075396|470261436|FG001|Overall Study|Enrolled but not-treated|1|||
130629144|NCT03363165|470261443|FG000|3-month Follow-up|Death|0|||
130629145|NCT03363165|470261444|FG001|3-month Follow-up|Death|1|||
130629146|NCT03363165|470261443|FG000|6-month Follow-up|Death|0|||
130629147|NCT03363165|470261444|FG001|6-month Follow-up|Death|1|||
130629148|NCT03363165|470261443|FG000|6-month Follow-up|Withdrawal by Subject|1|||
130629149|NCT03363165|470261444|FG001|6-month Follow-up|Withdrawal by Subject|1|||
130629150|NCT03363165|470261443|FG000|12-month Follow-up|Death|1|||
130629151|NCT03363165|470261444|FG001|12-month Follow-up|Death|1|||
130629152|NCT03363165|470261443|FG000|12-month Follow-up|Withdrawal by Subject|1|||
130629153|NCT03363165|470261444|FG001|12-month Follow-up|Withdrawal by Subject|1|||
130629154|NCT02255760|470261445|FG000|Overall Study|Lost to Follow-up|0|||
130629155|NCT02255760|470261446|FG001|Overall Study|Lost to Follow-up|1|||
130629156|NCT02255760|470261447|FG002|Overall Study|Lost to Follow-up|0|||
130629157|NCT02255760|470261448|FG003|Overall Study|Lost to Follow-up|0|||
130629158|NCT02255760|470261449|FG004|Overall Study|Lost to Follow-up|0|||
130629159|NCT00003838|470261450|FG000|Overall Study|Death|0|||
130629160|NCT00003838|470261451|FG001|Overall Study|Death|12|||
130629161|NCT00003838|470261452|FG002|Overall Study|Death|7|||
130629162|NCT00003838|470261450|FG000|Overall Study|Lost to Follow-up|0|||
130629163|NCT00003838|470261451|FG001|Overall Study|Lost to Follow-up|1|||
130629164|NCT00003838|470261452|FG002|Overall Study|Lost to Follow-up|1|||
130629165|NCT00003838|470261450|FG000|Overall Study|Disease Progression|0|||
130629166|NCT00003838|470261451|FG001|Overall Study|Disease Progression|12|||
130629167|NCT00003838|470261452|FG002|Overall Study|Disease Progression|0|||
130629168|NCT00618813|470261453|FG000|Overall Study|Lack of Efficacy|1|||
130629169|NCT00618813|470261453|FG000|Overall Study|Physician Decision|2|||
130629170|NCT00618813|470261453|FG000|Overall Study|Withdrawal by Subject|1|||
130629171|NCT01809197|470261454|FG000|Overall Study|Lost to Follow-up|4|||
130629172|NCT01809197|470261455|FG001|Overall Study|Lost to Follow-up|2|||
130629173|NCT01809197|470261454|FG000|Overall Study|Adverse Event|2|||
130629174|NCT01809197|470261455|FG001|Overall Study|Adverse Event|3|||
130629175|NCT01809197|470261454|FG000|Overall Study|Failed slit lamp exam|1|||
130629176|NCT01809197|470261455|FG001|Overall Study|Failed slit lamp exam|0|||
130629177|NCT01809197|470261454|FG000|Overall Study|Non-Compliance|1|||
130629178|NCT01809197|470261455|FG001|Overall Study|Non-Compliance|1|||
130629179|NCT01809197|470261454|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
130629180|NCT01809197|470261455|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
130629181|NCT01809197|470261454|FG000|Overall Study|Withdrawal by Subject|1|||
130629182|NCT01809197|470261455|FG001|Overall Study|Withdrawal by Subject|1|||
130629183|NCT01809197|470261454|FG000|Overall Study|Product not available|0|||
130629184|NCT01809197|470261455|FG001|Overall Study|Product not available|1|||
130629185|NCT02260388|470261456|FG000|Overall Study|Lost to Follow-up|2|||
130629186|NCT02260388|470261457|FG001|Overall Study|Lost to Follow-up|8|||
130629187|NCT02260388|470261458|FG002|Overall Study|Lost to Follow-up|3|||
130629188|NCT02260388|470261459|FG003|Overall Study|Lost to Follow-up|4|||
130629189|NCT02959190|470261460|FG000|Open Label|Adverse Event|5|||
130629190|NCT02959190|470261461|FG001|Open Label|Adverse Event|7|||
130629191|NCT02959190|470261462|FG002|Open Label|Adverse Event|3|||
130629192|NCT02959190|470261463|FG003|Open Label|Adverse Event|4|||
130629193|NCT02959190|470261460|FG000|Open Label|Pregnancy|0|||
130629194|NCT02959190|470261461|FG001|Open Label|Pregnancy|1|||
130629195|NCT02959190|470261462|FG002|Open Label|Pregnancy|0|||
130629196|NCT02959190|470261463|FG003|Open Label|Pregnancy|0|||
130629197|NCT02959190|470261460|FG000|Open Label|Withdrawal by Subject|2|||
130629198|NCT02959190|470261461|FG001|Open Label|Withdrawal by Subject|8|||
130629199|NCT02959190|470261462|FG002|Open Label|Withdrawal by Subject|0|||
130629200|NCT02959190|470261463|FG003|Open Label|Withdrawal by Subject|0|||
130629201|NCT02959190|470261460|FG000|Open Label|Physician Decision|0|||
130629202|NCT02959190|470261461|FG001|Open Label|Physician Decision|0|||
130629203|NCT02959190|470261462|FG002|Open Label|Physician Decision|1|||
130629204|NCT02959190|470261463|FG003|Open Label|Physician Decision|0|||
130629205|NCT02959190|470261460|FG000|Open Label|Protocol Violation|0|||
130629206|NCT02959190|470261461|FG001|Open Label|Protocol Violation|0|||
130629207|NCT02959190|470261462|FG002|Open Label|Protocol Violation|0|||
130629208|NCT02959190|470261463|FG003|Open Label|Protocol Violation|2|||
130629209|NCT02959190|470261460|FG000|Post Treatment Follow Up|Adverse Event|1|||
130629210|NCT02959190|470261461|FG001|Post Treatment Follow Up|Adverse Event|1|||
130629211|NCT02959190|470261462|FG002|Post Treatment Follow Up|Adverse Event|0|||
130629212|NCT02959190|470261463|FG003|Post Treatment Follow Up|Adverse Event|0|||
130629213|NCT02959190|470261460|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
130629214|NCT02959190|470261461|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
130629215|NCT02959190|470261462|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
130629216|NCT02959190|470261463|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
130629217|NCT02925312|470261470|FG000|Overall Study|Lost to Follow-up|25|||
130629218|NCT02925312|470261471|FG001|Overall Study|Lost to Follow-up|0|||
130629219|NCT02925312|470261470|FG000|Overall Study|Adverse Event|2|||
130629220|NCT02925312|470261471|FG001|Overall Study|Adverse Event|0|||
130629221|NCT02142504|470261472|FG000|Overall Study|Protocol Violation|2|||
130629222|NCT02142504|470261473|FG001|Overall Study|Protocol Violation|1|||
130629223|NCT02142504|470261474|FG002|Overall Study|Protocol Violation|2|||
130629224|NCT02142504|470261472|FG000|Overall Study|Adverse Event|2|||
130629225|NCT02142504|470261473|FG001|Overall Study|Adverse Event|3|||
130629226|NCT02142504|470261474|FG002|Overall Study|Adverse Event|4|||
130629227|NCT02142504|470261472|FG000|Overall Study|Lost to Follow-up|12|||
130629228|NCT02142504|470261473|FG001|Overall Study|Lost to Follow-up|19|||
130629229|NCT02142504|470261474|FG002|Overall Study|Lost to Follow-up|17|||
130629230|NCT02142504|470261472|FG000|Overall Study|Withdrawal by Subject|7|||
130629231|NCT02142504|470261473|FG001|Overall Study|Withdrawal by Subject|9|||
130629232|NCT02142504|470261474|FG002|Overall Study|Withdrawal by Subject|11|||
130629233|NCT02142504|470261472|FG000|Overall Study|Pregnancy|4|||
130629234|NCT02142504|470261473|FG001|Overall Study|Pregnancy|4|||
130629235|NCT02142504|470261474|FG002|Overall Study|Pregnancy|2|||
130629236|NCT02142504|470261472|FG000|Overall Study|Physician Decision|0|||
130629237|NCT02142504|470261473|FG001|Overall Study|Physician Decision|1|||
130629238|NCT02142504|470261474|FG002|Overall Study|Physician Decision|3|||
130629239|NCT02142504|470261472|FG000|Overall Study|Reason Not Specified|4|||
130629240|NCT02142504|470261473|FG001|Overall Study|Reason Not Specified|5|||
130629241|NCT02142504|470261474|FG002|Overall Study|Reason Not Specified|4|||
130629242|NCT01998399|470261475|FG000|Overall Study|Lost to Follow-up|1|||
130629243|NCT01998399|470261476|FG001|Overall Study|Lost to Follow-up|3|||
130629244|NCT01998399|470261475|FG000|Overall Study|Death|4|||
130629245|NCT01998399|470261476|FG001|Overall Study|Death|2|||
130629246|NCT01998399|470261475|FG000|Overall Study|Study stopped before dosing completed|3|||
130629247|NCT01998399|470261476|FG001|Overall Study|Study stopped before dosing completed|3|||
130629248|NCT01998399|470261475|FG000|Overall Study|Withdrawal by Subject|0|||
130629249|NCT01998399|470261476|FG001|Overall Study|Withdrawal by Subject|1|||
130629250|NCT00376246|470261477|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
130629251|NCT00376246|470261478|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
130629252|NCT00376246|470261477|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130629253|NCT00376246|470261478|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130629254|NCT00376246|470261477|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130629255|NCT00376246|470261478|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130629256|NCT00418717|470261483|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
130629257|NCT00418717|470261483|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
130629258|NCT00719537|470261485|FG000|Overall Study|Withdrawal by Subject|1|||
130629259|NCT00719537|470261486|FG001|Overall Study|Withdrawal by Subject|0|||
130629260|NCT00719537|470261485|FG000|Overall Study|Lost to Follow-up|0|||
130629261|NCT00719537|470261486|FG001|Overall Study|Lost to Follow-up|1|||
130629262|NCT01142193|470261487|FG000|Overall Study|Adverse Event|12|||
130629263|NCT01142193|470261488|FG001|Overall Study|Adverse Event|4|||
130629264|NCT01142193|470261487|FG000|Overall Study|Lack of Efficacy|2|||
130629265|NCT01142193|470261488|FG001|Overall Study|Lack of Efficacy|1|||
130629266|NCT01142193|470261487|FG000|Overall Study|Physician Decision|1|||
130629267|NCT01142193|470261488|FG001|Overall Study|Physician Decision|1|||
130629268|NCT01142193|470261487|FG000|Overall Study|Withdrawal by Subject|4|||
130629269|NCT01142193|470261488|FG001|Overall Study|Withdrawal by Subject|3|||
130629270|NCT01142193|470261487|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
130629271|NCT01142193|470261488|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
130629272|NCT01142193|470261487|FG000|Overall Study|Other|1|||
130629273|NCT01142193|470261488|FG001|Overall Study|Other|2|||
130629274|NCT01203787|470261492|FG000|Overall Study|Death|12|||
130629275|NCT01203787|470261493|FG001|Overall Study|Death|10|||
130629276|NCT01203787|470261492|FG000|Overall Study|Withdrawal by Subject|6|||
130629277|NCT01203787|470261493|FG001|Overall Study|Withdrawal by Subject|2|||
130629278|NCT01203787|470261492|FG000|Overall Study|Lost to Follow-up|2|||
130629279|NCT01203787|470261493|FG001|Overall Study|Lost to Follow-up|0|||
130629280|NCT01203787|470261492|FG000|Overall Study|Adverse Event|11|||
130629281|NCT01203787|470261493|FG001|Overall Study|Adverse Event|15|||
130629282|NCT03404518|470261494|FG000|Overall Study|Lost to Follow-up|28|||
130629283|NCT03404518|470261495|FG001|Overall Study|Lost to Follow-up|30|||
130629284|NCT03404518|470261494|FG000|Overall Study|Protocol Violation|13|||
130629285|NCT03404518|470261495|FG001|Overall Study|Protocol Violation|6|||
130629286|NCT03693404|470261498|FG000|Overall Study|Withdrawal by Subject|1|||
130629287|NCT03693404|470261499|FG001|Overall Study|Withdrawal by Subject|0|||
130629288|NCT03693404|470261498|FG000|Overall Study|Lost to Follow-up|0|||
130629289|NCT03693404|470261499|FG001|Overall Study|Lost to Follow-up|5|||
130629290|NCT03693404|470261498|FG000|Overall Study|Excluded from Analysis|0|||
130629291|NCT03693404|470261499|FG001|Overall Study|Excluded from Analysis|1|||
130629292|NCT01041404|470261502|FG000|Overall Study|Adverse Event|45|||
130629293|NCT01041404|470261503|FG001|Overall Study|Adverse Event|35|||
130629294|NCT01041404|470261502|FG000|Overall Study|Lack of Efficacy|200|||
130629295|NCT01041404|470261503|FG001|Overall Study|Lack of Efficacy|210|||
130629296|NCT01041404|470261502|FG000|Overall Study|Violation of Selection Criteria|0|||
130629297|NCT01041404|470261503|FG001|Overall Study|Violation of Selection Criteria|1|||
130629298|NCT01041404|470261502|FG000|Overall Study|Protocol Violation|4|||
130629299|NCT01041404|470261503|FG001|Overall Study|Protocol Violation|0|||
130629300|NCT01041404|470261502|FG000|Overall Study|Withdrawal by Subject|29|||
130629301|NCT01041404|470261503|FG001|Overall Study|Withdrawal by Subject|23|||
130629302|NCT01041404|470261502|FG000|Overall Study|Failure to Return|1|||
130629303|NCT01041404|470261503|FG001|Overall Study|Failure to Return|2|||
130629304|NCT01041404|470261502|FG000|Overall Study|Other|11|||
130629305|NCT01041404|470261503|FG001|Overall Study|Other|23|||
130629306|NCT03627494|470261504|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
130629307|NCT03627494|470261505|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629308|NCT03627494|470261506|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
130629309|NCT03627494|470261507|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629310|NCT03627494|470261508|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629311|NCT03627494|470261509|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629312|NCT03627494|470261510|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629313|NCT03627494|470261511|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629314|NCT03627494|470261512|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629315|NCT03627494|470261513|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629316|NCT03627494|470261514|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629317|NCT03627494|470261515|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
130629318|NCT03627494|470261504|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629319|NCT03627494|470261505|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629320|NCT03627494|470261506|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629321|NCT03627494|470261507|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629322|NCT03627494|470261508|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629323|NCT03627494|470261509|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629324|NCT03627494|470261510|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629325|NCT03627494|470261511|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629326|NCT03627494|470261512|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
130629327|NCT03627494|470261513|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629328|NCT03627494|470261514|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629329|NCT03627494|470261515|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
130629330|NCT03627494|470261504|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629331|NCT03627494|470261505|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629332|NCT03627494|470261506|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629333|NCT03627494|470261507|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629334|NCT03627494|470261508|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629335|NCT03627494|470261509|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629336|NCT03627494|470261510|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629337|NCT03627494|470261511|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629338|NCT03627494|470261512|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629339|NCT03627494|470261513|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
130629340|NCT03627494|470261514|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
130629341|NCT03627494|470261515|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
130629342|NCT03565991|470263139|FG000|Overall Study|Other|11|||
130629343|NCT03565991|470263140|FG001|Overall Study|Other|0|||
130629344|NCT03565991|470263139|FG000|Overall Study|Global deterioration of health status|14|||
130629345|NCT03565991|470263140|FG001|Overall Study|Global deterioration of health status|4|||
130629346|NCT03565991|470263139|FG000|Overall Study|Withdrawal by Subject|2|||
130629347|NCT03565991|470263140|FG001|Overall Study|Withdrawal by Subject|6|||
130629348|NCT03565991|470263139|FG000|Overall Study|Progressive disease|121|||
130629349|NCT03565991|470263140|FG001|Overall Study|Progressive disease|29|||
130629350|NCT03565991|470263139|FG000|Overall Study|Death|3|||
130629351|NCT03565991|470263140|FG001|Overall Study|Death|0|||
130629352|NCT03565991|470263139|FG000|Overall Study|Adverse Event|7|||
130629353|NCT03565991|470263140|FG001|Overall Study|Adverse Event|2|||
130629354|NCT00784459|470263141|FG000|Overall Study|Adverse Event|0|||
130629355|NCT00784459|470263142|FG001|Overall Study|Adverse Event|2|||
130629356|NCT02741310|470263155|FG000|Overall Study|Sponsor Decision|2|||
130629357|NCT02741310|470263156|FG001|Overall Study|Sponsor Decision|2|||
130629358|NCT00239356|470263157|FG000|Overall Study|Lack of Efficacy|1|||
130629359|NCT00239356|470263158|FG001|Overall Study|Lack of Efficacy|0|||
130629360|NCT00239356|470263157|FG000|Overall Study|Adverse Event|6|||
130629361|NCT00239356|470263158|FG001|Overall Study|Adverse Event|0|||
130629362|NCT00239356|470263157|FG000|Overall Study|Withdrawal by Subject|15|||
130629363|NCT00239356|470263158|FG001|Overall Study|Withdrawal by Subject|6|||
130629364|NCT00239356|470263157|FG000|Overall Study|Lost to Follow-up|3|||
130629365|NCT00239356|470263158|FG001|Overall Study|Lost to Follow-up|0|||
130629366|NCT00239356|470263157|FG000|Overall Study|poor/non-compliance|2|||
130629367|NCT00239356|470263158|FG001|Overall Study|poor/non-compliance|0|||
130629368|NCT00239356|470263157|FG000|Overall Study|Pregnancy|1|||
130629369|NCT00239356|470263158|FG001|Overall Study|Pregnancy|0|||
130629370|NCT00239356|470263157|FG000|Overall Study|Administrative reason|0|||
130629371|NCT00239356|470263158|FG001|Overall Study|Administrative reason|1|||
130629372|NCT00239356|470263157|FG000|Overall Study|Drug available on market|11|||
130629373|NCT00239356|470263158|FG001|Overall Study|Drug available on market|2|||
130629374|NCT02044822|470263159|FG000|Overall Study|Study Terminated by Sponsor|77|||
130629375|NCT02044822|470263159|FG000|Overall Study|Investigator's Discretion|10|||
130629376|NCT02044822|470263159|FG000|Overall Study|Withdrew Consent|3|||
130629377|NCT02044822|470263159|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
130629378|NCT02044822|470263159|FG000|Overall Study|Lost to Follow-up|1|||
130629379|NCT03417505|470263162|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
130629380|NCT03417505|470263163|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
130629381|NCT01237223|470263170|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
130629382|NCT01237223|470263171|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130629383|NCT01237223|470263172|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130629384|NCT01237223|470263173|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130629385|NCT01237223|470263174|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130629386|NCT01237223|470263175|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130629387|NCT01237223|470263170|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
130629388|NCT01237223|470263171|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130629389|NCT01237223|470263172|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130629390|NCT01237223|470263173|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130629391|NCT01237223|470263174|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130629392|NCT01237223|470263175|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130629393|NCT01237223|470263170|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
130629394|NCT01237223|470263171|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130629395|NCT01237223|470263172|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130629396|NCT01237223|470263173|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130629397|NCT01237223|470263174|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130629398|NCT01237223|470263175|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130629399|NCT01237223|470263170|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
130629400|NCT01237223|470263171|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130629401|NCT01237223|470263172|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130629402|NCT01237223|470263173|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130629403|NCT01237223|470263174|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130629404|NCT01237223|470263175|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130629405|NCT01237223|470263170|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
130629406|NCT01237223|470263171|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130629407|NCT01237223|470263172|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130629408|NCT01237223|470263173|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130629409|NCT01237223|470263174|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130629410|NCT01237223|470263175|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130629411|NCT01237223|470263170|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
130629412|NCT01237223|470263171|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
130629413|NCT01237223|470263172|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
130629414|NCT01237223|470263173|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
130629415|NCT01237223|470263174|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
130629416|NCT01237223|470263175|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
130629417|NCT01237223|470263170|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
130629418|NCT01237223|470263171|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
130629419|NCT01237223|470263172|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
130629420|NCT01237223|470263173|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
130629421|NCT01237223|470263174|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
130629422|NCT01237223|470263175|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
130629423|NCT01237223|470263170|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130629424|NCT01237223|470263171|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
130629425|NCT01237223|470263172|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
130629426|NCT01237223|470263173|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
130629427|NCT01237223|470263174|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130629428|NCT01237223|470263175|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130629429|NCT01237223|470263170|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130629430|NCT01237223|470263171|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130629431|NCT01237223|470263172|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130629432|NCT01237223|470263173|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130629433|NCT01237223|470263174|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130629434|NCT01237223|470263175|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
130629435|NCT01237223|470263170|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
130629436|NCT01237223|470263171|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130629437|NCT01237223|470263172|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130629438|NCT01237223|470263173|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
130629439|NCT01237223|470263174|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130629440|NCT01237223|470263175|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130629441|NCT00443846|470263180|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
130629442|NCT00443846|470263181|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
130629443|NCT00443846|470263180|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
130629444|NCT00443846|470263181|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
130629445|NCT00443846|470263180|FG000|Overall Study|Adverse Event|0|||
130629446|NCT00443846|470263181|FG001|Overall Study|Adverse Event|1|||
130629447|NCT00443846|470263180|FG000|Overall Study|Personal reason|8|||
130629448|NCT00443846|470263181|FG001|Overall Study|Personal reason|3|||
130629449|NCT00443846|470263180|FG000|Overall Study|Lost to Follow-up|1|||
130629450|NCT00443846|470263181|FG001|Overall Study|Lost to Follow-up|2|||
130629451|NCT00990249|470263182|FG000|Overall Study|Disease Progression|8|||
130629452|NCT00990249|470263182|FG000|Overall Study|Non-Compliance|1|||
130629453|NCT00990249|470263182|FG000|Overall Study|Death|2|||
130629454|NCT00990249|470263182|FG000|Overall Study|Not treated|2|||
130629455|NCT04583969|470263183|FG000|Overall Study|Death|31|||
130629456|NCT04583969|470263184|FG001|Overall Study|Death|38|||
130629457|NCT04583969|470263183|FG000|Overall Study|Lost to Follow-up|16|||
130629458|NCT04583969|470263184|FG001|Overall Study|Lost to Follow-up|13|||
130629459|NCT04583969|470263183|FG000|Overall Study|Protocol Violation|1|||
130629460|NCT04583969|470263184|FG001|Overall Study|Protocol Violation|0|||
130629461|NCT04583969|470263183|FG000|Overall Study|Withdrawal by Subject|3|||
130629462|NCT04583969|470263184|FG001|Overall Study|Withdrawal by Subject|3|||
130629463|NCT04583969|470263183|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
130629464|NCT04583969|470263184|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
130629465|NCT04583969|470263183|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
130629466|NCT04583969|470263184|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
130629467|NCT04583969|470263183|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
130629468|NCT04583969|470263184|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
130629469|NCT04583969|470263183|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
130629470|NCT04583969|470263184|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
130629471|NCT04583969|470263183|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
130629472|NCT04583969|470263184|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
130629473|NCT04397796|470263185|FG000|Overall Study|Death|3|||
130629474|NCT04397796|470263186|FG001|Overall Study|Death|1|||
130629475|NCT02640755|470263187|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
130629476|NCT02640755|470263188|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
130629477|NCT02640755|470263187|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
130629478|NCT02640755|470263188|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
130629479|NCT02640755|470263187|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
130629480|NCT02640755|470263188|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
130629481|NCT00770224|470263199|FG000|Step 1: Induction|Adverse Event|3|||
130629482|NCT00770224|470263200|FG001|Step 1: Induction|Adverse Event|0|||
130629483|NCT00770224|470263199|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
130629484|NCT00770224|470263200|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
130629485|NCT00770224|470263199|FG000|Step 1: Induction|Other reason not protocol specified|2|||
130629486|NCT00770224|470263200|FG001|Step 1: Induction|Other reason not protocol specified|0|||
130629487|NCT00770224|470263199|FG000|Step 1: Induction|Ineligible|2|||
130629488|NCT00770224|470263200|FG001|Step 1: Induction|Ineligible|0|||
130629489|NCT00770224|470263199|FG000|Step 1: Induction|No protocol treatment given|1|||
130629490|NCT00770224|470263200|FG001|Step 1: Induction|No protocol treatment given|0|||
130629491|NCT00770224|470263199|FG000|Step 2: Maintenance|Adverse Event|0|||
130629492|NCT00770224|470263200|FG001|Step 2: Maintenance|Adverse Event|10|||
130629493|NCT00770224|470263199|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
130629494|NCT00770224|470263200|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
130629495|NCT00770224|470263199|FG000|Step 2: Maintenance|Progression/relapse|0|||
130629496|NCT00770224|470263200|FG001|Step 2: Maintenance|Progression/relapse|1|||
130629497|NCT00770224|470263199|FG000|Step 2: Maintenance|Death|0|||
130629498|NCT00770224|470263200|FG001|Step 2: Maintenance|Death|2|||
130629499|NCT00770224|470263199|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
130629500|NCT00770224|470263200|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
130629501|NCT00770224|470263199|FG000|Step 2: Maintenance|Ineligible|0|||
130629502|NCT00770224|470263200|FG001|Step 2: Maintenance|Ineligible|2|||
130629503|NCT01484561|470263201|FG000|Overall Study|Lack of Efficacy|3|||
130629504|NCT01484561|470263202|FG001|Overall Study|Lack of Efficacy|1|||
130629505|NCT01484561|470263201|FG000|Overall Study|Lost to Follow-up|1|||
130629506|NCT01484561|470263202|FG001|Overall Study|Lost to Follow-up|0|||
130629507|NCT01484561|470263201|FG000|Overall Study|Withdrawal by Subject|3|||
130629508|NCT01484561|470263202|FG001|Overall Study|Withdrawal by Subject|0|||
130629509|NCT01484561|470263201|FG000|Overall Study|Other|1|||
130629510|NCT01484561|470263202|FG001|Overall Study|Other|1|||
130629511|NCT01484561|470263201|FG000|Overall Study|Adverse Event|1|||
130629512|NCT01484561|470263202|FG001|Overall Study|Adverse Event|4|||
130629513|NCT03371251|470263211|FG000|Overall Study|Withdrawal by Subject|1|||
130629514|NCT03371251|470263212|FG001|Overall Study|Withdrawal by Subject|0|||
130629515|NCT03371251|470263213|FG002|Overall Study|Withdrawal by Subject|1|||
130629516|NCT03371251|470263214|FG003|Overall Study|Withdrawal by Subject|0|||
130629517|NCT03371251|470263215|FG004|Overall Study|Withdrawal by Subject|2|||
130629518|NCT03371251|470263216|FG005|Overall Study|Withdrawal by Subject|2|||
130629519|NCT03371251|470263211|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
130629520|NCT03371251|470263212|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130629521|NCT03371251|470263213|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130629522|NCT03371251|470263214|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130629523|NCT03371251|470263215|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
130629524|NCT03371251|470263216|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
130629525|NCT03371251|470263211|FG000|Overall Study|Adverse Event|0|||
130629526|NCT03371251|470263212|FG001|Overall Study|Adverse Event|0|||
130629527|NCT03371251|470263213|FG002|Overall Study|Adverse Event|0|||
130629528|NCT03371251|470263214|FG003|Overall Study|Adverse Event|0|||
130629529|NCT03371251|470263215|FG004|Overall Study|Adverse Event|1|||
130629530|NCT03371251|470263216|FG005|Overall Study|Adverse Event|0|||
130629531|NCT03371251|470263211|FG000|Overall Study|Decision by Sponsor|0|||
130629532|NCT03371251|470263212|FG001|Overall Study|Decision by Sponsor|0|||
130629533|NCT03371251|470263213|FG002|Overall Study|Decision by Sponsor|0|||
130629534|NCT03371251|470263214|FG003|Overall Study|Decision by Sponsor|0|||
130629535|NCT03371251|470263215|FG004|Overall Study|Decision by Sponsor|2|||
130629536|NCT03371251|470263216|FG005|Overall Study|Decision by Sponsor|0|||
130629537|NCT00114218|470263217|FG000|Overall Study|Wrong Cell Type|2|||
130629538|NCT00114218|470263217|FG000|Overall Study|Wrong Primary|1|||
130629539|NCT00114218|470263217|FG000|Overall Study|Never Treated|1|||
130629540|NCT01505114|470263218|FG000|Overall Study|Withdrawal by Subject|5|||
130629541|NCT01505114|470263219|FG001|Overall Study|Withdrawal by Subject|4|||
130629542|NCT01505114|470263220|FG002|Overall Study|Withdrawal by Subject|4|||
130629543|NCT01505114|470263221|FG003|Overall Study|Withdrawal by Subject|7|||
130629544|NCT01505114|470263218|FG000|Overall Study|Death|1|||
130629545|NCT01505114|470263219|FG001|Overall Study|Death|0|||
130629546|NCT01505114|470263220|FG002|Overall Study|Death|0|||
130629547|NCT01505114|470263221|FG003|Overall Study|Death|1|||
130629548|NCT01505114|470263218|FG000|Overall Study|unable to adhere to visit schedule|3|||
130629549|NCT01505114|470263219|FG001|Overall Study|unable to adhere to visit schedule|2|||
130629550|NCT01505114|470263220|FG002|Overall Study|unable to adhere to visit schedule|3|||
130629551|NCT01505114|470263221|FG003|Overall Study|unable to adhere to visit schedule|3|||
130629552|NCT01505114|470263218|FG000|Overall Study|Lost to Follow-up|11|||
130629553|NCT01505114|470263219|FG001|Overall Study|Lost to Follow-up|5|||
130629554|NCT01505114|470263220|FG002|Overall Study|Lost to Follow-up|8|||
130629555|NCT01505114|470263221|FG003|Overall Study|Lost to Follow-up|7|||
130629556|NCT01505114|470263218|FG000|Overall Study|relocated|4|||
130629557|NCT01505114|470263219|FG001|Overall Study|relocated|2|||
130629558|NCT01505114|470263220|FG002|Overall Study|relocated|2|||
130629559|NCT01505114|470263221|FG003|Overall Study|relocated|3|||
130629560|NCT01505114|470263218|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
130629561|NCT01505114|470263219|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
130629562|NCT01505114|470263220|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
130629563|NCT01505114|470263221|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
130629564|NCT01505114|470263218|FG000|Overall Study|staff safety concerns|0|||
130629565|NCT01505114|470263219|FG001|Overall Study|staff safety concerns|0|||
130629566|NCT01505114|470263220|FG002|Overall Study|staff safety concerns|0|||
130629567|NCT01505114|470263221|FG003|Overall Study|staff safety concerns|1|||
130629568|NCT01505114|470263218|FG000|Overall Study|investigator decision|1|||
130629569|NCT01505114|470263219|FG001|Overall Study|investigator decision|0|||
130629570|NCT01505114|470263220|FG002|Overall Study|investigator decision|1|||
130629571|NCT01505114|470263221|FG003|Overall Study|investigator decision|0|||
130629572|NCT03168555|470263222|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
130629573|NCT03168555|470263222|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
130629574|NCT03168555|470263222|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
130629575|NCT03168555|470263222|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
130629576|NCT01040845|470263223|FG000|Overall Study|Withdrawal by Subject|1|||
130629577|NCT01040845|470263224|FG001|Overall Study|Withdrawal by Subject|1|||
130629578|NCT01040845|470263223|FG000|Overall Study|Physician Decision|1|||
130629579|NCT01040845|470263224|FG001|Overall Study|Physician Decision|0|||
130629580|NCT04445688|470263229|FG000|Washout (One Week)|Adverse Event|2|||
130629581|NCT04445688|470263229|FG000|Washout (One Week)|Withdrawal by Subject|1|||
130629582|NCT01235507|470263231|FG000|Overall Study|Adverse Event|1|||
130629583|NCT01235507|470263231|FG000|Overall Study|Withdrawal by Subject|1|||
130629584|NCT02017704|470263235|FG000|Overall Study|Withdrawal by Subject|2|||
130629585|NCT02017704|470263236|FG001|Overall Study|Withdrawal by Subject|0|||
130629586|NCT01587274|470263237|FG000|Overall Study|Lost to Follow-up|4|||
130629587|NCT01587274|470263238|FG001|Overall Study|Lost to Follow-up|5|||
130629588|NCT01587274|470263239|FG002|Overall Study|Lost to Follow-up|3|||
130629589|NCT00918346|470263240|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
130629590|NCT00918346|470263241|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
130629591|NCT02565615|470263242|FG000|Overall Study|Death|0|||
130629592|NCT02565615|470263243|FG001|Overall Study|Death|1|||
130629593|NCT02565615|470263244|FG002|Overall Study|Death|0|||
130629594|NCT02565615|470263245|FG003|Overall Study|Death|0|||
130629595|NCT02565615|470263246|FG004|Overall Study|Death|4|||
130629596|NCT02565615|470263242|FG000|Overall Study|Not willing to participate in study|2|||
130629597|NCT02565615|470263243|FG001|Overall Study|Not willing to participate in study|21|||
130629598|NCT02565615|470263244|FG002|Overall Study|Not willing to participate in study|0|||
130629599|NCT02565615|470263245|FG003|Overall Study|Not willing to participate in study|1|||
130629600|NCT02565615|470263246|FG004|Overall Study|Not willing to participate in study|169|||
130629601|NCT02565615|470263242|FG000|Overall Study|Lost to Follow-up|0|||
130629602|NCT02565615|470263243|FG001|Overall Study|Lost to Follow-up|4|||
130629603|NCT02565615|470263244|FG002|Overall Study|Lost to Follow-up|0|||
130629604|NCT02565615|470263245|FG003|Overall Study|Lost to Follow-up|1|||
130629605|NCT02565615|470263246|FG004|Overall Study|Lost to Follow-up|765|||
130629606|NCT02565615|470263242|FG000|Overall Study|Not meeting eligibility criteria|0|||
130629607|NCT02565615|470263243|FG001|Overall Study|Not meeting eligibility criteria|7|||
130629608|NCT02565615|470263244|FG002|Overall Study|Not meeting eligibility criteria|0|||
130629609|NCT02565615|470263245|FG003|Overall Study|Not meeting eligibility criteria|0|||
130629610|NCT02565615|470263246|FG004|Overall Study|Not meeting eligibility criteria|25|||
130629611|NCT02565615|470263242|FG000|Overall Study|Reason not defined|0|||
130629612|NCT02565615|470263243|FG001|Overall Study|Reason not defined|2|||
130629613|NCT02565615|470263244|FG002|Overall Study|Reason not defined|0|||
130629614|NCT02565615|470263245|FG003|Overall Study|Reason not defined|1|||
130629615|NCT02565615|470263246|FG004|Overall Study|Reason not defined|62|||
130629616|NCT02565615|470263242|FG000|Overall Study|Adverse Event|1|||
130629617|NCT02565615|470263243|FG001|Overall Study|Adverse Event|1|||
130629618|NCT02565615|470263244|FG002|Overall Study|Adverse Event|0|||
130629619|NCT02565615|470263245|FG003|Overall Study|Adverse Event|0|||
130629620|NCT02565615|470263246|FG004|Overall Study|Adverse Event|9|||
130629621|NCT02565615|470263242|FG000|Overall Study|Untreated|0|||
130629622|NCT02565615|470263243|FG001|Overall Study|Untreated|0|||
130629623|NCT02565615|470263244|FG002|Overall Study|Untreated|0|||
130629624|NCT02565615|470263245|FG003|Overall Study|Untreated|0|||
130629625|NCT02565615|470263246|FG004|Overall Study|Untreated|567|||
130629626|NCT01250756|470263247|FG000|Infant Series|Withdrawal by Subject|4|||
130629627|NCT01250756|470263248|FG001|Infant Series|Withdrawal by Subject|5|||
130629628|NCT01250756|470263247|FG000|Infant Series|Randomized, Not Vaccinated|2|||
130629629|NCT01250756|470263248|FG001|Infant Series|Randomized, Not Vaccinated|2|||
130629630|NCT01250756|470263247|FG000|Infant Series|Other|22|||
130629631|NCT01250756|470263248|FG001|Infant Series|Other|0|||
130629632|NCT01250756|470263247|FG000|After Infant Series|Adverse Event|5|||
130629633|NCT01250756|470263248|FG001|After Infant Series|Adverse Event|2|||
130629634|NCT01250756|470263247|FG000|After Infant Series|Withdrawal by Subject|4|||
130629635|NCT01250756|470263248|FG001|After Infant Series|Withdrawal by Subject|1|||
130629636|NCT01250756|470263247|FG000|After Infant Series|Other|2|||
130629637|NCT01250756|470263248|FG001|After Infant Series|Other|1|||
130629638|NCT01250756|470263247|FG000|Toddler Dose|Adverse Event|0|||
130629639|NCT01250756|470263248|FG001|Toddler Dose|Adverse Event|1|||
130629640|NCT01250756|470263247|FG000|After Toddler Dose|Adverse Event|0|||
130629641|NCT01250756|470263248|FG001|After Toddler Dose|Adverse Event|1|||
130629642|NCT01815580|470263250|FG000|Overall Study|Lost to Follow-up|4|||
130629643|NCT01815580|470263251|FG001|Overall Study|Lost to Follow-up|7|||
130629644|NCT01815580|470263250|FG000|Overall Study|Withdrawal by Subject|3|||
130629645|NCT01815580|470263251|FG001|Overall Study|Withdrawal by Subject|4|||
130629646|NCT01815580|470263250|FG000|Overall Study|Excluded from analysis|5|||
130629647|NCT01815580|470263251|FG001|Overall Study|Excluded from analysis|4|||
130629648|NCT02228564|470263252|FG000|Overall Study|Withdrawal by Subject|10|||
130629649|NCT02228564|470263252|FG000|Overall Study|Death|11|||
130629650|NCT02228564|470263252|FG000|Overall Study|Physician Decision|5|||
130629651|NCT02228564|470263252|FG000|Overall Study|Lost to Follow-up|17|||
130629652|NCT02228564|470263252|FG000|Overall Study|Other|6|||
130629653|NCT04114539|470263258|FG000|Overall Study|Adverse Event|14|||
130629654|NCT04114539|470263258|FG000|Overall Study|Lost to Follow-up|2|||
130629655|NCT04114539|470263258|FG000|Overall Study|Non-compliance with Protocol|2|||
130629656|NCT04114539|470263258|FG000|Overall Study|Non-compliance with Study Drug|1|||
130629657|NCT04114539|470263258|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
130629658|NCT04114539|470263258|FG000|Overall Study|Withdrew consent|10|||
130629659|NCT04114539|470263258|FG000|Overall Study|Others not specified|5|||
130629660|NCT04114539|470263258|FG000|Overall Study|Investigator Decision|2|||
130629661|NCT00617591|470263259|FG000|Overall Study|Withdrew consent during Induction|4|||
130629662|NCT00617591|470263259|FG000|Overall Study|Withdrew consent during Maintenance|6|||
130629663|NCT01072448|470263266|FG000|Overall Study|Adverse Event|9|||
130629664|NCT01072448|470263267|FG001|Overall Study|Adverse Event|10|||
130629665|NCT01072448|470263266|FG000|Overall Study|Subject withdrew consent|4|||
130629666|NCT01072448|470263267|FG001|Overall Study|Subject withdrew consent|9|||
130629667|NCT01072448|470263266|FG000|Overall Study|Protocol deviation|3|||
130629668|NCT01072448|470263267|FG001|Overall Study|Protocol deviation|4|||
130629669|NCT01072448|470263266|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130629670|NCT01072448|470263267|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130629671|NCT01072448|470263266|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130629672|NCT01072448|470263267|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130629673|NCT01072448|470263266|FG000|Overall Study|Lost to Follow-up|1|||
130629674|NCT01072448|470263267|FG001|Overall Study|Lost to Follow-up|1|||
130629675|NCT01072448|470263266|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130629676|NCT01072448|470263267|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130629677|NCT01072448|470263266|FG000|Overall Study|Death|0|||
130629678|NCT01072448|470263267|FG001|Overall Study|Death|2|||
130629679|NCT01400139|470263268|FG000|HYD Core Study|Adverse Event|210|||
130629680|NCT01400139|470263268|FG000|HYD Core Study|Lack of Efficacy|59|||
130629681|NCT01400139|470263268|FG000|HYD Core Study|Withdrawal by Subject|114|||
130629682|NCT01400139|470263268|FG000|HYD Core Study|Lost to Follow-up|39|||
130629683|NCT01400139|470263268|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
130629684|NCT01400139|470263268|FG000|HYD Core Study|Administrative|56|||
130629685|NCT01400139|470263268|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
130629686|NCT01400139|470263268|FG000|HYD Extension Period|Adverse Event|8|||
130629687|NCT01400139|470263268|FG000|HYD Extension Period|Withdrawal by Subject|5|||
130629688|NCT01400139|470263268|FG000|HYD Extension Period|Administrative|10|||
130629689|NCT00249795|470263269|FG000|Overall Study|Not treated|16|||
130629690|NCT00249795|470263270|FG001|Overall Study|Not treated|14|||
130629691|NCT00249795|470263269|FG000|Overall Study|Symptomatic hypotension|127|||
130629692|NCT00249795|470263270|FG001|Overall Study|Symptomatic hypotension|64|||
130629693|NCT00249795|470263269|FG000|Overall Study|Other Serious Adverse Event|84|||
130629694|NCT00249795|470263270|FG001|Overall Study|Other Serious Adverse Event|93|||
130629695|NCT00249795|470263269|FG000|Overall Study|Qualifying condition not present|26|||
130629696|NCT00249795|470263270|FG001|Overall Study|Qualifying condition not present|29|||
130629697|NCT00249795|470263269|FG000|Overall Study|Withdrawal by Subject|678|||
130629698|NCT00249795|470263270|FG001|Overall Study|Withdrawal by Subject|742|||
130629699|NCT00249795|470263269|FG000|Overall Study|Thromboembolic / outcome event|39|||
130629700|NCT00249795|470263270|FG001|Overall Study|Thromboembolic / outcome event|45|||
130629701|NCT00249795|470263269|FG000|Overall Study|Oral anticoagulant required|2|||
130629702|NCT00249795|470263270|FG001|Overall Study|Oral anticoagulant required|0|||
130629703|NCT00249795|470263269|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
130629704|NCT00249795|470263270|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
130629705|NCT00249795|470263269|FG000|Overall Study|Non-compliance|71|||
130629706|NCT00249795|470263270|FG001|Overall Study|Non-compliance|69|||
130629707|NCT00249795|470263269|FG000|Overall Study|Study drug intolerance|3|||
130629708|NCT00249795|470263270|FG001|Overall Study|Study drug intolerance|3|||
130629709|NCT00249795|470263269|FG000|Overall Study|Other adverse events (non-serious)|188|||
130629710|NCT00249795|470263270|FG001|Overall Study|Other adverse events (non-serious)|159|||
130629711|NCT00249795|470263269|FG000|Overall Study|Physician withdrew consent|71|||
130629712|NCT00249795|470263270|FG001|Overall Study|Physician withdrew consent|63|||
130629713|NCT00249795|470263269|FG000|Overall Study|Surgery / procedure|4|||
130629714|NCT00249795|470263270|FG001|Overall Study|Surgery / procedure|5|||
130629715|NCT00249795|470263269|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
130629716|NCT00249795|470263270|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
130629717|NCT00249795|470263269|FG000|Overall Study|Lightheadedness / dizziness|15|||
130629718|NCT00249795|470263270|FG001|Overall Study|Lightheadedness / dizziness|11|||
130629719|NCT00249795|470263269|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
130629720|NCT00249795|470263270|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
130629721|NCT00249795|470263269|FG000|Overall Study|Other contraindicated medication|1|||
130629722|NCT00249795|470263270|FG001|Overall Study|Other contraindicated medication|1|||
130629723|NCT00249795|470263269|FG000|Overall Study|Event related to cardiac condition|17|||
130629724|NCT00249795|470263270|FG001|Overall Study|Event related to cardiac condition|16|||
130629725|NCT00249795|470263269|FG000|Overall Study|Patient not wish to continue after May08|4|||
130629726|NCT00249795|470263270|FG001|Overall Study|Patient not wish to continue after May08|6|||
130629727|NCT00249795|470263269|FG000|Overall Study|Site not agree to continue after May08|1|||
130629728|NCT00249795|470263270|FG001|Overall Study|Site not agree to continue after May08|1|||
130629729|NCT00249795|470263269|FG000|Overall Study|Lost to Follow-up|0|||
130629730|NCT00249795|470263270|FG001|Overall Study|Lost to Follow-up|2|||
130629731|NCT00249795|470263269|FG000|Overall Study|Missing|0|||
130629732|NCT00249795|470263270|FG001|Overall Study|Missing|1|||
130629733|NCT02460978|470263272|FG000|Overall Study|Adverse Event|17|||
130629734|NCT02460978|470263273|FG001|Overall Study|Adverse Event|11|||
130629735|NCT02460978|470263274|FG002|Overall Study|Adverse Event|11|||
130629736|NCT02460978|470263272|FG000|Overall Study|Withdrawal by Subject|5|||
130629737|NCT02460978|470263273|FG001|Overall Study|Withdrawal by Subject|5|||
130629738|NCT02460978|470263274|FG002|Overall Study|Withdrawal by Subject|14|||
130629739|NCT02460978|470263272|FG000|Overall Study|Lost to Follow-up|2|||
130629740|NCT02460978|470263273|FG001|Overall Study|Lost to Follow-up|3|||
130629741|NCT02460978|470263274|FG002|Overall Study|Lost to Follow-up|1|||
130629742|NCT02460978|470263272|FG000|Overall Study|Protocol Violation|1|||
130629743|NCT02460978|470263273|FG001|Overall Study|Protocol Violation|1|||
130629744|NCT02460978|470263274|FG002|Overall Study|Protocol Violation|1|||
130629745|NCT02460978|470263272|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
130629746|NCT02460978|470263273|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
130629747|NCT02460978|470263274|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
130629748|NCT02460978|470263272|FG000|Overall Study|Pregnancy|0|||
130629749|NCT02460978|470263273|FG001|Overall Study|Pregnancy|0|||
130629750|NCT02460978|470263274|FG002|Overall Study|Pregnancy|2|||
130629751|NCT03549429|470263277|FG000|Overall Study|Protocol Violation|5|||
130629752|NCT03549429|470263278|FG001|Overall Study|Protocol Violation|3|||
130629753|NCT00588523|470263282|FG000|Overall Study|Not treated|3|||
130629754|NCT01459068|470263285|FG000|Overall Study|Withdrawal by Subject|8|||
130629755|NCT01459068|470263286|FG001|Overall Study|Withdrawal by Subject|18|||
130629756|NCT01459068|470263285|FG000|Overall Study|Lost to Follow-up|31|||
130629757|NCT01459068|470263286|FG001|Overall Study|Lost to Follow-up|15|||
130629758|NCT01459068|470263285|FG000|Overall Study|Death|0|||
130629759|NCT01459068|470263286|FG001|Overall Study|Death|1|||
130629760|NCT00196196|470263287|FG000|Overall Study|Withdrawal by Subject|2|||
130629761|NCT00196196|470263287|FG000|Overall Study|Did not have required condition (hydroce|5|||
130629762|NCT03032510|470263288|FG000|Overall Study|Adverse Event|5|||
130629763|NCT03032510|470263289|FG001|Overall Study|Adverse Event|2|||
130629764|NCT03032510|470263288|FG000|Overall Study|Lost to Follow-up|8|||
130629765|NCT03032510|470263289|FG001|Overall Study|Lost to Follow-up|7|||
130629766|NCT03032510|470263288|FG000|Overall Study|Withdrawal by Subject|8|||
130629767|NCT03032510|470263289|FG001|Overall Study|Withdrawal by Subject|7|||
130629768|NCT03032510|470263288|FG000|Overall Study|Subject noncompliance|4|||
130629769|NCT03032510|470263289|FG001|Overall Study|Subject noncompliance|2|||
130629770|NCT03032510|470263288|FG000|Overall Study|Physician Decision|2|||
130629771|NCT03032510|470263289|FG001|Overall Study|Physician Decision|0|||
130629772|NCT01601470|470263290|FG000|Period 2 - LCZ696|Physician Decision|1|||
130629773|NCT01079195|470263291|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
130629774|NCT01079195|470263291|FG000|Overall Study|No Documentation Available|437|||
130629775|NCT01079195|470263291|FG000|Overall Study|Adverse Event|157|||
130629776|NCT01079195|470263291|FG000|Overall Study|Reason Unknown|39|||
130629777|NCT01079195|470263291|FG000|Overall Study|Withdrawal by Subject|18|||
130629778|NCT01079195|470263291|FG000|Overall Study|Financial Reasons|15|||
130629779|NCT01079195|470263291|FG000|Overall Study|Lack of Effectiveness|12|||
130629780|NCT01079195|470263291|FG000|Overall Study|Physician Decision|4|||
130629781|NCT01079195|470263291|FG000|Overall Study|Improved Status of Participant|4|||
130629782|NCT01079195|470263291|FG000|Overall Study|No Follow-up Documentation Available|4|||
130629783|NCT01079195|470263291|FG000|Overall Study|Non-compliance|2|||
130629784|NCT02079519|470263294|FG000|Overall Study|Disease Progression|9|||
130629785|NCT02079519|470263294|FG000|Overall Study|Adverse Event|1|||
130629786|NCT01685203|470263296|FG000|Overall Study|Lost to Follow-up|3|||
130629787|NCT01685203|470263297|FG001|Overall Study|Lost to Follow-up|3|||
130629788|NCT01685203|470263298|FG002|Overall Study|Lost to Follow-up|0|||
130629789|NCT01685203|470263299|FG003|Overall Study|Lost to Follow-up|1|||
130629790|NCT01685203|470263300|FG004|Overall Study|Lost to Follow-up|0|||
130629791|NCT01685203|470263301|FG005|Overall Study|Lost to Follow-up|0|||
130629792|NCT01685203|470263302|FG006|Overall Study|Lost to Follow-up|0|||
130629793|NCT01685203|470263296|FG000|Overall Study|Adverse Event|0|||
130629794|NCT01685203|470263297|FG001|Overall Study|Adverse Event|0|||
130629795|NCT01685203|470263298|FG002|Overall Study|Adverse Event|0|||
130629796|NCT01685203|470263299|FG003|Overall Study|Adverse Event|0|||
130629797|NCT01685203|470263300|FG004|Overall Study|Adverse Event|0|||
130629798|NCT01685203|470263301|FG005|Overall Study|Adverse Event|2|||
130629799|NCT01685203|470263302|FG006|Overall Study|Adverse Event|0|||
130629800|NCT01685203|470263296|FG000|Overall Study|Adverse event and withdrew consent|1|||
130629801|NCT01685203|470263297|FG001|Overall Study|Adverse event and withdrew consent|0|||
130629802|NCT01685203|470263298|FG002|Overall Study|Adverse event and withdrew consent|0|||
130629803|NCT01685203|470263299|FG003|Overall Study|Adverse event and withdrew consent|0|||
130629804|NCT01685203|470263300|FG004|Overall Study|Adverse event and withdrew consent|0|||
130629805|NCT01685203|470263301|FG005|Overall Study|Adverse event and withdrew consent|0|||
130629806|NCT01685203|470263302|FG006|Overall Study|Adverse event and withdrew consent|0|||
130629807|NCT01685203|470263296|FG000|Overall Study|Patient's decision|0|||
130629808|NCT01685203|470263297|FG001|Overall Study|Patient's decision|0|||
130629809|NCT01685203|470263298|FG002|Overall Study|Patient's decision|0|||
130629810|NCT01685203|470263299|FG003|Overall Study|Patient's decision|0|||
130629811|NCT01685203|470263300|FG004|Overall Study|Patient's decision|0|||
130629812|NCT01685203|470263301|FG005|Overall Study|Patient's decision|1|||
130629813|NCT01685203|470263302|FG006|Overall Study|Patient's decision|0|||
130629814|NCT00318370|470263303|FG000|Period 1|Lack of Efficacy|5|||
130629815|NCT00318370|470263304|FG001|Period 1|Lack of Efficacy|0|||
130629816|NCT00318370|470263305|FG002|Period 1|Lack of Efficacy|0|||
130629817|NCT00318370|470263303|FG000|Period 1|Physician Decision|1|||
130629818|NCT00318370|470263304|FG001|Period 1|Physician Decision|0|||
130629819|NCT00318370|470263305|FG002|Period 1|Physician Decision|0|||
130629820|NCT00318370|470263303|FG000|Period 1|Withdrawal by Subject|1|||
130629821|NCT00318370|470263304|FG001|Period 1|Withdrawal by Subject|0|||
130629822|NCT00318370|470263305|FG002|Period 1|Withdrawal by Subject|0|||
130629823|NCT00318370|470263303|FG000|Period 2|Adverse Event|0|||
130629824|NCT00318370|470263304|FG001|Period 2|Adverse Event|3|||
130629825|NCT00318370|470263305|FG002|Period 2|Adverse Event|0|||
130629826|NCT00318370|470263303|FG000|Period 2|Lack of Efficacy|0|||
130629827|NCT00318370|470263304|FG001|Period 2|Lack of Efficacy|5|||
130629828|NCT00318370|470263305|FG002|Period 2|Lack of Efficacy|0|||
130629829|NCT00318370|470263303|FG000|Period 2|Physician Decision|0|||
130629830|NCT00318370|470263304|FG001|Period 2|Physician Decision|1|||
130629831|NCT00318370|470263305|FG002|Period 2|Physician Decision|0|||
130629832|NCT00318370|470263303|FG000|Period 2|Withdrawal by Subject|0|||
130629833|NCT00318370|470263304|FG001|Period 2|Withdrawal by Subject|1|||
130629834|NCT00318370|470263305|FG002|Period 2|Withdrawal by Subject|0|||
130629835|NCT00318370|470263303|FG000|Period 2|Other|0|||
130629836|NCT00318370|470263304|FG001|Period 2|Other|1|||
130629837|NCT00318370|470263305|FG002|Period 2|Other|0|||
130629838|NCT00318370|470263303|FG000|Period 3|Adverse Event|0|||
130629839|NCT00318370|470263304|FG001|Period 3|Adverse Event|0|||
130629840|NCT00318370|470263305|FG002|Period 3|Adverse Event|1|||
130629841|NCT00318370|470263303|FG000|Period 3|Lack of Efficacy|0|||
130629842|NCT00318370|470263304|FG001|Period 3|Lack of Efficacy|0|||
130629843|NCT00318370|470263305|FG002|Period 3|Lack of Efficacy|24|||
130629844|NCT00318370|470263303|FG000|Period 3|Death|0|||
130629845|NCT00318370|470263304|FG001|Period 3|Death|0|||
130629846|NCT00318370|470263305|FG002|Period 3|Death|1|||
130629847|NCT00318370|470263303|FG000|Period 3|Physician Decision|0|||
130629848|NCT00318370|470263304|FG001|Period 3|Physician Decision|0|||
130629849|NCT00318370|470263305|FG002|Period 3|Physician Decision|1|||
130629850|NCT00318370|470263303|FG000|Period 3|Withdrawal by Subject|0|||
130629851|NCT00318370|470263304|FG001|Period 3|Withdrawal by Subject|0|||
130629852|NCT00318370|470263305|FG002|Period 3|Withdrawal by Subject|3|||
130629853|NCT00318370|470263303|FG000|Period 3|Other|0|||
130629854|NCT00318370|470263304|FG001|Period 3|Other|0|||
130629855|NCT00318370|470263305|FG002|Period 3|Other|3|||
130629856|NCT01750840|470263306|FG000|Overall Study|Lost to Follow-up|4|||
130629857|NCT02431702|470265288|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
130629858|NCT02431702|470265289|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629859|NCT02431702|470265290|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629860|NCT02431702|470265291|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629861|NCT02431702|470265292|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629862|NCT02431702|470265293|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629863|NCT02431702|470265294|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130629864|NCT02431702|470265288|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
130629865|NCT02431702|470265289|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130629866|NCT02431702|470265290|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130629867|NCT02431702|470265291|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130629868|NCT02431702|470265292|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130629869|NCT02431702|470265293|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130629870|NCT02431702|470265294|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
130629871|NCT02431702|470265288|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
130629872|NCT02431702|470265289|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130629873|NCT02431702|470265290|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130629874|NCT02431702|470265291|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130629875|NCT02431702|470265292|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130629876|NCT02431702|470265293|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130629877|NCT02431702|470265294|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
130629878|NCT02431702|470265288|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
130629879|NCT02431702|470265289|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130629880|NCT02431702|470265290|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130629881|NCT02431702|470265291|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130629882|NCT02431702|470265292|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130629883|NCT02431702|470265293|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130629884|NCT02431702|470265294|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
130629885|NCT02431702|470265288|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
130629886|NCT02431702|470265289|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629887|NCT02431702|470265290|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629888|NCT02431702|470265291|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629889|NCT02431702|470265292|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629890|NCT02431702|470265293|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629891|NCT02431702|470265294|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130629892|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130629893|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
130629894|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
130629895|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130629896|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130629897|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130629898|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130629899|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130629900|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
130629901|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
130629902|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130629903|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130629904|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130629905|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130629906|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130629907|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
130629908|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
130629909|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130629910|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130629911|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130629912|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130629913|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629914|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
130629915|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629916|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629917|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629918|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629919|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130629920|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
130629921|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
130629922|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
130629923|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
130629924|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
130629925|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
130629926|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
130629927|NCT02431702|470265288|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629928|NCT02431702|470265289|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629929|NCT02431702|470265290|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
130629930|NCT02431702|470265291|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629931|NCT02431702|470265292|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629932|NCT02431702|470265293|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629933|NCT02431702|470265294|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130629934|NCT02431702|470265288|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130629935|NCT02431702|470265289|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130629936|NCT02431702|470265290|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130629937|NCT02431702|470265291|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
130629938|NCT02431702|470265292|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
130629939|NCT02431702|470265293|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130629940|NCT02431702|470265294|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130629941|NCT02431702|470265288|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130629942|NCT02431702|470265289|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130629943|NCT02431702|470265290|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130629944|NCT02431702|470265291|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
130629945|NCT02431702|470265292|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130629946|NCT02431702|470265293|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
130629947|NCT02431702|470265294|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130629948|NCT02431702|470265288|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130629949|NCT02431702|470265289|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130629950|NCT02431702|470265290|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130629951|NCT02431702|470265291|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
130629952|NCT02431702|470265292|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
130629953|NCT02431702|470265293|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
130629954|NCT02431702|470265294|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130629955|NCT02431702|470265288|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
130629956|NCT02431702|470265289|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
130629957|NCT02431702|470265290|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
130629958|NCT02431702|470265291|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
130629959|NCT02431702|470265292|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
130629960|NCT02431702|470265293|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
130629961|NCT02431702|470265294|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
130629962|NCT02959970|470265295|FG000|Overall Study|Adverse Event|1|||
130629963|NCT02959970|470265296|FG001|Overall Study|Adverse Event|0|||
130629964|NCT02959970|470265295|FG000|Overall Study|Withdrawal by Subject|0|||
130629965|NCT02959970|470265296|FG001|Overall Study|Withdrawal by Subject|2|||
130629966|NCT02959970|470265295|FG000|Overall Study|Lost to Follow-up|1|||
130629967|NCT02959970|470265296|FG001|Overall Study|Lost to Follow-up|5|||
130629968|NCT00693420|470265297|FG000|Overall Study|Adverse Event|4|||
130629969|NCT00693420|470265298|FG001|Overall Study|Adverse Event|4|||
130629970|NCT00693420|470265297|FG000|Overall Study|Lost to Follow-up|0|||
130629971|NCT00693420|470265298|FG001|Overall Study|Lost to Follow-up|3|||
130629972|NCT00693420|470265297|FG000|Overall Study|Withdrawal by Subject|1|||
130629973|NCT00693420|470265298|FG001|Overall Study|Withdrawal by Subject|0|||
130629974|NCT00693420|470265297|FG000|Overall Study|Protocol Violation|0|||
130629975|NCT00693420|470265298|FG001|Overall Study|Protocol Violation|2|||
130629976|NCT00693420|470265297|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
130629977|NCT00693420|470265298|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
130629978|NCT00693420|470265297|FG000|Overall Study|Personal Reasons|1|||
130629979|NCT00693420|470265298|FG001|Overall Study|Personal Reasons|4|||
130629980|NCT03250624|470265301|FG000|Overall Study|Lack of Efficacy|1|||
130629981|NCT03250624|470265302|FG001|Overall Study|Lack of Efficacy|4|||
130629982|NCT03250624|470265301|FG000|Overall Study|Adverse Event|0|||
130629983|NCT03250624|470265302|FG001|Overall Study|Adverse Event|1|||
130629984|NCT03250624|470265301|FG000|Overall Study|Other|1|||
130629985|NCT03250624|470265302|FG001|Overall Study|Other|2|||
130629986|NCT00509028|470265306|FG000|Overall Study|Adverse Event|2|||
130629987|NCT00509028|470265307|FG001|Overall Study|Adverse Event|0|||
130629988|NCT00509028|470265306|FG000|Overall Study|Withdrawal by Subject|4|||
130629989|NCT00509028|470265307|FG001|Overall Study|Withdrawal by Subject|3|||
130629990|NCT00509028|470265306|FG000|Overall Study|Lost to Follow-up|0|||
130629991|NCT00509028|470265307|FG001|Overall Study|Lost to Follow-up|1|||
130629992|NCT00509028|470265306|FG000|Overall Study|Protocol Violation|4|||
130629993|NCT00509028|470265307|FG001|Overall Study|Protocol Violation|2|||
130629994|NCT00509028|470265306|FG000|Overall Study|Non-compliance|2|||
130629995|NCT00509028|470265307|FG001|Overall Study|Non-compliance|1|||
130629996|NCT00948428|470265308|FG000|Overall Study|Withdrawal by Subject|6|||
130629997|NCT00948428|470265309|FG001|Overall Study|Withdrawal by Subject|12|||
130629998|NCT00948428|470265310|FG002|Overall Study|Withdrawal by Subject|7|||
130629999|NCT00948428|470265308|FG000|Overall Study|Adverse Event|6|||
130630000|NCT00948428|470265309|FG001|Overall Study|Adverse Event|3|||
130630001|NCT00948428|470265310|FG002|Overall Study|Adverse Event|0|||
130630002|NCT00948428|470265308|FG000|Overall Study|Lost to Follow-up|2|||
130630003|NCT00948428|470265309|FG001|Overall Study|Lost to Follow-up|1|||
130630004|NCT00948428|470265310|FG002|Overall Study|Lost to Follow-up|1|||
130630005|NCT00948428|470265308|FG000|Overall Study|Death|2|||
130630006|NCT00948428|470265309|FG001|Overall Study|Death|0|||
130630007|NCT00948428|470265310|FG002|Overall Study|Death|0|||
130630008|NCT00948428|470265308|FG000|Overall Study|Intercurrent Illness|1|||
130630009|NCT00948428|470265309|FG001|Overall Study|Intercurrent Illness|0|||
130630010|NCT00948428|470265310|FG002|Overall Study|Intercurrent Illness|0|||
130630011|NCT00948428|470265308|FG000|Overall Study|Non-compliance|1|||
130630012|NCT00948428|470265309|FG001|Overall Study|Non-compliance|2|||
130630013|NCT00948428|470265310|FG002|Overall Study|Non-compliance|0|||
130630014|NCT02471586|470265311|FG000|Overall Study|Lost to Follow-up|3|||
130630015|NCT02471586|470265312|FG001|Overall Study|Lost to Follow-up|8|||
130630016|NCT02471586|470265313|FG002|Overall Study|Lost to Follow-up|4|||
130630017|NCT02471586|470265311|FG000|Overall Study|Death|2|||
130630018|NCT02471586|470265312|FG001|Overall Study|Death|2|||
130630019|NCT02471586|470265313|FG002|Overall Study|Death|0|||
130630020|NCT00441727|470265316|FG000|Overall Study|Protocol Violation|19|||
130630021|NCT00441727|470265317|FG001|Overall Study|Protocol Violation|28|||
130630022|NCT00441727|470265318|FG002|Overall Study|Protocol Violation|32|||
130630023|NCT00441727|470265316|FG000|Overall Study|Adverse Event|26|||
130630024|NCT00441727|470265317|FG001|Overall Study|Adverse Event|33|||
130630025|NCT00441727|470265318|FG002|Overall Study|Adverse Event|28|||
130630026|NCT00441727|470265316|FG000|Overall Study|Lack of Efficacy|7|||
130630027|NCT00441727|470265317|FG001|Overall Study|Lack of Efficacy|8|||
130630028|NCT00441727|470265318|FG002|Overall Study|Lack of Efficacy|48|||
130630029|NCT00441727|470265316|FG000|Overall Study|Withdrawal by Subject|40|||
130630030|NCT00441727|470265317|FG001|Overall Study|Withdrawal by Subject|34|||
130630031|NCT00441727|470265318|FG002|Overall Study|Withdrawal by Subject|47|||
130630032|NCT00441727|470265316|FG000|Overall Study|Lost to Follow-up|5|||
130630033|NCT00441727|470265317|FG001|Overall Study|Lost to Follow-up|6|||
130630034|NCT00441727|470265318|FG002|Overall Study|Lost to Follow-up|5|||
130630035|NCT00441727|470265316|FG000|Overall Study|Safety Reasons|3|||
130630036|NCT00441727|470265317|FG001|Overall Study|Safety Reasons|1|||
130630037|NCT00441727|470265318|FG002|Overall Study|Safety Reasons|3|||
130630038|NCT00441727|470265316|FG000|Overall Study|Various reason specified|6|||
130630039|NCT00441727|470265317|FG001|Overall Study|Various reason specified|8|||
130630040|NCT00441727|470265318|FG002|Overall Study|Various reason specified|5|||
130630041|NCT03235726|470265319|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630042|NCT03235726|470265320|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630043|NCT03235726|470265321|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630044|NCT03235726|470265322|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630045|NCT03235726|470265323|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
130630046|NCT03235726|470265324|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630047|NCT03235726|470265325|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630048|NCT03235726|470265326|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630049|NCT03235726|470265327|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630050|NCT03235726|470265328|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130630051|NCT03235726|470265319|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630052|NCT03235726|470265320|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630053|NCT03235726|470265321|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630054|NCT03235726|470265322|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630055|NCT03235726|470265323|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
130630056|NCT03235726|470265324|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630057|NCT03235726|470265325|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630058|NCT03235726|470265326|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630059|NCT03235726|470265327|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630060|NCT03235726|470265328|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130630061|NCT03135262|470265332|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
130630062|NCT03135262|470265333|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130630063|NCT03135262|470265334|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130630064|NCT03135262|470265335|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130630065|NCT03135262|470265336|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130630066|NCT03135262|470265332|FG000|Overall Study|Progression of disease|0|||
130630067|NCT03135262|470265333|FG001|Overall Study|Progression of disease|0|||
130630068|NCT03135262|470265334|FG002|Overall Study|Progression of disease|0|||
130630069|NCT03135262|470265335|FG003|Overall Study|Progression of disease|1|||
130630070|NCT03135262|470265336|FG004|Overall Study|Progression of disease|0|||
130630071|NCT03135262|470265332|FG000|Overall Study|Death|6|||
130630072|NCT03135262|470265333|FG001|Overall Study|Death|2|||
130630073|NCT03135262|470265334|FG002|Overall Study|Death|2|||
130630074|NCT03135262|470265335|FG003|Overall Study|Death|2|||
130630075|NCT03135262|470265336|FG004|Overall Study|Death|0|||
130630076|NCT03135262|470265332|FG000|Overall Study|Withdrawal by Subject|0|||
130630077|NCT03135262|470265333|FG001|Overall Study|Withdrawal by Subject|0|||
130630078|NCT03135262|470265334|FG002|Overall Study|Withdrawal by Subject|1|||
130630079|NCT03135262|470265335|FG003|Overall Study|Withdrawal by Subject|0|||
130630080|NCT03135262|470265336|FG004|Overall Study|Withdrawal by Subject|1|||
130630081|NCT03135262|470265332|FG000|Overall Study|Study terminated by sponsor|2|||
130630082|NCT03135262|470265333|FG001|Overall Study|Study terminated by sponsor|4|||
130630083|NCT03135262|470265334|FG002|Overall Study|Study terminated by sponsor|4|||
130630084|NCT03135262|470265335|FG003|Overall Study|Study terminated by sponsor|3|||
130630085|NCT03135262|470265336|FG004|Overall Study|Study terminated by sponsor|0|||
130630086|NCT01675141|470265337|FG000|Overall Study|Lenalidomide outside NIH|3|||
130630087|NCT01675141|470265337|FG000|Overall Study|Withdrawal by Subject|3|||
130630088|NCT01675141|470265337|FG000|Overall Study|Physician Decision|4|||
130630089|NCT01675141|470265337|FG000|Overall Study|No treatment, per protocol|1|||
130630090|NCT01599806|470265341|FG000|Overall Study|Lost to Follow-up|20|||
130630091|NCT01599806|470265342|FG001|Overall Study|Lost to Follow-up|20|||
130630092|NCT01599806|470265341|FG000|Overall Study|Withdrawal by Subject|12|||
130630093|NCT01599806|470265342|FG001|Overall Study|Withdrawal by Subject|12|||
130630094|NCT01599806|470265341|FG000|Overall Study|Other Eligibility criteria|11|||
130630095|NCT01599806|470265342|FG001|Overall Study|Other Eligibility criteria|9|||
130630096|NCT00391807|470265344|FG000|Overall Study|Did not receive study medication|23|||
130630097|NCT00391807|470265344|FG000|Overall Study|Adverse Event|177|||
130630098|NCT00391807|470265344|FG000|Overall Study|Pregnancy|25|||
130630099|NCT00391807|470265344|FG000|Overall Study|Lost to Follow-up|227|||
130630100|NCT00391807|470265344|FG000|Overall Study|Withdrawal by Subject|147|||
130630101|NCT00391807|470265344|FG000|Overall Study|Protocol Violation|20|||
130630102|NCT00391807|470265344|FG000|Overall Study|Various|96|||
130630103|NCT01266070|470265353|FG000|Overall Study|Adverse Event|3|||
130630104|NCT01266070|470265353|FG000|Overall Study|Protocol Violation|1|||
130630105|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
130630106|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
130630107|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130630108|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130630109|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130630110|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130630111|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
130630112|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130630113|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130630114|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130630115|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130630116|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
130630117|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130630118|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130630119|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130630120|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
130630121|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
130630122|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130630123|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130630124|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130630125|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
130630126|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
130630127|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130630128|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130630129|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130630130|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
130630131|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
130630132|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130630133|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130630134|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130630135|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
130630136|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
130630137|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130630138|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130630139|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130630140|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
130630141|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
130630142|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130630143|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130630144|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130630145|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
130630146|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
130630147|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130630148|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130630149|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130630150|NCT03689972|470265354|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
130630151|NCT03689972|470265355|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
130630152|NCT03689972|470265356|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130630153|NCT03689972|470265357|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130630154|NCT03689972|470265358|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130630155|NCT03689972|470265354|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130630156|NCT03689972|470265355|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130630157|NCT03689972|470265356|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
130630158|NCT03689972|470265357|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130630159|NCT03689972|470265358|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130630160|NCT03689972|470265354|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130630161|NCT03689972|470265355|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130630162|NCT03689972|470265356|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
130630163|NCT03689972|470265357|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130630164|NCT03689972|470265358|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130630165|NCT03689972|470265354|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130630166|NCT03689972|470265355|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130630167|NCT03689972|470265356|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
130630168|NCT03689972|470265357|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130630169|NCT03689972|470265358|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130630170|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130630171|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130630172|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130630173|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
130630174|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
130630175|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130630176|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130630177|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130630178|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
130630179|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
130630180|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130630181|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130630182|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130630183|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
130630184|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
130630185|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130630186|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130630187|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130630188|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130630189|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
130630190|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130630191|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130630192|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130630193|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
130630194|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
130630195|NCT03689972|470265354|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130630196|NCT03689972|470265355|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130630197|NCT03689972|470265356|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130630198|NCT03689972|470265357|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130630199|NCT03689972|470265358|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
130630200|NCT01838213|470265359|FG000|Overall Study|Ineligible|166|||
130630201|NCT01838213|470265360|FG001|Overall Study|Ineligible|191|||
130630202|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
130630203|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
130630204|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
130630205|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
130630206|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
130630207|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
130630208|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130630209|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
130630210|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130630211|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
130630212|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130630213|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130630214|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130630215|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
130630216|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130630217|NCT02417064|470265361|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
130630218|NCT02417064|470265362|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
130630219|NCT02417064|470265363|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
130630220|NCT02417064|470265361|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
130630221|NCT02417064|470265362|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
130630222|NCT02417064|470265363|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
130630223|NCT02417064|470265361|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
130630224|NCT02417064|470265362|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
130630225|NCT02417064|470265363|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
130630226|NCT02417064|470265361|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
130630227|NCT02417064|470265362|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
130630228|NCT02417064|470265363|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
130630229|NCT02417064|470265361|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
130630230|NCT02417064|470265362|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
130630231|NCT02417064|470265363|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
130630232|NCT02417064|470265361|FG000|Follow-up Phase (24 Weeks)|Other|2|||
130630233|NCT02417064|470265362|FG001|Follow-up Phase (24 Weeks)|Other|2|||
130630234|NCT02417064|470265363|FG002|Follow-up Phase (24 Weeks)|Other|3|||
130630235|NCT01548417|470265366|FG000|Overall Study|Withdrawal by Subject|0|||
130630236|NCT01548417|470265367|FG001|Overall Study|Withdrawal by Subject|2|||
130630237|NCT01585168|470265368|FG000|Overall Study|Lost to Follow-up|3|||
130630238|NCT01585168|470265369|FG001|Overall Study|Lost to Follow-up|1|||
130630239|NCT01585168|470265370|FG002|Overall Study|Lost to Follow-up|1|||
130630240|NCT01585168|470265371|FG003|Overall Study|Lost to Follow-up|1|||
130630241|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
130630242|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
130630243|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
130630244|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
130630245|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
130630246|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
130630247|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
130630248|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
130630249|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
130630250|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
130630251|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
130630252|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
130630253|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130630254|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
130630255|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130630256|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130630257|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
130630258|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
130630259|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
130630260|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
130630261|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
130630262|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
130630263|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
130630264|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
130630265|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Other|0|||
130630266|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Other|1|||
130630267|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Other|0|||
130630268|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Other|0|||
130630269|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
130630270|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
130630271|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
130630272|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
130630273|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
130630274|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
130630275|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
130630276|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
130630277|NCT01194414|470265372|FG000|24 Weeks Double Blind Period|Death|0|||
130630278|NCT01194414|470265373|FG001|24 Weeks Double Blind Period|Death|1|||
130630279|NCT01194414|470265374|FG002|24 Weeks Double Blind Period|Death|0|||
130630280|NCT01194414|470265375|FG003|24 Weeks Double Blind Period|Death|0|||
130630281|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
130630282|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
130630283|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
130630284|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
130630285|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
130630286|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
130630287|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
130630288|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
130630289|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
130630290|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
130630291|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
130630292|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
130630293|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
130630294|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
130630295|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
130630296|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
130630297|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
130630298|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
130630299|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
130630300|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
130630301|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
130630302|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
130630303|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
130630304|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
130630305|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Other|2|||
130630306|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Other|1|||
130630307|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Other|0|||
130630308|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Other|0|||
130630309|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
130630310|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
130630311|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
130630312|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
130630313|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
130630314|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
130630315|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
130630316|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
130630317|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
130630318|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
130630319|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
130630320|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
130630321|NCT01194414|470265372|FG000|72 Weeks Open Label Extension|Death|1|||
130630322|NCT01194414|470265373|FG001|72 Weeks Open Label Extension|Death|2|||
130630323|NCT01194414|470265374|FG002|72 Weeks Open Label Extension|Death|0|||
130630324|NCT01194414|470265375|FG003|72 Weeks Open Label Extension|Death|2|||
130630325|NCT04737759|470265378|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
130630326|NCT04737759|470265379|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
130630327|NCT04737759|470265378|FG000|Overall Study|Death|2|||
130630328|NCT04737759|470265379|FG001|Overall Study|Death|0|||
130630329|NCT04737759|470265378|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
130630330|NCT04737759|470265379|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
130630331|NCT04737759|470265378|FG000|Overall Study|Lost to Follow-up|4|||
130630332|NCT04737759|470265379|FG001|Overall Study|Lost to Follow-up|12|||
130630333|NCT02475629|470265383|FG000|Overall Study|Adverse Event|1|||
130630334|NCT02475629|470265383|FG000|Overall Study|Death|4|||
130630335|NCT02475629|470265383|FG000|Overall Study|Physician Decision|1|||
130630336|NCT02475629|470265383|FG000|Overall Study|Withdrawal by Subject|1|||
130630337|NCT02475629|470265383|FG000|Overall Study|Lost to Follow-up|1|||
130630338|NCT02475629|470265383|FG000|Overall Study|Subject non-compliance|1|||
130630339|NCT01749800|470265392|FG000|Overall Study|not meeting inclusion criteria|3|||
130630340|NCT01749800|470265393|FG001|Overall Study|not meeting inclusion criteria|0|||
130630341|NCT01749800|470265394|FG002|Overall Study|not meeting inclusion criteria|0|||
130630342|NCT01749800|470265392|FG000|Overall Study|Withdrawal by Subject|0|||
130630343|NCT01749800|470265393|FG001|Overall Study|Withdrawal by Subject|1|||
130630344|NCT01749800|470265394|FG002|Overall Study|Withdrawal by Subject|0|||
130630345|NCT01451398|470265400|FG000|Overall Study|Adverse Event|7|||
130630346|NCT01451398|470265401|FG001|Overall Study|Adverse Event|9|||
130630347|NCT01451398|470265400|FG000|Overall Study|Protocol Violation|1|||
130630348|NCT01451398|470265401|FG001|Overall Study|Protocol Violation|2|||
130630349|NCT01451398|470265400|FG000|Overall Study|Physician Decision|1|||
130630350|NCT01451398|470265401|FG001|Overall Study|Physician Decision|1|||
130630351|NCT01451398|470265400|FG000|Overall Study|Withdrawal by Subject|10|||
130630352|NCT01451398|470265401|FG001|Overall Study|Withdrawal by Subject|14|||
130630353|NCT01451398|470265400|FG000|Overall Study|Lost to Follow-up|6|||
130630354|NCT01451398|470265401|FG001|Overall Study|Lost to Follow-up|4|||
130630355|NCT01451398|470265400|FG000|Overall Study|Non-compliance with study drug|1|||
130630356|NCT01451398|470265401|FG001|Overall Study|Non-compliance with study drug|3|||
130630357|NCT01451398|470265400|FG000|Overall Study|Non-compliance with protocol|1|||
130630358|NCT01451398|470265401|FG001|Overall Study|Non-compliance with protocol|1|||
130630359|NCT01451398|470265400|FG000|Overall Study|Moved out of country|0|||
130630360|NCT01451398|470265401|FG001|Overall Study|Moved out of country|1|||
130630361|NCT01451398|470265400|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
130630362|NCT01451398|470265401|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
130630363|NCT01451398|470265400|FG000|Overall Study|Lack of Efficacy|0|||
130630364|NCT01451398|470265401|FG001|Overall Study|Lack of Efficacy|1|||
130630365|NCT01000025|470265405|FG000|Overall Study|Adverse Event|43|||
130630366|NCT01000025|470265406|FG001|Overall Study|Adverse Event|2|||
130630367|NCT01000025|470265405|FG000|Overall Study|Withdrawal by Subject|13|||
130630368|NCT01000025|470265406|FG001|Overall Study|Withdrawal by Subject|8|||
130630369|NCT01000025|470265405|FG000|Overall Study|Death|23|||
130630370|NCT01000025|470265406|FG001|Overall Study|Death|13|||
130630371|NCT01000025|470265405|FG000|Overall Study|Lack of Efficacy|363|||
130630372|NCT01000025|470265406|FG001|Overall Study|Lack of Efficacy|208|||
130630373|NCT01000025|470265405|FG000|Overall Study|Intercurrent Illness|26|||
130630374|NCT01000025|470265406|FG001|Overall Study|Intercurrent Illness|7|||
130630375|NCT00422669|470265407|FG000|Overall Study|The study was terminated early.|98|||
130630376|NCT00422669|470265408|FG001|Overall Study|The study was terminated early.|100|||
130630377|NCT00422669|470265409|FG002|Overall Study|The study was terminated early.|7|||
130630378|NCT04423757|470265410|FG000|Overall Study|Adverse Event|2|||
130630379|NCT04423757|470265411|FG001|Overall Study|Adverse Event|0|||
130630380|NCT04423757|470265410|FG000|Overall Study|Not treated|1|||
130630381|NCT04423757|470265411|FG001|Overall Study|Not treated|1|||
130630382|NCT02709109|470265412|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
130630383|NCT02709109|470265413|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
130630384|NCT02709109|470265414|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
130630385|NCT02709109|470265415|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
130630386|NCT02709109|470265412|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130630387|NCT02709109|470265413|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
130630388|NCT02709109|470265414|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130630389|NCT02709109|470265415|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130630390|NCT02709109|470265412|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
130630391|NCT02709109|470265413|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130630392|NCT02709109|470265414|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130630393|NCT02709109|470265415|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130630394|NCT02709109|470265412|FG000|Washout Period (28 Days)|Other|2|||
130630395|NCT02709109|470265413|FG001|Washout Period (28 Days)|Other|2|||
130630396|NCT02709109|470265414|FG002|Washout Period (28 Days)|Other|3|||
130630397|NCT02709109|470265415|FG003|Washout Period (28 Days)|Other|0|||
130630398|NCT02709109|470265412|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
130630399|NCT02709109|470265413|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
130630400|NCT02709109|470265414|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
130630401|NCT02709109|470265415|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
130630402|NCT02709109|470265412|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
130630403|NCT02709109|470265413|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
130630404|NCT02709109|470265414|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
130630405|NCT02709109|470265415|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
130630406|NCT02709109|470265412|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130630407|NCT02709109|470265413|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130630408|NCT02709109|470265414|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
130630409|NCT02709109|470265415|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130630410|NCT02709109|470265412|FG000|Treatment Period 2 (28 Days)|Other|0|||
130630411|NCT02709109|470265413|FG001|Treatment Period 2 (28 Days)|Other|0|||
130630412|NCT02709109|470265414|FG002|Treatment Period 2 (28 Days)|Other|1|||
130630413|NCT02709109|470265415|FG003|Treatment Period 2 (28 Days)|Other|0|||
130630414|NCT02738580|470265416|FG000|Overall Study|Adverse Event|1|||
130630415|NCT02738580|470265417|FG001|Overall Study|Adverse Event|0|||
130630416|NCT02738580|470265416|FG000|Overall Study|Lack of Efficacy|3|||
130630417|NCT02738580|470265417|FG001|Overall Study|Lack of Efficacy|2|||
130630418|NCT02738580|470265416|FG000|Overall Study|Withdrawal by Subject|0|||
130630419|NCT02738580|470265417|FG001|Overall Study|Withdrawal by Subject|1|||
130630420|NCT02738580|470265416|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
130630421|NCT02738580|470265417|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
130630422|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
130630423|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
130630424|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
130630425|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130630426|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
130630427|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
130630428|NCT00996593|470265418|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
130630429|NCT00996593|470265418|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
130630430|NCT00996593|470265418|FG000|Long-Term Follow-Up|Site Closed|1|||
130630431|NCT02810951|470265422|FG000|Overall Study|Adverse Event|1|||
130630432|NCT01928082|470265423|FG000|Overall Study|Study terminated.|1|||
130630433|NCT05563714|470265424|FG000|Overall Study|Death|2|||
130630434|NCT05563714|470265425|FG001|Overall Study|Death|2|||
130630435|NCT05563714|470265426|FG002|Overall Study|Death|0|||
130630436|NCT05563714|470265427|FG003|Overall Study|Death|0|||
130630437|NCT05563714|470265424|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
130630438|NCT05563714|470265425|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
130630439|NCT05563714|470265426|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
130630440|NCT05563714|470265427|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
130630441|NCT05563714|470265424|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
130630442|NCT05563714|470265425|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
130630443|NCT05563714|470265426|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
130630444|NCT05563714|470265427|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
130630445|NCT05563714|470265424|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130630446|NCT05563714|470265425|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
130630447|NCT05563714|470265426|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130630448|NCT05563714|470265427|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130630449|NCT05563714|470265424|FG000|Overall Study|Lost to Follow-up|22|||
130630450|NCT05563714|470265425|FG001|Overall Study|Lost to Follow-up|19|||
130630451|NCT05563714|470265426|FG002|Overall Study|Lost to Follow-up|0|||
130630452|NCT05563714|470265427|FG003|Overall Study|Lost to Follow-up|0|||
130630453|NCT01610206|470265433|FG000|Overall Study|Adverse Event|10|||
130630454|NCT01610206|470265434|FG001|Overall Study|Adverse Event|30|||
130630455|NCT00166517|470265435|FG000|Overall Study|Lost to Follow-up|1|||
130630456|NCT00166517|470265436|FG001|Overall Study|Lost to Follow-up|0|||
130630457|NCT00166517|470265435|FG000|Overall Study|Protocol Violation|4|||
130630458|NCT00166517|470265436|FG001|Overall Study|Protocol Violation|1|||
130630459|NCT00166517|470265435|FG000|Overall Study|Withdrawal by Subject|0|||
130630460|NCT00166517|470265436|FG001|Overall Study|Withdrawal by Subject|1|||
130630461|NCT02186561|470265437|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
130630462|NCT02186561|470265437|FG000|Enrollment|Enrollment Cap Reached|5|||
130630463|NCT02186561|470265437|FG000|Enrollment|Insurance Denial|2|||
130630464|NCT02186561|470265437|FG000|Enrollment|Withdrawal by Subject|2|||
130630465|NCT02186561|470265437|FG000|Enrollment|Investigator Withdrew Consent|1|||
130630466|NCT02186561|470265437|FG000|30-Day Post Index Procedure Visit|Death|1|||
130630467|NCT02186561|470265437|FG000|1- Year Post Index Procedure Visit|Death|1|||
130630468|NCT02186561|470265437|FG000|1- Year Post Index Procedure Visit|Missed|1|||
130630469|NCT04285853|470265438|FG000|Overall Study|Withdrawal by Subject|1|||
130630470|NCT04285853|470265439|FG001|Overall Study|Withdrawal by Subject|0|||
130630471|NCT04285853|470265438|FG000|Overall Study|Lost to Follow-up|9|||
130630472|NCT04285853|470265439|FG001|Overall Study|Lost to Follow-up|5|||
130630473|NCT01176240|470265445|FG000|Study 306A|Lack of Efficacy|2|||
130630474|NCT01176240|470265446|FG001|Study 306A|Lack of Efficacy|1|||
130630475|NCT01176240|470265445|FG000|Study 306A|Protocol Violation|0|||
130630476|NCT01176240|470265446|FG001|Study 306A|Protocol Violation|1|||
130630477|NCT01176240|470265445|FG000|Study 306A|Withdrawal by Subject|0|||
130630478|NCT01176240|470265446|FG001|Study 306A|Withdrawal by Subject|1|||
130630479|NCT01176240|470265445|FG000|Study 306A|Stop due to diverse problems|1|||
130630480|NCT01176240|470265446|FG001|Study 306A|Stop due to diverse problems|0|||
130630481|NCT01176240|470265445|FG000|Study 306B|Lack of Efficacy|5|||
130630482|NCT01176240|470265446|FG001|Study 306B|Lack of Efficacy|3|||
130630483|NCT01176240|470265445|FG000|Study 306B|Adverse Event|10|||
130630484|NCT01176240|470265446|FG001|Study 306B|Adverse Event|5|||
130630485|NCT01176240|470265445|FG000|Study 306B|Protocol Violation|2|||
130630486|NCT01176240|470265446|FG001|Study 306B|Protocol Violation|3|||
130630487|NCT01176240|470265445|FG000|Study 306B|Withdrawal by Subject|4|||
130630488|NCT01176240|470265446|FG001|Study 306B|Withdrawal by Subject|1|||
130630489|NCT01176240|470265445|FG000|Study 306B|Physician Decision|2|||
130630490|NCT01176240|470265446|FG001|Study 306B|Physician Decision|1|||
130630491|NCT01176240|470265445|FG000|Study 306B|Supine Hypertension|1|||
130630492|NCT01176240|470265446|FG001|Study 306B|Supine Hypertension|2|||
130630493|NCT01176240|470265445|FG000|Study 306B|Lost to Follow-up|0|||
130630494|NCT01176240|470265446|FG001|Study 306B|Lost to Follow-up|1|||
130630495|NCT01176240|470265445|FG000|Study 306B|withdrew prior to dosing|2|||
130630496|NCT01176240|470265446|FG001|Study 306B|withdrew prior to dosing|1|||
130630497|NCT00807014|470265454|FG000|Overall Study|Participant Considered Disease Cured|13|||
130630498|NCT00807014|470265455|FG001|Overall Study|Participant Considered Disease Cured|2|||
130630499|NCT00807014|470265454|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
130630500|NCT00807014|470265455|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
130630501|NCT00807014|470265454|FG000|Overall Study|Protocol Violation|2|||
130630502|NCT00807014|470265455|FG001|Overall Study|Protocol Violation|8|||
130630503|NCT00807014|470265454|FG000|Overall Study|Adverse Event|0|||
130630504|NCT00807014|470265455|FG001|Overall Study|Adverse Event|2|||
130630505|NCT00807014|470265454|FG000|Overall Study|Lost to Follow-up|9|||
130630506|NCT00807014|470265455|FG001|Overall Study|Lost to Follow-up|7|||
130630507|NCT00807014|470265454|FG000|Overall Study|Recovery|1|||
130630508|NCT00807014|470265455|FG001|Overall Study|Recovery|0|||
130630509|NCT00807014|470265454|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
130630510|NCT00807014|470265455|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
130630511|NCT00651313|470265456|FG000|Overall Study|Adverse Event|0|||
130630512|NCT00651313|470265457|FG001|Overall Study|Adverse Event|1|||
130630513|NCT00651313|470265456|FG000|Overall Study|Withdrawal by Subject|3|||
130630514|NCT00651313|470265457|FG001|Overall Study|Withdrawal by Subject|1|||
130630515|NCT00651313|470265456|FG000|Overall Study|Lost to Follow-up|1|||
130630516|NCT00651313|470265457|FG001|Overall Study|Lost to Follow-up|1|||
130630517|NCT00651313|470265456|FG000|Overall Study|Adminstrative Discontinuation|2|||
130630518|NCT00651313|470265457|FG001|Overall Study|Adminstrative Discontinuation|3|||
130630519|NCT02650895|470265458|FG000|Overall Study|Withdrawal by Subject|0|||
130630520|NCT02650895|470265459|FG001|Overall Study|Withdrawal by Subject|1|||
130630521|NCT02650895|470265460|FG002|Overall Study|Withdrawal by Subject|0|||
130630522|NCT02650895|470265461|FG003|Overall Study|Withdrawal by Subject|0|||
130630523|NCT02650895|470265462|FG004|Overall Study|Withdrawal by Subject|0|||
130630524|NCT02650895|470265463|FG005|Overall Study|Withdrawal by Subject|0|||
130630525|NCT00981682|470265464|FG000|Overall Study|Adverse Event|48|||
130630526|NCT00981682|470265464|FG000|Overall Study|Withdrawal by Subject|52|||
130630527|NCT00981682|470265464|FG000|Overall Study|Lost to Follow-up|14|||
130630528|NCT00981682|470265464|FG000|Overall Study|Lack of Efficacy|13|||
130630529|NCT00981682|470265464|FG000|Overall Study|Protocol Violation|6|||
130630530|NCT00981682|470265464|FG000|Overall Study|administrative|9|||
130630531|NCT03906136|470267251|FG000|Overall Study|Adverse Event|1|||
130630532|NCT03906136|470267252|FG001|Overall Study|Adverse Event|0|||
130630533|NCT03906136|470267251|FG000|Overall Study|Lost to Follow-up|7|||
130630534|NCT03906136|470267252|FG001|Overall Study|Lost to Follow-up|4|||
130630535|NCT03906136|470267251|FG000|Overall Study|Physician Decision|1|||
130630536|NCT03906136|470267252|FG001|Overall Study|Physician Decision|0|||
130630537|NCT03906136|470267251|FG000|Overall Study|Withdrawal by Subject|3|||
130630538|NCT03906136|470267252|FG001|Overall Study|Withdrawal by Subject|7|||
130630539|NCT02371980|470267256|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
130630540|NCT02371980|470267257|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
130630541|NCT02371980|470267258|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
130630542|NCT02371980|470267259|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
130630543|NCT02371980|470267260|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
130630544|NCT02371980|470267256|FG000|Open-label Period|Significant Protocol Deviation|19|||
130630545|NCT02371980|470267257|FG001|Open-label Period|Significant Protocol Deviation|0|||
130630546|NCT02371980|470267258|FG002|Open-label Period|Significant Protocol Deviation|0|||
130630547|NCT02371980|470267259|FG003|Open-label Period|Significant Protocol Deviation|0|||
130630548|NCT02371980|470267260|FG004|Open-label Period|Significant Protocol Deviation|0|||
130630549|NCT02371980|470267256|FG000|Open-label Period|Noncompliance with Study Drug|10|||
130630550|NCT02371980|470267257|FG001|Open-label Period|Noncompliance with Study Drug|0|||
130630551|NCT02371980|470267258|FG002|Open-label Period|Noncompliance with Study Drug|0|||
130630552|NCT02371980|470267259|FG003|Open-label Period|Noncompliance with Study Drug|0|||
130630553|NCT02371980|470267260|FG004|Open-label Period|Noncompliance with Study Drug|0|||
130630554|NCT02371980|470267256|FG000|Open-label Period|Lost to Follow-up|55|||
130630555|NCT02371980|470267257|FG001|Open-label Period|Lost to Follow-up|0|||
130630556|NCT02371980|470267258|FG002|Open-label Period|Lost to Follow-up|0|||
130630557|NCT02371980|470267259|FG003|Open-label Period|Lost to Follow-up|0|||
130630558|NCT02371980|470267260|FG004|Open-label Period|Lost to Follow-up|0|||
130630559|NCT02371980|470267256|FG000|Open-label Period|Voluntary Withdrawal|91|||
130630560|NCT02371980|470267257|FG001|Open-label Period|Voluntary Withdrawal|0|||
130630561|NCT02371980|470267258|FG002|Open-label Period|Voluntary Withdrawal|0|||
130630562|NCT02371980|470267259|FG003|Open-label Period|Voluntary Withdrawal|0|||
130630563|NCT02371980|470267260|FG004|Open-label Period|Voluntary Withdrawal|0|||
130630564|NCT02371980|470267256|FG000|Open-label Period|Pregnancy|1|||
130630565|NCT02371980|470267257|FG001|Open-label Period|Pregnancy|0|||
130630566|NCT02371980|470267258|FG002|Open-label Period|Pregnancy|0|||
130630567|NCT02371980|470267259|FG003|Open-label Period|Pregnancy|0|||
130630568|NCT02371980|470267260|FG004|Open-label Period|Pregnancy|0|||
130630569|NCT02371980|470267256|FG000|Open-label Period|Lack of Efficacy|116|||
130630570|NCT02371980|470267257|FG001|Open-label Period|Lack of Efficacy|0|||
130630571|NCT02371980|470267258|FG002|Open-label Period|Lack of Efficacy|0|||
130630572|NCT02371980|470267259|FG003|Open-label Period|Lack of Efficacy|0|||
130630573|NCT02371980|470267260|FG004|Open-label Period|Lack of Efficacy|0|||
130630574|NCT02371980|470267256|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
130630575|NCT02371980|470267257|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
130630576|NCT02371980|470267258|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
130630577|NCT02371980|470267259|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
130630578|NCT02371980|470267260|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
130630579|NCT02371980|470267256|FG000|Open-label Period|Reason not Specified|9|||
130630580|NCT02371980|470267257|FG001|Open-label Period|Reason not Specified|0|||
130630581|NCT02371980|470267258|FG002|Open-label Period|Reason not Specified|0|||
130630582|NCT02371980|470267259|FG003|Open-label Period|Reason not Specified|0|||
130630583|NCT02371980|470267260|FG004|Open-label Period|Reason not Specified|0|||
130630584|NCT02371980|470267256|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
130630585|NCT02371980|470267257|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
130630586|NCT02371980|470267258|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
130630587|NCT02371980|470267259|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
130630588|NCT02371980|470267260|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
130630589|NCT02371980|470267256|FG000|Double-blind Period|Significant Protocol Deviation|0|||
130630590|NCT02371980|470267257|FG001|Double-blind Period|Significant Protocol Deviation|2|||
130630591|NCT02371980|470267258|FG002|Double-blind Period|Significant Protocol Deviation|7|||
130630592|NCT02371980|470267259|FG003|Double-blind Period|Significant Protocol Deviation|3|||
130630593|NCT02371980|470267260|FG004|Double-blind Period|Significant Protocol Deviation|3|||
130630594|NCT02371980|470267256|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
130630595|NCT02371980|470267257|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
130630596|NCT02371980|470267258|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
130630597|NCT02371980|470267259|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
130630598|NCT02371980|470267260|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
130630599|NCT02371980|470267256|FG000|Double-blind Period|Lost to Follow-up|0|||
130630600|NCT02371980|470267257|FG001|Double-blind Period|Lost to Follow-up|8|||
130630601|NCT02371980|470267258|FG002|Double-blind Period|Lost to Follow-up|8|||
130630602|NCT02371980|470267259|FG003|Double-blind Period|Lost to Follow-up|6|||
130630603|NCT02371980|470267260|FG004|Double-blind Period|Lost to Follow-up|5|||
130630604|NCT02371980|470267256|FG000|Double-blind Period|Voluntary Withdrawal|0|||
130630605|NCT02371980|470267257|FG001|Double-blind Period|Voluntary Withdrawal|12|||
130630606|NCT02371980|470267258|FG002|Double-blind Period|Voluntary Withdrawal|8|||
130630607|NCT02371980|470267259|FG003|Double-blind Period|Voluntary Withdrawal|9|||
130630608|NCT02371980|470267260|FG004|Double-blind Period|Voluntary Withdrawal|11|||
130630609|NCT02371980|470267256|FG000|Double-blind Period|Relapse|0|||
130630610|NCT02371980|470267257|FG001|Double-blind Period|Relapse|50|||
130630611|NCT02371980|470267258|FG002|Double-blind Period|Relapse|25|||
130630612|NCT02371980|470267259|FG003|Double-blind Period|Relapse|25|||
130630613|NCT02371980|470267260|FG004|Double-blind Period|Relapse|26|||
130630614|NCT02371980|470267256|FG000|Double-blind Period|Reason not Specified|0|||
130630615|NCT02371980|470267257|FG001|Double-blind Period|Reason not Specified|3|||
130630616|NCT02371980|470267258|FG002|Double-blind Period|Reason not Specified|3|||
130630617|NCT02371980|470267259|FG003|Double-blind Period|Reason not Specified|2|||
130630618|NCT02371980|470267260|FG004|Double-blind Period|Reason not Specified|1|||
130630619|NCT02371980|470267256|FG000|Double-blind Period|Missing|0|||
130630620|NCT02371980|470267257|FG001|Double-blind Period|Missing|1|||
130630621|NCT02371980|470267258|FG002|Double-blind Period|Missing|0|||
130630622|NCT02371980|470267259|FG003|Double-blind Period|Missing|0|||
130630623|NCT02371980|470267260|FG004|Double-blind Period|Missing|0|||
130630624|NCT01731990|470267261|FG000|Overall Study|Adverse Event|1|||
130630625|NCT01731990|470267262|FG001|Overall Study|Adverse Event|5|||
130630626|NCT01731990|470267261|FG000|Overall Study|Withdrawal by Subject|1|||
130630627|NCT01731990|470267262|FG001|Overall Study|Withdrawal by Subject|1|||
130630628|NCT01731990|470267261|FG000|Overall Study|Protocol deviation|1|||
130630629|NCT01731990|470267262|FG001|Overall Study|Protocol deviation|2|||
130630630|NCT01731990|470267261|FG000|Overall Study|Death|1|||
130630631|NCT01731990|470267262|FG001|Overall Study|Death|0|||
130630632|NCT01826448|470267264|FG000|Overall Study|Adverse Event|1|||
130630633|NCT01826448|470267265|FG001|Overall Study|Adverse Event|3|||
130630634|NCT01826448|470267264|FG000|Overall Study|Disease progression|2|||
130630635|NCT01826448|470267265|FG001|Overall Study|Disease progression|4|||
130630636|NCT01826448|470267264|FG000|Overall Study|Withdrawal by Subject|1|||
130630637|NCT01826448|470267265|FG001|Overall Study|Withdrawal by Subject|0|||
130630638|NCT01826448|470267264|FG000|Overall Study|Physician Decision|0|||
130630639|NCT01826448|470267265|FG001|Overall Study|Physician Decision|1|||
130630640|NCT01826448|470267264|FG000|Overall Study|2 active cancers|0|||
130630641|NCT01826448|470267265|FG001|Overall Study|2 active cancers|1|||
130630642|NCT00790218|470267267|FG000|Overall Study|Death|1|||
130630643|NCT00790218|470267268|FG001|Overall Study|Death|0|||
130630644|NCT00790218|470267269|FG002|Overall Study|Death|0|||
130630645|NCT03424044|470267272|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630646|NCT03424044|470267273|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630647|NCT03424044|470267274|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
130630648|NCT03424044|470267275|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630649|NCT03424044|470267276|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630650|NCT03424044|470267277|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630651|NCT03424044|470267278|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630652|NCT03424044|470267279|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630653|NCT03424044|470267280|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130630654|NCT03424044|470267272|FG000|First Intervention (76 Hours)|Adverse Event|0|||
130630655|NCT03424044|470267273|FG001|First Intervention (76 Hours)|Adverse Event|0|||
130630656|NCT03424044|470267274|FG002|First Intervention (76 Hours)|Adverse Event|0|||
130630657|NCT03424044|470267275|FG003|First Intervention (76 Hours)|Adverse Event|0|||
130630658|NCT03424044|470267276|FG004|First Intervention (76 Hours)|Adverse Event|1|||
130630659|NCT03424044|470267277|FG005|First Intervention (76 Hours)|Adverse Event|0|||
130630660|NCT03424044|470267278|FG006|First Intervention (76 Hours)|Adverse Event|0|||
130630661|NCT03424044|470267279|FG007|First Intervention (76 Hours)|Adverse Event|0|||
130630662|NCT03424044|470267280|FG008|First Intervention (76 Hours)|Adverse Event|0|||
130630663|NCT03424044|470267272|FG000|First Intervention (76 Hours)|device issues|0|||
130630664|NCT03424044|470267273|FG001|First Intervention (76 Hours)|device issues|0|||
130630665|NCT03424044|470267274|FG002|First Intervention (76 Hours)|device issues|0|||
130630666|NCT03424044|470267275|FG003|First Intervention (76 Hours)|device issues|0|||
130630667|NCT03424044|470267276|FG004|First Intervention (76 Hours)|device issues|0|||
130630668|NCT03424044|470267277|FG005|First Intervention (76 Hours)|device issues|0|||
130630669|NCT03424044|470267278|FG006|First Intervention (76 Hours)|device issues|1|||
130630670|NCT03424044|470267279|FG007|First Intervention (76 Hours)|device issues|1|||
130630671|NCT03424044|470267280|FG008|First Intervention (76 Hours)|device issues|1|||
130630672|NCT03424044|470267272|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
130630673|NCT03424044|470267273|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
130630674|NCT03424044|470267274|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
130630675|NCT03424044|470267275|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
130630676|NCT03424044|470267276|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
130630677|NCT03424044|470267277|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
130630678|NCT03424044|470267278|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
130630679|NCT03424044|470267279|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
130630680|NCT03424044|470267280|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
130630681|NCT03424044|470267272|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630682|NCT03424044|470267273|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630683|NCT03424044|470267274|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630684|NCT03424044|470267275|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
130630685|NCT03424044|470267276|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630686|NCT03424044|470267277|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630687|NCT03424044|470267278|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630688|NCT03424044|470267279|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630689|NCT03424044|470267280|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130630690|NCT02971007|470267281|FG000|Overall Study|Adverse Event|1|||
130630691|NCT02971007|470267282|FG001|Overall Study|Adverse Event|0|||
130630692|NCT02971007|470267283|FG002|Overall Study|Adverse Event|0|||
130630693|NCT02971007|470267281|FG000|Overall Study|Lost to Follow-up|0|||
130630694|NCT02971007|470267282|FG001|Overall Study|Lost to Follow-up|1|||
130630695|NCT02971007|470267283|FG002|Overall Study|Lost to Follow-up|1|||
130630696|NCT02971007|470267281|FG000|Overall Study|Withdrawal by Subject|0|||
130630697|NCT02971007|470267282|FG001|Overall Study|Withdrawal by Subject|1|||
130630698|NCT02971007|470267283|FG002|Overall Study|Withdrawal by Subject|0|||
130630699|NCT02971007|470267281|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
130630700|NCT02971007|470267282|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
130630701|NCT02971007|470267283|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
130630702|NCT02971007|470267281|FG000|Overall Study|Patient discontinued study drug|0|||
130630703|NCT02971007|470267282|FG001|Overall Study|Patient discontinued study drug|1|||
130630704|NCT02971007|470267283|FG002|Overall Study|Patient discontinued study drug|0|||
130630705|NCT00402285|470267284|FG000|Overall Study|insufficient RNA quality|7|||
130630706|NCT00402285|470267285|FG001|Overall Study|insufficient RNA quality|6|||
130630707|NCT00402285|470267286|FG002|Overall Study|insufficient RNA quality|2|||
130630708|NCT02009930|470267287|FG000|Overall Study|withdrawn|5|||
130630709|NCT02408484|470267298|FG000|Overall Study|Withdrawal by Subject|3|||
130630710|NCT02408484|470267298|FG000|Overall Study|Not treated during study period|1|||
130630711|NCT05516134|470267306|FG000|Overall Study|Lost to Follow-up|1|||
130630712|NCT05516134|470267307|FG001|Overall Study|Lost to Follow-up|0|||
130630713|NCT05516134|470267308|FG002|Overall Study|Lost to Follow-up|0|||
130630714|NCT03805971|470267309|FG000|Overall Study|Withdrawal by Subject|1|||
130630715|NCT03805971|470267309|FG000|Overall Study|Protocol Violation|2|||
130630716|NCT00254163|470267310|FG000|Overall Study|Adverse Event|29|||
130630717|NCT00254163|470267311|FG001|Overall Study|Adverse Event|26|||
130630718|NCT00254163|470267310|FG000|Overall Study|Patient request/withdrew consent|6|||
130630719|NCT00254163|470267311|FG001|Overall Study|Patient request/withdrew consent|4|||
130630720|NCT00254163|470267310|FG000|Overall Study|Investigator request|1|||
130630721|NCT00254163|470267311|FG001|Overall Study|Investigator request|3|||
130630722|NCT00254163|470267310|FG000|Overall Study|Failed entry|1|||
130630723|NCT00254163|470267311|FG001|Overall Study|Failed entry|3|||
130630724|NCT00254163|470267310|FG000|Overall Study|Progressive disease|0|||
130630725|NCT00254163|470267311|FG001|Overall Study|Progressive disease|1|||
130630726|NCT00254163|470267310|FG000|Overall Study|Death|0|||
130630727|NCT00254163|470267311|FG001|Overall Study|Death|1|||
130630728|NCT00254163|470267310|FG000|Overall Study|Other|8|||
130630729|NCT00254163|470267311|FG001|Overall Study|Other|8|||
130630730|NCT00517413|470267317|FG000|Overall Study|Adverse Event|7|||
130630731|NCT00517413|470267317|FG000|Overall Study|Death|13|||
130630732|NCT00517413|470267317|FG000|Overall Study|Protocol Violation|15|||
130630733|NCT00517413|470267317|FG000|Overall Study|Withdrawal by Subject|2|||
130630734|NCT00517413|470267317|FG000|Overall Study|Failure to return|1|||
130630735|NCT00517413|470267317|FG000|Overall Study|Other-Reasons|23|||
130630736|NCT01510028|470267318|FG000|Overall Study|Lack of Efficacy|1|||
130630737|NCT01510028|470267319|FG001|Overall Study|Lack of Efficacy|0|||
130630738|NCT01510028|470267320|FG002|Overall Study|Lack of Efficacy|0|||
130630739|NCT01510028|470267321|FG003|Overall Study|Lack of Efficacy|0|||
130630740|NCT01355497|470267322|FG000|Overall Study|Death|19|||
130630741|NCT01355497|470267323|FG001|Overall Study|Death|18|||
130630742|NCT01355497|470267322|FG000|Overall Study|Lost to Follow-up|3|||
130630743|NCT01355497|470267323|FG001|Overall Study|Lost to Follow-up|0|||
130630744|NCT01355497|470267322|FG000|Overall Study|Protocol Violation|0|||
130630745|NCT01355497|470267323|FG001|Overall Study|Protocol Violation|1|||
130630746|NCT01355497|470267322|FG000|Overall Study|other-not provided|9|||
130630747|NCT01355497|470267323|FG001|Overall Study|other-not provided|4|||
130630748|NCT01355497|470267322|FG000|Overall Study|Withdrawal by Subject|12|||
130630749|NCT01355497|470267323|FG001|Overall Study|Withdrawal by Subject|20|||
130630750|NCT01355497|470267322|FG000|Overall Study|noncompliance|1|||
130630751|NCT01355497|470267323|FG001|Overall Study|noncompliance|2|||
130630752|NCT01355497|470267322|FG000|Overall Study|progressive disease|11|||
130630753|NCT01355497|470267323|FG001|Overall Study|progressive disease|8|||
130630754|NCT01355497|470267322|FG000|Overall Study|Adverse Event|11|||
130630755|NCT01355497|470267323|FG001|Overall Study|Adverse Event|10|||
130630756|NCT01784211|470267331|FG000|Part A (Days 1-15)|Adverse Event|1|||
130630757|NCT01784211|470267332|FG001|Part A (Days 1-15)|Adverse Event|1|||
130630758|NCT01784211|470267333|FG002|Part A (Days 1-15)|Adverse Event|0|||
130630759|NCT01784211|470267334|FG003|Part A (Days 1-15)|Adverse Event|0|||
130630760|NCT01784211|470267335|FG004|Part A (Days 1-15)|Adverse Event|0|||
130630761|NCT01784211|470267336|FG005|Part A (Days 1-15)|Adverse Event|0|||
130630762|NCT01784211|470267331|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
130630763|NCT01784211|470267332|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
130630764|NCT01784211|470267333|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
130630765|NCT01784211|470267334|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
130630766|NCT01784211|470267335|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
130630767|NCT01784211|470267336|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
130630768|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
130630769|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
130630770|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
130630771|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
130630772|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
130630773|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
130630774|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
130630775|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
130630776|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
130630777|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
130630778|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
130630779|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
130630780|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
130630781|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
130630782|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
130630783|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
130630784|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
130630785|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
130630786|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
130630787|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
130630788|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
130630789|NCT01001572|470267337|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
130630790|NCT01001572|470267338|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
130630791|NCT01001572|470267339|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
130630792|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130630793|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
130630794|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
130630795|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130630796|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
130630797|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
130630798|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
130630799|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
130630800|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
130630801|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
130630802|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
130630803|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
130630804|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
130630805|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
130630806|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
130630807|NCT01001572|470267337|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130630808|NCT01001572|470267338|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130630809|NCT01001572|470267339|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130630810|NCT01094808|470267340|FG000|Overall Study|Withdrawal by Subject|1|||
130630811|NCT01094808|470267341|FG001|Overall Study|Withdrawal by Subject|1|||
130630812|NCT01094808|470267342|FG002|Overall Study|Withdrawal by Subject|0|||
130630813|NCT00369278|470267343|FG000|Overall Study|Adverse Event|14|||
130630814|NCT00369278|470267344|FG001|Overall Study|Adverse Event|11|||
130630815|NCT00369278|470267343|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130630816|NCT00369278|470267344|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130630817|NCT00369278|470267343|FG000|Overall Study|Protocol Violation|2|||
130630818|NCT00369278|470267344|FG001|Overall Study|Protocol Violation|1|||
130630819|NCT00369278|470267343|FG000|Overall Study|Withdrawal by Subject|2|||
130630820|NCT00369278|470267344|FG001|Overall Study|Withdrawal by Subject|2|||
130630821|NCT00369278|470267343|FG000|Overall Study|Lost to Follow-up|1|||
130630822|NCT00369278|470267344|FG001|Overall Study|Lost to Follow-up|0|||
130630823|NCT00369278|470267343|FG000|Overall Study|Graft loss|1|||
130630824|NCT00369278|470267344|FG001|Overall Study|Graft loss|2|||
130630825|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Death|3|||
130630826|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Death|0|||
130630827|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Death|0|||
130630828|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Death|0|||
130630829|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Death|0|||
130630830|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
130630831|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
130630832|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
130630833|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
130630834|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
130630835|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130630836|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
130630837|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
130630838|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130630839|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
130630840|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Other|0|||
130630841|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Other|0|||
130630842|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Other|1|||
130630843|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Other|0|||
130630844|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Other|0|||
130630845|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
130630846|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
130630847|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
130630848|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
130630849|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
130630850|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
130630851|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
130630852|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
130630853|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
130630854|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
130630855|NCT01224106|470267345|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130630856|NCT01224106|470267346|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130630857|NCT01224106|470267347|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130630858|NCT01224106|470267348|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130630859|NCT01224106|470267349|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130630860|NCT01224106|470267345|FG000|Open-Label Extension (OLE) Phase|Death|0|||
130630861|NCT01224106|470267346|FG001|Open-Label Extension (OLE) Phase|Death|0|||
130630862|NCT01224106|470267347|FG002|Open-Label Extension (OLE) Phase|Death|0|||
130630863|NCT01224106|470267348|FG003|Open-Label Extension (OLE) Phase|Death|1|||
130630864|NCT01224106|470267349|FG004|Open-Label Extension (OLE) Phase|Death|3|||
130630865|NCT01224106|470267345|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130630866|NCT01224106|470267346|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130630867|NCT01224106|470267347|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130630868|NCT01224106|470267348|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
130630869|NCT01224106|470267349|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
130630870|NCT01224106|470267345|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130630871|NCT01224106|470267346|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130630872|NCT01224106|470267347|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130630873|NCT01224106|470267348|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
130630874|NCT01224106|470267349|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
130630875|NCT01224106|470267345|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130630876|NCT01224106|470267346|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130630877|NCT01224106|470267347|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130630878|NCT01224106|470267348|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
130630879|NCT01224106|470267349|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
130630880|NCT01224106|470267345|FG000|Open-Label Extension (OLE) Phase|Other|0|||
130630881|NCT01224106|470267346|FG001|Open-Label Extension (OLE) Phase|Other|0|||
130630882|NCT01224106|470267347|FG002|Open-Label Extension (OLE) Phase|Other|0|||
130630883|NCT01224106|470267348|FG003|Open-Label Extension (OLE) Phase|Other|5|||
130630884|NCT01224106|470267349|FG004|Open-Label Extension (OLE) Phase|Other|3|||
130630885|NCT00446797|470267352|FG000|Overall Study|Lack of Efficacy|0|||
130630886|NCT00446797|470267353|FG001|Overall Study|Lack of Efficacy|2|||
130630887|NCT00446797|470267352|FG000|Overall Study|Lost to Follow-up|5|||
130630888|NCT00446797|470267353|FG001|Overall Study|Lost to Follow-up|3|||
130630889|NCT00446797|470267352|FG000|Overall Study|Withdrawal by Subject|2|||
130630890|NCT00446797|470267353|FG001|Overall Study|Withdrawal by Subject|2|||
130630891|NCT00446797|470267352|FG000|Overall Study|Protocol Violation|1|||
130630892|NCT00446797|470267353|FG001|Overall Study|Protocol Violation|3|||
130630893|NCT00446797|470267352|FG000|Overall Study|subject entered at another site|0|||
130630894|NCT00446797|470267353|FG001|Overall Study|subject entered at another site|1|||
130630895|NCT00446797|470267352|FG000|Overall Study|did not meet entrance criteria|0|||
130630896|NCT00446797|470267353|FG001|Overall Study|did not meet entrance criteria|1|||
130630897|NCT03551626|470267358|FG000|Overall Study|Adverse Event|88|||
130630898|NCT03551626|470267358|FG000|Overall Study|Disease relapse|18|||
130630899|NCT03551626|470267358|FG000|Overall Study|Withdrawal of informed consent|6|||
130630900|NCT03551626|470267358|FG000|Overall Study|Patient decision|5|||
130630901|NCT03551626|470267358|FG000|Overall Study|Physician Decision|4|||
130630902|NCT03551626|470267358|FG000|Overall Study|Lost to Follow-up|3|||
130630903|NCT03551626|470267358|FG000|Overall Study|Pregnancy|1|||
130630904|NCT03551626|470267358|FG000|Overall Study|Protocol deviation|1|||
130630905|NCT03551626|470267358|FG000|Overall Study|Technical problems|1|||
130630906|NCT02133001|470267359|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
130630907|NCT02133001|470267360|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
130630908|NCT02133001|470267359|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
130630909|NCT02133001|470267360|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
130630910|NCT02133001|470267359|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
130630911|NCT02133001|470267360|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
130630912|NCT02133001|470267359|FG000|Double Blind (Day 1-25)|Other|2|||
130630913|NCT02133001|470267360|FG001|Double Blind (Day 1-25)|Other|2|||
130630914|NCT02133001|470267359|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
130630915|NCT02133001|470267360|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
130630916|NCT02133001|470267359|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
130630917|NCT02133001|470267360|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
130630918|NCT02133001|470267359|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
130630919|NCT02133001|470267360|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
130630920|NCT02133001|470267359|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
130630921|NCT02133001|470267360|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
130630922|NCT04211961|470267361|FG000|Overall Study|Death|0|||
130630923|NCT04211961|470267362|FG001|Overall Study|Death|1|||
130630924|NCT04211961|470267361|FG000|Overall Study|Lost to Follow-up|0|||
130630925|NCT04211961|470267362|FG001|Overall Study|Lost to Follow-up|1|||
130630926|NCT04211961|470267361|FG000|Overall Study|Withdrawal by Subject|0|||
130630927|NCT04211961|470267362|FG001|Overall Study|Withdrawal by Subject|1|||
130630928|NCT02498392|470267369|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
130630929|NCT02498392|470267370|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
130630930|NCT02498392|470267369|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
130630931|NCT02498392|470267370|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
130630932|NCT02498392|470267369|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
130630933|NCT02498392|470267370|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
130630934|NCT02498392|470267369|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
130630935|NCT02498392|470267370|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
130630936|NCT02498392|470267369|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
130630937|NCT02498392|470267370|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
130630938|NCT02498392|470267369|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
130630939|NCT02498392|470267370|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
130630940|NCT05784129|470267371|FG000|Overall Study|Study terminated by sponsor|2|||
130630941|NCT05784129|470267372|FG001|Overall Study|Study terminated by sponsor|2|||
130630942|NCT01156363|470267373|FG000|Overall Study|Adverse Event|6|||
130630943|NCT01156363|470267373|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130630944|NCT01156363|470267373|FG000|Overall Study|Failure to Return|1|||
130630945|NCT01156363|470267373|FG000|Overall Study|Refused Treatment|4|||
130630946|NCT01156363|470267373|FG000|Overall Study|Other|6|||
130630947|NCT02873208|470267378|FG000|Overall Study|Withdrawal by Subject|36|||
130630948|NCT02873208|470267378|FG000|Overall Study|Lost to Follow-up|22|||
130630949|NCT02873208|470267378|FG000|Overall Study|Adverse Event|15|||
130630950|NCT02873208|470267378|FG000|Overall Study|Non-compliance with study drug|12|||
130630951|NCT02873208|470267378|FG000|Overall Study|Protocol Violation|8|||
130630952|NCT02873208|470267378|FG000|Overall Study|Pregnancy|2|||
130630953|NCT02873208|470267378|FG000|Overall Study|Incarceration|1|||
130630954|NCT02873208|470267378|FG000|Overall Study|Lack of Efficacy|1|||
130630955|NCT02873208|470267378|FG000|Overall Study|Physician Decision|1|||
130630956|NCT04080752|470267379|FG000|Overall Study|Adverse Event|2|||
130630957|NCT04080752|470267380|FG001|Overall Study|Adverse Event|3|||
130630958|NCT04080752|470267379|FG000|Overall Study|Lack of Efficacy|1|||
130630959|NCT04080752|470267380|FG001|Overall Study|Lack of Efficacy|0|||
130630960|NCT04080752|470267379|FG000|Overall Study|Lost to Follow-up|1|||
130630961|NCT04080752|470267380|FG001|Overall Study|Lost to Follow-up|0|||
130630962|NCT04080752|470267379|FG000|Overall Study|Pregnancy|0|||
130630963|NCT04080752|470267380|FG001|Overall Study|Pregnancy|1|||
130630964|NCT04080752|470267379|FG000|Overall Study|Withdrawal by Subject|7|||
130630965|NCT04080752|470267380|FG001|Overall Study|Withdrawal by Subject|0|||
130630966|NCT04080752|470267379|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130630967|NCT04080752|470267380|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130630968|NCT04080752|470267379|FG000|Overall Study|Other|2|||
130630969|NCT04080752|470267380|FG001|Overall Study|Other|1|||
130630970|NCT01192100|470267381|FG000|Overall Study|Withdrawal by Subject|0|||
130630971|NCT01192100|470267382|FG001|Overall Study|Withdrawal by Subject|0|||
130630972|NCT01192100|470267383|FG002|Overall Study|Withdrawal by Subject|0|||
130630973|NCT01192100|470267384|FG003|Overall Study|Withdrawal by Subject|0|||
130630974|NCT01192100|470267385|FG004|Overall Study|Withdrawal by Subject|1|||
130630975|NCT01192100|470267386|FG005|Overall Study|Withdrawal by Subject|0|||
130630976|NCT01192100|470267381|FG000|Overall Study|Protocol Violation|0|||
130630977|NCT01192100|470267382|FG001|Overall Study|Protocol Violation|0|||
130630978|NCT01192100|470267383|FG002|Overall Study|Protocol Violation|0|||
130630979|NCT01192100|470267384|FG003|Overall Study|Protocol Violation|1|||
130630980|NCT01192100|470267385|FG004|Overall Study|Protocol Violation|0|||
130630981|NCT01192100|470267386|FG005|Overall Study|Protocol Violation|0|||
130630982|NCT04685538|470267387|FG000|Overall Study|Adverse Event|0|||
130630983|NCT04685538|470267388|FG001|Overall Study|Adverse Event|1|||
130630984|NCT04685538|470267387|FG000|Overall Study|Lost to Follow-up|0|||
130630985|NCT04685538|470267388|FG001|Overall Study|Lost to Follow-up|2|||
130630986|NCT01421069|470267389|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
130630987|NCT01421069|470267389|FG000|Parent Study|Failed to return|3|||
130630988|NCT01421069|470267389|FG000|Parent Study|Withdrawal by Subject|1|||
130630989|NCT01421069|470267389|FG000|Parent Study|Lost to Follow-up|2|||
130630990|NCT01421069|470267389|FG000|Parent Study|Lack of Efficacy|1|||
130630991|NCT01421069|470267389|FG000|Overall Period for Extension Study|Other|2|||
130630992|NCT01421069|470267389|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
130630993|NCT01421069|470267389|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
130630994|NCT01421069|470267389|FG000|Overall Period for Extension Study|Pregnancy|1|||
130630995|NCT01421069|470267389|FG000|Overall Period for Extension Study|Adverse Event|1|||
130630996|NCT01421069|470267389|FG000|Overall Period for Extension Study|Protocol Violation|1|||
130630997|NCT01421069|470267389|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
130630998|NCT01421069|470267389|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
130630999|NCT01421069|470267389|FG000|Active Treatment Period|Other|1|||
130631000|NCT01421069|470267389|FG000|Active Treatment Period|No longer willing to participate in study|8|||
130631001|NCT01421069|470267389|FG000|Active Treatment Period|Insufficient clinical response|1|||
130631002|NCT01421069|470267389|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
130631003|NCT01421069|470267389|FG000|Active Treatment Period|Pregnancy|1|||
130631004|NCT01421069|470267389|FG000|Active Treatment Period|Adverse Event|1|||
130631005|NCT01421069|470267389|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
130631006|NCT01421069|470267389|FG000|Active Treatment Period|Enrolled in observational period|29|||
130631007|NCT01421069|470267389|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
130631008|NCT01421069|470267389|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
130631009|NCT01421069|470267389|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
130631010|NCT01421069|470267389|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
130631011|NCT01421069|470267389|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
130631012|NCT01421069|470267389|FG000|2b. Retreatment Period|Protocol Violation|1|||
130631013|NCT01421069|470267389|FG000|Observational Period|Other|1|||
130631014|NCT01421069|470267389|FG000|Observational Period|No longer willing to participate in study|4|||
130631015|NCT01421069|470267389|FG000|Observational Period|Lost to Follow-up|3|||
130631016|NCT01641081|470267390|FG000|Period 1|Sponsor request (potential unblinding)|0|||
130631017|NCT01641081|470267391|FG001|Period 1|Sponsor request (potential unblinding)|0|||
130631018|NCT01641081|470267392|FG002|Period 1|Sponsor request (potential unblinding)|0|||
130631019|NCT01641081|470267393|FG003|Period 1|Sponsor request (potential unblinding)|0|||
130631020|NCT01641081|470267394|FG004|Period 1|Sponsor request (potential unblinding)|0|||
130631021|NCT01641081|470267395|FG005|Period 1|Sponsor request (potential unblinding)|0|||
130631022|NCT01641081|470267396|FG006|Period 1|Sponsor request (potential unblinding)|1|||
130631023|NCT01641081|470267397|FG007|Period 1|Sponsor request (potential unblinding)|0|||
130631024|NCT01641081|470267398|FG008|Period 1|Sponsor request (potential unblinding)|0|||
130631025|NCT01641081|470267399|FG009|Period 1|Sponsor request (potential unblinding)|0|||
130631026|NCT01641081|470267390|FG000|Period 1|Protocol Violation|0|||
130631027|NCT01641081|470267391|FG001|Period 1|Protocol Violation|0|||
130631028|NCT01641081|470267392|FG002|Period 1|Protocol Violation|0|||
130631029|NCT01641081|470267393|FG003|Period 1|Protocol Violation|0|||
130631030|NCT01641081|470267394|FG004|Period 1|Protocol Violation|1|||
130631031|NCT01641081|470267395|FG005|Period 1|Protocol Violation|0|||
130631032|NCT01641081|470267396|FG006|Period 1|Protocol Violation|0|||
130631033|NCT01641081|470267397|FG007|Period 1|Protocol Violation|1|||
130631034|NCT01641081|470267398|FG008|Period 1|Protocol Violation|0|||
130631035|NCT01641081|470267399|FG009|Period 1|Protocol Violation|0|||
130631036|NCT01641081|470267390|FG000|Period 1|Adverse Event|1|||
130631037|NCT01641081|470267391|FG001|Period 1|Adverse Event|0|||
130631038|NCT01641081|470267392|FG002|Period 1|Adverse Event|0|||
130631039|NCT01641081|470267393|FG003|Period 1|Adverse Event|0|||
130631040|NCT01641081|470267394|FG004|Period 1|Adverse Event|0|||
130631041|NCT01641081|470267395|FG005|Period 1|Adverse Event|0|||
130631042|NCT01641081|470267396|FG006|Period 1|Adverse Event|0|||
130631043|NCT01641081|470267397|FG007|Period 1|Adverse Event|2|||
130631044|NCT01641081|470267398|FG008|Period 1|Adverse Event|0|||
130631045|NCT01641081|470267399|FG009|Period 1|Adverse Event|0|||
130631046|NCT01641081|470267390|FG000|Period 2|Adverse Event|0|||
130631047|NCT01641081|470267391|FG001|Period 2|Adverse Event|0|||
130631048|NCT01641081|470267392|FG002|Period 2|Adverse Event|0|||
130631049|NCT01641081|470267393|FG003|Period 2|Adverse Event|0|||
130631050|NCT01641081|470267394|FG004|Period 2|Adverse Event|0|||
130631051|NCT01641081|470267395|FG005|Period 2|Adverse Event|1|||
130631052|NCT01641081|470267396|FG006|Period 2|Adverse Event|0|||
130631053|NCT01641081|470267397|FG007|Period 2|Adverse Event|0|||
130631054|NCT01641081|470267398|FG008|Period 2|Adverse Event|0|||
130631055|NCT01641081|470267399|FG009|Period 2|Adverse Event|0|||
130631056|NCT01641081|470267390|FG000|Period 2|Withdrawal by Subject|0|||
130631057|NCT01641081|470267391|FG001|Period 2|Withdrawal by Subject|0|||
130631058|NCT01641081|470267392|FG002|Period 2|Withdrawal by Subject|0|||
130631059|NCT01641081|470267393|FG003|Period 2|Withdrawal by Subject|1|||
130631060|NCT01641081|470267394|FG004|Period 2|Withdrawal by Subject|0|||
130631061|NCT01641081|470267395|FG005|Period 2|Withdrawal by Subject|0|||
130631062|NCT01641081|470267396|FG006|Period 2|Withdrawal by Subject|2|||
130631063|NCT01641081|470267397|FG007|Period 2|Withdrawal by Subject|0|||
130631064|NCT01641081|470267398|FG008|Period 2|Withdrawal by Subject|0|||
130631065|NCT01641081|470267399|FG009|Period 2|Withdrawal by Subject|0|||
130631066|NCT01641081|470267390|FG000|Period 2|Protocol Violation|1|||
130631067|NCT01641081|470267391|FG001|Period 2|Protocol Violation|0|||
130631068|NCT01641081|470267392|FG002|Period 2|Protocol Violation|0|||
130631069|NCT01641081|470267393|FG003|Period 2|Protocol Violation|0|||
130631070|NCT01641081|470267394|FG004|Period 2|Protocol Violation|0|||
130631071|NCT01641081|470267395|FG005|Period 2|Protocol Violation|0|||
130631072|NCT01641081|470267396|FG006|Period 2|Protocol Violation|0|||
130631073|NCT01641081|470267397|FG007|Period 2|Protocol Violation|0|||
130631074|NCT01641081|470267398|FG008|Period 2|Protocol Violation|0|||
130631075|NCT01641081|470267399|FG009|Period 2|Protocol Violation|0|||
130631076|NCT01641081|470267390|FG000|Period 3|Adverse Event|0|||
130631077|NCT01641081|470267391|FG001|Period 3|Adverse Event|0|||
130631078|NCT01641081|470267392|FG002|Period 3|Adverse Event|1|||
130631079|NCT01641081|470267393|FG003|Period 3|Adverse Event|0|||
130631080|NCT01641081|470267394|FG004|Period 3|Adverse Event|0|||
130631081|NCT01641081|470267395|FG005|Period 3|Adverse Event|0|||
130631082|NCT01641081|470267396|FG006|Period 3|Adverse Event|0|||
130631083|NCT01641081|470267397|FG007|Period 3|Adverse Event|0|||
130631084|NCT01641081|470267398|FG008|Period 3|Adverse Event|0|||
130631085|NCT01641081|470267399|FG009|Period 3|Adverse Event|0|||
130631086|NCT01641081|470267390|FG000|Period 3|Withdrawal by Subject|0|||
130631087|NCT01641081|470267391|FG001|Period 3|Withdrawal by Subject|0|||
130631088|NCT01641081|470267392|FG002|Period 3|Withdrawal by Subject|0|||
130631089|NCT01641081|470267393|FG003|Period 3|Withdrawal by Subject|0|||
130631090|NCT01641081|470267394|FG004|Period 3|Withdrawal by Subject|0|||
130631091|NCT01641081|470267395|FG005|Period 3|Withdrawal by Subject|0|||
130631092|NCT01641081|470267396|FG006|Period 3|Withdrawal by Subject|0|||
130631093|NCT01641081|470267397|FG007|Period 3|Withdrawal by Subject|0|||
130631094|NCT01641081|470267398|FG008|Period 3|Withdrawal by Subject|1|||
130631095|NCT01641081|470267399|FG009|Period 3|Withdrawal by Subject|0|||
130631096|NCT01641081|470267390|FG000|Period 4|Adverse Event|0|||
130631097|NCT01641081|470267391|FG001|Period 4|Adverse Event|1|||
130631098|NCT01641081|470267392|FG002|Period 4|Adverse Event|0|||
130631099|NCT01641081|470267393|FG003|Period 4|Adverse Event|1|||
130631100|NCT01641081|470267394|FG004|Period 4|Adverse Event|0|||
130631101|NCT01641081|470267395|FG005|Period 4|Adverse Event|0|||
130631102|NCT01641081|470267396|FG006|Period 4|Adverse Event|0|||
130631103|NCT01641081|470267397|FG007|Period 4|Adverse Event|0|||
130631104|NCT01641081|470267398|FG008|Period 4|Adverse Event|0|||
130631105|NCT01641081|470267399|FG009|Period 4|Adverse Event|0|||
130631106|NCT01641081|470267390|FG000|Period 5|Adverse Event|0|||
130631107|NCT01641081|470267391|FG001|Period 5|Adverse Event|0|||
130631108|NCT01641081|470267392|FG002|Period 5|Adverse Event|2|||
130631109|NCT01641081|470267393|FG003|Period 5|Adverse Event|0|||
130631110|NCT01641081|470267394|FG004|Period 5|Adverse Event|0|||
130631111|NCT01641081|470267395|FG005|Period 5|Adverse Event|0|||
130631112|NCT01641081|470267396|FG006|Period 5|Adverse Event|0|||
130631113|NCT01641081|470267397|FG007|Period 5|Adverse Event|0|||
130631114|NCT01641081|470267398|FG008|Period 5|Adverse Event|0|||
130631115|NCT01641081|470267399|FG009|Period 5|Adverse Event|0|||
130631116|NCT01095666|470267400|FG000|Overall Study|Lack of Efficacy|0|||
130631117|NCT01095666|470267401|FG001|Overall Study|Lack of Efficacy|0|||
130631118|NCT01095666|470267402|FG002|Overall Study|Lack of Efficacy|1|||
130631119|NCT01095666|470267400|FG000|Overall Study|Adverse Event|2|||
130631120|NCT01095666|470267401|FG001|Overall Study|Adverse Event|1|||
130631121|NCT01095666|470267402|FG002|Overall Study|Adverse Event|3|||
130631122|NCT01095666|470267400|FG000|Overall Study|Lost to Follow-up|2|||
130631123|NCT01095666|470267401|FG001|Overall Study|Lost to Follow-up|2|||
130631124|NCT01095666|470267402|FG002|Overall Study|Lost to Follow-up|0|||
130631125|NCT01095666|470267400|FG000|Overall Study|Withdrawal by Subject|6|||
130631126|NCT01095666|470267401|FG001|Overall Study|Withdrawal by Subject|6|||
130631127|NCT01095666|470267402|FG002|Overall Study|Withdrawal by Subject|1|||
130631128|NCT01095666|470267400|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
130631129|NCT01095666|470267401|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
130631130|NCT01095666|470267402|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
130631131|NCT02917629|470267409|FG000|Overall Study|Withdrawal by Subject|0|||
130631132|NCT02917629|470267410|FG001|Overall Study|Withdrawal by Subject|1|||
130631133|NCT00718523|470267411|FG000|Overall Study|Withdrawal by Subject|5|||
130631134|NCT00718523|470267412|FG001|Overall Study|Withdrawal by Subject|7|||
130631135|NCT00718523|470267411|FG000|Overall Study|Death|13|||
130631136|NCT00718523|470267412|FG001|Overall Study|Death|17|||
130631137|NCT03136484|470267413|FG000|Overall Study|Withdrawal by Subject|19|||
130631138|NCT03136484|470267414|FG001|Overall Study|Withdrawal by Subject|14|||
130631139|NCT03136484|470267413|FG000|Overall Study|Lost to Follow-up|7|||
130631140|NCT03136484|470267414|FG001|Overall Study|Lost to Follow-up|8|||
130631141|NCT03136484|470267413|FG000|Overall Study|Death|1|||
130631142|NCT03136484|470267414|FG001|Overall Study|Death|0|||
130631143|NCT05041062|470267417|FG000|Overall Study|Adverse Event|2|||
130631144|NCT01802515|470267422|FG000|Overall Study|Withdrawal by Subject|3|||
130631145|NCT01802515|470267423|FG001|Overall Study|Withdrawal by Subject|0|||
130631146|NCT01802515|470267424|FG002|Overall Study|Withdrawal by Subject|0|||
130631147|NCT03038672|470269970|FG000|Initial Treatment|Unacceptable chemistry|0|||
130631148|NCT03038672|470269971|FG001|Initial Treatment|Unacceptable chemistry|1|||
130631149|NCT03038672|470269970|FG000|Initial Treatment|Progression prior to treatment|1|||
130631150|NCT03038672|470269971|FG001|Initial Treatment|Progression prior to treatment|0|||
130631151|NCT03038672|470269970|FG000|Initial Treatment|No treatment per protocol|1|||
130631152|NCT03038672|470269971|FG001|Initial Treatment|No treatment per protocol|0|||
130631153|NCT01696396|470269972|FG000|Overall Study|Withdrawal by Subject|19|||
130631154|NCT01696396|470269973|FG001|Overall Study|Withdrawal by Subject|5|||
130631155|NCT01696396|470269974|FG002|Overall Study|Withdrawal by Subject|19|||
130631156|NCT01696396|470269975|FG003|Overall Study|Withdrawal by Subject|11|||
130631157|NCT01696396|470269972|FG000|Overall Study|Decision by Sponsor|3|||
130631158|NCT01696396|470269973|FG001|Overall Study|Decision by Sponsor|1|||
130631159|NCT01696396|470269974|FG002|Overall Study|Decision by Sponsor|2|||
130631160|NCT01696396|470269975|FG003|Overall Study|Decision by Sponsor|2|||
130631161|NCT01696396|470269972|FG000|Overall Study|Lost to Follow-up|9|||
130631162|NCT01696396|470269973|FG001|Overall Study|Lost to Follow-up|1|||
130631163|NCT01696396|470269974|FG002|Overall Study|Lost to Follow-up|4|||
130631164|NCT01696396|470269975|FG003|Overall Study|Lost to Follow-up|1|||
130631165|NCT01696396|470269972|FG000|Overall Study|Death|0|||
130631166|NCT01696396|470269973|FG001|Overall Study|Death|0|||
130631167|NCT01696396|470269974|FG002|Overall Study|Death|1|||
130631168|NCT01696396|470269975|FG003|Overall Study|Death|0|||
130631169|NCT02712008|470269982|FG000|Baseline (Day 1) up to Week 12|Death|3|||
130631170|NCT02712008|470269983|FG001|Baseline (Day 1) up to Week 12|Death|0|||
130631171|NCT02712008|470269984|FG002|Baseline (Day 1) up to Week 12|Death|0|||
130631172|NCT02712008|470269985|FG003|Baseline (Day 1) up to Week 12|Death|0|||
130631173|NCT02712008|470269986|FG004|Baseline (Day 1) up to Week 12|Death|0|||
130631174|NCT02712008|470269987|FG005|Baseline (Day 1) up to Week 12|Death|0|||
130631175|NCT02712008|470269988|FG006|Baseline (Day 1) up to Week 12|Death|0|||
130631176|NCT02712008|470269989|FG007|Baseline (Day 1) up to Week 12|Death|0|||
130631177|NCT02712008|470269982|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631178|NCT02712008|470269983|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
130631179|NCT02712008|470269984|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
130631180|NCT02712008|470269985|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631181|NCT02712008|470269986|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631182|NCT02712008|470269987|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631183|NCT02712008|470269988|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631184|NCT02712008|470269989|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130631185|NCT02712008|470269982|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
130631186|NCT02712008|470269983|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631187|NCT02712008|470269984|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
130631188|NCT02712008|470269985|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631189|NCT02712008|470269986|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631190|NCT02712008|470269987|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631191|NCT02712008|470269988|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631192|NCT02712008|470269989|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130631193|NCT02712008|470269982|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631194|NCT02712008|470269983|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631195|NCT02712008|470269984|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
130631196|NCT02712008|470269985|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631197|NCT02712008|470269986|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631198|NCT02712008|470269987|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631199|NCT02712008|470269988|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631200|NCT02712008|470269989|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130631201|NCT02712008|470269982|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631202|NCT02712008|470269983|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
130631203|NCT02712008|470269984|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631204|NCT02712008|470269985|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631205|NCT02712008|470269986|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631206|NCT02712008|470269987|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631207|NCT02712008|470269988|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631208|NCT02712008|470269989|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130631209|NCT02712008|470269982|FG000|From Week 12 up to Week 36|Adverse Event|0|||
130631210|NCT02712008|470269983|FG001|From Week 12 up to Week 36|Adverse Event|0|||
130631211|NCT02712008|470269984|FG002|From Week 12 up to Week 36|Adverse Event|0|||
130631212|NCT02712008|470269985|FG003|From Week 12 up to Week 36|Adverse Event|0|||
130631213|NCT02712008|470269986|FG004|From Week 12 up to Week 36|Adverse Event|1|||
130631214|NCT02712008|470269987|FG005|From Week 12 up to Week 36|Adverse Event|0|||
130631215|NCT02712008|470269988|FG006|From Week 12 up to Week 36|Adverse Event|0|||
130631216|NCT02712008|470269989|FG007|From Week 12 up to Week 36|Adverse Event|2|||
130631217|NCT02712008|470269982|FG000|From Week 12 up to Week 36|Death|1|||
130631218|NCT02712008|470269983|FG001|From Week 12 up to Week 36|Death|0|||
130631219|NCT02712008|470269984|FG002|From Week 12 up to Week 36|Death|0|||
130631220|NCT02712008|470269985|FG003|From Week 12 up to Week 36|Death|0|||
130631221|NCT02712008|470269986|FG004|From Week 12 up to Week 36|Death|0|||
130631222|NCT02712008|470269987|FG005|From Week 12 up to Week 36|Death|0|||
130631223|NCT02712008|470269988|FG006|From Week 12 up to Week 36|Death|1|||
130631224|NCT02712008|470269989|FG007|From Week 12 up to Week 36|Death|0|||
130631225|NCT02712008|470269982|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631226|NCT02712008|470269983|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631227|NCT02712008|470269984|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631228|NCT02712008|470269985|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
130631229|NCT02712008|470269986|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631230|NCT02712008|470269987|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631231|NCT02712008|470269988|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
130631232|NCT02712008|470269989|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
130631233|NCT02712008|470269982|FG000|From Week 12 up to Week 36|Physician Decision|0|||
130631234|NCT02712008|470269983|FG001|From Week 12 up to Week 36|Physician Decision|0|||
130631235|NCT02712008|470269984|FG002|From Week 12 up to Week 36|Physician Decision|0|||
130631236|NCT02712008|470269985|FG003|From Week 12 up to Week 36|Physician Decision|1|||
130631237|NCT02712008|470269986|FG004|From Week 12 up to Week 36|Physician Decision|1|||
130631238|NCT02712008|470269987|FG005|From Week 12 up to Week 36|Physician Decision|0|||
130631239|NCT02712008|470269988|FG006|From Week 12 up to Week 36|Physician Decision|0|||
130631240|NCT02712008|470269989|FG007|From Week 12 up to Week 36|Physician Decision|0|||
130631241|NCT02712008|470269982|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631242|NCT02712008|470269983|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631243|NCT02712008|470269984|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631244|NCT02712008|470269985|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631245|NCT02712008|470269986|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631246|NCT02712008|470269987|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130631247|NCT02712008|470269988|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
130631248|NCT02712008|470269989|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
130631249|NCT01280812|470269990|FG000|Overall Study|Withdrawal by Subject|2|||
130631250|NCT01280812|470269991|FG001|Overall Study|Withdrawal by Subject|1|||
130631251|NCT01280812|470269992|FG002|Overall Study|Withdrawal by Subject|0|||
130631252|NCT01280812|470269990|FG000|Overall Study|Lost to Follow-up|1|||
130631253|NCT01280812|470269991|FG001|Overall Study|Lost to Follow-up|1|||
130631254|NCT01280812|470269992|FG002|Overall Study|Lost to Follow-up|1|||
130631255|NCT04483544|470269993|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
130631256|NCT04483544|470269993|FG000|Post-Treatment|Admitted to hospice|2|||
130631257|NCT04483544|470269993|FG000|Post-Treatment|Study terminated|3|||
130631258|NCT01131078|470270000|FG000|Overall Study|Adverse Event|22|||
130631259|NCT01131078|470270001|FG001|Overall Study|Adverse Event|12|||
130631260|NCT01131078|470270002|FG002|Overall Study|Adverse Event|17|||
130631261|NCT01131078|470270000|FG000|Overall Study|Progressive Disease|58|||
130631262|NCT01131078|470270001|FG001|Overall Study|Progressive Disease|77|||
130631263|NCT01131078|470270002|FG002|Overall Study|Progressive Disease|71|||
130631264|NCT01131078|470270000|FG000|Overall Study|Protocol Violation|1|||
130631265|NCT01131078|470270001|FG001|Overall Study|Protocol Violation|0|||
130631266|NCT01131078|470270002|FG002|Overall Study|Protocol Violation|0|||
130631267|NCT01131078|470270000|FG000|Overall Study|Lost to Follow-up|1|||
130631268|NCT01131078|470270001|FG001|Overall Study|Lost to Follow-up|1|||
130631269|NCT01131078|470270002|FG002|Overall Study|Lost to Follow-up|1|||
130631270|NCT01131078|470270000|FG000|Overall Study|Withdrawal by Subject|2|||
130631271|NCT01131078|470270001|FG001|Overall Study|Withdrawal by Subject|4|||
130631272|NCT01131078|470270002|FG002|Overall Study|Withdrawal by Subject|3|||
130631273|NCT01131078|470270000|FG000|Overall Study|Non-compliance|3|||
130631274|NCT01131078|470270001|FG001|Overall Study|Non-compliance|0|||
130631275|NCT01131078|470270002|FG002|Overall Study|Non-compliance|0|||
130631276|NCT01131078|470270000|FG000|Overall Study|Physician Decision|10|||
130631277|NCT01131078|470270001|FG001|Overall Study|Physician Decision|6|||
130631278|NCT01131078|470270002|FG002|Overall Study|Physician Decision|8|||
130631279|NCT01131078|470270000|FG000|Overall Study|Death|4|||
130631280|NCT01131078|470270001|FG001|Overall Study|Death|0|||
130631281|NCT01131078|470270002|FG002|Overall Study|Death|2|||
130631282|NCT01131078|470270000|FG000|Overall Study|Other|0|||
130631283|NCT01131078|470270001|FG001|Overall Study|Other|1|||
130631284|NCT01131078|470270002|FG002|Overall Study|Other|0|||
130631285|NCT00959894|470270004|FG000|Overall Study|Lost to Follow-up|10|||
130631286|NCT00959894|470270004|FG000|Overall Study|Adverse Event|3|||
130631287|NCT00959894|470270004|FG000|Overall Study|Withdrawal by Subject|1|||
130631288|NCT00959894|470270004|FG000|Overall Study|Need for contraindicated medication|1|||
130631289|NCT00959894|470270004|FG000|Overall Study|Subject moved out of town|1|||
130631290|NCT00653068|470270005|FG000|Overall Study|Death|9|||
130631291|NCT00653068|470270005|FG000|Overall Study|Lack of Efficacy|34|||
130631292|NCT00653068|470270005|FG000|Overall Study|Physician Decision|4|||
130631293|NCT00653068|470270005|FG000|Overall Study|Withdrawal by Subject|1|||
130631294|NCT00653068|470270005|FG000|Overall Study|Ineligible|2|||
130631295|NCT01305941|470270006|FG000|Overall Study|Adverse Event|6|||
130631296|NCT01305941|470270006|FG000|Overall Study|Clinical decline|2|||
130631297|NCT01305941|470270006|FG000|Overall Study|Withdrawal by Subject|1|||
130631298|NCT01305941|470270006|FG000|Overall Study|Death|1|||
130631299|NCT00608244|470270011|FG000|Overall Study|Adverse Event|1|||
130631300|NCT00608244|470270011|FG000|Overall Study|Low trough levels|1|||
130631301|NCT01685060|470270020|FG000|Overall Study|Rollover patients|16|||
130631302|NCT01685060|470270020|FG000|Overall Study|Adverse Event|12|||
130631303|NCT01685060|470270020|FG000|Overall Study|Progressive disease|69|||
130631304|NCT01685060|470270020|FG000|Overall Study|Physician Decision|14|||
130631305|NCT01685060|470270020|FG000|Overall Study|Subject/guardian decision|20|||
130631306|NCT01685060|470270020|FG000|Overall Study|Lost to Follow-up|1|||
130631307|NCT01685060|470270020|FG000|Overall Study|Death|8|||
130631308|NCT03597503|470270021|FG000|Overall Study|Withdrawal by Subject|0|||
130631309|NCT03597503|470270022|FG001|Overall Study|Withdrawal by Subject|2|||
130631310|NCT03597503|470270021|FG000|Overall Study|Lost to Follow-up|1|||
130631311|NCT03597503|470270022|FG001|Overall Study|Lost to Follow-up|2|||
130631312|NCT03597503|470270021|FG000|Overall Study|Protocol Violation|1|||
130631313|NCT03597503|470270022|FG001|Overall Study|Protocol Violation|0|||
130631314|NCT02944513|470270023|FG000|Overall Study|Withdrawal by Subject|4|||
130631315|NCT02944513|470270024|FG001|Overall Study|Withdrawal by Subject|1|||
130631316|NCT00937326|470270027|FG000|Overall Study|Adverse Event|0|||
130631317|NCT00937326|470270028|FG001|Overall Study|Adverse Event|3|||
130631318|NCT00937326|470270029|FG002|Overall Study|Adverse Event|1|||
130631319|NCT00937326|470270030|FG003|Overall Study|Adverse Event|1|||
130631320|NCT00937326|470270031|FG004|Overall Study|Adverse Event|2|||
130631321|NCT00937326|470270027|FG000|Overall Study|Death|0|||
130631322|NCT00937326|470270028|FG001|Overall Study|Death|0|||
130631323|NCT00937326|470270029|FG002|Overall Study|Death|1|||
130631324|NCT00937326|470270030|FG003|Overall Study|Death|0|||
130631325|NCT00937326|470270031|FG004|Overall Study|Death|0|||
130631326|NCT00937326|470270027|FG000|Overall Study|Withdrawal by Subject|3|||
130631327|NCT00937326|470270028|FG001|Overall Study|Withdrawal by Subject|4|||
130631328|NCT00937326|470270029|FG002|Overall Study|Withdrawal by Subject|1|||
130631329|NCT00937326|470270030|FG003|Overall Study|Withdrawal by Subject|4|||
130631330|NCT00937326|470270031|FG004|Overall Study|Withdrawal by Subject|3|||
130631331|NCT00937326|470270027|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130631332|NCT00937326|470270028|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130631333|NCT00937326|470270029|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
130631334|NCT00937326|470270030|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130631335|NCT00937326|470270031|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130631336|NCT02578992|470270032|FG000|Overall Study|equipment not available or malfunction|3|||
130631337|NCT02578992|470270033|FG001|Overall Study|equipment not available or malfunction|3|||
130631338|NCT00086385|470270036|FG000|Overall Study|Death|2|||
130631339|NCT00086385|470270037|FG001|Overall Study|Death|2|||
130631340|NCT00086385|470270038|FG002|Overall Study|Death|1|||
130631341|NCT00086385|470270039|FG003|Overall Study|Death|1|||
130631342|NCT00880100|470270042|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
130631343|NCT00880100|470270042|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
130631344|NCT00880100|470270042|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
130631345|NCT02443155|470270043|FG000|Overall Study|Adverse Event|3|||
130631346|NCT02443155|470270044|FG001|Overall Study|Adverse Event|4|||
130631347|NCT02443155|470270045|FG002|Overall Study|Adverse Event|1|||
130631348|NCT02443155|470270046|FG003|Overall Study|Adverse Event|2|||
130631349|NCT02443155|470270043|FG000|Overall Study|Unclassified|0|||
130631350|NCT02443155|470270044|FG001|Overall Study|Unclassified|0|||
130631351|NCT02443155|470270045|FG002|Overall Study|Unclassified|2|||
130631352|NCT02443155|470270046|FG003|Overall Study|Unclassified|1|||
130631353|NCT02443155|470270043|FG000|Overall Study|Withdrawal by Subject|4|||
130631354|NCT02443155|470270044|FG001|Overall Study|Withdrawal by Subject|7|||
130631355|NCT02443155|470270045|FG002|Overall Study|Withdrawal by Subject|3|||
130631356|NCT02443155|470270046|FG003|Overall Study|Withdrawal by Subject|9|||
130631357|NCT02443155|470270043|FG000|Overall Study|Pregnancy|3|||
130631358|NCT02443155|470270044|FG001|Overall Study|Pregnancy|1|||
130631359|NCT02443155|470270045|FG002|Overall Study|Pregnancy|1|||
130631360|NCT02443155|470270046|FG003|Overall Study|Pregnancy|2|||
130631361|NCT02443155|470270043|FG000|Overall Study|Lost to Follow-up|1|||
130631362|NCT02443155|470270044|FG001|Overall Study|Lost to Follow-up|2|||
130631363|NCT02443155|470270045|FG002|Overall Study|Lost to Follow-up|0|||
130631364|NCT02443155|470270046|FG003|Overall Study|Lost to Follow-up|1|||
130631365|NCT02443155|470270043|FG000|Overall Study|Protocol Violation|1|||
130631366|NCT02443155|470270044|FG001|Overall Study|Protocol Violation|0|||
130631367|NCT02443155|470270045|FG002|Overall Study|Protocol Violation|1|||
130631368|NCT02443155|470270046|FG003|Overall Study|Protocol Violation|1|||
130631369|NCT02443155|470270043|FG000|Overall Study|Death|0|||
130631370|NCT02443155|470270044|FG001|Overall Study|Death|0|||
130631371|NCT02443155|470270045|FG002|Overall Study|Death|1|||
130631372|NCT02443155|470270046|FG003|Overall Study|Death|0|||
130631373|NCT00405275|470270050|FG000|Overall Study|Death|1|||
130631374|NCT00405275|470270051|FG001|Overall Study|Death|0|||
130631375|NCT00405275|470270050|FG000|Overall Study|Lost to Follow-up|5|||
130631376|NCT00405275|470270051|FG001|Overall Study|Lost to Follow-up|1|||
130631377|NCT00405275|470270050|FG000|Overall Study|Withdrawal by Subject|7|||
130631378|NCT00405275|470270051|FG001|Overall Study|Withdrawal by Subject|9|||
130631379|NCT00405275|470270050|FG000|Overall Study|Unwilling to continue|10|||
130631380|NCT00405275|470270051|FG001|Overall Study|Unwilling to continue|9|||
130631381|NCT00731666|470270052|FG000|Overall Study|Adverse Event|2|||
130631382|NCT00731666|470270052|FG000|Overall Study|Lost to Follow-up|8|||
130631383|NCT00731666|470270052|FG000|Overall Study|Withdrawal by Subject|2|||
130631384|NCT02853123|470270053|FG000|Treatment Period 1|Adverse Event|0|||
130631385|NCT02853123|470270054|FG001|Treatment Period 1|Adverse Event|3|||
130631386|NCT02853123|470270053|FG000|Washout Period|Worsening of COPD|0|||
130631387|NCT02853123|470270054|FG001|Washout Period|Worsening of COPD|3|||
130631388|NCT02853123|470270053|FG000|Washout Period|Adverse Event|1|||
130631389|NCT02853123|470270054|FG001|Washout Period|Adverse Event|0|||
130631390|NCT00106249|470270055|FG000|Overall Study|Lost to Follow-up|3|||
130631391|NCT00106249|470270056|FG001|Overall Study|Lost to Follow-up|2|||
130631392|NCT01235338|470270059|FG000|Overall Study|Adverse Event|3|||
130631393|NCT01235338|470270060|FG001|Overall Study|Adverse Event|2|||
130631394|NCT01235338|470270059|FG000|Overall Study|Protocol Violation|1|||
130631395|NCT01235338|470270060|FG001|Overall Study|Protocol Violation|1|||
130631396|NCT01235338|470270059|FG000|Overall Study|Withdrawal by Subject|5|||
130631397|NCT01235338|470270060|FG001|Overall Study|Withdrawal by Subject|0|||
130631398|NCT01235338|470270059|FG000|Overall Study|Exclusion criteria violations|1|||
130631399|NCT01235338|470270060|FG001|Overall Study|Exclusion criteria violations|1|||
130631400|NCT01235338|470270059|FG000|Overall Study|Positive drug screen|0|||
130631401|NCT01235338|470270060|FG001|Overall Study|Positive drug screen|1|||
130631402|NCT01235338|470270059|FG000|Overall Study|Prohibited meds|1|||
130631403|NCT01235338|470270060|FG001|Overall Study|Prohibited meds|0|||
130631404|NCT02809118|470270061|FG000|Overall Study|Withdrawal by Subject|0|||
130631405|NCT02809118|470270062|FG001|Overall Study|Withdrawal by Subject|1|||
130631406|NCT02809118|470270063|FG002|Overall Study|Withdrawal by Subject|1|||
130631407|NCT05283499|470270067|FG000|Overall Study|Did not receive intervention|1|||
130631408|NCT05283499|470270068|FG001|Overall Study|Did not receive intervention|2|||
130631409|NCT01929018|470270073|FG000|Overall Study|Lost to Follow-up|1|||
130631410|NCT01929018|470270074|FG001|Overall Study|Lost to Follow-up|0|||
130631411|NCT01929018|470270073|FG000|Overall Study|Hospitalization|0|||
130631412|NCT01929018|470270074|FG001|Overall Study|Hospitalization|1|||
130631413|NCT04882072|470270075|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
130631414|NCT04882072|470270076|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
130631415|NCT04882072|470270075|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
130631416|NCT04882072|470270076|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
130631417|NCT04882072|470270075|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
130631418|NCT04882072|470270076|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
130631419|NCT03097133|470270077|FG000|Overall Study|Lost to Follow-up|3|||
130631420|NCT03097133|470270078|FG001|Overall Study|Lost to Follow-up|2|||
130631421|NCT03097133|470270077|FG000|Overall Study|Withdrawal by Subject|2|||
130631422|NCT03097133|470270078|FG001|Overall Study|Withdrawal by Subject|5|||
130631423|NCT03097133|470270077|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
130631424|NCT03097133|470270078|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
130631425|NCT03097133|470270077|FG000|Overall Study|Other|3|||
130631426|NCT03097133|470270078|FG001|Overall Study|Other|2|||
130631427|NCT03097133|470270077|FG000|Overall Study|Adverse Event|1|||
130631428|NCT03097133|470270078|FG001|Overall Study|Adverse Event|0|||
130631429|NCT00841672|470270084|FG000|Overall Study|Adverse Event|7|||
130631430|NCT00841672|470270085|FG001|Overall Study|Adverse Event|16|||
130631431|NCT00841672|470270084|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130631432|NCT00841672|470270085|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130631433|NCT00841672|470270084|FG000|Overall Study|Subject withdrew consent|2|||
130631434|NCT00841672|470270085|FG001|Overall Study|Subject withdrew consent|4|||
130631435|NCT00841672|470270084|FG000|Overall Study|Lost to Follow-up|1|||
130631436|NCT00841672|470270085|FG001|Overall Study|Lost to Follow-up|1|||
130631437|NCT00841672|470270084|FG000|Overall Study|Administrative problems|9|||
130631438|NCT00841672|470270085|FG001|Overall Study|Administrative problems|9|||
130631439|NCT00841672|470270084|FG000|Overall Study|Misrandomized|1|||
130631440|NCT00841672|470270085|FG001|Overall Study|Misrandomized|0|||
130631441|NCT00841672|470270084|FG000|Overall Study|Protocol Deviation|0|||
130631442|NCT00841672|470270085|FG001|Overall Study|Protocol Deviation|1|||
130631443|NCT00741260|470270090|FG000|Overall Study|Disease Progression|3|||
130631444|NCT00741260|470270091|FG001|Overall Study|Disease Progression|5|||
130631445|NCT00741260|470270092|FG002|Overall Study|Disease Progression|3|||
130631446|NCT00741260|470270093|FG003|Overall Study|Disease Progression|3|||
130631447|NCT00741260|470270094|FG004|Overall Study|Disease Progression|5|||
130631448|NCT00741260|470270095|FG005|Overall Study|Disease Progression|37|||
130631449|NCT00741260|470270096|FG006|Overall Study|Disease Progression|4|||
130631450|NCT00741260|470270090|FG000|Overall Study|Death|0|||
130631451|NCT00741260|470270091|FG001|Overall Study|Death|1|||
130631452|NCT00741260|470270092|FG002|Overall Study|Death|0|||
130631453|NCT00741260|470270093|FG003|Overall Study|Death|1|||
130631454|NCT00741260|470270094|FG004|Overall Study|Death|2|||
130631455|NCT00741260|470270095|FG005|Overall Study|Death|2|||
130631456|NCT00741260|470270096|FG006|Overall Study|Death|1|||
130631457|NCT00741260|470270090|FG000|Overall Study|Withdrawal by Subject|0|||
130631458|NCT00741260|470270091|FG001|Overall Study|Withdrawal by Subject|0|||
130631459|NCT00741260|470270092|FG002|Overall Study|Withdrawal by Subject|0|||
130631460|NCT00741260|470270093|FG003|Overall Study|Withdrawal by Subject|0|||
130631461|NCT00741260|470270094|FG004|Overall Study|Withdrawal by Subject|1|||
130631462|NCT00741260|470270095|FG005|Overall Study|Withdrawal by Subject|3|||
130631463|NCT00741260|470270096|FG006|Overall Study|Withdrawal by Subject|1|||
130631464|NCT00741260|470270090|FG000|Overall Study|Physician Decision|1|||
130631465|NCT00741260|470270091|FG001|Overall Study|Physician Decision|1|||
130631466|NCT00741260|470270092|FG002|Overall Study|Physician Decision|0|||
130631467|NCT00741260|470270093|FG003|Overall Study|Physician Decision|0|||
130631468|NCT00741260|470270094|FG004|Overall Study|Physician Decision|0|||
130631469|NCT00741260|470270095|FG005|Overall Study|Physician Decision|0|||
130631470|NCT00741260|470270096|FG006|Overall Study|Physician Decision|0|||
130631471|NCT00741260|470270090|FG000|Overall Study|Other|2|||
130631472|NCT00741260|470270091|FG001|Overall Study|Other|1|||
130631473|NCT00741260|470270092|FG002|Overall Study|Other|1|||
130631474|NCT00741260|470270093|FG003|Overall Study|Other|2|||
130631475|NCT00741260|470270094|FG004|Overall Study|Other|1|||
130631476|NCT00741260|470270095|FG005|Overall Study|Other|3|||
130631477|NCT00741260|470270096|FG006|Overall Study|Other|1|||
130631478|NCT02427100|470270097|FG000|Overall Study|Lost to Follow-up|0|||
130631479|NCT02427100|470270098|FG001|Overall Study|Lost to Follow-up|2|||
130631480|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
130631481|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
130631482|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
130631483|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
130631484|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
130631485|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
130631486|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
130631487|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
130631488|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631489|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631490|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631491|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631492|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631493|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130631494|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
130631495|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
130631496|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
130631497|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
130631498|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
130631499|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
130631500|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
130631501|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
130631502|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631503|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631504|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631505|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631506|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631507|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130631508|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
130631509|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631510|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631511|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631512|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631513|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631514|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130631515|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
130631516|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631517|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631518|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631519|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631520|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631521|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130631522|NCT02120352|470270099|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
130631523|NCT02120352|470270100|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
130631524|NCT02120352|470270101|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
130631525|NCT02120352|470270102|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
130631526|NCT02120352|470270103|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
130631527|NCT02120352|470270104|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
130631528|NCT02120352|470270105|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
130631529|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130631530|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
130631531|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
130631532|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
130631533|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130631534|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130631535|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130631536|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130631537|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
130631538|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130631539|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
130631540|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130631541|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130631542|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130631543|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130631544|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
130631545|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
130631546|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130631547|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130631548|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130631549|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130631550|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130631551|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130631552|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
130631553|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
130631554|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130631555|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130631556|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130631557|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631558|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631559|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631560|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
130631561|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631562|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631563|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130631564|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130631565|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
130631566|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
130631567|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
130631568|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130631569|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130631570|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130631571|NCT02120352|470270099|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631572|NCT02120352|470270100|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
130631573|NCT02120352|470270101|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631574|NCT02120352|470270102|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631575|NCT02120352|470270103|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631576|NCT02120352|470270104|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631577|NCT02120352|470270105|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130631578|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130631579|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
130631580|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
130631581|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130631582|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
130631583|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
130631584|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130631585|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631586|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631587|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631588|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631589|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
130631590|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631591|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130631592|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130631593|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
130631594|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
130631595|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130631596|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
130631597|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130631598|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130631599|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130631600|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
130631601|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
130631602|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130631603|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
130631604|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130631605|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130631606|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130631607|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
130631608|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
130631609|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130631610|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
130631611|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130631612|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130631613|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130631614|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
130631615|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
130631616|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130631617|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130631618|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130631619|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130631620|NCT02120352|470270099|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
130631621|NCT02120352|470270100|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
130631622|NCT02120352|470270101|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
130631623|NCT02120352|470270102|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
130631624|NCT02120352|470270103|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
130631625|NCT02120352|470270104|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
130631626|NCT02120352|470270105|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
130631627|NCT02120352|470270099|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631628|NCT02120352|470270100|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631629|NCT02120352|470270101|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631630|NCT02120352|470270102|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631631|NCT02120352|470270103|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631632|NCT02120352|470270104|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130631633|NCT02120352|470270105|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
130631634|NCT00842361|470270107|FG000|Overall Study|Protocol Violation|1|||
130631635|NCT00842361|470270108|FG001|Overall Study|Protocol Violation|0|||
130631636|NCT00842361|470270107|FG000|Overall Study|Unclassified|0|||
130631637|NCT00842361|470270108|FG001|Overall Study|Unclassified|2|||
130631638|NCT03094611|470270109|FG000|Overall Study|Lack of Efficacy|1|||
130631639|NCT03094611|470270109|FG000|Overall Study|Stem Cell Transplant|1|||
130631640|NCT02023112|470270119|FG000|Overall Study|Withdrawal by Subject|2|||
130631641|NCT02023112|470270120|FG001|Overall Study|Withdrawal by Subject|1|||
130631642|NCT00981747|470270124|FG000|Losartan|Withdrawal by Subject|1|||
130631643|NCT00981747|470270124|FG000|Losartan|Death|1|||
130631644|NCT00981747|470270124|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
130631645|NCT03034057|470270127|FG000|Overall Study|Withdrawal by Subject|10|||
130631646|NCT03034057|470270127|FG000|Overall Study|Protocol Violation|1|||
130631647|NCT03034057|470270127|FG000|Overall Study|Not defined|2|||
130631648|NCT03034057|470270127|FG000|Overall Study|Lost to Follow-up|19|||
130631649|NCT03034057|470270127|FG000|Overall Study|Adverse Event|22|||
130631650|NCT03034057|470270127|FG000|Overall Study|Medication error without associated AE|1|||
130631651|NCT01814826|470270128|FG000|Overall Study|Other|3|||
130631652|NCT01814826|470270129|FG001|Overall Study|Other|5|||
130631653|NCT01814826|470270130|FG002|Overall Study|Other|0|||
130631654|NCT01814826|470270128|FG000|Overall Study|Death|29|||
130631655|NCT01814826|470270129|FG001|Overall Study|Death|24|||
130631656|NCT01814826|470270130|FG002|Overall Study|Death|3|||
130631657|NCT03339401|470270131|FG000|Overall Study|Death|2|||
130631658|NCT03339401|470270132|FG001|Overall Study|Death|1|||
130631659|NCT03339401|470270131|FG000|Overall Study|Withdrawal by Subject|2|||
130631660|NCT03339401|470270132|FG001|Overall Study|Withdrawal by Subject|0|||
130631661|NCT03339401|470270131|FG000|Overall Study|Study terminated|4|||
130631662|NCT03339401|470270132|FG001|Overall Study|Study terminated|3|||
130631663|NCT03339401|470270131|FG000|Overall Study|Investigator Decision|1|||
130631664|NCT03339401|470270132|FG001|Overall Study|Investigator Decision|0|||
130631665|NCT03271307|470270133|FG000|Overall Study|Lost to Follow-up|0|||
130631666|NCT03271307|470270134|FG001|Overall Study|Lost to Follow-up|0|||
130631667|NCT03271307|470270135|FG002|Overall Study|Lost to Follow-up|0|||
130631668|NCT03271307|470270136|FG003|Overall Study|Lost to Follow-up|28|||
130631669|NCT03271307|470270137|FG004|Overall Study|Lost to Follow-up|91|||
130631670|NCT03365947|470270138|FG000|Overall Study|Lost to Follow-up|0|||
130631671|NCT03365947|470270139|FG001|Overall Study|Lost to Follow-up|0|||
130631672|NCT03365947|470270140|FG002|Overall Study|Lost to Follow-up|0|||
130631673|NCT03365947|470270141|FG003|Overall Study|Lost to Follow-up|0|||
130631674|NCT03365947|470270142|FG004|Overall Study|Lost to Follow-up|0|||
130631675|NCT03365947|470270143|FG005|Overall Study|Lost to Follow-up|1|||
130631676|NCT03365947|470270144|FG006|Overall Study|Lost to Follow-up|0|||
130631677|NCT03365947|470270145|FG007|Overall Study|Lost to Follow-up|0|||
130631678|NCT03365947|470270146|FG008|Overall Study|Lost to Follow-up|0|||
130631679|NCT03365947|470270147|FG009|Overall Study|Lost to Follow-up|0|||
130631680|NCT03365947|470270148|FG010|Overall Study|Lost to Follow-up|0|||
130631681|NCT03365947|470270149|FG011|Overall Study|Lost to Follow-up|0|||
130631682|NCT03365947|470270150|FG012|Overall Study|Lost to Follow-up|0|||
130631683|NCT03365947|470270151|FG013|Overall Study|Lost to Follow-up|0|||
130631684|NCT03365947|470270152|FG014|Overall Study|Lost to Follow-up|0|||
130631685|NCT03365947|470270153|FG015|Overall Study|Lost to Follow-up|0|||
130631686|NCT03365947|470270154|FG016|Overall Study|Lost to Follow-up|0|||
130631687|NCT03365947|470270155|FG017|Overall Study|Lost to Follow-up|0|||
130631688|NCT03365947|470270156|FG018|Overall Study|Lost to Follow-up|0|||
130631689|NCT01042938|470270157|FG000|Overall Study|Withdrawal by Subject|1|||
130631690|NCT01042938|470270158|FG001|Overall Study|Withdrawal by Subject|1|||
130631691|NCT01042938|470270157|FG000|Overall Study|Protocol Violation|1|||
130631692|NCT01042938|470270158|FG001|Overall Study|Protocol Violation|1|||
130631693|NCT01042938|470270157|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
130631694|NCT01042938|470270158|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
130631695|NCT03997760|470270161|FG000|Overall Study|Protocol Deviation|0|||
130631696|NCT03997760|470270162|FG001|Overall Study|Protocol Deviation|1|||
130631697|NCT03997760|470270163|FG002|Overall Study|Protocol Deviation|0|||
130631698|NCT03997760|470270164|FG003|Overall Study|Protocol Deviation|0|||
130631699|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
130631700|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
130631701|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
130631702|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
130631703|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
130631704|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130631705|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130631706|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130631707|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
130631708|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130631709|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130631710|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130631711|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130631712|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
130631713|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130631714|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130631715|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130631716|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130631717|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
130631718|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130631719|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130631720|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130631721|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130631722|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
130631723|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130631724|NCT00856986|470270165|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
130631725|NCT00856986|470270166|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
130631726|NCT00856986|470270167|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
130631727|NCT00856986|470270168|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
130631728|NCT00856986|470270169|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
130631729|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
130631730|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
130631731|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
130631732|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
130631733|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
130631734|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
130631735|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
130631736|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
130631737|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
130631738|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
130631739|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
130631740|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130631741|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
130631742|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130631743|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130631744|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
130631745|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
130631746|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
130631747|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
130631748|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
130631749|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
130631750|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
130631751|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130631752|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130631753|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130631754|NCT00856986|470270165|FG000|Main Period, Weeks 0-26|Unclassified|7|||
130631755|NCT00856986|470270166|FG001|Main Period, Weeks 0-26|Unclassified|6|||
130631756|NCT00856986|470270167|FG002|Main Period, Weeks 0-26|Unclassified|7|||
130631757|NCT00856986|470270168|FG003|Main Period, Weeks 0-26|Unclassified|0|||
130631758|NCT00856986|470270169|FG004|Main Period, Weeks 0-26|Unclassified|0|||
130631759|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
130631760|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
130631761|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
130631762|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
130631763|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
130631764|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
130631765|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
130631766|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
130631767|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
130631768|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
130631769|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
130631770|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130631771|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
130631772|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130631773|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130631774|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130631775|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
130631776|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
130631777|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130631778|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130631779|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
130631780|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
130631781|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
130631782|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
130631783|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
130631784|NCT00856986|470270165|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
130631785|NCT00856986|470270166|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
130631786|NCT00856986|470270167|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
130631787|NCT00856986|470270168|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
130631788|NCT00856986|470270169|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
130631789|NCT01199198|470271663|FG000|Overall Study|Adverse Event|3|||
130631790|NCT01199198|470271664|FG001|Overall Study|Adverse Event|0|||
130631791|NCT01199198|470271663|FG000|Overall Study|Lost to Follow-up|1|||
130631792|NCT01199198|470271664|FG001|Overall Study|Lost to Follow-up|5|||
130631793|NCT01199198|470271663|FG000|Overall Study|Withdrawal by Subject|1|||
130631794|NCT01199198|470271664|FG001|Overall Study|Withdrawal by Subject|2|||
130631795|NCT01199198|470271663|FG000|Overall Study|ICU Transfer|1|||
130631796|NCT01199198|470271664|FG001|Overall Study|ICU Transfer|2|||
130631797|NCT01199198|470271663|FG000|Overall Study|Hospice-care transfer|1|||
130631798|NCT01199198|470271664|FG001|Overall Study|Hospice-care transfer|2|||
130631799|NCT02892734|470271665|FG000|Treatment on Study|Progressive Disease|2|||
130631800|NCT02892734|470271665|FG000|Follow up for 2 Years|Death|2|||
130631801|NCT02892734|470271665|FG000|Follow up for 2 Years|Study closed early|1|||
130631802|NCT02043509|470271666|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
130631803|NCT02043509|470271667|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
130631804|NCT02043509|470271666|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
130631805|NCT02043509|470271667|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
130631806|NCT02043509|470271666|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
130631807|NCT02043509|470271667|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
130631808|NCT02043509|470271666|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
130631809|NCT02043509|470271667|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
130631810|NCT02000219|470271671|FG000|14-Week Study Period|Physician Decision|1|||
130631811|NCT02000219|470271671|FG000|14-Week Study Period|Adverse Event|1|||
130631812|NCT02000219|470271671|FG000|14-Week Study Period|Underwent transplantation|1|||
130631813|NCT02000219|470271671|FG000|Continuation Period|Withdrawal by Subject|1|||
130631814|NCT02000219|470271671|FG000|Continuation Period|Had liver transplant|2|||
130631815|NCT02000219|470271671|FG000|Continuation Period|Non-compliance with study drug|2|||
130631816|NCT00608894|470271675|FG000|Overall Study|Withdrawal by Subject|0|||
130631817|NCT00608894|470271676|FG001|Overall Study|Withdrawal by Subject|2|||
130631818|NCT01376388|470271684|FG000|Overall Study|Adverse Event|13|||
130631819|NCT01376388|470271684|FG000|Overall Study|Lack of Efficacy|2|||
130631820|NCT01376388|470271684|FG000|Overall Study|Withdrawal by Subject|3|||
130631821|NCT01495689|470271697|FG000|Overall Study|Death|0|||
130631822|NCT01495689|470271698|FG001|Overall Study|Death|1|||
130631823|NCT01495689|470271697|FG000|Overall Study|Withdrawal by Subject|3|||
130631824|NCT01495689|470271698|FG001|Overall Study|Withdrawal by Subject|0|||
130631825|NCT01495689|470271697|FG000|Overall Study|Lost to Follow-up|7|||
130631826|NCT01495689|470271698|FG001|Overall Study|Lost to Follow-up|6|||
130631827|NCT00524043|470271699|FG000|Overall Study|Lack of Efficacy|15|||
130631828|NCT00524043|470271700|FG001|Overall Study|Lack of Efficacy|13|||
130631829|NCT00524043|470271701|FG002|Overall Study|Lack of Efficacy|14|||
130631830|NCT00524043|470271699|FG000|Overall Study|Withdrawal by Subject|5|||
130631831|NCT00524043|470271700|FG001|Overall Study|Withdrawal by Subject|7|||
130631832|NCT00524043|470271701|FG002|Overall Study|Withdrawal by Subject|7|||
130631833|NCT00524043|470271699|FG000|Overall Study|Adverse Event|5|||
130631834|NCT00524043|470271700|FG001|Overall Study|Adverse Event|2|||
130631835|NCT00524043|470271701|FG002|Overall Study|Adverse Event|7|||
130631836|NCT00524043|470271699|FG000|Overall Study|Lost to Follow-up|3|||
130631837|NCT00524043|470271700|FG001|Overall Study|Lost to Follow-up|5|||
130631838|NCT00524043|470271701|FG002|Overall Study|Lost to Follow-up|3|||
130631839|NCT00524043|470271699|FG000|Overall Study|Various (eg, incarceration)|2|||
130631840|NCT00524043|470271700|FG001|Overall Study|Various (eg, incarceration)|1|||
130631841|NCT00524043|470271701|FG002|Overall Study|Various (eg, incarceration)|0|||
130631842|NCT01843205|470271706|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
130631843|NCT01843205|470271707|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
130631844|NCT00606177|470271708|FG000|Overall Study|Adverse Event|9|||
130631845|NCT00606177|470271709|FG001|Overall Study|Adverse Event|5|||
130631846|NCT00606177|470271708|FG000|Overall Study|Lack of Efficacy|3|||
130631847|NCT00606177|470271709|FG001|Overall Study|Lack of Efficacy|7|||
130631848|NCT00606177|470271708|FG000|Overall Study|Physician Decision|1|||
130631849|NCT00606177|470271709|FG001|Overall Study|Physician Decision|0|||
130631850|NCT00606177|470271708|FG000|Overall Study|Protocol Violation|1|||
130631851|NCT00606177|470271709|FG001|Overall Study|Protocol Violation|4|||
130631852|NCT00606177|470271708|FG000|Overall Study|Withdrawal by Subject|5|||
130631853|NCT00606177|470271709|FG001|Overall Study|Withdrawal by Subject|6|||
130631854|NCT00606177|470271708|FG000|Overall Study|Progression to depressive phase|6|||
130631855|NCT00606177|470271709|FG001|Overall Study|Progression to depressive phase|1|||
130631856|NCT00606177|470271708|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
130631857|NCT00606177|470271709|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
130631858|NCT00606177|470271708|FG000|Overall Study|Change of residence or other commitments|1|||
130631859|NCT00606177|470271709|FG001|Overall Study|Change of residence or other commitments|1|||
130631860|NCT00136357|470271710|FG000|Overall Study|Withdrawal by Subject|3|||
130631861|NCT00136357|470271711|FG001|Overall Study|Withdrawal by Subject|2|||
130631862|NCT00216086|470271714|FG000|Overall Study|Protocol Violation|1|||
130631863|NCT00216086|470271714|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
130631864|NCT00216086|470271714|FG000|Overall Study|Social Reasons|2|||
130631865|NCT02025530|470271718|FG000|Overall Study|No longer met elligibility criteria|5|||
130631866|NCT02025530|470271719|FG001|Overall Study|No longer met elligibility criteria|1|||
130631867|NCT01017549|470271722|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
130631868|NCT01017549|470271722|FG000|One-year Follow-up|Lost to Follow-up|2|||
130631869|NCT01017549|470271722|FG000|One-year Follow-up|Withdrawal by Subject|5|||
130631870|NCT01017549|470271722|FG000|5 Year Follow-up|Lost to Follow-up|9|||
130631871|NCT01017549|470271722|FG000|5 Year Follow-up|Mastectomy|3|||
130631872|NCT02728206|470271724|FG000|Overall Study|Death|1|||
130631873|NCT02773368|470271725|FG000|Overall Study|Lost to Follow-up|4|||
130631874|NCT02773368|470271726|FG001|Overall Study|Lost to Follow-up|1|||
130631875|NCT02773368|470271725|FG000|Overall Study|Withdrawal by Subject|5|||
130631876|NCT02773368|470271726|FG001|Overall Study|Withdrawal by Subject|1|||
130631877|NCT02773368|470271725|FG000|Overall Study|Unclassified|1|||
130631878|NCT02773368|470271726|FG001|Overall Study|Unclassified|1|||
130631879|NCT02773368|470271725|FG000|Overall Study|Missing|0|||
130631880|NCT02773368|470271726|FG001|Overall Study|Missing|1|||
130631881|NCT02635867|470271729|FG000|Overall Study|Lost to Follow-up|4|||
130631882|NCT02635867|470271730|FG001|Overall Study|Lost to Follow-up|3|||
130631883|NCT02635867|470271731|FG002|Overall Study|Lost to Follow-up|3|||
130631884|NCT02635867|470271732|FG003|Overall Study|Lost to Follow-up|4|||
130631885|NCT02635867|470271733|FG004|Overall Study|Lost to Follow-up|1|||
130631886|NCT01782885|470271734|FG000|Overall Study|Lost to Follow-up|4|||
130631887|NCT01782885|470271735|FG001|Overall Study|Lost to Follow-up|6|||
130631888|NCT00329784|470271736|FG000|Overall Study|Lost to Follow-up|0|||
130631889|NCT00329784|470271737|FG001|Overall Study|Lost to Follow-up|1|||
130631890|NCT00329784|470271738|FG002|Overall Study|Lost to Follow-up|0|||
130631891|NCT00329784|470271739|FG003|Overall Study|Lost to Follow-up|0|||
130631892|NCT00329784|470271736|FG000|Overall Study|Withdrawal by Subject|4|||
130631893|NCT00329784|470271737|FG001|Overall Study|Withdrawal by Subject|2|||
130631894|NCT00329784|470271738|FG002|Overall Study|Withdrawal by Subject|0|||
130631895|NCT00329784|470271739|FG003|Overall Study|Withdrawal by Subject|0|||
130631896|NCT00329784|470271736|FG000|Overall Study|Other|1|||
130631897|NCT00329784|470271737|FG001|Overall Study|Other|2|||
130631898|NCT00329784|470271738|FG002|Overall Study|Other|0|||
130631899|NCT00329784|470271739|FG003|Overall Study|Other|0|||
130631900|NCT00924729|470271743|FG000|Overall Study|insufficient volume for analysis|1|||
130631901|NCT00924729|470271744|FG001|Overall Study|insufficient volume for analysis|0|||
130631902|NCT00924729|470271743|FG000|Overall Study|Protocol Violation|1|||
130631903|NCT00924729|470271744|FG001|Overall Study|Protocol Violation|0|||
130631904|NCT01915095|470271745|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
130631905|NCT01915095|470271746|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
130631906|NCT01915095|470271747|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
130631907|NCT01915095|470271748|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
130631908|NCT01915095|470271749|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
130631909|NCT02067533|470271752|FG000|Overall Study|Lost to Follow-up|4|||
130631910|NCT02067533|470271753|FG001|Overall Study|Lost to Follow-up|2|||
130631911|NCT02999191|470271755|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
130631912|NCT02999191|470271756|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
130631913|NCT02999191|470271757|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
130631914|NCT02896192|470271759|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
130631915|NCT02896192|470271759|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
130631916|NCT02896192|470271759|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
130631917|NCT00479167|470271764|FG000|Overall Study|Withdrawal by Subject|1|||
130631918|NCT01997281|470271767|FG000|Overall Study|Withdrawal by Subject|1|||
130631919|NCT01997281|470271768|FG001|Overall Study|Withdrawal by Subject|0|||
130631920|NCT00560794|470271771|FG000|Overall Study|Adverse Event|2|||
130631921|NCT00560794|470271771|FG000|Overall Study|Patient was not Compliant|1|||
130631922|NCT00560794|470271771|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
130631923|NCT00560794|470271771|FG000|Overall Study|Hematological Relapse|1|||
130631924|NCT00560794|470271771|FG000|Overall Study|Received Bone Marrow Transplant|6|||
130631925|NCT04857892|470271772|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
130631926|NCT04857892|470271773|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130631927|NCT04857892|470271774|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130631928|NCT04857892|470271775|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130631929|NCT04857892|470271776|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130631930|NCT04857892|470271772|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
130631931|NCT04857892|470271773|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
130631932|NCT04857892|470271774|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
130631933|NCT04857892|470271775|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
130631934|NCT04857892|470271776|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
130631935|NCT04857892|470271772|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130631936|NCT04857892|470271773|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130631937|NCT04857892|470271774|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130631938|NCT04857892|470271775|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130631939|NCT04857892|470271776|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
130631940|NCT00368472|470271781|FG000|Overall Study|Adverse Event|22|||
130631941|NCT00368472|470271781|FG000|Overall Study|Medication non-compliance|4|||
130631942|NCT00368472|470271781|FG000|Overall Study|Protocol Violation|2|||
130631943|NCT00368472|470271781|FG000|Overall Study|Request of Investigator or Sponsor|3|||
130631944|NCT00368472|470271781|FG000|Overall Study|Withdrawal by Subject|40|||
130631945|NCT00368472|470271781|FG000|Overall Study|Diary non-compliance|1|||
130631946|NCT00368472|470271781|FG000|Overall Study|Other|32|||
130631947|NCT00368472|470271781|FG000|Overall Study|Missing Final Disposition Date|1|||
130631948|NCT02384993|470271782|FG000|Overall Study|Adverse Event|0|||
130631949|NCT02384993|470271783|FG001|Overall Study|Adverse Event|1|||
130631950|NCT00044213|470271784|FG000|Overall Study|Withdrawal by Subject|50|||
130631951|NCT00044213|470271785|FG001|Overall Study|Withdrawal by Subject|65|||
130631952|NCT00044213|470271786|FG002|Overall Study|Withdrawal by Subject|91|||
130631953|NCT00044213|470271787|FG003|Overall Study|Withdrawal by Subject|83|||
130631954|NCT00044213|470271784|FG000|Overall Study|Death|42|||
130631955|NCT00044213|470271785|FG001|Overall Study|Death|42|||
130631956|NCT00044213|470271786|FG002|Overall Study|Death|42|||
130631957|NCT00044213|470271787|FG003|Overall Study|Death|49|||
130631958|NCT00044213|470271784|FG000|Overall Study|Lost to Follow-up|8|||
130631959|NCT00044213|470271785|FG001|Overall Study|Lost to Follow-up|5|||
130631960|NCT00044213|470271786|FG002|Overall Study|Lost to Follow-up|5|||
130631961|NCT00044213|470271787|FG003|Overall Study|Lost to Follow-up|4|||
130631962|NCT00880607|470271788|FG000|Overall Study|Physician Decision|2|||
130631963|NCT00880607|470271789|FG001|Overall Study|Physician Decision|2|||
130631964|NCT00880607|470271788|FG000|Overall Study|Protocol Violation|2|||
130631965|NCT00880607|470271789|FG001|Overall Study|Protocol Violation|1|||
130631966|NCT00880607|470271788|FG000|Overall Study|surgery did not extend past L1 level|3|||
130631967|NCT00880607|470271789|FG001|Overall Study|surgery did not extend past L1 level|0|||
130631968|NCT02963766|470271791|FG000|Double-Blind Period|Adverse Event|1|||
130631969|NCT02963766|470271792|FG001|Double-Blind Period|Adverse Event|0|||
130631970|NCT02963766|470271793|FG002|Double-Blind Period|Adverse Event|1|||
130631971|NCT02963766|470271791|FG000|Double-Blind Period|Physician Decision|1|||
130631972|NCT02963766|470271792|FG001|Double-Blind Period|Physician Decision|0|||
130631973|NCT02963766|470271793|FG002|Double-Blind Period|Physician Decision|0|||
130631974|NCT02963766|470271791|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130631975|NCT02963766|470271792|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130631976|NCT02963766|470271793|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130631977|NCT02963766|470271791|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
130631978|NCT02963766|470271792|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
130631979|NCT02963766|470271793|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
130631980|NCT02963766|470271791|FG000|Double-Blind Period|Protocol Violation|1|||
130631981|NCT02963766|470271792|FG001|Double-Blind Period|Protocol Violation|0|||
130631982|NCT02963766|470271793|FG002|Double-Blind Period|Protocol Violation|0|||
130631983|NCT02963766|470271791|FG000|Double-Blind Period|Lost to Follow-up|0|||
130631984|NCT02963766|470271792|FG001|Double-Blind Period|Lost to Follow-up|1|||
130631985|NCT02963766|470271793|FG002|Double-Blind Period|Lost to Follow-up|0|||
130631986|NCT02963766|470271791|FG000|Open Label Extension (OLE)|Physician Decision|1|||
130631987|NCT02963766|470271792|FG001|Open Label Extension (OLE)|Physician Decision|2|||
130631988|NCT02963766|470271793|FG002|Open Label Extension (OLE)|Physician Decision|2|||
130631989|NCT02963766|470271791|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
130631990|NCT02963766|470271792|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
130631991|NCT02963766|470271793|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
130631992|NCT03938636|470273301|FG000|Overall Study|Protocol Violation|0|||
130631993|NCT03938636|470273302|FG001|Overall Study|Protocol Violation|1|||
130631994|NCT03938636|470273303|FG002|Overall Study|Protocol Violation|1|||
130631995|NCT03938636|470273301|FG000|Overall Study|Subject withdrew due to death in family|0|||
130631996|NCT03938636|470273302|FG001|Overall Study|Subject withdrew due to death in family|1|||
130631997|NCT03938636|470273303|FG002|Overall Study|Subject withdrew due to death in family|0|||
130631998|NCT03938636|470273301|FG000|Overall Study|Missed visit|0|||
130631999|NCT03938636|470273302|FG001|Overall Study|Missed visit|1|||
130632000|NCT03938636|470273303|FG002|Overall Study|Missed visit|0|||
130632001|NCT03938636|470273301|FG000|Overall Study|Adverse Event|0|||
130632002|NCT03938636|470273302|FG001|Overall Study|Adverse Event|0|||
130632003|NCT03938636|470273303|FG002|Overall Study|Adverse Event|1|||
130632004|NCT03938636|470273301|FG000|Overall Study|Lost to Follow-up|0|||
130632005|NCT03938636|470273302|FG001|Overall Study|Lost to Follow-up|0|||
130632006|NCT03938636|470273303|FG002|Overall Study|Lost to Follow-up|1|||
130632007|NCT01100658|470273304|FG000|Overall Study|Withdrawal by Subject|1|||
130632008|NCT00711412|470273305|FG000|Induction Treatment|Death|2|||
130632009|NCT00711412|470273305|FG000|Induction Treatment|Adverse Event|1|||
130632010|NCT00711412|470273305|FG000|Induction Treatment|Other|1|||
130632011|NCT00711412|470273305|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
130632012|NCT00711412|470273305|FG000|Evaluated for Combination Treatment|Death|1|||
130632013|NCT00711412|470273305|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
130632014|NCT00711412|470273305|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
130632015|NCT00711412|470273305|FG000|Combination Treatment|Progressive Disease|1|||
130632016|NCT00711412|470273305|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
130632017|NCT00711412|470273305|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
130632018|NCT00711412|470273305|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
130632019|NCT00711412|470273305|FG000|Evaluation for Response and Surgery|Death|1|||
130632020|NCT00711412|470273305|FG000|Survival Follow up Until Death|Other|12|||
130632021|NCT00420342|470273309|FG000|Overall Study|Lost to Follow-up|1|||
130632022|NCT00420342|470273310|FG001|Overall Study|Lost to Follow-up|0|||
130632023|NCT00420342|470273311|FG002|Overall Study|Lost to Follow-up|1|||
130632024|NCT00420342|470273309|FG000|Overall Study|Withdrawal by Subject|0|||
130632025|NCT00420342|470273310|FG001|Overall Study|Withdrawal by Subject|2|||
130632026|NCT00420342|470273311|FG002|Overall Study|Withdrawal by Subject|0|||
130632027|NCT04072575|470273312|FG000|Overall Study|Physician Decision|1|||
130632028|NCT04072575|470273312|FG000|Overall Study|Adverse Event|7|||
130632029|NCT04072575|470273312|FG000|Overall Study|Withdrawal by Subject|14|||
130632030|NCT04072575|470273312|FG000|Overall Study|Other|2|||
130632031|NCT02473289|470273313|FG000|Overall Study|Adverse Event|2|||
130632032|NCT02473289|470273314|FG001|Overall Study|Adverse Event|3|||
130632033|NCT02473289|470273313|FG000|Overall Study|Lost to Follow-up|1|||
130632034|NCT02473289|470273314|FG001|Overall Study|Lost to Follow-up|1|||
130632035|NCT02473289|470273313|FG000|Overall Study|Protocol Violation|0|||
130632036|NCT02473289|470273314|FG001|Overall Study|Protocol Violation|1|||
130632037|NCT02473289|470273313|FG000|Overall Study|Withdrawal of consent|6|||
130632038|NCT02473289|470273314|FG001|Overall Study|Withdrawal of consent|7|||
130632039|NCT02473289|470273313|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
130632040|NCT02473289|470273314|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
130632041|NCT02473289|470273313|FG000|Overall Study|Other|2|||
130632042|NCT02473289|470273314|FG001|Overall Study|Other|0|||
130632043|NCT02244619|470273315|FG000|Overall Study|Did not receive study intervention|8|||
130632044|NCT02244619|470273316|FG001|Overall Study|Did not receive study intervention|21|||
130632045|NCT03285490|470273318|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
130632046|NCT03285490|470273319|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
130632047|NCT03285490|470273318|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
130632048|NCT03285490|470273319|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
130632049|NCT03745989|470273320|FG000|Overall Study|Death|3|||
130632050|NCT03745989|470273321|FG001|Overall Study|Death|7|||
130632051|NCT03745989|470273322|FG002|Overall Study|Death|4|||
130632052|NCT03745989|470273320|FG000|Overall Study|Lost to Follow-up|0|||
130632053|NCT03745989|470273321|FG001|Overall Study|Lost to Follow-up|2|||
130632054|NCT03745989|470273322|FG002|Overall Study|Lost to Follow-up|0|||
130632055|NCT03745989|470273320|FG000|Overall Study|Sponsor Decision|0|||
130632056|NCT03745989|470273321|FG001|Overall Study|Sponsor Decision|2|||
130632057|NCT03745989|470273322|FG002|Overall Study|Sponsor Decision|8|||
130632058|NCT03745989|470273320|FG000|Overall Study|Withdrawal by Subject|0|||
130632059|NCT03745989|470273321|FG001|Overall Study|Withdrawal by Subject|1|||
130632060|NCT03745989|470273322|FG002|Overall Study|Withdrawal by Subject|3|||
130632061|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
130632062|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
130632063|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
130632064|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
130632065|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
130632066|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
130632067|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
130632068|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
130632069|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
130632070|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
130632071|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
130632072|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
130632073|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
130632074|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
130632075|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
130632076|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
130632077|NCT01291511|470273326|FG000|Cross-Titration and Stabilization Phase|Death|1|||
130632078|NCT01291511|470273327|FG001|Cross-Titration and Stabilization Phase|Death|0|||
130632079|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
130632080|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
130632081|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
130632082|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
130632083|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
130632084|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
130632085|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
130632086|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
130632087|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
130632088|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
130632089|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
130632090|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
130632091|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
130632092|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
130632093|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
130632094|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
130632095|NCT01291511|470273326|FG000|Double-blind Relapse Prevention Phase|Death|1|||
130632096|NCT01291511|470273327|FG001|Double-blind Relapse Prevention Phase|Death|0|||
130632097|NCT02565576|470273330|FG000|Overall Study|abnormal lab value|2|||
130632098|NCT02565576|470273331|FG001|Overall Study|abnormal lab value|0|||
130632099|NCT02565576|470273330|FG000|Overall Study|subject / guardian decision|1|||
130632100|NCT02565576|470273331|FG001|Overall Study|subject / guardian decision|3|||
130632101|NCT02565576|470273330|FG000|Overall Study|Lost to Follow-up|1|||
130632102|NCT02565576|470273331|FG001|Overall Study|Lost to Follow-up|0|||
130632103|NCT02565576|470273330|FG000|Overall Study|Death|0|||
130632104|NCT02565576|470273331|FG001|Overall Study|Death|2|||
130632105|NCT02565576|470273330|FG000|Overall Study|Adverse Event|1|||
130632106|NCT02565576|470273331|FG001|Overall Study|Adverse Event|0|||
130632107|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
130632108|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
130632109|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
130632110|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
130632111|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
130632112|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130632113|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130632114|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130632115|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
130632116|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130632117|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130632118|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130632119|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130632120|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
130632121|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130632122|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
130632123|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
130632124|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130632125|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130632126|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130632127|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130632128|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130632129|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130632130|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
130632131|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130632132|NCT02918318|470273332|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
130632133|NCT02918318|470273333|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
130632134|NCT02918318|470273334|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
130632135|NCT02918318|470273335|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
130632136|NCT02918318|470273336|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
130632137|NCT02918318|470273332|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130632138|NCT02918318|470273333|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130632139|NCT02918318|470273334|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130632140|NCT02918318|470273335|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
130632141|NCT02918318|470273336|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130632142|NCT02918318|470273332|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130632143|NCT02918318|470273333|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632144|NCT02918318|470273334|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130632145|NCT02918318|470273335|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130632146|NCT02918318|470273336|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632147|NCT02918318|470273332|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
130632148|NCT02918318|470273333|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130632149|NCT02918318|470273334|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130632150|NCT02918318|470273335|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
130632151|NCT02918318|470273336|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130632152|NCT02918318|470273332|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
130632153|NCT02918318|470273333|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
130632154|NCT02918318|470273334|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
130632155|NCT02918318|470273335|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
130632156|NCT02918318|470273336|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
130632157|NCT02918318|470273332|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130632158|NCT02918318|470273333|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130632159|NCT02918318|470273334|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130632160|NCT02918318|470273335|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130632161|NCT02918318|470273336|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
130632162|NCT02918318|470273332|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632163|NCT02918318|470273333|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632164|NCT02918318|470273334|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632165|NCT02918318|470273335|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130632166|NCT02918318|470273336|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
130632167|NCT03981744|470273337|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130632168|NCT03981744|470273338|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
130632169|NCT03981744|470273339|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130632170|NCT03981744|470273340|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130632171|NCT03981744|470273337|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130632172|NCT03981744|470273338|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130632173|NCT03981744|470273339|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
130632174|NCT03981744|470273340|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130632175|NCT03981744|470273337|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130632176|NCT03981744|470273338|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130632177|NCT03981744|470273339|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
130632178|NCT03981744|470273340|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130632179|NCT02782104|470273341|FG000|Overall Study|Other|215|||
130632180|NCT02782104|470273341|FG000|Overall Study|Induction Day 28 Non Responder|9|||
130632181|NCT02782104|470273341|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130632182|NCT02782104|470273341|FG000|Overall Study|Death|8|||
130632183|NCT02782104|470273341|FG000|Overall Study|Pregnancy|6|||
130632184|NCT02782104|470273341|FG000|Overall Study|Withdrawal by Subject|63|||
130632185|NCT02782104|470273341|FG000|Overall Study|Protocol Violation|7|||
130632186|NCT02782104|470273341|FG000|Overall Study|Lack of Efficacy|61|||
130632187|NCT02782104|470273341|FG000|Overall Study|Lost to Follow-up|23|||
130632188|NCT02782104|470273341|FG000|Overall Study|Adverse Event|74|||
130632189|NCT03185819|470273342|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130632190|NCT03185819|470273343|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130632191|NCT03185819|470273344|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130632192|NCT03185819|470273345|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
130632193|NCT03185819|470273342|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
130632194|NCT03185819|470273343|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
130632195|NCT03185819|470273344|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
130632196|NCT03185819|470273345|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
130632197|NCT03185819|470273342|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
130632198|NCT03185819|470273343|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130632199|NCT03185819|470273344|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130632200|NCT03185819|470273345|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130632201|NCT03185819|470273342|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
130632202|NCT03185819|470273343|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
130632203|NCT03185819|470273344|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
130632204|NCT03185819|470273345|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
130632205|NCT03185819|470273342|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130632206|NCT03185819|470273343|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130632207|NCT03185819|470273344|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130632208|NCT03185819|470273345|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
130632209|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
130632210|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
130632211|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
130632212|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
130632213|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
130632214|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
130632215|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
130632216|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
130632217|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130632218|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
130632219|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130632220|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130632221|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
130632222|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130632223|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130632224|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130632225|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
130632226|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
130632227|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
130632228|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
130632229|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
130632230|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
130632231|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
130632232|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
130632233|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
130632234|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
130632235|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
130632236|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
130632237|NCT03185819|470273342|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
130632238|NCT03185819|470273343|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130632239|NCT03185819|470273344|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130632240|NCT03185819|470273345|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130632241|NCT02438787|470273346|FG000|Overall Study|Adverse Event|1|||
130632242|NCT02438787|470273347|FG001|Overall Study|Adverse Event|0|||
130632243|NCT02438787|470273348|FG002|Overall Study|Adverse Event|2|||
130632244|NCT02438787|470273346|FG000|Overall Study|Lack of Efficacy|1|||
130632245|NCT02438787|470273347|FG001|Overall Study|Lack of Efficacy|2|||
130632246|NCT02438787|470273348|FG002|Overall Study|Lack of Efficacy|0|||
130632247|NCT02438787|470273346|FG000|Overall Study|Lost to Follow-up|0|||
130632248|NCT02438787|470273347|FG001|Overall Study|Lost to Follow-up|1|||
130632249|NCT02438787|470273348|FG002|Overall Study|Lost to Follow-up|0|||
130632250|NCT02438787|470273346|FG000|Overall Study|Protocol Violation|0|||
130632251|NCT02438787|470273347|FG001|Overall Study|Protocol Violation|0|||
130632252|NCT02438787|470273348|FG002|Overall Study|Protocol Violation|1|||
130632253|NCT02438787|470273346|FG000|Overall Study|Withdrawal by Subject|15|||
130632254|NCT02438787|470273347|FG001|Overall Study|Withdrawal by Subject|7|||
130632255|NCT02438787|470273348|FG002|Overall Study|Withdrawal by Subject|10|||
130632256|NCT02438787|470273346|FG000|Overall Study|Study discontinued by sponsor|64|||
130632257|NCT02438787|470273347|FG001|Overall Study|Study discontinued by sponsor|72|||
130632258|NCT02438787|470273348|FG002|Overall Study|Study discontinued by sponsor|69|||
130632259|NCT02438787|470273346|FG000|Overall Study|Other|0|||
130632260|NCT02438787|470273347|FG001|Overall Study|Other|1|||
130632261|NCT02438787|470273348|FG002|Overall Study|Other|0|||
130632262|NCT02438787|470273346|FG000|Overall Study|Site terminated by sponsor|0|||
130632263|NCT02438787|470273347|FG001|Overall Study|Site terminated by sponsor|0|||
130632264|NCT02438787|470273348|FG002|Overall Study|Site terminated by sponsor|1|||
130632265|NCT00732641|470273349|FG000|Overall Study|Relapse or Progressive Disease|65|||
130632266|NCT00732641|470273350|FG001|Overall Study|Relapse or Progressive Disease|101|||
130632267|NCT00732641|470273349|FG000|Overall Study|Serious Adverse Events|12|||
130632268|NCT00732641|470273350|FG001|Overall Study|Serious Adverse Events|3|||
130632269|NCT00732641|470273349|FG000|Overall Study|Physician Decision|6|||
130632270|NCT00732641|470273350|FG001|Overall Study|Physician Decision|0|||
130632271|NCT00732641|470273349|FG000|Overall Study|Withdrawal by Subject|4|||
130632272|NCT00732641|470273350|FG001|Overall Study|Withdrawal by Subject|2|||
130632273|NCT00732641|470273349|FG000|Overall Study|Unable to Complete|1|||
130632274|NCT00732641|470273350|FG001|Overall Study|Unable to Complete|1|||
130632275|NCT00732641|470273349|FG000|Overall Study|Other|18|||
130632276|NCT00732641|470273350|FG001|Overall Study|Other|5|||
130632277|NCT00732238|470273351|FG000|Overall Study|Bacteremia|4|||
130632278|NCT00732238|470273352|FG001|Overall Study|Bacteremia|1|||
130632279|NCT00732238|470273351|FG000|Overall Study|Asymptomatic bacteriuria|1|||
130632280|NCT00732238|470273352|FG001|Overall Study|Asymptomatic bacteriuria|0|||
130632281|NCT02910089|470273353|FG000|Overall Study|Lost insurance eligibility|22|||
130632282|NCT02910089|470273354|FG001|Overall Study|Lost insurance eligibility|16|||
130632283|NCT02939976|470273357|FG000|Overall Study|Lost to Follow-up|7|||
130632284|NCT02939976|470273358|FG001|Overall Study|Lost to Follow-up|1|||
130632285|NCT02939976|470273359|FG002|Overall Study|Lost to Follow-up|1|||
130632286|NCT02939976|470273360|FG003|Overall Study|Lost to Follow-up|2|||
130632287|NCT02939976|470273357|FG000|Overall Study|Withdrawal by Subject|4|||
130632288|NCT02939976|470273358|FG001|Overall Study|Withdrawal by Subject|0|||
130632289|NCT02939976|470273359|FG002|Overall Study|Withdrawal by Subject|2|||
130632290|NCT02939976|470273360|FG003|Overall Study|Withdrawal by Subject|4|||
130632291|NCT02939976|470273357|FG000|Overall Study|Due to early study closure|4|||
130632292|NCT02939976|470273358|FG001|Overall Study|Due to early study closure|3|||
130632293|NCT02939976|470273359|FG002|Overall Study|Due to early study closure|2|||
130632294|NCT02939976|470273360|FG003|Overall Study|Due to early study closure|3|||
130632295|NCT01872897|470273361|FG000|Overall Study|Withdrawal by Subject|1|||
130632296|NCT01872897|470273362|FG001|Overall Study|Withdrawal by Subject|0|||
130632297|NCT04159701|470273365|FG000|Period 1: Treatment Period|Pregnancy|1|||
130632298|NCT04159701|470273366|FG001|Period 1: Treatment Period|Pregnancy|0|||
130632299|NCT04159701|470273365|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
130632300|NCT04159701|470273366|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
130632301|NCT04159701|470273365|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
130632302|NCT04159701|470273366|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
130632303|NCT04159701|470273365|FG000|Washout Period|site terminated by sponsor|0|||
130632304|NCT04159701|470273366|FG001|Washout Period|site terminated by sponsor|1|||
130632305|NCT04159701|470273365|FG000|Washout Period|study terminated by sponsor|10|||
130632306|NCT04159701|470273366|FG001|Washout Period|study terminated by sponsor|3|||
130632307|NCT04159701|470273365|FG000|Washout Period|Withdrawal by Subject|1|||
130632308|NCT04159701|470273366|FG001|Washout Period|Withdrawal by Subject|0|||
130632309|NCT04159701|470273365|FG000|Washout Period|Inadvertent Enrollment|1|||
130632310|NCT04159701|470273366|FG001|Washout Period|Inadvertent Enrollment|0|||
130632311|NCT04159701|470273365|FG000|Washout Period|Miscellaneous|1|||
130632312|NCT04159701|470273366|FG001|Washout Period|Miscellaneous|0|||
130632313|NCT04159701|470273365|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
130632314|NCT04159701|470273366|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
130632315|NCT04159701|470273365|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
130632316|NCT04159701|470273366|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
130632317|NCT04159701|470273365|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
130632318|NCT04159701|470273366|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
130632319|NCT04159701|470273365|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
130632320|NCT04159701|470273366|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
130632321|NCT04159701|470273365|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
130632322|NCT04159701|470273366|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
130632323|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
130632324|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130632325|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130632326|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130632327|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
130632328|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130632329|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130632330|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130632331|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
130632332|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130632333|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130632334|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130632335|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
130632336|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130632337|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130632338|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130632339|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
130632340|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130632341|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130632342|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130632343|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
130632344|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130632345|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130632346|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130632347|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
130632348|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130632349|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130632350|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130632351|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
130632352|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130632353|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130632354|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130632355|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
130632356|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130632357|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130632358|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130632359|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
130632360|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130632361|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130632362|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130632363|NCT03605836|470273367|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
130632364|NCT03605836|470273368|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130632365|NCT03605836|470273369|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130632366|NCT03605836|470273370|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130632367|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
130632368|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
130632369|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
130632370|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
130632371|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
130632372|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
130632373|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
130632374|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
130632375|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
130632376|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
130632377|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
130632378|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
130632379|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
130632380|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
130632381|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
130632382|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
130632383|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
130632384|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
130632385|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
130632386|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
130632387|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130632388|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
130632389|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130632390|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130632391|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
130632392|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
130632393|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
130632394|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
130632395|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
130632396|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
130632397|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
130632398|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
130632399|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
130632400|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
130632401|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
130632402|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
130632403|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
130632404|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
130632405|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
130632406|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
130632407|NCT03605836|470273367|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
130632408|NCT03605836|470273368|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
130632409|NCT03605836|470273369|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
130632410|NCT03605836|470273370|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
130632411|NCT00865046|470273376|FG000|Overall Study|Lost to Follow-up|1|||
130632412|NCT00865046|470273377|FG001|Overall Study|Lost to Follow-up|4|||
130632413|NCT00865046|470273378|FG002|Overall Study|Lost to Follow-up|0|||
130632414|NCT00865046|470273376|FG000|Overall Study|Death|0|||
130632415|NCT00865046|470273377|FG001|Overall Study|Death|1|||
130632416|NCT00865046|470273378|FG002|Overall Study|Death|1|||
130632417|NCT00865046|470273376|FG000|Overall Study|Withdrawal by Subject|5|||
130632418|NCT00865046|470273377|FG001|Overall Study|Withdrawal by Subject|0|||
130632419|NCT00865046|470273378|FG002|Overall Study|Withdrawal by Subject|0|||
130632420|NCT03447821|470273380|FG000|Overall Study|Withdrawal by Subject|1|||
130632421|NCT03447821|470273381|FG001|Overall Study|Withdrawal by Subject|1|||
130632422|NCT03447821|470273382|FG002|Overall Study|Withdrawal by Subject|0|||
130632423|NCT03447821|470273380|FG000|Overall Study|Lost to Follow-up|0|||
130632424|NCT03447821|470273381|FG001|Overall Study|Lost to Follow-up|0|||
130632425|NCT03447821|470273382|FG002|Overall Study|Lost to Follow-up|1|||
130632426|NCT02977507|470273385|FG000|Overall Study|Protocol Deviation|1|||
130632427|NCT02977507|470273386|FG001|Overall Study|Protocol Deviation|0|||
130632428|NCT02977507|470273385|FG000|Overall Study|Lost to Follow-up|1|||
130632429|NCT02977507|470273386|FG001|Overall Study|Lost to Follow-up|0|||
130632430|NCT00633360|470273389|FG000|Overall Study|Lost to Follow-up|1|||
130632431|NCT00633360|470273390|FG001|Overall Study|Lost to Follow-up|1|||
130632432|NCT00633360|470273389|FG000|Overall Study|Adverse Event|3|||
130632433|NCT00633360|470273390|FG001|Overall Study|Adverse Event|1|||
130632434|NCT00633360|470273389|FG000|Overall Study|Protocol Violation|0|||
130632435|NCT00633360|470273390|FG001|Overall Study|Protocol Violation|1|||
130632436|NCT00481988|470273391|FG000|Overall Study|Withdrawal by Subject|1|||
130632437|NCT00481988|470273392|FG001|Overall Study|Withdrawal by Subject|1|||
130632438|NCT00610207|470273396|FG000|Overall Study|Lost to Follow-up|3|||
130632439|NCT02465489|470273399|FG000|Overall Study|Adverse Event|5|||
130632440|NCT00045630|470273402|FG000|Overall Study|Adverse Event|1|||
130632441|NCT00045630|470273402|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130632442|NCT00045630|470273402|FG000|Overall Study|Progression/relapse|1|||
130632443|NCT00045630|470273402|FG000|Overall Study|Death|1|||
130632444|NCT00045630|470273402|FG000|Overall Study|Ineligible|2|||
130632445|NCT00701103|470273403|FG000|Overall Study|Adverse Event|0|||
130632446|NCT00701103|470273404|FG001|Overall Study|Adverse Event|0|||
130632447|NCT00701103|470273405|FG002|Overall Study|Adverse Event|1|||
130632448|NCT00701103|470273406|FG003|Overall Study|Adverse Event|1|||
130632449|NCT00701103|470273407|FG004|Overall Study|Adverse Event|0|||
130632450|NCT00701103|470273408|FG005|Overall Study|Adverse Event|1|||
130632451|NCT00701103|470273409|FG006|Overall Study|Adverse Event|1|||
130632452|NCT00701103|470273410|FG007|Overall Study|Adverse Event|0|||
130632453|NCT00701103|470273411|FG008|Overall Study|Adverse Event|0|||
130632454|NCT00701103|470273412|FG009|Overall Study|Adverse Event|2|||
130632455|NCT00701103|470273413|FG010|Overall Study|Adverse Event|0|||
130632456|NCT00701103|470273403|FG000|Overall Study|Progressive Disease|5|||
130632457|NCT00701103|470273404|FG001|Overall Study|Progressive Disease|2|||
130632458|NCT00701103|470273405|FG002|Overall Study|Progressive Disease|6|||
130632459|NCT00701103|470273406|FG003|Overall Study|Progressive Disease|5|||
130632460|NCT00701103|470273407|FG004|Overall Study|Progressive Disease|6|||
130632461|NCT00701103|470273408|FG005|Overall Study|Progressive Disease|5|||
130632462|NCT00701103|470273409|FG006|Overall Study|Progressive Disease|7|||
130632463|NCT00701103|470273410|FG007|Overall Study|Progressive Disease|7|||
130632464|NCT00701103|470273411|FG008|Overall Study|Progressive Disease|8|||
130632465|NCT00701103|470273412|FG009|Overall Study|Progressive Disease|8|||
130632466|NCT00701103|470273413|FG010|Overall Study|Progressive Disease|11|||
130632467|NCT00701103|470273403|FG000|Overall Study|Withdrawal by Subject|0|||
130632468|NCT00701103|470273404|FG001|Overall Study|Withdrawal by Subject|1|||
130632469|NCT00701103|470273405|FG002|Overall Study|Withdrawal by Subject|1|||
130632470|NCT00701103|470273406|FG003|Overall Study|Withdrawal by Subject|0|||
130632471|NCT00701103|470273407|FG004|Overall Study|Withdrawal by Subject|0|||
130632472|NCT00701103|470273408|FG005|Overall Study|Withdrawal by Subject|0|||
130632473|NCT00701103|470273409|FG006|Overall Study|Withdrawal by Subject|0|||
130632474|NCT00701103|470273410|FG007|Overall Study|Withdrawal by Subject|0|||
130632475|NCT00701103|470273411|FG008|Overall Study|Withdrawal by Subject|0|||
130632476|NCT00701103|470273412|FG009|Overall Study|Withdrawal by Subject|0|||
130632477|NCT00701103|470273413|FG010|Overall Study|Withdrawal by Subject|0|||
130632478|NCT00701103|470273403|FG000|Overall Study|Other|0|||
130632479|NCT00701103|470273404|FG001|Overall Study|Other|0|||
130632480|NCT00701103|470273405|FG002|Overall Study|Other|0|||
130632481|NCT00701103|470273406|FG003|Overall Study|Other|0|||
130632482|NCT00701103|470273407|FG004|Overall Study|Other|0|||
130632483|NCT00701103|470273408|FG005|Overall Study|Other|0|||
130632484|NCT00701103|470273409|FG006|Overall Study|Other|0|||
130632485|NCT00701103|470273410|FG007|Overall Study|Other|0|||
130632486|NCT00701103|470273411|FG008|Overall Study|Other|1|||
130632487|NCT00701103|470273412|FG009|Overall Study|Other|1|||
130632488|NCT00701103|470273413|FG010|Overall Study|Other|0|||
130632489|NCT01929707|470273414|FG000|Intervention Period 1|Lost to Follow-up|0|||
130632490|NCT01929707|470273415|FG001|Intervention Period 1|Lost to Follow-up|0|||
130632491|NCT01929707|470273416|FG002|Intervention Period 1|Lost to Follow-up|0|||
130632492|NCT01929707|470273417|FG003|Intervention Period 1|Lost to Follow-up|1|||
130632493|NCT01929707|470273418|FG004|Intervention Period 1|Lost to Follow-up|0|||
130632494|NCT01929707|470273419|FG005|Intervention Period 1|Lost to Follow-up|0|||
130632495|NCT01929707|470273420|FG006|Intervention Period 1|Lost to Follow-up|0|||
130632496|NCT01929707|470273421|FG007|Intervention Period 1|Lost to Follow-up|0|||
130632497|NCT01929707|470273414|FG000|Intervention Period 1|Withdrawal by Subject|0|||
130632498|NCT01929707|470273415|FG001|Intervention Period 1|Withdrawal by Subject|0|||
130632499|NCT01929707|470273416|FG002|Intervention Period 1|Withdrawal by Subject|0|||
130632500|NCT01929707|470273417|FG003|Intervention Period 1|Withdrawal by Subject|2|||
130632501|NCT01929707|470273418|FG004|Intervention Period 1|Withdrawal by Subject|0|||
130632502|NCT01929707|470273419|FG005|Intervention Period 1|Withdrawal by Subject|0|||
130632503|NCT01929707|470273420|FG006|Intervention Period 1|Withdrawal by Subject|0|||
130632504|NCT01929707|470273421|FG007|Intervention Period 1|Withdrawal by Subject|0|||
130632505|NCT01929707|470273414|FG000|Intervention Period 2|Withdrawal by Subject|0|||
130632506|NCT01929707|470273415|FG001|Intervention Period 2|Withdrawal by Subject|0|||
130632507|NCT01929707|470273416|FG002|Intervention Period 2|Withdrawal by Subject|0|||
130632508|NCT01929707|470273417|FG003|Intervention Period 2|Withdrawal by Subject|0|||
130632509|NCT01929707|470273418|FG004|Intervention Period 2|Withdrawal by Subject|0|||
130632510|NCT01929707|470273419|FG005|Intervention Period 2|Withdrawal by Subject|2|||
130632511|NCT01929707|470273420|FG006|Intervention Period 2|Withdrawal by Subject|0|||
130632512|NCT01929707|470273421|FG007|Intervention Period 2|Withdrawal by Subject|0|||
130632513|NCT00179517|470273422|FG000|Overall Study|Withdrawal by Subject|2|||
130632514|NCT00179517|470273423|FG001|Overall Study|Withdrawal by Subject|1|||
130632515|NCT00437203|470273424|FG000|Overall Study|Death|0|||
130632516|NCT00437203|470273425|FG001|Overall Study|Death|0|||
130632517|NCT00437203|470273426|FG002|Overall Study|Death|1|||
130632518|NCT00437203|470273427|FG003|Overall Study|Death|0|||
130632519|NCT00437203|470273428|FG004|Overall Study|Death|0|||
130632520|NCT00437203|470273429|FG005|Overall Study|Death|0|||
130632521|NCT00437203|470273430|FG006|Overall Study|Death|0|||
130632522|NCT00437203|470273431|FG007|Overall Study|Death|1|||
130632523|NCT00437203|470273432|FG008|Overall Study|Death|0|||
130632524|NCT00437203|470273433|FG009|Overall Study|Death|1|||
130632525|NCT00437203|470273424|FG000|Overall Study|Adverse Event|1|||
130632526|NCT00437203|470273425|FG001|Overall Study|Adverse Event|1|||
130632527|NCT00437203|470273426|FG002|Overall Study|Adverse Event|0|||
130632528|NCT00437203|470273427|FG003|Overall Study|Adverse Event|0|||
130632529|NCT00437203|470273428|FG004|Overall Study|Adverse Event|0|||
130632530|NCT00437203|470273429|FG005|Overall Study|Adverse Event|0|||
130632531|NCT00437203|470273430|FG006|Overall Study|Adverse Event|0|||
130632532|NCT00437203|470273431|FG007|Overall Study|Adverse Event|1|||
130632533|NCT00437203|470273432|FG008|Overall Study|Adverse Event|0|||
130632534|NCT00437203|470273433|FG009|Overall Study|Adverse Event|1|||
130632535|NCT00437203|470273424|FG000|Overall Study|Study terminated by sponsor|0|||
130632536|NCT00437203|470273425|FG001|Overall Study|Study terminated by sponsor|0|||
130632537|NCT00437203|470273426|FG002|Overall Study|Study terminated by sponsor|0|||
130632538|NCT00437203|470273427|FG003|Overall Study|Study terminated by sponsor|0|||
130632539|NCT00437203|470273428|FG004|Overall Study|Study terminated by sponsor|0|||
130632540|NCT00437203|470273429|FG005|Overall Study|Study terminated by sponsor|0|||
130632541|NCT00437203|470273430|FG006|Overall Study|Study terminated by sponsor|0|||
130632542|NCT00437203|470273431|FG007|Overall Study|Study terminated by sponsor|0|||
130632543|NCT00437203|470273432|FG008|Overall Study|Study terminated by sponsor|1|||
130632544|NCT00437203|470273433|FG009|Overall Study|Study terminated by sponsor|0|||
130632545|NCT00437203|470273424|FG000|Overall Study|Objective progression or relapse|5|||
130632546|NCT00437203|470273425|FG001|Overall Study|Objective progression or relapse|6|||
130632547|NCT00437203|470273426|FG002|Overall Study|Objective progression or relapse|2|||
130632548|NCT00437203|470273427|FG003|Overall Study|Objective progression or relapse|3|||
130632549|NCT00437203|470273428|FG004|Overall Study|Objective progression or relapse|3|||
130632550|NCT00437203|470273429|FG005|Overall Study|Objective progression or relapse|3|||
130632551|NCT00437203|470273430|FG006|Overall Study|Objective progression or relapse|6|||
130632552|NCT00437203|470273431|FG007|Overall Study|Objective progression or relapse|1|||
130632553|NCT00437203|470273432|FG008|Overall Study|Objective progression or relapse|2|||
130632554|NCT00437203|470273433|FG009|Overall Study|Objective progression or relapse|2|||
130632555|NCT00437203|470273424|FG000|Overall Study|Other|0|||
130632556|NCT00437203|470273425|FG001|Overall Study|Other|1|||
130632557|NCT00437203|470273426|FG002|Overall Study|Other|0|||
130632558|NCT00437203|470273427|FG003|Overall Study|Other|0|||
130632559|NCT00437203|470273428|FG004|Overall Study|Other|0|||
130632560|NCT00437203|470273429|FG005|Overall Study|Other|0|||
130632561|NCT00437203|470273430|FG006|Overall Study|Other|1|||
130632562|NCT00437203|470273431|FG007|Overall Study|Other|0|||
130632563|NCT00437203|470273432|FG008|Overall Study|Other|0|||
130632564|NCT00437203|470273433|FG009|Overall Study|Other|0|||
130632565|NCT01449955|470273434|FG000|Overall Study|Withdrawal by Subject|1|||
130632566|NCT01449955|470273435|FG001|Overall Study|Withdrawal by Subject|2|||
130632567|NCT00431496|470273442|FG000|Overall Study|Adverse Event|3|||
130632568|NCT00431496|470273442|FG000|Overall Study|Lost to Follow-up|1|||
130632569|NCT00431496|470273442|FG000|Overall Study|Withdrawal by Subject|2|||
130632570|NCT00431496|470273442|FG000|Overall Study|Protocol-specified criteria|5|||
130632571|NCT04018612|470273443|FG000|Overall Study|Withdrawal by Subject|1|||
130632572|NCT04018612|470273444|FG001|Overall Study|Withdrawal by Subject|0|||
130632573|NCT04018612|470273445|FG002|Overall Study|Withdrawal by Subject|1|||
130632574|NCT00361218|470273446|FG000|Overall Study|Lost to Follow-up|11|||
130632575|NCT00361218|470273446|FG000|Overall Study|Personal Reasons|7|||
130632576|NCT00361218|470273446|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
130632577|NCT02671760|470273447|FG000|Overall Study|Lost to Follow-up|0|||
130632578|NCT02671760|470273448|FG001|Overall Study|Lost to Follow-up|1|||
130632579|NCT02671760|470273449|FG002|Overall Study|Lost to Follow-up|0|||
130632580|NCT02566109|470273450|FG000|Overall Study|Withdrawal by Subject|1|||
130632581|NCT01906476|470273451|FG000|Overall Study|Lost to Follow-up|17|||
130632582|NCT01906476|470273452|FG001|Overall Study|Lost to Follow-up|16|||
130632583|NCT01993667|470273453|FG000|Overall Study|Insufficient data to analyze|16|||
130632584|NCT01993667|470273454|FG001|Overall Study|Insufficient data to analyze|16|||
130632585|NCT01993667|470273453|FG000|Overall Study|Insufficient altitude reached|3|||
130632586|NCT01993667|470273454|FG001|Overall Study|Insufficient altitude reached|1|||
130632587|NCT01993667|470273453|FG000|Overall Study|Lost to Follow-up|2|||
130632588|NCT01993667|470273454|FG001|Overall Study|Lost to Follow-up|2|||
130632589|NCT01931150|470273455|FG000|Overall Study|Withdrawal by Subject|1|||
130632590|NCT01931150|470273456|FG001|Overall Study|Withdrawal by Subject|2|||
130632591|NCT01570309|470273459|FG000|Overall Study|Withdrawal by Subject|3|||
130632592|NCT01570309|470273460|FG001|Overall Study|Withdrawal by Subject|3|||
130632593|NCT01390038|470273461|FG000|Overall Study|Death|1|||
130632594|NCT01390038|470273461|FG000|Overall Study|Lost to Follow-up|1|||
130632595|NCT01390038|470273461|FG000|Overall Study|Withdrawal by Subject|4|||
130632596|NCT01390038|470273461|FG000|Overall Study|Simpliciti System Removal|2|||
130632597|NCT03619837|470273466|FG000|Screening|received organs from HCV-negative donors|47|||
130632598|NCT03619837|470273466|FG000|Screening|died on the wait-list|2|||
130632599|NCT03619837|470273466|FG000|Screening|remained on the wait list|40|||
130632600|NCT03619837|470273466|FG000|Screening|didn't meet eligibility criteria|3|||
130632601|NCT03619837|470273466|FG000|Screening|withdrew consent|2|||
130632602|NCT03619837|470273466|FG000|Screening|never listed for HCV-viremic donor|1|||
130632603|NCT03619837|470273466|FG000|Screening|developed exclusion criteria|2|||
130632604|NCT03619837|470273466|FG000|Screening|excluded by the investigator due to non-compliance|1|||
130632605|NCT04095793|470273467|FG000|Overall Study|Adverse Event|3|||
130632606|NCT04095793|470273467|FG000|Overall Study|Study Terminated by Sponsor|103|||
130632607|NCT04095793|470273467|FG000|Overall Study|Withdrawal by Subject|4|||
130632608|NCT01927068|470273469|FG000|Overall Study|Death|37|||
130632609|NCT01927068|470273470|FG001|Overall Study|Death|3|||
130632610|NCT01927068|470273469|FG000|Overall Study|Withdrawal by Subject|50|||
130632611|NCT01927068|470273470|FG001|Overall Study|Withdrawal by Subject|3|||
130632612|NCT01927068|470273469|FG000|Overall Study|Lost to Follow-up|10|||
130632613|NCT01927068|470273470|FG001|Overall Study|Lost to Follow-up|2|||
130632614|NCT01927068|470273469|FG000|Overall Study|Physician Decision|9|||
130632615|NCT01927068|470273470|FG001|Overall Study|Physician Decision|0|||
130632616|NCT01927068|470273469|FG000|Overall Study|Missed last follow-up visit|2|||
130632617|NCT01927068|470273470|FG001|Overall Study|Missed last follow-up visit|0|||
130632618|NCT00499460|470273474|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
130632619|NCT00499460|470273475|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
130632620|NCT00499460|470273474|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
130632621|NCT00499460|470273475|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
130632622|NCT00499460|470273474|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
130632623|NCT00499460|470273475|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
130632624|NCT02290340|470273477|FG000|Overall Study|Lost to Follow-up|0|||
130632625|NCT02290340|470273478|FG001|Overall Study|Lost to Follow-up|0|||
130632626|NCT02290340|470273479|FG002|Overall Study|Lost to Follow-up|0|||
130632627|NCT02290340|470273480|FG003|Overall Study|Lost to Follow-up|1|||
130632628|NCT02290340|470273477|FG000|Overall Study|Withdrawal by Subject|1|||
130632629|NCT02290340|470273478|FG001|Overall Study|Withdrawal by Subject|0|||
130632630|NCT02290340|470273479|FG002|Overall Study|Withdrawal by Subject|0|||
130632631|NCT02290340|470273480|FG003|Overall Study|Withdrawal by Subject|0|||
130632632|NCT02290340|470273477|FG000|Overall Study|Other|1|||
130632633|NCT02290340|470273478|FG001|Overall Study|Other|0|||
130632634|NCT02290340|470273479|FG002|Overall Study|Other|0|||
130632635|NCT02290340|470273480|FG003|Overall Study|Other|1|||
130632636|NCT04315298|470275957|FG000|Overall Study|Withdrawal by Subject|0|||
130632637|NCT04315298|470275958|FG001|Overall Study|Withdrawal by Subject|0|||
130632638|NCT04315298|470275959|FG002|Overall Study|Withdrawal by Subject|0|||
130632639|NCT04315298|470275960|FG003|Overall Study|Withdrawal by Subject|2|||
130632640|NCT04315298|470275961|FG004|Overall Study|Withdrawal by Subject|2|||
130632641|NCT04315298|470275962|FG005|Overall Study|Withdrawal by Subject|2|||
130632642|NCT04315298|470275963|FG006|Overall Study|Withdrawal by Subject|0|||
130632643|NCT04315298|470275964|FG007|Overall Study|Withdrawal by Subject|1|||
130632644|NCT04315298|470275965|FG008|Overall Study|Withdrawal by Subject|1|||
130632645|NCT04315298|470275966|FG009|Overall Study|Withdrawal by Subject|1|||
130632646|NCT04315298|470275967|FG010|Overall Study|Withdrawal by Subject|0|||
130632647|NCT04315298|470275968|FG011|Overall Study|Withdrawal by Subject|0|||
130632648|NCT04315298|470275969|FG012|Overall Study|Withdrawal by Subject|0|||
130632649|NCT04315298|470275970|FG013|Overall Study|Withdrawal by Subject|0|||
130632650|NCT04315298|470275971|FG014|Overall Study|Withdrawal by Subject|0|||
130632651|NCT04315298|470275972|FG015|Overall Study|Withdrawal by Subject|0|||
130632652|NCT04315298|470275973|FG016|Overall Study|Withdrawal by Subject|0|||
130632653|NCT04315298|470275974|FG017|Overall Study|Withdrawal by Subject|0|||
130632654|NCT04315298|470275975|FG018|Overall Study|Withdrawal by Subject|0|||
130632655|NCT04315298|470275957|FG000|Overall Study|Physician Decision|0|||
130632656|NCT04315298|470275958|FG001|Overall Study|Physician Decision|0|||
130632657|NCT04315298|470275959|FG002|Overall Study|Physician Decision|0|||
130632658|NCT04315298|470275960|FG003|Overall Study|Physician Decision|0|||
130632659|NCT04315298|470275961|FG004|Overall Study|Physician Decision|1|||
130632660|NCT04315298|470275962|FG005|Overall Study|Physician Decision|0|||
130632661|NCT04315298|470275963|FG006|Overall Study|Physician Decision|0|||
130632662|NCT04315298|470275964|FG007|Overall Study|Physician Decision|0|||
130632663|NCT04315298|470275965|FG008|Overall Study|Physician Decision|0|||
130632664|NCT04315298|470275966|FG009|Overall Study|Physician Decision|0|||
130632665|NCT04315298|470275967|FG010|Overall Study|Physician Decision|0|||
130632666|NCT04315298|470275968|FG011|Overall Study|Physician Decision|0|||
130632667|NCT04315298|470275969|FG012|Overall Study|Physician Decision|0|||
130632668|NCT04315298|470275970|FG013|Overall Study|Physician Decision|0|||
130632669|NCT04315298|470275971|FG014|Overall Study|Physician Decision|0|||
130632670|NCT04315298|470275972|FG015|Overall Study|Physician Decision|0|||
130632671|NCT04315298|470275973|FG016|Overall Study|Physician Decision|0|||
130632672|NCT04315298|470275974|FG017|Overall Study|Physician Decision|0|||
130632673|NCT04315298|470275975|FG018|Overall Study|Physician Decision|0|||
130632674|NCT04315298|470275957|FG000|Overall Study|Lost to Follow-up|5|||
130632675|NCT04315298|470275958|FG001|Overall Study|Lost to Follow-up|10|||
130632676|NCT04315298|470275959|FG002|Overall Study|Lost to Follow-up|6|||
130632677|NCT04315298|470275960|FG003|Overall Study|Lost to Follow-up|8|||
130632678|NCT04315298|470275961|FG004|Overall Study|Lost to Follow-up|12|||
130632679|NCT04315298|470275962|FG005|Overall Study|Lost to Follow-up|13|||
130632680|NCT04315298|470275963|FG006|Overall Study|Lost to Follow-up|9|||
130632681|NCT04315298|470275964|FG007|Overall Study|Lost to Follow-up|16|||
130632682|NCT04315298|470275965|FG008|Overall Study|Lost to Follow-up|14|||
130632683|NCT04315298|470275966|FG009|Overall Study|Lost to Follow-up|0|||
130632684|NCT04315298|470275967|FG010|Overall Study|Lost to Follow-up|2|||
130632685|NCT04315298|470275968|FG011|Overall Study|Lost to Follow-up|1|||
130632686|NCT04315298|470275969|FG012|Overall Study|Lost to Follow-up|0|||
130632687|NCT04315298|470275970|FG013|Overall Study|Lost to Follow-up|0|||
130632688|NCT04315298|470275971|FG014|Overall Study|Lost to Follow-up|0|||
130632689|NCT04315298|470275972|FG015|Overall Study|Lost to Follow-up|2|||
130632690|NCT04315298|470275973|FG016|Overall Study|Lost to Follow-up|0|||
130632691|NCT04315298|470275974|FG017|Overall Study|Lost to Follow-up|0|||
130632692|NCT04315298|470275975|FG018|Overall Study|Lost to Follow-up|0|||
130632693|NCT04315298|470275957|FG000|Overall Study|Death|24|||
130632694|NCT04315298|470275958|FG001|Overall Study|Death|60|||
130632695|NCT04315298|470275959|FG002|Overall Study|Death|49|||
130632696|NCT04315298|470275960|FG003|Overall Study|Death|59|||
130632697|NCT04315298|470275961|FG004|Overall Study|Death|70|||
130632698|NCT04315298|470275962|FG005|Overall Study|Death|114|||
130632699|NCT04315298|470275963|FG006|Overall Study|Death|9|||
130632700|NCT04315298|470275964|FG007|Overall Study|Death|12|||
130632701|NCT04315298|470275965|FG008|Overall Study|Death|21|||
130632702|NCT04315298|470275966|FG009|Overall Study|Death|16|||
130632703|NCT04315298|470275967|FG010|Overall Study|Death|40|||
130632704|NCT04315298|470275968|FG011|Overall Study|Death|40|||
130632705|NCT04315298|470275969|FG012|Overall Study|Death|3|||
130632706|NCT04315298|470275970|FG013|Overall Study|Death|4|||
130632707|NCT04315298|470275971|FG014|Overall Study|Death|6|||
130632708|NCT04315298|470275972|FG015|Overall Study|Death|4|||
130632709|NCT04315298|470275973|FG016|Overall Study|Death|3|||
130632710|NCT04315298|470275974|FG017|Overall Study|Death|1|||
130632711|NCT04315298|470275975|FG018|Overall Study|Death|0|||
130632712|NCT00736385|470275976|FG000|Overall Study|Withdrawal by Subject|2|||
130632713|NCT00736385|470275977|FG001|Overall Study|Withdrawal by Subject|2|||
130632714|NCT00736385|470275976|FG000|Overall Study|Adverse Event|0|||
130632715|NCT00736385|470275977|FG001|Overall Study|Adverse Event|1|||
130632716|NCT01183104|470275978|FG000|Overall Study|Adverse Event|8|||
130632717|NCT01183104|470275979|FG001|Overall Study|Adverse Event|6|||
130632718|NCT01183104|470275978|FG000|Overall Study|Death|0|||
130632719|NCT01183104|470275979|FG001|Overall Study|Death|1|||
130632720|NCT01183104|470275978|FG000|Overall Study|Lost to Follow-up|14|||
130632721|NCT01183104|470275979|FG001|Overall Study|Lost to Follow-up|7|||
130632722|NCT01183104|470275978|FG000|Overall Study|Physician Decision|5|||
130632723|NCT01183104|470275979|FG001|Overall Study|Physician Decision|8|||
130632724|NCT01183104|470275978|FG000|Overall Study|Withdrawal by Subject|6|||
130632725|NCT01183104|470275979|FG001|Overall Study|Withdrawal by Subject|11|||
130632726|NCT01183104|470275978|FG000|Overall Study|Nonparticipation in Extension Study|39|||
130632727|NCT01183104|470275979|FG001|Overall Study|Nonparticipation in Extension Study|50|||
130632728|NCT01183104|470275978|FG000|Overall Study|Did not receive study drug|5|||
130632729|NCT01183104|470275979|FG001|Overall Study|Did not receive study drug|9|||
130632730|NCT03267511|470275980|FG000|Overall Study|Lost to Follow-up|0|||
130632731|NCT03267511|470275981|FG001|Overall Study|Lost to Follow-up|0|||
130632732|NCT03267511|470275982|FG002|Overall Study|Lost to Follow-up|0|||
130632733|NCT03267511|470275983|FG003|Overall Study|Lost to Follow-up|1|||
130632734|NCT01594749|470275984|FG000|Overall Study|Adverse Event|2|||
130632735|NCT01594749|470275985|FG001|Overall Study|Adverse Event|1|||
130632736|NCT01594749|470275984|FG000|Overall Study|Withdrawal by Subject|2|||
130632737|NCT01594749|470275985|FG001|Overall Study|Withdrawal by Subject|2|||
130632738|NCT01594749|470275984|FG000|Overall Study|Protocol Violation|2|||
130632739|NCT01594749|470275985|FG001|Overall Study|Protocol Violation|0|||
130632740|NCT01594749|470275984|FG000|Overall Study|Physician Decision|1|||
130632741|NCT01594749|470275985|FG001|Overall Study|Physician Decision|1|||
130632742|NCT01594749|470275984|FG000|Overall Study|Non-compliance with Protocol|0|||
130632743|NCT01594749|470275985|FG001|Overall Study|Non-compliance with Protocol|1|||
130632744|NCT01594749|470275984|FG000|Overall Study|Lost to Follow-up|1|||
130632745|NCT01594749|470275985|FG001|Overall Study|Lost to Follow-up|0|||
130632746|NCT01594749|470275984|FG000|Overall Study|Death|9|||
130632747|NCT01594749|470275985|FG001|Overall Study|Death|3|||
130632748|NCT01594749|470275984|FG000|Overall Study|Not Treated|4|||
130632749|NCT01594749|470275985|FG001|Overall Study|Not Treated|10|||
130632750|NCT01594749|470275984|FG000|Overall Study|Lost Source Documentation|1|||
130632751|NCT01594749|470275985|FG001|Overall Study|Lost Source Documentation|0|||
130632752|NCT00364351|470275986|FG000|Overall Study|Adverse Event|90|||
130632753|NCT00364351|470275987|FG001|Overall Study|Adverse Event|44|||
130632754|NCT00364351|470275986|FG000|Overall Study|Condition under investigation worsened|469|||
130632755|NCT00364351|470275987|FG001|Overall Study|Condition under investigation worsened|497|||
130632756|NCT00364351|470275986|FG000|Overall Study|Prohibited concomitant medication|0|||
130632757|NCT00364351|470275987|FG001|Overall Study|Prohibited concomitant medication|2|||
130632758|NCT00364351|470275986|FG000|Overall Study|Lost to Follow-up|1|||
130632759|NCT00364351|470275987|FG001|Overall Study|Lost to Follow-up|1|||
130632760|NCT00364351|470275986|FG000|Overall Study|Withdrawal by Subject|30|||
130632761|NCT00364351|470275987|FG001|Overall Study|Withdrawal by Subject|29|||
130632762|NCT00364351|470275986|FG000|Overall Study|Incorrect enrollment|1|||
130632763|NCT00364351|470275987|FG001|Overall Study|Incorrect enrollment|1|||
130632764|NCT00364351|470275986|FG000|Overall Study|Sponsor decision|1|||
130632765|NCT00364351|470275987|FG001|Overall Study|Sponsor decision|0|||
130632766|NCT00364351|470275986|FG000|Overall Study|Poor treatment compliance|0|||
130632767|NCT00364351|470275987|FG001|Overall Study|Poor treatment compliance|3|||
130632768|NCT00364351|470275986|FG000|Overall Study|Investigator error|0|||
130632769|NCT00364351|470275987|FG001|Overall Study|Investigator error|2|||
130632770|NCT00364351|470275986|FG000|Overall Study|Patient could not travel to site|0|||
130632771|NCT00364351|470275987|FG001|Overall Study|Patient could not travel to site|1|||
130632772|NCT00364351|470275986|FG000|Overall Study|Randomised treatment not started|0|||
130632773|NCT00364351|470275987|FG001|Overall Study|Randomised treatment not started|3|||
130632774|NCT00922974|470275988|FG000|Phase II Component|Protocol Violation|2|||
130632775|NCT00922974|470275989|FG001|Phase II Component|Protocol Violation|0|||
130632776|NCT00922974|470275988|FG000|Phase II Component|Not evaluable for treatment review|5|||
130632777|NCT00922974|470275989|FG001|Phase II Component|Not evaluable for treatment review|0|||
130632778|NCT00922974|470275988|FG000|Phase III Component|Protocol Violation|8|||
130632779|NCT00922974|470275989|FG001|Phase III Component|Protocol Violation|6|||
130632780|NCT02177786|470275990|FG000|Overall Study|Withdrew Consent|2|||
130632781|NCT02177786|470275991|FG001|Overall Study|Withdrew Consent|6|||
130632782|NCT02177786|470275992|FG002|Overall Study|Withdrew Consent|9|||
130632783|NCT02177786|470275993|FG003|Overall Study|Withdrew Consent|5|||
130632784|NCT02177786|470275990|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
130632785|NCT02177786|470275991|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
130632786|NCT02177786|470275992|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
130632787|NCT02177786|470275993|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
130632788|NCT02177786|470275990|FG000|Overall Study|Adverse Event|1|||
130632789|NCT02177786|470275991|FG001|Overall Study|Adverse Event|1|||
130632790|NCT02177786|470275992|FG002|Overall Study|Adverse Event|2|||
130632791|NCT02177786|470275993|FG003|Overall Study|Adverse Event|3|||
130632792|NCT02177786|470275990|FG000|Overall Study|Death|1|||
130632793|NCT02177786|470275991|FG001|Overall Study|Death|1|||
130632794|NCT02177786|470275992|FG002|Overall Study|Death|1|||
130632795|NCT02177786|470275993|FG003|Overall Study|Death|1|||
130632796|NCT02177786|470275990|FG000|Overall Study|Lost to Follow-up|0|||
130632797|NCT02177786|470275991|FG001|Overall Study|Lost to Follow-up|0|||
130632798|NCT02177786|470275992|FG002|Overall Study|Lost to Follow-up|2|||
130632799|NCT02177786|470275993|FG003|Overall Study|Lost to Follow-up|2|||
130632800|NCT02177786|470275990|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130632801|NCT02177786|470275991|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130632802|NCT02177786|470275992|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130632803|NCT02177786|470275993|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130632804|NCT02177786|470275990|FG000|Overall Study|Protocol Violation|0|||
130632805|NCT02177786|470275991|FG001|Overall Study|Protocol Violation|0|||
130632806|NCT02177786|470275992|FG002|Overall Study|Protocol Violation|2|||
130632807|NCT02177786|470275993|FG003|Overall Study|Protocol Violation|0|||
130632808|NCT02177786|470275990|FG000|Overall Study|Progressive Disease|0|||
130632809|NCT02177786|470275991|FG001|Overall Study|Progressive Disease|1|||
130632810|NCT02177786|470275992|FG002|Overall Study|Progressive Disease|0|||
130632811|NCT02177786|470275993|FG003|Overall Study|Progressive Disease|0|||
130632812|NCT02177786|470275990|FG000|Overall Study|Missing study completion status|0|||
130632813|NCT02177786|470275991|FG001|Overall Study|Missing study completion status|1|||
130632814|NCT02177786|470275992|FG002|Overall Study|Missing study completion status|0|||
130632815|NCT02177786|470275993|FG003|Overall Study|Missing study completion status|0|||
130632816|NCT03950440|470275994|FG000|Overall Study|Death|8|||
130632817|NCT03950440|470275995|FG001|Overall Study|Death|2|||
130632818|NCT03950440|470275996|FG002|Overall Study|Death|1|||
130632819|NCT00439309|470275997|FG000|Follow-Up|Death|1|||
130632820|NCT00439309|470275998|FG001|Follow-Up|Death|0|||
130632821|NCT00439309|470275997|FG000|Follow-Up|Lost to Follow-up|2|||
130632822|NCT00439309|470275998|FG001|Follow-Up|Lost to Follow-up|0|||
130632823|NCT00439309|470275997|FG000|Follow-Up|Withdrawal by Subject|0|||
130632824|NCT00439309|470275998|FG001|Follow-Up|Withdrawal by Subject|1|||
130632825|NCT00439309|470275997|FG000|Follow-Up|Late response by subject|0|||
130632826|NCT00439309|470275998|FG001|Follow-Up|Late response by subject|1|||
130632827|NCT00430027|470275999|FG000|Overall Study|Study terminated|8|||
130632828|NCT01957215|470276000|FG000|Overall Study|Adverse Event|2|||
130632829|NCT01957215|470276001|FG001|Overall Study|Adverse Event|2|||
130632830|NCT01957215|470276000|FG000|Overall Study|Lost to Follow-up|3|||
130632831|NCT01957215|470276001|FG001|Overall Study|Lost to Follow-up|3|||
130632832|NCT01957215|470276000|FG000|Overall Study|Protocol Violation|1|||
130632833|NCT01957215|470276001|FG001|Overall Study|Protocol Violation|2|||
130632834|NCT01957215|470276000|FG000|Overall Study|Withdrawal by Subject|7|||
130632835|NCT01957215|470276001|FG001|Overall Study|Withdrawal by Subject|5|||
130632836|NCT01977040|470276002|FG000|Overall Study|Vasa previa not confirmed|2|||
130632837|NCT00634751|470276008|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
130632838|NCT00634751|470276009|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130632839|NCT00634751|470276010|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130632840|NCT00634751|470276011|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130632841|NCT00634751|470276008|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130632842|NCT00634751|470276009|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
130632843|NCT00634751|470276010|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130632844|NCT00634751|470276011|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130632845|NCT00634751|470276008|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
130632846|NCT00634751|470276009|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
130632847|NCT00634751|470276010|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
130632848|NCT00634751|470276011|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
130632849|NCT04402385|470276014|FG000|Overall Study|Withdrawal by Subject|4|||
130632850|NCT04402385|470276015|FG001|Overall Study|Withdrawal by Subject|4|||
130632851|NCT04402385|470276014|FG000|Overall Study|Lost to Follow-up|1|||
130632852|NCT04402385|470276015|FG001|Overall Study|Lost to Follow-up|1|||
130632853|NCT04402385|470276014|FG000|Overall Study|Physician Decision|0|||
130632854|NCT04402385|470276015|FG001|Overall Study|Physician Decision|1|||
130632855|NCT00088595|470276016|FG000|Overall Study|Adverse Event|11|||
130632856|NCT00088595|470276016|FG000|Overall Study|Withdrawal by Subject|8|||
130632857|NCT00088595|470276016|FG000|Overall Study|Ongoing (After Core)|7|||
130632858|NCT00088595|470276016|FG000|Overall Study|New Cancer Therapy|2|||
130632859|NCT01308853|470276022|FG000|Overall Study|Adverse Event|1|||
130632860|NCT01308853|470276022|FG000|Overall Study|Lost to Follow-up|2|||
130632861|NCT01308853|470276022|FG000|Overall Study|Insertion of permanent implants|1|||
130632862|NCT01473355|470276026|FG000|Overall Study|Protocol Violation|2|||
130632863|NCT01473355|470276026|FG000|Overall Study|Adverse Event|2|||
130632864|NCT01473355|470276026|FG000|Overall Study|Lost to Follow-up|2|||
130632865|NCT01119963|470276027|FG000|Overall Study|Lost to Follow-up|1|||
130632866|NCT01119963|470276028|FG001|Overall Study|Lost to Follow-up|1|||
130632867|NCT02603172|470276029|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632868|NCT02603172|470276030|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632869|NCT02603172|470276031|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
130632870|NCT02603172|470276032|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632871|NCT02603172|470276033|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632872|NCT02603172|470276034|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632873|NCT02603172|470276035|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632874|NCT02603172|470276036|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130632875|NCT00047008|470276037|FG000|Overall Study|Withdrawn consent|2|||
130632876|NCT00047008|470276038|FG001|Overall Study|Withdrawn consent|3|||
130632877|NCT00047008|470276037|FG000|Overall Study|Ineligible|9|||
130632878|NCT00047008|470276038|FG001|Overall Study|Ineligible|8|||
130632879|NCT00429572|470276039|FG000|Overall Study|Disease progression|1|||
130632880|NCT01366534|470276040|FG000|Overall Study|Lost to Follow-up|1|||
130632881|NCT01366534|470276041|FG001|Overall Study|Lost to Follow-up|0|||
130632882|NCT01366534|470276042|FG002|Overall Study|Lost to Follow-up|0|||
130632883|NCT01366534|470276040|FG000|Overall Study|Migrated|1|||
130632884|NCT01366534|470276041|FG001|Overall Study|Migrated|1|||
130632885|NCT01366534|470276042|FG002|Overall Study|Migrated|0|||
130632886|NCT01366534|470276040|FG000|Overall Study|Declined challenged|0|||
130632887|NCT01366534|470276041|FG001|Overall Study|Declined challenged|1|||
130632888|NCT01366534|470276042|FG002|Overall Study|Declined challenged|0|||
130632889|NCT01047436|470276044|FG000|Overall Study|Protocol Violation|1|||
130632890|NCT01047436|470276045|FG001|Overall Study|Protocol Violation|0|||
130632891|NCT00939341|470276046|FG000|Overall Study|Adverse Event|15|||
130632892|NCT00939341|470276046|FG000|Overall Study|Pregnancy|1|||
130632893|NCT00939341|470276046|FG000|Overall Study|Lost to Follow-up|23|||
130632894|NCT00939341|470276046|FG000|Overall Study|Withdrawal by Subject|13|||
130632895|NCT00939341|470276046|FG000|Overall Study|Protocol Violation|6|||
130632896|NCT00939341|470276046|FG000|Overall Study|Incorrect enrolment|8|||
130632897|NCT01408732|470276047|FG000|Overall Study|Withdrawal by Subject|2|||
130632898|NCT01408732|470276048|FG001|Overall Study|Withdrawal by Subject|2|||
130632899|NCT00424099|470276049|FG000|Overall Study|Adverse Event|0|||
130632900|NCT00424099|470276050|FG001|Overall Study|Adverse Event|1|||
130632901|NCT00424099|470276051|FG002|Overall Study|Adverse Event|1|||
130632902|NCT00424099|470276052|FG003|Overall Study|Adverse Event|0|||
130632903|NCT00424099|470276049|FG000|Overall Study|Death|0|||
130632904|NCT00424099|470276050|FG001|Overall Study|Death|1|||
130632905|NCT00424099|470276051|FG002|Overall Study|Death|0|||
130632906|NCT00424099|470276052|FG003|Overall Study|Death|0|||
130632907|NCT00424099|470276049|FG000|Overall Study|Illness|2|||
130632908|NCT00424099|470276050|FG001|Overall Study|Illness|0|||
130632909|NCT00424099|470276051|FG002|Overall Study|Illness|1|||
130632910|NCT00424099|470276052|FG003|Overall Study|Illness|4|||
130632911|NCT00424099|470276049|FG000|Overall Study|Lost to Follow-up|0|||
130632912|NCT00424099|470276050|FG001|Overall Study|Lost to Follow-up|0|||
130632913|NCT00424099|470276051|FG002|Overall Study|Lost to Follow-up|3|||
130632914|NCT00424099|470276052|FG003|Overall Study|Lost to Follow-up|0|||
130632915|NCT00424099|470276049|FG000|Overall Study|Hospitalized|1|||
130632916|NCT00424099|470276050|FG001|Overall Study|Hospitalized|2|||
130632917|NCT00424099|470276051|FG002|Overall Study|Hospitalized|1|||
130632918|NCT00424099|470276052|FG003|Overall Study|Hospitalized|3|||
130632919|NCT00424099|470276049|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
130632920|NCT00424099|470276050|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
130632921|NCT00424099|470276051|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
130632922|NCT00424099|470276052|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
130632923|NCT00424099|470276049|FG000|Overall Study|Withdrawal by Subject|1|||
130632924|NCT00424099|470276050|FG001|Overall Study|Withdrawal by Subject|9|||
130632925|NCT00424099|470276051|FG002|Overall Study|Withdrawal by Subject|4|||
130632926|NCT00424099|470276052|FG003|Overall Study|Withdrawal by Subject|6|||
130632927|NCT00424099|470276049|FG000|Overall Study|Physician Decision|0|||
130632928|NCT00424099|470276050|FG001|Overall Study|Physician Decision|0|||
130632929|NCT00424099|470276051|FG002|Overall Study|Physician Decision|1|||
130632930|NCT00424099|470276052|FG003|Overall Study|Physician Decision|0|||
130632931|NCT00424099|470276049|FG000|Overall Study|Missing|0|||
130632932|NCT00424099|470276050|FG001|Overall Study|Missing|0|||
130632933|NCT00424099|470276051|FG002|Overall Study|Missing|1|||
130632934|NCT00424099|470276052|FG003|Overall Study|Missing|0|||
130632935|NCT03377452|470276053|FG000|Overall Study|Refused assessment|0|||
130632936|NCT03377452|470276054|FG001|Overall Study|Refused assessment|2|||
130632937|NCT03377452|470276053|FG000|Overall Study|Lost to Follow-up|5|||
130632938|NCT03377452|470276054|FG001|Overall Study|Lost to Follow-up|4|||
130632939|NCT00796003|470276056|FG000|Overall Study|Disease Progression|2|||
130632940|NCT00796003|470276057|FG001|Overall Study|Disease Progression|13|||
130632941|NCT00796003|470276056|FG000|Overall Study|Adverse Event|1|||
130632942|NCT00796003|470276057|FG001|Overall Study|Adverse Event|7|||
130632943|NCT00796003|470276056|FG000|Overall Study|Specified organ function not met|0|||
130632944|NCT00796003|470276057|FG001|Overall Study|Specified organ function not met|1|||
130632945|NCT00796003|470276056|FG000|Overall Study|Physician Decision|0|||
130632946|NCT00796003|470276057|FG001|Overall Study|Physician Decision|4|||
130632947|NCT00796003|470276056|FG000|Overall Study|Withdrawal by Subject|0|||
130632948|NCT00796003|470276057|FG001|Overall Study|Withdrawal by Subject|1|||
130632949|NCT00796003|470276056|FG000|Overall Study|Other|0|||
130632950|NCT00796003|470276057|FG001|Overall Study|Other|1|||
130632951|NCT00796003|470276056|FG000|Overall Study|Participants Not treated|0|||
130632952|NCT00796003|470276057|FG001|Overall Study|Participants Not treated|2|||
130632953|NCT05179057|470276058|FG000|Overall Study|Adverse Event|3|||
130632954|NCT05179057|470276059|FG001|Overall Study|Adverse Event|2|||
130632955|NCT05179057|470276058|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
130632956|NCT05179057|470276059|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
130632957|NCT05179057|470276058|FG000|Overall Study|Study terminated|13|||
130632958|NCT05179057|470276059|FG001|Overall Study|Study terminated|7|||
130632959|NCT05179057|470276058|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
130632960|NCT05179057|470276059|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
130632961|NCT05179057|470276058|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
130632962|NCT05179057|470276059|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
130632963|NCT03345342|470276060|FG000|Open-Label Phase|Adverse Event|30|||
130632964|NCT03345342|470276061|FG001|Open-Label Phase|Adverse Event|0|||
130632965|NCT03345342|470276062|FG002|Open-Label Phase|Adverse Event|0|||
130632966|NCT03345342|470276063|FG003|Open-Label Phase|Adverse Event|0|||
130632967|NCT03345342|470276064|FG004|Open-Label Phase|Adverse Event|0|||
130632968|NCT03345342|470276060|FG000|Open-Label Phase|Death|1|||
130632969|NCT03345342|470276061|FG001|Open-Label Phase|Death|0|||
130632970|NCT03345342|470276062|FG002|Open-Label Phase|Death|0|||
130632971|NCT03345342|470276063|FG003|Open-Label Phase|Death|0|||
130632972|NCT03345342|470276064|FG004|Open-Label Phase|Death|0|||
130632973|NCT03345342|470276060|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
130632974|NCT03345342|470276061|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
130632975|NCT03345342|470276062|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
130632976|NCT03345342|470276063|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
130632977|NCT03345342|470276064|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
130632978|NCT03345342|470276060|FG000|Open-Label Phase|Lack of Efficacy|6|||
130632979|NCT03345342|470276061|FG001|Open-Label Phase|Lack of Efficacy|0|||
130632980|NCT03345342|470276062|FG002|Open-Label Phase|Lack of Efficacy|0|||
130632981|NCT03345342|470276063|FG003|Open-Label Phase|Lack of Efficacy|0|||
130632982|NCT03345342|470276064|FG004|Open-Label Phase|Lack of Efficacy|0|||
130632983|NCT03345342|470276060|FG000|Open-Label Phase|Lost to Follow-up|9|||
130632984|NCT03345342|470276061|FG001|Open-Label Phase|Lost to Follow-up|0|||
130632985|NCT03345342|470276062|FG002|Open-Label Phase|Lost to Follow-up|0|||
130632986|NCT03345342|470276063|FG003|Open-Label Phase|Lost to Follow-up|0|||
130632987|NCT03345342|470276064|FG004|Open-Label Phase|Lost to Follow-up|0|||
130632988|NCT03345342|470276060|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
130632989|NCT03345342|470276061|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
130632990|NCT03345342|470276062|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
130632991|NCT03345342|470276063|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
130632992|NCT03345342|470276064|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
130632993|NCT03345342|470276060|FG000|Open-Label Phase|Physician Decision|4|||
130632994|NCT03345342|470276061|FG001|Open-Label Phase|Physician Decision|0|||
130632995|NCT03345342|470276062|FG002|Open-Label Phase|Physician Decision|0|||
130632996|NCT03345342|470276063|FG003|Open-Label Phase|Physician Decision|0|||
130632997|NCT03345342|470276064|FG004|Open-Label Phase|Physician Decision|0|||
130632998|NCT03345342|470276060|FG000|Open-Label Phase|Protocol Violation|8|||
130632999|NCT03345342|470276061|FG001|Open-Label Phase|Protocol Violation|0|||
130633000|NCT03345342|470276062|FG002|Open-Label Phase|Protocol Violation|0|||
130633001|NCT03345342|470276063|FG003|Open-Label Phase|Protocol Violation|0|||
130633002|NCT03345342|470276064|FG004|Open-Label Phase|Protocol Violation|0|||
130633003|NCT03345342|470276060|FG000|Open-Label Phase|Withdrawal by Subject|57|||
130633004|NCT03345342|470276061|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130633005|NCT03345342|470276062|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130633006|NCT03345342|470276063|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130633007|NCT03345342|470276064|FG004|Open-Label Phase|Withdrawal by Subject|0|||
130633008|NCT03345342|470276060|FG000|Open-Label Phase|Other|15|||
130633009|NCT03345342|470276061|FG001|Open-Label Phase|Other|0|||
130633010|NCT03345342|470276062|FG002|Open-Label Phase|Other|0|||
130633011|NCT03345342|470276063|FG003|Open-Label Phase|Other|0|||
130633012|NCT03345342|470276064|FG004|Open-Label Phase|Other|0|||
130633013|NCT03345342|470276060|FG000|Double-Blind Phase|Adverse Event|0|||
130633014|NCT03345342|470276061|FG001|Double-Blind Phase|Adverse Event|1|||
130633015|NCT03345342|470276062|FG002|Double-Blind Phase|Adverse Event|6|||
130633016|NCT03345342|470276063|FG003|Double-Blind Phase|Adverse Event|0|||
130633017|NCT03345342|470276064|FG004|Double-Blind Phase|Adverse Event|0|||
130633018|NCT03345342|470276060|FG000|Double-Blind Phase|Death|0|||
130633019|NCT03345342|470276061|FG001|Double-Blind Phase|Death|2|||
130633020|NCT03345342|470276062|FG002|Double-Blind Phase|Death|1|||
130633021|NCT03345342|470276063|FG003|Double-Blind Phase|Death|0|||
130633022|NCT03345342|470276064|FG004|Double-Blind Phase|Death|0|||
130633023|NCT03345342|470276060|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
130633024|NCT03345342|470276061|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
130633025|NCT03345342|470276062|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
130633026|NCT03345342|470276063|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
130633027|NCT03345342|470276064|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
130633028|NCT03345342|470276060|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130633029|NCT03345342|470276061|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130633030|NCT03345342|470276062|FG002|Double-Blind Phase|Lost to Follow-up|7|||
130633031|NCT03345342|470276063|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130633032|NCT03345342|470276064|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130633033|NCT03345342|470276060|FG000|Double-Blind Phase|Physician Decision|0|||
130633034|NCT03345342|470276061|FG001|Double-Blind Phase|Physician Decision|1|||
130633035|NCT03345342|470276062|FG002|Double-Blind Phase|Physician Decision|4|||
130633036|NCT03345342|470276063|FG003|Double-Blind Phase|Physician Decision|0|||
130633037|NCT03345342|470276064|FG004|Double-Blind Phase|Physician Decision|0|||
130633038|NCT03345342|470276060|FG000|Double-Blind Phase|Protocol Violation|0|||
130633039|NCT03345342|470276061|FG001|Double-Blind Phase|Protocol Violation|0|||
130633040|NCT03345342|470276062|FG002|Double-Blind Phase|Protocol Violation|1|||
130633041|NCT03345342|470276063|FG003|Double-Blind Phase|Protocol Violation|0|||
130633042|NCT03345342|470276064|FG004|Double-Blind Phase|Protocol Violation|0|||
130633043|NCT03345342|470276060|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130633044|NCT03345342|470276061|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
130633045|NCT03345342|470276062|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
130633046|NCT03345342|470276063|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130633047|NCT03345342|470276064|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130633048|NCT03345342|470276060|FG000|Double-Blind Phase|Other|0|||
130633049|NCT03345342|470276061|FG001|Double-Blind Phase|Other|1|||
130633050|NCT03345342|470276062|FG002|Double-Blind Phase|Other|3|||
130633051|NCT03345342|470276063|FG003|Double-Blind Phase|Other|0|||
130633052|NCT03345342|470276064|FG004|Double-Blind Phase|Other|0|||
130633053|NCT03345342|470276060|FG000|Follow-Up Phase|Adverse Event|0|||
130633054|NCT03345342|470276061|FG001|Follow-Up Phase|Adverse Event|0|||
130633055|NCT03345342|470276062|FG002|Follow-Up Phase|Adverse Event|0|||
130633056|NCT03345342|470276063|FG003|Follow-Up Phase|Adverse Event|0|||
130633057|NCT03345342|470276064|FG004|Follow-Up Phase|Adverse Event|4|||
130633058|NCT03345342|470276060|FG000|Follow-Up Phase|Lost to Follow-up|0|||
130633059|NCT03345342|470276061|FG001|Follow-Up Phase|Lost to Follow-up|0|||
130633060|NCT03345342|470276062|FG002|Follow-Up Phase|Lost to Follow-up|0|||
130633061|NCT03345342|470276063|FG003|Follow-Up Phase|Lost to Follow-up|0|||
130633062|NCT03345342|470276064|FG004|Follow-Up Phase|Lost to Follow-up|6|||
130633063|NCT03345342|470276060|FG000|Follow-Up Phase|Physician Decision|0|||
130633064|NCT03345342|470276061|FG001|Follow-Up Phase|Physician Decision|0|||
130633065|NCT03345342|470276062|FG002|Follow-Up Phase|Physician Decision|0|||
130633066|NCT03345342|470276063|FG003|Follow-Up Phase|Physician Decision|0|||
130633067|NCT03345342|470276064|FG004|Follow-Up Phase|Physician Decision|5|||
130633068|NCT03345342|470276060|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130633069|NCT03345342|470276061|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130633070|NCT03345342|470276062|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
130633071|NCT03345342|470276063|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
130633072|NCT03345342|470276064|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
130633073|NCT03345342|470276060|FG000|Follow-Up Phase|Other|0|||
130633074|NCT03345342|470276061|FG001|Follow-Up Phase|Other|0|||
130633075|NCT03345342|470276062|FG002|Follow-Up Phase|Other|0|||
130633076|NCT03345342|470276063|FG003|Follow-Up Phase|Other|3|||
130633077|NCT03345342|470276064|FG004|Follow-Up Phase|Other|1|||
130633078|NCT02437162|470276065|FG000|Overall Study|Protocol Violation|0|||
130633079|NCT02437162|470276066|FG001|Overall Study|Protocol Violation|1|||
130633080|NCT02437162|470276067|FG002|Overall Study|Protocol Violation|0|||
130633081|NCT02437162|470276065|FG000|Overall Study|Randomized but not treated|0|||
130633082|NCT02437162|470276066|FG001|Overall Study|Randomized but not treated|0|||
130633083|NCT02437162|470276067|FG002|Overall Study|Randomized but not treated|1|||
130633084|NCT02437162|470276065|FG000|Overall Study|Study discontinued by Sponsor|93|||
130633085|NCT02437162|470276066|FG001|Overall Study|Study discontinued by Sponsor|98|||
130633086|NCT02437162|470276067|FG002|Overall Study|Study discontinued by Sponsor|97|||
130633087|NCT02437162|470276065|FG000|Overall Study|Withdrawal by Subject|13|||
130633088|NCT02437162|470276066|FG001|Overall Study|Withdrawal by Subject|7|||
130633089|NCT02437162|470276067|FG002|Overall Study|Withdrawal by Subject|9|||
130633090|NCT02437162|470276065|FG000|Overall Study|Adverse Event|0|||
130633091|NCT02437162|470276066|FG001|Overall Study|Adverse Event|1|||
130633092|NCT02437162|470276067|FG002|Overall Study|Adverse Event|0|||
130633093|NCT02437162|470276065|FG000|Overall Study|Lost to Follow-up|1|||
130633094|NCT02437162|470276066|FG001|Overall Study|Lost to Follow-up|0|||
130633095|NCT02437162|470276067|FG002|Overall Study|Lost to Follow-up|1|||
130633096|NCT02437162|470276065|FG000|Overall Study|Death|0|||
130633097|NCT02437162|470276066|FG001|Overall Study|Death|1|||
130633098|NCT02437162|470276067|FG002|Overall Study|Death|0|||
130633099|NCT02437162|470276065|FG000|Overall Study|Other|0|||
130633100|NCT02437162|470276066|FG001|Overall Study|Other|0|||
130633101|NCT02437162|470276067|FG002|Overall Study|Other|1|||
130633102|NCT04338321|470276072|FG000|Overall Study|Adverse Event|4|||
130633103|NCT04338321|470276073|FG001|Overall Study|Adverse Event|10|||
130633104|NCT04338321|470276072|FG000|Overall Study|Death|1|||
130633105|NCT04338321|470276073|FG001|Overall Study|Death|1|||
130633106|NCT04338321|470276072|FG000|Overall Study|Lost to Follow-up|4|||
130633107|NCT04338321|470276073|FG001|Overall Study|Lost to Follow-up|9|||
130633108|NCT04338321|470276072|FG000|Overall Study|Withdrawal by Subject|45|||
130633109|NCT04338321|470276073|FG001|Overall Study|Withdrawal by Subject|69|||
130633110|NCT04338321|470276072|FG000|Overall Study|Physician Decision|5|||
130633111|NCT04338321|470276073|FG001|Overall Study|Physician Decision|9|||
130633112|NCT04338321|470276072|FG000|Overall Study|Other|3|||
130633113|NCT04338321|470276073|FG001|Overall Study|Other|10|||
130633114|NCT03375203|470276074|FG000|Overall Study|Protocol Violation|0|||
130633115|NCT03375203|470276075|FG001|Overall Study|Protocol Violation|0|||
130633116|NCT03375203|470276076|FG002|Overall Study|Protocol Violation|1|||
130633117|NCT03375203|470276077|FG003|Overall Study|Protocol Violation|0|||
130633118|NCT03375203|470276078|FG004|Overall Study|Protocol Violation|0|||
130633119|NCT03375203|470276074|FG000|Overall Study|Adverse Event|2|||
130633120|NCT03375203|470276075|FG001|Overall Study|Adverse Event|3|||
130633121|NCT03375203|470276076|FG002|Overall Study|Adverse Event|0|||
130633122|NCT03375203|470276077|FG003|Overall Study|Adverse Event|2|||
130633123|NCT03375203|470276078|FG004|Overall Study|Adverse Event|2|||
130633124|NCT03375203|470276074|FG000|Overall Study|Withdrawal by Subject|3|||
130633125|NCT03375203|470276075|FG001|Overall Study|Withdrawal by Subject|0|||
130633126|NCT03375203|470276076|FG002|Overall Study|Withdrawal by Subject|1|||
130633127|NCT03375203|470276077|FG003|Overall Study|Withdrawal by Subject|0|||
130633128|NCT03375203|470276078|FG004|Overall Study|Withdrawal by Subject|2|||
130633129|NCT03375203|470276074|FG000|Overall Study|Non-compliance with study drug|1|||
130633130|NCT03375203|470276075|FG001|Overall Study|Non-compliance with study drug|0|||
130633131|NCT03375203|470276076|FG002|Overall Study|Non-compliance with study drug|0|||
130633132|NCT03375203|470276077|FG003|Overall Study|Non-compliance with study drug|0|||
130633133|NCT03375203|470276078|FG004|Overall Study|Non-compliance with study drug|0|||
130633134|NCT03375203|470276074|FG000|Overall Study|Randomized, not treated.|0|||
130633135|NCT03375203|470276075|FG001|Overall Study|Randomized, not treated.|1|||
130633136|NCT03375203|470276076|FG002|Overall Study|Randomized, not treated.|0|||
130633137|NCT03375203|470276077|FG003|Overall Study|Randomized, not treated.|0|||
130633138|NCT03375203|470276078|FG004|Overall Study|Randomized, not treated.|0|||
130633139|NCT03107793|470276079|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
130633140|NCT03107793|470276080|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
130633141|NCT03107793|470276081|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
130633142|NCT03107793|470276082|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
130633143|NCT03107793|470276083|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130633144|NCT03107793|470276079|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
130633145|NCT03107793|470276080|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
130633146|NCT03107793|470276081|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
130633147|NCT03107793|470276082|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
130633148|NCT03107793|470276083|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
130633149|NCT03107793|470276079|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
130633150|NCT03107793|470276080|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
130633151|NCT03107793|470276081|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
130633152|NCT03107793|470276082|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
130633153|NCT03107793|470276083|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
130633154|NCT03107793|470276079|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
130633155|NCT03107793|470276080|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130633156|NCT03107793|470276081|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130633157|NCT03107793|470276082|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130633158|NCT03107793|470276083|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130633159|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130633160|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
130633161|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
130633162|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130633163|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130633164|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130633165|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130633166|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
130633167|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130633168|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130633169|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130633170|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130633171|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
130633172|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130633173|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130633174|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130633175|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
130633176|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
130633177|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130633178|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130633179|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
130633180|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
130633181|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
130633182|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
130633183|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
130633184|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130633185|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
130633186|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
130633187|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130633188|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130633189|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130633190|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130633191|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130633192|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130633193|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130633194|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130633195|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
130633196|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
130633197|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130633198|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130633199|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130633200|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130633201|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
130633202|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130633203|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130633204|NCT03107793|470276079|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130633205|NCT03107793|470276080|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
130633206|NCT03107793|470276081|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
130633207|NCT03107793|470276082|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130633208|NCT03107793|470276083|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130633209|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130633210|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130633211|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130633212|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
130633213|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
130633214|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130633215|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130633216|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130633217|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130633218|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
130633219|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130633220|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130633221|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130633222|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
130633223|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
130633224|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Death|0|||
130633225|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Death|0|||
130633226|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Death|0|||
130633227|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Death|0|||
130633228|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Death|1|||
130633229|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130633230|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130633231|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130633232|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130633233|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
130633234|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130633235|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130633236|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130633237|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
130633238|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
130633239|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130633240|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130633241|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130633242|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
130633243|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
130633244|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130633245|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130633246|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130633247|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130633248|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
130633249|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130633250|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130633251|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130633252|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
130633253|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130633254|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Other|0|||
130633255|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Other|0|||
130633256|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Other|0|||
130633257|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Other|1|||
130633258|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Other|3|||
130633259|NCT03107793|470276079|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
130633260|NCT03107793|470276080|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
130633261|NCT03107793|470276081|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
130633262|NCT03107793|470276082|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
130633263|NCT03107793|470276083|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
130633264|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
130633265|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
130633266|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
130633267|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
130633268|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
130633269|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
130633270|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
130633271|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
130633272|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
130633273|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
130633274|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
130633275|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
130633276|NCT03321526|470276084|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
130633277|NCT03321526|470276085|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
130633278|NCT03321526|470276084|FG000|Follow-up Phase (2 Weeks)|Other|24|||
130633279|NCT03321526|470276085|FG001|Follow-up Phase (2 Weeks)|Other|24|||
130633280|NCT01989572|470276089|FG000|Overall Study|Lack of Efficacy|35|||
130633281|NCT01989572|470276090|FG001|Overall Study|Lack of Efficacy|48|||
130633282|NCT01989572|470276091|FG002|Overall Study|Lack of Efficacy|48|||
130633283|NCT01989572|470276092|FG003|Overall Study|Lack of Efficacy|43|||
130633284|NCT01989572|470276093|FG004|Overall Study|Lack of Efficacy|71|||
130633285|NCT01989572|470276094|FG005|Overall Study|Lack of Efficacy|79|||
130633286|NCT01989572|470276089|FG000|Overall Study|Adverse Event|2|||
130633287|NCT01989572|470276090|FG001|Overall Study|Adverse Event|1|||
130633288|NCT01989572|470276091|FG002|Overall Study|Adverse Event|3|||
130633289|NCT01989572|470276092|FG003|Overall Study|Adverse Event|0|||
130633290|NCT01989572|470276093|FG004|Overall Study|Adverse Event|3|||
130633291|NCT01989572|470276094|FG005|Overall Study|Adverse Event|0|||
130633292|NCT01989572|470276089|FG000|Overall Study|Death|0|||
130633293|NCT01989572|470276090|FG001|Overall Study|Death|0|||
130633294|NCT01989572|470276091|FG002|Overall Study|Death|0|||
130633295|NCT01989572|470276092|FG003|Overall Study|Death|0|||
130633296|NCT01989572|470276093|FG004|Overall Study|Death|1|||
130633297|NCT01989572|470276094|FG005|Overall Study|Death|0|||
130633298|NCT01989572|470276089|FG000|Overall Study|Withdrawal by Subject|4|||
130633299|NCT01989572|470276090|FG001|Overall Study|Withdrawal by Subject|1|||
130633300|NCT01989572|470276091|FG002|Overall Study|Withdrawal by Subject|5|||
130633301|NCT01989572|470276092|FG003|Overall Study|Withdrawal by Subject|1|||
130633302|NCT01989572|470276093|FG004|Overall Study|Withdrawal by Subject|12|||
130633303|NCT01989572|470276094|FG005|Overall Study|Withdrawal by Subject|4|||
130633304|NCT01989572|470276089|FG000|Overall Study|complicating disease|1|||
130633305|NCT01989572|470276090|FG001|Overall Study|complicating disease|1|||
130633306|NCT01989572|470276091|FG002|Overall Study|complicating disease|2|||
130633307|NCT01989572|470276092|FG003|Overall Study|complicating disease|0|||
130633308|NCT01989572|470276093|FG004|Overall Study|complicating disease|1|||
130633309|NCT01989572|470276094|FG005|Overall Study|complicating disease|0|||
130633310|NCT01989572|470276089|FG000|Overall Study|error|2|||
130633311|NCT01989572|470276090|FG001|Overall Study|error|1|||
130633312|NCT01989572|470276091|FG002|Overall Study|error|1|||
130633313|NCT01989572|470276092|FG003|Overall Study|error|1|||
130633314|NCT01989572|470276093|FG004|Overall Study|error|1|||
130633315|NCT01989572|470276094|FG005|Overall Study|error|1|||
130633316|NCT01989572|470276089|FG000|Overall Study|maximum dose reached|0|||
130633317|NCT01989572|470276090|FG001|Overall Study|maximum dose reached|1|||
130633318|NCT01989572|470276091|FG002|Overall Study|maximum dose reached|0|||
130633319|NCT01989572|470276092|FG003|Overall Study|maximum dose reached|0|||
130633320|NCT01989572|470276093|FG004|Overall Study|maximum dose reached|1|||
130633321|NCT01989572|470276094|FG005|Overall Study|maximum dose reached|0|||
130633322|NCT01989572|470276089|FG000|Overall Study|unknown/not specify|3|||
130633323|NCT01989572|470276090|FG001|Overall Study|unknown/not specify|4|||
130633324|NCT01989572|470276091|FG002|Overall Study|unknown/not specify|1|||
130633325|NCT01989572|470276092|FG003|Overall Study|unknown/not specify|3|||
130633326|NCT01989572|470276093|FG004|Overall Study|unknown/not specify|3|||
130633327|NCT01989572|470276094|FG005|Overall Study|unknown/not specify|5|||
130633328|NCT01989572|470276089|FG000|Overall Study|not start protocol therapy|5|||
130633329|NCT01989572|470276090|FG001|Overall Study|not start protocol therapy|1|||
130633330|NCT01989572|470276091|FG002|Overall Study|not start protocol therapy|2|||
130633331|NCT01989572|470276092|FG003|Overall Study|not start protocol therapy|3|||
130633332|NCT01989572|470276093|FG004|Overall Study|not start protocol therapy|4|||
130633333|NCT01989572|470276094|FG005|Overall Study|not start protocol therapy|18|||
130633334|NCT01989572|470276089|FG000|Overall Study|alternative therapy|3|||
130633335|NCT01989572|470276090|FG001|Overall Study|alternative therapy|0|||
130633336|NCT01989572|470276091|FG002|Overall Study|alternative therapy|0|||
130633337|NCT01989572|470276092|FG003|Overall Study|alternative therapy|0|||
130633338|NCT01989572|470276093|FG004|Overall Study|alternative therapy|1|||
130633339|NCT01989572|470276094|FG005|Overall Study|alternative therapy|3|||
130633340|NCT02280096|470276095|FG000|Overall Study|Pregnancy|1|||
130633341|NCT02280096|470276096|FG001|Overall Study|Pregnancy|0|||
130633342|NCT02280096|470276095|FG000|Overall Study|Functional neurological disorder|1|||
130633343|NCT02280096|470276096|FG001|Overall Study|Functional neurological disorder|0|||
130633344|NCT02280096|470276095|FG000|Overall Study|Lack of attachment|0|||
130633345|NCT02280096|470276096|FG001|Overall Study|Lack of attachment|1|||
130633346|NCT00246376|470276097|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
130633347|NCT00246376|470276098|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
130633348|NCT00246376|470276099|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
130633349|NCT00246376|470276100|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
130633350|NCT00246376|470276101|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
130633351|NCT00246376|470276097|FG000|Overall Study|Adverse Event|2|||
130633352|NCT00246376|470276098|FG001|Overall Study|Adverse Event|3|||
130633353|NCT00246376|470276099|FG002|Overall Study|Adverse Event|1|||
130633354|NCT00246376|470276100|FG003|Overall Study|Adverse Event|3|||
130633355|NCT00246376|470276101|FG004|Overall Study|Adverse Event|1|||
130633356|NCT00246376|470276097|FG000|Overall Study|Lost to Follow-up|2|||
130633357|NCT00246376|470276098|FG001|Overall Study|Lost to Follow-up|11|||
130633358|NCT00246376|470276099|FG002|Overall Study|Lost to Follow-up|11|||
130633359|NCT00246376|470276100|FG003|Overall Study|Lost to Follow-up|16|||
130633360|NCT00246376|470276101|FG004|Overall Study|Lost to Follow-up|13|||
130633361|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
130633362|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
130633363|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
130633364|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
130633365|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
130633366|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
130633367|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
130633368|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
130633369|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
130633370|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
130633371|NCT02418585|470276102|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
130633372|NCT02418585|470276103|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
130633373|NCT02418585|470276102|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
130633374|NCT02418585|470276103|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
130633375|NCT02418585|470276102|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
130633376|NCT02418585|470276103|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
130633377|NCT02418585|470276102|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
130633378|NCT02418585|470276103|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
130633379|NCT02418585|470276102|FG000|Follow-up Phase (24 Weeks)|Other|3|||
130633380|NCT02418585|470276103|FG001|Follow-up Phase (24 Weeks)|Other|2|||
130633381|NCT02040857|470276104|FG000|Overall Study|Adverse Event|14|||
130633382|NCT02040857|470276104|FG000|Overall Study|Physician Decision|5|||
130633383|NCT02040857|470276104|FG000|Overall Study|Withdrawal by Subject|31|||
130633384|NCT02040857|470276104|FG000|Overall Study|patient non-compliance|3|||
130633385|NCT02040857|470276104|FG000|Overall Study|Lost to Follow-up|2|||
130633386|NCT02040857|470276104|FG000|Overall Study|recurrence|4|||
130633387|NCT02040857|470276104|FG000|Overall Study|ineligible|1|||
130633388|NCT02057068|470276106|FG000|Overall Study|Withdrawal by Subject|2|||
130633389|NCT02057068|470276107|FG001|Overall Study|Withdrawal by Subject|2|||
130633390|NCT02057068|470276106|FG000|Overall Study|Caregiver (CG) Health|0|||
130633391|NCT02057068|470276107|FG001|Overall Study|Caregiver (CG) Health|2|||
130633392|NCT02057068|470276106|FG000|Overall Study|Carepartner (CP) Health|4|||
130633393|NCT02057068|470276107|FG001|Overall Study|Carepartner (CP) Health|2|||
130633394|NCT02057068|470276106|FG000|Overall Study|Lost to Follow-up|2|||
130633395|NCT02057068|470276107|FG001|Overall Study|Lost to Follow-up|2|||
130633396|NCT00654420|470276109|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
130633397|NCT00654420|470276110|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
130633398|NCT00654420|470276111|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
130633399|NCT00654420|470276112|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
130633400|NCT00654420|470276109|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
130633401|NCT00654420|470276110|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
130633402|NCT00654420|470276111|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
130633403|NCT00654420|470276112|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
130633404|NCT00654420|470276109|FG000|Phase II|Adverse Event|0|||
130633405|NCT00654420|470276110|FG001|Phase II|Adverse Event|0|||
130633406|NCT00654420|470276111|FG002|Phase II|Adverse Event|3|||
130633407|NCT00654420|470276112|FG003|Phase II|Adverse Event|3|||
130633408|NCT00654420|470276109|FG000|Phase II|Lost to Follow-up|0|||
130633409|NCT00654420|470276110|FG001|Phase II|Lost to Follow-up|0|||
130633410|NCT00654420|470276111|FG002|Phase II|Lost to Follow-up|0|||
130633411|NCT00654420|470276112|FG003|Phase II|Lost to Follow-up|1|||
130633412|NCT00654420|470276109|FG000|Phase II|Physician Decision|0|||
130633413|NCT00654420|470276110|FG001|Phase II|Physician Decision|0|||
130633414|NCT00654420|470276111|FG002|Phase II|Physician Decision|0|||
130633415|NCT00654420|470276112|FG003|Phase II|Physician Decision|4|||
130633416|NCT00654420|470276109|FG000|Phase II|Progressive Disease|0|||
130633417|NCT00654420|470276110|FG001|Phase II|Progressive Disease|0|||
130633418|NCT00654420|470276111|FG002|Phase II|Progressive Disease|29|||
130633419|NCT00654420|470276112|FG003|Phase II|Progressive Disease|29|||
130633420|NCT00654420|470276109|FG000|Phase II|Withdrawal by Subject|0|||
130633421|NCT00654420|470276110|FG001|Phase II|Withdrawal by Subject|0|||
130633422|NCT00654420|470276111|FG002|Phase II|Withdrawal by Subject|4|||
130633423|NCT00654420|470276112|FG003|Phase II|Withdrawal by Subject|1|||
130633424|NCT00654420|470276109|FG000|Phase II|Missing Disposition Record|0|||
130633425|NCT00654420|470276110|FG001|Phase II|Missing Disposition Record|0|||
130633426|NCT00654420|470276111|FG002|Phase II|Missing Disposition Record|1|||
130633427|NCT00654420|470276112|FG003|Phase II|Missing Disposition Record|0|||
130633428|NCT00471276|470276114|FG000|Overall Study|Death|2|||
130633429|NCT00471276|470276114|FG000|Overall Study|Adverse Event|16|||
130633430|NCT00471276|470276114|FG000|Overall Study|Protocol Violation|1|||
130633431|NCT00471276|470276114|FG000|Overall Study|Objective progression or relapse|54|||
130633432|NCT00471276|470276114|FG000|Overall Study|Global deterioration of health status|1|||
130633433|NCT00471276|470276114|FG000|Overall Study|Other|3|||
130633434|NCT00471276|470276114|FG000|Overall Study|Refused treatment|6|||
130633435|NCT01614795|470276115|FG000|Overall Study|Adverse Event|0|||
130633436|NCT01614795|470276116|FG001|Overall Study|Adverse Event|0|||
130633437|NCT01614795|470276117|FG002|Overall Study|Adverse Event|1|||
130633438|NCT01614795|470276118|FG003|Overall Study|Adverse Event|1|||
130633439|NCT01614795|470276115|FG000|Overall Study|Lack of Efficacy|10|||
130633440|NCT01614795|470276116|FG001|Overall Study|Lack of Efficacy|10|||
130633441|NCT01614795|470276117|FG002|Overall Study|Lack of Efficacy|9|||
130633442|NCT01614795|470276118|FG003|Overall Study|Lack of Efficacy|8|||
130633443|NCT01614795|470276115|FG000|Overall Study|Physician Decision|1|||
130633444|NCT01614795|470276116|FG001|Overall Study|Physician Decision|0|||
130633445|NCT01614795|470276117|FG002|Overall Study|Physician Decision|1|||
130633446|NCT01614795|470276118|FG003|Overall Study|Physician Decision|1|||
130633447|NCT01614795|470276115|FG000|Overall Study|Withdrawal by Subject|0|||
130633448|NCT01614795|470276116|FG001|Overall Study|Withdrawal by Subject|1|||
130633449|NCT01614795|470276117|FG002|Overall Study|Withdrawal by Subject|0|||
130633450|NCT01614795|470276118|FG003|Overall Study|Withdrawal by Subject|2|||
130633451|NCT01614795|470276115|FG000|Overall Study|Ineligible|0|||
130633452|NCT01614795|470276116|FG001|Overall Study|Ineligible|1|||
130633453|NCT01614795|470276117|FG002|Overall Study|Ineligible|0|||
130633454|NCT01614795|470276118|FG003|Overall Study|Ineligible|0|||
130633455|NCT00814307|470276120|FG000|Overall Study|Randomized but not treated|1|||
130633456|NCT00814307|470276121|FG001|Overall Study|Randomized but not treated|0|||
130633457|NCT00814307|470276122|FG002|Overall Study|Randomized but not treated|0|||
130633458|NCT00814307|470276123|FG003|Overall Study|Randomized but not treated|0|||
130633459|NCT00814307|470276120|FG000|Overall Study|Adverse Event|3|||
130633460|NCT00814307|470276121|FG001|Overall Study|Adverse Event|9|||
130633461|NCT00814307|470276122|FG002|Overall Study|Adverse Event|3|||
130633462|NCT00814307|470276123|FG003|Overall Study|Adverse Event|2|||
130633463|NCT00814307|470276120|FG000|Overall Study|Lack of Efficacy|1|||
130633464|NCT00814307|470276121|FG001|Overall Study|Lack of Efficacy|1|||
130633465|NCT00814307|470276122|FG002|Overall Study|Lack of Efficacy|3|||
130633466|NCT00814307|470276123|FG003|Overall Study|Lack of Efficacy|4|||
130633467|NCT00814307|470276120|FG000|Overall Study|Other|1|||
130633468|NCT00814307|470276121|FG001|Overall Study|Other|2|||
130633469|NCT00814307|470276122|FG002|Overall Study|Other|0|||
130633470|NCT00814307|470276123|FG003|Overall Study|Other|1|||
130633471|NCT00814307|470276120|FG000|Overall Study|Protocol Violation|2|||
130633472|NCT00814307|470276121|FG001|Overall Study|Protocol Violation|8|||
130633473|NCT00814307|470276122|FG002|Overall Study|Protocol Violation|1|||
130633474|NCT00814307|470276123|FG003|Overall Study|Protocol Violation|1|||
130633475|NCT00814307|470276120|FG000|Overall Study|Withdrawal by Subject|4|||
130633476|NCT00814307|470276121|FG001|Overall Study|Withdrawal by Subject|6|||
130633477|NCT00814307|470276122|FG002|Overall Study|Withdrawal by Subject|0|||
130633478|NCT00814307|470276123|FG003|Overall Study|Withdrawal by Subject|2|||
130633479|NCT00814307|470276120|FG000|Overall Study|Death|0|||
130633480|NCT00814307|470276121|FG001|Overall Study|Death|1|||
130633481|NCT00814307|470276122|FG002|Overall Study|Death|0|||
130633482|NCT00814307|470276123|FG003|Overall Study|Death|0|||
130633483|NCT03039192|470276124|FG000|Overall Study|Lost to Follow-up|4|||
130633484|NCT03039192|470276125|FG001|Overall Study|Lost to Follow-up|4|||
130633485|NCT03039192|470276124|FG000|Overall Study|Adverse event, serious fatal|0|||
130633486|NCT03039192|470276125|FG001|Overall Study|Adverse event, serious fatal|1|||
130633487|NCT03039192|470276124|FG000|Overall Study|Adverse event, non-fatal|0|||
130633488|NCT03039192|470276125|FG001|Overall Study|Adverse event, non-fatal|2|||
130633489|NCT03039192|470276124|FG000|Overall Study|Withdrawal by Subject|6|||
130633490|NCT03039192|470276125|FG001|Overall Study|Withdrawal by Subject|9|||
130633491|NCT03039192|470276124|FG000|Overall Study|Discontinued from treatment phase|19|||
130633492|NCT03039192|470276125|FG001|Overall Study|Discontinued from treatment phase|12|||
130633493|NCT03039192|470276124|FG000|Overall Study|Other|3|||
130633494|NCT03039192|470276125|FG001|Overall Study|Other|2|||
130633495|NCT00777257|470277993|FG000|Overall Study|Adverse Event|3|||
130633496|NCT00777257|470277994|FG001|Overall Study|Adverse Event|1|||
130633497|NCT00777257|470277995|FG002|Overall Study|Adverse Event|0|||
130633498|NCT00777257|470277993|FG000|Overall Study|Lost to Follow-up|3|||
130633499|NCT00777257|470277994|FG001|Overall Study|Lost to Follow-up|3|||
130633500|NCT00777257|470277995|FG002|Overall Study|Lost to Follow-up|2|||
130633501|NCT00777257|470277993|FG000|Overall Study|Protocol Violation|2|||
130633502|NCT00777257|470277994|FG001|Overall Study|Protocol Violation|2|||
130633503|NCT00777257|470277995|FG002|Overall Study|Protocol Violation|2|||
130633504|NCT00777257|470277993|FG000|Overall Study|Withdrawal by Subject|3|||
130633505|NCT00777257|470277994|FG001|Overall Study|Withdrawal by Subject|6|||
130633506|NCT00777257|470277995|FG002|Overall Study|Withdrawal by Subject|5|||
130633507|NCT00098865|470277996|FG000|Overall Study|Progressive Disease|6|||
130633508|NCT00098865|470277996|FG000|Overall Study|Adverse Event|2|||
130633509|NCT00098865|470277996|FG000|Overall Study|Alternative Therapy|1|||
130633510|NCT00688623|470277998|FG000|Overall Study|Adverse Event|22|||
130633511|NCT00688623|470277998|FG000|Overall Study|abnormal lab value|1|||
130633512|NCT00688623|470277998|FG000|Overall Study|Withdrawal by Subject|4|||
130633513|NCT00688623|470277998|FG000|Overall Study|Death|3|||
130633514|NCT00688623|470277998|FG000|Overall Study|disease progression|23|||
130633515|NCT00688623|470277998|FG000|Overall Study|Protocol Violation|2|||
130633516|NCT02667236|470277999|FG000|Overall Study|Adverse Event|1|||
130633517|NCT02667236|470278000|FG001|Overall Study|Adverse Event|1|||
130633518|NCT02667236|470277999|FG000|Overall Study|Withdrawal by Subject|2|||
130633519|NCT02667236|470278000|FG001|Overall Study|Withdrawal by Subject|0|||
130633520|NCT00464620|470278001|FG000|Overall Study|Physician Decision|1|||
130633521|NCT00464620|470278002|FG001|Overall Study|Physician Decision|0|||
130633522|NCT00464620|470278003|FG002|Overall Study|Physician Decision|0|||
130633523|NCT00464620|470278001|FG000|Overall Study|Withdrawal by Subject|1|||
130633524|NCT00464620|470278002|FG001|Overall Study|Withdrawal by Subject|0|||
130633525|NCT00464620|470278003|FG002|Overall Study|Withdrawal by Subject|3|||
130633526|NCT00464620|470278001|FG000|Overall Study|Ineligible sarcoma subtype|0|||
130633527|NCT00464620|470278002|FG001|Overall Study|Ineligible sarcoma subtype|2|||
130633528|NCT00464620|470278003|FG002|Overall Study|Ineligible sarcoma subtype|2|||
130633529|NCT00464620|470278001|FG000|Overall Study|Use of prohibited concomitant medication|0|||
130633530|NCT00464620|470278002|FG001|Overall Study|Use of prohibited concomitant medication|0|||
130633531|NCT00464620|470278003|FG002|Overall Study|Use of prohibited concomitant medication|2|||
130633532|NCT04984876|470278004|FG000|Overall Study|Subject decision|2|||
130633533|NCT04984876|470278005|FG001|Overall Study|Subject decision|10|||
130633534|NCT04984876|470278006|FG002|Overall Study|Subject decision|3|||
130633535|NCT04984876|470278007|FG003|Overall Study|Subject decision|3|||
130633536|NCT04984876|470278008|FG004|Overall Study|Subject decision|3|||
130633537|NCT04984876|470278009|FG005|Overall Study|Subject decision|0|||
130633538|NCT04984876|470278004|FG000|Overall Study|Guardian decision|0|||
130633539|NCT04984876|470278005|FG001|Overall Study|Guardian decision|1|||
130633540|NCT04984876|470278006|FG002|Overall Study|Guardian decision|0|||
130633541|NCT04984876|470278007|FG003|Overall Study|Guardian decision|2|||
130633542|NCT04984876|470278008|FG004|Overall Study|Guardian decision|0|||
130633543|NCT04984876|470278009|FG005|Overall Study|Guardian decision|1|||
130633544|NCT04984876|470278004|FG000|Overall Study|Lost to Follow-up|0|||
130633545|NCT04984876|470278005|FG001|Overall Study|Lost to Follow-up|0|||
130633546|NCT04984876|470278006|FG002|Overall Study|Lost to Follow-up|1|||
130633547|NCT04984876|470278007|FG003|Overall Study|Lost to Follow-up|1|||
130633548|NCT04984876|470278008|FG004|Overall Study|Lost to Follow-up|0|||
130633549|NCT04984876|470278009|FG005|Overall Study|Lost to Follow-up|0|||
130633550|NCT04984876|470278004|FG000|Overall Study|Physician Decision|1|||
130633551|NCT04984876|470278005|FG001|Overall Study|Physician Decision|0|||
130633552|NCT04984876|470278006|FG002|Overall Study|Physician Decision|0|||
130633553|NCT04984876|470278007|FG003|Overall Study|Physician Decision|1|||
130633554|NCT04984876|470278008|FG004|Overall Study|Physician Decision|0|||
130633555|NCT04984876|470278009|FG005|Overall Study|Physician Decision|0|||
130633556|NCT04984876|470278004|FG000|Overall Study|Adverse Event|0|||
130633557|NCT04984876|470278005|FG001|Overall Study|Adverse Event|0|||
130633558|NCT04984876|470278006|FG002|Overall Study|Adverse Event|1|||
130633559|NCT04984876|470278007|FG003|Overall Study|Adverse Event|0|||
130633560|NCT04984876|470278008|FG004|Overall Study|Adverse Event|0|||
130633561|NCT04984876|470278009|FG005|Overall Study|Adverse Event|0|||
130633562|NCT03654560|470278012|FG000|Overall Study|Death|3|||
130633563|NCT03654560|470278013|FG001|Overall Study|Death|1|||
130633564|NCT03654560|470278012|FG000|Overall Study|Lost to Follow-up|1|||
130633565|NCT03654560|470278013|FG001|Overall Study|Lost to Follow-up|0|||
130633566|NCT00209092|470278014|FG000|Overall Study|Progression of disease|7|||
130633567|NCT00209092|470278015|FG001|Overall Study|Progression of disease|1|||
130633568|NCT00209092|470278014|FG000|Overall Study|Adverse Event|0|||
130633569|NCT00209092|470278015|FG001|Overall Study|Adverse Event|1|||
130633570|NCT00209092|470278014|FG000|Overall Study|Withdrawal by Subject|1|||
130633571|NCT00209092|470278015|FG001|Overall Study|Withdrawal by Subject|0|||
130633572|NCT02436915|470278018|FG000|Overall Study|Withdrawal by Subject|0|||
130633573|NCT02436915|470278019|FG001|Overall Study|Withdrawal by Subject|1|||
130633574|NCT01117181|470278026|FG000|Overall Study|Lost to Follow-up|1|||
130633575|NCT01117181|470278027|FG001|Overall Study|Lost to Follow-up|0|||
130633576|NCT01117181|470278026|FG000|Overall Study|Withdrawal by Subject|0|||
130633577|NCT01117181|470278027|FG001|Overall Study|Withdrawal by Subject|2|||
130633578|NCT01518309|470278028|FG000|Overall Study|Adverse Event|6|||
130633579|NCT01518309|470278028|FG000|Overall Study|Death|6|||
130633580|NCT01518309|470278028|FG000|Overall Study|Lack of Efficacy|7|||
130633581|NCT01518309|470278028|FG000|Overall Study|Withdrawal by Subject|6|||
130633582|NCT01518309|470278028|FG000|Overall Study|Physician Decision|3|||
130633583|NCT01518309|470278028|FG000|Overall Study|Sponsor Decision|2|||
130633584|NCT01518309|470278028|FG000|Overall Study|Not in Predefined Categories|9|||
130633585|NCT00863317|470278029|FG000|Overall Study|Lost to Follow-up|8|||
130633586|NCT00863317|470278030|FG001|Overall Study|Lost to Follow-up|9|||
130633587|NCT00038142|470278033|FG000|Overall Study|Ineligible|1|||
130633588|NCT00038142|470278034|FG001|Overall Study|Ineligible|0|||
130633589|NCT00038142|470278033|FG000|Overall Study|Progressive Disease|11|||
130633590|NCT00038142|470278034|FG001|Overall Study|Progressive Disease|7|||
130633591|NCT00038142|470278033|FG000|Overall Study|Death|1|||
130633592|NCT00038142|470278034|FG001|Overall Study|Death|0|||
130633593|NCT00038142|470278033|FG000|Overall Study|Adverse Event|1|||
130633594|NCT00038142|470278034|FG001|Overall Study|Adverse Event|0|||
130633595|NCT00038142|470278033|FG000|Overall Study|Unknown Reason|8|||
130633596|NCT00038142|470278034|FG001|Overall Study|Unknown Reason|0|||
130633597|NCT00809614|470278041|FG000|Overall Study|Lack of Efficacy|2|||
130633598|NCT00809614|470278042|FG001|Overall Study|Lack of Efficacy|3|||
130633599|NCT00809614|470278041|FG000|Overall Study|Withdrawal by Subject|1|||
130633600|NCT00809614|470278042|FG001|Overall Study|Withdrawal by Subject|1|||
130633601|NCT01080625|470278043|FG000|Overall Study|Physician Decision|0|||
130633602|NCT01080625|470278044|FG001|Overall Study|Physician Decision|2|||
130633603|NCT01080625|470278045|FG002|Overall Study|Physician Decision|1|||
130633604|NCT00364832|470278049|FG000|Core Period|Early Withdrawals|2|||
130633605|NCT00364832|470278050|FG001|Core Period|Early Withdrawals|2|||
130633606|NCT00364832|470278051|FG002|Core Period|Early Withdrawals|1|||
130633607|NCT00364832|470278052|FG003|Core Period|Early Withdrawals|1|||
130633608|NCT00364832|470278053|FG004|Core Period|Early Withdrawals|0|||
130633609|NCT00364832|470278054|FG005|Core Period|Early Withdrawals|0|||
130633610|NCT00364832|470278055|FG006|Core Period|Early Withdrawals|4|||
130633611|NCT00364832|470278056|FG007|Core Period|Early Withdrawals|1|||
130633612|NCT00364832|470278057|FG008|Core Period|Early Withdrawals|0|||
130633613|NCT00364832|470278058|FG009|Core Period|Early Withdrawals|0|||
130633614|NCT00364832|470278059|FG010|Core Period|Early Withdrawals|0|||
130633615|NCT00364832|470278060|FG011|Core Period|Early Withdrawals|0|||
130633616|NCT00364832|470278049|FG000|Extension Year 1|Early Withdrawals|0|||
130633617|NCT00364832|470278050|FG001|Extension Year 1|Early Withdrawals|0|||
130633618|NCT00364832|470278051|FG002|Extension Year 1|Early Withdrawals|0|||
130633619|NCT00364832|470278052|FG003|Extension Year 1|Early Withdrawals|0|||
130633620|NCT00364832|470278053|FG004|Extension Year 1|Early Withdrawals|0|||
130633621|NCT00364832|470278054|FG005|Extension Year 1|Early Withdrawals|0|||
130633622|NCT00364832|470278055|FG006|Extension Year 1|Early Withdrawals|0|||
130633623|NCT00364832|470278056|FG007|Extension Year 1|Early Withdrawals|0|||
130633624|NCT00364832|470278057|FG008|Extension Year 1|Early Withdrawals|0|||
130633625|NCT00364832|470278058|FG009|Extension Year 1|Early Withdrawals|4|||
130633626|NCT00364832|470278059|FG010|Extension Year 1|Early Withdrawals|2|||
130633627|NCT00364832|470278060|FG011|Extension Year 1|Early Withdrawals|10|||
130633628|NCT00364832|470278049|FG000|Extension Year 2|Early Withdrawals|0|||
130633629|NCT00364832|470278050|FG001|Extension Year 2|Early Withdrawals|0|||
130633630|NCT00364832|470278051|FG002|Extension Year 2|Early Withdrawals|0|||
130633631|NCT00364832|470278052|FG003|Extension Year 2|Early Withdrawals|0|||
130633632|NCT00364832|470278053|FG004|Extension Year 2|Early Withdrawals|0|||
130633633|NCT00364832|470278054|FG005|Extension Year 2|Early Withdrawals|0|||
130633634|NCT00364832|470278055|FG006|Extension Year 2|Early Withdrawals|0|||
130633635|NCT00364832|470278056|FG007|Extension Year 2|Early Withdrawals|0|||
130633636|NCT00364832|470278057|FG008|Extension Year 2|Early Withdrawals|0|||
130633637|NCT00364832|470278058|FG009|Extension Year 2|Early Withdrawals|5|||
130633638|NCT00364832|470278059|FG010|Extension Year 2|Early Withdrawals|5|||
130633639|NCT00364832|470278060|FG011|Extension Year 2|Early Withdrawals|3|||
130633640|NCT01440972|470278063|FG000|Overall Study|Withdrawal by Subject|3|||
130633641|NCT01440972|470278064|FG001|Overall Study|Withdrawal by Subject|2|||
130633642|NCT04222673|470278065|FG000|Overall Study|Lost to Follow-up|5|||
130633643|NCT00068822|470278066|FG000|First Randomized Intervention|Lost to Follow-up|1|||
130633644|NCT00068822|470278067|FG001|First Randomized Intervention|Lost to Follow-up|2|||
130633645|NCT00735072|470278071|FG000|Overall Study|interrupted study med during ARV change|1|||
130633646|NCT00735072|470278072|FG001|Overall Study|interrupted study med during ARV change|0|||
130633647|NCT00735072|470278071|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
130633648|NCT00735072|470278072|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
130633649|NCT03146403|470278073|FG000|Overall Study|Withdrawal by Subject|0|||
130633650|NCT03146403|470278074|FG001|Overall Study|Withdrawal by Subject|3|||
130633651|NCT03146403|470278073|FG000|Overall Study|Lost to Follow-up|2|||
130633652|NCT03146403|470278074|FG001|Overall Study|Lost to Follow-up|0|||
130633653|NCT01024920|470278075|FG000|Overall Study|Progressive disease|47|||
130633654|NCT01024920|470278076|FG001|Overall Study|Progressive disease|25|||
130633655|NCT01024920|470278075|FG000|Overall Study|Adverse Event|8|||
130633656|NCT01024920|470278076|FG001|Overall Study|Adverse Event|4|||
130633657|NCT01024920|470278075|FG000|Overall Study|Lost to Follow-up|0|||
130633658|NCT01024920|470278076|FG001|Overall Study|Lost to Follow-up|1|||
130633659|NCT01024920|470278075|FG000|Overall Study|Patient refusal to continue|4|||
130633660|NCT01024920|470278076|FG001|Overall Study|Patient refusal to continue|0|||
130633661|NCT01024920|470278075|FG000|Overall Study|Other than listed|5|||
130633662|NCT01024920|470278076|FG001|Overall Study|Other than listed|1|||
130633663|NCT01024920|470278075|FG000|Overall Study|Not treated|3|||
130633664|NCT01024920|470278076|FG001|Overall Study|Not treated|0|||
130633665|NCT01024920|470278075|FG000|Overall Study|Protocol Violation|0|||
130633666|NCT01024920|470278076|FG001|Overall Study|Protocol Violation|1|||
130633667|NCT04599972|470278086|FG000|Overall Study|Withdrawal by Subject|6|||
130633668|NCT04599972|470278087|FG001|Overall Study|Withdrawal by Subject|1|||
130633669|NCT04599972|470278086|FG000|Overall Study|Adverse Event|1|||
130633670|NCT04599972|470278087|FG001|Overall Study|Adverse Event|1|||
130633671|NCT04599972|470278086|FG000|Overall Study|Lost to Follow-up|1|||
130633672|NCT04599972|470278087|FG001|Overall Study|Lost to Follow-up|6|||
130633673|NCT04599972|470278086|FG000|Overall Study|Protocol Violation|1|||
130633674|NCT04599972|470278087|FG001|Overall Study|Protocol Violation|0|||
130633675|NCT04599972|470278086|FG000|Overall Study|Other reason|1|||
130633676|NCT04599972|470278087|FG001|Overall Study|Other reason|0|||
130633677|NCT01594411|470278094|FG000|Overall Study|Lost to Follow-up|2|||
130633678|NCT04449276|470278100|FG000|Overall Study|Adverse Event|1|||
130633679|NCT04449276|470278101|FG001|Overall Study|Adverse Event|2|||
130633680|NCT04449276|470278102|FG002|Overall Study|Adverse Event|0|||
130633681|NCT04449276|470278103|FG003|Overall Study|Adverse Event|0|||
130633682|NCT04449276|470278104|FG004|Overall Study|Adverse Event|2|||
130633683|NCT04449276|470278105|FG005|Overall Study|Adverse Event|0|||
130633684|NCT04449276|470278106|FG006|Overall Study|Adverse Event|0|||
130633685|NCT04449276|470278107|FG007|Overall Study|Adverse Event|1|||
130633686|NCT04449276|470278100|FG000|Overall Study|Withdrawal by Subject|2|||
130633687|NCT04449276|470278101|FG001|Overall Study|Withdrawal by Subject|0|||
130633688|NCT04449276|470278102|FG002|Overall Study|Withdrawal by Subject|0|||
130633689|NCT04449276|470278103|FG003|Overall Study|Withdrawal by Subject|1|||
130633690|NCT04449276|470278104|FG004|Overall Study|Withdrawal by Subject|0|||
130633691|NCT04449276|470278105|FG005|Overall Study|Withdrawal by Subject|0|||
130633692|NCT04449276|470278106|FG006|Overall Study|Withdrawal by Subject|0|||
130633693|NCT04449276|470278107|FG007|Overall Study|Withdrawal by Subject|0|||
130633694|NCT04449276|470278100|FG000|Overall Study|Other|0|||
130633695|NCT04449276|470278101|FG001|Overall Study|Other|2|||
130633696|NCT04449276|470278102|FG002|Overall Study|Other|3|||
130633697|NCT04449276|470278103|FG003|Overall Study|Other|2|||
130633698|NCT04449276|470278104|FG004|Overall Study|Other|0|||
130633699|NCT04449276|470278105|FG005|Overall Study|Other|0|||
130633700|NCT04449276|470278106|FG006|Overall Study|Other|0|||
130633701|NCT04449276|470278107|FG007|Overall Study|Other|1|||
130633702|NCT00910728|470278111|FG000|Overall Study|Lack of Efficacy|2|||
130633703|NCT00910728|470278112|FG001|Overall Study|Lack of Efficacy|3|||
130633704|NCT00910728|470278113|FG002|Overall Study|Lack of Efficacy|1|||
130633705|NCT00910728|470278114|FG003|Overall Study|Lack of Efficacy|2|||
130633706|NCT00910728|470278115|FG004|Overall Study|Lack of Efficacy|1|||
130633707|NCT00910728|470278116|FG005|Overall Study|Lack of Efficacy|0|||
130633708|NCT00910728|470278117|FG006|Overall Study|Lack of Efficacy|2|||
130633709|NCT00910728|470278118|FG007|Overall Study|Lack of Efficacy|2|||
130633710|NCT00910728|470278119|FG008|Overall Study|Lack of Efficacy|2|||
130633711|NCT00910728|470278111|FG000|Overall Study|Withdrawal by Subject|0|||
130633712|NCT00910728|470278112|FG001|Overall Study|Withdrawal by Subject|0|||
130633713|NCT00910728|470278113|FG002|Overall Study|Withdrawal by Subject|0|||
130633714|NCT00910728|470278114|FG003|Overall Study|Withdrawal by Subject|0|||
130633715|NCT00910728|470278115|FG004|Overall Study|Withdrawal by Subject|3|||
130633716|NCT00910728|470278116|FG005|Overall Study|Withdrawal by Subject|1|||
130633717|NCT00910728|470278117|FG006|Overall Study|Withdrawal by Subject|2|||
130633718|NCT00910728|470278118|FG007|Overall Study|Withdrawal by Subject|0|||
130633719|NCT00910728|470278119|FG008|Overall Study|Withdrawal by Subject|0|||
130633720|NCT00910728|470278111|FG000|Overall Study|(not specified)|2|||
130633721|NCT00910728|470278112|FG001|Overall Study|(not specified)|0|||
130633722|NCT00910728|470278113|FG002|Overall Study|(not specified)|1|||
130633723|NCT00910728|470278114|FG003|Overall Study|(not specified)|0|||
130633724|NCT00910728|470278115|FG004|Overall Study|(not specified)|1|||
130633725|NCT00910728|470278116|FG005|Overall Study|(not specified)|0|||
130633726|NCT00910728|470278117|FG006|Overall Study|(not specified)|0|||
130633727|NCT00910728|470278118|FG007|Overall Study|(not specified)|0|||
130633728|NCT00910728|470278119|FG008|Overall Study|(not specified)|0|||
130633729|NCT00910728|470278111|FG000|Overall Study|Adverse Event|2|||
130633730|NCT00910728|470278112|FG001|Overall Study|Adverse Event|0|||
130633731|NCT00910728|470278113|FG002|Overall Study|Adverse Event|1|||
130633732|NCT00910728|470278114|FG003|Overall Study|Adverse Event|1|||
130633733|NCT00910728|470278115|FG004|Overall Study|Adverse Event|0|||
130633734|NCT00910728|470278116|FG005|Overall Study|Adverse Event|0|||
130633735|NCT00910728|470278117|FG006|Overall Study|Adverse Event|2|||
130633736|NCT00910728|470278118|FG007|Overall Study|Adverse Event|1|||
130633737|NCT00910728|470278119|FG008|Overall Study|Adverse Event|1|||
130633738|NCT00023712|470278120|FG000|Overall Study|Not platinum sensitive|1|||
130633739|NCT00023712|470278121|FG001|Overall Study|Not platinum sensitive|0|||
130633740|NCT00023712|470278120|FG000|Overall Study|Never treated|1|||
130633741|NCT00023712|470278121|FG001|Overall Study|Never treated|1|||
130633742|NCT00565812|470278124|FG000|Overall Study|Death|2|||
130633743|NCT00565812|470278125|FG001|Overall Study|Death|1|||
130633744|NCT00565812|470278126|FG002|Overall Study|Death|3|||
130633745|NCT00565812|470278124|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
130633746|NCT00565812|470278125|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
130633747|NCT00565812|470278126|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
130633748|NCT00565812|470278124|FG000|Overall Study|Lost to Follow-up|10|||
130633749|NCT00565812|470278125|FG001|Overall Study|Lost to Follow-up|8|||
130633750|NCT00565812|470278126|FG002|Overall Study|Lost to Follow-up|8|||
130633751|NCT00565812|470278124|FG000|Overall Study|Withdrawal by Subject|58|||
130633752|NCT00565812|470278125|FG001|Overall Study|Withdrawal by Subject|47|||
130633753|NCT00565812|470278126|FG002|Overall Study|Withdrawal by Subject|48|||
130633754|NCT00565812|470278124|FG000|Overall Study|Work Schedule|5|||
130633755|NCT00565812|470278125|FG001|Overall Study|Work Schedule|3|||
130633756|NCT00565812|470278126|FG002|Overall Study|Work Schedule|1|||
130633757|NCT00565812|470278124|FG000|Overall Study|Protocol Violation|2|||
130633758|NCT00565812|470278125|FG001|Overall Study|Protocol Violation|6|||
130633759|NCT00565812|470278126|FG002|Overall Study|Protocol Violation|4|||
130633760|NCT00565812|470278124|FG000|Overall Study|Adverse Event|41|||
130633761|NCT00565812|470278125|FG001|Overall Study|Adverse Event|54|||
130633762|NCT00565812|470278126|FG002|Overall Study|Adverse Event|40|||
130633763|NCT00565812|470278124|FG000|Overall Study|Jury Duty|1|||
130633764|NCT00565812|470278125|FG001|Overall Study|Jury Duty|0|||
130633765|NCT00565812|470278126|FG002|Overall Study|Jury Duty|0|||
130633766|NCT00565812|470278124|FG000|Overall Study|Relocated Out of Area|5|||
130633767|NCT00565812|470278125|FG001|Overall Study|Relocated Out of Area|8|||
130633768|NCT00565812|470278126|FG002|Overall Study|Relocated Out of Area|9|||
130633769|NCT00565812|470278124|FG000|Overall Study|Sponsor Decision|1|||
130633770|NCT00565812|470278125|FG001|Overall Study|Sponsor Decision|5|||
130633771|NCT00565812|470278126|FG002|Overall Study|Sponsor Decision|1|||
130633772|NCT00565812|470278124|FG000|Overall Study|Domestic Reasons|7|||
130633773|NCT00565812|470278125|FG001|Overall Study|Domestic Reasons|1|||
130633774|NCT00565812|470278126|FG002|Overall Study|Domestic Reasons|3|||
130633775|NCT00565812|470278124|FG000|Overall Study|Research Site Closure|6|||
130633776|NCT00565812|470278125|FG001|Overall Study|Research Site Closure|1|||
130633777|NCT00565812|470278126|FG002|Overall Study|Research Site Closure|8|||
130633778|NCT00565812|470278124|FG000|Overall Study|Surgical Intervention|0|||
130633779|NCT00565812|470278125|FG001|Overall Study|Surgical Intervention|1|||
130633780|NCT00565812|470278126|FG002|Overall Study|Surgical Intervention|2|||
130633781|NCT00565812|470278124|FG000|Overall Study|Low Compliance|1|||
130633782|NCT00565812|470278125|FG001|Overall Study|Low Compliance|0|||
130633783|NCT00565812|470278126|FG002|Overall Study|Low Compliance|1|||
130633784|NCT00565812|470278124|FG000|Overall Study|Follow-up Visit Not Completed|2|||
130633785|NCT00565812|470278125|FG001|Overall Study|Follow-up Visit Not Completed|0|||
130633786|NCT00565812|470278126|FG002|Overall Study|Follow-up Visit Not Completed|1|||
130633787|NCT00565812|470278124|FG000|Overall Study|Physician Decision|2|||
130633788|NCT00565812|470278125|FG001|Overall Study|Physician Decision|0|||
130633789|NCT00565812|470278126|FG002|Overall Study|Physician Decision|0|||
130633790|NCT04968353|470278127|FG000|Overall Study|Non-compliance|1|||
130633791|NCT04968353|470278128|FG001|Overall Study|Non-compliance|0|||
130633792|NCT04968353|470278129|FG002|Overall Study|Non-compliance|2|||
130633793|NCT04968353|470278130|FG003|Overall Study|Non-compliance|0|||
130633794|NCT03215667|470278134|FG000|Overall Study|Physician Decision|4|||
130633795|NCT01810380|470278137|FG000|Overall Study|Randomised not treated|2|||
130633796|NCT01810380|470278138|FG001|Overall Study|Randomised not treated|1|||
130633797|NCT01810380|470278139|FG002|Overall Study|Randomised not treated|1|||
130633798|NCT01810380|470278137|FG000|Overall Study|Adverse Event|11|||
130633799|NCT01810380|470278138|FG001|Overall Study|Adverse Event|14|||
130633800|NCT01810380|470278139|FG002|Overall Study|Adverse Event|4|||
130633801|NCT01810380|470278137|FG000|Overall Study|Lack of Efficacy|24|||
130633802|NCT01810380|470278138|FG001|Overall Study|Lack of Efficacy|10|||
130633803|NCT01810380|470278139|FG002|Overall Study|Lack of Efficacy|11|||
130633804|NCT01810380|470278137|FG000|Overall Study|Protocol Violation|1|||
130633805|NCT01810380|470278138|FG001|Overall Study|Protocol Violation|0|||
130633806|NCT01810380|470278139|FG002|Overall Study|Protocol Violation|1|||
130633807|NCT01810380|470278137|FG000|Overall Study|Withdrawal by Subject|6|||
130633808|NCT01810380|470278138|FG001|Overall Study|Withdrawal by Subject|0|||
130633809|NCT01810380|470278139|FG002|Overall Study|Withdrawal by Subject|6|||
130633810|NCT01810380|470278137|FG000|Overall Study|Administrative or other reasons|11|||
130633811|NCT01810380|470278138|FG001|Overall Study|Administrative or other reasons|13|||
130633812|NCT01810380|470278139|FG002|Overall Study|Administrative or other reasons|9|||
130633813|NCT00614991|470278140|FG000|Overall Study|Adverse Event|3|||
130633814|NCT00614991|470278141|FG001|Overall Study|Adverse Event|3|||
130633815|NCT00614991|470278142|FG002|Overall Study|Adverse Event|0|||
130633816|NCT00614991|470278143|FG003|Overall Study|Adverse Event|0|||
130633817|NCT00614991|470278144|FG004|Overall Study|Adverse Event|1|||
130633818|NCT00614991|470278145|FG005|Overall Study|Adverse Event|0|||
130633819|NCT03209362|470278150|FG000|Overall Study|Adverse Event|0|||
130633820|NCT03209362|470278151|FG001|Overall Study|Adverse Event|1|||
130633821|NCT03209362|470278150|FG000|Overall Study|Lost to Follow-up|0|||
130633822|NCT03209362|470278151|FG001|Overall Study|Lost to Follow-up|1|||
130633823|NCT03209362|470278150|FG000|Overall Study|Withdrawal by Subject|2|||
130633824|NCT03209362|470278151|FG001|Overall Study|Withdrawal by Subject|0|||
130633825|NCT03209362|470278150|FG000|Overall Study|Other|0|||
130633826|NCT03209362|470278151|FG001|Overall Study|Other|1|||
130633827|NCT00251589|470278154|FG000|Overall Study|Adverse Event|5|||
130633828|NCT00251589|470278155|FG001|Overall Study|Adverse Event|1|||
130633829|NCT00251589|470278156|FG002|Overall Study|Adverse Event|2|||
130633830|NCT00251589|470278157|FG003|Overall Study|Adverse Event|1|||
130633831|NCT00251589|470278154|FG000|Overall Study|Withdrawal by Subject|1|||
130633832|NCT00251589|470278155|FG001|Overall Study|Withdrawal by Subject|1|||
130633833|NCT00251589|470278156|FG002|Overall Study|Withdrawal by Subject|0|||
130633834|NCT00251589|470278157|FG003|Overall Study|Withdrawal by Subject|0|||
130633835|NCT00251589|470278154|FG000|Overall Study|Discontinued due to progressive disease|9|||
130633836|NCT00251589|470278155|FG001|Overall Study|Discontinued due to progressive disease|1|||
130633837|NCT00251589|470278156|FG002|Overall Study|Discontinued due to progressive disease|0|||
130633838|NCT00251589|470278157|FG003|Overall Study|Discontinued due to progressive disease|1|||
130633839|NCT02571972|470278160|FG000|Overall Study|Protocol Violation|2|||
130633840|NCT02571972|470278160|FG000|Overall Study|Withdrawal by Subject|2|||
130633841|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Adverse Event|22|||
130633842|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Adverse Event|0|||
130633843|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
130633844|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
130633845|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
130633846|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
130633847|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
130633848|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
130633849|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
130633850|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
130633851|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
130633852|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
130633853|NCT02493868|470278163|FG000|Induction Phase: DE Participants|Other|8|||
130633854|NCT02493868|470278164|FG001|Induction Phase: DE Participants|Other|0|||
130633855|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
130633856|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
130633857|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
130633858|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
130633859|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
130633860|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
130633861|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
130633862|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
130633863|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
130633864|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
130633865|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
130633866|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
130633867|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
130633868|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
130633869|NCT02493868|470278163|FG000|Optimization Phase: DE+TE Participants|Other|10|||
130633870|NCT02493868|470278164|FG001|Optimization Phase: DE+TE Participants|Other|2|||
130633871|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
130633872|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
130633873|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
130633874|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
130633875|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
130633876|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
130633877|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
130633878|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
130633879|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
130633880|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
130633881|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
130633882|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
130633883|NCT02493868|470278163|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
130633884|NCT02493868|470278164|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
130633885|NCT02493868|470278163|FG000|Follow-up Phase|Lost to Follow-up|1|||
130633886|NCT02493868|470278164|FG001|Follow-up Phase|Lost to Follow-up|0|||
130633887|NCT02493868|470278163|FG000|Follow-up Phase|Withdrawal by Subject|3|||
130633888|NCT02493868|470278164|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130633889|NCT02493868|470278163|FG000|Follow-up Phase|Investigator Decision|5|||
130633890|NCT02493868|470278164|FG001|Follow-up Phase|Investigator Decision|1|||
130633891|NCT02493868|470278163|FG000|Follow-up Phase|Other|2|||
130633892|NCT02493868|470278164|FG001|Follow-up Phase|Other|1|||
130633893|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
130633894|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
130633895|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
130633896|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
130633897|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
130633898|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
130633899|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
130633900|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
130633901|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
130633902|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
130633903|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
130633904|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
130633905|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
130633906|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Death|0|||
130633907|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Death|0|||
130633908|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Death|1|||
130633909|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Death|0|||
130633910|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Death|0|||
130633911|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Death|0|||
130633912|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Death|0|||
130633913|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Death|0|||
130633914|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Death|0|||
130633915|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Death|0|||
130633916|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Death|0|||
130633917|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Death|0|||
130633918|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Death|0|||
130633919|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
130633920|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
130633921|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
130633922|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633923|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633924|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633925|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633926|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633927|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633928|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633929|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633930|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633931|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130633932|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633933|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633934|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
130633935|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633936|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633937|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633938|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633939|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633940|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633941|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633942|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633943|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633944|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130633945|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
130633946|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
130633947|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
130633948|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
130633949|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
130633950|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
130633951|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
130633952|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
130633953|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
130633954|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
130633955|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
130633956|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
130633957|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
130633958|NCT02407236|470278165|FG000|Induction Study (8 Weeks)|Other|2|||
130633959|NCT02407236|470278166|FG001|Induction Study (8 Weeks)|Other|1|||
130633960|NCT02407236|470278167|FG002|Induction Study (8 Weeks)|Other|5|||
130633961|NCT02407236|470278168|FG003|Induction Study (8 Weeks)|Other|0|||
130633962|NCT02407236|470278169|FG004|Induction Study (8 Weeks)|Other|0|||
130633963|NCT02407236|470278170|FG005|Induction Study (8 Weeks)|Other|0|||
130633964|NCT02407236|470278171|FG006|Induction Study (8 Weeks)|Other|0|||
130633965|NCT02407236|470278172|FG007|Induction Study (8 Weeks)|Other|0|||
130633966|NCT02407236|470278173|FG008|Induction Study (8 Weeks)|Other|0|||
130633967|NCT02407236|470278174|FG009|Induction Study (8 Weeks)|Other|0|||
130633968|NCT02407236|470278175|FG010|Induction Study (8 Weeks)|Other|0|||
130633969|NCT02407236|470278176|FG011|Induction Study (8 Weeks)|Other|0|||
130633970|NCT02407236|470278177|FG012|Induction Study (8 Weeks)|Other|0|||
130633971|NCT02407236|470278165|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633972|NCT02407236|470278166|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633973|NCT02407236|470278167|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633974|NCT02407236|470278168|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
130633975|NCT02407236|470278169|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
130633976|NCT02407236|470278170|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
130633977|NCT02407236|470278171|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
130633978|NCT02407236|470278172|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
130633979|NCT02407236|470278173|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633980|NCT02407236|470278174|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633981|NCT02407236|470278175|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633982|NCT02407236|470278176|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633983|NCT02407236|470278177|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
130633984|NCT02407236|470278165|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633985|NCT02407236|470278166|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633986|NCT02407236|470278167|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633987|NCT02407236|470278168|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
130633988|NCT02407236|470278169|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
130633989|NCT02407236|470278170|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
130633990|NCT02407236|470278171|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
130633991|NCT02407236|470278172|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
130633992|NCT02407236|470278173|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633993|NCT02407236|470278174|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633994|NCT02407236|470278175|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633995|NCT02407236|470278176|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633996|NCT02407236|470278177|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130633997|NCT02407236|470278165|FG000|Maintenance Study (44 Weeks)|Other|0|||
130633998|NCT02407236|470278166|FG001|Maintenance Study (44 Weeks)|Other|0|||
130633999|NCT02407236|470278167|FG002|Maintenance Study (44 Weeks)|Other|0|||
130634000|NCT02407236|470278168|FG003|Maintenance Study (44 Weeks)|Other|5|||
130634001|NCT02407236|470278169|FG004|Maintenance Study (44 Weeks)|Other|7|||
130634002|NCT02407236|470278170|FG005|Maintenance Study (44 Weeks)|Other|8|||
130634003|NCT02407236|470278171|FG006|Maintenance Study (44 Weeks)|Other|4|||
130634004|NCT02407236|470278172|FG007|Maintenance Study (44 Weeks)|Other|6|||
130634005|NCT02407236|470278173|FG008|Maintenance Study (44 Weeks)|Other|0|||
130634006|NCT02407236|470278174|FG009|Maintenance Study (44 Weeks)|Other|0|||
130634007|NCT02407236|470278175|FG010|Maintenance Study (44 Weeks)|Other|0|||
130634008|NCT02407236|470278176|FG011|Maintenance Study (44 Weeks)|Other|0|||
130634009|NCT02407236|470278177|FG012|Maintenance Study (44 Weeks)|Other|0|||
130634010|NCT02407236|470278165|FG000|Maintenance Study (44 Weeks)|Death|0|||
130634011|NCT02407236|470278166|FG001|Maintenance Study (44 Weeks)|Death|0|||
130634012|NCT02407236|470278167|FG002|Maintenance Study (44 Weeks)|Death|0|||
130634013|NCT02407236|470278168|FG003|Maintenance Study (44 Weeks)|Death|0|||
130634014|NCT02407236|470278169|FG004|Maintenance Study (44 Weeks)|Death|0|||
130634015|NCT02407236|470278170|FG005|Maintenance Study (44 Weeks)|Death|0|||
130634016|NCT02407236|470278171|FG006|Maintenance Study (44 Weeks)|Death|0|||
130634017|NCT02407236|470278172|FG007|Maintenance Study (44 Weeks)|Death|1|||
130634018|NCT02407236|470278173|FG008|Maintenance Study (44 Weeks)|Death|0|||
130634019|NCT02407236|470278174|FG009|Maintenance Study (44 Weeks)|Death|0|||
130634020|NCT02407236|470278175|FG010|Maintenance Study (44 Weeks)|Death|0|||
130634021|NCT02407236|470278176|FG011|Maintenance Study (44 Weeks)|Death|0|||
130634022|NCT02407236|470278177|FG012|Maintenance Study (44 Weeks)|Death|0|||
130634023|NCT02407236|470278165|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634024|NCT02407236|470278166|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634025|NCT02407236|470278167|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634026|NCT02407236|470278168|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634027|NCT02407236|470278169|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634028|NCT02407236|470278170|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634029|NCT02407236|470278171|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634030|NCT02407236|470278172|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130634031|NCT02407236|470278173|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
130634032|NCT02407236|470278174|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
130634033|NCT02407236|470278175|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
130634034|NCT02407236|470278176|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
130634035|NCT02407236|470278177|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
130634036|NCT02407236|470278165|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634037|NCT02407236|470278166|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634038|NCT02407236|470278167|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634039|NCT02407236|470278168|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634040|NCT02407236|470278169|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634041|NCT02407236|470278170|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634042|NCT02407236|470278171|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634043|NCT02407236|470278172|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634044|NCT02407236|470278173|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634045|NCT02407236|470278174|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634046|NCT02407236|470278175|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
130634047|NCT02407236|470278176|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634048|NCT02407236|470278177|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130634049|NCT02407236|470278165|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634050|NCT02407236|470278166|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634051|NCT02407236|470278167|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634052|NCT02407236|470278168|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634053|NCT02407236|470278169|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634054|NCT02407236|470278170|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634055|NCT02407236|470278171|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634056|NCT02407236|470278172|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130634057|NCT02407236|470278173|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
130634058|NCT02407236|470278174|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
130634059|NCT02407236|470278175|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
130634060|NCT02407236|470278176|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
130634061|NCT02407236|470278177|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
130634062|NCT02407236|470278165|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
130634063|NCT02407236|470278166|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
130634064|NCT02407236|470278167|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
130634065|NCT02407236|470278168|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
130634066|NCT02407236|470278169|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
130634067|NCT02407236|470278170|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
130634068|NCT02407236|470278171|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
130634069|NCT02407236|470278172|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
130634070|NCT02407236|470278173|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
130634071|NCT02407236|470278174|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
130634072|NCT02407236|470278175|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
130634073|NCT02407236|470278176|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
130634074|NCT02407236|470278177|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
130634075|NCT00643448|470278178|FG000|Overall Study|Lack of Efficacy|2|||
130634076|NCT00643448|470278179|FG001|Overall Study|Lack of Efficacy|0|||
130634077|NCT00643448|470278180|FG002|Overall Study|Lack of Efficacy|4|||
130634078|NCT00643448|470278178|FG000|Overall Study|Adverse Event|2|||
130634079|NCT00643448|470278179|FG001|Overall Study|Adverse Event|2|||
130634080|NCT00643448|470278180|FG002|Overall Study|Adverse Event|2|||
130634081|NCT00643448|470278178|FG000|Overall Study|QTcF>550 ms|0|||
130634082|NCT00643448|470278179|FG001|Overall Study|QTcF>550 ms|3|||
130634083|NCT00643448|470278180|FG002|Overall Study|QTcF>550 ms|0|||
130634084|NCT05166603|470278184|FG000|Overall Study|Withdrawal by Subject|68|||
130634085|NCT05166603|470278185|FG001|Overall Study|Withdrawal by Subject|0|||
130634086|NCT02204410|470280249|FG000|Overall Study|Lost to Follow-up|5|||
130634087|NCT02204410|470280249|FG000|Overall Study|Physician Decision|2|||
130634088|NCT02204410|470280249|FG000|Overall Study|Protocol Violation|1|||
130634089|NCT02204410|470280249|FG000|Overall Study|Withdrawal by Subject|3|||
130634090|NCT01462045|470280250|FG000|Overall Study|Family matter|0|||
130634091|NCT01462045|470280251|FG001|Overall Study|Family matter|1|||
130634092|NCT01462045|470280252|FG002|Overall Study|Family matter|0|||
130634093|NCT02579863|470280253|FG000|Overall Study|Final Disposition Unknown|2|||
130634094|NCT02579863|470280254|FG001|Overall Study|Final Disposition Unknown|1|||
130634095|NCT02579863|470280253|FG000|Overall Study|Adverse Event|18|||
130634096|NCT02579863|470280254|FG001|Overall Study|Adverse Event|11|||
130634097|NCT02579863|470280253|FG000|Overall Study|Death|31|||
130634098|NCT02579863|470280254|FG001|Overall Study|Death|29|||
130634099|NCT02579863|470280253|FG000|Overall Study|Lost to Follow-up|2|||
130634100|NCT02579863|470280254|FG001|Overall Study|Lost to Follow-up|1|||
130634101|NCT02579863|470280253|FG000|Overall Study|Physician Decision|1|||
130634102|NCT02579863|470280254|FG001|Overall Study|Physician Decision|2|||
130634103|NCT02579863|470280253|FG000|Overall Study|Screen Failure|0|||
130634104|NCT02579863|470280254|FG001|Overall Study|Screen Failure|2|||
130634105|NCT02579863|470280253|FG000|Overall Study|Study Terminated at Selected Sites|82|||
130634106|NCT02579863|470280254|FG001|Overall Study|Study Terminated at Selected Sites|88|||
130634107|NCT02579863|470280253|FG000|Overall Study|Withdrawal by Subject|20|||
130634108|NCT02579863|470280254|FG001|Overall Study|Withdrawal by Subject|20|||
130634109|NCT02658149|470280256|FG000|Overall Study|Physician Decision|1|||
130634110|NCT02658149|470280257|FG001|Overall Study|Physician Decision|0|||
130634111|NCT03933215|470280265|FG000|Overall Study|Other|6|||
130634112|NCT03933215|470280265|FG000|Overall Study|Sponsor decision|5|||
130634113|NCT03933215|470280265|FG000|Overall Study|Protocol Violation|5|||
130634114|NCT03933215|470280265|FG000|Overall Study|Withdrawal by Subject|6|||
130634115|NCT03933215|470280265|FG000|Overall Study|Lost to Follow-up|6|||
130634116|NCT03933215|470280265|FG000|Overall Study|Enrolled but not treated|38|||
130634117|NCT02352090|470280266|FG000|Overall Study|general malaise|1|||
130634118|NCT02352090|470280267|FG001|Overall Study|general malaise|0|||
130634119|NCT02352090|470280268|FG002|Overall Study|general malaise|0|||
130634120|NCT02352090|470280266|FG000|Overall Study|non-specified mild side-effects|0|||
130634121|NCT02352090|470280267|FG001|Overall Study|non-specified mild side-effects|0|||
130634122|NCT02352090|470280268|FG002|Overall Study|non-specified mild side-effects|2|||
130634123|NCT00911144|470280269|FG000|Overall Study|Withdrawal by Subject|16|||
130634124|NCT00911144|470280270|FG001|Overall Study|Withdrawal by Subject|5|||
130634125|NCT01678313|470280275|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
130634126|NCT01678313|470280276|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
130634127|NCT01678313|470280275|FG000|Completed the 3-month Therapy|Physician Decision|3|||
130634128|NCT01678313|470280276|FG001|Completed the 3-month Therapy|Physician Decision|4|||
130634129|NCT01678313|470280275|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
130634130|NCT01678313|470280276|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
130634131|NCT01678313|470280275|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
130634132|NCT01678313|470280276|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
130634133|NCT00981292|470280277|FG000|Day 1|Protocol Violation|1|||
130634134|NCT00981292|470280278|FG001|Day 1|Protocol Violation|0|||
130634135|NCT00981292|470280279|FG002|Day 1|Protocol Violation|0|||
130634136|NCT00981292|470280280|FG003|Day 1|Protocol Violation|0|||
130634137|NCT00981292|470280281|FG004|Day 1|Protocol Violation|0|||
130634138|NCT00981292|470280282|FG005|Day 1|Protocol Violation|2|||
130634139|NCT00981292|470280277|FG000|Day 2|Protocol Violation|2|||
130634140|NCT00981292|470280278|FG001|Day 2|Protocol Violation|0|||
130634141|NCT00981292|470280279|FG002|Day 2|Protocol Violation|0|||
130634142|NCT00981292|470280280|FG003|Day 2|Protocol Violation|0|||
130634143|NCT00981292|470280281|FG004|Day 2|Protocol Violation|0|||
130634144|NCT00981292|470280282|FG005|Day 2|Protocol Violation|0|||
130634145|NCT00981292|470280277|FG000|Day 3|Protocol Violation|0|||
130634146|NCT00981292|470280278|FG001|Day 3|Protocol Violation|0|||
130634147|NCT00981292|470280279|FG002|Day 3|Protocol Violation|0|||
130634148|NCT00981292|470280280|FG003|Day 3|Protocol Violation|0|||
130634149|NCT00981292|470280281|FG004|Day 3|Protocol Violation|0|||
130634150|NCT00981292|470280282|FG005|Day 3|Protocol Violation|1|||
130634151|NCT01131130|470280283|FG000|Period 1 - Baseline|Pregnancy|1|||
130634152|NCT01131130|470280283|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
130634153|NCT03464136|470280284|FG000|Overall Study|Lost to Follow-up|5|||
130634154|NCT03464136|470280285|FG001|Overall Study|Lost to Follow-up|8|||
130634155|NCT03464136|470280284|FG000|Overall Study|Withdrawal by Subject|16|||
130634156|NCT03464136|470280285|FG001|Overall Study|Withdrawal by Subject|13|||
130634157|NCT03464136|470280284|FG000|Overall Study|Death|1|||
130634158|NCT03464136|470280285|FG001|Overall Study|Death|0|||
130634159|NCT03464136|470280284|FG000|Overall Study|Other|8|||
130634160|NCT03464136|470280285|FG001|Overall Study|Other|4|||
130634161|NCT03412565|470280286|FG000|Overall Study|Lost to Follow-up|0|||
130634162|NCT03412565|470280287|FG001|Overall Study|Lost to Follow-up|0|||
130634163|NCT03412565|470280288|FG002|Overall Study|Lost to Follow-up|1|||
130634164|NCT03412565|470280289|FG003|Overall Study|Lost to Follow-up|0|||
130634165|NCT03412565|470280286|FG000|Overall Study|Physician Decision|0|||
130634166|NCT03412565|470280287|FG001|Overall Study|Physician Decision|0|||
130634167|NCT03412565|470280288|FG002|Overall Study|Physician Decision|0|||
130634168|NCT03412565|470280289|FG003|Overall Study|Physician Decision|1|||
130634169|NCT03412565|470280286|FG000|Overall Study|Withdrawal by Subject|0|||
130634170|NCT03412565|470280287|FG001|Overall Study|Withdrawal by Subject|4|||
130634171|NCT03412565|470280288|FG002|Overall Study|Withdrawal by Subject|5|||
130634172|NCT03412565|470280289|FG003|Overall Study|Withdrawal by Subject|5|||
130634173|NCT03412565|470280286|FG000|Overall Study|Death|1|||
130634174|NCT03412565|470280287|FG001|Overall Study|Death|3|||
130634175|NCT03412565|470280288|FG002|Overall Study|Death|4|||
130634176|NCT03412565|470280289|FG003|Overall Study|Death|5|||
130634177|NCT03412565|470280286|FG000|Overall Study|Data collection ended|0|||
130634178|NCT03412565|470280287|FG001|Overall Study|Data collection ended|41|||
130634179|NCT03412565|470280288|FG002|Overall Study|Data collection ended|41|||
130634180|NCT03412565|470280289|FG003|Overall Study|Data collection ended|40|||
130634181|NCT01849562|470280292|FG000|Overall Study|Lost to Follow-up|1|||
130634182|NCT01849562|470280293|FG001|Overall Study|Lost to Follow-up|0|||
130634183|NCT01849562|470280294|FG002|Overall Study|Lost to Follow-up|0|||
130634184|NCT01849562|470280292|FG000|Overall Study|Non-compliance with Study Drug|1|||
130634185|NCT01849562|470280293|FG001|Overall Study|Non-compliance with Study Drug|0|||
130634186|NCT01849562|470280294|FG002|Overall Study|Non-compliance with Study Drug|0|||
130634187|NCT01098032|470280295|FG000|Overall Study|Withdrawal by Subject|1|||
130634188|NCT01098032|470280296|FG001|Overall Study|Withdrawal by Subject|1|||
130634189|NCT02182999|470280298|FG000|Overall Study|Adverse Event|4|||
130634190|NCT02182999|470280299|FG001|Overall Study|Adverse Event|3|||
130634191|NCT02182999|470280298|FG000|Overall Study|Physician Decision|1|||
130634192|NCT02182999|470280299|FG001|Overall Study|Physician Decision|0|||
130634193|NCT02252588|470280301|FG000|Overall Study|Withdrawal by Subject|4|||
130634194|NCT02252588|470280302|FG001|Overall Study|Withdrawal by Subject|0|||
130634195|NCT03039790|470280303|FG000|Overall Study|Lost to Follow-up|2|||
130634196|NCT03039790|470280304|FG001|Overall Study|Lost to Follow-up|0|||
130634197|NCT03039790|470280305|FG002|Overall Study|Lost to Follow-up|1|||
130634198|NCT03039790|470280306|FG003|Overall Study|Lost to Follow-up|1|||
130634199|NCT03039790|470280307|FG004|Overall Study|Lost to Follow-up|0|||
130634200|NCT03039790|470280308|FG005|Overall Study|Lost to Follow-up|1|||
130634201|NCT03039790|470280309|FG006|Overall Study|Lost to Follow-up|1|||
130634202|NCT03039790|470280310|FG007|Overall Study|Lost to Follow-up|1|||
130634203|NCT03039790|470280311|FG008|Overall Study|Lost to Follow-up|0|||
130634204|NCT03039790|470280312|FG009|Overall Study|Lost to Follow-up|1|||
130634205|NCT03039790|470280313|FG010|Overall Study|Lost to Follow-up|1|||
130634206|NCT03039790|470280314|FG011|Overall Study|Lost to Follow-up|0|||
130634207|NCT03039790|470280315|FG012|Overall Study|Lost to Follow-up|1|||
130634208|NCT03039790|470280316|FG013|Overall Study|Lost to Follow-up|0|||
130634209|NCT03039790|470280317|FG014|Overall Study|Lost to Follow-up|3|||
130634210|NCT03039790|470280318|FG015|Overall Study|Lost to Follow-up|1|||
130634211|NCT03039790|470280319|FG016|Overall Study|Lost to Follow-up|2|||
130634212|NCT03039790|470280320|FG017|Overall Study|Lost to Follow-up|2|||
130634213|NCT03039790|470280321|FG018|Overall Study|Lost to Follow-up|1|||
130634214|NCT03039790|470280322|FG019|Overall Study|Lost to Follow-up|3|||
130634215|NCT03039790|470280303|FG000|Overall Study|Withdrawal of Consent|1|||
130634216|NCT03039790|470280304|FG001|Overall Study|Withdrawal of Consent|0|||
130634217|NCT03039790|470280305|FG002|Overall Study|Withdrawal of Consent|0|||
130634218|NCT03039790|470280306|FG003|Overall Study|Withdrawal of Consent|1|||
130634219|NCT03039790|470280307|FG004|Overall Study|Withdrawal of Consent|0|||
130634220|NCT03039790|470280308|FG005|Overall Study|Withdrawal of Consent|0|||
130634221|NCT03039790|470280309|FG006|Overall Study|Withdrawal of Consent|0|||
130634222|NCT03039790|470280310|FG007|Overall Study|Withdrawal of Consent|0|||
130634223|NCT03039790|470280311|FG008|Overall Study|Withdrawal of Consent|0|||
130634224|NCT03039790|470280312|FG009|Overall Study|Withdrawal of Consent|1|||
130634225|NCT03039790|470280313|FG010|Overall Study|Withdrawal of Consent|0|||
130634226|NCT03039790|470280314|FG011|Overall Study|Withdrawal of Consent|0|||
130634227|NCT03039790|470280315|FG012|Overall Study|Withdrawal of Consent|2|||
130634228|NCT03039790|470280316|FG013|Overall Study|Withdrawal of Consent|0|||
130634229|NCT03039790|470280317|FG014|Overall Study|Withdrawal of Consent|1|||
130634230|NCT03039790|470280318|FG015|Overall Study|Withdrawal of Consent|5|||
130634231|NCT03039790|470280319|FG016|Overall Study|Withdrawal of Consent|3|||
130634232|NCT03039790|470280320|FG017|Overall Study|Withdrawal of Consent|0|||
130634233|NCT03039790|470280321|FG018|Overall Study|Withdrawal of Consent|2|||
130634234|NCT03039790|470280322|FG019|Overall Study|Withdrawal of Consent|5|||
130634235|NCT03039790|470280303|FG000|Overall Study|Death|0|||
130634236|NCT03039790|470280304|FG001|Overall Study|Death|0|||
130634237|NCT03039790|470280305|FG002|Overall Study|Death|0|||
130634238|NCT03039790|470280306|FG003|Overall Study|Death|0|||
130634239|NCT03039790|470280307|FG004|Overall Study|Death|0|||
130634240|NCT03039790|470280308|FG005|Overall Study|Death|0|||
130634241|NCT03039790|470280309|FG006|Overall Study|Death|0|||
130634242|NCT03039790|470280310|FG007|Overall Study|Death|0|||
130634243|NCT03039790|470280311|FG008|Overall Study|Death|0|||
130634244|NCT03039790|470280312|FG009|Overall Study|Death|0|||
130634245|NCT03039790|470280313|FG010|Overall Study|Death|0|||
130634246|NCT03039790|470280314|FG011|Overall Study|Death|0|||
130634247|NCT03039790|470280315|FG012|Overall Study|Death|0|||
130634248|NCT03039790|470280316|FG013|Overall Study|Death|0|||
130634249|NCT03039790|470280317|FG014|Overall Study|Death|0|||
130634250|NCT03039790|470280318|FG015|Overall Study|Death|1|||
130634251|NCT03039790|470280319|FG016|Overall Study|Death|3|||
130634252|NCT03039790|470280320|FG017|Overall Study|Death|0|||
130634253|NCT03039790|470280321|FG018|Overall Study|Death|2|||
130634254|NCT03039790|470280322|FG019|Overall Study|Death|0|||
130634255|NCT03039790|470280303|FG000|Overall Study|Reason, not Specified|1|||
130634256|NCT03039790|470280304|FG001|Overall Study|Reason, not Specified|0|||
130634257|NCT03039790|470280305|FG002|Overall Study|Reason, not Specified|0|||
130634258|NCT03039790|470280306|FG003|Overall Study|Reason, not Specified|0|||
130634259|NCT03039790|470280307|FG004|Overall Study|Reason, not Specified|0|||
130634260|NCT03039790|470280308|FG005|Overall Study|Reason, not Specified|0|||
130634261|NCT03039790|470280309|FG006|Overall Study|Reason, not Specified|0|||
130634262|NCT03039790|470280310|FG007|Overall Study|Reason, not Specified|0|||
130634263|NCT03039790|470280311|FG008|Overall Study|Reason, not Specified|0|||
130634264|NCT03039790|470280312|FG009|Overall Study|Reason, not Specified|0|||
130634265|NCT03039790|470280313|FG010|Overall Study|Reason, not Specified|0|||
130634266|NCT03039790|470280314|FG011|Overall Study|Reason, not Specified|0|||
130634267|NCT03039790|470280315|FG012|Overall Study|Reason, not Specified|0|||
130634268|NCT03039790|470280316|FG013|Overall Study|Reason, not Specified|0|||
130634269|NCT03039790|470280317|FG014|Overall Study|Reason, not Specified|0|||
130634270|NCT03039790|470280318|FG015|Overall Study|Reason, not Specified|0|||
130634271|NCT03039790|470280319|FG016|Overall Study|Reason, not Specified|2|||
130634272|NCT03039790|470280320|FG017|Overall Study|Reason, not Specified|0|||
130634273|NCT03039790|470280321|FG018|Overall Study|Reason, not Specified|1|||
130634274|NCT03039790|470280322|FG019|Overall Study|Reason, not Specified|0|||
130634275|NCT00498368|470280330|FG000|Overall Study|Withdrawal by Subject|3|||
130634276|NCT00498368|470280331|FG001|Overall Study|Withdrawal by Subject|2|||
130634277|NCT02266004|470280332|FG000|Overall Study|unrelated adverse event|1|||
130634278|NCT02266004|470280332|FG000|Overall Study|Physician Decision|1|||
130634279|NCT00537771|470280337|FG000|Overall Study|Withdrawal by Subject|6|||
130634280|NCT00537771|470280338|FG001|Overall Study|Withdrawal by Subject|23|||
130634281|NCT00537771|470280337|FG000|Overall Study|Adverse Event|8|||
130634282|NCT00537771|470280338|FG001|Overall Study|Adverse Event|15|||
130634283|NCT00537771|470280337|FG000|Overall Study|Lost to Follow-up|9|||
130634284|NCT00537771|470280338|FG001|Overall Study|Lost to Follow-up|15|||
130634285|NCT00537771|470280337|FG000|Overall Study|Protocol Violation|2|||
130634286|NCT00537771|470280338|FG001|Overall Study|Protocol Violation|6|||
130634287|NCT00537771|470280337|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130634288|NCT00537771|470280338|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130634289|NCT02972593|470280339|FG000|Overall Study|Lost to Follow-up|19|||
130634290|NCT02972593|470280340|FG001|Overall Study|Lost to Follow-up|15|||
130634291|NCT02972593|470280339|FG000|Overall Study|Protocol Violation|1|||
130634292|NCT02972593|470280340|FG001|Overall Study|Protocol Violation|0|||
130634293|NCT00693693|470280341|FG000|Overall Study|Lost to Follow-up|1|||
130634294|NCT00693693|470280342|FG001|Overall Study|Lost to Follow-up|1|||
130634295|NCT00693693|470280343|FG002|Overall Study|Lost to Follow-up|2|||
130634296|NCT00638690|470280348|FG000|Overall Study|Death|655|||
130634297|NCT00638690|470280349|FG001|Overall Study|Death|335|||
130634298|NCT00638690|470280348|FG000|Overall Study|Withdrawal by Subject|22|||
130634299|NCT00638690|470280349|FG001|Overall Study|Withdrawal by Subject|5|||
130634300|NCT00638690|470280348|FG000|Overall Study|Lost to Follow-up|4|||
130634301|NCT00638690|470280349|FG001|Overall Study|Lost to Follow-up|2|||
130634302|NCT00621244|470280360|FG000|Overall Study|Withdrawal by Subject|7|||
130634303|NCT00621244|470280361|FG001|Overall Study|Withdrawal by Subject|3|||
130634304|NCT00621244|470280362|FG002|Overall Study|Withdrawal by Subject|3|||
130634305|NCT00621244|470280363|FG003|Overall Study|Withdrawal by Subject|3|||
130634306|NCT00621244|470280360|FG000|Overall Study|Disease progression|44|||
130634307|NCT00621244|470280361|FG001|Overall Study|Disease progression|20|||
130634308|NCT00621244|470280362|FG002|Overall Study|Disease progression|20|||
130634309|NCT00621244|470280363|FG003|Overall Study|Disease progression|15|||
130634310|NCT00621244|470280360|FG000|Overall Study|Death|3|||
130634311|NCT00621244|470280361|FG001|Overall Study|Death|3|||
130634312|NCT00621244|470280362|FG002|Overall Study|Death|1|||
130634313|NCT00621244|470280363|FG003|Overall Study|Death|1|||
130634314|NCT00621244|470280360|FG000|Overall Study|Adverse Event|27|||
130634315|NCT00621244|470280361|FG001|Overall Study|Adverse Event|7|||
130634316|NCT00621244|470280362|FG002|Overall Study|Adverse Event|9|||
130634317|NCT00621244|470280363|FG003|Overall Study|Adverse Event|2|||
130634318|NCT00621244|470280360|FG000|Overall Study|Administrative problems|5|||
130634319|NCT00621244|470280361|FG001|Overall Study|Administrative problems|1|||
130634320|NCT00621244|470280362|FG002|Overall Study|Administrative problems|0|||
130634321|NCT00621244|470280363|FG003|Overall Study|Administrative problems|2|||
130634322|NCT01662986|470280364|FG000|Overall Study|Adverse Event|5|||
130634323|NCT01662986|470280365|FG001|Overall Study|Adverse Event|4|||
130634324|NCT01662986|470280364|FG000|Overall Study|Protocol Violation|2|||
130634325|NCT01662986|470280365|FG001|Overall Study|Protocol Violation|3|||
130634326|NCT01662986|470280364|FG000|Overall Study|Lost to Follow-up|5|||
130634327|NCT01662986|470280365|FG001|Overall Study|Lost to Follow-up|4|||
130634328|NCT01662986|470280364|FG000|Overall Study|Withdrawal by Subject|2|||
130634329|NCT01662986|470280365|FG001|Overall Study|Withdrawal by Subject|2|||
130634330|NCT01662986|470280364|FG000|Overall Study|Not Treated|1|||
130634331|NCT01662986|470280365|FG001|Overall Study|Not Treated|0|||
130634332|NCT01662986|470280364|FG000|Overall Study|Other than stated above|3|||
130634333|NCT01662986|470280365|FG001|Overall Study|Other than stated above|0|||
130634334|NCT00845845|470280372|FG000|Overall Study|Lost to Follow-up|0|||
130634335|NCT00845845|470280373|FG001|Overall Study|Lost to Follow-up|4|||
130634336|NCT02033850|470280375|FG000|Overall Study|Death|1|||
130634337|NCT02033850|470280376|FG001|Overall Study|Death|0|||
130634338|NCT02033850|470280375|FG000|Overall Study|unrelated medical reason|1|||
130634339|NCT02033850|470280376|FG001|Overall Study|unrelated medical reason|1|||
130634340|NCT02820038|470280377|FG000|Overall Study|Lost to Follow-up|7|||
130634341|NCT02820038|470280378|FG001|Overall Study|Lost to Follow-up|11|||
130634342|NCT02820038|470280379|FG002|Overall Study|Lost to Follow-up|2|||
130634343|NCT02820038|470280380|FG003|Overall Study|Lost to Follow-up|9|||
130634344|NCT02820038|470280377|FG000|Overall Study|Withdrawal by Subject|3|||
130634345|NCT02820038|470280378|FG001|Overall Study|Withdrawal by Subject|14|||
130634346|NCT02820038|470280379|FG002|Overall Study|Withdrawal by Subject|3|||
130634347|NCT02820038|470280380|FG003|Overall Study|Withdrawal by Subject|13|||
130634348|NCT00033371|470280381|FG000|Overall Study|Adverse Event|1|||
130634349|NCT00033371|470280382|FG001|Overall Study|Adverse Event|5|||
130634350|NCT00033371|470280381|FG000|Overall Study|Lost to Follow-up|2|||
130634351|NCT00033371|470280382|FG001|Overall Study|Lost to Follow-up|1|||
130634352|NCT00033371|470280381|FG000|Overall Study|Withdrawal by Subject|3|||
130634353|NCT00033371|470280382|FG001|Overall Study|Withdrawal by Subject|3|||
130634354|NCT00033371|470280381|FG000|Overall Study|Disease Progression|0|||
130634355|NCT00033371|470280382|FG001|Overall Study|Disease Progression|1|||
130634356|NCT03799627|470280387|FG000|Overall Study|Adverse Event|1|||
130634357|NCT03799627|470280388|FG001|Overall Study|Adverse Event|2|||
130634358|NCT03799627|470280389|FG002|Overall Study|Adverse Event|0|||
130634359|NCT03799627|470280390|FG003|Overall Study|Adverse Event|0|||
130634360|NCT03799627|470280391|FG004|Overall Study|Adverse Event|2|||
130634361|NCT03799627|470280392|FG005|Overall Study|Adverse Event|5|||
130634362|NCT03799627|470280393|FG006|Overall Study|Adverse Event|0|||
130634363|NCT03799627|470280394|FG007|Overall Study|Adverse Event|2|||
130634364|NCT03799627|470280395|FG008|Overall Study|Adverse Event|0|||
130634365|NCT03799627|470280387|FG000|Overall Study|Physician Decision|2|||
130634366|NCT03799627|470280388|FG001|Overall Study|Physician Decision|2|||
130634367|NCT03799627|470280389|FG002|Overall Study|Physician Decision|0|||
130634368|NCT03799627|470280390|FG003|Overall Study|Physician Decision|0|||
130634369|NCT03799627|470280391|FG004|Overall Study|Physician Decision|2|||
130634370|NCT03799627|470280392|FG005|Overall Study|Physician Decision|2|||
130634371|NCT03799627|470280393|FG006|Overall Study|Physician Decision|0|||
130634372|NCT03799627|470280394|FG007|Overall Study|Physician Decision|0|||
130634373|NCT03799627|470280395|FG008|Overall Study|Physician Decision|0|||
130634374|NCT03799627|470280387|FG000|Overall Study|Withdrawal by Subject|1|||
130634375|NCT03799627|470280388|FG001|Overall Study|Withdrawal by Subject|1|||
130634376|NCT03799627|470280389|FG002|Overall Study|Withdrawal by Subject|0|||
130634377|NCT03799627|470280390|FG003|Overall Study|Withdrawal by Subject|2|||
130634378|NCT03799627|470280391|FG004|Overall Study|Withdrawal by Subject|0|||
130634379|NCT03799627|470280392|FG005|Overall Study|Withdrawal by Subject|3|||
130634380|NCT03799627|470280393|FG006|Overall Study|Withdrawal by Subject|0|||
130634381|NCT03799627|470280394|FG007|Overall Study|Withdrawal by Subject|0|||
130634382|NCT03799627|470280395|FG008|Overall Study|Withdrawal by Subject|0|||
130634383|NCT03799627|470280387|FG000|Overall Study|Lack of Efficacy|0|||
130634384|NCT03799627|470280388|FG001|Overall Study|Lack of Efficacy|0|||
130634385|NCT03799627|470280389|FG002|Overall Study|Lack of Efficacy|0|||
130634386|NCT03799627|470280390|FG003|Overall Study|Lack of Efficacy|1|||
130634387|NCT03799627|470280391|FG004|Overall Study|Lack of Efficacy|0|||
130634388|NCT03799627|470280392|FG005|Overall Study|Lack of Efficacy|0|||
130634389|NCT03799627|470280393|FG006|Overall Study|Lack of Efficacy|0|||
130634390|NCT03799627|470280394|FG007|Overall Study|Lack of Efficacy|0|||
130634391|NCT03799627|470280395|FG008|Overall Study|Lack of Efficacy|0|||
130634392|NCT03799627|470280387|FG000|Overall Study|Lost to Follow-up|0|||
130634393|NCT03799627|470280388|FG001|Overall Study|Lost to Follow-up|0|||
130634394|NCT03799627|470280389|FG002|Overall Study|Lost to Follow-up|0|||
130634395|NCT03799627|470280390|FG003|Overall Study|Lost to Follow-up|0|||
130634396|NCT03799627|470280391|FG004|Overall Study|Lost to Follow-up|0|||
130634397|NCT03799627|470280392|FG005|Overall Study|Lost to Follow-up|0|||
130634398|NCT03799627|470280393|FG006|Overall Study|Lost to Follow-up|1|||
130634399|NCT03799627|470280394|FG007|Overall Study|Lost to Follow-up|0|||
130634400|NCT03799627|470280395|FG008|Overall Study|Lost to Follow-up|1|||
130634401|NCT03799627|470280387|FG000|Overall Study|Death|0|||
130634402|NCT03799627|470280388|FG001|Overall Study|Death|0|||
130634403|NCT03799627|470280389|FG002|Overall Study|Death|0|||
130634404|NCT03799627|470280390|FG003|Overall Study|Death|1|||
130634405|NCT03799627|470280391|FG004|Overall Study|Death|0|||
130634406|NCT03799627|470280392|FG005|Overall Study|Death|0|||
130634407|NCT03799627|470280393|FG006|Overall Study|Death|0|||
130634408|NCT03799627|470280394|FG007|Overall Study|Death|0|||
130634409|NCT03799627|470280395|FG008|Overall Study|Death|0|||
130634410|NCT03799627|470280387|FG000|Overall Study|Study Drug Put on Hold|1|||
130634411|NCT03799627|470280388|FG001|Overall Study|Study Drug Put on Hold|0|||
130634412|NCT03799627|470280389|FG002|Overall Study|Study Drug Put on Hold|0|||
130634413|NCT03799627|470280390|FG003|Overall Study|Study Drug Put on Hold|0|||
130634414|NCT03799627|470280391|FG004|Overall Study|Study Drug Put on Hold|0|||
130634415|NCT03799627|470280392|FG005|Overall Study|Study Drug Put on Hold|0|||
130634416|NCT03799627|470280393|FG006|Overall Study|Study Drug Put on Hold|0|||
130634417|NCT03799627|470280394|FG007|Overall Study|Study Drug Put on Hold|0|||
130634418|NCT03799627|470280395|FG008|Overall Study|Study Drug Put on Hold|0|||
130634419|NCT03799627|470280387|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
130634420|NCT03799627|470280388|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
130634421|NCT03799627|470280389|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
130634422|NCT03799627|470280390|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
130634423|NCT03799627|470280391|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
130634424|NCT03799627|470280392|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
130634425|NCT03799627|470280393|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
130634426|NCT03799627|470280394|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
130634427|NCT03799627|470280395|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
130634428|NCT03799627|470280387|FG000|Overall Study|Kidney Transplantation|1|||
130634429|NCT03799627|470280388|FG001|Overall Study|Kidney Transplantation|0|||
130634430|NCT03799627|470280389|FG002|Overall Study|Kidney Transplantation|0|||
130634431|NCT03799627|470280390|FG003|Overall Study|Kidney Transplantation|1|||
130634432|NCT03799627|470280391|FG004|Overall Study|Kidney Transplantation|1|||
130634433|NCT03799627|470280392|FG005|Overall Study|Kidney Transplantation|0|||
130634434|NCT03799627|470280393|FG006|Overall Study|Kidney Transplantation|0|||
130634435|NCT03799627|470280394|FG007|Overall Study|Kidney Transplantation|0|||
130634436|NCT03799627|470280395|FG008|Overall Study|Kidney Transplantation|0|||
130634437|NCT03799627|470280387|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
130634438|NCT03799627|470280388|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
130634439|NCT03799627|470280389|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
130634440|NCT03799627|470280390|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
130634441|NCT03799627|470280391|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
130634442|NCT03799627|470280392|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
130634443|NCT03799627|470280393|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
130634444|NCT03799627|470280394|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
130634445|NCT03799627|470280395|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
130634446|NCT03799627|470280387|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634447|NCT03799627|470280388|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
130634448|NCT03799627|470280389|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634449|NCT03799627|470280390|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634450|NCT03799627|470280391|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634451|NCT03799627|470280392|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634452|NCT03799627|470280393|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634453|NCT03799627|470280394|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634454|NCT03799627|470280395|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130634455|NCT03799627|470280387|FG000|Overall Study|Met Exclusion Criteria|0|||
130634456|NCT03799627|470280388|FG001|Overall Study|Met Exclusion Criteria|0|||
130634457|NCT03799627|470280389|FG002|Overall Study|Met Exclusion Criteria|0|||
130634458|NCT03799627|470280390|FG003|Overall Study|Met Exclusion Criteria|1|||
130634459|NCT03799627|470280391|FG004|Overall Study|Met Exclusion Criteria|0|||
130634460|NCT03799627|470280392|FG005|Overall Study|Met Exclusion Criteria|0|||
130634461|NCT03799627|470280393|FG006|Overall Study|Met Exclusion Criteria|0|||
130634462|NCT03799627|470280394|FG007|Overall Study|Met Exclusion Criteria|0|||
130634463|NCT03799627|470280395|FG008|Overall Study|Met Exclusion Criteria|0|||
130634464|NCT03799627|470280387|FG000|Overall Study|Investigational Product Noncompliance|0|||
130634465|NCT03799627|470280388|FG001|Overall Study|Investigational Product Noncompliance|0|||
130634466|NCT03799627|470280389|FG002|Overall Study|Investigational Product Noncompliance|0|||
130634467|NCT03799627|470280390|FG003|Overall Study|Investigational Product Noncompliance|1|||
130634468|NCT03799627|470280391|FG004|Overall Study|Investigational Product Noncompliance|0|||
130634469|NCT03799627|470280392|FG005|Overall Study|Investigational Product Noncompliance|0|||
130634470|NCT03799627|470280393|FG006|Overall Study|Investigational Product Noncompliance|0|||
130634471|NCT03799627|470280394|FG007|Overall Study|Investigational Product Noncompliance|0|||
130634472|NCT03799627|470280395|FG008|Overall Study|Investigational Product Noncompliance|0|||
130634473|NCT03799627|470280387|FG000|Overall Study|Participant Relocation|0|||
130634474|NCT03799627|470280388|FG001|Overall Study|Participant Relocation|0|||
130634475|NCT03799627|470280389|FG002|Overall Study|Participant Relocation|0|||
130634476|NCT03799627|470280390|FG003|Overall Study|Participant Relocation|1|||
130634477|NCT03799627|470280391|FG004|Overall Study|Participant Relocation|0|||
130634478|NCT03799627|470280392|FG005|Overall Study|Participant Relocation|1|||
130634479|NCT03799627|470280393|FG006|Overall Study|Participant Relocation|0|||
130634480|NCT03799627|470280394|FG007|Overall Study|Participant Relocation|0|||
130634481|NCT03799627|470280395|FG008|Overall Study|Participant Relocation|0|||
130634482|NCT03799627|470280387|FG000|Overall Study|Eurofin Issue|0|||
130634483|NCT03799627|470280388|FG001|Overall Study|Eurofin Issue|0|||
130634484|NCT03799627|470280389|FG002|Overall Study|Eurofin Issue|0|||
130634485|NCT03799627|470280390|FG003|Overall Study|Eurofin Issue|0|||
130634486|NCT03799627|470280391|FG004|Overall Study|Eurofin Issue|1|||
130634487|NCT03799627|470280392|FG005|Overall Study|Eurofin Issue|0|||
130634488|NCT03799627|470280393|FG006|Overall Study|Eurofin Issue|0|||
130634489|NCT03799627|470280394|FG007|Overall Study|Eurofin Issue|0|||
130634490|NCT03799627|470280395|FG008|Overall Study|Eurofin Issue|0|||
130634491|NCT03799627|470280387|FG000|Overall Study|Noncompliance with Site Instructions|0|||
130634492|NCT03799627|470280388|FG001|Overall Study|Noncompliance with Site Instructions|0|||
130634493|NCT03799627|470280389|FG002|Overall Study|Noncompliance with Site Instructions|0|||
130634494|NCT03799627|470280390|FG003|Overall Study|Noncompliance with Site Instructions|0|||
130634495|NCT03799627|470280391|FG004|Overall Study|Noncompliance with Site Instructions|1|||
130634496|NCT03799627|470280392|FG005|Overall Study|Noncompliance with Site Instructions|0|||
130634497|NCT03799627|470280393|FG006|Overall Study|Noncompliance with Site Instructions|0|||
130634498|NCT03799627|470280394|FG007|Overall Study|Noncompliance with Site Instructions|0|||
130634499|NCT03799627|470280395|FG008|Overall Study|Noncompliance with Site Instructions|0|||
130634500|NCT03799627|470280387|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634501|NCT03799627|470280388|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634502|NCT03799627|470280389|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634503|NCT03799627|470280390|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634504|NCT03799627|470280391|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
130634505|NCT03799627|470280392|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634506|NCT03799627|470280393|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634507|NCT03799627|470280394|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634508|NCT03799627|470280395|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130634509|NCT03799627|470280387|FG000|Overall Study|Changes In Hemoglobin Values|1|||
130634510|NCT03799627|470280388|FG001|Overall Study|Changes In Hemoglobin Values|2|||
130634511|NCT03799627|470280389|FG002|Overall Study|Changes In Hemoglobin Values|1|||
130634512|NCT03799627|470280390|FG003|Overall Study|Changes In Hemoglobin Values|0|||
130634513|NCT03799627|470280391|FG004|Overall Study|Changes In Hemoglobin Values|0|||
130634514|NCT03799627|470280392|FG005|Overall Study|Changes In Hemoglobin Values|2|||
130634515|NCT03799627|470280393|FG006|Overall Study|Changes In Hemoglobin Values|1|||
130634516|NCT03799627|470280394|FG007|Overall Study|Changes In Hemoglobin Values|0|||
130634517|NCT03799627|470280395|FG008|Overall Study|Changes In Hemoglobin Values|1|||
130634518|NCT01922739|470280398|FG000|Titration/Adjustment Period|Adverse Event|3|||
130634519|NCT01922739|470280398|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
130634520|NCT01922739|470280398|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
130634521|NCT01922739|470280398|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
130634522|NCT01922739|470280398|FG000|Open-label Treatment Period|Adverse Event|6|||
130634523|NCT01922739|470280398|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
130634524|NCT01922739|470280398|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
130634525|NCT01922739|470280398|FG000|Open-label Treatment Period|Protocol Violation|5|||
130634526|NCT01922739|470280398|FG000|Open-label Treatment Period|Pregnancy|1|||
130634527|NCT01922739|470280398|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
130634528|NCT01922739|470280398|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
130634529|NCT01922739|470280398|FG000|Open-label Treatment Period|Physician Decision|1|||
130634530|NCT01922739|470280398|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
130634531|NCT03148795|470280401|FG000|Overall Study|Progressive Disease|1|||
130634532|NCT04489940|470280402|FG000|Overall Study|Other|2|||
130634533|NCT04489940|470280402|FG000|Overall Study|Withdrawal by Subject|2|||
130634534|NCT04489940|470280402|FG000|Overall Study|Death|5|||
130634535|NCT04489940|470280402|FG000|Overall Study|Lost to Follow-up|1|||
130634536|NCT02725268|470280403|FG000|Overall Study|Death|58|||
130634537|NCT02725268|470280404|FG001|Overall Study|Death|59|||
130634538|NCT02725268|470280405|FG002|Overall Study|Death|30|||
130634539|NCT02725268|470280406|FG003|Overall Study|Death|16|||
130634540|NCT02725268|470280403|FG000|Overall Study|Lost to Follow-up|4|||
130634541|NCT02725268|470280404|FG001|Overall Study|Lost to Follow-up|3|||
130634542|NCT02725268|470280405|FG002|Overall Study|Lost to Follow-up|0|||
130634543|NCT02725268|470280406|FG003|Overall Study|Lost to Follow-up|1|||
130634544|NCT02725268|470280403|FG000|Overall Study|Site Terminated by Sponsor|0|||
130634545|NCT02725268|470280404|FG001|Overall Study|Site Terminated by Sponsor|1|||
130634546|NCT02725268|470280405|FG002|Overall Study|Site Terminated by Sponsor|0|||
130634547|NCT02725268|470280406|FG003|Overall Study|Site Terminated by Sponsor|0|||
130634548|NCT02725268|470280403|FG000|Overall Study|Withdrawal by Subject|8|||
130634549|NCT02725268|470280404|FG001|Overall Study|Withdrawal by Subject|6|||
130634550|NCT02725268|470280405|FG002|Overall Study|Withdrawal by Subject|8|||
130634551|NCT02725268|470280406|FG003|Overall Study|Withdrawal by Subject|1|||
130634552|NCT02725268|470280403|FG000|Overall Study|Reason not Specified|2|||
130634553|NCT02725268|470280404|FG001|Overall Study|Reason not Specified|1|||
130634554|NCT02725268|470280405|FG002|Overall Study|Reason not Specified|0|||
130634555|NCT02725268|470280406|FG003|Overall Study|Reason not Specified|0|||
130634556|NCT04498468|470280407|FG000|Overall Study|Lost to Follow-up|3|||
130634557|NCT04973085|470280414|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
130634558|NCT04973085|470280415|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
130634559|NCT02224274|470280416|FG000|Overall Study|Death|1|||
130634560|NCT02224274|470280417|FG001|Overall Study|Death|0|||
130634561|NCT01976624|470280418|FG000|Overall Study|Participants contraindicated|2|||
130634562|NCT01976624|470280418|FG000|Overall Study|Participants age less than 19 years|12|||
130634563|NCT03074318|470280428|FG000|Overall Study|Adverse Event|0|||
130634564|NCT03074318|470280429|FG001|Overall Study|Adverse Event|1|||
130634565|NCT03074318|470280430|FG002|Overall Study|Adverse Event|1|||
130634566|NCT03074318|470280431|FG003|Overall Study|Adverse Event|1|||
130634567|NCT03074318|470280428|FG000|Overall Study|Death|1|||
130634568|NCT03074318|470280429|FG001|Overall Study|Death|0|||
130634569|NCT03074318|470280430|FG002|Overall Study|Death|0|||
130634570|NCT03074318|470280431|FG003|Overall Study|Death|0|||
130634571|NCT03074318|470280428|FG000|Overall Study|Withdrawal by Subject|1|||
130634572|NCT03074318|470280429|FG001|Overall Study|Withdrawal by Subject|2|||
130634573|NCT03074318|470280430|FG002|Overall Study|Withdrawal by Subject|2|||
130634574|NCT03074318|470280431|FG003|Overall Study|Withdrawal by Subject|4|||
130634575|NCT03074318|470280428|FG000|Overall Study|Trial Closure|2|||
130634576|NCT03074318|470280429|FG001|Overall Study|Trial Closure|2|||
130634577|NCT03074318|470280430|FG002|Overall Study|Trial Closure|3|||
130634578|NCT03074318|470280431|FG003|Overall Study|Trial Closure|11|||
130634579|NCT01627782|470280434|FG000|Overall Study|Adverse Event|1|||
130634580|NCT01627782|470280435|FG001|Overall Study|Adverse Event|2|||
130634581|NCT01627782|470280436|FG002|Overall Study|Adverse Event|0|||
130634582|NCT01627782|470280437|FG003|Overall Study|Adverse Event|1|||
130634583|NCT01627782|470280434|FG000|Overall Study|Lack of Efficacy|11|||
130634584|NCT01627782|470280435|FG001|Overall Study|Lack of Efficacy|1|||
130634585|NCT01627782|470280436|FG002|Overall Study|Lack of Efficacy|15|||
130634586|NCT01627782|470280437|FG003|Overall Study|Lack of Efficacy|2|||
130634587|NCT01627782|470280434|FG000|Overall Study|Protocol Violation|1|||
130634588|NCT01627782|470280435|FG001|Overall Study|Protocol Violation|0|||
130634589|NCT01627782|470280436|FG002|Overall Study|Protocol Violation|0|||
130634590|NCT01627782|470280437|FG003|Overall Study|Protocol Violation|0|||
130634591|NCT01627782|470280434|FG000|Overall Study|Withdrawal by Subject|2|||
130634592|NCT01627782|470280435|FG001|Overall Study|Withdrawal by Subject|1|||
130634593|NCT01627782|470280436|FG002|Overall Study|Withdrawal by Subject|0|||
130634594|NCT01627782|470280437|FG003|Overall Study|Withdrawal by Subject|0|||
130634595|NCT01627782|470280434|FG000|Overall Study|Other|0|||
130634596|NCT01627782|470280435|FG001|Overall Study|Other|2|||
130634597|NCT01627782|470280436|FG002|Overall Study|Other|0|||
130634598|NCT01627782|470280437|FG003|Overall Study|Other|3|||
130634599|NCT01627782|470280434|FG000|Overall Study|Randomized But Not Treated|1|||
130634600|NCT01627782|470280435|FG001|Overall Study|Randomized But Not Treated|0|||
130634601|NCT01627782|470280436|FG002|Overall Study|Randomized But Not Treated|0|||
130634602|NCT01627782|470280437|FG003|Overall Study|Randomized But Not Treated|0|||
130634603|NCT02177812|470280438|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634604|NCT02177812|470280439|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634605|NCT02177812|470280440|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634606|NCT02177812|470280441|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634607|NCT02177812|470280442|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634608|NCT02177812|470280443|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
130634609|NCT02177812|470280444|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
130634610|NCT02177812|470280445|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
130634611|NCT02177812|470280446|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130634612|NCT02177812|470280438|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634613|NCT02177812|470280439|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634614|NCT02177812|470280440|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634615|NCT02177812|470280441|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634616|NCT02177812|470280442|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634617|NCT02177812|470280443|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
130634618|NCT02177812|470280444|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
130634619|NCT02177812|470280445|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634620|NCT02177812|470280446|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130634621|NCT02177812|470280438|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130634622|NCT02177812|470280439|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130634623|NCT02177812|470280440|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130634624|NCT02177812|470280441|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130634625|NCT02177812|470280442|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130634626|NCT02177812|470280443|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130634627|NCT02177812|470280444|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
130634628|NCT02177812|470280445|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130634629|NCT02177812|470280446|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130634630|NCT00089999|470280447|FG000|Overall Study|Adverse Event|4|||
130634631|NCT00089999|470280448|FG001|Overall Study|Adverse Event|7|||
130634632|NCT00089999|470280447|FG000|Overall Study|Withdrawal by Subject|0|||
130634633|NCT00089999|470280448|FG001|Overall Study|Withdrawal by Subject|4|||
130634634|NCT00089999|470280447|FG000|Overall Study|Lost to Follow-up|2|||
130634635|NCT00089999|470280448|FG001|Overall Study|Lost to Follow-up|1|||
130634636|NCT00089999|470280447|FG000|Overall Study|Radiological Progression of Cancer|52|||
130634637|NCT00089999|470280448|FG001|Overall Study|Radiological Progression of Cancer|44|||
130634638|NCT00089999|470280447|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
130634639|NCT00089999|470280448|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
130634640|NCT00089999|470280447|FG000|Overall Study|Death|3|||
130634641|NCT00089999|470280448|FG001|Overall Study|Death|3|||
130634642|NCT00089999|470280447|FG000|Overall Study|Poor General Condition|1|||
130634643|NCT00089999|470280448|FG001|Overall Study|Poor General Condition|0|||
130634644|NCT00089999|470280447|FG000|Overall Study|Clinical Progression|1|||
130634645|NCT00089999|470280448|FG001|Overall Study|Clinical Progression|2|||
130634646|NCT00089999|470280447|FG000|Overall Study|Physician Decision|2|||
130634647|NCT00089999|470280448|FG001|Overall Study|Physician Decision|2|||
130634648|NCT00089999|470280447|FG000|Overall Study|Patient Underwent Surgery|2|||
130634649|NCT00089999|470280448|FG001|Overall Study|Patient Underwent Surgery|0|||
130634650|NCT00089999|470280447|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
130634651|NCT00089999|470280448|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
130634652|NCT01167153|470280449|FG000|Overall Study|Non-effective therapy|1|||
130634653|NCT01167153|470280450|FG001|Overall Study|Non-effective therapy|4|||
130634654|NCT01167153|470280449|FG000|Overall Study|AE including clinical laboratory AE|2|||
130634655|NCT01167153|470280450|FG001|Overall Study|AE including clinical laboratory AE|8|||
130634656|NCT01167153|470280449|FG000|Overall Study|Hypotension|1|||
130634657|NCT01167153|470280450|FG001|Overall Study|Hypotension|0|||
130634658|NCT01167153|470280449|FG000|Overall Study|Lost to Follow-up|7|||
130634659|NCT01167153|470280450|FG001|Overall Study|Lost to Follow-up|9|||
130634660|NCT01167153|470280449|FG000|Overall Study|Non-compliance to concomitant medication|0|||
130634661|NCT01167153|470280450|FG001|Overall Study|Non-compliance to concomitant medication|2|||
130634662|NCT01167153|470280449|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
130634663|NCT01167153|470280450|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
130634664|NCT01167153|470280449|FG000|Overall Study|Withdrawal consent|1|||
130634665|NCT01167153|470280450|FG001|Overall Study|Withdrawal consent|1|||
130634666|NCT01167153|470280449|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
130634667|NCT01167153|470280450|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
130634668|NCT02828644|470282101|FG000|Overall Study|Lost to Follow-up|23|||
130634669|NCT02828644|470282102|FG001|Overall Study|Lost to Follow-up|22|||
130634670|NCT06048809|470282106|FG000|Overall Study|Adverse Event|2|||
130634671|NCT06048809|470282107|FG001|Overall Study|Adverse Event|0|||
130634672|NCT06048809|470282106|FG000|Overall Study|Withdrawal by Subject|1|||
130634673|NCT06048809|470282107|FG001|Overall Study|Withdrawal by Subject|1|||
130634674|NCT03887052|470282113|FG000|Overall Study|Adverse Event|2|||
130634675|NCT03887052|470282113|FG000|Overall Study|Physician Decision|2|||
130634676|NCT03887052|470282113|FG000|Overall Study|Withdrawal by Subject|3|||
130634677|NCT03887052|470282113|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
130634678|NCT03887052|470282113|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
130634679|NCT01804842|470282114|FG000|Overall Study|Adverse Event|1|||
130634680|NCT01804842|470282115|FG001|Overall Study|Adverse Event|1|||
130634681|NCT01804842|470282116|FG002|Overall Study|Adverse Event|0|||
130634682|NCT01804842|470282114|FG000|Overall Study|Lost to Follow-up|1|||
130634683|NCT01804842|470282115|FG001|Overall Study|Lost to Follow-up|0|||
130634684|NCT01804842|470282116|FG002|Overall Study|Lost to Follow-up|0|||
130634685|NCT01804842|470282114|FG000|Overall Study|Non-Compliance|1|||
130634686|NCT01804842|470282115|FG001|Overall Study|Non-Compliance|1|||
130634687|NCT01804842|470282116|FG002|Overall Study|Non-Compliance|0|||
130634688|NCT01804842|470282114|FG000|Overall Study|Personal Reason|0|||
130634689|NCT01804842|470282115|FG001|Overall Study|Personal Reason|0|||
130634690|NCT01804842|470282116|FG002|Overall Study|Personal Reason|1|||
130634691|NCT04097028|470282119|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
130634692|NCT04097028|470282119|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
130634693|NCT04097028|470282119|FG000|Overall Study|Disease Progression prior to Surgery|2|||
130634694|NCT04097028|470282119|FG000|Overall Study|Adverse Event prior to Surgery|1|||
130634695|NCT03687827|470282120|FG000|Treatment Period 1|Death|0|||
130634696|NCT03687827|470282121|FG001|Treatment Period 1|Death|1|||
130634697|NCT03687827|470282120|FG000|Treatment Period 1|Lost to Follow-up|2|||
130634698|NCT03687827|470282121|FG001|Treatment Period 1|Lost to Follow-up|2|||
130634699|NCT03687827|470282120|FG000|Treatment Period 1|Physician Decision|5|||
130634700|NCT03687827|470282121|FG001|Treatment Period 1|Physician Decision|2|||
130634701|NCT03687827|470282120|FG000|Treatment Period 1|Withdrawal by Subject|7|||
130634702|NCT03687827|470282121|FG001|Treatment Period 1|Withdrawal by Subject|3|||
130634703|NCT03687827|470282120|FG000|Treatment Period 2|Physician Decision|4|||
130634704|NCT03687827|470282121|FG001|Treatment Period 2|Physician Decision|1|||
130634705|NCT03687827|470282120|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130634706|NCT03687827|470282121|FG001|Treatment Period 2|Withdrawal by Subject|2|||
130634707|NCT03277105|470282124|FG000|Overall Study|Death|129|||
130634708|NCT03277105|470282125|FG001|Overall Study|Death|124|||
130634709|NCT03277105|470282124|FG000|Overall Study|Lost to Follow-up|2|||
130634710|NCT03277105|470282125|FG001|Overall Study|Lost to Follow-up|4|||
130634711|NCT03277105|470282124|FG000|Overall Study|Withdrawal by Subject|10|||
130634712|NCT03277105|470282125|FG001|Overall Study|Withdrawal by Subject|10|||
130634713|NCT03277105|470282124|FG000|Overall Study|Other|118|||
130634714|NCT03277105|470282125|FG001|Overall Study|Other|125|||
130634715|NCT02736929|470282133|FG000|Main Study|Lost to Follow-up|7|||
130634716|NCT02736929|470282134|FG001|Main Study|Lost to Follow-up|1|||
130634717|NCT02736929|470282135|FG002|Main Study|Lost to Follow-up|0|||
130634718|NCT02736929|470282133|FG000|Main Study|Withdrawal by Subject|1|||
130634719|NCT02736929|470282134|FG001|Main Study|Withdrawal by Subject|1|||
130634720|NCT02736929|470282135|FG002|Main Study|Withdrawal by Subject|0|||
130634721|NCT02736929|470282133|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
130634722|NCT02736929|470282134|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
130634723|NCT02736929|470282135|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
130634724|NCT01347073|470282136|FG000|Overall Study|Adverse Event|1|||
130634725|NCT01347073|470282136|FG000|Overall Study|Liver Transplant|1|||
130634726|NCT01690988|470282139|FG000|Overall Study|Withdrawal by Subject|2|||
130634727|NCT01690988|470282140|FG001|Overall Study|Withdrawal by Subject|2|||
130634728|NCT01690988|470282141|FG002|Overall Study|Withdrawal by Subject|3|||
130634729|NCT01690988|470282139|FG000|Overall Study|Physician Decision|0|||
130634730|NCT01690988|470282140|FG001|Overall Study|Physician Decision|0|||
130634731|NCT01690988|470282141|FG002|Overall Study|Physician Decision|1|||
130634732|NCT01690988|470282139|FG000|Overall Study|Operation Cancelled|1|||
130634733|NCT01690988|470282140|FG001|Overall Study|Operation Cancelled|1|||
130634734|NCT01690988|470282141|FG002|Overall Study|Operation Cancelled|0|||
130634735|NCT01690988|470282139|FG000|Overall Study|Determined ineligible|1|||
130634736|NCT01690988|470282140|FG001|Overall Study|Determined ineligible|0|||
130634737|NCT01690988|470282141|FG002|Overall Study|Determined ineligible|0|||
130634738|NCT01690988|470282139|FG000|Overall Study|Death|1|||
130634739|NCT01690988|470282140|FG001|Overall Study|Death|1|||
130634740|NCT01690988|470282141|FG002|Overall Study|Death|1|||
130634741|NCT01690988|470282139|FG000|Overall Study|Sedated|1|||
130634742|NCT01690988|470282140|FG001|Overall Study|Sedated|1|||
130634743|NCT01690988|470282141|FG002|Overall Study|Sedated|2|||
130634744|NCT00372489|470282142|FG000|Overall Study|Adverse Event|18|||
130634745|NCT00372489|470282142|FG000|Overall Study|Lack of Efficacy|1|||
130634746|NCT00372489|470282142|FG000|Overall Study|Lost to Follow-up|3|||
130634747|NCT00372489|470282142|FG000|Overall Study|Physician Decision|3|||
130634748|NCT00372489|470282142|FG000|Overall Study|Withdrawal by Subject|5|||
130634749|NCT00372489|470282142|FG000|Overall Study|Patient Relocation|2|||
130634750|NCT00372489|470282142|FG000|Overall Study|Renal transplant|6|||
130634751|NCT00372489|470282142|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
130634752|NCT03696576|470282156|FG000|Overall Study|Soreness of throat after therapy|1|||
130634753|NCT03696576|470282157|FG001|Overall Study|Soreness of throat after therapy|1|||
130634754|NCT03696576|470282156|FG000|Overall Study|Lost to Follow-up|2|||
130634755|NCT03696576|470282157|FG001|Overall Study|Lost to Follow-up|4|||
130634756|NCT00552344|470282160|FG000|Overall Study|Lack of Efficacy|55|||
130634757|NCT00552344|470282160|FG000|Overall Study|Loss of efficacy|75|||
130634758|NCT00552344|470282160|FG000|Overall Study|Lost to Follow-up|8|||
130634759|NCT00552344|470282160|FG000|Overall Study|Withdrawal by Subject|48|||
130634760|NCT00552344|470282160|FG000|Overall Study|SAE, non-fatal|6|||
130634761|NCT00552344|470282160|FG000|Overall Study|AE, non-serious non-fatal|38|||
130634762|NCT00552344|470282160|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
130634763|NCT00552344|470282160|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
130634764|NCT00552344|470282160|FG000|Overall Study|Other Reason|22|||
130634765|NCT01634100|470282161|FG000|Overall Study|Withdrawal by Subject|1|||
130634766|NCT01634100|470282162|FG001|Overall Study|Withdrawal by Subject|0|||
130634767|NCT01634100|470282163|FG002|Overall Study|Withdrawal by Subject|1|||
130634768|NCT01634100|470282164|FG003|Overall Study|Withdrawal by Subject|0|||
130634769|NCT01634100|470282165|FG004|Overall Study|Withdrawal by Subject|0|||
130634770|NCT01634100|470282166|FG005|Overall Study|Withdrawal by Subject|0|||
130634771|NCT01487863|470282174|FG000|Overall Study|Death|19|||
130634772|NCT01487863|470282175|FG001|Overall Study|Death|19|||
130634773|NCT00486889|470282176|FG000|Overall Study|Death|3|||
130634774|NCT00486889|470282176|FG000|Overall Study|Non-compliant|2|||
130634775|NCT00486889|470282176|FG000|Overall Study|Withdrawal by Subject|6|||
130634776|NCT00893763|470282177|FG000|Overall Study|extubated|110|||
130634777|NCT00893763|470282178|FG001|Overall Study|extubated|110|||
130634778|NCT01512693|470282179|FG000|Overall Study|Withdrawal by Subject|0|||
130634779|NCT01512693|470282180|FG001|Overall Study|Withdrawal by Subject|1|||
130634780|NCT01975376|470282181|FG000|Overall Study|Adverse Event|5|||
130634781|NCT01975376|470282182|FG001|Overall Study|Adverse Event|5|||
130634782|NCT01975376|470282181|FG000|Overall Study|Death|65|||
130634783|NCT01975376|470282182|FG001|Overall Study|Death|72|||
130634784|NCT01975376|470282181|FG000|Overall Study|Lost to Follow-up|70|||
130634785|NCT01975376|470282182|FG001|Overall Study|Lost to Follow-up|66|||
130634786|NCT01975376|470282181|FG000|Overall Study|Withdrew consent|68|||
130634787|NCT01975376|470282182|FG001|Overall Study|Withdrew consent|62|||
130634788|NCT01975376|470282181|FG000|Overall Study|Other|2|||
130634789|NCT01975376|470282182|FG001|Overall Study|Other|4|||
130634790|NCT01975376|470282181|FG000|Overall Study|Randomized, Not Treated|16|||
130634791|NCT01975376|470282182|FG001|Overall Study|Randomized, Not Treated|8|||
130634792|NCT04731922|470282186|FG000|Overall Study|Adverse Event|0|||
130634793|NCT04731922|470282187|FG001|Overall Study|Adverse Event|0|||
130634794|NCT04731922|470282188|FG002|Overall Study|Adverse Event|0|||
130634795|NCT04731922|470282189|FG003|Overall Study|Adverse Event|0|||
130634796|NCT04731922|470282190|FG004|Overall Study|Adverse Event|0|||
130634797|NCT04731922|470282191|FG005|Overall Study|Adverse Event|0|||
130634798|NCT04731922|470282192|FG006|Overall Study|Adverse Event|0|||
130634799|NCT04731922|470282193|FG007|Overall Study|Adverse Event|0|||
130634800|NCT04731922|470282194|FG008|Overall Study|Adverse Event|0|||
130634801|NCT04731922|470282195|FG009|Overall Study|Adverse Event|0|||
130634802|NCT04731922|470282196|FG010|Overall Study|Adverse Event|1|||
130634803|NCT04731922|470282197|FG011|Overall Study|Adverse Event|0|||
130634804|NCT04731922|470282198|FG012|Overall Study|Adverse Event|0|||
130634805|NCT04731922|470282199|FG013|Overall Study|Adverse Event|0|||
130634806|NCT04731922|470282200|FG014|Overall Study|Adverse Event|0|||
130634807|NCT04731922|470282201|FG015|Overall Study|Adverse Event|0|||
130634808|NCT04731922|470282202|FG016|Overall Study|Adverse Event|0|||
130634809|NCT04731922|470282186|FG000|Overall Study|Lost to Follow-up|0|||
130634810|NCT04731922|470282187|FG001|Overall Study|Lost to Follow-up|0|||
130634811|NCT04731922|470282188|FG002|Overall Study|Lost to Follow-up|0|||
130634812|NCT04731922|470282189|FG003|Overall Study|Lost to Follow-up|1|||
130634813|NCT04731922|470282190|FG004|Overall Study|Lost to Follow-up|0|||
130634814|NCT04731922|470282191|FG005|Overall Study|Lost to Follow-up|1|||
130634815|NCT04731922|470282192|FG006|Overall Study|Lost to Follow-up|0|||
130634816|NCT04731922|470282193|FG007|Overall Study|Lost to Follow-up|0|||
130634817|NCT04731922|470282194|FG008|Overall Study|Lost to Follow-up|0|||
130634818|NCT04731922|470282195|FG009|Overall Study|Lost to Follow-up|0|||
130634819|NCT04731922|470282196|FG010|Overall Study|Lost to Follow-up|0|||
130634820|NCT04731922|470282197|FG011|Overall Study|Lost to Follow-up|0|||
130634821|NCT04731922|470282198|FG012|Overall Study|Lost to Follow-up|0|||
130634822|NCT04731922|470282199|FG013|Overall Study|Lost to Follow-up|0|||
130634823|NCT04731922|470282200|FG014|Overall Study|Lost to Follow-up|0|||
130634824|NCT04731922|470282201|FG015|Overall Study|Lost to Follow-up|0|||
130634825|NCT04731922|470282202|FG016|Overall Study|Lost to Follow-up|0|||
130634826|NCT04731922|470282186|FG000|Overall Study|Withdrawal by Subject|1|||
130634827|NCT04731922|470282187|FG001|Overall Study|Withdrawal by Subject|0|||
130634828|NCT04731922|470282188|FG002|Overall Study|Withdrawal by Subject|0|||
130634829|NCT04731922|470282189|FG003|Overall Study|Withdrawal by Subject|0|||
130634830|NCT04731922|470282190|FG004|Overall Study|Withdrawal by Subject|1|||
130634831|NCT04731922|470282191|FG005|Overall Study|Withdrawal by Subject|0|||
130634832|NCT04731922|470282192|FG006|Overall Study|Withdrawal by Subject|1|||
130634833|NCT04731922|470282193|FG007|Overall Study|Withdrawal by Subject|0|||
130634834|NCT04731922|470282194|FG008|Overall Study|Withdrawal by Subject|0|||
130634835|NCT04731922|470282195|FG009|Overall Study|Withdrawal by Subject|0|||
130634836|NCT04731922|470282196|FG010|Overall Study|Withdrawal by Subject|0|||
130634837|NCT04731922|470282197|FG011|Overall Study|Withdrawal by Subject|0|||
130634838|NCT04731922|470282198|FG012|Overall Study|Withdrawal by Subject|0|||
130634839|NCT04731922|470282199|FG013|Overall Study|Withdrawal by Subject|1|||
130634840|NCT04731922|470282200|FG014|Overall Study|Withdrawal by Subject|0|||
130634841|NCT04731922|470282201|FG015|Overall Study|Withdrawal by Subject|0|||
130634842|NCT04731922|470282202|FG016|Overall Study|Withdrawal by Subject|0|||
130634843|NCT04731922|470282186|FG000|Overall Study|Other|0|||
130634844|NCT04731922|470282187|FG001|Overall Study|Other|0|||
130634845|NCT04731922|470282188|FG002|Overall Study|Other|0|||
130634846|NCT04731922|470282189|FG003|Overall Study|Other|0|||
130634847|NCT04731922|470282190|FG004|Overall Study|Other|0|||
130634848|NCT04731922|470282191|FG005|Overall Study|Other|0|||
130634849|NCT04731922|470282192|FG006|Overall Study|Other|1|||
130634850|NCT04731922|470282193|FG007|Overall Study|Other|0|||
130634851|NCT04731922|470282194|FG008|Overall Study|Other|0|||
130634852|NCT04731922|470282195|FG009|Overall Study|Other|0|||
130634853|NCT04731922|470282196|FG010|Overall Study|Other|0|||
130634854|NCT04731922|470282197|FG011|Overall Study|Other|0|||
130634855|NCT04731922|470282198|FG012|Overall Study|Other|0|||
130634856|NCT04731922|470282199|FG013|Overall Study|Other|0|||
130634857|NCT04731922|470282200|FG014|Overall Study|Other|0|||
130634858|NCT04731922|470282201|FG015|Overall Study|Other|0|||
130634859|NCT04731922|470282202|FG016|Overall Study|Other|0|||
130634860|NCT01819194|470282204|FG000|Overall Study|Loss of study articles|2|||
130634861|NCT02343952|470282205|FG000|Study Treatment|Disease Progression|23|||
130634862|NCT02343952|470282205|FG000|Study Treatment|Death|3|||
130634863|NCT02343952|470282205|FG000|Study Treatment|Adverse Event|19|||
130634864|NCT02343952|470282205|FG000|Study Treatment|Withdrawal by Subject|7|||
130634865|NCT02343952|470282205|FG000|Study Treatment|other complicating Diseases|1|||
130634866|NCT02343952|470282205|FG000|Follow up|Withdrawal by Subject|3|||
130634867|NCT02343952|470282205|FG000|Follow up|Death|33|||
130634868|NCT02343952|470282205|FG000|Follow up|Patient does not meet eligibility for study.|1|||
130634869|NCT02343952|470282205|FG000|Follow up|Research department closed by the practice.|5|||
130634870|NCT02343952|470282205|FG000|Follow up|Patient went home to Russia|1|||
130634871|NCT02343952|470282205|FG000|Follow up|Disease Progression|1|||
130634872|NCT02343952|470282205|FG000|Follow up|study terminated|1|||
130634873|NCT01448707|470282209|FG000|Overall Study|Adverse Event|3|||
130634874|NCT01448707|470282210|FG001|Overall Study|Adverse Event|1|||
130634875|NCT01448707|470282209|FG000|Overall Study|Lost to Follow-up|2|||
130634876|NCT01448707|470282210|FG001|Overall Study|Lost to Follow-up|6|||
130634877|NCT01448707|470282209|FG000|Overall Study|Withdrawal by Subject|6|||
130634878|NCT01448707|470282210|FG001|Overall Study|Withdrawal by Subject|7|||
130634879|NCT01448707|470282209|FG000|Overall Study|Other|7|||
130634880|NCT01448707|470282210|FG001|Overall Study|Other|4|||
130634881|NCT00441480|470282214|FG000|Overall Study|Protocol Violation|1|||
130634882|NCT00441480|470282215|FG001|Overall Study|Protocol Violation|1|||
130634883|NCT00441480|470282214|FG000|Overall Study|Withdrawal by Subject|2|||
130634884|NCT00441480|470282215|FG001|Overall Study|Withdrawal by Subject|3|||
130634885|NCT02623699|470282216|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634886|NCT02623699|470282217|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
130634887|NCT02623699|470282218|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634888|NCT02623699|470282219|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634889|NCT02623699|470282220|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634890|NCT02623699|470282221|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634891|NCT02623699|470282222|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634892|NCT02623699|470282223|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634893|NCT02623699|470282224|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634894|NCT02623699|470282225|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634895|NCT02623699|470282226|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634896|NCT02623699|470282227|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130634897|NCT02623699|470282216|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634898|NCT02623699|470282217|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634899|NCT02623699|470282218|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634900|NCT02623699|470282219|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634901|NCT02623699|470282220|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634902|NCT02623699|470282221|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634903|NCT02623699|470282222|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
130634904|NCT02623699|470282223|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634905|NCT02623699|470282224|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634906|NCT02623699|470282225|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634907|NCT02623699|470282226|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634908|NCT02623699|470282227|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130634909|NCT02623699|470282216|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634910|NCT02623699|470282217|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634911|NCT02623699|470282218|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634912|NCT02623699|470282219|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634913|NCT02623699|470282220|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634914|NCT02623699|470282221|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
130634915|NCT02623699|470282222|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634916|NCT02623699|470282223|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634917|NCT02623699|470282224|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634918|NCT02623699|470282225|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634919|NCT02623699|470282226|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634920|NCT02623699|470282227|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130634921|NCT02623699|470282216|FG000|Part B (Up to 289 Days)|Death|0|||
130634922|NCT02623699|470282217|FG001|Part B (Up to 289 Days)|Death|0|||
130634923|NCT02623699|470282218|FG002|Part B (Up to 289 Days)|Death|0|||
130634924|NCT02623699|470282219|FG003|Part B (Up to 289 Days)|Death|0|||
130634925|NCT02623699|470282220|FG004|Part B (Up to 289 Days)|Death|0|||
130634926|NCT02623699|470282221|FG005|Part B (Up to 289 Days)|Death|1|||
130634927|NCT02623699|470282222|FG006|Part B (Up to 289 Days)|Death|1|||
130634928|NCT02623699|470282223|FG007|Part B (Up to 289 Days)|Death|0|||
130634929|NCT02623699|470282224|FG008|Part B (Up to 289 Days)|Death|1|||
130634930|NCT02623699|470282225|FG009|Part B (Up to 289 Days)|Death|0|||
130634931|NCT02623699|470282226|FG010|Part B (Up to 289 Days)|Death|0|||
130634932|NCT02623699|470282227|FG011|Part B (Up to 289 Days)|Death|0|||
130634933|NCT02623699|470282216|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
130634934|NCT02623699|470282217|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
130634935|NCT02623699|470282218|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
130634936|NCT02623699|470282219|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
130634937|NCT02623699|470282220|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
130634938|NCT02623699|470282221|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
130634939|NCT02623699|470282222|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
130634940|NCT02623699|470282223|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
130634941|NCT02623699|470282224|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
130634942|NCT02623699|470282225|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
130634943|NCT02623699|470282226|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
130634944|NCT02623699|470282227|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
130634945|NCT02623699|470282216|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634946|NCT02623699|470282217|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634947|NCT02623699|470282218|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634948|NCT02623699|470282219|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634949|NCT02623699|470282220|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634950|NCT02623699|470282221|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634951|NCT02623699|470282222|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634952|NCT02623699|470282223|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634953|NCT02623699|470282224|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634954|NCT02623699|470282225|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130634955|NCT02623699|470282226|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
130634956|NCT02623699|470282227|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
130634957|NCT02623699|470282216|FG000|Part C (Up to 236 Days)|Death|0|||
130634958|NCT02623699|470282217|FG001|Part C (Up to 236 Days)|Death|0|||
130634959|NCT02623699|470282218|FG002|Part C (Up to 236 Days)|Death|0|||
130634960|NCT02623699|470282219|FG003|Part C (Up to 236 Days)|Death|0|||
130634961|NCT02623699|470282220|FG004|Part C (Up to 236 Days)|Death|0|||
130634962|NCT02623699|470282221|FG005|Part C (Up to 236 Days)|Death|0|||
130634963|NCT02623699|470282222|FG006|Part C (Up to 236 Days)|Death|0|||
130634964|NCT02623699|470282223|FG007|Part C (Up to 236 Days)|Death|0|||
130634965|NCT02623699|470282224|FG008|Part C (Up to 236 Days)|Death|0|||
130634966|NCT02623699|470282225|FG009|Part C (Up to 236 Days)|Death|0|||
130634967|NCT02623699|470282226|FG010|Part C (Up to 236 Days)|Death|0|||
130634968|NCT02623699|470282227|FG011|Part C (Up to 236 Days)|Death|1|||
130634969|NCT02623699|470282216|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
130634970|NCT02623699|470282217|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
130634971|NCT02623699|470282218|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
130634972|NCT02623699|470282219|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
130634973|NCT02623699|470282220|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
130634974|NCT02623699|470282221|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
130634975|NCT02623699|470282222|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
130634976|NCT02623699|470282223|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
130634977|NCT02623699|470282224|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
130634978|NCT02623699|470282225|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
130634979|NCT02623699|470282226|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
130634980|NCT02623699|470282227|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
130634981|NCT00899678|470282228|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
130634982|NCT00899678|470282229|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
130634983|NCT00899678|470282230|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
130634984|NCT00899678|470282228|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
130634985|NCT00899678|470282229|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
130634986|NCT00899678|470282230|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
130634987|NCT00899678|470282228|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
130634988|NCT00899678|470282229|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
130634989|NCT00899678|470282230|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
130634990|NCT00899678|470282228|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
130634991|NCT00899678|470282229|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
130634992|NCT00899678|470282230|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
130634993|NCT00899678|470282228|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
130634994|NCT00899678|470282229|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
130634995|NCT00899678|470282230|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
130634996|NCT00899678|470282228|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
130634997|NCT00899678|470282229|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
130634998|NCT00899678|470282230|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
130634999|NCT00899678|470282228|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
130635000|NCT00899678|470282229|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
130635001|NCT00899678|470282230|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
130635002|NCT00899678|470282228|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
130635003|NCT00899678|470282229|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
130635004|NCT00899678|470282230|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
130635005|NCT00899678|470282228|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
130635006|NCT00899678|470282229|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
130635007|NCT00899678|470282230|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
130635008|NCT02699125|470282233|FG000|Placebo|Lost to Follow-up|2|||
130635009|NCT02699125|470282234|FG001|Placebo|Lost to Follow-up|0|||
130635010|NCT02699125|470282233|FG000|Placebo|Protocol Violation|1|||
130635011|NCT02699125|470282234|FG001|Placebo|Protocol Violation|0|||
130635012|NCT02699125|470282233|FG000|Placebo|Withdrawal by Subject|0|||
130635013|NCT02699125|470282234|FG001|Placebo|Withdrawal by Subject|4|||
130635014|NCT02699125|470282233|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
130635015|NCT02699125|470282234|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
130635016|NCT03796195|470282235|FG000|Overall Study|Study closed early|1|||
130635017|NCT02092324|470282240|FG000|Overall Study|Adverse Event|1|||
130635018|NCT02092324|470282240|FG000|Overall Study|Lack of Efficacy|6|||
130635019|NCT02092324|470282240|FG000|Overall Study|Proceed to Transplant|3|||
130635020|NCT02092324|470282240|FG000|Overall Study|Physician Decision|7|||
130635021|NCT02092324|470282240|FG000|Overall Study|Misdiagnosis|2|||
130635022|NCT01039428|470282241|FG000|Overall Study|Protocol Violation|1|||
130635023|NCT01039428|470282242|FG001|Overall Study|Protocol Violation|0|||
130635024|NCT01039428|470282241|FG000|Overall Study|Withdrawal by Subject|1|||
130635025|NCT01039428|470282242|FG001|Overall Study|Withdrawal by Subject|0|||
130635026|NCT00441012|470282243|FG000|Overall Study|Adverse Event|0|||
130635027|NCT00441012|470282244|FG001|Overall Study|Adverse Event|1|||
130635028|NCT00441012|470282243|FG000|Overall Study|Lost to Follow-up|3|||
130635029|NCT00441012|470282244|FG001|Overall Study|Lost to Follow-up|3|||
130635030|NCT00441012|470282243|FG000|Overall Study|Protocol Violation|10|||
130635031|NCT00441012|470282244|FG001|Overall Study|Protocol Violation|9|||
130635032|NCT00441012|470282243|FG000|Overall Study|Withdrawal by Subject|4|||
130635033|NCT00441012|470282244|FG001|Overall Study|Withdrawal by Subject|0|||
130635034|NCT00441012|470282243|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
130635035|NCT00441012|470282244|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
130635036|NCT00262314|470282249|FG000|Overall Study|Changing physicians|38|||
130635037|NCT00262314|470282249|FG000|Overall Study|Death|12|||
130635038|NCT00262314|470282249|FG000|Overall Study|Patient's decision|92|||
130635039|NCT00262314|470282249|FG000|Overall Study|Other|95|||
130635040|NCT00262314|470282249|FG000|Overall Study|Lost to Follow-up|70|||
130635041|NCT00262314|470282249|FG000|Overall Study|Administrative withdrawal|30|||
130635042|NCT05104749|470282250|FG000|Overall Study|Lost to Follow-up|2|||
130635043|NCT05104749|470282251|FG001|Overall Study|Lost to Follow-up|3|||
130635044|NCT03964493|470282252|FG000|Overall Study|Withdrawal by Subject|4|||
130635045|NCT03964493|470282253|FG001|Overall Study|Withdrawal by Subject|1|||
130635046|NCT03964493|470282252|FG000|Overall Study|Lost to Follow-up|13|||
130635047|NCT03964493|470282253|FG001|Overall Study|Lost to Follow-up|4|||
130635048|NCT02470429|470282254|FG000|Overall Study|Adverse Event|1|||
130635049|NCT02470429|470282255|FG001|Overall Study|Adverse Event|0|||
130635050|NCT02470429|470282254|FG000|Overall Study|Withdrawal by Subject|1|||
130635051|NCT02470429|470282255|FG001|Overall Study|Withdrawal by Subject|0|||
130635052|NCT01300767|470282256|FG000|Overall Study|Discomfort|2|||
130635053|NCT01300767|470282256|FG000|Overall Study|Biomicroscopy|1|||
130635054|NCT01300767|470282256|FG000|Overall Study|Unacceptable fit|1|||
130635055|NCT00398138|470282257|FG000|Overall Study|Adverse Event|2|||
130635056|NCT00117572|470282259|FG000|Overall Study|Site withdrew before starting treatment|2|||
130635057|NCT00117572|470282260|FG001|Overall Study|Site withdrew before starting treatment|3|||
130635058|NCT00117572|470282259|FG000|Overall Study|Withdrawal by Subject|3|||
130635059|NCT00117572|470282260|FG001|Overall Study|Withdrawal by Subject|3|||
130635060|NCT00117572|470282259|FG000|Overall Study|Protocol Violation|1|||
130635061|NCT00117572|470282260|FG001|Overall Study|Protocol Violation|0|||
130635062|NCT00887068|470282261|FG000|Overall Study|Withdrawal by Subject|2|||
130635063|NCT00887068|470282262|FG001|Overall Study|Withdrawal by Subject|0|||
130635064|NCT00887068|470282261|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
130635065|NCT00887068|470282262|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
130635066|NCT01387594|470282263|FG000|Overall Study|Withdrawal by Subject|0|||
130635067|NCT01387594|470282264|FG001|Overall Study|Withdrawal by Subject|2|||
130635068|NCT01387594|470282263|FG000|Overall Study|Lost to Follow-up|0|||
130635069|NCT01387594|470282264|FG001|Overall Study|Lost to Follow-up|1|||
130635070|NCT03277794|470282269|FG000|Overall Study|Lost to Follow-up|2|||
130635071|NCT03277794|470282270|FG001|Overall Study|Lost to Follow-up|4|||
130635072|NCT03277794|470282269|FG000|Overall Study|Withdrew due to high acuity|1|||
130635073|NCT03277794|470282270|FG001|Overall Study|Withdrew due to high acuity|0|||
130635074|NCT03039569|470282274|FG000|Overall Study|Lost to Follow-up|5|||
130635075|NCT03039569|470282275|FG001|Overall Study|Lost to Follow-up|4|||
130635076|NCT02254304|470282277|FG000|Overall Study|Adverse Event|2|||
130635077|NCT02254304|470282278|FG001|Overall Study|Adverse Event|1|||
130635078|NCT02254304|470282277|FG000|Overall Study|Lost to Follow-up|2|||
130635079|NCT02254304|470282278|FG001|Overall Study|Lost to Follow-up|2|||
130635080|NCT02254304|470282277|FG000|Overall Study|Protocol Violation|1|||
130635081|NCT02254304|470282278|FG001|Overall Study|Protocol Violation|0|||
130635082|NCT02254304|470282277|FG000|Overall Study|Withdrawal by Subject|3|||
130635083|NCT02254304|470282278|FG001|Overall Study|Withdrawal by Subject|0|||
130635084|NCT02254304|470282277|FG000|Overall Study|Injection site pain and Injection fear|1|||
130635085|NCT02254304|470282278|FG001|Overall Study|Injection site pain and Injection fear|0|||
130635086|NCT02254304|470282277|FG000|Overall Study|Personal causes|4|||
130635087|NCT02254304|470282278|FG001|Overall Study|Personal causes|1|||
130635088|NCT02254304|470282277|FG000|Overall Study|Personal decision|1|||
130635089|NCT02254304|470282278|FG001|Overall Study|Personal decision|0|||
130635090|NCT04507360|470283724|FG000|Week 1|Lost to Follow-up|0|||
130635091|NCT04507360|470283725|FG001|Week 1|Lost to Follow-up|0|||
130635092|NCT04507360|470283726|FG002|Week 1|Lost to Follow-up|0|||
130635093|NCT04507360|470283727|FG003|Week 1|Lost to Follow-up|0|||
130635094|NCT04507360|470283728|FG004|Week 1|Lost to Follow-up|0|||
130635095|NCT04507360|470283729|FG005|Week 1|Lost to Follow-up|0|||
130635096|NCT04507360|470283730|FG006|Week 1|Lost to Follow-up|0|||
130635097|NCT04507360|470283731|FG007|Week 1|Lost to Follow-up|0|||
130635098|NCT04507360|470283732|FG008|Week 1|Lost to Follow-up|72|||
130635099|NCT04507360|470283733|FG009|Week 1|Lost to Follow-up|22|||
130635100|NCT04507360|470283734|FG010|Week 1|Lost to Follow-up|10|||
130635101|NCT04507360|470283724|FG000|Week 2|Lost to Follow-up|0|||
130635102|NCT04507360|470283725|FG001|Week 2|Lost to Follow-up|0|||
130635103|NCT04507360|470283726|FG002|Week 2|Lost to Follow-up|0|||
130635104|NCT04507360|470283727|FG003|Week 2|Lost to Follow-up|0|||
130635105|NCT04507360|470283728|FG004|Week 2|Lost to Follow-up|0|||
130635106|NCT04507360|470283729|FG005|Week 2|Lost to Follow-up|0|||
130635107|NCT04507360|470283730|FG006|Week 2|Lost to Follow-up|0|||
130635108|NCT04507360|470283731|FG007|Week 2|Lost to Follow-up|0|||
130635109|NCT04507360|470283732|FG008|Week 2|Lost to Follow-up|121|||
130635110|NCT04507360|470283733|FG009|Week 2|Lost to Follow-up|85|||
130635111|NCT04507360|470283734|FG010|Week 2|Lost to Follow-up|82|||
130635112|NCT04507360|470283724|FG000|Week 3|Lost to Follow-up|0|||
130635113|NCT04507360|470283725|FG001|Week 3|Lost to Follow-up|0|||
130635114|NCT04507360|470283726|FG002|Week 3|Lost to Follow-up|0|||
130635115|NCT04507360|470283727|FG003|Week 3|Lost to Follow-up|0|||
130635116|NCT04507360|470283728|FG004|Week 3|Lost to Follow-up|0|||
130635117|NCT04507360|470283729|FG005|Week 3|Lost to Follow-up|0|||
130635118|NCT04507360|470283730|FG006|Week 3|Lost to Follow-up|0|||
130635119|NCT04507360|470283731|FG007|Week 3|Lost to Follow-up|0|||
130635120|NCT04507360|470283732|FG008|Week 3|Lost to Follow-up|123|||
130635121|NCT04507360|470283733|FG009|Week 3|Lost to Follow-up|92|||
130635122|NCT04507360|470283734|FG010|Week 3|Lost to Follow-up|84|||
130635123|NCT04507360|470283724|FG000|Week 4|Lost to Follow-up|0|||
130635124|NCT04507360|470283725|FG001|Week 4|Lost to Follow-up|0|||
130635125|NCT04507360|470283726|FG002|Week 4|Lost to Follow-up|0|||
130635126|NCT04507360|470283727|FG003|Week 4|Lost to Follow-up|0|||
130635127|NCT04507360|470283728|FG004|Week 4|Lost to Follow-up|0|||
130635128|NCT04507360|470283729|FG005|Week 4|Lost to Follow-up|0|||
130635129|NCT04507360|470283730|FG006|Week 4|Lost to Follow-up|0|||
130635130|NCT04507360|470283731|FG007|Week 4|Lost to Follow-up|0|||
130635131|NCT04507360|470283732|FG008|Week 4|Lost to Follow-up|131|||
130635132|NCT04507360|470283733|FG009|Week 4|Lost to Follow-up|115|||
130635133|NCT04507360|470283734|FG010|Week 4|Lost to Follow-up|102|||
130635134|NCT04507360|470283724|FG000|Week 5|Lost to Follow-up|0|||
130635135|NCT04507360|470283725|FG001|Week 5|Lost to Follow-up|0|||
130635136|NCT04507360|470283726|FG002|Week 5|Lost to Follow-up|0|||
130635137|NCT04507360|470283727|FG003|Week 5|Lost to Follow-up|0|||
130635138|NCT04507360|470283728|FG004|Week 5|Lost to Follow-up|0|||
130635139|NCT04507360|470283729|FG005|Week 5|Lost to Follow-up|0|||
130635140|NCT04507360|470283730|FG006|Week 5|Lost to Follow-up|0|||
130635141|NCT04507360|470283731|FG007|Week 5|Lost to Follow-up|0|||
130635142|NCT04507360|470283732|FG008|Week 5|Lost to Follow-up|103|||
130635143|NCT04507360|470283733|FG009|Week 5|Lost to Follow-up|135|||
130635144|NCT04507360|470283734|FG010|Week 5|Lost to Follow-up|143|||
130635145|NCT04507360|470283724|FG000|Week 8|Lost to Follow-up|0|||
130635146|NCT04507360|470283725|FG001|Week 8|Lost to Follow-up|0|||
130635147|NCT04507360|470283726|FG002|Week 8|Lost to Follow-up|0|||
130635148|NCT04507360|470283727|FG003|Week 8|Lost to Follow-up|0|||
130635149|NCT04507360|470283728|FG004|Week 8|Lost to Follow-up|0|||
130635150|NCT04507360|470283729|FG005|Week 8|Lost to Follow-up|0|||
130635151|NCT04507360|470283730|FG006|Week 8|Lost to Follow-up|0|||
130635152|NCT04507360|470283731|FG007|Week 8|Lost to Follow-up|0|||
130635153|NCT04507360|470283732|FG008|Week 8|Lost to Follow-up|139|||
130635154|NCT04507360|470283733|FG009|Week 8|Lost to Follow-up|145|||
130635155|NCT04507360|470283734|FG010|Week 8|Lost to Follow-up|152|||
130635156|NCT01004159|470283735|FG000|Overall Study|Adverse Event|2|||
130635157|NCT01004159|470283735|FG000|Overall Study|Disease Progression|18|||
130635158|NCT03050307|470283739|FG000|Overall Study|Adverse Event|4|||
130635159|NCT03050307|470283740|FG001|Overall Study|Adverse Event|2|||
130635160|NCT03050307|470283739|FG000|Overall Study|Significant Protocol Deviation|0|||
130635161|NCT03050307|470283740|FG001|Overall Study|Significant Protocol Deviation|1|||
130635162|NCT03050307|470283739|FG000|Overall Study|Lost to Follow-up|0|||
130635163|NCT03050307|470283740|FG001|Overall Study|Lost to Follow-up|1|||
130635164|NCT03050307|470283739|FG000|Overall Study|Voluntary Withdrawal|3|||
130635165|NCT03050307|470283740|FG001|Overall Study|Voluntary Withdrawal|4|||
130635166|NCT03050307|470283739|FG000|Overall Study|Reason not Specified|1|||
130635167|NCT03050307|470283740|FG001|Overall Study|Reason not Specified|1|||
130635168|NCT02973997|470283741|FG000|Overall Study|Withdrawal by Subject|4|||
130635169|NCT02973997|470283742|FG001|Overall Study|Withdrawal by Subject|0|||
130635170|NCT02973997|470283741|FG000|Overall Study|Adverse Event|4|||
130635171|NCT02973997|470283742|FG001|Overall Study|Adverse Event|1|||
130635172|NCT02973997|470283741|FG000|Overall Study|Disease Progression|11|||
130635173|NCT02973997|470283742|FG001|Overall Study|Disease Progression|20|||
130635174|NCT02973997|470283741|FG000|Overall Study|Alternative Therapy|3|||
130635175|NCT02973997|470283742|FG001|Overall Study|Alternative Therapy|0|||
130635176|NCT02973997|470283741|FG000|Overall Study|Other complicating disease|0|||
130635177|NCT02973997|470283742|FG001|Overall Study|Other complicating disease|1|||
130635178|NCT02973997|470283741|FG000|Overall Study|Death|0|||
130635179|NCT02973997|470283742|FG001|Overall Study|Death|1|||
130635180|NCT00444951|470283743|FG000|Overall Study|Lost to Follow-up|1|||
130635181|NCT00444951|470283744|FG001|Overall Study|Lost to Follow-up|1|||
130635182|NCT00444951|470283745|FG002|Overall Study|Lost to Follow-up|0|||
130635183|NCT00444951|470283743|FG000|Overall Study|Withdrawal by Subject|4|||
130635184|NCT00444951|470283744|FG001|Overall Study|Withdrawal by Subject|5|||
130635185|NCT00444951|470283745|FG002|Overall Study|Withdrawal by Subject|3|||
130635186|NCT01998906|470283746|FG000|Overall Study|Participants ongoing in follow-up|77|||
130635187|NCT01998906|470283747|FG001|Overall Study|Participants ongoing in follow-up|60|||
130635188|NCT01998906|470283748|FG002|Overall Study|Participants ongoing in follow-up|58|||
130635189|NCT01998906|470283746|FG000|Overall Study|Death|21|||
130635190|NCT01998906|470283747|FG001|Overall Study|Death|30|||
130635191|NCT01998906|470283748|FG002|Overall Study|Death|17|||
130635192|NCT01998906|470283746|FG000|Overall Study|Lack of Efficacy|10|||
130635193|NCT01998906|470283747|FG001|Overall Study|Lack of Efficacy|9|||
130635194|NCT01998906|470283748|FG002|Overall Study|Lack of Efficacy|8|||
130635195|NCT01998906|470283746|FG000|Overall Study|Failure to return|0|||
130635196|NCT01998906|470283747|FG001|Overall Study|Failure to return|2|||
130635197|NCT01998906|470283748|FG002|Overall Study|Failure to return|4|||
130635198|NCT01998906|470283746|FG000|Overall Study|Violation of Selection Criteria|0|||
130635199|NCT01998906|470283747|FG001|Overall Study|Violation of Selection Criteria|0|||
130635200|NCT01998906|470283748|FG002|Overall Study|Violation of Selection Criteria|1|||
130635201|NCT01998906|470283746|FG000|Overall Study|Withdrawal by Subject|1|||
130635202|NCT01998906|470283747|FG001|Overall Study|Withdrawal by Subject|4|||
130635203|NCT01998906|470283748|FG002|Overall Study|Withdrawal by Subject|3|||
130635204|NCT01998906|470283746|FG000|Overall Study|Administrative/Other|2|||
130635205|NCT01998906|470283747|FG001|Overall Study|Administrative/Other|1|||
130635206|NCT01998906|470283748|FG002|Overall Study|Administrative/Other|3|||
130635207|NCT01998906|470283746|FG000|Overall Study|Other|3|||
130635208|NCT01998906|470283747|FG001|Overall Study|Other|8|||
130635209|NCT01998906|470283748|FG002|Overall Study|Other|4|||
130635210|NCT02996110|470283757|FG000|Pre-Treatment|Other Reasons|0|||
130635211|NCT02996110|470283758|FG001|Pre-Treatment|Other Reasons|1|||
130635212|NCT02996110|470283759|FG002|Pre-Treatment|Other Reasons|0|||
130635213|NCT02996110|470283760|FG003|Pre-Treatment|Other Reasons|0|||
130635214|NCT02996110|470283761|FG004|Pre-Treatment|Other Reasons|1|||
130635215|NCT02996110|470283757|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
130635216|NCT02996110|470283758|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
130635217|NCT02996110|470283759|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
130635218|NCT02996110|470283760|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
130635219|NCT02996110|470283761|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
130635220|NCT02996110|470283757|FG000|Track 1|Disease Progression|15|||
130635221|NCT02996110|470283758|FG001|Track 1|Disease Progression|17|||
130635222|NCT02996110|470283759|FG002|Track 1|Disease Progression|0|||
130635223|NCT02996110|470283760|FG003|Track 1|Disease Progression|0|||
130635224|NCT02996110|470283761|FG004|Track 1|Disease Progression|0|||
130635225|NCT02996110|470283757|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
130635226|NCT02996110|470283758|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
130635227|NCT02996110|470283759|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
130635228|NCT02996110|470283760|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
130635229|NCT02996110|470283761|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
130635230|NCT02996110|470283757|FG000|Track 1|Study Drug Toxicity|5|||
130635231|NCT02996110|470283758|FG001|Track 1|Study Drug Toxicity|3|||
130635232|NCT02996110|470283759|FG002|Track 1|Study Drug Toxicity|0|||
130635233|NCT02996110|470283760|FG003|Track 1|Study Drug Toxicity|0|||
130635234|NCT02996110|470283761|FG004|Track 1|Study Drug Toxicity|0|||
130635235|NCT02996110|470283757|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
130635236|NCT02996110|470283758|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130635237|NCT02996110|470283759|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130635238|NCT02996110|470283760|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130635239|NCT02996110|470283761|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130635240|NCT02996110|470283757|FG000|Track 1|Administrative Reason by Sponsor|0|||
130635241|NCT02996110|470283758|FG001|Track 1|Administrative Reason by Sponsor|1|||
130635242|NCT02996110|470283759|FG002|Track 1|Administrative Reason by Sponsor|0|||
130635243|NCT02996110|470283760|FG003|Track 1|Administrative Reason by Sponsor|0|||
130635244|NCT02996110|470283761|FG004|Track 1|Administrative Reason by Sponsor|0|||
130635245|NCT02996110|470283757|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
130635246|NCT02996110|470283758|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
130635247|NCT02996110|470283759|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
130635248|NCT02996110|470283760|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
130635249|NCT02996110|470283761|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
130635250|NCT02996110|470283757|FG000|Track 2|Disease Progression|33|||
130635251|NCT02996110|470283758|FG001|Track 2|Disease Progression|26|||
130635252|NCT02996110|470283759|FG002|Track 2|Disease Progression|19|||
130635253|NCT02996110|470283760|FG003|Track 2|Disease Progression|16|||
130635254|NCT02996110|470283761|FG004|Track 2|Disease Progression|15|||
130635255|NCT02996110|470283757|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
130635256|NCT02996110|470283758|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
130635257|NCT02996110|470283759|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
130635258|NCT02996110|470283760|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
130635259|NCT02996110|470283761|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
130635260|NCT02996110|470283757|FG000|Track 2|Death|0|||
130635261|NCT02996110|470283758|FG001|Track 2|Death|0|||
130635262|NCT02996110|470283759|FG002|Track 2|Death|1|||
130635263|NCT02996110|470283760|FG003|Track 2|Death|0|||
130635264|NCT02996110|470283761|FG004|Track 2|Death|1|||
130635265|NCT02996110|470283757|FG000|Track 2|Study Drug Toxicity|4|||
130635266|NCT02996110|470283758|FG001|Track 2|Study Drug Toxicity|1|||
130635267|NCT02996110|470283759|FG002|Track 2|Study Drug Toxicity|4|||
130635268|NCT02996110|470283760|FG003|Track 2|Study Drug Toxicity|1|||
130635269|NCT02996110|470283761|FG004|Track 2|Study Drug Toxicity|0|||
130635270|NCT02996110|470283757|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
130635271|NCT02996110|470283758|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
130635272|NCT02996110|470283759|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
130635273|NCT02996110|470283760|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
130635274|NCT02996110|470283761|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
130635275|NCT02996110|470283757|FG000|Track 2|Participant Withdrew Consent|1|||
130635276|NCT02996110|470283758|FG001|Track 2|Participant Withdrew Consent|2|||
130635277|NCT02996110|470283759|FG002|Track 2|Participant Withdrew Consent|3|||
130635278|NCT02996110|470283760|FG003|Track 2|Participant Withdrew Consent|1|||
130635279|NCT02996110|470283761|FG004|Track 2|Participant Withdrew Consent|1|||
130635280|NCT02996110|470283757|FG000|Track 2|Other Reasons|0|||
130635281|NCT02996110|470283758|FG001|Track 2|Other Reasons|0|||
130635282|NCT02996110|470283759|FG002|Track 2|Other Reasons|1|||
130635283|NCT02996110|470283760|FG003|Track 2|Other Reasons|0|||
130635284|NCT02996110|470283761|FG004|Track 2|Other Reasons|1|||
130635285|NCT01938391|470283762|FG000|6 Month Follow up|Withdrawal by Subject|1|||
130635286|NCT01938391|470283762|FG000|12 Month Follow up|Physician Decision|1|||
130635287|NCT01938391|470283762|FG000|12 Month Follow up|Withdrawal by Subject|1|||
130635288|NCT01077193|470283763|FG000|Overall Study|Lost to Follow-up|1|||
130635289|NCT01077193|470283763|FG000|Overall Study|Withdrawal by Subject|2|||
130635290|NCT01077193|470283763|FG000|Overall Study|Lack of Efficacy|1|||
130635291|NCT01077193|470283763|FG000|Overall Study|Study Terminated by Sponsor|40|||
130635292|NCT02158728|470283765|FG000|Overall Study|no procedure according to CIP done|3|||
130635293|NCT02158728|470283765|FG000|Overall Study|no qualified dataset|24|||
130635294|NCT03878160|470283771|FG000|Overall Study|Lost to Follow-up|1|||
130635295|NCT03878160|470283772|FG001|Overall Study|Lost to Follow-up|1|||
130635296|NCT03878160|470283773|FG002|Overall Study|Lost to Follow-up|1|||
130635297|NCT03878160|470283771|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
130635298|NCT03878160|470283772|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
130635299|NCT03878160|470283773|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
130635300|NCT00589602|470283789|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
130635301|NCT01536418|470283790|FG000|Overall Study|Protocol Violation|2|||
130635302|NCT01536418|470283791|FG001|Overall Study|Protocol Violation|3|||
130635303|NCT01536418|470283790|FG000|Overall Study|Physician Decision|1|||
130635304|NCT01536418|470283791|FG001|Overall Study|Physician Decision|3|||
130635305|NCT01536418|470283790|FG000|Overall Study|Study closed/terminated|41|||
130635306|NCT01536418|470283791|FG001|Overall Study|Study closed/terminated|37|||
130635307|NCT01536418|470283790|FG000|Overall Study|Lack of Efficacy|10|||
130635308|NCT01536418|470283791|FG001|Overall Study|Lack of Efficacy|16|||
130635309|NCT01536418|470283790|FG000|Overall Study|Adverse Event|9|||
130635310|NCT01536418|470283791|FG001|Overall Study|Adverse Event|4|||
130635311|NCT01536418|470283790|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
130635312|NCT01536418|470283791|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
130635313|NCT01536418|470283790|FG000|Overall Study|Withdrawal by Subject|5|||
130635314|NCT01536418|470283791|FG001|Overall Study|Withdrawal by Subject|3|||
130635315|NCT00285649|470283794|FG000|Overall Study|Lost to Follow-up|6|||
130635316|NCT00285649|470283795|FG001|Overall Study|Lost to Follow-up|4|||
130635317|NCT00285649|470283796|FG002|Overall Study|Lost to Follow-up|4|||
130635318|NCT00285649|470283794|FG000|Overall Study|Withdrawal by Subject|3|||
130635319|NCT00285649|470283795|FG001|Overall Study|Withdrawal by Subject|2|||
130635320|NCT00285649|470283796|FG002|Overall Study|Withdrawal by Subject|2|||
130635321|NCT03342404|470283797|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
130635322|NCT03342404|470283798|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
130635323|NCT03342404|470283797|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
130635324|NCT03342404|470283798|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
130635325|NCT03342404|470283797|FG000|Blinded Treatment Phase|Adverse Event|5|||
130635326|NCT03342404|470283798|FG001|Blinded Treatment Phase|Adverse Event|4|||
130635327|NCT03342404|470283797|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
130635328|NCT03342404|470283798|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
130635329|NCT03342404|470283797|FG000|Blinded Treatment Phase|Other reasons|1|||
130635330|NCT03342404|470283798|FG001|Blinded Treatment Phase|Other reasons|0|||
130635331|NCT03342404|470283797|FG000|Blinded Treatment Phase|Physician Decision|1|||
130635332|NCT03342404|470283798|FG001|Blinded Treatment Phase|Physician Decision|0|||
130635333|NCT03342404|470283797|FG000|Blinded Treatment Phase|Death|1|||
130635334|NCT03342404|470283798|FG001|Blinded Treatment Phase|Death|0|||
130635335|NCT03342404|470283797|FG000|Open-Label Phase|Lost to Follow-up|0|||
130635336|NCT03342404|470283798|FG001|Open-Label Phase|Lost to Follow-up|1|||
130635337|NCT03342404|470283797|FG000|Open-Label Phase|Other reasons|0|||
130635338|NCT03342404|470283798|FG001|Open-Label Phase|Other reasons|1|||
130635339|NCT03342404|470283797|FG000|Open-Label Phase|Adverse Event|0|||
130635340|NCT03342404|470283798|FG001|Open-Label Phase|Adverse Event|3|||
130635341|NCT03342404|470283797|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130635342|NCT03342404|470283798|FG001|Open-Label Phase|Withdrawal by Subject|6|||
130635343|NCT01855425|470283799|FG000|Overall Study|Physician Decision|20|||
130635344|NCT03748420|470283801|FG000|Overall Study|No 12 month medication adherence data available|0|||
130635345|NCT03748420|470283802|FG001|Overall Study|No 12 month medication adherence data available|1|||
130635346|NCT03748420|470283801|FG000|Overall Study|Death|24|||
130635347|NCT03748420|470283802|FG001|Overall Study|Death|28|||
130635348|NCT03748420|470283801|FG000|Overall Study|Lost to Follow-up|231|||
130635349|NCT03748420|470283802|FG001|Overall Study|Lost to Follow-up|230|||
130635350|NCT00373880|470283803|FG000|Overall Study|Physician Decision|3|||
130635351|NCT00373880|470283803|FG000|Overall Study|Arrested|1|||
130635352|NCT00373880|470283803|FG000|Overall Study|Protocol Violation|14|||
130635353|NCT01899768|470283805|FG000|Part A|Adverse Event|2|||
130635354|NCT01899768|470283805|FG000|Part A|Withdrawal by Subject|1|||
130635355|NCT01899768|470283805|FG000|Part B|Adverse Event|1|||
130635356|NCT01899768|470283805|FG000|Part B|Withdrawal by Subject|1|||
130635357|NCT04043416|470283806|FG000|Washout|Change in health condition|0|||
130635358|NCT04043416|470283807|FG001|Washout|Change in health condition|1|||
130635359|NCT03236506|470283808|FG000|Overall Study|Death|1|||
130635360|NCT03236506|470283809|FG001|Overall Study|Death|1|||
130635361|NCT03236506|470283810|FG002|Overall Study|Death|1|||
130635362|NCT03236506|470283808|FG000|Overall Study|Withdrawal by Subject|3|||
130635363|NCT03236506|470283809|FG001|Overall Study|Withdrawal by Subject|3|||
130635364|NCT03236506|470283810|FG002|Overall Study|Withdrawal by Subject|4|||
130635365|NCT03236506|470283808|FG000|Overall Study|Did not initiate treatment|2|||
130635366|NCT03236506|470283809|FG001|Overall Study|Did not initiate treatment|1|||
130635367|NCT03236506|470283810|FG002|Overall Study|Did not initiate treatment|2|||
130635368|NCT02865928|470283813|FG000|Overall Study|Withdrawal by Subject|1|||
130635369|NCT02865928|470283814|FG001|Overall Study|Withdrawal by Subject|0|||
130635370|NCT02865928|470283813|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
130635371|NCT02865928|470283814|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
130635372|NCT02865928|470283813|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
130635373|NCT02865928|470283814|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
130635374|NCT01925014|470283815|FG000|Overall Study|Inappropriate enrollment|4|||
130635375|NCT01925014|470283816|FG001|Overall Study|Inappropriate enrollment|6|||
130635376|NCT01925014|470283815|FG000|Overall Study|Withdrawal by Subject|5|||
130635377|NCT01925014|470283816|FG001|Overall Study|Withdrawal by Subject|13|||
130635378|NCT00312728|470283817|FG000|Overall Study|Progressive disease|53|||
130635379|NCT00312728|470283817|FG000|Overall Study|Adverse Event|32|||
130635380|NCT00312728|470283817|FG000|Overall Study|Withdrawal by Subject|10|||
130635381|NCT00312728|470283817|FG000|Overall Study|Required non-protocol cancer treatment|2|||
130635382|NCT00312728|470283817|FG000|Overall Study|Protocol Violation|2|||
130635383|NCT00312728|470283817|FG000|Overall Study|Other|10|||
130635384|NCT00312728|470283817|FG000|Overall Study|Other|1|||
130635385|NCT00422240|470283832|FG000|Overall Study|Lack of Efficacy|1|||
130635386|NCT00422240|470283833|FG001|Overall Study|Lack of Efficacy|2|||
130635387|NCT00422240|470283834|FG002|Overall Study|Lack of Efficacy|0|||
130635388|NCT00422240|470283835|FG003|Overall Study|Lack of Efficacy|1|||
130635389|NCT00422240|470283832|FG000|Overall Study|Adverse Event|11|||
130635390|NCT00422240|470283833|FG001|Overall Study|Adverse Event|4|||
130635391|NCT00422240|470283834|FG002|Overall Study|Adverse Event|5|||
130635392|NCT00422240|470283835|FG003|Overall Study|Adverse Event|2|||
130635393|NCT00422240|470283832|FG000|Overall Study|Subject request|21|||
130635394|NCT00422240|470283833|FG001|Overall Study|Subject request|17|||
130635395|NCT00422240|470283834|FG002|Overall Study|Subject request|18|||
130635396|NCT00422240|470283835|FG003|Overall Study|Subject request|30|||
130635397|NCT00422240|470283832|FG000|Overall Study|Protocol Violation|0|||
130635398|NCT00422240|470283833|FG001|Overall Study|Protocol Violation|1|||
130635399|NCT00422240|470283834|FG002|Overall Study|Protocol Violation|0|||
130635400|NCT00422240|470283835|FG003|Overall Study|Protocol Violation|1|||
130635401|NCT00422240|470283832|FG000|Overall Study|Lost to Follow-up|31|||
130635402|NCT00422240|470283833|FG001|Overall Study|Lost to Follow-up|32|||
130635403|NCT00422240|470283834|FG002|Overall Study|Lost to Follow-up|19|||
130635404|NCT00422240|470283835|FG003|Overall Study|Lost to Follow-up|34|||
130635405|NCT00422240|470283832|FG000|Overall Study|Other|1|||
130635406|NCT00422240|470283833|FG001|Overall Study|Other|0|||
130635407|NCT00422240|470283834|FG002|Overall Study|Other|0|||
130635408|NCT00422240|470283835|FG003|Overall Study|Other|1|||
130635409|NCT00422240|470283832|FG000|Overall Study|Pregnancy|3|||
130635410|NCT00422240|470283833|FG001|Overall Study|Pregnancy|1|||
130635411|NCT00422240|470283834|FG002|Overall Study|Pregnancy|1|||
130635412|NCT00422240|470283835|FG003|Overall Study|Pregnancy|2|||
130635413|NCT01624467|470283836|FG000|Overall Study|Withdrawal by Subject|2|||
130635414|NCT01624467|470283836|FG000|Overall Study|Lost to Follow-up|1|||
130635415|NCT01624467|470283836|FG000|Overall Study|Adverse Event|7|||
130635416|NCT01624467|470283836|FG000|Overall Study|Progressive Disease|19|||
130635417|NCT01624467|470283836|FG000|Overall Study|Per Sponsor Requirement|1|||
130635418|NCT01624467|470283836|FG000|Overall Study|Subject Withdrew from Treatment|1|||
130635419|NCT02201472|470283837|FG000|Overall Study|Lack of Efficacy|2|||
130635420|NCT01602744|470283838|FG000|Overall Study|Death|17|||
130635421|NCT01602744|470283839|FG001|Overall Study|Death|15|||
130635422|NCT01602744|470283838|FG000|Overall Study|Lost to Follow-up|13|||
130635423|NCT01602744|470283839|FG001|Overall Study|Lost to Follow-up|8|||
130635424|NCT03418376|470283840|FG000|Overall Study|Musculoskeletal injury|1|||
130635425|NCT03418376|470283841|FG001|Overall Study|Musculoskeletal injury|2|||
130635426|NCT03418376|470283842|FG002|Overall Study|Musculoskeletal injury|1|||
130635427|NCT03418376|470283843|FG003|Overall Study|Musculoskeletal injury|0|||
130635428|NCT03418376|470283840|FG000|Overall Study|Personal reasons|0|||
130635429|NCT03418376|470283841|FG001|Overall Study|Personal reasons|2|||
130635430|NCT03418376|470283842|FG002|Overall Study|Personal reasons|2|||
130635431|NCT03418376|470283843|FG003|Overall Study|Personal reasons|1|||
130635432|NCT03418376|470283840|FG000|Overall Study|Exacerbation|0|||
130635433|NCT03418376|470283841|FG001|Overall Study|Exacerbation|1|||
130635434|NCT03418376|470283842|FG002|Overall Study|Exacerbation|0|||
130635435|NCT03418376|470283843|FG003|Overall Study|Exacerbation|0|||
130635436|NCT00901394|470283844|FG000|Overall Study|Physician Decision|1|||
130635437|NCT00901394|470283845|FG001|Overall Study|Physician Decision|1|||
130635438|NCT00901394|470283846|FG002|Overall Study|Physician Decision|2|||
130635439|NCT03864627|470283849|FG000|Overall Study|Adverse Event|0|||
130635440|NCT03864627|470283850|FG001|Overall Study|Adverse Event|1|||
130635441|NCT03864627|470283849|FG000|Overall Study|Lack of Efficacy|0|||
130635442|NCT03864627|470283850|FG001|Overall Study|Lack of Efficacy|1|||
130635443|NCT03864627|470283849|FG000|Overall Study|Lost to Follow-up|0|||
130635444|NCT03864627|470283850|FG001|Overall Study|Lost to Follow-up|1|||
130635445|NCT03864627|470283849|FG000|Overall Study|Withdrawal by Subject|4|||
130635446|NCT03864627|470283850|FG001|Overall Study|Withdrawal by Subject|8|||
130635447|NCT03864627|470283849|FG000|Overall Study|Study terminated by sponsor|0|||
130635448|NCT03864627|470283850|FG001|Overall Study|Study terminated by sponsor|1|||
130635449|NCT01388491|470283851|FG000|Overall Study|Adverse Event|10|||
130635450|NCT01388491|470283852|FG001|Overall Study|Adverse Event|9|||
130635451|NCT01388491|470283851|FG000|Overall Study|Sponsor Request|9|||
130635452|NCT01388491|470283852|FG001|Overall Study|Sponsor Request|7|||
130635453|NCT01388491|470283851|FG000|Overall Study|Withdrawal by Subject|6|||
130635454|NCT01388491|470283852|FG001|Overall Study|Withdrawal by Subject|10|||
130635455|NCT01388491|470283851|FG000|Overall Study|Lost to Follow-up|4|||
130635456|NCT01388491|470283852|FG001|Overall Study|Lost to Follow-up|3|||
130635457|NCT01388491|470283851|FG000|Overall Study|Protocol Violation|2|||
130635458|NCT01388491|470283852|FG001|Overall Study|Protocol Violation|0|||
130635459|NCT01388491|470283851|FG000|Overall Study|Noncompliance|2|||
130635460|NCT01388491|470283852|FG001|Overall Study|Noncompliance|0|||
130635461|NCT01388491|470283851|FG000|Overall Study|Pregnancy|1|||
130635462|NCT01388491|470283852|FG001|Overall Study|Pregnancy|0|||
130635463|NCT00412113|470283855|FG000|Overall Study|Adverse Event|11|||
130635464|NCT00412113|470283856|FG001|Overall Study|Adverse Event|15|||
130635465|NCT00412113|470283855|FG000|Overall Study|did not receive treatment|1|||
130635466|NCT00412113|470283856|FG001|Overall Study|did not receive treatment|0|||
130635467|NCT01190020|470283861|FG000|Overall Study|Adverse Event|2|||
130635468|NCT01190020|470283862|FG001|Overall Study|Adverse Event|0|||
130635469|NCT01190020|470283861|FG000|Overall Study|Lost to Follow-up|2|||
130635470|NCT01190020|470283862|FG001|Overall Study|Lost to Follow-up|0|||
130635471|NCT01190020|470283861|FG000|Overall Study|Withdrawal by Subject|3|||
130635472|NCT01190020|470283862|FG001|Overall Study|Withdrawal by Subject|0|||
130635473|NCT00796224|470283863|FG000|Overall Study|Adverse Event|1|||
130635474|NCT00796224|470283864|FG001|Overall Study|Adverse Event|0|||
130635475|NCT00796224|470283863|FG000|Overall Study|Protocol Violation|0|||
130635476|NCT00796224|470283864|FG001|Overall Study|Protocol Violation|1|||
130635477|NCT04195750|470283865|FG000|Overall Study|Death|245|||
130635478|NCT04195750|470283866|FG001|Overall Study|Death|253|||
130635479|NCT04195750|470283867|FG002|Overall Study|Death|5|||
130635480|NCT04195750|470283865|FG000|Overall Study|Physician Decision|0|||
130635481|NCT04195750|470283866|FG001|Overall Study|Physician Decision|1|||
130635482|NCT04195750|470283867|FG002|Overall Study|Physician Decision|0|||
130635483|NCT04195750|470283865|FG000|Overall Study|Withdrawal by Subject|9|||
130635484|NCT04195750|470283866|FG001|Overall Study|Withdrawal by Subject|8|||
130635485|NCT04195750|470283867|FG002|Overall Study|Withdrawal by Subject|0|||
130635486|NCT04195750|470283865|FG000|Overall Study|Ongoing|120|||
130635487|NCT04195750|470283866|FG001|Overall Study|Ongoing|110|||
130635488|NCT04195750|470283867|FG002|Overall Study|Ongoing|4|||
130635489|NCT03559192|470283868|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
130635490|NCT03559192|470283869|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
130635491|NCT03559192|470283870|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
130635492|NCT03559192|470283868|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
130635493|NCT03559192|470283869|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
130635494|NCT03559192|470283870|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
130635495|NCT03559192|470283868|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
130635496|NCT03559192|470283869|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
130635497|NCT03559192|470283870|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
130635498|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
130635499|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
130635500|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
130635501|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
130635502|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
130635503|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
130635504|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
130635505|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
130635506|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
130635507|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
130635508|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
130635509|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
130635510|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
130635511|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
130635512|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
130635513|NCT03559192|470283868|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
130635514|NCT03559192|470283869|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
130635515|NCT03559192|470283870|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
130635516|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
130635517|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
130635518|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Death|0|||
130635519|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Death|4|||
130635520|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
130635521|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
130635522|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
130635523|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
130635524|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
130635525|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
130635526|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
130635527|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
130635528|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
130635529|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
130635530|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Other|4|||
130635531|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Other|3|||
130635532|NCT03517722|470283871|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
130635533|NCT03517722|470283872|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
130635534|NCT03517722|470283871|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
130635535|NCT03517722|470283872|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
130635536|NCT03517722|470283871|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
130635537|NCT03517722|470283872|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
130635538|NCT03517722|470283871|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
130635539|NCT03517722|470283872|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
130635540|NCT03517722|470283871|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
130635541|NCT03517722|470283872|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
130635542|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
130635543|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130635544|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
130635545|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130635546|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130635547|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
130635548|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
130635549|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
130635550|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
130635551|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
130635552|NCT02422186|470283873|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
130635553|NCT02422186|470283874|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
130635554|NCT02422186|470283873|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
130635555|NCT02422186|470283874|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
130635556|NCT02422186|470283873|FG000|Follow-up Phase (2 Weeks)|Other|3|||
130635557|NCT02422186|470283874|FG001|Follow-up Phase (2 Weeks)|Other|0|||
130635558|NCT03573804|470283877|FG000|Overall Study|claustrophobia or MRI table problems|10|||
130635559|NCT03399786|470283878|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130635560|NCT03399786|470283879|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130635561|NCT03399786|470283880|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130635562|NCT03399786|470283881|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130635563|NCT03399786|470283878|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130635564|NCT03399786|470283879|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130635565|NCT03399786|470283880|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
130635566|NCT03399786|470283881|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130635567|NCT03399786|470283878|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130635568|NCT03399786|470283879|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130635569|NCT03399786|470283880|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130635570|NCT03399786|470283881|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
130635571|NCT01673373|470285826|FG000|Overall Study|Death|2|||
130635572|NCT01572844|470285827|FG000|Overall Study|Physician Decision|1|||
130635573|NCT01572844|470285828|FG001|Overall Study|Physician Decision|1|||
130635574|NCT00366444|470285829|FG000|Overall Study|Withdrawal by Subject|1|||
130635575|NCT00366444|470285830|FG001|Overall Study|Withdrawal by Subject|1|||
130635576|NCT00366444|470285829|FG000|Overall Study|Lack of Efficacy|0|||
130635577|NCT00366444|470285830|FG001|Overall Study|Lack of Efficacy|1|||
130635578|NCT06073054|470285833|FG000|Overall Study|Withdrawal by Subject|2|||
130635579|NCT00413777|470285835|FG000|Fixed-dose Period|Lost to Follow-up|1|||
130635580|NCT00413777|470285836|FG001|Fixed-dose Period|Lost to Follow-up|1|||
130635581|NCT00413777|470285835|FG000|Fixed-dose Period|Adverse Event|2|||
130635582|NCT00413777|470285836|FG001|Fixed-dose Period|Adverse Event|1|||
130635583|NCT00413777|470285835|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
130635584|NCT00413777|470285836|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
130635585|NCT00413777|470285835|FG000|Fixed-dose Period|Withdrew Consent|0|||
130635586|NCT00413777|470285836|FG001|Fixed-dose Period|Withdrew Consent|1|||
130635587|NCT05505734|470285837|FG000|Overall Study|Withdrawal by Subject|51|||
130635588|NCT05505734|470285838|FG001|Overall Study|Withdrawal by Subject|64|||
130635589|NCT05505734|470285837|FG000|Overall Study|Adverse Event|6|||
130635590|NCT05505734|470285838|FG001|Overall Study|Adverse Event|20|||
130635591|NCT05505734|470285837|FG000|Overall Study|Protocol Violation|8|||
130635592|NCT05505734|470285838|FG001|Overall Study|Protocol Violation|15|||
130635593|NCT05505734|470285837|FG000|Overall Study|Lack of therapeutic response|0|||
130635594|NCT05505734|470285838|FG001|Overall Study|Lack of therapeutic response|1|||
130635595|NCT05505734|470285837|FG000|Overall Study|Lost to Follow-up|247|||
130635596|NCT05505734|470285838|FG001|Overall Study|Lost to Follow-up|237|||
130635597|NCT05505734|470285837|FG000|Overall Study|Physician Decision|22|||
130635598|NCT05505734|470285838|FG001|Overall Study|Physician Decision|13|||
130635599|NCT05505734|470285837|FG000|Overall Study|Death|2|||
130635600|NCT05505734|470285838|FG001|Overall Study|Death|1|||
130635601|NCT05505734|470285837|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130635602|NCT05505734|470285838|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130635603|NCT05505734|470285837|FG000|Overall Study|Pregnancy|1|||
130635604|NCT05505734|470285838|FG001|Overall Study|Pregnancy|0|||
130635605|NCT05505734|470285837|FG000|Overall Study|Other|17|||
130635606|NCT05505734|470285838|FG001|Overall Study|Other|13|||
130635607|NCT00764322|470285839|FG000|Overall Study|Withdrawal by Subject|11|||
130635608|NCT00764322|470285839|FG000|Overall Study|No CYP2D6 genotyping|9|||
130635609|NCT02348840|470285860|FG000|Overall Study|Withdrawal by Subject|2|||
130635610|NCT02348840|470285861|FG001|Overall Study|Withdrawal by Subject|1|||
130635611|NCT02348840|470285862|FG002|Overall Study|Withdrawal by Subject|0|||
130635612|NCT02348840|470285863|FG003|Overall Study|Withdrawal by Subject|0|||
130635613|NCT02203916|470285864|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130635614|NCT02203916|470285865|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130635615|NCT02203916|470285866|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
130635616|NCT02203916|470285864|FG000|Overall Study|Major Protocol Deviation|1|||
130635617|NCT02203916|470285865|FG001|Overall Study|Major Protocol Deviation|1|||
130635618|NCT02203916|470285866|FG002|Overall Study|Major Protocol Deviation|0|||
130635619|NCT02203916|470285864|FG000|Overall Study|Lost to Follow-up|0|||
130635620|NCT02203916|470285865|FG001|Overall Study|Lost to Follow-up|1|||
130635621|NCT02203916|470285866|FG002|Overall Study|Lost to Follow-up|0|||
130635622|NCT02203916|470285864|FG000|Overall Study|Voluntary Withdrawal|3|||
130635623|NCT02203916|470285865|FG001|Overall Study|Voluntary Withdrawal|3|||
130635624|NCT02203916|470285866|FG002|Overall Study|Voluntary Withdrawal|8|||
130635625|NCT02203916|470285864|FG000|Overall Study|Lack of Efficacy|3|||
130635626|NCT02203916|470285865|FG001|Overall Study|Lack of Efficacy|0|||
130635627|NCT02203916|470285866|FG002|Overall Study|Lack of Efficacy|0|||
130635628|NCT02203916|470285864|FG000|Overall Study|Reason Not Specified|0|||
130635629|NCT02203916|470285865|FG001|Overall Study|Reason Not Specified|2|||
130635630|NCT02203916|470285866|FG002|Overall Study|Reason Not Specified|1|||
130635631|NCT00414973|470285868|FG000|Overall Study|Withdrawal by Subject|14|||
130635632|NCT00414973|470285869|FG001|Overall Study|Withdrawal by Subject|4|||
130635633|NCT00414973|470285870|FG002|Overall Study|Withdrawal by Subject|1|||
130635634|NCT00414973|470285871|FG003|Overall Study|Withdrawal by Subject|0|||
130635635|NCT00414973|470285868|FG000|Overall Study|Adverse Event|10|||
130635636|NCT00414973|470285869|FG001|Overall Study|Adverse Event|0|||
130635637|NCT00414973|470285870|FG002|Overall Study|Adverse Event|1|||
130635638|NCT00414973|470285871|FG003|Overall Study|Adverse Event|0|||
130635639|NCT00414973|470285868|FG000|Overall Study|Protocol Violation|3|||
130635640|NCT00414973|470285869|FG001|Overall Study|Protocol Violation|4|||
130635641|NCT00414973|470285870|FG002|Overall Study|Protocol Violation|0|||
130635642|NCT00414973|470285871|FG003|Overall Study|Protocol Violation|0|||
130635643|NCT00414973|470285868|FG000|Overall Study|Lost to Follow-up|0|||
130635644|NCT00414973|470285869|FG001|Overall Study|Lost to Follow-up|2|||
130635645|NCT00414973|470285870|FG002|Overall Study|Lost to Follow-up|0|||
130635646|NCT00414973|470285871|FG003|Overall Study|Lost to Follow-up|0|||
130635647|NCT00414973|470285868|FG000|Overall Study|Sponsor Decision|1|||
130635648|NCT00414973|470285869|FG001|Overall Study|Sponsor Decision|0|||
130635649|NCT00414973|470285870|FG002|Overall Study|Sponsor Decision|0|||
130635650|NCT00414973|470285871|FG003|Overall Study|Sponsor Decision|0|||
130635651|NCT00414973|470285868|FG000|Overall Study|Death|0|||
130635652|NCT00414973|470285869|FG001|Overall Study|Death|0|||
130635653|NCT00414973|470285870|FG002|Overall Study|Death|1|||
130635654|NCT00414973|470285871|FG003|Overall Study|Death|0|||
130635655|NCT01466062|470285872|FG000|Overall Study|Adverse Event|1|||
130635656|NCT01466062|470285872|FG000|Overall Study|Withdrawal by Subject|1|||
130635657|NCT03152110|470285879|FG000|Overall Study|Withdrawal by Subject|3|||
130635658|NCT00850135|470285883|FG000|Overall Study|Physician Decision|1|||
130635659|NCT00338806|470285884|FG000|Acute Phase|Withdrawal by Subject|0|||
130635660|NCT00338806|470285885|FG001|Acute Phase|Withdrawal by Subject|1|||
130635661|NCT00338806|470285884|FG000|Follow-up|Lost to Follow-up|1|||
130635662|NCT00338806|470285885|FG001|Follow-up|Lost to Follow-up|3|||
130635663|NCT00744991|470285886|FG000|Overall Study|Progressive Disease|11|||
130635664|NCT00744991|470285886|FG000|Overall Study|Withdrawal by Subject|8|||
130635665|NCT00744991|470285886|FG000|Overall Study|Physician Decision|3|||
130635666|NCT00744991|470285886|FG000|Overall Study|Adverse Event|2|||
130635667|NCT00744991|470285886|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
130635668|NCT04259346|470285892|FG000|Overall Study|Lost to Follow-up|1|||
130635669|NCT04259346|470285893|FG001|Overall Study|Lost to Follow-up|3|||
130635670|NCT04259346|470285892|FG000|Overall Study|Protocol Violation|1|||
130635671|NCT04259346|470285893|FG001|Overall Study|Protocol Violation|0|||
130635672|NCT04259346|470285892|FG000|Overall Study|Withdrawal by Subject|1|||
130635673|NCT04259346|470285893|FG001|Overall Study|Withdrawal by Subject|0|||
130635674|NCT04259346|470285892|FG000|Overall Study|Adverse Event|1|||
130635675|NCT04259346|470285893|FG001|Overall Study|Adverse Event|1|||
130635676|NCT00085644|470285894|FG000|Double-Blind Period|Adverse Event|5|||
130635677|NCT00085644|470285895|FG001|Double-Blind Period|Adverse Event|2|||
130635678|NCT00085644|470285896|FG002|Double-Blind Period|Adverse Event|0|||
130635679|NCT00085644|470285894|FG000|Double-Blind Period|Withdrawal by Subject|3|||
130635680|NCT00085644|470285895|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130635681|NCT00085644|470285896|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130635682|NCT00085644|470285894|FG000|Double-Blind Period|Lost to Follow-up|2|||
130635683|NCT00085644|470285895|FG001|Double-Blind Period|Lost to Follow-up|1|||
130635684|NCT00085644|470285896|FG002|Double-Blind Period|Lost to Follow-up|0|||
130635685|NCT00085644|470285894|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
130635686|NCT00085644|470285895|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
130635687|NCT00085644|470285896|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
130635688|NCT00085644|470285894|FG000|Double-Blind Period|Contemplating pregnancy|1|||
130635689|NCT00085644|470285895|FG001|Double-Blind Period|Contemplating pregnancy|0|||
130635690|NCT00085644|470285896|FG002|Double-Blind Period|Contemplating pregnancy|0|||
130635691|NCT00085644|470285894|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
130635692|NCT00085644|470285895|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
130635693|NCT00085644|470285896|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
130635694|NCT00085644|470285894|FG000|Open-Label Period|Adverse Event|0|||
130635695|NCT00085644|470285895|FG001|Open-Label Period|Adverse Event|0|||
130635696|NCT00085644|470285896|FG002|Open-Label Period|Adverse Event|38|||
130635697|NCT00085644|470285894|FG000|Open-Label Period|Withdrawal by Subject|0|||
130635698|NCT00085644|470285895|FG001|Open-Label Period|Withdrawal by Subject|0|||
130635699|NCT00085644|470285896|FG002|Open-Label Period|Withdrawal by Subject|29|||
130635700|NCT00085644|470285894|FG000|Open-Label Period|Lost to Follow-up|0|||
130635701|NCT00085644|470285895|FG001|Open-Label Period|Lost to Follow-up|0|||
130635702|NCT00085644|470285896|FG002|Open-Label Period|Lost to Follow-up|13|||
130635703|NCT00085644|470285894|FG000|Open-Label Period|Lack of Efficacy|0|||
130635704|NCT00085644|470285895|FG001|Open-Label Period|Lack of Efficacy|0|||
130635705|NCT00085644|470285896|FG002|Open-Label Period|Lack of Efficacy|15|||
130635706|NCT00085644|470285894|FG000|Open-Label Period|Pregnancy|0|||
130635707|NCT00085644|470285895|FG001|Open-Label Period|Pregnancy|0|||
130635708|NCT00085644|470285896|FG002|Open-Label Period|Pregnancy|3|||
130635709|NCT00085644|470285894|FG000|Open-Label Period|Contemplating pregnancy|0|||
130635710|NCT00085644|470285895|FG001|Open-Label Period|Contemplating pregnancy|0|||
130635711|NCT00085644|470285896|FG002|Open-Label Period|Contemplating pregnancy|3|||
130635712|NCT00085644|470285894|FG000|Open-Label Period|Protocol Violation|0|||
130635713|NCT00085644|470285895|FG001|Open-Label Period|Protocol Violation|0|||
130635714|NCT00085644|470285896|FG002|Open-Label Period|Protocol Violation|4|||
130635715|NCT00085644|470285894|FG000|Open-Label Period|Personal reason|0|||
130635716|NCT00085644|470285895|FG001|Open-Label Period|Personal reason|0|||
130635717|NCT00085644|470285896|FG002|Open-Label Period|Personal reason|4|||
130635718|NCT03330106|470285897|FG000|Part A|Withdrawal by Subject|1|||
130635719|NCT03330106|470285898|FG001|Part A|Withdrawal by Subject|1|||
130635720|NCT03330106|470285899|FG002|Part A|Withdrawal by Subject|0|||
130635721|NCT03330106|470285900|FG003|Part A|Withdrawal by Subject|0|||
130635722|NCT03330106|470285897|FG000|Part A|Death|2|||
130635723|NCT03330106|470285898|FG001|Part A|Death|1|||
130635724|NCT03330106|470285899|FG002|Part A|Death|0|||
130635725|NCT03330106|470285900|FG003|Part A|Death|0|||
130635726|NCT03330106|470285897|FG000|Part A|Adverse Event|0|||
130635727|NCT03330106|470285898|FG001|Part A|Adverse Event|1|||
130635728|NCT03330106|470285899|FG002|Part A|Adverse Event|0|||
130635729|NCT03330106|470285900|FG003|Part A|Adverse Event|0|||
130635730|NCT03330106|470285897|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130635731|NCT03330106|470285898|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
130635732|NCT03330106|470285899|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130635733|NCT03330106|470285900|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130635734|NCT03330106|470285897|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
130635735|NCT03330106|470285898|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130635736|NCT03330106|470285899|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130635737|NCT03330106|470285900|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130635738|NCT03330106|470285897|FG000|Part A|Progressive Disease|0|||
130635739|NCT03330106|470285898|FG001|Part A|Progressive Disease|1|||
130635740|NCT03330106|470285899|FG002|Part A|Progressive Disease|0|||
130635741|NCT03330106|470285900|FG003|Part A|Progressive Disease|0|||
130635742|NCT03330106|470285897|FG000|Part B|Lost to Follow-up|0|||
130635743|NCT03330106|470285898|FG001|Part B|Lost to Follow-up|0|||
130635744|NCT03330106|470285899|FG002|Part B|Lost to Follow-up|0|||
130635745|NCT03330106|470285900|FG003|Part B|Lost to Follow-up|1|||
130635746|NCT03330106|470285897|FG000|Part B|Withdrawal by Subject|0|||
130635747|NCT03330106|470285898|FG001|Part B|Withdrawal by Subject|0|||
130635748|NCT03330106|470285899|FG002|Part B|Withdrawal by Subject|4|||
130635749|NCT03330106|470285900|FG003|Part B|Withdrawal by Subject|0|||
130635750|NCT03330106|470285897|FG000|Part B|Death|0|||
130635751|NCT03330106|470285898|FG001|Part B|Death|0|||
130635752|NCT03330106|470285899|FG002|Part B|Death|2|||
130635753|NCT03330106|470285900|FG003|Part B|Death|0|||
130635754|NCT03330106|470285897|FG000|Part B|Clinical Progression|0|||
130635755|NCT03330106|470285898|FG001|Part B|Clinical Progression|0|||
130635756|NCT03330106|470285899|FG002|Part B|Clinical Progression|1|||
130635757|NCT03330106|470285900|FG003|Part B|Clinical Progression|1|||
130635758|NCT03330106|470285897|FG000|Part B|Symptomatic Deterioration|0|||
130635759|NCT03330106|470285898|FG001|Part B|Symptomatic Deterioration|0|||
130635760|NCT03330106|470285899|FG002|Part B|Symptomatic Deterioration|0|||
130635761|NCT03330106|470285900|FG003|Part B|Symptomatic Deterioration|1|||
130635762|NCT03330106|470285897|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130635763|NCT03330106|470285898|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130635764|NCT03330106|470285899|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130635765|NCT03330106|470285900|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
130635766|NCT03330106|470285897|FG000|Part B|Progressive Disease|0|||
130635767|NCT03330106|470285898|FG001|Part B|Progressive Disease|0|||
130635768|NCT03330106|470285899|FG002|Part B|Progressive Disease|11|||
130635769|NCT03330106|470285900|FG003|Part B|Progressive Disease|4|||
130635770|NCT00623766|470285901|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
130635771|NCT00623766|470285902|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
130635772|NCT00623766|470285901|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
130635773|NCT00623766|470285902|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
130635774|NCT00623766|470285901|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
130635775|NCT00623766|470285902|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
130635776|NCT00623766|470285901|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
130635777|NCT00623766|470285902|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
130635778|NCT00623766|470285901|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
130635779|NCT00623766|470285902|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
130635780|NCT03198728|470285906|FG000|Overall Study|Adverse Event|10|||
130635781|NCT03198728|470285907|FG001|Overall Study|Adverse Event|5|||
130635782|NCT03198728|470285906|FG000|Overall Study|Lost to Follow-up|21|||
130635783|NCT03198728|470285907|FG001|Overall Study|Lost to Follow-up|7|||
130635784|NCT03198728|470285906|FG000|Overall Study|Physician Decision|7|||
130635785|NCT03198728|470285907|FG001|Overall Study|Physician Decision|2|||
130635786|NCT03198728|470285906|FG000|Overall Study|Withdrawal by Subject|14|||
130635787|NCT03198728|470285907|FG001|Overall Study|Withdrawal by Subject|10|||
130635788|NCT04051944|470285911|FG000|Overall Study|Study ending|1|||
130635789|NCT04051944|470285912|FG001|Overall Study|Study ending|1|||
130635790|NCT04051944|470285911|FG000|Overall Study|Early study termination by participant|1|||
130635791|NCT04051944|470285912|FG001|Overall Study|Early study termination by participant|0|||
130635792|NCT04051944|470285911|FG000|Overall Study|Withdrawal by Subject|2|||
130635793|NCT04051944|470285912|FG001|Overall Study|Withdrawal by Subject|2|||
130635794|NCT04051944|470285911|FG000|Overall Study|Lack of Efficacy|3|||
130635795|NCT04051944|470285912|FG001|Overall Study|Lack of Efficacy|0|||
130635796|NCT04051944|470285911|FG000|Overall Study|Adverse event, non- fatal|1|||
130635797|NCT04051944|470285912|FG001|Overall Study|Adverse event, non- fatal|1|||
130635798|NCT02139280|470285913|FG000|Overall Study|No longer eligible|2|||
130635799|NCT02139280|470285914|FG001|Overall Study|No longer eligible|0|||
130635800|NCT00736450|470285915|FG000|Overall Study|Not ABC gene eligible|19|||
130635801|NCT00736450|470285915|FG000|Overall Study|Withdrawal by Subject|5|||
130635802|NCT00736450|470285915|FG000|Overall Study|Physician Decision|1|||
130635803|NCT04157751|470285916|FG000|Overall Study|Withdrawal by Subject|12|||
130635804|NCT04157751|470285917|FG001|Overall Study|Withdrawal by Subject|17|||
130635805|NCT04157751|470285916|FG000|Overall Study|Lost to Follow-up|6|||
130635806|NCT04157751|470285917|FG001|Overall Study|Lost to Follow-up|2|||
130635807|NCT04157751|470285916|FG000|Overall Study|Adverse Event|34|||
130635808|NCT04157751|470285917|FG001|Overall Study|Adverse Event|23|||
130635809|NCT04157751|470285916|FG000|Overall Study|Not treated|1|||
130635810|NCT04157751|470285917|FG001|Overall Study|Not treated|5|||
130635811|NCT04157751|470285916|FG000|Overall Study|Other reason not stated above|10|||
130635812|NCT04157751|470285917|FG001|Overall Study|Other reason not stated above|10|||
130635813|NCT00422903|470285926|FG000|Overall Study|Disease Progression|3|||
130635814|NCT00422903|470285927|FG001|Overall Study|Disease Progression|1|||
130635815|NCT00422903|470285926|FG000|Overall Study|Adverse Event|0|||
130635816|NCT00422903|470285927|FG001|Overall Study|Adverse Event|2|||
130635817|NCT00422903|470285926|FG000|Overall Study|Informed Consent Withdrawn|1|||
130635818|NCT00422903|470285927|FG001|Overall Study|Informed Consent Withdrawn|2|||
130635819|NCT01947894|470285932|FG000|Overall Study|Other|3|||
130635820|NCT01947894|470285933|FG001|Overall Study|Other|4|||
130635821|NCT01947894|470285934|FG002|Overall Study|Other|3|||
130635822|NCT01947894|470285932|FG000|Overall Study|Withdrawal by Subject|12|||
130635823|NCT01947894|470285933|FG001|Overall Study|Withdrawal by Subject|4|||
130635824|NCT01947894|470285934|FG002|Overall Study|Withdrawal by Subject|1|||
130635825|NCT01947894|470285932|FG000|Overall Study|Death|12|||
130635826|NCT01947894|470285933|FG001|Overall Study|Death|1|||
130635827|NCT01947894|470285934|FG002|Overall Study|Death|0|||
130635828|NCT01947894|470285932|FG000|Overall Study|Physician Decision|2|||
130635829|NCT01947894|470285933|FG001|Overall Study|Physician Decision|0|||
130635830|NCT01947894|470285934|FG002|Overall Study|Physician Decision|0|||
130635831|NCT01947894|470285932|FG000|Overall Study|Adverse Event|5|||
130635832|NCT01947894|470285933|FG001|Overall Study|Adverse Event|1|||
130635833|NCT01947894|470285934|FG002|Overall Study|Adverse Event|0|||
130635834|NCT01947894|470285932|FG000|Overall Study|Switched to other growth hormone brand|53|||
130635835|NCT01947894|470285933|FG001|Overall Study|Switched to other growth hormone brand|8|||
130635836|NCT01947894|470285934|FG002|Overall Study|Switched to other growth hormone brand|23|||
130635837|NCT01302691|470285935|FG000|Overall Study|Adverse Event|2|||
130635838|NCT01302691|470285936|FG001|Overall Study|Adverse Event|0|||
130635839|NCT01302691|470285935|FG000|Overall Study|Death|0|||
130635840|NCT01302691|470285936|FG001|Overall Study|Death|1|||
130635841|NCT01302691|470285935|FG000|Overall Study|Lost to Follow-up|1|||
130635842|NCT01302691|470285936|FG001|Overall Study|Lost to Follow-up|0|||
130635843|NCT01302691|470285935|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
130635844|NCT01302691|470285936|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
130635845|NCT01302691|470285935|FG000|Overall Study|Physician Decision|0|||
130635846|NCT01302691|470285936|FG001|Overall Study|Physician Decision|1|||
130635847|NCT01302691|470285935|FG000|Overall Study|Protocol Violation|1|||
130635848|NCT01302691|470285936|FG001|Overall Study|Protocol Violation|0|||
130635849|NCT03446612|470285937|FG000|Overall Study|Protocol defined stopping criteria|0|||
130635850|NCT03446612|470285938|FG001|Overall Study|Protocol defined stopping criteria|1|||
130635851|NCT01437267|470285940|FG000|Overall Study|Withdrawal by Subject|0|||
130635852|NCT01437267|470285941|FG001|Overall Study|Withdrawal by Subject|0|||
130635853|NCT01437267|470285942|FG002|Overall Study|Withdrawal by Subject|0|||
130635854|NCT01437267|470285943|FG003|Overall Study|Withdrawal by Subject|1|||
130635855|NCT01437267|470285944|FG004|Overall Study|Withdrawal by Subject|0|||
130635856|NCT01437267|470285945|FG005|Overall Study|Withdrawal by Subject|0|||
130635857|NCT01437267|470285940|FG000|Overall Study|Protocol Violation|0|||
130635858|NCT01437267|470285941|FG001|Overall Study|Protocol Violation|1|||
130635859|NCT01437267|470285942|FG002|Overall Study|Protocol Violation|0|||
130635860|NCT01437267|470285943|FG003|Overall Study|Protocol Violation|0|||
130635861|NCT01437267|470285944|FG004|Overall Study|Protocol Violation|0|||
130635862|NCT01437267|470285945|FG005|Overall Study|Protocol Violation|0|||
130635863|NCT03934203|470285946|FG000|Overall Study|Adverse Event|0|||
130635864|NCT03934203|470285947|FG001|Overall Study|Adverse Event|0|||
130635865|NCT03934203|470285948|FG002|Overall Study|Adverse Event|1|||
130635866|NCT03934203|470285949|FG003|Overall Study|Adverse Event|0|||
130635867|NCT03934203|470285950|FG004|Overall Study|Adverse Event|1|||
130635868|NCT03934203|470285951|FG005|Overall Study|Adverse Event|0|||
130635869|NCT03934203|470285952|FG006|Overall Study|Adverse Event|2|||
130635870|NCT03934203|470285953|FG007|Overall Study|Adverse Event|0|||
130635871|NCT03934203|470285954|FG008|Overall Study|Adverse Event|0|||
130635872|NCT03934203|470285955|FG009|Overall Study|Adverse Event|0|||
130635873|NCT03934203|470285956|FG010|Overall Study|Adverse Event|0|||
130635874|NCT03934203|470285957|FG011|Overall Study|Adverse Event|0|||
130635875|NCT03934203|470285958|FG012|Overall Study|Adverse Event|0|||
130635876|NCT03934203|470285959|FG013|Overall Study|Adverse Event|1|||
130635877|NCT03934203|470285960|FG014|Overall Study|Adverse Event|0|||
130635878|NCT00333970|470285963|FG000|Overall Study|Withdrawal by Subject|13|||
130635879|NCT00333970|470285964|FG001|Overall Study|Withdrawal by Subject|7|||
130635880|NCT00608842|470285966|FG000|Overall Study|Participant's Request|0|||
130635881|NCT00608842|470285967|FG001|Overall Study|Participant's Request|1|||
130635882|NCT00608842|470285968|FG002|Overall Study|Participant's Request|2|||
130635883|NCT00608842|470285969|FG003|Overall Study|Participant's Request|1|||
130635884|NCT00608842|470285966|FG000|Overall Study|Lost to Follow-up|1|||
130635885|NCT00608842|470285967|FG001|Overall Study|Lost to Follow-up|0|||
130635886|NCT00608842|470285968|FG002|Overall Study|Lost to Follow-up|0|||
130635887|NCT00608842|470285969|FG003|Overall Study|Lost to Follow-up|0|||
130635888|NCT04445051|470285971|FG000|Overall Study|Adverse Event|0|||
130635889|NCT04445051|470285972|FG001|Overall Study|Adverse Event|0|||
130635890|NCT04445051|470285973|FG002|Overall Study|Adverse Event|1|||
130635891|NCT04445051|470285974|FG003|Overall Study|Adverse Event|0|||
130635892|NCT04445051|470285975|FG004|Overall Study|Adverse Event|0|||
130635893|NCT04445051|470285976|FG005|Overall Study|Adverse Event|0|||
130635894|NCT01188811|470285988|FG000|Overall Study|Withdrawal by Subject|0|||
130635895|NCT01188811|470285989|FG001|Overall Study|Withdrawal by Subject|2|||
130635896|NCT01188811|470285988|FG000|Overall Study|Adverse Event|6|||
130635897|NCT01188811|470285989|FG001|Overall Study|Adverse Event|0|||
130635898|NCT03924427|470285990|FG000|Overall Study|Adverse Event|4|||
130635899|NCT03924427|470285990|FG000|Overall Study|Lack of Efficacy|1|||
130635900|NCT03924427|470285990|FG000|Overall Study|Withdrawal by Subject|1|||
130635901|NCT04350372|470285995|FG000|Overall Study|Death|1|||
130635902|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
130635903|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
130635904|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130635905|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130635906|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130635907|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
130635908|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
130635909|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130635910|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130635911|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130635912|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
130635913|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
130635914|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130635915|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130635916|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130635917|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130635918|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
130635919|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130635920|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130635921|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130635922|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
130635923|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130635924|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130635925|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130635926|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130635927|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130635928|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
130635929|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130635930|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130635931|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130635932|NCT04757376|470285996|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
130635933|NCT04757376|470285997|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
130635934|NCT04757376|470285998|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130635935|NCT04757376|470285999|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130635936|NCT04757376|470286000|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130635937|NCT04757376|470285996|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130635938|NCT04757376|470285997|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130635939|NCT04757376|470285998|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
130635940|NCT04757376|470285999|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130635941|NCT04757376|470286000|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130635942|NCT01307046|470286001|FG000|Overall Study|Adverse Event|3|||
130635943|NCT01307046|470286002|FG001|Overall Study|Adverse Event|3|||
130635944|NCT01307046|470286001|FG000|Overall Study|Lack of Efficacy|0|||
130635945|NCT01307046|470286002|FG001|Overall Study|Lack of Efficacy|2|||
130635946|NCT01307046|470286001|FG000|Overall Study|Physician Decision|2|||
130635947|NCT01307046|470286002|FG001|Overall Study|Physician Decision|0|||
130635948|NCT01307046|470286001|FG000|Overall Study|Withdrawal by Subject|1|||
130635949|NCT01307046|470286002|FG001|Overall Study|Withdrawal by Subject|1|||
130635950|NCT01307046|470286001|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
130635951|NCT01307046|470286002|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
130635952|NCT01307046|470286001|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
130635953|NCT01307046|470286002|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
130635954|NCT01365091|470286005|FG000|Period 1|Adverse Event|1|||
130635955|NCT01365091|470286006|FG001|Period 1|Adverse Event|0|||
130635956|NCT01365091|470286007|FG002|Period 1|Adverse Event|2|||
130635957|NCT01365091|470286008|FG003|Period 1|Adverse Event|3|||
130635958|NCT01365091|470286005|FG000|Period 1|Positive test result for drugs of abuse|1|||
130635959|NCT01365091|470286006|FG001|Period 1|Positive test result for drugs of abuse|0|||
130635960|NCT01365091|470286007|FG002|Period 1|Positive test result for drugs of abuse|0|||
130635961|NCT01365091|470286008|FG003|Period 1|Positive test result for drugs of abuse|0|||
130635962|NCT01365091|470286005|FG000|Period 1|No longer met study criteria|0|||
130635963|NCT01365091|470286006|FG001|Period 1|No longer met study criteria|1|||
130635964|NCT01365091|470286007|FG002|Period 1|No longer met study criteria|0|||
130635965|NCT01365091|470286008|FG003|Period 1|No longer met study criteria|0|||
130635966|NCT01365091|470286005|FG000|Period 1|Withdrawal by Subject|0|||
130635967|NCT01365091|470286006|FG001|Period 1|Withdrawal by Subject|1|||
130635968|NCT01365091|470286007|FG002|Period 1|Withdrawal by Subject|0|||
130635969|NCT01365091|470286008|FG003|Period 1|Withdrawal by Subject|0|||
130635970|NCT01365091|470286005|FG000|Period 1|Personal reasons|0|||
130635971|NCT01365091|470286006|FG001|Period 1|Personal reasons|0|||
130635972|NCT01365091|470286007|FG002|Period 1|Personal reasons|1|||
130635973|NCT01365091|470286008|FG003|Period 1|Personal reasons|0|||
130635974|NCT01365091|470286005|FG000|Period 2|Withdrawal by Subject|1|||
130635975|NCT01365091|470286006|FG001|Period 2|Withdrawal by Subject|0|||
130635976|NCT01365091|470286007|FG002|Period 2|Withdrawal by Subject|0|||
130635977|NCT01365091|470286008|FG003|Period 2|Withdrawal by Subject|0|||
130635978|NCT01365091|470286005|FG000|Period 2|Adverse Event|0|||
130635979|NCT01365091|470286006|FG001|Period 2|Adverse Event|0|||
130635980|NCT01365091|470286007|FG002|Period 2|Adverse Event|1|||
130635981|NCT01365091|470286008|FG003|Period 2|Adverse Event|0|||
130635982|NCT02569398|470286009|FG000|Overall Study|Adverse Event|0|||
130635983|NCT02569398|470286010|FG001|Overall Study|Adverse Event|1|||
130635984|NCT02569398|470286011|FG002|Overall Study|Adverse Event|6|||
130635985|NCT02569398|470286009|FG000|Overall Study|Withdrawal by Subject|43|||
130635986|NCT02569398|470286010|FG001|Overall Study|Withdrawal by Subject|43|||
130635987|NCT02569398|470286011|FG002|Overall Study|Withdrawal by Subject|30|||
130635988|NCT02569398|470286009|FG000|Overall Study|Study terminated by sponsor|130|||
130635989|NCT02569398|470286010|FG001|Overall Study|Study terminated by sponsor|131|||
130635990|NCT02569398|470286011|FG002|Overall Study|Study terminated by sponsor|134|||
130635991|NCT02569398|470286009|FG000|Overall Study|Other|12|||
130635992|NCT02569398|470286010|FG001|Overall Study|Other|14|||
130635993|NCT02569398|470286011|FG002|Overall Study|Other|13|||
130635994|NCT02116361|470286014|FG000|Overall Study|Pregnancy|0|||
130635995|NCT02116361|470286015|FG001|Overall Study|Pregnancy|0|||
130635996|NCT02116361|470286016|FG002|Overall Study|Pregnancy|0|||
130635997|NCT02116361|470286017|FG003|Overall Study|Pregnancy|1|||
130635998|NCT02116361|470286014|FG000|Overall Study|Protocol Violation|1|||
130635999|NCT02116361|470286015|FG001|Overall Study|Protocol Violation|0|||
130636000|NCT02116361|470286016|FG002|Overall Study|Protocol Violation|0|||
130636001|NCT02116361|470286017|FG003|Overall Study|Protocol Violation|2|||
130636002|NCT02116361|470286014|FG000|Overall Study|Physician Decision|2|||
130636003|NCT02116361|470286015|FG001|Overall Study|Physician Decision|3|||
130636004|NCT02116361|470286016|FG002|Overall Study|Physician Decision|0|||
130636005|NCT02116361|470286017|FG003|Overall Study|Physician Decision|0|||
130636006|NCT02116361|470286014|FG000|Overall Study|Adverse Event|1|||
130636007|NCT02116361|470286015|FG001|Overall Study|Adverse Event|0|||
130636008|NCT02116361|470286016|FG002|Overall Study|Adverse Event|0|||
130636009|NCT02116361|470286017|FG003|Overall Study|Adverse Event|3|||
130636010|NCT02116361|470286014|FG000|Overall Study|Other Reasons|3|||
130636011|NCT02116361|470286015|FG001|Overall Study|Other Reasons|3|||
130636012|NCT02116361|470286016|FG002|Overall Study|Other Reasons|3|||
130636013|NCT02116361|470286017|FG003|Overall Study|Other Reasons|3|||
130636014|NCT02116361|470286014|FG000|Overall Study|Lack of Efficacy|5|||
130636015|NCT02116361|470286015|FG001|Overall Study|Lack of Efficacy|7|||
130636016|NCT02116361|470286016|FG002|Overall Study|Lack of Efficacy|4|||
130636017|NCT02116361|470286017|FG003|Overall Study|Lack of Efficacy|3|||
130636018|NCT02116361|470286014|FG000|Overall Study|Lost to Follow-up|4|||
130636019|NCT02116361|470286015|FG001|Overall Study|Lost to Follow-up|5|||
130636020|NCT02116361|470286016|FG002|Overall Study|Lost to Follow-up|7|||
130636021|NCT02116361|470286017|FG003|Overall Study|Lost to Follow-up|5|||
130636022|NCT02116361|470286014|FG000|Overall Study|Personal Reasons|6|||
130636023|NCT02116361|470286015|FG001|Overall Study|Personal Reasons|6|||
130636024|NCT02116361|470286016|FG002|Overall Study|Personal Reasons|4|||
130636025|NCT02116361|470286017|FG003|Overall Study|Personal Reasons|9|||
130636026|NCT02116361|470286014|FG000|Overall Study|Investigator Decision - Relapse|9|||
130636027|NCT02116361|470286015|FG001|Overall Study|Investigator Decision - Relapse|7|||
130636028|NCT02116361|470286016|FG002|Overall Study|Investigator Decision - Relapse|8|||
130636029|NCT02116361|470286017|FG003|Overall Study|Investigator Decision - Relapse|5|||
130636030|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130636031|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130636032|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
130636033|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130636034|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
130636035|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
130636036|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130636037|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130636038|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
130636039|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
130636040|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
130636041|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
130636042|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130636043|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130636044|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130636045|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130636046|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130636047|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130636048|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
130636049|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130636050|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
130636051|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
130636052|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
130636053|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
130636054|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
130636055|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130636056|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
130636057|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130636058|NCT03227224|470286018|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
130636059|NCT03227224|470286019|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
130636060|NCT03227224|470286020|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
130636061|NCT03227224|470286021|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
130636062|NCT03227224|470286018|FG000|Follow-up Phase (2 Weeks)|Other|4|||
130636063|NCT03227224|470286019|FG001|Follow-up Phase (2 Weeks)|Other|4|||
130636064|NCT03227224|470286020|FG002|Follow-up Phase (2 Weeks)|Other|6|||
130636065|NCT03227224|470286021|FG003|Follow-up Phase (2 Weeks)|Other|3|||
130636066|NCT02406027|470286022|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130636067|NCT02406027|470286023|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
130636068|NCT02406027|470286024|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
130636069|NCT02406027|470286025|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130636070|NCT02406027|470286026|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130636071|NCT02406027|470286027|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130636072|NCT02406027|470286028|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130636073|NCT02406027|470286022|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
130636074|NCT02406027|470286023|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130636075|NCT02406027|470286024|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
130636076|NCT02406027|470286025|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130636077|NCT02406027|470286026|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130636078|NCT02406027|470286027|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130636079|NCT02406027|470286028|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130636080|NCT02406027|470286022|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
130636081|NCT02406027|470286023|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
130636082|NCT02406027|470286024|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
130636083|NCT02406027|470286025|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130636084|NCT02406027|470286026|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130636085|NCT02406027|470286027|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130636086|NCT02406027|470286028|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130636087|NCT02406027|470286022|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
130636088|NCT02406027|470286023|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130636089|NCT02406027|470286024|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
130636090|NCT02406027|470286025|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130636091|NCT02406027|470286026|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130636092|NCT02406027|470286027|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130636093|NCT02406027|470286028|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130636094|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
130636095|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
130636096|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
130636097|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
130636098|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
130636099|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
130636100|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
130636101|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
130636102|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
130636103|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
130636104|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
130636105|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
130636106|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
130636107|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
130636108|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130636109|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130636110|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130636111|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
130636112|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
130636113|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130636114|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
130636115|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130636116|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130636117|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130636118|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
130636119|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
130636120|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
130636121|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
130636122|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636123|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636124|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636125|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636126|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636127|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
130636128|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130636129|NCT02406027|470286022|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636130|NCT02406027|470286023|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636131|NCT02406027|470286024|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636132|NCT02406027|470286025|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636133|NCT02406027|470286026|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
130636134|NCT02406027|470286027|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636135|NCT02406027|470286028|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130636136|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
130636137|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
130636138|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
130636139|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
130636140|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Other|13|||
130636141|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
130636142|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
130636143|NCT02497287|470286029|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
130636144|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
130636145|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
130636146|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
130636147|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
130636148|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
130636149|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
130636150|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
130636151|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
130636152|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
130636153|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
130636154|NCT02497287|470286029|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
130636155|NCT02497287|470286029|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
130636156|NCT02497287|470286029|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
130636157|NCT02497287|470286029|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
130636158|NCT02497287|470286029|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
130636159|NCT02497287|470286029|FG000|Follow-up Phase (4 Week)|Other|1|||
130636160|NCT03782376|470286030|FG000|Overall Study|Lost to Follow-up|2|||
130636161|NCT03782376|470286031|FG001|Overall Study|Lost to Follow-up|2|||
130636162|NCT03782376|470286030|FG000|Overall Study|Withdrawal by Subject|7|||
130636163|NCT03782376|470286031|FG001|Overall Study|Withdrawal by Subject|11|||
130636164|NCT03782376|470286030|FG000|Overall Study|Death|1|||
130636165|NCT03782376|470286031|FG001|Overall Study|Death|0|||
130636166|NCT03782376|470286030|FG000|Overall Study|Other|16|||
130636167|NCT03782376|470286031|FG001|Overall Study|Other|17|||
130636168|NCT01226472|470286032|FG000|Overall Study|Progressive Disease|1|||
130636169|NCT00952419|470286033|FG000|Overall Study|Adverse Event|2|||
130636170|NCT00952419|470286034|FG001|Overall Study|Adverse Event|0|||
130636171|NCT00952419|470286035|FG002|Overall Study|Adverse Event|0|||
130636172|NCT00952419|470286033|FG000|Overall Study|Protocol Violation|3|||
130636173|NCT00952419|470286034|FG001|Overall Study|Protocol Violation|7|||
130636174|NCT00952419|470286035|FG002|Overall Study|Protocol Violation|0|||
130636175|NCT00952419|470286033|FG000|Overall Study|Withdrawal by Subject|1|||
130636176|NCT00952419|470286034|FG001|Overall Study|Withdrawal by Subject|3|||
130636177|NCT00952419|470286035|FG002|Overall Study|Withdrawal by Subject|0|||
130636178|NCT00400946|470287743|FG000|Overall Study|Ineligible|0|||
130636179|NCT00400946|470287744|FG001|Overall Study|Ineligible|0|||
130636180|NCT00400946|470287745|FG002|Overall Study|Ineligible|0|||
130636181|NCT00400946|470287746|FG003|Overall Study|Ineligible|5|||
130636182|NCT00400946|470287747|FG004|Overall Study|Ineligible|1|||
130636183|NCT00400946|470287743|FG000|Overall Study|Induction Failure|0|||
130636184|NCT00400946|470287744|FG001|Overall Study|Induction Failure|0|||
130636185|NCT00400946|470287745|FG002|Overall Study|Induction Failure|0|||
130636186|NCT00400946|470287746|FG003|Overall Study|Induction Failure|11|||
130636187|NCT00400946|470287747|FG004|Overall Study|Induction Failure|8|||
130636188|NCT00400946|470287743|FG000|Overall Study|Induction Death|0|||
130636189|NCT00400946|470287744|FG001|Overall Study|Induction Death|0|||
130636190|NCT00400946|470287745|FG002|Overall Study|Induction Death|0|||
130636191|NCT00400946|470287746|FG003|Overall Study|Induction Death|13|||
130636192|NCT00400946|470287747|FG004|Overall Study|Induction Death|3|||
130636193|NCT00400946|470287743|FG000|Overall Study|Lost to Follow-up|1|||
130636194|NCT00400946|470287744|FG001|Overall Study|Lost to Follow-up|1|||
130636195|NCT00400946|470287745|FG002|Overall Study|Lost to Follow-up|0|||
130636196|NCT00400946|470287746|FG003|Overall Study|Lost to Follow-up|0|||
130636197|NCT00400946|470287747|FG004|Overall Study|Lost to Follow-up|1|||
130636198|NCT00400946|470287743|FG000|Overall Study|Remission Death|1|||
130636199|NCT00400946|470287744|FG001|Overall Study|Remission Death|1|||
130636200|NCT00400946|470287745|FG002|Overall Study|Remission Death|0|||
130636201|NCT00400946|470287746|FG003|Overall Study|Remission Death|0|||
130636202|NCT00400946|470287747|FG004|Overall Study|Remission Death|1|||
130636203|NCT00400946|470287743|FG000|Overall Study|Relapse|9|||
130636204|NCT00400946|470287744|FG001|Overall Study|Relapse|2|||
130636205|NCT00400946|470287745|FG002|Overall Study|Relapse|1|||
130636206|NCT00400946|470287746|FG003|Overall Study|Relapse|1|||
130636207|NCT00400946|470287747|FG004|Overall Study|Relapse|5|||
130636208|NCT00400946|470287743|FG000|Overall Study|Transplant in CR1|0|||
130636209|NCT00400946|470287744|FG001|Overall Study|Transplant in CR1|0|||
130636210|NCT00400946|470287745|FG002|Overall Study|Transplant in CR1|0|||
130636211|NCT00400946|470287746|FG003|Overall Study|Transplant in CR1|10|||
130636212|NCT00400946|470287747|FG004|Overall Study|Transplant in CR1|1|||
130636213|NCT00400946|470287743|FG000|Overall Study|Withdrawal by Subject|2|||
130636214|NCT00400946|470287744|FG001|Overall Study|Withdrawal by Subject|5|||
130636215|NCT00400946|470287745|FG002|Overall Study|Withdrawal by Subject|1|||
130636216|NCT00400946|470287746|FG003|Overall Study|Withdrawal by Subject|5|||
130636217|NCT00400946|470287747|FG004|Overall Study|Withdrawal by Subject|8|||
130636218|NCT00400946|470287743|FG000|Overall Study|Clinical|1|||
130636219|NCT00400946|470287744|FG001|Overall Study|Clinical|2|||
130636220|NCT00400946|470287745|FG002|Overall Study|Clinical|0|||
130636221|NCT00400946|470287746|FG003|Overall Study|Clinical|2|||
130636222|NCT00400946|470287747|FG004|Overall Study|Clinical|9|||
130636223|NCT00400946|470287743|FG000|Overall Study|Other|0|||
130636224|NCT00400946|470287744|FG001|Overall Study|Other|0|||
130636225|NCT00400946|470287745|FG002|Overall Study|Other|0|||
130636226|NCT00400946|470287746|FG003|Overall Study|Other|0|||
130636227|NCT00400946|470287747|FG004|Overall Study|Other|1|||
130636228|NCT05643170|470287748|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
130636229|NCT05643170|470287748|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
130636230|NCT01432756|470287749|FG000|Overall Study|Lost to Follow-up|1|||
130636231|NCT01432756|470287750|FG001|Overall Study|Lost to Follow-up|0|||
130636232|NCT01432756|470287751|FG002|Overall Study|Lost to Follow-up|2|||
130636233|NCT01432756|470287752|FG003|Overall Study|Lost to Follow-up|1|||
130636234|NCT05426460|470287759|FG000|Overall Study|Protocol Violation|1|||
130636235|NCT05426460|470287760|FG001|Overall Study|Protocol Violation|1|||
130636236|NCT05426460|470287761|FG002|Overall Study|Protocol Violation|1|||
130636237|NCT05426460|470287762|FG003|Overall Study|Protocol Violation|0|||
130636238|NCT01431521|470287766|FG000|Overall Study|Withdrawal by Subject|0|||
130636239|NCT01431521|470287767|FG001|Overall Study|Withdrawal by Subject|0|||
130636240|NCT01431521|470287768|FG002|Overall Study|Withdrawal by Subject|1|||
130636241|NCT01431521|470287769|FG003|Overall Study|Withdrawal by Subject|0|||
130636242|NCT05171816|470287771|FG000|Overall Study|Death|18|||
130636243|NCT05171816|470287772|FG001|Overall Study|Death|16|||
130636244|NCT04667949|470287773|FG000|Overall Study|Adverse Event|0|||
130636245|NCT04667949|470287774|FG001|Overall Study|Adverse Event|2|||
130636246|NCT04667949|470287773|FG000|Overall Study|Lost to Follow-up|0|||
130636247|NCT04667949|470287774|FG001|Overall Study|Lost to Follow-up|1|||
130636248|NCT04667949|470287773|FG000|Overall Study|Physician Decision|0|||
130636249|NCT04667949|470287774|FG001|Overall Study|Physician Decision|2|||
130636250|NCT04667949|470287773|FG000|Overall Study|Subject decision|1|||
130636251|NCT04667949|470287774|FG001|Overall Study|Subject decision|7|||
130636252|NCT02000622|470287775|FG000|Overall Study|Withdrawal by Subject|5|||
130636253|NCT02000622|470287776|FG001|Overall Study|Withdrawal by Subject|7|||
130636254|NCT02000622|470287775|FG000|Overall Study|Lost to Follow-up|4|||
130636255|NCT02000622|470287776|FG001|Overall Study|Lost to Follow-up|0|||
130636256|NCT02000622|470287775|FG000|Overall Study|Death|159|||
130636257|NCT02000622|470287776|FG001|Overall Study|Death|73|||
130636258|NCT02000622|470287775|FG000|Overall Study|Withdrawn due to site closure|1|||
130636259|NCT02000622|470287776|FG001|Overall Study|Withdrawn due to site closure|0|||
130636260|NCT01405027|470287780|FG000|Overall Study|Withdrawn consent|3|||
130636261|NCT01405027|470287781|FG001|Overall Study|Withdrawn consent|0|||
130636262|NCT01405027|470287780|FG000|Overall Study|Lost to Follow-up|16|||
130636263|NCT01405027|470287781|FG001|Overall Study|Lost to Follow-up|24|||
130636264|NCT01405027|470287780|FG000|Overall Study|Investigator judgement|0|||
130636265|NCT01405027|470287781|FG001|Overall Study|Investigator judgement|2|||
130636266|NCT01405027|470287780|FG000|Overall Study|Death|1|||
130636267|NCT01405027|470287781|FG001|Overall Study|Death|0|||
130636268|NCT01405027|470287780|FG000|Overall Study|Other or Unknown|12|||
130636269|NCT01405027|470287781|FG001|Overall Study|Other or Unknown|25|||
130636270|NCT01320033|470287783|FG000|Overall Study|Lack of Efficacy|0|||
130636271|NCT01320033|470287784|FG001|Overall Study|Lack of Efficacy|0|||
130636272|NCT01320033|470287785|FG002|Overall Study|Lack of Efficacy|1|||
130636273|NCT01320033|470287783|FG000|Overall Study|Adverse Event|9|||
130636274|NCT01320033|470287784|FG001|Overall Study|Adverse Event|7|||
130636275|NCT01320033|470287785|FG002|Overall Study|Adverse Event|8|||
130636276|NCT01320033|470287783|FG000|Overall Study|Withdrawal by Subject|22|||
130636277|NCT01320033|470287784|FG001|Overall Study|Withdrawal by Subject|23|||
130636278|NCT01320033|470287785|FG002|Overall Study|Withdrawal by Subject|23|||
130636279|NCT01320033|470287783|FG000|Overall Study|Protocol Violation|3|||
130636280|NCT01320033|470287784|FG001|Overall Study|Protocol Violation|5|||
130636281|NCT01320033|470287785|FG002|Overall Study|Protocol Violation|3|||
130636282|NCT01320033|470287783|FG000|Overall Study|Lost to Follow-up|22|||
130636283|NCT01320033|470287784|FG001|Overall Study|Lost to Follow-up|26|||
130636284|NCT01320033|470287785|FG002|Overall Study|Lost to Follow-up|17|||
130636285|NCT01320033|470287783|FG000|Overall Study|Other|2|||
130636286|NCT01320033|470287784|FG001|Overall Study|Other|3|||
130636287|NCT01320033|470287785|FG002|Overall Study|Other|1|||
130636288|NCT00963469|470287786|FG000|Overall Study|Adverse Event|15|||
130636289|NCT00963469|470287787|FG001|Overall Study|Adverse Event|11|||
130636290|NCT00963469|470287788|FG002|Overall Study|Adverse Event|1|||
130636291|NCT00963469|470287786|FG000|Overall Study|Lack of Efficacy|10|||
130636292|NCT00963469|470287787|FG001|Overall Study|Lack of Efficacy|7|||
130636293|NCT00963469|470287788|FG002|Overall Study|Lack of Efficacy|2|||
130636294|NCT00963469|470287786|FG000|Overall Study|Lost to Follow-up|1|||
130636295|NCT00963469|470287787|FG001|Overall Study|Lost to Follow-up|1|||
130636296|NCT00963469|470287788|FG002|Overall Study|Lost to Follow-up|0|||
130636297|NCT00963469|470287786|FG000|Overall Study|Protocol Violation|5|||
130636298|NCT00963469|470287787|FG001|Overall Study|Protocol Violation|5|||
130636299|NCT00963469|470287788|FG002|Overall Study|Protocol Violation|3|||
130636300|NCT00963469|470287786|FG000|Overall Study|Withdrawal by Subject|4|||
130636301|NCT00963469|470287787|FG001|Overall Study|Withdrawal by Subject|1|||
130636302|NCT00963469|470287788|FG002|Overall Study|Withdrawal by Subject|1|||
130636303|NCT00963469|470287786|FG000|Overall Study|Pre-randomization Adverse Event|1|||
130636304|NCT00963469|470287787|FG001|Overall Study|Pre-randomization Adverse Event|2|||
130636305|NCT00963469|470287788|FG002|Overall Study|Pre-randomization Adverse Event|0|||
130636306|NCT00963469|470287786|FG000|Overall Study|Moved|1|||
130636307|NCT00963469|470287787|FG001|Overall Study|Moved|0|||
130636308|NCT00963469|470287788|FG002|Overall Study|Moved|0|||
130636309|NCT00963469|470287786|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
130636310|NCT00963469|470287787|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
130636311|NCT00963469|470287788|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
130636312|NCT00378534|470287802|FG000|Overall Study|Participants did not receive transplant|3|||
130636313|NCT00378534|470287803|FG001|Overall Study|Participants did not receive transplant|0|||
130636314|NCT04969900|470287804|FG000|Overall Study|Physician Decision|1|||
130636315|NCT04969900|470287805|FG001|Overall Study|Physician Decision|1|||
130636316|NCT04969900|470287804|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
130636317|NCT04969900|470287805|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
130636318|NCT03671148|470287811|FG000|Overall Study|Adverse Event|3|||
130636319|NCT03671148|470287812|FG001|Overall Study|Adverse Event|2|||
130636320|NCT03671148|470287811|FG000|Overall Study|Withdrawal by Subject|8|||
130636321|NCT03671148|470287812|FG001|Overall Study|Withdrawal by Subject|2|||
130636322|NCT03671148|470287811|FG000|Overall Study|Lost to Follow-up|1|||
130636323|NCT03671148|470287812|FG001|Overall Study|Lost to Follow-up|2|||
130636324|NCT03671148|470287811|FG000|Overall Study|Lack of Efficacy|7|||
130636325|NCT03671148|470287812|FG001|Overall Study|Lack of Efficacy|2|||
130636326|NCT03671148|470287811|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
130636327|NCT03671148|470287812|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130636328|NCT03671148|470287811|FG000|Overall Study|Other|1|||
130636329|NCT03671148|470287812|FG001|Overall Study|Other|0|||
130636330|NCT03671148|470287811|FG000|Overall Study|Incomplete Randomization Visit|1|||
130636331|NCT03671148|470287812|FG001|Overall Study|Incomplete Randomization Visit|0|||
130636332|NCT00673816|470287813|FG000|Overall Study|Adverse Event|1|||
130636333|NCT00673816|470287813|FG000|Overall Study|Withdrawal by Subject|1|||
130636334|NCT02234050|470287814|FG000|Overall Study|Lack of Efficacy|38|||
130636335|NCT02234050|470287815|FG001|Overall Study|Lack of Efficacy|22|||
130636336|NCT02234050|470287814|FG000|Overall Study|Adverse Event|13|||
130636337|NCT02234050|470287815|FG001|Overall Study|Adverse Event|1|||
130636338|NCT02234050|470287814|FG000|Overall Study|Withdrawal by Subject|4|||
130636339|NCT02234050|470287815|FG001|Overall Study|Withdrawal by Subject|2|||
130636340|NCT02234050|470287814|FG000|Overall Study|Sponsor's decision|6|||
130636341|NCT02234050|470287815|FG001|Overall Study|Sponsor's decision|0|||
130636342|NCT02365506|470287817|FG000|Overall Study|Investigator's Discretion|0|||
130636343|NCT02365506|470287818|FG001|Overall Study|Investigator's Discretion|0|||
130636344|NCT02365506|470287819|FG002|Overall Study|Investigator's Discretion|1|||
130636345|NCT01680991|470287820|FG000|Overall Study|Adverse Event|1|||
130636346|NCT01680991|470287821|FG001|Overall Study|Adverse Event|0|||
130636347|NCT01680991|470287822|FG002|Overall Study|Adverse Event|0|||
130636348|NCT01680991|470287820|FG000|Overall Study|Death|1|||
130636349|NCT01680991|470287821|FG001|Overall Study|Death|0|||
130636350|NCT01680991|470287822|FG002|Overall Study|Death|1|||
130636351|NCT01680991|470287820|FG000|Overall Study|Protocol Violation|0|||
130636352|NCT01680991|470287821|FG001|Overall Study|Protocol Violation|1|||
130636353|NCT01680991|470287822|FG002|Overall Study|Protocol Violation|0|||
130636354|NCT01680991|470287820|FG000|Overall Study|Withdrawal by Subject|5|||
130636355|NCT01680991|470287821|FG001|Overall Study|Withdrawal by Subject|1|||
130636356|NCT01680991|470287822|FG002|Overall Study|Withdrawal by Subject|0|||
130636357|NCT01680991|470287820|FG000|Overall Study|Progressive disease (PD)|0|||
130636358|NCT01680991|470287821|FG001|Overall Study|Progressive disease (PD)|10|||
130636359|NCT01680991|470287822|FG002|Overall Study|Progressive disease (PD)|0|||
130636360|NCT01680991|470287820|FG000|Overall Study|Physician Decision|0|||
130636361|NCT01680991|470287821|FG001|Overall Study|Physician Decision|7|||
130636362|NCT01680991|470287822|FG002|Overall Study|Physician Decision|2|||
130636363|NCT01680991|470287820|FG000|Overall Study|Bad physical condition|0|||
130636364|NCT01680991|470287821|FG001|Overall Study|Bad physical condition|0|||
130636365|NCT01680991|470287822|FG002|Overall Study|Bad physical condition|1|||
130636366|NCT01680991|470287820|FG000|Overall Study|PD confirmed in other hospital|1|||
130636367|NCT01680991|470287821|FG001|Overall Study|PD confirmed in other hospital|0|||
130636368|NCT01680991|470287822|FG002|Overall Study|PD confirmed in other hospital|0|||
130636369|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
130636370|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
130636371|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Death|1|||
130636372|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Death|1|||
130636373|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
130636374|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
130636375|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
130636376|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
130636377|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
130636378|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
130636379|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
130636380|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
130636381|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
130636382|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
130636383|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
130636384|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
130636385|NCT03728881|470287823|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
130636386|NCT03728881|470287824|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
130636387|NCT03728881|470287823|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
130636388|NCT03728881|470287824|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
130636389|NCT03728881|470287823|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
130636390|NCT03728881|470287824|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
130636391|NCT03149029|470287825|FG000|Overall Study|Adverse Event|2|||
130636392|NCT03149029|470287826|FG001|Overall Study|Adverse Event|0|||
130636393|NCT04088331|470287830|FG000|Overall Study|Lost to Follow-up|3|||
130636394|NCT04088331|470287830|FG000|Overall Study|Withdrawal by Subject|7|||
130636395|NCT04088331|470287830|FG000|Overall Study|Adverse Event|4|||
130636396|NCT03233308|470287835|FG000|Overall Study|Adverse Event|1|||
130636397|NCT03233308|470287835|FG000|Overall Study|Protocol Violation|1|||
130636398|NCT00976963|470287837|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
130636399|NCT00976963|470287838|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
130636400|NCT00976963|470287837|FG000|Overall Study|administrative error|1|||
130636401|NCT00976963|470287838|FG001|Overall Study|administrative error|0|||
130636402|NCT00976963|470287837|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
130636403|NCT00976963|470287838|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
130636404|NCT01688999|470287843|FG000|Overall Study|Withdrawal by Subject|5|||
130636405|NCT01688999|470287844|FG001|Overall Study|Withdrawal by Subject|1|||
130636406|NCT01688999|470287845|FG002|Overall Study|Withdrawal by Subject|1|||
130636407|NCT01688999|470287843|FG000|Overall Study|Adverse Event|2|||
130636408|NCT01688999|470287844|FG001|Overall Study|Adverse Event|0|||
130636409|NCT01688999|470287845|FG002|Overall Study|Adverse Event|2|||
130636410|NCT01688999|470287843|FG000|Overall Study|Ineligible/Not treated|1|||
130636411|NCT01688999|470287844|FG001|Overall Study|Ineligible/Not treated|0|||
130636412|NCT01688999|470287845|FG002|Overall Study|Ineligible/Not treated|0|||
130636413|NCT02768103|470287846|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
130636414|NCT02148952|470287848|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
130636415|NCT02148952|470287849|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
130636416|NCT02148952|470287848|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
130636417|NCT02148952|470287849|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
130636418|NCT02148952|470287848|FG000|Follow-Up|Lost to Follow-up|219|||
130636419|NCT02148952|470287849|FG001|Follow-Up|Lost to Follow-up|231|||
130636420|NCT02148952|470287848|FG000|Follow-Up|Withdrawal by Subject|46|||
130636421|NCT02148952|470287849|FG001|Follow-Up|Withdrawal by Subject|48|||
130636422|NCT01600105|470287850|FG000|Total Participants|Withdrawal by Subject|1|||
130636423|NCT01600105|470287851|FG001|Total Participants|Withdrawal by Subject|0|||
130636424|NCT01600105|470287850|FG000|Total Participants|No images in PACS|10|||
130636425|NCT01600105|470287851|FG001|Total Participants|No images in PACS|0|||
130636426|NCT01600105|470287850|FG000|Total Participants|Insufficient image quality|30|||
130636427|NCT01600105|470287851|FG001|Total Participants|Insufficient image quality|10|||
130636428|NCT01600105|470287850|FG000|Sub Study I|Insufficient image quality|0|||
130636429|NCT01600105|470287851|FG001|Sub Study I|Insufficient image quality|10|||
130636430|NCT01600105|470287850|FG000|Sub Study II|Withdrawal by Subject|1|||
130636431|NCT01600105|470287851|FG001|Sub Study II|Withdrawal by Subject|0|||
130636432|NCT01600105|470287850|FG000|Sub Study II|No images in PACS|1|||
130636433|NCT01600105|470287851|FG001|Sub Study II|No images in PACS|0|||
130636434|NCT01600105|470287850|FG000|Sub Study II|Insufficient image quality|3|||
130636435|NCT01600105|470287851|FG001|Sub Study II|Insufficient image quality|0|||
130636436|NCT01600105|470287850|FG000|Sub Study III|Insufficient image quality|5|||
130636437|NCT01600105|470287851|FG001|Sub Study III|Insufficient image quality|0|||
130636438|NCT01600105|470287850|FG000|Sub Study V|Poor Image Quality|2|||
130636439|NCT01600105|470287851|FG001|Sub Study V|Poor Image Quality|0|||
130636440|NCT01025232|470287852|FG000|Overall Study|Study drug no longer available|3|||
130636441|NCT01025232|470287853|FG001|Overall Study|Study drug no longer available|6|||
130636442|NCT01263444|470287854|FG000|Overall Study|Adverse Event|8|||
130636443|NCT01263444|470287854|FG000|Overall Study|Withdrawal by Subject|1|||
130636444|NCT01263444|470287854|FG000|Overall Study|Protocol Violation|1|||
130636445|NCT04007367|470287855|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
130636446|NCT04007367|470287856|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
130636447|NCT04007367|470287857|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
130636448|NCT04007367|470287855|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
130636449|NCT04007367|470287856|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
130636450|NCT04007367|470287857|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
130636451|NCT04007367|470287855|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
130636452|NCT04007367|470287856|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
130636453|NCT04007367|470287857|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
130636454|NCT04007367|470287855|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
130636455|NCT04007367|470287856|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
130636456|NCT04007367|470287857|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
130636457|NCT04007367|470287855|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
130636458|NCT04007367|470287856|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
130636459|NCT04007367|470287857|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
130636460|NCT01764022|470287859|FG000|Overall Study|Death|3|||
130636461|NCT01764022|470287860|FG001|Overall Study|Death|5|||
130636462|NCT01764022|470287859|FG000|Overall Study|Withdrawal by Subject|2|||
130636463|NCT01764022|470287860|FG001|Overall Study|Withdrawal by Subject|6|||
130636464|NCT01764022|470287859|FG000|Overall Study|Lack of Efficacy|0|||
130636465|NCT01764022|470287860|FG001|Overall Study|Lack of Efficacy|1|||
130636466|NCT01764022|470287859|FG000|Overall Study|Physician Decision|0|||
130636467|NCT01764022|470287860|FG001|Overall Study|Physician Decision|2|||
130636468|NCT01764022|470287859|FG000|Overall Study|Lost to Follow-up|2|||
130636469|NCT01764022|470287860|FG001|Overall Study|Lost to Follow-up|0|||
130636470|NCT01764022|470287859|FG000|Overall Study|Protocol Violation|1|||
130636471|NCT01764022|470287860|FG001|Overall Study|Protocol Violation|0|||
130636472|NCT02324049|470287863|FG000|Part C|Study terminated|11|||
130636473|NCT00423592|470287865|FG000|Overall Study|Adverse Event (through Week 12)|2|||
130636474|NCT00423592|470287865|FG000|Overall Study|Adverse Event (post Week 12)|5|||
130636475|NCT00149890|470287869|FG000|Overall Study|Adverse Event|1|||
130636476|NCT00149890|470287870|FG001|Overall Study|Adverse Event|8|||
130636477|NCT00149890|470287869|FG000|Overall Study|Lack of Efficacy|8|||
130636478|NCT00149890|470287870|FG001|Overall Study|Lack of Efficacy|9|||
130636479|NCT00149890|470287869|FG000|Overall Study|Protocol Violation|1|||
130636480|NCT00149890|470287870|FG001|Overall Study|Protocol Violation|0|||
130636481|NCT00149890|470287869|FG000|Overall Study|Lost to Follow-up|1|||
130636482|NCT00149890|470287870|FG001|Overall Study|Lost to Follow-up|0|||
130636483|NCT00149890|470287869|FG000|Overall Study|Graft Loss|2|||
130636484|NCT00149890|470287870|FG001|Overall Study|Graft Loss|1|||
130636485|NCT01894776|470287871|FG000|Overall Study|Withdrawal by Subject|1|||
130636486|NCT02485860|470287872|FG000|Overall Study|Lost to Follow-up|4|||
130636487|NCT02485860|470287873|FG001|Overall Study|Lost to Follow-up|1|||
130636488|NCT02485860|470287872|FG000|Overall Study|Physician Decision|1|||
130636489|NCT02485860|470287873|FG001|Overall Study|Physician Decision|2|||
130636490|NCT02485860|470287872|FG000|Overall Study|Health context (COVID-19)|1|||
130636491|NCT02485860|470287873|FG001|Overall Study|Health context (COVID-19)|0|||
130636492|NCT03325010|470287875|FG000|Overall Study|Adverse Event|3|||
130636493|NCT03325010|470287876|FG001|Overall Study|Adverse Event|8|||
130636494|NCT03325010|470287875|FG000|Overall Study|Protocol Violation|1|||
130636495|NCT03325010|470287876|FG001|Overall Study|Protocol Violation|8|||
130636496|NCT03325010|470287875|FG000|Overall Study|Withdrawal by Subject|1|||
130636497|NCT03325010|470287876|FG001|Overall Study|Withdrawal by Subject|3|||
130636498|NCT03325010|470287875|FG000|Overall Study|Lost to Follow-up|1|||
130636499|NCT03325010|470287876|FG001|Overall Study|Lost to Follow-up|0|||
130636500|NCT03325010|470287875|FG000|Overall Study|Physician Decision|1|||
130636501|NCT03325010|470287876|FG001|Overall Study|Physician Decision|1|||
130636502|NCT03325010|470287875|FG000|Overall Study|Lack of Efficacy|2|||
130636503|NCT03325010|470287876|FG001|Overall Study|Lack of Efficacy|0|||
130636504|NCT03073200|470287883|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130636505|NCT03073200|470287884|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130636506|NCT03073200|470287885|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130636507|NCT03073200|470287886|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130636508|NCT03073200|470287887|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130636509|NCT03073200|470287888|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130636510|NCT03073200|470287889|FG006|Double Blind Treatment Period|Protocol Violation|0|||
130636511|NCT03073200|470287890|FG007|Double Blind Treatment Period|Protocol Violation|0|||
130636512|NCT03073200|470287891|FG008|Double Blind Treatment Period|Protocol Violation|0|||
130636513|NCT03073200|470287892|FG009|Double Blind Treatment Period|Protocol Violation|0|||
130636514|NCT03073200|470287893|FG010|Double Blind Treatment Period|Protocol Violation|0|||
130636515|NCT03073200|470287894|FG011|Double Blind Treatment Period|Protocol Violation|0|||
130636516|NCT03073200|470287895|FG012|Double Blind Treatment Period|Protocol Violation|0|||
130636517|NCT03073200|470287896|FG013|Double Blind Treatment Period|Protocol Violation|0|||
130636518|NCT03073200|470287897|FG014|Double Blind Treatment Period|Protocol Violation|0|||
130636519|NCT03073200|470287883|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636520|NCT03073200|470287884|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
130636521|NCT03073200|470287885|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636522|NCT03073200|470287886|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636523|NCT03073200|470287887|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636524|NCT03073200|470287888|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636525|NCT03073200|470287889|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636526|NCT03073200|470287890|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636527|NCT03073200|470287891|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636528|NCT03073200|470287892|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636529|NCT03073200|470287893|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636530|NCT03073200|470287894|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636531|NCT03073200|470287895|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636532|NCT03073200|470287896|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636533|NCT03073200|470287897|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130636534|NCT03073200|470287883|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
130636535|NCT03073200|470287884|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636536|NCT03073200|470287885|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636537|NCT03073200|470287886|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636538|NCT03073200|470287887|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636539|NCT03073200|470287888|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636540|NCT03073200|470287889|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636541|NCT03073200|470287890|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636542|NCT03073200|470287891|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636543|NCT03073200|470287892|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636544|NCT03073200|470287893|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636545|NCT03073200|470287894|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636546|NCT03073200|470287895|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636547|NCT03073200|470287896|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636548|NCT03073200|470287897|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
130636549|NCT03073200|470287883|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636550|NCT03073200|470287884|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636551|NCT03073200|470287885|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636552|NCT03073200|470287886|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
130636553|NCT03073200|470287887|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
130636554|NCT03073200|470287888|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636555|NCT03073200|470287889|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636556|NCT03073200|470287890|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636557|NCT03073200|470287891|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636558|NCT03073200|470287892|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636559|NCT03073200|470287893|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636560|NCT03073200|470287894|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636561|NCT03073200|470287895|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636562|NCT03073200|470287896|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636563|NCT03073200|470287897|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
130636564|NCT03073200|470287883|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
130636565|NCT03073200|470287884|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
130636566|NCT03073200|470287885|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
130636567|NCT03073200|470287886|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
130636568|NCT03073200|470287887|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
130636569|NCT03073200|470287888|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
130636570|NCT03073200|470287889|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
130636571|NCT03073200|470287890|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
130636572|NCT03073200|470287891|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
130636573|NCT03073200|470287892|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
130636574|NCT03073200|470287893|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
130636575|NCT03073200|470287894|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
130636576|NCT03073200|470287895|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
130636577|NCT03073200|470287896|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
130636578|NCT03073200|470287897|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
130636579|NCT03073200|470287883|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636580|NCT03073200|470287884|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636581|NCT03073200|470287885|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636582|NCT03073200|470287886|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636583|NCT03073200|470287887|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
130636584|NCT03073200|470287888|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636585|NCT03073200|470287889|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636586|NCT03073200|470287890|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636587|NCT03073200|470287891|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636588|NCT03073200|470287892|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636589|NCT03073200|470287893|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636590|NCT03073200|470287894|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636591|NCT03073200|470287895|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636592|NCT03073200|470287896|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636593|NCT03073200|470287897|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
130636594|NCT03073200|470287883|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636595|NCT03073200|470287884|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636596|NCT03073200|470287885|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636597|NCT03073200|470287886|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
130636598|NCT03073200|470287887|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
130636599|NCT03073200|470287888|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636600|NCT03073200|470287889|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636601|NCT03073200|470287890|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636602|NCT03073200|470287891|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636603|NCT03073200|470287892|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636604|NCT03073200|470287893|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636605|NCT03073200|470287894|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636606|NCT03073200|470287895|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636607|NCT03073200|470287896|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636608|NCT03073200|470287897|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130636609|NCT03073200|470287883|FG000|Extension Period|Lost to Follow-up|0|||
130636610|NCT03073200|470287884|FG001|Extension Period|Lost to Follow-up|0|||
130636611|NCT03073200|470287885|FG002|Extension Period|Lost to Follow-up|0|||
130636612|NCT03073200|470287886|FG003|Extension Period|Lost to Follow-up|0|||
130636613|NCT03073200|470287887|FG004|Extension Period|Lost to Follow-up|0|||
130636614|NCT03073200|470287888|FG005|Extension Period|Lost to Follow-up|0|||
130636615|NCT03073200|470287889|FG006|Extension Period|Lost to Follow-up|1|||
130636616|NCT03073200|470287890|FG007|Extension Period|Lost to Follow-up|1|||
130636617|NCT03073200|470287891|FG008|Extension Period|Lost to Follow-up|0|||
130636618|NCT03073200|470287892|FG009|Extension Period|Lost to Follow-up|0|||
130636619|NCT03073200|470287893|FG010|Extension Period|Lost to Follow-up|0|||
130636620|NCT03073200|470287894|FG011|Extension Period|Lost to Follow-up|0|||
130636621|NCT03073200|470287895|FG012|Extension Period|Lost to Follow-up|0|||
130636622|NCT03073200|470287896|FG013|Extension Period|Lost to Follow-up|0|||
130636623|NCT03073200|470287897|FG014|Extension Period|Lost to Follow-up|0|||
130636624|NCT03073200|470287883|FG000|Extension Period|Sponsor Decision|0|||
130636625|NCT03073200|470287884|FG001|Extension Period|Sponsor Decision|0|||
130636626|NCT03073200|470287885|FG002|Extension Period|Sponsor Decision|0|||
130636627|NCT03073200|470287886|FG003|Extension Period|Sponsor Decision|0|||
130636628|NCT03073200|470287887|FG004|Extension Period|Sponsor Decision|0|||
130636629|NCT03073200|470287888|FG005|Extension Period|Sponsor Decision|0|||
130636630|NCT03073200|470287889|FG006|Extension Period|Sponsor Decision|0|||
130636631|NCT03073200|470287890|FG007|Extension Period|Sponsor Decision|0|||
130636632|NCT03073200|470287891|FG008|Extension Period|Sponsor Decision|1|||
130636633|NCT03073200|470287892|FG009|Extension Period|Sponsor Decision|0|||
130636634|NCT03073200|470287893|FG010|Extension Period|Sponsor Decision|0|||
130636635|NCT03073200|470287894|FG011|Extension Period|Sponsor Decision|0|||
130636636|NCT03073200|470287895|FG012|Extension Period|Sponsor Decision|0|||
130636637|NCT03073200|470287896|FG013|Extension Period|Sponsor Decision|0|||
130636638|NCT03073200|470287897|FG014|Extension Period|Sponsor Decision|0|||
130636639|NCT03073200|470287883|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
130636640|NCT03073200|470287884|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
130636641|NCT03073200|470287885|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
130636642|NCT03073200|470287886|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
130636643|NCT03073200|470287887|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
130636644|NCT03073200|470287888|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
130636645|NCT03073200|470287889|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
130636646|NCT03073200|470287890|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
130636647|NCT03073200|470287891|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
130636648|NCT03073200|470287892|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
130636649|NCT03073200|470287893|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
130636650|NCT03073200|470287894|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
130636651|NCT03073200|470287895|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
130636652|NCT03073200|470287896|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
130636653|NCT03073200|470287897|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
130636654|NCT03073200|470287883|FG000|Extension Period|Withdrawal by Subject|0|||
130636655|NCT03073200|470287884|FG001|Extension Period|Withdrawal by Subject|0|||
130636656|NCT03073200|470287885|FG002|Extension Period|Withdrawal by Subject|0|||
130636657|NCT03073200|470287886|FG003|Extension Period|Withdrawal by Subject|0|||
130636658|NCT03073200|470287887|FG004|Extension Period|Withdrawal by Subject|0|||
130636659|NCT03073200|470287888|FG005|Extension Period|Withdrawal by Subject|0|||
130636660|NCT03073200|470287889|FG006|Extension Period|Withdrawal by Subject|1|||
130636661|NCT03073200|470287890|FG007|Extension Period|Withdrawal by Subject|2|||
130636662|NCT03073200|470287891|FG008|Extension Period|Withdrawal by Subject|0|||
130636663|NCT03073200|470287892|FG009|Extension Period|Withdrawal by Subject|0|||
130636664|NCT03073200|470287893|FG010|Extension Period|Withdrawal by Subject|0|||
130636665|NCT03073200|470287894|FG011|Extension Period|Withdrawal by Subject|0|||
130636666|NCT03073200|470287895|FG012|Extension Period|Withdrawal by Subject|0|||
130636667|NCT03073200|470287896|FG013|Extension Period|Withdrawal by Subject|0|||
130636668|NCT03073200|470287897|FG014|Extension Period|Withdrawal by Subject|0|||
130636669|NCT03073200|470287883|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636670|NCT03073200|470287884|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636671|NCT03073200|470287885|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636672|NCT03073200|470287886|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636673|NCT03073200|470287887|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636674|NCT03073200|470287888|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636675|NCT03073200|470287889|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636676|NCT03073200|470287890|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636677|NCT03073200|470287891|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636678|NCT03073200|470287892|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636679|NCT03073200|470287893|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636680|NCT03073200|470287894|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
130636681|NCT03073200|470287895|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636682|NCT03073200|470287896|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636683|NCT03073200|470287897|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
130636684|NCT03073200|470287883|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636685|NCT03073200|470287884|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636686|NCT03073200|470287885|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636687|NCT03073200|470287886|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636688|NCT03073200|470287887|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636689|NCT03073200|470287888|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636690|NCT03073200|470287889|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636691|NCT03073200|470287890|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636692|NCT03073200|470287891|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636693|NCT03073200|470287892|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636694|NCT03073200|470287893|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636695|NCT03073200|470287894|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
130636696|NCT03073200|470287895|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636697|NCT03073200|470287896|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636698|NCT03073200|470287897|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130636699|NCT03073200|470287883|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636700|NCT03073200|470287884|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636701|NCT03073200|470287885|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636702|NCT03073200|470287886|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636703|NCT03073200|470287887|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636704|NCT03073200|470287888|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636705|NCT03073200|470287889|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636706|NCT03073200|470287890|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636707|NCT03073200|470287891|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636708|NCT03073200|470287892|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636709|NCT03073200|470287893|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130636710|NCT03073200|470287894|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130636711|NCT03073200|470287895|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636712|NCT03073200|470287896|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636713|NCT03073200|470287897|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130636714|NCT03073200|470287883|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130636715|NCT03073200|470287884|FG001|Randomized Withdrawal Period|Adverse Event|0|||
130636716|NCT03073200|470287885|FG002|Randomized Withdrawal Period|Adverse Event|0|||
130636717|NCT03073200|470287886|FG003|Randomized Withdrawal Period|Adverse Event|0|||
130636718|NCT03073200|470287887|FG004|Randomized Withdrawal Period|Adverse Event|0|||
130636719|NCT03073200|470287888|FG005|Randomized Withdrawal Period|Adverse Event|0|||
130636720|NCT03073200|470287889|FG006|Randomized Withdrawal Period|Adverse Event|0|||
130636721|NCT03073200|470287890|FG007|Randomized Withdrawal Period|Adverse Event|0|||
130636722|NCT03073200|470287891|FG008|Randomized Withdrawal Period|Adverse Event|0|||
130636723|NCT03073200|470287892|FG009|Randomized Withdrawal Period|Adverse Event|0|||
130636724|NCT03073200|470287893|FG010|Randomized Withdrawal Period|Adverse Event|1|||
130636725|NCT03073200|470287894|FG011|Randomized Withdrawal Period|Adverse Event|0|||
130636726|NCT03073200|470287895|FG012|Randomized Withdrawal Period|Adverse Event|0|||
130636727|NCT03073200|470287896|FG013|Randomized Withdrawal Period|Adverse Event|0|||
130636728|NCT03073200|470287897|FG014|Randomized Withdrawal Period|Adverse Event|0|||
130636729|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636730|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636731|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636732|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636733|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636734|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636735|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636736|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636737|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636738|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636739|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636740|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636741|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636742|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
130636743|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
130636744|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636745|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636746|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636747|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636748|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636749|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636750|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636751|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636752|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636753|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636754|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636755|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636756|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636757|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130636758|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130636759|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636760|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636761|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636762|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636763|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636764|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636765|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636766|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636767|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636768|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636769|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636770|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636771|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636772|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
130636773|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130636774|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636775|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636776|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636777|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636778|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636779|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636780|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636781|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636782|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636783|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636784|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636785|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636786|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636787|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
130636788|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130636789|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636790|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636791|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636792|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636793|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636794|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636795|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636796|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636797|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636798|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636799|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636800|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636801|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636802|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130636803|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
130636804|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636805|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636806|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636807|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636808|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636809|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636810|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636811|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636812|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636813|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636814|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636815|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636816|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636817|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
130636818|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130636819|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636820|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636821|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636822|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636823|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636824|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636825|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636826|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636827|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636828|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636829|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636830|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636831|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636832|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
130636833|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130636834|NCT03073200|470287883|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636835|NCT03073200|470287884|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636836|NCT03073200|470287885|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636837|NCT03073200|470287886|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636838|NCT03073200|470287887|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636839|NCT03073200|470287888|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636840|NCT03073200|470287889|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636841|NCT03073200|470287890|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636842|NCT03073200|470287891|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636843|NCT03073200|470287892|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636844|NCT03073200|470287893|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636845|NCT03073200|470287894|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636846|NCT03073200|470287895|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636847|NCT03073200|470287896|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
130636848|NCT03073200|470287897|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130636849|NCT05116683|470287901|FG000|Overall Study|Physician Decision|4|||
130636850|NCT01474889|470287902|FG000|Overall Study|Physician Decision|1|||
130636851|NCT01474889|470287903|FG001|Overall Study|Physician Decision|0|||
130636852|NCT01474889|470287904|FG002|Overall Study|Physician Decision|0|||
130636853|NCT01474889|470287902|FG000|Overall Study|Did not meet inclusion|1|||
130636854|NCT01474889|470287903|FG001|Overall Study|Did not meet inclusion|0|||
130636855|NCT01474889|470287904|FG002|Overall Study|Did not meet inclusion|0|||
130636856|NCT01474889|470287902|FG000|Overall Study|Withdrawal by Subject|0|||
130636857|NCT01474889|470287903|FG001|Overall Study|Withdrawal by Subject|1|||
130636858|NCT01474889|470287904|FG002|Overall Study|Withdrawal by Subject|0|||
130636859|NCT03935594|470287908|FG000|Overall Study|Physician Decision|3|||
130636860|NCT01435122|470287909|FG000|Overall Study|Early withdrawal due to toxicity|8|||
130636861|NCT03954704|470287910|FG000|Overall Study|Death|1|||
130636862|NCT03954704|470287911|FG001|Overall Study|Death|1|||
130636863|NCT03954704|470287912|FG002|Overall Study|Death|1|||
130636864|NCT03954704|470287913|FG003|Overall Study|Death|3|||
130636865|NCT03954704|470287914|FG004|Overall Study|Death|2|||
130636866|NCT03954704|470287915|FG005|Overall Study|Death|2|||
130636867|NCT03954704|470287916|FG006|Overall Study|Death|0|||
130636868|NCT03954704|470287910|FG000|Overall Study|Withdrew Consent|0|||
130636869|NCT03954704|470287911|FG001|Overall Study|Withdrew Consent|0|||
130636870|NCT03954704|470287912|FG002|Overall Study|Withdrew Consent|1|||
130636871|NCT03954704|470287913|FG003|Overall Study|Withdrew Consent|0|||
130636872|NCT03954704|470287914|FG004|Overall Study|Withdrew Consent|0|||
130636873|NCT03954704|470287915|FG005|Overall Study|Withdrew Consent|1|||
130636874|NCT03954704|470287916|FG006|Overall Study|Withdrew Consent|0|||
130636875|NCT03954704|470287910|FG000|Overall Study|Lost to Follow-up|0|||
130636876|NCT03954704|470287911|FG001|Overall Study|Lost to Follow-up|0|||
130636877|NCT03954704|470287912|FG002|Overall Study|Lost to Follow-up|0|||
130636878|NCT03954704|470287913|FG003|Overall Study|Lost to Follow-up|0|||
130636879|NCT03954704|470287914|FG004|Overall Study|Lost to Follow-up|0|||
130636880|NCT03954704|470287915|FG005|Overall Study|Lost to Follow-up|0|||
130636881|NCT03954704|470287916|FG006|Overall Study|Lost to Follow-up|1|||
130636882|NCT03954704|470287910|FG000|Overall Study|Study Terminated by Sponsor|0|||
130636883|NCT03954704|470287911|FG001|Overall Study|Study Terminated by Sponsor|0|||
130636884|NCT03954704|470287912|FG002|Overall Study|Study Terminated by Sponsor|1|||
130636885|NCT03954704|470287913|FG003|Overall Study|Study Terminated by Sponsor|0|||
130636886|NCT03954704|470287914|FG004|Overall Study|Study Terminated by Sponsor|1|||
130636887|NCT03954704|470287915|FG005|Overall Study|Study Terminated by Sponsor|4|||
130636888|NCT03954704|470287916|FG006|Overall Study|Study Terminated by Sponsor|2|||
130636889|NCT03954704|470287910|FG000|Overall Study|Enrolled but not Treated|0|||
130636890|NCT03954704|470287911|FG001|Overall Study|Enrolled but not Treated|0|||
130636891|NCT03954704|470287912|FG002|Overall Study|Enrolled but not Treated|0|||
130636892|NCT03954704|470287913|FG003|Overall Study|Enrolled but not Treated|0|||
130636893|NCT03954704|470287914|FG004|Overall Study|Enrolled but not Treated|0|||
130636894|NCT03954704|470287915|FG005|Overall Study|Enrolled but not Treated|1|||
130636895|NCT03954704|470287916|FG006|Overall Study|Enrolled but not Treated|0|||
130636896|NCT04412668|470287917|FG000|Overall Study|Death - multiple comorbidities|2|||
130636897|NCT04412668|470287918|FG001|Overall Study|Death - multiple comorbidities|0|||
130636898|NCT04412668|470287919|FG002|Overall Study|Death - multiple comorbidities|0|||
130636899|NCT04412668|470287917|FG000|Overall Study|Withdrawal by Subject|3|||
130636900|NCT04412668|470287918|FG001|Overall Study|Withdrawal by Subject|0|||
130636901|NCT04412668|470287919|FG002|Overall Study|Withdrawal by Subject|0|||
130636902|NCT04412668|470287917|FG000|Overall Study|Other than Specified|2|||
130636903|NCT04412668|470287918|FG001|Overall Study|Other than Specified|0|||
130636904|NCT04412668|470287919|FG002|Overall Study|Other than Specified|0|||
130636905|NCT03695471|470289947|FG000|Overall Study|Cancellation|1|||
130636906|NCT02859558|470289948|FG000|Step 1|Not Eligible|0|||
130636907|NCT02859558|470289949|FG001|Step 1|Not Eligible|0|||
130636908|NCT02859558|470289950|FG002|Step 1|Not Eligible|0|||
130636909|NCT02859558|470289951|FG003|Step 1|Not Eligible|0|||
130636910|NCT02859558|470289952|FG004|Step 1|Not Eligible|3|||
130636911|NCT02859558|470289948|FG000|Step 1|Lost to Follow-up|1|||
130636912|NCT02859558|470289949|FG001|Step 1|Lost to Follow-up|3|||
130636913|NCT02859558|470289950|FG002|Step 1|Lost to Follow-up|3|||
130636914|NCT02859558|470289951|FG003|Step 1|Lost to Follow-up|0|||
130636915|NCT02859558|470289952|FG004|Step 1|Lost to Follow-up|0|||
130636916|NCT02859558|470289948|FG000|Step 1|Did Not Return to Clinic|2|||
130636917|NCT02859558|470289949|FG001|Step 1|Did Not Return to Clinic|3|||
130636918|NCT02859558|470289950|FG002|Step 1|Did Not Return to Clinic|4|||
130636919|NCT02859558|470289951|FG003|Step 1|Did Not Return to Clinic|0|||
130636920|NCT02859558|470289952|FG004|Step 1|Did Not Return to Clinic|0|||
130636921|NCT02859558|470289948|FG000|Step 1|Moved|0|||
130636922|NCT02859558|470289949|FG001|Step 1|Moved|1|||
130636923|NCT02859558|470289950|FG002|Step 1|Moved|1|||
130636924|NCT02859558|470289951|FG003|Step 1|Moved|0|||
130636925|NCT02859558|470289952|FG004|Step 1|Moved|0|||
130636926|NCT02859558|470289948|FG000|Step 1|Withdrawal By Participant|1|||
130636927|NCT02859558|470289949|FG001|Step 1|Withdrawal By Participant|2|||
130636928|NCT02859558|470289950|FG002|Step 1|Withdrawal By Participant|1|||
130636929|NCT02859558|470289951|FG003|Step 1|Withdrawal By Participant|0|||
130636930|NCT02859558|470289952|FG004|Step 1|Withdrawal By Participant|0|||
130636931|NCT02859558|470289948|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
130636932|NCT02859558|470289949|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130636933|NCT02859558|470289950|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130636934|NCT02859558|470289951|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130636935|NCT02859558|470289952|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130636936|NCT02859558|470289948|FG000|Step 1|Incarceration|0|||
130636937|NCT02859558|470289949|FG001|Step 1|Incarceration|1|||
130636938|NCT02859558|470289950|FG002|Step 1|Incarceration|0|||
130636939|NCT02859558|470289951|FG003|Step 1|Incarceration|0|||
130636940|NCT02859558|470289952|FG004|Step 1|Incarceration|0|||
130636941|NCT02859558|470289948|FG000|Step 1|Non-Adherence to Study Drug|2|||
130636942|NCT02859558|470289949|FG001|Step 1|Non-Adherence to Study Drug|0|||
130636943|NCT02859558|470289950|FG002|Step 1|Non-Adherence to Study Drug|1|||
130636944|NCT02859558|470289951|FG003|Step 1|Non-Adherence to Study Drug|0|||
130636945|NCT02859558|470289952|FG004|Step 1|Non-Adherence to Study Drug|0|||
130636946|NCT02859558|470289948|FG000|Step 1|Non-Adherence to Study Requirements|3|||
130636947|NCT02859558|470289949|FG001|Step 1|Non-Adherence to Study Requirements|1|||
130636948|NCT02859558|470289950|FG002|Step 1|Non-Adherence to Study Requirements|0|||
130636949|NCT02859558|470289951|FG003|Step 1|Non-Adherence to Study Requirements|0|||
130636950|NCT02859558|470289952|FG004|Step 1|Non-Adherence to Study Requirements|0|||
130636951|NCT02859558|470289948|FG000|Step 1|Virologic Failure|2|||
130636952|NCT02859558|470289949|FG001|Step 1|Virologic Failure|1|||
130636953|NCT02859558|470289950|FG002|Step 1|Virologic Failure|1|||
130636954|NCT02859558|470289951|FG003|Step 1|Virologic Failure|0|||
130636955|NCT02859558|470289952|FG004|Step 1|Virologic Failure|0|||
130636956|NCT02859558|470289948|FG000|Step 2|Lost to Follow-up|3|||
130636957|NCT02859558|470289949|FG001|Step 2|Lost to Follow-up|3|||
130636958|NCT02859558|470289950|FG002|Step 2|Lost to Follow-up|1|||
130636959|NCT02859558|470289951|FG003|Step 2|Lost to Follow-up|0|||
130636960|NCT02859558|470289952|FG004|Step 2|Lost to Follow-up|0|||
130636961|NCT02859558|470289948|FG000|Step 2|Withdrawal by Subject|0|||
130636962|NCT02859558|470289949|FG001|Step 2|Withdrawal by Subject|1|||
130636963|NCT02859558|470289950|FG002|Step 2|Withdrawal by Subject|1|||
130636964|NCT02859558|470289951|FG003|Step 2|Withdrawal by Subject|0|||
130636965|NCT02859558|470289952|FG004|Step 2|Withdrawal by Subject|0|||
130636966|NCT02859558|470289948|FG000|Step 2|Unexpected Closure of Site|0|||
130636967|NCT02859558|470289949|FG001|Step 2|Unexpected Closure of Site|1|||
130636968|NCT02859558|470289950|FG002|Step 2|Unexpected Closure of Site|1|||
130636969|NCT02859558|470289951|FG003|Step 2|Unexpected Closure of Site|0|||
130636970|NCT02859558|470289952|FG004|Step 2|Unexpected Closure of Site|0|||
130636971|NCT02859558|470289948|FG000|Step 2|Death|1|||
130636972|NCT02859558|470289949|FG001|Step 2|Death|0|||
130636973|NCT02859558|470289950|FG002|Step 2|Death|0|||
130636974|NCT02859558|470289951|FG003|Step 2|Death|0|||
130636975|NCT02859558|470289952|FG004|Step 2|Death|0|||
130636976|NCT02859558|470289948|FG000|Step 2|Incarceration|0|||
130636977|NCT02859558|470289949|FG001|Step 2|Incarceration|0|||
130636978|NCT02859558|470289950|FG002|Step 2|Incarceration|1|||
130636979|NCT02859558|470289951|FG003|Step 2|Incarceration|0|||
130636980|NCT02859558|470289952|FG004|Step 2|Incarceration|0|||
130636989|NCT04888507|470289955|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
130636990|NCT00636155|470289956|FG000|Overall Study|Adverse Event|8|||
130636991|NCT00636155|470289956|FG000|Overall Study|Lack of Efficacy|1|||
130636992|NCT00636155|470289956|FG000|Overall Study|Withdrawal by Subject|3|||
130636993|NCT00636155|470289956|FG000|Overall Study|Stem cell transplant|1|||
130636994|NCT00636155|470289956|FG000|Overall Study|Physician Decision|5|||
130636995|NCT00766142|470289957|FG000|Overall Study|Protocol Violation|4|||
130636996|NCT02358863|470289963|FG000|Overall Study|Physician Decision|3|||
130636997|NCT02531633|470289985|FG000|Part A (52 Weeks)|Sponsor request|24|||
130636998|NCT02531633|470289986|FG001|Part A (52 Weeks)|Sponsor request|24|||
130636999|NCT02531633|470289987|FG002|Part A (52 Weeks)|Sponsor request|18|||
130637000|NCT02531633|470289988|FG003|Part A (52 Weeks)|Sponsor request|18|||
130637001|NCT02531633|470289989|FG004|Part A (52 Weeks)|Sponsor request|19|||
130637002|NCT02531633|470289990|FG005|Part A (52 Weeks)|Sponsor request|0|||
130637003|NCT02531633|470289991|FG006|Part A (52 Weeks)|Sponsor request|0|||
130637004|NCT02531633|470289992|FG007|Part A (52 Weeks)|Sponsor request|0|||
130637005|NCT02531633|470289993|FG008|Part A (52 Weeks)|Sponsor request|0|||
130637006|NCT02531633|470289994|FG009|Part A (52 Weeks)|Sponsor request|0|||
130637007|NCT02531633|470289985|FG000|Part A (52 Weeks)|Protocol Violation|1|||
130637008|NCT02531633|470289986|FG001|Part A (52 Weeks)|Protocol Violation|0|||
130637009|NCT02531633|470289987|FG002|Part A (52 Weeks)|Protocol Violation|0|||
130637010|NCT02531633|470289988|FG003|Part A (52 Weeks)|Protocol Violation|0|||
130637011|NCT02531633|470289989|FG004|Part A (52 Weeks)|Protocol Violation|0|||
130637012|NCT02531633|470289990|FG005|Part A (52 Weeks)|Protocol Violation|0|||
130637013|NCT02531633|470289991|FG006|Part A (52 Weeks)|Protocol Violation|0|||
130637014|NCT02531633|470289992|FG007|Part A (52 Weeks)|Protocol Violation|0|||
130637015|NCT02531633|470289993|FG008|Part A (52 Weeks)|Protocol Violation|0|||
130637016|NCT02531633|470289994|FG009|Part A (52 Weeks)|Protocol Violation|0|||
130637017|NCT02531633|470289985|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
130637018|NCT02531633|470289986|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
130637019|NCT02531633|470289987|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
130637020|NCT02531633|470289988|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
130637021|NCT02531633|470289989|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
130637022|NCT02531633|470289990|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
130637023|NCT02531633|470289991|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
130637024|NCT02531633|470289992|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
130637025|NCT02531633|470289993|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
130637026|NCT02531633|470289994|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
130637027|NCT02531633|470289985|FG000|Part A (52 Weeks)|Physician Decision|1|||
130637028|NCT02531633|470289986|FG001|Part A (52 Weeks)|Physician Decision|4|||
130637029|NCT02531633|470289987|FG002|Part A (52 Weeks)|Physician Decision|3|||
130637030|NCT02531633|470289988|FG003|Part A (52 Weeks)|Physician Decision|1|||
130637031|NCT02531633|470289989|FG004|Part A (52 Weeks)|Physician Decision|0|||
130637032|NCT02531633|470289990|FG005|Part A (52 Weeks)|Physician Decision|0|||
130637033|NCT02531633|470289991|FG006|Part A (52 Weeks)|Physician Decision|0|||
130637034|NCT02531633|470289992|FG007|Part A (52 Weeks)|Physician Decision|0|||
130637035|NCT02531633|470289993|FG008|Part A (52 Weeks)|Physician Decision|0|||
130637036|NCT02531633|470289994|FG009|Part A (52 Weeks)|Physician Decision|0|||
130637037|NCT02531633|470289985|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
130637038|NCT02531633|470289986|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
130637039|NCT02531633|470289987|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
130637040|NCT02531633|470289988|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
130637041|NCT02531633|470289989|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
130637042|NCT02531633|470289990|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
130637043|NCT02531633|470289991|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
130637044|NCT02531633|470289992|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
130637045|NCT02531633|470289993|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
130637046|NCT02531633|470289994|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
130637047|NCT02531633|470289985|FG000|Part A (52 Weeks)|Other|2|||
130637048|NCT02531633|470289986|FG001|Part A (52 Weeks)|Other|0|||
130637049|NCT02531633|470289987|FG002|Part A (52 Weeks)|Other|0|||
130637050|NCT02531633|470289988|FG003|Part A (52 Weeks)|Other|0|||
130637051|NCT02531633|470289989|FG004|Part A (52 Weeks)|Other|0|||
130637052|NCT02531633|470289990|FG005|Part A (52 Weeks)|Other|0|||
130637053|NCT02531633|470289991|FG006|Part A (52 Weeks)|Other|0|||
130637054|NCT02531633|470289992|FG007|Part A (52 Weeks)|Other|0|||
130637055|NCT02531633|470289993|FG008|Part A (52 Weeks)|Other|0|||
130637056|NCT02531633|470289994|FG009|Part A (52 Weeks)|Other|0|||
130637057|NCT02531633|470289985|FG000|Part B (104 Weeks)|Sponsor request|0|||
130637058|NCT02531633|470289986|FG001|Part B (104 Weeks)|Sponsor request|0|||
130637059|NCT02531633|470289987|FG002|Part B (104 Weeks)|Sponsor request|0|||
130637060|NCT02531633|470289988|FG003|Part B (104 Weeks)|Sponsor request|0|||
130637061|NCT02531633|470289989|FG004|Part B (104 Weeks)|Sponsor request|0|||
130637062|NCT02531633|470289990|FG005|Part B (104 Weeks)|Sponsor request|8|||
130637063|NCT02531633|470289991|FG006|Part B (104 Weeks)|Sponsor request|5|||
130637064|NCT02531633|470289992|FG007|Part B (104 Weeks)|Sponsor request|3|||
130637065|NCT02531633|470289993|FG008|Part B (104 Weeks)|Sponsor request|5|||
130637066|NCT02531633|470289994|FG009|Part B (104 Weeks)|Sponsor request|4|||
130637067|NCT02531633|470289985|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
130637068|NCT02531633|470289986|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
130637069|NCT02531633|470289987|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
130637070|NCT02531633|470289988|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
130637071|NCT02531633|470289989|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
130637072|NCT02531633|470289990|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
130637073|NCT02531633|470289991|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
130637074|NCT02531633|470289992|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
130637075|NCT02531633|470289993|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
130637076|NCT02531633|470289994|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
130637077|NCT04960202|470290002|FG000|Overall Study|Other|5|||
130637078|NCT04960202|470290003|FG001|Overall Study|Other|0|||
130637079|NCT04960202|470290002|FG000|Overall Study|Withdrawal by Subject|37|||
130637080|NCT04960202|470290003|FG001|Overall Study|Withdrawal by Subject|43|||
130637081|NCT04960202|470290002|FG000|Overall Study|Lost to Follow-up|20|||
130637082|NCT04960202|470290003|FG001|Overall Study|Lost to Follow-up|16|||
130637083|NCT04960202|470290002|FG000|Overall Study|Death|0|||
130637084|NCT04960202|470290003|FG001|Overall Study|Death|15|||
130637085|NCT03558828|470290005|FG000|Overall Study|Lost to Follow-up|4|||
130637086|NCT03558828|470290006|FG001|Overall Study|Lost to Follow-up|3|||
130637087|NCT03558828|470290007|FG002|Overall Study|Lost to Follow-up|3|||
130637088|NCT03558828|470290008|FG003|Overall Study|Lost to Follow-up|5|||
130637089|NCT03558828|470290009|FG004|Overall Study|Lost to Follow-up|2|||
130637090|NCT03558828|470290010|FG005|Overall Study|Lost to Follow-up|3|||
130637091|NCT03558828|470290005|FG000|Overall Study|dropped before the intervention|1|||
130637092|NCT03558828|470290006|FG001|Overall Study|dropped before the intervention|1|||
130637093|NCT03558828|470290007|FG002|Overall Study|dropped before the intervention|0|||
130637094|NCT03558828|470290008|FG003|Overall Study|dropped before the intervention|0|||
130637095|NCT03558828|470290009|FG004|Overall Study|dropped before the intervention|0|||
130637096|NCT03558828|470290010|FG005|Overall Study|dropped before the intervention|0|||
130637097|NCT01852591|470290014|FG000|Overall Study|Withdrawal by Subject|2|||
130637098|NCT01852591|470290014|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
130637099|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
130637100|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
130637101|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
130637102|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
130637103|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
130637104|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
130637105|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
130637106|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
130637107|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
130637108|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
130637109|NCT03774875|470290015|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
130637110|NCT03774875|470290016|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
130637111|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
130637112|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
130637113|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
130637114|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
130637115|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
130637116|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
130637117|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
130637118|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
130637119|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
130637120|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
130637121|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
130637122|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
130637123|NCT03774875|470290015|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
130637124|NCT03774875|470290016|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
130637125|NCT02155712|470290025|FG000|Overall Study|Death|12|||
130637126|NCT02155712|470290026|FG001|Overall Study|Death|0|||
130637127|NCT02155712|470290025|FG000|Overall Study|Lost to Follow-up|37|||
130637128|NCT02155712|470290026|FG001|Overall Study|Lost to Follow-up|22|||
130637129|NCT02155712|470290025|FG000|Overall Study|Revision of device|4|||
130637130|NCT02155712|470290026|FG001|Overall Study|Revision of device|3|||
130637131|NCT02155712|470290025|FG000|Overall Study|Withdrawal by Subject|39|||
130637132|NCT02155712|470290026|FG001|Overall Study|Withdrawal by Subject|21|||
130637133|NCT02155712|470290025|FG000|Overall Study|Site termination|77|||
130637134|NCT02155712|470290026|FG001|Overall Study|Site termination|19|||
130637135|NCT02155712|470290025|FG000|Overall Study|Sponsor terminated study early|150|||
130637136|NCT02155712|470290026|FG001|Overall Study|Sponsor terminated study early|0|||
130637137|NCT02155712|470290025|FG000|Overall Study|Missed final 5-year protocol visit|0|||
130637138|NCT02155712|470290026|FG001|Overall Study|Missed final 5-year protocol visit|32|||
130637139|NCT02155712|470290025|FG000|Overall Study|Censored because surgery cancelled|6|||
130637140|NCT02155712|470290026|FG001|Overall Study|Censored because surgery cancelled|10|||
130637141|NCT02155712|470290025|FG000|Overall Study|Censored because study device was not implanted|61|||
130637142|NCT02155712|470290026|FG001|Overall Study|Censored because study device was not implanted|66|||
130637143|NCT02155712|470290025|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
130637144|NCT02155712|470290026|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
130637145|NCT05016037|470290027|FG000|Overall Study|Lost to Follow-up|2|||
130637146|NCT02756845|470290035|FG000|Overall Study|Death|12|||
130637147|NCT02756845|470290036|FG001|Overall Study|Death|2|||
130637148|NCT02756845|470290035|FG000|Overall Study|Withdrawal by Subject|1|||
130637149|NCT02756845|470290036|FG001|Overall Study|Withdrawal by Subject|0|||
130637150|NCT03369704|470290037|FG000|Treatment Epoch|technical problems|1|||
130637151|NCT03369704|470290038|FG001|Treatment Epoch|technical problems|0|||
130637152|NCT03369704|470290037|FG000|Treatment Epoch|Protocol Violation|1|||
130637153|NCT03369704|470290038|FG001|Treatment Epoch|Protocol Violation|0|||
130637154|NCT03369704|470290037|FG000|Treatment Epoch|Lost to Follow-up|0|||
130637155|NCT03369704|470290038|FG001|Treatment Epoch|Lost to Follow-up|1|||
130637156|NCT03369704|470290037|FG000|Treatment Epoch|Lack of Efficacy|0|||
130637157|NCT03369704|470290038|FG001|Treatment Epoch|Lack of Efficacy|2|||
130637158|NCT03369704|470290037|FG000|Treatment Epoch|Adverse Event|2|||
130637159|NCT03369704|470290038|FG001|Treatment Epoch|Adverse Event|0|||
130637160|NCT03369704|470290037|FG000|Follow-up Epoch|Lost to Follow-up|1|||
130637161|NCT03369704|470290038|FG001|Follow-up Epoch|Lost to Follow-up|0|||
130637162|NCT04247828|470290050|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
130637163|NCT03797144|470290051|FG000|Enrollment|Protocol Violation|4|||
130637164|NCT03797144|470290052|FG001|Enrollment|Protocol Violation|1|||
130637165|NCT03797144|470290051|FG000|Surgery|Protocol Violation|1|||
130637166|NCT03797144|470290052|FG001|Surgery|Protocol Violation|0|||
130637167|NCT03797144|470290051|FG000|3 Month|Early termination cut-off date|2|||
130637168|NCT03797144|470290052|FG001|3 Month|Early termination cut-off date|0|||
130637169|NCT03797144|470290051|FG000|12 Month|Early termination cut-off date|8|||
130637170|NCT03797144|470290052|FG001|12 Month|Early termination cut-off date|9|||
130637171|NCT03797144|470290051|FG000|24 Month|Early termination cut-off date|1|||
130637172|NCT03797144|470290052|FG001|24 Month|Early termination cut-off date|1|||
130637173|NCT03083470|470290053|FG000|Overall Study|Lost to Follow-up|0|||
130637174|NCT03083470|470290054|FG001|Overall Study|Lost to Follow-up|0|||
130637175|NCT03083470|470290055|FG002|Overall Study|Lost to Follow-up|0|||
130637176|NCT03083470|470290056|FG003|Overall Study|Lost to Follow-up|0|||
130637177|NCT03083470|470290057|FG004|Overall Study|Lost to Follow-up|1|||
130637178|NCT03083470|470290053|FG000|Overall Study|Withdrawal by Subject|0|||
130637179|NCT03083470|470290054|FG001|Overall Study|Withdrawal by Subject|0|||
130637180|NCT03083470|470290055|FG002|Overall Study|Withdrawal by Subject|0|||
130637181|NCT03083470|470290056|FG003|Overall Study|Withdrawal by Subject|0|||
130637182|NCT03083470|470290057|FG004|Overall Study|Withdrawal by Subject|1|||
130637183|NCT03077711|470290058|FG000|Overall Study|Lost to Follow-up|2|||
130637184|NCT03077711|470290059|FG001|Overall Study|Lost to Follow-up|2|||
130637185|NCT03077711|470290058|FG000|Overall Study|noncompliant taking medication|2|||
130637186|NCT03077711|470290059|FG001|Overall Study|noncompliant taking medication|0|||
130637187|NCT02943668|470290063|FG000|Overall Study|Disease Progression|1|||
130637188|NCT01678560|470290071|FG000|Overall Study|Physician Decision|4|||
130637189|NCT01678560|470290072|FG001|Overall Study|Physician Decision|4|||
130637190|NCT01678560|470290071|FG000|Overall Study|Death|0|||
130637191|NCT01678560|470290072|FG001|Overall Study|Death|1|||
130637192|NCT01678560|470290071|FG000|Overall Study|Withdrawal by Subject|0|||
130637193|NCT01678560|470290072|FG001|Overall Study|Withdrawal by Subject|1|||
130637194|NCT00322387|470290073|FG000|Treatment Period|Adverse Event|0|||
130637195|NCT00322387|470290074|FG001|Treatment Period|Adverse Event|1|||
130637196|NCT00322387|470290073|FG000|Follow-up Period|Final assessment not done|1|||
130637197|NCT00322387|470290074|FG001|Follow-up Period|Final assessment not done|3|||
130637198|NCT00322387|470290073|FG000|Follow-up Period|Death|1|||
130637199|NCT00322387|470290074|FG001|Follow-up Period|Death|0|||
130637200|NCT00090766|470290075|FG000|Overall Study|Nephrectomy Planned|0|||
130637201|NCT00090766|470290076|FG001|Overall Study|Nephrectomy Planned|0|||
130637202|NCT00090766|470290077|FG002|Overall Study|Nephrectomy Planned|1|||
130637203|NCT00090766|470290075|FG000|Overall Study|Death|1|||
130637204|NCT00090766|470290076|FG001|Overall Study|Death|0|||
130637205|NCT00090766|470290077|FG002|Overall Study|Death|0|||
130637206|NCT00090766|470290075|FG000|Overall Study|Admin|0|||
130637207|NCT00090766|470290076|FG001|Overall Study|Admin|2|||
130637208|NCT00090766|470290077|FG002|Overall Study|Admin|0|||
130637209|NCT00090766|470290075|FG000|Overall Study|Lost to Follow-up|2|||
130637210|NCT00090766|470290076|FG001|Overall Study|Lost to Follow-up|0|||
130637211|NCT00090766|470290077|FG002|Overall Study|Lost to Follow-up|2|||
130637212|NCT00654368|470290084|FG000|Overall Study|Ineligibility determined|6|||
130637213|NCT00654368|470290085|FG001|Overall Study|Ineligibility determined|0|||
130637214|NCT00654368|470290086|FG002|Overall Study|Ineligibility determined|0|||
130637215|NCT00654368|470290084|FG000|Overall Study|Protocol deviation|3|||
130637216|NCT00654368|470290085|FG001|Overall Study|Protocol deviation|2|||
130637217|NCT00654368|470290086|FG002|Overall Study|Protocol deviation|1|||
130637218|NCT00654368|470290084|FG000|Overall Study|Non-compliance|2|||
130637219|NCT00654368|470290085|FG001|Overall Study|Non-compliance|1|||
130637220|NCT00654368|470290086|FG002|Overall Study|Non-compliance|2|||
130637221|NCT00654368|470290084|FG000|Overall Study|Withdrawal by Subject|5|||
130637222|NCT00654368|470290085|FG001|Overall Study|Withdrawal by Subject|2|||
130637223|NCT00654368|470290086|FG002|Overall Study|Withdrawal by Subject|2|||
130637224|NCT00654368|470290084|FG000|Overall Study|Disease progression|21|||
130637225|NCT00654368|470290085|FG001|Overall Study|Disease progression|31|||
130637226|NCT00654368|470290086|FG002|Overall Study|Disease progression|13|||
130637227|NCT00654368|470290084|FG000|Overall Study|Requirement for alternative therapy|1|||
130637228|NCT00654368|470290085|FG001|Overall Study|Requirement for alternative therapy|1|||
130637229|NCT00654368|470290086|FG002|Overall Study|Requirement for alternative therapy|1|||
130637230|NCT00654368|470290084|FG000|Overall Study|Physician Decision|0|||
130637231|NCT00654368|470290085|FG001|Overall Study|Physician Decision|0|||
130637232|NCT00654368|470290086|FG002|Overall Study|Physician Decision|2|||
130637233|NCT00654368|470290084|FG000|Overall Study|Death|1|||
130637234|NCT00654368|470290085|FG001|Overall Study|Death|0|||
130637235|NCT00654368|470290086|FG002|Overall Study|Death|0|||
130637236|NCT00654368|470290084|FG000|Overall Study|Pregnancy|0|||
130637237|NCT00654368|470290085|FG001|Overall Study|Pregnancy|0|||
130637238|NCT00654368|470290086|FG002|Overall Study|Pregnancy|2|||
130637239|NCT00654368|470290084|FG000|Overall Study|Other|0|||
130637240|NCT00654368|470290085|FG001|Overall Study|Other|2|||
130637241|NCT00654368|470290086|FG002|Overall Study|Other|3|||
130637242|NCT00654368|470290084|FG000|Overall Study|Adverse Event|14|||
130637243|NCT00654368|470290085|FG001|Overall Study|Adverse Event|9|||
130637244|NCT00654368|470290086|FG002|Overall Study|Adverse Event|6|||
130637245|NCT00804986|470290087|FG000|Overall Study|Adverse Event|0|||
130637246|NCT00804986|470290088|FG001|Overall Study|Adverse Event|1|||
130637247|NCT00804986|470290089|FG002|Overall Study|Adverse Event|2|||
130637248|NCT00804986|470290090|FG003|Overall Study|Adverse Event|1|||
130637249|NCT00804986|470290091|FG004|Overall Study|Adverse Event|3|||
130637250|NCT00804986|470290092|FG005|Overall Study|Adverse Event|0|||
130637251|NCT00804986|470290087|FG000|Overall Study|Lack of Efficacy|0|||
130637252|NCT00804986|470290088|FG001|Overall Study|Lack of Efficacy|0|||
130637253|NCT00804986|470290089|FG002|Overall Study|Lack of Efficacy|0|||
130637254|NCT00804986|470290090|FG003|Overall Study|Lack of Efficacy|1|||
130637255|NCT00804986|470290091|FG004|Overall Study|Lack of Efficacy|0|||
130637256|NCT00804986|470290092|FG005|Overall Study|Lack of Efficacy|3|||
130637257|NCT00804986|470290087|FG000|Overall Study|Lost to Follow-up|0|||
130637258|NCT00804986|470290088|FG001|Overall Study|Lost to Follow-up|0|||
130637259|NCT00804986|470290089|FG002|Overall Study|Lost to Follow-up|0|||
130637260|NCT00804986|470290090|FG003|Overall Study|Lost to Follow-up|1|||
130637261|NCT00804986|470290091|FG004|Overall Study|Lost to Follow-up|1|||
130637262|NCT00804986|470290092|FG005|Overall Study|Lost to Follow-up|3|||
130637263|NCT00804986|470290087|FG000|Overall Study|Protocol Violation|0|||
130637264|NCT00804986|470290088|FG001|Overall Study|Protocol Violation|1|||
130637265|NCT00804986|470290089|FG002|Overall Study|Protocol Violation|0|||
130637266|NCT00804986|470290090|FG003|Overall Study|Protocol Violation|1|||
130637267|NCT00804986|470290091|FG004|Overall Study|Protocol Violation|0|||
130637268|NCT00804986|470290092|FG005|Overall Study|Protocol Violation|0|||
130637269|NCT00804986|470290087|FG000|Overall Study|Withdrawal by Subject|0|||
130637270|NCT00804986|470290088|FG001|Overall Study|Withdrawal by Subject|3|||
130637271|NCT00804986|470290089|FG002|Overall Study|Withdrawal by Subject|0|||
130637272|NCT00804986|470290090|FG003|Overall Study|Withdrawal by Subject|3|||
130637273|NCT00804986|470290091|FG004|Overall Study|Withdrawal by Subject|5|||
130637274|NCT00804986|470290092|FG005|Overall Study|Withdrawal by Subject|3|||
130637275|NCT00804986|470290087|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130637276|NCT00804986|470290088|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
130637277|NCT00804986|470290089|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
130637278|NCT00804986|470290090|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
130637279|NCT00804986|470290091|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
130637280|NCT00804986|470290092|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
130637281|NCT00804986|470290087|FG000|Overall Study|Sponsor Decision|0|||
130637282|NCT00804986|470290088|FG001|Overall Study|Sponsor Decision|1|||
130637283|NCT00804986|470290089|FG002|Overall Study|Sponsor Decision|0|||
130637284|NCT00804986|470290090|FG003|Overall Study|Sponsor Decision|0|||
130637285|NCT00804986|470290091|FG004|Overall Study|Sponsor Decision|0|||
130637286|NCT00804986|470290092|FG005|Overall Study|Sponsor Decision|0|||
130637287|NCT00804986|470290087|FG000|Overall Study|Physician Decision|1|||
130637288|NCT00804986|470290088|FG001|Overall Study|Physician Decision|0|||
130637289|NCT00804986|470290089|FG002|Overall Study|Physician Decision|0|||
130637290|NCT00804986|470290090|FG003|Overall Study|Physician Decision|0|||
130637291|NCT00804986|470290091|FG004|Overall Study|Physician Decision|0|||
130637292|NCT00804986|470290092|FG005|Overall Study|Physician Decision|0|||
130637293|NCT00959699|470290097|FG000|Treatment Period|Adverse Event|3|||
130637294|NCT00959699|470290098|FG001|Treatment Period|Adverse Event|13|||
130637295|NCT00959699|470290097|FG000|Treatment Period|Lack of Efficacy|15|||
130637296|NCT00959699|470290098|FG001|Treatment Period|Lack of Efficacy|6|||
130637297|NCT00959699|470290097|FG000|Treatment Period|Lost to Follow-up|0|||
130637298|NCT00959699|470290098|FG001|Treatment Period|Lost to Follow-up|1|||
130637299|NCT00959699|470290097|FG000|Treatment Period|Withdrawal by Subject|1|||
130637300|NCT00959699|470290098|FG001|Treatment Period|Withdrawal by Subject|3|||
130637301|NCT00959699|470290097|FG000|Treatment Period|Non-Compliance with Protocol|0|||
130637302|NCT00959699|470290098|FG001|Treatment Period|Non-Compliance with Protocol|1|||
130637303|NCT00959699|470290097|FG000|Treatment Period|Did not receive treatment|0|||
130637304|NCT00959699|470290098|FG001|Treatment Period|Did not receive treatment|1|||
130637305|NCT00959699|470290097|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
130637306|NCT00959699|470290098|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
130637307|NCT00959699|470290097|FG000|Follow-up Period|Lost to Follow-up|3|||
130637308|NCT00959699|470290098|FG001|Follow-up Period|Lost to Follow-up|2|||
130637309|NCT00959699|470290097|FG000|Follow-up Period|Withdrawal by Subject|3|||
130637310|NCT00959699|470290098|FG001|Follow-up Period|Withdrawal by Subject|4|||
130637311|NCT04228445|470290101|FG000|Overall Study|Lost to Follow-up|1|||
130637312|NCT04228445|470290102|FG001|Overall Study|Lost to Follow-up|1|||
130637313|NCT04228445|470290101|FG000|Overall Study|Physician Decision|1|||
130637314|NCT04228445|470290102|FG001|Overall Study|Physician Decision|2|||
130637315|NCT04228445|470290101|FG000|Overall Study|Withdrawal by Subject|0|||
130637316|NCT04228445|470290102|FG001|Overall Study|Withdrawal by Subject|1|||
130637317|NCT04228445|470290101|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
130637318|NCT04228445|470290102|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
130637319|NCT00606294|470290103|FG000|Overall Study|Withdrawal by Subject|36|||
130637320|NCT00606294|470290104|FG001|Overall Study|Withdrawal by Subject|0|||
130637321|NCT01316380|470290105|FG000|Overall Study|Adverse Event|0|||
130637322|NCT01316380|470290106|FG001|Overall Study|Adverse Event|2|||
130637323|NCT01316380|470290107|FG002|Overall Study|Adverse Event|1|||
130637324|NCT01316380|470290105|FG000|Overall Study|Protocol Violation|0|||
130637325|NCT01316380|470290106|FG001|Overall Study|Protocol Violation|0|||
130637326|NCT01316380|470290107|FG002|Overall Study|Protocol Violation|1|||
130637327|NCT01316380|470290105|FG000|Overall Study|Withdrawal by Subject|1|||
130637328|NCT01316380|470290106|FG001|Overall Study|Withdrawal by Subject|2|||
130637329|NCT01316380|470290107|FG002|Overall Study|Withdrawal by Subject|0|||
130637330|NCT01316380|470290105|FG000|Overall Study|Other|0|||
130637331|NCT01316380|470290106|FG001|Overall Study|Other|1|||
130637332|NCT01316380|470290107|FG002|Overall Study|Other|1|||
130637333|NCT01316380|470290105|FG000|Overall Study|Not treated|1|||
130637334|NCT01316380|470290106|FG001|Overall Study|Not treated|0|||
130637335|NCT01316380|470290107|FG002|Overall Study|Not treated|0|||
130637336|NCT00397891|470290108|FG000|Overall Study|Withdrawal by Subject|1|||
130637337|NCT00397891|470290109|FG001|Overall Study|Withdrawal by Subject|0|||
130637338|NCT00397891|470290110|FG002|Overall Study|Withdrawal by Subject|0|||
130637339|NCT00397891|470290111|FG003|Overall Study|Withdrawal by Subject|0|||
130637340|NCT00397891|470290112|FG004|Overall Study|Withdrawal by Subject|1|||
130637341|NCT02632344|470291622|FG000|Overall Study|Adverse Event|3|||
130637342|NCT02632344|470291622|FG000|Overall Study|Lack of Efficacy|3|||
130637343|NCT02632344|470291622|FG000|Overall Study|Withdrawal by Subject|2|||
130637344|NCT04076579|470291624|FG000|Overall Study|Adverse Event|2|||
130637345|NCT04076579|470291625|FG001|Overall Study|Adverse Event|0|||
130637346|NCT04076579|470291624|FG000|Overall Study|discontinued due to toxicity|1|||
130637347|NCT04076579|470291625|FG001|Overall Study|discontinued due to toxicity|0|||
130637348|NCT04076579|470291624|FG000|Overall Study|Physician Decision|1|||
130637349|NCT04076579|470291625|FG001|Overall Study|Physician Decision|0|||
130637350|NCT04076579|470291624|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
130637351|NCT04076579|470291625|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
130637352|NCT04076579|470291624|FG000|Overall Study|Noncompliance|0|||
130637353|NCT04076579|470291625|FG001|Overall Study|Noncompliance|1|||
130637354|NCT04076579|470291624|FG000|Overall Study|Withdrawal by Subject|0|||
130637355|NCT04076579|470291625|FG001|Overall Study|Withdrawal by Subject|2|||
130637356|NCT03793010|470291626|FG000|Overall Study|Withdrawal by Subject|5|||
130637357|NCT03793010|470291627|FG001|Overall Study|Withdrawal by Subject|7|||
130637358|NCT03793010|470291626|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
130637359|NCT03793010|470291627|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
130637360|NCT03793010|470291626|FG000|Overall Study|Lost to Follow-up|1|||
130637361|NCT03793010|470291627|FG001|Overall Study|Lost to Follow-up|2|||
130637362|NCT03793010|470291626|FG000|Overall Study|Patient couldn't sit still for injection|1|||
130637363|NCT03793010|470291627|FG001|Overall Study|Patient couldn't sit still for injection|0|||
130637364|NCT03793010|470291626|FG000|Overall Study|Withdrew to pursue other treatment|1|||
130637365|NCT03793010|470291627|FG001|Overall Study|Withdrew to pursue other treatment|0|||
130637366|NCT03793010|470291626|FG000|Overall Study|Did not meet eligibility criteria|1|||
130637367|NCT03793010|470291627|FG001|Overall Study|Did not meet eligibility criteria|0|||
130637368|NCT02903966|470291628|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
130637369|NCT02903966|470291629|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
130637370|NCT02903966|470291628|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
130637371|NCT02903966|470291629|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
130637372|NCT02903966|470291628|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
130637373|NCT02903966|470291629|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
130637374|NCT04924114|470291630|FG000|Overall Study|Withdrawal by Subject|0|||
130637375|NCT04924114|470291631|FG001|Overall Study|Withdrawal by Subject|2|||
130637376|NCT04924114|470291632|FG002|Overall Study|Withdrawal by Subject|2|||
130637377|NCT04924114|470291633|FG003|Overall Study|Withdrawal by Subject|0|||
130637378|NCT04924114|470291634|FG004|Overall Study|Withdrawal by Subject|2|||
130637379|NCT04423718|470291635|FG000|Main Study|Adverse Event|9|||
130637380|NCT04423718|470291636|FG001|Main Study|Adverse Event|5|||
130637381|NCT04423718|470291637|FG002|Main Study|Adverse Event|8|||
130637382|NCT04423718|470291635|FG000|Main Study|Physician Decision|3|||
130637383|NCT04423718|470291636|FG001|Main Study|Physician Decision|3|||
130637384|NCT04423718|470291637|FG002|Main Study|Physician Decision|2|||
130637385|NCT04423718|470291635|FG000|Main Study|Protocol Violation|0|||
130637386|NCT04423718|470291636|FG001|Main Study|Protocol Violation|0|||
130637387|NCT04423718|470291637|FG002|Main Study|Protocol Violation|1|||
130637388|NCT04423718|470291635|FG000|Main Study|Lost to Follow-up|3|||
130637389|NCT04423718|470291636|FG001|Main Study|Lost to Follow-up|3|||
130637390|NCT04423718|470291637|FG002|Main Study|Lost to Follow-up|4|||
130637391|NCT04423718|470291635|FG000|Main Study|Lack of Efficacy|2|||
130637392|NCT04423718|470291636|FG001|Main Study|Lack of Efficacy|1|||
130637393|NCT04423718|470291637|FG002|Main Study|Lack of Efficacy|0|||
130637394|NCT04423718|470291635|FG000|Main Study|Withdrawal by Subject|14|||
130637395|NCT04423718|470291636|FG001|Main Study|Withdrawal by Subject|20|||
130637396|NCT04423718|470291637|FG002|Main Study|Withdrawal by Subject|20|||
130637397|NCT04423718|470291635|FG000|Main Study|Death|10|||
130637398|NCT04423718|470291636|FG001|Main Study|Death|7|||
130637399|NCT04423718|470291637|FG002|Main Study|Death|7|||
130637400|NCT04423718|470291635|FG000|Main Study|COVID-19 pandemic|2|||
130637401|NCT04423718|470291636|FG001|Main Study|COVID-19 pandemic|2|||
130637402|NCT04423718|470291637|FG002|Main Study|COVID-19 pandemic|2|||
130637403|NCT04423718|470291635|FG000|Main Study|Other|7|||
130637404|NCT04423718|470291636|FG001|Main Study|Other|3|||
130637405|NCT04423718|470291637|FG002|Main Study|Other|2|||
130637406|NCT04423718|470291635|FG000|Extension Phase|Other|1|||
130637407|NCT04423718|470291636|FG001|Extension Phase|Other|0|||
130637408|NCT04423718|470291637|FG002|Extension Phase|Other|0|||
130637409|NCT04423718|470291635|FG000|Extension Phase|Logistical problems|0|||
130637410|NCT04423718|470291636|FG001|Extension Phase|Logistical problems|1|||
130637411|NCT04423718|470291637|FG002|Extension Phase|Logistical problems|1|||
130637412|NCT04423718|470291635|FG000|Extension Phase|Physician Decision|1|||
130637413|NCT04423718|470291636|FG001|Extension Phase|Physician Decision|0|||
130637414|NCT04423718|470291637|FG002|Extension Phase|Physician Decision|1|||
130637415|NCT04423718|470291635|FG000|Extension Phase|Lack of Efficacy|2|||
130637416|NCT04423718|470291636|FG001|Extension Phase|Lack of Efficacy|0|||
130637417|NCT04423718|470291637|FG002|Extension Phase|Lack of Efficacy|1|||
130637418|NCT04423718|470291635|FG000|Extension Phase|Lost to Follow-up|0|||
130637419|NCT04423718|470291636|FG001|Extension Phase|Lost to Follow-up|2|||
130637420|NCT04423718|470291637|FG002|Extension Phase|Lost to Follow-up|3|||
130637421|NCT04423718|470291635|FG000|Extension Phase|Adverse Event|2|||
130637422|NCT04423718|470291636|FG001|Extension Phase|Adverse Event|3|||
130637423|NCT04423718|470291637|FG002|Extension Phase|Adverse Event|1|||
130637424|NCT04423718|470291635|FG000|Extension Phase|Death|4|||
130637425|NCT04423718|470291636|FG001|Extension Phase|Death|7|||
130637426|NCT04423718|470291637|FG002|Extension Phase|Death|2|||
130637427|NCT04423718|470291635|FG000|Extension Phase|Withdrawal by Subject|11|||
130637428|NCT04423718|470291636|FG001|Extension Phase|Withdrawal by Subject|11|||
130637429|NCT04423718|470291637|FG002|Extension Phase|Withdrawal by Subject|7|||
130637430|NCT00425945|470291638|FG000|Overall Study|Concern about Supplement|2|||
130637431|NCT00425945|470291639|FG001|Overall Study|Concern about Supplement|0|||
130637432|NCT00425945|470291638|FG000|Overall Study|Inconvenience|0|||
130637433|NCT00425945|470291639|FG001|Overall Study|Inconvenience|2|||
130637434|NCT00425945|470291638|FG000|Overall Study|Lost to Follow-up|0|||
130637435|NCT00425945|470291639|FG001|Overall Study|Lost to Follow-up|2|||
130637436|NCT00425945|470291638|FG000|Overall Study|Began hypertension medication|1|||
130637437|NCT00425945|470291639|FG001|Overall Study|Began hypertension medication|0|||
130637438|NCT00425945|470291638|FG000|Overall Study|Began cancer treatments|1|||
130637439|NCT00425945|470291639|FG001|Overall Study|Began cancer treatments|0|||
130637440|NCT00425945|470291638|FG000|Overall Study|Moved from area|0|||
130637441|NCT00425945|470291639|FG001|Overall Study|Moved from area|1|||
130637442|NCT02881151|470291640|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
130637443|NCT04284787|470291641|FG000|Overall Study|Disease Progression|9|||
130637444|NCT04284787|470291642|FG001|Overall Study|Disease Progression|12|||
130637445|NCT04284787|470291641|FG000|Overall Study|Physician Decision|12|||
130637446|NCT04284787|470291642|FG001|Overall Study|Physician Decision|7|||
130637447|NCT04284787|470291641|FG000|Overall Study|Transplant|5|||
130637448|NCT04284787|470291642|FG001|Overall Study|Transplant|4|||
130637449|NCT04284787|470291641|FG000|Overall Study|Death|1|||
130637450|NCT04284787|470291642|FG001|Overall Study|Death|2|||
130637451|NCT04284787|470291641|FG000|Overall Study|Adverse Event|0|||
130637452|NCT04284787|470291642|FG001|Overall Study|Adverse Event|4|||
130637453|NCT04284787|470291641|FG000|Overall Study|Non-adherence|2|||
130637454|NCT04284787|470291642|FG001|Overall Study|Non-adherence|0|||
130637455|NCT04284787|470291641|FG000|Overall Study|Lack of Efficacy|2|||
130637456|NCT04284787|470291642|FG001|Overall Study|Lack of Efficacy|0|||
130637457|NCT04992507|470291645|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
130637458|NCT04992507|470291646|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
130637459|NCT04992507|470291645|FG000|Overall Study|Death|0|||
130637460|NCT04992507|470291646|FG001|Overall Study|Death|1|||
130637461|NCT02974621|470291647|FG000|Overall Study|Didn't receive study treatment|1|||
130637462|NCT02974621|470291648|FG001|Overall Study|Didn't receive study treatment|10|||
130637463|NCT00557323|470291649|FG000|Overall Study|Death|3|||
130637464|NCT00557323|470291649|FG000|Overall Study|Withdrawal by Subject|2|||
130637465|NCT00557323|470291649|FG000|Overall Study|Administrative change|2|||
130637466|NCT01196091|470291652|FG000|Overall Study|Adverse Event|22|||
130637467|NCT01196091|470291653|FG001|Overall Study|Adverse Event|27|||
130637468|NCT01196091|470291654|FG002|Overall Study|Adverse Event|26|||
130637469|NCT01196091|470291652|FG000|Overall Study|Death|3|||
130637470|NCT01196091|470291653|FG001|Overall Study|Death|2|||
130637471|NCT01196091|470291654|FG002|Overall Study|Death|2|||
130637472|NCT01196091|470291652|FG000|Overall Study|Entry Criteria Not Met|11|||
130637473|NCT01196091|470291653|FG001|Overall Study|Entry Criteria Not Met|11|||
130637474|NCT01196091|470291654|FG002|Overall Study|Entry Criteria Not Met|10|||
130637475|NCT01196091|470291652|FG000|Overall Study|Lack of Efficacy|15|||
130637476|NCT01196091|470291653|FG001|Overall Study|Lack of Efficacy|12|||
130637477|NCT01196091|470291654|FG002|Overall Study|Lack of Efficacy|17|||
130637478|NCT01196091|470291652|FG000|Overall Study|Lost to Follow-up|5|||
130637479|NCT01196091|470291653|FG001|Overall Study|Lost to Follow-up|5|||
130637480|NCT01196091|470291654|FG002|Overall Study|Lost to Follow-up|6|||
130637481|NCT01196091|470291652|FG000|Overall Study|Parent/Caregiver Decision|0|||
130637482|NCT01196091|470291653|FG001|Overall Study|Parent/Caregiver Decision|0|||
130637483|NCT01196091|470291654|FG002|Overall Study|Parent/Caregiver Decision|1|||
130637484|NCT01196091|470291652|FG000|Overall Study|Withdrawal by Subject|16|||
130637485|NCT01196091|470291653|FG001|Overall Study|Withdrawal by Subject|19|||
130637486|NCT01196091|470291654|FG002|Overall Study|Withdrawal by Subject|22|||
130637487|NCT01196091|470291652|FG000|Overall Study|Physician Decision|3|||
130637488|NCT01196091|470291653|FG001|Overall Study|Physician Decision|3|||
130637489|NCT01196091|470291654|FG002|Overall Study|Physician Decision|4|||
130637490|NCT01196091|470291652|FG000|Overall Study|Protocol Violation|1|||
130637491|NCT01196091|470291653|FG001|Overall Study|Protocol Violation|3|||
130637492|NCT01196091|470291654|FG002|Overall Study|Protocol Violation|3|||
130637493|NCT01196091|470291652|FG000|Overall Study|Sponsor Decision|6|||
130637494|NCT01196091|470291653|FG001|Overall Study|Sponsor Decision|5|||
130637495|NCT01196091|470291654|FG002|Overall Study|Sponsor Decision|4|||
130637496|NCT01196091|470291652|FG000|Overall Study|Excluded Site|5|||
130637497|NCT01196091|470291653|FG001|Overall Study|Excluded Site|11|||
130637498|NCT01196091|470291654|FG002|Overall Study|Excluded Site|8|||
130637499|NCT01196091|470291652|FG000|Overall Study|Randomized, No Study Drug Received|1|||
130637500|NCT01196091|470291653|FG001|Overall Study|Randomized, No Study Drug Received|0|||
130637501|NCT01196091|470291654|FG002|Overall Study|Randomized, No Study Drug Received|1|||
130637502|NCT03733249|470291655|FG000|Overall Study|Death|7|||
130637503|NCT03733249|470291655|FG000|Overall Study|Disease relapse|16|||
130637504|NCT03733249|470291655|FG000|Overall Study|Lost to Follow-up|4|||
130637505|NCT03733249|470291655|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
130637506|NCT03733249|470291655|FG000|Overall Study|Withdrawal by Subject|1|||
130637507|NCT00606229|470291656|FG000|Overall Study|Adverse Event|11|||
130637508|NCT00606229|470291656|FG000|Overall Study|Lack of Efficacy|1|||
130637509|NCT00606229|470291656|FG000|Overall Study|Withdrawal by Subject|4|||
130637510|NCT00606229|470291656|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
130637511|NCT00606229|470291656|FG000|Overall Study|change of residence or other commitments|2|||
130637512|NCT01526928|470291657|FG000|Overall Study|Progressive Disease|35|||
130637513|NCT01526928|470291658|FG001|Overall Study|Progressive Disease|17|||
130637514|NCT01526928|470291659|FG002|Overall Study|Progressive Disease|150|||
130637515|NCT01526928|470291660|FG003|Overall Study|Progressive Disease|182|||
130637516|NCT01526928|470291661|FG004|Overall Study|Progressive Disease|76|||
130637517|NCT01526928|470291662|FG005|Overall Study|Progressive Disease|4|||
130637518|NCT01526928|470291657|FG000|Overall Study|Adverse Event|2|||
130637519|NCT01526928|470291658|FG001|Overall Study|Adverse Event|1|||
130637520|NCT01526928|470291659|FG002|Overall Study|Adverse Event|29|||
130637521|NCT01526928|470291660|FG003|Overall Study|Adverse Event|40|||
130637522|NCT01526928|470291661|FG004|Overall Study|Adverse Event|13|||
130637523|NCT01526928|470291662|FG005|Overall Study|Adverse Event|2|||
130637524|NCT01526928|470291657|FG000|Overall Study|Death|0|||
130637525|NCT01526928|470291658|FG001|Overall Study|Death|0|||
130637526|NCT01526928|470291659|FG002|Overall Study|Death|3|||
130637527|NCT01526928|470291660|FG003|Overall Study|Death|0|||
130637528|NCT01526928|470291661|FG004|Overall Study|Death|0|||
130637529|NCT01526928|470291662|FG005|Overall Study|Death|0|||
130637530|NCT01526928|470291657|FG000|Overall Study|Withdrawal by Subject|1|||
130637531|NCT01526928|470291658|FG001|Overall Study|Withdrawal by Subject|0|||
130637532|NCT01526928|470291659|FG002|Overall Study|Withdrawal by Subject|13|||
130637533|NCT01526928|470291660|FG003|Overall Study|Withdrawal by Subject|11|||
130637534|NCT01526928|470291661|FG004|Overall Study|Withdrawal by Subject|3|||
130637535|NCT01526928|470291662|FG005|Overall Study|Withdrawal by Subject|0|||
130637536|NCT01526928|470291657|FG000|Overall Study|Physician Decision|0|||
130637537|NCT01526928|470291658|FG001|Overall Study|Physician Decision|0|||
130637538|NCT01526928|470291659|FG002|Overall Study|Physician Decision|2|||
130637539|NCT01526928|470291660|FG003|Overall Study|Physician Decision|5|||
130637540|NCT01526928|470291661|FG004|Overall Study|Physician Decision|0|||
130637541|NCT01526928|470291662|FG005|Overall Study|Physician Decision|0|||
130637542|NCT01526928|470291657|FG000|Overall Study|Other Reason|0|||
130637543|NCT01526928|470291658|FG001|Overall Study|Other Reason|1|||
130637544|NCT01526928|470291659|FG002|Overall Study|Other Reason|11|||
130637545|NCT01526928|470291660|FG003|Overall Study|Other Reason|4|||
130637546|NCT01526928|470291661|FG004|Overall Study|Other Reason|1|||
130637547|NCT01526928|470291662|FG005|Overall Study|Other Reason|0|||
130637548|NCT01526928|470291657|FG000|Overall Study|Lost to Follow-up|0|||
130637549|NCT01526928|470291658|FG001|Overall Study|Lost to Follow-up|0|||
130637550|NCT01526928|470291659|FG002|Overall Study|Lost to Follow-up|0|||
130637551|NCT01526928|470291660|FG003|Overall Study|Lost to Follow-up|1|||
130637552|NCT01526928|470291661|FG004|Overall Study|Lost to Follow-up|0|||
130637553|NCT01526928|470291662|FG005|Overall Study|Lost to Follow-up|0|||
130637554|NCT01526928|470291657|FG000|Overall Study|Protocol Deviation|0|||
130637555|NCT01526928|470291658|FG001|Overall Study|Protocol Deviation|0|||
130637556|NCT01526928|470291659|FG002|Overall Study|Protocol Deviation|0|||
130637557|NCT01526928|470291660|FG003|Overall Study|Protocol Deviation|2|||
130637558|NCT01526928|470291661|FG004|Overall Study|Protocol Deviation|0|||
130637559|NCT01526928|470291662|FG005|Overall Study|Protocol Deviation|0|||
130637560|NCT01526928|470291657|FG000|Overall Study|Missing|0|||
130637561|NCT01526928|470291658|FG001|Overall Study|Missing|0|||
130637562|NCT01526928|470291659|FG002|Overall Study|Missing|1|||
130637563|NCT01526928|470291660|FG003|Overall Study|Missing|0|||
130637564|NCT01526928|470291661|FG004|Overall Study|Missing|2|||
130637565|NCT01526928|470291662|FG005|Overall Study|Missing|0|||
130637566|NCT01108068|470291663|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
130637567|NCT01108068|470291664|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
130637568|NCT00836953|470291665|FG000|Overall Study|Withdrawal by Subject|1|||
130637569|NCT00836953|470291665|FG000|Overall Study|Lost to Follow-up|1|||
130637570|NCT00376675|470291666|FG000|Overall Study|Withdrawal by Subject|9|||
130637571|NCT00376675|470291667|FG001|Overall Study|Withdrawal by Subject|2|||
130637572|NCT00376675|470291666|FG000|Overall Study|Adverse Event|10|||
130637573|NCT00376675|470291667|FG001|Overall Study|Adverse Event|5|||
130637574|NCT00376675|470291666|FG000|Overall Study|Other Reason|1|||
130637575|NCT00376675|470291667|FG001|Overall Study|Other Reason|7|||
130637576|NCT02829775|470291668|FG000|Overall Study|Death|1|||
130637577|NCT02829775|470291668|FG000|Overall Study|Withdrawal by Subject|3|||
130637578|NCT02829775|470291668|FG000|Overall Study|Disease remission|1|||
130637579|NCT01249157|470291669|FG000|Overall Study|Withdrawal by Subject|1|||
130637580|NCT00062647|470291670|FG000|Overall Study|Death|2|||
130637581|NCT00062647|470291671|FG001|Overall Study|Death|2|||
130637582|NCT00062647|470291670|FG000|Overall Study|Adverse Event|1|||
130637583|NCT00062647|470291671|FG001|Overall Study|Adverse Event|1|||
130637584|NCT00062647|470291670|FG000|Overall Study|Withdrawal by Subject|2|||
130637585|NCT00062647|470291671|FG001|Overall Study|Withdrawal by Subject|1|||
130637586|NCT00062647|470291670|FG000|Overall Study|Protocol Violation|1|||
130637587|NCT00062647|470291671|FG001|Overall Study|Protocol Violation|0|||
130637588|NCT00062647|470291670|FG000|Overall Study|Lost to Follow-up|1|||
130637589|NCT00062647|470291671|FG001|Overall Study|Lost to Follow-up|2|||
130637590|NCT00062647|470291670|FG000|Overall Study|Failed continuation criteria|4|||
130637591|NCT00062647|470291671|FG001|Overall Study|Failed continuation criteria|2|||
130637592|NCT00062647|470291670|FG000|Overall Study|Other|4|||
130637593|NCT00062647|470291671|FG001|Overall Study|Other|4|||
130637594|NCT00062647|470291670|FG000|Overall Study|Never received study treatment|1|||
130637595|NCT00062647|470291671|FG001|Overall Study|Never received study treatment|1|||
130637596|NCT02392468|470291677|FG000|Overall Study|Adverse Event|0|||
130637597|NCT02392468|470291678|FG001|Overall Study|Adverse Event|1|||
130637598|NCT02392468|470291679|FG002|Overall Study|Adverse Event|0|||
130637599|NCT02392468|470291680|FG003|Overall Study|Adverse Event|0|||
130637600|NCT02392468|470291681|FG004|Overall Study|Adverse Event|0|||
130637601|NCT02392468|470291682|FG005|Overall Study|Adverse Event|1|||
130637602|NCT01313039|470291683|FG000|Overall Study|Physician Decision|1|||
130637603|NCT01313039|470291683|FG000|Overall Study|Adverse Event|1|||
130637604|NCT05083949|470291684|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
130637605|NCT05083949|470291685|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
130637606|NCT05083949|470291684|FG000|Period 1|Adverse Event|1|||
130637607|NCT05083949|470291685|FG001|Period 1|Adverse Event|1|||
130637608|NCT05083949|470291684|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
130637609|NCT05083949|470291685|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
130637610|NCT05083949|470291684|FG000|Period 2|Adverse Event|0|||
130637611|NCT05083949|470291685|FG001|Period 2|Adverse Event|2|||
130637612|NCT02996500|470291686|FG000|Overall Study|Adverse Event|1|||
130637613|NCT02996500|470291687|FG001|Overall Study|Adverse Event|1|||
130637614|NCT02996500|470291688|FG002|Overall Study|Adverse Event|4|||
130637615|NCT02996500|470291689|FG003|Overall Study|Adverse Event|3|||
130637616|NCT02996500|470291690|FG004|Overall Study|Adverse Event|1|||
130637617|NCT02996500|470291691|FG005|Overall Study|Adverse Event|2|||
130637618|NCT02996500|470291686|FG000|Overall Study|Lack of Efficacy|0|||
130637619|NCT02996500|470291687|FG001|Overall Study|Lack of Efficacy|0|||
130637620|NCT02996500|470291688|FG002|Overall Study|Lack of Efficacy|0|||
130637621|NCT02996500|470291689|FG003|Overall Study|Lack of Efficacy|0|||
130637622|NCT02996500|470291690|FG004|Overall Study|Lack of Efficacy|2|||
130637623|NCT02996500|470291691|FG005|Overall Study|Lack of Efficacy|0|||
130637624|NCT02996500|470291686|FG000|Overall Study|Lost to Follow-up|1|||
130637625|NCT02996500|470291687|FG001|Overall Study|Lost to Follow-up|0|||
130637626|NCT02996500|470291688|FG002|Overall Study|Lost to Follow-up|0|||
130637627|NCT02996500|470291689|FG003|Overall Study|Lost to Follow-up|0|||
130637628|NCT02996500|470291690|FG004|Overall Study|Lost to Follow-up|0|||
130637629|NCT02996500|470291691|FG005|Overall Study|Lost to Follow-up|1|||
130637630|NCT02996500|470291686|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130637631|NCT02996500|470291687|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130637632|NCT02996500|470291688|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130637633|NCT02996500|470291689|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130637634|NCT02996500|470291690|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130637635|NCT02996500|470291691|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130637636|NCT02996500|470291686|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130637637|NCT02996500|470291687|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130637638|NCT02996500|470291688|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130637639|NCT02996500|470291689|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130637640|NCT02996500|470291690|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130637641|NCT02996500|470291691|FG005|Overall Study|Non-Compliance With Study Drug|1|||
130637642|NCT02996500|470291686|FG000|Overall Study|Progressive Disease|1|||
130637643|NCT02996500|470291687|FG001|Overall Study|Progressive Disease|0|||
130637644|NCT02996500|470291688|FG002|Overall Study|Progressive Disease|0|||
130637645|NCT02996500|470291689|FG003|Overall Study|Progressive Disease|0|||
130637646|NCT02996500|470291690|FG004|Overall Study|Progressive Disease|0|||
130637647|NCT02996500|470291691|FG005|Overall Study|Progressive Disease|0|||
130637648|NCT02996500|470291686|FG000|Overall Study|Other|2|||
130637649|NCT02996500|470291687|FG001|Overall Study|Other|0|||
130637650|NCT02996500|470291688|FG002|Overall Study|Other|2|||
130637651|NCT02996500|470291689|FG003|Overall Study|Other|0|||
130637652|NCT02996500|470291690|FG004|Overall Study|Other|0|||
130637653|NCT02996500|470291691|FG005|Overall Study|Other|0|||
130637654|NCT02996500|470291686|FG000|Overall Study|Protocol Violation|0|||
130637655|NCT02996500|470291687|FG001|Overall Study|Protocol Violation|0|||
130637656|NCT02996500|470291688|FG002|Overall Study|Protocol Violation|0|||
130637657|NCT02996500|470291689|FG003|Overall Study|Protocol Violation|1|||
130637658|NCT02996500|470291690|FG004|Overall Study|Protocol Violation|0|||
130637659|NCT02996500|470291691|FG005|Overall Study|Protocol Violation|0|||
130637660|NCT02996500|470291686|FG000|Overall Study|Withdrawal by Subject|3|||
130637661|NCT02996500|470291687|FG001|Overall Study|Withdrawal by Subject|0|||
130637662|NCT02996500|470291688|FG002|Overall Study|Withdrawal by Subject|3|||
130637663|NCT02996500|470291689|FG003|Overall Study|Withdrawal by Subject|0|||
130637664|NCT02996500|470291690|FG004|Overall Study|Withdrawal by Subject|2|||
130637665|NCT02996500|470291691|FG005|Overall Study|Withdrawal by Subject|0|||
130637666|NCT00707486|470291699|FG000|Overall Study|Withdrawal by Subject|1|||
130637667|NCT02774291|470291707|FG000|Overall Study|Lost to Follow-up|1|||
130637668|NCT02332876|470291708|FG000|Overall Study|Lost to Follow-up|1|||
130637669|NCT02332876|470291709|FG001|Overall Study|Lost to Follow-up|1|||
130637670|NCT02415595|470291710|FG000|Overall Study|Administrative reason by sponsor|39|||
130637671|NCT02415595|470291711|FG001|Overall Study|Administrative reason by sponsor|40|||
130637672|NCT02415595|470291712|FG002|Overall Study|Administrative reason by sponsor|41|||
130637673|NCT02415595|470291713|FG003|Overall Study|Administrative reason by sponsor|39|||
130637674|NCT02415595|470291710|FG000|Overall Study|Adverse Event|1|||
130637675|NCT02415595|470291711|FG001|Overall Study|Adverse Event|3|||
130637676|NCT02415595|470291712|FG002|Overall Study|Adverse Event|5|||
130637677|NCT02415595|470291713|FG003|Overall Study|Adverse Event|10|||
130637678|NCT02415595|470291710|FG000|Overall Study|Lack of Efficacy|4|||
130637679|NCT02415595|470291711|FG001|Overall Study|Lack of Efficacy|4|||
130637680|NCT02415595|470291712|FG002|Overall Study|Lack of Efficacy|0|||
130637681|NCT02415595|470291713|FG003|Overall Study|Lack of Efficacy|0|||
130637682|NCT02415595|470291710|FG000|Overall Study|Lost to Follow-up|1|||
130637683|NCT02415595|470291711|FG001|Overall Study|Lost to Follow-up|3|||
130637684|NCT02415595|470291712|FG002|Overall Study|Lost to Follow-up|1|||
130637685|NCT02415595|470291713|FG003|Overall Study|Lost to Follow-up|1|||
130637686|NCT02415595|470291710|FG000|Overall Study|Poor/Non-compliance|1|||
130637687|NCT02415595|470291711|FG001|Overall Study|Poor/Non-compliance|0|||
130637688|NCT02415595|470291712|FG002|Overall Study|Poor/Non-compliance|1|||
130637689|NCT02415595|470291713|FG003|Overall Study|Poor/Non-compliance|0|||
130637690|NCT02415595|470291710|FG000|Overall Study|Reached stopping criteria|0|||
130637691|NCT02415595|470291711|FG001|Overall Study|Reached stopping criteria|1|||
130637692|NCT02415595|470291712|FG002|Overall Study|Reached stopping criteria|1|||
130637693|NCT02415595|470291713|FG003|Overall Study|Reached stopping criteria|0|||
130637694|NCT02415595|470291710|FG000|Overall Study|Withdrawal by Subject|4|||
130637695|NCT02415595|470291711|FG001|Overall Study|Withdrawal by Subject|0|||
130637696|NCT02415595|470291712|FG002|Overall Study|Withdrawal by Subject|1|||
130637697|NCT02415595|470291713|FG003|Overall Study|Withdrawal by Subject|3|||
130637698|NCT02415595|470291710|FG000|Overall Study|Other|0|||
130637699|NCT02415595|470291711|FG001|Overall Study|Other|1|||
130637700|NCT02415595|470291712|FG002|Overall Study|Other|1|||
130637701|NCT02415595|470291713|FG003|Overall Study|Other|0|||
130637702|NCT00471315|470291714|FG000|Overall Study|Adverse Event|7|||
130637703|NCT00471315|470291714|FG000|Overall Study|Withdrawal by Subject|1|||
130637704|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
130637705|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130637706|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
130637707|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130637708|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
130637709|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130637710|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130637711|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130637712|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
130637713|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130637714|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130637715|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130637716|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
130637717|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
130637718|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
130637719|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
130637720|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
130637721|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
130637722|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130637723|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
130637724|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
130637725|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130637726|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130637727|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130637728|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Screen failure|0|||
130637729|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Screen failure|1|||
130637730|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Screen failure|2|||
130637731|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Screen failure|0|||
130637732|NCT02614261|470291715|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
130637733|NCT02614261|470291716|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130637734|NCT02614261|470291717|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
130637735|NCT02614261|470291718|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130637736|NCT02614261|470291715|FG000|Open-Label Extension Phase|Adverse Event|23|||
130637737|NCT02614261|470291716|FG001|Open-Label Extension Phase|Adverse Event|12|||
130637738|NCT02614261|470291717|FG002|Open-Label Extension Phase|Adverse Event|11|||
130637739|NCT02614261|470291718|FG003|Open-Label Extension Phase|Adverse Event|0|||
130637740|NCT02614261|470291715|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
130637741|NCT02614261|470291716|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
130637742|NCT02614261|470291717|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
130637743|NCT02614261|470291718|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
130637744|NCT02614261|470291715|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
130637745|NCT02614261|470291716|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
130637746|NCT02614261|470291717|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
130637747|NCT02614261|470291718|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
130637748|NCT02614261|470291715|FG000|Open-Label Extension Phase|Physician Decision|2|||
130637749|NCT02614261|470291716|FG001|Open-Label Extension Phase|Physician Decision|0|||
130637750|NCT02614261|470291717|FG002|Open-Label Extension Phase|Physician Decision|0|||
130637751|NCT02614261|470291718|FG003|Open-Label Extension Phase|Physician Decision|0|||
130637752|NCT02614261|470291715|FG000|Open-Label Extension Phase|Pregnancy|1|||
130637753|NCT02614261|470291716|FG001|Open-Label Extension Phase|Pregnancy|2|||
130637754|NCT02614261|470291717|FG002|Open-Label Extension Phase|Pregnancy|1|||
130637755|NCT02614261|470291718|FG003|Open-Label Extension Phase|Pregnancy|0|||
130637756|NCT02614261|470291715|FG000|Open-Label Extension Phase|Protocol Violation|3|||
130637757|NCT02614261|470291716|FG001|Open-Label Extension Phase|Protocol Violation|4|||
130637758|NCT02614261|470291717|FG002|Open-Label Extension Phase|Protocol Violation|1|||
130637759|NCT02614261|470291718|FG003|Open-Label Extension Phase|Protocol Violation|0|||
130637760|NCT02614261|470291715|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
130637761|NCT02614261|470291716|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
130637762|NCT02614261|470291717|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
130637763|NCT02614261|470291718|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
130637764|NCT02614261|470291715|FG000|Follow-up Phase|Adverse Event|2|||
130637765|NCT02614261|470291716|FG001|Follow-up Phase|Adverse Event|0|||
130637766|NCT02614261|470291717|FG002|Follow-up Phase|Adverse Event|1|||
130637767|NCT02614261|470291718|FG003|Follow-up Phase|Adverse Event|0|||
130637768|NCT02614261|470291715|FG000|Follow-up Phase|Lost to Follow-up|12|||
130637769|NCT02614261|470291716|FG001|Follow-up Phase|Lost to Follow-up|5|||
130637770|NCT02614261|470291717|FG002|Follow-up Phase|Lost to Follow-up|2|||
130637771|NCT02614261|470291718|FG003|Follow-up Phase|Lost to Follow-up|0|||
130637772|NCT02614261|470291715|FG000|Follow-up Phase|Physician Decision|5|||
130637773|NCT02614261|470291716|FG001|Follow-up Phase|Physician Decision|1|||
130637774|NCT02614261|470291717|FG002|Follow-up Phase|Physician Decision|0|||
130637775|NCT02614261|470291718|FG003|Follow-up Phase|Physician Decision|0|||
130637776|NCT02614261|470291715|FG000|Follow-up Phase|Pregnancy|0|||
130637777|NCT02614261|470291716|FG001|Follow-up Phase|Pregnancy|1|||
130637778|NCT02614261|470291717|FG002|Follow-up Phase|Pregnancy|0|||
130637779|NCT02614261|470291718|FG003|Follow-up Phase|Pregnancy|0|||
130637780|NCT02614261|470291715|FG000|Follow-up Phase|Protocol Violation|1|||
130637781|NCT02614261|470291716|FG001|Follow-up Phase|Protocol Violation|0|||
130637782|NCT02614261|470291717|FG002|Follow-up Phase|Protocol Violation|0|||
130637783|NCT02614261|470291718|FG003|Follow-up Phase|Protocol Violation|0|||
130637784|NCT02614261|470291715|FG000|Follow-up Phase|Withdrawal by Subject|12|||
130637785|NCT02614261|470291716|FG001|Follow-up Phase|Withdrawal by Subject|4|||
130637786|NCT02614261|470291717|FG002|Follow-up Phase|Withdrawal by Subject|11|||
130637787|NCT02614261|470291718|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130637788|NCT02614261|470291715|FG000|Israel Addendum|Withdrawal by Subject|0|||
130637789|NCT02614261|470291716|FG001|Israel Addendum|Withdrawal by Subject|0|||
130637790|NCT02614261|470291717|FG002|Israel Addendum|Withdrawal by Subject|0|||
130637791|NCT02614261|470291718|FG003|Israel Addendum|Withdrawal by Subject|4|||
130637792|NCT03512275|470291723|FG000|Overall Study|Withdrawal by Subject|1|||
130637793|NCT03512275|470291724|FG001|Overall Study|Withdrawal by Subject|3|||
130637794|NCT03512275|470291723|FG000|Overall Study|Physician Decision|0|||
130637795|NCT03512275|470291724|FG001|Overall Study|Physician Decision|1|||
130637796|NCT03512275|470291723|FG000|Overall Study|Lost to Follow-up|0|||
130637797|NCT03512275|470291724|FG001|Overall Study|Lost to Follow-up|3|||
130637798|NCT03512275|470291723|FG000|Overall Study|Other|1|||
130637799|NCT03512275|470291724|FG001|Overall Study|Other|0|||
130637800|NCT00609167|470291725|FG000|Overall Study|Withdrawal by Subject|1|||
130637801|NCT00609167|470291726|FG001|Overall Study|Withdrawal by Subject|0|||
130637802|NCT00609167|470291725|FG000|Overall Study|Lack of Efficacy|1|||
130637803|NCT00609167|470291726|FG001|Overall Study|Lack of Efficacy|0|||
130637804|NCT00609167|470291725|FG000|Overall Study|Adverse Event|5|||
130637805|NCT00609167|470291726|FG001|Overall Study|Adverse Event|1|||
130637806|NCT00609167|470291725|FG000|Overall Study|Disease Progression|1|||
130637807|NCT00609167|470291726|FG001|Overall Study|Disease Progression|0|||
130637808|NCT00609167|470291725|FG000|Overall Study|Stem Cell Transplant|0|||
130637809|NCT00609167|470291726|FG001|Overall Study|Stem Cell Transplant|6|||
130637810|NCT03898323|470291727|FG000|Overall Study|Physician Decision|1|||
130637811|NCT00712270|470291729|FG000|Overall Study|Withdrawal by Subject|11|||
130637812|NCT00712270|470291729|FG000|Overall Study|Screen Failure|3|||
130637813|NCT02574520|470291730|FG000|Overall Study|Not dosed|2|||
130637814|NCT02574520|470291731|FG001|Overall Study|Not dosed|0|||
130637815|NCT02574520|470291732|FG002|Overall Study|Not dosed|5|||
130637816|NCT02574520|470291733|FG003|Overall Study|Not dosed|4|||
130637817|NCT02574520|470291730|FG000|Overall Study|Adverse Event|0|||
130637818|NCT02574520|470291731|FG001|Overall Study|Adverse Event|0|||
130637819|NCT02574520|470291732|FG002|Overall Study|Adverse Event|0|||
130637820|NCT02574520|470291733|FG003|Overall Study|Adverse Event|1|||
130637821|NCT02574520|470291730|FG000|Overall Study|Withdrawal by Subject|0|||
130637822|NCT02574520|470291731|FG001|Overall Study|Withdrawal by Subject|0|||
130637823|NCT02574520|470291732|FG002|Overall Study|Withdrawal by Subject|0|||
130637824|NCT02574520|470291733|FG003|Overall Study|Withdrawal by Subject|1|||
130637825|NCT02574520|470291730|FG000|Overall Study|Other|0|||
130637826|NCT02574520|470291731|FG001|Overall Study|Other|0|||
130637827|NCT02574520|470291732|FG002|Overall Study|Other|0|||
130637828|NCT02574520|470291733|FG003|Overall Study|Other|2|||
130637829|NCT00112840|470291741|FG000|Overall Study|Physician Decision|1|||
130637830|NCT00112840|470291742|FG001|Overall Study|Physician Decision|0|||
130637831|NCT00112840|470291743|FG002|Overall Study|Physician Decision|0|||
130637832|NCT00112840|470291741|FG000|Overall Study|Withdrawal by Subject|1|||
130637833|NCT00112840|470291742|FG001|Overall Study|Withdrawal by Subject|0|||
130637834|NCT00112840|470291743|FG002|Overall Study|Withdrawal by Subject|1|||
130637835|NCT00112840|470291741|FG000|Overall Study|Protocol Violation|0|||
130637836|NCT00112840|470291742|FG001|Overall Study|Protocol Violation|0|||
130637837|NCT00112840|470291743|FG002|Overall Study|Protocol Violation|5|||
130637838|NCT00691054|470291744|FG000|Overall Study|Withdrawal by Subject|1|||
130637839|NCT03595176|470291745|FG000|Overall Study|Death|0|||
130637840|NCT03595176|470291746|FG001|Overall Study|Death|2|||
130637841|NCT03595176|470291745|FG000|Overall Study|Lost to Follow-up|0|||
130637842|NCT03595176|470291746|FG001|Overall Study|Lost to Follow-up|1|||
130637843|NCT01868594|470291747|FG000|Overall Study|Do not meet inclusion criteria|4|||
130637844|NCT01868594|470291748|FG001|Overall Study|Do not meet inclusion criteria|3|||
130637845|NCT04964557|470291751|FG000|Overall Study|Withdrawal by Subject|3|||
130637846|NCT04964557|470291752|FG001|Overall Study|Withdrawal by Subject|2|||
130637847|NCT04964557|470291751|FG000|Overall Study|Lost to Follow-up|1|||
130637848|NCT04964557|470291752|FG001|Overall Study|Lost to Follow-up|2|||
130637849|NCT04964557|470291751|FG000|Overall Study|Physician Decision|2|||
130637850|NCT04964557|470291752|FG001|Overall Study|Physician Decision|0|||
130637851|NCT04964557|470291751|FG000|Overall Study|Death|3|||
130637852|NCT04964557|470291752|FG001|Overall Study|Death|0|||
130637853|NCT04964557|470291751|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
130637854|NCT04964557|470291752|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
130637855|NCT02659098|470291753|FG000|Overall Study|Withdrawal by Subject|7|||
130637856|NCT04363944|470291754|FG000|Overall Study|Withdrawal by Subject|2|||
130637857|NCT04363944|470291755|FG001|Overall Study|Withdrawal by Subject|0|||
130637858|NCT03258593|470293640|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
130637859|NCT03258593|470293641|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
130637860|NCT03258593|470293642|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
130637861|NCT03258593|470293643|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
130637862|NCT03258593|470293640|FG000|Run-In Maintenance Phase|Disease progression|3|||
130637863|NCT03258593|470293641|FG001|Run-In Maintenance Phase|Disease progression|0|||
130637864|NCT03258593|470293642|FG002|Run-In Maintenance Phase|Disease progression|0|||
130637865|NCT03258593|470293643|FG003|Run-In Maintenance Phase|Disease progression|0|||
130637866|NCT03258593|470293640|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130637867|NCT03258593|470293641|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
130637868|NCT03258593|470293642|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130637869|NCT03258593|470293643|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130637870|NCT03258593|470293640|FG000|Expansion Maintenance Phase|Physician Decision|0|||
130637871|NCT03258593|470293641|FG001|Expansion Maintenance Phase|Physician Decision|1|||
130637872|NCT03258593|470293642|FG002|Expansion Maintenance Phase|Physician Decision|0|||
130637873|NCT03258593|470293643|FG003|Expansion Maintenance Phase|Physician Decision|0|||
130637874|NCT05318183|470293647|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130637875|NCT05318183|470293648|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
130637876|NCT05318183|470293647|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
130637877|NCT05318183|470293648|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130637878|NCT03657576|470293649|FG000|Overall Study|Death|0|||
130637879|NCT03657576|470293650|FG001|Overall Study|Death|1|||
130637880|NCT03657576|470293651|FG002|Overall Study|Death|1|||
130637881|NCT03657576|470293652|FG003|Overall Study|Death|0|||
130637882|NCT03657576|470293653|FG004|Overall Study|Death|0|||
130637883|NCT03657576|470293654|FG005|Overall Study|Death|0|||
130637884|NCT03657576|470293649|FG000|Overall Study|Withdrawal by Subject|0|||
130637885|NCT03657576|470293650|FG001|Overall Study|Withdrawal by Subject|0|||
130637886|NCT03657576|470293651|FG002|Overall Study|Withdrawal by Subject|0|||
130637887|NCT03657576|470293652|FG003|Overall Study|Withdrawal by Subject|1|||
130637888|NCT03657576|470293653|FG004|Overall Study|Withdrawal by Subject|0|||
130637889|NCT03657576|470293654|FG005|Overall Study|Withdrawal by Subject|0|||
130637890|NCT03657576|470293649|FG000|Overall Study|Screen Fail|0|||
130637891|NCT03657576|470293650|FG001|Overall Study|Screen Fail|0|||
130637892|NCT03657576|470293651|FG002|Overall Study|Screen Fail|0|||
130637893|NCT03657576|470293652|FG003|Overall Study|Screen Fail|0|||
130637894|NCT03657576|470293653|FG004|Overall Study|Screen Fail|0|||
130637895|NCT03657576|470293654|FG005|Overall Study|Screen Fail|5|||
130637896|NCT03657576|470293649|FG000|Overall Study|Disease Progression|1|||
130637897|NCT03657576|470293650|FG001|Overall Study|Disease Progression|1|||
130637898|NCT03657576|470293651|FG002|Overall Study|Disease Progression|0|||
130637899|NCT03657576|470293652|FG003|Overall Study|Disease Progression|5|||
130637900|NCT03657576|470293653|FG004|Overall Study|Disease Progression|0|||
130637901|NCT03657576|470293654|FG005|Overall Study|Disease Progression|0|||
130637902|NCT03657576|470293649|FG000|Overall Study|Insurance Coverage|0|||
130637903|NCT03657576|470293650|FG001|Overall Study|Insurance Coverage|0|||
130637904|NCT03657576|470293651|FG002|Overall Study|Insurance Coverage|0|||
130637905|NCT03657576|470293652|FG003|Overall Study|Insurance Coverage|1|||
130637906|NCT03657576|470293653|FG004|Overall Study|Insurance Coverage|0|||
130637907|NCT03657576|470293654|FG005|Overall Study|Insurance Coverage|0|||
130637908|NCT03381274|470293657|FG000|Overall Study|Death|2|||
130637909|NCT03381274|470293658|FG001|Overall Study|Death|9|||
130637910|NCT03381274|470293659|FG002|Overall Study|Death|3|||
130637911|NCT03381274|470293660|FG003|Overall Study|Death|2|||
130637912|NCT03381274|470293661|FG004|Overall Study|Death|3|||
130637913|NCT03381274|470293657|FG000|Overall Study|Lost to Follow-up|0|||
130637914|NCT03381274|470293658|FG001|Overall Study|Lost to Follow-up|0|||
130637915|NCT03381274|470293659|FG002|Overall Study|Lost to Follow-up|0|||
130637916|NCT03381274|470293660|FG003|Overall Study|Lost to Follow-up|1|||
130637917|NCT03381274|470293661|FG004|Overall Study|Lost to Follow-up|0|||
130637918|NCT03381274|470293657|FG000|Overall Study|Withdrawal by Subject|2|||
130637919|NCT03381274|470293658|FG001|Overall Study|Withdrawal by Subject|1|||
130637920|NCT03381274|470293659|FG002|Overall Study|Withdrawal by Subject|3|||
130637921|NCT03381274|470293660|FG003|Overall Study|Withdrawal by Subject|1|||
130637922|NCT03381274|470293661|FG004|Overall Study|Withdrawal by Subject|0|||
130637923|NCT03381274|470293657|FG000|Overall Study|Other|1|||
130637924|NCT03381274|470293658|FG001|Overall Study|Other|11|||
130637925|NCT03381274|470293659|FG002|Overall Study|Other|0|||
130637926|NCT03381274|470293660|FG003|Overall Study|Other|2|||
130637927|NCT03381274|470293661|FG004|Overall Study|Other|2|||
130637928|NCT01874353|470293662|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
130637929|NCT01874353|470293663|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130637930|NCT01874353|470293664|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130637931|NCT01874353|470293665|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130637932|NCT01874353|470293662|FG000|Overall Study|Lost to Follow-up|2|||
130637933|NCT01874353|470293663|FG001|Overall Study|Lost to Follow-up|2|||
130637934|NCT01874353|470293664|FG002|Overall Study|Lost to Follow-up|2|||
130637935|NCT01874353|470293665|FG003|Overall Study|Lost to Follow-up|0|||
130637936|NCT01874353|470293662|FG000|Overall Study|Death|110|||
130637937|NCT01874353|470293663|FG001|Overall Study|Death|60|||
130637938|NCT01874353|470293664|FG002|Overall Study|Death|13|||
130637939|NCT01874353|470293665|FG003|Overall Study|Death|7|||
130637940|NCT01874353|470293662|FG000|Overall Study|Withdrawal by Subject|13|||
130637941|NCT01874353|470293663|FG001|Overall Study|Withdrawal by Subject|11|||
130637942|NCT01874353|470293664|FG002|Overall Study|Withdrawal by Subject|0|||
130637943|NCT01874353|470293665|FG003|Overall Study|Withdrawal by Subject|0|||
130637944|NCT04392154|470293666|FG000|Overall Study|Adverse Event|3|||
130637945|NCT04392154|470293667|FG001|Overall Study|Adverse Event|46|||
130637946|NCT04392154|470293666|FG000|Overall Study|Due to epidemic/pandemic|0|||
130637947|NCT04392154|470293667|FG001|Overall Study|Due to epidemic/pandemic|1|||
130637948|NCT04392154|470293666|FG000|Overall Study|Lack of Efficacy|1|||
130637949|NCT04392154|470293667|FG001|Overall Study|Lack of Efficacy|47|||
130637950|NCT04392154|470293666|FG000|Overall Study|Lost to Follow-up|11|||
130637951|NCT04392154|470293667|FG001|Overall Study|Lost to Follow-up|61|||
130637952|NCT04392154|470293666|FG000|Overall Study|Geopolitical conflict|1|||
130637953|NCT04392154|470293667|FG001|Overall Study|Geopolitical conflict|1|||
130637954|NCT04392154|470293666|FG000|Overall Study|Physician Decision|1|||
130637955|NCT04392154|470293667|FG001|Overall Study|Physician Decision|5|||
130637956|NCT04392154|470293666|FG000|Overall Study|Pregnancy|1|||
130637957|NCT04392154|470293667|FG001|Overall Study|Pregnancy|8|||
130637958|NCT04392154|470293666|FG000|Overall Study|Protocol deviation|1|||
130637959|NCT04392154|470293667|FG001|Overall Study|Protocol deviation|12|||
130637960|NCT04392154|470293666|FG000|Overall Study|Withdrawal by Subject|18|||
130637961|NCT04392154|470293667|FG001|Overall Study|Withdrawal by Subject|138|||
130637962|NCT04392154|470293666|FG000|Overall Study|Sponsor Decision|1|||
130637963|NCT04392154|470293667|FG001|Overall Study|Sponsor Decision|14|||
130637964|NCT04392154|470293666|FG000|Overall Study|Site Closure|0|||
130637965|NCT04392154|470293667|FG001|Overall Study|Site Closure|4|||
130637966|NCT01327573|470293668|FG000|Overall Study|Physician Decision|3|||
130637967|NCT01327573|470293669|FG001|Overall Study|Physician Decision|1|||
130637968|NCT03287830|470293670|FG000|Overall Study|Withdrawal by Subject|1|||
130637969|NCT03287830|470293671|FG001|Overall Study|Withdrawal by Subject|1|||
130637970|NCT03287830|470293670|FG000|Overall Study|not meeting inclusion criteria|5|||
130637971|NCT03287830|470293671|FG001|Overall Study|not meeting inclusion criteria|12|||
130637972|NCT02136134|470293672|FG000|Overall Study|Death|170|||
130637973|NCT02136134|470293673|FG001|Overall Study|Death|148|||
130637974|NCT02136134|470293672|FG000|Overall Study|Withdrawal by Subject|19|||
130637975|NCT02136134|470293673|FG001|Overall Study|Withdrawal by Subject|10|||
130637976|NCT02136134|470293672|FG000|Overall Study|Lost to Follow-up|3|||
130637977|NCT02136134|470293673|FG001|Overall Study|Lost to Follow-up|3|||
130637978|NCT02136134|470293672|FG000|Overall Study|Uspecified|55|||
130637979|NCT02136134|470293673|FG001|Overall Study|Uspecified|90|||
130637980|NCT03070119|470293676|FG000|Overall Study|Adverse Event|0|||
130637981|NCT03070119|470293677|FG001|Overall Study|Adverse Event|0|||
130637982|NCT03070119|470293678|FG002|Overall Study|Adverse Event|1|||
130637983|NCT03070119|470293676|FG000|Overall Study|Lost to Follow-up|0|||
130637984|NCT03070119|470293677|FG001|Overall Study|Lost to Follow-up|1|||
130637985|NCT03070119|470293678|FG002|Overall Study|Lost to Follow-up|0|||
130637986|NCT03070119|470293676|FG000|Overall Study|Consent Withdrawn|6|||
130637987|NCT03070119|470293677|FG001|Overall Study|Consent Withdrawn|5|||
130637988|NCT03070119|470293678|FG002|Overall Study|Consent Withdrawn|3|||
130637989|NCT03070119|470293676|FG000|Overall Study|Investigator Decision|0|||
130637990|NCT03070119|470293677|FG001|Overall Study|Investigator Decision|0|||
130637991|NCT03070119|470293678|FG002|Overall Study|Investigator Decision|1|||
130637992|NCT03070119|470293676|FG000|Overall Study|Death|7|||
130637993|NCT03070119|470293677|FG001|Overall Study|Death|14|||
130637994|NCT03070119|470293678|FG002|Overall Study|Death|5|||
130637995|NCT03070119|470293676|FG000|Overall Study|Disease Progression|5|||
130637996|NCT03070119|470293677|FG001|Overall Study|Disease Progression|7|||
130637997|NCT03070119|470293678|FG002|Overall Study|Disease Progression|7|||
130637998|NCT03070119|470293676|FG000|Overall Study|Reason not Specified|2|||
130637999|NCT03070119|470293677|FG001|Overall Study|Reason not Specified|2|||
130638000|NCT03070119|470293678|FG002|Overall Study|Reason not Specified|1|||
130638001|NCT00732472|470293679|FG000|Overall Study|Adverse Event|0|||
130638002|NCT00732472|470293680|FG001|Overall Study|Adverse Event|1|||
130638003|NCT00732472|470293681|FG002|Overall Study|Adverse Event|1|||
130638004|NCT00732472|470293682|FG003|Overall Study|Adverse Event|1|||
130638005|NCT00732472|470293679|FG000|Overall Study|Protocol Violation|0|||
130638006|NCT00732472|470293680|FG001|Overall Study|Protocol Violation|0|||
130638007|NCT00732472|470293681|FG002|Overall Study|Protocol Violation|0|||
130638008|NCT00732472|470293682|FG003|Overall Study|Protocol Violation|1|||
130638009|NCT00732472|470293679|FG000|Overall Study|Withdrawal by Subject|0|||
130638010|NCT00732472|470293680|FG001|Overall Study|Withdrawal by Subject|2|||
130638011|NCT00732472|470293681|FG002|Overall Study|Withdrawal by Subject|0|||
130638012|NCT00732472|470293682|FG003|Overall Study|Withdrawal by Subject|1|||
130638013|NCT01058395|470293684|FG000|Overall Study|Death|2|||
130638014|NCT01058395|470293685|FG001|Overall Study|Death|1|||
130638015|NCT01058395|470293684|FG000|Overall Study|Lost to Follow-up|1|||
130638016|NCT01058395|470293685|FG001|Overall Study|Lost to Follow-up|0|||
130638017|NCT01266876|470293686|FG000|Overall Study|Adverse Event|0|||
130638018|NCT01266876|470293687|FG001|Overall Study|Adverse Event|0|||
130638019|NCT01266876|470293688|FG002|Overall Study|Adverse Event|0|||
130638020|NCT01266876|470293689|FG003|Overall Study|Adverse Event|1|||
130638021|NCT01266876|470293690|FG004|Overall Study|Adverse Event|0|||
130638022|NCT05180721|470293691|FG000|Overall Study|Lost to Follow-up|4|||
130638023|NCT01996865|470293693|FG000|Induction Period|Protocol Violation|1|||
130638024|NCT01996865|470293694|FG001|Induction Period|Protocol Violation|0|||
130638025|NCT01996865|470293695|FG002|Induction Period|Protocol Violation|0|||
130638026|NCT01996865|470293693|FG000|Induction Period|Progressive Disease|4|||
130638027|NCT01996865|470293694|FG001|Induction Period|Progressive Disease|0|||
130638028|NCT01996865|470293695|FG002|Induction Period|Progressive Disease|0|||
130638029|NCT01996865|470293693|FG000|Induction Period|Lost to Follow-up|10|||
130638030|NCT01996865|470293694|FG001|Induction Period|Lost to Follow-up|0|||
130638031|NCT01996865|470293695|FG002|Induction Period|Lost to Follow-up|0|||
130638032|NCT01996865|470293693|FG000|Induction Period|Other Reasons|13|||
130638033|NCT01996865|470293694|FG001|Induction Period|Other Reasons|0|||
130638034|NCT01996865|470293695|FG002|Induction Period|Other Reasons|0|||
130638035|NCT01996865|470293693|FG000|Induction Period|Adverse Event|20|||
130638036|NCT01996865|470293694|FG001|Induction Period|Adverse Event|0|||
130638037|NCT01996865|470293695|FG002|Induction Period|Adverse Event|0|||
130638038|NCT01996865|470293693|FG000|Induction Period|Withdrawal by Subject|60|||
130638039|NCT01996865|470293694|FG001|Induction Period|Withdrawal by Subject|0|||
130638040|NCT01996865|470293695|FG002|Induction Period|Withdrawal by Subject|0|||
130638041|NCT01996865|470293693|FG000|Induction Period|Death|111|||
130638042|NCT01996865|470293694|FG001|Induction Period|Death|0|||
130638043|NCT01996865|470293695|FG002|Induction Period|Death|0|||
130638044|NCT01996865|470293693|FG000|Maintenance Period|Protocol Violation|0|||
130638045|NCT01996865|470293694|FG001|Maintenance Period|Protocol Violation|1|||
130638046|NCT01996865|470293695|FG002|Maintenance Period|Protocol Violation|1|||
130638047|NCT01996865|470293693|FG000|Maintenance Period|Other reasons|0|||
130638048|NCT01996865|470293694|FG001|Maintenance Period|Other reasons|8|||
130638049|NCT01996865|470293695|FG002|Maintenance Period|Other reasons|5|||
130638050|NCT01996865|470293693|FG000|Maintenance Period|Progressive Disease|0|||
130638051|NCT01996865|470293694|FG001|Maintenance Period|Progressive Disease|6|||
130638052|NCT01996865|470293695|FG002|Maintenance Period|Progressive Disease|23|||
130638053|NCT01996865|470293693|FG000|Maintenance Period|Withdrawal by Subject|0|||
130638054|NCT01996865|470293694|FG001|Maintenance Period|Withdrawal by Subject|18|||
130638055|NCT01996865|470293695|FG002|Maintenance Period|Withdrawal by Subject|4|||
130638056|NCT01996865|470293693|FG000|Maintenance Period|Adverse Event|0|||
130638057|NCT01996865|470293694|FG001|Maintenance Period|Adverse Event|7|||
130638058|NCT01996865|470293695|FG002|Maintenance Period|Adverse Event|7|||
130638059|NCT01996865|470293693|FG000|Maintenance Period|Death|0|||
130638060|NCT01996865|470293694|FG001|Maintenance Period|Death|15|||
130638061|NCT01996865|470293695|FG002|Maintenance Period|Death|3|||
130638062|NCT01996865|470293693|FG000|Maintenance Period|Lost to Follow-up|0|||
130638063|NCT01996865|470293694|FG001|Maintenance Period|Lost to Follow-up|2|||
130638064|NCT01996865|470293695|FG002|Maintenance Period|Lost to Follow-up|0|||
130638065|NCT04083781|470293696|FG000|Main Part|Physician Decision|0|||
130638066|NCT04083781|470293697|FG001|Main Part|Physician Decision|1|||
130638067|NCT04083781|470293698|FG002|Main Part|Physician Decision|2|||
130638068|NCT04083781|470293699|FG003|Main Part|Physician Decision|0|||
130638069|NCT04083781|470293696|FG000|Main Part|Death|1|||
130638070|NCT04083781|470293697|FG001|Main Part|Death|3|||
130638071|NCT04083781|470293698|FG002|Main Part|Death|1|||
130638072|NCT04083781|470293699|FG003|Main Part|Death|0|||
130638073|NCT04083781|470293696|FG000|Main Part|Withdrawal by Subject|5|||
130638074|NCT04083781|470293697|FG001|Main Part|Withdrawal by Subject|2|||
130638075|NCT04083781|470293698|FG002|Main Part|Withdrawal by Subject|3|||
130638076|NCT04083781|470293699|FG003|Main Part|Withdrawal by Subject|7|||
130638077|NCT04083781|470293696|FG000|Extension Part|Physician Decision|0|||
130638078|NCT04083781|470293697|FG001|Extension Part|Physician Decision|0|||
130638079|NCT04083781|470293698|FG002|Extension Part|Physician Decision|0|||
130638080|NCT04083781|470293699|FG003|Extension Part|Physician Decision|1|||
130638081|NCT04083781|470293696|FG000|Extension Part|Death|0|||
130638082|NCT04083781|470293697|FG001|Extension Part|Death|1|||
130638083|NCT04083781|470293698|FG002|Extension Part|Death|0|||
130638084|NCT04083781|470293699|FG003|Extension Part|Death|1|||
130638085|NCT04083781|470293696|FG000|Extension Part|Withdrawal by Subject|0|||
130638086|NCT04083781|470293697|FG001|Extension Part|Withdrawal by Subject|1|||
130638087|NCT04083781|470293698|FG002|Extension Part|Withdrawal by Subject|0|||
130638088|NCT04083781|470293699|FG003|Extension Part|Withdrawal by Subject|0|||
130638089|NCT04083781|470293696|FG000|Extension Part|Ongoing|13|||
130638090|NCT04083781|470293697|FG001|Extension Part|Ongoing|25|||
130638091|NCT04083781|470293698|FG002|Extension Part|Ongoing|15|||
130638092|NCT04083781|470293699|FG003|Extension Part|Ongoing|51|||
130638093|NCT03575351|470293702|FG000|Overall Study|Adverse Event|1|||
130638094|NCT03575351|470293703|FG001|Overall Study|Adverse Event|0|||
130638095|NCT03575351|470293702|FG000|Overall Study|Death|2|||
130638096|NCT03575351|470293703|FG001|Overall Study|Death|2|||
130638097|NCT03575351|470293702|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
130638098|NCT03575351|470293703|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
130638099|NCT03575351|470293702|FG000|Overall Study|Lack of Efficacy|28|||
130638100|NCT03575351|470293703|FG001|Overall Study|Lack of Efficacy|0|||
130638101|NCT03575351|470293702|FG000|Overall Study|Withdrawal by Subject|1|||
130638102|NCT03575351|470293703|FG001|Overall Study|Withdrawal by Subject|1|||
130638103|NCT03575351|470293702|FG000|Overall Study|Physician Decision|3|||
130638104|NCT03575351|470293703|FG001|Overall Study|Physician Decision|0|||
130638105|NCT03575351|470293702|FG000|Overall Study|Disease relapse|15|||
130638106|NCT03575351|470293703|FG001|Overall Study|Disease relapse|6|||
130638107|NCT03575351|470293702|FG000|Overall Study|Study drug manufacturing failure|0|||
130638108|NCT03575351|470293703|FG001|Overall Study|Study drug manufacturing failure|1|||
130638109|NCT03575351|470293702|FG000|Overall Study|other reasons|5|||
130638110|NCT03575351|470293703|FG001|Overall Study|other reasons|0|||
130638111|NCT04288089|470293709|FG000|Overall Study|Ongoing Treatment|2|||
130638112|NCT04288089|470293710|FG001|Overall Study|Ongoing Treatment|1|||
130638113|NCT04288089|470293711|FG002|Overall Study|Ongoing Treatment|1|||
130638114|NCT04288089|470293712|FG003|Overall Study|Ongoing Treatment|4|||
130638115|NCT03715205|470293713|FG000|Overall Study|Death|13|||
130638116|NCT03715205|470293713|FG000|Overall Study|Lost to Follow-up|2|||
130638117|NCT03715205|470293713|FG000|Overall Study|Physician Decision|93|||
130638118|NCT03715205|470293713|FG000|Overall Study|Withdrawal by Subject|26|||
130638119|NCT05245071|470293714|FG000|Overall Study|Progressive disease|18|||
130638120|NCT05245071|470293714|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
130638121|NCT05245071|470293714|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
130638122|NCT05304611|470293715|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638123|NCT05304611|470293716|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638124|NCT05304611|470293717|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638125|NCT05304611|470293718|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638126|NCT05304611|470293719|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638127|NCT05304611|470293720|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638128|NCT05304611|470293721|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
130638129|NCT05304611|470293722|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638130|NCT05304611|470293723|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
130638131|NCT05304611|470293724|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638132|NCT05304611|470293725|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638133|NCT05304611|470293726|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
130638134|NCT05304611|470293715|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
130638135|NCT05304611|470293716|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
130638136|NCT05304611|470293717|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
130638137|NCT05304611|470293718|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
130638138|NCT05304611|470293719|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
130638139|NCT05304611|470293720|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
130638140|NCT05304611|470293721|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
130638141|NCT05304611|470293722|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
130638142|NCT05304611|470293723|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
130638143|NCT05304611|470293724|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
130638144|NCT05304611|470293725|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
130638145|NCT05304611|470293726|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
130638146|NCT05304611|470293715|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
130638147|NCT05304611|470293716|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
130638148|NCT05304611|470293717|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
130638149|NCT05304611|470293718|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
130638150|NCT05304611|470293719|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
130638151|NCT05304611|470293720|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
130638152|NCT05304611|470293721|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
130638153|NCT05304611|470293722|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
130638154|NCT05304611|470293723|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
130638155|NCT05304611|470293724|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
130638156|NCT05304611|470293725|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
130638157|NCT05304611|470293726|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
130638158|NCT02354690|470293727|FG000|Overall Study|Physician Decision|1|||
130638159|NCT00963820|470293728|FG000|Dose Escalation Phase|Progressive Disease|3|||
130638160|NCT00963820|470293729|FG001|Dose Escalation Phase|Progressive Disease|3|||
130638161|NCT00963820|470293730|FG002|Dose Escalation Phase|Progressive Disease|3|||
130638162|NCT00963820|470293731|FG003|Dose Escalation Phase|Progressive Disease|3|||
130638163|NCT00963820|470293732|FG004|Dose Escalation Phase|Progressive Disease|4|||
130638164|NCT00963820|470293733|FG005|Dose Escalation Phase|Progressive Disease|3|||
130638165|NCT00963820|470293734|FG006|Dose Escalation Phase|Progressive Disease|3|||
130638166|NCT00963820|470293735|FG007|Dose Escalation Phase|Progressive Disease|2|||
130638167|NCT00963820|470293736|FG008|Dose Escalation Phase|Progressive Disease|0|||
130638168|NCT00963820|470293737|FG009|Dose Escalation Phase|Progressive Disease|0|||
130638169|NCT00963820|470293738|FG010|Dose Escalation Phase|Progressive Disease|0|||
130638170|NCT00963820|470293739|FG011|Dose Escalation Phase|Progressive Disease|0|||
130638171|NCT00963820|470293728|FG000|Dose Escalation Phase|Adverse Event|0|||
130638172|NCT00963820|470293729|FG001|Dose Escalation Phase|Adverse Event|0|||
130638173|NCT00963820|470293730|FG002|Dose Escalation Phase|Adverse Event|0|||
130638174|NCT00963820|470293731|FG003|Dose Escalation Phase|Adverse Event|0|||
130638175|NCT00963820|470293732|FG004|Dose Escalation Phase|Adverse Event|0|||
130638176|NCT00963820|470293733|FG005|Dose Escalation Phase|Adverse Event|0|||
130638177|NCT00963820|470293734|FG006|Dose Escalation Phase|Adverse Event|3|||
130638178|NCT00963820|470293735|FG007|Dose Escalation Phase|Adverse Event|1|||
130638179|NCT00963820|470293736|FG008|Dose Escalation Phase|Adverse Event|0|||
130638180|NCT00963820|470293737|FG009|Dose Escalation Phase|Adverse Event|0|||
130638181|NCT00963820|470293738|FG010|Dose Escalation Phase|Adverse Event|0|||
130638182|NCT00963820|470293739|FG011|Dose Escalation Phase|Adverse Event|0|||
130638183|NCT00963820|470293728|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130638184|NCT00963820|470293729|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130638185|NCT00963820|470293730|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130638186|NCT00963820|470293731|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130638187|NCT00963820|470293732|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130638188|NCT00963820|470293733|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
130638189|NCT00963820|470293734|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
130638190|NCT00963820|470293735|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
130638191|NCT00963820|470293736|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
130638192|NCT00963820|470293737|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
130638193|NCT00963820|470293738|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
130638194|NCT00963820|470293739|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
130638195|NCT00963820|470293728|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638196|NCT00963820|470293729|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638197|NCT00963820|470293730|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638198|NCT00963820|470293731|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638199|NCT00963820|470293732|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638200|NCT00963820|470293733|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638201|NCT00963820|470293734|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130638202|NCT00963820|470293735|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638203|NCT00963820|470293736|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638204|NCT00963820|470293737|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638205|NCT00963820|470293738|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638206|NCT00963820|470293739|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130638207|NCT00963820|470293728|FG000|Expansion Phase|Progressive Disease|0|||
130638208|NCT00963820|470293729|FG001|Expansion Phase|Progressive Disease|0|||
130638209|NCT00963820|470293730|FG002|Expansion Phase|Progressive Disease|0|||
130638210|NCT00963820|470293731|FG003|Expansion Phase|Progressive Disease|0|||
130638211|NCT00963820|470293732|FG004|Expansion Phase|Progressive Disease|0|||
130638212|NCT00963820|470293733|FG005|Expansion Phase|Progressive Disease|0|||
130638213|NCT00963820|470293734|FG006|Expansion Phase|Progressive Disease|0|||
130638214|NCT00963820|470293735|FG007|Expansion Phase|Progressive Disease|0|||
130638215|NCT00963820|470293736|FG008|Expansion Phase|Progressive Disease|8|||
130638216|NCT00963820|470293737|FG009|Expansion Phase|Progressive Disease|6|||
130638217|NCT00963820|470293738|FG010|Expansion Phase|Progressive Disease|4|||
130638218|NCT00963820|470293739|FG011|Expansion Phase|Progressive Disease|2|||
130638219|NCT00963820|470293728|FG000|Expansion Phase|Adverse Event|0|||
130638220|NCT00963820|470293729|FG001|Expansion Phase|Adverse Event|0|||
130638221|NCT00963820|470293730|FG002|Expansion Phase|Adverse Event|0|||
130638222|NCT00963820|470293731|FG003|Expansion Phase|Adverse Event|0|||
130638223|NCT00963820|470293732|FG004|Expansion Phase|Adverse Event|0|||
130638224|NCT00963820|470293733|FG005|Expansion Phase|Adverse Event|0|||
130638225|NCT00963820|470293734|FG006|Expansion Phase|Adverse Event|0|||
130638226|NCT00963820|470293735|FG007|Expansion Phase|Adverse Event|0|||
130638227|NCT00963820|470293736|FG008|Expansion Phase|Adverse Event|1|||
130638228|NCT00963820|470293737|FG009|Expansion Phase|Adverse Event|3|||
130638229|NCT00963820|470293738|FG010|Expansion Phase|Adverse Event|0|||
130638230|NCT00963820|470293739|FG011|Expansion Phase|Adverse Event|0|||
130638231|NCT00963820|470293728|FG000|Expansion Phase|Withdrawal by Subject|0|||
130638232|NCT00963820|470293729|FG001|Expansion Phase|Withdrawal by Subject|0|||
130638233|NCT00963820|470293730|FG002|Expansion Phase|Withdrawal by Subject|0|||
130638234|NCT00963820|470293731|FG003|Expansion Phase|Withdrawal by Subject|0|||
130638235|NCT00963820|470293732|FG004|Expansion Phase|Withdrawal by Subject|0|||
130638236|NCT00963820|470293733|FG005|Expansion Phase|Withdrawal by Subject|0|||
130638237|NCT00963820|470293734|FG006|Expansion Phase|Withdrawal by Subject|0|||
130638238|NCT00963820|470293735|FG007|Expansion Phase|Withdrawal by Subject|0|||
130638239|NCT00963820|470293736|FG008|Expansion Phase|Withdrawal by Subject|1|||
130638240|NCT00963820|470293737|FG009|Expansion Phase|Withdrawal by Subject|0|||
130638241|NCT00963820|470293738|FG010|Expansion Phase|Withdrawal by Subject|1|||
130638242|NCT00963820|470293739|FG011|Expansion Phase|Withdrawal by Subject|1|||
130638243|NCT00963820|470293728|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638244|NCT00963820|470293729|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638245|NCT00963820|470293730|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638246|NCT00963820|470293731|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638247|NCT00963820|470293732|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638248|NCT00963820|470293733|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638249|NCT00963820|470293734|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638250|NCT00963820|470293735|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638251|NCT00963820|470293736|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638252|NCT00963820|470293737|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638253|NCT00963820|470293738|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130638254|NCT00963820|470293739|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
130638255|NCT02253992|470293747|FG000|Overall Study|Study drug toxicity|1|||
130638256|NCT02253992|470293748|FG001|Overall Study|Study drug toxicity|0|||
130638257|NCT02253992|470293749|FG002|Overall Study|Study drug toxicity|10|||
130638258|NCT02253992|470293747|FG000|Overall Study|Disease progression|4|||
130638259|NCT02253992|470293748|FG001|Overall Study|Disease progression|3|||
130638260|NCT02253992|470293749|FG002|Overall Study|Disease progression|98|||
130638261|NCT02253992|470293747|FG000|Overall Study|Withdrawal by Subject|0|||
130638262|NCT02253992|470293748|FG001|Overall Study|Withdrawal by Subject|0|||
130638263|NCT02253992|470293749|FG002|Overall Study|Withdrawal by Subject|3|||
130638264|NCT02253992|470293747|FG000|Overall Study|Adverse Event|0|||
130638265|NCT02253992|470293748|FG001|Overall Study|Adverse Event|0|||
130638266|NCT02253992|470293749|FG002|Overall Study|Adverse Event|8|||
130638267|NCT02253992|470293747|FG000|Overall Study|Death|0|||
130638268|NCT02253992|470293748|FG001|Overall Study|Death|0|||
130638269|NCT02253992|470293749|FG002|Overall Study|Death|1|||
130638270|NCT02253992|470293747|FG000|Overall Study|Subject discontinued study drug|1|||
130638271|NCT02253992|470293748|FG001|Overall Study|Subject discontinued study drug|0|||
130638272|NCT02253992|470293749|FG002|Overall Study|Subject discontinued study drug|1|||
130638273|NCT02253992|470293747|FG000|Overall Study|Completed treatment as per protocol|0|||
130638274|NCT02253992|470293748|FG001|Overall Study|Completed treatment as per protocol|1|||
130638275|NCT02253992|470293749|FG002|Overall Study|Completed treatment as per protocol|22|||
130638276|NCT02253992|470293747|FG000|Overall Study|Other|0|||
130638277|NCT02253992|470293748|FG001|Overall Study|Other|0|||
130638278|NCT02253992|470293749|FG002|Overall Study|Other|1|||
130638279|NCT00772889|470293750|FG000|Overall Study|Adverse Event|7|||
130638280|NCT00772889|470293751|FG001|Overall Study|Adverse Event|4|||
130638281|NCT00772889|470293752|FG002|Overall Study|Adverse Event|0|||
130638282|NCT00772889|470293750|FG000|Overall Study|Withdrawal by Subject|9|||
130638283|NCT00772889|470293751|FG001|Overall Study|Withdrawal by Subject|8|||
130638284|NCT00772889|470293752|FG002|Overall Study|Withdrawal by Subject|9|||
130638285|NCT00772889|470293750|FG000|Overall Study|Lost to Follow-up|6|||
130638286|NCT00772889|470293751|FG001|Overall Study|Lost to Follow-up|6|||
130638287|NCT00772889|470293752|FG002|Overall Study|Lost to Follow-up|7|||
130638288|NCT03323086|470293753|FG000|Overall Study|Lost to Follow-up|3|||
130638289|NCT03323086|470293754|FG001|Overall Study|Lost to Follow-up|2|||
130638290|NCT00355615|470293755|FG000|Randomized Double Blind Period|Adverse Event|1|||
130638291|NCT00355615|470293756|FG001|Randomized Double Blind Period|Adverse Event|0|||
130638292|NCT00355615|470293757|FG002|Randomized Double Blind Period|Adverse Event|0|||
130638293|NCT00355615|470293758|FG003|Randomized Double Blind Period|Adverse Event|0|||
130638294|NCT00355615|470293759|FG004|Randomized Double Blind Period|Adverse Event|0|||
130638295|NCT00355615|470293755|FG000|Randomized Double Blind Period|Protocol Violation|0|||
130638296|NCT00355615|470293756|FG001|Randomized Double Blind Period|Protocol Violation|0|||
130638297|NCT00355615|470293757|FG002|Randomized Double Blind Period|Protocol Violation|1|||
130638298|NCT00355615|470293758|FG003|Randomized Double Blind Period|Protocol Violation|1|||
130638299|NCT00355615|470293759|FG004|Randomized Double Blind Period|Protocol Violation|0|||
130638300|NCT00355615|470293755|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130638301|NCT00355615|470293756|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130638302|NCT00355615|470293757|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130638303|NCT00355615|470293758|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130638304|NCT00355615|470293759|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
130638305|NCT00355615|470293755|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130638306|NCT00355615|470293756|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130638307|NCT00355615|470293757|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130638308|NCT00355615|470293758|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130638309|NCT00355615|470293759|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
130638310|NCT00355615|470293755|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130638311|NCT00355615|470293756|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130638312|NCT00355615|470293757|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130638313|NCT00355615|470293758|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130638314|NCT00355615|470293759|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
130638315|NCT00355615|470293755|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130638316|NCT00355615|470293756|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130638317|NCT00355615|470293757|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130638318|NCT00355615|470293758|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130638319|NCT00355615|470293759|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
130638320|NCT02159365|470293760|FG000|Overall Study|Disease Progression|23|||
130638321|NCT02159365|470293760|FG000|Overall Study|Other reasons|11|||
130638322|NCT02159365|470293760|FG000|Overall Study|Administrative reason by Sponsor|9|||
130638323|NCT02159365|470293760|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
130638324|NCT02159365|470293760|FG000|Overall Study|Study drug toxicity|7|||
130638325|NCT02159365|470293760|FG000|Overall Study|Maximum clinical benefit|3|||
130638326|NCT02159365|470293760|FG000|Overall Study|Subject request to discontinue treatment|3|||
130638327|NCT02159365|470293760|FG000|Overall Study|Subject withdrew consent|3|||
130638328|NCT02159365|470293760|FG000|Overall Study|Death|1|||
130638329|NCT02159365|470293760|FG000|Overall Study|Lost to Follow-up|1|||
130638330|NCT00796549|470293761|FG000|Overall Study|Adverse Event|11|||
130638331|NCT00796549|470293761|FG000|Overall Study|not entered|149|||
130638332|NCT00796549|470293761|FG000|Overall Study|Other|2|||
130638333|NCT00796549|470293761|FG000|Overall Study|Progressive disease|56|||
130638334|NCT01878175|470293763|FG000|Overall Study|Developed contraindicated health problem|2|||
130638335|NCT03523715|470293764|FG000|Overall Study|Lost to Follow-up|11|||
130638336|NCT03523715|470293765|FG001|Overall Study|Lost to Follow-up|14|||
130638337|NCT03523715|470293764|FG000|Overall Study|Did not meet inclusion criteria|1|||
130638338|NCT03523715|470293765|FG001|Overall Study|Did not meet inclusion criteria|0|||
130638339|NCT03523715|470293764|FG000|Overall Study|Internally inconsistent reporting|0|||
130638340|NCT03523715|470293765|FG001|Overall Study|Internally inconsistent reporting|2|||
130638341|NCT04430036|470293766|FG000|Safety Run in Phase|Progression of disease|2|||
130638342|NCT01842334|470293767|FG000|Overall Study|Withdrawal by Subject|3|||
130638343|NCT01842334|470293768|FG001|Overall Study|Withdrawal by Subject|3|||
130638344|NCT01842334|470293767|FG000|Overall Study|Moved away mid-study|0|||
130638345|NCT01842334|470293768|FG001|Overall Study|Moved away mid-study|1|||
130638346|NCT02201251|470293770|FG000|Overall Study|Adverse Event|1|||
130638347|NCT02201251|470293771|FG001|Overall Study|Adverse Event|1|||
130638348|NCT02201251|470293770|FG000|Overall Study|Protocol Violation|1|||
130638349|NCT02201251|470293771|FG001|Overall Study|Protocol Violation|0|||
130638350|NCT02201251|470293770|FG000|Overall Study|Noncompliance with Study Drug|0|||
130638351|NCT02201251|470293771|FG001|Overall Study|Noncompliance with Study Drug|1|||
130638352|NCT02201251|470293770|FG000|Overall Study|Withdrawal by Subject|2|||
130638353|NCT02201251|470293771|FG001|Overall Study|Withdrawal by Subject|1|||
130638354|NCT02877134|470293775|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638355|NCT02877134|470293776|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
130638356|NCT02877134|470293777|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638357|NCT02877134|470293778|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638358|NCT02877134|470293779|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638359|NCT02877134|470293780|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
130638360|NCT02877134|470293781|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638361|NCT02877134|470293782|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638362|NCT02877134|470293783|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638363|NCT02877134|470293784|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638364|NCT02877134|470293785|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638365|NCT02877134|470293786|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
130638366|NCT02877134|470293775|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638367|NCT02877134|470293776|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
130638368|NCT02877134|470293777|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638369|NCT02877134|470293778|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
130638370|NCT02877134|470293779|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638371|NCT02877134|470293780|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638372|NCT02877134|470293781|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
130638373|NCT02877134|470293782|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638374|NCT02877134|470293783|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638375|NCT02877134|470293784|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638376|NCT02877134|470293785|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638377|NCT02877134|470293786|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130638378|NCT02877134|470293775|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
130638379|NCT02877134|470293776|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
130638380|NCT02877134|470293777|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
130638381|NCT02877134|470293778|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
130638382|NCT02877134|470293779|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
130638383|NCT02877134|470293780|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
130638384|NCT02877134|470293781|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
130638385|NCT02877134|470293782|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130638386|NCT02877134|470293783|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130638387|NCT02877134|470293784|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130638388|NCT02877134|470293785|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130638389|NCT02877134|470293786|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130638390|NCT02877134|470293775|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
130638391|NCT02877134|470293776|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
130638392|NCT02877134|470293777|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
130638393|NCT02877134|470293778|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
130638394|NCT02877134|470293779|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
130638395|NCT02877134|470293780|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
130638396|NCT02877134|470293781|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
130638397|NCT02877134|470293782|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
130638398|NCT02877134|470293783|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
130638399|NCT02877134|470293784|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
130638400|NCT02877134|470293785|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
130638401|NCT02877134|470293786|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
130638402|NCT02877134|470293775|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638403|NCT02877134|470293776|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638404|NCT02877134|470293777|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638405|NCT02877134|470293778|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638406|NCT02877134|470293779|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638407|NCT02877134|470293780|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638408|NCT02877134|470293781|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638409|NCT02877134|470293782|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638410|NCT02877134|470293783|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
130638411|NCT02877134|470293784|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638412|NCT02877134|470293785|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638413|NCT02877134|470293786|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130638414|NCT02877134|470293775|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638415|NCT02877134|470293776|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638416|NCT02877134|470293777|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638417|NCT02877134|470293778|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638418|NCT02877134|470293779|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638419|NCT02877134|470293780|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638420|NCT02877134|470293781|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130638421|NCT02877134|470293782|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
130638422|NCT02877134|470293783|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
130638423|NCT02877134|470293784|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
130638424|NCT02877134|470293785|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
130638425|NCT02877134|470293786|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
130638426|NCT02877134|470293775|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638427|NCT02877134|470293776|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638428|NCT02877134|470293777|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638429|NCT02877134|470293778|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638430|NCT02877134|470293779|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638431|NCT02877134|470293780|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638432|NCT02877134|470293781|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638433|NCT02877134|470293782|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130638434|NCT02877134|470293783|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130638435|NCT02877134|470293784|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130638436|NCT02877134|470293785|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638437|NCT02877134|470293786|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130638438|NCT02877134|470293775|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
130638439|NCT02877134|470293776|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
130638440|NCT02877134|470293777|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
130638441|NCT02877134|470293778|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
130638442|NCT02877134|470293779|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
130638443|NCT02877134|470293780|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
130638444|NCT02877134|470293781|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
130638445|NCT02877134|470293782|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
130638446|NCT02877134|470293783|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
130638447|NCT02877134|470293784|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
130638448|NCT02877134|470293785|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
130638449|NCT02877134|470293786|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
130638450|NCT01332851|470293787|FG000|Overall Study|Withdrawal by Subject|4|||
130638451|NCT01332851|470293788|FG001|Overall Study|Withdrawal by Subject|2|||
130638452|NCT01332851|470293787|FG000|Overall Study|Lost to Follow-up|7|||
130638453|NCT01332851|470293788|FG001|Overall Study|Lost to Follow-up|11|||
130638454|NCT03299166|470293795|FG000|Overall Study|Adverse Event|9|||
130638455|NCT03299166|470293796|FG001|Overall Study|Adverse Event|4|||
130638456|NCT03299166|470293795|FG000|Overall Study|Withdrawal by Subject|6|||
130638457|NCT03299166|470293796|FG001|Overall Study|Withdrawal by Subject|5|||
130638458|NCT03299166|470293795|FG000|Overall Study|Physician Decision|1|||
130638459|NCT03299166|470293796|FG001|Overall Study|Physician Decision|1|||
130638460|NCT03299166|470293795|FG000|Overall Study|Sponsor Decision|3|||
130638461|NCT03299166|470293796|FG001|Overall Study|Sponsor Decision|0|||
130638462|NCT03299166|470293795|FG000|Overall Study|Lost to Follow-up|2|||
130638463|NCT03299166|470293796|FG001|Overall Study|Lost to Follow-up|4|||
130638464|NCT03299166|470293795|FG000|Overall Study|Randomization Error|0|||
130638465|NCT03299166|470293796|FG001|Overall Study|Randomization Error|1|||
130638466|NCT03299166|470293795|FG000|Overall Study|Subject unable to return due to COVID|1|||
130638467|NCT03299166|470293796|FG001|Overall Study|Subject unable to return due to COVID|0|||
130638468|NCT03299166|470293795|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
130638469|NCT03299166|470293796|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
130638470|NCT00255008|470293797|FG000|Overall Study|Adverse Event|1|||
130638471|NCT00255008|470293798|FG001|Overall Study|Adverse Event|1|||
130638472|NCT00255008|470293799|FG002|Overall Study|Adverse Event|2|||
130638473|NCT00255008|470293800|FG003|Overall Study|Adverse Event|0|||
130638474|NCT00255008|470293797|FG000|Overall Study|Lost to Follow-up|1|||
130638475|NCT00255008|470293798|FG001|Overall Study|Lost to Follow-up|0|||
130638476|NCT00255008|470293799|FG002|Overall Study|Lost to Follow-up|1|||
130638477|NCT00255008|470293800|FG003|Overall Study|Lost to Follow-up|2|||
130638478|NCT00255008|470293797|FG000|Overall Study|Did not meet viral reduction criteria|4|||
130638479|NCT00255008|470293798|FG001|Overall Study|Did not meet viral reduction criteria|5|||
130638480|NCT00255008|470293799|FG002|Overall Study|Did not meet viral reduction criteria|0|||
130638481|NCT00255008|470293800|FG003|Overall Study|Did not meet viral reduction criteria|1|||
130638482|NCT00255008|470293797|FG000|Overall Study|Withdrew consent|0|||
130638483|NCT00255008|470293798|FG001|Overall Study|Withdrew consent|0|||
130638484|NCT00255008|470293799|FG002|Overall Study|Withdrew consent|2|||
130638485|NCT00255008|470293800|FG003|Overall Study|Withdrew consent|0|||
130638486|NCT00255008|470293797|FG000|Overall Study|Sponsor request|18|||
130638487|NCT00255008|470293798|FG001|Overall Study|Sponsor request|3|||
130638488|NCT00255008|470293799|FG002|Overall Study|Sponsor request|8|||
130638489|NCT00255008|470293800|FG003|Overall Study|Sponsor request|17|||
130638490|NCT00255008|470293797|FG000|Overall Study|Adverse lab experience|1|||
130638491|NCT00255008|470293798|FG001|Overall Study|Adverse lab experience|0|||
130638492|NCT00255008|470293799|FG002|Overall Study|Adverse lab experience|0|||
130638493|NCT00255008|470293800|FG003|Overall Study|Adverse lab experience|0|||
130638494|NCT00255008|470293797|FG000|Overall Study|Other|7|||
130638495|NCT00255008|470293798|FG001|Overall Study|Other|0|||
130638496|NCT00255008|470293799|FG002|Overall Study|Other|3|||
130638497|NCT00255008|470293800|FG003|Overall Study|Other|2|||
130638498|NCT01833806|470293801|FG000|Overall Study|Alternative treatment|2|||
130638499|NCT01833806|470293801|FG000|Overall Study|Death|5|||
130638500|NCT01833806|470293801|FG000|Overall Study|Physician Decision|1|||
130638501|NCT01833806|470293801|FG000|Overall Study|Lost to Follow-up|1|||
130638502|NCT03457636|470293802|FG000|Overall Study|Lost to Follow-up|2|||
130638503|NCT00126425|470293805|FG000|Overall Study|Withdrawal by Subject|17|||
130638504|NCT00126425|470293806|FG001|Overall Study|Withdrawal by Subject|1|||
130638505|NCT00126425|470293805|FG000|Overall Study|Lost to Follow-up|8|||
130638506|NCT00126425|470293806|FG001|Overall Study|Lost to Follow-up|4|||
130638507|NCT00126425|470293805|FG000|Overall Study|Protocol Violation|9|||
130638508|NCT00126425|470293806|FG001|Overall Study|Protocol Violation|6|||
130638509|NCT00126425|470293805|FG000|Overall Study|Adverse Event|1|||
130638510|NCT00126425|470293806|FG001|Overall Study|Adverse Event|0|||
130638511|NCT00126425|470293805|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
130638512|NCT00126425|470293806|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
130638513|NCT00126425|470293805|FG000|Overall Study|Other|5|||
130638514|NCT00126425|470293806|FG001|Overall Study|Other|0|||
130638515|NCT04474366|470293807|FG000|Overall Study|Lost to Follow-up|2|||
130638516|NCT04474366|470293808|FG001|Overall Study|Lost to Follow-up|5|||
130638517|NCT04063865|470293809|FG000|Overall Study|Physician Decision|1|||
130638518|NCT04063865|470293810|FG001|Overall Study|Physician Decision|3|||
130638519|NCT04063865|470293809|FG000|Overall Study|Study Closed Prior to Completion|4|||
130638520|NCT04063865|470293810|FG001|Overall Study|Study Closed Prior to Completion|4|||
130638521|NCT04063865|470293809|FG000|Overall Study|Withdrawal by Subject|1|||
130638522|NCT04063865|470293810|FG001|Overall Study|Withdrawal by Subject|1|||
130638523|NCT00320190|470293811|FG000|First 12 Months|Completed but did not enter extension|5|||
130638524|NCT00320190|470293812|FG001|First 12 Months|Completed but did not enter extension|3|||
130638525|NCT00320190|470293811|FG000|First 12 Months|Sponsor terminated study|2|||
130638526|NCT00320190|470293812|FG001|First 12 Months|Sponsor terminated study|2|||
130638527|NCT00320190|470293811|FG000|First 12 Months|Lost to Follow-up|0|||
130638528|NCT00320190|470293812|FG001|First 12 Months|Lost to Follow-up|1|||
130638529|NCT00320190|470293811|FG000|First 12 Months|Enrollment failure|0|||
130638530|NCT00320190|470293812|FG001|First 12 Months|Enrollment failure|1|||
130638531|NCT00320190|470293811|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
130638532|NCT00320190|470293812|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
130638533|NCT00320190|470293811|FG000|First 12 Months|Investigator request|0|||
130638534|NCT00320190|470293812|FG001|First 12 Months|Investigator request|1|||
130638535|NCT00320190|470293811|FG000|First 12 Months|Study drug toxicity|0|||
130638536|NCT00320190|470293812|FG001|First 12 Months|Study drug toxicity|1|||
130638537|NCT00320190|470293811|FG000|First 12 Months|Withdrawal by Subject|0|||
130638538|NCT00320190|470293812|FG001|First 12 Months|Withdrawal by Subject|1|||
130638539|NCT00320190|470293811|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
130638540|NCT00320190|470293812|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
130638541|NCT00320190|470293811|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
130638542|NCT00320190|470293812|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
130638543|NCT00320190|470293811|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
130638544|NCT00320190|470293812|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
130638545|NCT00102804|470293825|FG000|Overall Study|Progressive Disease (PD)|307|||
130638546|NCT00102804|470293826|FG001|Overall Study|Progressive Disease (PD)|196|||
130638547|NCT00102804|470293825|FG000|Overall Study|Withdrawal by Subject|46|||
130638548|NCT00102804|470293826|FG001|Overall Study|Withdrawal by Subject|7|||
130638549|NCT00102804|470293825|FG000|Overall Study|Adverse Event|37|||
130638550|NCT00102804|470293826|FG001|Overall Study|Adverse Event|3|||
130638551|NCT00102804|470293825|FG000|Overall Study|Physician Decision|24|||
130638552|NCT00102804|470293826|FG001|Overall Study|Physician Decision|6|||
130638553|NCT00102804|470293825|FG000|Overall Study|Death|5|||
130638554|NCT00102804|470293826|FG001|Overall Study|Death|6|||
130638555|NCT00102804|470293825|FG000|Overall Study|Enrollment Criteria Not Met|6|||
130638556|NCT00102804|470293826|FG001|Overall Study|Enrollment Criteria Not Met|0|||
130638557|NCT00102804|470293825|FG000|Overall Study|Lost to Follow-up|4|||
130638558|NCT00102804|470293826|FG001|Overall Study|Lost to Follow-up|1|||
130638559|NCT00102804|470293825|FG000|Overall Study|Protocol Violation|2|||
130638560|NCT00102804|470293826|FG001|Overall Study|Protocol Violation|1|||
130638561|NCT00102804|470293825|FG000|Overall Study|Satisfactory Response|2|||
130638562|NCT00102804|470293826|FG001|Overall Study|Satisfactory Response|0|||
130638563|NCT00102804|470293825|FG000|Overall Study|Sponsor Decision|1|||
130638564|NCT00102804|470293826|FG001|Overall Study|Sponsor Decision|0|||
130638565|NCT00102804|470293825|FG000|Overall Study|Alive, Receiving Treatment|7|||
130638566|NCT00102804|470293826|FG001|Overall Study|Alive, Receiving Treatment|2|||
130638567|NCT00683774|470293827|FG000|Overall Study|Withdrawal by Subject|0|||
130638568|NCT00683774|470293828|FG001|Overall Study|Withdrawal by Subject|1|||
130638569|NCT00683774|470293827|FG000|Overall Study|Physician Decision|3|||
130638570|NCT00683774|470293828|FG001|Overall Study|Physician Decision|0|||
130638571|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
130638572|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130638573|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130638574|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130638575|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130638576|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130638577|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
130638578|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130638579|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130638580|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130638581|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130638582|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130638583|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
130638584|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130638585|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130638586|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130638587|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130638588|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130638589|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Other|14|||
130638590|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Other|0|||
130638591|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Other|0|||
130638592|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Other|0|||
130638593|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Other|0|||
130638594|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Other|0|||
130638595|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
130638596|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130638597|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130638598|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
130638599|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130638600|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
130638601|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
130638602|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130638603|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130638604|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130638605|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130638606|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130638607|NCT02141854|470293831|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
130638608|NCT02141854|470293832|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130638609|NCT02141854|470293833|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130638610|NCT02141854|470293834|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130638611|NCT02141854|470293835|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130638612|NCT02141854|470293836|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130638613|NCT02141854|470293831|FG000|Treatment Period|Protocol Violation|0|||
130638614|NCT02141854|470293832|FG001|Treatment Period|Protocol Violation|1|||
130638615|NCT02141854|470293833|FG002|Treatment Period|Protocol Violation|0|||
130638616|NCT02141854|470293834|FG003|Treatment Period|Protocol Violation|2|||
130638617|NCT02141854|470293835|FG004|Treatment Period|Protocol Violation|2|||
130638618|NCT02141854|470293836|FG005|Treatment Period|Protocol Violation|1|||
130638619|NCT02141854|470293831|FG000|Treatment Period|Noncompliance|0|||
130638620|NCT02141854|470293832|FG001|Treatment Period|Noncompliance|0|||
130638621|NCT02141854|470293833|FG002|Treatment Period|Noncompliance|0|||
130638622|NCT02141854|470293834|FG003|Treatment Period|Noncompliance|1|||
130638623|NCT02141854|470293835|FG004|Treatment Period|Noncompliance|0|||
130638624|NCT02141854|470293836|FG005|Treatment Period|Noncompliance|0|||
130638625|NCT02141854|470293831|FG000|Treatment Period|Lack of Efficacy|0|||
130638626|NCT02141854|470293832|FG001|Treatment Period|Lack of Efficacy|0|||
130638627|NCT02141854|470293833|FG002|Treatment Period|Lack of Efficacy|0|||
130638628|NCT02141854|470293834|FG003|Treatment Period|Lack of Efficacy|1|||
130638629|NCT02141854|470293835|FG004|Treatment Period|Lack of Efficacy|1|||
130638630|NCT02141854|470293836|FG005|Treatment Period|Lack of Efficacy|7|||
130638631|NCT02141854|470293831|FG000|Treatment Period|Pregnancy|0|||
130638632|NCT02141854|470293832|FG001|Treatment Period|Pregnancy|1|||
130638633|NCT02141854|470293833|FG002|Treatment Period|Pregnancy|0|||
130638634|NCT02141854|470293834|FG003|Treatment Period|Pregnancy|0|||
130638635|NCT02141854|470293835|FG004|Treatment Period|Pregnancy|0|||
130638636|NCT02141854|470293836|FG005|Treatment Period|Pregnancy|0|||
130638637|NCT02141854|470293831|FG000|Treatment Period|Other|0|||
130638638|NCT02141854|470293832|FG001|Treatment Period|Other|1|||
130638639|NCT02141854|470293833|FG002|Treatment Period|Other|2|||
130638640|NCT02141854|470293834|FG003|Treatment Period|Other|0|||
130638641|NCT02141854|470293835|FG004|Treatment Period|Other|1|||
130638642|NCT02141854|470293836|FG005|Treatment Period|Other|2|||
130638643|NCT02141854|470293831|FG000|Treatment Period|Adverse Event|0|||
130638644|NCT02141854|470293832|FG001|Treatment Period|Adverse Event|2|||
130638645|NCT02141854|470293833|FG002|Treatment Period|Adverse Event|2|||
130638646|NCT02141854|470293834|FG003|Treatment Period|Adverse Event|0|||
130638647|NCT02141854|470293835|FG004|Treatment Period|Adverse Event|2|||
130638648|NCT02141854|470293836|FG005|Treatment Period|Adverse Event|2|||
130638649|NCT02141854|470293831|FG000|Treatment Period|Withdrawal by Subject|0|||
130638650|NCT02141854|470293832|FG001|Treatment Period|Withdrawal by Subject|2|||
130638651|NCT02141854|470293833|FG002|Treatment Period|Withdrawal by Subject|3|||
130638652|NCT02141854|470293834|FG003|Treatment Period|Withdrawal by Subject|3|||
130638653|NCT02141854|470293835|FG004|Treatment Period|Withdrawal by Subject|4|||
130638654|NCT02141854|470293836|FG005|Treatment Period|Withdrawal by Subject|7|||
130638655|NCT02141854|470293831|FG000|Treatment Period|Disease progression|0|||
130638656|NCT02141854|470293832|FG001|Treatment Period|Disease progression|2|||
130638657|NCT02141854|470293833|FG002|Treatment Period|Disease progression|1|||
130638658|NCT02141854|470293834|FG003|Treatment Period|Disease progression|3|||
130638659|NCT02141854|470293835|FG004|Treatment Period|Disease progression|0|||
130638660|NCT02141854|470293836|FG005|Treatment Period|Disease progression|18|||
130638661|NCT02141854|470293831|FG000|Treatment Period|Lost to Follow-up|0|||
130638662|NCT02141854|470293832|FG001|Treatment Period|Lost to Follow-up|1|||
130638663|NCT02141854|470293833|FG002|Treatment Period|Lost to Follow-up|1|||
130638664|NCT02141854|470293834|FG003|Treatment Period|Lost to Follow-up|1|||
130638665|NCT02141854|470293835|FG004|Treatment Period|Lost to Follow-up|0|||
130638666|NCT02141854|470293836|FG005|Treatment Period|Lost to Follow-up|1|||
130638667|NCT03991936|470295488|FG000|Overall Study|Lost to Follow-up|1|||
130638668|NCT03991936|470295489|FG001|Overall Study|Lost to Follow-up|1|||
130638669|NCT03991936|470295490|FG002|Overall Study|Lost to Follow-up|1|||
130638670|NCT03991936|470295491|FG003|Overall Study|Lost to Follow-up|1|||
130638671|NCT03991936|470295492|FG004|Overall Study|Lost to Follow-up|1|||
130638672|NCT00939055|470295493|FG000|Overall Study|Discontinuation prior to procedure|4|||
130638673|NCT00939055|470295494|FG001|Overall Study|Discontinuation prior to procedure|0|||
130638674|NCT00584987|470295497|FG000|Overall Study|Protocol Violation|1|||
130638675|NCT00584987|470295498|FG001|Overall Study|Protocol Violation|1|||
130638676|NCT00584987|470295499|FG002|Overall Study|Protocol Violation|1|||
130638677|NCT00584987|470295500|FG003|Overall Study|Protocol Violation|0|||
130638678|NCT00584987|470295497|FG000|Overall Study|Adverse Event|0|||
130638679|NCT00584987|470295498|FG001|Overall Study|Adverse Event|0|||
130638680|NCT00584987|470295499|FG002|Overall Study|Adverse Event|0|||
130638681|NCT00584987|470295500|FG003|Overall Study|Adverse Event|1|||
130638682|NCT03225833|470295501|FG000|Overall Study|Adverse Event|0|||
130638683|NCT03225833|470295502|FG001|Overall Study|Adverse Event|1|||
130638684|NCT03225833|470295503|FG002|Overall Study|Adverse Event|2|||
130638685|NCT03225833|470295504|FG003|Overall Study|Adverse Event|0|||
130638686|NCT03225833|470295505|FG004|Overall Study|Adverse Event|0|||
130638687|NCT03225833|470295506|FG005|Overall Study|Adverse Event|2|||
130638688|NCT03225833|470295501|FG000|Overall Study|Withdrawal by Subject|1|||
130638689|NCT03225833|470295502|FG001|Overall Study|Withdrawal by Subject|0|||
130638690|NCT03225833|470295503|FG002|Overall Study|Withdrawal by Subject|0|||
130638691|NCT03225833|470295504|FG003|Overall Study|Withdrawal by Subject|0|||
130638692|NCT03225833|470295505|FG004|Overall Study|Withdrawal by Subject|1|||
130638693|NCT03225833|470295506|FG005|Overall Study|Withdrawal by Subject|0|||
130638694|NCT03225833|470295501|FG000|Overall Study|Termination of Study by Sponsor|4|||
130638695|NCT03225833|470295502|FG001|Overall Study|Termination of Study by Sponsor|0|||
130638696|NCT03225833|470295503|FG002|Overall Study|Termination of Study by Sponsor|0|||
130638697|NCT03225833|470295504|FG003|Overall Study|Termination of Study by Sponsor|0|||
130638698|NCT03225833|470295505|FG004|Overall Study|Termination of Study by Sponsor|0|||
130638699|NCT03225833|470295506|FG005|Overall Study|Termination of Study by Sponsor|7|||
130638700|NCT03225833|470295501|FG000|Overall Study|Sponsor Decision|0|||
130638701|NCT03225833|470295502|FG001|Overall Study|Sponsor Decision|0|||
130638702|NCT03225833|470295503|FG002|Overall Study|Sponsor Decision|0|||
130638703|NCT03225833|470295504|FG003|Overall Study|Sponsor Decision|0|||
130638704|NCT03225833|470295505|FG004|Overall Study|Sponsor Decision|0|||
130638705|NCT03225833|470295506|FG005|Overall Study|Sponsor Decision|1|||
130638706|NCT00081263|470295509|FG000|Overall Study|clerical error|1|||
130638707|NCT00081263|470295510|FG001|Overall Study|clerical error|0|||
130638708|NCT00081263|470295509|FG000|Overall Study|wrong cell type|7|||
130638709|NCT00081263|470295510|FG001|Overall Study|wrong cell type|5|||
130638710|NCT00081263|470295509|FG000|Overall Study|improper pre-protocol therapy|0|||
130638711|NCT00081263|470295510|FG001|Overall Study|improper pre-protocol therapy|1|||
130638712|NCT00081263|470295509|FG000|Overall Study|Inadequate pathology|0|||
130638713|NCT00081263|470295510|FG001|Overall Study|Inadequate pathology|1|||
130638714|NCT00081263|470295509|FG000|Overall Study|Never treated|4|||
130638715|NCT00081263|470295510|FG001|Overall Study|Never treated|5|||
130638716|NCT00081263|470295509|FG000|Overall Study|Inadequate data|5|||
130638717|NCT00081263|470295510|FG001|Overall Study|Inadequate data|10|||
130638718|NCT04564027|470295525|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
130638719|NCT04564027|470295526|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
130638720|NCT04564027|470295527|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
130638721|NCT04564027|470295528|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
130638722|NCT01267955|470295531|FG000|Stage 1 (6 Months)|Death|3|||
130638723|NCT01267955|470295531|FG000|Stage 2 (6 Months)|Death|5|||
130638724|NCT01267955|470295531|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
130638725|NCT04517253|470295534|FG000|Primary Treatment Period|Adverse Event|1|||
130638726|NCT04517253|470295535|FG001|Primary Treatment Period|Adverse Event|0|||
130638727|NCT04517253|470295536|FG002|Primary Treatment Period|Adverse Event|0|||
130638728|NCT04517253|470295534|FG000|Primary Treatment Period|Death|0|||
130638729|NCT04517253|470295535|FG001|Primary Treatment Period|Death|1|||
130638730|NCT04517253|470295536|FG002|Primary Treatment Period|Death|0|||
130638731|NCT04517253|470295534|FG000|Maintenance Period|Withdrawal by Subject|1|||
130638732|NCT04517253|470295535|FG001|Maintenance Period|Withdrawal by Subject|0|||
130638733|NCT04517253|470295536|FG002|Maintenance Period|Withdrawal by Subject|0|||
130638734|NCT04517253|470295534|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
130638735|NCT04517253|470295535|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
130638736|NCT04517253|470295536|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
130638737|NCT06048367|470295541|FG000|Overall Study|Withdrawal by Subject|0|||
130638738|NCT06048367|470295542|FG001|Overall Study|Withdrawal by Subject|1|||
130638739|NCT06048367|470295543|FG002|Overall Study|Withdrawal by Subject|0|||
130638740|NCT06048367|470295544|FG003|Overall Study|Withdrawal by Subject|0|||
130638741|NCT06048367|470295545|FG004|Overall Study|Withdrawal by Subject|0|||
130638742|NCT06048367|470295541|FG000|Overall Study|Withdrawal by Subject|0|||
130638743|NCT06048367|470295542|FG001|Overall Study|Withdrawal by Subject|0|||
130638744|NCT06048367|470295543|FG002|Overall Study|Withdrawal by Subject|1|||
130638745|NCT06048367|470295544|FG003|Overall Study|Withdrawal by Subject|0|||
130638746|NCT06048367|470295545|FG004|Overall Study|Withdrawal by Subject|0|||
130638747|NCT06048367|470295541|FG000|Overall Study|Withdrawal by Subject|0|||
130638748|NCT06048367|470295542|FG001|Overall Study|Withdrawal by Subject|0|||
130638749|NCT06048367|470295543|FG002|Overall Study|Withdrawal by Subject|0|||
130638750|NCT06048367|470295544|FG003|Overall Study|Withdrawal by Subject|1|||
130638751|NCT06048367|470295545|FG004|Overall Study|Withdrawal by Subject|0|||
130638752|NCT06048367|470295541|FG000|Overall Study|Withdrawal by Subject|0|||
130638753|NCT06048367|470295542|FG001|Overall Study|Withdrawal by Subject|0|||
130638754|NCT06048367|470295543|FG002|Overall Study|Withdrawal by Subject|0|||
130638755|NCT06048367|470295544|FG003|Overall Study|Withdrawal by Subject|1|||
130638756|NCT06048367|470295545|FG004|Overall Study|Withdrawal by Subject|0|||
130638757|NCT05549505|470295549|FG000|Overall Study|Lost to Follow-up|2|||
130638758|NCT05549505|470295550|FG001|Overall Study|Lost to Follow-up|0|||
130638759|NCT05549505|470295549|FG000|Overall Study|Withdrawal by Subject|3|||
130638760|NCT05549505|470295550|FG001|Overall Study|Withdrawal by Subject|3|||
130638761|NCT05549505|470295549|FG000|Overall Study|Other: Miscellaneous|3|||
130638762|NCT05549505|470295550|FG001|Overall Study|Other: Miscellaneous|6|||
130638763|NCT01602822|470295553|FG000|Overall Study|Adverse Event|11|||
130638764|NCT05492877|470295557|FG000|Overall Study|Adverse Event|11|||
130638765|NCT05492877|470295558|FG001|Overall Study|Adverse Event|7|||
130638766|NCT05492877|470295557|FG000|Overall Study|Death|1|||
130638767|NCT05492877|470295558|FG001|Overall Study|Death|0|||
130638768|NCT05492877|470295557|FG000|Overall Study|Lost to Follow-up|1|||
130638769|NCT05492877|470295558|FG001|Overall Study|Lost to Follow-up|1|||
130638770|NCT05492877|470295557|FG000|Overall Study|Physician Decision|1|||
130638771|NCT05492877|470295558|FG001|Overall Study|Physician Decision|2|||
130638772|NCT05492877|470295557|FG000|Overall Study|Protocol Violation|1|||
130638773|NCT05492877|470295558|FG001|Overall Study|Protocol Violation|1|||
130638774|NCT05492877|470295557|FG000|Overall Study|Withdrawal by Subject|3|||
130638775|NCT05492877|470295558|FG001|Overall Study|Withdrawal by Subject|7|||
130638776|NCT05492877|470295557|FG000|Overall Study|Reason not specified|6|||
130638777|NCT05492877|470295558|FG001|Overall Study|Reason not specified|4|||
130638778|NCT02286089|470295559|FG000|Overall Study|Ongoing in Study|1|||
130638779|NCT02286089|470295560|FG001|Overall Study|Ongoing in Study|1|||
130638780|NCT02286089|470295561|FG002|Overall Study|Ongoing in Study|4|||
130638781|NCT02286089|470295562|FG003|Overall Study|Ongoing in Study|10|||
130638782|NCT02286089|470295559|FG000|Overall Study|Withdrawal by Subject|0|||
130638783|NCT02286089|470295560|FG001|Overall Study|Withdrawal by Subject|0|||
130638784|NCT02286089|470295561|FG002|Overall Study|Withdrawal by Subject|2|||
130638785|NCT02286089|470295562|FG003|Overall Study|Withdrawal by Subject|2|||
130638786|NCT00129376|470295563|FG000|Overall Study|Adverse Event|1|||
130638787|NCT00129376|470295563|FG000|Overall Study|Lack of Efficacy|1|||
130638788|NCT03218826|470295564|FG000|Overall Study|Non-compliance with protocol|1|||
130638789|NCT03218826|470295565|FG001|Overall Study|Non-compliance with protocol|0|||
130638790|NCT03218826|470295566|FG002|Overall Study|Non-compliance with protocol|2|||
130638791|NCT03218826|470295567|FG003|Overall Study|Non-compliance with protocol|1|||
130638792|NCT03218826|470295568|FG004|Overall Study|Non-compliance with protocol|1|||
130638793|NCT01426009|470295569|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
130638794|NCT01426009|470295569|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
130638795|NCT01426009|470295569|FG000|Washout 1|Withdrawal by Subject|1|||
130638796|NCT01426009|470295569|FG000|Washout 1|Personal Reasons|1|||
130638797|NCT01426009|470295569|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
130638798|NCT01426009|470295569|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
130638799|NCT01426009|470295569|FG000|Washout 2|electrive surgery|1|||
130638800|NCT01426009|470295569|FG000|Washout 3|personal reasons|1|||
130638801|NCT01426009|470295569|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
130638802|NCT01426009|470295569|FG000|Washout 4|Lost to Follow-up|1|||
130638803|NCT00515099|470295576|FG000|Overall Study|Lost to Follow-up|0|||
130638804|NCT00515099|470295577|FG001|Overall Study|Lost to Follow-up|4|||
130638805|NCT00515099|470295576|FG000|Overall Study|Withdrawal by Subject|2|||
130638806|NCT00515099|470295577|FG001|Overall Study|Withdrawal by Subject|0|||
130638807|NCT00515099|470295576|FG000|Overall Study|IRB Recommendation|1|||
130638808|NCT00515099|470295577|FG001|Overall Study|IRB Recommendation|0|||
130638809|NCT04476108|470295578|FG000|Overall Study|Adverse Event|4|||
130638810|NCT04476108|470295579|FG001|Overall Study|Adverse Event|1|||
130638811|NCT04476108|470295578|FG000|Overall Study|Lost to Follow-up|1|||
130638812|NCT04476108|470295579|FG001|Overall Study|Lost to Follow-up|0|||
130638813|NCT04476108|470295578|FG000|Overall Study|Inadvertent Enrollment|1|||
130638814|NCT04476108|470295579|FG001|Overall Study|Inadvertent Enrollment|0|||
130638815|NCT04476108|470295578|FG000|Overall Study|Protocol Violation|1|||
130638816|NCT04476108|470295579|FG001|Overall Study|Protocol Violation|1|||
130638817|NCT04476108|470295578|FG000|Overall Study|Withdrawal by Subject|1|||
130638818|NCT04476108|470295579|FG001|Overall Study|Withdrawal by Subject|1|||
130638819|NCT03685643|470295582|FG000|Overall Study|Lost to Follow-up|14|||
130638820|NCT03685643|470295583|FG001|Overall Study|Lost to Follow-up|22|||
130638821|NCT01197794|470295586|FG000|Overall Study|Adverse Event|3|||
130638822|NCT01197794|470295587|FG001|Overall Study|Adverse Event|2|||
130638823|NCT01197794|470295588|FG002|Overall Study|Adverse Event|4|||
130638824|NCT01197794|470295589|FG003|Overall Study|Adverse Event|4|||
130638825|NCT01197794|470295590|FG004|Overall Study|Adverse Event|4|||
130638826|NCT01197794|470295591|FG005|Overall Study|Adverse Event|2|||
130638827|NCT01197794|470295592|FG006|Overall Study|Adverse Event|3|||
130638828|NCT01197794|470295586|FG000|Overall Study|Protocol Violation|0|||
130638829|NCT01197794|470295587|FG001|Overall Study|Protocol Violation|0|||
130638830|NCT01197794|470295588|FG002|Overall Study|Protocol Violation|0|||
130638831|NCT01197794|470295589|FG003|Overall Study|Protocol Violation|0|||
130638832|NCT01197794|470295590|FG004|Overall Study|Protocol Violation|2|||
130638833|NCT01197794|470295591|FG005|Overall Study|Protocol Violation|0|||
130638834|NCT01197794|470295592|FG006|Overall Study|Protocol Violation|1|||
130638835|NCT01197794|470295586|FG000|Overall Study|Development of study withdrawal criteria|3|||
130638836|NCT01197794|470295587|FG001|Overall Study|Development of study withdrawal criteria|0|||
130638837|NCT01197794|470295588|FG002|Overall Study|Development of study withdrawal criteria|0|||
130638838|NCT01197794|470295589|FG003|Overall Study|Development of study withdrawal criteria|1|||
130638839|NCT01197794|470295590|FG004|Overall Study|Development of study withdrawal criteria|0|||
130638840|NCT01197794|470295591|FG005|Overall Study|Development of study withdrawal criteria|0|||
130638841|NCT01197794|470295592|FG006|Overall Study|Development of study withdrawal criteria|1|||
130638842|NCT01197794|470295586|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
130638843|NCT01197794|470295587|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
130638844|NCT01197794|470295588|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130638845|NCT01197794|470295589|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
130638846|NCT01197794|470295590|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
130638847|NCT01197794|470295591|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
130638848|NCT01197794|470295592|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
130638849|NCT01197794|470295586|FG000|Overall Study|Withdrawal by Subject|3|||
130638850|NCT01197794|470295587|FG001|Overall Study|Withdrawal by Subject|3|||
130638851|NCT01197794|470295588|FG002|Overall Study|Withdrawal by Subject|4|||
130638852|NCT01197794|470295589|FG003|Overall Study|Withdrawal by Subject|1|||
130638853|NCT01197794|470295590|FG004|Overall Study|Withdrawal by Subject|1|||
130638854|NCT01197794|470295591|FG005|Overall Study|Withdrawal by Subject|5|||
130638855|NCT01197794|470295592|FG006|Overall Study|Withdrawal by Subject|6|||
130638856|NCT01197794|470295586|FG000|Overall Study|Lost to Follow-up|1|||
130638857|NCT01197794|470295587|FG001|Overall Study|Lost to Follow-up|1|||
130638858|NCT01197794|470295588|FG002|Overall Study|Lost to Follow-up|0|||
130638859|NCT01197794|470295589|FG003|Overall Study|Lost to Follow-up|1|||
130638860|NCT01197794|470295590|FG004|Overall Study|Lost to Follow-up|0|||
130638861|NCT01197794|470295591|FG005|Overall Study|Lost to Follow-up|1|||
130638862|NCT01197794|470295592|FG006|Overall Study|Lost to Follow-up|0|||
130638863|NCT01197794|470295586|FG000|Overall Study|Other|1|||
130638864|NCT01197794|470295587|FG001|Overall Study|Other|1|||
130638865|NCT01197794|470295588|FG002|Overall Study|Other|3|||
130638866|NCT01197794|470295589|FG003|Overall Study|Other|0|||
130638867|NCT01197794|470295590|FG004|Overall Study|Other|2|||
130638868|NCT01197794|470295591|FG005|Overall Study|Other|2|||
130638869|NCT01197794|470295592|FG006|Overall Study|Other|4|||
130638870|NCT01055457|470295593|FG000|Overall Study|Lost to Follow-up|0|||
130638871|NCT01055457|470295594|FG001|Overall Study|Lost to Follow-up|1|||
130638872|NCT01055457|470295595|FG002|Overall Study|Lost to Follow-up|0|||
130638873|NCT01055457|470295596|FG003|Overall Study|Lost to Follow-up|0|||
130638874|NCT01055457|470295597|FG004|Overall Study|Lost to Follow-up|0|||
130638875|NCT01055457|470295598|FG005|Overall Study|Lost to Follow-up|1|||
130638876|NCT01055457|470295599|FG006|Overall Study|Lost to Follow-up|0|||
130638877|NCT01055457|470295600|FG007|Overall Study|Lost to Follow-up|0|||
130638878|NCT01055457|470295601|FG008|Overall Study|Lost to Follow-up|0|||
130638879|NCT01055457|470295602|FG009|Overall Study|Lost to Follow-up|0|||
130638880|NCT01055457|470295593|FG000|Overall Study|Protocol Violation|0|||
130638881|NCT01055457|470295594|FG001|Overall Study|Protocol Violation|0|||
130638882|NCT01055457|470295595|FG002|Overall Study|Protocol Violation|1|||
130638883|NCT01055457|470295596|FG003|Overall Study|Protocol Violation|1|||
130638884|NCT01055457|470295597|FG004|Overall Study|Protocol Violation|1|||
130638885|NCT01055457|470295598|FG005|Overall Study|Protocol Violation|2|||
130638886|NCT01055457|470295599|FG006|Overall Study|Protocol Violation|1|||
130638887|NCT01055457|470295600|FG007|Overall Study|Protocol Violation|0|||
130638888|NCT01055457|470295601|FG008|Overall Study|Protocol Violation|0|||
130638889|NCT01055457|470295602|FG009|Overall Study|Protocol Violation|1|||
130638890|NCT01055457|470295593|FG000|Overall Study|Subject Disinterest|0|||
130638891|NCT01055457|470295594|FG001|Overall Study|Subject Disinterest|0|||
130638892|NCT01055457|470295595|FG002|Overall Study|Subject Disinterest|0|||
130638893|NCT01055457|470295596|FG003|Overall Study|Subject Disinterest|0|||
130638894|NCT01055457|470295597|FG004|Overall Study|Subject Disinterest|0|||
130638895|NCT01055457|470295598|FG005|Overall Study|Subject Disinterest|0|||
130638896|NCT01055457|470295599|FG006|Overall Study|Subject Disinterest|0|||
130638897|NCT01055457|470295600|FG007|Overall Study|Subject Disinterest|1|||
130638898|NCT01055457|470295601|FG008|Overall Study|Subject Disinterest|0|||
130638899|NCT01055457|470295602|FG009|Overall Study|Subject Disinterest|0|||
130638900|NCT01055457|470295593|FG000|Overall Study|Subject Ineligible|1|||
130638901|NCT01055457|470295594|FG001|Overall Study|Subject Ineligible|0|||
130638902|NCT01055457|470295595|FG002|Overall Study|Subject Ineligible|1|||
130638903|NCT01055457|470295596|FG003|Overall Study|Subject Ineligible|0|||
130638904|NCT01055457|470295597|FG004|Overall Study|Subject Ineligible|1|||
130638905|NCT01055457|470295598|FG005|Overall Study|Subject Ineligible|0|||
130638906|NCT01055457|470295599|FG006|Overall Study|Subject Ineligible|0|||
130638907|NCT01055457|470295600|FG007|Overall Study|Subject Ineligible|0|||
130638908|NCT01055457|470295601|FG008|Overall Study|Subject Ineligible|0|||
130638909|NCT01055457|470295602|FG009|Overall Study|Subject Ineligible|0|||
130638910|NCT01055457|470295593|FG000|Overall Study|Discomfort|0|||
130638911|NCT01055457|470295594|FG001|Overall Study|Discomfort|0|||
130638912|NCT01055457|470295595|FG002|Overall Study|Discomfort|0|||
130638913|NCT01055457|470295596|FG003|Overall Study|Discomfort|0|||
130638914|NCT01055457|470295597|FG004|Overall Study|Discomfort|1|||
130638915|NCT01055457|470295598|FG005|Overall Study|Discomfort|0|||
130638916|NCT01055457|470295599|FG006|Overall Study|Discomfort|0|||
130638917|NCT01055457|470295600|FG007|Overall Study|Discomfort|0|||
130638918|NCT01055457|470295601|FG008|Overall Study|Discomfort|0|||
130638919|NCT01055457|470295602|FG009|Overall Study|Discomfort|0|||
130638920|NCT01055457|470295593|FG000|Overall Study|Pregnancy|0|||
130638921|NCT01055457|470295594|FG001|Overall Study|Pregnancy|0|||
130638922|NCT01055457|470295595|FG002|Overall Study|Pregnancy|0|||
130638923|NCT01055457|470295596|FG003|Overall Study|Pregnancy|1|||
130638924|NCT01055457|470295597|FG004|Overall Study|Pregnancy|0|||
130638925|NCT01055457|470295598|FG005|Overall Study|Pregnancy|0|||
130638926|NCT01055457|470295599|FG006|Overall Study|Pregnancy|0|||
130638927|NCT01055457|470295600|FG007|Overall Study|Pregnancy|0|||
130638928|NCT01055457|470295601|FG008|Overall Study|Pregnancy|0|||
130638929|NCT01055457|470295602|FG009|Overall Study|Pregnancy|0|||
130638930|NCT01055457|470295593|FG000|Overall Study|Adverse Event|0|||
130638931|NCT01055457|470295594|FG001|Overall Study|Adverse Event|0|||
130638932|NCT01055457|470295595|FG002|Overall Study|Adverse Event|0|||
130638933|NCT01055457|470295596|FG003|Overall Study|Adverse Event|1|||
130638934|NCT01055457|470295597|FG004|Overall Study|Adverse Event|0|||
130638935|NCT01055457|470295598|FG005|Overall Study|Adverse Event|0|||
130638936|NCT01055457|470295599|FG006|Overall Study|Adverse Event|0|||
130638937|NCT01055457|470295600|FG007|Overall Study|Adverse Event|0|||
130638938|NCT01055457|470295601|FG008|Overall Study|Adverse Event|0|||
130638939|NCT01055457|470295602|FG009|Overall Study|Adverse Event|0|||
130638940|NCT04055844|470295603|FG000|Overall Study|Adverse Event|12|||
130638941|NCT04055844|470295603|FG000|Overall Study|Poor Performance|1|||
130638942|NCT04055844|470295603|FG000|Overall Study|Death|1|||
130638943|NCT00572728|470295608|FG000|Overall Study|Withdrawal by Subject|10|||
130638944|NCT00572728|470295608|FG000|Overall Study|Ineligible|3|||
130638945|NCT00572728|470295608|FG000|Overall Study|Enrolled under Amendment 4|5|||
130638946|NCT00572728|470295608|FG000|Overall Study|Offstudy due to complicating disease|1|||
130638947|NCT00572728|470295608|FG000|Overall Study|FLT1 not completed|4|||
130638948|NCT00572728|470295608|FG000|Overall Study|First Chemotherapy not initiated|2|||
130638949|NCT00572728|470295608|FG000|Overall Study|FLT2 not completed|5|||
130638950|NCT00572728|470295608|FG000|Overall Study|Second chemotherapy not initiated|1|||
130638951|NCT00572728|470295608|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
130638952|NCT00572728|470295608|FG000|Overall Study|Pathology missing|1|||
130638953|NCT03630016|470295613|FG000|Overall Study|Poor Sensor Placement|1|||
130638954|NCT00002981|470295614|FG000|Overall Study|Inevaluable|6|||
130638955|NCT02724111|470295617|FG000|Overall Study|Protocol Violation|2|||
130638956|NCT02724111|470295618|FG001|Overall Study|Protocol Violation|5|||
130638957|NCT01828567|470295619|FG000|Overall Study|Lost to Follow-up|27|||
130638958|NCT01828567|470295620|FG001|Overall Study|Lost to Follow-up|9|||
130638959|NCT01828567|470295619|FG000|Overall Study|Excluded - did not meet criteria|4|||
130638960|NCT01828567|470295620|FG001|Overall Study|Excluded - did not meet criteria|1|||
130638961|NCT01885104|470295621|FG000|Overall Study|Withdrawal of Consent|1|||
130638962|NCT01885104|470295622|FG001|Overall Study|Withdrawal of Consent|0|||
130638963|NCT01885104|470295621|FG000|Overall Study|Lost to Follow-up|0|||
130638964|NCT01885104|470295622|FG001|Overall Study|Lost to Follow-up|1|||
130638965|NCT01885104|470295621|FG000|Overall Study|Physician Decision|1|||
130638966|NCT01885104|470295622|FG001|Overall Study|Physician Decision|0|||
130638967|NCT00113555|470295624|FG000|Overall Study|Baseline Failure|59|||
130638968|NCT00113555|470295624|FG000|Overall Study|Permanently Explanted|7|||
130638969|NCT00113555|470295624|FG000|Overall Study|Death|1|||
130638970|NCT00113555|470295624|FG000|Overall Study|Missed Followup|4|||
130638971|NCT00113555|470295624|FG000|Overall Study|Lost to Follow-up|8|||
130638972|NCT05307523|470295625|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
130638973|NCT05307523|470295626|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
130638974|NCT05307523|470295625|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
130638975|NCT05307523|470295626|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
130638976|NCT00374127|470295627|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
130638977|NCT00374127|470295627|FG000|Overall Study|Blood could not be drawn.|2|||
130638978|NCT00374127|470295627|FG000|Overall Study|Protocol Violation|5|||
130638979|NCT00374127|470295627|FG000|Overall Study|Pregnancy|1|||
130638980|NCT04035473|470295628|FG000|Screening/Baseline|Death|0|||
130638981|NCT04035473|470295629|FG001|Screening/Baseline|Death|1|||
130638982|NCT04035473|470295628|FG000|Screening/Baseline|Adverse Event|0|||
130638983|NCT04035473|470295629|FG001|Screening/Baseline|Adverse Event|1|||
130638984|NCT04035473|470295628|FG000|Follow-up Period|Adverse Event|2|||
130638985|NCT04035473|470295629|FG001|Follow-up Period|Adverse Event|0|||
130638986|NCT02875366|470295630|FG000|Overall Study|Adverse Event|0|||
130638987|NCT02875366|470295631|FG001|Overall Study|Adverse Event|2|||
130638988|NCT02875366|470295630|FG000|Overall Study|Noncompliance|0|||
130638989|NCT02875366|470295631|FG001|Overall Study|Noncompliance|1|||
130638990|NCT02735044|470295632|FG000|Overall Study|Adverse Event|3|||
130638991|NCT02735044|470295633|FG001|Overall Study|Adverse Event|3|||
130638992|NCT02735044|470295632|FG000|Overall Study|Lack of Efficacy|1|||
130638993|NCT02735044|470295633|FG001|Overall Study|Lack of Efficacy|0|||
130638994|NCT02735044|470295632|FG000|Overall Study|Poor compliance to protocol|7|||
130638995|NCT02735044|470295633|FG001|Overall Study|Poor compliance to protocol|7|||
130638996|NCT02735044|470295632|FG000|Overall Study|Randomized and not treated|0|||
130638997|NCT02735044|470295633|FG001|Overall Study|Randomized and not treated|2|||
130638998|NCT02735044|470295632|FG000|Overall Study|Other, not specified above|5|||
130638999|NCT02735044|470295633|FG001|Overall Study|Other, not specified above|11|||
130639000|NCT01201967|470295636|FG000|Overall Study|Lost to Follow-up|6|||
130639001|NCT01201967|470295637|FG001|Overall Study|Lost to Follow-up|5|||
130639002|NCT04191096|470295641|FG000|Overall Study|Death|102|||
130639003|NCT04191096|470295642|FG001|Overall Study|Death|89|||
130639004|NCT04191096|470295641|FG000|Overall Study|Lost to Follow-up|1|||
130639005|NCT04191096|470295642|FG001|Overall Study|Lost to Follow-up|1|||
130639006|NCT04191096|470295641|FG000|Overall Study|Withdrawal by Subject|5|||
130639007|NCT04191096|470295642|FG001|Overall Study|Withdrawal by Subject|5|||
130639008|NCT04191096|470295641|FG000|Overall Study|Participants Ongoing|518|||
130639009|NCT04191096|470295642|FG001|Overall Study|Participants Ongoing|530|||
130639010|NCT03128307|470295643|FG000|Overall Study|Lost to Follow-up|29|||
130639011|NCT03128307|470295643|FG000|Overall Study|Withdrawal by Subject|5|||
130639012|NCT01888965|470297578|FG000|Overall Study|Adverse Event|5|||
130639013|NCT01888965|470297578|FG000|Overall Study|Lack of Efficacy|4|||
130639014|NCT01693562|470297579|FG000|Escalation Phase|Withdrawal by Subject|0|||
130639015|NCT01693562|470297580|FG001|Escalation Phase|Withdrawal by Subject|1|||
130639016|NCT01693562|470297581|FG002|Escalation Phase|Withdrawal by Subject|0|||
130639017|NCT01693562|470297582|FG003|Escalation Phase|Withdrawal by Subject|0|||
130639018|NCT01693562|470297583|FG004|Escalation Phase|Withdrawal by Subject|0|||
130639019|NCT01693562|470297584|FG005|Escalation Phase|Withdrawal by Subject|2|||
130639020|NCT01693562|470297585|FG006|Escalation Phase|Withdrawal by Subject|0|||
130639021|NCT01693562|470297586|FG007|Escalation Phase|Withdrawal by Subject|0|||
130639022|NCT01693562|470297587|FG008|Escalation Phase|Withdrawal by Subject|0|||
130639023|NCT01693562|470297588|FG009|Escalation Phase|Withdrawal by Subject|0|||
130639024|NCT01693562|470297589|FG010|Escalation Phase|Withdrawal by Subject|0|||
130639025|NCT01693562|470297590|FG011|Escalation Phase|Withdrawal by Subject|0|||
130639026|NCT01693562|470297591|FG012|Escalation Phase|Withdrawal by Subject|0|||
130639027|NCT01693562|470297592|FG013|Escalation Phase|Withdrawal by Subject|0|||
130639028|NCT01693562|470297593|FG014|Escalation Phase|Withdrawal by Subject|0|||
130639029|NCT01693562|470297594|FG015|Escalation Phase|Withdrawal by Subject|0|||
130639030|NCT01693562|470297595|FG016|Escalation Phase|Withdrawal by Subject|0|||
130639031|NCT01693562|470297596|FG017|Escalation Phase|Withdrawal by Subject|0|||
130639032|NCT01693562|470297597|FG018|Escalation Phase|Withdrawal by Subject|0|||
130639033|NCT01693562|470297598|FG019|Escalation Phase|Withdrawal by Subject|0|||
130639034|NCT01693562|470297599|FG020|Escalation Phase|Withdrawal by Subject|0|||
130639035|NCT01693562|470297600|FG021|Escalation Phase|Withdrawal by Subject|0|||
130639036|NCT01693562|470297601|FG022|Escalation Phase|Withdrawal by Subject|0|||
130639037|NCT01693562|470297579|FG000|Escalation Phase|Death|4|||
130639038|NCT01693562|470297580|FG001|Escalation Phase|Death|2|||
130639039|NCT01693562|470297581|FG002|Escalation Phase|Death|0|||
130639040|NCT01693562|470297582|FG003|Escalation Phase|Death|3|||
130639041|NCT01693562|470297583|FG004|Escalation Phase|Death|6|||
130639042|NCT01693562|470297584|FG005|Escalation Phase|Death|4|||
130639043|NCT01693562|470297585|FG006|Escalation Phase|Death|0|||
130639044|NCT01693562|470297586|FG007|Escalation Phase|Death|0|||
130639045|NCT01693562|470297587|FG008|Escalation Phase|Death|0|||
130639046|NCT01693562|470297588|FG009|Escalation Phase|Death|0|||
130639047|NCT01693562|470297589|FG010|Escalation Phase|Death|0|||
130639048|NCT01693562|470297590|FG011|Escalation Phase|Death|0|||
130639049|NCT01693562|470297591|FG012|Escalation Phase|Death|0|||
130639050|NCT01693562|470297592|FG013|Escalation Phase|Death|0|||
130639051|NCT01693562|470297593|FG014|Escalation Phase|Death|0|||
130639052|NCT01693562|470297594|FG015|Escalation Phase|Death|0|||
130639053|NCT01693562|470297595|FG016|Escalation Phase|Death|0|||
130639054|NCT01693562|470297596|FG017|Escalation Phase|Death|0|||
130639055|NCT01693562|470297597|FG018|Escalation Phase|Death|0|||
130639056|NCT01693562|470297598|FG019|Escalation Phase|Death|0|||
130639057|NCT01693562|470297599|FG020|Escalation Phase|Death|0|||
130639058|NCT01693562|470297600|FG021|Escalation Phase|Death|0|||
130639059|NCT01693562|470297601|FG022|Escalation Phase|Death|0|||
130639060|NCT01693562|470297579|FG000|Escalation Phase|Lost to Follow-up|0|||
130639061|NCT01693562|470297580|FG001|Escalation Phase|Lost to Follow-up|1|||
130639062|NCT01693562|470297581|FG002|Escalation Phase|Lost to Follow-up|1|||
130639063|NCT01693562|470297582|FG003|Escalation Phase|Lost to Follow-up|0|||
130639064|NCT01693562|470297583|FG004|Escalation Phase|Lost to Follow-up|0|||
130639065|NCT01693562|470297584|FG005|Escalation Phase|Lost to Follow-up|0|||
130639066|NCT01693562|470297585|FG006|Escalation Phase|Lost to Follow-up|0|||
130639067|NCT01693562|470297586|FG007|Escalation Phase|Lost to Follow-up|0|||
130639068|NCT01693562|470297587|FG008|Escalation Phase|Lost to Follow-up|0|||
130639069|NCT01693562|470297588|FG009|Escalation Phase|Lost to Follow-up|0|||
130639070|NCT01693562|470297589|FG010|Escalation Phase|Lost to Follow-up|0|||
130639071|NCT01693562|470297590|FG011|Escalation Phase|Lost to Follow-up|0|||
130639072|NCT01693562|470297591|FG012|Escalation Phase|Lost to Follow-up|0|||
130639073|NCT01693562|470297592|FG013|Escalation Phase|Lost to Follow-up|0|||
130639074|NCT01693562|470297593|FG014|Escalation Phase|Lost to Follow-up|0|||
130639075|NCT01693562|470297594|FG015|Escalation Phase|Lost to Follow-up|0|||
130639076|NCT01693562|470297595|FG016|Escalation Phase|Lost to Follow-up|0|||
130639077|NCT01693562|470297596|FG017|Escalation Phase|Lost to Follow-up|0|||
130639078|NCT01693562|470297597|FG018|Escalation Phase|Lost to Follow-up|0|||
130639079|NCT01693562|470297598|FG019|Escalation Phase|Lost to Follow-up|0|||
130639080|NCT01693562|470297599|FG020|Escalation Phase|Lost to Follow-up|0|||
130639081|NCT01693562|470297600|FG021|Escalation Phase|Lost to Follow-up|0|||
130639082|NCT01693562|470297601|FG022|Escalation Phase|Lost to Follow-up|0|||
130639083|NCT01693562|470297579|FG000|Escalation Phase|Other|0|||
130639084|NCT01693562|470297580|FG001|Escalation Phase|Other|0|||
130639085|NCT01693562|470297581|FG002|Escalation Phase|Other|2|||
130639086|NCT01693562|470297582|FG003|Escalation Phase|Other|0|||
130639087|NCT01693562|470297583|FG004|Escalation Phase|Other|0|||
130639088|NCT01693562|470297584|FG005|Escalation Phase|Other|1|||
130639089|NCT01693562|470297585|FG006|Escalation Phase|Other|0|||
130639090|NCT01693562|470297586|FG007|Escalation Phase|Other|0|||
130639091|NCT01693562|470297587|FG008|Escalation Phase|Other|0|||
130639092|NCT01693562|470297588|FG009|Escalation Phase|Other|0|||
130639093|NCT01693562|470297589|FG010|Escalation Phase|Other|0|||
130639094|NCT01693562|470297590|FG011|Escalation Phase|Other|0|||
130639095|NCT01693562|470297591|FG012|Escalation Phase|Other|0|||
130639096|NCT01693562|470297592|FG013|Escalation Phase|Other|0|||
130639097|NCT01693562|470297593|FG014|Escalation Phase|Other|0|||
130639098|NCT01693562|470297594|FG015|Escalation Phase|Other|0|||
130639099|NCT01693562|470297595|FG016|Escalation Phase|Other|0|||
130639100|NCT01693562|470297596|FG017|Escalation Phase|Other|0|||
130639101|NCT01693562|470297597|FG018|Escalation Phase|Other|0|||
130639102|NCT01693562|470297598|FG019|Escalation Phase|Other|0|||
130639103|NCT01693562|470297599|FG020|Escalation Phase|Other|0|||
130639104|NCT01693562|470297600|FG021|Escalation Phase|Other|0|||
130639105|NCT01693562|470297601|FG022|Escalation Phase|Other|0|||
130639106|NCT01693562|470297579|FG000|Exploration Phase|Withdrawal by Subject|0|||
130639107|NCT01693562|470297580|FG001|Exploration Phase|Withdrawal by Subject|0|||
130639108|NCT01693562|470297581|FG002|Exploration Phase|Withdrawal by Subject|0|||
130639109|NCT01693562|470297582|FG003|Exploration Phase|Withdrawal by Subject|0|||
130639110|NCT01693562|470297583|FG004|Exploration Phase|Withdrawal by Subject|0|||
130639111|NCT01693562|470297584|FG005|Exploration Phase|Withdrawal by Subject|0|||
130639112|NCT01693562|470297585|FG006|Exploration Phase|Withdrawal by Subject|2|||
130639113|NCT01693562|470297586|FG007|Exploration Phase|Withdrawal by Subject|0|||
130639114|NCT01693562|470297587|FG008|Exploration Phase|Withdrawal by Subject|0|||
130639115|NCT01693562|470297588|FG009|Exploration Phase|Withdrawal by Subject|0|||
130639116|NCT01693562|470297589|FG010|Exploration Phase|Withdrawal by Subject|0|||
130639117|NCT01693562|470297590|FG011|Exploration Phase|Withdrawal by Subject|0|||
130639118|NCT01693562|470297591|FG012|Exploration Phase|Withdrawal by Subject|0|||
130639119|NCT01693562|470297592|FG013|Exploration Phase|Withdrawal by Subject|0|||
130639120|NCT01693562|470297593|FG014|Exploration Phase|Withdrawal by Subject|0|||
130639121|NCT01693562|470297594|FG015|Exploration Phase|Withdrawal by Subject|0|||
130639122|NCT01693562|470297595|FG016|Exploration Phase|Withdrawal by Subject|0|||
130639123|NCT01693562|470297596|FG017|Exploration Phase|Withdrawal by Subject|0|||
130639124|NCT01693562|470297597|FG018|Exploration Phase|Withdrawal by Subject|0|||
130639125|NCT01693562|470297598|FG019|Exploration Phase|Withdrawal by Subject|0|||
130639126|NCT01693562|470297599|FG020|Exploration Phase|Withdrawal by Subject|0|||
130639127|NCT01693562|470297600|FG021|Exploration Phase|Withdrawal by Subject|0|||
130639128|NCT01693562|470297601|FG022|Exploration Phase|Withdrawal by Subject|0|||
130639129|NCT01693562|470297579|FG000|Exploration Phase|Death|0|||
130639130|NCT01693562|470297580|FG001|Exploration Phase|Death|0|||
130639131|NCT01693562|470297581|FG002|Exploration Phase|Death|0|||
130639132|NCT01693562|470297582|FG003|Exploration Phase|Death|0|||
130639133|NCT01693562|470297583|FG004|Exploration Phase|Death|0|||
130639134|NCT01693562|470297584|FG005|Exploration Phase|Death|0|||
130639135|NCT01693562|470297585|FG006|Exploration Phase|Death|17|||
130639136|NCT01693562|470297586|FG007|Exploration Phase|Death|0|||
130639137|NCT01693562|470297587|FG008|Exploration Phase|Death|0|||
130639138|NCT01693562|470297588|FG009|Exploration Phase|Death|0|||
130639139|NCT01693562|470297589|FG010|Exploration Phase|Death|0|||
130639140|NCT01693562|470297590|FG011|Exploration Phase|Death|0|||
130639141|NCT01693562|470297591|FG012|Exploration Phase|Death|0|||
130639142|NCT01693562|470297592|FG013|Exploration Phase|Death|0|||
130639143|NCT01693562|470297593|FG014|Exploration Phase|Death|0|||
130639144|NCT01693562|470297594|FG015|Exploration Phase|Death|0|||
130639145|NCT01693562|470297595|FG016|Exploration Phase|Death|0|||
130639146|NCT01693562|470297596|FG017|Exploration Phase|Death|0|||
130639147|NCT01693562|470297597|FG018|Exploration Phase|Death|0|||
130639148|NCT01693562|470297598|FG019|Exploration Phase|Death|0|||
130639149|NCT01693562|470297599|FG020|Exploration Phase|Death|0|||
130639150|NCT01693562|470297600|FG021|Exploration Phase|Death|0|||
130639151|NCT01693562|470297601|FG022|Exploration Phase|Death|0|||
130639152|NCT01693562|470297579|FG000|Exploration Phase|Other|0|||
130639153|NCT01693562|470297580|FG001|Exploration Phase|Other|0|||
130639154|NCT01693562|470297581|FG002|Exploration Phase|Other|0|||
130639155|NCT01693562|470297582|FG003|Exploration Phase|Other|0|||
130639156|NCT01693562|470297583|FG004|Exploration Phase|Other|0|||
130639157|NCT01693562|470297584|FG005|Exploration Phase|Other|0|||
130639158|NCT01693562|470297585|FG006|Exploration Phase|Other|2|||
130639159|NCT01693562|470297586|FG007|Exploration Phase|Other|0|||
130639160|NCT01693562|470297587|FG008|Exploration Phase|Other|0|||
130639161|NCT01693562|470297588|FG009|Exploration Phase|Other|0|||
130639162|NCT01693562|470297589|FG010|Exploration Phase|Other|0|||
130639163|NCT01693562|470297590|FG011|Exploration Phase|Other|0|||
130639164|NCT01693562|470297591|FG012|Exploration Phase|Other|0|||
130639165|NCT01693562|470297592|FG013|Exploration Phase|Other|0|||
130639166|NCT01693562|470297593|FG014|Exploration Phase|Other|0|||
130639167|NCT01693562|470297594|FG015|Exploration Phase|Other|0|||
130639168|NCT01693562|470297595|FG016|Exploration Phase|Other|0|||
130639169|NCT01693562|470297596|FG017|Exploration Phase|Other|0|||
130639170|NCT01693562|470297597|FG018|Exploration Phase|Other|0|||
130639171|NCT01693562|470297598|FG019|Exploration Phase|Other|0|||
130639172|NCT01693562|470297599|FG020|Exploration Phase|Other|0|||
130639173|NCT01693562|470297600|FG021|Exploration Phase|Other|0|||
130639174|NCT01693562|470297601|FG022|Exploration Phase|Other|0|||
130639175|NCT01693562|470297579|FG000|Expansion Phase|Withdrawal by Subject|0|||
130639176|NCT01693562|470297580|FG001|Expansion Phase|Withdrawal by Subject|0|||
130639177|NCT01693562|470297581|FG002|Expansion Phase|Withdrawal by Subject|0|||
130639178|NCT01693562|470297582|FG003|Expansion Phase|Withdrawal by Subject|0|||
130639179|NCT01693562|470297583|FG004|Expansion Phase|Withdrawal by Subject|0|||
130639180|NCT01693562|470297584|FG005|Expansion Phase|Withdrawal by Subject|0|||
130639181|NCT01693562|470297585|FG006|Expansion Phase|Withdrawal by Subject|0|||
130639182|NCT01693562|470297586|FG007|Expansion Phase|Withdrawal by Subject|16|||
130639183|NCT01693562|470297587|FG008|Expansion Phase|Withdrawal by Subject|2|||
130639184|NCT01693562|470297588|FG009|Expansion Phase|Withdrawal by Subject|54|||
130639185|NCT01693562|470297589|FG010|Expansion Phase|Withdrawal by Subject|2|||
130639186|NCT01693562|470297590|FG011|Expansion Phase|Withdrawal by Subject|2|||
130639187|NCT01693562|470297591|FG012|Expansion Phase|Withdrawal by Subject|3|||
130639188|NCT01693562|470297592|FG013|Expansion Phase|Withdrawal by Subject|5|||
130639189|NCT01693562|470297593|FG014|Expansion Phase|Withdrawal by Subject|16|||
130639190|NCT01693562|470297594|FG015|Expansion Phase|Withdrawal by Subject|7|||
130639191|NCT01693562|470297595|FG016|Expansion Phase|Withdrawal by Subject|40|||
130639192|NCT01693562|470297596|FG017|Expansion Phase|Withdrawal by Subject|4|||
130639193|NCT01693562|470297597|FG018|Expansion Phase|Withdrawal by Subject|8|||
130639194|NCT01693562|470297598|FG019|Expansion Phase|Withdrawal by Subject|3|||
130639195|NCT01693562|470297599|FG020|Expansion Phase|Withdrawal by Subject|1|||
130639196|NCT01693562|470297600|FG021|Expansion Phase|Withdrawal by Subject|8|||
130639197|NCT01693562|470297601|FG022|Expansion Phase|Withdrawal by Subject|1|||
130639198|NCT01693562|470297579|FG000|Expansion Phase|Death|0|||
130639199|NCT01693562|470297580|FG001|Expansion Phase|Death|0|||
130639200|NCT01693562|470297581|FG002|Expansion Phase|Death|0|||
130639201|NCT01693562|470297582|FG003|Expansion Phase|Death|0|||
130639202|NCT01693562|470297583|FG004|Expansion Phase|Death|0|||
130639203|NCT01693562|470297584|FG005|Expansion Phase|Death|0|||
130639204|NCT01693562|470297585|FG006|Expansion Phase|Death|0|||
130639205|NCT01693562|470297586|FG007|Expansion Phase|Death|42|||
130639206|NCT01693562|470297587|FG008|Expansion Phase|Death|17|||
130639207|NCT01693562|470297588|FG009|Expansion Phase|Death|208|||
130639208|NCT01693562|470297589|FG010|Expansion Phase|Death|30|||
130639209|NCT01693562|470297590|FG011|Expansion Phase|Death|8|||
130639210|NCT01693562|470297591|FG012|Expansion Phase|Death|19|||
130639211|NCT01693562|470297592|FG013|Expansion Phase|Death|42|||
130639212|NCT01693562|470297593|FG014|Expansion Phase|Death|23|||
130639213|NCT01693562|470297594|FG015|Expansion Phase|Death|23|||
130639214|NCT01693562|470297595|FG016|Expansion Phase|Death|128|||
130639215|NCT01693562|470297596|FG017|Expansion Phase|Death|16|||
130639216|NCT01693562|470297597|FG018|Expansion Phase|Death|36|||
130639217|NCT01693562|470297598|FG019|Expansion Phase|Death|16|||
130639218|NCT01693562|470297599|FG020|Expansion Phase|Death|17|||
130639219|NCT01693562|470297600|FG021|Expansion Phase|Death|35|||
130639220|NCT01693562|470297601|FG022|Expansion Phase|Death|7|||
130639221|NCT01693562|470297579|FG000|Expansion Phase|Lost to Follow-up|0|||
130639222|NCT01693562|470297580|FG001|Expansion Phase|Lost to Follow-up|0|||
130639223|NCT01693562|470297581|FG002|Expansion Phase|Lost to Follow-up|0|||
130639224|NCT01693562|470297582|FG003|Expansion Phase|Lost to Follow-up|0|||
130639225|NCT01693562|470297583|FG004|Expansion Phase|Lost to Follow-up|0|||
130639226|NCT01693562|470297584|FG005|Expansion Phase|Lost to Follow-up|0|||
130639227|NCT01693562|470297585|FG006|Expansion Phase|Lost to Follow-up|0|||
130639228|NCT01693562|470297586|FG007|Expansion Phase|Lost to Follow-up|1|||
130639229|NCT01693562|470297587|FG008|Expansion Phase|Lost to Follow-up|2|||
130639230|NCT01693562|470297588|FG009|Expansion Phase|Lost to Follow-up|10|||
130639231|NCT01693562|470297589|FG010|Expansion Phase|Lost to Follow-up|4|||
130639232|NCT01693562|470297590|FG011|Expansion Phase|Lost to Follow-up|4|||
130639233|NCT01693562|470297591|FG012|Expansion Phase|Lost to Follow-up|1|||
130639234|NCT01693562|470297592|FG013|Expansion Phase|Lost to Follow-up|3|||
130639235|NCT01693562|470297593|FG014|Expansion Phase|Lost to Follow-up|0|||
130639236|NCT01693562|470297594|FG015|Expansion Phase|Lost to Follow-up|1|||
130639237|NCT01693562|470297595|FG016|Expansion Phase|Lost to Follow-up|1|||
130639238|NCT01693562|470297596|FG017|Expansion Phase|Lost to Follow-up|0|||
130639239|NCT01693562|470297597|FG018|Expansion Phase|Lost to Follow-up|2|||
130639240|NCT01693562|470297598|FG019|Expansion Phase|Lost to Follow-up|1|||
130639241|NCT01693562|470297599|FG020|Expansion Phase|Lost to Follow-up|2|||
130639242|NCT01693562|470297600|FG021|Expansion Phase|Lost to Follow-up|2|||
130639243|NCT01693562|470297601|FG022|Expansion Phase|Lost to Follow-up|1|||
130639244|NCT01693562|470297579|FG000|Expansion Phase|Other|0|||
130639245|NCT01693562|470297580|FG001|Expansion Phase|Other|0|||
130639246|NCT01693562|470297581|FG002|Expansion Phase|Other|0|||
130639247|NCT01693562|470297582|FG003|Expansion Phase|Other|0|||
130639248|NCT01693562|470297583|FG004|Expansion Phase|Other|0|||
130639249|NCT01693562|470297584|FG005|Expansion Phase|Other|0|||
130639250|NCT01693562|470297585|FG006|Expansion Phase|Other|0|||
130639251|NCT01693562|470297586|FG007|Expansion Phase|Other|3|||
130639252|NCT01693562|470297587|FG008|Expansion Phase|Other|1|||
130639253|NCT01693562|470297588|FG009|Expansion Phase|Other|28|||
130639254|NCT01693562|470297589|FG010|Expansion Phase|Other|4|||
130639255|NCT01693562|470297590|FG011|Expansion Phase|Other|7|||
130639256|NCT01693562|470297591|FG012|Expansion Phase|Other|0|||
130639257|NCT01693562|470297592|FG013|Expansion Phase|Other|1|||
130639258|NCT01693562|470297593|FG014|Expansion Phase|Other|1|||
130639259|NCT01693562|470297594|FG015|Expansion Phase|Other|0|||
130639260|NCT01693562|470297595|FG016|Expansion Phase|Other|28|||
130639261|NCT01693562|470297596|FG017|Expansion Phase|Other|0|||
130639262|NCT01693562|470297597|FG018|Expansion Phase|Other|1|||
130639263|NCT01693562|470297598|FG019|Expansion Phase|Other|0|||
130639264|NCT01693562|470297599|FG020|Expansion Phase|Other|1|||
130639265|NCT01693562|470297600|FG021|Expansion Phase|Other|17|||
130639266|NCT01693562|470297601|FG022|Expansion Phase|Other|1|||
130639267|NCT00887822|470297607|FG000|Overall Study|Insufficient therapeutic response|53|||
130639268|NCT00887822|470297608|FG001|Overall Study|Insufficient therapeutic response|55|||
130639269|NCT00887822|470297607|FG000|Overall Study|Adverse Event|14|||
130639270|NCT00887822|470297608|FG001|Overall Study|Adverse Event|17|||
130639271|NCT00887822|470297607|FG000|Overall Study|Failure to return|11|||
130639272|NCT00887822|470297608|FG001|Overall Study|Failure to return|11|||
130639273|NCT00887822|470297607|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
130639274|NCT00887822|470297608|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
130639275|NCT00887822|470297607|FG000|Overall Study|Administrative/Other than specified|5|||
130639276|NCT00887822|470297608|FG001|Overall Study|Administrative/Other than specified|4|||
130639277|NCT00887822|470297607|FG000|Overall Study|Death|2|||
130639278|NCT00887822|470297608|FG001|Overall Study|Death|3|||
130639279|NCT00887822|470297607|FG000|Overall Study|Protocol Violation|0|||
130639280|NCT00887822|470297608|FG001|Overall Study|Protocol Violation|1|||
130639281|NCT00887822|470297607|FG000|Overall Study|Randomized but not treated|0|||
130639282|NCT00887822|470297608|FG001|Overall Study|Randomized but not treated|1|||
130639283|NCT02045979|470297609|FG000|Overall Study|Informed Consent Withdrawn|2|||
130639284|NCT02045979|470297610|FG001|Overall Study|Informed Consent Withdrawn|0|||
130639285|NCT02045979|470297611|FG002|Overall Study|Informed Consent Withdrawn|1|||
130639286|NCT02045979|470297609|FG000|Overall Study|not specified above|0|||
130639287|NCT02045979|470297610|FG001|Overall Study|not specified above|1|||
130639288|NCT02045979|470297611|FG002|Overall Study|not specified above|0|||
130639289|NCT02987205|470297613|FG000|Overall Study|Adverse Event|1|||
130639290|NCT02987205|470297613|FG000|Overall Study|Withdrawal by Subject|3|||
130639291|NCT02145429|470297614|FG000|Overall Study|Death|4|||
130639292|NCT02145429|470297615|FG001|Overall Study|Death|5|||
130639293|NCT02145429|470297614|FG000|Overall Study|Lost to Follow-up|4|||
130639294|NCT02145429|470297615|FG001|Overall Study|Lost to Follow-up|3|||
130639295|NCT02145429|470297614|FG000|Overall Study|Withdrawal by Subject|8|||
130639296|NCT02145429|470297615|FG001|Overall Study|Withdrawal by Subject|3|||
130639297|NCT02094612|470297616|FG000|Overall Study|Lost to Follow-up|47|||
130639298|NCT02094612|470297617|FG001|Overall Study|Lost to Follow-up|47|||
130639299|NCT02094612|470297616|FG000|Overall Study|Never started ADHD medication|32|||
130639300|NCT02094612|470297617|FG001|Overall Study|Never started ADHD medication|23|||
130639301|NCT04167514|470297618|FG000|Overall Study|Adverse event, not serious|0|||
130639302|NCT04167514|470297619|FG001|Overall Study|Adverse event, not serious|1|||
130639303|NCT04167514|470297618|FG000|Overall Study|Lost to Follow-up|1|||
130639304|NCT04167514|470297619|FG001|Overall Study|Lost to Follow-up|0|||
130639305|NCT04167514|470297618|FG000|Overall Study|Participant Decision|2|||
130639306|NCT04167514|470297619|FG001|Overall Study|Participant Decision|4|||
130639307|NCT04167514|470297618|FG000|Overall Study|Physician Decision|3|||
130639308|NCT04167514|470297619|FG001|Overall Study|Physician Decision|2|||
130639309|NCT04167514|470297618|FG000|Overall Study|Death|14|||
130639310|NCT04167514|470297619|FG001|Overall Study|Death|18|||
130639311|NCT04167514|470297618|FG000|Overall Study|Enrolled but treatment not administered|2|||
130639312|NCT04167514|470297619|FG001|Overall Study|Enrolled but treatment not administered|0|||
130639313|NCT04167514|470297618|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
130639314|NCT04167514|470297619|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
130639315|NCT04167514|470297618|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
130639316|NCT04167514|470297619|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
130639317|NCT03345849|470297620|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
130639318|NCT03345849|470297621|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
130639319|NCT03345849|470297622|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
130639320|NCT03345849|470297623|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
130639321|NCT03345849|470297620|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
130639322|NCT03345849|470297621|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
130639323|NCT03345849|470297622|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
130639324|NCT03345849|470297623|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
130639325|NCT03345849|470297620|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130639326|NCT03345849|470297621|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
130639327|NCT03345849|470297622|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130639328|NCT03345849|470297623|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130639329|NCT03345849|470297620|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
130639330|NCT03345849|470297621|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
130639331|NCT03345849|470297622|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
130639332|NCT03345849|470297623|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
130639333|NCT03345849|470297620|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130639334|NCT03345849|470297621|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
130639335|NCT03345849|470297622|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130639336|NCT03345849|470297623|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130639337|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
130639338|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
130639339|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
130639340|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
130639341|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
130639342|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
130639343|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
130639344|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
130639345|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
130639346|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
130639347|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
130639348|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
130639349|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130639350|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130639351|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130639352|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
130639353|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130639354|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130648459|NCT00151775|470333061|FG009|Period 4: Open Label|Lost to Follow-up|7|||
130639355|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
130639356|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130639357|NCT03345849|470297620|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
130639358|NCT03345849|470297621|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
130639359|NCT03345849|470297622|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
130639360|NCT03345849|470297623|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
130639361|NCT03261037|470297624|FG000|Overall Study|Withdrawal by Subject|2|||
130639362|NCT03261037|470297625|FG001|Overall Study|Withdrawal by Subject|13|||
130639363|NCT03261037|470297626|FG002|Overall Study|Withdrawal by Subject|0|||
130639364|NCT03261037|470297627|FG003|Overall Study|Withdrawal by Subject|18|||
130639365|NCT03261037|470297624|FG000|Overall Study|Non-compliance with study procedures|0|||
130639366|NCT03261037|470297625|FG001|Overall Study|Non-compliance with study procedures|2|||
130639367|NCT03261037|470297626|FG002|Overall Study|Non-compliance with study procedures|0|||
130639368|NCT03261037|470297627|FG003|Overall Study|Non-compliance with study procedures|6|||
130639369|NCT03261037|470297624|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
130639370|NCT03261037|470297625|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
130639371|NCT03261037|470297626|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
130639372|NCT03261037|470297627|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
130639373|NCT03261037|470297624|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
130639374|NCT03261037|470297625|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
130639375|NCT03261037|470297626|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
130639376|NCT03261037|470297627|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
130639377|NCT03261037|470297624|FG000|Overall Study|Diagnosed but protocol deviation|1|||
130639378|NCT03261037|470297625|FG001|Overall Study|Diagnosed but protocol deviation|0|||
130639379|NCT03261037|470297626|FG002|Overall Study|Diagnosed but protocol deviation|0|||
130639380|NCT03261037|470297627|FG003|Overall Study|Diagnosed but protocol deviation|0|||
130639381|NCT03261037|470297624|FG000|Overall Study|Participant did not want to continue the study|0|||
130639382|NCT03261037|470297625|FG001|Overall Study|Participant did not want to continue the study|1|||
130639383|NCT03261037|470297626|FG002|Overall Study|Participant did not want to continue the study|0|||
130639384|NCT03261037|470297627|FG003|Overall Study|Participant did not want to continue the study|0|||
130639385|NCT03261037|470297624|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130639386|NCT03261037|470297625|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130639387|NCT03261037|470297626|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130639388|NCT03261037|470297627|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
130639389|NCT03261037|470297624|FG000|Overall Study|Participant presented clinical improvement|0|||
130639390|NCT03261037|470297625|FG001|Overall Study|Participant presented clinical improvement|2|||
130639391|NCT03261037|470297626|FG002|Overall Study|Participant presented clinical improvement|0|||
130639392|NCT03261037|470297627|FG003|Overall Study|Participant presented clinical improvement|0|||
130639393|NCT03261037|470297624|FG000|Overall Study|Technical difficulties|0|||
130639394|NCT03261037|470297625|FG001|Overall Study|Technical difficulties|0|||
130639395|NCT03261037|470297626|FG002|Overall Study|Technical difficulties|0|||
130639396|NCT03261037|470297627|FG003|Overall Study|Technical difficulties|1|||
130639397|NCT03261037|470297624|FG000|Overall Study|Equipment failed to work|0|||
130639398|NCT03261037|470297625|FG001|Overall Study|Equipment failed to work|0|||
130639399|NCT03261037|470297626|FG002|Overall Study|Equipment failed to work|0|||
130639400|NCT03261037|470297627|FG003|Overall Study|Equipment failed to work|1|||
130639401|NCT03261037|470297624|FG000|Overall Study|End of study for participant and no follow up|0|||
130639402|NCT03261037|470297625|FG001|Overall Study|End of study for participant and no follow up|0|||
130639403|NCT03261037|470297626|FG002|Overall Study|End of study for participant and no follow up|0|||
130639404|NCT03261037|470297627|FG003|Overall Study|End of study for participant and no follow up|1|||
130639405|NCT03261037|470297624|FG000|Overall Study|Participant was too weak to continue in study|1|||
130639406|NCT03261037|470297625|FG001|Overall Study|Participant was too weak to continue in study|0|||
130639407|NCT03261037|470297626|FG002|Overall Study|Participant was too weak to continue in study|0|||
130639408|NCT03261037|470297627|FG003|Overall Study|Participant was too weak to continue in study|0|||
130639409|NCT05618808|470297630|FG000|Overall Study|Withdrawal by Subject|3|||
130639410|NCT05618808|470297631|FG001|Overall Study|Withdrawal by Subject|1|||
130639411|NCT05618808|470297632|FG002|Overall Study|Withdrawal by Subject|3|||
130639412|NCT05298774|470297639|FG000|Overall Study|Physician Decision|3|||
130639413|NCT05298774|470297639|FG000|Overall Study|Withdrawal by Subject|2|||
130639414|NCT05298774|470297639|FG000|Overall Study|Lost to Follow-up|3|||
130639415|NCT05298774|470297639|FG000|Overall Study|Screen failure|1|||
130639416|NCT00777036|470297646|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
130639417|NCT00777036|470297647|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
130639418|NCT00777036|470297648|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
130639419|NCT00777036|470297649|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
130639420|NCT00777036|470297646|FG000|On Treatment|Administrative Reason By Sponsor|1|||
130639421|NCT00777036|470297647|FG001|On Treatment|Administrative Reason By Sponsor|0|||
130639422|NCT00777036|470297648|FG002|On Treatment|Administrative Reason By Sponsor|9|||
130639423|NCT00777036|470297649|FG003|On Treatment|Administrative Reason By Sponsor|0|||
130639424|NCT00777036|470297646|FG000|On Treatment|Failure to Meet Study Criteria|0|||
130639425|NCT00777036|470297647|FG001|On Treatment|Failure to Meet Study Criteria|1|||
130639426|NCT00777036|470297648|FG002|On Treatment|Failure to Meet Study Criteria|4|||
130639427|NCT00777036|470297649|FG003|On Treatment|Failure to Meet Study Criteria|0|||
130639428|NCT00777036|470297646|FG000|On Treatment|Pregnancy|1|||
130639429|NCT00777036|470297647|FG001|On Treatment|Pregnancy|0|||
130639430|NCT00777036|470297648|FG002|On Treatment|Pregnancy|1|||
130639431|NCT00777036|470297649|FG003|On Treatment|Pregnancy|0|||
130639432|NCT00777036|470297646|FG000|On Treatment|Non-compliance with Study Drug|1|||
130639433|NCT00777036|470297647|FG001|On Treatment|Non-compliance with Study Drug|0|||
130639434|NCT00777036|470297648|FG002|On Treatment|Non-compliance with Study Drug|1|||
130639435|NCT00777036|470297649|FG003|On Treatment|Non-compliance with Study Drug|0|||
130639436|NCT00777036|470297646|FG000|On Treatment|Maximum Clinical Benefit|2|||
130639437|NCT00777036|470297647|FG001|On Treatment|Maximum Clinical Benefit|0|||
130639438|NCT00777036|470297648|FG002|On Treatment|Maximum Clinical Benefit|5|||
130639439|NCT00777036|470297649|FG003|On Treatment|Maximum Clinical Benefit|0|||
130639440|NCT00777036|470297646|FG000|On Treatment|Withdrawal by Subject|0|||
130639441|NCT00777036|470297647|FG001|On Treatment|Withdrawal by Subject|2|||
130639442|NCT00777036|470297648|FG002|On Treatment|Withdrawal by Subject|2|||
130639443|NCT00777036|470297649|FG003|On Treatment|Withdrawal by Subject|0|||
130639444|NCT00777036|470297646|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
130639445|NCT00777036|470297647|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
130639446|NCT00777036|470297648|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
130639447|NCT00777036|470297649|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
130639448|NCT00777036|470297646|FG000|On Treatment|Death|0|||
130639449|NCT00777036|470297647|FG001|On Treatment|Death|2|||
130639450|NCT00777036|470297648|FG002|On Treatment|Death|0|||
130639451|NCT00777036|470297649|FG003|On Treatment|Death|0|||
130639452|NCT00777036|470297646|FG000|On Treatment|Study Drug Toxicity|1|||
130639453|NCT00777036|470297647|FG001|On Treatment|Study Drug Toxicity|0|||
130639454|NCT00777036|470297648|FG002|On Treatment|Study Drug Toxicity|4|||
130639455|NCT00777036|470297649|FG003|On Treatment|Study Drug Toxicity|0|||
130639456|NCT00777036|470297646|FG000|On Treatment|Progressive Disease|6|||
130639457|NCT00777036|470297647|FG001|On Treatment|Progressive Disease|4|||
130639458|NCT00777036|470297648|FG002|On Treatment|Progressive Disease|7|||
130639459|NCT00777036|470297649|FG003|On Treatment|Progressive Disease|0|||
130639460|NCT00777036|470297646|FG000|On Treatment|Not Reported|0|||
130639461|NCT00777036|470297647|FG001|On Treatment|Not Reported|0|||
130639462|NCT00777036|470297648|FG002|On Treatment|Not Reported|2|||
130639463|NCT00777036|470297649|FG003|On Treatment|Not Reported|0|||
130639464|NCT00777036|470297646|FG000|On Treatment|Site Closed|0|||
130639465|NCT00777036|470297647|FG001|On Treatment|Site Closed|1|||
130639466|NCT00777036|470297648|FG002|On Treatment|Site Closed|1|||
130639467|NCT00777036|470297649|FG003|On Treatment|Site Closed|0|||
130639468|NCT00777036|470297646|FG000|Follow-Up|Withdrawal by Subject|0|||
130639469|NCT00777036|470297647|FG001|Follow-Up|Withdrawal by Subject|0|||
130639470|NCT00777036|470297648|FG002|Follow-Up|Withdrawal by Subject|5|||
130639471|NCT00777036|470297649|FG003|Follow-Up|Withdrawal by Subject|0|||
130639472|NCT00777036|470297646|FG000|Follow-Up|Death|1|||
130639473|NCT00777036|470297647|FG001|Follow-Up|Death|9|||
130639474|NCT00777036|470297648|FG002|Follow-Up|Death|0|||
130639475|NCT00777036|470297649|FG003|Follow-Up|Death|0|||
130639476|NCT00777036|470297646|FG000|Follow-Up|Lost to Follow-up|3|||
130639477|NCT00777036|470297647|FG001|Follow-Up|Lost to Follow-up|0|||
130639478|NCT00777036|470297648|FG002|Follow-Up|Lost to Follow-up|0|||
130639479|NCT00777036|470297649|FG003|Follow-Up|Lost to Follow-up|0|||
130639480|NCT00777036|470297646|FG000|Follow-Up|Reason Not Specified|4|||
130639481|NCT00777036|470297647|FG001|Follow-Up|Reason Not Specified|0|||
130639482|NCT00777036|470297648|FG002|Follow-Up|Reason Not Specified|13|||
130639483|NCT00777036|470297649|FG003|Follow-Up|Reason Not Specified|0|||
130639484|NCT00777036|470297646|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
130639485|NCT00777036|470297647|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
130639486|NCT00777036|470297648|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
130639487|NCT00777036|470297649|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
130639488|NCT05827978|470297650|FG000|Overall Study|Adverse Event|1|||
130639489|NCT05827978|470297651|FG001|Overall Study|Adverse Event|0|||
130639490|NCT05827978|470297652|FG002|Overall Study|Adverse Event|0|||
130639491|NCT05827978|470297653|FG003|Overall Study|Adverse Event|1|||
130639492|NCT05827978|470297654|FG004|Overall Study|Adverse Event|0|||
130639493|NCT05827978|470297655|FG005|Overall Study|Adverse Event|0|||
130639494|NCT05827978|470297650|FG000|Overall Study|Death|1|||
130639495|NCT05827978|470297651|FG001|Overall Study|Death|5|||
130639496|NCT05827978|470297652|FG002|Overall Study|Death|2|||
130639497|NCT05827978|470297653|FG003|Overall Study|Death|3|||
130639498|NCT05827978|470297654|FG004|Overall Study|Death|1|||
130639499|NCT05827978|470297655|FG005|Overall Study|Death|3|||
130639500|NCT05827978|470297650|FG000|Overall Study|Lost to Follow-up|57|||
130639501|NCT05827978|470297651|FG001|Overall Study|Lost to Follow-up|88|||
130639502|NCT05827978|470297652|FG002|Overall Study|Lost to Follow-up|54|||
130639503|NCT05827978|470297653|FG003|Overall Study|Lost to Follow-up|47|||
130639504|NCT05827978|470297654|FG004|Overall Study|Lost to Follow-up|25|||
130639505|NCT05827978|470297655|FG005|Overall Study|Lost to Follow-up|10|||
130639506|NCT05827978|470297650|FG000|Overall Study|Noncompliance with Study Procedures|0|||
130639507|NCT05827978|470297651|FG001|Overall Study|Noncompliance with Study Procedures|1|||
130639508|NCT05827978|470297652|FG002|Overall Study|Noncompliance with Study Procedures|1|||
130639509|NCT05827978|470297653|FG003|Overall Study|Noncompliance with Study Procedures|1|||
130639510|NCT05827978|470297654|FG004|Overall Study|Noncompliance with Study Procedures|1|||
130639511|NCT05827978|470297655|FG005|Overall Study|Noncompliance with Study Procedures|0|||
130639512|NCT05827978|470297650|FG000|Overall Study|Physician Decision|2|||
130639513|NCT05827978|470297651|FG001|Overall Study|Physician Decision|0|||
130639514|NCT05827978|470297652|FG002|Overall Study|Physician Decision|1|||
130639515|NCT05827978|470297653|FG003|Overall Study|Physician Decision|2|||
130639516|NCT05827978|470297654|FG004|Overall Study|Physician Decision|1|||
130639517|NCT05827978|470297655|FG005|Overall Study|Physician Decision|1|||
130639518|NCT05827978|470297650|FG000|Overall Study|Protocol Violation|5|||
130639519|NCT05827978|470297651|FG001|Overall Study|Protocol Violation|2|||
130639520|NCT05827978|470297652|FG002|Overall Study|Protocol Violation|0|||
130639521|NCT05827978|470297653|FG003|Overall Study|Protocol Violation|0|||
130639522|NCT05827978|470297654|FG004|Overall Study|Protocol Violation|0|||
130639523|NCT05827978|470297655|FG005|Overall Study|Protocol Violation|0|||
130639524|NCT05827978|470297650|FG000|Overall Study|Withdrawal by Subject|17|||
130639525|NCT05827978|470297651|FG001|Overall Study|Withdrawal by Subject|16|||
130639526|NCT05827978|470297652|FG002|Overall Study|Withdrawal by Subject|10|||
130639527|NCT05827978|470297653|FG003|Overall Study|Withdrawal by Subject|12|||
130639528|NCT05827978|470297654|FG004|Overall Study|Withdrawal by Subject|10|||
130639529|NCT05827978|470297655|FG005|Overall Study|Withdrawal by Subject|9|||
130639530|NCT05827978|470297650|FG000|Overall Study|Other Than Specified|0|||
130639531|NCT05827978|470297651|FG001|Overall Study|Other Than Specified|0|||
130639532|NCT05827978|470297652|FG002|Overall Study|Other Than Specified|1|||
130639533|NCT05827978|470297653|FG003|Overall Study|Other Than Specified|0|||
130639534|NCT05827978|470297654|FG004|Overall Study|Other Than Specified|2|||
130639535|NCT05827978|470297655|FG005|Overall Study|Other Than Specified|0|||
130639536|NCT04651777|470297656|FG000|Overall Study|Adverse Event|1|||
130639537|NCT04651777|470297656|FG000|Overall Study|Withdrawal by Subject|2|||
130639538|NCT04566445|470297657|FG000|Overall Study|Death|4|||
130639539|NCT04566445|470297658|FG001|Overall Study|Death|1|||
130639540|NCT04566445|470297659|FG002|Overall Study|Death|1|||
130639541|NCT04566445|470297657|FG000|Overall Study|Lost to Follow-up|3|||
130639542|NCT04566445|470297658|FG001|Overall Study|Lost to Follow-up|1|||
130639543|NCT04566445|470297659|FG002|Overall Study|Lost to Follow-up|1|||
130639544|NCT04566445|470297657|FG000|Overall Study|Study terminated by sponsor|11|||
130639545|NCT04566445|470297658|FG001|Overall Study|Study terminated by sponsor|17|||
130639546|NCT04566445|470297659|FG002|Overall Study|Study terminated by sponsor|32|||
130639547|NCT04566445|470297657|FG000|Overall Study|Withdrawal by Subject|12|||
130639548|NCT04566445|470297658|FG001|Overall Study|Withdrawal by Subject|14|||
130639549|NCT04566445|470297659|FG002|Overall Study|Withdrawal by Subject|13|||
130639550|NCT04566445|470297657|FG000|Overall Study|Randomized but not treated due to AE|2|||
130639551|NCT04566445|470297658|FG001|Overall Study|Randomized but not treated due to AE|1|||
130639552|NCT04566445|470297659|FG002|Overall Study|Randomized but not treated due to AE|0|||
130639553|NCT04566445|470297657|FG000|Overall Study|Adverse Event|1|||
130639554|NCT04566445|470297658|FG001|Overall Study|Adverse Event|1|||
130639555|NCT04566445|470297659|FG002|Overall Study|Adverse Event|0|||
130639556|NCT04785144|470297660|FG000|Overall Study|Withdrawal by Subject|4|||
130639557|NCT04785144|470297661|FG001|Overall Study|Withdrawal by Subject|1|||
130639558|NCT04785144|470297662|FG002|Overall Study|Withdrawal by Subject|0|||
130639559|NCT04785144|470297663|FG003|Overall Study|Withdrawal by Subject|0|||
130639560|NCT04785144|470297664|FG004|Overall Study|Withdrawal by Subject|0|||
130639561|NCT04785144|470297665|FG005|Overall Study|Withdrawal by Subject|2|||
130639562|NCT04785144|470297666|FG006|Overall Study|Withdrawal by Subject|2|||
130639563|NCT04785144|470297667|FG007|Overall Study|Withdrawal by Subject|0|||
130639564|NCT04785144|470297668|FG008|Overall Study|Withdrawal by Subject|1|||
130639565|NCT04785144|470297669|FG009|Overall Study|Withdrawal by Subject|0|||
130639566|NCT04785144|470297660|FG000|Overall Study|Lost to Follow-up|1|||
130639567|NCT04785144|470297661|FG001|Overall Study|Lost to Follow-up|0|||
130639568|NCT04785144|470297662|FG002|Overall Study|Lost to Follow-up|0|||
130639569|NCT04785144|470297663|FG003|Overall Study|Lost to Follow-up|0|||
130639570|NCT04785144|470297664|FG004|Overall Study|Lost to Follow-up|1|||
130639571|NCT04785144|470297665|FG005|Overall Study|Lost to Follow-up|2|||
130639572|NCT04785144|470297666|FG006|Overall Study|Lost to Follow-up|1|||
130639573|NCT04785144|470297667|FG007|Overall Study|Lost to Follow-up|2|||
130639574|NCT04785144|470297668|FG008|Overall Study|Lost to Follow-up|4|||
130639575|NCT04785144|470297669|FG009|Overall Study|Lost to Follow-up|1|||
130639576|NCT04785144|470297660|FG000|Overall Study|Protocol Violation|0|||
130639577|NCT04785144|470297661|FG001|Overall Study|Protocol Violation|0|||
130639578|NCT04785144|470297662|FG002|Overall Study|Protocol Violation|0|||
130639579|NCT04785144|470297663|FG003|Overall Study|Protocol Violation|0|||
130639580|NCT04785144|470297664|FG004|Overall Study|Protocol Violation|0|||
130639581|NCT04785144|470297665|FG005|Overall Study|Protocol Violation|0|||
130639582|NCT04785144|470297666|FG006|Overall Study|Protocol Violation|1|||
130639583|NCT04785144|470297667|FG007|Overall Study|Protocol Violation|0|||
130639584|NCT04785144|470297668|FG008|Overall Study|Protocol Violation|0|||
130639585|NCT04785144|470297669|FG009|Overall Study|Protocol Violation|0|||
130639586|NCT04785144|470297660|FG000|Overall Study|Physician Decision|0|||
130639587|NCT04785144|470297661|FG001|Overall Study|Physician Decision|0|||
130639588|NCT04785144|470297662|FG002|Overall Study|Physician Decision|0|||
130639589|NCT04785144|470297663|FG003|Overall Study|Physician Decision|0|||
130639590|NCT04785144|470297664|FG004|Overall Study|Physician Decision|0|||
130639591|NCT04785144|470297665|FG005|Overall Study|Physician Decision|0|||
130639592|NCT04785144|470297666|FG006|Overall Study|Physician Decision|0|||
130639593|NCT04785144|470297667|FG007|Overall Study|Physician Decision|0|||
130639594|NCT04785144|470297668|FG008|Overall Study|Physician Decision|0|||
130639595|NCT04785144|470297669|FG009|Overall Study|Physician Decision|1|||
130639596|NCT04785144|470297660|FG000|Overall Study|Unable to continue due to work schedule|0|||
130639597|NCT04785144|470297661|FG001|Overall Study|Unable to continue due to work schedule|0|||
130639598|NCT04785144|470297662|FG002|Overall Study|Unable to continue due to work schedule|0|||
130639599|NCT04785144|470297663|FG003|Overall Study|Unable to continue due to work schedule|0|||
130639600|NCT04785144|470297664|FG004|Overall Study|Unable to continue due to work schedule|0|||
130639601|NCT04785144|470297665|FG005|Overall Study|Unable to continue due to work schedule|0|||
130639602|NCT04785144|470297666|FG006|Overall Study|Unable to continue due to work schedule|0|||
130639603|NCT04785144|470297667|FG007|Overall Study|Unable to continue due to work schedule|0|||
130639604|NCT04785144|470297668|FG008|Overall Study|Unable to continue due to work schedule|0|||
130639605|NCT04785144|470297669|FG009|Overall Study|Unable to continue due to work schedule|1|||
130639606|NCT01263470|470297670|FG000|Overall Study|Adverse Event|2|||
130639607|NCT01263470|470297671|FG001|Overall Study|Adverse Event|2|||
130639608|NCT01263470|470297672|FG002|Overall Study|Adverse Event|1|||
130639609|NCT01263470|470297673|FG003|Overall Study|Adverse Event|1|||
130639610|NCT01263470|470297674|FG004|Overall Study|Adverse Event|2|||
130639611|NCT01263470|470297675|FG005|Overall Study|Adverse Event|2|||
130639612|NCT01263470|470297670|FG000|Overall Study|Protocol Violation|0|||
130639613|NCT01263470|470297671|FG001|Overall Study|Protocol Violation|1|||
130639614|NCT01263470|470297672|FG002|Overall Study|Protocol Violation|0|||
130639615|NCT01263470|470297673|FG003|Overall Study|Protocol Violation|0|||
130639616|NCT01263470|470297674|FG004|Overall Study|Protocol Violation|0|||
130639617|NCT01263470|470297675|FG005|Overall Study|Protocol Violation|1|||
130639618|NCT01263470|470297670|FG000|Overall Study|Withdrawal by Subject|0|||
130639619|NCT01263470|470297671|FG001|Overall Study|Withdrawal by Subject|1|||
130639620|NCT01263470|470297672|FG002|Overall Study|Withdrawal by Subject|1|||
130639621|NCT01263470|470297673|FG003|Overall Study|Withdrawal by Subject|2|||
130639622|NCT01263470|470297674|FG004|Overall Study|Withdrawal by Subject|0|||
130639623|NCT01263470|470297675|FG005|Overall Study|Withdrawal by Subject|2|||
130639624|NCT01263470|470297670|FG000|Overall Study|Lack of Efficacy|0|||
130639625|NCT01263470|470297671|FG001|Overall Study|Lack of Efficacy|0|||
130639626|NCT01263470|470297672|FG002|Overall Study|Lack of Efficacy|2|||
130639627|NCT01263470|470297673|FG003|Overall Study|Lack of Efficacy|0|||
130639628|NCT01263470|470297674|FG004|Overall Study|Lack of Efficacy|0|||
130639629|NCT01263470|470297675|FG005|Overall Study|Lack of Efficacy|0|||
130639630|NCT01263470|470297670|FG000|Overall Study|Participant Unavailability|0|||
130639631|NCT01263470|470297671|FG001|Overall Study|Participant Unavailability|1|||
130639632|NCT01263470|470297672|FG002|Overall Study|Participant Unavailability|0|||
130639633|NCT01263470|470297673|FG003|Overall Study|Participant Unavailability|0|||
130639634|NCT01263470|470297674|FG004|Overall Study|Participant Unavailability|0|||
130639635|NCT01263470|470297675|FG005|Overall Study|Participant Unavailability|0|||
130639636|NCT01263470|470297670|FG000|Overall Study|Study Drug Non-compliance|0|||
130639637|NCT01263470|470297671|FG001|Overall Study|Study Drug Non-compliance|0|||
130639638|NCT01263470|470297672|FG002|Overall Study|Study Drug Non-compliance|0|||
130639639|NCT01263470|470297673|FG003|Overall Study|Study Drug Non-compliance|0|||
130639640|NCT01263470|470297674|FG004|Overall Study|Study Drug Non-compliance|1|||
130639641|NCT01263470|470297675|FG005|Overall Study|Study Drug Non-compliance|0|||
130639642|NCT00610714|470297676|FG000|Overall Study|Adverse Event|3|||
130639643|NCT00610714|470297677|FG001|Overall Study|Adverse Event|1|||
130639644|NCT00610714|470297676|FG000|Overall Study|Death|12|||
130639645|NCT00610714|470297677|FG001|Overall Study|Death|18|||
130639646|NCT00610714|470297676|FG000|Overall Study|Withdrawal by Subject|9|||
130639647|NCT00610714|470297677|FG001|Overall Study|Withdrawal by Subject|3|||
130639648|NCT00610714|470297676|FG000|Overall Study|Study completion at 120 PFS events|2|||
130639649|NCT00610714|470297677|FG001|Overall Study|Study completion at 120 PFS events|2|||
130639650|NCT00712712|470297678|FG000|Overall Study|Protocol Violation|11|||
130639651|NCT00712712|470297678|FG000|Overall Study|Radiofrequency not done|3|||
130639652|NCT00712712|470297678|FG000|Overall Study|Death|8|||
130639653|NCT00712712|470297678|FG000|Overall Study|Withdrawal by Subject|1|||
130639654|NCT03598140|470297679|FG000|Overall Study|enrolled but didn't start|1|||
130639655|NCT03598140|470297680|FG001|Overall Study|enrolled but didn't start|0|||
130639656|NCT01029691|470297681|FG000|Continued APAP to Delivery|Death|0|||
130639657|NCT01029691|470297682|FG001|Continued APAP to Delivery|Death|0|||
130639658|NCT01029691|470297683|FG002|Continued APAP to Delivery|Death|1|||
130639659|NCT02723019|470297691|FG000|Overall Study|Death|17|||
130639660|NCT02723019|470297692|FG001|Overall Study|Death|13|||
130639661|NCT02723019|470297691|FG000|Overall Study|Withdrawal by Subject|11|||
130639662|NCT02723019|470297692|FG001|Overall Study|Withdrawal by Subject|7|||
130639663|NCT02723019|470297691|FG000|Overall Study|Lost to Follow-up|57|||
130639664|NCT02723019|470297692|FG001|Overall Study|Lost to Follow-up|70|||
130639665|NCT00592072|470297695|FG000|Wash Out Period|Lost to Follow-up|1|||
130639666|NCT00592072|470297696|FG001|Wash Out Period|Lost to Follow-up|1|||
130639667|NCT05333289|470297698|FG000|Overall Study|Other|1|||
130639668|NCT05333289|470297699|FG001|Overall Study|Other|0|||
130639669|NCT05333289|470297700|FG002|Overall Study|Other|0|||
130639670|NCT05333289|470297701|FG003|Overall Study|Other|1|||
130639671|NCT05333289|470297702|FG004|Overall Study|Other|1|||
130639672|NCT05333289|470297703|FG005|Overall Study|Other|2|||
130639673|NCT05333289|470297704|FG006|Overall Study|Other|2|||
130639674|NCT05333289|470297705|FG007|Overall Study|Other|0|||
130639675|NCT05333289|470297698|FG000|Overall Study|Withdrawal by Subject|1|||
130639676|NCT05333289|470297699|FG001|Overall Study|Withdrawal by Subject|2|||
130639677|NCT05333289|470297700|FG002|Overall Study|Withdrawal by Subject|2|||
130639678|NCT05333289|470297701|FG003|Overall Study|Withdrawal by Subject|1|||
130639679|NCT05333289|470297702|FG004|Overall Study|Withdrawal by Subject|1|||
130639680|NCT05333289|470297703|FG005|Overall Study|Withdrawal by Subject|2|||
130639681|NCT05333289|470297704|FG006|Overall Study|Withdrawal by Subject|1|||
130639682|NCT05333289|470297705|FG007|Overall Study|Withdrawal by Subject|3|||
130639683|NCT05333289|470297698|FG000|Overall Study|Protocol Violation|1|||
130639684|NCT05333289|470297699|FG001|Overall Study|Protocol Violation|0|||
130639685|NCT05333289|470297700|FG002|Overall Study|Protocol Violation|0|||
130639686|NCT05333289|470297701|FG003|Overall Study|Protocol Violation|0|||
130639687|NCT05333289|470297702|FG004|Overall Study|Protocol Violation|0|||
130639688|NCT05333289|470297703|FG005|Overall Study|Protocol Violation|0|||
130639689|NCT05333289|470297704|FG006|Overall Study|Protocol Violation|0|||
130639690|NCT05333289|470297705|FG007|Overall Study|Protocol Violation|0|||
130639691|NCT05333289|470297698|FG000|Overall Study|Physician Decision|0|||
130639692|NCT05333289|470297699|FG001|Overall Study|Physician Decision|0|||
130639693|NCT05333289|470297700|FG002|Overall Study|Physician Decision|1|||
130639694|NCT05333289|470297701|FG003|Overall Study|Physician Decision|0|||
130639695|NCT05333289|470297702|FG004|Overall Study|Physician Decision|0|||
130639696|NCT05333289|470297703|FG005|Overall Study|Physician Decision|2|||
130639697|NCT05333289|470297704|FG006|Overall Study|Physician Decision|0|||
130639698|NCT05333289|470297705|FG007|Overall Study|Physician Decision|0|||
130639699|NCT05333289|470297698|FG000|Overall Study|Lost to Follow-up|6|||
130639700|NCT05333289|470297699|FG001|Overall Study|Lost to Follow-up|0|||
130639701|NCT05333289|470297700|FG002|Overall Study|Lost to Follow-up|1|||
130639702|NCT05333289|470297701|FG003|Overall Study|Lost to Follow-up|6|||
130639703|NCT05333289|470297702|FG004|Overall Study|Lost to Follow-up|3|||
130639704|NCT05333289|470297703|FG005|Overall Study|Lost to Follow-up|3|||
130639705|NCT05333289|470297704|FG006|Overall Study|Lost to Follow-up|2|||
130639706|NCT05333289|470297705|FG007|Overall Study|Lost to Follow-up|1|||
130639707|NCT05333289|470297698|FG000|Overall Study|Death|1|||
130639708|NCT05333289|470297699|FG001|Overall Study|Death|0|||
130639709|NCT05333289|470297700|FG002|Overall Study|Death|0|||
130639710|NCT05333289|470297701|FG003|Overall Study|Death|0|||
130639711|NCT05333289|470297702|FG004|Overall Study|Death|0|||
130639712|NCT05333289|470297703|FG005|Overall Study|Death|0|||
130639713|NCT05333289|470297704|FG006|Overall Study|Death|0|||
130639714|NCT05333289|470297705|FG007|Overall Study|Death|0|||
130639715|NCT01347840|470297710|FG000|Overall Study|Withdrawal by Subject|1|||
130639716|NCT03858686|470297714|FG000|Period 1|Adverse Event|1|||
130639717|NCT03858686|470297715|FG001|Period 1|Adverse Event|1|||
130639718|NCT03858686|470297714|FG000|Period 1|Lack of compliance|0|||
130639719|NCT03858686|470297715|FG001|Period 1|Lack of compliance|1|||
130639720|NCT03858686|470297714|FG000|Period 1|Adverse Event|0|||
130639721|NCT03858686|470297715|FG001|Period 1|Adverse Event|1|||
130639722|NCT03858686|470297714|FG000|Period 2|Adverse Event|0|||
130639723|NCT03858686|470297715|FG001|Period 2|Adverse Event|1|||
130639724|NCT03231228|470297717|FG000|Overall Study|Lost to Follow-up|2|||
130639725|NCT03231228|470297718|FG001|Overall Study|Lost to Follow-up|0|||
130639726|NCT03231228|470297717|FG000|Overall Study|Physician Decision|1|||
130639727|NCT03231228|470297718|FG001|Overall Study|Physician Decision|0|||
130639728|NCT02299206|470297719|FG000|Overall Study|Lost to Follow-up|1|||
130639729|NCT02299206|470297719|FG000|Overall Study|Withdrawal by Subject|1|||
130639730|NCT01682759|470297723|FG000|Overall Study|Death|2|||
130639731|NCT01682759|470297724|FG001|Overall Study|Death|1|||
130639732|NCT01682759|470297723|FG000|Overall Study|Lost to Follow-up|10|||
130639733|NCT01682759|470297724|FG001|Overall Study|Lost to Follow-up|13|||
130639734|NCT01682759|470297723|FG000|Overall Study|Physician Decision|1|||
130639735|NCT01682759|470297724|FG001|Overall Study|Physician Decision|1|||
130639736|NCT01682759|470297723|FG000|Overall Study|Withdrawal by Subject|56|||
130639737|NCT01682759|470297724|FG001|Overall Study|Withdrawal by Subject|55|||
130639738|NCT02683668|470297728|FG000|Period 2|Withdrawal by Subject|0|||
130639739|NCT02683668|470297729|FG001|Period 2|Withdrawal by Subject|1|||
130639740|NCT02683668|470297730|FG002|Period 2|Withdrawal by Subject|0|||
130639741|NCT03893630|470297731|FG000|Overall Study|Lost to Follow-up|5|||
130639742|NCT03893630|470297732|FG001|Overall Study|Lost to Follow-up|4|||
130639743|NCT03893630|470297733|FG002|Overall Study|Lost to Follow-up|2|||
130639744|NCT03893630|470297731|FG000|Overall Study|Withdrawal by Subject|3|||
130639745|NCT03893630|470297732|FG001|Overall Study|Withdrawal by Subject|6|||
130639746|NCT03893630|470297733|FG002|Overall Study|Withdrawal by Subject|3|||
130639747|NCT03893630|470297731|FG000|Overall Study|Discontinued Intervention|0|||
130639748|NCT03893630|470297732|FG001|Overall Study|Discontinued Intervention|4|||
130639749|NCT03893630|470297733|FG002|Overall Study|Discontinued Intervention|2|||
130639750|NCT03650387|470299638|FG000|Overall Study|Withdrawal by Subject|13|||
130639751|NCT03650387|470299638|FG000|Overall Study|Lost to Follow-up|12|||
130639752|NCT03650387|470299638|FG000|Overall Study|Adverse Event (Not related)|1|||
130639753|NCT03650387|470299638|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
130639754|NCT05815758|470299639|FG000|Overall Study|Adverse Event|6|||
130639755|NCT05815758|470299640|FG001|Overall Study|Adverse Event|2|||
130639756|NCT05815758|470299639|FG000|Overall Study|Lost to Follow-up|14|||
130639757|NCT05815758|470299640|FG001|Overall Study|Lost to Follow-up|1|||
130639758|NCT05815758|470299639|FG000|Overall Study|Withdrawal by Subject|6|||
130639759|NCT05815758|470299640|FG001|Overall Study|Withdrawal by Subject|6|||
130639760|NCT05815758|470299639|FG000|Overall Study|Protocol Violation|1|||
130639761|NCT05815758|470299640|FG001|Overall Study|Protocol Violation|1|||
130639762|NCT05815758|470299639|FG000|Overall Study|Discontinued|4|||
130639763|NCT05815758|470299640|FG001|Overall Study|Discontinued|4|||
130639764|NCT03661983|470299641|FG000|Open Label Stabilization Phase|Adverse Event|5|||
130639765|NCT03661983|470299642|FG001|Open Label Stabilization Phase|Adverse Event|0|||
130639766|NCT03661983|470299643|FG002|Open Label Stabilization Phase|Adverse Event|0|||
130639767|NCT03661983|470299644|FG003|Open Label Stabilization Phase|Adverse Event|0|||
130639768|NCT03661983|470299641|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
130639769|NCT03661983|470299642|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
130639770|NCT03661983|470299643|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
130639771|NCT03661983|470299644|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
130639772|NCT03661983|470299641|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
130639773|NCT03661983|470299642|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130639774|NCT03661983|470299643|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130639775|NCT03661983|470299644|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130639776|NCT03661983|470299641|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
130639777|NCT03661983|470299642|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130639778|NCT03661983|470299643|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130639779|NCT03661983|470299644|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130639780|NCT03661983|470299641|FG000|Double-blind Randomized Phase|Adverse Event|0|||
130639781|NCT03661983|470299642|FG001|Double-blind Randomized Phase|Adverse Event|1|||
130639782|NCT03661983|470299643|FG002|Double-blind Randomized Phase|Adverse Event|0|||
130639783|NCT03661983|470299644|FG003|Double-blind Randomized Phase|Adverse Event|0|||
130639784|NCT03661983|470299641|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
130639785|NCT03661983|470299642|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
130639786|NCT03661983|470299643|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
130639787|NCT03661983|470299644|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
130639788|NCT03661983|470299641|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130639789|NCT03661983|470299642|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130639790|NCT03661983|470299643|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130639791|NCT03661983|470299644|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
130639792|NCT03661983|470299641|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
130639793|NCT03661983|470299642|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130639794|NCT03661983|470299643|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130639795|NCT03661983|470299644|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130639796|NCT02425891|470299645|FG000|Overall Study|Death|333|||
130639797|NCT02425891|470299646|FG001|Overall Study|Death|314|||
130639798|NCT02425891|470299645|FG000|Overall Study|Lost to Follow-up|4|||
130639799|NCT02425891|470299646|FG001|Overall Study|Lost to Follow-up|6|||
130639800|NCT02425891|470299645|FG000|Overall Study|Non-Compliance|1|||
130639801|NCT02425891|470299646|FG001|Overall Study|Non-Compliance|1|||
130639802|NCT02425891|470299645|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
130639803|NCT02425891|470299646|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
130639804|NCT02425891|470299645|FG000|Overall Study|Physician Decision|0|||
130639805|NCT02425891|470299646|FG001|Overall Study|Physician Decision|1|||
130639806|NCT02425891|470299645|FG000|Overall Study|Protocol Violation|1|||
130639807|NCT02425891|470299646|FG001|Overall Study|Protocol Violation|1|||
130639808|NCT02425891|470299645|FG000|Overall Study|Study Terminated By Sponsor|85|||
130639809|NCT02425891|470299646|FG001|Overall Study|Study Terminated By Sponsor|95|||
130639810|NCT02425891|470299645|FG000|Overall Study|Withdrawal by Subject|27|||
130639811|NCT02425891|470299646|FG001|Overall Study|Withdrawal by Subject|32|||
130639812|NCT04124952|470299647|FG000|Overall Study|Lost to Follow-up|1|||
130639813|NCT03558503|470299648|FG000|Overall Study|Adverse Event|1|||
130639814|NCT03558503|470299648|FG000|Overall Study|Death|1|||
130639815|NCT03558503|470299648|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
130639816|NCT02943577|470299651|FG000|Overall Study|Protocol Violation|0|||
130639817|NCT02943577|470299652|FG001|Overall Study|Protocol Violation|1|||
130639818|NCT02943577|470299651|FG000|Overall Study|Adverse Event|3|||
130639819|NCT02943577|470299652|FG001|Overall Study|Adverse Event|2|||
130639820|NCT02943577|470299651|FG000|Overall Study|Lost to Follow-up|0|||
130639821|NCT02943577|470299652|FG001|Overall Study|Lost to Follow-up|1|||
130639822|NCT02943577|470299651|FG000|Overall Study|Withdrawal by Subject|1|||
130639823|NCT02943577|470299652|FG001|Overall Study|Withdrawal by Subject|1|||
130639824|NCT02943577|470299651|FG000|Overall Study|Pregnancy|1|||
130639825|NCT02943577|470299652|FG001|Overall Study|Pregnancy|0|||
130639826|NCT01944462|470299657|FG000|PPPP Educational Program|Lost to Follow-up|60|||
130639827|NCT01222767|470299658|FG000|Overall Study|Progressive disease|13|||
130639828|NCT01222767|470299658|FG000|Overall Study|Adverse Event|2|||
130639829|NCT01222767|470299658|FG000|Overall Study|Surgical resection|1|||
130639830|NCT01222767|470299658|FG000|Overall Study|Never treated|1|||
130639831|NCT04437511|470299659|FG000|Overall Study|Adverse Event|50|||
130639832|NCT04437511|470299660|FG001|Overall Study|Adverse Event|21|||
130639833|NCT04437511|470299659|FG000|Overall Study|Death|15|||
130639834|NCT04437511|470299660|FG001|Overall Study|Death|10|||
130639835|NCT04437511|470299659|FG000|Overall Study|Lost to Follow-up|11|||
130639836|NCT04437511|470299660|FG001|Overall Study|Lost to Follow-up|11|||
130639837|NCT04437511|470299659|FG000|Overall Study|Physician Decision|19|||
130639838|NCT04437511|470299660|FG001|Overall Study|Physician Decision|10|||
130639839|NCT04437511|470299659|FG000|Overall Study|Progressive Disease|4|||
130639840|NCT04437511|470299660|FG001|Overall Study|Progressive Disease|7|||
130639841|NCT04437511|470299659|FG000|Overall Study|Withdrawal by Subject|111|||
130639842|NCT04437511|470299660|FG001|Overall Study|Withdrawal by Subject|94|||
130639843|NCT04437511|470299659|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
130639844|NCT04437511|470299660|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
130639845|NCT04437511|470299659|FG000|Overall Study|Continuing Study|7|||
130639846|NCT04437511|470299660|FG001|Overall Study|Continuing Study|5|||
130639847|NCT04654468|470299663|FG000|Overall Study|Death|1|||
130639848|NCT04654468|470299663|FG000|Overall Study|Ongoing in the Study|50|||
130639849|NCT03093350|470299668|FG000|Overall Study|Death|1|||
130639850|NCT03093350|470299668|FG000|Overall Study|Signed consent, never began treartment|1|||
130639851|NCT05564039|470299669|FG000|Overall Study|Adverse Event|1|||
130639852|NCT05564039|470299670|FG001|Overall Study|Adverse Event|0|||
130639853|NCT05564039|470299669|FG000|Overall Study|Death|1|||
130639854|NCT05564039|470299670|FG001|Overall Study|Death|1|||
130639855|NCT05564039|470299669|FG000|Overall Study|Lost to Follow-up|3|||
130639856|NCT05564039|470299670|FG001|Overall Study|Lost to Follow-up|2|||
130639857|NCT05564039|470299669|FG000|Overall Study|Withdrawal by Subject|2|||
130639858|NCT05564039|470299670|FG001|Overall Study|Withdrawal by Subject|0|||
130639859|NCT05564039|470299669|FG000|Overall Study|Inadvertent enrollment|3|||
130639860|NCT05564039|470299670|FG001|Overall Study|Inadvertent enrollment|6|||
130639861|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
130639862|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
130639863|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
130639864|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
130639865|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Death|38|||
130639866|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Death|10|||
130639867|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
130639868|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
130639869|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
130639870|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
130639871|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
130639872|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
130639873|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
130639874|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
130639875|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
130639876|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
130639877|NCT02421939|470299671|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
130639878|NCT02421939|470299672|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
130639879|NCT02421939|470299671|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
130639880|NCT02421939|470299672|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
130639881|NCT02421939|470299671|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
130639882|NCT02421939|470299672|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
130639883|NCT02421939|470299671|FG000|Long Term Follow up: up to 3 Years|Death|118|||
130639884|NCT02421939|470299672|FG001|Long Term Follow up: up to 3 Years|Death|65|||
130639885|NCT02421939|470299671|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
130639886|NCT02421939|470299672|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
130639887|NCT00729560|470299675|FG000|Overall Study|Withdrawal by Subject|3|||
130639888|NCT00103207|470299676|FG000|Overall Study|Adverse Event|3|||
130639889|NCT00103207|470299676|FG000|Overall Study|Death|1|||
130639890|NCT00103207|470299676|FG000|Overall Study|Withdrawal by Subject|2|||
130639891|NCT00103207|470299676|FG000|Overall Study|Other complicating disease|1|||
130639892|NCT00103207|470299676|FG000|Overall Study|Ineligible|4|||
130639893|NCT00103207|470299676|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
130639894|NCT03662789|470299677|FG000|Overall Study|Lost to Follow-up|1|||
130639895|NCT03662789|470299678|FG001|Overall Study|Lost to Follow-up|2|||
130639896|NCT03662789|470299677|FG000|Overall Study|Could not perform treadmill test|4|||
130639897|NCT03662789|470299678|FG001|Overall Study|Could not perform treadmill test|4|||
130639898|NCT03662789|470299677|FG000|Overall Study|Death|0|||
130639899|NCT03662789|470299678|FG001|Overall Study|Death|1|||
130639900|NCT01023516|470299680|FG000|Overall Study|Voluntary discontinuation|7|||
130639901|NCT01023516|470299681|FG001|Overall Study|Voluntary discontinuation|5|||
130639902|NCT01023516|470299680|FG000|Overall Study|Adverse Event|9|||
130639903|NCT01023516|470299681|FG001|Overall Study|Adverse Event|6|||
130639904|NCT01023516|470299680|FG000|Overall Study|Safety reason|0|||
130639905|NCT01023516|470299681|FG001|Overall Study|Safety reason|3|||
130639906|NCT01023516|470299680|FG000|Overall Study|Study-specific criteria|4|||
130639907|NCT01023516|470299681|FG001|Overall Study|Study-specific criteria|2|||
130639908|NCT01023516|470299680|FG000|Overall Study|Incorrect enrolment|4|||
130639909|NCT01023516|470299681|FG001|Overall Study|Incorrect enrolment|2|||
130639910|NCT02559115|470299682|FG000|Overall Study|Withdrawal by Subject|3|||
130639911|NCT02060903|470299687|FG000|Overall Study|Lost to Follow-up|4|||
130639912|NCT02060903|470299688|FG001|Overall Study|Lost to Follow-up|0|||
130639913|NCT02060903|470299687|FG000|Overall Study|Withdrawal by Subject|0|||
130639914|NCT02060903|470299688|FG001|Overall Study|Withdrawal by Subject|7|||
130639915|NCT00137267|470299689|FG000|Overall Study|Lost to Follow-up|15|||
130639916|NCT00137267|470299690|FG001|Overall Study|Lost to Follow-up|21|||
130639917|NCT00638989|470299691|FG000|Overall Study|Lost to Follow-up|0|||
130639918|NCT00638989|470299692|FG001|Overall Study|Lost to Follow-up|0|||
130639919|NCT00638989|470299693|FG002|Overall Study|Lost to Follow-up|1|||
130639920|NCT04556175|470299699|FG000|Overall Study|Study terminated due to COVID-19|8|||
130639921|NCT04556175|470299700|FG001|Overall Study|Study terminated due to COVID-19|8|||
130639922|NCT01553591|470299701|FG000|Overall Study|Voluntarily withdrew|94|||
130639923|NCT01553591|470299702|FG001|Overall Study|Voluntarily withdrew|79|||
130639924|NCT01553591|470299703|FG002|Overall Study|Voluntarily withdrew|96|||
130639925|NCT01553591|470299701|FG000|Overall Study|Adverse Event|36|||
130639926|NCT01553591|470299702|FG001|Overall Study|Adverse Event|45|||
130639927|NCT01553591|470299703|FG002|Overall Study|Adverse Event|16|||
130639928|NCT01553591|470299701|FG000|Overall Study|Lost to Follow-up|25|||
130639929|NCT01553591|470299702|FG001|Overall Study|Lost to Follow-up|23|||
130639930|NCT01553591|470299703|FG002|Overall Study|Lost to Follow-up|16|||
130639931|NCT01553591|470299701|FG000|Overall Study|Physician decision: other|11|||
130639932|NCT01553591|470299702|FG001|Overall Study|Physician decision: other|14|||
130639933|NCT01553591|470299703|FG002|Overall Study|Physician decision: other|16|||
130639934|NCT01553591|470299701|FG000|Overall Study|Physician decision: lack of efficacy|2|||
130639935|NCT01553591|470299702|FG001|Overall Study|Physician decision: lack of efficacy|3|||
130639936|NCT01553591|470299703|FG002|Overall Study|Physician decision: lack of efficacy|7|||
130639937|NCT01553591|470299701|FG000|Overall Study|Protocol Violation|3|||
130639938|NCT01553591|470299702|FG001|Overall Study|Protocol Violation|4|||
130639939|NCT01553591|470299703|FG002|Overall Study|Protocol Violation|4|||
130639940|NCT01553591|470299701|FG000|Overall Study|Sponsor decision|1|||
130639941|NCT01553591|470299702|FG001|Overall Study|Sponsor decision|0|||
130639942|NCT01553591|470299703|FG002|Overall Study|Sponsor decision|3|||
130639943|NCT01553591|470299701|FG000|Overall Study|Randomized and never dispensed drug|0|||
130639944|NCT01553591|470299702|FG001|Overall Study|Randomized and never dispensed drug|1|||
130639945|NCT01553591|470299703|FG002|Overall Study|Randomized and never dispensed drug|0|||
130639946|NCT02871791|470299704|FG000|Phase 1b|Death|0|||
130639947|NCT02871791|470299705|FG001|Phase 1b|Death|1|||
130639948|NCT02871791|470299704|FG000|Phase 1b|progressive disease|6|||
130639949|NCT02871791|470299705|FG001|Phase 1b|progressive disease|2|||
130639950|NCT02871791|470299704|FG000|Phase 2|Death|1|||
130639951|NCT02871791|470299705|FG001|Phase 2|Death|0|||
130639952|NCT02871791|470299704|FG000|Phase 2|Lost to Follow-up|2|||
130639953|NCT02871791|470299705|FG001|Phase 2|Lost to Follow-up|0|||
130639954|NCT04005755|470299706|FG000|Overall Study|Adverse Event|6|||
130639955|NCT04005755|470299706|FG000|Overall Study|Physician Decision|3|||
130639956|NCT04005755|470299706|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
130639957|NCT04005755|470299706|FG000|Overall Study|Withdrawal by Subject|3|||
130639958|NCT04005755|470299706|FG000|Overall Study|Lost to Follow-up|1|||
130639959|NCT00611767|470299707|FG000|Overall Study|Withdrawal by Subject|4|||
130639960|NCT00611767|470299708|FG001|Overall Study|Withdrawal by Subject|1|||
130639961|NCT00611767|470299707|FG000|Overall Study|Thiopental not available|3|||
130639962|NCT00611767|470299708|FG001|Overall Study|Thiopental not available|0|||
130639963|NCT00611767|470299707|FG000|Overall Study|didn't like the medication|1|||
130639964|NCT00611767|470299708|FG001|Overall Study|didn't like the medication|1|||
130639965|NCT00611767|470299707|FG000|Overall Study|Physician Decision|1|||
130639966|NCT00611767|470299708|FG001|Overall Study|Physician Decision|0|||
130639967|NCT00397631|470299712|FG000|Overall Study|Adverse Event|5|||
130639968|NCT00397631|470299713|FG001|Overall Study|Adverse Event|6|||
130639969|NCT00397631|470299712|FG000|Overall Study|Lack of Efficacy|7|||
130639970|NCT00397631|470299713|FG001|Overall Study|Lack of Efficacy|10|||
130639971|NCT00397631|470299712|FG000|Overall Study|Lost to Follow-up|8|||
130639972|NCT00397631|470299713|FG001|Overall Study|Lost to Follow-up|9|||
130639973|NCT00397631|470299712|FG000|Overall Study|Physician Decision|2|||
130639974|NCT00397631|470299713|FG001|Overall Study|Physician Decision|0|||
130639975|NCT00397631|470299712|FG000|Overall Study|Protocol Violation|0|||
130639976|NCT00397631|470299713|FG001|Overall Study|Protocol Violation|1|||
130639977|NCT00397631|470299712|FG000|Overall Study|Withdrawal by Subject|7|||
130639978|NCT00397631|470299713|FG001|Overall Study|Withdrawal by Subject|14|||
130639979|NCT00397631|470299712|FG000|Overall Study|protocol discontinuation criteria|1|||
130639980|NCT00397631|470299713|FG001|Overall Study|protocol discontinuation criteria|4|||
130639981|NCT02202161|470299714|FG000|Overall Study|Adverse Event|1|||
130639982|NCT02202161|470299715|FG001|Overall Study|Adverse Event|1|||
130639983|NCT02202161|470299716|FG002|Overall Study|Adverse Event|0|||
130639984|NCT02202161|470299717|FG003|Overall Study|Adverse Event|0|||
130639985|NCT02202161|470299718|FG004|Overall Study|Adverse Event|0|||
130639986|NCT02202161|470299719|FG005|Overall Study|Adverse Event|1|||
130639987|NCT02202161|470299720|FG006|Overall Study|Adverse Event|0|||
130639988|NCT02202161|470299721|FG007|Overall Study|Adverse Event|0|||
130639989|NCT02202161|470299714|FG000|Overall Study|Did not meet continuation criteria|0|||
130639990|NCT02202161|470299715|FG001|Overall Study|Did not meet continuation criteria|0|||
130639991|NCT02202161|470299716|FG002|Overall Study|Did not meet continuation criteria|0|||
130639992|NCT02202161|470299717|FG003|Overall Study|Did not meet continuation criteria|0|||
130639993|NCT02202161|470299718|FG004|Overall Study|Did not meet continuation criteria|0|||
130639994|NCT02202161|470299719|FG005|Overall Study|Did not meet continuation criteria|0|||
130639995|NCT02202161|470299720|FG006|Overall Study|Did not meet continuation criteria|0|||
130639996|NCT02202161|470299721|FG007|Overall Study|Did not meet continuation criteria|3|||
130639997|NCT02202161|470299714|FG000|Overall Study|Physician Decision|0|||
130639998|NCT02202161|470299715|FG001|Overall Study|Physician Decision|0|||
130639999|NCT02202161|470299716|FG002|Overall Study|Physician Decision|0|||
130640000|NCT02202161|470299717|FG003|Overall Study|Physician Decision|0|||
130640001|NCT02202161|470299718|FG004|Overall Study|Physician Decision|0|||
130640002|NCT02202161|470299719|FG005|Overall Study|Physician Decision|0|||
130640003|NCT02202161|470299720|FG006|Overall Study|Physician Decision|0|||
130640004|NCT02202161|470299721|FG007|Overall Study|Physician Decision|3|||
130640005|NCT02202161|470299714|FG000|Overall Study|Withdrawal by Subject|0|||
130640006|NCT02202161|470299715|FG001|Overall Study|Withdrawal by Subject|0|||
130640007|NCT02202161|470299716|FG002|Overall Study|Withdrawal by Subject|0|||
130640008|NCT02202161|470299717|FG003|Overall Study|Withdrawal by Subject|0|||
130640009|NCT02202161|470299718|FG004|Overall Study|Withdrawal by Subject|1|||
130640010|NCT02202161|470299719|FG005|Overall Study|Withdrawal by Subject|0|||
130640011|NCT02202161|470299720|FG006|Overall Study|Withdrawal by Subject|0|||
130640012|NCT02202161|470299721|FG007|Overall Study|Withdrawal by Subject|0|||
130640013|NCT00832091|470299722|FG000|Overall Study|Adverse Event|1|||
130640014|NCT00832091|470299723|FG001|Overall Study|Adverse Event|1|||
130640015|NCT00832091|470299722|FG000|Overall Study|Protocol Violation|1|||
130640016|NCT00832091|470299723|FG001|Overall Study|Protocol Violation|0|||
130640017|NCT00832091|470299722|FG000|Overall Study|Withdrawal by Subject|2|||
130640018|NCT00832091|470299723|FG001|Overall Study|Withdrawal by Subject|1|||
130640019|NCT00832091|470299722|FG000|Overall Study|Prohibited Medication|1|||
130640020|NCT00832091|470299723|FG001|Overall Study|Prohibited Medication|0|||
130640021|NCT02750501|470299724|FG000|Overall Study|Adverse Event|4|||
130640022|NCT02750501|470299724|FG000|Overall Study|Physician Decision|1|||
130640023|NCT02750501|470299724|FG000|Overall Study|Protocol Violation|1|||
130640024|NCT02750501|470299724|FG000|Overall Study|G-tube came out|1|||
130640025|NCT02750501|470299724|FG000|Overall Study|Non-compliant use of PERT|1|||
130640026|NCT01738594|470299725|FG000|Registration and Treatment Start|Adverse Event|0|||
130640027|NCT01738594|470299726|FG001|Registration and Treatment Start|Adverse Event|1|||
130640028|NCT01738594|470299727|FG002|Registration and Treatment Start|Adverse Event|0|||
130640029|NCT01738594|470299728|FG003|Registration and Treatment Start|Adverse Event|0|||
130640030|NCT01738594|470299729|FG004|Registration and Treatment Start|Adverse Event|0|||
130640031|NCT01738594|470299730|FG005|Registration and Treatment Start|Adverse Event|0|||
130640032|NCT01738594|470299731|FG006|Registration and Treatment Start|Adverse Event|0|||
130640033|NCT01738594|470299732|FG007|Registration and Treatment Start|Adverse Event|0|||
130640034|NCT01738594|470299725|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640035|NCT01738594|470299726|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640036|NCT01738594|470299727|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640037|NCT01738594|470299728|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640038|NCT01738594|470299729|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640039|NCT01738594|470299730|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
130640040|NCT01738594|470299731|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640041|NCT01738594|470299732|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130640042|NCT01738594|470299725|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640043|NCT01738594|470299726|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
130640044|NCT01738594|470299727|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640045|NCT01738594|470299728|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640046|NCT01738594|470299729|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640047|NCT01738594|470299730|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640048|NCT01738594|470299731|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640049|NCT01738594|470299732|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
130640050|NCT01738594|470299725|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640051|NCT01738594|470299726|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640052|NCT01738594|470299727|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640053|NCT01738594|470299728|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640054|NCT01738594|470299729|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640055|NCT01738594|470299730|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
130640056|NCT01738594|470299731|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640057|NCT01738594|470299732|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130640058|NCT01738594|470299725|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640059|NCT01738594|470299726|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640060|NCT01738594|470299727|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640061|NCT01738594|470299728|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640062|NCT01738594|470299729|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640063|NCT01738594|470299730|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
130640064|NCT01738594|470299731|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640065|NCT01738594|470299732|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130640066|NCT01738594|470299725|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640067|NCT01738594|470299726|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640068|NCT01738594|470299727|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640069|NCT01738594|470299728|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640070|NCT01738594|470299729|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
130640071|NCT01738594|470299730|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640072|NCT01738594|470299731|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640073|NCT01738594|470299732|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130640074|NCT01738594|470299725|FG000|Follow up for 1 Year|Death|0|||
130640075|NCT01738594|470299726|FG001|Follow up for 1 Year|Death|0|||
130640076|NCT01738594|470299727|FG002|Follow up for 1 Year|Death|0|||
130640077|NCT01738594|470299728|FG003|Follow up for 1 Year|Death|0|||
130640078|NCT01738594|470299729|FG004|Follow up for 1 Year|Death|0|||
130640079|NCT01738594|470299730|FG005|Follow up for 1 Year|Death|1|||
130640080|NCT01738594|470299731|FG006|Follow up for 1 Year|Death|0|||
130640081|NCT01738594|470299732|FG007|Follow up for 1 Year|Death|0|||
130640082|NCT01738594|470299725|FG000|Follow up for 1 Year|Other|0|||
130640083|NCT01738594|470299726|FG001|Follow up for 1 Year|Other|0|||
130640084|NCT01738594|470299727|FG002|Follow up for 1 Year|Other|0|||
130640085|NCT01738594|470299728|FG003|Follow up for 1 Year|Other|0|||
130640086|NCT01738594|470299729|FG004|Follow up for 1 Year|Other|0|||
130640087|NCT01738594|470299730|FG005|Follow up for 1 Year|Other|2|||
130640088|NCT01738594|470299731|FG006|Follow up for 1 Year|Other|0|||
130640089|NCT01738594|470299732|FG007|Follow up for 1 Year|Other|0|||
130640090|NCT00403390|470299733|FG000|Overall Study|Withdrawal by Subject|1|||
130640091|NCT00403390|470299734|FG001|Overall Study|Withdrawal by Subject|0|||
130640092|NCT00403390|470299733|FG000|Overall Study|samples lost|1|||
130640093|NCT00403390|470299734|FG001|Overall Study|samples lost|0|||
130640094|NCT00403390|470299733|FG000|Overall Study|non-compliant|1|||
130640095|NCT00403390|470299734|FG001|Overall Study|non-compliant|0|||
130640096|NCT00942422|470299735|FG000|Overall Study|Withdrawal by Subject|1|||
130640097|NCT00942422|470299735|FG000|Overall Study|Death|1|||
130640098|NCT00942422|470299735|FG000|Overall Study|Progressive diease|1|||
130640099|NCT02711553|470299738|FG000|Overall Study|Withdrawal by Subject|2|||
130640100|NCT02711553|470299739|FG001|Overall Study|Withdrawal by Subject|1|||
130640101|NCT02711553|470299740|FG002|Overall Study|Withdrawal by Subject|1|||
130640102|NCT02711553|470299741|FG003|Overall Study|Withdrawal by Subject|0|||
130640103|NCT02711553|470299738|FG000|Overall Study|Lost to Follow-up|3|||
130640104|NCT02711553|470299739|FG001|Overall Study|Lost to Follow-up|3|||
130640105|NCT02711553|470299740|FG002|Overall Study|Lost to Follow-up|6|||
130640106|NCT02711553|470299741|FG003|Overall Study|Lost to Follow-up|3|||
130640107|NCT02711553|470299738|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
130640108|NCT02711553|470299739|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
130640109|NCT02711553|470299740|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
130640110|NCT02711553|470299741|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
130640111|NCT05559203|470299742|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
130640112|NCT03117309|470299743|FG000|Overall Study|Not meeting inclusion criteria|0|||
130640113|NCT03117309|470299744|FG001|Overall Study|Not meeting inclusion criteria|1|||
130640114|NCT04048876|470299745|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
130640115|NCT04048876|470299746|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
130640116|NCT04048876|470299747|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
130640117|NCT04048876|470299748|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
130640118|NCT04048876|470299745|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
130640119|NCT04048876|470299746|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
130640120|NCT04048876|470299747|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
130640121|NCT04048876|470299748|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
130640122|NCT04048876|470299745|FG000|Placebo Controlled Phase|Adverse Event|0|||
130640123|NCT04048876|470299746|FG001|Placebo Controlled Phase|Adverse Event|1|||
130640124|NCT04048876|470299747|FG002|Placebo Controlled Phase|Adverse Event|0|||
130640125|NCT04048876|470299748|FG003|Placebo Controlled Phase|Adverse Event|0|||
130640126|NCT04048876|470299745|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
130640127|NCT04048876|470299746|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
130640128|NCT04048876|470299747|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
130640129|NCT04048876|470299748|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
130640130|NCT02187224|470299749|FG000|Overall Study|Did not show up for test day|1|||
130640131|NCT02187224|470299750|FG001|Overall Study|Did not show up for test day|0|||
130640132|NCT01010776|470299756|FG000|Main Phase|Withdrawal by Subject|14|||
130640133|NCT01010776|470299756|FG000|Main Phase|Lack of Efficacy|8|||
130640134|NCT01010776|470299756|FG000|Main Phase|Adverse Event|7|||
130640135|NCT01010776|470299756|FG000|Main Phase|Lost to Follow-up|6|||
130640136|NCT01010776|470299756|FG000|Main Phase|Non-compliance to study medication|5|||
130640137|NCT01010776|470299756|FG000|Main Phase|Selection failure|2|||
130640138|NCT01010776|470299756|FG000|Main Phase|Inform consent withdrawal|1|||
130640139|NCT01010776|470299756|FG000|Main Phase|Other|1|||
130640140|NCT01010776|470299756|FG000|Main Phase|Did not received study medication|5|||
130640141|NCT01010776|470299756|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
130640142|NCT01010776|470299756|FG000|Extension Phase|Other|3|||
130640143|NCT01012037|470299762|FG000|Overall Study|Adverse Event|0|||
130640144|NCT01012037|470299763|FG001|Overall Study|Adverse Event|8|||
130640145|NCT01012037|470299764|FG002|Overall Study|Adverse Event|3|||
130640146|NCT01012037|470299762|FG000|Overall Study|Protocol Violation|0|||
130640147|NCT01012037|470299763|FG001|Overall Study|Protocol Violation|3|||
130640148|NCT01012037|470299764|FG002|Overall Study|Protocol Violation|5|||
130640149|NCT01012037|470299762|FG000|Overall Study|Withdrawal by Subject|0|||
130640150|NCT01012037|470299763|FG001|Overall Study|Withdrawal by Subject|4|||
130640151|NCT01012037|470299764|FG002|Overall Study|Withdrawal by Subject|1|||
130640152|NCT01012037|470299762|FG000|Overall Study|Other reason (not specified)|1|||
130640153|NCT01012037|470299763|FG001|Overall Study|Other reason (not specified)|1|||
130640154|NCT01012037|470299764|FG002|Overall Study|Other reason (not specified)|1|||
130640155|NCT02583711|470299765|FG000|Overall Study|Withdrawal by Subject|0|||
130640156|NCT02583711|470299766|FG001|Overall Study|Withdrawal by Subject|10|||
130640157|NCT02583711|470299767|FG002|Overall Study|Withdrawal by Subject|0|||
130640158|NCT01060124|470299771|FG000|Overall Study|Other|16|||
130640159|NCT01060124|470299771|FG000|Overall Study|Adverse Event|14|||
130640160|NCT01060124|470299771|FG000|Overall Study|Withdrawal by Subject|7|||
130640161|NCT01855919|470300902|FG000|Overall Study|Adverse Event|16|||
130640162|NCT01855919|470300903|FG001|Overall Study|Adverse Event|8|||
130640163|NCT01855919|470300902|FG000|Overall Study|Lack of Efficacy|1|||
130640164|NCT01855919|470300903|FG001|Overall Study|Lack of Efficacy|3|||
130640165|NCT01855919|470300902|FG000|Overall Study|Withdrawal by Subject|4|||
130640166|NCT01855919|470300903|FG001|Overall Study|Withdrawal by Subject|10|||
130640167|NCT01855919|470300902|FG000|Overall Study|Entry Criteria Not Met|1|||
130640168|NCT01855919|470300903|FG001|Overall Study|Entry Criteria Not Met|1|||
130640169|NCT01855919|470300902|FG000|Overall Study|Protocol Violation|1|||
130640170|NCT01855919|470300903|FG001|Overall Study|Protocol Violation|4|||
130640171|NCT04459416|470300904|FG000|Overall Study|Lost to Follow-up|2|||
130640172|NCT04459416|470300905|FG001|Overall Study|Lost to Follow-up|0|||
130640173|NCT04459416|470300904|FG000|Overall Study|Withdrawal by Subject|8|||
130640174|NCT04459416|470300905|FG001|Overall Study|Withdrawal by Subject|10|||
130640175|NCT04459416|470300904|FG000|Overall Study|Disease progression|0|||
130640176|NCT04459416|470300905|FG001|Overall Study|Disease progression|3|||
130640177|NCT03455530|470300906|FG000|Overall Study|Withdrawal by Subject|9|||
130640178|NCT03455530|470300907|FG001|Overall Study|Withdrawal by Subject|1|||
130640179|NCT03455530|470300908|FG002|Overall Study|Withdrawal by Subject|3|||
130640180|NCT03455530|470300909|FG003|Overall Study|Withdrawal by Subject|3|||
130640181|NCT01592773|470300914|FG000|Overall Study|Study Terminated by Sponsor|582|||
130640182|NCT01592773|470300914|FG000|Overall Study|Withdrawal by Subject|35|||
130640183|NCT01592773|470300914|FG000|Overall Study|Lost to Follow-up|19|||
130640184|NCT01592773|470300914|FG000|Overall Study|Adverse Event|17|||
130640185|NCT01592773|470300914|FG000|Overall Study|Lack of Efficacy|9|||
130640186|NCT01592773|470300914|FG000|Overall Study|Protocol Violation|2|||
130640187|NCT01592773|470300914|FG000|Overall Study|Inclusion/exclusion not meet|1|||
130640188|NCT01592773|470300914|FG000|Overall Study|Other Reason|1|||
130640189|NCT04418427|470300916|FG000|Overall Study|Death|0|||
130640190|NCT04418427|470300917|FG001|Overall Study|Death|1|||
130640191|NCT04418427|470300918|FG002|Overall Study|Death|0|||
130640192|NCT04418427|470300916|FG000|Overall Study|Lost to Follow-up|0|||
130640193|NCT04418427|470300917|FG001|Overall Study|Lost to Follow-up|2|||
130640194|NCT04418427|470300918|FG002|Overall Study|Lost to Follow-up|2|||
130640195|NCT04418427|470300916|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
130640196|NCT04418427|470300917|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
130640197|NCT04418427|470300918|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
130640198|NCT04418427|470300916|FG000|Overall Study|Pre-existing medical condition|0|||
130640199|NCT04418427|470300917|FG001|Overall Study|Pre-existing medical condition|1|||
130640200|NCT04418427|470300918|FG002|Overall Study|Pre-existing medical condition|0|||
130640201|NCT01004861|470300919|FG000|Overall Study|Disease progression|3|||
130640202|NCT01004861|470300920|FG001|Overall Study|Disease progression|4|||
130640203|NCT01004861|470300921|FG002|Overall Study|Disease progression|5|||
130640204|NCT01004861|470300922|FG003|Overall Study|Disease progression|4|||
130640205|NCT01004861|470300923|FG004|Overall Study|Disease progression|4|||
130640206|NCT01004861|470300924|FG005|Overall Study|Disease progression|4|||
130640207|NCT01004861|470300925|FG006|Overall Study|Disease progression|5|||
130640208|NCT01004861|470300926|FG007|Overall Study|Disease progression|1|||
130640209|NCT01004861|470300927|FG008|Overall Study|Disease progression|4|||
130640210|NCT01004861|470300928|FG009|Overall Study|Disease progression|7|||
130640211|NCT01004861|470300929|FG010|Overall Study|Disease progression|6|||
130640212|NCT01004861|470300930|FG011|Overall Study|Disease progression|3|||
130640213|NCT01004861|470300931|FG012|Overall Study|Disease progression|8|||
130640214|NCT01004861|470300919|FG000|Overall Study|Physician Decision|0|||
130640215|NCT01004861|470300920|FG001|Overall Study|Physician Decision|2|||
130640216|NCT01004861|470300921|FG002|Overall Study|Physician Decision|1|||
130640217|NCT01004861|470300922|FG003|Overall Study|Physician Decision|1|||
130640218|NCT01004861|470300923|FG004|Overall Study|Physician Decision|1|||
130640219|NCT01004861|470300924|FG005|Overall Study|Physician Decision|0|||
130640220|NCT01004861|470300925|FG006|Overall Study|Physician Decision|0|||
130640221|NCT01004861|470300926|FG007|Overall Study|Physician Decision|1|||
130640222|NCT01004861|470300927|FG008|Overall Study|Physician Decision|0|||
130640223|NCT01004861|470300928|FG009|Overall Study|Physician Decision|0|||
130640224|NCT01004861|470300929|FG010|Overall Study|Physician Decision|0|||
130640225|NCT01004861|470300930|FG011|Overall Study|Physician Decision|0|||
130640226|NCT01004861|470300931|FG012|Overall Study|Physician Decision|3|||
130640227|NCT01004861|470300919|FG000|Overall Study|Adverse Event|0|||
130640228|NCT01004861|470300920|FG001|Overall Study|Adverse Event|0|||
130640229|NCT01004861|470300921|FG002|Overall Study|Adverse Event|0|||
130640230|NCT01004861|470300922|FG003|Overall Study|Adverse Event|1|||
130640231|NCT01004861|470300923|FG004|Overall Study|Adverse Event|0|||
130640232|NCT01004861|470300924|FG005|Overall Study|Adverse Event|2|||
130640233|NCT01004861|470300925|FG006|Overall Study|Adverse Event|1|||
130640234|NCT01004861|470300926|FG007|Overall Study|Adverse Event|1|||
130640235|NCT01004861|470300927|FG008|Overall Study|Adverse Event|13|||
130640236|NCT01004861|470300928|FG009|Overall Study|Adverse Event|1|||
130640237|NCT01004861|470300929|FG010|Overall Study|Adverse Event|1|||
130640238|NCT01004861|470300930|FG011|Overall Study|Adverse Event|0|||
130640239|NCT01004861|470300931|FG012|Overall Study|Adverse Event|2|||
130640240|NCT01004861|470300919|FG000|Overall Study|Protocol Violation|0|||
130640241|NCT01004861|470300920|FG001|Overall Study|Protocol Violation|0|||
130640242|NCT01004861|470300921|FG002|Overall Study|Protocol Violation|0|||
130640243|NCT01004861|470300922|FG003|Overall Study|Protocol Violation|0|||
130640244|NCT01004861|470300923|FG004|Overall Study|Protocol Violation|1|||
130640245|NCT01004861|470300924|FG005|Overall Study|Protocol Violation|0|||
130640246|NCT01004861|470300925|FG006|Overall Study|Protocol Violation|0|||
130640247|NCT01004861|470300926|FG007|Overall Study|Protocol Violation|0|||
130640248|NCT01004861|470300927|FG008|Overall Study|Protocol Violation|0|||
130640249|NCT01004861|470300928|FG009|Overall Study|Protocol Violation|0|||
130640250|NCT01004861|470300929|FG010|Overall Study|Protocol Violation|0|||
130640251|NCT01004861|470300930|FG011|Overall Study|Protocol Violation|0|||
130640252|NCT01004861|470300931|FG012|Overall Study|Protocol Violation|0|||
130640253|NCT01004861|470300919|FG000|Overall Study|Lost to Follow-up|0|||
130640254|NCT01004861|470300920|FG001|Overall Study|Lost to Follow-up|0|||
130640255|NCT01004861|470300921|FG002|Overall Study|Lost to Follow-up|0|||
130640256|NCT01004861|470300922|FG003|Overall Study|Lost to Follow-up|0|||
130640257|NCT01004861|470300923|FG004|Overall Study|Lost to Follow-up|0|||
130640258|NCT01004861|470300924|FG005|Overall Study|Lost to Follow-up|0|||
130640259|NCT01004861|470300925|FG006|Overall Study|Lost to Follow-up|0|||
130640260|NCT01004861|470300926|FG007|Overall Study|Lost to Follow-up|1|||
130640261|NCT01004861|470300927|FG008|Overall Study|Lost to Follow-up|3|||
130640262|NCT01004861|470300928|FG009|Overall Study|Lost to Follow-up|0|||
130640263|NCT01004861|470300929|FG010|Overall Study|Lost to Follow-up|0|||
130640264|NCT01004861|470300930|FG011|Overall Study|Lost to Follow-up|1|||
130640265|NCT01004861|470300931|FG012|Overall Study|Lost to Follow-up|0|||
130640266|NCT01004861|470300919|FG000|Overall Study|Non-compliance|0|||
130640267|NCT01004861|470300920|FG001|Overall Study|Non-compliance|0|||
130640268|NCT01004861|470300921|FG002|Overall Study|Non-compliance|0|||
130640269|NCT01004861|470300922|FG003|Overall Study|Non-compliance|0|||
130640270|NCT01004861|470300923|FG004|Overall Study|Non-compliance|0|||
130640271|NCT01004861|470300924|FG005|Overall Study|Non-compliance|0|||
130640272|NCT01004861|470300925|FG006|Overall Study|Non-compliance|0|||
130640273|NCT01004861|470300926|FG007|Overall Study|Non-compliance|0|||
130640274|NCT01004861|470300927|FG008|Overall Study|Non-compliance|5|||
130640275|NCT01004861|470300928|FG009|Overall Study|Non-compliance|0|||
130640276|NCT01004861|470300929|FG010|Overall Study|Non-compliance|0|||
130640277|NCT01004861|470300930|FG011|Overall Study|Non-compliance|0|||
130640278|NCT01004861|470300931|FG012|Overall Study|Non-compliance|1|||
130640279|NCT01004861|470300919|FG000|Overall Study|Other|0|||
130640280|NCT01004861|470300920|FG001|Overall Study|Other|0|||
130640281|NCT01004861|470300921|FG002|Overall Study|Other|0|||
130640282|NCT01004861|470300922|FG003|Overall Study|Other|0|||
130640283|NCT01004861|470300923|FG004|Overall Study|Other|0|||
130640284|NCT01004861|470300924|FG005|Overall Study|Other|0|||
130640285|NCT01004861|470300925|FG006|Overall Study|Other|0|||
130640286|NCT01004861|470300926|FG007|Overall Study|Other|0|||
130640287|NCT01004861|470300927|FG008|Overall Study|Other|0|||
130640288|NCT01004861|470300928|FG009|Overall Study|Other|2|||
130640289|NCT01004861|470300929|FG010|Overall Study|Other|1|||
130640290|NCT01004861|470300930|FG011|Overall Study|Other|2|||
130640291|NCT01004861|470300931|FG012|Overall Study|Other|3|||
130640292|NCT01004861|470300919|FG000|Overall Study|Patient decision|0|||
130640293|NCT01004861|470300920|FG001|Overall Study|Patient decision|0|||
130640294|NCT01004861|470300921|FG002|Overall Study|Patient decision|0|||
130640295|NCT01004861|470300922|FG003|Overall Study|Patient decision|0|||
130640296|NCT01004861|470300923|FG004|Overall Study|Patient decision|1|||
130640297|NCT01004861|470300924|FG005|Overall Study|Patient decision|0|||
130640298|NCT01004861|470300925|FG006|Overall Study|Patient decision|1|||
130640299|NCT01004861|470300926|FG007|Overall Study|Patient decision|0|||
130640300|NCT01004861|470300927|FG008|Overall Study|Patient decision|7|||
130640301|NCT01004861|470300928|FG009|Overall Study|Patient decision|1|||
130640302|NCT01004861|470300929|FG010|Overall Study|Patient decision|1|||
130640303|NCT01004861|470300930|FG011|Overall Study|Patient decision|2|||
130640304|NCT01004861|470300931|FG012|Overall Study|Patient decision|3|||
130640305|NCT01004861|470300919|FG000|Overall Study|Transitioned to Phase 4 study|0|||
130640306|NCT01004861|470300920|FG001|Overall Study|Transitioned to Phase 4 study|0|||
130640307|NCT01004861|470300921|FG002|Overall Study|Transitioned to Phase 4 study|0|||
130640308|NCT01004861|470300922|FG003|Overall Study|Transitioned to Phase 4 study|0|||
130640309|NCT01004861|470300923|FG004|Overall Study|Transitioned to Phase 4 study|0|||
130640310|NCT01004861|470300924|FG005|Overall Study|Transitioned to Phase 4 study|0|||
130640311|NCT01004861|470300925|FG006|Overall Study|Transitioned to Phase 4 study|0|||
130640312|NCT01004861|470300926|FG007|Overall Study|Transitioned to Phase 4 study|0|||
130640313|NCT01004861|470300927|FG008|Overall Study|Transitioned to Phase 4 study|2|||
130640314|NCT01004861|470300928|FG009|Overall Study|Transitioned to Phase 4 study|0|||
130640315|NCT01004861|470300929|FG010|Overall Study|Transitioned to Phase 4 study|0|||
130640316|NCT01004861|470300930|FG011|Overall Study|Transitioned to Phase 4 study|0|||
130640317|NCT01004861|470300931|FG012|Overall Study|Transitioned to Phase 4 study|0|||
130640318|NCT01004861|470300919|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640319|NCT01004861|470300920|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640320|NCT01004861|470300921|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640321|NCT01004861|470300922|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640322|NCT01004861|470300923|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640323|NCT01004861|470300924|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640324|NCT01004861|470300925|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640325|NCT01004861|470300926|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640326|NCT01004861|470300927|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
130640327|NCT01004861|470300928|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640328|NCT01004861|470300929|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640329|NCT01004861|470300930|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640330|NCT01004861|470300931|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130640331|NCT01004861|470300919|FG000|Overall Study|Patient withdrew|0|||
130640332|NCT01004861|470300920|FG001|Overall Study|Patient withdrew|0|||
130640333|NCT01004861|470300921|FG002|Overall Study|Patient withdrew|0|||
130640334|NCT01004861|470300922|FG003|Overall Study|Patient withdrew|0|||
130640335|NCT01004861|470300923|FG004|Overall Study|Patient withdrew|0|||
130640336|NCT01004861|470300924|FG005|Overall Study|Patient withdrew|0|||
130640337|NCT01004861|470300925|FG006|Overall Study|Patient withdrew|0|||
130640338|NCT01004861|470300926|FG007|Overall Study|Patient withdrew|0|||
130640339|NCT01004861|470300927|FG008|Overall Study|Patient withdrew|1|||
130640340|NCT01004861|470300928|FG009|Overall Study|Patient withdrew|0|||
130640341|NCT01004861|470300929|FG010|Overall Study|Patient withdrew|0|||
130640342|NCT01004861|470300930|FG011|Overall Study|Patient withdrew|0|||
130640343|NCT01004861|470300931|FG012|Overall Study|Patient withdrew|0|||
130640344|NCT01004861|470300919|FG000|Overall Study|Surgical resection|0|||
130640345|NCT01004861|470300920|FG001|Overall Study|Surgical resection|0|||
130640346|NCT01004861|470300921|FG002|Overall Study|Surgical resection|0|||
130640347|NCT01004861|470300922|FG003|Overall Study|Surgical resection|0|||
130640348|NCT01004861|470300923|FG004|Overall Study|Surgical resection|0|||
130640349|NCT01004861|470300924|FG005|Overall Study|Surgical resection|0|||
130640350|NCT01004861|470300925|FG006|Overall Study|Surgical resection|0|||
130640351|NCT01004861|470300926|FG007|Overall Study|Surgical resection|0|||
130640352|NCT01004861|470300927|FG008|Overall Study|Surgical resection|1|||
130640353|NCT01004861|470300928|FG009|Overall Study|Surgical resection|0|||
130640354|NCT01004861|470300929|FG010|Overall Study|Surgical resection|0|||
130640355|NCT01004861|470300930|FG011|Overall Study|Surgical resection|0|||
130640356|NCT01004861|470300931|FG012|Overall Study|Surgical resection|0|||
130640357|NCT01004861|470300919|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640358|NCT01004861|470300920|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640359|NCT01004861|470300921|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640360|NCT01004861|470300922|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640361|NCT01004861|470300923|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640362|NCT01004861|470300924|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640363|NCT01004861|470300925|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640364|NCT01004861|470300926|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640365|NCT01004861|470300927|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
130640366|NCT01004861|470300928|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640367|NCT01004861|470300929|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640368|NCT01004861|470300930|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640369|NCT01004861|470300931|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130640370|NCT01004861|470300919|FG000|Overall Study|Study termination by Sponsor|0|||
130640371|NCT01004861|470300920|FG001|Overall Study|Study termination by Sponsor|0|||
130640372|NCT01004861|470300921|FG002|Overall Study|Study termination by Sponsor|0|||
130640373|NCT01004861|470300922|FG003|Overall Study|Study termination by Sponsor|0|||
130640374|NCT01004861|470300923|FG004|Overall Study|Study termination by Sponsor|0|||
130640375|NCT01004861|470300924|FG005|Overall Study|Study termination by Sponsor|0|||
130640376|NCT01004861|470300925|FG006|Overall Study|Study termination by Sponsor|0|||
130640377|NCT01004861|470300926|FG007|Overall Study|Study termination by Sponsor|0|||
130640378|NCT01004861|470300927|FG008|Overall Study|Study termination by Sponsor|1|||
130640379|NCT01004861|470300928|FG009|Overall Study|Study termination by Sponsor|0|||
130640380|NCT01004861|470300929|FG010|Overall Study|Study termination by Sponsor|0|||
130640381|NCT01004861|470300930|FG011|Overall Study|Study termination by Sponsor|0|||
130640382|NCT01004861|470300931|FG012|Overall Study|Study termination by Sponsor|0|||
130640383|NCT02554721|470300933|FG000|Overall Study|Adverse Event|1|||
130640384|NCT02554721|470300934|FG001|Overall Study|Adverse Event|0|||
130640385|NCT02554721|470300935|FG002|Overall Study|Adverse Event|0|||
130640386|NCT02554721|470300936|FG003|Overall Study|Adverse Event|0|||
130640387|NCT02554721|470300937|FG004|Overall Study|Adverse Event|1|||
130640388|NCT02554721|470300933|FG000|Overall Study|Noncompliance|0|||
130640389|NCT02554721|470300934|FG001|Overall Study|Noncompliance|0|||
130640390|NCT02554721|470300935|FG002|Overall Study|Noncompliance|0|||
130640391|NCT02554721|470300936|FG003|Overall Study|Noncompliance|0|||
130640392|NCT02554721|470300937|FG004|Overall Study|Noncompliance|1|||
130640393|NCT00686699|470300938|FG000|Treatment Period 1|Adverse Event|0|||
130640394|NCT00686699|470300939|FG001|Treatment Period 1|Adverse Event|2|||
130640395|NCT00908895|470300940|FG000|Overall Study|Lost to Follow-up|1|||
130640396|NCT00908895|470300941|FG001|Overall Study|Lost to Follow-up|3|||
130640397|NCT00908895|470300940|FG000|Overall Study|algodystrophy|2|||
130640398|NCT00908895|470300941|FG001|Overall Study|algodystrophy|2|||
130640399|NCT00908895|470300940|FG000|Overall Study|Adverse Event|1|||
130640400|NCT00908895|470300941|FG001|Overall Study|Adverse Event|1|||
130640401|NCT02059174|470300943|FG000|Period 1|Withdrawal by Subject|0|||
130640402|NCT02059174|470300944|FG001|Period 1|Withdrawal by Subject|2|||
130640403|NCT02059174|470300943|FG000|Period 2|Withdrawal by Subject|0|||
130640404|NCT02059174|470300944|FG001|Period 2|Withdrawal by Subject|2|||
130640405|NCT02059174|470300943|FG000|Period 2|Protocol Violation|1|||
130640406|NCT02059174|470300944|FG001|Period 2|Protocol Violation|0|||
130640407|NCT02059174|470300943|FG000|Period 3|Physician Decision|1|||
130640408|NCT02059174|470300944|FG001|Period 3|Physician Decision|0|||
130640409|NCT02306148|470300945|FG000|Overall Study|Adverse Event|12|||
130640410|NCT02306148|470300946|FG001|Overall Study|Adverse Event|6|||
130640411|NCT02306148|470300945|FG000|Overall Study|Lost to Follow-up|1|||
130640412|NCT02306148|470300946|FG001|Overall Study|Lost to Follow-up|4|||
130640413|NCT00087594|470300951|FG000|Overall Study|Adverse Event|2|||
130640414|NCT00087594|470300952|FG001|Overall Study|Adverse Event|3|||
130640415|NCT00087594|470300951|FG000|Overall Study|Lost to Follow-up|0|||
130640416|NCT00087594|470300952|FG001|Overall Study|Lost to Follow-up|2|||
130640417|NCT00087594|470300951|FG000|Overall Study|Withdrawal by Subject|4|||
130640418|NCT00087594|470300952|FG001|Overall Study|Withdrawal by Subject|2|||
130640419|NCT00087594|470300951|FG000|Overall Study|Lack of Efficacy|2|||
130640420|NCT00087594|470300952|FG001|Overall Study|Lack of Efficacy|5|||
130640421|NCT01952041|470300953|FG000|Overall Study|Lost to Follow-up|9|||
130640422|NCT01952041|470300954|FG001|Overall Study|Lost to Follow-up|16|||
130640423|NCT01952041|470300953|FG000|Overall Study|Withdrawal by Subject|7|||
130640424|NCT01952041|470300954|FG001|Overall Study|Withdrawal by Subject|5|||
130640425|NCT01952041|470300953|FG000|Overall Study|Death|1|||
130640426|NCT01952041|470300954|FG001|Overall Study|Death|0|||
130640427|NCT00186121|470300955|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
130640428|NCT00186121|470300955|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
130640429|NCT00186121|470300955|FG000|Overall Study|Not eligible (no treatment)|1|||
130640430|NCT01569568|470300956|FG000|Overall Study|Physician Decision|0|||
130640431|NCT01569568|470300957|FG001|Overall Study|Physician Decision|2|||
130640432|NCT01370499|470300958|FG000|Overall Study|Adverse Event|38|||
130640433|NCT01370499|470300959|FG001|Overall Study|Adverse Event|12|||
130640434|NCT01370499|470300958|FG000|Overall Study|Lack of Efficacy|4|||
130640435|NCT01370499|470300959|FG001|Overall Study|Lack of Efficacy|2|||
130640436|NCT01370499|470300958|FG000|Overall Study|Lost to Follow-up|2|||
130640437|NCT01370499|470300959|FG001|Overall Study|Lost to Follow-up|1|||
130640438|NCT01370499|470300958|FG000|Overall Study|Physician Decision|3|||
130640439|NCT01370499|470300959|FG001|Overall Study|Physician Decision|3|||
130640440|NCT01370499|470300958|FG000|Overall Study|Protocol Violation|5|||
130640441|NCT01370499|470300959|FG001|Overall Study|Protocol Violation|4|||
130640442|NCT01370499|470300958|FG000|Overall Study|Withdrawal by Subject|18|||
130640443|NCT01370499|470300959|FG001|Overall Study|Withdrawal by Subject|7|||
130640444|NCT01370499|470300958|FG000|Overall Study|Sponsor Decision|41|||
130640445|NCT01370499|470300959|FG001|Overall Study|Sponsor Decision|15|||
130640446|NCT01654224|470300964|FG000|Overall Study|Lost to Follow-up|2|||
130640447|NCT01654224|470300965|FG001|Overall Study|Lost to Follow-up|2|||
130640448|NCT01654224|470300964|FG000|Overall Study|Did not receive allocation|1|||
130640449|NCT01654224|470300965|FG001|Overall Study|Did not receive allocation|8|||
130640450|NCT01654224|470300964|FG000|Overall Study|Insufficient blood sample|3|||
130640451|NCT01654224|470300965|FG001|Overall Study|Insufficient blood sample|2|||
130640452|NCT00166504|470300966|FG000|Overall Study|Adverse Event|3|||
130640453|NCT00166504|470300967|FG001|Overall Study|Adverse Event|3|||
130640454|NCT00166504|470300966|FG000|Overall Study|Lost to Follow-up|1|||
130640455|NCT00166504|470300967|FG001|Overall Study|Lost to Follow-up|1|||
130640456|NCT00166504|470300966|FG000|Overall Study|Withdrawal by Subject|1|||
130640457|NCT00166504|470300967|FG001|Overall Study|Withdrawal by Subject|0|||
130640458|NCT00723489|470300968|FG000|Overall Study|Physician Decision|0|||
130640459|NCT00723489|470300969|FG001|Overall Study|Physician Decision|1|||
130640460|NCT00723489|470300970|FG002|Overall Study|Physician Decision|0|||
130640461|NCT00723489|470300971|FG003|Overall Study|Physician Decision|0|||
130640462|NCT00723489|470300968|FG000|Overall Study|Pregnancy|0|||
130640463|NCT00723489|470300969|FG001|Overall Study|Pregnancy|0|||
130640464|NCT00723489|470300970|FG002|Overall Study|Pregnancy|0|||
130640465|NCT00723489|470300971|FG003|Overall Study|Pregnancy|1|||
130640466|NCT00723489|470300968|FG000|Overall Study|Withdrawal by Subject|0|||
130640467|NCT00723489|470300969|FG001|Overall Study|Withdrawal by Subject|0|||
130640468|NCT00723489|470300970|FG002|Overall Study|Withdrawal by Subject|0|||
130640469|NCT00723489|470300971|FG003|Overall Study|Withdrawal by Subject|1|||
130640470|NCT00723489|470300968|FG000|Overall Study|Seropositive at baseline|1|||
130640471|NCT00723489|470300969|FG001|Overall Study|Seropositive at baseline|0|||
130640472|NCT00723489|470300970|FG002|Overall Study|Seropositive at baseline|0|||
130640473|NCT00723489|470300971|FG003|Overall Study|Seropositive at baseline|0|||
130640474|NCT00723489|470300968|FG000|Overall Study|Prohibited Medication|0|||
130640475|NCT00723489|470300969|FG001|Overall Study|Prohibited Medication|0|||
130640476|NCT00723489|470300970|FG002|Overall Study|Prohibited Medication|0|||
130640477|NCT00723489|470300971|FG003|Overall Study|Prohibited Medication|1|||
130640478|NCT00723489|470300968|FG000|Overall Study|Samples Collected Out of Window|0|||
130640479|NCT00723489|470300969|FG001|Overall Study|Samples Collected Out of Window|3|||
130640480|NCT00723489|470300970|FG002|Overall Study|Samples Collected Out of Window|0|||
130640481|NCT00723489|470300971|FG003|Overall Study|Samples Collected Out of Window|0|||
130640482|NCT02274311|470300972|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
130640483|NCT00853112|470300974|FG000|Overall Study|Randomized but not treated|0|||
130640484|NCT00853112|470300975|FG001|Overall Study|Randomized but not treated|1|||
130640485|NCT00853112|470300976|FG002|Overall Study|Randomized but not treated|0|||
130640486|NCT00853112|470300977|FG003|Overall Study|Randomized but not treated|2|||
130640487|NCT00853112|470300978|FG004|Overall Study|Randomized but not treated|0|||
130640488|NCT00853112|470300979|FG005|Overall Study|Randomized but not treated|0|||
130640489|NCT00853112|470300980|FG006|Overall Study|Randomized but not treated|1|||
130640490|NCT02477800|470300983|FG000|Placebo-Controlled Period|Adverse Event|16|||
130640491|NCT02477800|470300984|FG001|Placebo-Controlled Period|Adverse Event|25|||
130640492|NCT02477800|470300985|FG002|Placebo-Controlled Period|Adverse Event|28|||
130640493|NCT02477800|470300986|FG003|Placebo-Controlled Period|Adverse Event|0|||
130640494|NCT02477800|470300987|FG004|Placebo-Controlled Period|Adverse Event|0|||
130640495|NCT02477800|470300988|FG005|Placebo-Controlled Period|Adverse Event|0|||
130640496|NCT02477800|470300989|FG006|Placebo-Controlled Period|Adverse Event|0|||
130640497|NCT02477800|470300983|FG000|Placebo-Controlled Period|Change of Treatment|1|||
130640498|NCT02477800|470300984|FG001|Placebo-Controlled Period|Change of Treatment|2|||
130640499|NCT02477800|470300985|FG002|Placebo-Controlled Period|Change of Treatment|1|||
130640500|NCT02477800|470300986|FG003|Placebo-Controlled Period|Change of Treatment|0|||
130640501|NCT02477800|470300987|FG004|Placebo-Controlled Period|Change of Treatment|0|||
130640502|NCT02477800|470300988|FG005|Placebo-Controlled Period|Change of Treatment|0|||
130640503|NCT02477800|470300989|FG006|Placebo-Controlled Period|Change of Treatment|0|||
130640504|NCT02477800|470300983|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
130640505|NCT02477800|470300984|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
130640506|NCT02477800|470300985|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
130640507|NCT02477800|470300986|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
130640508|NCT02477800|470300987|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
130640509|NCT02477800|470300988|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
130640510|NCT02477800|470300989|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
130640511|NCT02477800|470300983|FG000|Placebo-Controlled Period|Death|0|||
130640512|NCT02477800|470300984|FG001|Placebo-Controlled Period|Death|3|||
130640513|NCT02477800|470300985|FG002|Placebo-Controlled Period|Death|2|||
130640514|NCT02477800|470300986|FG003|Placebo-Controlled Period|Death|0|||
130640515|NCT02477800|470300987|FG004|Placebo-Controlled Period|Death|0|||
130640516|NCT02477800|470300988|FG005|Placebo-Controlled Period|Death|0|||
130640517|NCT02477800|470300989|FG006|Placebo-Controlled Period|Death|0|||
130640518|NCT02477800|470300983|FG000|Placebo-Controlled Period|Disease Progression|1|||
130640519|NCT02477800|470300984|FG001|Placebo-Controlled Period|Disease Progression|0|||
130640520|NCT02477800|470300985|FG002|Placebo-Controlled Period|Disease Progression|1|||
130640521|NCT02477800|470300986|FG003|Placebo-Controlled Period|Disease Progression|0|||
130640522|NCT02477800|470300987|FG004|Placebo-Controlled Period|Disease Progression|0|||
130640523|NCT02477800|470300988|FG005|Placebo-Controlled Period|Disease Progression|0|||
130640524|NCT02477800|470300989|FG006|Placebo-Controlled Period|Disease Progression|0|||
130640525|NCT02477800|470300983|FG000|Placebo-Controlled Period|Investigator Decision|3|||
130640526|NCT02477800|470300984|FG001|Placebo-Controlled Period|Investigator Decision|2|||
130640527|NCT02477800|470300985|FG002|Placebo-Controlled Period|Investigator Decision|1|||
130640528|NCT02477800|470300986|FG003|Placebo-Controlled Period|Investigator Decision|0|||
130640529|NCT02477800|470300987|FG004|Placebo-Controlled Period|Investigator Decision|0|||
130640530|NCT02477800|470300988|FG005|Placebo-Controlled Period|Investigator Decision|0|||
130640531|NCT02477800|470300989|FG006|Placebo-Controlled Period|Investigator Decision|0|||
130640532|NCT02477800|470300983|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
130640533|NCT02477800|470300984|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
130640534|NCT02477800|470300985|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
130640535|NCT02477800|470300986|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
130640536|NCT02477800|470300987|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
130640537|NCT02477800|470300988|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
130640538|NCT02477800|470300989|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
130640539|NCT02477800|470300983|FG000|Placebo-Controlled Period|Relocation|2|||
130640540|NCT02477800|470300984|FG001|Placebo-Controlled Period|Relocation|0|||
130640541|NCT02477800|470300985|FG002|Placebo-Controlled Period|Relocation|0|||
130640542|NCT02477800|470300986|FG003|Placebo-Controlled Period|Relocation|0|||
130640543|NCT02477800|470300987|FG004|Placebo-Controlled Period|Relocation|0|||
130640544|NCT02477800|470300988|FG005|Placebo-Controlled Period|Relocation|0|||
130640545|NCT02477800|470300989|FG006|Placebo-Controlled Period|Relocation|0|||
130640546|NCT02477800|470300983|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130640547|NCT02477800|470300984|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130640548|NCT02477800|470300985|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130640549|NCT02477800|470300986|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130640550|NCT02477800|470300987|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130640551|NCT02477800|470300988|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130640552|NCT02477800|470300989|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130640553|NCT02477800|470300983|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
130640554|NCT02477800|470300984|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
130640555|NCT02477800|470300985|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130640556|NCT02477800|470300986|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130640557|NCT02477800|470300987|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130640558|NCT02477800|470300988|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130640559|NCT02477800|470300989|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130640560|NCT02477800|470300983|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
130640561|NCT02477800|470300984|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
130640562|NCT02477800|470300985|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
130640563|NCT02477800|470300986|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
130640564|NCT02477800|470300987|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
130640565|NCT02477800|470300988|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
130640566|NCT02477800|470300989|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
130640567|NCT02477800|470300983|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
130640568|NCT02477800|470300984|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
130640569|NCT02477800|470300985|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
130640570|NCT02477800|470300986|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130640571|NCT02477800|470300987|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130640572|NCT02477800|470300988|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130640573|NCT02477800|470300989|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130640574|NCT02477800|470300983|FG000|Placebo-Controlled Period|Reason not Specified|161|||
130640575|NCT02477800|470300984|FG001|Placebo-Controlled Period|Reason not Specified|161|||
130640576|NCT02477800|470300985|FG002|Placebo-Controlled Period|Reason not Specified|189|||
130640577|NCT02477800|470300986|FG003|Placebo-Controlled Period|Reason not Specified|0|||
130640578|NCT02477800|470300987|FG004|Placebo-Controlled Period|Reason not Specified|0|||
130640579|NCT02477800|470300988|FG005|Placebo-Controlled Period|Reason not Specified|0|||
130640580|NCT02477800|470300989|FG006|Placebo-Controlled Period|Reason not Specified|0|||
130640581|NCT02477800|470300983|FG000|Long Term Extension Period|Adverse Event|0|||
130640582|NCT02477800|470300984|FG001|Long Term Extension Period|Adverse Event|0|||
130640583|NCT02477800|470300985|FG002|Long Term Extension Period|Adverse Event|0|||
130640584|NCT02477800|470300986|FG003|Long Term Extension Period|Adverse Event|6|||
130640585|NCT02477800|470300987|FG004|Long Term Extension Period|Adverse Event|2|||
130640586|NCT02477800|470300988|FG005|Long Term Extension Period|Adverse Event|4|||
130640587|NCT02477800|470300989|FG006|Long Term Extension Period|Adverse Event|3|||
130640588|NCT02477800|470300983|FG000|Long Term Extension Period|Death|0|||
130640589|NCT02477800|470300984|FG001|Long Term Extension Period|Death|0|||
130640590|NCT02477800|470300985|FG002|Long Term Extension Period|Death|0|||
130640591|NCT02477800|470300986|FG003|Long Term Extension Period|Death|1|||
130640592|NCT02477800|470300987|FG004|Long Term Extension Period|Death|1|||
130640593|NCT02477800|470300988|FG005|Long Term Extension Period|Death|1|||
130640594|NCT02477800|470300989|FG006|Long Term Extension Period|Death|2|||
130640595|NCT02477800|470300983|FG000|Long Term Extension Period|Consent Withdrawn|0|||
130640596|NCT02477800|470300984|FG001|Long Term Extension Period|Consent Withdrawn|0|||
130640597|NCT02477800|470300985|FG002|Long Term Extension Period|Consent Withdrawn|0|||
130640598|NCT02477800|470300986|FG003|Long Term Extension Period|Consent Withdrawn|10|||
130640599|NCT02477800|470300987|FG004|Long Term Extension Period|Consent Withdrawn|4|||
130640600|NCT02477800|470300988|FG005|Long Term Extension Period|Consent Withdrawn|13|||
130640601|NCT02477800|470300989|FG006|Long Term Extension Period|Consent Withdrawn|16|||
130640602|NCT02477800|470300983|FG000|Long Term Extension Period|Disease Progression|0|||
130640603|NCT02477800|470300984|FG001|Long Term Extension Period|Disease Progression|0|||
130640604|NCT02477800|470300985|FG002|Long Term Extension Period|Disease Progression|0|||
130640605|NCT02477800|470300986|FG003|Long Term Extension Period|Disease Progression|3|||
130640606|NCT02477800|470300987|FG004|Long Term Extension Period|Disease Progression|1|||
130640607|NCT02477800|470300988|FG005|Long Term Extension Period|Disease Progression|1|||
130640608|NCT02477800|470300989|FG006|Long Term Extension Period|Disease Progression|0|||
130640609|NCT02477800|470300983|FG000|Long Term Extension Period|Investigator Decision|0|||
130640610|NCT02477800|470300984|FG001|Long Term Extension Period|Investigator Decision|0|||
130640611|NCT02477800|470300985|FG002|Long Term Extension Period|Investigator Decision|0|||
130640612|NCT02477800|470300986|FG003|Long Term Extension Period|Investigator Decision|0|||
130640613|NCT02477800|470300987|FG004|Long Term Extension Period|Investigator Decision|0|||
130640614|NCT02477800|470300988|FG005|Long Term Extension Period|Investigator Decision|0|||
130640615|NCT02477800|470300989|FG006|Long Term Extension Period|Investigator Decision|2|||
130640616|NCT02477800|470300983|FG000|Long Term Extension Period|Lost to Follow-up|0|||
130640617|NCT02477800|470300984|FG001|Long Term Extension Period|Lost to Follow-up|0|||
130640618|NCT02477800|470300985|FG002|Long Term Extension Period|Lost to Follow-up|0|||
130640619|NCT02477800|470300986|FG003|Long Term Extension Period|Lost to Follow-up|0|||
130640620|NCT02477800|470300987|FG004|Long Term Extension Period|Lost to Follow-up|1|||
130640621|NCT02477800|470300988|FG005|Long Term Extension Period|Lost to Follow-up|3|||
130640622|NCT02477800|470300989|FG006|Long Term Extension Period|Lost to Follow-up|0|||
130640623|NCT02477800|470300983|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
130640624|NCT02477800|470300984|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
130640625|NCT02477800|470300985|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
130640626|NCT02477800|470300986|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
130640627|NCT02477800|470300987|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
130640628|NCT02477800|470300988|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
130640629|NCT02477800|470300989|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
130640630|NCT02477800|470300983|FG000|Long Term Extension Period|Study Visit Burden|0|||
130640631|NCT02477800|470300984|FG001|Long Term Extension Period|Study Visit Burden|0|||
130640632|NCT02477800|470300985|FG002|Long Term Extension Period|Study Visit Burden|0|||
130640633|NCT02477800|470300986|FG003|Long Term Extension Period|Study Visit Burden|3|||
130640634|NCT02477800|470300987|FG004|Long Term Extension Period|Study Visit Burden|0|||
130640635|NCT02477800|470300988|FG005|Long Term Extension Period|Study Visit Burden|2|||
130640636|NCT02477800|470300989|FG006|Long Term Extension Period|Study Visit Burden|2|||
130640637|NCT02477800|470300983|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130640638|NCT02477800|470300984|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130640639|NCT02477800|470300985|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130640640|NCT02477800|470300986|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
130640641|NCT02477800|470300987|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
130640642|NCT02477800|470300988|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
130640643|NCT02477800|470300989|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
130640644|NCT02477800|470300983|FG000|Long Term Extension Period|Reason not Specified|0|||
130640645|NCT02477800|470300984|FG001|Long Term Extension Period|Reason not Specified|0|||
130640646|NCT02477800|470300985|FG002|Long Term Extension Period|Reason not Specified|0|||
130640647|NCT02477800|470300986|FG003|Long Term Extension Period|Reason not Specified|126|||
130640648|NCT02477800|470300987|FG004|Long Term Extension Period|Reason not Specified|140|||
130640649|NCT02477800|470300988|FG005|Long Term Extension Period|Reason not Specified|270|||
130640650|NCT02477800|470300989|FG006|Long Term Extension Period|Reason not Specified|224|||
130640651|NCT00958191|470300991|FG000|Overall Study|Death|4|||
130640652|NCT00958191|470300991|FG000|Overall Study|Lost to Follow-up|5|||
130640653|NCT00958191|470300991|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
130640654|NCT00958191|470300991|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
130640655|NCT00958191|470300991|FG000|Overall Study|Revision of study device|4|||
130640656|NCT00958191|470300991|FG000|Overall Study|Site termination|11|||
130640657|NCT00958191|470300991|FG000|Overall Study|No 5 yr x-rays|56|||
130640658|NCT01818765|470300992|FG000|Overall Study|Death|2|||
130640659|NCT02010567|470300993|FG000|Overall Study|Adverse Event|0|||
130640660|NCT02010567|470300994|FG001|Overall Study|Adverse Event|0|||
130640661|NCT02010567|470300995|FG002|Overall Study|Adverse Event|1|||
130640662|NCT02010567|470300996|FG003|Overall Study|Adverse Event|0|||
130640663|NCT02010567|470300997|FG004|Overall Study|Adverse Event|1|||
130640664|NCT02005211|470300998|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640665|NCT02005211|470300999|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640666|NCT02005211|470301000|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640667|NCT02005211|470301001|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640668|NCT02005211|470301002|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
130640669|NCT02005211|470301003|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640670|NCT02005211|470301004|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130640671|NCT00415623|470301006|FG000|Overall Study|Adverse Event|3|||
130640672|NCT00415623|470301007|FG001|Overall Study|Adverse Event|4|||
130640673|NCT00415623|470301006|FG000|Overall Study|Death|1|||
130640674|NCT00415623|470301007|FG001|Overall Study|Death|0|||
130640675|NCT00415623|470301006|FG000|Overall Study|Withdrawal by Subject|1|||
130640676|NCT00415623|470301007|FG001|Overall Study|Withdrawal by Subject|1|||
130640677|NCT01708915|470301012|FG000|Overall Study|Adverse Event|1|||
130640678|NCT01708915|470301013|FG001|Overall Study|Adverse Event|0|||
130640679|NCT01708915|470301014|FG002|Overall Study|Adverse Event|9|||
130640680|NCT01708915|470301015|FG003|Overall Study|Adverse Event|13|||
130640681|NCT01708915|470301012|FG000|Overall Study|Lack of Efficacy|84|||
130640682|NCT01708915|470301013|FG001|Overall Study|Lack of Efficacy|60|||
130640683|NCT01708915|470301014|FG002|Overall Study|Lack of Efficacy|35|||
130640684|NCT01708915|470301015|FG003|Overall Study|Lack of Efficacy|15|||
130640685|NCT01708915|470301012|FG000|Overall Study|Protocol Violation|0|||
130640686|NCT01708915|470301013|FG001|Overall Study|Protocol Violation|0|||
130640687|NCT01708915|470301014|FG002|Overall Study|Protocol Violation|0|||
130640688|NCT01708915|470301015|FG003|Overall Study|Protocol Violation|1|||
130640689|NCT01708915|470301012|FG000|Overall Study|Withdrawal by Subject|0|||
130640690|NCT01708915|470301013|FG001|Overall Study|Withdrawal by Subject|1|||
130640691|NCT01708915|470301014|FG002|Overall Study|Withdrawal by Subject|2|||
130640692|NCT01708915|470301015|FG003|Overall Study|Withdrawal by Subject|2|||
130640693|NCT01708915|470301012|FG000|Overall Study|Other reasons than stated above|1|||
130640694|NCT01708915|470301013|FG001|Overall Study|Other reasons than stated above|1|||
130640695|NCT01708915|470301014|FG002|Overall Study|Other reasons than stated above|0|||
130640696|NCT01708915|470301015|FG003|Overall Study|Other reasons than stated above|2|||
130640697|NCT01432938|470301016|FG000|First Intervention|Protocol Violation|1|||
130640698|NCT01432938|470301017|FG001|First Intervention|Protocol Violation|0|||
130640699|NCT01432938|470301016|FG000|First Intervention|Physician Decision|1|||
130640700|NCT01432938|470301017|FG001|First Intervention|Physician Decision|0|||
130640701|NCT01432938|470301016|FG000|Second Intervention|Adverse Event|1|||
130640702|NCT01432938|470301017|FG001|Second Intervention|Adverse Event|0|||
130640703|NCT01601873|470301018|FG000|Overall Study|Lost to Follow-up|2|||
130640704|NCT01601873|470301019|FG001|Overall Study|Lost to Follow-up|3|||
130640705|NCT02096471|470301020|FG000|Overall Study|Adverse Event|1|||
130640706|NCT02096471|470301020|FG000|Overall Study|Lack of Efficacy|7|||
130640707|NCT02096471|470301020|FG000|Overall Study|Withdrawal by Subject|3|||
130640708|NCT02096471|470301020|FG000|Overall Study|Non-Compliant|2|||
130640709|NCT02449915|470301021|FG000|Overall Study|Exclusion criteria - drug use|1|||
130640710|NCT02449915|470301022|FG001|Overall Study|Exclusion criteria - drug use|0|||
130640711|NCT02449915|470301021|FG000|Overall Study|Withdrawal by Subject|0|||
130640712|NCT02449915|470301022|FG001|Overall Study|Withdrawal by Subject|2|||
130640713|NCT02449915|470301021|FG000|Overall Study|Intraoperative surgical findings|1|||
130640714|NCT02449915|470301022|FG001|Overall Study|Intraoperative surgical findings|1|||
130640715|NCT02449915|470301021|FG000|Overall Study|Abnormal preop lab|0|||
130640716|NCT02449915|470301022|FG001|Overall Study|Abnormal preop lab|1|||
130640717|NCT04223778|470301031|FG000|Overall Study|Death|1|||
130640718|NCT04223778|470301032|FG001|Overall Study|Death|1|||
130640719|NCT04223778|470301031|FG000|Overall Study|Lost to Follow-up|4|||
130640720|NCT04223778|470301032|FG001|Overall Study|Lost to Follow-up|5|||
130640721|NCT04223778|470301031|FG000|Overall Study|Physician Decision|10|||
130640722|NCT04223778|470301032|FG001|Overall Study|Physician Decision|6|||
130640723|NCT04223778|470301031|FG000|Overall Study|Withdrawal by Subject|35|||
130640724|NCT04223778|470301032|FG001|Overall Study|Withdrawal by Subject|17|||
130640725|NCT04223778|470301031|FG000|Overall Study|Not Reported|7|||
130640726|NCT04223778|470301032|FG001|Overall Study|Not Reported|8|||
130640727|NCT00740116|470302700|FG000|Overall Study|Withdrawal by Subject|1|||
130640728|NCT00740116|470302701|FG001|Overall Study|Withdrawal by Subject|1|||
130640729|NCT00740116|470302700|FG000|Overall Study|Protocol Violation|1|||
130640730|NCT00740116|470302701|FG001|Overall Study|Protocol Violation|4|||
130640731|NCT03037489|470302702|FG000|Overall Study|Adverse Event|4|||
130640732|NCT03037489|470302703|FG001|Overall Study|Adverse Event|0|||
130640733|NCT03037489|470302702|FG000|Overall Study|Withdrawal by Subject|3|||
130640734|NCT03037489|470302703|FG001|Overall Study|Withdrawal by Subject|0|||
130640735|NCT00621764|470302704|FG000|Overall Study|Protocol Violation|0|||
130640736|NCT00621764|470302705|FG001|Overall Study|Protocol Violation|0|||
130640737|NCT00621764|470302706|FG002|Overall Study|Protocol Violation|0|||
130640738|NCT00621764|470302707|FG003|Overall Study|Protocol Violation|1|||
130640739|NCT02499172|470302708|FG000|Overall Study|Financial reason|0|||
130640740|NCT02499172|470302709|FG001|Overall Study|Financial reason|0|||
130640741|NCT02499172|470302710|FG002|Overall Study|Financial reason|523|||
130640742|NCT02499172|470302711|FG003|Overall Study|Financial reason|436|||
130640743|NCT02499172|470302708|FG000|Overall Study|Lost to Follow-up|65|||
130640744|NCT02499172|470302709|FG001|Overall Study|Lost to Follow-up|64|||
130640745|NCT02499172|470302710|FG002|Overall Study|Lost to Follow-up|0|||
130640746|NCT02499172|470302711|FG003|Overall Study|Lost to Follow-up|0|||
130640747|NCT01293123|470302712|FG000|Overall Study|Lost to Follow-up|0|||
130640748|NCT01293123|470302713|FG001|Overall Study|Lost to Follow-up|1|||
130640749|NCT00121485|470302714|FG000|Overall Study|Not implanted|1|||
130640750|NCT00121485|470302715|FG001|Overall Study|Not implanted|5|||
130640751|NCT00121485|470302714|FG000|Overall Study|Crossover|0|||
130640752|NCT00121485|470302715|FG001|Overall Study|Crossover|2|||
130640753|NCT00724243|470302720|FG000|Overall Study|Lack of Efficacy|10|||
130640754|NCT00724243|470302720|FG000|Overall Study|Adverse Event|5|||
130640755|NCT03031327|470302723|FG000|Overall Study|Withdrawal by Subject|0|||
130640756|NCT03031327|470302724|FG001|Overall Study|Withdrawal by Subject|1|||
130640757|NCT03031327|470302725|FG002|Overall Study|Withdrawal by Subject|1|||
130640758|NCT00211536|470302726|FG000|Overall Study|Withdrawal by Subject|2|||
130640759|NCT00211536|470302727|FG001|Overall Study|Withdrawal by Subject|2|||
130640760|NCT00211536|470302726|FG000|Overall Study|Physician Decision|0|||
130640761|NCT00211536|470302727|FG001|Overall Study|Physician Decision|5|||
130640762|NCT00211536|470302726|FG000|Overall Study|Adverse Event|2|||
130640763|NCT00211536|470302727|FG001|Overall Study|Adverse Event|0|||
130640764|NCT00003389|470302728|FG000|Overall Study|Disease progression|6|||
130640765|NCT00003389|470302729|FG001|Overall Study|Disease progression|1|||
130640766|NCT00003389|470302728|FG000|Overall Study|Adverse Event|13|||
130640767|NCT00003389|470302729|FG001|Overall Study|Adverse Event|2|||
130640768|NCT00003389|470302728|FG000|Overall Study|Death|0|||
130640769|NCT00003389|470302729|FG001|Overall Study|Death|3|||
130640770|NCT00003389|470302728|FG000|Overall Study|Withdrawal by Subject|12|||
130640771|NCT00003389|470302729|FG001|Overall Study|Withdrawal by Subject|5|||
130640772|NCT00003389|470302728|FG000|Overall Study|Alternative therapy|2|||
130640773|NCT00003389|470302729|FG001|Overall Study|Alternative therapy|1|||
130640774|NCT00003389|470302728|FG000|Overall Study|Complicating disease|1|||
130640775|NCT00003389|470302729|FG001|Overall Study|Complicating disease|0|||
130640776|NCT00003389|470302728|FG000|Overall Study|Off-treatment reason missing|31|||
130640777|NCT00003389|470302729|FG001|Overall Study|Off-treatment reason missing|21|||
130640778|NCT00003389|470302728|FG000|Overall Study|Ineligible|33|||
130640779|NCT00003389|470302729|FG001|Overall Study|Ineligible|27|||
130640780|NCT04610827|470302730|FG000|Overall Study|Withdrawal by Subject|1|||
130640781|NCT04610827|470302731|FG001|Overall Study|Withdrawal by Subject|1|||
130640782|NCT04610827|470302732|FG002|Overall Study|Withdrawal by Subject|0|||
130640783|NCT01997892|470302735|FG000|Overall Study|Physician Decision|2|||
130640784|NCT01997892|470302735|FG000|Overall Study|Lost to Follow-up|6|||
130640785|NCT01997892|470302735|FG000|Overall Study|Death|14|||
130640786|NCT01997892|470302735|FG000|Overall Study|Renal transplant|8|||
130640787|NCT01997892|470302735|FG000|Overall Study|Other|3|||
130640788|NCT01997892|470302735|FG000|Overall Study|Study completion data not recorded|35|||
130640789|NCT02710422|470302736|FG000|Overall Study|Termination of study|9|||
130640790|NCT02710422|470302737|FG001|Overall Study|Termination of study|9|||
130640791|NCT02608099|470302757|FG000|Overall Study|Ablation procedure not initiated|3|||
130640792|NCT02608099|470302758|FG001|Overall Study|Ablation procedure not initiated|2|||
130640793|NCT04657003|470302764|FG000|Overall Study|Adverse Event|5|||
130640794|NCT04657003|470302765|FG001|Overall Study|Adverse Event|1|||
130640795|NCT04657003|470302766|FG002|Overall Study|Adverse Event|5|||
130640796|NCT04657003|470302764|FG000|Overall Study|Death|0|||
130640797|NCT04657003|470302765|FG001|Overall Study|Death|2|||
130640798|NCT04657003|470302766|FG002|Overall Study|Death|0|||
130640799|NCT04657003|470302764|FG000|Overall Study|Lost to Follow-up|8|||
130640800|NCT04657003|470302765|FG001|Overall Study|Lost to Follow-up|4|||
130640801|NCT04657003|470302766|FG002|Overall Study|Lost to Follow-up|10|||
130640802|NCT04657003|470302764|FG000|Overall Study|Other - As Reported by Investigator|3|||
130640803|NCT04657003|470302765|FG001|Overall Study|Other - As Reported by Investigator|2|||
130640804|NCT04657003|470302766|FG002|Overall Study|Other - As Reported by Investigator|2|||
130640805|NCT04657003|470302764|FG000|Overall Study|Pregnancy|2|||
130640806|NCT04657003|470302765|FG001|Overall Study|Pregnancy|0|||
130640807|NCT04657003|470302766|FG002|Overall Study|Pregnancy|2|||
130640808|NCT04657003|470302764|FG000|Overall Study|Withdrawal by Subject|16|||
130640809|NCT04657003|470302765|FG001|Overall Study|Withdrawal by Subject|7|||
130640810|NCT04657003|470302766|FG002|Overall Study|Withdrawal by Subject|10|||
130640811|NCT01736176|470302767|FG000|Overall Study|Adverse Event|3|||
130640812|NCT01736176|470302767|FG000|Overall Study|Withdrawal by Subject|4|||
130640813|NCT01736176|470302767|FG000|Overall Study|Lack of Efficacy|3|||
130640814|NCT01736176|470302767|FG000|Overall Study|Unable to Complete PEG Placement|1|||
130640815|NCT00417248|470302768|FG000|Overall Study|Study Terminated|6|||
130640816|NCT00417248|470302768|FG000|Overall Study|Death|1|||
130640817|NCT00417248|470302768|FG000|Overall Study|Lack of Efficacy|1|||
130640818|NCT00934791|470302769|FG000|Overall Study|Withdrawal by Subject|1|||
130640819|NCT00934791|470302770|FG001|Overall Study|Withdrawal by Subject|0|||
130640820|NCT03763942|470302771|FG000|Overall Study|Lost to Follow-up|114|||
130640821|NCT03763942|470302772|FG001|Overall Study|Lost to Follow-up|54|||
130640822|NCT03763942|470302771|FG000|Overall Study|Protocol Violation|1|||
130640823|NCT03763942|470302772|FG001|Overall Study|Protocol Violation|0|||
130640824|NCT03763942|470302771|FG000|Overall Study|Withdrawal by Subject|2|||
130640825|NCT03763942|470302772|FG001|Overall Study|Withdrawal by Subject|0|||
130640826|NCT03763942|470302771|FG000|Overall Study|Other|2|||
130640827|NCT03763942|470302772|FG001|Overall Study|Other|3|||
130640828|NCT02646891|470302773|FG000|Overall Study|Adverse Event|0|||
130640829|NCT02646891|470302774|FG001|Overall Study|Adverse Event|1|||
130640830|NCT02646891|470302775|FG002|Overall Study|Adverse Event|0|||
130640831|NCT02646891|470302776|FG003|Overall Study|Adverse Event|0|||
130640832|NCT02646891|470302777|FG004|Overall Study|Adverse Event|0|||
130640833|NCT02646891|470302778|FG005|Overall Study|Adverse Event|0|||
130640834|NCT02646891|470302779|FG006|Overall Study|Adverse Event|0|||
130640835|NCT02646891|470302780|FG007|Overall Study|Adverse Event|0|||
130640836|NCT02646891|470302781|FG008|Overall Study|Adverse Event|0|||
130640837|NCT02646891|470302782|FG009|Overall Study|Adverse Event|0|||
130640838|NCT02646891|470302773|FG000|Overall Study|Lost to Follow-up|0|||
130640839|NCT02646891|470302774|FG001|Overall Study|Lost to Follow-up|0|||
130640840|NCT02646891|470302775|FG002|Overall Study|Lost to Follow-up|0|||
130640841|NCT02646891|470302776|FG003|Overall Study|Lost to Follow-up|0|||
130640842|NCT02646891|470302777|FG004|Overall Study|Lost to Follow-up|0|||
130640843|NCT02646891|470302778|FG005|Overall Study|Lost to Follow-up|0|||
130640844|NCT02646891|470302779|FG006|Overall Study|Lost to Follow-up|2|||
130640845|NCT02646891|470302780|FG007|Overall Study|Lost to Follow-up|2|||
130640846|NCT02646891|470302781|FG008|Overall Study|Lost to Follow-up|2|||
130640847|NCT02646891|470302782|FG009|Overall Study|Lost to Follow-up|2|||
130640848|NCT02646891|470302773|FG000|Overall Study|Protocol Violation|0|||
130640849|NCT02646891|470302774|FG001|Overall Study|Protocol Violation|0|||
130640850|NCT02646891|470302775|FG002|Overall Study|Protocol Violation|0|||
130640851|NCT02646891|470302776|FG003|Overall Study|Protocol Violation|0|||
130640852|NCT02646891|470302777|FG004|Overall Study|Protocol Violation|0|||
130640853|NCT02646891|470302778|FG005|Overall Study|Protocol Violation|0|||
130640854|NCT02646891|470302779|FG006|Overall Study|Protocol Violation|1|||
130640855|NCT02646891|470302780|FG007|Overall Study|Protocol Violation|1|||
130640856|NCT02646891|470302781|FG008|Overall Study|Protocol Violation|0|||
130640857|NCT02646891|470302782|FG009|Overall Study|Protocol Violation|0|||
130640858|NCT02646891|470302773|FG000|Overall Study|Withdrawal by Subject|2|||
130640859|NCT02646891|470302774|FG001|Overall Study|Withdrawal by Subject|0|||
130640860|NCT02646891|470302775|FG002|Overall Study|Withdrawal by Subject|1|||
130640861|NCT02646891|470302776|FG003|Overall Study|Withdrawal by Subject|0|||
130640862|NCT02646891|470302777|FG004|Overall Study|Withdrawal by Subject|0|||
130640863|NCT02646891|470302778|FG005|Overall Study|Withdrawal by Subject|0|||
130640864|NCT02646891|470302779|FG006|Overall Study|Withdrawal by Subject|5|||
130640865|NCT02646891|470302780|FG007|Overall Study|Withdrawal by Subject|9|||
130640866|NCT02646891|470302781|FG008|Overall Study|Withdrawal by Subject|7|||
130640867|NCT02646891|470302782|FG009|Overall Study|Withdrawal by Subject|3|||
130640868|NCT02646891|470302773|FG000|Overall Study|Death|0|||
130640869|NCT02646891|470302774|FG001|Overall Study|Death|0|||
130640870|NCT02646891|470302775|FG002|Overall Study|Death|0|||
130640871|NCT02646891|470302776|FG003|Overall Study|Death|0|||
130640872|NCT02646891|470302777|FG004|Overall Study|Death|0|||
130640873|NCT02646891|470302778|FG005|Overall Study|Death|0|||
130640874|NCT02646891|470302779|FG006|Overall Study|Death|1|||
130640875|NCT02646891|470302780|FG007|Overall Study|Death|1|||
130640876|NCT02646891|470302781|FG008|Overall Study|Death|1|||
130640877|NCT02646891|470302782|FG009|Overall Study|Death|0|||
130640878|NCT01599585|470302783|FG000|Overall Study|Withdrawal by Subject|16|||
130640879|NCT01599585|470302784|FG001|Overall Study|Withdrawal by Subject|9|||
130640880|NCT01599585|470302783|FG000|Overall Study|Lost to Follow-up|3|||
130640881|NCT01599585|470302784|FG001|Overall Study|Lost to Follow-up|5|||
130640882|NCT01599585|470302783|FG000|Overall Study|randomized did not start treatment|3|||
130640883|NCT01599585|470302784|FG001|Overall Study|randomized did not start treatment|3|||
130640884|NCT00811395|470302790|FG000|Extension Treatment|Adverse Event|1|||
130640885|NCT00811395|470302791|FG001|Extension Treatment|Adverse Event|2|||
130640886|NCT00811395|470302792|FG002|Extension Treatment|Adverse Event|2|||
130640887|NCT00811395|470302793|FG003|Extension Treatment|Adverse Event|2|||
130640888|NCT00811395|470302794|FG004|Extension Treatment|Adverse Event|0|||
130640889|NCT00811395|470302795|FG005|Extension Treatment|Adverse Event|1|||
130640890|NCT00811395|470302790|FG000|Extension Treatment|Progressive disease|1|||
130640891|NCT00811395|470302791|FG001|Extension Treatment|Progressive disease|1|||
130640892|NCT00811395|470302792|FG002|Extension Treatment|Progressive disease|0|||
130640893|NCT00811395|470302793|FG003|Extension Treatment|Progressive disease|0|||
130640894|NCT00811395|470302794|FG004|Extension Treatment|Progressive disease|0|||
130640895|NCT00811395|470302795|FG005|Extension Treatment|Progressive disease|0|||
130640896|NCT00811395|470302790|FG000|Extension Treatment|Participant did not wish to continue|0|||
130640897|NCT00811395|470302791|FG001|Extension Treatment|Participant did not wish to continue|3|||
130640898|NCT00811395|470302792|FG002|Extension Treatment|Participant did not wish to continue|0|||
130640899|NCT00811395|470302793|FG003|Extension Treatment|Participant did not wish to continue|1|||
130640900|NCT00811395|470302794|FG004|Extension Treatment|Participant did not wish to continue|0|||
130640901|NCT00811395|470302795|FG005|Extension Treatment|Participant did not wish to continue|1|||
130640902|NCT00811395|470302790|FG000|Extension Treatment|Other than above|0|||
130640903|NCT00811395|470302791|FG001|Extension Treatment|Other than above|0|||
130640904|NCT00811395|470302792|FG002|Extension Treatment|Other than above|1|||
130640905|NCT00811395|470302793|FG003|Extension Treatment|Other than above|0|||
130640906|NCT00811395|470302794|FG004|Extension Treatment|Other than above|0|||
130640907|NCT00811395|470302795|FG005|Extension Treatment|Other than above|0|||
130640908|NCT00118040|470302802|FG000|Overall Study|Adverse Event|0|||
130640909|NCT00118040|470302803|FG001|Overall Study|Adverse Event|1|||
130640910|NCT00118040|470302804|FG002|Overall Study|Adverse Event|0|||
130640911|NCT00118040|470302802|FG000|Overall Study|Withdrawal by Subject|0|||
130640912|NCT00118040|470302803|FG001|Overall Study|Withdrawal by Subject|0|||
130640913|NCT00118040|470302804|FG002|Overall Study|Withdrawal by Subject|2|||
130640914|NCT00118040|470302802|FG000|Overall Study|Medical Contraindication|0|||
130640915|NCT00118040|470302803|FG001|Overall Study|Medical Contraindication|0|||
130640916|NCT00118040|470302804|FG002|Overall Study|Medical Contraindication|1|||
130640917|NCT00118040|470302802|FG000|Overall Study|Non-Compliant Participant|1|||
130640918|NCT00118040|470302803|FG001|Overall Study|Non-Compliant Participant|1|||
130640919|NCT00118040|470302804|FG002|Overall Study|Non-Compliant Participant|2|||
130640920|NCT00118040|470302802|FG000|Overall Study|Other|0|||
130640921|NCT00118040|470302803|FG001|Overall Study|Other|0|||
130640922|NCT00118040|470302804|FG002|Overall Study|Other|1|||
130640923|NCT01970540|470302807|FG000|Overall Study|Non-treatment-related AE|0|||
130640924|NCT01970540|470302808|FG001|Overall Study|Non-treatment-related AE|0|||
130640925|NCT01970540|470302809|FG002|Overall Study|Non-treatment-related AE|1|||
130640926|NCT01970540|470302807|FG000|Overall Study|Progressive disease|55|||
130640927|NCT01970540|470302808|FG001|Overall Study|Progressive disease|23|||
130640928|NCT01970540|470302809|FG002|Overall Study|Progressive disease|10|||
130640929|NCT01970540|470302807|FG000|Overall Study|Treatment delay over protocol|0|||
130640930|NCT01970540|470302808|FG001|Overall Study|Treatment delay over protocol|0|||
130640931|NCT01970540|470302809|FG002|Overall Study|Treatment delay over protocol|1|||
130640932|NCT01970540|470302807|FG000|Overall Study|Physician Decision|7|||
130640933|NCT01970540|470302808|FG001|Overall Study|Physician Decision|2|||
130640934|NCT01970540|470302809|FG002|Overall Study|Physician Decision|0|||
130640935|NCT01970540|470302807|FG000|Overall Study|Clinical progression|0|||
130640936|NCT01970540|470302808|FG001|Overall Study|Clinical progression|1|||
130640937|NCT01970540|470302809|FG002|Overall Study|Clinical progression|1|||
130640938|NCT01970540|470302807|FG000|Overall Study|End of study|2|||
130640939|NCT01970540|470302808|FG001|Overall Study|End of study|0|||
130640940|NCT01970540|470302809|FG002|Overall Study|End of study|2|||
130640941|NCT01970540|470302807|FG000|Overall Study|Adverse Event|0|||
130640942|NCT01970540|470302808|FG001|Overall Study|Adverse Event|2|||
130640943|NCT01970540|470302809|FG002|Overall Study|Adverse Event|1|||
130640944|NCT01970540|470302807|FG000|Overall Study|Treatment-related AE|4|||
130640945|NCT01970540|470302808|FG001|Overall Study|Treatment-related AE|0|||
130640946|NCT01970540|470302809|FG002|Overall Study|Treatment-related AE|2|||
130640947|NCT01970540|470302807|FG000|Overall Study|Withdrawal by Subject|4|||
130640948|NCT01970540|470302808|FG001|Overall Study|Withdrawal by Subject|0|||
130640949|NCT01970540|470302809|FG002|Overall Study|Withdrawal by Subject|1|||
130640950|NCT01970540|470302807|FG000|Overall Study|Clinical deterioration|1|||
130640951|NCT01970540|470302808|FG001|Overall Study|Clinical deterioration|0|||
130640952|NCT01970540|470302809|FG002|Overall Study|Clinical deterioration|0|||
130640953|NCT00952588|470302814|FG000|Overall Study|Death|28|||
130640954|NCT00952588|470302815|FG001|Overall Study|Death|13|||
130640955|NCT00952588|470302814|FG000|Overall Study|Withdrawal by Subject|2|||
130640956|NCT00952588|470302815|FG001|Overall Study|Withdrawal by Subject|5|||
130640957|NCT00952588|470302814|FG000|Overall Study|Adverse Event|2|||
130640958|NCT00952588|470302815|FG001|Overall Study|Adverse Event|3|||
130640959|NCT00952588|470302814|FG000|Overall Study|Lost to Follow-up|2|||
130640960|NCT00952588|470302815|FG001|Overall Study|Lost to Follow-up|0|||
130640961|NCT00952588|470302814|FG000|Overall Study|Physician Decision|0|||
130640962|NCT00952588|470302815|FG001|Overall Study|Physician Decision|1|||
130640963|NCT00952588|470302814|FG000|Overall Study|Lack of Efficacy|2|||
130640964|NCT00952588|470302815|FG001|Overall Study|Lack of Efficacy|2|||
130640965|NCT01796106|470302816|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
130640966|NCT01796106|470302817|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
130640967|NCT01766401|470302818|FG000|Overall Study|Adverse Event|7|||
130640968|NCT01766401|470302819|FG001|Overall Study|Adverse Event|22|||
130640969|NCT01766401|470302818|FG000|Overall Study|Lack of Efficacy|1|||
130640970|NCT01766401|470302819|FG001|Overall Study|Lack of Efficacy|2|||
130640971|NCT01766401|470302818|FG000|Overall Study|Protocol Violation|3|||
130640972|NCT01766401|470302819|FG001|Overall Study|Protocol Violation|8|||
130640973|NCT01766401|470302818|FG000|Overall Study|Withdrawal by Subject|15|||
130640974|NCT01766401|470302819|FG001|Overall Study|Withdrawal by Subject|12|||
130640975|NCT01766401|470302818|FG000|Overall Study|Lost to Follow-up|10|||
130640976|NCT01766401|470302819|FG001|Overall Study|Lost to Follow-up|11|||
130640977|NCT01766401|470302818|FG000|Overall Study|Pregnancy|1|||
130640978|NCT01766401|470302819|FG001|Overall Study|Pregnancy|1|||
130640979|NCT01021553|470302824|FG000|Overall Study|Adverse Event|1|||
130640980|NCT01021553|470302825|FG001|Overall Study|Adverse Event|0|||
130640981|NCT01021553|470302826|FG002|Overall Study|Adverse Event|0|||
130640982|NCT01021553|470302824|FG000|Overall Study|Lack of Efficacy|2|||
130640983|NCT01021553|470302825|FG001|Overall Study|Lack of Efficacy|2|||
130640984|NCT01021553|470302826|FG002|Overall Study|Lack of Efficacy|0|||
130640985|NCT01021553|470302824|FG000|Overall Study|Protocol Violation|0|||
130640986|NCT01021553|470302825|FG001|Overall Study|Protocol Violation|2|||
130640987|NCT01021553|470302826|FG002|Overall Study|Protocol Violation|2|||
130640988|NCT01021553|470302824|FG000|Overall Study|Lost to Follow-up|0|||
130640989|NCT01021553|470302825|FG001|Overall Study|Lost to Follow-up|0|||
130640990|NCT01021553|470302826|FG002|Overall Study|Lost to Follow-up|1|||
130640991|NCT01021553|470302824|FG000|Overall Study|Withdrawal by Subject|1|||
130640992|NCT01021553|470302825|FG001|Overall Study|Withdrawal by Subject|1|||
130640993|NCT01021553|470302826|FG002|Overall Study|Withdrawal by Subject|0|||
130640994|NCT01950364|470302827|FG000|Overall Study|Adverse Event|3|||
130640995|NCT01950364|470302828|FG001|Overall Study|Adverse Event|0|||
130640996|NCT01950364|470302827|FG000|Overall Study|Stem Cell Transplant|2|||
130640997|NCT01950364|470302828|FG001|Overall Study|Stem Cell Transplant|6|||
130640998|NCT01950364|470302827|FG000|Overall Study|Disease Progression|5|||
130640999|NCT01950364|470302828|FG001|Overall Study|Disease Progression|2|||
130641000|NCT01950364|470302827|FG000|Overall Study|Withdrawal by Subject|0|||
130641001|NCT01950364|470302828|FG001|Overall Study|Withdrawal by Subject|1|||
130641002|NCT01950364|470302827|FG000|Overall Study|Protocol Violation|0|||
130641003|NCT01950364|470302828|FG001|Overall Study|Protocol Violation|1|||
130641004|NCT00033293|470302829|FG000|Overall Study|Death|0|||
130641005|NCT00033293|470302830|FG001|Overall Study|Death|1|||
130641006|NCT00033293|470302829|FG000|Overall Study|Lack of Efficacy|5|||
130641007|NCT00033293|470302830|FG001|Overall Study|Lack of Efficacy|8|||
130641008|NCT00033293|470302829|FG000|Overall Study|Lost to Follow-up|0|||
130641009|NCT00033293|470302830|FG001|Overall Study|Lost to Follow-up|1|||
130641010|NCT00033293|470302829|FG000|Overall Study|Physician Decision|3|||
130641011|NCT00033293|470302830|FG001|Overall Study|Physician Decision|1|||
130641012|NCT00033293|470302829|FG000|Overall Study|Withdrawal by Subject|1|||
130641013|NCT00033293|470302830|FG001|Overall Study|Withdrawal by Subject|0|||
130641014|NCT00033293|470302829|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
130641015|NCT00033293|470302830|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
130641016|NCT00033293|470302829|FG000|Overall Study|Treatment refused|0|||
130641017|NCT00033293|470302830|FG001|Overall Study|Treatment refused|6|||
130641018|NCT00935701|470302831|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
130641019|NCT01700140|470302832|FG000|Overall Study|Use of rescue drugs|3|||
130641020|NCT01700140|470302833|FG001|Overall Study|Use of rescue drugs|3|||
130641021|NCT01700140|470302834|FG002|Overall Study|Use of rescue drugs|1|||
130641022|NCT01700140|470302832|FG000|Overall Study|Discontinuation of radiotherapy|1|||
130641023|NCT01700140|470302833|FG001|Overall Study|Discontinuation of radiotherapy|0|||
130641024|NCT01700140|470302834|FG002|Overall Study|Discontinuation of radiotherapy|0|||
130641025|NCT01700140|470302832|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
130641026|NCT01700140|470302833|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
130641027|NCT01700140|470302834|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
130641028|NCT01700140|470302832|FG000|Overall Study|Aggravation of symptoms|1|||
130641029|NCT01700140|470302833|FG001|Overall Study|Aggravation of symptoms|0|||
130641030|NCT01700140|470302834|FG002|Overall Study|Aggravation of symptoms|0|||
130641031|NCT01700140|470302832|FG000|Overall Study|Adverse Event|0|||
130641032|NCT01700140|470302833|FG001|Overall Study|Adverse Event|1|||
130641033|NCT01700140|470302834|FG002|Overall Study|Adverse Event|0|||
130641034|NCT01700140|470302832|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
130641035|NCT01700140|470302833|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
130641036|NCT01700140|470302834|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
130641037|NCT00542425|470302835|FG000|Initial 24 Weeks|Administrative reasons|0|||
130641038|NCT00542425|470302836|FG001|Initial 24 Weeks|Administrative reasons|0|||
130641039|NCT00542425|470302837|FG002|Initial 24 Weeks|Administrative reasons|1|||
130641040|NCT00542425|470302838|FG003|Initial 24 Weeks|Administrative reasons|1|||
130641041|NCT00542425|470302839|FG004|Initial 24 Weeks|Administrative reasons|0|||
130641042|NCT00542425|470302835|FG000|Initial 24 Weeks|Adverse Event|0|||
130641043|NCT00542425|470302836|FG001|Initial 24 Weeks|Adverse Event|1|||
130641044|NCT00542425|470302837|FG002|Initial 24 Weeks|Adverse Event|1|||
130641045|NCT00542425|470302838|FG003|Initial 24 Weeks|Adverse Event|3|||
130641046|NCT00542425|470302839|FG004|Initial 24 Weeks|Adverse Event|2|||
130641047|NCT00542425|470302835|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
130641048|NCT00542425|470302836|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
130641049|NCT00542425|470302837|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
130641050|NCT00542425|470302838|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
130641051|NCT00542425|470302839|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
130641052|NCT00542425|470302835|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
130641053|NCT00542425|470302836|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
130641054|NCT00542425|470302837|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
130641055|NCT00542425|470302838|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
130641056|NCT00542425|470302839|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
130641057|NCT00542425|470302835|FG000|Initial 24 Weeks|Non-compliance|0|||
130641058|NCT00542425|470302836|FG001|Initial 24 Weeks|Non-compliance|0|||
130641059|NCT00542425|470302837|FG002|Initial 24 Weeks|Non-compliance|0|||
130641060|NCT00542425|470302838|FG003|Initial 24 Weeks|Non-compliance|1|||
130641061|NCT00542425|470302839|FG004|Initial 24 Weeks|Non-compliance|1|||
130641062|NCT00542425|470302835|FG000|Initial 24 Weeks|Protocol Violation|0|||
130641063|NCT00542425|470302836|FG001|Initial 24 Weeks|Protocol Violation|0|||
130641064|NCT00542425|470302837|FG002|Initial 24 Weeks|Protocol Violation|0|||
130641065|NCT00542425|470302838|FG003|Initial 24 Weeks|Protocol Violation|1|||
130641066|NCT00542425|470302839|FG004|Initial 24 Weeks|Protocol Violation|0|||
130641067|NCT00542425|470302835|FG000|Initial 24 Weeks|Refusal of treatment|2|||
130641068|NCT00542425|470302836|FG001|Initial 24 Weeks|Refusal of treatment|2|||
130641069|NCT00542425|470302837|FG002|Initial 24 Weeks|Refusal of treatment|1|||
130641070|NCT00542425|470302838|FG003|Initial 24 Weeks|Refusal of treatment|4|||
130641071|NCT00542425|470302839|FG004|Initial 24 Weeks|Refusal of treatment|1|||
130641072|NCT00542425|470302835|FG000|Initial 24 Weeks|Other|0|||
130641073|NCT00542425|470302836|FG001|Initial 24 Weeks|Other|2|||
130641074|NCT00542425|470302837|FG002|Initial 24 Weeks|Other|1|||
130641075|NCT00542425|470302838|FG003|Initial 24 Weeks|Other|0|||
130641076|NCT00542425|470302839|FG004|Initial 24 Weeks|Other|0|||
130641077|NCT00542425|470302835|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
130641078|NCT00542425|470302836|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
130641079|NCT00542425|470302837|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
130641080|NCT00542425|470302838|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
130641081|NCT00542425|470302839|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
130641082|NCT00542425|470302835|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130641083|NCT00542425|470302836|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130641084|NCT00542425|470302837|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
130641085|NCT00542425|470302838|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130641086|NCT00542425|470302839|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130641087|NCT00542425|470302835|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130641088|NCT00542425|470302836|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
130641089|NCT00542425|470302837|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130641090|NCT00542425|470302838|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130641091|NCT00542425|470302839|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130641092|NCT00542425|470302835|FG000|Extended 24 Weeks of Treatment|Other|1|||
130641093|NCT00542425|470302836|FG001|Extended 24 Weeks of Treatment|Other|1|||
130641094|NCT00542425|470302837|FG002|Extended 24 Weeks of Treatment|Other|0|||
130641095|NCT00542425|470302838|FG003|Extended 24 Weeks of Treatment|Other|0|||
130641096|NCT00542425|470302839|FG004|Extended 24 Weeks of Treatment|Other|1|||
130641097|NCT01610414|470302840|FG000|Study Start - Month 13|Serious Adverse Event|65|||
130641098|NCT01610414|470302841|FG001|Study Start - Month 13|Serious Adverse Event|67|||
130641099|NCT01610414|470302840|FG000|Study Start - Month 13|Adverse Event|14|||
130641100|NCT01610414|470302841|FG001|Study Start - Month 13|Adverse Event|14|||
130641101|NCT01610414|470302840|FG000|Study Start - Month 13|Protocol Violation|3|||
130641102|NCT01610414|470302841|FG001|Study Start - Month 13|Protocol Violation|1|||
130641103|NCT01610414|470302840|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
130641104|NCT01610414|470302841|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
130641105|NCT01610414|470302840|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
130641106|NCT01610414|470302841|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
130641107|NCT01610414|470302840|FG000|Study Start - Month 13|Lost to Follow-up|4|||
130641108|NCT01610414|470302841|FG001|Study Start - Month 13|Lost to Follow-up|6|||
130641109|NCT01610414|470302840|FG000|Study Start - Month 13|Suspected HZ episode|1|||
130641110|NCT01610414|470302841|FG001|Study Start - Month 13|Suspected HZ episode|3|||
130641111|NCT01610414|470302840|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
130641112|NCT01610414|470302841|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
130641113|NCT01610414|470302840|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
130641114|NCT01610414|470302841|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
130641115|NCT01610414|470302840|FG000|Month 13 - Month 25|Adverse Event|8|||
130641116|NCT01610414|470302841|FG001|Month 13 - Month 25|Adverse Event|4|||
130641117|NCT01610414|470302840|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
130641118|NCT01610414|470302841|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
130641119|NCT01610414|470302840|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
130641120|NCT01610414|470302841|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
130641121|NCT01610414|470302840|FG000|Month 13 - Month 25|Protocol Violation|0|||
130641122|NCT01610414|470302841|FG001|Month 13 - Month 25|Protocol Violation|2|||
130641123|NCT01610414|470302840|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
130641124|NCT01610414|470302841|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
130641125|NCT01610414|470302840|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
130641126|NCT01610414|470302841|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
130641127|NCT01610414|470302840|FG000|After Month 25|Study end not reached|48|||
130641128|NCT01610414|470302841|FG001|After Month 25|Study end not reached|53|||
130641129|NCT02382276|470302842|FG000|Overall Study|Withdrawal by Subject|4|||
130641130|NCT02382276|470302843|FG001|Overall Study|Withdrawal by Subject|8|||
130641131|NCT02382276|470302844|FG002|Overall Study|Withdrawal by Subject|5|||
130641132|NCT02382276|470302842|FG000|Overall Study|Adverse Event|7|||
130641133|NCT02382276|470302843|FG001|Overall Study|Adverse Event|2|||
130641134|NCT02382276|470302844|FG002|Overall Study|Adverse Event|32|||
130641135|NCT02382276|470302842|FG000|Overall Study|Physician Decision|0|||
130641136|NCT02382276|470302843|FG001|Overall Study|Physician Decision|0|||
130641137|NCT02382276|470302844|FG002|Overall Study|Physician Decision|2|||
130641138|NCT00518336|470302845|FG000|Year 7|Lost to Follow-up|2|||
130641139|NCT00518336|470302846|FG001|Year 7|Lost to Follow-up|0|||
130641140|NCT00518336|470302845|FG000|Year 7|Could not attend in time|0|||
130641141|NCT00518336|470302846|FG001|Year 7|Could not attend in time|3|||
130641142|NCT00518336|470302845|FG000|Year 8|Lost to Follow-up|1|||
130641143|NCT00518336|470302846|FG001|Year 8|Lost to Follow-up|1|||
130641144|NCT00518336|470302845|FG000|Year 8|Could not attend in time|0|||
130641145|NCT00518336|470302846|FG001|Year 8|Could not attend in time|1|||
130641146|NCT00518336|470302845|FG000|Year 9|Migrated/moved from study area|1|||
130641147|NCT00518336|470302846|FG001|Year 9|Migrated/moved from study area|1|||
130641148|NCT00518336|470302845|FG000|Year 9|Lost to Follow-up|3|||
130641149|NCT00518336|470302846|FG001|Year 9|Lost to Follow-up|0|||
130641150|NCT00518336|470302845|FG000|Year 9|Personal reasons|1|||
130641151|NCT00518336|470302846|FG001|Year 9|Personal reasons|0|||
130641152|NCT00125268|470302847|FG000|Overall Study|Withdrawal by Subject|1|||
130641153|NCT00125268|470302848|FG001|Overall Study|Withdrawal by Subject|1|||
130641154|NCT00286156|470302849|FG000|Overall Study|Missed 12 month visit|0|||
130641155|NCT00286156|470302850|FG001|Overall Study|Missed 12 month visit|0|||
130641156|NCT00286156|470302851|FG002|Overall Study|Missed 12 month visit|1|||
130641157|NCT00286156|470302849|FG000|Overall Study|AE: pulmonary embolus|0|||
130641158|NCT00286156|470302850|FG001|Overall Study|AE: pulmonary embolus|1|||
130641159|NCT00286156|470302851|FG002|Overall Study|AE: pulmonary embolus|0|||
130641160|NCT00286156|470302849|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
130641161|NCT00286156|470302850|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
130641162|NCT00286156|470302851|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
130641163|NCT00286156|470302849|FG000|Overall Study|AE: pneumonia|1|||
130641164|NCT00286156|470302850|FG001|Overall Study|AE: pneumonia|0|||
130641165|NCT00286156|470302851|FG002|Overall Study|AE: pneumonia|0|||
130641166|NCT06334055|470302853|FG000|Overall Study|Adverse Event|4|||
130641167|NCT06334055|470302853|FG000|Overall Study|Disqualified|72|||
130641168|NCT00290355|470304313|FG000|Overall Study|Serious adverse event|7|||
130641169|NCT00290355|470304314|FG001|Overall Study|Serious adverse event|4|||
130641170|NCT00290355|470304313|FG000|Overall Study|Study product reactogenicity|1|||
130641171|NCT00290355|470304314|FG001|Overall Study|Study product reactogenicity|0|||
130641172|NCT00290355|470304313|FG000|Overall Study|Protocol Violation|1|||
130641173|NCT00290355|470304314|FG001|Overall Study|Protocol Violation|0|||
130641174|NCT00290355|470304313|FG000|Overall Study|Withdrawal by Subject|2|||
130641175|NCT00290355|470304314|FG001|Overall Study|Withdrawal by Subject|0|||
130641176|NCT00290355|470304313|FG000|Overall Study|Migrated / moved from the study area|1|||
130641177|NCT00290355|470304314|FG001|Overall Study|Migrated / moved from the study area|0|||
130641178|NCT00290355|470304313|FG000|Overall Study|Lost to Follow-up|3|||
130641179|NCT00290355|470304314|FG001|Overall Study|Lost to Follow-up|1|||
130641180|NCT00290355|470304313|FG000|Overall Study|Other|2|||
130641181|NCT00290355|470304314|FG001|Overall Study|Other|0|||
130641182|NCT01542632|470304315|FG000|Overall Study|Withdrawal of Consent|0|||
130641183|NCT01542632|470304316|FG001|Overall Study|Withdrawal of Consent|0|||
130641184|NCT01542632|470304317|FG002|Overall Study|Withdrawal of Consent|0|||
130641185|NCT01542632|470304318|FG003|Overall Study|Withdrawal of Consent|2|||
130641186|NCT01542632|470304319|FG004|Overall Study|Withdrawal of Consent|3|||
130641187|NCT01542632|470304320|FG005|Overall Study|Withdrawal of Consent|0|||
130641188|NCT01542632|470304315|FG000|Overall Study|Adverse Event|0|||
130641189|NCT01542632|470304316|FG001|Overall Study|Adverse Event|0|||
130641190|NCT01542632|470304317|FG002|Overall Study|Adverse Event|1|||
130641191|NCT01542632|470304318|FG003|Overall Study|Adverse Event|0|||
130641192|NCT01542632|470304319|FG004|Overall Study|Adverse Event|0|||
130641193|NCT01542632|470304320|FG005|Overall Study|Adverse Event|0|||
130641194|NCT01542632|470304315|FG000|Overall Study|Lost to Follow-up|0|||
130641195|NCT01542632|470304316|FG001|Overall Study|Lost to Follow-up|1|||
130641196|NCT01542632|470304317|FG002|Overall Study|Lost to Follow-up|0|||
130641197|NCT01542632|470304318|FG003|Overall Study|Lost to Follow-up|0|||
130641198|NCT01542632|470304319|FG004|Overall Study|Lost to Follow-up|0|||
130641199|NCT01542632|470304320|FG005|Overall Study|Lost to Follow-up|0|||
130641200|NCT01542632|470304315|FG000|Overall Study|Sponsor/Investigator Decision|0|||
130641201|NCT01542632|470304316|FG001|Overall Study|Sponsor/Investigator Decision|0|||
130641202|NCT01542632|470304317|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130641203|NCT01542632|470304318|FG003|Overall Study|Sponsor/Investigator Decision|0|||
130641204|NCT01542632|470304319|FG004|Overall Study|Sponsor/Investigator Decision|1|||
130641205|NCT01542632|470304320|FG005|Overall Study|Sponsor/Investigator Decision|0|||
130641208|NCT01108263|470304333|FG000|Overall Study|Adverse Event|0|||
130641209|NCT01108263|470304334|FG001|Overall Study|Adverse Event|1|||
130641210|NCT01685372|470304335|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
130641211|NCT01685372|470304336|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
130641212|NCT00829010|470304339|FG000|Overall Study|Adverse Event|1|||
130641213|NCT00829010|470304340|FG001|Overall Study|Adverse Event|0|||
130641214|NCT00829010|470304341|FG002|Overall Study|Adverse Event|0|||
130641215|NCT00829010|470304342|FG003|Overall Study|Adverse Event|0|||
130641216|NCT00829010|470304343|FG004|Overall Study|Adverse Event|0|||
130641217|NCT00829010|470304339|FG000|Overall Study|Withdrawal by Subject|0|||
130641218|NCT00829010|470304340|FG001|Overall Study|Withdrawal by Subject|1|||
130641219|NCT00829010|470304341|FG002|Overall Study|Withdrawal by Subject|1|||
130641220|NCT00829010|470304342|FG003|Overall Study|Withdrawal by Subject|0|||
130641221|NCT00829010|470304343|FG004|Overall Study|Withdrawal by Subject|2|||
130641222|NCT00829010|470304339|FG000|Overall Study|Lost to Follow-up|1|||
130641223|NCT00829010|470304340|FG001|Overall Study|Lost to Follow-up|0|||
130641224|NCT00829010|470304341|FG002|Overall Study|Lost to Follow-up|2|||
130641225|NCT00829010|470304342|FG003|Overall Study|Lost to Follow-up|0|||
130641226|NCT00829010|470304343|FG004|Overall Study|Lost to Follow-up|0|||
130641227|NCT00829010|470304339|FG000|Overall Study|Fatality|5|||
130641228|NCT00829010|470304340|FG001|Overall Study|Fatality|4|||
130641229|NCT00829010|470304341|FG002|Overall Study|Fatality|0|||
130641230|NCT00829010|470304342|FG003|Overall Study|Fatality|3|||
130641231|NCT00829010|470304343|FG004|Overall Study|Fatality|0|||
130641232|NCT00829010|470304339|FG000|Overall Study|Migrated/Moved from study area|3|||
130641233|NCT00829010|470304340|FG001|Overall Study|Migrated/Moved from study area|4|||
130641234|NCT00829010|470304341|FG002|Overall Study|Migrated/Moved from study area|0|||
130641235|NCT00829010|470304342|FG003|Overall Study|Migrated/Moved from study area|5|||
130641236|NCT00829010|470304343|FG004|Overall Study|Migrated/Moved from study area|0|||
130641237|NCT02289833|470304345|FG000|Overall Study|Study discontinuation|0|||
130641238|NCT02289833|470304346|FG001|Overall Study|Study discontinuation|1|||
130641239|NCT02289833|470304345|FG000|Overall Study|Lost to Follow-up|4|||
130641240|NCT02289833|470304346|FG001|Overall Study|Lost to Follow-up|0|||
130641241|NCT02289833|470304345|FG000|Overall Study|Death|23|||
130641242|NCT02289833|470304346|FG001|Overall Study|Death|16|||
130641243|NCT03442595|470304347|FG000|Overall Study|Lost to Follow-up|94|||
130641244|NCT03442595|470304348|FG001|Overall Study|Lost to Follow-up|0|||
130641245|NCT00170846|470304349|FG000|Overall Study|Subject withdrew Informed Consent|5|||
130641246|NCT00170846|470304350|FG001|Overall Study|Subject withdrew Informed Consent|12|||
130641247|NCT00170846|470304351|FG002|Overall Study|Subject withdrew Informed Consent|8|||
130641248|NCT00170846|470304349|FG000|Overall Study|Lost to Follow-up|6|||
130641249|NCT00170846|470304350|FG001|Overall Study|Lost to Follow-up|3|||
130641250|NCT00170846|470304351|FG002|Overall Study|Lost to Follow-up|2|||
130641251|NCT00170846|470304349|FG000|Overall Study|Death|0|||
130641252|NCT00170846|470304350|FG001|Overall Study|Death|3|||
130641253|NCT00170846|470304351|FG002|Overall Study|Death|3|||
130641254|NCT00170846|470304349|FG000|Overall Study|Reason Missing|0|||
130641255|NCT00170846|470304350|FG001|Overall Study|Reason Missing|1|||
130641256|NCT00170846|470304351|FG002|Overall Study|Reason Missing|0|||
130641257|NCT02607865|470304352|FG000|Overall Study|Lost to Follow-up|9|||
130641258|NCT02607865|470304353|FG001|Overall Study|Lost to Follow-up|7|||
130641259|NCT02607865|470304354|FG002|Overall Study|Lost to Follow-up|7|||
130641260|NCT02607865|470304355|FG003|Overall Study|Lost to Follow-up|5|||
130641261|NCT02607865|470304352|FG000|Overall Study|Withdrawal by Subject|18|||
130641262|NCT02607865|470304353|FG001|Overall Study|Withdrawal by Subject|18|||
130641263|NCT02607865|470304354|FG002|Overall Study|Withdrawal by Subject|17|||
130641264|NCT02607865|470304355|FG003|Overall Study|Withdrawal by Subject|8|||
130641265|NCT02607865|470304352|FG000|Overall Study|Death|5|||
130641266|NCT02607865|470304353|FG001|Overall Study|Death|4|||
130641267|NCT02607865|470304354|FG002|Overall Study|Death|1|||
130641268|NCT02607865|470304355|FG003|Overall Study|Death|3|||
130641269|NCT02607865|470304352|FG000|Overall Study|Unclassified|1|||
130641270|NCT02607865|470304353|FG001|Overall Study|Unclassified|1|||
130641271|NCT02607865|470304354|FG002|Overall Study|Unclassified|2|||
130641272|NCT02607865|470304355|FG003|Overall Study|Unclassified|0|||
130641273|NCT00528840|470304356|FG000|Overall Study|Lost to Follow-up|10|||
130641274|NCT00528840|470304356|FG000|Overall Study|Adverse Event|1|||
130641275|NCT00528840|470304356|FG000|Overall Study|Withdrawal by Subject|17|||
130641276|NCT00528840|470304356|FG000|Overall Study|Death|2|||
130641277|NCT00528840|470304356|FG000|Overall Study|Administrative Reasons|1|||
130641278|NCT00528840|470304356|FG000|Overall Study|Other|2|||
130641279|NCT01657253|470304357|FG000|Overall Study|Lost to Follow-up|6|||
130641280|NCT01657253|470304358|FG001|Overall Study|Lost to Follow-up|5|||
130641281|NCT01657253|470304357|FG000|Overall Study|Withdrawal by Subject|11|||
130641282|NCT01657253|470304358|FG001|Overall Study|Withdrawal by Subject|12|||
130641283|NCT01657253|470304357|FG000|Overall Study|Adverse Event|0|||
130641284|NCT01657253|470304358|FG001|Overall Study|Adverse Event|1|||
130641285|NCT01603628|470304359|FG000|Overall Study|Personal Reasons|1|||
130641286|NCT01603628|470304360|FG001|Overall Study|Personal Reasons|1|||
130641287|NCT01603628|470304361|FG002|Overall Study|Personal Reasons|2|||
130641288|NCT01603628|470304359|FG000|Overall Study|Protocol Violation|1|||
130641289|NCT01603628|470304360|FG001|Overall Study|Protocol Violation|1|||
130641290|NCT01603628|470304361|FG002|Overall Study|Protocol Violation|0|||
130641291|NCT01603628|470304359|FG000|Overall Study|Lost to Follow-up|0|||
130641292|NCT01603628|470304360|FG001|Overall Study|Lost to Follow-up|1|||
130641293|NCT01603628|470304361|FG002|Overall Study|Lost to Follow-up|0|||
130641294|NCT01603628|470304359|FG000|Overall Study|Other Miscellaneous Reason|1|||
130641295|NCT01603628|470304360|FG001|Overall Study|Other Miscellaneous Reason|0|||
130641296|NCT01603628|470304361|FG002|Overall Study|Other Miscellaneous Reason|0|||
130641297|NCT01756833|470304367|FG000|Overall Study|Withdrawal by Subject|4|||
130641298|NCT01756833|470304368|FG001|Overall Study|Withdrawal by Subject|3|||
130641299|NCT00886587|470304369|FG000|Overall Study|Adverse Event|2|||
130641300|NCT00886587|470304370|FG001|Overall Study|Adverse Event|1|||
130641301|NCT00886587|470304369|FG000|Overall Study|Protocol Violation|2|||
130641302|NCT00886587|470304370|FG001|Overall Study|Protocol Violation|0|||
130641303|NCT00886587|470304369|FG000|Overall Study|Withdrawal by Subject|0|||
130641304|NCT00886587|470304370|FG001|Overall Study|Withdrawal by Subject|1|||
130641305|NCT02795182|470304371|FG000|Overall Study|Death|5|||
130641306|NCT02795182|470304372|FG001|Overall Study|Death|4|||
130641307|NCT02795182|470304373|FG002|Overall Study|Death|4|||
130641308|NCT02795182|470304374|FG003|Overall Study|Death|18|||
130641309|NCT02795182|470304371|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130641310|NCT02795182|470304372|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130641311|NCT02795182|470304373|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130641312|NCT02795182|470304374|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
130641313|NCT02795182|470304371|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130641314|NCT02795182|470304372|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130641315|NCT02795182|470304373|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130641316|NCT02795182|470304374|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
130641317|NCT02795182|470304371|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
130641318|NCT02795182|470304372|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
130641319|NCT02795182|470304373|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
130641320|NCT02795182|470304374|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
130641321|NCT02795182|470304371|FG000|Overall Study|Withdrawal by Subject|4|||
130641322|NCT02795182|470304372|FG001|Overall Study|Withdrawal by Subject|0|||
130641323|NCT02795182|470304373|FG002|Overall Study|Withdrawal by Subject|0|||
130641324|NCT02795182|470304374|FG003|Overall Study|Withdrawal by Subject|3|||
130641325|NCT02795182|470304371|FG000|Overall Study|Lost to Follow-up|0|||
130641326|NCT02795182|470304372|FG001|Overall Study|Lost to Follow-up|0|||
130641327|NCT02795182|470304373|FG002|Overall Study|Lost to Follow-up|1|||
130641328|NCT02795182|470304374|FG003|Overall Study|Lost to Follow-up|1|||
130641329|NCT02795182|470304371|FG000|Overall Study|Roll Over to Long Term Extension|3|||
130641330|NCT02795182|470304372|FG001|Overall Study|Roll Over to Long Term Extension|3|||
130641331|NCT02795182|470304373|FG002|Overall Study|Roll Over to Long Term Extension|2|||
130641332|NCT02795182|470304374|FG003|Overall Study|Roll Over to Long Term Extension|5|||
130641333|NCT02795182|470304371|FG000|Overall Study|Progressive Disease|0|||
130641334|NCT02795182|470304372|FG001|Overall Study|Progressive Disease|1|||
130641335|NCT02795182|470304373|FG002|Overall Study|Progressive Disease|0|||
130641336|NCT02795182|470304374|FG003|Overall Study|Progressive Disease|4|||
130641337|NCT02795182|470304371|FG000|Overall Study|Physician Decision|0|||
130641338|NCT02795182|470304372|FG001|Overall Study|Physician Decision|0|||
130641339|NCT02795182|470304373|FG002|Overall Study|Physician Decision|0|||
130641340|NCT02795182|470304374|FG003|Overall Study|Physician Decision|1|||
130641341|NCT04107935|470304375|FG000|Overall Study|Death|1|||
130641342|NCT04107935|470304376|FG001|Overall Study|Death|0|||
130641343|NCT00398086|470304377|FG000|Overall Study|Unacceptable Toxicity|2|||
130641344|NCT00398086|470304378|FG001|Overall Study|Unacceptable Toxicity|8|||
130641345|NCT00398086|470304379|FG002|Overall Study|Unacceptable Toxicity|2|||
130641346|NCT00398086|470304377|FG000|Overall Study|Adverse Event|1|||
130641347|NCT00398086|470304378|FG001|Overall Study|Adverse Event|4|||
130641348|NCT00398086|470304379|FG002|Overall Study|Adverse Event|0|||
130641349|NCT00398086|470304377|FG000|Overall Study|Physician Decision|1|||
130641350|NCT00398086|470304378|FG001|Overall Study|Physician Decision|4|||
130641351|NCT00398086|470304379|FG002|Overall Study|Physician Decision|0|||
130641352|NCT00398086|470304377|FG000|Overall Study|Withdrawal by Subject|5|||
130641353|NCT00398086|470304378|FG001|Overall Study|Withdrawal by Subject|7|||
130641354|NCT00398086|470304379|FG002|Overall Study|Withdrawal by Subject|0|||
130641355|NCT02087241|470304380|FG000|Overall Study|Death|2|||
130641356|NCT02087241|470304381|FG001|Overall Study|Death|1|||
130641357|NCT02087241|470304382|FG002|Overall Study|Death|1|||
130641358|NCT02087241|470304383|FG003|Overall Study|Death|1|||
130641359|NCT02087241|470304380|FG000|Overall Study|Withdrawal by Subject|1|||
130641360|NCT02087241|470304381|FG001|Overall Study|Withdrawal by Subject|0|||
130641361|NCT02087241|470304382|FG002|Overall Study|Withdrawal by Subject|0|||
130641362|NCT02087241|470304383|FG003|Overall Study|Withdrawal by Subject|1|||
130641363|NCT02087241|470304380|FG000|Overall Study|Progressive Disease|0|||
130641364|NCT02087241|470304381|FG001|Overall Study|Progressive Disease|0|||
130641365|NCT02087241|470304382|FG002|Overall Study|Progressive Disease|0|||
130641366|NCT02087241|470304383|FG003|Overall Study|Progressive Disease|1|||
130641367|NCT02087241|470304380|FG000|Overall Study|Study Terminated by Sponsor|0|||
130641368|NCT02087241|470304381|FG001|Overall Study|Study Terminated by Sponsor|2|||
130641369|NCT02087241|470304382|FG002|Overall Study|Study Terminated by Sponsor|0|||
130641370|NCT02087241|470304383|FG003|Overall Study|Study Terminated by Sponsor|4|||
130641371|NCT00374452|470304386|FG000|Overall Study|Left clinic before intervention started|4|||
130641372|NCT00374452|470304387|FG001|Overall Study|Left clinic before intervention started|1|||
130641373|NCT00374452|470304386|FG000|Overall Study|Change in job role before intervention|0|||
130641374|NCT00374452|470304387|FG001|Overall Study|Change in job role before intervention|1|||
130641375|NCT00374452|470304386|FG000|Overall Study|Left clinic after intervention started|1|||
130641376|NCT00374452|470304387|FG001|Overall Study|Left clinic after intervention started|1|||
130641377|NCT00374452|470304386|FG000|Overall Study|Withdrawal by Subject|0|||
130641378|NCT00374452|470304387|FG001|Overall Study|Withdrawal by Subject|2|||
130641379|NCT00998985|470304390|FG000|Overall Study|Withdrawal by Subject|0|||
130641380|NCT00998985|470304391|FG001|Overall Study|Withdrawal by Subject|0|||
130641381|NCT00998985|470304392|FG002|Overall Study|Withdrawal by Subject|0|||
130641382|NCT00998985|470304393|FG003|Overall Study|Withdrawal by Subject|0|||
130641383|NCT00998985|470304394|FG004|Overall Study|Withdrawal by Subject|0|||
130641384|NCT00998985|470304395|FG005|Overall Study|Withdrawal by Subject|0|||
130641385|NCT00998985|470304396|FG006|Overall Study|Withdrawal by Subject|0|||
130641386|NCT00998985|470304397|FG007|Overall Study|Withdrawal by Subject|0|||
130641387|NCT00998985|470304398|FG008|Overall Study|Withdrawal by Subject|1|||
130641388|NCT00998985|470304399|FG009|Overall Study|Withdrawal by Subject|0|||
130641389|NCT00998985|470304400|FG010|Overall Study|Withdrawal by Subject|0|||
130641390|NCT00998985|470304401|FG011|Overall Study|Withdrawal by Subject|0|||
130641391|NCT00998985|470304402|FG012|Overall Study|Withdrawal by Subject|0|||
130641392|NCT00998985|470304403|FG013|Overall Study|Withdrawal by Subject|0|||
130641393|NCT00998985|470304390|FG000|Overall Study|Protocol Violation|0|||
130641394|NCT00998985|470304391|FG001|Overall Study|Protocol Violation|0|||
130641395|NCT00998985|470304392|FG002|Overall Study|Protocol Violation|0|||
130641396|NCT00998985|470304393|FG003|Overall Study|Protocol Violation|0|||
130641397|NCT00998985|470304394|FG004|Overall Study|Protocol Violation|0|||
130641398|NCT00998985|470304395|FG005|Overall Study|Protocol Violation|1|||
130641399|NCT00998985|470304396|FG006|Overall Study|Protocol Violation|0|||
130641400|NCT00998985|470304397|FG007|Overall Study|Protocol Violation|0|||
130641401|NCT00998985|470304398|FG008|Overall Study|Protocol Violation|0|||
130641402|NCT00998985|470304399|FG009|Overall Study|Protocol Violation|0|||
130641403|NCT00998985|470304400|FG010|Overall Study|Protocol Violation|0|||
130641404|NCT00998985|470304401|FG011|Overall Study|Protocol Violation|0|||
130641405|NCT00998985|470304402|FG012|Overall Study|Protocol Violation|0|||
130641406|NCT00998985|470304403|FG013|Overall Study|Protocol Violation|0|||
130641407|NCT01040728|470304404|FG000|Overall Study|Adverse Event|4|||
130641408|NCT01040728|470304405|FG001|Overall Study|Adverse Event|8|||
130641409|NCT01040728|470304406|FG002|Overall Study|Adverse Event|0|||
130641410|NCT01040728|470304407|FG003|Overall Study|Adverse Event|4|||
130641411|NCT01040728|470304404|FG000|Overall Study|Withdrawal by Subject|0|||
130641412|NCT01040728|470304405|FG001|Overall Study|Withdrawal by Subject|1|||
130641413|NCT01040728|470304406|FG002|Overall Study|Withdrawal by Subject|1|||
130641414|NCT01040728|470304407|FG003|Overall Study|Withdrawal by Subject|0|||
130641415|NCT01040728|470304404|FG000|Overall Study|Protocol Violation|0|||
130641416|NCT01040728|470304405|FG001|Overall Study|Protocol Violation|0|||
130641417|NCT01040728|470304406|FG002|Overall Study|Protocol Violation|0|||
130641418|NCT01040728|470304407|FG003|Overall Study|Protocol Violation|1|||
130641419|NCT01040728|470304404|FG000|Overall Study|Lack of Efficacy|0|||
130641420|NCT01040728|470304405|FG001|Overall Study|Lack of Efficacy|1|||
130641421|NCT01040728|470304406|FG002|Overall Study|Lack of Efficacy|0|||
130641422|NCT01040728|470304407|FG003|Overall Study|Lack of Efficacy|1|||
130641423|NCT01040728|470304404|FG000|Overall Study|Other reasons not listed above|0|||
130641424|NCT01040728|470304405|FG001|Overall Study|Other reasons not listed above|1|||
130641425|NCT01040728|470304406|FG002|Overall Study|Other reasons not listed above|0|||
130641426|NCT01040728|470304407|FG003|Overall Study|Other reasons not listed above|0|||
130641427|NCT02573012|470304408|FG000|Overall Study|Adverse Event|5|||
130641428|NCT02573012|470304409|FG001|Overall Study|Adverse Event|5|||
130641429|NCT02573012|470304408|FG000|Overall Study|Lack of Efficacy|5|||
130641430|NCT02573012|470304409|FG001|Overall Study|Lack of Efficacy|4|||
130641431|NCT02573012|470304408|FG000|Overall Study|Non-compliance|1|||
130641432|NCT02573012|470304409|FG001|Overall Study|Non-compliance|2|||
130641433|NCT02573012|470304408|FG000|Overall Study|Withdrawal by Subject|2|||
130641434|NCT02573012|470304409|FG001|Overall Study|Withdrawal by Subject|2|||
130641435|NCT02573012|470304408|FG000|Overall Study|Study Ended per Protocol|1|||
130641436|NCT02573012|470304409|FG001|Overall Study|Study Ended per Protocol|0|||
130641437|NCT02573012|470304408|FG000|Overall Study|Physician Decision|1|||
130641438|NCT02573012|470304409|FG001|Overall Study|Physician Decision|2|||
130641439|NCT01875874|470304410|FG000|Overall Study|Death|3|||
130641440|NCT00590031|470304411|FG000|Overall Study|Adverse Event|3|||
130641441|NCT00590031|470304411|FG000|Overall Study|Withdrawal by Subject|1|||
130641442|NCT00590031|470304411|FG000|Overall Study|Metastatic Disease|1|||
130641443|NCT00590031|470304411|FG000|Overall Study|Admin Hold|1|||
130641444|NCT02736474|470304418|FG000|Overall Study|Lost to Follow-up|0|||
130641445|NCT02736474|470304419|FG001|Overall Study|Lost to Follow-up|1|||
130641446|NCT02463331|470304420|FG000|Overall Study|Adverse Event|4|||
130641447|NCT02463331|470304421|FG001|Overall Study|Adverse Event|2|||
130641448|NCT02463331|470304420|FG000|Overall Study|Lost to Follow-up|1|||
130641449|NCT02463331|470304421|FG001|Overall Study|Lost to Follow-up|1|||
130641450|NCT02463331|470304420|FG000|Overall Study|Pregnancy|2|||
130641451|NCT02463331|470304421|FG001|Overall Study|Pregnancy|3|||
130641452|NCT02463331|470304420|FG000|Overall Study|Lack of Efficacy|6|||
130641453|NCT02463331|470304421|FG001|Overall Study|Lack of Efficacy|0|||
130641454|NCT02463331|470304420|FG000|Overall Study|Physician Decision|3|||
130641455|NCT02463331|470304421|FG001|Overall Study|Physician Decision|0|||
130641456|NCT00826540|470304422|FG000|Overall Study|ineligible|3|||
130641457|NCT00826540|470304422|FG000|Overall Study|Withdrawal by Subject|1|||
130641458|NCT01166386|470304423|FG000|Overall Study|Withdrawal by Subject|3|||
130641459|NCT01166386|470304424|FG001|Overall Study|Withdrawal by Subject|5|||
130641460|NCT02483611|470304425|FG000|Overall Study|Protocol Violation|0|||
130641461|NCT02483611|470304426|FG001|Overall Study|Protocol Violation|0|||
130641462|NCT02483611|470304427|FG002|Overall Study|Protocol Violation|1|||
130641463|NCT01222416|470304428|FG000|Overall Study|ineligible;metastasis|3|||
130641464|NCT01222416|470304429|FG001|Overall Study|ineligible;metastasis|0|||
130641465|NCT01222416|470304428|FG000|Overall Study|Adverse Event|4|||
130641466|NCT01222416|470304429|FG001|Overall Study|Adverse Event|0|||
130641467|NCT01222416|470304428|FG000|Overall Study|Withdrawal by Subject|5|||
130641468|NCT01222416|470304429|FG001|Overall Study|Withdrawal by Subject|0|||
130641469|NCT01222416|470304428|FG000|Overall Study|scheduling|6|||
130641470|NCT01222416|470304429|FG001|Overall Study|scheduling|0|||
130641471|NCT01222416|470304428|FG000|Overall Study|missed view/scan|1|||
130641472|NCT01222416|470304429|FG001|Overall Study|missed view/scan|0|||
130641473|NCT01222416|470304428|FG000|Overall Study|Death|1|||
130641474|NCT01222416|470304429|FG001|Overall Study|Death|0|||
130641475|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
130641476|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
130641477|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
130641478|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
130641479|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
130641480|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
130641481|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
130641482|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
130641483|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
130641484|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
130641485|NCT02178592|470304432|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
130641486|NCT02178592|470304433|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130641487|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
130641488|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
130641489|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
130641490|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
130641491|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
130641492|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
130641493|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
130641494|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
130641495|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
130641496|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
130641497|NCT02178592|470304432|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
130641498|NCT02178592|470304433|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
130641499|NCT02520141|470304436|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
130641500|NCT00703781|470304437|FG000|Overall Study|Withdrawal by Subject|1|||
130641501|NCT00703781|470304438|FG001|Overall Study|Withdrawal by Subject|2|||
130641502|NCT00703781|470304437|FG000|Overall Study|Cancelled surgery|1|||
130641503|NCT00703781|470304438|FG001|Overall Study|Cancelled surgery|0|||
130641504|NCT03452397|470304441|FG000|Overall Study|Adverse Event|1|||
130641505|NCT03452397|470304442|FG001|Overall Study|Adverse Event|0|||
130641506|NCT03452397|470304443|FG002|Overall Study|Adverse Event|0|||
130641507|NCT03452397|470304444|FG003|Overall Study|Adverse Event|0|||
130641508|NCT03452397|470304441|FG000|Overall Study|Administrative reason|0|||
130641509|NCT03452397|470304442|FG001|Overall Study|Administrative reason|0|||
130641510|NCT03452397|470304443|FG002|Overall Study|Administrative reason|1|||
130641511|NCT03452397|470304444|FG003|Overall Study|Administrative reason|1|||
130641512|NCT03452397|470304441|FG000|Overall Study|Withdrawal by Subject|0|||
130641513|NCT03452397|470304442|FG001|Overall Study|Withdrawal by Subject|0|||
130641514|NCT03452397|470304443|FG002|Overall Study|Withdrawal by Subject|1|||
130641515|NCT03452397|470304444|FG003|Overall Study|Withdrawal by Subject|0|||
130641516|NCT02691468|470304445|FG000|Overall Study|Bronchial blocker use|2|||
130641517|NCT02691468|470304446|FG001|Overall Study|Bronchial blocker use|1|||
130641518|NCT02691468|470304445|FG000|Overall Study|Lost to Follow-up|2|||
130641519|NCT02691468|470304446|FG001|Overall Study|Lost to Follow-up|1|||
130641520|NCT02691468|470304445|FG000|Overall Study|Failure to advance FOB|2|||
130641521|NCT02691468|470304446|FG001|Overall Study|Failure to advance FOB|0|||
130641522|NCT02545049|470304450|FG000|Overall Study|Withdrawal by Subject|1|||
130641523|NCT02545049|470304451|FG001|Overall Study|Withdrawal by Subject|7|||
130641524|NCT02545049|470304450|FG000|Overall Study|Lost to Follow-up|4|||
130641525|NCT02545049|470304451|FG001|Overall Study|Lost to Follow-up|6|||
130641526|NCT02545049|470304450|FG000|Overall Study|GCP violations|37|||
130641527|NCT02545049|470304451|FG001|Overall Study|GCP violations|48|||
130641528|NCT00768040|470305978|FG000|Overall Study|Adverse Event|3|||
130641529|NCT00768040|470305979|FG001|Overall Study|Adverse Event|2|||
130641530|NCT00768040|470305978|FG000|Overall Study|Abnormal laboratory value|1|||
130641531|NCT00768040|470305979|FG001|Overall Study|Abnormal laboratory value|1|||
130641532|NCT03557801|470305980|FG000|Overall Study|Protocol Violation|1|||
130641533|NCT03557801|470305981|FG001|Overall Study|Protocol Violation|0|||
130641534|NCT03557801|470305982|FG002|Overall Study|Protocol Violation|0|||
130641535|NCT03557801|470305980|FG000|Overall Study|Withdrawal by Subject|1|||
130641536|NCT03557801|470305981|FG001|Overall Study|Withdrawal by Subject|0|||
130641537|NCT03557801|470305982|FG002|Overall Study|Withdrawal by Subject|3|||
130641538|NCT03557801|470305980|FG000|Overall Study|Lost to Follow-up|0|||
130641539|NCT03557801|470305981|FG001|Overall Study|Lost to Follow-up|1|||
130641540|NCT03557801|470305982|FG002|Overall Study|Lost to Follow-up|0|||
130641541|NCT00141297|470305983|FG000|Overall Study|Adverse Event|0|||
130641542|NCT00141297|470305984|FG001|Overall Study|Adverse Event|0|||
130641543|NCT00141297|470305985|FG002|Overall Study|Adverse Event|1|||
130641544|NCT00141297|470305986|FG003|Overall Study|Adverse Event|0|||
130641545|NCT00141297|470305987|FG004|Overall Study|Adverse Event|1|||
130641546|NCT00141297|470305988|FG005|Overall Study|Adverse Event|1|||
130641547|NCT00141297|470305989|FG006|Overall Study|Adverse Event|0|||
130641548|NCT00141297|470305990|FG007|Overall Study|Adverse Event|1|||
130641549|NCT00141297|470305991|FG008|Overall Study|Adverse Event|1|||
130641550|NCT00141297|470305992|FG009|Overall Study|Adverse Event|0|||
130641551|NCT00141297|470305983|FG000|Overall Study|Death|1|||
130641552|NCT00141297|470305984|FG001|Overall Study|Death|0|||
130641553|NCT00141297|470305985|FG002|Overall Study|Death|0|||
130641554|NCT00141297|470305986|FG003|Overall Study|Death|0|||
130641555|NCT00141297|470305987|FG004|Overall Study|Death|0|||
130641556|NCT00141297|470305988|FG005|Overall Study|Death|0|||
130641557|NCT00141297|470305989|FG006|Overall Study|Death|0|||
130641558|NCT00141297|470305990|FG007|Overall Study|Death|0|||
130641559|NCT00141297|470305991|FG008|Overall Study|Death|1|||
130641560|NCT00141297|470305992|FG009|Overall Study|Death|0|||
130641561|NCT00141297|470305983|FG000|Overall Study|Withdrawal by Subject|0|||
130641562|NCT00141297|470305984|FG001|Overall Study|Withdrawal by Subject|0|||
130641563|NCT00141297|470305985|FG002|Overall Study|Withdrawal by Subject|0|||
130641564|NCT00141297|470305986|FG003|Overall Study|Withdrawal by Subject|0|||
130641565|NCT00141297|470305987|FG004|Overall Study|Withdrawal by Subject|0|||
130641566|NCT00141297|470305988|FG005|Overall Study|Withdrawal by Subject|0|||
130641567|NCT00141297|470305989|FG006|Overall Study|Withdrawal by Subject|0|||
130641568|NCT00141297|470305990|FG007|Overall Study|Withdrawal by Subject|0|||
130641569|NCT00141297|470305991|FG008|Overall Study|Withdrawal by Subject|1|||
130641570|NCT00141297|470305992|FG009|Overall Study|Withdrawal by Subject|0|||
130641571|NCT00141297|470305983|FG000|Overall Study|Other|0|||
130641572|NCT00141297|470305984|FG001|Overall Study|Other|0|||
130641573|NCT00141297|470305985|FG002|Overall Study|Other|0|||
130641574|NCT00141297|470305986|FG003|Overall Study|Other|1|||
130641575|NCT00141297|470305987|FG004|Overall Study|Other|5|||
130641576|NCT00141297|470305988|FG005|Overall Study|Other|0|||
130641577|NCT00141297|470305989|FG006|Overall Study|Other|0|||
130641578|NCT00141297|470305990|FG007|Overall Study|Other|0|||
130641579|NCT00141297|470305991|FG008|Overall Study|Other|2|||
130641580|NCT00141297|470305992|FG009|Overall Study|Other|0|||
130641581|NCT00141297|470305983|FG000|Overall Study|Progressive Disease|2|||
130641582|NCT00141297|470305984|FG001|Overall Study|Progressive Disease|3|||
130641583|NCT00141297|470305985|FG002|Overall Study|Progressive Disease|6|||
130641584|NCT00141297|470305986|FG003|Overall Study|Progressive Disease|2|||
130641585|NCT00141297|470305987|FG004|Overall Study|Progressive Disease|15|||
130641586|NCT00141297|470305988|FG005|Overall Study|Progressive Disease|2|||
130641587|NCT00141297|470305989|FG006|Overall Study|Progressive Disease|3|||
130641588|NCT00141297|470305990|FG007|Overall Study|Progressive Disease|3|||
130641589|NCT00141297|470305991|FG008|Overall Study|Progressive Disease|15|||
130641590|NCT00141297|470305992|FG009|Overall Study|Progressive Disease|6|||
130641591|NCT00141297|470305983|FG000|Overall Study|Transitioned|0|||
130641592|NCT00141297|470305984|FG001|Overall Study|Transitioned|0|||
130641593|NCT00141297|470305985|FG002|Overall Study|Transitioned|0|||
130641594|NCT00141297|470305986|FG003|Overall Study|Transitioned|0|||
130641595|NCT00141297|470305987|FG004|Overall Study|Transitioned|1|||
130641596|NCT00141297|470305988|FG005|Overall Study|Transitioned|0|||
130641597|NCT00141297|470305989|FG006|Overall Study|Transitioned|0|||
130641598|NCT00141297|470305990|FG007|Overall Study|Transitioned|0|||
130641599|NCT00141297|470305991|FG008|Overall Study|Transitioned|0|||
130641600|NCT00141297|470305992|FG009|Overall Study|Transitioned|0|||
130641601|NCT02200510|470305993|FG000|Overall Study|Death|1|||
130641602|NCT02200510|470305994|FG001|Overall Study|Death|1|||
130641603|NCT02200510|470305993|FG000|Overall Study|Protocol Violation|0|||
130641604|NCT02200510|470305994|FG001|Overall Study|Protocol Violation|1|||
130641605|NCT02200510|470305993|FG000|Overall Study|Lost to Follow-up|7|||
130641606|NCT02200510|470305994|FG001|Overall Study|Lost to Follow-up|1|||
130641607|NCT02200510|470305993|FG000|Overall Study|potential COI - joined study team|1|||
130641608|NCT02200510|470305994|FG001|Overall Study|potential COI - joined study team|0|||
130641609|NCT00033514|470305995|FG000|Overall Study|Lost to Follow-up|1|||
130641610|NCT00033514|470305996|FG001|Overall Study|Lost to Follow-up|1|||
130641611|NCT00033514|470305995|FG000|Overall Study|Withdrawal by Subject|0|||
130641612|NCT00033514|470305996|FG001|Overall Study|Withdrawal by Subject|3|||
130641613|NCT01488994|470305997|FG000|Overall Study|Withdrawal by Subject|0|||
130641614|NCT01488994|470305998|FG001|Overall Study|Withdrawal by Subject|1|||
130641615|NCT03798366|470305999|FG000|Overall Study|Lost to Follow-up|0|||
130641616|NCT03798366|470306000|FG001|Overall Study|Lost to Follow-up|1|||
130641617|NCT00474539|470306003|FG000|Infant Series|Withdrawal by Subject|3|||
130641618|NCT00474539|470306004|FG001|Infant Series|Withdrawal by Subject|4|||
130641619|NCT00474539|470306003|FG000|Infant Series|Randomization error|5|||
130641620|NCT00474539|470306004|FG001|Infant Series|Randomization error|0|||
130641621|NCT00474539|470306003|FG000|Infant Series|Lost to Follow-up|2|||
130641622|NCT00474539|470306004|FG001|Infant Series|Lost to Follow-up|1|||
130641623|NCT00474539|470306003|FG000|Infant Series|Protocol Violation|0|||
130641624|NCT00474539|470306004|FG001|Infant Series|Protocol Violation|1|||
130641625|NCT00474539|470306003|FG000|After Infant Series|Lost to Follow-up|3|||
130641626|NCT00474539|470306004|FG001|After Infant Series|Lost to Follow-up|0|||
130641627|NCT00474539|470306003|FG000|After Infant Series|Withdrawal by Subject|1|||
130641628|NCT00474539|470306004|FG001|After Infant Series|Withdrawal by Subject|0|||
130641629|NCT00474539|470306003|FG000|Toddler Dose|Protocol Violation|1|||
130641630|NCT00474539|470306004|FG001|Toddler Dose|Protocol Violation|0|||
130641631|NCT02061540|470306005|FG000|Overall Study|Adverse Event|2|||
130641632|NCT02061540|470306005|FG000|Overall Study|Withdrawal by Subject|2|||
130641633|NCT01227252|470306006|FG000|Overall Study|Sponsor Decision|0|||
130641634|NCT01227252|470306007|FG001|Overall Study|Sponsor Decision|1|||
130641635|NCT01227252|470306008|FG002|Overall Study|Sponsor Decision|0|||
130641636|NCT01227252|470306009|FG003|Overall Study|Sponsor Decision|0|||
130641637|NCT01227252|470306006|FG000|Overall Study|Lost to Follow-up|0|||
130641638|NCT01227252|470306007|FG001|Overall Study|Lost to Follow-up|1|||
130641639|NCT01227252|470306008|FG002|Overall Study|Lost to Follow-up|0|||
130641640|NCT01227252|470306009|FG003|Overall Study|Lost to Follow-up|0|||
130641641|NCT01227252|470306006|FG000|Overall Study|Withdrawal by Subject|0|||
130641642|NCT01227252|470306007|FG001|Overall Study|Withdrawal by Subject|1|||
130641643|NCT01227252|470306008|FG002|Overall Study|Withdrawal by Subject|0|||
130641644|NCT01227252|470306009|FG003|Overall Study|Withdrawal by Subject|0|||
130641645|NCT02561273|470306016|FG000|Overall Study|Protocol Violation|1|||
130641646|NCT02561273|470306017|FG001|Overall Study|Protocol Violation|0|||
130641647|NCT02192190|470306020|FG000|Overall Study|Adverse Event|1|||
130641648|NCT02192190|470306021|FG001|Overall Study|Adverse Event|1|||
130641649|NCT02192190|470306022|FG002|Overall Study|Adverse Event|0|||
130641650|NCT02192190|470306023|FG003|Overall Study|Adverse Event|0|||
130641651|NCT02192190|470306024|FG004|Overall Study|Adverse Event|0|||
130641652|NCT02192190|470306025|FG005|Overall Study|Adverse Event|0|||
130641653|NCT02192190|470306020|FG000|Overall Study|Lost to Follow-up|3|||
130641654|NCT02192190|470306021|FG001|Overall Study|Lost to Follow-up|3|||
130641655|NCT02192190|470306022|FG002|Overall Study|Lost to Follow-up|2|||
130641656|NCT02192190|470306023|FG003|Overall Study|Lost to Follow-up|1|||
130641657|NCT02192190|470306024|FG004|Overall Study|Lost to Follow-up|4|||
130641658|NCT02192190|470306025|FG005|Overall Study|Lost to Follow-up|3|||
130641659|NCT02192190|470306020|FG000|Overall Study|Physician Decision|2|||
130641660|NCT02192190|470306021|FG001|Overall Study|Physician Decision|0|||
130641661|NCT02192190|470306022|FG002|Overall Study|Physician Decision|0|||
130641662|NCT02192190|470306023|FG003|Overall Study|Physician Decision|0|||
130641663|NCT02192190|470306024|FG004|Overall Study|Physician Decision|0|||
130641664|NCT02192190|470306025|FG005|Overall Study|Physician Decision|0|||
130641665|NCT02192190|470306020|FG000|Overall Study|Terminated by Sponsor|43|||
130641666|NCT02192190|470306021|FG001|Overall Study|Terminated by Sponsor|23|||
130641667|NCT02192190|470306022|FG002|Overall Study|Terminated by Sponsor|20|||
130641668|NCT02192190|470306023|FG003|Overall Study|Terminated by Sponsor|23|||
130641669|NCT02192190|470306024|FG004|Overall Study|Terminated by Sponsor|21|||
130641670|NCT02192190|470306025|FG005|Overall Study|Terminated by Sponsor|23|||
130641671|NCT02192190|470306020|FG000|Overall Study|Withdrawal by Subject|4|||
130641672|NCT02192190|470306021|FG001|Overall Study|Withdrawal by Subject|1|||
130641673|NCT02192190|470306022|FG002|Overall Study|Withdrawal by Subject|2|||
130641674|NCT02192190|470306023|FG003|Overall Study|Withdrawal by Subject|1|||
130641675|NCT02192190|470306024|FG004|Overall Study|Withdrawal by Subject|5|||
130641676|NCT02192190|470306025|FG005|Overall Study|Withdrawal by Subject|3|||
130641677|NCT02192190|470306020|FG000|Overall Study|Could not Keep Visit Schedule|1|||
130641678|NCT02192190|470306021|FG001|Overall Study|Could not Keep Visit Schedule|0|||
130641679|NCT02192190|470306022|FG002|Overall Study|Could not Keep Visit Schedule|0|||
130641680|NCT02192190|470306023|FG003|Overall Study|Could not Keep Visit Schedule|0|||
130641681|NCT02192190|470306024|FG004|Overall Study|Could not Keep Visit Schedule|0|||
130641682|NCT02192190|470306025|FG005|Overall Study|Could not Keep Visit Schedule|0|||
130641683|NCT02192190|470306020|FG000|Overall Study|Positive Drug Screen|0|||
130641684|NCT02192190|470306021|FG001|Overall Study|Positive Drug Screen|0|||
130641685|NCT02192190|470306022|FG002|Overall Study|Positive Drug Screen|0|||
130641686|NCT02192190|470306023|FG003|Overall Study|Positive Drug Screen|1|||
130641687|NCT02192190|470306024|FG004|Overall Study|Positive Drug Screen|0|||
130641688|NCT02192190|470306025|FG005|Overall Study|Positive Drug Screen|0|||
130641689|NCT02192190|470306020|FG000|Overall Study|Inadequate Pain Relief|0|||
130641690|NCT02192190|470306021|FG001|Overall Study|Inadequate Pain Relief|1|||
130641691|NCT02192190|470306022|FG002|Overall Study|Inadequate Pain Relief|1|||
130641692|NCT02192190|470306023|FG003|Overall Study|Inadequate Pain Relief|0|||
130641693|NCT02192190|470306024|FG004|Overall Study|Inadequate Pain Relief|0|||
130641694|NCT02192190|470306025|FG005|Overall Study|Inadequate Pain Relief|0|||
130641695|NCT03227692|470306026|FG000|Overall Study|Protocol Violation|1|||
130641696|NCT03227692|470306027|FG001|Overall Study|Protocol Violation|1|||
130641697|NCT03227692|470306026|FG000|Overall Study|Lost to Follow-up|4|||
130641698|NCT03227692|470306027|FG001|Overall Study|Lost to Follow-up|2|||
130641699|NCT03227692|470306026|FG000|Overall Study|Adverse Event|0|||
130641700|NCT03227692|470306027|FG001|Overall Study|Adverse Event|2|||
130641701|NCT00890201|470306030|FG000|Overall Study|Protocol Violation|5|||
130641702|NCT00890201|470306031|FG001|Overall Study|Protocol Violation|56|||
130641703|NCT02181504|470306032|FG000|Overall Study|Adverse Event|1|||
130641704|NCT02181504|470306033|FG001|Overall Study|Adverse Event|1|||
130641705|NCT02181504|470306034|FG002|Overall Study|Adverse Event|1|||
130641706|NCT01289028|470306038|FG000|Overall Study|Progressive Disease|49|||
130641707|NCT01289028|470306038|FG000|Overall Study|Adverse Event|14|||
130641708|NCT01289028|470306038|FG000|Overall Study|Withdrawal by Subject|6|||
130641709|NCT01289028|470306038|FG000|Overall Study|Death|4|||
130641710|NCT01289028|470306038|FG000|Overall Study|Lack of Efficacy|2|||
130641711|NCT01289028|470306038|FG000|Overall Study|No longer required|2|||
130641712|NCT01289028|470306038|FG000|Overall Study|Lost to Follow-up|2|||
130641713|NCT01289028|470306038|FG000|Overall Study|New Cancer Therapy|2|||
130641714|NCT01289028|470306038|FG000|Overall Study|Abnormal Lab Value|1|||
130641715|NCT01289028|470306038|FG000|Overall Study|Missing reason for discon|1|||
130641716|NCT02120469|470306039|FG000|Overall Study|HER-2/neu-amplified|1|||
130641717|NCT02120469|470306040|FG001|Overall Study|HER-2/neu-amplified|0|||
130641718|NCT02120469|470306041|FG002|Overall Study|HER-2/neu-amplified|1|||
130641719|NCT03267576|470306049|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
130641720|NCT03267576|470306050|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
130641721|NCT03267576|470306049|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
130641722|NCT03267576|470306050|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
130641723|NCT01369069|470306051|FG000|Overall Study|Lost to Follow-up|8|||
130641724|NCT01369069|470306052|FG001|Overall Study|Lost to Follow-up|9|||
130641725|NCT01369069|470306051|FG000|Overall Study|Withdrawal by Subject|9|||
130641726|NCT01369069|470306052|FG001|Overall Study|Withdrawal by Subject|7|||
130641727|NCT00882362|470306053|FG000|Overall Study|Adverse Event|13|||
130641728|NCT00882362|470306054|FG001|Overall Study|Adverse Event|10|||
130641729|NCT00882362|470306053|FG000|Overall Study|Withdrawal by Subject|13|||
130641730|NCT00882362|470306054|FG001|Overall Study|Withdrawal by Subject|10|||
130641731|NCT00882362|470306053|FG000|Overall Study|Lack of Efficacy|3|||
130641732|NCT00882362|470306054|FG001|Overall Study|Lack of Efficacy|0|||
130641733|NCT00882362|470306053|FG000|Overall Study|Protocol Violation|7|||
130641734|NCT00882362|470306054|FG001|Overall Study|Protocol Violation|2|||
130641735|NCT00882362|470306053|FG000|Overall Study|Pregnancy|1|||
130641736|NCT00882362|470306054|FG001|Overall Study|Pregnancy|0|||
130641737|NCT00882362|470306053|FG000|Overall Study|Physician Decision|5|||
130641738|NCT00882362|470306054|FG001|Overall Study|Physician Decision|1|||
130641739|NCT00882362|470306053|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
130641740|NCT00882362|470306054|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
130641741|NCT00882362|470306053|FG000|Overall Study|change of residence or other commitments|5|||
130641742|NCT00882362|470306054|FG001|Overall Study|change of residence or other commitments|0|||
130641743|NCT01268514|470306055|FG000|Overall Study|Adverse Event|20|||
130641744|NCT01268514|470306055|FG000|Overall Study|Death|8|||
130641745|NCT01268514|470306055|FG000|Overall Study|Lost to Follow-up|5|||
130641746|NCT01268514|470306055|FG000|Overall Study|Withdrawal by Subject|3|||
130641747|NCT01268514|470306055|FG000|Overall Study|Withdrawal by Surgeon|5|||
130641748|NCT01846208|470306056|FG000|Overall Study|Withdrew prior to treatment|1|||
130641749|NCT01846208|470306057|FG001|Overall Study|Withdrew prior to treatment|1|||
130641750|NCT01846208|470306058|FG002|Overall Study|Withdrew prior to treatment|1|||
130641751|NCT01846208|470306056|FG000|Overall Study|Dosing Symptoms|1|||
130641752|NCT01846208|470306057|FG001|Overall Study|Dosing Symptoms|2|||
130641753|NCT01846208|470306058|FG002|Overall Study|Dosing Symptoms|6|||
130641754|NCT01846208|470306056|FG000|Overall Study|Withdrawal by Subject|5|||
130641755|NCT01846208|470306057|FG001|Overall Study|Withdrawal by Subject|0|||
130641756|NCT01846208|470306058|FG002|Overall Study|Withdrawal by Subject|0|||
130641757|NCT01846208|470306056|FG000|Overall Study|Non-compliance|1|||
130641758|NCT01846208|470306057|FG001|Overall Study|Non-compliance|1|||
130641759|NCT01846208|470306058|FG002|Overall Study|Non-compliance|0|||
130641760|NCT01846208|470306056|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
130641761|NCT01846208|470306057|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
130641762|NCT01846208|470306058|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
130641763|NCT01846208|470306056|FG000|Overall Study|Refused SU OFC|0|||
130641764|NCT01846208|470306057|FG001|Overall Study|Refused SU OFC|0|||
130641765|NCT01846208|470306058|FG002|Overall Study|Refused SU OFC|1|||
130641766|NCT01424306|470306059|FG000|Overall Study|Protocol Violation|0|||
130641767|NCT01424306|470306060|FG001|Overall Study|Protocol Violation|0|||
130641768|NCT01424306|470306061|FG002|Overall Study|Protocol Violation|0|||
130641769|NCT01424306|470306062|FG003|Overall Study|Protocol Violation|0|||
130641770|NCT01424306|470306063|FG004|Overall Study|Protocol Violation|1|||
130641771|NCT01424306|470306064|FG005|Overall Study|Protocol Violation|0|||
130641772|NCT01809327|470306072|FG000|Overall Study|Lost to Follow-up|5|||
130641773|NCT01809327|470306073|FG001|Overall Study|Lost to Follow-up|2|||
130641774|NCT01809327|470306074|FG002|Overall Study|Lost to Follow-up|4|||
130641775|NCT01809327|470306075|FG003|Overall Study|Lost to Follow-up|2|||
130641776|NCT01809327|470306076|FG004|Overall Study|Lost to Follow-up|3|||
130641777|NCT01809327|470306072|FG000|Overall Study|Withdrawal by Subject|6|||
130641778|NCT01809327|470306073|FG001|Overall Study|Withdrawal by Subject|4|||
130641779|NCT01809327|470306074|FG002|Overall Study|Withdrawal by Subject|4|||
130641780|NCT01809327|470306075|FG003|Overall Study|Withdrawal by Subject|2|||
130641781|NCT01809327|470306076|FG004|Overall Study|Withdrawal by Subject|5|||
130641782|NCT01809327|470306072|FG000|Overall Study|Adverse Event|4|||
130641783|NCT01809327|470306073|FG001|Overall Study|Adverse Event|3|||
130641784|NCT01809327|470306074|FG002|Overall Study|Adverse Event|7|||
130641785|NCT01809327|470306075|FG003|Overall Study|Adverse Event|4|||
130641786|NCT01809327|470306076|FG004|Overall Study|Adverse Event|8|||
130641787|NCT01809327|470306072|FG000|Overall Study|Death|1|||
130641788|NCT01809327|470306073|FG001|Overall Study|Death|0|||
130641789|NCT01809327|470306074|FG002|Overall Study|Death|0|||
130641790|NCT01809327|470306075|FG003|Overall Study|Death|0|||
130641791|NCT01809327|470306076|FG004|Overall Study|Death|0|||
130641792|NCT01809327|470306072|FG000|Overall Study|Protocol Violation|0|||
130641793|NCT01809327|470306073|FG001|Overall Study|Protocol Violation|1|||
130641794|NCT01809327|470306074|FG002|Overall Study|Protocol Violation|0|||
130641795|NCT01809327|470306075|FG003|Overall Study|Protocol Violation|0|||
130641796|NCT01809327|470306076|FG004|Overall Study|Protocol Violation|0|||
130641797|NCT01809327|470306072|FG000|Overall Study|Physician Decision|1|||
130641798|NCT01809327|470306073|FG001|Overall Study|Physician Decision|1|||
130641799|NCT01809327|470306074|FG002|Overall Study|Physician Decision|0|||
130641800|NCT01809327|470306075|FG003|Overall Study|Physician Decision|0|||
130641801|NCT01809327|470306076|FG004|Overall Study|Physician Decision|0|||
130641802|NCT01809327|470306072|FG000|Overall Study|Pregnancy|1|||
130641803|NCT01809327|470306073|FG001|Overall Study|Pregnancy|0|||
130641804|NCT01809327|470306074|FG002|Overall Study|Pregnancy|0|||
130641805|NCT01809327|470306075|FG003|Overall Study|Pregnancy|0|||
130641806|NCT01809327|470306076|FG004|Overall Study|Pregnancy|0|||
130641807|NCT01809327|470306072|FG000|Overall Study|Other|14|||
130641808|NCT01809327|470306073|FG001|Overall Study|Other|15|||
130641809|NCT01809327|470306074|FG002|Overall Study|Other|7|||
130641810|NCT01809327|470306075|FG003|Overall Study|Other|4|||
130641811|NCT01809327|470306076|FG004|Overall Study|Other|9|||
130641812|NCT03196973|470306077|FG000|Overall Study|Adverse Event|1|||
130641813|NCT03196973|470306078|FG001|Overall Study|Adverse Event|1|||
130641814|NCT03196973|470306079|FG002|Overall Study|Adverse Event|2|||
130641815|NCT03196973|470306077|FG000|Overall Study|Lack of Efficacy|2|||
130641816|NCT03196973|470306078|FG001|Overall Study|Lack of Efficacy|6|||
130641817|NCT03196973|470306079|FG002|Overall Study|Lack of Efficacy|1|||
130641818|NCT03196973|470306077|FG000|Overall Study|Lost to Follow-up|4|||
130641819|NCT03196973|470306078|FG001|Overall Study|Lost to Follow-up|3|||
130641820|NCT03196973|470306079|FG002|Overall Study|Lost to Follow-up|2|||
130641821|NCT03196973|470306077|FG000|Overall Study|Consent withdrawn|2|||
130641822|NCT03196973|470306078|FG001|Overall Study|Consent withdrawn|1|||
130641823|NCT03196973|470306079|FG002|Overall Study|Consent withdrawn|0|||
130641824|NCT03196973|470306077|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
130641825|NCT03196973|470306078|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
130641826|NCT03196973|470306079|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
130641827|NCT03344562|470306080|FG000|Overall Study|Withdrawal by Subject|2|||
130641828|NCT03344562|470306081|FG001|Overall Study|Withdrawal by Subject|0|||
130641829|NCT02390362|470306095|FG000|Overall Study|Withdrawal by Subject|0|||
130641830|NCT02390362|470306096|FG001|Overall Study|Withdrawal by Subject|1|||
130641831|NCT04009824|470306097|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
130641832|NCT04009824|470306098|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
130641833|NCT04009824|470306099|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
130641834|NCT04009824|470306100|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
130641835|NCT04009824|470306101|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
130641836|NCT01024946|470306102|FG000|Overall Study|Screen Failure|3|||
130641837|NCT01024946|470306102|FG000|Overall Study|Withdrawal by Subject|1|||
130641838|NCT01024946|470306102|FG000|Overall Study|Adverse Event|1|||
130641839|NCT02274766|470306103|FG000|Overall Study|Withdrawal by Subject|3|||
130641840|NCT02274766|470306104|FG001|Overall Study|Withdrawal by Subject|6|||
130641841|NCT02274766|470306103|FG000|Overall Study|Did Not Receive Study Drug|1|||
130641842|NCT02274766|470306104|FG001|Overall Study|Did Not Receive Study Drug|1|||
130641843|NCT02274766|470306103|FG000|Overall Study|Subject Unwilling to Proceed|0|||
130641844|NCT02274766|470306104|FG001|Overall Study|Subject Unwilling to Proceed|1|||
130641845|NCT02274766|470306103|FG000|Overall Study|Adverse Event|0|||
130641846|NCT02274766|470306104|FG001|Overall Study|Adverse Event|1|||
130641847|NCT03032523|470306105|FG000|Overall Study|Withdrawal by Subject|2|||
130641848|NCT03032523|470306106|FG001|Overall Study|Withdrawal by Subject|2|||
130641849|NCT03032523|470306105|FG000|Overall Study|Physician Decision|1|||
130641850|NCT03032523|470306106|FG001|Overall Study|Physician Decision|0|||
130641851|NCT00984009|470306109|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
130641852|NCT00281528|470306110|FG000|Overall Study|Progressive Disease|28|||
130641853|NCT00281528|470306111|FG001|Overall Study|Progressive Disease|18|||
130641854|NCT00281528|470306112|FG002|Overall Study|Progressive Disease|27|||
130641855|NCT00281528|470306110|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
130641856|NCT00281528|470306111|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
130641857|NCT00281528|470306112|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
130641858|NCT00281528|470306110|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
130641859|NCT00281528|470306111|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
130641860|NCT00281528|470306112|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
130641861|NCT00281528|470306110|FG000|Overall Study|Physician Decision|11|||
130641862|NCT00281528|470306111|FG001|Overall Study|Physician Decision|4|||
130641863|NCT00281528|470306112|FG002|Overall Study|Physician Decision|5|||
130641864|NCT00281528|470306110|FG000|Overall Study|Protocol Violation|1|||
130641865|NCT00281528|470306111|FG001|Overall Study|Protocol Violation|0|||
130641866|NCT00281528|470306112|FG002|Overall Study|Protocol Violation|1|||
130641867|NCT00281528|470306110|FG000|Overall Study|Withdrawal by Subject|5|||
130641868|NCT00281528|470306111|FG001|Overall Study|Withdrawal by Subject|5|||
130641869|NCT00281528|470306112|FG002|Overall Study|Withdrawal by Subject|7|||
130641870|NCT00281528|470306110|FG000|Overall Study|Other|6|||
130641871|NCT00281528|470306111|FG001|Overall Study|Other|3|||
130641872|NCT00281528|470306112|FG002|Overall Study|Other|5|||
130641873|NCT02036476|470306124|FG000|Overall Study|Withdrawal by Subject|2|||
130641874|NCT02036476|470306124|FG000|Overall Study|Progressive Disease|4|||
130641875|NCT02036476|470306124|FG000|Overall Study|Unacceptable Toxicity|2|||
130641876|NCT02168816|470306125|FG000|Overall Study|Lost to Follow-up|2|||
130641877|NCT02168816|470306126|FG001|Overall Study|Lost to Follow-up|2|||
130641878|NCT00424463|470306127|FG000|Overall Study|Adverse Event|2|||
130641879|NCT00424463|470306128|FG001|Overall Study|Adverse Event|3|||
130641880|NCT00424463|470306129|FG002|Overall Study|Adverse Event|2|||
130641881|NCT00424463|470306127|FG000|Overall Study|Physician Decision|0|||
130641882|NCT00424463|470306128|FG001|Overall Study|Physician Decision|2|||
130641883|NCT00424463|470306129|FG002|Overall Study|Physician Decision|2|||
130641884|NCT00424463|470306127|FG000|Overall Study|Withdrawal by Subject|4|||
130641885|NCT00424463|470306128|FG001|Overall Study|Withdrawal by Subject|2|||
130641886|NCT00424463|470306129|FG002|Overall Study|Withdrawal by Subject|5|||
130641887|NCT00424463|470306127|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
130641888|NCT00424463|470306128|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
130641889|NCT00424463|470306129|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
130641890|NCT00424463|470306127|FG000|Overall Study|Patient's convenience|0|||
130641891|NCT00424463|470306128|FG001|Overall Study|Patient's convenience|0|||
130641892|NCT00424463|470306129|FG002|Overall Study|Patient's convenience|1|||
130641893|NCT01436357|470306130|FG000|Overall Study|Death|5|||
130641894|NCT01436357|470306131|FG001|Overall Study|Death|1|||
130641895|NCT01436357|470306130|FG000|Overall Study|Enrolled but not vaccinated|1|||
130641896|NCT01436357|470306131|FG001|Overall Study|Enrolled but not vaccinated|1|||
130641897|NCT01436357|470306130|FG000|Overall Study|Incarceration|18|||
130641898|NCT01436357|470306131|FG001|Overall Study|Incarceration|20|||
130641899|NCT01436357|470306130|FG000|Overall Study|Lost to Follow-up|67|||
130641900|NCT01436357|470306131|FG001|Overall Study|Lost to Follow-up|61|||
130641901|NCT01436357|470306130|FG000|Overall Study|Protocol Violation|1|||
130641902|NCT01436357|470306131|FG001|Overall Study|Protocol Violation|0|||
130641903|NCT01436357|470306130|FG000|Overall Study|Withdrawal by Subject|26|||
130641904|NCT01436357|470306131|FG001|Overall Study|Withdrawal by Subject|38|||
130641905|NCT01436357|470306130|FG000|Overall Study|Physician Decision|3|||
130641906|NCT01436357|470306131|FG001|Overall Study|Physician Decision|4|||
130641907|NCT01436357|470306130|FG000|Overall Study|Moved out of area|1|||
130641908|NCT01436357|470306131|FG001|Overall Study|Moved out of area|2|||
130641909|NCT01436357|470306130|FG000|Overall Study|Subject in rehab|0|||
130641910|NCT01436357|470306131|FG001|Overall Study|Subject in rehab|1|||
130641911|NCT03053180|470307813|FG000|Overall Study|Failure to Return|1|||
130641912|NCT02972658|470307814|FG000|Overall Study|Adverse Event|0|||
130641913|NCT02972658|470307815|FG001|Overall Study|Adverse Event|3|||
130641914|NCT02972658|470307816|FG002|Overall Study|Adverse Event|0|||
130641915|NCT02972658|470307817|FG003|Overall Study|Adverse Event|2|||
130641916|NCT02972658|470307814|FG000|Overall Study|Other-determined by Investigator|1|||
130641917|NCT02972658|470307815|FG001|Overall Study|Other-determined by Investigator|1|||
130641918|NCT02972658|470307816|FG002|Overall Study|Other-determined by Investigator|0|||
130641919|NCT02972658|470307817|FG003|Overall Study|Other-determined by Investigator|0|||
130641920|NCT02972658|470307814|FG000|Overall Study|Death|0|||
130641921|NCT02972658|470307815|FG001|Overall Study|Death|0|||
130641922|NCT02972658|470307816|FG002|Overall Study|Death|0|||
130641923|NCT02972658|470307817|FG003|Overall Study|Death|1|||
130641924|NCT02972658|470307814|FG000|Overall Study|Lost to Follow-up|0|||
130641925|NCT02972658|470307815|FG001|Overall Study|Lost to Follow-up|1|||
130641926|NCT02972658|470307816|FG002|Overall Study|Lost to Follow-up|1|||
130641927|NCT02972658|470307817|FG003|Overall Study|Lost to Follow-up|2|||
130641928|NCT02972658|470307814|FG000|Overall Study|Progressive Disease|0|||
130641929|NCT02972658|470307815|FG001|Overall Study|Progressive Disease|1|||
130641930|NCT02972658|470307816|FG002|Overall Study|Progressive Disease|0|||
130641931|NCT02972658|470307817|FG003|Overall Study|Progressive Disease|1|||
130641932|NCT02972658|470307814|FG000|Overall Study|Withdrawal by Subject|4|||
130641933|NCT02972658|470307815|FG001|Overall Study|Withdrawal by Subject|4|||
130641934|NCT02972658|470307816|FG002|Overall Study|Withdrawal by Subject|1|||
130641935|NCT02972658|470307817|FG003|Overall Study|Withdrawal by Subject|6|||
130641936|NCT02972658|470307814|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130641937|NCT02972658|470307815|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130641938|NCT02972658|470307816|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130641939|NCT02972658|470307817|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
130641940|NCT02972658|470307814|FG000|Overall Study|Sponsor Decision|70|||
130641941|NCT02972658|470307815|FG001|Overall Study|Sponsor Decision|127|||
130641942|NCT02972658|470307816|FG002|Overall Study|Sponsor Decision|72|||
130641943|NCT02972658|470307817|FG003|Overall Study|Sponsor Decision|119|||
130641944|NCT03958149|470307818|FG000|Overall Study|Withdrawal by Subject|0|||
130641945|NCT03958149|470307819|FG001|Overall Study|Withdrawal by Subject|1|||
130641946|NCT02785588|470307820|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
130641947|NCT02785588|470307820|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
130641948|NCT02583399|470307822|FG000|Overall Study|Able to be discharged|3|||
130641949|NCT02583399|470307822|FG000|Overall Study|Wanted to use a restricted medication|3|||
130641950|NCT00364611|470307823|FG000|Overall Study|Did not receive study medication|0|||
130641951|NCT00364611|470307824|FG001|Overall Study|Did not receive study medication|1|||
130641952|NCT00364611|470307823|FG000|Overall Study|Adverse Event|7|||
130641953|NCT00364611|470307824|FG001|Overall Study|Adverse Event|4|||
130641954|NCT00364611|470307823|FG000|Overall Study|Participant's Request|3|||
130641955|NCT00364611|470307824|FG001|Overall Study|Participant's Request|4|||
130641956|NCT00364611|470307823|FG000|Overall Study|Disease Progression|38|||
130641957|NCT00364611|470307824|FG001|Overall Study|Disease Progression|8|||
130641958|NCT00364611|470307823|FG000|Overall Study|Investigator decision|2|||
130641959|NCT00364611|470307824|FG001|Overall Study|Investigator decision|2|||
130641960|NCT00364611|470307823|FG000|Overall Study|Found Ineligible|1|||
130641961|NCT00364611|470307824|FG001|Overall Study|Found Ineligible|0|||
130641962|NCT00364611|470307823|FG000|Overall Study|Presumed CR on Study|0|||
130641963|NCT00364611|470307824|FG001|Overall Study|Presumed CR on Study|1|||
130641964|NCT00364611|470307823|FG000|Overall Study|Receiving Liver Ablation|0|||
130641965|NCT00364611|470307824|FG001|Overall Study|Receiving Liver Ablation|1|||
130641966|NCT02759939|470307829|FG000|Overall Study|Missing data on first outcome assessed|11|||
130641967|NCT02759939|470307830|FG001|Overall Study|Missing data on first outcome assessed|2|||
130641968|NCT02759939|470307831|FG002|Overall Study|Missing data on first outcome assessed|5|||
130641969|NCT02759939|470307832|FG003|Overall Study|Missing data on first outcome assessed|2|||
130641970|NCT02759939|470307829|FG000|Overall Study|Ineligible for T2 and T3|310|||
130641971|NCT02759939|470307830|FG001|Overall Study|Ineligible for T2 and T3|179|||
130641972|NCT02759939|470307831|FG002|Overall Study|Ineligible for T2 and T3|366|||
130641973|NCT02759939|470307832|FG003|Overall Study|Ineligible for T2 and T3|391|||
130641974|NCT02759939|470307829|FG000|Overall Study|Lost to Follow-up|735|||
130641975|NCT02759939|470307830|FG001|Overall Study|Lost to Follow-up|791|||
130641976|NCT02759939|470307831|FG002|Overall Study|Lost to Follow-up|783|||
130641977|NCT02759939|470307832|FG003|Overall Study|Lost to Follow-up|650|||
130641978|NCT04397757|470307834|FG000|Overall Study|Death|3|||
130641979|NCT04397757|470307835|FG001|Overall Study|Death|11|||
130641980|NCT04397757|470307834|FG000|Overall Study|Withdrawal by Subject|2|||
130641981|NCT04397757|470307835|FG001|Overall Study|Withdrawal by Subject|0|||
130641982|NCT04397757|470307834|FG000|Overall Study|Lost to Follow-up|4|||
130641983|NCT04397757|470307835|FG001|Overall Study|Lost to Follow-up|3|||
130641984|NCT02185040|470307839|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
130641985|NCT02185040|470307840|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
130641986|NCT02185040|470307841|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
130641987|NCT02185040|470307842|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
130641988|NCT02185040|470307843|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
130641989|NCT02185040|470307844|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
130641990|NCT02185040|470307845|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
130641991|NCT02185040|470307839|FG000|Part 1 Treatment Phase|Adverse Event|1|||
130641992|NCT02185040|470307840|FG001|Part 1 Treatment Phase|Adverse Event|0|||
130641993|NCT02185040|470307841|FG002|Part 1 Treatment Phase|Adverse Event|0|||
130641994|NCT02185040|470307842|FG003|Part 1 Treatment Phase|Adverse Event|2|||
130641995|NCT02185040|470307843|FG004|Part 1 Treatment Phase|Adverse Event|3|||
130641996|NCT02185040|470307844|FG005|Part 1 Treatment Phase|Adverse Event|0|||
130641997|NCT02185040|470307845|FG006|Part 1 Treatment Phase|Adverse Event|0|||
130641998|NCT02185040|470307839|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130641999|NCT02185040|470307840|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
130642000|NCT02185040|470307841|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130642001|NCT02185040|470307842|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130642002|NCT02185040|470307843|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130642003|NCT02185040|470307844|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130642004|NCT02185040|470307845|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130642005|NCT02185040|470307839|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642006|NCT02185040|470307840|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
130642007|NCT02185040|470307841|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642008|NCT02185040|470307842|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642009|NCT02185040|470307843|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642010|NCT02185040|470307844|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642011|NCT02185040|470307845|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
130642012|NCT02185040|470307839|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
130642013|NCT02185040|470307840|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
130642014|NCT02185040|470307841|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
130642015|NCT02185040|470307842|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
130642016|NCT02185040|470307843|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
130642017|NCT02185040|470307844|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
130642018|NCT02185040|470307845|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
130642019|NCT02185040|470307839|FG000|Active Treatment Extension Phase|Adverse Event|0|||
130642020|NCT02185040|470307840|FG001|Active Treatment Extension Phase|Adverse Event|0|||
130642021|NCT02185040|470307841|FG002|Active Treatment Extension Phase|Adverse Event|0|||
130642022|NCT02185040|470307842|FG003|Active Treatment Extension Phase|Adverse Event|0|||
130642023|NCT02185040|470307843|FG004|Active Treatment Extension Phase|Adverse Event|0|||
130642024|NCT02185040|470307844|FG005|Active Treatment Extension Phase|Adverse Event|1|||
130642025|NCT02185040|470307845|FG006|Active Treatment Extension Phase|Adverse Event|4|||
130642026|NCT02185040|470307839|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130642027|NCT02185040|470307840|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130642028|NCT02185040|470307841|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130642029|NCT02185040|470307842|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130642030|NCT02185040|470307843|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130642031|NCT02185040|470307844|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
130642032|NCT02185040|470307845|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
130642033|NCT02185040|470307839|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642034|NCT02185040|470307840|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642035|NCT02185040|470307841|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642036|NCT02185040|470307842|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642037|NCT02185040|470307843|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642038|NCT02185040|470307844|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
130642039|NCT02185040|470307845|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
130642040|NCT03347279|470307846|FG000|Overall Study|Withdrawal by Subject|8|||
130642041|NCT03347279|470307847|FG001|Overall Study|Withdrawal by Subject|15|||
130642042|NCT03347279|470307846|FG000|Overall Study|Death|0|||
130642043|NCT03347279|470307847|FG001|Overall Study|Death|2|||
130642044|NCT03347279|470307846|FG000|Overall Study|Lost to Follow-up|5|||
130642045|NCT03347279|470307847|FG001|Overall Study|Lost to Follow-up|2|||
130642046|NCT03347279|470307846|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
130642047|NCT03347279|470307847|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
130642048|NCT03818399|470307852|FG000|Overall Study|Lost to Follow-up|11|||
130642049|NCT03818399|470307852|FG000|Overall Study|Withdrawal by Subject|1|||
130642050|NCT03818399|470307852|FG000|Overall Study|Protocol Violation|2|||
130642051|NCT00535236|470307855|FG000|Overall Study|Adverse Event|1|||
130642052|NCT00535236|470307856|FG001|Overall Study|Adverse Event|0|||
130642053|NCT00535236|470307857|FG002|Overall Study|Adverse Event|9|||
130642054|NCT00535236|470307858|FG003|Overall Study|Adverse Event|3|||
130642055|NCT00535236|470307859|FG004|Overall Study|Adverse Event|3|||
130642056|NCT00535236|470307860|FG005|Overall Study|Adverse Event|0|||
130642057|NCT00535236|470307861|FG006|Overall Study|Adverse Event|5|||
130642058|NCT00535236|470307862|FG007|Overall Study|Adverse Event|1|||
130642059|NCT00535236|470307863|FG008|Overall Study|Adverse Event|2|||
130642060|NCT00535236|470307864|FG009|Overall Study|Adverse Event|1|||
130642061|NCT00535236|470307855|FG000|Overall Study|Lost to Follow-up|1|||
130642062|NCT00535236|470307856|FG001|Overall Study|Lost to Follow-up|2|||
130642063|NCT00535236|470307857|FG002|Overall Study|Lost to Follow-up|0|||
130642064|NCT00535236|470307858|FG003|Overall Study|Lost to Follow-up|0|||
130642065|NCT00535236|470307859|FG004|Overall Study|Lost to Follow-up|2|||
130642066|NCT00535236|470307860|FG005|Overall Study|Lost to Follow-up|0|||
130642067|NCT00535236|470307861|FG006|Overall Study|Lost to Follow-up|0|||
130642068|NCT00535236|470307862|FG007|Overall Study|Lost to Follow-up|0|||
130642069|NCT00535236|470307863|FG008|Overall Study|Lost to Follow-up|6|||
130642070|NCT00535236|470307864|FG009|Overall Study|Lost to Follow-up|1|||
130642071|NCT00535236|470307855|FG000|Overall Study|Physician Decision|0|||
130642072|NCT00535236|470307856|FG001|Overall Study|Physician Decision|0|||
130642073|NCT00535236|470307857|FG002|Overall Study|Physician Decision|0|||
130642074|NCT00535236|470307858|FG003|Overall Study|Physician Decision|0|||
130642075|NCT00535236|470307859|FG004|Overall Study|Physician Decision|1|||
130642076|NCT00535236|470307860|FG005|Overall Study|Physician Decision|0|||
130642077|NCT00535236|470307861|FG006|Overall Study|Physician Decision|1|||
130642078|NCT00535236|470307862|FG007|Overall Study|Physician Decision|0|||
130642079|NCT00535236|470307863|FG008|Overall Study|Physician Decision|0|||
130642080|NCT00535236|470307864|FG009|Overall Study|Physician Decision|0|||
130642081|NCT00535236|470307855|FG000|Overall Study|Protocol Violation|2|||
130642082|NCT00535236|470307856|FG001|Overall Study|Protocol Violation|0|||
130642083|NCT00535236|470307857|FG002|Overall Study|Protocol Violation|1|||
130642084|NCT00535236|470307858|FG003|Overall Study|Protocol Violation|0|||
130642085|NCT00535236|470307859|FG004|Overall Study|Protocol Violation|0|||
130642086|NCT00535236|470307860|FG005|Overall Study|Protocol Violation|0|||
130642087|NCT00535236|470307861|FG006|Overall Study|Protocol Violation|0|||
130642088|NCT00535236|470307862|FG007|Overall Study|Protocol Violation|0|||
130642089|NCT00535236|470307863|FG008|Overall Study|Protocol Violation|1|||
130642090|NCT00535236|470307864|FG009|Overall Study|Protocol Violation|0|||
130642091|NCT00535236|470307855|FG000|Overall Study|Withdrawal by Subject|3|||
130642092|NCT00535236|470307856|FG001|Overall Study|Withdrawal by Subject|0|||
130642093|NCT00535236|470307857|FG002|Overall Study|Withdrawal by Subject|2|||
130642094|NCT00535236|470307858|FG003|Overall Study|Withdrawal by Subject|1|||
130642095|NCT00535236|470307859|FG004|Overall Study|Withdrawal by Subject|6|||
130642096|NCT00535236|470307860|FG005|Overall Study|Withdrawal by Subject|1|||
130642097|NCT00535236|470307861|FG006|Overall Study|Withdrawal by Subject|5|||
130642098|NCT00535236|470307862|FG007|Overall Study|Withdrawal by Subject|0|||
130642099|NCT00535236|470307863|FG008|Overall Study|Withdrawal by Subject|4|||
130642100|NCT00535236|470307864|FG009|Overall Study|Withdrawal by Subject|2|||
130642101|NCT03288987|470307866|FG000|Overall Study|Protocol Violation|10|||
130642102|NCT03288987|470307867|FG001|Overall Study|Protocol Violation|4|||
130642103|NCT04905563|470307870|FG000|Overall Study|Withdrawal by Subject|1|||
130642104|NCT04905563|470307871|FG001|Overall Study|Withdrawal by Subject|0|||
130642105|NCT04905563|470307870|FG000|Overall Study|Standard of care orders entered by resident|1|||
130642106|NCT04905563|470307871|FG001|Overall Study|Standard of care orders entered by resident|0|||
130642107|NCT04905563|470307870|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
130642108|NCT04905563|470307871|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
130642109|NCT04905563|470307870|FG000|Overall Study|Withdrawal by Subject|0|||
130642110|NCT04905563|470307871|FG001|Overall Study|Withdrawal by Subject|1|||
130642111|NCT01072500|470307875|FG000|Overall Study|Death|2|||
130642112|NCT01072500|470307876|FG001|Overall Study|Death|2|||
130642113|NCT01072500|470307875|FG000|Overall Study|Lost to Follow-up|5|||
130642114|NCT01072500|470307876|FG001|Overall Study|Lost to Follow-up|2|||
130642115|NCT01072500|470307875|FG000|Overall Study|Withdrawal by Subject|17|||
130642116|NCT01072500|470307876|FG001|Overall Study|Withdrawal by Subject|10|||
130642117|NCT01642004|470307886|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130642118|NCT01642004|470307887|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130642119|NCT01642004|470307886|FG000|Randomization|Participant withdrew consent|1|||
130642120|NCT01642004|470307887|FG001|Randomization|Participant withdrew consent|6|||
130642121|NCT01642004|470307886|FG000|Randomization|No longer meets study criteria|2|||
130642122|NCT01642004|470307887|FG001|Randomization|No longer meets study criteria|2|||
130642123|NCT01642004|470307886|FG000|Treatment|Disease progression|95|||
130642124|NCT01642004|470307887|FG001|Treatment|Disease progression|79|||
130642125|NCT01642004|470307886|FG000|Treatment|Study drug toxicity|10|||
130642126|NCT01642004|470307887|FG001|Treatment|Study drug toxicity|13|||
130642127|NCT01642004|470307886|FG000|Treatment|Death|1|||
130642128|NCT01642004|470307887|FG001|Treatment|Death|1|||
130642129|NCT01642004|470307886|FG000|Treatment|Adverse event unrelated to study drug|9|||
130642130|NCT01642004|470307887|FG001|Treatment|Adverse event unrelated to study drug|13|||
130642131|NCT01642004|470307886|FG000|Treatment|Maximum clinical benefit|1|||
130642132|NCT01642004|470307887|FG001|Treatment|Maximum clinical benefit|9|||
130642133|NCT01642004|470307886|FG000|Treatment|Poor/non-compliance|1|||
130642134|NCT01642004|470307887|FG001|Treatment|Poor/non-compliance|0|||
130642135|NCT01642004|470307886|FG000|Treatment|No longer meets study criteria|1|||
130642136|NCT01642004|470307887|FG001|Treatment|No longer meets study criteria|2|||
130642137|NCT01642004|470307886|FG000|Treatment|Other reasons|2|||
130642138|NCT01642004|470307887|FG001|Treatment|Other reasons|0|||
130642139|NCT01642004|470307886|FG000|Treatment|Not reported|0|||
130642140|NCT01642004|470307887|FG001|Treatment|Not reported|3|||
130642141|NCT01642004|470307886|FG000|Treatment|Participant request to discontinue study treatment|6|||
130642142|NCT01642004|470307887|FG001|Treatment|Participant request to discontinue study treatment|4|||
130642143|NCT01642004|470307886|FG000|Treatment|Participant withdrew consent|5|||
130642144|NCT01642004|470307887|FG001|Treatment|Participant withdrew consent|5|||
130642145|NCT02447952|470307890|FG000|Overall Study|Adverse Event|2|||
130642146|NCT02447952|470307890|FG000|Overall Study|Physician Decision|1|||
130642147|NCT02447952|470307890|FG000|Overall Study|Withdrawal by Subject|4|||
130642148|NCT04554394|470307891|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
130642149|NCT04554394|470307892|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
130642150|NCT04554394|470307891|FG000|Overall Study|Withdrawal by Subject|2|||
130642151|NCT04554394|470307892|FG001|Overall Study|Withdrawal by Subject|2|||
130642152|NCT04554394|470307891|FG000|Overall Study|Lost to Follow-up|2|||
130642153|NCT04554394|470307892|FG001|Overall Study|Lost to Follow-up|2|||
130642154|NCT04554394|470307891|FG000|Overall Study|Physician Decision|1|||
130642155|NCT04554394|470307892|FG001|Overall Study|Physician Decision|1|||
130642156|NCT02584660|470307896|FG000|Overall Study|Adverse Event|4|||
130642157|NCT02584660|470307897|FG001|Overall Study|Adverse Event|0|||
130642158|NCT02584660|470307896|FG000|Overall Study|Lost to Follow-up|3|||
130642159|NCT02584660|470307897|FG001|Overall Study|Lost to Follow-up|4|||
130642160|NCT02584660|470307896|FG000|Overall Study|Protocol Violation|0|||
130642161|NCT02584660|470307897|FG001|Overall Study|Protocol Violation|1|||
130642162|NCT02584660|470307896|FG000|Overall Study|Withdrawal by Subject|0|||
130642163|NCT02584660|470307897|FG001|Overall Study|Withdrawal by Subject|2|||
130642164|NCT02584660|470307896|FG000|Overall Study|Other|0|||
130642165|NCT02584660|470307897|FG001|Overall Study|Other|1|||
130642166|NCT03099304|470307900|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
130642167|NCT03099304|470307901|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
130642168|NCT03099304|470307902|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
130642169|NCT03099304|470307903|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
130642170|NCT03099304|470307904|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
130642171|NCT03099304|470307905|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
130642172|NCT03099304|470307900|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
130642173|NCT03099304|470307901|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
130642174|NCT03099304|470307902|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130642175|NCT03099304|470307903|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130642176|NCT03099304|470307904|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130642177|NCT03099304|470307905|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130642178|NCT03099304|470307900|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
130642179|NCT03099304|470307901|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
130642180|NCT03099304|470307902|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
130642181|NCT03099304|470307903|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
130642182|NCT03099304|470307904|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
130642183|NCT03099304|470307905|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
130642184|NCT03099304|470307900|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
130642185|NCT03099304|470307901|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
130642186|NCT03099304|470307902|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
130642187|NCT03099304|470307903|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
130642188|NCT03099304|470307904|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
130642189|NCT03099304|470307905|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
130642190|NCT03099304|470307900|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130642191|NCT03099304|470307901|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130642192|NCT03099304|470307902|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
130642193|NCT03099304|470307903|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
130642194|NCT03099304|470307904|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130642195|NCT03099304|470307905|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130642196|NCT03099304|470307900|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130642197|NCT03099304|470307901|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130642198|NCT03099304|470307902|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
130642199|NCT03099304|470307903|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130642200|NCT03099304|470307904|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130642201|NCT03099304|470307905|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130642202|NCT03099304|470307900|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130642203|NCT03099304|470307901|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130642204|NCT03099304|470307902|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130642205|NCT03099304|470307903|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130642206|NCT03099304|470307904|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130642207|NCT03099304|470307905|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130642208|NCT03099304|470307900|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
130642209|NCT03099304|470307901|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
130642210|NCT03099304|470307902|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
130642211|NCT03099304|470307903|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
130642212|NCT03099304|470307904|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
130642213|NCT03099304|470307905|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
130642214|NCT03099304|470307900|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130642215|NCT03099304|470307901|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130642216|NCT03099304|470307902|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130642217|NCT03099304|470307903|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
130642218|NCT03099304|470307904|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
130642219|NCT03099304|470307905|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130642220|NCT03099304|470307900|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
130642221|NCT03099304|470307901|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
130642222|NCT03099304|470307902|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
130642223|NCT03099304|470307903|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
130642224|NCT03099304|470307904|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
130642225|NCT03099304|470307905|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
130642226|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
130642227|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
130642228|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
130642229|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
130642230|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
130642231|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
130642232|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
130642233|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
130642234|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
130642235|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
130642236|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
130642237|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
130642238|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
130642239|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
130642240|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
130642241|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
130642242|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
130642243|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
130642244|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
130642245|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
130642246|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
130642247|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
130642248|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
130642249|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
130642250|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
130642251|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
130642252|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
130642253|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
130642254|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
130642255|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
130642256|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
130642257|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
130642258|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
130642259|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
130642260|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
130642261|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
130642262|NCT03099304|470307900|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
130642263|NCT03099304|470307901|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
130642264|NCT03099304|470307902|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
130642265|NCT03099304|470307903|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
130642266|NCT03099304|470307904|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
130642267|NCT03099304|470307905|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
130642268|NCT00715949|470307909|FG000|Overall Study|could not finish first test|4|||
130642269|NCT01142791|470307921|FG000|Overall Study|Alternative Treatment|1|||
130642270|NCT01142791|470307922|FG001|Overall Study|Alternative Treatment|0|||
130642271|NCT01142791|470307921|FG000|Overall Study|Lost to Follow-up|1|||
130642272|NCT01142791|470307922|FG001|Overall Study|Lost to Follow-up|0|||
130642273|NCT01142791|470307921|FG000|Overall Study|Withdrawal by Subject|5|||
130642274|NCT01142791|470307922|FG001|Overall Study|Withdrawal by Subject|0|||
130642275|NCT01142791|470307921|FG000|Overall Study|Received only 1 sonication|0|||
130642276|NCT01142791|470307922|FG001|Overall Study|Received only 1 sonication|6|||
130642277|NCT02608892|470307923|FG000|Overall Study|Lost to Follow-up|1|||
130642278|NCT02608892|470307924|FG001|Overall Study|Lost to Follow-up|0|||
130642279|NCT02590406|470307925|FG000|Overall Study|Adverse Event|1|||
130642280|NCT02590406|470307926|FG001|Overall Study|Adverse Event|0|||
130642281|NCT02590406|470307925|FG000|Overall Study|Saturometer malfunction|0|||
130642282|NCT02590406|470307926|FG001|Overall Study|Saturometer malfunction|1|||
130642283|NCT00957723|470307927|FG000|Overall Study|Death|3|||
130642284|NCT00957723|470307927|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
130642285|NCT00957723|470307927|FG000|Overall Study|Lost to Follow-up|8|||
130642286|NCT00957723|470307927|FG000|Overall Study|Withdrawal by Subject|24|||
130642287|NCT00957723|470307927|FG000|Overall Study|Investigative Site Terminated|61|||
130642288|NCT00957723|470307927|FG000|Overall Study|Intercurrent Illness|2|||
130642289|NCT00957723|470307927|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
130642290|NCT05375838|470307928|FG000|Overall Study|Other|0|||
130642291|NCT05375838|470307929|FG001|Overall Study|Other|0|||
130642292|NCT05375838|470307930|FG002|Overall Study|Other|0|||
130642293|NCT05375838|470307931|FG003|Overall Study|Other|1|||
130642294|NCT05375838|470307932|FG004|Overall Study|Other|1|||
130642295|NCT05375838|470307933|FG005|Overall Study|Other|0|||
130642296|NCT05375838|470307928|FG000|Overall Study|Withdrawal by Subject|2|||
130642297|NCT05375838|470307929|FG001|Overall Study|Withdrawal by Subject|1|||
130642298|NCT05375838|470307930|FG002|Overall Study|Withdrawal by Subject|3|||
130642299|NCT05375838|470307931|FG003|Overall Study|Withdrawal by Subject|2|||
130642300|NCT05375838|470307932|FG004|Overall Study|Withdrawal by Subject|2|||
130642301|NCT05375838|470307933|FG005|Overall Study|Withdrawal by Subject|0|||
130642302|NCT05375838|470307928|FG000|Overall Study|Protocol Violation|0|||
130642303|NCT05375838|470307929|FG001|Overall Study|Protocol Violation|0|||
130642304|NCT05375838|470307930|FG002|Overall Study|Protocol Violation|0|||
130642305|NCT05375838|470307931|FG003|Overall Study|Protocol Violation|0|||
130642306|NCT05375838|470307932|FG004|Overall Study|Protocol Violation|1|||
130642307|NCT05375838|470307933|FG005|Overall Study|Protocol Violation|0|||
130642308|NCT05375838|470307928|FG000|Overall Study|Physician Decision|0|||
130642309|NCT05375838|470307929|FG001|Overall Study|Physician Decision|1|||
130642310|NCT05375838|470307930|FG002|Overall Study|Physician Decision|0|||
130642311|NCT05375838|470307931|FG003|Overall Study|Physician Decision|0|||
130642312|NCT05375838|470307932|FG004|Overall Study|Physician Decision|0|||
130642313|NCT05375838|470307933|FG005|Overall Study|Physician Decision|1|||
130642314|NCT05375838|470307928|FG000|Overall Study|Lost to Follow-up|2|||
130642315|NCT05375838|470307929|FG001|Overall Study|Lost to Follow-up|7|||
130642316|NCT05375838|470307930|FG002|Overall Study|Lost to Follow-up|0|||
130642317|NCT05375838|470307931|FG003|Overall Study|Lost to Follow-up|4|||
130642318|NCT05375838|470307932|FG004|Overall Study|Lost to Follow-up|2|||
130642319|NCT05375838|470307933|FG005|Overall Study|Lost to Follow-up|3|||
130642320|NCT01984294|470307936|FG000|Overall Study|Randomized but Never Treated|0|||
130642321|NCT01984294|470307937|FG001|Overall Study|Randomized but Never Treated|0|||
130642322|NCT01984294|470307938|FG002|Overall Study|Randomized but Never Treated|1|||
130642323|NCT01984294|470307936|FG000|Overall Study|Lack of Efficacy|4|||
130642324|NCT01984294|470307937|FG001|Overall Study|Lack of Efficacy|2|||
130642325|NCT01984294|470307938|FG002|Overall Study|Lack of Efficacy|6|||
130642326|NCT01984294|470307936|FG000|Overall Study|Adverse Event|0|||
130642327|NCT01984294|470307937|FG001|Overall Study|Adverse Event|1|||
130642328|NCT01984294|470307938|FG002|Overall Study|Adverse Event|0|||
130642329|NCT01987609|470307939|FG000|Overall Study|Adverse Event|1|||
130642330|NCT00925522|470307944|FG000|Overall Study|study closed -- business decision|20|||
130642331|NCT02561572|470307945|FG000|Overall Study|Inadequate time before surgery|2|||
130642332|NCT02561572|470307946|FG001|Overall Study|Inadequate time before surgery|1|||
130642333|NCT02561572|470307945|FG000|Overall Study|Protocol Violation|0|||
130642334|NCT02561572|470307946|FG001|Overall Study|Protocol Violation|1|||
130642335|NCT00795717|470307947|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
130642336|NCT00795717|470307948|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
130642337|NCT00795717|470307947|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
130642338|NCT00795717|470307948|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
130642339|NCT00795717|470307947|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
130642340|NCT00795717|470307948|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
130642341|NCT00795717|470307947|FG000|Phase II|too busy|0|||
130642342|NCT00795717|470307948|FG001|Phase II|too busy|1|||
130642343|NCT00656799|470307951|FG000|Overall Study|Death|2|||
130642344|NCT05281094|470307952|FG000|Overall Study|Adverse Event|1|||
130642345|NCT05281094|470307953|FG001|Overall Study|Adverse Event|0|||
130642346|NCT05281094|470307952|FG000|Overall Study|Lost to Follow-up|29|||
130642347|NCT05281094|470307953|FG001|Overall Study|Lost to Follow-up|22|||
130642348|NCT05281094|470307952|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
130642349|NCT05281094|470307953|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
130642350|NCT05281094|470307952|FG000|Overall Study|Death|1|||
130642351|NCT05281094|470307953|FG001|Overall Study|Death|2|||
130642352|NCT05281094|470307952|FG000|Overall Study|Not pre-specified reason|8|||
130642353|NCT05281094|470307953|FG001|Overall Study|Not pre-specified reason|5|||
130642354|NCT00631969|470307958|FG000|Overall Study|Adverse Event|3|||
130642355|NCT00631969|470307959|FG001|Overall Study|Adverse Event|1|||
130642356|NCT00631969|470307958|FG000|Overall Study|Lack of Efficacy|2|||
130642357|NCT00631969|470307959|FG001|Overall Study|Lack of Efficacy|8|||
130642358|NCT00631969|470307958|FG000|Overall Study|Lost to Follow-up|2|||
130642359|NCT00631969|470307959|FG001|Overall Study|Lost to Follow-up|1|||
130642360|NCT00631969|470307958|FG000|Overall Study|Protocol Violation|1|||
130642361|NCT00631969|470307959|FG001|Overall Study|Protocol Violation|1|||
130642362|NCT00631969|470307958|FG000|Overall Study|Consent Withdrawn|5|||
130642363|NCT00631969|470307959|FG001|Overall Study|Consent Withdrawn|7|||
130642364|NCT00631969|470307958|FG000|Overall Study|Noncompliant With Study Medication|0|||
130642365|NCT00631969|470307959|FG001|Overall Study|Noncompliant With Study Medication|1|||
130642366|NCT00631969|470307958|FG000|Overall Study|No Drug Exposure|2|||
130642367|NCT00631969|470307959|FG001|Overall Study|No Drug Exposure|2|||
130642368|NCT05315297|470307960|FG000|Overall Study|Lost to Follow-up|6|||
130642369|NCT05315297|470307961|FG001|Overall Study|Lost to Follow-up|4|||
130642370|NCT05315297|470307960|FG000|Overall Study|Withdrawal by Subject|0|||
130642371|NCT05315297|470307961|FG001|Overall Study|Withdrawal by Subject|1|||
130642372|NCT04144140|470310180|FG000|Overall Study|Other|0|||
130642373|NCT04144140|470310181|FG001|Overall Study|Other|0|||
130642374|NCT04144140|470310182|FG002|Overall Study|Other|0|||
130642375|NCT04144140|470310183|FG003|Overall Study|Other|0|||
130642376|NCT04144140|470310184|FG004|Overall Study|Other|0|||
130642377|NCT04144140|470310185|FG005|Overall Study|Other|1|||
130642378|NCT04144140|470310186|FG006|Overall Study|Other|0|||
130642379|NCT01465958|470310187|FG000|Run-in Phase|Protocol Violation|1|||
130642380|NCT01465958|470310188|FG001|Run-in Phase|Protocol Violation|0|||
130642381|NCT01465958|470310187|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
130642382|NCT01465958|470310188|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
130642383|NCT00669240|470310197|FG000|Overall Study|Lack of Efficacy|33|||
130642384|NCT00669240|470310197|FG000|Overall Study|Withdrawal by Subject|42|||
130642385|NCT00669240|470310197|FG000|Overall Study|Lost to Follow-up|34|||
130642386|NCT00669240|470310197|FG000|Overall Study|Adverse Event|21|||
130642387|NCT00669240|470310197|FG000|Overall Study|Other|19|||
130642388|NCT00669240|470310197|FG000|Overall Study|Enrolled but not treated|15|||
130642389|NCT00669240|470310197|FG000|Overall Study|Enrolled but no dosing record|1|||
130642390|NCT00959192|470310202|FG000|Overall Study|Adverse Event|1|||
130642391|NCT00959192|470310203|FG001|Overall Study|Adverse Event|1|||
130642392|NCT00959192|470310204|FG002|Overall Study|Adverse Event|1|||
130642393|NCT00959192|470310205|FG003|Overall Study|Adverse Event|0|||
130642394|NCT00959192|470310202|FG000|Overall Study|Investigator Request|1|||
130642395|NCT00959192|470310203|FG001|Overall Study|Investigator Request|0|||
130642396|NCT00959192|470310204|FG002|Overall Study|Investigator Request|0|||
130642397|NCT00959192|470310205|FG003|Overall Study|Investigator Request|0|||
130642398|NCT00959192|470310202|FG000|Overall Study|Caregiver Request|0|||
130642399|NCT00959192|470310203|FG001|Overall Study|Caregiver Request|0|||
130642400|NCT00959192|470310204|FG002|Overall Study|Caregiver Request|2|||
130642401|NCT00959192|470310205|FG003|Overall Study|Caregiver Request|1|||
130642402|NCT00532441|470310206|FG000|Overall Study|Death|1|||
130642403|NCT00532441|470310207|FG001|Overall Study|Death|0|||
130642404|NCT01967134|470310208|FG000|Overall Study|Lost to Follow-up|0|||
130642405|NCT01967134|470310209|FG001|Overall Study|Lost to Follow-up|1|||
130642406|NCT01967134|470310210|FG002|Overall Study|Lost to Follow-up|0|||
130642407|NCT00443534|470310211|FG000|Overall Study|Lack of Efficacy|67|||
130642408|NCT00443534|470310211|FG000|Overall Study|Adverse Event|16|||
130642409|NCT00443534|470310211|FG000|Overall Study|Death|9|||
130642410|NCT00443534|470310211|FG000|Overall Study|Withdrawal by Subject|8|||
130642411|NCT00443534|470310211|FG000|Overall Study|Study Terminated by Sponsor|12|||
130642412|NCT00443534|470310211|FG000|Overall Study|Other|10|||
130642413|NCT00443534|470310211|FG000|Overall Study|Enrolled, Not Treated|1|||
130642414|NCT04097925|470310213|FG000|Overall Study|Withdrawal by Subject|1|||
130642415|NCT04735432|470310217|FG000|Overall Study|Other - due to personal reason|1|||
130642416|NCT04735432|470310218|FG001|Overall Study|Other - due to personal reason|0|||
130642417|NCT04735432|470310217|FG000|Overall Study|Adverse Event|2|||
130642418|NCT04735432|470310218|FG001|Overall Study|Adverse Event|0|||
130642419|NCT00626327|470310219|FG000|Overall Study|Withdrawal by Subject|21|||
130642420|NCT00626327|470310220|FG001|Overall Study|Withdrawal by Subject|29|||
130642421|NCT00626327|470310221|FG002|Overall Study|Withdrawal by Subject|30|||
130642422|NCT00626327|470310219|FG000|Overall Study|Adverse Event|1|||
130642423|NCT00626327|470310220|FG001|Overall Study|Adverse Event|0|||
130642424|NCT00626327|470310221|FG002|Overall Study|Adverse Event|0|||
130642425|NCT00626327|470310219|FG000|Overall Study|Lost to Follow-up|24|||
130642426|NCT00626327|470310220|FG001|Overall Study|Lost to Follow-up|21|||
130642427|NCT00626327|470310221|FG002|Overall Study|Lost to Follow-up|23|||
130642428|NCT00626327|470310219|FG000|Overall Study|Inappropriate enrollment|4|||
130642429|NCT00626327|470310220|FG001|Overall Study|Inappropriate enrollment|5|||
130642430|NCT00626327|470310221|FG002|Overall Study|Inappropriate enrollment|3|||
130642431|NCT00626327|470310219|FG000|Overall Study|Administrative Reason|2|||
130642432|NCT00626327|470310220|FG001|Overall Study|Administrative Reason|0|||
130642433|NCT00626327|470310221|FG002|Overall Study|Administrative Reason|6|||
130642434|NCT00626327|470310219|FG000|Overall Study|Protocol Violation|26|||
130642435|NCT00626327|470310220|FG001|Overall Study|Protocol Violation|4|||
130642436|NCT00626327|470310221|FG002|Overall Study|Protocol Violation|26|||
130642437|NCT01823991|470310222|FG000|Overall Study|Withdrawal by Subject|8|||
130642438|NCT01823991|470310223|FG001|Overall Study|Withdrawal by Subject|5|||
130642439|NCT05158244|470310224|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
130642440|NCT05158244|470310225|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130642441|NCT05158244|470310226|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130642442|NCT05158244|470310227|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130642443|NCT05158244|470310228|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130642444|NCT05158244|470310224|FG000|Overall Study|Withdrawal by Subject|0|||
130642445|NCT05158244|470310225|FG001|Overall Study|Withdrawal by Subject|0|||
130642446|NCT05158244|470310226|FG002|Overall Study|Withdrawal by Subject|1|||
130642447|NCT05158244|470310227|FG003|Overall Study|Withdrawal by Subject|0|||
130642448|NCT05158244|470310228|FG004|Overall Study|Withdrawal by Subject|0|||
130642449|NCT01066819|470310229|FG000|Overall Study|Adverse Event|18|||
130642450|NCT01066819|470310230|FG001|Overall Study|Adverse Event|1|||
130642451|NCT01066819|470310231|FG002|Overall Study|Adverse Event|6|||
130642452|NCT01066819|470310232|FG003|Overall Study|Adverse Event|0|||
130642453|NCT01066819|470310233|FG004|Overall Study|Adverse Event|0|||
130642454|NCT01066819|470310234|FG005|Overall Study|Adverse Event|0|||
130642455|NCT01066819|470310229|FG000|Overall Study|Death|5|||
130642456|NCT01066819|470310230|FG001|Overall Study|Death|0|||
130642457|NCT01066819|470310231|FG002|Overall Study|Death|1|||
130642458|NCT01066819|470310232|FG003|Overall Study|Death|0|||
130642459|NCT01066819|470310233|FG004|Overall Study|Death|0|||
130642460|NCT01066819|470310234|FG005|Overall Study|Death|0|||
130642461|NCT01066819|470310229|FG000|Overall Study|Lack of Efficacy|22|||
130642462|NCT01066819|470310230|FG001|Overall Study|Lack of Efficacy|1|||
130642463|NCT01066819|470310231|FG002|Overall Study|Lack of Efficacy|2|||
130642464|NCT01066819|470310232|FG003|Overall Study|Lack of Efficacy|1|||
130642465|NCT01066819|470310233|FG004|Overall Study|Lack of Efficacy|0|||
130642466|NCT01066819|470310234|FG005|Overall Study|Lack of Efficacy|0|||
130642467|NCT01066819|470310229|FG000|Overall Study|Physician Decision|6|||
130642468|NCT01066819|470310230|FG001|Overall Study|Physician Decision|2|||
130642469|NCT01066819|470310231|FG002|Overall Study|Physician Decision|3|||
130642470|NCT01066819|470310232|FG003|Overall Study|Physician Decision|0|||
130642471|NCT01066819|470310233|FG004|Overall Study|Physician Decision|0|||
130642472|NCT01066819|470310234|FG005|Overall Study|Physician Decision|0|||
130642473|NCT01066819|470310229|FG000|Overall Study|Protocol Violation|12|||
130642474|NCT01066819|470310230|FG001|Overall Study|Protocol Violation|6|||
130642475|NCT01066819|470310231|FG002|Overall Study|Protocol Violation|0|||
130642476|NCT01066819|470310232|FG003|Overall Study|Protocol Violation|0|||
130642477|NCT01066819|470310233|FG004|Overall Study|Protocol Violation|0|||
130642478|NCT01066819|470310234|FG005|Overall Study|Protocol Violation|0|||
130642479|NCT01066819|470310229|FG000|Overall Study|Withdrawal by Subject|29|||
130642480|NCT01066819|470310230|FG001|Overall Study|Withdrawal by Subject|11|||
130642481|NCT01066819|470310231|FG002|Overall Study|Withdrawal by Subject|6|||
130642482|NCT01066819|470310232|FG003|Overall Study|Withdrawal by Subject|0|||
130642483|NCT01066819|470310233|FG004|Overall Study|Withdrawal by Subject|0|||
130642484|NCT01066819|470310234|FG005|Overall Study|Withdrawal by Subject|0|||
130642485|NCT01066819|470310229|FG000|Overall Study|Administrative|6|||
130642486|NCT01066819|470310230|FG001|Overall Study|Administrative|4|||
130642487|NCT01066819|470310231|FG002|Overall Study|Administrative|2|||
130642488|NCT01066819|470310232|FG003|Overall Study|Administrative|0|||
130642489|NCT01066819|470310233|FG004|Overall Study|Administrative|0|||
130642490|NCT01066819|470310234|FG005|Overall Study|Administrative|0|||
130642491|NCT01066819|470310229|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
130642492|NCT01066819|470310230|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
130642493|NCT01066819|470310231|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
130642494|NCT01066819|470310232|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
130642495|NCT01066819|470310233|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
130642496|NCT01066819|470310234|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
130642497|NCT01066819|470310229|FG000|Overall Study|Early termination|2|||
130642498|NCT01066819|470310230|FG001|Overall Study|Early termination|0|||
130642499|NCT01066819|470310231|FG002|Overall Study|Early termination|0|||
130642500|NCT01066819|470310232|FG003|Overall Study|Early termination|0|||
130642501|NCT01066819|470310233|FG004|Overall Study|Early termination|0|||
130642502|NCT01066819|470310234|FG005|Overall Study|Early termination|0|||
130642503|NCT01066819|470310229|FG000|Overall Study|Failed to return|298|||
130642504|NCT01066819|470310230|FG001|Overall Study|Failed to return|107|||
130642505|NCT01066819|470310231|FG002|Overall Study|Failed to return|68|||
130642506|NCT01066819|470310232|FG003|Overall Study|Failed to return|7|||
130642507|NCT01066819|470310233|FG004|Overall Study|Failed to return|2|||
130642508|NCT01066819|470310234|FG005|Overall Study|Failed to return|3|||
130642509|NCT01066819|470310229|FG000|Overall Study|Lab test not done|9|||
130642510|NCT01066819|470310230|FG001|Overall Study|Lab test not done|0|||
130642511|NCT01066819|470310231|FG002|Overall Study|Lab test not done|2|||
130642512|NCT01066819|470310232|FG003|Overall Study|Lab test not done|1|||
130642513|NCT01066819|470310233|FG004|Overall Study|Lab test not done|0|||
130642514|NCT01066819|470310234|FG005|Overall Study|Lab test not done|0|||
130642515|NCT01066819|470310229|FG000|Overall Study|Miscellaneous|28|||
130642516|NCT01066819|470310230|FG001|Overall Study|Miscellaneous|10|||
130642517|NCT01066819|470310231|FG002|Overall Study|Miscellaneous|18|||
130642518|NCT01066819|470310232|FG003|Overall Study|Miscellaneous|1|||
130642519|NCT01066819|470310233|FG004|Overall Study|Miscellaneous|0|||
130642520|NCT01066819|470310234|FG005|Overall Study|Miscellaneous|0|||
130642521|NCT01066819|470310229|FG000|Overall Study|Non responders|123|||
130642522|NCT01066819|470310230|FG001|Overall Study|Non responders|2|||
130642523|NCT01066819|470310231|FG002|Overall Study|Non responders|7|||
130642524|NCT01066819|470310232|FG003|Overall Study|Non responders|2|||
130642525|NCT01066819|470310233|FG004|Overall Study|Non responders|0|||
130642526|NCT01066819|470310234|FG005|Overall Study|Non responders|1|||
130642527|NCT01066819|470310229|FG000|Overall Study|Not categorised|9|||
130642528|NCT01066819|470310230|FG001|Overall Study|Not categorised|2|||
130642529|NCT01066819|470310231|FG002|Overall Study|Not categorised|6|||
130642530|NCT01066819|470310232|FG003|Overall Study|Not categorised|1|||
130642531|NCT01066819|470310233|FG004|Overall Study|Not categorised|0|||
130642532|NCT01066819|470310234|FG005|Overall Study|Not categorised|0|||
130642533|NCT01066819|470310229|FG000|Overall Study|Relapse|16|||
130642534|NCT01066819|470310230|FG001|Overall Study|Relapse|4|||
130642535|NCT01066819|470310231|FG002|Overall Study|Relapse|3|||
130642536|NCT01066819|470310232|FG003|Overall Study|Relapse|0|||
130642537|NCT01066819|470310233|FG004|Overall Study|Relapse|0|||
130642538|NCT01066819|470310234|FG005|Overall Study|Relapse|0|||
130642539|NCT01066819|470310229|FG000|Overall Study|Results not available|1|||
130642540|NCT01066819|470310230|FG001|Overall Study|Results not available|0|||
130642541|NCT01066819|470310231|FG002|Overall Study|Results not available|0|||
130642542|NCT01066819|470310232|FG003|Overall Study|Results not available|0|||
130642543|NCT01066819|470310233|FG004|Overall Study|Results not available|0|||
130642544|NCT01066819|470310234|FG005|Overall Study|Results not available|0|||
130642545|NCT01066819|470310229|FG000|Overall Study|Screen failure|1|||
130642546|NCT01066819|470310230|FG001|Overall Study|Screen failure|0|||
130642547|NCT01066819|470310231|FG002|Overall Study|Screen failure|0|||
130642548|NCT01066819|470310232|FG003|Overall Study|Screen failure|0|||
130642549|NCT01066819|470310233|FG004|Overall Study|Screen failure|0|||
130642550|NCT01066819|470310234|FG005|Overall Study|Screen failure|0|||
130642551|NCT01066819|470310229|FG000|Overall Study|Spontaneous cure|1|||
130642552|NCT01066819|470310230|FG001|Overall Study|Spontaneous cure|0|||
130642553|NCT01066819|470310231|FG002|Overall Study|Spontaneous cure|0|||
130642554|NCT01066819|470310232|FG003|Overall Study|Spontaneous cure|0|||
130642555|NCT01066819|470310233|FG004|Overall Study|Spontaneous cure|0|||
130642556|NCT01066819|470310234|FG005|Overall Study|Spontaneous cure|0|||
130642557|NCT01066819|470310229|FG000|Overall Study|Treatment never started|85|||
130642558|NCT01066819|470310230|FG001|Overall Study|Treatment never started|19|||
130642559|NCT01066819|470310231|FG002|Overall Study|Treatment never started|19|||
130642560|NCT01066819|470310232|FG003|Overall Study|Treatment never started|3|||
130642561|NCT01066819|470310233|FG004|Overall Study|Treatment never started|2|||
130642562|NCT01066819|470310234|FG005|Overall Study|Treatment never started|2|||
130642563|NCT01066819|470310229|FG000|Overall Study|Treatment stopped|12|||
130642564|NCT01066819|470310230|FG001|Overall Study|Treatment stopped|1|||
130642565|NCT01066819|470310231|FG002|Overall Study|Treatment stopped|2|||
130642566|NCT01066819|470310232|FG003|Overall Study|Treatment stopped|1|||
130642567|NCT01066819|470310233|FG004|Overall Study|Treatment stopped|0|||
130642568|NCT01066819|470310234|FG005|Overall Study|Treatment stopped|0|||
130642569|NCT01066819|470310229|FG000|Overall Study|Other|5|||
130642570|NCT01066819|470310230|FG001|Overall Study|Other|1|||
130642571|NCT01066819|470310231|FG002|Overall Study|Other|1|||
130642572|NCT01066819|470310232|FG003|Overall Study|Other|0|||
130642573|NCT01066819|470310233|FG004|Overall Study|Other|0|||
130642574|NCT01066819|470310234|FG005|Overall Study|Other|0|||
130642575|NCT04005885|470310245|FG000|First Intervention|Withdrawal by Subject|1|||
130642576|NCT04005885|470310246|FG001|First Intervention|Withdrawal by Subject|1|||
130642577|NCT04005885|470310245|FG000|Second Intervention|Withdrawal by Subject|0|||
130642578|NCT04005885|470310246|FG001|Second Intervention|Withdrawal by Subject|2|||
130642579|NCT02718625|470310248|FG000|Overall Study|Adverse Event|0|||
130642580|NCT02718625|470310249|FG001|Overall Study|Adverse Event|1|||
130642581|NCT02718625|470310248|FG000|Overall Study|Termination of Study by Sponsor|0|||
130642582|NCT02718625|470310249|FG001|Overall Study|Termination of Study by Sponsor|1|||
130642583|NCT01947127|470310254|FG000|Overall Study|Protocol Violation|18|||
130642584|NCT01947127|470310255|FG001|Overall Study|Protocol Violation|38|||
130642585|NCT01947127|470310254|FG000|Overall Study|Withdrawal by Subject|1|||
130642586|NCT01947127|470310255|FG001|Overall Study|Withdrawal by Subject|1|||
130642587|NCT01947127|470310254|FG000|Overall Study|Data loss|4|||
130642588|NCT01947127|470310255|FG001|Overall Study|Data loss|4|||
130642589|NCT01836549|470310256|FG000|Overall Study|Did not receive study drug|0|||
130642590|NCT01836549|470310257|FG001|Overall Study|Did not receive study drug|0|||
130642591|NCT01836549|470310258|FG002|Overall Study|Did not receive study drug|1|||
130642592|NCT01836549|470310259|FG003|Overall Study|Did not receive study drug|0|||
130642593|NCT01836549|470310260|FG004|Overall Study|Did not receive study drug|0|||
130642594|NCT01836549|470310261|FG005|Overall Study|Did not receive study drug|0|||
130642595|NCT01836549|470310262|FG006|Overall Study|Did not receive study drug|0|||
130642596|NCT01836549|470310256|FG000|Overall Study|Patient declared ineligible|0|||
130642597|NCT01836549|470310257|FG001|Overall Study|Patient declared ineligible|0|||
130642598|NCT01836549|470310258|FG002|Overall Study|Patient declared ineligible|0|||
130642599|NCT01836549|470310259|FG003|Overall Study|Patient declared ineligible|1|||
130642600|NCT01836549|470310260|FG004|Overall Study|Patient declared ineligible|0|||
130642601|NCT01836549|470310261|FG005|Overall Study|Patient declared ineligible|0|||
130642602|NCT01836549|470310262|FG006|Overall Study|Patient declared ineligible|0|||
130642603|NCT01836549|470310256|FG000|Overall Study|Patient inevaluable to start therapy|0|||
130642604|NCT01836549|470310257|FG001|Overall Study|Patient inevaluable to start therapy|0|||
130642605|NCT01836549|470310258|FG002|Overall Study|Patient inevaluable to start therapy|0|||
130642606|NCT01836549|470310259|FG003|Overall Study|Patient inevaluable to start therapy|0|||
130642607|NCT01836549|470310260|FG004|Overall Study|Patient inevaluable to start therapy|0|||
130642608|NCT01836549|470310261|FG005|Overall Study|Patient inevaluable to start therapy|0|||
130642609|NCT01836549|470310262|FG006|Overall Study|Patient inevaluable to start therapy|1|||
130642610|NCT04652102|470310263|FG000|Overall Study|Adverse Event|14|||
130642611|NCT04652102|470310264|FG001|Overall Study|Adverse Event|13|||
130642612|NCT04652102|470310263|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
130642613|NCT04652102|470310264|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
130642614|NCT04652102|470310263|FG000|Overall Study|Physician Decision|78|||
130642615|NCT04652102|470310264|FG001|Overall Study|Physician Decision|40|||
130642616|NCT04652102|470310263|FG000|Overall Study|Study Ended by Sponsor|64|||
130642617|NCT04652102|470310264|FG001|Overall Study|Study Ended by Sponsor|17|||
130642618|NCT04652102|470310263|FG000|Overall Study|Withdrawal by Subject|4625|||
130642619|NCT04652102|470310264|FG001|Overall Study|Withdrawal by Subject|5594|||
130642620|NCT04652102|470310263|FG000|Overall Study|Lost to Follow-up|2019|||
130642621|NCT04652102|470310264|FG001|Overall Study|Lost to Follow-up|1082|||
130642622|NCT04652102|470310263|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
130642623|NCT04652102|470310264|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
130642624|NCT04652102|470310263|FG000|Overall Study|Miscellaneous|80|||
130642625|NCT04652102|470310264|FG001|Overall Study|Miscellaneous|64|||
130642626|NCT01969565|470310267|FG000|Overall Study|Withdrawal by Subject|1|||
130642627|NCT00696774|470310268|FG000|Period II|Adverse Event|0|||
130642628|NCT00696774|470310269|FG001|Period II|Adverse Event|0|||
130642629|NCT00696774|470310270|FG002|Period II|Adverse Event|15|||
130642630|NCT00696774|470310268|FG000|Period II|Lost to Follow-up|0|||
130642631|NCT00696774|470310269|FG001|Period II|Lost to Follow-up|0|||
130642632|NCT00696774|470310270|FG002|Period II|Lost to Follow-up|4|||
130642633|NCT00696774|470310268|FG000|Period II|Protocol Violation|0|||
130642634|NCT00696774|470310269|FG001|Period II|Protocol Violation|0|||
130642635|NCT00696774|470310270|FG002|Period II|Protocol Violation|11|||
130642636|NCT00696774|470310268|FG000|Period II|Withdrawal by Subject|0|||
130642637|NCT00696774|470310269|FG001|Period II|Withdrawal by Subject|0|||
130642638|NCT00696774|470310270|FG002|Period II|Withdrawal by Subject|4|||
130642639|NCT00696774|470310268|FG000|Period II|Sponsor Decision|0|||
130642640|NCT00696774|470310269|FG001|Period II|Sponsor Decision|0|||
130642641|NCT00696774|470310270|FG002|Period II|Sponsor Decision|0|||
130642642|NCT00696774|470310268|FG000|Period II|Lack of Efficacy|0|||
130642643|NCT00696774|470310269|FG001|Period II|Lack of Efficacy|0|||
130642644|NCT00696774|470310270|FG002|Period II|Lack of Efficacy|2|||
130642645|NCT00696774|470310268|FG000|Period III|Adverse Event|1|||
130642646|NCT00696774|470310269|FG001|Period III|Adverse Event|1|||
130642647|NCT00696774|470310270|FG002|Period III|Adverse Event|0|||
130642648|NCT00696774|470310268|FG000|Period III|Lost to Follow-up|2|||
130642649|NCT00696774|470310269|FG001|Period III|Lost to Follow-up|1|||
130642650|NCT00696774|470310270|FG002|Period III|Lost to Follow-up|0|||
130642651|NCT00696774|470310268|FG000|Period III|Protocol Violation|1|||
130642652|NCT00696774|470310269|FG001|Period III|Protocol Violation|1|||
130642653|NCT00696774|470310270|FG002|Period III|Protocol Violation|0|||
130642654|NCT00696774|470310268|FG000|Period III|Withdrawal by Subject|1|||
130642655|NCT00696774|470310269|FG001|Period III|Withdrawal by Subject|2|||
130642656|NCT00696774|470310270|FG002|Period III|Withdrawal by Subject|0|||
130642657|NCT00696774|470310268|FG000|Period III|Sponsor Decision|2|||
130642658|NCT00696774|470310269|FG001|Period III|Sponsor Decision|0|||
130642659|NCT00696774|470310270|FG002|Period III|Sponsor Decision|0|||
130642660|NCT00696774|470310268|FG000|Period III|Lack of Efficacy|0|||
130642661|NCT00696774|470310269|FG001|Period III|Lack of Efficacy|2|||
130642662|NCT00696774|470310270|FG002|Period III|Lack of Efficacy|0|||
130642663|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130642664|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130642665|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130642666|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
130642667|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
130642668|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
130642669|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
130642670|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
130642671|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Death|0|||
130642672|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Death|0|||
130642673|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Death|0|||
130642674|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Death|1|||
130642675|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Death|1|||
130642676|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Death|0|||
130642677|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Death|2|||
130642678|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Death|0|||
130642679|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642680|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642681|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642682|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
130642683|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642684|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642685|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642686|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130642687|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642688|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642689|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642690|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
130642691|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642692|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642693|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642694|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130642695|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130648460|NCT00151775|470333062|FG010|Period 4: Open Label|Lost to Follow-up|0|||
130642696|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130642697|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130642698|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
130642699|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130642700|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
130642701|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130642702|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
130642703|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130642704|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130642705|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130642706|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
130642707|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130642708|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
130642709|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
130642710|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130642711|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130642712|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130642713|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130642714|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130642715|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
130642716|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130642717|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
130642718|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
130642719|NCT02442765|470310271|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642720|NCT02442765|470310272|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642721|NCT02442765|470310273|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642722|NCT02442765|470310274|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642723|NCT02442765|470310275|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
130642724|NCT02442765|470310276|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642725|NCT02442765|470310277|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130642726|NCT02442765|470310278|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
130642727|NCT01200758|470310281|FG000|Stage I|Death|0|||
130642728|NCT01200758|470310282|FG001|Stage I|Death|1|||
130642729|NCT01200758|470310283|FG002|Stage I|Death|0|||
130642730|NCT01200758|470310284|FG003|Stage I|Death|0|||
130642731|NCT01200758|470310281|FG000|Stage I|Physician Decision|1|||
130642732|NCT01200758|470310282|FG001|Stage I|Physician Decision|1|||
130642733|NCT01200758|470310283|FG002|Stage I|Physician Decision|0|||
130642734|NCT01200758|470310284|FG003|Stage I|Physician Decision|0|||
130642735|NCT01200758|470310281|FG000|Stage I|Lack of Efficacy|2|||
130642736|NCT01200758|470310282|FG001|Stage I|Lack of Efficacy|1|||
130642737|NCT01200758|470310283|FG002|Stage I|Lack of Efficacy|0|||
130642738|NCT01200758|470310284|FG003|Stage I|Lack of Efficacy|0|||
130642739|NCT01200758|470310281|FG000|Stage I|Adverse Event|5|||
130642740|NCT01200758|470310282|FG001|Stage I|Adverse Event|5|||
130642741|NCT01200758|470310283|FG002|Stage I|Adverse Event|0|||
130642742|NCT01200758|470310284|FG003|Stage I|Adverse Event|0|||
130642743|NCT01200758|470310281|FG000|Stage I|Withdrawal by Subject|1|||
130642744|NCT01200758|470310282|FG001|Stage I|Withdrawal by Subject|2|||
130642745|NCT01200758|470310283|FG002|Stage I|Withdrawal by Subject|0|||
130642746|NCT01200758|470310284|FG003|Stage I|Withdrawal by Subject|0|||
130642747|NCT01200758|470310281|FG000|Stage I|Disease Progression|9|||
130642748|NCT01200758|470310282|FG001|Stage I|Disease Progression|7|||
130642749|NCT01200758|470310283|FG002|Stage I|Disease Progression|0|||
130642750|NCT01200758|470310284|FG003|Stage I|Disease Progression|0|||
130642751|NCT01200758|470310281|FG000|Stage 2|Disease Progression|0|||
130642752|NCT01200758|470310282|FG001|Stage 2|Disease Progression|0|||
130642753|NCT01200758|470310283|FG002|Stage 2|Disease Progression|16|||
130642754|NCT01200758|470310284|FG003|Stage 2|Disease Progression|21|||
130642755|NCT01200758|470310281|FG000|Stage 2|Lack of Efficacy|0|||
130642756|NCT01200758|470310282|FG001|Stage 2|Lack of Efficacy|0|||
130642757|NCT01200758|470310283|FG002|Stage 2|Lack of Efficacy|4|||
130642758|NCT01200758|470310284|FG003|Stage 2|Lack of Efficacy|2|||
130642759|NCT01200758|470310281|FG000|Stage 2|Physician Decision|0|||
130642760|NCT01200758|470310282|FG001|Stage 2|Physician Decision|0|||
130642761|NCT01200758|470310283|FG002|Stage 2|Physician Decision|5|||
130642762|NCT01200758|470310284|FG003|Stage 2|Physician Decision|7|||
130642763|NCT01200758|470310281|FG000|Stage 2|Adverse Event|0|||
130642764|NCT01200758|470310282|FG001|Stage 2|Adverse Event|0|||
130642765|NCT01200758|470310283|FG002|Stage 2|Adverse Event|5|||
130642766|NCT01200758|470310284|FG003|Stage 2|Adverse Event|9|||
130642767|NCT01200758|470310281|FG000|Stage 2|Withdrawal by Subject|0|||
130642768|NCT01200758|470310282|FG001|Stage 2|Withdrawal by Subject|0|||
130642769|NCT01200758|470310283|FG002|Stage 2|Withdrawal by Subject|4|||
130642770|NCT01200758|470310284|FG003|Stage 2|Withdrawal by Subject|1|||
130642771|NCT01200758|470310281|FG000|Stage 2|Lost to Follow-up|0|||
130642772|NCT01200758|470310282|FG001|Stage 2|Lost to Follow-up|0|||
130642773|NCT01200758|470310283|FG002|Stage 2|Lost to Follow-up|3|||
130642774|NCT01200758|470310284|FG003|Stage 2|Lost to Follow-up|1|||
130642775|NCT01200758|470310281|FG000|Stage 2|Protocol Violation|0|||
130642776|NCT01200758|470310282|FG001|Stage 2|Protocol Violation|0|||
130642777|NCT01200758|470310283|FG002|Stage 2|Protocol Violation|1|||
130642778|NCT01200758|470310284|FG003|Stage 2|Protocol Violation|4|||
130642779|NCT01200758|470310281|FG000|Stage 2|Death|0|||
130642780|NCT01200758|470310282|FG001|Stage 2|Death|0|||
130642781|NCT01200758|470310283|FG002|Stage 2|Death|3|||
130642782|NCT01200758|470310284|FG003|Stage 2|Death|5|||
130642783|NCT01371721|470310285|FG000|Overall Study|Adverse Event|5|||
130642784|NCT01371721|470310286|FG001|Overall Study|Adverse Event|4|||
130642785|NCT01371721|470310287|FG002|Overall Study|Adverse Event|5|||
130642786|NCT01371721|470310285|FG000|Overall Study|Protocol Violation|6|||
130642787|NCT01371721|470310286|FG001|Overall Study|Protocol Violation|4|||
130642788|NCT01371721|470310287|FG002|Overall Study|Protocol Violation|5|||
130642789|NCT01371721|470310285|FG000|Overall Study|Lost to Follow-up|8|||
130642790|NCT01371721|470310286|FG001|Overall Study|Lost to Follow-up|2|||
130642791|NCT01371721|470310287|FG002|Overall Study|Lost to Follow-up|6|||
130642792|NCT01371721|470310285|FG000|Overall Study|Withdrawal by Subject|5|||
130642793|NCT01371721|470310286|FG001|Overall Study|Withdrawal by Subject|7|||
130642794|NCT01371721|470310287|FG002|Overall Study|Withdrawal by Subject|11|||
130642795|NCT01371721|470310285|FG000|Overall Study|Other|2|||
130642796|NCT01371721|470310286|FG001|Overall Study|Other|3|||
130642797|NCT01371721|470310287|FG002|Overall Study|Other|0|||
130642798|NCT01371721|470310285|FG000|Overall Study|Lack of Efficacy|2|||
130642799|NCT01371721|470310286|FG001|Overall Study|Lack of Efficacy|4|||
130642800|NCT01371721|470310287|FG002|Overall Study|Lack of Efficacy|3|||
130642801|NCT01371721|470310285|FG000|Overall Study|Randomized but not treated|1|||
130642802|NCT01371721|470310286|FG001|Overall Study|Randomized but not treated|0|||
130642803|NCT01371721|470310287|FG002|Overall Study|Randomized but not treated|0|||
130642804|NCT00545584|470310288|FG000|Overall Study|Only one reason for discontinuation|62|||
130642805|NCT00545584|470310289|FG001|Overall Study|Only one reason for discontinuation|61|||
130642806|NCT00545584|470310290|FG002|Overall Study|Only one reason for discontinuation|48|||
130642807|NCT00545584|470310288|FG000|Overall Study|Two or more reasons for discontinuation|17|||
130642808|NCT00545584|470310289|FG001|Overall Study|Two or more reasons for discontinuation|19|||
130642809|NCT00545584|470310290|FG002|Overall Study|Two or more reasons for discontinuation|8|||
130642810|NCT03525613|470310293|FG000|Overall Study|Adverse Event|11|||
130642811|NCT03525613|470310294|FG001|Overall Study|Adverse Event|8|||
130642812|NCT03525613|470310295|FG002|Overall Study|Adverse Event|3|||
130642813|NCT03525613|470310296|FG003|Overall Study|Adverse Event|3|||
130642814|NCT03525613|470310293|FG000|Overall Study|Lost to Follow-up|4|||
130642815|NCT03525613|470310294|FG001|Overall Study|Lost to Follow-up|5|||
130642816|NCT03525613|470310295|FG002|Overall Study|Lost to Follow-up|3|||
130642817|NCT03525613|470310296|FG003|Overall Study|Lost to Follow-up|2|||
130642818|NCT03525613|470310293|FG000|Overall Study|Physician Decision|0|||
130642819|NCT03525613|470310294|FG001|Overall Study|Physician Decision|1|||
130642820|NCT03525613|470310295|FG002|Overall Study|Physician Decision|0|||
130642821|NCT03525613|470310296|FG003|Overall Study|Physician Decision|1|||
130642822|NCT03525613|470310293|FG000|Overall Study|Consent Withdrawal|25|||
130642823|NCT03525613|470310294|FG001|Overall Study|Consent Withdrawal|16|||
130642824|NCT03525613|470310295|FG002|Overall Study|Consent Withdrawal|12|||
130642825|NCT03525613|470310296|FG003|Overall Study|Consent Withdrawal|9|||
130642826|NCT03525613|470310293|FG000|Overall Study|Death|20|||
130642827|NCT03525613|470310294|FG001|Overall Study|Death|9|||
130642828|NCT03525613|470310295|FG002|Overall Study|Death|7|||
130642829|NCT03525613|470310296|FG003|Overall Study|Death|1|||
130642830|NCT03525613|470310293|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
130642831|NCT03525613|470310294|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
130642832|NCT03525613|470310295|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
130642833|NCT03525613|470310296|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
130642834|NCT00461552|470310297|FG000|Overall Study|Drug Dispensing error|0|||
130642835|NCT00461552|470310298|FG001|Overall Study|Drug Dispensing error|2|||
130642836|NCT00523744|470310299|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
130642837|NCT00523744|470310299|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
130642838|NCT00523744|470310299|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
130642839|NCT00523744|470310299|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
130642840|NCT00523744|470310299|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
130642841|NCT00523744|470310299|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
130642842|NCT02993783|470310302|FG000|Overall Study|Reason not Specified|6|||
130642843|NCT02993783|470310303|FG001|Overall Study|Reason not Specified|9|||
130642844|NCT03049852|470310307|FG000|Overall Study|Lost to Follow-up|0|||
130642845|NCT03049852|470310308|FG001|Overall Study|Lost to Follow-up|1|||
130642846|NCT03049852|470310309|FG002|Overall Study|Lost to Follow-up|0|||
130642847|NCT02610231|470310310|FG000|Overall Study|Withdrawal by Subject|27|||
130642848|NCT02610231|470310310|FG000|Overall Study|Adverse Event|20|||
130642849|NCT02610231|470310310|FG000|Overall Study|Death|5|||
130642850|NCT02610231|470310310|FG000|Overall Study|Surgery|2|||
130642851|NCT02610231|470310310|FG000|Overall Study|Physician Decision|1|||
130642852|NCT02610231|470310310|FG000|Overall Study|Non Compliance|2|||
130642853|NCT02610231|470310310|FG000|Overall Study|Other|3|||
130642854|NCT00806494|470310311|FG000|Overall Study|Adverse Event|29|||
130642855|NCT00806494|470310311|FG000|Overall Study|Lack of Efficacy|6|||
130642856|NCT00806494|470310311|FG000|Overall Study|Lost to Follow-up|10|||
130642857|NCT00806494|470310311|FG000|Overall Study|Other|30|||
130642858|NCT00806494|470310311|FG000|Overall Study|Withdrawal by Subject|5|||
130642859|NCT01279954|470310312|FG000|Overall Study|Lack of Efficacy|3|||
130642860|NCT01279954|470310313|FG001|Overall Study|Lack of Efficacy|4|||
130642861|NCT02709889|470310314|FG000|Overall Study|Withdrawal by Subject|11|||
130642862|NCT02709889|470310315|FG001|Overall Study|Withdrawal by Subject|10|||
130642863|NCT02709889|470310316|FG002|Overall Study|Withdrawal by Subject|2|||
130642864|NCT02709889|470310317|FG003|Overall Study|Withdrawal by Subject|12|||
130642865|NCT02709889|470310314|FG000|Overall Study|Death|25|||
130642866|NCT02709889|470310315|FG001|Overall Study|Death|38|||
130642867|NCT02709889|470310316|FG002|Overall Study|Death|4|||
130642868|NCT02709889|470310317|FG003|Overall Study|Death|44|||
130642869|NCT02709889|470310314|FG000|Overall Study|Physician Decision|1|||
130642870|NCT02709889|470310315|FG001|Overall Study|Physician Decision|2|||
130642871|NCT02709889|470310316|FG002|Overall Study|Physician Decision|3|||
130642872|NCT02709889|470310317|FG003|Overall Study|Physician Decision|5|||
130642873|NCT02709889|470310314|FG000|Overall Study|Lost to Follow-up|2|||
130642874|NCT02709889|470310315|FG001|Overall Study|Lost to Follow-up|0|||
130642875|NCT02709889|470310316|FG002|Overall Study|Lost to Follow-up|0|||
130642876|NCT02709889|470310317|FG003|Overall Study|Lost to Follow-up|4|||
130642877|NCT02709889|470310314|FG000|Overall Study|Study Terminated by Sponsor|4|||
130642878|NCT02709889|470310315|FG001|Overall Study|Study Terminated by Sponsor|6|||
130642879|NCT02709889|470310316|FG002|Overall Study|Study Terminated by Sponsor|2|||
130642880|NCT02709889|470310317|FG003|Overall Study|Study Terminated by Sponsor|17|||
130642881|NCT02709889|470310314|FG000|Overall Study|Other, Not Specified|0|||
130642882|NCT02709889|470310315|FG001|Overall Study|Other, Not Specified|1|||
130642883|NCT02709889|470310316|FG002|Overall Study|Other, Not Specified|1|||
130642884|NCT02709889|470310317|FG003|Overall Study|Other, Not Specified|6|||
130642885|NCT00537810|470310318|FG000|Overall Study|Withdrawal by Subject|4|||
130642886|NCT00537810|470310319|FG001|Overall Study|Withdrawal by Subject|11|||
130642887|NCT00537810|470310320|FG002|Overall Study|Withdrawal by Subject|4|||
130642888|NCT00537810|470310321|FG003|Overall Study|Withdrawal by Subject|3|||
130642889|NCT00537810|470310318|FG000|Overall Study|Medically withdrawn|2|||
130642890|NCT00537810|470310319|FG001|Overall Study|Medically withdrawn|2|||
130642891|NCT00537810|470310320|FG002|Overall Study|Medically withdrawn|0|||
130642892|NCT00537810|470310321|FG003|Overall Study|Medically withdrawn|1|||
130642893|NCT01066546|470310322|FG000|Overall Study|Study terminated by sponsor|5|||
130642894|NCT03258762|470310327|FG000|Overall Study|Lost to Follow-up|0|||
130642895|NCT03258762|470310328|FG001|Overall Study|Lost to Follow-up|1|||
130642896|NCT01711359|470310329|FG000|Treatment Period|Withdrawal by Subject|18|||
130642897|NCT01711359|470310330|FG001|Treatment Period|Withdrawal by Subject|7|||
130642898|NCT01711359|470310331|FG002|Treatment Period|Withdrawal by Subject|13|||
130642899|NCT01711359|470310329|FG000|Treatment Period|Lack of Efficacy|13|||
130642900|NCT01711359|470310330|FG001|Treatment Period|Lack of Efficacy|2|||
130642901|NCT01711359|470310331|FG002|Treatment Period|Lack of Efficacy|2|||
130642902|NCT01711359|470310329|FG000|Treatment Period|Adverse Event|8|||
130642903|NCT01711359|470310330|FG001|Treatment Period|Adverse Event|10|||
130642904|NCT01711359|470310331|FG002|Treatment Period|Adverse Event|24|||
130642905|NCT01711359|470310329|FG000|Treatment Period|Physician Decision|4|||
130642906|NCT01711359|470310330|FG001|Treatment Period|Physician Decision|3|||
130642907|NCT01711359|470310331|FG002|Treatment Period|Physician Decision|2|||
130642908|NCT01711359|470310329|FG000|Treatment Period|Death|3|||
130642909|NCT01711359|470310330|FG001|Treatment Period|Death|0|||
130642910|NCT01711359|470310331|FG002|Treatment Period|Death|0|||
130642911|NCT01711359|470310329|FG000|Treatment Period|Entry Criteria Not Met|1|||
130642912|NCT01711359|470310330|FG001|Treatment Period|Entry Criteria Not Met|0|||
130642913|NCT01711359|470310331|FG002|Treatment Period|Entry Criteria Not Met|0|||
130642914|NCT01711359|470310329|FG000|Treatment Period|Sponsor Decision|1|||
130642915|NCT01711359|470310330|FG001|Treatment Period|Sponsor Decision|0|||
130642916|NCT01711359|470310331|FG002|Treatment Period|Sponsor Decision|0|||
130642917|NCT01711359|470310329|FG000|Treatment Period|Lost to Follow-up|1|||
130642918|NCT01711359|470310330|FG001|Treatment Period|Lost to Follow-up|1|||
130642919|NCT01711359|470310331|FG002|Treatment Period|Lost to Follow-up|1|||
130642920|NCT01711359|470310329|FG000|Treatment Period|Randomized, Not Treated|3|||
130642921|NCT01711359|470310330|FG001|Treatment Period|Randomized, Not Treated|1|||
130642922|NCT01711359|470310331|FG002|Treatment Period|Randomized, Not Treated|0|||
130642923|NCT01385098|470310332|FG000|Overall Study|Adverse Event|10|||
130642924|NCT01385098|470310332|FG000|Overall Study|Lost to Follow-up|4|||
130642925|NCT00554840|470310333|FG000|Overall Study|Physician Decision|0|||
130642926|NCT00554840|470310334|FG001|Overall Study|Physician Decision|1|||
130642927|NCT02698176|470310335|FG000|Overall Study|Progressive disease|4|||
130642928|NCT02698176|470310336|FG001|Overall Study|Progressive disease|3|||
130642929|NCT02698176|470310337|FG002|Overall Study|Progressive disease|1|||
130642930|NCT02698176|470310338|FG003|Overall Study|Progressive disease|0|||
130642931|NCT02698176|470310335|FG000|Overall Study|Adverse Event|2|||
130642932|NCT02698176|470310336|FG001|Overall Study|Adverse Event|0|||
130642933|NCT02698176|470310337|FG002|Overall Study|Adverse Event|0|||
130642934|NCT02698176|470310338|FG003|Overall Study|Adverse Event|0|||
130642935|NCT02698176|470310335|FG000|Overall Study|Clinical progression|3|||
130642936|NCT02698176|470310336|FG001|Overall Study|Clinical progression|0|||
130642937|NCT02698176|470310337|FG002|Overall Study|Clinical progression|0|||
130642938|NCT02698176|470310338|FG003|Overall Study|Clinical progression|0|||
130642939|NCT00410514|470310345|FG000|Overall Study|Adverse Event|2|||
130642940|NCT00410514|470310346|FG001|Overall Study|Adverse Event|2|||
130642941|NCT00410514|470310347|FG002|Overall Study|Adverse Event|2|||
130642942|NCT00410514|470310345|FG000|Overall Study|Protocol Violation|0|||
130642943|NCT00410514|470310346|FG001|Overall Study|Protocol Violation|1|||
130642944|NCT00410514|470310347|FG002|Overall Study|Protocol Violation|1|||
130642945|NCT00410514|470310345|FG000|Overall Study|Lost to Follow-up|0|||
130642946|NCT00410514|470310346|FG001|Overall Study|Lost to Follow-up|0|||
130642947|NCT00410514|470310347|FG002|Overall Study|Lost to Follow-up|2|||
130642948|NCT00410514|470310345|FG000|Overall Study|Non-compliant with study procedures|0|||
130642949|NCT00410514|470310346|FG001|Overall Study|Non-compliant with study procedures|0|||
130642950|NCT00410514|470310347|FG002|Overall Study|Non-compliant with study procedures|2|||
130642951|NCT01021423|470310348|FG000|Overall Study|Study terminated|4|||
130642952|NCT01021423|470310349|FG001|Overall Study|Study terminated|5|||
130642953|NCT02985684|470310353|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
130642954|NCT02985684|470310353|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
130642955|NCT02985684|470310353|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
130642956|NCT04728815|470310355|FG000|Overall Study|Lost to Follow-up|3|||
130642957|NCT04728815|470310356|FG001|Overall Study|Lost to Follow-up|0|||
130642958|NCT04728815|470310357|FG002|Overall Study|Lost to Follow-up|0|||
130642959|NCT04728815|470310358|FG003|Overall Study|Lost to Follow-up|1|||
130642960|NCT04728815|470310359|FG004|Overall Study|Lost to Follow-up|1|||
130642961|NCT04728815|470310360|FG005|Overall Study|Lost to Follow-up|0|||
130642962|NCT04728815|470310361|FG006|Overall Study|Lost to Follow-up|2|||
130642963|NCT04728815|470310362|FG007|Overall Study|Lost to Follow-up|0|||
130642964|NCT04728815|470310355|FG000|Overall Study|Physician Decision|0|||
130642965|NCT04728815|470310356|FG001|Overall Study|Physician Decision|0|||
130642966|NCT04728815|470310357|FG002|Overall Study|Physician Decision|1|||
130642967|NCT04728815|470310358|FG003|Overall Study|Physician Decision|0|||
130642968|NCT04728815|470310359|FG004|Overall Study|Physician Decision|0|||
130642969|NCT04728815|470310360|FG005|Overall Study|Physician Decision|0|||
130642970|NCT04728815|470310361|FG006|Overall Study|Physician Decision|0|||
130642971|NCT04728815|470310362|FG007|Overall Study|Physician Decision|0|||
130642972|NCT04728815|470310355|FG000|Overall Study|Treatment drop|0|||
130642973|NCT04728815|470310356|FG001|Overall Study|Treatment drop|2|||
130642974|NCT04728815|470310357|FG002|Overall Study|Treatment drop|1|||
130642975|NCT04728815|470310358|FG003|Overall Study|Treatment drop|0|||
130642976|NCT04728815|470310359|FG004|Overall Study|Treatment drop|3|||
130642977|NCT04728815|470310360|FG005|Overall Study|Treatment drop|1|||
130642978|NCT04728815|470310361|FG006|Overall Study|Treatment drop|3|||
130642979|NCT04728815|470310362|FG007|Overall Study|Treatment drop|0|||
130642980|NCT04728815|470310355|FG000|Overall Study|Study drop|0|||
130642981|NCT04728815|470310356|FG001|Overall Study|Study drop|3|||
130642982|NCT04728815|470310357|FG002|Overall Study|Study drop|3|||
130642983|NCT04728815|470310358|FG003|Overall Study|Study drop|0|||
130642984|NCT04728815|470310359|FG004|Overall Study|Study drop|0|||
130642985|NCT04728815|470310360|FG005|Overall Study|Study drop|0|||
130642986|NCT04728815|470310361|FG006|Overall Study|Study drop|7|||
130642987|NCT04728815|470310362|FG007|Overall Study|Study drop|0|||
130642988|NCT00957034|470310365|FG000|Overall Study|Adverse Event|0|||
130642989|NCT00957034|470310366|FG001|Overall Study|Adverse Event|1|||
130642990|NCT00957034|470310367|FG002|Overall Study|Adverse Event|1|||
130642991|NCT00957034|470310365|FG000|Overall Study|Sponsor Terminated Study|6|||
130642992|NCT00957034|470310366|FG001|Overall Study|Sponsor Terminated Study|1|||
130642993|NCT00957034|470310367|FG002|Overall Study|Sponsor Terminated Study|5|||
130642994|NCT00957034|470310365|FG000|Overall Study|Withdrawal by Subject|0|||
130642995|NCT00957034|470310366|FG001|Overall Study|Withdrawal by Subject|2|||
130642996|NCT00957034|470310367|FG002|Overall Study|Withdrawal by Subject|0|||
130642997|NCT02390167|470312121|FG000|Overall Study|Lost to Follow-up|1|||
130642998|NCT02033369|470312122|FG000|Overall Study|Physician Decision|1|||
130642999|NCT02033369|470312123|FG001|Overall Study|Physician Decision|2|||
130643000|NCT02033369|470312122|FG000|Overall Study|Not a good demographic match|0|||
130643001|NCT02033369|470312123|FG001|Overall Study|Not a good demographic match|2|||
130643002|NCT02033369|470312122|FG000|Overall Study|Withdrawal by Subject|1|||
130643003|NCT02033369|470312123|FG001|Overall Study|Withdrawal by Subject|1|||
130643004|NCT02033369|470312122|FG000|Overall Study|Lost to Follow-up|1|||
130643005|NCT02033369|470312123|FG001|Overall Study|Lost to Follow-up|0|||
130643006|NCT02033369|470312122|FG000|Overall Study|Protocol Violation|2|||
130643007|NCT02033369|470312123|FG001|Overall Study|Protocol Violation|0|||
130643008|NCT01265719|470312129|FG000|Overall Study|Does not meet entrance criteria|0|||
130643009|NCT01265719|470312130|FG001|Overall Study|Does not meet entrance criteria|3|||
130643010|NCT01265719|470312129|FG000|Overall Study|Other reasons|2|||
130643011|NCT01265719|470312130|FG001|Overall Study|Other reasons|0|||
130643012|NCT01265719|470312129|FG000|Overall Study|Withdrawal by Subject|8|||
130643013|NCT01265719|470312130|FG001|Overall Study|Withdrawal by Subject|3|||
130643014|NCT01265719|470312129|FG000|Overall Study|Lost to Follow-up|2|||
130643015|NCT01265719|470312130|FG001|Overall Study|Lost to Follow-up|7|||
130643016|NCT01265719|470312129|FG000|Overall Study|Adverse Event|2|||
130643017|NCT01265719|470312130|FG001|Overall Study|Adverse Event|0|||
130643018|NCT04335929|470312131|FG000|Overall Study|Lost to Follow-up|10|||
130643019|NCT05466240|470312132|FG000|Overall Study|Adverse Event|1|||
130643020|NCT05466240|470312133|FG001|Overall Study|Adverse Event|0|||
130643021|NCT05466240|470312132|FG000|Overall Study|Withdrawal by Subject|1|||
130643022|NCT05466240|470312133|FG001|Overall Study|Withdrawal by Subject|0|||
130643023|NCT00305773|470312134|FG000|Overall Study|Death|3|||
130643024|NCT00305773|470312135|FG001|Overall Study|Death|2|||
130643025|NCT00305773|470312134|FG000|Overall Study|Adverse Event|1|||
130643026|NCT00305773|470312135|FG001|Overall Study|Adverse Event|2|||
130643027|NCT00305773|470312134|FG000|Overall Study|Alternative Treatment|4|||
130643028|NCT00305773|470312135|FG001|Overall Study|Alternative Treatment|4|||
130643029|NCT00305773|470312134|FG000|Overall Study|Physician Decision|1|||
130643030|NCT00305773|470312135|FG001|Overall Study|Physician Decision|1|||
130643031|NCT00305773|470312134|FG000|Overall Study|Withdrawal by Subject|1|||
130643032|NCT00305773|470312135|FG001|Overall Study|Withdrawal by Subject|4|||
130643033|NCT00305773|470312134|FG000|Overall Study|Disease Progression|1|||
130643034|NCT00305773|470312135|FG001|Overall Study|Disease Progression|3|||
130643035|NCT00305773|470312134|FG000|Overall Study|All other reasons|3|||
130643036|NCT00305773|470312135|FG001|Overall Study|All other reasons|2|||
130643037|NCT02679222|470312136|FG000|Overall Study|No time for project|1|||
130643038|NCT00413231|470312137|FG000|0 to 30-day Post Treatment|Death|5|||
130643039|NCT00413231|470312137|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
130643040|NCT00413231|470312137|FG000|30-day to 365-day Post Treatment|Death|13|||
130643041|NCT00413231|470312137|FG000|365-day to 60-month Post Treatment|Death|36|||
130643042|NCT00413231|470312137|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
130643043|NCT00413231|470312137|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
130643044|NCT00413231|470312137|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
130643045|NCT00945945|470312142|FG000|Overall Study|Adverse Event|15|||
130643046|NCT00945945|470312143|FG001|Overall Study|Adverse Event|35|||
130643047|NCT00945945|470312142|FG000|Overall Study|Withdrawal by Subject|7|||
130643048|NCT00945945|470312143|FG001|Overall Study|Withdrawal by Subject|10|||
130643049|NCT00945945|470312142|FG000|Overall Study|Lost to Follow-up|4|||
130643050|NCT00945945|470312143|FG001|Overall Study|Lost to Follow-up|5|||
130643051|NCT00945945|470312142|FG000|Overall Study|Lack of Efficacy|6|||
130643052|NCT00945945|470312143|FG001|Overall Study|Lack of Efficacy|2|||
130643053|NCT00945945|470312142|FG000|Overall Study|Protocol Violation|4|||
130643054|NCT00945945|470312143|FG001|Overall Study|Protocol Violation|2|||
130643055|NCT00945945|470312142|FG000|Overall Study|Entry Criteria Not Met|0|||
130643056|NCT00945945|470312143|FG001|Overall Study|Entry Criteria Not Met|1|||
130643057|NCT02408016|470312145|FG000|Overall Study|Death|6|||
130643058|NCT02408016|470312146|FG001|Overall Study|Death|1|||
130643059|NCT02408016|470312147|FG002|Overall Study|Death|0|||
130643060|NCT02408016|470312145|FG000|Overall Study|Physician Decision|0|||
130643061|NCT02408016|470312146|FG001|Overall Study|Physician Decision|2|||
130643062|NCT02408016|470312147|FG002|Overall Study|Physician Decision|0|||
130643063|NCT00805194|470312148|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
130643064|NCT00805194|470312149|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
130643065|NCT00805194|470312148|FG000|Overall Study|Worsening or AE of underlying disease|64|||
130643066|NCT00805194|470312149|FG001|Overall Study|Worsening or AE of underlying disease|70|||
130643067|NCT00805194|470312148|FG000|Overall Study|Other AE|84|||
130643068|NCT00805194|470312149|FG001|Overall Study|Other AE|73|||
130643069|NCT00805194|470312148|FG000|Overall Study|Protocol Violation|9|||
130643070|NCT00805194|470312149|FG001|Overall Study|Protocol Violation|9|||
130643071|NCT00805194|470312148|FG000|Overall Study|Lost to Follow-up|5|||
130643072|NCT00805194|470312149|FG001|Overall Study|Lost to Follow-up|5|||
130643073|NCT00805194|470312148|FG000|Overall Study|Withdrawal by Subject|60|||
130643074|NCT00805194|470312149|FG001|Overall Study|Withdrawal by Subject|42|||
130643075|NCT00805194|470312148|FG000|Overall Study|Not treated|3|||
130643076|NCT00805194|470312149|FG001|Overall Study|Not treated|4|||
130643077|NCT00805194|470312148|FG000|Overall Study|Reasons other than stated above|20|||
130643078|NCT00805194|470312149|FG001|Overall Study|Reasons other than stated above|16|||
130643079|NCT02275052|470312154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130643080|NCT02275052|470312155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130643081|NCT02275052|470312156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130643082|NCT02275052|470312157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130643083|NCT02275052|470312154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
130643084|NCT02275052|470312155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
130643085|NCT02275052|470312156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
130643086|NCT02275052|470312157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
130643087|NCT02275052|470312154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
130643088|NCT02275052|470312155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
130643089|NCT02275052|470312156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130643090|NCT02275052|470312157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130643091|NCT02275052|470312154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
130643092|NCT02275052|470312155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130643093|NCT02275052|470312156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130643094|NCT02275052|470312157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130643095|NCT02275052|470312154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130643096|NCT02275052|470312155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130643097|NCT02275052|470312156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130643098|NCT02275052|470312157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130643099|NCT02275052|470312154|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
130643100|NCT02275052|470312155|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130643101|NCT02275052|470312156|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130643102|NCT02275052|470312157|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130643103|NCT02275052|470312154|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
130643104|NCT02275052|470312155|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130643105|NCT02275052|470312156|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130643106|NCT02275052|470312157|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130643107|NCT02275052|470312154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130643108|NCT02275052|470312155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130643109|NCT02275052|470312156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
130643110|NCT02275052|470312157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
130643111|NCT02275052|470312154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130643112|NCT02275052|470312155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130643113|NCT02275052|470312156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130643114|NCT02275052|470312157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
130643115|NCT02275052|470312154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130643116|NCT02275052|470312155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130643117|NCT02275052|470312156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130643118|NCT02275052|470312157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
130643119|NCT02275052|470312154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130643120|NCT02275052|470312155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130643121|NCT02275052|470312156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130643122|NCT02275052|470312157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
130643123|NCT02807376|470312160|FG000|Overall Study|Intra-operative exclusion criteria|3|||
130643124|NCT02807376|470312161|FG001|Overall Study|Intra-operative exclusion criteria|0|||
130643125|NCT02807376|470312160|FG000|Overall Study|Lost to Follow-up|0|||
130643126|NCT02807376|470312161|FG001|Overall Study|Lost to Follow-up|1|||
130643127|NCT00846027|470312162|FG000|Overall Study|Death|3|||
130643128|NCT00846027|470312162|FG000|Overall Study|Disease Progression|30|||
130643129|NCT00846027|470312162|FG000|Overall Study|Toxicity|12|||
130643130|NCT00846027|470312162|FG000|Overall Study|Patient Decision|7|||
130643131|NCT00846027|470312162|FG000|Overall Study|Investigator Discretion|29|||
130643132|NCT00846027|470312162|FG000|Overall Study|Protocol Violation|2|||
130643133|NCT00846027|470312162|FG000|Overall Study|Subject Not Treated|7|||
130643134|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
130643135|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
130643136|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
130643137|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
130643138|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Other|1|||
130643139|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Other|0|||
130643140|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Other|2|||
130643141|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Other|4|||
130643142|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
130643143|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
130643144|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
130643145|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
130643146|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Adverse Event|0|||
130643147|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Adverse Event|0|||
130643148|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Adverse Event|1|||
130643149|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Adverse Event|2|||
130643150|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
130643151|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
130643152|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
130643153|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
130643154|NCT00808028|470312163|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
130643155|NCT00808028|470312164|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
130643156|NCT00808028|470312165|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
130643157|NCT00808028|470312166|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
130643158|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
130643159|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
130643160|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
130643161|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
130643162|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130643163|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130643164|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
130643165|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130643166|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
130643167|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
130643168|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
130643169|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
130643170|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
130643171|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
130643172|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
130643173|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
130643174|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
130643175|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
130643176|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
130643177|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
130643178|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
130643179|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
130643180|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
130643181|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
130643182|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130643183|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130643184|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
130643185|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130643186|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
130643187|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
130643188|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
130643189|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
130643190|NCT00808028|470312163|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130643191|NCT00808028|470312164|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130643192|NCT00808028|470312165|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
130643193|NCT00808028|470312166|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130643194|NCT01797302|470312167|FG000|Overall Study|Lost to Follow-up|16|||
130643195|NCT01797302|470312168|FG001|Overall Study|Lost to Follow-up|23|||
130643196|NCT01797302|470312169|FG002|Overall Study|Lost to Follow-up|22|||
130643197|NCT01797302|470312167|FG000|Overall Study|Withdrawal by Subject|1|||
130643198|NCT01797302|470312168|FG001|Overall Study|Withdrawal by Subject|3|||
130643199|NCT01797302|470312169|FG002|Overall Study|Withdrawal by Subject|4|||
130643200|NCT03228836|470312170|FG000|Overall Study|Adverse Event|3|||
130643201|NCT03228836|470312170|FG000|Overall Study|Withdrawal by Subject|1|||
130643202|NCT03228836|470312170|FG000|Overall Study|Death|1|||
130643203|NCT03228836|470312170|FG000|Overall Study|Physician Decision|1|||
130643204|NCT03228836|470312170|FG000|Overall Study|Disease Progression|7|||
130643205|NCT03228836|470312170|FG000|Overall Study|Other|4|||
130643206|NCT02773849|470312172|FG000|Overall Study|Lost to Follow-up|11|||
130643207|NCT02773849|470312172|FG000|Overall Study|Death|26|||
130643208|NCT02773849|470312172|FG000|Overall Study|Withdrawal by Subject|5|||
130643209|NCT02773849|470312172|FG000|Overall Study|Withdrawal of Consent|9|||
130643210|NCT02773849|470312172|FG000|Overall Study|Other: not due to lack of tolerability|11|||
130643211|NCT00948389|470312173|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
130643212|NCT00948389|470312174|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
130643213|NCT00948389|470312175|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
130643214|NCT00948389|470312176|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
130643215|NCT00948389|470312177|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
130643216|NCT00948389|470312173|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
130643217|NCT00948389|470312174|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
130643218|NCT00948389|470312175|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
130643219|NCT00948389|470312176|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
130643220|NCT00948389|470312177|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
130643221|NCT00948389|470312173|FG000|Overall Study|Both Progression and Toxicity|1|||
130643222|NCT00948389|470312174|FG001|Overall Study|Both Progression and Toxicity|0|||
130643223|NCT00948389|470312175|FG002|Overall Study|Both Progression and Toxicity|0|||
130643224|NCT00948389|470312176|FG003|Overall Study|Both Progression and Toxicity|0|||
130643225|NCT00948389|470312177|FG004|Overall Study|Both Progression and Toxicity|0|||
130643226|NCT02418000|470312182|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
130643227|NCT02418000|470312183|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643228|NCT02418000|470312184|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643229|NCT02418000|470312185|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643230|NCT02418000|470312186|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643231|NCT02418000|470312182|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
130643232|NCT02418000|470312183|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130643233|NCT02418000|470312184|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130643234|NCT02418000|470312185|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130643235|NCT02418000|470312186|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130643236|NCT02418000|470312182|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
130643237|NCT02418000|470312183|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130643238|NCT02418000|470312184|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130643239|NCT02418000|470312185|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130643240|NCT02418000|470312186|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130643241|NCT02418000|470312182|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643242|NCT02418000|470312183|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
130643243|NCT02418000|470312184|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643244|NCT02418000|470312185|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643245|NCT02418000|470312186|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130643246|NCT02418000|470312182|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130643247|NCT02418000|470312183|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
130643248|NCT02418000|470312184|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130643249|NCT02418000|470312185|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130643250|NCT02418000|470312186|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130643251|NCT02418000|470312182|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643252|NCT02418000|470312183|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643253|NCT02418000|470312184|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130643254|NCT02418000|470312185|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643255|NCT02418000|470312186|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643256|NCT02418000|470312182|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643257|NCT02418000|470312183|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643258|NCT02418000|470312184|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643259|NCT02418000|470312185|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130643260|NCT02418000|470312186|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643261|NCT02418000|470312182|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130643262|NCT02418000|470312183|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130643263|NCT02418000|470312184|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130643264|NCT02418000|470312185|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130643265|NCT02418000|470312186|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
130643266|NCT02418000|470312182|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643267|NCT02418000|470312183|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643268|NCT02418000|470312184|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643269|NCT02418000|470312185|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130643270|NCT02418000|470312186|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130643271|NCT00508001|470312188|FG000|Overall Study|Adverse Event|2|||
130643272|NCT00508001|470312189|FG001|Overall Study|Adverse Event|0|||
130643273|NCT00508001|470312190|FG002|Overall Study|Adverse Event|4|||
130643274|NCT00508001|470312188|FG000|Overall Study|condition under investigation worsened|13|||
130643275|NCT00508001|470312189|FG001|Overall Study|condition under investigation worsened|7|||
130643276|NCT00508001|470312190|FG002|Overall Study|condition under investigation worsened|1|||
130643277|NCT00508001|470312188|FG000|Overall Study|Death|0|||
130643278|NCT00508001|470312189|FG001|Overall Study|Death|1|||
130643279|NCT00508001|470312190|FG002|Overall Study|Death|1|||
130643280|NCT00508001|470312188|FG000|Overall Study|Withdrawal by Subject|4|||
130643281|NCT00508001|470312189|FG001|Overall Study|Withdrawal by Subject|4|||
130643282|NCT00508001|470312190|FG002|Overall Study|Withdrawal by Subject|1|||
130643283|NCT00732199|470312198|FG000|Overall Study|Withdrawal by Subject|25|||
130643284|NCT00732199|470312199|FG001|Overall Study|Withdrawal by Subject|18|||
130643285|NCT00732199|470312198|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
130643286|NCT00732199|470312199|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
130643287|NCT02870348|470312211|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
130643288|NCT01051856|470312212|FG000|Overall Study|Withdrawal by Subject|1|||
130643289|NCT01051856|470312213|FG001|Overall Study|Withdrawal by Subject|0|||
130643290|NCT02381795|470312214|FG000|Overall Study|Withdrawal by Subject|1|||
130643291|NCT02381795|470312214|FG000|Overall Study|Study Terminated|2|||
130643292|NCT02176226|470312215|FG000|Overall Study|Lost to Follow-up|3|||
130643293|NCT02176226|470312215|FG000|Overall Study|Withdrew prior to treatment|6|||
130643294|NCT02908841|470312218|FG000|Overall Study|Physician Decision|4|||
130643295|NCT02908841|470312219|FG001|Overall Study|Physician Decision|0|||
130643296|NCT01611558|470312220|FG000|Induction Phase|Study drug toxicity|15|||
130643297|NCT01611558|470312220|FG000|Induction Phase|Disease progression|18|||
130643298|NCT01611558|470312220|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
130643299|NCT01611558|470312220|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
130643300|NCT01611558|470312220|FG000|Induction Phase|Death|1|||
130643301|NCT01611558|470312220|FG000|Maintenance Phase|Withdrawal by Subject|1|||
130643302|NCT01611558|470312220|FG000|Maintenance Phase|Elevated Uric acid|1|||
130643303|NCT01412333|470312223|FG000|Overall Study|Adverse Event|40|||
130643304|NCT01412333|470312224|FG001|Overall Study|Adverse Event|42|||
130643305|NCT01412333|470312223|FG000|Overall Study|Death|5|||
130643306|NCT01412333|470312224|FG001|Overall Study|Death|6|||
130643307|NCT01412333|470312223|FG000|Overall Study|Lack of Efficacy|22|||
130643308|NCT01412333|470312224|FG001|Overall Study|Lack of Efficacy|10|||
130643309|NCT01412333|470312223|FG000|Overall Study|Lost to Follow-up|15|||
130643310|NCT01412333|470312224|FG001|Overall Study|Lost to Follow-up|12|||
130643311|NCT01412333|470312223|FG000|Overall Study|Non-Compliance|3|||
130643312|NCT01412333|470312224|FG001|Overall Study|Non-Compliance|7|||
130643313|NCT01412333|470312223|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130643314|NCT01412333|470312224|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130643315|NCT01412333|470312223|FG000|Overall Study|Other|30|||
130643316|NCT01412333|470312224|FG001|Overall Study|Other|33|||
130643317|NCT01412333|470312223|FG000|Overall Study|Physician Decision|11|||
130643318|NCT01412333|470312224|FG001|Overall Study|Physician Decision|16|||
130643319|NCT01412333|470312223|FG000|Overall Study|Pregnancy|6|||
130643320|NCT01412333|470312224|FG001|Overall Study|Pregnancy|4|||
130643321|NCT01412333|470312223|FG000|Overall Study|Protocol Violation|1|||
130643322|NCT01412333|470312224|FG001|Overall Study|Protocol Violation|2|||
130643323|NCT01412333|470312223|FG000|Overall Study|Study Terminated By Sponsor|3|||
130643324|NCT01412333|470312224|FG001|Overall Study|Study Terminated By Sponsor|2|||
130643325|NCT01412333|470312223|FG000|Overall Study|Withdrawal by Subject|51|||
130643326|NCT01412333|470312224|FG001|Overall Study|Withdrawal by Subject|54|||
130643327|NCT01412333|470312223|FG000|Overall Study|Missing|1|||
130643328|NCT01412333|470312224|FG001|Overall Study|Missing|3|||
130643329|NCT00750867|470312226|FG000|Overall Study|Adverse Event|2|||
130643330|NCT02516306|470312227|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
130643331|NCT02516306|470312228|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
130643332|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Adverse Event|30|||
130643333|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Adverse Event|25|||
130643334|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Adverse Event|23|||
130643335|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Adverse Event|14|||
130643336|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Death|0|||
130643337|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Death|0|||
130643338|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Death|1|||
130643339|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Death|0|||
130643340|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Physician Decision|0|||
130643341|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Physician Decision|1|||
130643342|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Physician Decision|0|||
130643343|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Physician Decision|1|||
130643344|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
130643345|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
130643346|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
130643347|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
130643348|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Other|6|||
130643349|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Other|1|||
130643350|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Other|0|||
130643351|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Other|2|||
130643352|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
130643353|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
130643354|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
130643355|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
130643356|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
130643357|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
130643358|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
130643359|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
130643360|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
130643361|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
130643362|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
130643363|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
130643364|NCT00242710|470312230|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
130643365|NCT00242710|470312231|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
130643366|NCT00242710|470312232|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
130643367|NCT00242710|470312233|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
130643368|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Adverse Event|2|||
130643369|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Adverse Event|3|||
130643370|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Adverse Event|5|||
130643371|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Adverse Event|2|||
130643372|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Physician Decision|1|||
130643373|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Physician Decision|1|||
130643374|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Physician Decision|0|||
130643375|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Physician Decision|0|||
130643376|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Other|24|||
130643377|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Other|24|||
130643378|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Other|9|||
130643379|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Other|11|||
130643380|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Extension not Available|17|||
130643381|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Extension not Available|21|||
130643382|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Extension not Available|8|||
130643383|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Extension not Available|7|||
130643384|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
130643385|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
130643386|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
130643387|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
130643388|NCT00242710|470312230|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
130643389|NCT00242710|470312231|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
130643390|NCT00242710|470312232|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
130643391|NCT00242710|470312233|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
130643392|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
130643393|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
130643394|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
130643395|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
130643396|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Death|0|||
130643397|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Death|0|||
130643398|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Death|0|||
130643399|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Death|1|||
130643400|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
130643401|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
130643402|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
130643403|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
130643404|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Other|3|||
130643405|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Other|5|||
130643406|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Other|4|||
130643407|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Other|3|||
130643408|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
130643409|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
130643410|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
130643411|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
130643412|NCT00242710|470312230|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
130643413|NCT00242710|470312231|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
130643414|NCT00242710|470312232|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
130643415|NCT00242710|470312233|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
130643416|NCT00579527|470312234|FG000|Overall Study|Death|4|||
130643417|NCT00808132|470312235|FG000|Overall Study|Adverse Event|34|||
130643418|NCT00808132|470312236|FG001|Overall Study|Adverse Event|33|||
130643419|NCT00808132|470312237|FG002|Overall Study|Adverse Event|16|||
130643420|NCT00808132|470312238|FG003|Overall Study|Adverse Event|31|||
130643421|NCT00808132|470312239|FG004|Overall Study|Adverse Event|33|||
130643422|NCT00808132|470312235|FG000|Overall Study|Death|0|||
130643423|NCT00808132|470312236|FG001|Overall Study|Death|0|||
130643424|NCT00808132|470312237|FG002|Overall Study|Death|0|||
130643425|NCT00808132|470312238|FG003|Overall Study|Death|0|||
130643426|NCT00808132|470312239|FG004|Overall Study|Death|1|||
130643427|NCT00808132|470312235|FG000|Overall Study|Physician Decision|0|||
130643428|NCT00808132|470312236|FG001|Overall Study|Physician Decision|1|||
130643429|NCT00808132|470312237|FG002|Overall Study|Physician Decision|0|||
130643430|NCT00808132|470312238|FG003|Overall Study|Physician Decision|0|||
130643431|NCT00808132|470312239|FG004|Overall Study|Physician Decision|0|||
130643432|NCT00808132|470312235|FG000|Overall Study|Lost to Follow-up|8|||
130643433|NCT00808132|470312236|FG001|Overall Study|Lost to Follow-up|10|||
130643434|NCT00808132|470312237|FG002|Overall Study|Lost to Follow-up|11|||
130643435|NCT00808132|470312238|FG003|Overall Study|Lost to Follow-up|8|||
130643436|NCT00808132|470312239|FG004|Overall Study|Lost to Follow-up|9|||
130643437|NCT00808132|470312235|FG000|Overall Study|Protocol Violation|8|||
130643438|NCT00808132|470312236|FG001|Overall Study|Protocol Violation|9|||
130643439|NCT00808132|470312237|FG002|Overall Study|Protocol Violation|4|||
130643440|NCT00808132|470312238|FG003|Overall Study|Protocol Violation|9|||
130643441|NCT00808132|470312239|FG004|Overall Study|Protocol Violation|5|||
130643442|NCT00808132|470312235|FG000|Overall Study|Withdrawal by Subject|27|||
130643443|NCT00808132|470312236|FG001|Overall Study|Withdrawal by Subject|18|||
130643444|NCT00808132|470312237|FG002|Overall Study|Withdrawal by Subject|2|||
130643445|NCT00808132|470312238|FG003|Overall Study|Withdrawal by Subject|7|||
130643446|NCT00808132|470312239|FG004|Overall Study|Withdrawal by Subject|16|||
130643447|NCT00808132|470312235|FG000|Overall Study|Other|6|||
130643448|NCT00808132|470312236|FG001|Overall Study|Other|4|||
130643449|NCT00808132|470312237|FG002|Overall Study|Other|6|||
130643450|NCT00808132|470312238|FG003|Overall Study|Other|2|||
130643451|NCT00808132|470312239|FG004|Overall Study|Other|15|||
130643452|NCT00808132|470312235|FG000|Overall Study|Randomized, but not treated|10|||
130643453|NCT00808132|470312236|FG001|Overall Study|Randomized, but not treated|7|||
130643454|NCT00808132|470312237|FG002|Overall Study|Randomized, but not treated|9|||
130643455|NCT00808132|470312238|FG003|Overall Study|Randomized, but not treated|8|||
130643456|NCT00808132|470312239|FG004|Overall Study|Randomized, but not treated|9|||
130643457|NCT00808132|470312235|FG000|Overall Study|Unsatisfactory response|5|||
130643458|NCT00808132|470312236|FG001|Overall Study|Unsatisfactory response|6|||
130643459|NCT00808132|470312237|FG002|Overall Study|Unsatisfactory response|6|||
130643460|NCT00808132|470312238|FG003|Overall Study|Unsatisfactory response|4|||
130643461|NCT00808132|470312239|FG004|Overall Study|Unsatisfactory response|12|||
130643462|NCT01948791|470312242|FG000|Overall Study|Adverse Event|12|||
130643463|NCT01948791|470312242|FG000|Overall Study|Lack of Efficacy|3|||
130643464|NCT01948791|470312242|FG000|Overall Study|Protocol Violation|2|||
130643465|NCT01948791|470312242|FG000|Overall Study|Withdrawal by Subject|5|||
130643466|NCT01948791|470312242|FG000|Overall Study|Lost to Follow-up|6|||
130643467|NCT01948791|470312242|FG000|Overall Study|Management issues|1|||
130643468|NCT01948791|470312242|FG000|Overall Study|Others|7|||
130643469|NCT01948791|470312242|FG000|Overall Study|Screening failure|35|||
130643470|NCT03490734|470312246|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
130643471|NCT03490734|470312247|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
130643472|NCT03490734|470312248|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
130643473|NCT03490734|470312249|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
130643474|NCT03490734|470312246|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130643475|NCT03490734|470312247|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130643476|NCT03490734|470312248|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130643477|NCT03490734|470312249|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
130643478|NCT03490734|470312246|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130643479|NCT03490734|470312247|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130643480|NCT03490734|470312248|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130643481|NCT03490734|470312249|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
130643482|NCT03490734|470312246|FG000|Post-intervention Scan Visit|Adverse Event|2|||
130643483|NCT03490734|470312247|FG001|Post-intervention Scan Visit|Adverse Event|0|||
130643484|NCT03490734|470312248|FG002|Post-intervention Scan Visit|Adverse Event|0|||
130643485|NCT03490734|470312249|FG003|Post-intervention Scan Visit|Adverse Event|0|||
130643486|NCT03490734|470312246|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
130643487|NCT03490734|470312247|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
130643488|NCT03490734|470312248|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
130643489|NCT03490734|470312249|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
130643490|NCT03490734|470312246|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
130643491|NCT03490734|470312247|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
130643492|NCT03490734|470312248|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
130643493|NCT03490734|470312249|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
130643494|NCT00702949|470312254|FG000|Overall Study|Refusal|3|||
130643495|NCT00702949|470312255|FG001|Overall Study|Refusal|2|||
130643496|NCT00702949|470312256|FG002|Overall Study|Refusal|2|||
130643497|NCT00702949|470312254|FG000|Overall Study|Adverse Event|1|||
130643498|NCT00702949|470312255|FG001|Overall Study|Adverse Event|6|||
130643499|NCT00702949|470312256|FG002|Overall Study|Adverse Event|3|||
130643500|NCT00702949|470312254|FG000|Overall Study|Other Medical Reason/unknown|1|||
130643501|NCT00702949|470312255|FG001|Overall Study|Other Medical Reason/unknown|1|||
130643502|NCT00702949|470312256|FG002|Overall Study|Other Medical Reason/unknown|3|||
130643503|NCT00887913|470312257|FG000|Overall Study|Withdrawal by Subject|6|||
130643504|NCT04491591|470312259|FG000|Overall Study|Accidently randomized|3|||
130643505|NCT04491591|470312260|FG001|Overall Study|Accidently randomized|1|||
130643506|NCT04491591|470312261|FG002|Overall Study|Accidently randomized|0|||
130643507|NCT04491591|470312259|FG000|Overall Study|Did not complete survey|28|||
130643508|NCT04491591|470312260|FG001|Overall Study|Did not complete survey|20|||
130643509|NCT04491591|470312261|FG002|Overall Study|Did not complete survey|3|||
130643510|NCT00135694|470312262|FG000|Overall Study|Adverse Event|17|||
130643511|NCT00135694|470312263|FG001|Overall Study|Adverse Event|4|||
130643512|NCT00135694|470312264|FG002|Overall Study|Adverse Event|0|||
130643513|NCT00135694|470312262|FG000|Overall Study|Death|14|||
130643514|NCT00135694|470312263|FG001|Overall Study|Death|1|||
130643515|NCT00135694|470312264|FG002|Overall Study|Death|2|||
130643516|NCT00135694|470312262|FG000|Overall Study|Lost to Follow-up|8|||
130643517|NCT00135694|470312263|FG001|Overall Study|Lost to Follow-up|7|||
130643518|NCT00135694|470312264|FG002|Overall Study|Lost to Follow-up|1|||
130643519|NCT00135694|470312262|FG000|Overall Study|Withdrawal by Subject|41|||
130643520|NCT00135694|470312263|FG001|Overall Study|Withdrawal by Subject|7|||
130643521|NCT00135694|470312264|FG002|Overall Study|Withdrawal by Subject|4|||
130643522|NCT00135694|470312262|FG000|Overall Study|Protocol Violation|19|||
130643523|NCT00135694|470312263|FG001|Overall Study|Protocol Violation|1|||
130643524|NCT00135694|470312264|FG002|Overall Study|Protocol Violation|0|||
130643525|NCT00135694|470312262|FG000|Overall Study|Hepatitis C related reasons|39|||
130643526|NCT00135694|470312263|FG001|Overall Study|Hepatitis C related reasons|1|||
130643527|NCT00135694|470312264|FG002|Overall Study|Hepatitis C related reasons|0|||
130643528|NCT00135694|470312262|FG000|Overall Study|Ineligible for Random assignment|42|||
130643529|NCT00135694|470312263|FG001|Overall Study|Ineligible for Random assignment|0|||
130643530|NCT00135694|470312264|FG002|Overall Study|Ineligible for Random assignment|0|||
130643531|NCT00472043|470312265|FG000|Overall Study|Withdrawal by Subject|1|||
130643532|NCT00472043|470312266|FG001|Overall Study|Withdrawal by Subject|0|||
130643533|NCT00472043|470312265|FG000|Overall Study|Death|1|||
130643534|NCT00472043|470312266|FG001|Overall Study|Death|0|||
130643535|NCT02802735|470312267|FG000|Overall Study|Withdrawal by Subject|0|||
130643536|NCT02802735|470312268|FG001|Overall Study|Withdrawal by Subject|1|||
130643537|NCT02802735|470312269|FG002|Overall Study|Withdrawal by Subject|0|||
130643538|NCT02802735|470312270|FG003|Overall Study|Withdrawal by Subject|0|||
130643539|NCT02802735|470312271|FG004|Overall Study|Withdrawal by Subject|0|||
130643540|NCT00420212|470312274|FG000|Overall Study|Adverse Event|22|||
130643541|NCT00420212|470312275|FG001|Overall Study|Adverse Event|40|||
130643542|NCT00420212|470312276|FG002|Overall Study|Adverse Event|36|||
130643543|NCT00420212|470312274|FG000|Overall Study|Lost to Follow-up|9|||
130643544|NCT00420212|470312275|FG001|Overall Study|Lost to Follow-up|11|||
130643545|NCT00420212|470312276|FG002|Overall Study|Lost to Follow-up|11|||
130643546|NCT00420212|470312274|FG000|Overall Study|Withdrawal by Subject|31|||
130643547|NCT00420212|470312275|FG001|Overall Study|Withdrawal by Subject|22|||
130643548|NCT00420212|470312276|FG002|Overall Study|Withdrawal by Subject|19|||
130643549|NCT00420212|470312274|FG000|Overall Study|Physician Decision|4|||
130643550|NCT00420212|470312275|FG001|Overall Study|Physician Decision|4|||
130643551|NCT00420212|470312276|FG002|Overall Study|Physician Decision|3|||
130643552|NCT00420212|470312274|FG000|Overall Study|Protocol Violation|4|||
130643553|NCT00420212|470312275|FG001|Overall Study|Protocol Violation|4|||
130643554|NCT00420212|470312276|FG002|Overall Study|Protocol Violation|8|||
130643555|NCT00420212|470312274|FG000|Overall Study|Death|0|||
130643556|NCT00420212|470312275|FG001|Overall Study|Death|0|||
130643557|NCT00420212|470312276|FG002|Overall Study|Death|1|||
130643558|NCT00420212|470312274|FG000|Overall Study|Other-Unspecified|21|||
130643559|NCT00420212|470312275|FG001|Overall Study|Other-Unspecified|14|||
130643560|NCT00420212|470312276|FG002|Overall Study|Other-Unspecified|18|||
130643561|NCT00877890|470312277|FG000|Overall Study|Adverse Event|6|||
130643562|NCT00877890|470312278|FG001|Overall Study|Adverse Event|6|||
130643563|NCT00877890|470312277|FG000|Overall Study|Lost to Follow-up|5|||
130643564|NCT00877890|470312278|FG001|Overall Study|Lost to Follow-up|5|||
130643565|NCT00877890|470312277|FG000|Overall Study|Protocol Violation|0|||
130643566|NCT00877890|470312278|FG001|Overall Study|Protocol Violation|1|||
130643567|NCT00877890|470312277|FG000|Overall Study|Withdrawal of Consent|6|||
130643568|NCT00877890|470312278|FG001|Overall Study|Withdrawal of Consent|12|||
130643569|NCT00877890|470312277|FG000|Overall Study|Investigator Decision|0|||
130643570|NCT00877890|470312278|FG001|Overall Study|Investigator Decision|2|||
130643571|NCT00877890|470312277|FG000|Overall Study|Loss of Glucose Control|3|||
130643572|NCT00877890|470312278|FG001|Overall Study|Loss of Glucose Control|4|||
130643573|NCT00027846|470314725|FG000|Overall Study|Lost to Follow-up|0|||
130643574|NCT00027846|470314726|FG001|Overall Study|Lost to Follow-up|41|||
130643575|NCT00027846|470314727|FG002|Overall Study|Lost to Follow-up|9|||
130643576|NCT00027846|470314725|FG000|Overall Study|Withdrawal by Subject|0|||
130643577|NCT00027846|470314726|FG001|Overall Study|Withdrawal by Subject|14|||
130643578|NCT00027846|470314727|FG002|Overall Study|Withdrawal by Subject|7|||
130643579|NCT00027846|470314725|FG000|Overall Study|Ineligible for study|2|||
130643580|NCT00027846|470314726|FG001|Overall Study|Ineligible for study|6|||
130643581|NCT00027846|470314727|FG002|Overall Study|Ineligible for study|14|||
130643582|NCT00027846|470314725|FG000|Overall Study|Entry into another COG therapeutic study|0|||
130643583|NCT00027846|470314726|FG001|Overall Study|Entry into another COG therapeutic study|5|||
130643584|NCT00027846|470314727|FG002|Overall Study|Entry into another COG therapeutic study|2|||
130643585|NCT00027846|470314725|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
130643586|NCT00027846|470314726|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
130643587|NCT00027846|470314727|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
130643588|NCT05604781|470314729|FG000|Overall Study|Lost to Follow-up|3|||
130643589|NCT05604781|470314729|FG000|Overall Study|Adverse Event|1|||
130643590|NCT01005966|470314730|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130643591|NCT01005966|470314731|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130643592|NCT01005966|470314732|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
130643593|NCT01005966|470314733|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
130643594|NCT01005966|470314734|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
130643595|NCT01005966|470314730|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130643596|NCT01005966|470314731|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130643597|NCT01005966|470314732|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130643598|NCT01005966|470314733|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130643599|NCT01005966|470314734|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130643600|NCT01005966|470314730|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130643601|NCT01005966|470314731|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130643602|NCT01005966|470314732|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130643603|NCT01005966|470314733|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
130643604|NCT01005966|470314734|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130643605|NCT01005966|470314730|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
130643606|NCT01005966|470314731|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
130643607|NCT01005966|470314732|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
130643608|NCT01005966|470314733|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130643609|NCT01005966|470314734|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
130643610|NCT01005966|470314730|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130643611|NCT01005966|470314731|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130643612|NCT01005966|470314732|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130643613|NCT01005966|470314733|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130643614|NCT01005966|470314734|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130643615|NCT01005966|470314730|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130643616|NCT01005966|470314731|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130643617|NCT01005966|470314732|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130643618|NCT01005966|470314733|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130643619|NCT01005966|470314734|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130643620|NCT01005966|470314730|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130643621|NCT01005966|470314731|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
130643622|NCT01005966|470314732|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130643623|NCT01005966|470314733|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130643624|NCT01005966|470314734|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
130643625|NCT01005966|470314730|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130643626|NCT01005966|470314731|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
130643627|NCT01005966|470314732|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130643628|NCT01005966|470314733|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130643629|NCT01005966|470314734|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130643630|NCT01005966|470314730|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
130643631|NCT01005966|470314731|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
130643632|NCT01005966|470314732|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
130643633|NCT01005966|470314733|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
130643634|NCT01005966|470314734|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
130643635|NCT01451203|470314735|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
130643636|NCT01451203|470314736|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
130643637|NCT01451203|470314735|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
130643638|NCT01451203|470314736|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
130643639|NCT01451203|470314735|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
130643640|NCT01451203|470314736|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
130643641|NCT01451203|470314735|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
130643642|NCT01451203|470314736|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
130643643|NCT01451203|470314735|FG000|Double-blind Treatment Period|Adverse Event|6|||
130643644|NCT01451203|470314736|FG001|Double-blind Treatment Period|Adverse Event|9|||
130643645|NCT01451203|470314735|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
130643646|NCT01451203|470314736|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
130643647|NCT01451203|470314735|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
130643648|NCT01451203|470314736|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
130643649|NCT01451203|470314735|FG000|Double-blind Treatment Period|Investigator decision|2|||
130643650|NCT01451203|470314736|FG001|Double-blind Treatment Period|Investigator decision|0|||
130643651|NCT01451203|470314735|FG000|Post-treatment Period|Consent withdrawn|2|||
130643652|NCT01451203|470314736|FG001|Post-treatment Period|Consent withdrawn|4|||
130643653|NCT01451203|470314735|FG000|Post-treatment Period|Lack of Efficacy|12|||
130643654|NCT01451203|470314736|FG001|Post-treatment Period|Lack of Efficacy|28|||
130643655|NCT01451203|470314735|FG000|Post-treatment Period|Adverse Event|0|||
130643656|NCT01451203|470314736|FG001|Post-treatment Period|Adverse Event|1|||
130643657|NCT01451203|470314735|FG000|Post-treatment Period|Investigator decision|0|||
130643658|NCT01451203|470314736|FG001|Post-treatment Period|Investigator decision|1|||
130643659|NCT03890731|470314737|FG000|Overall Study|Progressive disease|1|||
130643660|NCT03890731|470314737|FG000|Overall Study|Patient's decision|1|||
130643661|NCT03890731|470314737|FG000|Overall Study|Adverse Event|4|||
130643662|NCT00027027|470314738|FG000|Overall Study|Adverse Event|0|||
130643663|NCT00027027|470314739|FG001|Overall Study|Adverse Event|0|||
130643664|NCT00027027|470314740|FG002|Overall Study|Adverse Event|1|||
130643665|NCT00027027|470314741|FG003|Overall Study|Adverse Event|0|||
130643666|NCT00027027|470314742|FG004|Overall Study|Adverse Event|1|||
130643667|NCT00027027|470314738|FG000|Overall Study|Admitted for Signs of PD|0|||
130643668|NCT00027027|470314739|FG001|Overall Study|Admitted for Signs of PD|0|||
130643669|NCT00027027|470314740|FG002|Overall Study|Admitted for Signs of PD|0|||
130643670|NCT00027027|470314741|FG003|Overall Study|Admitted for Signs of PD|0|||
130643671|NCT00027027|470314742|FG004|Overall Study|Admitted for Signs of PD|1|||
130643672|NCT00027027|470314738|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
130643673|NCT00027027|470314739|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
130643674|NCT00027027|470314740|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
130643675|NCT00027027|470314741|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
130643676|NCT00027027|470314742|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
130643677|NCT00027027|470314738|FG000|Overall Study|PD Requiring Surgery|0|||
130643678|NCT00027027|470314739|FG001|Overall Study|PD Requiring Surgery|0|||
130643679|NCT00027027|470314740|FG002|Overall Study|PD Requiring Surgery|1|||
130643680|NCT00027027|470314741|FG003|Overall Study|PD Requiring Surgery|0|||
130643681|NCT00027027|470314742|FG004|Overall Study|PD Requiring Surgery|0|||
130643682|NCT00027027|470314738|FG000|Overall Study|Physician Decision Due To PD|2|||
130643683|NCT00027027|470314739|FG001|Overall Study|Physician Decision Due To PD|3|||
130643684|NCT00027027|470314740|FG002|Overall Study|Physician Decision Due To PD|2|||
130643685|NCT00027027|470314741|FG003|Overall Study|Physician Decision Due To PD|3|||
130643686|NCT00027027|470314742|FG004|Overall Study|Physician Decision Due To PD|5|||
130643687|NCT00027027|470314738|FG000|Overall Study|Withdrawal by Subject|0|||
130643688|NCT00027027|470314739|FG001|Overall Study|Withdrawal by Subject|0|||
130643689|NCT00027027|470314740|FG002|Overall Study|Withdrawal by Subject|0|||
130643690|NCT00027027|470314741|FG003|Overall Study|Withdrawal by Subject|0|||
130643691|NCT00027027|470314742|FG004|Overall Study|Withdrawal by Subject|1|||
130643692|NCT02967562|470314753|FG000|Overall Study|Consent not obtained|1|||
130643693|NCT02967562|470314754|FG001|Overall Study|Consent not obtained|0|||
130643694|NCT02967562|470314753|FG000|Overall Study|High leak precluding analysis|1|||
130643695|NCT02967562|470314754|FG001|Overall Study|High leak precluding analysis|1|||
130643696|NCT01038635|470314755|FG000|Overall Study|Disease Progression|2|||
130643697|NCT01038635|470314756|FG001|Overall Study|Disease Progression|0|||
130643698|NCT01038635|470314757|FG002|Overall Study|Disease Progression|0|||
130643699|NCT01038635|470314758|FG003|Overall Study|Disease Progression|0|||
130643700|NCT01038635|470314759|FG004|Overall Study|Disease Progression|0|||
130643701|NCT01038635|470314760|FG005|Overall Study|Disease Progression|0|||
130643702|NCT01038635|470314761|FG006|Overall Study|Disease Progression|1|||
130643703|NCT01038635|470314762|FG007|Overall Study|Disease Progression|4|||
130643704|NCT01038635|470314763|FG008|Overall Study|Disease Progression|0|||
130643705|NCT01038635|470314755|FG000|Overall Study|Death|0|||
130643706|NCT01038635|470314756|FG001|Overall Study|Death|0|||
130643707|NCT01038635|470314757|FG002|Overall Study|Death|0|||
130643708|NCT01038635|470314758|FG003|Overall Study|Death|0|||
130643709|NCT01038635|470314759|FG004|Overall Study|Death|1|||
130643710|NCT01038635|470314760|FG005|Overall Study|Death|0|||
130643711|NCT01038635|470314761|FG006|Overall Study|Death|1|||
130643712|NCT01038635|470314762|FG007|Overall Study|Death|1|||
130643713|NCT01038635|470314763|FG008|Overall Study|Death|2|||
130643714|NCT01060150|470314764|FG000|Overall Study|Adverse Event|6|||
130643715|NCT01060150|470314764|FG000|Overall Study|Lost to Follow-up|1|||
130643716|NCT01060150|470314764|FG000|Overall Study|Protocol Violation|6|||
130643717|NCT01060150|470314764|FG000|Overall Study|Withdrawal by Subject|8|||
130643718|NCT01060150|470314764|FG000|Overall Study|Enrolled, but not treated|2|||
130643719|NCT01562327|470314765|FG000|Overall Study|Adverse Event|2|||
130643720|NCT01562327|470314765|FG000|Overall Study|Lack of Efficacy|1|||
130643721|NCT01562327|470314765|FG000|Overall Study|Participant drop-out|1|||
130643722|NCT01562327|470314765|FG000|Overall Study|Infusion not received at 6 month window|4|||
130643723|NCT03018340|470314766|FG000|Overall Study|Adverse Event|1|||
130643724|NCT03018340|470314767|FG001|Overall Study|Adverse Event|2|||
130643725|NCT03018340|470314766|FG000|Overall Study|Withdrawal by Subject|0|||
130643726|NCT03018340|470314767|FG001|Overall Study|Withdrawal by Subject|8|||
130643727|NCT03018340|470314766|FG000|Overall Study|Lack of Efficacy|0|||
130643728|NCT03018340|470314767|FG001|Overall Study|Lack of Efficacy|1|||
130643729|NCT03018340|470314766|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
130643730|NCT03018340|470314767|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
130643731|NCT03018340|470314766|FG000|Overall Study|Lost to Follow-up|1|||
130643732|NCT03018340|470314767|FG001|Overall Study|Lost to Follow-up|7|||
130643733|NCT03018340|470314766|FG000|Overall Study|Protocol Violation|3|||
130643734|NCT03018340|470314767|FG001|Overall Study|Protocol Violation|7|||
130643735|NCT03018340|470314766|FG000|Overall Study|Not further specified|0|||
130643736|NCT03018340|470314767|FG001|Overall Study|Not further specified|1|||
130643737|NCT03961529|470314768|FG000|Overall Study|Adverse Event|13|||
130643738|NCT03961529|470314769|FG001|Overall Study|Adverse Event|5|||
130643739|NCT03961529|470314770|FG002|Overall Study|Adverse Event|2|||
130643740|NCT03961529|470314768|FG000|Overall Study|Withdrawal by Subject|17|||
130643741|NCT03961529|470314769|FG001|Overall Study|Withdrawal by Subject|2|||
130643742|NCT03961529|470314770|FG002|Overall Study|Withdrawal by Subject|1|||
130643743|NCT03961529|470314768|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130643744|NCT03961529|470314769|FG001|Overall Study|Withdrawal by parent/guardian|7|||
130643745|NCT03961529|470314770|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130643746|NCT03961529|470314768|FG000|Overall Study|Physician Decision|2|||
130643747|NCT03961529|470314769|FG001|Overall Study|Physician Decision|1|||
130643748|NCT03961529|470314770|FG002|Overall Study|Physician Decision|1|||
130643749|NCT03961529|470314768|FG000|Overall Study|Lost to Follow-up|2|||
130643750|NCT03961529|470314769|FG001|Overall Study|Lost to Follow-up|1|||
130643751|NCT03961529|470314770|FG002|Overall Study|Lost to Follow-up|0|||
130643752|NCT03961529|470314768|FG000|Overall Study|Lack of Efficacy|2|||
130643753|NCT03961529|470314769|FG001|Overall Study|Lack of Efficacy|0|||
130643754|NCT03961529|470314770|FG002|Overall Study|Lack of Efficacy|1|||
130643755|NCT03961529|470314768|FG000|Overall Study|Other|6|||
130643756|NCT03961529|470314769|FG001|Overall Study|Other|1|||
130643757|NCT03961529|470314770|FG002|Overall Study|Other|0|||
130643758|NCT03644173|470314771|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
130643759|NCT03644173|470314771|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
130643760|NCT03644173|470314771|FG000|Participants at the 1-month Follow up|Death|2|||
130643761|NCT03644173|470314771|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
130643762|NCT00381706|470314774|FG000|Overall Study|Never treated|7|||
130643763|NCT00381706|470314775|FG001|Overall Study|Never treated|2|||
130643764|NCT00381706|470314776|FG002|Overall Study|Never treated|1|||
130643765|NCT00256204|470314781|FG000|Overall Study|Adverse Event|10|||
130643766|NCT00256204|470314782|FG001|Overall Study|Adverse Event|14|||
130643767|NCT00256204|470314783|FG002|Overall Study|Adverse Event|16|||
130643768|NCT00256204|470314784|FG003|Overall Study|Adverse Event|14|||
130643769|NCT00256204|470314781|FG000|Overall Study|Death|0|||
130643770|NCT00256204|470314782|FG001|Overall Study|Death|1|||
130643771|NCT00256204|470314783|FG002|Overall Study|Death|0|||
130643772|NCT00256204|470314784|FG003|Overall Study|Death|0|||
130643773|NCT00256204|470314781|FG000|Overall Study|Lost to Follow-up|1|||
130643774|NCT00256204|470314782|FG001|Overall Study|Lost to Follow-up|1|||
130643775|NCT00256204|470314783|FG002|Overall Study|Lost to Follow-up|1|||
130643776|NCT00256204|470314784|FG003|Overall Study|Lost to Follow-up|2|||
130643777|NCT00256204|470314781|FG000|Overall Study|Protocol Violation|1|||
130643778|NCT00256204|470314782|FG001|Overall Study|Protocol Violation|0|||
130643779|NCT00256204|470314783|FG002|Overall Study|Protocol Violation|2|||
130643780|NCT00256204|470314784|FG003|Overall Study|Protocol Violation|1|||
130643781|NCT00256204|470314781|FG000|Overall Study|Physician Decision|0|||
130643782|NCT00256204|470314782|FG001|Overall Study|Physician Decision|0|||
130643783|NCT00256204|470314783|FG002|Overall Study|Physician Decision|1|||
130643784|NCT00256204|470314784|FG003|Overall Study|Physician Decision|2|||
130643785|NCT00256204|470314781|FG000|Overall Study|Withdrawal by Subject|17|||
130643786|NCT00256204|470314782|FG001|Overall Study|Withdrawal by Subject|6|||
130643787|NCT00256204|470314783|FG002|Overall Study|Withdrawal by Subject|7|||
130643788|NCT00256204|470314784|FG003|Overall Study|Withdrawal by Subject|5|||
130643789|NCT00256204|470314781|FG000|Overall Study|Need for additional prohibited treatment|38|||
130643790|NCT00256204|470314782|FG001|Overall Study|Need for additional prohibited treatment|28|||
130643791|NCT00256204|470314783|FG002|Overall Study|Need for additional prohibited treatment|27|||
130643792|NCT00256204|470314784|FG003|Overall Study|Need for additional prohibited treatment|25|||
130643793|NCT00550615|470314787|FG000|Overall Study|Withdrawal by Subject|0|||
130643794|NCT00550615|470314788|FG001|Overall Study|Withdrawal by Subject|0|||
130643795|NCT00550615|470314789|FG002|Overall Study|Withdrawal by Subject|2|||
130643796|NCT00550615|470314790|FG003|Overall Study|Withdrawal by Subject|3|||
130643797|NCT00550615|470314787|FG000|Overall Study|Not evaluable|0|||
130643798|NCT00550615|470314788|FG001|Overall Study|Not evaluable|0|||
130643799|NCT00550615|470314789|FG002|Overall Study|Not evaluable|2|||
130643800|NCT00550615|470314790|FG003|Overall Study|Not evaluable|7|||
130643801|NCT02405091|470314791|FG000|Overall Study|Adverse Event|16|||
130643802|NCT02405091|470314792|FG001|Overall Study|Adverse Event|10|||
130643803|NCT02405091|470314793|FG002|Overall Study|Adverse Event|0|||
130643804|NCT02405091|470314791|FG000|Overall Study|Protocol Violation|1|||
130643805|NCT02405091|470314792|FG001|Overall Study|Protocol Violation|0|||
130643806|NCT02405091|470314793|FG002|Overall Study|Protocol Violation|0|||
130643807|NCT02405091|470314791|FG000|Overall Study|Noncompliance|1|||
130643808|NCT02405091|470314792|FG001|Overall Study|Noncompliance|6|||
130643809|NCT02405091|470314793|FG002|Overall Study|Noncompliance|2|||
130643810|NCT02405091|470314791|FG000|Overall Study|Withdrawal by Subject|4|||
130643811|NCT02405091|470314792|FG001|Overall Study|Withdrawal by Subject|8|||
130643812|NCT02405091|470314793|FG002|Overall Study|Withdrawal by Subject|0|||
130643813|NCT02405091|470314791|FG000|Overall Study|Death|0|||
130643814|NCT02405091|470314792|FG001|Overall Study|Death|1|||
130643815|NCT02405091|470314793|FG002|Overall Study|Death|0|||
130643816|NCT02405091|470314791|FG000|Overall Study|Lost to Follow-up|5|||
130643817|NCT02405091|470314792|FG001|Overall Study|Lost to Follow-up|6|||
130643818|NCT02405091|470314793|FG002|Overall Study|Lost to Follow-up|0|||
130643819|NCT02405091|470314791|FG000|Overall Study|Physician Decision|2|||
130643820|NCT02405091|470314792|FG001|Overall Study|Physician Decision|2|||
130643821|NCT02405091|470314793|FG002|Overall Study|Physician Decision|0|||
130643822|NCT01955005|470314818|FG000|Overall Study|Withdrawal by Subject|3|||
130643823|NCT01955005|470314819|FG001|Overall Study|Withdrawal by Subject|5|||
130643824|NCT02555722|470314820|FG000|Week 2|Adverse Event|0|||
130643825|NCT02555722|470314821|FG001|Week 2|Adverse Event|1|||
130643826|NCT02555722|470314820|FG000|Week 2|Withdrawal by Subject|1|||
130643827|NCT02555722|470314821|FG001|Week 2|Withdrawal by Subject|0|||
130643828|NCT02555722|470314820|FG000|Month 1|Lens Discomfort|1|||
130643829|NCT02555722|470314821|FG001|Month 1|Lens Discomfort|0|||
130643830|NCT02555722|470314820|FG000|Month 2|Withdrawal by Subject|3|||
130643831|NCT02555722|470314821|FG001|Month 2|Withdrawal by Subject|0|||
130643832|NCT02555722|470314820|FG000|Month 2|Lost to Follow-up|1|||
130643833|NCT02555722|470314821|FG001|Month 2|Lost to Follow-up|0|||
130643834|NCT00352027|470314822|FG000|Overall Study|Progressive disease|3|||
130643835|NCT03922711|470314829|FG000|Overall Study|Adverse Event|3|||
130643836|NCT03922711|470314830|FG001|Overall Study|Adverse Event|2|||
130643837|NCT03922711|470314831|FG002|Overall Study|Adverse Event|2|||
130643838|NCT03922711|470314829|FG000|Overall Study|Protocol Violation|1|||
130643839|NCT03922711|470314830|FG001|Overall Study|Protocol Violation|0|||
130643840|NCT03922711|470314831|FG002|Overall Study|Protocol Violation|0|||
130643841|NCT03922711|470314829|FG000|Overall Study|Withdrawal by Subject|0|||
130643842|NCT03922711|470314830|FG001|Overall Study|Withdrawal by Subject|3|||
130643843|NCT03922711|470314831|FG002|Overall Study|Withdrawal by Subject|1|||
130643844|NCT03922711|470314829|FG000|Overall Study|Not further specified|0|||
130643845|NCT03922711|470314830|FG001|Overall Study|Not further specified|0|||
130643846|NCT03922711|470314831|FG002|Overall Study|Not further specified|1|||
130643847|NCT03147495|470314832|FG000|Overall Study|Physician Decision|0|||
130643848|NCT03147495|470314833|FG001|Overall Study|Physician Decision|6|||
130643849|NCT00742391|470314840|FG000|Overall Study|Adverse Event|2|||
130643850|NCT00742391|470314841|FG001|Overall Study|Adverse Event|1|||
130643851|NCT00742391|470314840|FG000|Overall Study|Lost to Follow-up|1|||
130643852|NCT00742391|470314841|FG001|Overall Study|Lost to Follow-up|0|||
130643853|NCT00742391|470314840|FG000|Overall Study|Protocol Violation|1|||
130643854|NCT00742391|470314841|FG001|Overall Study|Protocol Violation|0|||
130643855|NCT02975206|470314848|FG000|Overall Study|Withdrawal by Subject|14|||
130643856|NCT02975206|470314849|FG001|Overall Study|Withdrawal by Subject|11|||
130643857|NCT02975206|470314850|FG002|Overall Study|Withdrawal by Subject|11|||
130643858|NCT02975206|470314848|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
130643859|NCT02975206|470314849|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
130643860|NCT02975206|470314850|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
130643861|NCT01981096|470314851|FG000|Overall Study|Parent illness|1|||
130643862|NCT01981096|470314852|FG001|Overall Study|Parent illness|0|||
130643863|NCT01981096|470314851|FG000|Overall Study|Withdrawal by Subject|0|||
130643864|NCT01981096|470314852|FG001|Overall Study|Withdrawal by Subject|1|||
130643865|NCT01981096|470314851|FG000|Overall Study|Lost to Follow-up|2|||
130643866|NCT01981096|470314852|FG001|Overall Study|Lost to Follow-up|0|||
130643867|NCT00866606|470314853|FG000|Overall Study|Lost to Follow-up|3|||
130643868|NCT00866606|470314853|FG000|Overall Study|Adverse Event|1|||
130643869|NCT01225211|470314854|FG000|Overall Study|Adverse Event|0|||
130643870|NCT01225211|470314855|FG001|Overall Study|Adverse Event|0|||
130643871|NCT01225211|470314856|FG002|Overall Study|Adverse Event|1|||
130643872|NCT01225211|470314857|FG003|Overall Study|Adverse Event|0|||
130643873|NCT01225211|470314858|FG004|Overall Study|Adverse Event|0|||
130643874|NCT01225211|470314859|FG005|Overall Study|Adverse Event|0|||
130643875|NCT01225211|470314860|FG006|Overall Study|Adverse Event|0|||
130643876|NCT01225211|470314861|FG007|Overall Study|Adverse Event|0|||
130643877|NCT01225211|470314862|FG008|Overall Study|Adverse Event|0|||
130643878|NCT01225211|470314863|FG009|Overall Study|Adverse Event|1|||
130643879|NCT01225211|470314854|FG000|Overall Study|Withdrawal by Subject|0|||
130643880|NCT01225211|470314855|FG001|Overall Study|Withdrawal by Subject|0|||
130643881|NCT01225211|470314856|FG002|Overall Study|Withdrawal by Subject|0|||
130643882|NCT01225211|470314857|FG003|Overall Study|Withdrawal by Subject|0|||
130643883|NCT01225211|470314858|FG004|Overall Study|Withdrawal by Subject|0|||
130643884|NCT01225211|470314859|FG005|Overall Study|Withdrawal by Subject|0|||
130643885|NCT01225211|470314860|FG006|Overall Study|Withdrawal by Subject|1|||
130643886|NCT01225211|470314861|FG007|Overall Study|Withdrawal by Subject|0|||
130643887|NCT01225211|470314862|FG008|Overall Study|Withdrawal by Subject|1|||
130643888|NCT01225211|470314863|FG009|Overall Study|Withdrawal by Subject|3|||
130643889|NCT01225211|470314854|FG000|Overall Study|Other|0|||
130643890|NCT01225211|470314855|FG001|Overall Study|Other|0|||
130643891|NCT01225211|470314856|FG002|Overall Study|Other|0|||
130643892|NCT01225211|470314857|FG003|Overall Study|Other|0|||
130643893|NCT01225211|470314858|FG004|Overall Study|Other|0|||
130643894|NCT01225211|470314859|FG005|Overall Study|Other|0|||
130643895|NCT01225211|470314860|FG006|Overall Study|Other|0|||
130643896|NCT01225211|470314861|FG007|Overall Study|Other|0|||
130643897|NCT01225211|470314862|FG008|Overall Study|Other|0|||
130643898|NCT01225211|470314863|FG009|Overall Study|Other|1|||
130643899|NCT01058356|470314883|FG000|Overall Study|Adverse Event|5|||
130643900|NCT01058356|470314883|FG000|Overall Study|Administration of contraindicated drugs|12|||
130643901|NCT01058356|470314883|FG000|Overall Study|Withdrawal by Subject|21|||
130643902|NCT01058356|470314883|FG000|Overall Study|Lost to Follow-up|4|||
130643903|NCT00392210|470314884|FG000|First Voiding Trial|Physician Decision|2|||
130643904|NCT00392210|470314885|FG001|First Voiding Trial|Physician Decision|2|||
130643905|NCT00606021|470314886|FG000|Induction Phase|Death|73|||
130643906|NCT00606021|470314887|FG001|Induction Phase|Death|0|||
130643907|NCT00606021|470314888|FG002|Induction Phase|Death|0|||
130643908|NCT00606021|470314886|FG000|Induction Phase|Physician Decision|2|||
130643909|NCT00606021|470314887|FG001|Induction Phase|Physician Decision|0|||
130643910|NCT00606021|470314888|FG002|Induction Phase|Physician Decision|0|||
130643911|NCT00606021|470314886|FG000|Induction Phase|Withdrawal by Subject|2|||
130643912|NCT00606021|470314887|FG001|Induction Phase|Withdrawal by Subject|0|||
130643913|NCT00606021|470314888|FG002|Induction Phase|Withdrawal by Subject|0|||
130643914|NCT00606021|470314886|FG000|Induction Phase|Lost to Follow-up|10|||
130643915|NCT00606021|470314887|FG001|Induction Phase|Lost to Follow-up|0|||
130643916|NCT00606021|470314888|FG002|Induction Phase|Lost to Follow-up|0|||
130643917|NCT00606021|470314886|FG000|Maintenance Phase|Death|0|||
130643918|NCT00606021|470314887|FG001|Maintenance Phase|Death|17|||
130643919|NCT00606021|470314888|FG002|Maintenance Phase|Death|15|||
130643920|NCT00606021|470314886|FG000|Maintenance Phase|Physician Decision|0|||
130643921|NCT00606021|470314887|FG001|Maintenance Phase|Physician Decision|1|||
130643922|NCT00606021|470314888|FG002|Maintenance Phase|Physician Decision|0|||
130643923|NCT00606021|470314886|FG000|Maintenance Phase|Lost to Follow-up|0|||
130643924|NCT00606021|470314887|FG001|Maintenance Phase|Lost to Follow-up|5|||
130643925|NCT00606021|470314888|FG002|Maintenance Phase|Lost to Follow-up|2|||
130643926|NCT02067104|470314889|FG000|Overall Study|Study termination due to low accrual|4|||
130643927|NCT02067104|470314890|FG001|Overall Study|Study termination due to low accrual|5|||
130643928|NCT02140762|470314902|FG000|Overall Study|Adverse Event|1|||
130643929|NCT02140762|470314903|FG001|Overall Study|Adverse Event|1|||
130643930|NCT02140762|470314902|FG000|Overall Study|Lost to Follow-up|9|||
130643931|NCT02140762|470314903|FG001|Overall Study|Lost to Follow-up|5|||
130643932|NCT02140762|470314902|FG000|Overall Study|Protocol Violation|1|||
130643933|NCT02140762|470314903|FG001|Overall Study|Protocol Violation|1|||
130643934|NCT02140762|470314902|FG000|Overall Study|Withdrawal by Subject|6|||
130643935|NCT02140762|470314903|FG001|Overall Study|Withdrawal by Subject|4|||
130643936|NCT02140762|470314902|FG000|Overall Study|Other|0|||
130643937|NCT02140762|470314903|FG001|Overall Study|Other|1|||
130643938|NCT04815291|470314904|FG000|Overall Study|Lost to Follow-up|1|||
130643939|NCT04815291|470314904|FG000|Overall Study|Physician Decision|4|||
130643940|NCT04815291|470314904|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
130643941|NCT00095836|470314906|FG000|Overall Study|Lost to Follow-up|1|||
130643942|NCT00095836|470314906|FG000|Overall Study|Adverse Event|1|||
130643943|NCT00095836|470314906|FG000|Overall Study|Death|2|||
130643944|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
130643945|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
130643946|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
130643947|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130643948|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
130643949|NCT00989664|470314909|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
130643950|NCT00989664|470314909|FG000|Long-Term Follow-Up|Death|3|||
130643951|NCT00962780|470314911|FG000|Overall Study|Death|0|||
130643952|NCT00962780|470314912|FG001|Overall Study|Death|1|||
130643953|NCT00962780|470314911|FG000|Overall Study|Protocol Violation|9|||
130643954|NCT00962780|470314912|FG001|Overall Study|Protocol Violation|4|||
130643955|NCT00962780|470314911|FG000|Overall Study|Withdrawal by Subject|1|||
130643956|NCT00962780|470314912|FG001|Overall Study|Withdrawal by Subject|8|||
130643957|NCT00962780|470314911|FG000|Overall Study|Other|0|||
130643958|NCT00962780|470314912|FG001|Overall Study|Other|1|||
130643959|NCT02363322|470314913|FG000|Overall Study|Lost to Follow-up|1|||
130643960|NCT02363322|470314914|FG001|Overall Study|Lost to Follow-up|0|||
130643961|NCT02055976|470314915|FG000|Overall Study|Other|0|||
130643962|NCT02055976|470314916|FG001|Overall Study|Other|0|||
130643963|NCT02055976|470314917|FG002|Overall Study|Other|1|||
130643964|NCT02055976|470314918|FG003|Overall Study|Other|0|||
130643965|NCT02055976|470314919|FG004|Overall Study|Other|0|||
130643966|NCT02055976|470314920|FG005|Overall Study|Other|0|||
130643967|NCT02055976|470314921|FG006|Overall Study|Other|0|||
130643968|NCT02055976|470314922|FG007|Overall Study|Other|0|||
130643969|NCT02055976|470314923|FG008|Overall Study|Other|0|||
130643970|NCT02055976|470314915|FG000|Overall Study|Adverse Event|0|||
130643971|NCT02055976|470314916|FG001|Overall Study|Adverse Event|0|||
130643972|NCT02055976|470314917|FG002|Overall Study|Adverse Event|0|||
130643973|NCT02055976|470314918|FG003|Overall Study|Adverse Event|0|||
130643974|NCT02055976|470314919|FG004|Overall Study|Adverse Event|0|||
130643975|NCT02055976|470314920|FG005|Overall Study|Adverse Event|1|||
130643976|NCT02055976|470314921|FG006|Overall Study|Adverse Event|1|||
130643977|NCT02055976|470314922|FG007|Overall Study|Adverse Event|0|||
130643978|NCT02055976|470314923|FG008|Overall Study|Adverse Event|0|||
130643979|NCT02055976|470314915|FG000|Overall Study|Does not meet entrance criteria|0|||
130643980|NCT02055976|470314916|FG001|Overall Study|Does not meet entrance criteria|0|||
130643981|NCT02055976|470314917|FG002|Overall Study|Does not meet entrance criteria|0|||
130643982|NCT02055976|470314918|FG003|Overall Study|Does not meet entrance criteria|0|||
130643983|NCT02055976|470314919|FG004|Overall Study|Does not meet entrance criteria|0|||
130643984|NCT02055976|470314920|FG005|Overall Study|Does not meet entrance criteria|0|||
130643985|NCT02055976|470314921|FG006|Overall Study|Does not meet entrance criteria|1|||
130643986|NCT02055976|470314922|FG007|Overall Study|Does not meet entrance criteria|0|||
130643987|NCT02055976|470314923|FG008|Overall Study|Does not meet entrance criteria|0|||
130643988|NCT02055976|470314915|FG000|Overall Study|Lost to Follow-up|0|||
130643989|NCT02055976|470314916|FG001|Overall Study|Lost to Follow-up|0|||
130643990|NCT02055976|470314917|FG002|Overall Study|Lost to Follow-up|0|||
130643991|NCT02055976|470314918|FG003|Overall Study|Lost to Follow-up|1|||
130643992|NCT02055976|470314919|FG004|Overall Study|Lost to Follow-up|0|||
130643993|NCT02055976|470314920|FG005|Overall Study|Lost to Follow-up|0|||
130643994|NCT02055976|470314921|FG006|Overall Study|Lost to Follow-up|0|||
130643995|NCT02055976|470314922|FG007|Overall Study|Lost to Follow-up|0|||
130643996|NCT02055976|470314923|FG008|Overall Study|Lost to Follow-up|0|||
130643997|NCT01230827|470314924|FG000|Overall Study|Lost to Follow-up|0|||
130643998|NCT01230827|470314925|FG001|Overall Study|Lost to Follow-up|0|||
130643999|NCT01230827|470314926|FG002|Overall Study|Lost to Follow-up|1|||
130644000|NCT01230827|470314927|FG003|Overall Study|Lost to Follow-up|3|||
130644001|NCT01230827|470314924|FG000|Overall Study|Withdrawal by Subject|1|||
130644002|NCT01230827|470314925|FG001|Overall Study|Withdrawal by Subject|0|||
130644003|NCT01230827|470314926|FG002|Overall Study|Withdrawal by Subject|3|||
130644004|NCT01230827|470314927|FG003|Overall Study|Withdrawal by Subject|2|||
130644005|NCT01230827|470314924|FG000|Overall Study|Lack of Efficacy|14|||
130644006|NCT01230827|470314925|FG001|Overall Study|Lack of Efficacy|1|||
130644007|NCT01230827|470314926|FG002|Overall Study|Lack of Efficacy|2|||
130644008|NCT01230827|470314927|FG003|Overall Study|Lack of Efficacy|3|||
130644009|NCT01230827|470314924|FG000|Overall Study|Adverse Event|4|||
130644010|NCT01230827|470314925|FG001|Overall Study|Adverse Event|2|||
130644011|NCT01230827|470314926|FG002|Overall Study|Adverse Event|3|||
130644012|NCT01230827|470314927|FG003|Overall Study|Adverse Event|7|||
130644013|NCT01230827|470314924|FG000|Overall Study|Recovery|0|||
130644014|NCT01230827|470314925|FG001|Overall Study|Recovery|6|||
130644015|NCT01230827|470314926|FG002|Overall Study|Recovery|0|||
130644016|NCT01230827|470314927|FG003|Overall Study|Recovery|0|||
130644017|NCT01230827|470314924|FG000|Overall Study|Study terminated by Sponsor|0|||
130644018|NCT01230827|470314925|FG001|Overall Study|Study terminated by Sponsor|2|||
130644019|NCT01230827|470314926|FG002|Overall Study|Study terminated by Sponsor|56|||
130644020|NCT01230827|470314927|FG003|Overall Study|Study terminated by Sponsor|63|||
130644021|NCT00805142|470314928|FG000|Titration Period|Adverse Event|3|||
130644022|NCT00805142|470314929|FG001|Titration Period|Adverse Event|3|||
130644023|NCT00805142|470314928|FG000|Titration Period|Lack of Efficacy|1|||
130644024|NCT00805142|470314929|FG001|Titration Period|Lack of Efficacy|1|||
130644025|NCT00805142|470314928|FG000|Titration Period|Lost to Follow-up|0|||
130644026|NCT00805142|470314929|FG001|Titration Period|Lost to Follow-up|1|||
130644027|NCT00805142|470314928|FG000|Titration Period|Disease Progression|2|||
130644028|NCT00805142|470314929|FG001|Titration Period|Disease Progression|1|||
130644029|NCT00805142|470314928|FG000|Titration Period|Withdrawal of consent|0|||
130644030|NCT00805142|470314929|FG001|Titration Period|Withdrawal of consent|1|||
130644031|NCT00805142|470314928|FG000|Titration Period|Other|0|||
130644032|NCT00805142|470314929|FG001|Titration Period|Other|3|||
130644033|NCT00805142|470314928|FG000|Maintenance Period|Adverse Event|0|||
130644034|NCT00805142|470314929|FG001|Maintenance Period|Adverse Event|1|||
130644035|NCT00805142|470314928|FG000|Maintenance Period|Other|0|||
130644036|NCT00805142|470314929|FG001|Maintenance Period|Other|1|||
130644037|NCT00394654|470314930|FG000|Overall Study|Lost to Follow-up|1|||
130644038|NCT00394654|470314931|FG001|Overall Study|Lost to Follow-up|0|||
130644039|NCT00394654|470314930|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
130644040|NCT00394654|470314931|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
130644041|NCT02886338|470314932|FG000|Overall Study|Withdrawal by Subject|1|||
130644042|NCT00122317|470314933|FG000|Overall Study|Death|3|||
130644043|NCT00122317|470314933|FG000|Overall Study|Adverse Event|4|||
130644044|NCT00122317|470314933|FG000|Overall Study|Physician Decision|2|||
130644045|NCT00122317|470314933|FG000|Overall Study|patient non-compliance|1|||
130644046|NCT00122317|470314933|FG000|Overall Study|Withdrawal by Subject|1|||
130644047|NCT03756285|470314934|FG000|Overall Study|Lost to Follow-up|0|||
130644048|NCT03756285|470314935|FG001|Overall Study|Lost to Follow-up|1|||
130644049|NCT03756285|470314934|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
130644050|NCT03756285|470314935|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
130644051|NCT03756285|470314934|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
130644052|NCT03756285|470314935|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
130644053|NCT03458234|470314938|FG000|Overall Study|Withdrawal by Subject|1|||
130644054|NCT01021293|470314940|FG000|Overall Study|Serious Adverse Event|2|||
130644055|NCT01021293|470314941|FG001|Overall Study|Serious Adverse Event|1|||
130644056|NCT01021293|470314940|FG000|Overall Study|Adverse Event|2|||
130644057|NCT01021293|470314941|FG001|Overall Study|Adverse Event|1|||
130644058|NCT01021293|470314940|FG000|Overall Study|Withdrawal by Subject|1|||
130644059|NCT01021293|470314941|FG001|Overall Study|Withdrawal by Subject|3|||
130644060|NCT01021293|470314940|FG000|Overall Study|Migrated/moved from study area|6|||
130644061|NCT01021293|470314941|FG001|Overall Study|Migrated/moved from study area|18|||
130644062|NCT01021293|470314940|FG000|Overall Study|Lost to Follow-up|1|||
130644063|NCT01021293|470314941|FG001|Overall Study|Lost to Follow-up|1|||
130644064|NCT02889861|470317153|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
130644065|NCT01864746|470317154|FG000|Overall Study|Disease recurrence|25|||
130644066|NCT01864746|470317155|FG001|Overall Study|Disease recurrence|40|||
130644067|NCT01864746|470317154|FG000|Overall Study|Second primary invasive nonbreast|2|||
130644068|NCT01864746|470317155|FG001|Overall Study|Second primary invasive nonbreast|3|||
130644069|NCT01864746|470317154|FG000|Overall Study|Death|2|||
130644070|NCT01864746|470317155|FG001|Overall Study|Death|1|||
130644071|NCT01864746|470317154|FG000|Overall Study|Adverse Event|33|||
130644072|NCT01864746|470317155|FG001|Overall Study|Adverse Event|5|||
130644073|NCT01864746|470317154|FG000|Overall Study|Withdrawal by Subject|56|||
130644074|NCT01864746|470317155|FG001|Overall Study|Withdrawal by Subject|41|||
130644075|NCT01864746|470317154|FG000|Overall Study|Physician Decision|5|||
130644076|NCT01864746|470317155|FG001|Overall Study|Physician Decision|6|||
130644077|NCT02039687|470317161|FG000|Overall Study|Adverse Event|0|||
130644078|NCT02039687|470317162|FG001|Overall Study|Adverse Event|0|||
130644079|NCT02039687|470317163|FG002|Overall Study|Adverse Event|1|||
130644080|NCT02039687|470317164|FG003|Overall Study|Adverse Event|0|||
130644081|NCT02039687|470317161|FG000|Overall Study|Withdrawal by Subject|0|||
130644082|NCT02039687|470317162|FG001|Overall Study|Withdrawal by Subject|1|||
130644083|NCT02039687|470317163|FG002|Overall Study|Withdrawal by Subject|0|||
130644084|NCT02039687|470317164|FG003|Overall Study|Withdrawal by Subject|0|||
130644085|NCT02039687|470317161|FG000|Overall Study|treatment assignment could not be confir|0|||
130644086|NCT02039687|470317162|FG001|Overall Study|treatment assignment could not be confir|0|||
130644087|NCT02039687|470317163|FG002|Overall Study|treatment assignment could not be confir|2|||
130644088|NCT02039687|470317164|FG003|Overall Study|treatment assignment could not be confir|0|||
130644089|NCT00303329|470317169|FG000|Overall Study|Adverse Event|7|||
130644090|NCT00303329|470317170|FG001|Overall Study|Adverse Event|14|||
130644091|NCT00303329|470317169|FG000|Overall Study|Abnormal Laboratory Values|0|||
130644092|NCT00303329|470317170|FG001|Overall Study|Abnormal Laboratory Values|1|||
130644093|NCT00303329|470317169|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
130644094|NCT00303329|470317170|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130644095|NCT00303329|470317169|FG000|Overall Study|Condition no longer requires study drug|0|||
130644096|NCT00303329|470317170|FG001|Overall Study|Condition no longer requires study drug|8|||
130644097|NCT00303329|470317169|FG000|Overall Study|Protocol Violation|3|||
130644098|NCT00303329|470317170|FG001|Overall Study|Protocol Violation|0|||
130644099|NCT00303329|470317169|FG000|Overall Study|Withdrawal by Subject|9|||
130644100|NCT00303329|470317170|FG001|Overall Study|Withdrawal by Subject|15|||
130644101|NCT00303329|470317169|FG000|Overall Study|Lost to Follow-up|0|||
130644102|NCT00303329|470317170|FG001|Overall Study|Lost to Follow-up|1|||
130644103|NCT00303329|470317169|FG000|Overall Study|Administrative problems|1|||
130644104|NCT00303329|470317170|FG001|Overall Study|Administrative problems|0|||
130644105|NCT00303329|470317169|FG000|Overall Study|Death|2|||
130644106|NCT00303329|470317170|FG001|Overall Study|Death|12|||
130644107|NCT00303329|470317169|FG000|Overall Study|Stopped at end of core|3|||
130644108|NCT00303329|470317170|FG001|Overall Study|Stopped at end of core|9|||
130644109|NCT00303329|470317169|FG000|Overall Study|Stopped at end of extension 1|1|||
130644110|NCT00303329|470317170|FG001|Overall Study|Stopped at end of extension 1|0|||
130644111|NCT00542321|470317171|FG000|Overall Study|Death|0|||
130644112|NCT00542321|470317172|FG001|Overall Study|Death|1|||
130644113|NCT00253747|470317178|FG000|Overall Study|Lost to Follow-up|13|||
130644114|NCT00253747|470317179|FG001|Overall Study|Lost to Follow-up|14|||
130644115|NCT00253747|470317178|FG000|Overall Study|Withdrawal by Subject|10|||
130644116|NCT00253747|470317179|FG001|Overall Study|Withdrawal by Subject|11|||
130644117|NCT00253747|470317178|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
130644118|NCT00253747|470317179|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
130644119|NCT00718887|470317181|FG000|Overall Study|Withdrawal by Subject|3|||
130644120|NCT00718887|470317182|FG001|Overall Study|Withdrawal by Subject|2|||
130644121|NCT00718887|470317181|FG000|Overall Study|Not identified|2|||
130644122|NCT00718887|470317182|FG001|Overall Study|Not identified|7|||
130644123|NCT05102734|470317184|FG000|Overall Study|Did not require vasopressors|1|||
130644124|NCT05102734|470317185|FG001|Overall Study|Did not require vasopressors|0|||
130644125|NCT05102734|470317184|FG000|Overall Study|Did not have functioning PA catheter|1|||
130644126|NCT05102734|470317185|FG001|Overall Study|Did not have functioning PA catheter|0|||
130644127|NCT05102734|470317184|FG000|Overall Study|Inadequate video quality|2|||
130644128|NCT05102734|470317185|FG001|Overall Study|Inadequate video quality|0|||
130644129|NCT04235959|470317186|FG000|Overall Study|Protocol Violation|0|||
130644130|NCT04235959|470317187|FG001|Overall Study|Protocol Violation|1|||
130644131|NCT04235959|470317188|FG002|Overall Study|Protocol Violation|0|||
130644132|NCT04235959|470317186|FG000|Overall Study|Adverse Event|1|||
130644133|NCT04235959|470317187|FG001|Overall Study|Adverse Event|0|||
130644134|NCT04235959|470317188|FG002|Overall Study|Adverse Event|0|||
130644135|NCT00608426|470317189|FG000|Overall Study|Death|32|||
130644136|NCT00608426|470317190|FG001|Overall Study|Death|36|||
130644137|NCT00608426|470317189|FG000|Overall Study|Lost to Follow-up|485|||
130644138|NCT00608426|470317190|FG001|Overall Study|Lost to Follow-up|521|||
130644139|NCT00608426|470317189|FG000|Overall Study|refused, health issues, wrong address|319|||
130644140|NCT00608426|470317190|FG001|Overall Study|refused, health issues, wrong address|348|||
130644141|NCT03055806|470317194|FG000|Overall Study|Adverse Event|0|||
130644142|NCT03055806|470317195|FG001|Overall Study|Adverse Event|0|||
130644143|NCT03055806|470317196|FG002|Overall Study|Adverse Event|1|||
130644144|NCT03055806|470317197|FG003|Overall Study|Adverse Event|1|||
130644145|NCT03055806|470317194|FG000|Overall Study|Lost to Follow-up|0|||
130644146|NCT03055806|470317195|FG001|Overall Study|Lost to Follow-up|3|||
130644147|NCT03055806|470317196|FG002|Overall Study|Lost to Follow-up|6|||
130644148|NCT03055806|470317197|FG003|Overall Study|Lost to Follow-up|7|||
130644149|NCT03055806|470317194|FG000|Overall Study|Physician Decision|1|||
130644150|NCT03055806|470317195|FG001|Overall Study|Physician Decision|0|||
130644151|NCT03055806|470317196|FG002|Overall Study|Physician Decision|0|||
130644152|NCT03055806|470317197|FG003|Overall Study|Physician Decision|1|||
130644153|NCT03055806|470317194|FG000|Overall Study|Protocol Violation|1|||
130644154|NCT03055806|470317195|FG001|Overall Study|Protocol Violation|0|||
130644155|NCT03055806|470317196|FG002|Overall Study|Protocol Violation|0|||
130644156|NCT03055806|470317197|FG003|Overall Study|Protocol Violation|0|||
130644157|NCT03055806|470317194|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
130644158|NCT03055806|470317195|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
130644159|NCT03055806|470317196|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
130644160|NCT03055806|470317197|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
130644161|NCT03055806|470317194|FG000|Overall Study|Withdrawal of consent to continue study|2|||
130644162|NCT03055806|470317195|FG001|Overall Study|Withdrawal of consent to continue study|3|||
130644163|NCT03055806|470317196|FG002|Overall Study|Withdrawal of consent to continue study|4|||
130644164|NCT03055806|470317197|FG003|Overall Study|Withdrawal of consent to continue study|6|||
130644165|NCT03055806|470317194|FG000|Overall Study|Partner not willing to try intercourse|1|||
130644166|NCT03055806|470317195|FG001|Overall Study|Partner not willing to try intercourse|0|||
130644167|NCT03055806|470317196|FG002|Overall Study|Partner not willing to try intercourse|0|||
130644168|NCT03055806|470317197|FG003|Overall Study|Partner not willing to try intercourse|0|||
130644169|NCT04601194|470317198|FG000|Overall Study|Lost to Follow-up|7|||
130644170|NCT02630459|470317199|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644171|NCT02630459|470317200|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
130644172|NCT02630459|470317201|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644173|NCT02630459|470317202|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
130644174|NCT02630459|470317203|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644175|NCT02630459|470317204|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644176|NCT02630459|470317205|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644177|NCT02630459|470317206|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130644178|NCT02630459|470317199|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644179|NCT02630459|470317200|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644180|NCT02630459|470317201|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
130644181|NCT02630459|470317202|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644182|NCT02630459|470317203|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644183|NCT02630459|470317204|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644184|NCT02630459|470317205|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644185|NCT02630459|470317206|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130644186|NCT02630459|470317199|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
130644187|NCT02630459|470317200|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
130644188|NCT02630459|470317201|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
130644189|NCT02630459|470317202|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
130644190|NCT02630459|470317203|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130644191|NCT02630459|470317204|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130644192|NCT02630459|470317205|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130644193|NCT02630459|470317206|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130644194|NCT02630459|470317199|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
130644195|NCT02630459|470317200|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644196|NCT02630459|470317201|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644197|NCT02630459|470317202|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644198|NCT02630459|470317203|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644199|NCT02630459|470317204|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644200|NCT02630459|470317205|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644201|NCT02630459|470317206|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130644202|NCT02630459|470317199|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644203|NCT02630459|470317200|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644204|NCT02630459|470317201|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644205|NCT02630459|470317202|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644206|NCT02630459|470317203|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
130644207|NCT02630459|470317204|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
130644208|NCT02630459|470317205|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644209|NCT02630459|470317206|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130644210|NCT02630459|470317199|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644211|NCT02630459|470317200|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644212|NCT02630459|470317201|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644213|NCT02630459|470317202|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644214|NCT02630459|470317203|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
130644215|NCT02630459|470317204|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
130644216|NCT02630459|470317205|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644217|NCT02630459|470317206|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130644218|NCT02630459|470317199|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644219|NCT02630459|470317200|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644220|NCT02630459|470317201|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644221|NCT02630459|470317202|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644222|NCT02630459|470317203|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
130644223|NCT02630459|470317204|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644224|NCT02630459|470317205|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644225|NCT02630459|470317206|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130644226|NCT00125138|470317207|FG000|Overall Study|Adverse Event|1|||
130644227|NCT00125138|470317208|FG001|Overall Study|Adverse Event|0|||
130644228|NCT00125138|470317209|FG002|Overall Study|Adverse Event|3|||
130644229|NCT00125138|470317210|FG003|Overall Study|Adverse Event|2|||
130644230|NCT00125138|470317207|FG000|Overall Study|Withdrawal by Subject|2|||
130644231|NCT00125138|470317208|FG001|Overall Study|Withdrawal by Subject|3|||
130644232|NCT00125138|470317209|FG002|Overall Study|Withdrawal by Subject|1|||
130644233|NCT00125138|470317210|FG003|Overall Study|Withdrawal by Subject|1|||
130644234|NCT00125138|470317207|FG000|Overall Study|Lack of Efficacy|0|||
130644235|NCT00125138|470317208|FG001|Overall Study|Lack of Efficacy|0|||
130644236|NCT00125138|470317209|FG002|Overall Study|Lack of Efficacy|0|||
130644237|NCT00125138|470317210|FG003|Overall Study|Lack of Efficacy|1|||
130644238|NCT00125138|470317207|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
130644239|NCT00125138|470317208|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
130644240|NCT00125138|470317209|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
130644241|NCT00125138|470317210|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
130644242|NCT00348686|470317217|FG000|Overall Study|Withdrawal by Subject|45|||
130644243|NCT00348686|470317217|FG000|Overall Study|Adverse Event|5|||
130644244|NCT00348686|470317217|FG000|Overall Study|Protocol Violation|6|||
130644245|NCT00348686|470317217|FG000|Overall Study|Lost to Follow-up|2|||
130644246|NCT00348686|470317217|FG000|Overall Study|Multiple Reasons|8|||
130644247|NCT01258738|470317218|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
130644248|NCT01258738|470317219|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
130644249|NCT01258738|470317218|FG000|Double-blind Period|Withdrawal by Subject|2|||
130644250|NCT01258738|470317219|FG001|Double-blind Period|Withdrawal by Subject|2|||
130644251|NCT01258738|470317218|FG000|Double-blind Period|Protocol Violation|1|||
130644252|NCT01258738|470317219|FG001|Double-blind Period|Protocol Violation|1|||
130644253|NCT01258738|470317218|FG000|Double-blind Period|Adverse Event|3|||
130644254|NCT01258738|470317219|FG001|Double-blind Period|Adverse Event|1|||
130644255|NCT01258738|470317218|FG000|Open-label Period|Did not meet inclusion criteria|0|||
130644256|NCT01258738|470317219|FG001|Open-label Period|Did not meet inclusion criteria|1|||
130644257|NCT01258738|470317218|FG000|Open-label Period|Insufficient clinical response|5|||
130644258|NCT01258738|470317219|FG001|Open-label Period|Insufficient clinical response|3|||
130644259|NCT01258738|470317218|FG000|Open-label Period|Lost to Follow-up|0|||
130644260|NCT01258738|470317219|FG001|Open-label Period|Lost to Follow-up|2|||
130644261|NCT01258738|470317218|FG000|Open-label Period|Withdrawal by Subject|5|||
130644262|NCT01258738|470317219|FG001|Open-label Period|Withdrawal by Subject|6|||
130644263|NCT01258738|470317218|FG000|Open-label Period|Protocol Violation|2|||
130644264|NCT01258738|470317219|FG001|Open-label Period|Protocol Violation|2|||
130644265|NCT01258738|470317218|FG000|Open-label Period|Adverse Event|4|||
130644266|NCT01258738|470317219|FG001|Open-label Period|Adverse Event|5|||
130644267|NCT01258738|470317218|FG000|Open-label Period|Other Reasons|0|||
130644268|NCT01258738|470317219|FG001|Open-label Period|Other Reasons|1|||
130644269|NCT01258738|470317218|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
130644270|NCT01258738|470317219|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
130644271|NCT00689611|470317220|FG000|Overall Study|Death|6|||
130644272|NCT00689611|470317221|FG001|Overall Study|Death|9|||
130644273|NCT00689611|470317220|FG000|Overall Study|Withdrawal by Subject|8|||
130644274|NCT00689611|470317221|FG001|Overall Study|Withdrawal by Subject|9|||
130644275|NCT00689611|470317220|FG000|Overall Study|Lost to Follow-up|27|||
130644276|NCT00689611|470317221|FG001|Overall Study|Lost to Follow-up|28|||
130644277|NCT00568399|470317222|FG000|Overall Study|Death|2|||
130644278|NCT00568399|470317222|FG000|Overall Study|Adverse Event|5|||
130644279|NCT00568399|470317222|FG000|Overall Study|Withdrawal by Subject|8|||
130644280|NCT01904760|470317229|FG000|Overall Study|Protocol Violation|1|||
130644281|NCT01904760|470317230|FG001|Overall Study|Protocol Violation|0|||
130644282|NCT04249076|470317240|FG000|Overall Study|Adverse Event|1|||
130644283|NCT04249076|470317241|FG001|Overall Study|Adverse Event|1|||
130644284|NCT04249076|470317240|FG000|Overall Study|Protocol Violation|1|||
130644285|NCT04249076|470317241|FG001|Overall Study|Protocol Violation|2|||
130644286|NCT04249076|470317240|FG000|Overall Study|Lack of Efficacy|0|||
130644287|NCT04249076|470317241|FG001|Overall Study|Lack of Efficacy|1|||
130644288|NCT04249076|470317240|FG000|Overall Study|Withdrawal by Subject|0|||
130644289|NCT04249076|470317241|FG001|Overall Study|Withdrawal by Subject|1|||
130644290|NCT00783263|470317242|FG000|Overall Study|Adverse Event|3|||
130644291|NCT00783263|470317243|FG001|Overall Study|Adverse Event|0|||
130644292|NCT00783263|470317244|FG002|Overall Study|Adverse Event|2|||
130644293|NCT00783263|470317245|FG003|Overall Study|Adverse Event|1|||
130644294|NCT00783263|470317242|FG000|Overall Study|Lost to Follow-up|1|||
130644295|NCT00783263|470317243|FG001|Overall Study|Lost to Follow-up|1|||
130644296|NCT00783263|470317244|FG002|Overall Study|Lost to Follow-up|0|||
130644297|NCT00783263|470317245|FG003|Overall Study|Lost to Follow-up|0|||
130644298|NCT00783263|470317242|FG000|Overall Study|Withdrawal by Subject|0|||
130644299|NCT00783263|470317243|FG001|Overall Study|Withdrawal by Subject|1|||
130644300|NCT00783263|470317244|FG002|Overall Study|Withdrawal by Subject|1|||
130644301|NCT00783263|470317245|FG003|Overall Study|Withdrawal by Subject|2|||
130644302|NCT00106626|470317246|FG000|Overall Study|Adverse Event|5|||
130644303|NCT00106626|470317247|FG001|Overall Study|Adverse Event|4|||
130644304|NCT00106626|470317248|FG002|Overall Study|Adverse Event|3|||
130644305|NCT00106626|470317249|FG003|Overall Study|Adverse Event|3|||
130644306|NCT00106626|470317246|FG000|Overall Study|Progressive Disease|4|||
130644307|NCT00106626|470317247|FG001|Overall Study|Progressive Disease|1|||
130644308|NCT00106626|470317248|FG002|Overall Study|Progressive Disease|9|||
130644309|NCT00106626|470317249|FG003|Overall Study|Progressive Disease|10|||
130644310|NCT00106626|470317246|FG000|Overall Study|Received radiation on new therapy|1|||
130644311|NCT00106626|470317247|FG001|Overall Study|Received radiation on new therapy|0|||
130644312|NCT00106626|470317248|FG002|Overall Study|Received radiation on new therapy|0|||
130644313|NCT00106626|470317249|FG003|Overall Study|Received radiation on new therapy|0|||
130644314|NCT00106626|470317246|FG000|Overall Study|> 14 day delay in therapy start|0|||
130644315|NCT00106626|470317247|FG001|Overall Study|> 14 day delay in therapy start|1|||
130644316|NCT00106626|470317248|FG002|Overall Study|> 14 day delay in therapy start|0|||
130644317|NCT00106626|470317249|FG003|Overall Study|> 14 day delay in therapy start|0|||
130644318|NCT00405756|470317254|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
130644319|NCT00405756|470317255|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
130644320|NCT00405756|470317256|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
130644321|NCT00405756|470317254|FG000|Double-blind Treatment|Adverse Event|31|||
130644322|NCT00405756|470317255|FG001|Double-blind Treatment|Adverse Event|27|||
130644323|NCT00405756|470317256|FG002|Double-blind Treatment|Adverse Event|12|||
130644324|NCT00405756|470317254|FG000|Double-blind Treatment|Disease Progression|47|||
130644325|NCT00405756|470317255|FG001|Double-blind Treatment|Disease Progression|81|||
130644326|NCT00405756|470317256|FG002|Double-blind Treatment|Disease Progression|102|||
130644327|NCT00405756|470317254|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130644328|NCT00405756|470317255|FG001|Double-blind Treatment|Lack of Efficacy|4|||
130644329|NCT00405756|470317256|FG002|Double-blind Treatment|Lack of Efficacy|2|||
130644330|NCT00405756|470317254|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
130644331|NCT00405756|470317255|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
130644332|NCT00405756|470317256|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
130644333|NCT00405756|470317254|FG000|Double-blind Treatment|Lost to Follow-up|1|||
130644334|NCT00405756|470317255|FG001|Double-blind Treatment|Lost to Follow-up|0|||
130644335|NCT00405756|470317256|FG002|Double-blind Treatment|Lost to Follow-up|0|||
130644336|NCT00405756|470317254|FG000|Double-blind Treatment|Death|4|||
130644337|NCT00405756|470317255|FG001|Double-blind Treatment|Death|4|||
130644338|NCT00405756|470317256|FG002|Double-blind Treatment|Death|4|||
130644339|NCT00405756|470317254|FG000|Double-blind Treatment|Protocol Violation|1|||
130644340|NCT00405756|470317255|FG001|Double-blind Treatment|Protocol Violation|0|||
130644341|NCT00405756|470317256|FG002|Double-blind Treatment|Protocol Violation|2|||
130644342|NCT00405756|470317254|FG000|Double-blind Treatment|Other|7|||
130644343|NCT00405756|470317255|FG001|Double-blind Treatment|Other|4|||
130644344|NCT00405756|470317256|FG002|Double-blind Treatment|Other|4|||
130644345|NCT00405756|470317254|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
130644346|NCT00405756|470317255|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
130644347|NCT00405756|470317256|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
130644348|NCT00405756|470317254|FG000|Open-label Extension|Adverse Event|1|||
130644349|NCT00405756|470317255|FG001|Open-label Extension|Adverse Event|3|||
130644350|NCT00405756|470317256|FG002|Open-label Extension|Adverse Event|7|||
130644351|NCT00405756|470317254|FG000|Open-label Extension|Disease Progression|8|||
130644352|NCT00405756|470317255|FG001|Open-label Extension|Disease Progression|23|||
130644353|NCT00405756|470317256|FG002|Open-label Extension|Disease Progression|26|||
130644354|NCT00405756|470317254|FG000|Open-label Extension|Withdrawal by Subject|2|||
130644355|NCT00405756|470317255|FG001|Open-label Extension|Withdrawal by Subject|3|||
130644356|NCT00405756|470317256|FG002|Open-label Extension|Withdrawal by Subject|3|||
130644357|NCT00405756|470317254|FG000|Open-label Extension|Death|1|||
130644358|NCT00405756|470317255|FG001|Open-label Extension|Death|2|||
130644359|NCT00405756|470317256|FG002|Open-label Extension|Death|4|||
130644360|NCT00405756|470317254|FG000|Open-label Extension|Other|0|||
130644361|NCT00405756|470317255|FG001|Open-label Extension|Other|1|||
130644362|NCT00405756|470317256|FG002|Open-label Extension|Other|7|||
130644363|NCT00405756|470317254|FG000|Follow-up|Ongoing in Follow-up Period|52|||
130644364|NCT00405756|470317255|FG001|Follow-up|Ongoing in Follow-up Period|51|||
130644365|NCT00405756|470317256|FG002|Follow-up|Ongoing in Follow-up Period|60|||
130644366|NCT00405756|470317254|FG000|Follow-up|Death|21|||
130644367|NCT00405756|470317255|FG001|Follow-up|Death|31|||
130644368|NCT00405756|470317256|FG002|Follow-up|Death|24|||
130644369|NCT00405756|470317254|FG000|Follow-up|Lost to Follow-up|2|||
130644370|NCT00405756|470317255|FG001|Follow-up|Lost to Follow-up|8|||
130644371|NCT00405756|470317256|FG002|Follow-up|Lost to Follow-up|4|||
130644372|NCT00672139|470317257|FG000|Overall Study|Death|14|||
130644373|NCT00672139|470317258|FG001|Overall Study|Death|23|||
130644374|NCT00672139|470317257|FG000|Overall Study|Withdrawal by Subject|2|||
130644375|NCT00672139|470317258|FG001|Overall Study|Withdrawal by Subject|11|||
130644376|NCT00672139|470317257|FG000|Overall Study|Adverse Event|4|||
130644377|NCT00672139|470317258|FG001|Overall Study|Adverse Event|7|||
130644378|NCT00672139|470317257|FG000|Overall Study|Physician Decision|2|||
130644379|NCT00672139|470317258|FG001|Overall Study|Physician Decision|0|||
130644380|NCT00672139|470317257|FG000|Overall Study|Lack of Efficacy|4|||
130644381|NCT00672139|470317258|FG001|Overall Study|Lack of Efficacy|1|||
130644382|NCT00672139|470317257|FG000|Overall Study|Protocol Violation|1|||
130644383|NCT00672139|470317258|FG001|Overall Study|Protocol Violation|1|||
130644384|NCT00672139|470317257|FG000|Overall Study|hospice discharge, caregiver requests|3|||
130644385|NCT00672139|470317258|FG001|Overall Study|hospice discharge, caregiver requests|2|||
130644386|NCT01117428|470317264|FG000|Overall Study|Lack of Efficacy|1|||
130644387|NCT01117428|470317265|FG001|Overall Study|Lack of Efficacy|0|||
130644388|NCT01117428|470317266|FG002|Overall Study|Lack of Efficacy|0|||
130644389|NCT01117428|470317267|FG003|Overall Study|Lack of Efficacy|0|||
130644390|NCT01117428|470317268|FG004|Overall Study|Lack of Efficacy|0|||
130644391|NCT01117428|470317269|FG005|Overall Study|Lack of Efficacy|0|||
130644392|NCT01117428|470317264|FG000|Overall Study|Adverse Event|4|||
130644393|NCT01117428|470317265|FG001|Overall Study|Adverse Event|0|||
130644394|NCT01117428|470317266|FG002|Overall Study|Adverse Event|0|||
130644395|NCT01117428|470317267|FG003|Overall Study|Adverse Event|0|||
130644396|NCT01117428|470317268|FG004|Overall Study|Adverse Event|1|||
130644397|NCT01117428|470317269|FG005|Overall Study|Adverse Event|2|||
130644398|NCT01117428|470317264|FG000|Overall Study|Death|0|||
130644399|NCT01117428|470317265|FG001|Overall Study|Death|1|||
130644400|NCT01117428|470317266|FG002|Overall Study|Death|2|||
130644401|NCT01117428|470317267|FG003|Overall Study|Death|0|||
130644402|NCT01117428|470317268|FG004|Overall Study|Death|0|||
130644403|NCT01117428|470317269|FG005|Overall Study|Death|1|||
130644404|NCT01117428|470317264|FG000|Overall Study|Physician Decision|0|||
130644405|NCT01117428|470317265|FG001|Overall Study|Physician Decision|1|||
130644406|NCT01117428|470317266|FG002|Overall Study|Physician Decision|0|||
130644407|NCT01117428|470317267|FG003|Overall Study|Physician Decision|0|||
130644408|NCT01117428|470317268|FG004|Overall Study|Physician Decision|0|||
130644409|NCT01117428|470317269|FG005|Overall Study|Physician Decision|0|||
130644410|NCT01117428|470317264|FG000|Overall Study|Withdrawal by Subject|0|||
130644411|NCT01117428|470317265|FG001|Overall Study|Withdrawal by Subject|0|||
130644412|NCT01117428|470317266|FG002|Overall Study|Withdrawal by Subject|1|||
130644413|NCT01117428|470317267|FG003|Overall Study|Withdrawal by Subject|0|||
130644414|NCT01117428|470317268|FG004|Overall Study|Withdrawal by Subject|0|||
130644415|NCT01117428|470317269|FG005|Overall Study|Withdrawal by Subject|0|||
130644416|NCT01117428|470317264|FG000|Overall Study|Progressive disease|15|||
130644417|NCT01117428|470317265|FG001|Overall Study|Progressive disease|27|||
130644418|NCT01117428|470317266|FG002|Overall Study|Progressive disease|10|||
130644419|NCT01117428|470317267|FG003|Overall Study|Progressive disease|12|||
130644420|NCT01117428|470317268|FG004|Overall Study|Progressive disease|16|||
130644421|NCT01117428|470317269|FG005|Overall Study|Progressive disease|17|||
130644422|NCT03018028|470317271|FG000|Overall Study|Withdrawal by Subject|3|||
130644423|NCT03018028|470317272|FG001|Overall Study|Withdrawal by Subject|0|||
130644424|NCT03018028|470317273|FG002|Overall Study|Withdrawal by Subject|1|||
130644425|NCT03018028|470317274|FG003|Overall Study|Withdrawal by Subject|2|||
130644426|NCT03018028|470317275|FG004|Overall Study|Withdrawal by Subject|0|||
130644427|NCT02519777|470317277|FG000|Overall Study|Death|1|||
130644428|NCT02519777|470317278|FG001|Overall Study|Death|0|||
130644429|NCT02519777|470317279|FG002|Overall Study|Death|0|||
130644430|NCT02519777|470317277|FG000|Overall Study|Lost to Follow-up|0|||
130644431|NCT02519777|470317278|FG001|Overall Study|Lost to Follow-up|4|||
130644432|NCT02519777|470317279|FG002|Overall Study|Lost to Follow-up|2|||
130644433|NCT02519777|470317277|FG000|Overall Study|Withdrawal by Subject|3|||
130644434|NCT02519777|470317278|FG001|Overall Study|Withdrawal by Subject|1|||
130644435|NCT02519777|470317279|FG002|Overall Study|Withdrawal by Subject|0|||
130644436|NCT02519777|470317277|FG000|Overall Study|Severe Debilitation|1|||
130644437|NCT02519777|470317278|FG001|Overall Study|Severe Debilitation|1|||
130644438|NCT02519777|470317279|FG002|Overall Study|Severe Debilitation|1|||
130644439|NCT02519777|470317277|FG000|Overall Study|Not able to get to clinic|1|||
130644440|NCT02519777|470317278|FG001|Overall Study|Not able to get to clinic|2|||
130644441|NCT02519777|470317279|FG002|Overall Study|Not able to get to clinic|1|||
130644442|NCT01683058|470317284|FG000|Overall Study|Lost to Follow-up|9|||
130644443|NCT01683058|470317284|FG000|Overall Study|Adverse Event|6|||
130644444|NCT01683058|470317284|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
130644445|NCT01683058|470317284|FG000|Overall Study|Withdrawal by Subject|7|||
130644446|NCT01683058|470317284|FG000|Overall Study|Lack of Efficacy|2|||
130644447|NCT04062240|470317285|FG000|Overall Study|equipment malfunction|1|||
130644448|NCT01957111|470317286|FG000|Overall Study|Withdrawal by Subject|1|||
130644449|NCT01957111|470317287|FG001|Overall Study|Withdrawal by Subject|1|||
130644450|NCT01057394|470317288|FG000|Overall Study|Not eligible|0|||
130644451|NCT01057394|470317289|FG001|Overall Study|Not eligible|2|||
130644452|NCT01195636|470317290|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
130644453|NCT01195636|470317291|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
130644454|NCT01195636|470317290|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
130644455|NCT01195636|470317291|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
130644456|NCT01195636|470317290|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130644457|NCT01195636|470317291|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130644458|NCT01195636|470317290|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
130644459|NCT01195636|470317291|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
130644460|NCT01195636|470317290|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
130644461|NCT01195636|470317291|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
130644462|NCT01195636|470317290|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130644463|NCT01195636|470317291|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
130644464|NCT01195636|470317290|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
130644465|NCT01195636|470317291|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
130644466|NCT01195636|470317290|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130644467|NCT01195636|470317291|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130644468|NCT03500419|470317292|FG000|Overall Study|Withdrawal by Subject|2|||
130644469|NCT03500419|470317293|FG001|Overall Study|Withdrawal by Subject|25|||
130644470|NCT00203294|470317294|FG000|Overall Study|Withdrawal by Subject|8|||
130644471|NCT00203294|470317295|FG001|Overall Study|Withdrawal by Subject|13|||
130644472|NCT00082628|470317296|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130644473|NCT00082628|470317297|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
130644474|NCT00082628|470317298|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130644475|NCT00082628|470317299|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130644476|NCT00082628|470317300|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130644477|NCT00082628|470317296|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
130644478|NCT00082628|470317297|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
130644479|NCT00082628|470317298|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130644480|NCT00082628|470317299|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130644481|NCT00082628|470317300|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130644482|NCT00082628|470317296|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
130644483|NCT00082628|470317297|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
130644484|NCT00082628|470317298|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130644485|NCT00082628|470317299|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130644486|NCT00082628|470317300|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130644487|NCT00082628|470317296|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
130644488|NCT00082628|470317297|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
130644489|NCT00082628|470317298|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130644490|NCT00082628|470317299|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130644491|NCT00082628|470317300|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130644492|NCT00082628|470317296|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130644493|NCT00082628|470317297|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130644494|NCT00082628|470317298|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130644495|NCT00082628|470317299|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130644496|NCT00082628|470317300|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
130644497|NCT00082628|470317296|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130644498|NCT00082628|470317297|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130644499|NCT00082628|470317298|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130644500|NCT00082628|470317299|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
130644501|NCT00082628|470317300|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130644502|NCT00082628|470317296|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
130644503|NCT00082628|470317297|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
130644504|NCT00082628|470317298|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
130644505|NCT00082628|470317299|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
130644506|NCT00082628|470317300|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
130644507|NCT01566981|470317301|FG000|Overall Study|Lost to Follow-up|5|||
130644508|NCT01566981|470317302|FG001|Overall Study|Lost to Follow-up|8|||
130644509|NCT01234337|470317306|FG000|Overall Study|Adverse Event|58|||
130644510|NCT01234337|470317307|FG001|Overall Study|Adverse Event|21|||
130644511|NCT01234337|470317306|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
130644512|NCT01234337|470317307|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
130644513|NCT01234337|470317306|FG000|Overall Study|Investi. decision not protocol driven|5|||
130644514|NCT01234337|470317307|FG001|Overall Study|Investi. decision not protocol driven|6|||
130644515|NCT01234337|470317306|FG000|Overall Study|Non-compliant with study medication|3|||
130644516|NCT01234337|470317307|FG001|Overall Study|Non-compliant with study medication|2|||
130644517|NCT01234337|470317306|FG000|Overall Study|Randomized but not treated|6|||
130644518|NCT01234337|470317307|FG001|Overall Study|Randomized but not treated|4|||
130644519|NCT01234337|470317306|FG000|Overall Study|Lost to Follow-up|0|||
130644520|NCT01234337|470317307|FG001|Overall Study|Lost to Follow-up|1|||
130644521|NCT01234337|470317306|FG000|Overall Study|Protocol Violation|2|||
130644522|NCT01234337|470317307|FG001|Overall Study|Protocol Violation|3|||
130644523|NCT01234337|470317306|FG000|Overall Study|Withdrawal by Subject|11|||
130644524|NCT01234337|470317307|FG001|Overall Study|Withdrawal by Subject|9|||
130644525|NCT01234337|470317306|FG000|Overall Study|Death|0|||
130644526|NCT01234337|470317307|FG001|Overall Study|Death|1|||
130644527|NCT01234337|470317306|FG000|Overall Study|Switch to commercial drug|0|||
130644528|NCT01234337|470317307|FG001|Overall Study|Switch to commercial drug|1|||
130644529|NCT03481634|470317308|FG000|Overall Study|Withdrawal by Subject|16|||
130644530|NCT03481634|470317309|FG001|Overall Study|Withdrawal by Subject|19|||
130644531|NCT03481634|470317310|FG002|Overall Study|Withdrawal by Subject|14|||
130644532|NCT03481634|470317308|FG000|Overall Study|Protocol Violation|1|||
130644533|NCT03481634|470317309|FG001|Overall Study|Protocol Violation|0|||
130644534|NCT03481634|470317310|FG002|Overall Study|Protocol Violation|1|||
130644535|NCT03481634|470317308|FG000|Overall Study|Progressive disease|0|||
130644536|NCT03481634|470317309|FG001|Overall Study|Progressive disease|1|||
130644537|NCT03481634|470317310|FG002|Overall Study|Progressive disease|0|||
130644538|NCT03481634|470317308|FG000|Overall Study|Physician Decision|3|||
130644539|NCT03481634|470317309|FG001|Overall Study|Physician Decision|0|||
130644540|NCT03481634|470317310|FG002|Overall Study|Physician Decision|1|||
130644541|NCT03481634|470317308|FG000|Overall Study|Lost to Follow-up|3|||
130644542|NCT03481634|470317309|FG001|Overall Study|Lost to Follow-up|4|||
130644543|NCT03481634|470317310|FG002|Overall Study|Lost to Follow-up|4|||
130644544|NCT03481634|470317308|FG000|Overall Study|Death|4|||
130644545|NCT03481634|470317309|FG001|Overall Study|Death|8|||
130644546|NCT03481634|470317310|FG002|Overall Study|Death|7|||
130644547|NCT03481634|470317308|FG000|Overall Study|Adverse Event|6|||
130644548|NCT03481634|470317309|FG001|Overall Study|Adverse Event|3|||
130644549|NCT03481634|470317310|FG002|Overall Study|Adverse Event|7|||
130644550|NCT00994890|470317313|FG000|Overall Study|Adverse Event|13|||
130644551|NCT00994890|470317314|FG001|Overall Study|Adverse Event|9|||
130644552|NCT00994890|470317315|FG002|Overall Study|Adverse Event|11|||
130644553|NCT00994890|470317313|FG000|Overall Study|Lack of Efficacy|0|||
130644554|NCT00994890|470317314|FG001|Overall Study|Lack of Efficacy|0|||
130644555|NCT00994890|470317315|FG002|Overall Study|Lack of Efficacy|1|||
130644556|NCT00994890|470317313|FG000|Overall Study|Lost to Follow-up|6|||
130644557|NCT00994890|470317314|FG001|Overall Study|Lost to Follow-up|1|||
130644558|NCT00994890|470317315|FG002|Overall Study|Lost to Follow-up|3|||
130644559|NCT00994890|470317313|FG000|Overall Study|No longer willing to participate|8|||
130644560|NCT00994890|470317314|FG001|Overall Study|No longer willing to participate|5|||
130644561|NCT00994890|470317315|FG002|Overall Study|No longer willing to participate|13|||
130644562|NCT00994890|470317313|FG000|Overall Study|Protocol Violation|2|||
130644563|NCT00994890|470317314|FG001|Overall Study|Protocol Violation|4|||
130644564|NCT00994890|470317315|FG002|Overall Study|Protocol Violation|0|||
130644565|NCT00994890|470317313|FG000|Overall Study|Study terminated by sponsor|199|||
130644566|NCT00994890|470317314|FG001|Overall Study|Study terminated by sponsor|201|||
130644567|NCT00994890|470317315|FG002|Overall Study|Study terminated by sponsor|197|||
130644568|NCT00994890|470317313|FG000|Overall Study|Randomized, but not treated|1|||
130644569|NCT00994890|470317314|FG001|Overall Study|Randomized, but not treated|0|||
130644570|NCT00994890|470317315|FG002|Overall Study|Randomized, but not treated|0|||
130644571|NCT00994890|470317313|FG000|Overall Study|Other|2|||
130644572|NCT00994890|470317314|FG001|Overall Study|Other|2|||
130644573|NCT00994890|470317315|FG002|Overall Study|Other|1|||
130644574|NCT03323385|470317320|FG000|Overall Study|Withdrawal by Subject|1|||
130644575|NCT03323385|470317321|FG001|Overall Study|Withdrawal by Subject|2|||
130644576|NCT03323385|470317320|FG000|Overall Study|Noncompliance|0|||
130644577|NCT03323385|470317321|FG001|Overall Study|Noncompliance|1|||
130644578|NCT00247962|470317322|FG000|Overall Study|Adverse Event|15|||
130644579|NCT00247962|470317323|FG001|Overall Study|Adverse Event|12|||
130644580|NCT00247962|470317322|FG000|Overall Study|Lost to Follow-up|3|||
130644581|NCT00247962|470317323|FG001|Overall Study|Lost to Follow-up|1|||
130644582|NCT00247962|470317322|FG000|Overall Study|Physician Decision|0|||
130644583|NCT00247962|470317323|FG001|Overall Study|Physician Decision|1|||
130644584|NCT00247962|470317322|FG000|Overall Study|Protocol Violation|1|||
130644585|NCT00247962|470317323|FG001|Overall Study|Protocol Violation|1|||
130644586|NCT00247962|470317322|FG000|Overall Study|Withdrawal by Subject|3|||
130644587|NCT00247962|470317323|FG001|Overall Study|Withdrawal by Subject|2|||
130644588|NCT00247962|470317322|FG000|Overall Study|Lack of Efficacy|4|||
130644589|NCT00247962|470317323|FG001|Overall Study|Lack of Efficacy|2|||
130644590|NCT01849289|470317324|FG000|Overall Study|Adverse Event|3|||
130644591|NCT01849289|470317325|FG001|Overall Study|Adverse Event|3|||
130644592|NCT01849289|470317324|FG000|Overall Study|Protocol Violation|3|||
130644593|NCT01849289|470317325|FG001|Overall Study|Protocol Violation|3|||
130644594|NCT01849289|470317324|FG000|Overall Study|Withdrawal criteria|1|||
130644595|NCT01849289|470317325|FG001|Overall Study|Withdrawal criteria|0|||
130644596|NCT01849289|470317324|FG000|Overall Study|Unclassified|25|||
130644597|NCT01849289|470317325|FG001|Overall Study|Unclassified|18|||
130644598|NCT01469637|470317326|FG000|First Intervention|Unacceptable behavior|0|||
130644599|NCT01469637|470317327|FG001|First Intervention|Unacceptable behavior|1|||
130644600|NCT01469637|470317326|FG000|Second Intervention|Incarcerated|1|||
130644601|NCT01469637|470317327|FG001|Second Intervention|Incarcerated|0|||
130644602|NCT00598585|470317328|FG000|Overall Study|Lost to Follow-up|1|||
130644603|NCT00598585|470317329|FG001|Overall Study|Lost to Follow-up|0|||
130644604|NCT03480360|470317330|FG000|Overall Study|Death|2|||
130644605|NCT01084096|470319336|FG000|Overall Study|Lost to Follow-up|1501|||
130644606|NCT01084096|470319337|FG001|Overall Study|Lost to Follow-up|1833|||
130644607|NCT01084096|470319336|FG000|Overall Study|Withdrawal by Subject|3|||
130644608|NCT01084096|470319337|FG001|Overall Study|Withdrawal by Subject|0|||
130644609|NCT01084096|470319336|FG000|Overall Study|Woman had a miscarriage|21|||
130644610|NCT01084096|470319337|FG001|Overall Study|Woman had a miscarriage|17|||
130644611|NCT01354964|470319338|FG000|Overall Study|Lost to Follow-up|2|||
130644612|NCT01354964|470319339|FG001|Overall Study|Lost to Follow-up|0|||
130644613|NCT01354964|470319338|FG000|Overall Study|IV access issues|1|||
130644614|NCT01354964|470319339|FG001|Overall Study|IV access issues|1|||
130644615|NCT01354964|470319338|FG000|Overall Study|Physician Decision|1|||
130644616|NCT01354964|470319339|FG001|Overall Study|Physician Decision|0|||
130644617|NCT04450394|470319348|FG000|Overall Study|Adverse Event|2|||
130644618|NCT04450394|470319349|FG001|Overall Study|Adverse Event|0|||
130644619|NCT04450394|470319350|FG002|Overall Study|Adverse Event|0|||
130644620|NCT04450394|470319348|FG000|Overall Study|Death|0|||
130644621|NCT04450394|470319349|FG001|Overall Study|Death|1|||
130644622|NCT04450394|470319350|FG002|Overall Study|Death|0|||
130644623|NCT04450394|470319348|FG000|Overall Study|Lost to Follow-up|0|||
130644624|NCT04450394|470319349|FG001|Overall Study|Lost to Follow-up|3|||
130644625|NCT04450394|470319350|FG002|Overall Study|Lost to Follow-up|0|||
130644626|NCT04450394|470319348|FG000|Overall Study|Physician Decision|0|||
130644627|NCT04450394|470319349|FG001|Overall Study|Physician Decision|1|||
130644628|NCT04450394|470319350|FG002|Overall Study|Physician Decision|0|||
130644629|NCT04450394|470319348|FG000|Overall Study|Protocol Violation|2|||
130644630|NCT04450394|470319349|FG001|Overall Study|Protocol Violation|0|||
130644631|NCT04450394|470319350|FG002|Overall Study|Protocol Violation|0|||
130644632|NCT04450394|470319348|FG000|Overall Study|Withdrawal by Subject|6|||
130644633|NCT04450394|470319349|FG001|Overall Study|Withdrawal by Subject|9|||
130644634|NCT04450394|470319350|FG002|Overall Study|Withdrawal by Subject|0|||
130644635|NCT02155660|470319355|FG000|Overall Study|Other Reason|8|||
130644636|NCT02155660|470319356|FG001|Overall Study|Other Reason|6|||
130644637|NCT02155660|470319357|FG002|Overall Study|Other Reason|10|||
130644638|NCT02155660|470319358|FG003|Overall Study|Other Reason|10|||
130644639|NCT02155660|470319355|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130644640|NCT02155660|470319356|FG001|Overall Study|Study-specific withdrawal criteria|1|||
130644641|NCT02155660|470319357|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130644642|NCT02155660|470319358|FG003|Overall Study|Study-specific withdrawal criteria|1|||
130644643|NCT02155660|470319355|FG000|Overall Study|Severe non-compliance|0|||
130644644|NCT02155660|470319356|FG001|Overall Study|Severe non-compliance|4|||
130644645|NCT02155660|470319357|FG002|Overall Study|Severe non-compliance|0|||
130644646|NCT02155660|470319358|FG003|Overall Study|Severe non-compliance|1|||
130644647|NCT02155660|470319355|FG000|Overall Study|Adverse Event|2|||
130644648|NCT02155660|470319356|FG001|Overall Study|Adverse Event|6|||
130644649|NCT02155660|470319357|FG002|Overall Study|Adverse Event|3|||
130644650|NCT02155660|470319358|FG003|Overall Study|Adverse Event|1|||
130644651|NCT02155660|470319355|FG000|Overall Study|Lost to Follow-up|3|||
130644652|NCT02155660|470319356|FG001|Overall Study|Lost to Follow-up|6|||
130644653|NCT02155660|470319357|FG002|Overall Study|Lost to Follow-up|5|||
130644654|NCT02155660|470319358|FG003|Overall Study|Lost to Follow-up|8|||
130644655|NCT02155660|470319355|FG000|Overall Study|Death|17|||
130644656|NCT02155660|470319356|FG001|Overall Study|Death|19|||
130644657|NCT02155660|470319357|FG002|Overall Study|Death|17|||
130644658|NCT02155660|470319358|FG003|Overall Study|Death|19|||
130644659|NCT02155660|470319355|FG000|Overall Study|Withdrawal by Subject|28|||
130644660|NCT02155660|470319356|FG001|Overall Study|Withdrawal by Subject|31|||
130644661|NCT02155660|470319357|FG002|Overall Study|Withdrawal by Subject|24|||
130644662|NCT02155660|470319358|FG003|Overall Study|Withdrawal by Subject|21|||
130644663|NCT03812224|470319365|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
130644664|NCT03812224|470319366|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130644665|NCT03812224|470319365|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
130644666|NCT03812224|470319366|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
130644667|NCT03812224|470319365|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
130644668|NCT03812224|470319366|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
130644669|NCT03812224|470319365|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
130644670|NCT03812224|470319366|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
130644671|NCT00303719|470319367|FG000|Overall Study|Not evaluable, prior therapies|0|||
130644672|NCT00303719|470319368|FG001|Overall Study|Not evaluable, prior therapies|30|||
130644673|NCT00303719|470319367|FG000|Overall Study|Lost to Follow-up|0|||
130644674|NCT00303719|470319368|FG001|Overall Study|Lost to Follow-up|7|||
130644675|NCT01641952|470319369|FG000|Overall Study|Lost to Follow-up|28|||
130644676|NCT01641952|470319369|FG000|Overall Study|Adverse Event|6|||
130644677|NCT02500901|470319370|FG000|Overall Study|Disease ProgressionDD|2|||
130644678|NCT00561912|470319381|FG000|Overall Study|ineligible|1|||
130644679|NCT02643420|470319383|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
130644680|NCT02643420|470319384|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
130644681|NCT02643420|470319383|FG000|Overall Study|Withdrawal by Subject|25|||
130644682|NCT02643420|470319384|FG001|Overall Study|Withdrawal by Subject|19|||
130644683|NCT02643420|470319383|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
130644684|NCT02643420|470319384|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
130644685|NCT02643420|470319383|FG000|Overall Study|Lost to Follow-up|6|||
130644686|NCT02643420|470319384|FG001|Overall Study|Lost to Follow-up|10|||
130644687|NCT02643420|470319383|FG000|Overall Study|Investigator Decision|2|||
130644688|NCT02643420|470319384|FG001|Overall Study|Investigator Decision|4|||
130644689|NCT02643420|470319383|FG000|Overall Study|Sponsor decision|1|||
130644690|NCT02643420|470319384|FG001|Overall Study|Sponsor decision|1|||
130644691|NCT02643420|470319383|FG000|Overall Study|Death|0|||
130644692|NCT02643420|470319384|FG001|Overall Study|Death|2|||
130644693|NCT02643420|470319383|FG000|Overall Study|Reason not Specified|8|||
130644694|NCT02643420|470319384|FG001|Overall Study|Reason not Specified|7|||
130644695|NCT02127970|470319385|FG000|Overall Study|Adverse Event|2|||
130644696|NCT02127970|470319386|FG001|Overall Study|Adverse Event|1|||
130644697|NCT02127970|470319385|FG000|Overall Study|Death|1|||
130644698|NCT02127970|470319386|FG001|Overall Study|Death|1|||
130644699|NCT02127970|470319385|FG000|Overall Study|Lost to Follow-up|14|||
130644700|NCT02127970|470319386|FG001|Overall Study|Lost to Follow-up|14|||
130644701|NCT02127970|470319385|FG000|Overall Study|Reason not Specified|4|||
130644702|NCT02127970|470319386|FG001|Overall Study|Reason not Specified|7|||
130644703|NCT02127970|470319385|FG000|Overall Study|Pregnancy|0|||
130644704|NCT02127970|470319386|FG001|Overall Study|Pregnancy|1|||
130644705|NCT02127970|470319385|FG000|Overall Study|Subject Withdrew Consent|5|||
130644706|NCT02127970|470319386|FG001|Overall Study|Subject Withdrew Consent|3|||
130644707|NCT01398176|470319387|FG000|Overall Study|Lost to Follow-up|1|||
130644708|NCT01398176|470319388|FG001|Overall Study|Lost to Follow-up|3|||
130644709|NCT01398176|470319387|FG000|Overall Study|Physician Decision|2|||
130644710|NCT01398176|470319388|FG001|Overall Study|Physician Decision|3|||
130644711|NCT02988115|470319390|FG000|Overall Study|Adverse Event|6|||
130644712|NCT02988115|470319391|FG001|Overall Study|Adverse Event|1|||
130644713|NCT02988115|470319390|FG000|Overall Study|Sponsor Decision|5|||
130644714|NCT02988115|470319391|FG001|Overall Study|Sponsor Decision|2|||
130644715|NCT02988115|470319390|FG000|Overall Study|Withdrawal by Subject|1|||
130644716|NCT02988115|470319391|FG001|Overall Study|Withdrawal by Subject|1|||
130644717|NCT02988115|470319390|FG000|Overall Study|Withdrawn by Mistake|1|||
130644718|NCT02988115|470319391|FG001|Overall Study|Withdrawn by Mistake|0|||
130644719|NCT02988115|470319390|FG000|Overall Study|Lost to Follow-up|1|||
130644720|NCT02988115|470319391|FG001|Overall Study|Lost to Follow-up|0|||
130644721|NCT01731951|470319392|FG000|Overall Study|Documented Disease Progression|1|||
130644722|NCT01731951|470319393|FG001|Overall Study|Documented Disease Progression|0|||
130644723|NCT01731951|470319394|FG002|Overall Study|Documented Disease Progression|0|||
130644724|NCT01731951|470319395|FG003|Overall Study|Documented Disease Progression|0|||
130644725|NCT01731951|470319396|FG004|Overall Study|Documented Disease Progression|0|||
130644726|NCT01731951|470319397|FG005|Overall Study|Documented Disease Progression|0|||
130644727|NCT01731951|470319392|FG000|Overall Study|Lost to Follow-up|2|||
130644728|NCT01731951|470319393|FG001|Overall Study|Lost to Follow-up|0|||
130644729|NCT01731951|470319394|FG002|Overall Study|Lost to Follow-up|0|||
130644730|NCT01731951|470319395|FG003|Overall Study|Lost to Follow-up|1|||
130644731|NCT01731951|470319396|FG004|Overall Study|Lost to Follow-up|3|||
130644732|NCT01731951|470319397|FG005|Overall Study|Lost to Follow-up|1|||
130644733|NCT01731951|470319392|FG000|Overall Study|Withdrawal of Consent|1|||
130644734|NCT01731951|470319393|FG001|Overall Study|Withdrawal of Consent|0|||
130644735|NCT01731951|470319394|FG002|Overall Study|Withdrawal of Consent|0|||
130644736|NCT01731951|470319395|FG003|Overall Study|Withdrawal of Consent|0|||
130644737|NCT01731951|470319396|FG004|Overall Study|Withdrawal of Consent|0|||
130644738|NCT01731951|470319397|FG005|Overall Study|Withdrawal of Consent|2|||
130644739|NCT01731951|470319392|FG000|Overall Study|Death|13|||
130644740|NCT01731951|470319393|FG001|Overall Study|Death|15|||
130644741|NCT01731951|470319394|FG002|Overall Study|Death|9|||
130644742|NCT01731951|470319395|FG003|Overall Study|Death|8|||
130644743|NCT01731951|470319396|FG004|Overall Study|Death|9|||
130644744|NCT01731951|470319397|FG005|Overall Study|Death|6|||
130644745|NCT00775138|470319398|FG000|Overall Study|Withdrawal by Subject|0|||
130644746|NCT00775138|470319399|FG001|Overall Study|Withdrawal by Subject|0|||
130644747|NCT00775138|470319400|FG002|Overall Study|Withdrawal by Subject|2|||
130644748|NCT00775138|470319401|FG003|Overall Study|Withdrawal by Subject|2|||
130644749|NCT00775138|470319398|FG000|Overall Study|Adverse Event|0|||
130644750|NCT00775138|470319399|FG001|Overall Study|Adverse Event|0|||
130644751|NCT00775138|470319400|FG002|Overall Study|Adverse Event|1|||
130644752|NCT00775138|470319401|FG003|Overall Study|Adverse Event|0|||
130644753|NCT01034709|470319406|FG000|Overall Study|Protocol Violation|9|||
130644754|NCT01034709|470319407|FG001|Overall Study|Protocol Violation|16|||
130644755|NCT02364999|470319408|FG000|Overall Study|Death|136|||
130644756|NCT02364999|470319409|FG001|Overall Study|Death|138|||
130644757|NCT02364999|470319408|FG000|Overall Study|Lost to Follow-up|10|||
130644758|NCT02364999|470319409|FG001|Overall Study|Lost to Follow-up|15|||
130644759|NCT02364999|470319408|FG000|Overall Study|Protocol Violation|3|||
130644760|NCT02364999|470319409|FG001|Overall Study|Protocol Violation|2|||
130644761|NCT02364999|470319408|FG000|Overall Study|Withdrawal by Subject|14|||
130644762|NCT02364999|470319409|FG001|Overall Study|Withdrawal by Subject|14|||
130644763|NCT02364999|470319408|FG000|Overall Study|Other|0|||
130644764|NCT02364999|470319409|FG001|Overall Study|Other|1|||
130644765|NCT02364999|470319408|FG000|Overall Study|Randomized but did not receive treatment|2|||
130644766|NCT02364999|470319409|FG001|Overall Study|Randomized but did not receive treatment|3|||
130644767|NCT02177942|470319414|FG000|Overall Study|Adverse Event|1|||
130644768|NCT02177942|470319415|FG001|Overall Study|Adverse Event|0|||
130644769|NCT02177942|470319414|FG000|Overall Study|Lost to Follow-up|1|||
130644770|NCT02177942|470319415|FG001|Overall Study|Lost to Follow-up|1|||
130644771|NCT02177942|470319414|FG000|Overall Study|Protocol Violation|4|||
130644772|NCT02177942|470319415|FG001|Overall Study|Protocol Violation|6|||
130644773|NCT02177942|470319414|FG000|Overall Study|Withdrawal by Subject|71|||
130644774|NCT02177942|470319415|FG001|Overall Study|Withdrawal by Subject|81|||
130644775|NCT00699582|470319418|FG000|Overall Study|Adverse Event|4|||
130644776|NCT00699582|470319419|FG001|Overall Study|Adverse Event|11|||
130644777|NCT00699582|470319420|FG002|Overall Study|Adverse Event|23|||
130644778|NCT00699582|470319418|FG000|Overall Study|Withdrawal by Subject|6|||
130644779|NCT00699582|470319419|FG001|Overall Study|Withdrawal by Subject|7|||
130644780|NCT00699582|470319420|FG002|Overall Study|Withdrawal by Subject|4|||
130644781|NCT00699582|470319418|FG000|Overall Study|Lack of Efficacy|1|||
130644782|NCT00699582|470319419|FG001|Overall Study|Lack of Efficacy|0|||
130644783|NCT00699582|470319420|FG002|Overall Study|Lack of Efficacy|1|||
130644784|NCT00699582|470319418|FG000|Overall Study|Progressive Disease|1|||
130644785|NCT00699582|470319419|FG001|Overall Study|Progressive Disease|0|||
130644786|NCT00699582|470319420|FG002|Overall Study|Progressive Disease|0|||
130644787|NCT00699582|470319418|FG000|Overall Study|Administrative/Other|4|||
130644788|NCT00699582|470319419|FG001|Overall Study|Administrative/Other|3|||
130644789|NCT00699582|470319420|FG002|Overall Study|Administrative/Other|0|||
130644790|NCT00699582|470319418|FG000|Overall Study|Randomized, Not Treated|2|||
130644791|NCT00699582|470319419|FG001|Overall Study|Randomized, Not Treated|1|||
130644792|NCT00699582|470319420|FG002|Overall Study|Randomized, Not Treated|0|||
130644793|NCT02692560|470319423|FG000|Overall Study|Withdrawal by Subject|0|||
130644794|NCT02692560|470319424|FG001|Overall Study|Withdrawal by Subject|6|||
130644795|NCT01326910|470319425|FG000|Overall Study|Withdrawal by Subject|3|||
130644796|NCT01326910|470319426|FG001|Overall Study|Withdrawal by Subject|2|||
130644797|NCT01326910|470319425|FG000|Overall Study|Protocol Violation|1|||
130644798|NCT01326910|470319426|FG001|Overall Study|Protocol Violation|1|||
130644799|NCT02607735|470319427|FG000|Primary Study|Randomized but Never Treated|1|||
130644800|NCT02607735|470319428|FG001|Primary Study|Randomized but Never Treated|0|||
130644801|NCT02607735|470319429|FG002|Primary Study|Randomized but Never Treated|0|||
130644802|NCT02607735|470319427|FG000|Primary Study|Lost to Follow-up|4|||
130644803|NCT02607735|470319428|FG001|Primary Study|Lost to Follow-up|0|||
130644804|NCT02607735|470319429|FG002|Primary Study|Lost to Follow-up|0|||
130644805|NCT02607735|470319427|FG000|Primary Study|Withdrew Consent|2|||
130644806|NCT02607735|470319428|FG001|Primary Study|Withdrew Consent|0|||
130644807|NCT02607735|470319429|FG002|Primary Study|Withdrew Consent|0|||
130644808|NCT02607735|470319427|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
130644809|NCT02607735|470319428|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
130644810|NCT02607735|470319429|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
130644811|NCT02607735|470319427|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
130644812|NCT02607735|470319428|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
130644813|NCT02607735|470319429|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
130644814|NCT01681836|470319432|FG000|Second Intervention|Withdrawal by Subject|0|||
130644815|NCT01681836|470319433|FG001|Second Intervention|Withdrawal by Subject|1|||
130644816|NCT02394028|470319434|FG000|Induction Phase|Adverse Event|2|||
130644817|NCT02394028|470319435|FG001|Induction Phase|Adverse Event|4|||
130644818|NCT02394028|470319436|FG002|Induction Phase|Adverse Event|1|||
130644819|NCT02394028|470319437|FG003|Induction Phase|Adverse Event|2|||
130644820|NCT02394028|470319438|FG004|Induction Phase|Adverse Event|5|||
130644821|NCT02394028|470319439|FG005|Induction Phase|Adverse Event|2|||
130644822|NCT02394028|470319440|FG006|Induction Phase|Adverse Event|0|||
130644823|NCT02394028|470319441|FG007|Induction Phase|Adverse Event|0|||
130644824|NCT02394028|470319442|FG008|Induction Phase|Adverse Event|0|||
130644825|NCT02394028|470319443|FG009|Induction Phase|Adverse Event|0|||
130644826|NCT02394028|470319444|FG010|Induction Phase|Adverse Event|0|||
130644827|NCT02394028|470319434|FG000|Induction Phase|Lack of Efficacy|3|||
130644828|NCT02394028|470319435|FG001|Induction Phase|Lack of Efficacy|6|||
130644829|NCT02394028|470319436|FG002|Induction Phase|Lack of Efficacy|2|||
130644830|NCT02394028|470319437|FG003|Induction Phase|Lack of Efficacy|17|||
130644831|NCT02394028|470319438|FG004|Induction Phase|Lack of Efficacy|14|||
130644832|NCT02394028|470319439|FG005|Induction Phase|Lack of Efficacy|8|||
130644833|NCT02394028|470319440|FG006|Induction Phase|Lack of Efficacy|17|||
130644834|NCT02394028|470319441|FG007|Induction Phase|Lack of Efficacy|23|||
130644835|NCT02394028|470319442|FG008|Induction Phase|Lack of Efficacy|0|||
130644836|NCT02394028|470319443|FG009|Induction Phase|Lack of Efficacy|0|||
130644837|NCT02394028|470319444|FG010|Induction Phase|Lack of Efficacy|0|||
130644838|NCT02394028|470319434|FG000|Induction Phase|Lost to Follow-up|1|||
130644839|NCT02394028|470319435|FG001|Induction Phase|Lost to Follow-up|0|||
130644840|NCT02394028|470319436|FG002|Induction Phase|Lost to Follow-up|0|||
130644841|NCT02394028|470319437|FG003|Induction Phase|Lost to Follow-up|1|||
130644842|NCT02394028|470319438|FG004|Induction Phase|Lost to Follow-up|0|||
130644843|NCT02394028|470319439|FG005|Induction Phase|Lost to Follow-up|0|||
130644844|NCT02394028|470319440|FG006|Induction Phase|Lost to Follow-up|1|||
130644845|NCT02394028|470319441|FG007|Induction Phase|Lost to Follow-up|0|||
130644846|NCT02394028|470319442|FG008|Induction Phase|Lost to Follow-up|0|||
130644847|NCT02394028|470319443|FG009|Induction Phase|Lost to Follow-up|0|||
130644848|NCT02394028|470319444|FG010|Induction Phase|Lost to Follow-up|0|||
130644849|NCT02394028|470319434|FG000|Induction Phase|Non-compliance|0|||
130644850|NCT02394028|470319435|FG001|Induction Phase|Non-compliance|1|||
130644851|NCT02394028|470319436|FG002|Induction Phase|Non-compliance|3|||
130644852|NCT02394028|470319437|FG003|Induction Phase|Non-compliance|1|||
130644853|NCT02394028|470319438|FG004|Induction Phase|Non-compliance|3|||
130644854|NCT02394028|470319439|FG005|Induction Phase|Non-compliance|0|||
130644855|NCT02394028|470319440|FG006|Induction Phase|Non-compliance|1|||
130644856|NCT02394028|470319441|FG007|Induction Phase|Non-compliance|1|||
130644857|NCT02394028|470319442|FG008|Induction Phase|Non-compliance|0|||
130644858|NCT02394028|470319443|FG009|Induction Phase|Non-compliance|0|||
130644859|NCT02394028|470319444|FG010|Induction Phase|Non-compliance|0|||
130644860|NCT02394028|470319434|FG000|Induction Phase|Physician Decision|0|||
130644861|NCT02394028|470319435|FG001|Induction Phase|Physician Decision|0|||
130644862|NCT02394028|470319436|FG002|Induction Phase|Physician Decision|1|||
130644863|NCT02394028|470319437|FG003|Induction Phase|Physician Decision|4|||
130644864|NCT02394028|470319438|FG004|Induction Phase|Physician Decision|0|||
130644865|NCT02394028|470319439|FG005|Induction Phase|Physician Decision|2|||
130644866|NCT02394028|470319440|FG006|Induction Phase|Physician Decision|1|||
130644867|NCT02394028|470319441|FG007|Induction Phase|Physician Decision|0|||
130644868|NCT02394028|470319442|FG008|Induction Phase|Physician Decision|0|||
130644869|NCT02394028|470319443|FG009|Induction Phase|Physician Decision|0|||
130644870|NCT02394028|470319444|FG010|Induction Phase|Physician Decision|0|||
130644871|NCT02394028|470319434|FG000|Induction Phase|Protocol Violation|0|||
130644872|NCT02394028|470319435|FG001|Induction Phase|Protocol Violation|2|||
130644873|NCT02394028|470319436|FG002|Induction Phase|Protocol Violation|0|||
130644874|NCT02394028|470319437|FG003|Induction Phase|Protocol Violation|3|||
130644875|NCT02394028|470319438|FG004|Induction Phase|Protocol Violation|0|||
130644876|NCT02394028|470319439|FG005|Induction Phase|Protocol Violation|1|||
130644877|NCT02394028|470319440|FG006|Induction Phase|Protocol Violation|1|||
130644878|NCT02394028|470319441|FG007|Induction Phase|Protocol Violation|0|||
130644879|NCT02394028|470319442|FG008|Induction Phase|Protocol Violation|0|||
130644880|NCT02394028|470319443|FG009|Induction Phase|Protocol Violation|0|||
130644881|NCT02394028|470319444|FG010|Induction Phase|Protocol Violation|0|||
130644882|NCT02394028|470319434|FG000|Induction Phase|Withdrawal by Subject|1|||
130644883|NCT02394028|470319435|FG001|Induction Phase|Withdrawal by Subject|2|||
130644884|NCT02394028|470319436|FG002|Induction Phase|Withdrawal by Subject|4|||
130644885|NCT02394028|470319437|FG003|Induction Phase|Withdrawal by Subject|6|||
130644886|NCT02394028|470319438|FG004|Induction Phase|Withdrawal by Subject|7|||
130644887|NCT02394028|470319439|FG005|Induction Phase|Withdrawal by Subject|4|||
130644888|NCT02394028|470319440|FG006|Induction Phase|Withdrawal by Subject|3|||
130644889|NCT02394028|470319441|FG007|Induction Phase|Withdrawal by Subject|6|||
130644890|NCT02394028|470319442|FG008|Induction Phase|Withdrawal by Subject|0|||
130644891|NCT02394028|470319443|FG009|Induction Phase|Withdrawal by Subject|0|||
130644892|NCT02394028|470319444|FG010|Induction Phase|Withdrawal by Subject|0|||
130644893|NCT02394028|470319434|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644894|NCT02394028|470319435|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644895|NCT02394028|470319436|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
130648461|NCT00151775|470333063|FG011|Period 4: Open Label|Lost to Follow-up|0|||
130644896|NCT02394028|470319437|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644897|NCT02394028|470319438|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644898|NCT02394028|470319439|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644899|NCT02394028|470319440|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
130644900|NCT02394028|470319441|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644901|NCT02394028|470319442|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644902|NCT02394028|470319443|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644903|NCT02394028|470319444|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
130644904|NCT02394028|470319434|FG000|Induction Phase|Sponsor decision|0|||
130644905|NCT02394028|470319435|FG001|Induction Phase|Sponsor decision|1|||
130644906|NCT02394028|470319436|FG002|Induction Phase|Sponsor decision|2|||
130644907|NCT02394028|470319437|FG003|Induction Phase|Sponsor decision|0|||
130644908|NCT02394028|470319438|FG004|Induction Phase|Sponsor decision|0|||
130644909|NCT02394028|470319439|FG005|Induction Phase|Sponsor decision|0|||
130644910|NCT02394028|470319440|FG006|Induction Phase|Sponsor decision|0|||
130644911|NCT02394028|470319441|FG007|Induction Phase|Sponsor decision|0|||
130644912|NCT02394028|470319442|FG008|Induction Phase|Sponsor decision|0|||
130644913|NCT02394028|470319443|FG009|Induction Phase|Sponsor decision|0|||
130644914|NCT02394028|470319444|FG010|Induction Phase|Sponsor decision|0|||
130644915|NCT02394028|470319434|FG000|Induction Phase|Technical reason|0|||
130644916|NCT02394028|470319435|FG001|Induction Phase|Technical reason|0|||
130644917|NCT02394028|470319436|FG002|Induction Phase|Technical reason|0|||
130644918|NCT02394028|470319437|FG003|Induction Phase|Technical reason|1|||
130644919|NCT02394028|470319438|FG004|Induction Phase|Technical reason|0|||
130644920|NCT02394028|470319439|FG005|Induction Phase|Technical reason|0|||
130644921|NCT02394028|470319440|FG006|Induction Phase|Technical reason|0|||
130644922|NCT02394028|470319441|FG007|Induction Phase|Technical reason|0|||
130644923|NCT02394028|470319442|FG008|Induction Phase|Technical reason|0|||
130644924|NCT02394028|470319443|FG009|Induction Phase|Technical reason|0|||
130644925|NCT02394028|470319444|FG010|Induction Phase|Technical reason|0|||
130644926|NCT02394028|470319434|FG000|Induction Phase|:ack of calculation|0|||
130644927|NCT02394028|470319435|FG001|Induction Phase|:ack of calculation|0|||
130644928|NCT02394028|470319436|FG002|Induction Phase|:ack of calculation|0|||
130644929|NCT02394028|470319437|FG003|Induction Phase|:ack of calculation|0|||
130644930|NCT02394028|470319438|FG004|Induction Phase|:ack of calculation|0|||
130644931|NCT02394028|470319439|FG005|Induction Phase|:ack of calculation|0|||
130644932|NCT02394028|470319440|FG006|Induction Phase|:ack of calculation|0|||
130644933|NCT02394028|470319441|FG007|Induction Phase|:ack of calculation|1|||
130644934|NCT02394028|470319442|FG008|Induction Phase|:ack of calculation|0|||
130644935|NCT02394028|470319443|FG009|Induction Phase|:ack of calculation|0|||
130644936|NCT02394028|470319444|FG010|Induction Phase|:ack of calculation|0|||
130644937|NCT02394028|470319434|FG000|Maintenance Phase|Protocol Violation|0|||
130644938|NCT02394028|470319435|FG001|Maintenance Phase|Protocol Violation|0|||
130644939|NCT02394028|470319436|FG002|Maintenance Phase|Protocol Violation|0|||
130644940|NCT02394028|470319437|FG003|Maintenance Phase|Protocol Violation|0|||
130644941|NCT02394028|470319438|FG004|Maintenance Phase|Protocol Violation|0|||
130644942|NCT02394028|470319439|FG005|Maintenance Phase|Protocol Violation|0|||
130644943|NCT02394028|470319440|FG006|Maintenance Phase|Protocol Violation|0|||
130644944|NCT02394028|470319441|FG007|Maintenance Phase|Protocol Violation|0|||
130644945|NCT02394028|470319442|FG008|Maintenance Phase|Protocol Violation|0|||
130644946|NCT02394028|470319443|FG009|Maintenance Phase|Protocol Violation|0|||
130644947|NCT02394028|470319444|FG010|Maintenance Phase|Protocol Violation|1|||
130644948|NCT02394028|470319434|FG000|Maintenance Phase|Physician Decision|0|||
130644949|NCT02394028|470319435|FG001|Maintenance Phase|Physician Decision|0|||
130644950|NCT02394028|470319436|FG002|Maintenance Phase|Physician Decision|0|||
130644951|NCT02394028|470319437|FG003|Maintenance Phase|Physician Decision|0|||
130644952|NCT02394028|470319438|FG004|Maintenance Phase|Physician Decision|0|||
130644953|NCT02394028|470319439|FG005|Maintenance Phase|Physician Decision|0|||
130644954|NCT02394028|470319440|FG006|Maintenance Phase|Physician Decision|0|||
130644955|NCT02394028|470319441|FG007|Maintenance Phase|Physician Decision|0|||
130644956|NCT02394028|470319442|FG008|Maintenance Phase|Physician Decision|1|||
130644957|NCT02394028|470319443|FG009|Maintenance Phase|Physician Decision|3|||
130644958|NCT02394028|470319444|FG010|Maintenance Phase|Physician Decision|2|||
130644959|NCT02394028|470319434|FG000|Maintenance Phase|Lack of Efficacy|0|||
130644960|NCT02394028|470319435|FG001|Maintenance Phase|Lack of Efficacy|0|||
130644961|NCT02394028|470319436|FG002|Maintenance Phase|Lack of Efficacy|0|||
130644962|NCT02394028|470319437|FG003|Maintenance Phase|Lack of Efficacy|0|||
130644963|NCT02394028|470319438|FG004|Maintenance Phase|Lack of Efficacy|0|||
130644964|NCT02394028|470319439|FG005|Maintenance Phase|Lack of Efficacy|0|||
130644965|NCT02394028|470319440|FG006|Maintenance Phase|Lack of Efficacy|0|||
130644966|NCT02394028|470319441|FG007|Maintenance Phase|Lack of Efficacy|0|||
130644967|NCT02394028|470319442|FG008|Maintenance Phase|Lack of Efficacy|7|||
130644968|NCT02394028|470319443|FG009|Maintenance Phase|Lack of Efficacy|25|||
130644969|NCT02394028|470319444|FG010|Maintenance Phase|Lack of Efficacy|33|||
130644970|NCT02394028|470319434|FG000|Maintenance Phase|Death|0|||
130644971|NCT02394028|470319435|FG001|Maintenance Phase|Death|0|||
130644972|NCT02394028|470319436|FG002|Maintenance Phase|Death|0|||
130644973|NCT02394028|470319437|FG003|Maintenance Phase|Death|0|||
130644974|NCT02394028|470319438|FG004|Maintenance Phase|Death|0|||
130644975|NCT02394028|470319439|FG005|Maintenance Phase|Death|0|||
130644976|NCT02394028|470319440|FG006|Maintenance Phase|Death|0|||
130644977|NCT02394028|470319441|FG007|Maintenance Phase|Death|0|||
130644978|NCT02394028|470319442|FG008|Maintenance Phase|Death|0|||
130644979|NCT02394028|470319443|FG009|Maintenance Phase|Death|0|||
130644980|NCT02394028|470319444|FG010|Maintenance Phase|Death|1|||
130644981|NCT02394028|470319434|FG000|Maintenance Phase|Adverse Event|0|||
130644982|NCT02394028|470319435|FG001|Maintenance Phase|Adverse Event|0|||
130644983|NCT02394028|470319436|FG002|Maintenance Phase|Adverse Event|0|||
130644984|NCT02394028|470319437|FG003|Maintenance Phase|Adverse Event|0|||
130644985|NCT02394028|470319438|FG004|Maintenance Phase|Adverse Event|0|||
130644986|NCT02394028|470319439|FG005|Maintenance Phase|Adverse Event|0|||
130644987|NCT02394028|470319440|FG006|Maintenance Phase|Adverse Event|0|||
130644988|NCT02394028|470319441|FG007|Maintenance Phase|Adverse Event|0|||
130644989|NCT02394028|470319442|FG008|Maintenance Phase|Adverse Event|1|||
130644990|NCT02394028|470319443|FG009|Maintenance Phase|Adverse Event|1|||
130644991|NCT02394028|470319444|FG010|Maintenance Phase|Adverse Event|3|||
130644992|NCT02394028|470319434|FG000|Maintenance Phase|Site closure|0|||
130644993|NCT02394028|470319435|FG001|Maintenance Phase|Site closure|0|||
130644994|NCT02394028|470319436|FG002|Maintenance Phase|Site closure|0|||
130644995|NCT02394028|470319437|FG003|Maintenance Phase|Site closure|0|||
130644996|NCT02394028|470319438|FG004|Maintenance Phase|Site closure|0|||
130644997|NCT02394028|470319439|FG005|Maintenance Phase|Site closure|0|||
130644998|NCT02394028|470319440|FG006|Maintenance Phase|Site closure|0|||
130644999|NCT02394028|470319441|FG007|Maintenance Phase|Site closure|0|||
130645000|NCT02394028|470319442|FG008|Maintenance Phase|Site closure|0|||
130645001|NCT02394028|470319443|FG009|Maintenance Phase|Site closure|1|||
130645002|NCT02394028|470319444|FG010|Maintenance Phase|Site closure|0|||
130645003|NCT02394028|470319434|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130645004|NCT02394028|470319435|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130645005|NCT02394028|470319436|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130645006|NCT02394028|470319437|FG003|Maintenance Phase|Withdrawal by Subject|0|||
130645007|NCT02394028|470319438|FG004|Maintenance Phase|Withdrawal by Subject|0|||
130645008|NCT02394028|470319439|FG005|Maintenance Phase|Withdrawal by Subject|0|||
130645009|NCT02394028|470319440|FG006|Maintenance Phase|Withdrawal by Subject|0|||
130645010|NCT02394028|470319441|FG007|Maintenance Phase|Withdrawal by Subject|0|||
130645011|NCT02394028|470319442|FG008|Maintenance Phase|Withdrawal by Subject|3|||
130645012|NCT02394028|470319443|FG009|Maintenance Phase|Withdrawal by Subject|12|||
130645013|NCT02394028|470319444|FG010|Maintenance Phase|Withdrawal by Subject|12|||
130645014|NCT01241318|470319449|FG000|Overall Study|Woman: false pregnancies|27|||
130645015|NCT01241318|470319450|FG001|Overall Study|Woman: false pregnancies|15|||
130645016|NCT01241318|470319449|FG000|Overall Study|Woman: miscarriage/abortion|46|||
130645017|NCT01241318|470319450|FG001|Overall Study|Woman: miscarriage/abortion|38|||
130645018|NCT01241318|470319449|FG000|Overall Study|Withdrawal by Subject|175|||
130645019|NCT01241318|470319450|FG001|Overall Study|Withdrawal by Subject|46|||
130645020|NCT01241318|470319449|FG000|Overall Study|Lost to Follow-up|740|||
130645021|NCT01241318|470319450|FG001|Overall Study|Lost to Follow-up|455|||
130645022|NCT01241318|470319449|FG000|Overall Study|Death|2|||
130645023|NCT01241318|470319450|FG001|Overall Study|Death|4|||
130645024|NCT01241318|470319449|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
130645025|NCT01241318|470319450|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
130645026|NCT01241318|470319449|FG000|Overall Study|Woman: Stillborn infant|129|||
130645027|NCT01241318|470319450|FG001|Overall Study|Woman: Stillborn infant|146|||
130645028|NCT02355665|470319451|FG000|Overall Study|Adverse Event|16|||
130645029|NCT02355665|470319452|FG001|Overall Study|Adverse Event|24|||
130645030|NCT02355665|470319451|FG000|Overall Study|Protocol Violation|2|||
130645031|NCT02355665|470319452|FG001|Overall Study|Protocol Violation|0|||
130645032|NCT02355665|470319451|FG000|Overall Study|Withdrawal by Subject|90|||
130645033|NCT02355665|470319452|FG001|Overall Study|Withdrawal by Subject|100|||
130645034|NCT02355665|470319451|FG000|Overall Study|Lost to Follow-up|131|||
130645035|NCT02355665|470319452|FG001|Overall Study|Lost to Follow-up|103|||
130645036|NCT02355665|470319451|FG000|Overall Study|Death|4|||
130645037|NCT02355665|470319452|FG001|Overall Study|Death|2|||
130645038|NCT02355665|470319451|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
130645039|NCT02355665|470319452|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
130645040|NCT04129242|470319453|FG000|Overall Study|Physician Decision|1|||
130645041|NCT04129242|470319454|FG001|Overall Study|Physician Decision|1|||
130645042|NCT04129242|470319453|FG000|Overall Study|Protocol Violation|0|||
130645043|NCT04129242|470319454|FG001|Overall Study|Protocol Violation|1|||
130645044|NCT01454531|470319457|FG000|Overall Study|Adverse Event|14|||
130645045|NCT01454531|470319457|FG000|Overall Study|Withdrawal by Subject|5|||
130645046|NCT01454531|470319457|FG000|Overall Study|Lost to Follow-up|1|||
130645047|NCT01454531|470319457|FG000|Overall Study|Physician Decision|1|||
130645048|NCT01454531|470319457|FG000|Overall Study|Delay in IMP administration|1|||
130645049|NCT01454531|470319457|FG000|Overall Study|Other|1|||
130645050|NCT01775995|470319459|FG000|Overall Study|Lost to Follow-up|1|||
130645051|NCT01775995|470319460|FG001|Overall Study|Lost to Follow-up|1|||
130645052|NCT00440232|470319461|FG000|Overall Study|Lost to Follow-up|1|||
130645053|NCT00440232|470319462|FG001|Overall Study|Lost to Follow-up|1|||
130645054|NCT00440232|470319461|FG000|Overall Study|Unable to treat within allowed time|0|||
130645055|NCT00440232|470319462|FG001|Overall Study|Unable to treat within allowed time|1|||
130645056|NCT00440232|470319461|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
130645057|NCT00440232|470319462|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
130645058|NCT00426842|470319463|FG000|Overall Study|Lost to Follow-up|1|||
130645059|NCT01277666|470319466|FG000|Overall Study|Adverse Event|26|||
130645060|NCT01277666|470319467|FG001|Overall Study|Adverse Event|25|||
130645061|NCT01277666|470319468|FG002|Overall Study|Adverse Event|20|||
130645062|NCT01277666|470319466|FG000|Overall Study|Lack of Efficacy|8|||
130645063|NCT01277666|470319467|FG001|Overall Study|Lack of Efficacy|20|||
130645064|NCT01277666|470319468|FG002|Overall Study|Lack of Efficacy|12|||
130645065|NCT01277666|470319466|FG000|Overall Study|Protocol Violation|2|||
130645066|NCT01277666|470319467|FG001|Overall Study|Protocol Violation|3|||
130645067|NCT01277666|470319468|FG002|Overall Study|Protocol Violation|2|||
130645068|NCT01277666|470319466|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
130645069|NCT01277666|470319467|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
130645070|NCT01277666|470319468|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
130645071|NCT01277666|470319466|FG000|Overall Study|Lost to Follow-up|1|||
130645072|NCT01277666|470319467|FG001|Overall Study|Lost to Follow-up|1|||
130645073|NCT01277666|470319468|FG002|Overall Study|Lost to Follow-up|2|||
130645074|NCT01277666|470319466|FG000|Overall Study|Withdrawal by Subject|7|||
130645075|NCT01277666|470319467|FG001|Overall Study|Withdrawal by Subject|8|||
130645076|NCT01277666|470319468|FG002|Overall Study|Withdrawal by Subject|6|||
130645077|NCT01277666|470319466|FG000|Overall Study|Death|0|||
130645078|NCT01277666|470319467|FG001|Overall Study|Death|0|||
130645079|NCT01277666|470319468|FG002|Overall Study|Death|1|||
130645080|NCT02728804|470319476|FG000|Overall Study|Ineligible|3|||
130645081|NCT02728804|470319476|FG000|Overall Study|Did not complete baseline questionnaire|9|||
130645082|NCT02728804|470319476|FG000|Overall Study|Death|99|||
130645083|NCT02918006|470319482|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
130645084|NCT02918006|470319483|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
130645085|NCT02918006|470319484|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
130645086|NCT02918006|470319482|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
130645087|NCT02918006|470319483|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
130645088|NCT02918006|470319484|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
130645089|NCT02918006|470319482|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
130645090|NCT02918006|470319483|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
130645091|NCT02918006|470319484|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
130645092|NCT02918006|470319482|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
130645093|NCT02918006|470319483|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
130645094|NCT02918006|470319484|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
130645095|NCT02918006|470319482|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
130645096|NCT02918006|470319483|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
130645097|NCT02918006|470319484|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
130645098|NCT02918006|470319482|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
130645099|NCT02918006|470319483|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
130645100|NCT02918006|470319484|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
130645101|NCT02918006|470319482|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
130645102|NCT02918006|470319483|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
130645103|NCT02918006|470319484|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
130645104|NCT02918006|470319482|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
130645105|NCT02918006|470319483|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
130645106|NCT02918006|470319484|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
130645107|NCT02918006|470319482|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
130645108|NCT02918006|470319483|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
130645109|NCT02918006|470319484|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
130645110|NCT02475564|470319488|FG000|Overall Study|Withdrawal by Subject|1|||
130645111|NCT02475564|470319489|FG001|Overall Study|Withdrawal by Subject|0|||
130645112|NCT02475564|470319488|FG000|Overall Study|Lost to Follow-up|2|||
130645113|NCT02475564|470319489|FG001|Overall Study|Lost to Follow-up|1|||
130645114|NCT02475564|470319488|FG000|Overall Study|Intense Menstrual bleeding|1|||
130645115|NCT02475564|470319489|FG001|Overall Study|Intense Menstrual bleeding|0|||
130645116|NCT01156012|470319490|FG000|Overall Study|Adverse Event|3|||
130645117|NCT01156012|470319491|FG001|Overall Study|Adverse Event|1|||
130645118|NCT01156012|470319490|FG000|Overall Study|Lost to Follow-up|1|||
130645119|NCT01156012|470319491|FG001|Overall Study|Lost to Follow-up|0|||
130645120|NCT01156012|470319490|FG000|Overall Study|Withdrawal by Subject|1|||
130645121|NCT01156012|470319491|FG001|Overall Study|Withdrawal by Subject|0|||
130645122|NCT01156012|470319490|FG000|Overall Study|use of commercial drug instead of study|0|||
130645123|NCT01156012|470319491|FG001|Overall Study|use of commercial drug instead of study|1|||
130645124|NCT01156012|470319490|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
130645125|NCT01156012|470319491|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
130645126|NCT02705755|470319493|FG000|Part A (6 Days)|Adverse Event|1|||
130645127|NCT02705755|470319494|FG001|Part A (6 Days)|Adverse Event|0|||
130645128|NCT02705755|470319495|FG002|Part A (6 Days)|Adverse Event|0|||
130645129|NCT02705755|470319496|FG003|Part A (6 Days)|Adverse Event|0|||
130645130|NCT02705755|470319493|FG000|Part A (6 Days)|Physician Decision|3|||
130645131|NCT02705755|470319494|FG001|Part A (6 Days)|Physician Decision|0|||
130645132|NCT02705755|470319495|FG002|Part A (6 Days)|Physician Decision|0|||
130645133|NCT02705755|470319496|FG003|Part A (6 Days)|Physician Decision|0|||
130645134|NCT02705755|470319493|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
130645135|NCT02705755|470319494|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
130645136|NCT02705755|470319495|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
130645137|NCT02705755|470319496|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
130645138|NCT02705755|470319493|FG000|Part C (20 Weeks)|Physician Decision|0|||
130645139|NCT02705755|470319494|FG001|Part C (20 Weeks)|Physician Decision|0|||
130645140|NCT02705755|470319495|FG002|Part C (20 Weeks)|Physician Decision|0|||
130645141|NCT02705755|470319496|FG003|Part C (20 Weeks)|Physician Decision|2|||
130645142|NCT02705755|470319493|FG000|Part C (20 Weeks)|Adverse Event|0|||
130645143|NCT02705755|470319494|FG001|Part C (20 Weeks)|Adverse Event|0|||
130645144|NCT02705755|470319495|FG002|Part C (20 Weeks)|Adverse Event|0|||
130645145|NCT02705755|470319496|FG003|Part C (20 Weeks)|Adverse Event|6|||
130645146|NCT02705755|470319493|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
130645147|NCT02705755|470319494|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
130645148|NCT02705755|470319495|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
130645149|NCT02705755|470319496|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
130645150|NCT02551874|470321146|FG000|Overall Study|Lost to Follow-up|0|||
130645151|NCT02551874|470321147|FG001|Overall Study|Lost to Follow-up|2|||
130645152|NCT02551874|470321146|FG000|Overall Study|Pregnancy|0|||
130645153|NCT02551874|470321147|FG001|Overall Study|Pregnancy|1|||
130645154|NCT02551874|470321146|FG000|Overall Study|Reason not reported|10|||
130645155|NCT02551874|470321147|FG001|Overall Study|Reason not reported|4|||
130645156|NCT02551874|470321146|FG000|Overall Study|Did not receive randomized treatment|0|||
130645157|NCT02551874|470321147|FG001|Overall Study|Did not receive randomized treatment|7|||
130645158|NCT02551874|470321146|FG000|Overall Study|Did not enter long-term study|18|||
130645159|NCT02551874|470321147|FG001|Overall Study|Did not enter long-term study|25|||
130645160|NCT01640353|470321150|FG000|Overall Study|Withdrew prior to treatment|10|||
130645161|NCT01640353|470321150|FG000|Overall Study|Withdrawn from analysis at term site|12|||
130645162|NCT01640353|470321150|FG000|Overall Study|Withdrawal by Subject|5|||
130645163|NCT01640353|470321150|FG000|Overall Study|Death|2|||
130645164|NCT01640353|470321150|FG000|Overall Study|Early site termination|3|||
130645165|NCT01640353|470321150|FG000|Overall Study|Lost to Follow-up|12|||
130645166|NCT01640353|470321150|FG000|Overall Study|Physician Decision|1|||
130645167|NCT01524900|470321155|FG000|Overall Study|Lost to Follow-up|3|||
130645168|NCT01524900|470321156|FG001|Overall Study|Lost to Follow-up|12|||
130645169|NCT01524900|470321157|FG002|Overall Study|Lost to Follow-up|1|||
130645170|NCT01524900|470321158|FG003|Overall Study|Lost to Follow-up|0|||
130645171|NCT01524900|470321159|FG004|Overall Study|Lost to Follow-up|0|||
130645172|NCT01524900|470321155|FG000|Overall Study|Other reason than stated above|1|||
130645173|NCT01524900|470321156|FG001|Overall Study|Other reason than stated above|1|||
130645174|NCT01524900|470321157|FG002|Overall Study|Other reason than stated above|0|||
130645175|NCT01524900|470321158|FG003|Overall Study|Other reason than stated above|0|||
130645176|NCT01524900|470321159|FG004|Overall Study|Other reason than stated above|0|||
130645177|NCT01524900|470321155|FG000|Overall Study|No reason documented|2|||
130645178|NCT01524900|470321156|FG001|Overall Study|No reason documented|1|||
130645179|NCT01524900|470321157|FG002|Overall Study|No reason documented|0|||
130645180|NCT01524900|470321158|FG003|Overall Study|No reason documented|1|||
130645181|NCT01524900|470321159|FG004|Overall Study|No reason documented|0|||
130645182|NCT03758612|470321160|FG000|Washout Period|Withdrawal by Subject|0|||
130645183|NCT03758612|470321161|FG001|Washout Period|Withdrawal by Subject|0|||
130645184|NCT03758612|470321162|FG002|Washout Period|Withdrawal by Subject|2|||
130645185|NCT03758612|470321163|FG003|Washout Period|Withdrawal by Subject|0|||
130645186|NCT03758612|470321164|FG004|Washout Period|Withdrawal by Subject|0|||
130645187|NCT03758612|470321165|FG005|Washout Period|Withdrawal by Subject|0|||
130645188|NCT03758612|470321166|FG006|Washout Period|Withdrawal by Subject|0|||
130645189|NCT03758612|470321167|FG007|Washout Period|Withdrawal by Subject|0|||
130645190|NCT03758612|470321168|FG008|Washout Period|Withdrawal by Subject|0|||
130645191|NCT03758612|470321169|FG009|Washout Period|Withdrawal by Subject|0|||
130645192|NCT03758612|470321170|FG010|Washout Period|Withdrawal by Subject|0|||
130645193|NCT03758612|470321171|FG011|Washout Period|Withdrawal by Subject|0|||
130645194|NCT03758612|470321160|FG000|Period 2|Protocol Violation|0|||
130645195|NCT03758612|470321161|FG001|Period 2|Protocol Violation|0|||
130645196|NCT03758612|470321162|FG002|Period 2|Protocol Violation|0|||
130645197|NCT03758612|470321163|FG003|Period 2|Protocol Violation|0|||
130645198|NCT03758612|470321164|FG004|Period 2|Protocol Violation|1|||
130645199|NCT03758612|470321165|FG005|Period 2|Protocol Violation|0|||
130645200|NCT03758612|470321166|FG006|Period 2|Protocol Violation|0|||
130645201|NCT03758612|470321167|FG007|Period 2|Protocol Violation|0|||
130645202|NCT03758612|470321168|FG008|Period 2|Protocol Violation|0|||
130645203|NCT03758612|470321169|FG009|Period 2|Protocol Violation|0|||
130645204|NCT03758612|470321170|FG010|Period 2|Protocol Violation|0|||
130645205|NCT03758612|470321171|FG011|Period 2|Protocol Violation|0|||
130645206|NCT01603615|470321173|FG000|Overall Study|Did not Receive Treatment|7|||
130645207|NCT01603615|470321173|FG000|Overall Study|Lost to Follow-up|9|||
130645208|NCT01603615|470321173|FG000|Overall Study|Personal Reasons|17|||
130645209|NCT01603615|470321173|FG000|Overall Study|Other Miscellaneous|1|||
130645210|NCT03419741|470321174|FG000|Overall Study|Adverse Event|1|||
130645211|NCT03419741|470321175|FG001|Overall Study|Adverse Event|0|||
130645212|NCT03419741|470321174|FG000|Overall Study|Withdrawal by Subject|1|||
130645213|NCT03419741|470321175|FG001|Overall Study|Withdrawal by Subject|2|||
130645214|NCT04354870|470321176|FG000|Overall Study|Lost to Follow-up|32|||
130645215|NCT04354870|470321177|FG001|Overall Study|Lost to Follow-up|12|||
130645216|NCT04354870|470321176|FG000|Overall Study|Withdrawal by Subject|10|||
130645217|NCT04354870|470321177|FG001|Overall Study|Withdrawal by Subject|16|||
130645218|NCT04354870|470321176|FG000|Overall Study|Did not complete all study visits|6|||
130645219|NCT04354870|470321177|FG001|Overall Study|Did not complete all study visits|5|||
130645220|NCT03384316|470321178|FG000|Overall Study|Screen failure|0|||
130645221|NCT03384316|470321179|FG001|Overall Study|Screen failure|1|||
130645222|NCT02194699|470321190|FG000|Randomised|Did not receive treatment|1|||
130645223|NCT02194699|470321191|FG001|Randomised|Did not receive treatment|5|||
130645224|NCT02194699|470321190|FG000|Randomised|Without potential for 52 weeks of IP|5|||
130645225|NCT02194699|470321191|FG001|Randomised|Without potential for 52 weeks of IP|5|||
130645226|NCT02194699|470321190|FG000|Randomised|Duplicate patient|2|||
130645227|NCT02194699|470321191|FG001|Randomised|Duplicate patient|1|||
130645228|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
130645229|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
130645230|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
130645231|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
130645232|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
130645233|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
130645234|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
130645235|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
130645236|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
130645237|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
130645238|NCT02194699|470321190|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
130645239|NCT02194699|470321191|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
130645240|NCT00298766|470321192|FG000|Overall Study|Adverse Event|18|||
130645241|NCT00298766|470321192|FG000|Overall Study|Death|2|||
130645242|NCT00298766|470321192|FG000|Overall Study|Withdrawal by Subject|9|||
130645243|NCT00298766|470321192|FG000|Overall Study|Treatment ongoing|4|||
130645244|NCT00298766|470321192|FG000|Overall Study|Progression of amyloid markers|4|||
130645245|NCT00298766|470321192|FG000|Overall Study|Deterioration in KPS and organ function|1|||
130645246|NCT00298766|470321192|FG000|Overall Study|Subjects overall condition deterioration|4|||
130645247|NCT00298766|470321192|FG000|Overall Study|Other|4|||
130645248|NCT00386152|470321193|FG000|Overall Study|Adverse Event|6|||
130645249|NCT00386152|470321194|FG001|Overall Study|Adverse Event|5|||
130645250|NCT00386152|470321195|FG002|Overall Study|Adverse Event|4|||
130645251|NCT00386152|470321193|FG000|Overall Study|Chang from original chemo stratification|4|||
130645252|NCT00386152|470321194|FG001|Overall Study|Chang from original chemo stratification|5|||
130645253|NCT00386152|470321195|FG002|Overall Study|Chang from original chemo stratification|6|||
130645254|NCT00386152|470321193|FG000|Overall Study|Death|3|||
130645255|NCT00386152|470321194|FG001|Overall Study|Death|0|||
130645256|NCT00386152|470321195|FG002|Overall Study|Death|1|||
130645257|NCT00386152|470321193|FG000|Overall Study|Disease progression|7|||
130645258|NCT00386152|470321194|FG001|Overall Study|Disease progression|4|||
130645259|NCT00386152|470321195|FG002|Overall Study|Disease progression|5|||
130645260|NCT00386152|470321193|FG000|Overall Study|Physician Decision|13|||
130645261|NCT00386152|470321194|FG001|Overall Study|Physician Decision|10|||
130645262|NCT00386152|470321195|FG002|Overall Study|Physician Decision|4|||
130645263|NCT00386152|470321193|FG000|Overall Study|Lost to Follow-up|1|||
130645264|NCT00386152|470321194|FG001|Overall Study|Lost to Follow-up|0|||
130645265|NCT00386152|470321195|FG002|Overall Study|Lost to Follow-up|0|||
130645266|NCT00386152|470321193|FG000|Overall Study|Completed chemotherapy|4|||
130645267|NCT00386152|470321194|FG001|Overall Study|Completed chemotherapy|5|||
130645268|NCT00386152|470321195|FG002|Overall Study|Completed chemotherapy|1|||
130645269|NCT00386152|470321193|FG000|Overall Study|Protocol Violation|3|||
130645270|NCT00386152|470321194|FG001|Overall Study|Protocol Violation|5|||
130645271|NCT00386152|470321195|FG002|Overall Study|Protocol Violation|2|||
130645272|NCT00386152|470321193|FG000|Overall Study|Withdrawal by Subject|3|||
130645273|NCT00386152|470321194|FG001|Overall Study|Withdrawal by Subject|6|||
130645274|NCT00386152|470321195|FG002|Overall Study|Withdrawal by Subject|10|||
130645275|NCT03633461|470321210|FG000|Overall Study|Lost to Follow-up|0|||
130645276|NCT03633461|470321211|FG001|Overall Study|Lost to Follow-up|1|||
130645277|NCT03938857|470321214|FG000|Overall Study|Physician Decision|1|||
130645278|NCT03938857|470321215|FG001|Overall Study|Physician Decision|0|||
130645279|NCT03938857|470321216|FG002|Overall Study|Physician Decision|0|||
130645280|NCT03938857|470321217|FG003|Overall Study|Physician Decision|0|||
130645281|NCT02516605|470321218|FG000|Overall Study|Protocol Violation|0|||
130645282|NCT02516605|470321219|FG001|Overall Study|Protocol Violation|0|||
130645283|NCT02516605|470321220|FG002|Overall Study|Protocol Violation|0|||
130645284|NCT02516605|470321221|FG003|Overall Study|Protocol Violation|0|||
130645285|NCT02516605|470321222|FG004|Overall Study|Protocol Violation|1|||
130645286|NCT02516605|470321218|FG000|Overall Study|Withdrawal by Subject|0|||
130645287|NCT02516605|470321219|FG001|Overall Study|Withdrawal by Subject|0|||
130645288|NCT02516605|470321220|FG002|Overall Study|Withdrawal by Subject|0|||
130645289|NCT02516605|470321221|FG003|Overall Study|Withdrawal by Subject|1|||
130645290|NCT02516605|470321222|FG004|Overall Study|Withdrawal by Subject|0|||
130645291|NCT02577107|470321223|FG000|Overall Study|Protocol deviation|0|||
130645292|NCT02577107|470321224|FG001|Overall Study|Protocol deviation|1|||
130645293|NCT00577382|470321225|FG000|Overall Study|Adverse Event|0|||
130645294|NCT00577382|470321226|FG001|Overall Study|Adverse Event|6|||
130645295|NCT00577382|470321225|FG000|Overall Study|Withdrawal by Subject|0|||
130645296|NCT00577382|470321226|FG001|Overall Study|Withdrawal by Subject|1|||
130645297|NCT00577382|470321225|FG000|Overall Study|Progressive Disease|17|||
130645298|NCT00577382|470321226|FG001|Overall Study|Progressive Disease|19|||
130645299|NCT00577382|470321225|FG000|Overall Study|Intercurrent Illness|1|||
130645300|NCT00577382|470321226|FG001|Overall Study|Intercurrent Illness|2|||
130645301|NCT00577382|470321225|FG000|Overall Study|Death|1|||
130645302|NCT00577382|470321226|FG001|Overall Study|Death|1|||
130645303|NCT00577382|470321225|FG000|Overall Study|Lost to Follow-up|2|||
130645304|NCT00577382|470321226|FG001|Overall Study|Lost to Follow-up|2|||
130645305|NCT01710709|470321227|FG000|Overall Study|Lost to Follow-up|29|||
130645306|NCT01710709|470321227|FG000|Overall Study|Adverse Event|48|||
130645307|NCT01710709|470321227|FG000|Overall Study|Participant met withdrawal criteria|33|||
130645308|NCT01710709|470321227|FG000|Overall Study|Participant withdrawn by investigator|2|||
130645309|NCT01710709|470321227|FG000|Overall Study|Withdrawal by Subject|53|||
130645310|NCT01710709|470321227|FG000|Overall Study|Protocol Violation|5|||
130645311|NCT01710709|470321227|FG000|Overall Study|Lack of Efficacy|3|||
130645312|NCT03287089|470321229|FG000|Overall Study|Lost to Follow-up|0|||
130645313|NCT03287089|470321230|FG001|Overall Study|Lost to Follow-up|2|||
130645314|NCT03287089|470321229|FG000|Overall Study|Physician Decision|0|||
130645315|NCT03287089|470321230|FG001|Overall Study|Physician Decision|2|||
130645316|NCT03287089|470321229|FG000|Overall Study|Withdrawal by Subject|0|||
130645317|NCT03287089|470321230|FG001|Overall Study|Withdrawal by Subject|2|||
130645318|NCT04880642|470321231|FG000|Randomization|Withdrawal by Subject|2|||
130645319|NCT04880642|470321232|FG001|Randomization|Withdrawal by Subject|3|||
130645320|NCT04880642|470321231|FG000|Treatment Period|Adverse Event|0|||
130645321|NCT04880642|470321232|FG001|Treatment Period|Adverse Event|1|||
130645322|NCT04880642|470321231|FG000|Treatment Period|Death|6|||
130645323|NCT04880642|470321232|FG001|Treatment Period|Death|6|||
130645324|NCT04880642|470321231|FG000|Treatment Period|Lost to Follow-up|1|||
130645325|NCT04880642|470321232|FG001|Treatment Period|Lost to Follow-up|0|||
130645326|NCT04880642|470321231|FG000|Treatment Period|Protocol Violation|0|||
130645327|NCT04880642|470321232|FG001|Treatment Period|Protocol Violation|1|||
130645328|NCT04880642|470321231|FG000|Treatment Period|Withdrawal by Subject|5|||
130645329|NCT04880642|470321232|FG001|Treatment Period|Withdrawal by Subject|3|||
130645330|NCT04880642|470321231|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
130645331|NCT04880642|470321232|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
130645332|NCT04880642|470321231|FG000|Follow-up|Death|4|||
130645333|NCT04880642|470321232|FG001|Follow-up|Death|3|||
130645334|NCT04880642|470321231|FG000|Follow-up|Withdrawal by Subject|1|||
130645335|NCT04880642|470321232|FG001|Follow-up|Withdrawal by Subject|0|||
130645336|NCT00104299|470321233|FG000|Overall Study|Adverse Event|3|||
130645337|NCT00104299|470321234|FG001|Overall Study|Adverse Event|1|||
130645338|NCT00104299|470321233|FG000|Overall Study|Death|2|||
130645339|NCT00104299|470321234|FG001|Overall Study|Death|2|||
130645340|NCT00104299|470321233|FG000|Overall Study|Withdrawal by Subject|2|||
130645341|NCT00104299|470321234|FG001|Overall Study|Withdrawal by Subject|6|||
130645342|NCT00104299|470321233|FG000|Overall Study|Physician Decision|1|||
130645343|NCT00104299|470321234|FG001|Overall Study|Physician Decision|1|||
130645344|NCT00104299|470321233|FG000|Overall Study|To have renal transplant|1|||
130645345|NCT00104299|470321234|FG001|Overall Study|To have renal transplant|0|||
130645346|NCT02452034|470321235|FG000|Overall Study|Adverse Event|0|||
130645347|NCT02452034|470321236|FG001|Overall Study|Adverse Event|0|||
130645348|NCT02452034|470321237|FG002|Overall Study|Adverse Event|0|||
130645349|NCT02452034|470321238|FG003|Overall Study|Adverse Event|0|||
130645350|NCT02452034|470321239|FG004|Overall Study|Adverse Event|0|||
130645351|NCT02452034|470321240|FG005|Overall Study|Adverse Event|1|||
130645352|NCT02452034|470321235|FG000|Overall Study|Death|0|||
130645353|NCT02452034|470321236|FG001|Overall Study|Death|0|||
130645354|NCT02452034|470321237|FG002|Overall Study|Death|0|||
130645355|NCT02452034|470321238|FG003|Overall Study|Death|0|||
130645356|NCT02452034|470321239|FG004|Overall Study|Death|1|||
130645357|NCT02452034|470321240|FG005|Overall Study|Death|1|||
130645358|NCT02452034|470321235|FG000|Overall Study|Physician Decision|0|||
130645359|NCT02452034|470321236|FG001|Overall Study|Physician Decision|1|||
130645360|NCT02452034|470321237|FG002|Overall Study|Physician Decision|1|||
130645361|NCT02452034|470321238|FG003|Overall Study|Physician Decision|0|||
130645362|NCT02452034|470321239|FG004|Overall Study|Physician Decision|0|||
130645363|NCT02452034|470321240|FG005|Overall Study|Physician Decision|0|||
130645364|NCT02452034|470321235|FG000|Overall Study|Protocol Violation|0|||
130645365|NCT02452034|470321236|FG001|Overall Study|Protocol Violation|0|||
130645366|NCT02452034|470321237|FG002|Overall Study|Protocol Violation|0|||
130645367|NCT02452034|470321238|FG003|Overall Study|Protocol Violation|0|||
130645368|NCT02452034|470321239|FG004|Overall Study|Protocol Violation|0|||
130645369|NCT02452034|470321240|FG005|Overall Study|Protocol Violation|1|||
130645370|NCT02452034|470321235|FG000|Overall Study|Screen Failure|1|||
130645371|NCT02452034|470321236|FG001|Overall Study|Screen Failure|0|||
130645372|NCT02452034|470321237|FG002|Overall Study|Screen Failure|0|||
130645373|NCT02452034|470321238|FG003|Overall Study|Screen Failure|1|||
130645374|NCT02452034|470321239|FG004|Overall Study|Screen Failure|0|||
130645375|NCT02452034|470321240|FG005|Overall Study|Screen Failure|0|||
130645376|NCT02452034|470321235|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130645377|NCT02452034|470321236|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
130645378|NCT02452034|470321237|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130645379|NCT02452034|470321238|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
130645380|NCT02452034|470321239|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
130645381|NCT02452034|470321240|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
130645382|NCT00561795|470321241|FG000|Overall Study|Adverse Event|3|||
130645383|NCT00561795|470321242|FG001|Overall Study|Adverse Event|3|||
130645384|NCT00561795|470321243|FG002|Overall Study|Adverse Event|0|||
130645385|NCT00561795|470321244|FG003|Overall Study|Adverse Event|0|||
130645386|NCT00561795|470321241|FG000|Overall Study|Study Closed/Terminated|0|||
130645387|NCT00561795|470321242|FG001|Overall Study|Study Closed/Terminated|3|||
130645388|NCT00561795|470321243|FG002|Overall Study|Study Closed/Terminated|0|||
130645389|NCT00561795|470321244|FG003|Overall Study|Study Closed/Terminated|0|||
130645390|NCT00561795|470321241|FG000|Overall Study|Physician Decision|1|||
130645391|NCT00561795|470321242|FG001|Overall Study|Physician Decision|0|||
130645392|NCT00561795|470321243|FG002|Overall Study|Physician Decision|0|||
130645393|NCT00561795|470321244|FG003|Overall Study|Physician Decision|0|||
130645394|NCT00490815|470321249|FG000|Overall Study|Adverse Event|2|||
130645395|NCT00490815|470321250|FG001|Overall Study|Adverse Event|3|||
130645396|NCT00490815|470321249|FG000|Overall Study|Withdrawal by Subject|4|||
130645397|NCT00490815|470321250|FG001|Overall Study|Withdrawal by Subject|0|||
130645398|NCT00490815|470321249|FG000|Overall Study|Lost to Follow-up|1|||
130645399|NCT00490815|470321250|FG001|Overall Study|Lost to Follow-up|3|||
130645400|NCT00490815|470321249|FG000|Overall Study|Death|1|||
130645401|NCT00490815|470321250|FG001|Overall Study|Death|3|||
130645402|NCT02195531|470321253|FG000|Overall Study|Withdrawal by Subject|1|||
130645403|NCT02195531|470321254|FG001|Overall Study|Withdrawal by Subject|1|||
130645404|NCT02195531|470321255|FG002|Overall Study|Withdrawal by Subject|1|||
130645405|NCT02543801|470321256|FG000|Overall Study|Protocol Violation|1|||
130645406|NCT02543801|470321257|FG001|Overall Study|Protocol Violation|2|||
130645407|NCT02543801|470321258|FG002|Overall Study|Protocol Violation|0|||
130645408|NCT02543801|470321259|FG003|Overall Study|Protocol Violation|0|||
130645409|NCT01351415|470321271|FG000|Overall Study|Withdrawal by Subject|15|||
130645410|NCT01351415|470321272|FG001|Overall Study|Withdrawal by Subject|17|||
130645411|NCT01351415|470321271|FG000|Overall Study|Trial termination by the Sponsor|28|||
130645412|NCT01351415|470321272|FG001|Overall Study|Trial termination by the Sponsor|19|||
130645413|NCT01351415|470321271|FG000|Overall Study|Lost to Follow-up|5|||
130645414|NCT01351415|470321272|FG001|Overall Study|Lost to Follow-up|7|||
130645415|NCT01351415|470321271|FG000|Overall Study|Death|190|||
130645416|NCT01351415|470321272|FG001|Overall Study|Death|187|||
130645417|NCT01351415|470321271|FG000|Overall Study|Physician Decision|2|||
130645418|NCT01351415|470321272|FG001|Overall Study|Physician Decision|3|||
130645419|NCT01351415|470321271|FG000|Overall Study|Reason unknown|0|||
130645420|NCT01351415|470321272|FG001|Overall Study|Reason unknown|2|||
130645421|NCT01351415|470321271|FG000|Overall Study|Never Started|5|||
130645422|NCT01351415|470321272|FG001|Overall Study|Never Started|5|||
130645423|NCT04118127|470321277|FG000|Overall Study|Trial terminated by sponsor|0|||
130645424|NCT04118127|470321278|FG001|Overall Study|Trial terminated by sponsor|12|||
130645425|NCT04118127|470321277|FG000|Overall Study|Adverse Event|1|||
130645426|NCT04118127|470321278|FG001|Overall Study|Adverse Event|2|||
130645427|NCT04118127|470321277|FG000|Overall Study|Physician Decision|0|||
130645428|NCT04118127|470321278|FG001|Overall Study|Physician Decision|1|||
130645429|NCT04118127|470321277|FG000|Overall Study|Withdrawal by Subject|2|||
130645430|NCT04118127|470321278|FG001|Overall Study|Withdrawal by Subject|1|||
130645431|NCT00660816|470321279|FG000|Overall Study|Adverse Event|1|||
130645432|NCT00660816|470321280|FG001|Overall Study|Adverse Event|2|||
130645433|NCT00660816|470321279|FG000|Overall Study|Withdrawal by Subject|1|||
130645434|NCT00660816|470321280|FG001|Overall Study|Withdrawal by Subject|0|||
130645435|NCT00660816|470321279|FG000|Overall Study|Death|0|||
130645436|NCT00660816|470321280|FG001|Overall Study|Death|2|||
130645437|NCT00660816|470321279|FG000|Overall Study|Lack of Efficacy|1|||
130645438|NCT00660816|470321280|FG001|Overall Study|Lack of Efficacy|0|||
130645439|NCT00660816|470321279|FG000|Overall Study|Physician Decision|0|||
130645440|NCT00660816|470321280|FG001|Overall Study|Physician Decision|2|||
130645441|NCT00660816|470321279|FG000|Overall Study|Protocol Violation|1|||
130645442|NCT00660816|470321280|FG001|Overall Study|Protocol Violation|0|||
130645443|NCT00660816|470321279|FG000|Overall Study|Disease Progression|16|||
130645444|NCT00660816|470321280|FG001|Overall Study|Disease Progression|12|||
130645445|NCT00660816|470321279|FG000|Overall Study|Complicating Disease|0|||
130645446|NCT00660816|470321280|FG001|Overall Study|Complicating Disease|1|||
130645447|NCT01646255|470321281|FG000|Overall Study|Adverse Event|7|||
130645448|NCT01646255|470321282|FG001|Overall Study|Adverse Event|8|||
130645449|NCT01646255|470321281|FG000|Overall Study|Lack of Efficacy|2|||
130645450|NCT01646255|470321282|FG001|Overall Study|Lack of Efficacy|0|||
130645451|NCT01646255|470321281|FG000|Overall Study|Withdrawal by Subject|10|||
130645452|NCT01646255|470321282|FG001|Overall Study|Withdrawal by Subject|6|||
130645453|NCT01646255|470321281|FG000|Overall Study|Compliance is not well|1|||
130645454|NCT01646255|470321282|FG001|Overall Study|Compliance is not well|0|||
130645455|NCT01646255|470321281|FG000|Overall Study|Inclusion Criteria Deviation|1|||
130645456|NCT01646255|470321282|FG001|Overall Study|Inclusion Criteria Deviation|0|||
130645457|NCT02380703|470321285|FG000|Overall Study|Withdrawal by Subject|12|||
130645458|NCT02380703|470321286|FG001|Overall Study|Withdrawal by Subject|9|||
130645459|NCT02380703|470321285|FG000|Overall Study|Lost to Follow-up|12|||
130645460|NCT02380703|470321286|FG001|Overall Study|Lost to Follow-up|12|||
130645461|NCT02380703|470321285|FG000|Overall Study|Caregiver death|1|||
130645462|NCT02380703|470321286|FG001|Overall Study|Caregiver death|0|||
130645463|NCT02380703|470321285|FG000|Overall Study|Person with dementia (PWD) death|7|||
130645464|NCT02380703|470321286|FG001|Overall Study|Person with dementia (PWD) death|8|||
130645465|NCT02380703|470321285|FG000|Overall Study|Entered Long-term Care|4|||
130645466|NCT02380703|470321286|FG001|Overall Study|Entered Long-term Care|7|||
130645467|NCT01362049|470321287|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
130645468|NCT01362049|470321288|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
130645469|NCT01362049|470321289|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
130645470|NCT01362049|470321290|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
130645471|NCT01362049|470321287|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
130645472|NCT01362049|470321288|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
130645473|NCT01362049|470321289|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
130645474|NCT01362049|470321290|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
130645475|NCT03607994|470321291|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
130645476|NCT03607994|470321292|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
130645477|NCT02850276|470321297|FG000|Overall Study|screen failure|43|||
130645478|NCT02850276|470321297|FG000|Overall Study|Withdrawal by Subject|14|||
130645479|NCT02850276|470321297|FG000|Overall Study|Physician Decision|2|||
130645480|NCT02850276|470321297|FG000|Overall Study|Lost to Follow-up|2|||
130645481|NCT02504424|470321303|FG000|Overall Study|Withdrawal by Subject|2|||
130645482|NCT00819052|470321304|FG000|Overall Study|Adverse Event|0|||
130645483|NCT00819052|470321305|FG001|Overall Study|Adverse Event|5|||
130645484|NCT00819052|470321304|FG000|Overall Study|Protocol Violation|1|||
130645485|NCT00819052|470321305|FG001|Overall Study|Protocol Violation|2|||
130645486|NCT00819052|470321304|FG000|Overall Study|Lost to Follow-up|1|||
130645487|NCT00819052|470321305|FG001|Overall Study|Lost to Follow-up|2|||
130645488|NCT00819052|470321304|FG000|Overall Study|Withdrawal by Subject|1|||
130645489|NCT00819052|470321305|FG001|Overall Study|Withdrawal by Subject|2|||
130645490|NCT00819052|470321304|FG000|Overall Study|Lack of Efficacy|1|||
130645491|NCT00819052|470321305|FG001|Overall Study|Lack of Efficacy|1|||
130645492|NCT00819052|470321304|FG000|Overall Study|Pregnancy|1|||
130645493|NCT00819052|470321305|FG001|Overall Study|Pregnancy|2|||
130645494|NCT00819052|470321304|FG000|Overall Study|Death or events leading to death|1|||
130645495|NCT00819052|470321305|FG001|Overall Study|Death or events leading to death|0|||
130645496|NCT01747655|470321308|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
130645497|NCT01747655|470321309|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
130645498|NCT01747655|470321308|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
130645499|NCT01747655|470321309|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
130645500|NCT01747655|470321308|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
130645501|NCT01747655|470321309|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
130645502|NCT00982111|470321310|FG000|Overall Study|Adverse Event|1|||
130645503|NCT00982111|470321311|FG001|Overall Study|Adverse Event|1|||
130645504|NCT00982111|470321310|FG000|Overall Study|Progressive Disease|46|||
130645505|NCT00982111|470321311|FG001|Overall Study|Progressive Disease|39|||
130645506|NCT00982111|470321310|FG000|Overall Study|Lost to Follow-up|9|||
130645507|NCT00982111|470321311|FG001|Overall Study|Lost to Follow-up|6|||
130645508|NCT00982111|470321310|FG000|Overall Study|New Anti-Cancer Therapy|5|||
130645509|NCT00982111|470321311|FG001|Overall Study|New Anti-Cancer Therapy|5|||
130645510|NCT00982111|470321310|FG000|Overall Study|Medical Decision|1|||
130645511|NCT00982111|470321311|FG001|Overall Study|Medical Decision|0|||
130645512|NCT00982111|470321310|FG000|Overall Study|Withdrawal by Subject|17|||
130645513|NCT00982111|470321311|FG001|Overall Study|Withdrawal by Subject|19|||
130645514|NCT00982111|470321310|FG000|Overall Study|Global Study End|0|||
130645515|NCT00982111|470321311|FG001|Overall Study|Global Study End|1|||
130645516|NCT00982111|470321310|FG000|Overall Study|Sponsor's Decision|0|||
130645517|NCT00982111|470321311|FG001|Overall Study|Sponsor's Decision|1|||
130645518|NCT01070381|470321312|FG000|Period 2, 1 Week of Wear|Handling|0|||
130645519|NCT01070381|470321313|FG001|Period 2, 1 Week of Wear|Handling|1|||
130645520|NCT01070381|470321312|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
130645521|NCT01070381|470321313|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
130645522|NCT03512028|470321315|FG000|Overall Study|Withdrawal by Subject|2|||
130645523|NCT03512028|470321316|FG001|Overall Study|Withdrawal by Subject|0|||
130645524|NCT03512028|470321315|FG000|Overall Study|Protocol Violation|2|||
130645525|NCT03512028|470321316|FG001|Overall Study|Protocol Violation|0|||
130645526|NCT03529162|470321319|FG000|Overall Study|Lost to Follow-up|2|||
130645527|NCT03529162|470321320|FG001|Overall Study|Lost to Follow-up|2|||
130645528|NCT02719028|470323032|FG000|Overall Study|Adverse Event|2|||
130645529|NCT02719028|470323033|FG001|Overall Study|Adverse Event|1|||
130645530|NCT02719028|470323034|FG002|Overall Study|Adverse Event|4|||
130645531|NCT02719028|470323035|FG003|Overall Study|Adverse Event|8|||
130645532|NCT02719028|470323032|FG000|Overall Study|Physician Decision|0|||
130645533|NCT02719028|470323033|FG001|Overall Study|Physician Decision|1|||
130645534|NCT02719028|470323034|FG002|Overall Study|Physician Decision|1|||
130645535|NCT02719028|470323035|FG003|Overall Study|Physician Decision|1|||
130645536|NCT02719028|470323032|FG000|Overall Study|Use of prohibited medication|0|||
130645537|NCT02719028|470323033|FG001|Overall Study|Use of prohibited medication|0|||
130645538|NCT02719028|470323034|FG002|Overall Study|Use of prohibited medication|1|||
130645539|NCT02719028|470323035|FG003|Overall Study|Use of prohibited medication|0|||
130645540|NCT02719028|470323032|FG000|Overall Study|Protocol Violation|0|||
130645541|NCT02719028|470323033|FG001|Overall Study|Protocol Violation|0|||
130645542|NCT02719028|470323034|FG002|Overall Study|Protocol Violation|0|||
130645543|NCT02719028|470323035|FG003|Overall Study|Protocol Violation|1|||
130645544|NCT01539720|470323036|FG000|Overall Study|Screen Fail|15|||
130645545|NCT01539720|470323037|FG001|Overall Study|Screen Fail|3|||
130645546|NCT01539720|470323036|FG000|Overall Study|Lost to Follow-up|14|||
130645547|NCT01539720|470323037|FG001|Overall Study|Lost to Follow-up|7|||
130645548|NCT00508872|470323040|FG000|Overall Study|Lost to Follow-up|1|||
130645549|NCT00508872|470323040|FG000|Overall Study|Physician Decision|1|||
130645550|NCT03007472|470323042|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
130645551|NCT03007472|470323042|FG000|Overall Study|Death|2|||
130645552|NCT03007472|470323042|FG000|Overall Study|Loss to Follow Up|1|||
130645553|NCT01977651|470323051|FG000|4 Month Treatment Period|Adverse Event|34|||
130645554|NCT01977651|470323051|FG000|4 Month Treatment Period|Death|3|||
130645555|NCT01977651|470323051|FG000|4 Month Treatment Period|Progressive Disease|43|||
130645556|NCT01977651|470323051|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
130645557|NCT01977651|470323051|FG000|4 Month Treatment Period|Physician Decision|4|||
130645558|NCT01977651|470323051|FG000|1 Year Extension Period|Adverse Event|14|||
130645559|NCT01977651|470323051|FG000|1 Year Extension Period|Death|10|||
130645560|NCT01977651|470323051|FG000|1 Year Extension Period|Lost to Follow-up|2|||
130645561|NCT01977651|470323051|FG000|1 Year Extension Period|Progressive Disease|86|||
130645562|NCT01977651|470323051|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
130645563|NCT01977651|470323051|FG000|1 Year Extension Period|Physician Decision|6|||
130645564|NCT01977651|470323051|FG000|1 Year Extension Period|Miscellaneous|1|||
130645565|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Adverse Event|5|||
130645566|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Death|13|||
130645567|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
130645568|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
130645569|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Physician Decision|4|||
130645570|NCT01977651|470323051|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
130645571|NCT00661362|470323052|FG000|Overall Study|Adverse Event|5|||
130645572|NCT00661362|470323053|FG001|Overall Study|Adverse Event|4|||
130645573|NCT00661362|470323052|FG000|Overall Study|Incorrect enrollment|2|||
130645574|NCT00661362|470323053|FG001|Overall Study|Incorrect enrollment|0|||
130645575|NCT00661362|470323052|FG000|Overall Study|Study specific discontinuation criteria|4|||
130645576|NCT00661362|470323053|FG001|Overall Study|Study specific discontinuation criteria|11|||
130645577|NCT00661362|470323052|FG000|Overall Study|Withdrawal by Subject|13|||
130645578|NCT00661362|470323053|FG001|Overall Study|Withdrawal by Subject|23|||
130645579|NCT00661362|470323052|FG000|Overall Study|Lost to Follow-up|3|||
130645580|NCT00661362|470323053|FG001|Overall Study|Lost to Follow-up|1|||
130645581|NCT00661362|470323052|FG000|Overall Study|Severe non-compliance to protocol|0|||
130645582|NCT00661362|470323053|FG001|Overall Study|Severe non-compliance to protocol|1|||
130645583|NCT00661362|470323052|FG000|Overall Study|Safety reasons|1|||
130645584|NCT00661362|470323053|FG001|Overall Study|Safety reasons|0|||
130645585|NCT00661362|470323052|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
130645586|NCT00661362|470323053|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
130645587|NCT02906644|470323054|FG000|First 2 Weeks|Withdrawal by Subject|0|||
130645588|NCT02906644|470323055|FG001|First 2 Weeks|Withdrawal by Subject|2|||
130645589|NCT02906644|470323054|FG000|First 2 Weeks|Physician Decision|1|||
130645590|NCT02906644|470323055|FG001|First 2 Weeks|Physician Decision|1|||
130645591|NCT02906644|470323054|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
130645592|NCT02906644|470323055|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
130645593|NCT02906644|470323054|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
130645594|NCT02906644|470323055|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
130645595|NCT03672006|470323056|FG000|Overall Study|exclusion criteria met|0|||
130645596|NCT03672006|470323057|FG001|Overall Study|exclusion criteria met|1|||
130645597|NCT01453439|470323058|FG000|Treatment Phase|Withdrawal by Subject|13|||
130645598|NCT01453439|470323059|FG001|Treatment Phase|Withdrawal by Subject|10|||
130645599|NCT01453439|470323058|FG000|Treatment Phase|Suicidal Ideation|2|||
130645600|NCT01453439|470323059|FG001|Treatment Phase|Suicidal Ideation|0|||
130645601|NCT01453439|470323058|FG000|Treatment Phase|Need for higher level of care|1|||
130645602|NCT01453439|470323059|FG001|Treatment Phase|Need for higher level of care|1|||
130645603|NCT01453439|470323058|FG000|Treatment Phase|Therapist conflict of interest|1|||
130645604|NCT01453439|470323059|FG001|Treatment Phase|Therapist conflict of interest|0|||
130645605|NCT01453439|470323058|FG000|Follow-up|Withdrawal by Subject|0|||
130645606|NCT01453439|470323059|FG001|Follow-up|Withdrawal by Subject|1|||
130645607|NCT01453439|470323058|FG000|Follow-up|Lost to Follow-up|5|||
130645608|NCT01453439|470323059|FG001|Follow-up|Lost to Follow-up|10|||
130645609|NCT01014442|470323060|FG000|Overall Study|Adverse Event|0|||
130645610|NCT01014442|470323061|FG001|Overall Study|Adverse Event|8|||
130645611|NCT01014442|470323060|FG000|Overall Study|Withdrawal by Subject|4|||
130645612|NCT01014442|470323061|FG001|Overall Study|Withdrawal by Subject|4|||
130645613|NCT01014442|470323060|FG000|Overall Study|Protocol Violation|2|||
130645614|NCT01014442|470323061|FG001|Overall Study|Protocol Violation|5|||
130645615|NCT01014442|470323060|FG000|Overall Study|Lack of Compliance|0|||
130645616|NCT01014442|470323061|FG001|Overall Study|Lack of Compliance|1|||
130645617|NCT01014442|470323060|FG000|Overall Study|Unspecified Reason|1|||
130645618|NCT01014442|470323061|FG001|Overall Study|Unspecified Reason|1|||
130645619|NCT02135848|470323069|FG000|Overall Study|Adverse Event|2|||
130645620|NCT02135848|470323070|FG001|Overall Study|Adverse Event|0|||
130645621|NCT02135848|470323069|FG000|Overall Study|Withdrawal by Subject|1|||
130645622|NCT02135848|470323070|FG001|Overall Study|Withdrawal by Subject|1|||
130645623|NCT00089505|470323071|FG000|Overall Study|Death|4|||
130645624|NCT00089505|470323072|FG001|Overall Study|Death|1|||
130645625|NCT00089505|470323073|FG002|Overall Study|Death|5|||
130645626|NCT00089505|470323074|FG003|Overall Study|Death|8|||
130645627|NCT00089505|470323071|FG000|Overall Study|Withdrawal by Subject|3|||
130645628|NCT00089505|470323072|FG001|Overall Study|Withdrawal by Subject|0|||
130645629|NCT00089505|470323073|FG002|Overall Study|Withdrawal by Subject|6|||
130645630|NCT00089505|470323074|FG003|Overall Study|Withdrawal by Subject|6|||
130645631|NCT00089505|470323071|FG000|Overall Study|Lost to Follow-up|1|||
130645632|NCT00089505|470323072|FG001|Overall Study|Lost to Follow-up|1|||
130645633|NCT00089505|470323073|FG002|Overall Study|Lost to Follow-up|9|||
130645634|NCT00089505|470323074|FG003|Overall Study|Lost to Follow-up|7|||
130645635|NCT00089505|470323071|FG000|Overall Study|Physician Decision|1|||
130645636|NCT00089505|470323072|FG001|Overall Study|Physician Decision|0|||
130645637|NCT00089505|470323073|FG002|Overall Study|Physician Decision|0|||
130645638|NCT00089505|470323074|FG003|Overall Study|Physician Decision|0|||
130645639|NCT00089505|470323071|FG000|Overall Study|Protocol Violation|0|||
130645640|NCT00089505|470323072|FG001|Overall Study|Protocol Violation|0|||
130645641|NCT00089505|470323073|FG002|Overall Study|Protocol Violation|1|||
130645642|NCT00089505|470323074|FG003|Overall Study|Protocol Violation|0|||
130645643|NCT01284127|470323076|FG000|Overall Study|Adverse Event|2|||
130645644|NCT01284127|470323076|FG000|Overall Study|Withdrawal by Subject|4|||
130645645|NCT01284127|470323076|FG000|Overall Study|Physician Decision|1|||
130645646|NCT04212221|470323081|FG000|Overall Study|Remained on Treatment|0|||
130645647|NCT04212221|470323082|FG001|Overall Study|Remained on Treatment|0|||
130645648|NCT04212221|470323083|FG002|Overall Study|Remained on Treatment|0|||
130645649|NCT04212221|470323084|FG003|Overall Study|Remained on Treatment|1|||
130645650|NCT04212221|470323085|FG004|Overall Study|Remained on Treatment|0|||
130645651|NCT04212221|470323086|FG005|Overall Study|Remained on Treatment|0|||
130645652|NCT04212221|470323087|FG006|Overall Study|Remained on Treatment|3|||
130645653|NCT04212221|470323088|FG007|Overall Study|Remained on Treatment|9|||
130645654|NCT04212221|470323081|FG000|Overall Study|Adverse Event|0|||
130645655|NCT04212221|470323082|FG001|Overall Study|Adverse Event|0|||
130645656|NCT04212221|470323083|FG002|Overall Study|Adverse Event|0|||
130645657|NCT04212221|470323084|FG003|Overall Study|Adverse Event|0|||
130645658|NCT04212221|470323085|FG004|Overall Study|Adverse Event|0|||
130645659|NCT04212221|470323086|FG005|Overall Study|Adverse Event|0|||
130645660|NCT04212221|470323087|FG006|Overall Study|Adverse Event|2|||
130645661|NCT04212221|470323088|FG007|Overall Study|Adverse Event|3|||
130645662|NCT04212221|470323081|FG000|Overall Study|Death|0|||
130645663|NCT04212221|470323082|FG001|Overall Study|Death|0|||
130645664|NCT04212221|470323083|FG002|Overall Study|Death|0|||
130645665|NCT04212221|470323084|FG003|Overall Study|Death|0|||
130645666|NCT04212221|470323085|FG004|Overall Study|Death|0|||
130645667|NCT04212221|470323086|FG005|Overall Study|Death|0|||
130645668|NCT04212221|470323087|FG006|Overall Study|Death|0|||
130645669|NCT04212221|470323088|FG007|Overall Study|Death|2|||
130645670|NCT04212221|470323081|FG000|Overall Study|Disease progression according to irRECIST|1|||
130645671|NCT04212221|470323082|FG001|Overall Study|Disease progression according to irRECIST|2|||
130645672|NCT04212221|470323083|FG002|Overall Study|Disease progression according to irRECIST|3|||
130645673|NCT04212221|470323084|FG003|Overall Study|Disease progression according to irRECIST|3|||
130645674|NCT04212221|470323085|FG004|Overall Study|Disease progression according to irRECIST|2|||
130645675|NCT04212221|470323086|FG005|Overall Study|Disease progression according to irRECIST|2|||
130645676|NCT04212221|470323087|FG006|Overall Study|Disease progression according to irRECIST|21|||
130645677|NCT04212221|470323088|FG007|Overall Study|Disease progression according to irRECIST|17|||
130645678|NCT04212221|470323081|FG000|Overall Study|Global Deterioration of Health Status|0|||
130645679|NCT04212221|470323082|FG001|Overall Study|Global Deterioration of Health Status|0|||
130645680|NCT04212221|470323083|FG002|Overall Study|Global Deterioration of Health Status|0|||
130645681|NCT04212221|470323084|FG003|Overall Study|Global Deterioration of Health Status|0|||
130645682|NCT04212221|470323085|FG004|Overall Study|Global Deterioration of Health Status|0|||
130645683|NCT04212221|470323086|FG005|Overall Study|Global Deterioration of Health Status|0|||
130645684|NCT04212221|470323087|FG006|Overall Study|Global Deterioration of Health Status|0|||
130645685|NCT04212221|470323088|FG007|Overall Study|Global Deterioration of Health Status|2|||
130645686|NCT04212221|470323081|FG000|Overall Study|Investigator's Decision|0|||
130645687|NCT04212221|470323082|FG001|Overall Study|Investigator's Decision|0|||
130645688|NCT04212221|470323083|FG002|Overall Study|Investigator's Decision|0|||
130645689|NCT04212221|470323084|FG003|Overall Study|Investigator's Decision|1|||
130645690|NCT04212221|470323085|FG004|Overall Study|Investigator's Decision|0|||
130645691|NCT04212221|470323086|FG005|Overall Study|Investigator's Decision|0|||
130645692|NCT04212221|470323087|FG006|Overall Study|Investigator's Decision|3|||
130645693|NCT04212221|470323088|FG007|Overall Study|Investigator's Decision|0|||
130645694|NCT04212221|470323081|FG000|Overall Study|Participant refused to continue treatment|0|||
130645695|NCT04212221|470323082|FG001|Overall Study|Participant refused to continue treatment|1|||
130645696|NCT04212221|470323083|FG002|Overall Study|Participant refused to continue treatment|0|||
130645697|NCT04212221|470323084|FG003|Overall Study|Participant refused to continue treatment|1|||
130645698|NCT04212221|470323085|FG004|Overall Study|Participant refused to continue treatment|1|||
130645699|NCT04212221|470323086|FG005|Overall Study|Participant refused to continue treatment|2|||
130645700|NCT04212221|470323087|FG006|Overall Study|Participant refused to continue treatment|4|||
130645701|NCT04212221|470323088|FG007|Overall Study|Participant refused to continue treatment|2|||
130645702|NCT04212221|470323081|FG000|Overall Study|Protocol Violation|0|||
130645703|NCT04212221|470323082|FG001|Overall Study|Protocol Violation|0|||
130645704|NCT04212221|470323083|FG002|Overall Study|Protocol Violation|0|||
130645705|NCT04212221|470323084|FG003|Overall Study|Protocol Violation|0|||
130645706|NCT04212221|470323085|FG004|Overall Study|Protocol Violation|0|||
130645707|NCT04212221|470323086|FG005|Overall Study|Protocol Violation|0|||
130645708|NCT04212221|470323087|FG006|Overall Study|Protocol Violation|0|||
130645709|NCT04212221|470323088|FG007|Overall Study|Protocol Violation|1|||
130645710|NCT01624974|470323093|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
130645711|NCT01624974|470323094|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
130645712|NCT01624974|470323093|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
130645713|NCT01624974|470323094|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
130645714|NCT01624974|470323093|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
130645715|NCT01624974|470323094|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
130645716|NCT01624974|470323093|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
130645717|NCT01624974|470323094|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
130645718|NCT01624974|470323093|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
130645719|NCT01624974|470323094|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
130645720|NCT01624974|470323093|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
130645721|NCT01624974|470323094|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
130645722|NCT01624974|470323093|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
130645723|NCT01624974|470323094|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
130645724|NCT01624974|470323093|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
130645725|NCT01624974|470323094|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
130645726|NCT01624974|470323093|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
130645727|NCT01624974|470323094|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
130645728|NCT01624974|470323093|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
130645729|NCT01624974|470323094|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
130645730|NCT01624974|470323093|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
130645731|NCT01624974|470323094|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
130645732|NCT01624974|470323093|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
130645733|NCT01624974|470323094|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
130645734|NCT01376908|470323095|FG000|Overall Study|Protocol Violation|1|||
130645735|NCT01376908|470323096|FG001|Overall Study|Protocol Violation|1|||
130645736|NCT01376908|470323095|FG000|Overall Study|Withdrawal by Subject|1|||
130645737|NCT01376908|470323096|FG001|Overall Study|Withdrawal by Subject|2|||
130645738|NCT01468844|470323097|FG000|Overall Study|Adverse Event|1|||
130645739|NCT01468844|470323098|FG001|Overall Study|Adverse Event|0|||
130645740|NCT01468844|470323097|FG000|Overall Study|Withdrawal by Subject|1|||
130645741|NCT01468844|470323098|FG001|Overall Study|Withdrawal by Subject|0|||
130645742|NCT02142712|470323099|FG000|Overall Study|Lost to Follow-up|1|||
130645743|NCT02142712|470323100|FG001|Overall Study|Lost to Follow-up|1|||
130645744|NCT02142712|470323101|FG002|Overall Study|Lost to Follow-up|1|||
130645745|NCT02142712|470323102|FG003|Overall Study|Lost to Follow-up|0|||
130645746|NCT03480841|470323103|FG000|Overall Study|Lost to Follow-up|2|||
130645747|NCT00266695|470323104|FG000|Overall Study|Adverse Event|1|||
130645748|NCT00266695|470323104|FG000|Overall Study|Death|9|||
130645749|NCT00266695|470323104|FG000|Overall Study|Physician Decision|1|||
130645750|NCT00266695|470323104|FG000|Overall Study|Lost to Follow-up|3|||
130645751|NCT00266695|470323104|FG000|Overall Study|Withdrawal by Subject|15|||
130645752|NCT02417935|470323105|FG000|Treatment Period|Adverse Event|12|||
130645753|NCT02417935|470323106|FG001|Treatment Period|Adverse Event|10|||
130645754|NCT02417935|470323105|FG000|Treatment Period|Lost to Follow-up|1|||
130645755|NCT02417935|470323106|FG001|Treatment Period|Lost to Follow-up|0|||
130645756|NCT02417935|470323105|FG000|Treatment Period|Entry Criteria not met|0|||
130645757|NCT02417935|470323106|FG001|Treatment Period|Entry Criteria not met|1|||
130645758|NCT02417935|470323105|FG000|Treatment Period|Protocol Violation|2|||
130645759|NCT02417935|470323106|FG001|Treatment Period|Protocol Violation|1|||
130645760|NCT02417935|470323105|FG000|Treatment Period|Withdrawal by Subject|3|||
130645761|NCT02417935|470323106|FG001|Treatment Period|Withdrawal by Subject|3|||
130645762|NCT02417935|470323105|FG000|Treatment Period|Physician Decision|3|||
130645763|NCT02417935|470323106|FG001|Treatment Period|Physician Decision|1|||
130645764|NCT02853318|470323111|FG000|Overall Study|Withdrawal by Subject|1|||
130645765|NCT00252499|470323112|FG000|Overall Study|Lost to Follow-up|1|||
130645766|NCT00252499|470323113|FG001|Overall Study|Lost to Follow-up|0|||
130645767|NCT00252499|470323114|FG002|Overall Study|Lost to Follow-up|0|||
130645768|NCT02646332|470323115|FG000|Overall Study|Lost to Follow-up|0|||
130645769|NCT02646332|470323116|FG001|Overall Study|Lost to Follow-up|3|||
130645770|NCT04490499|470323117|FG000|Overall Study|Withdrawal by Subject|2|||
130645771|NCT01882439|470323125|FG000|Overall Study|Adverse event related to study drug|3|||
130645772|NCT01882439|470323126|FG001|Overall Study|Adverse event related to study drug|8|||
130645773|NCT01882439|470323127|FG002|Overall Study|Adverse event related to study drug|1|||
130645774|NCT01882439|470323128|FG003|Overall Study|Adverse event related to study drug|2|||
130645775|NCT01882439|470323125|FG000|Overall Study|Pregnancy|0|||
130645776|NCT01882439|470323126|FG001|Overall Study|Pregnancy|1|||
130645777|NCT01882439|470323127|FG002|Overall Study|Pregnancy|0|||
130645778|NCT01882439|470323128|FG003|Overall Study|Pregnancy|0|||
130645779|NCT01882439|470323125|FG000|Overall Study|Protocol Violation|2|||
130645780|NCT01882439|470323126|FG001|Overall Study|Protocol Violation|2|||
130645781|NCT01882439|470323127|FG002|Overall Study|Protocol Violation|0|||
130645782|NCT01882439|470323128|FG003|Overall Study|Protocol Violation|1|||
130645783|NCT01882439|470323125|FG000|Overall Study|No longer willing to participate|1|||
130645784|NCT01882439|470323126|FG001|Overall Study|No longer willing to participate|4|||
130645785|NCT01882439|470323127|FG002|Overall Study|No longer willing to participate|2|||
130645786|NCT01882439|470323128|FG003|Overall Study|No longer willing to participate|3|||
130645787|NCT01882439|470323125|FG000|Overall Study|Medication error with no associated AE|0|||
130645788|NCT01882439|470323126|FG001|Overall Study|Medication error with no associated AE|0|||
130645789|NCT01882439|470323127|FG002|Overall Study|Medication error with no associated AE|2|||
130645790|NCT01882439|470323128|FG003|Overall Study|Medication error with no associated AE|0|||
130645791|NCT01882439|470323125|FG000|Overall Study|Insufficient clinical response|1|||
130645792|NCT01882439|470323126|FG001|Overall Study|Insufficient clinical response|4|||
130645793|NCT01882439|470323127|FG002|Overall Study|Insufficient clinical response|4|||
130645794|NCT01882439|470323128|FG003|Overall Study|Insufficient clinical response|2|||
130645795|NCT01882439|470323125|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130645796|NCT01882439|470323126|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130645797|NCT01882439|470323127|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130645798|NCT01882439|470323128|FG003|Overall Study|Adverse event unrelated to study drug|1|||
130645799|NCT01997333|470323131|FG000|Randomization and Treatment|Disease Progression|70|||
130645800|NCT01997333|470323132|FG001|Randomization and Treatment|Disease Progression|159|||
130645801|NCT01997333|470323131|FG000|Randomization and Treatment|Adverse Event|10|||
130645802|NCT01997333|470323132|FG001|Randomization and Treatment|Adverse Event|32|||
130645803|NCT01997333|470323131|FG000|Randomization and Treatment|Physician Decision|0|||
130645804|NCT01997333|470323132|FG001|Randomization and Treatment|Physician Decision|4|||
130645805|NCT01997333|470323131|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
130645806|NCT01997333|470323132|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
130645807|NCT01997333|470323131|FG000|Randomization and Treatment|Did not receive treatment|17|||
130645808|NCT01997333|470323132|FG001|Randomization and Treatment|Did not receive treatment|5|||
130645809|NCT01997333|470323131|FG000|Survival Follow up|Withdrawal by Subject|15|||
130645810|NCT01997333|470323132|FG001|Survival Follow up|Withdrawal by Subject|6|||
130645811|NCT01997333|470323131|FG000|Survival Follow up|Lost to Follow-up|0|||
130645812|NCT01997333|470323132|FG001|Survival Follow up|Lost to Follow-up|6|||
130645813|NCT01997333|470323131|FG000|Survival Follow up|Various|1|||
130645814|NCT01997333|470323132|FG001|Survival Follow up|Various|2|||
130645815|NCT02269709|470323133|FG000|Time of Enrollment|Withdrawal by Subject|3|||
130645816|NCT02269709|470323133|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
130645817|NCT02269709|470323133|FG000|Six Month Follow-up|Lost to Follow-up|12|||
130645818|NCT02909504|470323134|FG000|Overall Study|Adverse Event|2|||
130645819|NCT02909504|470323134|FG000|Overall Study|Lack of Efficacy|3|||
130645820|NCT02909504|470323134|FG000|Overall Study|Withdrawal by Subject|4|||
130645821|NCT02909504|470323134|FG000|Overall Study|Pregnancy|1|||
130645822|NCT02909504|470323134|FG000|Overall Study|Subject moved|1|||
130645823|NCT02909504|470323134|FG000|Overall Study|Lost to Follow-up|1|||
130645824|NCT04411472|470323136|FG000|Overall Study|Adverse Event|5|||
130645825|NCT04411472|470323137|FG001|Overall Study|Adverse Event|10|||
130645826|NCT04411472|470323138|FG002|Overall Study|Adverse Event|1|||
130645827|NCT04411472|470323139|FG003|Overall Study|Adverse Event|0|||
130645828|NCT04411472|470323140|FG004|Overall Study|Adverse Event|0|||
130645829|NCT04411472|470323141|FG005|Overall Study|Adverse Event|0|||
130645830|NCT04411472|470323136|FG000|Overall Study|Protocol Violation|1|||
130645831|NCT04411472|470323137|FG001|Overall Study|Protocol Violation|0|||
130645832|NCT04411472|470323138|FG002|Overall Study|Protocol Violation|0|||
130645833|NCT04411472|470323139|FG003|Overall Study|Protocol Violation|0|||
130645834|NCT04411472|470323140|FG004|Overall Study|Protocol Violation|0|||
130645835|NCT04411472|470323141|FG005|Overall Study|Protocol Violation|0|||
130645836|NCT04411472|470323136|FG000|Overall Study|Withdrawal by Subject|0|||
130645837|NCT04411472|470323137|FG001|Overall Study|Withdrawal by Subject|1|||
130645838|NCT04411472|470323138|FG002|Overall Study|Withdrawal by Subject|0|||
130645839|NCT04411472|470323139|FG003|Overall Study|Withdrawal by Subject|1|||
130645840|NCT04411472|470323140|FG004|Overall Study|Withdrawal by Subject|0|||
130645841|NCT04411472|470323141|FG005|Overall Study|Withdrawal by Subject|0|||
130645842|NCT04411472|470323136|FG000|Overall Study|Physician Decision|1|||
130645843|NCT04411472|470323137|FG001|Overall Study|Physician Decision|0|||
130645844|NCT04411472|470323138|FG002|Overall Study|Physician Decision|0|||
130645845|NCT04411472|470323139|FG003|Overall Study|Physician Decision|0|||
130645846|NCT04411472|470323140|FG004|Overall Study|Physician Decision|0|||
130645847|NCT04411472|470323141|FG005|Overall Study|Physician Decision|0|||
130645848|NCT04411472|470323136|FG000|Overall Study|Study terminated by sponsor|17|||
130645849|NCT04411472|470323137|FG001|Overall Study|Study terminated by sponsor|20|||
130645850|NCT04411472|470323138|FG002|Overall Study|Study terminated by sponsor|3|||
130645851|NCT04411472|470323139|FG003|Overall Study|Study terminated by sponsor|0|||
130645852|NCT04411472|470323140|FG004|Overall Study|Study terminated by sponsor|0|||
130645853|NCT04411472|470323141|FG005|Overall Study|Study terminated by sponsor|0|||
130645854|NCT05060003|470323142|FG000|Overall Study|ctDNA negative|7|||
130645855|NCT00362297|470323143|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
130645856|NCT00362297|470323144|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
130645857|NCT03769753|470323145|FG000|Overall Study|Not Treated|6|||
130645858|NCT03769753|470323145|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
130645859|NCT03702166|470323146|FG000|Overall Study|Lost to Follow-up|1|||
130645860|NCT03702166|470323146|FG000|Overall Study|Withdrawal by Subject|1|||
130645861|NCT00684073|470323147|FG000|Selection|Selection/non-selection criteria|3|||
130645862|NCT00684073|470323147|FG000|Selection|Death|1|||
130645863|NCT00684073|470323147|FG000|Selection|noncompliance|1|||
130645864|NCT00684073|470323147|FG000|Selection|Lost to Follow-up|1|||
130645865|NCT00684073|470323147|FG000|Selection|request of the sponsor|1|||
130645866|NCT00684073|470323147|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
130645867|NCT01657903|470323148|FG000|Overall Study|Lost to Follow-up|1|||
130645868|NCT01657903|470323148|FG000|Overall Study|Withdrawal by Subject|1|||
130645869|NCT01259388|470323150|FG000|Overall Study|Adverse Event|3|||
130645870|NCT01259388|470323151|FG001|Overall Study|Adverse Event|0|||
130645871|NCT01259388|470323150|FG000|Overall Study|Withdrawal by Subject|1|||
130645872|NCT01259388|470323151|FG001|Overall Study|Withdrawal by Subject|1|||
130645873|NCT01259388|470323150|FG000|Overall Study|Physician Decision|1|||
130645874|NCT01259388|470323151|FG001|Overall Study|Physician Decision|0|||
130645875|NCT02743494|470323154|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
130645876|NCT02743494|470323155|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
130645877|NCT02743494|470323154|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
130645878|NCT02743494|470323155|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
130645879|NCT02743494|470323154|FG000|Treatment Period|Completed treatment|229|||
130645880|NCT02743494|470323155|FG001|Treatment Period|Completed treatment|99|||
130645881|NCT02743494|470323154|FG000|Treatment Period|Disease recurrence|149|||
130645882|NCT02743494|470323155|FG001|Treatment Period|Disease recurrence|113|||
130645883|NCT02743494|470323154|FG000|Treatment Period|Study drug toxicity|57|||
130645884|NCT02743494|470323155|FG001|Treatment Period|Study drug toxicity|8|||
130645885|NCT02743494|470323154|FG000|Treatment Period|Death|1|||
130645886|NCT02743494|470323155|FG001|Treatment Period|Death|0|||
130645887|NCT02743494|470323154|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
130645888|NCT02743494|470323155|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
130645889|NCT02743494|470323154|FG000|Treatment Period|Participant request to discontinue treatment|30|||
130645890|NCT02743494|470323155|FG001|Treatment Period|Participant request to discontinue treatment|5|||
130645891|NCT02743494|470323154|FG000|Treatment Period|Participant withdrew consent|12|||
130645892|NCT02743494|470323155|FG001|Treatment Period|Participant withdrew consent|4|||
130645893|NCT02743494|470323154|FG000|Treatment Period|Lost to Follow-up|0|||
130645894|NCT02743494|470323155|FG001|Treatment Period|Lost to Follow-up|1|||
130645895|NCT02743494|470323154|FG000|Treatment Period|Poor/Non-compliance|1|||
130645896|NCT02743494|470323155|FG001|Treatment Period|Poor/Non-compliance|0|||
130645897|NCT02743494|470323154|FG000|Treatment Period|Other reasons|7|||
130645898|NCT02743494|470323155|FG001|Treatment Period|Other reasons|2|||
130645899|NCT00983827|470323156|FG000|Overall Study|Withdrawal by Subject|1|||
130645900|NCT01521494|470323157|FG000|Overall Study|Adverse Event|1|||
130645901|NCT01521494|470323158|FG001|Overall Study|Adverse Event|2|||
130645902|NCT01521494|470323159|FG002|Overall Study|Adverse Event|9|||
130645903|NCT01521494|470323160|FG003|Overall Study|Adverse Event|6|||
130645904|NCT01521494|470323161|FG004|Overall Study|Adverse Event|2|||
130645905|NCT01521494|470323157|FG000|Overall Study|Lack of Efficacy|0|||
130645906|NCT01521494|470323158|FG001|Overall Study|Lack of Efficacy|0|||
130645907|NCT01521494|470323159|FG002|Overall Study|Lack of Efficacy|0|||
130645908|NCT01521494|470323160|FG003|Overall Study|Lack of Efficacy|0|||
130645909|NCT01521494|470323161|FG004|Overall Study|Lack of Efficacy|2|||
130645910|NCT01521494|470323157|FG000|Overall Study|Withdrawal by Subject|1|||
130645911|NCT01521494|470323158|FG001|Overall Study|Withdrawal by Subject|1|||
130645912|NCT01521494|470323159|FG002|Overall Study|Withdrawal by Subject|0|||
130645913|NCT01521494|470323160|FG003|Overall Study|Withdrawal by Subject|2|||
130645914|NCT01521494|470323161|FG004|Overall Study|Withdrawal by Subject|0|||
130645915|NCT01521494|470323157|FG000|Overall Study|Decrease in serum phosphate|0|||
130645916|NCT01521494|470323158|FG001|Overall Study|Decrease in serum phosphate|2|||
130645917|NCT01521494|470323159|FG002|Overall Study|Decrease in serum phosphate|3|||
130645918|NCT01521494|470323160|FG003|Overall Study|Decrease in serum phosphate|12|||
130645919|NCT01521494|470323161|FG004|Overall Study|Decrease in serum phosphate|0|||
130645920|NCT01521494|470323157|FG000|Overall Study|Decrease in serum calcium|0|||
130645921|NCT01521494|470323158|FG001|Overall Study|Decrease in serum calcium|0|||
130645922|NCT01521494|470323159|FG002|Overall Study|Decrease in serum calcium|0|||
130645923|NCT01521494|470323160|FG003|Overall Study|Decrease in serum calcium|1|||
130645924|NCT01521494|470323161|FG004|Overall Study|Decrease in serum calcium|1|||
130645925|NCT01521494|470323157|FG000|Overall Study|Physician Decision|0|||
130645926|NCT01521494|470323158|FG001|Overall Study|Physician Decision|0|||
130645927|NCT01521494|470323159|FG002|Overall Study|Physician Decision|0|||
130645928|NCT01521494|470323160|FG003|Overall Study|Physician Decision|0|||
130645929|NCT01521494|470323161|FG004|Overall Study|Physician Decision|2|||
130645930|NCT01888367|470323162|FG000|Overall Study|Physician Decision|3|||
130645931|NCT01888367|470323163|FG001|Overall Study|Physician Decision|4|||
130645932|NCT01888367|470323164|FG002|Overall Study|Physician Decision|2|||
130645933|NCT01888367|470323162|FG000|Overall Study|Death|2|||
130645934|NCT01888367|470323163|FG001|Overall Study|Death|0|||
130645935|NCT01888367|470323164|FG002|Overall Study|Death|1|||
130645936|NCT01888367|470323162|FG000|Overall Study|Withdrawal by Subject|1|||
130645937|NCT01888367|470323163|FG001|Overall Study|Withdrawal by Subject|0|||
130645938|NCT01888367|470323164|FG002|Overall Study|Withdrawal by Subject|1|||
130645939|NCT01888367|470323162|FG000|Overall Study|Lost to Follow-up|1|||
130645940|NCT01888367|470323163|FG001|Overall Study|Lost to Follow-up|1|||
130645941|NCT01888367|470323164|FG002|Overall Study|Lost to Follow-up|0|||
130645942|NCT01888367|470323162|FG000|Overall Study|Protocol Violation|0|||
130645943|NCT01888367|470323163|FG001|Overall Study|Protocol Violation|0|||
130645944|NCT01888367|470323164|FG002|Overall Study|Protocol Violation|1|||
130645945|NCT01888367|470323162|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
130645946|NCT01888367|470323163|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
130645947|NCT01888367|470323164|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
130645948|NCT01854918|470323165|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
130645949|NCT01854918|470323166|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
130645950|NCT01854918|470323165|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
130645951|NCT01854918|470323166|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
130645952|NCT01854918|470323165|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
130645953|NCT01854918|470323166|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
130645954|NCT01854918|470323165|FG000|SOC-controlled Period (Year 1)|Death|5|||
130645955|NCT01854918|470323166|FG001|SOC-controlled Period (Year 1)|Death|5|||
130645956|NCT01854918|470323165|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
130645957|NCT01854918|470323166|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
130645958|NCT01854918|470323165|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
130645959|NCT01854918|470323166|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
130645960|NCT01854918|470323165|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
130645961|NCT01854918|470323166|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
130645962|NCT01854918|470323165|FG000|All-IP Period (Years 2 and 3)|Death|5|||
130645963|NCT01854918|470323166|FG001|All-IP Period (Years 2 and 3)|Death|16|||
130645964|NCT02146352|470323167|FG000|Overall Study|Death|1|||
130645965|NCT02146352|470323167|FG000|Overall Study|Patient entered hospice care|1|||
130645966|NCT03969589|470323170|FG000|Overall Study|Lost to Follow-up|3|||
130645967|NCT03969589|470323171|FG001|Overall Study|Lost to Follow-up|2|||
130645968|NCT03969589|470323170|FG000|Overall Study|Declined Follow-Up|0|||
130645969|NCT03969589|470323171|FG001|Overall Study|Declined Follow-Up|1|||
130645970|NCT00517634|470323172|FG000|Second Treatment Period|Withdrawal by Subject|0|||
130645971|NCT00517634|470323173|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130645972|NCT00517634|470323174|FG002|Second Treatment Period|Withdrawal by Subject|0|||
130645973|NCT00517634|470323175|FG003|Second Treatment Period|Withdrawal by Subject|0|||
130645974|NCT00517634|470323176|FG004|Second Treatment Period|Withdrawal by Subject|1|||
130645975|NCT00517634|470323177|FG005|Second Treatment Period|Withdrawal by Subject|0|||
130645976|NCT03091920|470323180|FG000|Overall Study|Adverse Event|0|||
130645977|NCT03091920|470323181|FG001|Overall Study|Adverse Event|1|||
130645978|NCT03091920|470323182|FG002|Overall Study|Adverse Event|0|||
130645979|NCT03143855|470323183|FG000|Overall Study|Withdrawal by Subject|4|||
130645980|NCT03143855|470323184|FG001|Overall Study|Withdrawal by Subject|3|||
130645981|NCT03143855|470323183|FG000|Overall Study|Protocol Violation|1|||
130645982|NCT03143855|470323184|FG001|Overall Study|Protocol Violation|0|||
130645983|NCT03143855|470323183|FG000|Overall Study|Participant experienced withdrawal|0|||
130645984|NCT03143855|470323184|FG001|Overall Study|Participant experienced withdrawal|1|||
130645985|NCT00453349|470323186|FG000|Randomized|Adverse Event|12|||
130645986|NCT00453349|470323187|FG001|Randomized|Adverse Event|11|||
130645987|NCT00453349|470323186|FG000|Randomized|Lack of Efficacy|2|||
130645988|NCT00453349|470323187|FG001|Randomized|Lack of Efficacy|1|||
130645989|NCT00453349|470323186|FG000|Randomized|Lost to Follow-up|7|||
130645990|NCT00453349|470323187|FG001|Randomized|Lost to Follow-up|5|||
130645991|NCT00453349|470323186|FG000|Randomized|Protocol Violation|1|||
130645992|NCT00453349|470323187|FG001|Randomized|Protocol Violation|1|||
130645993|NCT00453349|470323186|FG000|Randomized|Withdrawal by Subject|3|||
130645994|NCT00453349|470323187|FG001|Randomized|Withdrawal by Subject|5|||
130645995|NCT00453349|470323186|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
130645996|NCT00453349|470323187|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
130645997|NCT00453349|470323186|FG000|Completed Study|Adverse Event|12|||
130645998|NCT00453349|470323187|FG001|Completed Study|Adverse Event|11|||
130645999|NCT00453349|470323186|FG000|Completed Study|Lack of Efficacy|2|||
130646000|NCT00453349|470323187|FG001|Completed Study|Lack of Efficacy|1|||
130646001|NCT00453349|470323186|FG000|Completed Study|Lost to Follow-up|7|||
130646002|NCT00453349|470323187|FG001|Completed Study|Lost to Follow-up|5|||
130646003|NCT00453349|470323186|FG000|Completed Study|Protocol Violation|1|||
130646004|NCT00453349|470323187|FG001|Completed Study|Protocol Violation|1|||
130646005|NCT00453349|470323186|FG000|Completed Study|Withdrawal by Subject|3|||
130646006|NCT00453349|470323187|FG001|Completed Study|Withdrawal by Subject|5|||
130646007|NCT00453349|470323186|FG000|Completed Study|Lost to follow up after study treatment|2|||
130646008|NCT00453349|470323187|FG001|Completed Study|Lost to follow up after study treatment|11|||
130646009|NCT01513460|470323189|FG000|Overall Study|Death|0|||
130646010|NCT01513460|470323190|FG001|Overall Study|Death|0|||
130646011|NCT01513460|470323191|FG002|Overall Study|Death|1|||
130646012|NCT01513460|470323189|FG000|Overall Study|Lost to Follow-up|0|||
130646013|NCT01513460|470323190|FG001|Overall Study|Lost to Follow-up|0|||
130646014|NCT01513460|470323191|FG002|Overall Study|Lost to Follow-up|2|||
130646015|NCT01513460|470323189|FG000|Overall Study|Abnormal laboratory value|1|||
130646016|NCT01513460|470323190|FG001|Overall Study|Abnormal laboratory value|0|||
130646017|NCT01513460|470323191|FG002|Overall Study|Abnormal laboratory value|1|||
130646018|NCT01513460|470323189|FG000|Overall Study|Lack of Efficacy|1|||
130646019|NCT01513460|470323190|FG001|Overall Study|Lack of Efficacy|2|||
130646020|NCT01513460|470323191|FG002|Overall Study|Lack of Efficacy|5|||
130646021|NCT01513460|470323189|FG000|Overall Study|Protocol deviations|3|||
130646022|NCT01513460|470323190|FG001|Overall Study|Protocol deviations|4|||
130646023|NCT01513460|470323191|FG002|Overall Study|Protocol deviations|3|||
130646024|NCT01513460|470323189|FG000|Overall Study|Withdrawal by Subject|7|||
130646025|NCT01513460|470323190|FG001|Overall Study|Withdrawal by Subject|8|||
130646026|NCT01513460|470323191|FG002|Overall Study|Withdrawal by Subject|21|||
130646027|NCT01513460|470323189|FG000|Overall Study|Adverse Event|16|||
130646028|NCT01513460|470323190|FG001|Overall Study|Adverse Event|18|||
130646029|NCT01513460|470323191|FG002|Overall Study|Adverse Event|23|||
130646030|NCT01513460|470323189|FG000|Overall Study|Abnormal test procedure|1|||
130646031|NCT01513460|470323190|FG001|Overall Study|Abnormal test procedure|0|||
130646032|NCT01513460|470323191|FG002|Overall Study|Abnormal test procedure|0|||
130646033|NCT00489216|470323195|FG000|Overall Study|Adverse Event|1|||
130646034|NCT00939094|470323196|FG000|Overall Study|Adverse Event|9|||
130646035|NCT00939094|470323197|FG001|Overall Study|Adverse Event|0|||
130646036|NCT00939094|470323196|FG000|Overall Study|Withdrawal by Subject|1|||
130646037|NCT00939094|470323197|FG001|Overall Study|Withdrawal by Subject|6|||
130646038|NCT00939094|470323196|FG000|Overall Study|Lost to Follow-up|1|||
130646039|NCT00939094|470323197|FG001|Overall Study|Lost to Follow-up|1|||
130646040|NCT00939094|470323196|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130646041|NCT00939094|470323197|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130646042|NCT00939094|470323196|FG000|Overall Study|Severe non-compliance to protocol|0|||
130646043|NCT00939094|470323197|FG001|Overall Study|Severe non-compliance to protocol|1|||
130646044|NCT00939094|470323196|FG000|Overall Study|Study stopped by sponsor|0|||
130646045|NCT00939094|470323197|FG001|Overall Study|Study stopped by sponsor|2|||
130646046|NCT00939094|470323196|FG000|Overall Study|Abnormal ECG findings|1|||
130646047|NCT00939094|470323197|FG001|Overall Study|Abnormal ECG findings|0|||
130646048|NCT01906489|470323198|FG000|Overall Study|Adverse Event|10|||
130646049|NCT01906489|470323199|FG001|Overall Study|Adverse Event|3|||
130646050|NCT01906489|470323198|FG000|Overall Study|Worsening of CKD|6|||
130646051|NCT01906489|470323199|FG001|Overall Study|Worsening of CKD|4|||
130646052|NCT01906489|470323198|FG000|Overall Study|Withdrawal by Subject|5|||
130646053|NCT01906489|470323199|FG001|Overall Study|Withdrawal by Subject|0|||
130646054|NCT01906489|470323198|FG000|Overall Study|Worsening of Anemia|1|||
130646055|NCT01906489|470323199|FG001|Overall Study|Worsening of Anemia|0|||
130646056|NCT01906489|470323198|FG000|Overall Study|Protocol Violation|0|||
130646057|NCT01906489|470323199|FG001|Overall Study|Protocol Violation|1|||
130646058|NCT01906489|470323198|FG000|Overall Study|Non- Compliance|1|||
130646059|NCT01906489|470323199|FG001|Overall Study|Non- Compliance|0|||
130646060|NCT01906489|470323198|FG000|Overall Study|Sponsor Decision|1|||
130646061|NCT01906489|470323199|FG001|Overall Study|Sponsor Decision|0|||
130646062|NCT01906489|470323198|FG000|Overall Study|Lost to Follow-up|1|||
130646063|NCT01906489|470323199|FG001|Overall Study|Lost to Follow-up|1|||
130646064|NCT01906489|470323198|FG000|Overall Study|Other|1|||
130646065|NCT01906489|470323199|FG001|Overall Study|Other|0|||
130646066|NCT01503229|470324863|FG000|Overall Study|Withdrew consent|1|||
130646067|NCT01884675|470324864|FG000|Overall Study|Study closed/terminated|3|||
130646068|NCT01884675|470324865|FG001|Overall Study|Study closed/terminated|2|||
130646069|NCT02361307|470324866|FG000|Overall Study|Unstable medical condition.|0|||
130646070|NCT02361307|470324867|FG001|Overall Study|Unstable medical condition.|1|||
130646071|NCT00303602|470324873|FG000|Overall Study|Adverse Event|2|||
130646072|NCT00303602|470324874|FG001|Overall Study|Adverse Event|2|||
130646073|NCT00303602|470324873|FG000|Overall Study|Withdrawal by Subject|5|||
130646074|NCT00303602|470324874|FG001|Overall Study|Withdrawal by Subject|6|||
130646075|NCT00303602|470324873|FG000|Overall Study|Lost to Follow-up|5|||
130646076|NCT00303602|470324874|FG001|Overall Study|Lost to Follow-up|2|||
130646077|NCT00303602|470324873|FG000|Overall Study|Protocol entry criteria not met|2|||
130646078|NCT00303602|470324874|FG001|Overall Study|Protocol entry criteria not met|2|||
130646079|NCT00303602|470324873|FG000|Overall Study|Physician Decision|2|||
130646080|NCT00303602|470324874|FG001|Overall Study|Physician Decision|1|||
130646081|NCT00303602|470324873|FG000|Overall Study|Noncompliance|2|||
130646082|NCT00303602|470324874|FG001|Overall Study|Noncompliance|2|||
130646083|NCT00303602|470324873|FG000|Overall Study|Protocol Violation|1|||
130646084|NCT00303602|470324874|FG001|Overall Study|Protocol Violation|0|||
130646085|NCT00313716|470324875|FG000|Overall Study|Death|3|||
130646086|NCT00313716|470324876|FG001|Overall Study|Death|2|||
130646087|NCT00313716|470324877|FG002|Overall Study|Death|9|||
130646088|NCT00313716|470324878|FG003|Overall Study|Death|3|||
130646089|NCT00313716|470324879|FG004|Overall Study|Death|5|||
130646090|NCT00313716|470324880|FG005|Overall Study|Death|9|||
130646091|NCT00313716|470324875|FG000|Overall Study|Lost to Follow-up|2|||
130646092|NCT00313716|470324876|FG001|Overall Study|Lost to Follow-up|5|||
130646093|NCT00313716|470324877|FG002|Overall Study|Lost to Follow-up|2|||
130646094|NCT00313716|470324878|FG003|Overall Study|Lost to Follow-up|1|||
130646095|NCT00313716|470324879|FG004|Overall Study|Lost to Follow-up|0|||
130646096|NCT00313716|470324880|FG005|Overall Study|Lost to Follow-up|4|||
130646097|NCT00313716|470324875|FG000|Overall Study|Withdrawal by Subject|0|||
130646098|NCT00313716|470324876|FG001|Overall Study|Withdrawal by Subject|1|||
130646099|NCT00313716|470324877|FG002|Overall Study|Withdrawal by Subject|1|||
130646100|NCT00313716|470324878|FG003|Overall Study|Withdrawal by Subject|0|||
130646101|NCT00313716|470324879|FG004|Overall Study|Withdrawal by Subject|1|||
130646102|NCT00313716|470324880|FG005|Overall Study|Withdrawal by Subject|0|||
130646103|NCT00663208|470324881|FG000|Treatment Period|Lost to Follow-up|0|||
130646104|NCT00663208|470324882|FG001|Treatment Period|Lost to Follow-up|1|||
130646105|NCT00663208|470324883|FG002|Treatment Period|Lost to Follow-up|0|||
130646106|NCT00663208|470324884|FG003|Treatment Period|Lost to Follow-up|0|||
130646107|NCT00663208|470324885|FG004|Treatment Period|Lost to Follow-up|0|||
130646108|NCT00663208|470324886|FG005|Treatment Period|Lost to Follow-up|0|||
130646109|NCT00663208|470324887|FG006|Treatment Period|Lost to Follow-up|0|||
130646110|NCT00663208|470324881|FG000|Follow-up Period|Lost to Follow-up|2|||
130646111|NCT00663208|470324882|FG001|Follow-up Period|Lost to Follow-up|0|||
130646112|NCT00663208|470324883|FG002|Follow-up Period|Lost to Follow-up|3|||
130646113|NCT00663208|470324884|FG003|Follow-up Period|Lost to Follow-up|2|||
130646114|NCT00663208|470324885|FG004|Follow-up Period|Lost to Follow-up|0|||
130646115|NCT00663208|470324886|FG005|Follow-up Period|Lost to Follow-up|0|||
130646116|NCT00663208|470324887|FG006|Follow-up Period|Lost to Follow-up|0|||
130646117|NCT00663208|470324881|FG000|Follow-up Period|Other reason|1|||
130646118|NCT00663208|470324882|FG001|Follow-up Period|Other reason|0|||
130646119|NCT00663208|470324883|FG002|Follow-up Period|Other reason|0|||
130646120|NCT00663208|470324884|FG003|Follow-up Period|Other reason|0|||
130646121|NCT00663208|470324885|FG004|Follow-up Period|Other reason|0|||
130646122|NCT00663208|470324886|FG005|Follow-up Period|Other reason|0|||
130646123|NCT00663208|470324887|FG006|Follow-up Period|Other reason|1|||
130646124|NCT01041027|470324888|FG000|Overall Study|Withdrawal by Subject|2|||
130646125|NCT01041027|470324888|FG000|Overall Study|Protocol Violation|1|||
130646126|NCT01041027|470324888|FG000|Overall Study|Delayed Radiation Therapy|1|||
130646127|NCT01041027|470324888|FG000|Overall Study|Adverse Event|4|||
130646128|NCT01249404|470324889|FG000|Overall Study|Study treatment not received|0|||
130646129|NCT01249404|470324890|FG001|Overall Study|Study treatment not received|1|||
130646130|NCT01249404|470324891|FG002|Overall Study|Study treatment not received|2|||
130646131|NCT01249404|470324889|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
130646132|NCT01249404|470324890|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
130646133|NCT01249404|470324891|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
130646134|NCT01249404|470324889|FG000|Overall Study|Adverse Event|2|||
130646135|NCT01249404|470324890|FG001|Overall Study|Adverse Event|2|||
130646136|NCT01249404|470324891|FG002|Overall Study|Adverse Event|2|||
130646137|NCT01249404|470324889|FG000|Overall Study|Withdrawal by Subject|2|||
130646138|NCT01249404|470324890|FG001|Overall Study|Withdrawal by Subject|2|||
130646139|NCT01249404|470324891|FG002|Overall Study|Withdrawal by Subject|0|||
130646140|NCT01249404|470324889|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
130646141|NCT01249404|470324890|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
130646142|NCT01249404|470324891|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
130646143|NCT01249404|470324889|FG000|Overall Study|Non compliance to visit schedule|0|||
130646144|NCT01249404|470324890|FG001|Overall Study|Non compliance to visit schedule|1|||
130646145|NCT01249404|470324891|FG002|Overall Study|Non compliance to visit schedule|0|||
130646146|NCT02927990|470324892|FG000|Overall Study|Protocol Violation|4|||
130646147|NCT02927990|470324892|FG000|Overall Study|Physician Decision|9|||
130646148|NCT02927990|470324892|FG000|Overall Study|Room switched and therefore no study device available|15|||
130646149|NCT02927990|470324892|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
130646150|NCT00960323|470324893|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
130646151|NCT02146274|470324894|FG000|Overall Study|Protocol Violation|73|||
130646152|NCT03824704|470324900|FG000|Overall Study|Study Terminated by Sponsor|1|||
130646153|NCT03287960|470324902|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
130646154|NCT03287960|470324902|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
130646155|NCT03730987|470324903|FG000|Overall Study|Lost to Follow-up|2|||
130646156|NCT03730987|470324904|FG001|Overall Study|Lost to Follow-up|0|||
130646157|NCT03730987|470324905|FG002|Overall Study|Lost to Follow-up|2|||
130646158|NCT03730987|470324906|FG003|Overall Study|Lost to Follow-up|0|||
130646159|NCT01191190|470324909|FG000|Overall Study|Withdrawal by Subject|1|||
130646160|NCT01667731|470324911|FG000|Overall Study|Enrolled but not treated|0|||
130646161|NCT01667731|470324912|FG001|Overall Study|Enrolled but not treated|0|||
130646162|NCT01667731|470324913|FG002|Overall Study|Enrolled but not treated|0|||
130646163|NCT01667731|470324914|FG003|Overall Study|Enrolled but not treated|0|||
130646164|NCT01667731|470324915|FG004|Overall Study|Enrolled but not treated|1|||
130646165|NCT01667731|470324911|FG000|Overall Study|Efficacy Failure|1|||
130646166|NCT01667731|470324912|FG001|Overall Study|Efficacy Failure|12|||
130646167|NCT01667731|470324913|FG002|Overall Study|Efficacy Failure|0|||
130646168|NCT01667731|470324914|FG003|Overall Study|Efficacy Failure|1|||
130646169|NCT01667731|470324915|FG004|Overall Study|Efficacy Failure|24|||
130646170|NCT01667731|470324911|FG000|Overall Study|Lost to Follow-up|2|||
130646171|NCT01667731|470324912|FG001|Overall Study|Lost to Follow-up|3|||
130646172|NCT01667731|470324913|FG002|Overall Study|Lost to Follow-up|1|||
130646173|NCT01667731|470324914|FG003|Overall Study|Lost to Follow-up|1|||
130646174|NCT01667731|470324915|FG004|Overall Study|Lost to Follow-up|2|||
130646175|NCT01667731|470324911|FG000|Overall Study|Subject Withdrew Consent|2|||
130646176|NCT01667731|470324912|FG001|Overall Study|Subject Withdrew Consent|0|||
130646177|NCT01667731|470324913|FG002|Overall Study|Subject Withdrew Consent|1|||
130646178|NCT01667731|470324914|FG003|Overall Study|Subject Withdrew Consent|0|||
130646179|NCT01667731|470324915|FG004|Overall Study|Subject Withdrew Consent|1|||
130646180|NCT01667731|470324911|FG000|Overall Study|Death|0|||
130646181|NCT01667731|470324912|FG001|Overall Study|Death|1|||
130646182|NCT01667731|470324913|FG002|Overall Study|Death|0|||
130646183|NCT01667731|470324914|FG003|Overall Study|Death|0|||
130646184|NCT01667731|470324915|FG004|Overall Study|Death|0|||
130646185|NCT01425268|470324916|FG000|Overall Study|Withdrawal by Subject|2|||
130646186|NCT01425268|470324917|FG001|Overall Study|Withdrawal by Subject|0|||
130646187|NCT01425268|470324916|FG000|Overall Study|Sponsor Decision|5|||
130646188|NCT01425268|470324917|FG001|Overall Study|Sponsor Decision|0|||
130646189|NCT01425268|470324916|FG000|Overall Study|Physician Decision|1|||
130646190|NCT01425268|470324917|FG001|Overall Study|Physician Decision|0|||
130646191|NCT02839330|470324918|FG000|Overall Study|Adverse Event|0|||
130646192|NCT02839330|470324919|FG001|Overall Study|Adverse Event|1|||
130646193|NCT02839330|470324920|FG002|Overall Study|Adverse Event|2|||
130646194|NCT02839330|470324921|FG003|Overall Study|Adverse Event|2|||
130646195|NCT02839330|470324918|FG000|Overall Study|Death|4|||
130646196|NCT02839330|470324919|FG001|Overall Study|Death|6|||
130646197|NCT02839330|470324920|FG002|Overall Study|Death|1|||
130646198|NCT02839330|470324921|FG003|Overall Study|Death|1|||
130646199|NCT02839330|470324918|FG000|Overall Study|Withdrawal by Subject|27|||
130646200|NCT02839330|470324919|FG001|Overall Study|Withdrawal by Subject|19|||
130646201|NCT02839330|470324920|FG002|Overall Study|Withdrawal by Subject|11|||
130646202|NCT02839330|470324921|FG003|Overall Study|Withdrawal by Subject|13|||
130646203|NCT02839330|470324918|FG000|Overall Study|Lost to Follow-up|22|||
130646204|NCT02839330|470324919|FG001|Overall Study|Lost to Follow-up|27|||
130646205|NCT02839330|470324920|FG002|Overall Study|Lost to Follow-up|29|||
130646206|NCT02839330|470324921|FG003|Overall Study|Lost to Follow-up|25|||
130646207|NCT02839330|470324918|FG000|Overall Study|Administrative Reason|0|||
130646208|NCT02839330|470324919|FG001|Overall Study|Administrative Reason|0|||
130646209|NCT02839330|470324920|FG002|Overall Study|Administrative Reason|0|||
130646210|NCT02839330|470324921|FG003|Overall Study|Administrative Reason|1|||
130646211|NCT02839330|470324918|FG000|Overall Study|Protocol Violation|1|||
130646212|NCT02839330|470324919|FG001|Overall Study|Protocol Violation|2|||
130646213|NCT02839330|470324920|FG002|Overall Study|Protocol Violation|2|||
130646214|NCT02839330|470324921|FG003|Overall Study|Protocol Violation|3|||
130646215|NCT02839330|470324918|FG000|Overall Study|Other reason, not specified|4|||
130646216|NCT02839330|470324919|FG001|Overall Study|Other reason, not specified|3|||
130646217|NCT02839330|470324920|FG002|Overall Study|Other reason, not specified|3|||
130646218|NCT02839330|470324921|FG003|Overall Study|Other reason, not specified|6|||
130646219|NCT01345162|470324929|FG000|Overall Study|Protocol Violation|2|||
130646220|NCT01345162|470324930|FG001|Overall Study|Protocol Violation|4|||
130646221|NCT01871870|470324931|FG000|Overall Study|Hardware issues|7|||
130646222|NCT01871870|470324931|FG000|Overall Study|hyperglycemia|2|||
130646223|NCT00883896|470324932|FG000|Overall Study|Lost to Follow-up|0|||
130646224|NCT00883896|470324933|FG001|Overall Study|Lost to Follow-up|0|||
130646225|NCT00883896|470324934|FG002|Overall Study|Lost to Follow-up|0|||
130646226|NCT00883896|470324935|FG003|Overall Study|Lost to Follow-up|2|||
130646227|NCT00883896|470324932|FG000|Overall Study|Withdrawal by Subject|5|||
130646228|NCT00883896|470324933|FG001|Overall Study|Withdrawal by Subject|0|||
130646229|NCT00883896|470324934|FG002|Overall Study|Withdrawal by Subject|1|||
130646230|NCT00883896|470324935|FG003|Overall Study|Withdrawal by Subject|3|||
130646231|NCT00883896|470324932|FG000|Overall Study|Lack of Efficacy|0|||
130646232|NCT00883896|470324933|FG001|Overall Study|Lack of Efficacy|0|||
130646233|NCT00883896|470324934|FG002|Overall Study|Lack of Efficacy|0|||
130646234|NCT00883896|470324935|FG003|Overall Study|Lack of Efficacy|2|||
130646235|NCT00883896|470324932|FG000|Overall Study|Other|1|||
130646236|NCT00883896|470324933|FG001|Overall Study|Other|0|||
130646237|NCT00883896|470324934|FG002|Overall Study|Other|0|||
130646238|NCT00883896|470324935|FG003|Overall Study|Other|0|||
130646239|NCT01856920|470324945|FG000|Overall Study|Disease Progression On Study|3|||
130646240|NCT01856920|470324946|FG001|Overall Study|Disease Progression On Study|4|||
130646241|NCT01856920|470324945|FG000|Overall Study|Disease Progression before Treatment|1|||
130646242|NCT01856920|470324946|FG001|Overall Study|Disease Progression before Treatment|0|||
130646243|NCT01856920|470324945|FG000|Overall Study|Ineligible|0|||
130646244|NCT01856920|470324946|FG001|Overall Study|Ineligible|1|||
130646245|NCT01856920|470324945|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
130646246|NCT01856920|470324946|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
130646247|NCT01856920|470324945|FG000|Overall Study|Refused further Treatment|5|||
130646248|NCT01856920|470324946|FG001|Overall Study|Refused further Treatment|1|||
130646249|NCT01856920|470324945|FG000|Overall Study|Other Reasons|0|||
130646250|NCT01856920|470324946|FG001|Overall Study|Other Reasons|1|||
130646251|NCT01856920|470324945|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
130646252|NCT01856920|470324946|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
130646253|NCT02545270|470324947|FG000|Overall Study|technical difficulties|0|||
130646254|NCT02545270|470324948|FG001|Overall Study|technical difficulties|1|||
130646255|NCT02545270|470324949|FG002|Overall Study|technical difficulties|0|||
130646256|NCT02545270|470324947|FG000|Overall Study|Videos being too similar to other|0|||
130646257|NCT02545270|470324948|FG001|Overall Study|Videos being too similar to other|0|||
130646258|NCT02545270|470324949|FG002|Overall Study|Videos being too similar to other|2|||
130646259|NCT01716585|470324956|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
130646260|NCT01716585|470324957|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
130646261|NCT01716585|470324956|FG000|Double-blind Treatment|Adverse Event|2|||
130646262|NCT01716585|470324957|FG001|Double-blind Treatment|Adverse Event|1|||
130646263|NCT01716585|470324956|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
130646264|NCT01716585|470324957|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
130646265|NCT01716585|470324956|FG000|Double-blind Treatment|Lost to Follow-up|2|||
130646266|NCT01716585|470324957|FG001|Double-blind Treatment|Lost to Follow-up|0|||
130646267|NCT01716585|470324956|FG000|Double-blind Treatment|Subject Noncompliant|1|||
130646268|NCT01716585|470324957|FG001|Double-blind Treatment|Subject Noncompliant|0|||
130646269|NCT01716585|470324956|FG000|Double-blind Treatment|Other|1|||
130646270|NCT01716585|470324957|FG001|Double-blind Treatment|Other|0|||
130646271|NCT01716585|470324956|FG000|Open-label Treatment|Adverse Event|0|||
130646272|NCT01716585|470324957|FG001|Open-label Treatment|Adverse Event|2|||
130646273|NCT01716585|470324956|FG000|Open-label Treatment|Virologic Failure|0|||
130646274|NCT01716585|470324957|FG001|Open-label Treatment|Virologic Failure|2|||
130646275|NCT01716585|470324956|FG000|Open-label Treatment|Withdrawal by Subject|0|||
130646276|NCT01716585|470324957|FG001|Open-label Treatment|Withdrawal by Subject|3|||
130646277|NCT01220024|470324960|FG000|Overall Study|Lost to Follow-up|1|||
130646278|NCT01220024|470324961|FG001|Overall Study|Lost to Follow-up|1|||
130646279|NCT00174460|470324962|FG000|Overall Study|Withdrawal by Subject|0|||
130646280|NCT00174460|470324963|FG001|Overall Study|Withdrawal by Subject|1|||
130646281|NCT00579059|470324966|FG000|Overall Study|Study Canceled at 1 Year|21|||
130646282|NCT00579059|470324967|FG001|Overall Study|Study Canceled at 1 Year|10|||
130646283|NCT00779506|470324969|FG000|Overall Study|Screening Failed|2|||
130646284|NCT00779506|470324969|FG000|Overall Study|Adverse Event|4|||
130646285|NCT00779506|470324969|FG000|Overall Study|Lack of Efficacy|11|||
130646286|NCT00779506|470324969|FG000|Overall Study|Protocol Violation|5|||
130646287|NCT00779506|470324969|FG000|Overall Study|Withdrawal by Subject|6|||
130646288|NCT00779506|470324969|FG000|Overall Study|Lost to Follow-up|1|||
130646289|NCT04047472|470324970|FG000|Overall Study|Adverse Event|3|||
130646290|NCT04047472|470324971|FG001|Overall Study|Adverse Event|3|||
130646291|NCT04047472|470324970|FG000|Overall Study|Death|0|||
130646292|NCT04047472|470324971|FG001|Overall Study|Death|1|||
130646293|NCT04047472|470324970|FG000|Overall Study|Lost to Follow-up|1|||
130646294|NCT04047472|470324971|FG001|Overall Study|Lost to Follow-up|0|||
130646295|NCT04047472|470324970|FG000|Overall Study|Physician Decision|1|||
130646296|NCT04047472|470324971|FG001|Overall Study|Physician Decision|2|||
130646297|NCT04047472|470324970|FG000|Overall Study|Protocol Violation|1|||
130646298|NCT04047472|470324971|FG001|Overall Study|Protocol Violation|0|||
130646299|NCT04047472|470324970|FG000|Overall Study|Withdrawal by Subject|10|||
130646300|NCT04047472|470324971|FG001|Overall Study|Withdrawal by Subject|10|||
130646301|NCT02030067|470324972|FG000|Overall Study|Disease Progression|1|||
130646302|NCT02030067|470324973|FG001|Overall Study|Disease Progression|1|||
130646303|NCT02030067|470324974|FG002|Overall Study|Disease Progression|2|||
130646304|NCT02030067|470324975|FG003|Overall Study|Disease Progression|2|||
130646305|NCT02030067|470324976|FG004|Overall Study|Disease Progression|3|||
130646306|NCT02030067|470324977|FG005|Overall Study|Disease Progression|2|||
130646307|NCT02030067|470324978|FG006|Overall Study|Disease Progression|3|||
130646308|NCT02030067|470324979|FG007|Overall Study|Disease Progression|3|||
130646309|NCT02030067|470324980|FG008|Overall Study|Disease Progression|4|||
130646310|NCT02030067|470324981|FG009|Overall Study|Disease Progression|3|||
130646311|NCT02030067|470324982|FG010|Overall Study|Disease Progression|7|||
130646312|NCT02030067|470324983|FG011|Overall Study|Disease Progression|2|||
130646313|NCT02030067|470324984|FG012|Overall Study|Disease Progression|59|||
130646314|NCT02030067|470324972|FG000|Overall Study|Withdrawal by Subject|0|||
130646315|NCT02030067|470324973|FG001|Overall Study|Withdrawal by Subject|0|||
130646316|NCT02030067|470324974|FG002|Overall Study|Withdrawal by Subject|0|||
130646317|NCT02030067|470324975|FG003|Overall Study|Withdrawal by Subject|1|||
130646318|NCT02030067|470324976|FG004|Overall Study|Withdrawal by Subject|0|||
130646319|NCT02030067|470324977|FG005|Overall Study|Withdrawal by Subject|0|||
130646320|NCT02030067|470324978|FG006|Overall Study|Withdrawal by Subject|0|||
130646321|NCT02030067|470324979|FG007|Overall Study|Withdrawal by Subject|1|||
130646322|NCT02030067|470324980|FG008|Overall Study|Withdrawal by Subject|0|||
130646323|NCT02030067|470324981|FG009|Overall Study|Withdrawal by Subject|0|||
130646324|NCT02030067|470324982|FG010|Overall Study|Withdrawal by Subject|3|||
130646325|NCT02030067|470324983|FG011|Overall Study|Withdrawal by Subject|0|||
130646326|NCT02030067|470324984|FG012|Overall Study|Withdrawal by Subject|6|||
130646327|NCT02030067|470324972|FG000|Overall Study|Physician Decision|0|||
130646328|NCT02030067|470324973|FG001|Overall Study|Physician Decision|0|||
130646329|NCT02030067|470324974|FG002|Overall Study|Physician Decision|0|||
130646330|NCT02030067|470324975|FG003|Overall Study|Physician Decision|0|||
130646331|NCT02030067|470324976|FG004|Overall Study|Physician Decision|0|||
130646332|NCT02030067|470324977|FG005|Overall Study|Physician Decision|0|||
130646333|NCT02030067|470324978|FG006|Overall Study|Physician Decision|0|||
130646334|NCT02030067|470324979|FG007|Overall Study|Physician Decision|0|||
130646335|NCT02030067|470324980|FG008|Overall Study|Physician Decision|0|||
130646336|NCT02030067|470324981|FG009|Overall Study|Physician Decision|0|||
130646337|NCT02030067|470324982|FG010|Overall Study|Physician Decision|1|||
130646338|NCT02030067|470324983|FG011|Overall Study|Physician Decision|0|||
130646339|NCT02030067|470324984|FG012|Overall Study|Physician Decision|3|||
130646340|NCT02030067|470324972|FG000|Overall Study|other reasons|0|||
130646341|NCT02030067|470324973|FG001|Overall Study|other reasons|0|||
130646342|NCT02030067|470324974|FG002|Overall Study|other reasons|0|||
130646343|NCT02030067|470324975|FG003|Overall Study|other reasons|0|||
130646344|NCT02030067|470324976|FG004|Overall Study|other reasons|0|||
130646345|NCT02030067|470324977|FG005|Overall Study|other reasons|1|||
130646346|NCT02030067|470324978|FG006|Overall Study|other reasons|0|||
130646347|NCT02030067|470324979|FG007|Overall Study|other reasons|0|||
130646348|NCT02030067|470324980|FG008|Overall Study|other reasons|2|||
130646349|NCT02030067|470324981|FG009|Overall Study|other reasons|0|||
130646350|NCT02030067|470324982|FG010|Overall Study|other reasons|0|||
130646351|NCT02030067|470324983|FG011|Overall Study|other reasons|0|||
130646352|NCT02030067|470324984|FG012|Overall Study|other reasons|4|||
130646353|NCT02030067|470324972|FG000|Overall Study|Adverse Event|0|||
130646354|NCT02030067|470324973|FG001|Overall Study|Adverse Event|0|||
130646355|NCT02030067|470324974|FG002|Overall Study|Adverse Event|0|||
130646356|NCT02030067|470324975|FG003|Overall Study|Adverse Event|0|||
130646357|NCT02030067|470324976|FG004|Overall Study|Adverse Event|0|||
130646358|NCT02030067|470324977|FG005|Overall Study|Adverse Event|0|||
130646359|NCT02030067|470324978|FG006|Overall Study|Adverse Event|0|||
130646360|NCT02030067|470324979|FG007|Overall Study|Adverse Event|0|||
130646361|NCT02030067|470324980|FG008|Overall Study|Adverse Event|0|||
130646362|NCT02030067|470324981|FG009|Overall Study|Adverse Event|0|||
130646363|NCT02030067|470324982|FG010|Overall Study|Adverse Event|0|||
130646364|NCT02030067|470324983|FG011|Overall Study|Adverse Event|1|||
130646365|NCT02030067|470324984|FG012|Overall Study|Adverse Event|8|||
130646366|NCT01632345|470324985|FG000|Treatment: Part I|Adverse Event|1|||
130646367|NCT01632345|470324986|FG001|Treatment: Part I|Adverse Event|4|||
130646368|NCT01632345|470324987|FG002|Treatment: Part I|Adverse Event|2|||
130646369|NCT01632345|470324988|FG003|Treatment: Part I|Adverse Event|1|||
130646370|NCT01632345|470324989|FG004|Treatment: Part I|Adverse Event|3|||
130646371|NCT01632345|470324990|FG005|Treatment: Part I|Adverse Event|0|||
130646372|NCT01632345|470324991|FG006|Treatment: Part I|Adverse Event|0|||
130646373|NCT01632345|470324985|FG000|Treatment: Part I|Lack of Efficacy|0|||
130646374|NCT01632345|470324986|FG001|Treatment: Part I|Lack of Efficacy|1|||
130646375|NCT01632345|470324987|FG002|Treatment: Part I|Lack of Efficacy|0|||
130646376|NCT01632345|470324988|FG003|Treatment: Part I|Lack of Efficacy|1|||
130646377|NCT01632345|470324989|FG004|Treatment: Part I|Lack of Efficacy|1|||
130646378|NCT01632345|470324990|FG005|Treatment: Part I|Lack of Efficacy|0|||
130646379|NCT01632345|470324991|FG006|Treatment: Part I|Lack of Efficacy|0|||
130646380|NCT01632345|470324985|FG000|Treatment: Part I|Lost to Follow-up|3|||
130646381|NCT01632345|470324986|FG001|Treatment: Part I|Lost to Follow-up|2|||
130646382|NCT01632345|470324987|FG002|Treatment: Part I|Lost to Follow-up|1|||
130646383|NCT01632345|470324988|FG003|Treatment: Part I|Lost to Follow-up|3|||
130646384|NCT01632345|470324989|FG004|Treatment: Part I|Lost to Follow-up|4|||
130646385|NCT01632345|470324990|FG005|Treatment: Part I|Lost to Follow-up|0|||
130646386|NCT01632345|470324991|FG006|Treatment: Part I|Lost to Follow-up|0|||
130646387|NCT01632345|470324985|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
130646388|NCT01632345|470324986|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
130646389|NCT01632345|470324987|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
130646390|NCT01632345|470324988|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
130646391|NCT01632345|470324989|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
130646392|NCT01632345|470324990|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
130646393|NCT01632345|470324991|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
130646394|NCT01632345|470324985|FG000|Treatment: Part I|Physician Decision|2|||
130646395|NCT01632345|470324986|FG001|Treatment: Part I|Physician Decision|1|||
130646396|NCT01632345|470324987|FG002|Treatment: Part I|Physician Decision|0|||
130646397|NCT01632345|470324988|FG003|Treatment: Part I|Physician Decision|0|||
130646398|NCT01632345|470324989|FG004|Treatment: Part I|Physician Decision|1|||
130646399|NCT01632345|470324990|FG005|Treatment: Part I|Physician Decision|0|||
130646400|NCT01632345|470324991|FG006|Treatment: Part I|Physician Decision|0|||
130646401|NCT01632345|470324985|FG000|Treatment: Part I|Pregnancy|0|||
130646402|NCT01632345|470324986|FG001|Treatment: Part I|Pregnancy|1|||
130646403|NCT01632345|470324987|FG002|Treatment: Part I|Pregnancy|0|||
130646404|NCT01632345|470324988|FG003|Treatment: Part I|Pregnancy|0|||
130646405|NCT01632345|470324989|FG004|Treatment: Part I|Pregnancy|0|||
130646406|NCT01632345|470324990|FG005|Treatment: Part I|Pregnancy|0|||
130646407|NCT01632345|470324991|FG006|Treatment: Part I|Pregnancy|0|||
130646408|NCT01632345|470324985|FG000|Treatment: Part I|Protocol Deviation|0|||
130646409|NCT01632345|470324986|FG001|Treatment: Part I|Protocol Deviation|0|||
130646410|NCT01632345|470324987|FG002|Treatment: Part I|Protocol Deviation|1|||
130646411|NCT01632345|470324988|FG003|Treatment: Part I|Protocol Deviation|1|||
130646412|NCT01632345|470324989|FG004|Treatment: Part I|Protocol Deviation|0|||
130646413|NCT01632345|470324990|FG005|Treatment: Part I|Protocol Deviation|0|||
130646414|NCT01632345|470324991|FG006|Treatment: Part I|Protocol Deviation|0|||
130646415|NCT01632345|470324985|FG000|Treatment: Part I|Withdrawal by Subject|3|||
130646416|NCT01632345|470324986|FG001|Treatment: Part I|Withdrawal by Subject|4|||
130646417|NCT01632345|470324987|FG002|Treatment: Part I|Withdrawal by Subject|4|||
130646418|NCT01632345|470324988|FG003|Treatment: Part I|Withdrawal by Subject|1|||
130646419|NCT01632345|470324989|FG004|Treatment: Part I|Withdrawal by Subject|4|||
130646420|NCT01632345|470324990|FG005|Treatment: Part I|Withdrawal by Subject|0|||
130646421|NCT01632345|470324991|FG006|Treatment: Part I|Withdrawal by Subject|0|||
130646422|NCT01632345|470324985|FG000|Treatment: Part II|Adverse Event|0|||
130646423|NCT01632345|470324986|FG001|Treatment: Part II|Adverse Event|0|||
130646424|NCT01632345|470324987|FG002|Treatment: Part II|Adverse Event|0|||
130646425|NCT01632345|470324988|FG003|Treatment: Part II|Adverse Event|0|||
130646426|NCT01632345|470324989|FG004|Treatment: Part II|Adverse Event|0|||
130646427|NCT01632345|470324990|FG005|Treatment: Part II|Adverse Event|3|||
130646428|NCT01632345|470324991|FG006|Treatment: Part II|Adverse Event|8|||
130646429|NCT01632345|470324985|FG000|Treatment: Part II|Lost to Follow-up|0|||
130646430|NCT01632345|470324986|FG001|Treatment: Part II|Lost to Follow-up|0|||
130646431|NCT01632345|470324987|FG002|Treatment: Part II|Lost to Follow-up|0|||
130646432|NCT01632345|470324988|FG003|Treatment: Part II|Lost to Follow-up|0|||
130646433|NCT01632345|470324989|FG004|Treatment: Part II|Lost to Follow-up|0|||
130646434|NCT01632345|470324990|FG005|Treatment: Part II|Lost to Follow-up|3|||
130646435|NCT01632345|470324991|FG006|Treatment: Part II|Lost to Follow-up|1|||
130646436|NCT01632345|470324985|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646437|NCT01632345|470324986|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646438|NCT01632345|470324987|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646439|NCT01632345|470324988|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646440|NCT01632345|470324989|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646441|NCT01632345|470324990|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
130646442|NCT01632345|470324991|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
130646443|NCT01632345|470324985|FG000|Treatment: Part II|Withdrawal by Subject|0|||
130646444|NCT01632345|470324986|FG001|Treatment: Part II|Withdrawal by Subject|0|||
130646445|NCT01632345|470324987|FG002|Treatment: Part II|Withdrawal by Subject|0|||
130646446|NCT01632345|470324988|FG003|Treatment: Part II|Withdrawal by Subject|0|||
130646447|NCT01632345|470324989|FG004|Treatment: Part II|Withdrawal by Subject|0|||
130646448|NCT01632345|470324990|FG005|Treatment: Part II|Withdrawal by Subject|2|||
130646449|NCT01632345|470324991|FG006|Treatment: Part II|Withdrawal by Subject|2|||
130646450|NCT01756846|470324992|FG000|Overall Study|Lost to Follow-up|5|||
130646451|NCT01756846|470324993|FG001|Overall Study|Lost to Follow-up|10|||
130646452|NCT01756846|470324992|FG000|Overall Study|Withdrawal by Subject|1|||
130646453|NCT01756846|470324993|FG001|Overall Study|Withdrawal by Subject|2|||
130646454|NCT00545740|470324996|FG000|Overall Study|Lack of Efficacy|34|||
130646455|NCT00545740|470324997|FG001|Overall Study|Lack of Efficacy|35|||
130646456|NCT00545740|470324998|FG002|Overall Study|Lack of Efficacy|47|||
130646457|NCT00545740|470324999|FG003|Overall Study|Lack of Efficacy|36|||
130646458|NCT00545740|470324996|FG000|Overall Study|Withdrawal by Subject|17|||
130646459|NCT00545740|470324997|FG001|Overall Study|Withdrawal by Subject|15|||
130646460|NCT00545740|470324998|FG002|Overall Study|Withdrawal by Subject|16|||
130646461|NCT00545740|470324999|FG003|Overall Study|Withdrawal by Subject|18|||
130646462|NCT00545740|470324996|FG000|Overall Study|Adverse Event|10|||
130646463|NCT00545740|470324997|FG001|Overall Study|Adverse Event|18|||
130646464|NCT00545740|470324998|FG002|Overall Study|Adverse Event|19|||
130646465|NCT00545740|470324999|FG003|Overall Study|Adverse Event|9|||
130646466|NCT00545740|470324996|FG000|Overall Study|Lost to Follow-up|7|||
130646467|NCT00545740|470324997|FG001|Overall Study|Lost to Follow-up|5|||
130646468|NCT00545740|470324998|FG002|Overall Study|Lost to Follow-up|5|||
130646469|NCT00545740|470324999|FG003|Overall Study|Lost to Follow-up|6|||
130646470|NCT00545740|470324996|FG000|Overall Study|Protocol Violation|1|||
130646471|NCT00545740|470324997|FG001|Overall Study|Protocol Violation|3|||
130646472|NCT00545740|470324998|FG002|Overall Study|Protocol Violation|1|||
130646473|NCT00545740|470324999|FG003|Overall Study|Protocol Violation|0|||
130646474|NCT00545740|470324996|FG000|Overall Study|Non-compliance|0|||
130646475|NCT00545740|470324997|FG001|Overall Study|Non-compliance|2|||
130646476|NCT00545740|470324998|FG002|Overall Study|Non-compliance|1|||
130646477|NCT00545740|470324999|FG003|Overall Study|Non-compliance|0|||
130646478|NCT00545740|470324996|FG000|Overall Study|Moved|2|||
130646479|NCT00545740|470324997|FG001|Overall Study|Moved|0|||
130646480|NCT00545740|470324998|FG002|Overall Study|Moved|1|||
130646481|NCT00545740|470324999|FG003|Overall Study|Moved|0|||
130646482|NCT00545740|470324996|FG000|Overall Study|Diverticulitis attack|0|||
130646483|NCT00545740|470324997|FG001|Overall Study|Diverticulitis attack|0|||
130646484|NCT00545740|470324998|FG002|Overall Study|Diverticulitis attack|1|||
130646485|NCT00545740|470324999|FG003|Overall Study|Diverticulitis attack|1|||
130646486|NCT00545740|470324996|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
130646487|NCT00545740|470324997|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
130646488|NCT00545740|470324998|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
130646489|NCT00545740|470324999|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
130646490|NCT00545740|470324996|FG000|Overall Study|Site closure|1|||
130646491|NCT00545740|470324997|FG001|Overall Study|Site closure|0|||
130646492|NCT00545740|470324998|FG002|Overall Study|Site closure|0|||
130646493|NCT00545740|470324999|FG003|Overall Study|Site closure|0|||
130646494|NCT00545740|470324996|FG000|Overall Study|Missed visit|1|||
130646495|NCT00545740|470324997|FG001|Overall Study|Missed visit|0|||
130646496|NCT00545740|470324998|FG002|Overall Study|Missed visit|0|||
130646497|NCT00545740|470324999|FG003|Overall Study|Missed visit|0|||
130646498|NCT00545740|470324996|FG000|Overall Study|Physician Decision|0|||
130646499|NCT00545740|470324997|FG001|Overall Study|Physician Decision|0|||
130646500|NCT00545740|470324998|FG002|Overall Study|Physician Decision|3|||
130646501|NCT00545740|470324999|FG003|Overall Study|Physician Decision|0|||
130646502|NCT00545740|470324996|FG000|Overall Study|Accepted only monthly telephone calls|1|||
130646503|NCT00545740|470324997|FG001|Overall Study|Accepted only monthly telephone calls|0|||
130646504|NCT00545740|470324998|FG002|Overall Study|Accepted only monthly telephone calls|0|||
130646505|NCT00545740|470324999|FG003|Overall Study|Accepted only monthly telephone calls|0|||
130646506|NCT00545740|470324996|FG000|Overall Study|Sponsor decision|0|||
130646507|NCT00545740|470324997|FG001|Overall Study|Sponsor decision|1|||
130646508|NCT00545740|470324998|FG002|Overall Study|Sponsor decision|0|||
130646509|NCT00545740|470324999|FG003|Overall Study|Sponsor decision|0|||
130646510|NCT00545740|470324996|FG000|Overall Study|Lack of time|0|||
130646511|NCT00545740|470324997|FG001|Overall Study|Lack of time|1|||
130646512|NCT00545740|470324998|FG002|Overall Study|Lack of time|0|||
130646513|NCT00545740|470324999|FG003|Overall Study|Lack of time|0|||
130646514|NCT00545740|470324996|FG000|Overall Study|Non-adherence to visits|0|||
130646515|NCT00545740|470324997|FG001|Overall Study|Non-adherence to visits|1|||
130646516|NCT00545740|470324998|FG002|Overall Study|Non-adherence to visits|0|||
130646517|NCT00545740|470324999|FG003|Overall Study|Non-adherence to visits|0|||
130646518|NCT00545740|470324996|FG000|Overall Study|Patient difficulties|0|||
130646519|NCT00545740|470324997|FG001|Overall Study|Patient difficulties|1|||
130646520|NCT00545740|470324998|FG002|Overall Study|Patient difficulties|0|||
130646521|NCT00545740|470324999|FG003|Overall Study|Patient difficulties|0|||
130646522|NCT00545740|470324996|FG000|Overall Study|Husband against study|0|||
130646523|NCT00545740|470324997|FG001|Overall Study|Husband against study|0|||
130646524|NCT00545740|470324998|FG002|Overall Study|Husband against study|1|||
130646525|NCT00545740|470324999|FG003|Overall Study|Husband against study|0|||
130646526|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
130646527|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
130646528|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
130646529|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
130646530|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
130646531|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
130646532|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Death|1|||
130646533|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Death|1|||
130646534|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Death|1|||
130646535|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Death|0|||
130646536|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Death|0|||
130646537|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Death|0|||
130646538|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
130646539|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
130646540|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130646541|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130646542|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130646543|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130646544|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130646545|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130646546|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
130646547|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130646548|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130646549|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130646550|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130646551|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
130646552|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130646553|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130646554|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130646555|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130646556|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
130646557|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
130646558|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
130646559|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130646560|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130646561|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130646562|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
130646563|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
130646564|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
130646565|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
130646566|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
130646567|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
130646568|NCT03370133|470325009|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
130646569|NCT03370133|470325010|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
130646570|NCT03370133|470325011|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
130646571|NCT03370133|470325012|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
130646572|NCT03370133|470325013|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
130646573|NCT03370133|470325014|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
130646574|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130646575|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130646576|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130646577|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
130646578|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
130646579|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
130646580|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130646581|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130646582|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130646583|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130646584|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
130646585|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
130646586|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130646587|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130646588|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130646589|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
130646590|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
130646591|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130646592|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130646593|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130646594|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130646595|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130646596|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
130646597|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
130646598|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130646599|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130646600|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130646601|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
130646602|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
130646603|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
130646604|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130646605|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130646606|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130646607|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130646608|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
130646609|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130646610|NCT03370133|470325009|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130646611|NCT03370133|470325010|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130646612|NCT03370133|470325011|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130646613|NCT03370133|470325012|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130646614|NCT03370133|470325013|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130646615|NCT03370133|470325014|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
130646616|NCT00636506|470325015|FG000|Overall Study|Lost to Follow-up|8|||
130646617|NCT00636506|470325015|FG000|Overall Study|Explanted|1|||
130646618|NCT00636506|470325015|FG000|Overall Study|Withdrawal by Subject|6|||
130646619|NCT00636506|470325015|FG000|Overall Study|Procedure aborted|1|||
130646620|NCT03742271|470325016|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130646621|NCT03742271|470325016|FG000|Overall Study|Withdrawal by Subject|3|||
130646622|NCT03742271|470325016|FG000|Overall Study|Lost to Follow-up|4|||
130646623|NCT03742271|470325016|FG000|Overall Study|Failed Insertion & removal|3|||
130646624|NCT03742271|470325016|FG000|Overall Study|Protocol Violation|1|||
130646625|NCT01899729|470325018|FG000|Overall Study|Adverse Event|1|||
130646626|NCT01899729|470325019|FG001|Overall Study|Adverse Event|0|||
130646627|NCT01899729|470325020|FG002|Overall Study|Adverse Event|0|||
130646628|NCT01899729|470325021|FG003|Overall Study|Adverse Event|0|||
130646629|NCT01899729|470325022|FG004|Overall Study|Adverse Event|1|||
130646630|NCT01899729|470325018|FG000|Overall Study|Withdrawal by Subject|1|||
130646631|NCT01899729|470325019|FG001|Overall Study|Withdrawal by Subject|2|||
130646632|NCT01899729|470325020|FG002|Overall Study|Withdrawal by Subject|0|||
130646633|NCT01899729|470325021|FG003|Overall Study|Withdrawal by Subject|0|||
130646634|NCT01899729|470325022|FG004|Overall Study|Withdrawal by Subject|0|||
130646635|NCT01899729|470325018|FG000|Overall Study|Lack of Efficacy|0|||
130646636|NCT01899729|470325019|FG001|Overall Study|Lack of Efficacy|0|||
130646637|NCT01899729|470325020|FG002|Overall Study|Lack of Efficacy|2|||
130646638|NCT01899729|470325021|FG003|Overall Study|Lack of Efficacy|0|||
130646639|NCT01899729|470325022|FG004|Overall Study|Lack of Efficacy|1|||
130646640|NCT03125902|470325023|FG000|Overall Study|Adverse Event|0|||
130646641|NCT03125902|470325024|FG001|Overall Study|Adverse Event|1|||
130646642|NCT03125902|470325023|FG000|Overall Study|Death|119|||
130646643|NCT03125902|470325024|FG001|Overall Study|Death|229|||
130646644|NCT03125902|470325023|FG000|Overall Study|Lost to Follow-up|4|||
130646645|NCT03125902|470325024|FG001|Overall Study|Lost to Follow-up|13|||
130646646|NCT03125902|470325023|FG000|Overall Study|Other|0|||
130646647|NCT03125902|470325024|FG001|Overall Study|Other|4|||
130646648|NCT03125902|470325023|FG000|Overall Study|Physician Decision|2|||
130646649|NCT03125902|470325024|FG001|Overall Study|Physician Decision|1|||
130646650|NCT03125902|470325023|FG000|Overall Study|Progressive Disease|0|||
130646651|NCT03125902|470325024|FG001|Overall Study|Progressive Disease|3|||
130646652|NCT03125902|470325023|FG000|Overall Study|Study Terminated By Sponsor|74|||
130646653|NCT03125902|470325024|FG001|Overall Study|Study Terminated By Sponsor|143|||
130646654|NCT03125902|470325023|FG000|Overall Study|Withdrawal by Subject|21|||
130646655|NCT03125902|470325024|FG001|Overall Study|Withdrawal by Subject|37|||
130646656|NCT01078389|470327173|FG000|Overall Study|Adverse Event|10|||
130646657|NCT01078389|470327174|FG001|Overall Study|Adverse Event|6|||
130646658|NCT01078389|470327173|FG000|Overall Study|Major Protocol Deviation|2|||
130646659|NCT01078389|470327174|FG001|Overall Study|Major Protocol Deviation|0|||
130646660|NCT01078389|470327173|FG000|Overall Study|Lost to Follow-up|23|||
130646661|NCT01078389|470327174|FG001|Overall Study|Lost to Follow-up|23|||
130646662|NCT01078389|470327173|FG000|Overall Study|Voluntary Withdrawal|20|||
130646663|NCT01078389|470327174|FG001|Overall Study|Voluntary Withdrawal|36|||
130646664|NCT01078389|470327173|FG000|Overall Study|Other|9|||
130646665|NCT01078389|470327174|FG001|Overall Study|Other|2|||
130646666|NCT01002573|470327175|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
130646667|NCT01002573|470327176|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
130646668|NCT03691831|470327179|FG000|Overall Study|Lost to Follow-up|16|||
130646669|NCT03691831|470327180|FG001|Overall Study|Lost to Follow-up|12|||
130646670|NCT03691831|470327179|FG000|Overall Study|Withdrawal by Subject|9|||
130646671|NCT03691831|470327180|FG001|Overall Study|Withdrawal by Subject|17|||
130646672|NCT03691831|470327179|FG000|Overall Study|Investigator Decision|2|||
130646673|NCT03691831|470327180|FG001|Overall Study|Investigator Decision|2|||
130646674|NCT02028182|470327181|FG000|Overall Study|Protocol Violation|2|||
130646675|NCT01684930|470327184|FG000|Overall Study|Withdrawal by Subject|3|||
130646676|NCT01684930|470327185|FG001|Overall Study|Withdrawal by Subject|1|||
130646677|NCT02198040|470327186|FG000|Overall Study|Work reasons|0|||
130646678|NCT02198040|470327187|FG001|Overall Study|Work reasons|1|||
130646679|NCT02198040|470327188|FG002|Overall Study|Work reasons|0|||
130646680|NCT02198040|470327186|FG000|Overall Study|Withdrawal by Subject|0|||
130646681|NCT02198040|470327187|FG001|Overall Study|Withdrawal by Subject|0|||
130646682|NCT02198040|470327188|FG002|Overall Study|Withdrawal by Subject|1|||
130646683|NCT04524663|470327189|FG000|Overall Study|Withdrawal by Subject|0|||
130646684|NCT04524663|470327190|FG001|Overall Study|Withdrawal by Subject|2|||
130646685|NCT00337935|470327191|FG000|Overall Study|Adverse Event|2|||
130646686|NCT00337935|470327192|FG001|Overall Study|Adverse Event|5|||
130646687|NCT00337935|470327191|FG000|Overall Study|Death|2|||
130646688|NCT00337935|470327192|FG001|Overall Study|Death|8|||
130646689|NCT00337935|470327191|FG000|Overall Study|Physician Decision|1|||
130646690|NCT00337935|470327192|FG001|Overall Study|Physician Decision|1|||
130646691|NCT00337935|470327191|FG000|Overall Study|Lost to Follow-up|0|||
130646692|NCT00337935|470327192|FG001|Overall Study|Lost to Follow-up|1|||
130646693|NCT00337935|470327191|FG000|Overall Study|Protocol Violation|4|||
130646694|NCT00337935|470327192|FG001|Overall Study|Protocol Violation|3|||
130646695|NCT00337935|470327191|FG000|Overall Study|Withdrawal by Subject|1|||
130646696|NCT00337935|470327192|FG001|Overall Study|Withdrawal by Subject|7|||
130646697|NCT00337935|470327191|FG000|Overall Study|Other|0|||
130646698|NCT00337935|470327192|FG001|Overall Study|Other|1|||
130646699|NCT00337935|470327191|FG000|Overall Study|Lack of Efficacy|0|||
130646700|NCT00337935|470327192|FG001|Overall Study|Lack of Efficacy|1|||
130646701|NCT00711009|470327193|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
130646702|NCT00711009|470327194|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
130646703|NCT00711009|470327193|FG000|Overall Study|Withdrawal by Subject|4|||
130646704|NCT00711009|470327194|FG001|Overall Study|Withdrawal by Subject|2|||
130646705|NCT00711009|470327193|FG000|Overall Study|Lost to Follow-up|3|||
130646706|NCT00711009|470327194|FG001|Overall Study|Lost to Follow-up|9|||
130646707|NCT00711009|470327193|FG000|Overall Study|Participant Noncompliant|0|||
130646708|NCT00711009|470327194|FG001|Overall Study|Participant Noncompliant|1|||
130646709|NCT00711009|470327193|FG000|Overall Study|Virologic Failure|2|||
130646710|NCT00711009|470327194|FG001|Overall Study|Virologic Failure|1|||
130646711|NCT00711009|470327193|FG000|Overall Study|Pregnancy|1|||
130646712|NCT00711009|470327194|FG001|Overall Study|Pregnancy|0|||
130646713|NCT00711009|470327193|FG000|Overall Study|Site closing|0|||
130646714|NCT00711009|470327194|FG001|Overall Study|Site closing|1|||
130646715|NCT00711009|470327193|FG000|Overall Study|Dose adjustment|1|||
130646716|NCT00711009|470327194|FG001|Overall Study|Dose adjustment|0|||
130646717|NCT03359811|470327195|FG000|Overall Study|Protocol Violation|2|||
130646718|NCT03359811|470327196|FG001|Overall Study|Protocol Violation|0|||
130646719|NCT01682876|470327198|FG000|Overall Study|Administrative reason|4|||
130646720|NCT01682876|470327199|FG001|Overall Study|Administrative reason|4|||
130646721|NCT01682876|470327200|FG002|Overall Study|Administrative reason|0|||
130646722|NCT01682876|470327201|FG003|Overall Study|Administrative reason|3|||
130646723|NCT01682876|470327198|FG000|Overall Study|Adverse Event|0|||
130646724|NCT01682876|470327199|FG001|Overall Study|Adverse Event|0|||
130646725|NCT01682876|470327200|FG002|Overall Study|Adverse Event|0|||
130646726|NCT01682876|470327201|FG003|Overall Study|Adverse Event|1|||
130646727|NCT01682876|470327198|FG000|Overall Study|Lost to Follow-up|11|||
130646728|NCT01682876|470327199|FG001|Overall Study|Lost to Follow-up|15|||
130646729|NCT01682876|470327200|FG002|Overall Study|Lost to Follow-up|9|||
130646730|NCT01682876|470327201|FG003|Overall Study|Lost to Follow-up|11|||
130646731|NCT01682876|470327198|FG000|Overall Study|Protocol Violation|1|||
130646732|NCT01682876|470327199|FG001|Overall Study|Protocol Violation|1|||
130646733|NCT01682876|470327200|FG002|Overall Study|Protocol Violation|1|||
130646734|NCT01682876|470327201|FG003|Overall Study|Protocol Violation|1|||
130646735|NCT01682876|470327198|FG000|Overall Study|Withdrawal by Subject|4|||
130646736|NCT01682876|470327199|FG001|Overall Study|Withdrawal by Subject|0|||
130646737|NCT01682876|470327200|FG002|Overall Study|Withdrawal by Subject|0|||
130646738|NCT01682876|470327201|FG003|Overall Study|Withdrawal by Subject|2|||
130646739|NCT01682876|470327198|FG000|Overall Study|Other|1|||
130646740|NCT01682876|470327199|FG001|Overall Study|Other|0|||
130646741|NCT01682876|470327200|FG002|Overall Study|Other|1|||
130646742|NCT01682876|470327201|FG003|Overall Study|Other|1|||
130646743|NCT02534324|470327205|FG000|Overall Study|Protocol Violation|4|||
130646744|NCT02534324|470327206|FG001|Overall Study|Protocol Violation|1|||
130646745|NCT02534324|470327205|FG000|Overall Study|Lost to Follow-up|20|||
130646746|NCT02534324|470327206|FG001|Overall Study|Lost to Follow-up|7|||
130646747|NCT02534324|470327205|FG000|Overall Study|Adverse Event|1|||
130646748|NCT02534324|470327206|FG001|Overall Study|Adverse Event|0|||
130646749|NCT01459016|470327207|FG000|Overall Study|Withdrawal by Subject|11|||
130646750|NCT01459016|470327207|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
130646751|NCT00240331|470327208|FG000|Overall Study|Withdrawal by Subject|125|||
130646752|NCT00240331|470327209|FG001|Overall Study|Withdrawal by Subject|132|||
130646753|NCT00240331|470327208|FG000|Overall Study|Option selected by investigator|1|||
130646754|NCT00240331|470327209|FG001|Overall Study|Option selected by investigator|2|||
130646755|NCT02491463|470327216|FG000|Overall Study|Withdrawal by Subject|1|||
130646756|NCT02491463|470327217|FG001|Overall Study|Withdrawal by Subject|2|||
130646757|NCT02491463|470327218|FG002|Overall Study|Withdrawal by Subject|0|||
130646758|NCT02491463|470327219|FG003|Overall Study|Withdrawal by Subject|0|||
130646759|NCT02491463|470327216|FG000|Overall Study|Migrated/moved from study area|1|||
130646760|NCT02491463|470327217|FG001|Overall Study|Migrated/moved from study area|5|||
130646761|NCT02491463|470327218|FG002|Overall Study|Migrated/moved from study area|1|||
130646762|NCT02491463|470327219|FG003|Overall Study|Migrated/moved from study area|1|||
130646763|NCT02491463|470327216|FG000|Overall Study|Lost to Follow-up|0|||
130646764|NCT02491463|470327217|FG001|Overall Study|Lost to Follow-up|3|||
130646765|NCT02491463|470327218|FG002|Overall Study|Lost to Follow-up|3|||
130646766|NCT02491463|470327219|FG003|Overall Study|Lost to Follow-up|0|||
130646767|NCT01491802|470327220|FG000|Overall Study|Adverse Event|1|||
130646768|NCT01491802|470327221|FG001|Overall Study|Adverse Event|1|||
130646769|NCT01491802|470327220|FG000|Overall Study|Withdrawal by Subject|0|||
130646770|NCT01491802|470327221|FG001|Overall Study|Withdrawal by Subject|1|||
130646771|NCT04067310|470327226|FG000|Overall Study|Physician Decision|2|||
130646772|NCT04067310|470327227|FG001|Overall Study|Physician Decision|6|||
130646773|NCT04067310|470327226|FG000|Overall Study|Lost to Follow-up|0|||
130646774|NCT04067310|470327227|FG001|Overall Study|Lost to Follow-up|1|||
130646775|NCT04067310|470327226|FG000|Overall Study|Withdrawal by Subject|3|||
130646776|NCT04067310|470327227|FG001|Overall Study|Withdrawal by Subject|0|||
130646777|NCT01347931|470327228|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
130646778|NCT04563845|470327229|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646779|NCT04563845|470327230|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646780|NCT04563845|470327231|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646781|NCT04563845|470327232|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646782|NCT04563845|470327233|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646783|NCT04563845|470327234|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646784|NCT04563845|470327235|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646785|NCT04563845|470327236|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
130646786|NCT04563845|470327237|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646787|NCT04563845|470327238|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646788|NCT04563845|470327239|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646789|NCT04563845|470327240|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646790|NCT04563845|470327241|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646791|NCT04563845|470327242|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130646792|NCT04563845|470327229|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646793|NCT04563845|470327230|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646794|NCT04563845|470327231|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646795|NCT04563845|470327232|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646796|NCT04563845|470327233|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
130646797|NCT04563845|470327234|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646798|NCT04563845|470327235|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646799|NCT04563845|470327236|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646800|NCT04563845|470327237|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646801|NCT04563845|470327238|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646802|NCT04563845|470327239|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646803|NCT04563845|470327240|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646804|NCT04563845|470327241|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646805|NCT04563845|470327242|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130646806|NCT01020812|470327243|FG000|Overall Study|Physician Decision|1|||
130646807|NCT01020812|470327243|FG000|Overall Study|Withdrawal by Subject|1|||
130646808|NCT01020812|470327243|FG000|Overall Study|Protocol Violation|1|||
130646809|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
130646810|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
130646811|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
130646812|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
130646813|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
130646814|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
130646815|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
130646816|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
130646817|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
130646818|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
130646819|NCT02528643|470327244|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
130646820|NCT02528643|470327245|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
130646821|NCT02528643|470327244|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
130646822|NCT02528643|470327245|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
130646823|NCT00761891|470327246|FG000|Overall Study|Withdrawal by Subject|10|||
130646824|NCT02074059|470327250|FG000|Overall Study|Death|0|||
130646825|NCT02074059|470327251|FG001|Overall Study|Death|0|||
130646826|NCT02074059|470327252|FG002|Overall Study|Death|0|||
130646827|NCT02074059|470327253|FG003|Overall Study|Death|0|||
130646828|NCT02074059|470327254|FG004|Overall Study|Death|1|||
130646829|NCT02074059|470327255|FG005|Overall Study|Death|1|||
130646830|NCT02764229|470327260|FG000|Overall Study|Withdrawal by Subject|15|||
130646831|NCT02764229|470327260|FG000|Overall Study|Adverse Event|9|||
130646832|NCT02764229|470327260|FG000|Overall Study|Physician Decision|5|||
130646833|NCT02764229|470327260|FG000|Overall Study|Lost to Follow-up|3|||
130646834|NCT02764229|470327260|FG000|Overall Study|Lack of Efficacy|1|||
130646835|NCT02764229|470327260|FG000|Overall Study|Study Stopped by Sponsor|69|||
130646836|NCT00779142|470327261|FG000|Overall Study|Screen Failures|3|||
130646837|NCT00265382|470327264|FG000|Overall Study|Adverse Event|21|||
130646838|NCT00265382|470327264|FG000|Overall Study|Laboratory Abnormality|1|||
130646839|NCT00265382|470327264|FG000|Overall Study|Lost to Follow-up|3|||
130646840|NCT00265382|470327264|FG000|Overall Study|Lack of Efficacy|6|||
130646841|NCT00265382|470327264|FG000|Overall Study|Miscellaneous|6|||
130646842|NCT00265382|470327264|FG000|Overall Study|Withdrawal by Subject|13|||
130646843|NCT00265382|470327264|FG000|Overall Study|Study terminated by sponsor|94|||
130646844|NCT00265382|470327264|FG000|Overall Study|Death|1|||
130646845|NCT00529152|470327267|FG000|Overall Study|Adverse Event|2|||
130646846|NCT00529152|470327267|FG000|Overall Study|Withdrawal by Subject|2|||
130646847|NCT00529152|470327267|FG000|Overall Study|Lost to Follow-up|1|||
130646848|NCT01843933|470327271|FG000|Overall Study|Data lost|6|||
130646849|NCT01843933|470327272|FG001|Overall Study|Data lost|4|||
130646850|NCT01535638|470327273|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
130646851|NCT01535638|470327274|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
130646852|NCT01535638|470327275|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
130646853|NCT01535638|470327276|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
130646854|NCT01535638|470327277|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
130646855|NCT01535638|470327278|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
130646856|NCT01535638|470327273|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
130646857|NCT01535638|470327274|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
130646858|NCT01535638|470327275|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
130646859|NCT01535638|470327276|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
130646860|NCT01535638|470327277|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
130646861|NCT01535638|470327278|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
130646862|NCT01482598|470327279|FG000|Overall Study|Death|7|||
130646863|NCT01482598|470327280|FG001|Overall Study|Death|10|||
130646864|NCT01482598|470327279|FG000|Overall Study|Physician Decision|0|||
130646865|NCT01482598|470327280|FG001|Overall Study|Physician Decision|3|||
130646866|NCT01482598|470327279|FG000|Overall Study|Withdrawal by Subject|4|||
130646867|NCT01482598|470327280|FG001|Overall Study|Withdrawal by Subject|5|||
130646868|NCT01482598|470327279|FG000|Overall Study|Lost to Follow-up|5|||
130646869|NCT01482598|470327280|FG001|Overall Study|Lost to Follow-up|4|||
130646870|NCT01373294|470327281|FG000|Overall Study|Adverse Event|1|||
130646871|NCT01373294|470327282|FG001|Overall Study|Adverse Event|0|||
130646872|NCT02694562|470327283|FG000|Overall Study|Death|8|||
130646873|NCT02694562|470327283|FG000|Overall Study|Protocol Violation|4|||
130646874|NCT02694562|470327283|FG000|Overall Study|Lost to Follow-up|3|||
130646875|NCT02694562|470327283|FG000|Overall Study|Screen Failure|2|||
130646876|NCT02694562|470327283|FG000|Overall Study|Physician Decision|1|||
130646877|NCT01333865|470327284|FG000|Overall Study|Adverse Event|2|||
130646878|NCT00620815|470327287|FG000|Overall Study|Adverse Event|1|||
130646879|NCT00620815|470327288|FG001|Overall Study|Adverse Event|1|||
130646880|NCT00620815|470327289|FG002|Overall Study|Adverse Event|2|||
130646881|NCT00620815|470327287|FG000|Overall Study|Withdrawal by Subject|1|||
130646882|NCT00620815|470327288|FG001|Overall Study|Withdrawal by Subject|2|||
130646883|NCT00620815|470327289|FG002|Overall Study|Withdrawal by Subject|0|||
130646884|NCT00620815|470327287|FG000|Overall Study|Lost to Follow-up|1|||
130646885|NCT00620815|470327288|FG001|Overall Study|Lost to Follow-up|6|||
130646886|NCT00620815|470327289|FG002|Overall Study|Lost to Follow-up|3|||
130646887|NCT00620815|470327287|FG000|Overall Study|Inappropriate enrolment|0|||
130646888|NCT00620815|470327288|FG001|Overall Study|Inappropriate enrolment|0|||
130646889|NCT00620815|470327289|FG002|Overall Study|Inappropriate enrolment|1|||
130646890|NCT00620815|470327287|FG000|Overall Study|Protocol Violation|1|||
130646891|NCT00620815|470327288|FG001|Overall Study|Protocol Violation|2|||
130646892|NCT00620815|470327289|FG002|Overall Study|Protocol Violation|1|||
130646893|NCT00877929|470327291|FG000|Overall Study|Adverse Event|11|||
130646894|NCT00877929|470327292|FG001|Overall Study|Adverse Event|20|||
130646895|NCT00877929|470327291|FG000|Overall Study|Protocol Violation|3|||
130646896|NCT00877929|470327292|FG001|Overall Study|Protocol Violation|3|||
130646897|NCT00877929|470327291|FG000|Overall Study|Lost to Follow-up|0|||
130646898|NCT00877929|470327292|FG001|Overall Study|Lost to Follow-up|1|||
130646899|NCT00877929|470327291|FG000|Overall Study|Withdrawal by Subject|4|||
130646900|NCT00877929|470327292|FG001|Overall Study|Withdrawal by Subject|4|||
130646901|NCT00877929|470327291|FG000|Overall Study|Lack of Efficacy|0|||
130646902|NCT00877929|470327292|FG001|Overall Study|Lack of Efficacy|1|||
130646903|NCT00877929|470327291|FG000|Overall Study|Other reason (not specified)|2|||
130646904|NCT00877929|470327292|FG001|Overall Study|Other reason (not specified)|6|||
130646905|NCT00689728|470327293|FG000|Double-Blind Treatment|Adverse Event|1|||
130646906|NCT00689728|470327294|FG001|Double-Blind Treatment|Adverse Event|0|||
130646907|NCT00689728|470327295|FG002|Double-Blind Treatment|Adverse Event|0|||
130646908|NCT00689728|470327293|FG000|Double-Blind Treatment|Protocol Violation|0|||
130646909|NCT00689728|470327294|FG001|Double-Blind Treatment|Protocol Violation|0|||
130646910|NCT00689728|470327295|FG002|Double-Blind Treatment|Protocol Violation|1|||
130646911|NCT00689728|470327293|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
130646912|NCT00689728|470327294|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
130646913|NCT00689728|470327295|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
130646914|NCT00689728|470327293|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
130646915|NCT00689728|470327294|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
130646916|NCT00689728|470327295|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
130646917|NCT00689728|470327293|FG000|Rescue|Adverse Event|0|||
130646918|NCT00689728|470327294|FG001|Rescue|Adverse Event|1|||
130646919|NCT00689728|470327295|FG002|Rescue|Adverse Event|0|||
130646920|NCT00689728|470327293|FG000|Rescue|Withdrawal by Subject|1|||
130646921|NCT00689728|470327294|FG001|Rescue|Withdrawal by Subject|1|||
130646922|NCT00689728|470327295|FG002|Rescue|Withdrawal by Subject|1|||
130646923|NCT00689728|470327293|FG000|Optional Follow-Up|Adverse Event|1|||
130646924|NCT00689728|470327294|FG001|Optional Follow-Up|Adverse Event|0|||
130646925|NCT00689728|470327295|FG002|Optional Follow-Up|Adverse Event|0|||
130646926|NCT00689728|470327293|FG000|Optional Follow-Up|Lack of Efficacy|0|||
130646927|NCT00689728|470327294|FG001|Optional Follow-Up|Lack of Efficacy|1|||
130646928|NCT00689728|470327295|FG002|Optional Follow-Up|Lack of Efficacy|1|||
130646929|NCT00689728|470327293|FG000|Optional Follow-Up|Lost to Follow-up|0|||
130646930|NCT00689728|470327294|FG001|Optional Follow-Up|Lost to Follow-up|1|||
130646931|NCT00689728|470327295|FG002|Optional Follow-Up|Lost to Follow-up|1|||
130646932|NCT00689728|470327293|FG000|Optional Follow-Up|Protocol Violation|0|||
130646933|NCT00689728|470327294|FG001|Optional Follow-Up|Protocol Violation|0|||
130646934|NCT00689728|470327295|FG002|Optional Follow-Up|Protocol Violation|1|||
130646935|NCT00689728|470327293|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
130646936|NCT00689728|470327294|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
130646937|NCT00689728|470327295|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
130646938|NCT03590613|470327297|FG000|Period 2, 4 Days|Physician Decision|0|||
130646939|NCT03590613|470327298|FG001|Period 2, 4 Days|Physician Decision|0|||
130646940|NCT03590613|470327299|FG002|Period 2, 4 Days|Physician Decision|0|||
130646941|NCT03590613|470327300|FG003|Period 2, 4 Days|Physician Decision|1|||
130646942|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Death|2|||
130646943|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Death|0|||
130646944|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Adverse Event|33|||
130646945|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Adverse Event|31|||
130646946|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
130646947|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
130646948|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
130646949|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
130646950|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
130646951|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
130646952|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Other|7|||
130646953|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Other|8|||
130646954|NCT00280059|470327301|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
130646955|NCT00280059|470327302|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
130646956|NCT04369742|470327303|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
130646957|NCT04369742|470327304|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
130646958|NCT04369742|470327303|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
130646959|NCT04369742|470327304|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
130646960|NCT01130831|470327309|FG000|Overall Study|Withdrawal by Subject|7|||
130646961|NCT01130831|470327309|FG000|Overall Study|Death|4|||
130646962|NCT01130831|470327309|FG000|Overall Study|Information was missing|3|||
130646963|NCT00951912|470327310|FG000|Overall Study|Lack of Efficacy|1|||
130646964|NCT00951912|470327311|FG001|Overall Study|Lack of Efficacy|0|||
130646965|NCT00951912|470327312|FG002|Overall Study|Lack of Efficacy|0|||
130646966|NCT00951912|470327310|FG000|Overall Study|Adverse Event|0|||
130646967|NCT00951912|470327311|FG001|Overall Study|Adverse Event|1|||
130646968|NCT00951912|470327312|FG002|Overall Study|Adverse Event|1|||
130646969|NCT00951912|470327310|FG000|Overall Study|Lost to Follow-up|2|||
130646970|NCT00951912|470327311|FG001|Overall Study|Lost to Follow-up|2|||
130646971|NCT00951912|470327312|FG002|Overall Study|Lost to Follow-up|0|||
130646972|NCT00951912|470327310|FG000|Overall Study|Physician Decision|1|||
130646973|NCT00951912|470327311|FG001|Overall Study|Physician Decision|0|||
130646974|NCT00951912|470327312|FG002|Overall Study|Physician Decision|1|||
130646975|NCT00951912|470327310|FG000|Overall Study|Withdrawal by Subject|1|||
130646976|NCT00951912|470327311|FG001|Overall Study|Withdrawal by Subject|1|||
130646977|NCT00951912|470327312|FG002|Overall Study|Withdrawal by Subject|0|||
130646978|NCT00951912|470327310|FG000|Overall Study|Other:Depression|1|||
130646979|NCT00951912|470327311|FG001|Overall Study|Other:Depression|0|||
130646980|NCT00951912|470327312|FG002|Overall Study|Other:Depression|0|||
130646981|NCT00951912|470327310|FG000|Overall Study|Other: Colon cancer|1|||
130646982|NCT00951912|470327311|FG001|Overall Study|Other: Colon cancer|0|||
130646983|NCT00951912|470327312|FG002|Overall Study|Other: Colon cancer|0|||
130646984|NCT00951912|470327310|FG000|Overall Study|Other: Stroke|0|||
130646985|NCT00951912|470327311|FG001|Overall Study|Other: Stroke|1|||
130646986|NCT00951912|470327312|FG002|Overall Study|Other: Stroke|0|||
130646987|NCT03417999|470327313|FG000|Overall Study|Withdrawal by Subject|1|||
130646988|NCT03417999|470327314|FG001|Overall Study|Withdrawal by Subject|0|||
130646989|NCT03417999|470327315|FG002|Overall Study|Withdrawal by Subject|0|||
130646990|NCT03417999|470327313|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
130646991|NCT03417999|470327314|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
130646992|NCT03417999|470327315|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
130646993|NCT03417999|470327313|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
130646994|NCT03417999|470327314|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
130646995|NCT03417999|470327315|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
130646996|NCT03417999|470327313|FG000|Overall Study|Inadequate study staff available to process samples|0|||
130646997|NCT03417999|470327314|FG001|Overall Study|Inadequate study staff available to process samples|0|||
130646998|NCT03417999|470327315|FG002|Overall Study|Inadequate study staff available to process samples|1|||
130646999|NCT00422942|470327321|FG000|Overall Study|Study terminated by Sponsor|3|||
130647000|NCT02612194|470327322|FG000|Overall Study|Death|5|||
130647001|NCT02612194|470327323|FG001|Overall Study|Death|0|||
130647002|NCT02612194|470327324|FG002|Overall Study|Death|2|||
130647003|NCT02612194|470327322|FG000|Overall Study|Early Study Termination|1|||
130647004|NCT02612194|470327323|FG001|Overall Study|Early Study Termination|0|||
130647005|NCT02612194|470327324|FG002|Overall Study|Early Study Termination|0|||
130647006|NCT02539160|470327327|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
130647007|NCT02539160|470327328|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
130647008|NCT02539160|470327329|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
130647009|NCT02539160|470327330|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
130647010|NCT02539160|470327327|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
130647011|NCT02539160|470327328|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
130647012|NCT02539160|470327329|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
130647013|NCT02539160|470327330|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
130647014|NCT02539160|470327327|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
130647015|NCT02539160|470327328|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
130647016|NCT02539160|470327329|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
130647017|NCT02539160|470327330|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
130647018|NCT01681004|470327331|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
130647019|NCT01681004|470327332|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
130647020|NCT01681004|470327331|FG000|Study Completion|Lost to Follow-up|8|||
130647021|NCT01681004|470327332|FG001|Study Completion|Lost to Follow-up|3|||
130647022|NCT01681004|470327331|FG000|Study Completion|Physician Decision|1|||
130647023|NCT01681004|470327332|FG001|Study Completion|Physician Decision|3|||
130647024|NCT01681004|470327331|FG000|Study Completion|Site Termination|2|||
130647025|NCT01681004|470327332|FG001|Study Completion|Site Termination|1|||
130647026|NCT01681004|470327331|FG000|Study Completion|Death|1|||
130647027|NCT01681004|470327332|FG001|Study Completion|Death|1|||
130647028|NCT02828982|470327333|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130647029|NCT02828982|470327334|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130647030|NCT00372905|470327335|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
130647031|NCT00372905|470327336|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130647032|NCT00372905|470327337|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130647033|NCT00372905|470327338|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130647034|NCT00372905|470327335|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130647035|NCT00372905|470327336|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130647036|NCT00372905|470327337|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
130647037|NCT00372905|470327338|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130647038|NCT00372905|470327335|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130647039|NCT00372905|470327336|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130647040|NCT00372905|470327337|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
130647041|NCT00372905|470327338|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130647042|NCT00372905|470327335|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130647043|NCT00372905|470327336|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130647044|NCT00372905|470327337|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130647045|NCT00372905|470327338|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
130647046|NCT00372905|470327335|FG000|Follow up Until Relapse or Progression|Study closed|0|||
130647047|NCT00372905|470327336|FG001|Follow up Until Relapse or Progression|Study closed|0|||
130647048|NCT00372905|470327337|FG002|Follow up Until Relapse or Progression|Study closed|0|||
130647049|NCT00372905|470327338|FG003|Follow up Until Relapse or Progression|Study closed|3|||
130647050|NCT00372905|470327335|FG000|Follow up Until Relapse or Progression|Other|0|||
130647051|NCT00372905|470327336|FG001|Follow up Until Relapse or Progression|Other|1|||
130647052|NCT00372905|470327337|FG002|Follow up Until Relapse or Progression|Other|0|||
130647053|NCT00372905|470327338|FG003|Follow up Until Relapse or Progression|Other|0|||
130647054|NCT02312934|470327339|FG000|Overall Study|Lost to Follow-up|1|||
130647055|NCT02312934|470327340|FG001|Overall Study|Lost to Follow-up|0|||
130647056|NCT02312934|470327339|FG000|Overall Study|Physician Decision|1|||
130647057|NCT02312934|470327340|FG001|Overall Study|Physician Decision|0|||
130647058|NCT00701064|470327342|FG000|Overall Study|Protocol Violation|1|||
130647059|NCT00701064|470327343|FG001|Overall Study|Protocol Violation|1|||
130647060|NCT00701064|470327342|FG000|Overall Study|Withdrawal by Subject|1|||
130647061|NCT00701064|470327343|FG001|Overall Study|Withdrawal by Subject|1|||
130647062|NCT00701064|470327342|FG000|Overall Study|initiated other PTSD treatment|2|||
130647063|NCT00701064|470327343|FG001|Overall Study|initiated other PTSD treatment|2|||
130647064|NCT00689299|470327344|FG000|Overall Study|Adverse Event|2|||
130647065|NCT00689299|470327345|FG001|Overall Study|Adverse Event|1|||
130647066|NCT00689299|470327346|FG002|Overall Study|Adverse Event|1|||
130647067|NCT00689299|470327344|FG000|Overall Study|Lost to Follow-up|0|||
130647068|NCT00689299|470327345|FG001|Overall Study|Lost to Follow-up|1|||
130647069|NCT00689299|470327346|FG002|Overall Study|Lost to Follow-up|1|||
130647070|NCT00689299|470327344|FG000|Overall Study|Withdrawal by Subject|4|||
130647071|NCT00689299|470327345|FG001|Overall Study|Withdrawal by Subject|1|||
130647072|NCT00689299|470327346|FG002|Overall Study|Withdrawal by Subject|3|||
130647073|NCT00689299|470327344|FG000|Overall Study|Protocol Violation|1|||
130647074|NCT00689299|470327345|FG001|Overall Study|Protocol Violation|0|||
130647075|NCT00689299|470327346|FG002|Overall Study|Protocol Violation|0|||
130647076|NCT02613910|470327349|FG000|Overall Study|Termination of study|1|||
130647077|NCT00695318|470327350|FG000|Overall Study|Lost to Follow-up|1|||
130647078|NCT00695318|470327351|FG001|Overall Study|Lost to Follow-up|0|||
130647079|NCT00695318|470327350|FG000|Overall Study|Withdrawal by Subject|2|||
130647080|NCT00695318|470327351|FG001|Overall Study|Withdrawal by Subject|0|||
130647081|NCT00695318|470327350|FG000|Overall Study|Death|1|||
130647082|NCT00695318|470327351|FG001|Overall Study|Death|1|||
130647083|NCT00695318|470327350|FG000|Overall Study|Study Terminated|1|||
130647084|NCT00695318|470327351|FG001|Overall Study|Study Terminated|0|||
130647085|NCT02098733|470327352|FG000|Overall Study|Data Not Available|5|||
130647086|NCT02098733|470327352|FG000|Overall Study|Lost to Follow-up|5|||
130647087|NCT03395704|470327353|FG000|Overall Study|Adverse Event|2|||
130647088|NCT03395704|470327354|FG001|Overall Study|Adverse Event|1|||
130647089|NCT03395704|470327353|FG000|Overall Study|Withdrawal by Subject|2|||
130647090|NCT03395704|470327354|FG001|Overall Study|Withdrawal by Subject|1|||
130647091|NCT03395704|470327353|FG000|Overall Study|Physician Decision|0|||
130647092|NCT03395704|470327354|FG001|Overall Study|Physician Decision|1|||
130647093|NCT00434876|470327357|FG000|Overall Study|Lost to Follow-up|1|||
130647094|NCT00434876|470327358|FG001|Overall Study|Lost to Follow-up|1|||
130647095|NCT00758394|470327359|FG000|2nd Intervention Order|Lost to Follow-up|0|||
130647096|NCT00758394|470327360|FG001|2nd Intervention Order|Lost to Follow-up|1|||
130647097|NCT00758394|470327361|FG002|2nd Intervention Order|Lost to Follow-up|0|||
130647098|NCT00758394|470327362|FG003|2nd Intervention Order|Lost to Follow-up|0|||
130647099|NCT00758394|470327359|FG000|3rd Intervention|Lost to Follow-up|1|||
130647100|NCT00758394|470327360|FG001|3rd Intervention|Lost to Follow-up|0|||
130647101|NCT00758394|470327361|FG002|3rd Intervention|Lost to Follow-up|0|||
130647102|NCT00758394|470327362|FG003|3rd Intervention|Lost to Follow-up|1|||
130647103|NCT03044730|470327373|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
130647104|NCT03044730|470327373|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
130647105|NCT03044730|470327373|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
130647106|NCT03044730|470327373|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
130647107|NCT03044730|470327373|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
130647108|NCT03044730|470327373|FG000|Cycles 4 and Beyond|Adverse Event|1|||
130647109|NCT03044730|470327373|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
130647110|NCT03044730|470327373|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
130647111|NCT03044730|470327373|FG000|On Follow-up for 2 Years|Death|17|||
130647112|NCT04823494|470329252|FG000|Overall Study|Programming software malfunction.|1|||
130647113|NCT04823494|470329253|FG001|Overall Study|Programming software malfunction.|0|||
130647114|NCT04823494|470329252|FG000|Overall Study|Withdrawal by Subject|1|||
130647115|NCT04823494|470329253|FG001|Overall Study|Withdrawal by Subject|0|||
130647116|NCT04823494|470329252|FG000|Overall Study|Devices lost|0|||
130647117|NCT04823494|470329253|FG001|Overall Study|Devices lost|1|||
130647118|NCT03726320|470329254|FG000|Overall Study|Lost to Follow-up|2|||
130647119|NCT03726320|470329255|FG001|Overall Study|Lost to Follow-up|4|||
130647120|NCT03726320|470329256|FG002|Overall Study|Lost to Follow-up|0|||
130647121|NCT03726320|470329254|FG000|Overall Study|Time Constraints|4|||
130647122|NCT03726320|470329255|FG001|Overall Study|Time Constraints|1|||
130647123|NCT03726320|470329256|FG002|Overall Study|Time Constraints|0|||
130647124|NCT03726320|470329254|FG000|Overall Study|Ineligible after enrollment|3|||
130647125|NCT03726320|470329255|FG001|Overall Study|Ineligible after enrollment|3|||
130647126|NCT03726320|470329256|FG002|Overall Study|Ineligible after enrollment|0|||
130647127|NCT03726320|470329254|FG000|Overall Study|Clinic / insurance issue|2|||
130647128|NCT03726320|470329255|FG001|Overall Study|Clinic / insurance issue|0|||
130647129|NCT03726320|470329256|FG002|Overall Study|Clinic / insurance issue|0|||
130647130|NCT03726320|470329254|FG000|Overall Study|Language barrier|1|||
130647131|NCT03726320|470329255|FG001|Overall Study|Language barrier|0|||
130647132|NCT03726320|470329256|FG002|Overall Study|Language barrier|0|||
130647133|NCT03726320|470329254|FG000|Overall Study|Provider left the clinic|0|||
130647134|NCT03726320|470329255|FG001|Overall Study|Provider left the clinic|0|||
130647135|NCT03726320|470329256|FG002|Overall Study|Provider left the clinic|1|||
130647136|NCT03922945|470329257|FG000|Overall Study|Adverse Event|1|||
130647137|NCT03922945|470329258|FG001|Overall Study|Adverse Event|1|||
130647138|NCT03922945|470329259|FG002|Overall Study|Adverse Event|2|||
130647139|NCT03922945|470329257|FG000|Overall Study|Lost to Follow-up|13|||
130647140|NCT03922945|470329258|FG001|Overall Study|Lost to Follow-up|9|||
130647141|NCT03922945|470329259|FG002|Overall Study|Lost to Follow-up|20|||
130647142|NCT03922945|470329257|FG000|Overall Study|Lack of Efficacy|2|||
130647143|NCT03922945|470329258|FG001|Overall Study|Lack of Efficacy|0|||
130647144|NCT03922945|470329259|FG002|Overall Study|Lack of Efficacy|1|||
130647145|NCT03922945|470329257|FG000|Overall Study|Protocol Non-Compliance|0|||
130647146|NCT03922945|470329258|FG001|Overall Study|Protocol Non-Compliance|0|||
130647147|NCT03922945|470329259|FG002|Overall Study|Protocol Non-Compliance|1|||
130647148|NCT03922945|470329257|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
130647149|NCT03922945|470329258|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
130647150|NCT03922945|470329259|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
130647151|NCT03922945|470329257|FG000|Overall Study|All Other Personal Reasons|1|||
130647152|NCT03922945|470329258|FG001|Overall Study|All Other Personal Reasons|1|||
130647153|NCT03922945|470329259|FG002|Overall Study|All Other Personal Reasons|2|||
130647154|NCT00039377|470329260|FG000|Initial Registration|Adverse Event|2|||
130647155|NCT00039377|470329261|FG001|Initial Registration|Adverse Event|0|||
130647156|NCT00039377|470329262|FG002|Initial Registration|Adverse Event|0|||
130647157|NCT00039377|470329263|FG003|Initial Registration|Adverse Event|0|||
130647158|NCT00039377|470329260|FG000|Initial Registration|Relapsed|6|||
130647159|NCT00039377|470329261|FG001|Initial Registration|Relapsed|0|||
130647160|NCT00039377|470329262|FG002|Initial Registration|Relapsed|0|||
130647161|NCT00039377|470329263|FG003|Initial Registration|Relapsed|0|||
130647162|NCT00039377|470329260|FG000|Initial Registration|Received non-protocol therapy|11|||
130647163|NCT00039377|470329261|FG001|Initial Registration|Received non-protocol therapy|0|||
130647164|NCT00039377|470329262|FG002|Initial Registration|Received non-protocol therapy|0|||
130647165|NCT00039377|470329263|FG003|Initial Registration|Received non-protocol therapy|0|||
130647166|NCT00039377|470329260|FG000|Initial Registration|Withdrawal by Subject|3|||
130647167|NCT00039377|470329261|FG001|Initial Registration|Withdrawal by Subject|0|||
130647168|NCT00039377|470329262|FG002|Initial Registration|Withdrawal by Subject|0|||
130647169|NCT00039377|470329263|FG003|Initial Registration|Withdrawal by Subject|0|||
130647170|NCT02493712|470329267|FG000|Overall Study|Withdrawal by Subject|1|||
130647171|NCT02493712|470329268|FG001|Overall Study|Withdrawal by Subject|0|||
130647172|NCT02493712|470329269|FG002|Overall Study|Withdrawal by Subject|2|||
130647173|NCT02493712|470329267|FG000|Overall Study|Protocol Violation|0|||
130647174|NCT02493712|470329268|FG001|Overall Study|Protocol Violation|0|||
130647175|NCT02493712|470329269|FG002|Overall Study|Protocol Violation|1|||
130647176|NCT02493712|470329267|FG000|Overall Study|Lost to Follow-up|1|||
130647177|NCT02493712|470329268|FG001|Overall Study|Lost to Follow-up|0|||
130647178|NCT02493712|470329269|FG002|Overall Study|Lost to Follow-up|0|||
130647179|NCT02493712|470329267|FG000|Overall Study|Physician Decision|0|||
130647180|NCT02493712|470329268|FG001|Overall Study|Physician Decision|1|||
130647181|NCT02493712|470329269|FG002|Overall Study|Physician Decision|0|||
130647182|NCT02493712|470329267|FG000|Overall Study|Lack of Efficacy|0|||
130647183|NCT02493712|470329268|FG001|Overall Study|Lack of Efficacy|5|||
130647184|NCT02493712|470329269|FG002|Overall Study|Lack of Efficacy|3|||
130647185|NCT00682539|470329270|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
130647186|NCT00682539|470329271|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
130647187|NCT00682539|470329272|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
130647188|NCT00682539|470329270|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
130647189|NCT00682539|470329271|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
130647190|NCT00682539|470329272|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
130647191|NCT01729559|470329279|FG000|Overall Study|Protocol Violation|31|||
130647192|NCT01729559|470329280|FG001|Overall Study|Protocol Violation|28|||
130647193|NCT03764813|470329281|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
130647194|NCT03764813|470329282|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
130647195|NCT03764813|470329283|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
130647196|NCT03764813|470329284|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
130647197|NCT01707667|470329285|FG000|Period 1|expulsion of colonic sensor catheter|1|||
130647198|NCT01707667|470329286|FG001|Period 1|expulsion of colonic sensor catheter|0|||
130647199|NCT03432819|470329290|FG000|Overall Study|Lost to Follow-up|2|||
130647200|NCT03432819|470329291|FG001|Overall Study|Lost to Follow-up|2|||
130647201|NCT03432819|470329290|FG000|Overall Study|Withdrawal by Subject|5|||
130647202|NCT03432819|470329291|FG001|Overall Study|Withdrawal by Subject|3|||
130647203|NCT04738123|470329297|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
130647204|NCT04738123|470329298|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
130647205|NCT04738123|470329297|FG000|Overall Study|Progressive Disease|0|||
130647206|NCT04738123|470329298|FG001|Overall Study|Progressive Disease|4|||
130647207|NCT04738123|470329297|FG000|Overall Study|Adverse Event|8|||
130647208|NCT04738123|470329298|FG001|Overall Study|Adverse Event|7|||
130647209|NCT04738123|470329297|FG000|Overall Study|Other Reasons|0|||
130647210|NCT04738123|470329298|FG001|Overall Study|Other Reasons|1|||
130647211|NCT04738123|470329297|FG000|Overall Study|Suicidal or assaultive behavior|0|||
130647212|NCT04738123|470329298|FG001|Overall Study|Suicidal or assaultive behavior|2|||
130647213|NCT04738123|470329297|FG000|Overall Study|Protocol Violation|2|||
130647214|NCT04738123|470329298|FG001|Overall Study|Protocol Violation|2|||
130647215|NCT04738123|470329297|FG000|Overall Study|Consent Withdrawn|35|||
130647216|NCT04738123|470329298|FG001|Overall Study|Consent Withdrawn|22|||
130647217|NCT03137433|470329300|FG000|Overall Study|Withdrawal by Subject|11|||
130647218|NCT03137433|470329301|FG001|Overall Study|Withdrawal by Subject|11|||
130647219|NCT03137433|470329300|FG000|Overall Study|Lost to Follow-up|5|||
130647220|NCT03137433|470329301|FG001|Overall Study|Lost to Follow-up|6|||
130647221|NCT03137433|470329300|FG000|Overall Study|Physician Decision|2|||
130647222|NCT03137433|470329301|FG001|Overall Study|Physician Decision|0|||
130647223|NCT03137433|470329300|FG000|Overall Study|Moved out of study area|1|||
130647224|NCT03137433|470329301|FG001|Overall Study|Moved out of study area|0|||
130647225|NCT03137433|470329300|FG000|Overall Study|Too far out of window due to COVID|0|||
130647226|NCT03137433|470329301|FG001|Overall Study|Too far out of window due to COVID|1|||
130647227|NCT00083616|470329302|FG000|Overall Study|Disease Progression|16|||
130647228|NCT00083616|470329302|FG000|Overall Study|Lost to Follow-up|1|||
130647229|NCT00083616|470329302|FG000|Overall Study|Physician Decision|2|||
130647230|NCT00083616|470329302|FG000|Overall Study|Withdrawal by Subject|3|||
130647231|NCT00083616|470329302|FG000|Overall Study|Ineligibility determined|2|||
130647232|NCT00083616|470329302|FG000|Overall Study|Non-compliance|1|||
130647233|NCT00083616|470329302|FG000|Overall Study|Other|6|||
130647234|NCT03258710|470329304|FG000|Overall Study|Adverse Event|1|||
130647235|NCT03258710|470329304|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130647236|NCT03258710|470329304|FG000|Overall Study|Physician Decision|1|||
130647237|NCT02242305|470329305|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
130647238|NCT02242305|470329306|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
130647239|NCT02242305|470329305|FG000|Overall Study|Adverse Event|1|||
130647240|NCT02242305|470329306|FG001|Overall Study|Adverse Event|0|||
130647241|NCT02242305|470329305|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
130647242|NCT02242305|470329306|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
130647243|NCT02242305|470329305|FG000|Overall Study|Subject withdraws inform consent|0|||
130647244|NCT02242305|470329306|FG001|Overall Study|Subject withdraws inform consent|4|||
130647245|NCT02242305|470329305|FG000|Overall Study|Lost to Follow-up|2|||
130647246|NCT02242305|470329306|FG001|Overall Study|Lost to Follow-up|0|||
130647247|NCT03451630|470329307|FG000|Overall Study|Death|15|||
130647248|NCT03451630|470329308|FG001|Overall Study|Death|16|||
130647249|NCT03451630|470329309|FG002|Overall Study|Death|11|||
130647250|NCT03451630|470329307|FG000|Overall Study|Lost to Follow-up|9|||
130647251|NCT03451630|470329308|FG001|Overall Study|Lost to Follow-up|0|||
130647252|NCT03451630|470329309|FG002|Overall Study|Lost to Follow-up|4|||
130647253|NCT03451630|470329307|FG000|Overall Study|Withdrawal by Subject|0|||
130647254|NCT03451630|470329308|FG001|Overall Study|Withdrawal by Subject|3|||
130647255|NCT03451630|470329309|FG002|Overall Study|Withdrawal by Subject|0|||
130647256|NCT03451630|470329307|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
130647257|NCT03451630|470329308|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
130647258|NCT03451630|470329309|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
130647259|NCT01724021|470329310|FG000|Overall Study|Adverse Event|11|||
130647260|NCT01724021|470329311|FG001|Overall Study|Adverse Event|6|||
130647261|NCT01724021|470329310|FG000|Overall Study|Death|46|||
130647262|NCT01724021|470329311|FG001|Overall Study|Death|58|||
130647263|NCT01724021|470329310|FG000|Overall Study|Participant request/ Withdrew consent|18|||
130647264|NCT01724021|470329311|FG001|Overall Study|Participant request/ Withdrew consent|14|||
130647265|NCT01724021|470329310|FG000|Overall Study|Lost to Follow-up|15|||
130647266|NCT01724021|470329311|FG001|Overall Study|Lost to Follow-up|15|||
130647267|NCT01724021|470329310|FG000|Overall Study|Reason Not Specified|36|||
130647268|NCT01724021|470329311|FG001|Overall Study|Reason Not Specified|39|||
130647269|NCT01724021|470329310|FG000|Overall Study|Missing|1|||
130647270|NCT01724021|470329311|FG001|Overall Study|Missing|1|||
130647271|NCT02041533|470329315|FG000|Pre-Treatment Period|Disease Progression|1|||
130647272|NCT02041533|470329316|FG001|Pre-Treatment Period|Disease Progression|1|||
130647273|NCT02041533|470329315|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
130647274|NCT02041533|470329316|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
130647275|NCT02041533|470329315|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
130647276|NCT02041533|470329316|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
130647277|NCT02041533|470329315|FG000|Treatment Period|Disease progression|189|||
130647278|NCT02041533|470329316|FG001|Treatment Period|Disease progression|146|||
130647279|NCT02041533|470329315|FG000|Treatment Period|Study drug toxicity|30|||
130647280|NCT02041533|470329316|FG001|Treatment Period|Study drug toxicity|34|||
130647281|NCT02041533|470329315|FG000|Treatment Period|Death|1|||
130647282|NCT02041533|470329316|FG001|Treatment Period|Death|0|||
130647283|NCT02041533|470329315|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
130647284|NCT02041533|470329316|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
130647285|NCT02041533|470329315|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
130647286|NCT02041533|470329316|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
130647287|NCT02041533|470329315|FG000|Treatment Period|Participant withdrew consent|2|||
130647288|NCT02041533|470329316|FG001|Treatment Period|Participant withdrew consent|2|||
130647289|NCT02041533|470329315|FG000|Treatment Period|Maximum clinical benefit|0|||
130647290|NCT02041533|470329316|FG001|Treatment Period|Maximum clinical benefit|18|||
130647291|NCT02041533|470329315|FG000|Treatment Period|Poor/Non-compliance|1|||
130647292|NCT02041533|470329316|FG001|Treatment Period|Poor/Non-compliance|0|||
130647293|NCT02041533|470329315|FG000|Treatment Period|Administrative reason by sponsor|1|||
130647294|NCT02041533|470329316|FG001|Treatment Period|Administrative reason by sponsor|0|||
130647295|NCT02041533|470329315|FG000|Treatment Period|Other reasons|9|||
130647296|NCT02041533|470329316|FG001|Treatment Period|Other reasons|2|||
130647297|NCT02041533|470329315|FG000|Treatment Period|Not Reported|0|||
130647298|NCT02041533|470329316|FG001|Treatment Period|Not Reported|1|||
130647299|NCT00565721|470329317|FG000|Overall Study|Screen Failure|2|||
130647300|NCT00565721|470329317|FG000|Overall Study|Lost to Follow-up|6|||
130647301|NCT00565721|470329317|FG000|Overall Study|Technical Problems|1|||
130647302|NCT00565721|470329317|FG000|Overall Study|Physician Decision|2|||
130647303|NCT00565721|470329317|FG000|Overall Study|Other reasons|6|||
130647304|NCT02500706|470329318|FG000|Overall Study|Adverse Event|0|||
130647305|NCT02500706|470329319|FG001|Overall Study|Adverse Event|0|||
130647306|NCT02500706|470329320|FG002|Overall Study|Adverse Event|1|||
130647307|NCT02500706|470329318|FG000|Overall Study|Lost to Follow-up|0|||
130647308|NCT02500706|470329319|FG001|Overall Study|Lost to Follow-up|1|||
130647309|NCT02500706|470329320|FG002|Overall Study|Lost to Follow-up|1|||
130647310|NCT02500706|470329318|FG000|Overall Study|Withdrawal by Subject|4|||
130647311|NCT02500706|470329319|FG001|Overall Study|Withdrawal by Subject|6|||
130647312|NCT02500706|470329320|FG002|Overall Study|Withdrawal by Subject|4|||
130647313|NCT02500706|470329318|FG000|Overall Study|Unclassified|0|||
130647314|NCT02500706|470329319|FG001|Overall Study|Unclassified|0|||
130647315|NCT02500706|470329320|FG002|Overall Study|Unclassified|1|||
130647316|NCT01497899|470329321|FG000|Double-Blind Phase|Randomized but not Treated|1|||
130647317|NCT01497899|470329322|FG001|Double-Blind Phase|Randomized but not Treated|0|||
130647318|NCT01497899|470329323|FG002|Double-Blind Phase|Randomized but not Treated|0|||
130647319|NCT01497899|470329324|FG003|Double-Blind Phase|Randomized but not Treated|0|||
130647320|NCT01497899|470329321|FG000|Double-Blind Phase|Adverse Event|1|||
130647321|NCT01497899|470329322|FG001|Double-Blind Phase|Adverse Event|0|||
130647322|NCT01497899|470329323|FG002|Double-Blind Phase|Adverse Event|0|||
130647323|NCT01497899|470329324|FG003|Double-Blind Phase|Adverse Event|0|||
130647324|NCT01497899|470329321|FG000|Double-Blind Phase|Lack of Efficacy|0|||
130647325|NCT01497899|470329322|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130647326|NCT01497899|470329323|FG002|Double-Blind Phase|Lack of Efficacy|0|||
130647327|NCT01497899|470329324|FG003|Double-Blind Phase|Lack of Efficacy|0|||
130647328|NCT01497899|470329321|FG000|Double-Blind Phase|Investigator's Discretion|1|||
130647329|NCT01497899|470329322|FG001|Double-Blind Phase|Investigator's Discretion|0|||
130647330|NCT01497899|470329323|FG002|Double-Blind Phase|Investigator's Discretion|0|||
130647331|NCT01497899|470329324|FG003|Double-Blind Phase|Investigator's Discretion|0|||
130647332|NCT01497899|470329321|FG000|Double-Blind Phase|Withdrew Consent|0|||
130647333|NCT01497899|470329322|FG001|Double-Blind Phase|Withdrew Consent|1|||
130647334|NCT01497899|470329323|FG002|Double-Blind Phase|Withdrew Consent|0|||
130647335|NCT01497899|470329324|FG003|Double-Blind Phase|Withdrew Consent|0|||
130647336|NCT01497899|470329321|FG000|Double-Blind Phase|Lost to Follow-up|3|||
130647337|NCT01497899|470329322|FG001|Double-Blind Phase|Lost to Follow-up|2|||
130647338|NCT01497899|470329323|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130647339|NCT01497899|470329324|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130647340|NCT01497899|470329321|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
130647341|NCT01497899|470329322|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
130647342|NCT01497899|470329323|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
130647343|NCT01497899|470329324|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
130647344|NCT01497899|470329321|FG000|Open-Label Extension Phase|Adverse Event|1|||
130647345|NCT01497899|470329322|FG001|Open-Label Extension Phase|Adverse Event|0|||
130647346|NCT01497899|470329323|FG002|Open-Label Extension Phase|Adverse Event|0|||
130647347|NCT01497899|470329324|FG003|Open-Label Extension Phase|Adverse Event|0|||
130647348|NCT01497899|470329321|FG000|Open-Label Extension Phase|Death|1|||
130647349|NCT01497899|470329322|FG001|Open-Label Extension Phase|Death|0|||
130647350|NCT01497899|470329323|FG002|Open-Label Extension Phase|Death|0|||
130647351|NCT01497899|470329324|FG003|Open-Label Extension Phase|Death|0|||
130647352|NCT01497899|470329321|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
130647353|NCT01497899|470329322|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
130647354|NCT01497899|470329323|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
130647355|NCT01497899|470329324|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
130647356|NCT01497899|470329321|FG000|Open-Label Extension Phase|Pregnancy|0|||
130647357|NCT01497899|470329322|FG001|Open-Label Extension Phase|Pregnancy|1|||
130647358|NCT01497899|470329323|FG002|Open-Label Extension Phase|Pregnancy|1|||
130647359|NCT01497899|470329324|FG003|Open-Label Extension Phase|Pregnancy|0|||
130647360|NCT01497899|470329321|FG000|Open-Label Extension Phase|Protocol Violation|0|||
130647361|NCT01497899|470329322|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130647362|NCT01497899|470329323|FG002|Open-Label Extension Phase|Protocol Violation|1|||
130647363|NCT01497899|470329324|FG003|Open-Label Extension Phase|Protocol Violation|0|||
130647364|NCT01497899|470329321|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
130647365|NCT01497899|470329322|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
130647366|NCT01497899|470329323|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
130647367|NCT01497899|470329324|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
130647368|NCT00286234|470329328|FG000|Overall Study|Protocol Violation|1|||
130647369|NCT00286234|470329329|FG001|Overall Study|Protocol Violation|2|||
130647370|NCT00286234|470329330|FG002|Overall Study|Protocol Violation|0|||
130647371|NCT00286234|470329331|FG003|Overall Study|Protocol Violation|1|||
130647372|NCT00286234|470329328|FG000|Overall Study|Physician Decision|1|||
130647373|NCT00286234|470329329|FG001|Overall Study|Physician Decision|0|||
130647374|NCT00286234|470329330|FG002|Overall Study|Physician Decision|0|||
130647375|NCT00286234|470329331|FG003|Overall Study|Physician Decision|1|||
130647376|NCT00286234|470329328|FG000|Overall Study|Adverse Event|0|||
130647377|NCT00286234|470329329|FG001|Overall Study|Adverse Event|0|||
130647378|NCT00286234|470329330|FG002|Overall Study|Adverse Event|0|||
130647379|NCT00286234|470329331|FG003|Overall Study|Adverse Event|1|||
130647380|NCT00286234|470329328|FG000|Overall Study|Adverse Event|0|||
130647381|NCT00286234|470329329|FG001|Overall Study|Adverse Event|0|||
130647382|NCT00286234|470329330|FG002|Overall Study|Adverse Event|0|||
130647383|NCT00286234|470329331|FG003|Overall Study|Adverse Event|1|||
130647384|NCT01874288|470329334|FG000|Overall Study|Withdrawal by Subject|1|||
130647385|NCT01874288|470329335|FG001|Overall Study|Withdrawal by Subject|0|||
130647386|NCT01874288|470329336|FG002|Overall Study|Withdrawal by Subject|2|||
130647387|NCT01874288|470329337|FG003|Overall Study|Withdrawal by Subject|1|||
130647388|NCT01874288|470329338|FG004|Overall Study|Withdrawal by Subject|1|||
130647389|NCT01874288|470329334|FG000|Overall Study|Physician Decision|0|||
130647390|NCT01874288|470329335|FG001|Overall Study|Physician Decision|0|||
130647391|NCT01874288|470329336|FG002|Overall Study|Physician Decision|0|||
130647392|NCT01874288|470329337|FG003|Overall Study|Physician Decision|1|||
130647393|NCT01874288|470329338|FG004|Overall Study|Physician Decision|0|||
130647394|NCT01874288|470329334|FG000|Overall Study|Progressive disease|2|||
130647395|NCT01874288|470329335|FG001|Overall Study|Progressive disease|0|||
130647396|NCT01874288|470329336|FG002|Overall Study|Progressive disease|3|||
130647397|NCT01874288|470329337|FG003|Overall Study|Progressive disease|5|||
130647398|NCT01874288|470329338|FG004|Overall Study|Progressive disease|1|||
130647399|NCT03524664|470329339|FG000|Overall Study|Withdrawal by Subject|1|||
130647400|NCT03524664|470329340|FG001|Overall Study|Withdrawal by Subject|2|||
130647401|NCT03524664|470329339|FG000|Overall Study|Lost to Follow-up|4|||
130647402|NCT03524664|470329340|FG001|Overall Study|Lost to Follow-up|13|||
130647403|NCT00591786|470329345|FG000|Overall Study|Withdrawal of Informed Consent|0|||
130647404|NCT00591786|470329346|FG001|Overall Study|Withdrawal of Informed Consent|0|||
130647405|NCT00591786|470329347|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130647406|NCT00591786|470329348|FG003|Overall Study|Withdrawal of Informed Consent|0|||
130647407|NCT00591786|470329349|FG004|Overall Study|Withdrawal of Informed Consent|0|||
130647408|NCT00591786|470329350|FG005|Overall Study|Withdrawal of Informed Consent|0|||
130647409|NCT00591786|470329351|FG006|Overall Study|Withdrawal of Informed Consent|0|||
130647410|NCT00591786|470329352|FG007|Overall Study|Withdrawal of Informed Consent|0|||
130647411|NCT00591786|470329353|FG008|Overall Study|Withdrawal of Informed Consent|0|||
130647412|NCT00591786|470329354|FG009|Overall Study|Withdrawal of Informed Consent|0|||
130647413|NCT01920061|470329355|FG000|Overall Study|Death|1|||
130647414|NCT01920061|470329356|FG001|Overall Study|Death|1|||
130647415|NCT01920061|470329357|FG002|Overall Study|Death|0|||
130647416|NCT01920061|470329358|FG003|Overall Study|Death|1|||
130647417|NCT01920061|470329359|FG004|Overall Study|Death|1|||
130647418|NCT01920061|470329360|FG005|Overall Study|Death|0|||
130647419|NCT01920061|470329361|FG006|Overall Study|Death|0|||
130647420|NCT01920061|470329362|FG007|Overall Study|Death|1|||
130647421|NCT01920061|470329363|FG008|Overall Study|Death|0|||
130647422|NCT01920061|470329364|FG009|Overall Study|Death|1|||
130647423|NCT01920061|470329365|FG010|Overall Study|Death|0|||
130647424|NCT01920061|470329366|FG011|Overall Study|Death|1|||
130647425|NCT01920061|470329367|FG012|Overall Study|Death|0|||
130647426|NCT01920061|470329368|FG013|Overall Study|Death|2|||
130647427|NCT01920061|470329369|FG014|Overall Study|Death|0|||
130647428|NCT01920061|470329370|FG015|Overall Study|Death|0|||
130647429|NCT01920061|470329371|FG016|Overall Study|Death|0|||
130647430|NCT01920061|470329372|FG017|Overall Study|Death|0|||
130647431|NCT01920061|470329373|FG018|Overall Study|Death|1|||
130647432|NCT01920061|470329374|FG019|Overall Study|Death|0|||
130647433|NCT01920061|470329355|FG000|Overall Study|Lost to Follow-up|0|||
130647434|NCT01920061|470329356|FG001|Overall Study|Lost to Follow-up|2|||
130647435|NCT01920061|470329357|FG002|Overall Study|Lost to Follow-up|0|||
130647436|NCT01920061|470329358|FG003|Overall Study|Lost to Follow-up|0|||
130647437|NCT01920061|470329359|FG004|Overall Study|Lost to Follow-up|0|||
130647438|NCT01920061|470329360|FG005|Overall Study|Lost to Follow-up|0|||
130647439|NCT01920061|470329361|FG006|Overall Study|Lost to Follow-up|1|||
130647440|NCT01920061|470329362|FG007|Overall Study|Lost to Follow-up|0|||
130647441|NCT01920061|470329363|FG008|Overall Study|Lost to Follow-up|0|||
130647442|NCT01920061|470329364|FG009|Overall Study|Lost to Follow-up|0|||
130647443|NCT01920061|470329365|FG010|Overall Study|Lost to Follow-up|3|||
130647444|NCT01920061|470329366|FG011|Overall Study|Lost to Follow-up|0|||
130647445|NCT01920061|470329367|FG012|Overall Study|Lost to Follow-up|0|||
130647446|NCT01920061|470329368|FG013|Overall Study|Lost to Follow-up|0|||
130647447|NCT01920061|470329369|FG014|Overall Study|Lost to Follow-up|0|||
130647448|NCT01920061|470329370|FG015|Overall Study|Lost to Follow-up|0|||
130647449|NCT01920061|470329371|FG016|Overall Study|Lost to Follow-up|0|||
130647450|NCT01920061|470329372|FG017|Overall Study|Lost to Follow-up|1|||
130647451|NCT01920061|470329373|FG018|Overall Study|Lost to Follow-up|4|||
130647452|NCT01920061|470329374|FG019|Overall Study|Lost to Follow-up|3|||
130647453|NCT01920061|470329355|FG000|Overall Study|Other|1|||
130647454|NCT01920061|470329356|FG001|Overall Study|Other|1|||
130647455|NCT01920061|470329357|FG002|Overall Study|Other|2|||
130647456|NCT01920061|470329358|FG003|Overall Study|Other|1|||
130647457|NCT01920061|470329359|FG004|Overall Study|Other|0|||
130647458|NCT01920061|470329360|FG005|Overall Study|Other|1|||
130647459|NCT01920061|470329361|FG006|Overall Study|Other|0|||
130647460|NCT01920061|470329362|FG007|Overall Study|Other|0|||
130647461|NCT01920061|470329363|FG008|Overall Study|Other|0|||
130647462|NCT01920061|470329364|FG009|Overall Study|Other|1|||
130647463|NCT01920061|470329365|FG010|Overall Study|Other|1|||
130647464|NCT01920061|470329366|FG011|Overall Study|Other|2|||
130647465|NCT01920061|470329367|FG012|Overall Study|Other|1|||
130647466|NCT01920061|470329368|FG013|Overall Study|Other|4|||
130647467|NCT01920061|470329369|FG014|Overall Study|Other|0|||
130647468|NCT01920061|470329370|FG015|Overall Study|Other|1|||
130647469|NCT01920061|470329371|FG016|Overall Study|Other|1|||
130647470|NCT01920061|470329372|FG017|Overall Study|Other|0|||
130647471|NCT01920061|470329373|FG018|Overall Study|Other|1|||
130647472|NCT01920061|470329374|FG019|Overall Study|Other|1|||
130647473|NCT01920061|470329355|FG000|Overall Study|Participant refused further follow-up|0|||
130647474|NCT01920061|470329356|FG001|Overall Study|Participant refused further follow-up|0|||
130647475|NCT01920061|470329357|FG002|Overall Study|Participant refused further follow-up|0|||
130647476|NCT01920061|470329358|FG003|Overall Study|Participant refused further follow-up|0|||
130647477|NCT01920061|470329359|FG004|Overall Study|Participant refused further follow-up|1|||
130647478|NCT01920061|470329360|FG005|Overall Study|Participant refused further follow-up|1|||
130647479|NCT01920061|470329361|FG006|Overall Study|Participant refused further follow-up|0|||
130647480|NCT01920061|470329362|FG007|Overall Study|Participant refused further follow-up|0|||
130647481|NCT01920061|470329363|FG008|Overall Study|Participant refused further follow-up|1|||
130647482|NCT01920061|470329364|FG009|Overall Study|Participant refused further follow-up|0|||
130647483|NCT01920061|470329365|FG010|Overall Study|Participant refused further follow-up|1|||
130647484|NCT01920061|470329366|FG011|Overall Study|Participant refused further follow-up|0|||
130647485|NCT01920061|470329367|FG012|Overall Study|Participant refused further follow-up|1|||
130647486|NCT01920061|470329368|FG013|Overall Study|Participant refused further follow-up|0|||
130647487|NCT01920061|470329369|FG014|Overall Study|Participant refused further follow-up|1|||
130647488|NCT01920061|470329370|FG015|Overall Study|Participant refused further follow-up|2|||
130647489|NCT01920061|470329371|FG016|Overall Study|Participant refused further follow-up|1|||
130647490|NCT01920061|470329372|FG017|Overall Study|Participant refused further follow-up|1|||
130647491|NCT01920061|470329373|FG018|Overall Study|Participant refused further follow-up|0|||
130647492|NCT01920061|470329374|FG019|Overall Study|Participant refused further follow-up|0|||
130647493|NCT00554229|470329375|FG000|Overall Study|Lost to Follow-up|3|||
130647494|NCT00554229|470329376|FG001|Overall Study|Lost to Follow-up|6|||
130647495|NCT00554229|470329375|FG000|Overall Study|Withdrawal by Subject|29|||
130647496|NCT00554229|470329376|FG001|Overall Study|Withdrawal by Subject|37|||
130647497|NCT00554229|470329375|FG000|Overall Study|Adverse Event|71|||
130647498|NCT00554229|470329376|FG001|Overall Study|Adverse Event|39|||
130647499|NCT00554229|470329375|FG000|Overall Study|Protocol Violation|3|||
130647500|NCT00554229|470329376|FG001|Overall Study|Protocol Violation|3|||
130647501|NCT00554229|470329375|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
130647502|NCT00554229|470329376|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
130647503|NCT00554229|470329375|FG000|Overall Study|Randomised but no treatment received|1|||
130647504|NCT00554229|470329376|FG001|Overall Study|Randomised but no treatment received|0|||
130647505|NCT01140646|470329377|FG000|Overall Study|Adverse Event|4|||
130647506|NCT01140646|470329377|FG000|Overall Study|Refused Further Treatment|5|||
130647507|NCT00842829|470329383|FG000|Dose Titration Period|Adverse Event|11|||
130647508|NCT00842829|470329384|FG001|Dose Titration Period|Adverse Event|10|||
130647509|NCT00842829|470329385|FG002|Dose Titration Period|Adverse Event|0|||
130647510|NCT00842829|470329383|FG000|Dose Titration Period|Lack of Efficacy|4|||
130647511|NCT00842829|470329384|FG001|Dose Titration Period|Lack of Efficacy|1|||
130647512|NCT00842829|470329385|FG002|Dose Titration Period|Lack of Efficacy|0|||
130647513|NCT00842829|470329383|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
130647514|NCT00842829|470329384|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
130647515|NCT00842829|470329385|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
130647516|NCT00842829|470329383|FG000|Dose Titration Period|Withdrawal by Subject|2|||
130647517|NCT00842829|470329384|FG001|Dose Titration Period|Withdrawal by Subject|6|||
130647518|NCT00842829|470329385|FG002|Dose Titration Period|Withdrawal by Subject|0|||
130647519|NCT00842829|470329383|FG000|Dose Titration Period|Other|5|||
130647520|NCT00842829|470329384|FG001|Dose Titration Period|Other|4|||
130647521|NCT00842829|470329385|FG002|Dose Titration Period|Other|0|||
130647522|NCT00842829|470329383|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
130647523|NCT00842829|470329384|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
130647524|NCT00842829|470329385|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
130647525|NCT00842829|470329383|FG000|Dose Titration Period|Non-compliance to study drug|2|||
130647526|NCT00842829|470329384|FG001|Dose Titration Period|Non-compliance to study drug|1|||
130647527|NCT00842829|470329385|FG002|Dose Titration Period|Non-compliance to study drug|0|||
130647528|NCT00842829|470329383|FG000|Treatment Period|Adverse Event|0|||
130647529|NCT00842829|470329384|FG001|Treatment Period|Adverse Event|0|||
130647530|NCT00842829|470329385|FG002|Treatment Period|Adverse Event|15|||
130647531|NCT00842829|470329383|FG000|Treatment Period|Lack of Efficacy|0|||
130647532|NCT00842829|470329384|FG001|Treatment Period|Lack of Efficacy|0|||
130647533|NCT00842829|470329385|FG002|Treatment Period|Lack of Efficacy|6|||
130647534|NCT00842829|470329383|FG000|Treatment Period|Unstable persistent cancer pain|0|||
130647535|NCT00842829|470329384|FG001|Treatment Period|Unstable persistent cancer pain|0|||
130647536|NCT00842829|470329385|FG002|Treatment Period|Unstable persistent cancer pain|5|||
130647537|NCT00842829|470329383|FG000|Treatment Period|Withdrawal by Subject|0|||
130647538|NCT00842829|470329384|FG001|Treatment Period|Withdrawal by Subject|0|||
130647539|NCT00842829|470329385|FG002|Treatment Period|Withdrawal by Subject|11|||
130647540|NCT00842829|470329383|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
130647541|NCT00842829|470329384|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
130647542|NCT00842829|470329385|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
130647543|NCT00842829|470329383|FG000|Treatment Period|Protocol Violation|0|||
130647544|NCT00842829|470329384|FG001|Treatment Period|Protocol Violation|0|||
130647545|NCT00842829|470329385|FG002|Treatment Period|Protocol Violation|2|||
130647546|NCT00842829|470329383|FG000|Treatment Period|Other|0|||
130647547|NCT00842829|470329384|FG001|Treatment Period|Other|0|||
130647548|NCT00842829|470329385|FG002|Treatment Period|Other|18|||
130647549|NCT00842829|470329383|FG000|Treatment Period|Non-compliance to study procedures|0|||
130647550|NCT00842829|470329384|FG001|Treatment Period|Non-compliance to study procedures|0|||
130647551|NCT00842829|470329385|FG002|Treatment Period|Non-compliance to study procedures|4|||
130647552|NCT00842829|470329383|FG000|Treatment Period|Unclear completion status|0|||
130647553|NCT00842829|470329384|FG001|Treatment Period|Unclear completion status|0|||
130647554|NCT00842829|470329385|FG002|Treatment Period|Unclear completion status|1|||
130647555|NCT00842829|470329383|FG000|Continuation Period|Adverse Event|0|||
130647556|NCT00842829|470329384|FG001|Continuation Period|Adverse Event|0|||
130647557|NCT00842829|470329385|FG002|Continuation Period|Adverse Event|32|||
130647558|NCT00842829|470329383|FG000|Continuation Period|Lack of Efficacy|0|||
130647559|NCT00842829|470329384|FG001|Continuation Period|Lack of Efficacy|0|||
130647560|NCT00842829|470329385|FG002|Continuation Period|Lack of Efficacy|6|||
130647561|NCT00842829|470329383|FG000|Continuation Period|Unstable persistent cancer pain|0|||
130647562|NCT00842829|470329384|FG001|Continuation Period|Unstable persistent cancer pain|0|||
130647563|NCT00842829|470329385|FG002|Continuation Period|Unstable persistent cancer pain|3|||
130647564|NCT00842829|470329383|FG000|Continuation Period|Withdrawal by Subject|0|||
130647565|NCT00842829|470329384|FG001|Continuation Period|Withdrawal by Subject|0|||
130647566|NCT00842829|470329385|FG002|Continuation Period|Withdrawal by Subject|10|||
130647567|NCT00842829|470329383|FG000|Continuation Period|Other|0|||
130647568|NCT00842829|470329384|FG001|Continuation Period|Other|0|||
130647569|NCT00842829|470329385|FG002|Continuation Period|Other|7|||
130647570|NCT00842829|470329383|FG000|Continuation Period|Non-compliance to study procedures|0|||
130647571|NCT00842829|470329384|FG001|Continuation Period|Non-compliance to study procedures|0|||
130647572|NCT00842829|470329385|FG002|Continuation Period|Non-compliance to study procedures|2|||
130647573|NCT00842829|470329383|FG000|Continuation Period|Non-compliance to study drug|0|||
130647574|NCT00842829|470329384|FG001|Continuation Period|Non-compliance to study drug|0|||
130647575|NCT00842829|470329385|FG002|Continuation Period|Non-compliance to study drug|1|||
130647576|NCT00784836|470329388|FG000|Overall Study|Early Study Termination|3|||
130647577|NCT00660829|470329389|FG000|Overall Study|Adverse Event|3|||
130647578|NCT00660829|470329390|FG001|Overall Study|Adverse Event|4|||
130647579|NCT00660829|470329389|FG000|Overall Study|Lack of Efficacy|2|||
130647580|NCT00660829|470329390|FG001|Overall Study|Lack of Efficacy|3|||
130647581|NCT00660829|470329389|FG000|Overall Study|Non-Compliance|0|||
130647582|NCT00660829|470329390|FG001|Overall Study|Non-Compliance|4|||
130647583|NCT00660829|470329389|FG000|Overall Study|Withdrawal by Subject|1|||
130647584|NCT00660829|470329390|FG001|Overall Study|Withdrawal by Subject|2|||
130647585|NCT00660829|470329389|FG000|Overall Study|Lost to Follow-up|3|||
130647586|NCT00660829|470329390|FG001|Overall Study|Lost to Follow-up|2|||
130647587|NCT00660829|470329389|FG000|Overall Study|Other|9|||
130647588|NCT00660829|470329390|FG001|Overall Study|Other|4|||
130647589|NCT02127931|470329391|FG000|Overall Study|Glitch in Game|1|||
130647590|NCT00690612|470330982|FG000|Overall Study|Adverse Event|1|||
130647591|NCT00690612|470330982|FG000|Overall Study|Withdrawal by Subject|2|||
130647592|NCT01233076|470330983|FG000|Period 2, One Week|Lost to Follow-up|1|||
130647593|NCT01233076|470330984|FG001|Period 2, One Week|Lost to Follow-up|0|||
130647594|NCT01786707|470330986|FG000|Overall Study|Lost to Follow-up|1|||
130647595|NCT01786707|470330987|FG001|Overall Study|Lost to Follow-up|1|||
130647596|NCT02058940|470330988|FG000|Overall Study|Discharged from Critical Care Unit|1|||
130647597|NCT01519700|470330989|FG000|Overall Study|Death|1|||
130647598|NCT01519700|470330990|FG001|Overall Study|Death|0|||
130647599|NCT01519700|470330991|FG002|Overall Study|Death|0|||
130647600|NCT01519700|470330992|FG003|Overall Study|Death|0|||
130647601|NCT01519700|470330989|FG000|Overall Study|Lost to Follow-up|0|||
130647602|NCT01519700|470330990|FG001|Overall Study|Lost to Follow-up|0|||
130647603|NCT01519700|470330991|FG002|Overall Study|Lost to Follow-up|1|||
130647604|NCT01519700|470330992|FG003|Overall Study|Lost to Follow-up|1|||
130647605|NCT01519700|470330989|FG000|Overall Study|Physician Decision|1|||
130647606|NCT01519700|470330990|FG001|Overall Study|Physician Decision|1|||
130647607|NCT01519700|470330991|FG002|Overall Study|Physician Decision|3|||
130647608|NCT01519700|470330992|FG003|Overall Study|Physician Decision|0|||
130647609|NCT01519700|470330989|FG000|Overall Study|Withdrawal by Subject|5|||
130647610|NCT01519700|470330990|FG001|Overall Study|Withdrawal by Subject|3|||
130647611|NCT01519700|470330991|FG002|Overall Study|Withdrawal by Subject|3|||
130647612|NCT01519700|470330992|FG003|Overall Study|Withdrawal by Subject|2|||
130647613|NCT01519700|470330989|FG000|Overall Study|Other Reason|2|||
130647614|NCT01519700|470330990|FG001|Overall Study|Other Reason|2|||
130647615|NCT01519700|470330991|FG002|Overall Study|Other Reason|0|||
130647616|NCT01519700|470330992|FG003|Overall Study|Other Reason|4|||
130647617|NCT04120116|470330993|FG000|Overall Study|Lost to Follow-up|0|||
130647618|NCT04120116|470330994|FG001|Overall Study|Lost to Follow-up|1|||
130647619|NCT04120116|470330995|FG002|Overall Study|Lost to Follow-up|0|||
130647620|NCT04120116|470330996|FG003|Overall Study|Lost to Follow-up|2|||
130647621|NCT04120116|470330993|FG000|Overall Study|Withdrawal by Subject|1|||
130647622|NCT04120116|470330994|FG001|Overall Study|Withdrawal by Subject|0|||
130647623|NCT04120116|470330995|FG002|Overall Study|Withdrawal by Subject|1|||
130647624|NCT04120116|470330996|FG003|Overall Study|Withdrawal by Subject|1|||
130647625|NCT04120116|470330993|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130647626|NCT04120116|470330994|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130647627|NCT04120116|470330995|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
130647628|NCT04120116|470330996|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130647629|NCT05637515|470330997|FG000|Overall Study|Withdrawal by Subject|17|||
130647630|NCT05637515|470330998|FG001|Overall Study|Withdrawal by Subject|17|||
130647631|NCT02079077|470331000|FG000|Overall Study|Lost to Follow-up|5|||
130647632|NCT02079077|470331001|FG001|Overall Study|Lost to Follow-up|7|||
130647633|NCT02079077|470331000|FG000|Overall Study|Became STIs Positive|1|||
130647634|NCT02079077|470331001|FG001|Overall Study|Became STIs Positive|2|||
130647635|NCT00772031|470331002|FG000|Overall Study|Early termination of trial|12|||
130647636|NCT00772031|470331003|FG001|Overall Study|Early termination of trial|10|||
130647637|NCT00772031|470331002|FG000|Overall Study|Lost to Follow-up|20|||
130647638|NCT00772031|470331003|FG001|Overall Study|Lost to Follow-up|33|||
130647639|NCT00656136|470331004|FG000|Overall Study|Progressive disease|177|||
130647640|NCT00656136|470331005|FG001|Overall Study|Progressive disease|322|||
130647641|NCT00656136|470331004|FG000|Overall Study|Other Adverse Event|5|||
130647642|NCT00656136|470331005|FG001|Overall Study|Other Adverse Event|51|||
130647643|NCT00656136|470331004|FG000|Overall Study|Protocol Violation|2|||
130647644|NCT00656136|470331005|FG001|Overall Study|Protocol Violation|3|||
130647645|NCT00656136|470331004|FG000|Overall Study|Patient refused to take study medication|7|||
130647646|NCT00656136|470331005|FG001|Overall Study|Patient refused to take study medication|10|||
130647647|NCT00656136|470331004|FG000|Overall Study|Unknown and others|4|||
130647648|NCT00656136|470331005|FG001|Overall Study|Unknown and others|4|||
130647649|NCT02087085|470331006|FG000|Overall Study|Adverse Event|10|||
130647650|NCT02087085|470331007|FG001|Overall Study|Adverse Event|14|||
130647651|NCT02087085|470331006|FG000|Overall Study|Lack of Efficacy|4|||
130647652|NCT02087085|470331007|FG001|Overall Study|Lack of Efficacy|3|||
130647653|NCT02087085|470331006|FG000|Overall Study|Lost to Follow-up|6|||
130647654|NCT02087085|470331007|FG001|Overall Study|Lost to Follow-up|4|||
130647655|NCT02087085|470331006|FG000|Overall Study|Withdrawal by Subject|9|||
130647656|NCT02087085|470331007|FG001|Overall Study|Withdrawal by Subject|11|||
130647657|NCT02087085|470331006|FG000|Overall Study|Protocol Violation|1|||
130647658|NCT02087085|470331007|FG001|Overall Study|Protocol Violation|0|||
130647659|NCT02087085|470331006|FG000|Overall Study|Study Terminated by Sponsor|87|||
130647660|NCT02087085|470331007|FG001|Overall Study|Study Terminated by Sponsor|80|||
130647661|NCT02087085|470331006|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130647662|NCT02087085|470331007|FG001|Overall Study|Other Miscellaneous Reasons|4|||
130647663|NCT00635804|470331008|FG000|Overall Study|Adverse Event|0|||
130647664|NCT00635804|470331009|FG001|Overall Study|Adverse Event|0|||
130647665|NCT00635804|470331010|FG002|Overall Study|Adverse Event|0|||
130647666|NCT00635804|470331011|FG003|Overall Study|Adverse Event|0|||
130647667|NCT00635804|470331012|FG004|Overall Study|Adverse Event|0|||
130647668|NCT00635804|470331013|FG005|Overall Study|Adverse Event|1|||
130647669|NCT00635804|470331014|FG006|Overall Study|Adverse Event|0|||
130647670|NCT00635804|470331015|FG007|Overall Study|Adverse Event|0|||
130647671|NCT00635804|470331008|FG000|Overall Study|Withdrawal by Subject|1|||
130647672|NCT00635804|470331009|FG001|Overall Study|Withdrawal by Subject|0|||
130647673|NCT00635804|470331010|FG002|Overall Study|Withdrawal by Subject|0|||
130647674|NCT00635804|470331011|FG003|Overall Study|Withdrawal by Subject|0|||
130647675|NCT00635804|470331012|FG004|Overall Study|Withdrawal by Subject|0|||
130647676|NCT00635804|470331013|FG005|Overall Study|Withdrawal by Subject|0|||
130647677|NCT00635804|470331014|FG006|Overall Study|Withdrawal by Subject|0|||
130647678|NCT00635804|470331015|FG007|Overall Study|Withdrawal by Subject|0|||
130647679|NCT02718131|470331022|FG000|Overall Study|Withdrawal by Subject|1|||
130647680|NCT02718131|470331023|FG001|Overall Study|Withdrawal by Subject|0|||
130647681|NCT02718131|470331022|FG000|Overall Study|Adverse Event|1|||
130647682|NCT02718131|470331023|FG001|Overall Study|Adverse Event|0|||
130647683|NCT02718131|470331022|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
130647684|NCT02718131|470331023|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
130647685|NCT03382639|470331025|FG000|Overall Study|Adverse Event|2|||
130647686|NCT03382639|470331026|FG001|Overall Study|Adverse Event|0|||
130647687|NCT03382639|470331027|FG002|Overall Study|Adverse Event|1|||
130647688|NCT03382639|470331028|FG003|Overall Study|Adverse Event|1|||
130647689|NCT03382639|470331025|FG000|Overall Study|Lost to Follow-up|1|||
130647690|NCT03382639|470331026|FG001|Overall Study|Lost to Follow-up|0|||
130647691|NCT03382639|470331027|FG002|Overall Study|Lost to Follow-up|0|||
130647692|NCT03382639|470331028|FG003|Overall Study|Lost to Follow-up|0|||
130647693|NCT03382639|470331025|FG000|Overall Study|Withdrawal by Subject|4|||
130647694|NCT03382639|470331026|FG001|Overall Study|Withdrawal by Subject|3|||
130647695|NCT03382639|470331027|FG002|Overall Study|Withdrawal by Subject|2|||
130647696|NCT03382639|470331028|FG003|Overall Study|Withdrawal by Subject|3|||
130647697|NCT03382639|470331025|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
130647698|NCT03382639|470331026|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
130647699|NCT03382639|470331027|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
130647700|NCT03382639|470331028|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
130647701|NCT03382639|470331025|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
130647702|NCT03382639|470331026|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
130647703|NCT03382639|470331027|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
130647704|NCT03382639|470331028|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
130647705|NCT03382639|470331025|FG000|Overall Study|Other|2|||
130647706|NCT03382639|470331026|FG001|Overall Study|Other|0|||
130647707|NCT03382639|470331027|FG002|Overall Study|Other|0|||
130647708|NCT03382639|470331028|FG003|Overall Study|Other|3|||
130647709|NCT02406586|470331029|FG000|Overall Study|Lost to Follow-up|0|||
130647710|NCT02406586|470331030|FG001|Overall Study|Lost to Follow-up|4|||
130647711|NCT02406586|470331031|FG002|Overall Study|Lost to Follow-up|2|||
130647712|NCT02406586|470331029|FG000|Overall Study|Withdrawal by Subject|1|||
130647713|NCT02406586|470331030|FG001|Overall Study|Withdrawal by Subject|0|||
130647714|NCT02406586|470331031|FG002|Overall Study|Withdrawal by Subject|0|||
130647715|NCT02477215|470331034|FG000|Dose Escalation Phase|Physician Decision|1|||
130647716|NCT02477215|470331035|FG001|Dose Escalation Phase|Physician Decision|2|||
130647717|NCT02477215|470331036|FG002|Dose Escalation Phase|Physician Decision|0|||
130647718|NCT02477215|470331034|FG000|Fixed Dose Phase|Physician Decision|0|||
130647719|NCT02477215|470331035|FG001|Fixed Dose Phase|Physician Decision|7|||
130647720|NCT02477215|470331036|FG002|Fixed Dose Phase|Physician Decision|0|||
130647721|NCT01911546|470331039|FG000|Overall Study|Lost to Follow-up|1|||
130647722|NCT01911546|470331039|FG000|Overall Study|Everolimus was discontinued|5|||
130647723|NCT01474291|470331040|FG000|Overall Study|Not Evaluable for Efficacy|26|||
130647724|NCT01474291|470331040|FG000|Overall Study|Lack of Treatment Efficacy|88|||
130647725|NCT01474291|470331040|FG000|Overall Study|Adverse Event|53|||
130647726|NCT01474291|470331040|FG000|Overall Study|Lost to Follow-up|29|||
130647727|NCT01474291|470331040|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
130647728|NCT01474291|470331040|FG000|Overall Study|No Reason Reported|10|||
130647729|NCT01474291|470331040|FG000|Overall Study|Death|2|||
130647730|NCT03339999|470331041|FG000|Overall Study|Adverse Event|1|||
130647731|NCT03339999|470331042|FG001|Overall Study|Adverse Event|2|||
130647732|NCT03339999|470331043|FG002|Overall Study|Adverse Event|2|||
130647733|NCT03339999|470331044|FG003|Overall Study|Adverse Event|1|||
130647734|NCT03339999|470331041|FG000|Overall Study|Lack of Efficacy|0|||
130647735|NCT03339999|470331042|FG001|Overall Study|Lack of Efficacy|1|||
130647736|NCT03339999|470331043|FG002|Overall Study|Lack of Efficacy|0|||
130647737|NCT03339999|470331044|FG003|Overall Study|Lack of Efficacy|0|||
130647738|NCT03339999|470331041|FG000|Overall Study|Lost to Follow-up|0|||
130647739|NCT03339999|470331042|FG001|Overall Study|Lost to Follow-up|0|||
130647740|NCT03339999|470331043|FG002|Overall Study|Lost to Follow-up|0|||
130647741|NCT03339999|470331044|FG003|Overall Study|Lost to Follow-up|1|||
130647742|NCT03339999|470331041|FG000|Overall Study|Study Terminated by Sponsor|6|||
130647743|NCT03339999|470331042|FG001|Overall Study|Study Terminated by Sponsor|3|||
130647744|NCT03339999|470331043|FG002|Overall Study|Study Terminated by Sponsor|4|||
130647745|NCT03339999|470331044|FG003|Overall Study|Study Terminated by Sponsor|3|||
130647746|NCT03380091|470331049|FG000|Overall Study|Withdrawal by Subject|2|||
130647747|NCT03380091|470331050|FG001|Overall Study|Withdrawal by Subject|1|||
130647748|NCT05602818|470331051|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
130647749|NCT05602818|470331052|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
130647750|NCT05602818|470331053|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
130647751|NCT05602818|470331054|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
130647752|NCT05602818|470331055|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
130647753|NCT05602818|470331056|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
130647754|NCT05602818|470331057|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
130647755|NCT05602818|470331058|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
130647756|NCT05602818|470331059|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
130647757|NCT05602818|470331060|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
130647758|NCT05602818|470331061|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
130647759|NCT05602818|470331062|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
130647760|NCT05602818|470331051|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
130647761|NCT05602818|470331052|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
130647762|NCT05602818|470331053|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647763|NCT05602818|470331054|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647764|NCT05602818|470331055|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647765|NCT05602818|470331056|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647766|NCT05602818|470331057|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647767|NCT05602818|470331058|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647768|NCT05602818|470331059|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647769|NCT05602818|470331060|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647770|NCT05602818|470331061|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647771|NCT05602818|470331062|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130647772|NCT05602818|470331051|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
130647773|NCT05602818|470331052|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647774|NCT05602818|470331053|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647775|NCT05602818|470331054|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647776|NCT05602818|470331055|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647777|NCT05602818|470331056|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647778|NCT05602818|470331057|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647779|NCT05602818|470331058|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647780|NCT05602818|470331059|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647781|NCT05602818|470331060|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647782|NCT05602818|470331061|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647783|NCT05602818|470331062|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130647784|NCT05602818|470331051|FG000|Qualification Phase (3 Days)|Other|1|||
130647785|NCT05602818|470331052|FG001|Qualification Phase (3 Days)|Other|0|||
130647786|NCT05602818|470331053|FG002|Qualification Phase (3 Days)|Other|0|||
130647787|NCT05602818|470331054|FG003|Qualification Phase (3 Days)|Other|0|||
130647788|NCT05602818|470331055|FG004|Qualification Phase (3 Days)|Other|0|||
130647789|NCT05602818|470331056|FG005|Qualification Phase (3 Days)|Other|0|||
130647790|NCT05602818|470331057|FG006|Qualification Phase (3 Days)|Other|0|||
130647791|NCT05602818|470331058|FG007|Qualification Phase (3 Days)|Other|0|||
130647792|NCT05602818|470331059|FG008|Qualification Phase (3 Days)|Other|0|||
130647793|NCT05602818|470331060|FG009|Qualification Phase (3 Days)|Other|0|||
130647794|NCT05602818|470331061|FG010|Qualification Phase (3 Days)|Other|0|||
130647795|NCT05602818|470331062|FG011|Qualification Phase (3 Days)|Other|0|||
130647796|NCT05602818|470331051|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647797|NCT05602818|470331052|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
130647798|NCT05602818|470331053|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647799|NCT05602818|470331054|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647800|NCT05602818|470331055|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647801|NCT05602818|470331056|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647802|NCT05602818|470331057|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647803|NCT05602818|470331058|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647804|NCT05602818|470331059|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647805|NCT05602818|470331060|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647806|NCT05602818|470331061|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647807|NCT05602818|470331062|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130647808|NCT05602818|470331051|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
130647809|NCT05602818|470331052|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
130647810|NCT05602818|470331053|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
130647811|NCT05602818|470331054|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
130647812|NCT05602818|470331055|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
130647813|NCT05602818|470331056|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
130647814|NCT05602818|470331057|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
130647815|NCT05602818|470331058|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
130647816|NCT05602818|470331059|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
130647817|NCT05602818|470331060|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
130647818|NCT05602818|470331061|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
130647819|NCT05602818|470331062|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
130647820|NCT05602818|470331051|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647821|NCT05602818|470331052|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647822|NCT05602818|470331053|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647823|NCT05602818|470331054|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647824|NCT05602818|470331055|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647825|NCT05602818|470331056|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647826|NCT05602818|470331057|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647827|NCT05602818|470331058|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647828|NCT05602818|470331059|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647829|NCT05602818|470331060|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130647830|NCT05602818|470331061|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
130647831|NCT05602818|470331062|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
130647832|NCT05602818|470331051|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
130647833|NCT05602818|470331052|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
130647834|NCT05602818|470331053|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
130647835|NCT05602818|470331054|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
130647836|NCT05602818|470331055|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
130647837|NCT05602818|470331056|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
130647838|NCT05602818|470331057|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
130647839|NCT05602818|470331058|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
130647840|NCT05602818|470331059|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
130647841|NCT05602818|470331060|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
130647842|NCT05602818|470331061|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
130647843|NCT05602818|470331062|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
130647844|NCT00679354|470331069|FG000|Overall Study|Death|3|||
130647845|NCT00679354|470331069|FG000|Overall Study|Lack of Efficacy|22|||
130647846|NCT00679354|470331069|FG000|Overall Study|Physician Decision|4|||
130647847|NCT00679354|470331069|FG000|Overall Study|Ineligible|1|||
130647848|NCT00535262|470331074|FG000|Overall Study|No funding|3|||
130647849|NCT02898662|470331075|FG000|Overall Study|Adverse Event|1|||
130647850|NCT02898662|470331076|FG001|Overall Study|Adverse Event|0|||
130647851|NCT02898662|470331075|FG000|Overall Study|Loss of asthma control|23|||
130647852|NCT02898662|470331076|FG001|Overall Study|Loss of asthma control|24|||
130647853|NCT02898662|470331075|FG000|Overall Study|Withdrawal by Subject|4|||
130647854|NCT02898662|470331076|FG001|Overall Study|Withdrawal by Subject|1|||
130647855|NCT02898662|470331075|FG000|Overall Study|Technical issue|0|||
130647856|NCT02898662|470331076|FG001|Overall Study|Technical issue|1|||
130647857|NCT02898662|470331075|FG000|Overall Study|Randomized in error|0|||
130647858|NCT02898662|470331076|FG001|Overall Study|Randomized in error|1|||
130647859|NCT02898662|470331075|FG000|Overall Study|Subject decision|1|||
130647860|NCT02898662|470331076|FG001|Overall Study|Subject decision|0|||
130647861|NCT02898662|470331075|FG000|Overall Study|Other|0|||
130647862|NCT02898662|470331076|FG001|Overall Study|Other|1|||
130647863|NCT03802331|470331077|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
130647864|NCT03802331|470331078|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
130647865|NCT00917553|470331079|FG000|Overall Study|Lost to Follow-up|2|||
130647866|NCT00917553|470331080|FG001|Overall Study|Lost to Follow-up|1|||
130647867|NCT01616173|470331081|FG000|Overall Study|Lost to Follow-up|0|||
130647868|NCT01616173|470331082|FG001|Overall Study|Lost to Follow-up|2|||
130647869|NCT01616173|470331083|FG002|Overall Study|Lost to Follow-up|0|||
130647870|NCT04382066|470331086|FG000|Overall Study|Adverse Event|1|||
130647871|NCT04382066|470331087|FG001|Overall Study|Adverse Event|0|||
130647872|NCT04382066|470331088|FG002|Overall Study|Adverse Event|0|||
130647873|NCT04382066|470331086|FG000|Overall Study|Death|1|||
130647874|NCT04382066|470331087|FG001|Overall Study|Death|0|||
130647875|NCT04382066|470331088|FG002|Overall Study|Death|1|||
130647876|NCT00504595|470331089|FG000|Overall Study|Lack of Efficacy|1|||
130647877|NCT00504595|470331090|FG001|Overall Study|Lack of Efficacy|0|||
130647878|NCT00504595|470331091|FG002|Overall Study|Lack of Efficacy|0|||
130647879|NCT00504595|470331092|FG003|Overall Study|Lack of Efficacy|0|||
130647880|NCT00504595|470331089|FG000|Overall Study|Other|0|||
130647881|NCT00504595|470331090|FG001|Overall Study|Other|0|||
130647882|NCT00504595|470331091|FG002|Overall Study|Other|2|||
130647883|NCT00504595|470331092|FG003|Overall Study|Other|0|||
130647884|NCT03326323|470331093|FG000|Overall Study|Unable to receive ANH protocol|3|||
130647885|NCT04225026|470331094|FG000|Overall Study|Withdrawal by Subject|4|||
130647886|NCT04225026|470331094|FG000|Overall Study|Adverse Event|1|||
130647887|NCT04225026|470331094|FG000|Overall Study|Other|1|||
130647888|NCT04225026|470331094|FG000|Overall Study|Death|11|||
130647889|NCT04225026|470331094|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
130647890|NCT00851721|470331095|FG000|Overall Study|planned surgery|1|||
130647891|NCT00851721|470331096|FG001|Overall Study|planned surgery|0|||
130647892|NCT00851721|470331095|FG000|Overall Study|Death|1|||
130647893|NCT00851721|470331096|FG001|Overall Study|Death|0|||
130647894|NCT00851721|470331095|FG000|Overall Study|Adverse Event|0|||
130647895|NCT00851721|470331096|FG001|Overall Study|Adverse Event|1|||
130647896|NCT03982069|470331099|FG000|Overall Study|Lost to Follow-up|5|||
130647897|NCT03982069|470331100|FG001|Overall Study|Lost to Follow-up|5|||
130647898|NCT03982069|470331101|FG002|Overall Study|Lost to Follow-up|3|||
130647899|NCT03982069|470331102|FG003|Overall Study|Lost to Follow-up|5|||
130647900|NCT03982069|470331099|FG000|Overall Study|Physician Decision|0|||
130647901|NCT03982069|470331100|FG001|Overall Study|Physician Decision|1|||
130647902|NCT03982069|470331101|FG002|Overall Study|Physician Decision|0|||
130647903|NCT03982069|470331102|FG003|Overall Study|Physician Decision|0|||
130647904|NCT03982069|470331099|FG000|Overall Study|Withdrawal by Subject|2|||
130647905|NCT03982069|470331100|FG001|Overall Study|Withdrawal by Subject|1|||
130647906|NCT03982069|470331101|FG002|Overall Study|Withdrawal by Subject|5|||
130647907|NCT03982069|470331102|FG003|Overall Study|Withdrawal by Subject|2|||
130647908|NCT03982069|470331099|FG000|Overall Study|Specimen loss|3|||
130647909|NCT03982069|470331100|FG001|Overall Study|Specimen loss|3|||
130647910|NCT03982069|470331101|FG002|Overall Study|Specimen loss|1|||
130647911|NCT03982069|470331102|FG003|Overall Study|Specimen loss|1|||
130647912|NCT01218477|470331103|FG000|Overall Study|Disease progression|2|||
130647913|NCT01218477|470331104|FG001|Overall Study|Disease progression|3|||
130647914|NCT01218477|470331105|FG002|Overall Study|Disease progression|6|||
130647915|NCT01218477|470331106|FG003|Overall Study|Disease progression|2|||
130647916|NCT01218477|470331103|FG000|Overall Study|Study drug toxicity|0|||
130647917|NCT01218477|470331104|FG001|Overall Study|Study drug toxicity|2|||
130647918|NCT01218477|470331105|FG002|Overall Study|Study drug toxicity|5|||
130647919|NCT01218477|470331106|FG003|Overall Study|Study drug toxicity|0|||
130647920|NCT01218477|470331103|FG000|Overall Study|No longer meets study criteria|1|||
130647921|NCT01218477|470331104|FG001|Overall Study|No longer meets study criteria|0|||
130647922|NCT01218477|470331105|FG002|Overall Study|No longer meets study criteria|0|||
130647923|NCT01218477|470331106|FG003|Overall Study|No longer meets study criteria|0|||
130647924|NCT01218477|470331103|FG000|Overall Study|Withdrawal by Subject|0|||
130647925|NCT01218477|470331104|FG001|Overall Study|Withdrawal by Subject|0|||
130647926|NCT01218477|470331105|FG002|Overall Study|Withdrawal by Subject|1|||
130647927|NCT01218477|470331106|FG003|Overall Study|Withdrawal by Subject|0|||
130647928|NCT01218477|470331103|FG000|Overall Study|Prepared for cell transplantation|0|||
130647929|NCT01218477|470331104|FG001|Overall Study|Prepared for cell transplantation|1|||
130647930|NCT01218477|470331105|FG002|Overall Study|Prepared for cell transplantation|1|||
130647931|NCT01218477|470331106|FG003|Overall Study|Prepared for cell transplantation|0|||
130647932|NCT01218477|470331103|FG000|Overall Study|Administrative reason by sponsor|0|||
130647933|NCT01218477|470331104|FG001|Overall Study|Administrative reason by sponsor|0|||
130647934|NCT01218477|470331105|FG002|Overall Study|Administrative reason by sponsor|1|||
130647935|NCT01218477|470331106|FG003|Overall Study|Administrative reason by sponsor|0|||
130647936|NCT01218477|470331103|FG000|Overall Study|Maximum clinical benefit|0|||
130647937|NCT01218477|470331104|FG001|Overall Study|Maximum clinical benefit|2|||
130647938|NCT01218477|470331105|FG002|Overall Study|Maximum clinical benefit|0|||
130647939|NCT01218477|470331106|FG003|Overall Study|Maximum clinical benefit|0|||
130647940|NCT00787527|470331107|FG000|Overall Study|Toxicity|3|||
130647941|NCT01474993|470331112|FG000|Overall Study|Lost to Follow-up|1|||
130647942|NCT01474993|470331113|FG001|Overall Study|Lost to Follow-up|2|||
130647943|NCT01474993|470331112|FG000|Overall Study|Adverse Event|0|||
130647944|NCT01474993|470331113|FG001|Overall Study|Adverse Event|1|||
130647945|NCT00760994|470331114|FG000|Overall Study|Lost to Follow-up|4|||
130647946|NCT00760994|470331115|FG001|Overall Study|Lost to Follow-up|4|||
130647947|NCT00760994|470331116|FG002|Overall Study|Lost to Follow-up|3|||
130647948|NCT01853397|470331117|FG000|Overall Study|Withdrawal by Subject|0|||
130647949|NCT01853397|470331118|FG001|Overall Study|Withdrawal by Subject|0|||
130647950|NCT01853397|470331119|FG002|Overall Study|Withdrawal by Subject|0|||
130647951|NCT01853397|470331120|FG003|Overall Study|Withdrawal by Subject|1|||
130647952|NCT01853397|470331117|FG000|Overall Study|Subject Noncompliance|0|||
130647953|NCT01853397|470331118|FG001|Overall Study|Subject Noncompliance|0|||
130647954|NCT01853397|470331119|FG002|Overall Study|Subject Noncompliance|0|||
130647955|NCT01853397|470331120|FG003|Overall Study|Subject Noncompliance|1|||
130647956|NCT02132312|470331121|FG000|Overall Study|Adverse Event|2|||
130647957|NCT02132312|470331122|FG001|Overall Study|Adverse Event|0|||
130647958|NCT02132312|470331121|FG000|Overall Study|Physician Decision|1|||
130647959|NCT02132312|470331122|FG001|Overall Study|Physician Decision|1|||
130647960|NCT02132312|470331121|FG000|Overall Study|Protocol Violation|0|||
130647961|NCT02132312|470331122|FG001|Overall Study|Protocol Violation|1|||
130647962|NCT02132312|470331121|FG000|Overall Study|Withdrawal by Subject|1|||
130647963|NCT02132312|470331122|FG001|Overall Study|Withdrawal by Subject|0|||
130647964|NCT02132312|470331121|FG000|Overall Study|Lost to Follow-up|2|||
130647965|NCT02132312|470331122|FG001|Overall Study|Lost to Follow-up|1|||
130647966|NCT00486720|470331123|FG000|Overall Study|Adverse Event|1|||
130647967|NCT00486720|470331124|FG001|Overall Study|Adverse Event|2|||
130647968|NCT00486720|470331123|FG000|Overall Study|Lack of Efficacy|4|||
130647969|NCT00486720|470331124|FG001|Overall Study|Lack of Efficacy|6|||
130647970|NCT00486720|470331123|FG000|Overall Study|Physician Decision|1|||
130647971|NCT00486720|470331124|FG001|Overall Study|Physician Decision|2|||
130647972|NCT00486720|470331123|FG000|Overall Study|Protocol Violation|1|||
130647973|NCT00486720|470331124|FG001|Overall Study|Protocol Violation|0|||
130647974|NCT00486720|470331123|FG000|Overall Study|Withdrawal by Subject|3|||
130647975|NCT00486720|470331124|FG001|Overall Study|Withdrawal by Subject|1|||
130647976|NCT00486720|470331123|FG000|Overall Study|Progressive Disease|0|||
130647977|NCT00486720|470331124|FG001|Overall Study|Progressive Disease|1|||
130647978|NCT02452892|470331125|FG000|Week 1 Initial Randommization|Adverse Event|1|||
130647979|NCT02452892|470331126|FG001|Week 1 Initial Randommization|Adverse Event|0|||
130647980|NCT02452892|470331127|FG002|Week 1 Initial Randommization|Adverse Event|0|||
130647981|NCT02452892|470331128|FG003|Week 1 Initial Randommization|Adverse Event|0|||
130647982|NCT02452892|470331125|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
130647983|NCT02452892|470331126|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
130647984|NCT02452892|470331127|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
130647985|NCT02452892|470331128|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
130647986|NCT02452892|470331125|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130647987|NCT02452892|470331126|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130647988|NCT02452892|470331127|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130647989|NCT02452892|470331128|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
130647990|NCT02452892|470331125|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
130647991|NCT02452892|470331126|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130647992|NCT02452892|470331127|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130647993|NCT02452892|470331128|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130647994|NCT02452892|470331125|FG000|Follow-up|Withdrawal by Subject|0|||
130647995|NCT02452892|470331126|FG001|Follow-up|Withdrawal by Subject|0|||
130647996|NCT02452892|470331127|FG002|Follow-up|Withdrawal by Subject|0|||
130647997|NCT02452892|470331128|FG003|Follow-up|Withdrawal by Subject|1|||
130647998|NCT02452892|470331125|FG000|Follow-up|Subject left town on Day 42|1|||
130647999|NCT02452892|470331126|FG001|Follow-up|Subject left town on Day 42|0|||
130648000|NCT02452892|470331127|FG002|Follow-up|Subject left town on Day 42|0|||
130648001|NCT02452892|470331128|FG003|Follow-up|Subject left town on Day 42|0|||
130648002|NCT02117024|470331129|FG000|Overall Study|Progressive Disease|26|||
130648003|NCT02117024|470331130|FG001|Overall Study|Progressive Disease|9|||
130648004|NCT02117024|470331129|FG000|Overall Study|Significant Clinical Progression|7|||
130648005|NCT02117024|470331130|FG001|Overall Study|Significant Clinical Progression|4|||
130648006|NCT02117024|470331129|FG000|Overall Study|Death|5|||
130648007|NCT02117024|470331130|FG001|Overall Study|Death|0|||
130648008|NCT02117024|470331129|FG000|Overall Study|Withdrawal by Subject|3|||
130648009|NCT02117024|470331130|FG001|Overall Study|Withdrawal by Subject|1|||
130648010|NCT02117024|470331129|FG000|Overall Study|Protocol Violation|1|||
130648011|NCT02117024|470331130|FG001|Overall Study|Protocol Violation|0|||
130648012|NCT02117024|470331129|FG000|Overall Study|Adverse Event|1|||
130648013|NCT02117024|470331130|FG001|Overall Study|Adverse Event|2|||
130648014|NCT02117024|470331129|FG000|Overall Study|Randomized in Error|1|||
130648015|NCT02117024|470331130|FG001|Overall Study|Randomized in Error|0|||
130648016|NCT02117024|470331129|FG000|Overall Study|Patient returned to primary oncologist|0|||
130648017|NCT02117024|470331130|FG001|Overall Study|Patient returned to primary oncologist|1|||
130648018|NCT02117024|470331129|FG000|Overall Study|Patient took treatment break|0|||
130648019|NCT02117024|470331130|FG001|Overall Study|Patient took treatment break|1|||
130648020|NCT02117024|470331129|FG000|Overall Study|Physician Decision|0|||
130648021|NCT02117024|470331130|FG001|Overall Study|Physician Decision|2|||
130648022|NCT02813681|470331133|FG000|Overall Study|Physician Decision|5|||
130648023|NCT02813681|470331134|FG001|Overall Study|Physician Decision|5|||
130648024|NCT02813681|470331135|FG002|Overall Study|Physician Decision|0|||
130648025|NCT02813681|470331133|FG000|Overall Study|Lost to Follow-up|0|||
130648026|NCT02813681|470331134|FG001|Overall Study|Lost to Follow-up|1|||
130648027|NCT02813681|470331135|FG002|Overall Study|Lost to Follow-up|0|||
130648028|NCT05047601|470331140|FG000|Overall Study|Lost to Follow-up|9|||
130648029|NCT05047601|470331141|FG001|Overall Study|Lost to Follow-up|11|||
130648030|NCT05047601|470331142|FG002|Overall Study|Lost to Follow-up|7|||
130648031|NCT05047601|470331140|FG000|Overall Study|Withdrawal by Subject|25|||
130648032|NCT05047601|470331141|FG001|Overall Study|Withdrawal by Subject|36|||
130648033|NCT05047601|470331142|FG002|Overall Study|Withdrawal by Subject|23|||
130648034|NCT05047601|470331140|FG000|Overall Study|Other|10|||
130648035|NCT05047601|470331141|FG001|Overall Study|Other|6|||
130648036|NCT05047601|470331142|FG002|Overall Study|Other|5|||
130648037|NCT00283062|470331147|FG000|Overall Study|Did not receive any study medication|5|||
130648038|NCT00283062|470331148|FG001|Overall Study|Did not receive any study medication|4|||
130648039|NCT00283062|470331149|FG002|Overall Study|Did not receive any study medication|36|||
130648040|NCT00283062|470331150|FG003|Overall Study|Did not receive any study medication|45|||
130648041|NCT00283062|470331147|FG000|Overall Study|Adverse Event|2|||
130648042|NCT00283062|470331148|FG001|Overall Study|Adverse Event|0|||
130648043|NCT00283062|470331149|FG002|Overall Study|Adverse Event|1|||
130648044|NCT00283062|470331150|FG003|Overall Study|Adverse Event|0|||
130648045|NCT00283062|470331147|FG000|Overall Study|Lost to Follow-up|1|||
130648046|NCT00283062|470331148|FG001|Overall Study|Lost to Follow-up|0|||
130648047|NCT00283062|470331149|FG002|Overall Study|Lost to Follow-up|1|||
130648048|NCT00283062|470331150|FG003|Overall Study|Lost to Follow-up|0|||
130648049|NCT00283062|470331147|FG000|Overall Study|Progressive disease|0|||
130648050|NCT00283062|470331148|FG001|Overall Study|Progressive disease|0|||
130648051|NCT00283062|470331149|FG002|Overall Study|Progressive disease|1|||
130648052|NCT00283062|470331150|FG003|Overall Study|Progressive disease|0|||
130648053|NCT00283062|470331147|FG000|Overall Study|Participant did not wish to continue|3|||
130648054|NCT00283062|470331148|FG001|Overall Study|Participant did not wish to continue|2|||
130648055|NCT00283062|470331149|FG002|Overall Study|Participant did not wish to continue|1|||
130648056|NCT00283062|470331150|FG003|Overall Study|Participant did not wish to continue|0|||
130648057|NCT00283062|470331147|FG000|Overall Study|Undefined|0|||
130648058|NCT00283062|470331148|FG001|Overall Study|Undefined|1|||
130648059|NCT00283062|470331149|FG002|Overall Study|Undefined|1|||
130648060|NCT00283062|470331150|FG003|Overall Study|Undefined|4|||
130648061|NCT00283062|470331147|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
130648062|NCT00283062|470331148|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
130648063|NCT00283062|470331149|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
130648064|NCT00283062|470331150|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
130648065|NCT03137173|470331151|FG000|Overall Study|Withdrawal by Subject|8|||
130648066|NCT03137173|470331152|FG001|Overall Study|Withdrawal by Subject|13|||
130648067|NCT03137173|470331151|FG000|Overall Study|Death|1|||
130648068|NCT03137173|470331152|FG001|Overall Study|Death|3|||
130648069|NCT03137173|470331151|FG000|Overall Study|Physician Decision|1|||
130648070|NCT03137173|470331152|FG001|Overall Study|Physician Decision|0|||
130648071|NCT03137173|470331151|FG000|Overall Study|Lost to Follow-up|13|||
130648072|NCT03137173|470331152|FG001|Overall Study|Lost to Follow-up|18|||
130648073|NCT03137173|470331151|FG000|Overall Study|Other reasons|3|||
130648074|NCT03137173|470331152|FG001|Overall Study|Other reasons|2|||
130648075|NCT01365468|470331153|FG000|Overall Study|Physician Decision|1|||
130648076|NCT01365468|470331154|FG001|Overall Study|Physician Decision|0|||
130648077|NCT01365468|470331153|FG000|Overall Study|Disease progression|1|||
130648078|NCT01365468|470331154|FG001|Overall Study|Disease progression|0|||
130648079|NCT01365468|470331153|FG000|Overall Study|Lost to Follow-up|2|||
130648080|NCT01365468|470331154|FG001|Overall Study|Lost to Follow-up|0|||
130648081|NCT00423267|470331157|FG000|Period A|Withdrawal by Subject|0|||
130648082|NCT00423267|470331158|FG001|Period A|Withdrawal by Subject|1|||
130648083|NCT00423267|470331157|FG000|Period A|Non-compliance with protocol|1|||
130648084|NCT00423267|470331158|FG001|Period A|Non-compliance with protocol|0|||
130648085|NCT00423267|470331157|FG000|Period A|Administrative|1|||
130648086|NCT00423267|470331158|FG001|Period A|Administrative|0|||
130648087|NCT00827112|470331159|FG000|Overall Study|Adverse Event|2|||
130648088|NCT00827112|470331160|FG001|Overall Study|Adverse Event|0|||
130648089|NCT00827112|470331159|FG000|Overall Study|Lack of Efficacy|2|||
130648090|NCT00827112|470331160|FG001|Overall Study|Lack of Efficacy|0|||
130648091|NCT00827112|470331159|FG000|Overall Study|Lost to Follow-up|3|||
130648092|NCT00827112|470331160|FG001|Overall Study|Lost to Follow-up|2|||
130648093|NCT00827112|470331159|FG000|Overall Study|Pregnancy|0|||
130648094|NCT00827112|470331160|FG001|Overall Study|Pregnancy|1|||
130648095|NCT00827112|470331159|FG000|Overall Study|Protocol Violation|0|||
130648096|NCT00827112|470331160|FG001|Overall Study|Protocol Violation|2|||
130648097|NCT00827112|470331159|FG000|Overall Study|Withdrawal by Subject|2|||
130648098|NCT00827112|470331160|FG001|Overall Study|Withdrawal by Subject|1|||
130648099|NCT00827112|470331159|FG000|Overall Study|Randomized but not treated|5|||
130648100|NCT00827112|470331160|FG001|Overall Study|Randomized but not treated|3|||
130648101|NCT00827112|470331159|FG000|Overall Study|Other|1|||
130648102|NCT00827112|470331160|FG001|Overall Study|Other|3|||
130648103|NCT01475214|470331161|FG000|Overall Study|Lost to Follow-up|1|||
130648104|NCT01475214|470331162|FG001|Overall Study|Lost to Follow-up|0|||
130648105|NCT01475214|470331163|FG002|Overall Study|Lost to Follow-up|1|||
130648106|NCT01475214|470331161|FG000|Overall Study|Physician Decision|2|||
130648107|NCT01475214|470331162|FG001|Overall Study|Physician Decision|0|||
130648108|NCT01475214|470331163|FG002|Overall Study|Physician Decision|0|||
130648109|NCT01475214|470331161|FG000|Overall Study|Withdrawal by Subject|2|||
130648110|NCT01475214|470331162|FG001|Overall Study|Withdrawal by Subject|4|||
130648111|NCT01475214|470331163|FG002|Overall Study|Withdrawal by Subject|1|||
130648112|NCT00911508|470333010|FG000|Overall Study|Lost to Follow-up|27|||
130648113|NCT00911508|470333011|FG001|Overall Study|Lost to Follow-up|18|||
130648114|NCT00911508|470333010|FG000|Overall Study|Withdrawal by Subject|79|||
130648115|NCT00911508|470333011|FG001|Overall Study|Withdrawal by Subject|112|||
130648116|NCT01409382|470333012|FG000|Overall Study|Lost to Follow-up|1|||
130648117|NCT01409382|470333013|FG001|Overall Study|Lost to Follow-up|1|||
130648118|NCT01409382|470333012|FG000|Overall Study|Protocol Violation|0|||
130648119|NCT01409382|470333013|FG001|Overall Study|Protocol Violation|3|||
130648120|NCT01409382|470333012|FG000|Overall Study|Multiple pregnancy|2|||
130648121|NCT01409382|470333013|FG001|Overall Study|Multiple pregnancy|4|||
130648122|NCT01409382|470333012|FG000|Overall Study|Still pregnant when study ended|13|||
130648123|NCT01409382|470333013|FG001|Overall Study|Still pregnant when study ended|2|||
130648124|NCT01409382|470333012|FG000|Overall Study|Did not manage to get pregnant|64|||
130648125|NCT01409382|470333013|FG001|Overall Study|Did not manage to get pregnant|70|||
130648126|NCT01409382|470333012|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
130648127|NCT01409382|470333013|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
130648128|NCT01004822|470333014|FG000|Overall Study|Objective progression or relapse|3|||
130648129|NCT01004822|470333015|FG001|Overall Study|Objective progression or relapse|3|||
130648130|NCT01004822|470333016|FG002|Overall Study|Objective progression or relapse|0|||
130648131|NCT01004822|470333017|FG003|Overall Study|Objective progression or relapse|1|||
130648132|NCT01004822|470333018|FG004|Overall Study|Objective progression or relapse|2|||
130648133|NCT01004822|470333019|FG005|Overall Study|Objective progression or relapse|2|||
130648134|NCT01004822|470333020|FG006|Overall Study|Objective progression or relapse|1|||
130648135|NCT01004822|470333021|FG007|Overall Study|Objective progression or relapse|4|||
130648136|NCT01004822|470333014|FG000|Overall Study|Global deterioration of health status|0|||
130648137|NCT01004822|470333015|FG001|Overall Study|Global deterioration of health status|0|||
130648138|NCT01004822|470333016|FG002|Overall Study|Global deterioration of health status|0|||
130648139|NCT01004822|470333017|FG003|Overall Study|Global deterioration of health status|1|||
130648140|NCT01004822|470333018|FG004|Overall Study|Global deterioration of health status|0|||
130648141|NCT01004822|470333019|FG005|Overall Study|Global deterioration of health status|0|||
130648142|NCT01004822|470333020|FG006|Overall Study|Global deterioration of health status|1|||
130648143|NCT01004822|470333021|FG007|Overall Study|Global deterioration of health status|0|||
130648144|NCT01004822|470333014|FG000|Overall Study|No longer willing to continue|0|||
130648145|NCT01004822|470333015|FG001|Overall Study|No longer willing to continue|0|||
130648146|NCT01004822|470333016|FG002|Overall Study|No longer willing to continue|0|||
130648147|NCT01004822|470333017|FG003|Overall Study|No longer willing to continue|1|||
130648148|NCT01004822|470333018|FG004|Overall Study|No longer willing to continue|2|||
130648149|NCT01004822|470333019|FG005|Overall Study|No longer willing to continue|1|||
130648150|NCT01004822|470333020|FG006|Overall Study|No longer willing to continue|1|||
130648151|NCT01004822|470333021|FG007|Overall Study|No longer willing to continue|0|||
130648152|NCT01004822|470333014|FG000|Overall Study|Adverse Event|0|||
130648153|NCT01004822|470333015|FG001|Overall Study|Adverse Event|0|||
130648154|NCT01004822|470333016|FG002|Overall Study|Adverse Event|0|||
130648155|NCT01004822|470333017|FG003|Overall Study|Adverse Event|0|||
130648156|NCT01004822|470333018|FG004|Overall Study|Adverse Event|0|||
130648157|NCT01004822|470333019|FG005|Overall Study|Adverse Event|0|||
130648158|NCT01004822|470333020|FG006|Overall Study|Adverse Event|1|||
130648159|NCT01004822|470333021|FG007|Overall Study|Adverse Event|1|||
130648160|NCT01004822|470333014|FG000|Overall Study|Other|0|||
130648161|NCT01004822|470333015|FG001|Overall Study|Other|0|||
130648162|NCT01004822|470333016|FG002|Overall Study|Other|4|||
130648163|NCT01004822|470333017|FG003|Overall Study|Other|1|||
130648164|NCT01004822|470333018|FG004|Overall Study|Other|0|||
130648165|NCT01004822|470333019|FG005|Overall Study|Other|1|||
130648166|NCT01004822|470333020|FG006|Overall Study|Other|0|||
130648167|NCT01004822|470333021|FG007|Overall Study|Other|0|||
130648168|NCT01858701|470333022|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
130648169|NCT01858701|470333023|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
130648170|NCT01858701|470333022|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
130648171|NCT01858701|470333023|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
130648172|NCT01858701|470333022|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
130648173|NCT01858701|470333023|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
130648174|NCT01858701|470333022|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
130648175|NCT01858701|470333023|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
130648176|NCT01789476|470333031|FG000|Overall Study|Lack of Efficacy|6|||
130648177|NCT01789476|470333032|FG001|Overall Study|Lack of Efficacy|2|||
130648178|NCT01789476|470333031|FG000|Overall Study|Adverse Event|1|||
130648179|NCT01789476|470333032|FG001|Overall Study|Adverse Event|0|||
130648180|NCT01789476|470333031|FG000|Overall Study|Unable to get IV access|1|||
130648181|NCT01789476|470333032|FG001|Overall Study|Unable to get IV access|0|||
130648182|NCT00501969|470333033|FG000|Overall Study|Major Protocol Violation|4|||
130648183|NCT00501969|470333033|FG000|Overall Study|Lack of Efficacy|29|||
130648184|NCT00501969|470333033|FG000|Overall Study|Adverse Event|76|||
130648185|NCT00501969|470333033|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
130648186|NCT00501969|470333033|FG000|Overall Study|Subject withdrew consent|51|||
130648187|NCT00501969|470333033|FG000|Overall Study|Lost to Follow-up|4|||
130648188|NCT00501969|470333033|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
130648189|NCT00501969|470333033|FG000|Overall Study|Other: Sponsors Request|10|||
130648190|NCT00501969|470333033|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
130648191|NCT00501969|470333033|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
130648192|NCT00501969|470333033|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
130648193|NCT00501969|470333033|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
130648194|NCT00501969|470333033|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
130648195|NCT00501969|470333033|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
130648196|NCT00501969|470333033|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
130648197|NCT00501969|470333033|FG000|Overall Study|Other: As Required by Local EC|2|||
130648198|NCT00501969|470333033|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
130648199|NCT00501969|470333033|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
130648200|NCT00965458|470333034|FG000|Overall Study|Adverse Event|1|||
130648201|NCT00965458|470333035|FG001|Overall Study|Adverse Event|0|||
130648202|NCT00965458|470333034|FG000|Overall Study|Lost to Follow-up|1|||
130648203|NCT00965458|470333035|FG001|Overall Study|Lost to Follow-up|3|||
130648204|NCT00965458|470333034|FG000|Overall Study|Withdrawal by Subject|0|||
130648205|NCT00965458|470333035|FG001|Overall Study|Withdrawal by Subject|1|||
130648206|NCT05111548|470333042|FG000|Overall Study|Withdrawal by Subject|2|||
130648207|NCT05111548|470333043|FG001|Overall Study|Withdrawal by Subject|1|||
130648208|NCT05111548|470333042|FG000|Overall Study|Adverse Event|1|||
130648209|NCT05111548|470333043|FG001|Overall Study|Adverse Event|0|||
130648210|NCT00379639|470333044|FG000|Overall Study|Disease Progression|3|||
130648211|NCT00379639|470333045|FG001|Overall Study|Disease Progression|3|||
130648212|NCT00379639|470333046|FG002|Overall Study|Disease Progression|3|||
130648213|NCT00379639|470333047|FG003|Overall Study|Disease Progression|4|||
130648214|NCT00379639|470333048|FG004|Overall Study|Disease Progression|4|||
130648215|NCT00379639|470333044|FG000|Overall Study|Physician Decision|0|||
130648216|NCT00379639|470333045|FG001|Overall Study|Physician Decision|2|||
130648217|NCT00379639|470333046|FG002|Overall Study|Physician Decision|1|||
130648218|NCT00379639|470333047|FG003|Overall Study|Physician Decision|1|||
130648219|NCT00379639|470333048|FG004|Overall Study|Physician Decision|0|||
130648220|NCT00379639|470333044|FG000|Overall Study|Symptomatic Deterioration|0|||
130648221|NCT00379639|470333045|FG001|Overall Study|Symptomatic Deterioration|0|||
130648222|NCT00379639|470333046|FG002|Overall Study|Symptomatic Deterioration|1|||
130648223|NCT00379639|470333047|FG003|Overall Study|Symptomatic Deterioration|0|||
130648224|NCT00379639|470333048|FG004|Overall Study|Symptomatic Deterioration|1|||
130648225|NCT00379639|470333044|FG000|Overall Study|Adverse Event|0|||
130648226|NCT00379639|470333045|FG001|Overall Study|Adverse Event|0|||
130648227|NCT00379639|470333046|FG002|Overall Study|Adverse Event|1|||
130648228|NCT00379639|470333047|FG003|Overall Study|Adverse Event|0|||
130648229|NCT00379639|470333048|FG004|Overall Study|Adverse Event|1|||
130648230|NCT00379639|470333044|FG000|Overall Study|Lost to Follow-up|0|||
130648231|NCT00379639|470333045|FG001|Overall Study|Lost to Follow-up|0|||
130648232|NCT00379639|470333046|FG002|Overall Study|Lost to Follow-up|0|||
130648233|NCT00379639|470333047|FG003|Overall Study|Lost to Follow-up|1|||
130648234|NCT00379639|470333048|FG004|Overall Study|Lost to Follow-up|0|||
130648235|NCT00379639|470333044|FG000|Overall Study|Other|0|||
130648236|NCT00379639|470333045|FG001|Overall Study|Other|0|||
130648237|NCT00379639|470333046|FG002|Overall Study|Other|3|||
130648238|NCT00379639|470333047|FG003|Overall Study|Other|0|||
130648239|NCT00379639|470333048|FG004|Overall Study|Other|0|||
130648240|NCT00594958|470333049|FG000|Overall Study|Withdrawal by Subject|1|||
130648241|NCT00594958|470333050|FG001|Overall Study|Withdrawal by Subject|0|||
130648242|NCT00594958|470333051|FG002|Overall Study|Withdrawal by Subject|1|||
130648243|NCT00594958|470333049|FG000|Overall Study|Adverse Event|4|||
130648244|NCT00594958|470333050|FG001|Overall Study|Adverse Event|1|||
130648245|NCT00594958|470333051|FG002|Overall Study|Adverse Event|2|||
130648246|NCT00594958|470333049|FG000|Overall Study|Pregnancy|0|||
130648247|NCT00594958|470333050|FG001|Overall Study|Pregnancy|2|||
130648248|NCT00594958|470333051|FG002|Overall Study|Pregnancy|0|||
130648249|NCT00594958|470333049|FG000|Overall Study|Protocol Violation|1|||
130648250|NCT00594958|470333050|FG001|Overall Study|Protocol Violation|0|||
130648251|NCT00594958|470333051|FG002|Overall Study|Protocol Violation|2|||
130648252|NCT00594958|470333049|FG000|Overall Study|Lost to Follow-up|5|||
130648253|NCT00594958|470333050|FG001|Overall Study|Lost to Follow-up|0|||
130648254|NCT00594958|470333051|FG002|Overall Study|Lost to Follow-up|3|||
130648255|NCT00594958|470333049|FG000|Overall Study|administrative|3|||
130648256|NCT00594958|470333050|FG001|Overall Study|administrative|0|||
130648257|NCT00594958|470333051|FG002|Overall Study|administrative|2|||
130648258|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
130648259|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
130648260|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648261|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648262|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648263|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648264|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648265|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648266|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648267|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648268|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648269|NCT00151775|470333063|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130648270|NCT00151775|470333052|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
130648271|NCT00151775|470333053|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648272|NCT00151775|470333054|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648273|NCT00151775|470333055|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648274|NCT00151775|470333056|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648275|NCT00151775|470333057|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648276|NCT00151775|470333058|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
130648277|NCT00151775|470333059|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648278|NCT00151775|470333060|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648279|NCT00151775|470333061|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130648280|NCT00151775|470333062|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
130648462|NCT00151775|470333052|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
130648463|NCT00151775|470333053|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
130648464|NCT00151775|470333054|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
130648465|NCT00151775|470333055|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
130648466|NCT00151775|470333056|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
130648467|NCT00151775|470333057|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
130648468|NCT00151775|470333058|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
130648469|NCT00151775|470333059|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
130648470|NCT00151775|470333060|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
130648471|NCT00151775|470333061|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
130648472|NCT00151775|470333062|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
130648473|NCT00151775|470333063|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
130648474|NCT00151775|470333052|FG000|Period 4: Open Label|Other|0|||
130648475|NCT00151775|470333053|FG001|Period 4: Open Label|Other|0|||
130648476|NCT00151775|470333054|FG002|Period 4: Open Label|Other|0|||
130648477|NCT00151775|470333055|FG003|Period 4: Open Label|Other|0|||
130648478|NCT00151775|470333056|FG004|Period 4: Open Label|Other|1|||
130648479|NCT00151775|470333057|FG005|Period 4: Open Label|Other|0|||
130648480|NCT00151775|470333058|FG006|Period 4: Open Label|Other|0|||
130648481|NCT00151775|470333059|FG007|Period 4: Open Label|Other|0|||
130648482|NCT00151775|470333060|FG008|Period 4: Open Label|Other|0|||
130648483|NCT00151775|470333061|FG009|Period 4: Open Label|Other|3|||
130648484|NCT00151775|470333062|FG010|Period 4: Open Label|Other|0|||
130648485|NCT00151775|470333063|FG011|Period 4: Open Label|Other|0|||
130648486|NCT00151775|470333052|FG000|Period 4: Open Label|Physician Decision|0|||
130648487|NCT00151775|470333053|FG001|Period 4: Open Label|Physician Decision|0|||
130648488|NCT00151775|470333054|FG002|Period 4: Open Label|Physician Decision|0|||
130648489|NCT00151775|470333055|FG003|Period 4: Open Label|Physician Decision|0|||
130648490|NCT00151775|470333056|FG004|Period 4: Open Label|Physician Decision|0|||
130648491|NCT00151775|470333057|FG005|Period 4: Open Label|Physician Decision|0|||
130648492|NCT00151775|470333058|FG006|Period 4: Open Label|Physician Decision|0|||
130648493|NCT00151775|470333059|FG007|Period 4: Open Label|Physician Decision|0|||
130648494|NCT00151775|470333060|FG008|Period 4: Open Label|Physician Decision|0|||
130648495|NCT00151775|470333061|FG009|Period 4: Open Label|Physician Decision|2|||
130648496|NCT00151775|470333062|FG010|Period 4: Open Label|Physician Decision|0|||
130648497|NCT00151775|470333063|FG011|Period 4: Open Label|Physician Decision|0|||
130648498|NCT00151775|470333052|FG000|Period 4: Open Label|Protocol Violation|0|||
130648499|NCT00151775|470333053|FG001|Period 4: Open Label|Protocol Violation|0|||
130648500|NCT00151775|470333054|FG002|Period 4: Open Label|Protocol Violation|0|||
130648501|NCT00151775|470333055|FG003|Period 4: Open Label|Protocol Violation|0|||
130648502|NCT00151775|470333056|FG004|Period 4: Open Label|Protocol Violation|1|||
130648503|NCT00151775|470333057|FG005|Period 4: Open Label|Protocol Violation|0|||
130648504|NCT00151775|470333058|FG006|Period 4: Open Label|Protocol Violation|0|||
130648505|NCT00151775|470333059|FG007|Period 4: Open Label|Protocol Violation|0|||
130648506|NCT00151775|470333060|FG008|Period 4: Open Label|Protocol Violation|0|||
130648507|NCT00151775|470333061|FG009|Period 4: Open Label|Protocol Violation|0|||
130648508|NCT00151775|470333062|FG010|Period 4: Open Label|Protocol Violation|0|||
130648509|NCT00151775|470333063|FG011|Period 4: Open Label|Protocol Violation|0|||
130648510|NCT04516291|470333064|FG000|Treatment Period (24 Weeks)|Other|1|||
130648511|NCT04516291|470333065|FG001|Treatment Period (24 Weeks)|Other|0|||
130648512|NCT04516291|470333066|FG002|Treatment Period (24 Weeks)|Other|0|||
130648513|NCT04516291|470333067|FG003|Treatment Period (24 Weeks)|Other|2|||
130648514|NCT04516291|470333068|FG004|Treatment Period (24 Weeks)|Other|2|||
130648515|NCT04516291|470333069|FG005|Treatment Period (24 Weeks)|Other|4|||
130648516|NCT04516291|470333070|FG006|Treatment Period (24 Weeks)|Other|2|||
130648517|NCT04516291|470333071|FG007|Treatment Period (24 Weeks)|Other|0|||
130648518|NCT04516291|470333064|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130648519|NCT04516291|470333065|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130648520|NCT04516291|470333066|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130648521|NCT04516291|470333067|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130648522|NCT04516291|470333068|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130648523|NCT04516291|470333069|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130648524|NCT04516291|470333070|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130648525|NCT04516291|470333071|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130648526|NCT04516291|470333064|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648527|NCT04516291|470333065|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648528|NCT04516291|470333066|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648529|NCT04516291|470333067|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
130648530|NCT04516291|470333068|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648531|NCT04516291|470333069|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648532|NCT04516291|470333070|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648533|NCT04516291|470333071|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
130648534|NCT04516291|470333064|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648535|NCT04516291|470333065|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130648536|NCT04516291|470333066|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648537|NCT04516291|470333067|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648538|NCT04516291|470333068|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648539|NCT04516291|470333069|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648540|NCT04516291|470333070|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648541|NCT04516291|470333071|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130648542|NCT04516291|470333064|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
130648543|NCT04516291|470333065|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
130648544|NCT04516291|470333066|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
130648545|NCT04516291|470333067|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
130648546|NCT04516291|470333068|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
130648547|NCT04516291|470333069|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
130648548|NCT04516291|470333070|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
130648549|NCT04516291|470333071|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
130648550|NCT04516291|470333064|FG000|Follow-up Period (12 Weeks)|Other|0|||
130648551|NCT04516291|470333065|FG001|Follow-up Period (12 Weeks)|Other|1|||
130648552|NCT04516291|470333066|FG002|Follow-up Period (12 Weeks)|Other|0|||
130648553|NCT04516291|470333067|FG003|Follow-up Period (12 Weeks)|Other|2|||
130648554|NCT04516291|470333068|FG004|Follow-up Period (12 Weeks)|Other|0|||
130648555|NCT04516291|470333069|FG005|Follow-up Period (12 Weeks)|Other|0|||
130648556|NCT04516291|470333070|FG006|Follow-up Period (12 Weeks)|Other|0|||
130648557|NCT04516291|470333071|FG007|Follow-up Period (12 Weeks)|Other|0|||
130648558|NCT04516291|470333064|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648559|NCT04516291|470333065|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648560|NCT04516291|470333066|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648561|NCT04516291|470333067|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648562|NCT04516291|470333068|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
130648563|NCT04516291|470333069|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648564|NCT04516291|470333070|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648565|NCT04516291|470333071|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130648566|NCT04516291|470333064|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648567|NCT04516291|470333065|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648568|NCT04516291|470333066|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
130648569|NCT04516291|470333067|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648570|NCT04516291|470333068|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
130648571|NCT04516291|470333069|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648572|NCT04516291|470333070|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648573|NCT04516291|470333071|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
130648574|NCT03039686|470333072|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
130648575|NCT03039686|470333073|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
130648576|NCT03039686|470333074|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
130648577|NCT03039686|470333072|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
130648578|NCT03039686|470333073|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
130648579|NCT03039686|470333074|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
130648580|NCT03039686|470333072|FG000|Double-blind Period|Withdrawal by Subject|2|||
130648581|NCT03039686|470333073|FG001|Double-blind Period|Withdrawal by Subject|2|||
130648582|NCT03039686|470333074|FG002|Double-blind Period|Withdrawal by Subject|1|||
130648583|NCT03039686|470333072|FG000|Double-blind Period|Death|0|||
130648584|NCT03039686|470333073|FG001|Double-blind Period|Death|0|||
130648585|NCT03039686|470333074|FG002|Double-blind Period|Death|1|||
130648586|NCT03039686|470333072|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
130648587|NCT03039686|470333073|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
130648588|NCT03039686|470333074|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
130648589|NCT03039686|470333072|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
130648590|NCT03039686|470333073|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
130648591|NCT03039686|470333074|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
130648592|NCT03039686|470333072|FG000|Open Label Period|Withdrawal by Subject|0|||
130648593|NCT03039686|470333073|FG001|Open Label Period|Withdrawal by Subject|3|||
130648594|NCT03039686|470333074|FG002|Open Label Period|Withdrawal by Subject|1|||
130648595|NCT02158949|470333075|FG000|Overall Study|Withdrawal by Subject|1|||
130648596|NCT02158949|470333076|FG001|Overall Study|Withdrawal by Subject|0|||
130648597|NCT02158949|470333075|FG000|Overall Study|Lost to Follow-up|5|||
130648598|NCT02158949|470333076|FG001|Overall Study|Lost to Follow-up|11|||
130648599|NCT02181634|470333077|FG000|Overall Study|Lack of Efficacy|33|||
130648600|NCT02181634|470333077|FG000|Overall Study|Adverse Event|17|||
130648601|NCT02181634|470333077|FG000|Overall Study|Physician Decision|8|||
130648602|NCT02181634|470333077|FG000|Overall Study|Withdrawal by Subject|5|||
130648603|NCT02181634|470333077|FG000|Overall Study|Death|2|||
130648604|NCT02181634|470333077|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
130648605|NCT02181634|470333077|FG000|Overall Study|Ineligible|1|||
130648606|NCT02181634|470333077|FG000|Overall Study|Max number of dose reduction|1|||
130648607|NCT02181634|470333077|FG000|Overall Study|Symptomatic progression|1|||
130648608|NCT02181634|470333077|FG000|Overall Study|Patient opted to proceed to surgery|1|||
130648609|NCT02505945|470333082|FG000|Overall Study|Withdrawal by Subject|13|||
130648610|NCT02505945|470333083|FG001|Overall Study|Withdrawal by Subject|2|||
130648611|NCT02505945|470333082|FG000|Overall Study|Adverse Event|1|||
130648612|NCT02505945|470333083|FG001|Overall Study|Adverse Event|0|||
130648613|NCT02505945|470333082|FG000|Overall Study|Physician Decision|2|||
130648614|NCT02505945|470333083|FG001|Overall Study|Physician Decision|1|||
130648615|NCT02505945|470333082|FG000|Overall Study|Lost to Follow-up|6|||
130648616|NCT02505945|470333083|FG001|Overall Study|Lost to Follow-up|1|||
130648617|NCT01097057|470333084|FG000|Overall Study|Physician Decision|3|||
130648618|NCT01101321|470333085|FG000|Period 1|Withdrawal by Subject|1|||
130648619|NCT01101321|470333086|FG001|Period 1|Withdrawal by Subject|1|||
130648620|NCT01101321|470333085|FG000|Period 1|Adverse Event|3|||
130648621|NCT01101321|470333086|FG001|Period 1|Adverse Event|3|||
130648622|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
130648623|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
130648624|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
130648625|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
130648626|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
130648627|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
130648628|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
130648629|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
130648630|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
130648631|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
130648632|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
130648633|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
130648634|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
130648635|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
130648636|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
130648637|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|Other|6|||
130648638|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|Other|6|||
130648639|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|Other|7|||
130648640|NCT02681094|470333087|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
130648641|NCT02681094|470333088|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
130648642|NCT02681094|470333089|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
130648643|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Participant decision|7|||
130648644|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Participant decision|10|||
130648645|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Participant decision|9|||
130648646|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
130648647|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
130648648|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
130648649|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
130648650|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
130648651|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
130648652|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
130648653|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
130648654|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
130648655|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
130648656|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
130648657|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
130648658|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|Other|6|||
130648659|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|Other|6|||
130648660|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|Other|7|||
130648661|NCT02681094|470333087|FG000|2 - Enrolled Participants Set|No treatment given|0|||
130648662|NCT02681094|470333088|FG001|2 - Enrolled Participants Set|No treatment given|1|||
130648663|NCT02681094|470333089|FG002|2 - Enrolled Participants Set|No treatment given|1|||
130648664|NCT01270139|470333090|FG000|Overall Study|Adverse Event|8|||
130648665|NCT01270139|470333091|FG001|Overall Study|Adverse Event|17|||
130648666|NCT01270139|470333092|FG002|Overall Study|Adverse Event|18|||
130648667|NCT01270139|470333090|FG000|Overall Study|Lost to Follow-up|10|||
130648668|NCT01270139|470333091|FG001|Overall Study|Lost to Follow-up|9|||
130648669|NCT01270139|470333092|FG002|Overall Study|Lost to Follow-up|2|||
130648670|NCT00134563|470333095|FG000|Overall Study|Not treated due to protocol violation|0|||
130648671|NCT00134563|470333096|FG001|Overall Study|Not treated due to protocol violation|1|||
130648672|NCT00134563|470333097|FG002|Overall Study|Not treated due to protocol violation|1|||
130648673|NCT00134563|470333095|FG000|Overall Study|Adverse Event|29|||
130648674|NCT00134563|470333096|FG001|Overall Study|Adverse Event|37|||
130648675|NCT00134563|470333097|FG002|Overall Study|Adverse Event|38|||
130648676|NCT00134563|470333095|FG000|Overall Study|Lack of Efficacy|24|||
130648677|NCT00134563|470333096|FG001|Overall Study|Lack of Efficacy|14|||
130648678|NCT00134563|470333097|FG002|Overall Study|Lack of Efficacy|17|||
130648679|NCT00134563|470333095|FG000|Overall Study|Protocol Violation|3|||
130648680|NCT00134563|470333096|FG001|Overall Study|Protocol Violation|2|||
130648681|NCT00134563|470333097|FG002|Overall Study|Protocol Violation|5|||
130648682|NCT00134563|470333095|FG000|Overall Study|Lost to Follow-up|4|||
130648683|NCT00134563|470333096|FG001|Overall Study|Lost to Follow-up|0|||
130648684|NCT00134563|470333097|FG002|Overall Study|Lost to Follow-up|2|||
130648685|NCT00134563|470333095|FG000|Overall Study|progressive disease|11|||
130648686|NCT00134563|470333096|FG001|Overall Study|progressive disease|4|||
130648687|NCT00134563|470333097|FG002|Overall Study|progressive disease|2|||
130648688|NCT00134563|470333095|FG000|Overall Study|did not wish to continue|33|||
130648689|NCT00134563|470333096|FG001|Overall Study|did not wish to continue|32|||
130648690|NCT00134563|470333097|FG002|Overall Study|did not wish to continue|26|||
130648691|NCT00134563|470333095|FG000|Overall Study|Reason other than above|0|||
130648692|NCT00134563|470333096|FG001|Overall Study|Reason other than above|2|||
130648693|NCT00134563|470333097|FG002|Overall Study|Reason other than above|5|||
130648694|NCT02210559|470333100|FG000|Overall Study|Progressive Disease|3|||
130648695|NCT02210559|470333101|FG001|Overall Study|Progressive Disease|2|||
130648696|NCT02210559|470333100|FG000|Overall Study|Adverse Event|2|||
130648697|NCT02210559|470333101|FG001|Overall Study|Adverse Event|2|||
130648698|NCT02210559|470333100|FG000|Overall Study|Physician Decision|1|||
130648699|NCT02210559|470333101|FG001|Overall Study|Physician Decision|0|||
130648700|NCT02210559|470333100|FG000|Overall Study|Withdrawal by Subject|0|||
130648701|NCT02210559|470333101|FG001|Overall Study|Withdrawal by Subject|1|||
130648702|NCT02210559|470333100|FG000|Overall Study|Other than specified|0|||
130648703|NCT02210559|470333101|FG001|Overall Study|Other than specified|1|||
130648704|NCT02546193|470333102|FG000|Overall Study|Withdrawal by Subject|2|||
130648705|NCT02546193|470333103|FG001|Overall Study|Withdrawal by Subject|0|||
130648706|NCT02546193|470333104|FG002|Overall Study|Withdrawal by Subject|1|||
130648707|NCT02546193|470333105|FG003|Overall Study|Withdrawal by Subject|0|||
130648708|NCT02546193|470333102|FG000|Overall Study|Not eligible at time of induction|4|||
130648709|NCT02546193|470333103|FG001|Overall Study|Not eligible at time of induction|6|||
130648710|NCT02546193|470333104|FG002|Overall Study|Not eligible at time of induction|1|||
130648711|NCT02546193|470333105|FG003|Overall Study|Not eligible at time of induction|0|||
130648712|NCT00310440|470333106|FG000|Overall Study|Lost to Follow-up|17|||
130648713|NCT00310440|470333107|FG001|Overall Study|Lost to Follow-up|8|||
130648714|NCT00310440|470333106|FG000|Overall Study|Withdrawal by Subject|2|||
130648715|NCT00310440|470333107|FG001|Overall Study|Withdrawal by Subject|1|||
130648716|NCT00310440|470333106|FG000|Overall Study|Missed 12 Month Visit|7|||
130648717|NCT00310440|470333107|FG001|Overall Study|Missed 12 Month Visit|4|||
130648718|NCT01287403|470333108|FG000|1st Intervention (1 Day)|Adverse Event|1|||
130648719|NCT00148109|470333109|FG000|Overall Study|Lack of Efficacy|10|||
130648720|NCT00148109|470333110|FG001|Overall Study|Lack of Efficacy|18|||
130648721|NCT00148109|470333109|FG000|Overall Study|Adverse Event|0|||
130648722|NCT00148109|470333110|FG001|Overall Study|Adverse Event|2|||
130648723|NCT00148109|470333109|FG000|Overall Study|Withdrawal by Subject|2|||
130648724|NCT00148109|470333110|FG001|Overall Study|Withdrawal by Subject|0|||
130648725|NCT01098266|470333111|FG000|Overall Study|Physician Decision|1|||
130648726|NCT01098266|470333112|FG001|Overall Study|Physician Decision|0|||
130648727|NCT01098266|470333111|FG000|Overall Study|Death|3|||
130648728|NCT01098266|470333112|FG001|Overall Study|Death|2|||
130648729|NCT01098266|470333111|FG000|Overall Study|Withdrawal by Subject|3|||
130648730|NCT01098266|470333112|FG001|Overall Study|Withdrawal by Subject|5|||
130648731|NCT00649220|470333116|FG000|Overall Study|Adverse Event|2|||
130648732|NCT00649220|470333116|FG000|Overall Study|Withdrawal by Subject|1|||
130648733|NCT00525499|470333117|FG000|Overall Study|Lost to Follow-up|2|||
130648734|NCT00525499|470333118|FG001|Overall Study|Lost to Follow-up|4|||
130648735|NCT00525499|470333119|FG002|Overall Study|Lost to Follow-up|1|||
130648736|NCT00525499|470333120|FG003|Overall Study|Lost to Follow-up|4|||
130648737|NCT00525499|470333117|FG000|Overall Study|Adverse Event|0|||
130648738|NCT00525499|470333118|FG001|Overall Study|Adverse Event|1|||
130648739|NCT00525499|470333119|FG002|Overall Study|Adverse Event|0|||
130648740|NCT00525499|470333120|FG003|Overall Study|Adverse Event|1|||
130648741|NCT00525499|470333117|FG000|Overall Study|Withdrawal by Subject|5|||
130648742|NCT00525499|470333118|FG001|Overall Study|Withdrawal by Subject|1|||
130648743|NCT00525499|470333119|FG002|Overall Study|Withdrawal by Subject|5|||
130648744|NCT00525499|470333120|FG003|Overall Study|Withdrawal by Subject|2|||
130648745|NCT00525499|470333117|FG000|Overall Study|Protocol Violation|0|||
130648746|NCT00525499|470333118|FG001|Overall Study|Protocol Violation|1|||
130648747|NCT00525499|470333119|FG002|Overall Study|Protocol Violation|1|||
130648748|NCT00525499|470333120|FG003|Overall Study|Protocol Violation|0|||
130648749|NCT00438815|470333121|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
130648750|NCT00438815|470333121|FG000|Overall Study|3-month follow-up no longer required|12|||
130648751|NCT00438815|470333121|FG000|Overall Study|Noncompliance with protocol requirements|9|||
130648752|NCT00438815|470333121|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
130648753|NCT00438815|470333121|FG000|Overall Study|Lost to Follow-up|6|||
130648754|NCT00438815|470333121|FG000|Overall Study|Withdrawal by Subject|6|||
130648755|NCT00438815|470333121|FG000|Overall Study|Death|1|||
130648756|NCT01733758|470333124|FG000|Overall Study|Adverse Event|5|||
130648757|NCT01733758|470333125|FG001|Overall Study|Adverse Event|7|||
130648758|NCT01733758|470333126|FG002|Overall Study|Adverse Event|8|||
130648759|NCT01733758|470333127|FG003|Overall Study|Adverse Event|1|||
130648760|NCT01733758|470333124|FG000|Overall Study|Withdrawal by Subject|1|||
130648761|NCT01733758|470333125|FG001|Overall Study|Withdrawal by Subject|1|||
130648762|NCT01733758|470333126|FG002|Overall Study|Withdrawal by Subject|5|||
130648763|NCT01733758|470333127|FG003|Overall Study|Withdrawal by Subject|3|||
130648764|NCT01733758|470333124|FG000|Overall Study|Persistent Hyperglycemia|3|||
130648765|NCT01733758|470333125|FG001|Overall Study|Persistent Hyperglycemia|2|||
130648766|NCT01733758|470333126|FG002|Overall Study|Persistent Hyperglycemia|0|||
130648767|NCT01733758|470333127|FG003|Overall Study|Persistent Hyperglycemia|0|||
130648768|NCT01733758|470333124|FG000|Overall Study|Protocol Violation|0|||
130648769|NCT01733758|470333125|FG001|Overall Study|Protocol Violation|1|||
130648770|NCT01733758|470333126|FG002|Overall Study|Protocol Violation|2|||
130648771|NCT01733758|470333127|FG003|Overall Study|Protocol Violation|2|||
130648772|NCT01733758|470333124|FG000|Overall Study|Non-compliance|1|||
130648773|NCT01733758|470333125|FG001|Overall Study|Non-compliance|0|||
130648774|NCT01733758|470333126|FG002|Overall Study|Non-compliance|0|||
130648775|NCT01733758|470333127|FG003|Overall Study|Non-compliance|0|||
130648776|NCT01733758|470333124|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
130648777|NCT01733758|470333125|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
130648778|NCT01733758|470333126|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
130648779|NCT01733758|470333127|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
130648780|NCT01733758|470333124|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
130648781|NCT01733758|470333125|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
130648782|NCT01733758|470333126|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
130648783|NCT01733758|470333127|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
130648784|NCT04594213|470333128|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130648785|NCT04594213|470333129|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
130648786|NCT04594213|470333130|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
130648787|NCT04594213|470333131|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130648788|NCT04594213|470333132|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130648789|NCT04594213|470333133|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130648790|NCT04594213|470333128|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130648791|NCT04594213|470333129|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
130648792|NCT04594213|470333130|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130648793|NCT04594213|470333131|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130648794|NCT04594213|470333132|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130648795|NCT04594213|470333133|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130648796|NCT04594213|470333128|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
130648797|NCT04594213|470333129|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130648798|NCT04594213|470333130|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
130648799|NCT04594213|470333131|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130648800|NCT04594213|470333132|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130648801|NCT04594213|470333133|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130648802|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130648803|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130648804|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130648805|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130648806|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
130648807|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130648808|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130648809|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130648810|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130648811|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
130648812|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
130648813|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
130648814|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130648815|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130648816|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130648817|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130648818|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130648819|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
130648820|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130648821|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130648822|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130648823|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
130648824|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130648825|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130648826|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130648827|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130648828|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130648829|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
130648830|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130648831|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130648832|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130648833|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130648834|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130648835|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
130648836|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
130648837|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
130648838|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130648839|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130648840|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130648841|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
130648842|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
130648843|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
130648844|NCT04594213|470333128|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
130648845|NCT04594213|470333129|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
130648846|NCT04594213|470333130|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
130648847|NCT04594213|470333131|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
130648848|NCT04594213|470333132|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
130648849|NCT04594213|470333133|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
130648850|NCT03814499|470333139|FG000|Overall Study|Lost to Follow-up|3|||
130648851|NCT01589185|470333140|FG000|Overall Study|Death|1|||
130648852|NCT01589185|470333141|FG001|Overall Study|Death|2|||
130648853|NCT01589185|470333142|FG002|Overall Study|Death|2|||
130648854|NCT01589185|470333143|FG003|Overall Study|Death|0|||
130648855|NCT01589185|470333144|FG004|Overall Study|Death|1|||
130648856|NCT01589185|470333140|FG000|Overall Study|Lost to Follow-up|1|||
130648857|NCT01589185|470333141|FG001|Overall Study|Lost to Follow-up|0|||
130648858|NCT01589185|470333142|FG002|Overall Study|Lost to Follow-up|2|||
130648859|NCT01589185|470333143|FG003|Overall Study|Lost to Follow-up|3|||
130648860|NCT01589185|470333144|FG004|Overall Study|Lost to Follow-up|0|||
130648861|NCT02046993|470333145|FG000|Overall Study|Withdrawal by Subject|2|||
130648862|NCT02046993|470333146|FG001|Overall Study|Withdrawal by Subject|10|||
130648863|NCT02046993|470333145|FG000|Overall Study|Lost to Follow-up|1|||
130648864|NCT02046993|470333146|FG001|Overall Study|Lost to Follow-up|1|||
130648865|NCT00598442|470333149|FG000|Overall Study|Adverse Event|3|||
130648866|NCT00598442|470333150|FG001|Overall Study|Adverse Event|0|||
130648867|NCT00598442|470333151|FG002|Overall Study|Adverse Event|0|||
130648868|NCT00598442|470333149|FG000|Overall Study|Death|19|||
130648869|NCT00598442|470333150|FG001|Overall Study|Death|11|||
130648870|NCT00598442|470333151|FG002|Overall Study|Death|11|||
130648871|NCT00598442|470333149|FG000|Overall Study|Lost to Follow-up|4|||
130648872|NCT00598442|470333150|FG001|Overall Study|Lost to Follow-up|3|||
130648873|NCT00598442|470333151|FG002|Overall Study|Lost to Follow-up|3|||
130648874|NCT00598442|470333149|FG000|Overall Study|Physician Decision|2|||
130648875|NCT00598442|470333150|FG001|Overall Study|Physician Decision|1|||
130648876|NCT00598442|470333151|FG002|Overall Study|Physician Decision|1|||
130648877|NCT00598442|470333149|FG000|Overall Study|Withdrawal by Subject|8|||
130648878|NCT00598442|470333150|FG001|Overall Study|Withdrawal by Subject|16|||
130648879|NCT00598442|470333151|FG002|Overall Study|Withdrawal by Subject|6|||
130648880|NCT00598442|470333149|FG000|Overall Study|Noncompliance|0|||
130648881|NCT00598442|470333150|FG001|Overall Study|Noncompliance|2|||
130648882|NCT00598442|470333151|FG002|Overall Study|Noncompliance|1|||
130648883|NCT00598442|470333149|FG000|Overall Study|Relocation|1|||
130648884|NCT00598442|470333150|FG001|Overall Study|Relocation|4|||
130648885|NCT00598442|470333151|FG002|Overall Study|Relocation|0|||
130648886|NCT00598442|470333149|FG000|Overall Study|Renal transplant|0|||
130648887|NCT00598442|470333150|FG001|Overall Study|Renal transplant|0|||
130648888|NCT00598442|470333151|FG002|Overall Study|Renal transplant|1|||
130648889|NCT00598442|470333149|FG000|Overall Study|Site closed by sponsor|5|||
130648890|NCT00598442|470333150|FG001|Overall Study|Site closed by sponsor|2|||
130648891|NCT00598442|470333151|FG002|Overall Study|Site closed by sponsor|1|||
130648892|NCT00598442|470333149|FG000|Overall Study|Started dialysis|1|||
130648893|NCT00598442|470333150|FG001|Overall Study|Started dialysis|0|||
130648894|NCT00598442|470333151|FG002|Overall Study|Started dialysis|0|||
130648895|NCT01654666|470333152|FG000|Overall Study|Protocol Violation|7|||
130648896|NCT01654666|470333153|FG001|Overall Study|Protocol Violation|4|||
130648897|NCT01654666|470333154|FG002|Overall Study|Protocol Violation|8|||
130648898|NCT01654666|470333152|FG000|Overall Study|Lost to Follow-up|4|||
130648899|NCT01654666|470333153|FG001|Overall Study|Lost to Follow-up|5|||
130648900|NCT01654666|470333154|FG002|Overall Study|Lost to Follow-up|5|||
130648901|NCT01654666|470333152|FG000|Overall Study|Withdrawal by Subject|4|||
130648902|NCT01654666|470333153|FG001|Overall Study|Withdrawal by Subject|4|||
130648903|NCT01654666|470333154|FG002|Overall Study|Withdrawal by Subject|1|||
130648904|NCT00368069|470333157|FG000|Overall Study|Adverse Event|5|||
130648905|NCT00368069|470333158|FG001|Overall Study|Adverse Event|2|||
130648906|NCT00368069|470333157|FG000|Overall Study|Lack of Efficacy|0|||
130648907|NCT00368069|470333158|FG001|Overall Study|Lack of Efficacy|1|||
130648908|NCT00368069|470333157|FG000|Overall Study|Lost to Follow-up|1|||
130648909|NCT00368069|470333158|FG001|Overall Study|Lost to Follow-up|0|||
130648910|NCT00368069|470333157|FG000|Overall Study|Protocol Violation|0|||
130648911|NCT00368069|470333158|FG001|Overall Study|Protocol Violation|2|||
130648912|NCT00368069|470333157|FG000|Overall Study|Withdrawal of Consent|2|||
130648913|NCT00368069|470333158|FG001|Overall Study|Withdrawal of Consent|1|||
130648914|NCT00368069|470333157|FG000|Overall Study|no blood sampling possible|0|||
130648915|NCT00368069|470333158|FG001|Overall Study|no blood sampling possible|1|||
130648916|NCT03907072|470333162|FG000|Overall Study|Study Terminated by Sponsor|2|||
130648917|NCT03907072|470333163|FG001|Overall Study|Study Terminated by Sponsor|2|||
130648918|NCT03907072|470333164|FG002|Overall Study|Study Terminated by Sponsor|2|||
130648919|NCT01430559|470333168|FG000|Overall Study|Adverse Event|7|||
130648920|NCT01430559|470333169|FG001|Overall Study|Adverse Event|3|||
130648921|NCT01430559|470333168|FG000|Overall Study|Entry criteria not met|1|||
130648922|NCT01430559|470333169|FG001|Overall Study|Entry criteria not met|1|||
130648923|NCT01430559|470333168|FG000|Overall Study|Lost to Follow-up|1|||
130648924|NCT01430559|470333169|FG001|Overall Study|Lost to Follow-up|0|||
130648925|NCT01430559|470333168|FG000|Overall Study|Medication error|1|||
130648926|NCT01430559|470333169|FG001|Overall Study|Medication error|0|||
130648927|NCT01430559|470333168|FG000|Overall Study|Withdrawal by Subject|3|||
130648928|NCT01430559|470333169|FG001|Overall Study|Withdrawal by Subject|2|||
130648929|NCT01430559|470333168|FG000|Overall Study|Protocol Violation|1|||
130648930|NCT01430559|470333169|FG001|Overall Study|Protocol Violation|0|||
130648931|NCT01430559|470333168|FG000|Overall Study|Other|3|||
130648932|NCT01430559|470333169|FG001|Overall Study|Other|3|||
130648933|NCT01430559|470333168|FG000|Overall Study|Randomized, Not Treated|3|||
130648934|NCT01430559|470333169|FG001|Overall Study|Randomized, Not Treated|3|||
130648935|NCT01177943|470333170|FG000|First Intervention|Withdrawal by Subject|2|||
130648936|NCT01177943|470333171|FG001|First Intervention|Withdrawal by Subject|0|||
130648937|NCT00672490|470333172|FG000|Overall Study|Withdrawal by Subject|8|||
130648938|NCT00672490|470333173|FG001|Overall Study|Withdrawal by Subject|8|||
130648939|NCT00672490|470333172|FG000|Overall Study|Lack of Compliance|2|||
130648940|NCT00672490|470333173|FG001|Overall Study|Lack of Compliance|7|||
130648941|NCT00672490|470333172|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
130648942|NCT00672490|470333173|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
130648943|NCT00672490|470333172|FG000|Overall Study|Adverse Event|5|||
130648944|NCT00672490|470333173|FG001|Overall Study|Adverse Event|8|||
130648945|NCT00672490|470333172|FG000|Overall Study|Violation of Concomitant Medicine|1|||
130648946|NCT00672490|470333173|FG001|Overall Study|Violation of Concomitant Medicine|0|||
130648947|NCT00672490|470333172|FG000|Overall Study|Intolerance|0|||
130648948|NCT00672490|470333173|FG001|Overall Study|Intolerance|2|||
130648949|NCT00672490|470333172|FG000|Overall Study|Lost to Follow-up|1|||
130648950|NCT00672490|470333173|FG001|Overall Study|Lost to Follow-up|5|||
130648951|NCT00672490|470333172|FG000|Overall Study|No reason was provided|6|||
130648952|NCT00672490|470333173|FG001|Overall Study|No reason was provided|2|||
130648953|NCT03319160|470333176|FG000|Overall Study|Data not available.|7|||
130648954|NCT03604159|470333177|FG000|Overall Study|Lost to Follow-up|6|||
130648955|NCT03604159|470333178|FG001|Overall Study|Lost to Follow-up|7|||
130648956|NCT04533204|470333181|FG000|Overall Study|Unable to understand training instructions|1|||
130648957|NCT04533204|470333182|FG001|Overall Study|Unable to understand training instructions|1|||
130648958|NCT00697255|470333183|FG000|Stage 1a|Insufficient ovarian response|1|||
130648959|NCT00697255|470333184|FG001|Stage 1a|Insufficient ovarian response|0|||
130648960|NCT00697255|470333183|FG000|Stage 1a|Multifollicular growth|1|||
130648961|NCT00697255|470333184|FG001|Stage 1a|Multifollicular growth|0|||
130648962|NCT00697255|470333183|FG000|Stage 1a|Not growing of dominant follicle|1|||
130648963|NCT00697255|470333184|FG001|Stage 1a|Not growing of dominant follicle|0|||
130648964|NCT00697255|470333183|FG000|Stage 1b|Not growing of dominant follicle|0|||
130648965|NCT00697255|470333184|FG001|Stage 1b|Not growing of dominant follicle|1|||
130648966|NCT00697255|470333183|FG000|Stage 1b|Insufficient ovarian response|0|||
130648967|NCT00697255|470333184|FG001|Stage 1b|Insufficient ovarian response|1|||
130648968|NCT01303159|470333188|FG000|Overall Study|Death|16|||
130648969|NCT01303159|470333188|FG000|Overall Study|Study Termination|7|||
130648970|NCT00955682|470333189|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
130648971|NCT00955682|470333190|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
130648972|NCT02926833|470335247|FG000|Overall Study|Death|1|||
130648973|NCT02926833|470335248|FG001|Overall Study|Death|1|||
130648974|NCT02926833|470335249|FG002|Overall Study|Death|2|||
130648975|NCT02926833|470335250|FG003|Overall Study|Death|13|||
130648976|NCT02926833|470335247|FG000|Overall Study|Lost to Follow-up|1|||
130648977|NCT02926833|470335248|FG001|Overall Study|Lost to Follow-up|2|||
130648978|NCT02926833|470335249|FG002|Overall Study|Lost to Follow-up|0|||
130648979|NCT02926833|470335250|FG003|Overall Study|Lost to Follow-up|3|||
130648980|NCT02926833|470335247|FG000|Overall Study|Full Consent Withdrawal|0|||
130648981|NCT02926833|470335248|FG001|Overall Study|Full Consent Withdrawal|0|||
130648982|NCT02926833|470335249|FG002|Overall Study|Full Consent Withdrawal|0|||
130648983|NCT02926833|470335250|FG003|Overall Study|Full Consent Withdrawal|2|||
130648984|NCT02926833|470335247|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
130648985|NCT02926833|470335248|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
130648986|NCT02926833|470335249|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
130648987|NCT02926833|470335250|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
130648988|NCT02926833|470335247|FG000|Overall Study|Investigator Decision|0|||
130648989|NCT02926833|470335248|FG001|Overall Study|Investigator Decision|1|||
130648990|NCT02926833|470335249|FG002|Overall Study|Investigator Decision|0|||
130648991|NCT02926833|470335250|FG003|Overall Study|Investigator Decision|0|||
130648992|NCT02926833|470335247|FG000|Overall Study|Adverse Event|0|||
130648993|NCT02926833|470335248|FG001|Overall Study|Adverse Event|0|||
130648994|NCT02926833|470335249|FG002|Overall Study|Adverse Event|1|||
130648995|NCT02926833|470335250|FG003|Overall Study|Adverse Event|0|||
130648996|NCT02926833|470335247|FG000|Overall Study|Partial Withdrawal of Consent|0|||
130648997|NCT02926833|470335248|FG001|Overall Study|Partial Withdrawal of Consent|0|||
130648998|NCT02926833|470335249|FG002|Overall Study|Partial Withdrawal of Consent|0|||
130648999|NCT02926833|470335250|FG003|Overall Study|Partial Withdrawal of Consent|1|||
130649000|NCT01189201|470335253|FG000|Overall Study|Adverse Event|1|||
130649001|NCT01277757|470335254|FG000|Overall Study|Disease Progression|1|||
130649002|NCT01277757|470335254|FG000|Overall Study|Withdrawal by Subject|1|||
130649003|NCT04308668|470335255|FG000|Overall Study|Lost to Follow-up|32|||
130649004|NCT04308668|470335256|FG001|Overall Study|Lost to Follow-up|38|||
130649005|NCT04308668|470335255|FG000|Overall Study|Withdrawal by Subject|4|||
130649006|NCT04308668|470335256|FG001|Overall Study|Withdrawal by Subject|4|||
130649007|NCT01336647|470335257|FG000|Overall Study|Lost to Follow-up|4|||
130649008|NCT01336647|470335258|FG001|Overall Study|Lost to Follow-up|1|||
130649009|NCT01336647|470335259|FG002|Overall Study|Lost to Follow-up|3|||
130649010|NCT03808298|470335260|FG000|Overall Study|Adverse Event|3|||
130649011|NCT03808298|470335260|FG000|Overall Study|Physician Decision|1|||
130649012|NCT03808298|470335260|FG000|Overall Study|Withdrawal by Subject|1|||
130649013|NCT03808298|470335260|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
130649014|NCT01801475|470335261|FG000|Overall Study|Withdrawal by Subject|0|||
130649015|NCT01801475|470335262|FG001|Overall Study|Withdrawal by Subject|0|||
130649016|NCT01801475|470335263|FG002|Overall Study|Withdrawal by Subject|0|||
130649017|NCT01801475|470335264|FG003|Overall Study|Withdrawal by Subject|0|||
130649018|NCT01801475|470335265|FG004|Overall Study|Withdrawal by Subject|1|||
130649019|NCT00421928|470335266|FG000|Overall Study|Adverse Event|61|||
130649020|NCT00421928|470335267|FG001|Overall Study|Adverse Event|140|||
130649021|NCT00421928|470335268|FG002|Overall Study|Adverse Event|22|||
130649022|NCT00421928|470335266|FG000|Overall Study|Lost to Follow-up|5|||
130649023|NCT00421928|470335267|FG001|Overall Study|Lost to Follow-up|0|||
130649024|NCT00421928|470335268|FG002|Overall Study|Lost to Follow-up|3|||
130649025|NCT00421928|470335266|FG000|Overall Study|Withdrawal by Subject|50|||
130649026|NCT00421928|470335267|FG001|Overall Study|Withdrawal by Subject|48|||
130649027|NCT00421928|470335268|FG002|Overall Study|Withdrawal by Subject|43|||
130649028|NCT00421928|470335266|FG000|Overall Study|Lack of Efficacy|15|||
130649029|NCT00421928|470335267|FG001|Overall Study|Lack of Efficacy|7|||
130649030|NCT00421928|470335268|FG002|Overall Study|Lack of Efficacy|35|||
130649031|NCT00421928|470335266|FG000|Overall Study|Study drug non-compliant|6|||
130649032|NCT00421928|470335267|FG001|Overall Study|Study drug non-compliant|7|||
130649033|NCT00421928|470335268|FG002|Overall Study|Study drug non-compliant|4|||
130649034|NCT00421928|470335266|FG000|Overall Study|All other|26|||
130649035|NCT00421928|470335267|FG001|Overall Study|All other|21|||
130649036|NCT00421928|470335268|FG002|Overall Study|All other|27|||
130649037|NCT00421928|470335266|FG000|Overall Study|Death|0|||
130649038|NCT00421928|470335267|FG001|Overall Study|Death|1|||
130649039|NCT00421928|470335268|FG002|Overall Study|Death|0|||
130649040|NCT01928758|470335299|FG000|Overall Study|Lost to Follow-up|14|||
130649041|NCT01928758|470335300|FG001|Overall Study|Lost to Follow-up|9|||
130649042|NCT01928758|470335299|FG000|Overall Study|Withdrawal by Subject|5|||
130649043|NCT01928758|470335300|FG001|Overall Study|Withdrawal by Subject|2|||
130649044|NCT01928758|470335299|FG000|Overall Study|Adverse Event|3|||
130649045|NCT01928758|470335300|FG001|Overall Study|Adverse Event|5|||
130649046|NCT01928758|470335299|FG000|Overall Study|Protocol Violation|3|||
130649047|NCT01928758|470335300|FG001|Overall Study|Protocol Violation|4|||
130649048|NCT00719706|470335301|FG000|Overall Study|Adverse Event|5|||
130649049|NCT00719706|470335302|FG001|Overall Study|Adverse Event|4|||
130649050|NCT00719706|470335301|FG000|Overall Study|Withdrawal by Subject|1|||
130649051|NCT00719706|470335302|FG001|Overall Study|Withdrawal by Subject|2|||
130649052|NCT00719706|470335301|FG000|Overall Study|Protocol Violation|3|||
130649053|NCT00719706|470335302|FG001|Overall Study|Protocol Violation|0|||
130649054|NCT02452320|470335306|FG000|Overall Study|Adverse Event|0|||
130649055|NCT02452320|470335307|FG001|Overall Study|Adverse Event|1|||
130649056|NCT03198559|470335308|FG000|Overall Study|Adverse Event|2|||
130649057|NCT01072175|470335309|FG000|Part A (Drug-Drug Interaction)|Death|1|||
130649058|NCT01072175|470335310|FG001|Part A (Drug-Drug Interaction)|Death|0|||
130649059|NCT01072175|470335311|FG002|Part A (Drug-Drug Interaction)|Death|0|||
130649060|NCT01072175|470335312|FG003|Part A (Drug-Drug Interaction)|Death|0|||
130649061|NCT01072175|470335313|FG004|Part A (Drug-Drug Interaction)|Death|0|||
130649062|NCT01072175|470335314|FG005|Part A (Drug-Drug Interaction)|Death|0|||
130649063|NCT01072175|470335315|FG006|Part A (Drug-Drug Interaction)|Death|0|||
130649064|NCT01072175|470335316|FG007|Part A (Drug-Drug Interaction)|Death|0|||
130649065|NCT01072175|470335317|FG008|Part A (Drug-Drug Interaction)|Death|0|||
130649066|NCT01072175|470335318|FG009|Part A (Drug-Drug Interaction)|Death|0|||
130649067|NCT01072175|470335319|FG010|Part A (Drug-Drug Interaction)|Death|0|||
130649068|NCT01072175|470335320|FG011|Part A (Drug-Drug Interaction)|Death|0|||
130649069|NCT01072175|470335321|FG012|Part A (Drug-Drug Interaction)|Death|0|||
130649070|NCT01072175|470335309|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
130649071|NCT01072175|470335310|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649072|NCT01072175|470335311|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649073|NCT01072175|470335312|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649074|NCT01072175|470335313|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649075|NCT01072175|470335314|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649076|NCT01072175|470335315|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649077|NCT01072175|470335316|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649078|NCT01072175|470335317|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649079|NCT01072175|470335318|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649080|NCT01072175|470335319|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649081|NCT01072175|470335320|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649082|NCT01072175|470335321|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130649083|NCT01072175|470335309|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
130649084|NCT01072175|470335310|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649085|NCT01072175|470335311|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649086|NCT01072175|470335312|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649087|NCT01072175|470335313|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649088|NCT01072175|470335314|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649089|NCT01072175|470335315|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649090|NCT01072175|470335316|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649091|NCT01072175|470335317|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649092|NCT01072175|470335318|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649093|NCT01072175|470335319|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649094|NCT01072175|470335320|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649095|NCT01072175|470335321|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130649096|NCT01072175|470335309|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
130649097|NCT01072175|470335310|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
130649098|NCT01072175|470335311|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
130649099|NCT01072175|470335312|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
130649100|NCT01072175|470335313|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
130649101|NCT01072175|470335314|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
130649102|NCT01072175|470335315|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
130649103|NCT01072175|470335316|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
130649104|NCT01072175|470335317|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
130649105|NCT01072175|470335318|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
130649106|NCT01072175|470335319|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
130649107|NCT01072175|470335320|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
130649108|NCT01072175|470335321|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
130649109|NCT01072175|470335309|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649110|NCT01072175|470335310|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649111|NCT01072175|470335311|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
130649112|NCT01072175|470335312|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649113|NCT01072175|470335313|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
130649114|NCT01072175|470335314|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649115|NCT01072175|470335315|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649116|NCT01072175|470335316|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649117|NCT01072175|470335317|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649118|NCT01072175|470335318|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649119|NCT01072175|470335319|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649120|NCT01072175|470335320|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649121|NCT01072175|470335321|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130649122|NCT01072175|470335309|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649123|NCT01072175|470335310|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
130649124|NCT01072175|470335311|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649125|NCT01072175|470335312|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
130649126|NCT01072175|470335313|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
130649127|NCT01072175|470335314|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649128|NCT01072175|470335315|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649129|NCT01072175|470335316|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649130|NCT01072175|470335317|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649131|NCT01072175|470335318|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649132|NCT01072175|470335319|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649133|NCT01072175|470335320|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649134|NCT01072175|470335321|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130649135|NCT01072175|470335309|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649136|NCT01072175|470335310|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649137|NCT01072175|470335311|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
130649138|NCT01072175|470335312|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
130649139|NCT01072175|470335313|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
130649140|NCT01072175|470335314|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649141|NCT01072175|470335315|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649142|NCT01072175|470335316|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649143|NCT01072175|470335317|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649144|NCT01072175|470335318|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649145|NCT01072175|470335319|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649146|NCT01072175|470335320|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649147|NCT01072175|470335321|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130649148|NCT01072175|470335309|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649149|NCT01072175|470335310|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
130649150|NCT01072175|470335311|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649151|NCT01072175|470335312|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
130649152|NCT01072175|470335313|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
130649153|NCT01072175|470335314|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649154|NCT01072175|470335315|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649155|NCT01072175|470335316|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649156|NCT01072175|470335317|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649157|NCT01072175|470335318|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649158|NCT01072175|470335319|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649159|NCT01072175|470335320|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649160|NCT01072175|470335321|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130649161|NCT01072175|470335309|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
130649162|NCT01072175|470335310|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
130649163|NCT01072175|470335311|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
130649164|NCT01072175|470335312|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
130649165|NCT01072175|470335313|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
130649166|NCT01072175|470335314|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
130649167|NCT01072175|470335315|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
130649168|NCT01072175|470335316|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
130649169|NCT01072175|470335317|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
130649170|NCT01072175|470335318|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
130649171|NCT01072175|470335319|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
130649172|NCT01072175|470335320|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
130649173|NCT01072175|470335321|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
130649174|NCT01072175|470335309|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649175|NCT01072175|470335310|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649176|NCT01072175|470335311|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649177|NCT01072175|470335312|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649178|NCT01072175|470335313|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649179|NCT01072175|470335314|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130649180|NCT01072175|470335315|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130649181|NCT01072175|470335316|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130649182|NCT01072175|470335317|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649183|NCT01072175|470335318|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649184|NCT01072175|470335319|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649185|NCT01072175|470335320|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649186|NCT01072175|470335321|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130649187|NCT01072175|470335309|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649188|NCT01072175|470335310|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649189|NCT01072175|470335311|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649190|NCT01072175|470335312|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649191|NCT01072175|470335313|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649192|NCT01072175|470335314|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649193|NCT01072175|470335315|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
130649194|NCT01072175|470335316|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
130649195|NCT01072175|470335317|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649196|NCT01072175|470335318|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649197|NCT01072175|470335319|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649198|NCT01072175|470335320|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649199|NCT01072175|470335321|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130649200|NCT01072175|470335309|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649201|NCT01072175|470335310|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649202|NCT01072175|470335311|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649203|NCT01072175|470335312|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649204|NCT01072175|470335313|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649205|NCT01072175|470335314|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
130649206|NCT01072175|470335315|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
130649207|NCT01072175|470335316|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
130649208|NCT01072175|470335317|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649209|NCT01072175|470335318|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649210|NCT01072175|470335319|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649211|NCT01072175|470335320|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649212|NCT01072175|470335321|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130649213|NCT01072175|470335309|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649214|NCT01072175|470335310|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649215|NCT01072175|470335311|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649216|NCT01072175|470335312|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649217|NCT01072175|470335313|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649218|NCT01072175|470335314|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
130649219|NCT01072175|470335315|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
130649220|NCT01072175|470335316|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649221|NCT01072175|470335317|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649222|NCT01072175|470335318|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649223|NCT01072175|470335319|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649224|NCT01072175|470335320|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649225|NCT01072175|470335321|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130649226|NCT01072175|470335309|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649227|NCT01072175|470335310|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649228|NCT01072175|470335311|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649229|NCT01072175|470335312|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649230|NCT01072175|470335313|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649231|NCT01072175|470335314|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649232|NCT01072175|470335315|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649233|NCT01072175|470335316|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649234|NCT01072175|470335317|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
130649235|NCT01072175|470335318|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649236|NCT01072175|470335319|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649237|NCT01072175|470335320|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649238|NCT01072175|470335321|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130649239|NCT01072175|470335309|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649240|NCT01072175|470335310|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649241|NCT01072175|470335311|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649242|NCT01072175|470335312|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649243|NCT01072175|470335313|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649244|NCT01072175|470335314|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649245|NCT01072175|470335315|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649246|NCT01072175|470335316|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649247|NCT01072175|470335317|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
130649248|NCT01072175|470335318|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649249|NCT01072175|470335319|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649250|NCT01072175|470335320|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649251|NCT01072175|470335321|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130649252|NCT01072175|470335309|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649253|NCT01072175|470335310|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649254|NCT01072175|470335311|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649255|NCT01072175|470335312|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649256|NCT01072175|470335313|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649257|NCT01072175|470335314|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649258|NCT01072175|470335315|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649259|NCT01072175|470335316|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649260|NCT01072175|470335317|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
130649261|NCT01072175|470335318|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649262|NCT01072175|470335319|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649263|NCT01072175|470335320|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649264|NCT01072175|470335321|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130649265|NCT01072175|470335309|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649266|NCT01072175|470335310|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649267|NCT01072175|470335311|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649268|NCT01072175|470335312|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649269|NCT01072175|470335313|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649270|NCT01072175|470335314|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649271|NCT01072175|470335315|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649272|NCT01072175|470335316|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649273|NCT01072175|470335317|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
130649274|NCT01072175|470335318|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649275|NCT01072175|470335319|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649276|NCT01072175|470335320|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649277|NCT01072175|470335321|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130649278|NCT01072175|470335309|FG000|Part D (HPMC Capsules)|Death|0|||
130649279|NCT01072175|470335310|FG001|Part D (HPMC Capsules)|Death|0|||
130649280|NCT01072175|470335311|FG002|Part D (HPMC Capsules)|Death|0|||
130649281|NCT01072175|470335312|FG003|Part D (HPMC Capsules)|Death|0|||
130649282|NCT01072175|470335313|FG004|Part D (HPMC Capsules)|Death|0|||
130649283|NCT01072175|470335314|FG005|Part D (HPMC Capsules)|Death|0|||
130649284|NCT01072175|470335315|FG006|Part D (HPMC Capsules)|Death|0|||
130649285|NCT01072175|470335316|FG007|Part D (HPMC Capsules)|Death|0|||
130649286|NCT01072175|470335317|FG008|Part D (HPMC Capsules)|Death|0|||
130649287|NCT01072175|470335318|FG009|Part D (HPMC Capsules)|Death|10|||
130649288|NCT01072175|470335319|FG010|Part D (HPMC Capsules)|Death|12|||
130649289|NCT01072175|470335320|FG011|Part D (HPMC Capsules)|Death|28|||
130649290|NCT01072175|470335321|FG012|Part D (HPMC Capsules)|Death|26|||
130649291|NCT01072175|470335309|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
130649292|NCT01072175|470335310|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
130649293|NCT01072175|470335311|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
130649294|NCT01072175|470335312|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
130649295|NCT01072175|470335313|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
130649296|NCT01072175|470335314|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
130649297|NCT01072175|470335315|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
130649298|NCT01072175|470335316|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
130649299|NCT01072175|470335317|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
130649300|NCT01072175|470335318|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
130649301|NCT01072175|470335319|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
130649302|NCT01072175|470335320|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
130649303|NCT01072175|470335321|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
130649304|NCT01072175|470335309|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649305|NCT01072175|470335310|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649306|NCT01072175|470335311|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649307|NCT01072175|470335312|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649308|NCT01072175|470335313|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649309|NCT01072175|470335314|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649310|NCT01072175|470335315|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649311|NCT01072175|470335316|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649312|NCT01072175|470335317|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649313|NCT01072175|470335318|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130649314|NCT01072175|470335319|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
130649315|NCT01072175|470335320|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
130649316|NCT01072175|470335321|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
130649317|NCT01072175|470335309|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649318|NCT01072175|470335310|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649319|NCT01072175|470335311|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649320|NCT01072175|470335312|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649321|NCT01072175|470335313|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649322|NCT01072175|470335314|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649323|NCT01072175|470335315|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649324|NCT01072175|470335316|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649325|NCT01072175|470335317|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
130649326|NCT01072175|470335318|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
130649327|NCT01072175|470335319|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
130649328|NCT01072175|470335320|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
130649329|NCT01072175|470335321|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
130649330|NCT01072175|470335309|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649331|NCT01072175|470335310|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649332|NCT01072175|470335311|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649333|NCT01072175|470335312|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649334|NCT01072175|470335313|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649335|NCT01072175|470335314|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649336|NCT01072175|470335315|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649337|NCT01072175|470335316|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649338|NCT01072175|470335317|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649339|NCT01072175|470335318|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649340|NCT01072175|470335319|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
130649341|NCT01072175|470335320|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
130649342|NCT01072175|470335321|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130649343|NCT02557308|470335322|FG000|Overall Study|Withdrawal by Subject|11|||
130649344|NCT02557308|470335323|FG001|Overall Study|Withdrawal by Subject|3|||
130649345|NCT02557308|470335324|FG002|Overall Study|Withdrawal by Subject|2|||
130649346|NCT02557308|470335325|FG003|Overall Study|Withdrawal by Subject|0|||
130649347|NCT02557308|470335326|FG004|Overall Study|Withdrawal by Subject|1|||
130649348|NCT02557308|470335327|FG005|Overall Study|Withdrawal by Subject|0|||
130649349|NCT02557308|470335328|FG006|Overall Study|Withdrawal by Subject|10|||
130649350|NCT02557308|470335329|FG007|Overall Study|Withdrawal by Subject|1|||
130649351|NCT02557308|470335322|FG000|Overall Study|Disease Progression|0|||
130649352|NCT02557308|470335323|FG001|Overall Study|Disease Progression|1|||
130649353|NCT02557308|470335324|FG002|Overall Study|Disease Progression|0|||
130649354|NCT02557308|470335325|FG003|Overall Study|Disease Progression|0|||
130649355|NCT02557308|470335326|FG004|Overall Study|Disease Progression|0|||
130649356|NCT02557308|470335327|FG005|Overall Study|Disease Progression|0|||
130649357|NCT02557308|470335328|FG006|Overall Study|Disease Progression|0|||
130649358|NCT02557308|470335329|FG007|Overall Study|Disease Progression|0|||
130649359|NCT02557308|470335322|FG000|Overall Study|Lack of Efficacy|3|||
130649360|NCT02557308|470335323|FG001|Overall Study|Lack of Efficacy|0|||
130649361|NCT02557308|470335324|FG002|Overall Study|Lack of Efficacy|0|||
130649362|NCT02557308|470335325|FG003|Overall Study|Lack of Efficacy|0|||
130649363|NCT02557308|470335326|FG004|Overall Study|Lack of Efficacy|0|||
130649364|NCT02557308|470335327|FG005|Overall Study|Lack of Efficacy|0|||
130649365|NCT02557308|470335328|FG006|Overall Study|Lack of Efficacy|1|||
130649366|NCT02557308|470335329|FG007|Overall Study|Lack of Efficacy|0|||
130649367|NCT02557308|470335322|FG000|Overall Study|Adverse Event|4|||
130649368|NCT02557308|470335323|FG001|Overall Study|Adverse Event|1|||
130649369|NCT02557308|470335324|FG002|Overall Study|Adverse Event|2|||
130649370|NCT02557308|470335325|FG003|Overall Study|Adverse Event|0|||
130649371|NCT02557308|470335326|FG004|Overall Study|Adverse Event|0|||
130649372|NCT02557308|470335327|FG005|Overall Study|Adverse Event|0|||
130649373|NCT02557308|470335328|FG006|Overall Study|Adverse Event|4|||
130649374|NCT02557308|470335329|FG007|Overall Study|Adverse Event|1|||
130649375|NCT02557308|470335322|FG000|Overall Study|Lost to Follow-up|2|||
130649376|NCT02557308|470335323|FG001|Overall Study|Lost to Follow-up|0|||
130649377|NCT02557308|470335324|FG002|Overall Study|Lost to Follow-up|1|||
130649378|NCT02557308|470335325|FG003|Overall Study|Lost to Follow-up|0|||
130649379|NCT02557308|470335326|FG004|Overall Study|Lost to Follow-up|0|||
130649380|NCT02557308|470335327|FG005|Overall Study|Lost to Follow-up|0|||
130649381|NCT02557308|470335328|FG006|Overall Study|Lost to Follow-up|2|||
130649382|NCT02557308|470335329|FG007|Overall Study|Lost to Follow-up|0|||
130649383|NCT02557308|470335322|FG000|Overall Study|Death|1|||
130649384|NCT02557308|470335323|FG001|Overall Study|Death|0|||
130649385|NCT02557308|470335324|FG002|Overall Study|Death|0|||
130649386|NCT02557308|470335325|FG003|Overall Study|Death|0|||
130649387|NCT02557308|470335326|FG004|Overall Study|Death|0|||
130649388|NCT02557308|470335327|FG005|Overall Study|Death|0|||
130649389|NCT02557308|470335328|FG006|Overall Study|Death|0|||
130649390|NCT02557308|470335329|FG007|Overall Study|Death|0|||
130649391|NCT02557308|470335322|FG000|Overall Study|Study Close|98|||
130649392|NCT02557308|470335323|FG001|Overall Study|Study Close|18|||
130649393|NCT02557308|470335324|FG002|Overall Study|Study Close|5|||
130649394|NCT02557308|470335325|FG003|Overall Study|Study Close|3|||
130649395|NCT02557308|470335326|FG004|Overall Study|Study Close|1|||
130649396|NCT02557308|470335327|FG005|Overall Study|Study Close|0|||
130649397|NCT02557308|470335328|FG006|Overall Study|Study Close|123|||
130649398|NCT02557308|470335329|FG007|Overall Study|Study Close|5|||
130649399|NCT02557308|470335322|FG000|Overall Study|Except for study close|5|||
130649400|NCT02557308|470335323|FG001|Overall Study|Except for study close|0|||
130649401|NCT02557308|470335324|FG002|Overall Study|Except for study close|0|||
130649402|NCT02557308|470335325|FG003|Overall Study|Except for study close|0|||
130649403|NCT02557308|470335326|FG004|Overall Study|Except for study close|3|||
130649404|NCT02557308|470335327|FG005|Overall Study|Except for study close|0|||
130649405|NCT02557308|470335328|FG006|Overall Study|Except for study close|6|||
130649406|NCT02557308|470335329|FG007|Overall Study|Except for study close|10|||
130649407|NCT01980056|470335332|FG000|Overall Study|Death|1|||
130649408|NCT01980056|470335333|FG001|Overall Study|Death|1|||
130649409|NCT01980056|470335334|FG002|Overall Study|Death|0|||
130649410|NCT00351611|470335335|FG000|Overall Study|Adverse Event|11|||
130649411|NCT00351611|470335336|FG001|Overall Study|Adverse Event|3|||
130649412|NCT00351611|470335335|FG000|Overall Study|Death|1|||
130649413|NCT00351611|470335336|FG001|Overall Study|Death|0|||
130649414|NCT00351611|470335335|FG000|Overall Study|Lost to Follow-up|1|||
130649415|NCT00351611|470335336|FG001|Overall Study|Lost to Follow-up|0|||
130649416|NCT00351611|470335335|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
130649417|NCT00351611|470335336|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
130649418|NCT00351611|470335335|FG000|Overall Study|Other|1|||
130649419|NCT00351611|470335336|FG001|Overall Study|Other|0|||
130649420|NCT00351611|470335335|FG000|Overall Study|Protocol Violation|0|||
130649421|NCT00351611|470335336|FG001|Overall Study|Protocol Violation|2|||
130649422|NCT00808665|470335337|FG000|Overall Study|Withdrawal by Subject|1|||
130649423|NCT00808665|470335338|FG001|Overall Study|Withdrawal by Subject|0|||
130649424|NCT00808665|470335337|FG000|Overall Study|only required minimally invasive surgery|1|||
130649425|NCT00808665|470335338|FG001|Overall Study|only required minimally invasive surgery|0|||
130649426|NCT00808665|470335337|FG000|Overall Study|surgery cancelled|1|||
130649427|NCT00808665|470335338|FG001|Overall Study|surgery cancelled|0|||
130649428|NCT00808665|470335337|FG000|Overall Study|required an additional procedure|0|||
130649429|NCT00808665|470335338|FG001|Overall Study|required an additional procedure|1|||
130649430|NCT00808665|470335337|FG000|Overall Study|Physician Decision|3|||
130649431|NCT00808665|470335338|FG001|Overall Study|Physician Decision|1|||
130649432|NCT00808665|470335337|FG000|Overall Study|Medication stopped by resident|0|||
130649433|NCT00808665|470335338|FG001|Overall Study|Medication stopped by resident|1|||
130649434|NCT00665002|470335339|FG000|Overall Study|Progression/relapse during treatment|11|||
130649435|NCT00665002|470335339|FG000|Overall Study|Cytogenetic resistance|1|||
130649436|NCT00496782|470335350|FG000|Overall Study|Protocol Violation|1|||
130649437|NCT00496782|470335351|FG001|Overall Study|Protocol Violation|2|||
130649438|NCT01288911|470335356|FG000|Double-blind Period|Death|11|||
130649439|NCT01288911|470335357|FG001|Double-blind Period|Death|7|||
130649440|NCT01288911|470335356|FG000|Double-blind Period|Lost to Follow-up|0|||
130649441|NCT01288911|470335357|FG001|Double-blind Period|Lost to Follow-up|2|||
130649442|NCT01288911|470335356|FG000|Double-blind Period|Progressive Disease|75|||
130649443|NCT01288911|470335357|FG001|Double-blind Period|Progressive Disease|103|||
130649444|NCT01288911|470335356|FG000|Double-blind Period|Protocol Violation|1|||
130649445|NCT01288911|470335357|FG001|Double-blind Period|Protocol Violation|0|||
130649446|NCT01288911|470335356|FG000|Double-blind Period|Withdrawal by Subject|25|||
130649447|NCT01288911|470335357|FG001|Double-blind Period|Withdrawal by Subject|26|||
130649448|NCT01288911|470335356|FG000|Double-blind Period|Miscellaneous Reason|29|||
130649449|NCT01288911|470335357|FG001|Double-blind Period|Miscellaneous Reason|42|||
130649450|NCT01288911|470335356|FG000|Double-blind Period|Randomized but never received study drug|1|||
130649451|NCT01288911|470335357|FG001|Double-blind Period|Randomized but never received study drug|2|||
130649452|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Death|0|||
130649453|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Death|1|||
130649454|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
130649455|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
130649456|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
130649457|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
130649458|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
130649459|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
130649460|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
130649461|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
130649462|NCT01288911|470335356|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
130649463|NCT01288911|470335357|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
130649464|NCT02431559|470335358|FG000|Overall Study|Adverse Event|0|||
130649465|NCT02431559|470335359|FG001|Overall Study|Adverse Event|1|||
130649466|NCT02431559|470335360|FG002|Overall Study|Adverse Event|0|||
130649467|NCT02431559|470335361|FG003|Overall Study|Adverse Event|4|||
130649468|NCT02431559|470335358|FG000|Overall Study|Progressive disease|2|||
130649469|NCT02431559|470335359|FG001|Overall Study|Progressive disease|1|||
130649470|NCT02431559|470335360|FG002|Overall Study|Progressive disease|4|||
130649471|NCT02431559|470335361|FG003|Overall Study|Progressive disease|22|||
130649472|NCT02431559|470335358|FG000|Overall Study|Withdrawal by Subject|0|||
130649473|NCT02431559|470335359|FG001|Overall Study|Withdrawal by Subject|1|||
130649474|NCT02431559|470335360|FG002|Overall Study|Withdrawal by Subject|0|||
130649475|NCT02431559|470335361|FG003|Overall Study|Withdrawal by Subject|4|||
130649476|NCT02431559|470335358|FG000|Overall Study|Physician Decision|0|||
130649477|NCT02431559|470335359|FG001|Overall Study|Physician Decision|0|||
130649478|NCT02431559|470335360|FG002|Overall Study|Physician Decision|0|||
130649479|NCT02431559|470335361|FG003|Overall Study|Physician Decision|1|||
130649480|NCT02543918|470335362|FG000|Overall Study|Never treated|0|||
130649481|NCT02543918|470335363|FG001|Overall Study|Never treated|1|||
130649482|NCT02543918|470335362|FG000|Overall Study|Lost to Follow-up|1|||
130649483|NCT02543918|470335363|FG001|Overall Study|Lost to Follow-up|1|||
130649484|NCT02543918|470335362|FG000|Overall Study|Withdrawal by Subject|1|||
130649485|NCT02543918|470335363|FG001|Overall Study|Withdrawal by Subject|1|||
130649486|NCT02543918|470335362|FG000|Overall Study|Adverse Event|1|||
130649487|NCT02543918|470335363|FG001|Overall Study|Adverse Event|1|||
130649488|NCT01005875|470335368|FG000|Overall Study|Death|3|||
130649489|NCT01348828|470335371|FG000|Overall Study|Death|20|||
130649490|NCT01348828|470335371|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
130649491|NCT01348828|470335371|FG000|Overall Study|Conversion|2|||
130649492|NCT01348828|470335371|FG000|Overall Study|missed visit|1|||
130649493|NCT00242658|470335374|FG000|Overall Study|Lost to Follow-up|22|||
130649494|NCT00242658|470335375|FG001|Overall Study|Lost to Follow-up|19|||
130649495|NCT01815099|470335376|FG000|Overall Study|Lack of Efficacy|1|||
130649496|NCT01815099|470335376|FG000|Overall Study|unable to attend study visits|1|||
130649497|NCT00643851|470335377|FG000|Overall Study|Death|0|||
130649498|NCT00643851|470335378|FG001|Overall Study|Death|1|||
130649499|NCT00643851|470335379|FG002|Overall Study|Death|0|||
130649500|NCT00643851|470335377|FG000|Overall Study|Lack of Efficacy|0|||
130649501|NCT00643851|470335378|FG001|Overall Study|Lack of Efficacy|1|||
130649502|NCT00643851|470335379|FG002|Overall Study|Lack of Efficacy|0|||
130649503|NCT00643851|470335377|FG000|Overall Study|Adverse Event|2|||
130649504|NCT00643851|470335378|FG001|Overall Study|Adverse Event|6|||
130649505|NCT00643851|470335379|FG002|Overall Study|Adverse Event|6|||
130649506|NCT00643851|470335377|FG000|Overall Study|Lost to Follow-up|4|||
130649507|NCT00643851|470335378|FG001|Overall Study|Lost to Follow-up|6|||
130649508|NCT00643851|470335379|FG002|Overall Study|Lost to Follow-up|9|||
130649509|NCT00643851|470335377|FG000|Overall Study|Withdrawal by Subject|8|||
130649510|NCT00643851|470335378|FG001|Overall Study|Withdrawal by Subject|15|||
130649511|NCT00643851|470335379|FG002|Overall Study|Withdrawal by Subject|9|||
130649512|NCT00643851|470335377|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
130649513|NCT00643851|470335378|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
130649514|NCT00643851|470335379|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
130649515|NCT04806334|470335382|FG000|Overall Study|Withdrawal by Subject|1|||
130649516|NCT04557189|470335383|FG000|Overall Study|Adverse Event|0|||
130649517|NCT04557189|470335384|FG001|Overall Study|Adverse Event|1|||
130649518|NCT04557189|470335383|FG000|Overall Study|Lost to Follow-up|1|||
130649519|NCT04557189|470335384|FG001|Overall Study|Lost to Follow-up|1|||
130649520|NCT04557189|470335383|FG000|Overall Study|Withdrawal by Subject|2|||
130649521|NCT04557189|470335384|FG001|Overall Study|Withdrawal by Subject|1|||
130649522|NCT04557189|470335383|FG000|Overall Study|Reason not Specified|3|||
130649523|NCT04557189|470335384|FG001|Overall Study|Reason not Specified|6|||
130649524|NCT01731600|470335387|FG000|Overall Study|Adverse Event|2|||
130649525|NCT01731600|470335388|FG001|Overall Study|Adverse Event|0|||
130649526|NCT01731600|470335387|FG000|Overall Study|Withdrawal criteria|1|||
130649527|NCT01731600|470335388|FG001|Overall Study|Withdrawal criteria|0|||
130649528|NCT01731600|470335387|FG000|Overall Study|Other reasons|3|||
130649529|NCT01731600|470335388|FG001|Overall Study|Other reasons|0|||
130649530|NCT00465894|470335389|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
130649531|NCT00465894|470335390|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
130649532|NCT00465894|470335389|FG000|Treatment For 12 Weeks|Family Issues|1|||
130649533|NCT00465894|470335390|FG001|Treatment For 12 Weeks|Family Issues|1|||
130649534|NCT00465894|470335389|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
130649535|NCT00465894|470335390|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
130649536|NCT01636076|470335391|FG000|Overall Study|Terminated by sponsor|1|||
130649537|NCT01636076|470335392|FG001|Overall Study|Terminated by sponsor|1|||
130649538|NCT01636076|470335391|FG000|Overall Study|Lack of Efficacy|0|||
130649539|NCT01636076|470335392|FG001|Overall Study|Lack of Efficacy|1|||
130649540|NCT01636076|470335391|FG000|Overall Study|Lost to Follow-up|1|||
130649541|NCT01636076|470335392|FG001|Overall Study|Lost to Follow-up|0|||
130649542|NCT01636076|470335391|FG000|Overall Study|Physician Decision|1|||
130649543|NCT01636076|470335392|FG001|Overall Study|Physician Decision|1|||
130649544|NCT01636076|470335391|FG000|Overall Study|Non-compliance with study treatment|1|||
130649545|NCT01636076|470335392|FG001|Overall Study|Non-compliance with study treatment|1|||
130649546|NCT01636076|470335391|FG000|Overall Study|Adverse Event|6|||
130649547|NCT01636076|470335392|FG001|Overall Study|Adverse Event|11|||
130649548|NCT01636076|470335391|FG000|Overall Study|Withdrawal by Subject|7|||
130649549|NCT01636076|470335392|FG001|Overall Study|Withdrawal by Subject|10|||
130649550|NCT02173158|470335394|FG000|Efficacy Phase|Adverse Event|1|||
130649551|NCT01728454|470335406|FG000|Stage 1 and 2|Pregnancy|1|||
130649552|NCT01728454|470335407|FG001|Stage 1 and 2|Pregnancy|0|||
130649553|NCT01728454|470335408|FG002|Stage 1 and 2|Pregnancy|0|||
130649554|NCT01728454|470335406|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
130649555|NCT01728454|470335407|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
130649556|NCT01728454|470335408|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
130649557|NCT01728454|470335406|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
130649558|NCT01728454|470335407|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
130649559|NCT01728454|470335408|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
130649560|NCT01728454|470335406|FG000|Stage 1 and 2|Lost to Follow-up|1|||
130649561|NCT01728454|470335407|FG001|Stage 1 and 2|Lost to Follow-up|1|||
130649562|NCT01728454|470335408|FG002|Stage 1 and 2|Lost to Follow-up|0|||
130649563|NCT01728454|470335406|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
130649564|NCT01728454|470335407|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
130649565|NCT01728454|470335408|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
130649566|NCT01728454|470335406|FG000|Stage 3|Reason Missing|0|||
130649567|NCT01728454|470335407|FG001|Stage 3|Reason Missing|0|||
130649568|NCT01728454|470335408|FG002|Stage 3|Reason Missing|1|||
130649569|NCT01728454|470335406|FG000|Stage 3|Subject Required Other Treatment|0|||
130649570|NCT01728454|470335407|FG001|Stage 3|Subject Required Other Treatment|1|||
130649571|NCT01728454|470335408|FG002|Stage 3|Subject Required Other Treatment|0|||
130649572|NCT01728454|470335406|FG000|Stage 3|Pregnancy|1|||
130649573|NCT01728454|470335407|FG001|Stage 3|Pregnancy|0|||
130649574|NCT01728454|470335408|FG002|Stage 3|Pregnancy|0|||
130649575|NCT01728454|470335406|FG000|Stage 3|Withdrew Consent|1|||
130649576|NCT01728454|470335407|FG001|Stage 3|Withdrew Consent|0|||
130649577|NCT01728454|470335408|FG002|Stage 3|Withdrew Consent|1|||
130649578|NCT01728454|470335406|FG000|Stage 3|Non-compliance with Protocol|0|||
130649579|NCT01728454|470335407|FG001|Stage 3|Non-compliance with Protocol|0|||
130649580|NCT01728454|470335408|FG002|Stage 3|Non-compliance with Protocol|1|||
130649581|NCT01728454|470335406|FG000|Stage 3|Lost to Follow-up|0|||
130649582|NCT01728454|470335407|FG001|Stage 3|Lost to Follow-up|3|||
130649583|NCT01728454|470335408|FG002|Stage 3|Lost to Follow-up|1|||
130649584|NCT01728454|470335406|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
130649585|NCT01728454|470335407|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
130649586|NCT01728454|470335408|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
130649587|NCT01190839|470335409|FG000|Overall Study|Adverse Event|32|||
130649588|NCT01190839|470335410|FG001|Overall Study|Adverse Event|41|||
130649589|NCT01190839|470335409|FG000|Overall Study|Protocol Violation|2|||
130649590|NCT01190839|470335410|FG001|Overall Study|Protocol Violation|2|||
130649591|NCT01190839|470335409|FG000|Overall Study|Lost to Follow-up|7|||
130649592|NCT01190839|470335410|FG001|Overall Study|Lost to Follow-up|1|||
130649593|NCT01190839|470335409|FG000|Overall Study|Death|1|||
130649594|NCT01190839|470335410|FG001|Overall Study|Death|0|||
130649595|NCT01190839|470335409|FG000|Overall Study|Trial stopped by Sponsor|71|||
130649596|NCT01190839|470335410|FG001|Overall Study|Trial stopped by Sponsor|68|||
130649597|NCT01190839|470335409|FG000|Overall Study|Undefined|35|||
130649598|NCT01190839|470335410|FG001|Overall Study|Undefined|31|||
130649599|NCT01190839|470335409|FG000|Overall Study|Randomized but not treated|2|||
130649600|NCT01190839|470335410|FG001|Overall Study|Randomized but not treated|4|||
130649601|NCT03077646|470335414|FG000|Overall Study|Lost to Follow-up|29|||
130649602|NCT03077646|470335415|FG001|Overall Study|Lost to Follow-up|30|||
130649603|NCT03077646|470335416|FG002|Overall Study|Lost to Follow-up|31|||
130649604|NCT00765726|470335417|FG000|Overall Study|Withdrawal by Subject|1|||
130649605|NCT00765726|470335417|FG000|Overall Study|Discontinuation of study by sponsor|8|||
130649606|NCT02058966|470335418|FG000|Open-Label Methamphetamine|Adverse Event|1|||
130649607|NCT02058966|470335418|FG000|First Intervention|Withdrawal by Subject|1|||
130649608|NCT02993731|470335419|FG000|Overall Study|Study Termination|101|||
130649609|NCT02993731|470335420|FG001|Overall Study|Study Termination|105|||
130649610|NCT01265511|470335421|FG000|Overall Study|Lack of Efficacy|2|||
130649611|NCT01265511|470335422|FG001|Overall Study|Lack of Efficacy|1|||
130649612|NCT01265511|470335421|FG000|Overall Study|Met stopping rules|0|||
130649613|NCT01265511|470335422|FG001|Overall Study|Met stopping rules|2|||
130649614|NCT00323479|470335423|FG000|Overall Study|Adverse Event|2|||
130649615|NCT00323479|470335423|FG000|Overall Study|Withdrawal by Subject|2|||
130649616|NCT00323479|470335423|FG000|Overall Study|Protocol Violation|3|||
130649617|NCT00323479|470335423|FG000|Overall Study|house moving|1|||
130649618|NCT01362062|470335426|FG000|Overall Study|Adverse Event|1|||
130649619|NCT01362062|470335427|FG001|Overall Study|Adverse Event|0|||
130649620|NCT01362062|470335426|FG000|Overall Study|Lost to Follow-up|11|||
130649621|NCT01362062|470335427|FG001|Overall Study|Lost to Follow-up|0|||
130649622|NCT01362062|470335426|FG000|Overall Study|Withdrawal by Subject|2|||
130649623|NCT01362062|470335427|FG001|Overall Study|Withdrawal by Subject|0|||
130649624|NCT01362062|470335426|FG000|Overall Study|Non-compliant participant|2|||
130649625|NCT01362062|470335427|FG001|Overall Study|Non-compliant participant|0|||
130649626|NCT01362062|470335426|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
130649627|NCT01362062|470335427|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
130649628|NCT01362062|470335426|FG000|Overall Study|Had significant improvement|9|||
130649629|NCT01362062|470335427|FG001|Overall Study|Had significant improvement|0|||
130649630|NCT02545504|470335430|FG000|Overall Study|Death|174|||
130649631|NCT02545504|470335431|FG001|Overall Study|Death|168|||
130649632|NCT02545504|470335430|FG000|Overall Study|Unknown reason|30|||
130649633|NCT02545504|470335431|FG001|Overall Study|Unknown reason|32|||
130649634|NCT02545504|470335430|FG000|Overall Study|Withdrew consent|9|||
130649635|NCT02545504|470335431|FG001|Overall Study|Withdrew consent|11|||
130649636|NCT02545504|470335430|FG000|Overall Study|Investigator's discretion|3|||
130649637|NCT02545504|470335431|FG001|Overall Study|Investigator's discretion|1|||
130649638|NCT02545504|470335430|FG000|Overall Study|Lost to Follow-up|2|||
130649639|NCT02545504|470335431|FG001|Overall Study|Lost to Follow-up|2|||
130649640|NCT00967343|470335432|FG000|Overall Study|Study termination by sponsor|12|||
130649641|NCT00967343|470335432|FG000|Overall Study|Death|24|||
130649642|NCT00967343|470335432|FG000|Overall Study|Relapse|1|||
130649643|NCT00967343|470335432|FG000|Overall Study|Lost to Follow-up|1|||
130649644|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
130649645|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
130649646|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
130649647|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130649648|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
130649649|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
130649650|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
130649651|NCT00950755|470335434|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
130649652|NCT00950755|470335434|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
130649653|NCT00950755|470335434|FG000|Long-Term Follow-Up|Death|8|||
130649654|NCT00508820|470335436|FG000|Overall Study|Adverse Event|6|||
130649655|NCT00508820|470335437|FG001|Overall Study|Adverse Event|10|||
130649656|NCT00508820|470335436|FG000|Overall Study|Death|6|||
130649657|NCT00508820|470335437|FG001|Overall Study|Death|8|||
130649658|NCT00508820|470335436|FG000|Overall Study|Lost to Follow-up|1|||
130649659|NCT00508820|470335437|FG001|Overall Study|Lost to Follow-up|1|||
130649660|NCT00508820|470335436|FG000|Overall Study|Physician Decision|8|||
130649661|NCT00508820|470335437|FG001|Overall Study|Physician Decision|2|||
130649662|NCT00508820|470335436|FG000|Overall Study|Pregnancy|0|||
130649663|NCT00508820|470335437|FG001|Overall Study|Pregnancy|2|||
130649664|NCT00508820|470335436|FG000|Overall Study|Protocol Violation|2|||
130649665|NCT00508820|470335437|FG001|Overall Study|Protocol Violation|0|||
130649666|NCT00508820|470335436|FG000|Overall Study|Withdrawal by Subject|10|||
130649667|NCT00508820|470335437|FG001|Overall Study|Withdrawal by Subject|12|||
130649668|NCT00508820|470335436|FG000|Overall Study|Other|11|||
130649669|NCT00508820|470335437|FG001|Overall Study|Other|2|||
130649670|NCT00508820|470335436|FG000|Overall Study|Noncompliance|1|||
130649671|NCT00508820|470335437|FG001|Overall Study|Noncompliance|0|||
130649672|NCT00508820|470335436|FG000|Overall Study|Requirement for alternative therapy|7|||
130649673|NCT00508820|470335437|FG001|Overall Study|Requirement for alternative therapy|15|||
130649674|NCT00508820|470335436|FG000|Overall Study|Protocol-specified Criteria|3|||
130649675|NCT00508820|470335437|FG001|Overall Study|Protocol-specified Criteria|12|||
130649676|NCT01266967|470337274|FG000|Overall Study|Death|69|||
130649677|NCT01266967|470337275|FG001|Overall Study|Death|61|||
130649678|NCT01266967|470337274|FG000|Overall Study|Study Closed/Terminated|15|||
130649679|NCT01266967|470337275|FG001|Overall Study|Study Closed/Terminated|17|||
130649680|NCT01266967|470337274|FG000|Overall Study|Lost to Follow-up|2|||
130649681|NCT01266967|470337275|FG001|Overall Study|Lost to Follow-up|1|||
130649682|NCT01266967|470337274|FG000|Overall Study|Physician Decision|0|||
130649683|NCT01266967|470337275|FG001|Overall Study|Physician Decision|1|||
130649684|NCT01266967|470337274|FG000|Overall Study|Withdrawal by Subject|3|||
130649685|NCT01266967|470337275|FG001|Overall Study|Withdrawal by Subject|3|||
130649686|NCT01945866|470337276|FG000|Overall Study|Eyes did not complete or were dropped|2|||
130649687|NCT01945866|470337277|FG001|Overall Study|Eyes did not complete or were dropped|0|||
130649688|NCT04398030|470337278|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
130649689|NCT04398030|470337279|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
130649690|NCT04398030|470337278|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
130649691|NCT04398030|470337279|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
130649692|NCT01674010|470337280|FG000|Open Treatment Phase 1|Adverse Event|10|||
130649693|NCT01674010|470337281|FG001|Open Treatment Phase 1|Adverse Event|0|||
130649694|NCT01674010|470337282|FG002|Open Treatment Phase 1|Adverse Event|0|||
130649695|NCT01674010|470337280|FG000|Open Treatment Phase 1|Death|1|||
130649696|NCT01674010|470337281|FG001|Open Treatment Phase 1|Death|0|||
130649697|NCT01674010|470337282|FG002|Open Treatment Phase 1|Death|0|||
130649698|NCT01674010|470337280|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
130649699|NCT01674010|470337281|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
130649700|NCT01674010|470337282|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
130649701|NCT01674010|470337280|FG000|Open Treatment Phase 1|Physician Decision|9|||
130649702|NCT01674010|470337281|FG001|Open Treatment Phase 1|Physician Decision|0|||
130649703|NCT01674010|470337282|FG002|Open Treatment Phase 1|Physician Decision|0|||
130649704|NCT01674010|470337280|FG000|Open Treatment Phase 1|Protocol Violation|7|||
130649705|NCT01674010|470337281|FG001|Open Treatment Phase 1|Protocol Violation|0|||
130649706|NCT01674010|470337282|FG002|Open Treatment Phase 1|Protocol Violation|0|||
130649707|NCT01674010|470337280|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
130649708|NCT01674010|470337281|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
130649709|NCT01674010|470337282|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
130649710|NCT01674010|470337280|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
130649711|NCT01674010|470337281|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
130649712|NCT01674010|470337282|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
130649713|NCT01674010|470337280|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
130649714|NCT01674010|470337281|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
130649715|NCT01674010|470337282|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
130649716|NCT01674010|470337280|FG000|Randomization Phase 2|Adverse Event|0|||
130649717|NCT01674010|470337281|FG001|Randomization Phase 2|Adverse Event|1|||
130649718|NCT01674010|470337282|FG002|Randomization Phase 2|Adverse Event|1|||
130649719|NCT01674010|470337280|FG000|Randomization Phase 2|Lost to Follow-up|0|||
130649720|NCT01674010|470337281|FG001|Randomization Phase 2|Lost to Follow-up|1|||
130649721|NCT01674010|470337282|FG002|Randomization Phase 2|Lost to Follow-up|2|||
130649722|NCT01674010|470337280|FG000|Randomization Phase 2|Mood episode recurrence|0|||
130649723|NCT01674010|470337281|FG001|Randomization Phase 2|Mood episode recurrence|8|||
130649724|NCT01674010|470337282|FG002|Randomization Phase 2|Mood episode recurrence|2|||
130649725|NCT01674010|470337280|FG000|Randomization Phase 2|Physician Decision|0|||
130649726|NCT01674010|470337281|FG001|Randomization Phase 2|Physician Decision|0|||
130649727|NCT01674010|470337282|FG002|Randomization Phase 2|Physician Decision|2|||
130649728|NCT01674010|470337280|FG000|Randomization Phase 2|Pregnancy|0|||
130649729|NCT01674010|470337281|FG001|Randomization Phase 2|Pregnancy|1|||
130649730|NCT01674010|470337282|FG002|Randomization Phase 2|Pregnancy|1|||
130649731|NCT01674010|470337280|FG000|Randomization Phase 2|Protocol Violation|0|||
130649732|NCT01674010|470337281|FG001|Randomization Phase 2|Protocol Violation|1|||
130649733|NCT01674010|470337282|FG002|Randomization Phase 2|Protocol Violation|1|||
130649734|NCT01674010|470337280|FG000|Randomization Phase 2|Sponsor Decision|0|||
130649735|NCT01674010|470337281|FG001|Randomization Phase 2|Sponsor Decision|42|||
130649736|NCT01674010|470337282|FG002|Randomization Phase 2|Sponsor Decision|45|||
130649737|NCT01674010|470337280|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
130649738|NCT01674010|470337281|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
130649739|NCT01674010|470337282|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
130649740|NCT03159455|470337285|FG000|Overall Study|Adverse Event|0|||
130649741|NCT03159455|470337286|FG001|Overall Study|Adverse Event|0|||
130649742|NCT03159455|470337287|FG002|Overall Study|Adverse Event|0|||
130649743|NCT03159455|470337288|FG003|Overall Study|Adverse Event|0|||
130649744|NCT03159455|470337289|FG004|Overall Study|Adverse Event|0|||
130649745|NCT03159455|470337290|FG005|Overall Study|Adverse Event|1|||
130649746|NCT05056311|470337300|FG000|Overall Study|Lost to Follow-up|14|||
130649747|NCT05056311|470337300|FG000|Overall Study|Withdrawal by Subject|1|||
130649748|NCT05056311|470337300|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
130649749|NCT02713490|470337302|FG000|Overall Study|Withdrawal by Subject|2|||
130649750|NCT02713490|470337303|FG001|Overall Study|Withdrawal by Subject|1|||
130649751|NCT02713490|470337302|FG000|Overall Study|Did not receive study drug|1|||
130649752|NCT02713490|470337303|FG001|Overall Study|Did not receive study drug|0|||
130649753|NCT02713490|470337302|FG000|Overall Study|Met exclusion criteria|0|||
130649754|NCT02713490|470337303|FG001|Overall Study|Met exclusion criteria|1|||
130649755|NCT00346775|470337304|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
130649756|NCT00346775|470337305|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
130649757|NCT00346775|470337304|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
130649758|NCT00346775|470337305|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
130649759|NCT00346775|470337304|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
130649760|NCT00346775|470337305|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
130649761|NCT02946515|470337306|FG000|Overall Study|Lost to Follow-up|2|||
130649762|NCT02946515|470337307|FG001|Overall Study|Lost to Follow-up|1|||
130649763|NCT03799198|470337308|FG000|Overall Study|Lost to Follow-up|4|||
130649764|NCT03799198|470337309|FG001|Overall Study|Lost to Follow-up|8|||
130649765|NCT03799198|470337308|FG000|Overall Study|Death|0|||
130649766|NCT03799198|470337309|FG001|Overall Study|Death|1|||
130649767|NCT00960869|470337310|FG000|Overall Study|Adverse Event|17|||
130649768|NCT00960869|470337311|FG001|Overall Study|Adverse Event|26|||
130649769|NCT00960869|470337310|FG000|Overall Study|Withdrawal by Subject|16|||
130649770|NCT00960869|470337311|FG001|Overall Study|Withdrawal by Subject|14|||
130649771|NCT00960869|470337310|FG000|Overall Study|Lost to Follow-up|1|||
130649772|NCT00960869|470337311|FG001|Overall Study|Lost to Follow-up|4|||
130649773|NCT00960869|470337310|FG000|Overall Study|Misc|19|||
130649774|NCT00960869|470337311|FG001|Overall Study|Misc|18|||
130649775|NCT01714726|470337312|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
130649776|NCT01714726|470337313|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
130649777|NCT01714726|470337314|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
130649778|NCT01714726|470337315|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
130649779|NCT01714726|470337312|FG000|Double-Blinded Induction Period|Adverse Event|0|||
130649780|NCT01714726|470337313|FG001|Double-Blinded Induction Period|Adverse Event|1|||
130649781|NCT01714726|470337314|FG002|Double-Blinded Induction Period|Adverse Event|0|||
130649782|NCT01714726|470337315|FG003|Double-Blinded Induction Period|Adverse Event|0|||
130649783|NCT01714726|470337312|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
130649784|NCT01714726|470337313|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
130649785|NCT01714726|470337314|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
130649786|NCT01714726|470337315|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
130649787|NCT01714726|470337312|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
130649788|NCT01714726|470337313|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
130649789|NCT01714726|470337314|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
130649790|NCT01714726|470337315|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
130649791|NCT01714726|470337312|FG000|Open-Label Period|Other|0|||
130649792|NCT01714726|470337313|FG001|Open-Label Period|Other|0|||
130649793|NCT01714726|470337314|FG002|Open-Label Period|Other|1|||
130649794|NCT01714726|470337315|FG003|Open-Label Period|Other|3|||
130649795|NCT01714726|470337312|FG000|Open-Label Period|Adverse Event|0|||
130649796|NCT01714726|470337313|FG001|Open-Label Period|Adverse Event|0|||
130649797|NCT01714726|470337314|FG002|Open-Label Period|Adverse Event|1|||
130649798|NCT01714726|470337315|FG003|Open-Label Period|Adverse Event|0|||
130649799|NCT01714726|470337312|FG000|Open-Label Period|Withdrawal by Subject|0|||
130649800|NCT01714726|470337313|FG001|Open-Label Period|Withdrawal by Subject|0|||
130649801|NCT01714726|470337314|FG002|Open-Label Period|Withdrawal by Subject|9|||
130649802|NCT01714726|470337315|FG003|Open-Label Period|Withdrawal by Subject|19|||
130649803|NCT01714726|470337312|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
130649804|NCT01714726|470337313|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
130649805|NCT01714726|470337314|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
130649806|NCT01714726|470337315|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
130649807|NCT01714726|470337312|FG000|Open-Label Period|Lost to Follow-up|0|||
130649808|NCT01714726|470337313|FG001|Open-Label Period|Lost to Follow-up|0|||
130649809|NCT01714726|470337314|FG002|Open-Label Period|Lost to Follow-up|3|||
130649810|NCT01714726|470337315|FG003|Open-Label Period|Lost to Follow-up|4|||
130649811|NCT01096017|470337318|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
130649812|NCT01096017|470337319|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
130649813|NCT01846442|470337320|FG000|Overall Study|Adverse Event|2|||
130649814|NCT01846442|470337321|FG001|Overall Study|Adverse Event|4|||
130649815|NCT01846442|470337322|FG002|Overall Study|Adverse Event|2|||
130649816|NCT01846442|470337323|FG003|Overall Study|Adverse Event|1|||
130649817|NCT01846442|470337320|FG000|Overall Study|Lost to Follow-up|0|||
130649818|NCT01846442|470337321|FG001|Overall Study|Lost to Follow-up|0|||
130649819|NCT01846442|470337322|FG002|Overall Study|Lost to Follow-up|1|||
130649820|NCT01846442|470337323|FG003|Overall Study|Lost to Follow-up|0|||
130649821|NCT01846442|470337320|FG000|Overall Study|Withdrawal by Subject|3|||
130649822|NCT01846442|470337321|FG001|Overall Study|Withdrawal by Subject|2|||
130649823|NCT01846442|470337322|FG002|Overall Study|Withdrawal by Subject|0|||
130649824|NCT01846442|470337323|FG003|Overall Study|Withdrawal by Subject|1|||
130649825|NCT01846442|470337320|FG000|Overall Study|Left the city/Lost medication|1|||
130649826|NCT01846442|470337321|FG001|Overall Study|Left the city/Lost medication|0|||
130649827|NCT01846442|470337322|FG002|Overall Study|Left the city/Lost medication|1|||
130649828|NCT01846442|470337323|FG003|Overall Study|Left the city/Lost medication|1|||
130649829|NCT00665366|470337326|FG000|Overall Study|Lack of Efficacy|11|||
130649830|NCT00665366|470337327|FG001|Overall Study|Lack of Efficacy|10|||
130649831|NCT00665366|470337326|FG000|Overall Study|Adverse Event|25|||
130649832|NCT00665366|470337327|FG001|Overall Study|Adverse Event|23|||
130649833|NCT00665366|470337326|FG000|Overall Study|Withdrawal by Subject|11|||
130649834|NCT00665366|470337327|FG001|Overall Study|Withdrawal by Subject|14|||
130649835|NCT00665366|470337326|FG000|Overall Study|Lost to Follow-up|3|||
130649836|NCT00665366|470337327|FG001|Overall Study|Lost to Follow-up|5|||
130649837|NCT00665366|470337326|FG000|Overall Study|Poor compliance/noncompliance|3|||
130649838|NCT00665366|470337327|FG001|Overall Study|Poor compliance/noncompliance|5|||
130649839|NCT00665366|470337326|FG000|Overall Study|Pregnancy|1|||
130649840|NCT00665366|470337327|FG001|Overall Study|Pregnancy|0|||
130649841|NCT00665366|470337326|FG000|Overall Study|No longer meets study criteria|0|||
130649842|NCT00665366|470337327|FG001|Overall Study|No longer meets study criteria|1|||
130649843|NCT00665366|470337326|FG000|Overall Study|Other reasons|4|||
130649844|NCT00665366|470337327|FG001|Overall Study|Other reasons|1|||
130649845|NCT04177862|470337328|FG000|Overall Study|Protocol Violation|2|||
130649846|NCT04177862|470337329|FG001|Overall Study|Protocol Violation|7|||
130649847|NCT03233009|470337330|FG000|Overall Study|Lost to Follow-up|1|||
130649848|NCT00474994|470337340|FG000|Overall Study|Patient Not treated|1|||
130649849|NCT00474994|470337340|FG000|Overall Study|Patient evaluable for toxicity only|3|||
130649850|NCT00474994|470337340|FG000|Overall Study|Patient found to be ineligible|1|||
130649851|NCT00278473|470337341|FG000|Overall Study|drop out|4|||
130649852|NCT00278473|470337342|FG001|Overall Study|drop out|3|||
130649853|NCT02322866|470337344|FG000|Overall Study|Adverse Event|6|||
130649854|NCT02322866|470337345|FG001|Overall Study|Adverse Event|11|||
130649855|NCT02322866|470337344|FG000|Overall Study|Withdrawal of Consent|16|||
130649856|NCT02322866|470337345|FG001|Overall Study|Withdrawal of Consent|25|||
130649857|NCT02322866|470337344|FG000|Overall Study|Lost to Follow-up|36|||
130649858|NCT02322866|470337345|FG001|Overall Study|Lost to Follow-up|39|||
130649859|NCT02322866|470337344|FG000|Overall Study|Protocol Violation|1|||
130649860|NCT02322866|470337345|FG001|Overall Study|Protocol Violation|0|||
130649861|NCT02322866|470337344|FG000|Overall Study|Noncompliance with Treatment|3|||
130649862|NCT02322866|470337345|FG001|Overall Study|Noncompliance with Treatment|4|||
130649863|NCT02322866|470337344|FG000|Overall Study|Lack of Efficacy|3|||
130649864|NCT02322866|470337345|FG001|Overall Study|Lack of Efficacy|1|||
130649865|NCT02322866|470337344|FG000|Overall Study|Other Miscellaneous Reasons|6|||
130649866|NCT02322866|470337345|FG001|Overall Study|Other Miscellaneous Reasons|6|||
130649867|NCT06045026|470337350|FG000|Overall Study|Lost to Follow-up|60|||
130649868|NCT06045026|470337350|FG000|Overall Study|Adverse Event|12|||
130649869|NCT06045026|470337350|FG000|Overall Study|Withdrawal by Subject|3|||
130649870|NCT06045026|470337350|FG000|Overall Study|Enrollment closed|1|||
130649871|NCT00408408|470337356|FG000|Overall Study|No follow up data|2|||
130649872|NCT00408408|470337357|FG001|Overall Study|No follow up data|3|||
130649873|NCT00408408|470337358|FG002|Overall Study|No follow up data|0|||
130649874|NCT00408408|470337359|FG003|Overall Study|No follow up data|7|||
130649875|NCT00408408|470337360|FG004|Overall Study|No follow up data|5|||
130649876|NCT00408408|470337361|FG005|Overall Study|No follow up data|3|||
130649877|NCT00267202|470337362|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
130649878|NCT00267202|470337363|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130649879|NCT00267202|470337362|FG000|Overall Study|Withdrawal by Subject|12|||
130649880|NCT00267202|470337363|FG001|Overall Study|Withdrawal by Subject|15|||
130649881|NCT00267202|470337362|FG000|Overall Study|Adverse Event|13|||
130649882|NCT00267202|470337363|FG001|Overall Study|Adverse Event|7|||
130649883|NCT00267202|470337362|FG000|Overall Study|Protocol Violation|2|||
130649884|NCT00267202|470337363|FG001|Overall Study|Protocol Violation|3|||
130649885|NCT00267202|470337362|FG000|Overall Study|Administrative problems|2|||
130649886|NCT00267202|470337363|FG001|Overall Study|Administrative problems|1|||
130649887|NCT00267202|470337362|FG000|Overall Study|Lost to Follow-up|3|||
130649888|NCT00267202|470337363|FG001|Overall Study|Lost to Follow-up|0|||
130649889|NCT00606931|470337367|FG000|Overall Study|Withdrawal by Subject|3|||
130649890|NCT02924129|470337381|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
130649891|NCT02924129|470337382|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
130649892|NCT02924129|470337381|FG000|Overall Study|Withdrawal by Subject|2|||
130649893|NCT02924129|470337382|FG001|Overall Study|Withdrawal by Subject|2|||
130649894|NCT02924129|470337381|FG000|Overall Study|Physician Decision|1|||
130649895|NCT02924129|470337382|FG001|Overall Study|Physician Decision|0|||
130649896|NCT02924129|470337381|FG000|Overall Study|Missed Visit|0|||
130649897|NCT02924129|470337382|FG001|Overall Study|Missed Visit|1|||
130649898|NCT00302731|470337387|FG000|Overall Study|Lost to Follow-up|1|||
130649899|NCT00302731|470337388|FG001|Overall Study|Lost to Follow-up|2|||
130649900|NCT00302731|470337389|FG002|Overall Study|Lost to Follow-up|0|||
130649901|NCT00302731|470337390|FG003|Overall Study|Lost to Follow-up|0|||
130649902|NCT00302731|470337387|FG000|Overall Study|Adverse Event|0|||
130649903|NCT00302731|470337388|FG001|Overall Study|Adverse Event|2|||
130649904|NCT00302731|470337389|FG002|Overall Study|Adverse Event|2|||
130649905|NCT00302731|470337390|FG003|Overall Study|Adverse Event|0|||
130649906|NCT00302731|470337387|FG000|Overall Study|Withdrawal by Subject|1|||
130649907|NCT00302731|470337388|FG001|Overall Study|Withdrawal by Subject|1|||
130649908|NCT00302731|470337389|FG002|Overall Study|Withdrawal by Subject|0|||
130649909|NCT00302731|470337390|FG003|Overall Study|Withdrawal by Subject|0|||
130649910|NCT00302731|470337387|FG000|Overall Study|Protocol Violation|1|||
130649911|NCT00302731|470337388|FG001|Overall Study|Protocol Violation|0|||
130649912|NCT00302731|470337389|FG002|Overall Study|Protocol Violation|0|||
130649913|NCT00302731|470337390|FG003|Overall Study|Protocol Violation|0|||
130649914|NCT00302731|470337387|FG000|Overall Study|cancer unrelated to study discovered|1|||
130649915|NCT00302731|470337388|FG001|Overall Study|cancer unrelated to study discovered|0|||
130649916|NCT00302731|470337389|FG002|Overall Study|cancer unrelated to study discovered|1|||
130649917|NCT00302731|470337390|FG003|Overall Study|cancer unrelated to study discovered|0|||
130649918|NCT01000311|470337391|FG000|Overall Study|Adverse Event|2|||
130649919|NCT01000311|470337392|FG001|Overall Study|Adverse Event|5|||
130649920|NCT01000311|470337391|FG000|Overall Study|Withdrawal by Subject|16|||
130649921|NCT01000311|470337392|FG001|Overall Study|Withdrawal by Subject|24|||
130649922|NCT01000311|470337391|FG000|Overall Study|Lost to Follow-up|15|||
130649923|NCT01000311|470337392|FG001|Overall Study|Lost to Follow-up|24|||
130649924|NCT01000311|470337391|FG000|Overall Study|Protocol Violation|1|||
130649925|NCT01000311|470337392|FG001|Overall Study|Protocol Violation|2|||
130649926|NCT01000311|470337391|FG000|Overall Study|Inappropriate enrollment|2|||
130649927|NCT01000311|470337392|FG001|Overall Study|Inappropriate enrollment|0|||
130649928|NCT01000311|470337391|FG000|Overall Study|Administrative reason|9|||
130649929|NCT01000311|470337392|FG001|Overall Study|Administrative reason|15|||
130649930|NCT01610752|470337395|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
130649931|NCT01610752|470337396|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
130649932|NCT01610752|470337397|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
130649933|NCT02815670|470337398|FG000|Overall Study|Prematurely discontinued of the trial|1|||
130649934|NCT01411917|470337399|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
130649935|NCT01411917|470337400|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
130649936|NCT02354599|470337406|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130649937|NCT02354599|470337407|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130649938|NCT02354599|470337408|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130649939|NCT02354599|470337409|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
130649940|NCT02354599|470337410|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130649941|NCT02354599|470337411|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
130649942|NCT02354599|470337406|FG000|Overall Study|Withdrawal by Subject|1|||
130649943|NCT02354599|470337407|FG001|Overall Study|Withdrawal by Subject|1|||
130649944|NCT02354599|470337408|FG002|Overall Study|Withdrawal by Subject|0|||
130649945|NCT02354599|470337409|FG003|Overall Study|Withdrawal by Subject|0|||
130649946|NCT02354599|470337410|FG004|Overall Study|Withdrawal by Subject|0|||
130649947|NCT02354599|470337411|FG005|Overall Study|Withdrawal by Subject|0|||
130649948|NCT01087944|470337431|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
130649949|NCT01087944|470337432|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
130649950|NCT01087944|470337431|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
130649951|NCT01087944|470337432|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
130649952|NCT01159665|470337433|FG000|Overall Study|Withdrawal by Subject|0|||
130649953|NCT01159665|470337434|FG001|Overall Study|Withdrawal by Subject|1|||
130649954|NCT01159665|470337435|FG002|Overall Study|Withdrawal by Subject|0|||
130649955|NCT01159665|470337436|FG003|Overall Study|Withdrawal by Subject|0|||
130649956|NCT01159665|470337437|FG004|Overall Study|Withdrawal by Subject|0|||
130649957|NCT01159665|470337438|FG005|Overall Study|Withdrawal by Subject|0|||
130649958|NCT00540228|470337440|FG000|Overall Study|Adverse Event|2|||
130649959|NCT00540228|470337441|FG001|Overall Study|Adverse Event|0|||
130649960|NCT00540228|470337442|FG002|Overall Study|Adverse Event|0|||
130649961|NCT00540228|470337443|FG003|Overall Study|Adverse Event|0|||
130649962|NCT00540228|470337444|FG004|Overall Study|Adverse Event|0|||
130649963|NCT00540228|470337440|FG000|Overall Study|Lost to Follow-up|1|||
130649964|NCT00540228|470337441|FG001|Overall Study|Lost to Follow-up|1|||
130649965|NCT00540228|470337442|FG002|Overall Study|Lost to Follow-up|0|||
130649966|NCT00540228|470337443|FG003|Overall Study|Lost to Follow-up|0|||
130649967|NCT00540228|470337444|FG004|Overall Study|Lost to Follow-up|0|||
130649968|NCT01377194|470337445|FG000|Overall Study|Adverse Event|3|||
130649969|NCT01377194|470337446|FG001|Overall Study|Adverse Event|12|||
130649970|NCT01377194|470337447|FG002|Overall Study|Adverse Event|19|||
130649971|NCT01377194|470337445|FG000|Overall Study|Lack of Efficacy|3|||
130649972|NCT01377194|470337446|FG001|Overall Study|Lack of Efficacy|3|||
130649973|NCT01377194|470337447|FG002|Overall Study|Lack of Efficacy|3|||
130649974|NCT01377194|470337445|FG000|Overall Study|Protocol Violation|4|||
130649975|NCT01377194|470337446|FG001|Overall Study|Protocol Violation|10|||
130649976|NCT01377194|470337447|FG002|Overall Study|Protocol Violation|6|||
130649977|NCT01377194|470337445|FG000|Overall Study|Withdrawal by Subject|8|||
130649978|NCT01377194|470337446|FG001|Overall Study|Withdrawal by Subject|10|||
130649979|NCT01377194|470337447|FG002|Overall Study|Withdrawal by Subject|7|||
130649980|NCT01377194|470337445|FG000|Overall Study|Lost to Follow-up|14|||
130649981|NCT01377194|470337446|FG001|Overall Study|Lost to Follow-up|8|||
130649982|NCT01377194|470337447|FG002|Overall Study|Lost to Follow-up|11|||
130649983|NCT02451137|470337450|FG000|Overall Study|Randomized but not treated|19|||
130649984|NCT02451137|470337451|FG001|Overall Study|Randomized but not treated|27|||
130649985|NCT02451137|470337450|FG000|Overall Study|Adverse Event|43|||
130649986|NCT02451137|470337451|FG001|Overall Study|Adverse Event|42|||
130649987|NCT02451137|470337450|FG000|Overall Study|Lack of Efficacy|4|||
130649988|NCT02451137|470337451|FG001|Overall Study|Lack of Efficacy|9|||
130649989|NCT02451137|470337450|FG000|Overall Study|Participant decision:discontinue insulin|41|||
130649990|NCT02451137|470337451|FG001|Overall Study|Participant decision:discontinue insulin|43|||
130649991|NCT02451137|470337450|FG000|Overall Study|Hypoglycemia|2|||
130649992|NCT02451137|470337451|FG001|Overall Study|Hypoglycemia|1|||
130649993|NCT02451137|470337450|FG000|Overall Study|Investigator's decision|23|||
130649994|NCT02451137|470337451|FG001|Overall Study|Investigator's decision|19|||
130649995|NCT02451137|470337450|FG000|Overall Study|Lost to Follow-up|53|||
130649996|NCT02451137|470337451|FG001|Overall Study|Lost to Follow-up|61|||
130649997|NCT02451137|470337450|FG000|Overall Study|Physician Decision|6|||
130649998|NCT02451137|470337451|FG001|Overall Study|Physician Decision|5|||
130649999|NCT02451137|470337450|FG000|Overall Study|Sponsor decision|13|||
130650000|NCT02451137|470337451|FG001|Overall Study|Sponsor decision|25|||
130650001|NCT02451137|470337450|FG000|Overall Study|Withdrawal by Subject|40|||
130650002|NCT02451137|470337451|FG001|Overall Study|Withdrawal by Subject|63|||
130650003|NCT02451137|470337450|FG000|Overall Study|Other than specified above|2|||
130650004|NCT02451137|470337451|FG001|Overall Study|Other than specified above|3|||
130650005|NCT01977573|470337454|FG000|Overall Study|Adverse Event|7|||
130650006|NCT01977573|470337455|FG001|Overall Study|Adverse Event|0|||
130650007|NCT01977573|470337456|FG002|Overall Study|Adverse Event|2|||
130650008|NCT01977573|470337457|FG003|Overall Study|Adverse Event|1|||
130650009|NCT01977573|470337454|FG000|Overall Study|Lost to Follow-up|1|||
130650010|NCT01977573|470337455|FG001|Overall Study|Lost to Follow-up|0|||
130650011|NCT01977573|470337456|FG002|Overall Study|Lost to Follow-up|0|||
130650012|NCT01977573|470337457|FG003|Overall Study|Lost to Follow-up|1|||
130650013|NCT01977573|470337454|FG000|Overall Study|Physician Decision|1|||
130650014|NCT01977573|470337455|FG001|Overall Study|Physician Decision|0|||
130650015|NCT01977573|470337456|FG002|Overall Study|Physician Decision|0|||
130650016|NCT01977573|470337457|FG003|Overall Study|Physician Decision|0|||
130650017|NCT01977573|470337454|FG000|Overall Study|Protocol Violation|3|||
130650018|NCT01977573|470337455|FG001|Overall Study|Protocol Violation|1|||
130650019|NCT01977573|470337456|FG002|Overall Study|Protocol Violation|0|||
130650020|NCT01977573|470337457|FG003|Overall Study|Protocol Violation|0|||
130650021|NCT01977573|470337454|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
130650022|NCT01977573|470337455|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
130650023|NCT01977573|470337456|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
130650024|NCT01977573|470337457|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
130650025|NCT01977573|470337454|FG000|Overall Study|Withdrawal by Subject|6|||
130650026|NCT01977573|470337455|FG001|Overall Study|Withdrawal by Subject|1|||
130650027|NCT01977573|470337456|FG002|Overall Study|Withdrawal by Subject|1|||
130650028|NCT01977573|470337457|FG003|Overall Study|Withdrawal by Subject|1|||
130650029|NCT02501642|470339020|FG000|Overall Study|Lost to Follow-up|7|||
130650030|NCT02501642|470339021|FG001|Overall Study|Lost to Follow-up|11|||
130650031|NCT00548340|470339022|FG000|Overall Study|Protocol Violation|2|||
130650032|NCT00548340|470339023|FG001|Overall Study|Protocol Violation|3|||
130650033|NCT00548340|470339024|FG002|Overall Study|Protocol Violation|3|||
130650034|NCT00548340|470339022|FG000|Overall Study|Adverse Event|2|||
130650035|NCT00548340|470339023|FG001|Overall Study|Adverse Event|2|||
130650036|NCT00548340|470339024|FG002|Overall Study|Adverse Event|2|||
130650037|NCT00548340|470339022|FG000|Overall Study|Lost to Follow-up|1|||
130650038|NCT00548340|470339023|FG001|Overall Study|Lost to Follow-up|1|||
130650039|NCT00548340|470339024|FG002|Overall Study|Lost to Follow-up|0|||
130650040|NCT00548340|470339022|FG000|Overall Study|Withdrawal by Subject|2|||
130650041|NCT00548340|470339023|FG001|Overall Study|Withdrawal by Subject|4|||
130650042|NCT00548340|470339024|FG002|Overall Study|Withdrawal by Subject|3|||
130650043|NCT00548340|470339022|FG000|Overall Study|Other|1|||
130650044|NCT00548340|470339023|FG001|Overall Study|Other|1|||
130650045|NCT00548340|470339024|FG002|Overall Study|Other|1|||
130650046|NCT02687815|470339034|FG000|Overall Study|Lost to Follow-up|2|||
130650047|NCT02687815|470339035|FG001|Overall Study|Lost to Follow-up|4|||
130650048|NCT02687815|470339034|FG000|Overall Study|Withdrawal by Subject|2|||
130650049|NCT02687815|470339035|FG001|Overall Study|Withdrawal by Subject|4|||
130650050|NCT01399619|470339040|FG000|Overall Study|Adverse Event|10|||
130650051|NCT01399619|470339041|FG001|Overall Study|Adverse Event|0|||
130650052|NCT01399619|470339042|FG002|Overall Study|Adverse Event|4|||
130650053|NCT01399619|470339043|FG003|Overall Study|Adverse Event|10|||
130650054|NCT01399619|470339040|FG000|Overall Study|Lack of Efficacy|9|||
130650055|NCT01399619|470339041|FG001|Overall Study|Lack of Efficacy|0|||
130650056|NCT01399619|470339042|FG002|Overall Study|Lack of Efficacy|5|||
130650057|NCT01399619|470339043|FG003|Overall Study|Lack of Efficacy|0|||
130650058|NCT01399619|470339040|FG000|Overall Study|Withdrawal by Subject|6|||
130650059|NCT01399619|470339041|FG001|Overall Study|Withdrawal by Subject|0|||
130650060|NCT01399619|470339042|FG002|Overall Study|Withdrawal by Subject|3|||
130650061|NCT01399619|470339043|FG003|Overall Study|Withdrawal by Subject|4|||
130650062|NCT01399619|470339040|FG000|Overall Study|Protocol Violation|0|||
130650063|NCT01399619|470339041|FG001|Overall Study|Protocol Violation|0|||
130650064|NCT01399619|470339042|FG002|Overall Study|Protocol Violation|0|||
130650065|NCT01399619|470339043|FG003|Overall Study|Protocol Violation|1|||
130650066|NCT01399619|470339040|FG000|Overall Study|Not treated|0|||
130650067|NCT01399619|470339041|FG001|Overall Study|Not treated|0|||
130650068|NCT01399619|470339042|FG002|Overall Study|Not treated|0|||
130650069|NCT01399619|470339043|FG003|Overall Study|Not treated|2|||
130650070|NCT00462501|470339044|FG000|Overall Study|Not treated|3|||
130650071|NCT00462501|470339044|FG000|Overall Study|Adverse Event|2|||
130650072|NCT00998166|470339045|FG000|Overall Study|Early Study Termination|8|||
130650073|NCT04626947|470339059|FG000|Overall Study|Study terminated|14|||
130650074|NCT00399542|470339062|FG000|Overall Study|Adverse Event|18|||
130650075|NCT00399542|470339063|FG001|Overall Study|Adverse Event|15|||
130650076|NCT00399542|470339062|FG000|Overall Study|Protocol Violation|13|||
130650077|NCT00399542|470339063|FG001|Overall Study|Protocol Violation|3|||
130650078|NCT00399542|470339062|FG000|Overall Study|Withdrawal by Subject|28|||
130650079|NCT00399542|470339063|FG001|Overall Study|Withdrawal by Subject|10|||
130650080|NCT00399542|470339062|FG000|Overall Study|Lack of Efficacy|18|||
130650081|NCT00399542|470339063|FG001|Overall Study|Lack of Efficacy|8|||
130650082|NCT00399542|470339062|FG000|Overall Study|Lost to Follow-up|6|||
130650083|NCT00399542|470339063|FG001|Overall Study|Lost to Follow-up|6|||
130650084|NCT00399542|470339062|FG000|Overall Study|Other|1|||
130650085|NCT00399542|470339063|FG001|Overall Study|Other|0|||
130650086|NCT00399542|470339062|FG000|Overall Study|Physician Decision|0|||
130650087|NCT00399542|470339063|FG001|Overall Study|Physician Decision|1|||
130650088|NCT03172026|470339064|FG000|Overall Study|Withdrawal by Subject|1|||
130650089|NCT03172026|470339065|FG001|Overall Study|Withdrawal by Subject|0|||
130650090|NCT03172026|470339064|FG000|Overall Study|COVID restrictions|1|||
130650091|NCT03172026|470339065|FG001|Overall Study|COVID restrictions|0|||
130650092|NCT00612456|470339066|FG000|Overall Study|Adverse Event|1|||
130650093|NCT00612456|470339067|FG001|Overall Study|Adverse Event|0|||
130650094|NCT00612456|470339068|FG002|Overall Study|Adverse Event|0|||
130650095|NCT00612456|470339066|FG000|Overall Study|Lack of Efficacy|1|||
130650096|NCT00612456|470339067|FG001|Overall Study|Lack of Efficacy|1|||
130650097|NCT00612456|470339068|FG002|Overall Study|Lack of Efficacy|0|||
130650098|NCT00612456|470339066|FG000|Overall Study|Withdrawal by Subject|0|||
130650099|NCT00612456|470339067|FG001|Overall Study|Withdrawal by Subject|1|||
130650100|NCT00612456|470339068|FG002|Overall Study|Withdrawal by Subject|0|||
130650101|NCT00265109|470339069|FG000|Overall Study|Withdrawal by Subject|5|||
130650102|NCT00265109|470339069|FG000|Overall Study|Adverse Event|1|||
130650103|NCT02463097|470339070|FG000|Overall Study|Withdrawal by Subject|1|||
130650104|NCT01757821|470339071|FG000|Overall Study|Adverse Event|1|||
130650105|NCT00920582|470339072|FG000|Overall Study|Lost to Follow-up|5|||
130650106|NCT00920582|470339073|FG001|Overall Study|Lost to Follow-up|1|||
130650107|NCT00920582|470339074|FG002|Overall Study|Lost to Follow-up|2|||
130650108|NCT00920582|470339075|FG003|Overall Study|Lost to Follow-up|0|||
130650109|NCT00920582|470339072|FG000|Overall Study|Withdrawal by Subject|5|||
130650110|NCT00920582|470339073|FG001|Overall Study|Withdrawal by Subject|4|||
130650111|NCT00920582|470339074|FG002|Overall Study|Withdrawal by Subject|6|||
130650112|NCT00920582|470339075|FG003|Overall Study|Withdrawal by Subject|3|||
130650113|NCT00920582|470339072|FG000|Overall Study|Protocol Violation|1|||
130650114|NCT00920582|470339073|FG001|Overall Study|Protocol Violation|0|||
130650115|NCT00920582|470339074|FG002|Overall Study|Protocol Violation|0|||
130650116|NCT00920582|470339075|FG003|Overall Study|Protocol Violation|0|||
130650117|NCT00920582|470339072|FG000|Overall Study|Other|2|||
130650118|NCT00920582|470339073|FG001|Overall Study|Other|1|||
130650119|NCT00920582|470339074|FG002|Overall Study|Other|3|||
130650120|NCT00920582|470339075|FG003|Overall Study|Other|2|||
130650121|NCT01552408|470339076|FG000|Overall Study|Lost to Follow-up|2|||
130650122|NCT01552408|470339077|FG001|Overall Study|Lost to Follow-up|0|||
130650123|NCT01552408|470339076|FG000|Overall Study|Relocation|0|||
130650124|NCT01552408|470339077|FG001|Overall Study|Relocation|1|||
130650125|NCT01552408|470339076|FG000|Overall Study|Withdrawal by Subject|2|||
130650126|NCT01552408|470339077|FG001|Overall Study|Withdrawal by Subject|1|||
130650127|NCT00383292|470339080|FG000|Overall Study|Adverse Event|4|||
130650128|NCT00383292|470339081|FG001|Overall Study|Adverse Event|1|||
130650129|NCT00383292|470339082|FG002|Overall Study|Adverse Event|2|||
130650130|NCT00383292|470339080|FG000|Overall Study|Death|3|||
130650131|NCT00383292|470339081|FG001|Overall Study|Death|3|||
130650132|NCT00383292|470339082|FG002|Overall Study|Death|3|||
130650133|NCT00383292|470339080|FG000|Overall Study|Physician Decision|4|||
130650134|NCT00383292|470339081|FG001|Overall Study|Physician Decision|0|||
130650135|NCT00383292|470339082|FG002|Overall Study|Physician Decision|1|||
130650136|NCT00383292|470339080|FG000|Overall Study|Withdrawal by Subject|3|||
130650137|NCT00383292|470339081|FG001|Overall Study|Withdrawal by Subject|2|||
130650138|NCT00383292|470339082|FG002|Overall Study|Withdrawal by Subject|2|||
130650139|NCT00383292|470339080|FG000|Overall Study|Other|1|||
130650140|NCT00383292|470339081|FG001|Overall Study|Other|0|||
130650141|NCT00383292|470339082|FG002|Overall Study|Other|0|||
130650142|NCT03457701|470339085|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130650143|NCT03457701|470339086|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130650144|NCT03457701|470339085|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
130650145|NCT03457701|470339086|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130650146|NCT02243306|470339087|FG000|Overall Study|Adverse Event|0|||
130650147|NCT02243306|470339088|FG001|Overall Study|Adverse Event|1|||
130650148|NCT02243306|470339087|FG000|Overall Study|Other: Reached stopping criteria|0|||
130650149|NCT02243306|470339088|FG001|Overall Study|Other: Reached stopping criteria|1|||
130650150|NCT02243306|470339087|FG000|Overall Study|Physician Decision|0|||
130650151|NCT02243306|470339088|FG001|Overall Study|Physician Decision|1|||
130650152|NCT01016912|470339089|FG000|End of Treatment Period|Lack of Efficacy|0|||
130650153|NCT01016912|470339090|FG001|End of Treatment Period|Lack of Efficacy|1|||
130650154|NCT01016912|470339091|FG002|End of Treatment Period|Lack of Efficacy|0|||
130650155|NCT01016912|470339092|FG003|End of Treatment Period|Lack of Efficacy|4|||
130650156|NCT01016912|470339093|FG004|End of Treatment Period|Lack of Efficacy|4|||
130650157|NCT01016912|470339089|FG000|End of Treatment Period|Adverse Event|0|||
130650158|NCT01016912|470339090|FG001|End of Treatment Period|Adverse Event|1|||
130650159|NCT01016912|470339091|FG002|End of Treatment Period|Adverse Event|1|||
130650160|NCT01016912|470339092|FG003|End of Treatment Period|Adverse Event|0|||
130650161|NCT01016912|470339093|FG004|End of Treatment Period|Adverse Event|0|||
130650162|NCT01016912|470339089|FG000|End of Treatment Period|Completed double-blind period only|0|||
130650163|NCT01016912|470339090|FG001|End of Treatment Period|Completed double-blind period only|1|||
130650164|NCT01016912|470339091|FG002|End of Treatment Period|Completed double-blind period only|0|||
130650165|NCT01016912|470339092|FG003|End of Treatment Period|Completed double-blind period only|0|||
130650166|NCT01016912|470339093|FG004|End of Treatment Period|Completed double-blind period only|0|||
130650167|NCT01016912|470339089|FG000|Follow-up Period|Other reason|0|||
130650168|NCT01016912|470339090|FG001|Follow-up Period|Other reason|0|||
130650169|NCT01016912|470339091|FG002|Follow-up Period|Other reason|1|||
130650170|NCT01016912|470339092|FG003|Follow-up Period|Other reason|1|||
130650171|NCT01016912|470339093|FG004|Follow-up Period|Other reason|0|||
130650172|NCT02370173|470339100|FG000|Overall Study|Protocol Violation|1|||
130650173|NCT02370173|470339101|FG001|Overall Study|Protocol Violation|1|||
130650174|NCT02370173|470339100|FG000|Overall Study|Withdrawal by Subject|2|||
130650175|NCT02370173|470339101|FG001|Overall Study|Withdrawal by Subject|2|||
130650176|NCT01326481|470339107|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
130650177|NCT00307736|470339108|FG000|Overall Study|Adverse Event|0|||
130650178|NCT00307736|470339109|FG001|Overall Study|Adverse Event|0|||
130650179|NCT00307736|470339110|FG002|Overall Study|Adverse Event|1|||
130650180|NCT00307736|470339111|FG003|Overall Study|Adverse Event|3|||
130650181|NCT00307736|470339108|FG000|Overall Study|Withdrawal by Subject|0|||
130650182|NCT00307736|470339109|FG001|Overall Study|Withdrawal by Subject|0|||
130650183|NCT00307736|470339110|FG002|Overall Study|Withdrawal by Subject|2|||
130650184|NCT00307736|470339111|FG003|Overall Study|Withdrawal by Subject|0|||
130650185|NCT02260791|470339114|FG000|Overall Study|Lost to Follow-up|4|||
130650186|NCT02260791|470339115|FG001|Overall Study|Lost to Follow-up|4|||
130650187|NCT02260791|470339114|FG000|Overall Study|Lack of Efficacy|2|||
130650188|NCT02260791|470339115|FG001|Overall Study|Lack of Efficacy|1|||
130650189|NCT02260791|470339114|FG000|Overall Study|Adverse Event|13|||
130650190|NCT02260791|470339115|FG001|Overall Study|Adverse Event|9|||
130650191|NCT02260791|470339114|FG000|Overall Study|Death|1|||
130650192|NCT02260791|470339115|FG001|Overall Study|Death|0|||
130650193|NCT02260791|470339114|FG000|Overall Study|Withdrawal by Subject|11|||
130650194|NCT02260791|470339115|FG001|Overall Study|Withdrawal by Subject|16|||
130650195|NCT02260791|470339114|FG000|Overall Study|Screen failure|0|||
130650196|NCT02260791|470339115|FG001|Overall Study|Screen failure|1|||
130650197|NCT02260791|470339114|FG000|Overall Study|Protocol deviation|2|||
130650198|NCT02260791|470339115|FG001|Overall Study|Protocol deviation|3|||
130650199|NCT04246996|470339117|FG000|Overall Study|Physician Decision|1|||
130650200|NCT04246996|470339118|FG001|Overall Study|Physician Decision|1|||
130650201|NCT04246996|470339117|FG000|Overall Study|Did not meet eligibility criteria|1|||
130650202|NCT04246996|470339118|FG001|Overall Study|Did not meet eligibility criteria|4|||
130650203|NCT02442284|470339119|FG000|Overall Study|Adverse Event|1|||
130650204|NCT02442284|470339119|FG000|Overall Study|Withdrew Consent|2|||
130650205|NCT02442284|470339119|FG000|Overall Study|Lost to Follow-up|3|||
130650206|NCT02442284|470339119|FG000|Overall Study|Other|1|||
130650207|NCT02600559|470340783|FG000|Overall Study|Withdrawal by Subject|3|||
130650208|NCT02600559|470340783|FG000|Overall Study|Lost to Follow-up|20|||
130650209|NCT01153971|470340786|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
130650210|NCT01153971|470340786|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
130650211|NCT01153971|470340786|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
130650212|NCT01153971|470340786|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
130650213|NCT01153971|470340786|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
130650214|NCT01153971|470340786|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
130650215|NCT01153971|470340786|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
130650216|NCT03410693|470340787|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
130650217|NCT03410693|470340788|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
130650218|NCT03410693|470340787|FG000|Overall Study|Disc trt: Lost to follow up|0|||
130650219|NCT03410693|470340788|FG001|Overall Study|Disc trt: Lost to follow up|1|||
130650220|NCT03410693|470340787|FG000|Overall Study|Disc trt: radiological progression|58|||
130650221|NCT03410693|470340788|FG001|Overall Study|Disc trt: radiological progression|50|||
130650222|NCT03410693|470340787|FG000|Overall Study|Disc trt: Other|1|||
130650223|NCT03410693|470340788|FG001|Overall Study|Disc trt: Other|0|||
130650224|NCT03410693|470340787|FG000|Overall Study|Study drug never administered|1|||
130650225|NCT03410693|470340788|FG001|Overall Study|Study drug never administered|6|||
130650226|NCT03410693|470340787|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
130650227|NCT03410693|470340788|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
130650228|NCT03410693|470340787|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
130650229|NCT03410693|470340788|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
130650230|NCT03410693|470340787|FG000|Overall Study|Disc trt: Physician decision|0|||
130650231|NCT03410693|470340788|FG001|Overall Study|Disc trt: Physician decision|5|||
130650232|NCT03410693|470340787|FG000|Overall Study|Disc trt: clinical progression|1|||
130650233|NCT03410693|470340788|FG001|Overall Study|Disc trt: clinical progression|5|||
130650234|NCT03410693|470340787|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
130650235|NCT03410693|470340788|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
130650236|NCT00953576|470340789|FG000|Overall Study|Adverse Event|0|||
130650237|NCT00953576|470340790|FG001|Overall Study|Adverse Event|1|||
130650238|NCT00953576|470340789|FG000|Overall Study|Ineligible after Consent|2|||
130650239|NCT00953576|470340790|FG001|Overall Study|Ineligible after Consent|0|||
130650240|NCT03628781|470340793|FG000|Overall Study|Lost to Follow-up|16|||
130650241|NCT03628781|470340794|FG001|Overall Study|Lost to Follow-up|8|||
130650242|NCT03628781|470340793|FG000|Overall Study|Withdrawal by Subject|16|||
130650243|NCT03628781|470340794|FG001|Overall Study|Withdrawal by Subject|1|||
130650244|NCT00656669|470340795|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
130650245|NCT00656669|470340795|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
130650246|NCT00656669|470340795|FG000|AC (Cycles 6-9)|Adverse Event|1|||
130650247|NCT00656669|470340795|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
130650248|NCT03778021|470340796|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
130650249|NCT03778021|470340797|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
130650250|NCT01545375|470340798|FG000|Overall Study|Adverse Event|2|||
130650251|NCT01545375|470340799|FG001|Overall Study|Adverse Event|1|||
130650252|NCT01545375|470340798|FG000|Overall Study|Lost to Follow-up|34|||
130650253|NCT01545375|470340799|FG001|Overall Study|Lost to Follow-up|31|||
130650254|NCT01545375|470340798|FG000|Overall Study|Protocol Violation|3|||
130650255|NCT01545375|470340799|FG001|Overall Study|Protocol Violation|3|||
130650256|NCT01545375|470340798|FG000|Overall Study|Withdrawal by Subject|58|||
130650257|NCT01545375|470340799|FG001|Overall Study|Withdrawal by Subject|55|||
130650258|NCT00679042|470340800|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
130650259|NCT00679042|470340800|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
130650260|NCT00679042|470340800|FG000|5-Year Follow Up|Death|1|||
130650261|NCT00679042|470340800|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
130650262|NCT00679042|470340800|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
130650263|NCT01846039|470340801|FG000|Overall Study|Protocol Violation|1|||
130650264|NCT01846039|470340801|FG000|Overall Study|Subject Withdrew Consent|1|||
130650265|NCT00247416|470340804|FG000|Overall Study|3 patients were found to be ineligible|1|||
130650266|NCT00247416|470340805|FG001|Overall Study|3 patients were found to be ineligible|2|||
130650267|NCT04854421|470340806|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
130650268|NCT04854421|470340807|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
130650269|NCT00798161|470340808|FG000|Overall Study|Adverse Event|3|||
130650270|NCT00798161|470340809|FG001|Overall Study|Adverse Event|4|||
130650271|NCT00798161|470340810|FG002|Overall Study|Adverse Event|6|||
130650272|NCT00798161|470340811|FG003|Overall Study|Adverse Event|6|||
130650273|NCT00798161|470340812|FG004|Overall Study|Adverse Event|5|||
130650274|NCT00798161|470340813|FG005|Overall Study|Adverse Event|2|||
130650275|NCT00798161|470340814|FG006|Overall Study|Adverse Event|4|||
130650276|NCT00798161|470340808|FG000|Overall Study|Protocol Violation|2|||
130650277|NCT00798161|470340809|FG001|Overall Study|Protocol Violation|1|||
130650278|NCT00798161|470340810|FG002|Overall Study|Protocol Violation|3|||
130650279|NCT00798161|470340811|FG003|Overall Study|Protocol Violation|3|||
130650280|NCT00798161|470340812|FG004|Overall Study|Protocol Violation|3|||
130650281|NCT00798161|470340813|FG005|Overall Study|Protocol Violation|2|||
130650282|NCT00798161|470340814|FG006|Overall Study|Protocol Violation|0|||
130650283|NCT00798161|470340808|FG000|Overall Study|Lost to Follow-up|1|||
130650284|NCT00798161|470340809|FG001|Overall Study|Lost to Follow-up|3|||
130650285|NCT00798161|470340810|FG002|Overall Study|Lost to Follow-up|4|||
130650286|NCT00798161|470340811|FG003|Overall Study|Lost to Follow-up|3|||
130650287|NCT00798161|470340812|FG004|Overall Study|Lost to Follow-up|4|||
130650288|NCT00798161|470340813|FG005|Overall Study|Lost to Follow-up|0|||
130650289|NCT00798161|470340814|FG006|Overall Study|Lost to Follow-up|0|||
130650290|NCT00798161|470340808|FG000|Overall Study|Withdrawal by Subject|5|||
130650291|NCT00798161|470340809|FG001|Overall Study|Withdrawal by Subject|4|||
130650292|NCT00798161|470340810|FG002|Overall Study|Withdrawal by Subject|5|||
130650293|NCT00798161|470340811|FG003|Overall Study|Withdrawal by Subject|4|||
130650294|NCT00798161|470340812|FG004|Overall Study|Withdrawal by Subject|2|||
130650295|NCT00798161|470340813|FG005|Overall Study|Withdrawal by Subject|3|||
130650296|NCT00798161|470340814|FG006|Overall Study|Withdrawal by Subject|1|||
130650297|NCT00798161|470340808|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
130650298|NCT00798161|470340809|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
130650299|NCT00798161|470340810|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
130650300|NCT00798161|470340811|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
130650301|NCT00798161|470340812|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
130650302|NCT00798161|470340813|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
130650303|NCT00798161|470340814|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
130650304|NCT00761761|470340815|FG000|Overall Study|Lost to Follow-up|3|||
130650305|NCT00761761|470340816|FG001|Overall Study|Lost to Follow-up|1|||
130650306|NCT00761761|470340815|FG000|Overall Study|Withdrawal by Subject|3|||
130650307|NCT00761761|470340816|FG001|Overall Study|Withdrawal by Subject|0|||
130650308|NCT03472586|470340822|FG000|Overall Study|Physician Decision|6|||
130650309|NCT03472586|470340822|FG000|Overall Study|Death|6|||
130650310|NCT03472586|470340822|FG000|Overall Study|Adverse Event|1|||
130650311|NCT02528331|470340824|FG000|Overall Study|Withdrawal by Subject|2|||
130650312|NCT01224171|470340825|FG000|Overall Study|Adverse Event|8|||
130650313|NCT01224171|470340826|FG001|Overall Study|Adverse Event|4|||
130650314|NCT01224171|470340825|FG000|Overall Study|Protocol Violation|0|||
130650315|NCT01224171|470340826|FG001|Overall Study|Protocol Violation|1|||
130650316|NCT01224171|470340825|FG000|Overall Study|Lack of Efficacy|5|||
130650317|NCT01224171|470340826|FG001|Overall Study|Lack of Efficacy|1|||
130650318|NCT01224171|470340825|FG000|Overall Study|Withdrawal of Consent|2|||
130650319|NCT01224171|470340826|FG001|Overall Study|Withdrawal of Consent|4|||
130650320|NCT01224171|470340825|FG000|Overall Study|Lost to Follow-up|0|||
130650321|NCT01224171|470340826|FG001|Overall Study|Lost to Follow-up|3|||
130650322|NCT03737812|470340827|FG000|Overall Study|Withdrawal by Subject|1|||
130650323|NCT03737812|470340828|FG001|Overall Study|Withdrawal by Subject|2|||
130650324|NCT03737812|470340829|FG002|Overall Study|Withdrawal by Subject|1|||
130650325|NCT03737812|470340827|FG000|Overall Study|Sponsor Discontinued the Study|4|||
130650326|NCT03737812|470340828|FG001|Overall Study|Sponsor Discontinued the Study|3|||
130650327|NCT03737812|470340829|FG002|Overall Study|Sponsor Discontinued the Study|2|||
130650328|NCT03737812|470340827|FG000|Overall Study|Adverse Event|0|||
130650329|NCT03737812|470340828|FG001|Overall Study|Adverse Event|1|||
130650330|NCT03737812|470340829|FG002|Overall Study|Adverse Event|0|||
130650331|NCT03737812|470340827|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
130650332|NCT03737812|470340828|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
130650333|NCT03737812|470340829|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
130650334|NCT02624713|470340830|FG000|Overall Study|Lost to Follow-up|14|||
130650335|NCT02624713|470340831|FG001|Overall Study|Lost to Follow-up|0|||
130650336|NCT00285857|470340835|FG000|Overall Study|Withdrawal by Subject|2|||
130650337|NCT00285857|470340835|FG000|Overall Study|Inadequate initial breast cytology|1|||
130650338|NCT00285857|470340835|FG000|Overall Study|Adverse Event|1|||
130650339|NCT01161173|470340841|FG000|Overall Study|Protocol Violation|13|||
130650340|NCT01161173|470340841|FG000|Overall Study|Lost to Follow-up|7|||
130650341|NCT01161173|470340841|FG000|Overall Study|Progressive Disease|82|||
130650342|NCT01161173|470340841|FG000|Overall Study|Withdrawal of Consent|5|||
130650343|NCT01161173|470340841|FG000|Overall Study|Unacceptable Toxicity|21|||
130650344|NCT01161173|470340841|FG000|Overall Study|Death|194|||
130650345|NCT01161173|470340841|FG000|Overall Study|End of Study|2|||
130650346|NCT01161173|470340841|FG000|Overall Study|Reasons Not Specified|23|||
130650347|NCT00792467|470340844|FG000|Overall Study|progression of disease|17|||
130650348|NCT00792467|470340844|FG000|Overall Study|Adverse Event|1|||
130650349|NCT00792467|470340844|FG000|Overall Study|patient request|1|||
130650350|NCT00792467|470340844|FG000|Overall Study|Lost to Follow-up|1|||
130650351|NCT00792467|470340844|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
130650352|NCT00792467|470340844|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
130650353|NCT03911401|470340845|FG000|Overall Study|Adverse Event|1|||
130650354|NCT03911401|470340846|FG001|Overall Study|Adverse Event|2|||
130650355|NCT03911401|470340847|FG002|Overall Study|Adverse Event|5|||
130650356|NCT03911401|470340845|FG000|Overall Study|Lack of Efficacy|1|||
130650357|NCT03911401|470340846|FG001|Overall Study|Lack of Efficacy|1|||
130650358|NCT03911401|470340847|FG002|Overall Study|Lack of Efficacy|8|||
130650359|NCT03911401|470340845|FG000|Overall Study|Physician Decision|0|||
130650360|NCT03911401|470340846|FG001|Overall Study|Physician Decision|0|||
130650361|NCT03911401|470340847|FG002|Overall Study|Physician Decision|1|||
130650362|NCT03911401|470340845|FG000|Overall Study|Withdrawal by Subject|1|||
130650363|NCT03911401|470340846|FG001|Overall Study|Withdrawal by Subject|2|||
130650364|NCT03911401|470340847|FG002|Overall Study|Withdrawal by Subject|0|||
130650365|NCT03911401|470340845|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130650366|NCT03911401|470340846|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130650367|NCT03911401|470340847|FG002|Overall Study|Withdrawal by parent/guardian|11|||
130650368|NCT02918968|470340848|FG000|1st Line AAT|Progressive disease|9|||
130650369|NCT02918968|470340849|FG001|1st Line AAT|Progressive disease|4|||
130650370|NCT02918968|470340848|FG000|1st Line AAT|Adverse Event|12|||
130650371|NCT02918968|470340849|FG001|1st Line AAT|Adverse Event|3|||
130650372|NCT02918968|470340848|FG000|1st Line AAT|Physician Decision|4|||
130650373|NCT02918968|470340849|FG001|1st Line AAT|Physician Decision|2|||
130650374|NCT02918968|470340848|FG000|1st Line AAT|Withdrawal by Subject|2|||
130650375|NCT02918968|470340849|FG001|1st Line AAT|Withdrawal by Subject|1|||
130650376|NCT02918968|470340848|FG000|1st Line AAT|Lost to Follow-up|0|||
130650377|NCT02918968|470340849|FG001|1st Line AAT|Lost to Follow-up|1|||
130650378|NCT02918968|470340848|FG000|1st Line AAT|Death|1|||
130650379|NCT02918968|470340849|FG001|1st Line AAT|Death|0|||
130650380|NCT02918968|470340848|FG000|1st Line AAT|Miscellaneous|1|||
130650381|NCT02918968|470340849|FG001|1st Line AAT|Miscellaneous|0|||
130650382|NCT02918968|470340848|FG000|2nd Line AAT|Progressive disease|21|||
130650383|NCT02918968|470340849|FG001|2nd Line AAT|Progressive disease|3|||
130650384|NCT02918968|470340848|FG000|2nd Line AAT|Adverse Event|2|||
130650385|NCT02918968|470340849|FG001|2nd Line AAT|Adverse Event|5|||
130650386|NCT02918968|470340848|FG000|2nd Line AAT|Physician Decision|0|||
130650387|NCT02918968|470340849|FG001|2nd Line AAT|Physician Decision|1|||
130650388|NCT02918968|470340848|FG000|2nd Line AAT|Withdrawal by Subject|2|||
130650389|NCT02918968|470340849|FG001|2nd Line AAT|Withdrawal by Subject|2|||
130650390|NCT02918968|470340848|FG000|2nd Line AAT|Death|0|||
130650391|NCT02918968|470340849|FG001|2nd Line AAT|Death|1|||
130650392|NCT03781167|470340859|FG000|Overall Study|Adverse Event|23|||
130650393|NCT03781167|470340860|FG001|Overall Study|Adverse Event|25|||
130650394|NCT03781167|470340859|FG000|Overall Study|Withdrew consent|16|||
130650395|NCT03781167|470340860|FG001|Overall Study|Withdrew consent|12|||
130650396|NCT03781167|470340859|FG000|Overall Study|Lost to Follow-up|0|||
130650397|NCT03781167|470340860|FG001|Overall Study|Lost to Follow-up|1|||
130650398|NCT03781167|470340859|FG000|Overall Study|Lack of Efficacy|4|||
130650399|NCT03781167|470340860|FG001|Overall Study|Lack of Efficacy|5|||
130650400|NCT03781167|470340859|FG000|Overall Study|Difficulty with drug delivery system|2|||
130650401|NCT03781167|470340860|FG001|Overall Study|Difficulty with drug delivery system|3|||
130650402|NCT03781167|470340859|FG000|Overall Study|Other, not specified|2|||
130650403|NCT03781167|470340860|FG001|Overall Study|Other, not specified|2|||
130650404|NCT01590628|470340862|FG000|Overall Study|Death|2|||
130650405|NCT01590628|470340863|FG001|Overall Study|Death|0|||
130650406|NCT00475657|470340864|FG000|Overall Study|Death|1|||
130650407|NCT00475657|470340864|FG000|Overall Study|Sponsor's Decision|3|||
130650408|NCT00381680|470340865|FG000|Overall Study|Adverse Event|9|||
130650409|NCT00381680|470340866|FG001|Overall Study|Adverse Event|3|||
130650410|NCT00381680|470340865|FG000|Overall Study|Death|10|||
130650411|NCT00381680|470340866|FG001|Overall Study|Death|7|||
130650412|NCT00381680|470340865|FG000|Overall Study|Lost to Follow-up|3|||
130650413|NCT00381680|470340866|FG001|Overall Study|Lost to Follow-up|2|||
130650414|NCT00381680|470340865|FG000|Overall Study|Physician Decision|25|||
130650415|NCT00381680|470340866|FG001|Overall Study|Physician Decision|6|||
130650416|NCT00381680|470340865|FG000|Overall Study|Withdrawal by Subject|3|||
130650417|NCT00381680|470340866|FG001|Overall Study|Withdrawal by Subject|1|||
130650418|NCT00381680|470340865|FG000|Overall Study|Entry onto another COG Trial|1|||
130650419|NCT00381680|470340866|FG001|Overall Study|Entry onto another COG Trial|2|||
130650420|NCT00381680|470340865|FG000|Overall Study|Alternative Therapy|11|||
130650421|NCT00381680|470340866|FG001|Overall Study|Alternative Therapy|5|||
130650422|NCT00381680|470340865|FG000|Overall Study|Secondary Malignancy|3|||
130650423|NCT00381680|470340866|FG001|Overall Study|Secondary Malignancy|0|||
130650424|NCT00381680|470340865|FG000|Overall Study|Delay initiation|1|||
130650425|NCT00381680|470340866|FG001|Overall Study|Delay initiation|0|||
130650426|NCT00381680|470340865|FG000|Overall Study|Stem Cell Transplant|26|||
130650427|NCT00381680|470340866|FG001|Overall Study|Stem Cell Transplant|10|||
130650428|NCT00381680|470340865|FG000|Overall Study|Relapse|18|||
130650429|NCT00381680|470340866|FG001|Overall Study|Relapse|9|||
130650430|NCT00381680|470340865|FG000|Overall Study|Induction Failure|4|||
130650431|NCT00381680|470340866|FG001|Overall Study|Induction Failure|1|||
130650432|NCT00381680|470340865|FG000|Overall Study|Progression|1|||
130650433|NCT00381680|470340866|FG001|Overall Study|Progression|1|||
130650434|NCT00381680|470340865|FG000|Overall Study|Other not otherwise specified|7|||
130650435|NCT00381680|470340866|FG001|Overall Study|Other not otherwise specified|2|||
130650436|NCT00381680|470340865|FG000|Overall Study|Ineligible|3|||
130650437|NCT00381680|470340866|FG001|Overall Study|Ineligible|1|||
130650438|NCT00933543|470340873|FG000|Overall Study|Adverse Event|2|||
130650439|NCT00933543|470340874|FG001|Overall Study|Adverse Event|1|||
130650440|NCT00933543|470340873|FG000|Overall Study|Lost to Follow-up|0|||
130650441|NCT00933543|470340874|FG001|Overall Study|Lost to Follow-up|1|||
130650442|NCT00933543|470340873|FG000|Overall Study|Withdrawal by Subject|0|||
130650443|NCT00933543|470340874|FG001|Overall Study|Withdrawal by Subject|1|||
130650444|NCT00933543|470340873|FG000|Overall Study|Lack of Efficacy|0|||
130650445|NCT00933543|470340874|FG001|Overall Study|Lack of Efficacy|3|||
130650446|NCT00933543|470340873|FG000|Overall Study|Other|1|||
130650447|NCT00933543|470340874|FG001|Overall Study|Other|1|||
130650448|NCT04988035|470340875|FG000|Overall Study|Death|19|||
130650449|NCT04988035|470340876|FG001|Overall Study|Death|13|||
130650450|NCT04988035|470340875|FG000|Overall Study|Lost to Follow-up|12|||
130650451|NCT04988035|470340876|FG001|Overall Study|Lost to Follow-up|6|||
130650452|NCT04988035|470340875|FG000|Overall Study|Protocol Violation|0|||
130650453|NCT04988035|470340876|FG001|Overall Study|Protocol Violation|1|||
130650454|NCT04988035|470340875|FG000|Overall Study|Withdrawal by Subject|2|||
130650455|NCT04988035|470340876|FG001|Overall Study|Withdrawal by Subject|4|||
130650456|NCT04988035|470340875|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
130650457|NCT04988035|470340876|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
130650458|NCT03831282|470340877|FG000|Overall Study|Could not place sensor|1|||
130650459|NCT00334893|470340878|FG000|Overall Study|Not Treated|1|||
130650460|NCT00334893|470340879|FG001|Overall Study|Not Treated|0|||
130650461|NCT01258803|470340880|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
130650462|NCT01258803|470340881|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
130650463|NCT01258803|470340882|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130650464|NCT01258803|470340883|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130650465|NCT01258803|470340884|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130650466|NCT01258803|470340885|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
130650467|NCT01258803|470340880|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130650468|NCT01258803|470340881|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
130650469|NCT01258803|470340882|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130650470|NCT01258803|470340883|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130650471|NCT01258803|470340884|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130650472|NCT01258803|470340885|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130650473|NCT01258803|470340880|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130650474|NCT01258803|470340881|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130650475|NCT01258803|470340882|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
130650476|NCT01258803|470340883|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130650477|NCT01258803|470340884|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130650478|NCT01258803|470340885|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130650479|NCT04652245|470340892|FG000|Wash-Out Period|Adverse Event|0|||
130650480|NCT04652245|470340893|FG001|Wash-Out Period|Adverse Event|2|||
130650481|NCT04652245|470340892|FG000|Wash-Out Period|Withdrawal by Subject|0|||
130650482|NCT04652245|470340893|FG001|Wash-Out Period|Withdrawal by Subject|2|||
130650483|NCT03556202|470340896|FG000|Extension Treatment Period|Adverse Event|18|||
130650484|NCT03556202|470340897|FG001|Extension Treatment Period|Adverse Event|14|||
130650485|NCT03556202|470340898|FG002|Extension Treatment Period|Adverse Event|9|||
130650486|NCT03556202|470340896|FG000|Extension Treatment Period|Death|2|||
130650487|NCT03556202|470340897|FG001|Extension Treatment Period|Death|6|||
130650488|NCT03556202|470340898|FG002|Extension Treatment Period|Death|0|||
130650489|NCT03556202|470340896|FG000|Extension Treatment Period|Lack of Efficacy|5|||
130650490|NCT03556202|470340897|FG001|Extension Treatment Period|Lack of Efficacy|12|||
130650491|NCT03556202|470340898|FG002|Extension Treatment Period|Lack of Efficacy|18|||
130650492|NCT03556202|470340896|FG000|Extension Treatment Period|Lost to Follow-up|9|||
130650493|NCT03556202|470340897|FG001|Extension Treatment Period|Lost to Follow-up|20|||
130650494|NCT03556202|470340898|FG002|Extension Treatment Period|Lost to Follow-up|2|||
130650495|NCT03556202|470340896|FG000|Extension Treatment Period|Pregnancy|2|||
130650496|NCT03556202|470340897|FG001|Extension Treatment Period|Pregnancy|4|||
130650497|NCT03556202|470340898|FG002|Extension Treatment Period|Pregnancy|3|||
130650498|NCT03556202|470340896|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
130650499|NCT03556202|470340897|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
130650500|NCT03556202|470340898|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
130650501|NCT03556202|470340896|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
130650502|NCT03556202|470340897|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
130650503|NCT03556202|470340898|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
130650504|NCT03556202|470340896|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
130650505|NCT03556202|470340897|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
130650506|NCT03556202|470340898|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
130650507|NCT03556202|470340896|FG000|Extension Treatment Period|Physician Decision|0|||
130650508|NCT03556202|470340897|FG001|Extension Treatment Period|Physician Decision|8|||
130650509|NCT03556202|470340898|FG002|Extension Treatment Period|Physician Decision|2|||
130650510|NCT03556202|470340896|FG000|Extension Treatment Period|Protocol Violation|0|||
130650511|NCT03556202|470340897|FG001|Extension Treatment Period|Protocol Violation|1|||
130650512|NCT03556202|470340898|FG002|Extension Treatment Period|Protocol Violation|1|||
130650513|NCT03556202|470340896|FG000|Extension Treatment Period|Sponsor Decision|0|||
130650514|NCT03556202|470340897|FG001|Extension Treatment Period|Sponsor Decision|1|||
130650515|NCT03556202|470340898|FG002|Extension Treatment Period|Sponsor Decision|0|||
130650516|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
130650517|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
130650518|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
130650519|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Death|1|||
130650520|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Death|0|||
130650521|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Death|0|||
130650522|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
130650523|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
130650524|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
130650525|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
130650526|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
130650527|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
130650528|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
130650529|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
130650530|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
130650531|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
130650532|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
130650533|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
130650534|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
130650535|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
130650536|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
130650537|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
130650538|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
130650539|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
130650540|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
130650541|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
130650542|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
130650543|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
130650544|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
130650545|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
130650546|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
130650547|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
130650548|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
130650549|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
130650550|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
130650551|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
130650552|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
130650553|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
130650554|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
130650555|NCT03556202|470340896|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
130650556|NCT03556202|470340897|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
130650557|NCT03556202|470340898|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
130650558|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Adverse Event|6|||
130650559|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Adverse Event|6|||
130650560|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Death|14|||
130650561|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Death|11|||
130650562|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
130650563|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
130650564|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
130650565|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
130650566|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
130650567|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
130650568|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Disease Progression|1|||
130650569|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Disease Progression|0|||
130650570|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
130650571|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
130650572|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
130650573|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
130650574|NCT04419558|470340899|FG000|DB Period (48 Weeks)|Participant Decision|4|||
130650575|NCT04419558|470340900|FG001|DB Period (48 Weeks)|Participant Decision|3|||
130650576|NCT04419558|470340899|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
130650577|NCT04419558|470340900|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
130650578|NCT04419558|470340899|FG000|OLE Period (48 Weeks)|Death|4|||
130650579|NCT04419558|470340900|FG001|OLE Period (48 Weeks)|Death|6|||
130650580|NCT04419558|470340899|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
130650581|NCT04419558|470340900|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
130650582|NCT04419558|470340899|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
130650583|NCT04419558|470340900|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
130650584|NCT00903357|470340901|FG000|First Intervention|Withdrawal by Subject|5|||
130650585|NCT00903357|470340902|FG001|First Intervention|Withdrawal by Subject|3|||
130650586|NCT00903357|470340901|FG000|First Intervention|Flu|0|||
130650587|NCT00903357|470340902|FG001|First Intervention|Flu|1|||
130650588|NCT00903357|470340901|FG000|Wash Out Period of 2 Weeks|Flu|0|||
130650589|NCT00903357|470340902|FG001|Wash Out Period of 2 Weeks|Flu|1|||
130650590|NCT00903357|470340901|FG000|Second Intervention|Lost to Follow-up|1|||
130650591|NCT00903357|470340902|FG001|Second Intervention|Lost to Follow-up|0|||
130650592|NCT05146999|470340903|FG000|Overall Study|Withdrew consent|6|||
130650593|NCT05146999|470340904|FG001|Overall Study|Withdrew consent|1|||
130650594|NCT05146999|470340903|FG000|Overall Study|Lost to Follow-up|3|||
130650595|NCT05146999|470340904|FG001|Overall Study|Lost to Follow-up|2|||
130650596|NCT05146999|470340903|FG000|Overall Study|Other|1|||
130650597|NCT05146999|470340904|FG001|Overall Study|Other|3|||
130650598|NCT02221882|470340905|FG000|Overall Study|Withdrawal by Subject|0|||
130650599|NCT02221882|470340906|FG001|Overall Study|Withdrawal by Subject|0|||
130650600|NCT02221882|470340907|FG002|Overall Study|Withdrawal by Subject|4|||
130650601|NCT02221882|470340908|FG003|Overall Study|Withdrawal by Subject|2|||
130650602|NCT02221882|470340909|FG004|Overall Study|Withdrawal by Subject|2|||
130650603|NCT02221882|470340910|FG005|Overall Study|Withdrawal by Subject|2|||
130650604|NCT02221882|470340905|FG000|Overall Study|Death|0|||
130650605|NCT02221882|470340906|FG001|Overall Study|Death|1|||
130650606|NCT02221882|470340907|FG002|Overall Study|Death|0|||
130650607|NCT02221882|470340908|FG003|Overall Study|Death|0|||
130650608|NCT02221882|470340909|FG004|Overall Study|Death|0|||
130650609|NCT02221882|470340910|FG005|Overall Study|Death|0|||
130650610|NCT05664672|470340911|FG000|Overall Study|Adverse Event|0|||
130650611|NCT05664672|470340912|FG001|Overall Study|Adverse Event|0|||
130650612|NCT05664672|470340913|FG002|Overall Study|Adverse Event|0|||
130650613|NCT05664672|470340914|FG003|Overall Study|Adverse Event|0|||
130650614|NCT05664672|470340915|FG004|Overall Study|Adverse Event|0|||
130650615|NCT05664672|470340916|FG005|Overall Study|Adverse Event|1|||
130650616|NCT05664672|470340911|FG000|Overall Study|Withdrawal by Subject|0|||
130650617|NCT05664672|470340912|FG001|Overall Study|Withdrawal by Subject|1|||
130650618|NCT05664672|470340913|FG002|Overall Study|Withdrawal by Subject|3|||
130650619|NCT05664672|470340914|FG003|Overall Study|Withdrawal by Subject|0|||
130650620|NCT05664672|470340915|FG004|Overall Study|Withdrawal by Subject|5|||
130650621|NCT05664672|470340916|FG005|Overall Study|Withdrawal by Subject|6|||
130650622|NCT05664672|470340911|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
130650623|NCT05664672|470340912|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130650624|NCT05664672|470340913|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130650625|NCT05664672|470340914|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
130650626|NCT05664672|470340915|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130650627|NCT05664672|470340916|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
130650628|NCT05664672|470340911|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
130650629|NCT05664672|470340912|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130650630|NCT05664672|470340913|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130650631|NCT05664672|470340914|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130650632|NCT05664672|470340915|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130650633|NCT05664672|470340916|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130650634|NCT04236986|470340921|FG000|Overall Study|Withdrawal by Subject|3|||
130650635|NCT04236986|470340922|FG001|Overall Study|Withdrawal by Subject|1|||
130650636|NCT04034225|470340923|FG000|Overall Study|Death|3|||
130650637|NCT04034225|470340923|FG000|Overall Study|Withdrawal by Subject|2|||
130650638|NCT04034225|470340923|FG000|Overall Study|Study termination by Sponsor|18|||
130650639|NCT04034225|470340923|FG000|Overall Study|Physician Decision|1|||
130650640|NCT04034225|470340923|FG000|Overall Study|Lack of Efficacy|1|||
130650641|NCT01018680|470342259|FG000|Overall Study|Adverse Event|23|||
130650642|NCT01018680|470342260|FG001|Overall Study|Adverse Event|40|||
130650643|NCT01018680|470342259|FG000|Overall Study|Withdrawal by Subject|10|||
130650644|NCT01018680|470342260|FG001|Overall Study|Withdrawal by Subject|10|||
130650645|NCT01018680|470342259|FG000|Overall Study|Protocol Violation|5|||
130650646|NCT01018680|470342260|FG001|Overall Study|Protocol Violation|8|||
130650647|NCT01018680|470342259|FG000|Overall Study|Sponsor Decision|6|||
130650648|NCT01018680|470342260|FG001|Overall Study|Sponsor Decision|7|||
130650649|NCT01018680|470342259|FG000|Overall Study|Lack of Efficacy|8|||
130650650|NCT01018680|470342260|FG001|Overall Study|Lack of Efficacy|2|||
130650651|NCT01018680|470342259|FG000|Overall Study|Lost to Follow-up|5|||
130650652|NCT01018680|470342260|FG001|Overall Study|Lost to Follow-up|3|||
130650653|NCT01018680|470342259|FG000|Overall Study|Entry Criteria Not Met|1|||
130650654|NCT01018680|470342260|FG001|Overall Study|Entry Criteria Not Met|4|||
130650655|NCT01018680|470342259|FG000|Overall Study|Physician Decision|3|||
130650656|NCT01018680|470342260|FG001|Overall Study|Physician Decision|1|||
130650657|NCT02930889|470342261|FG000|Overall Study|Lost to Follow-up|2|||
130650658|NCT02930889|470342261|FG000|Overall Study|Withdrawal by Subject|6|||
130650659|NCT02930889|470342261|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
130650660|NCT04511533|470342268|FG000|Treatment|Other|2|||
130650661|NCT04511533|470342268|FG000|Treatment|Withdrawal by Subject|11|||
130650662|NCT04511533|470342268|FG000|Treatment|Death|5|||
130650663|NCT04511533|470342268|FG000|Treatment|Physician Decision|1|||
130650664|NCT04511533|470342268|FG000|Treatment|Progressive Disease|61|||
130650665|NCT04511533|470342268|FG000|Follow-Up|Other|7|||
130650666|NCT04511533|470342268|FG000|Follow-Up|Withdrawal by Subject|5|||
130650667|NCT04511533|470342268|FG000|Follow-Up|Lost to Follow-up|2|||
130650668|NCT04511533|470342268|FG000|Follow-Up|Death|4|||
130650669|NCT01319422|470342269|FG000|Overall Study|Withdrawal by Subject|1|||
130650670|NCT01319422|470342270|FG001|Overall Study|Withdrawal by Subject|0|||
130650671|NCT01428882|470342277|FG000|Overall Study|Lack of Efficacy|2|||
130650672|NCT01428882|470342278|FG001|Overall Study|Lack of Efficacy|7|||
130650673|NCT01428882|470342277|FG000|Overall Study|Protocol Violation|4|||
130650674|NCT01428882|470342278|FG001|Overall Study|Protocol Violation|3|||
130650675|NCT01539512|470342285|FG000|Overall Study|Adverse Event|9|||
130650676|NCT01539512|470342286|FG001|Overall Study|Adverse Event|7|||
130650677|NCT01539512|470342285|FG000|Overall Study|Physician Decision|1|||
130650678|NCT01539512|470342286|FG001|Overall Study|Physician Decision|1|||
130650679|NCT01539512|470342285|FG000|Overall Study|Withdrawal by Subject|12|||
130650680|NCT01539512|470342286|FG001|Overall Study|Withdrawal by Subject|5|||
130650681|NCT01539512|470342285|FG000|Overall Study|Richter's Transformation|1|||
130650682|NCT01539512|470342286|FG001|Overall Study|Richter's Transformation|0|||
130650683|NCT04668157|470342287|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
130650684|NCT04668157|470342288|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130650685|NCT04668157|470342287|FG000|Treatment Period (52 Weeks)|Other|0|||
130650686|NCT04668157|470342288|FG001|Treatment Period (52 Weeks)|Other|2|||
130650687|NCT04479358|470342295|FG000|Overall Study|Withdrawal by Subject|0|||
130650688|NCT04479358|470342296|FG001|Overall Study|Withdrawal by Subject|0|||
130650689|NCT04479358|470342297|FG002|Overall Study|Withdrawal by Subject|1|||
130650690|NCT04479358|470342298|FG003|Overall Study|Withdrawal by Subject|0|||
130650691|NCT04479358|470342299|FG004|Overall Study|Withdrawal by Subject|0|||
130650692|NCT04479358|470342300|FG005|Overall Study|Withdrawal by Subject|1|||
130650693|NCT00764465|470342301|FG000|Overall Study|Adverse Event|2|||
130650694|NCT00764465|470342302|FG001|Overall Study|Adverse Event|0|||
130650695|NCT00764465|470342303|FG002|Overall Study|Adverse Event|0|||
130650696|NCT00764465|470342304|FG003|Overall Study|Adverse Event|1|||
130650697|NCT00764465|470342305|FG004|Overall Study|Adverse Event|1|||
130650698|NCT00764465|470342306|FG005|Overall Study|Adverse Event|1|||
130650699|NCT00764465|470342301|FG000|Overall Study|Withdrawal by Subject|0|||
130650700|NCT00764465|470342302|FG001|Overall Study|Withdrawal by Subject|1|||
130650701|NCT00764465|470342303|FG002|Overall Study|Withdrawal by Subject|1|||
130650702|NCT00764465|470342304|FG003|Overall Study|Withdrawal by Subject|0|||
130650703|NCT00764465|470342305|FG004|Overall Study|Withdrawal by Subject|0|||
130650704|NCT00764465|470342306|FG005|Overall Study|Withdrawal by Subject|0|||
130650705|NCT01333501|470342307|FG000|Overall Study|Adverse Event|3|||
130650706|NCT01333501|470342308|FG001|Overall Study|Adverse Event|1|||
130650707|NCT01333501|470342307|FG000|Overall Study|Abnormal laboratory value|2|||
130650708|NCT01333501|470342308|FG001|Overall Study|Abnormal laboratory value|1|||
130650709|NCT01333501|470342307|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130650710|NCT01333501|470342308|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
130650711|NCT01333501|470342307|FG000|Overall Study|Withdrawn consent|3|||
130650712|NCT01333501|470342308|FG001|Overall Study|Withdrawn consent|12|||
130650713|NCT00674440|470342309|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
130650714|NCT00674440|470342309|FG000|Overall Study|did not have surgery, so unevaluable|7|||
130650715|NCT00674440|470342309|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
130650716|NCT03329404|470342310|FG000|Overall Study|The study was suspended.|1|||
130650717|NCT03329404|470342311|FG001|Overall Study|The study was suspended.|4|||
130650718|NCT00914940|470342312|FG000|D0 to D100 Post-transplant|Death|2|||
130650719|NCT00914940|470342312|FG000|D101 to 2 Years Post-transplant|Death|8|||
130650720|NCT00914940|470342312|FG000|2 Years to 5 Years Post-transplant|Death|3|||
130650721|NCT00796367|470342313|FG000|Overall Study|Adverse Event|6|||
130650722|NCT00796367|470342314|FG001|Overall Study|Adverse Event|4|||
130650723|NCT00796367|470342315|FG002|Overall Study|Adverse Event|7|||
130650724|NCT00796367|470342313|FG000|Overall Study|Lost to Follow-up|5|||
130650725|NCT00796367|470342314|FG001|Overall Study|Lost to Follow-up|4|||
130650726|NCT00796367|470342315|FG002|Overall Study|Lost to Follow-up|21|||
130650727|NCT00796367|470342313|FG000|Overall Study|Withdrawal by Subject|9|||
130650728|NCT00796367|470342314|FG001|Overall Study|Withdrawal by Subject|11|||
130650729|NCT00796367|470342315|FG002|Overall Study|Withdrawal by Subject|12|||
130650730|NCT00796367|470342313|FG000|Overall Study|Lack of Efficacy|2|||
130650731|NCT00796367|470342314|FG001|Overall Study|Lack of Efficacy|1|||
130650732|NCT00796367|470342315|FG002|Overall Study|Lack of Efficacy|0|||
130650733|NCT00796367|470342313|FG000|Overall Study|non compliance|3|||
130650734|NCT00796367|470342314|FG001|Overall Study|non compliance|1|||
130650735|NCT00796367|470342315|FG002|Overall Study|non compliance|1|||
130650736|NCT00796367|470342313|FG000|Overall Study|Pregnancy|1|||
130650737|NCT00796367|470342314|FG001|Overall Study|Pregnancy|0|||
130650738|NCT00796367|470342315|FG002|Overall Study|Pregnancy|1|||
130650739|NCT00796367|470342313|FG000|Overall Study|Requirement for restricted medication|2|||
130650740|NCT00796367|470342314|FG001|Overall Study|Requirement for restricted medication|0|||
130650741|NCT00796367|470342315|FG002|Overall Study|Requirement for restricted medication|2|||
130650742|NCT00796367|470342313|FG000|Overall Study|other|2|||
130650743|NCT00796367|470342314|FG001|Overall Study|other|4|||
130650744|NCT00796367|470342315|FG002|Overall Study|other|3|||
130650745|NCT01365182|470342318|FG000|Overall Study|Withdrawal by Subject|10|||
130650746|NCT01365182|470342319|FG001|Overall Study|Withdrawal by Subject|13|||
130650747|NCT01365182|470342320|FG002|Overall Study|Withdrawal by Subject|12|||
130650748|NCT01728194|470342327|FG000|Overall Study|Lost to Follow-up|4|||
130650749|NCT01728194|470342328|FG001|Overall Study|Lost to Follow-up|3|||
130650750|NCT01728194|470342327|FG000|Overall Study|Physician Decision|4|||
130650751|NCT01728194|470342328|FG001|Overall Study|Physician Decision|0|||
130650752|NCT01728194|470342327|FG000|Overall Study|Withdrawal by Subject|7|||
130650753|NCT01728194|470342328|FG001|Overall Study|Withdrawal by Subject|3|||
130650754|NCT01728194|470342327|FG000|Overall Study|Perceived Medication Side Effects|4|||
130650755|NCT01728194|470342328|FG001|Overall Study|Perceived Medication Side Effects|0|||
130650756|NCT01728194|470342327|FG000|Overall Study|Family Member Request|1|||
130650757|NCT01728194|470342328|FG001|Overall Study|Family Member Request|0|||
130650758|NCT02309372|470342329|FG000|Overall Study|Lost to Follow-up|3|||
130650759|NCT02309372|470342330|FG001|Overall Study|Lost to Follow-up|2|||
130650760|NCT01590810|470342333|FG000|Overall Study|Physician Decision|0|||
130650761|NCT01590810|470342334|FG001|Overall Study|Physician Decision|1|||
130650762|NCT01590810|470342335|FG002|Overall Study|Physician Decision|1|||
130650763|NCT01590810|470342336|FG003|Overall Study|Physician Decision|0|||
130650764|NCT01590810|470342337|FG004|Overall Study|Physician Decision|0|||
130650765|NCT04604015|470342338|FG000|Overall Study|Incomplete Data Collection|33|||
130650766|NCT02129192|470342339|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
130650767|NCT02129192|470342340|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
130650768|NCT01231620|470342341|FG000|Overall Study|Physician Decision|3|||
130650769|NCT01231620|470342342|FG001|Overall Study|Physician Decision|5|||
130650770|NCT01231620|470342343|FG002|Overall Study|Physician Decision|10|||
130650771|NCT01231620|470342341|FG000|Overall Study|Death|12|||
130650772|NCT01231620|470342342|FG001|Overall Study|Death|14|||
130650773|NCT01231620|470342343|FG002|Overall Study|Death|11|||
130650774|NCT01231620|470342341|FG000|Overall Study|Adverse Event|2|||
130650775|NCT01231620|470342342|FG001|Overall Study|Adverse Event|2|||
130650776|NCT01231620|470342343|FG002|Overall Study|Adverse Event|1|||
130650777|NCT01231620|470342341|FG000|Overall Study|Withdrawal by Subject|6|||
130650778|NCT01231620|470342342|FG001|Overall Study|Withdrawal by Subject|6|||
130650779|NCT01231620|470342343|FG002|Overall Study|Withdrawal by Subject|8|||
130650780|NCT01231620|470342341|FG000|Overall Study|Lost to Follow-up|3|||
130650781|NCT01231620|470342342|FG001|Overall Study|Lost to Follow-up|4|||
130650782|NCT01231620|470342343|FG002|Overall Study|Lost to Follow-up|9|||
130650783|NCT02400281|470342345|FG000|Overall Study|Adverse Event|0|||
130650784|NCT02400281|470342346|FG001|Overall Study|Adverse Event|0|||
130650785|NCT02400281|470342347|FG002|Overall Study|Adverse Event|1|||
130650786|NCT02400281|470342348|FG003|Overall Study|Adverse Event|0|||
130650787|NCT02400281|470342349|FG004|Overall Study|Adverse Event|1|||
130650788|NCT02400281|470342350|FG005|Overall Study|Adverse Event|0|||
130650789|NCT02400281|470342345|FG000|Overall Study|Physician Decision|0|||
130650790|NCT02400281|470342346|FG001|Overall Study|Physician Decision|0|||
130650791|NCT02400281|470342347|FG002|Overall Study|Physician Decision|1|||
130650792|NCT02400281|470342348|FG003|Overall Study|Physician Decision|0|||
130650793|NCT02400281|470342349|FG004|Overall Study|Physician Decision|0|||
130650794|NCT02400281|470342350|FG005|Overall Study|Physician Decision|0|||
130650795|NCT02576652|470342353|FG000|Overall Study|Withdrawal by Subject|2|||
130650796|NCT00553319|470342362|FG000|Overall Study|Lost to Follow-up|10|||
130650797|NCT00553319|470342363|FG001|Overall Study|Lost to Follow-up|9|||
130650798|NCT00553319|470342364|FG002|Overall Study|Lost to Follow-up|5|||
130650799|NCT00553319|470342362|FG000|Overall Study|wanted treatment elsewhere|2|||
130650800|NCT00553319|470342363|FG001|Overall Study|wanted treatment elsewhere|1|||
130650801|NCT00553319|470342364|FG002|Overall Study|wanted treatment elsewhere|1|||
130650802|NCT00553319|470342362|FG000|Overall Study|non-compliance|0|||
130650803|NCT00553319|470342363|FG001|Overall Study|non-compliance|0|||
130650804|NCT00553319|470342364|FG002|Overall Study|non-compliance|2|||
130650805|NCT00553319|470342362|FG000|Overall Study|incarceration|1|||
130650806|NCT00553319|470342363|FG001|Overall Study|incarceration|0|||
130650807|NCT00553319|470342364|FG002|Overall Study|incarceration|0|||
130650808|NCT00553319|470342362|FG000|Overall Study|moved|1|||
130650809|NCT00553319|470342363|FG001|Overall Study|moved|0|||
130650810|NCT00553319|470342364|FG002|Overall Study|moved|1|||
130650811|NCT01078974|470342365|FG000|Overall Study|Adverse Event|3|||
130650812|NCT03575975|470342367|FG000|Overall Study|Lost to Follow-up|1|||
130650813|NCT03575975|470342368|FG001|Overall Study|Lost to Follow-up|0|||
130650814|NCT03575975|470342369|FG002|Overall Study|Lost to Follow-up|0|||
130650815|NCT00495794|470342370|FG000|Overall Study|Pharmacist did not activate patient|522|||
130650816|NCT00495794|470342371|FG001|Overall Study|Pharmacist did not activate patient|0|||
130650817|NCT02441517|470342372|FG000|Overall Study|Lost to Follow-up|1|||
130650818|NCT02441517|470342372|FG000|Overall Study|Withdrawal by Subject|2|||
130650819|NCT02441517|470342372|FG000|Overall Study|Study Terminated by Sponsor|1|||
130650820|NCT01393444|470342373|FG000|Overall Study|Withdrawal by Subject|1|||
130650821|NCT01393444|470342373|FG000|Overall Study|Determined ineligible during screening.|2|||
130650822|NCT03039699|470342375|FG000|Overall Study|Incorrect inclusion|5|||
130650823|NCT03039699|470342376|FG001|Overall Study|Incorrect inclusion|4|||
130650824|NCT03039699|470342375|FG000|Overall Study|Lack of data to assess study endpoint|5|||
130650825|NCT03039699|470342376|FG001|Overall Study|Lack of data to assess study endpoint|3|||
130650826|NCT03039699|470342375|FG000|Overall Study|Bacterial infection|12|||
130650827|NCT03039699|470342376|FG001|Overall Study|Bacterial infection|28|||
130650828|NCT00129220|470342377|FG000|Study Period II|Adverse Event|9|||
130650829|NCT00129220|470342378|FG001|Study Period II|Adverse Event|5|||
130650830|NCT00129220|470342379|FG002|Study Period II|Adverse Event|7|||
130650831|NCT00129220|470342377|FG000|Study Period II|Lack of Efficacy|15|||
130650832|NCT00129220|470342378|FG001|Study Period II|Lack of Efficacy|1|||
130650833|NCT00129220|470342379|FG002|Study Period II|Lack of Efficacy|28|||
130650834|NCT00129220|470342377|FG000|Study Period II|Entry Criteria Not Met|2|||
130650835|NCT00129220|470342378|FG001|Study Period II|Entry Criteria Not Met|0|||
130650836|NCT00129220|470342379|FG002|Study Period II|Entry Criteria Not Met|2|||
130650837|NCT00129220|470342377|FG000|Study Period II|Protocol Violation|4|||
130650838|NCT00129220|470342378|FG001|Study Period II|Protocol Violation|2|||
130650839|NCT00129220|470342379|FG002|Study Period II|Protocol Violation|1|||
130650840|NCT00129220|470342377|FG000|Study Period II|Physician Decision|0|||
130650841|NCT00129220|470342378|FG001|Study Period II|Physician Decision|1|||
130650842|NCT00129220|470342379|FG002|Study Period II|Physician Decision|0|||
130650843|NCT00129220|470342377|FG000|Study Period II|Withdrawal by Subject|1|||
130650844|NCT00129220|470342378|FG001|Study Period II|Withdrawal by Subject|3|||
130650845|NCT00129220|470342379|FG002|Study Period II|Withdrawal by Subject|4|||
130650846|NCT00129220|470342377|FG000|Study Period II|Reason Not Specified|2|||
130650847|NCT00129220|470342378|FG001|Study Period II|Reason Not Specified|0|||
130650848|NCT00129220|470342379|FG002|Study Period II|Reason Not Specified|5|||
130650849|NCT00129220|470342377|FG000|Study Period III|Adverse Event|1|||
130650850|NCT00129220|470342378|FG001|Study Period III|Adverse Event|0|||
130650851|NCT00129220|470342379|FG002|Study Period III|Adverse Event|3|||
130650852|NCT00129220|470342377|FG000|Study Period III|Protocol Violation|1|||
130650853|NCT00129220|470342378|FG001|Study Period III|Protocol Violation|1|||
130650854|NCT00129220|470342379|FG002|Study Period III|Protocol Violation|2|||
130650855|NCT00129220|470342377|FG000|Study Period III|Withdrawal by Subject|1|||
130650856|NCT00129220|470342378|FG001|Study Period III|Withdrawal by Subject|0|||
130650857|NCT00129220|470342379|FG002|Study Period III|Withdrawal by Subject|3|||
130650858|NCT00129220|470342377|FG000|Study Period III|Sponsor Decision|1|||
130650859|NCT00129220|470342378|FG001|Study Period III|Sponsor Decision|0|||
130650860|NCT00129220|470342379|FG002|Study Period III|Sponsor Decision|0|||
130650861|NCT00129220|470342377|FG000|Study Period III|Reason Not Specified|9|||
130650862|NCT00129220|470342378|FG001|Study Period III|Reason Not Specified|0|||
130650863|NCT00129220|470342379|FG002|Study Period III|Reason Not Specified|2|||
130650864|NCT01883362|470342380|FG000|Treatment|Adverse Event|1|||
130650865|NCT01883362|470342381|FG001|Treatment|Adverse Event|8|||
130650866|NCT01883362|470342380|FG000|Treatment|Withdrawal by Subject|6|||
130650867|NCT01883362|470342381|FG001|Treatment|Withdrawal by Subject|2|||
130650868|NCT01883362|470342380|FG000|Treatment|Administrative problems|4|||
130650869|NCT01883362|470342381|FG001|Treatment|Administrative problems|1|||
130650870|NCT01883362|470342380|FG000|Treatment|Relapse|4|||
130650871|NCT01883362|470342381|FG001|Treatment|Relapse|2|||
130650872|NCT01883362|470342380|FG000|Treatment|Randomized, not treated|1|||
130650873|NCT01883362|470342381|FG001|Treatment|Randomized, not treated|1|||
130650874|NCT01883362|470342380|FG000|Post Treatment Follow-up|Protocol Violation|0|||
130650875|NCT01883362|470342381|FG001|Post Treatment Follow-up|Protocol Violation|1|||
130650876|NCT01883362|470342380|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
130650877|NCT01883362|470342381|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
130650878|NCT01883362|470342380|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
130650879|NCT01883362|470342381|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
130650880|NCT01883362|470342380|FG000|Post Treatment Follow-up|Administrative problems|2|||
130650881|NCT01883362|470342381|FG001|Post Treatment Follow-up|Administrative problems|0|||
130650882|NCT01883362|470342380|FG000|Post Treatment Follow-up|Death|8|||
130650883|NCT01883362|470342381|FG001|Post Treatment Follow-up|Death|4|||
130650884|NCT01883362|470342380|FG000|Post Treatment Follow-up|Relapse|1|||
130650885|NCT01883362|470342381|FG001|Post Treatment Follow-up|Relapse|2|||
130650886|NCT01349816|470342382|FG000|Overall Study|Withdrawal by Subject|4|||
130650887|NCT01349816|470342382|FG000|Overall Study|Physician Decision|1|||
130650888|NCT01349816|470342382|FG000|Overall Study|Adverse Event|14|||
130650889|NCT01349816|470342382|FG000|Overall Study|Lost to Follow-up|2|||
130650890|NCT01349816|470342382|FG000|Overall Study|Protocol Violation|1|||
130650891|NCT01349816|470342382|FG000|Overall Study|Protocol-specified criteria|8|||
130650892|NCT02911285|470342386|FG000|Overall Study|Lost to Follow-up|8|||
130650893|NCT02911285|470342387|FG001|Overall Study|Lost to Follow-up|5|||
130650894|NCT02911285|470342386|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
130650895|NCT02911285|470342387|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
130650896|NCT01230489|470342388|FG000|Overall Study|Death|2|||
130650897|NCT01230489|470342388|FG000|Overall Study|Adverse Event|2|||
130650898|NCT01230489|470342388|FG000|Overall Study|Treatment modality changed|1|||
130650899|NCT01791543|470342389|FG000|Overall Study|Lost to Follow-up|1|||
130650900|NCT01791543|470342389|FG000|Overall Study|Adverse Event|1|||
130650901|NCT02985541|470344110|FG000|Overall Study|Withdrawal by Subject|33|||
130650902|NCT02985541|470344110|FG000|Overall Study|Lost to Follow-up|26|||
130650903|NCT02985541|470344110|FG000|Overall Study|Adverse Event|27|||
130650904|NCT02985541|470344110|FG000|Overall Study|Physician Decision|2|||
130650905|NCT02985541|470344110|FG000|Overall Study|Pregnancy|2|||
130650906|NCT02985541|470344110|FG000|Overall Study|Wish for pregnancy|44|||
130650907|NCT02985541|470344110|FG000|Overall Study|Other reason|5|||
130650908|NCT02985541|470344110|FG000|Overall Study|Not valid for analysis|2|||
130650909|NCT03996694|470344111|FG000|First Washout (7 Days)|positive urine drug screen|0|||
130650910|NCT03996694|470344112|FG001|First Washout (7 Days)|positive urine drug screen|0|||
130650911|NCT03996694|470344113|FG002|First Washout (7 Days)|positive urine drug screen|1|||
130650912|NCT03996694|470344114|FG003|First Washout (7 Days)|positive urine drug screen|0|||
130650913|NCT03996694|470344115|FG004|First Washout (7 Days)|positive urine drug screen|0|||
130650914|NCT03996694|470344116|FG005|First Washout (7 Days)|positive urine drug screen|0|||
130650915|NCT03996694|470344111|FG000|First Washout (7 Days)|Adverse Event|0|||
130650916|NCT03996694|470344112|FG001|First Washout (7 Days)|Adverse Event|1|||
130650917|NCT03996694|470344113|FG002|First Washout (7 Days)|Adverse Event|0|||
130650918|NCT03996694|470344114|FG003|First Washout (7 Days)|Adverse Event|0|||
130650919|NCT03996694|470344115|FG004|First Washout (7 Days)|Adverse Event|0|||
130650920|NCT03996694|470344116|FG005|First Washout (7 Days)|Adverse Event|0|||
130650921|NCT03996694|470344111|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
130650922|NCT03996694|470344112|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
130650923|NCT03996694|470344113|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
130650924|NCT03996694|470344114|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
130650925|NCT03996694|470344115|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
130650926|NCT03996694|470344116|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
130650927|NCT03996694|470344111|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
130650928|NCT03996694|470344112|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
130650929|NCT03996694|470344113|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
130650930|NCT03996694|470344114|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
130650931|NCT03996694|470344115|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
130650932|NCT03996694|470344116|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
130650933|NCT03053102|470344119|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
130650934|NCT03053102|470344119|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
130650935|NCT01458535|470344120|FG000|Overall Study|Other|0|||
130650936|NCT01458535|470344121|FG001|Overall Study|Other|0|||
130650937|NCT01458535|470344122|FG002|Overall Study|Other|0|||
130650938|NCT01458535|470344123|FG003|Overall Study|Other|0|||
130650939|NCT01458535|470344124|FG004|Overall Study|Other|1|||
130650940|NCT01458535|470344125|FG005|Overall Study|Other|1|||
130650941|NCT01458535|470344120|FG000|Overall Study|Withdrawal by Subject|0|||
130650942|NCT01458535|470344121|FG001|Overall Study|Withdrawal by Subject|0|||
130650943|NCT01458535|470344122|FG002|Overall Study|Withdrawal by Subject|2|||
130650944|NCT01458535|470344123|FG003|Overall Study|Withdrawal by Subject|0|||
130650945|NCT01458535|470344124|FG004|Overall Study|Withdrawal by Subject|1|||
130650946|NCT01458535|470344125|FG005|Overall Study|Withdrawal by Subject|1|||
130650947|NCT01458535|470344120|FG000|Overall Study|Lost to Follow-up|0|||
130650948|NCT01458535|470344121|FG001|Overall Study|Lost to Follow-up|2|||
130650949|NCT01458535|470344122|FG002|Overall Study|Lost to Follow-up|0|||
130650950|NCT01458535|470344123|FG003|Overall Study|Lost to Follow-up|3|||
130650951|NCT01458535|470344124|FG004|Overall Study|Lost to Follow-up|2|||
130650952|NCT01458535|470344125|FG005|Overall Study|Lost to Follow-up|2|||
130650953|NCT01458535|470344120|FG000|Overall Study|Adverse Event|0|||
130650954|NCT01458535|470344121|FG001|Overall Study|Adverse Event|0|||
130650955|NCT01458535|470344122|FG002|Overall Study|Adverse Event|0|||
130650956|NCT01458535|470344123|FG003|Overall Study|Adverse Event|1|||
130650957|NCT01458535|470344124|FG004|Overall Study|Adverse Event|0|||
130650958|NCT01458535|470344125|FG005|Overall Study|Adverse Event|0|||
130650959|NCT01238861|470344126|FG000|Overall Study|Lost to Follow-up|4|||
130650960|NCT01238861|470344127|FG001|Overall Study|Lost to Follow-up|2|||
130650961|NCT01238861|470344128|FG002|Overall Study|Lost to Follow-up|3|||
130650962|NCT01238861|470344129|FG003|Overall Study|Lost to Follow-up|1|||
130650963|NCT01238861|470344130|FG004|Overall Study|Lost to Follow-up|1|||
130650964|NCT01238861|470344131|FG005|Overall Study|Lost to Follow-up|2|||
130650965|NCT01238861|470344126|FG000|Overall Study|Unplanned surgery|1|||
130650966|NCT01238861|470344127|FG001|Overall Study|Unplanned surgery|0|||
130650967|NCT01238861|470344128|FG002|Overall Study|Unplanned surgery|0|||
130650968|NCT01238861|470344129|FG003|Overall Study|Unplanned surgery|0|||
130650969|NCT01238861|470344130|FG004|Overall Study|Unplanned surgery|0|||
130650970|NCT01238861|470344131|FG005|Overall Study|Unplanned surgery|0|||
130650971|NCT01238861|470344126|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130650972|NCT01238861|470344127|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130650973|NCT01238861|470344128|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130650974|NCT01238861|470344129|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130650975|NCT01238861|470344130|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130650976|NCT01238861|470344131|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130650977|NCT01238861|470344126|FG000|Overall Study|Incorrect enrollment/randomization|0|||
130650978|NCT01238861|470344127|FG001|Overall Study|Incorrect enrollment/randomization|0|||
130650979|NCT01238861|470344128|FG002|Overall Study|Incorrect enrollment/randomization|1|||
130650980|NCT01238861|470344129|FG003|Overall Study|Incorrect enrollment/randomization|0|||
130650981|NCT01238861|470344130|FG004|Overall Study|Incorrect enrollment/randomization|1|||
130650982|NCT01238861|470344131|FG005|Overall Study|Incorrect enrollment/randomization|0|||
130650983|NCT01238861|470344126|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
130650984|NCT01238861|470344127|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
130650985|NCT01238861|470344128|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
130650986|NCT01238861|470344129|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
130650987|NCT01238861|470344130|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
130650988|NCT01238861|470344131|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
130650989|NCT01238861|470344126|FG000|Overall Study|Subject moved out of state/area|0|||
130650990|NCT01238861|470344127|FG001|Overall Study|Subject moved out of state/area|0|||
130650991|NCT01238861|470344128|FG002|Overall Study|Subject moved out of state/area|1|||
130650992|NCT01238861|470344129|FG003|Overall Study|Subject moved out of state/area|1|||
130650993|NCT01238861|470344130|FG004|Overall Study|Subject moved out of state/area|0|||
130650994|NCT01238861|470344131|FG005|Overall Study|Subject moved out of state/area|0|||
130650995|NCT01238861|470344126|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
130650996|NCT01238861|470344127|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
130650997|NCT01238861|470344128|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
130650998|NCT01238861|470344129|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
130650999|NCT01238861|470344130|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
130651000|NCT01238861|470344131|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
130651001|NCT01238861|470344126|FG000|Overall Study|Personal problems|0|||
130651002|NCT01238861|470344127|FG001|Overall Study|Personal problems|0|||
130651003|NCT01238861|470344128|FG002|Overall Study|Personal problems|0|||
130651004|NCT01238861|470344129|FG003|Overall Study|Personal problems|1|||
130651005|NCT01238861|470344130|FG004|Overall Study|Personal problems|0|||
130651006|NCT01238861|470344131|FG005|Overall Study|Personal problems|0|||
130651007|NCT01238861|470344126|FG000|Overall Study|Unable to continue visits|0|||
130651008|NCT01238861|470344127|FG001|Overall Study|Unable to continue visits|0|||
130651009|NCT01238861|470344128|FG002|Overall Study|Unable to continue visits|0|||
130651010|NCT01238861|470344129|FG003|Overall Study|Unable to continue visits|1|||
130651011|NCT01238861|470344130|FG004|Overall Study|Unable to continue visits|0|||
130651012|NCT01238861|470344131|FG005|Overall Study|Unable to continue visits|1|||
130651013|NCT01238861|470344126|FG000|Overall Study|Serious adverse event|0|||
130651014|NCT01238861|470344127|FG001|Overall Study|Serious adverse event|0|||
130651015|NCT01238861|470344128|FG002|Overall Study|Serious adverse event|0|||
130651016|NCT01238861|470344129|FG003|Overall Study|Serious adverse event|0|||
130651017|NCT01238861|470344130|FG004|Overall Study|Serious adverse event|0|||
130651018|NCT01238861|470344131|FG005|Overall Study|Serious adverse event|1|||
130651019|NCT01238861|470344126|FG000|Overall Study|Lack of compliance|0|||
130651020|NCT01238861|470344127|FG001|Overall Study|Lack of compliance|0|||
130651021|NCT01238861|470344128|FG002|Overall Study|Lack of compliance|0|||
130651022|NCT01238861|470344129|FG003|Overall Study|Lack of compliance|0|||
130651023|NCT01238861|470344130|FG004|Overall Study|Lack of compliance|0|||
130651024|NCT01238861|470344131|FG005|Overall Study|Lack of compliance|1|||
130651025|NCT01238861|470344126|FG000|Overall Study|Adverse Event|0|||
130651026|NCT01238861|470344127|FG001|Overall Study|Adverse Event|1|||
130651027|NCT01238861|470344128|FG002|Overall Study|Adverse Event|0|||
130651028|NCT01238861|470344129|FG003|Overall Study|Adverse Event|0|||
130651029|NCT01238861|470344130|FG004|Overall Study|Adverse Event|0|||
130651030|NCT01238861|470344131|FG005|Overall Study|Adverse Event|0|||
130651031|NCT01238861|470344126|FG000|Overall Study|Withdrawal by Subject|6|||
130651032|NCT01238861|470344127|FG001|Overall Study|Withdrawal by Subject|5|||
130651033|NCT01238861|470344128|FG002|Overall Study|Withdrawal by Subject|4|||
130651034|NCT01238861|470344129|FG003|Overall Study|Withdrawal by Subject|8|||
130651035|NCT01238861|470344130|FG004|Overall Study|Withdrawal by Subject|10|||
130651036|NCT01238861|470344131|FG005|Overall Study|Withdrawal by Subject|9|||
130651037|NCT01269346|470344132|FG000|Treatment Phase|Disease progression|3|||
130651038|NCT01269346|470344132|FG000|Treatment Phase|Adverse Event|3|||
130651039|NCT01269346|470344132|FG000|Treatment Phase|Withdrawal by Subject|1|||
130651040|NCT01269346|470344132|FG000|Treatment Phase|Other|2|||
130651041|NCT01269346|470344132|FG000|Extension Phase|Adverse Event|6|||
130651042|NCT01269346|470344132|FG000|Extension Phase|Withdrawal by Subject|4|||
130651043|NCT01269346|470344132|FG000|Extension Phase|Disease progression|22|||
130651044|NCT01269346|470344132|FG000|Extension Phase|Physician decision or participant choice|9|||
130651045|NCT01269346|470344132|FG000|Extension Phase|Clinical progression|1|||
130651046|NCT01269346|470344132|FG000|Extension Phase|Started a prohibited con med|1|||
130651047|NCT01855607|470344133|FG000|Overall Study|Withdrawal by Subject|1|||
130651048|NCT01855607|470344133|FG000|Overall Study|Study was terminated|11|||
130651049|NCT04963231|470344141|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
130651050|NCT04963231|470344142|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
130651051|NCT04963231|470344143|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
130651052|NCT04963231|470344141|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
130651053|NCT04963231|470344142|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
130651054|NCT04963231|470344143|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
130651055|NCT04963231|470344141|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
130651056|NCT04963231|470344142|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
130651057|NCT04963231|470344143|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
130651058|NCT04963231|470344141|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
130651059|NCT04963231|470344142|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
130651060|NCT04963231|470344143|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
130651061|NCT04963231|470344141|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
130651062|NCT04963231|470344142|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
130651063|NCT04963231|470344143|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
130651064|NCT04963231|470344141|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
130651065|NCT04963231|470344142|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
130651066|NCT04963231|470344143|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
130651067|NCT04963231|470344141|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
130651068|NCT04963231|470344142|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
130651069|NCT04963231|470344143|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
130651070|NCT01982942|470344146|FG000|Overall Study|Adverse Event|10|||
130651071|NCT01982942|470344147|FG001|Overall Study|Adverse Event|5|||
130651072|NCT01982942|470344146|FG000|Overall Study|Lost to Follow-up|4|||
130651073|NCT01982942|470344147|FG001|Overall Study|Lost to Follow-up|3|||
130651074|NCT01982942|470344146|FG000|Overall Study|Multiple sclerosis progression|3|||
130651075|NCT01982942|470344147|FG001|Overall Study|Multiple sclerosis progression|2|||
130651076|NCT01982942|470344146|FG000|Overall Study|Wanted to try therapy not permitted|1|||
130651077|NCT01982942|470344147|FG001|Overall Study|Wanted to try therapy not permitted|0|||
130651078|NCT01982942|470344146|FG000|Overall Study|Subject declined future visits|0|||
130651079|NCT01982942|470344147|FG001|Overall Study|Subject declined future visits|1|||
130651080|NCT01982942|470344146|FG000|Overall Study|Left geographical area|2|||
130651081|NCT01982942|470344147|FG001|Overall Study|Left geographical area|0|||
130651082|NCT01982942|470344146|FG000|Overall Study|Too many pills|1|||
130651083|NCT01982942|470344147|FG001|Overall Study|Too many pills|0|||
130651084|NCT01982942|470344146|FG000|Overall Study|MS Relapse|0|||
130651085|NCT01982942|470344147|FG001|Overall Study|MS Relapse|1|||
130651086|NCT01982942|470344146|FG000|Overall Study|Chose to join a stem cell trial|0|||
130651087|NCT01982942|470344147|FG001|Overall Study|Chose to join a stem cell trial|1|||
130651088|NCT01982942|470344146|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
130651089|NCT01982942|470344147|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
130651090|NCT04576702|470344148|FG000|Overall Study|Death|1|||
130651091|NCT04576702|470344149|FG001|Overall Study|Death|0|||
130651092|NCT04576702|470344150|FG002|Overall Study|Death|0|||
130651093|NCT04576702|470344151|FG003|Overall Study|Death|0|||
130651094|NCT04576702|470344148|FG000|Overall Study|Withdrawal by Subject|0|||
130651095|NCT04576702|470344149|FG001|Overall Study|Withdrawal by Subject|2|||
130651096|NCT04576702|470344150|FG002|Overall Study|Withdrawal by Subject|1|||
130651097|NCT04576702|470344151|FG003|Overall Study|Withdrawal by Subject|0|||
130651098|NCT04576702|470344148|FG000|Overall Study|Lost to Follow-up|3|||
130651099|NCT04576702|470344149|FG001|Overall Study|Lost to Follow-up|3|||
130651100|NCT04576702|470344150|FG002|Overall Study|Lost to Follow-up|3|||
130651101|NCT04576702|470344151|FG003|Overall Study|Lost to Follow-up|4|||
130651102|NCT06104423|470344154|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
130651103|NCT06104423|470344155|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
130651104|NCT06104423|470344156|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
130651105|NCT06104423|470344154|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
130651106|NCT06104423|470344155|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
130651107|NCT06104423|470344156|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
130651108|NCT00750061|470344157|FG000|Overall Study|Adverse Event|2|||
130651109|NCT00750061|470344158|FG001|Overall Study|Adverse Event|0|||
130651110|NCT00750061|470344157|FG000|Overall Study|Withdrawal by Subject|0|||
130651111|NCT00750061|470344158|FG001|Overall Study|Withdrawal by Subject|1|||
130651112|NCT00750061|470344157|FG000|Overall Study|Physician Decision|0|||
130651113|NCT00750061|470344158|FG001|Overall Study|Physician Decision|1|||
130651114|NCT00727246|470344159|FG000|Overall Study|could not complete MRI|0|||
130651115|NCT00727246|470344160|FG001|Overall Study|could not complete MRI|1|||
130651116|NCT00727246|470344161|FG002|Overall Study|could not complete MRI|0|||
130651117|NCT00727246|470344162|FG003|Overall Study|could not complete MRI|1|||
130651118|NCT00727246|470344159|FG000|Overall Study|incidental finding|0|||
130651119|NCT00727246|470344160|FG001|Overall Study|incidental finding|0|||
130651120|NCT00727246|470344161|FG002|Overall Study|incidental finding|0|||
130651121|NCT00727246|470344162|FG003|Overall Study|incidental finding|1|||
130651122|NCT00727246|470344159|FG000|Overall Study|withdrawn|0|||
130651123|NCT00727246|470344160|FG001|Overall Study|withdrawn|0|||
130651124|NCT00727246|470344161|FG002|Overall Study|withdrawn|1|||
130651125|NCT00727246|470344162|FG003|Overall Study|withdrawn|0|||
130651126|NCT02696382|470344165|FG000|Overall Study|Death|7|||
130651127|NCT02696382|470344166|FG001|Overall Study|Death|2|||
130651128|NCT02696382|470344165|FG000|Overall Study|Withdrawal by Subject|5|||
130651129|NCT02696382|470344166|FG001|Overall Study|Withdrawal by Subject|12|||
130651130|NCT02696382|470344165|FG000|Overall Study|Lost to Follow-up|4|||
130651131|NCT02696382|470344166|FG001|Overall Study|Lost to Follow-up|7|||
130651132|NCT03417245|470344167|FG000|Overall Study|Adverse Event|1|||
130651133|NCT03417245|470344168|FG001|Overall Study|Adverse Event|0|||
130651134|NCT03417245|470344167|FG000|Overall Study|Protocol Violation|1|||
130651135|NCT03417245|470344168|FG001|Overall Study|Protocol Violation|0|||
130651136|NCT03417245|470344167|FG000|Overall Study|Withdrawal by Subject|1|||
130651137|NCT03417245|470344168|FG001|Overall Study|Withdrawal by Subject|1|||
130651138|NCT02708524|470344176|FG000|Overall Study|Adverse Event|0|||
130651139|NCT02708524|470344177|FG001|Overall Study|Adverse Event|1|||
130651140|NCT02708524|470344178|FG002|Overall Study|Adverse Event|0|||
130651141|NCT02708524|470344179|FG003|Overall Study|Adverse Event|0|||
130651142|NCT02708524|470344176|FG000|Overall Study|Lens Discomfort|1|||
130651143|NCT02708524|470344177|FG001|Overall Study|Lens Discomfort|0|||
130651144|NCT02708524|470344178|FG002|Overall Study|Lens Discomfort|1|||
130651145|NCT02708524|470344179|FG003|Overall Study|Lens Discomfort|0|||
130651146|NCT02708524|470344176|FG000|Overall Study|Lost to Follow-up|1|||
130651147|NCT02708524|470344177|FG001|Overall Study|Lost to Follow-up|1|||
130651148|NCT02708524|470344178|FG002|Overall Study|Lost to Follow-up|1|||
130651149|NCT02708524|470344179|FG003|Overall Study|Lost to Follow-up|0|||
130651150|NCT02708524|470344176|FG000|Overall Study|Protocol Violation|0|||
130651151|NCT02708524|470344177|FG001|Overall Study|Protocol Violation|1|||
130651152|NCT02708524|470344178|FG002|Overall Study|Protocol Violation|0|||
130651153|NCT02708524|470344179|FG003|Overall Study|Protocol Violation|0|||
130651154|NCT02708524|470344176|FG000|Overall Study|Withdrawal by Subject|1|||
130651155|NCT02708524|470344177|FG001|Overall Study|Withdrawal by Subject|1|||
130651156|NCT02708524|470344178|FG002|Overall Study|Withdrawal by Subject|0|||
130651157|NCT02708524|470344179|FG003|Overall Study|Withdrawal by Subject|0|||
130651158|NCT02708524|470344176|FG000|Overall Study|Dispensed incorrect study lens|0|||
130651159|NCT02708524|470344177|FG001|Overall Study|Dispensed incorrect study lens|1|||
130651160|NCT02708524|470344178|FG002|Overall Study|Dispensed incorrect study lens|1|||
130651161|NCT02708524|470344179|FG003|Overall Study|Dispensed incorrect study lens|0|||
130651162|NCT02708524|470344176|FG000|Overall Study|Did not wear lens at final visit|0|||
130651163|NCT02708524|470344177|FG001|Overall Study|Did not wear lens at final visit|1|||
130651164|NCT02708524|470344178|FG002|Overall Study|Did not wear lens at final visit|0|||
130651165|NCT02708524|470344179|FG003|Overall Study|Did not wear lens at final visit|0|||
130651166|NCT02708524|470344176|FG000|Overall Study|Subject lost study lens|1|||
130651167|NCT02708524|470344177|FG001|Overall Study|Subject lost study lens|0|||
130651168|NCT02708524|470344178|FG002|Overall Study|Subject lost study lens|0|||
130651169|NCT02708524|470344179|FG003|Overall Study|Subject lost study lens|0|||
130651170|NCT00229931|470344186|FG000|Overall Study|Death|1|||
130651171|NCT00229931|470344187|FG001|Overall Study|Death|0|||
130651172|NCT00229931|470344186|FG000|Overall Study|Lost to Follow-up|3|||
130651173|NCT00229931|470344187|FG001|Overall Study|Lost to Follow-up|2|||
130651174|NCT02992743|470344188|FG000|Overall Study|Withdrawal by Subject|1|||
130651175|NCT02992743|470344189|FG001|Overall Study|Withdrawal by Subject|1|||
130651176|NCT02992743|470344188|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
130651177|NCT02992743|470344189|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
130651178|NCT02992743|470344188|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
130651179|NCT02992743|470344189|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
130651180|NCT02992743|470344188|FG000|Overall Study|No measurable disease|1|||
130651181|NCT02992743|470344189|FG001|Overall Study|No measurable disease|0|||
130651182|NCT02992743|470344188|FG000|Overall Study|Lost to Follow-up|0|||
130651183|NCT02992743|470344189|FG001|Overall Study|Lost to Follow-up|1|||
130651184|NCT00761735|470344190|FG000|Overall Study|Lost to Follow-up|6|||
130651185|NCT00761735|470344190|FG000|Overall Study|Withdrawal by Subject|6|||
130651186|NCT00761735|470344190|FG000|Overall Study|Non-compliance with protocol|1|||
130651187|NCT00761735|470344190|FG000|Overall Study|Administrative|1|||
130651188|NCT03290131|470344191|FG000|Overall Study|Adverse Event|22|||
130651189|NCT03290131|470344192|FG001|Overall Study|Adverse Event|57|||
130651190|NCT03290131|470344193|FG002|Overall Study|Adverse Event|11|||
130651191|NCT03290131|470344191|FG000|Overall Study|Withdrawal by Subject|18|||
130651192|NCT03290131|470344192|FG001|Overall Study|Withdrawal by Subject|13|||
130651193|NCT03290131|470344193|FG002|Overall Study|Withdrawal by Subject|8|||
130651194|NCT03290131|470344191|FG000|Overall Study|MS Relapse|2|||
130651195|NCT03290131|470344192|FG001|Overall Study|MS Relapse|1|||
130651196|NCT03290131|470344193|FG002|Overall Study|MS Relapse|0|||
130651197|NCT03290131|470344191|FG000|Overall Study|Unknown reason|0|||
130651198|NCT03290131|470344192|FG001|Overall Study|Unknown reason|1|||
130651199|NCT03290131|470344193|FG002|Overall Study|Unknown reason|0|||
130651200|NCT00465101|470344194|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
130651201|NCT00465101|470344194|FG000|Overall Study|Change in health precluded follow up|4|||
130651202|NCT00465101|470344194|FG000|Overall Study|Did not meet study criteria|4|||
130651203|NCT00465101|470344194|FG000|Overall Study|Lost to Follow-up|5|||
130651204|NCT00465101|470344194|FG000|Overall Study|Other|6|||
130651205|NCT00465101|470344194|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
130651206|NCT00465101|470344194|FG000|Overall Study|Patient postponed procedure|1|||
130651207|NCT00465101|470344194|FG000|Overall Study|Site closed due to IRB expiration|1|||
130651208|NCT00465101|470344194|FG000|Overall Study|Unable to obtain IRB approval|1|||
130651209|NCT00465101|470344194|FG000|Overall Study|Death|3|||
130651210|NCT00465101|470344194|FG000|Overall Study|Withdrawal by Subject|25|||
130651211|NCT00465101|470344194|FG000|Overall Study|Physician Decision|1|||
130651212|NCT00465101|470344194|FG000|Overall Study|Withdrew consent prior to procedure|3|||
130651213|NCT00483574|470344195|FG000|Overall Study|Adverse Event|6|||
130651214|NCT00483574|470344196|FG001|Overall Study|Adverse Event|0|||
130651215|NCT00483574|470344195|FG000|Overall Study|Protocol Violation|28|||
130651216|NCT00483574|470344196|FG001|Overall Study|Protocol Violation|9|||
130651217|NCT00483574|470344195|FG000|Overall Study|Lost to Follow-up|16|||
130651218|NCT00483574|470344196|FG001|Overall Study|Lost to Follow-up|4|||
130651219|NCT00483574|470344195|FG000|Overall Study|Withdrawal by Subject|52|||
130651220|NCT00483574|470344196|FG001|Overall Study|Withdrawal by Subject|0|||
130651221|NCT03099096|470344199|FG000|Overall Study|Adverse Event|1|||
130651222|NCT03099096|470344199|FG000|Overall Study|Physician Decision|1|||
130651223|NCT00361504|470344202|FG000|Overall Study|Withdrawal by Subject|94|||
130651224|NCT00361504|470344203|FG001|Overall Study|Withdrawal by Subject|31|||
130651225|NCT00361504|470344202|FG000|Overall Study|Lost to Follow-up|40|||
130651226|NCT00361504|470344203|FG001|Overall Study|Lost to Follow-up|7|||
130651227|NCT00361504|470344202|FG000|Overall Study|Adverse Event|203|||
130651228|NCT00361504|470344203|FG001|Overall Study|Adverse Event|82|||
130651229|NCT00361504|470344202|FG000|Overall Study|Lack of Efficacy|72|||
130651230|NCT00361504|470344203|FG001|Overall Study|Lack of Efficacy|7|||
130651231|NCT00361504|470344202|FG000|Overall Study|Resolution of Pain|2|||
130651232|NCT00361504|470344203|FG001|Overall Study|Resolution of Pain|0|||
130651233|NCT00361504|470344202|FG000|Overall Study|Study medication non compliant|42|||
130651234|NCT00361504|470344203|FG001|Overall Study|Study medication non compliant|15|||
130651235|NCT00361504|470344202|FG000|Overall Study|All other|28|||
130651236|NCT00361504|470344203|FG001|Overall Study|All other|3|||
130651237|NCT00450814|470344211|FG000|Overall Study|Failed to complete the initial therapy|0|||
130651238|NCT00450814|470344212|FG001|Overall Study|Failed to complete the initial therapy|0|||
130651239|NCT00450814|470344213|FG002|Overall Study|Failed to complete the initial therapy|0|||
130651240|NCT00450814|470344214|FG003|Overall Study|Failed to complete the initial therapy|1|||
130651241|NCT00450814|470344215|FG004|Overall Study|Failed to complete the initial therapy|1|||
130651242|NCT00450814|470344216|FG005|Overall Study|Failed to complete the initial therapy|1|||
130651243|NCT00450814|470344217|FG006|Overall Study|Failed to complete the initial therapy|0|||
130651244|NCT00450814|470344218|FG007|Overall Study|Failed to complete the initial therapy|0|||
130651245|NCT00450814|470344219|FG008|Overall Study|Failed to complete the initial therapy|0|||
130651246|NCT00450814|470344220|FG009|Overall Study|Failed to complete the initial therapy|0|||
130651247|NCT00450814|470344221|FG010|Overall Study|Failed to complete the initial therapy|0|||
130651248|NCT00450814|470344211|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
130651249|NCT00450814|470344212|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
130651250|NCT00450814|470344213|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
130651251|NCT00450814|470344214|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
130651252|NCT00450814|470344215|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
130651253|NCT00450814|470344216|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
130651254|NCT00450814|470344217|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
130651255|NCT00450814|470344218|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
130651256|NCT00450814|470344219|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
130651257|NCT00450814|470344220|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
130651258|NCT00450814|470344221|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
130651259|NCT04145531|470344222|FG000|Part A|Adverse Event|2|||
130651260|NCT04145531|470344223|FG001|Part A|Adverse Event|12|||
130651261|NCT04145531|470344224|FG002|Part A|Adverse Event|6|||
130651262|NCT04145531|470344225|FG003|Part A|Adverse Event|0|||
130651263|NCT04145531|470344222|FG000|Part A|Death|1|||
130651264|NCT04145531|470344223|FG001|Part A|Death|2|||
130651265|NCT04145531|470344224|FG002|Part A|Death|0|||
130651266|NCT04145531|470344225|FG003|Part A|Death|0|||
130651267|NCT04145531|470344222|FG000|Part A|Physician Decision|2|||
130651268|NCT04145531|470344223|FG001|Part A|Physician Decision|5|||
130651269|NCT04145531|470344224|FG002|Part A|Physician Decision|2|||
130651270|NCT04145531|470344225|FG003|Part A|Physician Decision|0|||
130651271|NCT04145531|470344222|FG000|Part A|Progressive disease|0|||
130651272|NCT04145531|470344223|FG001|Part A|Progressive disease|2|||
130651273|NCT04145531|470344224|FG002|Part A|Progressive disease|1|||
130651274|NCT04145531|470344225|FG003|Part A|Progressive disease|0|||
130651275|NCT04145531|470344222|FG000|Part A|Protocol deviation|0|||
130651276|NCT04145531|470344223|FG001|Part A|Protocol deviation|0|||
130651277|NCT04145531|470344224|FG002|Part A|Protocol deviation|1|||
130651278|NCT04145531|470344225|FG003|Part A|Protocol deviation|0|||
130651279|NCT04145531|470344222|FG000|Part A|Withdrawal by parent or guardian|1|||
130651280|NCT04145531|470344223|FG001|Part A|Withdrawal by parent or guardian|0|||
130651281|NCT04145531|470344224|FG002|Part A|Withdrawal by parent or guardian|0|||
130651282|NCT04145531|470344225|FG003|Part A|Withdrawal by parent or guardian|0|||
130651283|NCT04145531|470344222|FG000|Part A|Withdrawal by participant|0|||
130651284|NCT04145531|470344223|FG001|Part A|Withdrawal by participant|0|||
130651285|NCT04145531|470344224|FG002|Part A|Withdrawal by participant|1|||
130651286|NCT04145531|470344225|FG003|Part A|Withdrawal by participant|0|||
130651287|NCT04145531|470344222|FG000|Part A|Other|0|||
130651288|NCT04145531|470344223|FG001|Part A|Other|0|||
130651289|NCT04145531|470344224|FG002|Part A|Other|1|||
130651290|NCT04145531|470344225|FG003|Part A|Other|0|||
130651291|NCT04145531|470344222|FG000|Part B|Adverse Event|0|||
130651292|NCT04145531|470344223|FG001|Part B|Adverse Event|0|||
130651293|NCT04145531|470344224|FG002|Part B|Adverse Event|0|||
130651294|NCT04145531|470344225|FG003|Part B|Adverse Event|21|||
130651295|NCT04145531|470344222|FG000|Part B|Physician Decision|0|||
130651296|NCT04145531|470344223|FG001|Part B|Physician Decision|0|||
130651297|NCT04145531|470344224|FG002|Part B|Physician Decision|0|||
130651298|NCT04145531|470344225|FG003|Part B|Physician Decision|7|||
130651299|NCT04145531|470344222|FG000|Part B|Progressive disease|0|||
130651300|NCT04145531|470344223|FG001|Part B|Progressive disease|0|||
130651301|NCT04145531|470344224|FG002|Part B|Progressive disease|0|||
130651302|NCT04145531|470344225|FG003|Part B|Progressive disease|1|||
130651303|NCT04145531|470344222|FG000|Part B|Recurrent disease|0|||
130651304|NCT04145531|470344223|FG001|Part B|Recurrent disease|0|||
130651305|NCT04145531|470344224|FG002|Part B|Recurrent disease|0|||
130651306|NCT04145531|470344225|FG003|Part B|Recurrent disease|1|||
130651307|NCT04145531|470344222|FG000|Part B|Withdrawal by parent or guardian|0|||
130651308|NCT04145531|470344223|FG001|Part B|Withdrawal by parent or guardian|0|||
130651309|NCT04145531|470344224|FG002|Part B|Withdrawal by parent or guardian|0|||
130651310|NCT04145531|470344225|FG003|Part B|Withdrawal by parent or guardian|3|||
130651311|NCT04145531|470344222|FG000|Part B|Withdrawal by participant|0|||
130651312|NCT04145531|470344223|FG001|Part B|Withdrawal by participant|0|||
130651313|NCT04145531|470344224|FG002|Part B|Withdrawal by participant|0|||
130651314|NCT04145531|470344225|FG003|Part B|Withdrawal by participant|1|||
130651315|NCT04145531|470344222|FG000|Part B|Other|0|||
130651316|NCT04145531|470344223|FG001|Part B|Other|0|||
130651317|NCT04145531|470344224|FG002|Part B|Other|0|||
130651318|NCT04145531|470344225|FG003|Part B|Other|1|||
130651319|NCT02067728|470344226|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
130651320|NCT02067728|470344227|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
130651321|NCT02067728|470344226|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
130651322|NCT02067728|470344227|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
130651323|NCT02067728|470344226|FG000|6 Month Measurements|Unable to attend|114|||
130651324|NCT02067728|470344227|FG001|6 Month Measurements|Unable to attend|97|||
130651325|NCT03602976|470344231|FG000|Overall Study|Withdrawal by Subject|1|||
130651326|NCT04837807|470344232|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
130651327|NCT04837807|470344233|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
130651328|NCT04629534|470344234|FG000|Overall Study|Physician Decision|1|||
130651329|NCT04629534|470344235|FG001|Overall Study|Physician Decision|0|||
130651330|NCT04629534|470344234|FG000|Overall Study|Protocol Violation|0|||
130651331|NCT04629534|470344235|FG001|Overall Study|Protocol Violation|2|||
130651332|NCT03732534|470344236|FG000|Overall Study|Study terminated by Sponsor|6|||
130651333|NCT02190604|470344237|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651334|NCT02190604|470344238|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651335|NCT02190604|470344239|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651336|NCT02190604|470344240|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651337|NCT02190604|470344241|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651338|NCT02190604|470344242|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651339|NCT02190604|470344243|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651340|NCT02190604|470344244|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651341|NCT02190604|470344245|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651342|NCT02190604|470344246|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130175167|NCT01496976|468598756|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
130651343|NCT02190604|470344247|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651344|NCT02190604|470344248|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651345|NCT02190604|470344249|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651346|NCT02190604|470344250|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651347|NCT02190604|470344251|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
130651348|NCT02190604|470344252|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651349|NCT02190604|470344253|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651350|NCT02190604|470344254|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651351|NCT02190604|470344255|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130651352|NCT02190604|470344237|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651353|NCT02190604|470344238|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651354|NCT02190604|470344239|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651355|NCT02190604|470344240|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651356|NCT02190604|470344241|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651357|NCT02190604|470344242|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651358|NCT02190604|470344243|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651359|NCT02190604|470344244|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651360|NCT02190604|470344245|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651361|NCT02190604|470344246|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651362|NCT02190604|470344247|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651363|NCT02190604|470344248|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651364|NCT02190604|470344249|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651365|NCT02190604|470344250|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
130651366|NCT02190604|470344251|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651367|NCT02190604|470344252|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651368|NCT02190604|470344253|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130175312|NCT01625988|468598797|FG000|Overall Study|Lost to Follow-up|5|||
130175313|NCT01625988|468598798|FG001|Overall Study|Lost to Follow-up|6|||
130175314|NCT01625988|468598797|FG000|Overall Study|Withdrawal by Subject|8|||
130175315|NCT01625988|468598798|FG001|Overall Study|Withdrawal by Subject|3|||
130175316|NCT01625988|468598797|FG000|Overall Study|Adverse Event|0|||
130175317|NCT01625988|468598798|FG001|Overall Study|Adverse Event|1|||
130175318|NCT01625988|468598797|FG000|Overall Study|Lack of Efficacy|0|||
130175319|NCT01625988|468598798|FG001|Overall Study|Lack of Efficacy|1|||
130175320|NCT01625988|468598797|FG000|Overall Study|Randomized Inappropriately|1|||
130175321|NCT01625988|468598798|FG001|Overall Study|Randomized Inappropriately|0|||
130175322|NCT01625988|468598797|FG000|Overall Study|Protocol Violation|0|||
130175323|NCT01625988|468598798|FG001|Overall Study|Protocol Violation|2|||
130175324|NCT01644617|468598799|FG000|Overall Study|Withdrawal by Subject|3|||
130175325|NCT01644617|468598800|FG001|Overall Study|Withdrawal by Subject|4|||
130175326|NCT01644617|468598801|FG002|Overall Study|Withdrawal by Subject|1|||
130175327|NCT01644617|468598799|FG000|Overall Study|Lost to Follow-up|0|||
130175328|NCT01644617|468598800|FG001|Overall Study|Lost to Follow-up|1|||
130175329|NCT01644617|468598801|FG002|Overall Study|Lost to Follow-up|0|||
130175330|NCT01644617|468598799|FG000|Overall Study|Adverse Event|3|||
130175331|NCT01644617|468598800|FG001|Overall Study|Adverse Event|0|||
130175332|NCT01644617|468598801|FG002|Overall Study|Adverse Event|6|||
130651369|NCT02190604|470344254|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130651370|NCT02190604|470344255|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130175349|NCT05223920|468598811|FG000|Overall Study|Adverse Event|6|||
130175350|NCT05223920|468598812|FG001|Overall Study|Adverse Event|3|||
130175351|NCT05223920|468598811|FG000|Overall Study|Death|2|||
130175352|NCT05223920|468598812|FG001|Overall Study|Death|0|||
130175353|NCT05223920|468598811|FG000|Overall Study|Disease Progression|1|||
130175354|NCT05223920|468598812|FG001|Overall Study|Disease Progression|2|||
130175355|NCT05223920|468598811|FG000|Overall Study|Physician Decision|1|||
130175356|NCT05223920|468598812|FG001|Overall Study|Physician Decision|2|||
130175357|NCT05223920|468598811|FG000|Overall Study|Sponsor decision|11|||
130175358|NCT05223920|468598812|FG001|Overall Study|Sponsor decision|9|||
130175359|NCT05223920|468598811|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
130175360|NCT05223920|468598812|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
130175361|NCT05223920|468598811|FG000|Overall Study|Subject decision|1|||
130175362|NCT05223920|468598812|FG001|Overall Study|Subject decision|0|||
130175363|NCT05223920|468598811|FG000|Overall Study|Withdrawal by Subject|1|||
130175364|NCT05223920|468598812|FG001|Overall Study|Withdrawal by Subject|6|||
130175387|NCT03154125|468598830|FG000|Overall Study|Lost to Follow-up|11|||
130175388|NCT03154125|468598831|FG001|Overall Study|Lost to Follow-up|11|||
130175389|NCT03154125|468598832|FG002|Overall Study|Lost to Follow-up|0|||
130175390|NCT03154125|468598830|FG000|Overall Study|Withdrawal by Subject|49|||
130175391|NCT03154125|468598831|FG001|Overall Study|Withdrawal by Subject|55|||
130175392|NCT03154125|468598832|FG002|Overall Study|Withdrawal by Subject|8|||
130175393|NCT03154125|468598830|FG000|Overall Study|Physician Decision|13|||
130175394|NCT03154125|468598831|FG001|Overall Study|Physician Decision|6|||
130175395|NCT03154125|468598832|FG002|Overall Study|Physician Decision|0|||
130175396|NCT03154125|468598830|FG000|Overall Study|Protocol Violation|3|||
130175397|NCT03154125|468598831|FG001|Overall Study|Protocol Violation|5|||
130175398|NCT03154125|468598832|FG002|Overall Study|Protocol Violation|0|||
130175433|NCT00810511|468598837|FG000|Overall Study|Protocol Violation|0|||
130175434|NCT00810511|468598838|FG001|Overall Study|Protocol Violation|1|||
130175435|NCT00810511|468598837|FG000|Overall Study|Lack of Efficacy|9|||
130175436|NCT00810511|468598838|FG001|Overall Study|Lack of Efficacy|1|||
130175437|NCT00810511|468598837|FG000|Overall Study|death in the family|0|||
130175438|NCT00810511|468598838|FG001|Overall Study|death in the family|1|||
130175439|NCT00810511|468598837|FG000|Overall Study|Lost to Follow-up|1|||
130175440|NCT00810511|468598838|FG001|Overall Study|Lost to Follow-up|0|||
130175441|NCT00810511|468598837|FG000|Overall Study|deposits on contact lens|0|||
130175442|NCT00810511|468598838|FG001|Overall Study|deposits on contact lens|1|||
130651371|NCT02797951|470344256|FG000|Overall Study|Adverse Event|4|||
130651372|NCT02797951|470344256|FG000|Overall Study|Death|1|||
130651373|NCT02797951|470344256|FG000|Overall Study|Lack of Efficacy|19|||
130651374|NCT02797951|470344256|FG000|Overall Study|Lost to Follow-up|4|||
130651375|NCT02797951|470344256|FG000|Overall Study|Physician Decision|6|||
130651376|NCT02797951|470344256|FG000|Overall Study|Withdrawal by Subject|15|||
130651377|NCT03735849|470344258|FG000|Overall Study|Lost to Follow-up|1|||
130651378|NCT03735849|470344259|FG001|Overall Study|Lost to Follow-up|0|||
130651379|NCT03735849|470344260|FG002|Overall Study|Lost to Follow-up|0|||
130651380|NCT03735849|470344258|FG000|Overall Study|Participant unable to adhere to visit|1|||
130651381|NCT03735849|470344259|FG001|Overall Study|Participant unable to adhere to visit|0|||
130175761|NCT01954745|468598908|FG000|Overall Study|Radiological Progression|11|||
130175762|NCT01954745|468598908|FG000|Overall Study|Clinical Progression|5|||
130175763|NCT01954745|468598908|FG000|Overall Study|Adverse Event|2|||
130175764|NCT01954745|468598908|FG000|Overall Study|Death|1|||
130175767|NCT05938621|468599959|FG000|Overall Study|Lost to Follow-up|1|||
130175768|NCT05938621|468599960|FG001|Overall Study|Lost to Follow-up|5|||
130175769|NCT05938621|468599961|FG002|Overall Study|Lost to Follow-up|2|||
130175770|NCT05938621|468599962|FG003|Overall Study|Lost to Follow-up|2|||
130175771|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130175772|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
130175773|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130175774|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175775|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175776|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175777|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
130175778|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
130175779|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
130175780|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
130175781|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
130175782|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
130175783|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175784|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175785|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175786|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
130175787|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175788|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175789|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
130175790|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
130175791|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
130175792|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175793|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175794|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175795|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175796|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175797|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175798|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
130175799|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
130175800|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
130175801|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175802|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175803|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175804|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175805|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175806|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175807|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
130175808|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
130175809|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
130175810|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175811|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175812|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175813|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
130175814|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175815|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175816|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
130175817|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175818|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175819|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175820|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175821|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175822|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175823|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175824|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175825|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175826|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
130175827|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175828|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175829|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175830|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175831|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175832|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175833|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175834|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175835|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175836|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
130175837|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175838|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175839|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175840|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175841|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175842|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175843|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
130175844|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175845|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130651382|NCT03735849|470344260|FG002|Overall Study|Participant unable to adhere to visit|0|||
130651383|NCT03735849|470344258|FG000|Overall Study|Not Randomized|0|||
130175846|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175847|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175848|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175849|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175850|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175851|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175852|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
130175853|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175854|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175855|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175856|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175857|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175858|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175859|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175860|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175861|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
130175862|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175863|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175864|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175865|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175866|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175867|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175868|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175869|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175870|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175871|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
130175872|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
130175873|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175874|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175875|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175876|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175877|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175878|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175879|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
130175880|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
130175881|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175882|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175883|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175884|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175885|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175886|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175887|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175888|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175889|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
130175890|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175891|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175892|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175893|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175894|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175895|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175896|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175897|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175898|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
130175899|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175900|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175901|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175902|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175903|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175904|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175905|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130651384|NCT03735849|470344259|FG001|Overall Study|Not Randomized|0|||
130651385|NCT03735849|470344260|FG002|Overall Study|Not Randomized|4|||
130175906|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175907|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175908|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
130175909|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175910|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175911|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175912|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175913|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175914|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175915|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175916|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175917|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
130175918|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175919|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175920|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175921|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175922|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175923|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175924|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175925|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175926|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
130175927|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175928|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175929|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175930|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175931|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175932|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175933|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175934|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175935|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175936|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175937|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175938|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175939|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
130175940|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175941|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175942|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
130175943|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
130175944|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175945|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175946|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175947|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175948|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175949|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175950|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175951|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175952|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175953|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
130175954|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175955|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175956|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175957|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175958|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175959|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175960|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175961|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175962|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175963|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130175964|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
130175965|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130175966|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175967|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175968|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175969|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175970|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175971|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175972|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
130175973|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175974|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175975|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175976|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175977|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175978|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175979|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175980|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175981|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
130175982|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175983|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175984|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175985|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175986|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175987|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175988|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175989|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175990|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130175991|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130175992|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175993|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175994|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175995|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175996|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175997|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175998|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175999|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
130176000|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176001|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176002|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176003|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176004|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176005|NCT05929651|468599975|FG000|Overall Study|Protocol Deviation|1|||
130176006|NCT05929651|468599975|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
130176007|NCT02260570|468599976|FG000|Overall Study|Withdrawal by Subject|2|||
130176008|NCT02260570|468599977|FG001|Overall Study|Withdrawal by Subject|1|||
130176009|NCT02260570|468599976|FG000|Overall Study|Physician Decision|1|||
130176010|NCT02260570|468599977|FG001|Overall Study|Physician Decision|1|||
130176011|NCT05026177|468599978|FG000|Overall Study|Adverse Event|33|||
130176012|NCT05026177|468599979|FG001|Overall Study|Adverse Event|33|||
130176013|NCT05026177|468599980|FG002|Overall Study|Adverse Event|17|||
130176014|NCT05026177|468599978|FG000|Overall Study|Lost to Follow-up|7|||
130176015|NCT05026177|468599979|FG001|Overall Study|Lost to Follow-up|6|||
130176016|NCT05026177|468599980|FG002|Overall Study|Lost to Follow-up|8|||
130176017|NCT05026177|468599978|FG000|Overall Study|Noncompliance with study drug|6|||
130176018|NCT05026177|468599979|FG001|Overall Study|Noncompliance with study drug|2|||
130176019|NCT05026177|468599980|FG002|Overall Study|Noncompliance with study drug|1|||
130176020|NCT05026177|468599978|FG000|Overall Study|Physician Decision|4|||
130176021|NCT05026177|468599979|FG001|Overall Study|Physician Decision|1|||
130176022|NCT05026177|468599980|FG002|Overall Study|Physician Decision|0|||
130176023|NCT05026177|468599978|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
130176024|NCT05026177|468599979|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
130176025|NCT05026177|468599980|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
130176026|NCT05026177|468599978|FG000|Overall Study|Withdrawal by Subject|53|||
130176027|NCT05026177|468599979|FG001|Overall Study|Withdrawal by Subject|51|||
130176028|NCT05026177|468599980|FG002|Overall Study|Withdrawal by Subject|55|||
130176029|NCT05026177|468599978|FG000|Overall Study|Protocol Violation|0|||
130176030|NCT05026177|468599979|FG001|Overall Study|Protocol Violation|1|||
130176031|NCT05026177|468599980|FG002|Overall Study|Protocol Violation|0|||
130176032|NCT05026177|468599978|FG000|Overall Study|Study terminated by sponsor|70|||
130176033|NCT05026177|468599979|FG001|Overall Study|Study terminated by sponsor|74|||
130176034|NCT05026177|468599980|FG002|Overall Study|Study terminated by sponsor|67|||
130176035|NCT05026177|468599978|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
130176036|NCT05026177|468599979|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
130176037|NCT05026177|468599980|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
130176038|NCT05026177|468599978|FG000|Overall Study|Starting alternative treatment|0|||
130176039|NCT05026177|468599979|FG001|Overall Study|Starting alternative treatment|1|||
130176040|NCT05026177|468599980|FG002|Overall Study|Starting alternative treatment|1|||
130176041|NCT05026177|468599978|FG000|Overall Study|Noncompliance with study procedures|0|||
130176042|NCT05026177|468599979|FG001|Overall Study|Noncompliance with study procedures|1|||
130176043|NCT05026177|468599980|FG002|Overall Study|Noncompliance with study procedures|1|||
130176044|NCT05026177|468599978|FG000|Overall Study|Met stopping criteria|0|||
130176045|NCT05026177|468599979|FG001|Overall Study|Met stopping criteria|0|||
130176046|NCT05026177|468599980|FG002|Overall Study|Met stopping criteria|1|||
130176047|NCT05026177|468599978|FG000|Overall Study|Health issues preventing continuation|0|||
130176048|NCT05026177|468599979|FG001|Overall Study|Health issues preventing continuation|0|||
130176049|NCT05026177|468599980|FG002|Overall Study|Health issues preventing continuation|1|||
130176050|NCT05026177|468599978|FG000|Overall Study|Randomized in error, not treated|0|||
130176051|NCT05026177|468599979|FG001|Overall Study|Randomized in error, not treated|0|||
130176052|NCT05026177|468599980|FG002|Overall Study|Randomized in error, not treated|2|||
130176053|NCT04856917|468599981|FG000|Overall Study|Withdrawal by Subject|4|||
130176054|NCT04856917|468599982|FG001|Overall Study|Withdrawal by Subject|3|||
130176055|NCT04856917|468599983|FG002|Overall Study|Withdrawal by Subject|1|||
130176056|NCT04856917|468599981|FG000|Overall Study|Lost to Follow-up|3|||
130176057|NCT04856917|468599982|FG001|Overall Study|Lost to Follow-up|1|||
130176058|NCT04856917|468599983|FG002|Overall Study|Lost to Follow-up|1|||
130176059|NCT04856917|468599981|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
130176060|NCT04856917|468599982|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
130176061|NCT04856917|468599983|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
130176062|NCT04856917|468599981|FG000|Overall Study|Other|1|||
130176063|NCT04856917|468599982|FG001|Overall Study|Other|1|||
130176064|NCT04856917|468599983|FG002|Overall Study|Other|0|||
130176065|NCT01169337|468599984|FG000|Overall Study|Lack of Efficacy|5|||
130176066|NCT01169337|468599985|FG001|Overall Study|Lack of Efficacy|7|||
130176067|NCT01169337|468599986|FG002|Overall Study|Lack of Efficacy|0|||
130176068|NCT01169337|468599984|FG000|Overall Study|Adverse Event|12|||
130176069|NCT01169337|468599985|FG001|Overall Study|Adverse Event|18|||
130176070|NCT01169337|468599986|FG002|Overall Study|Adverse Event|0|||
130176071|NCT01169337|468599984|FG000|Overall Study|Death|2|||
130176072|NCT01169337|468599985|FG001|Overall Study|Death|0|||
130176073|NCT01169337|468599986|FG002|Overall Study|Death|0|||
130176074|NCT01169337|468599984|FG000|Overall Study|Withdrawal by Subject|11|||
130176075|NCT01169337|468599985|FG001|Overall Study|Withdrawal by Subject|11|||
130176076|NCT01169337|468599986|FG002|Overall Study|Withdrawal by Subject|6|||
130176077|NCT01169337|468599984|FG000|Overall Study|Noncompliance|2|||
130176078|NCT01169337|468599985|FG001|Overall Study|Noncompliance|0|||
130176079|NCT01169337|468599986|FG002|Overall Study|Noncompliance|0|||
130176080|NCT01169337|468599984|FG000|Overall Study|Other complicating disease|1|||
130176081|NCT01169337|468599985|FG001|Overall Study|Other complicating disease|1|||
130176082|NCT01169337|468599986|FG002|Overall Study|Other complicating disease|0|||
130176083|NCT01169337|468599984|FG000|Overall Study|Physician Decision|1|||
130176084|NCT01169337|468599985|FG001|Overall Study|Physician Decision|5|||
130176085|NCT01169337|468599986|FG002|Overall Study|Physician Decision|0|||
130176086|NCT01169337|468599984|FG000|Overall Study|Alternative therapy|0|||
130176087|NCT01169337|468599985|FG001|Overall Study|Alternative therapy|2|||
130176088|NCT01169337|468599986|FG002|Overall Study|Alternative therapy|0|||
130176089|NCT01169337|468599984|FG000|Overall Study|Changed hospital|0|||
130176090|NCT01169337|468599985|FG001|Overall Study|Changed hospital|1|||
130176091|NCT01169337|468599986|FG002|Overall Study|Changed hospital|0|||
130176092|NCT01169337|468599984|FG000|Overall Study|Never started treatment|0|||
130176093|NCT01169337|468599985|FG001|Overall Study|Never started treatment|2|||
130176094|NCT01169337|468599986|FG002|Overall Study|Never started treatment|0|||
130176095|NCT01169337|468599984|FG000|Overall Study|Reason not reported|1|||
130176096|NCT01169337|468599985|FG001|Overall Study|Reason not reported|0|||
130176097|NCT01169337|468599986|FG002|Overall Study|Reason not reported|0|||
130176098|NCT01169337|468599984|FG000|Overall Study|Continuing lenalidomide|9|||
130176099|NCT01169337|468599985|FG001|Overall Study|Continuing lenalidomide|43|||
130176100|NCT01169337|468599986|FG002|Overall Study|Continuing lenalidomide|0|||
130176101|NCT03560037|468599987|FG000|Overall Study|Protocol Violation|1|||
130176102|NCT03560037|468599988|FG001|Overall Study|Protocol Violation|0|||
130176103|NCT03560037|468599987|FG000|Overall Study|Physician Decision|0|||
130176104|NCT03560037|468599988|FG001|Overall Study|Physician Decision|1|||
130176105|NCT03816878|468599991|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
130176106|NCT03816878|468599992|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
130176107|NCT03816878|468599991|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
130176108|NCT03816878|468599992|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
130176109|NCT03355469|468599993|FG000|Overall Study|COVID-19|3|||
130176110|NCT03355469|468599994|FG001|Overall Study|COVID-19|2|||
130176111|NCT03355469|468599995|FG002|Overall Study|COVID-19|3|||
130176112|NCT03355469|468599996|FG003|Overall Study|COVID-19|3|||
130176113|NCT03355469|468599993|FG000|Overall Study|Lost to Follow-up|1|||
130176114|NCT03355469|468599994|FG001|Overall Study|Lost to Follow-up|0|||
130176115|NCT03355469|468599995|FG002|Overall Study|Lost to Follow-up|1|||
130176116|NCT03355469|468599996|FG003|Overall Study|Lost to Follow-up|0|||
130176117|NCT03355469|468599993|FG000|Overall Study|Withdrawal by Subject|2|||
130176118|NCT03355469|468599994|FG001|Overall Study|Withdrawal by Subject|1|||
130176119|NCT03355469|468599995|FG002|Overall Study|Withdrawal by Subject|0|||
130176120|NCT03355469|468599996|FG003|Overall Study|Withdrawal by Subject|3|||
130176121|NCT01708941|468599997|FG000|Overall Study|Adverse Event|4|||
130176122|NCT01708941|468599998|FG001|Overall Study|Adverse Event|6|||
130176123|NCT01708941|468599999|FG002|Overall Study|Adverse Event|1|||
130176124|NCT01708941|468600000|FG003|Overall Study|Adverse Event|0|||
130176125|NCT01708941|468599997|FG000|Overall Study|Death|1|||
130176126|NCT01708941|468599998|FG001|Overall Study|Death|1|||
130176127|NCT01708941|468599999|FG002|Overall Study|Death|2|||
130176128|NCT01708941|468600000|FG003|Overall Study|Death|14|||
130176129|NCT01708941|468599997|FG000|Overall Study|Withdrawal by Subject|1|||
130176130|NCT01708941|468599998|FG001|Overall Study|Withdrawal by Subject|0|||
130176131|NCT01708941|468599999|FG002|Overall Study|Withdrawal by Subject|3|||
130176132|NCT01708941|468600000|FG003|Overall Study|Withdrawal by Subject|4|||
130176133|NCT01708941|468599997|FG000|Overall Study|Disease progression|9|||
130176134|NCT01708941|468599998|FG001|Overall Study|Disease progression|10|||
130176135|NCT01708941|468599999|FG002|Overall Study|Disease progression|8|||
130176136|NCT01708941|468600000|FG003|Overall Study|Disease progression|0|||
130176137|NCT01708941|468599997|FG000|Overall Study|Alternative therapy|0|||
130176138|NCT01708941|468599998|FG001|Overall Study|Alternative therapy|0|||
130176139|NCT01708941|468599999|FG002|Overall Study|Alternative therapy|2|||
130176140|NCT01708941|468600000|FG003|Overall Study|Alternative therapy|0|||
130176141|NCT01708941|468599997|FG000|Overall Study|Ineligible and never started treatment|1|||
130176142|NCT01708941|468599998|FG001|Overall Study|Ineligible and never started treatment|0|||
130176143|NCT01708941|468599999|FG002|Overall Study|Ineligible and never started treatment|1|||
130176144|NCT01708941|468600000|FG003|Overall Study|Ineligible and never started treatment|0|||
130176145|NCT01708941|468599997|FG000|Overall Study|Never started treatment|2|||
130176146|NCT01708941|468599998|FG001|Overall Study|Never started treatment|1|||
130176147|NCT01708941|468599999|FG002|Overall Study|Never started treatment|0|||
130176148|NCT01708941|468600000|FG003|Overall Study|Never started treatment|0|||
130176149|NCT01708941|468599997|FG000|Overall Study|Ineligible|0|||
130176150|NCT01708941|468599998|FG001|Overall Study|Ineligible|0|||
130176151|NCT01708941|468599999|FG002|Overall Study|Ineligible|2|||
130176152|NCT01708941|468600000|FG003|Overall Study|Ineligible|0|||
130176153|NCT01575548|468600001|FG000|Overall Study|Adverse Event|15|||
130176154|NCT01575548|468600002|FG001|Overall Study|Adverse Event|2|||
130176155|NCT01575548|468600001|FG000|Overall Study|Disease progression|12|||
130176156|NCT01575548|468600002|FG001|Overall Study|Disease progression|25|||
130176157|NCT01575548|468600001|FG000|Overall Study|Death|1|||
130176158|NCT01575548|468600002|FG001|Overall Study|Death|0|||
130176159|NCT01575548|468600001|FG000|Overall Study|Other complicating disease|1|||
130176160|NCT01575548|468600002|FG001|Overall Study|Other complicating disease|0|||
130176161|NCT01575548|468600001|FG000|Overall Study|Withdrawal by Subject|7|||
130176162|NCT01575548|468600002|FG001|Overall Study|Withdrawal by Subject|3|||
130176163|NCT01575548|468600001|FG000|Overall Study|Noncompliance|1|||
130176164|NCT01575548|468600002|FG001|Overall Study|Noncompliance|0|||
130176165|NCT01575548|468600001|FG000|Overall Study|Anticipated surgery|0|||
130176166|NCT01575548|468600002|FG001|Overall Study|Anticipated surgery|1|||
130176167|NCT01575548|468600001|FG000|Overall Study|Never started protocol therapy|3|||
130176168|NCT01575548|468600002|FG001|Overall Study|Never started protocol therapy|2|||
130176169|NCT04175912|468600003|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
130176170|NCT04175912|468600004|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
130176171|NCT04175912|468600003|FG000|Overall Study|Adverse Event|0|||
130176172|NCT04175912|468600004|FG001|Overall Study|Adverse Event|3|||
130176173|NCT04175912|468600003|FG000|Overall Study|Never started treatment|3|||
130176174|NCT04175912|468600004|FG001|Overall Study|Never started treatment|3|||
130176175|NCT04175912|468600003|FG000|Overall Study|Death|0|||
130176176|NCT04175912|468600004|FG001|Overall Study|Death|1|||
130176177|NCT02048813|468600005|FG000|Overall Study|Still on treatment|279|||
130176178|NCT02048813|468600006|FG001|Overall Study|Still on treatment|0|||
130176179|NCT02048813|468600005|FG000|Overall Study|Adverse Event|40|||
130176180|NCT02048813|468600006|FG001|Overall Study|Adverse Event|38|||
130176181|NCT02048813|468600005|FG000|Overall Study|Disease progression|13|||
130176182|NCT02048813|468600006|FG001|Overall Study|Disease progression|3|||
130176183|NCT02048813|468600005|FG000|Overall Study|Withdrawal by Subject|7|||
130176184|NCT02048813|468600006|FG001|Overall Study|Withdrawal by Subject|8|||
130176185|NCT02048813|468600005|FG000|Overall Study|Death|2|||
130176186|NCT02048813|468600006|FG001|Overall Study|Death|1|||
130176187|NCT02048813|468600005|FG000|Overall Study|Complication|2|||
130176188|NCT02048813|468600006|FG001|Overall Study|Complication|2|||
130176189|NCT02048813|468600005|FG000|Overall Study|Non-protocol therapy|0|||
130176190|NCT02048813|468600006|FG001|Overall Study|Non-protocol therapy|1|||
130176191|NCT02048813|468600005|FG000|Overall Study|Second primary cancer|2|||
130176192|NCT02048813|468600006|FG001|Overall Study|Second primary cancer|0|||
130176193|NCT02048813|468600005|FG000|Overall Study|Insurance|2|||
130176194|NCT02048813|468600006|FG001|Overall Study|Insurance|0|||
130176195|NCT02048813|468600005|FG000|Overall Study|Wound infection/healing|2|||
130176196|NCT02048813|468600006|FG001|Overall Study|Wound infection/healing|0|||
130176197|NCT02048813|468600005|FG000|Overall Study|Missed appointment|3|||
130176198|NCT02048813|468600006|FG001|Overall Study|Missed appointment|0|||
130176199|NCT02048813|468600005|FG000|Overall Study|Never started treatment|2|||
130176200|NCT02048813|468600006|FG001|Overall Study|Never started treatment|17|||
130176201|NCT01708954|468600007|FG000|Step 1|Disease progression|26|||
130176202|NCT01708954|468600008|FG001|Step 1|Disease progression|17|||
130176203|NCT01708954|468600009|FG002|Step 1|Disease progression|14|||
130176204|NCT01708954|468600007|FG000|Step 1|Adverse Event|3|||
130176205|NCT01708954|468600008|FG001|Step 1|Adverse Event|11|||
130176206|NCT01708954|468600009|FG002|Step 1|Adverse Event|13|||
130176207|NCT01708954|468600007|FG000|Step 1|Death|3|||
130176208|NCT01708954|468600008|FG001|Step 1|Death|2|||
130176209|NCT01708954|468600009|FG002|Step 1|Death|3|||
130176210|NCT01708954|468600007|FG000|Step 1|Withdrawal by Subject|2|||
130176211|NCT01708954|468600008|FG001|Step 1|Withdrawal by Subject|5|||
130176212|NCT01708954|468600009|FG002|Step 1|Withdrawal by Subject|3|||
130176213|NCT01708954|468600007|FG000|Step 1|Other complicating disease|0|||
130176214|NCT01708954|468600008|FG001|Step 1|Other complicating disease|2|||
130176215|NCT01708954|468600009|FG002|Step 1|Other complicating disease|0|||
130176216|NCT01708954|468600007|FG000|Step 1|Crossed over to Step 2|2|||
130176217|NCT01708954|468600008|FG001|Step 1|Crossed over to Step 2|0|||
130176218|NCT01708954|468600009|FG002|Step 1|Crossed over to Step 2|0|||
130176219|NCT01708954|468600007|FG000|Step 1|Symptomatic deterioration|1|||
130176220|NCT01708954|468600008|FG001|Step 1|Symptomatic deterioration|0|||
130176221|NCT01708954|468600009|FG002|Step 1|Symptomatic deterioration|1|||
130176222|NCT01708954|468600007|FG000|Step 1|Off-treatment reason not submitted|1|||
130176223|NCT01708954|468600008|FG001|Step 1|Off-treatment reason not submitted|1|||
130176224|NCT01708954|468600009|FG002|Step 1|Off-treatment reason not submitted|1|||
130176225|NCT01708954|468600007|FG000|Step 1|Ineligible or never received treatment|4|||
130176226|NCT01708954|468600008|FG001|Step 1|Ineligible or never received treatment|2|||
130176227|NCT01708954|468600009|FG002|Step 1|Ineligible or never received treatment|8|||
130176228|NCT01708954|468600007|FG000|Step 2|Disease progression|9|||
130176229|NCT01708954|468600008|FG001|Step 2|Disease progression|4|||
130176230|NCT01708954|468600009|FG002|Step 2|Disease progression|0|||
130176231|NCT01708954|468600007|FG000|Step 2|Adverse Event|3|||
130176232|NCT01708954|468600008|FG001|Step 2|Adverse Event|2|||
130176233|NCT01708954|468600009|FG002|Step 2|Adverse Event|0|||
130176234|NCT01708954|468600007|FG000|Step 2|Withdrawal by Subject|1|||
130176235|NCT01708954|468600008|FG001|Step 2|Withdrawal by Subject|1|||
130176236|NCT01708954|468600009|FG002|Step 2|Withdrawal by Subject|0|||
130176237|NCT06400251|468600010|FG000|Overall Study|Never Start Protocol Therapy|1|||
130176238|NCT06400251|468600010|FG000|Overall Study|Ineligible|2|||
130176239|NCT06400251|468600010|FG000|Overall Study|Mutation Status Not Confirmed|3|||
130651386|NCT04585906|470344263|FG000|Overall Study|Lost to Follow-up|8|||
130651387|NCT04585906|470344264|FG001|Overall Study|Lost to Follow-up|5|||
130651388|NCT00429026|470344269|FG000|Overall Study|Inevaluable for response.|40|||
130651389|NCT01484691|470344272|FG000|Overall Study|Withdrawal by Subject|1|||
130176240|NCT06400251|468600010|FG000|Overall Study|Disease Progression|25|||
130176241|NCT06400251|468600010|FG000|Overall Study|Adverse Event|1|||
130176242|NCT06400251|468600010|FG000|Overall Study|Complicating Disease|1|||
130176243|NCT06400251|468600010|FG000|Overall Study|Physician Decision|2|||
130176244|NCT04759703|468600018|FG000|Overall Study|Withdrawal by Subject|4|||
130176245|NCT04759703|468600019|FG001|Overall Study|Withdrawal by Subject|9|||
130176246|NCT04759703|468600018|FG000|Overall Study|Adverse Event|1|||
130176247|NCT04759703|468600019|FG001|Overall Study|Adverse Event|0|||
130176248|NCT04759703|468600018|FG000|Overall Study|Lost to Follow-up|2|||
130176249|NCT04759703|468600019|FG001|Overall Study|Lost to Follow-up|0|||
130176250|NCT04186845|468600020|FG000|Overall Study|Death|2|||
130176251|NCT04186845|468600020|FG000|Overall Study|Lost to Follow-up|1|||
130176252|NCT04186845|468600020|FG000|Overall Study|Physician Decision|1|||
130176253|NCT04186845|468600020|FG000|Overall Study|Protocol Violation|1|||
130651390|NCT01484691|470344273|FG001|Overall Study|Withdrawal by Subject|1|||
130651391|NCT01484691|470344274|FG002|Overall Study|Withdrawal by Subject|1|||
130176254|NCT04186845|468600020|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
130176255|NCT04186845|468600020|FG000|Overall Study|Biopsy ordered but not done|1|||
130176256|NCT04186845|468600020|FG000|Overall Study|It was previously confirmed|1|||
130176257|NCT04186845|468600020|FG000|Overall Study|Patient cancelled scheduled scans|2|||
130176258|NCT04186845|468600020|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
130176259|NCT04186845|468600020|FG000|Overall Study|Subject refused confirmatory imaging|1|||
130176260|NCT04186845|468600020|FG000|Overall Study|Too small to biopsy|1|||
130176261|NCT01814553|468600023|FG000|Overall Study|PD per clinical progression|6|||
130176262|NCT01814553|468600024|FG001|Overall Study|PD per clinical progression|8|||
130176263|NCT01814553|468600023|FG000|Overall Study|Other Adverse Event|4|||
130176264|NCT01814553|468600024|FG001|Overall Study|Other Adverse Event|5|||
130176265|NCT01814553|468600023|FG000|Overall Study|Withdrawal by Subject|1|||
130176266|NCT01814553|468600024|FG001|Overall Study|Withdrawal by Subject|1|||
130176267|NCT01814553|468600023|FG000|Overall Study|Other than stated|7|||
130176268|NCT01814553|468600024|FG001|Overall Study|Other than stated|8|||
130176269|NCT04138823|468600025|FG000|Overall Study|Clinical disease progression|0|||
130176270|NCT04138823|468600026|FG001|Overall Study|Clinical disease progression|0|||
130176271|NCT04138823|468600027|FG002|Overall Study|Clinical disease progression|1|||
130176272|NCT04138823|468600025|FG000|Overall Study|Objective disease progression|3|||
130176273|NCT04138823|468600026|FG001|Overall Study|Objective disease progression|2|||
130176274|NCT04138823|468600027|FG002|Overall Study|Objective disease progression|5|||
130176275|NCT02859142|468600028|FG000|Overall Study|Adverse Event|1|||
130176276|NCT02859142|468600029|FG001|Overall Study|Adverse Event|2|||
130176277|NCT02859142|468600028|FG000|Overall Study|Lost to Follow-up|1|||
130176278|NCT02859142|468600029|FG001|Overall Study|Lost to Follow-up|4|||
130176279|NCT02859142|468600028|FG000|Overall Study|Withdrawal by Subject|2|||
130176280|NCT02859142|468600029|FG001|Overall Study|Withdrawal by Subject|0|||
130176281|NCT02859142|468600028|FG000|Overall Study|Scheduling difficulties|0|||
130176282|NCT02859142|468600029|FG001|Overall Study|Scheduling difficulties|3|||
130176283|NCT03290079|468600030|FG000|Overall Study|Death|2|||
130176284|NCT02676765|468600031|FG000|Overall Study|Lost to Follow-up|0|||
130176285|NCT02676765|468600032|FG001|Overall Study|Lost to Follow-up|1|||
130176286|NCT01941498|468600035|FG000|Overall Study|Relocated out of state|1|||
130176287|NCT04877457|468600036|FG000|Overall Study|Early termination of study due to low enrollment|2|||
130176288|NCT04877457|468600037|FG001|Overall Study|Early termination of study due to low enrollment|1|||
130176289|NCT04697069|468600039|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
130176290|NCT04697069|468600040|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
130176291|NCT04697069|468600039|FG000|Overall Study|Study termination|2|||
130176292|NCT04697069|468600040|FG001|Overall Study|Study termination|1|||
130176293|NCT04597632|468600041|FG000|Overall Study|Withdrawal by Subject|10|||
130176294|NCT04597632|468600041|FG000|Overall Study|Lost to Follow-up|1|||
130176295|NCT04597632|468600041|FG000|Overall Study|Death|1|||
130176296|NCT04597632|468600041|FG000|Overall Study|Adverse Event|5|||
130176297|NCT01893346|468600042|FG000|Overall Study|Lost to Follow-up|0|||
130176298|NCT01893346|468600043|FG001|Overall Study|Lost to Follow-up|1|||
130176299|NCT01893346|468600044|FG002|Overall Study|Lost to Follow-up|0|||
130176300|NCT01893346|468600045|FG003|Overall Study|Lost to Follow-up|0|||
130176301|NCT01893346|468600042|FG000|Overall Study|Protocol Violation|1|||
130176302|NCT01893346|468600043|FG001|Overall Study|Protocol Violation|0|||
130176303|NCT01893346|468600044|FG002|Overall Study|Protocol Violation|0|||
130176304|NCT01893346|468600045|FG003|Overall Study|Protocol Violation|0|||
130176305|NCT01893346|468600042|FG000|Overall Study|Withdrawal by Subject|2|||
130176306|NCT01893346|468600043|FG001|Overall Study|Withdrawal by Subject|0|||
130176307|NCT01893346|468600044|FG002|Overall Study|Withdrawal by Subject|0|||
130176308|NCT01893346|468600045|FG003|Overall Study|Withdrawal by Subject|0|||
130176309|NCT01449812|468600046|FG000|Overall Study|Migrated/moved from study area|1|||
130176310|NCT01449812|468600047|FG001|Overall Study|Migrated/moved from study area|0|||
130176311|NCT01449812|468600048|FG002|Overall Study|Migrated/moved from study area|0|||
130176312|NCT01449812|468600046|FG000|Overall Study|Withdrawal by Subject|0|||
130176313|NCT01449812|468600047|FG001|Overall Study|Withdrawal by Subject|0|||
130176314|NCT01449812|468600048|FG002|Overall Study|Withdrawal by Subject|1|||
130176315|NCT01449812|468600046|FG000|Overall Study|Lost to Follow-up|1|||
130176316|NCT01449812|468600047|FG001|Overall Study|Lost to Follow-up|0|||
130176317|NCT01449812|468600048|FG002|Overall Study|Lost to Follow-up|0|||
130176318|NCT04239027|468600051|FG000|Overall Study|Adverse Event|4|||
130176319|NCT04239027|468600051|FG000|Overall Study|Withdrawal by Subject|9|||
130176320|NCT04239027|468600051|FG000|Overall Study|Death|1|||
130176321|NCT04239027|468600051|FG000|Overall Study|Physician Decision|9|||
130176322|NCT04239027|468600051|FG000|Overall Study|Lost to Follow-up|2|||
130176323|NCT04239027|468600051|FG000|Overall Study|Lack of Efficacy|1|||
130176324|NCT02839707|468600054|FG000|Phase I|Not eligible for analysis|9|||
130176325|NCT02839707|468600055|FG001|Phase I|Not eligible for analysis|0|||
130176326|NCT02839707|468600056|FG002|Phase I|Not eligible for analysis|0|||
130176327|NCT02839707|468600054|FG000|Phase II|Not treated according to protocol|4|||
130176328|NCT02839707|468600055|FG001|Phase II|Not treated according to protocol|0|||
130176329|NCT02839707|468600056|FG002|Phase II|Not treated according to protocol|2|||
130176330|NCT02839707|468600054|FG000|Phase III|Not treated according to protocol|0|||
130176331|NCT02839707|468600055|FG001|Phase III|Not treated according to protocol|0|||
130176332|NCT02839707|468600056|FG002|Phase III|Not treated according to protocol|4|||
130176333|NCT01290302|468602212|FG000|Overall Study|Adverse Event|2|||
130176334|NCT01290302|468602213|FG001|Overall Study|Adverse Event|0|||
130176335|NCT01290302|468602212|FG000|Overall Study|Withdrawal by Subject|1|||
130176336|NCT01290302|468602213|FG001|Overall Study|Withdrawal by Subject|0|||
130176337|NCT01290302|468602212|FG000|Overall Study|Physician Decision|0|||
130176338|NCT01290302|468602213|FG001|Overall Study|Physician Decision|2|||
130176339|NCT01290302|468602212|FG000|Overall Study|Expiration of time for screening window|1|||
130176340|NCT01290302|468602213|FG001|Overall Study|Expiration of time for screening window|0|||
130176341|NCT06419907|468602216|FG000|Overall Study|Protocol Violation|0|||
130176342|NCT06419907|468602217|FG001|Overall Study|Protocol Violation|3|||
130176343|NCT06419907|468602218|FG002|Overall Study|Protocol Violation|0|||
130176344|NCT06419907|468602219|FG003|Overall Study|Protocol Violation|1|||
130176345|NCT06419907|468602216|FG000|Overall Study|Lost to Follow-up|0|||
130176346|NCT06419907|468602217|FG001|Overall Study|Lost to Follow-up|0|||
130176347|NCT06419907|468602218|FG002|Overall Study|Lost to Follow-up|2|||
130176348|NCT06419907|468602219|FG003|Overall Study|Lost to Follow-up|1|||
130176349|NCT02586688|468602222|FG000|Overall Study|Lost to Follow-up|2|||
130176350|NCT02586688|468602223|FG001|Overall Study|Lost to Follow-up|1|||
130176351|NCT02586688|468602222|FG000|Overall Study|Withdrawal by Subject|1|||
130176352|NCT02586688|468602223|FG001|Overall Study|Withdrawal by Subject|1|||
130176353|NCT02586688|468602222|FG000|Overall Study|Adverse Event|3|||
130176354|NCT02586688|468602223|FG001|Overall Study|Adverse Event|1|||
130176355|NCT02454608|468602224|FG000|Double-Blind Period|Lack of Efficacy|0|||
130176356|NCT02454608|468602225|FG001|Double-Blind Period|Lack of Efficacy|2|||
130176357|NCT02454608|468602226|FG002|Double-Blind Period|Lack of Efficacy|0|||
130176358|NCT02454608|468602224|FG000|Open Label Period|Lost to Follow-up|0|||
130176359|NCT02454608|468602225|FG001|Open Label Period|Lost to Follow-up|0|||
130176360|NCT02454608|468602226|FG002|Open Label Period|Lost to Follow-up|11|||
130176361|NCT02454608|468602224|FG000|Open Label Period|Withdrawal by Subject|0|||
130176362|NCT02454608|468602225|FG001|Open Label Period|Withdrawal by Subject|0|||
130176363|NCT02454608|468602226|FG002|Open Label Period|Withdrawal by Subject|8|||
130176364|NCT03573830|468602227|FG000|Overall Study|Dropped without completing treatment|0|||
130176365|NCT03573830|468602228|FG001|Overall Study|Dropped without completing treatment|7|||
130176366|NCT03573830|468602227|FG000|Overall Study|Lost to Follow-up|4|||
130176367|NCT03573830|468602228|FG001|Overall Study|Lost to Follow-up|0|||
130176368|NCT01769456|468602229|FG000|Overall Study|Lost to Follow-up|19|||
130176369|NCT01769456|468602229|FG000|Overall Study|Withdrawal by Subject|3|||
130176370|NCT01769456|468602229|FG000|Overall Study|Did not receive PCC intervention|6|||
130176371|NCT01769456|468602229|FG000|Overall Study|Moved out of the area|3|||
130176372|NCT01769456|468602229|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
130176373|NCT01769456|468602229|FG000|Overall Study|Parental request to youth to withdraw|1|||
130176374|NCT02465398|468602236|FG000|Overall Study|Death|7|||
130176375|NCT02465398|468602236|FG000|Overall Study|Revision|7|||
130176376|NCT02465398|468602236|FG000|Overall Study|did not receive study device|1|||
130176377|NCT02465398|468602236|FG000|Overall Study|Withdrawal by Subject|1|||
130176378|NCT02465398|468602236|FG000|Overall Study|Lost to Follow-up|14|||
130176379|NCT05244122|468602241|FG000|Overall Study|Withdrawal by Subject|318|||
130176380|NCT00064987|468602246|FG000|Overall Study|Physician Decision|3|||
130176381|NCT00064987|468602247|FG001|Overall Study|Physician Decision|0|||
130176382|NCT02969382|468602248|FG000|Overall Study|Adverse Event|8|||
130176383|NCT02969382|468602249|FG001|Overall Study|Adverse Event|10|||
130176384|NCT02969382|468602248|FG000|Overall Study|Lack of Efficacy|4|||
130176385|NCT02969382|468602249|FG001|Overall Study|Lack of Efficacy|5|||
130176386|NCT02969382|468602248|FG000|Overall Study|Death|0|||
130176387|NCT02969382|468602249|FG001|Overall Study|Death|1|||
130176388|NCT02969382|468602248|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130176389|NCT02969382|468602249|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130176390|NCT02969382|468602248|FG000|Overall Study|Withdrawal by Subject|14|||
130176391|NCT02969382|468602249|FG001|Overall Study|Withdrawal by Subject|9|||
130176392|NCT00764881|468602250|FG000|Overall Study|Adverse Event|5|||
130176393|NCT00764881|468602251|FG001|Overall Study|Adverse Event|1|||
130176394|NCT00764881|468602250|FG000|Overall Study|Withdrawal by Subject|1|||
130176395|NCT00764881|468602251|FG001|Overall Study|Withdrawal by Subject|3|||
130176396|NCT00764881|468602250|FG000|Overall Study|Protocol Violation|2|||
130176397|NCT00764881|468602251|FG001|Overall Study|Protocol Violation|2|||
130176398|NCT00764881|468602250|FG000|Overall Study|Lost to Follow-up|2|||
130176399|NCT00764881|468602251|FG001|Overall Study|Lost to Follow-up|0|||
130176400|NCT00764881|468602250|FG000|Overall Study|Noncompliant|1|||
130176401|NCT00764881|468602251|FG001|Overall Study|Noncompliant|0|||
130176402|NCT00764881|468602250|FG000|Overall Study|Accidentally discontinued study drug|1|||
130176403|NCT00764881|468602251|FG001|Overall Study|Accidentally discontinued study drug|0|||
130176404|NCT00764881|468602250|FG000|Overall Study|Wished to become pregnant|1|||
130176405|NCT00764881|468602251|FG001|Overall Study|Wished to become pregnant|0|||
130176406|NCT00764881|468602250|FG000|Overall Study|Carcinoma detected|1|||
130176407|NCT00764881|468602251|FG001|Overall Study|Carcinoma detected|0|||
130176408|NCT00764881|468602250|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
130176409|NCT00764881|468602251|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
130176410|NCT00764881|468602250|FG000|Overall Study|no treatment or no observation|2|||
130176411|NCT00764881|468602251|FG001|Overall Study|no treatment or no observation|2|||
130176412|NCT01567462|468602252|FG000|Overall Study|Withdrawal by Subject|4|||
130176413|NCT01567462|468602253|FG001|Overall Study|Withdrawal by Subject|7|||
130176414|NCT01977417|468602261|FG000|Overall Study|Adverse Event|1|||
130176415|NCT01977417|468602262|FG001|Overall Study|Adverse Event|0|||
130176416|NCT01977417|468602261|FG000|Overall Study|Withdrawal by Subject|2|||
130176417|NCT01977417|468602262|FG001|Overall Study|Withdrawal by Subject|4|||
130176418|NCT01977417|468602261|FG000|Overall Study|Female enrollment goal met|0|||
130176419|NCT01977417|468602262|FG001|Overall Study|Female enrollment goal met|2|||
130176420|NCT01692626|468602263|FG000|Overall Study|Death|0|||
130176421|NCT01692626|468602264|FG001|Overall Study|Death|1|||
130176422|NCT01692626|468602263|FG000|Overall Study|Adverse Event|2|||
130176423|NCT01692626|468602264|FG001|Overall Study|Adverse Event|3|||
130176424|NCT01692626|468602263|FG000|Overall Study|Protocol Violation|1|||
130176425|NCT01692626|468602264|FG001|Overall Study|Protocol Violation|2|||
130176426|NCT01692626|468602263|FG000|Overall Study|Withdrawal by Subject|1|||
130176427|NCT01692626|468602264|FG001|Overall Study|Withdrawal by Subject|0|||
130176428|NCT00855894|468602267|FG000|Overall Study|Death|31|||
130176429|NCT00855894|468602267|FG000|Overall Study|Patient's decision|1|||
130176430|NCT00855894|468602267|FG000|Overall Study|Disease progression|1|||
130176431|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
130176432|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
130176433|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130176434|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
130176435|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130176436|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130176437|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130176438|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130176439|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
130176440|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
130176441|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130176442|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130176443|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
130176444|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130176445|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130176446|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
130176447|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
130176448|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
130176449|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
130176450|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130176451|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130176452|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130176453|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
130176454|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
130176455|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
130651392|NCT01484691|470344272|FG000|Overall Study|Physician Decision|0|||
130651393|NCT01484691|470344273|FG001|Overall Study|Physician Decision|2|||
130651394|NCT01484691|470344274|FG002|Overall Study|Physician Decision|1|||
130651395|NCT04095039|470344279|FG000|Overall Study|Withdrawal by Subject|2|||
130651396|NCT04095039|470344280|FG001|Overall Study|Withdrawal by Subject|16|||
130651397|NCT04095039|470344279|FG000|Overall Study|Transplanted|21|||
130651398|NCT04095039|470344280|FG001|Overall Study|Transplanted|24|||
130176456|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
130176457|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130176458|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
130176459|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
130176460|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
130176461|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
130176462|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
130176463|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
130176464|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
130176465|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
130651399|NCT04095039|470344279|FG000|Overall Study|Transferred to Non-study Facility|47|||
130651400|NCT04095039|470344280|FG001|Overall Study|Transferred to Non-study Facility|44|||
130176466|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
130176467|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
130176468|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
130176469|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130176470|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130176471|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
130176472|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
130176473|NCT04071405|468602270|FG000|Overall Study|Protocol Violation|3|||
130176474|NCT00369941|468602271|FG000|Overall Study|Never Treated|1|||
130176475|NCT00369941|468602272|FG001|Overall Study|Never Treated|2|||
130176476|NCT00369941|468602271|FG000|Overall Study|Adverse Event|14|||
130176477|NCT00369941|468602272|FG001|Overall Study|Adverse Event|28|||
130176478|NCT00369941|468602271|FG000|Overall Study|Lack of Efficacy|6|||
130176479|NCT00369941|468602272|FG001|Overall Study|Lack of Efficacy|10|||
130176480|NCT00369941|468602271|FG000|Overall Study|Lost to Follow-up|12|||
130176481|NCT00369941|468602272|FG001|Overall Study|Lost to Follow-up|22|||
130176482|NCT00369941|468602271|FG000|Overall Study|Protocol Violation|5|||
130176483|NCT00369941|468602272|FG001|Overall Study|Protocol Violation|3|||
130176484|NCT00369941|468602271|FG000|Overall Study|Withdrawal by Subject|5|||
130176485|NCT00369941|468602272|FG001|Overall Study|Withdrawal by Subject|18|||
130176486|NCT00369941|468602271|FG000|Overall Study|Pregnancy|4|||
130176487|NCT00369941|468602272|FG001|Overall Study|Pregnancy|2|||
130176488|NCT00369941|468602271|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
130176489|NCT00369941|468602272|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
130176490|NCT00369941|468602271|FG000|Overall Study|Moved|11|||
130176491|NCT00369941|468602272|FG001|Overall Study|Moved|5|||
130176492|NCT00369941|468602271|FG000|Overall Study|Treatment with Prohibited Medication|3|||
130176493|NCT00369941|468602272|FG001|Overall Study|Treatment with Prohibited Medication|1|||
130176494|NCT00369941|468602271|FG000|Overall Study|Employment Interfered with Study Visits|1|||
130176495|NCT00369941|468602272|FG001|Overall Study|Employment Interfered with Study Visits|0|||
130176496|NCT00369941|468602271|FG000|Overall Study|Study Site Terminated|2|||
130176497|NCT00369941|468602272|FG001|Overall Study|Study Site Terminated|0|||
130176498|NCT00369941|468602271|FG000|Overall Study|Miscellaneous|3|||
130176499|NCT00369941|468602272|FG001|Overall Study|Miscellaneous|3|||
130176500|NCT00403585|468602273|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130176501|NCT00403585|468602273|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
130176502|NCT00403585|468602273|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
130176503|NCT02276807|468602274|FG000|Overall Study|Withdrawal by Subject|8|||
130176504|NCT02276807|468602275|FG001|Overall Study|Withdrawal by Subject|7|||
130176505|NCT02276807|468602274|FG000|Overall Study|Lost to Follow-up|10|||
130176506|NCT02276807|468602275|FG001|Overall Study|Lost to Follow-up|10|||
130176507|NCT03971474|468602276|FG000|Overall Study|Adverse Event|11|||
130176508|NCT03971474|468602277|FG001|Overall Study|Adverse Event|7|||
130176509|NCT03971474|468602276|FG000|Overall Study|Refusal unrelated to adverse event|5|||
130176510|NCT03971474|468602277|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130176511|NCT03971474|468602276|FG000|Overall Study|Progression/relapse|40|||
130176512|NCT03971474|468602277|FG001|Overall Study|Progression/relapse|47|||
130176513|NCT03971474|468602276|FG000|Overall Study|Death|6|||
130176514|NCT03971474|468602277|FG001|Overall Study|Death|3|||
130176515|NCT03971474|468602276|FG000|Overall Study|Other - not protocol specified|5|||
130176516|NCT03971474|468602277|FG001|Overall Study|Other - not protocol specified|4|||
130176517|NCT03971474|468602276|FG000|Overall Study|On treatment|0|||
130176518|NCT03971474|468602277|FG001|Overall Study|On treatment|7|||
130176519|NCT00261950|468602278|FG000|Overall Study|Lost to Follow-up|2|||
130176520|NCT00261950|468602278|FG000|Overall Study|Death|6|||
130176521|NCT00261950|468602278|FG000|Overall Study|Withdrawal by Subject|5|||
130176522|NCT00261950|468602278|FG000|Overall Study|Other|1|||
130176523|NCT00261950|468602278|FG000|Overall Study|Physician Decision|1|||
130176524|NCT00261950|468602278|FG000|Overall Study|Protocol specified Criteria|11|||
130176525|NCT01937871|468602285|FG000|Overall Study|Adverse Event|6|||
130176526|NCT01937871|468602286|FG001|Overall Study|Adverse Event|6|||
130176527|NCT01937871|468602287|FG002|Overall Study|Adverse Event|2|||
130176528|NCT01937871|468602285|FG000|Overall Study|Lost to Follow-up|8|||
130176529|NCT01937871|468602286|FG001|Overall Study|Lost to Follow-up|2|||
130176530|NCT01937871|468602287|FG002|Overall Study|Lost to Follow-up|4|||
130176531|NCT01937871|468602285|FG000|Overall Study|Withdrawal by Subject|9|||
130176532|NCT01937871|468602286|FG001|Overall Study|Withdrawal by Subject|6|||
130176533|NCT01937871|468602287|FG002|Overall Study|Withdrawal by Subject|4|||
130176534|NCT01937871|468602285|FG000|Overall Study|Physician Decision|0|||
130176535|NCT01937871|468602286|FG001|Overall Study|Physician Decision|1|||
130176536|NCT01937871|468602287|FG002|Overall Study|Physician Decision|0|||
130176537|NCT01937871|468602285|FG000|Overall Study|Entry Criteria Not Met|1|||
130176538|NCT01937871|468602286|FG001|Overall Study|Entry Criteria Not Met|2|||
130176539|NCT01937871|468602287|FG002|Overall Study|Entry Criteria Not Met|1|||
130176540|NCT00577863|468602294|FG000|Overall Study|Adverse Event|4|||
130176541|NCT00577863|468602295|FG001|Overall Study|Adverse Event|2|||
130176542|NCT00577863|468602294|FG000|Overall Study|Death|1|||
130176543|NCT00577863|468602295|FG001|Overall Study|Death|0|||
130176544|NCT00577863|468602294|FG000|Overall Study|Lost to Follow-up|2|||
130176545|NCT00577863|468602295|FG001|Overall Study|Lost to Follow-up|2|||
130176546|NCT00577863|468602294|FG000|Overall Study|Entry Criteria Exclusion|1|||
130176547|NCT00577863|468602295|FG001|Overall Study|Entry Criteria Exclusion|0|||
130176548|NCT00577863|468602294|FG000|Overall Study|Withdrawal by Subject|0|||
130176549|NCT00577863|468602295|FG001|Overall Study|Withdrawal by Subject|2|||
130176550|NCT00577863|468602294|FG000|Overall Study|Sponsor Decision|2|||
130176551|NCT00577863|468602295|FG001|Overall Study|Sponsor Decision|7|||
130176552|NCT00577863|468602294|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
130176553|NCT00577863|468602295|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
130176554|NCT00668317|468602300|FG000|Overall Study|Adverse Event|2|||
130176555|NCT05211726|468602309|FG000|Overall Study|Withdrawal by Subject|2|||
130176556|NCT05211726|468602310|FG001|Overall Study|Withdrawal by Subject|3|||
130176557|NCT05211726|468602309|FG000|Overall Study|Protocol Violation|0|||
130176558|NCT05211726|468602310|FG001|Overall Study|Protocol Violation|1|||
130176559|NCT03509467|468602311|FG000|Overall Study|Withdrawal by Subject|5|||
130176560|NCT03509467|468602312|FG001|Overall Study|Withdrawal by Subject|1|||
130176561|NCT03509467|468602313|FG002|Overall Study|Withdrawal by Subject|6|||
130176562|NCT03509467|468602314|FG003|Overall Study|Withdrawal by Subject|7|||
130176563|NCT03509467|468602315|FG004|Overall Study|Withdrawal by Subject|10|||
130176564|NCT03509467|468602316|FG005|Overall Study|Withdrawal by Subject|10|||
130176565|NCT03509467|468602317|FG006|Overall Study|Withdrawal by Subject|10|||
130176566|NCT03509467|468602318|FG007|Overall Study|Withdrawal by Subject|10|||
130176567|NCT03509467|468602311|FG000|Overall Study|Death|0|||
130176568|NCT03509467|468602312|FG001|Overall Study|Death|0|||
130176569|NCT03509467|468602313|FG002|Overall Study|Death|2|||
130176570|NCT03509467|468602314|FG003|Overall Study|Death|2|||
130176571|NCT03509467|468602315|FG004|Overall Study|Death|1|||
130176572|NCT03509467|468602316|FG005|Overall Study|Death|0|||
130176573|NCT03509467|468602317|FG006|Overall Study|Death|1|||
130176574|NCT03509467|468602318|FG007|Overall Study|Death|0|||
130176575|NCT03509467|468602311|FG000|Overall Study|Proxy Withdrawal|0|||
130176576|NCT03509467|468602312|FG001|Overall Study|Proxy Withdrawal|0|||
130176577|NCT03509467|468602313|FG002|Overall Study|Proxy Withdrawal|0|||
130176578|NCT03509467|468602314|FG003|Overall Study|Proxy Withdrawal|0|||
130176579|NCT03509467|468602315|FG004|Overall Study|Proxy Withdrawal|0|||
130176580|NCT03509467|468602316|FG005|Overall Study|Proxy Withdrawal|0|||
130176581|NCT03509467|468602317|FG006|Overall Study|Proxy Withdrawal|0|||
130176582|NCT03509467|468602318|FG007|Overall Study|Proxy Withdrawal|1|||
130176583|NCT02829918|468602320|FG000|Overall Study|Death|2|||
130176584|NCT02829918|468602320|FG000|Overall Study|Withdrawal by Subject|4|||
130176585|NCT02829918|468602320|FG000|Overall Study|Adverse Event|1|||
130176586|NCT02829918|468602320|FG000|Overall Study|Progression|1|||
130176587|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Death|8|||
130176588|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Death|5|||
130176589|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Death|5|||
130176590|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Death|7|||
130176591|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
130176592|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130176593|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130176594|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
130176595|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
130176596|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130176597|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130176598|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
130176599|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
130176600|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
130176601|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
130651401|NCT04095039|470344279|FG000|Overall Study|Withdrawal from internvention target|0|||
130176602|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
130176603|NCT02466685|468602331|FG000|Overall Study|Adverse Event|5|||
130176604|NCT02466685|468602332|FG001|Overall Study|Adverse Event|2|||
130176605|NCT02466685|468602331|FG000|Overall Study|Lost to Follow-up|1|||
130176606|NCT02466685|468602332|FG001|Overall Study|Lost to Follow-up|1|||
130176607|NCT02466685|468602331|FG000|Overall Study|Withdrawal by Subject|1|||
130176608|NCT02466685|468602332|FG001|Overall Study|Withdrawal by Subject|0|||
130176609|NCT02466685|468602331|FG000|Overall Study|Physician Decision|1|||
130176610|NCT02466685|468602332|FG001|Overall Study|Physician Decision|1|||
130176611|NCT02374346|468602333|FG000|Overall Study|operated or discharged during weekend|48|||
130176612|NCT05299528|468602336|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176613|NCT05299528|468602337|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
130176614|NCT05299528|468602338|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176615|NCT05299528|468602339|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176616|NCT05299528|468602340|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176617|NCT05299528|468602341|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176618|NCT05299528|468602342|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176619|NCT05299528|468602336|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176620|NCT05299528|468602337|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176621|NCT05299528|468602338|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176622|NCT05299528|468602339|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176623|NCT05299528|468602340|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176624|NCT05299528|468602341|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
130176625|NCT05299528|468602342|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176626|NCT05299528|468602336|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
130176627|NCT05299528|468602337|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
130176628|NCT05299528|468602338|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
130176629|NCT05299528|468602339|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
130176630|NCT05299528|468602340|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
130176631|NCT05299528|468602341|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
130176632|NCT05299528|468602342|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
130176633|NCT05180227|468602346|FG000|Overall Study|Hypertension at screening|1|||
130176634|NCT05180227|468602346|FG000|Overall Study|Lost to Follow-up|1|||
130176635|NCT03548337|468602347|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
130176636|NCT03548337|468602348|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
130176637|NCT03548337|468602347|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
130176638|NCT03548337|468602348|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
130176639|NCT03548337|468602347|FG000|Infant Series|Lost to Follow-up|2|||
130176640|NCT03548337|468602348|FG001|Infant Series|Lost to Follow-up|1|||
130176641|NCT03548337|468602347|FG000|Infant Series|Adverse Event|0|||
130176642|NCT03548337|468602348|FG001|Infant Series|Adverse Event|2|||
130176643|NCT03548337|468602347|FG000|Infant Series|Randomized but Not Vaccinated|1|||
130176644|NCT03548337|468602348|FG001|Infant Series|Randomized but Not Vaccinated|0|||
130176645|NCT03548337|468602347|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
130176646|NCT03548337|468602348|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
130176647|NCT01911273|468602351|FG000|Overall Study|Progression of Disease|1|||
130176648|NCT01911273|468602352|FG001|Overall Study|Progression of Disease|0|||
130176649|NCT01911273|468602351|FG000|Overall Study|Withdrawal by Subject|0|||
130176650|NCT01911273|468602352|FG001|Overall Study|Withdrawal by Subject|2|||
130176651|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
130176652|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Off-label use|283|||
130176653|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
130176654|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
130176655|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
130176656|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
130176657|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
130176658|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
130176659|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
130176660|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
130176661|NCT02445963|468602354|FG000|Overall Study|Lost to Follow-up|1|||
130176662|NCT02445963|468602355|FG001|Overall Study|Lost to Follow-up|0|||
130176663|NCT02445963|468602356|FG002|Overall Study|Lost to Follow-up|0|||
130176664|NCT02445963|468602357|FG003|Overall Study|Lost to Follow-up|0|||
130176665|NCT02445963|468602354|FG000|Overall Study|Change in employment|1|||
130176666|NCT02445963|468602355|FG001|Overall Study|Change in employment|0|||
130176667|NCT02445963|468602356|FG002|Overall Study|Change in employment|0|||
130176668|NCT02445963|468602357|FG003|Overall Study|Change in employment|0|||
130176669|NCT02445963|468602354|FG000|Overall Study|Symptoms post-vaccination|0|||
130176670|NCT02445963|468602355|FG001|Overall Study|Symptoms post-vaccination|0|||
130176671|NCT02445963|468602356|FG002|Overall Study|Symptoms post-vaccination|1|||
130176672|NCT02445963|468602357|FG003|Overall Study|Symptoms post-vaccination|0|||
130176673|NCT01957176|468602361|FG000|Overall Study|Adverse Event|2|||
130176674|NCT01957176|468602362|FG001|Overall Study|Adverse Event|0|||
130176675|NCT01957176|468602361|FG000|Overall Study|Physician Decision|2|||
130176676|NCT01957176|468602362|FG001|Overall Study|Physician Decision|1|||
130176677|NCT01957176|468602361|FG000|Overall Study|Withdrawal by Subject|1|||
130176678|NCT01957176|468602362|FG001|Overall Study|Withdrawal by Subject|0|||
130176679|NCT02359994|468602363|FG000|Overall Population Study|Adverse Event|1|||
130176680|NCT02359994|468602364|FG001|Overall Population Study|Adverse Event|1|||
130176681|NCT02359994|468602363|FG000|Overall Population Study|Death|1|||
130176682|NCT02359994|468602364|FG001|Overall Population Study|Death|5|||
130176683|NCT02359994|468602363|FG000|Overall Population Study|Lost to Follow-up|1|||
130176684|NCT02359994|468602364|FG001|Overall Population Study|Lost to Follow-up|1|||
130176685|NCT02359994|468602363|FG000|Overall Population Study|Withdrawal by Subject|1|||
130176686|NCT02359994|468602364|FG001|Overall Population Study|Withdrawal by Subject|0|||
130176687|NCT02359994|468602363|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
130176688|NCT02359994|468602364|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
130176689|NCT02359994|468602363|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
130176690|NCT02359994|468602364|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
130176691|NCT02359994|468602363|FG000|Extended Oncology 24-Month Survival|Death|19|||
130176692|NCT02359994|468602364|FG001|Extended Oncology 24-Month Survival|Death|21|||
130176693|NCT02359994|468602363|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
130176694|NCT02359994|468602364|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
130176695|NCT01823835|468602367|FG000|Overall Study|Adverse Event|0|||
130176696|NCT01823835|468602368|FG001|Overall Study|Adverse Event|0|||
130176697|NCT01823835|468602369|FG002|Overall Study|Adverse Event|0|||
130176698|NCT01823835|468602370|FG003|Overall Study|Adverse Event|0|||
130651402|NCT04095039|470344280|FG001|Overall Study|Withdrawal from internvention target|2|||
130651403|NCT04095039|470344279|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
130651404|NCT04095039|470344280|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
130651405|NCT04095039|470344279|FG000|Overall Study|Cacliphylaxis|0|||
130651406|NCT04095039|470344280|FG001|Overall Study|Cacliphylaxis|1|||
130651407|NCT04095039|470344279|FG000|Overall Study|Pregnancy|1|||
130651408|NCT04095039|470344280|FG001|Overall Study|Pregnancy|0|||
130651409|NCT03655951|470344282|FG000|Overall Study|Lost to Follow-up|39|||
130176699|NCT01823835|468602371|FG004|Overall Study|Adverse Event|1|||
130176700|NCT01823835|468602372|FG005|Overall Study|Adverse Event|0|||
130176701|NCT01823835|468602373|FG006|Overall Study|Adverse Event|1|||
130176702|NCT01823835|468602374|FG007|Overall Study|Adverse Event|0|||
130176703|NCT01823835|468602375|FG008|Overall Study|Adverse Event|0|||
130176704|NCT01823835|468602376|FG009|Overall Study|Adverse Event|0|||
130176705|NCT01823835|468602377|FG010|Overall Study|Adverse Event|1|||
130176706|NCT01823835|468602378|FG011|Overall Study|Adverse Event|2|||
130176707|NCT01823835|468602379|FG012|Overall Study|Adverse Event|0|||
130176708|NCT01823835|468602380|FG013|Overall Study|Adverse Event|0|||
130176709|NCT01823835|468602381|FG014|Overall Study|Adverse Event|0|||
130176710|NCT01823835|468602367|FG000|Overall Study|Physician Decision|0|||
130176711|NCT01823835|468602368|FG001|Overall Study|Physician Decision|0|||
130176712|NCT01823835|468602369|FG002|Overall Study|Physician Decision|0|||
130176713|NCT01823835|468602370|FG003|Overall Study|Physician Decision|0|||
130176714|NCT01823835|468602371|FG004|Overall Study|Physician Decision|0|||
130176715|NCT01823835|468602372|FG005|Overall Study|Physician Decision|0|||
130176716|NCT01823835|468602373|FG006|Overall Study|Physician Decision|0|||
130176717|NCT01823835|468602374|FG007|Overall Study|Physician Decision|0|||
130176718|NCT01823835|468602375|FG008|Overall Study|Physician Decision|0|||
130176719|NCT01823835|468602376|FG009|Overall Study|Physician Decision|0|||
130176720|NCT01823835|468602377|FG010|Overall Study|Physician Decision|0|||
130176721|NCT01823835|468602378|FG011|Overall Study|Physician Decision|2|||
130176722|NCT01823835|468602379|FG012|Overall Study|Physician Decision|0|||
130176723|NCT01823835|468602380|FG013|Overall Study|Physician Decision|0|||
130176724|NCT01823835|468602381|FG014|Overall Study|Physician Decision|0|||
130176725|NCT01823835|468602367|FG000|Overall Study|Progressive Disease|3|||
130176726|NCT01823835|468602368|FG001|Overall Study|Progressive Disease|4|||
130176727|NCT01823835|468602369|FG002|Overall Study|Progressive Disease|3|||
130176728|NCT01823835|468602370|FG003|Overall Study|Progressive Disease|6|||
130176729|NCT01823835|468602371|FG004|Overall Study|Progressive Disease|4|||
130176730|NCT01823835|468602372|FG005|Overall Study|Progressive Disease|6|||
130176731|NCT01823835|468602373|FG006|Overall Study|Progressive Disease|5|||
130176732|NCT01823835|468602374|FG007|Overall Study|Progressive Disease|3|||
130176733|NCT01823835|468602375|FG008|Overall Study|Progressive Disease|3|||
130176734|NCT01823835|468602376|FG009|Overall Study|Progressive Disease|18|||
130176735|NCT01823835|468602377|FG010|Overall Study|Progressive Disease|8|||
130176736|NCT01823835|468602378|FG011|Overall Study|Progressive Disease|46|||
130651410|NCT03655951|470344283|FG001|Overall Study|Lost to Follow-up|20|||
130176737|NCT01823835|468602379|FG012|Overall Study|Progressive Disease|18|||
130176738|NCT01823835|468602380|FG013|Overall Study|Progressive Disease|4|||
130176739|NCT01823835|468602381|FG014|Overall Study|Progressive Disease|6|||
130176740|NCT01823835|468602367|FG000|Overall Study|Study Termination|0|||
130176741|NCT01823835|468602368|FG001|Overall Study|Study Termination|0|||
130176742|NCT01823835|468602369|FG002|Overall Study|Study Termination|0|||
130651411|NCT03655951|470344282|FG000|Overall Study|Withdrawal by Subject|0|||
130176743|NCT01823835|468602370|FG003|Overall Study|Study Termination|0|||
130176744|NCT01823835|468602371|FG004|Overall Study|Study Termination|1|||
130176745|NCT01823835|468602372|FG005|Overall Study|Study Termination|0|||
130176746|NCT01823835|468602373|FG006|Overall Study|Study Termination|0|||
130176747|NCT01823835|468602374|FG007|Overall Study|Study Termination|0|||
130651412|NCT03655951|470344283|FG001|Overall Study|Withdrawal by Subject|1|||
130176748|NCT01823835|468602375|FG008|Overall Study|Study Termination|0|||
130176749|NCT01823835|468602376|FG009|Overall Study|Study Termination|0|||
130176750|NCT01823835|468602377|FG010|Overall Study|Study Termination|0|||
130176751|NCT01823835|468602378|FG011|Overall Study|Study Termination|1|||
130176752|NCT01823835|468602379|FG012|Overall Study|Study Termination|0|||
130176753|NCT01823835|468602380|FG013|Overall Study|Study Termination|0|||
130176754|NCT01823835|468602381|FG014|Overall Study|Study Termination|0|||
130176755|NCT01823835|468602367|FG000|Overall Study|Withdrawal by Subject|0|||
130176756|NCT01823835|468602368|FG001|Overall Study|Withdrawal by Subject|0|||
130176757|NCT01823835|468602369|FG002|Overall Study|Withdrawal by Subject|1|||
130176758|NCT01823835|468602370|FG003|Overall Study|Withdrawal by Subject|0|||
130176759|NCT01823835|468602371|FG004|Overall Study|Withdrawal by Subject|0|||
130176760|NCT01823835|468602372|FG005|Overall Study|Withdrawal by Subject|0|||
130176761|NCT01823835|468602373|FG006|Overall Study|Withdrawal by Subject|0|||
130176762|NCT01823835|468602374|FG007|Overall Study|Withdrawal by Subject|0|||
130176763|NCT01823835|468602375|FG008|Overall Study|Withdrawal by Subject|0|||
130176764|NCT01823835|468602376|FG009|Overall Study|Withdrawal by Subject|1|||
130176765|NCT01823835|468602377|FG010|Overall Study|Withdrawal by Subject|1|||
130176766|NCT01823835|468602378|FG011|Overall Study|Withdrawal by Subject|2|||
130176767|NCT01823835|468602379|FG012|Overall Study|Withdrawal by Subject|1|||
130176768|NCT01823835|468602380|FG013|Overall Study|Withdrawal by Subject|0|||
130176769|NCT01823835|468602381|FG014|Overall Study|Withdrawal by Subject|0|||
130176770|NCT03017612|468602382|FG000|Overall Study|Adverse Event|2|||
130176771|NCT04895982|468602383|FG000|Overall Study|Withdrawal by Subject|0|||
130176772|NCT04895982|468602384|FG001|Overall Study|Withdrawal by Subject|0|||
130176773|NCT04895982|468602385|FG002|Overall Study|Withdrawal by Subject|0|||
130176774|NCT04895982|468602386|FG003|Overall Study|Withdrawal by Subject|0|||
130176775|NCT04895982|468602387|FG004|Overall Study|Withdrawal by Subject|0|||
130176776|NCT04895982|468602388|FG005|Overall Study|Withdrawal by Subject|1|||
130176777|NCT04895982|468602389|FG006|Overall Study|Withdrawal by Subject|1|||
130176778|NCT04895982|468602390|FG007|Overall Study|Withdrawal by Subject|0|||
130176779|NCT04895982|468602391|FG008|Overall Study|Withdrawal by Subject|0|||
130176780|NCT04895982|468602392|FG009|Overall Study|Withdrawal by Subject|1|||
130176781|NCT04895982|468602393|FG010|Overall Study|Withdrawal by Subject|0|||
130176782|NCT04895982|468602394|FG011|Overall Study|Withdrawal by Subject|1|||
130176783|NCT04895982|468602383|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130176784|NCT04895982|468602384|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130176785|NCT04895982|468602385|FG002|Overall Study|Withdrawal by parent/guardian|3|||
130176786|NCT04895982|468602386|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130176787|NCT04895982|468602387|FG004|Overall Study|Withdrawal by parent/guardian|3|||
130176788|NCT04895982|468602388|FG005|Overall Study|Withdrawal by parent/guardian|2|||
130176789|NCT04895982|468602389|FG006|Overall Study|Withdrawal by parent/guardian|1|||
130176790|NCT04895982|468602390|FG007|Overall Study|Withdrawal by parent/guardian|0|||
130176791|NCT04895982|468602391|FG008|Overall Study|Withdrawal by parent/guardian|3|||
130176792|NCT04895982|468602392|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130176793|NCT04895982|468602393|FG010|Overall Study|Withdrawal by parent/guardian|0|||
130176794|NCT04895982|468602394|FG011|Overall Study|Withdrawal by parent/guardian|0|||
130176795|NCT04895982|468602383|FG000|Overall Study|Other|0|||
130176796|NCT04895982|468602384|FG001|Overall Study|Other|0|||
130176797|NCT04895982|468602385|FG002|Overall Study|Other|1|||
130176798|NCT04895982|468602386|FG003|Overall Study|Other|1|||
130176799|NCT04895982|468602387|FG004|Overall Study|Other|0|||
130176800|NCT04895982|468602388|FG005|Overall Study|Other|0|||
130176801|NCT04895982|468602389|FG006|Overall Study|Other|0|||
130176802|NCT04895982|468602390|FG007|Overall Study|Other|0|||
130176803|NCT04895982|468602391|FG008|Overall Study|Other|0|||
130176804|NCT04895982|468602392|FG009|Overall Study|Other|1|||
130176805|NCT04895982|468602393|FG010|Overall Study|Other|0|||
130176806|NCT04895982|468602394|FG011|Overall Study|Other|0|||
130176807|NCT04895982|468602383|FG000|Overall Study|Protocol Violation|0|||
130176808|NCT04895982|468602384|FG001|Overall Study|Protocol Violation|0|||
130176809|NCT04895982|468602385|FG002|Overall Study|Protocol Violation|1|||
130176810|NCT04895982|468602386|FG003|Overall Study|Protocol Violation|1|||
130176811|NCT04895982|468602387|FG004|Overall Study|Protocol Violation|1|||
130176812|NCT04895982|468602388|FG005|Overall Study|Protocol Violation|0|||
130176813|NCT04895982|468602389|FG006|Overall Study|Protocol Violation|0|||
130176814|NCT04895982|468602390|FG007|Overall Study|Protocol Violation|1|||
130176815|NCT04895982|468602391|FG008|Overall Study|Protocol Violation|0|||
130176816|NCT04895982|468602392|FG009|Overall Study|Protocol Violation|0|||
130176817|NCT04895982|468602393|FG010|Overall Study|Protocol Violation|0|||
130176818|NCT04895982|468602394|FG011|Overall Study|Protocol Violation|0|||
130176819|NCT04895982|468602383|FG000|Overall Study|Lost to Follow-up|0|||
130176820|NCT04895982|468602384|FG001|Overall Study|Lost to Follow-up|0|||
130176821|NCT04895982|468602385|FG002|Overall Study|Lost to Follow-up|1|||
130176822|NCT04895982|468602386|FG003|Overall Study|Lost to Follow-up|0|||
130176823|NCT04895982|468602387|FG004|Overall Study|Lost to Follow-up|0|||
130176824|NCT04895982|468602388|FG005|Overall Study|Lost to Follow-up|1|||
130176825|NCT04895982|468602389|FG006|Overall Study|Lost to Follow-up|0|||
130176826|NCT04895982|468602390|FG007|Overall Study|Lost to Follow-up|0|||
130176827|NCT04895982|468602391|FG008|Overall Study|Lost to Follow-up|1|||
130176828|NCT04895982|468602392|FG009|Overall Study|Lost to Follow-up|0|||
130176829|NCT04895982|468602393|FG010|Overall Study|Lost to Follow-up|0|||
130176830|NCT04895982|468602394|FG011|Overall Study|Lost to Follow-up|0|||
130176831|NCT04895982|468602383|FG000|Overall Study|Refused further study procedures|0|||
130176832|NCT04895982|468602384|FG001|Overall Study|Refused further study procedures|0|||
130176833|NCT04895982|468602385|FG002|Overall Study|Refused further study procedures|1|||
130176834|NCT04895982|468602386|FG003|Overall Study|Refused further study procedures|0|||
130176835|NCT04895982|468602387|FG004|Overall Study|Refused further study procedures|0|||
130176836|NCT04895982|468602388|FG005|Overall Study|Refused further study procedures|0|||
130176837|NCT04895982|468602389|FG006|Overall Study|Refused further study procedures|0|||
130176838|NCT04895982|468602390|FG007|Overall Study|Refused further study procedures|0|||
130176839|NCT04895982|468602391|FG008|Overall Study|Refused further study procedures|0|||
130176840|NCT04895982|468602392|FG009|Overall Study|Refused further study procedures|0|||
130176841|NCT04895982|468602393|FG010|Overall Study|Refused further study procedures|0|||
130176842|NCT04895982|468602394|FG011|Overall Study|Refused further study procedures|0|||
130176843|NCT01059786|468604022|FG000|Overall Study|Did not receive 6 cycles.|0|||
130176844|NCT01059786|468604023|FG001|Overall Study|Did not receive 6 cycles.|0|||
130176845|NCT01059786|468604024|FG002|Overall Study|Did not receive 6 cycles.|4|||
130176846|NCT01059786|468604025|FG003|Overall Study|Did not receive 6 cycles.|1|||
130176847|NCT01059786|468604026|FG004|Overall Study|Did not receive 6 cycles.|0|||
130176848|NCT04460885|468604027|FG000|Overall Study|Withdrawal by Subject|6|||
130176849|NCT04460885|468604028|FG001|Overall Study|Withdrawal by Subject|8|||
130176850|NCT04460885|468604027|FG000|Overall Study|Site closure|1|||
130176851|NCT04460885|468604028|FG001|Overall Study|Site closure|0|||
130176852|NCT04460885|468604027|FG000|Overall Study|Death|5|||
130176853|NCT04460885|468604028|FG001|Overall Study|Death|4|||
130176854|NCT04460885|468604027|FG000|Overall Study|Physician Decision|2|||
130176855|NCT04460885|468604028|FG001|Overall Study|Physician Decision|1|||
130176856|NCT04460885|468604027|FG000|Overall Study|Lost to Follow-up|4|||
130176857|NCT04460885|468604028|FG001|Overall Study|Lost to Follow-up|4|||
130176858|NCT04559347|468604029|FG000|Overall Study|Death|1|||
130176859|NCT04559347|468604030|FG001|Overall Study|Death|0|||
130176860|NCT04559347|468604029|FG000|Overall Study|Thoracotomy conversion|1|||
130176861|NCT04559347|468604030|FG001|Overall Study|Thoracotomy conversion|1|||
130176862|NCT04559347|468604029|FG000|Overall Study|Provider unavailable|2|||
130176863|NCT04559347|468604030|FG001|Overall Study|Provider unavailable|1|||
130176864|NCT04559347|468604029|FG000|Overall Study|Other|2|||
130176865|NCT04559347|468604030|FG001|Overall Study|Other|1|||
130176866|NCT02717455|468604032|FG000|Overall Study|Adverse Event|1|||
130176867|NCT02717455|468604033|FG001|Overall Study|Adverse Event|0|||
130176868|NCT02717455|468604034|FG002|Overall Study|Adverse Event|0|||
130176869|NCT02717455|468604035|FG003|Overall Study|Adverse Event|2|||
130176870|NCT02717455|468604036|FG004|Overall Study|Adverse Event|2|||
130176871|NCT02717455|468604037|FG005|Overall Study|Adverse Event|2|||
130176872|NCT02717455|468604032|FG000|Overall Study|Withdrawal by Subject|1|||
130176873|NCT02717455|468604033|FG001|Overall Study|Withdrawal by Subject|1|||
130176874|NCT02717455|468604034|FG002|Overall Study|Withdrawal by Subject|0|||
130176875|NCT02717455|468604035|FG003|Overall Study|Withdrawal by Subject|2|||
130176876|NCT02717455|468604036|FG004|Overall Study|Withdrawal by Subject|2|||
130176877|NCT02717455|468604037|FG005|Overall Study|Withdrawal by Subject|1|||
130176878|NCT02717455|468604032|FG000|Overall Study|Death|1|||
130176879|NCT02717455|468604033|FG001|Overall Study|Death|0|||
130176880|NCT02717455|468604034|FG002|Overall Study|Death|0|||
130176881|NCT02717455|468604035|FG003|Overall Study|Death|0|||
130176882|NCT02717455|468604036|FG004|Overall Study|Death|1|||
130176883|NCT02717455|468604037|FG005|Overall Study|Death|0|||
130176884|NCT02717455|468604032|FG000|Overall Study|Did not receive study drug|0|||
130176885|NCT02717455|468604033|FG001|Overall Study|Did not receive study drug|0|||
130176886|NCT02717455|468604034|FG002|Overall Study|Did not receive study drug|0|||
130176887|NCT02717455|468604035|FG003|Overall Study|Did not receive study drug|1|||
130176888|NCT02717455|468604036|FG004|Overall Study|Did not receive study drug|0|||
130176889|NCT02717455|468604037|FG005|Overall Study|Did not receive study drug|1|||
130176890|NCT02717455|468604032|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176891|NCT02717455|468604033|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176892|NCT02717455|468604034|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176893|NCT02717455|468604035|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176894|NCT02717455|468604036|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176895|NCT02717455|468604037|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
130176896|NCT02717455|468604032|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
130176897|NCT02717455|468604033|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
130176898|NCT02717455|468604034|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
130651413|NCT02811640|470344284|FG000|Overall Study|Technology malfunction|2|||
130176899|NCT02717455|468604035|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
130176900|NCT02717455|468604036|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
130176901|NCT02717455|468604037|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
130176902|NCT01433055|468604038|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
130176903|NCT01433055|468604039|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
130176904|NCT01433055|468604038|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
130176905|NCT01433055|468604039|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
130176906|NCT00233948|468604043|FG000|Overall Study|Adverse Event|1|||
130176907|NCT00233948|468604044|FG001|Overall Study|Adverse Event|0|||
130176908|NCT00233948|468604045|FG002|Overall Study|Adverse Event|0|||
130176909|NCT00233948|468604046|FG003|Overall Study|Adverse Event|0|||
130176910|NCT00233948|468604047|FG004|Overall Study|Adverse Event|0|||
130176911|NCT00233948|468604048|FG005|Overall Study|Adverse Event|0|||
130176912|NCT01214655|468604056|FG000|Part A|Progressive Disease|7|||
130176913|NCT01214655|468604057|FG001|Part A|Progressive Disease|0|||
130176914|NCT01214655|468604058|FG002|Part A|Progressive Disease|0|||
130176915|NCT01214655|468604056|FG000|Part A|Physician Decision|1|||
130176916|NCT01214655|468604057|FG001|Part A|Physician Decision|0|||
130176917|NCT01214655|468604058|FG002|Part A|Physician Decision|0|||
130176918|NCT01214655|468604056|FG000|Part B|Progressive disease|0|||
130176919|NCT01214655|468604057|FG001|Part B|Progressive disease|10|||
130176920|NCT01214655|468604058|FG002|Part B|Progressive disease|0|||
130176921|NCT01214655|468604056|FG000|Part B|Death|0|||
130176922|NCT01214655|468604057|FG001|Part B|Death|1|||
130176923|NCT01214655|468604058|FG002|Part B|Death|0|||
130176924|NCT01214655|468604056|FG000|Part B|Withdrawal by Subject|0|||
130176925|NCT01214655|468604057|FG001|Part B|Withdrawal by Subject|2|||
130176926|NCT01214655|468604058|FG002|Part B|Withdrawal by Subject|0|||
130176927|NCT01214655|468604056|FG000|Part C|Progressive Disease|0|||
130176928|NCT01214655|468604057|FG001|Part C|Progressive Disease|0|||
130176929|NCT01214655|468604058|FG002|Part C|Progressive Disease|5|||
130176930|NCT01214655|468604056|FG000|Part C|Death|0|||
130176931|NCT01214655|468604057|FG001|Part C|Death|0|||
130176932|NCT01214655|468604058|FG002|Part C|Death|1|||
130176933|NCT01214655|468604056|FG000|Part C|Physician Decision|0|||
130176934|NCT01214655|468604057|FG001|Part C|Physician Decision|0|||
130176935|NCT01214655|468604058|FG002|Part C|Physician Decision|1|||
130176936|NCT05256134|468604059|FG000|Overall Study|Study Terminated by Sponsor|11|||
130176937|NCT05256134|468604060|FG001|Overall Study|Study Terminated by Sponsor|10|||
130176938|NCT05256134|468604059|FG000|Overall Study|Withdrawal by Subject|1|||
130176939|NCT05256134|468604060|FG001|Overall Study|Withdrawal by Subject|3|||
130176940|NCT00886015|468604063|FG000|Overall Study|Death|0|||
130176941|NCT00886015|468604064|FG001|Overall Study|Death|2|||
130176942|NCT05490771|468604070|FG000|Overall Study|Disease progression|18|||
130176943|NCT05490771|468604070|FG000|Overall Study|Adverse Event|3|||
130176944|NCT05490771|468604070|FG000|Overall Study|Other complicating disease|1|||
130176945|NCT05490771|468604070|FG000|Overall Study|Withdrawal by Subject|3|||
130176946|NCT05490771|468604070|FG000|Overall Study|Physician Decision|1|||
130176947|NCT05490771|468604070|FG000|Overall Study|Still on treatment|2|||
130176948|NCT05490771|468604070|FG000|Overall Study|Never start protocol therapy|5|||
130176949|NCT05490771|468604070|FG000|Overall Study|Ineligible|2|||
130176950|NCT01720225|468604071|FG000|Overall Study|Withdrawal by Subject|0|||
130176951|NCT01720225|468604072|FG001|Overall Study|Withdrawal by Subject|1|||
130176952|NCT01720225|468604071|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
130176953|NCT01720225|468604072|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
130176954|NCT00661193|468604076|FG000|Overall Study|Adverse Event|2|||
130176955|NCT00661193|468604077|FG001|Overall Study|Adverse Event|1|||
130176956|NCT00661193|468604076|FG000|Overall Study|Withdrawal by Subject|3|||
130176957|NCT00661193|468604077|FG001|Overall Study|Withdrawal by Subject|1|||
130176958|NCT00661193|468604076|FG000|Overall Study|Progression|27|||
130176959|NCT00661193|468604077|FG001|Overall Study|Progression|24|||
130176960|NCT00661193|468604076|FG000|Overall Study|Not protocol specified|1|||
130176961|NCT00661193|468604077|FG001|Overall Study|Not protocol specified|0|||
130176962|NCT02964312|468604078|FG000|Overall Study|Lost to Follow-up|28|||
130176963|NCT02964312|468604078|FG000|Overall Study|Withdrawal by Subject|11|||
130176964|NCT02964312|468604078|FG000|Overall Study|Lack of Efficacy|10|||
130176965|NCT02964312|468604078|FG000|Overall Study|Did not consent to long-term FU|14|||
130176966|NCT02964312|468604078|FG000|Overall Study|Death|1|||
130176967|NCT02862730|468604087|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176968|NCT02862730|468604088|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176969|NCT02862730|468604089|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
130176970|NCT02862730|468604090|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176971|NCT02862730|468604091|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176972|NCT02862730|468604092|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176973|NCT02862730|468604093|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176974|NCT02862730|468604087|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
130176975|NCT02862730|468604088|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176976|NCT02862730|468604089|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176977|NCT02862730|468604090|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176978|NCT02862730|468604091|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176979|NCT02862730|468604092|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176980|NCT02862730|468604093|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176981|NCT02862730|468604087|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176982|NCT02862730|468604088|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176983|NCT02862730|468604089|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130176984|NCT02862730|468604090|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176985|NCT02862730|468604091|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130176986|NCT02862730|468604092|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176987|NCT02862730|468604093|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176988|NCT02862730|468604087|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176989|NCT02862730|468604088|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176990|NCT02862730|468604089|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176991|NCT02862730|468604090|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
130176992|NCT02862730|468604091|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176993|NCT02862730|468604092|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176994|NCT02862730|468604093|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176995|NCT03685344|468604094|FG000|Overall Study|Withdrawal by Subject|1|||
130176996|NCT03685344|468604095|FG001|Overall Study|Withdrawal by Subject|1|||
130176997|NCT03685344|468604096|FG002|Overall Study|Withdrawal by Subject|2|||
130176998|NCT03685344|468604097|FG003|Overall Study|Withdrawal by Subject|0|||
130176999|NCT03685344|468604094|FG000|Overall Study|Physician Decision|1|||
130177000|NCT03685344|468604095|FG001|Overall Study|Physician Decision|1|||
130177001|NCT03685344|468604096|FG002|Overall Study|Physician Decision|5|||
130177002|NCT03685344|468604097|FG003|Overall Study|Physician Decision|0|||
130177003|NCT03685344|468604094|FG000|Overall Study|Death|1|||
130177004|NCT03685344|468604095|FG001|Overall Study|Death|1|||
130177005|NCT03685344|468604096|FG002|Overall Study|Death|0|||
130177006|NCT03685344|468604097|FG003|Overall Study|Death|0|||
130177007|NCT03126435|468604099|FG000|Overall Study|Death|90|||
130177008|NCT03126435|468604100|FG001|Overall Study|Death|84|||
130177009|NCT03126435|468604099|FG000|Overall Study|Lost to Follow-up|4|||
130177010|NCT03126435|468604100|FG001|Overall Study|Lost to Follow-up|3|||
130177011|NCT03126435|468604099|FG000|Overall Study|Physician Decision|0|||
130177012|NCT03126435|468604100|FG001|Overall Study|Physician Decision|1|||
130177013|NCT03126435|468604099|FG000|Overall Study|Withdrawal by Subject|6|||
130177014|NCT03126435|468604100|FG001|Overall Study|Withdrawal by Subject|12|||
130177015|NCT03126435|468604099|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
130177016|NCT03126435|468604100|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
130177017|NCT01023035|468604102|FG000|Treatment Period|Adverse Event|27|||
130177018|NCT01023035|468604103|FG001|Treatment Period|Adverse Event|32|||
130177019|NCT01023035|468604104|FG002|Treatment Period|Adverse Event|50|||
130177020|NCT01023035|468604102|FG000|Treatment Period|Non-Medical Reasons|19|||
130177021|NCT01023035|468604103|FG001|Treatment Period|Non-Medical Reasons|22|||
130177022|NCT01023035|468604104|FG002|Treatment Period|Non-Medical Reasons|44|||
130177023|NCT01023035|468604102|FG000|Treatment Period|Treatment Failure|26|||
130177024|NCT01023035|468604103|FG001|Treatment Period|Treatment Failure|31|||
130177025|NCT01023035|468604104|FG002|Treatment Period|Treatment Failure|24|||
130177026|NCT01023035|468604102|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
130177027|NCT01023035|468604103|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
130177028|NCT01023035|468604104|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
130177029|NCT01023035|468604102|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
130177030|NCT01023035|468604103|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
130177031|NCT01023035|468604104|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
130177032|NCT00524420|468604108|FG000|Overall Study|Lack of Efficacy|1|||
130177033|NCT00524420|468604109|FG001|Overall Study|Lack of Efficacy|0|||
130651414|NCT00198107|470346218|FG000|Double-Blind Period|Adverse Event|1|||
130651415|NCT00198107|470346219|FG001|Double-Blind Period|Adverse Event|1|||
130651416|NCT00198107|470346220|FG002|Double-Blind Period|Adverse Event|0|||
130651417|NCT00198107|470346218|FG000|Double-Blind Period|Lack of Efficacy|2|||
130651418|NCT00198107|470346219|FG001|Double-Blind Period|Lack of Efficacy|0|||
130651419|NCT00198107|470346220|FG002|Double-Blind Period|Lack of Efficacy|0|||
130177034|NCT01090414|468604110|FG000|Study 101-99|Progressive Disease|28|||
130177035|NCT01090414|468604111|FG001|Study 101-99|Progressive Disease|48|||
130177036|NCT01090414|468604112|FG002|Study 101-99|Progressive Disease|10|||
130177037|NCT01090414|468604113|FG003|Study 101-99|Progressive Disease|4|||
130177038|NCT01090414|468604110|FG000|Study 101-99|Adverse Event|10|||
130177039|NCT01090414|468604111|FG001|Study 101-99|Adverse Event|28|||
130177040|NCT01090414|468604112|FG002|Study 101-99|Adverse Event|18|||
130651420|NCT00198107|470346218|FG000|Double-Blind Period|Lost to Follow-up|2|||
130651421|NCT00198107|470346219|FG001|Double-Blind Period|Lost to Follow-up|1|||
130651422|NCT00198107|470346220|FG002|Double-Blind Period|Lost to Follow-up|0|||
130177041|NCT01090414|468604113|FG003|Study 101-99|Adverse Event|0|||
130177042|NCT01090414|468604110|FG000|Study 101-99|Investigator Request|1|||
130177043|NCT01090414|468604111|FG001|Study 101-99|Investigator Request|11|||
130177044|NCT01090414|468604112|FG002|Study 101-99|Investigator Request|4|||
130177045|NCT01090414|468604113|FG003|Study 101-99|Investigator Request|0|||
130177046|NCT01090414|468604110|FG000|Study 101-99|Death|3|||
130177047|NCT01090414|468604111|FG001|Study 101-99|Death|8|||
130177048|NCT01090414|468604112|FG002|Study 101-99|Death|1|||
130177049|NCT01090414|468604113|FG003|Study 101-99|Death|0|||
130177050|NCT01090414|468604110|FG000|Study 101-99|Sponsor Discontinued Study|0|||
130177051|NCT01090414|468604111|FG001|Study 101-99|Sponsor Discontinued Study|7|||
130177052|NCT01090414|468604112|FG002|Study 101-99|Sponsor Discontinued Study|5|||
130177053|NCT01090414|468604113|FG003|Study 101-99|Sponsor Discontinued Study|0|||
130177054|NCT01090414|468604110|FG000|Study 101-99|Other (Unknown Reasons)|3|||
130177055|NCT01090414|468604111|FG001|Study 101-99|Other (Unknown Reasons)|3|||
130177056|NCT01090414|468604112|FG002|Study 101-99|Other (Unknown Reasons)|0|||
130177057|NCT01090414|468604113|FG003|Study 101-99|Other (Unknown Reasons)|0|||
130177058|NCT01090414|468604110|FG000|Study 101-99|Withdrew Consent|0|||
130177059|NCT01090414|468604111|FG001|Study 101-99|Withdrew Consent|2|||
130177060|NCT01090414|468604112|FG002|Study 101-99|Withdrew Consent|3|||
130177061|NCT01090414|468604113|FG003|Study 101-99|Withdrew Consent|1|||
130177062|NCT01090414|468604110|FG000|Study 101-99|Participant Request|3|||
130177063|NCT01090414|468604111|FG001|Study 101-99|Participant Request|1|||
130177064|NCT01090414|468604112|FG002|Study 101-99|Participant Request|0|||
130177065|NCT01090414|468604113|FG003|Study 101-99|Participant Request|0|||
130177066|NCT02413229|468604119|FG000|Overall Study|Adverse Event|0|||
130177067|NCT02413229|468604120|FG001|Overall Study|Adverse Event|0|||
130177068|NCT02413229|468604121|FG002|Overall Study|Adverse Event|0|||
130177069|NCT02413229|468604122|FG003|Overall Study|Adverse Event|1|||
130177070|NCT02413229|468604123|FG004|Overall Study|Adverse Event|0|||
130177071|NCT02413229|468604124|FG005|Overall Study|Adverse Event|0|||
130177072|NCT02413229|468604125|FG006|Overall Study|Adverse Event|0|||
130177073|NCT02413229|468604126|FG007|Overall Study|Adverse Event|1|||
130177074|NCT02413229|468604119|FG000|Overall Study|Lost to Follow-up|0|||
130177075|NCT02413229|468604120|FG001|Overall Study|Lost to Follow-up|0|||
130177076|NCT02413229|468604121|FG002|Overall Study|Lost to Follow-up|1|||
130177077|NCT02413229|468604122|FG003|Overall Study|Lost to Follow-up|0|||
130177078|NCT02413229|468604123|FG004|Overall Study|Lost to Follow-up|2|||
130177079|NCT02413229|468604124|FG005|Overall Study|Lost to Follow-up|0|||
130177080|NCT02413229|468604125|FG006|Overall Study|Lost to Follow-up|0|||
130177081|NCT02413229|468604126|FG007|Overall Study|Lost to Follow-up|0|||
130177082|NCT02413229|468604119|FG000|Overall Study|Withdrawal by Subject|1|||
130177083|NCT02413229|468604120|FG001|Overall Study|Withdrawal by Subject|1|||
130177084|NCT02413229|468604121|FG002|Overall Study|Withdrawal by Subject|0|||
130177085|NCT02413229|468604122|FG003|Overall Study|Withdrawal by Subject|0|||
130177086|NCT02413229|468604123|FG004|Overall Study|Withdrawal by Subject|1|||
130177087|NCT02413229|468604124|FG005|Overall Study|Withdrawal by Subject|0|||
130177088|NCT02413229|468604125|FG006|Overall Study|Withdrawal by Subject|0|||
130177089|NCT02413229|468604126|FG007|Overall Study|Withdrawal by Subject|2|||
130177090|NCT02413229|468604119|FG000|Overall Study|Progressive Disease|0|||
130177091|NCT02413229|468604120|FG001|Overall Study|Progressive Disease|0|||
130177092|NCT02413229|468604121|FG002|Overall Study|Progressive Disease|0|||
130177093|NCT02413229|468604122|FG003|Overall Study|Progressive Disease|0|||
130177094|NCT02413229|468604123|FG004|Overall Study|Progressive Disease|0|||
130177095|NCT02413229|468604124|FG005|Overall Study|Progressive Disease|0|||
130177096|NCT02413229|468604125|FG006|Overall Study|Progressive Disease|0|||
130177097|NCT02413229|468604126|FG007|Overall Study|Progressive Disease|1|||
130177098|NCT03594071|468604127|FG000|Overall Study|Re-operation|3|||
130177099|NCT03594071|468604127|FG000|Overall Study|Missed visit|2|||
130177100|NCT03022370|468604128|FG000|Overall Study|Death|6|||
130177101|NCT03022370|468604129|FG001|Overall Study|Death|12|||
130177102|NCT03022370|468604128|FG000|Overall Study|Lost to Follow-up|174|||
130177103|NCT03022370|468604129|FG001|Overall Study|Lost to Follow-up|109|||
130177104|NCT00699816|468604130|FG000|Overall Study|Protocol Violation|1|||
130177105|NCT00699816|468604131|FG001|Overall Study|Protocol Violation|3|||
130177106|NCT02454933|468604136|FG000|Overall Study|Progressive disease|10|||
130177107|NCT02454933|468604137|FG001|Overall Study|Progressive disease|7|||
130177108|NCT02454933|468604136|FG000|Overall Study|Adverse Event|1|||
130177109|NCT02454933|468604137|FG001|Overall Study|Adverse Event|1|||
130177110|NCT02454933|468604136|FG000|Overall Study|Withdrawal by Subject|0|||
130177111|NCT02454933|468604137|FG001|Overall Study|Withdrawal by Subject|3|||
130177112|NCT02454933|468604136|FG000|Overall Study|Lost to Follow-up|1|||
130177113|NCT02454933|468604137|FG001|Overall Study|Lost to Follow-up|0|||
130177114|NCT03668808|468604138|FG000|First Intervention|Withdrawal by Subject|2|||
130177115|NCT03668808|468604139|FG001|First Intervention|Withdrawal by Subject|2|||
130177116|NCT01526655|468604140|FG000|Overall Study|Withdrawal by Subject|0|||
130177117|NCT01526655|468604141|FG001|Overall Study|Withdrawal by Subject|1|||
130177118|NCT02288325|468604145|FG000|Run-in Period|Adverse Event|48|||
130177119|NCT02288325|468604146|FG001|Run-in Period|Adverse Event|0|||
130177120|NCT02288325|468604147|FG002|Run-in Period|Adverse Event|0|||
130177121|NCT02288325|468604145|FG000|Run-in Period|Lack of Efficacy|16|||
130177122|NCT02288325|468604146|FG001|Run-in Period|Lack of Efficacy|0|||
130177123|NCT02288325|468604147|FG002|Run-in Period|Lack of Efficacy|0|||
130177124|NCT02288325|468604145|FG000|Run-in Period|Withdrawal of Consent|28|||
130177125|NCT02288325|468604146|FG001|Run-in Period|Withdrawal of Consent|0|||
130177126|NCT02288325|468604147|FG002|Run-in Period|Withdrawal of Consent|0|||
130177127|NCT02288325|468604145|FG000|Run-in Period|Lost to Follow-up|25|||
130177128|NCT02288325|468604146|FG001|Run-in Period|Lost to Follow-up|0|||
130177129|NCT02288325|468604147|FG002|Run-in Period|Lost to Follow-up|0|||
130177130|NCT02288325|468604145|FG000|Run-in Period|Protocol Violation|17|||
130177131|NCT02288325|468604146|FG001|Run-in Period|Protocol Violation|0|||
130177132|NCT02288325|468604147|FG002|Run-in Period|Protocol Violation|0|||
130177133|NCT02288325|468604145|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
130177134|NCT02288325|468604146|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
130177135|NCT02288325|468604147|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
130177136|NCT02288325|468604145|FG000|Run-in Period|Reason not Specified|8|||
130177137|NCT02288325|468604146|FG001|Run-in Period|Reason not Specified|0|||
130177138|NCT02288325|468604147|FG002|Run-in Period|Reason not Specified|0|||
130177139|NCT02288325|468604145|FG000|Stabilization Period|Adverse Event|13|||
130177140|NCT02288325|468604146|FG001|Stabilization Period|Adverse Event|0|||
130177141|NCT02288325|468604147|FG002|Stabilization Period|Adverse Event|0|||
130177142|NCT02288325|468604145|FG000|Stabilization Period|Lack of Efficacy|22|||
130177143|NCT02288325|468604146|FG001|Stabilization Period|Lack of Efficacy|0|||
130177144|NCT02288325|468604147|FG002|Stabilization Period|Lack of Efficacy|0|||
130177145|NCT02288325|468604145|FG000|Stabilization Period|Withdrawal of Consent|23|||
130177146|NCT02288325|468604146|FG001|Stabilization Period|Withdrawal of Consent|0|||
130177147|NCT02288325|468604147|FG002|Stabilization Period|Withdrawal of Consent|0|||
130177148|NCT02288325|468604145|FG000|Stabilization Period|Lost to Follow-up|12|||
130177149|NCT02288325|468604146|FG001|Stabilization Period|Lost to Follow-up|0|||
130177150|NCT02288325|468604147|FG002|Stabilization Period|Lost to Follow-up|0|||
130177151|NCT02288325|468604145|FG000|Stabilization Period|Protocol Violation|8|||
130177152|NCT02288325|468604146|FG001|Stabilization Period|Protocol Violation|0|||
130177153|NCT02288325|468604147|FG002|Stabilization Period|Protocol Violation|0|||
130177154|NCT02288325|468604145|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
130177155|NCT02288325|468604146|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
130177156|NCT02288325|468604147|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
130177157|NCT02288325|468604145|FG000|Stabilization Period|Reason not Specified|15|||
130177158|NCT02288325|468604146|FG001|Stabilization Period|Reason not Specified|0|||
130177159|NCT02288325|468604147|FG002|Stabilization Period|Reason not Specified|0|||
130177160|NCT02288325|468604145|FG000|Double-blind Treatment Period|Adverse Event|0|||
130177161|NCT02288325|468604146|FG001|Double-blind Treatment Period|Adverse Event|2|||
130177162|NCT02288325|468604147|FG002|Double-blind Treatment Period|Adverse Event|5|||
130177163|NCT02288325|468604145|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
130177164|NCT02288325|468604146|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
130177165|NCT02288325|468604147|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
130177166|NCT02288325|468604145|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130177167|NCT02288325|468604146|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130177168|NCT02288325|468604147|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130177169|NCT02288325|468604145|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130177170|NCT02288325|468604146|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130177171|NCT02288325|468604147|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130177172|NCT02288325|468604145|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
130177173|NCT02288325|468604146|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
130177174|NCT02288325|468604147|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
130177175|NCT02288325|468604145|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
130177176|NCT02288325|468604146|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
130177177|NCT02288325|468604147|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
130177178|NCT05061420|468604160|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
130177179|NCT05061420|468604161|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130177180|NCT05061420|468604162|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130177181|NCT05061420|468604160|FG000|Overall Study|Progressive disease|11|||
130177182|NCT05061420|468604161|FG001|Overall Study|Progressive disease|15|||
130177183|NCT05061420|468604162|FG002|Overall Study|Progressive disease|14|||
130177184|NCT05061420|468604160|FG000|Overall Study|Withdrawal by Subject|2|||
130177185|NCT05061420|468604161|FG001|Overall Study|Withdrawal by Subject|0|||
130177186|NCT05061420|468604162|FG002|Overall Study|Withdrawal by Subject|1|||
130177187|NCT05061420|468604160|FG000|Overall Study|Not related to COVID-19|2|||
130177188|NCT05061420|468604161|FG001|Overall Study|Not related to COVID-19|0|||
130177189|NCT05061420|468604162|FG002|Overall Study|Not related to COVID-19|0|||
130177190|NCT04868500|468604163|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
130177191|NCT04868500|468604164|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
130177192|NCT04868500|468604163|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
130177193|NCT04868500|468604164|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
130177194|NCT04807400|468604166|FG000|Overall Study|Adverse Event|2|||
130177195|NCT04807400|468604167|FG001|Overall Study|Adverse Event|3|||
130177196|NCT04807400|468604168|FG002|Overall Study|Adverse Event|3|||
130177197|NCT04807400|468604166|FG000|Overall Study|Death|2|||
130177198|NCT04807400|468604167|FG001|Overall Study|Death|0|||
130177199|NCT04807400|468604168|FG002|Overall Study|Death|0|||
130177200|NCT04807400|468604166|FG000|Overall Study|Lost to Follow-up|8|||
130177201|NCT04807400|468604167|FG001|Overall Study|Lost to Follow-up|6|||
130177202|NCT04807400|468604168|FG002|Overall Study|Lost to Follow-up|6|||
130177203|NCT04807400|468604166|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130177204|NCT04807400|468604167|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130177205|NCT04807400|468604168|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130177206|NCT04807400|468604166|FG000|Overall Study|Participant Decision|20|||
130177207|NCT04807400|468604167|FG001|Overall Study|Participant Decision|19|||
130177208|NCT04807400|468604168|FG002|Overall Study|Participant Decision|26|||
130177209|NCT04807400|468604166|FG000|Overall Study|Physician Decision|0|||
130177210|NCT04807400|468604167|FG001|Overall Study|Physician Decision|1|||
130177211|NCT04807400|468604168|FG002|Overall Study|Physician Decision|0|||
130177212|NCT04807400|468604166|FG000|Overall Study|Protocol Violation|4|||
130177213|NCT04807400|468604167|FG001|Overall Study|Protocol Violation|3|||
130177214|NCT04807400|468604168|FG002|Overall Study|Protocol Violation|7|||
130177215|NCT04807400|468604166|FG000|Overall Study|Withdrawal by Subject|13|||
130177216|NCT04807400|468604167|FG001|Overall Study|Withdrawal by Subject|9|||
130177217|NCT04807400|468604168|FG002|Overall Study|Withdrawal by Subject|20|||
130177218|NCT04807400|468604166|FG000|Overall Study|Mis-randomized|1|||
130177219|NCT04807400|468604167|FG001|Overall Study|Mis-randomized|0|||
130177220|NCT04807400|468604168|FG002|Overall Study|Mis-randomized|0|||
130177221|NCT01332292|468604173|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130177222|NCT01332292|468604174|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130177223|NCT01332292|468604173|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130177224|NCT01332292|468604174|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130177225|NCT01332292|468604173|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
130177226|NCT01332292|468604174|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
130177227|NCT04650204|468604175|FG000|Overall Study|Study was Terminated|2|||
130177228|NCT04650204|468604176|FG001|Overall Study|Study was Terminated|1|||
130177229|NCT01330303|468604177|FG000|Period 1|Adverse Event|1|||
130177230|NCT01330303|468604178|FG001|Period 1|Adverse Event|0|||
130177231|NCT01330303|468604177|FG000|Period 1|Protocol Violation|0|||
130177232|NCT01330303|468604178|FG001|Period 1|Protocol Violation|1|||
130177233|NCT01330303|468604177|FG000|Period 1|Withdrawal by Subject|0|||
130177234|NCT01330303|468604178|FG001|Period 1|Withdrawal by Subject|1|||
130177235|NCT01107197|468604179|FG000|Overall Study|Death|12|||
130177236|NCT01107197|468604180|FG001|Overall Study|Death|10|||
130177237|NCT01107197|468604179|FG000|Overall Study|Lost to Follow-up|5|||
130177238|NCT01107197|468604180|FG001|Overall Study|Lost to Follow-up|8|||
130177239|NCT01107197|468604179|FG000|Overall Study|Withdrawal by Subject|3|||
130177240|NCT01107197|468604180|FG001|Overall Study|Withdrawal by Subject|5|||
130177241|NCT03999996|468605838|FG000|Prior to Booster|Adverse Event|2|||
130177242|NCT03999996|468605839|FG001|Prior to Booster|Adverse Event|0|||
130177243|NCT03999996|468605840|FG002|Prior to Booster|Adverse Event|0|||
130177244|NCT03999996|468605841|FG003|Prior to Booster|Adverse Event|0|||
130177245|NCT03999996|468605838|FG000|Prior to Booster|Lost to Follow-up|17|||
130177246|NCT03999996|468605839|FG001|Prior to Booster|Lost to Follow-up|22|||
130177247|NCT03999996|468605840|FG002|Prior to Booster|Lost to Follow-up|0|||
130177248|NCT03999996|468605841|FG003|Prior to Booster|Lost to Follow-up|0|||
130177249|NCT03999996|468605838|FG000|Prior to Booster|Withdrawal of Consent|51|||
130177250|NCT03999996|468605839|FG001|Prior to Booster|Withdrawal of Consent|8|||
130177251|NCT03999996|468605840|FG002|Prior to Booster|Withdrawal of Consent|0|||
130177252|NCT03999996|468605841|FG003|Prior to Booster|Withdrawal of Consent|0|||
130177253|NCT03999996|468605838|FG000|Prior to Booster|Death|0|||
130177254|NCT03999996|468605839|FG001|Prior to Booster|Death|1|||
130177255|NCT03999996|468605840|FG002|Prior to Booster|Death|0|||
130177256|NCT03999996|468605841|FG003|Prior to Booster|Death|0|||
130177257|NCT03999996|468605838|FG000|Prior to Booster|Reason Not Specified|27|||
130177258|NCT03999996|468605839|FG001|Prior to Booster|Reason Not Specified|4|||
130177259|NCT03999996|468605840|FG002|Prior to Booster|Reason Not Specified|0|||
130177260|NCT03999996|468605841|FG003|Prior to Booster|Reason Not Specified|0|||
130177261|NCT03999996|468605838|FG000|Booster Phase|Lost to Follow-up|0|||
130177262|NCT03999996|468605839|FG001|Booster Phase|Lost to Follow-up|0|||
130177263|NCT03999996|468605840|FG002|Booster Phase|Lost to Follow-up|3|||
130177264|NCT03999996|468605841|FG003|Booster Phase|Lost to Follow-up|3|||
130177265|NCT03999996|468605838|FG000|Booster Phase|Withdrawal of Consent|0|||
130177266|NCT03999996|468605839|FG001|Booster Phase|Withdrawal of Consent|0|||
130177267|NCT03999996|468605840|FG002|Booster Phase|Withdrawal of Consent|0|||
130177268|NCT03999996|468605841|FG003|Booster Phase|Withdrawal of Consent|1|||
130177269|NCT03999996|468605838|FG000|Booster Phase|Reason Not Specified|0|||
130177270|NCT03999996|468605839|FG001|Booster Phase|Reason Not Specified|0|||
130177271|NCT03999996|468605840|FG002|Booster Phase|Reason Not Specified|0|||
130177272|NCT03999996|468605841|FG003|Booster Phase|Reason Not Specified|1|||
130177273|NCT00733005|468605844|FG000|Overall Study|Adverse Event|0|||
130177274|NCT00733005|468605845|FG001|Overall Study|Adverse Event|1|||
130177275|NCT00733005|468605844|FG000|Overall Study|Treatment Failure|0|||
130177276|NCT00733005|468605845|FG001|Overall Study|Treatment Failure|1|||
130177277|NCT00733005|468605844|FG000|Overall Study|Withdrawal by Subject|0|||
130177278|NCT00733005|468605845|FG001|Overall Study|Withdrawal by Subject|1|||
130177279|NCT00733005|468605844|FG000|Overall Study|Protocol Violation|2|||
130177280|NCT00733005|468605845|FG001|Overall Study|Protocol Violation|0|||
130177281|NCT00266630|468605846|FG000|Overall Study|Adverse Event|8|||
130177282|NCT00266630|468605847|FG001|Overall Study|Adverse Event|6|||
130177283|NCT00266630|468605846|FG000|Overall Study|Lack of Efficacy|1|||
130177284|NCT00266630|468605847|FG001|Overall Study|Lack of Efficacy|4|||
130177285|NCT00266630|468605846|FG000|Overall Study|Entry Criteria not met|1|||
130177286|NCT00266630|468605847|FG001|Overall Study|Entry Criteria not met|0|||
130177287|NCT00266630|468605846|FG000|Overall Study|Protocol Violation|1|||
130177288|NCT00266630|468605847|FG001|Overall Study|Protocol Violation|3|||
130177289|NCT00266630|468605846|FG000|Overall Study|Physician Decision|1|||
130177290|NCT00266630|468605847|FG001|Overall Study|Physician Decision|2|||
130177291|NCT00266630|468605846|FG000|Overall Study|Withdrawal by Subject|10|||
130177292|NCT00266630|468605847|FG001|Overall Study|Withdrawal by Subject|2|||
130177293|NCT00266630|468605846|FG000|Overall Study|Lost to Follow-up|1|||
130177294|NCT00266630|468605847|FG001|Overall Study|Lost to Follow-up|0|||
130177295|NCT00266630|468605846|FG000|Overall Study|Other|19|||
130177296|NCT00266630|468605847|FG001|Overall Study|Other|11|||
130177297|NCT03410056|468605848|FG000|Overall Study|Decision by Sponsor|0|||
130177298|NCT03410056|468605849|FG001|Overall Study|Decision by Sponsor|0|||
130177299|NCT03410056|468605850|FG002|Overall Study|Decision by Sponsor|3|||
130177300|NCT03410056|468605851|FG003|Overall Study|Decision by Sponsor|0|||
130177301|NCT03410056|468605852|FG004|Overall Study|Decision by Sponsor|0|||
130177302|NCT03410056|468605853|FG005|Overall Study|Decision by Sponsor|0|||
130177303|NCT03410056|468605854|FG006|Overall Study|Decision by Sponsor|0|||
130177304|NCT03410056|468605848|FG000|Overall Study|Withdrawal by Subject|0|||
130177305|NCT03410056|468605849|FG001|Overall Study|Withdrawal by Subject|2|||
130177306|NCT03410056|468605850|FG002|Overall Study|Withdrawal by Subject|5|||
130177307|NCT03410056|468605851|FG003|Overall Study|Withdrawal by Subject|5|||
130177308|NCT03410056|468605852|FG004|Overall Study|Withdrawal by Subject|0|||
130177309|NCT03410056|468605853|FG005|Overall Study|Withdrawal by Subject|0|||
130177310|NCT03410056|468605854|FG006|Overall Study|Withdrawal by Subject|0|||
130177311|NCT02548156|468605860|FG000|Washout Period 1|Lost to Follow-up|0|||
130177312|NCT02548156|468605861|FG001|Washout Period 1|Lost to Follow-up|0|||
130177313|NCT02548156|468605862|FG002|Washout Period 1|Lost to Follow-up|0|||
130177314|NCT02548156|468605863|FG003|Washout Period 1|Lost to Follow-up|0|||
130177315|NCT02548156|468605864|FG004|Washout Period 1|Lost to Follow-up|1|||
130177316|NCT02548156|468605865|FG005|Washout Period 1|Lost to Follow-up|0|||
130177317|NCT01068262|468605870|FG000|Overall Study|Adverse Event|2|||
130177318|NCT01068262|468605871|FG001|Overall Study|Adverse Event|0|||
130177319|NCT01068262|468605872|FG002|Overall Study|Adverse Event|1|||
130177320|NCT01068262|468605873|FG003|Overall Study|Adverse Event|0|||
130177321|NCT01068262|468605870|FG000|Overall Study|Protocol Violation|1|||
130177322|NCT01068262|468605871|FG001|Overall Study|Protocol Violation|0|||
130177323|NCT01068262|468605872|FG002|Overall Study|Protocol Violation|0|||
130177324|NCT01068262|468605873|FG003|Overall Study|Protocol Violation|0|||
130177325|NCT01068262|468605870|FG000|Overall Study|Withdrawal by Subject|0|||
130177326|NCT01068262|468605871|FG001|Overall Study|Withdrawal by Subject|1|||
130177327|NCT01068262|468605872|FG002|Overall Study|Withdrawal by Subject|0|||
130177328|NCT01068262|468605873|FG003|Overall Study|Withdrawal by Subject|0|||
130177329|NCT00444587|468605876|FG000|Overall Study|Death|2|||
130177330|NCT00444587|468605877|FG001|Overall Study|Death|1|||
130177331|NCT00444587|468605876|FG000|Overall Study|Progression of the disease|73|||
130177332|NCT00444587|468605877|FG001|Overall Study|Progression of the disease|8|||
130177333|NCT00444587|468605876|FG000|Overall Study|Refused treatment/did not cooperate|4|||
130177334|NCT00444587|468605877|FG001|Overall Study|Refused treatment/did not cooperate|1|||
130177335|NCT00444587|468605876|FG000|Overall Study|Investigator decision|3|||
130177336|NCT00444587|468605877|FG001|Overall Study|Investigator decision|0|||
130177337|NCT00444587|468605876|FG000|Overall Study|Protocol Violation|1|||
130177338|NCT00444587|468605877|FG001|Overall Study|Protocol Violation|0|||
130177339|NCT00444587|468605876|FG000|Overall Study|Missing|0|||
130177340|NCT00444587|468605877|FG001|Overall Study|Missing|5|||
130177341|NCT01473407|468605886|FG000|Overall Study|Physician Decision|1|||
130177342|NCT01473407|468605887|FG001|Overall Study|Physician Decision|4|||
130177343|NCT01473407|468605886|FG000|Overall Study|Lost to Follow-up|10|||
130177344|NCT01473407|468605887|FG001|Overall Study|Lost to Follow-up|4|||
130651423|NCT00198107|470346218|FG000|Double-Blind Period|Physician Decision|1|||
130177345|NCT01473407|468605886|FG000|Overall Study|Adverse Event|8|||
130177346|NCT01473407|468605887|FG001|Overall Study|Adverse Event|8|||
130651424|NCT00198107|470346219|FG001|Double-Blind Period|Physician Decision|0|||
130177347|NCT01473407|468605886|FG000|Overall Study|Randomization Error|3|||
130177348|NCT01473407|468605887|FG001|Overall Study|Randomization Error|1|||
130177349|NCT01473407|468605886|FG000|Overall Study|Withdrawal by Subject|4|||
130177350|NCT01473407|468605887|FG001|Overall Study|Withdrawal by Subject|7|||
130177351|NCT01473407|468605886|FG000|Overall Study|Kidney Transplant|7|||
130177352|NCT01473407|468605887|FG001|Overall Study|Kidney Transplant|6|||
130177353|NCT01473407|468605886|FG000|Overall Study|Vacation/Travel|1|||
130177354|NCT01473407|468605887|FG001|Overall Study|Vacation/Travel|1|||
130177355|NCT01473407|468605886|FG000|Overall Study|Elevated Hemoglobin|1|||
130177356|NCT01473407|468605887|FG001|Overall Study|Elevated Hemoglobin|0|||
130177357|NCT01473407|468605886|FG000|Overall Study|Patient Received Aranesp|1|||
130177358|NCT01473407|468605887|FG001|Overall Study|Patient Received Aranesp|0|||
130177359|NCT01473407|468605886|FG000|Overall Study|Patient Lost Green Card Status|1|||
130177360|NCT01473407|468605887|FG001|Overall Study|Patient Lost Green Card Status|0|||
130177361|NCT01473407|468605886|FG000|Overall Study|Temperature Excursion|2|||
130177362|NCT01473407|468605887|FG001|Overall Study|Temperature Excursion|3|||
130177363|NCT01473407|468605886|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
130177364|NCT01473407|468605887|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
130177365|NCT01473407|468605886|FG000|Overall Study|Sponsor's Decision|10|||
130177366|NCT01473407|468605887|FG001|Overall Study|Sponsor's Decision|10|||
130177367|NCT01473407|468605886|FG000|Overall Study|Site Closure|1|||
130177368|NCT01473407|468605887|FG001|Overall Study|Site Closure|0|||
130177369|NCT01027702|468605890|FG000|Overall Study|Received subsequent therapy|1|||
130651425|NCT00198107|470346220|FG002|Double-Blind Period|Physician Decision|0|||
130651426|NCT00198107|470346218|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130651427|NCT00198107|470346219|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130651428|NCT00198107|470346220|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130651429|NCT00198107|470346218|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
130651430|NCT00198107|470346219|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
130177370|NCT01027702|468605891|FG001|Overall Study|Received subsequent therapy|2|||
130177371|NCT01027702|468605892|FG002|Overall Study|Received subsequent therapy|0|||
130177372|NCT01027702|468605893|FG003|Overall Study|Received subsequent therapy|4|||
130177373|NCT01027702|468605894|FG004|Overall Study|Received subsequent therapy|1|||
130177374|NCT01027702|468605895|FG005|Overall Study|Received subsequent therapy|0|||
130177375|NCT01027702|468605896|FG006|Overall Study|Received subsequent therapy|1|||
130177376|NCT01027702|468605890|FG000|Overall Study|Death|0|||
130177377|NCT01027702|468605891|FG001|Overall Study|Death|0|||
130177378|NCT01027702|468605892|FG002|Overall Study|Death|1|||
130177379|NCT01027702|468605893|FG003|Overall Study|Death|0|||
130177380|NCT01027702|468605894|FG004|Overall Study|Death|0|||
130177381|NCT01027702|468605895|FG005|Overall Study|Death|0|||
130177382|NCT01027702|468605896|FG006|Overall Study|Death|0|||
130177383|NCT02301390|468605897|FG000|Overall Study|Withdrawal by Subject|3|||
130177384|NCT02301390|468605898|FG001|Overall Study|Withdrawal by Subject|5|||
130177385|NCT02301390|468605897|FG000|Overall Study|Protocol Violation|1|||
130177386|NCT02301390|468605898|FG001|Overall Study|Protocol Violation|0|||
130177387|NCT02301390|468605897|FG000|Overall Study|Physician Decision|1|||
130177388|NCT02301390|468605898|FG001|Overall Study|Physician Decision|0|||
130177389|NCT02301390|468605897|FG000|Overall Study|Lost to Follow-up|0|||
130177390|NCT02301390|468605898|FG001|Overall Study|Lost to Follow-up|1|||
130177391|NCT02301390|468605897|FG000|Overall Study|Death|2|||
130177392|NCT02301390|468605898|FG001|Overall Study|Death|2|||
130177393|NCT02301390|468605897|FG000|Overall Study|Procedure not completed|0|||
130177394|NCT02301390|468605898|FG001|Overall Study|Procedure not completed|4|||
130177395|NCT02301390|468605897|FG000|Overall Study|Missed multiple visits|1|||
130177396|NCT02301390|468605898|FG001|Overall Study|Missed multiple visits|1|||
130177397|NCT02301390|468605897|FG000|Overall Study|study terminated|2|||
130177398|NCT02301390|468605898|FG001|Overall Study|study terminated|0|||
130177399|NCT02121652|468605901|FG000|Overall Study|Lost to Follow-up|2|||
130177400|NCT02121652|468605902|FG001|Overall Study|Lost to Follow-up|1|||
130177401|NCT02121652|468605901|FG000|Overall Study|Death|1|||
130177402|NCT02121652|468605902|FG001|Overall Study|Death|0|||
130177403|NCT02121652|468605901|FG000|Overall Study|Withdrawal by Subject|3|||
130177404|NCT02121652|468605902|FG001|Overall Study|Withdrawal by Subject|3|||
130177405|NCT01153425|468605903|FG000|Overall Study|Withdrawal by Subject|3|||
130177406|NCT01153425|468605904|FG001|Overall Study|Withdrawal by Subject|3|||
130177407|NCT02932462|468605905|FG000|Overall Study|Adverse Event|1|||
130177408|NCT02932462|468605906|FG001|Overall Study|Adverse Event|2|||
130177409|NCT02932462|468605905|FG000|Overall Study|Lost to Follow-up|4|||
130177410|NCT02932462|468605906|FG001|Overall Study|Lost to Follow-up|1|||
130177411|NCT02932462|468605905|FG000|Overall Study|Protocol Violation|0|||
130177412|NCT02932462|468605906|FG001|Overall Study|Protocol Violation|5|||
130177413|NCT02932462|468605905|FG000|Overall Study|Withdrawal by Subject|1|||
130177414|NCT02932462|468605906|FG001|Overall Study|Withdrawal by Subject|4|||
130177415|NCT02932462|468605905|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130177416|NCT02932462|468605906|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130177417|NCT02932462|468605905|FG000|Overall Study|Progressive Disease|1|||
130177418|NCT02932462|468605906|FG001|Overall Study|Progressive Disease|0|||
130177419|NCT02652949|468605907|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
130177420|NCT02652949|468605907|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
130177421|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
130177422|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130177423|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130177424|NCT02652949|468605907|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
130177425|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130177426|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
130177427|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
130177428|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
130177429|NCT02652949|468605907|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
130177430|NCT02652949|468605907|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130177431|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
130177432|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130177433|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130177434|NCT02652949|468605907|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
130177435|NCT02652949|468605907|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130177436|NCT00280735|468605917|FG000|Overall Study|Adverse Event|5|||
130177437|NCT00280735|468605917|FG000|Overall Study|Lack of Efficacy|3|||
130177438|NCT00280735|468605917|FG000|Overall Study|Withdrawal by Subject|8|||
130177439|NCT00280735|468605917|FG000|Overall Study|Intercurrent Illness|2|||
130177440|NCT04753216|468605918|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
130177441|NCT04753216|468605918|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
130177442|NCT04753216|468605918|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
130177443|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
130177444|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Death|1|||
130177445|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
130177446|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
130177447|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
130177448|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
130177449|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
130177450|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
130177451|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
130177452|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
130177453|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
130177454|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Other|3|||
130177455|NCT01895777|468605921|FG000|Overall Study|Adverse Event|1|||
130177456|NCT01895777|468605922|FG001|Overall Study|Adverse Event|2|||
130177457|NCT01895777|468605921|FG000|Overall Study|Lost to Follow-up|2|||
130177458|NCT01895777|468605922|FG001|Overall Study|Lost to Follow-up|0|||
130177459|NCT01895777|468605921|FG000|Overall Study|Not treated|1|||
130177460|NCT01895777|468605922|FG001|Overall Study|Not treated|0|||
130177461|NCT01895777|468605921|FG000|Overall Study|Other reasons|3|||
130177462|NCT01895777|468605922|FG001|Overall Study|Other reasons|2|||
130177463|NCT01895777|468605921|FG000|Overall Study|Non-compliance with the CTP|2|||
130177464|NCT01895777|468605922|FG001|Overall Study|Non-compliance with the CTP|1|||
130177465|NCT01965860|468605923|FG000|Overall Study|Pregnancy|1|||
130177466|NCT01965860|468605924|FG001|Overall Study|Pregnancy|0|||
130177467|NCT01965860|468605925|FG002|Overall Study|Pregnancy|1|||
130177468|NCT01965860|468605923|FG000|Overall Study|Logistics|1|||
130177469|NCT01965860|468605924|FG001|Overall Study|Logistics|0|||
130177470|NCT01965860|468605925|FG002|Overall Study|Logistics|0|||
130177471|NCT03735121|468605929|FG000|Overall Study|Death|3|||
130177472|NCT03735121|468605930|FG001|Overall Study|Death|6|||
130177473|NCT03735121|468605931|FG002|Overall Study|Death|8|||
130177474|NCT03735121|468605932|FG003|Overall Study|Death|37|||
130177475|NCT03735121|468605933|FG004|Overall Study|Death|86|||
130177476|NCT03735121|468605929|FG000|Overall Study|Withdrawal by Subject|1|||
130177477|NCT03735121|468605930|FG001|Overall Study|Withdrawal by Subject|1|||
130177478|NCT03735121|468605931|FG002|Overall Study|Withdrawal by Subject|3|||
130177479|NCT03735121|468605932|FG003|Overall Study|Withdrawal by Subject|4|||
130177480|NCT03735121|468605933|FG004|Overall Study|Withdrawal by Subject|2|||
130177481|NCT03735121|468605929|FG000|Overall Study|Progressive Disease|0|||
130177482|NCT03735121|468605930|FG001|Overall Study|Progressive Disease|0|||
130177483|NCT03735121|468605931|FG002|Overall Study|Progressive Disease|1|||
130177484|NCT03735121|468605932|FG003|Overall Study|Progressive Disease|0|||
130177485|NCT03735121|468605933|FG004|Overall Study|Progressive Disease|0|||
130177486|NCT03735121|468605929|FG000|Overall Study|Lost to Follow-up|0|||
130177487|NCT03735121|468605930|FG001|Overall Study|Lost to Follow-up|0|||
130177488|NCT03735121|468605931|FG002|Overall Study|Lost to Follow-up|0|||
130177489|NCT03735121|468605932|FG003|Overall Study|Lost to Follow-up|0|||
130177490|NCT03735121|468605933|FG004|Overall Study|Lost to Follow-up|1|||
130177491|NCT03735121|468605929|FG000|Overall Study|Ongoing|3|||
130177492|NCT03735121|468605930|FG001|Overall Study|Ongoing|3|||
130177493|NCT03735121|468605931|FG002|Overall Study|Ongoing|26|||
130177494|NCT03735121|468605932|FG003|Overall Study|Ongoing|83|||
130177495|NCT03735121|468605933|FG004|Overall Study|Ongoing|158|||
130177496|NCT00344448|468605934|FG000|Screening|Withdrawal by Subject|0|||
130177497|NCT00344448|468605935|FG001|Screening|Withdrawal by Subject|1|||
130177498|NCT00344448|468605934|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
130177499|NCT00344448|468605935|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
130177500|NCT00344448|468605934|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
130177501|NCT00344448|468605935|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
130177502|NCT00344448|468605934|FG000|Open Label|Withdrawal by Subject|1|||
130177503|NCT00344448|468605935|FG001|Open Label|Withdrawal by Subject|1|||
130177504|NCT00344448|468605934|FG000|Open Label|Study terminated|1|||
130177505|NCT00344448|468605935|FG001|Open Label|Study terminated|0|||
130177506|NCT03138655|468605937|FG000|Overall Study|Adverse Event|2|||
130177507|NCT03138655|468605938|FG001|Overall Study|Adverse Event|1|||
130177508|NCT03138655|468605939|FG002|Overall Study|Adverse Event|2|||
130177509|NCT03138655|468605940|FG003|Overall Study|Adverse Event|1|||
130177510|NCT03138655|468605941|FG004|Overall Study|Adverse Event|1|||
130177511|NCT03138655|468605942|FG005|Overall Study|Adverse Event|4|||
130177512|NCT03138655|468605943|FG006|Overall Study|Adverse Event|2|||
130177513|NCT03138655|468605944|FG007|Overall Study|Adverse Event|2|||
130177514|NCT03138655|468605937|FG000|Overall Study|Withdrawal by Subject|0|||
130177515|NCT03138655|468605938|FG001|Overall Study|Withdrawal by Subject|1|||
130177516|NCT03138655|468605939|FG002|Overall Study|Withdrawal by Subject|0|||
130177517|NCT03138655|468605940|FG003|Overall Study|Withdrawal by Subject|0|||
130177518|NCT03138655|468605941|FG004|Overall Study|Withdrawal by Subject|0|||
130177519|NCT03138655|468605942|FG005|Overall Study|Withdrawal by Subject|0|||
130177520|NCT03138655|468605943|FG006|Overall Study|Withdrawal by Subject|1|||
130177521|NCT03138655|468605944|FG007|Overall Study|Withdrawal by Subject|0|||
130177522|NCT03138655|468605937|FG000|Overall Study|Reason not Specified|1|||
130177523|NCT03138655|468605938|FG001|Overall Study|Reason not Specified|0|||
130177524|NCT03138655|468605939|FG002|Overall Study|Reason not Specified|0|||
130177525|NCT03138655|468605940|FG003|Overall Study|Reason not Specified|2|||
130177526|NCT03138655|468605941|FG004|Overall Study|Reason not Specified|1|||
130177527|NCT03138655|468605942|FG005|Overall Study|Reason not Specified|1|||
130177528|NCT03138655|468605943|FG006|Overall Study|Reason not Specified|0|||
130177529|NCT03138655|468605944|FG007|Overall Study|Reason not Specified|0|||
130177530|NCT02565511|468605945|FG000|Overall Study|Study terminated by Sponsor|35|||
130177531|NCT02565511|468605946|FG001|Overall Study|Study terminated by Sponsor|22|||
130177532|NCT02565511|468605947|FG002|Overall Study|Study terminated by Sponsor|235|||
130177533|NCT02565511|468605948|FG003|Overall Study|Study terminated by Sponsor|156|||
130177534|NCT02565511|468605945|FG000|Overall Study|Withdrawal by Subject|3|||
130177535|NCT02565511|468605946|FG001|Overall Study|Withdrawal by Subject|0|||
130177536|NCT02565511|468605947|FG002|Overall Study|Withdrawal by Subject|12|||
130177537|NCT02565511|468605948|FG003|Overall Study|Withdrawal by Subject|5|||
130177538|NCT02565511|468605945|FG000|Overall Study|Adverse Event|0|||
130177539|NCT02565511|468605946|FG001|Overall Study|Adverse Event|0|||
130177540|NCT02565511|468605947|FG002|Overall Study|Adverse Event|1|||
130177541|NCT02565511|468605948|FG003|Overall Study|Adverse Event|1|||
130177542|NCT02565511|468605945|FG000|Overall Study|Lost to Follow-up|4|||
130177543|NCT02565511|468605946|FG001|Overall Study|Lost to Follow-up|1|||
130177544|NCT02565511|468605947|FG002|Overall Study|Lost to Follow-up|0|||
130177545|NCT02565511|468605948|FG003|Overall Study|Lost to Follow-up|1|||
130177546|NCT02565511|468605945|FG000|Overall Study|Physician Decision|0|||
130177547|NCT02565511|468605946|FG001|Overall Study|Physician Decision|0|||
130177548|NCT02565511|468605947|FG002|Overall Study|Physician Decision|0|||
130177549|NCT02565511|468605948|FG003|Overall Study|Physician Decision|1|||
130177550|NCT02565511|468605945|FG000|Overall Study|Protocol deviation|0|||
130177551|NCT02565511|468605946|FG001|Overall Study|Protocol deviation|0|||
130177552|NCT02565511|468605947|FG002|Overall Study|Protocol deviation|3|||
130177553|NCT02565511|468605948|FG003|Overall Study|Protocol deviation|0|||
130177554|NCT03656744|468605951|FG000|Overall Study|Adverse Event|1|||
130177555|NCT03656744|468605952|FG001|Overall Study|Adverse Event|4|||
130177556|NCT03656744|468605953|FG002|Overall Study|Adverse Event|1|||
130177557|NCT03656744|468605951|FG000|Overall Study|Protocol Violation|1|||
130177558|NCT03656744|468605952|FG001|Overall Study|Protocol Violation|0|||
130177559|NCT03656744|468605953|FG002|Overall Study|Protocol Violation|0|||
130177560|NCT03656744|468605951|FG000|Overall Study|Lost to Follow-up|2|||
130177561|NCT03656744|468605952|FG001|Overall Study|Lost to Follow-up|2|||
130177562|NCT03656744|468605953|FG002|Overall Study|Lost to Follow-up|0|||
130177563|NCT03656744|468605951|FG000|Overall Study|Withdrawal by Subject|0|||
130177564|NCT03656744|468605952|FG001|Overall Study|Withdrawal by Subject|1|||
130177565|NCT03656744|468605953|FG002|Overall Study|Withdrawal by Subject|0|||
130177566|NCT03656744|468605951|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
130177567|NCT03656744|468605952|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130177568|NCT03656744|468605953|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130177569|NCT00098774|468605957|FG000|Overall Study|Adverse Event|2|||
130177570|NCT00098774|468605957|FG000|Overall Study|Disease Progression|9|||
130177571|NCT00098774|468605957|FG000|Overall Study|Withdrawal by Subject|1|||
130177572|NCT00098774|468605957|FG000|Overall Study|Failed (to respond) during induction|4|||
130177573|NCT00098774|468605957|FG000|Overall Study|Physician Decision|2|||
130177574|NCT03910673|468605958|FG000|Overall Study|Adverse Event|0|||
130177575|NCT03910673|468605959|FG001|Overall Study|Adverse Event|0|||
130177576|NCT03910673|468605960|FG002|Overall Study|Adverse Event|0|||
130177577|NCT03910673|468605961|FG003|Overall Study|Adverse Event|2|||
130177578|NCT03910673|468605962|FG004|Overall Study|Adverse Event|0|||
130177579|NCT00796757|468605963|FG000|Overall Study|Withdrawal by Subject|14|||
130177580|NCT00796757|468605963|FG000|Overall Study|Death|61|||
130177581|NCT00796757|468605963|FG000|Overall Study|Protocol Violation|1|||
130177582|NCT00796757|468605963|FG000|Overall Study|Participant noncompliance|1|||
130177583|NCT00796757|468605963|FG000|Overall Study|Investigator's decision|2|||
130177584|NCT00796757|468605963|FG000|Overall Study|Other|7|||
130177585|NCT01277211|468605964|FG000|Overall Study|Adverse Event|60|||
130177586|NCT01277211|468605965|FG001|Overall Study|Adverse Event|22|||
130177587|NCT01277211|468605964|FG000|Overall Study|Pregnancy|9|||
130177588|NCT01277211|468605965|FG001|Overall Study|Pregnancy|4|||
130177589|NCT01277211|468605964|FG000|Overall Study|Lost to Follow-up|14|||
130177590|NCT01277211|468605965|FG001|Overall Study|Lost to Follow-up|9|||
130177591|NCT01277211|468605964|FG000|Overall Study|Did not wish to continue|17|||
130177592|NCT01277211|468605965|FG001|Overall Study|Did not wish to continue|0|||
130177593|NCT01277211|468605964|FG000|Overall Study|Withdrew Consent|9|||
130177594|NCT01277211|468605965|FG001|Overall Study|Withdrew Consent|9|||
130177595|NCT01277211|468605964|FG000|Overall Study|Non-compliance with protocol|13|||
130177596|NCT01277211|468605965|FG001|Overall Study|Non-compliance with protocol|4|||
130177597|NCT01277211|468605964|FG000|Overall Study|Did not meet protocol eligibility|1|||
130177598|NCT01277211|468605965|FG001|Overall Study|Did not meet protocol eligibility|0|||
130177599|NCT01277211|468605964|FG000|Overall Study|Administrative|3|||
130177600|NCT01277211|468605965|FG001|Overall Study|Administrative|0|||
130177601|NCT01277211|468605964|FG000|Overall Study|Pregnancy wish|0|||
130177602|NCT01277211|468605965|FG001|Overall Study|Pregnancy wish|2|||
130177603|NCT01277211|468605964|FG000|Overall Study|Discontinued prior to treatment|24|||
130177604|NCT01277211|468605965|FG001|Overall Study|Discontinued prior to treatment|13|||
130177605|NCT00879086|468605966|FG000|Overall Study|Adverse Event|3|||
130177606|NCT00879086|468605967|FG001|Overall Study|Adverse Event|15|||
130177607|NCT00879086|468605966|FG000|Overall Study|Participant choice|2|||
130177608|NCT00879086|468605967|FG001|Overall Study|Participant choice|2|||
130177609|NCT00879086|468605966|FG000|Overall Study|Progression of disease|40|||
130177610|NCT00879086|468605967|FG001|Overall Study|Progression of disease|26|||
130177611|NCT00879086|468605966|FG000|Overall Study|Withdrawal of consent|2|||
130177612|NCT00879086|468605967|FG001|Overall Study|Withdrawal of consent|1|||
130177613|NCT00879086|468605966|FG000|Overall Study|Other|4|||
130177614|NCT00879086|468605967|FG001|Overall Study|Other|6|||
130177615|NCT00879086|468605966|FG000|Overall Study|Death|1|||
130177616|NCT00879086|468605967|FG001|Overall Study|Death|2|||
130177617|NCT01487525|468605968|FG000|Overall Study|Withdrawal by Subject|0|||
130177618|NCT01487525|468605969|FG001|Overall Study|Withdrawal by Subject|1|||
130177619|NCT01855828|468605970|FG000|Overall Study|Adverse Event|1|||
130177620|NCT01855828|468605970|FG000|Overall Study|Withdrawal by Subject|1|||
130177621|NCT01866098|468605971|FG000|Overall Study|Lost to Follow-up|11|||
130177622|NCT01866098|468605972|FG001|Overall Study|Lost to Follow-up|18|||
130177623|NCT01866098|468605973|FG002|Overall Study|Lost to Follow-up|13|||
130177624|NCT01866098|468605971|FG000|Overall Study|Physician Decision|0|||
130177625|NCT01866098|468605972|FG001|Overall Study|Physician Decision|1|||
130177626|NCT01866098|468605973|FG002|Overall Study|Physician Decision|2|||
130177627|NCT01866098|468605971|FG000|Overall Study|Adverse Event|1|||
130177628|NCT01866098|468605972|FG001|Overall Study|Adverse Event|5|||
130177629|NCT01866098|468605973|FG002|Overall Study|Adverse Event|4|||
130177630|NCT01866098|468605971|FG000|Overall Study|Protocol Violation|1|||
130177631|NCT01866098|468605972|FG001|Overall Study|Protocol Violation|0|||
130177632|NCT01866098|468605973|FG002|Overall Study|Protocol Violation|0|||
130177633|NCT01866098|468605971|FG000|Overall Study|Withdrawal by Subject|1|||
130177634|NCT01866098|468605972|FG001|Overall Study|Withdrawal by Subject|2|||
130177635|NCT01866098|468605973|FG002|Overall Study|Withdrawal by Subject|0|||
130177636|NCT01866098|468605971|FG000|Overall Study|Unrelated Hospitalization|2|||
130177637|NCT01866098|468605972|FG001|Overall Study|Unrelated Hospitalization|0|||
130177638|NCT01866098|468605973|FG002|Overall Study|Unrelated Hospitalization|1|||
130177639|NCT01866098|468605971|FG000|Overall Study|Non-compliance|1|||
130177640|NCT01866098|468605972|FG001|Overall Study|Non-compliance|0|||
130177641|NCT01866098|468605973|FG002|Overall Study|Non-compliance|1|||
130177642|NCT01866098|468605971|FG000|Overall Study|Pregnancy|2|||
130177643|NCT01866098|468605972|FG001|Overall Study|Pregnancy|0|||
130177644|NCT01866098|468605973|FG002|Overall Study|Pregnancy|0|||
130177645|NCT01866098|468605971|FG000|Overall Study|Death|0|||
130177646|NCT01866098|468605972|FG001|Overall Study|Death|1|||
130177647|NCT01866098|468605973|FG002|Overall Study|Death|0|||
130177648|NCT03449446|468605984|FG000|Overall Study|Randomized but Never Treated|0|||
130177649|NCT03449446|468605985|FG001|Overall Study|Randomized but Never Treated|0|||
130177650|NCT03449446|468605986|FG002|Overall Study|Randomized but Never Treated|1|||
130177651|NCT03449446|468605987|FG003|Overall Study|Randomized but Never Treated|1|||
130177652|NCT03449446|468605988|FG004|Overall Study|Randomized but Never Treated|1|||
130177653|NCT03449446|468605989|FG005|Overall Study|Randomized but Never Treated|0|||
130177654|NCT03449446|468605990|FG006|Overall Study|Randomized but Never Treated|0|||
130177655|NCT03449446|468605984|FG000|Overall Study|Unknown Reason|33|||
130177656|NCT03449446|468605985|FG001|Overall Study|Unknown Reason|1|||
130177657|NCT03449446|468605986|FG002|Overall Study|Unknown Reason|1|||
130177658|NCT03449446|468605987|FG003|Overall Study|Unknown Reason|1|||
130177659|NCT03449446|468605988|FG004|Overall Study|Unknown Reason|2|||
130177660|NCT03449446|468605989|FG005|Overall Study|Unknown Reason|2|||
130177661|NCT03449446|468605990|FG006|Overall Study|Unknown Reason|0|||
130177662|NCT03449446|468605984|FG000|Overall Study|Withdrew Consent|1|||
130177663|NCT03449446|468605985|FG001|Overall Study|Withdrew Consent|3|||
130177664|NCT03449446|468605986|FG002|Overall Study|Withdrew Consent|1|||
130177665|NCT03449446|468605987|FG003|Overall Study|Withdrew Consent|4|||
130177666|NCT03449446|468605988|FG004|Overall Study|Withdrew Consent|4|||
130177667|NCT03449446|468605989|FG005|Overall Study|Withdrew Consent|4|||
130177668|NCT03449446|468605990|FG006|Overall Study|Withdrew Consent|1|||
130177669|NCT03449446|468605984|FG000|Overall Study|Adverse Event|1|||
130177670|NCT03449446|468605985|FG001|Overall Study|Adverse Event|2|||
130177671|NCT03449446|468605986|FG002|Overall Study|Adverse Event|1|||
130177672|NCT03449446|468605987|FG003|Overall Study|Adverse Event|0|||
130177673|NCT03449446|468605988|FG004|Overall Study|Adverse Event|0|||
130177674|NCT03449446|468605989|FG005|Overall Study|Adverse Event|2|||
130177675|NCT03449446|468605990|FG006|Overall Study|Adverse Event|0|||
130177676|NCT03449446|468605984|FG000|Overall Study|Lost to Follow-up|0|||
130177677|NCT03449446|468605985|FG001|Overall Study|Lost to Follow-up|0|||
130177678|NCT03449446|468605986|FG002|Overall Study|Lost to Follow-up|2|||
130177679|NCT03449446|468605987|FG003|Overall Study|Lost to Follow-up|1|||
130177680|NCT03449446|468605988|FG004|Overall Study|Lost to Follow-up|3|||
130177681|NCT03449446|468605989|FG005|Overall Study|Lost to Follow-up|0|||
130177682|NCT03449446|468605990|FG006|Overall Study|Lost to Follow-up|0|||
130177683|NCT03449446|468605984|FG000|Overall Study|Investigator's Discretion|0|||
130177684|NCT03449446|468605985|FG001|Overall Study|Investigator's Discretion|1|||
130177685|NCT03449446|468605986|FG002|Overall Study|Investigator's Discretion|1|||
130177686|NCT03449446|468605987|FG003|Overall Study|Investigator's Discretion|2|||
130177687|NCT03449446|468605988|FG004|Overall Study|Investigator's Discretion|0|||
130177688|NCT03449446|468605989|FG005|Overall Study|Investigator's Discretion|0|||
130177689|NCT03449446|468605990|FG006|Overall Study|Investigator's Discretion|0|||
130177690|NCT03449446|468605984|FG000|Overall Study|Non Compliance with Study Drug|1|||
130177691|NCT03449446|468605985|FG001|Overall Study|Non Compliance with Study Drug|0|||
130651431|NCT00198107|470346220|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
130651432|NCT02383966|470346226|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
130651433|NCT02383966|470346227|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
130651434|NCT02383966|470346226|FG000|Overall Study|Randomized, but not treated|1|||
130651435|NCT02383966|470346227|FG001|Overall Study|Randomized, but not treated|3|||
130651436|NCT02163759|470346228|FG000|Overall Study|Withdrawal by Subject|1|||
130651437|NCT02163759|470346229|FG001|Overall Study|Withdrawal by Subject|5|||
130651438|NCT02163759|470346230|FG002|Overall Study|Withdrawal by Subject|1|||
130651439|NCT02163759|470346228|FG000|Overall Study|Adverse Event|0|||
130651440|NCT02163759|470346229|FG001|Overall Study|Adverse Event|0|||
130651441|NCT02163759|470346230|FG002|Overall Study|Adverse Event|1|||
130651442|NCT02163759|470346228|FG000|Overall Study|Death|0|||
130651443|NCT02163759|470346229|FG001|Overall Study|Death|0|||
130651444|NCT02163759|470346230|FG002|Overall Study|Death|1|||
130651445|NCT00451191|470346242|FG000|Overall Study|withdrawal or received alternate tx|15|||
130651446|NCT00451191|470346243|FG001|Overall Study|withdrawal or received alternate tx|11|||
130651447|NCT03575806|470346255|FG000|Overall Study|Withdrawal by Subject|0|||
130651448|NCT03575806|470346256|FG001|Overall Study|Withdrawal by Subject|2|||
130651449|NCT03575806|470346255|FG000|Overall Study|Protocol Violation|0|||
130651450|NCT03575806|470346256|FG001|Overall Study|Protocol Violation|2|||
130651451|NCT00219349|470346257|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
130651452|NCT00219349|470346257|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
130651453|NCT00219349|470346257|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
130651454|NCT00219349|470346257|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
130651455|NCT02777554|470346259|FG000|Overall Study|Adverse Event|4|||
130651456|NCT02777554|470346260|FG001|Overall Study|Adverse Event|4|||
130651457|NCT02777554|470346261|FG002|Overall Study|Adverse Event|0|||
130177692|NCT03449446|468605986|FG002|Overall Study|Non Compliance with Study Drug|0|||
130651458|NCT02777554|470346262|FG003|Overall Study|Adverse Event|1|||
130651459|NCT02777554|470346263|FG004|Overall Study|Adverse Event|0|||
130651460|NCT02777554|470346264|FG005|Overall Study|Adverse Event|0|||
130651461|NCT02777554|470346259|FG000|Overall Study|Withdrawal by Subject|3|||
130651462|NCT02777554|470346260|FG001|Overall Study|Withdrawal by Subject|1|||
130651463|NCT02777554|470346261|FG002|Overall Study|Withdrawal by Subject|1|||
130177693|NCT03449446|468605987|FG003|Overall Study|Non Compliance with Study Drug|0|||
130177694|NCT03449446|468605988|FG004|Overall Study|Non Compliance with Study Drug|0|||
130177695|NCT03449446|468605989|FG005|Overall Study|Non Compliance with Study Drug|0|||
130177696|NCT03449446|468605990|FG006|Overall Study|Non Compliance with Study Drug|0|||
130177697|NCT03449446|468605984|FG000|Overall Study|Protocol Violation|0|||
130177698|NCT03449446|468605985|FG001|Overall Study|Protocol Violation|0|||
130177699|NCT03449446|468605986|FG002|Overall Study|Protocol Violation|0|||
130177700|NCT03449446|468605987|FG003|Overall Study|Protocol Violation|0|||
130177701|NCT03449446|468605988|FG004|Overall Study|Protocol Violation|1|||
130177702|NCT03449446|468605989|FG005|Overall Study|Protocol Violation|1|||
130177703|NCT03449446|468605990|FG006|Overall Study|Protocol Violation|0|||
130177704|NCT03449446|468605984|FG000|Overall Study|Death|0|||
130177705|NCT03449446|468605985|FG001|Overall Study|Death|0|||
130177706|NCT03449446|468605986|FG002|Overall Study|Death|0|||
130177707|NCT03449446|468605987|FG003|Overall Study|Death|0|||
130177708|NCT03449446|468605988|FG004|Overall Study|Death|1|||
130177709|NCT03449446|468605989|FG005|Overall Study|Death|0|||
130177710|NCT03449446|468605990|FG006|Overall Study|Death|0|||
130177711|NCT01450683|468606011|FG000|Overall Study|Adverse Event|2|||
130177712|NCT02108912|468606013|FG000|Overall Study|Lost to Follow-up|1|||
130177713|NCT02108912|468606014|FG001|Overall Study|Lost to Follow-up|1|||
130177714|NCT02108912|468606013|FG000|Overall Study|lack of transportation|1|||
130177715|NCT02108912|468606014|FG001|Overall Study|lack of transportation|0|||
130177716|NCT02108912|468606013|FG000|Overall Study|high blood pressure|1|||
130177717|NCT02108912|468606014|FG001|Overall Study|high blood pressure|0|||
130177718|NCT01950390|468606020|FG000|Overall Study|Never started treatment|3|||
130177719|NCT01950390|468606021|FG001|Overall Study|Never started treatment|2|||
130177720|NCT01950390|468606020|FG000|Overall Study|Disease progression|45|||
130177721|NCT01950390|468606021|FG001|Overall Study|Disease progression|52|||
130177722|NCT01950390|468606020|FG000|Overall Study|Adverse Event|22|||
130177723|NCT01950390|468606021|FG001|Overall Study|Adverse Event|16|||
130177724|NCT01950390|468606020|FG000|Overall Study|Death|5|||
130177725|NCT01950390|468606021|FG001|Overall Study|Death|3|||
130177726|NCT01950390|468606020|FG000|Overall Study|Withdrawal by Subject|5|||
130177727|NCT01950390|468606021|FG001|Overall Study|Withdrawal by Subject|1|||
130177728|NCT01950390|468606020|FG000|Overall Study|Alternative therapy|0|||
130177729|NCT01950390|468606021|FG001|Overall Study|Alternative therapy|3|||
130177730|NCT01950390|468606020|FG000|Overall Study|Complicating disease|1|||
130177731|NCT01950390|468606021|FG001|Overall Study|Complicating disease|0|||
130177732|NCT01950390|468606020|FG000|Overall Study|On treatment|1|||
130177733|NCT01950390|468606021|FG001|Overall Study|On treatment|0|||
130177734|NCT01950390|468606020|FG000|Overall Study|Symptomatic deterioration|2|||
130177735|NCT01950390|468606021|FG001|Overall Study|Symptomatic deterioration|1|||
130177736|NCT01950390|468606020|FG000|Overall Study|Physician Decision|0|||
130177737|NCT01950390|468606021|FG001|Overall Study|Physician Decision|4|||
130177738|NCT01950390|468606020|FG000|Overall Study|Lack of clinical benefit|0|||
130177739|NCT01950390|468606021|FG001|Overall Study|Lack of clinical benefit|1|||
130177740|NCT01950390|468606020|FG000|Overall Study|Maintained PR and moved to observation only|0|||
130177741|NCT01950390|468606021|FG001|Overall Study|Maintained PR and moved to observation only|1|||
130177742|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177743|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177744|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177745|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177746|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
130177747|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177748|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177749|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
130177750|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
130177751|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
130177752|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
130177753|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
130177754|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
130177755|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
130177756|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177757|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177758|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177759|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177760|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
130177761|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177762|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177763|NCT01682811|468606022|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177764|NCT01682811|468606023|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177765|NCT01682811|468606024|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177766|NCT01682811|468606025|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177767|NCT01682811|468606026|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177768|NCT01682811|468606027|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
130177769|NCT01682811|468606028|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177770|NCT01128179|468606029|FG000|Overall Study|Death|1|||
130177771|NCT01128179|468606030|FG001|Overall Study|Death|0|||
130177772|NCT01128179|468606029|FG000|Overall Study|Protocol Violation|1|||
130177773|NCT01128179|468606030|FG001|Overall Study|Protocol Violation|0|||
130177774|NCT05192889|468606031|FG000|Block 1: All Eligible Patients|Death|2|||
130177775|NCT05192889|468606032|FG001|Block 1: All Eligible Patients|Death|0|||
130177776|NCT05192889|468606033|FG002|Block 1: All Eligible Patients|Death|0|||
130177777|NCT05192889|468606031|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
130177778|NCT05192889|468606032|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
130177779|NCT05192889|468606033|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
130177780|NCT05192889|468606031|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
130177781|NCT05192889|468606032|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
130177782|NCT05192889|468606033|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
130177783|NCT02731638|468608156|FG000|Overall Study|Lost to Follow-up|6|||
130177784|NCT02731638|468608157|FG001|Overall Study|Lost to Follow-up|9|||
130177785|NCT03284723|468608158|FG000|Overall Study|Death|0|||
130177786|NCT03284723|468608159|FG001|Overall Study|Death|0|||
130177787|NCT03284723|468608160|FG002|Overall Study|Death|0|||
130177788|NCT03284723|468608161|FG003|Overall Study|Death|1|||
130177789|NCT03284723|468608162|FG004|Overall Study|Death|0|||
130177790|NCT03284723|468608163|FG005|Overall Study|Death|0|||
130177791|NCT03284723|468608164|FG006|Overall Study|Death|1|||
130177792|NCT03284723|468608165|FG007|Overall Study|Death|0|||
130177793|NCT03284723|468608166|FG008|Overall Study|Death|0|||
130177794|NCT03284723|468608167|FG009|Overall Study|Death|2|||
130177795|NCT03284723|468608168|FG010|Overall Study|Death|1|||
130177796|NCT03284723|468608169|FG011|Overall Study|Death|0|||
130177797|NCT03284723|468608158|FG000|Overall Study|Lost to Follow-up|0|||
130177798|NCT03284723|468608159|FG001|Overall Study|Lost to Follow-up|0|||
130177799|NCT03284723|468608160|FG002|Overall Study|Lost to Follow-up|0|||
130177800|NCT03284723|468608161|FG003|Overall Study|Lost to Follow-up|0|||
130177801|NCT03284723|468608162|FG004|Overall Study|Lost to Follow-up|0|||
130177802|NCT03284723|468608163|FG005|Overall Study|Lost to Follow-up|2|||
130177803|NCT03284723|468608164|FG006|Overall Study|Lost to Follow-up|1|||
130177804|NCT03284723|468608165|FG007|Overall Study|Lost to Follow-up|0|||
130177805|NCT03284723|468608166|FG008|Overall Study|Lost to Follow-up|0|||
130177806|NCT03284723|468608167|FG009|Overall Study|Lost to Follow-up|2|||
130177807|NCT03284723|468608168|FG010|Overall Study|Lost to Follow-up|0|||
130177808|NCT03284723|468608169|FG011|Overall Study|Lost to Follow-up|0|||
130177809|NCT03284723|468608158|FG000|Overall Study|Study Terminated By Sponsor|0|||
130177810|NCT03284723|468608159|FG001|Overall Study|Study Terminated By Sponsor|0|||
130177811|NCT03284723|468608160|FG002|Overall Study|Study Terminated By Sponsor|0|||
130177812|NCT03284723|468608161|FG003|Overall Study|Study Terminated By Sponsor|0|||
130177813|NCT03284723|468608162|FG004|Overall Study|Study Terminated By Sponsor|1|||
130177814|NCT03284723|468608163|FG005|Overall Study|Study Terminated By Sponsor|0|||
130177815|NCT03284723|468608164|FG006|Overall Study|Study Terminated By Sponsor|0|||
130177816|NCT03284723|468608165|FG007|Overall Study|Study Terminated By Sponsor|0|||
130177817|NCT03284723|468608166|FG008|Overall Study|Study Terminated By Sponsor|1|||
130177818|NCT03284723|468608167|FG009|Overall Study|Study Terminated By Sponsor|1|||
130177819|NCT03284723|468608168|FG010|Overall Study|Study Terminated By Sponsor|1|||
130177820|NCT03284723|468608169|FG011|Overall Study|Study Terminated By Sponsor|1|||
130177821|NCT03284723|468608158|FG000|Overall Study|Withdrawal by Subject|0|||
130177822|NCT03284723|468608159|FG001|Overall Study|Withdrawal by Subject|0|||
130177823|NCT03284723|468608160|FG002|Overall Study|Withdrawal by Subject|0|||
130177824|NCT03284723|468608161|FG003|Overall Study|Withdrawal by Subject|0|||
130177825|NCT03284723|468608162|FG004|Overall Study|Withdrawal by Subject|5|||
130177826|NCT03284723|468608163|FG005|Overall Study|Withdrawal by Subject|3|||
130177827|NCT03284723|468608164|FG006|Overall Study|Withdrawal by Subject|1|||
130177828|NCT03284723|468608165|FG007|Overall Study|Withdrawal by Subject|0|||
130177829|NCT03284723|468608166|FG008|Overall Study|Withdrawal by Subject|6|||
130177830|NCT03284723|468608167|FG009|Overall Study|Withdrawal by Subject|0|||
130177831|NCT03284723|468608168|FG010|Overall Study|Withdrawal by Subject|3|||
130177832|NCT03284723|468608169|FG011|Overall Study|Withdrawal by Subject|1|||
130177833|NCT03284723|468608158|FG000|Overall Study|Other|1|||
130177834|NCT03284723|468608159|FG001|Overall Study|Other|0|||
130177835|NCT03284723|468608160|FG002|Overall Study|Other|1|||
130177836|NCT03284723|468608161|FG003|Overall Study|Other|0|||
130177837|NCT03284723|468608162|FG004|Overall Study|Other|1|||
130177838|NCT03284723|468608163|FG005|Overall Study|Other|0|||
130177839|NCT03284723|468608164|FG006|Overall Study|Other|0|||
130177840|NCT03284723|468608165|FG007|Overall Study|Other|0|||
130177841|NCT03284723|468608166|FG008|Overall Study|Other|0|||
130177842|NCT03284723|468608167|FG009|Overall Study|Other|0|||
130177843|NCT03284723|468608168|FG010|Overall Study|Other|1|||
130177844|NCT03284723|468608169|FG011|Overall Study|Other|0|||
130177845|NCT03284723|468608158|FG000|Overall Study|Adverse Event|0|||
130177846|NCT03284723|468608159|FG001|Overall Study|Adverse Event|0|||
130177847|NCT03284723|468608160|FG002|Overall Study|Adverse Event|0|||
130177848|NCT03284723|468608161|FG003|Overall Study|Adverse Event|0|||
130177849|NCT03284723|468608162|FG004|Overall Study|Adverse Event|0|||
130177850|NCT03284723|468608163|FG005|Overall Study|Adverse Event|0|||
130177851|NCT03284723|468608164|FG006|Overall Study|Adverse Event|0|||
130177852|NCT03284723|468608165|FG007|Overall Study|Adverse Event|0|||
130177853|NCT03284723|468608166|FG008|Overall Study|Adverse Event|1|||
130177854|NCT03284723|468608167|FG009|Overall Study|Adverse Event|0|||
130177855|NCT03284723|468608168|FG010|Overall Study|Adverse Event|0|||
130177856|NCT03284723|468608169|FG011|Overall Study|Adverse Event|0|||
130177857|NCT00615199|468608170|FG000|Overall Study|Adverse Event|3|||
130177858|NCT00615199|468608171|FG001|Overall Study|Adverse Event|1|||
130177859|NCT00615199|468608172|FG002|Overall Study|Adverse Event|1|||
130177860|NCT00615199|468608173|FG003|Overall Study|Adverse Event|0|||
130177861|NCT00615199|468608170|FG000|Overall Study|Lack of Efficacy|2|||
130177862|NCT00615199|468608171|FG001|Overall Study|Lack of Efficacy|0|||
130177863|NCT00615199|468608172|FG002|Overall Study|Lack of Efficacy|0|||
130177864|NCT00615199|468608173|FG003|Overall Study|Lack of Efficacy|1|||
130177865|NCT00615199|468608170|FG000|Overall Study|Lost to Follow-up|1|||
130177866|NCT00615199|468608171|FG001|Overall Study|Lost to Follow-up|0|||
130177867|NCT00615199|468608172|FG002|Overall Study|Lost to Follow-up|0|||
130177868|NCT00615199|468608173|FG003|Overall Study|Lost to Follow-up|0|||
130177869|NCT00615199|468608170|FG000|Overall Study|Other|0|||
130177870|NCT00615199|468608171|FG001|Overall Study|Other|0|||
130177871|NCT00615199|468608172|FG002|Overall Study|Other|0|||
130177872|NCT00615199|468608173|FG003|Overall Study|Other|1|||
130177873|NCT00615199|468608170|FG000|Overall Study|Withdrawal by Subject|2|||
130177874|NCT00615199|468608171|FG001|Overall Study|Withdrawal by Subject|1|||
130177875|NCT00615199|468608172|FG002|Overall Study|Withdrawal by Subject|0|||
130177876|NCT00615199|468608173|FG003|Overall Study|Withdrawal by Subject|0|||
130177877|NCT01499095|468608174|FG000|Overall Study|Randomized But Not Treated|1|||
130177878|NCT01499095|468608175|FG001|Overall Study|Randomized But Not Treated|1|||
130177879|NCT01499095|468608174|FG000|Overall Study|Adverse Event|12|||
130177880|NCT01499095|468608175|FG001|Overall Study|Adverse Event|7|||
130177881|NCT01499095|468608174|FG000|Overall Study|Lack of Efficacy|2|||
130177882|NCT01499095|468608175|FG001|Overall Study|Lack of Efficacy|1|||
130177883|NCT01499095|468608174|FG000|Overall Study|Protocol Violation|6|||
130177884|NCT01499095|468608175|FG001|Overall Study|Protocol Violation|7|||
130177885|NCT01499095|468608174|FG000|Overall Study|Received Rescue Therapy|32|||
130177886|NCT01499095|468608175|FG001|Overall Study|Received Rescue Therapy|40|||
130177887|NCT01499095|468608174|FG000|Overall Study|Diverse Reasons|22|||
130177888|NCT01499095|468608175|FG001|Overall Study|Diverse Reasons|25|||
130177889|NCT01499095|468608174|FG000|Overall Study|Lost to Follow-up|6|||
130177890|NCT01499095|468608175|FG001|Overall Study|Lost to Follow-up|4|||
130177891|NCT01499095|468608174|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
130177892|NCT01499095|468608175|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
130177893|NCT01499095|468608174|FG000|Overall Study|Hypoglycemia|3|||
130177894|NCT01499095|468608175|FG001|Overall Study|Hypoglycemia|1|||
130177895|NCT01499095|468608174|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
130177896|NCT01499095|468608175|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
130177897|NCT01499095|468608174|FG000|Overall Study|Change in Injection Schedule|2|||
130177898|NCT01499095|468608175|FG001|Overall Study|Change in Injection Schedule|0|||
130177899|NCT01499095|468608174|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130177900|NCT01499095|468608175|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130177901|NCT01811472|468608181|FG000|Overall Study|Adverse Event|1|||
130177902|NCT01811472|468608182|FG001|Overall Study|Adverse Event|0|||
130177903|NCT01811472|468608183|FG002|Overall Study|Adverse Event|4|||
130177904|NCT01811472|468608181|FG000|Overall Study|Lost to Follow-up|0|||
130177905|NCT01811472|468608182|FG001|Overall Study|Lost to Follow-up|0|||
130177906|NCT01811472|468608183|FG002|Overall Study|Lost to Follow-up|1|||
130177907|NCT01811472|468608181|FG000|Overall Study|Subject/guardian decision|1|||
130177908|NCT01811472|468608182|FG001|Overall Study|Subject/guardian decision|0|||
130177909|NCT01811472|468608183|FG002|Overall Study|Subject/guardian decision|0|||
130177910|NCT03280264|468608184|FG000|Overall Study|Adverse Event|1|||
130177911|NCT03280264|468608184|FG000|Overall Study|Physician Decision|1|||
130177912|NCT03280264|468608184|FG000|Overall Study|Withdrawal by Subject|1|||
130177913|NCT02738138|468608185|FG000|Overall Study|Adverse Event|0|||
130177914|NCT02738138|468608186|FG001|Overall Study|Adverse Event|1|||
130177915|NCT02738138|468608185|FG000|Overall Study|Lost to Follow-up|2|||
130177916|NCT02738138|468608186|FG001|Overall Study|Lost to Follow-up|0|||
130177917|NCT02738138|468608185|FG000|Overall Study|Other - not further specified|1|||
130177918|NCT02738138|468608186|FG001|Overall Study|Other - not further specified|0|||
130177919|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Other|34|||
130177920|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Other|0|||
130177921|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Other|0|||
130177922|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Other|0|||
130177923|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Death|14|||
130177924|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Death|0|||
130177925|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Death|0|||
130177926|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Death|0|||
130177927|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
130177928|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
130177929|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
130177930|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
130177931|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
130177932|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177933|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177934|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177935|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
130177936|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
130177937|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
130177938|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
130177939|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
130177940|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177941|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177942|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177943|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
130177944|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177945|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177946|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177947|NCT01995513|468608192|FG000|Period 1: Second Open Label Treatment|Other|0|||
130177948|NCT01995513|468608193|FG001|Period 1: Second Open Label Treatment|Other|2|||
130177949|NCT01995513|468608194|FG002|Period 1: Second Open Label Treatment|Other|0|||
130177950|NCT01995513|468608195|FG003|Period 1: Second Open Label Treatment|Other|0|||
130177951|NCT01995513|468608192|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177952|NCT01995513|468608193|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
130177953|NCT01995513|468608194|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177954|NCT01995513|468608195|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177955|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Death|0|||
130177956|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Death|0|||
130177957|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Death|0|||
130177958|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Death|1|||
130177959|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Other|0|||
130177960|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Other|0|||
130177961|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Other|3|||
130177962|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Other|3|||
130177963|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
130177964|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
130177965|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
130177966|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
130177967|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
130177968|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
130177969|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
130177970|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
130177971|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130177972|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130177973|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
130177974|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
130177975|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177976|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177977|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177978|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
130177979|NCT01232452|468608196|FG000|Overall Study|Adverse Event|17|||
130177980|NCT01232452|468608197|FG001|Overall Study|Adverse Event|15|||
130177981|NCT01232452|468608196|FG000|Overall Study|Withdrawal by Subject|11|||
130177982|NCT01232452|468608197|FG001|Overall Study|Withdrawal by Subject|8|||
130177983|NCT01232452|468608196|FG000|Overall Study|Physician Decision|8|||
130177984|NCT01232452|468608197|FG001|Overall Study|Physician Decision|12|||
130651464|NCT02777554|470346262|FG003|Overall Study|Withdrawal by Subject|0|||
130651465|NCT02777554|470346263|FG004|Overall Study|Withdrawal by Subject|0|||
130651466|NCT02777554|470346264|FG005|Overall Study|Withdrawal by Subject|0|||
130651467|NCT02777554|470346259|FG000|Overall Study|Discharged early due to hurricane|22|||
130177985|NCT01232452|468608196|FG000|Overall Study|Protocol entry criterion not met|0|||
130177986|NCT01232452|468608197|FG001|Overall Study|Protocol entry criterion not met|2|||
130177987|NCT01232452|468608196|FG000|Overall Study|Sponsor Decision|3|||
130177988|NCT01232452|468608197|FG001|Overall Study|Sponsor Decision|1|||
130177989|NCT01232452|468608196|FG000|Overall Study|Protocol Violation|0|||
130177990|NCT01232452|468608197|FG001|Overall Study|Protocol Violation|1|||
130177991|NCT04108299|468608199|FG000|Overall Study|Not interested in participating|2|||
130177992|NCT04108299|468608200|FG001|Overall Study|Not interested in participating|1|||
130177993|NCT04108299|468608201|FG002|Overall Study|Not interested in participating|2|||
130177994|NCT04108299|468608202|FG003|Overall Study|Not interested in participating|1|||
130177995|NCT00247676|468608203|FG000|Overall Study|Death|5|||
130177996|NCT00247676|468608203|FG000|Overall Study|Adverse Event|11|||
130177997|NCT00247676|468608203|FG000|Overall Study|Lack of Efficacy|15|||
130651468|NCT02777554|470346260|FG001|Overall Study|Discharged early due to hurricane|20|||
130651469|NCT02777554|470346261|FG002|Overall Study|Discharged early due to hurricane|0|||
130651470|NCT02777554|470346262|FG003|Overall Study|Discharged early due to hurricane|0|||
130651471|NCT02777554|470346263|FG004|Overall Study|Discharged early due to hurricane|0|||
130651472|NCT02777554|470346264|FG005|Overall Study|Discharged early due to hurricane|0|||
130651473|NCT02777554|470346259|FG000|Overall Study|Other - Miscellaneous|1|||
130651474|NCT02777554|470346260|FG001|Overall Study|Other - Miscellaneous|0|||
130651475|NCT02777554|470346261|FG002|Overall Study|Other - Miscellaneous|0|||
130651476|NCT02777554|470346262|FG003|Overall Study|Other - Miscellaneous|0|||
130651477|NCT02777554|470346263|FG004|Overall Study|Other - Miscellaneous|0|||
130651478|NCT02777554|470346264|FG005|Overall Study|Other - Miscellaneous|0|||
130651479|NCT00270205|470346265|FG000|Overall Study|Lost to Follow-up|1|||
130651480|NCT00270205|470346266|FG001|Overall Study|Lost to Follow-up|0|||
130651481|NCT00270205|470346267|FG002|Overall Study|Lost to Follow-up|0|||
130651482|NCT00270205|470346268|FG003|Overall Study|Lost to Follow-up|1|||
130651483|NCT00066573|470346269|FG000|Overall Study|Did not received protocol treatment|28|||
130651484|NCT00066573|470346270|FG001|Overall Study|Did not received protocol treatment|28|||
130651485|NCT00869362|470346271|FG000|Overall Study|Death|0|||
130651486|NCT00869362|470346272|FG001|Overall Study|Death|2|||
130651487|NCT00869362|470346271|FG000|Overall Study|Lost to Follow-up|1|||
130651488|NCT00869362|470346272|FG001|Overall Study|Lost to Follow-up|3|||
130651489|NCT01241591|470346273|FG000|Overall Study|Lack of Efficacy|5|||
130651490|NCT01241591|470346274|FG001|Overall Study|Lack of Efficacy|2|||
130651491|NCT01241591|470346275|FG002|Overall Study|Lack of Efficacy|2|||
130651492|NCT01241591|470346276|FG003|Overall Study|Lack of Efficacy|3|||
130651493|NCT01241591|470346273|FG000|Overall Study|Protocol Violation|5|||
130651494|NCT01241591|470346274|FG001|Overall Study|Protocol Violation|2|||
130651495|NCT01241591|470346275|FG002|Overall Study|Protocol Violation|3|||
130651496|NCT01241591|470346276|FG003|Overall Study|Protocol Violation|0|||
130651497|NCT01241591|470346273|FG000|Overall Study|Lost to Follow-up|1|||
130651498|NCT01241591|470346274|FG001|Overall Study|Lost to Follow-up|2|||
130651499|NCT01241591|470346275|FG002|Overall Study|Lost to Follow-up|2|||
130651500|NCT01241591|470346276|FG003|Overall Study|Lost to Follow-up|2|||
130651501|NCT01241591|470346273|FG000|Overall Study|Screen Failure|3|||
130651502|NCT01241591|470346274|FG001|Overall Study|Screen Failure|2|||
130651503|NCT01241591|470346275|FG002|Overall Study|Screen Failure|1|||
130651504|NCT01241591|470346276|FG003|Overall Study|Screen Failure|0|||
130651505|NCT01241591|470346273|FG000|Overall Study|Withdrawal by Subject|6|||
130651506|NCT01241591|470346274|FG001|Overall Study|Withdrawal by Subject|4|||
130651507|NCT01241591|470346275|FG002|Overall Study|Withdrawal by Subject|2|||
130651508|NCT01241591|470346276|FG003|Overall Study|Withdrawal by Subject|2|||
130651509|NCT01241591|470346273|FG000|Overall Study|Other|0|||
130651510|NCT01241591|470346274|FG001|Overall Study|Other|1|||
130651511|NCT01241591|470346275|FG002|Overall Study|Other|0|||
130651512|NCT01241591|470346276|FG003|Overall Study|Other|1|||
130651513|NCT01241591|470346273|FG000|Overall Study|Adverse Event|3|||
130651514|NCT01241591|470346274|FG001|Overall Study|Adverse Event|11|||
130651515|NCT01241591|470346275|FG002|Overall Study|Adverse Event|12|||
130651516|NCT01241591|470346276|FG003|Overall Study|Adverse Event|4|||
130651517|NCT01945034|470346277|FG000|Overall Study|Medication Error|0|||
130651518|NCT01945034|470346278|FG001|Overall Study|Medication Error|1|||
130651519|NCT01945034|470346279|FG002|Overall Study|Medication Error|0|||
130651520|NCT01945034|470346277|FG000|Overall Study|Withdrawal by Subject|0|||
130651521|NCT01945034|470346278|FG001|Overall Study|Withdrawal by Subject|3|||
130651522|NCT01945034|470346279|FG002|Overall Study|Withdrawal by Subject|1|||
130651523|NCT01945034|470346277|FG000|Overall Study|Other|0|||
130651524|NCT01945034|470346278|FG001|Overall Study|Other|1|||
130177998|NCT00247676|468608203|FG000|Overall Study|Other|3|||
130651525|NCT01945034|470346279|FG002|Overall Study|Other|3|||
130651526|NCT01945034|470346277|FG000|Overall Study|Lost to Follow-up|0|||
130651527|NCT01945034|470346278|FG001|Overall Study|Lost to Follow-up|0|||
130651528|NCT01945034|470346279|FG002|Overall Study|Lost to Follow-up|2|||
130651529|NCT01945034|470346277|FG000|Overall Study|Protocol Violation|1|||
130651530|NCT01945034|470346278|FG001|Overall Study|Protocol Violation|0|||
130651531|NCT01945034|470346279|FG002|Overall Study|Protocol Violation|1|||
130651532|NCT02147132|470346280|FG000|Overall Study|Lost to Follow-up|1|||
130651533|NCT02147132|470346281|FG001|Overall Study|Lost to Follow-up|0|||
130651534|NCT02147132|470346282|FG002|Overall Study|Lost to Follow-up|0|||
130651535|NCT02147132|470346283|FG003|Overall Study|Lost to Follow-up|0|||
130651536|NCT04001790|470346284|FG000|Overall Study|Withdrawal by Subject|1|||
130651537|NCT04001790|470346285|FG001|Overall Study|Withdrawal by Subject|2|||
130651538|NCT02706327|470346286|FG000|Overall Study|Lost to Follow-up|1|||
130651539|NCT02706327|470346287|FG001|Overall Study|Lost to Follow-up|1|||
130177999|NCT00247676|468608203|FG000|Overall Study|Withdrawal by Subject|2|||
130178000|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
130178001|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
130178002|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
130178003|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
130178004|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
130178005|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
130178006|NCT00662649|468608206|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
130178007|NCT00662649|468608207|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
130178008|NCT00662649|468608208|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
130178009|NCT00662649|468608209|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
130178010|NCT00662649|468608210|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
130178011|NCT00662649|468608206|FG000|Core Study (24 Months)|Adverse Event|22|||
130178012|NCT00662649|468608207|FG001|Core Study (24 Months)|Adverse Event|13|||
130178013|NCT00662649|468608208|FG002|Core Study (24 Months)|Adverse Event|18|||
130178014|NCT00662649|468608209|FG003|Core Study (24 Months)|Adverse Event|0|||
130178015|NCT00662649|468608210|FG004|Core Study (24 Months)|Adverse Event|0|||
130178016|NCT00662649|468608206|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
130178017|NCT00662649|468608207|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
130178018|NCT00662649|468608208|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
130178019|NCT00662649|468608209|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130178020|NCT00662649|468608210|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130178021|NCT00662649|468608206|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
130178022|NCT00662649|468608207|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
130178023|NCT00662649|468608208|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
130178024|NCT00662649|468608209|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130178025|NCT00662649|468608210|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130178026|NCT00662649|468608206|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
130178027|NCT00662649|468608207|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
130178028|NCT00662649|468608208|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
130178029|NCT00662649|468608209|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
130178030|NCT00662649|468608210|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
130178031|NCT00662649|468608206|FG000|Core Study (24 Months)|Protocol Violation|5|||
130178032|NCT00662649|468608207|FG001|Core Study (24 Months)|Protocol Violation|5|||
130178033|NCT00662649|468608208|FG002|Core Study (24 Months)|Protocol Violation|4|||
130178034|NCT00662649|468608209|FG003|Core Study (24 Months)|Protocol Violation|0|||
130178035|NCT00662649|468608210|FG004|Core Study (24 Months)|Protocol Violation|0|||
130178036|NCT00662649|468608206|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
130178037|NCT00662649|468608207|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130178038|NCT00662649|468608208|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130178039|NCT00662649|468608209|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130178040|NCT00662649|468608210|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130178041|NCT00662649|468608206|FG000|Core Study (24 Months)|Death|1|||
130178042|NCT00662649|468608207|FG001|Core Study (24 Months)|Death|0|||
130178043|NCT00662649|468608208|FG002|Core Study (24 Months)|Death|2|||
130178044|NCT00662649|468608209|FG003|Core Study (24 Months)|Death|0|||
130178045|NCT00662649|468608210|FG004|Core Study (24 Months)|Death|0|||
130178046|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
130178047|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
130178048|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
130178049|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
130178050|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
130178051|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
130178052|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130178053|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
130178054|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130178055|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
130178056|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178057|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178058|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178059|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
130178060|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178061|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
130178062|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
130178063|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
130178064|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
130178065|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
130178066|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
130178067|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130178068|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130178069|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130178070|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130178071|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130178072|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130178073|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178074|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178075|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178076|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
130178077|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
130178078|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
130178079|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
130178080|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
130178081|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178082|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
130178083|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178084|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178085|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178086|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130178087|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130178088|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
130178089|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130178090|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130178091|NCT02009722|468608217|FG000|Overall Study|Protocol Violation|1|||
130178092|NCT02009722|468608218|FG001|Overall Study|Protocol Violation|2|||
130178093|NCT02009722|468608217|FG000|Overall Study|Did not receive intervention|0|||
130178094|NCT02009722|468608218|FG001|Overall Study|Did not receive intervention|1|||
130178095|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
130178096|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
130178097|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
130178098|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
130178099|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
130178100|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
130178101|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Other|3|||
130178102|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Other|2|||
130178103|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Adverse Event|11|||
130178104|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Adverse Event|7|||
130178105|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
130178106|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
130178107|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
130178108|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
130178109|NCT02955212|468608219|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
130178110|NCT02955212|468608220|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
130178111|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Other|2|||
130178112|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Other|4|||
130178113|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Physician Decision|3|||
130178114|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
130178115|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Disease Progression|1|||
130178116|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
130178117|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
130178118|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
130178119|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
130178120|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
130178121|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
130178122|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Death|2|||
130178123|NCT04428034|468608226|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
130178124|NCT00560391|468608231|FG000|Overall Study|Still on treatment|0|||
130178125|NCT00560391|468608232|FG001|Overall Study|Still on treatment|0|||
130178126|NCT00560391|468608233|FG002|Overall Study|Still on treatment|0|||
130178127|NCT00560391|468608234|FG003|Overall Study|Still on treatment|1|||
130178128|NCT00560391|468608235|FG004|Overall Study|Still on treatment|2|||
130178129|NCT02556801|468608236|FG000|Overall Study|Lost to Follow-up|1|||
130178130|NCT02556801|468608237|FG001|Overall Study|Lost to Follow-up|0|||
130178131|NCT02556801|468608238|FG002|Overall Study|Lost to Follow-up|2|||
130178132|NCT02556801|468608239|FG003|Overall Study|Lost to Follow-up|0|||
130178133|NCT02556801|468608236|FG000|Overall Study|Withdrawal by Subject|1|||
130178134|NCT02556801|468608237|FG001|Overall Study|Withdrawal by Subject|1|||
130178135|NCT02556801|468608238|FG002|Overall Study|Withdrawal by Subject|1|||
130178136|NCT02556801|468608239|FG003|Overall Study|Withdrawal by Subject|0|||
130178137|NCT02556801|468608236|FG000|Overall Study|Protocol Violation|0|||
130178138|NCT02556801|468608237|FG001|Overall Study|Protocol Violation|3|||
130178139|NCT02556801|468608238|FG002|Overall Study|Protocol Violation|1|||
130178140|NCT02556801|468608239|FG003|Overall Study|Protocol Violation|1|||
130178141|NCT02556801|468608236|FG000|Overall Study|Adverse Event|0|||
130178142|NCT02556801|468608237|FG001|Overall Study|Adverse Event|2|||
130178143|NCT02556801|468608238|FG002|Overall Study|Adverse Event|0|||
130178144|NCT02556801|468608239|FG003|Overall Study|Adverse Event|3|||
130178145|NCT02556801|468608236|FG000|Overall Study|Pregnancy|0|||
130178146|NCT02556801|468608237|FG001|Overall Study|Pregnancy|1|||
130178147|NCT02556801|468608238|FG002|Overall Study|Pregnancy|0|||
130178148|NCT02556801|468608239|FG003|Overall Study|Pregnancy|0|||
130178149|NCT02556801|468608236|FG000|Overall Study|Personal reasons patient|0|||
130178150|NCT02556801|468608237|FG001|Overall Study|Personal reasons patient|0|||
130178151|NCT02556801|468608238|FG002|Overall Study|Personal reasons patient|0|||
130178152|NCT02556801|468608239|FG003|Overall Study|Personal reasons patient|1|||
130178153|NCT02071225|468608240|FG000|Overall Study|Withdrawal of Consent|2|||
130178154|NCT02071225|468608240|FG000|Overall Study|Protocol Deviation|1|||
130178155|NCT02071225|468608240|FG000|Overall Study|Lost to Follow-up|2|||
130178156|NCT02071225|468608240|FG000|Overall Study|Death|25|||
130178157|NCT02064296|468608241|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
130178158|NCT02064296|468608242|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130178159|NCT02064296|468608243|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130178160|NCT02064296|468608241|FG000|Intervention|Withdrawal by Subject|0|||
130178161|NCT02064296|468608242|FG001|Intervention|Withdrawal by Subject|1|||
130178162|NCT02064296|468608243|FG002|Intervention|Withdrawal by Subject|2|||
130178163|NCT03519087|468608248|FG000|Clinic Evaluation|Physician Decision|15|||
130178164|NCT03519087|468608249|FG001|Clinic Evaluation|Physician Decision|18|||
130178165|NCT03519087|468608250|FG002|Clinic Evaluation|Physician Decision|0|||
130178166|NCT03519087|468608251|FG003|Clinic Evaluation|Physician Decision|0|||
130178167|NCT03519087|468608252|FG004|Clinic Evaluation|Physician Decision|0|||
130178168|NCT03519087|468608248|FG000|Clinic Evaluation|Protocol Violation|1|||
130178169|NCT03519087|468608249|FG001|Clinic Evaluation|Protocol Violation|0|||
130178170|NCT03519087|468608250|FG002|Clinic Evaluation|Protocol Violation|0|||
130178171|NCT03519087|468608251|FG003|Clinic Evaluation|Protocol Violation|0|||
130178172|NCT03519087|468608252|FG004|Clinic Evaluation|Protocol Violation|0|||
130178173|NCT03519087|468608248|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
130178174|NCT03519087|468608249|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
130178175|NCT03519087|468608250|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178176|NCT03519087|468608251|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178177|NCT03519087|468608252|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178178|NCT03519087|468608248|FG000|Re-randomization for Treatment|Not appropriate|2|||
130178179|NCT03519087|468608249|FG001|Re-randomization for Treatment|Not appropriate|3|||
130178180|NCT03519087|468608250|FG002|Re-randomization for Treatment|Not appropriate|0|||
130178181|NCT03519087|468608251|FG003|Re-randomization for Treatment|Not appropriate|0|||
130178182|NCT03519087|468608252|FG004|Re-randomization for Treatment|Not appropriate|0|||
130178183|NCT03519087|468608248|FG000|Laboratory Testing|Lost to Follow-up|0|||
130178184|NCT03519087|468608249|FG001|Laboratory Testing|Lost to Follow-up|0|||
130178185|NCT03519087|468608250|FG002|Laboratory Testing|Lost to Follow-up|2|||
130178186|NCT03519087|468608251|FG003|Laboratory Testing|Lost to Follow-up|3|||
130178187|NCT03519087|468608252|FG004|Laboratory Testing|Lost to Follow-up|6|||
130178188|NCT03519087|468608248|FG000|Laboratory Testing|Protocol Violation|0|||
130178189|NCT03519087|468608249|FG001|Laboratory Testing|Protocol Violation|0|||
130178190|NCT03519087|468608250|FG002|Laboratory Testing|Protocol Violation|0|||
130178191|NCT03519087|468608251|FG003|Laboratory Testing|Protocol Violation|1|||
130178192|NCT03519087|468608252|FG004|Laboratory Testing|Protocol Violation|0|||
130178193|NCT01137071|468608253|FG000|Overall Study|Disease Progression|11|||
130178194|NCT01137071|468608253|FG000|Overall Study|Withdrawal by Subject|2|||
130178195|NCT01137071|468608253|FG000|Overall Study|Wrongly Included|1|||
130178196|NCT02324582|468608254|FG000|Overall Study|Screen Failures|0|||
130178197|NCT02324582|468608255|FG001|Overall Study|Screen Failures|5|||
130178198|NCT04388553|468608258|FG000|Overall Study|Protocol Violation|1|||
130178199|NCT04388553|468608259|FG001|Overall Study|Protocol Violation|0|||
130178200|NCT02123446|468608260|FG000|Washout Period (1 Day)|Physician Decision|1|||
130178201|NCT02123446|468608261|FG001|Washout Period (1 Day)|Physician Decision|0|||
130178202|NCT04604795|468608262|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130178203|NCT04604795|468608263|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130178204|NCT04604795|468608264|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178205|NCT04604795|468608265|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178206|NCT04604795|468608266|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178207|NCT04604795|468608267|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178208|NCT04604795|468608268|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178209|NCT04604795|468608269|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178210|NCT04604795|468608270|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178211|NCT04604795|468608271|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178212|NCT04604795|468608262|FG000|Part B: Up to Day 14|Adverse Event|0|||
130178213|NCT04604795|468608263|FG001|Part B: Up to Day 14|Adverse Event|0|||
130178214|NCT04604795|468608264|FG002|Part B: Up to Day 14|Adverse Event|0|||
130178215|NCT04604795|468608265|FG003|Part B: Up to Day 14|Adverse Event|0|||
130178216|NCT04604795|468608266|FG004|Part B: Up to Day 14|Adverse Event|2|||
130178217|NCT04604795|468608267|FG005|Part B: Up to Day 14|Adverse Event|1|||
130178218|NCT04604795|468608268|FG006|Part B: Up to Day 14|Adverse Event|0|||
130178219|NCT04604795|468608269|FG007|Part B: Up to Day 14|Adverse Event|0|||
130178220|NCT04604795|468608270|FG008|Part B: Up to Day 14|Adverse Event|0|||
130178221|NCT04604795|468608271|FG009|Part B: Up to Day 14|Adverse Event|0|||
130178222|NCT04604795|468608262|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178223|NCT04604795|468608263|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178224|NCT04604795|468608264|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178225|NCT04604795|468608265|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178226|NCT04604795|468608266|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178227|NCT04604795|468608267|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178228|NCT04604795|468608268|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178229|NCT04604795|468608269|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178230|NCT04604795|468608270|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178231|NCT04604795|468608271|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
130178232|NCT04604795|468608262|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178233|NCT04604795|468608263|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178234|NCT04604795|468608264|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178235|NCT04604795|468608265|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178236|NCT04604795|468608266|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178237|NCT04604795|468608267|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178238|NCT04604795|468608268|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178239|NCT04604795|468608269|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178240|NCT04604795|468608270|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
130178241|NCT04604795|468608271|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178242|NCT04604795|468608262|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178243|NCT04604795|468608263|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178244|NCT04604795|468608264|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178245|NCT04604795|468608265|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178246|NCT04604795|468608266|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178247|NCT04604795|468608267|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178248|NCT04604795|468608268|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178249|NCT04604795|468608269|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178250|NCT04604795|468608270|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
130178251|NCT04604795|468608271|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178252|NCT04604795|468608262|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178253|NCT04604795|468608263|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178254|NCT04604795|468608264|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178255|NCT04604795|468608265|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178256|NCT04604795|468608266|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178257|NCT04604795|468608267|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178258|NCT04604795|468608268|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178259|NCT04604795|468608269|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178260|NCT04604795|468608270|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
130178261|NCT04604795|468608271|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178262|NCT04502212|468608277|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130178263|NCT04502212|468608277|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130178264|NCT00111241|468608282|FG000|Overall Study|Lost to Follow-up|1|||
130178265|NCT00111241|468608283|FG001|Overall Study|Lost to Follow-up|0|||
130178266|NCT00111241|468608282|FG000|Overall Study|Withdrawal by Subject|4|||
130178267|NCT00111241|468608283|FG001|Overall Study|Withdrawal by Subject|0|||
130178268|NCT00111241|468608282|FG000|Overall Study|Protocol Violation|9|||
130178269|NCT00111241|468608283|FG001|Overall Study|Protocol Violation|8|||
130178270|NCT00111241|468608282|FG000|Overall Study|Adverse Event|1|||
130178271|NCT00111241|468608283|FG001|Overall Study|Adverse Event|0|||
130178272|NCT02096744|468608284|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
130178273|NCT02096744|468608285|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
130178274|NCT02096744|468608284|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
130178275|NCT02096744|468608285|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
130178276|NCT02096744|468608284|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
130178277|NCT02096744|468608285|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
130178278|NCT00952731|468608291|FG000|Overall Study|Drug supply expired|1|||
130178279|NCT00952731|468608292|FG001|Overall Study|Drug supply expired|0|||
130178280|NCT02517463|468608294|FG000|Overall Study|Lost to Follow-up|5|||
130178281|NCT02517463|468608295|FG001|Overall Study|Lost to Follow-up|2|||
130178282|NCT03172494|468608300|FG000|Overall Study|Adverse Event|5|||
130178283|NCT03172494|468608301|FG001|Overall Study|Adverse Event|1|||
130178284|NCT03172494|468608302|FG002|Overall Study|Adverse Event|15|||
130178285|NCT03172494|468608300|FG000|Overall Study|Protocol Violation|3|||
130178286|NCT03172494|468608301|FG001|Overall Study|Protocol Violation|2|||
130178287|NCT03172494|468608302|FG002|Overall Study|Protocol Violation|1|||
130178288|NCT03172494|468608300|FG000|Overall Study|Lack of Efficacy|0|||
130178289|NCT03172494|468608301|FG001|Overall Study|Lack of Efficacy|0|||
130178290|NCT03172494|468608302|FG002|Overall Study|Lack of Efficacy|4|||
130178291|NCT03172494|468608300|FG000|Overall Study|Pregnancy|0|||
130178292|NCT03172494|468608301|FG001|Overall Study|Pregnancy|1|||
130178293|NCT03172494|468608302|FG002|Overall Study|Pregnancy|0|||
130178294|NCT03172494|468608300|FG000|Overall Study|Withdrawal by Subject|10|||
130178295|NCT03172494|468608301|FG001|Overall Study|Withdrawal by Subject|8|||
130178296|NCT03172494|468608302|FG002|Overall Study|Withdrawal by Subject|8|||
130178297|NCT03172494|468608300|FG000|Overall Study|Severe hypoglycaemic episode|0|||
130178298|NCT03172494|468608301|FG001|Overall Study|Severe hypoglycaemic episode|0|||
130178299|NCT03172494|468608302|FG002|Overall Study|Severe hypoglycaemic episode|1|||
130178300|NCT03172494|468608300|FG000|Overall Study|Non-compliance towards treatment|2|||
130178301|NCT03172494|468608301|FG001|Overall Study|Non-compliance towards treatment|0|||
130178302|NCT03172494|468608302|FG002|Overall Study|Non-compliance towards treatment|0|||
130178303|NCT02764151|468608303|FG000|Overall Study|Subject refused further follow-up|0|||
130178304|NCT02764151|468608304|FG001|Overall Study|Subject refused further follow-up|0|||
130178305|NCT02764151|468608305|FG002|Overall Study|Subject refused further follow-up|0|||
130178306|NCT02764151|468608306|FG003|Overall Study|Subject refused further follow-up|1|||
130178307|NCT02764151|468608303|FG000|Overall Study|Other|0|||
130178308|NCT02764151|468608304|FG001|Overall Study|Other|0|||
130178309|NCT02764151|468608305|FG002|Overall Study|Other|0|||
130178310|NCT02764151|468608306|FG003|Overall Study|Other|2|||
130178311|NCT00852202|468608307|FG000|Overall Study|Adverse Event|2|||
130178312|NCT00852202|468608308|FG001|Overall Study|Adverse Event|3|||
130178313|NCT00852202|468608309|FG002|Overall Study|Adverse Event|7|||
130178314|NCT00852202|468608307|FG000|Overall Study|Lack of Efficacy|4|||
130178315|NCT00852202|468608308|FG001|Overall Study|Lack of Efficacy|1|||
130178316|NCT00852202|468608309|FG002|Overall Study|Lack of Efficacy|2|||
130178317|NCT00852202|468608307|FG000|Overall Study|Protocol Violation|2|||
130178318|NCT00852202|468608308|FG001|Overall Study|Protocol Violation|2|||
130178319|NCT00852202|468608309|FG002|Overall Study|Protocol Violation|7|||
130178320|NCT00852202|468608307|FG000|Overall Study|Withdrawal by Subject|3|||
130178321|NCT00852202|468608308|FG001|Overall Study|Withdrawal by Subject|1|||
130178322|NCT00852202|468608309|FG002|Overall Study|Withdrawal by Subject|2|||
130178323|NCT00852202|468608307|FG000|Overall Study|Lost to Follow-up|5|||
130178324|NCT00852202|468608308|FG001|Overall Study|Lost to Follow-up|5|||
130178325|NCT00852202|468608309|FG002|Overall Study|Lost to Follow-up|6|||
130178326|NCT00852202|468608307|FG000|Overall Study|pregnancy,moving away and surgery|1|||
130178327|NCT00852202|468608308|FG001|Overall Study|pregnancy,moving away and surgery|0|||
130178328|NCT00852202|468608309|FG002|Overall Study|pregnancy,moving away and surgery|2|||
130178329|NCT05022212|468608312|FG000|Overall Study|Lost to Follow-up|0|||
130178330|NCT05022212|468608313|FG001|Overall Study|Lost to Follow-up|2|||
130178331|NCT02890355|468608314|FG000|Overall Study|Adverse Event|5|||
130178332|NCT02890355|468608315|FG001|Overall Study|Adverse Event|5|||
130178333|NCT02890355|468608314|FG000|Overall Study|Refusal unrelated to adverse event|5|||
130178334|NCT02890355|468608315|FG001|Overall Study|Refusal unrelated to adverse event|10|||
130178335|NCT02890355|468608314|FG000|Overall Study|Progression/relapse|46|||
130178336|NCT02890355|468608315|FG001|Overall Study|Progression/relapse|39|||
130178337|NCT02890355|468608314|FG000|Overall Study|Not protocol specified|3|||
130178338|NCT02890355|468608315|FG001|Overall Study|Not protocol specified|4|||
130178339|NCT02694328|468608316|FG000|Overall Study|Adverse Event|27|||
130178340|NCT02694328|468608317|FG001|Overall Study|Adverse Event|33|||
130178341|NCT02694328|468608316|FG000|Overall Study|Withdrawal by Subject|27|||
130178342|NCT02694328|468608317|FG001|Overall Study|Withdrawal by Subject|23|||
130178343|NCT02694328|468608316|FG000|Overall Study|Lost to Follow-up|26|||
130178344|NCT02694328|468608317|FG001|Overall Study|Lost to Follow-up|22|||
130178345|NCT02694328|468608316|FG000|Overall Study|Noncompliant with study drug|11|||
130178346|NCT02694328|468608317|FG001|Overall Study|Noncompliant with study drug|8|||
130178347|NCT02694328|468608316|FG000|Overall Study|Incarceration|1|||
130178348|NCT02694328|468608317|FG001|Overall Study|Incarceration|1|||
130178349|NCT02694328|468608316|FG000|Overall Study|Lack of Efficacy|1|||
130178350|NCT02694328|468608317|FG001|Overall Study|Lack of Efficacy|2|||
130178351|NCT02694328|468608316|FG000|Overall Study|Pregnancy|1|||
130178352|NCT02694328|468608317|FG001|Overall Study|Pregnancy|1|||
130178353|NCT02694328|468608316|FG000|Overall Study|Protocol Violation|6|||
130178354|NCT02694328|468608317|FG001|Overall Study|Protocol Violation|5|||
130178355|NCT02694328|468608316|FG000|Overall Study|Abnormal Laboratory Value|0|||
130178356|NCT02694328|468608317|FG001|Overall Study|Abnormal Laboratory Value|3|||
130178357|NCT01260701|468608318|FG000|Overall Study|Adverse Event|9|||
130178358|NCT01260701|468608318|FG000|Overall Study|Withdrawal by Subject|2|||
130178359|NCT01260701|468608318|FG000|Overall Study|Progression|53|||
130178360|NCT01260701|468608318|FG000|Overall Study|Death|2|||
130178361|NCT01260701|468608318|FG000|Overall Study|Not protocol specified|3|||
130178362|NCT01260701|468608318|FG000|Overall Study|Under review|1|||
130178363|NCT01260701|468608318|FG000|Overall Study|Ineligible|4|||
130178364|NCT01260701|468608318|FG000|Overall Study|Did not begin protocol therapy|1|||
130178365|NCT00720382|468608320|FG000|Overall Study|Adverse Event|54|||
130178366|NCT00720382|468608321|FG001|Overall Study|Adverse Event|17|||
130178367|NCT00720382|468608320|FG000|Overall Study|Lack of Efficacy|18|||
130178368|NCT00720382|468608321|FG001|Overall Study|Lack of Efficacy|7|||
130178369|NCT00720382|468608320|FG000|Overall Study|Non-Compliance|15|||
130178370|NCT00720382|468608321|FG001|Overall Study|Non-Compliance|5|||
130178371|NCT00720382|468608320|FG000|Overall Study|Withdrawal by Subject|47|||
130178372|NCT00720382|468608321|FG001|Overall Study|Withdrawal by Subject|11|||
130178373|NCT00720382|468608320|FG000|Overall Study|Lost to Follow-up|28|||
130178374|NCT00720382|468608321|FG001|Overall Study|Lost to Follow-up|14|||
130178375|NCT00720382|468608320|FG000|Overall Study|administrative|14|||
130178376|NCT00720382|468608321|FG001|Overall Study|administrative|5|||
130178377|NCT04205812|468609976|FG000|Randomized Treatment Period|Ongoing|28|||
130178378|NCT04205812|468609977|FG001|Randomized Treatment Period|Ongoing|138|||
130178379|NCT04205812|468609976|FG000|Randomized Treatment Period|Death|94|||
130178380|NCT04205812|468609977|FG001|Randomized Treatment Period|Death|226|||
130178381|NCT04205812|468609976|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
130178382|NCT04205812|468609977|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
130178383|NCT04205812|468609976|FG000|Randomized Treatment Period|Physician Decision|1|||
130178384|NCT04205812|468609977|FG001|Randomized Treatment Period|Physician Decision|4|||
130178385|NCT04205812|468609976|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
130178386|NCT04205812|468609977|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
130178387|NCT04205812|468609976|FG000|Randomized Treatment Period|Progressive Disease|0|||
130178388|NCT04205812|468609977|FG001|Randomized Treatment Period|Progressive Disease|1|||
130178389|NCT04205812|468609976|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
130178390|NCT04205812|468609977|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
130178391|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Ongoing|17|||
130178392|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Ongoing|0|||
130178393|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Death|39|||
130178394|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Death|0|||
130178395|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
130178396|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
130178397|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
130178398|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
130178399|NCT05221320|468609978|FG000|Overall Study|Lack of Efficacy|3|||
130178400|NCT05221320|468609979|FG001|Overall Study|Lack of Efficacy|7|||
130178401|NCT05221320|468609980|FG002|Overall Study|Lack of Efficacy|10|||
130178402|NCT05221320|468609981|FG003|Overall Study|Lack of Efficacy|1|||
130178403|NCT05221320|468609982|FG004|Overall Study|Lack of Efficacy|0|||
130178404|NCT05221320|468609983|FG005|Overall Study|Lack of Efficacy|0|||
130178405|NCT05221320|468609978|FG000|Overall Study|Physician Decision|1|||
130178406|NCT05221320|468609979|FG001|Overall Study|Physician Decision|0|||
130178407|NCT05221320|468609980|FG002|Overall Study|Physician Decision|3|||
130178408|NCT05221320|468609981|FG003|Overall Study|Physician Decision|1|||
130178409|NCT05221320|468609982|FG004|Overall Study|Physician Decision|0|||
130178410|NCT05221320|468609983|FG005|Overall Study|Physician Decision|0|||
130651540|NCT02706327|470346288|FG002|Overall Study|Lost to Follow-up|2|||
130178411|NCT05221320|468609978|FG000|Overall Study|Withdrawal by Subject|0|||
130178412|NCT05221320|468609979|FG001|Overall Study|Withdrawal by Subject|3|||
130178413|NCT05221320|468609980|FG002|Overall Study|Withdrawal by Subject|1|||
130178414|NCT05221320|468609981|FG003|Overall Study|Withdrawal by Subject|0|||
130178415|NCT05221320|468609982|FG004|Overall Study|Withdrawal by Subject|0|||
130178416|NCT05221320|468609983|FG005|Overall Study|Withdrawal by Subject|0|||
130178417|NCT05221320|468609978|FG000|Overall Study|Death|0|||
130178418|NCT05221320|468609979|FG001|Overall Study|Death|5|||
130178419|NCT05221320|468609980|FG002|Overall Study|Death|6|||
130178420|NCT05221320|468609981|FG003|Overall Study|Death|0|||
130178421|NCT05221320|468609982|FG004|Overall Study|Death|1|||
130178422|NCT05221320|468609983|FG005|Overall Study|Death|0|||
130178423|NCT06473519|468609984|FG000|Overall Study|Lost to Follow-up|2|||
130178424|NCT06473519|468609985|FG001|Overall Study|Lost to Follow-up|5|||
130178425|NCT06473519|468609984|FG000|Overall Study|Withdrawal by Subject|1|||
130178426|NCT06473519|468609985|FG001|Overall Study|Withdrawal by Subject|4|||
130178427|NCT06473519|468609984|FG000|Overall Study|Randomized but not vaccinated|1|||
130178428|NCT06473519|468609985|FG001|Overall Study|Randomized but not vaccinated|2|||
130178429|NCT02514447|468609987|FG000|Overall Study|Withdrawal by Subject|3|||
130178430|NCT02514447|468609988|FG001|Overall Study|Withdrawal by Subject|1|||
130178431|NCT02514447|468609989|FG002|Overall Study|Withdrawal by Subject|1|||
130178432|NCT02514447|468609990|FG003|Overall Study|Withdrawal by Subject|0|||
130178433|NCT02514447|468609991|FG004|Overall Study|Withdrawal by Subject|0|||
130178434|NCT02514447|468609992|FG005|Overall Study|Withdrawal by Subject|0|||
130178435|NCT02514447|468609993|FG006|Overall Study|Withdrawal by Subject|0|||
130178436|NCT02514447|468609994|FG007|Overall Study|Withdrawal by Subject|1|||
130178437|NCT02514447|468609995|FG008|Overall Study|Withdrawal by Subject|1|||
130178438|NCT02514447|468609987|FG000|Overall Study|Death|24|||
130178439|NCT02514447|468609988|FG001|Overall Study|Death|28|||
130178440|NCT02514447|468609989|FG002|Overall Study|Death|29|||
130178441|NCT02514447|468609990|FG003|Overall Study|Death|0|||
130178442|NCT02514447|468609991|FG004|Overall Study|Death|3|||
130178443|NCT02514447|468609992|FG005|Overall Study|Death|4|||
130178444|NCT02514447|468609993|FG006|Overall Study|Death|8|||
130178445|NCT02514447|468609994|FG007|Overall Study|Death|6|||
130178446|NCT02514447|468609995|FG008|Overall Study|Death|5|||
130178447|NCT02514447|468609987|FG000|Overall Study|Lost to Follow-up|1|||
130178448|NCT02514447|468609988|FG001|Overall Study|Lost to Follow-up|0|||
130178449|NCT02514447|468609989|FG002|Overall Study|Lost to Follow-up|0|||
130178450|NCT02514447|468609990|FG003|Overall Study|Lost to Follow-up|0|||
130178451|NCT02514447|468609991|FG004|Overall Study|Lost to Follow-up|0|||
130178452|NCT02514447|468609992|FG005|Overall Study|Lost to Follow-up|0|||
130178453|NCT02514447|468609993|FG006|Overall Study|Lost to Follow-up|0|||
130178454|NCT02514447|468609994|FG007|Overall Study|Lost to Follow-up|0|||
130178455|NCT02514447|468609995|FG008|Overall Study|Lost to Follow-up|1|||
130178456|NCT02514447|468609987|FG000|Overall Study|Sponsor Termination of Study|0|||
130178457|NCT02514447|468609988|FG001|Overall Study|Sponsor Termination of Study|1|||
130178458|NCT02514447|468609989|FG002|Overall Study|Sponsor Termination of Study|1|||
130178459|NCT02514447|468609990|FG003|Overall Study|Sponsor Termination of Study|0|||
130178460|NCT02514447|468609991|FG004|Overall Study|Sponsor Termination of Study|0|||
130178461|NCT02514447|468609992|FG005|Overall Study|Sponsor Termination of Study|0|||
130178462|NCT02514447|468609993|FG006|Overall Study|Sponsor Termination of Study|0|||
130178463|NCT02514447|468609994|FG007|Overall Study|Sponsor Termination of Study|0|||
130178464|NCT02514447|468609995|FG008|Overall Study|Sponsor Termination of Study|0|||
130178465|NCT02514447|468609987|FG000|Overall Study|Study completion per Investigator|1|||
130178466|NCT02514447|468609988|FG001|Overall Study|Study completion per Investigator|0|||
130178467|NCT02514447|468609989|FG002|Overall Study|Study completion per Investigator|1|||
130178468|NCT02514447|468609990|FG003|Overall Study|Study completion per Investigator|2|||
130178469|NCT02514447|468609991|FG004|Overall Study|Study completion per Investigator|0|||
130178470|NCT02514447|468609992|FG005|Overall Study|Study completion per Investigator|0|||
130178471|NCT02514447|468609993|FG006|Overall Study|Study completion per Investigator|0|||
130178472|NCT02514447|468609994|FG007|Overall Study|Study completion per Investigator|0|||
130178473|NCT02514447|468609995|FG008|Overall Study|Study completion per Investigator|1|||
130178474|NCT05626231|468609996|FG000|Provider Enrollment|Worked part-time|4|||
130178475|NCT05626231|468609996|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
130178476|NCT05626231|468609996|FG000|Provider Enrollment|Non-clinical employee|1|||
130178477|NCT05626231|468609996|FG000|Provider Enrollment|Provider does not see clients|3|||
130178478|NCT05626231|468609996|FG000|Provider Enrollment|Other|5|||
130178479|NCT02653625|468609997|FG000|Overall Study|Adverse Event|1|||
130178480|NCT02653625|468609997|FG000|Overall Study|Non-compliance with Study Drug|1|||
130178481|NCT02653625|468609997|FG000|Overall Study|Protocol Violation|1|||
130178482|NCT02653625|468609997|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
130178483|NCT05377749|468610000|FG000|3 Weeks|Lost to Follow-up|2|||
130178484|NCT05377749|468610001|FG001|3 Weeks|Lost to Follow-up|4|||
130178485|NCT05377749|468610000|FG000|3 Weeks|Withdrawal by Subject|1|||
130178486|NCT05377749|468610001|FG001|3 Weeks|Withdrawal by Subject|1|||
130178487|NCT02762929|468610002|FG000|Overall Study|Adverse Event|0|||
130178488|NCT02762929|468610003|FG001|Overall Study|Adverse Event|0|||
130178489|NCT02762929|468610004|FG002|Overall Study|Adverse Event|0|||
130178490|NCT02762929|468610005|FG003|Overall Study|Adverse Event|1|||
130178491|NCT02762929|468610006|FG004|Overall Study|Adverse Event|0|||
130178492|NCT02762929|468610007|FG005|Overall Study|Adverse Event|0|||
130178493|NCT02762929|468610002|FG000|Overall Study|Lost to Follow-up|1|||
130178494|NCT02762929|468610003|FG001|Overall Study|Lost to Follow-up|2|||
130178495|NCT02762929|468610004|FG002|Overall Study|Lost to Follow-up|0|||
130178496|NCT02762929|468610005|FG003|Overall Study|Lost to Follow-up|1|||
130178497|NCT02762929|468610006|FG004|Overall Study|Lost to Follow-up|0|||
130178498|NCT02762929|468610007|FG005|Overall Study|Lost to Follow-up|0|||
130178499|NCT02762929|468610002|FG000|Overall Study|Withdrawal by Subject|0|||
130178500|NCT02762929|468610003|FG001|Overall Study|Withdrawal by Subject|1|||
130178501|NCT02762929|468610004|FG002|Overall Study|Withdrawal by Subject|0|||
130178502|NCT02762929|468610005|FG003|Overall Study|Withdrawal by Subject|0|||
130178503|NCT02762929|468610006|FG004|Overall Study|Withdrawal by Subject|0|||
130178504|NCT02762929|468610007|FG005|Overall Study|Withdrawal by Subject|0|||
130178505|NCT02762929|468610002|FG000|Overall Study|exclusionary medication disclosed late|0|||
130178506|NCT02762929|468610003|FG001|Overall Study|exclusionary medication disclosed late|0|||
130178507|NCT02762929|468610004|FG002|Overall Study|exclusionary medication disclosed late|0|||
130178508|NCT02762929|468610005|FG003|Overall Study|exclusionary medication disclosed late|1|||
130178509|NCT02762929|468610006|FG004|Overall Study|exclusionary medication disclosed late|0|||
130178510|NCT02762929|468610007|FG005|Overall Study|exclusionary medication disclosed late|0|||
130178511|NCT04123405|468610013|FG000|Overall Study|Adverse Event|1|||
130178512|NCT04123405|468610014|FG001|Overall Study|Adverse Event|2|||
130178513|NCT04123405|468610015|FG002|Overall Study|Adverse Event|3|||
130178514|NCT04123405|468610016|FG003|Overall Study|Adverse Event|3|||
130178515|NCT04123405|468610013|FG000|Overall Study|Exclusion criteria met|1|||
130178516|NCT04123405|468610014|FG001|Overall Study|Exclusion criteria met|2|||
130178517|NCT04123405|468610015|FG002|Overall Study|Exclusion criteria met|0|||
130178518|NCT04123405|468610016|FG003|Overall Study|Exclusion criteria met|2|||
130178519|NCT04123405|468610013|FG000|Overall Study|Withdrawal by Subject|1|||
130178520|NCT04123405|468610014|FG001|Overall Study|Withdrawal by Subject|3|||
130178521|NCT04123405|468610015|FG002|Overall Study|Withdrawal by Subject|0|||
130178522|NCT04123405|468610016|FG003|Overall Study|Withdrawal by Subject|2|||
130178523|NCT04123405|468610013|FG000|Overall Study|Contact to subject lost|0|||
130178524|NCT04123405|468610014|FG001|Overall Study|Contact to subject lost|0|||
130178525|NCT04123405|468610015|FG002|Overall Study|Contact to subject lost|0|||
130178526|NCT04123405|468610016|FG003|Overall Study|Contact to subject lost|1|||
130178527|NCT04123405|468610013|FG000|Overall Study|screening failure|1|||
130178528|NCT04123405|468610014|FG001|Overall Study|screening failure|0|||
130178529|NCT04123405|468610015|FG002|Overall Study|screening failure|0|||
130178530|NCT04123405|468610016|FG003|Overall Study|screening failure|0|||
130178531|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Adverse Event|2|||
130178532|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Adverse Event|1|||
130178533|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
130178534|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
130178535|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Physician Decision|0|||
130178536|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Physician Decision|4|||
130178537|NCT01026194|468610017|FG000|Period 2：Open-label Period|Adverse Event|4|||
130178538|NCT01026194|468610018|FG001|Period 2：Open-label Period|Adverse Event|5|||
130178539|NCT01026194|468610017|FG000|Period 2：Open-label Period|Physician Decision|3|||
130178540|NCT01026194|468610018|FG001|Period 2：Open-label Period|Physician Decision|1|||
130178541|NCT01026194|468610017|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
130178542|NCT01026194|468610018|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
130178543|NCT01750190|468610019|FG000|Overall Study|Adverse Event|47|||
130178544|NCT01750190|468610020|FG001|Overall Study|Adverse Event|19|||
130178545|NCT01750190|468610019|FG000|Overall Study|Death|38|||
130178546|NCT01750190|468610020|FG001|Overall Study|Death|11|||
130178547|NCT01750190|468610019|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
130178548|NCT01750190|468610020|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
130178549|NCT01750190|468610019|FG000|Overall Study|Lost to Follow-up|28|||
130178550|NCT01750190|468610020|FG001|Overall Study|Lost to Follow-up|7|||
130178551|NCT01750190|468610019|FG000|Overall Study|Physician Decision|16|||
130178552|NCT01750190|468610020|FG001|Overall Study|Physician Decision|17|||
130178553|NCT01750190|468610019|FG000|Overall Study|Protocol Violation|6|||
130178554|NCT01750190|468610020|FG001|Overall Study|Protocol Violation|5|||
130178555|NCT01750190|468610019|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
130178556|NCT01750190|468610020|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
130178557|NCT01750190|468610019|FG000|Overall Study|Withdrawal by Subject|83|||
130178558|NCT01750190|468610020|FG001|Overall Study|Withdrawal by Subject|89|||
130178559|NCT01750190|468610019|FG000|Overall Study|Kidney Transplant|8|||
130178560|NCT01750190|468610020|FG001|Overall Study|Kidney Transplant|4|||
130178561|NCT01750190|468610019|FG000|Overall Study|Dialysis|22|||
130178562|NCT01750190|468610020|FG001|Overall Study|Dialysis|8|||
130178563|NCT01750190|468610019|FG000|Overall Study|Other than Specified|13|||
130178564|NCT01750190|468610020|FG001|Overall Study|Other than Specified|4|||
130178565|NCT03934541|468610032|FG000|Overall Study|Study Terminated by Sponsor|0|||
130178566|NCT03934541|468610033|FG001|Overall Study|Study Terminated by Sponsor|1|||
130178567|NCT03934541|468610034|FG002|Overall Study|Study Terminated by Sponsor|0|||
130178568|NCT03934541|468610035|FG003|Overall Study|Study Terminated by Sponsor|0|||
130178569|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
130178570|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
130178571|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
130178572|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
130178573|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
130178574|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
130178575|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130178576|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130178577|NCT02441686|468610038|FG000|Induction|Adverse Event|4|||
130178578|NCT02441686|468610038|FG000|Induction|Complicating disease|1|||
130178579|NCT02441686|468610038|FG000|Induction|Physician Decision|1|||
130178580|NCT02441686|468610038|FG000|Induction|Withdrawal by Subject|1|||
130178581|NCT02441686|468610038|FG000|Induction|Did not receive treatment|1|||
130178582|NCT02441686|468610038|FG000|Maintenance|Remaining on Treatment|23|||
130178583|NCT02441686|468610038|FG000|Maintenance|Physician Decision|1|||
130178584|NCT02441686|468610038|FG000|Maintenance|Adverse Event|3|||
130178585|NCT02441686|468610038|FG000|Maintenance|Progressive Disease|10|||
130178586|NCT02441686|468610038|FG000|Maintenance|Withdrawal by Subject|1|||
130178587|NCT03151304|468610039|FG000|Overall Study|Termination of study by Sponsor|23|||
130178588|NCT03151304|468610039|FG000|Overall Study|missing|3|||
130178589|NCT03151304|468610039|FG000|Overall Study|Withdrawal by Subject|8|||
130178590|NCT03151304|468610039|FG000|Overall Study|multiple reasons|30|||
130178591|NCT04194645|468610042|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178592|NCT04194645|468610043|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178593|NCT04194645|468610044|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178594|NCT04194645|468610045|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178595|NCT04194645|468610046|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178596|NCT04194645|468610047|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178597|NCT04194645|468610048|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178598|NCT04194645|468610049|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178599|NCT04194645|468610050|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178600|NCT04194645|468610051|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
130178601|NCT04194645|468610052|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178602|NCT04194645|468610053|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178603|NCT04194645|468610054|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178604|NCT04194645|468610055|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178605|NCT04194645|468610056|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178606|NCT03076775|468610057|FG000|Overall Study|Lost to Follow-up|1|||
130178607|NCT03076775|468610058|FG001|Overall Study|Lost to Follow-up|0|||
130178608|NCT01783886|468610059|FG000|Overall Study|Lost to Follow-up|0|||
130178609|NCT01783886|468610060|FG001|Overall Study|Lost to Follow-up|3|||
130178610|NCT01783886|468610061|FG002|Overall Study|Lost to Follow-up|0|||
130178611|NCT01783886|468610059|FG000|Overall Study|Protocol deviation|0|||
130178612|NCT01783886|468610060|FG001|Overall Study|Protocol deviation|0|||
130178613|NCT01783886|468610061|FG002|Overall Study|Protocol deviation|2|||
130178614|NCT01783886|468610059|FG000|Overall Study|Withdrawal of consent by participant|1|||
130178615|NCT01783886|468610060|FG001|Overall Study|Withdrawal of consent by participant|3|||
130178616|NCT01783886|468610061|FG002|Overall Study|Withdrawal of consent by participant|4|||
130178617|NCT01783886|468610059|FG000|Overall Study|Adverse Event|4|||
130178618|NCT01783886|468610060|FG001|Overall Study|Adverse Event|5|||
130178619|NCT01783886|468610061|FG002|Overall Study|Adverse Event|4|||
130178620|NCT04542057|468610062|FG000|Overall Study|Death|3|||
130178621|NCT04542057|468610063|FG001|Overall Study|Death|1|||
130178622|NCT04542057|468610062|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
130178623|NCT04542057|468610063|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
130178624|NCT04542057|468610062|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
130178625|NCT04542057|468610063|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130178626|NCT04542057|468610062|FG000|Overall Study|Adverse Event|15|||
130178627|NCT04542057|468610063|FG001|Overall Study|Adverse Event|6|||
130178628|NCT04542057|468610062|FG000|Overall Study|COVID-19 adverse event|6|||
130178629|NCT04542057|468610063|FG001|Overall Study|COVID-19 adverse event|4|||
130178630|NCT04542057|468610062|FG000|Overall Study|Lack of Efficacy|2|||
130178631|NCT04542057|468610063|FG001|Overall Study|Lack of Efficacy|5|||
130178632|NCT04542057|468610062|FG000|Overall Study|Study terminated by sponsor|1|||
130178633|NCT04542057|468610063|FG001|Overall Study|Study terminated by sponsor|0|||
130178634|NCT04542057|468610062|FG000|Overall Study|Investigator discretion|2|||
130178635|NCT04542057|468610063|FG001|Overall Study|Investigator discretion|1|||
130178636|NCT04542057|468610062|FG000|Overall Study|Withdrawal by Subject|52|||
130178637|NCT04542057|468610063|FG001|Overall Study|Withdrawal by Subject|30|||
130178638|NCT04542057|468610062|FG000|Overall Study|Lost to Follow-up|8|||
130178639|NCT04542057|468610063|FG001|Overall Study|Lost to Follow-up|11|||
130178640|NCT04542057|468610062|FG000|Overall Study|Other|2|||
130178641|NCT04542057|468610063|FG001|Overall Study|Other|2|||
130178642|NCT00104572|468610064|FG000|Overall Study|Withdrawal by Subject|3|||
130178643|NCT00104572|468610065|FG001|Overall Study|Withdrawal by Subject|3|||
130178644|NCT00104572|468610066|FG002|Overall Study|Withdrawal by Subject|0|||
130178645|NCT00940316|468610069|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
130178646|NCT00940316|468610070|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
130178647|NCT00940316|468610071|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
130178648|NCT00940316|468610069|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
130178649|NCT00940316|468610070|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
130178650|NCT00940316|468610071|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
130178651|NCT00940316|468610069|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
130178652|NCT00940316|468610070|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
130178653|NCT00940316|468610071|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
130178654|NCT00940316|468610069|FG000|Treated After Cycle 5|Adverse Event|0|||
130178655|NCT00940316|468610070|FG001|Treated After Cycle 5|Adverse Event|0|||
130178656|NCT00940316|468610071|FG002|Treated After Cycle 5|Adverse Event|1|||
130178657|NCT00940316|468610069|FG000|Treated After Cycle 5|Progressive disease|0|||
130178658|NCT00940316|468610070|FG001|Treated After Cycle 5|Progressive disease|1|||
130178659|NCT00940316|468610071|FG002|Treated After Cycle 5|Progressive disease|0|||
130178660|NCT02290405|468610075|FG000|Overall Study|Withdrawal by Subject|1|||
130178661|NCT02290405|468610076|FG001|Overall Study|Withdrawal by Subject|0|||
130178662|NCT02016183|468610077|FG000|Overall Study|Case Report Forms Uncollected|13|||
130178663|NCT02016183|468610077|FG000|Overall Study|Protocol Violation|52|||
130178664|NCT00996489|468610078|FG000|Overall Study|Device failure|45|||
130178665|NCT00996489|468610078|FG000|Overall Study|Discontinued|116|||
130178666|NCT03142191|468610079|FG000|Placebo Controlled Period|Death|0|||
130178667|NCT03142191|468610080|FG001|Placebo Controlled Period|Death|1|||
130178668|NCT03142191|468610081|FG002|Placebo Controlled Period|Death|1|||
130178669|NCT03142191|468610082|FG003|Placebo Controlled Period|Death|0|||
130178670|NCT03142191|468610083|FG004|Placebo Controlled Period|Death|0|||
130178671|NCT03142191|468610079|FG000|Placebo Controlled Period|Adverse Event|4|||
130178672|NCT03142191|468610080|FG001|Placebo Controlled Period|Adverse Event|5|||
130178673|NCT03142191|468610081|FG002|Placebo Controlled Period|Adverse Event|1|||
130178674|NCT03142191|468610082|FG003|Placebo Controlled Period|Adverse Event|0|||
130178675|NCT03142191|468610083|FG004|Placebo Controlled Period|Adverse Event|0|||
130178676|NCT03142191|468610079|FG000|Placebo Controlled Period|Progressive Disease|1|||
130178677|NCT03142191|468610080|FG001|Placebo Controlled Period|Progressive Disease|0|||
130178678|NCT03142191|468610081|FG002|Placebo Controlled Period|Progressive Disease|1|||
130178679|NCT03142191|468610082|FG003|Placebo Controlled Period|Progressive Disease|0|||
130178680|NCT03142191|468610083|FG004|Placebo Controlled Period|Progressive Disease|0|||
130178681|NCT03142191|468610079|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
130178682|NCT03142191|468610080|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
130178683|NCT03142191|468610081|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
130178684|NCT03142191|468610082|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
130178685|NCT03142191|468610083|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
130178686|NCT03142191|468610079|FG000|Placebo Controlled Period|Other Reasons|1|||
130178687|NCT03142191|468610080|FG001|Placebo Controlled Period|Other Reasons|0|||
130178688|NCT03142191|468610081|FG002|Placebo Controlled Period|Other Reasons|0|||
130178689|NCT03142191|468610082|FG003|Placebo Controlled Period|Other Reasons|0|||
130178690|NCT03142191|468610083|FG004|Placebo Controlled Period|Other Reasons|0|||
130178691|NCT03142191|468610079|FG000|Active Treatment Extension Period|Death|2|||
130178692|NCT03142191|468610080|FG001|Active Treatment Extension Period|Death|1|||
130178693|NCT03142191|468610081|FG002|Active Treatment Extension Period|Death|1|||
130178694|NCT03142191|468610082|FG003|Active Treatment Extension Period|Death|1|||
130178695|NCT03142191|468610083|FG004|Active Treatment Extension Period|Death|0|||
130178696|NCT03142191|468610079|FG000|Active Treatment Extension Period|Adverse Event|6|||
130178697|NCT03142191|468610080|FG001|Active Treatment Extension Period|Adverse Event|5|||
130178698|NCT03142191|468610081|FG002|Active Treatment Extension Period|Adverse Event|4|||
130178699|NCT03142191|468610082|FG003|Active Treatment Extension Period|Adverse Event|1|||
130178700|NCT03142191|468610083|FG004|Active Treatment Extension Period|Adverse Event|0|||
130178701|NCT03142191|468610079|FG000|Active Treatment Extension Period|Progressive Disease|10|||
130178702|NCT03142191|468610080|FG001|Active Treatment Extension Period|Progressive Disease|5|||
130178703|NCT03142191|468610081|FG002|Active Treatment Extension Period|Progressive Disease|4|||
130178704|NCT03142191|468610082|FG003|Active Treatment Extension Period|Progressive Disease|1|||
130178705|NCT03142191|468610083|FG004|Active Treatment Extension Period|Progressive Disease|2|||
130178706|NCT03142191|468610079|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
130178707|NCT03142191|468610080|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
130178708|NCT03142191|468610081|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
130178709|NCT03142191|468610082|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
130178710|NCT03142191|468610083|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
130178711|NCT03142191|468610079|FG000|Active Treatment Extension Period|Physician Decision|2|||
130178712|NCT03142191|468610080|FG001|Active Treatment Extension Period|Physician Decision|0|||
130178713|NCT03142191|468610081|FG002|Active Treatment Extension Period|Physician Decision|0|||
130178714|NCT03142191|468610082|FG003|Active Treatment Extension Period|Physician Decision|0|||
130178715|NCT03142191|468610083|FG004|Active Treatment Extension Period|Physician Decision|0|||
130178716|NCT03142191|468610079|FG000|Active Treatment Extension Period|Other Reasons|3|||
130178717|NCT03142191|468610080|FG001|Active Treatment Extension Period|Other Reasons|3|||
130178718|NCT03142191|468610081|FG002|Active Treatment Extension Period|Other Reasons|3|||
130178719|NCT03142191|468610082|FG003|Active Treatment Extension Period|Other Reasons|8|||
130178720|NCT03142191|468610083|FG004|Active Treatment Extension Period|Other Reasons|3|||
130178721|NCT03142191|468610079|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
130178722|NCT03142191|468610080|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
130178723|NCT03142191|468610081|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
130178724|NCT03142191|468610082|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
130178725|NCT03142191|468610083|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
130178726|NCT00770328|468610086|FG000|Overall Study|Adverse Event|11|||
130178727|NCT00770328|468610087|FG001|Overall Study|Adverse Event|2|||
130178728|NCT00770328|468610086|FG000|Overall Study|Lost to Follow-up|2|||
130178729|NCT00770328|468610087|FG001|Overall Study|Lost to Follow-up|2|||
130178730|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
130178731|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
130178732|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
130178733|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
130178734|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
130178735|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
130178736|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
130178737|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
130178738|NCT03452943|468610088|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
130178739|NCT03452943|468610089|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
130178740|NCT03452943|468610088|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
130178741|NCT03452943|468610089|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
130178742|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
130178743|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130178744|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130178745|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
130178746|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130178747|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130178748|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
130178749|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130178750|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130178751|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
130178752|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130178753|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130178754|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
130178755|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130178756|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130178757|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130178758|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
130178759|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130178760|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130178761|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
130178762|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130178763|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
130651541|NCT03471507|470346289|FG000|Overall Study|Lost to Follow-up|1|||
130651542|NCT03471507|470346290|FG001|Overall Study|Lost to Follow-up|3|||
130651543|NCT03471507|470346289|FG000|Overall Study|Physician Decision|0|||
130651544|NCT03471507|470346290|FG001|Overall Study|Physician Decision|1|||
130651545|NCT03471507|470346289|FG000|Overall Study|Withdrawal by Subject|2|||
130651546|NCT03471507|470346290|FG001|Overall Study|Withdrawal by Subject|1|||
130651547|NCT02213666|470346291|FG000|Overall Study|Withdrawal by Subject|1|||
130651548|NCT03246152|470346295|FG000|Overall Study|Lost to Follow-up|2|||
130651549|NCT03246152|470346295|FG000|Overall Study|Protocol Violation|1|||
130651550|NCT01374516|470346296|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
130651551|NCT01374516|470346297|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
130651552|NCT01374516|470346296|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
130651553|NCT01374516|470346297|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
130651554|NCT01374516|470346296|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
130651555|NCT01374516|470346297|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
130651556|NCT01374516|470346296|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
130651557|NCT01374516|470346297|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
130651558|NCT01374516|470346296|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
130651559|NCT01374516|470346297|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
130651560|NCT01374516|470346296|FG000|Surveillance Expansion Period|Protocol Violation|386|||
130651561|NCT01374516|470346297|FG001|Surveillance Expansion Period|Protocol Violation|217|||
130651562|NCT01374516|470346296|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
130651563|NCT01374516|470346297|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
130651564|NCT01374516|470346296|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
130651565|NCT01374516|470346297|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
130651566|NCT01374516|470346296|FG000|Surveillance Expansion Period|Serious adverse event|20|||
130651567|NCT01374516|470346297|FG001|Surveillance Expansion Period|Serious adverse event|5|||
130651568|NCT03219372|470346298|FG000|Overall Study|Withdrawal by Subject|1|||
130651569|NCT03219372|470346299|FG001|Overall Study|Withdrawal by Subject|0|||
130651570|NCT00814502|470346303|FG000|Overall Study|Adverse Event|1|||
130178764|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
130178765|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
130178766|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130178767|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130178768|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
130178769|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130178770|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130178771|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
130178772|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130178773|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130178774|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
130178775|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130178776|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130178777|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
130178778|NCT01130493|468610090|FG000|Part 2: OLE|Adverse Event|0|||
130178779|NCT01130493|468610091|FG001|Part 2: OLE|Adverse Event|2|||
130178780|NCT01130493|468610092|FG002|Part 2: OLE|Adverse Event|1|||
130178781|NCT01130493|468610090|FG000|Part 2: OLE|Withdrawal by Subject|0|||
130178782|NCT01130493|468610091|FG001|Part 2: OLE|Withdrawal by Subject|1|||
130178783|NCT01130493|468610092|FG002|Part 2: OLE|Withdrawal by Subject|4|||
130178784|NCT03541317|468610093|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
130178785|NCT03541317|468610094|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178786|NCT03541317|468610095|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178787|NCT03541317|468610096|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178788|NCT03541317|468610097|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178789|NCT03541317|468610098|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178790|NCT02286843|468610099|FG000|Overall Study|Not Treated|4|||
130178791|NCT02286843|468610099|FG000|Overall Study|Protocol Violation|1|||
130178792|NCT02286843|468610099|FG000|Overall Study|Withdrawal by Subject|1|||
130178793|NCT02536846|468610100|FG000|Overall Study|Withdrawal by Subject|1|||
130178794|NCT02593110|468610101|FG000|Overall Study|Withdrawal by Subject|0|||
130178795|NCT02593110|468610102|FG001|Overall Study|Withdrawal by Subject|3|||
130178796|NCT02593110|468610103|FG002|Overall Study|Withdrawal by Subject|3|||
130178797|NCT02593110|468610104|FG003|Overall Study|Withdrawal by Subject|2|||
130178798|NCT02593110|468610101|FG000|Overall Study|Death|0|||
130178799|NCT02593110|468610102|FG001|Overall Study|Death|0|||
130178800|NCT02593110|468610103|FG002|Overall Study|Death|1|||
130178801|NCT02593110|468610104|FG003|Overall Study|Death|0|||
130178802|NCT03086551|468610105|FG000|First Intervention|Failure to meet inclusion criterion|1|||
130178803|NCT03086551|468610106|FG001|First Intervention|Failure to meet inclusion criterion|0|||
130178804|NCT03086551|468610105|FG000|First Intervention|Lost to Follow-up|0|||
130178805|NCT03086551|468610106|FG001|First Intervention|Lost to Follow-up|1|||
130178806|NCT03086551|468610105|FG000|Washout|Lost to Follow-up|1|||
130178807|NCT03086551|468610106|FG001|Washout|Lost to Follow-up|2|||
130178808|NCT03086551|468610105|FG000|Washout|Withdrawal by Subject|2|||
130178809|NCT03086551|468610106|FG001|Washout|Withdrawal by Subject|1|||
130178810|NCT00625872|468610109|FG000|Overall Study|Withdrawal by Subject|1|||
130178811|NCT00625872|468610110|FG001|Overall Study|Withdrawal by Subject|0|||
130178812|NCT00625872|468610109|FG000|Overall Study|Does not meet inclusion criteria|1|||
130178813|NCT00625872|468610110|FG001|Overall Study|Does not meet inclusion criteria|0|||
130178814|NCT00625872|468610109|FG000|Overall Study|Terminated by sponsor|2|||
130178815|NCT00625872|468610110|FG001|Overall Study|Terminated by sponsor|5|||
130178816|NCT00625872|468610109|FG000|Overall Study|Randomized but not treated|0|||
130178817|NCT00625872|468610110|FG001|Overall Study|Randomized but not treated|1|||
130178818|NCT04208750|468610111|FG000|Overall Study|Lost to Follow-up|16|||
130178819|NCT04208750|468610112|FG001|Overall Study|Lost to Follow-up|15|||
130178820|NCT02201277|468610113|FG000|Overall Study|Death|3|||
130178821|NCT02201277|468610114|FG001|Overall Study|Death|4|||
130178822|NCT02201277|468610113|FG000|Overall Study|Lost to Follow-up|2|||
130178823|NCT02201277|468610114|FG001|Overall Study|Lost to Follow-up|1|||
130178824|NCT02201277|468610113|FG000|Overall Study|Failed retrieval|1|||
130178825|NCT02201277|468610114|FG001|Overall Study|Failed retrieval|0|||
130178826|NCT02201277|468610113|FG000|Overall Study|Physician Decision|1|||
130178827|NCT02201277|468610114|FG001|Overall Study|Physician Decision|0|||
130178828|NCT03485352|468610115|FG000|Overall Study|Lost to Follow-up|9|||
130178829|NCT01512160|468610116|FG000|Overall Study|Lost to Follow-up|1|||
130178830|NCT01512160|468610117|FG001|Overall Study|Lost to Follow-up|0|||
130651571|NCT00814502|470346304|FG001|Overall Study|Adverse Event|0|||
130178831|NCT01512160|468610118|FG002|Overall Study|Lost to Follow-up|0|||
130178832|NCT01512160|468610119|FG003|Overall Study|Lost to Follow-up|0|||
130178833|NCT01512160|468610116|FG000|Overall Study|Withdrawal by Subject|1|||
130178834|NCT01512160|468610117|FG001|Overall Study|Withdrawal by Subject|0|||
130178835|NCT01512160|468610118|FG002|Overall Study|Withdrawal by Subject|0|||
130178836|NCT01512160|468610119|FG003|Overall Study|Withdrawal by Subject|1|||
130178837|NCT02163057|468610121|FG000|Overall Study|Participant Refusal to Continue|2|||
130178838|NCT02163057|468610122|FG001|Overall Study|Participant Refusal to Continue|2|||
130178839|NCT02163057|468610121|FG000|Overall Study|Participant Significant Noncompliance|0|||
130178840|NCT02163057|468610122|FG001|Overall Study|Participant Significant Noncompliance|1|||
130178841|NCT02163057|468610121|FG000|Overall Study|Progression of Disease|1|||
130178842|NCT02163057|468610122|FG001|Overall Study|Progression of Disease|2|||
130178843|NCT01959295|468610123|FG000|Overall Study|Adverse Event|2|||
130178844|NCT01959295|468610124|FG001|Overall Study|Adverse Event|0|||
130178845|NCT01959295|468610123|FG000|Overall Study|Lost to Follow-up|0|||
130178846|NCT01959295|468610124|FG001|Overall Study|Lost to Follow-up|2|||
130178847|NCT01959295|468610123|FG000|Overall Study|Physician Decision|2|||
130178848|NCT01959295|468610124|FG001|Overall Study|Physician Decision|3|||
130178849|NCT01959295|468610123|FG000|Overall Study|Protocol Violation|16|||
130178850|NCT01959295|468610124|FG001|Overall Study|Protocol Violation|5|||
130178851|NCT01959295|468610123|FG000|Overall Study|Withdrawal by Subject|3|||
130178852|NCT01959295|468610124|FG001|Overall Study|Withdrawal by Subject|1|||
130178853|NCT01959295|468610123|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
130178854|NCT01959295|468610124|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
130178855|NCT04903288|468611521|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
130178856|NCT04903288|468611521|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
130178857|NCT04903288|468611521|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
130178858|NCT04903288|468611521|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
130178859|NCT02498613|468611526|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
130178860|NCT02498613|468611527|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
130178861|NCT02498613|468611528|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
130178862|NCT02498613|468611529|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
130178863|NCT02498613|468611526|FG000|Overall Study|Withdrawal by Subject|3|||
130178864|NCT02498613|468611527|FG001|Overall Study|Withdrawal by Subject|1|||
130178865|NCT02498613|468611528|FG002|Overall Study|Withdrawal by Subject|0|||
130178866|NCT02498613|468611529|FG003|Overall Study|Withdrawal by Subject|0|||
130178867|NCT05168202|468611530|FG000|Overall Study|Progressive Disease|4|||
130178868|NCT05168202|468611531|FG001|Overall Study|Progressive Disease|4|||
130178869|NCT05168202|468611532|FG002|Overall Study|Progressive Disease|2|||
130178870|NCT05168202|468611533|FG003|Overall Study|Progressive Disease|3|||
130178871|NCT05168202|468611534|FG004|Overall Study|Progressive Disease|2|||
130178872|NCT05168202|468611535|FG005|Overall Study|Progressive Disease|3|||
130178873|NCT05168202|468611536|FG006|Overall Study|Progressive Disease|2|||
130178874|NCT05168202|468611530|FG000|Overall Study|Adverse Event|2|||
130178875|NCT05168202|468611531|FG001|Overall Study|Adverse Event|1|||
130178876|NCT05168202|468611532|FG002|Overall Study|Adverse Event|4|||
130178877|NCT05168202|468611533|FG003|Overall Study|Adverse Event|4|||
130178878|NCT05168202|468611534|FG004|Overall Study|Adverse Event|3|||
130178879|NCT05168202|468611535|FG005|Overall Study|Adverse Event|2|||
130178880|NCT05168202|468611536|FG006|Overall Study|Adverse Event|0|||
130178881|NCT05168202|468611530|FG000|Overall Study|Lack of Efficacy|0|||
130178882|NCT05168202|468611531|FG001|Overall Study|Lack of Efficacy|1|||
130178883|NCT05168202|468611532|FG002|Overall Study|Lack of Efficacy|1|||
130178884|NCT05168202|468611533|FG003|Overall Study|Lack of Efficacy|0|||
130178885|NCT05168202|468611534|FG004|Overall Study|Lack of Efficacy|1|||
130178886|NCT05168202|468611535|FG005|Overall Study|Lack of Efficacy|2|||
130178887|NCT05168202|468611536|FG006|Overall Study|Lack of Efficacy|2|||
130178888|NCT05168202|468611530|FG000|Overall Study|Withdrawal by Subject|0|||
130178889|NCT05168202|468611531|FG001|Overall Study|Withdrawal by Subject|0|||
130178890|NCT05168202|468611532|FG002|Overall Study|Withdrawal by Subject|1|||
130178891|NCT05168202|468611533|FG003|Overall Study|Withdrawal by Subject|1|||
130178892|NCT05168202|468611534|FG004|Overall Study|Withdrawal by Subject|1|||
130178893|NCT05168202|468611535|FG005|Overall Study|Withdrawal by Subject|1|||
130178894|NCT05168202|468611536|FG006|Overall Study|Withdrawal by Subject|0|||
130178895|NCT05168202|468611530|FG000|Overall Study|Disease Relapse|0|||
130178896|NCT05168202|468611531|FG001|Overall Study|Disease Relapse|1|||
130178897|NCT05168202|468611532|FG002|Overall Study|Disease Relapse|0|||
130178898|NCT05168202|468611533|FG003|Overall Study|Disease Relapse|1|||
130178899|NCT05168202|468611534|FG004|Overall Study|Disease Relapse|1|||
130178900|NCT05168202|468611535|FG005|Overall Study|Disease Relapse|0|||
130178901|NCT05168202|468611536|FG006|Overall Study|Disease Relapse|0|||
130178902|NCT05168202|468611530|FG000|Overall Study|Other Reasons|0|||
130178903|NCT05168202|468611531|FG001|Overall Study|Other Reasons|0|||
130178904|NCT05168202|468611532|FG002|Overall Study|Other Reasons|0|||
130178905|NCT05168202|468611533|FG003|Overall Study|Other Reasons|0|||
130178906|NCT05168202|468611534|FG004|Overall Study|Other Reasons|0|||
130178907|NCT05168202|468611535|FG005|Overall Study|Other Reasons|2|||
130178908|NCT05168202|468611536|FG006|Overall Study|Other Reasons|1|||
130178909|NCT05168202|468611530|FG000|Overall Study|Physician Decision|0|||
130178910|NCT05168202|468611531|FG001|Overall Study|Physician Decision|1|||
130178911|NCT05168202|468611532|FG002|Overall Study|Physician Decision|1|||
130178912|NCT05168202|468611533|FG003|Overall Study|Physician Decision|0|||
130178913|NCT05168202|468611534|FG004|Overall Study|Physician Decision|0|||
130178914|NCT05168202|468611535|FG005|Overall Study|Physician Decision|0|||
130178915|NCT05168202|468611536|FG006|Overall Study|Physician Decision|0|||
130178916|NCT05168202|468611530|FG000|Overall Study|Study Terminated by Sponsor|0|||
130178917|NCT05168202|468611531|FG001|Overall Study|Study Terminated by Sponsor|0|||
130178918|NCT05168202|468611532|FG002|Overall Study|Study Terminated by Sponsor|0|||
130178919|NCT05168202|468611533|FG003|Overall Study|Study Terminated by Sponsor|1|||
130178920|NCT05168202|468611534|FG004|Overall Study|Study Terminated by Sponsor|0|||
130178921|NCT05168202|468611535|FG005|Overall Study|Study Terminated by Sponsor|0|||
130178922|NCT05168202|468611536|FG006|Overall Study|Study Terminated by Sponsor|0|||
130178923|NCT05878093|468611537|FG000|Overall Study|Withdrawal by Subject|3|||
130178924|NCT05878093|468611538|FG001|Overall Study|Withdrawal by Subject|1|||
130178925|NCT03690388|468611541|FG000|Overall Study|Adverse Event|8|||
130178926|NCT03690388|468611542|FG001|Overall Study|Adverse Event|1|||
130178927|NCT03690388|468611541|FG000|Overall Study|Radiographic Progression|14|||
130178928|NCT03690388|468611542|FG001|Overall Study|Radiographic Progression|29|||
130178929|NCT03690388|468611541|FG000|Overall Study|Clinical deterioration|10|||
130178930|NCT03690388|468611542|FG001|Overall Study|Clinical deterioration|6|||
130178931|NCT03690388|468611541|FG000|Overall Study|Withdrawal by Subject|2|||
130178932|NCT03690388|468611542|FG001|Overall Study|Withdrawal by Subject|0|||
130178933|NCT03690388|468611541|FG000|Overall Study|Lack of Efficacy|1|||
130178934|NCT03690388|468611542|FG001|Overall Study|Lack of Efficacy|0|||
130178935|NCT03690388|468611541|FG000|Overall Study|Lost to Follow-up|1|||
130178936|NCT03690388|468611542|FG001|Overall Study|Lost to Follow-up|0|||
130178937|NCT04100018|468611544|FG000|Pre-Treatment Period|Not Reported|0|||
130178938|NCT04100018|468611545|FG001|Pre-Treatment Period|Not Reported|4|||
130178939|NCT04100018|468611544|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130178940|NCT04100018|468611545|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130178941|NCT04100018|468611544|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
130178942|NCT04100018|468611545|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
130178943|NCT04100018|468611544|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
130178944|NCT04100018|468611545|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130178945|NCT04100018|468611544|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130178946|NCT04100018|468611545|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130178947|NCT04100018|468611544|FG000|Treatment Period|Ongoing Treatment|1|||
130178948|NCT04100018|468611545|FG001|Treatment Period|Ongoing Treatment|0|||
130178949|NCT04100018|468611544|FG000|Treatment Period|Other Reason|26|||
130178950|NCT04100018|468611545|FG001|Treatment Period|Other Reason|37|||
130178951|NCT04100018|468611544|FG000|Treatment Period|Completed treatment as per protocol|1|||
130178952|NCT04100018|468611545|FG001|Treatment Period|Completed treatment as per protocol|2|||
130178953|NCT04100018|468611544|FG000|Treatment Period|Maximum clinical benefit|3|||
130178954|NCT04100018|468611545|FG001|Treatment Period|Maximum clinical benefit|0|||
130178955|NCT04100018|468611544|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130178956|NCT04100018|468611545|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
130178957|NCT04100018|468611544|FG000|Treatment Period|Study drug toxicity|67|||
130178958|NCT04100018|468611545|FG001|Treatment Period|Study drug toxicity|28|||
130178959|NCT04100018|468611544|FG000|Treatment Period|Disease Progression|284|||
130178960|NCT04100018|468611545|FG001|Treatment Period|Disease Progression|327|||
130178961|NCT04100018|468611544|FG000|Treatment Period|Administrative reasons by sponsor|16|||
130178962|NCT04100018|468611545|FG001|Treatment Period|Administrative reasons by sponsor|30|||
130178963|NCT04100018|468611544|FG000|Treatment Period|Poor/Non-Compliance|1|||
130178964|NCT04100018|468611545|FG001|Treatment Period|Poor/Non-Compliance|0|||
130178965|NCT04100018|468611544|FG000|Treatment Period|Lost to Follow-up|2|||
130178966|NCT04100018|468611545|FG001|Treatment Period|Lost to Follow-up|2|||
130178967|NCT04100018|468611544|FG000|Treatment Period|Death|16|||
130178968|NCT04100018|468611545|FG001|Treatment Period|Death|11|||
130178969|NCT04100018|468611544|FG000|Treatment Period|Participant withdrew consent|10|||
130178970|NCT04100018|468611545|FG001|Treatment Period|Participant withdrew consent|10|||
130178971|NCT04100018|468611544|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
130178972|NCT04100018|468611545|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
130178973|NCT04100018|468611544|FG000|Treatment Period|Adverse Event|14|||
130178974|NCT04100018|468611545|FG001|Treatment Period|Adverse Event|6|||
130178975|NCT04100018|468611544|FG000|Treatment Period|Lack of Efficacy|4|||
130178976|NCT04100018|468611545|FG001|Treatment Period|Lack of Efficacy|2|||
130178977|NCT02090725|468611550|FG000|Overall Study|Withdrawal by Subject|1|||
130178978|NCT02090725|468611550|FG000|Overall Study|participants moved from area|3|||
130178979|NCT04358081|468611551|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
130178980|NCT04358081|468611552|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
130178981|NCT04358081|468611553|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
130178982|NCT04358081|468611551|FG000|Treatment Phase of Study|Adverse Event|1|||
130178983|NCT04358081|468611552|FG001|Treatment Phase of Study|Adverse Event|0|||
130178984|NCT04358081|468611553|FG002|Treatment Phase of Study|Adverse Event|1|||
130178985|NCT04358081|468611551|FG000|Treatment Phase of Study|Physician Decision|2|||
130178986|NCT04358081|468611552|FG001|Treatment Phase of Study|Physician Decision|0|||
130651572|NCT00814502|470346303|FG000|Overall Study|Withdrawal by Subject|0|||
130178987|NCT04358081|468611553|FG002|Treatment Phase of Study|Physician Decision|1|||
130178988|NCT04358081|468611551|FG000|Treatment Phase of Study|Protocol Violation|1|||
130178989|NCT04358081|468611552|FG001|Treatment Phase of Study|Protocol Violation|0|||
130178990|NCT04358081|468611553|FG002|Treatment Phase of Study|Protocol Violation|0|||
130178991|NCT04358081|468611551|FG000|Study Completion Phase|Death|0|||
130178992|NCT04358081|468611552|FG001|Study Completion Phase|Death|0|||
130178993|NCT04358081|468611553|FG002|Study Completion Phase|Death|1|||
130178994|NCT04358081|468611551|FG000|Study Completion Phase|Lost to Follow-up|1|||
130178995|NCT04358081|468611552|FG001|Study Completion Phase|Lost to Follow-up|0|||
130178996|NCT04358081|468611553|FG002|Study Completion Phase|Lost to Follow-up|1|||
130178997|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
130178998|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
130178999|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
130179000|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
130179001|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130179002|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
130179003|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130179004|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
130179005|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
130179006|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130179007|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
130179008|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130179009|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130179010|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130179011|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
130179012|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
130179013|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
130179014|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
130179015|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
130179016|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
130179017|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
130179018|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
130179019|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
130179020|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
130179021|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130179022|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130179023|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
130179024|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
130179025|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
130179026|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
130179027|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
130179028|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
130179029|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179030|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179031|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179032|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
130179033|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179034|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179035|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179036|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
130179037|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179038|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179039|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179040|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
130179041|NCT02656303|468611558|FG000|Overall Study|Adverse Event|3|||
130179042|NCT02656303|468611559|FG001|Overall Study|Adverse Event|2|||
130179043|NCT02656303|468611560|FG002|Overall Study|Adverse Event|0|||
130179044|NCT02656303|468611558|FG000|Overall Study|Death|12|||
130179045|NCT02656303|468611559|FG001|Overall Study|Death|4|||
130179046|NCT02656303|468611560|FG002|Overall Study|Death|1|||
130179047|NCT02656303|468611558|FG000|Overall Study|Lack of Efficacy|1|||
130179048|NCT02656303|468611559|FG001|Overall Study|Lack of Efficacy|0|||
130179049|NCT02656303|468611560|FG002|Overall Study|Lack of Efficacy|0|||
130179050|NCT02656303|468611558|FG000|Overall Study|Non-Compliance with Study|1|||
130179051|NCT02656303|468611559|FG001|Overall Study|Non-Compliance with Study|1|||
130179052|NCT02656303|468611560|FG002|Overall Study|Non-Compliance with Study|0|||
130179053|NCT02656303|468611558|FG000|Overall Study|Investigator Decision|2|||
130179054|NCT02656303|468611559|FG001|Overall Study|Investigator Decision|1|||
130179055|NCT02656303|468611560|FG002|Overall Study|Investigator Decision|0|||
130179056|NCT02656303|468611558|FG000|Overall Study|Progressive Disease|25|||
130179057|NCT02656303|468611559|FG001|Overall Study|Progressive Disease|14|||
130179058|NCT02656303|468611560|FG002|Overall Study|Progressive Disease|10|||
130179059|NCT02656303|468611558|FG000|Overall Study|Study Terminated by Sponsor|20|||
130179060|NCT02656303|468611559|FG001|Overall Study|Study Terminated by Sponsor|7|||
130179061|NCT02656303|468611560|FG002|Overall Study|Study Terminated by Sponsor|5|||
130179062|NCT02656303|468611558|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
130179063|NCT02656303|468611559|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
130179064|NCT02656303|468611560|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
130179065|NCT02656303|468611558|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
130179066|NCT02656303|468611559|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
130179067|NCT02656303|468611560|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
130179068|NCT02656303|468611558|FG000|Overall Study|Reason not Specified|1|||
130179069|NCT02656303|468611559|FG001|Overall Study|Reason not Specified|1|||
130179070|NCT02656303|468611560|FG002|Overall Study|Reason not Specified|2|||
130179071|NCT03041311|468611561|FG000|Overall Study|Death|39|||
130179072|NCT03041311|468611562|FG001|Overall Study|Death|42|||
130179073|NCT03041311|468611561|FG000|Overall Study|Lost to Follow-up|0|||
130179074|NCT03041311|468611562|FG001|Overall Study|Lost to Follow-up|1|||
130179075|NCT03041311|468611561|FG000|Overall Study|Withdrawal by Subject|8|||
130179076|NCT03041311|468611562|FG001|Overall Study|Withdrawal by Subject|5|||
130179077|NCT03041311|468611561|FG000|Overall Study|Sponsor Terminated Study|2|||
130179078|NCT03041311|468611562|FG001|Overall Study|Sponsor Terminated Study|4|||
130179079|NCT03041311|468611561|FG000|Overall Study|Disease Progression|3|||
130179080|NCT03041311|468611562|FG001|Overall Study|Disease Progression|1|||
130179081|NCT03041311|468611561|FG000|Overall Study|Randomized in error, did not receive drug|2|||
130179082|NCT03041311|468611562|FG001|Overall Study|Randomized in error, did not receive drug|0|||
130179083|NCT01842438|468611563|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
130179084|NCT01842438|468611564|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
130179085|NCT01842438|468611563|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
130179086|NCT01842438|468611564|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
130179087|NCT01842438|468611563|FG000|T2: 6month Follow-up|Death|0|||
130179088|NCT01842438|468611564|FG001|T2: 6month Follow-up|Death|1|||
130179089|NCT00782626|468611568|FG000|Overall Study|Adverse Event|1|||
130179090|NCT00782626|468611568|FG000|Overall Study|Progressive Disease|5|||
130179091|NCT00782626|468611568|FG000|Overall Study|Other Complicating Disease|1|||
130179092|NCT04909853|468611569|FG000|Part 1|Assigned but not treated|0|||
130179093|NCT04909853|468611570|FG001|Part 1|Assigned but not treated|0|||
130179094|NCT04909853|468611571|FG002|Part 1|Assigned but not treated|1|||
130179095|NCT04909853|468611572|FG003|Part 1|Assigned but not treated|0|||
130179096|NCT04909853|468611569|FG000|Part 2|Adverse Event|0|||
130179097|NCT04909853|468611570|FG001|Part 2|Adverse Event|0|||
130179098|NCT04909853|468611571|FG002|Part 2|Adverse Event|0|||
130179099|NCT04909853|468611572|FG003|Part 2|Adverse Event|1|||
130179100|NCT04054765|468611573|FG000|Baseline|Withdrawal by Subject|5|||
130179101|NCT04054765|468611574|FG001|Baseline|Withdrawal by Subject|3|||
130179102|NCT04054765|468611573|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
130179103|NCT04054765|468611574|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
130179104|NCT04054765|468611573|FG000|3-month Follow up|Withdrawal by Subject|0|||
130179105|NCT04054765|468611574|FG001|3-month Follow up|Withdrawal by Subject|3|||
130179106|NCT04054765|468611573|FG000|6-month Follow up|Lost to Follow-up|32|||
130179107|NCT04054765|468611574|FG001|6-month Follow up|Lost to Follow-up|32|||
130179108|NCT00077207|468611576|FG000|Overall Study|Adverse Event|5|||
130179109|NCT00077207|468611576|FG000|Overall Study|Lack of Efficacy|12|||
130179110|NCT00077207|468611576|FG000|Overall Study|Physician Decision|6|||
130179111|NCT00077207|468611576|FG000|Overall Study|Withdrawal by Subject|6|||
130179112|NCT00077207|468611576|FG000|Overall Study|Ineligible|1|||
130179113|NCT04182490|468611577|FG000|Overall Study|Withdrawal by Subject|3|||
130179114|NCT04182490|468611578|FG001|Overall Study|Withdrawal by Subject|3|||
130179115|NCT04182490|468611577|FG000|Overall Study|Lost to Follow-up|0|||
130179116|NCT04182490|468611578|FG001|Overall Study|Lost to Follow-up|1|||
130179117|NCT04182490|468611577|FG000|Overall Study|Physician Decision|0|||
130179118|NCT04182490|468611578|FG001|Overall Study|Physician Decision|1|||
130179119|NCT00853099|468611579|FG000|Double-blind Period|Adverse Event|7|||
130179120|NCT00853099|468611580|FG001|Double-blind Period|Adverse Event|9|||
130179121|NCT00853099|468611581|FG002|Double-blind Period|Adverse Event|13|||
130179122|NCT00853099|468611582|FG003|Double-blind Period|Adverse Event|0|||
130179123|NCT00853099|468611579|FG000|Double-blind Period|Withdrawal by Subject|2|||
130179124|NCT00853099|468611580|FG001|Double-blind Period|Withdrawal by Subject|3|||
130179125|NCT00853099|468611581|FG002|Double-blind Period|Withdrawal by Subject|0|||
130179126|NCT00853099|468611582|FG003|Double-blind Period|Withdrawal by Subject|0|||
130179127|NCT00853099|468611579|FG000|Double-blind Period|Lack of Efficacy|14|||
130179128|NCT00853099|468611580|FG001|Double-blind Period|Lack of Efficacy|17|||
130179129|NCT00853099|468611581|FG002|Double-blind Period|Lack of Efficacy|16|||
130179130|NCT00853099|468611582|FG003|Double-blind Period|Lack of Efficacy|0|||
130179131|NCT00853099|468611579|FG000|Double-blind Period|Other|0|||
130179132|NCT00853099|468611580|FG001|Double-blind Period|Other|0|||
130179133|NCT00853099|468611581|FG002|Double-blind Period|Other|1|||
130179134|NCT00853099|468611582|FG003|Double-blind Period|Other|0|||
130179135|NCT00853099|468611579|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
130179136|NCT00853099|468611580|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
130179137|NCT00853099|468611581|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
130179138|NCT00853099|468611582|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
130179139|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179140|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179141|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179142|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
130179143|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
130179144|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
130179145|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
130179146|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
130179147|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179148|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179149|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179150|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
130179151|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Other|0|||
130179152|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Other|0|||
130179153|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Other|0|||
130179154|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Other|6|||
130179155|NCT01342081|468611591|FG000|Overall Study|Did not receive allocated intervention|0|||
130179156|NCT01342081|468611592|FG001|Overall Study|Did not receive allocated intervention|0|||
130179157|NCT01342081|468611593|FG002|Overall Study|Did not receive allocated intervention|1|||
130179158|NCT01342081|468611591|FG000|Overall Study|Adverse Event|1|||
130179159|NCT01342081|468611592|FG001|Overall Study|Adverse Event|0|||
130179160|NCT01342081|468611593|FG002|Overall Study|Adverse Event|0|||
130179161|NCT01342081|468611591|FG000|Overall Study|Physician Decision|0|||
130179162|NCT01342081|468611592|FG001|Overall Study|Physician Decision|1|||
130179163|NCT01342081|468611593|FG002|Overall Study|Physician Decision|0|||
130179164|NCT01342081|468611591|FG000|Overall Study|Withdrawal by Subject|1|||
130179165|NCT01342081|468611592|FG001|Overall Study|Withdrawal by Subject|1|||
130179166|NCT01342081|468611593|FG002|Overall Study|Withdrawal by Subject|0|||
130179167|NCT02790437|468611594|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
130179168|NCT02790437|468611595|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
130179169|NCT02790437|468611594|FG000|Overall Study|Adverse Event|1|||
130179170|NCT02790437|468611595|FG001|Overall Study|Adverse Event|0|||
130179171|NCT02790437|468611594|FG000|Overall Study|Withdrawal by Subject|1|||
130179172|NCT02790437|468611595|FG001|Overall Study|Withdrawal by Subject|0|||
130179173|NCT03908125|468611600|FG000|Overall Study|Withdrawal by Subject|92|||
130179174|NCT03908125|468611600|FG000|Overall Study|Lost to Follow-up|8|||
130179175|NCT01071915|468611601|FG000|Overall Study|Adverse Event|3|||
130179176|NCT01071915|468611601|FG000|Overall Study|Physician Decision|2|||
130179177|NCT01071915|468611601|FG000|Overall Study|Withdrawal by Subject|2|||
130179178|NCT01071915|468611601|FG000|Overall Study|Miscellaneous Reasons|2|||
130179179|NCT00114140|468611602|FG000|Overall Study|Protocol Violation|7|||
130179180|NCT00666328|468611606|FG000|Overall Study|Death|2|||
130179181|NCT00666328|468611606|FG000|Overall Study|Lost to Follow-up|2|||
130179182|NCT00666328|468611606|FG000|Overall Study|No longer met eligibility criteria|1|||
130179183|NCT03885661|468611609|FG000|Overall Study|Withdrawal by Subject|0|||
130179184|NCT03885661|468611610|FG001|Overall Study|Withdrawal by Subject|1|||
130179185|NCT03885661|468611609|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
130179186|NCT03885661|468611610|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
130179187|NCT05064397|468611611|FG000|Overall Study|Adverse Event|4|||
130179188|NCT05064397|468611611|FG000|Overall Study|Lack of Efficacy|12|||
130179189|NCT05064397|468611611|FG000|Overall Study|Withdrawal by Subject|3|||
130179190|NCT05064397|468611611|FG000|Overall Study|Lost to Follow-up|1|||
130179191|NCT05064397|468611611|FG000|Overall Study|Other reasons|3|||
130179192|NCT02232984|468611612|FG000|Overall Study|Withdrawal by Subject|5|||
130179193|NCT02232984|468611612|FG000|Overall Study|Death|1|||
130651573|NCT00814502|470346304|FG001|Overall Study|Withdrawal by Subject|2|||
130651574|NCT01050998|470346308|FG000|Overall Study|Adverse Event|1|||
130651575|NCT01050998|470346309|FG001|Overall Study|Adverse Event|0|||
130651576|NCT01050998|470346310|FG002|Overall Study|Adverse Event|1|||
130179194|NCT02232984|468611612|FG000|Overall Study|Investigator withdrawal|10|||
130179195|NCT02232984|468611612|FG000|Overall Study|Device implant unsuccessful|53|||
130179196|NCT02232984|468611612|FG000|Overall Study|not disclosed by site|7|||
130179197|NCT02232984|468611612|FG000|Overall Study|Protocol Violation|1|||
130179198|NCT00535405|468611617|FG000|Overall Study|Adverse Event|6|||
130179199|NCT00535405|468611618|FG001|Overall Study|Adverse Event|8|||
130179200|NCT00535405|468611619|FG002|Overall Study|Adverse Event|3|||
130179201|NCT00535405|468611620|FG003|Overall Study|Adverse Event|8|||
130179202|NCT00535405|468611621|FG004|Overall Study|Adverse Event|6|||
130179203|NCT00535405|468611617|FG000|Overall Study|Lost to Follow-up|1|||
130179204|NCT00535405|468611618|FG001|Overall Study|Lost to Follow-up|3|||
130179205|NCT00535405|468611619|FG002|Overall Study|Lost to Follow-up|3|||
130179206|NCT00535405|468611620|FG003|Overall Study|Lost to Follow-up|2|||
130179207|NCT00535405|468611621|FG004|Overall Study|Lost to Follow-up|1|||
130651577|NCT01050998|470346311|FG003|Overall Study|Adverse Event|0|||
130179208|NCT00535405|468611617|FG000|Overall Study|Physician Decision|3|||
130179209|NCT00535405|468611618|FG001|Overall Study|Physician Decision|2|||
130179210|NCT00535405|468611619|FG002|Overall Study|Physician Decision|0|||
130179211|NCT00535405|468611620|FG003|Overall Study|Physician Decision|1|||
130179212|NCT00535405|468611621|FG004|Overall Study|Physician Decision|1|||
130179213|NCT00535405|468611617|FG000|Overall Study|Protocol Violation|2|||
130179214|NCT00535405|468611618|FG001|Overall Study|Protocol Violation|2|||
130179215|NCT00535405|468611619|FG002|Overall Study|Protocol Violation|2|||
130179216|NCT00535405|468611620|FG003|Overall Study|Protocol Violation|1|||
130179217|NCT00535405|468611621|FG004|Overall Study|Protocol Violation|0|||
130179218|NCT00535405|468611617|FG000|Overall Study|Withdrawal by Subject|5|||
130179219|NCT00535405|468611618|FG001|Overall Study|Withdrawal by Subject|11|||
130179220|NCT00535405|468611619|FG002|Overall Study|Withdrawal by Subject|10|||
130179221|NCT00535405|468611620|FG003|Overall Study|Withdrawal by Subject|10|||
130179222|NCT00535405|468611621|FG004|Overall Study|Withdrawal by Subject|8|||
130179223|NCT02969044|468611624|FG000|Overall Study|Withdrawal by Subject|2|||
130179224|NCT02969044|468611625|FG001|Overall Study|Withdrawal by Subject|6|||
130179225|NCT02969044|468611624|FG000|Overall Study|Adverse Event|3|||
130179226|NCT02969044|468611625|FG001|Overall Study|Adverse Event|0|||
130179227|NCT04728802|468611626|FG000|Overall Study|Withdrawal by Subject|4|||
130179228|NCT04728802|468611627|FG001|Overall Study|Withdrawal by Subject|20|||
130179229|NCT04728802|468611626|FG000|Overall Study|Physician Decision|7|||
130179230|NCT04728802|468611627|FG001|Overall Study|Physician Decision|7|||
130179231|NCT04728802|468611626|FG000|Overall Study|Protocol Violation|10|||
130179232|NCT04728802|468611627|FG001|Overall Study|Protocol Violation|4|||
130179233|NCT04728802|468611626|FG000|Overall Study|Transfer|1|||
130179234|NCT04728802|468611627|FG001|Overall Study|Transfer|0|||
130179235|NCT04728802|468611626|FG000|Overall Study|Death|4|||
130179236|NCT04728802|468611627|FG001|Overall Study|Death|5|||
130179237|NCT04728802|468611626|FG000|Overall Study|Other|3|||
130179238|NCT04728802|468611627|FG001|Overall Study|Other|0|||
130179239|NCT01176513|468611628|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
130179240|NCT03164616|468611632|FG000|Overall Study|Death|250|||
130179241|NCT03164616|468611633|FG001|Overall Study|Death|264|||
130179242|NCT03164616|468611634|FG002|Overall Study|Death|279|||
130179243|NCT03164616|468611632|FG000|Overall Study|Lost to Follow-up|2|||
130179244|NCT03164616|468611633|FG001|Overall Study|Lost to Follow-up|2|||
130179245|NCT03164616|468611634|FG002|Overall Study|Lost to Follow-up|2|||
130179246|NCT03164616|468611632|FG000|Overall Study|Withdrawal by Subject|6|||
130179247|NCT03164616|468611633|FG001|Overall Study|Withdrawal by Subject|7|||
130179248|NCT03164616|468611634|FG002|Overall Study|Withdrawal by Subject|16|||
130179249|NCT00489255|468611646|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
130179250|NCT00489255|468611647|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
130179251|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
130179252|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
130179253|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
130179254|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
130179255|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
130179256|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
130179257|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
130179258|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
130179259|NCT00489255|468611646|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
130179260|NCT00489255|468611647|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
130179261|NCT00489255|468611646|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
130179262|NCT00489255|468611647|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
130179263|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
130179264|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
130179265|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
130179266|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
130179267|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
130179268|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
130179269|NCT01625091|468611648|FG000|Intervention|Death|1|||
130179270|NCT01625091|468611649|FG001|Intervention|Death|1|||
130179271|NCT01625091|468611648|FG000|Intervention|Withdrawal by Subject|4|||
130179272|NCT01625091|468611649|FG001|Intervention|Withdrawal by Subject|1|||
130179273|NCT01625091|468611648|FG000|Intervention|Adverse Event|0|||
130179274|NCT01625091|468611649|FG001|Intervention|Adverse Event|2|||
130179275|NCT01625091|468611648|FG000|Intervention|Lost to Follow-up|4|||
130179276|NCT01625091|468611649|FG001|Intervention|Lost to Follow-up|4|||
130179277|NCT01625091|468611648|FG000|Intervention|Study termination|2|||
130179278|NCT01625091|468611649|FG001|Intervention|Study termination|3|||
130179279|NCT01625091|468611648|FG000|Post-intervention|Death|0|||
130179280|NCT01625091|468611649|FG001|Post-intervention|Death|1|||
130179281|NCT01625091|468611648|FG000|Post-intervention|Lost to Follow-up|2|||
130179282|NCT01625091|468611649|FG001|Post-intervention|Lost to Follow-up|0|||
130179283|NCT01625091|468611648|FG000|Post-intervention|Study termination|2|||
130179284|NCT01625091|468611649|FG001|Post-intervention|Study termination|1|||
130179285|NCT03130777|468613530|FG000|Overall Study|Death|0|||
130179286|NCT03130777|468613531|FG001|Overall Study|Death|1|||
130179287|NCT03130777|468613530|FG000|Overall Study|Did not meet eligibility criteria|1|||
130179288|NCT03130777|468613531|FG001|Overall Study|Did not meet eligibility criteria|0|||
130179289|NCT05109611|468613532|FG000|Overall Study|Adverse Event|13|||
130179290|NCT05109611|468613533|FG001|Overall Study|Adverse Event|10|||
130179291|NCT05109611|468613532|FG000|Overall Study|Withdrawal by Subject|1|||
130179292|NCT05109611|468613533|FG001|Overall Study|Withdrawal by Subject|0|||
130179293|NCT05109611|468613532|FG000|Overall Study|Lost to Follow-up|1|||
130179294|NCT05109611|468613533|FG001|Overall Study|Lost to Follow-up|2|||
130179295|NCT05109611|468613532|FG000|Overall Study|Protocol Violation|0|||
130179296|NCT05109611|468613533|FG001|Overall Study|Protocol Violation|4|||
130179297|NCT05109611|468613532|FG000|Overall Study|Information unavailable|1|||
130179298|NCT05109611|468613533|FG001|Overall Study|Information unavailable|1|||
130179299|NCT06195930|468613536|FG000|Overall Study|Adverse Event|4|||
130179300|NCT04995029|468613537|FG000|Induction Phase|Did not meet eligibility criteria|5|||
130179301|NCT04995029|468613538|FG001|Induction Phase|Did not meet eligibility criteria|2|||
130179302|NCT04995029|468613539|FG002|Induction Phase|Did not meet eligibility criteria|0|||
130179303|NCT04995029|468613540|FG003|Induction Phase|Did not meet eligibility criteria|0|||
130179304|NCT04995029|468613537|FG000|Induction Phase|Withdrawal by Subject|85|||
130179305|NCT04995029|468613538|FG001|Induction Phase|Withdrawal by Subject|42|||
130179306|NCT04995029|468613539|FG002|Induction Phase|Withdrawal by Subject|0|||
130179307|NCT04995029|468613540|FG003|Induction Phase|Withdrawal by Subject|0|||
130179308|NCT04995029|468613537|FG000|Induction Phase|Lost to Follow-up|103|||
130179309|NCT04995029|468613538|FG001|Induction Phase|Lost to Follow-up|67|||
130179310|NCT04995029|468613539|FG002|Induction Phase|Lost to Follow-up|0|||
130179311|NCT04995029|468613540|FG003|Induction Phase|Lost to Follow-up|0|||
130179312|NCT04995029|468613537|FG000|Induction Phase|Adverse Event|5|||
130179313|NCT04995029|468613538|FG001|Induction Phase|Adverse Event|3|||
130179314|NCT04995029|468613539|FG002|Induction Phase|Adverse Event|0|||
130179315|NCT04995029|468613540|FG003|Induction Phase|Adverse Event|0|||
130179316|NCT04995029|468613537|FG000|Induction Phase|Physician Decision|11|||
130179317|NCT04995029|468613538|FG001|Induction Phase|Physician Decision|8|||
130179318|NCT04995029|468613539|FG002|Induction Phase|Physician Decision|0|||
130179319|NCT04995029|468613540|FG003|Induction Phase|Physician Decision|0|||
130179320|NCT04995029|468613537|FG000|Induction Phase|Incarceration|6|||
130179321|NCT04995029|468613538|FG001|Induction Phase|Incarceration|3|||
130179322|NCT04995029|468613539|FG002|Induction Phase|Incarceration|0|||
130179323|NCT04995029|468613540|FG003|Induction Phase|Incarceration|0|||
130179324|NCT04995029|468613537|FG000|Induction Phase|Not otherwise described|5|||
130179325|NCT04995029|468613538|FG001|Induction Phase|Not otherwise described|5|||
130179326|NCT04995029|468613539|FG002|Induction Phase|Not otherwise described|0|||
130179327|NCT04995029|468613540|FG003|Induction Phase|Not otherwise described|0|||
130179328|NCT04995029|468613537|FG000|Maintenance Phase|Lost to Follow-up|0|||
130179329|NCT04995029|468613538|FG001|Maintenance Phase|Lost to Follow-up|0|||
130179330|NCT04995029|468613539|FG002|Maintenance Phase|Lost to Follow-up|51|||
130179331|NCT04995029|468613540|FG003|Maintenance Phase|Lost to Follow-up|44|||
130179332|NCT04995029|468613537|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
130179333|NCT04995029|468613538|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
130179334|NCT04995029|468613539|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
130179335|NCT04995029|468613540|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
130179336|NCT04995029|468613537|FG000|Maintenance Phase|Adverse Event|0|||
130179337|NCT04995029|468613538|FG001|Maintenance Phase|Adverse Event|0|||
130179338|NCT04995029|468613539|FG002|Maintenance Phase|Adverse Event|0|||
130179339|NCT04995029|468613540|FG003|Maintenance Phase|Adverse Event|1|||
130179340|NCT04995029|468613537|FG000|Maintenance Phase|Physician Decision|0|||
130179341|NCT04995029|468613538|FG001|Maintenance Phase|Physician Decision|0|||
130179342|NCT04995029|468613539|FG002|Maintenance Phase|Physician Decision|8|||
130179343|NCT04995029|468613540|FG003|Maintenance Phase|Physician Decision|4|||
130179344|NCT04995029|468613537|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130179345|NCT04995029|468613538|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130179346|NCT04995029|468613539|FG002|Maintenance Phase|Withdrawal by Subject|17|||
130179347|NCT04995029|468613540|FG003|Maintenance Phase|Withdrawal by Subject|31|||
130179348|NCT04995029|468613537|FG000|Maintenance Phase|Incarceration|0|||
130179349|NCT04995029|468613538|FG001|Maintenance Phase|Incarceration|0|||
130179350|NCT04995029|468613539|FG002|Maintenance Phase|Incarceration|4|||
130179351|NCT04995029|468613540|FG003|Maintenance Phase|Incarceration|3|||
130179352|NCT04995029|468613537|FG000|Maintenance Phase|Not otherwise described|0|||
130179353|NCT04995029|468613538|FG001|Maintenance Phase|Not otherwise described|0|||
130179354|NCT04995029|468613539|FG002|Maintenance Phase|Not otherwise described|2|||
130179355|NCT04995029|468613540|FG003|Maintenance Phase|Not otherwise described|3|||
130179356|NCT04995029|468613537|FG000|Maintenance Phase|Pregnancy|0|||
130179357|NCT04995029|468613538|FG001|Maintenance Phase|Pregnancy|0|||
130179358|NCT04995029|468613539|FG002|Maintenance Phase|Pregnancy|2|||
130179359|NCT04995029|468613540|FG003|Maintenance Phase|Pregnancy|2|||
130179360|NCT00970593|468613547|FG000|Overall Study|Adverse Event|1|||
130179361|NCT00970593|468613548|FG001|Overall Study|Adverse Event|1|||
130179362|NCT00970593|468613549|FG002|Overall Study|Adverse Event|0|||
130179363|NCT00970593|468613550|FG003|Overall Study|Adverse Event|0|||
130179364|NCT00970593|468613551|FG004|Overall Study|Adverse Event|0|||
130179365|NCT00970593|468613552|FG005|Overall Study|Adverse Event|0|||
130179366|NCT00970593|468613553|FG006|Overall Study|Adverse Event|0|||
130179367|NCT00970593|468613547|FG000|Overall Study|Discontinuation of study by sponsor|0|||
130179368|NCT00970593|468613548|FG001|Overall Study|Discontinuation of study by sponsor|0|||
130179369|NCT00970593|468613549|FG002|Overall Study|Discontinuation of study by sponsor|5|||
130179370|NCT00970593|468613550|FG003|Overall Study|Discontinuation of study by sponsor|0|||
130179371|NCT00970593|468613551|FG004|Overall Study|Discontinuation of study by sponsor|0|||
130179372|NCT00970593|468613552|FG005|Overall Study|Discontinuation of study by sponsor|0|||
130179373|NCT00970593|468613553|FG006|Overall Study|Discontinuation of study by sponsor|2|||
130179374|NCT00970593|468613547|FG000|Overall Study|Withdrawal by Subject|0|||
130179375|NCT00970593|468613548|FG001|Overall Study|Withdrawal by Subject|0|||
130179376|NCT00970593|468613549|FG002|Overall Study|Withdrawal by Subject|1|||
130179377|NCT00970593|468613550|FG003|Overall Study|Withdrawal by Subject|0|||
130179378|NCT00970593|468613551|FG004|Overall Study|Withdrawal by Subject|0|||
130179379|NCT00970593|468613552|FG005|Overall Study|Withdrawal by Subject|0|||
130179380|NCT00970593|468613553|FG006|Overall Study|Withdrawal by Subject|0|||
130179381|NCT03889886|468613561|FG000|Overall Study|Other|0|||
130179382|NCT03889886|468613562|FG001|Overall Study|Other|1|||
130179383|NCT03889886|468613563|FG002|Overall Study|Other|0|||
130179384|NCT03889886|468613564|FG003|Overall Study|Other|1|||
130179385|NCT03889886|468613561|FG000|Overall Study|Withdrawal by Subject|0|||
130179386|NCT03889886|468613562|FG001|Overall Study|Withdrawal by Subject|0|||
130179387|NCT03889886|468613563|FG002|Overall Study|Withdrawal by Subject|1|||
130179388|NCT03889886|468613564|FG003|Overall Study|Withdrawal by Subject|0|||
130179389|NCT03889886|468613561|FG000|Overall Study|Adverse Event|0|||
130179390|NCT03889886|468613562|FG001|Overall Study|Adverse Event|0|||
130179391|NCT03889886|468613563|FG002|Overall Study|Adverse Event|0|||
130179392|NCT03889886|468613564|FG003|Overall Study|Adverse Event|6|||
130179393|NCT04176250|468613565|FG000|Overall Study|Adverse Event|0|||
130179394|NCT04176250|468613566|FG001|Overall Study|Adverse Event|1|||
130179395|NCT04176250|468613567|FG002|Overall Study|Adverse Event|0|||
130179396|NCT04176250|468613568|FG003|Overall Study|Adverse Event|1|||
130179397|NCT04176250|468613569|FG004|Overall Study|Adverse Event|0|||
130179398|NCT04176250|468613570|FG005|Overall Study|Adverse Event|1|||
130179399|NCT04176250|468613565|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179400|NCT04176250|468613566|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179401|NCT04176250|468613567|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130179402|NCT04176250|468613568|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130179403|NCT04176250|468613569|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179404|NCT04176250|468613570|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179405|NCT04176250|468613565|FG000|Overall Study|Withdrawal by Subject|0|||
130179406|NCT04176250|468613566|FG001|Overall Study|Withdrawal by Subject|0|||
130179407|NCT04176250|468613567|FG002|Overall Study|Withdrawal by Subject|0|||
130179408|NCT04176250|468613568|FG003|Overall Study|Withdrawal by Subject|0|||
130179409|NCT04176250|468613569|FG004|Overall Study|Withdrawal by Subject|0|||
130179410|NCT04176250|468613570|FG005|Overall Study|Withdrawal by Subject|1|||
130179411|NCT04176250|468613565|FG000|Overall Study|Randomized in error|0|||
130179412|NCT04176250|468613566|FG001|Overall Study|Randomized in error|0|||
130179413|NCT04176250|468613567|FG002|Overall Study|Randomized in error|0|||
130179414|NCT04176250|468613568|FG003|Overall Study|Randomized in error|0|||
130179415|NCT04176250|468613569|FG004|Overall Study|Randomized in error|1|||
130179416|NCT04176250|468613570|FG005|Overall Study|Randomized in error|0|||
130179417|NCT04747470|468613586|FG000|Overall Study|Death|0|||
130179418|NCT04747470|468613587|FG001|Overall Study|Death|3|||
130179419|NCT04747470|468613588|FG002|Overall Study|Death|2|||
130179420|NCT04747470|468613589|FG003|Overall Study|Death|2|||
130179421|NCT04747470|468613590|FG004|Overall Study|Death|2|||
130179422|NCT04747470|468613591|FG005|Overall Study|Death|0|||
130179423|NCT04747470|468613592|FG006|Overall Study|Death|0|||
130179424|NCT04747470|468613593|FG007|Overall Study|Death|0|||
130179425|NCT04747470|468613594|FG008|Overall Study|Death|0|||
130179426|NCT04747470|468613595|FG009|Overall Study|Death|0|||
130179427|NCT04747470|468613596|FG010|Overall Study|Death|0|||
130179428|NCT04747470|468613586|FG000|Overall Study|Withdrew Consent|0|||
130179429|NCT04747470|468613587|FG001|Overall Study|Withdrew Consent|0|||
130179430|NCT04747470|468613588|FG002|Overall Study|Withdrew Consent|0|||
130179431|NCT04747470|468613589|FG003|Overall Study|Withdrew Consent|1|||
130179432|NCT04747470|468613590|FG004|Overall Study|Withdrew Consent|0|||
130179433|NCT04747470|468613591|FG005|Overall Study|Withdrew Consent|0|||
130179434|NCT04747470|468613592|FG006|Overall Study|Withdrew Consent|0|||
130179435|NCT04747470|468613593|FG007|Overall Study|Withdrew Consent|0|||
130179436|NCT04747470|468613594|FG008|Overall Study|Withdrew Consent|0|||
130179437|NCT04747470|468613595|FG009|Overall Study|Withdrew Consent|0|||
130179438|NCT04747470|468613596|FG010|Overall Study|Withdrew Consent|0|||
130179439|NCT04747470|468613586|FG000|Overall Study|Study Terminated by Sponsor|0|||
130179440|NCT04747470|468613587|FG001|Overall Study|Study Terminated by Sponsor|0|||
130179441|NCT04747470|468613588|FG002|Overall Study|Study Terminated by Sponsor|1|||
130179442|NCT04747470|468613589|FG003|Overall Study|Study Terminated by Sponsor|0|||
130179443|NCT04747470|468613590|FG004|Overall Study|Study Terminated by Sponsor|2|||
130179444|NCT04747470|468613591|FG005|Overall Study|Study Terminated by Sponsor|0|||
130179445|NCT04747470|468613592|FG006|Overall Study|Study Terminated by Sponsor|0|||
130179446|NCT04747470|468613593|FG007|Overall Study|Study Terminated by Sponsor|0|||
130179447|NCT04747470|468613594|FG008|Overall Study|Study Terminated by Sponsor|0|||
130179448|NCT04747470|468613595|FG009|Overall Study|Study Terminated by Sponsor|0|||
130179449|NCT04747470|468613596|FG010|Overall Study|Study Terminated by Sponsor|0|||
130179450|NCT01202175|468613597|FG000|Overall Study|Lost to Follow-up|2|||
130179451|NCT01202175|468613597|FG000|Overall Study|Withdrawal by Subject|1|||
130179452|NCT01202175|468613597|FG000|Overall Study|Adverse Event|2|||
130179453|NCT04688671|468613601|FG000|Overall Study|Adverse Event|3|||
130179454|NCT04688671|468613602|FG001|Overall Study|Adverse Event|1|||
130179455|NCT04688671|468613601|FG000|Overall Study|Withdrawal by Subject|3|||
130179456|NCT04688671|468613602|FG001|Overall Study|Withdrawal by Subject|1|||
130179457|NCT04688671|468613601|FG000|Overall Study|Lack of Efficacy|1|||
130179458|NCT04688671|468613602|FG001|Overall Study|Lack of Efficacy|1|||
130179459|NCT04688671|468613601|FG000|Overall Study|Protocol Violation|1|||
130179460|NCT04688671|468613602|FG001|Overall Study|Protocol Violation|0|||
130179461|NCT04688671|468613601|FG000|Overall Study|Lost to Follow-up|0|||
130179462|NCT04688671|468613602|FG001|Overall Study|Lost to Follow-up|1|||
130179463|NCT04720053|468613603|FG000|Overall Study|Lost to Follow-up|12|||
130179464|NCT01942993|468613604|FG000|Overall Study|Lost to Follow-up|1|||
130179465|NCT01942993|468613604|FG000|Overall Study|Physician Decision|1|||
130179466|NCT01350271|468613605|FG000|Overall Study|Lost to Follow-up|21|||
130179467|NCT01350271|468613606|FG001|Overall Study|Lost to Follow-up|17|||
130179468|NCT01350271|468613607|FG002|Overall Study|Lost to Follow-up|26|||
130179469|NCT02906670|468613611|FG000|Cohort 1, QW|Radiological Progression|1|||
130179470|NCT02906670|468613612|FG001|Cohort 1, QW|Radiological Progression|0|||
130179471|NCT02906670|468613613|FG002|Cohort 1, QW|Radiological Progression|0|||
130179472|NCT02906670|468613614|FG003|Cohort 1, QW|Radiological Progression|0|||
130179473|NCT02906670|468613615|FG004|Cohort 1, QW|Radiological Progression|0|||
130179474|NCT02906670|468613616|FG005|Cohort 1, QW|Radiological Progression|0|||
130179475|NCT02906670|468613617|FG006|Cohort 1, QW|Radiological Progression|0|||
130179476|NCT02906670|468613618|FG007|Cohort 1, QW|Radiological Progression|0|||
130179477|NCT02906670|468613619|FG008|Cohort 1, QW|Radiological Progression|0|||
130179478|NCT02906670|468613620|FG009|Cohort 1, QW|Radiological Progression|0|||
130179479|NCT02906670|468613611|FG000|Cohort 2, QW|Radiological Progression|0|||
130179480|NCT02906670|468613612|FG001|Cohort 2, QW|Radiological Progression|1|||
130179481|NCT02906670|468613613|FG002|Cohort 2, QW|Radiological Progression|0|||
130179482|NCT02906670|468613614|FG003|Cohort 2, QW|Radiological Progression|0|||
130179483|NCT02906670|468613615|FG004|Cohort 2, QW|Radiological Progression|0|||
130179484|NCT02906670|468613616|FG005|Cohort 2, QW|Radiological Progression|0|||
130179485|NCT02906670|468613617|FG006|Cohort 2, QW|Radiological Progression|0|||
130179486|NCT02906670|468613618|FG007|Cohort 2, QW|Radiological Progression|0|||
130179487|NCT02906670|468613619|FG008|Cohort 2, QW|Radiological Progression|0|||
130179488|NCT02906670|468613620|FG009|Cohort 2, QW|Radiological Progression|0|||
130179489|NCT02906670|468613611|FG000|Cohort 3, QW|Radiological Progression|0|||
130179490|NCT02906670|468613612|FG001|Cohort 3, QW|Radiological Progression|0|||
130179491|NCT02906670|468613613|FG002|Cohort 3, QW|Radiological Progression|2|||
130179492|NCT02906670|468613614|FG003|Cohort 3, QW|Radiological Progression|0|||
130179493|NCT02906670|468613615|FG004|Cohort 3, QW|Radiological Progression|0|||
130179494|NCT02906670|468613616|FG005|Cohort 3, QW|Radiological Progression|0|||
130179495|NCT02906670|468613617|FG006|Cohort 3, QW|Radiological Progression|0|||
130179496|NCT02906670|468613618|FG007|Cohort 3, QW|Radiological Progression|0|||
130179497|NCT02906670|468613619|FG008|Cohort 3, QW|Radiological Progression|0|||
130179498|NCT02906670|468613620|FG009|Cohort 3, QW|Radiological Progression|0|||
130179499|NCT02906670|468613611|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179500|NCT02906670|468613612|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179501|NCT02906670|468613613|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
130179502|NCT02906670|468613614|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179503|NCT02906670|468613615|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179504|NCT02906670|468613616|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179505|NCT02906670|468613617|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179506|NCT02906670|468613618|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179507|NCT02906670|468613619|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179508|NCT02906670|468613620|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179509|NCT02906670|468613611|FG000|Cohort 4, Q2W|Radiological Progression|0|||
130179510|NCT02906670|468613612|FG001|Cohort 4, Q2W|Radiological Progression|0|||
130179511|NCT02906670|468613613|FG002|Cohort 4, Q2W|Radiological Progression|0|||
130179512|NCT02906670|468613614|FG003|Cohort 4, Q2W|Radiological Progression|0|||
130179513|NCT02906670|468613615|FG004|Cohort 4, Q2W|Radiological Progression|0|||
130179514|NCT02906670|468613616|FG005|Cohort 4, Q2W|Radiological Progression|1|||
130179515|NCT02906670|468613617|FG006|Cohort 4, Q2W|Radiological Progression|0|||
130179516|NCT02906670|468613618|FG007|Cohort 4, Q2W|Radiological Progression|0|||
130179517|NCT02906670|468613619|FG008|Cohort 4, Q2W|Radiological Progression|0|||
130179518|NCT02906670|468613620|FG009|Cohort 4, Q2W|Radiological Progression|0|||
130179519|NCT02906670|468613611|FG000|Cohort 4, Q2W|Clinical Progression|0|||
130179520|NCT02906670|468613612|FG001|Cohort 4, Q2W|Clinical Progression|0|||
130179521|NCT02906670|468613613|FG002|Cohort 4, Q2W|Clinical Progression|0|||
130179522|NCT02906670|468613614|FG003|Cohort 4, Q2W|Clinical Progression|0|||
130179523|NCT02906670|468613615|FG004|Cohort 4, Q2W|Clinical Progression|0|||
130179524|NCT02906670|468613616|FG005|Cohort 4, Q2W|Clinical Progression|2|||
130179525|NCT02906670|468613617|FG006|Cohort 4, Q2W|Clinical Progression|0|||
130179526|NCT02906670|468613618|FG007|Cohort 4, Q2W|Clinical Progression|0|||
130179527|NCT02906670|468613619|FG008|Cohort 4, Q2W|Clinical Progression|0|||
130179528|NCT02906670|468613620|FG009|Cohort 4, Q2W|Clinical Progression|0|||
130179529|NCT02906670|468613611|FG000|Cohort 5, Q2W|Radiological Progression|0|||
130179530|NCT02906670|468613612|FG001|Cohort 5, Q2W|Radiological Progression|0|||
130179531|NCT02906670|468613613|FG002|Cohort 5, Q2W|Radiological Progression|0|||
130179532|NCT02906670|468613614|FG003|Cohort 5, Q2W|Radiological Progression|0|||
130179533|NCT02906670|468613615|FG004|Cohort 5, Q2W|Radiological Progression|0|||
130179534|NCT02906670|468613616|FG005|Cohort 5, Q2W|Radiological Progression|0|||
130179535|NCT02906670|468613617|FG006|Cohort 5, Q2W|Radiological Progression|4|||
130179536|NCT02906670|468613618|FG007|Cohort 5, Q2W|Radiological Progression|0|||
130179537|NCT02906670|468613619|FG008|Cohort 5, Q2W|Radiological Progression|0|||
130179538|NCT02906670|468613620|FG009|Cohort 5, Q2W|Radiological Progression|0|||
130179539|NCT02906670|468613611|FG000|Cohort 5, Q2W|Clinical Progression|0|||
130179540|NCT02906670|468613612|FG001|Cohort 5, Q2W|Clinical Progression|0|||
130179541|NCT02906670|468613613|FG002|Cohort 5, Q2W|Clinical Progression|0|||
130179542|NCT02906670|468613614|FG003|Cohort 5, Q2W|Clinical Progression|0|||
130179543|NCT02906670|468613615|FG004|Cohort 5, Q2W|Clinical Progression|0|||
130179544|NCT02906670|468613616|FG005|Cohort 5, Q2W|Clinical Progression|0|||
130179545|NCT02906670|468613617|FG006|Cohort 5, Q2W|Clinical Progression|1|||
130179546|NCT02906670|468613618|FG007|Cohort 5, Q2W|Clinical Progression|0|||
130179547|NCT02906670|468613619|FG008|Cohort 5, Q2W|Clinical Progression|0|||
130179548|NCT02906670|468613620|FG009|Cohort 5, Q2W|Clinical Progression|0|||
130179549|NCT02906670|468613611|FG000|Cohort 5, Q2W|Adverse Event|0|||
130179550|NCT02906670|468613612|FG001|Cohort 5, Q2W|Adverse Event|0|||
130179551|NCT02906670|468613613|FG002|Cohort 5, Q2W|Adverse Event|0|||
130179552|NCT02906670|468613614|FG003|Cohort 5, Q2W|Adverse Event|0|||
130179553|NCT02906670|468613615|FG004|Cohort 5, Q2W|Adverse Event|0|||
130179554|NCT02906670|468613616|FG005|Cohort 5, Q2W|Adverse Event|0|||
130179555|NCT02906670|468613617|FG006|Cohort 5, Q2W|Adverse Event|1|||
130179556|NCT02906670|468613618|FG007|Cohort 5, Q2W|Adverse Event|0|||
130179557|NCT02906670|468613619|FG008|Cohort 5, Q2W|Adverse Event|0|||
130179558|NCT02906670|468613620|FG009|Cohort 5, Q2W|Adverse Event|0|||
130179559|NCT02906670|468613611|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179560|NCT02906670|468613612|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179561|NCT02906670|468613613|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179562|NCT02906670|468613614|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179563|NCT02906670|468613615|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179564|NCT02906670|468613616|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179565|NCT02906670|468613617|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
130179566|NCT02906670|468613618|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179567|NCT02906670|468613619|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179568|NCT02906670|468613620|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179569|NCT02906670|468613611|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
130179570|NCT02906670|468613612|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
130179571|NCT02906670|468613613|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
130179572|NCT02906670|468613614|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
130179573|NCT02906670|468613615|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
130179574|NCT02906670|468613616|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
130179575|NCT02906670|468613617|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
130179576|NCT02906670|468613618|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
130179577|NCT02906670|468613619|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
130179578|NCT02906670|468613620|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
130179579|NCT02906670|468613611|FG000|Cohort 5P, Q2W|Adverse Event|0|||
130179580|NCT02906670|468613612|FG001|Cohort 5P, Q2W|Adverse Event|0|||
130179581|NCT02906670|468613613|FG002|Cohort 5P, Q2W|Adverse Event|0|||
130179582|NCT02906670|468613614|FG003|Cohort 5P, Q2W|Adverse Event|0|||
130179583|NCT02906670|468613615|FG004|Cohort 5P, Q2W|Adverse Event|0|||
130179584|NCT02906670|468613616|FG005|Cohort 5P, Q2W|Adverse Event|0|||
130179585|NCT02906670|468613617|FG006|Cohort 5P, Q2W|Adverse Event|0|||
130179586|NCT02906670|468613618|FG007|Cohort 5P, Q2W|Adverse Event|1|||
130179587|NCT02906670|468613619|FG008|Cohort 5P, Q2W|Adverse Event|0|||
130179588|NCT02906670|468613620|FG009|Cohort 5P, Q2W|Adverse Event|0|||
130179589|NCT02906670|468613611|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
130179590|NCT02906670|468613612|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
130179591|NCT02906670|468613613|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
130179592|NCT02906670|468613614|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
130179593|NCT02906670|468613615|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
130179594|NCT02906670|468613616|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
130179595|NCT02906670|468613617|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
130179596|NCT02906670|468613618|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
130651578|NCT01050998|470346312|FG004|Overall Study|Adverse Event|2|||
130651579|NCT01050998|470346308|FG000|Overall Study|Withdrawal by Subject|0|||
130651580|NCT01050998|470346309|FG001|Overall Study|Withdrawal by Subject|0|||
130651581|NCT01050998|470346310|FG002|Overall Study|Withdrawal by Subject|0|||
130651582|NCT01050998|470346311|FG003|Overall Study|Withdrawal by Subject|1|||
130651583|NCT01050998|470346312|FG004|Overall Study|Withdrawal by Subject|3|||
130651584|NCT01050998|470346308|FG000|Overall Study|Other|3|||
130651585|NCT01050998|470346309|FG001|Overall Study|Other|2|||
130651586|NCT01050998|470346310|FG002|Overall Study|Other|1|||
130651587|NCT01050998|470346311|FG003|Overall Study|Other|1|||
130651588|NCT01050998|470346312|FG004|Overall Study|Other|5|||
130651589|NCT01050998|470346308|FG000|Overall Study|Data integrity issues|0|||
130651590|NCT01050998|470346309|FG001|Overall Study|Data integrity issues|0|||
130651591|NCT01050998|470346310|FG002|Overall Study|Data integrity issues|1|||
130651592|NCT01050998|470346311|FG003|Overall Study|Data integrity issues|1|||
130651593|NCT01050998|470346312|FG004|Overall Study|Data integrity issues|4|||
130651594|NCT02219477|470346315|FG000|Overall Study|Adverse Event|0|||
130651595|NCT02219477|470346316|FG001|Overall Study|Adverse Event|1|||
130651596|NCT02219477|470346317|FG002|Overall Study|Adverse Event|1|||
130651597|NCT02219477|470346315|FG000|Overall Study|Withdrawal by Subject|0|||
130651598|NCT02219477|470346316|FG001|Overall Study|Withdrawal by Subject|1|||
130651599|NCT02219477|470346317|FG002|Overall Study|Withdrawal by Subject|0|||
130651600|NCT00234533|470346324|FG000|Overall Study|Withdrawal by Subject|6|||
130651601|NCT00234533|470346324|FG000|Overall Study|Adverse Event|2|||
130651602|NCT00234533|470346324|FG000|Overall Study|Enrolled but not treated|3|||
130651603|NCT00976989|470346325|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130651604|NCT00976989|470346326|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130651605|NCT00976989|470346327|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
130651606|NCT00976989|470346325|FG000|Overall Study|Death|5|||
130651607|NCT00976989|470346326|FG001|Overall Study|Death|7|||
130651608|NCT00976989|470346327|FG002|Overall Study|Death|10|||
130651609|NCT00976989|470346325|FG000|Overall Study|Refused Treatment|4|||
130651610|NCT00976989|470346326|FG001|Overall Study|Refused Treatment|3|||
130651611|NCT00976989|470346327|FG002|Overall Study|Refused Treatment|5|||
130651612|NCT00976989|470346325|FG000|Overall Study|Failure to Return|2|||
130651613|NCT00976989|470346326|FG001|Overall Study|Failure to Return|1|||
130651614|NCT00976989|470346327|FG002|Overall Study|Failure to Return|0|||
130651615|NCT00976989|470346325|FG000|Overall Study|Recurrence of Disease|0|||
130651616|NCT00976989|470346326|FG001|Overall Study|Recurrence of Disease|1|||
130651617|NCT00976989|470346327|FG002|Overall Study|Recurrence of Disease|0|||
130651618|NCT00976989|470346325|FG000|Overall Study|Other|1|||
130651619|NCT00976989|470346326|FG001|Overall Study|Other|0|||
130651620|NCT00976989|470346327|FG002|Overall Study|Other|1|||
130651621|NCT00678652|470346329|FG000|Overall Study|Protocol Violation|2|||
130651622|NCT00678652|470346330|FG001|Overall Study|Protocol Violation|0|||
130651623|NCT00678652|470346331|FG002|Overall Study|Protocol Violation|0|||
130651624|NCT00678652|470346332|FG003|Overall Study|Protocol Violation|0|||
130651625|NCT00678652|470346329|FG000|Overall Study|Pregnancy|0|||
130651626|NCT00678652|470346330|FG001|Overall Study|Pregnancy|0|||
130651627|NCT00678652|470346331|FG002|Overall Study|Pregnancy|1|||
130651628|NCT00678652|470346332|FG003|Overall Study|Pregnancy|0|||
130651629|NCT00678652|470346329|FG000|Overall Study|Relocation|1|||
130651630|NCT00678652|470346330|FG001|Overall Study|Relocation|0|||
130651631|NCT00678652|470346331|FG002|Overall Study|Relocation|0|||
130651632|NCT00678652|470346332|FG003|Overall Study|Relocation|0|||
130651633|NCT03205605|470346333|FG000|Overall Study|Withdrawal by Subject|1|||
130651634|NCT03328325|470346336|FG000|Overall Study|Lost to Follow-up|4|||
130179597|NCT02906670|468613619|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
130179598|NCT02906670|468613620|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
130179599|NCT02906670|468613611|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
130651635|NCT03328325|470346336|FG000|Overall Study|Physician Decision|1|||
130651636|NCT03328325|470346336|FG000|Overall Study|Withdrawal by Subject|3|||
130651637|NCT03328325|470346336|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
130651638|NCT04794491|470346337|FG000|Overall Study|Adverse Event|1|||
130651639|NCT04794491|470346337|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
130651640|NCT04794491|470346337|FG000|Overall Study|Noncompliance With Study Intervention|1|||
130651641|NCT04794491|470346337|FG000|Overall Study|Withdrawal by Subject|2|||
130651642|NCT00736840|470346338|FG000|Overall Study|Lost to Follow-up|13|||
130651643|NCT01990339|470346339|FG000|Overall Study|Data Not Available|49|||
130651644|NCT01990339|470346339|FG000|Overall Study|Voluntary Withdrawal|1402|||
130651645|NCT01990339|470346339|FG000|Overall Study|Lost to Follow-up|861|||
130651646|NCT01038609|470346340|FG000|Overall Study|Adverse Event|0|||
130651647|NCT01038609|470346341|FG001|Overall Study|Adverse Event|0|||
130179600|NCT02906670|468613612|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
130179601|NCT02906670|468613613|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
130179602|NCT02906670|468613614|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
130179603|NCT02906670|468613615|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
130179604|NCT02906670|468613616|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
130179605|NCT02906670|468613617|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
130179606|NCT02906670|468613618|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
130179607|NCT02906670|468613619|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
130179608|NCT02906670|468613620|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
130179609|NCT02906670|468613611|FG000|Cohort 4P, QW|Radiological Progression|0|||
130179610|NCT02906670|468613612|FG001|Cohort 4P, QW|Radiological Progression|0|||
130179611|NCT02906670|468613613|FG002|Cohort 4P, QW|Radiological Progression|0|||
130179612|NCT02906670|468613614|FG003|Cohort 4P, QW|Radiological Progression|3|||
130179613|NCT02906670|468613615|FG004|Cohort 4P, QW|Radiological Progression|0|||
130179614|NCT02906670|468613616|FG005|Cohort 4P, QW|Radiological Progression|0|||
130179615|NCT02906670|468613617|FG006|Cohort 4P, QW|Radiological Progression|0|||
130179616|NCT02906670|468613618|FG007|Cohort 4P, QW|Radiological Progression|0|||
130179617|NCT02906670|468613619|FG008|Cohort 4P, QW|Radiological Progression|0|||
130179618|NCT02906670|468613620|FG009|Cohort 4P, QW|Radiological Progression|0|||
130179619|NCT02906670|468613611|FG000|Cohort 7P, Q2W|Adverse Event|0|||
130179620|NCT02906670|468613612|FG001|Cohort 7P, Q2W|Adverse Event|0|||
130179621|NCT02906670|468613613|FG002|Cohort 7P, Q2W|Adverse Event|0|||
130179622|NCT02906670|468613614|FG003|Cohort 7P, Q2W|Adverse Event|0|||
130179623|NCT02906670|468613615|FG004|Cohort 7P, Q2W|Adverse Event|0|||
130179624|NCT02906670|468613616|FG005|Cohort 7P, Q2W|Adverse Event|0|||
130651648|NCT01038609|470346342|FG002|Overall Study|Adverse Event|1|||
130651649|NCT01038609|470346343|FG003|Overall Study|Adverse Event|0|||
130651650|NCT01038609|470346344|FG004|Overall Study|Adverse Event|0|||
130651651|NCT01038609|470346340|FG000|Overall Study|Dosing Error|0|||
130651652|NCT01038609|470346341|FG001|Overall Study|Dosing Error|0|||
130651653|NCT01038609|470346342|FG002|Overall Study|Dosing Error|0|||
130651654|NCT01038609|470346343|FG003|Overall Study|Dosing Error|1|||
130651655|NCT01038609|470346344|FG004|Overall Study|Dosing Error|1|||
130651656|NCT01038609|470346340|FG000|Overall Study|Death in the Family|1|||
130651657|NCT01038609|470346341|FG001|Overall Study|Death in the Family|0|||
130651658|NCT01038609|470346342|FG002|Overall Study|Death in the Family|0|||
130651659|NCT01038609|470346343|FG003|Overall Study|Death in the Family|0|||
130651660|NCT01038609|470346344|FG004|Overall Study|Death in the Family|0|||
130651661|NCT01038609|470346340|FG000|Overall Study|Refusal of Blood Draws|0|||
130651662|NCT01038609|470346341|FG001|Overall Study|Refusal of Blood Draws|1|||
130651663|NCT01038609|470346342|FG002|Overall Study|Refusal of Blood Draws|0|||
130651664|NCT01038609|470346343|FG003|Overall Study|Refusal of Blood Draws|0|||
130651665|NCT01038609|470346344|FG004|Overall Study|Refusal of Blood Draws|0|||
130651666|NCT03289676|470346347|FG000|Overall Study|Withdrawal by Subject|2|||
130651667|NCT03289676|470346348|FG001|Overall Study|Withdrawal by Subject|0|||
130651668|NCT03289676|470346347|FG000|Overall Study|Protocol Violation|2|||
130651669|NCT03289676|470346348|FG001|Overall Study|Protocol Violation|0|||
130651670|NCT03289676|470346347|FG000|Overall Study|Lost to Follow-up|0|||
130651671|NCT03289676|470346348|FG001|Overall Study|Lost to Follow-up|1|||
130651672|NCT01314261|470346349|FG000|Overall Study|Adverse Event|1|||
130651673|NCT01314261|470346350|FG001|Overall Study|Adverse Event|0|||
130651674|NCT01314261|470346351|FG002|Overall Study|Adverse Event|0|||
130651675|NCT01314261|470346352|FG003|Overall Study|Adverse Event|0|||
130651676|NCT01314261|470346349|FG000|Overall Study|Withdrawal by Subject|0|||
130651677|NCT01314261|470346350|FG001|Overall Study|Withdrawal by Subject|3|||
130651678|NCT01314261|470346351|FG002|Overall Study|Withdrawal by Subject|1|||
130651679|NCT01314261|470346352|FG003|Overall Study|Withdrawal by Subject|0|||
130651680|NCT01314261|470346349|FG000|Overall Study|Lost to Follow-up|1|||
130651681|NCT01314261|470346350|FG001|Overall Study|Lost to Follow-up|0|||
130651682|NCT01314261|470346351|FG002|Overall Study|Lost to Follow-up|2|||
130651683|NCT01314261|470346352|FG003|Overall Study|Lost to Follow-up|2|||
130651684|NCT01314261|470346349|FG000|Overall Study|Virologic Failure|0|||
130651685|NCT01314261|470346350|FG001|Overall Study|Virologic Failure|1|||
130651686|NCT01314261|470346351|FG002|Overall Study|Virologic Failure|0|||
130651687|NCT01314261|470346352|FG003|Overall Study|Virologic Failure|1|||
130651688|NCT04524507|470346353|FG000|Overall Study|Lost to Follow-up|2|||
130651689|NCT04524507|470346354|FG001|Overall Study|Lost to Follow-up|4|||
130179625|NCT02906670|468613617|FG006|Cohort 7P, Q2W|Adverse Event|0|||
130179626|NCT02906670|468613618|FG007|Cohort 7P, Q2W|Adverse Event|0|||
130179627|NCT02906670|468613619|FG008|Cohort 7P, Q2W|Adverse Event|0|||
130651690|NCT04524507|470346353|FG000|Overall Study|Withdrawal by Subject|2|||
130651691|NCT04524507|470346354|FG001|Overall Study|Withdrawal by Subject|9|||
130651692|NCT04524507|470346353|FG000|Overall Study|Death|2|||
130651693|NCT04524507|470346354|FG001|Overall Study|Death|10|||
130651694|NCT00412360|470346355|FG000|Overall Study|Lost to Follow-up|0|||
130651695|NCT00412360|470346356|FG001|Overall Study|Lost to Follow-up|1|||
130651696|NCT00412360|470346355|FG000|Overall Study|Not Transplanted|1|||
130651697|NCT00412360|470346356|FG001|Overall Study|Not Transplanted|2|||
130651698|NCT02711306|470346357|FG000|Overall Study|Withdrawal by Subject|2|||
130179628|NCT02906670|468613620|FG009|Cohort 7P, Q2W|Adverse Event|1|||
130179629|NCT02906670|468613611|FG000|Cohort 7P, Q2W|Physician Decision|0|||
130179630|NCT02906670|468613612|FG001|Cohort 7P, Q2W|Physician Decision|0|||
130179631|NCT02906670|468613613|FG002|Cohort 7P, Q2W|Physician Decision|0|||
130179632|NCT02906670|468613614|FG003|Cohort 7P, Q2W|Physician Decision|0|||
130179633|NCT02906670|468613615|FG004|Cohort 7P, Q2W|Physician Decision|0|||
130651699|NCT02711306|470346358|FG001|Overall Study|Withdrawal by Subject|2|||
130651700|NCT02569996|470346359|FG000|Overall Study|Adverse Event|6|||
130651701|NCT02569996|470346359|FG000|Overall Study|Physician Decision|3|||
130651702|NCT02569996|470346359|FG000|Overall Study|Progression of the disease|18|||
130651703|NCT02569996|470346359|FG000|Overall Study|New anti-lymphoma treatment|1|||
130651704|NCT02569996|470346359|FG000|Overall Study|Non-compliance|9|||
130651705|NCT02569996|470346359|FG000|Overall Study|Withdrawal by Subject|5|||
130651706|NCT02569996|470346359|FG000|Overall Study|Lost to Follow-up|5|||
130651707|NCT02569996|470346359|FG000|Overall Study|Complete remission|7|||
130651708|NCT02569996|470346359|FG000|Overall Study|Unknown reason|1|||
130651709|NCT01383317|470346360|FG000|Overall Study|Lost to Follow-up|2|||
130651710|NCT01383317|470346361|FG001|Overall Study|Lost to Follow-up|1|||
130651711|NCT01383317|470346360|FG000|Overall Study|Death|1|||
130651712|NCT01383317|470346361|FG001|Overall Study|Death|0|||
130651713|NCT01383317|470346360|FG000|Overall Study|Adverse Event|0|||
130651714|NCT01383317|470346361|FG001|Overall Study|Adverse Event|1|||
130651715|NCT01397409|470346363|FG000|Stage 2|Adverse Event|0|||
130651716|NCT01397409|470346364|FG001|Stage 2|Adverse Event|0|||
130651717|NCT01397409|470346365|FG002|Stage 2|Adverse Event|0|||
130651718|NCT01397409|470346366|FG003|Stage 2|Adverse Event|0|||
130651719|NCT01397409|470346367|FG004|Stage 2|Adverse Event|6|||
130651720|NCT01397409|470346368|FG005|Stage 2|Adverse Event|3|||
130651721|NCT01397409|470346369|FG006|Stage 2|Adverse Event|0|||
130651722|NCT01397409|470346370|FG007|Stage 2|Adverse Event|0|||
130651723|NCT01397409|470346371|FG008|Stage 2|Adverse Event|0|||
130651724|NCT01397409|470346372|FG009|Stage 2|Adverse Event|0|||
130651725|NCT01397409|470346363|FG000|Stage 2|Personal Reasons|0|||
130651726|NCT01397409|470346364|FG001|Stage 2|Personal Reasons|0|||
130651727|NCT01397409|470346365|FG002|Stage 2|Personal Reasons|0|||
130651728|NCT01397409|470346366|FG003|Stage 2|Personal Reasons|0|||
130651729|NCT01397409|470346367|FG004|Stage 2|Personal Reasons|1|||
130651730|NCT01397409|470346368|FG005|Stage 2|Personal Reasons|0|||
130651731|NCT01397409|470346369|FG006|Stage 2|Personal Reasons|0|||
130651732|NCT01397409|470346370|FG007|Stage 2|Personal Reasons|0|||
130651733|NCT01397409|470346371|FG008|Stage 2|Personal Reasons|0|||
130651734|NCT01397409|470346372|FG009|Stage 2|Personal Reasons|0|||
130651735|NCT01397409|470346363|FG000|Stage 2|Other Miscellaneous Reasons|0|||
130651736|NCT01397409|470346364|FG001|Stage 2|Other Miscellaneous Reasons|0|||
130651737|NCT01397409|470346365|FG002|Stage 2|Other Miscellaneous Reasons|0|||
130651738|NCT01397409|470346366|FG003|Stage 2|Other Miscellaneous Reasons|0|||
130651739|NCT01397409|470346367|FG004|Stage 2|Other Miscellaneous Reasons|1|||
130651740|NCT01397409|470346368|FG005|Stage 2|Other Miscellaneous Reasons|1|||
130651741|NCT01397409|470346369|FG006|Stage 2|Other Miscellaneous Reasons|0|||
130651742|NCT01397409|470346370|FG007|Stage 2|Other Miscellaneous Reasons|0|||
130651743|NCT01397409|470346371|FG008|Stage 2|Other Miscellaneous Reasons|0|||
130651744|NCT01397409|470346372|FG009|Stage 2|Other Miscellaneous Reasons|0|||
130651745|NCT01397409|470346363|FG000|Stage 3|Adverse Event|0|||
130651746|NCT01397409|470346364|FG001|Stage 3|Adverse Event|0|||
130651747|NCT01397409|470346365|FG002|Stage 3|Adverse Event|0|||
130651748|NCT01397409|470346366|FG003|Stage 3|Adverse Event|0|||
130651749|NCT01397409|470346367|FG004|Stage 3|Adverse Event|0|||
130651750|NCT01397409|470346368|FG005|Stage 3|Adverse Event|0|||
130651751|NCT01397409|470346369|FG006|Stage 3|Adverse Event|0|||
130651752|NCT01397409|470346370|FG007|Stage 3|Adverse Event|1|||
130651753|NCT01397409|470346371|FG008|Stage 3|Adverse Event|0|||
130651754|NCT01397409|470346372|FG009|Stage 3|Adverse Event|0|||
130651755|NCT01397409|470346363|FG000|Stage 3|Other Miscellaneous Reasons|0|||
130651756|NCT01397409|470346364|FG001|Stage 3|Other Miscellaneous Reasons|0|||
130651757|NCT01397409|470346365|FG002|Stage 3|Other Miscellaneous Reasons|0|||
130651758|NCT01397409|470346366|FG003|Stage 3|Other Miscellaneous Reasons|0|||
130651759|NCT01397409|470346367|FG004|Stage 3|Other Miscellaneous Reasons|0|||
130651760|NCT01397409|470346368|FG005|Stage 3|Other Miscellaneous Reasons|0|||
130651761|NCT01397409|470346369|FG006|Stage 3|Other Miscellaneous Reasons|0|||
130651762|NCT01397409|470346370|FG007|Stage 3|Other Miscellaneous Reasons|1|||
130651763|NCT01397409|470346371|FG008|Stage 3|Other Miscellaneous Reasons|0|||
130651764|NCT01397409|470346372|FG009|Stage 3|Other Miscellaneous Reasons|0|||
130651765|NCT00422227|470346373|FG000|Overall Study|Adverse Event|3|||
130651766|NCT00422227|470346374|FG001|Overall Study|Adverse Event|8|||
130179634|NCT02906670|468613616|FG005|Cohort 7P, Q2W|Physician Decision|0|||
130651767|NCT00422227|470346373|FG000|Overall Study|Lost to Follow-up|1|||
130651768|NCT00422227|470346374|FG001|Overall Study|Lost to Follow-up|3|||
130651769|NCT00422227|470346373|FG000|Overall Study|Withdrawal by Subject|0|||
130651770|NCT00422227|470346374|FG001|Overall Study|Withdrawal by Subject|4|||
130651771|NCT01207427|470346375|FG000|Double-blind Treatment Period|Adverse Event|0|||
130651772|NCT01207427|470346376|FG001|Double-blind Treatment Period|Adverse Event|1|||
130179635|NCT02906670|468613617|FG006|Cohort 7P, Q2W|Physician Decision|0|||
130179636|NCT02906670|468613618|FG007|Cohort 7P, Q2W|Physician Decision|0|||
130179637|NCT02906670|468613619|FG008|Cohort 7P, Q2W|Physician Decision|0|||
130179638|NCT02906670|468613620|FG009|Cohort 7P, Q2W|Physician Decision|1|||
130179639|NCT02906670|468613611|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179640|NCT02906670|468613612|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179641|NCT02906670|468613613|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179642|NCT02906670|468613614|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179643|NCT02906670|468613615|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179644|NCT02906670|468613616|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179645|NCT02906670|468613617|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179646|NCT02906670|468613618|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179647|NCT02906670|468613619|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179648|NCT02906670|468613620|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
130179649|NCT02906670|468613611|FG000|Cohort 5P, QW|Radiological Progression|0|||
130179650|NCT02906670|468613612|FG001|Cohort 5P, QW|Radiological Progression|0|||
130179651|NCT02906670|468613613|FG002|Cohort 5P, QW|Radiological Progression|0|||
130179652|NCT02906670|468613614|FG003|Cohort 5P, QW|Radiological Progression|0|||
130179653|NCT02906670|468613615|FG004|Cohort 5P, QW|Radiological Progression|3|||
130179654|NCT02906670|468613616|FG005|Cohort 5P, QW|Radiological Progression|0|||
130179655|NCT02906670|468613617|FG006|Cohort 5P, QW|Radiological Progression|0|||
130179656|NCT02906670|468613618|FG007|Cohort 5P, QW|Radiological Progression|0|||
130179657|NCT02906670|468613619|FG008|Cohort 5P, QW|Radiological Progression|0|||
130179658|NCT02906670|468613620|FG009|Cohort 5P, QW|Radiological Progression|0|||
130179659|NCT01349192|468613621|FG000|Overall Study|Protocol Violation|0|||
130179660|NCT01349192|468613622|FG001|Overall Study|Protocol Violation|1|||
130179661|NCT01349192|468613621|FG000|Overall Study|Withdrawal by Subject|0|||
130179662|NCT01349192|468613622|FG001|Overall Study|Withdrawal by Subject|2|||
130179663|NCT01349192|468613621|FG000|Overall Study|Lost to Follow-up|1|||
130179664|NCT01349192|468613622|FG001|Overall Study|Lost to Follow-up|3|||
130179665|NCT01349192|468613621|FG000|Overall Study|Failure to adhere to Protocol|2|||
130179666|NCT01349192|468613622|FG001|Overall Study|Failure to adhere to Protocol|0|||
130179667|NCT03749330|468613623|FG000|Overall Study|Clinicians left work in the CICU|0|||
130179668|NCT03749330|468613624|FG001|Overall Study|Clinicians left work in the CICU|2|||
130179669|NCT03749330|468613625|FG002|Overall Study|Clinicians left work in the CICU|0|||
130179670|NCT03749330|468613626|FG003|Overall Study|Clinicians left work in the CICU|0|||
130179671|NCT03749330|468613627|FG004|Overall Study|Clinicians left work in the CICU|0|||
130179672|NCT03749330|468613628|FG005|Overall Study|Clinicians left work in the CICU|0|||
130179673|NCT01973439|468613629|FG000|Overall Study|Lost samples from one PK Day|2|||
130179674|NCT01973439|468613629|FG000|Overall Study|Vomiting after commencing once daily|1|||
130179675|NCT01973439|468613629|FG000|Overall Study|PK curve incomplete|2|||
130179676|NCT02262325|468613631|FG000|Overall Study|Death|16|||
130179677|NCT02262325|468613631|FG000|Overall Study|Lost to Follow-up|1|||
130179678|NCT02815995|468613632|FG000|Overall Study|Disease Progression|3|||
130179679|NCT02815995|468613633|FG001|Overall Study|Disease Progression|7|||
130179680|NCT02815995|468613634|FG002|Overall Study|Disease Progression|2|||
130179681|NCT02815995|468613635|FG003|Overall Study|Disease Progression|4|||
130179682|NCT02815995|468613636|FG004|Overall Study|Disease Progression|3|||
130179683|NCT02815995|468613637|FG005|Overall Study|Disease Progression|9|||
130179684|NCT02815995|468613638|FG006|Overall Study|Disease Progression|3|||
130179685|NCT02815995|468613639|FG007|Overall Study|Disease Progression|1|||
130179686|NCT02815995|468613632|FG000|Overall Study|Adverse Event|1|||
130179687|NCT02815995|468613633|FG001|Overall Study|Adverse Event|2|||
130179688|NCT02815995|468613634|FG002|Overall Study|Adverse Event|2|||
130179689|NCT02815995|468613635|FG003|Overall Study|Adverse Event|0|||
130179690|NCT02815995|468613636|FG004|Overall Study|Adverse Event|0|||
130179691|NCT02815995|468613637|FG005|Overall Study|Adverse Event|1|||
130651773|NCT01207427|470346377|FG002|Double-blind Treatment Period|Adverse Event|0|||
130179692|NCT02815995|468613638|FG006|Overall Study|Adverse Event|0|||
130179693|NCT02815995|468613639|FG007|Overall Study|Adverse Event|0|||
130179694|NCT02815995|468613632|FG000|Overall Study|Pregnancy|0|||
130179695|NCT02815995|468613633|FG001|Overall Study|Pregnancy|0|||
130179696|NCT02815995|468613634|FG002|Overall Study|Pregnancy|0|||
130179697|NCT02815995|468613635|FG003|Overall Study|Pregnancy|0|||
130179698|NCT02815995|468613636|FG004|Overall Study|Pregnancy|0|||
130179699|NCT02815995|468613637|FG005|Overall Study|Pregnancy|0|||
130179700|NCT02815995|468613638|FG006|Overall Study|Pregnancy|1|||
130179701|NCT02815995|468613639|FG007|Overall Study|Pregnancy|0|||
130179702|NCT03571828|468613644|FG000|Overall Study|Withdrawal by Subject|1|||
130179703|NCT03571828|468613645|FG001|Overall Study|Withdrawal by Subject|0|||
130179704|NCT03571828|468613644|FG000|Overall Study|Decision by sponsor|5|||
130179705|NCT03571828|468613645|FG001|Overall Study|Decision by sponsor|1|||
130179706|NCT03571828|468613644|FG000|Overall Study|Death|2|||
130179707|NCT03571828|468613645|FG001|Overall Study|Death|0|||
130179708|NCT00769379|468613646|FG000|Overall Study|No follow up data mapped to Other.|3|||
130179709|NCT00769379|468613647|FG001|Overall Study|No follow up data mapped to Other.|13|||
130179710|NCT03404674|468613648|FG000|Overall Study|Inability to Attend Future Visits|0|||
130179711|NCT03404674|468613649|FG001|Overall Study|Inability to Attend Future Visits|1|||
130179712|NCT03404674|468613650|FG002|Overall Study|Inability to Attend Future Visits|1|||
130179713|NCT03404674|468613651|FG003|Overall Study|Inability to Attend Future Visits|0|||
130179714|NCT03404674|468613652|FG004|Overall Study|Inability to Attend Future Visits|0|||
130179715|NCT03404674|468613653|FG005|Overall Study|Inability to Attend Future Visits|0|||
130179716|NCT03404674|468613648|FG000|Overall Study|Behavioral Problems|0|||
130179717|NCT03404674|468613649|FG001|Overall Study|Behavioral Problems|0|||
130179718|NCT03404674|468613650|FG002|Overall Study|Behavioral Problems|1|||
130179719|NCT03404674|468613651|FG003|Overall Study|Behavioral Problems|0|||
130179720|NCT03404674|468613652|FG004|Overall Study|Behavioral Problems|0|||
130179721|NCT03404674|468613653|FG005|Overall Study|Behavioral Problems|0|||
130179722|NCT03404674|468613648|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179723|NCT03404674|468613649|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179724|NCT03404674|468613650|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179725|NCT03404674|468613651|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
130179726|NCT03404674|468613652|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179727|NCT03404674|468613653|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
130179728|NCT00143390|468613662|FG000|Overall Study|Death|2|||
130179729|NCT00143390|468613663|FG001|Overall Study|Death|0|||
130179730|NCT00143390|468613662|FG000|Overall Study|Not meeting entry criteria|2|||
130179731|NCT00143390|468613663|FG001|Overall Study|Not meeting entry criteria|5|||
130179732|NCT00143390|468613662|FG000|Overall Study|Withdrawal by Subject|4|||
130179733|NCT00143390|468613663|FG001|Overall Study|Withdrawal by Subject|4|||
130179734|NCT00143390|468613662|FG000|Overall Study|Progressive disease|119|||
130179735|NCT00143390|468613663|FG001|Overall Study|Progressive disease|115|||
130179736|NCT00143390|468613662|FG000|Overall Study|Protocol Violation|2|||
130179737|NCT00143390|468613663|FG001|Overall Study|Protocol Violation|0|||
130179738|NCT00143390|468613662|FG000|Overall Study|Study termination|10|||
130179739|NCT00143390|468613663|FG001|Overall Study|Study termination|15|||
130179740|NCT00143390|468613662|FG000|Overall Study|Adverse Event|9|||
130179741|NCT00143390|468613663|FG001|Overall Study|Adverse Event|8|||
130179742|NCT00143390|468613662|FG000|Overall Study|Other|1|||
130179743|NCT00143390|468613663|FG001|Overall Study|Other|2|||
130179744|NCT00041132|468613664|FG000|Overall Study|Adverse Event|19|||
130179745|NCT00041132|468613664|FG000|Overall Study|Death|1|||
130179746|NCT00041132|468613664|FG000|Overall Study|Not Eligible|7|||
130179747|NCT00041132|468613664|FG000|Overall Study|Withdrawal by Subject|1|||
130179748|NCT00041132|468613664|FG000|Overall Study|Physician Decision|2|||
130179749|NCT03180645|468613667|FG000|Overall Study|Adverse Event|0|||
130179750|NCT03180645|468613668|FG001|Overall Study|Adverse Event|1|||
130179751|NCT03180645|468613669|FG002|Overall Study|Adverse Event|2|||
130179752|NCT02729909|468613671|FG000|Overall Study|Lost to Follow-up|0|||
130179753|NCT02729909|468613672|FG001|Overall Study|Lost to Follow-up|1|||
130179754|NCT02729909|468613671|FG000|Overall Study|Lack of Efficacy|0|||
130179755|NCT02729909|468613672|FG001|Overall Study|Lack of Efficacy|2|||
130179756|NCT02729909|468613671|FG000|Overall Study|Significant Protocol Deviation|0|||
130179757|NCT02729909|468613672|FG001|Overall Study|Significant Protocol Deviation|2|||
130179758|NCT02729909|468613671|FG000|Overall Study|Voluntary Withdrawal|1|||
130179759|NCT02729909|468613672|FG001|Overall Study|Voluntary Withdrawal|0|||
130179760|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
130179761|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
130179762|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130179763|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130179764|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
130179765|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179766|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179767|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179768|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
130179769|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179770|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179771|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179772|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130179773|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130179774|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130179775|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130179776|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
130179777|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
130179778|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
130179779|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
130179780|NCT00866359|468613673|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130179781|NCT00866359|468613674|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130179782|NCT00866359|468613675|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
130179783|NCT00866359|468613676|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
130651774|NCT01207427|470346375|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130651775|NCT01207427|470346376|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130651776|NCT01207427|470346377|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130651777|NCT01207427|470346375|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130651778|NCT01207427|470346376|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130651779|NCT01207427|470346377|FG002|Double-blind Treatment Period|Protocol Violation|1|||
130651780|NCT01207427|470346375|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130651781|NCT01207427|470346376|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130651782|NCT01207427|470346377|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130651783|NCT01798056|470347641|FG000|Overall Study|Serious Adverse Event|13|||
130651784|NCT01798056|470347642|FG001|Overall Study|Serious Adverse Event|12|||
130651785|NCT01798056|470347641|FG000|Overall Study|Withdrawal by Subject|12|||
130651786|NCT01798056|470347642|FG001|Overall Study|Withdrawal by Subject|9|||
130651787|NCT01798056|470347641|FG000|Overall Study|Migrated/moved from study area|1|||
130651788|NCT01798056|470347642|FG001|Overall Study|Migrated/moved from study area|1|||
130651789|NCT01798056|470347641|FG000|Overall Study|Lost to Follow-up|1|||
130651790|NCT01798056|470347642|FG001|Overall Study|Lost to Follow-up|1|||
130651791|NCT01798056|470347641|FG000|Overall Study|Other|0|||
130651792|NCT01798056|470347642|FG001|Overall Study|Other|2|||
130651793|NCT02842736|470347645|FG000|Overall Study|Lost to Follow-up|13|||
130651794|NCT02842736|470347645|FG000|Overall Study|Intervention for menstrual bleeding|17|||
130651795|NCT02842736|470347645|FG000|Overall Study|Withdrawal by Subject|4|||
130651796|NCT02842736|470347645|FG000|Overall Study|Pregnancy|3|||
130651797|NCT02842736|470347645|FG000|Overall Study|Hysterectomy for fibroids|2|||
130651798|NCT02842736|470347645|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
130651799|NCT02842736|470347645|FG000|Overall Study|IUD: Mirena|1|||
130651800|NCT03323034|470347647|FG000|Overall Study|Lack of Efficacy|5|||
130651801|NCT03323034|470347648|FG001|Overall Study|Lack of Efficacy|5|||
130651802|NCT03323034|470347649|FG002|Overall Study|Lack of Efficacy|6|||
130651803|NCT03323034|470347650|FG003|Overall Study|Lack of Efficacy|5|||
130651804|NCT03323034|470347651|FG004|Overall Study|Lack of Efficacy|5|||
130651805|NCT03323034|470347647|FG000|Overall Study|Physician Decision|0|||
130651806|NCT03323034|470347648|FG001|Overall Study|Physician Decision|0|||
130651807|NCT03323034|470347649|FG002|Overall Study|Physician Decision|0|||
130651808|NCT03323034|470347650|FG003|Overall Study|Physician Decision|0|||
130651809|NCT03323034|470347651|FG004|Overall Study|Physician Decision|1|||
130651810|NCT03323034|470347647|FG000|Overall Study|Withdrawal by Subject|1|||
130651811|NCT03323034|470347648|FG001|Overall Study|Withdrawal by Subject|1|||
130651812|NCT03323034|470347649|FG002|Overall Study|Withdrawal by Subject|0|||
130651813|NCT03323034|470347650|FG003|Overall Study|Withdrawal by Subject|1|||
130651814|NCT03323034|470347651|FG004|Overall Study|Withdrawal by Subject|0|||
130651815|NCT02646566|470347652|FG000|Overall Study|Lost to Follow-up|5|||
130651816|NCT02646566|470347653|FG001|Overall Study|Lost to Follow-up|4|||
130651817|NCT02646566|470347654|FG002|Overall Study|Lost to Follow-up|5|||
130651818|NCT02646566|470347652|FG000|Overall Study|Treatment failure|1|||
130651819|NCT02646566|470347653|FG001|Overall Study|Treatment failure|0|||
130651820|NCT02646566|470347654|FG002|Overall Study|Treatment failure|0|||
130651821|NCT02815540|470347657|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
130651822|NCT02222246|470347658|FG000|Overall Study|No Emergency Department Visits|27|||
130651823|NCT02222246|470347659|FG001|Overall Study|No Emergency Department Visits|26|||
130651824|NCT02222246|470347658|FG000|Overall Study|Physician Decision|0|||
130651825|NCT02222246|470347659|FG001|Overall Study|Physician Decision|1|||
130651826|NCT02660489|470347660|FG000|Overall Study|Lost to Follow-up|1|||
130651827|NCT02660489|470347661|FG001|Overall Study|Lost to Follow-up|1|||
130651828|NCT02660489|470347660|FG000|Overall Study|Adverse Event|1|||
130651829|NCT02660489|470347661|FG001|Overall Study|Adverse Event|3|||
130651830|NCT02660489|470347660|FG000|Overall Study|no rhinovirus infection|4|||
130651831|NCT02660489|470347661|FG001|Overall Study|no rhinovirus infection|4|||
130651832|NCT02064231|470347662|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
130651833|NCT02064231|470347663|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
130651834|NCT02064231|470347664|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
130651835|NCT02064231|470347665|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
130651836|NCT02064231|470347662|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
130651837|NCT02064231|470347663|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
130651838|NCT02064231|470347664|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
130651839|NCT02064231|470347665|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
130651840|NCT02064231|470347662|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
130651841|NCT02064231|470347663|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
130651842|NCT02064231|470347664|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
130651843|NCT02064231|470347665|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
130651844|NCT02064231|470347662|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
130651845|NCT02064231|470347663|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
130651846|NCT02064231|470347664|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
130179784|NCT00768248|468613678|FG000|Overall Study|Research coordinator didn't collect data|1|||
130179785|NCT00768248|468613679|FG001|Overall Study|Research coordinator didn't collect data|1|||
130179786|NCT01547390|468613680|FG000|Overall Study|Withdrawal by Subject|10|||
130179787|NCT01547390|468613681|FG001|Overall Study|Withdrawal by Subject|7|||
130179788|NCT01547390|468613680|FG000|Overall Study|termination of pregnancy|0|||
130179789|NCT01547390|468613681|FG001|Overall Study|termination of pregnancy|1|||
130179790|NCT01547390|468613680|FG000|Overall Study|Lost to Follow-up|0|||
130179791|NCT01547390|468613681|FG001|Overall Study|Lost to Follow-up|2|||
130179792|NCT01547390|468613680|FG000|Overall Study|Adverse Event|3|||
130179793|NCT01547390|468613681|FG001|Overall Study|Adverse Event|0|||
130179794|NCT01459783|468613682|FG000|Baseline to 6 Months|Death|1|||
130179795|NCT01459783|468613683|FG001|Baseline to 6 Months|Death|0|||
130179796|NCT01459783|468613682|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
130179797|NCT01459783|468613683|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
130179798|NCT01459783|468613682|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
130179799|NCT01459783|468613683|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
130179800|NCT01459783|468613682|FG000|6 Months to 12 Months|Death|0|||
130179801|NCT01459783|468613683|FG001|6 Months to 12 Months|Death|1|||
130179802|NCT01459783|468613682|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
130179803|NCT01459783|468613683|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
130179804|NCT01459783|468613682|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
130179805|NCT01459783|468613683|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
130179806|NCT01459783|468613682|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
130179807|NCT01459783|468613683|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
130179808|NCT06018129|468613685|FG000|Overall Study|Death|1|||
130179809|NCT06018129|468613686|FG001|Overall Study|Death|1|||
130179810|NCT06018129|468613687|FG002|Overall Study|Death|2|||
130179811|NCT06018129|468613685|FG000|Overall Study|Sponsor Decision|2|||
130179812|NCT06018129|468613686|FG001|Overall Study|Sponsor Decision|2|||
130179813|NCT06018129|468613687|FG002|Overall Study|Sponsor Decision|1|||
130179814|NCT04917861|468613688|FG000|Main Study (196 Days)|Adverse Event|0|||
130179815|NCT04917861|468613689|FG001|Main Study (196 Days)|Adverse Event|1|||
130179816|NCT04917861|468613690|FG002|Main Study (196 Days)|Adverse Event|0|||
130179817|NCT04917861|468613691|FG003|Main Study (196 Days)|Adverse Event|0|||
130179818|NCT04917861|468613688|FG000|Main Study (196 Days)|Death|0|||
130179819|NCT04917861|468613689|FG001|Main Study (196 Days)|Death|0|||
130179820|NCT04917861|468613690|FG002|Main Study (196 Days)|Death|0|||
130179821|NCT04917861|468613691|FG003|Main Study (196 Days)|Death|1|||
130179822|NCT04917861|468613688|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
130179823|NCT04917861|468613689|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
130179824|NCT04917861|468613690|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
130179825|NCT04917861|468613691|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
130179826|NCT04917861|468613688|FG000|Main Study (196 Days)|Physician Decision|0|||
130179827|NCT04917861|468613689|FG001|Main Study (196 Days)|Physician Decision|0|||
130179828|NCT04917861|468613690|FG002|Main Study (196 Days)|Physician Decision|0|||
130179829|NCT04917861|468613691|FG003|Main Study (196 Days)|Physician Decision|1|||
130179830|NCT04917861|468613688|FG000|Main Study (196 Days)|Pregnancy|1|||
130179831|NCT04917861|468613689|FG001|Main Study (196 Days)|Pregnancy|1|||
130179832|NCT04917861|468613690|FG002|Main Study (196 Days)|Pregnancy|0|||
130179833|NCT04917861|468613691|FG003|Main Study (196 Days)|Pregnancy|0|||
130179834|NCT04917861|468613688|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
130179835|NCT04917861|468613689|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
130179836|NCT04917861|468613690|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
130179837|NCT04917861|468613691|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
130179838|NCT04917861|468613688|FG000|Main Study (196 Days)|Other Than Specified|1|||
130179839|NCT04917861|468613689|FG001|Main Study (196 Days)|Other Than Specified|0|||
130179840|NCT04917861|468613690|FG002|Main Study (196 Days)|Other Than Specified|1|||
130179841|NCT04917861|468613691|FG003|Main Study (196 Days)|Other Than Specified|2|||
130179842|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
130179843|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
130179844|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
130179845|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
130179846|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179847|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
130179848|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179849|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179850|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179851|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
130179852|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179853|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179854|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
130179855|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130179856|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130179857|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
130179858|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179859|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
130179860|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179861|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179862|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
130179863|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
130179864|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
130179865|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
130179866|NCT06389487|468613692|FG000|Overall Study|Lost to Follow-up|9|||
130179867|NCT06389487|468613693|FG001|Overall Study|Lost to Follow-up|5|||
130179868|NCT06389487|468613694|FG002|Overall Study|Lost to Follow-up|13|||
130179869|NCT06389487|468613692|FG000|Overall Study|Protocol Violation|0|||
130179870|NCT06389487|468613693|FG001|Overall Study|Protocol Violation|0|||
130179871|NCT06389487|468613694|FG002|Overall Study|Protocol Violation|2|||
130179872|NCT06389487|468613692|FG000|Overall Study|Withdrawal by Subject|2|||
130179873|NCT06389487|468613693|FG001|Overall Study|Withdrawal by Subject|2|||
130179874|NCT06389487|468613694|FG002|Overall Study|Withdrawal by Subject|1|||
130179875|NCT06389487|468613692|FG000|Overall Study|Other|1|||
130179876|NCT06389487|468613693|FG001|Overall Study|Other|0|||
130179877|NCT06389487|468613694|FG002|Overall Study|Other|1|||
130179878|NCT03493685|468615412|FG000|Overall Study|Death|4|||
130179879|NCT03493685|468615413|FG001|Overall Study|Death|3|||
130179880|NCT03493685|468615412|FG000|Overall Study|Lost to Follow-up|3|||
130179881|NCT03493685|468615413|FG001|Overall Study|Lost to Follow-up|2|||
130179882|NCT03493685|468615412|FG000|Overall Study|Physician Decision|2|||
130179883|NCT03493685|468615413|FG001|Overall Study|Physician Decision|0|||
130179884|NCT03493685|468615412|FG000|Overall Study|Withdrawal by Subject|7|||
130179885|NCT03493685|468615413|FG001|Overall Study|Withdrawal by Subject|11|||
130179886|NCT04452669|468615414|FG000|Overall Study|Death|1|||
130179887|NCT04452669|468615415|FG001|Overall Study|Death|4|||
130179888|NCT03300817|468615416|FG000|Overall Study|Withdrawal by Subject|1|||
130179889|NCT03300817|468615416|FG000|Overall Study|Adverse Event|1|||
130179890|NCT03300817|468615416|FG000|Overall Study|Subject Found to be Ineligible|2|||
130179891|NCT03729596|468615419|FG000|Overall Study|Death|3|||
130179892|NCT03729596|468615420|FG001|Overall Study|Death|5|||
130179893|NCT03729596|468615421|FG002|Overall Study|Death|4|||
130179894|NCT03729596|468615422|FG003|Overall Study|Death|1|||
130179895|NCT03729596|468615423|FG004|Overall Study|Death|0|||
130179896|NCT03729596|468615424|FG005|Overall Study|Death|34|||
130179897|NCT03729596|468615425|FG006|Overall Study|Death|18|||
130179898|NCT03729596|468615426|FG007|Overall Study|Death|14|||
130179899|NCT03729596|468615427|FG008|Overall Study|Death|19|||
130179900|NCT03729596|468615428|FG009|Overall Study|Death|9|||
130179901|NCT03729596|468615419|FG000|Overall Study|Lost to Follow-up|0|||
130179902|NCT03729596|468615420|FG001|Overall Study|Lost to Follow-up|0|||
130179903|NCT03729596|468615421|FG002|Overall Study|Lost to Follow-up|0|||
130179904|NCT03729596|468615422|FG003|Overall Study|Lost to Follow-up|0|||
130179905|NCT03729596|468615423|FG004|Overall Study|Lost to Follow-up|0|||
130179906|NCT03729596|468615424|FG005|Overall Study|Lost to Follow-up|0|||
130179907|NCT03729596|468615425|FG006|Overall Study|Lost to Follow-up|1|||
130179908|NCT03729596|468615426|FG007|Overall Study|Lost to Follow-up|0|||
130179909|NCT03729596|468615427|FG008|Overall Study|Lost to Follow-up|0|||
130179910|NCT03729596|468615428|FG009|Overall Study|Lost to Follow-up|1|||
130179911|NCT03729596|468615419|FG000|Overall Study|protocol amendment|0|||
130179912|NCT03729596|468615420|FG001|Overall Study|protocol amendment|1|||
130179913|NCT03729596|468615421|FG002|Overall Study|protocol amendment|3|||
130179914|NCT03729596|468615422|FG003|Overall Study|protocol amendment|6|||
130179915|NCT03729596|468615423|FG004|Overall Study|protocol amendment|5|||
130179916|NCT03729596|468615424|FG005|Overall Study|protocol amendment|0|||
130179917|NCT03729596|468615425|FG006|Overall Study|protocol amendment|0|||
130179918|NCT03729596|468615426|FG007|Overall Study|protocol amendment|0|||
130179919|NCT03729596|468615427|FG008|Overall Study|protocol amendment|0|||
130179920|NCT03729596|468615428|FG009|Overall Study|protocol amendment|0|||
130179921|NCT03729596|468615419|FG000|Overall Study|Withdrawal by Subject|0|||
130179922|NCT03729596|468615420|FG001|Overall Study|Withdrawal by Subject|0|||
130179923|NCT03729596|468615421|FG002|Overall Study|Withdrawal by Subject|0|||
130179924|NCT03729596|468615422|FG003|Overall Study|Withdrawal by Subject|0|||
130179925|NCT03729596|468615423|FG004|Overall Study|Withdrawal by Subject|0|||
130179926|NCT03729596|468615424|FG005|Overall Study|Withdrawal by Subject|4|||
130179927|NCT03729596|468615425|FG006|Overall Study|Withdrawal by Subject|2|||
130179928|NCT03729596|468615426|FG007|Overall Study|Withdrawal by Subject|3|||
130179929|NCT03729596|468615427|FG008|Overall Study|Withdrawal by Subject|2|||
130179930|NCT03729596|468615428|FG009|Overall Study|Withdrawal by Subject|3|||
130179931|NCT03729596|468615419|FG000|Overall Study|study terminated by sponsor|0|||
130179932|NCT03729596|468615420|FG001|Overall Study|study terminated by sponsor|0|||
130179933|NCT03729596|468615421|FG002|Overall Study|study terminated by sponsor|0|||
130179934|NCT03729596|468615422|FG003|Overall Study|study terminated by sponsor|0|||
130179935|NCT03729596|468615423|FG004|Overall Study|study terminated by sponsor|1|||
130179936|NCT03729596|468615424|FG005|Overall Study|study terminated by sponsor|3|||
130179937|NCT03729596|468615425|FG006|Overall Study|study terminated by sponsor|0|||
130179938|NCT03729596|468615426|FG007|Overall Study|study terminated by sponsor|1|||
130179939|NCT03729596|468615427|FG008|Overall Study|study terminated by sponsor|0|||
130179940|NCT03729596|468615428|FG009|Overall Study|study terminated by sponsor|0|||
130179941|NCT03713593|468615429|FG000|Overall Study|Sponsor Decision|73|||
130179942|NCT03713593|468615430|FG001|Overall Study|Sponsor Decision|41|||
130179943|NCT03713593|468615429|FG000|Overall Study|Lost to Follow-up|2|||
130179944|NCT03713593|468615430|FG001|Overall Study|Lost to Follow-up|1|||
130179945|NCT03713593|468615429|FG000|Overall Study|Death|314|||
130179946|NCT03713593|468615430|FG001|Overall Study|Death|349|||
130179947|NCT03713593|468615429|FG000|Overall Study|Withdrawal by Subject|6|||
130179948|NCT03713593|468615430|FG001|Overall Study|Withdrawal by Subject|8|||
130179949|NCT04653454|468615431|FG000|Overall Study|Withdrawal by Subject|1|||
130179950|NCT04653454|468615431|FG000|Overall Study|Physician Decision|40|||
130179951|NCT03620708|468615432|FG000|Overall Study|Lost to Follow-up|1|||
130179952|NCT03620708|468615433|FG001|Overall Study|Lost to Follow-up|1|||
130179953|NCT03620708|468615434|FG002|Overall Study|Lost to Follow-up|2|||
130179954|NCT03620708|468615432|FG000|Overall Study|Withdrawal by Subject|0|||
130179955|NCT03620708|468615433|FG001|Overall Study|Withdrawal by Subject|0|||
130179956|NCT03620708|468615434|FG002|Overall Study|Withdrawal by Subject|1|||
130179957|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
130179958|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
130179959|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
130179960|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
130179961|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
130179962|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
130179963|NCT04011722|468615440|FG000|30 Days|Death|5|||
130179964|NCT04011722|468615441|FG001|30 Days|Death|1|||
130179965|NCT04011722|468615440|FG000|1 Year|Death|13|||
130179966|NCT04011722|468615441|FG001|1 Year|Death|5|||
130179967|NCT04011722|468615440|FG000|1 Year|Withdrawal by Subject|8|||
130179968|NCT04011722|468615441|FG001|1 Year|Withdrawal by Subject|2|||
130179969|NCT04011722|468615440|FG000|1 Year|Missed Visit|6|||
130179970|NCT04011722|468615441|FG001|1 Year|Missed Visit|1|||
130179971|NCT04011722|468615440|FG000|1 Year|Pending Visit|0|||
130179972|NCT04011722|468615441|FG001|1 Year|Pending Visit|11|||
130179973|NCT04011722|468615440|FG000|1 Year|Not Yet Due|0|||
130179974|NCT04011722|468615441|FG001|1 Year|Not Yet Due|9|||
130179975|NCT04011722|468615440|FG000|2 Year|Death|16|||
130179976|NCT04011722|468615441|FG001|2 Year|Death|1|||
130179977|NCT04011722|468615440|FG000|2 Year|Withdrawal by Subject|10|||
130179978|NCT04011722|468615441|FG001|2 Year|Withdrawal by Subject|1|||
130179979|NCT04011722|468615440|FG000|2 Year|Missed Visit|9|||
130179980|NCT04011722|468615441|FG001|2 Year|Missed Visit|0|||
130179981|NCT04011722|468615440|FG000|2 Year|Visit Pending|1|||
130179982|NCT04011722|468615441|FG001|2 Year|Visit Pending|3|||
130179983|NCT04011722|468615440|FG000|2 Year|Not Yet Due|43|||
130179984|NCT04011722|468615441|FG001|2 Year|Not Yet Due|54|||
130179985|NCT04011722|468615440|FG000|3 Year|Death|10|||
130179986|NCT04011722|468615441|FG001|3 Year|Death|0|||
130179987|NCT04011722|468615440|FG000|3 Year|Withdrawal by Subject|2|||
130179988|NCT04011722|468615441|FG001|3 Year|Withdrawal by Subject|0|||
130179989|NCT04011722|468615440|FG000|3 Year|Missed Visit|2|||
130179990|NCT04011722|468615441|FG001|3 Year|Missed Visit|0|||
130179991|NCT04011722|468615440|FG000|3 Year|Pending Visit|34|||
130179992|NCT04011722|468615441|FG001|3 Year|Pending Visit|0|||
130179993|NCT04011722|468615440|FG000|3 Year|Not Yet Due|99|||
130179994|NCT04011722|468615441|FG001|3 Year|Not Yet Due|0|||
130179995|NCT05061134|468615442|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
130179996|NCT05061134|468615443|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
130179997|NCT05061134|468615444|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
130179998|NCT05061134|468615442|FG000|Overall Study|Subject not treated|0|||
130179999|NCT05061134|468615443|FG001|Overall Study|Subject not treated|0|||
130180000|NCT05061134|468615444|FG002|Overall Study|Subject not treated|2|||
130180001|NCT05061134|468615442|FG000|Overall Study|Other|0|||
130180002|NCT05061134|468615443|FG001|Overall Study|Other|0|||
130180003|NCT05061134|468615444|FG002|Overall Study|Other|9|||
130180004|NCT05061134|468615442|FG000|Overall Study|Withdrawal by Subject|9|||
130180005|NCT05061134|468615443|FG001|Overall Study|Withdrawal by Subject|8|||
130180006|NCT05061134|468615444|FG002|Overall Study|Withdrawal by Subject|5|||
130180007|NCT05061134|468615442|FG000|Overall Study|Study Terminated by Sponsor|22|||
130651847|NCT02064231|470347665|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
130180008|NCT05061134|468615443|FG001|Overall Study|Study Terminated by Sponsor|14|||
130180009|NCT05061134|468615444|FG002|Overall Study|Study Terminated by Sponsor|7|||
130180010|NCT05061134|468615442|FG000|Overall Study|Progressive Disease|1|||
130180011|NCT05061134|468615443|FG001|Overall Study|Progressive Disease|2|||
130180012|NCT05061134|468615444|FG002|Overall Study|Progressive Disease|0|||
130180013|NCT05061134|468615442|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
130651848|NCT02392078|470347666|FG000|Overall Study|Did not have procedure|32|||
130651849|NCT02392078|470347667|FG001|Overall Study|Did not have procedure|43|||
130651850|NCT02392078|470347668|FG002|Overall Study|Did not have procedure|20|||
130651851|NCT02392078|470347669|FG003|Overall Study|Did not have procedure|1|||
130651852|NCT02652793|470347670|FG000|Overall Study|Adverse Event|1|||
130651853|NCT02652793|470347670|FG000|Overall Study|Lost to Follow-up|2|||
130651854|NCT02652793|470347670|FG000|Overall Study|Withdrawal by Subject|1|||
130651855|NCT05450198|470347671|FG000|Overall Study|Withdrawal by Subject|1|||
130651856|NCT05450198|470347672|FG001|Overall Study|Withdrawal by Subject|1|||
130651857|NCT05450198|470347673|FG002|Overall Study|Withdrawal by Subject|2|||
130651858|NCT05450198|470347674|FG003|Overall Study|Withdrawal by Subject|0|||
130651859|NCT05450198|470347671|FG000|Overall Study|Lost to Follow-up|1|||
130651860|NCT05450198|470347672|FG001|Overall Study|Lost to Follow-up|0|||
130651861|NCT05450198|470347673|FG002|Overall Study|Lost to Follow-up|2|||
130651862|NCT05450198|470347674|FG003|Overall Study|Lost to Follow-up|1|||
130651863|NCT02059265|470347675|FG000|Overall Study|Ineligible|4|||
130651864|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
130651865|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
130651866|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
130651867|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
130180014|NCT05061134|468615443|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130180015|NCT05061134|468615444|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130180016|NCT05061134|468615442|FG000|Overall Study|Lost to Follow-up|1|||
130180017|NCT05061134|468615443|FG001|Overall Study|Lost to Follow-up|0|||
130180018|NCT05061134|468615444|FG002|Overall Study|Lost to Follow-up|0|||
130180019|NCT05061134|468615442|FG000|Overall Study|Physician Decision|1|||
130180020|NCT05061134|468615443|FG001|Overall Study|Physician Decision|1|||
130180021|NCT05061134|468615444|FG002|Overall Study|Physician Decision|0|||
130180022|NCT05061134|468615442|FG000|Overall Study|Disease progression|1|||
130180023|NCT05061134|468615443|FG001|Overall Study|Disease progression|0|||
130180024|NCT05061134|468615444|FG002|Overall Study|Disease progression|0|||
130180025|NCT05061134|468615442|FG000|Overall Study|Death|43|||
130180026|NCT05061134|468615443|FG001|Overall Study|Death|23|||
130180027|NCT05061134|468615444|FG002|Overall Study|Death|14|||
130180028|NCT05061134|468615442|FG000|Overall Study|Database lock|2|||
130180029|NCT05061134|468615443|FG001|Overall Study|Database lock|0|||
130180030|NCT05061134|468615444|FG002|Overall Study|Database lock|0|||
130180031|NCT00001521|468615450|FG000|Overall Study|Withdrawal by Subject|3|||
130180032|NCT00001521|468615451|FG001|Overall Study|Withdrawal by Subject|3|||
130180033|NCT00001521|468615450|FG000|Overall Study|Physician Decision|1|||
130180034|NCT00001521|468615451|FG001|Overall Study|Physician Decision|1|||
130180035|NCT00001521|468615450|FG000|Overall Study|Noncompliant|6|||
130180036|NCT00001521|468615451|FG001|Overall Study|Noncompliant|3|||
130180037|NCT02366689|468615456|FG000|Overall Study|Withdrawal by Subject|1|||
130180038|NCT02366689|468615457|FG001|Overall Study|Withdrawal by Subject|0|||
130180039|NCT02366689|468615458|FG002|Overall Study|Withdrawal by Subject|1|||
130180040|NCT02366689|468615456|FG000|Overall Study|Lost to Follow-up|3|||
130180041|NCT02366689|468615457|FG001|Overall Study|Lost to Follow-up|2|||
130180042|NCT02366689|468615458|FG002|Overall Study|Lost to Follow-up|0|||
130180043|NCT02366689|468615456|FG000|Overall Study|Pregnancy|0|||
130180044|NCT02366689|468615457|FG001|Overall Study|Pregnancy|1|||
130180045|NCT02366689|468615458|FG002|Overall Study|Pregnancy|1|||
130180046|NCT03283566|468615459|FG000|Overall Study|Lost to Follow-up|1|||
130180047|NCT03283566|468615460|FG001|Overall Study|Lost to Follow-up|2|||
130180048|NCT03288714|468615463|FG000|Overall Study|Lost to Follow-up|2|||
130180049|NCT03288714|468615464|FG001|Overall Study|Lost to Follow-up|1|||
130180050|NCT03288714|468615463|FG000|Overall Study|Non-compliance with study schedule|2|||
130180051|NCT03288714|468615464|FG001|Overall Study|Non-compliance with study schedule|0|||
130180052|NCT03288714|468615463|FG000|Overall Study|Withdrawal by Subject|3|||
130180053|NCT03288714|468615464|FG001|Overall Study|Withdrawal by Subject|1|||
130180054|NCT03288714|468615463|FG000|Overall Study|Clinical Worsening|2|||
130180055|NCT03288714|468615464|FG001|Overall Study|Clinical Worsening|1|||
130180056|NCT03288714|468615463|FG000|Overall Study|Adverse Event|1|||
130180057|NCT03288714|468615464|FG001|Overall Study|Adverse Event|0|||
130180058|NCT04882241|468615466|FG000|Overall Study|Ongoing in study|46|||
130180059|NCT04882241|468615467|FG001|Overall Study|Ongoing in study|48|||
130180060|NCT04882241|468615468|FG002|Overall Study|Ongoing in study|0|||
130180061|NCT04882241|468615469|FG003|Overall Study|Ongoing in study|0|||
130180062|NCT04882241|468615466|FG000|Overall Study|Death|13|||
130180063|NCT04882241|468615467|FG001|Overall Study|Death|13|||
130651868|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
130180064|NCT04882241|468615468|FG002|Overall Study|Death|0|||
130180065|NCT04882241|468615469|FG003|Overall Study|Death|0|||
130180066|NCT00470535|468615482|FG000|Overall Study|Disease Progression|13|||
130180067|NCT00470535|468615482|FG000|Overall Study|Withdrawal by Subject|1|||
130180068|NCT00470535|468615482|FG000|Overall Study|Adverse Event|1|||
130180069|NCT00470535|468615482|FG000|Overall Study|Death|1|||
130651869|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Death|1|||
130651870|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Death|0|||
130651871|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Death|0|||
130180070|NCT00470535|468615482|FG000|Overall Study|Other|2|||
130180071|NCT02070965|468615487|FG000|Overall Study|Lost to Follow-up|0|||
130180072|NCT02070965|468615488|FG001|Overall Study|Lost to Follow-up|1|||
130180073|NCT02070965|468615489|FG002|Overall Study|Lost to Follow-up|0|||
130180074|NCT02070965|468615487|FG000|Overall Study|Withdrawal by Subject|1|||
130651872|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Death|0|||
130651873|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Death|0|||
130651874|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
130651875|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
130651876|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
130651877|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
130651878|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
130651879|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
130651880|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
130651881|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
130651882|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
130651883|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
130651884|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130651885|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
130651886|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
130651887|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130651888|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130651889|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130651890|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
130651891|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
130651892|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130180075|NCT02070965|468615488|FG001|Overall Study|Withdrawal by Subject|1|||
130180076|NCT02070965|468615489|FG002|Overall Study|Withdrawal by Subject|1|||
130180077|NCT02070965|468615487|FG000|Overall Study|Subject moved|1|||
130180078|NCT02070965|468615488|FG001|Overall Study|Subject moved|0|||
130180079|NCT02070965|468615489|FG002|Overall Study|Subject moved|0|||
130180080|NCT02515331|468615490|FG000|Overall Study|Withdrawal by Subject|0|||
130180081|NCT02515331|468615491|FG001|Overall Study|Withdrawal by Subject|0|||
130180082|NCT02515331|468615492|FG002|Overall Study|Withdrawal by Subject|1|||
130180083|NCT02515331|468615490|FG000|Overall Study|Protocol deviation|0|||
130180084|NCT02515331|468615491|FG001|Overall Study|Protocol deviation|0|||
130180085|NCT02515331|468615492|FG002|Overall Study|Protocol deviation|3|||
130180086|NCT02515331|468615490|FG000|Overall Study|Adverse Event|2|||
130180087|NCT02515331|468615491|FG001|Overall Study|Adverse Event|0|||
130180088|NCT02515331|468615492|FG002|Overall Study|Adverse Event|0|||
130180089|NCT00124748|468615493|FG000|Overall Study|Adverse Event|8|||
130180090|NCT00124748|468615494|FG001|Overall Study|Adverse Event|39|||
130651893|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130651894|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
130651895|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
130651896|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130651897|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130651898|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130651899|NCT00634933|470347677|FG000|Part A: Baseline to Week 24|Other|1|||
130651900|NCT00634933|470347678|FG001|Part A: Baseline to Week 24|Other|8|||
130651901|NCT00634933|470347679|FG002|Part A: Baseline to Week 24|Other|5|||
130651902|NCT00634933|470347680|FG003|Part A: Baseline to Week 24|Other|0|||
130651903|NCT00634933|470347681|FG004|Part A: Baseline to Week 24|Other|0|||
130651904|NCT00634933|470347677|FG000|Between Part A and Part B|Physician Decision|0|||
130651905|NCT00634933|470347678|FG001|Between Part A and Part B|Physician Decision|1|||
130651906|NCT00634933|470347679|FG002|Between Part A and Part B|Physician Decision|0|||
130651907|NCT00634933|470347680|FG003|Between Part A and Part B|Physician Decision|0|||
130651908|NCT00634933|470347681|FG004|Between Part A and Part B|Physician Decision|0|||
130651909|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
130651910|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
130651911|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
130651912|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
130651913|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
130651914|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
130651915|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
130651916|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
130651917|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
130651918|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
130180091|NCT00124748|468615493|FG000|Overall Study|Abnormal laboratory Value|2|||
130651919|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
130651920|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
130651921|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
130651922|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
130651923|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
130651924|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
130651925|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
130651926|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
130651927|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
130651928|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
130651929|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130651930|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130651931|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130651932|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
130651933|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
130651934|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130651935|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
130651936|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
130651937|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130651938|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130651939|NCT00634933|470347677|FG000|Part B: Week 24 to Week 52|Other|0|||
130651940|NCT00634933|470347678|FG001|Part B: Week 24 to Week 52|Other|0|||
130651941|NCT00634933|470347679|FG002|Part B: Week 24 to Week 52|Other|5|||
130651942|NCT00634933|470347680|FG003|Part B: Week 24 to Week 52|Other|0|||
130651943|NCT00634933|470347681|FG004|Part B: Week 24 to Week 52|Other|1|||
130651944|NCT02058849|470347682|FG000|Overall Study|Hospitalization|1|||
130651945|NCT02058849|470347683|FG001|Overall Study|Hospitalization|1|||
130651946|NCT02058849|470347682|FG000|Overall Study|Death|1|||
130651947|NCT02058849|470347683|FG001|Overall Study|Death|0|||
130651948|NCT02058849|470347682|FG000|Overall Study|Lost to Follow-up|1|||
130651949|NCT02058849|470347683|FG001|Overall Study|Lost to Follow-up|0|||
130651950|NCT02058849|470347682|FG000|Overall Study|Withdrawal by Subject|4|||
130651951|NCT02058849|470347683|FG001|Overall Study|Withdrawal by Subject|0|||
130651952|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
130651953|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
130651954|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
130651955|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
130651956|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
130651957|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
130651958|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
130651959|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
130651960|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
130651961|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
130651962|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
130651963|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
130651964|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
130651965|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
130651966|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
130651967|NCT01694849|470347684|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
130651968|NCT01694849|470347685|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
130651969|NCT01694849|470347686|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
130651970|NCT01694849|470347684|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
130651971|NCT01694849|470347685|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
130651972|NCT01694849|470347686|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
130651973|NCT01694849|470347684|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
130651974|NCT01694849|470347685|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
130651975|NCT01694849|470347686|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
130651976|NCT02304484|470347689|FG000|Overall Study|Death|9|||
130651977|NCT02304484|470347689|FG000|Overall Study|Withdrawal by Subject|14|||
130651978|NCT02304484|470347689|FG000|Overall Study|Lost to Follow-up|2|||
130651979|NCT04338685|470347690|FG000|Overall Study|Death|3|||
130651980|NCT04338685|470347691|FG001|Overall Study|Death|4|||
130651981|NCT04338685|470347692|FG002|Overall Study|Death|2|||
130651982|NCT04338685|470347693|FG003|Overall Study|Death|4|||
130651983|NCT04338685|470347694|FG004|Overall Study|Death|4|||
130651984|NCT04338685|470347695|FG005|Overall Study|Death|8|||
130651985|NCT04338685|470347696|FG006|Overall Study|Death|1|||
130651986|NCT04338685|470347697|FG007|Overall Study|Death|0|||
130651987|NCT04338685|470347698|FG008|Overall Study|Death|0|||
130651988|NCT04338685|470347690|FG000|Overall Study|Study terminated by Sponsor|0|||
130651989|NCT04338685|470347691|FG001|Overall Study|Study terminated by Sponsor|0|||
130651990|NCT04338685|470347692|FG002|Overall Study|Study terminated by Sponsor|1|||
130651991|NCT04338685|470347693|FG003|Overall Study|Study terminated by Sponsor|4|||
130651992|NCT04338685|470347694|FG004|Overall Study|Study terminated by Sponsor|0|||
130651993|NCT04338685|470347695|FG005|Overall Study|Study terminated by Sponsor|5|||
130651994|NCT04338685|470347696|FG006|Overall Study|Study terminated by Sponsor|2|||
130651995|NCT04338685|470347697|FG007|Overall Study|Study terminated by Sponsor|4|||
130180092|NCT00124748|468615494|FG001|Overall Study|Abnormal laboratory Value|2|||
130180093|NCT00124748|468615493|FG000|Overall Study|Abnormal Procedure|0|||
130180094|NCT00124748|468615494|FG001|Overall Study|Abnormal Procedure|1|||
130180095|NCT00124748|468615493|FG000|Overall Study|Lack of Efficacy|20|||
130180096|NCT00124748|468615494|FG001|Overall Study|Lack of Efficacy|41|||
130180097|NCT00124748|468615493|FG000|Overall Study|No longer requires study drug|1|||
130180098|NCT00124748|468615494|FG001|Overall Study|No longer requires study drug|1|||
130180099|NCT00124748|468615493|FG000|Overall Study|Protocol Violation|3|||
130180100|NCT00124748|468615494|FG001|Overall Study|Protocol Violation|1|||
130180101|NCT00124748|468615493|FG000|Overall Study|Withdrawal by Subject|5|||
130180102|NCT00124748|468615494|FG001|Overall Study|Withdrawal by Subject|15|||
130180103|NCT00124748|468615493|FG000|Overall Study|Lost to Follow-up|2|||
130180104|NCT00124748|468615494|FG001|Overall Study|Lost to Follow-up|7|||
130180105|NCT00124748|468615493|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
130180106|NCT00124748|468615494|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
130180107|NCT00124748|468615493|FG000|Overall Study|Death|1|||
130180108|NCT00124748|468615494|FG001|Overall Study|Death|3|||
130180109|NCT00322712|468615495|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
130180110|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130180111|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
130180112|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
130180113|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180114|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130180115|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
130180116|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180117|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180118|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180119|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180120|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180121|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180122|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180123|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180124|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180125|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180126|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180127|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180128|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180129|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
130180130|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180131|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
130180132|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180133|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180134|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180135|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180136|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180137|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180138|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180139|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180140|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180141|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180142|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180143|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180144|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130180145|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180146|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180147|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
130180148|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130180149|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180150|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180151|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180152|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180153|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180154|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180155|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180156|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180157|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180158|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180159|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180160|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180161|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180162|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130180163|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130180164|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180165|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130180166|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130180167|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180168|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180169|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180170|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180171|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180172|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180173|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180174|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180175|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180176|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180177|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180178|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180179|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180180|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130180181|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130180182|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180183|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180184|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180185|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180186|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180187|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180188|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180189|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180190|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180191|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180192|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180193|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180194|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180195|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180196|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180197|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180198|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180199|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
130180200|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180201|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180202|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180203|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180204|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180205|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180206|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180207|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180208|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180209|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180210|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180211|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180212|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180213|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
130180214|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180215|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180216|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180217|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180218|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180219|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180220|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180221|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180222|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180223|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180224|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180225|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130651996|NCT04338685|470347698|FG008|Overall Study|Study terminated by Sponsor|1|||
130651997|NCT04338685|470347690|FG000|Overall Study|Withdrawal by Subject|1|||
130180226|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180227|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180228|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180229|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180230|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
130180231|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180232|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180233|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180234|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180235|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180236|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180237|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180238|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180239|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180240|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180241|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180242|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180243|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180244|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180245|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180246|NCT00758524|468615496|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180247|NCT00758524|468615497|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180248|NCT00758524|468615498|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180249|NCT00758524|468615499|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180250|NCT00758524|468615500|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180251|NCT00758524|468615501|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180252|NCT00758524|468615502|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180253|NCT00758524|468615503|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180254|NCT00758524|468615504|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
130180255|NCT00758524|468615505|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180256|NCT00758524|468615506|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180257|NCT00758524|468615507|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180258|NCT00758524|468615508|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180259|NCT00758524|468615509|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180260|NCT00758524|468615510|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180261|NCT00758524|468615511|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180262|NCT00758524|468615512|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180263|NCT00758524|468615496|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180264|NCT00758524|468615497|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180265|NCT00758524|468615498|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180266|NCT00758524|468615499|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180267|NCT00758524|468615500|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180268|NCT00758524|468615501|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180269|NCT00758524|468615502|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
130180270|NCT00758524|468615503|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180271|NCT00758524|468615504|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180272|NCT00758524|468615505|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180273|NCT00758524|468615506|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180274|NCT00758524|468615507|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180275|NCT00758524|468615508|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180276|NCT00758524|468615509|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180277|NCT00758524|468615510|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180278|NCT00758524|468615511|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180279|NCT00758524|468615512|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180280|NCT01269918|468615513|FG000|Overall Study|Did not receive study drug|0|||
130180281|NCT01269918|468615514|FG001|Overall Study|Did not receive study drug|3|||
130180282|NCT01928472|468615515|FG000|Overall Study|Death|0|||
130180283|NCT01928472|468615516|FG001|Overall Study|Death|0|||
130180284|NCT01928472|468615517|FG002|Overall Study|Death|1|||
130180285|NCT01928472|468615518|FG003|Overall Study|Death|0|||
130180286|NCT01928472|468615515|FG000|Overall Study|Withdrawal by Subject|4|||
130180287|NCT01928472|468615516|FG001|Overall Study|Withdrawal by Subject|4|||
130180288|NCT01928472|468615517|FG002|Overall Study|Withdrawal by Subject|1|||
130180289|NCT01928472|468615518|FG003|Overall Study|Withdrawal by Subject|2|||
130180290|NCT01928472|468615515|FG000|Overall Study|Lost to Follow-up|2|||
130180291|NCT01928472|468615516|FG001|Overall Study|Lost to Follow-up|3|||
130180292|NCT01928472|468615517|FG002|Overall Study|Lost to Follow-up|4|||
130180293|NCT01928472|468615518|FG003|Overall Study|Lost to Follow-up|0|||
130180294|NCT01928472|468615515|FG000|Overall Study|Administrative Reason|2|||
130180295|NCT01928472|468615516|FG001|Overall Study|Administrative Reason|1|||
130180296|NCT01928472|468615517|FG002|Overall Study|Administrative Reason|0|||
130180297|NCT01928472|468615518|FG003|Overall Study|Administrative Reason|0|||
130180298|NCT01928472|468615515|FG000|Overall Study|Unclassified|0|||
130180299|NCT01928472|468615516|FG001|Overall Study|Unclassified|0|||
130180300|NCT01928472|468615517|FG002|Overall Study|Unclassified|1|||
130180301|NCT01928472|468615518|FG003|Overall Study|Unclassified|0|||
130180302|NCT01308424|468615519|FG000|Baseline Eligibility|Screen Failures|71|||
130180303|NCT01308424|468615520|FG001|Baseline Eligibility|Screen Failures|0|||
130180304|NCT01308424|468615521|FG002|Baseline Eligibility|Screen Failures|0|||
130180305|NCT01308424|468615519|FG000|Randomization|Adverse Event|0|||
130180306|NCT01308424|468615520|FG001|Randomization|Adverse Event|1|||
130180307|NCT01308424|468615521|FG002|Randomization|Adverse Event|1|||
130180308|NCT01308424|468615519|FG000|Randomization|Lost to Follow-up|0|||
130180309|NCT01308424|468615520|FG001|Randomization|Lost to Follow-up|1|||
130180310|NCT01308424|468615521|FG002|Randomization|Lost to Follow-up|0|||
130180311|NCT01308424|468615519|FG000|Randomization|Physician Decision|0|||
130180312|NCT01308424|468615520|FG001|Randomization|Physician Decision|1|||
130180313|NCT01308424|468615521|FG002|Randomization|Physician Decision|1|||
130180314|NCT04471428|468615525|FG000|Overall Study|Withdrawal by Subject|29|||
130180315|NCT04471428|468615526|FG001|Overall Study|Withdrawal by Subject|1|||
130180316|NCT04471428|468615525|FG000|Overall Study|Physician Decision|0|||
130180317|NCT04471428|468615526|FG001|Overall Study|Physician Decision|1|||
130180318|NCT04471428|468615525|FG000|Overall Study|Reason Not Specified|0|||
130180319|NCT04471428|468615526|FG001|Overall Study|Reason Not Specified|2|||
130180320|NCT04471428|468615525|FG000|Overall Study|Death|106|||
130180321|NCT04471428|468615526|FG001|Overall Study|Death|114|||
130180322|NCT04471428|468615525|FG000|Overall Study|Ongoing in the study|45|||
130180323|NCT04471428|468615526|FG001|Overall Study|Ongoing in the study|68|||
130180324|NCT00129545|468615529|FG000|Overall Study|Death|5|||
130180325|NCT00129545|468615530|FG001|Overall Study|Death|60|||
130180326|NCT00129545|468615531|FG002|Overall Study|Death|44|||
130180327|NCT00129545|468615529|FG000|Overall Study|Withdrawal by Subject|3|||
130180328|NCT00129545|468615530|FG001|Overall Study|Withdrawal by Subject|18|||
130180329|NCT00129545|468615531|FG002|Overall Study|Withdrawal by Subject|44|||
130180330|NCT00129545|468615529|FG000|Overall Study|Lost to Follow-up|2|||
130180331|NCT00129545|468615530|FG001|Overall Study|Lost to Follow-up|22|||
130180332|NCT00129545|468615531|FG002|Overall Study|Lost to Follow-up|13|||
130180333|NCT00129545|468615529|FG000|Overall Study|Physician Decision|0|||
130180334|NCT00129545|468615530|FG001|Overall Study|Physician Decision|3|||
130180335|NCT00129545|468615531|FG002|Overall Study|Physician Decision|10|||
130180336|NCT00129545|468615529|FG000|Overall Study|Device not implanted|16|||
130180337|NCT00129545|468615530|FG001|Overall Study|Device not implanted|61|||
130180338|NCT00129545|468615531|FG002|Overall Study|Device not implanted|0|||
130180339|NCT01841593|468615532|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
130180340|NCT01841593|468615533|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
130180341|NCT01841593|468615532|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
130180342|NCT01841593|468615533|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
130180343|NCT00307086|468615534|FG000|Overall Study|ineligible|5|||
130180344|NCT01870778|468615538|FG000|Overall Study|Withdrawal by Subject|8|||
130180345|NCT01870778|468615539|FG001|Overall Study|Withdrawal by Subject|7|||
130180346|NCT01870778|468615538|FG000|Overall Study|Lost to Follow-up|0|||
130180347|NCT01870778|468615539|FG001|Overall Study|Lost to Follow-up|2|||
130180348|NCT00312338|468615540|FG000|Overall Study|Adverse Event|7|||
130180349|NCT00312338|468615541|FG001|Overall Study|Adverse Event|2|||
130180350|NCT00312338|468615540|FG000|Overall Study|Lost to Follow-up|9|||
130180351|NCT00312338|468615541|FG001|Overall Study|Lost to Follow-up|1|||
130180352|NCT00312338|468615540|FG000|Overall Study|Withdrawal by Subject|4|||
130180353|NCT00312338|468615541|FG001|Overall Study|Withdrawal by Subject|0|||
130180354|NCT00312338|468615540|FG000|Overall Study|Subsequent infection|2|||
130180355|NCT00312338|468615541|FG001|Overall Study|Subsequent infection|0|||
130180356|NCT00262028|468615542|FG000|Overall Study|Withdrawal by Subject|6|||
130180357|NCT00262028|468615543|FG001|Overall Study|Withdrawal by Subject|3|||
130180358|NCT00262028|468615544|FG002|Overall Study|Withdrawal by Subject|6|||
130180359|NCT00262028|468615545|FG003|Overall Study|Withdrawal by Subject|5|||
130180360|NCT00262028|468615546|FG004|Overall Study|Withdrawal by Subject|2|||
130180361|NCT00262028|468615547|FG005|Overall Study|Withdrawal by Subject|3|||
130180362|NCT00262028|468615548|FG006|Overall Study|Withdrawal by Subject|5|||
130180363|NCT00262028|468615549|FG007|Overall Study|Withdrawal by Subject|7|||
130180364|NCT00262028|468615550|FG008|Overall Study|Withdrawal by Subject|2|||
130180365|NCT00262028|468615542|FG000|Overall Study|Lost to Follow-up|7|||
130180366|NCT00262028|468615543|FG001|Overall Study|Lost to Follow-up|7|||
130180367|NCT00262028|468615544|FG002|Overall Study|Lost to Follow-up|5|||
130180368|NCT00262028|468615545|FG003|Overall Study|Lost to Follow-up|5|||
130180369|NCT00262028|468615546|FG004|Overall Study|Lost to Follow-up|4|||
130180370|NCT00262028|468615547|FG005|Overall Study|Lost to Follow-up|3|||
130180371|NCT00262028|468615548|FG006|Overall Study|Lost to Follow-up|3|||
130180372|NCT00262028|468615549|FG007|Overall Study|Lost to Follow-up|5|||
130180373|NCT00262028|468615550|FG008|Overall Study|Lost to Follow-up|6|||
130180374|NCT00262028|468615542|FG000|Overall Study|Administrative Reason|11|||
130180375|NCT00262028|468615543|FG001|Overall Study|Administrative Reason|14|||
130180376|NCT00262028|468615544|FG002|Overall Study|Administrative Reason|9|||
130180377|NCT00262028|468615545|FG003|Overall Study|Administrative Reason|12|||
130180378|NCT00262028|468615546|FG004|Overall Study|Administrative Reason|6|||
130180379|NCT00262028|468615547|FG005|Overall Study|Administrative Reason|7|||
130180380|NCT00262028|468615548|FG006|Overall Study|Administrative Reason|4|||
130180381|NCT00262028|468615549|FG007|Overall Study|Administrative Reason|6|||
130180382|NCT00262028|468615550|FG008|Overall Study|Administrative Reason|10|||
130180383|NCT00262028|468615542|FG000|Overall Study|Protocol Violation|0|||
130180384|NCT00262028|468615543|FG001|Overall Study|Protocol Violation|0|||
130180385|NCT00262028|468615544|FG002|Overall Study|Protocol Violation|0|||
130180386|NCT00262028|468615545|FG003|Overall Study|Protocol Violation|1|||
130180387|NCT00262028|468615546|FG004|Overall Study|Protocol Violation|0|||
130180388|NCT00262028|468615547|FG005|Overall Study|Protocol Violation|0|||
130180389|NCT00262028|468615548|FG006|Overall Study|Protocol Violation|0|||
130180390|NCT00262028|468615549|FG007|Overall Study|Protocol Violation|0|||
130180391|NCT00262028|468615550|FG008|Overall Study|Protocol Violation|0|||
130180392|NCT00262028|468615542|FG000|Overall Study|Unable to classify|0|||
130180393|NCT00262028|468615543|FG001|Overall Study|Unable to classify|3|||
130180394|NCT00262028|468615544|FG002|Overall Study|Unable to classify|0|||
130180395|NCT00262028|468615545|FG003|Overall Study|Unable to classify|0|||
130180396|NCT00262028|468615546|FG004|Overall Study|Unable to classify|0|||
130180397|NCT00262028|468615547|FG005|Overall Study|Unable to classify|0|||
130180398|NCT00262028|468615548|FG006|Overall Study|Unable to classify|0|||
130180399|NCT00262028|468615549|FG007|Overall Study|Unable to classify|0|||
130180400|NCT00262028|468615550|FG008|Overall Study|Unable to classify|1|||
130180401|NCT02308124|468615551|FG000|Overall Study|Lost to Follow-up|6|||
130180402|NCT02308124|468615552|FG001|Overall Study|Lost to Follow-up|6|||
130180403|NCT02308124|468615553|FG002|Overall Study|Lost to Follow-up|6|||
130180404|NCT02308124|468615551|FG000|Overall Study|Adverse Event|0|||
130180405|NCT02308124|468615552|FG001|Overall Study|Adverse Event|2|||
130180406|NCT02308124|468615553|FG002|Overall Study|Adverse Event|2|||
130180407|NCT02553772|468615555|FG000|Overall Study|Adverse Event|2|||
130180408|NCT02553772|468615556|FG001|Overall Study|Adverse Event|3|||
130180409|NCT02553772|468615555|FG000|Overall Study|Lost to Follow-up|2|||
130180410|NCT02553772|468615556|FG001|Overall Study|Lost to Follow-up|1|||
130651998|NCT04338685|470347691|FG001|Overall Study|Withdrawal by Subject|2|||
130651999|NCT04338685|470347692|FG002|Overall Study|Withdrawal by Subject|0|||
130652000|NCT04338685|470347693|FG003|Overall Study|Withdrawal by Subject|2|||
130652001|NCT04338685|470347694|FG004|Overall Study|Withdrawal by Subject|0|||
130652002|NCT04338685|470347695|FG005|Overall Study|Withdrawal by Subject|5|||
130652003|NCT04338685|470347696|FG006|Overall Study|Withdrawal by Subject|1|||
130652004|NCT04338685|470347697|FG007|Overall Study|Withdrawal by Subject|1|||
130652005|NCT04338685|470347698|FG008|Overall Study|Withdrawal by Subject|0|||
130652006|NCT02967055|470347699|FG000|Overall Study|Excluded|40|||
130652007|NCT02967055|470347699|FG000|Overall Study|Screen fail|3|||
130652008|NCT02967055|470347699|FG000|Overall Study|Lost to Follow-up|2|||
130652009|NCT02967055|470347699|FG000|Overall Study|Stopped due to side effects|3|||
130652010|NCT02967055|470347699|FG000|Overall Study|Stopped due to drug cost|1|||
130180411|NCT02553772|468615555|FG000|Overall Study|Withdrawal of Consent|1|||
130180412|NCT02553772|468615556|FG001|Overall Study|Withdrawal of Consent|1|||
130180413|NCT02553772|468615555|FG000|Overall Study|Lack of Efficacy|1|||
130180414|NCT02553772|468615556|FG001|Overall Study|Lack of Efficacy|0|||
130180415|NCT02553772|468615555|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130180416|NCT02553772|468615556|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130180417|NCT05724589|468615557|FG000|Overall Study|Lost to Follow-up|1|||
130180418|NCT00786409|468615558|FG000|Overall Study|Withdrawal by Subject|2|||
130180419|NCT00786409|468615558|FG000|Overall Study|Adverse Event|2|||
130180420|NCT00786409|468615558|FG000|Overall Study|Pregnancy|2|||
130180421|NCT00786409|468615558|FG000|Overall Study|Lost to Follow-up|1|||
130180422|NCT00610129|468615559|FG000|Overall Study|Not treated since patients ineligible|3|||
130180423|NCT02273388|468615562|FG000|Overall Study|Adverse Event|0|||
130180424|NCT02273388|468615563|FG001|Overall Study|Adverse Event|0|||
130180425|NCT02273388|468615564|FG002|Overall Study|Adverse Event|0|||
130180426|NCT02273388|468615565|FG003|Overall Study|Adverse Event|0|||
130180427|NCT02273388|468615566|FG004|Overall Study|Adverse Event|0|||
130180428|NCT02273388|468615567|FG005|Overall Study|Adverse Event|0|||
130180429|NCT02273388|468615568|FG006|Overall Study|Adverse Event|1|||
130180430|NCT02273388|468615569|FG007|Overall Study|Adverse Event|2|||
130180431|NCT02273388|468615570|FG008|Overall Study|Adverse Event|0|||
130180432|NCT02273388|468615571|FG009|Overall Study|Adverse Event|0|||
130652011|NCT00145795|470347700|FG000|Overall Study|Adverse Event|1|||
130652012|NCT00145795|470347701|FG001|Overall Study|Adverse Event|0|||
130180433|NCT02273388|468615572|FG010|Overall Study|Adverse Event|0|||
130180434|NCT02273388|468615573|FG011|Overall Study|Adverse Event|0|||
130180435|NCT02273388|468615562|FG000|Overall Study|Adverse Event study disease worse|4|||
130180436|NCT02273388|468615563|FG001|Overall Study|Adverse Event study disease worse|3|||
130180437|NCT02273388|468615564|FG002|Overall Study|Adverse Event study disease worse|3|||
130180438|NCT02273388|468615565|FG003|Overall Study|Adverse Event study disease worse|2|||
130180439|NCT02273388|468615566|FG004|Overall Study|Adverse Event study disease worse|4|||
130180440|NCT02273388|468615567|FG005|Overall Study|Adverse Event study disease worse|3|||
130180441|NCT02273388|468615568|FG006|Overall Study|Adverse Event study disease worse|14|||
130180442|NCT02273388|468615569|FG007|Overall Study|Adverse Event study disease worse|6|||
130180443|NCT02273388|468615570|FG008|Overall Study|Adverse Event study disease worse|6|||
130180444|NCT02273388|468615571|FG009|Overall Study|Adverse Event study disease worse|5|||
130180445|NCT02273388|468615572|FG010|Overall Study|Adverse Event study disease worse|10|||
130180446|NCT02273388|468615573|FG011|Overall Study|Adverse Event study disease worse|1|||
130180447|NCT02273388|468615562|FG000|Overall Study|Sponsor decision|0|||
130180448|NCT02273388|468615563|FG001|Overall Study|Sponsor decision|0|||
130180449|NCT02273388|468615564|FG002|Overall Study|Sponsor decision|0|||
130180450|NCT02273388|468615565|FG003|Overall Study|Sponsor decision|0|||
130180451|NCT02273388|468615566|FG004|Overall Study|Sponsor decision|0|||
130180452|NCT02273388|468615567|FG005|Overall Study|Sponsor decision|0|||
130180453|NCT02273388|468615568|FG006|Overall Study|Sponsor decision|0|||
130180454|NCT02273388|468615569|FG007|Overall Study|Sponsor decision|0|||
130180455|NCT02273388|468615570|FG008|Overall Study|Sponsor decision|0|||
130180456|NCT02273388|468615571|FG009|Overall Study|Sponsor decision|0|||
130180457|NCT02273388|468615572|FG010|Overall Study|Sponsor decision|0|||
130180458|NCT02273388|468615573|FG011|Overall Study|Sponsor decision|1|||
130180459|NCT01042093|468615574|FG000|Overall Study|Protocol Violation|2|||
130180460|NCT01042093|468615575|FG001|Overall Study|Protocol Violation|2|||
130180461|NCT01042093|468615576|FG002|Overall Study|Protocol Violation|2|||
130180462|NCT01042093|468615577|FG003|Overall Study|Protocol Violation|3|||
130180463|NCT01042093|468615574|FG000|Overall Study|Withdrawal by Subject|0|||
130180464|NCT01042093|468615575|FG001|Overall Study|Withdrawal by Subject|0|||
130180465|NCT01042093|468615576|FG002|Overall Study|Withdrawal by Subject|0|||
130180466|NCT01042093|468615577|FG003|Overall Study|Withdrawal by Subject|1|||
130180467|NCT04331808|468615578|FG000|Overall Study|Withdrew consent|1|||
130180468|NCT04331808|468615579|FG001|Overall Study|Withdrew consent|0|||
130180469|NCT04331808|468615580|FG002|Overall Study|Withdrew consent|2|||
130652013|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
130652014|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
130652015|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
130652016|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
130652017|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
130652018|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
130652019|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
130652020|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
130652021|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
130652022|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
130652023|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
130652024|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
130652025|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
130652026|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
130652027|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
130652028|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
130652029|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
130652030|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
130652031|NCT00570492|470347702|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
130652032|NCT00570492|470347703|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
130180470|NCT04331808|468615581|FG003|Overall Study|Withdrew consent|3|||
130180471|NCT01184079|468615585|FG000|Overall Study|Lost to Follow-up|14|||
130180472|NCT01184079|468615586|FG001|Overall Study|Lost to Follow-up|2|||
130180473|NCT04233073|468615587|FG000|Overall Study|Death|5|||
130180474|NCT02198963|468615588|FG000|Overall Study|Adverse Event|1|||
130180475|NCT02198963|468615588|FG000|Overall Study|Withdrawal by Subject|6|||
130180476|NCT02905032|468615595|FG000|Overall Study|Withdrawal by Subject|2|||
130180477|NCT02905032|468615596|FG001|Overall Study|Withdrawal by Subject|0|||
130180478|NCT02905032|468615597|FG002|Overall Study|Withdrawal by Subject|0|||
130180479|NCT02905032|468615595|FG000|Overall Study|Protocol Violation|6|||
130180480|NCT02905032|468615596|FG001|Overall Study|Protocol Violation|12|||
130180481|NCT02905032|468615597|FG002|Overall Study|Protocol Violation|0|||
130180482|NCT02603146|468617300|FG000|Overall Study|Lost to Follow-up|5|||
130180483|NCT02603146|468617301|FG001|Overall Study|Lost to Follow-up|6|||
130180484|NCT02603146|468617300|FG000|Overall Study|Withdrawal by Subject|8|||
130180485|NCT02603146|468617301|FG001|Overall Study|Withdrawal by Subject|10|||
130180486|NCT02603146|468617300|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
130180487|NCT02603146|468617301|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
130180488|NCT02603146|468617300|FG000|Overall Study|Participant moved|2|||
130180489|NCT02603146|468617301|FG001|Overall Study|Participant moved|0|||
130180490|NCT02603146|468617300|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
130180491|NCT02603146|468617301|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
130180492|NCT00265759|468617302|FG000|Overall Study|Withdrawal by Subject|0|||
130180493|NCT00265759|468617303|FG001|Overall Study|Withdrawal by Subject|1|||
130180494|NCT00265759|468617304|FG002|Overall Study|Withdrawal by Subject|2|||
130180495|NCT00265759|468617305|FG003|Overall Study|Withdrawal by Subject|2|||
130180496|NCT00265759|468617302|FG000|Overall Study|Cancel|0|||
130180497|NCT00265759|468617303|FG001|Overall Study|Cancel|0|||
130180498|NCT00265759|468617304|FG002|Overall Study|Cancel|0|||
130180499|NCT00265759|468617305|FG003|Overall Study|Cancel|3|||
130180500|NCT00265759|468617302|FG000|Overall Study|Ineligible|0|||
130180501|NCT00265759|468617303|FG001|Overall Study|Ineligible|0|||
130180502|NCT00265759|468617304|FG002|Overall Study|Ineligible|0|||
130180503|NCT00265759|468617305|FG003|Overall Study|Ineligible|1|||
130180504|NCT00265759|468617302|FG000|Overall Study|Bilateral disease|0|||
130180505|NCT00265759|468617303|FG001|Overall Study|Bilateral disease|0|||
130180506|NCT00265759|468617304|FG002|Overall Study|Bilateral disease|0|||
130180507|NCT00265759|468617305|FG003|Overall Study|Bilateral disease|2|||
130180508|NCT00265759|468617302|FG000|Overall Study|Discontinued due to intolerability|0|||
130180509|NCT00265759|468617303|FG001|Overall Study|Discontinued due to intolerability|0|||
130180510|NCT00265759|468617304|FG002|Overall Study|Discontinued due to intolerability|0|||
130180511|NCT00265759|468617305|FG003|Overall Study|Discontinued due to intolerability|1|||
130180512|NCT04467840|468617306|FG000|Overall Study|Death|35|||
130180513|NCT04467840|468617307|FG001|Overall Study|Death|39|||
130180514|NCT04467840|468617306|FG000|Overall Study|Withdrawal by Subject|8|||
130180515|NCT04467840|468617307|FG001|Overall Study|Withdrawal by Subject|4|||
130180516|NCT04467840|468617306|FG000|Overall Study|Adverse Event|2|||
130180517|NCT04467840|468617307|FG001|Overall Study|Adverse Event|0|||
130180518|NCT04467840|468617306|FG000|Overall Study|Lost to Follow-up|1|||
130180519|NCT04467840|468617307|FG001|Overall Study|Lost to Follow-up|3|||
130180520|NCT04467840|468617306|FG000|Overall Study|Physician Decision|1|||
130180521|NCT04467840|468617307|FG001|Overall Study|Physician Decision|0|||
130180522|NCT04467840|468617306|FG000|Overall Study|Other|1|||
130180523|NCT04467840|468617307|FG001|Overall Study|Other|5|||
130180524|NCT04467840|468617306|FG000|Overall Study|Missing study completion status|3|||
130180525|NCT04467840|468617307|FG001|Overall Study|Missing study completion status|1|||
130180526|NCT05201794|468617310|FG000|Overall Study|Withdrawal by Subject|13|||
130180527|NCT05201794|468617311|FG001|Overall Study|Withdrawal by Subject|12|||
130180528|NCT05201794|468617312|FG002|Overall Study|Withdrawal by Subject|14|||
130180529|NCT05201794|468617313|FG003|Overall Study|Withdrawal by Subject|0|||
130180530|NCT05201794|468617310|FG000|Overall Study|Adverse Event|5|||
130180531|NCT05201794|468617311|FG001|Overall Study|Adverse Event|5|||
130180532|NCT05201794|468617312|FG002|Overall Study|Adverse Event|4|||
130180533|NCT05201794|468617313|FG003|Overall Study|Adverse Event|0|||
130180534|NCT05201794|468617310|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130180535|NCT05201794|468617311|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130180536|NCT05201794|468617312|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
130652033|NCT00570492|470347704|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
130652034|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130652035|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
130652036|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
130652037|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
130180537|NCT05201794|468617313|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130180538|NCT05201794|468617310|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130180539|NCT05201794|468617311|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130180540|NCT05201794|468617312|FG002|Overall Study|Non-Compliance With Study Drug|3|||
130180541|NCT05201794|468617313|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130180542|NCT05201794|468617310|FG000|Overall Study|Physician Decision|1|||
130180543|NCT05201794|468617311|FG001|Overall Study|Physician Decision|3|||
130180544|NCT05201794|468617312|FG002|Overall Study|Physician Decision|2|||
130180545|NCT05201794|468617313|FG003|Overall Study|Physician Decision|0|||
130180546|NCT05201794|468617310|FG000|Overall Study|Lost to Follow-up|2|||
130180547|NCT05201794|468617311|FG001|Overall Study|Lost to Follow-up|2|||
130180548|NCT05201794|468617312|FG002|Overall Study|Lost to Follow-up|0|||
130180549|NCT05201794|468617313|FG003|Overall Study|Lost to Follow-up|0|||
130180550|NCT05201794|468617310|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
130180551|NCT05201794|468617311|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
130180552|NCT05201794|468617312|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
130180553|NCT05201794|468617313|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
130180554|NCT05201794|468617310|FG000|Overall Study|Protocol Violation|2|||
130180555|NCT05201794|468617311|FG001|Overall Study|Protocol Violation|0|||
130180556|NCT05201794|468617312|FG002|Overall Study|Protocol Violation|1|||
130180557|NCT05201794|468617313|FG003|Overall Study|Protocol Violation|0|||
130180558|NCT05201794|468617310|FG000|Overall Study|Death|1|||
130180559|NCT05201794|468617311|FG001|Overall Study|Death|0|||
130180560|NCT05201794|468617312|FG002|Overall Study|Death|0|||
130180561|NCT05201794|468617313|FG003|Overall Study|Death|0|||
130180562|NCT05201794|468617310|FG000|Overall Study|Site Terminated By Sponsor|0|||
130180563|NCT05201794|468617311|FG001|Overall Study|Site Terminated By Sponsor|1|||
130180564|NCT05201794|468617312|FG002|Overall Study|Site Terminated By Sponsor|0|||
130180565|NCT05201794|468617313|FG003|Overall Study|Site Terminated By Sponsor|0|||
130180566|NCT05201794|468617310|FG000|Overall Study|Other|3|||
130180567|NCT05201794|468617311|FG001|Overall Study|Other|3|||
130180568|NCT05201794|468617312|FG002|Overall Study|Other|3|||
130180569|NCT05201794|468617313|FG003|Overall Study|Other|0|||
130180570|NCT05201794|468617310|FG000|Overall Study|Randomized But Not Treated|1|||
130180571|NCT05201794|468617311|FG001|Overall Study|Randomized But Not Treated|2|||
130180572|NCT05201794|468617312|FG002|Overall Study|Randomized But Not Treated|1|||
130180573|NCT05201794|468617313|FG003|Overall Study|Randomized But Not Treated|0|||
130180574|NCT06082843|468617319|FG000|Overall Study|Withdrawal by Subject|0|||
130180575|NCT06082843|468617320|FG001|Overall Study|Withdrawal by Subject|2|||
130180576|NCT06082843|468617319|FG000|Overall Study|Study terminated by sponsor|12|||
130180577|NCT06082843|468617320|FG001|Overall Study|Study terminated by sponsor|8|||
130180578|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Death|1|||
130180579|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Death|0|||
130180580|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130180581|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130180582|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
130180583|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
130180584|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
130180585|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
130180586|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
130180587|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
130180588|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
130180589|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
130180590|NCT03176134|468617326|FG000|Overall Study|Lost to Follow-up|0|||
130180591|NCT03176134|468617327|FG001|Overall Study|Lost to Follow-up|2|||
130180592|NCT03176134|468617328|FG002|Overall Study|Lost to Follow-up|0|||
130180593|NCT03176134|468617329|FG003|Overall Study|Lost to Follow-up|0|||
130180594|NCT03176134|468617330|FG004|Overall Study|Lost to Follow-up|0|||
130180595|NCT03176134|468617331|FG005|Overall Study|Lost to Follow-up|0|||
130180596|NCT03176134|468617332|FG006|Overall Study|Lost to Follow-up|0|||
130180597|NCT03176134|468617333|FG007|Overall Study|Lost to Follow-up|0|||
130180598|NCT03176134|468617326|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130180599|NCT03176134|468617327|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130180600|NCT03176134|468617328|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130180601|NCT03176134|468617329|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130180602|NCT03176134|468617330|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130180603|NCT03176134|468617331|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130180604|NCT03176134|468617332|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130180605|NCT03176134|468617333|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130180606|NCT01368497|468617334|FG000|Overall Study|Lost to Follow-up|2|||
130180607|NCT05989672|468617336|FG000|Overall Study|Adverse Event|3|||
130180608|NCT05989672|468617337|FG001|Overall Study|Adverse Event|0|||
130180609|NCT05989672|468617338|FG002|Overall Study|Adverse Event|0|||
130180610|NCT00443729|468617339|FG000|Overall Study|Never Treated|0|||
130180611|NCT00443729|468617340|FG001|Overall Study|Never Treated|1|||
130180612|NCT00443729|468617339|FG000|Overall Study|Lack of Efficacy|4|||
130180613|NCT00443729|468617340|FG001|Overall Study|Lack of Efficacy|2|||
130180614|NCT00443729|468617339|FG000|Overall Study|Lost to Follow-up|0|||
130180615|NCT00443729|468617340|FG001|Overall Study|Lost to Follow-up|1|||
130180616|NCT00443729|468617339|FG000|Overall Study|Physician Decision|2|||
130180617|NCT00443729|468617340|FG001|Overall Study|Physician Decision|1|||
130180618|NCT00443729|468617339|FG000|Overall Study|Protocol Violation|1|||
130180619|NCT00443729|468617340|FG001|Overall Study|Protocol Violation|1|||
130180620|NCT00443729|468617339|FG000|Overall Study|Withdrawal by Subject|3|||
130180621|NCT00443729|468617340|FG001|Overall Study|Withdrawal by Subject|1|||
130180622|NCT03718832|468617343|FG000|Analysis Sample|Withdrawal by Subject|18|||
130180623|NCT03718832|468617344|FG001|Analysis Sample|Withdrawal by Subject|15|||
130180624|NCT03718832|468617343|FG000|Analysis Sample|Legal hold on data|1|||
130180625|NCT03718832|468617344|FG001|Analysis Sample|Legal hold on data|0|||
130180626|NCT03718832|468617343|FG000|Analysis Sample|Participant from treated household|0|||
130180627|NCT03718832|468617344|FG001|Analysis Sample|Participant from treated household|1|||
130180628|NCT03718832|468617343|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
130180629|NCT03718832|468617344|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
130180630|NCT00276484|468617348|FG000|Overall Study|Adverse Event|4|||
130180631|NCT00276484|468617349|FG001|Overall Study|Adverse Event|7|||
130180632|NCT00276484|468617348|FG000|Overall Study|Lost to Follow-up|1|||
130180633|NCT00276484|468617349|FG001|Overall Study|Lost to Follow-up|1|||
130180634|NCT00276484|468617348|FG000|Overall Study|Protocol Violation|0|||
130180635|NCT00276484|468617349|FG001|Overall Study|Protocol Violation|1|||
130180636|NCT00276484|468617348|FG000|Overall Study|Withdrawal by Subject|4|||
130180637|NCT00276484|468617349|FG001|Overall Study|Withdrawal by Subject|3|||
130180638|NCT00276484|468617348|FG000|Overall Study|Could not take time off work|0|||
130180639|NCT00276484|468617349|FG001|Overall Study|Could not take time off work|1|||
130180640|NCT01626690|468617350|FG000|Overall Study|Protocol Violation|1|||
130180641|NCT01626690|468617351|FG001|Overall Study|Protocol Violation|0|||
130180642|NCT01626690|468617350|FG000|Overall Study|Adverse Event|1|||
130180643|NCT01626690|468617351|FG001|Overall Study|Adverse Event|0|||
130180644|NCT00110396|468617352|FG000|Overall Study|Adverse Event|15|||
130180645|NCT00110396|468617352|FG000|Overall Study|Lost to Follow-up|1|||
130180646|NCT00110396|468617352|FG000|Overall Study|Administration of plasmapheresis|1|||
130180647|NCT00110396|468617352|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
130180648|NCT00110396|468617352|FG000|Overall Study|Lack of Efficacy|1|||
130180649|NCT00110396|468617352|FG000|Overall Study|Decided not to continue treatment|1|||
130180650|NCT00110396|468617352|FG000|Overall Study|Patient non-compliance|1|||
130180651|NCT00110396|468617352|FG000|Overall Study|Patient refused to continue|1|||
130180652|NCT00110396|468617352|FG000|Overall Study|Patient refused to participate|1|||
130180653|NCT00110396|468617352|FG000|Overall Study|Patient will|1|||
130180654|NCT00110396|468617352|FG000|Overall Study|Patient's decision|1|||
130180655|NCT00110396|468617352|FG000|Overall Study|Participation in MS vaccine study|1|||
130180656|NCT00110396|468617352|FG000|Overall Study|Pregnancy|1|||
130180657|NCT00110396|468617352|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
130180658|NCT00110396|468617352|FG000|Overall Study|Protocol Violation|2|||
130180659|NCT00110396|468617352|FG000|Overall Study|Patient refused to come back|1|||
130652038|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
130652039|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
130652040|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
130652041|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
130652042|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
130652043|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
130652044|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
130652045|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
130652046|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
130652047|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
130652048|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
130652049|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130652050|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
130652051|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130652052|NCT00570492|470347702|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
130652053|NCT00570492|470347703|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
130652054|NCT00570492|470347704|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
130652055|NCT00908375|470347705|FG000|Overall Study|Withdrawal by Subject|2|||
130652056|NCT00908375|470347706|FG001|Overall Study|Withdrawal by Subject|4|||
130652057|NCT00908375|470347705|FG000|Overall Study|Lost to Follow-up|8|||
130652058|NCT00908375|470347706|FG001|Overall Study|Lost to Follow-up|6|||
130652059|NCT00752206|470347707|FG000|Overall Study|Disease progression|8|||
130652060|NCT00752206|470347708|FG001|Overall Study|Disease progression|11|||
130652061|NCT00752206|470347707|FG000|Overall Study|Pregnancy|1|||
130652062|NCT00752206|470347708|FG001|Overall Study|Pregnancy|0|||
130652063|NCT03958045|470347711|FG000|Overall Study|Withdrawal by Subject|1|||
130652064|NCT02283411|470347712|FG000|Overall Study|Withdrawal by Subject|3|||
130652065|NCT02283411|470347712|FG000|Overall Study|Screen Failed|28|||
130652066|NCT01298323|470347714|FG000|Overall Study|Adverse Event|2|||
130652067|NCT01298323|470347715|FG001|Overall Study|Adverse Event|4|||
130652068|NCT01298323|470347714|FG000|Overall Study|Death|11|||
130652069|NCT01298323|470347715|FG001|Overall Study|Death|16|||
130652070|NCT01298323|470347714|FG000|Overall Study|Lost to Follow-up|1|||
130652071|NCT01298323|470347715|FG001|Overall Study|Lost to Follow-up|0|||
130652072|NCT01298323|470347714|FG000|Overall Study|Withdrawal by Subject|6|||
130180660|NCT00110396|468617352|FG000|Overall Study|The patient has refused|2|||
130180661|NCT00110396|468617352|FG000|Overall Study|The patient has refused to visit site|1|||
130180662|NCT00110396|468617352|FG000|Overall Study|Patient is to be administered copaxone|1|||
130652073|NCT01298323|470347715|FG001|Overall Study|Withdrawal by Subject|3|||
130652074|NCT01298323|470347714|FG000|Overall Study|Protocol Violation|1|||
130180663|NCT02414958|468617353|FG000|Overall Study|Adverse Event|6|||
130180664|NCT02414958|468617354|FG001|Overall Study|Adverse Event|6|||
130180665|NCT02414958|468617355|FG002|Overall Study|Adverse Event|3|||
130180666|NCT02414958|468617353|FG000|Overall Study|Protocol Violation|10|||
130180667|NCT02414958|468617354|FG001|Overall Study|Protocol Violation|3|||
130652075|NCT01298323|470347715|FG001|Overall Study|Protocol Violation|0|||
130652076|NCT01298323|470347714|FG000|Overall Study|Other|10|||
130652077|NCT01298323|470347715|FG001|Overall Study|Other|9|||
130652078|NCT01298323|470347714|FG000|Overall Study|Ongoing|55|||
130652079|NCT01298323|470347715|FG001|Overall Study|Ongoing|55|||
130652080|NCT01298323|470347714|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130652081|NCT01298323|470347715|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130652082|NCT02500732|470347716|FG000|Overall Study|Physician Decision|0|||
130652083|NCT02500732|470347717|FG001|Overall Study|Physician Decision|1|||
130652084|NCT04409262|470347718|FG000|Overall Study|Adverse Event|0|||
130652085|NCT04409262|470347719|FG001|Overall Study|Adverse Event|2|||
130652086|NCT04409262|470347718|FG000|Overall Study|Death|55|||
130652087|NCT04409262|470347719|FG001|Overall Study|Death|97|||
130652088|NCT04409262|470347718|FG000|Overall Study|Lost to Follow-up|12|||
130652089|NCT04409262|470347719|FG001|Overall Study|Lost to Follow-up|23|||
130652090|NCT04409262|470347718|FG000|Overall Study|Lack of Staff|0|||
130652091|NCT04409262|470347719|FG001|Overall Study|Lack of Staff|1|||
130652092|NCT04409262|470347718|FG000|Overall Study|Protocol Violation|3|||
130652093|NCT04409262|470347719|FG001|Overall Study|Protocol Violation|1|||
130652094|NCT04409262|470347718|FG000|Overall Study|Withdrawal by Subject|5|||
130652095|NCT04409262|470347719|FG001|Overall Study|Withdrawal by Subject|10|||
130652096|NCT02396849|470347720|FG000|Overall Study|Lost to Follow-up|1|||
130652097|NCT02396849|470347721|FG001|Overall Study|Lost to Follow-up|1|||
130652098|NCT02396849|470347720|FG000|Overall Study|Did not tolerate intervention|1|||
130652099|NCT02396849|470347721|FG001|Overall Study|Did not tolerate intervention|1|||
130652100|NCT00931515|470347724|FG000|Overall Study|Lost to Follow-up|2|||
130652101|NCT00931515|470347725|FG001|Overall Study|Lost to Follow-up|5|||
130652102|NCT03759340|470347726|FG000|Overall Study|Adverse Event|2|||
130652103|NCT03759340|470347726|FG000|Overall Study|Lost to Follow-up|1|||
130652104|NCT03759340|470347726|FG000|Overall Study|Withdrawal by Subject|15|||
130652105|NCT03759340|470347726|FG000|Overall Study|Study Terminated by Sponsor|38|||
130652106|NCT02950831|470347727|FG000|Overall Study|Lost to Follow-up|1|||
130652107|NCT02950831|470347727|FG000|Overall Study|Withdrawal by Subject|3|||
130652108|NCT02950831|470347727|FG000|Overall Study|stimulation trail failure|5|||
130652109|NCT00945815|470347728|FG000|Overall Study|Death|3|||
130652110|NCT00945815|470347728|FG000|Overall Study|Not protocol specified|1|||
130652111|NCT00945815|470347728|FG000|Overall Study|Ineligible|3|||
130652112|NCT00945815|470347728|FG000|Overall Study|Did not begin protocol therapy|1|||
130652113|NCT01965600|470347729|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
130652114|NCT01965600|470347730|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
130652115|NCT01965600|470347731|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
130652116|NCT01965600|470347732|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
130652117|NCT01965600|470347729|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130652118|NCT01965600|470347730|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
130652119|NCT01965600|470347731|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130652120|NCT01965600|470347732|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130652121|NCT01965600|470347729|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
130652122|NCT01965600|470347730|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130652123|NCT01965600|470347731|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130652124|NCT01965600|470347732|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130652125|NCT01965600|470347729|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
130652126|NCT01965600|470347730|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
130652127|NCT01965600|470347731|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
130652128|NCT01965600|470347732|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
130652129|NCT01965600|470347729|FG000|Second Intervention|Study terminated by Sponsor|0|||
130652130|NCT01965600|470347730|FG001|Second Intervention|Study terminated by Sponsor|0|||
130652131|NCT01965600|470347731|FG002|Second Intervention|Study terminated by Sponsor|2|||
130652132|NCT01965600|470347732|FG003|Second Intervention|Study terminated by Sponsor|2|||
130652133|NCT03418727|470347740|FG000|Overall Study|Adverse Event|1|||
130652134|NCT03418727|470347741|FG001|Overall Study|Adverse Event|2|||
130652135|NCT03418727|470347742|FG002|Overall Study|Adverse Event|0|||
130652136|NCT03418727|470347740|FG000|Overall Study|Withdrawal by Subject|0|||
130652137|NCT03418727|470347741|FG001|Overall Study|Withdrawal by Subject|0|||
130652138|NCT03418727|470347742|FG002|Overall Study|Withdrawal by Subject|2|||
130652139|NCT00686894|470347744|FG000|Overall Study|Relapse|2|||
130652140|NCT00686894|470347744|FG000|Overall Study|Protocol Violation|4|||
130652141|NCT01790633|470347745|FG000|Overall Study|Protocol Violation|1|||
130652142|NCT01790633|470347746|FG001|Overall Study|Protocol Violation|2|||
130652143|NCT01790633|470347745|FG000|Overall Study|Did not have serology performed|47|||
130652144|NCT01790633|470347746|FG001|Overall Study|Did not have serology performed|0|||
130652145|NCT01790633|470347745|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
130652146|NCT01790633|470347746|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
130652147|NCT00157157|470347747|FG000|Overall Study|Withdrawal by Subject|6|||
130652148|NCT00157157|470347747|FG000|Overall Study|Physician Decision|1|||
130180668|NCT02414958|468617355|FG002|Overall Study|Protocol Violation|1|||
130180669|NCT02414958|468617353|FG000|Overall Study|Lost to Follow-up|7|||
130180670|NCT02414958|468617354|FG001|Overall Study|Lost to Follow-up|4|||
130180671|NCT02414958|468617355|FG002|Overall Study|Lost to Follow-up|0|||
130180672|NCT02414958|468617353|FG000|Overall Study|Withdrawal by Subject|5|||
130180673|NCT02414958|468617354|FG001|Overall Study|Withdrawal by Subject|3|||
130180674|NCT02414958|468617355|FG002|Overall Study|Withdrawal by Subject|5|||
130180675|NCT02414958|468617353|FG000|Overall Study|Other than specified|4|||
130180676|NCT02414958|468617354|FG001|Overall Study|Other than specified|4|||
130180677|NCT02414958|468617355|FG002|Overall Study|Other than specified|5|||
130180678|NCT00476190|468617358|FG000|Overall Study|Ineligible|1|||
130180679|NCT00476190|468617359|FG001|Overall Study|Ineligible|1|||
130180680|NCT00476190|468617358|FG000|Overall Study|Induction Death|2|||
130180681|NCT00476190|468617359|FG001|Overall Study|Induction Death|0|||
130180682|NCT00476190|468617358|FG000|Overall Study|Induction Failure|2|||
130180683|NCT00476190|468617359|FG001|Overall Study|Induction Failure|4|||
130180684|NCT00476190|468617358|FG000|Overall Study|Lost to Follow-up|1|||
130180685|NCT00476190|468617359|FG001|Overall Study|Lost to Follow-up|0|||
130180686|NCT00476190|468617358|FG000|Overall Study|Relapse/Progression|5|||
130180687|NCT00476190|468617359|FG001|Overall Study|Relapse/Progression|2|||
130180688|NCT00476190|468617358|FG000|Overall Study|Remission Death|0|||
130180689|NCT00476190|468617359|FG001|Overall Study|Remission Death|1|||
130180690|NCT00476190|468617358|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
130180691|NCT00476190|468617359|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
130180692|NCT00476190|468617358|FG000|Overall Study|Withdrawal by Subject|6|||
130180693|NCT00476190|468617359|FG001|Overall Study|Withdrawal by Subject|2|||
130180694|NCT00476190|468617358|FG000|Overall Study|Other|9|||
130180695|NCT00476190|468617359|FG001|Overall Study|Other|10|||
130180696|NCT01329900|468617362|FG000|Overall Study|Elevated creatinine/renal function|1|||
130180697|NCT00995774|468617366|FG000|Training Period 2|Withdrawal by Subject|2|||
130180698|NCT00995774|468617367|FG001|Training Period 2|Withdrawal by Subject|0|||
130180699|NCT01808573|468617368|FG000|Overall Study|Death|212|||
130180700|NCT01808573|468617369|FG001|Overall Study|Death|240|||
130180701|NCT01808573|468617368|FG000|Overall Study|Withdrawal by Subject|12|||
130180702|NCT01808573|468617369|FG001|Overall Study|Withdrawal by Subject|10|||
130180703|NCT01808573|468617368|FG000|Overall Study|Lost to Follow-up|3|||
130180704|NCT01808573|468617369|FG001|Overall Study|Lost to Follow-up|0|||
130180705|NCT01808573|468617368|FG000|Overall Study|Discontinuation of study by sponsor|79|||
130180706|NCT01808573|468617369|FG001|Overall Study|Discontinuation of study by sponsor|64|||
130180707|NCT01808573|468617368|FG000|Overall Study|Randomized in Error|1|||
130180708|NCT01808573|468617369|FG001|Overall Study|Randomized in Error|0|||
130180709|NCT01523002|468617372|FG000|Period 1|Withdrawal by Subject|1|||
130180710|NCT01523002|468617373|FG001|Period 1|Withdrawal by Subject|3|||
130180711|NCT01523002|468617372|FG000|Period 1|Lost to Follow-up|1|||
130180712|NCT01523002|468617373|FG001|Period 1|Lost to Follow-up|0|||
130180713|NCT01523002|468617372|FG000|Period 1|Adverse Event|0|||
130180714|NCT01523002|468617373|FG001|Period 1|Adverse Event|8|||
130180715|NCT01523002|468617372|FG000|Period 2|Withdrawal by Subject|4|||
130180716|NCT01523002|468617373|FG001|Period 2|Withdrawal by Subject|1|||
130180717|NCT01523002|468617372|FG000|Period 2|Adverse Event|2|||
130180718|NCT01523002|468617373|FG001|Period 2|Adverse Event|5|||
130180719|NCT01523002|468617372|FG000|Period 3|Withdrawal by Subject|1|||
130180720|NCT01523002|468617373|FG001|Period 3|Withdrawal by Subject|0|||
130180721|NCT01523002|468617372|FG000|Period 3|Adverse Event|3|||
130180722|NCT01523002|468617373|FG001|Period 3|Adverse Event|0|||
130180723|NCT01256502|468617375|FG000|Overall Study|Had scaffold removed|4|||
130180724|NCT01256502|468617375|FG000|Overall Study|Personal reasons|5|||
130180725|NCT01256502|468617375|FG000|Overall Study|Protocol deviation|1|||
130180726|NCT03953612|468617376|FG000|Overall Study|Randomized but did not start|1|||
130180727|NCT03953612|468617377|FG001|Overall Study|Randomized but did not start|1|||
130180728|NCT03953612|468617378|FG002|Overall Study|Randomized but did not start|1|||
130180729|NCT03953612|468617376|FG000|Overall Study|Withdrawal by Subject|2|||
130180730|NCT03953612|468617377|FG001|Overall Study|Withdrawal by Subject|1|||
130180731|NCT03953612|468617378|FG002|Overall Study|Withdrawal by Subject|0|||
130180732|NCT03200717|468617394|FG000|Overall Study|Progressive disease|24|||
130180733|NCT03200717|468617395|FG001|Overall Study|Progressive disease|5|||
130180734|NCT03200717|468617394|FG000|Overall Study|Adverse Event|11|||
130180735|NCT03200717|468617395|FG001|Overall Study|Adverse Event|8|||
130180736|NCT03200717|468617394|FG000|Overall Study|Physician Decision|3|||
130180737|NCT03200717|468617395|FG001|Overall Study|Physician Decision|2|||
130180738|NCT03200717|468617394|FG000|Overall Study|Death|2|||
130180739|NCT03200717|468617395|FG001|Overall Study|Death|0|||
130180740|NCT03200717|468617394|FG000|Overall Study|Subject/Guardian Decision|1|||
130180741|NCT03200717|468617395|FG001|Overall Study|Subject/Guardian Decision|0|||
130180742|NCT01461538|468617396|FG000|Overall Study|Death|15|||
130180743|NCT01461538|468617397|FG001|Overall Study|Death|6|||
130180744|NCT01461538|468617398|FG002|Overall Study|Death|2|||
130180745|NCT01461538|468617396|FG000|Overall Study|Study Stopped by Sponsor|2|||
130180746|NCT01461538|468617397|FG001|Overall Study|Study Stopped by Sponsor|1|||
130652149|NCT00157157|470347747|FG000|Overall Study|Lost to Follow-up|1|||
130180747|NCT01461538|468617398|FG002|Overall Study|Study Stopped by Sponsor|0|||
130180748|NCT01461538|468617396|FG000|Overall Study|Withdrawal by Subject|1|||
130180749|NCT01461538|468617397|FG001|Overall Study|Withdrawal by Subject|1|||
130180750|NCT01461538|468617398|FG002|Overall Study|Withdrawal by Subject|0|||
130180751|NCT00141778|468617399|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
130180752|NCT00141778|468617400|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
130180753|NCT00141778|468617401|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
130180754|NCT00141778|468617399|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
130180755|NCT00141778|468617400|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
130180756|NCT00141778|468617401|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
130180757|NCT00141778|468617399|FG000|Started Study Medication|Withdrawal by Subject|0|||
130180758|NCT00141778|468617400|FG001|Started Study Medication|Withdrawal by Subject|2|||
130180759|NCT00141778|468617401|FG002|Started Study Medication|Withdrawal by Subject|0|||
130180760|NCT00141778|468617399|FG000|Started Study Medication|Difficulty Swallowing|0|||
130180761|NCT00141778|468617400|FG001|Started Study Medication|Difficulty Swallowing|1|||
130180762|NCT00141778|468617401|FG002|Started Study Medication|Difficulty Swallowing|0|||
130180763|NCT00141778|468617399|FG000|Started Study Medication|Chest Discomfort|0|||
130180764|NCT00141778|468617400|FG001|Started Study Medication|Chest Discomfort|0|||
130180765|NCT00141778|468617401|FG002|Started Study Medication|Chest Discomfort|1|||
130652150|NCT00157157|470347747|FG000|Overall Study|Enrolled in another study|1|||
130652151|NCT00157157|470347747|FG000|Overall Study|Met exclusion criteria|1|||
130652152|NCT00157157|470347747|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
130652153|NCT02260804|470347754|FG000|Induction Study Period|Protocol Violation|2|||
130652154|NCT02260804|470347755|FG001|Induction Study Period|Protocol Violation|0|||
130652155|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
130652156|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
130652157|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
130652158|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
130652159|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
130652160|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
130652161|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
130652162|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
130652163|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
130652164|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
130652165|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
130652166|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
130652167|NCT02260804|470347754|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
130652168|NCT02260804|470347755|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
130652169|NCT02260804|470347754|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
130652170|NCT02260804|470347755|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
130652171|NCT02260804|470347754|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
130652172|NCT02260804|470347755|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
130652173|NCT02260804|470347754|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
130652174|NCT02260804|470347755|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
130180766|NCT01245283|468617406|FG000|Overall Study|Lost to Follow-up|14|||
130180767|NCT01245283|468617407|FG001|Overall Study|Lost to Follow-up|11|||
130180768|NCT01245283|468617408|FG002|Overall Study|Lost to Follow-up|11|||
130180769|NCT01610492|468617411|FG000|Overall Study|Adverse Event|1|||
130180770|NCT01610492|468617411|FG000|Overall Study|Lack of Efficacy|3|||
130180771|NCT01610492|468617411|FG000|Overall Study|Other: Reached stopping criteria|1|||
130180772|NCT01610492|468617411|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
130180773|NCT01982955|468617412|FG000|Overall Study|Randomized but not treated|0|||
130180774|NCT01982955|468617413|FG001|Overall Study|Randomized but not treated|0|||
130180775|NCT01982955|468617414|FG002|Overall Study|Randomized but not treated|0|||
130180776|NCT01982955|468617415|FG003|Overall Study|Randomized but not treated|1|||
130180777|NCT01982955|468617416|FG004|Overall Study|Randomized but not treated|0|||
130180778|NCT04211831|468617419|FG000|Overall Study|Withdrawal by Subject|4|||
130180779|NCT04211831|468617420|FG001|Overall Study|Withdrawal by Subject|1|||
130180780|NCT04211831|468617421|FG002|Overall Study|Withdrawal by Subject|1|||
130180781|NCT04211831|468617419|FG000|Overall Study|Protocol Violation|0|||
130180782|NCT04211831|468617420|FG001|Overall Study|Protocol Violation|0|||
130180783|NCT04211831|468617421|FG002|Overall Study|Protocol Violation|1|||
130180784|NCT04211831|468617419|FG000|Overall Study|Adverse Event|0|||
130180785|NCT04211831|468617420|FG001|Overall Study|Adverse Event|1|||
130180786|NCT04211831|468617421|FG002|Overall Study|Adverse Event|0|||
130180787|NCT04211831|468617419|FG000|Overall Study|Lack of Efficacy|0|||
130180788|NCT04211831|468617420|FG001|Overall Study|Lack of Efficacy|0|||
130180789|NCT04211831|468617421|FG002|Overall Study|Lack of Efficacy|1|||
130180790|NCT04211831|468617419|FG000|Overall Study|Lost to Follow-up|0|||
130180791|NCT04211831|468617420|FG001|Overall Study|Lost to Follow-up|0|||
130180792|NCT04211831|468617421|FG002|Overall Study|Lost to Follow-up|2|||
130180793|NCT04211831|468617419|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
130180794|NCT04211831|468617420|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
130180795|NCT04211831|468617421|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
130180796|NCT04211831|468617419|FG000|Overall Study|Other|0|||
130180797|NCT04211831|468617420|FG001|Overall Study|Other|1|||
130180798|NCT04211831|468617421|FG002|Overall Study|Other|0|||
130180799|NCT01256879|468617422|FG000|Overall Study|Withdrawal by Subject|1|||
130180800|NCT00397514|468617423|FG000|Overall Study|Withdrawal by Subject|1|||
130180801|NCT00397514|468617423|FG000|Overall Study|Pacing wire malfunction|1|||
130180802|NCT00397514|468617423|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
130180803|NCT00397514|468617423|FG000|Overall Study|early extubation|2|||
130180804|NCT00397514|468617423|FG000|Overall Study|poor echocardiographic windows|1|||
130180805|NCT00640315|468617425|FG000|Overall Study|Withdrawal by Subject|0|||
130180806|NCT00640315|468617426|FG001|Overall Study|Withdrawal by Subject|1|||
130180807|NCT05525520|468619060|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
130180808|NCT05525520|468619061|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
130180809|NCT05525520|468619060|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130180810|NCT05525520|468619061|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130180811|NCT03657797|468619062|FG000|Overall Study|Lost to Follow-up|0|||
130180812|NCT03657797|468619063|FG001|Overall Study|Lost to Follow-up|1|||
130180813|NCT03657797|468619064|FG002|Overall Study|Lost to Follow-up|1|||
130180814|NCT03657797|468619065|FG003|Overall Study|Lost to Follow-up|0|||
130180815|NCT03657797|468619062|FG000|Overall Study|Physician Decision|0|||
130180816|NCT03657797|468619063|FG001|Overall Study|Physician Decision|1|||
130180817|NCT03657797|468619064|FG002|Overall Study|Physician Decision|0|||
130180818|NCT03657797|468619065|FG003|Overall Study|Physician Decision|0|||
130180819|NCT03657797|468619062|FG000|Overall Study|Withdrawal by Subject|0|||
130180820|NCT03657797|468619063|FG001|Overall Study|Withdrawal by Subject|1|||
130180821|NCT03657797|468619064|FG002|Overall Study|Withdrawal by Subject|2|||
130180822|NCT03657797|468619065|FG003|Overall Study|Withdrawal by Subject|0|||
130180823|NCT03657797|468619062|FG000|Overall Study|Adverse Event|0|||
130180824|NCT03657797|468619063|FG001|Overall Study|Adverse Event|0|||
130180825|NCT03657797|468619064|FG002|Overall Study|Adverse Event|2|||
130180826|NCT03657797|468619065|FG003|Overall Study|Adverse Event|0|||
130180827|NCT00118157|468619066|FG000|Overall Study|Adverse Event|2|||
130180828|NCT00118157|468619066|FG000|Overall Study|Death|8|||
130180829|NCT00118157|468619066|FG000|Overall Study|Withdrawal by Subject|2|||
130180830|NCT00696423|468619067|FG000|Overall Study|Lost to Follow-up|0|||
130180831|NCT00696423|468619068|FG001|Overall Study|Lost to Follow-up|5|||
130180832|NCT03989102|468619069|FG000|Year 1|Withdrawal by Subject|6|||
130180833|NCT03989102|468619070|FG001|Year 1|Withdrawal by Subject|2|||
130180834|NCT03989102|468619071|FG002|Year 1|Withdrawal by Subject|7|||
130180835|NCT03989102|468619069|FG000|Year 1|Lost to Follow-up|5|||
130180836|NCT03989102|468619070|FG001|Year 1|Lost to Follow-up|2|||
130180837|NCT03989102|468619071|FG002|Year 1|Lost to Follow-up|5|||
130180838|NCT03989102|468619069|FG000|Year 1|Subject met withdrawal criteria|1|||
130180839|NCT03989102|468619070|FG001|Year 1|Subject met withdrawal criteria|0|||
130180840|NCT03989102|468619071|FG002|Year 1|Subject met withdrawal criteria|1|||
130180841|NCT03989102|468619069|FG000|Year 2|Lost to Follow-up|7|||
130180842|NCT03989102|468619070|FG001|Year 2|Lost to Follow-up|3|||
130180843|NCT03989102|468619071|FG002|Year 2|Lost to Follow-up|4|||
130180844|NCT03989102|468619069|FG000|Year 2|Withdrawal by Subject|3|||
130180845|NCT03989102|468619070|FG001|Year 2|Withdrawal by Subject|1|||
130180846|NCT03989102|468619071|FG002|Year 2|Withdrawal by Subject|2|||
130180847|NCT03989102|468619069|FG000|Year 2|Subject non-compliant|3|||
130180848|NCT03989102|468619070|FG001|Year 2|Subject non-compliant|2|||
130180849|NCT03989102|468619071|FG002|Year 2|Subject non-compliant|0|||
130180850|NCT03989102|468619069|FG000|Year 2|Travel|1|||
130180851|NCT03989102|468619070|FG001|Year 2|Travel|0|||
130180852|NCT03989102|468619071|FG002|Year 2|Travel|1|||
130180853|NCT03989102|468619069|FG000|Year 2|P16 missing|4|||
130180854|NCT03989102|468619070|FG001|Year 2|P16 missing|2|||
130180855|NCT03989102|468619071|FG002|Year 2|P16 missing|1|||
130180856|NCT03989102|468619069|FG000|Year 2|P11 missing|1|||
130180857|NCT03989102|468619070|FG001|Year 2|P11 missing|3|||
130180858|NCT03989102|468619071|FG002|Year 2|P11 missing|7|||
130180859|NCT03989102|468619069|FG000|Year 2|Definitive displacement outside the study site|0|||
130180860|NCT03989102|468619070|FG001|Year 2|Definitive displacement outside the study site|1|||
130180861|NCT03989102|468619071|FG002|Year 2|Definitive displacement outside the study site|0|||
130180862|NCT03989102|468619069|FG000|Year 2|Subject missed last study visit|0|||
130180863|NCT03989102|468619070|FG001|Year 2|Subject missed last study visit|1|||
130180864|NCT03989102|468619071|FG002|Year 2|Subject missed last study visit|0|||
130180865|NCT03989102|468619069|FG000|Year 2|Death|0|||
130180866|NCT03989102|468619070|FG001|Year 2|Death|1|||
130180867|NCT03989102|468619071|FG002|Year 2|Death|0|||
130180868|NCT03989102|468619069|FG000|Year 2|Subject not reachable|0|||
130180869|NCT03989102|468619070|FG001|Year 2|Subject not reachable|0|||
130180870|NCT03989102|468619071|FG002|Year 2|Subject not reachable|1|||
130180871|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
130180872|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130180873|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130180874|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180875|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180876|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180877|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
130180878|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130180879|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130180880|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
130180881|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
130180882|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
130180883|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130180884|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
130180885|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130180886|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130180887|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130180888|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
130180889|NCT03642262|468619072|FG000|Period 1|Withdrawal by Subject|1|||
130180890|NCT03642262|468619073|FG001|Period 1|Withdrawal by Subject|1|||
130180891|NCT03642262|468619072|FG000|Period 1|Adverse Event|0|||
130180892|NCT03642262|468619073|FG001|Period 1|Adverse Event|1|||
130180893|NCT02760004|468619078|FG000|Overall Study|Lost to Follow-up|13|||
130180894|NCT02760004|468619079|FG001|Overall Study|Lost to Follow-up|22|||
130180895|NCT02203357|468619082|FG000|Overall Study|Lost to Follow-up|58|||
130180896|NCT02203357|468619083|FG001|Overall Study|Lost to Follow-up|66|||
130180897|NCT02203357|468619084|FG002|Overall Study|Lost to Follow-up|70|||
130180898|NCT01431079|468619085|FG000|Overall Study|Lost to Follow-up|35|||
130180899|NCT01431079|468619086|FG001|Overall Study|Lost to Follow-up|39|||
130180900|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180901|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
130180902|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180903|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180904|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
130180905|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180906|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180907|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180908|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180909|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
130180910|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180911|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180912|NCT02038010|468619090|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130180913|NCT02038010|468619091|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130180914|NCT02038010|468619092|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130180915|NCT02038010|468619093|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130180916|NCT02038010|468619090|FG000|Follow Up|Death|4|||
130180917|NCT02038010|468619091|FG001|Follow Up|Death|3|||
130180918|NCT02038010|468619092|FG002|Follow Up|Death|0|||
130180919|NCT02038010|468619093|FG003|Follow Up|Death|0|||
130180920|NCT02038010|468619090|FG000|Follow Up|Other|3|||
130180921|NCT02038010|468619091|FG001|Follow Up|Other|0|||
130180922|NCT02038010|468619092|FG002|Follow Up|Other|0|||
130180923|NCT02038010|468619093|FG003|Follow Up|Other|0|||
130180924|NCT00245466|468619095|FG000|Overall Study|Adverse Event|2|||
130180925|NCT00245466|468619096|FG001|Overall Study|Adverse Event|8|||
130180926|NCT00245466|468619097|FG002|Overall Study|Adverse Event|4|||
130180927|NCT00245466|468619095|FG000|Overall Study|Low prostate specific antigen suppr|16|||
130180928|NCT00245466|468619096|FG001|Overall Study|Low prostate specific antigen suppr|14|||
130180929|NCT00245466|468619097|FG002|Overall Study|Low prostate specific antigen suppr|5|||
130180930|NCT00245466|468619095|FG000|Overall Study|Insufficient testosterone suppr|12|||
130180931|NCT00245466|468619096|FG001|Overall Study|Insufficient testosterone suppr|12|||
130180932|NCT00245466|468619097|FG002|Overall Study|Insufficient testosterone suppr|21|||
130180933|NCT00245466|468619095|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
130180934|NCT00245466|468619096|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
130180935|NCT00245466|468619097|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
130180936|NCT00245466|468619095|FG000|Overall Study|Withdrawal by Subject|2|||
130180937|NCT00245466|468619096|FG001|Overall Study|Withdrawal by Subject|2|||
130180938|NCT00245466|468619097|FG002|Overall Study|Withdrawal by Subject|1|||
130180939|NCT00245466|468619095|FG000|Overall Study|Lost to Follow-up|3|||
130180940|NCT00245466|468619096|FG001|Overall Study|Lost to Follow-up|0|||
130180941|NCT00245466|468619097|FG002|Overall Study|Lost to Follow-up|0|||
130180942|NCT00245466|468619095|FG000|Overall Study|Disease progression|0|||
130180943|NCT00245466|468619096|FG001|Overall Study|Disease progression|3|||
130180944|NCT00245466|468619097|FG002|Overall Study|Disease progression|1|||
130180945|NCT00245466|468619095|FG000|Overall Study|Protocol Violation|1|||
130180946|NCT00245466|468619096|FG001|Overall Study|Protocol Violation|2|||
130180947|NCT00245466|468619097|FG002|Overall Study|Protocol Violation|2|||
130180948|NCT00245466|468619095|FG000|Overall Study|Death|0|||
130180949|NCT00245466|468619096|FG001|Overall Study|Death|2|||
130180950|NCT00245466|468619097|FG002|Overall Study|Death|0|||
130180951|NCT00245466|468619095|FG000|Overall Study|Administrative reasons|0|||
130180952|NCT00245466|468619096|FG001|Overall Study|Administrative reasons|1|||
130180953|NCT00245466|468619097|FG002|Overall Study|Administrative reasons|0|||
130180954|NCT01958437|468619098|FG000|Overall Study|Incidental MRI findings|0|||
130180955|NCT01958437|468619099|FG001|Overall Study|Incidental MRI findings|0|||
130180956|NCT01958437|468619100|FG002|Overall Study|Incidental MRI findings|1|||
130180957|NCT01958437|468619101|FG003|Overall Study|Incidental MRI findings|1|||
130180958|NCT04886596|468619104|FG000|Overall Study|Adverse Event|442|||
130180959|NCT04886596|468619105|FG001|Overall Study|Adverse Event|441|||
130180960|NCT04886596|468619104|FG000|Overall Study|Lost to Follow-up|448|||
130180961|NCT04886596|468619105|FG001|Overall Study|Lost to Follow-up|465|||
130180962|NCT04886596|468619104|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
130180963|NCT04886596|468619105|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
130180964|NCT04886596|468619104|FG000|Overall Study|Migrated/moved from the study area|201|||
130180965|NCT04886596|468619105|FG001|Overall Study|Migrated/moved from the study area|184|||
130180966|NCT04886596|468619104|FG000|Overall Study|Other|298|||
130180967|NCT04886596|468619105|FG001|Overall Study|Other|326|||
130180968|NCT00948155|468619108|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
130180969|NCT00948155|468619109|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
130180970|NCT00948155|468619108|FG000|Washout 14 Days|Lost to Follow-up|1|||
130180971|NCT00948155|468619109|FG001|Washout 14 Days|Lost to Follow-up|2|||
130180972|NCT03473925|468619110|FG000|Overall Study|Death|48|||
130180973|NCT03473925|468619111|FG001|Overall Study|Death|44|||
130180974|NCT03473925|468619110|FG000|Overall Study|Sponsor Decision|2|||
130180975|NCT03473925|468619111|FG001|Overall Study|Sponsor Decision|7|||
130180976|NCT03473925|468619110|FG000|Overall Study|Withdrawal by Subject|1|||
130180977|NCT03473925|468619111|FG001|Overall Study|Withdrawal by Subject|3|||
130180978|NCT03473925|468619110|FG000|Overall Study|Not Treated|1|||
130180979|NCT03473925|468619111|FG001|Overall Study|Not Treated|1|||
130180980|NCT04661150|468619116|FG000|Overall Study|Ongoing in study|19|||
130180981|NCT04661150|468619117|FG001|Overall Study|Ongoing in study|20|||
130180982|NCT04661150|468619116|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
130180983|NCT04661150|468619117|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
130180984|NCT04661150|468619116|FG000|Overall Study|Death|2|||
130180985|NCT04661150|468619117|FG001|Overall Study|Death|0|||
130180986|NCT05767905|468619118|FG000|Overall Study|Adverse Event|0|||
130180987|NCT05767905|468619119|FG001|Overall Study|Adverse Event|0|||
130180988|NCT05767905|468619120|FG002|Overall Study|Adverse Event|1|||
130180989|NCT03762239|468619121|FG000|Overall Study|Appointment to the doctor|1|||
130180990|NCT03762239|468619122|FG001|Overall Study|Appointment to the doctor|1|||
130180991|NCT03645863|468619123|FG000|Overall Study|Withdrawal by Subject|1|||
130180992|NCT03645863|468619124|FG001|Overall Study|Withdrawal by Subject|0|||
130180993|NCT03645863|468619125|FG002|Overall Study|Withdrawal by Subject|0|||
130180994|NCT04660331|468619139|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130180995|NCT04660331|468619140|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130180996|NCT04660331|468619141|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
130180997|NCT03624192|468619142|FG000|Overall Study|Lost to Follow-up|1|||
130180998|NCT03624192|468619143|FG001|Overall Study|Lost to Follow-up|1|||
130180999|NCT02635984|468619144|FG000|Overall Study|Lost to Follow-up|2|||
130181000|NCT02635984|468619145|FG001|Overall Study|Lost to Follow-up|4|||
130181001|NCT02635984|468619144|FG000|Overall Study|Study Arm Closed|1|||
130181002|NCT02635984|468619145|FG001|Overall Study|Study Arm Closed|0|||
130181003|NCT01640249|468619147|FG000|Period 1|Withdrawal by Subject|1|||
130181004|NCT01640249|468619148|FG001|Period 1|Withdrawal by Subject|0|||
130181005|NCT01640249|468619149|FG002|Period 1|Withdrawal by Subject|0|||
130181006|NCT01640249|468619150|FG003|Period 1|Withdrawal by Subject|0|||
130181007|NCT01640249|468619151|FG004|Period 1|Withdrawal by Subject|0|||
130181008|NCT01640249|468619152|FG005|Period 1|Withdrawal by Subject|1|||
130181009|NCT01640249|468619153|FG006|Period 1|Withdrawal by Subject|0|||
130181010|NCT00065156|468619156|FG000|Overall Study|Adverse Event|37|||
130181011|NCT00065156|468619156|FG000|Overall Study|Lack of Efficacy|52|||
130181012|NCT00065156|468619156|FG000|Overall Study|Withdrawal by Subject|8|||
130181013|NCT00065156|468619156|FG000|Overall Study|Lost to Follow-up|1|||
130181014|NCT00065156|468619156|FG000|Overall Study|Death|11|||
130181015|NCT00065156|468619156|FG000|Overall Study|Study Closed by Sponsor|2|||
130181016|NCT00065156|468619156|FG000|Overall Study|Disease Progression|7|||
130181017|NCT00065156|468619156|FG000|Overall Study|Investigator Decision|2|||
130181018|NCT00065156|468619156|FG000|Overall Study|Non-Compliance|2|||
130181019|NCT00065156|468619156|FG000|Overall Study|Loss of Response|1|||
130181020|NCT00065156|468619156|FG000|Overall Study|Secondary Malign Disease|1|||
130181021|NCT03518008|468619157|FG000|Period 2, Second Week of Wear|Family emergency|0|||
130181022|NCT03518008|468619158|FG001|Period 2, Second Week of Wear|Family emergency|1|||
130181023|NCT01215136|468619159|FG000|Overall Study|Adverse Event|2|||
130181024|NCT01215136|468619160|FG001|Overall Study|Adverse Event|9|||
130181025|NCT01215136|468619159|FG000|Overall Study|Disease Progression|3|||
130181026|NCT01215136|468619160|FG001|Overall Study|Disease Progression|14|||
130181027|NCT01215136|468619159|FG000|Overall Study|Symptomatic Deterioration|1|||
130181028|NCT01215136|468619160|FG001|Overall Study|Symptomatic Deterioration|1|||
130181029|NCT01215136|468619159|FG000|Overall Study|Death|0|||
130181030|NCT01215136|468619160|FG001|Overall Study|Death|2|||
130181031|NCT01215136|468619159|FG000|Overall Study|Withdrawal by Subject|0|||
130181032|NCT01215136|468619160|FG001|Overall Study|Withdrawal by Subject|1|||
130181033|NCT00951496|468619165|FG000|Overall Study|Did not initiate study treatment|10|||
130181034|NCT00951496|468619166|FG001|Overall Study|Did not initiate study treatment|8|||
130181035|NCT00951496|468619167|FG002|Overall Study|Did not initiate study treatment|13|||
130181036|NCT01526057|468619169|FG000|Overall Study|Withdrawal by Subject|3|||
130181037|NCT01526057|468619170|FG001|Overall Study|Withdrawal by Subject|2|||
130181038|NCT01526057|468619171|FG002|Overall Study|Withdrawal by Subject|2|||
130181039|NCT01526057|468619169|FG000|Overall Study|Adverse Event|3|||
130181040|NCT01526057|468619170|FG001|Overall Study|Adverse Event|1|||
130181041|NCT01526057|468619171|FG002|Overall Study|Adverse Event|1|||
130181042|NCT01526057|468619169|FG000|Overall Study|Death|1|||
130181043|NCT01526057|468619170|FG001|Overall Study|Death|0|||
130181044|NCT01526057|468619171|FG002|Overall Study|Death|0|||
130181045|NCT01526057|468619169|FG000|Overall Study|Lost to Follow-up|1|||
130181046|NCT01526057|468619170|FG001|Overall Study|Lost to Follow-up|0|||
130181047|NCT01526057|468619171|FG002|Overall Study|Lost to Follow-up|1|||
130181048|NCT01526057|468619169|FG000|Overall Study|Other|1|||
130181049|NCT01526057|468619170|FG001|Overall Study|Other|0|||
130181050|NCT01526057|468619171|FG002|Overall Study|Other|1|||
130181051|NCT01526057|468619169|FG000|Overall Study|Protocol Violation|0|||
130181052|NCT01526057|468619170|FG001|Overall Study|Protocol Violation|0|||
130181053|NCT01526057|468619171|FG002|Overall Study|Protocol Violation|1|||
130181054|NCT02289729|468619182|FG000|Overall Study|Lack of Efficacy|3|||
130181055|NCT02289729|468619182|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
130181056|NCT02289729|468619182|FG000|Overall Study|Withdrawal by Subject|1|||
130181057|NCT02289729|468619182|FG000|Overall Study|Death|1|||
130181058|NCT04870710|468619186|FG000|Overall Study|Lost to Follow-up|3|||
130181059|NCT00281957|468619201|FG000|Overall Study|Adverse Event|7|||
130181060|NCT00281957|468619202|FG001|Overall Study|Adverse Event|2|||
130181061|NCT00281957|468619201|FG000|Overall Study|Death|1|||
130181062|NCT00281957|468619202|FG001|Overall Study|Death|0|||
130181063|NCT00281957|468619201|FG000|Overall Study|Progression/relapse|47|||
130181064|NCT00281957|468619202|FG001|Overall Study|Progression/relapse|35|||
130181065|NCT00281957|468619201|FG000|Overall Study|Not protocol specified|8|||
130181066|NCT00281957|468619202|FG001|Overall Study|Not protocol specified|1|||
130181067|NCT00281957|468619201|FG000|Overall Study|Not eligible|1|||
130181068|NCT00281957|468619202|FG001|Overall Study|Not eligible|2|||
130181069|NCT00281957|468619201|FG000|Overall Study|Did not start treatment|3|||
130181070|NCT00281957|468619202|FG001|Overall Study|Did not start treatment|1|||
130181071|NCT00281957|468619201|FG000|Overall Study|Refusal unrelated to adverse events|0|||
130181072|NCT00281957|468619202|FG001|Overall Study|Refusal unrelated to adverse events|1|||
130181073|NCT01876446|468619203|FG000|Overall Study|Death|0|||
130181074|NCT01876446|468619204|FG001|Overall Study|Death|1|||
130181075|NCT01876446|468619203|FG000|Overall Study|Withdrawal by Subject|1|||
130181076|NCT01876446|468619204|FG001|Overall Study|Withdrawal by Subject|2|||
130181077|NCT01876446|468619203|FG000|Overall Study|Physician Decision|1|||
130181078|NCT01876446|468619204|FG001|Overall Study|Physician Decision|3|||
130181079|NCT00822692|468619205|FG000|Overall Study|Lost to Follow-up|17|||
130181080|NCT00822692|468619206|FG001|Overall Study|Lost to Follow-up|25|||
130181081|NCT03629184|468619207|FG000|Overall Study|Withdrawal by Subject|2|||
130181082|NCT03629184|468619208|FG001|Overall Study|Withdrawal by Subject|1|||
130181083|NCT03629184|468619207|FG000|Overall Study|Physician Decision|1|||
130181084|NCT03629184|468619208|FG001|Overall Study|Physician Decision|0|||
130181085|NCT02548143|468619210|FG000|Overall Study|Adverse Event|1|||
130181086|NCT02548143|468619211|FG001|Overall Study|Adverse Event|0|||
130181087|NCT02548143|468619210|FG000|Overall Study|Withdrawal by Subject|0|||
130181088|NCT02548143|468619211|FG001|Overall Study|Withdrawal by Subject|1|||
130181089|NCT05620082|468619215|FG000|Overall Study|Discharged before study end|1|||
130181090|NCT05620082|468619216|FG001|Overall Study|Discharged before study end|4|||
130181091|NCT05620082|468619217|FG002|Overall Study|Discharged before study end|0|||
130181092|NCT05620082|468619215|FG000|Overall Study|Moved to a different ward|1|||
130181093|NCT05620082|468619216|FG001|Overall Study|Moved to a different ward|0|||
130181094|NCT05620082|468619217|FG002|Overall Study|Moved to a different ward|0|||
130181095|NCT05620082|468619215|FG000|Overall Study|Feeling too unwell|1|||
130181096|NCT05620082|468619216|FG001|Overall Study|Feeling too unwell|0|||
130181097|NCT05620082|468619217|FG002|Overall Study|Feeling too unwell|0|||
130181098|NCT02721732|468621156|FG000|Overall Study|Adverse Event|2|||
130181099|NCT02721732|468621157|FG001|Overall Study|Adverse Event|0|||
130181100|NCT02721732|468621158|FG002|Overall Study|Adverse Event|2|||
130181101|NCT02721732|468621159|FG003|Overall Study|Adverse Event|0|||
130181102|NCT02721732|468621160|FG004|Overall Study|Adverse Event|1|||
130181103|NCT02721732|468621161|FG005|Overall Study|Adverse Event|0|||
130181104|NCT02721732|468621162|FG006|Overall Study|Adverse Event|1|||
130181105|NCT02721732|468621163|FG007|Overall Study|Adverse Event|0|||
130181106|NCT02721732|468621164|FG008|Overall Study|Adverse Event|1|||
130181107|NCT02721732|468621165|FG009|Overall Study|Adverse Event|1|||
130181108|NCT02721732|468621156|FG000|Overall Study|Death|0|||
130181109|NCT02721732|468621157|FG001|Overall Study|Death|0|||
130181110|NCT02721732|468621158|FG002|Overall Study|Death|0|||
130181111|NCT02721732|468621159|FG003|Overall Study|Death|0|||
130181112|NCT02721732|468621160|FG004|Overall Study|Death|1|||
130181113|NCT02721732|468621161|FG005|Overall Study|Death|0|||
130181114|NCT02721732|468621162|FG006|Overall Study|Death|1|||
130181115|NCT02721732|468621163|FG007|Overall Study|Death|0|||
130181116|NCT02721732|468621164|FG008|Overall Study|Death|0|||
130181117|NCT02721732|468621165|FG009|Overall Study|Death|1|||
130181118|NCT02721732|468621156|FG000|Overall Study|Lack of Efficacy|12|||
130181119|NCT02721732|468621157|FG001|Overall Study|Lack of Efficacy|11|||
130181120|NCT02721732|468621158|FG002|Overall Study|Lack of Efficacy|18|||
130181121|NCT02721732|468621159|FG003|Overall Study|Lack of Efficacy|5|||
130181122|NCT02721732|468621160|FG004|Overall Study|Lack of Efficacy|21|||
130181123|NCT02721732|468621161|FG005|Overall Study|Lack of Efficacy|2|||
130181124|NCT02721732|468621162|FG006|Overall Study|Lack of Efficacy|8|||
130181125|NCT02721732|468621163|FG007|Overall Study|Lack of Efficacy|11|||
130181126|NCT02721732|468621164|FG008|Overall Study|Lack of Efficacy|10|||
130181127|NCT02721732|468621165|FG009|Overall Study|Lack of Efficacy|20|||
130181128|NCT02721732|468621156|FG000|Overall Study|Physician Decision|0|||
130181129|NCT02721732|468621157|FG001|Overall Study|Physician Decision|0|||
130181130|NCT02721732|468621158|FG002|Overall Study|Physician Decision|1|||
130181131|NCT02721732|468621159|FG003|Overall Study|Physician Decision|0|||
130181132|NCT02721732|468621160|FG004|Overall Study|Physician Decision|0|||
130181133|NCT02721732|468621161|FG005|Overall Study|Physician Decision|0|||
130181134|NCT02721732|468621162|FG006|Overall Study|Physician Decision|0|||
130181135|NCT02721732|468621163|FG007|Overall Study|Physician Decision|0|||
130181136|NCT02721732|468621164|FG008|Overall Study|Physician Decision|0|||
130181137|NCT02721732|468621165|FG009|Overall Study|Physician Decision|0|||
130181138|NCT02721732|468621156|FG000|Overall Study|Withdrawal by Subject|1|||
130181139|NCT02721732|468621157|FG001|Overall Study|Withdrawal by Subject|0|||
130181140|NCT02721732|468621158|FG002|Overall Study|Withdrawal by Subject|0|||
130181141|NCT02721732|468621159|FG003|Overall Study|Withdrawal by Subject|0|||
130181142|NCT02721732|468621160|FG004|Overall Study|Withdrawal by Subject|3|||
130181143|NCT02721732|468621161|FG005|Overall Study|Withdrawal by Subject|0|||
130181144|NCT02721732|468621162|FG006|Overall Study|Withdrawal by Subject|1|||
130181145|NCT02721732|468621163|FG007|Overall Study|Withdrawal by Subject|1|||
130181146|NCT02721732|468621164|FG008|Overall Study|Withdrawal by Subject|0|||
130181147|NCT02721732|468621165|FG009|Overall Study|Withdrawal by Subject|1|||
130181148|NCT02721732|468621156|FG000|Overall Study|Participant Choice|1|||
130181149|NCT02721732|468621157|FG001|Overall Study|Participant Choice|0|||
130181150|NCT02721732|468621158|FG002|Overall Study|Participant Choice|0|||
130181151|NCT02721732|468621159|FG003|Overall Study|Participant Choice|0|||
130181152|NCT02721732|468621160|FG004|Overall Study|Participant Choice|0|||
130181153|NCT02721732|468621161|FG005|Overall Study|Participant Choice|0|||
130181154|NCT02721732|468621162|FG006|Overall Study|Participant Choice|0|||
130181155|NCT02721732|468621163|FG007|Overall Study|Participant Choice|0|||
130181156|NCT02721732|468621164|FG008|Overall Study|Participant Choice|0|||
130181157|NCT02721732|468621165|FG009|Overall Study|Participant Choice|1|||
130181158|NCT02721732|468621156|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181159|NCT02721732|468621157|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181160|NCT02721732|468621158|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
130181161|NCT02721732|468621159|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181162|NCT02721732|468621160|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181163|NCT02721732|468621161|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181164|NCT02721732|468621162|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181165|NCT02721732|468621163|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181166|NCT02721732|468621164|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181167|NCT02721732|468621165|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181168|NCT02721732|468621156|FG000|Overall Study|Progression and withdrew consent|1|||
130181169|NCT02721732|468621157|FG001|Overall Study|Progression and withdrew consent|1|||
130181170|NCT02721732|468621158|FG002|Overall Study|Progression and withdrew consent|0|||
130181171|NCT02721732|468621159|FG003|Overall Study|Progression and withdrew consent|0|||
130181172|NCT02721732|468621160|FG004|Overall Study|Progression and withdrew consent|0|||
130181173|NCT02721732|468621161|FG005|Overall Study|Progression and withdrew consent|0|||
130181174|NCT02721732|468621162|FG006|Overall Study|Progression and withdrew consent|0|||
130181175|NCT02721732|468621163|FG007|Overall Study|Progression and withdrew consent|0|||
130181176|NCT02721732|468621164|FG008|Overall Study|Progression and withdrew consent|0|||
130181177|NCT02721732|468621165|FG009|Overall Study|Progression and withdrew consent|1|||
130181178|NCT02721732|468621156|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
130181179|NCT02721732|468621157|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
130181180|NCT02721732|468621158|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
130181181|NCT02721732|468621159|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
130181182|NCT02721732|468621160|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
130181183|NCT02721732|468621161|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
130181184|NCT02721732|468621162|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
130181185|NCT02721732|468621163|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
130181186|NCT02721732|468621164|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
130181187|NCT02721732|468621165|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
130181188|NCT00725283|468621166|FG000|Overall Study|Missing Code|3|||
130181189|NCT00725283|468621166|FG000|Overall Study|Death|5|||
130181190|NCT00725283|468621166|FG000|Overall Study|Other|6|||
130181191|NCT00725283|468621166|FG000|Overall Study|Withdrawal by Subject|10|||
130181192|NCT01996241|468621167|FG000|Overall Study|Lost to Follow-up|252|||
130181193|NCT01996241|468621168|FG001|Overall Study|Lost to Follow-up|235|||
130181194|NCT04515147|468621170|FG000|Overall Study|Withdrawal by Subject|1|||
130181195|NCT04515147|468621171|FG001|Overall Study|Withdrawal by Subject|0|||
130181196|NCT04515147|468621172|FG002|Overall Study|Withdrawal by Subject|10|||
130181197|NCT04515147|468621173|FG003|Overall Study|Withdrawal by Subject|18|||
130181198|NCT04515147|468621174|FG004|Overall Study|Withdrawal by Subject|1|||
130181199|NCT04515147|468621175|FG005|Overall Study|Withdrawal by Subject|8|||
130181200|NCT04515147|468621170|FG000|Overall Study|Lost to Follow-up|0|||
130181201|NCT04515147|468621171|FG001|Overall Study|Lost to Follow-up|1|||
130181202|NCT04515147|468621172|FG002|Overall Study|Lost to Follow-up|5|||
130181203|NCT04515147|468621173|FG003|Overall Study|Lost to Follow-up|6|||
130181204|NCT04515147|468621174|FG004|Overall Study|Lost to Follow-up|2|||
130181205|NCT04515147|468621175|FG005|Overall Study|Lost to Follow-up|1|||
130181206|NCT04515147|468621170|FG000|Overall Study|Adverse Event|0|||
130181207|NCT04515147|468621171|FG001|Overall Study|Adverse Event|0|||
130181208|NCT04515147|468621172|FG002|Overall Study|Adverse Event|0|||
130181209|NCT04515147|468621173|FG003|Overall Study|Adverse Event|2|||
130181210|NCT04515147|468621174|FG004|Overall Study|Adverse Event|0|||
130181211|NCT04515147|468621175|FG005|Overall Study|Adverse Event|0|||
130181212|NCT04515147|468621170|FG000|Overall Study|Miscellaneous|0|||
130181213|NCT04515147|468621171|FG001|Overall Study|Miscellaneous|0|||
130181214|NCT04515147|468621172|FG002|Overall Study|Miscellaneous|0|||
130181215|NCT04515147|468621173|FG003|Overall Study|Miscellaneous|1|||
130181216|NCT04515147|468621174|FG004|Overall Study|Miscellaneous|0|||
130181217|NCT04515147|468621175|FG005|Overall Study|Miscellaneous|1|||
130181218|NCT03052751|468621176|FG000|Dosing Period 1|Adverse Event|0|||
130181219|NCT03052751|468621177|FG001|Dosing Period 1|Adverse Event|1|||
130181220|NCT03052751|468621178|FG002|Dosing Period 1|Adverse Event|0|||
130181221|NCT03052751|468621179|FG003|Dosing Period 1|Adverse Event|0|||
130181222|NCT03052751|468621180|FG004|Dosing Period 1|Adverse Event|0|||
130181223|NCT03052751|468621181|FG005|Dosing Period 1|Adverse Event|0|||
130181224|NCT03052751|468621176|FG000|Dosing Period 2|Adverse Event|0|||
130181225|NCT03052751|468621177|FG001|Dosing Period 2|Adverse Event|0|||
130181226|NCT03052751|468621178|FG002|Dosing Period 2|Adverse Event|3|||
130181227|NCT03052751|468621179|FG003|Dosing Period 2|Adverse Event|0|||
130181228|NCT03052751|468621180|FG004|Dosing Period 2|Adverse Event|0|||
130181229|NCT03052751|468621181|FG005|Dosing Period 2|Adverse Event|0|||
130181230|NCT03052751|468621176|FG000|Observation Period|Adverse Event|0|||
130181231|NCT03052751|468621177|FG001|Observation Period|Adverse Event|0|||
130181232|NCT03052751|468621178|FG002|Observation Period|Adverse Event|0|||
130181233|NCT03052751|468621179|FG003|Observation Period|Adverse Event|0|||
130181234|NCT03052751|468621180|FG004|Observation Period|Adverse Event|1|||
130181235|NCT03052751|468621181|FG005|Observation Period|Adverse Event|0|||
130181236|NCT02719184|468621182|FG000|Overall Study|Other than listed|1|||
130181237|NCT02719184|468621183|FG001|Overall Study|Other than listed|12|||
130181238|NCT02719184|468621184|FG002|Overall Study|Other than listed|13|||
130181239|NCT02719184|468621185|FG003|Overall Study|Other than listed|22|||
130181240|NCT02719184|468621186|FG004|Overall Study|Other than listed|9|||
130181241|NCT02719184|468621182|FG000|Overall Study|Withdrawal by Subject|5|||
130181242|NCT02719184|468621183|FG001|Overall Study|Withdrawal by Subject|3|||
130181243|NCT02719184|468621184|FG002|Overall Study|Withdrawal by Subject|6|||
130181244|NCT02719184|468621185|FG003|Overall Study|Withdrawal by Subject|6|||
130181245|NCT02719184|468621186|FG004|Overall Study|Withdrawal by Subject|0|||
130181246|NCT02719184|468621182|FG000|Overall Study|Lost to Follow-up|0|||
130181247|NCT02719184|468621183|FG001|Overall Study|Lost to Follow-up|4|||
130181248|NCT02719184|468621184|FG002|Overall Study|Lost to Follow-up|1|||
130181249|NCT02719184|468621185|FG003|Overall Study|Lost to Follow-up|3|||
130181250|NCT02719184|468621186|FG004|Overall Study|Lost to Follow-up|0|||
130181251|NCT02719184|468621182|FG000|Overall Study|Protocol Violation|0|||
130181252|NCT02719184|468621183|FG001|Overall Study|Protocol Violation|3|||
130181253|NCT02719184|468621184|FG002|Overall Study|Protocol Violation|0|||
130181254|NCT02719184|468621185|FG003|Overall Study|Protocol Violation|2|||
130181255|NCT02719184|468621186|FG004|Overall Study|Protocol Violation|0|||
130181256|NCT02719184|468621182|FG000|Overall Study|Adverse Event|0|||
130181257|NCT02719184|468621183|FG001|Overall Study|Adverse Event|0|||
130181258|NCT02719184|468621184|FG002|Overall Study|Adverse Event|0|||
130181259|NCT02719184|468621185|FG003|Overall Study|Adverse Event|3|||
130181260|NCT02719184|468621186|FG004|Overall Study|Adverse Event|0|||
130181261|NCT02439216|468621187|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
130181262|NCT02439216|468621188|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181263|NCT02439216|468621189|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181264|NCT02439216|468621190|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181265|NCT02439216|468621191|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181266|NCT02439216|468621192|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181267|NCT02439216|468621193|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181268|NCT02439216|468621194|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181269|NCT02439216|468621195|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181270|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181271|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181272|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181273|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181274|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181275|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181276|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181277|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
130181278|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181279|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181280|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181281|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181282|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181283|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181284|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181285|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181286|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
130181287|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
130181288|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181289|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181290|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181291|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181292|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181293|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181294|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181295|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181296|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
130181297|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181298|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181299|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181300|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181301|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181302|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181303|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181304|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
130181305|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
130181306|NCT02094300|468621196|FG000|Overall Study|Death|7|||
130181307|NCT02094300|468621196|FG000|Overall Study|Lost to Follow-up|10|||
130181308|NCT02094300|468621196|FG000|Overall Study|Still be eligible for follow-up|3|||
130181309|NCT01050530|468621200|FG000|Overall Study|Adverse Event|6|||
130181310|NCT01050530|468621201|FG001|Overall Study|Adverse Event|3|||
130181311|NCT01050530|468621200|FG000|Overall Study|Lack of Efficacy|1|||
130181312|NCT01050530|468621201|FG001|Overall Study|Lack of Efficacy|4|||
130181313|NCT01050530|468621200|FG000|Overall Study|Withdrawal by Subject|0|||
130181314|NCT01050530|468621201|FG001|Overall Study|Withdrawal by Subject|3|||
130181315|NCT01050530|468621200|FG000|Overall Study|Protocol Violation|1|||
130181316|NCT01050530|468621201|FG001|Overall Study|Protocol Violation|0|||
130181317|NCT02288312|468621204|FG000|Overall Study|Pregnancy|1|||
130181318|NCT02288312|468621205|FG001|Overall Study|Pregnancy|0|||
130181319|NCT02288312|468621206|FG002|Overall Study|Pregnancy|0|||
130181320|NCT01276041|468621207|FG000|Overall Study|Adverse Event|2|||
130181321|NCT01276041|468621207|FG000|Overall Study|Protocol Violation|1|||
130181322|NCT00485264|468621214|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
130181323|NCT00485264|468621215|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
130181324|NCT00485264|468621216|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
130181325|NCT00485264|468621217|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
130181326|NCT00485264|468621218|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
130181327|NCT00485264|468621219|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
130181328|NCT00485264|468621214|FG000|Overall Study|Death|1|||
130181329|NCT00485264|468621215|FG001|Overall Study|Death|0|||
130181330|NCT00485264|468621216|FG002|Overall Study|Death|0|||
130181331|NCT00485264|468621217|FG003|Overall Study|Death|0|||
130181332|NCT00485264|468621218|FG004|Overall Study|Death|1|||
130181333|NCT00485264|468621219|FG005|Overall Study|Death|0|||
130181334|NCT00485264|468621214|FG000|Overall Study|Adverse Event|1|||
130181335|NCT00485264|468621215|FG001|Overall Study|Adverse Event|0|||
130181336|NCT00485264|468621216|FG002|Overall Study|Adverse Event|2|||
130181337|NCT00485264|468621217|FG003|Overall Study|Adverse Event|3|||
130181338|NCT00485264|468621218|FG004|Overall Study|Adverse Event|1|||
130181339|NCT00485264|468621219|FG005|Overall Study|Adverse Event|3|||
130181340|NCT00485264|468621214|FG000|Overall Study|Pregnancy|4|||
130181341|NCT00485264|468621215|FG001|Overall Study|Pregnancy|0|||
130181342|NCT00485264|468621216|FG002|Overall Study|Pregnancy|0|||
130181343|NCT00485264|468621217|FG003|Overall Study|Pregnancy|0|||
130181344|NCT00485264|468621218|FG004|Overall Study|Pregnancy|0|||
130181345|NCT00485264|468621219|FG005|Overall Study|Pregnancy|0|||
130181346|NCT00485264|468621214|FG000|Overall Study|Disallowed Medication|0|||
130181347|NCT00485264|468621215|FG001|Overall Study|Disallowed Medication|0|||
130181348|NCT00485264|468621216|FG002|Overall Study|Disallowed Medication|0|||
130181349|NCT00485264|468621217|FG003|Overall Study|Disallowed Medication|0|||
130181350|NCT00485264|468621218|FG004|Overall Study|Disallowed Medication|0|||
130181351|NCT00485264|468621219|FG005|Overall Study|Disallowed Medication|1|||
130181352|NCT00485264|468621214|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
130181353|NCT00485264|468621215|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
130181354|NCT00485264|468621216|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
130181355|NCT00485264|468621217|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181356|NCT00485264|468621218|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181357|NCT00485264|468621219|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181358|NCT00485264|468621214|FG000|Overall Study|Lack of Efficacy|0|||
130181359|NCT00485264|468621215|FG001|Overall Study|Lack of Efficacy|1|||
130181360|NCT00485264|468621216|FG002|Overall Study|Lack of Efficacy|0|||
130181361|NCT00485264|468621217|FG003|Overall Study|Lack of Efficacy|0|||
130181362|NCT00485264|468621218|FG004|Overall Study|Lack of Efficacy|0|||
130181363|NCT00485264|468621219|FG005|Overall Study|Lack of Efficacy|0|||
130181364|NCT00485264|468621214|FG000|Overall Study|Guardian Consent Withdrawn|1|||
130181365|NCT00485264|468621215|FG001|Overall Study|Guardian Consent Withdrawn|0|||
130181366|NCT00485264|468621216|FG002|Overall Study|Guardian Consent Withdrawn|0|||
130181367|NCT00485264|468621217|FG003|Overall Study|Guardian Consent Withdrawn|0|||
130181368|NCT00485264|468621218|FG004|Overall Study|Guardian Consent Withdrawn|1|||
130181369|NCT00485264|468621219|FG005|Overall Study|Guardian Consent Withdrawn|0|||
130181370|NCT00485264|468621214|FG000|Overall Study|Physician Decision|0|||
130181371|NCT00485264|468621215|FG001|Overall Study|Physician Decision|2|||
130181372|NCT00485264|468621216|FG002|Overall Study|Physician Decision|0|||
130181373|NCT00485264|468621217|FG003|Overall Study|Physician Decision|0|||
130181374|NCT00485264|468621218|FG004|Overall Study|Physician Decision|0|||
130181375|NCT00485264|468621219|FG005|Overall Study|Physician Decision|0|||
130181376|NCT00485264|468621214|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181377|NCT00485264|468621215|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181378|NCT00485264|468621216|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
130181379|NCT00485264|468621217|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181380|NCT00485264|468621218|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181381|NCT00485264|468621219|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181382|NCT00485264|468621214|FG000|Overall Study|Not Able to Attend Clinic|5|||
130181383|NCT00485264|468621215|FG001|Overall Study|Not Able to Attend Clinic|0|||
130181384|NCT00485264|468621216|FG002|Overall Study|Not Able to Attend Clinic|0|||
130181385|NCT00485264|468621217|FG003|Overall Study|Not Able to Attend Clinic|1|||
130181386|NCT00485264|468621218|FG004|Overall Study|Not Able to Attend Clinic|1|||
130181387|NCT00485264|468621219|FG005|Overall Study|Not Able to Attend Clinic|2|||
130181388|NCT00485264|468621214|FG000|Overall Study|Non-Compliant|17|||
130181389|NCT00485264|468621215|FG001|Overall Study|Non-Compliant|2|||
130181390|NCT00485264|468621216|FG002|Overall Study|Non-Compliant|1|||
130181391|NCT00485264|468621217|FG003|Overall Study|Non-Compliant|0|||
130181392|NCT00485264|468621218|FG004|Overall Study|Non-Compliant|1|||
130181393|NCT00485264|468621219|FG005|Overall Study|Non-Compliant|0|||
130181394|NCT00485264|468621214|FG000|Overall Study|Lost to Follow-up|2|||
130181395|NCT00485264|468621215|FG001|Overall Study|Lost to Follow-up|1|||
130181396|NCT00485264|468621216|FG002|Overall Study|Lost to Follow-up|1|||
130181397|NCT00485264|468621217|FG003|Overall Study|Lost to Follow-up|0|||
130181398|NCT00485264|468621218|FG004|Overall Study|Lost to Follow-up|0|||
130181399|NCT00485264|468621219|FG005|Overall Study|Lost to Follow-up|1|||
130181400|NCT00485264|468621214|FG000|Overall Study|Other Reason|3|||
130181401|NCT00485264|468621215|FG001|Overall Study|Other Reason|0|||
130181402|NCT00485264|468621216|FG002|Overall Study|Other Reason|0|||
130181403|NCT00485264|468621217|FG003|Overall Study|Other Reason|0|||
130181404|NCT00485264|468621218|FG004|Overall Study|Other Reason|0|||
130181405|NCT00485264|468621219|FG005|Overall Study|Other Reason|0|||
130181406|NCT00654095|468621221|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
130181407|NCT00654095|468621221|FG000|Overall Study|Elevated triglyceride level (2)|1|||
130181408|NCT00654095|468621221|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
130181409|NCT00654095|468621221|FG000|Overall Study|Adverse Event|11|||
130181410|NCT00654095|468621221|FG000|Overall Study|Withdrawal by Subject|5|||
130181411|NCT00654095|468621221|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
130181412|NCT00654095|468621221|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
130181413|NCT00654095|468621221|FG000|Overall Study|Did not meet inclusion criteria|1|||
130181414|NCT02440464|468621222|FG000|Overall Study|Withdrawal by Subject|3|||
130181415|NCT02440464|468621223|FG001|Overall Study|Withdrawal by Subject|2|||
130181416|NCT04620746|468621239|FG000|Overall Study|Adverse Event|2|||
130181417|NCT04620746|468621240|FG001|Overall Study|Adverse Event|0|||
130181418|NCT04620746|468621239|FG000|Overall Study|Uniterpretable skin test|1|||
130181419|NCT04620746|468621240|FG001|Overall Study|Uniterpretable skin test|0|||
130181420|NCT04620746|468621239|FG000|Overall Study|Withdrawal by Subject|0|||
130181421|NCT04620746|468621240|FG001|Overall Study|Withdrawal by Subject|1|||
130181422|NCT03411863|468621241|FG000|Overall Study|Withdrawal by Subject|3|||
130181423|NCT03411863|468621242|FG001|Overall Study|Withdrawal by Subject|1|||
130181424|NCT03411863|468621241|FG000|Overall Study|Physician Decision|0|||
130181425|NCT03411863|468621242|FG001|Overall Study|Physician Decision|1|||
130181426|NCT03535740|468621243|FG000|Overall Study|Death|44|||
130181427|NCT03535740|468621243|FG000|Overall Study|Lost to Follow-up|1|||
130181428|NCT03535740|468621243|FG000|Overall Study|Withdrawal by Subject|13|||
130181429|NCT03535740|468621243|FG000|Overall Study|Site terminated by Sponsor|45|||
130181430|NCT05198518|468621248|FG000|Screening Visit|Deemed unable to participate|58|||
130181431|NCT05198518|468621249|FG001|Screening Visit|Deemed unable to participate|0|||
130181432|NCT05198518|468621250|FG002|Screening Visit|Deemed unable to participate|0|||
130181433|NCT02756611|468621254|FG000|Overall Study|Death|70|||
130181434|NCT02756611|468621254|FG000|Overall Study|Withdrawal by Subject|2|||
130181435|NCT02756611|468621254|FG000|Overall Study|Lost to Follow-up|3|||
130181436|NCT02756611|468621254|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
130181437|NCT02756611|468621254|FG000|Overall Study|Other|10|||
130181438|NCT03125798|468621255|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
130181439|NCT03125798|468621256|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
130181440|NCT03125798|468621255|FG000|Overall Study|Conversion to thoracotomy|7|||
130181441|NCT03125798|468621256|FG001|Overall Study|Conversion to thoracotomy|7|||
130181442|NCT00100828|468621260|FG000|Overall Study|Physician Decision|6|||
130181443|NCT04583735|468621261|FG000|Double-masked Treatment Period|Adverse Event|0|||
130181444|NCT04583735|468621262|FG001|Double-masked Treatment Period|Adverse Event|1|||
130181445|NCT04583735|468621261|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
130181446|NCT04583735|468621262|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
130181447|NCT04583735|468621261|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
130181448|NCT04583735|468621262|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
130181449|NCT04583735|468621261|FG000|Open-label Treatment Period|Adverse Event|1|||
130181450|NCT04583735|468621262|FG001|Open-label Treatment Period|Adverse Event|1|||
130181451|NCT04583735|468621261|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130181452|NCT04583735|468621262|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130181453|NCT04583735|468621261|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130181454|NCT04583735|468621262|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130181455|NCT00124917|468621263|FG000|Overall Study|Physician Decision|3|||
130181456|NCT00613171|468621264|FG000|Overall Study|Adverse Event|7|||
130181457|NCT00613171|468621264|FG000|Overall Study|Withdrawal by Subject|3|||
130181458|NCT00613171|468621264|FG000|Overall Study|Reason not Specified|4|||
130181459|NCT01197911|468621265|FG000|Overall Study|Adverse Event|0|||
130181460|NCT01197911|468621266|FG001|Overall Study|Adverse Event|0|||
130181461|NCT01197911|468621267|FG002|Overall Study|Adverse Event|1|||
130181462|NCT01169350|468621268|FG000|Overall Study|Physician Decision|3|||
130181463|NCT01169350|468621268|FG000|Overall Study|Lost to Follow-up|2|||
130181464|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
130181465|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
130181466|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
130181467|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
130181468|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
130181469|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
130181470|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
130181471|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
130181472|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
130181473|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
130181474|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130181475|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130181476|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
130181477|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
130181478|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130181479|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130181480|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
130181481|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
130181482|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
130181483|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
130181484|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
130181485|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
130181486|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
130181487|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
130181488|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
130181489|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
130181490|NCT04338022|468621269|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
130181491|NCT04338022|468621270|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
130181492|NCT02860546|468621272|FG000|Overall Study|Clinical Progression|6|||
130181493|NCT02860546|468621272|FG000|Overall Study|Radiological Progression|12|||
130181494|NCT02466321|468621273|FG000|Overall Study|Death|26|||
130181495|NCT02466321|468621273|FG000|Overall Study|Revision|6|||
130181496|NCT02466321|468621273|FG000|Overall Study|Lost to Follow-up|60|||
130181497|NCT02466321|468621273|FG000|Overall Study|Did not receive study device|1|||
130181498|NCT06071754|468621274|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
130181499|NCT02189837|468621275|FG000|Overall Study|Withdrawal by Subject|2|||
130181500|NCT02189837|468621276|FG001|Overall Study|Withdrawal by Subject|1|||
130181501|NCT02189837|468621277|FG002|Overall Study|Withdrawal by Subject|3|||
130181502|NCT02189837|468621278|FG003|Overall Study|Withdrawal by Subject|1|||
130181503|NCT02189837|468621275|FG000|Overall Study|Sponsor Decision|0|||
130181504|NCT02189837|468621276|FG001|Overall Study|Sponsor Decision|0|||
130181505|NCT02189837|468621277|FG002|Overall Study|Sponsor Decision|0|||
130181506|NCT02189837|468621278|FG003|Overall Study|Sponsor Decision|1|||
130181507|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181508|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181509|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181510|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181511|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181512|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
130181513|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181514|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181515|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181516|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181517|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181518|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130181519|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181520|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181521|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181522|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181523|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181524|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130181525|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181526|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181527|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181528|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181529|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181530|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181531|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181532|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181533|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181534|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
130181535|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181536|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181537|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181538|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181539|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181540|NCT00456300|468621296|FG000|Overall Study|Adverse Event|1|||
130181541|NCT00456300|468621297|FG001|Overall Study|Adverse Event|0|||
130181542|NCT01478373|468621298|FG000|Treatment Phase|Protocol Violation|1|||
130181543|NCT01478373|468621298|FG000|Survival Phase|Adverse Event|8|||
130181544|NCT01478373|468621298|FG000|Survival Phase|Protocol Violation|1|||
130181545|NCT01478373|468621298|FG000|Survival Phase|crossover to another study|2|||
130181546|NCT01478373|468621298|FG000|Survival Phase|Progressive Disease|27|||
130181547|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
130181548|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181549|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181550|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181551|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181552|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
130181553|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181554|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181555|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181556|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181557|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
130181558|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181559|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181560|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181561|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181562|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
130181563|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181564|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181565|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181566|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181567|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181568|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
130181569|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
130181570|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181571|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181572|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181573|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
130181574|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
130181575|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181576|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181577|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181578|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130181579|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130181580|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181581|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181582|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181583|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
130181584|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181585|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181586|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181587|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181588|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130181589|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130181590|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181591|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181592|NCT01074944|468621302|FG000|Long Term Treatment|Adverse Event|0|||
130181593|NCT01074944|468621303|FG001|Long Term Treatment|Adverse Event|0|||
130181594|NCT01074944|468621304|FG002|Long Term Treatment|Adverse Event|0|||
130181595|NCT01074944|468621305|FG003|Long Term Treatment|Adverse Event|3|||
130181596|NCT01074944|468621306|FG004|Long Term Treatment|Adverse Event|0|||
130181597|NCT01074944|468621302|FG000|Long Term Treatment|Lost to Follow-up|0|||
130181598|NCT01074944|468621303|FG001|Long Term Treatment|Lost to Follow-up|0|||
130181599|NCT01074944|468621304|FG002|Long Term Treatment|Lost to Follow-up|0|||
130181600|NCT01074944|468621305|FG003|Long Term Treatment|Lost to Follow-up|2|||
130181601|NCT01074944|468621306|FG004|Long Term Treatment|Lost to Follow-up|0|||
130181602|NCT01074944|468621302|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181603|NCT01074944|468621303|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181604|NCT01074944|468621304|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181605|NCT01074944|468621305|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
130181606|NCT01074944|468621306|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181607|NCT01074944|468621302|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181608|NCT01074944|468621303|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181609|NCT01074944|468621304|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181610|NCT01074944|468621305|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
130181611|NCT01074944|468621306|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181612|NCT01074944|468621302|FG000|Long Term Treatment|Withdrawal by Subject|0|||
130181613|NCT01074944|468621303|FG001|Long Term Treatment|Withdrawal by Subject|0|||
130181614|NCT01074944|468621304|FG002|Long Term Treatment|Withdrawal by Subject|0|||
130181615|NCT01074944|468621305|FG003|Long Term Treatment|Withdrawal by Subject|2|||
130181616|NCT01074944|468621306|FG004|Long Term Treatment|Withdrawal by Subject|0|||
130181617|NCT01074944|468621302|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181618|NCT01074944|468621303|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181619|NCT01074944|468621304|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181620|NCT01074944|468621305|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181621|NCT01074944|468621306|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
130181622|NCT01074944|468621302|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181623|NCT01074944|468621303|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181624|NCT01074944|468621304|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181625|NCT01074944|468621305|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181626|NCT01074944|468621306|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
130181627|NCT02348112|468621307|FG000|Overall Study|Withdrawal by Subject|32|||
130181628|NCT02348112|468621308|FG001|Overall Study|Withdrawal by Subject|29|||
130181629|NCT02348112|468621307|FG000|Overall Study|Lost to Follow-up|24|||
130181630|NCT02348112|468621308|FG001|Overall Study|Lost to Follow-up|20|||
130181631|NCT02348112|468621307|FG000|Overall Study|Physician Decision|17|||
130181632|NCT02348112|468621308|FG001|Overall Study|Physician Decision|15|||
130181633|NCT02348112|468621307|FG000|Overall Study|Site closed due to PI leaving|0|||
130181634|NCT02348112|468621308|FG001|Overall Study|Site closed due to PI leaving|30|||
130181635|NCT02348112|468621307|FG000|Overall Study|Sponsor withdrawal|0|||
130181636|NCT02348112|468621308|FG001|Overall Study|Sponsor withdrawal|7|||
130181637|NCT02348112|468621307|FG000|Overall Study|Death|0|||
130181638|NCT02348112|468621308|FG001|Overall Study|Death|1|||
130181639|NCT01998841|468621315|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130181640|NCT01998841|468621316|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130181641|NCT01998841|468621317|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
130181642|NCT01998841|468621318|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181643|NCT01998841|468621319|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181644|NCT01998841|468621315|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181645|NCT01998841|468621316|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181646|NCT01998841|468621317|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181647|NCT01998841|468621318|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
130181648|NCT01998841|468621319|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
130181649|NCT05101343|468621320|FG000|Overall Study|Withdrawal by Subject|2|||
130181650|NCT05101343|468621321|FG001|Overall Study|Withdrawal by Subject|1|||
130181651|NCT02046603|468621322|FG000|Overall Study|Other|11|||
130181652|NCT02046603|468621323|FG001|Overall Study|Other|66|||
130181653|NCT02046603|468621322|FG000|Overall Study|Protocol Violation|0|||
130181654|NCT02046603|468621323|FG001|Overall Study|Protocol Violation|1|||
130181655|NCT02046603|468621322|FG000|Overall Study|Participant/legal guardian decision|1|||
130181656|NCT02046603|468621323|FG001|Overall Study|Participant/legal guardian decision|3|||
130181657|NCT02046603|468621322|FG000|Overall Study|Physician Decision|2|||
130181658|NCT02046603|468621323|FG001|Overall Study|Physician Decision|1|||
130181659|NCT02046603|468621322|FG000|Overall Study|Lost to Follow-up|1|||
130181660|NCT02046603|468621323|FG001|Overall Study|Lost to Follow-up|2|||
130181661|NCT02046603|468621322|FG000|Overall Study|Death|0|||
130181662|NCT02046603|468621323|FG001|Overall Study|Death|1|||
130181663|NCT02046603|468621322|FG000|Overall Study|Adverse Event|0|||
130181664|NCT02046603|468621323|FG001|Overall Study|Adverse Event|1|||
130181665|NCT03447743|468621324|FG000|Overall Study|Withdrawal by Subject|2|||
130181666|NCT03447743|468621324|FG000|Overall Study|Lost to Follow-up|3|||
130181667|NCT03447743|468621324|FG000|Overall Study|Adverse Event|1|||
130181668|NCT03447743|468621324|FG000|Overall Study|Did not meet criteria to continue|1|||
130181669|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
130181670|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
130181671|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Physician Decision|2|||
130181672|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Adverse Event|2|||
130181673|NCT00193050|468621325|FG000|Adjuvant|Physician Decision|5|||
130181674|NCT00193050|468621325|FG000|Adjuvant|Intercurrent Hospitalization|3|||
130181675|NCT00193050|468621325|FG000|Adjuvant|Lack of Efficacy|2|||
130181676|NCT00061932|468621326|FG000|Overall Study|Withdrawal by Subject|13|||
130181677|NCT00061932|468621327|FG001|Overall Study|Withdrawal by Subject|4|||
130181678|NCT03567980|468621328|FG000|Overall Study|Adverse Event|1|||
130181679|NCT03093259|468621330|FG000|Overall Study|Adverse Event|1|||
130181680|NCT03093259|468621331|FG001|Overall Study|Adverse Event|0|||
130181681|NCT03093259|468621330|FG000|Overall Study|Withdrawal by Subject|1|||
130181682|NCT03093259|468621331|FG001|Overall Study|Withdrawal by Subject|0|||
130181683|NCT02575833|468621332|FG000|Overall Study|Withdrawal by Subject|0|||
130181684|NCT02575833|468621333|FG001|Overall Study|Withdrawal by Subject|1|||
130181685|NCT02575833|468621332|FG000|Overall Study|Lost to Follow-up|1|||
130181686|NCT02575833|468621333|FG001|Overall Study|Lost to Follow-up|0|||
130181687|NCT00445146|468621334|FG000|Overall Study|Withdrew Consent|29|||
130181688|NCT00445146|468621334|FG000|Overall Study|Lack of Efficacy|28|||
130181689|NCT00445146|468621334|FG000|Overall Study|Investigator's Discretion|22|||
130181690|NCT00445146|468621334|FG000|Overall Study|Adverse Event|13|||
130181691|NCT00445146|468621334|FG000|Overall Study|Lost to Follow-up|13|||
130181692|NCT00445146|468621334|FG000|Overall Study|Death|9|||
130181693|NCT00445146|468621334|FG000|Overall Study|Protocol Violation|4|||
130181694|NCT00445146|468621334|FG000|Overall Study|Pregnancy|1|||
130181695|NCT00625820|468621335|FG000|Overall Study|Withdrawal by Subject|1|||
130181696|NCT00967330|468621336|FG000|Overall Study|Protocol Violation|3|||
130181697|NCT00967330|468621337|FG001|Overall Study|Protocol Violation|4|||
130181698|NCT00967330|468621336|FG000|Overall Study|Regular|10|||
130181699|NCT00967330|468621337|FG001|Overall Study|Regular|3|||
130181700|NCT00967330|468621336|FG000|Overall Study|Withdrawal by Subject|6|||
130181701|NCT00967330|468621337|FG001|Overall Study|Withdrawal by Subject|0|||
130181702|NCT00967330|468621336|FG000|Overall Study|Lost to Follow-up|1|||
130181703|NCT00967330|468621337|FG001|Overall Study|Lost to Follow-up|1|||
130181704|NCT00967330|468621336|FG000|Overall Study|Death|102|||
130181705|NCT00967330|468621337|FG001|Overall Study|Death|51|||
130181706|NCT00967330|468621336|FG000|Overall Study|Severe protocol deviation|0|||
130181707|NCT00967330|468621337|FG001|Overall Study|Severe protocol deviation|1|||
130181708|NCT03759392|468621338|FG000|Overall Study|Adverse Event|12|||
130181709|NCT03759392|468621339|FG001|Overall Study|Adverse Event|4|||
130181710|NCT03759392|468621338|FG000|Overall Study|Death|2|||
130181711|NCT03759392|468621339|FG001|Overall Study|Death|1|||
130181712|NCT03759392|468621338|FG000|Overall Study|Withdrawal by Subject|2|||
130181713|NCT03759392|468621339|FG001|Overall Study|Withdrawal by Subject|0|||
130181714|NCT03759392|468621338|FG000|Overall Study|Protocol Violation|2|||
130181715|NCT03759392|468621339|FG001|Overall Study|Protocol Violation|0|||
130181716|NCT03759392|468621338|FG000|Overall Study|Physician Decision|0|||
130181717|NCT03759392|468621339|FG001|Overall Study|Physician Decision|1|||
130181718|NCT03759392|468621338|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
130181719|NCT03759392|468621339|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
130181720|NCT03759392|468621338|FG000|Overall Study|No longer able to take medicines|1|||
130181721|NCT03759392|468621339|FG001|Overall Study|No longer able to take medicines|0|||
130181722|NCT03759392|468621338|FG000|Overall Study|Stopped taking study drug|1|||
130181723|NCT03759392|468621339|FG001|Overall Study|Stopped taking study drug|0|||
130181724|NCT02623725|468621340|FG000|Overall Study|Non compliance with protocol|9|||
130181725|NCT02623725|468621341|FG001|Overall Study|Non compliance with protocol|3|||
130181726|NCT02623725|468621340|FG000|Overall Study|Serious adverse event|0|||
130181727|NCT02623725|468621341|FG001|Overall Study|Serious adverse event|2|||
130181728|NCT02623725|468621340|FG000|Overall Study|Withdrawal by Subject|7|||
130181729|NCT02623725|468621341|FG001|Overall Study|Withdrawal by Subject|1|||
130181730|NCT02848001|468624039|FG000|Overall Study|other reasons|0|||
130181731|NCT02848001|468624040|FG001|Overall Study|other reasons|0|||
130181732|NCT02848001|468624041|FG002|Overall Study|other reasons|1|||
130181733|NCT02848001|468624042|FG003|Overall Study|other reasons|0|||
130181734|NCT02848001|468624043|FG004|Overall Study|other reasons|4|||
130181735|NCT02848001|468624044|FG005|Overall Study|other reasons|1|||
130181736|NCT02848001|468624045|FG006|Overall Study|other reasons|0|||
130181737|NCT02848001|468624046|FG007|Overall Study|other reasons|2|||
130181738|NCT02848001|468624047|FG008|Overall Study|other reasons|2|||
130181739|NCT02848001|468624048|FG009|Overall Study|other reasons|3|||
130181740|NCT02848001|468624049|FG010|Overall Study|other reasons|0|||
130181741|NCT02848001|468624050|FG011|Overall Study|other reasons|1|||
130181742|NCT02848001|468624051|FG012|Overall Study|other reasons|1|||
130181743|NCT02848001|468624052|FG013|Overall Study|other reasons|0|||
130181744|NCT02848001|468624053|FG014|Overall Study|other reasons|0|||
130181745|NCT02848001|468624054|FG015|Overall Study|other reasons|2|||
130181746|NCT02848001|468624055|FG016|Overall Study|other reasons|1|||
130181747|NCT02848001|468624039|FG000|Overall Study|Lack of Efficacy|0|||
130181748|NCT02848001|468624040|FG001|Overall Study|Lack of Efficacy|1|||
130181749|NCT02848001|468624041|FG002|Overall Study|Lack of Efficacy|1|||
130181750|NCT02848001|468624042|FG003|Overall Study|Lack of Efficacy|2|||
130181751|NCT02848001|468624043|FG004|Overall Study|Lack of Efficacy|3|||
130181752|NCT02848001|468624044|FG005|Overall Study|Lack of Efficacy|0|||
130181753|NCT02848001|468624045|FG006|Overall Study|Lack of Efficacy|1|||
130181754|NCT02848001|468624046|FG007|Overall Study|Lack of Efficacy|0|||
130181755|NCT02848001|468624047|FG008|Overall Study|Lack of Efficacy|0|||
130181756|NCT02848001|468624048|FG009|Overall Study|Lack of Efficacy|1|||
130181757|NCT02848001|468624049|FG010|Overall Study|Lack of Efficacy|0|||
130181758|NCT02848001|468624050|FG011|Overall Study|Lack of Efficacy|2|||
130181759|NCT02848001|468624051|FG012|Overall Study|Lack of Efficacy|0|||
130181760|NCT02848001|468624052|FG013|Overall Study|Lack of Efficacy|2|||
130181761|NCT02848001|468624053|FG014|Overall Study|Lack of Efficacy|2|||
130181762|NCT02848001|468624054|FG015|Overall Study|Lack of Efficacy|0|||
130181763|NCT02848001|468624055|FG016|Overall Study|Lack of Efficacy|0|||
130181764|NCT02848001|468624039|FG000|Overall Study|Progressive Disease|2|||
130181765|NCT02848001|468624040|FG001|Overall Study|Progressive Disease|1|||
130181766|NCT02848001|468624041|FG002|Overall Study|Progressive Disease|0|||
130181767|NCT02848001|468624042|FG003|Overall Study|Progressive Disease|4|||
130181768|NCT02848001|468624043|FG004|Overall Study|Progressive Disease|3|||
130181769|NCT02848001|468624044|FG005|Overall Study|Progressive Disease|0|||
130181770|NCT02848001|468624045|FG006|Overall Study|Progressive Disease|4|||
130181771|NCT02848001|468624046|FG007|Overall Study|Progressive Disease|1|||
130181772|NCT02848001|468624047|FG008|Overall Study|Progressive Disease|0|||
130181773|NCT02848001|468624048|FG009|Overall Study|Progressive Disease|2|||
130181774|NCT02848001|468624049|FG010|Overall Study|Progressive Disease|3|||
130181775|NCT02848001|468624050|FG011|Overall Study|Progressive Disease|2|||
130181776|NCT02848001|468624051|FG012|Overall Study|Progressive Disease|1|||
130181777|NCT02848001|468624052|FG013|Overall Study|Progressive Disease|0|||
130181778|NCT02848001|468624053|FG014|Overall Study|Progressive Disease|2|||
130181779|NCT02848001|468624054|FG015|Overall Study|Progressive Disease|4|||
130181780|NCT02848001|468624055|FG016|Overall Study|Progressive Disease|0|||
130181781|NCT02848001|468624039|FG000|Overall Study|Adverse Event|0|||
130181782|NCT02848001|468624040|FG001|Overall Study|Adverse Event|0|||
130181783|NCT02848001|468624041|FG002|Overall Study|Adverse Event|0|||
130181784|NCT02848001|468624042|FG003|Overall Study|Adverse Event|0|||
130181785|NCT02848001|468624043|FG004|Overall Study|Adverse Event|2|||
130181786|NCT02848001|468624044|FG005|Overall Study|Adverse Event|0|||
130181787|NCT02848001|468624045|FG006|Overall Study|Adverse Event|0|||
130181788|NCT02848001|468624046|FG007|Overall Study|Adverse Event|0|||
130181789|NCT02848001|468624047|FG008|Overall Study|Adverse Event|0|||
130181790|NCT02848001|468624048|FG009|Overall Study|Adverse Event|1|||
130181791|NCT02848001|468624049|FG010|Overall Study|Adverse Event|0|||
130181792|NCT02848001|468624050|FG011|Overall Study|Adverse Event|1|||
130181793|NCT02848001|468624051|FG012|Overall Study|Adverse Event|1|||
130181794|NCT02848001|468624052|FG013|Overall Study|Adverse Event|0|||
130181795|NCT02848001|468624053|FG014|Overall Study|Adverse Event|2|||
130181796|NCT02848001|468624054|FG015|Overall Study|Adverse Event|0|||
130181797|NCT02848001|468624055|FG016|Overall Study|Adverse Event|0|||
130181798|NCT02848001|468624039|FG000|Overall Study|Death|0|||
130181799|NCT02848001|468624040|FG001|Overall Study|Death|0|||
130181800|NCT02848001|468624041|FG002|Overall Study|Death|0|||
130181801|NCT02848001|468624042|FG003|Overall Study|Death|1|||
130181802|NCT02848001|468624043|FG004|Overall Study|Death|3|||
130181803|NCT02848001|468624044|FG005|Overall Study|Death|1|||
130181804|NCT02848001|468624045|FG006|Overall Study|Death|2|||
130181805|NCT02848001|468624046|FG007|Overall Study|Death|3|||
130181806|NCT02848001|468624047|FG008|Overall Study|Death|4|||
130181807|NCT02848001|468624048|FG009|Overall Study|Death|1|||
130181808|NCT02848001|468624049|FG010|Overall Study|Death|0|||
130181809|NCT02848001|468624050|FG011|Overall Study|Death|1|||
130181810|NCT02848001|468624051|FG012|Overall Study|Death|3|||
130181811|NCT02848001|468624052|FG013|Overall Study|Death|0|||
130181812|NCT02848001|468624053|FG014|Overall Study|Death|2|||
130181813|NCT02848001|468624054|FG015|Overall Study|Death|3|||
130181814|NCT02848001|468624055|FG016|Overall Study|Death|0|||
130181815|NCT02848001|468624039|FG000|Overall Study|Physician Decision|0|||
130181816|NCT02848001|468624040|FG001|Overall Study|Physician Decision|0|||
130181817|NCT02848001|468624041|FG002|Overall Study|Physician Decision|0|||
130181818|NCT02848001|468624042|FG003|Overall Study|Physician Decision|0|||
130181819|NCT02848001|468624043|FG004|Overall Study|Physician Decision|0|||
130181820|NCT02848001|468624044|FG005|Overall Study|Physician Decision|0|||
130181821|NCT02848001|468624045|FG006|Overall Study|Physician Decision|0|||
130181822|NCT02848001|468624046|FG007|Overall Study|Physician Decision|0|||
130181823|NCT02848001|468624047|FG008|Overall Study|Physician Decision|1|||
130181824|NCT02848001|468624048|FG009|Overall Study|Physician Decision|1|||
130181825|NCT02848001|468624049|FG010|Overall Study|Physician Decision|0|||
130181826|NCT02848001|468624050|FG011|Overall Study|Physician Decision|0|||
130181827|NCT02848001|468624051|FG012|Overall Study|Physician Decision|2|||
130181828|NCT02848001|468624052|FG013|Overall Study|Physician Decision|0|||
130181829|NCT02848001|468624053|FG014|Overall Study|Physician Decision|0|||
130181830|NCT02848001|468624054|FG015|Overall Study|Physician Decision|0|||
130181831|NCT02848001|468624055|FG016|Overall Study|Physician Decision|0|||
130181832|NCT02848001|468624039|FG000|Overall Study|Withdrawal by Subject|0|||
130181833|NCT02848001|468624040|FG001|Overall Study|Withdrawal by Subject|0|||
130181834|NCT02848001|468624041|FG002|Overall Study|Withdrawal by Subject|0|||
130181835|NCT02848001|468624042|FG003|Overall Study|Withdrawal by Subject|0|||
130181836|NCT02848001|468624043|FG004|Overall Study|Withdrawal by Subject|0|||
130181837|NCT02848001|468624044|FG005|Overall Study|Withdrawal by Subject|1|||
130181838|NCT02848001|468624045|FG006|Overall Study|Withdrawal by Subject|1|||
130181839|NCT02848001|468624046|FG007|Overall Study|Withdrawal by Subject|1|||
130181840|NCT02848001|468624047|FG008|Overall Study|Withdrawal by Subject|0|||
130181841|NCT02848001|468624048|FG009|Overall Study|Withdrawal by Subject|0|||
130181842|NCT02848001|468624049|FG010|Overall Study|Withdrawal by Subject|0|||
130181843|NCT02848001|468624050|FG011|Overall Study|Withdrawal by Subject|0|||
130181844|NCT02848001|468624051|FG012|Overall Study|Withdrawal by Subject|0|||
130181845|NCT02848001|468624052|FG013|Overall Study|Withdrawal by Subject|0|||
130181846|NCT02848001|468624053|FG014|Overall Study|Withdrawal by Subject|0|||
130181847|NCT02848001|468624054|FG015|Overall Study|Withdrawal by Subject|0|||
130181848|NCT02848001|468624055|FG016|Overall Study|Withdrawal by Subject|0|||
130181849|NCT00711243|468624061|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
130181850|NCT00711243|468624062|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
130181851|NCT00711243|468624063|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
130181852|NCT00711243|468624064|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
130181853|NCT00711243|468624065|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
130181854|NCT00711243|468624066|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
130181855|NCT00711243|468624061|FG000|Reached First Response/4 Cycles|Death|0|||
130181856|NCT00711243|468624062|FG001|Reached First Response/4 Cycles|Death|0|||
130181857|NCT00711243|468624063|FG002|Reached First Response/4 Cycles|Death|0|||
130181858|NCT00711243|468624064|FG003|Reached First Response/4 Cycles|Death|0|||
130181859|NCT00711243|468624065|FG004|Reached First Response/4 Cycles|Death|0|||
130181860|NCT00711243|468624066|FG005|Reached First Response/4 Cycles|Death|2|||
130181861|NCT00711243|468624061|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
130181862|NCT00711243|468624062|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
130181863|NCT00711243|468624063|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
130181864|NCT00711243|468624064|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
130181865|NCT00711243|468624065|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
130181866|NCT00711243|468624066|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
130181867|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
130181868|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
130181869|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
130181870|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
130181871|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
130181872|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
130181873|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Death|0|||
130181874|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Death|0|||
130181875|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Death|0|||
130181876|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Death|0|||
130181877|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Death|0|||
130181878|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Death|2|||
130181879|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181880|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181881|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181882|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181883|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181884|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
130181885|NCT00711243|468624061|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181886|NCT00711243|468624062|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181887|NCT00711243|468624063|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181888|NCT00711243|468624064|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181889|NCT00711243|468624065|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181890|NCT00711243|468624066|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
130181891|NCT01402570|468624069|FG000|Overall Study|Adverse Event|1|||
130181892|NCT01962103|468624073|FG000|Phase 1|Adverse Event|4|||
130181893|NCT01962103|468624074|FG001|Phase 1|Adverse Event|0|||
130181894|NCT01962103|468624075|FG002|Phase 1|Adverse Event|2|||
130181895|NCT01962103|468624076|FG003|Phase 1|Adverse Event|1|||
130181896|NCT01962103|468624077|FG004|Phase 1|Adverse Event|2|||
130181897|NCT01962103|468624078|FG005|Phase 1|Adverse Event|2|||
130181898|NCT01962103|468624079|FG006|Phase 1|Adverse Event|0|||
130181899|NCT01962103|468624080|FG007|Phase 1|Adverse Event|0|||
130181900|NCT01962103|468624081|FG008|Phase 1|Adverse Event|0|||
130181901|NCT01962103|468624073|FG000|Phase 1|Progressive Disease|8|||
130181902|NCT01962103|468624074|FG001|Phase 1|Progressive Disease|6|||
130181903|NCT01962103|468624075|FG002|Phase 1|Progressive Disease|8|||
130181904|NCT01962103|468624076|FG003|Phase 1|Progressive Disease|4|||
130181905|NCT01962103|468624077|FG004|Phase 1|Progressive Disease|5|||
130181906|NCT01962103|468624078|FG005|Phase 1|Progressive Disease|4|||
130181907|NCT01962103|468624079|FG006|Phase 1|Progressive Disease|0|||
130181908|NCT01962103|468624080|FG007|Phase 1|Progressive Disease|0|||
130181909|NCT01962103|468624081|FG008|Phase 1|Progressive Disease|0|||
130181910|NCT01962103|468624073|FG000|Phase 1|Withdrawal by Subject|0|||
130181911|NCT01962103|468624074|FG001|Phase 1|Withdrawal by Subject|0|||
130181912|NCT01962103|468624075|FG002|Phase 1|Withdrawal by Subject|0|||
130181913|NCT01962103|468624076|FG003|Phase 1|Withdrawal by Subject|2|||
130181914|NCT01962103|468624077|FG004|Phase 1|Withdrawal by Subject|0|||
130181915|NCT01962103|468624078|FG005|Phase 1|Withdrawal by Subject|0|||
130181916|NCT01962103|468624079|FG006|Phase 1|Withdrawal by Subject|0|||
130181917|NCT01962103|468624080|FG007|Phase 1|Withdrawal by Subject|0|||
130181918|NCT01962103|468624081|FG008|Phase 1|Withdrawal by Subject|0|||
130181919|NCT01962103|468624073|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
130181920|NCT01962103|468624074|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
130181921|NCT01962103|468624075|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
130181922|NCT01962103|468624076|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
130181923|NCT01962103|468624077|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
130181924|NCT01962103|468624078|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
130181925|NCT01962103|468624079|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
130181926|NCT01962103|468624080|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
130181927|NCT01962103|468624081|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
130181928|NCT01962103|468624073|FG000|Phase 1|Physician Decision|0|||
130181929|NCT01962103|468624074|FG001|Phase 1|Physician Decision|0|||
130181930|NCT01962103|468624075|FG002|Phase 1|Physician Decision|0|||
130181931|NCT01962103|468624076|FG003|Phase 1|Physician Decision|1|||
130181932|NCT01962103|468624077|FG004|Phase 1|Physician Decision|0|||
130181933|NCT01962103|468624078|FG005|Phase 1|Physician Decision|0|||
130181934|NCT01962103|468624079|FG006|Phase 1|Physician Decision|0|||
130181935|NCT01962103|468624080|FG007|Phase 1|Physician Decision|0|||
130181936|NCT01962103|468624081|FG008|Phase 1|Physician Decision|0|||
130181937|NCT01962103|468624073|FG000|Phase 1|Symptomatic Deterioration|3|||
130181938|NCT01962103|468624074|FG001|Phase 1|Symptomatic Deterioration|2|||
130181939|NCT01962103|468624075|FG002|Phase 1|Symptomatic Deterioration|2|||
130181940|NCT01962103|468624076|FG003|Phase 1|Symptomatic Deterioration|2|||
130181941|NCT01962103|468624077|FG004|Phase 1|Symptomatic Deterioration|1|||
130181942|NCT01962103|468624078|FG005|Phase 1|Symptomatic Deterioration|1|||
130181943|NCT01962103|468624079|FG006|Phase 1|Symptomatic Deterioration|0|||
130181944|NCT01962103|468624080|FG007|Phase 1|Symptomatic Deterioration|0|||
130181945|NCT01962103|468624081|FG008|Phase 1|Symptomatic Deterioration|0|||
130181946|NCT01962103|468624073|FG000|Phase 1|Miscellaneous|1|||
130181947|NCT01962103|468624074|FG001|Phase 1|Miscellaneous|0|||
130181948|NCT01962103|468624075|FG002|Phase 1|Miscellaneous|0|||
130181949|NCT01962103|468624076|FG003|Phase 1|Miscellaneous|0|||
130181950|NCT01962103|468624077|FG004|Phase 1|Miscellaneous|0|||
130181951|NCT01962103|468624078|FG005|Phase 1|Miscellaneous|0|||
130181952|NCT01962103|468624079|FG006|Phase 1|Miscellaneous|0|||
130181953|NCT01962103|468624080|FG007|Phase 1|Miscellaneous|0|||
130181954|NCT01962103|468624081|FG008|Phase 1|Miscellaneous|0|||
130181955|NCT01962103|468624073|FG000|Phase 2|Adverse Event|0|||
130181956|NCT01962103|468624074|FG001|Phase 2|Adverse Event|0|||
130181957|NCT01962103|468624075|FG002|Phase 2|Adverse Event|0|||
130181958|NCT01962103|468624076|FG003|Phase 2|Adverse Event|0|||
130181959|NCT01962103|468624077|FG004|Phase 2|Adverse Event|0|||
130181960|NCT01962103|468624078|FG005|Phase 2|Adverse Event|0|||
130181961|NCT01962103|468624079|FG006|Phase 2|Adverse Event|1|||
130181962|NCT01962103|468624080|FG007|Phase 2|Adverse Event|0|||
130181963|NCT01962103|468624081|FG008|Phase 2|Adverse Event|3|||
130181964|NCT01962103|468624073|FG000|Phase 2|Progressive Disease|0|||
130181965|NCT01962103|468624074|FG001|Phase 2|Progressive Disease|0|||
130181966|NCT01962103|468624075|FG002|Phase 2|Progressive Disease|0|||
130181967|NCT01962103|468624076|FG003|Phase 2|Progressive Disease|0|||
130181968|NCT01962103|468624077|FG004|Phase 2|Progressive Disease|0|||
130181969|NCT01962103|468624078|FG005|Phase 2|Progressive Disease|0|||
130181970|NCT01962103|468624079|FG006|Phase 2|Progressive Disease|11|||
130181971|NCT01962103|468624080|FG007|Phase 2|Progressive Disease|12|||
130181972|NCT01962103|468624081|FG008|Phase 2|Progressive Disease|11|||
130181973|NCT01962103|468624073|FG000|Phase 2|Symptomatic Deterioration|0|||
130181974|NCT01962103|468624074|FG001|Phase 2|Symptomatic Deterioration|0|||
130181975|NCT01962103|468624075|FG002|Phase 2|Symptomatic Deterioration|0|||
130181976|NCT01962103|468624076|FG003|Phase 2|Symptomatic Deterioration|0|||
130181977|NCT01962103|468624077|FG004|Phase 2|Symptomatic Deterioration|0|||
130181978|NCT01962103|468624078|FG005|Phase 2|Symptomatic Deterioration|0|||
130181979|NCT01962103|468624079|FG006|Phase 2|Symptomatic Deterioration|2|||
130181980|NCT01962103|468624080|FG007|Phase 2|Symptomatic Deterioration|2|||
130181981|NCT01962103|468624081|FG008|Phase 2|Symptomatic Deterioration|0|||
130181982|NCT01321749|468624082|FG000|Overall Study|Lost to Follow-up|4|||
130181983|NCT01321749|468624083|FG001|Overall Study|Lost to Follow-up|11|||
130181984|NCT01321749|468624082|FG000|Overall Study|Protocol Violation|4|||
130181985|NCT01321749|468624083|FG001|Overall Study|Protocol Violation|7|||
130181986|NCT01321749|468624082|FG000|Overall Study|Withdrawal by Subject|5|||
130181987|NCT01321749|468624083|FG001|Overall Study|Withdrawal by Subject|4|||
130181988|NCT04179838|468624087|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130181989|NCT04179838|468624088|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
130181990|NCT04179838|468624087|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
130181991|NCT04179838|468624088|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
130181992|NCT01290068|468624093|FG000|Overall Study|Adverse Event|1|||
130181993|NCT01290068|468624094|FG001|Overall Study|Adverse Event|3|||
130181994|NCT01290068|468624093|FG000|Overall Study|Lost to Follow-up|3|||
130181995|NCT01290068|468624094|FG001|Overall Study|Lost to Follow-up|0|||
130181996|NCT01290068|468624093|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
130181997|NCT01290068|468624094|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
130181998|NCT01290068|468624093|FG000|Overall Study|Other|3|||
130181999|NCT01290068|468624094|FG001|Overall Study|Other|1|||
130182000|NCT00513695|468624095|FG000|Overall Study|Discontinued therapy|2|||
130182001|NCT00513695|468624095|FG000|Overall Study|Progression prior to surgery|3|||
130182002|NCT01417156|468624102|FG000|Overall Study|Adverse Event|12|||
130182003|NCT01417156|468624102|FG000|Overall Study|Protocol Violation|2|||
130182004|NCT00818766|468624105|FG000|Overall Study|Could not be Contacted on Day 28|11|||
130182005|NCT00818766|468624106|FG001|Overall Study|Could not be Contacted on Day 28|10|||
130182006|NCT00818766|468624105|FG000|Overall Study|Death|1|||
130182007|NCT00818766|468624106|FG001|Overall Study|Death|0|||
130182008|NCT00818766|468624105|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
130182009|NCT00818766|468624106|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
130182010|NCT00086684|468624107|FG000|Overall Study|Adverse Event|12|||
130182011|NCT00086684|468624108|FG001|Overall Study|Adverse Event|17|||
130182012|NCT00086684|468624109|FG002|Overall Study|Adverse Event|14|||
130182013|NCT00086684|468624107|FG000|Overall Study|Lack of Efficacy|6|||
130182014|NCT00086684|468624108|FG001|Overall Study|Lack of Efficacy|6|||
130182015|NCT00086684|468624109|FG002|Overall Study|Lack of Efficacy|5|||
130182016|NCT00086684|468624107|FG000|Overall Study|Lost to Follow-up|15|||
130182017|NCT00086684|468624108|FG001|Overall Study|Lost to Follow-up|8|||
130182018|NCT00086684|468624109|FG002|Overall Study|Lost to Follow-up|10|||
130182019|NCT00086684|468624107|FG000|Overall Study|Protocol Violation|8|||
130182020|NCT00086684|468624108|FG001|Overall Study|Protocol Violation|3|||
130182021|NCT00086684|468624109|FG002|Overall Study|Protocol Violation|0|||
130182022|NCT00086684|468624107|FG000|Overall Study|Withdrawal by Subject|0|||
130182023|NCT00086684|468624108|FG001|Overall Study|Withdrawal by Subject|4|||
130182024|NCT00086684|468624109|FG002|Overall Study|Withdrawal by Subject|10|||
130182025|NCT00086684|468624107|FG000|Overall Study|NONCOMPLIANCE|5|||
130182026|NCT00086684|468624108|FG001|Overall Study|NONCOMPLIANCE|7|||
130182027|NCT00086684|468624109|FG002|Overall Study|NONCOMPLIANCE|6|||
130182028|NCT00086684|468624107|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130182029|NCT00086684|468624108|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130182030|NCT00086684|468624109|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130182031|NCT00086684|468624107|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
130182032|NCT00086684|468624108|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
130182033|NCT00086684|468624109|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
130182034|NCT00086684|468624107|FG000|Overall Study|Other|4|||
130182035|NCT00086684|468624108|FG001|Overall Study|Other|2|||
130182036|NCT00086684|468624109|FG002|Overall Study|Other|3|||
130182037|NCT00725491|468624119|FG000|Overall Study|Adverse Event|3|||
130182038|NCT00725491|468624120|FG001|Overall Study|Adverse Event|2|||
130182039|NCT00725491|468624119|FG000|Overall Study|Pregnancy|0|||
130182040|NCT00725491|468624120|FG001|Overall Study|Pregnancy|3|||
130182041|NCT00725491|468624119|FG000|Overall Study|Risk for hyperstimulation|2|||
130182042|NCT00725491|468624120|FG001|Overall Study|Risk for hyperstimulation|9|||
130182043|NCT00725491|468624119|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130182044|NCT00725491|468624120|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130182045|NCT00725491|468624119|FG000|Overall Study|Fertilization failure|0|||
130182046|NCT00725491|468624120|FG001|Overall Study|Fertilization failure|1|||
130182047|NCT00725491|468624119|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
130182048|NCT00725491|468624120|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
130182049|NCT03359850|468624125|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
130182050|NCT03359850|468624126|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
130182051|NCT03359850|468624125|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
130182052|NCT03359850|468624126|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
130182053|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Death|2|||
130182054|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Death|4|||
130182055|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
130182056|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
130182057|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
130182058|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
130182059|NCT00942357|468624134|FG000|Overall Study|Ineligible|37|||
130182060|NCT00942357|468624135|FG001|Overall Study|Ineligible|40|||
130182061|NCT00882518|468624136|FG000|Overall Study|Adverse Event|9|||
130182062|NCT00882518|468624137|FG001|Overall Study|Adverse Event|18|||
130182063|NCT00882518|468624136|FG000|Overall Study|Withdrawal by Subject|9|||
130182064|NCT00882518|468624137|FG001|Overall Study|Withdrawal by Subject|13|||
130182065|NCT00882518|468624136|FG000|Overall Study|Lack of Efficacy|12|||
130182066|NCT00882518|468624137|FG001|Overall Study|Lack of Efficacy|9|||
130182067|NCT00882518|468624136|FG000|Overall Study|Severe non-compliance to protocol|3|||
130182068|NCT00882518|468624137|FG001|Overall Study|Severe non-compliance to protocol|1|||
130182069|NCT00882518|468624136|FG000|Overall Study|Incorrect enrolment|4|||
130182070|NCT00882518|468624137|FG001|Overall Study|Incorrect enrolment|2|||
130182071|NCT00882518|468624136|FG000|Overall Study|Central lab closure for National day|1|||
130182072|NCT00882518|468624137|FG001|Overall Study|Central lab closure for National day|0|||
130182073|NCT00882518|468624136|FG000|Overall Study|Allocating random number by mistake|0|||
130182074|NCT00882518|468624137|FG001|Overall Study|Allocating random number by mistake|1|||
130182075|NCT02137252|468624138|FG000|Overall Study|trial terminated early|2|||
130182076|NCT02137252|468624139|FG001|Overall Study|trial terminated early|1|||
130182077|NCT04421131|468624142|FG000|Overall Study|Lost to Follow-up|1|||
130182078|NCT04421131|468624142|FG000|Overall Study|Protocol Violation|2|||
130182079|NCT04421131|468624142|FG000|Overall Study|App crashed|5|||
130182080|NCT00729937|468624143|FG000|Overall Study|Lost to Follow-up|49|||
130182081|NCT00729937|468624144|FG001|Overall Study|Lost to Follow-up|58|||
130182082|NCT00729937|468624145|FG002|Overall Study|Lost to Follow-up|18|||
130182083|NCT00729937|468624146|FG003|Overall Study|Lost to Follow-up|33|||
130182084|NCT00729937|468624147|FG004|Overall Study|Lost to Follow-up|18|||
130182085|NCT00729937|468624148|FG005|Overall Study|Lost to Follow-up|23|||
130182086|NCT00729937|468624143|FG000|Overall Study|Physician Decision|7|||
130182087|NCT00729937|468624144|FG001|Overall Study|Physician Decision|16|||
130182088|NCT00729937|468624145|FG002|Overall Study|Physician Decision|2|||
130182089|NCT00729937|468624146|FG003|Overall Study|Physician Decision|0|||
130182090|NCT00729937|468624147|FG004|Overall Study|Physician Decision|5|||
130182091|NCT00729937|468624148|FG005|Overall Study|Physician Decision|8|||
130182092|NCT00729937|468624143|FG000|Overall Study|Death|1|||
130182093|NCT00729937|468624144|FG001|Overall Study|Death|0|||
130182094|NCT00729937|468624145|FG002|Overall Study|Death|1|||
130182095|NCT00729937|468624146|FG003|Overall Study|Death|0|||
130182096|NCT00729937|468624147|FG004|Overall Study|Death|0|||
130182097|NCT00729937|468624148|FG005|Overall Study|Death|1|||
130182098|NCT00729937|468624143|FG000|Overall Study|Withdrawal by Subject|3|||
130182099|NCT00729937|468624144|FG001|Overall Study|Withdrawal by Subject|5|||
130182100|NCT00729937|468624145|FG002|Overall Study|Withdrawal by Subject|6|||
130182101|NCT00729937|468624146|FG003|Overall Study|Withdrawal by Subject|0|||
130182102|NCT00729937|468624147|FG004|Overall Study|Withdrawal by Subject|4|||
130182103|NCT00729937|468624148|FG005|Overall Study|Withdrawal by Subject|2|||
130182104|NCT00729937|468624143|FG000|Overall Study|Randomized but not treated|12|||
130182105|NCT00729937|468624144|FG001|Overall Study|Randomized but not treated|6|||
130182106|NCT00729937|468624145|FG002|Overall Study|Randomized but not treated|1|||
130182107|NCT00729937|468624146|FG003|Overall Study|Randomized but not treated|0|||
130182108|NCT00729937|468624147|FG004|Overall Study|Randomized but not treated|1|||
130182109|NCT00729937|468624148|FG005|Overall Study|Randomized but not treated|3|||
130182110|NCT00729937|468624143|FG000|Overall Study|Did not meet eligibility criteria|2|||
130182111|NCT00729937|468624144|FG001|Overall Study|Did not meet eligibility criteria|1|||
130182112|NCT00729937|468624145|FG002|Overall Study|Did not meet eligibility criteria|0|||
130182113|NCT00729937|468624146|FG003|Overall Study|Did not meet eligibility criteria|0|||
130182114|NCT00729937|468624147|FG004|Overall Study|Did not meet eligibility criteria|0|||
130182115|NCT00729937|468624148|FG005|Overall Study|Did not meet eligibility criteria|0|||
130182116|NCT00729937|468624143|FG000|Overall Study|Incarcerated|0|||
130182117|NCT00729937|468624144|FG001|Overall Study|Incarcerated|2|||
130182118|NCT00729937|468624145|FG002|Overall Study|Incarcerated|1|||
130182119|NCT00729937|468624146|FG003|Overall Study|Incarcerated|1|||
130182120|NCT00729937|468624147|FG004|Overall Study|Incarcerated|0|||
130182121|NCT00729937|468624148|FG005|Overall Study|Incarcerated|0|||
130182122|NCT00243412|468624149|FG000|Overall Study|Death|0|||
130182123|NCT00243412|468624150|FG001|Overall Study|Death|1|||
130182124|NCT00243412|468624149|FG000|Overall Study|Adverse Event|4|||
130182125|NCT00243412|468624150|FG001|Overall Study|Adverse Event|2|||
130182126|NCT00243412|468624149|FG000|Overall Study|Lost to Follow-up|0|||
130182127|NCT00243412|468624150|FG001|Overall Study|Lost to Follow-up|1|||
130182128|NCT00243412|468624149|FG000|Overall Study|Physician Decision|1|||
130182129|NCT00243412|468624150|FG001|Overall Study|Physician Decision|1|||
130182130|NCT00243412|468624149|FG000|Overall Study|Withdrawal by Subject|4|||
130182131|NCT00243412|468624150|FG001|Overall Study|Withdrawal by Subject|5|||
130182132|NCT00243412|468624149|FG000|Overall Study|Other|1|||
130182133|NCT00243412|468624150|FG001|Overall Study|Other|1|||
130182134|NCT03281876|468624159|FG000|Overall Study|Adverse Event|4|||
130182135|NCT03281876|468624160|FG001|Overall Study|Adverse Event|15|||
130182136|NCT03281876|468624159|FG000|Overall Study|Lost to Follow-up|1|||
130182137|NCT03281876|468624160|FG001|Overall Study|Lost to Follow-up|4|||
130182138|NCT03281876|468624159|FG000|Overall Study|Withdrawal by Subject|11|||
130182139|NCT03281876|468624160|FG001|Overall Study|Withdrawal by Subject|15|||
130182140|NCT03281876|468624159|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130182141|NCT03281876|468624160|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130182142|NCT03281876|468624159|FG000|Overall Study|OTHER|5|||
130182143|NCT03281876|468624160|FG001|Overall Study|OTHER|5|||
130182144|NCT02208089|468624161|FG000|Overall Study|Withdrawal by Subject|1|||
130182145|NCT02208089|468624162|FG001|Overall Study|Withdrawal by Subject|0|||
130182146|NCT02208089|468624161|FG000|Overall Study|Lost to Follow-up|6|||
130182147|NCT02208089|468624162|FG001|Overall Study|Lost to Follow-up|0|||
130182148|NCT00683657|468624165|FG000|Overall Study|Adverse Event|0|||
130182149|NCT00683657|468624166|FG001|Overall Study|Adverse Event|1|||
130182150|NCT00683657|468624165|FG000|Overall Study|Subject Withdrew Consent|1|||
130182151|NCT00683657|468624166|FG001|Overall Study|Subject Withdrew Consent|0|||
130182152|NCT01408043|468624172|FG000|Overall Study|unable to collect cells|1|||
130182153|NCT00972595|468624173|FG000|Period 1|Adverse Event|1|||
130182154|NCT00972595|468624174|FG001|Period 1|Adverse Event|0|||
130182155|NCT02552121|468624175|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
130182156|NCT02552121|468624176|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182157|NCT02552121|468624177|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182158|NCT02552121|468624178|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182159|NCT02552121|468624179|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182160|NCT02552121|468624180|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182161|NCT02552121|468624181|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182162|NCT02552121|468624182|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182163|NCT02552121|468624175|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
130182164|NCT02552121|468624176|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182165|NCT02552121|468624177|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182166|NCT02552121|468624178|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182167|NCT02552121|468624179|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182168|NCT02552121|468624180|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182169|NCT02552121|468624181|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182170|NCT02552121|468624182|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182171|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182172|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
130182173|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182174|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182175|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182176|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182177|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182178|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182179|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182180|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
130182181|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182182|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182183|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182184|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182185|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182186|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182187|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182188|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
130182189|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182190|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182191|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182192|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182193|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182194|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182195|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182196|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
130182197|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182198|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182199|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182200|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182201|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182202|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182203|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
130182204|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
130182205|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
130182206|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
130182207|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
130182208|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
130182209|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
130182210|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
130182211|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
130182212|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
130182213|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
130182214|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
130182215|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
130182216|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
130182217|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
130182218|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
130182219|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
130182220|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
130182221|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
130182222|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
130182223|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
130182224|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
130182225|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
130182226|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
130182227|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Death|0|||
130182228|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Death|0|||
130182229|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Death|1|||
130182230|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Death|0|||
130182231|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Death|0|||
130182232|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Death|0|||
130182233|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Death|0|||
130182234|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Death|0|||
130182235|NCT02586155|468624183|FG000|Overall Study|Adverse Event|2|||
130182236|NCT02586155|468624184|FG001|Overall Study|Adverse Event|3|||
130182237|NCT02586155|468624183|FG000|Overall Study|Withdrawal by Subject|31|||
130182238|NCT02586155|468624184|FG001|Overall Study|Withdrawal by Subject|24|||
130182239|NCT02586155|468624183|FG000|Overall Study|Lost to Follow-up|7|||
130182240|NCT02586155|468624184|FG001|Overall Study|Lost to Follow-up|13|||
130182241|NCT02586155|468624183|FG000|Overall Study|Death|61|||
130182242|NCT02586155|468624184|FG001|Overall Study|Death|72|||
130182243|NCT02586155|468624183|FG000|Overall Study|Other reasons|26|||
130182244|NCT02586155|468624184|FG001|Overall Study|Other reasons|15|||
130182245|NCT00739063|468624187|FG000|Overall Study|Screen failures|8|||
130182246|NCT04779879|468624188|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182247|NCT04779879|468624189|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182248|NCT04779879|468624190|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182249|NCT04779879|468624191|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
130182250|NCT04779879|468624192|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182251|NCT04779879|468624193|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182252|NCT04779879|468624188|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182253|NCT04779879|468624189|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182254|NCT04779879|468624190|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182255|NCT04779879|468624191|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
130182256|NCT04779879|468624192|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182257|NCT04779879|468624193|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182258|NCT04779879|468624188|FG000|Part C: Up to Week 36|Death|0|||
130182259|NCT04779879|468624189|FG001|Part C: Up to Week 36|Death|0|||
130182260|NCT04779879|468624190|FG002|Part C: Up to Week 36|Death|0|||
130182261|NCT04779879|468624191|FG003|Part C: Up to Week 36|Death|0|||
130182262|NCT04779879|468624192|FG004|Part C: Up to Week 36|Death|0|||
130182263|NCT04779879|468624193|FG005|Part C: Up to Week 36|Death|1|||
130182264|NCT04779879|468624188|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182265|NCT04779879|468624189|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182266|NCT04779879|468624190|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182267|NCT04779879|468624191|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182268|NCT04779879|468624192|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
130182269|NCT04779879|468624193|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
130182270|NCT02461160|468624194|FG000|Overall Study|Lost to Follow-up|0|||
130182271|NCT02461160|468624195|FG001|Overall Study|Lost to Follow-up|0|||
130182272|NCT02461160|468624196|FG002|Overall Study|Lost to Follow-up|0|||
130182273|NCT02461160|468624197|FG003|Overall Study|Lost to Follow-up|0|||
130182274|NCT02461160|468624198|FG004|Overall Study|Lost to Follow-up|0|||
130182275|NCT02461160|468624199|FG005|Overall Study|Lost to Follow-up|0|||
130182276|NCT02461160|468624200|FG006|Overall Study|Lost to Follow-up|0|||
130182277|NCT02461160|468624201|FG007|Overall Study|Lost to Follow-up|1|||
130182278|NCT02461160|468624202|FG008|Overall Study|Lost to Follow-up|0|||
130182279|NCT02461160|468624203|FG009|Overall Study|Lost to Follow-up|0|||
130182280|NCT02461160|468624204|FG010|Overall Study|Lost to Follow-up|0|||
130182281|NCT02461160|468624205|FG011|Overall Study|Lost to Follow-up|0|||
130182282|NCT02461160|468624206|FG012|Overall Study|Lost to Follow-up|0|||
130182283|NCT02854527|468624207|FG000|Overall Study|Adverse Event|0|||
130182284|NCT02854527|468624208|FG001|Overall Study|Adverse Event|0|||
130182285|NCT02854527|468624209|FG002|Overall Study|Adverse Event|0|||
130182286|NCT02854527|468624210|FG003|Overall Study|Adverse Event|0|||
130182287|NCT02854527|468624211|FG004|Overall Study|Adverse Event|1|||
130182288|NCT02854527|468624212|FG005|Overall Study|Adverse Event|0|||
130182289|NCT02854527|468624213|FG006|Overall Study|Adverse Event|0|||
130182290|NCT02854527|468624214|FG007|Overall Study|Adverse Event|0|||
130182291|NCT02854527|468624215|FG008|Overall Study|Adverse Event|0|||
130182292|NCT02854527|468624216|FG009|Overall Study|Adverse Event|0|||
130182293|NCT02854527|468624207|FG000|Overall Study|Lost to Follow-up|0|||
130182294|NCT02854527|468624208|FG001|Overall Study|Lost to Follow-up|0|||
130182295|NCT02854527|468624209|FG002|Overall Study|Lost to Follow-up|0|||
130182296|NCT02854527|468624210|FG003|Overall Study|Lost to Follow-up|1|||
130182297|NCT02854527|468624211|FG004|Overall Study|Lost to Follow-up|0|||
130182298|NCT02854527|468624212|FG005|Overall Study|Lost to Follow-up|0|||
130182299|NCT02854527|468624213|FG006|Overall Study|Lost to Follow-up|0|||
130182300|NCT02854527|468624214|FG007|Overall Study|Lost to Follow-up|0|||
130182301|NCT02854527|468624215|FG008|Overall Study|Lost to Follow-up|0|||
130182302|NCT02854527|468624216|FG009|Overall Study|Lost to Follow-up|0|||
130182303|NCT02899962|468624217|FG000|Open-label Phase|Adverse Event|2|||
130182304|NCT02899962|468624218|FG001|Open-label Phase|Adverse Event|0|||
130182305|NCT02899962|468624219|FG002|Open-label Phase|Adverse Event|0|||
130182306|NCT02899962|468624217|FG000|Open-label Phase|Lost to Follow-up|9|||
130182307|NCT02899962|468624218|FG001|Open-label Phase|Lost to Follow-up|0|||
130182308|NCT02899962|468624219|FG002|Open-label Phase|Lost to Follow-up|0|||
130182309|NCT02899962|468624217|FG000|Open-label Phase|Other reasons|9|||
130182310|NCT02899962|468624218|FG001|Open-label Phase|Other reasons|0|||
130182311|NCT02899962|468624219|FG002|Open-label Phase|Other reasons|0|||
130182312|NCT02899962|468624217|FG000|Open-label Phase|Withdrawal by Subject|7|||
130182313|NCT02899962|468624218|FG001|Open-label Phase|Withdrawal by Subject|0|||
130182314|NCT02899962|468624219|FG002|Open-label Phase|Withdrawal by Subject|0|||
130182315|NCT02899962|468624217|FG000|Maintenance Phase|Adverse Event|0|||
130182316|NCT02899962|468624218|FG001|Maintenance Phase|Adverse Event|2|||
130182317|NCT02899962|468624219|FG002|Maintenance Phase|Adverse Event|1|||
130182318|NCT02899962|468624217|FG000|Maintenance Phase|Death|0|||
130182319|NCT02899962|468624218|FG001|Maintenance Phase|Death|0|||
130182320|NCT02899962|468624219|FG002|Maintenance Phase|Death|1|||
130182321|NCT02899962|468624217|FG000|Maintenance Phase|Lack of Efficacy|0|||
130182322|NCT02899962|468624218|FG001|Maintenance Phase|Lack of Efficacy|20|||
130182323|NCT02899962|468624219|FG002|Maintenance Phase|Lack of Efficacy|16|||
130182324|NCT02899962|468624217|FG000|Maintenance Phase|Lost to Follow-up|0|||
130182325|NCT02899962|468624218|FG001|Maintenance Phase|Lost to Follow-up|12|||
130182326|NCT02899962|468624219|FG002|Maintenance Phase|Lost to Follow-up|14|||
130182327|NCT02899962|468624217|FG000|Maintenance Phase|Other reasons|0|||
130182328|NCT02899962|468624218|FG001|Maintenance Phase|Other reasons|9|||
130182329|NCT02899962|468624219|FG002|Maintenance Phase|Other reasons|13|||
130182330|NCT02899962|468624217|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
130182331|NCT02899962|468624218|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
130182332|NCT02899962|468624219|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
130182333|NCT02899962|468624217|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
130182334|NCT02899962|468624218|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
130182335|NCT02899962|468624219|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
130182336|NCT02899962|468624217|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130182337|NCT02899962|468624218|FG001|Maintenance Phase|Withdrawal by Subject|30|||
130182338|NCT02899962|468624219|FG002|Maintenance Phase|Withdrawal by Subject|36|||
130182339|NCT01821807|468624226|FG000|Overall Study|Lost to Follow-up|3|||
130182340|NCT01821807|468624227|FG001|Overall Study|Lost to Follow-up|1|||
130182341|NCT02633787|468624229|FG000|Overall Study|Withdrawal by Subject|1|||
130182342|NCT00550459|468624230|FG000|Overall Study|Adverse Event|0|||
130182343|NCT00550459|468624231|FG001|Overall Study|Adverse Event|2|||
130182344|NCT00550459|468624230|FG000|Overall Study|Withdrawal by Subject|1|||
130182345|NCT00550459|468624231|FG001|Overall Study|Withdrawal by Subject|1|||
130182346|NCT01742897|468624232|FG000|Overall Study|Adverse Event|3|||
130182347|NCT01742897|468624232|FG000|Overall Study|Withdrawal by Subject|1|||
130182348|NCT01742897|468624232|FG000|Overall Study|Other|1|||
130182349|NCT02404805|468624233|FG000|Overall Study|Withdrawal by Subject|1|||
130182350|NCT02404805|468624234|FG001|Overall Study|Withdrawal by Subject|0|||
130182351|NCT02404805|468624235|FG002|Overall Study|Withdrawal by Subject|0|||
130182352|NCT02404805|468624236|FG003|Overall Study|Withdrawal by Subject|0|||
130182353|NCT02404805|468624237|FG004|Overall Study|Withdrawal by Subject|0|||
130182354|NCT02404805|468624238|FG005|Overall Study|Withdrawal by Subject|0|||
130182355|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182356|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182357|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182358|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182359|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182360|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182361|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182362|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182363|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182364|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
130182365|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
130182366|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
130182367|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182368|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182369|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182370|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182371|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182372|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182373|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
130182374|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
130182375|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
130182376|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182377|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182378|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182379|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182380|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182381|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182382|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182383|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182384|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182385|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
130182386|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
130182387|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182388|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182389|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182390|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
130182391|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182392|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182393|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182394|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
130182395|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
130182396|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130182397|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130182398|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130182399|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130182400|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182401|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182402|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182403|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182404|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182405|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182406|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182407|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
130182408|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182409|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182410|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182411|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182412|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130182413|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
130182414|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130182415|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
130182416|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130182417|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130182418|NCT04720105|468624249|FG000|Overall Study|Lack of Efficacy|1|||
130182419|NCT04720105|468624249|FG000|Overall Study|Lost to Follow-up|1|||
130182420|NCT04720105|468624249|FG000|Overall Study|Withdrawal by Subject|3|||
130182421|NCT04871776|468624253|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
130182422|NCT04871776|468624254|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
130182423|NCT04871776|468624255|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
130182424|NCT04871776|468624253|FG000|Overall Study|Did not meet eligibility criteria|1|||
130182425|NCT04871776|468624254|FG001|Overall Study|Did not meet eligibility criteria|1|||
130182426|NCT04871776|468624255|FG002|Overall Study|Did not meet eligibility criteria|1|||
130182427|NCT04075487|468625670|FG000|Overall Study|Withdrawal by Subject|1|||
130182428|NCT02750618|468625673|FG000|Overall Study|Withdrawal by Subject|1|||
130182429|NCT02572570|468625679|FG000|Overall Study|Study Terminated|27|||
130182430|NCT02763046|468625680|FG000|Overall Study|Adverse Event|5|||
130182431|NCT02763046|468625681|FG001|Overall Study|Adverse Event|4|||
130182432|NCT02763046|468625682|FG002|Overall Study|Adverse Event|0|||
130182433|NCT02763046|468625680|FG000|Overall Study|Lack of Efficacy|1|||
130182434|NCT02763046|468625681|FG001|Overall Study|Lack of Efficacy|1|||
130182435|NCT02763046|468625682|FG002|Overall Study|Lack of Efficacy|3|||
130182436|NCT02763046|468625680|FG000|Overall Study|Physician Decision|1|||
130182437|NCT02763046|468625681|FG001|Overall Study|Physician Decision|0|||
130182438|NCT02763046|468625682|FG002|Overall Study|Physician Decision|1|||
130182439|NCT02763046|468625680|FG000|Overall Study|Subject/guardian decision|2|||
130182440|NCT02763046|468625681|FG001|Overall Study|Subject/guardian decision|0|||
130182441|NCT02763046|468625682|FG002|Overall Study|Subject/guardian decision|4|||
130182442|NCT01067105|468625683|FG000|Overall Study|Adverse Event|14|||
130182443|NCT01067105|468625683|FG000|Overall Study|Protocol Violation|48|||
130182444|NCT01067105|468625683|FG000|Overall Study|Withdrawal by Subject|36|||
130182445|NCT01067105|468625683|FG000|Overall Study|Lost to Follow-up|6|||
130182446|NCT01067105|468625683|FG000|Overall Study|Physician Decision|6|||
130182447|NCT01067105|468625683|FG000|Overall Study|Other|31|||
130182448|NCT02302833|468625686|FG000|Overall Study|Lost to Follow-up|3|||
130182449|NCT04878432|468625687|FG000|Overall Study|Adverse Event|1|||
130182450|NCT04878432|468625687|FG000|Overall Study|Death|2|||
130182451|NCT04878432|468625687|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130182452|NCT04878432|468625687|FG000|Overall Study|Withdrawal by Subject|6|||
130182453|NCT04878432|468625687|FG000|Overall Study|Progressive Disease|7|||
130182454|NCT04878432|468625687|FG000|Overall Study|New Therapy for Study Indication|7|||
130182455|NCT04878432|468625687|FG000|Overall Study|Physician Decision|11|||
130182456|NCT05017246|468625688|FG000|Overall Study|Withdrawal by Subject|5|||
130182457|NCT05017246|468625689|FG001|Overall Study|Withdrawal by Subject|3|||
130182458|NCT05017246|468625688|FG000|Overall Study|Determined to be ineligible|0|||
130182459|NCT05017246|468625689|FG001|Overall Study|Determined to be ineligible|1|||
130182460|NCT05017246|468625688|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
130182461|NCT05017246|468625689|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
130182462|NCT05017246|468625688|FG000|Overall Study|Technical failure|1|||
130182463|NCT05017246|468625689|FG001|Overall Study|Technical failure|3|||
130182464|NCT01495000|468625690|FG000|Overall Study|Lost to Follow-up|2|||
130182465|NCT01495000|468625691|FG001|Overall Study|Lost to Follow-up|2|||
130182466|NCT01495000|468625690|FG000|Overall Study|Protocol Violation|1|||
130182467|NCT01495000|468625691|FG001|Overall Study|Protocol Violation|0|||
130182468|NCT01495000|468625690|FG000|Overall Study|Withdrawal by Subject|10|||
130182469|NCT01495000|468625691|FG001|Overall Study|Withdrawal by Subject|10|||
130182470|NCT01514461|468625692|FG000|Overall Study|Adverse Event|2|||
130182471|NCT01514461|468625693|FG001|Overall Study|Adverse Event|1|||
130182472|NCT01514461|468625694|FG002|Overall Study|Adverse Event|3|||
130182473|NCT01514461|468625692|FG000|Overall Study|Physician Decision|1|||
130182474|NCT01514461|468625693|FG001|Overall Study|Physician Decision|1|||
130182475|NCT01514461|468625694|FG002|Overall Study|Physician Decision|0|||
130182476|NCT01514461|468625692|FG000|Overall Study|Patient/guardian decision|1|||
130182477|NCT01514461|468625693|FG001|Overall Study|Patient/guardian decision|1|||
130182478|NCT01514461|468625694|FG002|Overall Study|Patient/guardian decision|1|||
130182479|NCT01514461|468625692|FG000|Overall Study|Death|1|||
130182480|NCT01514461|468625693|FG001|Overall Study|Death|0|||
130182481|NCT01514461|468625694|FG002|Overall Study|Death|0|||
130182482|NCT03499067|468625695|FG000|First Intervention|Physician Decision|2|||
130182483|NCT03499067|468625696|FG001|First Intervention|Physician Decision|1|||
130182484|NCT03499067|468625695|FG000|First Intervention|Withdrawal by Subject|3|||
130182485|NCT03499067|468625696|FG001|First Intervention|Withdrawal by Subject|6|||
130182486|NCT02548832|468625697|FG000|Overall Study|Lost to Follow-up|2|||
130182487|NCT02548832|468625698|FG001|Overall Study|Lost to Follow-up|2|||
130182488|NCT02548832|468625699|FG002|Overall Study|Lost to Follow-up|2|||
130182489|NCT03565900|468625700|FG000|Overall Study|Disposition Unknown|4|||
130182490|NCT03565900|468625701|FG001|Overall Study|Disposition Unknown|1|||
130182491|NCT03565900|468625700|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130182492|NCT03565900|468625701|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130182493|NCT03565900|468625700|FG000|Overall Study|Withdrawal by Subject|4|||
130182494|NCT03565900|468625701|FG001|Overall Study|Withdrawal by Subject|5|||
130182495|NCT03565900|468625700|FG000|Overall Study|Randomized By Mistake|0|||
130182496|NCT03565900|468625701|FG001|Overall Study|Randomized By Mistake|2|||
130182497|NCT03565900|468625700|FG000|Overall Study|Physician Decision|7|||
130182498|NCT03565900|468625701|FG001|Overall Study|Physician Decision|11|||
130182499|NCT03565900|468625700|FG000|Overall Study|Death|9|||
130182500|NCT03565900|468625701|FG001|Overall Study|Death|7|||
130182501|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
130182502|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130182503|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130182504|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
130182505|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130182506|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130182507|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
130182508|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130182509|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130182510|NCT02002221|468625710|FG000|Overall Study|Adverse Event|2|||
130182511|NCT02002221|468625711|FG001|Overall Study|Adverse Event|1|||
130182512|NCT02002221|468625710|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130182513|NCT02002221|468625711|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130182514|NCT02002221|468625710|FG000|Overall Study|Patient withdrew consent|0|||
130182515|NCT02002221|468625711|FG001|Overall Study|Patient withdrew consent|1|||
130182516|NCT03347110|468625712|FG000|Overall Study|Other (Participant is incarcerated)|1|||
130182517|NCT03347110|468625712|FG000|Overall Study|Withdrawal by Subject|9|||
130182518|NCT03347110|468625712|FG000|Overall Study|Lost to Follow-up|1|||
130182519|NCT03347110|468625712|FG000|Overall Study|Lack of Efficacy|2|||
130182520|NCT03347110|468625712|FG000|Overall Study|Adverse Event, non-fatal|9|||
130182521|NCT02105467|468625715|FG000|Period 1|Lost to Follow-up|1|||
130182522|NCT02105467|468625716|FG001|Period 1|Lost to Follow-up|0|||
130182523|NCT02105467|468625715|FG000|Period 1|Death|1|||
130182524|NCT02105467|468625716|FG001|Period 1|Death|0|||
130182525|NCT02105467|468625715|FG000|Period 2|Lost to Follow-up|1|||
130182526|NCT02105467|468625716|FG001|Period 2|Lost to Follow-up|0|||
130182527|NCT02105467|468625715|FG000|Period 2|Death|1|||
130182528|NCT02105467|468625716|FG001|Period 2|Death|0|||
130182529|NCT02105467|468625715|FG000|Period 2|Withdrawal by Subject|0|||
130182530|NCT02105467|468625716|FG001|Period 2|Withdrawal by Subject|2|||
130182531|NCT02105467|468625715|FG000|Period 3|Lost to Follow-up|0|||
130182532|NCT02105467|468625716|FG001|Period 3|Lost to Follow-up|1|||
130182533|NCT01518322|468625718|FG000|Overall Study|FeNO measurement was missing|13|||
130182534|NCT02792517|468625723|FG000|Overall Study|Withdrawal by Subject|10|||
130182535|NCT02792517|468625723|FG000|Overall Study|Decision by Sponsor|7|||
130182536|NCT02792517|468625723|FG000|Overall Study|Lost to Follow-up|3|||
130182537|NCT00856193|468625726|FG000|Period 2|Abnormal test procedure results|0|||
130182538|NCT00856193|468625727|FG001|Period 2|Abnormal test procedure results|1|||
130182539|NCT00856193|468625726|FG000|Period 2|Lost to Follow-up|0|||
130182540|NCT00856193|468625727|FG001|Period 2|Lost to Follow-up|1|||
130182541|NCT02766335|468625729|FG000|Initial Registration|Adverse Event|6|||
130182542|NCT02766335|468625730|FG001|Initial Registration|Adverse Event|3|||
130182543|NCT02766335|468625731|FG002|Initial Registration|Adverse Event|0|||
130182544|NCT02766335|468625729|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
130182545|NCT02766335|468625730|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
130182546|NCT02766335|468625731|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
130182547|NCT02766335|468625729|FG000|Initial Registration|Progression/relapse|49|||
130182548|NCT02766335|468625730|FG001|Initial Registration|Progression/relapse|15|||
130182549|NCT02766335|468625731|FG002|Initial Registration|Progression/relapse|0|||
130182550|NCT02766335|468625729|FG000|Initial Registration|Death|1|||
130182551|NCT02766335|468625730|FG001|Initial Registration|Death|3|||
130182552|NCT02766335|468625731|FG002|Initial Registration|Death|0|||
130182553|NCT02766335|468625729|FG000|Initial Registration|not protocol specified|1|||
130182554|NCT02766335|468625730|FG001|Initial Registration|not protocol specified|9|||
130182555|NCT02766335|468625731|FG002|Initial Registration|not protocol specified|0|||
130182556|NCT02766335|468625729|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
130182557|NCT02766335|468625730|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
130182558|NCT02766335|468625731|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
130182559|NCT02766335|468625729|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130182560|NCT02766335|468625730|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130182561|NCT02766335|468625731|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
130182562|NCT03164551|468625745|FG000|Overall Study|Imaging discontinued prior completion|8|||
130182563|NCT03164551|468625746|FG001|Overall Study|Imaging discontinued prior completion|0|||
130182564|NCT03164551|468625745|FG000|Overall Study|Participant was non-compliant|1|||
130182565|NCT03164551|468625746|FG001|Overall Study|Participant was non-compliant|0|||
130182566|NCT03164551|468625745|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
130182567|NCT03164551|468625746|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
130182568|NCT03164551|468625745|FG000|Overall Study|Other|8|||
130182569|NCT03164551|468625746|FG001|Overall Study|Other|2|||
130182570|NCT01515423|468625747|FG000|Open Label Phase|Adverse Event|57|||
130182571|NCT01515423|468625748|FG001|Open Label Phase|Adverse Event|0|||
130182572|NCT01515423|468625749|FG002|Open Label Phase|Adverse Event|0|||
130182573|NCT01515423|468625747|FG000|Open Label Phase|Death|2|||
130182574|NCT01515423|468625748|FG001|Open Label Phase|Death|0|||
130182575|NCT01515423|468625749|FG002|Open Label Phase|Death|0|||
130182576|NCT01515423|468625747|FG000|Open Label Phase|Lack of Efficacy|117|||
130182577|NCT01515423|468625748|FG001|Open Label Phase|Lack of Efficacy|0|||
130182578|NCT01515423|468625749|FG002|Open Label Phase|Lack of Efficacy|0|||
130182579|NCT01515423|468625747|FG000|Open Label Phase|Lost to Follow-up|21|||
130182580|NCT01515423|468625748|FG001|Open Label Phase|Lost to Follow-up|0|||
130182581|NCT01515423|468625749|FG002|Open Label Phase|Lost to Follow-up|0|||
130182582|NCT01515423|468625747|FG000|Open Label Phase|Withdrawal by Subject|118|||
130182583|NCT01515423|468625748|FG001|Open Label Phase|Withdrawal by Subject|0|||
130182584|NCT01515423|468625749|FG002|Open Label Phase|Withdrawal by Subject|0|||
130182585|NCT01515423|468625747|FG000|Open Label Phase|excluded from DB Phase|70|||
130182586|NCT01515423|468625748|FG001|Open Label Phase|excluded from DB Phase|0|||
130182587|NCT01515423|468625749|FG002|Open Label Phase|excluded from DB Phase|0|||
130182588|NCT01515423|468625747|FG000|Open Label Phase|Other|28|||
130182589|NCT01515423|468625748|FG001|Open Label Phase|Other|0|||
130182590|NCT01515423|468625749|FG002|Open Label Phase|Other|0|||
130182591|NCT01515423|468625747|FG000|DOUBLE BLIND|Adverse Event|0|||
130182592|NCT01515423|468625748|FG001|DOUBLE BLIND|Adverse Event|15|||
130182593|NCT01515423|468625749|FG002|DOUBLE BLIND|Adverse Event|13|||
130182594|NCT01515423|468625747|FG000|DOUBLE BLIND|Death|0|||
130182595|NCT01515423|468625748|FG001|DOUBLE BLIND|Death|1|||
130182596|NCT01515423|468625749|FG002|DOUBLE BLIND|Death|2|||
130182597|NCT01515423|468625747|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
130182598|NCT01515423|468625748|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
130182599|NCT01515423|468625749|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
130182600|NCT01515423|468625747|FG000|DOUBLE BLIND|Pregnancy|0|||
130182601|NCT01515423|468625748|FG001|DOUBLE BLIND|Pregnancy|2|||
130182602|NCT01515423|468625749|FG002|DOUBLE BLIND|Pregnancy|0|||
130182603|NCT01515423|468625747|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
130182604|NCT01515423|468625748|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
130182605|NCT01515423|468625749|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
130182606|NCT01515423|468625747|FG000|DOUBLE BLIND|Other|0|||
130182607|NCT01515423|468625748|FG001|DOUBLE BLIND|Other|6|||
130182608|NCT01515423|468625749|FG002|DOUBLE BLIND|Other|12|||
130182609|NCT01515423|468625747|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
130182610|NCT01515423|468625748|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
130182611|NCT01515423|468625749|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
130182612|NCT01125917|468625754|FG000|Overall Study|Adverse Event|43|||
130182613|NCT01125917|468625754|FG000|Overall Study|Lost to Follow-up|23|||
130182614|NCT01125917|468625754|FG000|Overall Study|Withdrawal by Subject|31|||
130182615|NCT01125917|468625754|FG000|Overall Study|Administrative|223|||
130182616|NCT01125917|468625754|FG000|Overall Study|Lack of Efficacy|19|||
130182617|NCT02501928|468625756|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130182618|NCT02501928|468625757|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130182619|NCT02501928|468625758|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130182620|NCT02501928|468625759|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
130182621|NCT02501928|468625760|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
130182622|NCT02501928|468625761|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130182623|NCT00838526|468625769|FG000|Overall Study|Adverse Event|3|||
130182624|NCT00838526|468625770|FG001|Overall Study|Adverse Event|12|||
130182625|NCT00838526|468625769|FG000|Overall Study|Lost to Follow-up|4|||
130182626|NCT00838526|468625770|FG001|Overall Study|Lost to Follow-up|12|||
130182627|NCT00838526|468625769|FG000|Overall Study|Withdrawal by Subject|4|||
130182628|NCT00838526|468625770|FG001|Overall Study|Withdrawal by Subject|5|||
130182629|NCT00838526|468625769|FG000|Overall Study|Lack of Efficacy|2|||
130182630|NCT00838526|468625770|FG001|Overall Study|Lack of Efficacy|3|||
130182631|NCT00838526|468625769|FG000|Overall Study|Other|11|||
130182632|NCT00838526|468625770|FG001|Overall Study|Other|7|||
130182633|NCT01320293|468625771|FG000|Overall Study|Lack of Efficacy|1|||
130182634|NCT01320293|468625771|FG000|Overall Study|Adverse Event|1|||
130182635|NCT00931411|468625772|FG000|First Intervention - 42 Days|Adverse Event|2|||
130182636|NCT00931411|468625773|FG001|First Intervention - 42 Days|Adverse Event|3|||
130182637|NCT00931411|468625772|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
130182638|NCT00931411|468625773|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
130182639|NCT00931411|468625772|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
130182640|NCT00931411|468625773|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
130182641|NCT03483012|468625776|FG000|Overall Study|Lack of Efficacy|6|||
130182642|NCT04782076|468625777|FG000|Overall Study|Family Emergency|1|||
130182643|NCT01949662|468625788|FG000|Overall Study|Death|9|||
130182644|NCT01949662|468625789|FG001|Overall Study|Death|7|||
130182645|NCT01949662|468625788|FG000|Overall Study|Discharged before an agitation event|8|||
130182646|NCT01949662|468625789|FG001|Overall Study|Discharged before an agitation event|3|||
130182647|NCT01949662|468625788|FG000|Overall Study|Dropped out|1|||
130182648|NCT01949662|468625789|FG001|Overall Study|Dropped out|3|||
130182649|NCT01949662|468625788|FG000|Overall Study|Ineligible|0|||
130182650|NCT01949662|468625789|FG001|Overall Study|Ineligible|1|||
130182651|NCT04135937|468625791|FG000|Overall Study|Lost to Follow-up|2|||
130182652|NCT04135937|468625791|FG000|Overall Study|Withdrawal by Subject|1|||
130182653|NCT00856492|468625794|FG000|Overall Study|Ineligible or withdrew consent|1|||
130182654|NCT00856492|468625795|FG001|Overall Study|Ineligible or withdrew consent|1|||
130182655|NCT00856492|468625796|FG002|Overall Study|Ineligible or withdrew consent|2|||
130182656|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
130182657|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
130182658|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
130182659|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
130182660|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
130182661|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
130182662|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
130182663|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
130182664|NCT00070564|468626874|FG000|Overall Study|Progression|2|||
130182665|NCT00070564|468626875|FG001|Overall Study|Progression|4|||
130182666|NCT00070564|468626876|FG002|Overall Study|Progression|7|||
130182667|NCT00070564|468626877|FG003|Overall Study|Progression|7|||
130182668|NCT00070564|468626878|FG004|Overall Study|Progression|1|||
130182669|NCT00070564|468626879|FG005|Overall Study|Progression|0|||
130182670|NCT00070564|468626874|FG000|Overall Study|Delinquent|1|||
130182671|NCT00070564|468626875|FG001|Overall Study|Delinquent|4|||
130182672|NCT00070564|468626876|FG002|Overall Study|Delinquent|2|||
130182673|NCT00070564|468626877|FG003|Overall Study|Delinquent|0|||
130182674|NCT00070564|468626878|FG004|Overall Study|Delinquent|0|||
130182675|NCT00070564|468626879|FG005|Overall Study|Delinquent|0|||
130182676|NCT00070564|468626874|FG000|Overall Study|Adverse Event|150|||
130182677|NCT00070564|468626875|FG001|Overall Study|Adverse Event|142|||
130182678|NCT00070564|468626876|FG002|Overall Study|Adverse Event|120|||
130182679|NCT00070564|468626877|FG003|Overall Study|Adverse Event|108|||
130182680|NCT00070564|468626878|FG004|Overall Study|Adverse Event|63|||
130182681|NCT00070564|468626879|FG005|Overall Study|Adverse Event|36|||
130182682|NCT00070564|468626874|FG000|Overall Study|Death|4|||
130182683|NCT00070564|468626875|FG001|Overall Study|Death|1|||
130182684|NCT00070564|468626876|FG002|Overall Study|Death|5|||
130182685|NCT00070564|468626877|FG003|Overall Study|Death|3|||
130182686|NCT00070564|468626878|FG004|Overall Study|Death|0|||
130182687|NCT00070564|468626879|FG005|Overall Study|Death|1|||
130182688|NCT00070564|468626874|FG000|Overall Study|Other, not protocol specified|17|||
130182689|NCT00070564|468626875|FG001|Overall Study|Other, not protocol specified|15|||
130182690|NCT00070564|468626876|FG002|Overall Study|Other, not protocol specified|14|||
130182691|NCT00070564|468626877|FG003|Overall Study|Other, not protocol specified|19|||
130182692|NCT00070564|468626878|FG004|Overall Study|Other, not protocol specified|6|||
130182693|NCT00070564|468626879|FG005|Overall Study|Other, not protocol specified|7|||
130182694|NCT00070564|468626874|FG000|Overall Study|Withdrawal by Subject|26|||
130182695|NCT00070564|468626875|FG001|Overall Study|Withdrawal by Subject|37|||
130182696|NCT00070564|468626876|FG002|Overall Study|Withdrawal by Subject|23|||
130182697|NCT00070564|468626877|FG003|Overall Study|Withdrawal by Subject|30|||
130182698|NCT00070564|468626878|FG004|Overall Study|Withdrawal by Subject|8|||
130182699|NCT00070564|468626879|FG005|Overall Study|Withdrawal by Subject|8|||
130182700|NCT00070564|468626874|FG000|Overall Study|Not reported|0|||
130182701|NCT00070564|468626875|FG001|Overall Study|Not reported|0|||
130182702|NCT00070564|468626876|FG002|Overall Study|Not reported|0|||
130182703|NCT00070564|468626877|FG003|Overall Study|Not reported|0|||
130182704|NCT00070564|468626878|FG004|Overall Study|Not reported|1|||
130182705|NCT00070564|468626879|FG005|Overall Study|Not reported|0|||
130182706|NCT00931528|468626880|FG000|Overall Study|Protocol Violation|9|||
130182707|NCT00931528|468626881|FG001|Overall Study|Protocol Violation|12|||
130182708|NCT00931528|468626880|FG000|Overall Study|Withdrawal by Subject|4|||
130182709|NCT00931528|468626881|FG001|Overall Study|Withdrawal by Subject|12|||
130182710|NCT00931528|468626880|FG000|Overall Study|Lost to Follow-up|6|||
130182711|NCT00931528|468626881|FG001|Overall Study|Lost to Follow-up|13|||
130182712|NCT00931528|468626880|FG000|Overall Study|Assessment outside of Time Frame|22|||
130182713|NCT00931528|468626881|FG001|Overall Study|Assessment outside of Time Frame|23|||
130182714|NCT02115269|468626882|FG000|Overall Study|Lost to Follow-up|43|||
130182715|NCT02115269|468626882|FG000|Overall Study|Did not complete patient diary|3|||
130182716|NCT02115269|468626882|FG000|Overall Study|Moved to another city|7|||
130182717|NCT02115269|468626882|FG000|Overall Study|Withdrawal by Subject|2|||
130182718|NCT02115269|468626882|FG000|Overall Study|Didn't take study drug|2|||
130182719|NCT01557504|468626883|FG000|Overall Study|Physician Decision|1|||
130182720|NCT01557504|468626884|FG001|Overall Study|Physician Decision|0|||
130182721|NCT02058069|468626885|FG000|Overall Study|Exclusion due to implant size|5|||
130182722|NCT02058069|468626885|FG000|Overall Study|Withdrawal by Subject|6|||
130182723|NCT02676882|468626889|FG000|Overall Study|Adverse Event|1|||
130182724|NCT02676882|468626890|FG001|Overall Study|Adverse Event|0|||
130182725|NCT02676882|468626889|FG000|Overall Study|Lost to Follow-up|1|||
130182726|NCT02676882|468626890|FG001|Overall Study|Lost to Follow-up|0|||
130182727|NCT02676882|468626889|FG000|Overall Study|Withdrawal by Subject|1|||
130182728|NCT02676882|468626890|FG001|Overall Study|Withdrawal by Subject|2|||
130182729|NCT02568072|468626891|FG000|Overall Study|Unavailable for appointment|23|||
130182730|NCT02568072|468626891|FG000|Overall Study|Unable to contact|3|||
130182731|NCT02568072|468626891|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
130182732|NCT02568072|468626891|FG000|Overall Study|Withdrawal by Subject|1|||
130182733|NCT02568072|468626891|FG000|Overall Study|Sustained injury, marathon not run|24|||
130182734|NCT00958828|468626893|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
130182735|NCT00958828|468626894|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
130182736|NCT00958828|468626893|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
130182737|NCT00958828|468626894|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
130182738|NCT02687451|468626895|FG000|Overall Study|Withdrawal by Subject|1|||
130182739|NCT02687451|468626896|FG001|Overall Study|Withdrawal by Subject|0|||
130182740|NCT02687451|468626897|FG002|Overall Study|Withdrawal by Subject|0|||
130182741|NCT02687451|468626898|FG003|Overall Study|Withdrawal by Subject|0|||
130182742|NCT02687451|468626899|FG004|Overall Study|Withdrawal by Subject|0|||
130182743|NCT02687451|468626900|FG005|Overall Study|Withdrawal by Subject|1|||
130182744|NCT00927589|468626907|FG000|Overall Study|Death|1|||
130182745|NCT00927589|468626907|FG000|Overall Study|Physician Decision|1|||
130182746|NCT00927589|468626907|FG000|Overall Study|Withdrawal by Subject|3|||
130182747|NCT00927589|468626907|FG000|Overall Study|Adverse Event|2|||
130182748|NCT00927589|468626907|FG000|Overall Study|Disease Progression|8|||
130182749|NCT00927589|468626907|FG000|Overall Study|Non-compliance|1|||
130182750|NCT01125189|468626908|FG000|Treatment Period|Lack of Efficacy|15|||
130182751|NCT01125189|468626909|FG001|Treatment Period|Lack of Efficacy|18|||
130182752|NCT01125189|468626910|FG002|Treatment Period|Lack of Efficacy|25|||
130182753|NCT01125189|468626908|FG000|Treatment Period|Adverse Event|7|||
130182754|NCT01125189|468626909|FG001|Treatment Period|Adverse Event|8|||
130182755|NCT01125189|468626910|FG002|Treatment Period|Adverse Event|8|||
130182756|NCT01125189|468626908|FG000|Treatment Period|Withdrawal by Subject|3|||
130182757|NCT01125189|468626909|FG001|Treatment Period|Withdrawal by Subject|1|||
130182758|NCT01125189|468626910|FG002|Treatment Period|Withdrawal by Subject|1|||
130182759|NCT01125189|468626908|FG000|Treatment Period|Death|1|||
130182760|NCT01125189|468626909|FG001|Treatment Period|Death|0|||
130182761|NCT01125189|468626910|FG002|Treatment Period|Death|0|||
130182762|NCT01125189|468626908|FG000|Treatment Period|Lost to Follow-up|1|||
130182763|NCT01125189|468626909|FG001|Treatment Period|Lost to Follow-up|2|||
130182764|NCT01125189|468626910|FG002|Treatment Period|Lost to Follow-up|1|||
130182765|NCT01125189|468626908|FG000|Treatment Period|Poor compliance/noncompliance|0|||
130182766|NCT01125189|468626909|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130182767|NCT01125189|468626910|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130182768|NCT01125189|468626908|FG000|Treatment Period|Participants requested to discontinue|1|||
130182769|NCT01125189|468626909|FG001|Treatment Period|Participants requested to discontinue|3|||
130182770|NCT01125189|468626910|FG002|Treatment Period|Participants requested to discontinue|4|||
130182771|NCT01125189|468626908|FG000|Treatment Period|Other reasons|1|||
130182772|NCT01125189|468626909|FG001|Treatment Period|Other reasons|1|||
130182773|NCT01125189|468626910|FG002|Treatment Period|Other reasons|0|||
130182774|NCT01125189|468626908|FG000|Treatment Period|Completed 24 week treatment period only|2|||
130182775|NCT01125189|468626909|FG001|Treatment Period|Completed 24 week treatment period only|1|||
130182776|NCT01125189|468626910|FG002|Treatment Period|Completed 24 week treatment period only|2|||
130182777|NCT01125189|468626908|FG000|Follow up Period|Withdrawal by Subject|3|||
130182778|NCT01125189|468626909|FG001|Follow up Period|Withdrawal by Subject|2|||
130182779|NCT01125189|468626910|FG002|Follow up Period|Withdrawal by Subject|5|||
130182780|NCT01125189|468626908|FG000|Follow up Period|Death|1|||
130182781|NCT01125189|468626909|FG001|Follow up Period|Death|0|||
130182782|NCT01125189|468626910|FG002|Follow up Period|Death|0|||
130182783|NCT01125189|468626908|FG000|Follow up Period|Lost to Follow-up|12|||
130182784|NCT01125189|468626909|FG001|Follow up Period|Lost to Follow-up|9|||
130182785|NCT01125189|468626910|FG002|Follow up Period|Lost to Follow-up|6|||
130182786|NCT01125189|468626908|FG000|Follow up Period|Other reasons|4|||
130182787|NCT01125189|468626909|FG001|Follow up Period|Other reasons|4|||
130182788|NCT01125189|468626910|FG002|Follow up Period|Other reasons|5|||
130182789|NCT00707239|468626911|FG000|Overall Study|Adverse Event|5|||
130182790|NCT00707239|468626912|FG001|Overall Study|Adverse Event|3|||
130182791|NCT00707239|468626913|FG002|Overall Study|Adverse Event|2|||
130182792|NCT00707239|468626911|FG000|Overall Study|Death|3|||
130182793|NCT00707239|468626912|FG001|Overall Study|Death|1|||
130182794|NCT00707239|468626913|FG002|Overall Study|Death|3|||
130182795|NCT00707239|468626911|FG000|Overall Study|Physician Decision|1|||
130182796|NCT00707239|468626912|FG001|Overall Study|Physician Decision|1|||
130182797|NCT00707239|468626913|FG002|Overall Study|Physician Decision|2|||
130182798|NCT00707239|468626911|FG000|Overall Study|Protocol Violation|0|||
130182799|NCT00707239|468626912|FG001|Overall Study|Protocol Violation|0|||
130182800|NCT00707239|468626913|FG002|Overall Study|Protocol Violation|1|||
130182801|NCT00707239|468626911|FG000|Overall Study|Lack of Efficacy|1|||
130182802|NCT00707239|468626912|FG001|Overall Study|Lack of Efficacy|2|||
130182803|NCT00707239|468626913|FG002|Overall Study|Lack of Efficacy|0|||
130182804|NCT00707239|468626911|FG000|Overall Study|Randomized, but not treated|1|||
130182805|NCT00707239|468626912|FG001|Overall Study|Randomized, but not treated|1|||
130182806|NCT00707239|468626913|FG002|Overall Study|Randomized, but not treated|1|||
130182807|NCT00707239|468626911|FG000|Overall Study|Other|8|||
130182808|NCT00707239|468626912|FG001|Overall Study|Other|3|||
130182809|NCT00707239|468626913|FG002|Overall Study|Other|5|||
130182810|NCT02088177|468626914|FG000|Overall Study|Lost to Follow-up|3|||
130182811|NCT01778530|468626915|FG000|Overall Study|Progression on study|1|||
130182812|NCT01778530|468626915|FG000|Overall Study|Adverse event/side effect|1|||
130182813|NCT03472014|468626916|FG000|Overall Study|Lost to Follow-up|4|||
130182814|NCT01894919|468626917|FG000|Overall Study|Withdrawal by Subject|1|||
130182815|NCT01894919|468626918|FG001|Overall Study|Withdrawal by Subject|0|||
130182816|NCT01894919|468626919|FG002|Overall Study|Withdrawal by Subject|0|||
130182817|NCT01894919|468626920|FG003|Overall Study|Withdrawal by Subject|0|||
130182818|NCT01894919|468626921|FG004|Overall Study|Withdrawal by Subject|1|||
130182819|NCT01894919|468626922|FG005|Overall Study|Withdrawal by Subject|0|||
130182820|NCT01894919|468626923|FG006|Overall Study|Withdrawal by Subject|0|||
130182821|NCT01894919|468626924|FG007|Overall Study|Withdrawal by Subject|0|||
130182822|NCT01894919|468626925|FG008|Overall Study|Withdrawal by Subject|0|||
130182823|NCT01894919|468626926|FG009|Overall Study|Withdrawal by Subject|1|||
130182824|NCT01894919|468626927|FG010|Overall Study|Withdrawal by Subject|1|||
130182825|NCT01894919|468626928|FG011|Overall Study|Withdrawal by Subject|0|||
130182826|NCT01894919|468626929|FG012|Overall Study|Withdrawal by Subject|0|||
130182827|NCT01894919|468626917|FG000|Overall Study|Adverse Event|0|||
130182828|NCT01894919|468626918|FG001|Overall Study|Adverse Event|0|||
130182829|NCT01894919|468626919|FG002|Overall Study|Adverse Event|0|||
130182830|NCT01894919|468626920|FG003|Overall Study|Adverse Event|0|||
130182831|NCT01894919|468626921|FG004|Overall Study|Adverse Event|0|||
130182832|NCT01894919|468626922|FG005|Overall Study|Adverse Event|0|||
130182833|NCT01894919|468626923|FG006|Overall Study|Adverse Event|0|||
130182834|NCT01894919|468626924|FG007|Overall Study|Adverse Event|0|||
130182835|NCT01894919|468626925|FG008|Overall Study|Adverse Event|0|||
130182836|NCT01894919|468626926|FG009|Overall Study|Adverse Event|0|||
130182837|NCT01894919|468626927|FG010|Overall Study|Adverse Event|1|||
130182838|NCT01894919|468626928|FG011|Overall Study|Adverse Event|0|||
130182839|NCT01894919|468626929|FG012|Overall Study|Adverse Event|0|||
130182840|NCT01894919|468626917|FG000|Overall Study|Other-Unspecified|1|||
130182841|NCT01894919|468626918|FG001|Overall Study|Other-Unspecified|0|||
130182842|NCT01894919|468626919|FG002|Overall Study|Other-Unspecified|0|||
130182843|NCT01894919|468626920|FG003|Overall Study|Other-Unspecified|0|||
130182844|NCT01894919|468626921|FG004|Overall Study|Other-Unspecified|0|||
130182845|NCT01894919|468626922|FG005|Overall Study|Other-Unspecified|0|||
130182846|NCT01894919|468626923|FG006|Overall Study|Other-Unspecified|0|||
130182847|NCT01894919|468626924|FG007|Overall Study|Other-Unspecified|0|||
130182848|NCT01894919|468626925|FG008|Overall Study|Other-Unspecified|0|||
130182849|NCT01894919|468626926|FG009|Overall Study|Other-Unspecified|0|||
130182850|NCT01894919|468626927|FG010|Overall Study|Other-Unspecified|0|||
130182851|NCT01894919|468626928|FG011|Overall Study|Other-Unspecified|0|||
130182852|NCT01894919|468626929|FG012|Overall Study|Other-Unspecified|0|||
130182853|NCT01894919|468626917|FG000|Overall Study|Lost to Follow-up|0|||
130182854|NCT01894919|468626918|FG001|Overall Study|Lost to Follow-up|0|||
130182855|NCT01894919|468626919|FG002|Overall Study|Lost to Follow-up|0|||
130182856|NCT01894919|468626920|FG003|Overall Study|Lost to Follow-up|0|||
130182857|NCT01894919|468626921|FG004|Overall Study|Lost to Follow-up|2|||
130182858|NCT01894919|468626922|FG005|Overall Study|Lost to Follow-up|0|||
130182859|NCT01894919|468626923|FG006|Overall Study|Lost to Follow-up|0|||
130182860|NCT01894919|468626924|FG007|Overall Study|Lost to Follow-up|0|||
130182861|NCT01894919|468626925|FG008|Overall Study|Lost to Follow-up|0|||
130182862|NCT01894919|468626926|FG009|Overall Study|Lost to Follow-up|0|||
130182863|NCT01894919|468626927|FG010|Overall Study|Lost to Follow-up|0|||
130182864|NCT01894919|468626928|FG011|Overall Study|Lost to Follow-up|0|||
130182865|NCT01894919|468626929|FG012|Overall Study|Lost to Follow-up|0|||
130182866|NCT01433471|468626930|FG000|Overall Study|Withdrawal by Subject|0|||
130182867|NCT01433471|468626931|FG001|Overall Study|Withdrawal by Subject|1|||
130182868|NCT03711188|468626932|FG000|Overall Study|Disease progression|11|||
130182869|NCT03711188|468626932|FG000|Overall Study|Adverse Event|1|||
130182870|NCT03743051|468626937|FG000|Overall Study|Adverse Event|5|||
130182871|NCT03743051|468626938|FG001|Overall Study|Adverse Event|9|||
130182872|NCT03743051|468626937|FG000|Overall Study|Death|27|||
130182873|NCT03743051|468626938|FG001|Overall Study|Death|26|||
130182874|NCT03743051|468626937|FG000|Overall Study|Lost to Follow-up|4|||
130182875|NCT03743051|468626938|FG001|Overall Study|Lost to Follow-up|8|||
130182876|NCT03743051|468626937|FG000|Overall Study|Withdrawal by Subject|32|||
130182877|NCT03743051|468626938|FG001|Overall Study|Withdrawal by Subject|19|||
130182878|NCT03743051|468626937|FG000|Overall Study|Physician Decision|10|||
130182879|NCT03743051|468626938|FG001|Overall Study|Physician Decision|15|||
130182880|NCT03743051|468626937|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
130182881|NCT03743051|468626938|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130182882|NCT00711087|468626941|FG000|Overall Study|Lost to Follow-up|1|||
130182883|NCT00711087|468626942|FG001|Overall Study|Lost to Follow-up|0|||
130182884|NCT00811733|468626943|FG000|Overall Study|Investigator Discretion|10|||
130182885|NCT00811733|468626944|FG001|Overall Study|Investigator Discretion|8|||
130182886|NCT00811733|468626943|FG000|Overall Study|Withdrawal by Subject|1|||
130182887|NCT00811733|468626944|FG001|Overall Study|Withdrawal by Subject|2|||
130182888|NCT00793871|468626945|FG000|Overall Study|Death|50|||
130182889|NCT00793871|468626945|FG000|Overall Study|Lost to Follow-up|3|||
130182890|NCT00793871|468626945|FG000|Overall Study|Study terminated by the Sponsor|7|||
130182891|NCT02500589|468626946|FG000|Overall Study|Withdrawal by Subject|11|||
130182892|NCT02500589|468626947|FG001|Overall Study|Withdrawal by Subject|14|||
130182893|NCT02500589|468626946|FG000|Overall Study|Lost to Follow-up|10|||
130182894|NCT02500589|468626947|FG001|Overall Study|Lost to Follow-up|12|||
130182895|NCT02500589|468626946|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
130182896|NCT02500589|468626947|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
130182897|NCT02500589|468626946|FG000|Overall Study|Death|7|||
130182898|NCT02500589|468626947|FG001|Overall Study|Death|5|||
130182899|NCT01113892|468626954|FG000|Overall Study|Lost to Follow-up|2|||
130182900|NCT01113892|468626955|FG001|Overall Study|Lost to Follow-up|2|||
130182901|NCT01113892|468626954|FG000|Overall Study|Withdrawal by Subject|1|||
130182902|NCT01113892|468626955|FG001|Overall Study|Withdrawal by Subject|1|||
130182903|NCT01113892|468626954|FG000|Overall Study|Death|2|||
130182904|NCT01113892|468626955|FG001|Overall Study|Death|4|||
130182905|NCT01113892|468626954|FG000|Overall Study|Graft no longer evaluable|9|||
130182906|NCT01113892|468626955|FG001|Overall Study|Graft no longer evaluable|9|||
130182907|NCT02569801|468626956|FG000|Overall Study|Withdrawal by Subject|9|||
130182908|NCT02569801|468626957|FG001|Overall Study|Withdrawal by Subject|9|||
130182909|NCT02569801|468626956|FG000|Overall Study|Sponsor Decision|13|||
130182910|NCT02569801|468626957|FG001|Overall Study|Sponsor Decision|14|||
130182911|NCT02569801|468626956|FG000|Overall Study|Progressive Disease|2|||
130182912|NCT02569801|468626957|FG001|Overall Study|Progressive Disease|7|||
130182913|NCT02569801|468626956|FG000|Overall Study|Lost to Follow-up|0|||
130182914|NCT02569801|468626957|FG001|Overall Study|Lost to Follow-up|1|||
130182915|NCT02569801|468626956|FG000|Overall Study|Death|12|||
130182916|NCT02569801|468626957|FG001|Overall Study|Death|4|||
130182917|NCT00428246|468626958|FG000|Overall Study|Withdrawal by Subject|0|||
130182918|NCT00428246|468626959|FG001|Overall Study|Withdrawal by Subject|0|||
130182919|NCT00428246|468626960|FG002|Overall Study|Withdrawal by Subject|1|||
130182920|NCT00428246|468626958|FG000|Overall Study|Adverse Event|1|||
130182921|NCT00428246|468626959|FG001|Overall Study|Adverse Event|0|||
130182922|NCT00428246|468626960|FG002|Overall Study|Adverse Event|0|||
130182923|NCT03442751|468626962|FG000|Overall Study|Withdrawal by Subject|3|||
130182924|NCT03442751|468626963|FG001|Overall Study|Withdrawal by Subject|1|||
130182925|NCT03442751|468626962|FG000|Overall Study|Lost to Follow-up|3|||
130182926|NCT03442751|468626963|FG001|Overall Study|Lost to Follow-up|0|||
130182927|NCT02603887|468626964|FG000|Stage 1|Adverse Event|4|||
130182928|NCT02603887|468626964|FG000|Stage 1|Disease progression|1|||
130182929|NCT02603887|468626964|FG000|Stage 2|FDA guidance|1|||
130182930|NCT00470470|468626970|FG000|Overall Study|Adverse Event|2|||
130182931|NCT00470470|468626970|FG000|Overall Study|Death|2|||
130182932|NCT00470470|468626970|FG000|Overall Study|Not treated|1|||
130182933|NCT02452476|468626977|FG000|Overall Study|Death|4|||
130182934|NCT02452476|468626978|FG001|Overall Study|Death|7|||
130182935|NCT02452476|468626977|FG000|Overall Study|Lost to Follow-up|1|||
130182936|NCT02452476|468626978|FG001|Overall Study|Lost to Follow-up|1|||
130182937|NCT02452476|468626977|FG000|Overall Study|Physician Decision|1|||
130182938|NCT02452476|468626978|FG001|Overall Study|Physician Decision|1|||
130182939|NCT02452476|468626977|FG000|Overall Study|Not treated|5|||
130182940|NCT02452476|468626978|FG001|Overall Study|Not treated|1|||
130182941|NCT03552380|468626979|FG000|Study Treatment|Disease Progression|3|||
130182942|NCT03552380|468626980|FG001|Study Treatment|Disease Progression|4|||
130182943|NCT03552380|468626979|FG000|Study Treatment|Adverse Event|2|||
130182944|NCT03552380|468626980|FG001|Study Treatment|Adverse Event|2|||
130182945|NCT03552380|468626979|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130182946|NCT03552380|468626980|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130182947|NCT03552380|468626979|FG000|Follow up|Death|3|||
130182948|NCT03552380|468626980|FG001|Follow up|Death|4|||
130182949|NCT03552380|468626979|FG000|Follow up|Site IRB terminated|0|||
130182950|NCT03552380|468626980|FG001|Follow up|Site IRB terminated|1|||
130182951|NCT02072980|468626981|FG000|Period 2, Second Wear|Adverse Event|0|||
130182952|NCT02072980|468626982|FG001|Period 2, Second Wear|Adverse Event|1|||
130182953|NCT01757275|468626983|FG000|Overall Study|Lost to Follow-up|1|||
130182954|NCT01757275|468626984|FG001|Overall Study|Lost to Follow-up|2|||
130182955|NCT01757275|468626983|FG000|Overall Study|Adverse Event|3|||
130182956|NCT01757275|468626984|FG001|Overall Study|Adverse Event|3|||
130182957|NCT01757275|468626983|FG000|Overall Study|Withdrawal by Subject|2|||
130182958|NCT01757275|468626984|FG001|Overall Study|Withdrawal by Subject|4|||
130182959|NCT01757275|468626983|FG000|Overall Study|Not treated|3|||
130182960|NCT01757275|468626984|FG001|Overall Study|Not treated|4|||
130182961|NCT01401452|468626987|FG000|Overall Study|Adverse reaction|9|||
130182962|NCT01401452|468626987|FG000|Overall Study|Lost to Follow-up|12|||
130182963|NCT01401452|468626987|FG000|Overall Study|Lack of Efficacy|30|||
130182964|NCT01401452|468626987|FG000|Overall Study|Participant developed breast cancer|1|||
130182965|NCT01401452|468626987|FG000|Overall Study|Tx stopped due to financial reasons|1|||
130182966|NCT01401452|468626987|FG000|Overall Study|Tx stopped by psychiatrist|1|||
130182967|NCT01401452|468626987|FG000|Overall Study|No more visits within the 36 wk followup|4|||
130182968|NCT01401452|468626987|FG000|Overall Study|Subject did not come to follow up visits|2|||
130182969|NCT01401452|468626987|FG000|Overall Study|Subject didn't return for routine visits|1|||
130182970|NCT01401452|468626987|FG000|Overall Study|Subject moved to another city|1|||
130182971|NCT01401452|468626987|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
130182972|NCT01401452|468626987|FG000|Overall Study|Psoriatic arthritis|1|||
130182973|NCT01401452|468626987|FG000|Overall Study|Participant stopped Tx|2|||
130182974|NCT01401452|468626987|FG000|Overall Study|Discontinuation for personal reasons|1|||
130182975|NCT01401452|468626987|FG000|Overall Study|Treatment failure|1|||
130182976|NCT01401452|468626987|FG000|Overall Study|Unsatisfactory output|1|||
130182977|NCT01401452|468626987|FG000|Overall Study|Subject withdrew because of Tx success|1|||
130182978|NCT01401452|468626987|FG000|Overall Study|Subject chose to discontinue treatment|1|||
130182979|NCT01401452|468626987|FG000|Overall Study|Participant withdrew consent|1|||
130182980|NCT02601014|468626988|FG000|Overall Study|Adverse Event|3|||
130182981|NCT02601014|468626989|FG001|Overall Study|Adverse Event|3|||
130182982|NCT02601014|468626988|FG000|Overall Study|Death|3|||
130182983|NCT02601014|468626989|FG001|Overall Study|Death|1|||
130182984|NCT02601014|468626988|FG000|Overall Study|Disease progression|4|||
130182985|NCT02601014|468626989|FG001|Overall Study|Disease progression|8|||
130182986|NCT01168427|468626990|FG000|Overall Study|Patient exited prior to implant|1|||
130182987|NCT01133067|468626995|FG000|Overall Study|Death|136|||
130182988|NCT01133067|468626995|FG000|Overall Study|Lost to Follow-up|3|||
130182989|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130182990|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130182991|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130182992|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130182993|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130182994|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130182995|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182996|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182997|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182998|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Other|1|||
130182999|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Other|0|||
130183000|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Other|4|||
130183001|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130183002|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130183003|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
130183004|NCT00420420|468627000|FG000|Overall Study|Adverse Event|5|||
130183005|NCT00420420|468627001|FG001|Overall Study|Adverse Event|3|||
130183006|NCT00420420|468627000|FG000|Overall Study|Protocol Violation|1|||
130183007|NCT00420420|468627001|FG001|Overall Study|Protocol Violation|1|||
130183008|NCT00420420|468627000|FG000|Overall Study|Withdrawal by Subject|1|||
130183009|NCT00420420|468627001|FG001|Overall Study|Withdrawal by Subject|0|||
130183010|NCT00420420|468627000|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
130183011|NCT00420420|468627001|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
130183012|NCT00273182|468627002|FG000|Overall Study|Death|450|||
130183013|NCT00273182|468627002|FG000|Overall Study|Lost to Follow-up|88|||
130183014|NCT00273182|468627002|FG000|Overall Study|Withdrawal by Subject|257|||
130183015|NCT00273182|468627002|FG000|Overall Study|Device/System Explant|154|||
130183016|NCT00273182|468627002|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
130183017|NCT03641469|468627003|FG000|Overall Study|Ineligible|2|||
130183018|NCT03641469|468627003|FG000|Overall Study|Withdrawal by Subject|5|||
130183019|NCT03641469|468627003|FG000|Overall Study|Physician Decision|1|||
130183020|NCT03641469|468627003|FG000|Overall Study|Protocol Violation|1|||
130183021|NCT03641469|468627003|FG000|Overall Study|Lost to Follow-up|2|||
130183022|NCT00868530|468627004|FG000|Overall Study|Adverse Event|3|||
130183023|NCT00868530|468627004|FG000|Overall Study|Lost to Follow-up|1|||
130183024|NCT00858273|468627005|FG000|Overall Study|Protocol Violation|3|||
130183025|NCT00858273|468627006|FG001|Overall Study|Protocol Violation|5|||
130183026|NCT04199104|468628905|FG000|Overall Study|Death|148|||
130183027|NCT04199104|468628906|FG001|Overall Study|Death|134|||
130183028|NCT04199104|468628905|FG000|Overall Study|Lost to Follow-up|1|||
130183029|NCT04199104|468628906|FG001|Overall Study|Lost to Follow-up|1|||
130183030|NCT04199104|468628905|FG000|Overall Study|Withdrawal by Subject|4|||
130183031|NCT04199104|468628906|FG001|Overall Study|Withdrawal by Subject|4|||
130183032|NCT04199104|468628905|FG000|Overall Study|Participants Ongoing|103|||
130183033|NCT04199104|468628906|FG001|Overall Study|Participants Ongoing|116|||
130183034|NCT02562235|468628909|FG000|Overall Study|Adverse Event|3|||
130183035|NCT05655546|468628912|FG000|Overall Study|Withdrawal by Subject|2|||
130183036|NCT05655546|468628913|FG001|Overall Study|Withdrawal by Subject|4|||
130183037|NCT01168232|468628914|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
130183038|NCT01168232|468628914|FG000|Overall Study|Ineligible- Wrong cell type|6|||
130183039|NCT01168232|468628914|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
130183040|NCT04576507|468628918|FG000|Overall Study|Adverse Event|4|||
130183041|NCT04576507|468628918|FG000|Overall Study|Withdrawal by Subject|1|||
130183042|NCT05012098|468628923|FG000|Overall Study|Disease progression|5|||
130183043|NCT05012098|468628924|FG001|Overall Study|Disease progression|2|||
130183044|NCT05012098|468628923|FG000|Overall Study|Adverse Event|1|||
130183045|NCT05012098|468628924|FG001|Overall Study|Adverse Event|0|||
130183046|NCT05012098|468628923|FG000|Overall Study|Withdrawal by Subject|1|||
130183047|NCT05012098|468628924|FG001|Overall Study|Withdrawal by Subject|0|||
130183048|NCT05012098|468628923|FG000|Overall Study|Discontinuation per protocol|1|||
130183049|NCT05012098|468628924|FG001|Overall Study|Discontinuation per protocol|0|||
130183050|NCT01490086|468628925|FG000|Overall Study|Consent withdrawn|4|||
130183051|NCT01490086|468628926|FG001|Overall Study|Consent withdrawn|4|||
130183052|NCT01490086|468628927|FG002|Overall Study|Consent withdrawn|3|||
130183053|NCT01490086|468628928|FG003|Overall Study|Consent withdrawn|0|||
130183054|NCT01490086|468628929|FG004|Overall Study|Consent withdrawn|1|||
130183055|NCT01490086|468628925|FG000|Overall Study|Non-compliance|0|||
130183056|NCT01490086|468628926|FG001|Overall Study|Non-compliance|1|||
130183057|NCT01490086|468628927|FG002|Overall Study|Non-compliance|0|||
130183058|NCT01490086|468628928|FG003|Overall Study|Non-compliance|0|||
130183059|NCT01490086|468628929|FG004|Overall Study|Non-compliance|0|||
130183060|NCT01490086|468628925|FG000|Overall Study|Abnormal laboratory findings|1|||
130183061|NCT01490086|468628926|FG001|Overall Study|Abnormal laboratory findings|0|||
130183062|NCT01490086|468628927|FG002|Overall Study|Abnormal laboratory findings|0|||
130183063|NCT01490086|468628928|FG003|Overall Study|Abnormal laboratory findings|0|||
130183064|NCT01490086|468628929|FG004|Overall Study|Abnormal laboratory findings|0|||
130183065|NCT01490086|468628925|FG000|Overall Study|Lost to Follow-up|0|||
130183066|NCT01490086|468628926|FG001|Overall Study|Lost to Follow-up|0|||
130183067|NCT01490086|468628927|FG002|Overall Study|Lost to Follow-up|0|||
130183068|NCT01490086|468628928|FG003|Overall Study|Lost to Follow-up|0|||
130183069|NCT01490086|468628929|FG004|Overall Study|Lost to Follow-up|1|||
130183070|NCT01490086|468628925|FG000|Overall Study|Physician Decision|3|||
130183071|NCT01490086|468628926|FG001|Overall Study|Physician Decision|4|||
130183072|NCT01490086|468628927|FG002|Overall Study|Physician Decision|2|||
130183073|NCT01490086|468628928|FG003|Overall Study|Physician Decision|3|||
130183074|NCT01490086|468628929|FG004|Overall Study|Physician Decision|1|||
130183075|NCT01490086|468628925|FG000|Overall Study|Adverse Event|0|||
130183076|NCT01490086|468628926|FG001|Overall Study|Adverse Event|0|||
130183077|NCT01490086|468628927|FG002|Overall Study|Adverse Event|1|||
130183078|NCT01490086|468628928|FG003|Overall Study|Adverse Event|2|||
130183079|NCT01490086|468628929|FG004|Overall Study|Adverse Event|0|||
130183080|NCT01490086|468628925|FG000|Overall Study|Lack of Efficacy|0|||
130183081|NCT01490086|468628926|FG001|Overall Study|Lack of Efficacy|3|||
130183082|NCT01490086|468628927|FG002|Overall Study|Lack of Efficacy|1|||
130183083|NCT01490086|468628928|FG003|Overall Study|Lack of Efficacy|0|||
130183084|NCT01490086|468628929|FG004|Overall Study|Lack of Efficacy|8|||
130183085|NCT01490086|468628925|FG000|Overall Study|Worsening of symptoms|0|||
130183086|NCT01490086|468628926|FG001|Overall Study|Worsening of symptoms|1|||
130183087|NCT01490086|468628927|FG002|Overall Study|Worsening of symptoms|0|||
130183088|NCT01490086|468628928|FG003|Overall Study|Worsening of symptoms|1|||
130183089|NCT01490086|468628929|FG004|Overall Study|Worsening of symptoms|0|||
130183090|NCT01490086|468628925|FG000|Overall Study|Subject uncontrollable and abusive|0|||
130183091|NCT01490086|468628926|FG001|Overall Study|Subject uncontrollable and abusive|1|||
130183092|NCT01490086|468628927|FG002|Overall Study|Subject uncontrollable and abusive|0|||
130183093|NCT01490086|468628928|FG003|Overall Study|Subject uncontrollable and abusive|0|||
130183094|NCT01490086|468628929|FG004|Overall Study|Subject uncontrollable and abusive|0|||
130183095|NCT01490086|468628925|FG000|Overall Study|Subject left hospital|0|||
130183096|NCT01490086|468628926|FG001|Overall Study|Subject left hospital|1|||
130183097|NCT01490086|468628927|FG002|Overall Study|Subject left hospital|0|||
130183098|NCT01490086|468628928|FG003|Overall Study|Subject left hospital|1|||
130183099|NCT01490086|468628929|FG004|Overall Study|Subject left hospital|0|||
130183100|NCT05825404|468628930|FG000|First Intervention (Weeks 2-5)|Death|0|||
130183101|NCT05825404|468628931|FG001|First Intervention (Weeks 2-5)|Death|1|||
130183102|NCT05825404|468628930|FG000|Second Intervention (Weeks 8-11)|Death|0|||
130183103|NCT05825404|468628931|FG001|Second Intervention (Weeks 8-11)|Death|1|||
130183104|NCT02157935|468628932|FG000|Overall Study|Withdrawal by Subject|25|||
130183105|NCT02157935|468628933|FG001|Overall Study|Withdrawal by Subject|39|||
130183106|NCT02157935|468628932|FG000|Overall Study|Screen failure|1|||
130183107|NCT02157935|468628933|FG001|Overall Study|Screen failure|2|||
130183108|NCT02157935|468628932|FG000|Overall Study|Protocol Violation|1|||
130183109|NCT02157935|468628933|FG001|Overall Study|Protocol Violation|0|||
130183110|NCT02157935|468628932|FG000|Overall Study|Progressive disease|0|||
130183111|NCT02157935|468628933|FG001|Overall Study|Progressive disease|2|||
130183112|NCT02157935|468628932|FG000|Overall Study|Other|5|||
130183113|NCT02157935|468628933|FG001|Overall Study|Other|12|||
130183114|NCT02157935|468628932|FG000|Overall Study|Lack of Efficacy|0|||
130183115|NCT02157935|468628933|FG001|Overall Study|Lack of Efficacy|1|||
130183116|NCT02157935|468628932|FG000|Overall Study|Death|4|||
130183117|NCT02157935|468628933|FG001|Overall Study|Death|4|||
130183118|NCT02157935|468628932|FG000|Overall Study|Adverse Event|3|||
130183119|NCT02157935|468628933|FG001|Overall Study|Adverse Event|5|||
130183120|NCT01103180|468628942|FG000|Overall Study|Withdrawal by Subject|8|||
130183121|NCT01103180|468628943|FG001|Overall Study|Withdrawal by Subject|13|||
130183122|NCT01103180|468628942|FG000|Overall Study|Lost to Follow-up|13|||
130183123|NCT01103180|468628943|FG001|Overall Study|Lost to Follow-up|7|||
130183124|NCT01103180|468628942|FG000|Overall Study|Physician Decision|1|||
130183125|NCT01103180|468628943|FG001|Overall Study|Physician Decision|0|||
130183126|NCT01103180|468628942|FG000|Overall Study|Protocol Violation|0|||
130183127|NCT01103180|468628943|FG001|Overall Study|Protocol Violation|1|||
130183128|NCT02493660|468628944|FG000|Overall Study|Physician Decision|0|||
130183129|NCT02493660|468628945|FG001|Overall Study|Physician Decision|1|||
130183130|NCT02493660|468628944|FG000|Overall Study|Adverse Event|4|||
130183131|NCT02493660|468628945|FG001|Overall Study|Adverse Event|2|||
130183132|NCT02493660|468628944|FG000|Overall Study|Withdrawal by Subject|2|||
130183133|NCT02493660|468628945|FG001|Overall Study|Withdrawal by Subject|3|||
130183134|NCT02493660|468628944|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
130183135|NCT02493660|468628945|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
130183136|NCT02493660|468628944|FG000|Overall Study|Protocol Violation|0|||
130183137|NCT02493660|468628945|FG001|Overall Study|Protocol Violation|1|||
130183138|NCT02493660|468628944|FG000|Overall Study|Death|0|||
130183139|NCT02493660|468628945|FG001|Overall Study|Death|1|||
130183140|NCT02493660|468628944|FG000|Overall Study|Lost to Follow-up|2|||
130183141|NCT02493660|468628945|FG001|Overall Study|Lost to Follow-up|4|||
130183142|NCT02392481|468628949|FG000|Overall Study|Adverse Event|0|||
130183143|NCT02392481|468628950|FG001|Overall Study|Adverse Event|0|||
130183144|NCT02392481|468628951|FG002|Overall Study|Adverse Event|1|||
130183145|NCT02392481|468628952|FG003|Overall Study|Adverse Event|2|||
130183146|NCT02392481|468628949|FG000|Overall Study|Withdrawal by Subject|0|||
130183147|NCT02392481|468628950|FG001|Overall Study|Withdrawal by Subject|0|||
130183148|NCT02392481|468628951|FG002|Overall Study|Withdrawal by Subject|1|||
130183149|NCT02392481|468628952|FG003|Overall Study|Withdrawal by Subject|0|||
130183150|NCT02502149|468628954|FG000|Intermediate|Discontinued prematurely|1|||
130183151|NCT02502149|468628955|FG001|Intermediate|Discontinued prematurely|0|||
130183152|NCT02502149|468628956|FG002|Intermediate|Discontinued prematurely|0|||
130183153|NCT02502149|468628957|FG003|Intermediate|Discontinued prematurely|0|||
130183154|NCT02502149|468628958|FG004|Intermediate|Discontinued prematurely|0|||
130183155|NCT02968576|468628959|FG000|Overall Study|Pregnancy|0|||
130183156|NCT02968576|468628960|FG001|Overall Study|Pregnancy|1|||
130183157|NCT02222922|468628961|FG000|Overall Study|Death|0|||
130183158|NCT02222922|468628962|FG001|Overall Study|Death|0|||
130183159|NCT02222922|468628963|FG002|Overall Study|Death|0|||
130183160|NCT02222922|468628964|FG003|Overall Study|Death|0|||
130183161|NCT02222922|468628965|FG004|Overall Study|Death|13|||
130183162|NCT02222922|468628966|FG005|Overall Study|Death|0|||
130183163|NCT02222922|468628967|FG006|Overall Study|Death|0|||
130183164|NCT02222922|468628968|FG007|Overall Study|Death|0|||
130183165|NCT02222922|468628969|FG008|Overall Study|Death|2|||
130183166|NCT02222922|468628961|FG000|Overall Study|Lost to Follow-up|0|||
130183167|NCT02222922|468628962|FG001|Overall Study|Lost to Follow-up|0|||
130183168|NCT02222922|468628963|FG002|Overall Study|Lost to Follow-up|1|||
130183169|NCT02222922|468628964|FG003|Overall Study|Lost to Follow-up|0|||
130183170|NCT02222922|468628965|FG004|Overall Study|Lost to Follow-up|9|||
130183171|NCT02222922|468628966|FG005|Overall Study|Lost to Follow-up|1|||
130183172|NCT02222922|468628967|FG006|Overall Study|Lost to Follow-up|0|||
130183173|NCT02222922|468628968|FG007|Overall Study|Lost to Follow-up|0|||
130183174|NCT02222922|468628969|FG008|Overall Study|Lost to Follow-up|0|||
130183175|NCT02222922|468628961|FG000|Overall Study|Other|0|||
130183176|NCT02222922|468628962|FG001|Overall Study|Other|0|||
130183177|NCT02222922|468628963|FG002|Overall Study|Other|0|||
130183178|NCT02222922|468628964|FG003|Overall Study|Other|2|||
130183179|NCT02222922|468628965|FG004|Overall Study|Other|10|||
130183180|NCT02222922|468628966|FG005|Overall Study|Other|2|||
130183181|NCT02222922|468628967|FG006|Overall Study|Other|2|||
130183182|NCT02222922|468628968|FG007|Overall Study|Other|4|||
130183183|NCT02222922|468628969|FG008|Overall Study|Other|1|||
130183184|NCT02222922|468628961|FG000|Overall Study|Participant refused further follow-up|1|||
130183185|NCT02222922|468628962|FG001|Overall Study|Participant refused further follow-up|0|||
130183186|NCT02222922|468628963|FG002|Overall Study|Participant refused further follow-up|0|||
130183187|NCT02222922|468628964|FG003|Overall Study|Participant refused further follow-up|1|||
130183188|NCT02222922|468628965|FG004|Overall Study|Participant refused further follow-up|6|||
130183189|NCT02222922|468628966|FG005|Overall Study|Participant refused further follow-up|0|||
130183190|NCT02222922|468628967|FG006|Overall Study|Participant refused further follow-up|0|||
130183191|NCT02222922|468628968|FG007|Overall Study|Participant refused further follow-up|0|||
130183192|NCT02222922|468628969|FG008|Overall Study|Participant refused further follow-up|3|||
130183193|NCT01254643|468628970|FG000|Overall Study|Withdrawal by Subject|1|||
130183194|NCT00116779|468628976|FG000|Overall Study|Adverse Event|4|||
130183195|NCT00116779|468628977|FG001|Overall Study|Adverse Event|2|||
130183196|NCT00116779|468628976|FG000|Overall Study|Protocol Violation|1|||
130183197|NCT00116779|468628977|FG001|Overall Study|Protocol Violation|4|||
130183198|NCT00116779|468628976|FG000|Overall Study|Withdrawal by Subject|4|||
130183199|NCT00116779|468628977|FG001|Overall Study|Withdrawal by Subject|1|||
130183200|NCT00116779|468628976|FG000|Overall Study|Inadequate testosterone suppression|7|||
130183201|NCT00116779|468628977|FG001|Overall Study|Inadequate testosterone suppression|9|||
130183202|NCT00116779|468628976|FG000|Overall Study|Physician Decision|3|||
130183203|NCT00116779|468628977|FG001|Overall Study|Physician Decision|1|||
130183204|NCT00116779|468628976|FG000|Overall Study|Elevated PSA levels|2|||
130183205|NCT00116779|468628977|FG001|Overall Study|Elevated PSA levels|2|||
130183206|NCT01037218|468628982|FG000|Overall Study|Adverse Event|4|||
130183207|NCT01037218|468628983|FG001|Overall Study|Adverse Event|2|||
130183208|NCT01037218|468628984|FG002|Overall Study|Adverse Event|2|||
130183209|NCT01037218|468628985|FG003|Overall Study|Adverse Event|1|||
130183210|NCT01037218|468628982|FG000|Overall Study|Lack of Efficacy|0|||
130183211|NCT01037218|468628983|FG001|Overall Study|Lack of Efficacy|2|||
130183212|NCT01037218|468628984|FG002|Overall Study|Lack of Efficacy|1|||
130183213|NCT01037218|468628985|FG003|Overall Study|Lack of Efficacy|5|||
130183214|NCT01037218|468628982|FG000|Overall Study|Lost to Follow-up|3|||
130183215|NCT01037218|468628983|FG001|Overall Study|Lost to Follow-up|5|||
130183216|NCT01037218|468628984|FG002|Overall Study|Lost to Follow-up|4|||
130183217|NCT01037218|468628985|FG003|Overall Study|Lost to Follow-up|2|||
130183218|NCT01037218|468628982|FG000|Overall Study|Withdrawal by Subject|6|||
130183219|NCT01037218|468628983|FG001|Overall Study|Withdrawal by Subject|7|||
130183220|NCT01037218|468628984|FG002|Overall Study|Withdrawal by Subject|7|||
130183221|NCT01037218|468628985|FG003|Overall Study|Withdrawal by Subject|4|||
130183222|NCT01037218|468628982|FG000|Overall Study|Partner Withdrew Consent|0|||
130183223|NCT01037218|468628983|FG001|Overall Study|Partner Withdrew Consent|3|||
130183224|NCT01037218|468628984|FG002|Overall Study|Partner Withdrew Consent|2|||
130183225|NCT01037218|468628985|FG003|Overall Study|Partner Withdrew Consent|1|||
130183226|NCT01037218|468628982|FG000|Overall Study|Protocol Violation|0|||
130183227|NCT01037218|468628983|FG001|Overall Study|Protocol Violation|0|||
130183228|NCT01037218|468628984|FG002|Overall Study|Protocol Violation|2|||
130183229|NCT01037218|468628985|FG003|Overall Study|Protocol Violation|2|||
130183230|NCT01037218|468628982|FG000|Overall Study|Various|3|||
130183231|NCT01037218|468628983|FG001|Overall Study|Various|2|||
130183232|NCT01037218|468628984|FG002|Overall Study|Various|3|||
130183233|NCT01037218|468628985|FG003|Overall Study|Various|1|||
130183234|NCT01651117|468628989|FG000|Overall Study|Death|2|||
130183235|NCT01651117|468628990|FG001|Overall Study|Death|3|||
130183236|NCT01651117|468628991|FG002|Overall Study|Death|2|||
130183237|NCT01651117|468628992|FG003|Overall Study|Death|2|||
130183238|NCT02714218|468628995|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130183239|NCT02714218|468628996|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130183240|NCT02714218|468628997|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130183241|NCT02714218|468628995|FG000|Pre-Treatment Period|Other reasons|0|||
130183242|NCT02714218|468628996|FG001|Pre-Treatment Period|Other reasons|1|||
130183243|NCT02714218|468628997|FG002|Pre-Treatment Period|Other reasons|0|||
130183244|NCT02714218|468628995|FG000|Treatment Period|Disease Progression|55|||
130183245|NCT02714218|468628996|FG001|Treatment Period|Disease Progression|52|||
130183246|NCT02714218|468628997|FG002|Treatment Period|Disease Progression|14|||
130183247|NCT02714218|468628995|FG000|Treatment Period|Study drug toxicity|46|||
130183248|NCT02714218|468628996|FG001|Treatment Period|Study drug toxicity|70|||
130183249|NCT02714218|468628997|FG002|Treatment Period|Study drug toxicity|6|||
130183250|NCT02714218|468628995|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130183251|NCT02714218|468628996|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
130183252|NCT02714218|468628997|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
130183253|NCT02714218|468628995|FG000|Treatment Period|Request to discontinue treatment|1|||
130183254|NCT02714218|468628996|FG001|Treatment Period|Request to discontinue treatment|4|||
130183255|NCT02714218|468628997|FG002|Treatment Period|Request to discontinue treatment|1|||
130183256|NCT02714218|468628995|FG000|Treatment Period|Participant withdrew consent|2|||
130183257|NCT02714218|468628996|FG001|Treatment Period|Participant withdrew consent|2|||
130183258|NCT02714218|468628997|FG002|Treatment Period|Participant withdrew consent|0|||
130183259|NCT02714218|468628995|FG000|Treatment Period|Maximum clinical benefit|4|||
130183260|NCT02714218|468628996|FG001|Treatment Period|Maximum clinical benefit|2|||
130183261|NCT02714218|468628997|FG002|Treatment Period|Maximum clinical benefit|0|||
130183262|NCT02714218|468628995|FG000|Treatment Period|Administrative reason by sponsor|2|||
130183263|NCT02714218|468628996|FG001|Treatment Period|Administrative reason by sponsor|1|||
130183264|NCT02714218|468628997|FG002|Treatment Period|Administrative reason by sponsor|0|||
130183265|NCT02714218|468628995|FG000|Treatment Period|Other reasons|6|||
130183266|NCT02714218|468628996|FG001|Treatment Period|Other reasons|6|||
130183267|NCT02714218|468628997|FG002|Treatment Period|Other reasons|0|||
130183268|NCT02714218|468628995|FG000|Treatment Period|Completed treatment as per protocol|36|||
130183269|NCT02714218|468628996|FG001|Treatment Period|Completed treatment as per protocol|27|||
130183270|NCT02714218|468628997|FG002|Treatment Period|Completed treatment as per protocol|3|||
130183271|NCT02714218|468628995|FG000|Treatment Period|Not reported|9|||
130183272|NCT02714218|468628996|FG001|Treatment Period|Not reported|6|||
130183273|NCT02714218|468628997|FG002|Treatment Period|Not reported|0|||
130183274|NCT01199939|468629001|FG000|Overall Study|Adverse Event|4|||
130183275|NCT01199939|468629001|FG000|Overall Study|Protocol Violation|3|||
130183276|NCT01199939|468629001|FG000|Overall Study|Lost to Follow-up|2|||
130183277|NCT01199939|468629001|FG000|Overall Study|Reached a virologic endpoint|4|||
130183278|NCT03238651|468629004|FG000|Overall Study|Other|0|||
130183279|NCT03238651|468629005|FG001|Overall Study|Other|0|||
130183280|NCT03238651|468629006|FG002|Overall Study|Other|0|||
130183281|NCT03238651|468629007|FG003|Overall Study|Other|0|||
130183282|NCT03238651|468629008|FG004|Overall Study|Other|1|||
130183283|NCT03238651|468629004|FG000|Overall Study|Progressive Disease|2|||
130183284|NCT03238651|468629005|FG001|Overall Study|Progressive Disease|2|||
130183285|NCT03238651|468629006|FG002|Overall Study|Progressive Disease|2|||
130183286|NCT03238651|468629007|FG003|Overall Study|Progressive Disease|2|||
130183287|NCT03238651|468629008|FG004|Overall Study|Progressive Disease|0|||
130183288|NCT03238651|468629004|FG000|Overall Study|Withdrawal by Subject|0|||
130183289|NCT03238651|468629005|FG001|Overall Study|Withdrawal by Subject|1|||
130183290|NCT03238651|468629006|FG002|Overall Study|Withdrawal by Subject|0|||
130183291|NCT03238651|468629007|FG003|Overall Study|Withdrawal by Subject|1|||
130183292|NCT03238651|468629008|FG004|Overall Study|Withdrawal by Subject|0|||
130183293|NCT03238651|468629004|FG000|Overall Study|Adverse Event|1|||
130183294|NCT03238651|468629005|FG001|Overall Study|Adverse Event|3|||
130183295|NCT03238651|468629006|FG002|Overall Study|Adverse Event|2|||
130183296|NCT03238651|468629007|FG003|Overall Study|Adverse Event|0|||
130183297|NCT03238651|468629008|FG004|Overall Study|Adverse Event|0|||
130183298|NCT03875508|468629009|FG000|Overall Study|Adverse Event|1|||
130183299|NCT03875508|468629009|FG000|Overall Study|Lost to Follow-up|8|||
130183300|NCT03875508|468629009|FG000|Overall Study|Lack of Efficacy|1|||
130183301|NCT03875508|468629009|FG000|Overall Study|Other, not specified|2|||
130183302|NCT03652051|468629011|FG000|Stage 1|Adverse Event|0|||
130183303|NCT03652051|468629012|FG001|Stage 1|Adverse Event|5|||
130183304|NCT03652051|468629013|FG002|Stage 1|Adverse Event|7|||
130183305|NCT03652051|468629014|FG003|Stage 1|Adverse Event|1|||
130183306|NCT03652051|468629011|FG000|Stage 1|Withdrawal by Subject|0|||
130183307|NCT03652051|468629012|FG001|Stage 1|Withdrawal by Subject|0|||
130183308|NCT03652051|468629013|FG002|Stage 1|Withdrawal by Subject|1|||
130183309|NCT03652051|468629014|FG003|Stage 1|Withdrawal by Subject|0|||
130183310|NCT03652051|468629011|FG000|Stage 2|Adverse Event|0|||
130183311|NCT03652051|468629012|FG001|Stage 2|Adverse Event|2|||
130183312|NCT03652051|468629013|FG002|Stage 2|Adverse Event|1|||
130183313|NCT03652051|468629014|FG003|Stage 2|Adverse Event|0|||
130183314|NCT03652051|468629011|FG000|Stage 2|Protocol Violation|0|||
130183315|NCT03652051|468629012|FG001|Stage 2|Protocol Violation|1|||
130183316|NCT03652051|468629013|FG002|Stage 2|Protocol Violation|6|||
130183317|NCT03652051|468629014|FG003|Stage 2|Protocol Violation|0|||
130183318|NCT03652051|468629011|FG000|Stage 2|Lost to Follow-up|0|||
130183319|NCT03652051|468629012|FG001|Stage 2|Lost to Follow-up|2|||
130183320|NCT03652051|468629013|FG002|Stage 2|Lost to Follow-up|0|||
130183321|NCT03652051|468629014|FG003|Stage 2|Lost to Follow-up|3|||
130183322|NCT03652051|468629011|FG000|Stage 2|Withdrawal by Subject|0|||
130183323|NCT03652051|468629012|FG001|Stage 2|Withdrawal by Subject|11|||
130183324|NCT03652051|468629013|FG002|Stage 2|Withdrawal by Subject|9|||
130183325|NCT03652051|468629014|FG003|Stage 2|Withdrawal by Subject|3|||
130183326|NCT02550561|468629015|FG000|Overall Study|Lost to Follow-up|5|||
130183327|NCT02550561|468629015|FG000|Overall Study|Withdrawal by Subject|1|||
130183328|NCT02394600|468629016|FG000|Overall Study|Adverse Event|3|||
130183329|NCT02394600|468629017|FG001|Overall Study|Adverse Event|0|||
130183330|NCT02394600|468629016|FG000|Overall Study|Lost to Follow-up|0|||
130183331|NCT02394600|468629017|FG001|Overall Study|Lost to Follow-up|1|||
130183332|NCT02394600|468629016|FG000|Overall Study|Withdrawal by Subject|0|||
130183333|NCT02394600|468629017|FG001|Overall Study|Withdrawal by Subject|1|||
130183334|NCT02394600|468629016|FG000|Overall Study|Protocol Violation|1|||
130183335|NCT02394600|468629017|FG001|Overall Study|Protocol Violation|0|||
130183336|NCT01686373|468629018|FG000|Overall Study|Lost to Follow-up|3|||
130183337|NCT01686373|468629019|FG001|Overall Study|Lost to Follow-up|0|||
130183338|NCT01686373|468629018|FG000|Overall Study|Withdrawal by Subject|0|||
130183339|NCT01686373|468629019|FG001|Overall Study|Withdrawal by Subject|1|||
130183340|NCT01686373|468629018|FG000|Overall Study|Adverse Event|0|||
130183341|NCT01686373|468629019|FG001|Overall Study|Adverse Event|1|||
130183342|NCT04052620|468629021|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
130183343|NCT04052620|468629022|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
130183344|NCT04052620|468629021|FG000|Overall Study|Withdrawal by Subject|1|||
130183345|NCT04052620|468629022|FG001|Overall Study|Withdrawal by Subject|0|||
130183346|NCT04052620|468629021|FG000|Overall Study|Lost to Follow-up|1|||
130183347|NCT04052620|468629022|FG001|Overall Study|Lost to Follow-up|1|||
130183348|NCT04052620|468629021|FG000|Overall Study|Adverse Event|1|||
130183349|NCT04052620|468629022|FG001|Overall Study|Adverse Event|0|||
130183350|NCT04052620|468629021|FG000|Overall Study|Subject did not meet study Criteria|0|||
130183351|NCT04052620|468629022|FG001|Overall Study|Subject did not meet study Criteria|1|||
130183352|NCT04052620|468629021|FG000|Overall Study|Screened failure, randomized by mistake|0|||
130183353|NCT04052620|468629022|FG001|Overall Study|Screened failure, randomized by mistake|1|||
130183354|NCT04052620|468629021|FG000|Overall Study|Personal reasons|2|||
130183355|NCT04052620|468629022|FG001|Overall Study|Personal reasons|4|||
130183356|NCT04052620|468629021|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
130183357|NCT04052620|468629022|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
130183358|NCT02201784|468629023|FG000|Overall Study|Failure to achieve adequate block|2|||
130183359|NCT02201784|468629024|FG001|Overall Study|Failure to achieve adequate block|0|||
130183360|NCT02431364|468629025|FG000|Overall Study|Adverse Event|0|||
130183361|NCT02431364|468629026|FG001|Overall Study|Adverse Event|1|||
130183362|NCT02431364|468629027|FG002|Overall Study|Adverse Event|0|||
130183363|NCT02431364|468629028|FG003|Overall Study|Adverse Event|0|||
130183364|NCT02431364|468629029|FG004|Overall Study|Adverse Event|0|||
130183365|NCT02431364|468629025|FG000|Overall Study|Randomized but never treated|0|||
130183366|NCT02431364|468629026|FG001|Overall Study|Randomized but never treated|0|||
130183367|NCT02431364|468629027|FG002|Overall Study|Randomized but never treated|0|||
130183368|NCT02431364|468629028|FG003|Overall Study|Randomized but never treated|1|||
130183369|NCT02431364|468629029|FG004|Overall Study|Randomized but never treated|0|||
130183370|NCT00916383|468629030|FG000|Overall Study|Adverse Event|1|||
130183371|NCT00916383|468629030|FG000|Overall Study|Death|1|||
130183372|NCT00916383|468629030|FG000|Overall Study|Protocol Violation|1|||
130183373|NCT00258960|468629031|FG000|Overall Study|Death|2|||
130183374|NCT00258960|468629031|FG000|Overall Study|Disease Progression|7|||
130183375|NCT00258960|468629031|FG000|Overall Study|Adverse Event|4|||
130183376|NCT00258960|468629031|FG000|Overall Study|Physician Decision|1|||
130183377|NCT00258960|468629031|FG000|Overall Study|Withdrawal by Subject|1|||
130183378|NCT00258960|468629031|FG000|Overall Study|Mistake|2|||
130183379|NCT01112059|468629032|FG000|Overall Study|Withdrawal by Subject|1|||
130183380|NCT01112059|468629033|FG001|Overall Study|Withdrawal by Subject|0|||
130183381|NCT02235454|468629036|FG000|Overall Study|Withdrawal by Subject|2|||
130183382|NCT03323398|468629037|FG000|Overall Study|Other than Specified|0|||
130183383|NCT03323398|468629038|FG001|Overall Study|Other than Specified|1|||
130183384|NCT03323398|468629039|FG002|Overall Study|Other than Specified|2|||
130183385|NCT03323398|468629040|FG003|Overall Study|Other than Specified|0|||
130183386|NCT03323398|468629041|FG004|Overall Study|Other than Specified|0|||
130183387|NCT03323398|468629042|FG005|Overall Study|Other than Specified|0|||
130183388|NCT03323398|468629043|FG006|Overall Study|Other than Specified|1|||
130183389|NCT03323398|468629044|FG007|Overall Study|Other than Specified|0|||
130183390|NCT03323398|468629045|FG008|Overall Study|Other than Specified|2|||
130183391|NCT03323398|468629037|FG000|Overall Study|Lost to Follow-up|1|||
130183392|NCT03323398|468629038|FG001|Overall Study|Lost to Follow-up|2|||
130183393|NCT03323398|468629039|FG002|Overall Study|Lost to Follow-up|1|||
130183394|NCT03323398|468629040|FG003|Overall Study|Lost to Follow-up|0|||
130183395|NCT03323398|468629041|FG004|Overall Study|Lost to Follow-up|0|||
130183396|NCT03323398|468629042|FG005|Overall Study|Lost to Follow-up|0|||
130183397|NCT03323398|468629043|FG006|Overall Study|Lost to Follow-up|0|||
130183398|NCT03323398|468629044|FG007|Overall Study|Lost to Follow-up|0|||
130183399|NCT03323398|468629045|FG008|Overall Study|Lost to Follow-up|0|||
130183400|NCT03323398|468629037|FG000|Overall Study|Death|4|||
130183401|NCT03323398|468629038|FG001|Overall Study|Death|6|||
130183402|NCT03323398|468629039|FG002|Overall Study|Death|2|||
130183403|NCT03323398|468629040|FG003|Overall Study|Death|2|||
130183404|NCT03323398|468629041|FG004|Overall Study|Death|1|||
130183405|NCT03323398|468629042|FG005|Overall Study|Death|2|||
130183406|NCT03323398|468629043|FG006|Overall Study|Death|0|||
130183407|NCT03323398|468629044|FG007|Overall Study|Death|0|||
130183408|NCT03323398|468629045|FG008|Overall Study|Death|6|||
130183409|NCT03323398|468629037|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
130183410|NCT03323398|468629038|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
130183411|NCT03323398|468629039|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
130183412|NCT03323398|468629040|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
130183413|NCT03323398|468629041|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
130183414|NCT03323398|468629042|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
130183415|NCT03323398|468629043|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
130183416|NCT03323398|468629044|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
130183417|NCT03323398|468629045|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
130183418|NCT03323398|468629037|FG000|Overall Study|Withdrawal by Subject|2|||
130183419|NCT03323398|468629038|FG001|Overall Study|Withdrawal by Subject|1|||
130183420|NCT03323398|468629039|FG002|Overall Study|Withdrawal by Subject|3|||
130183421|NCT03323398|468629040|FG003|Overall Study|Withdrawal by Subject|0|||
130183422|NCT03323398|468629041|FG004|Overall Study|Withdrawal by Subject|0|||
130183423|NCT03323398|468629042|FG005|Overall Study|Withdrawal by Subject|1|||
130183424|NCT03323398|468629043|FG006|Overall Study|Withdrawal by Subject|0|||
130183425|NCT03323398|468629044|FG007|Overall Study|Withdrawal by Subject|0|||
130183426|NCT03323398|468629045|FG008|Overall Study|Withdrawal by Subject|0|||
130183427|NCT03323398|468629037|FG000|Overall Study|Participant was Put on Hospice|0|||
130183428|NCT03323398|468629038|FG001|Overall Study|Participant was Put on Hospice|0|||
130183429|NCT03323398|468629039|FG002|Overall Study|Participant was Put on Hospice|0|||
130183430|NCT03323398|468629040|FG003|Overall Study|Participant was Put on Hospice|0|||
130183431|NCT03323398|468629041|FG004|Overall Study|Participant was Put on Hospice|0|||
130183432|NCT03323398|468629042|FG005|Overall Study|Participant was Put on Hospice|0|||
130183433|NCT03323398|468629043|FG006|Overall Study|Participant was Put on Hospice|1|||
130183434|NCT03323398|468629044|FG007|Overall Study|Participant was Put on Hospice|0|||
130183435|NCT03323398|468629045|FG008|Overall Study|Participant was Put on Hospice|0|||
130183436|NCT03323398|468629037|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
130183437|NCT03323398|468629038|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
130183438|NCT03323398|468629039|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
130183439|NCT03323398|468629040|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
130183440|NCT03323398|468629041|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
130183441|NCT03323398|468629042|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
130183442|NCT03323398|468629043|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
130183443|NCT03323398|468629044|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
130183444|NCT03323398|468629045|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
130183445|NCT06025721|468630353|FG000|Overall Study|Physician Decision|1|||
130183446|NCT06025721|468630353|FG000|Overall Study|Protocol Violation|1|||
130183447|NCT06025721|468630353|FG000|Overall Study|Incarceration|1|||
130183448|NCT04510090|468630354|FG000|FE-HS|Withdrawal by Subject|0|||
130183449|NCT04510090|468630355|FG001|FE-HS|Withdrawal by Subject|0|||
130183450|NCT04510090|468630356|FG002|FE-HS|Withdrawal by Subject|0|||
130183451|NCT04510090|468630357|FG003|FE-HS|Withdrawal by Subject|0|||
130183452|NCT04510090|468630358|FG004|FE-HS|Withdrawal by Subject|1|||
130183453|NCT04510090|468630359|FG005|FE-HS|Withdrawal by Subject|0|||
130183454|NCT04510090|468630360|FG006|FE-HS|Withdrawal by Subject|0|||
130183455|NCT04510090|468630361|FG007|FE-HS|Withdrawal by Subject|0|||
130183456|NCT01749826|468630362|FG000|Overall Study|Study Terminated|20|||
130183457|NCT01749826|468630363|FG001|Overall Study|Study Terminated|0|||
130183458|NCT05085834|468630364|FG000|Overall Study|Lost to Follow-up|9|||
130183459|NCT05085834|468630365|FG001|Overall Study|Lost to Follow-up|2|||
130183460|NCT05085834|468630364|FG000|Overall Study|Adverse Event|6|||
130183461|NCT05085834|468630365|FG001|Overall Study|Adverse Event|0|||
130183462|NCT05085834|468630364|FG000|Overall Study|Death|1|||
130183463|NCT05085834|468630365|FG001|Overall Study|Death|0|||
130183464|NCT05085834|468630364|FG000|Overall Study|Inability to swallow the pill|0|||
130183465|NCT05085834|468630365|FG001|Overall Study|Inability to swallow the pill|1|||
130183466|NCT05842967|468630366|FG000|Period 1: SSA|Adverse Event|1|||
130183467|NCT05842967|468630367|FG001|Period 1: SSA|Adverse Event|1|||
130183468|NCT05842967|468630368|FG002|Period 1: SSA|Adverse Event|0|||
130183469|NCT05842967|468630369|FG003|Period 1: SSA|Adverse Event|0|||
130183470|NCT05842967|468630366|FG000|Period 1: SSA|Death|1|||
130183471|NCT05842967|468630367|FG001|Period 1: SSA|Death|0|||
130183472|NCT05842967|468630368|FG002|Period 1: SSA|Death|0|||
130183473|NCT05842967|468630369|FG003|Period 1: SSA|Death|0|||
130183474|NCT05842967|468630366|FG000|Period 1: SSA|Lost to Follow-up|16|||
130183475|NCT05842967|468630367|FG001|Period 1: SSA|Lost to Follow-up|4|||
130183476|NCT05842967|468630368|FG002|Period 1: SSA|Lost to Follow-up|0|||
130183477|NCT05842967|468630369|FG003|Period 1: SSA|Lost to Follow-up|0|||
130183478|NCT05842967|468630366|FG000|Period 1: SSA|Physician Decision|1|||
130183479|NCT05842967|468630367|FG001|Period 1: SSA|Physician Decision|0|||
130183480|NCT05842967|468630368|FG002|Period 1: SSA|Physician Decision|0|||
130183481|NCT05842967|468630369|FG003|Period 1: SSA|Physician Decision|0|||
130183482|NCT05842967|468630366|FG000|Period 1: SSA|Withdrawal by Subject|2|||
130183483|NCT05842967|468630367|FG001|Period 1: SSA|Withdrawal by Subject|2|||
130183484|NCT05842967|468630368|FG002|Period 1: SSA|Withdrawal by Subject|0|||
130183485|NCT05842967|468630369|FG003|Period 1: SSA|Withdrawal by Subject|0|||
130183486|NCT05842967|468630366|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
130183487|NCT05842967|468630367|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
130183488|NCT05842967|468630368|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
130183489|NCT05842967|468630369|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
130183490|NCT05842967|468630366|FG000|Period 2: SSB|Adverse Event|0|||
130183491|NCT05842967|468630367|FG001|Period 2: SSB|Adverse Event|0|||
130183492|NCT05842967|468630368|FG002|Period 2: SSB|Adverse Event|2|||
130183493|NCT05842967|468630369|FG003|Period 2: SSB|Adverse Event|0|||
130183494|NCT05842967|468630366|FG000|Period 2: SSB|Lost to Follow-up|0|||
130183495|NCT05842967|468630367|FG001|Period 2: SSB|Lost to Follow-up|0|||
130183496|NCT05842967|468630368|FG002|Period 2: SSB|Lost to Follow-up|4|||
130183497|NCT05842967|468630369|FG003|Period 2: SSB|Lost to Follow-up|3|||
130183498|NCT05842967|468630366|FG000|Period 2: SSB|Withdrawal by Subject|0|||
130183499|NCT05842967|468630367|FG001|Period 2: SSB|Withdrawal by Subject|0|||
130183500|NCT05842967|468630368|FG002|Period 2: SSB|Withdrawal by Subject|1|||
130183501|NCT05842967|468630369|FG003|Period 2: SSB|Withdrawal by Subject|0|||
130183502|NCT05842967|468630366|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
130183503|NCT05842967|468630367|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
130183504|NCT05842967|468630368|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
130183505|NCT05842967|468630369|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
130183506|NCT05842967|468630366|FG000|Period 2: SSB|Protocol Violation|0|||
130183507|NCT05842967|468630367|FG001|Period 2: SSB|Protocol Violation|0|||
130183508|NCT05842967|468630368|FG002|Period 2: SSB|Protocol Violation|0|||
130183509|NCT05842967|468630369|FG003|Period 2: SSB|Protocol Violation|1|||
130183510|NCT01823328|468630371|FG000|Overall Study|Withdrawal by Subject|8|||
130183511|NCT01823328|468630372|FG001|Overall Study|Withdrawal by Subject|6|||
130183512|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
130183513|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
130183514|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130183515|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130183516|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130183517|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130183518|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
130183519|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
130183520|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
130183521|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
130183522|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
130183523|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
130183524|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
130183525|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
130183526|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
130183527|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
130183528|NCT01479465|468630375|FG000|Overall Study|Disease Progression|9|||
130183529|NCT01479465|468630376|FG001|Overall Study|Disease Progression|61|||
130183530|NCT01479465|468630377|FG002|Overall Study|Disease Progression|65|||
130183531|NCT01479465|468630378|FG003|Overall Study|Disease Progression|70|||
130183532|NCT01479465|468630375|FG000|Overall Study|Study Discontinued by Sponsor|0|||
130183533|NCT01479465|468630376|FG001|Overall Study|Study Discontinued by Sponsor|7|||
130183534|NCT01479465|468630377|FG002|Overall Study|Study Discontinued by Sponsor|5|||
130183535|NCT01479465|468630378|FG003|Overall Study|Study Discontinued by Sponsor|3|||
130183536|NCT01479465|468630375|FG000|Overall Study|Adverse Event|0|||
130183537|NCT01479465|468630376|FG001|Overall Study|Adverse Event|3|||
130183538|NCT01479465|468630377|FG002|Overall Study|Adverse Event|6|||
130183539|NCT01479465|468630378|FG003|Overall Study|Adverse Event|4|||
130183540|NCT01479465|468630375|FG000|Overall Study|Investigator Discretion|1|||
130183541|NCT01479465|468630376|FG001|Overall Study|Investigator Discretion|4|||
130183542|NCT01479465|468630377|FG002|Overall Study|Investigator Discretion|2|||
130183543|NCT01479465|468630378|FG003|Overall Study|Investigator Discretion|4|||
130183544|NCT01479465|468630375|FG000|Overall Study|Subject Request|1|||
130183545|NCT01479465|468630376|FG001|Overall Study|Subject Request|3|||
130183546|NCT01479465|468630377|FG002|Overall Study|Subject Request|4|||
130183547|NCT01479465|468630378|FG003|Overall Study|Subject Request|2|||
130183548|NCT01479465|468630375|FG000|Overall Study|Subject Withdrew Consent|0|||
130183549|NCT01479465|468630376|FG001|Overall Study|Subject Withdrew Consent|5|||
130183550|NCT01479465|468630377|FG002|Overall Study|Subject Withdrew Consent|2|||
130183551|NCT01479465|468630378|FG003|Overall Study|Subject Withdrew Consent|1|||
130183552|NCT01479465|468630375|FG000|Overall Study|Protocol Violation|0|||
130183553|NCT01479465|468630376|FG001|Overall Study|Protocol Violation|1|||
130183554|NCT01479465|468630377|FG002|Overall Study|Protocol Violation|1|||
130183555|NCT01479465|468630378|FG003|Overall Study|Protocol Violation|0|||
130183556|NCT01479465|468630375|FG000|Overall Study|Death|0|||
130183557|NCT01479465|468630376|FG001|Overall Study|Death|0|||
130183558|NCT01479465|468630377|FG002|Overall Study|Death|0|||
130183559|NCT01479465|468630378|FG003|Overall Study|Death|1|||
130183560|NCT01479465|468630375|FG000|Overall Study|Lost to Follow-up|0|||
130183561|NCT01479465|468630376|FG001|Overall Study|Lost to Follow-up|0|||
130183562|NCT01479465|468630377|FG002|Overall Study|Lost to Follow-up|1|||
130183563|NCT01479465|468630378|FG003|Overall Study|Lost to Follow-up|0|||
130183564|NCT01173523|468630379|FG000|Overall Study|Clinical Progression|1|||
130183565|NCT01173523|468630380|FG001|Overall Study|Clinical Progression|1|||
130183566|NCT01173523|468630379|FG000|Overall Study|Progressive Disease|10|||
130183567|NCT01173523|468630380|FG001|Overall Study|Progressive Disease|8|||
130183568|NCT01173523|468630379|FG000|Overall Study|Other|2|||
130183569|NCT01173523|468630380|FG001|Overall Study|Other|3|||
130183570|NCT02717507|468630385|FG000|Overall Study|Lost to Follow-up|5|||
130183571|NCT02717507|468630386|FG001|Overall Study|Lost to Follow-up|8|||
130183572|NCT02717507|468630385|FG000|Overall Study|Pregnancy|1|||
130183573|NCT02717507|468630386|FG001|Overall Study|Pregnancy|1|||
130183574|NCT02717507|468630385|FG000|Overall Study|Protocol Violation|2|||
130183575|NCT02717507|468630386|FG001|Overall Study|Protocol Violation|2|||
130183576|NCT02717507|468630385|FG000|Overall Study|Withdrawal by Subject|20|||
130183577|NCT02717507|468630386|FG001|Overall Study|Withdrawal by Subject|20|||
130183578|NCT02717507|468630385|FG000|Overall Study|Relapse|1|||
130183579|NCT02717507|468630386|FG001|Overall Study|Relapse|1|||
130183580|NCT02717507|468630385|FG000|Overall Study|Cardiac Event|2|||
130183581|NCT02717507|468630386|FG001|Overall Study|Cardiac Event|6|||
130183582|NCT01439802|468630387|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
130183583|NCT01439802|468630387|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
130183584|NCT01866826|468630388|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
130183585|NCT01866826|468630389|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
130183586|NCT01866826|468630388|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
130183587|NCT01866826|468630389|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
130183588|NCT01866826|468630388|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
130183589|NCT01866826|468630389|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
130183590|NCT00709995|468630390|FG000|Overall Study|Adverse Event|4|||
130183591|NCT00709995|468630391|FG001|Overall Study|Adverse Event|2|||
130183592|NCT00709995|468630390|FG000|Overall Study|Withdrawal by Subject|1|||
130183593|NCT00709995|468630391|FG001|Overall Study|Withdrawal by Subject|3|||
130183594|NCT00742209|468630396|FG000|Overall Study|Adverse Event|11|||
130183595|NCT00742209|468630397|FG001|Overall Study|Adverse Event|4|||
130183596|NCT00742209|468630398|FG002|Overall Study|Adverse Event|17|||
130183597|NCT00742209|468630399|FG003|Overall Study|Adverse Event|16|||
130183598|NCT00742209|468630400|FG004|Overall Study|Adverse Event|13|||
130183599|NCT00742209|468630396|FG000|Overall Study|Participant Withdrew Consent|8|||
130183600|NCT00742209|468630397|FG001|Overall Study|Participant Withdrew Consent|4|||
130183601|NCT00742209|468630398|FG002|Overall Study|Participant Withdrew Consent|14|||
130183602|NCT00742209|468630399|FG003|Overall Study|Participant Withdrew Consent|7|||
130183603|NCT00742209|468630400|FG004|Overall Study|Participant Withdrew Consent|4|||
130183604|NCT00742209|468630396|FG000|Overall Study|Protocol Violation|6|||
130183605|NCT00742209|468630397|FG001|Overall Study|Protocol Violation|5|||
130183606|NCT00742209|468630398|FG002|Overall Study|Protocol Violation|4|||
130183607|NCT00742209|468630399|FG003|Overall Study|Protocol Violation|5|||
130183608|NCT00742209|468630400|FG004|Overall Study|Protocol Violation|3|||
130183609|NCT00742209|468630396|FG000|Overall Study|Lost to Follow-up|3|||
130183610|NCT00742209|468630397|FG001|Overall Study|Lost to Follow-up|4|||
130183611|NCT00742209|468630398|FG002|Overall Study|Lost to Follow-up|5|||
130183612|NCT00742209|468630399|FG003|Overall Study|Lost to Follow-up|5|||
130183613|NCT00742209|468630400|FG004|Overall Study|Lost to Follow-up|3|||
130183614|NCT00742209|468630396|FG000|Overall Study|Lack of Efficacy|6|||
130183615|NCT00742209|468630397|FG001|Overall Study|Lack of Efficacy|1|||
130183616|NCT00742209|468630398|FG002|Overall Study|Lack of Efficacy|1|||
130183617|NCT00742209|468630399|FG003|Overall Study|Lack of Efficacy|3|||
130183618|NCT00742209|468630400|FG004|Overall Study|Lack of Efficacy|1|||
130183619|NCT00742209|468630396|FG000|Overall Study|Investigator Discretion|0|||
130183620|NCT00742209|468630397|FG001|Overall Study|Investigator Discretion|0|||
130183621|NCT00742209|468630398|FG002|Overall Study|Investigator Discretion|5|||
130183622|NCT00742209|468630399|FG003|Overall Study|Investigator Discretion|1|||
130183623|NCT00742209|468630400|FG004|Overall Study|Investigator Discretion|1|||
130183624|NCT00595621|468630404|FG000|Open Label Run in|Adverse Event|1|||
130183625|NCT00595621|468630405|FG001|Open Label Run in|Adverse Event|0|||
130183626|NCT00595621|468630404|FG000|Open Label Run in|Physician Decision|1|||
130183627|NCT00595621|468630405|FG001|Open Label Run in|Physician Decision|0|||
130183628|NCT00595621|468630404|FG000|Open Label Run in|Withdrawal by Subject|1|||
130183629|NCT00595621|468630405|FG001|Open Label Run in|Withdrawal by Subject|0|||
130183630|NCT00595621|468630404|FG000|Randomization and Study|Adverse Event|2|||
130183631|NCT00595621|468630405|FG001|Randomization and Study|Adverse Event|0|||
130183632|NCT00595621|468630404|FG000|Randomization and Study|Withdrawal by Subject|0|||
130183633|NCT00595621|468630405|FG001|Randomization and Study|Withdrawal by Subject|1|||
130183634|NCT00324987|468630406|FG000|Overall Study|Adverse Event|2|||
130183635|NCT00324987|468630407|FG001|Overall Study|Adverse Event|1|||
130183636|NCT00324987|468630406|FG000|Overall Study|Withdrawal by Subject|1|||
130183637|NCT00324987|468630407|FG001|Overall Study|Withdrawal by Subject|1|||
130183638|NCT00324987|468630406|FG000|Overall Study|Progression|1|||
130183639|NCT00324987|468630407|FG001|Overall Study|Progression|1|||
130183640|NCT00324987|468630406|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
130183641|NCT00324987|468630407|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
130183642|NCT03817125|468630408|FG000|Overall Study|Adverse Event|1|||
130183643|NCT03817125|468630409|FG001|Overall Study|Adverse Event|0|||
130183644|NCT03817125|468630408|FG000|Overall Study|Physician Decision|0|||
130183645|NCT03817125|468630409|FG001|Overall Study|Physician Decision|1|||
130183646|NCT03817125|468630408|FG000|Overall Study|Lack of Efficacy|1|||
130183647|NCT03817125|468630409|FG001|Overall Study|Lack of Efficacy|5|||
130183648|NCT00942084|468630410|FG000|Overall Study|Death|2|||
130183649|NCT01998919|468630411|FG000|Overall Study|Death|2|||
130183650|NCT01998919|468630412|FG001|Overall Study|Death|2|||
130183651|NCT01998919|468630411|FG000|Overall Study|Adverse Event|0|||
130183652|NCT01998919|468630412|FG001|Overall Study|Adverse Event|5|||
130183653|NCT01998919|468630411|FG000|Overall Study|Disease progression|31|||
130183654|NCT01998919|468630412|FG001|Overall Study|Disease progression|22|||
130183655|NCT01998919|468630411|FG000|Overall Study|Withdrawal by Subject|2|||
130183656|NCT01998919|468630412|FG001|Overall Study|Withdrawal by Subject|4|||
130183657|NCT01998919|468630411|FG000|Overall Study|Lost to Follow-up|2|||
130183658|NCT01998919|468630412|FG001|Overall Study|Lost to Follow-up|0|||
130183659|NCT01998919|468630411|FG000|Overall Study|Other|5|||
130183660|NCT01998919|468630412|FG001|Overall Study|Other|2|||
130183661|NCT00897715|468630416|FG000|Overall Study|Lost to Follow-up|0|||
130183662|NCT00897715|468630417|FG001|Overall Study|Lost to Follow-up|1|||
130183663|NCT00897715|468630416|FG000|Overall Study|Physician Decision|1|||
130183664|NCT00897715|468630417|FG001|Overall Study|Physician Decision|0|||
130183665|NCT00897715|468630416|FG000|Overall Study|increased risk of infection|1|||
130183666|NCT00897715|468630417|FG001|Overall Study|increased risk of infection|0|||
130183667|NCT00063934|468630418|FG000|Overall Study|Ineligible|1|||
130183668|NCT04341363|468630419|FG000|Overall Study|Adverse Event|1|||
130183669|NCT04341363|468630419|FG000|Overall Study|Withdrawal by Subject|1|||
130183670|NCT00840749|468630420|FG000|Overall Study|Death|1|||
130183671|NCT00840749|468630421|FG001|Overall Study|Death|2|||
130183672|NCT00840749|468630420|FG000|Overall Study|not treated on study arm|11|||
130183673|NCT00840749|468630421|FG001|Overall Study|not treated on study arm|11|||
130183674|NCT00840749|468630420|FG000|Overall Study|study closed|19|||
130183675|NCT00840749|468630421|FG001|Overall Study|study closed|14|||
130183676|NCT01960413|468630422|FG000|Overall Study|Withdrawal by Subject|1|||
130183677|NCT01960413|468630423|FG001|Overall Study|Withdrawal by Subject|1|||
130183678|NCT01960413|468630422|FG000|Overall Study|Physician Decision|1|||
130183679|NCT01960413|468630423|FG001|Overall Study|Physician Decision|0|||
130183680|NCT01960413|468630422|FG000|Overall Study|Lost to Follow-up|2|||
130183681|NCT01960413|468630423|FG001|Overall Study|Lost to Follow-up|0|||
130183682|NCT00791778|468630427|FG000|Double-blind Treatment|Adverse Event|49|||
130183683|NCT00791778|468630428|FG001|Double-blind Treatment|Adverse Event|9|||
130183684|NCT00791778|468630427|FG000|Double-blind Treatment|Physician Decision|6|||
130183685|NCT00791778|468630428|FG001|Double-blind Treatment|Physician Decision|26|||
130183686|NCT00791778|468630427|FG000|Double-blind Treatment|Protocol Violation|0|||
130183687|NCT00791778|468630428|FG001|Double-blind Treatment|Protocol Violation|4|||
130183688|NCT00791778|468630427|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
130183689|NCT00791778|468630428|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
130183690|NCT00791778|468630427|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
130183691|NCT00791778|468630428|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
130183692|NCT00791778|468630427|FG000|Follow-up|Withdrawal by Subject|3|||
130183693|NCT00791778|468630428|FG001|Follow-up|Withdrawal by Subject|0|||
130183694|NCT00791778|468630427|FG000|Follow-up|Lost to Follow-up|2|||
130183695|NCT00791778|468630428|FG001|Follow-up|Lost to Follow-up|1|||
130183696|NCT03335475|468630429|FG000|Overall Study|Did not wear accelerometer|4|||
130183697|NCT03335475|468630430|FG001|Overall Study|Did not wear accelerometer|0|||
130183698|NCT03335475|468630429|FG000|Overall Study|Withdrawal by Subject|0|||
130183699|NCT03335475|468630430|FG001|Overall Study|Withdrawal by Subject|1|||
130183700|NCT05921903|468630433|FG000|Overall Study|Unsolicited non-SAE|0|||
130183701|NCT05921903|468630434|FG001|Overall Study|Unsolicited non-SAE|1|||
130183702|NCT05921903|468630435|FG002|Overall Study|Unsolicited non-SAE|0|||
130183703|NCT05921903|468630433|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
130183704|NCT05921903|468630434|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
130183705|NCT05921903|468630435|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
130183706|NCT05921903|468630433|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
130183707|NCT05921903|468630434|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
130183708|NCT05921903|468630435|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
130183709|NCT05317312|468630438|FG000|Overall Study|Withdrawal by Subject|0|||
130183710|NCT05317312|468630439|FG001|Overall Study|Withdrawal by Subject|1|||
130183711|NCT05317312|468630440|FG002|Overall Study|Withdrawal by Subject|0|||
130183712|NCT05317312|468630441|FG003|Overall Study|Withdrawal by Subject|0|||
130183713|NCT05317312|468630438|FG000|Overall Study|Lost to Follow-up|0|||
130183714|NCT05317312|468630439|FG001|Overall Study|Lost to Follow-up|0|||
130183715|NCT05317312|468630440|FG002|Overall Study|Lost to Follow-up|0|||
130183716|NCT05317312|468630441|FG003|Overall Study|Lost to Follow-up|1|||
130183717|NCT05317312|468630438|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
130183718|NCT05317312|468630439|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
130183719|NCT05317312|468630440|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
130183720|NCT05317312|468630441|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
130183721|NCT00235755|468630442|FG000|4-Week Titration Phase|Adverse Event|6|||
130183722|NCT00235755|468630443|FG001|4-Week Titration Phase|Adverse Event|14|||
130183723|NCT00235755|468630444|FG002|4-Week Titration Phase|Adverse Event|20|||
130183724|NCT00235755|468630442|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
130183725|NCT00235755|468630443|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
130183726|NCT00235755|468630444|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
130183727|NCT00235755|468630442|FG000|4-Week Titration Phase|Protocol Violation|2|||
130183728|NCT00235755|468630443|FG001|4-Week Titration Phase|Protocol Violation|2|||
130183729|NCT00235755|468630444|FG002|4-Week Titration Phase|Protocol Violation|1|||
130183730|NCT00235755|468630442|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
130183731|NCT00235755|468630443|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
130183732|NCT00235755|468630444|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
130183733|NCT00235755|468630442|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130183734|NCT00235755|468630443|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130183735|NCT00235755|468630444|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130183736|NCT00235755|468630442|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
130183737|NCT00235755|468630443|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
130183738|NCT00235755|468630444|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
130183739|NCT00235755|468630442|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
130183740|NCT00235755|468630443|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130183741|NCT00235755|468630444|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130183742|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Adverse Event|8|||
130183743|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Adverse Event|12|||
130183744|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Adverse Event|26|||
130183745|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
130183746|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
130183747|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
130183748|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
130183749|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
130183750|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
130183751|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
130183752|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
130183753|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
130183754|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
130183755|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
130183756|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
130183757|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
130183758|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130183759|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130183760|NCT02314026|468630445|FG000|Overall Study|Protocol Violation|28|||
130183761|NCT01532934|468630446|FG000|Overall Study|Lost to Follow-up|11|||
130183762|NCT01532934|468630447|FG001|Overall Study|Lost to Follow-up|11|||
130183763|NCT01532934|468630446|FG000|Overall Study|In controlled environment|3|||
130183764|NCT01532934|468630447|FG001|Overall Study|In controlled environment|2|||
130183765|NCT02291237|468630448|FG000|Overall Study|Study Terminated by Sponsor|72|||
130183766|NCT02291237|468630449|FG001|Overall Study|Study Terminated by Sponsor|67|||
130183767|NCT02291237|468630448|FG000|Overall Study|Adverse Event|1|||
130183768|NCT02291237|468630449|FG001|Overall Study|Adverse Event|3|||
130183769|NCT02291237|468630448|FG000|Overall Study|Investigator's Discretion|0|||
130183770|NCT02291237|468630449|FG001|Overall Study|Investigator's Discretion|3|||
130183771|NCT02291237|468630448|FG000|Overall Study|Withdrew Consent|11|||
130183772|NCT02291237|468630449|FG001|Overall Study|Withdrew Consent|11|||
130183773|NCT02291237|468630448|FG000|Overall Study|Lost to Follow-up|0|||
130183774|NCT02291237|468630449|FG001|Overall Study|Lost to Follow-up|2|||
130183775|NCT02291237|468630448|FG000|Overall Study|Subject Required Prohibited Medication|2|||
130183776|NCT02291237|468630449|FG001|Overall Study|Subject Required Prohibited Medication|0|||
130183777|NCT01149863|468630450|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
130183778|NCT01306305|468630451|FG000|Overall Study|Lost to Follow-up|1|||
130183779|NCT01306305|468630452|FG001|Overall Study|Lost to Follow-up|0|||
130183780|NCT01306305|468630451|FG000|Overall Study|Withdrew consent|1|||
130183781|NCT01306305|468630452|FG001|Overall Study|Withdrew consent|0|||
130183782|NCT03326193|468630453|FG000|Overall Study|Sponsor decision|35|||
130183783|NCT00699998|468630455|FG000|Overall Study|Withdrawal by Subject|194|||
130183784|NCT00699998|468630456|FG001|Overall Study|Withdrawal by Subject|83|||
130183785|NCT00699998|468630457|FG002|Overall Study|Withdrawal by Subject|202|||
130183786|NCT00699998|468630458|FG003|Overall Study|Withdrawal by Subject|80|||
130183787|NCT00699998|468630455|FG000|Overall Study|Physician Decision|3|||
130183788|NCT00699998|468630456|FG001|Overall Study|Physician Decision|2|||
130183789|NCT00699998|468630457|FG002|Overall Study|Physician Decision|1|||
130183790|NCT00699998|468630458|FG003|Overall Study|Physician Decision|1|||
130183791|NCT00699998|468630455|FG000|Overall Study|Lost to Follow-up|2|||
130183792|NCT00699998|468630456|FG001|Overall Study|Lost to Follow-up|1|||
130183793|NCT00699998|468630457|FG002|Overall Study|Lost to Follow-up|3|||
130183794|NCT00699998|468630458|FG003|Overall Study|Lost to Follow-up|1|||
130183795|NCT01406574|468630459|FG000|Overall Study|Adverse Event|0|||
130183796|NCT01406574|468630460|FG001|Overall Study|Adverse Event|0|||
130183797|NCT01406574|468630461|FG002|Overall Study|Adverse Event|1|||
130183798|NCT01406574|468630462|FG003|Overall Study|Adverse Event|3|||
130183799|NCT01406574|468630459|FG000|Overall Study|Physician Decision|0|||
130183800|NCT01406574|468630460|FG001|Overall Study|Physician Decision|0|||
130183801|NCT01406574|468630461|FG002|Overall Study|Physician Decision|0|||
130183802|NCT01406574|468630462|FG003|Overall Study|Physician Decision|1|||
130183803|NCT01406574|468630459|FG000|Overall Study|Withdrawal by Subject|0|||
130183804|NCT01406574|468630460|FG001|Overall Study|Withdrawal by Subject|1|||
130183805|NCT01406574|468630461|FG002|Overall Study|Withdrawal by Subject|0|||
130183806|NCT01406574|468630462|FG003|Overall Study|Withdrawal by Subject|0|||
130183807|NCT01406574|468630459|FG000|Overall Study|Definite progression of primary disease|1|||
130183808|NCT01406574|468630460|FG001|Overall Study|Definite progression of primary disease|0|||
130183809|NCT01406574|468630461|FG002|Overall Study|Definite progression of primary disease|0|||
130183810|NCT01406574|468630462|FG003|Overall Study|Definite progression of primary disease|0|||
130183811|NCT00473590|468630467|FG000|Overall Study|Adverse Event|3|||
130183812|NCT00473590|468630468|FG001|Overall Study|Adverse Event|3|||
130183813|NCT00473590|468630467|FG000|Overall Study|Death|4|||
130183814|NCT00473590|468630468|FG001|Overall Study|Death|2|||
130183815|NCT00473590|468630467|FG000|Overall Study|Progression not resulting in death|24|||
130183816|NCT00473590|468630468|FG001|Overall Study|Progression not resulting in death|20|||
130183817|NCT00473590|468630467|FG000|Overall Study|Non-protocol-specified therapy|7|||
130183818|NCT00473590|468630468|FG001|Overall Study|Non-protocol-specified therapy|5|||
130183819|NCT00473590|468630467|FG000|Overall Study|Physician Decision|2|||
130183820|NCT00473590|468630468|FG001|Overall Study|Physician Decision|4|||
130183821|NCT00473590|468630467|FG000|Overall Study|Withdrawal by Subject|5|||
130183822|NCT00473590|468630468|FG001|Overall Study|Withdrawal by Subject|3|||
130183823|NCT00473590|468630467|FG000|Overall Study|Other|0|||
130183824|NCT00473590|468630468|FG001|Overall Study|Other|1|||
130183825|NCT03367819|468630471|FG000|Overall Study|Adverse Event|4|||
130183826|NCT03367819|468630472|FG001|Overall Study|Adverse Event|4|||
130183827|NCT03367819|468630471|FG000|Overall Study|Progressive Disease|15|||
130183828|NCT03367819|468630472|FG001|Overall Study|Progressive Disease|13|||
130183829|NCT03367819|468630471|FG000|Overall Study|Withdrawal by Subject|1|||
130183830|NCT03367819|468630472|FG001|Overall Study|Withdrawal by Subject|0|||
130183831|NCT03367819|468630471|FG000|Overall Study|Other|4|||
130183832|NCT03367819|468630472|FG001|Overall Study|Other|2|||
130183833|NCT00584454|468630473|FG000|Overall Study|Adverse Event|1|||
130183834|NCT00584454|468630473|FG000|Overall Study|Relocation|1|||
130183835|NCT00584454|468630473|FG000|Overall Study|Clinical Hold|2|||
130183836|NCT00982657|468630474|FG000|Overall Study|Death|1|||
130183837|NCT00982657|468630475|FG001|Overall Study|Death|0|||
130183838|NCT00982657|468630476|FG002|Overall Study|Death|1|||
130183839|NCT00982657|468630477|FG003|Overall Study|Death|1|||
130183840|NCT00982657|468630474|FG000|Overall Study|Withdrawal by Subject|0|||
130183841|NCT00982657|468630475|FG001|Overall Study|Withdrawal by Subject|0|||
130183842|NCT00982657|468630476|FG002|Overall Study|Withdrawal by Subject|1|||
130183843|NCT00982657|468630477|FG003|Overall Study|Withdrawal by Subject|3|||
130183844|NCT00982657|468630474|FG000|Overall Study|Other|0|||
130183845|NCT00982657|468630475|FG001|Overall Study|Other|0|||
130183846|NCT00982657|468630476|FG002|Overall Study|Other|0|||
130183847|NCT00982657|468630477|FG003|Overall Study|Other|4|||
130183848|NCT00982657|468630474|FG000|Overall Study|On going at date of cut-off|0|||
130183849|NCT00982657|468630475|FG001|Overall Study|On going at date of cut-off|0|||
130183850|NCT00982657|468630476|FG002|Overall Study|On going at date of cut-off|0|||
130183851|NCT00982657|468630477|FG003|Overall Study|On going at date of cut-off|1|||
130183852|NCT00725920|468630478|FG000|Overall Study|Lack of Efficacy|3|||
130183853|NCT00725920|468630479|FG001|Overall Study|Lack of Efficacy|6|||
130183854|NCT05373108|468630480|FG000|Overall Study|Withdrawal by Subject|2|||
130183855|NCT02546986|468632418|FG000|Treatment Period|Progressive Disease|20|||
130183856|NCT02546986|468632419|FG001|Treatment Period|Progressive Disease|22|||
130183857|NCT02546986|468632418|FG000|Treatment Period|Adverse Event|14|||
130183858|NCT02546986|468632419|FG001|Treatment Period|Adverse Event|6|||
130183859|NCT02546986|468632418|FG000|Treatment Period|Symptomatic Deterioration|4|||
130183860|NCT02546986|468632419|FG001|Treatment Period|Symptomatic Deterioration|3|||
130183861|NCT02546986|468632418|FG000|Treatment Period|Death|3|||
130183862|NCT02546986|468632419|FG001|Treatment Period|Death|4|||
130183863|NCT02546986|468632418|FG000|Treatment Period|Physician Decision|1|||
130183864|NCT02546986|468632419|FG001|Treatment Period|Physician Decision|2|||
130183865|NCT02546986|468632418|FG000|Treatment Period|Protocol Violation|1|||
130183866|NCT02546986|468632419|FG001|Treatment Period|Protocol Violation|0|||
130183867|NCT02546986|468632418|FG000|Treatment Period|Withdrawal by Subject|1|||
130183868|NCT02546986|468632419|FG001|Treatment Period|Withdrawal by Subject|1|||
130183869|NCT02546986|468632418|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130183870|NCT02546986|468632419|FG001|Treatment Period|Non-compliance with Study Drug|1|||
130183871|NCT02546986|468632418|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130183872|NCT02546986|468632419|FG001|Treatment Period|Study Terminated by Sponsor|1|||
130183873|NCT02546986|468632418|FG000|Treatment Period|Miscellaneous|7|||
130183874|NCT02546986|468632419|FG001|Treatment Period|Miscellaneous|9|||
130183875|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Missing Status|3|||
130183876|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Missing Status|5|||
130183877|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Death|18|||
130183878|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Death|12|||
130183879|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Alive|13|||
130183880|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Alive|16|||
130183881|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
130183882|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
130183883|NCT05016960|468632420|FG000|Overall Study|Withdrawal by Subject|1|||
130183884|NCT05016960|468632421|FG001|Overall Study|Withdrawal by Subject|9|||
130183885|NCT04796961|468632422|FG000|Overall Study|Lost to Follow-up|10|||
130183886|NCT04796961|468632422|FG000|Overall Study|Withdrawal by Subject|3|||
130183887|NCT04796961|468632422|FG000|Overall Study|Left Organization|10|||
130183888|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
130183889|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183890|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183891|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183892|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
130183893|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183894|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183895|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183896|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
130183897|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183898|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183899|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183900|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
130183901|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183902|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183903|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183904|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
130183905|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183906|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183907|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183908|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
130183909|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183910|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183911|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183912|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
130183913|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183914|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183915|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183916|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130183917|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130183918|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
130183919|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
130183920|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
130183921|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183922|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183923|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183924|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
130183925|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183926|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183927|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183928|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
130183929|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183930|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183931|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183932|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183933|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
130183934|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183935|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183936|NCT03428958|468632430|FG000|Overall Study|Adverse Event|0|||
130183937|NCT03428958|468632431|FG001|Overall Study|Adverse Event|0|||
130183938|NCT03428958|468632432|FG002|Overall Study|Adverse Event|0|||
130183939|NCT03428958|468632433|FG003|Overall Study|Adverse Event|1|||
130183940|NCT03428958|468632434|FG004|Overall Study|Adverse Event|0|||
130183941|NCT03428958|468632435|FG005|Overall Study|Adverse Event|2|||
130183942|NCT03428958|468632436|FG006|Overall Study|Adverse Event|1|||
130183943|NCT03428958|468632437|FG007|Overall Study|Adverse Event|0|||
130183944|NCT03428958|468632438|FG008|Overall Study|Adverse Event|0|||
130183945|NCT03428958|468632439|FG009|Overall Study|Adverse Event|0|||
130183946|NCT03428958|468632440|FG010|Overall Study|Adverse Event|0|||
130183947|NCT03428958|468632441|FG011|Overall Study|Adverse Event|0|||
130183948|NCT03428958|468632442|FG012|Overall Study|Adverse Event|0|||
130183949|NCT03428958|468632443|FG013|Overall Study|Adverse Event|0|||
130183950|NCT03428958|468632444|FG014|Overall Study|Adverse Event|0|||
130183951|NCT03428958|468632445|FG015|Overall Study|Adverse Event|0|||
130183952|NCT03428958|468632446|FG016|Overall Study|Adverse Event|0|||
130183953|NCT03428958|468632430|FG000|Overall Study|Clinical Progression|2|||
130183954|NCT03428958|468632431|FG001|Overall Study|Clinical Progression|3|||
130183955|NCT03428958|468632432|FG002|Overall Study|Clinical Progression|2|||
130183956|NCT03428958|468632433|FG003|Overall Study|Clinical Progression|1|||
130183957|NCT03428958|468632434|FG004|Overall Study|Clinical Progression|0|||
130183958|NCT03428958|468632435|FG005|Overall Study|Clinical Progression|2|||
130183959|NCT03428958|468632436|FG006|Overall Study|Clinical Progression|0|||
130183960|NCT03428958|468632437|FG007|Overall Study|Clinical Progression|0|||
130183961|NCT03428958|468632438|FG008|Overall Study|Clinical Progression|0|||
130183962|NCT03428958|468632439|FG009|Overall Study|Clinical Progression|0|||
130183963|NCT03428958|468632440|FG010|Overall Study|Clinical Progression|0|||
130183964|NCT03428958|468632441|FG011|Overall Study|Clinical Progression|0|||
130183965|NCT03428958|468632442|FG012|Overall Study|Clinical Progression|0|||
130183966|NCT03428958|468632443|FG013|Overall Study|Clinical Progression|0|||
130183967|NCT03428958|468632444|FG014|Overall Study|Clinical Progression|0|||
130183968|NCT03428958|468632445|FG015|Overall Study|Clinical Progression|0|||
130183969|NCT03428958|468632446|FG016|Overall Study|Clinical Progression|0|||
130183970|NCT03428958|468632430|FG000|Overall Study|Progression per RECIST|6|||
130183971|NCT03428958|468632431|FG001|Overall Study|Progression per RECIST|6|||
130183972|NCT03428958|468632432|FG002|Overall Study|Progression per RECIST|7|||
130183973|NCT03428958|468632433|FG003|Overall Study|Progression per RECIST|4|||
130183974|NCT03428958|468632434|FG004|Overall Study|Progression per RECIST|0|||
130183975|NCT03428958|468632435|FG005|Overall Study|Progression per RECIST|7|||
130183976|NCT03428958|468632436|FG006|Overall Study|Progression per RECIST|8|||
130183977|NCT03428958|468632437|FG007|Overall Study|Progression per RECIST|0|||
130183978|NCT03428958|468632438|FG008|Overall Study|Progression per RECIST|0|||
130183979|NCT03428958|468632439|FG009|Overall Study|Progression per RECIST|0|||
130183980|NCT03428958|468632440|FG010|Overall Study|Progression per RECIST|0|||
130183981|NCT03428958|468632441|FG011|Overall Study|Progression per RECIST|0|||
130183982|NCT03428958|468632442|FG012|Overall Study|Progression per RECIST|1|||
130183983|NCT03428958|468632443|FG013|Overall Study|Progression per RECIST|0|||
130183984|NCT03428958|468632444|FG014|Overall Study|Progression per RECIST|0|||
130183985|NCT03428958|468632445|FG015|Overall Study|Progression per RECIST|0|||
130183986|NCT03428958|468632446|FG016|Overall Study|Progression per RECIST|0|||
130183987|NCT03428958|468632430|FG000|Overall Study|Death|2|||
130183988|NCT03428958|468632431|FG001|Overall Study|Death|2|||
130183989|NCT03428958|468632432|FG002|Overall Study|Death|0|||
130183990|NCT03428958|468632433|FG003|Overall Study|Death|0|||
130183991|NCT03428958|468632434|FG004|Overall Study|Death|0|||
130183992|NCT03428958|468632435|FG005|Overall Study|Death|7|||
130183993|NCT03428958|468632436|FG006|Overall Study|Death|9|||
130183994|NCT03428958|468632437|FG007|Overall Study|Death|6|||
130183995|NCT03428958|468632438|FG008|Overall Study|Death|0|||
130183996|NCT03428958|468632439|FG009|Overall Study|Death|0|||
130183997|NCT03428958|468632440|FG010|Overall Study|Death|3|||
130183998|NCT03428958|468632441|FG011|Overall Study|Death|0|||
130183999|NCT03428958|468632442|FG012|Overall Study|Death|4|||
130184000|NCT03428958|468632443|FG013|Overall Study|Death|0|||
130184001|NCT03428958|468632444|FG014|Overall Study|Death|0|||
130184002|NCT03428958|468632445|FG015|Overall Study|Death|0|||
130184003|NCT03428958|468632446|FG016|Overall Study|Death|0|||
130184004|NCT03428958|468632430|FG000|Overall Study|Lost to Follow-up|0|||
130184005|NCT03428958|468632431|FG001|Overall Study|Lost to Follow-up|0|||
130184006|NCT03428958|468632432|FG002|Overall Study|Lost to Follow-up|0|||
130184007|NCT03428958|468632433|FG003|Overall Study|Lost to Follow-up|0|||
130184008|NCT03428958|468632434|FG004|Overall Study|Lost to Follow-up|0|||
130184009|NCT03428958|468632435|FG005|Overall Study|Lost to Follow-up|1|||
130184010|NCT03428958|468632436|FG006|Overall Study|Lost to Follow-up|1|||
130184011|NCT03428958|468632437|FG007|Overall Study|Lost to Follow-up|0|||
130184012|NCT03428958|468632438|FG008|Overall Study|Lost to Follow-up|0|||
130184013|NCT03428958|468632439|FG009|Overall Study|Lost to Follow-up|0|||
130184014|NCT03428958|468632440|FG010|Overall Study|Lost to Follow-up|0|||
130184015|NCT03428958|468632441|FG011|Overall Study|Lost to Follow-up|0|||
130184016|NCT03428958|468632442|FG012|Overall Study|Lost to Follow-up|0|||
130184017|NCT03428958|468632443|FG013|Overall Study|Lost to Follow-up|0|||
130184018|NCT03428958|468632444|FG014|Overall Study|Lost to Follow-up|0|||
130184019|NCT03428958|468632445|FG015|Overall Study|Lost to Follow-up|0|||
130184020|NCT03428958|468632446|FG016|Overall Study|Lost to Follow-up|0|||
130184021|NCT03428958|468632430|FG000|Overall Study|Physician/Sponsor Decision|1|||
130184022|NCT03428958|468632431|FG001|Overall Study|Physician/Sponsor Decision|0|||
130184023|NCT03428958|468632432|FG002|Overall Study|Physician/Sponsor Decision|1|||
130184024|NCT03428958|468632433|FG003|Overall Study|Physician/Sponsor Decision|0|||
130184025|NCT03428958|468632434|FG004|Overall Study|Physician/Sponsor Decision|0|||
130184026|NCT03428958|468632435|FG005|Overall Study|Physician/Sponsor Decision|2|||
130184027|NCT03428958|468632436|FG006|Overall Study|Physician/Sponsor Decision|2|||
130184028|NCT03428958|468632437|FG007|Overall Study|Physician/Sponsor Decision|2|||
130184029|NCT03428958|468632438|FG008|Overall Study|Physician/Sponsor Decision|0|||
130184030|NCT03428958|468632439|FG009|Overall Study|Physician/Sponsor Decision|0|||
130184031|NCT03428958|468632440|FG010|Overall Study|Physician/Sponsor Decision|2|||
130184032|NCT03428958|468632441|FG011|Overall Study|Physician/Sponsor Decision|0|||
130184033|NCT03428958|468632442|FG012|Overall Study|Physician/Sponsor Decision|4|||
130184034|NCT03428958|468632443|FG013|Overall Study|Physician/Sponsor Decision|0|||
130184035|NCT03428958|468632444|FG014|Overall Study|Physician/Sponsor Decision|0|||
130184036|NCT03428958|468632445|FG015|Overall Study|Physician/Sponsor Decision|0|||
130184037|NCT03428958|468632446|FG016|Overall Study|Physician/Sponsor Decision|0|||
130184038|NCT03428958|468632430|FG000|Overall Study|Withdrawal by Subject|0|||
130184039|NCT03428958|468632431|FG001|Overall Study|Withdrawal by Subject|0|||
130184040|NCT03428958|468632432|FG002|Overall Study|Withdrawal by Subject|2|||
130184041|NCT03428958|468632433|FG003|Overall Study|Withdrawal by Subject|0|||
130184042|NCT03428958|468632434|FG004|Overall Study|Withdrawal by Subject|0|||
130184043|NCT03428958|468632435|FG005|Overall Study|Withdrawal by Subject|2|||
130184044|NCT03428958|468632436|FG006|Overall Study|Withdrawal by Subject|4|||
130184045|NCT03428958|468632437|FG007|Overall Study|Withdrawal by Subject|1|||
130184046|NCT03428958|468632438|FG008|Overall Study|Withdrawal by Subject|0|||
130184047|NCT03428958|468632439|FG009|Overall Study|Withdrawal by Subject|0|||
130184048|NCT03428958|468632440|FG010|Overall Study|Withdrawal by Subject|0|||
130184049|NCT03428958|468632441|FG011|Overall Study|Withdrawal by Subject|0|||
130184050|NCT03428958|468632442|FG012|Overall Study|Withdrawal by Subject|0|||
130184051|NCT03428958|468632443|FG013|Overall Study|Withdrawal by Subject|0|||
130184052|NCT03428958|468632444|FG014|Overall Study|Withdrawal by Subject|0|||
130184053|NCT03428958|468632445|FG015|Overall Study|Withdrawal by Subject|0|||
130184054|NCT03428958|468632446|FG016|Overall Study|Withdrawal by Subject|0|||
130184055|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
130184056|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
130184057|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130184058|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130184059|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130184060|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130184061|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
130184062|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
130184063|NCT03874117|468632447|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130184064|NCT03874117|468632448|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130184065|NCT05258773|468632449|FG000|Overall Study|Screen Failure|1|||
130184066|NCT05258773|468632450|FG001|Overall Study|Screen Failure|1|||
130184067|NCT05258773|468632449|FG000|Overall Study|Adverse Event|1|||
130184068|NCT05258773|468632450|FG001|Overall Study|Adverse Event|0|||
130184069|NCT05258773|468632449|FG000|Overall Study|Withdrawal by Subject|0|||
130184070|NCT05258773|468632450|FG001|Overall Study|Withdrawal by Subject|1|||
130184071|NCT03018288|468632453|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
130184072|NCT03018288|468632454|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
130184073|NCT03018288|468632455|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
130184074|NCT03018288|468632456|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
130184075|NCT03018288|468632453|FG000|Overall Study|Participant withdrew consent.|0|||
130184076|NCT03018288|468632454|FG001|Overall Study|Participant withdrew consent.|0|||
130184077|NCT03018288|468632455|FG002|Overall Study|Participant withdrew consent.|1|||
130184078|NCT03018288|468632456|FG003|Overall Study|Participant withdrew consent.|0|||
130184079|NCT03018288|468632453|FG000|Overall Study|Switched to alternative treatment.|0|||
130184080|NCT03018288|468632454|FG001|Overall Study|Switched to alternative treatment.|0|||
130184081|NCT03018288|468632455|FG002|Overall Study|Switched to alternative treatment.|1|||
130184082|NCT03018288|468632456|FG003|Overall Study|Switched to alternative treatment.|0|||
130184083|NCT03018288|468632453|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184084|NCT03018288|468632454|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184085|NCT03018288|468632455|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
130184086|NCT03018288|468632456|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184087|NCT03018288|468632453|FG000|Overall Study|Screen failures|0|||
130184088|NCT03018288|468632454|FG001|Overall Study|Screen failures|0|||
130184089|NCT03018288|468632455|FG002|Overall Study|Screen failures|0|||
130184090|NCT03018288|468632456|FG003|Overall Study|Screen failures|51|||
130184091|NCT03018288|468632453|FG000|Overall Study|Chose treatment outside of UNC|0|||
130184092|NCT03018288|468632454|FG001|Overall Study|Chose treatment outside of UNC|0|||
130184093|NCT03018288|468632455|FG002|Overall Study|Chose treatment outside of UNC|0|||
130184094|NCT03018288|468632456|FG003|Overall Study|Chose treatment outside of UNC|1|||
130184095|NCT03018288|468632453|FG000|Overall Study|Unable to comply with protocol requirements|1|||
130184096|NCT03018288|468632454|FG001|Overall Study|Unable to comply with protocol requirements|1|||
130184097|NCT03018288|468632455|FG002|Overall Study|Unable to comply with protocol requirements|0|||
130184098|NCT03018288|468632456|FG003|Overall Study|Unable to comply with protocol requirements|1|||
130184099|NCT03018288|468632453|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130184100|NCT03018288|468632454|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
130184101|NCT03018288|468632455|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
130184102|NCT03018288|468632456|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
130184103|NCT03018288|468632453|FG000|Overall Study|Physician Decision|0|||
130184104|NCT03018288|468632454|FG001|Overall Study|Physician Decision|0|||
130184105|NCT03018288|468632455|FG002|Overall Study|Physician Decision|0|||
130184106|NCT03018288|468632456|FG003|Overall Study|Physician Decision|1|||
130184107|NCT01127256|468632459|FG000|Overall Study|Adverse Event|13|||
130184108|NCT01127256|468632460|FG001|Overall Study|Adverse Event|13|||
130184109|NCT01127256|468632459|FG000|Overall Study|Lack of Efficacy|4|||
130184110|NCT01127256|468632460|FG001|Overall Study|Lack of Efficacy|0|||
130184111|NCT01127256|468632459|FG000|Overall Study|Lost to Follow-up|16|||
130184112|NCT01127256|468632460|FG001|Overall Study|Lost to Follow-up|17|||
130184113|NCT01127256|468632459|FG000|Overall Study|Withdrawal by Subject|5|||
130184114|NCT01127256|468632460|FG001|Overall Study|Withdrawal by Subject|9|||
130184115|NCT01127256|468632459|FG000|Overall Study|Protocol Violation|1|||
130184116|NCT01127256|468632460|FG001|Overall Study|Protocol Violation|0|||
130184117|NCT01415518|468632461|FG000|Overall Study|Withdrawal by Subject|2|||
130184118|NCT01415518|468632462|FG001|Overall Study|Withdrawal by Subject|12|||
130184119|NCT01415518|468632461|FG000|Overall Study|Protocol Violation|6|||
130184120|NCT01415518|468632462|FG001|Overall Study|Protocol Violation|8|||
130184121|NCT01415518|468632461|FG000|Overall Study|Lost to Follow-up|3|||
130184122|NCT01415518|468632462|FG001|Overall Study|Lost to Follow-up|5|||
130184123|NCT01415518|468632461|FG000|Overall Study|Adverse Event|3|||
130184124|NCT01415518|468632462|FG001|Overall Study|Adverse Event|4|||
130184125|NCT01415518|468632461|FG000|Overall Study|Death|1|||
130184126|NCT01415518|468632462|FG001|Overall Study|Death|1|||
130184127|NCT01415518|468632461|FG000|Overall Study|Condition under Investigation Worsened|1|||
130184128|NCT01415518|468632462|FG001|Overall Study|Condition under Investigation Worsened|1|||
130184129|NCT00679211|468632463|FG000|Overall Study|Progressive disease|82|||
130184130|NCT00679211|468632463|FG000|Overall Study|Adverse Event|7|||
130184131|NCT00679211|468632463|FG000|Overall Study|Withdrawal by Subject|2|||
130184132|NCT00679211|468632463|FG000|Overall Study|Physician Decision|5|||
130184133|NCT00679211|468632463|FG000|Overall Study|Refused to undergo protocol procedures|1|||
130184134|NCT00679211|468632463|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
130184135|NCT00679211|468632463|FG000|Overall Study|Other|1|||
130184136|NCT01922037|468632464|FG000|Overall Study|Withdrawal by Subject|2|||
130184137|NCT01922037|468632465|FG001|Overall Study|Withdrawal by Subject|44|||
130184138|NCT01922037|468632464|FG000|Overall Study|Adverse Event|1|||
130184139|NCT01922037|468632465|FG001|Overall Study|Adverse Event|7|||
130184140|NCT01922037|468632464|FG000|Overall Study|Death|0|||
130184141|NCT01922037|468632465|FG001|Overall Study|Death|5|||
130184142|NCT01922037|468632464|FG000|Overall Study|Pregnancy|0|||
130184143|NCT01922037|468632465|FG001|Overall Study|Pregnancy|2|||
130184144|NCT01922037|468632464|FG000|Overall Study|Participant non-compliance|4|||
130184145|NCT01922037|468632465|FG001|Overall Study|Participant non-compliance|46|||
130184146|NCT01922037|468632464|FG000|Overall Study|Investigator/Sponsor decision|1|||
130184147|NCT01922037|468632465|FG001|Overall Study|Investigator/Sponsor decision|4|||
130184148|NCT01922037|468632464|FG000|Overall Study|Other unspecified|2|||
130184149|NCT01922037|468632465|FG001|Overall Study|Other unspecified|66|||
130184150|NCT01730053|468632467|FG000|Overall Study|Participant moved|0|||
130184151|NCT01730053|468632468|FG001|Overall Study|Participant moved|0|||
130184152|NCT01730053|468632469|FG002|Overall Study|Participant moved|1|||
130184153|NCT01730053|468632470|FG003|Overall Study|Participant moved|0|||
130184154|NCT01730053|468632471|FG004|Overall Study|Participant moved|0|||
130184155|NCT01730053|468632472|FG005|Overall Study|Participant moved|0|||
130184156|NCT01730053|468632467|FG000|Overall Study|Physician Decision|0|||
130184157|NCT01730053|468632468|FG001|Overall Study|Physician Decision|0|||
130184158|NCT01730053|468632469|FG002|Overall Study|Physician Decision|0|||
130184159|NCT01730053|468632470|FG003|Overall Study|Physician Decision|1|||
130184160|NCT01730053|468632471|FG004|Overall Study|Physician Decision|0|||
130184161|NCT01730053|468632472|FG005|Overall Study|Physician Decision|0|||
130184162|NCT01730053|468632467|FG000|Overall Study|Adverse Event|2|||
130184163|NCT01730053|468632468|FG001|Overall Study|Adverse Event|6|||
130184164|NCT01730053|468632469|FG002|Overall Study|Adverse Event|3|||
130184165|NCT01730053|468632470|FG003|Overall Study|Adverse Event|3|||
130184166|NCT01730053|468632471|FG004|Overall Study|Adverse Event|2|||
130184167|NCT01730053|468632472|FG005|Overall Study|Adverse Event|2|||
130184168|NCT01730053|468632467|FG000|Overall Study|Poor compliance to protocol|1|||
130184169|NCT01730053|468632468|FG001|Overall Study|Poor compliance to protocol|2|||
130184170|NCT01730053|468632469|FG002|Overall Study|Poor compliance to protocol|2|||
130184171|NCT01730053|468632470|FG003|Overall Study|Poor compliance to protocol|0|||
130184172|NCT01730053|468632471|FG004|Overall Study|Poor compliance to protocol|0|||
130184173|NCT01730053|468632472|FG005|Overall Study|Poor compliance to protocol|2|||
130184174|NCT01730053|468632467|FG000|Overall Study|Other than specified|2|||
130184175|NCT01730053|468632468|FG001|Overall Study|Other than specified|6|||
130184176|NCT01730053|468632469|FG002|Overall Study|Other than specified|5|||
130184177|NCT01730053|468632470|FG003|Overall Study|Other than specified|4|||
130184178|NCT01730053|468632471|FG004|Overall Study|Other than specified|7|||
130184179|NCT01730053|468632472|FG005|Overall Study|Other than specified|9|||
130184180|NCT01470248|468632473|FG000|Overall Study|Withdrawal by Subject|1|||
130184181|NCT02243605|468632476|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130184182|NCT02243605|468632477|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130184183|NCT02243605|468632476|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
130184184|NCT02243605|468632477|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
130184185|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
130184186|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
130184187|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
130184188|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
130184189|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Progression|0|||
130184190|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Progression|1|||
130184191|NCT02019472|468632478|FG000|Overall Study|Adverse Event|14|||
130184192|NCT02019472|468632479|FG001|Overall Study|Adverse Event|23|||
130184193|NCT02019472|468632480|FG002|Overall Study|Adverse Event|17|||
130184194|NCT02019472|468632478|FG000|Overall Study|Death|0|||
130184195|NCT02019472|468632479|FG001|Overall Study|Death|1|||
130184196|NCT02019472|468632480|FG002|Overall Study|Death|1|||
130184197|NCT02019472|468632478|FG000|Overall Study|Lack of Efficacy|7|||
130184198|NCT02019472|468632479|FG001|Overall Study|Lack of Efficacy|4|||
130184199|NCT02019472|468632480|FG002|Overall Study|Lack of Efficacy|4|||
130184200|NCT02019472|468632478|FG000|Overall Study|Lost to Follow-up|0|||
130184201|NCT02019472|468632479|FG001|Overall Study|Lost to Follow-up|2|||
130184202|NCT02019472|468632480|FG002|Overall Study|Lost to Follow-up|1|||
130184203|NCT02019472|468632478|FG000|Overall Study|Physician Decision|1|||
130184204|NCT02019472|468632479|FG001|Overall Study|Physician Decision|2|||
130184205|NCT02019472|468632480|FG002|Overall Study|Physician Decision|0|||
130184206|NCT02019472|468632478|FG000|Overall Study|Pregnancy|1|||
130184207|NCT02019472|468632479|FG001|Overall Study|Pregnancy|2|||
130184208|NCT02019472|468632480|FG002|Overall Study|Pregnancy|2|||
130184209|NCT02019472|468632478|FG000|Overall Study|Withdrawal by Subject|11|||
130184210|NCT02019472|468632479|FG001|Overall Study|Withdrawal by Subject|10|||
130184211|NCT02019472|468632480|FG002|Overall Study|Withdrawal by Subject|11|||
130184212|NCT02019472|468632478|FG000|Overall Study|Other|3|||
130184213|NCT02019472|468632479|FG001|Overall Study|Other|8|||
130184214|NCT02019472|468632480|FG002|Overall Study|Other|6|||
130184215|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
130184216|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
130184217|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184218|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184219|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184220|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184221|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
130184222|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
130184223|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
130184224|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
130184225|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
130184226|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
130184227|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
130184228|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
130184229|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
130184230|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184231|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184232|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184233|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
130184234|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
130184235|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
130184236|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184237|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184238|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184239|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
130184240|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
130184241|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
130184242|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184243|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184244|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184245|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Death|9|||
130184246|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Death|18|||
130184247|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Death|5|||
130184248|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Death|0|||
130184249|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Death|0|||
130184250|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Death|0|||
130184251|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184252|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184253|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184254|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
130184255|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184256|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184257|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184258|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184259|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184260|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184261|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184262|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184263|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184264|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184265|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184266|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184267|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
130184268|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
130184269|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184270|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184271|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184272|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130184273|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
130184274|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130184275|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184276|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184277|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184278|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
130184279|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130184280|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130184281|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184282|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184283|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184284|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130184285|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
130184286|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130184287|NCT05516108|468632491|FG000|Overall Study|Time Commitment|3|||
130184288|NCT05516108|468632492|FG001|Overall Study|Time Commitment|1|||
130184289|NCT05516108|468632491|FG000|Overall Study|Reason Unknown|2|||
130184290|NCT05516108|468632492|FG001|Overall Study|Reason Unknown|4|||
130184291|NCT02003209|468632493|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
130184292|NCT02003209|468632494|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
130184293|NCT00638508|468632495|FG000|Overall Study|Physician Decision|5|||
130184294|NCT00638508|468632496|FG001|Overall Study|Physician Decision|2|||
130184295|NCT00370552|468632497|FG000|Overall Study|Adverse Event|2|||
130184296|NCT00370552|468632498|FG001|Overall Study|Adverse Event|2|||
130184297|NCT00370552|468632499|FG002|Overall Study|Adverse Event|2|||
130184298|NCT00370552|468632497|FG000|Overall Study|Disease progression|23|||
130184299|NCT00370552|468632498|FG001|Overall Study|Disease progression|23|||
130184300|NCT00370552|468632499|FG002|Overall Study|Disease progression|15|||
130184301|NCT00370552|468632497|FG000|Overall Study|Maximum clinical benefit|3|||
130184302|NCT00370552|468632498|FG001|Overall Study|Maximum clinical benefit|5|||
130184303|NCT00370552|468632499|FG002|Overall Study|Maximum clinical benefit|5|||
130184304|NCT00370552|468632497|FG000|Overall Study|Poor or noncompliance|0|||
130184305|NCT00370552|468632498|FG001|Overall Study|Poor or noncompliance|0|||
130184306|NCT00370552|468632499|FG002|Overall Study|Poor or noncompliance|1|||
130184307|NCT00370552|468632497|FG000|Overall Study|Study drug toxicity|11|||
130184308|NCT00370552|468632498|FG001|Overall Study|Study drug toxicity|8|||
130184309|NCT00370552|468632499|FG002|Overall Study|Study drug toxicity|6|||
130184310|NCT00370552|468632497|FG000|Overall Study|Withdrawal by Subject|2|||
130184311|NCT00370552|468632498|FG001|Overall Study|Withdrawal by Subject|0|||
130184312|NCT00370552|468632499|FG002|Overall Study|Withdrawal by Subject|1|||
130184313|NCT00370552|468632497|FG000|Overall Study|Still on treatment|1|||
130184314|NCT00370552|468632498|FG001|Overall Study|Still on treatment|3|||
130184315|NCT00370552|468632499|FG002|Overall Study|Still on treatment|2|||
130184316|NCT00370552|468632497|FG000|Overall Study|Never treated|1|||
130184317|NCT00370552|468632498|FG001|Overall Study|Never treated|0|||
130184318|NCT00370552|468632499|FG002|Overall Study|Never treated|0|||
130184319|NCT00370552|468632497|FG000|Overall Study|Physician Decision|1|||
130184320|NCT00370552|468632498|FG001|Overall Study|Physician Decision|1|||
130184321|NCT00370552|468632499|FG002|Overall Study|Physician Decision|0|||
130184322|NCT00370552|468632497|FG000|Overall Study|Investigator decision|2|||
130184323|NCT00370552|468632498|FG001|Overall Study|Investigator decision|1|||
130184324|NCT00370552|468632499|FG002|Overall Study|Investigator decision|0|||
130184325|NCT00370552|468632497|FG000|Overall Study|High risk of allergic reaction|0|||
130184326|NCT00370552|468632498|FG001|Overall Study|High risk of allergic reaction|1|||
130184327|NCT00370552|468632499|FG002|Overall Study|High risk of allergic reaction|0|||
130184328|NCT00370552|468632497|FG000|Overall Study|Planned radiation for palliation|0|||
130184329|NCT00370552|468632498|FG001|Overall Study|Planned radiation for palliation|1|||
130184330|NCT00370552|468632499|FG002|Overall Study|Planned radiation for palliation|0|||
130184331|NCT03500198|468632500|FG000|Overall Study|Lost to Follow-up|0|||
130184332|NCT03500198|468632501|FG001|Overall Study|Lost to Follow-up|1|||
130184333|NCT01836471|468632513|FG000|Overall Study|Pregnancy|1|||
130184334|NCT01836471|468632514|FG001|Overall Study|Pregnancy|0|||
130184335|NCT01836471|468632515|FG002|Overall Study|Pregnancy|0|||
130184336|NCT01836471|468632516|FG003|Overall Study|Pregnancy|0|||
130184337|NCT01836471|468632517|FG004|Overall Study|Pregnancy|0|||
130184338|NCT01836471|468632513|FG000|Overall Study|Withdrawal by Subject|3|||
130184339|NCT01836471|468632514|FG001|Overall Study|Withdrawal by Subject|4|||
130184340|NCT01836471|468632515|FG002|Overall Study|Withdrawal by Subject|1|||
130184341|NCT01836471|468632516|FG003|Overall Study|Withdrawal by Subject|0|||
130184342|NCT01836471|468632517|FG004|Overall Study|Withdrawal by Subject|2|||
130184343|NCT01836471|468632513|FG000|Overall Study|Physician Decision|0|||
130184344|NCT01836471|468632514|FG001|Overall Study|Physician Decision|1|||
130184345|NCT01836471|468632515|FG002|Overall Study|Physician Decision|0|||
130184346|NCT01836471|468632516|FG003|Overall Study|Physician Decision|0|||
130184347|NCT01836471|468632517|FG004|Overall Study|Physician Decision|0|||
130184348|NCT01836471|468632513|FG000|Overall Study|Lost to Follow-up|0|||
130184349|NCT01836471|468632514|FG001|Overall Study|Lost to Follow-up|0|||
130184350|NCT01836471|468632515|FG002|Overall Study|Lost to Follow-up|0|||
130184351|NCT01836471|468632516|FG003|Overall Study|Lost to Follow-up|1|||
130184352|NCT01836471|468632517|FG004|Overall Study|Lost to Follow-up|1|||
130184353|NCT01836471|468632513|FG000|Overall Study|Adverse Event|6|||
130184354|NCT01836471|468632514|FG001|Overall Study|Adverse Event|3|||
130184355|NCT01836471|468632515|FG002|Overall Study|Adverse Event|1|||
130184356|NCT01836471|468632516|FG003|Overall Study|Adverse Event|1|||
130184357|NCT01836471|468632517|FG004|Overall Study|Adverse Event|2|||
130184358|NCT01836471|468632513|FG000|Overall Study|Non compliance with tx|1|||
130184359|NCT01836471|468632514|FG001|Overall Study|Non compliance with tx|1|||
130184360|NCT01836471|468632515|FG002|Overall Study|Non compliance with tx|0|||
130184361|NCT01836471|468632516|FG003|Overall Study|Non compliance with tx|0|||
130184362|NCT01836471|468632517|FG004|Overall Study|Non compliance with tx|0|||
130184363|NCT02285361|468632520|FG000|Overall Study|Protocol Violation|43|||
130184364|NCT02285361|468632520|FG000|Overall Study|Lost to Follow-up|5|||
130184365|NCT02285361|468632520|FG000|Overall Study|Not taken GIOTRIF|2|||
130184366|NCT02285361|468632520|FG000|Overall Study|Consented prior to the contract date|1|||
130184367|NCT03776357|468632524|FG000|Overall Study|Lost to Follow-up|3|||
130184368|NCT02755103|468632527|FG000|Overall Study|Lost to Follow-up|17|||
130184369|NCT02755103|468632528|FG001|Overall Study|Lost to Follow-up|15|||
130184370|NCT02755103|468632527|FG000|Overall Study|Death|0|||
130184371|NCT02755103|468632528|FG001|Overall Study|Death|1|||
130184372|NCT02755103|468632527|FG000|Overall Study|Physician Decision|0|||
130184373|NCT02755103|468632528|FG001|Overall Study|Physician Decision|1|||
130184374|NCT02755103|468632527|FG000|Overall Study|Pregnancy|0|||
130184375|NCT02755103|468632528|FG001|Overall Study|Pregnancy|1|||
130184376|NCT02755103|468632527|FG000|Overall Study|Withdrawal by Subject|3|||
130184377|NCT02755103|468632528|FG001|Overall Study|Withdrawal by Subject|0|||
130184378|NCT00658723|468632532|FG000|Overall Study|Lost to Follow-up|0|||
130184379|NCT00658723|468632533|FG001|Overall Study|Lost to Follow-up|2|||
130184380|NCT00658723|468632534|FG002|Overall Study|Lost to Follow-up|2|||
130184381|NCT00658723|468632532|FG000|Overall Study|Death|2|||
130184382|NCT00658723|468632533|FG001|Overall Study|Death|1|||
130184383|NCT00658723|468632534|FG002|Overall Study|Death|4|||
130184384|NCT00658723|468632532|FG000|Overall Study|Scheduling Issue|1|||
130184385|NCT00658723|468632533|FG001|Overall Study|Scheduling Issue|1|||
130184386|NCT00658723|468632534|FG002|Overall Study|Scheduling Issue|0|||
130184387|NCT00658723|468632532|FG000|Overall Study|Withdrawal by Subject|1|||
130184388|NCT00658723|468632533|FG001|Overall Study|Withdrawal by Subject|0|||
130184389|NCT00658723|468632534|FG002|Overall Study|Withdrawal by Subject|1|||
130184390|NCT02411656|468632535|FG000|Overall Study|Adverse Event|4|||
130184391|NCT02411656|468632535|FG000|Overall Study|Clinical Progression|33|||
130184392|NCT06481709|468632536|FG000|Overall Study|Withdrawal by Subject|0|||
130184393|NCT06481709|468632537|FG001|Overall Study|Withdrawal by Subject|0|||
130184394|NCT06481709|468632538|FG002|Overall Study|Withdrawal by Subject|2|||
130184395|NCT06481709|468632539|FG003|Overall Study|Withdrawal by Subject|0|||
130184396|NCT03305848|468632540|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
130184397|NCT03305848|468632540|FG000|Overall Study|Physician Decision|2|||
130184398|NCT05366010|468632544|FG000|Overall Study|Withdrawal by Subject|1|||
130184399|NCT05366010|468632544|FG000|Overall Study|Protocol Violation|1|||
130184400|NCT05366010|468632544|FG000|Overall Study|Lost to Follow-up|2|||
130184401|NCT05366010|468632544|FG000|Overall Study|Screen Failure|2|||
130184402|NCT00586703|468632545|FG000|Overall Study|Death|12|||
130184403|NCT01422213|468632546|FG000|Overall Study|Adverse Event|8|||
130184404|NCT01422213|468632547|FG001|Overall Study|Adverse Event|7|||
130184405|NCT01422213|468632548|FG002|Overall Study|Adverse Event|11|||
130184406|NCT01422213|468632546|FG000|Overall Study|Lack of Efficacy|10|||
130184407|NCT01422213|468632547|FG001|Overall Study|Lack of Efficacy|2|||
130184408|NCT01422213|468632548|FG002|Overall Study|Lack of Efficacy|2|||
130184409|NCT01422213|468632546|FG000|Overall Study|Non-compliance with study drug|0|||
130184410|NCT01422213|468632547|FG001|Overall Study|Non-compliance with study drug|1|||
130184411|NCT01422213|468632548|FG002|Overall Study|Non-compliance with study drug|0|||
130184412|NCT01422213|468632546|FG000|Overall Study|Protocol Violation|0|||
130184413|NCT01422213|468632547|FG001|Overall Study|Protocol Violation|2|||
130184414|NCT01422213|468632548|FG002|Overall Study|Protocol Violation|4|||
130184415|NCT01422213|468632546|FG000|Overall Study|Withdrawal of Consent|7|||
130184416|NCT01422213|468632547|FG001|Overall Study|Withdrawal of Consent|3|||
130184417|NCT01422213|468632548|FG002|Overall Study|Withdrawal of Consent|5|||
130184418|NCT01422213|468632546|FG000|Overall Study|Lost to Follow-up|3|||
130184419|NCT01422213|468632547|FG001|Overall Study|Lost to Follow-up|3|||
130184420|NCT01422213|468632548|FG002|Overall Study|Lost to Follow-up|5|||
130184421|NCT01422213|468632546|FG000|Overall Study|Administrative or Other Reason(s)|5|||
130184422|NCT01422213|468632547|FG001|Overall Study|Administrative or Other Reason(s)|4|||
130184423|NCT01422213|468632548|FG002|Overall Study|Administrative or Other Reason(s)|2|||
130184424|NCT05271175|468632549|FG000|One Week Follow up|Lost to Follow-up|10|||
130184425|NCT05271175|468632550|FG001|One Week Follow up|Lost to Follow-up|7|||
130184426|NCT05271175|468632551|FG002|One Week Follow up|Lost to Follow-up|5|||
130184427|NCT05271175|468632549|FG000|One Month Follow up|Lost to Follow-up|12|||
130184428|NCT05271175|468632550|FG001|One Month Follow up|Lost to Follow-up|7|||
130184429|NCT05271175|468632551|FG002|One Month Follow up|Lost to Follow-up|9|||
130184430|NCT05271175|468632549|FG000|Six Months Follow up|Lost to Follow-up|8|||
130184431|NCT05271175|468632550|FG001|Six Months Follow up|Lost to Follow-up|2|||
130184432|NCT05271175|468632551|FG002|Six Months Follow up|Lost to Follow-up|2|||
130184433|NCT00991887|468632552|FG000|Overall Study|Lost to Follow-up|2|||
130184434|NCT00991887|468632553|FG001|Overall Study|Lost to Follow-up|1|||
130184435|NCT01964976|468632554|FG000|Overall Study|Protocol Violation|31|||
130184436|NCT01891864|468632557|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130184437|NCT01891864|468632558|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130184438|NCT01891864|468632559|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184439|NCT01891864|468632560|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184440|NCT01891864|468632561|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184441|NCT01891864|468632562|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184442|NCT01891864|468632557|FG000|Treatment Period 1|Physician Decision|0|||
130184443|NCT01891864|468632558|FG001|Treatment Period 1|Physician Decision|1|||
130184444|NCT01891864|468632559|FG002|Treatment Period 1|Physician Decision|0|||
130184445|NCT01891864|468632560|FG003|Treatment Period 1|Physician Decision|0|||
130184446|NCT01891864|468632561|FG004|Treatment Period 1|Physician Decision|0|||
130184447|NCT01891864|468632562|FG005|Treatment Period 1|Physician Decision|0|||
130184448|NCT01891864|468632557|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184449|NCT01891864|468632558|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
130184450|NCT01891864|468632559|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184451|NCT01891864|468632560|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184452|NCT01891864|468632561|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184453|NCT01891864|468632562|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184454|NCT01891864|468632557|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130184455|NCT01891864|468632558|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130184456|NCT01891864|468632559|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184457|NCT01891864|468632560|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184458|NCT01891864|468632561|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184459|NCT01891864|468632562|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184460|NCT01891864|468632557|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130184461|NCT01891864|468632558|FG001|Treatment Period 1|Withdrawal by Subject|5|||
130184462|NCT01891864|468632559|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130184463|NCT01891864|468632560|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130184464|NCT01891864|468632561|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130184465|NCT01891864|468632562|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130184466|NCT01891864|468632557|FG000|Treatment Period 1|Lost to Follow-up|1|||
130184467|NCT01891864|468632558|FG001|Treatment Period 1|Lost to Follow-up|0|||
130184468|NCT01891864|468632559|FG002|Treatment Period 1|Lost to Follow-up|0|||
130184469|NCT01891864|468632560|FG003|Treatment Period 1|Lost to Follow-up|0|||
130184470|NCT01891864|468632561|FG004|Treatment Period 1|Lost to Follow-up|0|||
130184471|NCT01891864|468632562|FG005|Treatment Period 1|Lost to Follow-up|0|||
130184472|NCT01891864|468632557|FG000|Treatment Period 2|Protocol Violation|0|||
130184473|NCT01891864|468632558|FG001|Treatment Period 2|Protocol Violation|0|||
130184474|NCT01891864|468632559|FG002|Treatment Period 2|Protocol Violation|0|||
130184475|NCT01891864|468632560|FG003|Treatment Period 2|Protocol Violation|1|||
130184476|NCT01891864|468632561|FG004|Treatment Period 2|Protocol Violation|0|||
130184477|NCT01891864|468632562|FG005|Treatment Period 2|Protocol Violation|0|||
130184478|NCT01891864|468632557|FG000|Treatment Period 2|Physician Decision|0|||
130184479|NCT01891864|468632558|FG001|Treatment Period 2|Physician Decision|0|||
130184480|NCT01891864|468632559|FG002|Treatment Period 2|Physician Decision|1|||
130184481|NCT01891864|468632560|FG003|Treatment Period 2|Physician Decision|0|||
130184482|NCT01891864|468632561|FG004|Treatment Period 2|Physician Decision|0|||
130184483|NCT01891864|468632562|FG005|Treatment Period 2|Physician Decision|0|||
130184484|NCT01891864|468632557|FG000|Treatment Period 2|Site Termination|0|||
130184485|NCT01891864|468632558|FG001|Treatment Period 2|Site Termination|0|||
130184486|NCT01891864|468632559|FG002|Treatment Period 2|Site Termination|1|||
130184487|NCT01891864|468632560|FG003|Treatment Period 2|Site Termination|2|||
130184488|NCT01891864|468632561|FG004|Treatment Period 2|Site Termination|0|||
130184489|NCT01891864|468632562|FG005|Treatment Period 2|Site Termination|0|||
130184490|NCT01891864|468632557|FG000|Treatment Period 2|Lack of Efficacy|0|||
130184491|NCT01891864|468632558|FG001|Treatment Period 2|Lack of Efficacy|0|||
130184492|NCT01891864|468632559|FG002|Treatment Period 2|Lack of Efficacy|1|||
130184493|NCT01891864|468632560|FG003|Treatment Period 2|Lack of Efficacy|0|||
130184494|NCT01891864|468632561|FG004|Treatment Period 2|Lack of Efficacy|1|||
130184495|NCT01891864|468632562|FG005|Treatment Period 2|Lack of Efficacy|0|||
130184496|NCT01891864|468632557|FG000|Treatment Period 2|Adverse Event|0|||
130184497|NCT01891864|468632558|FG001|Treatment Period 2|Adverse Event|0|||
130184498|NCT01891864|468632559|FG002|Treatment Period 2|Adverse Event|1|||
130184499|NCT01891864|468632560|FG003|Treatment Period 2|Adverse Event|2|||
130184500|NCT01891864|468632561|FG004|Treatment Period 2|Adverse Event|0|||
130184501|NCT01891864|468632562|FG005|Treatment Period 2|Adverse Event|4|||
130184502|NCT01891864|468632557|FG000|Treatment Period 2|Termination of Site|0|||
130184503|NCT01891864|468632558|FG001|Treatment Period 2|Termination of Site|0|||
130184504|NCT01891864|468632559|FG002|Treatment Period 2|Termination of Site|0|||
130184505|NCT01891864|468632560|FG003|Treatment Period 2|Termination of Site|0|||
130184506|NCT01891864|468632561|FG004|Treatment Period 2|Termination of Site|2|||
130184507|NCT01891864|468632562|FG005|Treatment Period 2|Termination of Site|0|||
130184508|NCT01891864|468632557|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130184509|NCT01891864|468632558|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130184510|NCT01891864|468632559|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130184511|NCT01891864|468632560|FG003|Treatment Period 2|Withdrawal by Subject|4|||
130184512|NCT01891864|468632561|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130184513|NCT01891864|468632562|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130184514|NCT01891864|468632557|FG000|Extension Period|Lack of Efficacy|0|||
130184515|NCT01891864|468632558|FG001|Extension Period|Lack of Efficacy|0|||
130184516|NCT01891864|468632559|FG002|Extension Period|Lack of Efficacy|0|||
130184517|NCT01891864|468632560|FG003|Extension Period|Lack of Efficacy|1|||
130184518|NCT01891864|468632561|FG004|Extension Period|Lack of Efficacy|1|||
130184519|NCT01891864|468632562|FG005|Extension Period|Lack of Efficacy|0|||
130184520|NCT01891864|468632557|FG000|Extension Period|Pregnancy|0|||
130184521|NCT01891864|468632558|FG001|Extension Period|Pregnancy|0|||
130184522|NCT01891864|468632559|FG002|Extension Period|Pregnancy|1|||
130184523|NCT01891864|468632560|FG003|Extension Period|Pregnancy|0|||
130184524|NCT01891864|468632561|FG004|Extension Period|Pregnancy|0|||
130184525|NCT01891864|468632562|FG005|Extension Period|Pregnancy|0|||
130184526|NCT01891864|468632557|FG000|Extension Period|Adverse Event|0|||
130184527|NCT01891864|468632558|FG001|Extension Period|Adverse Event|0|||
130184528|NCT01891864|468632559|FG002|Extension Period|Adverse Event|4|||
130184529|NCT01891864|468632560|FG003|Extension Period|Adverse Event|2|||
130184530|NCT01891864|468632561|FG004|Extension Period|Adverse Event|2|||
130184531|NCT01891864|468632562|FG005|Extension Period|Adverse Event|0|||
130184532|NCT01891864|468632557|FG000|Extension Period|Withdrawal by Subject|0|||
130184533|NCT01891864|468632558|FG001|Extension Period|Withdrawal by Subject|0|||
130184534|NCT01891864|468632559|FG002|Extension Period|Withdrawal by Subject|1|||
130184535|NCT01891864|468632560|FG003|Extension Period|Withdrawal by Subject|2|||
130184536|NCT01891864|468632561|FG004|Extension Period|Withdrawal by Subject|4|||
130184537|NCT01891864|468632562|FG005|Extension Period|Withdrawal by Subject|0|||
130184538|NCT01891864|468632557|FG000|Extension Period|Lost to Follow-up|0|||
130184539|NCT01891864|468632558|FG001|Extension Period|Lost to Follow-up|0|||
130184540|NCT01891864|468632559|FG002|Extension Period|Lost to Follow-up|2|||
130184541|NCT01891864|468632560|FG003|Extension Period|Lost to Follow-up|0|||
130184542|NCT01891864|468632561|FG004|Extension Period|Lost to Follow-up|0|||
130184543|NCT01891864|468632562|FG005|Extension Period|Lost to Follow-up|0|||
130184544|NCT02698163|468632563|FG000|Overall Study|Lost to Follow-up|0|||
130184545|NCT02698163|468632564|FG001|Overall Study|Lost to Follow-up|1|||
130184546|NCT02892331|468632565|FG000|Overall Study|Withdrawal by Subject|0|||
130184547|NCT02892331|468632566|FG001|Overall Study|Withdrawal by Subject|1|||
130184548|NCT02892331|468632567|FG002|Overall Study|Withdrawal by Subject|1|||
130184549|NCT02892331|468632565|FG000|Overall Study|Sick family member|0|||
130184550|NCT02892331|468632566|FG001|Overall Study|Sick family member|0|||
130184551|NCT02892331|468632567|FG002|Overall Study|Sick family member|1|||
130184552|NCT02892331|468632565|FG000|Overall Study|Corona virus pandemic|1|||
130184553|NCT02892331|468632566|FG001|Overall Study|Corona virus pandemic|0|||
130184554|NCT02892331|468632567|FG002|Overall Study|Corona virus pandemic|1|||
130184555|NCT02892331|468632565|FG000|Overall Study|Lost to Follow-up|1|||
130184556|NCT02892331|468632566|FG001|Overall Study|Lost to Follow-up|0|||
130184557|NCT02892331|468632567|FG002|Overall Study|Lost to Follow-up|1|||
130184558|NCT02892331|468632565|FG000|Overall Study|Blood pressure was too elevated|0|||
130184559|NCT02892331|468632566|FG001|Overall Study|Blood pressure was too elevated|1|||
130184560|NCT02892331|468632567|FG002|Overall Study|Blood pressure was too elevated|0|||
130184561|NCT02892331|468632565|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130184562|NCT02892331|468632566|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
130184563|NCT02892331|468632567|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130184564|NCT00752128|468632571|FG000|Overall Study|Withdrawal by Subject|4|||
130184565|NCT00349973|468632572|FG000|Overall Study|Adverse Event|3|||
130184566|NCT00349973|468632573|FG001|Overall Study|Adverse Event|3|||
130184567|NCT00349973|468632572|FG000|Overall Study|Withdrawal by Subject|1|||
130184568|NCT00349973|468632573|FG001|Overall Study|Withdrawal by Subject|0|||
130184569|NCT02286713|468632574|FG000|One Week Follow-Up|Death|1|||
130184570|NCT02286713|468632575|FG001|One Week Follow-Up|Death|0|||
130184571|NCT02286713|468632574|FG000|One Week Follow-Up|Lost to Follow-up|17|||
130184572|NCT02286713|468632575|FG001|One Week Follow-Up|Lost to Follow-up|21|||
130184573|NCT02286713|468632574|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
130184574|NCT02286713|468632575|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
130184575|NCT02286713|468632574|FG000|Three Month Follow-Up|Death|1|||
130184576|NCT02286713|468632575|FG001|Three Month Follow-Up|Death|1|||
130184577|NCT02286713|468632574|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
130184578|NCT02286713|468632575|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
130184579|NCT02286713|468632574|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
130184580|NCT02286713|468632575|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
130184581|NCT02286713|468632574|FG000|Six Month Follow-Up|Death|2|||
130184582|NCT02286713|468632575|FG001|Six Month Follow-Up|Death|0|||
130184583|NCT02286713|468632574|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
130184584|NCT02286713|468632575|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
130184585|NCT04314037|468632576|FG000|Treatment Period 2|Adverse Event|1|||
130184586|NCT04314037|468632577|FG001|Treatment Period 2|Adverse Event|0|||
130184587|NCT04314037|468632576|FG000|Treatment Period 3|Protocol Violation|1|||
130184588|NCT04314037|468632577|FG001|Treatment Period 3|Protocol Violation|0|||
130184589|NCT04314037|468632576|FG000|Treatment Period 3|Adverse Event|0|||
130184590|NCT04314037|468632577|FG001|Treatment Period 3|Adverse Event|1|||
130184591|NCT03832686|468632580|FG000|Overall Study|Lost to Follow-up|6|||
130184592|NCT03832686|468632581|FG001|Overall Study|Lost to Follow-up|9|||
130184593|NCT03832686|468632580|FG000|Overall Study|Discontinued Intervention|5|||
130184594|NCT03832686|468632581|FG001|Overall Study|Discontinued Intervention|4|||
130184595|NCT05479435|468632582|FG000|Overall Study|Withdrawal by Subject|1|||
130184596|NCT05479435|468632583|FG001|Overall Study|Withdrawal by Subject|0|||
130184597|NCT05479435|468632584|FG002|Overall Study|Withdrawal by Subject|0|||
130184598|NCT05479435|468632582|FG000|Overall Study|Covid 19|0|||
130184599|NCT05479435|468632583|FG001|Overall Study|Covid 19|0|||
130184600|NCT05479435|468632584|FG002|Overall Study|Covid 19|2|||
130184601|NCT02325973|468634804|FG000|Overall Study|Death|5|||
130184602|NCT02325973|468634804|FG000|Overall Study|Withdrawal by subject or investigator|16|||
130184603|NCT02068508|468634805|FG000|Overall Study|Case report forms uncollected|27|||
130184604|NCT02068508|468634805|FG000|Overall Study|Patient did not visit the study site|1|||
130184605|NCT02068508|468634805|FG000|Overall Study|Protocol Violation|4|||
130184606|NCT03511105|468634809|FG000|Overall Study|Adverse Event|1|||
130184607|NCT03511105|468634810|FG001|Overall Study|Adverse Event|0|||
130184608|NCT03511105|468634809|FG000|Overall Study|Withdrew consent|1|||
130184609|NCT03511105|468634810|FG001|Overall Study|Withdrew consent|0|||
130184610|NCT02810457|468634811|FG000|Overall Study|Randomised but no treatment received|2|||
130184611|NCT02810457|468634812|FG001|Overall Study|Randomised but no treatment received|1|||
130184612|NCT02810457|468634811|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
130184613|NCT02810457|468634812|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
130184614|NCT02810457|468634811|FG000|Overall Study|Adverse Event|37|||
130184615|NCT02810457|468634812|FG001|Overall Study|Adverse Event|43|||
130184616|NCT02810457|468634811|FG000|Overall Study|Patient decision|31|||
130184617|NCT02810457|468634812|FG001|Overall Study|Patient decision|35|||
130184618|NCT02810457|468634811|FG000|Overall Study|Patient lost to follow-up|2|||
130184619|NCT02810457|468634812|FG001|Overall Study|Patient lost to follow-up|2|||
130184620|NCT02810457|468634811|FG000|Overall Study|Death|39|||
130184621|NCT02810457|468634812|FG001|Overall Study|Death|28|||
130184622|NCT02810457|468634811|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
130184623|NCT02810457|468634812|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
130184624|NCT02810457|468634811|FG000|Overall Study|Clinical progression|15|||
130184625|NCT02810457|468634812|FG001|Overall Study|Clinical progression|16|||
130184626|NCT02810457|468634811|FG000|Overall Study|Investigator decision|3|||
130184627|NCT02810457|468634812|FG001|Overall Study|Investigator decision|2|||
130184628|NCT02810457|468634811|FG000|Overall Study|Patient ineligibility|3|||
130184629|NCT02810457|468634812|FG001|Overall Study|Patient ineligibility|0|||
130184630|NCT02810457|468634811|FG000|Overall Study|Miscalculated PD|1|||
130184631|NCT02810457|468634812|FG001|Overall Study|Miscalculated PD|0|||
130184632|NCT02810457|468634811|FG000|Overall Study|Physician Decision|0|||
130184633|NCT02810457|468634812|FG001|Overall Study|Physician Decision|1|||
130184634|NCT04173507|468634813|FG000|Overall Study|On Treatment|3|||
130184635|NCT04173507|468634813|FG000|Overall Study|Adverse Event|3|||
130184636|NCT04173507|468634813|FG000|Overall Study|Progression/Relapse|34|||
130184637|NCT04173507|468634813|FG000|Overall Study|Death|2|||
130184638|NCT01217112|468634816|FG000|Overall Study|Adverse Event|0|||
130184639|NCT01217112|468634817|FG001|Overall Study|Adverse Event|2|||
130184640|NCT01217112|468634818|FG002|Overall Study|Adverse Event|0|||
130184641|NCT01217112|468634819|FG003|Overall Study|Adverse Event|2|||
130184642|NCT01217112|468634820|FG004|Overall Study|Adverse Event|0|||
130184643|NCT01217112|468634816|FG000|Overall Study|Withdrawal by Subject|0|||
130184644|NCT01217112|468634817|FG001|Overall Study|Withdrawal by Subject|0|||
130184645|NCT01217112|468634818|FG002|Overall Study|Withdrawal by Subject|1|||
130184646|NCT01217112|468634819|FG003|Overall Study|Withdrawal by Subject|0|||
130184647|NCT01217112|468634820|FG004|Overall Study|Withdrawal by Subject|0|||
130184648|NCT01217112|468634816|FG000|Overall Study|Physician Decision|0|||
130184649|NCT01217112|468634817|FG001|Overall Study|Physician Decision|0|||
130184650|NCT01217112|468634818|FG002|Overall Study|Physician Decision|0|||
130184651|NCT01217112|468634819|FG003|Overall Study|Physician Decision|0|||
130184652|NCT01217112|468634820|FG004|Overall Study|Physician Decision|1|||
130184653|NCT03192488|468634821|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
130184654|NCT03192488|468634822|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
130184655|NCT03192488|468634823|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
130184656|NCT03192488|468634824|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
130184657|NCT03192488|468634825|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
130184658|NCT03192488|468634826|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
130184659|NCT03192488|468634821|FG000|Third Intervention (d1)|Adverse Event|0|||
130184660|NCT03192488|468634822|FG001|Third Intervention (d1)|Adverse Event|0|||
130184661|NCT03192488|468634823|FG002|Third Intervention (d1)|Adverse Event|0|||
130184662|NCT03192488|468634824|FG003|Third Intervention (d1)|Adverse Event|0|||
130184663|NCT03192488|468634825|FG004|Third Intervention (d1)|Adverse Event|1|||
130184664|NCT03192488|468634826|FG005|Third Intervention (d1)|Adverse Event|0|||
130184665|NCT01401361|468634827|FG000|Overall Study|Withdrawal by Subject|16|||
130184666|NCT01401361|468634827|FG000|Overall Study|Lack of Efficacy|6|||
130184667|NCT01401361|468634827|FG000|Overall Study|Physician Decision|1|||
130184668|NCT01401361|468634827|FG000|Overall Study|Lost to Follow-up|3|||
130184669|NCT01401361|468634827|FG000|Overall Study|Subject/family decision post procedure|2|||
130184670|NCT02512302|468634829|FG000|Period 1|Adverse Event|0|||
130184671|NCT02512302|468634830|FG001|Period 1|Adverse Event|1|||
130184672|NCT02512302|468634831|FG002|Period 1|Adverse Event|0|||
130184673|NCT02512302|468634832|FG003|Period 1|Adverse Event|0|||
130184674|NCT02512302|468634833|FG004|Period 1|Adverse Event|0|||
130184675|NCT02512302|468634834|FG005|Period 1|Adverse Event|0|||
130184676|NCT02512302|468634835|FG006|Period 1|Adverse Event|0|||
130184677|NCT02512302|468634836|FG007|Period 1|Adverse Event|0|||
130184678|NCT02512302|468634837|FG008|Period 1|Adverse Event|0|||
130184679|NCT02512302|468634838|FG009|Period 1|Adverse Event|0|||
130184680|NCT02512302|468634829|FG000|Period 2|Adverse Event|0|||
130184681|NCT02512302|468634830|FG001|Period 2|Adverse Event|0|||
130184682|NCT02512302|468634831|FG002|Period 2|Adverse Event|0|||
130184683|NCT02512302|468634832|FG003|Period 2|Adverse Event|0|||
130184684|NCT02512302|468634833|FG004|Period 2|Adverse Event|0|||
130184685|NCT02512302|468634834|FG005|Period 2|Adverse Event|0|||
130184686|NCT02512302|468634835|FG006|Period 2|Adverse Event|0|||
130184687|NCT02512302|468634836|FG007|Period 2|Adverse Event|0|||
130184688|NCT02512302|468634837|FG008|Period 2|Adverse Event|0|||
130184689|NCT02512302|468634838|FG009|Period 2|Adverse Event|1|||
130184690|NCT02512302|468634829|FG000|Period 3|Lost to Follow-up|0|||
130184691|NCT02512302|468634830|FG001|Period 3|Lost to Follow-up|0|||
130184692|NCT02512302|468634831|FG002|Period 3|Lost to Follow-up|1|||
130184693|NCT02512302|468634832|FG003|Period 3|Lost to Follow-up|0|||
130184694|NCT02512302|468634833|FG004|Period 3|Lost to Follow-up|0|||
130184695|NCT02512302|468634834|FG005|Period 3|Lost to Follow-up|0|||
130184696|NCT02512302|468634835|FG006|Period 3|Lost to Follow-up|0|||
130184697|NCT02512302|468634836|FG007|Period 3|Lost to Follow-up|0|||
130184698|NCT02512302|468634837|FG008|Period 3|Lost to Follow-up|0|||
130184699|NCT02512302|468634838|FG009|Period 3|Lost to Follow-up|0|||
130184700|NCT02512302|468634829|FG000|Period 4|Adverse Event|0|||
130184701|NCT02512302|468634830|FG001|Period 4|Adverse Event|0|||
130184702|NCT02512302|468634831|FG002|Period 4|Adverse Event|0|||
130184703|NCT02512302|468634832|FG003|Period 4|Adverse Event|0|||
130184704|NCT02512302|468634833|FG004|Period 4|Adverse Event|0|||
130184705|NCT02512302|468634834|FG005|Period 4|Adverse Event|0|||
130184706|NCT02512302|468634835|FG006|Period 4|Adverse Event|1|||
130184707|NCT02512302|468634836|FG007|Period 4|Adverse Event|0|||
130184708|NCT02512302|468634837|FG008|Period 4|Adverse Event|0|||
130184709|NCT02512302|468634838|FG009|Period 4|Adverse Event|0|||
130184710|NCT02764762|468634842|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130184711|NCT02764762|468634842|FG000|Overall Study|Lost to Follow-up|4|||
130184712|NCT02764762|468634842|FG000|Overall Study|Voluntary Withdrawal|8|||
130184713|NCT02764762|468634842|FG000|Overall Study|Site Termination|1|||
130184714|NCT02764762|468634842|FG000|Overall Study|Lack of Efficacy|16|||
130184715|NCT02764762|468634842|FG000|Overall Study|Reason not Specified|1|||
130184716|NCT01002989|468634843|FG000|Overall Study|exclusion criteria, no consent|5|||
130184717|NCT01892501|468634844|FG000|Overall Study|Protocol Violation|2|||
130184718|NCT01892501|468634844|FG000|Overall Study|Puncture not carried out|9|||
130184719|NCT01892501|468634844|FG000|Overall Study|Radiological monitoring not carried out|5|||
130184720|NCT01892501|468634844|FG000|Overall Study|Non-contributory histological result|12|||
130184721|NCT01068860|468634846|FG000|Overall Study|Withdrawal by Subject|0|||
130184722|NCT01068860|468634847|FG001|Overall Study|Withdrawal by Subject|0|||
130184723|NCT01068860|468634848|FG002|Overall Study|Withdrawal by Subject|0|||
130184724|NCT01068860|468634849|FG003|Overall Study|Withdrawal by Subject|0|||
130184725|NCT01068860|468634850|FG004|Overall Study|Withdrawal by Subject|0|||
130184726|NCT01068860|468634851|FG005|Overall Study|Withdrawal by Subject|2|||
130184727|NCT01068860|468634852|FG006|Overall Study|Withdrawal by Subject|0|||
130184728|NCT01068860|468634853|FG007|Overall Study|Withdrawal by Subject|0|||
130184729|NCT01068860|468634854|FG008|Overall Study|Withdrawal by Subject|0|||
130184730|NCT01068860|468634855|FG009|Overall Study|Withdrawal by Subject|3|||
130184731|NCT01068860|468634846|FG000|Overall Study|Administrative problems; misrandomized|0|||
130184732|NCT01068860|468634847|FG001|Overall Study|Administrative problems; misrandomized|0|||
130184733|NCT01068860|468634848|FG002|Overall Study|Administrative problems; misrandomized|0|||
130184734|NCT01068860|468634849|FG003|Overall Study|Administrative problems; misrandomized|1|||
130184735|NCT01068860|468634850|FG004|Overall Study|Administrative problems; misrandomized|0|||
130184736|NCT01068860|468634851|FG005|Overall Study|Administrative problems; misrandomized|0|||
130184737|NCT01068860|468634852|FG006|Overall Study|Administrative problems; misrandomized|0|||
130184738|NCT01068860|468634853|FG007|Overall Study|Administrative problems; misrandomized|0|||
130184739|NCT01068860|468634854|FG008|Overall Study|Administrative problems; misrandomized|0|||
130184740|NCT01068860|468634855|FG009|Overall Study|Administrative problems; misrandomized|1|||
130184741|NCT01068860|468634846|FG000|Overall Study|Lost to Follow-up|0|||
130184742|NCT01068860|468634847|FG001|Overall Study|Lost to Follow-up|1|||
130184743|NCT01068860|468634848|FG002|Overall Study|Lost to Follow-up|0|||
130184744|NCT01068860|468634849|FG003|Overall Study|Lost to Follow-up|0|||
130184745|NCT01068860|468634850|FG004|Overall Study|Lost to Follow-up|0|||
130184746|NCT01068860|468634851|FG005|Overall Study|Lost to Follow-up|0|||
130184747|NCT01068860|468634852|FG006|Overall Study|Lost to Follow-up|0|||
130184748|NCT01068860|468634853|FG007|Overall Study|Lost to Follow-up|0|||
130184749|NCT01068860|468634854|FG008|Overall Study|Lost to Follow-up|0|||
130184750|NCT01068860|468634855|FG009|Overall Study|Lost to Follow-up|0|||
130184751|NCT01321879|468634856|FG000|Overall Study|Lack of Efficacy|5|||
130184752|NCT01321879|468634856|FG000|Overall Study|Adverse Event|5|||
130184753|NCT01321879|468634856|FG000|Overall Study|Death|3|||
130184754|NCT01321879|468634856|FG000|Overall Study|Withdrawal by Subject|1|||
130184755|NCT00513240|468634858|FG000|Overall Study|Did not have intended surgery|3|||
130184756|NCT00513240|468634859|FG001|Overall Study|Did not have intended surgery|0|||
130184757|NCT00513240|468634858|FG000|Overall Study|Death|3|||
130184758|NCT00513240|468634859|FG001|Overall Study|Death|3|||
130184759|NCT00513240|468634858|FG000|Overall Study|Withdrawal by Subject|7|||
130184760|NCT00513240|468634859|FG001|Overall Study|Withdrawal by Subject|4|||
130184761|NCT05263908|468634860|FG000|Overall Study|No informed consent for publication of study results|397|||
130184762|NCT05263908|468634860|FG000|Overall Study|CRF not collected|1|||
130184763|NCT01641640|468634861|FG000|Overall Study|Enrolled but not treated|1|||
130184764|NCT01641640|468634861|FG000|Overall Study|Efficacy failure|29|||
130184765|NCT01641640|468634861|FG000|Overall Study|Lost to Follow-up|3|||
130184766|NCT01641640|468634861|FG000|Overall Study|Withdrawal by Subject|2|||
130184767|NCT01641640|468634861|FG000|Overall Study|Adverse Event|1|||
130184768|NCT01234350|468634863|FG000|Overall Study|Adverse Event|277|||
130184769|NCT01234350|468634864|FG001|Overall Study|Adverse Event|92|||
130184770|NCT01234350|468634863|FG000|Overall Study|Withdrawal by Subject|61|||
130184771|NCT01234350|468634864|FG001|Overall Study|Withdrawal by Subject|36|||
130184772|NCT01234350|468634863|FG000|Overall Study|Lost to Follow-up|115|||
130184773|NCT01234350|468634864|FG001|Overall Study|Lost to Follow-up|47|||
130184774|NCT01234350|468634863|FG000|Overall Study|Covers a diverse set of reasons|234|||
130184775|NCT01234350|468634864|FG001|Overall Study|Covers a diverse set of reasons|92|||
130184776|NCT01930162|468634867|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130184777|NCT01930162|468634867|FG000|Overall Study|Death|1|||
130184778|NCT01051960|468634868|FG000|Overall Study|Adverse Event|1|||
130184779|NCT02069015|468634878|FG000|Overall Study|Lost to Follow-up|39|||
130184780|NCT02069015|468634879|FG001|Overall Study|Lost to Follow-up|32|||
130184781|NCT02069015|468634878|FG000|Overall Study|Withdrawal by Subject|1|||
130184782|NCT02069015|468634879|FG001|Overall Study|Withdrawal by Subject|1|||
130184783|NCT01082328|468634880|FG000|Overall Study|Adverse Event|1|||
130184784|NCT00031590|468634881|FG000|Overall Study|Adverse Event|1|||
130184785|NCT00031590|468634881|FG000|Overall Study|Withdrawal by parents|2|||
130184786|NCT05506046|468634882|FG000|Overall Study|Lost to Follow-up|89|||
130184787|NCT05506046|468634883|FG001|Overall Study|Lost to Follow-up|101|||
130184788|NCT05506046|468634884|FG002|Overall Study|Lost to Follow-up|102|||
130184789|NCT05506046|468634885|FG003|Overall Study|Lost to Follow-up|99|||
130184790|NCT03051100|468634887|FG000|Overall Study|Withdrawal by Subject|1|||
130184791|NCT03051100|468634888|FG001|Overall Study|Withdrawal by Subject|0|||
130184792|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
130184793|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
130184794|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
130184795|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
130184796|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
130184797|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
130184798|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
130184799|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
130184800|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
130184801|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
130184802|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
130184803|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
130184804|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
130184805|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
130184806|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
130184807|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
130184808|NCT00789854|468634893|FG000|Overall Study|Adverse Event|28|||
130184809|NCT00789854|468634894|FG001|Overall Study|Adverse Event|23|||
130184810|NCT00789854|468634895|FG002|Overall Study|Adverse Event|18|||
130184811|NCT00789854|468634893|FG000|Overall Study|Lost to Follow-up|1|||
130184812|NCT00789854|468634894|FG001|Overall Study|Lost to Follow-up|1|||
130184813|NCT00789854|468634895|FG002|Overall Study|Lost to Follow-up|4|||
130184814|NCT00789854|468634893|FG000|Overall Study|Withdrawal by Subject|9|||
130184815|NCT00789854|468634894|FG001|Overall Study|Withdrawal by Subject|6|||
130184816|NCT00789854|468634895|FG002|Overall Study|Withdrawal by Subject|17|||
130184817|NCT00789854|468634893|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130184818|NCT00789854|468634894|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
130184819|NCT00789854|468634895|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130184820|NCT00789854|468634893|FG000|Overall Study|Severe non-compliance to the protocol|3|||
130184821|NCT00789854|468634894|FG001|Overall Study|Severe non-compliance to the protocol|0|||
130184822|NCT00789854|468634895|FG002|Overall Study|Severe non-compliance to the protocol|0|||
130184823|NCT00789854|468634893|FG000|Overall Study|Safety reasons|0|||
130184824|NCT00789854|468634894|FG001|Overall Study|Safety reasons|0|||
130184825|NCT00789854|468634895|FG002|Overall Study|Safety reasons|2|||
130184826|NCT00789854|468634893|FG000|Overall Study|Other|6|||
130184827|NCT00789854|468634894|FG001|Overall Study|Other|0|||
130184828|NCT00789854|468634895|FG002|Overall Study|Other|5|||
130184829|NCT00923013|468634896|FG000|Overall Study|Refused further treatment|0|||
130184830|NCT00923013|468634897|FG001|Overall Study|Refused further treatment|1|||
130184831|NCT00923013|468634898|FG002|Overall Study|Refused further treatment|2|||
130184832|NCT00923013|468634899|FG003|Overall Study|Refused further treatment|0|||
130184833|NCT00923013|468634900|FG004|Overall Study|Refused further treatment|0|||
130184834|NCT00923013|468634901|FG005|Overall Study|Refused further treatment|0|||
130184835|NCT00923013|468634896|FG000|Overall Study|Switched to alternative treatment|0|||
130184836|NCT00923013|468634897|FG001|Overall Study|Switched to alternative treatment|1|||
130184837|NCT00923013|468634898|FG002|Overall Study|Switched to alternative treatment|0|||
130184838|NCT00923013|468634899|FG003|Overall Study|Switched to alternative treatment|0|||
130184839|NCT00923013|468634900|FG004|Overall Study|Switched to alternative treatment|0|||
130184840|NCT00923013|468634901|FG005|Overall Study|Switched to alternative treatment|0|||
130184841|NCT00923013|468634896|FG000|Overall Study|Death on study|2|||
130184842|NCT00923013|468634897|FG001|Overall Study|Death on study|2|||
130184843|NCT00923013|468634898|FG002|Overall Study|Death on study|0|||
130184844|NCT00923013|468634899|FG003|Overall Study|Death on study|1|||
130184845|NCT00923013|468634900|FG004|Overall Study|Death on study|0|||
130184846|NCT00923013|468634901|FG005|Overall Study|Death on study|0|||
130184847|NCT02224157|468634903|FG000|Overall Study|Severe non-compliance to protocol|2|||
130184848|NCT02224157|468634904|FG001|Overall Study|Severe non-compliance to protocol|2|||
130184849|NCT02224157|468634903|FG000|Overall Study|Other|13|||
130184850|NCT02224157|468634904|FG001|Overall Study|Other|10|||
130184851|NCT02224157|468634903|FG000|Overall Study|Subject decision|58|||
130184852|NCT02224157|468634904|FG001|Overall Study|Subject decision|50|||
130184853|NCT02224157|468634903|FG000|Overall Study|Prematurely closed site|4|||
130184854|NCT02224157|468634904|FG001|Overall Study|Prematurely closed site|2|||
130184855|NCT02224157|468634903|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130184856|NCT02224157|468634904|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
130184857|NCT02224157|468634903|FG000|Overall Study|Lost to Follow-up|27|||
130184858|NCT02224157|468634904|FG001|Overall Study|Lost to Follow-up|35|||
130184859|NCT02224157|468634903|FG000|Overall Study|Death|1|||
130184860|NCT02224157|468634904|FG001|Overall Study|Death|1|||
130184861|NCT02224157|468634903|FG000|Overall Study|Adverse Event|1|||
130184862|NCT02224157|468634904|FG001|Overall Study|Adverse Event|3|||
130184863|NCT05906628|468634907|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
130184864|NCT05906628|468634908|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
130184865|NCT05906628|468634907|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
130184866|NCT05906628|468634908|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
130184867|NCT05906628|468634907|FG000|16-Week DBVC Period|Protocol Violation|4|||
130184868|NCT05906628|468634908|FG001|16-Week DBVC Period|Protocol Violation|2|||
130184869|NCT05906628|468634907|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
130184870|NCT05906628|468634908|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
130184871|NCT05906628|468634907|FG000|16-Week OLE Period|Death|1|||
130184872|NCT05906628|468634908|FG001|16-Week OLE Period|Death|0|||
130184873|NCT05906628|468634907|FG000|16-Week OLE Period|Lost to Follow-up|1|||
130184874|NCT05906628|468634908|FG001|16-Week OLE Period|Lost to Follow-up|1|||
130184875|NCT05906628|468634907|FG000|16-Week OLE Period|Protocol Violation|0|||
130184876|NCT05906628|468634908|FG001|16-Week OLE Period|Protocol Violation|1|||
130184877|NCT05906628|468634907|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
130184878|NCT05906628|468634908|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
130184879|NCT04578535|468634909|FG000|Overall Study|Lost to Follow-up|1|||
130184880|NCT04578535|468634910|FG001|Overall Study|Lost to Follow-up|0|||
130184881|NCT04578535|468634911|FG002|Overall Study|Lost to Follow-up|0|||
130184882|NCT04578535|468634912|FG003|Overall Study|Lost to Follow-up|1|||
130184883|NCT04578535|468634913|FG004|Overall Study|Lost to Follow-up|0|||
130184884|NCT04578535|468634914|FG005|Overall Study|Lost to Follow-up|2|||
130184885|NCT04578535|468634909|FG000|Overall Study|Pregnancy|1|||
130184886|NCT04578535|468634910|FG001|Overall Study|Pregnancy|0|||
130184887|NCT04578535|468634911|FG002|Overall Study|Pregnancy|0|||
130184888|NCT04578535|468634912|FG003|Overall Study|Pregnancy|0|||
130184889|NCT04578535|468634913|FG004|Overall Study|Pregnancy|0|||
130184890|NCT04578535|468634914|FG005|Overall Study|Pregnancy|0|||
130184891|NCT04578535|468634909|FG000|Overall Study|Withdrawal by Subject|0|||
130184892|NCT04578535|468634910|FG001|Overall Study|Withdrawal by Subject|0|||
130184893|NCT04578535|468634911|FG002|Overall Study|Withdrawal by Subject|0|||
130184894|NCT04578535|468634912|FG003|Overall Study|Withdrawal by Subject|1|||
130184895|NCT04578535|468634913|FG004|Overall Study|Withdrawal by Subject|1|||
130184896|NCT04578535|468634914|FG005|Overall Study|Withdrawal by Subject|5|||
130184897|NCT04578535|468634909|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
130184898|NCT04578535|468634910|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
130184899|NCT04578535|468634911|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
130184900|NCT04578535|468634912|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
130184901|NCT04578535|468634913|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
130184902|NCT04578535|468634914|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
130184903|NCT01060072|468634915|FG000|Overall Study|Adverse Event|1|||
130184904|NCT01060072|468634916|FG001|Overall Study|Adverse Event|1|||
130184905|NCT01060072|468634915|FG000|Overall Study|Physician Decision|0|||
130184906|NCT01060072|468634916|FG001|Overall Study|Physician Decision|2|||
130184907|NCT01060072|468634915|FG000|Overall Study|Protocol Violation|0|||
130184908|NCT01060072|468634916|FG001|Overall Study|Protocol Violation|1|||
130184909|NCT01060072|468634915|FG000|Overall Study|Acute cholecystitis|1|||
130184910|NCT01060072|468634916|FG001|Overall Study|Acute cholecystitis|0|||
130184911|NCT01060072|468634915|FG000|Overall Study|Excluded Medications|0|||
130184912|NCT01060072|468634916|FG001|Overall Study|Excluded Medications|1|||
130184913|NCT00837148|468634917|FG000|Overall Study|Adverse Event|1|||
130184914|NCT00837148|468634917|FG000|Overall Study|Death|1|||
130184915|NCT02301169|468634920|FG000|Overall Study|Adverse Event|1|||
130184916|NCT02301169|468634921|FG001|Overall Study|Adverse Event|0|||
130184917|NCT03839628|468634922|FG000|Overall Study|Withdrawal by Subject|1|||
130184918|NCT00380874|468634923|FG000|Overall Study|Adverse Event|7|||
130184919|NCT00380874|468634924|FG001|Overall Study|Adverse Event|7|||
130184920|NCT00380874|468634923|FG000|Overall Study|Death|1|||
130184921|NCT00380874|468634924|FG001|Overall Study|Death|0|||
130184922|NCT00380874|468634923|FG000|Overall Study|Withdrawal by Subject|2|||
130184923|NCT00380874|468634924|FG001|Overall Study|Withdrawal by Subject|1|||
130184924|NCT00380874|468634923|FG000|Overall Study|Not related to study drug|3|||
130184925|NCT00380874|468634924|FG001|Overall Study|Not related to study drug|2|||
130184926|NCT01707290|468634929|FG000|Overall Study|Adverse event (AE)|1|||
130184927|NCT01707290|468634930|FG001|Overall Study|Adverse event (AE)|0|||
130184928|NCT01707290|468634929|FG000|Overall Study|Physician Decision|1|||
130184929|NCT01707290|468634930|FG001|Overall Study|Physician Decision|0|||
130184930|NCT01707290|468634929|FG000|Overall Study|Lost to Follow-up|3|||
130184931|NCT01707290|468634930|FG001|Overall Study|Lost to Follow-up|0|||
130184932|NCT01707290|468634929|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
130184933|NCT01707290|468634930|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
130184934|NCT01707290|468634929|FG000|Overall Study|Commercial drug available|60|||
130184935|NCT01707290|468634930|FG001|Overall Study|Commercial drug available|1|||
130184936|NCT01707290|468634929|FG000|Overall Study|Other unspecified|17|||
130184937|NCT01707290|468634930|FG001|Overall Study|Other unspecified|0|||
130184938|NCT01198470|468634931|FG000|Overall Study|Adverse Event|2|||
130184939|NCT02949973|468634932|FG000|Overall Study|Physician Decision|1|||
130184940|NCT02857816|468634933|FG000|Overall Study|Screen Failure|33|||
130184941|NCT02857816|468634933|FG000|Overall Study|Withdrawal by Subject|4|||
130184942|NCT02857816|468634933|FG000|Overall Study|Lost to Follow-up|1|||
130184943|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130184944|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184945|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184946|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184947|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184948|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130184949|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184950|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
130184951|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
130184952|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
130184953|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
130184954|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
130184955|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
130184956|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
130184957|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184958|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
130184959|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184960|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184961|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184962|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
130184963|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184964|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Other|0|||
130184965|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Other|3|||
130184966|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Other|3|||
130184967|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Other|0|||
130184968|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Other|1|||
130184969|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Other|0|||
130184970|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Other|0|||
130184971|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184972|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184973|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184974|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184975|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184976|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184977|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184978|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184979|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184980|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184981|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
130184982|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184983|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184984|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184985|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184986|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
130184987|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184988|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184989|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184990|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184991|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184992|NCT03181633|468634943|FG000|Overall Study|Withdrawal by Subject|1|||
130184993|NCT03181633|468634943|FG000|Overall Study|Missing follow-up visit|1|||
130184994|NCT01597778|468634945|FG000|Overall Study|Death|7|||
130184995|NCT01597778|468634946|FG001|Overall Study|Death|10|||
130184996|NCT01597778|468634945|FG000|Overall Study|Withdrawal by Subject|3|||
130184997|NCT01597778|468634946|FG001|Overall Study|Withdrawal by Subject|4|||
130184998|NCT01597778|468634945|FG000|Overall Study|Adverse Event|1|||
130184999|NCT01597778|468634946|FG001|Overall Study|Adverse Event|1|||
130185000|NCT01597778|468634945|FG000|Overall Study|Protocol Violation|1|||
130185001|NCT01597778|468634946|FG001|Overall Study|Protocol Violation|11|||
130185002|NCT01597778|468634945|FG000|Overall Study|Transplanted off protocol|2|||
130185003|NCT01597778|468634946|FG001|Overall Study|Transplanted off protocol|3|||
130185004|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185005|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
130185006|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185007|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185008|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
130185009|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185010|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
130185011|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
130185012|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185013|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185014|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185015|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
130185016|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185017|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185018|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185019|NCT04837196|468634956|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185020|NCT04837196|468634957|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185021|NCT04837196|468634958|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
130185022|NCT04837196|468634959|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185023|NCT04837196|468634960|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185024|NCT04837196|468634956|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185025|NCT04837196|468634957|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185026|NCT04837196|468634958|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
130185027|NCT04837196|468634959|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185028|NCT04837196|468634960|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185029|NCT01522456|468634961|FG000|Overall Study|Adverse Event|2|||
130185030|NCT01522456|468634961|FG000|Overall Study|Lost to Follow-up|2|||
130185031|NCT01522456|468634961|FG000|Overall Study|Withdrawal by Subject|2|||
130185032|NCT01522456|468634961|FG000|Overall Study|Pregnancy|1|||
130185033|NCT01522456|468634961|FG000|Overall Study|Tolerability Assessment|1|||
130185034|NCT01565889|468634965|FG000|Part A|Withdrawal by Subject|1|||
130185035|NCT01565889|468634966|FG001|Part A|Withdrawal by Subject|0|||
130185036|NCT01565889|468634967|FG002|Part A|Withdrawal by Subject|0|||
130185037|NCT01565889|468634968|FG003|Part A|Withdrawal by Subject|0|||
130185038|NCT01565889|468634969|FG004|Part A|Withdrawal by Subject|0|||
130185039|NCT01565889|468634970|FG005|Part A|Withdrawal by Subject|0|||
130185040|NCT01565889|468634965|FG000|Part B|Withdrawal by Subject|0|||
130185041|NCT01565889|468634966|FG001|Part B|Withdrawal by Subject|0|||
130185042|NCT01565889|468634967|FG002|Part B|Withdrawal by Subject|0|||
130185043|NCT01565889|468634968|FG003|Part B|Withdrawal by Subject|0|||
130185044|NCT01565889|468634969|FG004|Part B|Withdrawal by Subject|0|||
130185045|NCT01565889|468634970|FG005|Part B|Withdrawal by Subject|1|||
130185046|NCT01565889|468634965|FG000|Part B|Lack of Efficacy|0|||
130185047|NCT01565889|468634966|FG001|Part B|Lack of Efficacy|0|||
130185048|NCT01565889|468634967|FG002|Part B|Lack of Efficacy|0|||
130185049|NCT01565889|468634968|FG003|Part B|Lack of Efficacy|0|||
130185050|NCT01565889|468634969|FG004|Part B|Lack of Efficacy|0|||
130185051|NCT01565889|468634970|FG005|Part B|Lack of Efficacy|2|||
130185052|NCT01565889|468634965|FG000|Part B|Lost to Follow-up|0|||
130185053|NCT01565889|468634966|FG001|Part B|Lost to Follow-up|0|||
130185054|NCT01565889|468634967|FG002|Part B|Lost to Follow-up|0|||
130185055|NCT01565889|468634968|FG003|Part B|Lost to Follow-up|0|||
130185056|NCT01565889|468634969|FG004|Part B|Lost to Follow-up|0|||
130185057|NCT01565889|468634970|FG005|Part B|Lost to Follow-up|1|||
130185058|NCT02723344|468634971|FG000|Overall Study|Lost to Follow-up|0|||
130185059|NCT02723344|468634972|FG001|Overall Study|Lost to Follow-up|4|||
130185060|NCT01326845|468634975|FG000|Overall Study|Administrative Problems|5|||
130185061|NCT01326845|468634976|FG001|Overall Study|Administrative Problems|2|||
130185062|NCT01326845|468634975|FG000|Overall Study|Adverse Event|1|||
130185063|NCT01326845|468634976|FG001|Overall Study|Adverse Event|0|||
130185064|NCT01326845|468634975|FG000|Overall Study|Misisng|1|||
130185065|NCT01326845|468634976|FG001|Overall Study|Misisng|3|||
130185066|NCT02964247|468634977|FG000|Overall Study|Lost to Follow-up|2|||
130185067|NCT02964247|468634978|FG001|Overall Study|Lost to Follow-up|0|||
130185068|NCT02964247|468634977|FG000|Overall Study|Withdrawal by Subject|1|||
130185069|NCT02964247|468634978|FG001|Overall Study|Withdrawal by Subject|2|||
130185070|NCT03918629|468634979|FG000|Overall Study|Adverse Event|19|||
130185071|NCT03918629|468634980|FG001|Overall Study|Adverse Event|20|||
130185072|NCT03918629|468634979|FG000|Overall Study|Death|14|||
130185073|NCT03918629|468634980|FG001|Overall Study|Death|7|||
130185074|NCT03918629|468634979|FG000|Overall Study|Lost to Follow-up|36|||
130185075|NCT03918629|468634980|FG001|Overall Study|Lost to Follow-up|28|||
130185076|NCT03918629|468634979|FG000|Overall Study|Physician Decision|1|||
130185077|NCT03918629|468634980|FG001|Overall Study|Physician Decision|0|||
130185078|NCT03918629|468634979|FG000|Overall Study|Protocol Violation|7|||
130185079|NCT03918629|468634980|FG001|Overall Study|Protocol Violation|4|||
130185080|NCT03918629|468634979|FG000|Overall Study|Withdrawal by Subject|47|||
130185081|NCT03918629|468634980|FG001|Overall Study|Withdrawal by Subject|47|||
130185082|NCT03918629|468634979|FG000|Overall Study|Other|7|||
130185083|NCT03918629|468634980|FG001|Overall Study|Other|11|||
130185084|NCT03918629|468634979|FG000|Overall Study|Randomized but not vaccinated|2|||
130185085|NCT03918629|468634980|FG001|Overall Study|Randomized but not vaccinated|1|||
130185086|NCT01709500|468634984|FG000|Overall Study|Randomized but not treated|0|||
130185087|NCT01709500|468634985|FG001|Overall Study|Randomized but not treated|1|||
130185088|NCT01709500|468634984|FG000|Overall Study|Adverse Event|5|||
130185089|NCT01709500|468634985|FG001|Overall Study|Adverse Event|1|||
130185090|NCT01709500|468634984|FG000|Overall Study|Poor compliance to protocol|2|||
130185091|NCT01709500|468634985|FG001|Overall Study|Poor compliance to protocol|1|||
130185092|NCT01709500|468634984|FG000|Overall Study|Other|3|||
130185093|NCT01709500|468634985|FG001|Overall Study|Other|1|||
130185094|NCT01709500|468634984|FG000|Overall Study|Related to IMP administration|1|||
130185095|NCT01709500|468634985|FG001|Overall Study|Related to IMP administration|0|||
130185096|NCT01709500|468634984|FG000|Overall Study|Treatment ongoing|156|||
130185097|NCT01709500|468634985|FG001|Overall Study|Treatment ongoing|78|||
130185098|NCT00740636|468634987|FG000|Overall Study|Adverse Event|0|||
130185099|NCT00740636|468634988|FG001|Overall Study|Adverse Event|2|||
130185100|NCT00740636|468634987|FG000|Overall Study|Patient Ineligible|0|||
130185101|NCT00740636|468634988|FG001|Overall Study|Patient Ineligible|1|||
130185102|NCT00740636|468634987|FG000|Overall Study|Patient Not Treated|0|||
130185103|NCT00740636|468634988|FG001|Overall Study|Patient Not Treated|1|||
130185104|NCT00740636|468634987|FG000|Overall Study|Progressive Disease|1|||
130185105|NCT00740636|468634988|FG001|Overall Study|Progressive Disease|0|||
130185106|NCT00740636|468634987|FG000|Overall Study|Death|1|||
130185107|NCT00740636|468634988|FG001|Overall Study|Death|0|||
130185108|NCT02844543|468636637|FG000|Overall Study|Withdrawal by Subject|4|||
130185109|NCT02844543|468636637|FG000|Overall Study|Did not meet eligibility criteria|1|||
130185110|NCT04710576|468636643|FG000|Overall Study|Participants still in the study|73|||
130185111|NCT04710576|468636644|FG001|Overall Study|Participants still in the study|70|||
130185112|NCT04710576|468636645|FG002|Overall Study|Participants still in the study|60|||
130185113|NCT04710576|468636643|FG000|Overall Study|Death|2|||
130185114|NCT04710576|468636644|FG001|Overall Study|Death|7|||
130185115|NCT04710576|468636645|FG002|Overall Study|Death|12|||
130185116|NCT04710576|468636643|FG000|Overall Study|Withdrawal by Subject|4|||
130185117|NCT04710576|468636644|FG001|Overall Study|Withdrawal by Subject|3|||
130185118|NCT04710576|468636645|FG002|Overall Study|Withdrawal by Subject|7|||
130185119|NCT04710576|468636643|FG000|Overall Study|Sponsor decision|1|||
130185120|NCT04710576|468636644|FG001|Overall Study|Sponsor decision|0|||
130185121|NCT04710576|468636645|FG002|Overall Study|Sponsor decision|0|||
130185122|NCT04581824|468636646|FG000|Overall Study|Lost to Follow-up|1|||
130185123|NCT04581824|468636647|FG001|Overall Study|Lost to Follow-up|0|||
130185124|NCT04581824|468636646|FG000|Overall Study|Withdrawal by Subject|2|||
130185125|NCT04581824|468636647|FG001|Overall Study|Withdrawal by Subject|7|||
130185126|NCT04581824|468636646|FG000|Overall Study|Study terminated by sponsor|37|||
130185127|NCT04581824|468636647|FG001|Overall Study|Study terminated by sponsor|23|||
130185128|NCT04796909|468636648|FG000|Overall Study|Withdrawal by Subject|1|||
130185129|NCT04796909|468636649|FG001|Overall Study|Withdrawal by Subject|1|||
130185130|NCT03879135|468636650|FG000|Overall Study|Physician Decision|0|||
130185131|NCT03879135|468636651|FG001|Overall Study|Physician Decision|0|||
130185132|NCT03879135|468636652|FG002|Overall Study|Physician Decision|0|||
130185133|NCT03879135|468636653|FG003|Overall Study|Physician Decision|1|||
130185134|NCT03879135|468636654|FG004|Overall Study|Physician Decision|0|||
130185135|NCT03879135|468636655|FG005|Overall Study|Physician Decision|0|||
130185136|NCT03879135|468636650|FG000|Overall Study|Withdrawal by Subject|0|||
130185137|NCT03879135|468636651|FG001|Overall Study|Withdrawal by Subject|0|||
130185138|NCT03879135|468636652|FG002|Overall Study|Withdrawal by Subject|0|||
130185139|NCT03879135|468636653|FG003|Overall Study|Withdrawal by Subject|0|||
130185140|NCT03879135|468636654|FG004|Overall Study|Withdrawal by Subject|0|||
130185141|NCT03879135|468636655|FG005|Overall Study|Withdrawal by Subject|1|||
130185142|NCT03879135|468636650|FG000|Overall Study|Site Closed by Sponsor|0|||
130185143|NCT03879135|468636651|FG001|Overall Study|Site Closed by Sponsor|0|||
130185144|NCT03879135|468636652|FG002|Overall Study|Site Closed by Sponsor|0|||
130185145|NCT03879135|468636653|FG003|Overall Study|Site Closed by Sponsor|1|||
130185146|NCT03879135|468636654|FG004|Overall Study|Site Closed by Sponsor|1|||
130185147|NCT03879135|468636655|FG005|Overall Study|Site Closed by Sponsor|0|||
130185148|NCT04162847|468636656|FG000|Overall Study|Withdrawal by Subject|7|||
130185149|NCT04162847|468636657|FG001|Overall Study|Withdrawal by Subject|1|||
130185150|NCT00813150|468636658|FG000|Treatment Period|Adverse Event|16|||
130185151|NCT00813150|468636659|FG001|Treatment Period|Adverse Event|15|||
130185152|NCT00813150|468636658|FG000|Treatment Period|Death|2|||
130185153|NCT00813150|468636659|FG001|Treatment Period|Death|0|||
130185154|NCT00813150|468636658|FG000|Treatment Period|Progressive disease|1|||
130185155|NCT00813150|468636659|FG001|Treatment Period|Progressive disease|0|||
130185156|NCT00813150|468636658|FG000|Treatment Period|Complete response|0|||
130185157|NCT00813150|468636659|FG001|Treatment Period|Complete response|1|||
130185158|NCT00813150|468636658|FG000|Treatment Period|Stable disease|1|||
130185159|NCT00813150|468636659|FG001|Treatment Period|Stable disease|2|||
130185160|NCT00813150|468636658|FG000|Treatment Period|Protocol Violation|3|||
130185161|NCT00813150|468636659|FG001|Treatment Period|Protocol Violation|4|||
130185162|NCT00813150|468636658|FG000|Treatment Period|Withdrawal by Subject|5|||
130185163|NCT00813150|468636659|FG001|Treatment Period|Withdrawal by Subject|3|||
130185164|NCT00813150|468636658|FG000|Treatment Period|Non compliance|0|||
130185165|NCT00813150|468636659|FG001|Treatment Period|Non compliance|1|||
130185166|NCT00813150|468636658|FG000|Treatment Period|Reason not specified|3|||
130185167|NCT00813150|468636659|FG001|Treatment Period|Reason not specified|4|||
130185168|NCT00813150|468636658|FG000|Treatment Period|Data not available|1|||
130185169|NCT00813150|468636659|FG001|Treatment Period|Data not available|2|||
130185170|NCT00813150|468636658|FG000|Long Term Follow-up|Death|0|||
130185171|NCT00813150|468636659|FG001|Long Term Follow-up|Death|4|||
130185172|NCT00813150|468636658|FG000|Long Term Follow-up|Other|0|||
130185173|NCT00813150|468636659|FG001|Long Term Follow-up|Other|3|||
130185174|NCT00813150|468636658|FG000|Long Term Follow-up|Lost to Follow-up|2|||
130185175|NCT00813150|468636659|FG001|Long Term Follow-up|Lost to Follow-up|0|||
130185176|NCT00813150|468636658|FG000|Long Term Follow-up|Progression/Relapse|22|||
130185177|NCT00813150|468636659|FG001|Long Term Follow-up|Progression/Relapse|24|||
130185178|NCT05423093|468636660|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
130185179|NCT05423093|468636660|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
130185180|NCT05423093|468636660|FG000|Attended Intervention Session|Lost to Follow-up|3|||
130185181|NCT05423093|468636660|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
130185182|NCT05423093|468636660|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
130185183|NCT02832687|468636661|FG000|Overall Study|Adverse Event|0|||
130185184|NCT02832687|468636662|FG001|Overall Study|Adverse Event|2|||
130185185|NCT00471822|468636663|FG000|Overall Study|Protocol Violation|2|||
130185186|NCT03664232|468636664|FG000|Overall Study|Withdrawal by Subject|0|||
130185187|NCT03664232|468636665|FG001|Overall Study|Withdrawal by Subject|1|||
130185188|NCT03664232|468636666|FG002|Overall Study|Withdrawal by Subject|0|||
130185189|NCT03664232|468636667|FG003|Overall Study|Withdrawal by Subject|1|||
130185190|NCT03664232|468636664|FG000|Overall Study|Adverse Event|0|||
130185191|NCT03664232|468636665|FG001|Overall Study|Adverse Event|0|||
130185192|NCT03664232|468636666|FG002|Overall Study|Adverse Event|1|||
130185193|NCT03664232|468636667|FG003|Overall Study|Adverse Event|0|||
130185194|NCT03664232|468636664|FG000|Overall Study|Other-Non-compliance with study drug|0|||
130185195|NCT03664232|468636665|FG001|Overall Study|Other-Non-compliance with study drug|1|||
130185196|NCT03664232|468636666|FG002|Overall Study|Other-Non-compliance with study drug|0|||
130185197|NCT03664232|468636667|FG003|Overall Study|Other-Non-compliance with study drug|2|||
130185198|NCT03664232|468636664|FG000|Overall Study|Other-Unspecified|0|||
130185199|NCT03664232|468636665|FG001|Overall Study|Other-Unspecified|3|||
130185200|NCT03664232|468636666|FG002|Overall Study|Other-Unspecified|0|||
130185201|NCT03664232|468636667|FG003|Overall Study|Other-Unspecified|1|||
130185202|NCT03664232|468636664|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185203|NCT03664232|468636665|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185204|NCT03664232|468636666|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185205|NCT03664232|468636667|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
130185206|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
130185207|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
130185208|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
130185209|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
130185210|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
130185211|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185212|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185213|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185214|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185215|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185216|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185217|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185218|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185219|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185220|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185221|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
130185222|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
130185223|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
130185224|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
130185225|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
130185226|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185227|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185228|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185229|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185230|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185231|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185232|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185233|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185234|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185235|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185236|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
130185237|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
130185238|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
130185239|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
130185240|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
130185241|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185242|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185243|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185244|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185245|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185246|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185247|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185248|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185249|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185250|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185251|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
130185252|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
130185253|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
130185254|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
130185255|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
130185256|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185257|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185258|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185259|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185260|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185261|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185262|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185263|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185264|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185265|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185266|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
130185267|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185268|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
130185269|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130185270|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130185271|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185272|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185273|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185274|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185275|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185276|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185277|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185278|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185279|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185280|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185281|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185282|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185283|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185284|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
130185285|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185286|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185287|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185288|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185289|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185290|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185291|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185292|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185293|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185294|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185295|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185296|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185297|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
130185298|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
130185299|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
130185300|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
130185301|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185302|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185303|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185304|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185305|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185306|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185307|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185308|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185309|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185310|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185311|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185312|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185313|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185314|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185315|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185316|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185317|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
130185318|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185319|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
130185320|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
130185321|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185322|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
130185323|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
130185324|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
130185325|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
130185326|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185327|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185328|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185329|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185330|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185331|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
130185332|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
130185333|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
130185334|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130185335|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
130185336|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
130185337|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130185338|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
130185339|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
130185340|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
130185341|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185342|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185343|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185344|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185345|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185346|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
130185347|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
130185348|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
130185349|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
130185350|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
130185351|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
130185352|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
130185353|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185354|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
130185355|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
130185356|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185357|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185358|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185359|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185360|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185361|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
130185362|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
130185363|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185364|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185365|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130185366|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
130185367|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130185368|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185369|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
130185370|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
130185371|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185372|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185373|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185374|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185375|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185376|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185377|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130185378|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130185379|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
130185380|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185381|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185382|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185383|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185384|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130185385|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130185386|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185387|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185388|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185389|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185390|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185391|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185392|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185393|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185394|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185395|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185396|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185397|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130185398|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185399|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130185400|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185401|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185402|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185403|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185404|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185405|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185406|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
130185407|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185408|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185409|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185410|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185411|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185412|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185413|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185414|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185415|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
130185416|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185417|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185418|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185419|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185420|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185421|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185422|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185423|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185424|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185425|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
130185426|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185427|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185428|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185429|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185430|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185431|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185432|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185433|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185434|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185435|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185436|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185437|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185438|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185439|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185440|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185441|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185442|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185443|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185444|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130185445|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130185446|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185447|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185448|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185449|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185450|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185451|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185452|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185453|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185454|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185455|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185456|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185457|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185458|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185459|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185460|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185461|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185462|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185463|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185464|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185465|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185466|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185467|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185468|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185469|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185470|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185471|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185472|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
130185473|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185474|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185475|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185476|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185477|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185478|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185479|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185480|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185481|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185482|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185483|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185484|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185485|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185486|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185487|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185488|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185489|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185490|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185491|NCT03922321|468636683|FG000|Overall Study|Participant Moved|1|||
130185492|NCT03922321|468636683|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
130185493|NCT04067050|468636684|FG000|One Month|Lost to Follow-up|4|||
130185494|NCT04067050|468636685|FG001|One Month|Lost to Follow-up|0|||
130185495|NCT04067050|468636684|FG000|Two Month|Lost to Follow-up|1|||
130185496|NCT04067050|468636685|FG001|Two Month|Lost to Follow-up|0|||
130185497|NCT04067050|468636684|FG000|Two Month|Adverse Event|1|||
130185498|NCT04067050|468636685|FG001|Two Month|Adverse Event|0|||
130185499|NCT01062425|468636690|FG000|Overall Study|Protocol Violation|3|||
130185500|NCT01062425|468636691|FG001|Overall Study|Protocol Violation|6|||
130185501|NCT02342678|468636692|FG000|Overall Study|Lost to Follow-up|0|||
130185502|NCT02342678|468636693|FG001|Overall Study|Lost to Follow-up|1|||
130185503|NCT02342678|468636692|FG000|Overall Study|Too busy to complete study|0|||
130185504|NCT02342678|468636693|FG001|Overall Study|Too busy to complete study|2|||
130185505|NCT02342678|468636692|FG000|Overall Study|Family illness/emergency|0|||
130185506|NCT02342678|468636693|FG001|Overall Study|Family illness/emergency|1|||
130185507|NCT02342678|468636692|FG000|Overall Study|Illness/medical reason|1|||
130185508|NCT02342678|468636693|FG001|Overall Study|Illness/medical reason|1|||
130185509|NCT02383017|468636694|FG000|Overall Study|Injury Sustained Outside Study|1|||
130185510|NCT02383017|468636695|FG001|Overall Study|Injury Sustained Outside Study|0|||
130185511|NCT02383017|468636694|FG000|Overall Study|Compliance|3|||
130185512|NCT02383017|468636695|FG001|Overall Study|Compliance|2|||
130185513|NCT02383017|468636694|FG000|Overall Study|Found to be Hypogonadal|1|||
130185514|NCT02383017|468636695|FG001|Overall Study|Found to be Hypogonadal|0|||
130185515|NCT00460603|468636696|FG000|Phase 1|Death|1|||
130185516|NCT00460603|468636697|FG001|Phase 1|Death|0|||
130185517|NCT00460603|468636698|FG002|Phase 1|Death|0|||
130185518|NCT00460603|468636699|FG003|Phase 1|Death|2|||
130185519|NCT00460603|468636700|FG004|Phase 1|Death|0|||
130185520|NCT00460603|468636701|FG005|Phase 1|Death|0|||
130185521|NCT00460603|468636702|FG006|Phase 1|Death|0|||
130185522|NCT00460603|468636703|FG007|Phase 1|Death|0|||
130185523|NCT00460603|468636704|FG008|Phase 1|Death|1|||
130185524|NCT00460603|468636705|FG009|Phase 1|Death|0|||
130185525|NCT00460603|468636706|FG010|Phase 1|Death|0|||
130185526|NCT00460603|468636707|FG011|Phase 1|Death|0|||
130185527|NCT00460603|468636696|FG000|Phase 1|Adverse Event|3|||
130185528|NCT00460603|468636697|FG001|Phase 1|Adverse Event|1|||
130185529|NCT00460603|468636698|FG002|Phase 1|Adverse Event|1|||
130185530|NCT00460603|468636699|FG003|Phase 1|Adverse Event|2|||
130185531|NCT00460603|468636700|FG004|Phase 1|Adverse Event|0|||
130185532|NCT00460603|468636701|FG005|Phase 1|Adverse Event|0|||
130185533|NCT00460603|468636702|FG006|Phase 1|Adverse Event|3|||
130185534|NCT00460603|468636703|FG007|Phase 1|Adverse Event|0|||
130185535|NCT00460603|468636704|FG008|Phase 1|Adverse Event|4|||
130185536|NCT00460603|468636705|FG009|Phase 1|Adverse Event|0|||
130185537|NCT00460603|468636706|FG010|Phase 1|Adverse Event|0|||
130185538|NCT00460603|468636707|FG011|Phase 1|Adverse Event|0|||
130185539|NCT00460603|468636696|FG000|Phase 1|Lack of Efficacy|1|||
130185540|NCT00460603|468636697|FG001|Phase 1|Lack of Efficacy|0|||
130185541|NCT00460603|468636698|FG002|Phase 1|Lack of Efficacy|1|||
130185542|NCT00460603|468636699|FG003|Phase 1|Lack of Efficacy|2|||
130185543|NCT00460603|468636700|FG004|Phase 1|Lack of Efficacy|2|||
130185544|NCT00460603|468636701|FG005|Phase 1|Lack of Efficacy|2|||
130185545|NCT00460603|468636702|FG006|Phase 1|Lack of Efficacy|2|||
130185546|NCT00460603|468636703|FG007|Phase 1|Lack of Efficacy|2|||
130185547|NCT00460603|468636704|FG008|Phase 1|Lack of Efficacy|11|||
130185548|NCT00460603|468636705|FG009|Phase 1|Lack of Efficacy|0|||
130185549|NCT00460603|468636706|FG010|Phase 1|Lack of Efficacy|0|||
130185550|NCT00460603|468636707|FG011|Phase 1|Lack of Efficacy|0|||
130185551|NCT00460603|468636696|FG000|Phase 1|Withdrawal by Subject|1|||
130185552|NCT00460603|468636697|FG001|Phase 1|Withdrawal by Subject|2|||
130185553|NCT00460603|468636698|FG002|Phase 1|Withdrawal by Subject|1|||
130185554|NCT00460603|468636699|FG003|Phase 1|Withdrawal by Subject|1|||
130185555|NCT00460603|468636700|FG004|Phase 1|Withdrawal by Subject|3|||
130185556|NCT00460603|468636701|FG005|Phase 1|Withdrawal by Subject|0|||
130185557|NCT00460603|468636702|FG006|Phase 1|Withdrawal by Subject|1|||
130185558|NCT00460603|468636703|FG007|Phase 1|Withdrawal by Subject|0|||
130185559|NCT00460603|468636704|FG008|Phase 1|Withdrawal by Subject|2|||
130185560|NCT00460603|468636705|FG009|Phase 1|Withdrawal by Subject|0|||
130185561|NCT00460603|468636706|FG010|Phase 1|Withdrawal by Subject|0|||
130185562|NCT00460603|468636707|FG011|Phase 1|Withdrawal by Subject|0|||
130185563|NCT00460603|468636696|FG000|Phase 1|Other|0|||
130185564|NCT00460603|468636697|FG001|Phase 1|Other|3|||
130185565|NCT00460603|468636698|FG002|Phase 1|Other|1|||
130185566|NCT00460603|468636699|FG003|Phase 1|Other|1|||
130185567|NCT00460603|468636700|FG004|Phase 1|Other|1|||
130185568|NCT00460603|468636701|FG005|Phase 1|Other|2|||
130185569|NCT00460603|468636702|FG006|Phase 1|Other|0|||
130185570|NCT00460603|468636703|FG007|Phase 1|Other|1|||
130185571|NCT00460603|468636704|FG008|Phase 1|Other|0|||
130185572|NCT00460603|468636705|FG009|Phase 1|Other|0|||
130185573|NCT00460603|468636706|FG010|Phase 1|Other|0|||
130185574|NCT00460603|468636707|FG011|Phase 1|Other|0|||
130185575|NCT00460603|468636696|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185576|NCT00460603|468636697|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185577|NCT00460603|468636698|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185578|NCT00460603|468636699|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185579|NCT00460603|468636700|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185580|NCT00460603|468636701|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185581|NCT00460603|468636702|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185582|NCT00460603|468636703|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185583|NCT00460603|468636704|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185584|NCT00460603|468636705|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
130185585|NCT00460603|468636706|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185586|NCT00460603|468636707|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185587|NCT00460603|468636696|FG000|Phase 2|Adverse Event|0|||
130185588|NCT00460603|468636697|FG001|Phase 2|Adverse Event|0|||
130185589|NCT00460603|468636698|FG002|Phase 2|Adverse Event|0|||
130185590|NCT00460603|468636699|FG003|Phase 2|Adverse Event|0|||
130185591|NCT00460603|468636700|FG004|Phase 2|Adverse Event|0|||
130185592|NCT00460603|468636701|FG005|Phase 2|Adverse Event|0|||
130185593|NCT00460603|468636702|FG006|Phase 2|Adverse Event|0|||
130185594|NCT00460603|468636703|FG007|Phase 2|Adverse Event|0|||
130185595|NCT00460603|468636704|FG008|Phase 2|Adverse Event|0|||
130185596|NCT00460603|468636705|FG009|Phase 2|Adverse Event|12|||
130185597|NCT00460603|468636706|FG010|Phase 2|Adverse Event|9|||
130185598|NCT00460603|468636707|FG011|Phase 2|Adverse Event|10|||
130185599|NCT00460603|468636696|FG000|Phase 2|Death|0|||
130185600|NCT00460603|468636697|FG001|Phase 2|Death|0|||
130185601|NCT00460603|468636698|FG002|Phase 2|Death|0|||
130185602|NCT00460603|468636699|FG003|Phase 2|Death|0|||
130185603|NCT00460603|468636700|FG004|Phase 2|Death|0|||
130185604|NCT00460603|468636701|FG005|Phase 2|Death|0|||
130185605|NCT00460603|468636702|FG006|Phase 2|Death|0|||
130185606|NCT00460603|468636703|FG007|Phase 2|Death|0|||
130185607|NCT00460603|468636704|FG008|Phase 2|Death|0|||
130185608|NCT00460603|468636705|FG009|Phase 2|Death|4|||
130185609|NCT00460603|468636706|FG010|Phase 2|Death|2|||
130185610|NCT00460603|468636707|FG011|Phase 2|Death|2|||
130185611|NCT00460603|468636696|FG000|Phase 2|Protocol Violation|0|||
130185612|NCT00460603|468636697|FG001|Phase 2|Protocol Violation|0|||
130185613|NCT00460603|468636698|FG002|Phase 2|Protocol Violation|0|||
130185614|NCT00460603|468636699|FG003|Phase 2|Protocol Violation|0|||
130185615|NCT00460603|468636700|FG004|Phase 2|Protocol Violation|0|||
130185616|NCT00460603|468636701|FG005|Phase 2|Protocol Violation|0|||
130185617|NCT00460603|468636702|FG006|Phase 2|Protocol Violation|0|||
130185618|NCT00460603|468636703|FG007|Phase 2|Protocol Violation|0|||
130185619|NCT00460603|468636704|FG008|Phase 2|Protocol Violation|0|||
130185620|NCT00460603|468636705|FG009|Phase 2|Protocol Violation|1|||
130185621|NCT00460603|468636706|FG010|Phase 2|Protocol Violation|1|||
130185622|NCT00460603|468636707|FG011|Phase 2|Protocol Violation|0|||
130185623|NCT00460603|468636696|FG000|Phase 2|Lost to Follow-up|0|||
130185624|NCT00460603|468636697|FG001|Phase 2|Lost to Follow-up|0|||
130185625|NCT00460603|468636698|FG002|Phase 2|Lost to Follow-up|0|||
130185626|NCT00460603|468636699|FG003|Phase 2|Lost to Follow-up|0|||
130185627|NCT00460603|468636700|FG004|Phase 2|Lost to Follow-up|0|||
130185628|NCT00460603|468636701|FG005|Phase 2|Lost to Follow-up|0|||
130185629|NCT00460603|468636702|FG006|Phase 2|Lost to Follow-up|0|||
130185630|NCT00460603|468636703|FG007|Phase 2|Lost to Follow-up|0|||
130185631|NCT00460603|468636704|FG008|Phase 2|Lost to Follow-up|0|||
130185632|NCT00460603|468636705|FG009|Phase 2|Lost to Follow-up|1|||
130185633|NCT00460603|468636706|FG010|Phase 2|Lost to Follow-up|0|||
130185634|NCT00460603|468636707|FG011|Phase 2|Lost to Follow-up|0|||
130185635|NCT00460603|468636696|FG000|Phase 2|Other|0|||
130185636|NCT00460603|468636697|FG001|Phase 2|Other|0|||
130185637|NCT00460603|468636698|FG002|Phase 2|Other|0|||
130185638|NCT00460603|468636699|FG003|Phase 2|Other|0|||
130185639|NCT00460603|468636700|FG004|Phase 2|Other|0|||
130185640|NCT00460603|468636701|FG005|Phase 2|Other|0|||
130185641|NCT00460603|468636702|FG006|Phase 2|Other|0|||
130185642|NCT00460603|468636703|FG007|Phase 2|Other|0|||
130185643|NCT00460603|468636704|FG008|Phase 2|Other|0|||
130185644|NCT00460603|468636705|FG009|Phase 2|Other|6|||
130185645|NCT00460603|468636706|FG010|Phase 2|Other|16|||
130185646|NCT00460603|468636707|FG011|Phase 2|Other|7|||
130185647|NCT00460603|468636696|FG000|Phase 2|Objective Progression or Relapse|0|||
130185648|NCT00460603|468636697|FG001|Phase 2|Objective Progression or Relapse|0|||
130185649|NCT00460603|468636698|FG002|Phase 2|Objective Progression or Relapse|0|||
130185650|NCT00460603|468636699|FG003|Phase 2|Objective Progression or Relapse|0|||
130185651|NCT00460603|468636700|FG004|Phase 2|Objective Progression or Relapse|0|||
130185652|NCT00460603|468636701|FG005|Phase 2|Objective Progression or Relapse|0|||
130185653|NCT00460603|468636702|FG006|Phase 2|Objective Progression or Relapse|0|||
130185654|NCT00460603|468636703|FG007|Phase 2|Objective Progression or Relapse|0|||
130185655|NCT00460603|468636704|FG008|Phase 2|Objective Progression or Relapse|0|||
130185656|NCT00460603|468636705|FG009|Phase 2|Objective Progression or Relapse|9|||
130185657|NCT00460603|468636706|FG010|Phase 2|Objective Progression or Relapse|10|||
130185658|NCT00460603|468636707|FG011|Phase 2|Objective Progression or Relapse|17|||
130185659|NCT00460603|468636696|FG000|Phase 2|Global Deterioration of Health Status|0|||
130185660|NCT00460603|468636697|FG001|Phase 2|Global Deterioration of Health Status|0|||
130185661|NCT00460603|468636698|FG002|Phase 2|Global Deterioration of Health Status|0|||
130185662|NCT00460603|468636699|FG003|Phase 2|Global Deterioration of Health Status|0|||
130185663|NCT00460603|468636700|FG004|Phase 2|Global Deterioration of Health Status|0|||
130185664|NCT00460603|468636701|FG005|Phase 2|Global Deterioration of Health Status|0|||
130185665|NCT00460603|468636702|FG006|Phase 2|Global Deterioration of Health Status|0|||
130185666|NCT00460603|468636703|FG007|Phase 2|Global Deterioration of Health Status|0|||
130185667|NCT00460603|468636704|FG008|Phase 2|Global Deterioration of Health Status|0|||
130185668|NCT00460603|468636705|FG009|Phase 2|Global Deterioration of Health Status|0|||
130185669|NCT00460603|468636706|FG010|Phase 2|Global Deterioration of Health Status|1|||
130185670|NCT00460603|468636707|FG011|Phase 2|Global Deterioration of Health Status|0|||
130185671|NCT00460603|468636696|FG000|Phase 2|Withdrawal by Subject|0|||
130185672|NCT00460603|468636697|FG001|Phase 2|Withdrawal by Subject|0|||
130185673|NCT00460603|468636698|FG002|Phase 2|Withdrawal by Subject|0|||
130185674|NCT00460603|468636699|FG003|Phase 2|Withdrawal by Subject|0|||
130185675|NCT00460603|468636700|FG004|Phase 2|Withdrawal by Subject|0|||
130185676|NCT00460603|468636701|FG005|Phase 2|Withdrawal by Subject|0|||
130185677|NCT00460603|468636702|FG006|Phase 2|Withdrawal by Subject|0|||
130185678|NCT00460603|468636703|FG007|Phase 2|Withdrawal by Subject|0|||
130185679|NCT00460603|468636704|FG008|Phase 2|Withdrawal by Subject|0|||
130185680|NCT00460603|468636705|FG009|Phase 2|Withdrawal by Subject|5|||
130185681|NCT00460603|468636706|FG010|Phase 2|Withdrawal by Subject|4|||
130185682|NCT00460603|468636707|FG011|Phase 2|Withdrawal by Subject|5|||
130185683|NCT00460603|468636696|FG000|Phase 2|Randomized, but not treated|0|||
130185684|NCT00460603|468636697|FG001|Phase 2|Randomized, but not treated|0|||
130185685|NCT00460603|468636698|FG002|Phase 2|Randomized, but not treated|0|||
130185686|NCT00460603|468636699|FG003|Phase 2|Randomized, but not treated|0|||
130185687|NCT00460603|468636700|FG004|Phase 2|Randomized, but not treated|0|||
130185688|NCT00460603|468636701|FG005|Phase 2|Randomized, but not treated|0|||
130185689|NCT00460603|468636702|FG006|Phase 2|Randomized, but not treated|0|||
130185690|NCT00460603|468636703|FG007|Phase 2|Randomized, but not treated|0|||
130185691|NCT00460603|468636704|FG008|Phase 2|Randomized, but not treated|0|||
130185692|NCT00460603|468636705|FG009|Phase 2|Randomized, but not treated|3|||
130185693|NCT00460603|468636706|FG010|Phase 2|Randomized, but not treated|0|||
130185694|NCT00460603|468636707|FG011|Phase 2|Randomized, but not treated|0|||
130185695|NCT00289848|468636708|FG000|Overall Study|Adverse Event|6|||
130185696|NCT00289848|468636709|FG001|Overall Study|Adverse Event|4|||
130185697|NCT00289848|468636708|FG000|Overall Study|Death|1|||
130185698|NCT00289848|468636709|FG001|Overall Study|Death|0|||
130185699|NCT00289848|468636708|FG000|Overall Study|Lack of Efficacy|20|||
130185700|NCT00289848|468636709|FG001|Overall Study|Lack of Efficacy|24|||
130185701|NCT00289848|468636708|FG000|Overall Study|Lost to Follow-up|3|||
130185702|NCT00289848|468636709|FG001|Overall Study|Lost to Follow-up|1|||
130185703|NCT00289848|468636708|FG000|Overall Study|Protocol Violation|5|||
130185704|NCT00289848|468636709|FG001|Overall Study|Protocol Violation|2|||
130185705|NCT00289848|468636708|FG000|Overall Study|Withdrawal by Subject|5|||
130185706|NCT00289848|468636709|FG001|Overall Study|Withdrawal by Subject|11|||
130185707|NCT00289848|468636708|FG000|Overall Study|Patient Moved|6|||
130185708|NCT00289848|468636709|FG001|Overall Study|Patient Moved|2|||
130185709|NCT00289848|468636708|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
130185710|NCT00289848|468636709|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
130185711|NCT03871543|468636712|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
130185712|NCT03871543|468636712|FG000|Period 1|Investigator Error|1|||
130185713|NCT03871543|468636712|FG000|Period 1|Protocol Violation|2|||
130185714|NCT03871543|468636712|FG000|Period 1|COVID-19 Related|1|||
130185715|NCT03871543|468636712|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
130185716|NCT03871543|468636712|FG000|Period 1|Withdrawal by Subject|10|||
130185717|NCT03871543|468636712|FG000|Period 2|Adverse Event|1|||
130185718|NCT03871543|468636712|FG000|Period 2|Withdrawal by Subject|1|||
130185719|NCT03534687|468636717|FG000|Overall Study|Lost to Follow-up|7|||
130185720|NCT03534687|468636718|FG001|Overall Study|Lost to Follow-up|2|||
130185721|NCT00395629|468636719|FG000|Core Study|Adverse Event|0|||
130185722|NCT00395629|468636720|FG001|Core Study|Adverse Event|3|||
130185723|NCT00395629|468636721|FG002|Core Study|Adverse Event|4|||
130185724|NCT00395629|468636719|FG000|Core Study|Abnormal laboratory value(s)|0|||
130185725|NCT00395629|468636720|FG001|Core Study|Abnormal laboratory value(s)|0|||
130185726|NCT00395629|468636721|FG002|Core Study|Abnormal laboratory value(s)|1|||
130185727|NCT00395629|468636719|FG000|Core Study|Protocol Violation|1|||
130185728|NCT00395629|468636720|FG001|Core Study|Protocol Violation|0|||
130185729|NCT00395629|468636721|FG002|Core Study|Protocol Violation|0|||
130185730|NCT00395629|468636719|FG000|Core Study|Withdrawal by Subject|0|||
130185731|NCT00395629|468636720|FG001|Core Study|Withdrawal by Subject|1|||
130185732|NCT00395629|468636721|FG002|Core Study|Withdrawal by Subject|1|||
130185733|NCT00395629|468636719|FG000|Core Study|Lost to Follow-up|0|||
130185734|NCT00395629|468636720|FG001|Core Study|Lost to Follow-up|0|||
130185735|NCT00395629|468636721|FG002|Core Study|Lost to Follow-up|1|||
130185736|NCT00395629|468636719|FG000|Extension Study|Adverse Event|0|||
130185737|NCT00395629|468636720|FG001|Extension Study|Adverse Event|0|||
130185738|NCT00395629|468636721|FG002|Extension Study|Adverse Event|2|||
130185739|NCT00395629|468636719|FG000|Extension Study|Administrative problems|0|||
130185740|NCT00395629|468636720|FG001|Extension Study|Administrative problems|0|||
130185741|NCT00395629|468636721|FG002|Extension Study|Administrative problems|1|||
130185742|NCT02570308|468636722|FG000|Overall Study|Death|1|||
130185743|NCT02570308|468636723|FG001|Overall Study|Death|5|||
130185744|NCT02570308|468636724|FG002|Overall Study|Death|4|||
130185745|NCT02570308|468636725|FG003|Overall Study|Death|4|||
130185746|NCT02570308|468636726|FG004|Overall Study|Death|69|||
130185747|NCT02570308|468636722|FG000|Overall Study|Lost to Follow-up|0|||
130185748|NCT02570308|468636723|FG001|Overall Study|Lost to Follow-up|0|||
130185749|NCT02570308|468636724|FG002|Overall Study|Lost to Follow-up|0|||
130185750|NCT02570308|468636725|FG003|Overall Study|Lost to Follow-up|0|||
130185751|NCT02570308|468636726|FG004|Overall Study|Lost to Follow-up|2|||
130185752|NCT02570308|468636722|FG000|Overall Study|Withdrawal by Subject|0|||
130185753|NCT02570308|468636723|FG001|Overall Study|Withdrawal by Subject|0|||
130185754|NCT02570308|468636724|FG002|Overall Study|Withdrawal by Subject|0|||
130185755|NCT02570308|468636725|FG003|Overall Study|Withdrawal by Subject|0|||
130185756|NCT02570308|468636726|FG004|Overall Study|Withdrawal by Subject|1|||
130185757|NCT02570308|468636722|FG000|Overall Study|Other|0|||
130185758|NCT02570308|468636723|FG001|Overall Study|Other|0|||
130185759|NCT02570308|468636724|FG002|Overall Study|Other|0|||
130185760|NCT02570308|468636725|FG003|Overall Study|Other|0|||
130185761|NCT02570308|468636726|FG004|Overall Study|Other|2|||
130185762|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130185763|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130185764|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
130185765|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185766|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185767|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185768|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185769|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185770|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185771|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
130185772|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185773|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185774|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185775|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185776|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130185777|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185778|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130185779|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185780|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185781|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185782|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185783|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130185784|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185785|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130185786|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185787|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185788|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185789|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185790|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
130185791|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
130185792|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
130185793|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185794|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185795|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185796|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185797|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185798|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185799|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
130185800|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185801|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185802|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185803|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185804|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185805|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185806|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
130185807|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185808|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185809|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185810|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185811|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185812|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
130185813|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130185814|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185815|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185816|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185817|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185818|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185819|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185820|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185821|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185822|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130185823|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130185824|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
130185825|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185826|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185827|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185828|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185829|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
130185830|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130185831|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130185832|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185833|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185834|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185835|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185836|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185837|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130185838|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130185839|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185840|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185841|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185842|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130185843|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130185844|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
130185845|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130185846|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185847|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185848|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185849|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
130185850|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
130185851|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
130185852|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130185853|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185854|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185855|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185856|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185857|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
130185858|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185859|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185860|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185861|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185862|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185863|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185864|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185865|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
130185866|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185867|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185868|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185869|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185870|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185871|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185872|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130185873|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130185874|NCT00765102|468636734|FG000|Overall Study|Progressive disease|18|||
130185875|NCT00765102|468636734|FG000|Overall Study|Adverse Event|6|||
130185876|NCT00765102|468636734|FG000|Overall Study|Physician Decision|4|||
130185877|NCT00765102|468636734|FG000|Overall Study|Withdrawal by Subject|2|||
130185878|NCT00765102|468636734|FG000|Overall Study|Protocol Violation|1|||
130185879|NCT04129125|468636741|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
130185880|NCT04129125|468636741|FG000|Overall Study|Study device was not used|3|||
130185886|NCT02962648|468636745|FG000|Overall Study|Withdrawal by Subject|3|||
130185887|NCT02962648|468636745|FG000|Overall Study|Lost to Follow-up|3|||
130185888|NCT02962648|468636745|FG000|Overall Study|Physician Decision|1|||
130185889|NCT02962648|468636745|FG000|Overall Study|Subject had problems with transportation|2|||
130185890|NCT04383327|468636746|FG000|Overall Study|Lost to Follow-up|112|||
130185891|NCT04383327|468636747|FG001|Overall Study|Lost to Follow-up|14|||
130185892|NCT04383327|468636748|FG002|Overall Study|Lost to Follow-up|78|||
130185893|NCT04383327|468636749|FG003|Overall Study|Lost to Follow-up|13|||
130185894|NCT04383327|468636750|FG004|Overall Study|Lost to Follow-up|110|||
130185895|NCT04383327|468636751|FG005|Overall Study|Lost to Follow-up|13|||
130185896|NCT04383327|468636752|FG006|Overall Study|Lost to Follow-up|74|||
130185897|NCT04383327|468636753|FG007|Overall Study|Lost to Follow-up|13|||
130185898|NCT04383327|468636754|FG008|Overall Study|Lost to Follow-up|78|||
130185899|NCT04383327|468636755|FG009|Overall Study|Lost to Follow-up|10|||
130185900|NCT04383327|468636756|FG010|Overall Study|Lost to Follow-up|160|||
130185901|NCT04383327|468636757|FG011|Overall Study|Lost to Follow-up|13|||
130185902|NCT05303194|468636758|FG000|Overall Study|Lost to Follow-up|1|||
130185903|NCT05303194|468636759|FG001|Overall Study|Lost to Follow-up|1|||
130185904|NCT05303194|468636758|FG000|Overall Study|Withdrawal by Subject|0|||
130185905|NCT05303194|468636759|FG001|Overall Study|Withdrawal by Subject|1|||
130185906|NCT01289678|468636760|FG000|Overall Study|Physician Decision|6|||
130185907|NCT04030299|468636761|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130185908|NCT04030299|468636761|FG000|Overall Study|Withdrawal by Subject|3|||
130185909|NCT01530464|468636766|FG000|Washout (24h)|Withdrawal by Subject|1|||
130185910|NCT01530464|468636767|FG001|Washout (24h)|Withdrawal by Subject|0|||
130185911|NCT01530464|468636766|FG000|Washout (24h)|Withdrawal by Subject|0|||
130185912|NCT01530464|468636767|FG001|Washout (24h)|Withdrawal by Subject|1|||
130185913|NCT00908544|468636768|FG000|Overall Study|Withdrawal by Subject|2|||
130185914|NCT00908544|468636769|FG001|Overall Study|Withdrawal by Subject|4|||
130185915|NCT00908544|468636768|FG000|Overall Study|Lack of Efficacy|0|||
130185916|NCT00908544|468636769|FG001|Overall Study|Lack of Efficacy|1|||
130185917|NCT00908544|468636768|FG000|Overall Study|Pregnancy|1|||
130185918|NCT00908544|468636769|FG001|Overall Study|Pregnancy|0|||
130185919|NCT00908544|468636768|FG000|Overall Study|Relocation abroad|1|||
130185920|NCT00908544|468636769|FG001|Overall Study|Relocation abroad|1|||
130185921|NCT00908544|468636768|FG000|Overall Study|Unable to visit sutdy center|1|||
130185922|NCT00908544|468636769|FG001|Overall Study|Unable to visit sutdy center|0|||
130185923|NCT03539302|468636775|FG000|Overall Study|Spontaneous cardio version|0|||
130185924|NCT03539302|468636776|FG001|Overall Study|Spontaneous cardio version|0|||
130185925|NCT03539302|468636777|FG002|Overall Study|Spontaneous cardio version|0|||
130185926|NCT03539302|468636778|FG003|Overall Study|Spontaneous cardio version|0|||
130185927|NCT03539302|468636779|FG004|Overall Study|Spontaneous cardio version|0|||
130185928|NCT03539302|468636780|FG005|Overall Study|Spontaneous cardio version|1|||
130185929|NCT03539302|468636781|FG006|Overall Study|Spontaneous cardio version|1|||
130185930|NCT02107131|468636783|FG000|Overall Study|Lost to Follow-up|4|||
130185931|NCT02107131|468636784|FG001|Overall Study|Lost to Follow-up|4|||
130185932|NCT02107131|468636783|FG000|Overall Study|Physician Decision|1|||
130185933|NCT02107131|468636784|FG001|Overall Study|Physician Decision|0|||
130185934|NCT02107131|468636783|FG000|Overall Study|Withdrawal by Subject|2|||
130185935|NCT02107131|468636784|FG001|Overall Study|Withdrawal by Subject|0|||
130185936|NCT02107131|468636783|FG000|Overall Study|mental instability|1|||
130185937|NCT02107131|468636784|FG001|Overall Study|mental instability|0|||
130185938|NCT02107131|468636783|FG000|Overall Study|Death|0|||
130185939|NCT02107131|468636784|FG001|Overall Study|Death|1|||
130185940|NCT02107131|468636783|FG000|Overall Study|Protocol Violation|0|||
130185941|NCT02107131|468636784|FG001|Overall Study|Protocol Violation|4|||
130185942|NCT01609790|468636789|FG000|Overall Study|Protocol Violation|1|||
130185943|NCT01609790|468636790|FG001|Overall Study|Protocol Violation|7|||
130185944|NCT01609790|468636791|FG002|Overall Study|Protocol Violation|8|||
130185945|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Adverse Event|7|||
130185946|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
130185947|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Non-compliance|3|||
130185948|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Other|17|||
130185949|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Physician Decision|2|||
130185950|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130185951|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
130185952|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
130185953|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
130185954|NCT05207865|468638416|FG000|Follow-up Phase|Lost to Follow-up|1|||
130185955|NCT05207865|468638416|FG000|Follow-up Phase|Non-compliance|1|||
130185956|NCT05207865|468638416|FG000|Follow-up Phase|Not reported|2|||
130185957|NCT05207865|468638416|FG000|Follow-up Phase|Not collected|11|||
130185958|NCT05364931|468638434|FG000|Overall Study|Adverse Event|0|||
130185959|NCT05364931|468638435|FG001|Overall Study|Adverse Event|2|||
130185960|NCT05364931|468638436|FG002|Overall Study|Adverse Event|1|||
130185961|NCT05364931|468638437|FG003|Overall Study|Adverse Event|0|||
130185962|NCT05364931|468638434|FG000|Overall Study|Lost to Follow-up|1|||
130185963|NCT05364931|468638435|FG001|Overall Study|Lost to Follow-up|0|||
130185964|NCT05364931|468638436|FG002|Overall Study|Lost to Follow-up|0|||
130185965|NCT05364931|468638437|FG003|Overall Study|Lost to Follow-up|0|||
130185966|NCT05364931|468638434|FG000|Overall Study|Withdrawal by Subject|1|||
130185967|NCT05364931|468638435|FG001|Overall Study|Withdrawal by Subject|1|||
130185968|NCT05364931|468638436|FG002|Overall Study|Withdrawal by Subject|3|||
130185969|NCT05364931|468638437|FG003|Overall Study|Withdrawal by Subject|2|||
130185970|NCT05364931|468638434|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185971|NCT05364931|468638435|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
130185972|NCT05364931|468638436|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185973|NCT05364931|468638437|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185974|NCT05364931|468638434|FG000|Overall Study|Discontinued|1|||
130185975|NCT05364931|468638435|FG001|Overall Study|Discontinued|0|||
130185976|NCT05364931|468638436|FG002|Overall Study|Discontinued|0|||
130185977|NCT05364931|468638437|FG003|Overall Study|Discontinued|0|||
130185978|NCT03593525|468638438|FG000|Overall Study|Withdrawal by Subject|1|||
130185979|NCT03593525|468638439|FG001|Overall Study|Withdrawal by Subject|0|||
130185980|NCT03593525|468638438|FG000|Overall Study|Lost to Follow-up|7|||
130185981|NCT03593525|468638439|FG001|Overall Study|Lost to Follow-up|5|||
130185982|NCT03103087|468638447|FG000|Overall Study|Did not receive any study drug|1|||
130185983|NCT03103087|468638448|FG001|Overall Study|Did not receive any study drug|0|||
130185984|NCT03103087|468638449|FG002|Overall Study|Did not receive any study drug|0|||
130185985|NCT03103087|468638447|FG000|Overall Study|Protocol Violation|1|||
130185986|NCT03103087|468638448|FG001|Overall Study|Protocol Violation|2|||
130185987|NCT03103087|468638449|FG002|Overall Study|Protocol Violation|1|||
130185988|NCT03103087|468638447|FG000|Overall Study|Lack of Efficacy|2|||
130185989|NCT03103087|468638448|FG001|Overall Study|Lack of Efficacy|1|||
130185990|NCT03103087|468638449|FG002|Overall Study|Lack of Efficacy|1|||
130185991|NCT03103087|468638447|FG000|Overall Study|Pregnancy|0|||
130185992|NCT03103087|468638448|FG001|Overall Study|Pregnancy|0|||
130185993|NCT03103087|468638449|FG002|Overall Study|Pregnancy|1|||
130185994|NCT03103087|468638447|FG000|Overall Study|Adverse Event|2|||
130185995|NCT03103087|468638448|FG001|Overall Study|Adverse Event|15|||
130185996|NCT03103087|468638449|FG002|Overall Study|Adverse Event|6|||
130185997|NCT03103087|468638447|FG000|Overall Study|Withdrawal by Subject|13|||
130185998|NCT03103087|468638448|FG001|Overall Study|Withdrawal by Subject|6|||
130185999|NCT03103087|468638449|FG002|Overall Study|Withdrawal by Subject|6|||
130186000|NCT03103087|468638447|FG000|Overall Study|Lost to Follow-up|4|||
130186001|NCT03103087|468638448|FG001|Overall Study|Lost to Follow-up|2|||
130186002|NCT03103087|468638449|FG002|Overall Study|Lost to Follow-up|7|||
130186003|NCT03103087|468638447|FG000|Overall Study|Other reason not reported|1|||
130186004|NCT03103087|468638448|FG001|Overall Study|Other reason not reported|3|||
130186005|NCT03103087|468638449|FG002|Overall Study|Other reason not reported|5|||
130186006|NCT03504397|468638450|FG000|Overall Study|Progressive Disease|151|||
130186007|NCT03504397|468638451|FG001|Overall Study|Progressive Disease|199|||
130186008|NCT03504397|468638450|FG000|Overall Study|Withdrawal by Subject|29|||
130186009|NCT03504397|468638451|FG001|Overall Study|Withdrawal by Subject|17|||
130186010|NCT03504397|468638450|FG000|Overall Study|Lost to Follow-up|1|||
130186011|NCT03504397|468638451|FG001|Overall Study|Lost to Follow-up|0|||
130186012|NCT03504397|468638450|FG000|Overall Study|Death|14|||
130186013|NCT03504397|468638451|FG001|Overall Study|Death|16|||
130186014|NCT03504397|468638450|FG000|Overall Study|Adverse Event|40|||
130186015|NCT03504397|468638451|FG001|Overall Study|Adverse Event|14|||
130186016|NCT03504397|468638450|FG000|Overall Study|miscellaneous|17|||
130186017|NCT03504397|468638451|FG001|Overall Study|miscellaneous|15|||
130186018|NCT03504397|468638450|FG000|Overall Study|Protocol deviation|1|||
130186019|NCT03504397|468638451|FG001|Overall Study|Protocol deviation|0|||
130186020|NCT03504397|468638450|FG000|Overall Study|Participants who did not take the study drug|4|||
130186021|NCT03504397|468638451|FG001|Overall Study|Participants who did not take the study drug|4|||
130186022|NCT00413699|468638452|FG000|Initial Period|Death|25|||
130186023|NCT00413699|468638453|FG001|Initial Period|Death|30|||
130186024|NCT00413699|468638454|FG002|Initial Period|Death|0|||
130186025|NCT00413699|468638452|FG000|Initial Period|Lack of Efficacy|59|||
130186026|NCT00413699|468638453|FG001|Initial Period|Lack of Efficacy|115|||
130186027|NCT00413699|468638454|FG002|Initial Period|Lack of Efficacy|0|||
130186028|NCT00413699|468638452|FG000|Initial Period|Lost to Follow-up|31|||
130186029|NCT00413699|468638453|FG001|Initial Period|Lost to Follow-up|101|||
130186030|NCT00413699|468638454|FG002|Initial Period|Lost to Follow-up|0|||
130186031|NCT00413699|468638452|FG000|Initial Period|Protocol Violation|38|||
130186032|NCT00413699|468638453|FG001|Initial Period|Protocol Violation|89|||
130186033|NCT00413699|468638454|FG002|Initial Period|Protocol Violation|0|||
130186034|NCT00413699|468638452|FG000|Initial Period|Pregnancy|10|||
130186035|NCT00413699|468638453|FG001|Initial Period|Pregnancy|8|||
130186036|NCT00413699|468638454|FG002|Initial Period|Pregnancy|0|||
130186037|NCT00413699|468638452|FG000|Initial Period|Did not meet entrance criteria|2|||
130186038|NCT00413699|468638453|FG001|Initial Period|Did not meet entrance criteria|2|||
130186039|NCT00413699|468638454|FG002|Initial Period|Did not meet entrance criteria|0|||
130186040|NCT00413699|468638452|FG000|Initial Period|Medication error without adverse event|0|||
130186041|NCT00413699|468638453|FG001|Initial Period|Medication error without adverse event|1|||
130186042|NCT00413699|468638454|FG002|Initial Period|Medication error without adverse event|0|||
130186043|NCT00413699|468638452|FG000|Initial Period|Study terminated by Sponsor|0|||
130186044|NCT00413699|468638453|FG001|Initial Period|Study terminated by Sponsor|1|||
130186045|NCT00413699|468638454|FG002|Initial Period|Study terminated by Sponsor|0|||
130186046|NCT00413699|468638452|FG000|Initial Period|Other|67|||
130186047|NCT00413699|468638453|FG001|Initial Period|Other|211|||
130186048|NCT00413699|468638454|FG002|Initial Period|Other|0|||
130186049|NCT00413699|468638452|FG000|Initial Period|Adverse event related to study drug|178|||
130186050|NCT00413699|468638453|FG001|Initial Period|Adverse event related to study drug|527|||
130186051|NCT00413699|468638454|FG002|Initial Period|Adverse event related to study drug|0|||
130186052|NCT00413699|468638452|FG000|Initial Period|Adverse event not related to study drug|113|||
130186053|NCT00413699|468638453|FG001|Initial Period|Adverse event not related to study drug|248|||
130186054|NCT00413699|468638454|FG002|Initial Period|Adverse event not related to study drug|0|||
130186055|NCT00413699|468638452|FG000|Initial Period|Missing end of study page|0|||
130186056|NCT00413699|468638453|FG001|Initial Period|Missing end of study page|4|||
130186057|NCT00413699|468638454|FG002|Initial Period|Missing end of study page|0|||
130186058|NCT00413699|468638452|FG000|Initial Period|No longer willing to participate|116|||
130186059|NCT00413699|468638453|FG001|Initial Period|No longer willing to participate|368|||
130186060|NCT00413699|468638454|FG002|Initial Period|No longer willing to participate|0|||
130186061|NCT00413699|468638452|FG000|Extension Period|No Longer Willing to Participate|0|||
130186062|NCT00413699|468638453|FG001|Extension Period|No Longer Willing to Participate|0|||
130186063|NCT00413699|468638454|FG002|Extension Period|No Longer Willing to Participate|2|||
130186064|NCT00413699|468638452|FG000|Extension Period|Protocol Violation|0|||
130186065|NCT00413699|468638453|FG001|Extension Period|Protocol Violation|0|||
130186066|NCT00413699|468638454|FG002|Extension Period|Protocol Violation|1|||
130186067|NCT00413699|468638452|FG000|Extension Period|Adverse Event|0|||
130186068|NCT00413699|468638453|FG001|Extension Period|Adverse Event|0|||
130186069|NCT00413699|468638454|FG002|Extension Period|Adverse Event|2|||
130186070|NCT00075816|468638455|FG000|Overall Study|Did not undergo transplantation|14|||
130186071|NCT00075816|468638456|FG001|Overall Study|Did not undergo transplantation|11|||
130186072|NCT04231825|468638457|FG000|Overall Study|Protocol Violation|3|||
130186073|NCT04231825|468638458|FG001|Overall Study|Protocol Violation|3|||
130186074|NCT04231825|468638457|FG000|Overall Study|Lost to Follow-up|0|||
130186075|NCT04231825|468638458|FG001|Overall Study|Lost to Follow-up|1|||
130186076|NCT01662635|468638459|FG000|Overall Study|scarce samples for evaluation|30|||
130186077|NCT02445248|468638460|FG000|Overall Study|Death|45|||
130186078|NCT02445248|468638461|FG001|Overall Study|Death|12|||
130186079|NCT02445248|468638460|FG000|Overall Study|Progressive disease|13|||
130186080|NCT02445248|468638461|FG001|Overall Study|Progressive disease|1|||
130186081|NCT02445248|468638460|FG000|Overall Study|Subject decision|8|||
130186082|NCT02445248|468638461|FG001|Overall Study|Subject decision|0|||
130186083|NCT02445248|468638460|FG000|Overall Study|Physician Decision|5|||
130186084|NCT02445248|468638461|FG001|Overall Study|Physician Decision|0|||
130186085|NCT02445248|468638460|FG000|Overall Study|Adverse Event|1|||
130186086|NCT02445248|468638461|FG001|Overall Study|Adverse Event|0|||
130186087|NCT02445248|468638460|FG000|Overall Study|Lost to Follow-up|1|||
130186088|NCT02445248|468638461|FG001|Overall Study|Lost to Follow-up|0|||
130186089|NCT02596971|468638462|FG000|Overall Study|Death|5|||
130186090|NCT02596971|468638463|FG001|Overall Study|Death|1|||
130186091|NCT02596971|468638464|FG002|Overall Study|Death|5|||
130186092|NCT02596971|468638462|FG000|Overall Study|Withdrawal by Subject|5|||
130186093|NCT02596971|468638463|FG001|Overall Study|Withdrawal by Subject|1|||
130186094|NCT02596971|468638464|FG002|Overall Study|Withdrawal by Subject|4|||
130186095|NCT00595920|468638467|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
130186096|NCT00351468|468638468|FG000|Overall Study|Adverse Event|42|||
130186097|NCT00351468|468638468|FG000|Overall Study|Withdrawal by Subject|39|||
130186098|NCT00351468|468638468|FG000|Overall Study|Various -follow up w clinical team|39|||
130186099|NCT00351468|468638468|FG000|Overall Study|Lack of Efficacy|32|||
130186100|NCT00351468|468638468|FG000|Overall Study|Non-compliance|8|||
130186101|NCT00351468|468638468|FG000|Overall Study|Lost to Follow-up|4|||
130186102|NCT00351468|468638468|FG000|Overall Study|Protocol Violation|3|||
130186103|NCT03588910|468638469|FG000|Overall Study|Withdrawal by Subject|1|||
130186104|NCT03588910|468638470|FG001|Overall Study|Withdrawal by Subject|0|||
130186105|NCT03588910|468638469|FG000|Overall Study|Allergy|2|||
130186106|NCT03588910|468638470|FG001|Overall Study|Allergy|0|||
130186107|NCT03588910|468638469|FG000|Overall Study|Protocol Violation|0|||
130186108|NCT03588910|468638470|FG001|Overall Study|Protocol Violation|3|||
130186109|NCT03588910|468638469|FG000|Overall Study|Did not complete Day 1 Survey|5|||
130186110|NCT03588910|468638470|FG001|Overall Study|Did not complete Day 1 Survey|10|||
130186111|NCT03588910|468638469|FG000|Overall Study|Did not complete Day 7 Survey|5|||
130186112|NCT03588910|468638470|FG001|Overall Study|Did not complete Day 7 Survey|2|||
130186113|NCT00611923|468638471|FG000|Overall Study|Withdrawal by Subject|2|||
130186114|NCT00611923|468638472|FG001|Overall Study|Withdrawal by Subject|2|||
130186115|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
130186116|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
130186117|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
130186118|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
130186119|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
130186120|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
130186121|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
130186122|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
130186123|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
130186124|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
130186125|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
130186126|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
130186127|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186128|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186129|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
130186130|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186131|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
130186132|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
130186133|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
130186134|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
130186135|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
130186136|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
130186137|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
130186138|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
130186139|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
130186140|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
130186141|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
130186142|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
130186143|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
130186144|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130186145|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130186146|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
130186147|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186148|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
130186149|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186150|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186151|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186152|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186153|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186154|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
130186155|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
130186156|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186157|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186158|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186159|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
130186160|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130186161|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
130186162|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
130186163|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186164|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186165|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
130186166|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186167|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Site closed|0|||
130186168|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Site closed|0|||
130186169|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Site closed|1|||
130186170|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Site closed|0|||
130186171|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
130186172|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186173|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186174|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186175|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130186176|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130186177|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130186178|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130186179|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
130186180|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186181|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186182|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186183|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130186184|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130186185|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
130186186|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
130186187|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130186188|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
130186189|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
130186190|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
130186191|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
130186192|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
130186193|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
130186194|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
130186195|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
130186196|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130186197|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
130186198|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130186199|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
130186200|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
130186201|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130186202|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130186203|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186204|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186205|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186206|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186207|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
130186208|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130186209|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
130186210|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130186211|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186212|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
130186213|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186214|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186215|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186216|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
130186217|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186218|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186219|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186220|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186221|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186222|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
130186223|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Missing|1|||
130186224|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Missing|2|||
130186225|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Missing|1|||
130186226|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Missing|1|||
130186227|NCT04565145|468638477|FG000|Overall Study|Withdrawal by Subject|1|||
130186228|NCT04565145|468638478|FG001|Overall Study|Withdrawal by Subject|1|||
130186229|NCT00683618|468638479|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
130186230|NCT00683618|468638480|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
130186231|NCT00683618|468638481|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
130186232|NCT00683618|468638479|FG000|Randomised Treatment Period|Protocol Violation|0|||
130186233|NCT00683618|468638480|FG001|Randomised Treatment Period|Protocol Violation|1|||
130186234|NCT00683618|468638481|FG002|Randomised Treatment Period|Protocol Violation|0|||
130186235|NCT00683618|468638479|FG000|Randomised Treatment Period|Adverse Event|2|||
130186236|NCT00683618|468638480|FG001|Randomised Treatment Period|Adverse Event|0|||
130186237|NCT00683618|468638481|FG002|Randomised Treatment Period|Adverse Event|2|||
130186238|NCT00683618|468638479|FG000|Randomised Treatment Period|Reason not provided|0|||
130186239|NCT00683618|468638480|FG001|Randomised Treatment Period|Reason not provided|0|||
130186240|NCT00683618|468638481|FG002|Randomised Treatment Period|Reason not provided|2|||
130186241|NCT00683618|468638479|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130186242|NCT00683618|468638480|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130186243|NCT00683618|468638481|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130186244|NCT00683618|468638479|FG000|Extension Treatment Period|Adverse Event|1|||
130186245|NCT00683618|468638480|FG001|Extension Treatment Period|Adverse Event|0|||
130186246|NCT00683618|468638481|FG002|Extension Treatment Period|Adverse Event|0|||
130186247|NCT00683618|468638479|FG000|Extension Treatment Period|Protocol Violation|1|||
130186248|NCT00683618|468638480|FG001|Extension Treatment Period|Protocol Violation|0|||
130186249|NCT00683618|468638481|FG002|Extension Treatment Period|Protocol Violation|0|||
130186250|NCT04570670|468638482|FG000|Overall Study|Withdrawal by Subject|1|||
130186251|NCT04570670|468638483|FG001|Overall Study|Withdrawal by Subject|0|||
130186252|NCT02549859|468638484|FG000|Long-term 60 Hz DBS|Study Closed|1|||
130186253|NCT03003962|468638493|FG000|Overall Study|Withdrawal by Subject|5|||
130186254|NCT03003962|468638494|FG001|Overall Study|Withdrawal by Subject|17|||
130186255|NCT03003962|468638493|FG000|Overall Study|Death|274|||
130186256|NCT03003962|468638494|FG001|Overall Study|Death|277|||
130186257|NCT03003962|468638493|FG000|Overall Study|Participants ongoing at DCO|55|||
130186258|NCT03003962|468638494|FG001|Overall Study|Participants ongoing at DCO|40|||
130186259|NCT03802825|468638502|FG000|Overall Study|Lost to follow-up for intervention|12|||
130186260|NCT03802825|468638503|FG001|Overall Study|Lost to follow-up for intervention|3|||
130186261|NCT03802825|468638502|FG000|Overall Study|Received only 1 component of intervention|0|||
130186262|NCT03802825|468638503|FG001|Overall Study|Received only 1 component of intervention|13|||
130186263|NCT03428152|468638505|FG000|Overall Study|Physician Decision|4|||
130186264|NCT03428152|468638506|FG001|Overall Study|Physician Decision|2|||
130186265|NCT03428152|468638505|FG000|Overall Study|Protocol Violation|3|||
130186266|NCT03428152|468638506|FG001|Overall Study|Protocol Violation|5|||
130186267|NCT03428152|468638505|FG000|Overall Study|Lack of Efficacy|0|||
130186268|NCT03428152|468638506|FG001|Overall Study|Lack of Efficacy|4|||
130186269|NCT01293695|468638513|FG000|Overall Study|Withdrawal by Subject|7|||
130186270|NCT01293695|468638514|FG001|Overall Study|Withdrawal by Subject|1|||
130186271|NCT01293695|468638513|FG000|Overall Study|Lost to Follow-up|8|||
130186272|NCT01293695|468638514|FG001|Overall Study|Lost to Follow-up|6|||
130186273|NCT00468819|468638515|FG000|Overall Study|Withdrawal by Subject|4|||
130186274|NCT00468819|468638516|FG001|Overall Study|Withdrawal by Subject|0|||
130186275|NCT00468819|468638517|FG002|Overall Study|Withdrawal by Subject|1|||
130186276|NCT00468819|468638515|FG000|Overall Study|Lost to Follow-up|0|||
130186277|NCT00468819|468638516|FG001|Overall Study|Lost to Follow-up|0|||
130186278|NCT00468819|468638517|FG002|Overall Study|Lost to Follow-up|1|||
130186279|NCT00468819|468638515|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
130186280|NCT00468819|468638516|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
130186281|NCT00468819|468638517|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
130186282|NCT04616612|468638518|FG000|Overall Study|Lost to Follow-up|6|||
130186283|NCT04616612|468638519|FG001|Overall Study|Lost to Follow-up|3|||
130186284|NCT04740918|468638520|FG000|Overall Study|Study Terminated by Sponsor|41|||
130186285|NCT04740918|468638521|FG001|Overall Study|Study Terminated by Sponsor|32|||
130186286|NCT04740918|468638520|FG000|Overall Study|Death|3|||
130186287|NCT04740918|468638521|FG001|Overall Study|Death|6|||
130186288|NCT04740918|468638520|FG000|Overall Study|Withdrawal by Subject|5|||
130186289|NCT04740918|468638521|FG001|Overall Study|Withdrawal by Subject|4|||
130186290|NCT04740918|468638520|FG000|Overall Study|Lost to Follow-up|1|||
130186291|NCT04740918|468638521|FG001|Overall Study|Lost to Follow-up|3|||
130186292|NCT04740918|468638520|FG000|Overall Study|Progressive disease|0|||
130186293|NCT04740918|468638521|FG001|Overall Study|Progressive disease|1|||
130186294|NCT02524847|468638522|FG000|Overall Study|Adverse Event|4|||
130186295|NCT02524847|468638522|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130186296|NCT02524847|468638522|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
130186297|NCT02524847|468638522|FG000|Overall Study|Death|1|||
130186298|NCT02524847|468638522|FG000|Overall Study|Reason not Specified|1|||
130186299|NCT04352101|468638523|FG000|Overall Study|Physician Decision|2|||
130186300|NCT04352101|468638524|FG001|Overall Study|Physician Decision|1|||
130186301|NCT01288079|468638530|FG000|Overall Study|Withdrawal by Subject|2|||
130186302|NCT01288079|468638531|FG001|Overall Study|Withdrawal by Subject|4|||
130186303|NCT01288079|468638532|FG002|Overall Study|Withdrawal by Subject|1|||
130186304|NCT01288079|468638533|FG003|Overall Study|Withdrawal by Subject|0|||
130186305|NCT01288079|468638530|FG000|Overall Study|Adverse Event|2|||
130186306|NCT01288079|468638531|FG001|Overall Study|Adverse Event|1|||
130186307|NCT01288079|468638532|FG002|Overall Study|Adverse Event|2|||
130186308|NCT01288079|468638533|FG003|Overall Study|Adverse Event|3|||
130186309|NCT01288079|468638530|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130186310|NCT01288079|468638531|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
130186311|NCT01288079|468638532|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130186312|NCT01288079|468638533|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
130186313|NCT01288079|468638530|FG000|Overall Study|Condition under Investigation Worsened|0|||
130186314|NCT01288079|468638531|FG001|Overall Study|Condition under Investigation Worsened|0|||
130186315|NCT01288079|468638532|FG002|Overall Study|Condition under Investigation Worsened|0|||
130186316|NCT01288079|468638533|FG003|Overall Study|Condition under Investigation Worsened|1|||
130186317|NCT01288079|468638530|FG000|Overall Study|Lack of Efficacy|2|||
130186318|NCT01288079|468638531|FG001|Overall Study|Lack of Efficacy|2|||
130186319|NCT01288079|468638532|FG002|Overall Study|Lack of Efficacy|0|||
130186320|NCT01288079|468638533|FG003|Overall Study|Lack of Efficacy|2|||
130186321|NCT01288079|468638530|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130186322|NCT01288079|468638531|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130186323|NCT01288079|468638532|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130186324|NCT01288079|468638533|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
130186325|NCT01288079|468638530|FG000|Overall Study|Lost to Follow-up|1|||
130186326|NCT01288079|468638531|FG001|Overall Study|Lost to Follow-up|1|||
130186327|NCT01288079|468638532|FG002|Overall Study|Lost to Follow-up|1|||
130186328|NCT01288079|468638533|FG003|Overall Study|Lost to Follow-up|0|||
130186329|NCT01288079|468638530|FG000|Overall Study|Other or Study Termination|11|||
130186330|NCT01288079|468638531|FG001|Overall Study|Other or Study Termination|15|||
130186331|NCT01288079|468638532|FG002|Overall Study|Other or Study Termination|14|||
130186332|NCT01288079|468638533|FG003|Overall Study|Other or Study Termination|8|||
130186333|NCT03170544|468638534|FG000|Part 1|Lost to Follow-up|1|||
130186334|NCT03170544|468638535|FG001|Part 1|Lost to Follow-up|0|||
130186335|NCT03170544|468638536|FG002|Part 1|Lost to Follow-up|0|||
130186336|NCT03170544|468638537|FG003|Part 1|Lost to Follow-up|0|||
130186337|NCT03170544|468638538|FG004|Part 1|Lost to Follow-up|0|||
130186338|NCT03170544|468638539|FG005|Part 1|Lost to Follow-up|0|||
130186339|NCT03170544|468638540|FG006|Part 1|Lost to Follow-up|0|||
130186340|NCT03170544|468638541|FG007|Part 1|Lost to Follow-up|0|||
130186341|NCT03170544|468638542|FG008|Part 1|Lost to Follow-up|0|||
130186342|NCT03170544|468638543|FG009|Part 1|Lost to Follow-up|0|||
130186343|NCT03170544|468638544|FG010|Part 1|Lost to Follow-up|0|||
130186344|NCT03170544|468638545|FG011|Part 1|Lost to Follow-up|0|||
130186345|NCT03170544|468638534|FG000|Part 1|Not treated|0|||
130186346|NCT03170544|468638535|FG001|Part 1|Not treated|0|||
130186347|NCT03170544|468638536|FG002|Part 1|Not treated|0|||
130186348|NCT03170544|468638537|FG003|Part 1|Not treated|1|||
130186349|NCT03170544|468638538|FG004|Part 1|Not treated|0|||
130186350|NCT03170544|468638539|FG005|Part 1|Not treated|0|||
130186351|NCT03170544|468638540|FG006|Part 1|Not treated|0|||
130186352|NCT03170544|468638541|FG007|Part 1|Not treated|0|||
130186353|NCT03170544|468638542|FG008|Part 1|Not treated|0|||
130186354|NCT03170544|468638543|FG009|Part 1|Not treated|0|||
130186355|NCT03170544|468638544|FG010|Part 1|Not treated|0|||
130186356|NCT03170544|468638545|FG011|Part 1|Not treated|0|||
130186357|NCT02387840|468638546|FG000|Overall Study|Death|0|||
130186358|NCT02387840|468638547|FG001|Overall Study|Death|0|||
130186359|NCT02387840|468638548|FG002|Overall Study|Death|0|||
130186360|NCT02387840|468638549|FG003|Overall Study|Death|0|||
130186361|NCT02387840|468638550|FG004|Overall Study|Death|0|||
130186362|NCT02387840|468638551|FG005|Overall Study|Death|1|||
130186363|NCT02174627|468638554|FG000|Overall Study|Missing|0|||
130186364|NCT02174627|468638555|FG001|Overall Study|Missing|1|||
130186365|NCT02174627|468638554|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130186366|NCT02174627|468638555|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130186367|NCT02174627|468638554|FG000|Overall Study|Participant decision|84|||
130186368|NCT02174627|468638555|FG001|Overall Study|Participant decision|128|||
130186369|NCT04564092|468638556|FG000|Overall Study|Withdrawal by Subject|1|||
130186370|NCT00071110|468638557|FG000|Overall Study|Protocol Violation|0|||
130186371|NCT00071110|468638558|FG001|Overall Study|Protocol Violation|4|||
130186372|NCT02259010|468638562|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
130186373|NCT03578367|468638563|FG000|Overall Study|Adverse Event|0|||
130186374|NCT03578367|468638564|FG001|Overall Study|Adverse Event|3|||
130186375|NCT03578367|468638565|FG002|Overall Study|Adverse Event|0|||
130186376|NCT03578367|468638566|FG003|Overall Study|Adverse Event|5|||
130186377|NCT03578367|468638563|FG000|Overall Study|Withdrawal by Subject|2|||
130186378|NCT03578367|468638564|FG001|Overall Study|Withdrawal by Subject|2|||
130186379|NCT03578367|468638565|FG002|Overall Study|Withdrawal by Subject|1|||
130186380|NCT03578367|468638566|FG003|Overall Study|Withdrawal by Subject|3|||
130186381|NCT03578367|468638563|FG000|Overall Study|Physician Decision|0|||
130186382|NCT03578367|468638564|FG001|Overall Study|Physician Decision|0|||
130186383|NCT03578367|468638565|FG002|Overall Study|Physician Decision|14|||
130186384|NCT03578367|468638566|FG003|Overall Study|Physician Decision|0|||
130186385|NCT03578367|468638563|FG000|Overall Study|Death|1|||
130186386|NCT03578367|468638564|FG001|Overall Study|Death|0|||
130186387|NCT03578367|468638565|FG002|Overall Study|Death|0|||
130186388|NCT03578367|468638566|FG003|Overall Study|Death|0|||
130186389|NCT03578367|468638563|FG000|Overall Study|Not treated|0|||
130186390|NCT03578367|468638564|FG001|Overall Study|Not treated|0|||
130186391|NCT03578367|468638565|FG002|Overall Study|Not treated|1|||
130186392|NCT03578367|468638566|FG003|Overall Study|Not treated|0|||
130186393|NCT02729025|468638570|FG000|Overall Study|Sponsor Decision|0|||
130186394|NCT02729025|468638571|FG001|Overall Study|Sponsor Decision|1|||
130186395|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130186396|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
130186397|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
130186398|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186399|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186400|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186401|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186402|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186403|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130186404|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130186405|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186406|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186407|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186408|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186409|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130186410|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130186411|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
130186412|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186413|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186414|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186415|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186416|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
130186417|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
130186418|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
130186419|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186420|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186421|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186422|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186423|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
130186424|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186425|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186426|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186427|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186428|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186429|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186430|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186431|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186432|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
130186433|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186434|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186435|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186436|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186437|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186438|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186439|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
130186440|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186441|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186442|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186443|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186444|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186445|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130186446|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
130186447|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186448|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186449|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186450|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186451|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186452|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186453|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186454|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
130186455|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130186456|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
130186457|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130186458|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186459|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186460|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186461|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
130186462|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
130186463|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130186464|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130186465|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186466|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186467|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186468|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130186469|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130186470|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130186471|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130186472|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186473|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186474|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186475|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130186476|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
130186477|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130186478|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130186479|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186480|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186481|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186482|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
130186483|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
130186484|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130186485|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
130186486|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186487|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186488|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186489|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
130186490|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186491|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186492|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186493|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186494|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186495|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186496|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186497|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
130186498|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186499|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186500|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186501|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186502|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186503|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186504|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
130186505|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186506|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186507|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186508|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186509|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186510|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186511|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
130186512|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186513|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186514|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186515|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186516|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186517|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186518|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
130186519|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186520|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186521|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186522|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186523|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186524|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186525|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
130186526|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186527|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186528|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186529|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186530|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186531|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186532|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186533|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
130186534|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186535|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186536|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186537|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186538|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186539|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186540|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
130186541|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186542|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186543|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186544|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186545|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186546|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186547|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186548|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
130186549|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186550|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186551|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186552|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186553|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186554|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186555|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
130186556|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186557|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186558|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186559|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186560|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186561|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186562|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
130186563|NCT00739882|468640281|FG000|Double-blind Period|Adverse Event|1|||
130186564|NCT00739882|468640282|FG001|Double-blind Period|Adverse Event|2|||
130186565|NCT00739882|468640281|FG000|Double-blind Period|Protocol Violation|1|||
130186566|NCT00739882|468640282|FG001|Double-blind Period|Protocol Violation|0|||
130186567|NCT00739882|468640281|FG000|Double-blind Period|Lack of Efficacy|1|||
130186568|NCT00739882|468640282|FG001|Double-blind Period|Lack of Efficacy|1|||
130186569|NCT00739882|468640281|FG000|Double-blind Period|Other|16|||
130186570|NCT00739882|468640282|FG001|Double-blind Period|Other|8|||
130186571|NCT00739882|468640281|FG000|Open-label Period|Adverse Event|1|||
130186572|NCT00739882|468640282|FG001|Open-label Period|Adverse Event|0|||
130186573|NCT00739882|468640281|FG000|Open-label Period|Other|9|||
130186574|NCT00739882|468640282|FG001|Open-label Period|Other|5|||
130186575|NCT04021914|468640283|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
130186576|NCT03349060|468640284|FG000|Overall Study|Adverse Event|9|||
130186577|NCT03349060|468640285|FG001|Overall Study|Adverse Event|9|||
130186578|NCT03349060|468640286|FG002|Overall Study|Adverse Event|7|||
130186579|NCT03349060|468640284|FG000|Overall Study|Lack of Efficacy|1|||
130186580|NCT03349060|468640285|FG001|Overall Study|Lack of Efficacy|0|||
130186581|NCT03349060|468640286|FG002|Overall Study|Lack of Efficacy|2|||
130186582|NCT03349060|468640284|FG000|Overall Study|Lost to Follow-up|2|||
130186583|NCT03349060|468640285|FG001|Overall Study|Lost to Follow-up|1|||
130186584|NCT03349060|468640286|FG002|Overall Study|Lost to Follow-up|1|||
130186585|NCT03349060|468640284|FG000|Overall Study|Protocol Violation|2|||
130186586|NCT03349060|468640285|FG001|Overall Study|Protocol Violation|2|||
130186587|NCT03349060|468640286|FG002|Overall Study|Protocol Violation|1|||
130186588|NCT03349060|468640284|FG000|Overall Study|Withdrawal by Subject|5|||
130186589|NCT03349060|468640285|FG001|Overall Study|Withdrawal by Subject|3|||
130186590|NCT03349060|468640286|FG002|Overall Study|Withdrawal by Subject|4|||
130186591|NCT03349060|468640284|FG000|Overall Study|Medication error,no linked adverse event|0|||
130186592|NCT03349060|468640285|FG001|Overall Study|Medication error,no linked adverse event|0|||
130186593|NCT03349060|468640286|FG002|Overall Study|Medication error,no linked adverse event|1|||
130186594|NCT03349060|468640284|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130186595|NCT03349060|468640285|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130186596|NCT03349060|468640286|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130186597|NCT03349060|468640284|FG000|Overall Study|Other|2|||
130186598|NCT03349060|468640285|FG001|Overall Study|Other|1|||
130186599|NCT03349060|468640286|FG002|Overall Study|Other|0|||
130186600|NCT02861586|468640287|FG000|Overall Study|Withdrawal by Subject|1|||
130186601|NCT02861586|468640288|FG001|Overall Study|Withdrawal by Subject|2|||
130186602|NCT02861586|468640289|FG002|Overall Study|Withdrawal by Subject|0|||
130186603|NCT02861586|468640290|FG003|Overall Study|Withdrawal by Subject|0|||
130186604|NCT02861586|468640291|FG004|Overall Study|Withdrawal by Subject|0|||
130186605|NCT02861586|468640292|FG005|Overall Study|Withdrawal by Subject|1|||
130186606|NCT02861586|468640293|FG006|Overall Study|Withdrawal by Subject|1|||
130186607|NCT02861586|468640294|FG007|Overall Study|Withdrawal by Subject|0|||
130186608|NCT02861586|468640287|FG000|Overall Study|Lost to Follow-up|3|||
130186609|NCT02861586|468640288|FG001|Overall Study|Lost to Follow-up|1|||
130186610|NCT02861586|468640289|FG002|Overall Study|Lost to Follow-up|1|||
130186611|NCT02861586|468640290|FG003|Overall Study|Lost to Follow-up|0|||
130186612|NCT02861586|468640291|FG004|Overall Study|Lost to Follow-up|0|||
130186613|NCT02861586|468640292|FG005|Overall Study|Lost to Follow-up|3|||
130186614|NCT02861586|468640293|FG006|Overall Study|Lost to Follow-up|0|||
130186615|NCT02861586|468640294|FG007|Overall Study|Lost to Follow-up|0|||
130186616|NCT02861586|468640287|FG000|Overall Study|Adverse Event|0|||
130186617|NCT02861586|468640288|FG001|Overall Study|Adverse Event|0|||
130186618|NCT02861586|468640289|FG002|Overall Study|Adverse Event|0|||
130186619|NCT02861586|468640290|FG003|Overall Study|Adverse Event|0|||
130186620|NCT02861586|468640291|FG004|Overall Study|Adverse Event|0|||
130186621|NCT02861586|468640292|FG005|Overall Study|Adverse Event|1|||
130186622|NCT02861586|468640293|FG006|Overall Study|Adverse Event|0|||
130186623|NCT02861586|468640294|FG007|Overall Study|Adverse Event|0|||
130186624|NCT00485732|468640295|FG000|Overall Study|Protocol Violation|1|||
130186625|NCT00485732|468640296|FG001|Overall Study|Protocol Violation|3|||
130186626|NCT00485732|468640295|FG000|Overall Study|Withdrawal by Subject|5|||
130186627|NCT00485732|468640296|FG001|Overall Study|Withdrawal by Subject|4|||
130186628|NCT00485732|468640295|FG000|Overall Study|Lost to Follow-up|2|||
130186629|NCT00485732|468640296|FG001|Overall Study|Lost to Follow-up|2|||
130186630|NCT01880554|468640297|FG000|Overall Study|Protocol Violation|14|||
130186631|NCT01880554|468640297|FG000|Overall Study|Simon's design requirements|2|||
130186632|NCT03985800|468640298|FG000|Overall Study|Death|1|||
130186633|NCT03985800|468640299|FG001|Overall Study|Death|2|||
130186634|NCT03985800|468640298|FG000|Overall Study|Withdrawal by Subject|3|||
130186635|NCT03985800|468640299|FG001|Overall Study|Withdrawal by Subject|6|||
130186636|NCT03985800|468640298|FG000|Overall Study|Protocol Violation|2|||
130186637|NCT03985800|468640299|FG001|Overall Study|Protocol Violation|0|||
130186638|NCT04281485|468640300|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
130186639|NCT04281485|468640301|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
130186640|NCT04281485|468640300|FG000|Overall Study|Ongoing (Safety data collection)|10|||
130186641|NCT04281485|468640301|FG001|Overall Study|Ongoing (Safety data collection)|5|||
130186642|NCT03096314|468640304|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
130186643|NCT03096314|468640305|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
130186644|NCT00957801|468640308|FG000|Overall Study|Withdrawal by Subject|0|||
130186645|NCT00957801|468640309|FG001|Overall Study|Withdrawal by Subject|0|||
130186646|NCT00957801|468640310|FG002|Overall Study|Withdrawal by Subject|0|||
130186647|NCT00957801|468640311|FG003|Overall Study|Withdrawal by Subject|1|||
130186648|NCT01778855|468640312|FG000|Overall Study|Death|0|||
130186649|NCT01778855|468640313|FG001|Overall Study|Death|1|||
130186650|NCT00191477|468640314|FG000|Overall Study|Tumor Recurrence|49|||
130186651|NCT00191477|468640315|FG001|Overall Study|Tumor Recurrence|48|||
130186652|NCT00191477|468640314|FG000|Overall Study|Death, Study Disease|1|||
130186653|NCT00191477|468640315|FG001|Overall Study|Death, Study Disease|1|||
130186654|NCT00191477|468640314|FG000|Overall Study|Death, Other Cause|3|||
130186655|NCT00191477|468640315|FG001|Overall Study|Death, Other Cause|6|||
130186656|NCT00191477|468640314|FG000|Overall Study|Lost to Follow-up|23|||
130186657|NCT00191477|468640315|FG001|Overall Study|Lost to Follow-up|21|||
130186658|NCT00191477|468640314|FG000|Overall Study|Protocol Violation|1|||
130186659|NCT00191477|468640315|FG001|Overall Study|Protocol Violation|1|||
130186660|NCT00191477|468640314|FG000|Overall Study|Treatment Change|2|||
130186661|NCT00191477|468640315|FG001|Overall Study|Treatment Change|0|||
130186662|NCT00191477|468640314|FG000|Overall Study|Withdrawal by Subject|2|||
130186663|NCT00191477|468640315|FG001|Overall Study|Withdrawal by Subject|0|||
130186664|NCT00191477|468640314|FG000|Overall Study|Other|2|||
130186665|NCT00191477|468640315|FG001|Overall Study|Other|0|||
130186666|NCT00191477|468640314|FG000|Overall Study|Not Eligible|41|||
130186667|NCT00191477|468640315|FG001|Overall Study|Not Eligible|38|||
130186668|NCT00191477|468640314|FG000|Overall Study|Pathological Specimen Lost|1|||
130186669|NCT00191477|468640315|FG001|Overall Study|Pathological Specimen Lost|0|||
130186670|NCT00191477|468640314|FG000|Overall Study|Discontinued Prior to Instillation|13|||
130186671|NCT00191477|468640315|FG001|Overall Study|Discontinued Prior to Instillation|14|||
130186672|NCT01286467|468640320|FG000|Overall Study|Death|1|||
130186673|NCT01286467|468640321|FG001|Overall Study|Death|1|||
130186674|NCT01286467|468640322|FG002|Overall Study|Death|1|||
130186675|NCT01286467|468640323|FG003|Overall Study|Death|0|||
130186676|NCT01286467|468640320|FG000|Overall Study|Lost to Follow-up|0|||
130186677|NCT01286467|468640321|FG001|Overall Study|Lost to Follow-up|0|||
130186678|NCT01286467|468640322|FG002|Overall Study|Lost to Follow-up|0|||
130186679|NCT01286467|468640323|FG003|Overall Study|Lost to Follow-up|1|||
130186680|NCT01286467|468640320|FG000|Overall Study|Withdrawal by Subject|0|||
130186681|NCT01286467|468640321|FG001|Overall Study|Withdrawal by Subject|0|||
130186682|NCT01286467|468640322|FG002|Overall Study|Withdrawal by Subject|1|||
130186683|NCT01286467|468640323|FG003|Overall Study|Withdrawal by Subject|0|||
130186684|NCT01286467|468640320|FG000|Overall Study|Physician Decision|0|||
130186685|NCT01286467|468640321|FG001|Overall Study|Physician Decision|0|||
130186686|NCT01286467|468640322|FG002|Overall Study|Physician Decision|0|||
130186687|NCT01286467|468640323|FG003|Overall Study|Physician Decision|1|||
130186688|NCT01286467|468640320|FG000|Overall Study|Disease progression|3|||
130186689|NCT01286467|468640321|FG001|Overall Study|Disease progression|2|||
130186690|NCT01286467|468640322|FG002|Overall Study|Disease progression|2|||
130186691|NCT01286467|468640323|FG003|Overall Study|Disease progression|3|||
130186692|NCT01286467|468640320|FG000|Overall Study|Adverse Event|0|||
130186693|NCT01286467|468640321|FG001|Overall Study|Adverse Event|1|||
130186694|NCT01286467|468640322|FG002|Overall Study|Adverse Event|2|||
130186695|NCT01286467|468640323|FG003|Overall Study|Adverse Event|3|||
130186696|NCT01286467|468640320|FG000|Overall Study|Study drug stop longer than 14 days|0|||
130186697|NCT01286467|468640321|FG001|Overall Study|Study drug stop longer than 14 days|0|||
130186698|NCT01286467|468640322|FG002|Overall Study|Study drug stop longer than 14 days|1|||
130186699|NCT01286467|468640323|FG003|Overall Study|Study drug stop longer than 14 days|0|||
130186700|NCT01058642|468640324|FG000|Treatment Period 1|Adverse Event|0|||
130186701|NCT01058642|468640325|FG001|Treatment Period 1|Adverse Event|1|||
130186702|NCT01058642|468640326|FG002|Treatment Period 1|Adverse Event|1|||
130186703|NCT01058642|468640327|FG003|Treatment Period 1|Adverse Event|0|||
130186704|NCT01058642|468640324|FG000|Treatment Period 1|Physician Decision|0|||
130186705|NCT01058642|468640325|FG001|Treatment Period 1|Physician Decision|0|||
130186706|NCT01058642|468640326|FG002|Treatment Period 1|Physician Decision|1|||
130186707|NCT01058642|468640327|FG003|Treatment Period 1|Physician Decision|0|||
130186708|NCT01058642|468640324|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130186709|NCT01058642|468640325|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130186710|NCT01058642|468640326|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130186711|NCT01058642|468640327|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130186712|NCT01058642|468640324|FG000|Treatment Period 1|Lack of Efficacy|0|||
130186713|NCT01058642|468640325|FG001|Treatment Period 1|Lack of Efficacy|0|||
130186714|NCT01058642|468640326|FG002|Treatment Period 1|Lack of Efficacy|0|||
130186715|NCT01058642|468640327|FG003|Treatment Period 1|Lack of Efficacy|1|||
130186716|NCT01058642|468640324|FG000|Treatment Period 1|Protocol Violation|0|||
130186717|NCT01058642|468640325|FG001|Treatment Period 1|Protocol Violation|0|||
130186718|NCT01058642|468640326|FG002|Treatment Period 1|Protocol Violation|0|||
130186719|NCT01058642|468640327|FG003|Treatment Period 1|Protocol Violation|1|||
130186720|NCT01058642|468640324|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
130186721|NCT01058642|468640325|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186722|NCT01058642|468640326|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186723|NCT01058642|468640327|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186724|NCT03876743|468640328|FG000|Overall Study|Lost to Follow-up|6|||
130186725|NCT03876743|468640329|FG001|Overall Study|Lost to Follow-up|4|||
130186726|NCT03876743|468640330|FG002|Overall Study|Lost to Follow-up|4|||
130186727|NCT03876743|468640331|FG003|Overall Study|Lost to Follow-up|7|||
130186728|NCT00092118|468640332|FG000|Overall Study|Adverse Event|35|||
130186729|NCT00092118|468640333|FG001|Overall Study|Adverse Event|32|||
130186730|NCT00092118|468640332|FG000|Overall Study|Lack of Efficacy|12|||
130186731|NCT00092118|468640333|FG001|Overall Study|Lack of Efficacy|14|||
130186732|NCT00092118|468640332|FG000|Overall Study|Lost to Follow-up|4|||
130186733|NCT00092118|468640333|FG001|Overall Study|Lost to Follow-up|3|||
130186734|NCT00092118|468640332|FG000|Overall Study|Protocol Violation|23|||
130186735|NCT00092118|468640333|FG001|Overall Study|Protocol Violation|25|||
130186736|NCT00092118|468640332|FG000|Overall Study|Withdrawal by Subject|4|||
130186737|NCT00092118|468640333|FG001|Overall Study|Withdrawal by Subject|10|||
130186738|NCT00092118|468640332|FG000|Overall Study|Other|6|||
130186739|NCT00092118|468640333|FG001|Overall Study|Other|5|||
130186740|NCT01139125|468640334|FG000|Overall Study|Withdrawal by Subject|1|||
130186741|NCT03751098|468640335|FG000|Overall Study|Withdrawal by Subject|0|||
130186742|NCT03751098|468640336|FG001|Overall Study|Withdrawal by Subject|1|||
130186743|NCT01108718|468640339|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
130186744|NCT01108718|468640340|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
130186745|NCT03380429|468640341|FG000|Overall Study|Physician Decision|0|||
130186746|NCT03380429|468640342|FG001|Overall Study|Physician Decision|1|||
130186747|NCT03380429|468640343|FG002|Overall Study|Physician Decision|0|||
130186748|NCT03380429|468640344|FG003|Overall Study|Physician Decision|1|||
130186749|NCT03380429|468640345|FG004|Overall Study|Physician Decision|1|||
130186750|NCT03380429|468640341|FG000|Overall Study|Withdrawal by Subject|3|||
130186751|NCT03380429|468640342|FG001|Overall Study|Withdrawal by Subject|3|||
130186752|NCT03380429|468640343|FG002|Overall Study|Withdrawal by Subject|5|||
130186753|NCT03380429|468640344|FG003|Overall Study|Withdrawal by Subject|2|||
130186754|NCT03380429|468640345|FG004|Overall Study|Withdrawal by Subject|1|||
130186755|NCT03380429|468640341|FG000|Overall Study|Lost to Follow-up|0|||
130186756|NCT03380429|468640342|FG001|Overall Study|Lost to Follow-up|2|||
130186757|NCT03380429|468640343|FG002|Overall Study|Lost to Follow-up|4|||
130186758|NCT03380429|468640344|FG003|Overall Study|Lost to Follow-up|3|||
130186759|NCT03380429|468640345|FG004|Overall Study|Lost to Follow-up|1|||
130186760|NCT03380429|468640341|FG000|Overall Study|Protocol Violation|1|||
130186761|NCT03380429|468640342|FG001|Overall Study|Protocol Violation|0|||
130186762|NCT03380429|468640343|FG002|Overall Study|Protocol Violation|1|||
130186763|NCT03380429|468640344|FG003|Overall Study|Protocol Violation|0|||
130186764|NCT03380429|468640345|FG004|Overall Study|Protocol Violation|1|||
130186765|NCT03380429|468640341|FG000|Overall Study|Lack of Efficacy|0|||
130186766|NCT03380429|468640342|FG001|Overall Study|Lack of Efficacy|0|||
130186767|NCT03380429|468640343|FG002|Overall Study|Lack of Efficacy|0|||
130186768|NCT03380429|468640344|FG003|Overall Study|Lack of Efficacy|2|||
130186769|NCT03380429|468640345|FG004|Overall Study|Lack of Efficacy|1|||
130186770|NCT03380429|468640341|FG000|Overall Study|Adverse Event|1|||
130186771|NCT03380429|468640342|FG001|Overall Study|Adverse Event|1|||
130186772|NCT03380429|468640343|FG002|Overall Study|Adverse Event|1|||
130186773|NCT03380429|468640344|FG003|Overall Study|Adverse Event|2|||
130186774|NCT03380429|468640345|FG004|Overall Study|Adverse Event|0|||
130186775|NCT04760626|468640348|FG000|Overall Study|Withdrawal by Subject|24|||
130186776|NCT04760626|468640349|FG001|Overall Study|Withdrawal by Subject|20|||
130186777|NCT04760626|468640348|FG000|Overall Study|Lost to Follow-up|14|||
130186778|NCT04760626|468640349|FG001|Overall Study|Lost to Follow-up|19|||
130186779|NCT04760626|468640348|FG000|Overall Study|Physician Decision|3|||
130186780|NCT04760626|468640349|FG001|Overall Study|Physician Decision|5|||
130186781|NCT04760626|468640348|FG000|Overall Study|Death|3|||
130186782|NCT04760626|468640349|FG001|Overall Study|Death|6|||
130186783|NCT04760626|468640348|FG000|Overall Study|Site closure|1|||
130186784|NCT04760626|468640349|FG001|Overall Study|Site closure|0|||
130186785|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
130186786|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
130186787|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
130186788|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
130186789|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
130186790|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
130186791|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
130186792|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
130186793|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
130186794|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
130186795|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Other|0|||
130186796|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Other|1|||
130186797|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
130186798|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
130186799|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
130186800|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
130186801|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
130186802|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
130186803|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
130186804|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
130186805|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
130186806|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
130186807|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
130186808|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
130186809|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
130186810|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
130186811|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
130186812|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
130186813|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Other|1|||
130186814|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Other|0|||
130186815|NCT00806403|468640356|FG000|Overall Study|Death|4|||
130186816|NCT00806403|468640357|FG001|Overall Study|Death|3|||
130186817|NCT01882985|468640358|FG000|Overall Study|Lost to Follow-up|1|||
130186818|NCT01882985|468640358|FG000|Overall Study|Withdrawal by Subject|1|||
130186819|NCT01383174|468640359|FG000|3 Month Assessment|Death|0|||
130186820|NCT01383174|468640360|FG001|3 Month Assessment|Death|1|||
130186821|NCT01383174|468640359|FG000|3 Month Assessment|Lost to Follow-up|2|||
130186822|NCT01383174|468640360|FG001|3 Month Assessment|Lost to Follow-up|0|||
130186823|NCT01383174|468640359|FG000|3 Month Assessment|Refused to complete|4|||
130186824|NCT01383174|468640360|FG001|3 Month Assessment|Refused to complete|0|||
130186825|NCT01383174|468640359|FG000|6 Month Assessment|Lost to Follow-up|1|||
130186826|NCT01383174|468640360|FG001|6 Month Assessment|Lost to Follow-up|1|||
130186827|NCT01383174|468640359|FG000|6 Month Assessment|Refused to complete|4|||
130186828|NCT01383174|468640360|FG001|6 Month Assessment|Refused to complete|0|||
130186829|NCT01787292|468640361|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130186830|NCT01787292|468640362|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130186831|NCT01787292|468640361|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
130186832|NCT01787292|468640362|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
130186833|NCT01827111|468640363|FG000|Overall Study|Disease Progression|1|||
130186834|NCT02169271|468640364|FG000|Overall Study|Protocol Violation|1|||
130186835|NCT02169271|468640365|FG001|Overall Study|Protocol Violation|2|||
130186836|NCT01924689|468640368|FG000|Overall Study|Death|0|||
130186837|NCT01924689|468640369|FG001|Overall Study|Death|1|||
130186838|NCT01924689|468640370|FG002|Overall Study|Death|0|||
130186839|NCT01924689|468640371|FG003|Overall Study|Death|1|||
130186840|NCT01924689|468640372|FG004|Overall Study|Death|0|||
130186841|NCT01924689|468640373|FG005|Overall Study|Death|0|||
130186842|NCT01924689|468640368|FG000|Overall Study|Disease progression|0|||
130186843|NCT01924689|468640369|FG001|Overall Study|Disease progression|0|||
130186844|NCT01924689|468640370|FG002|Overall Study|Disease progression|2|||
130186845|NCT01924689|468640371|FG003|Overall Study|Disease progression|0|||
130186846|NCT01924689|468640372|FG004|Overall Study|Disease progression|3|||
130186847|NCT01924689|468640373|FG005|Overall Study|Disease progression|2|||
130186848|NCT01924689|468640368|FG000|Overall Study|New therapy or study|3|||
130186849|NCT01924689|468640369|FG001|Overall Study|New therapy or study|2|||
130186850|NCT01924689|468640370|FG002|Overall Study|New therapy or study|1|||
130186851|NCT01924689|468640371|FG003|Overall Study|New therapy or study|4|||
130186852|NCT01924689|468640372|FG004|Overall Study|New therapy or study|2|||
130186853|NCT01924689|468640373|FG005|Overall Study|New therapy or study|0|||
130186854|NCT01924689|468640368|FG000|Overall Study|Withdrawal of consent|0|||
130186855|NCT01924689|468640369|FG001|Overall Study|Withdrawal of consent|0|||
130186856|NCT01924689|468640370|FG002|Overall Study|Withdrawal of consent|1|||
130186857|NCT01924689|468640371|FG003|Overall Study|Withdrawal of consent|1|||
130186858|NCT01924689|468640372|FG004|Overall Study|Withdrawal of consent|0|||
130186859|NCT01924689|468640373|FG005|Overall Study|Withdrawal of consent|0|||
130186860|NCT01924689|468640368|FG000|Overall Study|Other|0|||
130186861|NCT01924689|468640369|FG001|Overall Study|Other|0|||
130186862|NCT01924689|468640370|FG002|Overall Study|Other|0|||
130186863|NCT01924689|468640371|FG003|Overall Study|Other|0|||
130186864|NCT01924689|468640372|FG004|Overall Study|Other|1|||
130186865|NCT01924689|468640373|FG005|Overall Study|Other|0|||
130186866|NCT03267212|468640374|FG000|First Intervention|Lost to Follow-up|0|||
130186867|NCT03267212|468640375|FG001|First Intervention|Lost to Follow-up|2|||
130186868|NCT03267212|468640374|FG000|First Intervention|Withdrawal by Subject|1|||
130186869|NCT03267212|468640375|FG001|First Intervention|Withdrawal by Subject|1|||
130186870|NCT03267212|468640374|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
130186871|NCT03267212|468640375|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
130186872|NCT00226499|468640378|FG000|Overall Study|Adverse Event|10|||
130186873|NCT00226499|468640379|FG001|Overall Study|Adverse Event|6|||
130186874|NCT00226499|468640380|FG002|Overall Study|Adverse Event|3|||
130186875|NCT00226499|468640378|FG000|Overall Study|Others|1064|||
130186876|NCT00226499|468640379|FG001|Overall Study|Others|1066|||
130186877|NCT00226499|468640380|FG002|Overall Study|Others|356|||
130186878|NCT00946920|468640381|FG000|Overall Study|Withdrawal by Subject|28|||
130186879|NCT00946920|468640382|FG001|Overall Study|Withdrawal by Subject|15|||
130186880|NCT00946920|468640381|FG000|Overall Study|Lost to Follow-up|2|||
130186881|NCT00946920|468640382|FG001|Overall Study|Lost to Follow-up|2|||
130186882|NCT00946920|468640381|FG000|Overall Study|Physician Decision|5|||
130186883|NCT00946920|468640382|FG001|Overall Study|Physician Decision|2|||
130186884|NCT00946920|468640381|FG000|Overall Study|Adverse Event|41|||
130186885|NCT00946920|468640382|FG001|Overall Study|Adverse Event|14|||
130186886|NCT00946920|468640381|FG000|Overall Study|Protocol Violation|16|||
130186887|NCT00946920|468640382|FG001|Overall Study|Protocol Violation|8|||
130186888|NCT00946920|468640381|FG000|Overall Study|Miscellaneous reasons|18|||
130186889|NCT00946920|468640382|FG001|Overall Study|Miscellaneous reasons|3|||
130186890|NCT01597973|468640383|FG000|Overall Study|Found ineligible before study medication started|4|||
130186891|NCT01597973|468640384|FG001|Overall Study|Found ineligible before study medication started|2|||
130186892|NCT01597973|468640383|FG000|Overall Study|Eligible pathogen not confirmed|14|||
130186893|NCT01597973|468640384|FG001|Overall Study|Eligible pathogen not confirmed|15|||
130186894|NCT01597973|468640383|FG000|Overall Study|LAR not authorized to consent|0|||
130186895|NCT01597973|468640384|FG001|Overall Study|LAR not authorized to consent|1|||
130186896|NCT01597973|468640383|FG000|Overall Study|Ineligible due to early seizures|1|||
130186897|NCT01597973|468640384|FG001|Overall Study|Ineligible due to early seizures|0|||
130186898|NCT01597973|468640383|FG000|Overall Study|Ineligible due to non-target infection|1|||
130186899|NCT01597973|468640384|FG001|Overall Study|Ineligible due to non-target infection|1|||
130186900|NCT02389829|468640391|FG000|Overall Study|Lost to Follow-up|0|||
130186901|NCT02389829|468640392|FG001|Overall Study|Lost to Follow-up|1|||
130186902|NCT02362360|468640393|FG000|Period 1|Lack of Efficacy|1|||
130186903|NCT02362360|468640394|FG001|Period 1|Lack of Efficacy|0|||
130186904|NCT02362360|468640393|FG000|Period 1|Withdrawal by Subject|2|||
130186905|NCT02362360|468640394|FG001|Period 1|Withdrawal by Subject|1|||
130186906|NCT02208362|468640395|FG000|Overall Study|Participant did not complete treatment|0|||
130186907|NCT02208362|468640396|FG001|Overall Study|Participant did not complete treatment|1|||
130186908|NCT02208362|468640397|FG002|Overall Study|Participant did not complete treatment|0|||
130186909|NCT02208362|468640398|FG003|Overall Study|Participant did not complete treatment|0|||
130186910|NCT02208362|468640399|FG004|Overall Study|Participant did not complete treatment|0|||
130186911|NCT02208362|468640400|FG005|Overall Study|Participant did not complete treatment|0|||
130186912|NCT02208362|468640401|FG006|Overall Study|Participant did not complete treatment|1|||
130186913|NCT02208362|468640402|FG007|Overall Study|Participant did not complete treatment|1|||
130186914|NCT02208362|468640403|FG008|Overall Study|Participant did not complete treatment|2|||
130186915|NCT02208362|468640404|FG009|Overall Study|Participant did not complete treatment|0|||
130186916|NCT02208362|468640405|FG010|Overall Study|Participant did not complete treatment|1|||
130186917|NCT02208362|468640406|FG011|Overall Study|Participant did not complete treatment|0|||
130186918|NCT02208362|468640395|FG000|Overall Study|Participant received disallowed treatment|0|||
130186919|NCT02208362|468640396|FG001|Overall Study|Participant received disallowed treatment|0|||
130186920|NCT02208362|468640397|FG002|Overall Study|Participant received disallowed treatment|0|||
130186921|NCT02208362|468640398|FG003|Overall Study|Participant received disallowed treatment|0|||
130186922|NCT02208362|468640399|FG004|Overall Study|Participant received disallowed treatment|0|||
130186923|NCT02208362|468640400|FG005|Overall Study|Participant received disallowed treatment|0|||
130186924|NCT02208362|468640401|FG006|Overall Study|Participant received disallowed treatment|0|||
130186925|NCT02208362|468640402|FG007|Overall Study|Participant received disallowed treatment|0|||
130186926|NCT02208362|468640403|FG008|Overall Study|Participant received disallowed treatment|1|||
130186927|NCT02208362|468640404|FG009|Overall Study|Participant received disallowed treatment|0|||
130186928|NCT02208362|468640405|FG010|Overall Study|Participant received disallowed treatment|0|||
130186929|NCT02208362|468640406|FG011|Overall Study|Participant received disallowed treatment|0|||
130186930|NCT05966584|468640411|FG000|Overall Study|Lost to Follow-up|1|||
130186931|NCT00955409|468641630|FG000|Overall Study|Lack of Efficacy|1|||
130186932|NCT00955409|468641631|FG001|Overall Study|Lack of Efficacy|0|||
130186933|NCT00955409|468641632|FG002|Overall Study|Lack of Efficacy|0|||
130186934|NCT00955409|468641633|FG003|Overall Study|Lack of Efficacy|0|||
130186935|NCT00955409|468641634|FG004|Overall Study|Lack of Efficacy|0|||
130186936|NCT00955409|468641635|FG005|Overall Study|Lack of Efficacy|0|||
130186937|NCT00955409|468641636|FG006|Overall Study|Lack of Efficacy|0|||
130186938|NCT00955409|468641637|FG007|Overall Study|Lack of Efficacy|0|||
130186939|NCT00955409|468641638|FG008|Overall Study|Lack of Efficacy|0|||
130186940|NCT00955409|468641639|FG009|Overall Study|Lack of Efficacy|0|||
130186941|NCT00955409|468641630|FG000|Overall Study|Withdrawal by Subject|1|||
130186942|NCT00955409|468641631|FG001|Overall Study|Withdrawal by Subject|0|||
130186943|NCT00955409|468641632|FG002|Overall Study|Withdrawal by Subject|5|||
130186944|NCT00955409|468641633|FG003|Overall Study|Withdrawal by Subject|2|||
130186945|NCT00955409|468641634|FG004|Overall Study|Withdrawal by Subject|0|||
130186946|NCT00955409|468641635|FG005|Overall Study|Withdrawal by Subject|0|||
130186947|NCT00955409|468641636|FG006|Overall Study|Withdrawal by Subject|2|||
130186948|NCT00955409|468641637|FG007|Overall Study|Withdrawal by Subject|0|||
130186949|NCT00955409|468641638|FG008|Overall Study|Withdrawal by Subject|1|||
130186950|NCT00955409|468641639|FG009|Overall Study|Withdrawal by Subject|0|||
130186951|NCT00955409|468641630|FG000|Overall Study|Caregiver Request|2|||
130186952|NCT00955409|468641631|FG001|Overall Study|Caregiver Request|0|||
130186953|NCT00955409|468641632|FG002|Overall Study|Caregiver Request|6|||
130186954|NCT00955409|468641633|FG003|Overall Study|Caregiver Request|5|||
130186955|NCT00955409|468641634|FG004|Overall Study|Caregiver Request|0|||
130186956|NCT00955409|468641635|FG005|Overall Study|Caregiver Request|2|||
130186957|NCT00955409|468641636|FG006|Overall Study|Caregiver Request|3|||
130186958|NCT00955409|468641637|FG007|Overall Study|Caregiver Request|1|||
130186959|NCT00955409|468641638|FG008|Overall Study|Caregiver Request|3|||
130186960|NCT00955409|468641639|FG009|Overall Study|Caregiver Request|0|||
130186961|NCT00955409|468641630|FG000|Overall Study|Investigator Request|0|||
130186962|NCT00955409|468641631|FG001|Overall Study|Investigator Request|0|||
130186963|NCT00955409|468641632|FG002|Overall Study|Investigator Request|1|||
130186964|NCT00955409|468641633|FG003|Overall Study|Investigator Request|0|||
130186965|NCT00955409|468641634|FG004|Overall Study|Investigator Request|0|||
130186966|NCT00955409|468641635|FG005|Overall Study|Investigator Request|0|||
130186967|NCT00955409|468641636|FG006|Overall Study|Investigator Request|0|||
130186968|NCT00955409|468641637|FG007|Overall Study|Investigator Request|0|||
130186969|NCT00955409|468641638|FG008|Overall Study|Investigator Request|0|||
130186970|NCT00955409|468641639|FG009|Overall Study|Investigator Request|0|||
130186971|NCT00955409|468641630|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
130186972|NCT00955409|468641631|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130186973|NCT00955409|468641632|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
130186974|NCT00955409|468641633|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130186975|NCT00955409|468641634|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
130186976|NCT00955409|468641635|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
130186977|NCT00955409|468641636|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
130186978|NCT00955409|468641637|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
130186979|NCT00955409|468641638|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
130186980|NCT00955409|468641639|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
130186981|NCT00955409|468641630|FG000|Overall Study|Lost to Follow-up|0|||
130186982|NCT00955409|468641631|FG001|Overall Study|Lost to Follow-up|0|||
130186983|NCT00955409|468641632|FG002|Overall Study|Lost to Follow-up|1|||
130186984|NCT00955409|468641633|FG003|Overall Study|Lost to Follow-up|0|||
130186985|NCT00955409|468641634|FG004|Overall Study|Lost to Follow-up|0|||
130186986|NCT00955409|468641635|FG005|Overall Study|Lost to Follow-up|0|||
130186987|NCT00955409|468641636|FG006|Overall Study|Lost to Follow-up|1|||
130186988|NCT00955409|468641637|FG007|Overall Study|Lost to Follow-up|0|||
130186989|NCT00955409|468641638|FG008|Overall Study|Lost to Follow-up|0|||
130186990|NCT00955409|468641639|FG009|Overall Study|Lost to Follow-up|0|||
130186991|NCT00955409|468641630|FG000|Overall Study|Failed to Return|2|||
130186992|NCT00955409|468641631|FG001|Overall Study|Failed to Return|0|||
130186993|NCT00955409|468641632|FG002|Overall Study|Failed to Return|0|||
130186994|NCT00955409|468641633|FG003|Overall Study|Failed to Return|0|||
130186995|NCT00955409|468641634|FG004|Overall Study|Failed to Return|0|||
130186996|NCT00955409|468641635|FG005|Overall Study|Failed to Return|0|||
130186997|NCT00955409|468641636|FG006|Overall Study|Failed to Return|0|||
130186998|NCT00955409|468641637|FG007|Overall Study|Failed to Return|2|||
130186999|NCT00955409|468641638|FG008|Overall Study|Failed to Return|0|||
130187000|NCT00955409|468641639|FG009|Overall Study|Failed to Return|0|||
130187001|NCT00955409|468641630|FG000|Overall Study|Adverse Event (AE)|2|||
130187002|NCT00955409|468641631|FG001|Overall Study|Adverse Event (AE)|0|||
130187003|NCT00955409|468641632|FG002|Overall Study|Adverse Event (AE)|0|||
130187004|NCT00955409|468641633|FG003|Overall Study|Adverse Event (AE)|0|||
130187005|NCT00955409|468641634|FG004|Overall Study|Adverse Event (AE)|0|||
130187006|NCT00955409|468641635|FG005|Overall Study|Adverse Event (AE)|1|||
130187007|NCT00955409|468641636|FG006|Overall Study|Adverse Event (AE)|2|||
130187008|NCT00955409|468641637|FG007|Overall Study|Adverse Event (AE)|0|||
130187009|NCT00955409|468641638|FG008|Overall Study|Adverse Event (AE)|2|||
130187010|NCT00955409|468641639|FG009|Overall Study|Adverse Event (AE)|0|||
130187011|NCT00955409|468641630|FG000|Overall Study|Reason not Specified|2|||
130187012|NCT00955409|468641631|FG001|Overall Study|Reason not Specified|1|||
130187013|NCT00955409|468641632|FG002|Overall Study|Reason not Specified|13|||
130187014|NCT00955409|468641633|FG003|Overall Study|Reason not Specified|1|||
130187015|NCT00955409|468641634|FG004|Overall Study|Reason not Specified|2|||
130187016|NCT00955409|468641635|FG005|Overall Study|Reason not Specified|0|||
130187017|NCT00955409|468641636|FG006|Overall Study|Reason not Specified|16|||
130187018|NCT00955409|468641637|FG007|Overall Study|Reason not Specified|0|||
130187019|NCT00955409|468641638|FG008|Overall Study|Reason not Specified|8|||
130187020|NCT00955409|468641639|FG009|Overall Study|Reason not Specified|1|||
130187021|NCT00803790|468641640|FG000|Period 1|Adverse Event|0|||
130187022|NCT00803790|468641641|FG001|Period 1|Adverse Event|1|||
130187023|NCT00803790|468641642|FG002|Period 1|Adverse Event|0|||
130187024|NCT00803790|468641643|FG003|Period 1|Adverse Event|0|||
130187025|NCT00803790|468641640|FG000|Period 1|Lost to Follow-up|1|||
130187026|NCT00803790|468641641|FG001|Period 1|Lost to Follow-up|2|||
130187027|NCT00803790|468641642|FG002|Period 1|Lost to Follow-up|0|||
130187028|NCT00803790|468641643|FG003|Period 1|Lost to Follow-up|0|||
130187029|NCT00803790|468641640|FG000|Period 1|Withdrawal by Subject|8|||
130187030|NCT00803790|468641641|FG001|Period 1|Withdrawal by Subject|6|||
130187031|NCT00803790|468641642|FG002|Period 1|Withdrawal by Subject|0|||
130187032|NCT00803790|468641643|FG003|Period 1|Withdrawal by Subject|0|||
130187033|NCT00803790|468641640|FG000|Period 1|positive drug screen or personal reasons|0|||
130187034|NCT00803790|468641641|FG001|Period 1|positive drug screen or personal reasons|3|||
130187035|NCT00803790|468641642|FG002|Period 1|positive drug screen or personal reasons|0|||
130187036|NCT00803790|468641643|FG003|Period 1|positive drug screen or personal reasons|4|||
130187037|NCT00803790|468641640|FG000|Period 1|Protocol Violation|0|||
130187038|NCT00803790|468641641|FG001|Period 1|Protocol Violation|0|||
130187039|NCT00803790|468641642|FG002|Period 1|Protocol Violation|1|||
130187040|NCT00803790|468641643|FG003|Period 1|Protocol Violation|0|||
130187041|NCT00803790|468641640|FG000|Period 2|Adverse Event|0|||
130187042|NCT00803790|468641641|FG001|Period 2|Adverse Event|0|||
130187043|NCT00803790|468641642|FG002|Period 2|Adverse Event|1|||
130187044|NCT00803790|468641643|FG003|Period 2|Adverse Event|1|||
130187045|NCT00803790|468641640|FG000|Period 2|Withdrawal by Subject|1|||
130187046|NCT00803790|468641641|FG001|Period 2|Withdrawal by Subject|0|||
130187047|NCT00803790|468641642|FG002|Period 2|Withdrawal by Subject|0|||
130187048|NCT00803790|468641643|FG003|Period 2|Withdrawal by Subject|0|||
130187049|NCT00803790|468641640|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
130187050|NCT00803790|468641641|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187051|NCT00803790|468641642|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187052|NCT00803790|468641643|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187053|NCT05161481|468641644|FG000|Overall Study|Withdrawal of consent|0|||
130187054|NCT05161481|468641645|FG001|Overall Study|Withdrawal of consent|1|||
130187055|NCT05161481|468641646|FG002|Overall Study|Withdrawal of consent|1|||
130187056|NCT05161481|468641644|FG000|Overall Study|Study terminated by sponsor|3|||
130187057|NCT05161481|468641645|FG001|Overall Study|Study terminated by sponsor|3|||
130187058|NCT05161481|468641646|FG002|Overall Study|Study terminated by sponsor|2|||
130187059|NCT05161481|468641644|FG000|Overall Study|Adverse Event|3|||
130187060|NCT05161481|468641645|FG001|Overall Study|Adverse Event|0|||
130187061|NCT05161481|468641646|FG002|Overall Study|Adverse Event|6|||
130187062|NCT05161481|468641644|FG000|Overall Study|Randomised in error and was not treated|1|||
130187063|NCT05161481|468641645|FG001|Overall Study|Randomised in error and was not treated|0|||
130187064|NCT05161481|468641646|FG002|Overall Study|Randomised in error and was not treated|0|||
130187065|NCT05161481|468641644|FG000|Overall Study|Subject decision|0|||
130187066|NCT05161481|468641645|FG001|Overall Study|Subject decision|0|||
130187067|NCT05161481|468641646|FG002|Overall Study|Subject decision|1|||
130187068|NCT04815083|468641647|FG000|Overall Study|Physician Decision|1|||
130187069|NCT04815083|468641647|FG000|Overall Study|Study pause|2|||
130187070|NCT04815083|468641647|FG000|Overall Study|Screening failure|4|||
130187071|NCT00471081|468641648|FG000|Active Phase|Protocol Violation|1|||
130187072|NCT00471081|468641649|FG001|Active Phase|Protocol Violation|1|||
130187073|NCT00471081|468641648|FG000|Active Phase|Withdrawal by Subject|0|||
130187074|NCT00471081|468641649|FG001|Active Phase|Withdrawal by Subject|3|||
130187075|NCT00471081|468641648|FG000|Active Phase|Lost to Follow-up|0|||
130187076|NCT00471081|468641649|FG001|Active Phase|Lost to Follow-up|1|||
130187077|NCT00471081|468641648|FG000|Active Phase|Lost health plan/insurance|1|||
130187078|NCT00471081|468641649|FG001|Active Phase|Lost health plan/insurance|8|||
130187079|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
130187080|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
130187081|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
130187082|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
130187083|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
130187084|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
130187085|NCT04335123|468641651|FG000|Overall Study|Withdrawal by Subject|2|||
130187086|NCT04335123|468641652|FG001|Overall Study|Withdrawal by Subject|0|||
130187087|NCT04335123|468641651|FG000|Overall Study|Physician Decision|2|||
130187088|NCT04335123|468641652|FG001|Overall Study|Physician Decision|0|||
130187089|NCT01283464|468641653|FG000|Overall Study|Lost to Follow-up|0|||
130187090|NCT01283464|468641654|FG001|Overall Study|Lost to Follow-up|1|||
130187091|NCT01283464|468641653|FG000|Overall Study|Withdrawal by Subject|1|||
130187092|NCT01283464|468641654|FG001|Overall Study|Withdrawal by Subject|0|||
130187093|NCT01283464|468641653|FG000|Overall Study|Physician Decision|1|||
130187094|NCT01283464|468641654|FG001|Overall Study|Physician Decision|0|||
130187095|NCT02626026|468641655|FG000|Overall Study|Randomized but Never Treated|0|||
130187096|NCT02626026|468641656|FG001|Overall Study|Randomized but Never Treated|0|||
130187097|NCT02626026|468641657|FG002|Overall Study|Randomized but Never Treated|0|||
130187098|NCT02626026|468641658|FG003|Overall Study|Randomized but Never Treated|0|||
130187099|NCT02626026|468641659|FG004|Overall Study|Randomized but Never Treated|1|||
130187100|NCT02626026|468641660|FG005|Overall Study|Randomized but Never Treated|0|||
130187101|NCT03922308|468641665|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130187102|NCT03922308|468641666|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
130187103|NCT03922308|468641667|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130187104|NCT03922308|468641665|FG000|Overall Study|Lost to Follow-up|1|||
130187105|NCT03922308|468641666|FG001|Overall Study|Lost to Follow-up|0|||
130187106|NCT03922308|468641667|FG002|Overall Study|Lost to Follow-up|0|||
130187107|NCT03922308|468641665|FG000|Overall Study|Reason not Specified|0|||
130187108|NCT03922308|468641666|FG001|Overall Study|Reason not Specified|2|||
130187109|NCT03922308|468641667|FG002|Overall Study|Reason not Specified|1|||
130187110|NCT03376789|468641668|FG000|Overall Study|Withdrawal by Subject|3|||
130187111|NCT03376789|468641669|FG001|Overall Study|Withdrawal by Subject|5|||
130187112|NCT03376789|468641668|FG000|Overall Study|Protocol Violation|0|||
130187113|NCT03376789|468641669|FG001|Overall Study|Protocol Violation|1|||
130187114|NCT03376789|468641668|FG000|Overall Study|Adverse Event|0|||
130187115|NCT03376789|468641669|FG001|Overall Study|Adverse Event|1|||
130187116|NCT03376789|468641668|FG000|Overall Study|Lost to Follow-up|1|||
130187117|NCT03376789|468641669|FG001|Overall Study|Lost to Follow-up|1|||
130187118|NCT03376789|468641668|FG000|Overall Study|Per sponsor due to noncompliance|1|||
130187119|NCT03376789|468641669|FG001|Overall Study|Per sponsor due to noncompliance|0|||
130187120|NCT03376789|468641668|FG000|Overall Study|Subject off study medication|0|||
130187121|NCT03376789|468641669|FG001|Overall Study|Subject off study medication|1|||
130187122|NCT04177095|468641672|FG000|Overall Study|Withdrawal by Subject|3|||
130187123|NCT04177095|468641672|FG000|Overall Study|Screen Failure|3|||
130187124|NCT04177095|468641672|FG000|Overall Study|Problems with the Trugraf assay|1|||
130187125|NCT00777296|468641673|FG000|Overall Study|Adverse Event|0|||
130187126|NCT00777296|468641674|FG001|Overall Study|Adverse Event|1|||
130187127|NCT00777296|468641675|FG002|Overall Study|Adverse Event|0|||
130187128|NCT00777296|468641676|FG003|Overall Study|Adverse Event|1|||
130187129|NCT00777296|468641673|FG000|Overall Study|Withdrawal by Subject|1|||
130187130|NCT00777296|468641674|FG001|Overall Study|Withdrawal by Subject|0|||
130187131|NCT00777296|468641675|FG002|Overall Study|Withdrawal by Subject|0|||
130187132|NCT00777296|468641676|FG003|Overall Study|Withdrawal by Subject|0|||
130187133|NCT00777296|468641673|FG000|Overall Study|CRF form not completed|0|||
130187134|NCT00777296|468641674|FG001|Overall Study|CRF form not completed|0|||
130187135|NCT00777296|468641675|FG002|Overall Study|CRF form not completed|2|||
130187136|NCT00777296|468641676|FG003|Overall Study|CRF form not completed|0|||
130187137|NCT01592786|468641677|FG000|Overall Study|Adverse Event|60|||
130187138|NCT01592786|468641677|FG000|Overall Study|Lack of Efficacy|19|||
130187139|NCT01592786|468641677|FG000|Overall Study|Protocol Violation|14|||
130187140|NCT01592786|468641677|FG000|Overall Study|Withdrawal by Subject|23|||
130187141|NCT01592786|468641677|FG000|Overall Study|Lost to Follow-up|19|||
130187142|NCT01592786|468641677|FG000|Overall Study|Other|3|||
130187143|NCT02172664|468641678|FG000|Overall Study|Lost to Follow-up|4|||
130187144|NCT02172664|468641679|FG001|Overall Study|Lost to Follow-up|4|||
130187145|NCT02172664|468641678|FG000|Overall Study|Death|1|||
130187146|NCT02172664|468641679|FG001|Overall Study|Death|1|||
130187147|NCT02172664|468641678|FG000|Overall Study|Moved out of area|1|||
130187148|NCT02172664|468641679|FG001|Overall Study|Moved out of area|1|||
130187149|NCT04426006|468641680|FG000|Inclusion|Protocol Violation|1|||
130187150|NCT04426006|468641680|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
130187151|NCT04426006|468641680|FG000|Inclusion|Blood sample at inclusion not done|1|||
130187152|NCT04426006|468641680|FG000|3 Months|Lost to Follow-up|17|||
130187153|NCT04426006|468641680|FG000|12 Months|Lost to Follow-up|38|||
130187154|NCT02946463|468641681|FG000|Primary Evaluation Period|Physician Decision|0|||
130187155|NCT02946463|468641682|FG001|Primary Evaluation Period|Physician Decision|1|||
130187156|NCT02946463|468641683|FG002|Primary Evaluation Period|Physician Decision|0|||
130187157|NCT02946463|468641684|FG003|Primary Evaluation Period|Physician Decision|0|||
130187158|NCT02946463|468641681|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
130187159|NCT02946463|468641682|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
130187160|NCT02946463|468641683|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
130187161|NCT02946463|468641684|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
130187162|NCT02946463|468641681|FG000|Extension Period|Death|4|||
130187163|NCT02946463|468641682|FG001|Extension Period|Death|4|||
130187164|NCT02946463|468641683|FG002|Extension Period|Death|0|||
130187165|NCT02946463|468641684|FG003|Extension Period|Death|0|||
130187166|NCT02946463|468641681|FG000|Extension Period|Withdrawal by Subject|4|||
130187167|NCT02946463|468641682|FG001|Extension Period|Withdrawal by Subject|3|||
130187168|NCT02946463|468641683|FG002|Extension Period|Withdrawal by Subject|0|||
130187169|NCT02946463|468641684|FG003|Extension Period|Withdrawal by Subject|0|||
130187170|NCT02946463|468641681|FG000|Extension Period|Other than specified|2|||
130187171|NCT02946463|468641682|FG001|Extension Period|Other than specified|3|||
130187172|NCT02946463|468641683|FG002|Extension Period|Other than specified|2|||
130187173|NCT02946463|468641684|FG003|Extension Period|Other than specified|0|||
130187174|NCT02946463|468641681|FG000|Extension Period|Physician Decision|1|||
130187175|NCT02946463|468641682|FG001|Extension Period|Physician Decision|4|||
130187176|NCT02946463|468641683|FG002|Extension Period|Physician Decision|0|||
130187177|NCT02946463|468641684|FG003|Extension Period|Physician Decision|0|||
130187178|NCT02946463|468641681|FG000|Extension Period|Pregnancy|3|||
130187179|NCT02946463|468641682|FG001|Extension Period|Pregnancy|1|||
130187180|NCT02946463|468641683|FG002|Extension Period|Pregnancy|0|||
130187181|NCT02946463|468641684|FG003|Extension Period|Pregnancy|0|||
130187182|NCT02946463|468641681|FG000|Extension Period|Adverse Event|1|||
130187183|NCT02946463|468641682|FG001|Extension Period|Adverse Event|2|||
130187184|NCT02946463|468641683|FG002|Extension Period|Adverse Event|0|||
130187185|NCT02946463|468641684|FG003|Extension Period|Adverse Event|0|||
130187186|NCT02946463|468641681|FG000|Extension Period|Lost to Follow-up|1|||
130187187|NCT02946463|468641682|FG001|Extension Period|Lost to Follow-up|0|||
130187188|NCT02946463|468641683|FG002|Extension Period|Lost to Follow-up|0|||
130187189|NCT02946463|468641684|FG003|Extension Period|Lost to Follow-up|0|||
130187190|NCT05691712|468641687|FG000|Overall Study|Adverse Event|0|||
130187191|NCT05691712|468641688|FG001|Overall Study|Adverse Event|1|||
130187192|NCT05691712|468641689|FG002|Overall Study|Adverse Event|2|||
130187193|NCT05691712|468641690|FG003|Overall Study|Adverse Event|1|||
130187194|NCT05691712|468641687|FG000|Overall Study|Withdrawal by Subject|2|||
130187195|NCT05691712|468641688|FG001|Overall Study|Withdrawal by Subject|3|||
130187196|NCT05691712|468641689|FG002|Overall Study|Withdrawal by Subject|3|||
130187197|NCT05691712|468641690|FG003|Overall Study|Withdrawal by Subject|1|||
130187198|NCT05691712|468641687|FG000|Overall Study|Death|1|||
130187199|NCT05691712|468641688|FG001|Overall Study|Death|0|||
130187200|NCT05691712|468641689|FG002|Overall Study|Death|0|||
130187201|NCT05691712|468641690|FG003|Overall Study|Death|0|||
130187202|NCT05691712|468641687|FG000|Overall Study|Pregnancy|0|||
130187203|NCT05691712|468641688|FG001|Overall Study|Pregnancy|1|||
130187204|NCT05691712|468641689|FG002|Overall Study|Pregnancy|0|||
130187205|NCT05691712|468641690|FG003|Overall Study|Pregnancy|0|||
130187206|NCT05691712|468641687|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130187207|NCT05691712|468641688|FG001|Overall Study|Assigned Treatment by Mistake|0|||
130187208|NCT05691712|468641689|FG002|Overall Study|Assigned Treatment by Mistake|0|||
130187209|NCT05691712|468641690|FG003|Overall Study|Assigned Treatment by Mistake|1|||
130187210|NCT02166333|468641693|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
130187211|NCT02166333|468641694|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187212|NCT02166333|468641695|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187213|NCT02166333|468641696|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187214|NCT02166333|468641697|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
130187215|NCT02166333|468641698|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
130187216|NCT02166333|468641693|FG000|Stage 1|Death|4|||
130187217|NCT02166333|468641694|FG001|Stage 1|Death|0|||
130187218|NCT02166333|468641695|FG002|Stage 1|Death|2|||
130187219|NCT02166333|468641696|FG003|Stage 1|Death|0|||
130187220|NCT02166333|468641697|FG004|Stage 1|Death|3|||
130187221|NCT02166333|468641698|FG005|Stage 1|Death|2|||
130187222|NCT02166333|468641693|FG000|Stage 1|Lost to Follow-up|12|||
130187223|NCT02166333|468641694|FG001|Stage 1|Lost to Follow-up|0|||
130187224|NCT02166333|468641695|FG002|Stage 1|Lost to Follow-up|6|||
130187225|NCT02166333|468641696|FG003|Stage 1|Lost to Follow-up|0|||
130187226|NCT02166333|468641697|FG004|Stage 1|Lost to Follow-up|3|||
130187227|NCT02166333|468641698|FG005|Stage 1|Lost to Follow-up|3|||
130187228|NCT02166333|468641693|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
130187229|NCT02166333|468641694|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130187230|NCT02166333|468641695|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
130187231|NCT02166333|468641696|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130187232|NCT02166333|468641697|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
130187233|NCT02166333|468641698|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
130187234|NCT02166333|468641693|FG000|Stage 2|Death|4|||
130187235|NCT02166333|468641694|FG001|Stage 2|Death|2|||
130187236|NCT02166333|468641695|FG002|Stage 2|Death|1|||
130187237|NCT02166333|468641696|FG003|Stage 2|Death|0|||
130187238|NCT02166333|468641697|FG004|Stage 2|Death|0|||
130187239|NCT02166333|468641698|FG005|Stage 2|Death|1|||
130187240|NCT02166333|468641693|FG000|Stage 2|Lost to Follow-up|23|||
130187241|NCT02166333|468641694|FG001|Stage 2|Lost to Follow-up|4|||
130187242|NCT02166333|468641695|FG002|Stage 2|Lost to Follow-up|11|||
130187243|NCT02166333|468641696|FG003|Stage 2|Lost to Follow-up|9|||
130187244|NCT02166333|468641697|FG004|Stage 2|Lost to Follow-up|3|||
130187245|NCT02166333|468641698|FG005|Stage 2|Lost to Follow-up|6|||
130187246|NCT00682786|468641700|FG000|Overall Study|Withdrawal by Subject|2|||
130187247|NCT00682786|468641701|FG001|Overall Study|Withdrawal by Subject|2|||
130187248|NCT00682786|468641700|FG000|Overall Study|Did not receive irinotecan|0|||
130187249|NCT00682786|468641701|FG001|Overall Study|Did not receive irinotecan|1|||
130187250|NCT00359424|468641702|FG000|Overall Study|Death|99|||
130187251|NCT00359424|468641703|FG001|Overall Study|Death|58|||
130187252|NCT00359424|468641702|FG000|Overall Study|Lost to Follow-up|19|||
130187253|NCT00359424|468641703|FG001|Overall Study|Lost to Follow-up|7|||
130187254|NCT00359424|468641702|FG000|Overall Study|Withdrawal by Subject|10|||
130187255|NCT00359424|468641703|FG001|Overall Study|Withdrawal by Subject|2|||
130187256|NCT00359424|468641702|FG000|Overall Study|follow up not conducted|2|||
130187257|NCT00359424|468641703|FG001|Overall Study|follow up not conducted|0|||
130187258|NCT01831635|468641704|FG000|Overall Study|Withdrawal by Subject|0|||
130187259|NCT01831635|468641705|FG001|Overall Study|Withdrawal by Subject|2|||
130187260|NCT01831635|468641706|FG002|Overall Study|Withdrawal by Subject|0|||
130187261|NCT03830333|468641709|FG000|Overall Study|Death|0|||
130187262|NCT03830333|468641710|FG001|Overall Study|Death|1|||
130187263|NCT03830333|468641709|FG000|Overall Study|Withdrawal by Subject|5|||
130187264|NCT03830333|468641710|FG001|Overall Study|Withdrawal by Subject|1|||
130187265|NCT03830333|468641709|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
130187266|NCT03830333|468641710|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
130187267|NCT03805412|468641711|FG000|Overall Study|Lost to Follow-up|0|||
130187268|NCT03805412|468641712|FG001|Overall Study|Lost to Follow-up|1|||
130187269|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
130187270|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130187271|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130187272|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130187273|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130187274|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
130187275|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
130187276|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187277|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187278|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187279|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130187280|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
130187281|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130187282|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130187283|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130187284|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
130187285|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
130187286|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
130187287|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
130187288|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
130187289|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
130187290|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
130187291|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
130187292|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130187293|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130187294|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
130187295|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
130187296|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187297|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187298|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187299|NCT02747108|468641732|FG000|Overall Study|Death|2|||
130187300|NCT02747108|468641733|FG001|Overall Study|Death|2|||
130187301|NCT02747108|468641732|FG000|Overall Study|Withdrawal by Subject|1|||
130187302|NCT02747108|468641733|FG001|Overall Study|Withdrawal by Subject|0|||
130187303|NCT02747108|468641732|FG000|Overall Study|Protocol Violation|2|||
130187304|NCT02747108|468641733|FG001|Overall Study|Protocol Violation|0|||
130187305|NCT04563754|468642569|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
130187306|NCT04563754|468642570|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
130187307|NCT04563754|468642571|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
130187308|NCT04563754|468642569|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130187309|NCT04563754|468642570|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130187310|NCT04563754|468642571|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
130187311|NCT04563754|468642569|FG000|Follow up|Lost to Follow-up|61|||
130187312|NCT04563754|468642570|FG001|Follow up|Lost to Follow-up|23|||
130187313|NCT04563754|468642571|FG002|Follow up|Lost to Follow-up|5|||
130187314|NCT04563754|468642569|FG000|Follow up|Death|0|||
130187315|NCT04563754|468642570|FG001|Follow up|Death|2|||
130187316|NCT04563754|468642571|FG002|Follow up|Death|0|||
130187317|NCT04563754|468642569|FG000|Follow up|Ongoing|0|||
130187318|NCT04563754|468642570|FG001|Follow up|Ongoing|28|||
130187319|NCT04563754|468642571|FG002|Follow up|Ongoing|0|||
130187320|NCT04023396|468642572|FG000|Overall Study|Adverse Event|16|||
130187321|NCT04023396|468642572|FG000|Overall Study|Death|1|||
130187322|NCT04023396|468642572|FG000|Overall Study|Lost to Follow-up|1|||
130187323|NCT04023396|468642572|FG000|Overall Study|Withdrawal by Subject|14|||
130187324|NCT04023396|468642572|FG000|Overall Study|Pregnancy|4|||
130187325|NCT04023396|468642572|FG000|Overall Study|Lack of Efficacy|3|||
130187326|NCT04023396|468642572|FG000|Overall Study|Physician Decision|4|||
130187327|NCT04023396|468642572|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
130187328|NCT04075825|468642573|FG000|Overall Study|Withdrawal by Subject|6|||
130187329|NCT04075825|468642574|FG001|Overall Study|Withdrawal by Subject|8|||
130187330|NCT04075825|468642573|FG000|Overall Study|Physician Decision|3|||
130187331|NCT04075825|468642574|FG001|Overall Study|Physician Decision|1|||
130187332|NCT04075825|468642573|FG000|Overall Study|Lost to Follow-up|5|||
130187333|NCT04075825|468642574|FG001|Overall Study|Lost to Follow-up|1|||
130187334|NCT04075825|468642573|FG000|Overall Study|Participation in New Clinical Trial|1|||
130187335|NCT04075825|468642574|FG001|Overall Study|Participation in New Clinical Trial|1|||
130187336|NCT04075825|468642573|FG000|Overall Study|Reason Not Specified|2|||
130187337|NCT04075825|468642574|FG001|Overall Study|Reason Not Specified|2|||
130187338|NCT04225715|468642575|FG000|Overall Study|Reason not Specified|1|||
130187339|NCT04225715|468642576|FG001|Overall Study|Reason not Specified|0|||
130187340|NCT04225715|468642577|FG002|Overall Study|Reason not Specified|0|||
130187341|NCT04225715|468642578|FG003|Overall Study|Reason not Specified|0|||
130187342|NCT04225715|468642579|FG004|Overall Study|Reason not Specified|0|||
130187343|NCT04225715|468642580|FG005|Overall Study|Reason not Specified|0|||
130187344|NCT04225715|468642581|FG006|Overall Study|Reason not Specified|0|||
130187345|NCT04225715|468642582|FG007|Overall Study|Reason not Specified|0|||
130187346|NCT04225715|468642583|FG008|Overall Study|Reason not Specified|0|||
130187347|NCT04225715|468642575|FG000|Overall Study|Protocol Violation|1|||
130187348|NCT04225715|468642576|FG001|Overall Study|Protocol Violation|0|||
130187349|NCT04225715|468642577|FG002|Overall Study|Protocol Violation|0|||
130187350|NCT04225715|468642578|FG003|Overall Study|Protocol Violation|0|||
130187351|NCT04225715|468642579|FG004|Overall Study|Protocol Violation|0|||
130187352|NCT04225715|468642580|FG005|Overall Study|Protocol Violation|9|||
130187353|NCT04225715|468642581|FG006|Overall Study|Protocol Violation|0|||
130187354|NCT04225715|468642582|FG007|Overall Study|Protocol Violation|0|||
130187355|NCT04225715|468642583|FG008|Overall Study|Protocol Violation|0|||
130187356|NCT04225715|468642575|FG000|Overall Study|Withdrawal by Subject|4|||
130187357|NCT04225715|468642576|FG001|Overall Study|Withdrawal by Subject|1|||
130187358|NCT04225715|468642577|FG002|Overall Study|Withdrawal by Subject|1|||
130187359|NCT04225715|468642578|FG003|Overall Study|Withdrawal by Subject|0|||
130187360|NCT04225715|468642579|FG004|Overall Study|Withdrawal by Subject|3|||
130187361|NCT04225715|468642580|FG005|Overall Study|Withdrawal by Subject|1|||
130187362|NCT04225715|468642581|FG006|Overall Study|Withdrawal by Subject|1|||
130187363|NCT04225715|468642582|FG007|Overall Study|Withdrawal by Subject|1|||
130187364|NCT04225715|468642583|FG008|Overall Study|Withdrawal by Subject|0|||
130187365|NCT04225715|468642575|FG000|Overall Study|Adverse Event|0|||
130187366|NCT04225715|468642576|FG001|Overall Study|Adverse Event|0|||
130187367|NCT04225715|468642577|FG002|Overall Study|Adverse Event|0|||
130187368|NCT04225715|468642578|FG003|Overall Study|Adverse Event|0|||
130187369|NCT04225715|468642579|FG004|Overall Study|Adverse Event|0|||
130187370|NCT04225715|468642580|FG005|Overall Study|Adverse Event|0|||
130187371|NCT04225715|468642581|FG006|Overall Study|Adverse Event|0|||
130187372|NCT04225715|468642582|FG007|Overall Study|Adverse Event|0|||
130187373|NCT04225715|468642583|FG008|Overall Study|Adverse Event|1|||
130187374|NCT04225715|468642575|FG000|Overall Study|Arm Terminated By Sponsor|0|||
130187375|NCT04225715|468642576|FG001|Overall Study|Arm Terminated By Sponsor|0|||
130187376|NCT04225715|468642577|FG002|Overall Study|Arm Terminated By Sponsor|0|||
130187377|NCT04225715|468642578|FG003|Overall Study|Arm Terminated By Sponsor|0|||
130187378|NCT04225715|468642579|FG004|Overall Study|Arm Terminated By Sponsor|0|||
130187379|NCT04225715|468642580|FG005|Overall Study|Arm Terminated By Sponsor|0|||
130187380|NCT04225715|468642581|FG006|Overall Study|Arm Terminated By Sponsor|0|||
130187381|NCT04225715|468642582|FG007|Overall Study|Arm Terminated By Sponsor|17|||
130187382|NCT04225715|468642583|FG008|Overall Study|Arm Terminated By Sponsor|18|||
130187383|NCT03318861|468642591|FG000|Overall Study|Death|2|||
130187384|NCT03318861|468642592|FG001|Overall Study|Death|3|||
130187385|NCT03318861|468642593|FG002|Overall Study|Death|3|||
130187386|NCT03318861|468642594|FG003|Overall Study|Death|2|||
130187387|NCT03318861|468642595|FG004|Overall Study|Death|2|||
130187388|NCT03318861|468642591|FG000|Overall Study|Enrolled But Never Treated|0|||
130187389|NCT03318861|468642592|FG001|Overall Study|Enrolled But Never Treated|1|||
130187390|NCT03318861|468642593|FG002|Overall Study|Enrolled But Never Treated|0|||
130187391|NCT03318861|468642594|FG003|Overall Study|Enrolled But Never Treated|1|||
130187392|NCT03318861|468642595|FG004|Overall Study|Enrolled But Never Treated|1|||
130187393|NCT03318861|468642591|FG000|Overall Study|Informed Consent Withdraw|0|||
130187394|NCT03318861|468642592|FG001|Overall Study|Informed Consent Withdraw|0|||
130187395|NCT03318861|468642593|FG002|Overall Study|Informed Consent Withdraw|0|||
130187396|NCT03318861|468642594|FG003|Overall Study|Informed Consent Withdraw|1|||
130187397|NCT03318861|468642595|FG004|Overall Study|Informed Consent Withdraw|0|||
130187398|NCT03318861|468642591|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
130187399|NCT03318861|468642592|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187400|NCT03318861|468642593|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187401|NCT03318861|468642594|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187402|NCT03318861|468642595|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187403|NCT00917852|468642596|FG000|Overall Study|Death|6|||
130187404|NCT02844933|468642597|FG000|Overall Study|Discontinued due to premature termination of study|3|||
130187405|NCT02844933|468642598|FG001|Overall Study|Discontinued due to premature termination of study|2|||
130187406|NCT04537078|468642599|FG000|Overall Study|Protocol Violation|3|||
130187407|NCT04537078|468642600|FG001|Overall Study|Protocol Violation|2|||
130187408|NCT04537078|468642599|FG000|Overall Study|Lost to Follow-up|1|||
130187409|NCT04537078|468642600|FG001|Overall Study|Lost to Follow-up|0|||
130187410|NCT04537078|468642599|FG000|Overall Study|Withdrawal by Subject|0|||
130187411|NCT04537078|468642600|FG001|Overall Study|Withdrawal by Subject|1|||
130187412|NCT01568892|468642602|FG000|Open-label Phase|Adverse Event|2|||
130187413|NCT01568892|468642603|FG001|Open-label Phase|Adverse Event|0|||
130187414|NCT01568892|468642602|FG000|Open-label Phase|Lack of Efficacy|4|||
130187415|NCT01568892|468642603|FG001|Open-label Phase|Lack of Efficacy|2|||
130187416|NCT01568892|468642602|FG000|Open-label Phase|Lost to Follow-up|0|||
130187417|NCT01568892|468642603|FG001|Open-label Phase|Lost to Follow-up|1|||
130187418|NCT01256450|468642606|FG000|Open-label Titration|Adverse Event|39|||
130187419|NCT01256450|468642607|FG001|Open-label Titration|Adverse Event|0|||
130187420|NCT01256450|468642608|FG002|Open-label Titration|Adverse Event|0|||
130187421|NCT01256450|468642606|FG000|Open-label Titration|Lost to Follow-up|7|||
130187422|NCT01256450|468642607|FG001|Open-label Titration|Lost to Follow-up|0|||
130187423|NCT01256450|468642608|FG002|Open-label Titration|Lost to Follow-up|0|||
130187424|NCT01256450|468642606|FG000|Open-label Titration|Lack of analgesic effect|30|||
130187425|NCT01256450|468642607|FG001|Open-label Titration|Lack of analgesic effect|0|||
130187426|NCT01256450|468642608|FG002|Open-label Titration|Lack of analgesic effect|0|||
130187427|NCT01256450|468642606|FG000|Open-label Titration|Non-compliance|9|||
130187428|NCT01256450|468642607|FG001|Open-label Titration|Non-compliance|0|||
130187429|NCT01256450|468642608|FG002|Open-label Titration|Non-compliance|0|||
130187430|NCT01256450|468642606|FG000|Open-label Titration|Screen failure|1|||
130187431|NCT01256450|468642607|FG001|Open-label Titration|Screen failure|0|||
130187432|NCT01256450|468642608|FG002|Open-label Titration|Screen failure|0|||
130187433|NCT01256450|468642606|FG000|Open-label Titration|Other|13|||
130187434|NCT01256450|468642607|FG001|Open-label Titration|Other|0|||
130187435|NCT01256450|468642608|FG002|Open-label Titration|Other|0|||
130187436|NCT01256450|468642606|FG000|Double-blind Treatment|Adverse Event|0|||
130187437|NCT01256450|468642607|FG001|Double-blind Treatment|Adverse Event|8|||
130187438|NCT01256450|468642608|FG002|Double-blind Treatment|Adverse Event|6|||
130187439|NCT01256450|468642606|FG000|Double-blind Treatment|Lost to Follow-up|0|||
130187440|NCT01256450|468642607|FG001|Double-blind Treatment|Lost to Follow-up|1|||
130187441|NCT01256450|468642608|FG002|Double-blind Treatment|Lost to Follow-up|7|||
130187442|NCT01256450|468642606|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130187443|NCT01256450|468642607|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
130187444|NCT01256450|468642608|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
130187445|NCT01256450|468642606|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
130187446|NCT01256450|468642607|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
130187447|NCT01256450|468642608|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
130187448|NCT01256450|468642606|FG000|Double-blind Treatment|Non-compliance|0|||
130187449|NCT01256450|468642607|FG001|Double-blind Treatment|Non-compliance|5|||
130187450|NCT01256450|468642608|FG002|Double-blind Treatment|Non-compliance|4|||
130187451|NCT01256450|468642606|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130187452|NCT01256450|468642607|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130187453|NCT01256450|468642608|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
130187454|NCT01256450|468642606|FG000|Double-blind Treatment|Other|0|||
130187455|NCT01256450|468642607|FG001|Double-blind Treatment|Other|9|||
130187456|NCT01256450|468642608|FG002|Double-blind Treatment|Other|12|||
130187457|NCT03889418|468642616|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
130187458|NCT03889418|468642617|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187459|NCT03889418|468642618|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187460|NCT03889418|468642619|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187461|NCT03889418|468642620|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187462|NCT03889418|468642621|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187463|NCT03889418|468642622|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187464|NCT03889418|468642623|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187465|NCT03889418|468642624|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187466|NCT03889418|468642625|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187467|NCT03889418|468642616|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187468|NCT03889418|468642617|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130187469|NCT03889418|468642618|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130187470|NCT03889418|468642619|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187471|NCT03889418|468642620|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187472|NCT03889418|468642621|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187473|NCT03889418|468642622|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187474|NCT03889418|468642623|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187475|NCT03889418|468642624|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187476|NCT03889418|468642625|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187477|NCT03889418|468642616|FG000|October-December 2019 (Month 7-9)|Death|0|||
130187478|NCT03889418|468642617|FG001|October-December 2019 (Month 7-9)|Death|0|||
130187479|NCT03889418|468642618|FG002|October-December 2019 (Month 7-9)|Death|0|||
130187480|NCT03889418|468642619|FG003|October-December 2019 (Month 7-9)|Death|0|||
130187481|NCT03889418|468642620|FG004|October-December 2019 (Month 7-9)|Death|0|||
130187482|NCT03889418|468642621|FG005|October-December 2019 (Month 7-9)|Death|0|||
130187483|NCT03889418|468642622|FG006|October-December 2019 (Month 7-9)|Death|0|||
130187484|NCT03889418|468642623|FG007|October-December 2019 (Month 7-9)|Death|0|||
130187485|NCT03889418|468642624|FG008|October-December 2019 (Month 7-9)|Death|1|||
130187486|NCT03889418|468642625|FG009|October-December 2019 (Month 7-9)|Death|0|||
130187487|NCT03889418|468642616|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187488|NCT03889418|468642617|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187489|NCT03889418|468642618|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187490|NCT03889418|468642619|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
130187491|NCT03889418|468642620|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187492|NCT03889418|468642621|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187493|NCT03889418|468642622|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187494|NCT03889418|468642623|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
130187495|NCT03889418|468642624|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187496|NCT03889418|468642625|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187497|NCT03889418|468642616|FG000|April - June 2020 (Month 13-15)|Death|0|||
130187498|NCT03889418|468642617|FG001|April - June 2020 (Month 13-15)|Death|1|||
130187499|NCT03889418|468642618|FG002|April - June 2020 (Month 13-15)|Death|0|||
130187500|NCT03889418|468642619|FG003|April - June 2020 (Month 13-15)|Death|0|||
130187501|NCT03889418|468642620|FG004|April - June 2020 (Month 13-15)|Death|0|||
130187502|NCT03889418|468642621|FG005|April - June 2020 (Month 13-15)|Death|0|||
130187503|NCT03889418|468642622|FG006|April - June 2020 (Month 13-15)|Death|0|||
130187504|NCT03889418|468642623|FG007|April - June 2020 (Month 13-15)|Death|0|||
130187505|NCT03889418|468642624|FG008|April - June 2020 (Month 13-15)|Death|0|||
130187506|NCT03889418|468642625|FG009|April - June 2020 (Month 13-15)|Death|0|||
130187507|NCT03889418|468642616|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187508|NCT03889418|468642617|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187509|NCT03889418|468642618|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187510|NCT03889418|468642619|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
130187511|NCT03889418|468642620|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187512|NCT03889418|468642621|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187513|NCT03889418|468642622|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187514|NCT03889418|468642623|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187515|NCT03889418|468642624|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187516|NCT03889418|468642625|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187517|NCT03889418|468642616|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187518|NCT03889418|468642617|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187519|NCT03889418|468642618|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
130187520|NCT03889418|468642619|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187521|NCT03889418|468642620|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187522|NCT03889418|468642621|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187523|NCT03889418|468642622|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187524|NCT03889418|468642623|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187525|NCT03889418|468642624|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187526|NCT03889418|468642625|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187527|NCT03889418|468642616|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187528|NCT03889418|468642617|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130187529|NCT03889418|468642618|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
130187530|NCT03889418|468642619|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130187531|NCT03889418|468642620|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187532|NCT03889418|468642621|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187533|NCT03889418|468642622|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187534|NCT03889418|468642623|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130187535|NCT03889418|468642624|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187536|NCT03889418|468642625|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130187537|NCT01909934|468642632|FG000|Overall Study|Withdrawal by Subject|3|||
130187538|NCT01909934|468642632|FG000|Overall Study|Lost to Follow-up|1|||
130187539|NCT01909934|468642632|FG000|Overall Study|Death|25|||
130187540|NCT01909934|468642632|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130187541|NCT01909934|468642632|FG000|Overall Study|Reason Not Specified|1|||
130187542|NCT03810092|468642633|FG000|Overall Study|no ground support|17|||
130187543|NCT03810092|468642633|FG000|Overall Study|ADL not done at J0|16|||
130187544|NCT03810092|468642633|FG000|Overall Study|No hemoglobin measure at J5|27|||
130187545|NCT01139775|468642639|FG000|Overall Study|Adverse Event|0|||
130187546|NCT01139775|468642640|FG001|Overall Study|Adverse Event|6|||
130187547|NCT01139775|468642641|FG002|Overall Study|Adverse Event|2|||
130187548|NCT01139775|468642639|FG000|Overall Study|Protocol Violation|0|||
130187549|NCT01139775|468642640|FG001|Overall Study|Protocol Violation|5|||
130187550|NCT01139775|468642641|FG002|Overall Study|Protocol Violation|0|||
130187551|NCT01139775|468642639|FG000|Overall Study|Withdrawal by Subject|1|||
130187552|NCT01139775|468642640|FG001|Overall Study|Withdrawal by Subject|0|||
130187553|NCT01139775|468642641|FG002|Overall Study|Withdrawal by Subject|2|||
130187554|NCT01139775|468642639|FG000|Overall Study|Physician Decision|0|||
130187555|NCT01139775|468642640|FG001|Overall Study|Physician Decision|2|||
130187556|NCT01139775|468642641|FG002|Overall Study|Physician Decision|2|||
130187557|NCT01753310|468642644|FG000|Overall Study|Entered into open label extension study|25|||
130187558|NCT01753310|468642645|FG001|Overall Study|Entered into open label extension study|22|||
130187559|NCT01753310|468642644|FG000|Overall Study|Adverse Event|1|||
130187560|NCT01753310|468642645|FG001|Overall Study|Adverse Event|0|||
130187561|NCT01753310|468642644|FG000|Overall Study|Lost to Follow-up|2|||
130187562|NCT01753310|468642645|FG001|Overall Study|Lost to Follow-up|0|||
130187563|NCT01753310|468642644|FG000|Overall Study|Subject decision|2|||
130187564|NCT01753310|468642645|FG001|Overall Study|Subject decision|2|||
130187565|NCT01753310|468642644|FG000|Overall Study|Sponsor decision|1|||
130187566|NCT01753310|468642645|FG001|Overall Study|Sponsor decision|0|||
130187567|NCT01753310|468642644|FG000|Overall Study|Withdrawal by Subject|1|||
130187568|NCT01753310|468642645|FG001|Overall Study|Withdrawal by Subject|0|||
130187569|NCT03193853|468642646|FG000|Overall Study|Death|6|||
130187570|NCT02022202|468642647|FG000|Overall Study|Withdrawal by Subject|2|||
130187571|NCT02022202|468642647|FG000|Overall Study|Disease Progression|3|||
130187572|NCT02022202|468642647|FG000|Overall Study|Desire go to immediately to surgery|3|||
130187573|NCT05581641|468642651|FG000|Overall Study|Withdrawal by Subject|0|||
130187574|NCT05581641|468642652|FG001|Overall Study|Withdrawal by Subject|1|||
130187575|NCT05581641|468642653|FG002|Overall Study|Withdrawal by Subject|3|||
130187576|NCT05581641|468642654|FG003|Overall Study|Withdrawal by Subject|1|||
130187577|NCT05581641|468642651|FG000|Overall Study|Lost to Follow-up|0|||
130187578|NCT05581641|468642652|FG001|Overall Study|Lost to Follow-up|1|||
130187579|NCT05581641|468642653|FG002|Overall Study|Lost to Follow-up|0|||
130187580|NCT05581641|468642654|FG003|Overall Study|Lost to Follow-up|1|||
130187581|NCT05581641|468642651|FG000|Overall Study|Protocol Violation|1|||
130187582|NCT05581641|468642652|FG001|Overall Study|Protocol Violation|0|||
130187583|NCT05581641|468642653|FG002|Overall Study|Protocol Violation|0|||
130187584|NCT05581641|468642654|FG003|Overall Study|Protocol Violation|0|||
130187585|NCT05581641|468642651|FG000|Overall Study|Other|1|||
130187586|NCT05581641|468642652|FG001|Overall Study|Other|0|||
130187587|NCT05581641|468642653|FG002|Overall Study|Other|2|||
130187588|NCT05581641|468642654|FG003|Overall Study|Other|1|||
130187589|NCT00503698|468642661|FG000|Overall Study|Protocol Violation|5|||
130187590|NCT00503698|468642662|FG001|Overall Study|Protocol Violation|6|||
130187591|NCT00503698|468642661|FG000|Overall Study|Adverse Event|52|||
130187592|NCT00503698|468642662|FG001|Overall Study|Adverse Event|41|||
130187593|NCT00503698|468642661|FG000|Overall Study|Death|1|||
130187594|NCT00503698|468642662|FG001|Overall Study|Death|0|||
130187595|NCT00503698|468642661|FG000|Overall Study|Lack of Efficacy|3|||
130187596|NCT00503698|468642662|FG001|Overall Study|Lack of Efficacy|4|||
130187597|NCT00503698|468642661|FG000|Overall Study|Trial terminated|216|||
130187598|NCT00503698|468642662|FG001|Overall Study|Trial terminated|253|||
130187599|NCT00503698|468642661|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
130187600|NCT00503698|468642662|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
130187601|NCT00503698|468642661|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
130187602|NCT00503698|468642662|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
130187603|NCT00503698|468642661|FG000|Overall Study|Any condition in exclusion criteria|4|||
130187604|NCT00503698|468642662|FG001|Overall Study|Any condition in exclusion criteria|6|||
130187605|NCT00503698|468642661|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
130187606|NCT00503698|468642662|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
130187607|NCT00503698|468642661|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
130187608|NCT00503698|468642662|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
130187609|NCT00503698|468642661|FG000|Overall Study|Critically ill|2|||
130187610|NCT00503698|468642662|FG001|Overall Study|Critically ill|0|||
130187611|NCT00503698|468642661|FG000|Overall Study|Unclassified|48|||
130187612|NCT00503698|468642662|FG001|Overall Study|Unclassified|32|||
130187613|NCT00503698|468642661|FG000|Overall Study|Not exposed to trial drug|11|||
130187614|NCT00503698|468642662|FG001|Overall Study|Not exposed to trial drug|6|||
130187615|NCT02462603|468642670|FG000|Overall Study|Investigator Decision|1|||
130187616|NCT02462603|468642670|FG000|Overall Study|Non-Compliance|1|||
130187617|NCT02462603|468642670|FG000|Overall Study|Withdrawal by Subject|2|||
130187618|NCT01591096|468642672|FG000|Overall Study|Adverse Event|1|||
130187619|NCT01445730|468642673|FG000|Overall Study|Adverse Event|1|||
130187620|NCT01445730|468642673|FG000|Overall Study|For the advice of a dentist|1|||
130187621|NCT01445730|468642673|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
130187622|NCT00734994|468642674|FG000|Overall Study|Withdrawal by Subject|1|||
130187623|NCT01546025|468642675|FG000|Overall Study|Lost to Follow-up|0|||
130187624|NCT01546025|468642676|FG001|Overall Study|Lost to Follow-up|1|||
130187625|NCT05514873|468642677|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
130187626|NCT05514873|468642677|FG000|Main Treatment Period|Adverse Event|2|||
130187627|NCT05514873|468642677|FG000|Extension Treatment Period|Lost to Follow-up|3|||
130187628|NCT05177484|468643890|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
130187629|NCT05177484|468643891|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
130187630|NCT05177484|468643890|FG000|Overall Study|Inadvertently withdrawn|3|||
130187631|NCT05177484|468643891|FG001|Overall Study|Inadvertently withdrawn|1|||
130187632|NCT05177484|468643890|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
130187633|NCT05177484|468643891|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
130187634|NCT02393950|468643896|FG000|Overall Study|Adverse Event|1|||
130187635|NCT02393950|468643897|FG001|Overall Study|Adverse Event|0|||
130187636|NCT02393950|468643896|FG000|Overall Study|Withdrawal by Subject|0|||
130187637|NCT02393950|468643897|FG001|Overall Study|Withdrawal by Subject|1|||
130187638|NCT05486091|468643898|FG000|Overall Study|Withdrawal by Subject|1|||
130187639|NCT05486091|468643898|FG000|Overall Study|Lost to Follow-up|2|||
130187640|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187641|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
130187642|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187643|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187644|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187645|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
130187646|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
130187647|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
130187648|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130187649|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130187650|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
130187651|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
130187652|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
130187653|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
130187654|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
130187655|NCT03971071|468643899|FG000|Open-label Treatment Period|Sponsor decision|0|||
130187656|NCT03971071|468643900|FG001|Open-label Treatment Period|Sponsor decision|0|||
130187657|NCT03971071|468643901|FG002|Open-label Treatment Period|Sponsor decision|0|||
130187658|NCT03971071|468643902|FG003|Open-label Treatment Period|Sponsor decision|0|||
130187659|NCT03971071|468643903|FG004|Open-label Treatment Period|Sponsor decision|1|||
130187660|NCT03971071|468643899|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130187661|NCT03971071|468643900|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130187662|NCT03971071|468643901|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130187663|NCT03971071|468643902|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
130187664|NCT03971071|468643903|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
130187665|NCT03971071|468643899|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130187666|NCT03971071|468643900|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130187667|NCT03971071|468643901|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130187668|NCT03971071|468643902|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
130187669|NCT03971071|468643903|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
130187670|NCT01697748|468643904|FG000|Overall Study|ineligible skin incision|1|||
130187671|NCT01697748|468643905|FG001|Overall Study|ineligible skin incision|2|||
130187672|NCT01697748|468643904|FG000|Overall Study|ineligible uterine incision|4|||
130187673|NCT01697748|468643905|FG001|Overall Study|ineligible uterine incision|1|||
130187674|NCT01697748|468643904|FG000|Overall Study|Lost to Follow-up|53|||
130187675|NCT01697748|468643905|FG001|Overall Study|Lost to Follow-up|65|||
130187676|NCT01704495|468643909|FG000|Subjects Randomized|Other Reason|3|||
130187677|NCT01704495|468643910|FG001|Subjects Randomized|Other Reason|2|||
130187678|NCT01704495|468643911|FG002|Subjects Randomized|Other Reason|3|||
130187679|NCT01704495|468643912|FG003|Subjects Randomized|Other Reason|2|||
130187680|NCT01704495|468643909|FG000|Subjects Randomized|Discontinuation criteria met|4|||
130187681|NCT01704495|468643910|FG001|Subjects Randomized|Discontinuation criteria met|2|||
130187682|NCT01704495|468643911|FG002|Subjects Randomized|Discontinuation criteria met|2|||
130187683|NCT01704495|468643912|FG003|Subjects Randomized|Discontinuation criteria met|0|||
130187684|NCT01704495|468643909|FG000|Subjects Randomized|Adverse Event|8|||
130187685|NCT01704495|468643910|FG001|Subjects Randomized|Adverse Event|2|||
130187686|NCT01704495|468643911|FG002|Subjects Randomized|Adverse Event|0|||
130187687|NCT01704495|468643912|FG003|Subjects Randomized|Adverse Event|7|||
130187688|NCT01704495|468643909|FG000|Subjects Randomized|Withdrawal by Subject|5|||
130187689|NCT01704495|468643910|FG001|Subjects Randomized|Withdrawal by Subject|5|||
130187690|NCT01704495|468643911|FG002|Subjects Randomized|Withdrawal by Subject|5|||
130187691|NCT01704495|468643912|FG003|Subjects Randomized|Withdrawal by Subject|5|||
130187692|NCT01704495|468643909|FG000|Subjects Randomized|Protocol Violation|1|||
130187693|NCT01704495|468643910|FG001|Subjects Randomized|Protocol Violation|1|||
130187694|NCT01704495|468643911|FG002|Subjects Randomized|Protocol Violation|2|||
130187695|NCT01704495|468643912|FG003|Subjects Randomized|Protocol Violation|0|||
130187696|NCT01704495|468643909|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
130187697|NCT01704495|468643910|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130187698|NCT01704495|468643911|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
130187699|NCT01704495|468643912|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130187700|NCT01704495|468643909|FG000|Optional Safety Extension|Adverse Event|0|||
130187701|NCT01704495|468643910|FG001|Optional Safety Extension|Adverse Event|4|||
130187702|NCT01704495|468643911|FG002|Optional Safety Extension|Adverse Event|0|||
130187703|NCT01704495|468643912|FG003|Optional Safety Extension|Adverse Event|1|||
130187704|NCT01704495|468643909|FG000|Optional Safety Extension|Other reason|27|||
130187705|NCT01704495|468643910|FG001|Optional Safety Extension|Other reason|29|||
130187706|NCT01704495|468643911|FG002|Optional Safety Extension|Other reason|30|||
130187707|NCT01704495|468643912|FG003|Optional Safety Extension|Other reason|28|||
130187708|NCT01704495|468643909|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
130187709|NCT01704495|468643910|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
130187710|NCT01704495|468643911|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
130187711|NCT01704495|468643912|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
130187712|NCT03866512|468643913|FG000|Overall Study|Lost to Follow-up|1|||
130187713|NCT03866512|468643914|FG001|Overall Study|Lost to Follow-up|2|||
130187714|NCT03866512|468643915|FG002|Overall Study|Lost to Follow-up|1|||
130187715|NCT03866512|468643913|FG000|Overall Study|Cannulation issues|0|||
130187716|NCT03866512|468643914|FG001|Overall Study|Cannulation issues|1|||
130187717|NCT03866512|468643915|FG002|Overall Study|Cannulation issues|2|||
130187718|NCT00997373|468643920|FG000|Overall Study|Withdrawal by Subject|5|||
130187719|NCT00997373|468643921|FG001|Overall Study|Withdrawal by Subject|0|||
130187720|NCT00997373|468643920|FG000|Overall Study|wrong tumor type|4|||
130187721|NCT00997373|468643921|FG001|Overall Study|wrong tumor type|0|||
130187722|NCT00997373|468643920|FG000|Overall Study|could not have hysterectomy|6|||
130187723|NCT00997373|468643921|FG001|Overall Study|could not have hysterectomy|0|||
130187724|NCT03210714|468643927|FG000|Overall Study|Adverse Event|6|||
130187725|NCT03210714|468643927|FG000|Overall Study|Physician Decision|1|||
130187726|NCT03210714|468643927|FG000|Overall Study|Progressive disease|11|||
130187727|NCT03210714|468643927|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
130187728|NCT01956773|468643928|FG000|Overall Study|Lost to Follow-up|628|||
130187729|NCT01956773|468643929|FG001|Overall Study|Lost to Follow-up|1|||
130187730|NCT00450437|468643930|FG000|Overall Study|Withdrawal by Subject|10|||
130187731|NCT00450437|468643931|FG001|Overall Study|Withdrawal by Subject|2|||
130187732|NCT00450437|468643932|FG002|Overall Study|Withdrawal by Subject|0|||
130187733|NCT00450437|468643933|FG003|Overall Study|Withdrawal by Subject|1|||
130187734|NCT00450437|468643930|FG000|Overall Study|Lost to Follow-up|31|||
130187735|NCT00450437|468643931|FG001|Overall Study|Lost to Follow-up|12|||
130187736|NCT00450437|468643932|FG002|Overall Study|Lost to Follow-up|19|||
130187737|NCT00450437|468643933|FG003|Overall Study|Lost to Follow-up|9|||
130187738|NCT00450437|468643930|FG000|Overall Study|Protocol Violation|0|||
130187739|NCT00450437|468643931|FG001|Overall Study|Protocol Violation|1|||
130187740|NCT00450437|468643932|FG002|Overall Study|Protocol Violation|0|||
130187741|NCT00450437|468643933|FG003|Overall Study|Protocol Violation|1|||
130187742|NCT00450437|468643930|FG000|Overall Study|Inappropriate enrollment|4|||
130187743|NCT00450437|468643931|FG001|Overall Study|Inappropriate enrollment|1|||
130187744|NCT00450437|468643932|FG002|Overall Study|Inappropriate enrollment|3|||
130187745|NCT00450437|468643933|FG003|Overall Study|Inappropriate enrollment|0|||
130187746|NCT00450437|468643930|FG000|Overall Study|Administrative reason|0|||
130187747|NCT00450437|468643931|FG001|Overall Study|Administrative reason|0|||
130187748|NCT00450437|468643932|FG002|Overall Study|Administrative reason|1|||
130187749|NCT00450437|468643933|FG003|Overall Study|Administrative reason|0|||
130187750|NCT00450437|468643930|FG000|Overall Study|Unable to Classify|1|||
130187751|NCT00450437|468643931|FG001|Overall Study|Unable to Classify|0|||
130187752|NCT00450437|468643932|FG002|Overall Study|Unable to Classify|1|||
130187753|NCT00450437|468643933|FG003|Overall Study|Unable to Classify|0|||
130187754|NCT02492867|468643934|FG000|Overall Study|Alternate therapy|1|||
130187755|NCT02492867|468643934|FG000|Overall Study|Withdrawal by Subject|2|||
130187756|NCT02492867|468643934|FG000|Overall Study|Disease progression after treatment started|1|||
130187757|NCT02492867|468643934|FG000|Overall Study|Death|1|||
130187758|NCT03296527|468643935|FG000|Overall Study|Adverse Event|15|||
130187759|NCT03296527|468643936|FG001|Overall Study|Adverse Event|33|||
130187760|NCT03296527|468643935|FG000|Overall Study|Protocol Deviation|4|||
130187761|NCT03296527|468643936|FG001|Overall Study|Protocol Deviation|0|||
130187762|NCT03296527|468643935|FG000|Overall Study|Participant withdrew consent|3|||
130187763|NCT03296527|468643936|FG001|Overall Study|Participant withdrew consent|1|||
130187764|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
130187765|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
130187766|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
130187767|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
130187768|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
130187769|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
130187770|NCT03296527|468643935|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
130187771|NCT03296527|468643936|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
130187772|NCT03296527|468643935|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
130187773|NCT03296527|468643936|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
130187774|NCT00122382|468643937|FG000|Double-Blind Study|Adverse Event|9|||
130187775|NCT00122382|468643938|FG001|Double-Blind Study|Adverse Event|11|||
130187776|NCT00122382|468643939|FG002|Double-Blind Study|Adverse Event|0|||
130187777|NCT00122382|468643937|FG000|Double-Blind Study|Death|2|||
130187778|NCT00122382|468643938|FG001|Double-Blind Study|Death|2|||
130187779|NCT00122382|468643939|FG002|Double-Blind Study|Death|0|||
130187780|NCT00122382|468643937|FG000|Double-Blind Study|Lack of Efficacy|0|||
130187781|NCT00122382|468643938|FG001|Double-Blind Study|Lack of Efficacy|8|||
130187782|NCT00122382|468643939|FG002|Double-Blind Study|Lack of Efficacy|0|||
130187783|NCT00122382|468643937|FG000|Double-Blind Study|Lost to Follow-up|2|||
130187784|NCT00122382|468643938|FG001|Double-Blind Study|Lost to Follow-up|1|||
130187785|NCT00122382|468643939|FG002|Double-Blind Study|Lost to Follow-up|0|||
130187786|NCT00122382|468643937|FG000|Double-Blind Study|Pregnancy|2|||
130187787|NCT00122382|468643938|FG001|Double-Blind Study|Pregnancy|0|||
130187788|NCT00122382|468643939|FG002|Double-Blind Study|Pregnancy|0|||
130187789|NCT00122382|468643937|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
130187790|NCT00122382|468643938|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130187791|NCT00122382|468643939|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130187792|NCT00122382|468643937|FG000|Double-Blind Study|Withdrawal of Consent|7|||
130187793|NCT00122382|468643938|FG001|Double-Blind Study|Withdrawal of Consent|3|||
130187794|NCT00122382|468643939|FG002|Double-Blind Study|Withdrawal of Consent|0|||
130187795|NCT00122382|468643937|FG000|Double-Blind Study|Protocol Violation|1|||
130187796|NCT00122382|468643938|FG001|Double-Blind Study|Protocol Violation|0|||
130187797|NCT00122382|468643939|FG002|Double-Blind Study|Protocol Violation|0|||
130187798|NCT00122382|468643937|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
130187799|NCT00122382|468643938|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
130187800|NCT00122382|468643939|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
130187801|NCT00122382|468643937|FG000|Double-Blind Study|Randomized but not treated|0|||
130187802|NCT00122382|468643938|FG001|Double-Blind Study|Randomized but not treated|2|||
130187803|NCT00122382|468643939|FG002|Double-Blind Study|Randomized but not treated|0|||
130187804|NCT00122382|468643937|FG000|Open-Label Study|Adverse Event|0|||
130187805|NCT00122382|468643938|FG001|Open-Label Study|Adverse Event|0|||
130187806|NCT00122382|468643939|FG002|Open-Label Study|Adverse Event|11|||
130187807|NCT00122382|468643937|FG000|Open-Label Study|Death|0|||
130187808|NCT00122382|468643938|FG001|Open-Label Study|Death|0|||
130187809|NCT00122382|468643939|FG002|Open-Label Study|Death|2|||
130187810|NCT00122382|468643937|FG000|Open-Label Study|Lack of Efficacy|0|||
130187811|NCT00122382|468643938|FG001|Open-Label Study|Lack of Efficacy|0|||
130187812|NCT00122382|468643939|FG002|Open-Label Study|Lack of Efficacy|3|||
130187813|NCT00122382|468643937|FG000|Open-Label Study|Lost to Follow-up|0|||
130187814|NCT00122382|468643938|FG001|Open-Label Study|Lost to Follow-up|0|||
130187815|NCT00122382|468643939|FG002|Open-Label Study|Lost to Follow-up|3|||
130187816|NCT00122382|468643937|FG000|Open-Label Study|Pregnancy|0|||
130187817|NCT00122382|468643938|FG001|Open-Label Study|Pregnancy|0|||
130187818|NCT00122382|468643939|FG002|Open-Label Study|Pregnancy|2|||
130187819|NCT00122382|468643937|FG000|Open-Label Study|Poor/Non-Compliance|0|||
130187820|NCT00122382|468643938|FG001|Open-Label Study|Poor/Non-Compliance|0|||
130187821|NCT00122382|468643939|FG002|Open-Label Study|Poor/Non-Compliance|1|||
130187822|NCT00122382|468643937|FG000|Open-Label Study|Withdrawal of Consent|0|||
130187823|NCT00122382|468643938|FG001|Open-Label Study|Withdrawal of Consent|0|||
130187824|NCT00122382|468643939|FG002|Open-Label Study|Withdrawal of Consent|4|||
130187825|NCT02040805|468643940|FG000|Overall Study|Lost to Follow-up|14|||
130187826|NCT02040805|468643941|FG001|Overall Study|Lost to Follow-up|9|||
130187827|NCT02040805|468643940|FG000|Overall Study|Withdrawal by Subject|28|||
130187828|NCT02040805|468643941|FG001|Overall Study|Withdrawal by Subject|41|||
130187829|NCT01213966|468643943|FG000|Overall Study|Protocol Violation|1|||
130187830|NCT01213966|468643944|FG001|Overall Study|Protocol Violation|0|||
130187831|NCT01213966|468643945|FG002|Overall Study|Protocol Violation|3|||
130187832|NCT01213966|468643946|FG003|Overall Study|Protocol Violation|1|||
130187833|NCT03591874|468643947|FG000|Overall Study|Adverse Event|4|||
130187834|NCT03591874|468643948|FG001|Overall Study|Adverse Event|0|||
130187835|NCT03591874|468643947|FG000|Overall Study|Withdrawal by Subject|2|||
130187836|NCT03591874|468643948|FG001|Overall Study|Withdrawal by Subject|1|||
130187837|NCT03591874|468643947|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
130187838|NCT03591874|468643948|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
130187839|NCT03591874|468643947|FG000|Overall Study|On Study at Time of Study Termination|12|||
130187840|NCT03591874|468643948|FG001|Overall Study|On Study at Time of Study Termination|6|||
130187841|NCT03644342|468643951|FG000|Overall Study|Adverse Event|2|||
130187842|NCT03644342|468643952|FG001|Overall Study|Adverse Event|0|||
130187843|NCT03644342|468643951|FG000|Overall Study|Protocol Violation|0|||
130187844|NCT03644342|468643952|FG001|Overall Study|Protocol Violation|1|||
130187845|NCT03655405|468643953|FG000|Overall Study|Death after initial data collection|4|||
130187846|NCT03655405|468643954|FG001|Overall Study|Death after initial data collection|2|||
130187847|NCT03655405|468643953|FG000|Overall Study|Died before initial data collection|1|||
130187848|NCT03655405|468643954|FG001|Overall Study|Died before initial data collection|2|||
130187849|NCT03655405|468643953|FG000|Overall Study|Protocol Violation|0|||
130187850|NCT03655405|468643954|FG001|Overall Study|Protocol Violation|1|||
130187851|NCT01991743|468643956|FG000|Overall Study|external cephalic version not performed|0|||
130187852|NCT01991743|468643957|FG001|Overall Study|external cephalic version not performed|0|||
130187853|NCT01991743|468643958|FG002|Overall Study|external cephalic version not performed|1|||
130187854|NCT01991743|468643959|FG003|Overall Study|external cephalic version not performed|0|||
130187855|NCT02859337|468643961|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130187856|NCT02859337|468643962|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130187857|NCT02859337|468643963|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
130187858|NCT02859337|468643961|FG000|Overall Study|Withdrawal by Subject|3|||
130187859|NCT02859337|468643962|FG001|Overall Study|Withdrawal by Subject|1|||
130187860|NCT02859337|468643963|FG002|Overall Study|Withdrawal by Subject|0|||
130187861|NCT02859337|468643961|FG000|Overall Study|Lost to Follow-up|1|||
130187862|NCT02859337|468643962|FG001|Overall Study|Lost to Follow-up|0|||
130187863|NCT02859337|468643963|FG002|Overall Study|Lost to Follow-up|0|||
130187864|NCT01167140|468643966|FG000|Overall Study|Withdrawal by Subject|1|||
130187865|NCT04390113|468643967|FG000|Overall Study|Not Treated|0|||
130187866|NCT04390113|468643968|FG001|Overall Study|Not Treated|1|||
130187867|NCT04390113|468643967|FG000|Overall Study|Adverse Event|1|||
130187868|NCT04390113|468643968|FG001|Overall Study|Adverse Event|0|||
130187869|NCT04390113|468643967|FG000|Overall Study|Death|2|||
130187870|NCT04390113|468643968|FG001|Overall Study|Death|1|||
130187871|NCT04390113|468643967|FG000|Overall Study|Physician Decision|1|||
130187872|NCT04390113|468643968|FG001|Overall Study|Physician Decision|3|||
130187873|NCT04390113|468643967|FG000|Overall Study|Study Terminated by Sponsor|5|||
130187874|NCT04390113|468643968|FG001|Overall Study|Study Terminated by Sponsor|3|||
130187875|NCT04390113|468643967|FG000|Overall Study|Withdrawal by Subject|10|||
130187876|NCT04390113|468643968|FG001|Overall Study|Withdrawal by Subject|5|||
130187877|NCT04390113|468643967|FG000|Overall Study|Other|1|||
130187878|NCT04390113|468643968|FG001|Overall Study|Other|0|||
130187879|NCT04390113|468643967|FG000|Overall Study|Missing|0|||
130187880|NCT04390113|468643968|FG001|Overall Study|Missing|1|||
130187881|NCT01611883|468643969|FG000|Overall Study|Adverse Event|1|||
130187882|NCT01611883|468643970|FG001|Overall Study|Adverse Event|1|||
130187883|NCT00030901|468643973|FG000|Initial Registration|Ineligible|167|||
130187884|NCT00030901|468643974|FG001|Initial Registration|Ineligible|0|||
130187885|NCT00030901|468643975|FG002|Initial Registration|Ineligible|0|||
130187886|NCT00030901|468643973|FG000|Randomization|Adverse Event|0|||
130187887|NCT00030901|468643974|FG001|Randomization|Adverse Event|11|||
130187888|NCT00030901|468643975|FG002|Randomization|Adverse Event|7|||
130187889|NCT00030901|468643973|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
130187890|NCT00030901|468643974|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
130187891|NCT00030901|468643975|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
130187892|NCT00030901|468643973|FG000|Randomization|Progression/Relapse|0|||
130187893|NCT00030901|468643974|FG001|Randomization|Progression/Relapse|22|||
130187894|NCT00030901|468643975|FG002|Randomization|Progression/Relapse|21|||
130187895|NCT00030901|468643973|FG000|Randomization|Death|0|||
130187896|NCT00030901|468643974|FG001|Randomization|Death|1|||
130187897|NCT00030901|468643975|FG002|Randomization|Death|3|||
130187898|NCT00030901|468643973|FG000|Randomization|Other|0|||
130187899|NCT00030901|468643974|FG001|Randomization|Other|36|||
130187900|NCT00030901|468643975|FG002|Randomization|Other|33|||
130187901|NCT00030901|468643973|FG000|Randomization|Ineligible|0|||
130187902|NCT00030901|468643974|FG001|Randomization|Ineligible|15|||
130187903|NCT00030901|468643975|FG002|Randomization|Ineligible|14|||
130187904|NCT02576847|468643976|FG000|Overall Study|Adverse Event|27|||
130187905|NCT02576847|468643976|FG000|Overall Study|Lost to Follow-up|22|||
130187906|NCT02576847|468643976|FG000|Overall Study|Physician Decision|1|||
130187907|NCT02576847|468643976|FG000|Overall Study|Pregnancy|1|||
130187908|NCT02576847|468643976|FG000|Overall Study|Protocol Violation|3|||
130187909|NCT02576847|468643976|FG000|Overall Study|Withdrawal by Subject|78|||
130187910|NCT02576847|468643976|FG000|Overall Study|Other|5|||
130187911|NCT01806051|468643977|FG000|Overall Study|Withdrawal by Subject|6|||
130187912|NCT01205776|468643978|FG000|Overall Study|Lost to Follow-up|53|||
130187913|NCT01205776|468643979|FG001|Overall Study|Lost to Follow-up|61|||
130187914|NCT01205776|468643978|FG000|Overall Study|Withdrawal by Subject|11|||
130187915|NCT01205776|468643979|FG001|Overall Study|Withdrawal by Subject|34|||
130187916|NCT05142722|468645161|FG000|Overall Study|Lost to Follow-up|16|||
130187917|NCT05142722|468645162|FG001|Overall Study|Lost to Follow-up|38|||
130187918|NCT05142722|468645161|FG000|Overall Study|Withdrawal by Subject|20|||
130187919|NCT05142722|468645162|FG001|Overall Study|Withdrawal by Subject|27|||
130187920|NCT05142722|468645161|FG000|Overall Study|Death|11|||
130187921|NCT05142722|468645162|FG001|Overall Study|Death|17|||
130187922|NCT05142722|468645161|FG000|Overall Study|Physician Decision|0|||
130187923|NCT05142722|468645162|FG001|Overall Study|Physician Decision|1|||
130187924|NCT05142722|468645161|FG000|Overall Study|Participant Moved Away|0|||
130187925|NCT05142722|468645162|FG001|Overall Study|Participant Moved Away|2|||
130187926|NCT05142722|468645161|FG000|Overall Study|Adverse Event|2|||
130187927|NCT05142722|468645162|FG001|Overall Study|Adverse Event|1|||
130187928|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187929|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187930|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187931|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187932|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187933|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187934|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187935|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187936|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187937|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187938|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130187939|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187940|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187941|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130187942|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187943|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187944|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187945|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187946|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187947|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187948|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187949|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187950|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187951|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187952|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187953|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187954|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187955|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187956|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187957|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187958|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187959|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187960|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187961|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187962|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
130187963|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187964|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187965|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187966|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
130187967|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187968|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187969|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187970|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130187971|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187972|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187973|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
130187974|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187975|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130187976|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
130187977|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
130187978|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187979|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187980|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187981|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187982|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187983|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187984|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187985|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
130187986|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187987|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187988|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187989|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187990|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187991|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187992|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187993|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187994|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187995|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187996|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
130187997|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187998|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187999|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130188000|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188001|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188002|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188003|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188004|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188005|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
130188006|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188007|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188008|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188009|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188010|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188011|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188012|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188013|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130188014|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130188015|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188016|NCT05734157|468645171|FG000|Overall Study|Death|3|||
130188017|NCT05734157|468645171|FG000|Overall Study|Withdrawal by Subject|2|||
130188018|NCT05734157|468645171|FG000|Overall Study|Lost to Follow-up|1|||
130188019|NCT05734157|468645171|FG000|Overall Study|Telephone call|3|||
130188020|NCT01467713|468645173|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
130188021|NCT01467713|468645174|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130188022|NCT01467713|468645175|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130188023|NCT01467713|468645176|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
130188024|NCT01467713|468645173|FG000|Overall Study|Major Protocol Deviation|2|||
130188025|NCT01467713|468645174|FG001|Overall Study|Major Protocol Deviation|4|||
130188026|NCT01467713|468645175|FG002|Overall Study|Major Protocol Deviation|4|||
130188027|NCT01467713|468645176|FG003|Overall Study|Major Protocol Deviation|1|||
130188028|NCT01467713|468645173|FG000|Overall Study|Lost to Follow-up|9|||
130188029|NCT01467713|468645174|FG001|Overall Study|Lost to Follow-up|12|||
130188030|NCT01467713|468645175|FG002|Overall Study|Lost to Follow-up|6|||
130188031|NCT01467713|468645176|FG003|Overall Study|Lost to Follow-up|9|||
130188032|NCT01467713|468645173|FG000|Overall Study|Voluntary Withdrawal|18|||
130188033|NCT01467713|468645174|FG001|Overall Study|Voluntary Withdrawal|14|||
130188034|NCT01467713|468645175|FG002|Overall Study|Voluntary Withdrawal|21|||
130188035|NCT01467713|468645176|FG003|Overall Study|Voluntary Withdrawal|20|||
130188036|NCT01467713|468645173|FG000|Overall Study|Study Termination|23|||
130188037|NCT01467713|468645174|FG001|Overall Study|Study Termination|33|||
130188038|NCT01467713|468645175|FG002|Overall Study|Study Termination|28|||
130188039|NCT01467713|468645176|FG003|Overall Study|Study Termination|29|||
130188040|NCT01467713|468645173|FG000|Overall Study|Pregnancy|0|||
130188041|NCT01467713|468645174|FG001|Overall Study|Pregnancy|1|||
130188042|NCT01467713|468645175|FG002|Overall Study|Pregnancy|1|||
130188043|NCT01467713|468645176|FG003|Overall Study|Pregnancy|3|||
130188044|NCT01467713|468645173|FG000|Overall Study|Relapse|35|||
130188045|NCT01467713|468645174|FG001|Overall Study|Relapse|25|||
130188046|NCT01467713|468645175|FG002|Overall Study|Relapse|28|||
130188047|NCT01467713|468645176|FG003|Overall Study|Relapse|35|||
130188048|NCT01467713|468645173|FG000|Overall Study|Reason not Specified|6|||
130188049|NCT01467713|468645174|FG001|Overall Study|Reason not Specified|11|||
130188050|NCT01467713|468645175|FG002|Overall Study|Reason not Specified|8|||
130188051|NCT01467713|468645176|FG003|Overall Study|Reason not Specified|7|||
130188052|NCT00210210|468645177|FG000|Overall Study|Withdrawal by Subject|3|||
130188053|NCT00210210|468645178|FG001|Overall Study|Withdrawal by Subject|2|||
130188054|NCT00210210|468645177|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
130188055|NCT00210210|468645178|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
130188056|NCT01100086|468645180|FG000|Period 1|Withdrawal by Subject|1|||
130188057|NCT01100086|468645181|FG001|Period 1|Withdrawal by Subject|0|||
130188058|NCT01611935|468645184|FG000|Overall Study|Family Declined Participation|1|||
130188059|NCT01611935|468645185|FG001|Overall Study|Family Declined Participation|0|||
130188060|NCT01735916|468645186|FG000|Overall Study|Subject not eligible to be randomized|11|||
130188061|NCT01735916|468645187|FG001|Overall Study|Subject not eligible to be randomized|0|||
130188062|NCT01735916|468645188|FG002|Overall Study|Subject not eligible to be randomized|0|||
130188063|NCT01735916|468645186|FG000|Overall Study|Early termination of study by sponsor|4|||
130188064|NCT01735916|468645187|FG001|Overall Study|Early termination of study by sponsor|19|||
130188065|NCT01735916|468645188|FG002|Overall Study|Early termination of study by sponsor|7|||
130188066|NCT01735916|468645186|FG000|Overall Study|Withdrawal by Subject|3|||
130188067|NCT01735916|468645187|FG001|Overall Study|Withdrawal by Subject|0|||
130188068|NCT01735916|468645188|FG002|Overall Study|Withdrawal by Subject|0|||
130188069|NCT02275546|468645199|FG000|Treatment Period 2|Withdrawal by Subject|2|||
130188070|NCT02275546|468645200|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130188071|NCT02275546|468645199|FG000|Treatment Period 2|Protocol Violation|0|||
130188072|NCT02275546|468645200|FG001|Treatment Period 2|Protocol Violation|1|||
130188073|NCT02955355|468645201|FG000|Overall Study|Adverse Event|4|||
130188074|NCT02955355|468645201|FG000|Overall Study|Death|1|||
130188075|NCT02955355|468645201|FG000|Overall Study|Physician Decision|21|||
130188076|NCT02955355|468645201|FG000|Overall Study|Site Terminated by Sponsor|35|||
130188077|NCT02955355|468645201|FG000|Overall Study|Withdrawal by Subject|19|||
130188078|NCT02955355|468645201|FG000|Overall Study|Reason Not Specified|5|||
130188079|NCT02612623|468645202|FG000|Overall Study|Withdrawal by Subject|0|||
130188080|NCT02612623|468645203|FG001|Overall Study|Withdrawal by Subject|1|||
130188081|NCT02612623|468645204|FG002|Overall Study|Withdrawal by Subject|0|||
130188082|NCT02612623|468645205|FG003|Overall Study|Withdrawal by Subject|0|||
130188083|NCT02612623|468645202|FG000|Overall Study|Adverse Event|1|||
130188084|NCT02612623|468645203|FG001|Overall Study|Adverse Event|0|||
130188085|NCT02612623|468645204|FG002|Overall Study|Adverse Event|1|||
130188086|NCT02612623|468645205|FG003|Overall Study|Adverse Event|0|||
130188087|NCT05344560|468645212|FG000|Period 1|Subject out of visit window|1|||
130188088|NCT05344560|468645213|FG001|Period 1|Subject out of visit window|1|||
130188089|NCT05344560|468645212|FG000|Period 2|Covid-19 Related|1|||
130188090|NCT05344560|468645213|FG001|Period 2|Covid-19 Related|0|||
130188091|NCT05344560|468645212|FG000|Period 2|Adverse Event|1|||
130188092|NCT05344560|468645213|FG001|Period 2|Adverse Event|0|||
130188093|NCT05344560|468645212|FG000|Period 2|Subject out of visit window|1|||
130188094|NCT05344560|468645213|FG001|Period 2|Subject out of visit window|1|||
130188095|NCT05344560|468645212|FG000|Period 3|Subject out of visit window|1|||
130188096|NCT05344560|468645213|FG001|Period 3|Subject out of visit window|0|||
130188097|NCT00360282|468645214|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188098|NCT00360282|468645215|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188099|NCT00360282|468645216|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
130188100|NCT00360282|468645217|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188101|NCT00360282|468645214|FG000|Second Intervention|Adverse Event|0|||
130188102|NCT00360282|468645215|FG001|Second Intervention|Adverse Event|1|||
130188103|NCT00360282|468645216|FG002|Second Intervention|Adverse Event|0|||
130188104|NCT00360282|468645217|FG003|Second Intervention|Adverse Event|0|||
130188105|NCT03817853|468645218|FG000|Induction Phase|Adverse Event|5|||
130188106|NCT03817853|468645219|FG001|Induction Phase|Adverse Event|0|||
130188107|NCT03817853|468645220|FG002|Induction Phase|Adverse Event|0|||
130188108|NCT03817853|468645218|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
130188109|NCT03817853|468645219|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130188110|NCT03817853|468645220|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130188111|NCT03817853|468645218|FG000|Induction Phase|Physician Decision|2|||
130188112|NCT03817853|468645219|FG001|Induction Phase|Physician Decision|0|||
130188113|NCT03817853|468645220|FG002|Induction Phase|Physician Decision|0|||
130188114|NCT03817853|468645218|FG000|Induction Phase|Progressive Disease|6|||
130188115|NCT03817853|468645219|FG001|Induction Phase|Progressive Disease|0|||
130188116|NCT03817853|468645220|FG002|Induction Phase|Progressive Disease|0|||
130188117|NCT03817853|468645218|FG000|Induction Phase|Withdrawal by Subject|4|||
130188118|NCT03817853|468645219|FG001|Induction Phase|Withdrawal by Subject|0|||
130188119|NCT03817853|468645220|FG002|Induction Phase|Withdrawal by Subject|0|||
130188120|NCT03817853|468645218|FG000|Maintenance Phase|Adverse Event|0|||
130188121|NCT03817853|468645219|FG001|Maintenance Phase|Adverse Event|8|||
130188122|NCT03817853|468645220|FG002|Maintenance Phase|Adverse Event|0|||
130188123|NCT03817853|468645218|FG000|Maintenance Phase|Death|0|||
130188124|NCT03817853|468645219|FG001|Maintenance Phase|Death|5|||
130188125|NCT03817853|468645220|FG002|Maintenance Phase|Death|0|||
130188126|NCT03817853|468645218|FG000|Maintenance Phase|Progressive Disease|0|||
130188127|NCT03817853|468645219|FG001|Maintenance Phase|Progressive Disease|7|||
130188128|NCT03817853|468645220|FG002|Maintenance Phase|Progressive Disease|0|||
130188129|NCT03817853|468645218|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130188130|NCT03817853|468645219|FG001|Maintenance Phase|Withdrawal by Subject|2|||
130188131|NCT03817853|468645220|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130188132|NCT03817853|468645218|FG000|Maintenance Phase|Physician Decision|0|||
130188133|NCT03817853|468645219|FG001|Maintenance Phase|Physician Decision|1|||
130188134|NCT03817853|468645220|FG002|Maintenance Phase|Physician Decision|0|||
130188135|NCT03817853|468645218|FG000|Maintenance Phase|Various reasons|0|||
130188136|NCT03817853|468645219|FG001|Maintenance Phase|Various reasons|4|||
130188137|NCT03817853|468645220|FG002|Maintenance Phase|Various reasons|0|||
130188138|NCT03817853|468645218|FG000|Maintenance Phase|Protocol Deviation|0|||
130188139|NCT03817853|468645219|FG001|Maintenance Phase|Protocol Deviation|1|||
130188140|NCT03817853|468645220|FG002|Maintenance Phase|Protocol Deviation|0|||
130188141|NCT03817853|468645218|FG000|Follow-up Phase|Adverse Event|0|||
130188142|NCT03817853|468645219|FG001|Follow-up Phase|Adverse Event|0|||
130188143|NCT03817853|468645220|FG002|Follow-up Phase|Adverse Event|2|||
130188144|NCT03817853|468645218|FG000|Follow-up Phase|Death|0|||
130188145|NCT03817853|468645219|FG001|Follow-up Phase|Death|0|||
130188146|NCT03817853|468645220|FG002|Follow-up Phase|Death|1|||
130188147|NCT03817853|468645218|FG000|Follow-up Phase|Progressive Disease|0|||
130188148|NCT03817853|468645219|FG001|Follow-up Phase|Progressive Disease|0|||
130188149|NCT03817853|468645220|FG002|Follow-up Phase|Progressive Disease|3|||
130188150|NCT03817853|468645218|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130188151|NCT03817853|468645219|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130188152|NCT03817853|468645220|FG002|Follow-up Phase|Withdrawal by Subject|1|||
130188153|NCT00314340|468645221|FG000|Overall Study|lost interest|1|||
130188154|NCT01620138|468645224|FG000|Overall Study|Withdrawal by Subject|3|||
130188155|NCT01620138|468645225|FG001|Overall Study|Withdrawal by Subject|0|||
130188156|NCT01620138|468645224|FG000|Overall Study|Lack of Efficacy|1|||
130188157|NCT01620138|468645225|FG001|Overall Study|Lack of Efficacy|0|||
130188158|NCT01620138|468645224|FG000|Overall Study|Adverse Event|2|||
130188159|NCT01620138|468645225|FG001|Overall Study|Adverse Event|0|||
130188160|NCT00449865|468645228|FG000|Overall Study|Withdrawal by Subject|110|||
130188161|NCT00449865|468645229|FG001|Overall Study|Withdrawal by Subject|110|||
130188162|NCT00449865|468645228|FG000|Overall Study|Lost to Follow-up|36|||
130188163|NCT00449865|468645229|FG001|Overall Study|Lost to Follow-up|37|||
130188164|NCT00449865|468645228|FG000|Overall Study|Physician Decision|13|||
130188165|NCT00449865|468645229|FG001|Overall Study|Physician Decision|12|||
130188166|NCT00449865|468645228|FG000|Overall Study|Death|31|||
130188167|NCT00449865|468645229|FG001|Overall Study|Death|40|||
130188168|NCT00449865|468645228|FG000|Overall Study|Protocol Violation|8|||
130188169|NCT00449865|468645229|FG001|Overall Study|Protocol Violation|7|||
130188170|NCT00449865|468645228|FG000|Overall Study|Study was stopped|324|||
130188171|NCT00449865|468645229|FG001|Overall Study|Study was stopped|328|||
130188172|NCT03252535|468645230|FG000|Overall Study|Withdrawal by Subject|1|||
130188173|NCT03252535|468645231|FG001|Overall Study|Withdrawal by Subject|0|||
130188174|NCT03252535|468645232|FG002|Overall Study|Withdrawal by Subject|0|||
130188175|NCT03252535|468645230|FG000|Overall Study|Physician Decision|0|||
130188176|NCT03252535|468645231|FG001|Overall Study|Physician Decision|1|||
130188177|NCT03252535|468645232|FG002|Overall Study|Physician Decision|0|||
130188178|NCT03252535|468645230|FG000|Overall Study|Met discontinuation criteria|0|||
130188179|NCT03252535|468645231|FG001|Overall Study|Met discontinuation criteria|1|||
130188180|NCT03252535|468645232|FG002|Overall Study|Met discontinuation criteria|0|||
130188181|NCT01346059|468645233|FG000|Overall Study|Withdrawal by Subject|1|||
130188182|NCT01346059|468645234|FG001|Overall Study|Withdrawal by Subject|0|||
130188183|NCT05600283|468645238|FG000|Overall Study|Withdrawal by Subject|3|||
130188184|NCT05600283|468645239|FG001|Overall Study|Withdrawal by Subject|8|||
130188185|NCT05600283|468645238|FG000|Overall Study|invalid individual swab|1|||
130188186|NCT05600283|468645239|FG001|Overall Study|invalid individual swab|0|||
130188187|NCT05600283|468645238|FG000|Overall Study|missing clinician collection|3|||
130188188|NCT05600283|468645239|FG001|Overall Study|missing clinician collection|0|||
130188189|NCT05600283|468645238|FG000|Overall Study|screening failure|0|||
130188190|NCT05600283|468645239|FG001|Overall Study|screening failure|2|||
130188203|NCT02269098|468645246|FG000|Overall Study|Lost to Follow-up|14|||
130188204|NCT02269098|468645247|FG001|Overall Study|Lost to Follow-up|9|||
130188205|NCT03194542|468645250|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
130188206|NCT03194542|468645251|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188207|NCT03194542|468645252|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188208|NCT03194542|468645253|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188209|NCT03194542|468645250|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130188210|NCT03194542|468645251|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130188211|NCT03194542|468645252|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
130188212|NCT03194542|468645253|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
130188213|NCT03194542|468645250|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130188214|NCT03194542|468645251|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130188215|NCT03194542|468645252|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130188216|NCT03194542|468645253|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130188217|NCT03194542|468645250|FG000|Overall Study|Loss of Response|4|||
130188218|NCT03194542|468645251|FG001|Overall Study|Loss of Response|2|||
130188219|NCT03194542|468645252|FG002|Overall Study|Loss of Response|3|||
130188220|NCT03194542|468645253|FG003|Overall Study|Loss of Response|4|||
130188221|NCT03194542|468645250|FG000|Overall Study|Physician Decision|0|||
130188222|NCT03194542|468645251|FG001|Overall Study|Physician Decision|1|||
130188223|NCT03194542|468645252|FG002|Overall Study|Physician Decision|0|||
130188224|NCT03194542|468645253|FG003|Overall Study|Physician Decision|0|||
130188225|NCT03194542|468645250|FG000|Overall Study|Lack of Efficacy|2|||
130188226|NCT03194542|468645251|FG001|Overall Study|Lack of Efficacy|2|||
130188227|NCT03194542|468645252|FG002|Overall Study|Lack of Efficacy|2|||
130188228|NCT03194542|468645253|FG003|Overall Study|Lack of Efficacy|6|||
130188229|NCT03194542|468645250|FG000|Overall Study|Withdrawal by Subject|2|||
130188230|NCT03194542|468645251|FG001|Overall Study|Withdrawal by Subject|1|||
130188231|NCT03194542|468645252|FG002|Overall Study|Withdrawal by Subject|5|||
130188232|NCT03194542|468645253|FG003|Overall Study|Withdrawal by Subject|4|||
130188233|NCT03194542|468645250|FG000|Overall Study|Progressive Disease|1|||
130188234|NCT03194542|468645251|FG001|Overall Study|Progressive Disease|0|||
130188235|NCT03194542|468645252|FG002|Overall Study|Progressive Disease|1|||
130188236|NCT03194542|468645253|FG003|Overall Study|Progressive Disease|1|||
130188237|NCT03194542|468645250|FG000|Overall Study|Adverse Event|1|||
130188238|NCT03194542|468645251|FG001|Overall Study|Adverse Event|2|||
130188239|NCT03194542|468645252|FG002|Overall Study|Adverse Event|0|||
130188240|NCT03194542|468645253|FG003|Overall Study|Adverse Event|5|||
130188241|NCT03194542|468645250|FG000|Overall Study|Death|1|||
130188242|NCT03194542|468645251|FG001|Overall Study|Death|2|||
130188243|NCT03194542|468645252|FG002|Overall Study|Death|0|||
130188244|NCT03194542|468645253|FG003|Overall Study|Death|5|||
130188245|NCT03194542|468645250|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130188246|NCT03194542|468645251|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
130188247|NCT03194542|468645252|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
130188248|NCT03194542|468645253|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130188249|NCT04762160|468645254|FG000|Overall Study|Study terminated early due to business reasons|5|||
130188250|NCT00571727|468645261|FG000|Overall Study|Did not enter in this study|1|||
130188251|NCT00571727|468645261|FG000|Overall Study|Non-compliance|4|||
130188252|NCT00571727|468645261|FG000|Overall Study|Lost to Follow-up|30|||
130188253|NCT00571727|468645261|FG000|Overall Study|Poor growth|1|||
130188254|NCT00571727|468645261|FG000|Overall Study|Parent/patient decision|2|||
130188255|NCT00571727|468645261|FG000|Overall Study|Participant transferred to commercial drug|14|||
130188256|NCT00571727|468645261|FG000|Overall Study|Unable to provide study drug|6|||
130188257|NCT00571727|468645261|FG000|Overall Study|On-treatment at end of study|8|||
130188258|NCT03817190|468645262|FG000|Overall Study|Early Termination|13|||
130188259|NCT03817190|468645263|FG001|Overall Study|Early Termination|20|||
130188260|NCT03817190|468645262|FG000|Overall Study|Adverse Event|10|||
130188261|NCT03817190|468645263|FG001|Overall Study|Adverse Event|17|||
130188262|NCT03817190|468645262|FG000|Overall Study|Withdrawal by Subject|12|||
130188263|NCT03817190|468645263|FG001|Overall Study|Withdrawal by Subject|8|||
130188264|NCT03817190|468645262|FG000|Overall Study|Lost to Follow-up|11|||
130188265|NCT03817190|468645263|FG001|Overall Study|Lost to Follow-up|7|||
130188266|NCT03817190|468645262|FG000|Overall Study|Lack of Efficacy|7|||
130188267|NCT03817190|468645263|FG001|Overall Study|Lack of Efficacy|5|||
130188268|NCT03817190|468645262|FG000|Overall Study|Investigator Decision|5|||
130188269|NCT03817190|468645263|FG001|Overall Study|Investigator Decision|1|||
130188270|NCT03817190|468645262|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
130188271|NCT03817190|468645263|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
130188272|NCT03817190|468645262|FG000|Overall Study|Lack of Contact|1|||
130188273|NCT03817190|468645263|FG001|Overall Study|Lack of Contact|0|||
130188274|NCT03817190|468645262|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
130188275|NCT03817190|468645263|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
130188276|NCT01622673|468645264|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130188277|NCT01622673|468645265|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130188278|NCT01622673|468645266|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130188279|NCT01622673|468645267|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130188280|NCT01622673|468645268|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130188281|NCT01622673|468645269|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130188282|NCT01622673|468645264|FG000|Treatment Period 1|Protocol Violation|0|||
130188283|NCT01622673|468645265|FG001|Treatment Period 1|Protocol Violation|1|||
130188284|NCT01622673|468645266|FG002|Treatment Period 1|Protocol Violation|0|||
130188285|NCT01622673|468645267|FG003|Treatment Period 1|Protocol Violation|0|||
130188286|NCT01622673|468645268|FG004|Treatment Period 1|Protocol Violation|0|||
130188287|NCT01622673|468645269|FG005|Treatment Period 1|Protocol Violation|0|||
130188288|NCT01622673|468645264|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130188289|NCT01622673|468645265|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130188290|NCT01622673|468645266|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130188291|NCT01622673|468645267|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130188292|NCT01622673|468645268|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130188293|NCT01622673|468645269|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130188294|NCT01622673|468645264|FG000|Treatment Period 3|Protocol Violation|0|||
130188295|NCT01622673|468645265|FG001|Treatment Period 3|Protocol Violation|1|||
130188296|NCT01622673|468645266|FG002|Treatment Period 3|Protocol Violation|0|||
130188297|NCT01622673|468645267|FG003|Treatment Period 3|Protocol Violation|0|||
130188298|NCT01622673|468645268|FG004|Treatment Period 3|Protocol Violation|0|||
130188299|NCT01622673|468645269|FG005|Treatment Period 3|Protocol Violation|0|||
130188300|NCT04146012|468645270|FG000|Overall Study|Study Terminated|30|||
130188301|NCT04146012|468645271|FG001|Overall Study|Study Terminated|15|||
130188302|NCT05731700|468646271|FG000|Overall Study|Death|1|||
130188303|NCT00437021|468646290|FG000|Overall Study|Adverse Event|0|||
130188304|NCT00437021|468646291|FG001|Overall Study|Adverse Event|0|||
130188305|NCT00437021|468646292|FG002|Overall Study|Adverse Event|0|||
130188306|NCT00437021|468646293|FG003|Overall Study|Adverse Event|0|||
130188307|NCT00437021|468646294|FG004|Overall Study|Adverse Event|0|||
130188308|NCT00437021|468646295|FG005|Overall Study|Adverse Event|0|||
130188309|NCT00437021|468646296|FG006|Overall Study|Adverse Event|1|||
130188310|NCT00437021|468646297|FG007|Overall Study|Adverse Event|0|||
130188311|NCT00437021|468646298|FG008|Overall Study|Adverse Event|0|||
130188312|NCT00437021|468646299|FG009|Overall Study|Adverse Event|0|||
130188313|NCT00437021|468646300|FG010|Overall Study|Adverse Event|0|||
130188314|NCT00437021|468646301|FG011|Overall Study|Adverse Event|0|||
130188315|NCT00437021|468646290|FG000|Overall Study|Lost to Follow-up|0|||
130188316|NCT00437021|468646291|FG001|Overall Study|Lost to Follow-up|3|||
130188317|NCT00437021|468646292|FG002|Overall Study|Lost to Follow-up|0|||
130188318|NCT00437021|468646293|FG003|Overall Study|Lost to Follow-up|0|||
130188319|NCT00437021|468646294|FG004|Overall Study|Lost to Follow-up|0|||
130188320|NCT00437021|468646295|FG005|Overall Study|Lost to Follow-up|2|||
130188321|NCT00437021|468646296|FG006|Overall Study|Lost to Follow-up|0|||
130188322|NCT00437021|468646297|FG007|Overall Study|Lost to Follow-up|1|||
130188323|NCT00437021|468646298|FG008|Overall Study|Lost to Follow-up|0|||
130188324|NCT00437021|468646299|FG009|Overall Study|Lost to Follow-up|0|||
130188325|NCT00437021|468646300|FG010|Overall Study|Lost to Follow-up|0|||
130188326|NCT00437021|468646301|FG011|Overall Study|Lost to Follow-up|0|||
130188327|NCT00437021|468646290|FG000|Overall Study|Withdrawal by Subject|2|||
130188328|NCT00437021|468646291|FG001|Overall Study|Withdrawal by Subject|1|||
130188329|NCT00437021|468646292|FG002|Overall Study|Withdrawal by Subject|0|||
130188330|NCT00437021|468646293|FG003|Overall Study|Withdrawal by Subject|0|||
130188331|NCT00437021|468646294|FG004|Overall Study|Withdrawal by Subject|0|||
130188332|NCT00437021|468646295|FG005|Overall Study|Withdrawal by Subject|0|||
130188333|NCT00437021|468646296|FG006|Overall Study|Withdrawal by Subject|0|||
130188334|NCT00437021|468646297|FG007|Overall Study|Withdrawal by Subject|0|||
130188335|NCT00437021|468646298|FG008|Overall Study|Withdrawal by Subject|0|||
130188336|NCT00437021|468646299|FG009|Overall Study|Withdrawal by Subject|0|||
130188337|NCT00437021|468646300|FG010|Overall Study|Withdrawal by Subject|0|||
130188338|NCT00437021|468646301|FG011|Overall Study|Withdrawal by Subject|0|||
130188339|NCT05468164|468646302|FG000|Treatment Period 4|Adverse Event|0|||
130188340|NCT05468164|468646303|FG001|Treatment Period 4|Adverse Event|0|||
130188341|NCT05468164|468646304|FG002|Treatment Period 4|Adverse Event|0|||
130188342|NCT05468164|468646305|FG003|Treatment Period 4|Adverse Event|1|||
130188343|NCT05573464|468646306|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
130188344|NCT05573464|468646307|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
130188345|NCT05573464|468646306|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
130188346|NCT05573464|468646307|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
130188347|NCT05573464|468646306|FG000|12-week Treatment Period|Protocol Violation|3|||
130188348|NCT05573464|468646307|FG001|12-week Treatment Period|Protocol Violation|1|||
130188349|NCT05573464|468646306|FG000|12-week Treatment Period|Physician Decision|1|||
130188350|NCT05573464|468646307|FG001|12-week Treatment Period|Physician Decision|2|||
130188351|NCT05573464|468646306|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130188352|NCT05573464|468646307|FG001|12-week Treatment Period|Lost to Follow-up|0|||
130188353|NCT05573464|468646306|FG000|12-week Treatment Period|Adverse Event|20|||
130188354|NCT05573464|468646307|FG001|12-week Treatment Period|Adverse Event|9|||
130188355|NCT05573464|468646306|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
130188356|NCT05573464|468646307|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
130188357|NCT05573464|468646306|FG000|12-week Treatment Period|Randomised, not treated|0|||
130188358|NCT05573464|468646307|FG001|12-week Treatment Period|Randomised, not treated|1|||
130188359|NCT05573464|468646306|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
130188360|NCT05573464|468646307|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
130188361|NCT05573464|468646306|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
130188362|NCT05573464|468646307|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
130188363|NCT05573464|468646306|FG000|52-week Treatment Period|Protocol Violation|1|||
130188364|NCT05573464|468646307|FG001|52-week Treatment Period|Protocol Violation|1|||
130188365|NCT05573464|468646306|FG000|52-week Treatment Period|Physician Decision|2|||
130188366|NCT05573464|468646307|FG001|52-week Treatment Period|Physician Decision|2|||
130188367|NCT05573464|468646306|FG000|52-week Treatment Period|Lost to Follow-up|1|||
130188368|NCT05573464|468646307|FG001|52-week Treatment Period|Lost to Follow-up|1|||
130188369|NCT05573464|468646306|FG000|52-week Treatment Period|Adverse Event|11|||
130188370|NCT05573464|468646307|FG001|52-week Treatment Period|Adverse Event|8|||
130188371|NCT05573464|468646306|FG000|52-week Treatment Period|Death|1|||
130188372|NCT05573464|468646307|FG001|52-week Treatment Period|Death|1|||
130188373|NCT04846569|468646308|FG000|Overall Study|Withdrawal by Subject|3|||
130188374|NCT04846569|468646309|FG001|Overall Study|Withdrawal by Subject|1|||
130188375|NCT00536939|468646314|FG000|Overall Study|Withdrawal by Subject|1|||
130188376|NCT00536939|468646315|FG001|Overall Study|Withdrawal by Subject|0|||
130188377|NCT00536939|468646314|FG000|Overall Study|Other Complicating Disease|1|||
130188378|NCT00536939|468646315|FG001|Overall Study|Other Complicating Disease|0|||
130188379|NCT02954601|468646316|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188380|NCT02954601|468646317|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188381|NCT02954601|468646318|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
130188382|NCT02954601|468646319|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188383|NCT04227197|468646323|FG000|Randomization|Protocol Violation|1|||
130188384|NCT04227197|468646324|FG001|Randomization|Protocol Violation|0|||
130188385|NCT04227197|468646323|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
130188386|NCT04227197|468646324|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
130188387|NCT04227197|468646323|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
130188388|NCT04227197|468646324|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
130188389|NCT04227197|468646323|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
130188390|NCT04227197|468646324|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
130188391|NCT04227197|468646323|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
130188392|NCT04227197|468646324|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
130188393|NCT04227197|468646323|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
130188394|NCT04227197|468646324|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
130188395|NCT04227197|468646323|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
130188396|NCT04227197|468646324|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
130188397|NCT00333983|468646325|FG000|Overall Study|Lost to Follow-up|2|||
130188398|NCT00333983|468646326|FG001|Overall Study|Lost to Follow-up|1|||
130188399|NCT00333983|468646327|FG002|Overall Study|Lost to Follow-up|0|||
130188400|NCT00333983|468646325|FG000|Overall Study|Adverse Event|1|||
130188401|NCT00333983|468646326|FG001|Overall Study|Adverse Event|1|||
130188402|NCT00333983|468646327|FG002|Overall Study|Adverse Event|1|||
130188403|NCT00333983|468646325|FG000|Overall Study|Withdrawal by Subject|0|||
130188404|NCT00333983|468646326|FG001|Overall Study|Withdrawal by Subject|3|||
130188405|NCT00333983|468646327|FG002|Overall Study|Withdrawal by Subject|1|||
130188406|NCT00570141|468646328|FG000|Overall Study|Adverse Event|1|||
130188407|NCT00570141|468646328|FG000|Overall Study|Missed visits|1|||
130188408|NCT00570141|468646328|FG000|Overall Study|Lost to Follow-up|1|||
130188409|NCT01209949|468646338|FG000|Overall Study|Lost to Follow-up|3|||
130188410|NCT00729612|468646343|FG000|Overall Study|Non evaluable for response|10|||
130188411|NCT02075203|468646344|FG000|Overall Study|Withdrawal by Subject|1|||
130188412|NCT02075203|468646345|FG001|Overall Study|Withdrawal by Subject|0|||
130188413|NCT02075203|468646346|FG002|Overall Study|Withdrawal by Subject|1|||
130188414|NCT02075203|468646344|FG000|Overall Study|Adverse Event|1|||
130188415|NCT02075203|468646345|FG001|Overall Study|Adverse Event|0|||
130188416|NCT02075203|468646346|FG002|Overall Study|Adverse Event|0|||
130188417|NCT02075203|468646344|FG000|Overall Study|participant refused to use contraception|1|||
130188418|NCT02075203|468646345|FG001|Overall Study|participant refused to use contraception|0|||
130188419|NCT02075203|468646346|FG002|Overall Study|participant refused to use contraception|0|||
130188420|NCT05266053|468646347|FG000|Overall Study|Withdrawal by Subject|8|||
130188421|NCT05266053|468646348|FG001|Overall Study|Withdrawal by Subject|4|||
130188422|NCT02996968|468646349|FG000|Overall Study|Withdrawal by Subject|1|||
130188423|NCT02996968|468646350|FG001|Overall Study|Withdrawal by Subject|0|||
130188424|NCT00444535|468646353|FG000|Overall Study|Withdrawal by Subject|5|||
130188425|NCT00444535|468646353|FG000|Overall Study|Physician Decision|5|||
130188426|NCT00444535|468646353|FG000|Overall Study|progressive disease|1|||
130188427|NCT00444535|468646353|FG000|Overall Study|Adverse Event|2|||
130188428|NCT05005507|468646355|FG000|Overall Study|Premature termination of study|1|||
130188429|NCT02556775|468646359|FG000|Overall Study|Withdrawal by Subject|1|||
130188430|NCT02556775|468646360|FG001|Overall Study|Withdrawal by Subject|0|||
130188431|NCT02556775|468646361|FG002|Overall Study|Withdrawal by Subject|1|||
130188432|NCT02556775|468646362|FG003|Overall Study|Withdrawal by Subject|0|||
130188433|NCT02556775|468646359|FG000|Overall Study|Lost to Follow-up|1|||
130188434|NCT02556775|468646360|FG001|Overall Study|Lost to Follow-up|0|||
130188435|NCT02556775|468646361|FG002|Overall Study|Lost to Follow-up|0|||
130188436|NCT02556775|468646362|FG003|Overall Study|Lost to Follow-up|0|||
130188437|NCT00558467|468646363|FG000|Overall Study|Adverse Event|1|||
130188438|NCT00558467|468646364|FG001|Overall Study|Adverse Event|2|||
130188439|NCT00558467|468646363|FG000|Overall Study|Lack of Efficacy|0|||
130188440|NCT00558467|468646364|FG001|Overall Study|Lack of Efficacy|1|||
130188441|NCT00558467|468646363|FG000|Overall Study|Patient moving out of state|0|||
130188442|NCT00558467|468646364|FG001|Overall Study|Patient moving out of state|1|||
130188443|NCT02025725|468646371|FG000|Overall Study|Adverse Event|5|||
130188444|NCT02025725|468646372|FG001|Overall Study|Adverse Event|0|||
130188445|NCT02025725|468646371|FG000|Overall Study|Lost to Follow-up|2|||
130188446|NCT02025725|468646372|FG001|Overall Study|Lost to Follow-up|0|||
130188447|NCT02025725|468646371|FG000|Overall Study|Protocol Violation|1|||
130188448|NCT02025725|468646372|FG001|Overall Study|Protocol Violation|1|||
130188449|NCT02025725|468646371|FG000|Overall Study|Withdrawal by Subject|3|||
130188450|NCT02025725|468646372|FG001|Overall Study|Withdrawal by Subject|2|||
130188451|NCT02025725|468646371|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
130188452|NCT02025725|468646372|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
130188453|NCT05047211|468646374|FG000|Overall Study|Lost to Follow-up|8|||
130188454|NCT05047211|468646375|FG001|Overall Study|Lost to Follow-up|5|||
130188455|NCT02867592|468646376|FG000|Overall Study|Adverse Event|3|||
130188456|NCT02867592|468646377|FG001|Overall Study|Adverse Event|0|||
130188457|NCT02867592|468646378|FG002|Overall Study|Adverse Event|2|||
130188458|NCT02867592|468646379|FG003|Overall Study|Adverse Event|1|||
130188459|NCT02867592|468646380|FG004|Overall Study|Adverse Event|1|||
130188460|NCT02867592|468646381|FG005|Overall Study|Adverse Event|5|||
130188461|NCT02867592|468646376|FG000|Overall Study|Death|0|||
130188462|NCT02867592|468646377|FG001|Overall Study|Death|0|||
130188463|NCT02867592|468646378|FG002|Overall Study|Death|0|||
130188464|NCT02867592|468646379|FG003|Overall Study|Death|1|||
130188465|NCT02867592|468646380|FG004|Overall Study|Death|0|||
130188466|NCT02867592|468646381|FG005|Overall Study|Death|1|||
130188467|NCT02867592|468646376|FG000|Overall Study|Lack of Efficacy|8|||
130188468|NCT02867592|468646377|FG001|Overall Study|Lack of Efficacy|10|||
130188469|NCT02867592|468646378|FG002|Overall Study|Lack of Efficacy|8|||
130188470|NCT02867592|468646379|FG003|Overall Study|Lack of Efficacy|8|||
130188471|NCT02867592|468646380|FG004|Overall Study|Lack of Efficacy|12|||
130188472|NCT02867592|468646381|FG005|Overall Study|Lack of Efficacy|17|||
130188473|NCT02867592|468646376|FG000|Overall Study|Physician Decision|1|||
130188474|NCT02867592|468646377|FG001|Overall Study|Physician Decision|2|||
130188475|NCT02867592|468646378|FG002|Overall Study|Physician Decision|2|||
130188476|NCT02867592|468646379|FG003|Overall Study|Physician Decision|0|||
130188477|NCT02867592|468646380|FG004|Overall Study|Physician Decision|5|||
130188478|NCT02867592|468646381|FG005|Overall Study|Physician Decision|1|||
130188479|NCT02867592|468646376|FG000|Overall Study|Protocol Violation|0|||
130188480|NCT02867592|468646377|FG001|Overall Study|Protocol Violation|0|||
130188481|NCT02867592|468646378|FG002|Overall Study|Protocol Violation|0|||
130188482|NCT02867592|468646379|FG003|Overall Study|Protocol Violation|0|||
130188483|NCT02867592|468646380|FG004|Overall Study|Protocol Violation|1|||
130188484|NCT02867592|468646381|FG005|Overall Study|Protocol Violation|1|||
130188485|NCT02867592|468646376|FG000|Overall Study|Withdrawal by Subject|0|||
130188486|NCT02867592|468646377|FG001|Overall Study|Withdrawal by Subject|1|||
130188487|NCT02867592|468646378|FG002|Overall Study|Withdrawal by Subject|0|||
130188488|NCT02867592|468646379|FG003|Overall Study|Withdrawal by Subject|1|||
130188489|NCT02867592|468646380|FG004|Overall Study|Withdrawal by Subject|3|||
130188490|NCT02867592|468646381|FG005|Overall Study|Withdrawal by Subject|3|||
130188491|NCT02867592|468646376|FG000|Overall Study|Ineligible|1|||
130188492|NCT02867592|468646377|FG001|Overall Study|Ineligible|1|||
130188493|NCT02867592|468646378|FG002|Overall Study|Ineligible|0|||
130188494|NCT02867592|468646379|FG003|Overall Study|Ineligible|0|||
130188495|NCT02867592|468646380|FG004|Overall Study|Ineligible|2|||
130188496|NCT02867592|468646381|FG005|Overall Study|Ineligible|0|||
130188497|NCT02867592|468646376|FG000|Overall Study|No Treatment|1|||
130188498|NCT02867592|468646377|FG001|Overall Study|No Treatment|0|||
130188499|NCT02867592|468646378|FG002|Overall Study|No Treatment|0|||
130188500|NCT02867592|468646379|FG003|Overall Study|No Treatment|0|||
130188501|NCT02867592|468646380|FG004|Overall Study|No Treatment|0|||
130188502|NCT02867592|468646381|FG005|Overall Study|No Treatment|0|||
130188503|NCT02867592|468646376|FG000|Overall Study|Still on Therapy|0|||
130188504|NCT02867592|468646377|FG001|Overall Study|Still on Therapy|0|||
130188505|NCT02867592|468646378|FG002|Overall Study|Still on Therapy|0|||
130188506|NCT02867592|468646379|FG003|Overall Study|Still on Therapy|0|||
130188507|NCT02867592|468646380|FG004|Overall Study|Still on Therapy|1|||
130188508|NCT02867592|468646381|FG005|Overall Study|Still on Therapy|0|||
130188509|NCT02867592|468646376|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188510|NCT02867592|468646377|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188511|NCT02867592|468646378|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188512|NCT02867592|468646379|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188513|NCT02867592|468646380|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188514|NCT02867592|468646381|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
130188515|NCT02867592|468646376|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130188516|NCT02867592|468646377|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188517|NCT02867592|468646378|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130188518|NCT02867592|468646379|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
130188519|NCT02867592|468646380|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188520|NCT02867592|468646381|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188521|NCT00594165|468646382|FG000|Overall Study|Major protocol violation|1|||
130188522|NCT00594165|468646382|FG000|Overall Study|Lack of Efficacy|12|||
130188523|NCT00594165|468646382|FG000|Overall Study|Adverse Event|52|||
130188524|NCT00594165|468646382|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
130188525|NCT00594165|468646382|FG000|Overall Study|Subject withdrew consent|27|||
130188526|NCT00594165|468646382|FG000|Overall Study|Study ended per sponsor|102|||
130188527|NCT00594165|468646382|FG000|Overall Study|Lost to Follow-up|4|||
130188528|NCT00594165|468646382|FG000|Overall Study|Other: PI discretion|5|||
130188529|NCT00594165|468646382|FG000|Overall Study|Other: Subject moving|3|||
130188530|NCT00594165|468646382|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
130188531|NCT00594165|468646382|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
130188532|NCT00594165|468646382|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
130188533|NCT00594165|468646382|FG000|Overall Study|Other: Site terminated participation|2|||
130188534|NCT03581292|468646387|FG000|Overall Study|Physician Decision|9|||
130188535|NCT03581292|468646388|FG001|Overall Study|Physician Decision|5|||
130188536|NCT03581292|468646387|FG000|Overall Study|Withdrawal by Subject|3|||
130188537|NCT03581292|468646388|FG001|Overall Study|Withdrawal by Subject|0|||
130188538|NCT03581292|468646387|FG000|Overall Study|Withdrawal before Therapy Start|1|||
130188539|NCT03581292|468646388|FG001|Overall Study|Withdrawal before Therapy Start|0|||
130188540|NCT00824772|468647720|FG000|Overall Study|Withdrawal by Subject|8|||
130188541|NCT03214224|468647729|FG000|Overall Study|Protocol Violation|1|||
130188542|NCT03214224|468647729|FG000|Overall Study|Withdrawal by Subject|2|||
130188543|NCT03214224|468647729|FG000|Overall Study|Practice controls or therapists|6|||
130188544|NCT02712320|468647730|FG000|Overall Study|Lost to Follow-up|1|||
130188545|NCT02712320|468647730|FG000|Overall Study|Withdrawal by Subject|1|||
130188546|NCT02712320|468647730|FG000|Overall Study|Transferred to another facility|1|||
130188547|NCT02712320|468647730|FG000|Overall Study|Treating with the prohibited medications|2|||
130188548|NCT00568451|468647733|FG000|Overall Study|Disease Progression|0|||
130188549|NCT00568451|468647734|FG001|Overall Study|Disease Progression|0|||
130188550|NCT00568451|468647735|FG002|Overall Study|Disease Progression|2|||
130188551|NCT00568451|468647736|FG003|Overall Study|Disease Progression|7|||
130188552|NCT01343043|468647739|FG000|Overall Study|Disease progression before treatment|1|||
130188553|NCT01343043|468647740|FG001|Overall Study|Disease progression before treatment|0|||
130188554|NCT01343043|468647741|FG002|Overall Study|Disease progression before treatment|0|||
130188555|NCT01343043|468647742|FG003|Overall Study|Disease progression before treatment|0|||
130188556|NCT01343043|468647739|FG000|Overall Study|Withdrawal by Subject|1|||
130188557|NCT01343043|468647740|FG001|Overall Study|Withdrawal by Subject|0|||
130188558|NCT01343043|468647741|FG002|Overall Study|Withdrawal by Subject|0|||
130188559|NCT01343043|468647742|FG003|Overall Study|Withdrawal by Subject|0|||
130188560|NCT01343043|468647739|FG000|Overall Study|Death|1|||
130188561|NCT01343043|468647740|FG001|Overall Study|Death|1|||
130188562|NCT01343043|468647741|FG002|Overall Study|Death|0|||
130188563|NCT01343043|468647742|FG003|Overall Study|Death|1|||
130188564|NCT00925704|468647743|FG000|First Intervention|Withdrew consent|0|||
130188565|NCT00925704|468647744|FG001|First Intervention|Withdrew consent|0|||
130188566|NCT00925704|468647745|FG002|First Intervention|Withdrew consent|0|||
130188567|NCT00925704|468647746|FG003|First Intervention|Withdrew consent|1|||
130188568|NCT00925704|468647747|FG004|First Intervention|Withdrew consent|1|||
130188569|NCT00925704|468647748|FG005|First Intervention|Withdrew consent|0|||
130188570|NCT00925704|468647743|FG000|Second Intervention|Withdrawal by Subject|1|||
130188571|NCT00925704|468647744|FG001|Second Intervention|Withdrawal by Subject|0|||
130188572|NCT00925704|468647745|FG002|Second Intervention|Withdrawal by Subject|0|||
130188573|NCT00925704|468647746|FG003|Second Intervention|Withdrawal by Subject|0|||
130188574|NCT00925704|468647747|FG004|Second Intervention|Withdrawal by Subject|1|||
130188575|NCT00925704|468647748|FG005|Second Intervention|Withdrawal by Subject|0|||
130188576|NCT00925704|468647743|FG000|Third Intervention|Withdrew consent|0|||
130188577|NCT00925704|468647744|FG001|Third Intervention|Withdrew consent|0|||
130188578|NCT00925704|468647745|FG002|Third Intervention|Withdrew consent|0|||
130188579|NCT00925704|468647746|FG003|Third Intervention|Withdrew consent|0|||
130188580|NCT00925704|468647747|FG004|Third Intervention|Withdrew consent|0|||
130188581|NCT00925704|468647748|FG005|Third Intervention|Withdrew consent|1|||
130188582|NCT02044302|468647752|FG000|Overall Study|study terminated|2|||
130188583|NCT02044302|468647753|FG001|Overall Study|study terminated|0|||
130188584|NCT03207815|468647754|FG000|Overall Study|Protocol Violation|3|||
130188585|NCT03207815|468647755|FG001|Overall Study|Protocol Violation|1|||
130188586|NCT03207815|468647754|FG000|Overall Study|Adverse Event|1|||
130188587|NCT03207815|468647755|FG001|Overall Study|Adverse Event|2|||
130188588|NCT03207815|468647754|FG000|Overall Study|Lost to Follow-up|1|||
130188589|NCT03207815|468647755|FG001|Overall Study|Lost to Follow-up|2|||
130188590|NCT03207815|468647754|FG000|Overall Study|Investigator's Discretion|1|||
130188591|NCT03207815|468647755|FG001|Overall Study|Investigator's Discretion|1|||
130188592|NCT03207815|468647754|FG000|Overall Study|Lack of Efficacy|0|||
130188593|NCT03207815|468647755|FG001|Overall Study|Lack of Efficacy|1|||
130188594|NCT03207815|468647754|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
130188595|NCT03207815|468647755|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
130188596|NCT03207815|468647754|FG000|Overall Study|Withdrew Consent|1|||
130188597|NCT03207815|468647755|FG001|Overall Study|Withdrew Consent|0|||
130188598|NCT01671007|468647756|FG000|Overall Study|Other reasons than listed|166|||
130188599|NCT01671007|468647757|FG001|Overall Study|Other reasons than listed|373|||
130188600|NCT01671007|468647758|FG002|Overall Study|Other reasons than listed|197|||
130188601|NCT01671007|468647759|FG003|Overall Study|Other reasons than listed|228|||
130188602|NCT01671007|468647760|FG004|Overall Study|Other reasons than listed|14|||
130188603|NCT01671007|468647761|FG005|Overall Study|Other reasons than listed|71|||
130188604|NCT01671007|468647762|FG006|Overall Study|Other reasons than listed|17|||
130188605|NCT01671007|468647763|FG007|Overall Study|Other reasons than listed|66|||
130188606|NCT01671007|468647764|FG008|Overall Study|Other reasons than listed|0|||
130188607|NCT01671007|468647756|FG000|Overall Study|Withdrawal by Subject|36|||
130188608|NCT01671007|468647757|FG001|Overall Study|Withdrawal by Subject|59|||
130188609|NCT01671007|468647758|FG002|Overall Study|Withdrawal by Subject|53|||
130188610|NCT01671007|468647759|FG003|Overall Study|Withdrawal by Subject|58|||
130188611|NCT01671007|468647760|FG004|Overall Study|Withdrawal by Subject|4|||
130188612|NCT01671007|468647761|FG005|Overall Study|Withdrawal by Subject|15|||
130188613|NCT01671007|468647762|FG006|Overall Study|Withdrawal by Subject|1|||
130188614|NCT01671007|468647763|FG007|Overall Study|Withdrawal by Subject|19|||
130188615|NCT01671007|468647764|FG008|Overall Study|Withdrawal by Subject|0|||
130188616|NCT01671007|468647756|FG000|Overall Study|Lost to Follow-up|93|||
130188617|NCT01671007|468647757|FG001|Overall Study|Lost to Follow-up|142|||
130188618|NCT01671007|468647758|FG002|Overall Study|Lost to Follow-up|91|||
130188619|NCT01671007|468647759|FG003|Overall Study|Lost to Follow-up|63|||
130188620|NCT01671007|468647760|FG004|Overall Study|Lost to Follow-up|7|||
130188621|NCT01671007|468647761|FG005|Overall Study|Lost to Follow-up|20|||
130188622|NCT01671007|468647762|FG006|Overall Study|Lost to Follow-up|2|||
130188623|NCT01671007|468647763|FG007|Overall Study|Lost to Follow-up|28|||
130188624|NCT01671007|468647764|FG008|Overall Study|Lost to Follow-up|0|||
130188625|NCT01671007|468647756|FG000|Overall Study|No end of study case report form|3|||
130188626|NCT01671007|468647757|FG001|Overall Study|No end of study case report form|1|||
130188627|NCT01671007|468647758|FG002|Overall Study|No end of study case report form|0|||
130188628|NCT01671007|468647759|FG003|Overall Study|No end of study case report form|2|||
130188629|NCT01671007|468647760|FG004|Overall Study|No end of study case report form|0|||
130188630|NCT01671007|468647761|FG005|Overall Study|No end of study case report form|0|||
130188631|NCT01671007|468647762|FG006|Overall Study|No end of study case report form|0|||
130188632|NCT01671007|468647763|FG007|Overall Study|No end of study case report form|0|||
130188633|NCT01671007|468647764|FG008|Overall Study|No end of study case report form|0|||
130188634|NCT01671007|468647756|FG000|Overall Study|Not eligible|23|||
130188635|NCT01671007|468647757|FG001|Overall Study|Not eligible|76|||
130188636|NCT01671007|468647758|FG002|Overall Study|Not eligible|25|||
130188637|NCT01671007|468647759|FG003|Overall Study|Not eligible|17|||
130188638|NCT01671007|468647760|FG004|Overall Study|Not eligible|0|||
130188639|NCT01671007|468647761|FG005|Overall Study|Not eligible|6|||
130188640|NCT01671007|468647762|FG006|Overall Study|Not eligible|1|||
130188641|NCT01671007|468647763|FG007|Overall Study|Not eligible|19|||
130188642|NCT01671007|468647764|FG008|Overall Study|Not eligible|0|||
130188643|NCT00391768|468647765|FG000|Overall Study|Withdrawal by Subject|0|||
130188644|NCT00391768|468647766|FG001|Overall Study|Withdrawal by Subject|0|||
130188645|NCT00391768|468647767|FG002|Overall Study|Withdrawal by Subject|1|||
130188646|NCT00391768|468647768|FG003|Overall Study|Withdrawal by Subject|0|||
130188647|NCT00391768|468647769|FG004|Overall Study|Withdrawal by Subject|0|||
130188648|NCT00391768|468647770|FG005|Overall Study|Withdrawal by Subject|1|||
130188649|NCT00391768|468647771|FG006|Overall Study|Withdrawal by Subject|1|||
130188650|NCT00391768|468647765|FG000|Overall Study|Lost to Follow-up|0|||
130188651|NCT00391768|468647766|FG001|Overall Study|Lost to Follow-up|0|||
130188652|NCT00391768|468647767|FG002|Overall Study|Lost to Follow-up|0|||
130188653|NCT00391768|468647768|FG003|Overall Study|Lost to Follow-up|1|||
130188654|NCT00391768|468647769|FG004|Overall Study|Lost to Follow-up|2|||
130188655|NCT00391768|468647770|FG005|Overall Study|Lost to Follow-up|2|||
130188656|NCT00391768|468647771|FG006|Overall Study|Lost to Follow-up|3|||
130188657|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
130188658|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130188659|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
130188660|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
130188661|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
130188662|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
130188663|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
130188664|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
130188665|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
130188666|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
130188667|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
130188668|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
130188669|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130188670|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130188671|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
130188672|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
130188673|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
130188674|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
130188675|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
130188676|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
130188677|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
130188678|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
130188679|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
130188680|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
130188681|NCT00171210|468647774|FG000|Overall Study|Adverse Event|16|||
130188682|NCT00171210|468647775|FG001|Overall Study|Adverse Event|27|||
130188683|NCT00171210|468647774|FG000|Overall Study|Abnormal laboratory value(s)|6|||
130188684|NCT00171210|468647775|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130188685|NCT00171210|468647774|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130188686|NCT00171210|468647775|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130188687|NCT00171210|468647774|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
130188688|NCT00171210|468647775|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
130188689|NCT00171210|468647774|FG000|Overall Study|Protocol Violation|0|||
130188690|NCT00171210|468647775|FG001|Overall Study|Protocol Violation|2|||
130188691|NCT00171210|468647774|FG000|Overall Study|Withdrawal by Subject|32|||
130188692|NCT00171210|468647775|FG001|Overall Study|Withdrawal by Subject|30|||
130188693|NCT00171210|468647774|FG000|Overall Study|Lost to Follow-up|1|||
130188694|NCT00171210|468647775|FG001|Overall Study|Lost to Follow-up|0|||
130188695|NCT00171210|468647774|FG000|Overall Study|Administrative problems|1|||
130188696|NCT00171210|468647775|FG001|Overall Study|Administrative problems|1|||
130188697|NCT00171210|468647774|FG000|Overall Study|Death|2|||
130188698|NCT00171210|468647775|FG001|Overall Study|Death|3|||
130188699|NCT00171210|468647774|FG000|Overall Study|Stopped at end of core|0|||
130188700|NCT00171210|468647775|FG001|Overall Study|Stopped at end of core|32|||
130188701|NCT00171210|468647774|FG000|Overall Study|Stopped at end of extension 1|0|||
130188702|NCT00171210|468647775|FG001|Overall Study|Stopped at end of extension 1|1|||
130188703|NCT03187301|468647778|FG000|Titration Period|Adverse Event|0|||
130188704|NCT03187301|468647779|FG001|Titration Period|Adverse Event|0|||
130188705|NCT03187301|468647780|FG002|Titration Period|Adverse Event|0|||
130188706|NCT03187301|468647781|FG003|Titration Period|Adverse Event|0|||
130188707|NCT03187301|468647782|FG004|Titration Period|Adverse Event|0|||
130188708|NCT03187301|468647783|FG005|Titration Period|Adverse Event|0|||
130188709|NCT03187301|468647784|FG006|Titration Period|Adverse Event|5|||
130188710|NCT03187301|468647778|FG000|Titration Period|Withdrawal by Subject|0|||
130188711|NCT03187301|468647779|FG001|Titration Period|Withdrawal by Subject|0|||
130188712|NCT03187301|468647780|FG002|Titration Period|Withdrawal by Subject|0|||
130188713|NCT03187301|468647781|FG003|Titration Period|Withdrawal by Subject|0|||
130188714|NCT03187301|468647782|FG004|Titration Period|Withdrawal by Subject|0|||
130188715|NCT03187301|468647783|FG005|Titration Period|Withdrawal by Subject|0|||
130188716|NCT03187301|468647784|FG006|Titration Period|Withdrawal by Subject|1|||
130188717|NCT03187301|468647778|FG000|Titration Period|Exclusion Criteria Met|0|||
130188718|NCT03187301|468647779|FG001|Titration Period|Exclusion Criteria Met|0|||
130188719|NCT03187301|468647780|FG002|Titration Period|Exclusion Criteria Met|0|||
130188720|NCT03187301|468647781|FG003|Titration Period|Exclusion Criteria Met|0|||
130188721|NCT03187301|468647782|FG004|Titration Period|Exclusion Criteria Met|0|||
130188722|NCT03187301|468647783|FG005|Titration Period|Exclusion Criteria Met|0|||
130188723|NCT03187301|468647784|FG006|Titration Period|Exclusion Criteria Met|1|||
130188724|NCT03187301|468647778|FG000|Pre-Intervention|Withdrawal by Subject|1|||
130188725|NCT03187301|468647779|FG001|Pre-Intervention|Withdrawal by Subject|0|||
130188726|NCT03187301|468647780|FG002|Pre-Intervention|Withdrawal by Subject|0|||
130188727|NCT03187301|468647781|FG003|Pre-Intervention|Withdrawal by Subject|0|||
130188728|NCT03187301|468647782|FG004|Pre-Intervention|Withdrawal by Subject|0|||
130188729|NCT03187301|468647783|FG005|Pre-Intervention|Withdrawal by Subject|0|||
130188730|NCT03187301|468647784|FG006|Pre-Intervention|Withdrawal by Subject|0|||
130188731|NCT02182843|468647791|FG000|Overall Study|Withdrawal by Subject|7|||
130188732|NCT02182843|468647791|FG000|Overall Study|Lost to Follow-up|2|||
130188733|NCT02182843|468647791|FG000|Overall Study|Adverse Event|1|||
130188734|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130188735|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130188736|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
130188737|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188738|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188739|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188740|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130188741|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130188742|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
130188743|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130188744|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130188745|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
130188746|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
130188747|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130188748|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130188749|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130188750|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
130188751|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130188752|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
130188753|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
130188754|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
130188755|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130188756|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130188757|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
130188758|NCT00832455|468647796|FG000|Overall Study|Adverse Event|13|||
130188759|NCT00832455|468647796|FG000|Overall Study|Lost to Follow-up|26|||
130188760|NCT00832455|468647796|FG000|Overall Study|Protocol Violation|4|||
130188761|NCT00832455|468647796|FG000|Overall Study|Withdrawal by Subject|17|||
130188762|NCT00832455|468647796|FG000|Overall Study|Screening Failure|2|||
130188763|NCT00832455|468647796|FG000|Overall Study|Stopped Medication|4|||
130188764|NCT00832455|468647796|FG000|Overall Study|Parent misunderstood study|1|||
130188765|NCT00832455|468647796|FG000|Overall Study|Parent dissatisfied|1|||
130188766|NCT00832455|468647796|FG000|Overall Study|No improvement|3|||
130188767|NCT00832455|468647796|FG000|Overall Study|Patient moved|1|||
130188768|NCT00561392|468647799|FG000|Overall Study|Adverse Event|38|||
130188769|NCT00561392|468647799|FG000|Overall Study|Lack of Efficacy|2|||
130188770|NCT00561392|468647799|FG000|Overall Study|Protocol Violation|1|||
130188771|NCT00561392|468647799|FG000|Overall Study|Withdrawal by Subject|8|||
130188772|NCT00561392|468647799|FG000|Overall Study|Administrative problems|4|||
130188773|NCT01741688|468647800|FG000|Overall Study|Lack of insurance coverage|2|||
130188774|NCT01741688|468647800|FG000|Overall Study|Withdrawal by Subject|1|||
130188775|NCT01262872|468647805|FG000|Step 2|Death|0|||
130188776|NCT01262872|468647806|FG001|Step 2|Death|0|||
130188777|NCT01262872|468647807|FG002|Step 2|Death|0|||
130188778|NCT01262872|468647808|FG003|Step 2|Death|1|||
130188779|NCT01262872|468647809|FG004|Step 2|Death|0|||
130188780|NCT01262872|468647810|FG005|Step 2|Death|2|||
130188781|NCT01262872|468647811|FG006|Step 2|Death|2|||
130188782|NCT01262872|468647812|FG007|Step 2|Death|1|||
130188783|NCT01262872|468647805|FG000|Step 2|Protocol Violation|0|||
130188784|NCT01262872|468647806|FG001|Step 2|Protocol Violation|0|||
130188785|NCT01262872|468647807|FG002|Step 2|Protocol Violation|1|||
130188786|NCT01262872|468647808|FG003|Step 2|Protocol Violation|0|||
130188787|NCT01262872|468647809|FG004|Step 2|Protocol Violation|0|||
130188788|NCT01262872|468647810|FG005|Step 2|Protocol Violation|0|||
130188789|NCT01262872|468647811|FG006|Step 2|Protocol Violation|3|||
130188790|NCT01262872|468647812|FG007|Step 2|Protocol Violation|1|||
130188791|NCT01262872|468647805|FG000|Step 2|Withdrawal by Subject|0|||
130188792|NCT01262872|468647806|FG001|Step 2|Withdrawal by Subject|0|||
130188793|NCT01262872|468647807|FG002|Step 2|Withdrawal by Subject|4|||
130188794|NCT01262872|468647808|FG003|Step 2|Withdrawal by Subject|6|||
130188795|NCT01262872|468647809|FG004|Step 2|Withdrawal by Subject|3|||
130188796|NCT01262872|468647810|FG005|Step 2|Withdrawal by Subject|1|||
130188797|NCT01262872|468647811|FG006|Step 2|Withdrawal by Subject|2|||
130188798|NCT01262872|468647812|FG007|Step 2|Withdrawal by Subject|1|||
130188799|NCT01262872|468647805|FG000|Step 2|Migrated/moved from study area|0|||
130188800|NCT01262872|468647806|FG001|Step 2|Migrated/moved from study area|0|||
130188801|NCT01262872|468647807|FG002|Step 2|Migrated/moved from study area|4|||
130188802|NCT01262872|468647808|FG003|Step 2|Migrated/moved from study area|3|||
130188803|NCT01262872|468647809|FG004|Step 2|Migrated/moved from study area|2|||
130188804|NCT01262872|468647810|FG005|Step 2|Migrated/moved from study area|6|||
130188805|NCT01262872|468647811|FG006|Step 2|Migrated/moved from study area|2|||
130188806|NCT01262872|468647812|FG007|Step 2|Migrated/moved from study area|3|||
130188807|NCT00365794|468647815|FG000|Overall Study|Withdrawal by Subject|2|||
130188808|NCT00745901|468647816|FG000|Overall Study|Adverse Event|3|||
130188809|NCT00745901|468647817|FG001|Overall Study|Adverse Event|4|||
130188810|NCT00745901|468647816|FG000|Overall Study|Protocol Violation|0|||
130188811|NCT00745901|468647817|FG001|Overall Study|Protocol Violation|1|||
130188812|NCT00745901|468647816|FG000|Overall Study|Withdrawal by Subject|1|||
130188813|NCT00745901|468647817|FG001|Overall Study|Withdrawal by Subject|0|||
130188814|NCT00745901|468647816|FG000|Overall Study|Lost to Follow-up|7|||
130188815|NCT00745901|468647817|FG001|Overall Study|Lost to Follow-up|4|||
130188816|NCT00745901|468647816|FG000|Overall Study|Pregnancy|2|||
130188817|NCT00745901|468647817|FG001|Overall Study|Pregnancy|4|||
130188818|NCT00745901|468647816|FG000|Overall Study|Lack of compliance|2|||
130188819|NCT00745901|468647817|FG001|Overall Study|Lack of compliance|2|||
130188820|NCT00745901|468647816|FG000|Overall Study|Patient's next menses did not start with|1|||
130188821|NCT00745901|468647817|FG001|Overall Study|Patient's next menses did not start with|0|||
130188822|NCT00745901|468647816|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
130188823|NCT00745901|468647817|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
130188824|NCT00745901|468647816|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130188825|NCT00745901|468647817|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130188826|NCT00745901|468647816|FG000|Overall Study|Patient didn't take any study medication|7|||
130188827|NCT00745901|468647817|FG001|Overall Study|Patient didn't take any study medication|3|||
130188828|NCT01804946|468647819|FG000|Overall Study|Protocol Violation|1|||
130188829|NCT01804946|468647820|FG001|Overall Study|Protocol Violation|0|||
130188830|NCT01804946|468647819|FG000|Overall Study|Adverse Event|0|||
130188831|NCT01804946|468647820|FG001|Overall Study|Adverse Event|1|||
130188832|NCT01804946|468647819|FG000|Overall Study|Insufficient data available|0|||
130188833|NCT01804946|468647820|FG001|Overall Study|Insufficient data available|1|||
130188834|NCT01804946|468647819|FG000|Overall Study|Do not meet inclusion criteria|1|||
130188835|NCT01804946|468647820|FG001|Overall Study|Do not meet inclusion criteria|2|||
130188836|NCT00722137|468647822|FG000|Overall Study|Overt Disease Progression|5|||
130188837|NCT00722137|468647823|FG001|Overall Study|Overt Disease Progression|4|||
130188838|NCT00722137|468647822|FG000|Overall Study|Adverse Event|17|||
130188839|NCT00722137|468647823|FG001|Overall Study|Adverse Event|21|||
130188840|NCT00722137|468647822|FG000|Overall Study|Death|12|||
130188841|NCT00722137|468647823|FG001|Overall Study|Death|7|||
130188842|NCT00722137|468647822|FG000|Overall Study|Withdrawal by Subject|6|||
130188843|NCT00722137|468647823|FG001|Overall Study|Withdrawal by Subject|9|||
130188844|NCT00722137|468647822|FG000|Overall Study|Other Reason Unknown|3|||
130188845|NCT00722137|468647823|FG001|Overall Study|Other Reason Unknown|4|||
130188846|NCT00722137|468647822|FG000|Overall Study|Randomized But Not Treated|2|||
130188847|NCT00722137|468647823|FG001|Overall Study|Randomized But Not Treated|3|||
130188848|NCT00848718|468647824|FG000|Overall Study|Adverse Event|2|||
130188849|NCT00848718|468647825|FG001|Overall Study|Adverse Event|2|||
130188850|NCT00848718|468647826|FG002|Overall Study|Adverse Event|1|||
130188851|NCT00848718|468647827|FG003|Overall Study|Adverse Event|1|||
130188852|NCT00848718|468647828|FG004|Overall Study|Adverse Event|1|||
130188853|NCT00848718|468647829|FG005|Overall Study|Adverse Event|0|||
130188854|NCT00848718|468647830|FG006|Overall Study|Adverse Event|0|||
130188855|NCT00848718|468647831|FG007|Overall Study|Adverse Event|1|||
130188856|NCT00848718|468647832|FG008|Overall Study|Adverse Event|1|||
130188857|NCT00848718|468647833|FG009|Overall Study|Adverse Event|0|||
130188858|NCT00848718|468647834|FG010|Overall Study|Adverse Event|0|||
130188859|NCT00848718|468647835|FG011|Overall Study|Adverse Event|0|||
130188860|NCT00848718|468647836|FG012|Overall Study|Adverse Event|2|||
130188861|NCT00848718|468647824|FG000|Overall Study|Lack of Efficacy|0|||
130188862|NCT00848718|468647825|FG001|Overall Study|Lack of Efficacy|0|||
130188863|NCT00848718|468647826|FG002|Overall Study|Lack of Efficacy|1|||
130188864|NCT00848718|468647827|FG003|Overall Study|Lack of Efficacy|0|||
130188865|NCT00848718|468647828|FG004|Overall Study|Lack of Efficacy|0|||
130188866|NCT00848718|468647829|FG005|Overall Study|Lack of Efficacy|0|||
130188867|NCT00848718|468647830|FG006|Overall Study|Lack of Efficacy|1|||
130188868|NCT00848718|468647831|FG007|Overall Study|Lack of Efficacy|0|||
130188869|NCT00848718|468647832|FG008|Overall Study|Lack of Efficacy|0|||
130188870|NCT00848718|468647833|FG009|Overall Study|Lack of Efficacy|0|||
130188871|NCT00848718|468647834|FG010|Overall Study|Lack of Efficacy|0|||
130188872|NCT00848718|468647835|FG011|Overall Study|Lack of Efficacy|0|||
130188873|NCT00848718|468647836|FG012|Overall Study|Lack of Efficacy|0|||
130188874|NCT00848718|468647824|FG000|Overall Study|Physician Decision|0|||
130188875|NCT00848718|468647825|FG001|Overall Study|Physician Decision|1|||
130188876|NCT00848718|468647826|FG002|Overall Study|Physician Decision|0|||
130188877|NCT00848718|468647827|FG003|Overall Study|Physician Decision|0|||
130188878|NCT00848718|468647828|FG004|Overall Study|Physician Decision|1|||
130188879|NCT00848718|468647829|FG005|Overall Study|Physician Decision|1|||
130188880|NCT00848718|468647830|FG006|Overall Study|Physician Decision|0|||
130188881|NCT00848718|468647831|FG007|Overall Study|Physician Decision|0|||
130188882|NCT00848718|468647832|FG008|Overall Study|Physician Decision|1|||
130188883|NCT00848718|468647833|FG009|Overall Study|Physician Decision|2|||
130188884|NCT00848718|468647834|FG010|Overall Study|Physician Decision|0|||
130188885|NCT00848718|468647835|FG011|Overall Study|Physician Decision|0|||
130188886|NCT00848718|468647836|FG012|Overall Study|Physician Decision|1|||
130188887|NCT00848718|468647824|FG000|Overall Study|Progressive disease before treatment|1|||
130188888|NCT00848718|468647825|FG001|Overall Study|Progressive disease before treatment|5|||
130188889|NCT00848718|468647826|FG002|Overall Study|Progressive disease before treatment|1|||
130188890|NCT00848718|468647827|FG003|Overall Study|Progressive disease before treatment|3|||
130188891|NCT00848718|468647828|FG004|Overall Study|Progressive disease before treatment|4|||
130188892|NCT00848718|468647829|FG005|Overall Study|Progressive disease before treatment|4|||
130188893|NCT00848718|468647830|FG006|Overall Study|Progressive disease before treatment|2|||
130188894|NCT00848718|468647831|FG007|Overall Study|Progressive disease before treatment|1|||
130188895|NCT00848718|468647832|FG008|Overall Study|Progressive disease before treatment|2|||
130188896|NCT00848718|468647833|FG009|Overall Study|Progressive disease before treatment|7|||
130188897|NCT00848718|468647834|FG010|Overall Study|Progressive disease before treatment|3|||
130188898|NCT00848718|468647835|FG011|Overall Study|Progressive disease before treatment|6|||
130188899|NCT00848718|468647836|FG012|Overall Study|Progressive disease before treatment|2|||
130188900|NCT00848718|468647824|FG000|Overall Study|Protocol Violation|0|||
130188901|NCT00848718|468647825|FG001|Overall Study|Protocol Violation|1|||
130188902|NCT00848718|468647826|FG002|Overall Study|Protocol Violation|0|||
130188903|NCT00848718|468647827|FG003|Overall Study|Protocol Violation|0|||
130188904|NCT00848718|468647828|FG004|Overall Study|Protocol Violation|0|||
130188905|NCT00848718|468647829|FG005|Overall Study|Protocol Violation|0|||
130188906|NCT00848718|468647830|FG006|Overall Study|Protocol Violation|0|||
130188907|NCT00848718|468647831|FG007|Overall Study|Protocol Violation|1|||
130188908|NCT00848718|468647832|FG008|Overall Study|Protocol Violation|0|||
130188909|NCT00848718|468647833|FG009|Overall Study|Protocol Violation|0|||
130188910|NCT00848718|468647834|FG010|Overall Study|Protocol Violation|0|||
130188911|NCT00848718|468647835|FG011|Overall Study|Protocol Violation|0|||
130188912|NCT00848718|468647836|FG012|Overall Study|Protocol Violation|1|||
130188913|NCT00848718|468647824|FG000|Overall Study|Withdrawal by Subject|1|||
130188914|NCT00848718|468647825|FG001|Overall Study|Withdrawal by Subject|0|||
130188915|NCT00848718|468647826|FG002|Overall Study|Withdrawal by Subject|0|||
130188916|NCT00848718|468647827|FG003|Overall Study|Withdrawal by Subject|1|||
130188917|NCT00848718|468647828|FG004|Overall Study|Withdrawal by Subject|0|||
130188918|NCT00848718|468647829|FG005|Overall Study|Withdrawal by Subject|0|||
130188919|NCT00848718|468647830|FG006|Overall Study|Withdrawal by Subject|0|||
130188920|NCT00848718|468647831|FG007|Overall Study|Withdrawal by Subject|0|||
130188921|NCT00848718|468647832|FG008|Overall Study|Withdrawal by Subject|0|||
130188922|NCT00848718|468647833|FG009|Overall Study|Withdrawal by Subject|0|||
130188923|NCT00848718|468647834|FG010|Overall Study|Withdrawal by Subject|1|||
130188924|NCT00848718|468647835|FG011|Overall Study|Withdrawal by Subject|0|||
130188925|NCT00848718|468647836|FG012|Overall Study|Withdrawal by Subject|0|||
130188926|NCT00848718|468647824|FG000|Overall Study|Progressive disease during treatment|3|||
130188927|NCT00848718|468647825|FG001|Overall Study|Progressive disease during treatment|0|||
130188928|NCT00848718|468647826|FG002|Overall Study|Progressive disease during treatment|3|||
130188929|NCT00848718|468647827|FG003|Overall Study|Progressive disease during treatment|0|||
130188930|NCT00848718|468647828|FG004|Overall Study|Progressive disease during treatment|0|||
130188931|NCT00848718|468647829|FG005|Overall Study|Progressive disease during treatment|0|||
130188932|NCT00848718|468647830|FG006|Overall Study|Progressive disease during treatment|0|||
130188933|NCT00848718|468647831|FG007|Overall Study|Progressive disease during treatment|2|||
130188934|NCT00848718|468647832|FG008|Overall Study|Progressive disease during treatment|0|||
130188935|NCT00848718|468647833|FG009|Overall Study|Progressive disease during treatment|0|||
130188936|NCT00848718|468647834|FG010|Overall Study|Progressive disease during treatment|0|||
130188937|NCT00848718|468647835|FG011|Overall Study|Progressive disease during treatment|0|||
130188938|NCT00848718|468647836|FG012|Overall Study|Progressive disease during treatment|2|||
130188939|NCT02431676|468647838|FG000|Overall Study|no lab obtained|0|||
130188940|NCT02431676|468647839|FG001|Overall Study|no lab obtained|1|||
130188941|NCT02431676|468647840|FG002|Overall Study|no lab obtained|2|||
130188942|NCT01120184|468650188|FG000|Overall Study|Adverse Event|0|||
130188943|NCT01120184|468650189|FG001|Overall Study|Adverse Event|1|||
130188944|NCT01120184|468650190|FG002|Overall Study|Adverse Event|0|||
130188945|NCT01120184|468650188|FG000|Overall Study|Lost to Follow-up|13|||
130188946|NCT01120184|468650189|FG001|Overall Study|Lost to Follow-up|13|||
130188947|NCT01120184|468650190|FG002|Overall Study|Lost to Follow-up|11|||
130188948|NCT01120184|468650188|FG000|Overall Study|Physician Decision|9|||
130188949|NCT01120184|468650189|FG001|Overall Study|Physician Decision|1|||
130188950|NCT01120184|468650190|FG002|Overall Study|Physician Decision|3|||
130188951|NCT01120184|468650188|FG000|Overall Study|Reason not Specified|8|||
130188952|NCT01120184|468650189|FG001|Overall Study|Reason not Specified|3|||
130188953|NCT01120184|468650190|FG002|Overall Study|Reason not Specified|12|||
130188954|NCT01120184|468650188|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
130188955|NCT01120184|468650189|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
130188956|NCT01120184|468650190|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
130188957|NCT01120184|468650188|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
130188958|NCT01120184|468650189|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
130188959|NCT01120184|468650190|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
130188960|NCT01120184|468650188|FG000|Overall Study|Death|170|||
130188961|NCT01120184|468650189|FG001|Overall Study|Death|176|||
130188962|NCT01120184|468650190|FG002|Overall Study|Death|169|||
130188963|NCT02525783|468650191|FG000|Overall Study|Lost to Follow-up|10|||
130188964|NCT00866281|468650192|FG000|Overall Study|Adverse Event|1|||
130188965|NCT00866281|468650193|FG001|Overall Study|Adverse Event|0|||
130188966|NCT00866281|468650192|FG000|Overall Study|Withdrawal by participants|3|||
130188967|NCT00866281|468650193|FG001|Overall Study|Withdrawal by participants|0|||
130188968|NCT00866281|468650192|FG000|Overall Study|Disease progression|3|||
130188969|NCT00866281|468650193|FG001|Overall Study|Disease progression|11|||
130188970|NCT00866281|468650192|FG000|Overall Study|New cancer therapy|0|||
130188971|NCT00866281|468650193|FG001|Overall Study|New cancer therapy|4|||
130188972|NCT01894841|468650194|FG000|Overall Study|Withdrawal by Subject|9|||
130188973|NCT01894841|468650195|FG001|Overall Study|Withdrawal by Subject|4|||
130188974|NCT01894841|468650194|FG000|Overall Study|Withdrawn by investigator|2|||
130188975|NCT01894841|468650195|FG001|Overall Study|Withdrawn by investigator|2|||
130188976|NCT01894841|468650194|FG000|Overall Study|Lost to Follow-up|7|||
130188977|NCT01894841|468650195|FG001|Overall Study|Lost to Follow-up|3|||
130188978|NCT00529087|468650203|FG000|Overall Study|Adverse Event|10|||
130188979|NCT00529087|468650204|FG001|Overall Study|Adverse Event|13|||
130188980|NCT00529087|468650205|FG002|Overall Study|Adverse Event|4|||
130188981|NCT00529087|468650203|FG000|Overall Study|Lost to Follow-up|6|||
130188982|NCT00529087|468650204|FG001|Overall Study|Lost to Follow-up|4|||
130188983|NCT00529087|468650205|FG002|Overall Study|Lost to Follow-up|1|||
130188984|NCT00529087|468650203|FG000|Overall Study|Protocol Violation|8|||
130188985|NCT00529087|468650204|FG001|Overall Study|Protocol Violation|7|||
130188986|NCT00529087|468650205|FG002|Overall Study|Protocol Violation|6|||
130188987|NCT00529087|468650203|FG000|Overall Study|Withdrawal by Subject|3|||
130188988|NCT00529087|468650204|FG001|Overall Study|Withdrawal by Subject|3|||
130188989|NCT00529087|468650205|FG002|Overall Study|Withdrawal by Subject|3|||
130188990|NCT00529087|468650203|FG000|Overall Study|Protocol deviation|1|||
130188991|NCT00529087|468650204|FG001|Overall Study|Protocol deviation|1|||
130188992|NCT00529087|468650205|FG002|Overall Study|Protocol deviation|2|||
130188993|NCT00318474|468650206|FG000|Overall Study|Adverse Event|1|||
130188994|NCT00318474|468650207|FG001|Overall Study|Adverse Event|1|||
130188995|NCT00318474|468650206|FG000|Overall Study|Lost to Follow-up|0|||
130188996|NCT00318474|468650207|FG001|Overall Study|Lost to Follow-up|1|||
130188997|NCT00318474|468650206|FG000|Overall Study|Pregnancy|0|||
130188998|NCT00318474|468650207|FG001|Overall Study|Pregnancy|2|||
130188999|NCT00318474|468650206|FG000|Overall Study|Protocol Violation|1|||
130189000|NCT00318474|468650207|FG001|Overall Study|Protocol Violation|0|||
130189001|NCT00318474|468650206|FG000|Overall Study|Withdrawal by Subject|3|||
130189002|NCT00318474|468650207|FG001|Overall Study|Withdrawal by Subject|2|||
130189003|NCT00318474|468650206|FG000|Overall Study|Fall in GFR|3|||
130189004|NCT00318474|468650207|FG001|Overall Study|Fall in GFR|3|||
130189005|NCT00318474|468650206|FG000|Overall Study|Post-therapy hyperflycemia|0|||
130189006|NCT00318474|468650207|FG001|Overall Study|Post-therapy hyperflycemia|1|||
130189007|NCT00318474|468650206|FG000|Overall Study|Trial terminated|10|||
130189008|NCT00318474|468650207|FG001|Overall Study|Trial terminated|7|||
130189009|NCT00833105|468650217|FG000|Overall Study|Withdrawal by Subject|1|||
130189010|NCT00833105|468650217|FG000|Overall Study|Adverse Event|2|||
130189011|NCT03656068|468650222|FG000|Overall Study|Withdrawal by Subject|4|||
130189012|NCT03656068|468650222|FG000|Overall Study|Adverse Event|1|||
130189013|NCT05326529|468650223|FG000|Overall Study|Lack of Efficacy|0|||
130189014|NCT05326529|468650224|FG001|Overall Study|Lack of Efficacy|1|||
130189015|NCT05326529|468650225|FG002|Overall Study|Lack of Efficacy|0|||
130189016|NCT05326529|468650223|FG000|Overall Study|Physician Decision|0|||
130189017|NCT05326529|468650224|FG001|Overall Study|Physician Decision|0|||
130189018|NCT05326529|468650225|FG002|Overall Study|Physician Decision|2|||
130189019|NCT01379768|468650226|FG000|Overall Study|Adverse Event|1|||
130189020|NCT01379768|468650227|FG001|Overall Study|Adverse Event|1|||
130189021|NCT01379768|468650228|FG002|Overall Study|Adverse Event|0|||
130189022|NCT01379768|468650226|FG000|Overall Study|Lost to Follow-up|2|||
130189023|NCT01379768|468650227|FG001|Overall Study|Lost to Follow-up|0|||
130189024|NCT01379768|468650228|FG002|Overall Study|Lost to Follow-up|0|||
130189025|NCT00708552|468650229|FG000|Overall Study|Adverse Event|10|||
130189026|NCT00708552|468650230|FG001|Overall Study|Adverse Event|3|||
130189027|NCT00708552|468650231|FG002|Overall Study|Adverse Event|4|||
130189028|NCT00708552|468650232|FG003|Overall Study|Adverse Event|6|||
130189029|NCT00708552|468650229|FG000|Overall Study|Lack of Efficacy|0|||
130189030|NCT00708552|468650230|FG001|Overall Study|Lack of Efficacy|4|||
130189031|NCT00708552|468650231|FG002|Overall Study|Lack of Efficacy|1|||
130189032|NCT00708552|468650232|FG003|Overall Study|Lack of Efficacy|0|||
130189033|NCT00708552|468650229|FG000|Overall Study|Protocol Violation|0|||
130189034|NCT00708552|468650230|FG001|Overall Study|Protocol Violation|0|||
130189035|NCT00708552|468650231|FG002|Overall Study|Protocol Violation|2|||
130189036|NCT00708552|468650232|FG003|Overall Study|Protocol Violation|4|||
130189037|NCT00708552|468650229|FG000|Overall Study|Lost to Follow-up|4|||
130189038|NCT00708552|468650230|FG001|Overall Study|Lost to Follow-up|2|||
130189039|NCT00708552|468650231|FG002|Overall Study|Lost to Follow-up|0|||
130189040|NCT00708552|468650232|FG003|Overall Study|Lost to Follow-up|1|||
130189041|NCT00708552|468650229|FG000|Overall Study|Physician Decision|1|||
130189042|NCT00708552|468650230|FG001|Overall Study|Physician Decision|2|||
130189043|NCT00708552|468650231|FG002|Overall Study|Physician Decision|0|||
130189044|NCT00708552|468650232|FG003|Overall Study|Physician Decision|0|||
130189045|NCT00708552|468650229|FG000|Overall Study|Withdrawal by Subject|12|||
130189046|NCT00708552|468650230|FG001|Overall Study|Withdrawal by Subject|7|||
130189047|NCT00708552|468650231|FG002|Overall Study|Withdrawal by Subject|8|||
130189048|NCT00708552|468650232|FG003|Overall Study|Withdrawal by Subject|10|||
130189049|NCT00455403|468650234|FG000|Overall Study|Lost to Follow-up|2|||
130189050|NCT00455403|468650235|FG001|Overall Study|Lost to Follow-up|1|||
130189051|NCT00455403|468650234|FG000|Overall Study|Withdrawal by Subject|1|||
130189052|NCT00455403|468650235|FG001|Overall Study|Withdrawal by Subject|3|||
130189053|NCT00455403|468650234|FG000|Overall Study|Protocol Violation|0|||
130189054|NCT00455403|468650235|FG001|Overall Study|Protocol Violation|2|||
130189055|NCT00350207|468650236|FG000|Overall Study|Adverse Event|5|||
130189056|NCT00350207|468650237|FG001|Overall Study|Adverse Event|2|||
130189057|NCT00350207|468650238|FG002|Overall Study|Adverse Event|2|||
130189058|NCT00350207|468650236|FG000|Overall Study|Lack of Efficacy|1|||
130189059|NCT00350207|468650237|FG001|Overall Study|Lack of Efficacy|0|||
130189060|NCT00350207|468650238|FG002|Overall Study|Lack of Efficacy|2|||
130189061|NCT00350207|468650236|FG000|Overall Study|Lost to Follow-up|1|||
130189062|NCT00350207|468650237|FG001|Overall Study|Lost to Follow-up|0|||
130189063|NCT00350207|468650238|FG002|Overall Study|Lost to Follow-up|1|||
130189064|NCT00350207|468650236|FG000|Overall Study|Withdrawal by Subject|0|||
130189065|NCT00350207|468650237|FG001|Overall Study|Withdrawal by Subject|1|||
130189066|NCT00350207|468650238|FG002|Overall Study|Withdrawal by Subject|1|||
130189067|NCT00350207|468650236|FG000|Overall Study|Other|1|||
130189068|NCT00350207|468650237|FG001|Overall Study|Other|3|||
130189069|NCT00350207|468650238|FG002|Overall Study|Other|1|||
130189070|NCT00495391|468650239|FG000|Overall Study|Lack of Efficacy|34|||
130189071|NCT00495391|468650240|FG001|Overall Study|Lack of Efficacy|18|||
130189072|NCT00495391|468650239|FG000|Overall Study|Withdrawal by Subject|2|||
130189073|NCT00495391|468650240|FG001|Overall Study|Withdrawal by Subject|3|||
130189074|NCT04509076|468650249|FG000|Overall Study|Withdrawal by Subject|1|||
130189075|NCT04509076|468650250|FG001|Overall Study|Withdrawal by Subject|2|||
130189076|NCT04509076|468650249|FG000|Overall Study|Lost to Follow-up|1|||
130189077|NCT04509076|468650250|FG001|Overall Study|Lost to Follow-up|2|||
130189078|NCT00502242|468650255|FG000|Overall Study|Lack of Efficacy|1|||
130189079|NCT00502242|468650256|FG001|Overall Study|Lack of Efficacy|11|||
130189080|NCT00502242|468650255|FG000|Overall Study|Adverse Event|31|||
130189081|NCT00502242|468650256|FG001|Overall Study|Adverse Event|20|||
130189082|NCT00502242|468650255|FG000|Overall Study|Physician Decision|2|||
130189083|NCT00502242|468650256|FG001|Overall Study|Physician Decision|3|||
130189084|NCT00502242|468650255|FG000|Overall Study|Other - Unspecified|8|||
130189085|NCT00502242|468650256|FG001|Overall Study|Other - Unspecified|14|||
130189086|NCT00502242|468650255|FG000|Overall Study|Protocol Violation|3|||
130189087|NCT00502242|468650256|FG001|Overall Study|Protocol Violation|1|||
130189088|NCT00502242|468650255|FG000|Overall Study|Withdrawal by Subject|6|||
130189089|NCT00502242|468650256|FG001|Overall Study|Withdrawal by Subject|7|||
130189090|NCT01812109|468650257|FG000|Overall Study|research personnel delay|16|||
130189091|NCT01812109|468650257|FG000|Overall Study|NIRS Unattainable|17|||
130189092|NCT03313180|468650258|FG000|Overall Study|Adverse Event|120|||
130189093|NCT03313180|468650258|FG000|Overall Study|Lost to Follow-up|3|||
130189094|NCT03313180|468650258|FG000|Overall Study|Withdrawal by Subject|39|||
130189095|NCT03313180|468650258|FG000|Overall Study|Other than listed above|15|||
130189096|NCT03313180|468650258|FG000|Overall Study|Covid-19 related|2|||
130189097|NCT01966120|468650259|FG000|Overall Study|Withdrawal by Subject|0|||
130189098|NCT01966120|468650260|FG001|Overall Study|Withdrawal by Subject|5|||
130189099|NCT01966120|468650259|FG000|Overall Study|Lost to Follow-up|1|||
130189100|NCT01966120|468650260|FG001|Overall Study|Lost to Follow-up|1|||
130189101|NCT00461630|468650261|FG000|Overall Study|Death|798|||
130189102|NCT00461630|468650262|FG001|Overall Study|Death|732|||
130189103|NCT00461630|468650261|FG000|Overall Study|Lost to Follow-up|108|||
130189104|NCT00461630|468650262|FG001|Overall Study|Lost to Follow-up|95|||
130189105|NCT04630002|468650263|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130189106|NCT04630002|468650264|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189107|NCT04630002|468650265|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189108|NCT04630002|468650263|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
130189109|NCT04630002|468650264|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189110|NCT04630002|468650265|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189111|NCT04630002|468650263|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130189112|NCT04630002|468650264|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189113|NCT04630002|468650265|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189114|NCT04630002|468650263|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189115|NCT04630002|468650264|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130189116|NCT04630002|468650265|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189117|NCT04630002|468650263|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189118|NCT04630002|468650264|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
130189119|NCT04630002|468650265|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189120|NCT04630002|468650263|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189121|NCT04630002|468650264|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130189122|NCT04630002|468650265|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189123|NCT04630002|468650263|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130189124|NCT04630002|468650264|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130189125|NCT04630002|468650265|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
130189126|NCT04630002|468650263|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130189127|NCT04630002|468650264|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130189128|NCT04630002|468650265|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
130189129|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
130189130|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
130189131|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Death|0|||
130189132|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Death|1|||
130189133|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
130189134|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
130189135|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
130189136|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
130189137|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
130189138|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
130189139|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130189140|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130189141|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
130189142|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
130189143|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
130189144|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
130189145|NCT04498182|468650269|FG000|Overall Study|Adverse Event|2|||
130189146|NCT04498182|468650270|FG001|Overall Study|Adverse Event|3|||
130189147|NCT04498182|468650271|FG002|Overall Study|Adverse Event|2|||
130189148|NCT04498182|468650269|FG000|Overall Study|Withdrawal of Consent|3|||
130189149|NCT04498182|468650270|FG001|Overall Study|Withdrawal of Consent|4|||
130189150|NCT04498182|468650271|FG002|Overall Study|Withdrawal of Consent|3|||
130189151|NCT04498182|468650269|FG000|Overall Study|Non-Compliant|1|||
130189152|NCT04498182|468650270|FG001|Overall Study|Non-Compliant|0|||
130189153|NCT04498182|468650271|FG002|Overall Study|Non-Compliant|1|||
130189154|NCT04498182|468650269|FG000|Overall Study|Lost to Follow-up|0|||
130189155|NCT04498182|468650270|FG001|Overall Study|Lost to Follow-up|0|||
130189156|NCT04498182|468650271|FG002|Overall Study|Lost to Follow-up|1|||
130189157|NCT04498182|468650269|FG000|Overall Study|Investigator Decision|0|||
130189158|NCT04498182|468650270|FG001|Overall Study|Investigator Decision|0|||
130189159|NCT04498182|468650271|FG002|Overall Study|Investigator Decision|1|||
130189160|NCT04498182|468650269|FG000|Overall Study|Protocol Violation|1|||
130189161|NCT04498182|468650270|FG001|Overall Study|Protocol Violation|0|||
130189162|NCT04498182|468650271|FG002|Overall Study|Protocol Violation|2|||
130189163|NCT00891020|468650276|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
130189164|NCT00891020|468650277|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
130189165|NCT00891020|468650278|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
130189166|NCT00891020|468650276|FG000|24 Week Treatment Period|Death|0|||
130189167|NCT00891020|468650277|FG001|24 Week Treatment Period|Death|2|||
130189168|NCT00891020|468650278|FG002|24 Week Treatment Period|Death|0|||
130189169|NCT00891020|468650276|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
130189170|NCT00891020|468650277|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
130189171|NCT00891020|468650278|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
130189172|NCT00891020|468650276|FG000|24 Week Treatment Period|Failure to return|4|||
130189173|NCT00891020|468650277|FG001|24 Week Treatment Period|Failure to return|5|||
130189174|NCT00891020|468650278|FG002|24 Week Treatment Period|Failure to return|5|||
130189175|NCT00891020|468650276|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
130189176|NCT00891020|468650277|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
130189177|NCT00891020|468650278|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
130189178|NCT00891020|468650276|FG000|24 Week Treatment Period|Other protocol violation|1|||
130189179|NCT00891020|468650277|FG001|24 Week Treatment Period|Other protocol violation|1|||
130189180|NCT00891020|468650278|FG002|24 Week Treatment Period|Other protocol violation|2|||
130189181|NCT00891020|468650276|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
130189182|NCT00891020|468650277|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
130189183|NCT00891020|468650278|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
130189184|NCT00891020|468650276|FG000|24 Week Treatment Period|Withdrew consent|6|||
130189185|NCT00891020|468650277|FG001|24 Week Treatment Period|Withdrew consent|3|||
130189186|NCT00891020|468650278|FG002|24 Week Treatment Period|Withdrew consent|15|||
130189187|NCT00891020|468650276|FG000|24 Week Treatment Period|Administrative/Other|5|||
130189188|NCT00891020|468650277|FG001|24 Week Treatment Period|Administrative/Other|6|||
130189189|NCT00891020|468650278|FG002|24 Week Treatment Period|Administrative/Other|1|||
130189190|NCT00891020|468650276|FG000|Long-term Extension Period|Adverse Event|1|||
130189191|NCT00891020|468650277|FG001|Long-term Extension Period|Adverse Event|11|||
130189192|NCT00891020|468650278|FG002|Long-term Extension Period|Adverse Event|10|||
130189193|NCT00891020|468650276|FG000|Long-term Extension Period|Death|0|||
130189194|NCT00891020|468650277|FG001|Long-term Extension Period|Death|0|||
130189195|NCT00891020|468650278|FG002|Long-term Extension Period|Death|1|||
130189196|NCT00891020|468650276|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
130189197|NCT00891020|468650277|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
130189198|NCT00891020|468650278|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
130189199|NCT00891020|468650276|FG000|Long-term Extension Period|Protocol Violation|0|||
130189200|NCT00891020|468650277|FG001|Long-term Extension Period|Protocol Violation|1|||
130189201|NCT00891020|468650278|FG002|Long-term Extension Period|Protocol Violation|1|||
130189202|NCT00891020|468650276|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
130189203|NCT00891020|468650277|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
130189204|NCT00891020|468650278|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
130189205|NCT00891020|468650276|FG000|Long-term Extension Period|Failure to return|0|||
130189206|NCT00891020|468650277|FG001|Long-term Extension Period|Failure to return|2|||
130189207|NCT00891020|468650278|FG002|Long-term Extension Period|Failure to return|3|||
130189208|NCT00891020|468650276|FG000|Long-term Extension Period|Administrative|1|||
130189209|NCT00891020|468650277|FG001|Long-term Extension Period|Administrative|2|||
130189210|NCT00891020|468650278|FG002|Long-term Extension Period|Administrative|2|||
130189211|NCT00320710|468650286|FG000|Overall Study|Disease progression|24|||
130189212|NCT00320710|468650287|FG001|Overall Study|Disease progression|19|||
130189213|NCT00320710|468650288|FG002|Overall Study|Disease progression|2|||
130189214|NCT00320710|468650286|FG000|Overall Study|Death|10|||
130189215|NCT00320710|468650287|FG001|Overall Study|Death|7|||
130189216|NCT00320710|468650288|FG002|Overall Study|Death|1|||
130189217|NCT00320710|468650286|FG000|Overall Study|Administrative problems|1|||
130189218|NCT00320710|468650287|FG001|Overall Study|Administrative problems|2|||
130189219|NCT00320710|468650288|FG002|Overall Study|Administrative problems|0|||
130189220|NCT00320710|468650286|FG000|Overall Study|Withdrawal by Subject|20|||
130189221|NCT00320710|468650287|FG001|Overall Study|Withdrawal by Subject|26|||
130189222|NCT00320710|468650288|FG002|Overall Study|Withdrawal by Subject|1|||
130189223|NCT00320710|468650286|FG000|Overall Study|Protocol Violation|6|||
130189224|NCT00320710|468650287|FG001|Overall Study|Protocol Violation|5|||
130189225|NCT00320710|468650288|FG002|Overall Study|Protocol Violation|0|||
130189226|NCT00320710|468650286|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130189227|NCT00320710|468650287|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130189228|NCT00320710|468650288|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130189229|NCT00320710|468650286|FG000|Overall Study|Abnormal laboratory value(s)|12|||
130189230|NCT00320710|468650287|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130189231|NCT00320710|468650288|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130189232|NCT00320710|468650286|FG000|Overall Study|Adverse Event|18|||
130189233|NCT00320710|468650287|FG001|Overall Study|Adverse Event|14|||
130189234|NCT00320710|468650288|FG002|Overall Study|Adverse Event|1|||
130189235|NCT00320710|468650286|FG000|Overall Study|Lost to Follow-up|1|||
130189236|NCT00320710|468650287|FG001|Overall Study|Lost to Follow-up|0|||
130189237|NCT00320710|468650288|FG002|Overall Study|Lost to Follow-up|0|||
130189238|NCT03448419|468650289|FG000|Overall Study|Adverse Event|10|||
130189239|NCT03448419|468650290|FG001|Overall Study|Adverse Event|9|||
130189240|NCT03448419|468650289|FG000|Overall Study|Lost to Follow-up|0|||
130189241|NCT03448419|468650290|FG001|Overall Study|Lost to Follow-up|2|||
130189242|NCT03448419|468650289|FG000|Overall Study|Withdrawal by Subject|3|||
130189243|NCT03448419|468650290|FG001|Overall Study|Withdrawal by Subject|1|||
130189244|NCT03448419|468650289|FG000|Overall Study|Not treated|0|||
130189245|NCT03448419|468650290|FG001|Overall Study|Not treated|1|||
130189246|NCT03448419|468650289|FG000|Overall Study|Patient did not attend all visits|0|||
130189247|NCT03448419|468650290|FG001|Overall Study|Patient did not attend all visits|2|||
130189248|NCT03448419|468650289|FG000|Overall Study|Withdrawn by Sponsor|0|||
130189249|NCT03448419|468650290|FG001|Overall Study|Withdrawn by Sponsor|1|||
130189250|NCT02841995|468650291|FG000|Overall Study|Disease progression|5|||
130189251|NCT02841995|468650292|FG001|Overall Study|Disease progression|11|||
130189252|NCT02841995|468650293|FG002|Overall Study|Disease progression|8|||
130189253|NCT02841995|468650291|FG000|Overall Study|Withdrawal by Subject|2|||
130189254|NCT02841995|468650292|FG001|Overall Study|Withdrawal by Subject|4|||
130189255|NCT02841995|468650293|FG002|Overall Study|Withdrawal by Subject|4|||
130189256|NCT02841995|468650291|FG000|Overall Study|Adverse Event|2|||
130189257|NCT02841995|468650292|FG001|Overall Study|Adverse Event|0|||
130189258|NCT02841995|468650293|FG002|Overall Study|Adverse Event|1|||
130189259|NCT02841995|468650291|FG000|Overall Study|Investigator decision|2|||
130189260|NCT02841995|468650292|FG001|Overall Study|Investigator decision|0|||
130189261|NCT02841995|468650293|FG002|Overall Study|Investigator decision|1|||
130189262|NCT02841995|468650291|FG000|Overall Study|Death|0|||
130189263|NCT02841995|468650292|FG001|Overall Study|Death|0|||
130189264|NCT02841995|468650293|FG002|Overall Study|Death|2|||
130189265|NCT02841995|468650291|FG000|Overall Study|Noncompliance to protocol|1|||
130189266|NCT02841995|468650292|FG001|Overall Study|Noncompliance to protocol|0|||
130189267|NCT02841995|468650293|FG002|Overall Study|Noncompliance to protocol|0|||
130189268|NCT02841995|468650291|FG000|Overall Study|Sponsor decision|1|||
130189269|NCT02841995|468650292|FG001|Overall Study|Sponsor decision|0|||
130189270|NCT02841995|468650293|FG002|Overall Study|Sponsor decision|0|||
130189271|NCT02841995|468650291|FG000|Overall Study|Other|4|||
130189272|NCT02841995|468650292|FG001|Overall Study|Other|1|||
130189273|NCT02841995|468650293|FG002|Overall Study|Other|5|||
130189274|NCT01703260|468650294|FG000|Overall Study|Adverse Event|1|||
130189275|NCT01703260|468650295|FG001|Overall Study|Adverse Event|2|||
130189276|NCT01703260|468650296|FG002|Overall Study|Adverse Event|2|||
130189277|NCT01703260|468650294|FG000|Overall Study|Lost to Follow-up|1|||
130189278|NCT01703260|468650295|FG001|Overall Study|Lost to Follow-up|0|||
130189279|NCT01703260|468650296|FG002|Overall Study|Lost to Follow-up|0|||
130189280|NCT01703260|468650294|FG000|Overall Study|Withdrawal by Subject|0|||
130189281|NCT01703260|468650295|FG001|Overall Study|Withdrawal by Subject|0|||
130189282|NCT01703260|468650296|FG002|Overall Study|Withdrawal by Subject|1|||
130189283|NCT01703260|468650294|FG000|Overall Study|Study Termination|1|||
130189284|NCT01703260|468650295|FG001|Overall Study|Study Termination|2|||
130189285|NCT01703260|468650296|FG002|Overall Study|Study Termination|0|||
130189286|NCT04548193|468650300|FG000|Overall Study|Lost to Follow-up|0|||
130189287|NCT04548193|468650301|FG001|Overall Study|Lost to Follow-up|1|||
130189288|NCT04548193|468650300|FG000|Overall Study|Death|0|||
130189289|NCT04548193|468650301|FG001|Overall Study|Death|1|||
130189290|NCT04548193|468650300|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
130189291|NCT04548193|468650301|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
130189292|NCT04548193|468650300|FG000|Overall Study|Withdrawal by Subject|2|||
130189293|NCT04548193|468650301|FG001|Overall Study|Withdrawal by Subject|2|||
130189294|NCT00630825|468650302|FG000|Overall Study|Adverse Event|4|||
130189295|NCT00630825|468650303|FG001|Overall Study|Adverse Event|4|||
130189296|NCT00630825|468650304|FG002|Overall Study|Adverse Event|3|||
130189297|NCT00630825|468650305|FG003|Overall Study|Adverse Event|1|||
130189298|NCT00630825|468650302|FG000|Overall Study|Entry Criteria Not Met|1|||
130189299|NCT00630825|468650303|FG001|Overall Study|Entry Criteria Not Met|0|||
130189300|NCT00630825|468650304|FG002|Overall Study|Entry Criteria Not Met|2|||
130189301|NCT00630825|468650305|FG003|Overall Study|Entry Criteria Not Met|1|||
130189302|NCT00630825|468650302|FG000|Overall Study|Lost to Follow-up|1|||
130189303|NCT00630825|468650303|FG001|Overall Study|Lost to Follow-up|1|||
130189304|NCT00630825|468650304|FG002|Overall Study|Lost to Follow-up|1|||
130189305|NCT00630825|468650305|FG003|Overall Study|Lost to Follow-up|1|||
130189306|NCT00630825|468650302|FG000|Overall Study|Physician Decision|1|||
130189307|NCT00630825|468650303|FG001|Overall Study|Physician Decision|0|||
130189308|NCT00630825|468650304|FG002|Overall Study|Physician Decision|0|||
130189309|NCT00630825|468650305|FG003|Overall Study|Physician Decision|0|||
130189310|NCT00630825|468650302|FG000|Overall Study|Withdrawal by Subject|2|||
130189311|NCT00630825|468650303|FG001|Overall Study|Withdrawal by Subject|2|||
130189312|NCT00630825|468650304|FG002|Overall Study|Withdrawal by Subject|2|||
130189313|NCT00630825|468650305|FG003|Overall Study|Withdrawal by Subject|3|||
130189314|NCT02275819|468650306|FG000|Overall Study|Adverse Event|0|||
130189315|NCT02275819|468650307|FG001|Overall Study|Adverse Event|1|||
130189316|NCT02211209|468650311|FG000|Overall Study|Investigator judgment|0|||
130189317|NCT02211209|468650312|FG001|Overall Study|Investigator judgment|1|||
130189318|NCT02211209|468650311|FG000|Overall Study|Voluntary withdrawal|1|||
130189319|NCT02211209|468650312|FG001|Overall Study|Voluntary withdrawal|4|||
130189320|NCT02211209|468650311|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130189321|NCT02211209|468650312|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
130189322|NCT02211209|468650311|FG000|Overall Study|Reason Not Specified|1|||
130189323|NCT02211209|468650312|FG001|Overall Study|Reason Not Specified|0|||
130189324|NCT02792062|468650315|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
130189325|NCT02792062|468650316|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189326|NCT02792062|468650317|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189327|NCT02792062|468650318|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189328|NCT02792062|468650319|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189329|NCT02792062|468650320|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189330|NCT00931255|468650323|FG000|Overall Study|Follow up biopsy not done|2|||
130189331|NCT00931255|468650324|FG001|Overall Study|Follow up biopsy not done|3|||
130189332|NCT01681212|468650330|FG000|Overall Study|No longer met study criteria|5|||
130189333|NCT01681212|468650330|FG000|Overall Study|Administrative reason by sponsor|1|||
130189334|NCT02220764|468650333|FG000|Overall Study|Lost to Follow-up|3|||
130189335|NCT02220764|468650334|FG001|Overall Study|Lost to Follow-up|1|||
130189336|NCT02220764|468650333|FG000|Overall Study|Death|1|||
130189337|NCT02220764|468650334|FG001|Overall Study|Death|0|||
130189338|NCT02198664|468650335|FG000|Overall Study|Adverse Event|2|||
130189339|NCT02198664|468650336|FG001|Overall Study|Adverse Event|0|||
130189340|NCT02198664|468650335|FG000|Overall Study|Withdrawal by Subject|11|||
130189341|NCT02198664|468650336|FG001|Overall Study|Withdrawal by Subject|8|||
130189342|NCT02198664|468650335|FG000|Overall Study|Failure to tolerate|2|||
130189343|NCT02198664|468650336|FG001|Overall Study|Failure to tolerate|0|||
130189344|NCT02198664|468650335|FG000|Overall Study|Not stated|1|||
130189345|NCT02198664|468650336|FG001|Overall Study|Not stated|0|||
130189346|NCT03859427|468650340|FG000|Overall Study|Withdrawal by Subject|4|||
130189347|NCT03859427|468650341|FG001|Overall Study|Withdrawal by Subject|7|||
130189348|NCT03859427|468650340|FG000|Overall Study|Decision by sponsor|0|||
130189349|NCT03859427|468650341|FG001|Overall Study|Decision by sponsor|3|||
130189350|NCT03859427|468650340|FG000|Overall Study|Lost to Follow-up|3|||
130189351|NCT03859427|468650341|FG001|Overall Study|Lost to Follow-up|2|||
130189352|NCT03859427|468650340|FG000|Overall Study|Death|22|||
130189353|NCT03859427|468650341|FG001|Overall Study|Death|25|||
130189354|NCT02503540|468650342|FG000|Overall Study|Death|2|||
130189355|NCT02503540|468650342|FG000|Overall Study|Withdrawal by Subject|1|||
130189356|NCT01662492|468650343|FG000|Overall Study|Other miscellaneous reasons.|1|||
130189357|NCT01662492|468650344|FG001|Overall Study|Other miscellaneous reasons.|0|||
130189358|NCT01662492|468650345|FG002|Overall Study|Other miscellaneous reasons.|1|||
130189359|NCT01662492|468650343|FG000|Overall Study|Withdrawal by Subject|0|||
130189360|NCT01662492|468650344|FG001|Overall Study|Withdrawal by Subject|0|||
130189361|NCT01662492|468650345|FG002|Overall Study|Withdrawal by Subject|1|||
130189362|NCT01662492|468650343|FG000|Overall Study|Protocol Violation|1|||
130189363|NCT01662492|468650344|FG001|Overall Study|Protocol Violation|0|||
130189364|NCT01662492|468650345|FG002|Overall Study|Protocol Violation|0|||
130189365|NCT01662492|468650343|FG000|Overall Study|Lost to Follow-up|0|||
130189366|NCT01662492|468650344|FG001|Overall Study|Lost to Follow-up|0|||
130189367|NCT01662492|468650345|FG002|Overall Study|Lost to Follow-up|2|||
130189368|NCT01662492|468650343|FG000|Overall Study|Lack of Efficacy|1|||
130189369|NCT01662492|468650344|FG001|Overall Study|Lack of Efficacy|1|||
130189370|NCT01662492|468650345|FG002|Overall Study|Lack of Efficacy|2|||
130189371|NCT02418182|468650350|FG000|Overall Study|Unable to re-consent|18|||
130189372|NCT02418182|468650351|FG001|Overall Study|Unable to re-consent|15|||
130189373|NCT02418182|468650350|FG000|Overall Study|Lost to Follow-up|0|||
130189374|NCT02418182|468650351|FG001|Overall Study|Lost to Follow-up|2|||
130189375|NCT00570687|468652060|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189376|NCT00570687|468652061|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189377|NCT00570687|468652062|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189378|NCT00570687|468652063|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189379|NCT00570687|468652064|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189380|NCT00570687|468652065|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189381|NCT00570687|468652066|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130189382|NCT00570687|468652067|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189383|NCT00570687|468652068|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130189384|NCT00570687|468652069|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189385|NCT00570687|468652060|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189386|NCT00570687|468652061|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189387|NCT00570687|468652062|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189388|NCT00570687|468652063|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189389|NCT00570687|468652064|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189390|NCT00570687|468652065|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189391|NCT00570687|468652066|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189392|NCT00570687|468652067|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189393|NCT00570687|468652068|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130189394|NCT00570687|468652069|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189395|NCT00570687|468652060|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189396|NCT00570687|468652061|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189397|NCT00570687|468652062|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189398|NCT00570687|468652063|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189399|NCT00570687|468652064|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189400|NCT00570687|468652065|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189401|NCT00570687|468652066|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130189402|NCT00570687|468652067|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189403|NCT00570687|468652068|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189404|NCT00570687|468652069|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189405|NCT01102257|468652077|FG000|Overall Study|Adverse Event|1|||
130189406|NCT01102257|468652078|FG001|Overall Study|Adverse Event|0|||
130189407|NCT01102257|468652077|FG000|Overall Study|Adverse Event|1|||
130189408|NCT01102257|468652078|FG001|Overall Study|Adverse Event|0|||
130189409|NCT04003636|468652079|FG000|Overall Study|Death|409|||
130189410|NCT04003636|468652080|FG001|Overall Study|Death|443|||
130189411|NCT04003636|468652079|FG000|Overall Study|Lost to Follow-up|0|||
130189412|NCT04003636|468652080|FG001|Overall Study|Lost to Follow-up|1|||
130189413|NCT04003636|468652079|FG000|Overall Study|Withdrawal by Subject|5|||
130189414|NCT04003636|468652080|FG001|Overall Study|Withdrawal by Subject|2|||
130189415|NCT04003636|468652079|FG000|Overall Study|Participant On-going|119|||
130189416|NCT04003636|468652080|FG001|Overall Study|Participant On-going|90|||
130189417|NCT03048747|468652081|FG000|Overall Study|Adverse Event|2|||
130189418|NCT03048747|468652081|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
130189419|NCT03048747|468652081|FG000|Overall Study|Physician Decision|1|||
130189420|NCT03270657|468652083|FG000|Overall Study|Withdrawal by Subject|1|||
130189421|NCT00162981|468652084|FG000|Overall Study|Adverse Event|2|||
130189422|NCT00162981|468652085|FG001|Overall Study|Adverse Event|5|||
130189423|NCT00162981|468652084|FG000|Overall Study|Withdrawal by Subject|1|||
130189424|NCT00162981|468652085|FG001|Overall Study|Withdrawal by Subject|1|||
130189425|NCT00162981|468652084|FG000|Overall Study|Physician Decision|1|||
130189426|NCT00162981|468652085|FG001|Overall Study|Physician Decision|0|||
130189427|NCT02588612|468652093|FG000|Overall Study|Physician Decision|1|||
130189428|NCT02588612|468652093|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
130189429|NCT02588612|468652093|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
130189430|NCT02588612|468652093|FG000|Overall Study|Death prior to T-cell infusion|1|||
130189431|NCT03809663|468652094|FG000|Overall Study|Decision by sponsor|24|||
130189432|NCT03809663|468652095|FG001|Overall Study|Decision by sponsor|18|||
130189433|NCT03809663|468652096|FG002|Overall Study|Decision by sponsor|20|||
130189434|NCT03809663|468652097|FG003|Overall Study|Decision by sponsor|20|||
130189435|NCT03809663|468652098|FG004|Overall Study|Decision by sponsor|0|||
130189436|NCT03809663|468652099|FG005|Overall Study|Decision by sponsor|0|||
130189437|NCT03809663|468652094|FG000|Overall Study|Withdrawal by Subject|26|||
130189438|NCT03809663|468652095|FG001|Overall Study|Withdrawal by Subject|22|||
130189439|NCT03809663|468652096|FG002|Overall Study|Withdrawal by Subject|27|||
130189440|NCT03809663|468652097|FG003|Overall Study|Withdrawal by Subject|26|||
130189441|NCT03809663|468652098|FG004|Overall Study|Withdrawal by Subject|0|||
130189442|NCT03809663|468652099|FG005|Overall Study|Withdrawal by Subject|0|||
130189443|NCT03809663|468652094|FG000|Overall Study|Lost to Follow-up|1|||
130189444|NCT03809663|468652095|FG001|Overall Study|Lost to Follow-up|4|||
130189445|NCT03809663|468652096|FG002|Overall Study|Lost to Follow-up|1|||
130189446|NCT03809663|468652097|FG003|Overall Study|Lost to Follow-up|1|||
130189447|NCT03809663|468652098|FG004|Overall Study|Lost to Follow-up|0|||
130189448|NCT03809663|468652099|FG005|Overall Study|Lost to Follow-up|0|||
130189449|NCT02042014|468652100|FG000|Overall Study|Adverse Event|1|||
130189450|NCT02042014|468652100|FG000|Overall Study|Physician Decision|7|||
130189451|NCT03309943|468652101|FG000|Overall Study|Withdrawal by Subject|0|||
130189452|NCT03309943|468652102|FG001|Overall Study|Withdrawal by Subject|1|||
130189453|NCT03309943|468652101|FG000|Overall Study|Inappropriate behavior towards staff|0|||
130189454|NCT03309943|468652102|FG001|Overall Study|Inappropriate behavior towards staff|1|||
130189455|NCT01372995|468652103|FG000|Overall Study|Spouse withdrew participant from study|0|||
130189456|NCT01372995|468652104|FG001|Overall Study|Spouse withdrew participant from study|1|||
130189457|NCT01372995|468652105|FG002|Overall Study|Spouse withdrew participant from study|0|||
130189458|NCT01372995|468652103|FG000|Overall Study|Physician Decision|0|||
130189459|NCT01372995|468652104|FG001|Overall Study|Physician Decision|0|||
130189460|NCT01372995|468652105|FG002|Overall Study|Physician Decision|1|||
130189461|NCT03123393|468652109|FG000|Overall Study|Study Terminated by Sponsor|6|||
130189462|NCT03123393|468652110|FG001|Overall Study|Study Terminated by Sponsor|9|||
130189463|NCT03123393|468652109|FG000|Overall Study|Withdrawal by Subject|2|||
130189464|NCT03123393|468652110|FG001|Overall Study|Withdrawal by Subject|1|||
130189465|NCT03123393|468652109|FG000|Overall Study|Reason not Specified|13|||
130189466|NCT03123393|468652110|FG001|Overall Study|Reason not Specified|13|||
130189467|NCT00558701|468652111|FG000|Overall Study|Protocol Deviations|1|||
130189468|NCT00558701|468652112|FG001|Overall Study|Protocol Deviations|4|||
130189469|NCT00427648|468652113|FG000|Overall Study|Protocol Violation|1|||
130189470|NCT00427648|468652114|FG001|Overall Study|Protocol Violation|2|||
130189471|NCT00427648|468652113|FG000|Overall Study|Adverse Event|0|||
130189472|NCT00427648|468652114|FG001|Overall Study|Adverse Event|1|||
130189473|NCT00105079|468652115|FG000|Overall Study|Adverse Event|5|||
130189474|NCT00105079|468652116|FG001|Overall Study|Adverse Event|12|||
130189475|NCT00105079|468652115|FG000|Overall Study|Death|3|||
130189476|NCT00105079|468652116|FG001|Overall Study|Death|1|||
130189477|NCT00105079|468652115|FG000|Overall Study|Lost to Follow-up|12|||
130189478|NCT00105079|468652116|FG001|Overall Study|Lost to Follow-up|12|||
130189479|NCT00105079|468652115|FG000|Overall Study|Lack of Efficacy|9|||
130189480|NCT00105079|468652116|FG001|Overall Study|Lack of Efficacy|3|||
130189481|NCT00105079|468652115|FG000|Overall Study|Refused treatment|6|||
130189482|NCT00105079|468652116|FG001|Overall Study|Refused treatment|4|||
130189483|NCT00105079|468652115|FG000|Overall Study|Violation of selection criteria at entry|0|||
130189484|NCT00105079|468652116|FG001|Overall Study|Violation of selection criteria at entry|2|||
130189485|NCT00105079|468652115|FG000|Overall Study|Protocol Violation|1|||
130189486|NCT00105079|468652116|FG001|Overall Study|Protocol Violation|0|||
130189487|NCT00105079|468652115|FG000|Overall Study|Other|3|||
130189488|NCT00105079|468652116|FG001|Overall Study|Other|1|||
130189489|NCT01609296|468652117|FG000|Overall Study|Death|253|||
130189490|NCT01609296|468652117|FG000|Overall Study|Withdrawal by Subject|151|||
130189491|NCT01609296|468652117|FG000|Overall Study|Lost to Follow-up|21|||
130189492|NCT01609296|468652117|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
130189493|NCT01609296|468652117|FG000|Overall Study|missed visit but known to be alive|28|||
130189494|NCT00386360|468652118|FG000|Overall Study|Adverse Event|4|||
130189495|NCT00386360|468652119|FG001|Overall Study|Adverse Event|2|||
130189496|NCT00386360|468652118|FG000|Overall Study|Physician Decision|2|||
130189497|NCT00386360|468652119|FG001|Overall Study|Physician Decision|2|||
130189498|NCT00386360|468652118|FG000|Overall Study|Lost to Follow-up|0|||
130189499|NCT00386360|468652119|FG001|Overall Study|Lost to Follow-up|2|||
130189500|NCT00386360|468652118|FG000|Overall Study|Protocol Violation|0|||
130189501|NCT00386360|468652119|FG001|Overall Study|Protocol Violation|3|||
130189502|NCT00386360|468652118|FG000|Overall Study|Withdrawal by Subject|3|||
130189503|NCT00386360|468652119|FG001|Overall Study|Withdrawal by Subject|6|||
130189504|NCT00386360|468652118|FG000|Overall Study|Did not take any study medication|0|||
130189505|NCT00386360|468652119|FG001|Overall Study|Did not take any study medication|2|||
130189506|NCT02230904|468652122|FG000|Overall Study|Safety follow up could not take place|0|||
130189507|NCT02230904|468652123|FG001|Overall Study|Safety follow up could not take place|1|||
130189508|NCT01464424|468652124|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
130189509|NCT01464424|468652125|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
130189510|NCT01464333|468652127|FG000|Overall Study|Adverse Event|34|||
130189511|NCT01464333|468652127|FG000|Overall Study|Lack of Efficacy|72|||
130189512|NCT01464333|468652127|FG000|Overall Study|Withdrawal by Subject|11|||
130189513|NCT01464333|468652127|FG000|Overall Study|Other|4|||
130189514|NCT01464333|468652127|FG000|Overall Study|No Hospital Visit|42|||
130189515|NCT02187198|468652130|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
130189516|NCT02187198|468652131|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
130189517|NCT02187198|468652130|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
130189518|NCT02187198|468652131|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
130189519|NCT01532518|468652132|FG000|Overall Study|Withdrawal by Subject|0|||
130189520|NCT01532518|468652133|FG001|Overall Study|Withdrawal by Subject|0|||
130189521|NCT01532518|468652134|FG002|Overall Study|Withdrawal by Subject|1|||
130189522|NCT01575834|468652135|FG000|Overall Study|Withdrawal by Subject|352|||
130189523|NCT01575834|468652136|FG001|Overall Study|Withdrawal by Subject|390|||
130189524|NCT01575834|468652135|FG000|Overall Study|Death|81|||
130189525|NCT01575834|468652136|FG001|Overall Study|Death|74|||
130189526|NCT01575834|468652135|FG000|Overall Study|Other|70|||
130189527|NCT01575834|468652136|FG001|Overall Study|Other|70|||
130189528|NCT01575834|468652135|FG000|Overall Study|Adverse Event|63|||
130189529|NCT01575834|468652136|FG001|Overall Study|Adverse Event|61|||
130189530|NCT01575834|468652135|FG000|Overall Study|Lost to Follow-up|55|||
130189531|NCT01575834|468652136|FG001|Overall Study|Lost to Follow-up|68|||
130189532|NCT01575834|468652135|FG000|Overall Study|Noncompliance|52|||
130189533|NCT01575834|468652136|FG001|Overall Study|Noncompliance|27|||
130189534|NCT01575834|468652135|FG000|Overall Study|Administrative decision|15|||
130189535|NCT01575834|468652136|FG001|Overall Study|Administrative decision|33|||
130189536|NCT01575834|468652135|FG000|Overall Study|Ineligibility Determined|5|||
130189537|NCT01575834|468652136|FG001|Overall Study|Ineligibility Determined|8|||
130189538|NCT01575834|468652135|FG000|Overall Study|Protocol Deviation|4|||
130189539|NCT01575834|468652136|FG001|Overall Study|Protocol Deviation|3|||
130189540|NCT01575834|468652135|FG000|Overall Study|Requirement for Alternative Therapy|2|||
130189541|NCT01575834|468652136|FG001|Overall Study|Requirement for Alternative Therapy|4|||
130189542|NCT02155283|468652138|FG000|Overall Study|Lost to Follow-up|3|||
130189543|NCT02155283|468652138|FG000|Overall Study|Withdrawal by Subject|1|||
130189544|NCT02155283|468652138|FG000|Overall Study|Protocol Violation|3|||
130189545|NCT02282813|468652140|FG000|Overall Study|Withdrawal by Subject|4|||
130189546|NCT02282813|468652141|FG001|Overall Study|Withdrawal by Subject|5|||
130189547|NCT02282813|468652142|FG002|Overall Study|Withdrawal by Subject|0|||
130189548|NCT02282813|468652140|FG000|Overall Study|Adverse Event|3|||
130189549|NCT02282813|468652141|FG001|Overall Study|Adverse Event|10|||
130189550|NCT02282813|468652142|FG002|Overall Study|Adverse Event|1|||
130189551|NCT02282813|468652140|FG000|Overall Study|Subject non-compliance|1|||
130189552|NCT02282813|468652141|FG001|Overall Study|Subject non-compliance|4|||
130189553|NCT02282813|468652142|FG002|Overall Study|Subject non-compliance|0|||
130189554|NCT02282813|468652140|FG000|Overall Study|Physician Decision|0|||
130189555|NCT02282813|468652141|FG001|Overall Study|Physician Decision|3|||
130189556|NCT02282813|468652142|FG002|Overall Study|Physician Decision|1|||
130189557|NCT02282813|468652140|FG000|Overall Study|Lost to Follow-up|2|||
130189558|NCT02282813|468652141|FG001|Overall Study|Lost to Follow-up|0|||
130189559|NCT02282813|468652142|FG002|Overall Study|Lost to Follow-up|1|||
130189560|NCT02282813|468652140|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
130189561|NCT02282813|468652141|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130189562|NCT02282813|468652142|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130189563|NCT02282813|468652140|FG000|Overall Study|Lack of Efficacy|1|||
130189564|NCT02282813|468652141|FG001|Overall Study|Lack of Efficacy|0|||
130189565|NCT02282813|468652142|FG002|Overall Study|Lack of Efficacy|0|||
130189566|NCT02282813|468652140|FG000|Overall Study|Administrative reasons|0|||
130189567|NCT02282813|468652141|FG001|Overall Study|Administrative reasons|1|||
130189568|NCT02282813|468652142|FG002|Overall Study|Administrative reasons|0|||
130189569|NCT05000164|468652147|FG000|Overall Study|Adverse Event|1|||
130189570|NCT05000164|468652147|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130189571|NCT05000164|468652147|FG000|Overall Study|Lens Discomfort|3|||
130189572|NCT05000164|468652147|FG000|Overall Study|Withdrew Consent during Study|2|||
130189573|NCT05000164|468652147|FG000|Overall Study|Subject Withdrawn by PI|2|||
130189574|NCT05000164|468652147|FG000|Overall Study|Other Fractured Test Article|1|||
130189575|NCT06509438|468652153|FG000|Overall Study|Adverse Event|1|||
130189576|NCT06509438|468652153|FG000|Overall Study|Lost to Follow-up|3|||
130189577|NCT03331796|468652154|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
130189578|NCT03331796|468652155|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130189579|NCT03331796|468652156|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130189580|NCT03331796|468652154|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130189581|NCT03331796|468652155|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130189582|NCT03331796|468652156|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
130189583|NCT03331796|468652154|FG000|Extended Follow-up|Adverse Event|1|||
130189584|NCT03331796|468652155|FG001|Extended Follow-up|Adverse Event|0|||
130189585|NCT03331796|468652156|FG002|Extended Follow-up|Adverse Event|1|||
130189586|NCT03331796|468652154|FG000|Extended Follow-up|Lost to Follow-up|0|||
130189587|NCT03331796|468652155|FG001|Extended Follow-up|Lost to Follow-up|0|||
130189588|NCT03331796|468652156|FG002|Extended Follow-up|Lost to Follow-up|1|||
130189589|NCT03331796|468652154|FG000|Extended Follow-up|Withdrawal by Subject|1|||
130189590|NCT03331796|468652155|FG001|Extended Follow-up|Withdrawal by Subject|0|||
130189591|NCT03331796|468652156|FG002|Extended Follow-up|Withdrawal by Subject|0|||
130189592|NCT03331796|468652154|FG000|Extended Follow-up|Termination of Funding|0|||
130189593|NCT03331796|468652155|FG001|Extended Follow-up|Termination of Funding|1|||
130189594|NCT03331796|468652156|FG002|Extended Follow-up|Termination of Funding|0|||
130189595|NCT01753570|468652157|FG000|Overall Study|Adverse Event|1|||
130189596|NCT01753570|468652158|FG001|Overall Study|Adverse Event|0|||
130189597|NCT01753570|468652159|FG002|Overall Study|Adverse Event|1|||
130189598|NCT01753570|468652157|FG000|Overall Study|Physician Decision|0|||
130189599|NCT01753570|468652158|FG001|Overall Study|Physician Decision|1|||
130189600|NCT01753570|468652159|FG002|Overall Study|Physician Decision|0|||
130189601|NCT01753570|468652157|FG000|Overall Study|Withdrawal by Subject|1|||
130189602|NCT01753570|468652158|FG001|Overall Study|Withdrawal by Subject|4|||
130189603|NCT01753570|468652159|FG002|Overall Study|Withdrawal by Subject|0|||
130189604|NCT01000155|468652160|FG000|Overall Study|Withdrawal by Subject|1|||
130189605|NCT01000155|468652160|FG000|Overall Study|Adverse Event|1|||
130189606|NCT00720213|468652163|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
130189607|NCT00720213|468652164|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130189608|NCT00720213|468652165|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130189609|NCT01808066|468652168|FG000|Overall Study|Withdrawal by Subject|15|||
130189610|NCT01252095|468652170|FG000|Overall Study|Disease progression|1|||
130189611|NCT01252095|468652171|FG001|Overall Study|Disease progression|0|||
130189612|NCT01420068|468652172|FG000|Overall Study|Administrative problems|1|||
130189613|NCT01420068|468652173|FG001|Overall Study|Administrative problems|3|||
130189614|NCT01420068|468652172|FG000|Overall Study|Withdrawal by Subject|1|||
130189615|NCT01420068|468652173|FG001|Overall Study|Withdrawal by Subject|2|||
130189616|NCT02554682|468652174|FG000|Overall Study|Lost to Follow-up|11|||
130189617|NCT02554682|468652175|FG001|Overall Study|Lost to Follow-up|9|||
130189618|NCT02554682|468652176|FG002|Overall Study|Lost to Follow-up|4|||
130189619|NCT02554682|468652177|FG003|Overall Study|Lost to Follow-up|3|||
130189620|NCT02554682|468652178|FG004|Overall Study|Lost to Follow-up|2|||
130189621|NCT02554682|468652179|FG005|Overall Study|Lost to Follow-up|1|||
130189622|NCT02554682|468652180|FG006|Overall Study|Lost to Follow-up|6|||
130189623|NCT02554682|468652181|FG007|Overall Study|Lost to Follow-up|6|||
130189624|NCT02554682|468652182|FG008|Overall Study|Lost to Follow-up|2|||
130189625|NCT02554682|468652183|FG009|Overall Study|Lost to Follow-up|2|||
130189626|NCT02554682|468652174|FG000|Overall Study|Withdrawal by Subject|2|||
130189627|NCT02554682|468652175|FG001|Overall Study|Withdrawal by Subject|1|||
130189628|NCT02554682|468652176|FG002|Overall Study|Withdrawal by Subject|0|||
130189629|NCT02554682|468652177|FG003|Overall Study|Withdrawal by Subject|0|||
130189630|NCT02554682|468652178|FG004|Overall Study|Withdrawal by Subject|0|||
130189631|NCT02554682|468652179|FG005|Overall Study|Withdrawal by Subject|0|||
130189632|NCT02554682|468652180|FG006|Overall Study|Withdrawal by Subject|0|||
130189633|NCT02554682|468652181|FG007|Overall Study|Withdrawal by Subject|0|||
130189634|NCT02554682|468652182|FG008|Overall Study|Withdrawal by Subject|0|||
130189635|NCT02554682|468652183|FG009|Overall Study|Withdrawal by Subject|0|||
130189636|NCT02554682|468652174|FG000|Overall Study|Physician Decision|2|||
130189637|NCT02554682|468652175|FG001|Overall Study|Physician Decision|2|||
130189638|NCT02554682|468652176|FG002|Overall Study|Physician Decision|0|||
130189639|NCT02554682|468652177|FG003|Overall Study|Physician Decision|0|||
130189640|NCT02554682|468652178|FG004|Overall Study|Physician Decision|0|||
130189641|NCT02554682|468652179|FG005|Overall Study|Physician Decision|0|||
130189642|NCT02554682|468652180|FG006|Overall Study|Physician Decision|0|||
130189643|NCT02554682|468652181|FG007|Overall Study|Physician Decision|0|||
130189644|NCT02554682|468652182|FG008|Overall Study|Physician Decision|0|||
130189645|NCT02554682|468652183|FG009|Overall Study|Physician Decision|0|||
130189646|NCT00884117|468652186|FG000|Overall Study|Adverse Event|2|||
130189647|NCT00884117|468652186|FG000|Overall Study|Withdrawal by Subject|89|||
130189648|NCT00884117|468652186|FG000|Overall Study|Death|3|||
130189649|NCT00884117|468652186|FG000|Overall Study|Lost to Follow-up|143|||
130189650|NCT00884117|468652186|FG000|Overall Study|Other|12|||
130189651|NCT04830969|468652189|FG000|Overall Study|Withdrawal by Subject|6|||
130189652|NCT04830969|468652190|FG001|Overall Study|Withdrawal by Subject|2|||
130189653|NCT04830969|468652189|FG000|Overall Study|Protocol Violation|3|||
130189654|NCT04830969|468652190|FG001|Overall Study|Protocol Violation|9|||
130189655|NCT04830969|468652189|FG000|Overall Study|Lost to Follow-up|4|||
130189656|NCT04830969|468652190|FG001|Overall Study|Lost to Follow-up|4|||
130189657|NCT01153815|468652195|FG000|Overall Study|Adverse Event|3|||
130189658|NCT01153815|468652196|FG001|Overall Study|Adverse Event|1|||
130189659|NCT01153815|468652195|FG000|Overall Study|Withdrawal by Subject|6|||
130189660|NCT01153815|468652196|FG001|Overall Study|Withdrawal by Subject|4|||
130189661|NCT01786993|468652197|FG000|Overall Study|Death|6|||
130189662|NCT01786993|468652198|FG001|Overall Study|Death|7|||
130189663|NCT01786993|468652197|FG000|Overall Study|Withdrawal by Subject|3|||
130189664|NCT01786993|468652198|FG001|Overall Study|Withdrawal by Subject|2|||
130189665|NCT01786993|468652197|FG000|Overall Study|Lost to Follow-up|0|||
130189666|NCT01786993|468652198|FG001|Overall Study|Lost to Follow-up|1|||
130189667|NCT01786993|468652197|FG000|Overall Study|Subject Non-Compliance|1|||
130189668|NCT01786993|468652198|FG001|Overall Study|Subject Non-Compliance|0|||
130189669|NCT01786993|468652197|FG000|Overall Study|System Explant|1|||
130189670|NCT01786993|468652198|FG001|Overall Study|System Explant|0|||
130189671|NCT01786993|468652197|FG000|Overall Study|Hospice Admission|1|||
130189672|NCT01786993|468652198|FG001|Overall Study|Hospice Admission|0|||
130189673|NCT01890122|468652199|FG000|Overall Study|Adverse Event|1|||
130189674|NCT01890122|468652200|FG001|Overall Study|Adverse Event|1|||
130189675|NCT01890122|468652201|FG002|Overall Study|Adverse Event|1|||
130189676|NCT01890122|468652202|FG003|Overall Study|Adverse Event|2|||
130189677|NCT01890122|468652199|FG000|Overall Study|Major Protocol Deviation|3|||
130189678|NCT01890122|468652200|FG001|Overall Study|Major Protocol Deviation|1|||
130189679|NCT01890122|468652201|FG002|Overall Study|Major Protocol Deviation|0|||
130189680|NCT01890122|468652202|FG003|Overall Study|Major Protocol Deviation|1|||
130189681|NCT01890122|468652199|FG000|Overall Study|Lost to Follow-up|0|||
130189682|NCT01890122|468652200|FG001|Overall Study|Lost to Follow-up|1|||
130189683|NCT01890122|468652201|FG002|Overall Study|Lost to Follow-up|2|||
130189684|NCT01890122|468652202|FG003|Overall Study|Lost to Follow-up|2|||
130189685|NCT01890122|468652199|FG000|Overall Study|Voluntary Withdrawal|8|||
130189686|NCT01890122|468652200|FG001|Overall Study|Voluntary Withdrawal|8|||
130189687|NCT01890122|468652201|FG002|Overall Study|Voluntary Withdrawal|2|||
130189688|NCT01890122|468652202|FG003|Overall Study|Voluntary Withdrawal|11|||
130189689|NCT01890122|468652199|FG000|Overall Study|Lack of Efficacy|14|||
130189690|NCT01890122|468652200|FG001|Overall Study|Lack of Efficacy|24|||
130189691|NCT01890122|468652201|FG002|Overall Study|Lack of Efficacy|7|||
130189692|NCT01890122|468652202|FG003|Overall Study|Lack of Efficacy|41|||
130189693|NCT01890122|468652199|FG000|Overall Study|Reason not Specified|0|||
130189694|NCT01890122|468652200|FG001|Overall Study|Reason not Specified|1|||
130189695|NCT01890122|468652201|FG002|Overall Study|Reason not Specified|1|||
130189696|NCT01890122|468652202|FG003|Overall Study|Reason not Specified|2|||
130189697|NCT01890122|468652199|FG000|Overall Study|Randomized but not Treated|1|||
130189698|NCT01890122|468652200|FG001|Overall Study|Randomized but not Treated|1|||
130189699|NCT01890122|468652201|FG002|Overall Study|Randomized but not Treated|0|||
130189700|NCT01890122|468652202|FG003|Overall Study|Randomized but not Treated|0|||
130189701|NCT02505217|468652206|FG000|Overall Study|Withdrawal by Subject|1|||
130189702|NCT02505217|468652207|FG001|Overall Study|Withdrawal by Subject|2|||
130189703|NCT00153179|468652217|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
130189704|NCT00153179|468652218|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
130189705|NCT00153179|468652219|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
130189706|NCT00153179|468652220|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
130189707|NCT04495829|468652221|FG000|Overall Study|Lost to Follow-up|2|||
130189708|NCT04495829|468652221|FG000|Overall Study|Inclusion criterion not met|3|||
130189709|NCT02712554|468652224|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
130189710|NCT02712554|468652225|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
130189711|NCT02712554|468652224|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
130189712|NCT02712554|468652225|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
130189713|NCT02712554|468652224|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
130189714|NCT02712554|468652225|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
130189715|NCT02712554|468652224|FG000|Part B: Qualification Phase|Adverse Event|0|||
130189716|NCT02712554|468652225|FG001|Part B: Qualification Phase|Adverse Event|1|||
130189717|NCT02712554|468652224|FG000|Part B: Treatment Phase|Adverse Event|0|||
130189718|NCT02712554|468652225|FG001|Part B: Treatment Phase|Adverse Event|1|||
130189719|NCT02712554|468652224|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
130189720|NCT02712554|468652225|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
130189721|NCT02712554|468652224|FG000|Part B: Treatment Phase|Other|0|||
130189722|NCT02712554|468652225|FG001|Part B: Treatment Phase|Other|1|||
130189723|NCT00979654|468652226|FG000|Overall Study|Lost to Follow-up|1|||
130189724|NCT00979654|468652226|FG000|Overall Study|Withdrawal by Subject|22|||
130189725|NCT00979654|468652226|FG000|Overall Study|Death|1|||
130189726|NCT00979654|468652226|FG000|Overall Study|Lack of Efficacy|6|||
130189727|NCT00979654|468652226|FG000|Overall Study|Adverse Event|1|||
130189728|NCT00979654|468652226|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
130189729|NCT00979654|468652226|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
130189730|NCT00979654|468652226|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
130189731|NCT00979654|468652226|FG000|Overall Study|Serious Adverse Event|1|||
130189732|NCT00979654|468652226|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
130189733|NCT01129557|468652227|FG000|Overall Study|Adverse Event|1|||
130189734|NCT01129557|468652228|FG001|Overall Study|Adverse Event|2|||
130189735|NCT01129557|468652229|FG002|Overall Study|Adverse Event|2|||
130189736|NCT01129557|468652227|FG000|Overall Study|Novartis terminated study early|3|||
130189737|NCT01129557|468652228|FG001|Overall Study|Novartis terminated study early|3|||
130189738|NCT01129557|468652229|FG002|Overall Study|Novartis terminated study early|2|||
130189739|NCT00669669|468652230|FG000|Overall Study|To late to start treatment|1|||
130189740|NCT01068678|468653741|FG000|Overall Study|Lack of Efficacy|3|||
130189741|NCT01068678|468653742|FG001|Overall Study|Lack of Efficacy|2|||
130189742|NCT01068678|468653741|FG000|Overall Study|Protocol Violation|5|||
130189743|NCT01068678|468653742|FG001|Overall Study|Protocol Violation|1|||
130189744|NCT01068678|468653741|FG000|Overall Study|Withdrawal criteria|12|||
130189745|NCT01068678|468653742|FG001|Overall Study|Withdrawal criteria|6|||
130189746|NCT01068678|468653741|FG000|Overall Study|Unclassified|18|||
130189747|NCT01068678|468653742|FG001|Overall Study|Unclassified|15|||
130189748|NCT03055338|468653745|FG000|Overall Study|Lost to Follow-up|9|||
130189749|NCT03055338|468653746|FG001|Overall Study|Lost to Follow-up|2|||
130189750|NCT03055338|468653747|FG002|Overall Study|Lost to Follow-up|3|||
130189751|NCT03055338|468653745|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
130189752|NCT03055338|468653746|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
130189753|NCT03055338|468653747|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
130189754|NCT03055338|468653745|FG000|Overall Study|Physician Decision|0|||
130189755|NCT03055338|468653746|FG001|Overall Study|Physician Decision|0|||
130189756|NCT03055338|468653747|FG002|Overall Study|Physician Decision|2|||
130189757|NCT03055338|468653745|FG000|Overall Study|Withdrawal by Subject|9|||
130189758|NCT03055338|468653746|FG001|Overall Study|Withdrawal by Subject|8|||
130189759|NCT03055338|468653747|FG002|Overall Study|Withdrawal by Subject|7|||
130189760|NCT00975611|468653748|FG000|Overall Study|Screen Fail|16|||
130189761|NCT00975611|468653748|FG000|Overall Study|Physician Decision|1|||
130189762|NCT03058705|468653749|FG000|Overall Study|Withdrawal by Subject|2|||
130189763|NCT03058705|468653749|FG000|Overall Study|Physician Decision|2|||
130189764|NCT01682226|468653750|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
130189765|NCT01682226|468653750|FG000|Overall Study|Participants did not receive treatment|2|||
130189766|NCT01682226|468653750|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
130189767|NCT02159053|468653751|FG000|Overall Study|Death|2|||
130189768|NCT02159053|468653752|FG001|Overall Study|Death|0|||
130189769|NCT02159053|468653753|FG002|Overall Study|Death|1|||
130189770|NCT02159053|468653751|FG000|Overall Study|Physician Decision|0|||
130189771|NCT02159053|468653752|FG001|Overall Study|Physician Decision|1|||
130189772|NCT02159053|468653753|FG002|Overall Study|Physician Decision|1|||
130189773|NCT02159053|468653751|FG000|Overall Study|Lack of Efficacy|3|||
130189774|NCT02159053|468653752|FG001|Overall Study|Lack of Efficacy|4|||
130189775|NCT02159053|468653753|FG002|Overall Study|Lack of Efficacy|7|||
130189776|NCT02159053|468653751|FG000|Overall Study|Adverse Event|7|||
130189777|NCT02159053|468653752|FG001|Overall Study|Adverse Event|6|||
130189778|NCT02159053|468653753|FG002|Overall Study|Adverse Event|5|||
130189779|NCT02159053|468653751|FG000|Overall Study|Participants/guardian decision|8|||
130189780|NCT02159053|468653752|FG001|Overall Study|Participants/guardian decision|10|||
130189781|NCT02159053|468653753|FG002|Overall Study|Participants/guardian decision|6|||
130189782|NCT00457002|468653758|FG000|Overall Study|Death|40|||
130189783|NCT00457002|468653759|FG001|Overall Study|Death|47|||
130189784|NCT00457002|468653758|FG000|Overall Study|Adverse Event|284|||
130189785|NCT00457002|468653759|FG001|Overall Study|Adverse Event|260|||
130189786|NCT00457002|468653758|FG000|Overall Study|Withdrawal by Subject|299|||
130189787|NCT00457002|468653759|FG001|Overall Study|Withdrawal by Subject|271|||
130189788|NCT00457002|468653758|FG000|Overall Study|Lost to Follow-up|72|||
130189789|NCT00457002|468653759|FG001|Overall Study|Lost to Follow-up|71|||
130189790|NCT00457002|468653758|FG000|Overall Study|Poor/Non-compliance|46|||
130189791|NCT00457002|468653759|FG001|Overall Study|Poor/Non-compliance|33|||
130189792|NCT00457002|468653758|FG000|Overall Study|No longer met criteria|41|||
130189793|NCT00457002|468653759|FG001|Overall Study|No longer met criteria|37|||
130189794|NCT00457002|468653758|FG000|Overall Study|Administrative reason by Sponsor|1|||
130189795|NCT00457002|468653759|FG001|Overall Study|Administrative reason by Sponsor|0|||
130189796|NCT00457002|468653758|FG000|Overall Study|non-specified|29|||
130189797|NCT00457002|468653759|FG001|Overall Study|non-specified|38|||
130189798|NCT00457002|468653758|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
130189799|NCT00457002|468653759|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
130189800|NCT02283268|468653760|FG000|Overall Study|Withdrawal by Subject|1|||
130189801|NCT00454246|468653761|FG000|Overall Study|Adverse Event|2|||
130189802|NCT00454246|468653762|FG001|Overall Study|Adverse Event|2|||
130189803|NCT00454246|468653763|FG002|Overall Study|Adverse Event|0|||
130189804|NCT00454246|468653761|FG000|Overall Study|Violation of selection criteria at entry|6|||
130189805|NCT00454246|468653762|FG001|Overall Study|Violation of selection criteria at entry|0|||
130189806|NCT00454246|468653763|FG002|Overall Study|Violation of selection criteria at entry|0|||
130189807|NCT00454246|468653761|FG000|Overall Study|Protocol Violation|1|||
130189808|NCT00454246|468653762|FG001|Overall Study|Protocol Violation|0|||
130189809|NCT00454246|468653763|FG002|Overall Study|Protocol Violation|0|||
130189810|NCT00454246|468653761|FG000|Overall Study|Refused Treatment|1|||
130189811|NCT00454246|468653762|FG001|Overall Study|Refused Treatment|1|||
130189812|NCT00454246|468653763|FG002|Overall Study|Refused Treatment|0|||
130189813|NCT00454246|468653761|FG000|Overall Study|Failure to return|1|||
130189814|NCT00454246|468653762|FG001|Overall Study|Failure to return|0|||
130189815|NCT00454246|468653763|FG002|Overall Study|Failure to return|0|||
130189816|NCT00454246|468653761|FG000|Overall Study|Early termination of study|62|||
130189817|NCT00454246|468653762|FG001|Overall Study|Early termination of study|26|||
130189818|NCT00454246|468653763|FG002|Overall Study|Early termination of study|9|||
130189819|NCT01085630|468653774|FG000|Overall Study|Insufficient data|1|||
130189820|NCT01085630|468653775|FG001|Overall Study|Insufficient data|0|||
130189821|NCT01085630|468653774|FG000|Overall Study|Ineligible|3|||
130189822|NCT01085630|468653775|FG001|Overall Study|Ineligible|0|||
130189823|NCT01017874|468653776|FG000|Overall Study|Withdrawal by Subject|23|||
130189824|NCT01017874|468653777|FG001|Overall Study|Withdrawal by Subject|20|||
130189825|NCT01017874|468653776|FG000|Overall Study|Sponsor decision|3|||
130189826|NCT01017874|468653777|FG001|Overall Study|Sponsor decision|1|||
130189827|NCT01017874|468653776|FG000|Overall Study|Lost to Follow-up|3|||
130189828|NCT01017874|468653777|FG001|Overall Study|Lost to Follow-up|2|||
130189829|NCT01017874|468653776|FG000|Overall Study|Physician Decision|1|||
130189830|NCT01017874|468653777|FG001|Overall Study|Physician Decision|3|||
130189831|NCT01346696|468653778|FG000|Overall Study|Death|1|||
130189832|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
130189833|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189834|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189835|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189836|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
130189837|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189838|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189839|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189840|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
130189841|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189842|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189843|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189844|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
130189845|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189846|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189847|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189848|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
130189849|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189850|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189851|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189852|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
130189853|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189854|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189855|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189856|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
130189857|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189858|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189859|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189860|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
130189861|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189862|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189863|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189864|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
130189865|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189866|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189867|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189868|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130189869|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
130189870|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
130189871|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130189872|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
130189873|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
130189874|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
130189875|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
130189876|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130189877|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130189878|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130189879|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130189880|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130189881|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
130189882|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
130189883|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130189884|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130189885|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
130189886|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
130189887|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130189888|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130189889|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
130189890|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
130189891|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130189892|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130189893|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
130189894|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
130189895|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130189896|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189897|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189898|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
130189899|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189900|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189901|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189902|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189903|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
130189904|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189905|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189906|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189907|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
130189908|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189909|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189910|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189911|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
130189912|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189913|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189914|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189915|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
130189916|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189917|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189918|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189919|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
130189920|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189921|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189922|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189923|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
130189924|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189925|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189926|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189927|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
130189928|NCT04578457|468653793|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
130189929|NCT04578457|468653793|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
130189930|NCT04578457|468653793|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
130189931|NCT04578457|468653793|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
130189932|NCT01297517|468653809|FG000|Overall Study|Adverse Event|21|||
130189933|NCT01297517|468653810|FG001|Overall Study|Adverse Event|7|||
130189934|NCT01297517|468653811|FG002|Overall Study|Adverse Event|16|||
130189935|NCT01297517|468653809|FG000|Overall Study|Lost to Follow-up|1|||
130189936|NCT01297517|468653810|FG001|Overall Study|Lost to Follow-up|0|||
130189937|NCT01297517|468653811|FG002|Overall Study|Lost to Follow-up|1|||
130189938|NCT01297517|468653809|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
130189939|NCT01297517|468653810|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
130189940|NCT01297517|468653811|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
130189941|NCT01297517|468653809|FG000|Overall Study|Noncompliance|1|||
130189942|NCT01297517|468653810|FG001|Overall Study|Noncompliance|0|||
130189943|NCT01297517|468653811|FG002|Overall Study|Noncompliance|0|||
130189944|NCT01297517|468653809|FG000|Overall Study|Protocol Violation|1|||
130189945|NCT01297517|468653810|FG001|Overall Study|Protocol Violation|1|||
130189946|NCT01297517|468653811|FG002|Overall Study|Protocol Violation|1|||
130189947|NCT01297517|468653809|FG000|Overall Study|Inadequate Control of IOP|1|||
130189948|NCT01297517|468653810|FG001|Overall Study|Inadequate Control of IOP|1|||
130189949|NCT01297517|468653811|FG002|Overall Study|Inadequate Control of IOP|2|||
130189950|NCT00628212|468653814|FG000|Overall Study|Adverse Event|2|||
130189951|NCT00628212|468653815|FG001|Overall Study|Adverse Event|0|||
130189952|NCT00628212|468653816|FG002|Overall Study|Adverse Event|1|||
130189953|NCT00628212|468653817|FG003|Overall Study|Adverse Event|2|||
130189954|NCT00628212|468653814|FG000|Overall Study|Physician Decision|1|||
130189955|NCT00628212|468653815|FG001|Overall Study|Physician Decision|1|||
130189956|NCT00628212|468653816|FG002|Overall Study|Physician Decision|2|||
130189957|NCT00628212|468653817|FG003|Overall Study|Physician Decision|3|||
130189958|NCT00789373|468653820|FG000|Induction|Adverse Event|64|||
130189959|NCT00789373|468653821|FG001|Induction|Adverse Event|0|||
130189960|NCT00789373|468653822|FG002|Induction|Adverse Event|0|||
130189961|NCT00789373|468653820|FG000|Induction|Death Due to study disease|24|||
130189962|NCT00789373|468653821|FG001|Induction|Death Due to study disease|0|||
130189963|NCT00789373|468653822|FG002|Induction|Death Due to study disease|0|||
130189964|NCT00789373|468653820|FG000|Induction|Death due to adverse event|19|||
130189965|NCT00789373|468653821|FG001|Induction|Death due to adverse event|0|||
130189966|NCT00789373|468653822|FG002|Induction|Death due to adverse event|0|||
130189967|NCT00789373|468653820|FG000|Induction|Death due to toxicity|11|||
130189968|NCT00789373|468653821|FG001|Induction|Death due to toxicity|0|||
130189969|NCT00789373|468653822|FG002|Induction|Death due to toxicity|0|||
130189970|NCT00789373|468653820|FG000|Induction|Death due to procedure|1|||
130189971|NCT00789373|468653821|FG001|Induction|Death due to procedure|0|||
130189972|NCT00789373|468653822|FG002|Induction|Death due to procedure|0|||
130189973|NCT00789373|468653820|FG000|Induction|Investigator decision|7|||
130189974|NCT00789373|468653821|FG001|Induction|Investigator decision|0|||
130189975|NCT00789373|468653822|FG002|Induction|Investigator decision|0|||
130189976|NCT00789373|468653820|FG000|Induction|Protocol entry criteria not met|9|||
130189977|NCT00789373|468653821|FG001|Induction|Protocol entry criteria not met|0|||
130189978|NCT00789373|468653822|FG002|Induction|Protocol entry criteria not met|0|||
130189979|NCT00789373|468653820|FG000|Induction|Lost to Follow-up|6|||
130189980|NCT00789373|468653821|FG001|Induction|Lost to Follow-up|0|||
130189981|NCT00789373|468653822|FG002|Induction|Lost to Follow-up|0|||
130189982|NCT00789373|468653820|FG000|Induction|Protocol Violation|1|||
130189983|NCT00789373|468653821|FG001|Induction|Protocol Violation|0|||
130189984|NCT00789373|468653822|FG002|Induction|Protocol Violation|0|||
130189985|NCT00789373|468653820|FG000|Induction|Progressive Disease|220|||
130189986|NCT00789373|468653821|FG001|Induction|Progressive Disease|0|||
130189987|NCT00789373|468653822|FG002|Induction|Progressive Disease|0|||
130189988|NCT00789373|468653820|FG000|Induction|Withdrawal by Subject|37|||
130189989|NCT00789373|468653821|FG001|Induction|Withdrawal by Subject|0|||
130189990|NCT00789373|468653822|FG002|Induction|Withdrawal by Subject|0|||
130189991|NCT00789373|468653820|FG000|Maintenance|Adverse Event|0|||
130189992|NCT00789373|468653821|FG001|Maintenance|Adverse Event|65|||
130189993|NCT00789373|468653822|FG002|Maintenance|Adverse Event|12|||
130189994|NCT00789373|468653820|FG000|Maintenance|Death due to study disease|0|||
130189995|NCT00789373|468653821|FG001|Maintenance|Death due to study disease|3|||
130189996|NCT00789373|468653822|FG002|Maintenance|Death due to study disease|1|||
130189997|NCT00789373|468653820|FG000|Maintenance|Death due to adverse event|0|||
130189998|NCT00789373|468653821|FG001|Maintenance|Death due to adverse event|4|||
130189999|NCT00789373|468653822|FG002|Maintenance|Death due to adverse event|1|||
130190000|NCT00789373|468653820|FG000|Maintenance|Death due to toxicity|0|||
130190001|NCT00789373|468653821|FG001|Maintenance|Death due to toxicity|1|||
130190002|NCT00789373|468653822|FG002|Maintenance|Death due to toxicity|2|||
130190003|NCT00789373|468653820|FG000|Maintenance|Investigator Decision|0|||
130190004|NCT00789373|468653821|FG001|Maintenance|Investigator Decision|4|||
130190005|NCT00789373|468653822|FG002|Maintenance|Investigator Decision|2|||
130190006|NCT00789373|468653820|FG000|Maintenance|Protocol entry criteria not met|0|||
130190007|NCT00789373|468653821|FG001|Maintenance|Protocol entry criteria not met|2|||
130190008|NCT00789373|468653822|FG002|Maintenance|Protocol entry criteria not met|0|||
130190009|NCT00789373|468653820|FG000|Maintenance|Lost to Follow-up|0|||
130190010|NCT00789373|468653821|FG001|Maintenance|Lost to Follow-up|2|||
130190011|NCT00789373|468653822|FG002|Maintenance|Lost to Follow-up|0|||
130190012|NCT00789373|468653820|FG000|Maintenance|Progressive Disease|0|||
130190013|NCT00789373|468653821|FG001|Maintenance|Progressive Disease|253|||
130190014|NCT00789373|468653822|FG002|Maintenance|Progressive Disease|152|||
130190015|NCT00789373|468653820|FG000|Maintenance|Withdrawal by Subject|0|||
130190016|NCT00789373|468653821|FG001|Maintenance|Withdrawal by Subject|21|||
130190017|NCT00789373|468653822|FG002|Maintenance|Withdrawal by Subject|8|||
130190018|NCT00789373|468653820|FG000|Maintenance|Sponsor Decision|0|||
130190019|NCT00789373|468653821|FG001|Maintenance|Sponsor Decision|0|||
130190020|NCT00789373|468653822|FG002|Maintenance|Sponsor Decision|2|||
130190021|NCT00789373|468653820|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
130190022|NCT00789373|468653821|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
130190023|NCT00789373|468653822|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
130190024|NCT00546377|468653823|FG000|Overall Study|Deemed ineligible|1|||
130190025|NCT00546377|468653823|FG000|Overall Study|Adverse Event|6|||
130190026|NCT03321968|468653824|FG000|Overall Study|Withdrawal by Subject|1|||
130190027|NCT03321968|468653825|FG001|Overall Study|Withdrawal by Subject|2|||
130190028|NCT03321968|468653826|FG002|Overall Study|Withdrawal by Subject|1|||
130190029|NCT03321968|468653824|FG000|Overall Study|Lost to Follow-up|2|||
130190030|NCT03321968|468653825|FG001|Overall Study|Lost to Follow-up|0|||
130190031|NCT03321968|468653826|FG002|Overall Study|Lost to Follow-up|1|||
130190032|NCT03321968|468653824|FG000|Overall Study|Other than specified|0|||
130190033|NCT03321968|468653825|FG001|Overall Study|Other than specified|0|||
130190034|NCT03321968|468653826|FG002|Overall Study|Other than specified|1|||
130190035|NCT00463047|468653832|FG000|Titration Period 1|Adverse Event|10|||
130190036|NCT00463047|468653833|FG001|Titration Period 1|Adverse Event|8|||
130190037|NCT00463047|468653832|FG000|Titration Period 1|Lack of Efficacy|10|||
130190038|NCT00463047|468653833|FG001|Titration Period 1|Lack of Efficacy|4|||
130190039|NCT00463047|468653832|FG000|Titration Period 1|Lost to Follow-up|2|||
130190040|NCT00463047|468653833|FG001|Titration Period 1|Lost to Follow-up|0|||
130190041|NCT00463047|468653832|FG000|Titration Period 1|Non-compliance with study medication|3|||
130190042|NCT00463047|468653833|FG001|Titration Period 1|Non-compliance with study medication|5|||
130190043|NCT00463047|468653832|FG000|Titration Period 1|Protocol Violation|5|||
130190044|NCT00463047|468653833|FG001|Titration Period 1|Protocol Violation|5|||
130190045|NCT00463047|468653832|FG000|Titration Period 1|Withdrawal by Subject|3|||
130190046|NCT00463047|468653833|FG001|Titration Period 1|Withdrawal by Subject|5|||
130190047|NCT00463047|468653832|FG000|Titration Period 1|Non-compliance procedures|4|||
130190048|NCT00463047|468653833|FG001|Titration Period 1|Non-compliance procedures|10|||
130190049|NCT00463047|468653832|FG000|Titration Period 1|Other|0|||
130190050|NCT00463047|468653833|FG001|Titration Period 1|Other|2|||
130190051|NCT00463047|468653832|FG000|Titration Period 2|Adverse Event|9|||
130190052|NCT00463047|468653833|FG001|Titration Period 2|Adverse Event|9|||
130190053|NCT00463047|468653832|FG000|Titration Period 2|Lack of Efficacy|6|||
130190054|NCT00463047|468653833|FG001|Titration Period 2|Lack of Efficacy|4|||
130190055|NCT00463047|468653832|FG000|Titration Period 2|Withdrawal by Subject|1|||
130190056|NCT00463047|468653833|FG001|Titration Period 2|Withdrawal by Subject|0|||
130190057|NCT00463047|468653832|FG000|Titration Period 2|Protocol Violation|2|||
130190058|NCT00463047|468653833|FG001|Titration Period 2|Protocol Violation|3|||
130190059|NCT00463047|468653832|FG000|Titration Period 2|Lost to Follow-up|1|||
130190060|NCT00463047|468653833|FG001|Titration Period 2|Lost to Follow-up|2|||
130190061|NCT00463047|468653832|FG000|Titration Period 2|Non-compliance study medication|4|||
130190062|NCT00463047|468653833|FG001|Titration Period 2|Non-compliance study medication|2|||
130190063|NCT00463047|468653832|FG000|Titration Period 2|Non-compliance procedures|4|||
130190064|NCT00463047|468653833|FG001|Titration Period 2|Non-compliance procedures|1|||
130190065|NCT00463047|468653832|FG000|Titration Period 2|Other|3|||
130190066|NCT00463047|468653833|FG001|Titration Period 2|Other|2|||
130190067|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
130190068|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
130190069|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
130190070|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
130190071|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
130190072|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
130190073|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Other|1|||
130190074|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Other|0|||
130190075|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
130190076|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
130190077|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130190078|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
130190079|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
130190080|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
130190081|NCT02861807|468653837|FG000|Overall Study|Lost to Follow-up|7|||
130190082|NCT02861807|468653838|FG001|Overall Study|Lost to Follow-up|6|||
130190083|NCT02861807|468653837|FG000|Overall Study|Withdrawal by Subject|5|||
130190084|NCT02861807|468653838|FG001|Overall Study|Withdrawal by Subject|8|||
130190085|NCT03020992|468653839|FG000|Overall Study|Adverse Event|5|||
130190086|NCT03020992|468653839|FG000|Overall Study|Withdrawal by Subject|1|||
130190087|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
130190088|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
130190089|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
130190090|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
130190091|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Pregnancy|0|||
130190092|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Pregnancy|1|||
130190093|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
130190094|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
130190095|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
130190096|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
130190097|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
130190098|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
130190099|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Other|3|||
130190100|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Other|0|||
130190101|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Adverse Event|0|||
130190102|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Adverse Event|4|||
130190103|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
130190104|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
130190105|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130190106|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130190107|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130190108|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
130190109|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130190110|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
130190111|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Death|0|||
130190112|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Death|1|||
130190113|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
130190114|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
130190115|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130190116|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130190117|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
130190118|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
130190119|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
130190120|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
130190121|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130190122|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130190123|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130190124|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
130190125|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130190126|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
130190127|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
130190128|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
130190129|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
130190130|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
130190131|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
130190132|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
130190133|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130190134|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130190135|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
130190136|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
130190137|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130190138|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130190139|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
130190140|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
130190141|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
130190142|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
130190143|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
130190144|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
130190145|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130190146|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130190147|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
130190148|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
130190149|NCT00739661|468653848|FG000|Overall Study|Adverse Event|2|||
130190150|NCT00739661|468653849|FG001|Overall Study|Adverse Event|0|||
130190151|NCT00739661|468653848|FG000|Overall Study|Physician decision to withdraw patient|1|||
130190152|NCT00739661|468653849|FG001|Overall Study|Physician decision to withdraw patient|0|||
130190153|NCT00739661|468653848|FG000|Overall Study|Patient decision to withdraw|9|||
130190154|NCT00739661|468653849|FG001|Overall Study|Patient decision to withdraw|4|||
130190155|NCT00739661|468653848|FG000|Overall Study|Disease progression, radiographic|33|||
130190156|NCT00739661|468653849|FG001|Overall Study|Disease progression, radiographic|37|||
130190157|NCT00739661|468653848|FG000|Overall Study|Reason for discontinuation not available|1|||
130190158|NCT00739661|468653849|FG001|Overall Study|Reason for discontinuation not available|1|||
130190159|NCT00529308|468653850|FG000|Overall Study|Withdrawal by Subject|1|||
130190160|NCT00529308|468653851|FG001|Overall Study|Withdrawal by Subject|1|||
130190161|NCT05343364|468653858|FG000|Overall Study|Miscellaneous|0|||
130190162|NCT05343364|468653859|FG001|Overall Study|Miscellaneous|1|||
130190163|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
130190164|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190165|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190166|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190167|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190168|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190169|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
130190170|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
130190171|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190172|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190173|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190174|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190175|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
130190176|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
130190177|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190178|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190179|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190180|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190181|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190182|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190183|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190184|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190185|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190186|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190187|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
130190188|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
130190189|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190190|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190191|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190192|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190193|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190194|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
130190195|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190196|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190197|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190198|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190199|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190200|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190201|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
130190202|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
130190203|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190204|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190205|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190206|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190207|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
130190208|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
130190209|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190210|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190211|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190212|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190213|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
130190214|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
130190215|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190216|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190217|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190218|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190219|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
130190220|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190221|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190222|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190223|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190224|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190225|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
130190226|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190227|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190228|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190229|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190230|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190231|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190232|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
130190233|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190234|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190235|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190236|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190237|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
130190238|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190239|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190240|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190241|NCT02105987|468653860|FG000|Continuation Phase|Protocol Violation|0|||
130190242|NCT02105987|468653861|FG001|Continuation Phase|Protocol Violation|0|||
130190243|NCT02105987|468653862|FG002|Continuation Phase|Protocol Violation|0|||
130190244|NCT02105987|468653863|FG003|Continuation Phase|Protocol Violation|0|||
130190245|NCT02105987|468653864|FG004|Continuation Phase|Protocol Violation|1|||
130190246|NCT02105987|468653865|FG005|Continuation Phase|Protocol Violation|0|||
130190247|NCT02268916|468653870|FG000|Overall Study|Lost to Follow-up|1|||
130190248|NCT02268916|468653871|FG001|Overall Study|Lost to Follow-up|1|||
130190249|NCT02268916|468653870|FG000|Overall Study|Withdrawal by Subject|6|||
130190250|NCT02268916|468653871|FG001|Overall Study|Withdrawal by Subject|5|||
130190251|NCT02268916|468653870|FG000|Overall Study|Participant did not have diabetes|1|||
130190252|NCT02268916|468653871|FG001|Overall Study|Participant did not have diabetes|0|||
130190253|NCT02268916|468653870|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
130190254|NCT02268916|468653871|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
130190255|NCT02418949|468653872|FG000|Overall Study|Withdrawal by Subject|1|||
130190256|NCT02418949|468653873|FG001|Overall Study|Withdrawal by Subject|0|||
130190257|NCT02418949|468653874|FG002|Overall Study|Withdrawal by Subject|1|||
130190258|NCT02418949|468653875|FG003|Overall Study|Withdrawal by Subject|1|||
130190259|NCT02418949|468653872|FG000|Overall Study|Lost to Follow-up|1|||
130190260|NCT02418949|468653873|FG001|Overall Study|Lost to Follow-up|0|||
130190261|NCT02418949|468653874|FG002|Overall Study|Lost to Follow-up|1|||
130190262|NCT02418949|468653875|FG003|Overall Study|Lost to Follow-up|0|||
130190263|NCT02418949|468653872|FG000|Overall Study|Physician Decision|1|||
130190264|NCT02418949|468653873|FG001|Overall Study|Physician Decision|1|||
130190265|NCT02418949|468653874|FG002|Overall Study|Physician Decision|1|||
130190266|NCT02418949|468653875|FG003|Overall Study|Physician Decision|0|||
130190267|NCT03926117|468653876|FG000|Overall Study|Unclassified|1|||
130190268|NCT03926117|468653877|FG001|Overall Study|Unclassified|4|||
130190269|NCT03926117|468653878|FG002|Overall Study|Unclassified|1|||
130190270|NCT03926117|468653879|FG003|Overall Study|Unclassified|4|||
130190271|NCT03926117|468653876|FG000|Overall Study|Withdrawal by Subject|3|||
130190272|NCT03926117|468653877|FG001|Overall Study|Withdrawal by Subject|0|||
130190273|NCT03926117|468653878|FG002|Overall Study|Withdrawal by Subject|1|||
130190274|NCT03926117|468653879|FG003|Overall Study|Withdrawal by Subject|1|||
130190275|NCT03926117|468653876|FG000|Overall Study|Lost to Follow-up|0|||
130190276|NCT03926117|468653877|FG001|Overall Study|Lost to Follow-up|2|||
130190277|NCT03926117|468653878|FG002|Overall Study|Lost to Follow-up|1|||
130190278|NCT03926117|468653879|FG003|Overall Study|Lost to Follow-up|0|||
130190279|NCT03926117|468653876|FG000|Overall Study|Adverse Event|1|||
130190280|NCT03926117|468653877|FG001|Overall Study|Adverse Event|2|||
130190281|NCT03926117|468653878|FG002|Overall Study|Adverse Event|3|||
130190282|NCT03926117|468653879|FG003|Overall Study|Adverse Event|1|||
130190283|NCT03926117|468653876|FG000|Overall Study|Randomized but not treated|1|||
130190284|NCT03926117|468653877|FG001|Overall Study|Randomized but not treated|1|||
130190285|NCT03926117|468653878|FG002|Overall Study|Randomized but not treated|0|||
130190286|NCT03926117|468653879|FG003|Overall Study|Randomized but not treated|1|||
130190287|NCT04526288|468653882|FG000|Overall Study|Disease Progression|1|||
130190288|NCT04526288|468653883|FG001|Overall Study|Disease Progression|0|||
130190289|NCT02684097|468653886|FG000|Overall Study|Lack of Efficacy|13|||
130190290|NCT02684097|468653887|FG001|Overall Study|Lack of Efficacy|6|||
130190291|NCT00460811|468653888|FG000|Overall Study|Adverse Event|4|||
130190292|NCT00460811|468653889|FG001|Overall Study|Adverse Event|6|||
130190293|NCT00460811|468653890|FG002|Overall Study|Adverse Event|3|||
130190294|NCT00460811|468653891|FG003|Overall Study|Adverse Event|10|||
130190295|NCT00460811|468653892|FG004|Overall Study|Adverse Event|2|||
130190296|NCT00460811|468653888|FG000|Overall Study|Noncompliance|1|||
130190297|NCT00460811|468653889|FG001|Overall Study|Noncompliance|0|||
130190298|NCT00460811|468653890|FG002|Overall Study|Noncompliance|0|||
130190299|NCT00460811|468653891|FG003|Overall Study|Noncompliance|2|||
130190300|NCT00460811|468653892|FG004|Overall Study|Noncompliance|1|||
130190301|NCT00460811|468653888|FG000|Overall Study|Withdrawal by Subject|7|||
130190302|NCT00460811|468653889|FG001|Overall Study|Withdrawal by Subject|7|||
130190303|NCT00460811|468653890|FG002|Overall Study|Withdrawal by Subject|6|||
130190304|NCT00460811|468653891|FG003|Overall Study|Withdrawal by Subject|3|||
130190305|NCT00460811|468653892|FG004|Overall Study|Withdrawal by Subject|11|||
130190306|NCT00460811|468653888|FG000|Overall Study|Physician Decision|1|||
130190307|NCT00460811|468653889|FG001|Overall Study|Physician Decision|0|||
130190308|NCT00460811|468653890|FG002|Overall Study|Physician Decision|0|||
130190309|NCT00460811|468653891|FG003|Overall Study|Physician Decision|0|||
130190310|NCT00460811|468653892|FG004|Overall Study|Physician Decision|0|||
130190311|NCT00460811|468653888|FG000|Overall Study|Lost to Follow-up|3|||
130190312|NCT00460811|468653889|FG001|Overall Study|Lost to Follow-up|2|||
130190313|NCT00460811|468653890|FG002|Overall Study|Lost to Follow-up|5|||
130190314|NCT00460811|468653891|FG003|Overall Study|Lost to Follow-up|3|||
130190315|NCT00460811|468653892|FG004|Overall Study|Lost to Follow-up|6|||
130190316|NCT02748356|468653893|FG000|Overall Study|Withdrawal by Subject|1|||
130190317|NCT00237458|468653894|FG000|Overall Study|Lack of Efficacy|1|||
130190318|NCT00237458|468653894|FG000|Overall Study|Adverse Event|1|||
130190319|NCT00237458|468653894|FG000|Overall Study|Withdrawal by Subject|1|||
130190320|NCT00952068|468653895|FG000|Overall Study|Adverse Event|3|||
130190321|NCT00952068|468653895|FG000|Overall Study|Withdrawal by Subject|4|||
130190322|NCT05870371|468653896|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
130190323|NCT05870371|468653897|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
130190324|NCT02062450|468653901|FG000|Overall Study|No follow-up visit|124|||
130190325|NCT02907177|468653904|FG000|Overall Study|Death|0|||
130190326|NCT02907177|468653905|FG001|Overall Study|Death|1|||
130190327|NCT02907177|468653904|FG000|Overall Study|Physician Decision|3|||
130190328|NCT02907177|468653905|FG001|Overall Study|Physician Decision|3|||
130190329|NCT02907177|468653904|FG000|Overall Study|Withdrawal by Subject|15|||
130190330|NCT02907177|468653905|FG001|Overall Study|Withdrawal by Subject|7|||
130190331|NCT02907177|468653904|FG000|Overall Study|Sponsor's Decision|50|||
130190332|NCT02907177|468653905|FG001|Overall Study|Sponsor's Decision|57|||
130190333|NCT01537042|468653911|FG000|Overall Study|Adverse Event|0|||
130190334|NCT01537042|468653912|FG001|Overall Study|Adverse Event|2|||
130190335|NCT01537042|468653911|FG000|Overall Study|Lack of Efficacy|0|||
130190336|NCT01537042|468653912|FG001|Overall Study|Lack of Efficacy|1|||
130190337|NCT01537042|468653911|FG000|Overall Study|Protocol Violation|0|||
130190338|NCT01537042|468653912|FG001|Overall Study|Protocol Violation|1|||
130190339|NCT01537042|468653911|FG000|Overall Study|Other|0|||
130190340|NCT01537042|468653912|FG001|Overall Study|Other|1|||
130190341|NCT02151851|468655632|FG000|Overall Study|Lack of Efficacy|67|||
130190342|NCT02151851|468655633|FG001|Overall Study|Lack of Efficacy|94|||
130190343|NCT02151851|468655632|FG000|Overall Study|Protocol Violation|0|||
130190344|NCT02151851|468655633|FG001|Overall Study|Protocol Violation|1|||
130190345|NCT02151851|468655632|FG000|Overall Study|Withdrawal by Subject|2|||
130190346|NCT02151851|468655633|FG001|Overall Study|Withdrawal by Subject|5|||
130190347|NCT02151851|468655632|FG000|Overall Study|Medical impairment|1|||
130190348|NCT02151851|468655633|FG001|Overall Study|Medical impairment|0|||
130190349|NCT02151851|468655632|FG000|Overall Study|Low compliance to study visits|0|||
130190350|NCT02151851|468655633|FG001|Overall Study|Low compliance to study visits|1|||
130190351|NCT02151851|468655632|FG000|Overall Study|Subject entered into study in error|0|||
130190352|NCT02151851|468655633|FG001|Overall Study|Subject entered into study in error|1|||
130190353|NCT02151851|468655632|FG000|Overall Study|Adverse Event|6|||
130190354|NCT02151851|468655633|FG001|Overall Study|Adverse Event|28|||
130190355|NCT01540487|468655634|FG000|Overall Study|Protocol Violation|1|||
130190356|NCT01540487|468655635|FG001|Overall Study|Protocol Violation|0|||
130190357|NCT03503370|468655638|FG000|Overall Study|Death|3|||
130190358|NCT03503370|468655639|FG001|Overall Study|Death|1|||
130190359|NCT00298272|468655644|FG000|Double-blind Phase|Adverse Event|2|||
130190360|NCT00298272|468655645|FG001|Double-blind Phase|Adverse Event|0|||
130190361|NCT00298272|468655644|FG000|Double-blind Phase|Failure to Return|2|||
130190362|NCT00298272|468655645|FG001|Double-blind Phase|Failure to Return|0|||
130190363|NCT00298272|468655644|FG000|Double-blind Phase|Protocol Violation|2|||
130190364|NCT00298272|468655645|FG001|Double-blind Phase|Protocol Violation|0|||
130190365|NCT00298272|468655644|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130190366|NCT00298272|468655645|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130190367|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Adverse Event|1|||
130190368|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Adverse Event|2|||
130190369|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
130190370|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
130190371|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Failure to Return|1|||
130190372|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Failure to Return|0|||
130190373|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
130190374|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
130190375|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
130190376|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
130190377|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
130190378|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
130190379|NCT00298272|468655644|FG000|Safety Follow-up Phase|Failure to Return|1|||
130190380|NCT00298272|468655645|FG001|Safety Follow-up Phase|Failure to Return|1|||
130190381|NCT00298272|468655644|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
130190382|NCT00298272|468655645|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
130190383|NCT00298272|468655644|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
130190384|NCT00298272|468655645|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
130190385|NCT04168112|468655646|FG000|Overall Study|Lost to Follow-up|1|||
130190386|NCT04168112|468655647|FG001|Overall Study|Lost to Follow-up|0|||
130190387|NCT04168112|468655646|FG000|Overall Study|Withdrawal by Subject|1|||
130190388|NCT04168112|468655647|FG001|Overall Study|Withdrawal by Subject|0|||
130190389|NCT05253573|468655650|FG000|Overall Study|Death|1|||
130190390|NCT05253573|468655651|FG001|Overall Study|Death|0|||
130190391|NCT01436370|468655652|FG000|Overall Study|Lost to Follow-up|0|||
130190392|NCT01436370|468655653|FG001|Overall Study|Lost to Follow-up|0|||
130190393|NCT01436370|468655654|FG002|Overall Study|Lost to Follow-up|0|||
130190394|NCT01436370|468655655|FG003|Overall Study|Lost to Follow-up|0|||
130190395|NCT01436370|468655656|FG004|Overall Study|Lost to Follow-up|1|||
130190396|NCT01436370|468655657|FG005|Overall Study|Lost to Follow-up|0|||
130190397|NCT01436370|468655658|FG006|Overall Study|Lost to Follow-up|0|||
130190398|NCT01436370|468655659|FG007|Overall Study|Lost to Follow-up|0|||
130190399|NCT02395848|468655660|FG000|Overall Study|Lost to Follow-up|2|||
130190400|NCT01754129|468655661|FG000|Overall Study|Death|13|||
130190401|NCT01754129|468655661|FG000|Overall Study|Duodopa discontinuation|9|||
130190402|NCT01754129|468655661|FG000|Overall Study|Lost to Follow-up|7|||
130190403|NCT01754129|468655661|FG000|Overall Study|Withdrew consent|1|||
130190404|NCT01754129|468655661|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
130190405|NCT02276560|468655662|FG000|Overall Study|Adverse Event|1|||
130190406|NCT02276560|468655663|FG001|Overall Study|Adverse Event|0|||
130190407|NCT02276560|468655664|FG002|Overall Study|Adverse Event|0|||
130190408|NCT02126579|468655666|FG000|Overall Study|disease progression|0|||
130190409|NCT02126579|468655667|FG001|Overall Study|disease progression|0|||
130190410|NCT02126579|468655668|FG002|Overall Study|disease progression|0|||
130190411|NCT02126579|468655669|FG003|Overall Study|disease progression|1|||
130190412|NCT02126579|468655670|FG004|Overall Study|disease progression|0|||
130190413|NCT02126579|468655671|FG005|Overall Study|disease progression|0|||
130190414|NCT02126579|468655672|FG006|Overall Study|disease progression|1|||
130190415|NCT01780038|468655676|FG000|Overall Study|Lost to Follow-up|4|||
130190416|NCT01780038|468655677|FG001|Overall Study|Lost to Follow-up|1|||
130190417|NCT02609607|468655683|FG000|Overall Study|Lost to Follow-up|0|||
130190418|NCT02609607|468655684|FG001|Overall Study|Lost to Follow-up|1|||
130190419|NCT03168711|468655687|FG000|Overall Study|Adverse Event|2|||
130190420|NCT03168711|468655688|FG001|Overall Study|Adverse Event|0|||
130190421|NCT03168711|468655687|FG000|Overall Study|Withdrawal by Subject|0|||
130190422|NCT03168711|468655688|FG001|Overall Study|Withdrawal by Subject|1|||
130190423|NCT03168711|468655687|FG000|Overall Study|Death|0|||
130190424|NCT03168711|468655688|FG001|Overall Study|Death|1|||
130190425|NCT02877004|468655695|FG000|Overall Study|Pregnancy|0|||
130190426|NCT02877004|468655696|FG001|Overall Study|Pregnancy|0|||
130190427|NCT02877004|468655697|FG002|Overall Study|Pregnancy|1|||
130190428|NCT02633293|468655698|FG000|Overall Study|Death|56|||
130190429|NCT02633293|468655698|FG000|Overall Study|Progressive Disease|12|||
130190430|NCT02633293|468655698|FG000|Overall Study|Adverse Event|29|||
130190431|NCT02633293|468655698|FG000|Overall Study|Withdrawal by Subject|41|||
130190432|NCT02633293|468655698|FG000|Overall Study|Protocol Violation|1|||
130190433|NCT02633293|468655698|FG000|Overall Study|Lost to Follow-up|1|||
130190434|NCT02633293|468655698|FG000|Overall Study|Study Terminated by Sponsor|24|||
130190435|NCT02633293|468655698|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
130190436|NCT02633293|468655698|FG000|Overall Study|Lung Transplant|5|||
130190437|NCT02633293|468655698|FG000|Overall Study|Lack of Efficacy|2|||
130190438|NCT02633293|468655698|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
130190439|NCT00778817|468655699|FG000|Overall Study|Adverse Event|2|||
130190440|NCT00778817|468655699|FG000|Overall Study|Withdrawal by Subject|2|||
130190441|NCT02356588|468655700|FG000|Overall Study|Lack of Efficacy|4|||
130190442|NCT02356588|468655701|FG001|Overall Study|Lack of Efficacy|10|||
130190443|NCT02356588|468655700|FG000|Overall Study|Adverse Event|0|||
130190444|NCT02356588|468655701|FG001|Overall Study|Adverse Event|2|||
130190445|NCT02356588|468655700|FG000|Overall Study|Withdrawal by Subject|1|||
130190446|NCT02356588|468655701|FG001|Overall Study|Withdrawal by Subject|0|||
130190447|NCT02356588|468655700|FG000|Overall Study|Protocol Violation|0|||
130190448|NCT02356588|468655701|FG001|Overall Study|Protocol Violation|1|||
130190449|NCT01418378|468655702|FG000|Overall Study|Death|1|||
130190450|NCT01418378|468655703|FG001|Overall Study|Death|2|||
130190451|NCT01418378|468655702|FG000|Overall Study|Physician Decision|0|||
130190452|NCT01418378|468655703|FG001|Overall Study|Physician Decision|1|||
130190453|NCT01418378|468655702|FG000|Overall Study|ligament imbalance|0|||
130190454|NCT01418378|468655703|FG001|Overall Study|ligament imbalance|1|||
130190455|NCT01418378|468655702|FG000|Overall Study|developed chronic myopathy|0|||
130190456|NCT01418378|468655703|FG001|Overall Study|developed chronic myopathy|1|||
130190457|NCT01790984|468655704|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130190458|NCT01790984|468655705|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130190459|NCT01790984|468655706|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130190460|NCT01790984|468655707|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130190461|NCT01051791|468655710|FG000|Overall Study|Failed screening|3|||
130190462|NCT01051791|468655710|FG000|Overall Study|Withdrawal by Subject|1|||
130190463|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
130190464|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
130190465|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130190466|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130190467|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
130190468|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
130190469|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
130190470|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
130190471|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Adverse Event|14|||
130190472|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Adverse Event|11|||
130190473|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Death|1|||
130190474|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Death|1|||
130190475|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
130190476|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
130190477|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
130190478|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
130190479|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Pregnancy|1|||
130190480|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Pregnancy|0|||
130190481|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
130190482|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
130190483|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
130190484|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
130190485|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Other|0|||
130190486|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Other|1|||
130190487|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Ineligibility|3|||
130190488|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Ineligibility|4|||
130190489|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
130190490|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
130190491|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Patient Moved|2|||
130190492|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Patient Moved|2|||
130190493|NCT00507455|468655717|FG000|Overall Study|Adverse Event|3|||
130190494|NCT00507455|468655718|FG001|Overall Study|Adverse Event|3|||
130190495|NCT00507455|468655719|FG002|Overall Study|Adverse Event|6|||
130190496|NCT00507455|468655717|FG000|Overall Study|Withdrawal by Subject|2|||
130190497|NCT00507455|468655718|FG001|Overall Study|Withdrawal by Subject|1|||
130190498|NCT00507455|468655719|FG002|Overall Study|Withdrawal by Subject|2|||
130190499|NCT00507455|468655717|FG000|Overall Study|Protocol Violation|4|||
130190500|NCT00507455|468655718|FG001|Overall Study|Protocol Violation|1|||
130190501|NCT00507455|468655719|FG002|Overall Study|Protocol Violation|1|||
130190502|NCT00507455|468655717|FG000|Overall Study|Lost to Follow-up|2|||
130190503|NCT00507455|468655718|FG001|Overall Study|Lost to Follow-up|0|||
130190504|NCT00507455|468655719|FG002|Overall Study|Lost to Follow-up|2|||
130190505|NCT00507455|468655717|FG000|Overall Study|Lack of Efficacy|0|||
130190506|NCT00507455|468655718|FG001|Overall Study|Lack of Efficacy|1|||
130190507|NCT00507455|468655719|FG002|Overall Study|Lack of Efficacy|0|||
130190508|NCT00507455|468655717|FG000|Overall Study|Other - miscellaneous reason|1|||
130190509|NCT00507455|468655718|FG001|Overall Study|Other - miscellaneous reason|0|||
130190510|NCT00507455|468655719|FG002|Overall Study|Other - miscellaneous reason|1|||
130190511|NCT01737710|468655720|FG000|Overall Study|Lost to Follow-up|0|||
130190512|NCT01737710|468655721|FG001|Overall Study|Lost to Follow-up|2|||
130190513|NCT01737710|468655722|FG002|Overall Study|Lost to Follow-up|2|||
130190514|NCT01737710|468655723|FG003|Overall Study|Lost to Follow-up|0|||
130190515|NCT01737710|468655724|FG004|Overall Study|Lost to Follow-up|0|||
130190516|NCT01737710|468655720|FG000|Overall Study|Withdrawal by Subject|1|||
130190517|NCT01737710|468655721|FG001|Overall Study|Withdrawal by Subject|1|||
130190518|NCT01737710|468655722|FG002|Overall Study|Withdrawal by Subject|1|||
130190519|NCT01737710|468655723|FG003|Overall Study|Withdrawal by Subject|0|||
130190520|NCT01737710|468655724|FG004|Overall Study|Withdrawal by Subject|0|||
130190521|NCT01737710|468655720|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
130190522|NCT01737710|468655721|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
130190523|NCT01737710|468655722|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
130190524|NCT01737710|468655723|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
130190525|NCT01737710|468655724|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
130190526|NCT03363776|468655725|FG000|Overall Study|Progressive disease|2|||
130190527|NCT03363776|468655726|FG001|Overall Study|Progressive disease|3|||
130190528|NCT03363776|468655727|FG002|Overall Study|Progressive disease|1|||
130190529|NCT03363776|468655725|FG000|Overall Study|Study drug toxicity|0|||
130190530|NCT03363776|468655726|FG001|Overall Study|Study drug toxicity|0|||
130190531|NCT03363776|468655727|FG002|Overall Study|Study drug toxicity|1|||
130190532|NCT03363776|468655725|FG000|Overall Study|Death|1|||
130190533|NCT03363776|468655726|FG001|Overall Study|Death|0|||
130190534|NCT03363776|468655727|FG002|Overall Study|Death|0|||
130190535|NCT00410813|468655728|FG000|Overall Study|Adverse Event|6|||
130190536|NCT00410813|468655729|FG001|Overall Study|Adverse Event|11|||
130190537|NCT00410813|468655728|FG000|Overall Study|Progression|32|||
130190538|NCT00410813|468655729|FG001|Overall Study|Progression|21|||
130190539|NCT00410813|468655728|FG000|Overall Study|Not protocol specified|3|||
130190540|NCT00410813|468655729|FG001|Overall Study|Not protocol specified|4|||
130190541|NCT00410813|468655728|FG000|Overall Study|Ineligible|2|||
130190542|NCT00410813|468655729|FG001|Overall Study|Ineligible|4|||
130190543|NCT00410813|468655728|FG000|Overall Study|Death|0|||
130190544|NCT00410813|468655729|FG001|Overall Study|Death|2|||
130190545|NCT00812981|468655730|FG000|Overall Study|Other|0|||
130190546|NCT00812981|468655731|FG001|Overall Study|Other|1|||
130190547|NCT02199795|468655732|FG000|Overall Study|no longer met inclusion criteria|1|||
130190548|NCT02199795|468655733|FG001|Overall Study|no longer met inclusion criteria|0|||
130190549|NCT02199795|468655732|FG000|Overall Study|withdrew due to shoulder pain|1|||
130190550|NCT02199795|468655733|FG001|Overall Study|withdrew due to shoulder pain|0|||
130190551|NCT01791894|468655735|FG000|Overall Study|Adverse Event|1|||
130190552|NCT00996125|468655737|FG000|Overall Study|Adverse Event|0|||
130190553|NCT00996125|468655738|FG001|Overall Study|Adverse Event|2|||
130190554|NCT00996125|468655737|FG000|Overall Study|Lost to Follow-up|1|||
130190555|NCT00996125|468655738|FG001|Overall Study|Lost to Follow-up|6|||
130190556|NCT00996125|468655737|FG000|Overall Study|Withdrawal by Subject|4|||
130190557|NCT00996125|468655738|FG001|Overall Study|Withdrawal by Subject|3|||
130190558|NCT04331067|468655739|FG000|Overall Study|Adverse Event|1|||
130190559|NCT04331067|468655740|FG001|Overall Study|Adverse Event|3|||
130190560|NCT04331067|468655741|FG002|Overall Study|Adverse Event|1|||
130190561|NCT04331067|468655739|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
130190562|NCT04331067|468655740|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
130190563|NCT04331067|468655741|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
130190564|NCT02203721|468655742|FG000|Overall Study|Lost to Follow-up|1|||
130190565|NCT02203721|468655743|FG001|Overall Study|Lost to Follow-up|0|||
130190566|NCT02203721|468655742|FG000|Overall Study|Death|0|||
130190567|NCT02203721|468655743|FG001|Overall Study|Death|2|||
130190568|NCT02203721|468655742|FG000|Overall Study|Illness|0|||
130190569|NCT02203721|468655743|FG001|Overall Study|Illness|1|||
130190570|NCT00708461|468655746|FG000|Overall Study|Lost to Follow-up|18|||
130190571|NCT00708461|468655747|FG001|Overall Study|Lost to Follow-up|11|||
130190572|NCT00708461|468655746|FG000|Overall Study|Withdrawal by Subject|8|||
130190573|NCT00708461|468655747|FG001|Overall Study|Withdrawal by Subject|9|||
130190574|NCT00708461|468655746|FG000|Overall Study|left workforce|115|||
130190575|NCT00708461|468655747|FG001|Overall Study|left workforce|180|||
130190576|NCT01796392|468655750|FG000|Overall Study|Withdrawal by Subject|2|||
130190577|NCT01796392|468655751|FG001|Overall Study|Withdrawal by Subject|0|||
130190578|NCT01796392|468655750|FG000|Overall Study|Death|5|||
130190579|NCT01796392|468655751|FG001|Overall Study|Death|1|||
130190580|NCT01796392|468655750|FG000|Overall Study|Excluded for medical reasons|1|||
130190581|NCT01796392|468655751|FG001|Overall Study|Excluded for medical reasons|2|||
130190582|NCT01796392|468655750|FG000|Overall Study|Lost to Follow-up|1|||
130190583|NCT01796392|468655751|FG001|Overall Study|Lost to Follow-up|0|||
130190584|NCT03517540|468655754|FG000|Overall Study|Protocol Violation|2|||
130190585|NCT03517540|468655755|FG001|Overall Study|Protocol Violation|0|||
130190586|NCT03517540|468655756|FG002|Overall Study|Protocol Violation|0|||
130190587|NCT03517540|468655757|FG003|Overall Study|Protocol Violation|1|||
130190588|NCT03517540|468655754|FG000|Overall Study|Adverse Event|9|||
130190589|NCT03517540|468655755|FG001|Overall Study|Adverse Event|3|||
130190590|NCT03517540|468655756|FG002|Overall Study|Adverse Event|8|||
130190591|NCT03517540|468655757|FG003|Overall Study|Adverse Event|1|||
130190592|NCT03517540|468655754|FG000|Overall Study|Withdrawal by Subject|3|||
130190593|NCT03517540|468655755|FG001|Overall Study|Withdrawal by Subject|4|||
130190594|NCT03517540|468655756|FG002|Overall Study|Withdrawal by Subject|1|||
130190595|NCT03517540|468655757|FG003|Overall Study|Withdrawal by Subject|3|||
130190596|NCT01779440|468655760|FG000|Overall Study|Withdrawal by Subject|3|||
130190597|NCT01779440|468655761|FG001|Overall Study|Withdrawal by Subject|5|||
130190598|NCT01205269|468655762|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190599|NCT01205269|468655763|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190600|NCT01205269|468655764|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190601|NCT01205269|468655765|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
130190602|NCT01205269|468655766|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190603|NCT01205269|468655767|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190604|NCT01408303|468655768|FG000|Overall Study|Adverse Event|3|||
130190605|NCT01408303|468655769|FG001|Overall Study|Adverse Event|7|||
130190606|NCT01408303|468655770|FG002|Overall Study|Adverse Event|2|||
130190607|NCT01408303|468655768|FG000|Overall Study|Lost to Follow-up|0|||
130190608|NCT01408303|468655769|FG001|Overall Study|Lost to Follow-up|1|||
130190609|NCT01408303|468655770|FG002|Overall Study|Lost to Follow-up|2|||
130190610|NCT01408303|468655768|FG000|Overall Study|Withdrawal by Subject|2|||
130190611|NCT01408303|468655769|FG001|Overall Study|Withdrawal by Subject|3|||
130190612|NCT01408303|468655770|FG002|Overall Study|Withdrawal by Subject|1|||
130190613|NCT01408303|468655768|FG000|Overall Study|Protocol Violation|0|||
130190614|NCT01408303|468655769|FG001|Overall Study|Protocol Violation|1|||
130190615|NCT01408303|468655770|FG002|Overall Study|Protocol Violation|0|||
130190616|NCT01408303|468655768|FG000|Overall Study|Noncompliance|1|||
130190617|NCT01408303|468655769|FG001|Overall Study|Noncompliance|0|||
130190618|NCT01408303|468655770|FG002|Overall Study|Noncompliance|1|||
130190619|NCT01207687|468655771|FG000|Overall Study|Adverse Event|1|||
130190620|NCT01207687|468655771|FG000|Overall Study|Withdrawal by Subject|1|||
130190621|NCT01486446|468655772|FG000|Overall Study|Adverse Event|1|||
130190622|NCT01486446|468655773|FG001|Overall Study|Adverse Event|0|||
130190623|NCT00523848|468655774|FG000|Overall Study|Adverse Event|11|||
130190624|NCT00523848|468655774|FG000|Overall Study|Withdrawal by Subject|2|||
130190625|NCT00523848|468655774|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
130190626|NCT00523848|468655774|FG000|Overall Study|Disease Progression|5|||
130190627|NCT00523848|468655774|FG000|Overall Study|Other, unspecified|4|||
130190628|NCT01801865|468655775|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
130190629|NCT01801865|468655775|FG000|Overall Study|Physician Decision|7|||
130190630|NCT01367886|468655776|FG000|Overall Study|Lost to Follow-up|4|||
130190631|NCT01367886|468655776|FG000|Overall Study|Lack of Efficacy|2|||
130190632|NCT01367886|468655776|FG000|Overall Study|Death|1|||
130190633|NCT00985504|468655783|FG000|Acute Treatment Period|Adverse Event|3|||
130190634|NCT00985504|468655784|FG001|Acute Treatment Period|Adverse Event|4|||
130190635|NCT00985504|468655783|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
130190636|NCT00985504|468655784|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
130190637|NCT00985504|468655783|FG000|Acute Treatment Period|Protocol Violation|2|||
130190638|NCT00985504|468655784|FG001|Acute Treatment Period|Protocol Violation|0|||
130190639|NCT00985504|468655783|FG000|Acute Treatment Period|Sponsor Decision|0|||
130190640|NCT00985504|468655784|FG001|Acute Treatment Period|Sponsor Decision|1|||
130190641|NCT00985504|468655783|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
130190642|NCT00985504|468655784|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
130190643|NCT00985504|468655783|FG000|Optimization Period|Adverse Event|7|||
130190644|NCT00985504|468655784|FG001|Optimization Period|Adverse Event|9|||
130190645|NCT00985504|468655783|FG000|Optimization Period|Death|0|||
130190646|NCT00985504|468655784|FG001|Optimization Period|Death|1|||
130190647|NCT00985504|468655783|FG000|Optimization Period|Lack of Efficacy|5|||
130190648|NCT00985504|468655784|FG001|Optimization Period|Lack of Efficacy|3|||
130190649|NCT00985504|468655783|FG000|Optimization Period|Lost to Follow-up|0|||
130190650|NCT00985504|468655784|FG001|Optimization Period|Lost to Follow-up|1|||
130190651|NCT00985504|468655783|FG000|Optimization Period|Physician Decision|1|||
130190652|NCT00985504|468655784|FG001|Optimization Period|Physician Decision|0|||
130190653|NCT00985504|468655783|FG000|Optimization Period|Protocol Violation|3|||
130190654|NCT00985504|468655784|FG001|Optimization Period|Protocol Violation|1|||
130190655|NCT00985504|468655783|FG000|Optimization Period|Withdrawal by Subject|10|||
130190656|NCT00985504|468655784|FG001|Optimization Period|Withdrawal by Subject|8|||
130190657|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
130190658|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
130190659|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
130190660|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
130190661|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
130190662|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
130190663|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
130190664|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
130190665|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
130190666|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
130190667|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
130190668|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
130190669|NCT03379727|468655787|FG000|Overall Study|Lack of Efficacy|73|||
130190670|NCT03379727|468655787|FG000|Overall Study|Adverse Event|32|||
130190671|NCT03379727|468655787|FG000|Overall Study|Death|18|||
130190672|NCT03379727|468655787|FG000|Overall Study|Patient/guardian decision|17|||
130190673|NCT03379727|468655787|FG000|Overall Study|Physician Decision|104|||
130190674|NCT03379727|468655787|FG000|Overall Study|Protocol Violation|4|||
130190675|NCT03379727|468655787|FG000|Overall Study|Lost to Follow-up|1|||
130190676|NCT04031846|468655791|FG000|Overall Study|Lost to Follow-up|4|||
130190677|NCT04031846|468655792|FG001|Overall Study|Lost to Follow-up|4|||
130190678|NCT04031846|468655791|FG000|Overall Study|Physician Decision|0|||
130190679|NCT04031846|468655792|FG001|Overall Study|Physician Decision|1|||
130190680|NCT04031846|468655791|FG000|Overall Study|Protocol Violation|1|||
130190681|NCT04031846|468655792|FG001|Overall Study|Protocol Violation|1|||
130190682|NCT04031846|468655791|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
130190683|NCT04031846|468655792|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
130190684|NCT06868654|468655793|FG000|Overall Study|Death|4|||
130190685|NCT06868654|468655794|FG001|Overall Study|Death|14|||
130190686|NCT06868654|468655793|FG000|Overall Study|Lost to Follow-up|0|||
130190687|NCT06868654|468655794|FG001|Overall Study|Lost to Follow-up|1|||
130190688|NCT06868654|468655793|FG000|Overall Study|Withdrawal by Subject|5|||
130190689|NCT06868654|468655794|FG001|Overall Study|Withdrawal by Subject|3|||
130190690|NCT06868654|468655793|FG000|Overall Study|Physician Decision|0|||
130190691|NCT06868654|468655794|FG001|Overall Study|Physician Decision|1|||
130190692|NCT06868654|468655793|FG000|Overall Study|Ongoing|23|||
130190693|NCT06868654|468655794|FG001|Overall Study|Ongoing|21|||
130190694|NCT01777282|468655801|FG000|Overall Study|Persistent Hyperglycemia|0|||
130190695|NCT01777282|468655802|FG001|Overall Study|Persistent Hyperglycemia|0|||
130190696|NCT01777282|468655803|FG002|Overall Study|Persistent Hyperglycemia|1|||
130190697|NCT01777282|468655804|FG003|Overall Study|Persistent Hyperglycemia|0|||
130190698|NCT01777282|468655805|FG004|Overall Study|Persistent Hyperglycemia|0|||
130190699|NCT01777282|468655801|FG000|Overall Study|New Antidiabetic Medication|0|||
130190700|NCT01777282|468655802|FG001|Overall Study|New Antidiabetic Medication|0|||
130190701|NCT01777282|468655803|FG002|Overall Study|New Antidiabetic Medication|1|||
130190702|NCT01777282|468655804|FG003|Overall Study|New Antidiabetic Medication|0|||
130190703|NCT01777282|468655805|FG004|Overall Study|New Antidiabetic Medication|0|||
130190704|NCT01777282|468655801|FG000|Overall Study|Adverse Event|4|||
130190705|NCT01777282|468655802|FG001|Overall Study|Adverse Event|4|||
130190706|NCT01777282|468655803|FG002|Overall Study|Adverse Event|2|||
130190707|NCT01777282|468655804|FG003|Overall Study|Adverse Event|1|||
130190708|NCT01777282|468655805|FG004|Overall Study|Adverse Event|3|||
130190709|NCT01777282|468655801|FG000|Overall Study|Withdrawal by Subject|4|||
130190710|NCT01777282|468655802|FG001|Overall Study|Withdrawal by Subject|0|||
130190711|NCT01777282|468655803|FG002|Overall Study|Withdrawal by Subject|0|||
130190712|NCT01777282|468655804|FG003|Overall Study|Withdrawal by Subject|1|||
130190713|NCT01777282|468655805|FG004|Overall Study|Withdrawal by Subject|2|||
130190714|NCT01777282|468655801|FG000|Overall Study|Protocol Violation|2|||
130190715|NCT01777282|468655802|FG001|Overall Study|Protocol Violation|0|||
130190716|NCT01777282|468655803|FG002|Overall Study|Protocol Violation|1|||
130190717|NCT01777282|468655804|FG003|Overall Study|Protocol Violation|0|||
130190718|NCT01777282|468655805|FG004|Overall Study|Protocol Violation|2|||
130190719|NCT01777282|468655801|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130190720|NCT01777282|468655802|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190721|NCT01777282|468655803|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130190722|NCT01777282|468655804|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190723|NCT01777282|468655805|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190724|NCT01131455|468655806|FG000|Overall Study|Death of PI|6|||
130190725|NCT01131455|468655807|FG001|Overall Study|Death of PI|4|||
130190726|NCT01131455|468655808|FG002|Overall Study|Death of PI|0|||
130190727|NCT00764660|468655809|FG000|Overall Study|Adverse Event|6|||
130190728|NCT00764660|468655810|FG001|Overall Study|Adverse Event|3|||
130190729|NCT00764660|468655809|FG000|Overall Study|Lost to Follow-up|3|||
130190730|NCT00764660|468655810|FG001|Overall Study|Lost to Follow-up|4|||
130190731|NCT00764660|468655809|FG000|Overall Study|Withdrawal by Subject|7|||
130190732|NCT00764660|468655810|FG001|Overall Study|Withdrawal by Subject|3|||
130190733|NCT00764660|468655809|FG000|Overall Study|Noncompliance With Protocol|5|||
130190734|NCT00764660|468655810|FG001|Overall Study|Noncompliance With Protocol|1|||
130190735|NCT00764660|468655809|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130190736|NCT00764660|468655810|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130190737|NCT03103152|468655811|FG000|Overall Study|Physician Decision|5|||
130190738|NCT03103152|468655812|FG001|Overall Study|Physician Decision|2|||
130190739|NCT03103152|468655813|FG002|Overall Study|Physician Decision|6|||
130190740|NCT03103152|468655814|FG003|Overall Study|Physician Decision|3|||
130190741|NCT03103152|468655815|FG004|Overall Study|Physician Decision|3|||
130190742|NCT03103152|468655816|FG005|Overall Study|Physician Decision|1|||
130190743|NCT03103152|468655811|FG000|Overall Study|Protocol Violation|2|||
130190744|NCT03103152|468655812|FG001|Overall Study|Protocol Violation|2|||
130190745|NCT03103152|468655813|FG002|Overall Study|Protocol Violation|1|||
130190746|NCT03103152|468655814|FG003|Overall Study|Protocol Violation|2|||
130190747|NCT03103152|468655815|FG004|Overall Study|Protocol Violation|1|||
130190748|NCT03103152|468655816|FG005|Overall Study|Protocol Violation|1|||
130190749|NCT03103152|468655811|FG000|Overall Study|Inter-current illness|0|||
130190750|NCT03103152|468655812|FG001|Overall Study|Inter-current illness|0|||
130190751|NCT03103152|468655813|FG002|Overall Study|Inter-current illness|1|||
130190752|NCT03103152|468655814|FG003|Overall Study|Inter-current illness|0|||
130190753|NCT03103152|468655815|FG004|Overall Study|Inter-current illness|0|||
130190754|NCT03103152|468655816|FG005|Overall Study|Inter-current illness|0|||
130190755|NCT03103152|468655811|FG000|Overall Study|Death|0|||
130190756|NCT03103152|468655812|FG001|Overall Study|Death|1|||
130190757|NCT03103152|468655813|FG002|Overall Study|Death|0|||
130190758|NCT03103152|468655814|FG003|Overall Study|Death|0|||
130190759|NCT03103152|468655815|FG004|Overall Study|Death|0|||
130190760|NCT03103152|468655816|FG005|Overall Study|Death|0|||
130190761|NCT03103152|468655811|FG000|Overall Study|Adverse Event|0|||
130190762|NCT03103152|468655812|FG001|Overall Study|Adverse Event|0|||
130190763|NCT03103152|468655813|FG002|Overall Study|Adverse Event|1|||
130190764|NCT03103152|468655814|FG003|Overall Study|Adverse Event|0|||
130190765|NCT03103152|468655815|FG004|Overall Study|Adverse Event|0|||
130190766|NCT03103152|468655816|FG005|Overall Study|Adverse Event|1|||
130190767|NCT03103152|468655811|FG000|Overall Study|Withdrawal by Subject|1|||
130190768|NCT03103152|468655812|FG001|Overall Study|Withdrawal by Subject|0|||
130190769|NCT03103152|468655813|FG002|Overall Study|Withdrawal by Subject|1|||
130190770|NCT03103152|468655814|FG003|Overall Study|Withdrawal by Subject|1|||
130190771|NCT03103152|468655815|FG004|Overall Study|Withdrawal by Subject|1|||
130190772|NCT03103152|468655816|FG005|Overall Study|Withdrawal by Subject|1|||
130190773|NCT03103152|468655811|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
130190774|NCT03103152|468655812|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
130190775|NCT03103152|468655813|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
130190776|NCT03103152|468655814|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
130190777|NCT03103152|468655815|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
130190778|NCT03103152|468655816|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
130190779|NCT03103152|468655811|FG000|Overall Study|Unacceptable side effects|0|||
130190780|NCT03103152|468655812|FG001|Overall Study|Unacceptable side effects|0|||
130190781|NCT03103152|468655813|FG002|Overall Study|Unacceptable side effects|0|||
130190782|NCT03103152|468655814|FG003|Overall Study|Unacceptable side effects|0|||
130190783|NCT03103152|468655815|FG004|Overall Study|Unacceptable side effects|0|||
130190784|NCT03103152|468655816|FG005|Overall Study|Unacceptable side effects|1|||
130190785|NCT03103152|468655811|FG000|Overall Study|Lost to Follow-up|0|||
130190786|NCT03103152|468655812|FG001|Overall Study|Lost to Follow-up|1|||
130190787|NCT03103152|468655813|FG002|Overall Study|Lost to Follow-up|0|||
130190788|NCT03103152|468655814|FG003|Overall Study|Lost to Follow-up|1|||
130190789|NCT03103152|468655815|FG004|Overall Study|Lost to Follow-up|0|||
130190790|NCT03103152|468655816|FG005|Overall Study|Lost to Follow-up|1|||
130190791|NCT03103152|468655811|FG000|Overall Study|Testicular pain|0|||
130190792|NCT03103152|468655812|FG001|Overall Study|Testicular pain|0|||
130190793|NCT03103152|468655813|FG002|Overall Study|Testicular pain|0|||
130190794|NCT03103152|468655814|FG003|Overall Study|Testicular pain|1|||
130190795|NCT03103152|468655815|FG004|Overall Study|Testicular pain|0|||
130190796|NCT03103152|468655816|FG005|Overall Study|Testicular pain|0|||
130190797|NCT03668119|468657204|FG000|Pre-treatment|Disease Progression|1|||
130190798|NCT03668119|468657205|FG001|Pre-treatment|Disease Progression|0|||
130190799|NCT03668119|468657204|FG000|Treatment|Disease Progression|76|||
130190800|NCT03668119|468657205|FG001|Treatment|Disease Progression|57|||
130190801|NCT03668119|468657204|FG000|Treatment|Study drug toxicity|19|||
130190802|NCT03668119|468657205|FG001|Treatment|Study drug toxicity|1|||
130190803|NCT03668119|468657204|FG000|Treatment|Death|3|||
130190804|NCT03668119|468657205|FG001|Treatment|Death|0|||
130190805|NCT03668119|468657204|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
130190806|NCT03668119|468657205|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
130190807|NCT03668119|468657204|FG000|Treatment|Withdrawal by Subject|1|||
130190808|NCT03668119|468657205|FG001|Treatment|Withdrawal by Subject|1|||
130190809|NCT03668119|468657204|FG000|Treatment|Participant request to discontinue study treatment|3|||
130190810|NCT03668119|468657205|FG001|Treatment|Participant request to discontinue study treatment|1|||
130190811|NCT03668119|468657204|FG000|Treatment|Maximum Clinical Benefit|0|||
130190812|NCT03668119|468657205|FG001|Treatment|Maximum Clinical Benefit|1|||
130190813|NCT03668119|468657204|FG000|Treatment|Participants completed treatment|27|||
130190814|NCT03668119|468657205|FG001|Treatment|Participants completed treatment|11|||
130190815|NCT03668119|468657204|FG000|Treatment|Other reasons|2|||
130190816|NCT03668119|468657205|FG001|Treatment|Other reasons|1|||
130190817|NCT05336227|468657206|FG000|Overall Study|Adverse Event|1|||
130190818|NCT05336227|468657207|FG001|Overall Study|Adverse Event|0|||
130190819|NCT05336227|468657206|FG000|Overall Study|Lost to Follow-up|2|||
130190820|NCT05336227|468657207|FG001|Overall Study|Lost to Follow-up|0|||
130190821|NCT05336227|468657206|FG000|Overall Study|Withdrawal by Subject|1|||
130190822|NCT05336227|468657207|FG001|Overall Study|Withdrawal by Subject|0|||
130190823|NCT00684411|468657210|FG000|Overall Study|New Primary Cancer|1|||
130190824|NCT00684411|468657210|FG000|Overall Study|Disease Progression|10|||
130190825|NCT00684411|468657210|FG000|Overall Study|Adverse Event|1|||
130190826|NCT01344824|468657211|FG000|Overall Study|Adverse Event|15|||
130190827|NCT01344824|468657211|FG000|Overall Study|Withdrawal by Subject|6|||
130190828|NCT01344824|468657211|FG000|Overall Study|Other complicating disease|1|||
130190829|NCT01344824|468657211|FG000|Overall Study|Progression|15|||
130190830|NCT01295671|468657214|FG000|Overall Study|Lost to Follow-up|4|||
130190831|NCT01295671|468657215|FG001|Overall Study|Lost to Follow-up|6|||
130190832|NCT01295671|468657216|FG002|Overall Study|Lost to Follow-up|3|||
130190833|NCT01295671|468657214|FG000|Overall Study|Withdrawal by Subject|3|||
130190834|NCT01295671|468657215|FG001|Overall Study|Withdrawal by Subject|1|||
130190835|NCT01295671|468657216|FG002|Overall Study|Withdrawal by Subject|0|||
130190836|NCT02058537|468657217|FG000|Overall Study|Withdrawal by Subject|1|||
130190837|NCT02366637|468657218|FG000|First Intervention Period|Adverse Event|0|||
130190838|NCT02366637|468657219|FG001|First Intervention Period|Adverse Event|1|||
130190839|NCT02366637|468657218|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
130190840|NCT02366637|468657219|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
130190841|NCT02366637|468657218|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
130190842|NCT02366637|468657219|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
130190843|NCT00651261|468657220|FG000|Overall Study|Adverse Event|32|||
130190844|NCT00651261|468657221|FG001|Overall Study|Adverse Event|22|||
130190845|NCT00651261|468657220|FG000|Overall Study|Death|18|||
130190846|NCT00651261|468657221|FG001|Overall Study|Death|18|||
130190847|NCT00651261|468657220|FG000|Overall Study|Withdrawal by Subject|22|||
130190848|NCT00651261|468657221|FG001|Overall Study|Withdrawal by Subject|40|||
130190849|NCT00651261|468657220|FG000|Overall Study|Induction failure|24|||
130190850|NCT00651261|468657221|FG001|Overall Study|Induction failure|35|||
130190851|NCT00651261|468657220|FG000|Overall Study|Disease progression|58|||
130190852|NCT00651261|468657221|FG001|Overall Study|Disease progression|58|||
130190853|NCT00651261|468657220|FG000|Overall Study|Alternative therapy|109|||
130190854|NCT00651261|468657221|FG001|Overall Study|Alternative therapy|107|||
130190855|NCT00651261|468657220|FG000|Overall Study|Other disease or participant decisions|23|||
130190856|NCT00651261|468657221|FG001|Overall Study|Other disease or participant decisions|23|||
130190857|NCT00651261|468657220|FG000|Overall Study|Never treated|5|||
130190858|NCT00651261|468657221|FG001|Overall Study|Never treated|3|||
130190859|NCT01609010|468657222|FG000|Overall Study|Stable disease (SD)|22|||
130190860|NCT01609010|468657223|FG001|Overall Study|Stable disease (SD)|16|||
130190861|NCT01609010|468657222|FG000|Overall Study|Progressive disease (PD)|8|||
130190862|NCT01609010|468657223|FG001|Overall Study|Progressive disease (PD)|10|||
130190863|NCT01609010|468657222|FG000|Overall Study|Adverse Event|3|||
130190864|NCT01609010|468657223|FG001|Overall Study|Adverse Event|6|||
130190865|NCT01609010|468657222|FG000|Overall Study|Withdrawal by Subject|2|||
130190866|NCT01609010|468657223|FG001|Overall Study|Withdrawal by Subject|2|||
130190867|NCT01609010|468657222|FG000|Overall Study|Other|2|||
130190868|NCT01609010|468657223|FG001|Overall Study|Other|0|||
130190869|NCT01609010|468657222|FG000|Overall Study|Other malignancy|1|||
130190870|NCT01609010|468657223|FG001|Overall Study|Other malignancy|0|||
130190871|NCT01609010|468657222|FG000|Overall Study|Pathology review|2|||
130190872|NCT01609010|468657223|FG001|Overall Study|Pathology review|1|||
130190873|NCT01609010|468657222|FG000|Overall Study|Protocol Violation|1|||
130190874|NCT01609010|468657223|FG001|Overall Study|Protocol Violation|1|||
130190875|NCT01609010|468657222|FG000|Overall Study|New cancer|1|||
130190876|NCT01609010|468657223|FG001|Overall Study|New cancer|0|||
130190877|NCT01609010|468657222|FG000|Overall Study|Lost to Follow-up|1|||
130190878|NCT01609010|468657223|FG001|Overall Study|Lost to Follow-up|1|||
130190879|NCT00687271|468657224|FG000|Overall Study|Adverse Event|1|||
130190880|NCT00687271|468657225|FG001|Overall Study|Adverse Event|3|||
130190881|NCT00687271|468657226|FG002|Overall Study|Adverse Event|1|||
130190882|NCT00687271|468657227|FG003|Overall Study|Adverse Event|0|||
130190883|NCT00687271|468657224|FG000|Overall Study|Lost to Follow-up|0|||
130190884|NCT00687271|468657225|FG001|Overall Study|Lost to Follow-up|1|||
130190885|NCT00687271|468657226|FG002|Overall Study|Lost to Follow-up|0|||
130190886|NCT00687271|468657227|FG003|Overall Study|Lost to Follow-up|0|||
130190887|NCT00687271|468657224|FG000|Overall Study|Protocol Violation|2|||
130190888|NCT00687271|468657225|FG001|Overall Study|Protocol Violation|1|||
130190889|NCT00687271|468657226|FG002|Overall Study|Protocol Violation|1|||
130190890|NCT00687271|468657227|FG003|Overall Study|Protocol Violation|0|||
130190891|NCT00687271|468657224|FG000|Overall Study|Withdrawal by Subject|0|||
130190892|NCT00687271|468657225|FG001|Overall Study|Withdrawal by Subject|1|||
130190893|NCT00687271|468657226|FG002|Overall Study|Withdrawal by Subject|3|||
130190894|NCT00687271|468657227|FG003|Overall Study|Withdrawal by Subject|0|||
130190895|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
130190896|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
130190897|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130190898|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130190899|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
130190900|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
130190901|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
130190902|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
130190903|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
130190904|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
130190905|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
130190906|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
130190907|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
130190908|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
130190909|NCT05483686|468657236|FG000|Overall Study|Lost to Follow-up|5|||
130190910|NCT05483686|468657237|FG001|Overall Study|Lost to Follow-up|7|||
130190911|NCT03351608|468657241|FG000|Overall Study|Lost to Follow-up|0|||
130190912|NCT03351608|468657242|FG001|Overall Study|Lost to Follow-up|1|||
130190913|NCT03351608|468657243|FG002|Overall Study|Lost to Follow-up|1|||
130190914|NCT03351608|468657244|FG003|Overall Study|Lost to Follow-up|1|||
130190915|NCT03351608|468657245|FG004|Overall Study|Lost to Follow-up|1|||
130190916|NCT03351608|468657241|FG000|Overall Study|Physician Decision|1|||
130190917|NCT03351608|468657242|FG001|Overall Study|Physician Decision|0|||
130190918|NCT03351608|468657243|FG002|Overall Study|Physician Decision|0|||
130190919|NCT03351608|468657244|FG003|Overall Study|Physician Decision|2|||
130190920|NCT03351608|468657245|FG004|Overall Study|Physician Decision|1|||
130190921|NCT03351608|468657241|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
130190922|NCT03351608|468657242|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
130190923|NCT03351608|468657243|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
130190924|NCT03351608|468657244|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
130190925|NCT03351608|468657245|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
130190926|NCT03351608|468657241|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130190927|NCT03351608|468657242|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130190928|NCT03351608|468657243|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130190929|NCT03351608|468657244|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130190930|NCT03351608|468657245|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130190931|NCT03351608|468657241|FG000|Overall Study|Other|0|||
130190932|NCT03351608|468657242|FG001|Overall Study|Other|1|||
130190933|NCT03351608|468657243|FG002|Overall Study|Other|1|||
130190934|NCT03351608|468657244|FG003|Overall Study|Other|3|||
130190935|NCT03351608|468657245|FG004|Overall Study|Other|0|||
130190936|NCT02727478|468657246|FG000|Overall Study|Withdrawal by Subject|8|||
130190937|NCT02727478|468657247|FG001|Overall Study|Withdrawal by Subject|10|||
130190938|NCT00808210|468657251|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
130190939|NCT00808210|468657252|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
130190940|NCT00808210|468657251|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
130190941|NCT00808210|468657252|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
130190942|NCT00808210|468657251|FG000|Double-Blind TX Period|Adverse Event|0|||
130190943|NCT00808210|468657252|FG001|Double-Blind TX Period|Adverse Event|1|||
130190944|NCT00808210|468657251|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130190945|NCT00808210|468657252|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130190946|NCT00808210|468657251|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130190947|NCT00808210|468657252|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130190948|NCT00808210|468657251|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
130190949|NCT00808210|468657252|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
130190950|NCT03877068|468657253|FG000|Overall Study|Physician Decision|9|||
130190951|NCT03877068|468657254|FG001|Overall Study|Physician Decision|3|||
130190952|NCT03150719|468657257|FG000|Overall Study|Adverse Event|0|||
130190953|NCT03150719|468657258|FG001|Overall Study|Adverse Event|1|||
130190954|NCT03150719|468657257|FG000|Overall Study|Death|0|||
130190955|NCT03150719|468657258|FG001|Overall Study|Death|1|||
130190956|NCT03150719|468657257|FG000|Overall Study|Other|1|||
130190957|NCT03150719|468657258|FG001|Overall Study|Other|0|||
130190958|NCT00288626|468657263|FG000|Overall Study|Death|3|||
130190959|NCT00288626|468657263|FG000|Overall Study|Withdrawal by Subject|4|||
130190960|NCT02019264|468657265|FG000|Overall Study|Not treated|6|||
130190961|NCT02019264|468657266|FG001|Overall Study|Not treated|4|||
130190962|NCT02019264|468657265|FG000|Overall Study|Lost to Follow-up|50|||
130190963|NCT02019264|468657266|FG001|Overall Study|Lost to Follow-up|47|||
130190964|NCT02019264|468657265|FG000|Overall Study|Withdrawal by Subject|142|||
130190965|NCT02019264|468657266|FG001|Overall Study|Withdrawal by Subject|117|||
130190966|NCT02019264|468657265|FG000|Overall Study|Administrative reason|36|||
130190967|NCT02019264|468657266|FG001|Overall Study|Administrative reason|28|||
130190968|NCT02019264|468657265|FG000|Overall Study|Missing|14|||
130190969|NCT02019264|468657266|FG001|Overall Study|Missing|11|||
130190970|NCT02914613|468657267|FG000|Overall Study|Withdrawal by Subject|1|||
130190971|NCT02914613|468657268|FG001|Overall Study|Withdrawal by Subject|2|||
130190972|NCT02914613|468657267|FG000|Overall Study|Adverse Event|1|||
130190973|NCT02914613|468657268|FG001|Overall Study|Adverse Event|0|||
130190974|NCT01964222|468657272|FG000|Overall Study|Lost to Follow-up|7|||
130190975|NCT01964222|468657273|FG001|Overall Study|Lost to Follow-up|5|||
130190976|NCT01964222|468657272|FG000|Overall Study|Withdrawal by Subject|6|||
130190977|NCT01964222|468657273|FG001|Overall Study|Withdrawal by Subject|6|||
130190978|NCT01964222|468657272|FG000|Overall Study|Screening Failure|2|||
130190979|NCT01964222|468657273|FG001|Overall Study|Screening Failure|0|||
130190980|NCT02677922|468657284|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130190981|NCT02677922|468657285|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
130190982|NCT02677922|468657286|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
130190983|NCT02677922|468657287|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
130190984|NCT02677922|468657288|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
130190985|NCT02677922|468657289|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
130190986|NCT02677922|468657284|FG000|Treatment Period|Adverse Event|0|||
130190987|NCT02677922|468657285|FG001|Treatment Period|Adverse Event|0|||
130190988|NCT02677922|468657286|FG002|Treatment Period|Adverse Event|1|||
130190989|NCT02677922|468657287|FG003|Treatment Period|Adverse Event|3|||
130190990|NCT02677922|468657288|FG004|Treatment Period|Adverse Event|5|||
130190991|NCT02677922|468657289|FG005|Treatment Period|Adverse Event|2|||
130190992|NCT02677922|468657284|FG000|Treatment Period|Progressive Disease|1|||
130190993|NCT02677922|468657285|FG001|Treatment Period|Progressive Disease|1|||
130190994|NCT02677922|468657286|FG002|Treatment Period|Progressive Disease|0|||
130190995|NCT02677922|468657287|FG003|Treatment Period|Progressive Disease|0|||
130190996|NCT02677922|468657288|FG004|Treatment Period|Progressive Disease|8|||
130190997|NCT02677922|468657289|FG005|Treatment Period|Progressive Disease|7|||
130190998|NCT02677922|468657284|FG000|Treatment Period|Lack of Efficacy|0|||
130190999|NCT02677922|468657285|FG001|Treatment Period|Lack of Efficacy|0|||
130191000|NCT02677922|468657286|FG002|Treatment Period|Lack of Efficacy|0|||
130191001|NCT02677922|468657287|FG003|Treatment Period|Lack of Efficacy|1|||
130191002|NCT02677922|468657288|FG004|Treatment Period|Lack of Efficacy|1|||
130191003|NCT02677922|468657289|FG005|Treatment Period|Lack of Efficacy|6|||
130191004|NCT02677922|468657284|FG000|Treatment Period|Withdrawal by Subject|0|||
130191005|NCT02677922|468657285|FG001|Treatment Period|Withdrawal by Subject|0|||
130191006|NCT02677922|468657286|FG002|Treatment Period|Withdrawal by Subject|1|||
130191007|NCT02677922|468657287|FG003|Treatment Period|Withdrawal by Subject|3|||
130191008|NCT02677922|468657288|FG004|Treatment Period|Withdrawal by Subject|5|||
130191009|NCT02677922|468657289|FG005|Treatment Period|Withdrawal by Subject|5|||
130191010|NCT02677922|468657284|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
130191011|NCT02677922|468657285|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
130191012|NCT02677922|468657286|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
130191013|NCT02677922|468657287|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
130191014|NCT02677922|468657288|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
130191015|NCT02677922|468657289|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
130191016|NCT02677922|468657284|FG000|Treatment Period|Disease Relapse|0|||
130191017|NCT02677922|468657285|FG001|Treatment Period|Disease Relapse|0|||
130191018|NCT02677922|468657286|FG002|Treatment Period|Disease Relapse|0|||
130191019|NCT02677922|468657287|FG003|Treatment Period|Disease Relapse|3|||
130191020|NCT02677922|468657288|FG004|Treatment Period|Disease Relapse|6|||
130191021|NCT02677922|468657289|FG005|Treatment Period|Disease Relapse|1|||
130191022|NCT02677922|468657284|FG000|Treatment Period|Allogeneic HSCT|1|||
130191023|NCT02677922|468657285|FG001|Treatment Period|Allogeneic HSCT|0|||
130191024|NCT02677922|468657286|FG002|Treatment Period|Allogeneic HSCT|0|||
130191025|NCT02677922|468657287|FG003|Treatment Period|Allogeneic HSCT|1|||
130191026|NCT02677922|468657288|FG004|Treatment Period|Allogeneic HSCT|4|||
130191027|NCT02677922|468657289|FG005|Treatment Period|Allogeneic HSCT|1|||
130191028|NCT02677922|468657284|FG000|Treatment Period|Other Reasons|0|||
130191029|NCT02677922|468657285|FG001|Treatment Period|Other Reasons|0|||
130191030|NCT02677922|468657286|FG002|Treatment Period|Other Reasons|0|||
130191031|NCT02677922|468657287|FG003|Treatment Period|Other Reasons|1|||
130191032|NCT02677922|468657288|FG004|Treatment Period|Other Reasons|3|||
130191033|NCT02677922|468657289|FG005|Treatment Period|Other Reasons|5|||
130191034|NCT02677922|468657284|FG000|Treatment Period|Death|0|||
130191035|NCT02677922|468657285|FG001|Treatment Period|Death|0|||
130191036|NCT02677922|468657286|FG002|Treatment Period|Death|0|||
130191037|NCT02677922|468657287|FG003|Treatment Period|Death|0|||
130191038|NCT02677922|468657288|FG004|Treatment Period|Death|12|||
130191039|NCT02677922|468657289|FG005|Treatment Period|Death|1|||
130191040|NCT02677922|468657284|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130191041|NCT02677922|468657285|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130191042|NCT02677922|468657286|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130191043|NCT02677922|468657287|FG003|Treatment Period|Non-compliance with Study Drug|0|||
130191044|NCT02677922|468657288|FG004|Treatment Period|Non-compliance with Study Drug|1|||
130191045|NCT02677922|468657289|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130191046|NCT02677922|468657284|FG000|Treatment Period|Physician Decision|0|||
130191047|NCT02677922|468657285|FG001|Treatment Period|Physician Decision|0|||
130191048|NCT02677922|468657286|FG002|Treatment Period|Physician Decision|0|||
130191049|NCT02677922|468657287|FG003|Treatment Period|Physician Decision|0|||
130191050|NCT02677922|468657288|FG004|Treatment Period|Physician Decision|0|||
130191051|NCT02677922|468657289|FG005|Treatment Period|Physician Decision|1|||
130191052|NCT02677922|468657284|FG000|Treatment Period|Symptomatic Deterioration|0|||
130191053|NCT02677922|468657285|FG001|Treatment Period|Symptomatic Deterioration|0|||
130191054|NCT02677922|468657286|FG002|Treatment Period|Symptomatic Deterioration|0|||
130191055|NCT02677922|468657287|FG003|Treatment Period|Symptomatic Deterioration|0|||
130191056|NCT02677922|468657288|FG004|Treatment Period|Symptomatic Deterioration|1|||
130191057|NCT02677922|468657289|FG005|Treatment Period|Symptomatic Deterioration|0|||
130191058|NCT05310071|468657290|FG000|Overall Study|Death|0|||
130191059|NCT05310071|468657291|FG001|Overall Study|Death|3|||
130191060|NCT05310071|468657290|FG000|Overall Study|Adverse Event|4|||
130191061|NCT05310071|468657291|FG001|Overall Study|Adverse Event|31|||
130191062|NCT05310071|468657290|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
130191063|NCT05310071|468657291|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
130191064|NCT05310071|468657290|FG000|Overall Study|Protocol Deviation|2|||
130191065|NCT05310071|468657291|FG001|Overall Study|Protocol Deviation|0|||
130191066|NCT05310071|468657290|FG000|Overall Study|Randomized by Mistake|0|||
130191067|NCT05310071|468657291|FG001|Overall Study|Randomized by Mistake|1|||
130191068|NCT05310071|468657290|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
130191069|NCT05310071|468657291|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130191070|NCT05310071|468657290|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130191071|NCT05310071|468657291|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130191072|NCT05310071|468657290|FG000|Overall Study|Site Terminated by Sponsor|0|||
130191073|NCT05310071|468657291|FG001|Overall Study|Site Terminated by Sponsor|2|||
130191074|NCT05310071|468657290|FG000|Overall Study|Study Terminated by Sponsor|282|||
130191075|NCT05310071|468657291|FG001|Overall Study|Study Terminated by Sponsor|559|||
130191076|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
130191077|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
130191078|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
130191079|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
130191080|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
130191081|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
130191082|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
130191083|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
130191084|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Other|25|||
130191085|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Other|30|||
130191086|NCT05310071|468657290|FG000|Overall Study|Lost to Follow-up|2|||
130191087|NCT05310071|468657291|FG001|Overall Study|Lost to Follow-up|4|||
130191088|NCT05310071|468657290|FG000|Overall Study|Reason Not Specified|1|||
130191089|NCT05310071|468657291|FG001|Overall Study|Reason Not Specified|3|||
130191090|NCT03515811|468657296|FG000|Overall Study|Lost to Follow-up|2|||
130191091|NCT03515811|468657297|FG001|Overall Study|Lost to Follow-up|1|||
130191092|NCT03515811|468657296|FG000|Overall Study|Protocol Violation|1|||
130191093|NCT03515811|468657297|FG001|Overall Study|Protocol Violation|1|||
130191094|NCT03515811|468657296|FG000|Overall Study|Death|1|||
130191095|NCT03515811|468657297|FG001|Overall Study|Death|1|||
130191096|NCT03515811|468657296|FG000|Overall Study|Withdrawal by Subject|0|||
130191097|NCT03515811|468657297|FG001|Overall Study|Withdrawal by Subject|2|||
130191098|NCT03515811|468657296|FG000|Overall Study|Technical Problems|1|||
130191099|NCT03515811|468657297|FG001|Overall Study|Technical Problems|0|||
130191100|NCT03515811|468657296|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
130191101|NCT03515811|468657297|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
130191102|NCT03515811|468657296|FG000|Overall Study|COVID-19|0|||
130191103|NCT03515811|468657297|FG001|Overall Study|COVID-19|1|||
130191104|NCT05107492|468657298|FG000|Overall Study|Lost to Follow-up|1|||
130191105|NCT05107492|468657299|FG001|Overall Study|Lost to Follow-up|0|||
130191106|NCT04339062|468657300|FG000|Overall Study|Death|0|||
130191107|NCT04339062|468657301|FG001|Overall Study|Death|1|||
130191108|NCT02589639|468657303|FG000|Overall Study|Lost to Follow-up|1|||
130191109|NCT02589639|468657304|FG001|Overall Study|Lost to Follow-up|0|||
130191110|NCT02589639|468657305|FG002|Overall Study|Lost to Follow-up|0|||
130191111|NCT02589639|468657303|FG000|Overall Study|Protocol Violation|1|||
130191112|NCT02589639|468657304|FG001|Overall Study|Protocol Violation|0|||
130191113|NCT02589639|468657305|FG002|Overall Study|Protocol Violation|0|||
130191114|NCT02589639|468657303|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
130191115|NCT02589639|468657304|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
130191116|NCT02589639|468657305|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
130191117|NCT02589639|468657303|FG000|Overall Study|Adverse Event|4|||
130191118|NCT02589639|468657304|FG001|Overall Study|Adverse Event|5|||
130191119|NCT02589639|468657305|FG002|Overall Study|Adverse Event|3|||
130191120|NCT02589639|468657303|FG000|Overall Study|Other reason than specified above|1|||
130191121|NCT02589639|468657304|FG001|Overall Study|Other reason than specified above|2|||
130191122|NCT02589639|468657305|FG002|Overall Study|Other reason than specified above|1|||
130191123|NCT02589639|468657303|FG000|Overall Study|Not Treated|0|||
130191124|NCT02589639|468657304|FG001|Overall Study|Not Treated|3|||
130191125|NCT02589639|468657305|FG002|Overall Study|Not Treated|0|||
130191126|NCT00703157|468657306|FG000|Overall Study|Lost to Follow-up|0|||
130191127|NCT00703157|468657307|FG001|Overall Study|Lost to Follow-up|1|||
130191128|NCT00703157|468657306|FG000|Overall Study|source data permanently lost/ other|4|||
130191129|NCT00703157|468657307|FG001|Overall Study|source data permanently lost/ other|1|||
130191130|NCT02968173|468657308|FG000|Overall Study|Withdrawal by Subject|1|||
130191131|NCT02670525|468657309|FG000|Overall Study|Death|94|||
130191132|NCT02670525|468657310|FG001|Overall Study|Death|14|||
130191133|NCT02670525|468657309|FG000|Overall Study|Lost to Follow-up|4|||
130191134|NCT02670525|468657310|FG001|Overall Study|Lost to Follow-up|1|||
130191135|NCT02670525|468657309|FG000|Overall Study|Subject withdrew consent|1|||
130191136|NCT02670525|468657310|FG001|Overall Study|Subject withdrew consent|0|||
130191137|NCT02670525|468657309|FG000|Overall Study|Unknown, data entry delayed|123|||
130191138|NCT02670525|468657310|FG001|Overall Study|Unknown, data entry delayed|78|||
130191139|NCT00591565|468657311|FG000|Overall Study|lost follow up, withdrawn|5|||
130191140|NCT03564119|468657315|FG000|Overall Study|Adverse Event|4|||
130191141|NCT03564119|468657316|FG001|Overall Study|Adverse Event|0|||
130191142|NCT03564119|468657315|FG000|Overall Study|Lost to Follow-up|1|||
130191143|NCT03564119|468657316|FG001|Overall Study|Lost to Follow-up|4|||
130191144|NCT03564119|468657315|FG000|Overall Study|Protocol Violation|1|||
130191145|NCT03564119|468657316|FG001|Overall Study|Protocol Violation|0|||
130191146|NCT03564119|468657315|FG000|Overall Study|Withdrawal by Subject|9|||
130191147|NCT03564119|468657316|FG001|Overall Study|Withdrawal by Subject|4|||
130191148|NCT03564119|468657315|FG000|Overall Study|Other Than Specified|0|||
130191149|NCT03564119|468657316|FG001|Overall Study|Other Than Specified|1|||
130191150|NCT00634036|468657317|FG000|Overall Study|Lost to Follow-up|1|||
130191151|NCT00634036|468657318|FG001|Overall Study|Lost to Follow-up|1|||
130191152|NCT00634036|468657317|FG000|Overall Study|Withdrawal by Subject|1|||
130191153|NCT00634036|468657318|FG001|Overall Study|Withdrawal by Subject|1|||
130191154|NCT03896022|468657324|FG000|Overall Study|Withdrawal by Subject|1|||
130191155|NCT03896022|468657325|FG001|Overall Study|Withdrawal by Subject|0|||
130191156|NCT03896022|468657326|FG002|Overall Study|Withdrawal by Subject|0|||
130191157|NCT03896022|468657324|FG000|Overall Study|Did not have procedure|3|||
130191158|NCT03896022|468657325|FG001|Overall Study|Did not have procedure|0|||
130191159|NCT03896022|468657326|FG002|Overall Study|Did not have procedure|0|||
130191160|NCT00564850|468657331|FG000|Overall Study|Protocol Violation|2|||
130191161|NCT00314327|468657332|FG000|Overall Study|Withdrawal by Subject|1|||
130191162|NCT02741076|468657333|FG000|Overall Study|Adverse Event|0|||
130191163|NCT02741076|468657334|FG001|Overall Study|Adverse Event|1|||
130191164|NCT02741076|468657335|FG002|Overall Study|Adverse Event|1|||
130191165|NCT02741076|468657336|FG003|Overall Study|Adverse Event|0|||
130191166|NCT02741076|468657333|FG000|Overall Study|Lack of Efficacy|1|||
130191167|NCT02741076|468657334|FG001|Overall Study|Lack of Efficacy|0|||
130191168|NCT02741076|468657335|FG002|Overall Study|Lack of Efficacy|0|||
130191169|NCT02741076|468657336|FG003|Overall Study|Lack of Efficacy|0|||
130191170|NCT02741076|468657333|FG000|Overall Study|Withdrawal by Subject|0|||
130191171|NCT02741076|468657334|FG001|Overall Study|Withdrawal by Subject|1|||
130191172|NCT02741076|468657335|FG002|Overall Study|Withdrawal by Subject|0|||
130191173|NCT02741076|468657336|FG003|Overall Study|Withdrawal by Subject|0|||
130191174|NCT02741076|468657333|FG000|Overall Study|Sponsor Request|2|||
130191175|NCT02741076|468657334|FG001|Overall Study|Sponsor Request|3|||
130191176|NCT02741076|468657335|FG002|Overall Study|Sponsor Request|0|||
130191177|NCT02741076|468657336|FG003|Overall Study|Sponsor Request|1|||
130191178|NCT02741076|468657333|FG000|Overall Study|No additional information available|0|||
130191179|NCT02741076|468657334|FG001|Overall Study|No additional information available|0|||
130191180|NCT02741076|468657335|FG002|Overall Study|No additional information available|1|||
130191181|NCT02741076|468657336|FG003|Overall Study|No additional information available|1|||
130191182|NCT01500382|468657339|FG000|Washout Period|Study site went out of business|0|||
130191183|NCT01500382|468657340|FG001|Washout Period|Study site went out of business|0|||
130191184|NCT01500382|468657341|FG002|Washout Period|Study site went out of business|1|||
130191185|NCT01500382|468657342|FG003|Washout Period|Study site went out of business|0|||
130191186|NCT02134015|468657343|FG000|Overall Study|Protocol Violation|0|||
130191187|NCT02134015|468657344|FG001|Overall Study|Protocol Violation|1|||
130191188|NCT02134015|468657343|FG000|Overall Study|Death|2|||
130191189|NCT02134015|468657344|FG001|Overall Study|Death|1|||
130191190|NCT02134015|468657343|FG000|Overall Study|Reason not provided|1|||
130191191|NCT02134015|468657344|FG001|Overall Study|Reason not provided|2|||
130191192|NCT02134015|468657343|FG000|Overall Study|Clinical progression|14|||
130191193|NCT02134015|468657344|FG001|Overall Study|Clinical progression|7|||
130191194|NCT02134015|468657343|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
130191195|NCT02134015|468657344|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
130191196|NCT02134015|468657343|FG000|Overall Study|Study terminated by sponsor|2|||
130191197|NCT02134015|468657344|FG001|Overall Study|Study terminated by sponsor|3|||
130191198|NCT02134015|468657343|FG000|Overall Study|Adverse Event|9|||
130191199|NCT02134015|468657344|FG001|Overall Study|Adverse Event|10|||
130191200|NCT02134015|468657343|FG000|Overall Study|Withdrawal by Subject|3|||
130191201|NCT02134015|468657344|FG001|Overall Study|Withdrawal by Subject|7|||
130191202|NCT00347958|468659087|FG000|Overall Study|Adverse Event|1|||
130191203|NCT00347958|468659087|FG000|Overall Study|Protocol Violation|2|||
130191204|NCT00347958|468659087|FG000|Overall Study|Withdrawal by Subject|1|||
130191205|NCT00754234|468659088|FG000|Overall Study|Withdrawal by Subject|3|||
130191206|NCT00915018|468659089|FG000|Overall Study|Death|75|||
130191207|NCT00915018|468659090|FG001|Overall Study|Death|70|||
130191208|NCT00915018|468659089|FG000|Overall Study|Lost to Follow-up|10|||
130191209|NCT00915018|468659090|FG001|Overall Study|Lost to Follow-up|5|||
130191210|NCT00915018|468659089|FG000|Overall Study|Withdrawal by Subject|38|||
130191211|NCT00915018|468659090|FG001|Overall Study|Withdrawal by Subject|27|||
130191212|NCT00915018|468659089|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
130191213|NCT00915018|468659090|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
130191214|NCT00326716|468659091|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
130191215|NCT00326716|468659092|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
130191216|NCT00326716|468659093|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130191217|NCT00326716|468659094|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130191218|NCT04134767|468659095|FG000|Overall Study|Death|0|||
130191219|NCT04134767|468659096|FG001|Overall Study|Death|1|||
130191220|NCT04134767|468659095|FG000|Overall Study|Removed for harassing staff|0|||
130191221|NCT04134767|468659096|FG001|Overall Study|Removed for harassing staff|1|||
130191222|NCT04134767|468659095|FG000|Overall Study|Lost to Follow-up|44|||
130191223|NCT04134767|468659096|FG001|Overall Study|Lost to Follow-up|40|||
130191224|NCT00300885|468659097|FG000|Treatment|Adverse Event|134|||
130191225|NCT00300885|468659098|FG001|Treatment|Adverse Event|82|||
130191226|NCT00300885|468659097|FG000|Treatment|Death|20|||
130191227|NCT00300885|468659098|FG001|Treatment|Death|7|||
130191228|NCT00300885|468659097|FG000|Treatment|Lack of Efficacy|1|||
130191229|NCT00300885|468659098|FG001|Treatment|Lack of Efficacy|1|||
130191230|NCT00300885|468659097|FG000|Treatment|Lost to Follow-up|3|||
130191231|NCT00300885|468659098|FG001|Treatment|Lost to Follow-up|2|||
130191232|NCT00300885|468659097|FG000|Treatment|Physician Decision|4|||
130191233|NCT00300885|468659098|FG001|Treatment|Physician Decision|5|||
130191234|NCT00300885|468659097|FG000|Treatment|Protocol Violation|11|||
130191235|NCT00300885|468659098|FG001|Treatment|Protocol Violation|11|||
130191236|NCT00300885|468659097|FG000|Treatment|Withdrawal by Subject|26|||
130191237|NCT00300885|468659098|FG001|Treatment|Withdrawal by Subject|23|||
130191238|NCT00300885|468659097|FG000|Treatment|Disease progression|171|||
130191239|NCT00300885|468659098|FG001|Treatment|Disease progression|238|||
130191240|NCT00300885|468659097|FG000|Treatment|Random code broken (subject died)|0|||
130191241|NCT00300885|468659098|FG001|Treatment|Random code broken (subject died)|1|||
130191242|NCT00300885|468659097|FG000|Treatment|Non-compliant with study medication|3|||
130191243|NCT00300885|468659098|FG001|Treatment|Non-compliant with study medication|4|||
130191244|NCT00300885|468659097|FG000|Follow-up|Death|141|||
130191245|NCT00300885|468659098|FG001|Follow-up|Death|163|||
130191246|NCT00300885|468659097|FG000|Follow-up|Lost to Follow-up|11|||
130191247|NCT00300885|468659098|FG001|Follow-up|Lost to Follow-up|7|||
130191248|NCT00300885|468659097|FG000|Follow-up|Withdrawal by Subject|26|||
130191249|NCT00300885|468659098|FG001|Follow-up|Withdrawal by Subject|25|||
130191250|NCT02309411|468659107|FG000|Overall Study|Physician Decision|1|||
130191251|NCT02309411|468659108|FG001|Overall Study|Physician Decision|0|||
130191252|NCT02309411|468659109|FG002|Overall Study|Physician Decision|0|||
130191253|NCT02309411|468659107|FG000|Overall Study|Withdrawal by Subject|1|||
130191254|NCT02309411|468659108|FG001|Overall Study|Withdrawal by Subject|1|||
130191255|NCT02309411|468659109|FG002|Overall Study|Withdrawal by Subject|0|||
130191256|NCT03656692|468659110|FG000|Overall Study|Worsening of disease activity|2|||
130191257|NCT03656692|468659110|FG000|Overall Study|Physician Decision|1|||
130191258|NCT02693106|468659111|FG000|Overall Study|No time|3|||
130191259|NCT00839800|468659112|FG000|Overall Study|Adverse Event|8|||
130191260|NCT00839800|468659113|FG001|Overall Study|Adverse Event|12|||
130191261|NCT00839800|468659112|FG000|Overall Study|Lost to Follow-up|31|||
130191262|NCT00839800|468659113|FG001|Overall Study|Lost to Follow-up|26|||
130191263|NCT00839800|468659112|FG000|Overall Study|Withdrawal by Subject|28|||
130191264|NCT00839800|468659113|FG001|Overall Study|Withdrawal by Subject|34|||
130191265|NCT00839800|468659112|FG000|Overall Study|Incorrect Enrolment|3|||
130191266|NCT00839800|468659113|FG001|Overall Study|Incorrect Enrolment|3|||
130191267|NCT00839800|468659112|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
130191268|NCT00839800|468659113|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
130191269|NCT00839800|468659112|FG000|Overall Study|Safety Reasons|2|||
130191270|NCT00839800|468659113|FG001|Overall Study|Safety Reasons|1|||
130191271|NCT00839800|468659112|FG000|Overall Study|Other|8|||
130191272|NCT00839800|468659113|FG001|Overall Study|Other|14|||
130191273|NCT00839800|468659112|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
130191274|NCT00839800|468659113|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
130191275|NCT01372618|468659117|FG000|Overall Study|PI Died. Study Terminated|9|||
130191276|NCT02801617|468659118|FG000|Overall Study|Protocol Violation|2|||
130191277|NCT02801617|468659119|FG001|Overall Study|Protocol Violation|6|||
130191278|NCT01954056|468659120|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
130191279|NCT01954056|468659121|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
130191280|NCT06110494|468659122|FG000|Overall Study|Protocol Violation|2|||
130191281|NCT06110494|468659123|FG001|Overall Study|Protocol Violation|0|||
130191282|NCT06110494|468659124|FG002|Overall Study|Protocol Violation|1|||
130191283|NCT06110494|468659122|FG000|Overall Study|Dixon's test for outlier analysis|1|||
130191284|NCT06110494|468659123|FG001|Overall Study|Dixon's test for outlier analysis|1|||
130191285|NCT06110494|468659124|FG002|Overall Study|Dixon's test for outlier analysis|0|||
130191286|NCT04938180|468659129|FG000|Overall Study|Adverse Event|1|||
130191287|NCT03850496|468659141|FG000|Overall Study|Withdrawal by Subject|1|||
130191288|NCT03850496|468659142|FG001|Overall Study|Withdrawal by Subject|0|||
130191289|NCT03850496|468659143|FG002|Overall Study|Withdrawal by Subject|0|||
130191290|NCT03850496|468659141|FG000|Overall Study|Lost to Follow-up|0|||
130191291|NCT03850496|468659142|FG001|Overall Study|Lost to Follow-up|1|||
130191292|NCT03850496|468659143|FG002|Overall Study|Lost to Follow-up|4|||
130191293|NCT03674112|468659144|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
130191294|NCT03674112|468659145|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
130191295|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
130191296|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
130191297|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
130191298|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
130191299|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
130191300|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
130191301|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130191302|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130191303|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
130191304|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
130191305|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Death|2|||
130191306|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Death|0|||
130191307|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130191308|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130191309|NCT02097238|468659149|FG000|Overall Study|Death|1|||
130191310|NCT02097238|468659149|FG000|Overall Study|Physician Decision|1|||
130191311|NCT02097238|468659149|FG000|Overall Study|Progressive Disease|17|||
130191312|NCT01106911|468659150|FG000|Overall Study|Physician Decision|2|||
130191313|NCT01106911|468659150|FG000|Overall Study|deemed ineligible after screening|3|||
130191314|NCT01814696|468659158|FG000|Overall Study|Withdrawal by Subject|1|||
130191315|NCT01814696|468659159|FG001|Overall Study|Withdrawal by Subject|0|||
130191316|NCT01814696|468659158|FG000|Overall Study|Randomized to wrong group|1|||
130191317|NCT01814696|468659159|FG001|Overall Study|Randomized to wrong group|0|||
130191318|NCT00954941|468659160|FG000|Overall Study|Received treatment at home|1|||
130191319|NCT00954941|468659161|FG001|Overall Study|Received treatment at home|0|||
130191320|NCT00954941|468659160|FG000|Overall Study|Withdrawal by Subject|1|||
130191321|NCT00954941|468659161|FG001|Overall Study|Withdrawal by Subject|0|||
130191322|NCT00954941|468659160|FG000|Overall Study|Insurance Denial|2|||
130191323|NCT00954941|468659161|FG001|Overall Study|Insurance Denial|2|||
130191324|NCT00954941|468659160|FG000|Overall Study|Physician Decision|2|||
130191325|NCT00954941|468659161|FG001|Overall Study|Physician Decision|2|||
130191326|NCT00954941|468659160|FG000|Overall Study|Ineligible|2|||
130191327|NCT00954941|468659161|FG001|Overall Study|Ineligible|2|||
130191328|NCT00954941|468659160|FG000|Overall Study|Adverse Event|0|||
130191329|NCT00954941|468659161|FG001|Overall Study|Adverse Event|1|||
130191330|NCT00984542|468659178|FG000|Overall Study|disease progression|19|||
130191331|NCT00984542|468659178|FG000|Overall Study|toxicity|7|||
130191332|NCT00984542|468659178|FG000|Overall Study|Death|7|||
130191333|NCT00984542|468659178|FG000|Overall Study|complicating disease|3|||
130191334|NCT00984542|468659178|FG000|Overall Study|Withdrawal by Subject|3|||
130191335|NCT00984542|468659178|FG000|Overall Study|clinical deterioration|2|||
130191336|NCT01422889|468659179|FG000|Overall Study|No Data Entered for Study Stent|9|||
130191337|NCT00488644|468659184|FG000|Overall Study|Not Eligible|1|||
130191338|NCT00488644|468659184|FG000|Overall Study|Not Evaluable|1|||
130191339|NCT02977572|468659185|FG000|Overall Study|Exclusion criterion|2|||
130191340|NCT02977572|468659186|FG001|Overall Study|Exclusion criterion|2|||
130191341|NCT01197534|468659188|FG000|Overall Study|Not reported|16|||
130191342|NCT01197534|468659189|FG001|Overall Study|Not reported|10|||
130191343|NCT01197534|468659190|FG002|Overall Study|Not reported|16|||
130191344|NCT01197534|468659188|FG000|Overall Study|Enrolment in long term extension|57|||
130191345|NCT01197534|468659189|FG001|Overall Study|Enrolment in long term extension|66|||
130191346|NCT01197534|468659190|FG002|Overall Study|Enrolment in long term extension|119|||
130191347|NCT01197534|468659188|FG000|Overall Study|Severe non-compliance to protocol|3|||
130191348|NCT01197534|468659189|FG001|Overall Study|Severe non-compliance to protocol|4|||
130191349|NCT01197534|468659190|FG002|Overall Study|Severe non-compliance to protocol|1|||
130191350|NCT01197534|468659188|FG000|Overall Study|Lack of therapeutic response|9|||
130191351|NCT01197534|468659189|FG001|Overall Study|Lack of therapeutic response|4|||
130191352|NCT01197534|468659190|FG002|Overall Study|Lack of therapeutic response|9|||
130191353|NCT01197534|468659188|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
130191354|NCT01197534|468659189|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
130191355|NCT01197534|468659190|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130191356|NCT01197534|468659188|FG000|Overall Study|Lost to Follow-up|1|||
130191357|NCT01197534|468659189|FG001|Overall Study|Lost to Follow-up|4|||
130191358|NCT01197534|468659190|FG002|Overall Study|Lost to Follow-up|2|||
130191359|NCT01197534|468659188|FG000|Overall Study|Adverse Event|35|||
130191360|NCT01197534|468659189|FG001|Overall Study|Adverse Event|36|||
130191361|NCT01197534|468659190|FG002|Overall Study|Adverse Event|24|||
130191362|NCT02593097|468659203|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
130191363|NCT02593097|468659204|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
130191364|NCT02593097|468659203|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130191365|NCT02593097|468659204|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130191366|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130191367|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130191368|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
130191369|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
130191370|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130191371|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
130191372|NCT02522884|468659205|FG000|Overall Study|Withdrawal by Subject|6|||
130191373|NCT02522884|468659205|FG000|Overall Study|Death|3|||
130191374|NCT02522884|468659205|FG000|Overall Study|Missed 12-month Follow-up|9|||
130191375|NCT02630251|468659206|FG000|Overall Study|Physician Decision|0|||
130191376|NCT02630251|468659207|FG001|Overall Study|Physician Decision|0|||
130191377|NCT02630251|468659208|FG002|Overall Study|Physician Decision|1|||
130191378|NCT02630251|468659209|FG003|Overall Study|Physician Decision|0|||
130191379|NCT01863667|468659210|FG000|Overall Study|Adverse Event|1|||
130191380|NCT01863667|468659211|FG001|Overall Study|Adverse Event|0|||
130191381|NCT01863667|468659210|FG000|Overall Study|Study terminated by Sponsor|30|||
130191382|NCT01863667|468659211|FG001|Overall Study|Study terminated by Sponsor|30|||
130191383|NCT01863667|468659210|FG000|Overall Study|Withdrawal by Subject|2|||
130191384|NCT01863667|468659211|FG001|Overall Study|Withdrawal by Subject|2|||
130191385|NCT03627546|468659212|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
130191386|NCT03627546|468659213|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
130191387|NCT03627546|468659214|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
130191388|NCT03627546|468659212|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130191389|NCT03627546|468659213|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130191390|NCT03627546|468659214|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
130191391|NCT00615550|468659217|FG000|Overall Study|Lost to Follow-up|6|||
130191392|NCT00615550|468659218|FG001|Overall Study|Lost to Follow-up|1|||
130191393|NCT02640664|468659219|FG000|Epoch 1|Withdrawal of informed consent|1|||
130191394|NCT02640664|468659220|FG001|Epoch 1|Withdrawal of informed consent|0|||
130191395|NCT02640664|468659221|FG002|Epoch 1|Withdrawal of informed consent|0|||
130191396|NCT02640664|468659219|FG000|Epoch 1|Death|0|||
130191397|NCT02640664|468659220|FG001|Epoch 1|Death|0|||
130191398|NCT02640664|468659221|FG002|Epoch 1|Death|1|||
130191399|NCT02640664|468659219|FG000|Epoch 2|Withdrawal of informed consent|3|||
130191400|NCT02640664|468659220|FG001|Epoch 2|Withdrawal of informed consent|4|||
130191401|NCT02640664|468659221|FG002|Epoch 2|Withdrawal of informed consent|2|||
130191402|NCT02640664|468659219|FG000|Epoch 2|Subject/guardian decision|0|||
130191403|NCT02640664|468659220|FG001|Epoch 2|Subject/guardian decision|2|||
130191404|NCT02640664|468659221|FG002|Epoch 2|Subject/guardian decision|2|||
130191405|NCT02640664|468659219|FG000|Epoch 2|Lost to Follow-up|3|||
130191406|NCT02640664|468659220|FG001|Epoch 2|Lost to Follow-up|4|||
130191407|NCT02640664|468659221|FG002|Epoch 2|Lost to Follow-up|1|||
130191408|NCT02640664|468659219|FG000|Epoch 2|Death|0|||
130191409|NCT02640664|468659220|FG001|Epoch 2|Death|0|||
130191410|NCT02640664|468659221|FG002|Epoch 2|Death|1|||
130191411|NCT02965573|468659223|FG000|Overall Study|Lack of Efficacy|1|||
130191412|NCT02965573|468659224|FG001|Overall Study|Lack of Efficacy|0|||
130191413|NCT00315458|468659225|FG000|Overall Study|Administrative|0|||
130191414|NCT00315458|468659226|FG001|Overall Study|Administrative|3|||
130191415|NCT00315458|468659227|FG002|Overall Study|Administrative|8|||
130191416|NCT00315458|468659228|FG003|Overall Study|Administrative|21|||
130191417|NCT00315458|468659225|FG000|Overall Study|Adverse Event|2|||
130191418|NCT00315458|468659226|FG001|Overall Study|Adverse Event|4|||
130191419|NCT00315458|468659227|FG002|Overall Study|Adverse Event|23|||
130191420|NCT00315458|468659228|FG003|Overall Study|Adverse Event|3|||
130191421|NCT00315458|468659225|FG000|Overall Study|Lost to Follow-up|1|||
130191422|NCT00315458|468659226|FG001|Overall Study|Lost to Follow-up|2|||
130191423|NCT00315458|468659227|FG002|Overall Study|Lost to Follow-up|0|||
130191424|NCT00315458|468659228|FG003|Overall Study|Lost to Follow-up|2|||
130191425|NCT00315458|468659225|FG000|Overall Study|Withdrawal by Subject|0|||
130191426|NCT00315458|468659226|FG001|Overall Study|Withdrawal by Subject|3|||
130191427|NCT00315458|468659227|FG002|Overall Study|Withdrawal by Subject|0|||
130191428|NCT00315458|468659228|FG003|Overall Study|Withdrawal by Subject|2|||
130191429|NCT00315458|468659225|FG000|Overall Study|Lack of Efficacy|0|||
130191430|NCT00315458|468659226|FG001|Overall Study|Lack of Efficacy|0|||
130191431|NCT00315458|468659227|FG002|Overall Study|Lack of Efficacy|20|||
130191432|NCT00315458|468659228|FG003|Overall Study|Lack of Efficacy|1|||
130191433|NCT00315458|468659225|FG000|Overall Study|Did not qualify|0|||
130191434|NCT00315458|468659226|FG001|Overall Study|Did not qualify|0|||
130191435|NCT00315458|468659227|FG002|Overall Study|Did not qualify|1|||
130191436|NCT00315458|468659228|FG003|Overall Study|Did not qualify|0|||
130191437|NCT00987337|468659229|FG000|Overall Study|Adverse Event|10|||
130191438|NCT00987337|468659230|FG001|Overall Study|Adverse Event|9|||
130191439|NCT00987337|468659231|FG002|Overall Study|Adverse Event|8|||
130191440|NCT00987337|468659229|FG000|Overall Study|Insufficient Virologic Response|10|||
130191441|NCT00987337|468659230|FG001|Overall Study|Insufficient Virologic Response|7|||
130191442|NCT00987337|468659231|FG002|Overall Study|Insufficient Virologic Response|12|||
130191443|NCT00987337|468659229|FG000|Overall Study|Virologic Breakthrough|2|||
130191444|NCT00987337|468659230|FG001|Overall Study|Virologic Breakthrough|2|||
130191445|NCT00987337|468659231|FG002|Overall Study|Virologic Breakthrough|8|||
130191446|NCT00987337|468659229|FG000|Overall Study|Lost to Follow-up|10|||
130191447|NCT00987337|468659230|FG001|Overall Study|Lost to Follow-up|6|||
130191448|NCT00987337|468659231|FG002|Overall Study|Lost to Follow-up|2|||
130191449|NCT00987337|468659229|FG000|Overall Study|Withdrawal by Subject|6|||
130191450|NCT00987337|468659230|FG001|Overall Study|Withdrawal by Subject|9|||
130191451|NCT00987337|468659231|FG002|Overall Study|Withdrawal by Subject|9|||
130191452|NCT00987337|468659229|FG000|Overall Study|Other|0|||
130191453|NCT00987337|468659230|FG001|Overall Study|Other|2|||
130191454|NCT00987337|468659231|FG002|Overall Study|Other|5|||
130191455|NCT00987337|468659229|FG000|Overall Study|Protocol Violation|1|||
130191456|NCT00987337|468659230|FG001|Overall Study|Protocol Violation|0|||
130191457|NCT00987337|468659231|FG002|Overall Study|Protocol Violation|2|||
130191458|NCT00987337|468659229|FG000|Overall Study|Participant Relapsed|18|||
130191459|NCT00987337|468659230|FG001|Overall Study|Participant Relapsed|20|||
130191460|NCT00987337|468659231|FG002|Overall Study|Participant Relapsed|5|||
130191461|NCT00086619|468659234|FG000|Overall Study|Withdrawal by Subject|6|||
130191462|NCT00086619|468659235|FG001|Overall Study|Withdrawal by Subject|6|||
130191463|NCT00086619|468659234|FG000|Overall Study|Adverse Event|8|||
130191464|NCT00086619|468659235|FG001|Overall Study|Adverse Event|10|||
130191465|NCT00086619|468659234|FG000|Overall Study|Protocol Violation|1|||
130191466|NCT00086619|468659235|FG001|Overall Study|Protocol Violation|1|||
130191467|NCT00489918|468659236|FG000|Overall Study|Withdrawal by Subject|2|||
130191468|NCT00489918|468659237|FG001|Overall Study|Withdrawal by Subject|1|||
130191469|NCT00489918|468659238|FG002|Overall Study|Withdrawal by Subject|1|||
130191470|NCT00489918|468659239|FG003|Overall Study|Withdrawal by Subject|0|||
130191471|NCT00489918|468659240|FG004|Overall Study|Withdrawal by Subject|1|||
130191472|NCT00489918|468659236|FG000|Overall Study|Adverse Event|0|||
130191473|NCT00489918|468659237|FG001|Overall Study|Adverse Event|1|||
130191474|NCT00489918|468659238|FG002|Overall Study|Adverse Event|1|||
130191475|NCT00489918|468659239|FG003|Overall Study|Adverse Event|0|||
130191476|NCT00489918|468659240|FG004|Overall Study|Adverse Event|0|||
130191477|NCT00489918|468659236|FG000|Overall Study|Lost to Follow-up|0|||
130191478|NCT00489918|468659237|FG001|Overall Study|Lost to Follow-up|0|||
130191479|NCT00489918|468659238|FG002|Overall Study|Lost to Follow-up|1|||
130191480|NCT00489918|468659239|FG003|Overall Study|Lost to Follow-up|1|||
130191481|NCT00489918|468659240|FG004|Overall Study|Lost to Follow-up|0|||
130191482|NCT00489918|468659236|FG000|Overall Study|Physician Decision|0|||
130191483|NCT00489918|468659237|FG001|Overall Study|Physician Decision|0|||
130191484|NCT00489918|468659238|FG002|Overall Study|Physician Decision|1|||
130191485|NCT00489918|468659239|FG003|Overall Study|Physician Decision|0|||
130191486|NCT00489918|468659240|FG004|Overall Study|Physician Decision|0|||
130191487|NCT02748213|468659241|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
130191488|NCT02748213|468659242|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
130191489|NCT02748213|468659241|FG000|Overall Study|Abnormal Laboratory Test|1|||
130191490|NCT02748213|468659242|FG001|Overall Study|Abnormal Laboratory Test|0|||
130191491|NCT02748213|468659241|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
130191492|NCT02748213|468659242|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
130191493|NCT02748213|468659241|FG000|Overall Study|Death|5|||
130191494|NCT02748213|468659242|FG001|Overall Study|Death|3|||
130191495|NCT02748213|468659241|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130191496|NCT02748213|468659242|FG001|Overall Study|Insufficient Therapeutic Response|57|||
130191497|NCT02748213|468659241|FG000|Overall Study|Violation of Selection Criteria|2|||
130191498|NCT02748213|468659242|FG001|Overall Study|Violation of Selection Criteria|0|||
130191499|NCT02748213|468659241|FG000|Overall Study|Protocol Violation|6|||
130191500|NCT02748213|468659242|FG001|Overall Study|Protocol Violation|4|||
130191501|NCT02748213|468659241|FG000|Overall Study|Refused Treatment*|6|||
130191502|NCT02748213|468659242|FG001|Overall Study|Refused Treatment*|6|||
130191503|NCT02748213|468659241|FG000|Overall Study|Failure to Return|1|||
130191504|NCT02748213|468659242|FG001|Overall Study|Failure to Return|0|||
130191505|NCT02748213|468659241|FG000|Overall Study|Other|30|||
130191506|NCT02748213|468659242|FG001|Overall Study|Other|29|||
130191507|NCT01209520|468659244|FG000|Overall Study|Withdrawal by Subject|3|||
130191508|NCT00961350|468659245|FG000|Overall Study|Adverse Event|18|||
130191509|NCT00961350|468659246|FG001|Overall Study|Adverse Event|33|||
130191510|NCT00961350|468659245|FG000|Overall Study|Withdrawal by Subject|10|||
130191511|NCT00961350|468659246|FG001|Overall Study|Withdrawal by Subject|10|||
130191512|NCT00961350|468659245|FG000|Overall Study|Lost to Follow-up|3|||
130191513|NCT00961350|468659246|FG001|Overall Study|Lost to Follow-up|3|||
130191514|NCT00961350|468659245|FG000|Overall Study|Misc|16|||
130191515|NCT00961350|468659246|FG001|Overall Study|Misc|21|||
130191516|NCT00550745|468659247|FG000|Overall Study|Death|20|||
130191517|NCT00550745|468659248|FG001|Overall Study|Death|16|||
130191518|NCT00550745|468659247|FG000|Overall Study|Lost to Follow-up|45|||
130191519|NCT00550745|468659248|FG001|Overall Study|Lost to Follow-up|30|||
130191520|NCT00550745|468659247|FG000|Overall Study|Physician Decision|0|||
130191521|NCT00550745|468659248|FG001|Overall Study|Physician Decision|2|||
130191522|NCT00550745|468659247|FG000|Overall Study|Protocol Violation|4|||
130191523|NCT00550745|468659248|FG001|Overall Study|Protocol Violation|2|||
130191524|NCT00550745|468659247|FG000|Overall Study|Withdrawal by Subject|17|||
130191525|NCT00550745|468659248|FG001|Overall Study|Withdrawal by Subject|10|||
130191526|NCT00550745|468659247|FG000|Overall Study|Screen failure|1|||
130191527|NCT00550745|468659248|FG001|Overall Study|Screen failure|0|||
130191528|NCT00617890|468661269|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
130191529|NCT00617890|468661270|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
130191530|NCT00617890|468661271|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
130191531|NCT00617890|468661272|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
130191532|NCT00617890|468661269|FG000|Overall Study|Lack of Efficacy|23|||
130191533|NCT00617890|468661270|FG001|Overall Study|Lack of Efficacy|26|||
130191534|NCT00617890|468661271|FG002|Overall Study|Lack of Efficacy|30|||
130191535|NCT00617890|468661272|FG003|Overall Study|Lack of Efficacy|97|||
130191536|NCT00617890|468661269|FG000|Overall Study|Lost to Follow-up|0|||
130191537|NCT00617890|468661270|FG001|Overall Study|Lost to Follow-up|0|||
130191538|NCT00617890|468661271|FG002|Overall Study|Lost to Follow-up|1|||
130191539|NCT00617890|468661272|FG003|Overall Study|Lost to Follow-up|2|||
130191540|NCT00617890|468661269|FG000|Overall Study|Withdrawal by Subject|4|||
130191541|NCT00617890|468661270|FG001|Overall Study|Withdrawal by Subject|1|||
130191542|NCT00617890|468661271|FG002|Overall Study|Withdrawal by Subject|0|||
130191543|NCT00617890|468661272|FG003|Overall Study|Withdrawal by Subject|2|||
130191544|NCT00617890|468661269|FG000|Overall Study|Protocol Violation|2|||
130191545|NCT00617890|468661270|FG001|Overall Study|Protocol Violation|1|||
130191546|NCT00617890|468661271|FG002|Overall Study|Protocol Violation|0|||
130191547|NCT00617890|468661272|FG003|Overall Study|Protocol Violation|0|||
130191548|NCT00617890|468661269|FG000|Overall Study|Adverse Event|1|||
130191549|NCT00617890|468661270|FG001|Overall Study|Adverse Event|0|||
130191550|NCT00617890|468661271|FG002|Overall Study|Adverse Event|3|||
130191551|NCT00617890|468661272|FG003|Overall Study|Adverse Event|8|||
130191552|NCT00617890|468661269|FG000|Overall Study|Not treated|1|||
130191553|NCT00617890|468661270|FG001|Overall Study|Not treated|0|||
130191554|NCT00617890|468661271|FG002|Overall Study|Not treated|1|||
130191555|NCT00617890|468661272|FG003|Overall Study|Not treated|1|||
130191556|NCT02640950|468661274|FG000|Overall Study|Adverse Event|1|||
130191557|NCT02640950|468661274|FG000|Overall Study|Withdrawal by Subject|1|||
130191558|NCT00154284|468661275|FG000|Overall Study|Adverse Event|6|||
130191559|NCT00154284|468661276|FG001|Overall Study|Adverse Event|9|||
130191560|NCT00154284|468661275|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130191561|NCT00154284|468661276|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130191562|NCT00154284|468661275|FG000|Overall Study|Lack of Efficacy|1|||
130191563|NCT00154284|468661276|FG001|Overall Study|Lack of Efficacy|2|||
130191564|NCT00154284|468661275|FG000|Overall Study|Protocol Violation|0|||
130191565|NCT00154284|468661276|FG001|Overall Study|Protocol Violation|1|||
130191566|NCT00566020|468661277|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
130191567|NCT00566020|468661278|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
130191568|NCT00566020|468661277|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
130191569|NCT00566020|468661278|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
130191570|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
130191571|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
130191572|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
130191573|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
130191574|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
130191575|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
130191576|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
130191577|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
130191578|NCT02582242|468661279|FG000|Overall Study|Adverse Event|4|||
130191579|NCT02582242|468661280|FG001|Overall Study|Adverse Event|3|||
130191580|NCT02582242|468661279|FG000|Overall Study|Protocol Violation|3|||
130191581|NCT02582242|468661280|FG001|Overall Study|Protocol Violation|1|||
130191582|NCT02582242|468661279|FG000|Overall Study|Lost to Follow-up|0|||
130191583|NCT02582242|468661280|FG001|Overall Study|Lost to Follow-up|1|||
130191584|NCT02582242|468661279|FG000|Overall Study|Withdrawal by Subject|11|||
130191585|NCT02582242|468661280|FG001|Overall Study|Withdrawal by Subject|11|||
130191586|NCT02582242|468661279|FG000|Overall Study|Unclassified|2|||
130191587|NCT02582242|468661280|FG001|Overall Study|Unclassified|1|||
130191588|NCT02101736|468661281|FG000|Overall Study|Protocol Violation|3|||
130191589|NCT02101736|468661282|FG001|Overall Study|Protocol Violation|0|||
130191590|NCT02101736|468661281|FG000|Overall Study|Withdrawal by Subject|1|||
130191591|NCT02101736|468661282|FG001|Overall Study|Withdrawal by Subject|1|||
130191592|NCT00459290|468661283|FG000|Overall Study|Adverse Event|3|||
130191593|NCT00459290|468661283|FG000|Overall Study|Ineligible|2|||
130191594|NCT02176655|468661291|FG000|Overall Study|Subjects did not treat|6|||
130191595|NCT01464593|468661296|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
130191596|NCT02476578|468661301|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
130191597|NCT02476578|468661302|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
130191598|NCT02476578|468661301|FG000|Overall Study|Lost to Follow-up|6|||
130191599|NCT02476578|468661302|FG001|Overall Study|Lost to Follow-up|13|||
130191600|NCT01019694|468661303|FG000|Overall Study|Adverse Event|12|||
130191601|NCT01019694|468661304|FG001|Overall Study|Adverse Event|16|||
130191602|NCT01019694|468661305|FG002|Overall Study|Adverse Event|19|||
130191603|NCT01019694|468661303|FG000|Overall Study|Protocol Violation|2|||
130191604|NCT01019694|468661304|FG001|Overall Study|Protocol Violation|6|||
130191605|NCT01019694|468661305|FG002|Overall Study|Protocol Violation|4|||
130191606|NCT01019694|468661303|FG000|Overall Study|Lost to Follow-up|5|||
130191607|NCT01019694|468661304|FG001|Overall Study|Lost to Follow-up|3|||
130191608|NCT01019694|468661305|FG002|Overall Study|Lost to Follow-up|3|||
130191609|NCT01019694|468661303|FG000|Overall Study|Withdrawal by Subject|4|||
130191610|NCT01019694|468661304|FG001|Overall Study|Withdrawal by Subject|6|||
130191611|NCT01019694|468661305|FG002|Overall Study|Withdrawal by Subject|12|||
130191612|NCT01019694|468661303|FG000|Overall Study|Not treated|0|||
130191613|NCT01019694|468661304|FG001|Overall Study|Not treated|2|||
130191614|NCT01019694|468661305|FG002|Overall Study|Not treated|3|||
130191615|NCT01019694|468661303|FG000|Overall Study|Other reason (not specified)|1|||
130191616|NCT01019694|468661304|FG001|Overall Study|Other reason (not specified)|5|||
130191617|NCT01019694|468661305|FG002|Overall Study|Other reason (not specified)|6|||
130191618|NCT00026494|468661312|FG000|Overall Study|Withdrawal by Subject|1|||
130191619|NCT00026494|468661313|FG001|Overall Study|Withdrawal by Subject|0|||
130191620|NCT00026494|468661314|FG002|Overall Study|Withdrawal by Subject|1|||
130191621|NCT00026494|468661315|FG003|Overall Study|Withdrawal by Subject|0|||
130191622|NCT00026494|468661312|FG000|Overall Study|Patient non-compliance|1|||
130191623|NCT00026494|468661313|FG001|Overall Study|Patient non-compliance|0|||
130191624|NCT00026494|468661314|FG002|Overall Study|Patient non-compliance|0|||
130191625|NCT00026494|468661315|FG003|Overall Study|Patient non-compliance|0|||
130191626|NCT00026494|468661312|FG000|Overall Study|Patient not treated|0|||
130191627|NCT00026494|468661313|FG001|Overall Study|Patient not treated|0|||
130191628|NCT00026494|468661314|FG002|Overall Study|Patient not treated|2|||
130191629|NCT00026494|468661315|FG003|Overall Study|Patient not treated|0|||
130191630|NCT00026494|468661312|FG000|Overall Study|Clinical progression|0|||
130191631|NCT00026494|468661313|FG001|Overall Study|Clinical progression|0|||
130191632|NCT00026494|468661314|FG002|Overall Study|Clinical progression|3|||
130191633|NCT00026494|468661315|FG003|Overall Study|Clinical progression|0|||
130191634|NCT01684423|468661316|FG000|Overall Study|Withdrawal by Subject|0|||
130191635|NCT01684423|468661317|FG001|Overall Study|Withdrawal by Subject|0|||
130191636|NCT01684423|468661318|FG002|Overall Study|Withdrawal by Subject|1|||
130191637|NCT01684423|468661319|FG003|Overall Study|Withdrawal by Subject|0|||
130191638|NCT01684423|468661320|FG004|Overall Study|Withdrawal by Subject|0|||
130191639|NCT01455597|468661321|FG000|Overall Study|Adverse Event|7|||
130191640|NCT01455597|468661322|FG001|Overall Study|Adverse Event|0|||
130191641|NCT01455597|468661323|FG002|Overall Study|Adverse Event|5|||
130191642|NCT01455597|468661324|FG003|Overall Study|Adverse Event|1|||
130191643|NCT01455597|468661321|FG000|Overall Study|Lack of Efficacy|0|||
130191644|NCT01455597|468661322|FG001|Overall Study|Lack of Efficacy|1|||
130191645|NCT01455597|468661323|FG002|Overall Study|Lack of Efficacy|2|||
130191646|NCT01455597|468661324|FG003|Overall Study|Lack of Efficacy|0|||
130191647|NCT01455597|468661321|FG000|Overall Study|Lost to Follow-up|3|||
130191648|NCT01455597|468661322|FG001|Overall Study|Lost to Follow-up|0|||
130191649|NCT01455597|468661323|FG002|Overall Study|Lost to Follow-up|2|||
130191650|NCT01455597|468661324|FG003|Overall Study|Lost to Follow-up|1|||
130191651|NCT01455597|468661321|FG000|Overall Study|Withdrew Consent|6|||
130191652|NCT01455597|468661322|FG001|Overall Study|Withdrew Consent|5|||
130191653|NCT01455597|468661323|FG002|Overall Study|Withdrew Consent|8|||
130191654|NCT01455597|468661324|FG003|Overall Study|Withdrew Consent|5|||
130191655|NCT01455597|468661321|FG000|Overall Study|Reason not Specified|1|||
130191656|NCT01455597|468661322|FG001|Overall Study|Reason not Specified|2|||
130191657|NCT01455597|468661323|FG002|Overall Study|Reason not Specified|3|||
130191658|NCT01455597|468661324|FG003|Overall Study|Reason not Specified|3|||
130191659|NCT00441129|468661325|FG000|Overall Study|Withdrawal by Subject|6|||
130191660|NCT00441129|468661326|FG001|Overall Study|Withdrawal by Subject|14|||
130191661|NCT03412734|468661329|FG000|Overall Study|Incorrect labeling of samples|2|||
130191662|NCT03412734|468661330|FG001|Overall Study|Incorrect labeling of samples|0|||
130191663|NCT03412734|468661329|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
130191664|NCT03412734|468661330|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
130191665|NCT04747886|468661331|FG000|Overall Study|Withdrawal by Subject|1|||
130191666|NCT04747886|468661332|FG001|Overall Study|Withdrawal by Subject|4|||
130191667|NCT03777436|468661336|FG000|Placebo-controlled Phase|Adverse Event|8|||
130191668|NCT03777436|468661337|FG001|Placebo-controlled Phase|Adverse Event|10|||
130191669|NCT03777436|468661338|FG002|Placebo-controlled Phase|Adverse Event|0|||
130191670|NCT03777436|468661336|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
130191671|NCT03777436|468661337|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
130191672|NCT03777436|468661338|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
130191673|NCT03777436|468661336|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
130191674|NCT03777436|468661337|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
130191675|NCT03777436|468661338|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
130191676|NCT03777436|468661336|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
130191677|NCT03777436|468661337|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
130191678|NCT03777436|468661338|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
130191679|NCT03777436|468661336|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
130191680|NCT03777436|468661337|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
130191681|NCT03777436|468661338|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
130191682|NCT03777436|468661336|FG000|Placebo-controlled Phase|Physician Decision|0|||
130191683|NCT03777436|468661337|FG001|Placebo-controlled Phase|Physician Decision|1|||
130191684|NCT03777436|468661338|FG002|Placebo-controlled Phase|Physician Decision|0|||
130191685|NCT03777436|468661336|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
130191686|NCT03777436|468661337|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130191687|NCT03777436|468661338|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130191688|NCT03777436|468661336|FG000|Apremilast Extension Phase|Adverse Event|0|||
130191689|NCT03777436|468661337|FG001|Apremilast Extension Phase|Adverse Event|0|||
130191690|NCT03777436|468661338|FG002|Apremilast Extension Phase|Adverse Event|6|||
130191691|NCT03777436|468661336|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
130191692|NCT03777436|468661337|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
130191693|NCT03777436|468661338|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
130191694|NCT03777436|468661336|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
130191695|NCT03777436|468661337|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
130191696|NCT03777436|468661338|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
130191697|NCT03777436|468661336|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
130191698|NCT03777436|468661337|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
130191699|NCT03777436|468661338|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
130191700|NCT03777436|468661336|FG000|Apremilast Extension Phase|Miscellaneous|0|||
130191701|NCT03777436|468661337|FG001|Apremilast Extension Phase|Miscellaneous|0|||
130191702|NCT03777436|468661338|FG002|Apremilast Extension Phase|Miscellaneous|1|||
130191703|NCT00869999|468661344|FG000|Overall Study|Withdrawal by Subject|1|||
130191704|NCT00869999|468661344|FG000|Overall Study|removed prior to starting therapy|1|||
130191705|NCT04478695|468661345|FG000|Overall Study|Death|1|||
130191706|NCT04478695|468661346|FG001|Overall Study|Death|0|||
130191707|NCT00644917|468661347|FG000|Overall Study|Withdrawal by Subject|2|||
130191708|NCT01136356|468661348|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
130191709|NCT01136356|468661349|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
130191710|NCT01136356|468661348|FG000|First 18-day Withdrawal|Physician Decision|1|||
130191711|NCT01136356|468661349|FG001|First 18-day Withdrawal|Physician Decision|0|||
130191712|NCT01136356|468661348|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
130191713|NCT01136356|468661349|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
130191714|NCT00758485|468661350|FG000|Overall Study|Lost to Follow-up|0|||
130191715|NCT00758485|468661351|FG001|Overall Study|Lost to Follow-up|1|||
130191716|NCT00758485|468661350|FG000|Overall Study|Not Treated|1|||
130191717|NCT00758485|468661351|FG001|Overall Study|Not Treated|2|||
130191718|NCT00402688|468661352|FG000|Overall Study|Adverse Event|12|||
130191719|NCT00402688|468661353|FG001|Overall Study|Adverse Event|9|||
130191720|NCT00402688|468661354|FG002|Overall Study|Adverse Event|3|||
130191721|NCT00402688|468661352|FG000|Overall Study|Withdrawal by Subject|3|||
130191722|NCT00402688|468661353|FG001|Overall Study|Withdrawal by Subject|1|||
130191723|NCT00402688|468661354|FG002|Overall Study|Withdrawal by Subject|1|||
130191724|NCT00402688|468661352|FG000|Overall Study|Physician Decision|0|||
130191725|NCT00402688|468661353|FG001|Overall Study|Physician Decision|0|||
130191726|NCT00402688|468661354|FG002|Overall Study|Physician Decision|1|||
130191727|NCT00402688|468661352|FG000|Overall Study|Lack of Efficacy|4|||
130191728|NCT00402688|468661353|FG001|Overall Study|Lack of Efficacy|4|||
130191729|NCT00402688|468661354|FG002|Overall Study|Lack of Efficacy|5|||
130191730|NCT00402688|468661352|FG000|Overall Study|Protocol Violation|1|||
130191731|NCT00402688|468661353|FG001|Overall Study|Protocol Violation|1|||
130191732|NCT00402688|468661354|FG002|Overall Study|Protocol Violation|1|||
130191733|NCT00402688|468661352|FG000|Overall Study|Lost to Follow-up|1|||
130191734|NCT00402688|468661353|FG001|Overall Study|Lost to Follow-up|0|||
130191735|NCT00402688|468661354|FG002|Overall Study|Lost to Follow-up|2|||
130191736|NCT00402688|468661352|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130191737|NCT00402688|468661353|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
130191738|NCT00402688|468661354|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130191739|NCT00402688|468661352|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130191740|NCT00402688|468661353|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130191741|NCT00402688|468661354|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
130191742|NCT00402688|468661352|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
130191743|NCT00402688|468661353|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
130191744|NCT00402688|468661354|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
130191745|NCT02347774|468661355|FG000|Study Participation|Lost to Follow-up|3|||
130191746|NCT02347774|468661356|FG001|Study Participation|Lost to Follow-up|6|||
130191747|NCT02347774|468661357|FG002|Study Participation|Lost to Follow-up|2|||
130191748|NCT02347774|468661355|FG000|Study Participation|Withdrawal by Subject|8|||
130191749|NCT02347774|468661356|FG001|Study Participation|Withdrawal by Subject|9|||
130191750|NCT02347774|468661357|FG002|Study Participation|Withdrawal by Subject|15|||
130191751|NCT02347774|468661355|FG000|Study Participation|Adverse Event|1|||
130191752|NCT02347774|468661356|FG001|Study Participation|Adverse Event|4|||
130191753|NCT02347774|468661357|FG002|Study Participation|Adverse Event|6|||
130191754|NCT02347774|468661355|FG000|Study Participation|withdrew consent|1|||
130191755|NCT02347774|468661356|FG001|Study Participation|withdrew consent|1|||
130191756|NCT02347774|468661357|FG002|Study Participation|withdrew consent|1|||
130191757|NCT02347774|468661355|FG000|Study Participation|Met Prolonged QT criteria|1|||
130191758|NCT02347774|468661356|FG001|Study Participation|Met Prolonged QT criteria|0|||
130191759|NCT02347774|468661357|FG002|Study Participation|Met Prolonged QT criteria|0|||
130191760|NCT02347774|468661355|FG000|Study Participation|non-compliance with study drug|0|||
130191761|NCT02347774|468661356|FG001|Study Participation|non-compliance with study drug|1|||
130191762|NCT02347774|468661357|FG002|Study Participation|non-compliance with study drug|0|||
130191763|NCT02347774|468661355|FG000|Study Participation|incarceration|1|||
130191764|NCT02347774|468661356|FG001|Study Participation|incarceration|0|||
130191765|NCT02347774|468661357|FG002|Study Participation|incarceration|0|||
130191766|NCT02347774|468661355|FG000|Study Participation|randomized in error|0|||
130191767|NCT02347774|468661356|FG001|Study Participation|randomized in error|0|||
130191768|NCT02347774|468661357|FG002|Study Participation|randomized in error|1|||
130191769|NCT02347774|468661355|FG000|On Study Treatment|Adverse Event|9|||
130191770|NCT02347774|468661356|FG001|On Study Treatment|Adverse Event|15|||
130191771|NCT02347774|468661357|FG002|On Study Treatment|Adverse Event|19|||
130191772|NCT02347774|468661355|FG000|On Study Treatment|Lack of Efficacy|3|||
130191773|NCT02347774|468661356|FG001|On Study Treatment|Lack of Efficacy|0|||
130191774|NCT02347774|468661357|FG002|On Study Treatment|Lack of Efficacy|2|||
130191775|NCT02347774|468661355|FG000|On Study Treatment|non-complicance with study medication|0|||
130191776|NCT02347774|468661356|FG001|On Study Treatment|non-complicance with study medication|2|||
130191777|NCT02347774|468661357|FG002|On Study Treatment|non-complicance with study medication|0|||
130191778|NCT02347774|468661355|FG000|On Study Treatment|Protocol Violation|0|||
130191779|NCT02347774|468661356|FG001|On Study Treatment|Protocol Violation|0|||
130191780|NCT02347774|468661357|FG002|On Study Treatment|Protocol Violation|1|||
130191781|NCT02347774|468661355|FG000|On Study Treatment|withdrew consent|9|||
130191782|NCT02347774|468661356|FG001|On Study Treatment|withdrew consent|8|||
130191783|NCT02347774|468661357|FG002|On Study Treatment|withdrew consent|12|||
130191784|NCT02347774|468661355|FG000|On Study Treatment|Lost to Follow-up|2|||
130191785|NCT02347774|468661356|FG001|On Study Treatment|Lost to Follow-up|6|||
130191786|NCT02347774|468661357|FG002|On Study Treatment|Lost to Follow-up|1|||
130191787|NCT02347774|468661355|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
130191788|NCT02347774|468661356|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
130191789|NCT02347774|468661357|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
130191790|NCT02347774|468661355|FG000|On Study Treatment|ranomized in error|0|||
130191791|NCT02347774|468661356|FG001|On Study Treatment|ranomized in error|0|||
130191792|NCT02347774|468661357|FG002|On Study Treatment|ranomized in error|1|||
130191793|NCT00921557|468661358|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
130191794|NCT00921557|468661359|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130191795|NCT00921557|468661360|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130191796|NCT00921557|468661358|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130191797|NCT00921557|468661359|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
130191798|NCT00921557|468661360|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130191799|NCT00921557|468661358|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130191800|NCT00921557|468661359|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130191801|NCT00921557|468661360|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
130191802|NCT00921557|468661358|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
130191803|NCT00921557|468661359|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130191804|NCT00921557|468661360|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130191805|NCT00921557|468661358|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
130191806|NCT00921557|468661359|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130191807|NCT00921557|468661360|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130191808|NCT00656292|468661361|FG000|Overall Study|Withdrawal by Subject|2|||
130191809|NCT00656292|468661362|FG001|Overall Study|Withdrawal by Subject|3|||
130191810|NCT00656292|468661361|FG000|Overall Study|Screen failure|1|||
130191811|NCT00656292|468661362|FG001|Overall Study|Screen failure|2|||
130191812|NCT03259425|468661363|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
130191813|NCT04112043|468661364|FG000|Overall Study|Withdrawal by Subject|1|||
130191814|NCT04112043|468661365|FG001|Overall Study|Withdrawal by Subject|1|||
130191815|NCT04112043|468661366|FG002|Overall Study|Withdrawal by Subject|1|||
130191816|NCT04112043|468661364|FG000|Overall Study|Taking NR supplement|1|||
130191817|NCT04112043|468661365|FG001|Overall Study|Taking NR supplement|0|||
130191818|NCT04112043|468661366|FG002|Overall Study|Taking NR supplement|0|||
130191819|NCT04112043|468661364|FG000|Overall Study|Adverse Event|0|||
130191820|NCT04112043|468661365|FG001|Overall Study|Adverse Event|1|||
130191821|NCT04112043|468661366|FG002|Overall Study|Adverse Event|0|||
130191822|NCT04157296|468661367|FG000|Overall Study|Withdrawal by Subject|0|||
130191823|NCT04157296|468661368|FG001|Overall Study|Withdrawal by Subject|1|||
130191824|NCT04157296|468661367|FG000|Overall Study|Did not obtain second fMRI.|0|||
130191825|NCT04157296|468661368|FG001|Overall Study|Did not obtain second fMRI.|1|||
130191826|NCT04157296|468661367|FG000|Overall Study|MRI failed/no second fMRI|0|||
130191827|NCT04157296|468661368|FG001|Overall Study|MRI failed/no second fMRI|1|||
130191828|NCT00356148|468661371|FG000|Overall Study|Reoperation within 30 days|2|||
130191829|NCT00356148|468661372|FG001|Overall Study|Reoperation within 30 days|1|||
130191830|NCT02484456|468661373|FG000|Washout Period|Withdrawal by Subject|0|||
130191831|NCT02484456|468661374|FG001|Washout Period|Withdrawal by Subject|1|||
130191832|NCT02484456|468661373|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
130191833|NCT02484456|468661374|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
130191834|NCT02484456|468661373|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
130191835|NCT02484456|468661374|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
130191836|NCT02484456|468661373|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
130191837|NCT02484456|468661374|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
130191838|NCT01996254|468661375|FG000|Overall Study|Change in Eligibility|0|||
130191839|NCT01996254|468661376|FG001|Overall Study|Change in Eligibility|2|||
130191840|NCT01996254|468661377|FG002|Overall Study|Change in Eligibility|0|||
130191841|NCT01996254|468661375|FG000|Overall Study|Withdrawal by Subject|0|||
130191842|NCT01996254|468661376|FG001|Overall Study|Withdrawal by Subject|3|||
130191843|NCT01996254|468661377|FG002|Overall Study|Withdrawal by Subject|4|||
130191844|NCT01996254|468661375|FG000|Overall Study|Lost to Follow-up|1|||
130191845|NCT01996254|468661376|FG001|Overall Study|Lost to Follow-up|0|||
130191846|NCT01996254|468661377|FG002|Overall Study|Lost to Follow-up|4|||
130191847|NCT03348930|468661380|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130191848|NCT03348930|468661381|FG001|Washout (1 Week)|Lost to Follow-up|1|||
130191849|NCT02091089|468661383|FG000|Overall Study|Lost to Follow-up|2|||
130191850|NCT01580670|468661384|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
130191851|NCT01580670|468661384|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
130191852|NCT02097745|468661385|FG000|Overall Study|Adverse Event|25|||
130191853|NCT02097745|468661385|FG000|Overall Study|Death|16|||
130191854|NCT02097745|468661385|FG000|Overall Study|Failure to Return|14|||
130191855|NCT02097745|468661385|FG000|Overall Study|Administrative/Other|27|||
130191856|NCT02097745|468661385|FG000|Overall Study|Reason Not Specified|96|||
130191857|NCT00425750|468661386|FG000|Overall Study|Death|1|||
130191858|NCT00425750|468661386|FG000|Overall Study|Withdrawal by Subject|3|||
130191859|NCT00425750|468661386|FG000|Overall Study|Adverse Event|3|||
130191860|NCT00425750|468661386|FG000|Overall Study|Progression of disease|18|||
130191861|NCT01757184|468661387|FG000|Double-blind Period|Adverse Event|1|||
130191862|NCT01757184|468661388|FG001|Double-blind Period|Adverse Event|0|||
130191863|NCT01757184|468661389|FG002|Double-blind Period|Adverse Event|0|||
130191864|NCT01757184|468661390|FG003|Double-blind Period|Adverse Event|0|||
130191865|NCT01757184|468661387|FG000|Open-label Period|Lost to Follow-up|0|||
130191866|NCT01757184|468661388|FG001|Open-label Period|Lost to Follow-up|0|||
130191867|NCT01757184|468661389|FG002|Open-label Period|Lost to Follow-up|2|||
130191868|NCT01757184|468661390|FG003|Open-label Period|Lost to Follow-up|0|||
130191869|NCT01757184|468661387|FG000|Open-label Period|Withdrawal by Subject|0|||
130191870|NCT01757184|468661388|FG001|Open-label Period|Withdrawal by Subject|0|||
130191871|NCT01757184|468661389|FG002|Open-label Period|Withdrawal by Subject|1|||
130191872|NCT01757184|468661390|FG003|Open-label Period|Withdrawal by Subject|1|||
130191873|NCT01757184|468661387|FG000|Open-label Period|Discontinued by Sponsor|0|||
130191874|NCT01757184|468661388|FG001|Open-label Period|Discontinued by Sponsor|0|||
130191875|NCT01757184|468661389|FG002|Open-label Period|Discontinued by Sponsor|1|||
130191876|NCT01757184|468661390|FG003|Open-label Period|Discontinued by Sponsor|2|||
130191877|NCT00554515|468661391|FG000|Overall Study|Withdrawal by Subject|3|||
130191878|NCT00554515|468661391|FG000|Overall Study|Disease progression|52|||
130191879|NCT00554515|468661391|FG000|Overall Study|Physician Decision|18|||
130191880|NCT00554515|468661391|FG000|Overall Study|Withdrawal by Subject|11|||
130191881|NCT00554515|468661391|FG000|Overall Study|Adverse Event|9|||
130191882|NCT00554515|468661391|FG000|Overall Study|Death|2|||
130191883|NCT00554515|468661391|FG000|Overall Study|Achieved Stable Disease|7|||
130191884|NCT00554515|468661391|FG000|Overall Study|Other|1|||
130191885|NCT00554515|468661391|FG000|Overall Study|Misc|15|||
130191886|NCT01276756|468661394|FG000|Overall Study|Lost to Follow-up|2|||
130191887|NCT01276756|468661395|FG001|Overall Study|Lost to Follow-up|0|||
130191888|NCT01276756|468661394|FG000|Overall Study|Adverse Event|3|||
130191889|NCT01276756|468661395|FG001|Overall Study|Adverse Event|2|||
130191890|NCT01554527|468661403|FG000|Overall Study|Withdrawal by Subject|1|||
130191891|NCT01554527|468661404|FG001|Overall Study|Withdrawal by Subject|0|||
130191892|NCT01554527|468661405|FG002|Overall Study|Withdrawal by Subject|3|||
130191893|NCT01554527|468661403|FG000|Overall Study|Lost to Follow-up|0|||
130191894|NCT01554527|468661404|FG001|Overall Study|Lost to Follow-up|0|||
130191895|NCT01554527|468661405|FG002|Overall Study|Lost to Follow-up|4|||
130191896|NCT01554527|468661403|FG000|Overall Study|Physician Decision|0|||
130191897|NCT01554527|468661404|FG001|Overall Study|Physician Decision|0|||
130191898|NCT01554527|468661405|FG002|Overall Study|Physician Decision|1|||
130191899|NCT01052480|468661406|FG000|Overall Study|Lost to Follow-up|3|||
130191900|NCT01052480|468661407|FG001|Overall Study|Lost to Follow-up|3|||
130191901|NCT01052480|468661406|FG000|Overall Study|Protocol Violation|1|||
130191902|NCT01052480|468661407|FG001|Overall Study|Protocol Violation|0|||
130191903|NCT01052480|468661406|FG000|Overall Study|Withdrawal by Subject|3|||
130191904|NCT01052480|468661407|FG001|Overall Study|Withdrawal by Subject|7|||
130191905|NCT01052480|468661406|FG000|Overall Study|Physician Decision|0|||
130191906|NCT01052480|468661407|FG001|Overall Study|Physician Decision|2|||
130191907|NCT01052480|468661406|FG000|Overall Study|Death|1|||
130191908|NCT01052480|468661407|FG001|Overall Study|Death|5|||
130191909|NCT00529373|468661408|FG000|Base Study|Adverse Event|525|||
130191910|NCT00529373|468661409|FG001|Base Study|Adverse Event|470|||
130191911|NCT00529373|468661408|FG000|Base Study|Lack of Efficacy|16|||
130191912|NCT00529373|468661409|FG001|Base Study|Lack of Efficacy|75|||
130191913|NCT00529373|468661408|FG000|Base Study|Lost to Follow-up|221|||
130191914|NCT00529373|468661409|FG001|Base Study|Lost to Follow-up|208|||
130191915|NCT00529373|468661408|FG000|Base Study|Other Protocol Specified Criteria|19|||
130191916|NCT00529373|468661409|FG001|Base Study|Other Protocol Specified Criteria|20|||
130191917|NCT00529373|468661408|FG000|Base Study|Physician Decision|60|||
130191918|NCT00529373|468661409|FG001|Base Study|Physician Decision|52|||
130191919|NCT00529373|468661408|FG000|Base Study|Protocol Violation|48|||
130191920|NCT00529373|468661409|FG001|Base Study|Protocol Violation|38|||
130191921|NCT00529373|468661408|FG000|Base Study|Withdrawal by Subject|1062|||
130191922|NCT00529373|468661409|FG001|Base Study|Withdrawal by Subject|967|||
130191923|NCT00529373|468661408|FG000|Base Study|Did not continue into Extension|1795|||
130191924|NCT00529373|468661409|FG001|Base Study|Did not continue into Extension|2238|||
130191925|NCT00529373|468661408|FG000|First Extension Study|Adverse Event|162|||
130191926|NCT00529373|468661409|FG001|First Extension Study|Adverse Event|142|||
130191927|NCT00529373|468661408|FG000|First Extension Study|Lack of Efficacy|65|||
130191928|NCT00529373|468661409|FG001|First Extension Study|Lack of Efficacy|427|||
130191929|NCT00529373|468661408|FG000|First Extension Study|Lost to Follow-up|41|||
130191930|NCT00529373|468661409|FG001|First Extension Study|Lost to Follow-up|37|||
130191931|NCT00529373|468661408|FG000|First Extension Study|Other|27|||
130191932|NCT00529373|468661409|FG001|First Extension Study|Other|47|||
130191933|NCT00529373|468661408|FG000|First Extension Study|Physician Decision|50|||
130191934|NCT00529373|468661409|FG001|First Extension Study|Physician Decision|45|||
130191935|NCT00529373|468661408|FG000|First Extension Study|Protocol Violation|16|||
130191936|NCT00529373|468661409|FG001|First Extension Study|Protocol Violation|13|||
130191937|NCT00529373|468661408|FG000|First Extension Study|Withdrawal by Subject|296|||
130191938|NCT00529373|468661409|FG001|First Extension Study|Withdrawal by Subject|287|||
130191939|NCT00529373|468661408|FG000|First Extension Study|Disposition record non-existing|0|||
130191940|NCT00529373|468661409|FG001|First Extension Study|Disposition record non-existing|1|||
130191941|NCT00529373|468661408|FG000|First Extension Study|Discontinued after 5 years completion|208|||
130191942|NCT00529373|468661409|FG001|First Extension Study|Discontinued after 5 years completion|346|||
130191943|NCT00529373|468661408|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
130191944|NCT00529373|468661409|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
130191945|NCT00529373|468661408|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
130191946|NCT00529373|468661409|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
130191947|NCT00529373|468661408|FG000|Second Extension Study|Adverse Event|101|||
130191948|NCT00529373|468661409|FG001|Second Extension Study|Adverse Event|51|||
130191949|NCT00529373|468661408|FG000|Second Extension Study|Lack of Efficacy|7|||
130191950|NCT00529373|468661409|FG001|Second Extension Study|Lack of Efficacy|15|||
130191951|NCT00529373|468661408|FG000|Second Extension Study|Lost to Follow-up|18|||
130191952|NCT00529373|468661409|FG001|Second Extension Study|Lost to Follow-up|12|||
130191953|NCT00529373|468661408|FG000|Second Extension Study|Other|7|||
130191954|NCT00529373|468661409|FG001|Second Extension Study|Other|12|||
130191955|NCT00529373|468661408|FG000|Second Extension Study|Physician Decision|63|||
130191956|NCT00529373|468661409|FG001|Second Extension Study|Physician Decision|26|||
130191957|NCT00529373|468661408|FG000|Second Extension Study|Protocol Violation|2|||
130191958|NCT00529373|468661409|FG001|Second Extension Study|Protocol Violation|1|||
130191959|NCT00529373|468661408|FG000|Second Extension Study|Withdrawal by Subject|97|||
130191960|NCT00529373|468661409|FG001|Second Extension Study|Withdrawal by Subject|75|||
130191961|NCT00529373|468661408|FG000|Second Extension Study|Status Missing|5|||
130191962|NCT00529373|468661409|FG001|Second Extension Study|Status Missing|5|||
130191963|NCT00757042|468661418|FG000|Overall Study|Lost to Follow-up|0|||
130191964|NCT00757042|468661419|FG001|Overall Study|Lost to Follow-up|0|||
130191965|NCT00757042|468661420|FG002|Overall Study|Lost to Follow-up|0|||
130191966|NCT00757042|468661421|FG003|Overall Study|Lost to Follow-up|0|||
130191967|NCT00757042|468661422|FG004|Overall Study|Lost to Follow-up|0|||
130191968|NCT00757042|468661423|FG005|Overall Study|Lost to Follow-up|0|||
130191969|NCT00757042|468661424|FG006|Overall Study|Lost to Follow-up|0|||
130191970|NCT00757042|468661425|FG007|Overall Study|Lost to Follow-up|0|||
130191971|NCT00757042|468661426|FG008|Overall Study|Lost to Follow-up|1|||
130191972|NCT00757042|468661427|FG009|Overall Study|Lost to Follow-up|0|||
130191973|NCT00757042|468661428|FG010|Overall Study|Lost to Follow-up|0|||
130191974|NCT00757042|468661418|FG000|Overall Study|Ineligibility Determined|0|||
130191975|NCT00757042|468661419|FG001|Overall Study|Ineligibility Determined|0|||
130191976|NCT00757042|468661420|FG002|Overall Study|Ineligibility Determined|0|||
130191977|NCT00757042|468661421|FG003|Overall Study|Ineligibility Determined|0|||
130191978|NCT00757042|468661422|FG004|Overall Study|Ineligibility Determined|0|||
130191979|NCT00757042|468661423|FG005|Overall Study|Ineligibility Determined|0|||
130191980|NCT00757042|468661424|FG006|Overall Study|Ineligibility Determined|0|||
130191981|NCT00757042|468661425|FG007|Overall Study|Ineligibility Determined|0|||
130191982|NCT00757042|468661426|FG008|Overall Study|Ineligibility Determined|0|||
130191983|NCT00757042|468661427|FG009|Overall Study|Ineligibility Determined|0|||
130191984|NCT00757042|468661428|FG010|Overall Study|Ineligibility Determined|1|||
130191985|NCT00757042|468661418|FG000|Overall Study|Withdrawal by Subject|0|||
130191986|NCT00757042|468661419|FG001|Overall Study|Withdrawal by Subject|0|||
130191987|NCT00757042|468661420|FG002|Overall Study|Withdrawal by Subject|0|||
130191988|NCT00757042|468661421|FG003|Overall Study|Withdrawal by Subject|0|||
130191989|NCT00757042|468661422|FG004|Overall Study|Withdrawal by Subject|0|||
130191990|NCT00757042|468661423|FG005|Overall Study|Withdrawal by Subject|0|||
130191991|NCT00757042|468661424|FG006|Overall Study|Withdrawal by Subject|0|||
130191992|NCT00757042|468661425|FG007|Overall Study|Withdrawal by Subject|0|||
130191993|NCT00757042|468661426|FG008|Overall Study|Withdrawal by Subject|0|||
130191994|NCT00757042|468661427|FG009|Overall Study|Withdrawal by Subject|1|||
130191995|NCT00757042|468661428|FG010|Overall Study|Withdrawal by Subject|0|||
130191996|NCT01870973|468661432|FG000|Overall Study|Lost to Follow-up|10|||
130191997|NCT01870973|468661433|FG001|Overall Study|Lost to Follow-up|3|||
130191998|NCT01266291|468661435|FG000|Overall Study|Adverse Event|1|||
130191999|NCT03291431|468661436|FG000|Overall Study|Protocol Violation|2|||
130192000|NCT03291431|468661437|FG001|Overall Study|Protocol Violation|1|||
130192001|NCT03291431|468661436|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
130192002|NCT03291431|468661437|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
130192003|NCT03291431|468661436|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
130192004|NCT03291431|468661437|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
130192005|NCT03850483|468661442|FG000|Treatment for Stage 1|Adverse Event|1|||
130192006|NCT03850483|468661443|FG001|Treatment for Stage 1|Adverse Event|1|||
130192007|NCT03850483|468661444|FG002|Treatment for Stage 1|Adverse Event|3|||
130192008|NCT03850483|468661445|FG003|Treatment for Stage 1|Adverse Event|0|||
130192009|NCT03850483|468661446|FG004|Treatment for Stage 1|Adverse Event|2|||
130192010|NCT03850483|468661447|FG005|Treatment for Stage 1|Adverse Event|0|||
130192011|NCT03850483|468661448|FG006|Treatment for Stage 1|Adverse Event|2|||
130192012|NCT03850483|468661449|FG007|Treatment for Stage 1|Adverse Event|2|||
130192013|NCT03850483|468661450|FG008|Treatment for Stage 1|Adverse Event|0|||
130192014|NCT03850483|468661451|FG009|Treatment for Stage 1|Adverse Event|0|||
130192015|NCT03850483|468661442|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
130192016|NCT03850483|468661443|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
130192017|NCT03850483|468661444|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
130192018|NCT03850483|468661445|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
130192019|NCT03850483|468661446|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
130192020|NCT03850483|468661447|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
130192021|NCT03850483|468661448|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
130192022|NCT03850483|468661449|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
130192023|NCT03850483|468661450|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
130192024|NCT03850483|468661451|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
130192025|NCT03850483|468661442|FG000|Treatment for Stage 1|Protocol Violation|1|||
130192026|NCT03850483|468661443|FG001|Treatment for Stage 1|Protocol Violation|0|||
130192027|NCT03850483|468661444|FG002|Treatment for Stage 1|Protocol Violation|0|||
130192028|NCT03850483|468661445|FG003|Treatment for Stage 1|Protocol Violation|0|||
130192029|NCT03850483|468661446|FG004|Treatment for Stage 1|Protocol Violation|0|||
130192030|NCT03850483|468661447|FG005|Treatment for Stage 1|Protocol Violation|0|||
130192031|NCT03850483|468661448|FG006|Treatment for Stage 1|Protocol Violation|1|||
130192032|NCT03850483|468661449|FG007|Treatment for Stage 1|Protocol Violation|0|||
130192033|NCT03850483|468661450|FG008|Treatment for Stage 1|Protocol Violation|0|||
130192034|NCT03850483|468661451|FG009|Treatment for Stage 1|Protocol Violation|0|||
130192035|NCT03850483|468661442|FG000|Treatment for Stage 1|Physician Decision|0|||
130192036|NCT03850483|468661443|FG001|Treatment for Stage 1|Physician Decision|0|||
130192037|NCT03850483|468661444|FG002|Treatment for Stage 1|Physician Decision|0|||
130192038|NCT03850483|468661445|FG003|Treatment for Stage 1|Physician Decision|0|||
130192039|NCT03850483|468661446|FG004|Treatment for Stage 1|Physician Decision|0|||
130192040|NCT03850483|468661447|FG005|Treatment for Stage 1|Physician Decision|1|||
130192041|NCT03850483|468661448|FG006|Treatment for Stage 1|Physician Decision|0|||
130192042|NCT03850483|468661449|FG007|Treatment for Stage 1|Physician Decision|0|||
130192043|NCT03850483|468661450|FG008|Treatment for Stage 1|Physician Decision|0|||
130192044|NCT03850483|468661451|FG009|Treatment for Stage 1|Physician Decision|0|||
130192045|NCT03850483|468661442|FG000|Treatment for Stage 1|Other|0|||
130192046|NCT03850483|468661443|FG001|Treatment for Stage 1|Other|0|||
130192047|NCT03850483|468661444|FG002|Treatment for Stage 1|Other|0|||
130192048|NCT03850483|468661445|FG003|Treatment for Stage 1|Other|0|||
130192049|NCT03850483|468661446|FG004|Treatment for Stage 1|Other|2|||
130192050|NCT03850483|468661447|FG005|Treatment for Stage 1|Other|1|||
130192051|NCT03850483|468661448|FG006|Treatment for Stage 1|Other|0|||
130192052|NCT03850483|468661449|FG007|Treatment for Stage 1|Other|0|||
130192053|NCT03850483|468661450|FG008|Treatment for Stage 1|Other|0|||
130192054|NCT03850483|468661451|FG009|Treatment for Stage 1|Other|0|||
130192055|NCT03850483|468661442|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192056|NCT03850483|468661443|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192057|NCT03850483|468661444|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
130192058|NCT03850483|468661445|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192059|NCT03850483|468661446|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192060|NCT03850483|468661447|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192061|NCT03850483|468661448|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192062|NCT03850483|468661449|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192063|NCT03850483|468661450|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192064|NCT03850483|468661451|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192065|NCT03850483|468661442|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192066|NCT03850483|468661443|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192067|NCT03850483|468661444|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192068|NCT03850483|468661445|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192069|NCT03850483|468661446|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192070|NCT03850483|468661447|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
130192071|NCT03850483|468661448|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192072|NCT03850483|468661449|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192073|NCT03850483|468661450|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192074|NCT03850483|468661451|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192075|NCT03850483|468661442|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
130192076|NCT03850483|468661443|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
130192077|NCT03850483|468661444|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
130192078|NCT03850483|468661445|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
130192079|NCT03850483|468661446|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
130192080|NCT03850483|468661447|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
130192081|NCT03850483|468661448|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
130192082|NCT03850483|468661449|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
130192083|NCT03850483|468661450|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
130192084|NCT03850483|468661451|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
130192085|NCT03850483|468661442|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
130192086|NCT03850483|468661443|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
130192087|NCT03850483|468661444|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
130192088|NCT03850483|468661445|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
130192089|NCT03850483|468661446|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
130192090|NCT03850483|468661447|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
130192091|NCT03850483|468661448|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
130192092|NCT03850483|468661449|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
130192093|NCT03850483|468661450|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
130192094|NCT03850483|468661451|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
130192095|NCT03850483|468661442|FG000|Treatment for Stage 1|Death|0|||
130192096|NCT03850483|468661443|FG001|Treatment for Stage 1|Death|0|||
130192097|NCT03850483|468661444|FG002|Treatment for Stage 1|Death|0|||
130192098|NCT03850483|468661445|FG003|Treatment for Stage 1|Death|0|||
130192099|NCT03850483|468661446|FG004|Treatment for Stage 1|Death|0|||
130192100|NCT03850483|468661447|FG005|Treatment for Stage 1|Death|1|||
130192101|NCT03850483|468661448|FG006|Treatment for Stage 1|Death|0|||
130192102|NCT03850483|468661449|FG007|Treatment for Stage 1|Death|0|||
130192103|NCT03850483|468661450|FG008|Treatment for Stage 1|Death|0|||
130192104|NCT03850483|468661451|FG009|Treatment for Stage 1|Death|0|||
130192105|NCT03850483|468661442|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
130192106|NCT03850483|468661443|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
130192107|NCT03850483|468661444|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
130192108|NCT03850483|468661445|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
130192109|NCT03850483|468661446|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
130192110|NCT03850483|468661447|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
130192111|NCT03850483|468661448|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
130192112|NCT03850483|468661449|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
130192113|NCT03850483|468661450|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
130192114|NCT03850483|468661451|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
130192115|NCT03850483|468661442|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
130192116|NCT03850483|468661443|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
130192117|NCT03850483|468661444|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
130192118|NCT03850483|468661445|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
130192119|NCT03850483|468661446|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
130192120|NCT03850483|468661447|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
130192121|NCT03850483|468661448|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
130192122|NCT03850483|468661449|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
130192123|NCT03850483|468661450|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
130192124|NCT03850483|468661451|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
130192125|NCT03850483|468661442|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192126|NCT03850483|468661443|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192127|NCT03850483|468661444|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192128|NCT03850483|468661445|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192129|NCT03850483|468661446|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192130|NCT03850483|468661447|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192131|NCT03850483|468661448|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
130192132|NCT03850483|468661449|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
130192133|NCT03850483|468661450|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192134|NCT03850483|468661451|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192135|NCT03850483|468661442|FG000|Follow-up for Stage 1|Physician Decision|0|||
130192136|NCT03850483|468661443|FG001|Follow-up for Stage 1|Physician Decision|0|||
130192137|NCT03850483|468661444|FG002|Follow-up for Stage 1|Physician Decision|0|||
130192138|NCT03850483|468661445|FG003|Follow-up for Stage 1|Physician Decision|0|||
130192139|NCT03850483|468661446|FG004|Follow-up for Stage 1|Physician Decision|1|||
130192140|NCT03850483|468661447|FG005|Follow-up for Stage 1|Physician Decision|0|||
130192141|NCT03850483|468661448|FG006|Follow-up for Stage 1|Physician Decision|1|||
130192142|NCT03850483|468661449|FG007|Follow-up for Stage 1|Physician Decision|0|||
130192143|NCT03850483|468661450|FG008|Follow-up for Stage 1|Physician Decision|0|||
130192144|NCT03850483|468661451|FG009|Follow-up for Stage 1|Physician Decision|0|||
130192145|NCT03850483|468661442|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
130192146|NCT03850483|468661443|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
130192147|NCT03850483|468661444|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
130192148|NCT03850483|468661445|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
130192149|NCT03850483|468661446|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
130192150|NCT03850483|468661447|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
130192151|NCT03850483|468661448|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
130192152|NCT03850483|468661449|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
130192153|NCT03850483|468661450|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
130192154|NCT03850483|468661451|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
130192155|NCT03850483|468661442|FG000|Follow-up for Stage 1|Adverse Event|0|||
130192156|NCT03850483|468661443|FG001|Follow-up for Stage 1|Adverse Event|0|||
130192157|NCT03850483|468661444|FG002|Follow-up for Stage 1|Adverse Event|1|||
130192158|NCT03850483|468661445|FG003|Follow-up for Stage 1|Adverse Event|0|||
130192159|NCT03850483|468661446|FG004|Follow-up for Stage 1|Adverse Event|0|||
130192160|NCT03850483|468661447|FG005|Follow-up for Stage 1|Adverse Event|1|||
130192161|NCT03850483|468661448|FG006|Follow-up for Stage 1|Adverse Event|0|||
130192162|NCT03850483|468661449|FG007|Follow-up for Stage 1|Adverse Event|0|||
130192163|NCT03850483|468661450|FG008|Follow-up for Stage 1|Adverse Event|0|||
130192164|NCT03850483|468661451|FG009|Follow-up for Stage 1|Adverse Event|0|||
130192165|NCT03850483|468661442|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192166|NCT03850483|468661443|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
130192167|NCT03850483|468661444|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192168|NCT03850483|468661445|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192169|NCT03850483|468661446|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130192170|NCT03850483|468661447|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130192171|NCT03850483|468661448|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192172|NCT03850483|468661449|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192173|NCT03850483|468661450|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192174|NCT03850483|468661451|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192175|NCT03850483|468661442|FG000|Follow-up for Stage 1|Other|0|||
130192176|NCT03850483|468661443|FG001|Follow-up for Stage 1|Other|2|||
130192177|NCT03850483|468661444|FG002|Follow-up for Stage 1|Other|0|||
130192178|NCT03850483|468661445|FG003|Follow-up for Stage 1|Other|2|||
130192179|NCT03850483|468661446|FG004|Follow-up for Stage 1|Other|0|||
130192180|NCT03850483|468661447|FG005|Follow-up for Stage 1|Other|1|||
130192181|NCT03850483|468661448|FG006|Follow-up for Stage 1|Other|0|||
130192182|NCT03850483|468661449|FG007|Follow-up for Stage 1|Other|0|||
130192183|NCT03850483|468661450|FG008|Follow-up for Stage 1|Other|0|||
130192184|NCT03850483|468661451|FG009|Follow-up for Stage 1|Other|0|||
130192185|NCT03850483|468661442|FG000|Treatment for Stage 2|Adverse Event|0|||
130192186|NCT03850483|468661443|FG001|Treatment for Stage 2|Adverse Event|0|||
130192187|NCT03850483|468661444|FG002|Treatment for Stage 2|Adverse Event|0|||
130192188|NCT03850483|468661445|FG003|Treatment for Stage 2|Adverse Event|0|||
130192189|NCT03850483|468661446|FG004|Treatment for Stage 2|Adverse Event|0|||
130192190|NCT03850483|468661447|FG005|Treatment for Stage 2|Adverse Event|0|||
130192191|NCT03850483|468661448|FG006|Treatment for Stage 2|Adverse Event|0|||
130192192|NCT03850483|468661449|FG007|Treatment for Stage 2|Adverse Event|0|||
130192193|NCT03850483|468661450|FG008|Treatment for Stage 2|Adverse Event|0|||
130192194|NCT03850483|468661451|FG009|Treatment for Stage 2|Adverse Event|1|||
130192195|NCT03850483|468661442|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
130192196|NCT03850483|468661443|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
130192197|NCT03850483|468661444|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
130192198|NCT03850483|468661445|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
130192199|NCT03850483|468661446|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
130192200|NCT03850483|468661447|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
130192201|NCT03850483|468661448|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
130192202|NCT03850483|468661449|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
130192203|NCT03850483|468661450|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
130192204|NCT03850483|468661451|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
130192205|NCT03850483|468661442|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
130192206|NCT03850483|468661443|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
130192207|NCT03850483|468661444|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
130192208|NCT03850483|468661445|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
130192209|NCT03850483|468661446|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
130192210|NCT03850483|468661447|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
130192211|NCT03850483|468661448|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
130192212|NCT03850483|468661449|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
130192213|NCT03850483|468661450|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
130192214|NCT03850483|468661451|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
130192215|NCT03850483|468661442|FG000|Treatment for Stage 2|Physician Decision|0|||
130192216|NCT03850483|468661443|FG001|Treatment for Stage 2|Physician Decision|0|||
130192217|NCT03850483|468661444|FG002|Treatment for Stage 2|Physician Decision|0|||
130192218|NCT03850483|468661445|FG003|Treatment for Stage 2|Physician Decision|0|||
130192219|NCT03850483|468661446|FG004|Treatment for Stage 2|Physician Decision|0|||
130192220|NCT03850483|468661447|FG005|Treatment for Stage 2|Physician Decision|0|||
130192221|NCT03850483|468661448|FG006|Treatment for Stage 2|Physician Decision|0|||
130192222|NCT03850483|468661449|FG007|Treatment for Stage 2|Physician Decision|0|||
130192223|NCT03850483|468661450|FG008|Treatment for Stage 2|Physician Decision|0|||
130192224|NCT03850483|468661451|FG009|Treatment for Stage 2|Physician Decision|1|||
130192225|NCT03850483|468661442|FG000|Treatment for Stage 2|Protocol Violation|0|||
130192226|NCT03850483|468661443|FG001|Treatment for Stage 2|Protocol Violation|0|||
130192227|NCT03850483|468661444|FG002|Treatment for Stage 2|Protocol Violation|0|||
130192228|NCT03850483|468661445|FG003|Treatment for Stage 2|Protocol Violation|0|||
130192229|NCT03850483|468661446|FG004|Treatment for Stage 2|Protocol Violation|0|||
130192230|NCT03850483|468661447|FG005|Treatment for Stage 2|Protocol Violation|0|||
130192231|NCT03850483|468661448|FG006|Treatment for Stage 2|Protocol Violation|0|||
130192232|NCT03850483|468661449|FG007|Treatment for Stage 2|Protocol Violation|0|||
130192233|NCT03850483|468661450|FG008|Treatment for Stage 2|Protocol Violation|1|||
130192234|NCT03850483|468661451|FG009|Treatment for Stage 2|Protocol Violation|0|||
130192235|NCT03850483|468661442|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
130192236|NCT03850483|468661443|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
130192237|NCT03850483|468661444|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
130192238|NCT03850483|468661445|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
130192239|NCT03850483|468661446|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
130192240|NCT03850483|468661447|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
130192241|NCT03850483|468661448|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
130192242|NCT03850483|468661449|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
130192243|NCT03850483|468661450|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
130192244|NCT03850483|468661451|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
130192245|NCT03850483|468661442|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192246|NCT03850483|468661443|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192247|NCT03850483|468661444|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192248|NCT03850483|468661445|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192249|NCT03850483|468661446|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192250|NCT03850483|468661447|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192251|NCT03850483|468661448|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192252|NCT03850483|468661449|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192253|NCT03850483|468661450|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192254|NCT03850483|468661451|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
130192255|NCT03850483|468661442|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
130192256|NCT03850483|468661443|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
130192257|NCT03850483|468661444|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
130192258|NCT03850483|468661445|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
130192259|NCT03850483|468661446|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
130192260|NCT03850483|468661447|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
130192261|NCT03850483|468661448|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
130192262|NCT03850483|468661449|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
130192263|NCT03850483|468661450|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
130192264|NCT03850483|468661451|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
130192265|NCT03850483|468661442|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
130192266|NCT03850483|468661443|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
130192267|NCT03850483|468661444|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
130192268|NCT03850483|468661445|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
130192269|NCT03850483|468661446|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
130192270|NCT03850483|468661447|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
130192271|NCT03850483|468661448|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
130192272|NCT03850483|468661449|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
130192273|NCT03850483|468661450|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
130192274|NCT03850483|468661451|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
130192275|NCT03850483|468661442|FG000|Follow-up For Stage 2|Other|0|||
130192276|NCT03850483|468661443|FG001|Follow-up For Stage 2|Other|0|||
130192277|NCT03850483|468661444|FG002|Follow-up For Stage 2|Other|0|||
130192278|NCT03850483|468661445|FG003|Follow-up For Stage 2|Other|0|||
130192279|NCT03850483|468661446|FG004|Follow-up For Stage 2|Other|0|||
130192280|NCT03850483|468661447|FG005|Follow-up For Stage 2|Other|0|||
130192281|NCT03850483|468661448|FG006|Follow-up For Stage 2|Other|0|||
130192282|NCT03850483|468661449|FG007|Follow-up For Stage 2|Other|0|||
130192283|NCT03850483|468661450|FG008|Follow-up For Stage 2|Other|0|||
130192284|NCT03850483|468661451|FG009|Follow-up For Stage 2|Other|1|||
130192285|NCT04432831|468663211|FG000|Overall Study|Withdrawal by Subject|24|||
130192286|NCT04432831|468663212|FG001|Overall Study|Withdrawal by Subject|28|||
130192287|NCT04432831|468663213|FG002|Overall Study|Withdrawal by Subject|21|||
130192288|NCT04432831|468663211|FG000|Overall Study|Death|23|||
130192289|NCT04432831|468663212|FG001|Overall Study|Death|23|||
130192290|NCT04432831|468663213|FG002|Overall Study|Death|17|||
130192291|NCT04432831|468663211|FG000|Overall Study|Lost to Follow-up|15|||
130192292|NCT04432831|468663212|FG001|Overall Study|Lost to Follow-up|15|||
130192293|NCT04432831|468663213|FG002|Overall Study|Lost to Follow-up|12|||
130192294|NCT04432831|468663211|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
130192295|NCT04432831|468663212|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
130192296|NCT04432831|468663213|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
130192297|NCT04432831|468663211|FG000|Overall Study|Reason Not Specified|7|||
130192298|NCT04432831|468663212|FG001|Overall Study|Reason Not Specified|11|||
130192299|NCT04432831|468663213|FG002|Overall Study|Reason Not Specified|9|||
130192300|NCT04432831|468663211|FG000|Overall Study|Adverse Event|7|||
130192301|NCT04432831|468663212|FG001|Overall Study|Adverse Event|7|||
130192302|NCT04432831|468663213|FG002|Overall Study|Adverse Event|7|||
130192303|NCT04432831|468663211|FG000|Overall Study|Physician Decision|1|||
130192304|NCT04432831|468663212|FG001|Overall Study|Physician Decision|3|||
130192305|NCT04432831|468663213|FG002|Overall Study|Physician Decision|6|||
130192306|NCT04432831|468663211|FG000|Overall Study|Protocol Violation|1|||
130192307|NCT04432831|468663212|FG001|Overall Study|Protocol Violation|0|||
130192308|NCT04432831|468663213|FG002|Overall Study|Protocol Violation|2|||
130192309|NCT04432831|468663211|FG000|Overall Study|Pregnancy|0|||
130192310|NCT04432831|468663212|FG001|Overall Study|Pregnancy|1|||
130192311|NCT04432831|468663213|FG002|Overall Study|Pregnancy|0|||
130192312|NCT04432831|468663211|FG000|Overall Study|Lack of Efficacy|0|||
130192313|NCT04432831|468663212|FG001|Overall Study|Lack of Efficacy|0|||
130192314|NCT04432831|468663213|FG002|Overall Study|Lack of Efficacy|2|||
130192315|NCT00652626|468663216|FG000|Initial Treatment Phase|Adverse Event|0|||
130192316|NCT00652626|468663217|FG001|Initial Treatment Phase|Adverse Event|0|||
130192317|NCT00652626|468663218|FG002|Initial Treatment Phase|Adverse Event|0|||
130192318|NCT00652626|468663219|FG003|Initial Treatment Phase|Adverse Event|0|||
130192319|NCT00652626|468663220|FG004|Initial Treatment Phase|Adverse Event|1|||
130192320|NCT00652626|468663221|FG005|Initial Treatment Phase|Adverse Event|0|||
130192321|NCT00652626|468663222|FG006|Initial Treatment Phase|Adverse Event|0|||
130192322|NCT00652626|468663216|FG000|Initial Treatment Phase|Protocol Violation|0|||
130192323|NCT00652626|468663217|FG001|Initial Treatment Phase|Protocol Violation|0|||
130192324|NCT00652626|468663218|FG002|Initial Treatment Phase|Protocol Violation|0|||
130192325|NCT00652626|468663219|FG003|Initial Treatment Phase|Protocol Violation|1|||
130192326|NCT00652626|468663220|FG004|Initial Treatment Phase|Protocol Violation|0|||
130192327|NCT00652626|468663221|FG005|Initial Treatment Phase|Protocol Violation|0|||
130192328|NCT00652626|468663222|FG006|Initial Treatment Phase|Protocol Violation|0|||
130192329|NCT00652626|468663216|FG000|Initial Treatment Phase|Physician Decision|0|||
130192330|NCT00652626|468663217|FG001|Initial Treatment Phase|Physician Decision|0|||
130192331|NCT00652626|468663218|FG002|Initial Treatment Phase|Physician Decision|0|||
130192332|NCT00652626|468663219|FG003|Initial Treatment Phase|Physician Decision|0|||
130192333|NCT00652626|468663220|FG004|Initial Treatment Phase|Physician Decision|1|||
130192334|NCT00652626|468663221|FG005|Initial Treatment Phase|Physician Decision|0|||
130192335|NCT00652626|468663222|FG006|Initial Treatment Phase|Physician Decision|0|||
130192336|NCT00652626|468663216|FG000|Initial Treatment Phase|Sponsor Request|0|||
130192337|NCT00652626|468663217|FG001|Initial Treatment Phase|Sponsor Request|0|||
130192338|NCT00652626|468663218|FG002|Initial Treatment Phase|Sponsor Request|1|||
130192339|NCT00652626|468663219|FG003|Initial Treatment Phase|Sponsor Request|0|||
130192340|NCT00652626|468663220|FG004|Initial Treatment Phase|Sponsor Request|0|||
130192341|NCT00652626|468663221|FG005|Initial Treatment Phase|Sponsor Request|0|||
130192342|NCT00652626|468663222|FG006|Initial Treatment Phase|Sponsor Request|0|||
130192343|NCT00652626|468663216|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
130192344|NCT00652626|468663217|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
130192345|NCT00652626|468663218|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
130192346|NCT00652626|468663219|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
130192347|NCT00652626|468663220|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
130192348|NCT00652626|468663221|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
130192349|NCT00652626|468663222|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
130192350|NCT00652626|468663216|FG000|Extension Phase|Withdrawal by Subject|0|||
130192351|NCT00652626|468663217|FG001|Extension Phase|Withdrawal by Subject|0|||
130192352|NCT00652626|468663218|FG002|Extension Phase|Withdrawal by Subject|0|||
130192353|NCT00652626|468663219|FG003|Extension Phase|Withdrawal by Subject|0|||
130192354|NCT00652626|468663220|FG004|Extension Phase|Withdrawal by Subject|0|||
130192355|NCT00652626|468663221|FG005|Extension Phase|Withdrawal by Subject|2|||
130192356|NCT00652626|468663222|FG006|Extension Phase|Withdrawal by Subject|0|||
130192357|NCT00652626|468663216|FG000|Extension Phase|Adverse Event|0|||
130192358|NCT00652626|468663217|FG001|Extension Phase|Adverse Event|0|||
130192359|NCT00652626|468663218|FG002|Extension Phase|Adverse Event|0|||
130192360|NCT00652626|468663219|FG003|Extension Phase|Adverse Event|0|||
130192361|NCT00652626|468663220|FG004|Extension Phase|Adverse Event|0|||
130192362|NCT00652626|468663221|FG005|Extension Phase|Adverse Event|2|||
130192363|NCT00652626|468663222|FG006|Extension Phase|Adverse Event|1|||
130192364|NCT00652626|468663216|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192365|NCT00652626|468663217|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192366|NCT00652626|468663218|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192367|NCT00652626|468663219|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192368|NCT00652626|468663220|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192369|NCT00652626|468663221|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
130192370|NCT00652626|468663222|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192371|NCT00652626|468663216|FG000|Extension Phase|Physician Decision|0|||
130192372|NCT00652626|468663217|FG001|Extension Phase|Physician Decision|0|||
130192373|NCT00652626|468663218|FG002|Extension Phase|Physician Decision|0|||
130192374|NCT00652626|468663219|FG003|Extension Phase|Physician Decision|0|||
130192375|NCT00652626|468663220|FG004|Extension Phase|Physician Decision|0|||
130192376|NCT00652626|468663221|FG005|Extension Phase|Physician Decision|1|||
130192377|NCT00652626|468663222|FG006|Extension Phase|Physician Decision|1|||
130192378|NCT00652626|468663216|FG000|Extension Phase|Death|0|||
130192379|NCT00652626|468663217|FG001|Extension Phase|Death|0|||
130192380|NCT00652626|468663218|FG002|Extension Phase|Death|0|||
130192381|NCT00652626|468663219|FG003|Extension Phase|Death|0|||
130192382|NCT00652626|468663220|FG004|Extension Phase|Death|0|||
130192383|NCT00652626|468663221|FG005|Extension Phase|Death|1|||
130192384|NCT00652626|468663222|FG006|Extension Phase|Death|1|||
130192385|NCT01623310|468663223|FG000|Overall Study|Adverse Event|21|||
130192386|NCT01623310|468663223|FG000|Overall Study|Lost to Follow-up|18|||
130192387|NCT01623310|468663223|FG000|Overall Study|Lack of Efficacy|6|||
130192388|NCT01623310|468663223|FG000|Overall Study|Protocol Violation|6|||
130192389|NCT01623310|468663223|FG000|Overall Study|Withdrawal by Subject|25|||
130192390|NCT01623310|468663223|FG000|Overall Study|Became potentially child-bearing|1|||
130192391|NCT01623310|468663223|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
130192392|NCT01623310|468663223|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
130192393|NCT02898597|468663224|FG000|Overall Study|Protocol Violation|4|||
130192394|NCT02898597|468663225|FG001|Overall Study|Protocol Violation|2|||
130192395|NCT02898597|468663224|FG000|Overall Study|Lost to Follow-up|0|||
130192396|NCT02898597|468663225|FG001|Overall Study|Lost to Follow-up|9|||
130192397|NCT02898597|468663224|FG000|Overall Study|Death|0|||
130192398|NCT02898597|468663225|FG001|Overall Study|Death|1|||
130192399|NCT02530125|468663226|FG000|Completed Treatment|Early termination of study|1|||
130192400|NCT02530125|468663226|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
130192401|NCT01568034|468663227|FG000|Overall Study|Withdrawal by Subject|1|||
130192402|NCT01568034|468663228|FG001|Overall Study|Withdrawal by Subject|0|||
130192403|NCT01568034|468663229|FG002|Overall Study|Withdrawal by Subject|0|||
130192404|NCT01568034|468663230|FG003|Overall Study|Withdrawal by Subject|0|||
130192405|NCT06098339|468663231|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
130192406|NCT06098339|468663232|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
130192407|NCT06098339|468663231|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130192408|NCT06098339|468663232|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130192409|NCT02492984|468663233|FG000|Overall Study|Adverse Event|1|||
130192410|NCT02492984|468663234|FG001|Overall Study|Adverse Event|0|||
130192411|NCT02492984|468663233|FG000|Overall Study|Protocol Violation|1|||
130192412|NCT02492984|468663234|FG001|Overall Study|Protocol Violation|0|||
130192413|NCT02492984|468663233|FG000|Overall Study|Withdrawal by Subject|1|||
130192414|NCT02492984|468663234|FG001|Overall Study|Withdrawal by Subject|0|||
130192415|NCT02498444|468663235|FG000|Overall Study|Withdrawal by Subject|3|||
130192416|NCT02498444|468663236|FG001|Overall Study|Withdrawal by Subject|0|||
130192417|NCT02498444|468663235|FG000|Overall Study|Physician Decision|1|||
130192418|NCT02498444|468663236|FG001|Overall Study|Physician Decision|0|||
130192419|NCT02027545|468663237|FG000|Overall Study|Failed to sign HIPAA|0|||
130192420|NCT02027545|468663238|FG001|Overall Study|Failed to sign HIPAA|2|||
130192421|NCT02027545|468663237|FG000|Overall Study|Failed to attend study visit|2|||
130192422|NCT02027545|468663238|FG001|Overall Study|Failed to attend study visit|0|||
130192423|NCT02027545|468663237|FG000|Overall Study|Protocol Violation|1|||
130192424|NCT02027545|468663238|FG001|Overall Study|Protocol Violation|0|||
130192425|NCT02453334|468663239|FG000|Overall Study|Death|15|||
130192426|NCT02453334|468663240|FG001|Overall Study|Death|13|||
130192427|NCT02453334|468663239|FG000|Overall Study|Adverse Event|2|||
130192428|NCT02453334|468663240|FG001|Overall Study|Adverse Event|1|||
130192429|NCT02453334|468663239|FG000|Overall Study|Lost to Follow-up|5|||
130192430|NCT02453334|468663240|FG001|Overall Study|Lost to Follow-up|9|||
130192431|NCT02453334|468663239|FG000|Overall Study|Physician Decision|1|||
130192432|NCT02453334|468663240|FG001|Overall Study|Physician Decision|0|||
130192433|NCT02453334|468663239|FG000|Overall Study|Withdrawal by Subject|17|||
130192434|NCT02453334|468663240|FG001|Overall Study|Withdrawal by Subject|13|||
130192435|NCT02453334|468663239|FG000|Overall Study|Other reason|1|||
130192436|NCT02453334|468663240|FG001|Overall Study|Other reason|4|||
130192437|NCT04090060|468663243|FG000|Overall Study|Lost to Follow-up|76|||
130192438|NCT04090060|468663244|FG001|Overall Study|Lost to Follow-up|77|||
130192439|NCT03337113|468663251|FG000|Overall Study|Adverse Event|1|||
130192440|NCT03337113|468663252|FG001|Overall Study|Adverse Event|1|||
130192441|NCT03337113|468663253|FG002|Overall Study|Adverse Event|0|||
130192442|NCT03337113|468663254|FG003|Overall Study|Adverse Event|1|||
130192443|NCT03337113|468663251|FG000|Overall Study|Physician Decision|0|||
130192444|NCT03337113|468663252|FG001|Overall Study|Physician Decision|2|||
130192445|NCT03337113|468663253|FG002|Overall Study|Physician Decision|0|||
130192446|NCT03337113|468663254|FG003|Overall Study|Physician Decision|1|||
130192447|NCT03337113|468663251|FG000|Overall Study|Withdrawal by Subject|0|||
130192448|NCT03337113|468663252|FG001|Overall Study|Withdrawal by Subject|0|||
130192449|NCT03337113|468663253|FG002|Overall Study|Withdrawal by Subject|1|||
130192450|NCT03337113|468663254|FG003|Overall Study|Withdrawal by Subject|0|||
130192451|NCT01164579|468663255|FG000|Overall Study|Lack of Efficacy|0|||
130192452|NCT01164579|468663256|FG001|Overall Study|Lack of Efficacy|0|||
130192453|NCT01164579|468663257|FG002|Overall Study|Lack of Efficacy|6|||
130192454|NCT01164579|468663255|FG000|Overall Study|Lost to Follow-up|1|||
130192455|NCT01164579|468663256|FG001|Overall Study|Lost to Follow-up|1|||
130192456|NCT01164579|468663257|FG002|Overall Study|Lost to Follow-up|0|||
130192457|NCT01164579|468663255|FG000|Overall Study|Withdrawal by Subject|2|||
130192458|NCT01164579|468663256|FG001|Overall Study|Withdrawal by Subject|5|||
130192459|NCT01164579|468663257|FG002|Overall Study|Withdrawal by Subject|3|||
130192460|NCT01164579|468663255|FG000|Overall Study|Protocol Violation|0|||
130192461|NCT01164579|468663256|FG001|Overall Study|Protocol Violation|1|||
130192462|NCT01164579|468663257|FG002|Overall Study|Protocol Violation|2|||
130192463|NCT01164579|468663255|FG000|Overall Study|Adverse Event|4|||
130192464|NCT01164579|468663256|FG001|Overall Study|Adverse Event|2|||
130192465|NCT01164579|468663257|FG002|Overall Study|Adverse Event|5|||
130192466|NCT01164579|468663255|FG000|Overall Study|Reason not specified|1|||
130192467|NCT01164579|468663256|FG001|Overall Study|Reason not specified|0|||
130192468|NCT01164579|468663257|FG002|Overall Study|Reason not specified|0|||
130192469|NCT00302328|468663258|FG000|Overall Study|Physician Decision|0|||
130192470|NCT00302328|468663259|FG001|Overall Study|Physician Decision|1|||
130192471|NCT00302328|468663260|FG002|Overall Study|Physician Decision|0|||
130192472|NCT03491462|468663265|FG000|Overall Study|Lost to Follow-up|2|||
130192473|NCT03491462|468663266|FG001|Overall Study|Lost to Follow-up|0|||
130192474|NCT03491462|468663265|FG000|Overall Study|Adverse Event|11|||
130192475|NCT03491462|468663266|FG001|Overall Study|Adverse Event|1|||
130192476|NCT03491462|468663265|FG000|Overall Study|Physician Decision|3|||
130192477|NCT03491462|468663266|FG001|Overall Study|Physician Decision|0|||
130192478|NCT03491462|468663265|FG000|Overall Study|Withdrawal by Subject|22|||
130192479|NCT03491462|468663266|FG001|Overall Study|Withdrawal by Subject|15|||
130192480|NCT00423332|468663270|FG000|Overall Study|Adverse Event|6|||
130192481|NCT00423332|468663271|FG001|Overall Study|Adverse Event|2|||
130192482|NCT00423332|468663270|FG000|Overall Study|Withdrawal by Subject|1|||
130192483|NCT00423332|468663271|FG001|Overall Study|Withdrawal by Subject|0|||
130192484|NCT00423332|468663270|FG000|Overall Study|Condition under investigation worsened|1|||
130192485|NCT00423332|468663271|FG001|Overall Study|Condition under investigation worsened|1|||
130192486|NCT00423332|468663270|FG000|Overall Study|Progressive at Week 6|0|||
130192487|NCT00423332|468663271|FG001|Overall Study|Progressive at Week 6|1|||
130192488|NCT00423332|468663270|FG000|Overall Study|Unblinded before 12 weeks|1|||
130192489|NCT00423332|468663271|FG001|Overall Study|Unblinded before 12 weeks|3|||
130192490|NCT00685399|468663282|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130192491|NCT00685399|468663283|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130192492|NCT00685399|468663284|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130192493|NCT00685399|468663285|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130192494|NCT00685399|468663286|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130192495|NCT00685399|468663287|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130192496|NCT00685399|468663288|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130192497|NCT00685399|468663289|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130192498|NCT00685399|468663282|FG000|Treatment Period 1|Protocol Violation|1|||
130192499|NCT00685399|468663283|FG001|Treatment Period 1|Protocol Violation|0|||
130192500|NCT00685399|468663284|FG002|Treatment Period 1|Protocol Violation|0|||
130192501|NCT00685399|468663285|FG003|Treatment Period 1|Protocol Violation|0|||
130192502|NCT00685399|468663286|FG004|Treatment Period 1|Protocol Violation|0|||
130192503|NCT00685399|468663287|FG005|Treatment Period 1|Protocol Violation|0|||
130192504|NCT00685399|468663288|FG006|Treatment Period 1|Protocol Violation|0|||
130192505|NCT00685399|468663289|FG007|Treatment Period 1|Protocol Violation|0|||
130192506|NCT00685399|468663282|FG000|Treatment Period 1|Administrative|2|||
130192507|NCT00685399|468663283|FG001|Treatment Period 1|Administrative|0|||
130192508|NCT00685399|468663284|FG002|Treatment Period 1|Administrative|0|||
130192509|NCT00685399|468663285|FG003|Treatment Period 1|Administrative|0|||
130192510|NCT00685399|468663286|FG004|Treatment Period 1|Administrative|0|||
130192511|NCT00685399|468663287|FG005|Treatment Period 1|Administrative|0|||
130192512|NCT00685399|468663288|FG006|Treatment Period 1|Administrative|0|||
130192513|NCT00685399|468663289|FG007|Treatment Period 1|Administrative|0|||
130192514|NCT00685399|468663282|FG000|Treatment Period 1|Lack of Efficacy|1|||
130192515|NCT00685399|468663283|FG001|Treatment Period 1|Lack of Efficacy|0|||
130192516|NCT00685399|468663284|FG002|Treatment Period 1|Lack of Efficacy|0|||
130192517|NCT00685399|468663285|FG003|Treatment Period 1|Lack of Efficacy|0|||
130192518|NCT00685399|468663286|FG004|Treatment Period 1|Lack of Efficacy|0|||
130192519|NCT00685399|468663287|FG005|Treatment Period 1|Lack of Efficacy|0|||
130192520|NCT00685399|468663288|FG006|Treatment Period 1|Lack of Efficacy|0|||
130192521|NCT00685399|468663289|FG007|Treatment Period 1|Lack of Efficacy|0|||
130192522|NCT00685399|468663282|FG000|Treatment Period 2|Administrative Problems|0|||
130192523|NCT00685399|468663283|FG001|Treatment Period 2|Administrative Problems|2|||
130192524|NCT00685399|468663284|FG002|Treatment Period 2|Administrative Problems|1|||
130192525|NCT00685399|468663285|FG003|Treatment Period 2|Administrative Problems|0|||
130192526|NCT00685399|468663286|FG004|Treatment Period 2|Administrative Problems|0|||
130192527|NCT00685399|468663287|FG005|Treatment Period 2|Administrative Problems|0|||
130192528|NCT00685399|468663288|FG006|Treatment Period 2|Administrative Problems|0|||
130192529|NCT00685399|468663289|FG007|Treatment Period 2|Administrative Problems|0|||
130192530|NCT00685399|468663282|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130192531|NCT00685399|468663283|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130192532|NCT00685399|468663284|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130192533|NCT00685399|468663285|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130192534|NCT00685399|468663286|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130192535|NCT00685399|468663287|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130192536|NCT00685399|468663288|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130192537|NCT00685399|468663289|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130192538|NCT00685399|468663282|FG000|Treatment Period 2|Adverse Event|0|||
130192539|NCT00685399|468663283|FG001|Treatment Period 2|Adverse Event|0|||
130192540|NCT00685399|468663284|FG002|Treatment Period 2|Adverse Event|0|||
130192541|NCT00685399|468663285|FG003|Treatment Period 2|Adverse Event|0|||
130192542|NCT00685399|468663286|FG004|Treatment Period 2|Adverse Event|0|||
130192543|NCT00685399|468663287|FG005|Treatment Period 2|Adverse Event|1|||
130192544|NCT00685399|468663288|FG006|Treatment Period 2|Adverse Event|0|||
130192545|NCT00685399|468663289|FG007|Treatment Period 2|Adverse Event|0|||
130192546|NCT00685399|468663282|FG000|Treatment Period 2|Lack of Efficacy|0|||
130192547|NCT00685399|468663283|FG001|Treatment Period 2|Lack of Efficacy|10|||
130192548|NCT00685399|468663284|FG002|Treatment Period 2|Lack of Efficacy|2|||
130192549|NCT00685399|468663285|FG003|Treatment Period 2|Lack of Efficacy|0|||
130192550|NCT00685399|468663286|FG004|Treatment Period 2|Lack of Efficacy|0|||
130192551|NCT00685399|468663287|FG005|Treatment Period 2|Lack of Efficacy|1|||
130192552|NCT00685399|468663288|FG006|Treatment Period 2|Lack of Efficacy|0|||
130192553|NCT00685399|468663289|FG007|Treatment Period 2|Lack of Efficacy|0|||
130192554|NCT00685399|468663282|FG000|Extension|Administrative Issues|0|||
130192555|NCT00685399|468663283|FG001|Extension|Administrative Issues|0|||
130192556|NCT00685399|468663284|FG002|Extension|Administrative Issues|0|||
130192557|NCT00685399|468663285|FG003|Extension|Administrative Issues|1|||
130192558|NCT00685399|468663286|FG004|Extension|Administrative Issues|0|||
130192559|NCT00685399|468663287|FG005|Extension|Administrative Issues|0|||
130192560|NCT00685399|468663288|FG006|Extension|Administrative Issues|0|||
130192561|NCT00685399|468663289|FG007|Extension|Administrative Issues|0|||
130192562|NCT00685399|468663282|FG000|Extension|Withdrawal by Subject|0|||
130192563|NCT00685399|468663283|FG001|Extension|Withdrawal by Subject|0|||
130192564|NCT00685399|468663284|FG002|Extension|Withdrawal by Subject|0|||
130192565|NCT00685399|468663285|FG003|Extension|Withdrawal by Subject|1|||
130192566|NCT00685399|468663286|FG004|Extension|Withdrawal by Subject|0|||
130192567|NCT00685399|468663287|FG005|Extension|Withdrawal by Subject|0|||
130192568|NCT00685399|468663288|FG006|Extension|Withdrawal by Subject|0|||
130192569|NCT00685399|468663289|FG007|Extension|Withdrawal by Subject|0|||
130192570|NCT00685399|468663282|FG000|Extension|Protocol Violation|0|||
130192571|NCT00685399|468663283|FG001|Extension|Protocol Violation|0|||
130192572|NCT00685399|468663284|FG002|Extension|Protocol Violation|0|||
130192573|NCT00685399|468663285|FG003|Extension|Protocol Violation|1|||
130192574|NCT00685399|468663286|FG004|Extension|Protocol Violation|0|||
130192575|NCT00685399|468663287|FG005|Extension|Protocol Violation|0|||
130192576|NCT00685399|468663288|FG006|Extension|Protocol Violation|0|||
130192577|NCT00685399|468663289|FG007|Extension|Protocol Violation|0|||
130192578|NCT00685399|468663282|FG000|Extension|Lack of Efficacy|0|||
130192579|NCT00685399|468663283|FG001|Extension|Lack of Efficacy|0|||
130192580|NCT00685399|468663284|FG002|Extension|Lack of Efficacy|0|||
130192581|NCT00685399|468663285|FG003|Extension|Lack of Efficacy|2|||
130192582|NCT00685399|468663286|FG004|Extension|Lack of Efficacy|0|||
130192583|NCT00685399|468663287|FG005|Extension|Lack of Efficacy|0|||
130192584|NCT00685399|468663288|FG006|Extension|Lack of Efficacy|0|||
130192585|NCT00685399|468663289|FG007|Extension|Lack of Efficacy|0|||
130192586|NCT00685399|468663282|FG000|Extension|Adverse Event|0|||
130192587|NCT00685399|468663283|FG001|Extension|Adverse Event|0|||
130192588|NCT00685399|468663284|FG002|Extension|Adverse Event|0|||
130192589|NCT00685399|468663285|FG003|Extension|Adverse Event|2|||
130192590|NCT00685399|468663286|FG004|Extension|Adverse Event|0|||
130192591|NCT00685399|468663287|FG005|Extension|Adverse Event|0|||
130192592|NCT00685399|468663288|FG006|Extension|Adverse Event|0|||
130192593|NCT00685399|468663289|FG007|Extension|Adverse Event|0|||
130192594|NCT00927862|468663290|FG000|Overall Study|Missing data needed for endpt analyses|27|||
130192595|NCT00927862|468663291|FG001|Overall Study|Missing data needed for endpt analyses|45|||
130192596|NCT00820248|468663292|FG000|Overall Study|No treated|4|||
130192597|NCT00820248|468663293|FG001|Overall Study|No treated|1|||
130192598|NCT02237196|468663295|FG000|Overall Study|Adverse Event|0|||
130192599|NCT02237196|468663296|FG001|Overall Study|Adverse Event|1|||
130192600|NCT02237196|468663297|FG002|Overall Study|Adverse Event|1|||
130192601|NCT02237196|468663298|FG003|Overall Study|Adverse Event|0|||
130192602|NCT02237196|468663295|FG000|Overall Study|Lost to Follow-up|4|||
130192603|NCT02237196|468663296|FG001|Overall Study|Lost to Follow-up|2|||
130192604|NCT02237196|468663297|FG002|Overall Study|Lost to Follow-up|4|||
130192605|NCT02237196|468663298|FG003|Overall Study|Lost to Follow-up|6|||
130192606|NCT02237196|468663295|FG000|Overall Study|Physician Decision|2|||
130192607|NCT02237196|468663296|FG001|Overall Study|Physician Decision|0|||
130192608|NCT02237196|468663297|FG002|Overall Study|Physician Decision|0|||
130192609|NCT02237196|468663298|FG003|Overall Study|Physician Decision|1|||
130192610|NCT02237196|468663295|FG000|Overall Study|Pregnancy|0|||
130192611|NCT02237196|468663296|FG001|Overall Study|Pregnancy|0|||
130192612|NCT02237196|468663297|FG002|Overall Study|Pregnancy|1|||
130192613|NCT02237196|468663298|FG003|Overall Study|Pregnancy|1|||
130192614|NCT02237196|468663295|FG000|Overall Study|Withdrawal by Subject|1|||
130192615|NCT02237196|468663296|FG001|Overall Study|Withdrawal by Subject|1|||
130192616|NCT02237196|468663297|FG002|Overall Study|Withdrawal by Subject|4|||
130192617|NCT02237196|468663298|FG003|Overall Study|Withdrawal by Subject|1|||
130192618|NCT02237196|468663295|FG000|Overall Study|Site Error|1|||
130192619|NCT02237196|468663296|FG001|Overall Study|Site Error|2|||
130192620|NCT02237196|468663297|FG002|Overall Study|Site Error|0|||
130192621|NCT02237196|468663298|FG003|Overall Study|Site Error|2|||
130192622|NCT01750697|468663301|FG000|Overall Study|Transferred Back to Local Hospital|1|||
130192623|NCT01750697|468663301|FG000|Overall Study|Physician and Family Decision|1|||
130192624|NCT01750697|468663301|FG000|Overall Study|Transferred to Adult Services|5|||
130192625|NCT01750697|468663301|FG000|Overall Study|Physician Decision|1|||
130192626|NCT01750697|468663301|FG000|Overall Study|Withdrawal by Subject|1|||
130192627|NCT01562782|468663311|FG000|Overall Study|Withdrawal by Subject|3|||
130192628|NCT01562782|468663312|FG001|Overall Study|Withdrawal by Subject|3|||
130192629|NCT01562782|468663311|FG000|Overall Study|screen failure|1|||
130192630|NCT01562782|468663312|FG001|Overall Study|screen failure|2|||
130192631|NCT01421225|468663315|FG000|Overall Study|Withdrawal by Subject|0|||
130192632|NCT01421225|468663316|FG001|Overall Study|Withdrawal by Subject|1|||
130192633|NCT02049814|468663319|FG000|Overall Study|Reason not Specified|4|||
130192634|NCT02049814|468663320|FG001|Overall Study|Reason not Specified|3|||
130192635|NCT02049814|468663319|FG000|Overall Study|Pregnancy|1|||
130192636|NCT02049814|468663320|FG001|Overall Study|Pregnancy|0|||
130192637|NCT02049814|468663319|FG000|Overall Study|Lost to Follow-up|2|||
130192638|NCT02049814|468663320|FG001|Overall Study|Lost to Follow-up|3|||
130192639|NCT02049814|468663319|FG000|Overall Study|Serious Protocol Violation|5|||
130192640|NCT02049814|468663320|FG001|Overall Study|Serious Protocol Violation|7|||
130192641|NCT02049814|468663319|FG000|Overall Study|Study Termination|0|||
130192642|NCT02049814|468663320|FG001|Overall Study|Study Termination|1|||
130192643|NCT02049814|468663319|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
130192644|NCT02049814|468663320|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
130192645|NCT02049814|468663319|FG000|Overall Study|Voluntary withdrawal|9|||
130192646|NCT02049814|468663320|FG001|Overall Study|Voluntary withdrawal|8|||
130192647|NCT01282372|468663321|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
130192648|NCT01282372|468663321|FG000|Overall Study|Lost to Follow-up|23|||
130192649|NCT01282372|468663321|FG000|Overall Study|Withdrawal by Subject|11|||
130192650|NCT01282372|468663321|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
130192651|NCT01282372|468663321|FG000|Overall Study|Death|1|||
130192652|NCT01282372|468663321|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
130192653|NCT01282372|468663321|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
130192654|NCT01282372|468663321|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
130192655|NCT01282372|468663321|FG000|Overall Study|Adverse Event|12|||
130192656|NCT02993250|468663323|FG000|Overall Study|Lost to Follow-up|0|||
130192657|NCT02993250|468663324|FG001|Overall Study|Lost to Follow-up|1|||
130192658|NCT02527434|468663325|FG000|Overall Study|Lost to Follow-up|2|||
130192659|NCT02527434|468663326|FG001|Overall Study|Lost to Follow-up|2|||
130192660|NCT02527434|468663327|FG002|Overall Study|Lost to Follow-up|0|||
130192661|NCT02527434|468663325|FG000|Overall Study|Death|19|||
130192662|NCT02527434|468663326|FG001|Overall Study|Death|6|||
130192663|NCT02527434|468663327|FG002|Overall Study|Death|17|||
130192664|NCT02527434|468663325|FG000|Overall Study|Withdrawal by Subject|5|||
130192665|NCT02527434|468663326|FG001|Overall Study|Withdrawal by Subject|3|||
130192666|NCT02527434|468663327|FG002|Overall Study|Withdrawal by Subject|3|||
130192667|NCT02527434|468663325|FG000|Overall Study|Reason Not Specified|1|||
130192668|NCT02527434|468663326|FG001|Overall Study|Reason Not Specified|0|||
130192669|NCT02527434|468663327|FG002|Overall Study|Reason Not Specified|0|||
130192670|NCT02527434|468663325|FG000|Overall Study|Site closure|1|||
130192671|NCT02527434|468663326|FG001|Overall Study|Site closure|0|||
130192672|NCT02527434|468663327|FG002|Overall Study|Site closure|0|||
130192673|NCT00713258|468663328|FG000|Overall Study|Adverse Event|2|||
130192674|NCT00713258|468663329|FG001|Overall Study|Adverse Event|4|||
130192675|NCT00713258|468663328|FG000|Overall Study|Non-Compliance|2|||
130192676|NCT00713258|468663329|FG001|Overall Study|Non-Compliance|1|||
130192677|NCT00713258|468663328|FG000|Overall Study|Other|1|||
130192678|NCT00713258|468663329|FG001|Overall Study|Other|1|||
130192679|NCT01322490|468663330|FG000|Treatment Period|Adverse Event|12|||
130192680|NCT01322490|468663331|FG001|Treatment Period|Adverse Event|18|||
130192681|NCT01322490|468663332|FG002|Treatment Period|Adverse Event|15|||
130192682|NCT01322490|468663330|FG000|Treatment Period|Death|5|||
130192683|NCT01322490|468663331|FG001|Treatment Period|Death|7|||
130192684|NCT01322490|468663332|FG002|Treatment Period|Death|3|||
130192685|NCT01322490|468663330|FG000|Treatment Period|Lack of Efficacy|89|||
130192686|NCT01322490|468663331|FG001|Treatment Period|Lack of Efficacy|100|||
130192687|NCT01322490|468663332|FG002|Treatment Period|Lack of Efficacy|112|||
130192688|NCT01322490|468663330|FG000|Treatment Period|Physician Decision|0|||
130192689|NCT01322490|468663331|FG001|Treatment Period|Physician Decision|2|||
130192690|NCT01322490|468663332|FG002|Treatment Period|Physician Decision|1|||
130192691|NCT01322490|468663330|FG000|Treatment Period|Protocol Violation|7|||
130192692|NCT01322490|468663331|FG001|Treatment Period|Protocol Violation|5|||
130192693|NCT01322490|468663332|FG002|Treatment Period|Protocol Violation|4|||
130192694|NCT01322490|468663330|FG000|Treatment Period|Withdrawal by Subject|14|||
130192695|NCT01322490|468663331|FG001|Treatment Period|Withdrawal by Subject|16|||
130192696|NCT01322490|468663332|FG002|Treatment Period|Withdrawal by Subject|11|||
130192697|NCT01322490|468663330|FG000|Treatment Period|Non-compliance with study drug|0|||
130192698|NCT01322490|468663331|FG001|Treatment Period|Non-compliance with study drug|0|||
130192699|NCT01322490|468663332|FG002|Treatment Period|Non-compliance with study drug|1|||
130192700|NCT01322490|468663330|FG000|Treatment Period|Other per report|2|||
130192701|NCT01322490|468663331|FG001|Treatment Period|Other per report|2|||
130192702|NCT01322490|468663332|FG002|Treatment Period|Other per report|1|||
130192703|NCT01322490|468663330|FG000|Treatment Period|Randomized but Not Treated|3|||
130192704|NCT01322490|468663331|FG001|Treatment Period|Randomized but Not Treated|3|||
130192705|NCT01322490|468663332|FG002|Treatment Period|Randomized but Not Treated|5|||
130192706|NCT01322490|468663330|FG000|Long Term Follow-up Period|Death|235|||
130192707|NCT01322490|468663331|FG001|Long Term Follow-up Period|Death|239|||
130192708|NCT01322490|468663332|FG002|Long Term Follow-up Period|Death|236|||
130192709|NCT01322490|468663330|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
130192710|NCT01322490|468663331|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
130192711|NCT01322490|468663332|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
130192712|NCT01322490|468663330|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
130192713|NCT01322490|468663331|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
130192714|NCT01322490|468663332|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
130192715|NCT01322490|468663330|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
130192716|NCT01322490|468663331|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
130192717|NCT01322490|468663332|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
130192718|NCT01322490|468663330|FG000|Long Term Follow-up Period|Other per report|3|||
130192719|NCT01322490|468663331|FG001|Long Term Follow-up Period|Other per report|2|||
130192720|NCT01322490|468663332|FG002|Long Term Follow-up Period|Other per report|2|||
130192721|NCT01322490|468663330|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
130192722|NCT01322490|468663331|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
130192723|NCT01322490|468663332|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
130192724|NCT01431716|468663333|FG000|Overall Study|Withdrawal of consent|1|||
130192725|NCT00568061|468663334|FG000|Overall Study|Inclusion / exclusion criteria|5|||
130192726|NCT00568061|468663335|FG001|Overall Study|Inclusion / exclusion criteria|1|||
130192727|NCT00568061|468663334|FG000|Overall Study|Adverse Event|0|||
130192728|NCT00568061|468663335|FG001|Overall Study|Adverse Event|1|||
130192729|NCT05027451|468663336|FG000|Overall Study|Lost to Follow-up|1|||
130192730|NCT05027451|468663337|FG001|Overall Study|Lost to Follow-up|1|||
130192731|NCT01896128|468663338|FG000|Overall Study|Withdrawal by Subject|3|||
130192732|NCT01896128|468663339|FG001|Overall Study|Withdrawal by Subject|3|||
130192733|NCT02693002|468663342|FG000|Overall Study|Withdrawal by Subject|1|||
130192734|NCT02693002|468663343|FG001|Overall Study|Withdrawal by Subject|0|||
130192735|NCT00708214|468663346|FG000|Overall Study|Other Adverse Event|3|||
130192736|NCT00708214|468663347|FG001|Overall Study|Other Adverse Event|6|||
130192737|NCT00708214|468663348|FG002|Overall Study|Other Adverse Event|2|||
130192738|NCT00708214|468663346|FG000|Overall Study|Other|0|||
130192739|NCT00708214|468663347|FG001|Overall Study|Other|1|||
130192740|NCT00708214|468663348|FG002|Overall Study|Other|1|||
130192741|NCT00708214|468663346|FG000|Overall Study|Progressive Disease|4|||
130192742|NCT00708214|468663347|FG001|Overall Study|Progressive Disease|6|||
130192743|NCT00708214|468663348|FG002|Overall Study|Progressive Disease|5|||
130192744|NCT02929589|468663383|FG000|Overall Study|Withdrawal by Subject|1|||
130192745|NCT02929589|468663384|FG001|Overall Study|Withdrawal by Subject|0|||
130192746|NCT02929589|468663385|FG002|Overall Study|Withdrawal by Subject|0|||
130192747|NCT02929589|468663386|FG003|Overall Study|Withdrawal by Subject|0|||
130192748|NCT02929589|468663383|FG000|Overall Study|Physician Decision|2|||
130192749|NCT02929589|468663384|FG001|Overall Study|Physician Decision|0|||
130192750|NCT02929589|468663385|FG002|Overall Study|Physician Decision|0|||
130192751|NCT02929589|468663386|FG003|Overall Study|Physician Decision|0|||
130192752|NCT02343939|468663387|FG000|Overall Study|Death|0|||
130192753|NCT02343939|468663388|FG001|Overall Study|Death|15|||
130192754|NCT02343939|468663389|FG002|Overall Study|Death|4|||
130192755|NCT02343939|468663390|FG003|Overall Study|Death|2|||
130192756|NCT02343939|468663391|FG004|Overall Study|Death|5|||
130192757|NCT02343939|468663392|FG005|Overall Study|Death|11|||
130192758|NCT02343939|468663393|FG006|Overall Study|Death|8|||
130192759|NCT02343939|468663394|FG007|Overall Study|Death|22|||
130192760|NCT02343939|468663395|FG008|Overall Study|Death|1|||
130192761|NCT02343939|468663387|FG000|Overall Study|Study terminated by sponsor|0|||
130192762|NCT02343939|468663388|FG001|Overall Study|Study terminated by sponsor|27|||
130192763|NCT02343939|468663389|FG002|Overall Study|Study terminated by sponsor|0|||
130192764|NCT02343939|468663390|FG003|Overall Study|Study terminated by sponsor|1|||
130192765|NCT02343939|468663391|FG004|Overall Study|Study terminated by sponsor|1|||
130192766|NCT02343939|468663392|FG005|Overall Study|Study terminated by sponsor|5|||
130192767|NCT02343939|468663393|FG006|Overall Study|Study terminated by sponsor|3|||
130192768|NCT02343939|468663394|FG007|Overall Study|Study terminated by sponsor|4|||
130192769|NCT02343939|468663395|FG008|Overall Study|Study terminated by sponsor|0|||
130192770|NCT02343939|468663387|FG000|Overall Study|Withdrew consent|3|||
130192771|NCT02343939|468663388|FG001|Overall Study|Withdrew consent|6|||
130192772|NCT02343939|468663389|FG002|Overall Study|Withdrew consent|1|||
130192773|NCT02343939|468663390|FG003|Overall Study|Withdrew consent|2|||
130192774|NCT02343939|468663391|FG004|Overall Study|Withdrew consent|2|||
130192775|NCT02343939|468663392|FG005|Overall Study|Withdrew consent|0|||
130192776|NCT02343939|468663393|FG006|Overall Study|Withdrew consent|0|||
130192777|NCT02343939|468663394|FG007|Overall Study|Withdrew consent|8|||
130192778|NCT02343939|468663395|FG008|Overall Study|Withdrew consent|6|||
130192779|NCT02343939|468663387|FG000|Overall Study|Treatment failure|0|||
130192780|NCT02343939|468663388|FG001|Overall Study|Treatment failure|0|||
130192781|NCT02343939|468663389|FG002|Overall Study|Treatment failure|0|||
130192782|NCT02343939|468663390|FG003|Overall Study|Treatment failure|0|||
130192783|NCT02343939|468663391|FG004|Overall Study|Treatment failure|0|||
130192784|NCT02343939|468663392|FG005|Overall Study|Treatment failure|0|||
130192785|NCT02343939|468663393|FG006|Overall Study|Treatment failure|2|||
130192786|NCT02343939|468663394|FG007|Overall Study|Treatment failure|1|||
130192787|NCT02343939|468663395|FG008|Overall Study|Treatment failure|0|||
130192788|NCT02343939|468663387|FG000|Overall Study|Investigator's discretion|0|||
130192789|NCT02343939|468663388|FG001|Overall Study|Investigator's discretion|0|||
130192790|NCT02343939|468663389|FG002|Overall Study|Investigator's discretion|0|||
130192791|NCT02343939|468663390|FG003|Overall Study|Investigator's discretion|1|||
130192792|NCT02343939|468663391|FG004|Overall Study|Investigator's discretion|0|||
130192793|NCT02343939|468663392|FG005|Overall Study|Investigator's discretion|0|||
130192794|NCT02343939|468663393|FG006|Overall Study|Investigator's discretion|1|||
130192795|NCT02343939|468663394|FG007|Overall Study|Investigator's discretion|0|||
130192796|NCT02343939|468663395|FG008|Overall Study|Investigator's discretion|0|||
130192797|NCT02343939|468663387|FG000|Overall Study|Adverse Event|0|||
130192798|NCT02343939|468663388|FG001|Overall Study|Adverse Event|0|||
130192799|NCT02343939|468663389|FG002|Overall Study|Adverse Event|0|||
130192800|NCT02343939|468663390|FG003|Overall Study|Adverse Event|0|||
130192801|NCT02343939|468663391|FG004|Overall Study|Adverse Event|0|||
130192802|NCT02343939|468663392|FG005|Overall Study|Adverse Event|1|||
130192803|NCT02343939|468663393|FG006|Overall Study|Adverse Event|0|||
130192804|NCT02343939|468663394|FG007|Overall Study|Adverse Event|0|||
130192805|NCT02343939|468663395|FG008|Overall Study|Adverse Event|0|||
130192806|NCT02343939|468663387|FG000|Overall Study|Never Treated With ENTO|0|||
130192807|NCT02343939|468663388|FG001|Overall Study|Never Treated With ENTO|0|||
130192808|NCT02343939|468663389|FG002|Overall Study|Never Treated With ENTO|0|||
130192809|NCT02343939|468663390|FG003|Overall Study|Never Treated With ENTO|0|||
130192810|NCT02343939|468663391|FG004|Overall Study|Never Treated With ENTO|0|||
130192811|NCT02343939|468663392|FG005|Overall Study|Never Treated With ENTO|0|||
130192812|NCT02343939|468663393|FG006|Overall Study|Never Treated With ENTO|1|||
130192813|NCT02343939|468663394|FG007|Overall Study|Never Treated With ENTO|2|||
130192814|NCT02343939|468663395|FG008|Overall Study|Never Treated With ENTO|0|||
130192815|NCT01303172|468663402|FG000|Overall Study|Physician Decision|9|||
130192816|NCT01303172|468663403|FG001|Overall Study|Physician Decision|6|||
130192817|NCT01303172|468663402|FG000|Overall Study|Adverse Event|5|||
130192818|NCT01303172|468663403|FG001|Overall Study|Adverse Event|2|||
130192819|NCT01303172|468663402|FG000|Overall Study|Withdrawal by Subject|4|||
130192820|NCT01303172|468663403|FG001|Overall Study|Withdrawal by Subject|2|||
130192821|NCT01303172|468663402|FG000|Overall Study|Death|20|||
130192822|NCT01303172|468663403|FG001|Overall Study|Death|7|||
130192823|NCT01303172|468663402|FG000|Overall Study|Lack of Efficacy|25|||
130192824|NCT01303172|468663403|FG001|Overall Study|Lack of Efficacy|17|||
130192825|NCT00462709|468663406|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
130192826|NCT00462709|468663406|FG000|Overall Study|Lost to Follow-up|10|||
130192827|NCT00462709|468663406|FG000|Overall Study|Withdrawal by Subject|8|||
130192828|NCT00462709|468663406|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
130192829|NCT00462709|468663406|FG000|Overall Study|Death|2|||
130192830|NCT00462709|468663406|FG000|Overall Study|Logistical reasons|2|||
130192831|NCT00462709|468663406|FG000|Overall Study|Physician Decision|1|||
130192832|NCT00462709|468663406|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
130192833|NCT04468347|468663407|FG000|Overall Study|Withdrawal by Subject|0|||
130192834|NCT04468347|468663408|FG001|Overall Study|Withdrawal by Subject|1|||
130192835|NCT04468347|468663409|FG002|Overall Study|Withdrawal by Subject|3|||
130192836|NCT04468347|468663410|FG003|Overall Study|Withdrawal by Subject|3|||
130192837|NCT04468347|468663407|FG000|Overall Study|Lost to Follow-up|0|||
130192838|NCT04468347|468663408|FG001|Overall Study|Lost to Follow-up|0|||
130192839|NCT04468347|468663409|FG002|Overall Study|Lost to Follow-up|1|||
130192840|NCT04468347|468663410|FG003|Overall Study|Lost to Follow-up|1|||
130192841|NCT04468347|468663407|FG000|Overall Study|Physician Decision|1|||
130192842|NCT04468347|468663408|FG001|Overall Study|Physician Decision|0|||
130192843|NCT04468347|468663409|FG002|Overall Study|Physician Decision|2|||
130192844|NCT04468347|468663410|FG003|Overall Study|Physician Decision|0|||
130192845|NCT04468347|468663407|FG000|Overall Study|Protocol Violation|1|||
130192846|NCT04468347|468663408|FG001|Overall Study|Protocol Violation|0|||
130192847|NCT04468347|468663409|FG002|Overall Study|Protocol Violation|0|||
130192848|NCT04468347|468663410|FG003|Overall Study|Protocol Violation|0|||
130192849|NCT00665431|468663411|FG000|Overall Study|Adverse Event|16|||
130192850|NCT00665431|468663412|FG001|Overall Study|Adverse Event|22|||
130192851|NCT00665431|468663413|FG002|Overall Study|Adverse Event|6|||
130192852|NCT00665431|468663411|FG000|Overall Study|Withdrawal by Subject|17|||
130192853|NCT00665431|468663412|FG001|Overall Study|Withdrawal by Subject|25|||
130192854|NCT00665431|468663413|FG002|Overall Study|Withdrawal by Subject|15|||
130192855|NCT00665431|468663411|FG000|Overall Study|Lost to Follow-up|3|||
130192856|NCT00665431|468663412|FG001|Overall Study|Lost to Follow-up|3|||
130192857|NCT00665431|468663413|FG002|Overall Study|Lost to Follow-up|1|||
130192858|NCT00665431|468663411|FG000|Overall Study|Other|4|||
130192859|NCT00665431|468663412|FG001|Overall Study|Other|7|||
130192860|NCT00665431|468663413|FG002|Overall Study|Other|2|||
130192861|NCT03483961|468665421|FG000|Overall Study|Lost to Follow-up|7|||
130192862|NCT03483961|468665422|FG001|Overall Study|Lost to Follow-up|6|||
130192863|NCT03483961|468665423|FG002|Overall Study|Lost to Follow-up|6|||
130192864|NCT03483961|468665424|FG003|Overall Study|Lost to Follow-up|6|||
130192865|NCT03483961|468665425|FG004|Overall Study|Lost to Follow-up|6|||
130192866|NCT03483961|468665426|FG005|Overall Study|Lost to Follow-up|4|||
130192867|NCT03483961|468665427|FG006|Overall Study|Lost to Follow-up|4|||
130192868|NCT03483961|468665428|FG007|Overall Study|Lost to Follow-up|11|||
130192869|NCT03483961|468665429|FG008|Overall Study|Lost to Follow-up|1|||
130192870|NCT03483961|468665430|FG009|Overall Study|Lost to Follow-up|0|||
130192871|NCT03483961|468665421|FG000|Overall Study|Withdrawal by Subject|3|||
130192872|NCT03483961|468665422|FG001|Overall Study|Withdrawal by Subject|4|||
130192873|NCT03483961|468665423|FG002|Overall Study|Withdrawal by Subject|5|||
130192874|NCT03483961|468665424|FG003|Overall Study|Withdrawal by Subject|3|||
130192875|NCT03483961|468665425|FG004|Overall Study|Withdrawal by Subject|4|||
130192876|NCT03483961|468665426|FG005|Overall Study|Withdrawal by Subject|2|||
130192877|NCT03483961|468665427|FG006|Overall Study|Withdrawal by Subject|1|||
130192878|NCT03483961|468665428|FG007|Overall Study|Withdrawal by Subject|2|||
130192879|NCT03483961|468665429|FG008|Overall Study|Withdrawal by Subject|1|||
130192880|NCT03483961|468665430|FG009|Overall Study|Withdrawal by Subject|0|||
130192881|NCT03483961|468665421|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
130192882|NCT03483961|468665422|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192883|NCT03483961|468665423|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192884|NCT03483961|468665424|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192885|NCT03483961|468665425|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192886|NCT03483961|468665426|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192887|NCT03483961|468665427|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192888|NCT03483961|468665428|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192889|NCT03483961|468665429|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192890|NCT03483961|468665430|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192891|NCT03483961|468665421|FG000|Overall Study|Adverse Event|0|||
130192892|NCT03483961|468665422|FG001|Overall Study|Adverse Event|0|||
130192893|NCT03483961|468665423|FG002|Overall Study|Adverse Event|1|||
130192894|NCT03483961|468665424|FG003|Overall Study|Adverse Event|0|||
130192895|NCT03483961|468665425|FG004|Overall Study|Adverse Event|0|||
130192896|NCT03483961|468665426|FG005|Overall Study|Adverse Event|0|||
130192897|NCT03483961|468665427|FG006|Overall Study|Adverse Event|0|||
130192898|NCT03483961|468665428|FG007|Overall Study|Adverse Event|0|||
130192899|NCT03483961|468665429|FG008|Overall Study|Adverse Event|0|||
130192900|NCT03483961|468665430|FG009|Overall Study|Adverse Event|0|||
130192901|NCT00356603|468665431|FG000|Overall Study|Other|6|||
130192902|NCT00356603|468665432|FG001|Overall Study|Other|3|||
130192903|NCT00728468|468665434|FG000|Overall Study|Enrolled but not treated|1|||
130192904|NCT00728468|468665434|FG000|Overall Study|Death|1|||
130192905|NCT00728468|468665434|FG000|Overall Study|Protocol Violation|4|||
130192906|NCT00728468|468665434|FG000|Overall Study|Objective progression or relapse|9|||
130192907|NCT00728468|468665434|FG000|Overall Study|Study terminated by sponsor|1|||
130192908|NCT01262287|468665435|FG000|Overall Study|Lost to Follow-up|2|||
130192909|NCT01262287|468665436|FG001|Overall Study|Lost to Follow-up|1|||
130192910|NCT00932373|468665437|FG000|Overall Study|Progressive disease|3|||
130192911|NCT00932373|468665438|FG001|Overall Study|Progressive disease|1|||
130192912|NCT00932373|468665439|FG002|Overall Study|Progressive disease|0|||
130192913|NCT00932373|468665440|FG003|Overall Study|Progressive disease|0|||
130192914|NCT00932373|468665441|FG004|Overall Study|Progressive disease|10|||
130192915|NCT00932373|468665442|FG005|Overall Study|Progressive disease|1|||
130192916|NCT00932373|468665443|FG006|Overall Study|Progressive disease|0|||
130192917|NCT00932373|468665444|FG007|Overall Study|Progressive disease|2|||
130192918|NCT00932373|468665445|FG008|Overall Study|Progressive disease|1|||
130192919|NCT00932373|468665446|FG009|Overall Study|Progressive disease|9|||
130192920|NCT00932373|468665447|FG010|Overall Study|Progressive disease|2|||
130192921|NCT00932373|468665437|FG000|Overall Study|Adverse Event|0|||
130192922|NCT00932373|468665438|FG001|Overall Study|Adverse Event|0|||
130192923|NCT00932373|468665439|FG002|Overall Study|Adverse Event|0|||
130192924|NCT00932373|468665440|FG003|Overall Study|Adverse Event|0|||
130192925|NCT00932373|468665441|FG004|Overall Study|Adverse Event|2|||
130192926|NCT00932373|468665442|FG005|Overall Study|Adverse Event|1|||
130192927|NCT00932373|468665443|FG006|Overall Study|Adverse Event|0|||
130192928|NCT00932373|468665444|FG007|Overall Study|Adverse Event|1|||
130192929|NCT00932373|468665445|FG008|Overall Study|Adverse Event|0|||
130192930|NCT00932373|468665446|FG009|Overall Study|Adverse Event|2|||
130192931|NCT00932373|468665447|FG010|Overall Study|Adverse Event|1|||
130192932|NCT00932373|468665437|FG000|Overall Study|Physician Decision|0|||
130192933|NCT00932373|468665438|FG001|Overall Study|Physician Decision|0|||
130192934|NCT00932373|468665439|FG002|Overall Study|Physician Decision|1|||
130192935|NCT00932373|468665440|FG003|Overall Study|Physician Decision|0|||
130192936|NCT00932373|468665441|FG004|Overall Study|Physician Decision|2|||
130192937|NCT00932373|468665442|FG005|Overall Study|Physician Decision|0|||
130192938|NCT00932373|468665443|FG006|Overall Study|Physician Decision|0|||
130192939|NCT00932373|468665444|FG007|Overall Study|Physician Decision|0|||
130192940|NCT00932373|468665445|FG008|Overall Study|Physician Decision|0|||
130192941|NCT00932373|468665446|FG009|Overall Study|Physician Decision|1|||
130192942|NCT00932373|468665447|FG010|Overall Study|Physician Decision|0|||
130192943|NCT00932373|468665437|FG000|Overall Study|Dose limiting toxicity|0|||
130192944|NCT00932373|468665438|FG001|Overall Study|Dose limiting toxicity|0|||
130192945|NCT00932373|468665439|FG002|Overall Study|Dose limiting toxicity|0|||
130192946|NCT00932373|468665440|FG003|Overall Study|Dose limiting toxicity|0|||
130192947|NCT00932373|468665441|FG004|Overall Study|Dose limiting toxicity|0|||
130192948|NCT00932373|468665442|FG005|Overall Study|Dose limiting toxicity|1|||
130192949|NCT00932373|468665443|FG006|Overall Study|Dose limiting toxicity|0|||
130192950|NCT00932373|468665444|FG007|Overall Study|Dose limiting toxicity|0|||
130192951|NCT00932373|468665445|FG008|Overall Study|Dose limiting toxicity|0|||
130192952|NCT00932373|468665446|FG009|Overall Study|Dose limiting toxicity|0|||
130192953|NCT00932373|468665447|FG010|Overall Study|Dose limiting toxicity|0|||
130192954|NCT00932373|468665437|FG000|Overall Study|Withdrawal by Subject|0|||
130192955|NCT00932373|468665438|FG001|Overall Study|Withdrawal by Subject|0|||
130192956|NCT00932373|468665439|FG002|Overall Study|Withdrawal by Subject|0|||
130192957|NCT00932373|468665440|FG003|Overall Study|Withdrawal by Subject|0|||
130192958|NCT00932373|468665441|FG004|Overall Study|Withdrawal by Subject|0|||
130192959|NCT00932373|468665442|FG005|Overall Study|Withdrawal by Subject|0|||
130192960|NCT00932373|468665443|FG006|Overall Study|Withdrawal by Subject|0|||
130192961|NCT00932373|468665444|FG007|Overall Study|Withdrawal by Subject|0|||
130192962|NCT00932373|468665445|FG008|Overall Study|Withdrawal by Subject|1|||
130192963|NCT00932373|468665446|FG009|Overall Study|Withdrawal by Subject|0|||
130192964|NCT00932373|468665447|FG010|Overall Study|Withdrawal by Subject|0|||
130192965|NCT00932373|468665437|FG000|Overall Study|Clinical progression|0|||
130192966|NCT00932373|468665438|FG001|Overall Study|Clinical progression|0|||
130192967|NCT00932373|468665439|FG002|Overall Study|Clinical progression|0|||
130192968|NCT00932373|468665440|FG003|Overall Study|Clinical progression|0|||
130192969|NCT00932373|468665441|FG004|Overall Study|Clinical progression|0|||
130192970|NCT00932373|468665442|FG005|Overall Study|Clinical progression|0|||
130192971|NCT00932373|468665443|FG006|Overall Study|Clinical progression|1|||
130192972|NCT00932373|468665444|FG007|Overall Study|Clinical progression|0|||
130192973|NCT00932373|468665445|FG008|Overall Study|Clinical progression|0|||
130192974|NCT00932373|468665446|FG009|Overall Study|Clinical progression|0|||
130192975|NCT00932373|468665447|FG010|Overall Study|Clinical progression|0|||
130192976|NCT00932373|468665437|FG000|Overall Study|Lack of Efficacy|0|||
130192977|NCT00932373|468665438|FG001|Overall Study|Lack of Efficacy|0|||
130192978|NCT00932373|468665439|FG002|Overall Study|Lack of Efficacy|0|||
130192979|NCT00932373|468665440|FG003|Overall Study|Lack of Efficacy|0|||
130192980|NCT00932373|468665441|FG004|Overall Study|Lack of Efficacy|0|||
130192981|NCT00932373|468665442|FG005|Overall Study|Lack of Efficacy|0|||
130192982|NCT00932373|468665443|FG006|Overall Study|Lack of Efficacy|0|||
130192983|NCT00932373|468665444|FG007|Overall Study|Lack of Efficacy|0|||
130192984|NCT00932373|468665445|FG008|Overall Study|Lack of Efficacy|0|||
130192985|NCT00932373|468665446|FG009|Overall Study|Lack of Efficacy|1|||
130192986|NCT00932373|468665447|FG010|Overall Study|Lack of Efficacy|0|||
130192987|NCT01637922|468665448|FG000|Overall Study|Adverse Event|0|||
130192988|NCT01637922|468665449|FG001|Overall Study|Adverse Event|1|||
130192989|NCT01637922|468665448|FG000|Overall Study|Protocol Violation|0|||
130192990|NCT01637922|468665449|FG001|Overall Study|Protocol Violation|1|||
130192991|NCT01637922|468665448|FG000|Overall Study|Withdrawal by Subject|0|||
130192992|NCT01637922|468665449|FG001|Overall Study|Withdrawal by Subject|3|||
130192993|NCT01637922|468665448|FG000|Overall Study|Lost to Follow-up|2|||
130192994|NCT01637922|468665449|FG001|Overall Study|Lost to Follow-up|0|||
130192995|NCT00638404|468665450|FG000|Overall Study|Physician Decision|8|||
130192996|NCT00638404|468665451|FG001|Overall Study|Physician Decision|0|||
130192997|NCT02509507|468665452|FG000|Overall Study|Death|21|||
130192998|NCT02509507|468665453|FG001|Overall Study|Death|3|||
130192999|NCT02509507|468665454|FG002|Overall Study|Death|22|||
130193000|NCT02509507|468665455|FG003|Overall Study|Death|14|||
130193001|NCT02509507|468665456|FG004|Overall Study|Death|8|||
130193002|NCT02509507|468665457|FG005|Overall Study|Death|12|||
130193003|NCT02509507|468665458|FG006|Overall Study|Death|5|||
130193004|NCT02509507|468665459|FG007|Overall Study|Death|4|||
130193005|NCT02509507|468665460|FG008|Overall Study|Death|8|||
130193006|NCT02509507|468665452|FG000|Overall Study|Lost to Follow-up|0|||
130193007|NCT02509507|468665453|FG001|Overall Study|Lost to Follow-up|1|||
130193008|NCT02509507|468665454|FG002|Overall Study|Lost to Follow-up|0|||
130193009|NCT02509507|468665455|FG003|Overall Study|Lost to Follow-up|0|||
130193010|NCT02509507|468665456|FG004|Overall Study|Lost to Follow-up|0|||
130193011|NCT02509507|468665457|FG005|Overall Study|Lost to Follow-up|2|||
130193012|NCT02509507|468665458|FG006|Overall Study|Lost to Follow-up|0|||
130193013|NCT02509507|468665459|FG007|Overall Study|Lost to Follow-up|0|||
130193014|NCT02509507|468665460|FG008|Overall Study|Lost to Follow-up|0|||
130193015|NCT02509507|468665452|FG000|Overall Study|Withdrawal by Subject|2|||
130193016|NCT02509507|468665453|FG001|Overall Study|Withdrawal by Subject|0|||
130193017|NCT02509507|468665454|FG002|Overall Study|Withdrawal by Subject|1|||
130193018|NCT02509507|468665455|FG003|Overall Study|Withdrawal by Subject|4|||
130193019|NCT02509507|468665456|FG004|Overall Study|Withdrawal by Subject|1|||
130193020|NCT02509507|468665457|FG005|Overall Study|Withdrawal by Subject|3|||
130193021|NCT02509507|468665458|FG006|Overall Study|Withdrawal by Subject|4|||
130193022|NCT02509507|468665459|FG007|Overall Study|Withdrawal by Subject|0|||
130193023|NCT02509507|468665460|FG008|Overall Study|Withdrawal by Subject|1|||
130193024|NCT02510664|468665464|FG000|Overall Study|Transferred Care|9|||
130193025|NCT02510664|468665465|FG001|Overall Study|Transferred Care|9|||
130193026|NCT02510664|468665466|FG002|Overall Study|Transferred Care|0|||
130193027|NCT02510664|468665464|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
130193028|NCT02510664|468665465|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
130193029|NCT02510664|468665466|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
130193030|NCT02510664|468665464|FG000|Overall Study|Time Constraints|1|||
130193031|NCT02510664|468665465|FG001|Overall Study|Time Constraints|1|||
130193032|NCT02510664|468665466|FG002|Overall Study|Time Constraints|0|||
130193033|NCT00912743|468665479|FG000|Overall Study|Adverse Event|3|||
130193034|NCT00912743|468665480|FG001|Overall Study|Adverse Event|1|||
130193035|NCT00912743|468665479|FG000|Overall Study|Lack of Efficacy|9|||
130193036|NCT00912743|468665480|FG001|Overall Study|Lack of Efficacy|18|||
130193037|NCT00912743|468665479|FG000|Overall Study|Toxicity|0|||
130193038|NCT00912743|468665480|FG001|Overall Study|Toxicity|1|||
130193039|NCT00912743|468665479|FG000|Overall Study|End of treatment form was not collected|1|||
130193040|NCT00912743|468665480|FG001|Overall Study|End of treatment form was not collected|0|||
130193041|NCT00862823|468665482|FG000|First Intervention|Withdrawal by Subject|1|||
130193042|NCT00862823|468665483|FG001|First Intervention|Withdrawal by Subject|1|||
130193043|NCT02714595|468665487|FG000|Overall Study|Lost to Follow-up|1|||
130193044|NCT02714595|468665488|FG001|Overall Study|Lost to Follow-up|0|||
130193045|NCT02714595|468665487|FG000|Overall Study|Withdrawal by Subject|1|||
130193046|NCT02714595|468665488|FG001|Overall Study|Withdrawal by Subject|2|||
130193047|NCT02714595|468665487|FG000|Overall Study|Lack of Efficacy|0|||
130193048|NCT02714595|468665488|FG001|Overall Study|Lack of Efficacy|1|||
130193049|NCT02714595|468665487|FG000|Overall Study|Death|30|||
130193050|NCT02714595|468665488|FG001|Overall Study|Death|9|||
130193051|NCT02714595|468665487|FG000|Overall Study|Other-Miscellaneous|0|||
130193052|NCT02714595|468665488|FG001|Overall Study|Other-Miscellaneous|1|||
130193053|NCT02411396|468665489|FG000|Overall Study|Lost to Follow-up|31|||
130193054|NCT02411396|468665489|FG000|Overall Study|Death|10|||
130193055|NCT02423343|468665490|FG000|Overall Study|Withdrawal by Subject|0|||
130193056|NCT02423343|468665491|FG001|Overall Study|Withdrawal by Subject|1|||
130193057|NCT02423343|468665492|FG002|Overall Study|Withdrawal by Subject|0|||
130193058|NCT02423343|468665493|FG003|Overall Study|Withdrawal by Subject|0|||
130193059|NCT02423343|468665494|FG004|Overall Study|Withdrawal by Subject|0|||
130193060|NCT02423343|468665495|FG005|Overall Study|Withdrawal by Subject|0|||
130193061|NCT02423343|468665490|FG000|Overall Study|Progressive Disease|0|||
130193062|NCT02423343|468665491|FG001|Overall Study|Progressive Disease|0|||
130193063|NCT02423343|468665492|FG002|Overall Study|Progressive Disease|0|||
130193064|NCT02423343|468665493|FG003|Overall Study|Progressive Disease|0|||
130193065|NCT02423343|468665494|FG004|Overall Study|Progressive Disease|2|||
130193066|NCT02423343|468665495|FG005|Overall Study|Progressive Disease|0|||
130193067|NCT02423343|468665490|FG000|Overall Study|Adverse Event|0|||
130193068|NCT02423343|468665491|FG001|Overall Study|Adverse Event|0|||
130193069|NCT02423343|468665492|FG002|Overall Study|Adverse Event|0|||
130193070|NCT02423343|468665493|FG003|Overall Study|Adverse Event|0|||
130193071|NCT02423343|468665494|FG004|Overall Study|Adverse Event|2|||
130193072|NCT02423343|468665495|FG005|Overall Study|Adverse Event|0|||
130193073|NCT02423343|468665490|FG000|Overall Study|Death|0|||
130193074|NCT02423343|468665491|FG001|Overall Study|Death|0|||
130193075|NCT02423343|468665492|FG002|Overall Study|Death|0|||
130193076|NCT02423343|468665493|FG003|Overall Study|Death|0|||
130193077|NCT02423343|468665494|FG004|Overall Study|Death|1|||
130193078|NCT02423343|468665495|FG005|Overall Study|Death|0|||
130193079|NCT02865499|468665496|FG000|Baseline|Adverse Event|1|||
130193080|NCT02865499|468665496|FG000|Baseline|Withdrawal by Subject|1|||
130193081|NCT01860040|468665502|FG000|Overall Study|Withdrawal by Subject|1|||
130193082|NCT01860040|468665503|FG001|Overall Study|Withdrawal by Subject|0|||
130193083|NCT01931995|468665504|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
130193084|NCT01931995|468665505|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
130193085|NCT01931995|468665504|FG000|First Intervention (1 Day)|Physician Decision|1|||
130193086|NCT01931995|468665505|FG001|First Intervention (1 Day)|Physician Decision|1|||
130193087|NCT01931995|468665504|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
130193088|NCT01931995|468665505|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
130193089|NCT00014495|468665506|FG000|Overall Study|Death|0|||
130193090|NCT00014495|468665507|FG001|Overall Study|Death|0|||
130193091|NCT00014495|468665508|FG002|Overall Study|Death|1|||
130193092|NCT00014495|468665509|FG003|Overall Study|Death|0|||
130193093|NCT00014495|468665506|FG000|Overall Study|Clinical deterioration|0|||
130193094|NCT00014495|468665507|FG001|Overall Study|Clinical deterioration|0|||
130193095|NCT00014495|468665508|FG002|Overall Study|Clinical deterioration|0|||
130193096|NCT00014495|468665509|FG003|Overall Study|Clinical deterioration|1|||
130193097|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
130193098|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
130193099|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
130193100|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
130193101|NCT00403481|468665511|FG000|Olm 40 mg|Adverse Event|2|||
130193102|NCT00403481|468665511|FG000|Olm 40 mg|Protocol Violation|1|||
130193103|NCT00403481|468665511|FG000|Olm 40 mg|Withdrawal by Subject|1|||
130193104|NCT00403481|468665511|FG000|Olm 40 mg|Other|1|||
130193105|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
130193106|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
130193107|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
130193108|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
130193109|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
130193110|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130193111|NCT02099110|468665519|FG000|Overall Study|Protocol Violation|2|||
130193112|NCT02099110|468665520|FG001|Overall Study|Protocol Violation|1|||
130193113|NCT02099110|468665521|FG002|Overall Study|Protocol Violation|0|||
130193114|NCT02099110|468665522|FG003|Overall Study|Protocol Violation|3|||
130193115|NCT02099110|468665523|FG004|Overall Study|Protocol Violation|1|||
130193116|NCT02099110|468665519|FG000|Overall Study|Participant moved|1|||
130193117|NCT02099110|468665520|FG001|Overall Study|Participant moved|1|||
130193118|NCT02099110|468665521|FG002|Overall Study|Participant moved|1|||
130193119|NCT02099110|468665522|FG003|Overall Study|Participant moved|0|||
130193120|NCT02099110|468665523|FG004|Overall Study|Participant moved|2|||
130193121|NCT02099110|468665519|FG000|Overall Study|Withdrawal by Subject|7|||
130193122|NCT02099110|468665520|FG001|Overall Study|Withdrawal by Subject|11|||
130193123|NCT02099110|468665521|FG002|Overall Study|Withdrawal by Subject|13|||
130193124|NCT02099110|468665522|FG003|Overall Study|Withdrawal by Subject|9|||
130193125|NCT02099110|468665523|FG004|Overall Study|Withdrawal by Subject|13|||
130193126|NCT02099110|468665519|FG000|Overall Study|Adverse Event|3|||
130193127|NCT02099110|468665520|FG001|Overall Study|Adverse Event|5|||
130193128|NCT02099110|468665521|FG002|Overall Study|Adverse Event|2|||
130193129|NCT02099110|468665522|FG003|Overall Study|Adverse Event|3|||
130193130|NCT02099110|468665523|FG004|Overall Study|Adverse Event|2|||
130193131|NCT02099110|468665519|FG000|Overall Study|Lost to Follow-up|6|||
130193132|NCT02099110|468665520|FG001|Overall Study|Lost to Follow-up|12|||
130193133|NCT02099110|468665521|FG002|Overall Study|Lost to Follow-up|11|||
130193134|NCT02099110|468665522|FG003|Overall Study|Lost to Follow-up|5|||
130193135|NCT02099110|468665523|FG004|Overall Study|Lost to Follow-up|6|||
130193136|NCT02099110|468665519|FG000|Overall Study|Death|0|||
130193137|NCT02099110|468665520|FG001|Overall Study|Death|1|||
130193138|NCT02099110|468665521|FG002|Overall Study|Death|0|||
130193139|NCT02099110|468665522|FG003|Overall Study|Death|0|||
130193140|NCT02099110|468665523|FG004|Overall Study|Death|0|||
130193141|NCT02099110|468665519|FG000|Overall Study|Screen failure|0|||
130193142|NCT02099110|468665520|FG001|Overall Study|Screen failure|0|||
130193143|NCT02099110|468665521|FG002|Overall Study|Screen failure|0|||
130193144|NCT02099110|468665522|FG003|Overall Study|Screen failure|0|||
130193145|NCT02099110|468665523|FG004|Overall Study|Screen failure|1|||
130193146|NCT02099110|468665519|FG000|Overall Study|Non-compliance with study drug|2|||
130193147|NCT02099110|468665520|FG001|Overall Study|Non-compliance with study drug|0|||
130193148|NCT02099110|468665521|FG002|Overall Study|Non-compliance with study drug|0|||
130193149|NCT02099110|468665522|FG003|Overall Study|Non-compliance with study drug|0|||
130193150|NCT02099110|468665523|FG004|Overall Study|Non-compliance with study drug|1|||
130193151|NCT02099110|468665519|FG000|Overall Study|Physician Decision|3|||
130193152|NCT02099110|468665520|FG001|Overall Study|Physician Decision|0|||
130193153|NCT02099110|468665521|FG002|Overall Study|Physician Decision|1|||
130193154|NCT02099110|468665522|FG003|Overall Study|Physician Decision|2|||
130193155|NCT02099110|468665523|FG004|Overall Study|Physician Decision|1|||
130193156|NCT02064816|468665524|FG000|Overall Study|Adverse Event|3|||
130193157|NCT02064816|468665525|FG001|Overall Study|Adverse Event|2|||
130193158|NCT02064816|468665524|FG000|Overall Study|Withdrawal by Subject|2|||
130193159|NCT02064816|468665525|FG001|Overall Study|Withdrawal by Subject|1|||
130193160|NCT02064816|468665524|FG000|Overall Study|Lost to Follow-up|2|||
130193161|NCT02064816|468665525|FG001|Overall Study|Lost to Follow-up|1|||
130193162|NCT02064816|468665524|FG000|Overall Study|Therapeutic failure|0|||
130193163|NCT02064816|468665525|FG001|Overall Study|Therapeutic failure|1|||
130193164|NCT02064816|468665524|FG000|Overall Study|Other|1|||
130193165|NCT02064816|468665525|FG001|Overall Study|Other|3|||
130193166|NCT01732458|468665530|FG000|Overall Study|Lost to Follow-up|0|||
130193167|NCT01732458|468665531|FG001|Overall Study|Lost to Follow-up|2|||
130193168|NCT01732458|468665532|FG002|Overall Study|Lost to Follow-up|0|||
130193169|NCT01732458|468665533|FG003|Overall Study|Lost to Follow-up|0|||
130193170|NCT01732458|468665530|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130193171|NCT01732458|468665531|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130193172|NCT01732458|468665532|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130193173|NCT01732458|468665533|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130193174|NCT01732458|468665530|FG000|Overall Study|Physician Decision|1|||
130193175|NCT01732458|468665531|FG001|Overall Study|Physician Decision|2|||
130193176|NCT01732458|468665532|FG002|Overall Study|Physician Decision|2|||
130193177|NCT01732458|468665533|FG003|Overall Study|Physician Decision|0|||
130193178|NCT01732458|468665530|FG000|Overall Study|Protocol Violation|2|||
130193179|NCT01732458|468665531|FG001|Overall Study|Protocol Violation|0|||
130193180|NCT01732458|468665532|FG002|Overall Study|Protocol Violation|0|||
130193181|NCT01732458|468665533|FG003|Overall Study|Protocol Violation|2|||
130193182|NCT01732458|468665530|FG000|Overall Study|Screen Failure|0|||
130193183|NCT01732458|468665531|FG001|Overall Study|Screen Failure|1|||
130193184|NCT01732458|468665532|FG002|Overall Study|Screen Failure|0|||
130193185|NCT01732458|468665533|FG003|Overall Study|Screen Failure|0|||
130193186|NCT00994461|468665534|FG000|Overall Study|Adverse Event|2|||
130193187|NCT00994461|468665535|FG001|Overall Study|Adverse Event|1|||
130193188|NCT00994461|468665536|FG002|Overall Study|Adverse Event|0|||
130193189|NCT02887248|468665542|FG000|Overall Study|Withdrawal by Subject|1|||
130193190|NCT02887248|468665542|FG000|Overall Study|Adverse Event|1|||
130193191|NCT02887248|468665542|FG000|Overall Study|Progressive Disease|1|||
130193192|NCT03759587|468665543|FG000|Overall Study|Adverse Event|5|||
130193193|NCT03759587|468665543|FG000|Overall Study|Progressive Disease|10|||
130193194|NCT03759587|468665543|FG000|Overall Study|Site Terminated by Sponsor|3|||
130193195|NCT03759587|468665543|FG000|Overall Study|Withdrawal by Subject|1|||
130193196|NCT00454363|468665546|FG000|Overall Study|Adverse Event|1|||
130193197|NCT00454363|468665547|FG001|Overall Study|Adverse Event|2|||
130193198|NCT00454363|468665546|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
130193199|NCT00454363|468665547|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
130193200|NCT00570063|468665548|FG000|Overall Study|Adverse Event|4|||
130193201|NCT00570063|468665549|FG001|Overall Study|Adverse Event|1|||
130193202|NCT00570063|468665548|FG000|Overall Study|Lack of Efficacy|0|||
130193203|NCT00570063|468665549|FG001|Overall Study|Lack of Efficacy|1|||
130193204|NCT00570063|468665548|FG000|Overall Study|Withdrawal by Subject|4|||
130193205|NCT00570063|468665549|FG001|Overall Study|Withdrawal by Subject|3|||
130193206|NCT00570063|468665548|FG000|Overall Study|Sponsor's Decision|7|||
130193207|NCT00570063|468665549|FG001|Overall Study|Sponsor's Decision|3|||
130193208|NCT00697463|468665550|FG000|Overall Study|Withdrawal by Subject|1|||
130193209|NCT03307252|468665551|FG000|Part 2, Period 1|Treatment not received|0|||
130193210|NCT03307252|468665552|FG001|Part 2, Period 1|Treatment not received|0|||
130193211|NCT03307252|468665553|FG002|Part 2, Period 1|Treatment not received|0|||
130193212|NCT03307252|468665554|FG003|Part 2, Period 1|Treatment not received|0|||
130193213|NCT03307252|468665555|FG004|Part 2, Period 1|Treatment not received|0|||
130193214|NCT03307252|468665556|FG005|Part 2, Period 1|Treatment not received|1|||
130193215|NCT03307252|468665557|FG006|Part 2, Period 1|Treatment not received|0|||
130193216|NCT03307252|468665558|FG007|Part 2, Period 1|Treatment not received|0|||
130193217|NCT03307252|468665559|FG008|Part 2, Period 1|Treatment not received|0|||
130193218|NCT03307252|468665560|FG009|Part 2, Period 1|Treatment not received|0|||
130193219|NCT03307252|468665561|FG010|Part 2, Period 1|Treatment not received|0|||
130193220|NCT03307252|468665551|FG000|Part 2, Period 3|Other than listed|0|||
130193221|NCT03307252|468665552|FG001|Part 2, Period 3|Other than listed|0|||
130193222|NCT03307252|468665553|FG002|Part 2, Period 3|Other than listed|0|||
130193223|NCT03307252|468665554|FG003|Part 2, Period 3|Other than listed|0|||
130193224|NCT03307252|468665555|FG004|Part 2, Period 3|Other than listed|1|||
130193225|NCT03307252|468665556|FG005|Part 2, Period 3|Other than listed|0|||
130193226|NCT03307252|468665557|FG006|Part 2, Period 3|Other than listed|0|||
130193227|NCT03307252|468665558|FG007|Part 2, Period 3|Other than listed|0|||
130193228|NCT03307252|468665559|FG008|Part 2, Period 3|Other than listed|0|||
130193229|NCT03307252|468665560|FG009|Part 2, Period 3|Other than listed|0|||
130193230|NCT03307252|468665561|FG010|Part 2, Period 3|Other than listed|0|||
130193231|NCT03307252|468665551|FG000|Part 2, Period 4|Other than listed|0|||
130193232|NCT03307252|468665552|FG001|Part 2, Period 4|Other than listed|0|||
130193233|NCT03307252|468665553|FG002|Part 2, Period 4|Other than listed|0|||
130193234|NCT03307252|468665554|FG003|Part 2, Period 4|Other than listed|0|||
130193235|NCT03307252|468665555|FG004|Part 2, Period 4|Other than listed|0|||
130193236|NCT03307252|468665556|FG005|Part 2, Period 4|Other than listed|0|||
130193237|NCT03307252|468665557|FG006|Part 2, Period 4|Other than listed|1|||
130193238|NCT03307252|468665558|FG007|Part 2, Period 4|Other than listed|0|||
130193239|NCT03307252|468665559|FG008|Part 2, Period 4|Other than listed|0|||
130193240|NCT03307252|468665560|FG009|Part 2, Period 4|Other than listed|0|||
130193241|NCT03307252|468665561|FG010|Part 2, Period 4|Other than listed|0|||
130193242|NCT03307252|468665551|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193243|NCT03307252|468665552|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193244|NCT03307252|468665553|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193245|NCT03307252|468665554|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193246|NCT03307252|468665555|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193247|NCT03307252|468665556|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193248|NCT03307252|468665557|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193249|NCT03307252|468665558|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193250|NCT03307252|468665559|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193251|NCT03307252|468665560|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193252|NCT03307252|468665561|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
130193253|NCT03482453|468665562|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193254|NCT03482453|468665563|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193255|NCT03482453|468665564|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193256|NCT03482453|468665565|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193257|NCT03482453|468665566|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193258|NCT03482453|468665567|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193259|NCT03482453|468665568|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193260|NCT03482453|468665569|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193261|NCT03482453|468665570|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193262|NCT03482453|468665571|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193263|NCT03482453|468665572|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
130193264|NCT03482453|468665573|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193265|NCT02568189|468665574|FG000|Overall Study|Protocol Violation|0|||
130193266|NCT02568189|468665575|FG001|Overall Study|Protocol Violation|0|||
130193267|NCT02568189|468665576|FG002|Overall Study|Protocol Violation|19|||
130193268|NCT02568189|468665577|FG003|Overall Study|Protocol Violation|18|||
130193269|NCT02157376|468665578|FG000|Overall Study|Death|10|||
130193270|NCT02157376|468665579|FG001|Overall Study|Death|4|||
130193271|NCT02157376|468665578|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130193272|NCT02157376|468665579|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130193273|NCT02157376|468665578|FG000|Overall Study|Withdrawal by Subject|3|||
130193274|NCT02157376|468665579|FG001|Overall Study|Withdrawal by Subject|8|||
130193275|NCT02157376|468665578|FG000|Overall Study|Not treated|8|||
130193276|NCT02157376|468665579|FG001|Overall Study|Not treated|3|||
130193277|NCT02157376|468665578|FG000|Overall Study|Investigator's misjudgement|1|||
130193278|NCT02157376|468665579|FG001|Overall Study|Investigator's misjudgement|2|||
130193279|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
130193280|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
130193281|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
130193282|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
130193283|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
130193284|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
130193285|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
130193286|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
130193287|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
130193288|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
130193289|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130193290|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130193291|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
130193292|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
130193293|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130193294|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130193295|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
130193296|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
130193297|NCT01578239|468665584|FG000|Treatment Period|Progressive Disease|19|||
130193298|NCT01578239|468665585|FG001|Treatment Period|Progressive Disease|64|||
130193299|NCT01578239|468665584|FG000|Treatment Period|Physician Decision|17|||
130193300|NCT01578239|468665585|FG001|Treatment Period|Physician Decision|17|||
130193301|NCT01578239|468665584|FG000|Treatment Period|Adverse Event|13|||
130193302|NCT01578239|468665585|FG001|Treatment Period|Adverse Event|10|||
130193303|NCT01578239|468665584|FG000|Treatment Period|Non-compliance|2|||
130193304|NCT01578239|468665585|FG001|Treatment Period|Non-compliance|0|||
130193305|NCT01578239|468665584|FG000|Treatment Period|Withdrawal by Subject|10|||
130193306|NCT01578239|468665585|FG001|Treatment Period|Withdrawal by Subject|9|||
130193307|NCT01578239|468665584|FG000|Treatment Period|Other|6|||
130193308|NCT01578239|468665585|FG001|Treatment Period|Other|1|||
130193309|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Death|69|||
130193310|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Death|64|||
130193311|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
130193312|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
130193313|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
130193314|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
130193315|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Other|2|||
130193316|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Other|2|||
130193317|NCT02347813|468665589|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130193318|NCT02347813|468665590|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130193319|NCT02347813|468665589|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
130193320|NCT02347813|468665590|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
130193321|NCT02837731|468665595|FG000|Allocation|Admitted to General Floor|3|||
130193322|NCT02837731|468665596|FG001|Allocation|Admitted to General Floor|4|||
130193323|NCT02837731|468665595|FG000|Allocation|Immediate surgery/withdrew|2|||
130193324|NCT02837731|468665596|FG001|Allocation|Immediate surgery/withdrew|0|||
130193325|NCT02837731|468665595|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
130193326|NCT02837731|468665596|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
130193327|NCT02837731|468665595|FG000|Allocation|Withdrawal by Subject|2|||
130193328|NCT02837731|468665596|FG001|Allocation|Withdrawal by Subject|0|||
130193329|NCT02837731|468665595|FG000|Allocation|Device not available|1|||
130193330|NCT02837731|468665596|FG001|Allocation|Device not available|0|||
130193331|NCT02837731|468665595|FG000|Allocation|Protocol not implemented|7|||
130193332|NCT02837731|468665596|FG001|Allocation|Protocol not implemented|0|||
130193333|NCT02837731|468665595|FG000|Allocation|Moribund/Do not resuscitate|2|||
130193334|NCT02837731|468665596|FG001|Allocation|Moribund/Do not resuscitate|0|||
130193335|NCT02837731|468665595|FG000|Allocation|Did not meet sepsis criteria|1|||
130193336|NCT02837731|468665596|FG001|Allocation|Did not meet sepsis criteria|2|||
130193337|NCT02837731|468665595|FG000|Allocation|Known aortic abnormalities|0|||
130193338|NCT02837731|468665596|FG001|Allocation|Known aortic abnormalities|1|||
130193339|NCT01119859|468665597|FG000|Overall Study|Adverse Event|9|||
130193340|NCT01119859|468665598|FG001|Overall Study|Adverse Event|10|||
130193341|NCT01119859|468665597|FG000|Overall Study|Death|2|||
130193342|NCT01119859|468665598|FG001|Overall Study|Death|0|||
130193343|NCT01119859|468665597|FG000|Overall Study|Insufficient therapeutic response|7|||
130193344|NCT01119859|468665598|FG001|Overall Study|Insufficient therapeutic response|14|||
130193345|NCT01119859|468665597|FG000|Overall Study|Refused treatment|3|||
130193346|NCT01119859|468665598|FG001|Overall Study|Refused treatment|6|||
130193347|NCT01119859|468665597|FG000|Overall Study|Failure to return|3|||
130193348|NCT01119859|468665598|FG001|Overall Study|Failure to return|0|||
130193349|NCT04200651|468665599|FG000|Overall Study|Moved to another country during follow-up|2|||
130193350|NCT04200651|468665600|FG001|Overall Study|Moved to another country during follow-up|2|||
130193351|NCT04200651|468665599|FG000|Overall Study|Lost to Follow-up|1|||
130193352|NCT04200651|468665600|FG001|Overall Study|Lost to Follow-up|3|||
130193353|NCT03225105|468665601|FG000|Overall Study|Withdrawal by Subject|1|||
130193354|NCT03225105|468665602|FG001|Overall Study|Withdrawal by Subject|0|||
130193355|NCT03225105|468665603|FG002|Overall Study|Withdrawal by Subject|0|||
130193356|NCT03225105|468665604|FG003|Overall Study|Withdrawal by Subject|0|||
130193357|NCT03225105|468665601|FG000|Overall Study|Death|0|||
130193358|NCT03225105|468665602|FG001|Overall Study|Death|4|||
130193359|NCT03225105|468665603|FG002|Overall Study|Death|2|||
130193360|NCT03225105|468665604|FG003|Overall Study|Death|0|||
130193361|NCT03225105|468665601|FG000|Overall Study|Study termination per Sponsor Decision|2|||
130193362|NCT03225105|468665602|FG001|Overall Study|Study termination per Sponsor Decision|0|||
130193363|NCT03225105|468665603|FG002|Overall Study|Study termination per Sponsor Decision|3|||
130193364|NCT03225105|468665604|FG003|Overall Study|Study termination per Sponsor Decision|3|||
130193365|NCT02887183|468665606|FG000|Overall Study|Adverse Event|44|||
130193366|NCT02887183|468665606|FG000|Overall Study|Death|30|||
130193367|NCT02887183|468665606|FG000|Overall Study|Pregnancy|1|||
130193368|NCT02887183|468665606|FG000|Overall Study|Protocol Violation|6|||
130193369|NCT02887183|468665606|FG000|Overall Study|Technical Problems|2|||
130193370|NCT02887183|468665606|FG000|Overall Study|Lost to Follow-up|13|||
130193371|NCT02887183|468665606|FG000|Overall Study|Physician Decision|10|||
130193372|NCT02887183|468665606|FG000|Overall Study|Withdrawal by Subject|35|||
130193373|NCT01031680|468665607|FG000|Overall Study|Adverse Event|8|||
130193374|NCT01031680|468665608|FG001|Overall Study|Adverse Event|3|||
130193375|NCT01031680|468665607|FG000|Overall Study|Lost to Follow-up|2|||
130193376|NCT01031680|468665608|FG001|Overall Study|Lost to Follow-up|10|||
130193377|NCT01031680|468665607|FG000|Overall Study|Withdrawal by Subject|12|||
130193378|NCT01031680|468665608|FG001|Overall Study|Withdrawal by Subject|16|||
130193379|NCT01031680|468665607|FG000|Overall Study|Death|2|||
130193380|NCT01031680|468665608|FG001|Overall Study|Death|1|||
130193381|NCT01031680|468665607|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
130193382|NCT01031680|468665608|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
130193383|NCT01031680|468665607|FG000|Overall Study|Poor/Non-compliance|5|||
130193384|NCT01031680|468665608|FG001|Overall Study|Poor/Non-compliance|6|||
130193385|NCT01031680|468665607|FG000|Overall Study|Safety|1|||
130193386|NCT01031680|468665608|FG001|Overall Study|Safety|0|||
130193387|NCT01031680|468665607|FG000|Overall Study|Incorrect Enrolment|1|||
130193388|NCT01031680|468665608|FG001|Overall Study|Incorrect Enrolment|2|||
130193389|NCT01031680|468665607|FG000|Overall Study|Administrative Reason by Sponsor|0|||
130193390|NCT01031680|468665608|FG001|Overall Study|Administrative Reason by Sponsor|1|||
130193391|NCT01031680|468665607|FG000|Overall Study|Various|0|||
130193392|NCT01031680|468665608|FG001|Overall Study|Various|2|||
130193393|NCT02654977|468665615|FG000|Overall Study|Death|1|||
130193394|NCT02654977|468665615|FG000|Overall Study|Lost to Follow-up|1|||
130193395|NCT02654977|468665615|FG000|Overall Study|Adverse Event|1|||
130193396|NCT02654977|468665615|FG000|Overall Study|Withdrawal by Subject|1|||
130193397|NCT02654977|468665615|FG000|Overall Study|Lack of Efficacy|3|||
130193398|NCT01921101|468665616|FG000|Overall Study|Death|16|||
130193399|NCT01921101|468665617|FG001|Overall Study|Death|6|||
130193400|NCT01483027|468665618|FG000|Overall Study|Administrative Reasons|2|||
130193401|NCT01483027|468665619|FG001|Overall Study|Administrative Reasons|1|||
130193402|NCT01483027|468665618|FG000|Overall Study|Withdrawal by Subject|21|||
130193403|NCT01483027|468665619|FG001|Overall Study|Withdrawal by Subject|32|||
130193404|NCT01483027|468665618|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
130193405|NCT01483027|468665619|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
130193406|NCT01483027|468665618|FG000|Overall Study|Lost to Follow-up|1|||
130193407|NCT01483027|468665619|FG001|Overall Study|Lost to Follow-up|1|||
130193408|NCT01483027|468665618|FG000|Overall Study|Adverse Event|0|||
130193409|NCT01483027|468665619|FG001|Overall Study|Adverse Event|1|||
130193410|NCT01483027|468665618|FG000|Overall Study|Withdrawal by Subject|0|||
130193411|NCT01483027|468665619|FG001|Overall Study|Withdrawal by Subject|1|||
130193412|NCT03691207|468666838|FG000|Overall Study|Death|41|||
130193413|NCT03691207|468666839|FG001|Overall Study|Death|26|||
130193414|NCT03691207|468666838|FG000|Overall Study|Lost to Follow-up|1|||
130193415|NCT03691207|468666839|FG001|Overall Study|Lost to Follow-up|1|||
130193416|NCT03691207|468666838|FG000|Overall Study|Withdrawal by Subject|2|||
130193417|NCT03691207|468666839|FG001|Overall Study|Withdrawal by Subject|8|||
130193418|NCT03691207|468666838|FG000|Overall Study|Sponsor decision|1|||
130193419|NCT03691207|468666839|FG001|Overall Study|Sponsor decision|7|||
130193420|NCT01288937|468666842|FG000|Overall Study|Adverse Event|1|||
130193421|NCT01288937|468666843|FG001|Overall Study|Adverse Event|0|||
130193422|NCT02490371|468666844|FG000|Overall Study|Lost to Follow-up|1|||
130193423|NCT02490371|468666845|FG001|Overall Study|Lost to Follow-up|1|||
130193424|NCT00610155|468666846|FG000|Period 1|Withdrawal by Subject|0|||
130193425|NCT00610155|468666847|FG001|Period 1|Withdrawal by Subject|0|||
130193426|NCT00610155|468666848|FG002|Period 1|Withdrawal by Subject|1|||
130193427|NCT00610155|468666849|FG003|Period 1|Withdrawal by Subject|0|||
130193428|NCT00610155|468666850|FG004|Period 1|Withdrawal by Subject|0|||
130193429|NCT00610155|468666851|FG005|Period 1|Withdrawal by Subject|0|||
130193430|NCT00610155|468666846|FG000|Period 3|Adverse Event|1|||
130193431|NCT00610155|468666847|FG001|Period 3|Adverse Event|0|||
130193432|NCT00610155|468666848|FG002|Period 3|Adverse Event|0|||
130193433|NCT00610155|468666849|FG003|Period 3|Adverse Event|0|||
130193434|NCT00610155|468666850|FG004|Period 3|Adverse Event|0|||
130193435|NCT00610155|468666851|FG005|Period 3|Adverse Event|0|||
130193436|NCT01718535|468666852|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
130193437|NCT01718535|468666853|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
130193438|NCT01718535|468666854|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
130193439|NCT01718535|468666855|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
130193440|NCT01718535|468666856|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
130193441|NCT01718535|468666857|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
130193442|NCT01718535|468666858|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
130193443|NCT01718535|468666859|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
130193444|NCT01718535|468666860|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
130193445|NCT01718535|468666861|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
130193446|NCT03018080|468666867|FG000|Overall Study|Death|12|||
130193447|NCT03018080|468666868|FG001|Overall Study|Death|19|||
130193448|NCT00740792|468666869|FG000|Overall Study|Adverse Event|3|||
130193449|NCT00740792|468666870|FG001|Overall Study|Adverse Event|1|||
130193450|NCT00740792|468666871|FG002|Overall Study|Adverse Event|1|||
130193451|NCT00740792|468666872|FG003|Overall Study|Adverse Event|3|||
130193452|NCT00740792|468666869|FG000|Overall Study|Lack of Efficacy|1|||
130193453|NCT00740792|468666870|FG001|Overall Study|Lack of Efficacy|1|||
130193454|NCT00740792|468666871|FG002|Overall Study|Lack of Efficacy|0|||
130193455|NCT00740792|468666872|FG003|Overall Study|Lack of Efficacy|3|||
130193456|NCT00740792|468666869|FG000|Overall Study|Lost to Follow-up|2|||
130193457|NCT00740792|468666870|FG001|Overall Study|Lost to Follow-up|1|||
130193458|NCT00740792|468666871|FG002|Overall Study|Lost to Follow-up|0|||
130193459|NCT00740792|468666872|FG003|Overall Study|Lost to Follow-up|0|||
130193460|NCT00740792|468666869|FG000|Overall Study|Protocol Violation|0|||
130193461|NCT00740792|468666870|FG001|Overall Study|Protocol Violation|1|||
130193462|NCT00740792|468666871|FG002|Overall Study|Protocol Violation|0|||
130193463|NCT00740792|468666872|FG003|Overall Study|Protocol Violation|2|||
130193464|NCT00740792|468666869|FG000|Overall Study|Withdrawal by Subject|1|||
130193465|NCT00740792|468666870|FG001|Overall Study|Withdrawal by Subject|1|||
130193466|NCT00740792|468666871|FG002|Overall Study|Withdrawal by Subject|0|||
130193467|NCT00740792|468666872|FG003|Overall Study|Withdrawal by Subject|0|||
130193468|NCT00740792|468666869|FG000|Overall Study|administrative|3|||
130193469|NCT00740792|468666870|FG001|Overall Study|administrative|3|||
130193470|NCT00740792|468666871|FG002|Overall Study|administrative|8|||
130193471|NCT00740792|468666872|FG003|Overall Study|administrative|2|||
130193472|NCT00179660|468666873|FG000|Overall Study|Adverse Event|7|||
130193473|NCT00179660|468666873|FG000|Overall Study|Lack of therapeutic effect|28|||
130193474|NCT00179660|468666873|FG000|Overall Study|Withdrawal by Subject|2|||
130193475|NCT00179660|468666873|FG000|Overall Study|Lost to Follow-up|1|||
130193476|NCT00179660|468666873|FG000|Overall Study|Death|3|||
130193477|NCT00179660|468666873|FG000|Overall Study|Other - Unspecified|9|||
130193478|NCT02035202|468666876|FG000|Overall Study|Lost to Follow-up|8|||
130193479|NCT02035202|468666877|FG001|Overall Study|Lost to Follow-up|16|||
130193480|NCT02035202|468666878|FG002|Overall Study|Lost to Follow-up|2|||
130193481|NCT00178685|468666879|FG000|Overall Study|Death|3|||
130193482|NCT00178685|468666880|FG001|Overall Study|Death|3|||
130193483|NCT00178685|468666881|FG002|Overall Study|Death|6|||
130193484|NCT00178685|468666879|FG000|Overall Study|Lost to Follow-up|100|||
130193485|NCT00178685|468666880|FG001|Overall Study|Lost to Follow-up|187|||
130193486|NCT00178685|468666881|FG002|Overall Study|Lost to Follow-up|183|||
130193487|NCT00178685|468666879|FG000|Overall Study|Withdrawal by Subject|8|||
130193488|NCT00178685|468666880|FG001|Overall Study|Withdrawal by Subject|14|||
130193489|NCT00178685|468666881|FG002|Overall Study|Withdrawal by Subject|7|||
130193490|NCT00267969|468666893|FG000|Controlled Period|Adverse Event|6|||
130193491|NCT00267969|468666894|FG001|Controlled Period|Adverse Event|0|||
130193492|NCT00267969|468666895|FG002|Controlled Period|Adverse Event|2|||
130193493|NCT00267969|468666896|FG003|Controlled Period|Adverse Event|0|||
130193494|NCT00267969|468666897|FG004|Controlled Period|Adverse Event|0|||
130193495|NCT00267969|468666898|FG005|Controlled Period|Adverse Event|0|||
130193496|NCT00267969|468666899|FG006|Controlled Period|Adverse Event|0|||
130193497|NCT00267969|468666893|FG000|Controlled Period|Lack of Efficacy|3|||
130193498|NCT00267969|468666894|FG001|Controlled Period|Lack of Efficacy|0|||
130193499|NCT00267969|468666895|FG002|Controlled Period|Lack of Efficacy|1|||
130193500|NCT00267969|468666896|FG003|Controlled Period|Lack of Efficacy|0|||
130193501|NCT00267969|468666897|FG004|Controlled Period|Lack of Efficacy|0|||
130193502|NCT00267969|468666898|FG005|Controlled Period|Lack of Efficacy|0|||
130193503|NCT00267969|468666899|FG006|Controlled Period|Lack of Efficacy|0|||
130193504|NCT00267969|468666893|FG000|Controlled Period|Lost to Follow-up|1|||
130193505|NCT00267969|468666894|FG001|Controlled Period|Lost to Follow-up|0|||
130193506|NCT00267969|468666895|FG002|Controlled Period|Lost to Follow-up|1|||
130193507|NCT00267969|468666896|FG003|Controlled Period|Lost to Follow-up|0|||
130193508|NCT00267969|468666897|FG004|Controlled Period|Lost to Follow-up|0|||
130193509|NCT00267969|468666898|FG005|Controlled Period|Lost to Follow-up|0|||
130193510|NCT00267969|468666899|FG006|Controlled Period|Lost to Follow-up|0|||
130193511|NCT00267969|468666893|FG000|Controlled Period|Randomized but not treated|0|||
130193512|NCT00267969|468666894|FG001|Controlled Period|Randomized but not treated|0|||
130193513|NCT00267969|468666895|FG002|Controlled Period|Randomized but not treated|1|||
130193514|NCT00267969|468666896|FG003|Controlled Period|Randomized but not treated|0|||
130193515|NCT00267969|468666897|FG004|Controlled Period|Randomized but not treated|0|||
130193516|NCT00267969|468666898|FG005|Controlled Period|Randomized but not treated|0|||
130193517|NCT00267969|468666899|FG006|Controlled Period|Randomized but not treated|0|||
130193518|NCT00267969|468666893|FG000|Controlled Period|Other|2|||
130193519|NCT00267969|468666894|FG001|Controlled Period|Other|1|||
130193520|NCT00267969|468666895|FG002|Controlled Period|Other|6|||
130193521|NCT00267969|468666896|FG003|Controlled Period|Other|0|||
130193522|NCT00267969|468666897|FG004|Controlled Period|Other|0|||
130193523|NCT00267969|468666898|FG005|Controlled Period|Other|0|||
130193524|NCT00267969|468666899|FG006|Controlled Period|Other|0|||
130193525|NCT00267969|468666893|FG000|After Controlled Period|Adverse Event|0|||
130193526|NCT00267969|468666894|FG001|After Controlled Period|Adverse Event|0|||
130193527|NCT00267969|468666895|FG002|After Controlled Period|Adverse Event|0|||
130193528|NCT00267969|468666896|FG003|After Controlled Period|Adverse Event|7|||
130193529|NCT00267969|468666897|FG004|After Controlled Period|Adverse Event|8|||
130193530|NCT00267969|468666898|FG005|After Controlled Period|Adverse Event|23|||
130193531|NCT00267969|468666899|FG006|After Controlled Period|Adverse Event|21|||
130193532|NCT00267969|468666893|FG000|After Controlled Period|Death|0|||
130193533|NCT00267969|468666894|FG001|After Controlled Period|Death|0|||
130193534|NCT00267969|468666895|FG002|After Controlled Period|Death|0|||
130193535|NCT00267969|468666896|FG003|After Controlled Period|Death|1|||
130193536|NCT00267969|468666897|FG004|After Controlled Period|Death|2|||
130193537|NCT00267969|468666898|FG005|After Controlled Period|Death|0|||
130193538|NCT00267969|468666899|FG006|After Controlled Period|Death|1|||
130193539|NCT00267969|468666893|FG000|After Controlled Period|Lack of Efficacy|0|||
130193540|NCT00267969|468666894|FG001|After Controlled Period|Lack of Efficacy|0|||
130193541|NCT00267969|468666895|FG002|After Controlled Period|Lack of Efficacy|0|||
130193542|NCT00267969|468666896|FG003|After Controlled Period|Lack of Efficacy|10|||
130193543|NCT00267969|468666897|FG004|After Controlled Period|Lack of Efficacy|6|||
130193544|NCT00267969|468666898|FG005|After Controlled Period|Lack of Efficacy|28|||
130193545|NCT00267969|468666899|FG006|After Controlled Period|Lack of Efficacy|15|||
130193546|NCT00267969|468666893|FG000|After Controlled Period|Lost to Follow-up|0|||
130193547|NCT00267969|468666894|FG001|After Controlled Period|Lost to Follow-up|0|||
130193548|NCT00267969|468666895|FG002|After Controlled Period|Lost to Follow-up|0|||
130193549|NCT00267969|468666896|FG003|After Controlled Period|Lost to Follow-up|5|||
130193550|NCT00267969|468666897|FG004|After Controlled Period|Lost to Follow-up|8|||
130193551|NCT00267969|468666898|FG005|After Controlled Period|Lost to Follow-up|9|||
130193552|NCT00267969|468666899|FG006|After Controlled Period|Lost to Follow-up|10|||
130193553|NCT00267969|468666893|FG000|After Controlled Period|Other|0|||
130193554|NCT00267969|468666894|FG001|After Controlled Period|Other|0|||
130193555|NCT00267969|468666895|FG002|After Controlled Period|Other|0|||
130193556|NCT00267969|468666896|FG003|After Controlled Period|Other|13|||
130193557|NCT00267969|468666897|FG004|After Controlled Period|Other|11|||
130193558|NCT00267969|468666898|FG005|After Controlled Period|Other|22|||
130193559|NCT00267969|468666899|FG006|After Controlled Period|Other|25|||
130193560|NCT01053663|468666903|FG000|Overall Study|Death|2|||
130193561|NCT01053663|468666903|FG000|Overall Study|Lost to Follow-up|1|||
130193562|NCT01053663|468666903|FG000|Overall Study|Poor IV Access|1|||
130193563|NCT01053663|468666903|FG000|Overall Study|Transferred to Another Hospital|1|||
130193564|NCT01053663|468666903|FG000|Overall Study|Negative Influenza Diagnosis|1|||
130193565|NCT03533114|468666904|FG000|Overall|Adverse Event|16|||
130193566|NCT03533114|468666905|FG001|Overall|Adverse Event|11|||
130193567|NCT03533114|468666904|FG000|Overall|Consent Withdrawal by Participant|7|||
130193568|NCT03533114|468666905|FG001|Overall|Consent Withdrawal by Participant|6|||
130193569|NCT03533114|468666904|FG000|Overall|Lack of Efficacy|5|||
130193570|NCT03533114|468666905|FG001|Overall|Lack of Efficacy|3|||
130193571|NCT03533114|468666904|FG000|Overall|Lost to Follow-up|1|||
130193572|NCT03533114|468666905|FG001|Overall|Lost to Follow-up|1|||
130193573|NCT03533114|468666904|FG000|Overall|Physician Decision|0|||
130193574|NCT03533114|468666905|FG001|Overall|Physician Decision|2|||
130193575|NCT03533114|468666904|FG000|Overall|Protocol deviation|1|||
130193576|NCT03533114|468666905|FG001|Overall|Protocol deviation|1|||
130193577|NCT03533114|468666904|FG000|Overall|Failure to meet randomization criteria|1|||
130193578|NCT03533114|468666905|FG001|Overall|Failure to meet randomization criteria|2|||
130193579|NCT03533114|468666904|FG000|Overall|Non-Compliance with study drug|0|||
130193580|NCT03533114|468666905|FG001|Overall|Non-Compliance with study drug|1|||
130193581|NCT03533114|468666904|FG000|Overall|Other|0|||
130193582|NCT03533114|468666905|FG001|Overall|Other|1|||
130193583|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Adverse Event|11|||
130193584|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Adverse Event|8|||
130193585|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
130193586|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
130193587|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
130193588|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
130193589|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
130193590|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
130193591|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
130193592|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
130193593|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
130193594|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
130193595|NCT03533114|468666904|FG000|Stable Dose|Adverse Event|0|||
130193596|NCT03533114|468666905|FG001|Stable Dose|Adverse Event|2|||
130193597|NCT03533114|468666904|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
130193598|NCT03533114|468666905|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
130193599|NCT03533114|468666904|FG000|Stable Dose|Lack of Efficacy|1|||
130193600|NCT03533114|468666905|FG001|Stable Dose|Lack of Efficacy|0|||
130193601|NCT03533114|468666904|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130193602|NCT03533114|468666905|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130193603|NCT03533114|468666904|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
130193604|NCT03533114|468666905|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
130193605|NCT03533114|468666904|FG000|Open-Label Safety Extension|Adverse Event|3|||
130193606|NCT03533114|468666905|FG001|Open-Label Safety Extension|Adverse Event|0|||
130193607|NCT03533114|468666904|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
130193608|NCT03533114|468666905|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
130193609|NCT03533114|468666904|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
130193610|NCT03533114|468666905|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
130193611|NCT03533114|468666904|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
130193612|NCT03533114|468666905|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
130193613|NCT03533114|468666904|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
130193614|NCT03533114|468666905|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
130193615|NCT01862250|468666906|FG000|Overall Study|Adverse Event|4|||
130193616|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
130193617|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
130193618|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
130193619|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
130193620|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
130193621|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
130193622|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
130193623|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
130193624|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
130193625|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
130193626|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
130193627|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
130193628|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
130193629|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
130193630|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193631|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193632|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193633|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193634|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
130193635|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
130193636|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
130193637|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
130193638|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
130193639|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
130193640|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
130193641|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
130193642|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
130193643|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
130193644|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
130193645|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
130193646|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
130193647|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
130193648|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193649|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193650|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193651|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193652|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
130193653|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
130193654|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193655|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193656|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193657|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193658|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193659|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193660|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193661|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193662|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193663|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
130193664|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130193665|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130193666|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130193667|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
130193668|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
130193669|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130193670|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
130193671|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
130193672|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
130193673|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
130193674|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
130193675|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
130193676|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Death|0|||
130193677|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Death|0|||
130193678|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Death|0|||
130193679|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Death|0|||
130193680|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Death|0|||
130193681|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Death|1|||
130193682|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
130193683|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
130193684|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
130193685|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
130193686|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
130193687|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
130193688|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130193689|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130193690|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
130193691|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130193692|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130193693|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
130193694|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193695|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193696|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130193697|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193698|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193699|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130193700|NCT02016105|468666907|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
130193701|NCT02016105|468666908|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
130193702|NCT02016105|468666909|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
130193703|NCT02016105|468666910|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
130193704|NCT02016105|468666911|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
130193705|NCT02016105|468666912|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
130193706|NCT02016105|468666907|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
130193707|NCT02016105|468666908|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
130193708|NCT02016105|468666909|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
130193709|NCT02016105|468666910|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
130193710|NCT02016105|468666911|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
130193711|NCT02016105|468666912|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
130193712|NCT02016105|468666907|FG000|EXTENSION PERIOD|Adverse Event|0|||
130193713|NCT02016105|468666908|FG001|EXTENSION PERIOD|Adverse Event|0|||
130193714|NCT02016105|468666909|FG002|EXTENSION PERIOD|Adverse Event|2|||
130193715|NCT02016105|468666910|FG003|EXTENSION PERIOD|Adverse Event|0|||
130193716|NCT02016105|468666911|FG004|EXTENSION PERIOD|Adverse Event|1|||
130193717|NCT02016105|468666912|FG005|EXTENSION PERIOD|Adverse Event|0|||
130193718|NCT02016105|468666907|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
130193719|NCT02016105|468666908|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
130193720|NCT02016105|468666909|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193721|NCT02016105|468666910|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193722|NCT02016105|468666911|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193723|NCT02016105|468666912|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193724|NCT02016105|468666907|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193725|NCT02016105|468666908|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193726|NCT02016105|468666909|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193727|NCT02016105|468666910|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193728|NCT02016105|468666911|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
130193729|NCT02016105|468666912|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193730|NCT02016105|468666907|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
130193731|NCT02016105|468666908|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
130193732|NCT02016105|468666909|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
130193733|NCT02016105|468666910|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
130193734|NCT02016105|468666911|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
130193735|NCT02016105|468666912|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
130193736|NCT00900159|468666917|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
130193737|NCT00900159|468666918|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
130193738|NCT01377922|468666925|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
130193739|NCT01377922|468666926|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
130193740|NCT03170362|468666927|FG000|Overall Study|Death|2|||
130193741|NCT03170362|468666928|FG001|Overall Study|Death|2|||
130193742|NCT03170362|468666927|FG000|Overall Study|Withdrawal by Subject|23|||
130193743|NCT03170362|468666928|FG001|Overall Study|Withdrawal by Subject|22|||
130193744|NCT03170362|468666927|FG000|Overall Study|Lost to Follow-up|187|||
130193745|NCT03170362|468666928|FG001|Overall Study|Lost to Follow-up|167|||
130193746|NCT04615403|468666929|FG000|Overall Study|Death|1|||
130193747|NCT03340454|468666930|FG000|Overall Study|Lost to Follow-up|0|||
130193748|NCT03340454|468666931|FG001|Overall Study|Lost to Follow-up|4|||
130193749|NCT03682848|468666932|FG000|Overall Study|Withdrawal by Subject|2|||
130193750|NCT03682848|468666932|FG000|Overall Study|Site closed|5|||
130193751|NCT03682848|468666932|FG000|Overall Study|Protocol Deviation|1|||
130193752|NCT03682848|468666932|FG000|Overall Study|Adverse Event|1|||
130193753|NCT01464164|468666933|FG000|Overall Study|Screen failure|0|||
130193754|NCT01464164|468666934|FG001|Overall Study|Screen failure|1|||
130193755|NCT01464164|468666935|FG002|Overall Study|Screen failure|2|||
130193756|NCT01464164|468666936|FG003|Overall Study|Screen failure|0|||
130193757|NCT01464164|468666937|FG004|Overall Study|Screen failure|0|||
130193758|NCT01464164|468666938|FG005|Overall Study|Screen failure|0|||
130193759|NCT01464164|468666939|FG006|Overall Study|Screen failure|0|||
130193760|NCT01464164|468666933|FG000|Overall Study|Physician Decision|0|||
130193761|NCT01464164|468666934|FG001|Overall Study|Physician Decision|1|||
130193762|NCT01464164|468666935|FG002|Overall Study|Physician Decision|0|||
130193763|NCT01464164|468666936|FG003|Overall Study|Physician Decision|0|||
130193764|NCT01464164|468666937|FG004|Overall Study|Physician Decision|0|||
130193765|NCT01464164|468666938|FG005|Overall Study|Physician Decision|0|||
130193766|NCT01464164|468666939|FG006|Overall Study|Physician Decision|2|||
130193767|NCT00603473|468666940|FG000|Overall Study|Adverse Event|4|||
130193768|NCT00603473|468666940|FG000|Overall Study|Lack of Efficacy|4|||
130193769|NCT00603473|468666940|FG000|Overall Study|Protocol Violation|1|||
130193770|NCT02644668|468666941|FG000|Overall Study|Adverse Event|2|||
130193771|NCT02644668|468666942|FG001|Overall Study|Adverse Event|0|||
130193772|NCT02644668|468666943|FG002|Overall Study|Adverse Event|1|||
130193773|NCT02644668|468666941|FG000|Overall Study|Protocol Violation|0|||
130193774|NCT02644668|468666942|FG001|Overall Study|Protocol Violation|0|||
130193775|NCT02644668|468666943|FG002|Overall Study|Protocol Violation|1|||
130193776|NCT02644668|468666941|FG000|Overall Study|Withdrawal by Subject|0|||
130193777|NCT02644668|468666942|FG001|Overall Study|Withdrawal by Subject|0|||
130193778|NCT02644668|468666943|FG002|Overall Study|Withdrawal by Subject|1|||
130193779|NCT01134939|468666947|FG000|Overall Study|Adverse Event|9|||
130193780|NCT01134939|468666948|FG001|Overall Study|Adverse Event|3|||
130193781|NCT01134939|468666949|FG002|Overall Study|Adverse Event|4|||
130193782|NCT01134939|468666950|FG003|Overall Study|Adverse Event|5|||
130193783|NCT01134939|468666951|FG004|Overall Study|Adverse Event|5|||
130193784|NCT01134939|468666952|FG005|Overall Study|Adverse Event|5|||
130193785|NCT01134939|468666953|FG006|Overall Study|Adverse Event|1|||
130193786|NCT01134939|468666954|FG007|Overall Study|Adverse Event|0|||
130193787|NCT01134939|468666947|FG000|Overall Study|Lack of Efficacy|2|||
130193788|NCT01134939|468666948|FG001|Overall Study|Lack of Efficacy|5|||
130193789|NCT01134939|468666949|FG002|Overall Study|Lack of Efficacy|1|||
130193790|NCT01134939|468666950|FG003|Overall Study|Lack of Efficacy|0|||
130193791|NCT01134939|468666951|FG004|Overall Study|Lack of Efficacy|3|||
130193792|NCT01134939|468666952|FG005|Overall Study|Lack of Efficacy|0|||
130193793|NCT01134939|468666953|FG006|Overall Study|Lack of Efficacy|1|||
130193794|NCT01134939|468666954|FG007|Overall Study|Lack of Efficacy|0|||
130193795|NCT01134939|468666947|FG000|Overall Study|Lost to Follow-up|2|||
130193796|NCT01134939|468666948|FG001|Overall Study|Lost to Follow-up|3|||
130193797|NCT01134939|468666949|FG002|Overall Study|Lost to Follow-up|0|||
130193798|NCT01134939|468666950|FG003|Overall Study|Lost to Follow-up|1|||
130193799|NCT01134939|468666951|FG004|Overall Study|Lost to Follow-up|2|||
130193800|NCT01134939|468666952|FG005|Overall Study|Lost to Follow-up|1|||
130193801|NCT01134939|468666953|FG006|Overall Study|Lost to Follow-up|0|||
130193802|NCT01134939|468666954|FG007|Overall Study|Lost to Follow-up|0|||
130193803|NCT01134939|468666947|FG000|Overall Study|Death|0|||
130193804|NCT01134939|468666948|FG001|Overall Study|Death|1|||
130193805|NCT01134939|468666949|FG002|Overall Study|Death|0|||
130193806|NCT01134939|468666950|FG003|Overall Study|Death|0|||
130193807|NCT01134939|468666951|FG004|Overall Study|Death|0|||
130193808|NCT01134939|468666952|FG005|Overall Study|Death|0|||
130193809|NCT01134939|468666953|FG006|Overall Study|Death|0|||
130193810|NCT01134939|468666954|FG007|Overall Study|Death|0|||
130193811|NCT01134939|468666947|FG000|Overall Study|Termination page not available|4|||
130193812|NCT01134939|468666948|FG001|Overall Study|Termination page not available|6|||
130193813|NCT01134939|468666949|FG002|Overall Study|Termination page not available|5|||
130193814|NCT01134939|468666950|FG003|Overall Study|Termination page not available|8|||
130193815|NCT01134939|468666951|FG004|Overall Study|Termination page not available|0|||
130193816|NCT01134939|468666952|FG005|Overall Study|Termination page not available|3|||
130193817|NCT01134939|468666953|FG006|Overall Study|Termination page not available|7|||
130193818|NCT01134939|468666954|FG007|Overall Study|Termination page not available|0|||
130193819|NCT00733421|468666955|FG000|Overall Study|Withdrawal by Subject|1|||
130193820|NCT00733421|468666956|FG001|Overall Study|Withdrawal by Subject|1|||
130193821|NCT02547220|468666961|FG000|Overall Study|Withdrawal by Subject|1|||
130193822|NCT02547220|468666962|FG001|Overall Study|Withdrawal by Subject|0|||
130193823|NCT02547220|468666961|FG000|Overall Study|Study terminated by sponsor|18|||
130193824|NCT02547220|468666962|FG001|Overall Study|Study terminated by sponsor|20|||
130193825|NCT00550043|468666966|FG000|Overall Study|Adverse Event|0|||
130193826|NCT00550043|468666967|FG001|Overall Study|Adverse Event|0|||
130193827|NCT00550043|468666968|FG002|Overall Study|Adverse Event|0|||
130193828|NCT00550043|468666969|FG003|Overall Study|Adverse Event|1|||
130193829|NCT00550043|468666970|FG004|Overall Study|Adverse Event|1|||
130193830|NCT00550043|468666966|FG000|Overall Study|Subject Withdrew Consent|0|||
130193831|NCT00550043|468666967|FG001|Overall Study|Subject Withdrew Consent|2|||
130193832|NCT00550043|468666968|FG002|Overall Study|Subject Withdrew Consent|1|||
130193833|NCT00550043|468666969|FG003|Overall Study|Subject Withdrew Consent|0|||
130193834|NCT00550043|468666970|FG004|Overall Study|Subject Withdrew Consent|0|||
130193835|NCT00550043|468666966|FG000|Overall Study|Other Reasons- Unspecified|0|||
130193836|NCT00550043|468666967|FG001|Overall Study|Other Reasons- Unspecified|1|||
130193837|NCT00550043|468666968|FG002|Overall Study|Other Reasons- Unspecified|0|||
130193838|NCT00550043|468666969|FG003|Overall Study|Other Reasons- Unspecified|1|||
130193839|NCT00550043|468666970|FG004|Overall Study|Other Reasons- Unspecified|0|||
130193840|NCT04185220|468666971|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
130193841|NCT04185220|468666972|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
130193842|NCT04185220|468666971|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
130193843|NCT04185220|468666972|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
130193844|NCT03478644|468666974|FG000|Phase 2|Withdrawal by Subject|2|||
130193845|NCT03478644|468666975|FG001|Phase 2|Withdrawal by Subject|1|||
130193846|NCT03478644|468666974|FG000|Phase 2|Lost to Follow-up|1|||
130193847|NCT03478644|468666975|FG001|Phase 2|Lost to Follow-up|0|||
130193848|NCT01029782|468666976|FG000|Overall Study|Lost to Follow-up|2|||
130193849|NCT01029782|468666977|FG001|Overall Study|Lost to Follow-up|2|||
130193850|NCT01029782|468666976|FG000|Overall Study|Diagnosis changed|1|||
130193851|NCT01029782|468666977|FG001|Overall Study|Diagnosis changed|1|||
130193852|NCT01029782|468666976|FG000|Overall Study|Adverse Event|0|||
130193853|NCT01029782|468666977|FG001|Overall Study|Adverse Event|1|||
130193854|NCT01029782|468666976|FG000|Overall Study|Physician Decision|0|||
130193855|NCT01029782|468666977|FG001|Overall Study|Physician Decision|1|||
130193856|NCT01029782|468666976|FG000|Overall Study|Protocol Violation|0|||
130193857|NCT01029782|468666977|FG001|Overall Study|Protocol Violation|2|||
130193858|NCT01029782|468666976|FG000|Overall Study|Withdrawal by Subject|0|||
130193859|NCT01029782|468666977|FG001|Overall Study|Withdrawal by Subject|1|||
130193860|NCT02195869|468666979|FG000|Overall Study|cGVHD Progression|5|||
130193861|NCT02195869|468666979|FG000|Overall Study|Malignancy Progression/relapse|2|||
130193862|NCT02195869|468666979|FG000|Overall Study|Adverse Event|15|||
130193863|NCT02195869|468666979|FG000|Overall Study|Withdrawal by Subject|7|||
130193864|NCT02195869|468666979|FG000|Overall Study|Physician Decision|4|||
130193865|NCT02195869|468666979|FG000|Overall Study|Study Terminated by Sponsor|7|||
130193866|NCT02195869|468666979|FG000|Overall Study|Noncompliance with study drug|2|||
130193867|NCT00789698|468666980|FG000|Overall Study|Lack of Efficacy|10|||
130193868|NCT00789698|468666981|FG001|Overall Study|Lack of Efficacy|4|||
130193869|NCT00789698|468666982|FG002|Overall Study|Lack of Efficacy|5|||
130193870|NCT00789698|468666983|FG003|Overall Study|Lack of Efficacy|18|||
130193871|NCT00789698|468666980|FG000|Overall Study|Adverse Event|5|||
130193872|NCT00789698|468666981|FG001|Overall Study|Adverse Event|5|||
130193873|NCT00789698|468666982|FG002|Overall Study|Adverse Event|3|||
130193874|NCT00789698|468666983|FG003|Overall Study|Adverse Event|4|||
130193875|NCT00789698|468666980|FG000|Overall Study|Lost to Follow-up|5|||
130193876|NCT00789698|468666981|FG001|Overall Study|Lost to Follow-up|5|||
130193877|NCT00789698|468666982|FG002|Overall Study|Lost to Follow-up|2|||
130193878|NCT00789698|468666983|FG003|Overall Study|Lost to Follow-up|9|||
130193879|NCT00789698|468666980|FG000|Overall Study|Protocol Violation|6|||
130193880|NCT00789698|468666981|FG001|Overall Study|Protocol Violation|1|||
130193881|NCT00789698|468666982|FG002|Overall Study|Protocol Violation|2|||
130193882|NCT00789698|468666983|FG003|Overall Study|Protocol Violation|1|||
130193883|NCT00789698|468666980|FG000|Overall Study|Withdrawal by Subject|14|||
130193884|NCT00789698|468666981|FG001|Overall Study|Withdrawal by Subject|15|||
130193885|NCT00789698|468666982|FG002|Overall Study|Withdrawal by Subject|12|||
130193886|NCT00789698|468666983|FG003|Overall Study|Withdrawal by Subject|19|||
130193887|NCT00789698|468666980|FG000|Overall Study|Administrative|0|||
130193888|NCT00789698|468666981|FG001|Overall Study|Administrative|3|||
130193889|NCT00789698|468666982|FG002|Overall Study|Administrative|3|||
130193890|NCT00789698|468666983|FG003|Overall Study|Administrative|1|||
130193891|NCT03300505|468668847|FG000|Overall Study|Death|0|||
130193892|NCT03300505|468668848|FG001|Overall Study|Death|1|||
130193893|NCT03300505|468668849|FG002|Overall Study|Death|0|||
130193894|NCT03300505|468668847|FG000|Overall Study|Withdrawal by Subject|0|||
130193895|NCT03300505|468668848|FG001|Overall Study|Withdrawal by Subject|1|||
130193896|NCT03300505|468668849|FG002|Overall Study|Withdrawal by Subject|1|||
130193897|NCT03300505|468668847|FG000|Overall Study|Sponsor Termination|0|||
130193898|NCT03300505|468668848|FG001|Overall Study|Sponsor Termination|1|||
130193899|NCT03300505|468668849|FG002|Overall Study|Sponsor Termination|0|||
130193900|NCT03300505|468668847|FG000|Overall Study|Adverse Event|0|||
130193901|NCT03300505|468668848|FG001|Overall Study|Adverse Event|0|||
130193902|NCT03300505|468668849|FG002|Overall Study|Adverse Event|2|||
130193903|NCT05119595|468668850|FG000|Overall Study|Death|1|||
130193904|NCT05119595|468668850|FG000|Overall Study|Lost to Follow-up|7|||
130193905|NCT03056638|468668853|FG000|Overall Study|Death|1|||
130193906|NCT03056638|468668854|FG001|Overall Study|Death|0|||
130193907|NCT00468481|468668855|FG000|Overall Study|Adverse Event|13|||
130193908|NCT00468481|468668856|FG001|Overall Study|Adverse Event|3|||
130193909|NCT00468481|468668855|FG000|Overall Study|Lost to Follow-up|25|||
130193910|NCT00468481|468668856|FG001|Overall Study|Lost to Follow-up|8|||
130193911|NCT00468481|468668855|FG000|Overall Study|Pregnancy|2|||
130193912|NCT00468481|468668856|FG001|Overall Study|Pregnancy|0|||
130193913|NCT00468481|468668855|FG000|Overall Study|Protocol Violation|18|||
130193914|NCT00468481|468668856|FG001|Overall Study|Protocol Violation|8|||
130193915|NCT00468481|468668855|FG000|Overall Study|Withdrawal by Subject|12|||
130193916|NCT00468481|468668856|FG001|Overall Study|Withdrawal by Subject|3|||
130193917|NCT00468481|468668855|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
130193918|NCT00468481|468668856|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
130193919|NCT00468481|468668855|FG000|Overall Study|Prohibited Medication|1|||
130193920|NCT00468481|468668856|FG001|Overall Study|Prohibited Medication|1|||
130193921|NCT00468481|468668855|FG000|Overall Study|Egg Donor|1|||
130193922|NCT00468481|468668856|FG001|Overall Study|Egg Donor|0|||
130193923|NCT00468481|468668855|FG000|Overall Study|Moved out of area|4|||
130193924|NCT00468481|468668856|FG001|Overall Study|Moved out of area|1|||
130193925|NCT00468481|468668855|FG000|Overall Study|Non-Compliance|5|||
130193926|NCT00468481|468668856|FG001|Overall Study|Non-Compliance|0|||
130193927|NCT00468481|468668855|FG000|Overall Study|Other|6|||
130193928|NCT00468481|468668856|FG001|Overall Study|Other|0|||
130193929|NCT00734162|468668857|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130193930|NCT00734162|468668858|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
130193931|NCT00734162|468668859|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130193932|NCT00734162|468668860|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
130193933|NCT00734162|468668857|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193934|NCT00734162|468668858|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193935|NCT00734162|468668859|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193936|NCT00734162|468668860|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
130193937|NCT00734162|468668857|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
130193938|NCT00734162|468668858|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193939|NCT00734162|468668859|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193940|NCT00734162|468668860|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193941|NCT00734162|468668857|FG000|Open-Label Phase|Withdrew Consent|1|||
130193942|NCT00734162|468668858|FG001|Open-Label Phase|Withdrew Consent|0|||
130193943|NCT00734162|468668859|FG002|Open-Label Phase|Withdrew Consent|1|||
130193944|NCT00734162|468668860|FG003|Open-Label Phase|Withdrew Consent|1|||
130193945|NCT00734162|468668857|FG000|Open-Label Phase|Lost to Follow-up|1|||
130193946|NCT00734162|468668858|FG001|Open-Label Phase|Lost to Follow-up|2|||
130193947|NCT00734162|468668859|FG002|Open-Label Phase|Lost to Follow-up|0|||
130193948|NCT00734162|468668860|FG003|Open-Label Phase|Lost to Follow-up|1|||
130193949|NCT00734162|468668857|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193950|NCT00734162|468668858|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193951|NCT00734162|468668859|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193952|NCT00734162|468668860|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
130193953|NCT03831113|468668861|FG000|Overall Study|Withdrawal by Subject|0|||
130193954|NCT03831113|468668862|FG001|Overall Study|Withdrawal by Subject|2|||
130193955|NCT03831113|468668861|FG000|Overall Study|Protocol Violation|0|||
130193956|NCT03831113|468668862|FG001|Overall Study|Protocol Violation|9|||
130193957|NCT03508726|468668863|FG000|Overall Study|Withdrawal by Subject|0|||
130193958|NCT03508726|468668864|FG001|Overall Study|Withdrawal by Subject|1|||
130193959|NCT01515865|468668866|FG000|Part A (Open-label)|Other|3|||
130193960|NCT01515865|468668867|FG001|Part A (Open-label)|Other|0|||
130193961|NCT01515865|468668868|FG002|Part A (Open-label)|Other|0|||
130193962|NCT01515865|468668866|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
130193963|NCT01515865|468668867|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
130193964|NCT01515865|468668868|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
130193965|NCT01515865|468668866|FG000|Part B (Open-label)|Other|1|||
130193966|NCT01515865|468668867|FG001|Part B (Open-label)|Other|0|||
130193967|NCT01515865|468668868|FG002|Part B (Open-label)|Other|0|||
130193968|NCT01073605|468668869|FG000|Overall Study|Ongoing at Cutoff Date|1|||
130193969|NCT01073605|468668870|FG001|Overall Study|Ongoing at Cutoff Date|1|||
130193970|NCT01073605|468668871|FG002|Overall Study|Ongoing at Cutoff Date|0|||
130193971|NCT01073605|468668869|FG000|Overall Study|Adverse Event|2|||
130193972|NCT01073605|468668870|FG001|Overall Study|Adverse Event|1|||
130193973|NCT01073605|468668871|FG002|Overall Study|Adverse Event|0|||
130193974|NCT01073605|468668869|FG000|Overall Study|Lost to Follow-up|3|||
130193975|NCT01073605|468668870|FG001|Overall Study|Lost to Follow-up|4|||
130193976|NCT01073605|468668871|FG002|Overall Study|Lost to Follow-up|9|||
130193977|NCT01073605|468668869|FG000|Overall Study|Other|25|||
130193978|NCT01073605|468668870|FG001|Overall Study|Other|21|||
130193979|NCT01073605|468668871|FG002|Overall Study|Other|29|||
130193980|NCT01073605|468668869|FG000|Overall Study|Withdrawal by Subject|31|||
130193981|NCT01073605|468668870|FG001|Overall Study|Withdrawal by Subject|39|||
130193982|NCT01073605|468668871|FG002|Overall Study|Withdrawal by Subject|22|||
130193983|NCT01073605|468668869|FG000|Overall Study|Randomized But Not Treated|0|||
130193984|NCT01073605|468668870|FG001|Overall Study|Randomized But Not Treated|1|||
130193985|NCT01073605|468668871|FG002|Overall Study|Randomized But Not Treated|1|||
130193986|NCT02875613|468668874|FG000|Overall Study|Withdrawal by Subject|1|||
130193987|NCT02875613|468668874|FG000|Overall Study|Screen Failure|1|||
130193988|NCT02308540|468668876|FG000|Overall Study|Lost to Follow-up|0|||
130193989|NCT02308540|468668877|FG001|Overall Study|Lost to Follow-up|0|||
130193990|NCT02308540|468668878|FG002|Overall Study|Lost to Follow-up|0|||
130193991|NCT02308540|468668879|FG003|Overall Study|Lost to Follow-up|0|||
130193992|NCT02308540|468668880|FG004|Overall Study|Lost to Follow-up|0|||
130193993|NCT02308540|468668881|FG005|Overall Study|Lost to Follow-up|1|||
130193994|NCT02285166|468668882|FG000|Overall Study|Case Report Forms Uncollected|564|||
130193995|NCT02285166|468668882|FG000|Overall Study|Protocol Deviation|402|||
130193996|NCT00443079|468668883|FG000|Overall Study|Lost to Follow-up|0|||
130193997|NCT00443079|468668884|FG001|Overall Study|Lost to Follow-up|1|||
130193998|NCT02649439|468668885|FG000|Overall Study|Switched to alternative treatment|6|||
130193999|NCT02649439|468668886|FG001|Overall Study|Switched to alternative treatment|4|||
130194000|NCT02649439|468668885|FG000|Overall Study|Patient decision|1|||
130194001|NCT02649439|468668886|FG001|Overall Study|Patient decision|0|||
130194002|NCT02649439|468668885|FG000|Overall Study|Patient going out of country|1|||
130194003|NCT02649439|468668886|FG001|Overall Study|Patient going out of country|0|||
130194004|NCT02649439|468668885|FG000|Overall Study|To start finasteride|1|||
130194005|NCT02649439|468668886|FG001|Overall Study|To start finasteride|0|||
130194006|NCT02649439|468668885|FG000|Overall Study|Physician Decision|1|||
130194007|NCT02649439|468668886|FG001|Overall Study|Physician Decision|0|||
130194008|NCT02649439|468668885|FG000|Overall Study|Disease progression on study|12|||
130194009|NCT02649439|468668886|FG001|Overall Study|Disease progression on study|13|||
130194010|NCT02649439|468668885|FG000|Overall Study|Refused further treatment|1|||
130194011|NCT02649439|468668886|FG001|Overall Study|Refused further treatment|0|||
130194012|NCT02649439|468668885|FG000|Overall Study|Refused further follow up|2|||
130194013|NCT02649439|468668886|FG001|Overall Study|Refused further follow up|7|||
130194014|NCT02649439|468668885|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
130194015|NCT02649439|468668886|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
130194016|NCT02649439|468668885|FG000|Overall Study|No treatment, per protocol|1|||
130194017|NCT02649439|468668886|FG001|Overall Study|No treatment, per protocol|0|||
130194018|NCT02649439|468668885|FG000|Overall Study|PSA DT makes ineligible|0|||
130194019|NCT02649439|468668886|FG001|Overall Study|PSA DT makes ineligible|1|||
130194020|NCT02649439|468668885|FG000|Overall Study|Rising PSA No Mets|0|||
130194021|NCT02649439|468668886|FG001|Overall Study|Rising PSA No Mets|1|||
130194022|NCT02649439|468668885|FG000|Overall Study|Rising PSA|0|||
130194023|NCT02649439|468668886|FG001|Overall Study|Rising PSA|1|||
130194024|NCT02649439|468668885|FG000|Overall Study|Signed follow up protocol|0|||
130194025|NCT02649439|468668886|FG001|Overall Study|Signed follow up protocol|1|||
130194026|NCT00090493|468668889|FG000|Overall Study|Physician Decision|2|||
130194027|NCT02071706|468668890|FG000|Overall Study|Adverse Event|1|||
130194028|NCT02071706|468668890|FG000|Overall Study|Withdrawal by Subject|2|||
130194029|NCT01908829|468668896|FG000|Overall Study|Adverse Event|13|||
130194030|NCT01908829|468668897|FG001|Overall Study|Adverse Event|11|||
130194031|NCT01908829|468668898|FG002|Overall Study|Adverse Event|13|||
130194032|NCT01908829|468668896|FG000|Overall Study|Lost to Follow-up|4|||
130194033|NCT01908829|468668897|FG001|Overall Study|Lost to Follow-up|2|||
130194034|NCT01908829|468668898|FG002|Overall Study|Lost to Follow-up|1|||
130194035|NCT01908829|468668896|FG000|Overall Study|Randomized no double-blind drug received|1|||
130194036|NCT01908829|468668897|FG001|Overall Study|Randomized no double-blind drug received|0|||
130194037|NCT01908829|468668898|FG002|Overall Study|Randomized no double-blind drug received|1|||
130194038|NCT01908829|468668896|FG000|Overall Study|Discontinued (no EoT page)|2|||
130194039|NCT01908829|468668897|FG001|Overall Study|Discontinued (no EoT page)|0|||
130194040|NCT01908829|468668898|FG002|Overall Study|Discontinued (no EoT page)|0|||
130194041|NCT01908829|468668896|FG000|Overall Study|Miscellaneous|0|||
130194042|NCT01908829|468668897|FG001|Overall Study|Miscellaneous|2|||
130194043|NCT01908829|468668898|FG002|Overall Study|Miscellaneous|0|||
130194044|NCT01908829|468668896|FG000|Overall Study|Protocol Violation|2|||
130194045|NCT01908829|468668897|FG001|Overall Study|Protocol Violation|2|||
130194046|NCT01908829|468668898|FG002|Overall Study|Protocol Violation|0|||
130194047|NCT01908829|468668896|FG000|Overall Study|Lack of Efficacy|1|||
130194048|NCT01908829|468668897|FG001|Overall Study|Lack of Efficacy|3|||
130194049|NCT01908829|468668898|FG002|Overall Study|Lack of Efficacy|2|||
130194050|NCT01908829|468668896|FG000|Overall Study|Withdrawal by Subject|26|||
130194051|NCT01908829|468668897|FG001|Overall Study|Withdrawal by Subject|29|||
130194052|NCT01908829|468668898|FG002|Overall Study|Withdrawal by Subject|22|||
130194053|NCT02792192|468668899|FG000|Overall Study|Death|1|||
130194054|NCT02792192|468668900|FG001|Overall Study|Death|0|||
130194055|NCT02792192|468668901|FG002|Overall Study|Death|0|||
130194056|NCT02792192|468668902|FG003|Overall Study|Death|0|||
130194057|NCT02792192|468668899|FG000|Overall Study|Informed Consent Withdrawn|4|||
130194058|NCT02792192|468668900|FG001|Overall Study|Informed Consent Withdrawn|0|||
130194059|NCT02792192|468668901|FG002|Overall Study|Informed Consent Withdrawn|0|||
130194060|NCT02792192|468668902|FG003|Overall Study|Informed Consent Withdrawn|0|||
130194061|NCT02792192|468668899|FG000|Overall Study|Physician Decision|1|||
130194062|NCT02792192|468668900|FG001|Overall Study|Physician Decision|0|||
130194063|NCT02792192|468668901|FG002|Overall Study|Physician Decision|0|||
130194064|NCT02792192|468668902|FG003|Overall Study|Physician Decision|0|||
130194065|NCT02792192|468668899|FG000|Overall Study|Progressive Disease|0|||
130194066|NCT02792192|468668900|FG001|Overall Study|Progressive Disease|1|||
130194067|NCT02792192|468668901|FG002|Overall Study|Progressive Disease|0|||
130194068|NCT02792192|468668902|FG003|Overall Study|Progressive Disease|0|||
130194069|NCT02792192|468668899|FG000|Overall Study|Study Terminated By Sponsor|6|||
130194070|NCT02792192|468668900|FG001|Overall Study|Study Terminated By Sponsor|10|||
130194071|NCT02792192|468668901|FG002|Overall Study|Study Terminated By Sponsor|0|||
130194072|NCT02792192|468668902|FG003|Overall Study|Study Terminated By Sponsor|0|||
130194073|NCT02247440|468668903|FG000|Overall Study|Withdrawal by Subject|1|||
130194074|NCT02247440|468668903|FG000|Overall Study|Lack of Efficacy|3|||
130194075|NCT02320058|468668904|FG000|Overall Study|Death|25|||
130194076|NCT02320058|468668905|FG001|Overall Study|Death|10|||
130194077|NCT02320058|468668904|FG000|Overall Study|Lost to Follow-up|4|||
130194078|NCT02320058|468668905|FG001|Overall Study|Lost to Follow-up|0|||
130194079|NCT02320058|468668904|FG000|Overall Study|Other reasons|4|||
130194080|NCT02320058|468668905|FG001|Overall Study|Other reasons|1|||
130194081|NCT02320058|468668904|FG000|Overall Study|Withdrawal by Subject|8|||
130194082|NCT02320058|468668905|FG001|Overall Study|Withdrawal by Subject|2|||
130194083|NCT02320058|468668904|FG000|Overall Study|Not reported|1|||
130194084|NCT02320058|468668905|FG001|Overall Study|Not reported|0|||
130194085|NCT01339923|468668906|FG000|Overall Study|Adverse Event|1|||
130194086|NCT01339923|468668907|FG001|Overall Study|Adverse Event|1|||
130194087|NCT01339923|468668908|FG002|Overall Study|Adverse Event|1|||
130194088|NCT01339923|468668909|FG003|Overall Study|Adverse Event|0|||
130194089|NCT01339923|468668910|FG004|Overall Study|Adverse Event|0|||
130194090|NCT01339923|468668911|FG005|Overall Study|Adverse Event|0|||
130194091|NCT01339923|468668912|FG006|Overall Study|Adverse Event|1|||
130194092|NCT01339923|468668906|FG000|Overall Study|Inappropriate Enrollment|1|||
130194093|NCT01339923|468668907|FG001|Overall Study|Inappropriate Enrollment|0|||
130194094|NCT01339923|468668908|FG002|Overall Study|Inappropriate Enrollment|0|||
130194095|NCT01339923|468668909|FG003|Overall Study|Inappropriate Enrollment|0|||
130194096|NCT01339923|468668910|FG004|Overall Study|Inappropriate Enrollment|0|||
130194097|NCT01339923|468668911|FG005|Overall Study|Inappropriate Enrollment|1|||
130194098|NCT01339923|468668912|FG006|Overall Study|Inappropriate Enrollment|0|||
130194099|NCT01339923|468668906|FG000|Overall Study|Lost to Follow-up|4|||
130194100|NCT01339923|468668907|FG001|Overall Study|Lost to Follow-up|4|||
130194101|NCT01339923|468668908|FG002|Overall Study|Lost to Follow-up|0|||
130194102|NCT01339923|468668909|FG003|Overall Study|Lost to Follow-up|3|||
130194103|NCT01339923|468668910|FG004|Overall Study|Lost to Follow-up|1|||
130194104|NCT01339923|468668911|FG005|Overall Study|Lost to Follow-up|1|||
130194105|NCT01339923|468668912|FG006|Overall Study|Lost to Follow-up|5|||
130194106|NCT01339923|468668906|FG000|Overall Study|Protocol Violation|0|||
130194107|NCT01339923|468668907|FG001|Overall Study|Protocol Violation|0|||
130194108|NCT01339923|468668908|FG002|Overall Study|Protocol Violation|0|||
130194109|NCT01339923|468668909|FG003|Overall Study|Protocol Violation|0|||
130194110|NCT01339923|468668910|FG004|Overall Study|Protocol Violation|0|||
130194111|NCT01339923|468668911|FG005|Overall Study|Protocol Violation|3|||
130194112|NCT01339923|468668912|FG006|Overall Study|Protocol Violation|1|||
130194113|NCT01339923|468668906|FG000|Overall Study|Unable to Classify|1|||
130194114|NCT01339923|468668907|FG001|Overall Study|Unable to Classify|0|||
130194115|NCT01339923|468668908|FG002|Overall Study|Unable to Classify|1|||
130194116|NCT01339923|468668909|FG003|Overall Study|Unable to Classify|0|||
130194117|NCT01339923|468668910|FG004|Overall Study|Unable to Classify|0|||
130194118|NCT01339923|468668911|FG005|Overall Study|Unable to Classify|1|||
130194119|NCT01339923|468668912|FG006|Overall Study|Unable to Classify|5|||
130194120|NCT01339923|468668906|FG000|Overall Study|Withdrawal by Subject|7|||
130194121|NCT01339923|468668907|FG001|Overall Study|Withdrawal by Subject|11|||
130194122|NCT01339923|468668908|FG002|Overall Study|Withdrawal by Subject|6|||
130194123|NCT01339923|468668909|FG003|Overall Study|Withdrawal by Subject|1|||
130194124|NCT01339923|468668910|FG004|Overall Study|Withdrawal by Subject|4|||
130194125|NCT01339923|468668911|FG005|Overall Study|Withdrawal by Subject|3|||
130194126|NCT01339923|468668912|FG006|Overall Study|Withdrawal by Subject|2|||
130194127|NCT00729157|468668913|FG000|Overall Study|Withdrawal by Subject|1|||
130194128|NCT01430403|468668919|FG000|Overall Study|Lost to Follow-up|5|||
130194129|NCT01430403|468668920|FG001|Overall Study|Lost to Follow-up|5|||
130194130|NCT01430403|468668921|FG002|Overall Study|Lost to Follow-up|3|||
130194131|NCT01430403|468668919|FG000|Overall Study|Physician Decision|1|||
130194132|NCT01430403|468668920|FG001|Overall Study|Physician Decision|0|||
130194133|NCT01430403|468668921|FG002|Overall Study|Physician Decision|0|||
130194134|NCT01430403|468668919|FG000|Overall Study|Protocol Violation|2|||
130194135|NCT01430403|468668920|FG001|Overall Study|Protocol Violation|3|||
130194136|NCT01430403|468668921|FG002|Overall Study|Protocol Violation|2|||
130194137|NCT01430403|468668919|FG000|Overall Study|Withdrawal by Subject|9|||
130194138|NCT01430403|468668920|FG001|Overall Study|Withdrawal by Subject|1|||
130194139|NCT01430403|468668921|FG002|Overall Study|Withdrawal by Subject|3|||
130194140|NCT04481789|468668922|FG000|Period 1|Withdrawal by Subject|1|||
130194141|NCT04481789|468668923|FG001|Period 1|Withdrawal by Subject|0|||
130194142|NCT04481789|468668924|FG002|Period 1|Withdrawal by Subject|0|||
130194143|NCT04481789|468668925|FG003|Period 1|Withdrawal by Subject|0|||
130194144|NCT04481789|468668926|FG004|Period 1|Withdrawal by Subject|0|||
130194145|NCT04481789|468668927|FG005|Period 1|Withdrawal by Subject|0|||
130194146|NCT03124407|468668934|FG000|Overall Study|Lost to Follow-up|1|||
130194147|NCT03124407|468668935|FG001|Overall Study|Lost to Follow-up|0|||
130194148|NCT03124407|468668936|FG002|Overall Study|Lost to Follow-up|0|||
130194149|NCT03124407|468668937|FG003|Overall Study|Lost to Follow-up|0|||
130194150|NCT03124407|468668934|FG000|Overall Study|Adverse Event|0|||
130194151|NCT03124407|468668935|FG001|Overall Study|Adverse Event|0|||
130194152|NCT03124407|468668936|FG002|Overall Study|Adverse Event|1|||
130194153|NCT03124407|468668937|FG003|Overall Study|Adverse Event|0|||
130194154|NCT00396656|468668938|FG000|First Treatment Period|Withdrawal by Subject|0|||
130194155|NCT00396656|468668939|FG001|First Treatment Period|Withdrawal by Subject|2|||
130194156|NCT00396656|468668938|FG000|Second Treatment Period|Adverse Event|0|||
130194157|NCT00396656|468668939|FG001|Second Treatment Period|Adverse Event|1|||
130194158|NCT02821754|468668940|FG000|Overall Study|Procedure not required prior to amendment change|13|||
130194159|NCT02821754|468668941|FG001|Overall Study|Procedure not required prior to amendment change|11|||
130194160|NCT02821754|468668942|FG002|Overall Study|Procedure not required prior to amendment change|0|||
130194161|NCT02821754|468668940|FG000|Overall Study|Participant's Clinical status|2|||
130194162|NCT02821754|468668941|FG001|Overall Study|Participant's Clinical status|0|||
130194163|NCT02821754|468668942|FG002|Overall Study|Participant's Clinical status|0|||
130194164|NCT02821754|468668940|FG000|Overall Study|Participant removed for noncompliance|1|||
130194165|NCT02821754|468668941|FG001|Overall Study|Participant removed for noncompliance|0|||
130194166|NCT02821754|468668942|FG002|Overall Study|Participant removed for noncompliance|0|||
130194167|NCT02821754|468668940|FG000|Overall Study|Drug not available.|0|||
130194168|NCT02821754|468668941|FG001|Overall Study|Drug not available.|0|||
130194169|NCT02821754|468668942|FG002|Overall Study|Drug not available.|1|||
130194170|NCT02821754|468668940|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
130194171|NCT02821754|468668941|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
130194172|NCT02821754|468668942|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
130194173|NCT02477332|468668952|FG000|Overall Study|Adverse Event|0|||
130194174|NCT02477332|468668953|FG001|Overall Study|Adverse Event|1|||
130194175|NCT02477332|468668954|FG002|Overall Study|Adverse Event|1|||
130194176|NCT02477332|468668955|FG003|Overall Study|Adverse Event|2|||
130194177|NCT02477332|468668956|FG004|Overall Study|Adverse Event|1|||
130194178|NCT02477332|468668957|FG005|Overall Study|Adverse Event|2|||
130194179|NCT02477332|468668952|FG000|Overall Study|Lack of Efficacy|1|||
130194180|NCT02477332|468668953|FG001|Overall Study|Lack of Efficacy|2|||
130194181|NCT02477332|468668954|FG002|Overall Study|Lack of Efficacy|1|||
130194182|NCT02477332|468668955|FG003|Overall Study|Lack of Efficacy|2|||
130194183|NCT02477332|468668956|FG004|Overall Study|Lack of Efficacy|1|||
130194184|NCT02477332|468668957|FG005|Overall Study|Lack of Efficacy|1|||
130194185|NCT02477332|468668952|FG000|Overall Study|Non-compliance with study treatment|0|||
130194186|NCT02477332|468668953|FG001|Overall Study|Non-compliance with study treatment|1|||
130194187|NCT02477332|468668954|FG002|Overall Study|Non-compliance with study treatment|2|||
130194188|NCT02477332|468668955|FG003|Overall Study|Non-compliance with study treatment|0|||
130194189|NCT02477332|468668956|FG004|Overall Study|Non-compliance with study treatment|0|||
130194190|NCT02477332|468668957|FG005|Overall Study|Non-compliance with study treatment|0|||
130194191|NCT02477332|468668952|FG000|Overall Study|Pregnancy|0|||
130194192|NCT02477332|468668953|FG001|Overall Study|Pregnancy|0|||
130194193|NCT02477332|468668954|FG002|Overall Study|Pregnancy|0|||
130194194|NCT02477332|468668955|FG003|Overall Study|Pregnancy|1|||
130194195|NCT02477332|468668956|FG004|Overall Study|Pregnancy|0|||
130194196|NCT02477332|468668957|FG005|Overall Study|Pregnancy|0|||
130194197|NCT02477332|468668952|FG000|Overall Study|Protocol Violation|2|||
130194198|NCT02477332|468668953|FG001|Overall Study|Protocol Violation|0|||
130194199|NCT02477332|468668954|FG002|Overall Study|Protocol Violation|3|||
130194200|NCT02477332|468668955|FG003|Overall Study|Protocol Violation|3|||
130194201|NCT02477332|468668956|FG004|Overall Study|Protocol Violation|1|||
130194202|NCT02477332|468668957|FG005|Overall Study|Protocol Violation|1|||
130194203|NCT02477332|468668952|FG000|Overall Study|Technical problems|0|||
130194204|NCT02477332|468668953|FG001|Overall Study|Technical problems|0|||
130194205|NCT02477332|468668954|FG002|Overall Study|Technical problems|1|||
130194206|NCT02477332|468668955|FG003|Overall Study|Technical problems|0|||
130194207|NCT02477332|468668956|FG004|Overall Study|Technical problems|0|||
130194208|NCT02477332|468668957|FG005|Overall Study|Technical problems|0|||
130194209|NCT02477332|468668952|FG000|Overall Study|Lost to Follow-up|0|||
130194210|NCT02477332|468668953|FG001|Overall Study|Lost to Follow-up|0|||
130194211|NCT02477332|468668954|FG002|Overall Study|Lost to Follow-up|2|||
130194212|NCT02477332|468668955|FG003|Overall Study|Lost to Follow-up|0|||
130194213|NCT02477332|468668956|FG004|Overall Study|Lost to Follow-up|0|||
130194214|NCT02477332|468668957|FG005|Overall Study|Lost to Follow-up|0|||
130194215|NCT02477332|468668952|FG000|Overall Study|Physician Decision|0|||
130194216|NCT02477332|468668953|FG001|Overall Study|Physician Decision|0|||
130194217|NCT02477332|468668954|FG002|Overall Study|Physician Decision|1|||
130194218|NCT02477332|468668955|FG003|Overall Study|Physician Decision|3|||
130194219|NCT02477332|468668956|FG004|Overall Study|Physician Decision|0|||
130194220|NCT02477332|468668957|FG005|Overall Study|Physician Decision|1|||
130194221|NCT02477332|468668952|FG000|Overall Study|Withdrawal by Subject|0|||
130194222|NCT02477332|468668953|FG001|Overall Study|Withdrawal by Subject|3|||
130194223|NCT02477332|468668954|FG002|Overall Study|Withdrawal by Subject|1|||
130194224|NCT02477332|468668955|FG003|Overall Study|Withdrawal by Subject|2|||
130194225|NCT02477332|468668956|FG004|Overall Study|Withdrawal by Subject|1|||
130194226|NCT02477332|468668957|FG005|Overall Study|Withdrawal by Subject|0|||
130194227|NCT02549287|468668958|FG000|Overall Study|Lost to Follow-up|65|||
130194228|NCT02549287|468668959|FG001|Overall Study|Lost to Follow-up|26|||
130194229|NCT02549287|468668958|FG000|Overall Study|Withdrawal by Subject|15|||
130194230|NCT02549287|468668959|FG001|Overall Study|Withdrawal by Subject|6|||
130194231|NCT03793842|468668960|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
130194232|NCT03793842|468668961|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
130194233|NCT03793842|468668960|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
130194234|NCT03793842|468668961|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
130194235|NCT00427921|468668962|FG000|Overall Study|Adverse Event|26|||
130194236|NCT00427921|468668962|FG000|Overall Study|Withdrawal by Subject|4|||
130194237|NCT00427921|468668962|FG000|Overall Study|Lost to Follow-up|2|||
130194238|NCT00427921|468668962|FG000|Overall Study|Other reason not specified|10|||
130194239|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Hospitalization|1|||
130194240|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
130194241|NCT00427921|468668962|FG000|Overall Study|Adverse Event + No Response|1|||
130194242|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
130194243|NCT00427921|468668962|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
130194244|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Lost Response|1|||
130194245|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
130194246|NCT00427921|468668962|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
130194247|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
130194248|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
130194249|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
130194250|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
130194251|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
130194252|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
130194253|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
130194254|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
130194255|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
130194256|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
130194257|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
130194258|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
130194259|NCT00347009|468668965|FG000|Overall Study|Death|1|||
130194260|NCT00347009|468668965|FG000|Overall Study|Adverse Event|6|||
130194261|NCT00347009|468668965|FG000|Overall Study|Withdrawal by Subject|3|||
130194262|NCT00347009|468668965|FG000|Overall Study|Physician Decision|5|||
130194263|NCT00347009|468668965|FG000|Overall Study|Lost to Follow-up|4|||
130194264|NCT00347009|468668965|FG000|Overall Study|Protocol Violation|2|||
130194265|NCT00347009|468668965|FG000|Overall Study|Adverse Laboratory Experience|1|||
130194266|NCT00347009|468668965|FG000|Overall Study|Insufficient Viral Suppression|3|||
130194267|NCT00347009|468668965|FG000|Overall Study|Increased ALT/HBV DNA|1|||
130194268|NCT00347009|468668965|FG000|Overall Study|Serious Adverse Event|1|||
130194269|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Death|1|||
130194270|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Death|0|||
130194271|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
130194272|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
130194273|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
130194274|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
130194275|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
130194276|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
130194277|NCT01972438|468668967|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
130194278|NCT01972438|468668968|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
130194279|NCT01972438|468668967|FG000|Months 6-12 Study Period|Death|1|||
130194280|NCT01972438|468668968|FG001|Months 6-12 Study Period|Death|0|||
130194281|NCT01972438|468668967|FG000|Months 6-12 Study Period|Early Study Closure|2|||
130194282|NCT01972438|468668968|FG001|Months 6-12 Study Period|Early Study Closure|2|||
130194283|NCT01972438|468668967|FG000|Post Month 12 Study Period|Early Study Closure|3|||
130194284|NCT01972438|468668968|FG001|Post Month 12 Study Period|Early Study Closure|4|||
130194285|NCT01186692|468668971|FG000|Overall Study|Not Catheterized|11|||
130194286|NCT01186692|468668971|FG000|Overall Study|Futher testing contraindicated implant|19|||
130194287|NCT01186692|468668971|FG000|Overall Study|Adverse Event|2|||
130194288|NCT00596817|468668972|FG000|Open-label Period|Adverse Event|0|||
130194289|NCT00596817|468668973|FG001|Open-label Period|Adverse Event|49|||
130194290|NCT00596817|468668972|FG000|Open-label Period|Lack of Efficacy|0|||
130194291|NCT00596817|468668973|FG001|Open-label Period|Lack of Efficacy|33|||
130194292|NCT00596817|468668972|FG000|Open-label Period|Other Reasons|0|||
130194293|NCT00596817|468668973|FG001|Open-label Period|Other Reasons|65|||
130194294|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
130194295|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
130194296|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
130194297|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
130194298|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
130194299|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
130194300|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
130194301|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
130194302|NCT00596817|468668972|FG000|Double-blind Period|Adverse Event|5|||
130194303|NCT00596817|468668973|FG001|Double-blind Period|Adverse Event|16|||
130194304|NCT00596817|468668972|FG000|Double-blind Period|Lack of Efficacy|52|||
130194305|NCT00596817|468668973|FG001|Double-blind Period|Lack of Efficacy|28|||
130194306|NCT00596817|468668972|FG000|Double-blind Period|Non-compliance With Study Product|3|||
130194307|NCT00596817|468668973|FG001|Double-blind Period|Non-compliance With Study Product|4|||
130194308|NCT00596817|468668972|FG000|Double-blind Period|Protocol Violation|11|||
130194309|NCT00596817|468668973|FG001|Double-blind Period|Protocol Violation|8|||
130194310|NCT00596817|468668972|FG000|Double-blind Period|Withdrawal of Consent|7|||
130194311|NCT00596817|468668973|FG001|Double-blind Period|Withdrawal of Consent|3|||
130194312|NCT00596817|468668972|FG000|Double-blind Period|Lost to Follow-up|0|||
130194313|NCT00596817|468668973|FG001|Double-blind Period|Lost to Follow-up|2|||
130194314|NCT00596817|468668972|FG000|Double-blind Period|Other Reasons|10|||
130194315|NCT00596817|468668973|FG001|Double-blind Period|Other Reasons|18|||
130194316|NCT00679029|468670195|FG000|Overall Study|Adverse Event|3|||
130194317|NCT00679029|468670195|FG000|Overall Study|Withdrawal by Subject|1|||
130194318|NCT00679029|468670195|FG000|Overall Study|Lost to Follow-up|1|||
130194319|NCT01108341|468670196|FG000|Overall Study|Death|2|||
130194320|NCT01108341|468670196|FG000|Overall Study|Withdrawal by Subject|1|||
130194321|NCT01108341|468670196|FG000|Overall Study|Lost to Follow-up|1|||
130194322|NCT01108341|468670196|FG000|Overall Study|Other|1|||
130194323|NCT04402138|468670197|FG000|Overall Study|Progressive Disease|2|||
130194324|NCT04402138|468670197|FG000|Overall Study|Adverse Event|1|||
130194325|NCT00596687|468670200|FG000|Overall Study|< 24 hours of insulin treatment|8|||
130194326|NCT00596687|468670201|FG001|Overall Study|< 24 hours of insulin treatment|6|||
130194327|NCT00596687|468670200|FG000|Overall Study|continuous insulin infusion during TPN|2|||
130194328|NCT00596687|468670201|FG001|Overall Study|continuous insulin infusion during TPN|1|||
130194329|NCT00596687|468670200|FG000|Overall Study|Withdrawal by Subject|3|||
130194330|NCT00596687|468670201|FG001|Overall Study|Withdrawal by Subject|1|||
130194331|NCT00596687|468670200|FG000|Overall Study|cancelled surgery|1|||
130194332|NCT00596687|468670201|FG001|Overall Study|cancelled surgery|1|||
130194333|NCT01284348|468670204|FG000|Overall Study|Death|1|||
130194334|NCT01284348|468670205|FG001|Overall Study|Death|1|||
130194335|NCT01284348|468670204|FG000|Overall Study|Withdrew consent|0|||
130194336|NCT01284348|468670205|FG001|Overall Study|Withdrew consent|1|||
130194337|NCT01284348|468670204|FG000|Overall Study|Status not recorded|9|||
130194338|NCT01284348|468670205|FG001|Overall Study|Status not recorded|10|||
130194339|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
130194340|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194341|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194342|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194343|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194344|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
130194345|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194346|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194347|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194348|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194349|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
130194350|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194351|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
130194352|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130194353|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130194354|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
130194355|NCT01057810|468670216|FG000|Overall Study|Disease progression|156|||
130194356|NCT01057810|468670217|FG001|Overall Study|Disease progression|197|||
130194357|NCT01057810|468670216|FG000|Overall Study|Study drug toxicity|5|||
130194358|NCT01057810|468670217|FG001|Overall Study|Study drug toxicity|114|||
130194359|NCT01057810|468670216|FG000|Overall Study|Adverse event unrelated to study drug|13|||
130194360|NCT01057810|468670217|FG001|Overall Study|Adverse event unrelated to study drug|29|||
130194361|NCT01057810|468670216|FG000|Overall Study|Withdrawal by Subject|10|||
130194362|NCT01057810|468670217|FG001|Overall Study|Withdrawal by Subject|25|||
130194363|NCT01057810|468670216|FG000|Overall Study|Death|2|||
130194364|NCT01057810|468670217|FG001|Overall Study|Death|12|||
130194365|NCT01057810|468670216|FG000|Overall Study|Maximum clinical benefit|5|||
130194366|NCT01057810|468670217|FG001|Overall Study|Maximum clinical benefit|5|||
130194367|NCT01057810|468670216|FG000|Overall Study|Poor/non-compliance|0|||
130194368|NCT01057810|468670217|FG001|Overall Study|Poor/non-compliance|1|||
130194369|NCT01057810|468670216|FG000|Overall Study|No longer met study criteria|0|||
130194370|NCT01057810|468670217|FG001|Overall Study|No longer met study criteria|1|||
130194371|NCT01057810|468670216|FG000|Overall Study|Other|7|||
130194372|NCT01057810|468670217|FG001|Overall Study|Other|14|||
130194373|NCT02088905|468670218|FG000|Overall Study|Withdrawal by Subject|5|||
130194374|NCT02088905|468670219|FG001|Overall Study|Withdrawal by Subject|1|||
130194375|NCT01091662|468670220|FG000|Overall Study|Adverse Event|1|||
130194376|NCT01091662|468670221|FG001|Overall Study|Adverse Event|9|||
130194377|NCT01091662|468670220|FG000|Overall Study|Physician Decision|1|||
130194378|NCT01091662|468670221|FG001|Overall Study|Physician Decision|1|||
130194379|NCT01091662|468670220|FG000|Overall Study|Withdrawal by Subject|7|||
130194380|NCT01091662|468670221|FG001|Overall Study|Withdrawal by Subject|6|||
130194381|NCT01091662|468670220|FG000|Overall Study|met exit criteria|7|||
130194382|NCT01091662|468670221|FG001|Overall Study|met exit criteria|13|||
130194383|NCT01091662|468670220|FG000|Overall Study|met exclusion criteria|1|||
130194384|NCT01091662|468670221|FG001|Overall Study|met exclusion criteria|0|||
130194385|NCT01091662|468670220|FG000|Overall Study|Lost to Follow-up|0|||
130194386|NCT01091662|468670221|FG001|Overall Study|Lost to Follow-up|1|||
130194387|NCT01091662|468670220|FG000|Overall Study|Pregnancy|0|||
130194388|NCT01091662|468670221|FG001|Overall Study|Pregnancy|1|||
130194389|NCT01091662|468670220|FG000|Overall Study|Protocol Violation|0|||
130194390|NCT01091662|468670221|FG001|Overall Study|Protocol Violation|2|||
130194391|NCT01091662|468670220|FG000|Overall Study|unable to swallow capsule|0|||
130194392|NCT01091662|468670221|FG001|Overall Study|unable to swallow capsule|1|||
130194393|NCT01222520|468670222|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
130194394|NCT01222520|468670223|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
130194395|NCT01222520|468670222|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
130194396|NCT01222520|468670223|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
130194397|NCT01222520|468670222|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
130194398|NCT01222520|468670223|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
130194399|NCT01222520|468670222|FG000|Double-blind Period|Adverse Event|0|||
130194400|NCT01222520|468670223|FG001|Double-blind Period|Adverse Event|1|||
130194401|NCT01222520|468670222|FG000|Double-blind Period|Lack of Efficacy|0|||
130194402|NCT01222520|468670223|FG001|Double-blind Period|Lack of Efficacy|1|||
130194403|NCT01222520|468670222|FG000|Double-blind Period|Study medication stolen|1|||
130194404|NCT01222520|468670223|FG001|Double-blind Period|Study medication stolen|0|||
130194405|NCT04109391|468670224|FG000|Overall Study|Adverse Event|2|||
130194406|NCT04109391|468670225|FG001|Overall Study|Adverse Event|2|||
130194407|NCT04109391|468670226|FG002|Overall Study|Adverse Event|0|||
130194408|NCT04109391|468670224|FG000|Overall Study|Withdrawal by Subject|2|||
130194409|NCT04109391|468670225|FG001|Overall Study|Withdrawal by Subject|0|||
130194410|NCT04109391|468670226|FG002|Overall Study|Withdrawal by Subject|0|||
130194411|NCT04109391|468670224|FG000|Overall Study|Pregnancy|1|||
130194412|NCT04109391|468670225|FG001|Overall Study|Pregnancy|0|||
130194413|NCT04109391|468670226|FG002|Overall Study|Pregnancy|0|||
130194414|NCT04109391|468670224|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
130194415|NCT04109391|468670225|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
130194416|NCT04109391|468670226|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
130194417|NCT04109391|468670224|FG000|Overall Study|Lost to Follow-up|0|||
130194418|NCT04109391|468670225|FG001|Overall Study|Lost to Follow-up|0|||
130194419|NCT04109391|468670226|FG002|Overall Study|Lost to Follow-up|1|||
130194420|NCT04109391|468670224|FG000|Overall Study|Lack of Efficacy|2|||
130194421|NCT04109391|468670225|FG001|Overall Study|Lack of Efficacy|2|||
130194422|NCT04109391|468670226|FG002|Overall Study|Lack of Efficacy|3|||
130194423|NCT01089608|468670229|FG000|Overall Study|Adverse Event|0|||
130194424|NCT01089608|468670230|FG001|Overall Study|Adverse Event|4|||
130194425|NCT01089608|468670229|FG000|Overall Study|Lost to Follow-up|0|||
130194426|NCT01089608|468670230|FG001|Overall Study|Lost to Follow-up|2|||
130194427|NCT00384839|468670233|FG000|Overall Study|Adverse Event|4|||
130194428|NCT00384839|468670233|FG000|Overall Study|Investigator Request|1|||
130194429|NCT00384839|468670233|FG000|Overall Study|Patient Request|1|||
130194430|NCT00384839|468670233|FG000|Overall Study|Ineligible|2|||
130194431|NCT00280397|468670234|FG000|Overall Study|Adverse Event|1|||
130194432|NCT02257489|468670235|FG000|Overall Study|Withdrawal by Subject|0|||
130194433|NCT02257489|468670236|FG001|Overall Study|Withdrawal by Subject|0|||
130194434|NCT02257489|468670237|FG002|Overall Study|Withdrawal by Subject|0|||
130194435|NCT02257489|468670238|FG003|Overall Study|Withdrawal by Subject|1|||
130194436|NCT02257489|468670239|FG004|Overall Study|Withdrawal by Subject|0|||
130194437|NCT02257489|468670240|FG005|Overall Study|Withdrawal by Subject|0|||
130194438|NCT02257489|468670241|FG006|Overall Study|Withdrawal by Subject|0|||
130194439|NCT02257489|468670242|FG007|Overall Study|Withdrawal by Subject|0|||
130194440|NCT02257489|468670243|FG008|Overall Study|Withdrawal by Subject|0|||
130194441|NCT04606394|468670244|FG000|Overall Study|Withdrawal by Subject|3|||
130194442|NCT04606394|468670244|FG000|Overall Study|Exclusion criteria screen failure|12|||
130194443|NCT00955955|468670245|FG000|Overall Study|Lost to Follow-up|2|||
130194444|NCT00955955|468670246|FG001|Overall Study|Lost to Follow-up|0|||
130194445|NCT00955955|468670247|FG002|Overall Study|Lost to Follow-up|0|||
130194446|NCT03423173|468670248|FG000|Overall Study|Randomized but not vaccinated|1|||
130194447|NCT03423173|468670249|FG001|Overall Study|Randomized but not vaccinated|0|||
130194448|NCT03423173|468670250|FG002|Overall Study|Randomized but not vaccinated|2|||
130194449|NCT03423173|468670251|FG003|Overall Study|Randomized but not vaccinated|1|||
130194450|NCT03423173|468670248|FG000|Overall Study|Adverse Event|1|||
130194451|NCT03423173|468670249|FG001|Overall Study|Adverse Event|1|||
130194452|NCT03423173|468670250|FG002|Overall Study|Adverse Event|1|||
130194453|NCT03423173|468670251|FG003|Overall Study|Adverse Event|1|||
130194454|NCT03423173|468670248|FG000|Overall Study|Lost to Follow-up|10|||
130194455|NCT03423173|468670249|FG001|Overall Study|Lost to Follow-up|19|||
130194456|NCT03423173|468670250|FG002|Overall Study|Lost to Follow-up|17|||
130194457|NCT03423173|468670251|FG003|Overall Study|Lost to Follow-up|22|||
130194458|NCT03423173|468670248|FG000|Overall Study|Withdrawal of consent|4|||
130194459|NCT03423173|468670249|FG001|Overall Study|Withdrawal of consent|10|||
130194460|NCT03423173|468670250|FG002|Overall Study|Withdrawal of consent|4|||
130194461|NCT03423173|468670251|FG003|Overall Study|Withdrawal of consent|5|||
130194462|NCT03423173|468670248|FG000|Overall Study|Death|1|||
130194463|NCT03423173|468670249|FG001|Overall Study|Death|0|||
130194464|NCT03423173|468670250|FG002|Overall Study|Death|0|||
130194465|NCT03423173|468670251|FG003|Overall Study|Death|0|||
130194466|NCT03423173|468670248|FG000|Overall Study|Reason not Specified|2|||
130194467|NCT03423173|468670249|FG001|Overall Study|Reason not Specified|5|||
130194468|NCT03423173|468670250|FG002|Overall Study|Reason not Specified|3|||
130194469|NCT03423173|468670251|FG003|Overall Study|Reason not Specified|1|||
130194470|NCT03852264|468670252|FG000|Third Research Visit|Lost to Follow-up|1|||
130194471|NCT03852264|468670253|FG001|Third Research Visit|Lost to Follow-up|0|||
130194472|NCT02217410|468670259|FG000|Overall Study|Graft Loss|0|||
130194473|NCT02217410|468670260|FG001|Overall Study|Graft Loss|0|||
130194474|NCT02217410|468670261|FG002|Overall Study|Graft Loss|2|||
130194475|NCT02217410|468670259|FG000|Overall Study|Withdrawal by Subject|0|||
130194476|NCT02217410|468670260|FG001|Overall Study|Withdrawal by Subject|0|||
130194477|NCT02217410|468670261|FG002|Overall Study|Withdrawal by Subject|2|||
130194478|NCT02217410|468670259|FG000|Overall Study|Lost to Follow-up|0|||
130194479|NCT02217410|468670260|FG001|Overall Study|Lost to Follow-up|0|||
130194480|NCT02217410|468670261|FG002|Overall Study|Lost to Follow-up|1|||
130194481|NCT02217410|468670259|FG000|Overall Study|Lack of Efficacy|0|||
130194482|NCT02217410|468670260|FG001|Overall Study|Lack of Efficacy|1|||
130194483|NCT02217410|468670261|FG002|Overall Study|Lack of Efficacy|0|||
130194484|NCT02217410|468670259|FG000|Overall Study|Physician Decision|1|||
130194485|NCT02217410|468670260|FG001|Overall Study|Physician Decision|3|||
130194486|NCT02217410|468670261|FG002|Overall Study|Physician Decision|0|||
130194487|NCT00661609|468670263|FG000|Overall Study|Adverse Event|4|||
130194488|NCT00661609|468670263|FG000|Overall Study|Death|20|||
130194489|NCT00661609|468670263|FG000|Overall Study|Withdrawal by Subject|2|||
130194490|NCT00661609|468670263|FG000|Overall Study|PI Decision|1|||
130194491|NCT00661609|468670263|FG000|Overall Study|Survival follow up stage discontinued|11|||
130194492|NCT00661609|468670263|FG000|Overall Study|Disease progression|3|||
130194493|NCT00637000|468670264|FG000|Overall Study|Withdrawal by Subject|4|||
130194494|NCT00637000|468670265|FG001|Overall Study|Withdrawal by Subject|3|||
130194495|NCT02751450|468670268|FG000|Overall Study|Adverse Event|1|||
130194496|NCT02751450|468670269|FG001|Overall Study|Adverse Event|0|||
130194497|NCT01290679|468670270|FG000|Overall Study|Adverse Event|2|||
130194498|NCT01290679|468670271|FG001|Overall Study|Adverse Event|0|||
130194499|NCT01290679|468670270|FG000|Overall Study|Lost to Follow-up|8|||
130194500|NCT01290679|468670271|FG001|Overall Study|Lost to Follow-up|10|||
130194501|NCT01290679|468670270|FG000|Overall Study|Protocol Violation|0|||
130194502|NCT01290679|468670271|FG001|Overall Study|Protocol Violation|1|||
130194503|NCT01290679|468670270|FG000|Overall Study|Withdrawal by Subject|6|||
130194504|NCT01290679|468670271|FG001|Overall Study|Withdrawal by Subject|5|||
130194505|NCT01290679|468670270|FG000|Overall Study|Subject Entered Another Trial|0|||
130194506|NCT01290679|468670271|FG001|Overall Study|Subject Entered Another Trial|5|||
130194507|NCT00562302|468670272|FG000|Overall Study|Lost to Follow-up|3|||
130194508|NCT00562302|468670273|FG001|Overall Study|Lost to Follow-up|3|||
130194509|NCT00562302|468670272|FG000|Overall Study|Adverse Event|0|||
130194510|NCT00562302|468670273|FG001|Overall Study|Adverse Event|6|||
130194511|NCT00562302|468670272|FG000|Overall Study|Non-compliance|1|||
130194512|NCT00562302|468670273|FG001|Overall Study|Non-compliance|2|||
130194513|NCT00562302|468670272|FG000|Overall Study|Withdrawal by Subject|7|||
130194514|NCT00562302|468670273|FG001|Overall Study|Withdrawal by Subject|8|||
130194515|NCT00562302|468670272|FG000|Overall Study|Death|1|||
130194516|NCT00562302|468670273|FG001|Overall Study|Death|2|||
130194517|NCT00562302|468670272|FG000|Overall Study|Lung resection prior to study completion|7|||
130194518|NCT00562302|468670273|FG001|Overall Study|Lung resection prior to study completion|7|||
130194519|NCT00562302|468670272|FG000|Overall Study|Not stated|1|||
130194520|NCT00562302|468670273|FG001|Overall Study|Not stated|4|||
130194521|NCT01855243|468670274|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
130194522|NCT01855243|468670275|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
130194523|NCT01855243|468670276|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
130194524|NCT03315286|468670277|FG000|Overall Study|Lost to Follow-up|0|||
130194525|NCT03315286|468670278|FG001|Overall Study|Lost to Follow-up|3|||
130194526|NCT03315286|468670277|FG000|Overall Study|Withdrawal by Subject|1|||
130194527|NCT03315286|468670278|FG001|Overall Study|Withdrawal by Subject|0|||
130194528|NCT03315286|468670277|FG000|Overall Study|Protocol Violation|0|||
130194529|NCT03315286|468670278|FG001|Overall Study|Protocol Violation|1|||
130194530|NCT03075891|468670279|FG000|Overall Study|Withdrawal by Subject|3|||
130194531|NCT03075891|468670280|FG001|Overall Study|Withdrawal by Subject|6|||
130194532|NCT03075891|468670279|FG000|Overall Study|Lost to Follow-up|1|||
130194533|NCT03075891|468670280|FG001|Overall Study|Lost to Follow-up|0|||
130194534|NCT03075891|468670279|FG000|Overall Study|Pregnancy|3|||
130194535|NCT03075891|468670280|FG001|Overall Study|Pregnancy|1|||
130194536|NCT03075891|468670279|FG000|Overall Study|visits not performed (no time)|1|||
130194537|NCT03075891|468670280|FG001|Overall Study|visits not performed (no time)|0|||
130194538|NCT03075891|468670279|FG000|Overall Study|Drug abuse relapse issue|0|||
130194539|NCT03075891|468670280|FG001|Overall Study|Drug abuse relapse issue|1|||
130194540|NCT03075891|468670279|FG000|Overall Study|Participant requiring study withdrawal|0|||
130194541|NCT03075891|468670280|FG001|Overall Study|Participant requiring study withdrawal|1|||
130194542|NCT03075891|468670279|FG000|Overall Study|Adverse event, non-fatal|1|||
130194543|NCT03075891|468670280|FG001|Overall Study|Adverse event, non-fatal|4|||
130194544|NCT00828568|468670283|FG000|Randomized|Withdrawal by Subject|1|||
130194545|NCT00828568|468670284|FG001|Randomized|Withdrawal by Subject|0|||
130194546|NCT00828568|468670285|FG002|Randomized|Withdrawal by Subject|2|||
130194547|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
130194548|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
130194549|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
130194550|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
130194551|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
130194552|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
130194553|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130194554|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
130194555|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130194556|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
130194557|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
130194558|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
130194559|NCT03474731|468670286|FG000|Overall Study|Withdrawal by Subject|36|||
130194560|NCT03474731|468670287|FG001|Overall Study|Withdrawal by Subject|29|||
130194561|NCT03474731|468670288|FG002|Overall Study|Withdrawal by Subject|11|||
130194562|NCT03474731|468670289|FG003|Overall Study|Withdrawal by Subject|27|||
130194563|NCT03474731|468670286|FG000|Overall Study|COVID|0|||
130194564|NCT03474731|468670287|FG001|Overall Study|COVID|23|||
130194565|NCT03474731|468670288|FG002|Overall Study|COVID|0|||
130194566|NCT03474731|468670289|FG003|Overall Study|COVID|0|||
130194567|NCT03474731|468670286|FG000|Overall Study|Participant moved from area|1|||
130194568|NCT03474731|468670287|FG001|Overall Study|Participant moved from area|0|||
130194569|NCT03474731|468670288|FG002|Overall Study|Participant moved from area|0|||
130194570|NCT03474731|468670289|FG003|Overall Study|Participant moved from area|0|||
130194571|NCT03474731|468670286|FG000|Overall Study|Lost to Follow-up|11|||
130194572|NCT03474731|468670287|FG001|Overall Study|Lost to Follow-up|3|||
130194573|NCT03474731|468670288|FG002|Overall Study|Lost to Follow-up|18|||
130194574|NCT03474731|468670289|FG003|Overall Study|Lost to Follow-up|17|||
130194575|NCT03474731|468670286|FG000|Overall Study|Death|0|||
130194576|NCT03474731|468670287|FG001|Overall Study|Death|1|||
130194577|NCT03474731|468670288|FG002|Overall Study|Death|0|||
130194578|NCT03474731|468670289|FG003|Overall Study|Death|0|||
130194579|NCT03474731|468670286|FG000|Overall Study|Participant Removed|0|||
130194580|NCT03474731|468670287|FG001|Overall Study|Participant Removed|0|||
130194581|NCT03474731|468670288|FG002|Overall Study|Participant Removed|0|||
130194582|NCT03474731|468670289|FG003|Overall Study|Participant Removed|1|||
130194583|NCT00766636|468670290|FG000|Overall Study|Withdrawal by Subject|1|||
130194584|NCT00766636|468670291|FG001|Overall Study|Withdrawal by Subject|1|||
130194585|NCT00766636|468670290|FG000|Overall Study|Incomplete Treatment|0|||
130194586|NCT00766636|468670291|FG001|Overall Study|Incomplete Treatment|1|||
130194587|NCT00766636|468670290|FG000|Overall Study|Adverse Event|1|||
130194588|NCT00766636|468670291|FG001|Overall Study|Adverse Event|0|||
130194589|NCT00766636|468670290|FG000|Overall Study|Disease Progression|1|||
130194590|NCT00766636|468670291|FG001|Overall Study|Disease Progression|0|||
130194591|NCT04657198|468670292|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
130194592|NCT04657198|468670293|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130194593|NCT04657198|468670294|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130194594|NCT01075256|468670297|FG000|Overall Study|Withdrawal by Subject|1|||
130194595|NCT01075256|468670298|FG001|Overall Study|Withdrawal by Subject|0|||
130194596|NCT01075256|468670299|FG002|Overall Study|Withdrawal by Subject|0|||
130194597|NCT00765336|468670300|FG000|Overall Study|Protocol Violation|4|||
130194598|NCT00765336|468670301|FG001|Overall Study|Protocol Violation|2|||
130194599|NCT00765336|468670300|FG000|Overall Study|Withdrawal by Subject|6|||
130194600|NCT00765336|468670301|FG001|Overall Study|Withdrawal by Subject|4|||
130194601|NCT00765336|468670300|FG000|Overall Study|Lost to Follow-up|7|||
130194602|NCT00765336|468670301|FG001|Overall Study|Lost to Follow-up|9|||
130194603|NCT00765336|468670300|FG000|Overall Study|Adverse Event|2|||
130194604|NCT00765336|468670301|FG001|Overall Study|Adverse Event|1|||
130194605|NCT02858583|468670302|FG000|Overall Study|Declined consent|1|||
130194606|NCT02858583|468670303|FG001|Overall Study|Declined consent|1|||
130194607|NCT01218087|468670304|FG000|Overall Study|Death|2|||
130194608|NCT01218087|468670305|FG001|Overall Study|Death|1|||
130194609|NCT01218087|468670304|FG000|Overall Study|Withdrawal by Subject|5|||
130194610|NCT01218087|468670305|FG001|Overall Study|Withdrawal by Subject|0|||
130194611|NCT01218087|468670304|FG000|Overall Study|Transferred|8|||
130194612|NCT01218087|468670305|FG001|Overall Study|Transferred|5|||
130194613|NCT01314872|468670311|FG000|Treatment Period 1|Protocol Violation|2|||
130194614|NCT01314872|468670312|FG001|Treatment Period 1|Protocol Violation|1|||
130194615|NCT01314872|468670313|FG002|Treatment Period 1|Protocol Violation|1|||
130194616|NCT01314872|468670314|FG003|Treatment Period 1|Protocol Violation|0|||
130194617|NCT01314872|468670315|FG004|Treatment Period 1|Protocol Violation|1|||
130194618|NCT01314872|468670316|FG005|Treatment Period 1|Protocol Violation|0|||
130194619|NCT01314872|468670317|FG006|Treatment Period 1|Protocol Violation|0|||
130194620|NCT01314872|468670318|FG007|Treatment Period 1|Protocol Violation|0|||
130194621|NCT01314872|468670319|FG008|Treatment Period 1|Protocol Violation|0|||
130194622|NCT01314872|468670320|FG009|Treatment Period 1|Protocol Violation|1|||
130194623|NCT01314872|468670321|FG010|Treatment Period 1|Protocol Violation|1|||
130194624|NCT01314872|468670322|FG011|Treatment Period 1|Protocol Violation|0|||
130194625|NCT01314872|468670323|FG012|Treatment Period 1|Protocol Violation|0|||
130194626|NCT01314872|468670324|FG013|Treatment Period 1|Protocol Violation|0|||
130194627|NCT01314872|468670325|FG014|Treatment Period 1|Protocol Violation|0|||
130194628|NCT01314872|468670311|FG000|Treatment Period 1|Physician Decision|0|||
130194629|NCT01314872|468670312|FG001|Treatment Period 1|Physician Decision|1|||
130194630|NCT01314872|468670313|FG002|Treatment Period 1|Physician Decision|0|||
130194631|NCT01314872|468670314|FG003|Treatment Period 1|Physician Decision|1|||
130194632|NCT01314872|468670315|FG004|Treatment Period 1|Physician Decision|0|||
130194633|NCT01314872|468670316|FG005|Treatment Period 1|Physician Decision|0|||
130194634|NCT01314872|468670317|FG006|Treatment Period 1|Physician Decision|0|||
130194635|NCT01314872|468670318|FG007|Treatment Period 1|Physician Decision|0|||
130194636|NCT01314872|468670319|FG008|Treatment Period 1|Physician Decision|0|||
130194637|NCT01314872|468670320|FG009|Treatment Period 1|Physician Decision|1|||
130194638|NCT01314872|468670321|FG010|Treatment Period 1|Physician Decision|0|||
130194639|NCT01314872|468670322|FG011|Treatment Period 1|Physician Decision|0|||
130194640|NCT01314872|468670323|FG012|Treatment Period 1|Physician Decision|0|||
130194641|NCT01314872|468670324|FG013|Treatment Period 1|Physician Decision|0|||
130194642|NCT01314872|468670325|FG014|Treatment Period 1|Physician Decision|0|||
130194643|NCT01314872|468670311|FG000|Treatment Period 1|Lack of Efficacy|1|||
130194644|NCT01314872|468670312|FG001|Treatment Period 1|Lack of Efficacy|0|||
130194645|NCT01314872|468670313|FG002|Treatment Period 1|Lack of Efficacy|0|||
130194646|NCT01314872|468670314|FG003|Treatment Period 1|Lack of Efficacy|0|||
130194647|NCT01314872|468670315|FG004|Treatment Period 1|Lack of Efficacy|0|||
130194648|NCT01314872|468670316|FG005|Treatment Period 1|Lack of Efficacy|1|||
130194649|NCT01314872|468670317|FG006|Treatment Period 1|Lack of Efficacy|0|||
130194650|NCT01314872|468670318|FG007|Treatment Period 1|Lack of Efficacy|2|||
130194651|NCT01314872|468670319|FG008|Treatment Period 1|Lack of Efficacy|0|||
130194652|NCT01314872|468670320|FG009|Treatment Period 1|Lack of Efficacy|0|||
130194653|NCT01314872|468670321|FG010|Treatment Period 1|Lack of Efficacy|0|||
130194654|NCT01314872|468670322|FG011|Treatment Period 1|Lack of Efficacy|0|||
130194655|NCT01314872|468670323|FG012|Treatment Period 1|Lack of Efficacy|0|||
130194656|NCT01314872|468670324|FG013|Treatment Period 1|Lack of Efficacy|0|||
130194657|NCT01314872|468670325|FG014|Treatment Period 1|Lack of Efficacy|0|||
130194658|NCT01314872|468670311|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
130194659|NCT01314872|468670312|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
130194660|NCT01314872|468670313|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
130194661|NCT01314872|468670314|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
130194662|NCT01314872|468670315|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
130194663|NCT01314872|468670316|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
130194664|NCT01314872|468670317|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
130194665|NCT01314872|468670318|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
130194666|NCT01314872|468670319|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
130194667|NCT01314872|468670320|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
130194668|NCT01314872|468670321|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
130194669|NCT01314872|468670322|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
130194670|NCT01314872|468670323|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
130194671|NCT01314872|468670324|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
130194672|NCT01314872|468670325|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
130194673|NCT01314872|468670311|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130194674|NCT01314872|468670312|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130194675|NCT01314872|468670313|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130194676|NCT01314872|468670314|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130194677|NCT01314872|468670315|FG004|Treatment Period 1|Withdrawal by Subject|3|||
130194678|NCT01314872|468670316|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130194679|NCT01314872|468670317|FG006|Treatment Period 1|Withdrawal by Subject|3|||
130194680|NCT01314872|468670318|FG007|Treatment Period 1|Withdrawal by Subject|2|||
130194681|NCT01314872|468670319|FG008|Treatment Period 1|Withdrawal by Subject|2|||
130194682|NCT01314872|468670320|FG009|Treatment Period 1|Withdrawal by Subject|2|||
130194683|NCT01314872|468670321|FG010|Treatment Period 1|Withdrawal by Subject|1|||
130194684|NCT01314872|468670322|FG011|Treatment Period 1|Withdrawal by Subject|0|||
130194685|NCT01314872|468670323|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130194686|NCT01314872|468670324|FG013|Treatment Period 1|Withdrawal by Subject|0|||
130194687|NCT01314872|468670325|FG014|Treatment Period 1|Withdrawal by Subject|0|||
130194688|NCT01314872|468670311|FG000|Treatment Period 1|Lost to Follow-up|0|||
130194689|NCT01314872|468670312|FG001|Treatment Period 1|Lost to Follow-up|1|||
130194690|NCT01314872|468670313|FG002|Treatment Period 1|Lost to Follow-up|2|||
130194691|NCT01314872|468670314|FG003|Treatment Period 1|Lost to Follow-up|2|||
130194692|NCT01314872|468670315|FG004|Treatment Period 1|Lost to Follow-up|1|||
130194693|NCT01314872|468670316|FG005|Treatment Period 1|Lost to Follow-up|1|||
130194694|NCT01314872|468670317|FG006|Treatment Period 1|Lost to Follow-up|1|||
130194695|NCT01314872|468670318|FG007|Treatment Period 1|Lost to Follow-up|1|||
130194696|NCT01314872|468670319|FG008|Treatment Period 1|Lost to Follow-up|1|||
130194697|NCT01314872|468670320|FG009|Treatment Period 1|Lost to Follow-up|0|||
130194698|NCT01314872|468670321|FG010|Treatment Period 1|Lost to Follow-up|0|||
130194699|NCT01314872|468670322|FG011|Treatment Period 1|Lost to Follow-up|0|||
130194700|NCT01314872|468670323|FG012|Treatment Period 1|Lost to Follow-up|0|||
130194701|NCT01314872|468670324|FG013|Treatment Period 1|Lost to Follow-up|0|||
130194702|NCT01314872|468670325|FG014|Treatment Period 1|Lost to Follow-up|0|||
130194703|NCT01314872|468670311|FG000|Period 2|Protocol Violation|0|||
130194704|NCT01314872|468670312|FG001|Period 2|Protocol Violation|0|||
130194705|NCT01314872|468670313|FG002|Period 2|Protocol Violation|0|||
130194706|NCT01314872|468670314|FG003|Period 2|Protocol Violation|0|||
130194707|NCT01314872|468670315|FG004|Period 2|Protocol Violation|0|||
130194708|NCT01314872|468670316|FG005|Period 2|Protocol Violation|0|||
130194709|NCT01314872|468670317|FG006|Period 2|Protocol Violation|0|||
130194710|NCT01314872|468670318|FG007|Period 2|Protocol Violation|0|||
130194711|NCT01314872|468670319|FG008|Period 2|Protocol Violation|0|||
130194712|NCT01314872|468670320|FG009|Period 2|Protocol Violation|0|||
130194713|NCT01314872|468670321|FG010|Period 2|Protocol Violation|0|||
130194714|NCT01314872|468670322|FG011|Period 2|Protocol Violation|3|||
130194715|NCT01314872|468670323|FG012|Period 2|Protocol Violation|3|||
130194716|NCT01314872|468670324|FG013|Period 2|Protocol Violation|2|||
130194717|NCT01314872|468670325|FG014|Period 2|Protocol Violation|0|||
130194718|NCT01314872|468670311|FG000|Period 2|Non-compliance with study drug|0|||
130194719|NCT01314872|468670312|FG001|Period 2|Non-compliance with study drug|0|||
130194720|NCT01314872|468670313|FG002|Period 2|Non-compliance with study drug|0|||
130194721|NCT01314872|468670314|FG003|Period 2|Non-compliance with study drug|0|||
130194722|NCT01314872|468670315|FG004|Period 2|Non-compliance with study drug|0|||
130194723|NCT01314872|468670316|FG005|Period 2|Non-compliance with study drug|0|||
130194724|NCT01314872|468670317|FG006|Period 2|Non-compliance with study drug|0|||
130194725|NCT01314872|468670318|FG007|Period 2|Non-compliance with study drug|0|||
130194726|NCT01314872|468670319|FG008|Period 2|Non-compliance with study drug|0|||
130194727|NCT01314872|468670320|FG009|Period 2|Non-compliance with study drug|0|||
130194728|NCT01314872|468670321|FG010|Period 2|Non-compliance with study drug|0|||
130194729|NCT01314872|468670322|FG011|Period 2|Non-compliance with study drug|3|||
130194730|NCT01314872|468670323|FG012|Period 2|Non-compliance with study drug|3|||
130194731|NCT01314872|468670324|FG013|Period 2|Non-compliance with study drug|1|||
130194732|NCT01314872|468670325|FG014|Period 2|Non-compliance with study drug|2|||
130194733|NCT01314872|468670311|FG000|Period 2|Lack of Efficacy|0|||
130194734|NCT01314872|468670312|FG001|Period 2|Lack of Efficacy|0|||
130194735|NCT01314872|468670313|FG002|Period 2|Lack of Efficacy|0|||
130194736|NCT01314872|468670314|FG003|Period 2|Lack of Efficacy|0|||
130194737|NCT01314872|468670315|FG004|Period 2|Lack of Efficacy|0|||
130194738|NCT01314872|468670316|FG005|Period 2|Lack of Efficacy|0|||
130194739|NCT01314872|468670317|FG006|Period 2|Lack of Efficacy|0|||
130194740|NCT01314872|468670318|FG007|Period 2|Lack of Efficacy|0|||
130194741|NCT01314872|468670319|FG008|Period 2|Lack of Efficacy|0|||
130194742|NCT01314872|468670320|FG009|Period 2|Lack of Efficacy|0|||
130194743|NCT01314872|468670321|FG010|Period 2|Lack of Efficacy|0|||
130194744|NCT01314872|468670322|FG011|Period 2|Lack of Efficacy|7|||
130194745|NCT01314872|468670323|FG012|Period 2|Lack of Efficacy|12|||
130194746|NCT01314872|468670324|FG013|Period 2|Lack of Efficacy|9|||
130194747|NCT01314872|468670325|FG014|Period 2|Lack of Efficacy|2|||
130194748|NCT01314872|468670311|FG000|Period 2|Pregnancy|0|||
130194749|NCT01314872|468670312|FG001|Period 2|Pregnancy|0|||
130194750|NCT01314872|468670313|FG002|Period 2|Pregnancy|0|||
130194751|NCT01314872|468670314|FG003|Period 2|Pregnancy|0|||
130194752|NCT01314872|468670315|FG004|Period 2|Pregnancy|0|||
130194753|NCT01314872|468670316|FG005|Period 2|Pregnancy|0|||
130194754|NCT01314872|468670317|FG006|Period 2|Pregnancy|0|||
130194755|NCT01314872|468670318|FG007|Period 2|Pregnancy|0|||
130194756|NCT01314872|468670319|FG008|Period 2|Pregnancy|0|||
130194757|NCT01314872|468670320|FG009|Period 2|Pregnancy|0|||
130194758|NCT01314872|468670321|FG010|Period 2|Pregnancy|0|||
130194759|NCT01314872|468670322|FG011|Period 2|Pregnancy|0|||
130194760|NCT01314872|468670323|FG012|Period 2|Pregnancy|0|||
130194761|NCT01314872|468670324|FG013|Period 2|Pregnancy|0|||
130194762|NCT01314872|468670325|FG014|Period 2|Pregnancy|1|||
130194763|NCT01314872|468670311|FG000|Period 2|Study terminated by Sponsor|0|||
130194764|NCT01314872|468670312|FG001|Period 2|Study terminated by Sponsor|0|||
130194765|NCT01314872|468670313|FG002|Period 2|Study terminated by Sponsor|0|||
130194766|NCT01314872|468670314|FG003|Period 2|Study terminated by Sponsor|0|||
130194767|NCT01314872|468670315|FG004|Period 2|Study terminated by Sponsor|0|||
130194768|NCT01314872|468670316|FG005|Period 2|Study terminated by Sponsor|0|||
130194769|NCT01314872|468670317|FG006|Period 2|Study terminated by Sponsor|0|||
130194770|NCT01314872|468670318|FG007|Period 2|Study terminated by Sponsor|0|||
130194771|NCT01314872|468670319|FG008|Period 2|Study terminated by Sponsor|0|||
130194772|NCT01314872|468670320|FG009|Period 2|Study terminated by Sponsor|0|||
130194773|NCT01314872|468670321|FG010|Period 2|Study terminated by Sponsor|0|||
130194774|NCT01314872|468670322|FG011|Period 2|Study terminated by Sponsor|2|||
130194775|NCT01314872|468670323|FG012|Period 2|Study terminated by Sponsor|2|||
130194776|NCT01314872|468670324|FG013|Period 2|Study terminated by Sponsor|3|||
130194777|NCT01314872|468670325|FG014|Period 2|Study terminated by Sponsor|0|||
130194778|NCT01314872|468670311|FG000|Period 2|Adverse event, non-fatal|0|||
130194779|NCT01314872|468670312|FG001|Period 2|Adverse event, non-fatal|0|||
130194780|NCT01314872|468670313|FG002|Period 2|Adverse event, non-fatal|0|||
130194781|NCT01314872|468670314|FG003|Period 2|Adverse event, non-fatal|0|||
130194782|NCT01314872|468670315|FG004|Period 2|Adverse event, non-fatal|0|||
130194783|NCT01314872|468670316|FG005|Period 2|Adverse event, non-fatal|0|||
130194784|NCT01314872|468670317|FG006|Period 2|Adverse event, non-fatal|0|||
130194785|NCT01314872|468670318|FG007|Period 2|Adverse event, non-fatal|0|||
130194786|NCT01314872|468670319|FG008|Period 2|Adverse event, non-fatal|0|||
130194787|NCT01314872|468670320|FG009|Period 2|Adverse event, non-fatal|0|||
130194788|NCT01314872|468670321|FG010|Period 2|Adverse event, non-fatal|0|||
130194789|NCT01314872|468670322|FG011|Period 2|Adverse event, non-fatal|13|||
130194790|NCT01314872|468670323|FG012|Period 2|Adverse event, non-fatal|16|||
130194791|NCT01314872|468670324|FG013|Period 2|Adverse event, non-fatal|24|||
130194792|NCT01314872|468670325|FG014|Period 2|Adverse event, non-fatal|9|||
130194793|NCT01314872|468670311|FG000|Period 2|Withdrawal by Subject|0|||
130194794|NCT01314872|468670312|FG001|Period 2|Withdrawal by Subject|0|||
130194795|NCT01314872|468670313|FG002|Period 2|Withdrawal by Subject|0|||
130194796|NCT01314872|468670314|FG003|Period 2|Withdrawal by Subject|0|||
130194797|NCT01314872|468670315|FG004|Period 2|Withdrawal by Subject|0|||
130194798|NCT01314872|468670316|FG005|Period 2|Withdrawal by Subject|0|||
130194799|NCT01314872|468670317|FG006|Period 2|Withdrawal by Subject|0|||
130194800|NCT01314872|468670318|FG007|Period 2|Withdrawal by Subject|0|||
130194801|NCT01314872|468670319|FG008|Period 2|Withdrawal by Subject|0|||
130194802|NCT01314872|468670320|FG009|Period 2|Withdrawal by Subject|0|||
130194803|NCT01314872|468670321|FG010|Period 2|Withdrawal by Subject|0|||
130194804|NCT01314872|468670322|FG011|Period 2|Withdrawal by Subject|14|||
130194805|NCT01314872|468670323|FG012|Period 2|Withdrawal by Subject|17|||
130194806|NCT01314872|468670324|FG013|Period 2|Withdrawal by Subject|12|||
130194807|NCT01314872|468670325|FG014|Period 2|Withdrawal by Subject|4|||
130194808|NCT01314872|468670311|FG000|Period 2|Lost to Follow-up|0|||
130194809|NCT01314872|468670312|FG001|Period 2|Lost to Follow-up|0|||
130194810|NCT01314872|468670313|FG002|Period 2|Lost to Follow-up|0|||
130194811|NCT01314872|468670314|FG003|Period 2|Lost to Follow-up|0|||
130194812|NCT01314872|468670315|FG004|Period 2|Lost to Follow-up|0|||
130194813|NCT01314872|468670316|FG005|Period 2|Lost to Follow-up|0|||
130194814|NCT01314872|468670317|FG006|Period 2|Lost to Follow-up|0|||
130194815|NCT01314872|468670318|FG007|Period 2|Lost to Follow-up|0|||
130194816|NCT01314872|468670319|FG008|Period 2|Lost to Follow-up|0|||
130194817|NCT01314872|468670320|FG009|Period 2|Lost to Follow-up|0|||
130194818|NCT01314872|468670321|FG010|Period 2|Lost to Follow-up|0|||
130194819|NCT01314872|468670322|FG011|Period 2|Lost to Follow-up|6|||
130194820|NCT01314872|468670323|FG012|Period 2|Lost to Follow-up|7|||
130194821|NCT01314872|468670324|FG013|Period 2|Lost to Follow-up|2|||
130194822|NCT01314872|468670325|FG014|Period 2|Lost to Follow-up|6|||
130194823|NCT03232931|468671737|FG000|Overall Study|Physician Decision|1|||
130194824|NCT03232931|468671738|FG001|Overall Study|Physician Decision|1|||
130194825|NCT03232931|468671737|FG000|Overall Study|Withdrawal by Subject|6|||
130194826|NCT03232931|468671738|FG001|Overall Study|Withdrawal by Subject|0|||
130194827|NCT03232931|468671737|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
130194828|NCT03232931|468671738|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
130194829|NCT03232931|468671737|FG000|Overall Study|Parent did not record voice|1|||
130194830|NCT03232931|468671738|FG001|Overall Study|Parent did not record voice|2|||
130194831|NCT03232931|468671737|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
130194832|NCT03232931|468671738|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
130194833|NCT04925557|468671739|FG000|Overall Study|Study closed|5|||
130194834|NCT04925557|468671740|FG001|Overall Study|Study closed|3|||
130194835|NCT05488470|468671741|FG000|Overall Study|Physician Decision|2|||
130194836|NCT05488470|468671741|FG000|Overall Study|Withdrawal by Subject|1|||
130194837|NCT05488470|468671741|FG000|Overall Study|Death|1|||
130194838|NCT04390503|468671748|FG000|Overall Study|Physician Decision|2|||
130194839|NCT04390503|468671749|FG001|Overall Study|Physician Decision|1|||
130194840|NCT04390503|468671748|FG000|Overall Study|Adverse Event|1|||
130194841|NCT04390503|468671749|FG001|Overall Study|Adverse Event|0|||
130194842|NCT01068730|468671751|FG000|Period 3|Personal reason|1|||
130194843|NCT01068730|468671752|FG001|Period 3|Personal reason|0|||
130194844|NCT01068730|468671753|FG002|Period 3|Personal reason|0|||
130194845|NCT01068730|468671754|FG003|Period 3|Personal reason|0|||
130194846|NCT01068730|468671751|FG000|Period 4|Family emergency|0|||
130194847|NCT01068730|468671752|FG001|Period 4|Family emergency|1|||
130194848|NCT01068730|468671753|FG002|Period 4|Family emergency|0|||
130194849|NCT01068730|468671754|FG003|Period 4|Family emergency|0|||
130194850|NCT00594100|468671758|FG000|Procedure|Technical Failure|9|||
130194851|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
130194852|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
130194853|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
130194854|NCT01270464|468671759|FG000|Overall Study|Protocol Violation|4|||
130194855|NCT01270464|468671760|FG001|Overall Study|Protocol Violation|3|||
130194856|NCT01270464|468671761|FG002|Overall Study|Protocol Violation|2|||
130194857|NCT01270464|468671759|FG000|Overall Study|Lack of Efficacy|2|||
130194858|NCT01270464|468671760|FG001|Overall Study|Lack of Efficacy|3|||
130194859|NCT01270464|468671761|FG002|Overall Study|Lack of Efficacy|1|||
130194860|NCT01270464|468671759|FG000|Overall Study|Adverse Event|9|||
130194861|NCT01270464|468671760|FG001|Overall Study|Adverse Event|1|||
130194862|NCT01270464|468671761|FG002|Overall Study|Adverse Event|7|||
130194863|NCT01270464|468671759|FG000|Overall Study|Withdrawal by Subject|2|||
130194864|NCT01270464|468671760|FG001|Overall Study|Withdrawal by Subject|1|||
130194865|NCT01270464|468671761|FG002|Overall Study|Withdrawal by Subject|4|||
130194866|NCT01270464|468671759|FG000|Overall Study|Lost to Follow-up|2|||
130194867|NCT01270464|468671760|FG001|Overall Study|Lost to Follow-up|3|||
130194868|NCT01270464|468671761|FG002|Overall Study|Lost to Follow-up|1|||
130194869|NCT01270464|468671759|FG000|Overall Study|Other|1|||
130194870|NCT01270464|468671760|FG001|Overall Study|Other|1|||
130194871|NCT01270464|468671761|FG002|Overall Study|Other|3|||
130194872|NCT02448537|468671762|FG000|Overall Study|Withdrawal by Subject|1|||
130194873|NCT02448537|468671763|FG001|Overall Study|Withdrawal by Subject|1|||
130194874|NCT02448537|468671764|FG002|Overall Study|Withdrawal by Subject|1|||
130194875|NCT03981900|468671765|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
130194876|NCT03981900|468671765|FG000|Overall Study|Adverse Event|5|||
130194877|NCT03981900|468671765|FG000|Overall Study|Protocol Violation|1|||
130194878|NCT03981900|468671765|FG000|Overall Study|Withdrawal by Subject|7|||
130194879|NCT03981900|468671765|FG000|Overall Study|Lost to Follow-up|46|||
130194880|NCT03981900|468671765|FG000|Overall Study|Decision of the researcher|3|||
130194881|NCT03981900|468671765|FG000|Overall Study|Death|3|||
130194882|NCT03981900|468671765|FG000|Overall Study|Other|5|||
130194883|NCT04725812|468671770|FG000|Overall Study|Withdrawal by Subject|1|||
130194884|NCT04696055|468671775|FG000|Overall Study|Adverse Event|10|||
130194885|NCT04696055|468671776|FG001|Overall Study|Adverse Event|2|||
130194886|NCT04696055|468671775|FG000|Overall Study|Death|4|||
130194887|NCT04696055|468671776|FG001|Overall Study|Death|0|||
130194888|NCT04696055|468671775|FG000|Overall Study|Other|7|||
130194889|NCT04696055|468671776|FG001|Overall Study|Other|2|||
130194890|NCT04696055|468671775|FG000|Overall Study|Physician Decision|3|||
130194891|NCT04696055|468671776|FG001|Overall Study|Physician Decision|0|||
130194892|NCT04696055|468671775|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
130194893|NCT04696055|468671776|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
130194894|NCT04696055|468671775|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
130194895|NCT04696055|468671776|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
130194896|NCT04696055|468671775|FG000|Overall Study|Subject Decision|1|||
130194897|NCT04696055|468671776|FG001|Overall Study|Subject Decision|2|||
130194898|NCT03969901|468671777|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130194899|NCT03969901|468671778|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130194900|NCT03969901|468671779|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130194901|NCT03969901|468671780|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130194902|NCT03969901|468671781|FG004|Overall Study|Withdrawal by parent/guardian|1|||
130194903|NCT03969901|468671782|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130194904|NCT03969901|468671783|FG006|Overall Study|Withdrawal by parent/guardian|0|||
130194905|NCT03969901|468671784|FG007|Overall Study|Withdrawal by parent/guardian|1|||
130194906|NCT03969901|468671785|FG008|Overall Study|Withdrawal by parent/guardian|1|||
130194907|NCT03969901|468671786|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130194908|NCT04411810|468671787|FG000|Overall Study|Screen failure|1|||
130194909|NCT04411810|468671787|FG000|Overall Study|Withdrawal by Subject|1|||
130194910|NCT01920958|468671788|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
130194911|NCT01560234|468671789|FG000|Overall Study|Lost to Follow-up|3|||
130194912|NCT01560234|468671790|FG001|Overall Study|Lost to Follow-up|0|||
130194913|NCT01560234|468671791|FG002|Overall Study|Lost to Follow-up|1|||
130194914|NCT01560234|468671792|FG003|Overall Study|Lost to Follow-up|0|||
130194915|NCT01560234|468671793|FG004|Overall Study|Lost to Follow-up|0|||
130194916|NCT01560234|468671794|FG005|Overall Study|Lost to Follow-up|2|||
130194917|NCT01560234|468671795|FG006|Overall Study|Lost to Follow-up|0|||
130194918|NCT01560234|468671796|FG007|Overall Study|Lost to Follow-up|2|||
130194919|NCT00083759|468671801|FG000|Overall Study|Adverse Event|5|||
130194920|NCT00083759|468671802|FG001|Overall Study|Adverse Event|3|||
130194921|NCT00083759|468671801|FG000|Overall Study|Lost to Follow-up|1|||
130194922|NCT00083759|468671802|FG001|Overall Study|Lost to Follow-up|0|||
130194923|NCT00083759|468671801|FG000|Overall Study|Death|1|||
130194924|NCT00083759|468671802|FG001|Overall Study|Death|1|||
130194925|NCT00083759|468671801|FG000|Overall Study|Inadequate Therapeutic Response|32|||
130194926|NCT00083759|468671802|FG001|Overall Study|Inadequate Therapeutic Response|35|||
130194927|NCT00083759|468671801|FG000|Overall Study|Subject Withdrew Consent|2|||
130194928|NCT00083759|468671802|FG001|Overall Study|Subject Withdrew Consent|2|||
130194929|NCT00083759|468671801|FG000|Overall Study|Non-Compliance|1|||
130194930|NCT00083759|468671802|FG001|Overall Study|Non-Compliance|0|||
130194931|NCT00083759|468671801|FG000|Overall Study|Sponsor's Discretion|28|||
130194932|NCT00083759|468671802|FG001|Overall Study|Sponsor's Discretion|29|||
130194933|NCT00083759|468671801|FG000|Overall Study|Other|14|||
130194934|NCT00083759|468671802|FG001|Overall Study|Other|13|||
130194935|NCT00887315|468671805|FG000|Overall Study|Study termination|7|||
130194936|NCT00887315|468671806|FG001|Overall Study|Study termination|4|||
130194937|NCT00379080|468671807|FG000|Overall Study|Withdrawal by Subject|0|||
130194938|NCT00379080|468671808|FG001|Overall Study|Withdrawal by Subject|4|||
130194939|NCT00379080|468671809|FG002|Overall Study|Withdrawal by Subject|0|||
130194940|NCT00619892|468671810|FG000|Overall Study|Adverse Event|3|||
130194941|NCT00619892|468671811|FG001|Overall Study|Adverse Event|0|||
130194942|NCT00619892|468671810|FG000|Overall Study|Lost to Follow-up|0|||
130194943|NCT00619892|468671811|FG001|Overall Study|Lost to Follow-up|1|||
130194944|NCT00619892|468671810|FG000|Overall Study|Intercurrent illness|0|||
130194945|NCT00619892|468671811|FG001|Overall Study|Intercurrent illness|1|||
130194946|NCT00857896|468671817|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
130194947|NCT02920008|468671822|FG000|Overall Study|Death|117|||
130194948|NCT02920008|468671823|FG001|Overall Study|Death|127|||
130194949|NCT02920008|468671822|FG000|Overall Study|Withdrawal by Subject|3|||
130194950|NCT02920008|468671823|FG001|Overall Study|Withdrawal by Subject|6|||
130194951|NCT02920008|468671822|FG000|Overall Study|Lost to Follow-up|0|||
130194952|NCT02920008|468671823|FG001|Overall Study|Lost to Follow-up|1|||
130194953|NCT02737930|468671824|FG000|Overall Study|Withdrawal by Subject|0|||
130194954|NCT02737930|468671825|FG001|Overall Study|Withdrawal by Subject|1|||
130194955|NCT03169881|468671826|FG000|Overall Study|Incomplete Follow-up|10|||
130194956|NCT03169881|468671827|FG001|Overall Study|Incomplete Follow-up|15|||
130194957|NCT03169881|468671826|FG000|Overall Study|Lost to Follow-up|18|||
130194958|NCT03169881|468671827|FG001|Overall Study|Lost to Follow-up|20|||
130194959|NCT03169881|468671826|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130194960|NCT03169881|468671827|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
130194961|NCT01028014|468671828|FG000|Overall Study|Lost to Follow-up|1|||
130194962|NCT01028014|468671829|FG001|Overall Study|Lost to Follow-up|2|||
130194963|NCT01028014|468671830|FG002|Overall Study|Lost to Follow-up|0|||
130194964|NCT01028014|468671831|FG003|Overall Study|Lost to Follow-up|1|||
130194965|NCT01028014|468671832|FG004|Overall Study|Lost to Follow-up|1|||
130194966|NCT01028014|468671833|FG005|Overall Study|Lost to Follow-up|2|||
130194967|NCT01127451|468671843|FG000|Overall Study|Other|2|||
130194968|NCT01127451|468671844|FG001|Overall Study|Other|1|||
130194969|NCT01127451|468671843|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
130194970|NCT01127451|468671844|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
130194971|NCT01127451|468671843|FG000|Overall Study|Death|22|||
130194972|NCT01127451|468671844|FG001|Overall Study|Death|17|||
130194973|NCT01127451|468671843|FG000|Overall Study|Lost to Follow-up|3|||
130194974|NCT01127451|468671844|FG001|Overall Study|Lost to Follow-up|0|||
130194975|NCT01127451|468671843|FG000|Overall Study|Administrative Reason by Sponsor|2|||
130194976|NCT01127451|468671844|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130194977|NCT00930774|468671845|FG000|Overall Study|Withdrawal by Subject|1|||
130194978|NCT00930774|468671846|FG001|Overall Study|Withdrawal by Subject|9|||
130194979|NCT00930774|468671847|FG002|Overall Study|Withdrawal by Subject|2|||
130194980|NCT00930774|468671848|FG003|Overall Study|Withdrawal by Subject|0|||
130194981|NCT03200704|468671849|FG000|Overall Study|Withdrawal by Subject|1|||
130194982|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130194983|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
130194984|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
130194985|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
130194986|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
130194987|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
130194988|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
130194989|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
130194990|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
130194991|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
130194992|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
130194993|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130194994|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
130194995|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
130194996|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
130194997|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130194998|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
130194999|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130195000|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
130195001|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
130195002|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
130195003|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
130195004|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
130195005|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
130195006|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130195007|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130195008|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
130195009|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130195010|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130195011|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130195012|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
130195013|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
130195014|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
130195015|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130195016|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130195017|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
130195018|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130195019|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
130195020|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130195021|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130195022|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130195023|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
130195024|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
130195025|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
130195026|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
130195027|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
130195028|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
130195029|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
130195030|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130195031|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130195032|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130195033|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
130195034|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
130195035|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
130195036|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
130195037|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130195038|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130195039|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
130195040|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130195041|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130195042|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130195043|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
130195044|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130195045|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130195046|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
130195047|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130195048|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130195049|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
130195050|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130195051|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
130195052|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130195053|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130195054|NCT01704651|468671856|FG000|Overall Study|Pre-op withdrawal by subject|1|||
130195055|NCT01704651|468671857|FG001|Overall Study|Pre-op withdrawal by subject|1|||
130195056|NCT01704651|468671856|FG000|Overall Study|Pre-op change in treatment plan|1|||
130195057|NCT01704651|468671857|FG001|Overall Study|Pre-op change in treatment plan|4|||
130195058|NCT01704651|468671856|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
130195059|NCT01704651|468671857|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
130195060|NCT01704651|468671856|FG000|Overall Study|Post-op did not have laparotomy|2|||
130195061|NCT01704651|468671857|FG001|Overall Study|Post-op did not have laparotomy|1|||
130195062|NCT00634803|468671859|FG000|Overall Study|Lost to Follow-up|6|||
130195063|NCT00634803|468671860|FG001|Overall Study|Lost to Follow-up|7|||
130195064|NCT00634803|468671861|FG002|Overall Study|Lost to Follow-up|7|||
130195065|NCT00364923|468671863|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
130195066|NCT00364923|468671863|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
130195067|NCT04087720|468671867|FG000|Overall Study|Withdrawal by Subject|2|||
130195068|NCT04087720|468671867|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
130195069|NCT03706430|468671870|FG000|Overall Study|No A-Line placed|5|||
130195070|NCT03706430|468671870|FG000|Overall Study|Subject had gel nail polish|1|||
130195071|NCT03706430|468671870|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
130195072|NCT03706430|468671870|FG000|Overall Study|Cancelled Case|6|||
130195073|NCT03706430|468671870|FG000|Overall Study|Physician Decision|2|||
130195074|NCT00520533|468671871|FG000|Overall Study|Death|1|||
130195075|NCT00520533|468671871|FG000|Overall Study|Suspension of the study for safety reasons|1|||
130195076|NCT00520533|468671871|FG000|Overall Study|Withdrawal by Subject|1|||
130195077|NCT00520533|468671871|FG000|Overall Study|Physician Decision|1|||
130195078|NCT00478777|468671872|FG000|Overall Study|Adverse Event|29|||
130195079|NCT00478777|468671872|FG000|Overall Study|Lack of Efficacy|23|||
130195080|NCT00478777|468671872|FG000|Overall Study|Withdrawal by Subject|4|||
130195081|NCT00478777|468671872|FG000|Overall Study|Death|3|||
130195082|NCT00478777|468671872|FG000|Overall Study|Protocol Violation|3|||
130195083|NCT00478777|468671872|FG000|Overall Study|Lost to Follow-up|3|||
130195084|NCT00478777|468671872|FG000|Overall Study|Physician Decision|1|||
130195085|NCT00478777|468671872|FG000|Overall Study|Intolerance of therapy|1|||
130195086|NCT00478777|468671872|FG000|Overall Study|Lack of compliance|1|||
130195087|NCT00478777|468671872|FG000|Overall Study|Lymphocytes infusion|1|||
130195088|NCT00478777|468671872|FG000|Overall Study|End of therapy|2|||
130195089|NCT00478777|468671872|FG000|Overall Study|Not treated with lenalidomide|6|||
130195090|NCT00552396|468671873|FG000|Overall Study|protocol withdrawal criteria|3|||
130195091|NCT00552396|468671874|FG001|Overall Study|protocol withdrawal criteria|3|||
130195092|NCT00552396|468671875|FG002|Overall Study|protocol withdrawal criteria|3|||
130195093|NCT00552396|468671876|FG003|Overall Study|protocol withdrawal criteria|6|||
130195094|NCT00552396|468671877|FG004|Overall Study|protocol withdrawal criteria|3|||
130195095|NCT00552396|468671878|FG005|Overall Study|protocol withdrawal criteria|3|||
130195096|NCT00552396|468671879|FG006|Overall Study|protocol withdrawal criteria|9|||
130195097|NCT02553499|468671880|FG000|Overall Study|Adverse Event|0|||
130195098|NCT02553499|468671881|FG001|Overall Study|Adverse Event|0|||
130195099|NCT02553499|468671882|FG002|Overall Study|Adverse Event|0|||
130195100|NCT02553499|468671883|FG003|Overall Study|Adverse Event|0|||
130195101|NCT02553499|468671884|FG004|Overall Study|Adverse Event|0|||
130195102|NCT02553499|468671885|FG005|Overall Study|Adverse Event|0|||
130195103|NCT02553499|468671886|FG006|Overall Study|Adverse Event|1|||
130195104|NCT02553499|468671887|FG007|Overall Study|Adverse Event|1|||
130195105|NCT02553499|468671888|FG008|Overall Study|Adverse Event|0|||
130195106|NCT02553499|468671889|FG009|Overall Study|Adverse Event|0|||
130195107|NCT02553499|468671890|FG010|Overall Study|Adverse Event|0|||
130195108|NCT02553499|468671891|FG011|Overall Study|Adverse Event|0|||
130195109|NCT02553499|468671892|FG012|Overall Study|Adverse Event|0|||
130195110|NCT02553499|468671893|FG013|Overall Study|Adverse Event|1|||
130195111|NCT02553499|468671880|FG000|Overall Study|Death|0|||
130195112|NCT02553499|468671881|FG001|Overall Study|Death|1|||
130195113|NCT02553499|468671882|FG002|Overall Study|Death|1|||
130195114|NCT02553499|468671883|FG003|Overall Study|Death|0|||
130195115|NCT02553499|468671884|FG004|Overall Study|Death|1|||
130195116|NCT02553499|468671885|FG005|Overall Study|Death|2|||
130195117|NCT02553499|468671886|FG006|Overall Study|Death|0|||
130195118|NCT02553499|468671887|FG007|Overall Study|Death|0|||
130195119|NCT02553499|468671888|FG008|Overall Study|Death|0|||
130195120|NCT02553499|468671889|FG009|Overall Study|Death|0|||
130195121|NCT02553499|468671890|FG010|Overall Study|Death|1|||
130195122|NCT02553499|468671891|FG011|Overall Study|Death|0|||
130195123|NCT02553499|468671892|FG012|Overall Study|Death|0|||
130195124|NCT02553499|468671893|FG013|Overall Study|Death|0|||
130195125|NCT02553499|468671880|FG000|Overall Study|Lost to Follow-up|0|||
130195126|NCT02553499|468671881|FG001|Overall Study|Lost to Follow-up|0|||
130195127|NCT02553499|468671882|FG002|Overall Study|Lost to Follow-up|0|||
130195128|NCT02553499|468671883|FG003|Overall Study|Lost to Follow-up|0|||
130195129|NCT02553499|468671884|FG004|Overall Study|Lost to Follow-up|0|||
130195130|NCT02553499|468671885|FG005|Overall Study|Lost to Follow-up|0|||
130195131|NCT02553499|468671886|FG006|Overall Study|Lost to Follow-up|1|||
130195132|NCT02553499|468671887|FG007|Overall Study|Lost to Follow-up|0|||
130195133|NCT02553499|468671888|FG008|Overall Study|Lost to Follow-up|0|||
130195134|NCT02553499|468671889|FG009|Overall Study|Lost to Follow-up|0|||
130195135|NCT02553499|468671890|FG010|Overall Study|Lost to Follow-up|0|||
130195136|NCT02553499|468671891|FG011|Overall Study|Lost to Follow-up|0|||
130195137|NCT02553499|468671892|FG012|Overall Study|Lost to Follow-up|0|||
130195138|NCT02553499|468671893|FG013|Overall Study|Lost to Follow-up|0|||
130195139|NCT02553499|468671880|FG000|Overall Study|Physician Decision|0|||
130195140|NCT02553499|468671881|FG001|Overall Study|Physician Decision|1|||
130195141|NCT02553499|468671882|FG002|Overall Study|Physician Decision|1|||
130195142|NCT02553499|468671883|FG003|Overall Study|Physician Decision|0|||
130195143|NCT02553499|468671884|FG004|Overall Study|Physician Decision|1|||
130195144|NCT02553499|468671885|FG005|Overall Study|Physician Decision|0|||
130195145|NCT02553499|468671886|FG006|Overall Study|Physician Decision|0|||
130195146|NCT02553499|468671887|FG007|Overall Study|Physician Decision|1|||
130195147|NCT02553499|468671888|FG008|Overall Study|Physician Decision|1|||
130195148|NCT02553499|468671889|FG009|Overall Study|Physician Decision|2|||
130195149|NCT02553499|468671890|FG010|Overall Study|Physician Decision|1|||
130195150|NCT02553499|468671891|FG011|Overall Study|Physician Decision|3|||
130195151|NCT02553499|468671892|FG012|Overall Study|Physician Decision|1|||
130195152|NCT02553499|468671893|FG013|Overall Study|Physician Decision|0|||
130195153|NCT02553499|468671880|FG000|Overall Study|Progressive Disease|0|||
130195154|NCT02553499|468671881|FG001|Overall Study|Progressive Disease|0|||
130195155|NCT02553499|468671882|FG002|Overall Study|Progressive Disease|0|||
130195156|NCT02553499|468671883|FG003|Overall Study|Progressive Disease|2|||
130195157|NCT02553499|468671884|FG004|Overall Study|Progressive Disease|1|||
130195158|NCT02553499|468671885|FG005|Overall Study|Progressive Disease|1|||
130195159|NCT02553499|468671886|FG006|Overall Study|Progressive Disease|1|||
130195160|NCT02553499|468671887|FG007|Overall Study|Progressive Disease|0|||
130195161|NCT02553499|468671888|FG008|Overall Study|Progressive Disease|0|||
130195162|NCT02553499|468671889|FG009|Overall Study|Progressive Disease|1|||
130195163|NCT02553499|468671890|FG010|Overall Study|Progressive Disease|0|||
130195164|NCT02553499|468671891|FG011|Overall Study|Progressive Disease|0|||
130195165|NCT02553499|468671892|FG012|Overall Study|Progressive Disease|2|||
130195166|NCT02553499|468671893|FG013|Overall Study|Progressive Disease|1|||
130195167|NCT02553499|468671880|FG000|Overall Study|Study Terminated by Sponsor|0|||
130195168|NCT02553499|468671881|FG001|Overall Study|Study Terminated by Sponsor|0|||
130195169|NCT02553499|468671882|FG002|Overall Study|Study Terminated by Sponsor|0|||
130195170|NCT02553499|468671883|FG003|Overall Study|Study Terminated by Sponsor|0|||
130195171|NCT02553499|468671884|FG004|Overall Study|Study Terminated by Sponsor|0|||
130195172|NCT02553499|468671885|FG005|Overall Study|Study Terminated by Sponsor|0|||
130195173|NCT02553499|468671886|FG006|Overall Study|Study Terminated by Sponsor|0|||
130195174|NCT02553499|468671887|FG007|Overall Study|Study Terminated by Sponsor|0|||
130195175|NCT02553499|468671888|FG008|Overall Study|Study Terminated by Sponsor|1|||
130195176|NCT02553499|468671889|FG009|Overall Study|Study Terminated by Sponsor|0|||
130195177|NCT02553499|468671890|FG010|Overall Study|Study Terminated by Sponsor|0|||
130195178|NCT02553499|468671891|FG011|Overall Study|Study Terminated by Sponsor|0|||
130195179|NCT02553499|468671892|FG012|Overall Study|Study Terminated by Sponsor|0|||
130195180|NCT02553499|468671893|FG013|Overall Study|Study Terminated by Sponsor|0|||
130195181|NCT02553499|468671880|FG000|Overall Study|Withdrawal by Subject|2|||
130195182|NCT02553499|468671881|FG001|Overall Study|Withdrawal by Subject|0|||
130195183|NCT02553499|468671882|FG002|Overall Study|Withdrawal by Subject|0|||
130195184|NCT02553499|468671883|FG003|Overall Study|Withdrawal by Subject|0|||
130195185|NCT02553499|468671884|FG004|Overall Study|Withdrawal by Subject|0|||
130195186|NCT02553499|468671885|FG005|Overall Study|Withdrawal by Subject|0|||
130195187|NCT02553499|468671886|FG006|Overall Study|Withdrawal by Subject|0|||
130195188|NCT02553499|468671887|FG007|Overall Study|Withdrawal by Subject|1|||
130195189|NCT02553499|468671888|FG008|Overall Study|Withdrawal by Subject|1|||
130195190|NCT02553499|468671889|FG009|Overall Study|Withdrawal by Subject|0|||
130195191|NCT02553499|468671890|FG010|Overall Study|Withdrawal by Subject|1|||
130195192|NCT02553499|468671891|FG011|Overall Study|Withdrawal by Subject|0|||
130195193|NCT02553499|468671892|FG012|Overall Study|Withdrawal by Subject|0|||
130195194|NCT02553499|468671893|FG013|Overall Study|Withdrawal by Subject|0|||
130195195|NCT03319732|468671899|FG000|Overall Study|Adverse Event|40|||
130195196|NCT03319732|468671899|FG000|Overall Study|Withdrawal by Subject|50|||
130195197|NCT03319732|468671899|FG000|Overall Study|MS relapse|10|||
130195198|NCT03319732|468671899|FG000|Overall Study|reason not specified|5|||
130195199|NCT00767455|468671900|FG000|Overall Study|Investigator error|19|||
130195200|NCT03386994|468671901|FG000|Overall Study|Lung transplant|1|||
130195201|NCT03386994|468671901|FG000|Overall Study|Adverse Event|14|||
130195202|NCT03386994|468671901|FG000|Overall Study|Lost to Follow-up|4|||
130195203|NCT03386994|468671901|FG000|Overall Study|Withdrawal by Subject|3|||
130195204|NCT03386994|468671901|FG000|Overall Study|Death|16|||
130195211|NCT00068393|468673502|FG000|Overall Study|Adverse Event|2|||
130195212|NCT00068393|468673502|FG000|Overall Study|Death|3|||
130195213|NCT00068393|468673502|FG000|Overall Study|Withdrawal by Subject|3|||
130195214|NCT00068393|468673502|FG000|Overall Study|Alternative treatment|1|||
130195215|NCT00068393|468673502|FG000|Overall Study|Quality of life worsening|1|||
130195216|NCT04981470|468673506|FG000|Overall Study|Device failure in all 4 patients|4|||
130195217|NCT00593684|468673507|FG000|Overall Study|Death|2|||
130195218|NCT00593684|468673508|FG001|Overall Study|Death|1|||
130195219|NCT00078767|468673509|FG000|Overall Study|Withdrawal by Subject|1|||
130195220|NCT00078767|468673510|FG001|Overall Study|Withdrawal by Subject|1|||
130195221|NCT02282631|468673515|FG000|Overall Study|Lost to Follow-up|2|||
130195222|NCT02282631|468673516|FG001|Overall Study|Lost to Follow-up|0|||
130195223|NCT01736397|468673517|FG000|Overall Study|Lack of Efficacy|1|||
130195224|NCT01736397|468673518|FG001|Overall Study|Lack of Efficacy|11|||
130195225|NCT01736397|468673517|FG000|Overall Study|Withdrawal by Subject|6|||
130195226|NCT01736397|468673518|FG001|Overall Study|Withdrawal by Subject|5|||
130195227|NCT01736397|468673517|FG000|Overall Study|Lost to Follow-up|0|||
130195228|NCT01736397|468673518|FG001|Overall Study|Lost to Follow-up|1|||
130195229|NCT01736397|468673517|FG000|Overall Study|Adverse Event|6|||
130195230|NCT01736397|468673518|FG001|Overall Study|Adverse Event|3|||
130195231|NCT01736397|468673517|FG000|Overall Study|Not stated|1|||
130195232|NCT01736397|468673518|FG001|Overall Study|Not stated|4|||
130195233|NCT05088603|468673519|FG000|Overall Study|Protocol Violation|6|||
130195234|NCT05088603|468673520|FG001|Overall Study|Protocol Violation|1|||
130195235|NCT01841762|468673522|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
130195236|NCT01841762|468673522|FG000|Treatment Period|Adverse Event|16|||
130195237|NCT01841762|468673522|FG000|Treatment Period|Death|1|||
130195238|NCT01841762|468673522|FG000|Treatment Period|Withdrawal by Subject|7|||
130195239|NCT01841762|468673522|FG000|Treatment Period|Lost to Follow-up|1|||
130195240|NCT01841762|468673522|FG000|Treatment Period|Physician Decision|2|||
130195241|NCT01841762|468673522|FG000|Treatment Period|Other, including non-compliance|5|||
130195242|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
130195243|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
130195244|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
130195245|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
130195246|NCT03260244|468673523|FG000|Overall Study|Death|19|||
130195247|NCT03260244|468673523|FG000|Overall Study|Lost to Follow-up|60|||
130195248|NCT03260244|468673523|FG000|Overall Study|Withdrawal by Subject|48|||
130195249|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed|21|||
130195250|NCT03260244|468673523|FG000|Overall Study|Enrollment Criteria Not Met|31|||
130195251|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
130195252|NCT03260244|468673523|FG000|Overall Study|Subject Noncompliance|6|||
130195253|NCT03260244|468673523|FG000|Overall Study|No inducible Arrhythmia|2|||
130195254|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
130195255|NCT03260244|468673523|FG000|Overall Study|Screen Failure|2|||
130195256|NCT03260244|468673523|FG000|Overall Study|Treated Off Label|69|||
130195257|NCT03260244|468673523|FG000|Overall Study|No Radiofrequency Ablation|14|||
130195258|NCT03528369|468673528|FG000|Overall Study|Withdrawal by Subject|2|||
130195259|NCT03528369|468673529|FG001|Overall Study|Withdrawal by Subject|0|||
130195260|NCT03528369|468673530|FG002|Overall Study|Withdrawal by Subject|0|||
130195261|NCT03528369|468673528|FG000|Overall Study|Lost to Follow-up|1|||
130195262|NCT03528369|468673529|FG001|Overall Study|Lost to Follow-up|0|||
130195263|NCT03528369|468673530|FG002|Overall Study|Lost to Follow-up|0|||
130195264|NCT03528369|468673528|FG000|Overall Study|Adverse Event|0|||
130195265|NCT03528369|468673529|FG001|Overall Study|Adverse Event|1|||
130195266|NCT03528369|468673530|FG002|Overall Study|Adverse Event|0|||
130195267|NCT02162719|468673531|FG000|Overall Study|Death|41|||
130195268|NCT02162719|468673532|FG001|Overall Study|Death|46|||
130195269|NCT02162719|468673531|FG000|Overall Study|Lost to Follow-up|1|||
130195270|NCT02162719|468673532|FG001|Overall Study|Lost to Follow-up|3|||
130195271|NCT02162719|468673531|FG000|Overall Study|Disease Progression|2|||
130195272|NCT02162719|468673532|FG001|Overall Study|Disease Progression|1|||
130195273|NCT02162719|468673531|FG000|Overall Study|Withdrawal by Subject|8|||
130195274|NCT02162719|468673532|FG001|Overall Study|Withdrawal by Subject|2|||
130195275|NCT02162719|468673531|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130195276|NCT02162719|468673532|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130195277|NCT03555565|468673533|FG000|Overall Study|Case Report Forms Uncollected|2|||
130195278|NCT03555565|468673533|FG000|Overall Study|Protocol Deviation|13|||
130195279|NCT01163851|468673539|FG000|Overall Study|Site Closure|0|||
130195280|NCT01163851|468673540|FG001|Overall Study|Site Closure|1|||
130195281|NCT01163851|468673539|FG000|Overall Study|Enrolled but not treated|1|||
130195282|NCT01163851|468673540|FG001|Overall Study|Enrolled but not treated|0|||
130195283|NCT03192306|468673543|FG000|Overall Study|Did not treat cold sore during study|149|||
130195284|NCT03192306|468673544|FG001|Overall Study|Did not treat cold sore during study|143|||
130195285|NCT03192306|468673543|FG000|Overall Study|Withdrawal by Subject|1|||
130195286|NCT03192306|468673544|FG001|Overall Study|Withdrawal by Subject|1|||
130195287|NCT03192306|468673543|FG000|Overall Study|Lost to Follow-up|1|||
130195288|NCT03192306|468673544|FG001|Overall Study|Lost to Follow-up|0|||
130195289|NCT03192306|468673543|FG000|Overall Study|Protocol Violation|1|||
130195290|NCT03192306|468673544|FG001|Overall Study|Protocol Violation|1|||
130195291|NCT02589626|468673549|FG000|Overall Study|Other than the reason specified|1|||
130195292|NCT02589626|468673550|FG001|Overall Study|Other than the reason specified|0|||
130195293|NCT02589626|468673549|FG000|Overall Study|Withdrawal by Subject|1|||
130195294|NCT02589626|468673550|FG001|Overall Study|Withdrawal by Subject|1|||
130195295|NCT02589626|468673549|FG000|Overall Study|Adverse Event|1|||
130195296|NCT02589626|468673550|FG001|Overall Study|Adverse Event|1|||
130195297|NCT02564900|468673551|FG000|Dose Escalation|Progressive disease per RECIST|2|||
130195298|NCT02564900|468673552|FG001|Dose Escalation|Progressive disease per RECIST|3|||
130195299|NCT02564900|468673553|FG002|Dose Escalation|Progressive disease per RECIST|3|||
130195300|NCT02564900|468673554|FG003|Dose Escalation|Progressive disease per RECIST|3|||
130195301|NCT02564900|468673555|FG004|Dose Escalation|Progressive disease per RECIST|3|||
130195302|NCT02564900|468673556|FG005|Dose Escalation|Progressive disease per RECIST|1|||
130195303|NCT02564900|468673557|FG006|Dose Escalation|Progressive disease per RECIST|0|||
130195304|NCT02564900|468673558|FG007|Dose Escalation|Progressive disease per RECIST|0|||
130195305|NCT02564900|468673559|FG008|Dose Escalation|Progressive disease per RECIST|0|||
130195306|NCT02564900|468673560|FG009|Dose Escalation|Progressive disease per RECIST|0|||
130195307|NCT02564900|468673561|FG010|Dose Escalation|Progressive disease per RECIST|0|||
130195308|NCT02564900|468673562|FG011|Dose Escalation|Progressive disease per RECIST|0|||
130195309|NCT02564900|468673563|FG012|Dose Escalation|Progressive disease per RECIST|0|||
130195310|NCT02564900|468673564|FG013|Dose Escalation|Progressive disease per RECIST|0|||
130195311|NCT02564900|468673565|FG014|Dose Escalation|Progressive disease per RECIST|0|||
130195312|NCT02564900|468673551|FG000|Dose Escalation|Ongoing|1|||
130195313|NCT02564900|468673552|FG001|Dose Escalation|Ongoing|0|||
130195314|NCT02564900|468673553|FG002|Dose Escalation|Ongoing|0|||
130195315|NCT02564900|468673554|FG003|Dose Escalation|Ongoing|2|||
130195316|NCT02564900|468673555|FG004|Dose Escalation|Ongoing|2|||
130195317|NCT02564900|468673556|FG005|Dose Escalation|Ongoing|2|||
130195318|NCT02564900|468673557|FG006|Dose Escalation|Ongoing|0|||
130195319|NCT02564900|468673558|FG007|Dose Escalation|Ongoing|0|||
130195320|NCT02564900|468673559|FG008|Dose Escalation|Ongoing|0|||
130195321|NCT02564900|468673560|FG009|Dose Escalation|Ongoing|0|||
130195322|NCT02564900|468673561|FG010|Dose Escalation|Ongoing|0|||
130195323|NCT02564900|468673562|FG011|Dose Escalation|Ongoing|0|||
130195324|NCT02564900|468673563|FG012|Dose Escalation|Ongoing|0|||
130195325|NCT02564900|468673564|FG013|Dose Escalation|Ongoing|0|||
130195326|NCT02564900|468673565|FG014|Dose Escalation|Ongoing|0|||
130195327|NCT02564900|468673551|FG000|Dose Escalation|Adverse Event|0|||
130195328|NCT02564900|468673552|FG001|Dose Escalation|Adverse Event|0|||
130195329|NCT02564900|468673553|FG002|Dose Escalation|Adverse Event|0|||
130195330|NCT02564900|468673554|FG003|Dose Escalation|Adverse Event|1|||
130195331|NCT02564900|468673555|FG004|Dose Escalation|Adverse Event|1|||
130195332|NCT02564900|468673556|FG005|Dose Escalation|Adverse Event|3|||
130195333|NCT02564900|468673557|FG006|Dose Escalation|Adverse Event|0|||
130195334|NCT02564900|468673558|FG007|Dose Escalation|Adverse Event|0|||
130195335|NCT02564900|468673559|FG008|Dose Escalation|Adverse Event|0|||
130195336|NCT02564900|468673560|FG009|Dose Escalation|Adverse Event|0|||
130195337|NCT02564900|468673561|FG010|Dose Escalation|Adverse Event|0|||
130195338|NCT02564900|468673562|FG011|Dose Escalation|Adverse Event|0|||
130195339|NCT02564900|468673563|FG012|Dose Escalation|Adverse Event|0|||
130195340|NCT02564900|468673564|FG013|Dose Escalation|Adverse Event|0|||
130195341|NCT02564900|468673565|FG014|Dose Escalation|Adverse Event|0|||
130195342|NCT02564900|468673551|FG000|Dose Expansion|Progressive disease per RECIST|0|||
130195343|NCT02564900|468673552|FG001|Dose Expansion|Progressive disease per RECIST|0|||
130195344|NCT02564900|468673553|FG002|Dose Expansion|Progressive disease per RECIST|0|||
130195345|NCT02564900|468673554|FG003|Dose Expansion|Progressive disease per RECIST|0|||
130195346|NCT02564900|468673555|FG004|Dose Expansion|Progressive disease per RECIST|0|||
130195347|NCT02564900|468673556|FG005|Dose Expansion|Progressive disease per RECIST|0|||
130195348|NCT02564900|468673557|FG006|Dose Expansion|Progressive disease per RECIST|19|||
130195349|NCT02564900|468673558|FG007|Dose Expansion|Progressive disease per RECIST|17|||
130195350|NCT02564900|468673559|FG008|Dose Expansion|Progressive disease per RECIST|8|||
130195351|NCT02564900|468673560|FG009|Dose Expansion|Progressive disease per RECIST|16|||
130195352|NCT02564900|468673561|FG010|Dose Expansion|Progressive disease per RECIST|13|||
130195353|NCT02564900|468673562|FG011|Dose Expansion|Progressive disease per RECIST|19|||
130195354|NCT02564900|468673563|FG012|Dose Expansion|Progressive disease per RECIST|10|||
130195355|NCT02564900|468673564|FG013|Dose Expansion|Progressive disease per RECIST|13|||
130195356|NCT02564900|468673565|FG014|Dose Expansion|Progressive disease per RECIST|11|||
130195357|NCT02564900|468673551|FG000|Dose Expansion|Clinical progression|0|||
130195358|NCT02564900|468673552|FG001|Dose Expansion|Clinical progression|0|||
130195359|NCT02564900|468673553|FG002|Dose Expansion|Clinical progression|0|||
130195360|NCT02564900|468673554|FG003|Dose Expansion|Clinical progression|0|||
130195361|NCT02564900|468673555|FG004|Dose Expansion|Clinical progression|0|||
130195362|NCT02564900|468673556|FG005|Dose Expansion|Clinical progression|0|||
130195363|NCT02564900|468673557|FG006|Dose Expansion|Clinical progression|5|||
130195364|NCT02564900|468673558|FG007|Dose Expansion|Clinical progression|12|||
130195365|NCT02564900|468673559|FG008|Dose Expansion|Clinical progression|0|||
130195366|NCT02564900|468673560|FG009|Dose Expansion|Clinical progression|3|||
130195367|NCT02564900|468673561|FG010|Dose Expansion|Clinical progression|2|||
130195368|NCT02564900|468673562|FG011|Dose Expansion|Clinical progression|0|||
130195369|NCT02564900|468673563|FG012|Dose Expansion|Clinical progression|1|||
130195370|NCT02564900|468673564|FG013|Dose Expansion|Clinical progression|3|||
130195371|NCT02564900|468673565|FG014|Dose Expansion|Clinical progression|1|||
130195372|NCT02564900|468673551|FG000|Dose Expansion|Adverse Event|0|||
130195373|NCT02564900|468673552|FG001|Dose Expansion|Adverse Event|0|||
130195374|NCT02564900|468673553|FG002|Dose Expansion|Adverse Event|0|||
130195375|NCT02564900|468673554|FG003|Dose Expansion|Adverse Event|0|||
130195376|NCT02564900|468673555|FG004|Dose Expansion|Adverse Event|0|||
130195377|NCT02564900|468673556|FG005|Dose Expansion|Adverse Event|0|||
130195378|NCT02564900|468673557|FG006|Dose Expansion|Adverse Event|9|||
130195379|NCT02564900|468673558|FG007|Dose Expansion|Adverse Event|22|||
130195380|NCT02564900|468673559|FG008|Dose Expansion|Adverse Event|0|||
130195381|NCT02564900|468673560|FG009|Dose Expansion|Adverse Event|11|||
130195382|NCT02564900|468673561|FG010|Dose Expansion|Adverse Event|0|||
130195383|NCT02564900|468673562|FG011|Dose Expansion|Adverse Event|5|||
130195384|NCT02564900|468673563|FG012|Dose Expansion|Adverse Event|2|||
130195385|NCT02564900|468673564|FG013|Dose Expansion|Adverse Event|2|||
130195386|NCT02564900|468673565|FG014|Dose Expansion|Adverse Event|1|||
130195387|NCT02564900|468673551|FG000|Dose Expansion|Ongoing|0|||
130195388|NCT02564900|468673552|FG001|Dose Expansion|Ongoing|0|||
130195389|NCT02564900|468673553|FG002|Dose Expansion|Ongoing|0|||
130195390|NCT02564900|468673554|FG003|Dose Expansion|Ongoing|0|||
130195391|NCT02564900|468673555|FG004|Dose Expansion|Ongoing|0|||
130195392|NCT02564900|468673556|FG005|Dose Expansion|Ongoing|0|||
130195393|NCT02564900|468673557|FG006|Dose Expansion|Ongoing|9|||
130195394|NCT02564900|468673558|FG007|Dose Expansion|Ongoing|10|||
130195395|NCT02564900|468673559|FG008|Dose Expansion|Ongoing|11|||
130195396|NCT02564900|468673560|FG009|Dose Expansion|Ongoing|3|||
130195397|NCT02564900|468673561|FG010|Dose Expansion|Ongoing|0|||
130195398|NCT02564900|468673562|FG011|Dose Expansion|Ongoing|0|||
130195399|NCT02564900|468673563|FG012|Dose Expansion|Ongoing|4|||
130195400|NCT02564900|468673564|FG013|Dose Expansion|Ongoing|0|||
130195401|NCT02564900|468673565|FG014|Dose Expansion|Ongoing|6|||
130195402|NCT02564900|468673551|FG000|Dose Expansion|Death|0|||
130195403|NCT02564900|468673552|FG001|Dose Expansion|Death|0|||
130195404|NCT02564900|468673553|FG002|Dose Expansion|Death|0|||
130195405|NCT02564900|468673554|FG003|Dose Expansion|Death|0|||
130195406|NCT02564900|468673555|FG004|Dose Expansion|Death|0|||
130195407|NCT02564900|468673556|FG005|Dose Expansion|Death|0|||
130195408|NCT02564900|468673557|FG006|Dose Expansion|Death|1|||
130195409|NCT02564900|468673558|FG007|Dose Expansion|Death|0|||
130195410|NCT02564900|468673559|FG008|Dose Expansion|Death|0|||
130195411|NCT02564900|468673560|FG009|Dose Expansion|Death|0|||
130195412|NCT02564900|468673561|FG010|Dose Expansion|Death|1|||
130195413|NCT02564900|468673562|FG011|Dose Expansion|Death|0|||
130195414|NCT02564900|468673563|FG012|Dose Expansion|Death|1|||
130195415|NCT02564900|468673564|FG013|Dose Expansion|Death|1|||
130195416|NCT02564900|468673565|FG014|Dose Expansion|Death|0|||
130195417|NCT02564900|468673551|FG000|Dose Expansion|Withdrawal by Subject|0|||
130195418|NCT02564900|468673552|FG001|Dose Expansion|Withdrawal by Subject|0|||
130195419|NCT02564900|468673553|FG002|Dose Expansion|Withdrawal by Subject|0|||
130195420|NCT02564900|468673554|FG003|Dose Expansion|Withdrawal by Subject|0|||
130195421|NCT02564900|468673555|FG004|Dose Expansion|Withdrawal by Subject|0|||
130195422|NCT02564900|468673556|FG005|Dose Expansion|Withdrawal by Subject|0|||
130195423|NCT02564900|468673557|FG006|Dose Expansion|Withdrawal by Subject|4|||
130195424|NCT02564900|468673558|FG007|Dose Expansion|Withdrawal by Subject|0|||
130195425|NCT02564900|468673559|FG008|Dose Expansion|Withdrawal by Subject|0|||
130195426|NCT02564900|468673560|FG009|Dose Expansion|Withdrawal by Subject|0|||
130195427|NCT02564900|468673561|FG010|Dose Expansion|Withdrawal by Subject|1|||
130195428|NCT02564900|468673562|FG011|Dose Expansion|Withdrawal by Subject|0|||
130195429|NCT02564900|468673563|FG012|Dose Expansion|Withdrawal by Subject|0|||
130195430|NCT02564900|468673564|FG013|Dose Expansion|Withdrawal by Subject|1|||
130195431|NCT02564900|468673565|FG014|Dose Expansion|Withdrawal by Subject|1|||
130195432|NCT02564900|468673551|FG000|Dose Expansion|Other|0|||
130195433|NCT02564900|468673552|FG001|Dose Expansion|Other|0|||
130195434|NCT02564900|468673553|FG002|Dose Expansion|Other|0|||
130195435|NCT02564900|468673554|FG003|Dose Expansion|Other|0|||
130195436|NCT02564900|468673555|FG004|Dose Expansion|Other|0|||
130195437|NCT02564900|468673556|FG005|Dose Expansion|Other|0|||
130195438|NCT02564900|468673557|FG006|Dose Expansion|Other|1|||
130195439|NCT02564900|468673558|FG007|Dose Expansion|Other|0|||
130195440|NCT02564900|468673559|FG008|Dose Expansion|Other|1|||
130195441|NCT02564900|468673560|FG009|Dose Expansion|Other|0|||
130195442|NCT02564900|468673561|FG010|Dose Expansion|Other|0|||
130195443|NCT02564900|468673562|FG011|Dose Expansion|Other|0|||
130195444|NCT02564900|468673563|FG012|Dose Expansion|Other|0|||
130195445|NCT02564900|468673564|FG013|Dose Expansion|Other|0|||
130195446|NCT02564900|468673565|FG014|Dose Expansion|Other|1|||
130195447|NCT02564900|468673551|FG000|Dose Expansion|Did not receive treatment|0|||
130195448|NCT02564900|468673552|FG001|Dose Expansion|Did not receive treatment|0|||
130195449|NCT02564900|468673553|FG002|Dose Expansion|Did not receive treatment|0|||
130195450|NCT02564900|468673554|FG003|Dose Expansion|Did not receive treatment|0|||
130195451|NCT02564900|468673555|FG004|Dose Expansion|Did not receive treatment|0|||
130195452|NCT02564900|468673556|FG005|Dose Expansion|Did not receive treatment|0|||
130195453|NCT02564900|468673557|FG006|Dose Expansion|Did not receive treatment|1|||
130195454|NCT02564900|468673558|FG007|Dose Expansion|Did not receive treatment|1|||
130195455|NCT02564900|468673559|FG008|Dose Expansion|Did not receive treatment|0|||
130195456|NCT02564900|468673560|FG009|Dose Expansion|Did not receive treatment|0|||
130195457|NCT02564900|468673561|FG010|Dose Expansion|Did not receive treatment|0|||
130195458|NCT02564900|468673562|FG011|Dose Expansion|Did not receive treatment|0|||
130195459|NCT02564900|468673563|FG012|Dose Expansion|Did not receive treatment|0|||
130195460|NCT02564900|468673564|FG013|Dose Expansion|Did not receive treatment|0|||
130195461|NCT02564900|468673565|FG014|Dose Expansion|Did not receive treatment|1|||
130195462|NCT00892151|468673566|FG000|Overall Study|Protocol Violation|1|||
130195463|NCT04075682|468673569|FG000|Overall Study|Lost to Follow-up|5|||
130195464|NCT04075682|468673570|FG001|Overall Study|Lost to Follow-up|5|||
130195465|NCT04075682|468673571|FG002|Overall Study|Lost to Follow-up|2|||
130195466|NCT04075682|468673572|FG003|Overall Study|Lost to Follow-up|2|||
130195467|NCT04075682|468673569|FG000|Overall Study|Withdrawal by Subject|1|||
130195468|NCT04075682|468673570|FG001|Overall Study|Withdrawal by Subject|0|||
130195469|NCT04075682|468673571|FG002|Overall Study|Withdrawal by Subject|1|||
130195470|NCT04075682|468673572|FG003|Overall Study|Withdrawal by Subject|0|||
130195471|NCT04075682|468673569|FG000|Overall Study|Protocol Violation|0|||
130195472|NCT04075682|468673570|FG001|Overall Study|Protocol Violation|1|||
130195473|NCT04075682|468673571|FG002|Overall Study|Protocol Violation|1|||
130195474|NCT04075682|468673572|FG003|Overall Study|Protocol Violation|0|||
130195475|NCT04075682|468673569|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
130195476|NCT04075682|468673570|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
130195477|NCT04075682|468673571|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
130195478|NCT04075682|468673572|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
130195479|NCT04075682|468673569|FG000|Overall Study|Lost study phone the first day of study participation|0|||
130195480|NCT04075682|468673570|FG001|Overall Study|Lost study phone the first day of study participation|1|||
130195481|NCT04075682|468673571|FG002|Overall Study|Lost study phone the first day of study participation|0|||
130195482|NCT04075682|468673572|FG003|Overall Study|Lost study phone the first day of study participation|0|||
130195483|NCT01289639|468673577|FG000|Overall Study|Lost to Follow-up|1|||
130195484|NCT01289639|468673578|FG001|Overall Study|Lost to Follow-up|0|||
130195485|NCT01289639|468673579|FG002|Overall Study|Lost to Follow-up|0|||
130195486|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
130195487|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
130195488|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
130195489|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
130195490|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
130195491|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
130195492|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
130195493|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
130195494|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
130195495|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
130195496|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
130195497|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
130195498|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
130195499|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
130195500|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
130195501|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
130195502|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
130195503|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
130195504|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
130195505|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
130195506|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130195507|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130195508|NCT04292912|468673584|FG000|Overall Study|Physician Decision|1|||
130195509|NCT04292912|468673584|FG000|Overall Study|Protocol Violation|6|||
130195510|NCT02475265|468673594|FG000|Overall Study|Physician Decision|1|||
130195511|NCT02475265|468673594|FG000|Overall Study|Withdrawal by Subject|2|||
130195512|NCT01323387|468673598|FG000|Overall Study|Withdrawal by Subject|41|||
130195513|NCT01323387|468673598|FG000|Overall Study|Radiographic Data Unavailable|1|||
130195514|NCT01323387|468673598|FG000|Overall Study|Revision|14|||
130195515|NCT01323387|468673598|FG000|Overall Study|Protocol Violation|12|||
130195516|NCT01323387|468673598|FG000|Overall Study|Randomized but Never Treated|16|||
130195517|NCT01726270|468673599|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
130195518|NCT01726270|468673599|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
130195519|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
130195520|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
130195521|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
130195522|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
130195523|NCT00582608|468673600|FG000|Overall Study|Not Treated|7|||
130195524|NCT00582608|468673600|FG000|Overall Study|Patient Ineligible|1|||
130195525|NCT00582608|468673600|FG000|Overall Study|Lack of accrual|4|||
130195526|NCT02073929|468673616|FG000|Overall Study|Lost to Follow-up|2|||
130195527|NCT02073929|468673617|FG001|Overall Study|Lost to Follow-up|1|||
130195528|NCT02073929|468673616|FG000|Overall Study|Adverse Event|2|||
130195529|NCT02073929|468673617|FG001|Overall Study|Adverse Event|1|||
130195530|NCT02073929|468673616|FG000|Overall Study|Withdrawal by Subject|0|||
130195531|NCT02073929|468673617|FG001|Overall Study|Withdrawal by Subject|1|||
130195532|NCT00430573|468673618|FG000|Overall Study|Withdrawal by Subject|5|||
130195533|NCT04463251|468673619|FG000|Overall Study|Death|1|||
130195534|NCT04463251|468673620|FG001|Overall Study|Death|0|||
130195535|NCT04463251|468673621|FG002|Overall Study|Death|1|||
130195536|NCT04463251|468673619|FG000|Overall Study|Adverse Event|0|||
130195537|NCT04463251|468673620|FG001|Overall Study|Adverse Event|1|||
130195538|NCT04463251|468673621|FG002|Overall Study|Adverse Event|0|||
130195539|NCT04463251|468673619|FG000|Overall Study|Lost to Follow-up|0|||
130195540|NCT04463251|468673620|FG001|Overall Study|Lost to Follow-up|1|||
130195541|NCT04463251|468673621|FG002|Overall Study|Lost to Follow-up|0|||
130195542|NCT04463251|468673619|FG000|Overall Study|Withdrawal by Subject|0|||
130195543|NCT04463251|468673620|FG001|Overall Study|Withdrawal by Subject|2|||
130195544|NCT04463251|468673621|FG002|Overall Study|Withdrawal by Subject|2|||
130195545|NCT05020665|468673622|FG000|Overall Study|Study terminated by Sponsor|5|||
130195546|NCT05020665|468673623|FG001|Overall Study|Study terminated by Sponsor|4|||
130195547|NCT05020665|468673622|FG000|Overall Study|Death|2|||
130195548|NCT05020665|468673623|FG001|Overall Study|Death|1|||
130195549|NCT05020665|468673622|FG000|Overall Study|Physician Decision|0|||
130195550|NCT05020665|468673623|FG001|Overall Study|Physician Decision|1|||
130195551|NCT05020665|468673622|FG000|Overall Study|Withdrawal by Subject|0|||
130195552|NCT05020665|468673623|FG001|Overall Study|Withdrawal by Subject|1|||
130195553|NCT05020665|468673622|FG000|Overall Study|Reason not specified|1|||
130195554|NCT05020665|468673623|FG001|Overall Study|Reason not specified|0|||
130195555|NCT01732640|468673624|FG000|Overall Study|Adverse Event|0|||
130195556|NCT01732640|468673625|FG001|Overall Study|Adverse Event|1|||
130195557|NCT01732640|468673624|FG000|Overall Study|Death|0|||
130195558|NCT01732640|468673625|FG001|Overall Study|Death|1|||
130195559|NCT03070002|468673626|FG000|Follow up for 2 Years|Death|1|||
130195560|NCT02147158|468673627|FG000|Treatment Course 1|Adverse Event|1|||
130195561|NCT02147158|468673628|FG001|Treatment Course 1|Adverse Event|4|||
130195562|NCT02147158|468673629|FG002|Treatment Course 1|Adverse Event|3|||
130195563|NCT02147158|468673630|FG003|Treatment Course 1|Adverse Event|4|||
130195564|NCT02147158|468673631|FG004|Treatment Course 1|Adverse Event|1|||
130195565|NCT02147158|468673632|FG005|Treatment Course 1|Adverse Event|2|||
130195566|NCT02147158|468673627|FG000|Treatment Course 1|Lost to Follow-up|2|||
130195567|NCT02147158|468673628|FG001|Treatment Course 1|Lost to Follow-up|4|||
130195568|NCT02147158|468673629|FG002|Treatment Course 1|Lost to Follow-up|3|||
130195569|NCT02147158|468673630|FG003|Treatment Course 1|Lost to Follow-up|3|||
130195570|NCT02147158|468673631|FG004|Treatment Course 1|Lost to Follow-up|2|||
130195571|NCT02147158|468673632|FG005|Treatment Course 1|Lost to Follow-up|4|||
130195572|NCT02147158|468673627|FG000|Treatment Course 1|Protocol Violation|0|||
130195573|NCT02147158|468673628|FG001|Treatment Course 1|Protocol Violation|0|||
130195574|NCT02147158|468673629|FG002|Treatment Course 1|Protocol Violation|1|||
130195575|NCT02147158|468673630|FG003|Treatment Course 1|Protocol Violation|1|||
130195576|NCT02147158|468673631|FG004|Treatment Course 1|Protocol Violation|0|||
130195577|NCT02147158|468673632|FG005|Treatment Course 1|Protocol Violation|0|||
130195578|NCT02147158|468673627|FG000|Treatment Course 1|Withdrawal of Consent|1|||
130195579|NCT02147158|468673628|FG001|Treatment Course 1|Withdrawal of Consent|1|||
130195580|NCT02147158|468673629|FG002|Treatment Course 1|Withdrawal of Consent|1|||
130195581|NCT02147158|468673630|FG003|Treatment Course 1|Withdrawal of Consent|5|||
130195582|NCT02147158|468673631|FG004|Treatment Course 1|Withdrawal of Consent|3|||
130195583|NCT02147158|468673632|FG005|Treatment Course 1|Withdrawal of Consent|2|||
130195584|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Adverse Event|1|||
130195585|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Adverse Event|0|||
130195586|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Adverse Event|0|||
130195587|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Adverse Event|1|||
130195588|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Adverse Event|0|||
130195589|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Adverse Event|0|||
130195590|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195591|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
130195592|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
130195593|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195594|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
130195595|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195596|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
130195597|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
130195598|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
130195599|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
130195600|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
130195601|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
130195602|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
130195603|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130195604|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
130195605|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
130195606|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
130195607|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130195608|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195609|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195610|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
130195611|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195612|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
130195613|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195614|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130195615|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195616|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
130195617|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130195618|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195619|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195620|NCT02147158|468673627|FG000|Treatment Course 2|Adverse Event|0|||
130195621|NCT02147158|468673628|FG001|Treatment Course 2|Adverse Event|4|||
130195622|NCT02147158|468673629|FG002|Treatment Course 2|Adverse Event|2|||
130195623|NCT02147158|468673630|FG003|Treatment Course 2|Adverse Event|1|||
130195624|NCT02147158|468673631|FG004|Treatment Course 2|Adverse Event|0|||
130195625|NCT02147158|468673632|FG005|Treatment Course 2|Adverse Event|1|||
130195626|NCT02147158|468673627|FG000|Treatment Course 2|Withdrawal of Consent|0|||
130195627|NCT02147158|468673628|FG001|Treatment Course 2|Withdrawal of Consent|1|||
130195628|NCT02147158|468673629|FG002|Treatment Course 2|Withdrawal of Consent|2|||
130195629|NCT02147158|468673630|FG003|Treatment Course 2|Withdrawal of Consent|3|||
130195630|NCT02147158|468673631|FG004|Treatment Course 2|Withdrawal of Consent|0|||
130195631|NCT02147158|468673632|FG005|Treatment Course 2|Withdrawal of Consent|0|||
130195632|NCT02147158|468673627|FG000|Treatment Course 2|Lost to Follow-up|1|||
130195633|NCT02147158|468673628|FG001|Treatment Course 2|Lost to Follow-up|0|||
130195634|NCT02147158|468673629|FG002|Treatment Course 2|Lost to Follow-up|1|||
130195635|NCT02147158|468673630|FG003|Treatment Course 2|Lost to Follow-up|1|||
130195636|NCT02147158|468673631|FG004|Treatment Course 2|Lost to Follow-up|0|||
130195637|NCT02147158|468673632|FG005|Treatment Course 2|Lost to Follow-up|1|||
130195638|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195639|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
130195640|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
130195641|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195642|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195643|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195644|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130195645|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130195646|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
130195647|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130195648|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130195649|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
130195650|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
130195651|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
130195652|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
130195653|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195654|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195655|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195656|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
130195657|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
130195658|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
130195659|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
130195660|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
130195661|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
130195662|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130195663|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
130195664|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130195665|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
130195666|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130195667|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130195668|NCT03425396|468673633|FG000|Overall Study|Lost to Follow-up|2|||
130195669|NCT03425396|468673634|FG001|Overall Study|Lost to Follow-up|5|||
130195670|NCT03425396|468673635|FG002|Overall Study|Lost to Follow-up|2|||
130195671|NCT03425396|468673636|FG003|Overall Study|Lost to Follow-up|0|||
130195672|NCT03425396|468673637|FG004|Overall Study|Lost to Follow-up|0|||
130195673|NCT03425396|468673633|FG000|Overall Study|Withdrawal by Subject|0|||
130195674|NCT03425396|468673634|FG001|Overall Study|Withdrawal by Subject|1|||
130195675|NCT03425396|468673635|FG002|Overall Study|Withdrawal by Subject|0|||
130195676|NCT03425396|468673636|FG003|Overall Study|Withdrawal by Subject|1|||
130195677|NCT03425396|468673637|FG004|Overall Study|Withdrawal by Subject|0|||
130195678|NCT03425396|468673633|FG000|Overall Study|Other|0|||
130195679|NCT03425396|468673634|FG001|Overall Study|Other|1|||
130195680|NCT03425396|468673635|FG002|Overall Study|Other|1|||
130195681|NCT03425396|468673636|FG003|Overall Study|Other|0|||
130195682|NCT03425396|468673637|FG004|Overall Study|Other|1|||
130195683|NCT01441765|468673639|FG000|Overall Study|Death|1|||
130195684|NCT01441765|468673640|FG001|Overall Study|Death|0|||
130195685|NCT04520997|468673641|FG000|Overall Study|Lost to Follow-up|1|||
130195686|NCT04520997|468673642|FG001|Overall Study|Lost to Follow-up|1|||
130195687|NCT04520997|468673641|FG000|Overall Study|Withdrawal by Subject|1|||
130195688|NCT04520997|468673642|FG001|Overall Study|Withdrawal by Subject|0|||
130195689|NCT04520997|468673641|FG000|Overall Study|Not Treated|0|||
130195690|NCT04520997|468673642|FG001|Overall Study|Not Treated|1|||
130195691|NCT02981082|468673645|FG000|Overall Study|Withdrawal by Subject|2|||
130195692|NCT02981082|468673646|FG001|Overall Study|Withdrawal by Subject|0|||
130195693|NCT02981082|468673645|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
130195694|NCT02981082|468673646|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
130195695|NCT02981082|468673645|FG000|Overall Study|Adverse Event|0|||
130195696|NCT02981082|468673646|FG001|Overall Study|Adverse Event|1|||
130195697|NCT03689374|468673647|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
130195698|NCT03689374|468673648|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
130195699|NCT03689374|468673649|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
130195700|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
130195701|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
130195702|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
130195703|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
130195704|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
130195705|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
130195706|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Death|0|||
130195707|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Death|11|||
130195708|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Death|1|||
130195709|NCT05367973|468673650|FG000|Overall Study|Adverse Event|0|||
130195710|NCT05367973|468673651|FG001|Overall Study|Adverse Event|2|||
130195711|NCT02805660|468673652|FG000|Overall Study|Death|5|||
130195712|NCT02805660|468673653|FG001|Overall Study|Death|2|||
130195713|NCT02805660|468673654|FG002|Overall Study|Death|9|||
130195714|NCT02805660|468673655|FG003|Overall Study|Death|5|||
130195715|NCT02805660|468673656|FG004|Overall Study|Death|0|||
130195716|NCT02805660|468673657|FG005|Overall Study|Death|14|||
130195717|NCT02805660|468673658|FG006|Overall Study|Death|12|||
130195718|NCT02805660|468673652|FG000|Overall Study|Lost to Follow-up|0|||
130195719|NCT02805660|468673653|FG001|Overall Study|Lost to Follow-up|1|||
130195720|NCT02805660|468673654|FG002|Overall Study|Lost to Follow-up|1|||
130195721|NCT02805660|468673655|FG003|Overall Study|Lost to Follow-up|2|||
130195722|NCT02805660|468673656|FG004|Overall Study|Lost to Follow-up|0|||
130195723|NCT02805660|468673657|FG005|Overall Study|Lost to Follow-up|0|||
130195724|NCT02805660|468673658|FG006|Overall Study|Lost to Follow-up|0|||
130195725|NCT02805660|468673652|FG000|Overall Study|Withdrawal by Subject|0|||
130195726|NCT02805660|468673653|FG001|Overall Study|Withdrawal by Subject|0|||
130195727|NCT02805660|468673654|FG002|Overall Study|Withdrawal by Subject|0|||
130195728|NCT02805660|468673655|FG003|Overall Study|Withdrawal by Subject|3|||
130195729|NCT02805660|468673656|FG004|Overall Study|Withdrawal by Subject|1|||
130195730|NCT02805660|468673657|FG005|Overall Study|Withdrawal by Subject|0|||
130195731|NCT02805660|468673658|FG006|Overall Study|Withdrawal by Subject|2|||
130195732|NCT02805660|468673652|FG000|Overall Study|Study terminated by Sponsor|0|||
130195733|NCT02805660|468673653|FG001|Overall Study|Study terminated by Sponsor|0|||
130195734|NCT02805660|468673654|FG002|Overall Study|Study terminated by Sponsor|1|||
130195735|NCT02805660|468673655|FG003|Overall Study|Study terminated by Sponsor|4|||
130195736|NCT02805660|468673656|FG004|Overall Study|Study terminated by Sponsor|2|||
130195737|NCT02805660|468673657|FG005|Overall Study|Study terminated by Sponsor|3|||
130195738|NCT02805660|468673658|FG006|Overall Study|Study terminated by Sponsor|1|||
130195739|NCT02805660|468673652|FG000|Overall Study|Miscellaneous|0|||
130195740|NCT02805660|468673653|FG001|Overall Study|Miscellaneous|1|||
130195741|NCT02805660|468673654|FG002|Overall Study|Miscellaneous|0|||
130195742|NCT02805660|468673655|FG003|Overall Study|Miscellaneous|4|||
130195743|NCT02805660|468673656|FG004|Overall Study|Miscellaneous|0|||
130195744|NCT02805660|468673657|FG005|Overall Study|Miscellaneous|6|||
130195745|NCT02805660|468673658|FG006|Overall Study|Miscellaneous|4|||
130195746|NCT00809471|468674789|FG000|Overall Study|Protocol non-compliance|15|||
130195747|NCT00809471|468674790|FG001|Overall Study|Protocol non-compliance|15|||
130195748|NCT00809471|468674791|FG002|Overall Study|Protocol non-compliance|6|||
130195749|NCT00809471|468674789|FG000|Overall Study|Lost to Follow-up|4|||
130195750|NCT00809471|468674790|FG001|Overall Study|Lost to Follow-up|2|||
130195751|NCT00809471|468674791|FG002|Overall Study|Lost to Follow-up|9|||
130195752|NCT00809471|468674789|FG000|Overall Study|Adverse Event|0|||
130195753|NCT00809471|468674790|FG001|Overall Study|Adverse Event|2|||
130195754|NCT00809471|468674791|FG002|Overall Study|Adverse Event|2|||
130195755|NCT00809471|468674789|FG000|Overall Study|Requirement for restricted medication|1|||
130195756|NCT00809471|468674790|FG001|Overall Study|Requirement for restricted medication|1|||
130195757|NCT00809471|468674791|FG002|Overall Study|Requirement for restricted medication|0|||
130195758|NCT00831311|468674792|FG000|Overall Study|Definitive Contraindication|3|||
130195759|NCT00831311|468674793|FG001|Overall Study|Definitive Contraindication|3|||
130195760|NCT00831311|468674792|FG000|Overall Study|Lost to Follow-up|3|||
130195761|NCT00831311|468674793|FG001|Overall Study|Lost to Follow-up|0|||
130195762|NCT00831311|468674792|FG000|Overall Study|Physician Decision|0|||
130195763|NCT00831311|468674793|FG001|Overall Study|Physician Decision|1|||
130195764|NCT00831311|468674792|FG000|Overall Study|Withdrawal by Subject|6|||
130195765|NCT00831311|468674793|FG001|Overall Study|Withdrawal by Subject|4|||
130195766|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
130195767|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
130195768|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
130195769|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
130195770|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
130195771|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
130195772|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
130195773|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
130195774|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Death|0|||
130195775|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Death|1|||
130195776|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
130195777|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
130195778|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
130195779|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
130195780|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
130195781|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
130195782|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
130195783|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
130195784|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
130195785|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
130195786|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Non compliance|0|||
130195787|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Non compliance|1|||
130195788|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
130195789|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
130195790|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
130195791|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
130195792|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
130195793|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
130195794|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
130195795|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
130195796|NCT02028767|468674798|FG000|Treatment Period 2|Non compliant with protocol|1|||
130195797|NCT02028767|468674799|FG001|Treatment Period 2|Non compliant with protocol|0|||
130195798|NCT02028767|468674798|FG000|Treatment Period 2|Reason other than those specified above|1|||
130195799|NCT02028767|468674799|FG001|Treatment Period 2|Reason other than those specified above|0|||
130195800|NCT02780713|468674800|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195801|NCT02780713|468674801|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195802|NCT02780713|468674802|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
130195803|NCT02780713|468674803|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195804|NCT02780713|468674804|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195805|NCT05338502|468674807|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130195806|NCT05338502|468674808|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
130195807|NCT05338502|468674809|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130195808|NCT05338502|468674807|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130195809|NCT05338502|468674808|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
130195810|NCT05338502|468674809|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130195811|NCT03575793|468674810|FG000|Overall Study|Withdrawal by Subject|0|||
130195812|NCT03575793|468674811|FG001|Overall Study|Withdrawal by Subject|1|||
130195813|NCT03575793|468674810|FG000|Overall Study|Never Treated|0|||
130195814|NCT03575793|468674811|FG001|Overall Study|Never Treated|2|||
130195815|NCT01250873|468674812|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
130195816|NCT01250873|468674812|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
130195817|NCT02278939|468674813|FG000|Overall Study|lack of time|1|||
130195818|NCT02278939|468674814|FG001|Overall Study|lack of time|0|||
130195819|NCT02278939|468674813|FG000|Overall Study|Lost to Follow-up|1|||
130195820|NCT02278939|468674814|FG001|Overall Study|Lost to Follow-up|1|||
130195821|NCT02278939|468674813|FG000|Overall Study|death in family|1|||
130195822|NCT02278939|468674814|FG001|Overall Study|death in family|0|||
130195823|NCT02278939|468674813|FG000|Overall Study|family emergency unable to commit|2|||
130195824|NCT02278939|468674814|FG001|Overall Study|family emergency unable to commit|0|||
130195825|NCT03436693|468674817|FG000|Overall Study|Adverse Event|22|||
130195826|NCT03436693|468674818|FG001|Overall Study|Adverse Event|10|||
130195827|NCT03436693|468674817|FG000|Overall Study|Physician Decision|3|||
130195828|NCT03436693|468674818|FG001|Overall Study|Physician Decision|3|||
130195829|NCT03436693|468674817|FG000|Overall Study|Withdrawal by Subject|4|||
130195830|NCT03436693|468674818|FG001|Overall Study|Withdrawal by Subject|13|||
130195831|NCT03436693|468674817|FG000|Overall Study|Progressive Disease|1|||
130195832|NCT03436693|468674818|FG001|Overall Study|Progressive Disease|1|||
130195833|NCT01680861|468674819|FG000|Early Post-transplant Period|Protocol Violation|1|||
130195834|NCT01680861|468674820|FG001|Early Post-transplant Period|Protocol Violation|1|||
130195835|NCT02111577|468674821|FG000|Overall Study|Protocol Violation|2|||
130195836|NCT02111577|468674822|FG001|Overall Study|Protocol Violation|0|||
130195837|NCT02111577|468674821|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
130195838|NCT02111577|468674822|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
130195839|NCT02111577|468674821|FG000|Overall Study|Failure to produce study treatment|6|||
130195840|NCT02111577|468674822|FG001|Overall Study|Failure to produce study treatment|0|||
130195841|NCT02111577|468674821|FG000|Overall Study|Death|518|||
130195842|NCT02111577|468674822|FG001|Overall Study|Death|254|||
130195843|NCT02111577|468674821|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
130195844|NCT02111577|468674822|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
130195845|NCT02111577|468674821|FG000|Overall Study|Adverse Event|1|||
130195846|NCT02111577|468674822|FG001|Overall Study|Adverse Event|1|||
130195847|NCT02111577|468674821|FG000|Overall Study|Withdrawal by Subject|51|||
130195848|NCT02111577|468674822|FG001|Overall Study|Withdrawal by Subject|23|||
130195849|NCT02111577|468674821|FG000|Overall Study|Disease progression|0|||
130195850|NCT02111577|468674822|FG001|Overall Study|Disease progression|1|||
130195851|NCT02111577|468674821|FG000|Overall Study|Lost to Follow-up|19|||
130195852|NCT02111577|468674822|FG001|Overall Study|Lost to Follow-up|10|||
130195853|NCT00654875|468674823|FG000|Overall Study|Adverse Event|5|||
130195854|NCT00654875|468674824|FG001|Overall Study|Adverse Event|5|||
130195855|NCT00654875|468674823|FG000|Overall Study|Withdrawal by Subject|4|||
130195856|NCT00654875|468674824|FG001|Overall Study|Withdrawal by Subject|4|||
130195857|NCT00654875|468674823|FG000|Overall Study|Protocol Violation|3|||
130195858|NCT00654875|468674824|FG001|Overall Study|Protocol Violation|3|||
130195859|NCT00654875|468674823|FG000|Overall Study|Lack of Efficacy|2|||
130195860|NCT00654875|468674824|FG001|Overall Study|Lack of Efficacy|2|||
130195861|NCT00654875|468674823|FG000|Overall Study|Lost to Follow-up|1|||
130195862|NCT00654875|468674824|FG001|Overall Study|Lost to Follow-up|3|||
130195863|NCT00654875|468674823|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130195864|NCT00654875|468674824|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130195865|NCT00654875|468674823|FG000|Overall Study|Administrative Problems|1|||
130195866|NCT00654875|468674824|FG001|Overall Study|Administrative Problems|0|||
130195867|NCT04967885|468674825|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
130195868|NCT04967885|468674826|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
130195869|NCT04967885|468674825|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
130195870|NCT04967885|468674826|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
130195871|NCT04967885|468674825|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
130195872|NCT04967885|468674826|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
130195873|NCT04967885|468674825|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
130195874|NCT04967885|468674826|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
130195875|NCT04967885|468674825|FG000|EMI-II Intervention|Lost to Follow-up|14|||
130195876|NCT04967885|468674826|FG001|EMI-II Intervention|Lost to Follow-up|10|||
130195877|NCT02042950|468674829|FG000|Overall Study|Progressive Disease|4|||
130195878|NCT00886743|468674832|FG000|Overall Study|Adverse Event|3|||
130195879|NCT00886743|468674832|FG000|Overall Study|Other|1|||
130195880|NCT01940887|468674833|FG000|Year 1|Protocol Violation|0|||
130195881|NCT01940887|468674834|FG001|Year 1|Protocol Violation|1|||
130195882|NCT01940887|468674833|FG000|Year 1|Physician Decision|7|||
130195883|NCT01940887|468674834|FG001|Year 1|Physician Decision|3|||
130195884|NCT01940887|468674833|FG000|Year 1|Death|5|||
130195885|NCT01940887|468674834|FG001|Year 1|Death|3|||
130195886|NCT01940887|468674833|FG000|Year 1|Adverse Event|7|||
130195887|NCT01940887|468674834|FG001|Year 1|Adverse Event|6|||
130195888|NCT01940887|468674833|FG000|Year 1|Withdrawal by Subject|18|||
130195889|NCT01940887|468674834|FG001|Year 1|Withdrawal by Subject|9|||
130195890|NCT01940887|468674833|FG000|Year 1|Lost to Follow-up|2|||
130195891|NCT01940887|468674834|FG001|Year 1|Lost to Follow-up|1|||
130195892|NCT01940887|468674833|FG000|Year 2|Physician Decision|8|||
130195893|NCT01940887|468674834|FG001|Year 2|Physician Decision|1|||
130195894|NCT01940887|468674833|FG000|Year 2|Death|0|||
130195895|NCT01940887|468674834|FG001|Year 2|Death|2|||
130195896|NCT01940887|468674833|FG000|Year 2|Sponsor Decision, early termination|192|||
130195897|NCT01940887|468674834|FG001|Year 2|Sponsor Decision, early termination|203|||
130195898|NCT01940887|468674833|FG000|Year 2|Adverse Event|8|||
130195899|NCT01940887|468674834|FG001|Year 2|Adverse Event|2|||
130195900|NCT01940887|468674833|FG000|Year 2|Withdrawal by Subject|8|||
130195901|NCT01940887|468674834|FG001|Year 2|Withdrawal by Subject|8|||
130195902|NCT01940887|468674833|FG000|Year 2|Lost to Follow-up|1|||
130195903|NCT01940887|468674834|FG001|Year 2|Lost to Follow-up|6|||
130195904|NCT02429778|468674836|FG000|Overall Study|Lost to Follow-up|2|||
130195905|NCT02429778|468674837|FG001|Overall Study|Lost to Follow-up|0|||
130195906|NCT02429778|468674836|FG000|Overall Study|Withdrawal by Subject|5|||
130195907|NCT02429778|468674837|FG001|Overall Study|Withdrawal by Subject|0|||
130195908|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
130195909|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
130195910|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
130195911|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
130195912|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195913|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195914|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195915|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195916|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195917|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195918|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195919|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130195920|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195921|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
130195922|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130195923|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195924|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195925|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195926|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195927|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195928|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195929|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195930|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
130195931|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130195932|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
130195933|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130195934|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195935|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195936|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195937|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195938|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195939|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195940|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195941|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
130195942|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
130195943|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
130195944|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
130195945|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195946|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195947|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195948|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195949|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195950|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195951|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195952|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195953|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195954|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195955|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
130195956|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195957|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195958|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195959|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195960|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195961|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195962|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195963|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195964|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195965|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195966|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195967|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130195968|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130195969|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
130195970|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195971|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195972|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195973|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
130195974|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195975|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195976|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195977|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195978|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195979|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195980|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195981|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195982|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195983|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
130195984|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195985|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195986|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195987|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195988|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195989|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
130195990|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
130195991|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130195992|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195993|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
130195994|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
130195995|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130195996|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195997|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195998|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195999|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130196000|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
130196001|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
130196002|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
130196003|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
130196004|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
130196005|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
130196006|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
130196007|NCT00355147|468674856|FG000|Overall Study|Lost to Follow-up|10|||
130196008|NCT00355147|468674857|FG001|Overall Study|Lost to Follow-up|8|||
130196009|NCT00355147|468674856|FG000|Overall Study|Withdrawal by Subject|8|||
130196010|NCT00355147|468674857|FG001|Overall Study|Withdrawal by Subject|12|||
130196011|NCT00072280|468674866|FG000|Treatment|Found ineligible|1|||
130196012|NCT00072280|468674867|FG001|Treatment|Found ineligible|2|||
130196013|NCT00072280|468674866|FG000|Follow-up|Early termination of study|2|||
130196014|NCT00072280|468674867|FG001|Follow-up|Early termination of study|2|||
130196015|NCT00022698|468674873|FG000|Overall Study|Adverse Event|5|||
130196016|NCT00022698|468674874|FG001|Overall Study|Adverse Event|9|||
130196017|NCT00022698|468674873|FG000|Overall Study|Death|0|||
130196018|NCT00022698|468674874|FG001|Overall Study|Death|2|||
130196019|NCT00022698|468674873|FG000|Overall Study|Failure to return|0|||
130196020|NCT00022698|468674874|FG001|Overall Study|Failure to return|1|||
130196021|NCT00022698|468674873|FG000|Overall Study|Refused treatment|0|||
130196022|NCT00022698|468674874|FG001|Overall Study|Refused treatment|2|||
130196023|NCT00022698|468674873|FG000|Overall Study|Insufficient therapeutic response|2|||
130196024|NCT00022698|468674874|FG001|Overall Study|Insufficient therapeutic response|14|||
130196025|NCT00022698|468674873|FG000|Overall Study|Administrative /other|1|||
130196026|NCT00022698|468674874|FG001|Overall Study|Administrative /other|7|||
130196027|NCT02504827|468674875|FG000|Overall Study|Could not produce sputum|1|||
130196028|NCT00877487|468674884|FG000|Open-label Treatment Phase|Adverse Event|1|||
130196029|NCT00877487|468674885|FG001|Open-label Treatment Phase|Adverse Event|0|||
130196030|NCT00877487|468674884|FG000|Open-label Treatment Phase|Protocol Violation|3|||
130196031|NCT00877487|468674885|FG001|Open-label Treatment Phase|Protocol Violation|0|||
130196032|NCT00877487|468674884|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
130196033|NCT00877487|468674885|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130196034|NCT00877487|468674884|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
130196035|NCT00877487|468674885|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130196036|NCT00877487|468674884|FG000|Open-label Treatment Phase|Out of country for business|1|||
130196037|NCT00877487|468674885|FG001|Open-label Treatment Phase|Out of country for business|0|||
130196038|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
130196039|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
130196040|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
130196041|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
130196042|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
130196043|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
130196044|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
130196045|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
130196046|NCT00712543|468674888|FG000|Day 8-14|Lost to Follow-up|0|||
130196047|NCT00712543|468674889|FG001|Day 8-14|Lost to Follow-up|2|||
130196048|NCT02729051|468674892|FG000|Overall Study|Adverse Event|21|||
130196049|NCT02729051|468674893|FG001|Overall Study|Adverse Event|11|||
130196050|NCT02729051|468674892|FG000|Overall Study|Lack of Efficacy|1|||
130196051|NCT02729051|468674893|FG001|Overall Study|Lack of Efficacy|1|||
130196052|NCT02729051|468674892|FG000|Overall Study|Lost to Follow-up|1|||
130196053|NCT02729051|468674893|FG001|Overall Study|Lost to Follow-up|2|||
130196054|NCT02729051|468674892|FG000|Overall Study|Physician Decision|1|||
130196055|NCT02729051|468674893|FG001|Overall Study|Physician Decision|1|||
130196056|NCT02729051|468674892|FG000|Overall Study|Withdrawal by Subject|6|||
130196057|NCT02729051|468674893|FG001|Overall Study|Withdrawal by Subject|17|||
130196058|NCT02702388|468674894|FG000|Overall Study|Disease Progression|18|||
130196059|NCT02702388|468674895|FG001|Overall Study|Disease Progression|25|||
130196060|NCT02702388|468674894|FG000|Overall Study|Withdrawal by Subject|9|||
130196061|NCT02702388|468674895|FG001|Overall Study|Withdrawal by Subject|7|||
130196062|NCT02702388|468674894|FG000|Overall Study|Adverse Event|11|||
130196063|NCT02702388|468674895|FG001|Overall Study|Adverse Event|15|||
130196064|NCT02702388|468674894|FG000|Overall Study|Other|2|||
130196065|NCT02702388|468674895|FG001|Overall Study|Other|4|||
130196066|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
130196067|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
130196068|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
130196069|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
130196070|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130196071|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130196072|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
130196073|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
130196074|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
130196075|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
130196076|NCT04740827|468674907|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
130196077|NCT04740827|468674908|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
130196078|NCT01190410|468676886|FG000|Overall Study|Adverse Event|0|||
130196079|NCT01190410|468676887|FG001|Overall Study|Adverse Event|3|||
130196080|NCT01190410|468676886|FG000|Overall Study|Lack of Efficacy|0|||
130196081|NCT01190410|468676887|FG001|Overall Study|Lack of Efficacy|2|||
130196082|NCT01190410|468676886|FG000|Overall Study|Withdrawal by Subject|0|||
130196083|NCT01190410|468676887|FG001|Overall Study|Withdrawal by Subject|2|||
130196084|NCT01190410|468676886|FG000|Overall Study|Administrative decision|1|||
130196085|NCT01190410|468676887|FG001|Overall Study|Administrative decision|0|||
130196086|NCT01190410|468676886|FG000|Overall Study|PI discretion|0|||
130196087|NCT01190410|468676887|FG001|Overall Study|PI discretion|2|||
130196088|NCT03652636|468676888|FG000|Overall Study|Withdrawal by Subject|7|||
130196089|NCT00504725|468676897|FG000|Overall Study|Protocol Violation|1|||
130196090|NCT00504725|468676898|FG001|Overall Study|Protocol Violation|0|||
130196091|NCT01435018|468676899|FG000|Overall Study|Death|37|||
130196092|NCT01435018|468676900|FG001|Overall Study|Death|18|||
130196093|NCT01435018|468676901|FG002|Overall Study|Death|25|||
130196094|NCT01435018|468676899|FG000|Overall Study|Site is closing|4|||
130196095|NCT01435018|468676900|FG001|Overall Study|Site is closing|9|||
130196096|NCT01435018|468676901|FG002|Overall Study|Site is closing|7|||
130196097|NCT01435018|468676899|FG000|Overall Study|Withdrew consent|0|||
130196098|NCT01435018|468676900|FG001|Overall Study|Withdrew consent|3|||
130196099|NCT01435018|468676901|FG002|Overall Study|Withdrew consent|1|||
130196100|NCT01435018|468676899|FG000|Overall Study|Not willing to adhere to requirements|0|||
130196101|NCT01435018|468676900|FG001|Overall Study|Not willing to adhere to requirements|2|||
130196102|NCT01435018|468676901|FG002|Overall Study|Not willing to adhere to requirements|3|||
130196103|NCT01435018|468676899|FG000|Overall Study|Not able to get to clinic|2|||
130196104|NCT01435018|468676900|FG001|Overall Study|Not able to get to clinic|0|||
130196105|NCT01435018|468676901|FG002|Overall Study|Not able to get to clinic|2|||
130196106|NCT01435018|468676899|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130196107|NCT01435018|468676900|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130196108|NCT01435018|468676901|FG002|Overall Study|Severe debilitation, unable to continue|1|||
130196109|NCT01435018|468676899|FG000|Overall Study|Unable to contact participant/parent|1|||
130196110|NCT01435018|468676900|FG001|Overall Study|Unable to contact participant/parent|1|||
130196111|NCT01435018|468676901|FG002|Overall Study|Unable to contact participant/parent|1|||
130196112|NCT01435018|468676899|FG000|Overall Study|Enrollment Violation|0|||
130196113|NCT01435018|468676900|FG001|Overall Study|Enrollment Violation|1|||
130196114|NCT01435018|468676901|FG002|Overall Study|Enrollment Violation|0|||
130196115|NCT01435018|468676899|FG000|Overall Study|Never started chemotherapy|3|||
130196116|NCT01435018|468676900|FG001|Overall Study|Never started chemotherapy|0|||
130196117|NCT01435018|468676901|FG002|Overall Study|Never started chemotherapy|1|||
130196118|NCT00769067|468676903|FG000|Overall Study|Death|89|||
130196119|NCT00769067|468676904|FG001|Overall Study|Death|86|||
130196120|NCT00769067|468676903|FG000|Overall Study|Lost to Follow-up|3|||
130196121|NCT00769067|468676904|FG001|Overall Study|Lost to Follow-up|1|||
130196122|NCT00769067|468676903|FG000|Overall Study|Study terminated by sponsor|1|||
130196123|NCT00769067|468676904|FG001|Overall Study|Study terminated by sponsor|3|||
130196124|NCT00769067|468676903|FG000|Overall Study|Other|1|||
130196125|NCT00769067|468676904|FG001|Overall Study|Other|3|||
130196126|NCT00769067|468676903|FG000|Overall Study|Withdrawal by Subject|0|||
130196127|NCT00769067|468676904|FG001|Overall Study|Withdrawal by Subject|1|||
130196128|NCT03806933|468676905|FG000|Main Period|Physician Decision|0|||
130196129|NCT03806933|468676906|FG001|Main Period|Physician Decision|0|||
130196130|NCT03806933|468676907|FG002|Main Period|Physician Decision|0|||
130196131|NCT03806933|468676908|FG003|Main Period|Physician Decision|1|||
130196132|NCT03806933|468676905|FG000|Main Period|Pregnancy|0|||
130196133|NCT03806933|468676906|FG001|Main Period|Pregnancy|0|||
130196134|NCT03806933|468676907|FG002|Main Period|Pregnancy|1|||
130196135|NCT03806933|468676908|FG003|Main Period|Pregnancy|0|||
130196136|NCT03806933|468676905|FG000|Main Period|Withdrawal by Subject|2|||
130196137|NCT03806933|468676906|FG001|Main Period|Withdrawal by Subject|1|||
130196138|NCT03806933|468676907|FG002|Main Period|Withdrawal by Subject|1|||
130196139|NCT03806933|468676908|FG003|Main Period|Withdrawal by Subject|2|||
130196140|NCT03806933|468676905|FG000|Main Period|Lost to Follow-up|2|||
130196141|NCT03806933|468676906|FG001|Main Period|Lost to Follow-up|2|||
130196142|NCT03806933|468676907|FG002|Main Period|Lost to Follow-up|0|||
130196143|NCT03806933|468676908|FG003|Main Period|Lost to Follow-up|0|||
130196144|NCT03806933|468676905|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196145|NCT03806933|468676906|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196146|NCT03806933|468676907|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196147|NCT03806933|468676908|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
130196148|NCT03625466|468676909|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130196149|NCT03625466|468676910|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
130196150|NCT03625466|468676911|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130196151|NCT03625466|468676909|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196152|NCT03625466|468676910|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130196153|NCT03625466|468676911|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196154|NCT03625466|468676909|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196155|NCT03625466|468676910|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196156|NCT03625466|468676911|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130196157|NCT01868438|468676914|FG000|First Intervention|Withdrawal by Subject|5|||
130196158|NCT01868438|468676915|FG001|First Intervention|Withdrawal by Subject|1|||
130196159|NCT01868438|468676914|FG000|First Intervention|Lost to Follow-up|2|||
130196160|NCT01868438|468676915|FG001|First Intervention|Lost to Follow-up|3|||
130196161|NCT01868438|468676914|FG000|First Intervention|Meeting the non-redosing criteria|0|||
130196162|NCT01868438|468676915|FG001|First Intervention|Meeting the non-redosing criteria|1|||
130196163|NCT01868438|468676914|FG000|Second Intervention|Adverse Event|3|||
130196164|NCT01868438|468676915|FG001|Second Intervention|Adverse Event|3|||
130196165|NCT00956592|468676919|FG000|Overall Study|Protocol Violation|1|||
130196166|NCT00956592|468676920|FG001|Overall Study|Protocol Violation|3|||
130196167|NCT00076752|468676921|FG000|Overall Study|Death|2|||
130196168|NCT00076752|468676921|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
130196169|NCT02632409|468676924|FG000|Randomized|AE unrelated to study Drug|0|||
130196170|NCT02632409|468676925|FG001|Randomized|AE unrelated to study Drug|1|||
130196171|NCT02632409|468676924|FG000|Randomized|Participant withdrew consent|2|||
130196172|NCT02632409|468676925|FG001|Randomized|Participant withdrew consent|1|||
130196173|NCT02632409|468676924|FG000|Randomized|No Longer meets study criteria|5|||
130196174|NCT02632409|468676925|FG001|Randomized|No Longer meets study criteria|0|||
130196175|NCT02632409|468676924|FG000|Randomized|other reasons|1|||
130196176|NCT02632409|468676925|FG001|Randomized|other reasons|0|||
130196177|NCT02632409|468676924|FG000|Treatment Period|Ongoing Treatment|20|||
130196178|NCT02632409|468676925|FG001|Treatment Period|Ongoing Treatment|21|||
130196179|NCT02632409|468676924|FG000|Treatment Period|Disease Recurrence|147|||
130196180|NCT02632409|468676925|FG001|Treatment Period|Disease Recurrence|90|||
130196181|NCT02632409|468676924|FG000|Treatment Period|Study Drug Toxicity|8|||
130196182|NCT02632409|468676925|FG001|Treatment Period|Study Drug Toxicity|49|||
130196183|NCT02632409|468676924|FG000|Treatment Period|Death|1|||
130196184|NCT02632409|468676925|FG001|Treatment Period|Death|0|||
130196185|NCT02632409|468676924|FG000|Treatment Period|AE unrelated to study drug|15|||
130196186|NCT02632409|468676925|FG001|Treatment Period|AE unrelated to study drug|16|||
130196187|NCT02632409|468676924|FG000|Treatment Period|Request to discontinue treatment|4|||
130196188|NCT02632409|468676925|FG001|Treatment Period|Request to discontinue treatment|19|||
130196189|NCT02632409|468676924|FG000|Treatment Period|Participant withdrew consent|7|||
130196190|NCT02632409|468676925|FG001|Treatment Period|Participant withdrew consent|5|||
130196191|NCT02632409|468676924|FG000|Treatment Period|Lost to Follow-up|0|||
130196192|NCT02632409|468676925|FG001|Treatment Period|Lost to Follow-up|1|||
130196193|NCT02632409|468676924|FG000|Treatment Period|Maximum clinical benefit|1|||
130196194|NCT02632409|468676925|FG001|Treatment Period|Maximum clinical benefit|0|||
130196195|NCT02632409|468676924|FG000|Treatment Period|No longer meets study criteria|3|||
130196196|NCT02632409|468676925|FG001|Treatment Period|No longer meets study criteria|0|||
130196197|NCT02632409|468676924|FG000|Treatment Period|Administrative Reason by sponsor|0|||
130196198|NCT02632409|468676925|FG001|Treatment Period|Administrative Reason by sponsor|1|||
130196199|NCT02632409|468676924|FG000|Treatment Period|Other Reasons|10|||
130196200|NCT02632409|468676925|FG001|Treatment Period|Other Reasons|6|||
130196201|NCT01867710|468676926|FG000|Overall Study|Death|25|||
130196202|NCT01867710|468676927|FG001|Overall Study|Death|15|||
130196203|NCT01867710|468676928|FG002|Overall Study|Death|27|||
130196204|NCT01867710|468676929|FG003|Overall Study|Death|20|||
130196205|NCT01867710|468676926|FG000|Overall Study|Lost to Follow-up|3|||
130196206|NCT01867710|468676927|FG001|Overall Study|Lost to Follow-up|4|||
130196207|NCT01867710|468676928|FG002|Overall Study|Lost to Follow-up|3|||
130196208|NCT01867710|468676929|FG003|Overall Study|Lost to Follow-up|2|||
130196209|NCT01867710|468676926|FG000|Overall Study|Withdrawal of consent|2|||
130196210|NCT01867710|468676927|FG001|Overall Study|Withdrawal of consent|5|||
130196211|NCT01867710|468676928|FG002|Overall Study|Withdrawal of consent|1|||
130196212|NCT01867710|468676929|FG003|Overall Study|Withdrawal of consent|2|||
130196213|NCT01867710|468676926|FG000|Overall Study|Study Terminated by Sponsor|9|||
130196214|NCT01867710|468676927|FG001|Overall Study|Study Terminated by Sponsor|13|||
130196215|NCT01867710|468676928|FG002|Overall Study|Study Terminated by Sponsor|8|||
130196216|NCT01867710|468676929|FG003|Overall Study|Study Terminated by Sponsor|16|||
130196217|NCT01867710|468676926|FG000|Overall Study|Biochemical progression|0|||
130196218|NCT01867710|468676927|FG001|Overall Study|Biochemical progression|1|||
130196219|NCT01867710|468676928|FG002|Overall Study|Biochemical progression|0|||
130196220|NCT01867710|468676929|FG003|Overall Study|Biochemical progression|0|||
130196221|NCT01867710|468676926|FG000|Overall Study|Clinical progression|0|||
130196222|NCT01867710|468676927|FG001|Overall Study|Clinical progression|0|||
130196223|NCT01867710|468676928|FG002|Overall Study|Clinical progression|1|||
130196224|NCT01867710|468676929|FG003|Overall Study|Clinical progression|0|||
130196225|NCT01867710|468676926|FG000|Overall Study|Disease progression|1|||
130196226|NCT01867710|468676927|FG001|Overall Study|Disease progression|0|||
130196227|NCT01867710|468676928|FG002|Overall Study|Disease progression|0|||
130196228|NCT01867710|468676929|FG003|Overall Study|Disease progression|0|||
130196229|NCT01867710|468676926|FG000|Overall Study|Patient decision|0|||
130196230|NCT01867710|468676927|FG001|Overall Study|Patient decision|0|||
130196231|NCT01867710|468676928|FG002|Overall Study|Patient decision|0|||
130196232|NCT01867710|468676929|FG003|Overall Study|Patient decision|1|||
130196233|NCT01867710|468676926|FG000|Overall Study|Patient to follow subsequent treatment|0|||
130196234|NCT01867710|468676927|FG001|Overall Study|Patient to follow subsequent treatment|1|||
130196235|NCT01867710|468676928|FG002|Overall Study|Patient to follow subsequent treatment|0|||
130196236|NCT01867710|468676929|FG003|Overall Study|Patient to follow subsequent treatment|0|||
130196237|NCT01867710|468676926|FG000|Overall Study|Progressive disease|1|||
130196238|NCT01867710|468676927|FG001|Overall Study|Progressive disease|0|||
130196239|NCT01867710|468676928|FG002|Overall Study|Progressive disease|0|||
130196240|NCT01867710|468676929|FG003|Overall Study|Progressive disease|0|||
130196241|NCT01867710|468676926|FG000|Overall Study|Protocol Violation|0|||
130196242|NCT01867710|468676927|FG001|Overall Study|Protocol Violation|0|||
130196243|NCT01867710|468676928|FG002|Overall Study|Protocol Violation|0|||
130196244|NCT01867710|468676929|FG003|Overall Study|Protocol Violation|1|||
130196245|NCT01867710|468676926|FG000|Overall Study|PSA-progression|0|||
130196246|NCT01867710|468676927|FG001|Overall Study|PSA-progression|1|||
130196247|NCT01867710|468676928|FG002|Overall Study|PSA-progression|0|||
130196248|NCT01867710|468676929|FG003|Overall Study|PSA-progression|0|||
130196249|NCT01867710|468676926|FG000|Overall Study|Study medication no longer effective|0|||
130196250|NCT01867710|468676927|FG001|Overall Study|Study medication no longer effective|1|||
130196251|NCT01867710|468676928|FG002|Overall Study|Study medication no longer effective|0|||
130196252|NCT01867710|468676929|FG003|Overall Study|Study medication no longer effective|0|||
130196253|NCT03521115|468676930|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
130196254|NCT03521115|468676931|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
130196255|NCT03521115|468676930|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
130196256|NCT03521115|468676931|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
130196257|NCT01981954|468676936|FG000|Titration Period|Protocol Deviation|1|||
130196258|NCT01981954|468676936|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
130196259|NCT03655470|468676937|FG000|Overall Study|Lost to Follow-up|6|||
130196260|NCT03655470|468676938|FG001|Overall Study|Lost to Follow-up|7|||
130196261|NCT03063086|468676941|FG000|Overall Study|technical problems|1|||
130196262|NCT03063086|468676942|FG001|Overall Study|technical problems|0|||
130196263|NCT03063086|468676943|FG002|Overall Study|technical problems|0|||
130196264|NCT03063086|468676944|FG003|Overall Study|technical problems|0|||
130196265|NCT03063086|468676945|FG004|Overall Study|technical problems|0|||
130196266|NCT03063086|468676946|FG005|Overall Study|technical problems|0|||
130196267|NCT03063086|468676941|FG000|Overall Study|Adverse Event|1|||
130196268|NCT03063086|468676942|FG001|Overall Study|Adverse Event|1|||
130196269|NCT03063086|468676943|FG002|Overall Study|Adverse Event|1|||
130196270|NCT03063086|468676944|FG003|Overall Study|Adverse Event|1|||
130196271|NCT03063086|468676945|FG004|Overall Study|Adverse Event|0|||
130196272|NCT03063086|468676946|FG005|Overall Study|Adverse Event|0|||
130196273|NCT03063086|468676941|FG000|Overall Study|subject/guardian decision|1|||
130196274|NCT03063086|468676942|FG001|Overall Study|subject/guardian decision|0|||
130196275|NCT03063086|468676943|FG002|Overall Study|subject/guardian decision|0|||
130196276|NCT03063086|468676944|FG003|Overall Study|subject/guardian decision|0|||
130196277|NCT03063086|468676945|FG004|Overall Study|subject/guardian decision|0|||
130196278|NCT03063086|468676946|FG005|Overall Study|subject/guardian decision|0|||
130196279|NCT03063086|468676941|FG000|Overall Study|Non-compliance with study treatment|0|||
130196280|NCT03063086|468676942|FG001|Overall Study|Non-compliance with study treatment|0|||
130196281|NCT03063086|468676943|FG002|Overall Study|Non-compliance with study treatment|0|||
130196282|NCT03063086|468676944|FG003|Overall Study|Non-compliance with study treatment|1|||
130196283|NCT03063086|468676945|FG004|Overall Study|Non-compliance with study treatment|0|||
130196284|NCT03063086|468676946|FG005|Overall Study|Non-compliance with study treatment|1|||
130196285|NCT03063086|468676941|FG000|Overall Study|Physician Decision|0|||
130196286|NCT03063086|468676942|FG001|Overall Study|Physician Decision|0|||
130196287|NCT03063086|468676943|FG002|Overall Study|Physician Decision|0|||
130196288|NCT03063086|468676944|FG003|Overall Study|Physician Decision|1|||
130196289|NCT03063086|468676945|FG004|Overall Study|Physician Decision|0|||
130196290|NCT03063086|468676946|FG005|Overall Study|Physician Decision|0|||
130196291|NCT04590586|468676948|FG000|Overall Study|Death|7|||
130196292|NCT04590586|468676949|FG001|Overall Study|Death|1|||
130196293|NCT04590586|468676950|FG002|Overall Study|Death|37|||
130196294|NCT04590586|468676951|FG003|Overall Study|Death|34|||
130196295|NCT04590586|468676952|FG004|Overall Study|Death|19|||
130196296|NCT04590586|468676953|FG005|Overall Study|Death|3|||
130196297|NCT04590586|468676948|FG000|Overall Study|Lost to Follow-up|3|||
130196298|NCT04590586|468676949|FG001|Overall Study|Lost to Follow-up|0|||
130196299|NCT04590586|468676950|FG002|Overall Study|Lost to Follow-up|11|||
130196300|NCT04590586|468676951|FG003|Overall Study|Lost to Follow-up|11|||
130196301|NCT04590586|468676952|FG004|Overall Study|Lost to Follow-up|6|||
130196302|NCT04590586|468676953|FG005|Overall Study|Lost to Follow-up|0|||
130196303|NCT04590586|468676948|FG000|Overall Study|Withdrawal by Subject|0|||
130196304|NCT04590586|468676949|FG001|Overall Study|Withdrawal by Subject|0|||
130196305|NCT04590586|468676950|FG002|Overall Study|Withdrawal by Subject|6|||
130196306|NCT04590586|468676951|FG003|Overall Study|Withdrawal by Subject|0|||
130196307|NCT04590586|468676952|FG004|Overall Study|Withdrawal by Subject|3|||
130196308|NCT04590586|468676953|FG005|Overall Study|Withdrawal by Subject|0|||
130196309|NCT04590586|468676948|FG000|Overall Study|Other|3|||
130196310|NCT04590586|468676949|FG001|Overall Study|Other|0|||
130196311|NCT04590586|468676950|FG002|Overall Study|Other|1|||
130196312|NCT04590586|468676951|FG003|Overall Study|Other|1|||
130196313|NCT04590586|468676952|FG004|Overall Study|Other|2|||
130196314|NCT04590586|468676953|FG005|Overall Study|Other|1|||
130196315|NCT01893281|468676954|FG000|Overall Study|Adverse Event|1|||
130196316|NCT01893281|468676954|FG000|Overall Study|Protocol Violation|1|||
130196317|NCT01893281|468676954|FG000|Overall Study|Withdrawal by Subject|1|||
130196318|NCT02218736|468676955|FG000|Overall Study|Withdrawal by Subject|10|||
130196319|NCT02218736|468676956|FG001|Overall Study|Withdrawal by Subject|9|||
130196320|NCT02218736|468676955|FG000|Overall Study|Protocol Violation|2|||
130196321|NCT02218736|468676956|FG001|Overall Study|Protocol Violation|0|||
130196322|NCT05481125|468676959|FG000|Overall Study|Adverse Event|1|||
130196323|NCT05481125|468676960|FG001|Overall Study|Adverse Event|0|||
130196324|NCT05481125|468676959|FG000|Overall Study|Lost to Follow-up|0|||
130196325|NCT05481125|468676960|FG001|Overall Study|Lost to Follow-up|1|||
130196326|NCT05481125|468676959|FG000|Overall Study|Withdrawal by Subject|0|||
130196327|NCT05481125|468676960|FG001|Overall Study|Withdrawal by Subject|1|||
130196328|NCT02244463|468676961|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
130196329|NCT02244463|468676962|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196330|NCT02244463|468676963|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196331|NCT02244463|468676964|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196332|NCT02244463|468676965|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196333|NCT02244463|468676966|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196334|NCT02244463|468676961|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
130196335|NCT02244463|468676962|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
130196336|NCT02244463|468676963|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
130196337|NCT02244463|468676964|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
130196338|NCT02244463|468676965|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
130196339|NCT02244463|468676966|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
130196340|NCT02244463|468676961|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196341|NCT02244463|468676962|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
130196342|NCT02244463|468676963|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196343|NCT02244463|468676964|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196344|NCT02244463|468676965|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196345|NCT02244463|468676966|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196346|NCT02244463|468676961|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196347|NCT02244463|468676962|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196348|NCT02244463|468676963|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
130196349|NCT02244463|468676964|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196350|NCT02244463|468676965|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196351|NCT02244463|468676966|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196352|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196353|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196354|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196355|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
130196356|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196357|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196358|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196359|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196360|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196361|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
130196362|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196363|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196364|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196365|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196366|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196367|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
130196368|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196369|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196370|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196371|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196372|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196373|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
130196374|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196375|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196376|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196377|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196378|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196379|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
130196380|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196381|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196382|NCT02244463|468676961|FG000|Period 5: Phase II|Disease Progression|0|||
130196383|NCT02244463|468676962|FG001|Period 5: Phase II|Disease Progression|0|||
130196384|NCT02244463|468676963|FG002|Period 5: Phase II|Disease Progression|0|||
130196385|NCT02244463|468676964|FG003|Period 5: Phase II|Disease Progression|0|||
130196386|NCT02244463|468676965|FG004|Period 5: Phase II|Disease Progression|10|||
130196387|NCT02244463|468676966|FG005|Period 5: Phase II|Disease Progression|11|||
130196388|NCT02244463|468676961|FG000|Period 5: Phase II|Physician Decision|0|||
130196389|NCT02244463|468676962|FG001|Period 5: Phase II|Physician Decision|0|||
130196390|NCT02244463|468676963|FG002|Period 5: Phase II|Physician Decision|0|||
130196391|NCT02244463|468676964|FG003|Period 5: Phase II|Physician Decision|0|||
130196392|NCT02244463|468676965|FG004|Period 5: Phase II|Physician Decision|3|||
130196393|NCT02244463|468676966|FG005|Period 5: Phase II|Physician Decision|2|||
130196394|NCT02244463|468676961|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
130196395|NCT02244463|468676962|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
130196396|NCT02244463|468676963|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
130196397|NCT02244463|468676964|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
130196398|NCT02244463|468676965|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
130196399|NCT02244463|468676966|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
130196400|NCT02244463|468676961|FG000|Period 5: Phase II|Intercurrent Illness|0|||
130196401|NCT02244463|468676962|FG001|Period 5: Phase II|Intercurrent Illness|0|||
130196402|NCT02244463|468676963|FG002|Period 5: Phase II|Intercurrent Illness|0|||
130196403|NCT02244463|468676964|FG003|Period 5: Phase II|Intercurrent Illness|0|||
130196404|NCT02244463|468676965|FG004|Period 5: Phase II|Intercurrent Illness|2|||
130196405|NCT02244463|468676966|FG005|Period 5: Phase II|Intercurrent Illness|0|||
130196406|NCT02244463|468676961|FG000|Period 5: Phase II|Adverse Event|0|||
130196407|NCT02244463|468676962|FG001|Period 5: Phase II|Adverse Event|0|||
130196408|NCT02244463|468676963|FG002|Period 5: Phase II|Adverse Event|0|||
130196409|NCT02244463|468676964|FG003|Period 5: Phase II|Adverse Event|0|||
130196410|NCT02244463|468676965|FG004|Period 5: Phase II|Adverse Event|0|||
130196411|NCT02244463|468676966|FG005|Period 5: Phase II|Adverse Event|2|||
130196412|NCT02244463|468676961|FG000|Period 5: Phase II|Still On treatment|0|||
130196413|NCT02244463|468676962|FG001|Period 5: Phase II|Still On treatment|0|||
130196414|NCT02244463|468676963|FG002|Period 5: Phase II|Still On treatment|0|||
130196415|NCT02244463|468676964|FG003|Period 5: Phase II|Still On treatment|0|||
130196416|NCT02244463|468676965|FG004|Period 5: Phase II|Still On treatment|0|||
130196417|NCT02244463|468676966|FG005|Period 5: Phase II|Still On treatment|3|||
130196418|NCT01769508|468676967|FG000|Overall Study|Death|3|||
130196419|NCT01769508|468676967|FG000|Overall Study|Withdrawal by Subject|1|||
130196420|NCT01769508|468676967|FG000|Overall Study|Adverse Event|1|||
130196421|NCT01769508|468676967|FG000|Overall Study|Lost to Follow-up|1|||
130196422|NCT01598090|468676971|FG000|Treatment Period|Poor/non-compliance|0|||
130196423|NCT01598090|468676972|FG001|Treatment Period|Poor/non-compliance|2|||
130196424|NCT01598090|468676973|FG002|Treatment Period|Poor/non-compliance|0|||
130196425|NCT01598090|468676971|FG000|Treatment Period|No longer meet study criteria|0|||
130196426|NCT01598090|468676972|FG001|Treatment Period|No longer meet study criteria|1|||
130196427|NCT01598090|468676973|FG002|Treatment Period|No longer meet study criteria|0|||
130196428|NCT01598090|468676971|FG000|Treatment Period|Lack of Efficacy|5|||
130196429|NCT01598090|468676972|FG001|Treatment Period|Lack of Efficacy|14|||
130196430|NCT01598090|468676973|FG002|Treatment Period|Lack of Efficacy|6|||
130196431|NCT01598090|468676971|FG000|Treatment Period|Adverse Event|2|||
130196432|NCT01598090|468676972|FG001|Treatment Period|Adverse Event|33|||
130196433|NCT01598090|468676973|FG002|Treatment Period|Adverse Event|17|||
130196434|NCT01598090|468676971|FG000|Treatment Period|Other reasons|0|||
130196435|NCT01598090|468676972|FG001|Treatment Period|Other reasons|4|||
130196436|NCT01598090|468676973|FG002|Treatment Period|Other reasons|1|||
130196437|NCT01598090|468676971|FG000|Treatment Period|Withdrawal by Subject|3|||
130196438|NCT01598090|468676972|FG001|Treatment Period|Withdrawal by Subject|13|||
130196439|NCT01598090|468676973|FG002|Treatment Period|Withdrawal by Subject|10|||
130196440|NCT01598090|468676971|FG000|Treatment Period|Lost to Follow-up|1|||
130196441|NCT01598090|468676972|FG001|Treatment Period|Lost to Follow-up|5|||
130196442|NCT01598090|468676973|FG002|Treatment Period|Lost to Follow-up|1|||
130196443|NCT01598090|468676971|FG000|Follow-up Period|Death|0|||
130196444|NCT01598090|468676972|FG001|Follow-up Period|Death|1|||
130196445|NCT01598090|468676973|FG002|Follow-up Period|Death|0|||
130196446|NCT01598090|468676971|FG000|Follow-up Period|No longer required per protocol|1|||
130196447|NCT01598090|468676972|FG001|Follow-up Period|No longer required per protocol|3|||
130196448|NCT01598090|468676973|FG002|Follow-up Period|No longer required per protocol|2|||
130196449|NCT01598090|468676971|FG000|Follow-up Period|Not reported|0|||
130196450|NCT01598090|468676972|FG001|Follow-up Period|Not reported|10|||
130196451|NCT01598090|468676973|FG002|Follow-up Period|Not reported|4|||
130196452|NCT01598090|468676971|FG000|Follow-up Period|Withdrawal by Subject|0|||
130196453|NCT01598090|468676972|FG001|Follow-up Period|Withdrawal by Subject|3|||
130196454|NCT01598090|468676973|FG002|Follow-up Period|Withdrawal by Subject|2|||
130196455|NCT01598090|468676971|FG000|Follow-up Period|Other reasons|2|||
130196456|NCT01598090|468676972|FG001|Follow-up Period|Other reasons|8|||
130196457|NCT01598090|468676973|FG002|Follow-up Period|Other reasons|8|||
130196458|NCT01598090|468676971|FG000|Follow-up Period|Lost to Follow-up|2|||
130196459|NCT01598090|468676972|FG001|Follow-up Period|Lost to Follow-up|10|||
130196460|NCT01598090|468676973|FG002|Follow-up Period|Lost to Follow-up|12|||
130196461|NCT03615144|468676974|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
130196462|NCT03615144|468676975|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
130196463|NCT02587598|468676978|FG000|Overall Study|Death|4|||
130196464|NCT02587598|468676979|FG001|Overall Study|Death|8|||
130196465|NCT02587598|468676980|FG002|Overall Study|Death|4|||
130196466|NCT02587598|468676981|FG003|Overall Study|Death|16|||
130196467|NCT02587598|468676982|FG004|Overall Study|Death|9|||
130196468|NCT02587598|468676983|FG005|Overall Study|Death|4|||
130196469|NCT02587598|468676984|FG006|Overall Study|Death|6|||
130196470|NCT02587598|468676985|FG007|Overall Study|Death|7|||
130196471|NCT02587598|468676986|FG008|Overall Study|Death|9|||
130196472|NCT02587598|468676987|FG009|Overall Study|Death|1|||
130196473|NCT02587598|468676988|FG010|Overall Study|Death|3|||
130196474|NCT02587598|468676978|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130196475|NCT02587598|468676979|FG001|Overall Study|Study Terminated by the Sponsor|1|||
130196476|NCT02587598|468676980|FG002|Overall Study|Study Terminated by the Sponsor|0|||
130196477|NCT02587598|468676981|FG003|Overall Study|Study Terminated by the Sponsor|3|||
130196478|NCT02587598|468676982|FG004|Overall Study|Study Terminated by the Sponsor|0|||
130196479|NCT02587598|468676983|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130196480|NCT02587598|468676984|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130196481|NCT02587598|468676985|FG007|Overall Study|Study Terminated by the Sponsor|0|||
130196482|NCT02587598|468676986|FG008|Overall Study|Study Terminated by the Sponsor|0|||
130196483|NCT02587598|468676987|FG009|Overall Study|Study Terminated by the Sponsor|1|||
130196484|NCT02587598|468676988|FG010|Overall Study|Study Terminated by the Sponsor|6|||
130196485|NCT02587598|468676978|FG000|Overall Study|Reason for study withdrawal not specified|0|||
130196486|NCT02587598|468676979|FG001|Overall Study|Reason for study withdrawal not specified|1|||
130196487|NCT02587598|468676980|FG002|Overall Study|Reason for study withdrawal not specified|0|||
130196488|NCT02587598|468676981|FG003|Overall Study|Reason for study withdrawal not specified|0|||
130196489|NCT02587598|468676982|FG004|Overall Study|Reason for study withdrawal not specified|0|||
130196490|NCT02587598|468676983|FG005|Overall Study|Reason for study withdrawal not specified|0|||
130196491|NCT02587598|468676984|FG006|Overall Study|Reason for study withdrawal not specified|0|||
130196492|NCT02587598|468676985|FG007|Overall Study|Reason for study withdrawal not specified|0|||
130196493|NCT02587598|468676986|FG008|Overall Study|Reason for study withdrawal not specified|0|||
130196494|NCT02587598|468676987|FG009|Overall Study|Reason for study withdrawal not specified|0|||
130196495|NCT02587598|468676988|FG010|Overall Study|Reason for study withdrawal not specified|0|||
130196496|NCT02587598|468676978|FG000|Overall Study|Withdrawal by Subject|0|||
130196497|NCT02587598|468676979|FG001|Overall Study|Withdrawal by Subject|1|||
130196498|NCT02587598|468676980|FG002|Overall Study|Withdrawal by Subject|0|||
130196499|NCT02587598|468676981|FG003|Overall Study|Withdrawal by Subject|2|||
130196500|NCT02587598|468676982|FG004|Overall Study|Withdrawal by Subject|3|||
130196501|NCT02587598|468676983|FG005|Overall Study|Withdrawal by Subject|1|||
130196502|NCT02587598|468676984|FG006|Overall Study|Withdrawal by Subject|0|||
130196503|NCT02587598|468676985|FG007|Overall Study|Withdrawal by Subject|0|||
130196504|NCT02587598|468676986|FG008|Overall Study|Withdrawal by Subject|0|||
130196505|NCT02587598|468676987|FG009|Overall Study|Withdrawal by Subject|1|||
130196506|NCT02587598|468676988|FG010|Overall Study|Withdrawal by Subject|2|||
130196507|NCT02587598|468676978|FG000|Overall Study|Physician Decision|0|||
130196508|NCT02587598|468676979|FG001|Overall Study|Physician Decision|0|||
130196509|NCT02587598|468676980|FG002|Overall Study|Physician Decision|0|||
130196510|NCT02587598|468676981|FG003|Overall Study|Physician Decision|0|||
130196511|NCT02587598|468676982|FG004|Overall Study|Physician Decision|0|||
130196512|NCT02587598|468676983|FG005|Overall Study|Physician Decision|0|||
130196513|NCT02587598|468676984|FG006|Overall Study|Physician Decision|0|||
130196514|NCT02587598|468676985|FG007|Overall Study|Physician Decision|0|||
130196515|NCT02587598|468676986|FG008|Overall Study|Physician Decision|0|||
130196516|NCT02587598|468676987|FG009|Overall Study|Physician Decision|0|||
130196517|NCT02587598|468676988|FG010|Overall Study|Physician Decision|3|||
130196518|NCT02394340|468676993|FG000|Overall Study|Failed drug screen test|1|||
130196519|NCT02394340|468676993|FG000|Overall Study|Adverse Event|1|||
130196520|NCT02828124|468676994|FG000|Overall Study|Disease Progression|1|||
130196521|NCT02828124|468676995|FG001|Overall Study|Disease Progression|2|||
130196522|NCT02828124|468676996|FG002|Overall Study|Disease Progression|1|||
130196523|NCT02828124|468676997|FG003|Overall Study|Disease Progression|4|||
130196524|NCT02828124|468676994|FG000|Overall Study|AE Unrelated to Study Drug|0|||
130196525|NCT02828124|468676995|FG001|Overall Study|AE Unrelated to Study Drug|0|||
130196526|NCT02828124|468676996|FG002|Overall Study|AE Unrelated to Study Drug|0|||
130196527|NCT02828124|468676997|FG003|Overall Study|AE Unrelated to Study Drug|1|||
130196528|NCT02828124|468676994|FG000|Overall Study|Subject Withdrew Consent|0|||
130196529|NCT02828124|468676995|FG001|Overall Study|Subject Withdrew Consent|0|||
130196530|NCT02828124|468676996|FG002|Overall Study|Subject Withdrew Consent|0|||
130196531|NCT02828124|468676997|FG003|Overall Study|Subject Withdrew Consent|1|||
130196532|NCT00256854|468676998|FG000|Overall Study|Withdrawal by Subject|2|||
130196533|NCT00256854|468676999|FG001|Overall Study|Withdrawal by Subject|3|||
130196534|NCT00256854|468677000|FG002|Overall Study|Withdrawal by Subject|0|||
130196535|NCT00256854|468677001|FG003|Overall Study|Withdrawal by Subject|0|||
130196536|NCT00256854|468677002|FG004|Overall Study|Withdrawal by Subject|0|||
130196537|NCT00256854|468677003|FG005|Overall Study|Withdrawal by Subject|0|||
130196538|NCT00256854|468676998|FG000|Overall Study|Lack of Efficacy|1|||
130196539|NCT00256854|468676999|FG001|Overall Study|Lack of Efficacy|0|||
130196540|NCT00256854|468677000|FG002|Overall Study|Lack of Efficacy|0|||
130196541|NCT00256854|468677001|FG003|Overall Study|Lack of Efficacy|0|||
130196542|NCT00256854|468677002|FG004|Overall Study|Lack of Efficacy|0|||
130196543|NCT00256854|468677003|FG005|Overall Study|Lack of Efficacy|0|||
130196544|NCT00256854|468676998|FG000|Overall Study|Protocol Violation|0|||
130196545|NCT00256854|468676999|FG001|Overall Study|Protocol Violation|1|||
130196546|NCT00256854|468677000|FG002|Overall Study|Protocol Violation|1|||
130196547|NCT00256854|468677001|FG003|Overall Study|Protocol Violation|1|||
130196548|NCT00256854|468677002|FG004|Overall Study|Protocol Violation|0|||
130196549|NCT00256854|468677003|FG005|Overall Study|Protocol Violation|0|||
130196550|NCT00256854|468676998|FG000|Overall Study|Adverse Event|0|||
130196551|NCT00256854|468676999|FG001|Overall Study|Adverse Event|0|||
130196552|NCT00256854|468677000|FG002|Overall Study|Adverse Event|2|||
130196553|NCT00256854|468677001|FG003|Overall Study|Adverse Event|2|||
130196554|NCT00256854|468677002|FG004|Overall Study|Adverse Event|0|||
130196555|NCT00256854|468677003|FG005|Overall Study|Adverse Event|1|||
130196556|NCT00256854|468676998|FG000|Overall Study|Not compliant with the study drug|0|||
130196557|NCT00256854|468676999|FG001|Overall Study|Not compliant with the study drug|0|||
130196558|NCT00256854|468677000|FG002|Overall Study|Not compliant with the study drug|0|||
130196559|NCT00256854|468677001|FG003|Overall Study|Not compliant with the study drug|0|||
130196560|NCT00256854|468677002|FG004|Overall Study|Not compliant with the study drug|1|||
130196561|NCT00256854|468677003|FG005|Overall Study|Not compliant with the study drug|0|||
130196562|NCT02353442|468677004|FG000|Overall Study|Withdrawal by Subject|3|||
130196563|NCT02353442|468677005|FG001|Overall Study|Withdrawal by Subject|4|||
130196564|NCT03514485|468677006|FG000|Overall Study|Lost to Follow-up|5|||
130196565|NCT03514485|468677007|FG001|Overall Study|Lost to Follow-up|3|||
130196566|NCT03514485|468677008|FG002|Overall Study|Lost to Follow-up|2|||
130196567|NCT03514485|468677009|FG003|Overall Study|Lost to Follow-up|0|||
130196568|NCT03514485|468677010|FG004|Overall Study|Lost to Follow-up|1|||
130196569|NCT03514485|468677011|FG005|Overall Study|Lost to Follow-up|4|||
130196570|NCT03514485|468677006|FG000|Overall Study|Withdrawal by Subject|0|||
130196571|NCT03514485|468677007|FG001|Overall Study|Withdrawal by Subject|1|||
130196572|NCT03514485|468677008|FG002|Overall Study|Withdrawal by Subject|3|||
130196573|NCT03514485|468677009|FG003|Overall Study|Withdrawal by Subject|1|||
130196574|NCT03514485|468677010|FG004|Overall Study|Withdrawal by Subject|2|||
130196575|NCT03514485|468677011|FG005|Overall Study|Withdrawal by Subject|1|||
130196576|NCT00791661|468677012|FG000|7 Day Wash-out|Adverse Event|0|||
130196577|NCT00791661|468677013|FG001|7 Day Wash-out|Adverse Event|0|||
130196578|NCT00791661|468677014|FG002|7 Day Wash-out|Adverse Event|1|||
130196579|NCT00791661|468677012|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130196580|NCT00791661|468677013|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130196581|NCT00791661|468677014|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
130196582|NCT01355575|468677017|FG000|Overall Study|Withdrawal by Subject|2|||
130196583|NCT02294396|468677018|FG000|Overall Study|Adverse Event|26|||
130196584|NCT02294396|468677019|FG001|Overall Study|Adverse Event|25|||
130196585|NCT02294396|468677020|FG002|Overall Study|Adverse Event|21|||
130196586|NCT02294396|468677021|FG003|Overall Study|Adverse Event|24|||
130196587|NCT02294396|468677018|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
130196588|NCT02294396|468677019|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
130196589|NCT02294396|468677020|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
130196590|NCT02294396|468677021|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
130196591|NCT02294396|468677018|FG000|Overall Study|Withdrawal by Subject|8|||
130196592|NCT02294396|468677019|FG001|Overall Study|Withdrawal by Subject|6|||
130196593|NCT02294396|468677020|FG002|Overall Study|Withdrawal by Subject|6|||
130196594|NCT02294396|468677021|FG003|Overall Study|Withdrawal by Subject|8|||
130196595|NCT02294396|468677018|FG000|Overall Study|Lost to Follow-up|0|||
130196596|NCT02294396|468677019|FG001|Overall Study|Lost to Follow-up|0|||
130196597|NCT02294396|468677020|FG002|Overall Study|Lost to Follow-up|1|||
130196598|NCT02294396|468677021|FG003|Overall Study|Lost to Follow-up|1|||
130196599|NCT02294396|468677018|FG000|Overall Study|Protocol Deviation|3|||
130196600|NCT02294396|468677019|FG001|Overall Study|Protocol Deviation|2|||
130196601|NCT02294396|468677020|FG002|Overall Study|Protocol Deviation|2|||
130196602|NCT02294396|468677021|FG003|Overall Study|Protocol Deviation|1|||
130196603|NCT02294396|468677018|FG000|Overall Study|Miscellaneous|2|||
130196604|NCT02294396|468677019|FG001|Overall Study|Miscellaneous|0|||
130196605|NCT02294396|468677020|FG002|Overall Study|Miscellaneous|5|||
130196606|NCT02294396|468677021|FG003|Overall Study|Miscellaneous|2|||
130196607|NCT02120833|468677022|FG000|Overall Study|Adverse Event|1|||
130196608|NCT02120833|468677023|FG001|Overall Study|Adverse Event|0|||
130196609|NCT02120833|468677022|FG000|Overall Study|Withdrawal by Subject|2|||
130196610|NCT02120833|468677023|FG001|Overall Study|Withdrawal by Subject|0|||
130196611|NCT02120833|468677022|FG000|Overall Study|Lost to Follow-up|1|||
130196612|NCT02120833|468677023|FG001|Overall Study|Lost to Follow-up|1|||
130196613|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
130196614|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130196615|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130196616|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130196617|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
130196618|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196619|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196620|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196621|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130196622|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130196623|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130196624|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130196625|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130196626|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
130196627|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130196628|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130196629|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
130196630|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
130196631|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
130196632|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
130196633|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Adverse Event|11|||
130196634|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Adverse Event|6|||
130196635|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Adverse Event|0|||
130196636|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Adverse Event|0|||
130196637|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
130196638|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
130196639|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
130196640|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
130196641|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196642|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
130196643|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196644|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196645|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
130196646|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130196647|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130196648|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130196649|NCT02438826|468677024|FG000|Post-Treatment Phase|Adverse Event|3|||
130196650|NCT02438826|468677025|FG001|Post-Treatment Phase|Adverse Event|0|||
130196651|NCT02438826|468677026|FG002|Post-Treatment Phase|Adverse Event|0|||
130196652|NCT02438826|468677027|FG003|Post-Treatment Phase|Adverse Event|0|||
130196653|NCT02438826|468677024|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
130196654|NCT02438826|468677025|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
130196655|NCT02438826|468677026|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
130196656|NCT02438826|468677027|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
130196657|NCT02438826|468677024|FG000|Post-Treatment Phase|Physician Decision|1|||
130196658|NCT02438826|468677025|FG001|Post-Treatment Phase|Physician Decision|0|||
130196659|NCT02438826|468677026|FG002|Post-Treatment Phase|Physician Decision|0|||
130196660|NCT02438826|468677027|FG003|Post-Treatment Phase|Physician Decision|0|||
130196661|NCT02438826|468677024|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
130196662|NCT02438826|468677025|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
130196663|NCT02438826|468677026|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
130196664|NCT02438826|468677027|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
130196665|NCT04105218|468677033|FG000|Overall Study|Withdrawal by Subject|3|||
130196666|NCT04105218|468677034|FG001|Overall Study|Withdrawal by Subject|2|||
130196667|NCT04105218|468677033|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
130196668|NCT04105218|468677034|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
130196669|NCT04105218|468677033|FG000|Overall Study|Failed screening tests|2|||
130196670|NCT04105218|468677034|FG001|Overall Study|Failed screening tests|1|||
130196671|NCT01435460|468677035|FG000|Overall Study|Adverse Event|2|||
130196672|NCT01435460|468677036|FG001|Overall Study|Adverse Event|1|||
130196673|NCT01435460|468677035|FG000|Overall Study|Lost to Follow-up|6|||
130196674|NCT01435460|468677036|FG001|Overall Study|Lost to Follow-up|1|||
130196675|NCT01435460|468677035|FG000|Overall Study|Withdrawal by Subject|1|||
130196676|NCT01435460|468677036|FG001|Overall Study|Withdrawal by Subject|3|||
130196677|NCT01435460|468677035|FG000|Overall Study|Protocol Violation|0|||
130196678|NCT01435460|468677036|FG001|Overall Study|Protocol Violation|1|||
130196679|NCT01435460|468677035|FG000|Overall Study|Did not meet eligibility criteria|2|||
130196680|NCT01435460|468677036|FG001|Overall Study|Did not meet eligibility criteria|0|||
130196681|NCT01706939|468677037|FG000|Pre Randomization|Screen Failure|1|||
130196682|NCT01706939|468677038|FG001|Pre Randomization|Screen Failure|0|||
130196683|NCT01706939|468677039|FG002|Pre Randomization|Screen Failure|0|||
130196684|NCT01706939|468677037|FG000|Pre Randomization|Ineligible for Randomization|1|||
130196685|NCT01706939|468677038|FG001|Pre Randomization|Ineligible for Randomization|0|||
130196686|NCT01706939|468677039|FG002|Pre Randomization|Ineligible for Randomization|0|||
130196687|NCT01706939|468677037|FG000|Pre Randomization|Withdrawal by Subject|1|||
130196688|NCT01706939|468677038|FG001|Pre Randomization|Withdrawal by Subject|0|||
130196689|NCT01706939|468677039|FG002|Pre Randomization|Withdrawal by Subject|0|||
130196690|NCT01706939|468677037|FG000|Randomization|Insufficient QoL survey compliance|0|||
130196691|NCT01706939|468677038|FG001|Randomization|Insufficient QoL survey compliance|1|||
130196692|NCT01706939|468677039|FG002|Randomization|Insufficient QoL survey compliance|1|||
130196693|NCT01706939|468677037|FG000|Randomization|Progression of disease|0|||
130196694|NCT01706939|468677038|FG001|Randomization|Progression of disease|2|||
130196695|NCT01706939|468677039|FG002|Randomization|Progression of disease|1|||
130196696|NCT01046903|468677041|FG000|Overall Study|Lost to Follow-up|16|||
130196697|NCT01046903|468677041|FG000|Overall Study|Adverse Event|4|||
130196698|NCT01046903|468677041|FG000|Overall Study|Withdrawal by Subject|3|||
130196699|NCT01046903|468677041|FG000|Overall Study|Other|5|||
130196700|NCT04152837|468677053|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
130196701|NCT04152837|468677053|FG000|Maintenance Period|Adverse Event|1|||
130196702|NCT04152837|468677053|FG000|Maintenance Period|Withdrawal by Subject|1|||
130196703|NCT04152837|468677053|FG000|Maintenance Period|Sponsor Termination of Study|2|||
130196704|NCT00101166|468677056|FG000|Overall Study|progressive disease|10|||
130196705|NCT00686829|468677057|FG000|Overall Study|Adverse Event|5|||
130196706|NCT00686829|468677057|FG000|Overall Study|Lack of Efficacy|6|||
130196707|NCT00686829|468677057|FG000|Overall Study|Lost to Follow-up|4|||
130196708|NCT00686829|468677057|FG000|Overall Study|Withdrawal by Subject|14|||
130196709|NCT00686829|468677057|FG000|Overall Study|Protocol Violation|3|||
130196710|NCT00686829|468677057|FG000|Overall Study|Sponsor discontinued VCV|47|||
130196711|NCT01217476|468677060|FG000|Overall Study|Adverse Event|6|||
130196712|NCT01217476|468677061|FG001|Overall Study|Adverse Event|1|||
130196713|NCT01217476|468677060|FG000|Overall Study|Physician Decision|0|||
130196714|NCT01217476|468677061|FG001|Overall Study|Physician Decision|1|||
130196715|NCT01217476|468677060|FG000|Overall Study|Withdrawal by Subject|3|||
130196716|NCT01217476|468677061|FG001|Overall Study|Withdrawal by Subject|3|||
130196717|NCT01217476|468677060|FG000|Overall Study|Surgery on the Target Limb|0|||
130196718|NCT01217476|468677061|FG001|Overall Study|Surgery on the Target Limb|2|||
130196719|NCT01217476|468677060|FG000|Overall Study|Protocol Deviation|1|||
130196720|NCT01217476|468677061|FG001|Overall Study|Protocol Deviation|0|||
130196721|NCT01217476|468677060|FG000|Overall Study|Other|2|||
130196722|NCT01217476|468677061|FG001|Overall Study|Other|0|||
130196723|NCT03033602|468677062|FG000|Overall Study|Withdrawal by Subject|11|||
130196724|NCT03033602|468677063|FG001|Overall Study|Withdrawal by Subject|21|||
130196725|NCT03033602|468677062|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
130196726|NCT03033602|468677063|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
130196727|NCT04445714|468677064|FG000|Overall Study|Discontinuation of the study|14|||
130196728|NCT04445714|468677064|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
130196729|NCT04445714|468677064|FG000|Overall Study|Withdrawal of Informed Consent|8|||
130196730|NCT01672710|468677065|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
130196731|NCT01672710|468677066|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
130196732|NCT01672710|468677065|FG000|3 Month Follow up|Lost to Follow-up|2|||
130196733|NCT01672710|468677066|FG001|3 Month Follow up|Lost to Follow-up|3|||
130196734|NCT01672710|468677065|FG000|3 Month Follow up|follow up due after termination date|4|||
130196735|NCT01672710|468677066|FG001|3 Month Follow up|follow up due after termination date|1|||
130196736|NCT04999163|468677067|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
130196737|NCT04999163|468677068|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
130196738|NCT04999163|468677067|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
130196739|NCT04999163|468677068|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
130196740|NCT04999163|468677067|FG000|Overall Study|Withdrawal by Subject|1|||
130196741|NCT04999163|468677068|FG001|Overall Study|Withdrawal by Subject|0|||
130196742|NCT01399047|468678949|FG000|Overall Study|Withdrawal by Subject|0|||
130196743|NCT01399047|468678950|FG001|Overall Study|Withdrawal by Subject|1|||
130196744|NCT01283334|468678958|FG000|Overall Study|Withdrawal by Subject|1|||
130196745|NCT01283334|468678958|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
130196746|NCT01283334|468678958|FG000|Overall Study|Adverse Event|4|||
130196747|NCT01283334|468678958|FG000|Overall Study|Physician Decision|1|||
130196748|NCT03467217|468678959|FG000|Overall Study|Trial stopped early|5|||
130196749|NCT03467217|468678960|FG001|Overall Study|Trial stopped early|2|||
130196750|NCT03467217|468678959|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
130196751|NCT03467217|468678960|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
130196752|NCT03467217|468678959|FG000|Overall Study|Lost to Follow-up|0|||
130196753|NCT03467217|468678960|FG001|Overall Study|Lost to Follow-up|2|||
130196754|NCT03233529|468678964|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
130196755|NCT03233529|468678964|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
130196756|NCT01177293|468678965|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
130196757|NCT01177293|468678966|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
130196758|NCT00160706|468678968|FG000|Overall Study|Adverse Event|53|||
130196759|NCT00160706|468678968|FG000|Overall Study|Adverse Event and Other Reason|105|||
130196760|NCT00160706|468678968|FG000|Overall Study|Protocol Violation|3|||
130196761|NCT00160706|468678968|FG000|Overall Study|Withdrawal by Subject|41|||
130196762|NCT00160706|468678968|FG000|Overall Study|Withdrawal by Subject and Other|12|||
130196763|NCT00160706|468678968|FG000|Overall Study|Physician Decision|10|||
130196764|NCT00160706|468678968|FG000|Overall Study|Physician Decision and Other|3|||
130196765|NCT00160706|468678968|FG000|Overall Study|Lost to Follow-up|4|||
130196766|NCT00160706|468678968|FG000|Overall Study|Lost to Follow-up and Other|1|||
130196767|NCT00160706|468678968|FG000|Overall Study|Lack of Efficacy|42|||
130196768|NCT00160706|468678968|FG000|Overall Study|Lack of Efficacy and Other|1|||
130196769|NCT00160706|468678968|FG000|Overall Study|Other Reason|11|||
130196770|NCT03214380|468678969|FG000|Lead-in|Adverse Event|3|||
130196771|NCT03214380|468678970|FG001|Lead-in|Adverse Event|0|||
130196772|NCT03214380|468678971|FG002|Lead-in|Adverse Event|0|||
130196773|NCT03214380|468678972|FG003|Lead-in|Adverse Event|1|||
130196774|NCT03214380|468678973|FG004|Lead-in|Adverse Event|0|||
130196775|NCT03214380|468678974|FG005|Lead-in|Adverse Event|0|||
130196776|NCT03214380|468678969|FG000|Lead-in|Lost to Follow-up|4|||
130196777|NCT03214380|468678970|FG001|Lead-in|Lost to Follow-up|0|||
130196778|NCT03214380|468678971|FG002|Lead-in|Lost to Follow-up|0|||
130196779|NCT03214380|468678972|FG003|Lead-in|Lost to Follow-up|1|||
130196780|NCT03214380|468678973|FG004|Lead-in|Lost to Follow-up|0|||
130196781|NCT03214380|468678974|FG005|Lead-in|Lost to Follow-up|0|||
130196782|NCT03214380|468678969|FG000|Lead-in|Eligibility Criteria|3|||
130196783|NCT03214380|468678970|FG001|Lead-in|Eligibility Criteria|0|||
130196784|NCT03214380|468678971|FG002|Lead-in|Eligibility Criteria|0|||
130196785|NCT03214380|468678972|FG003|Lead-in|Eligibility Criteria|0|||
130196786|NCT03214380|468678973|FG004|Lead-in|Eligibility Criteria|0|||
130196787|NCT03214380|468678974|FG005|Lead-in|Eligibility Criteria|0|||
130196788|NCT03214380|468678969|FG000|Lead-in|Physician Decision|6|||
130196789|NCT03214380|468678970|FG001|Lead-in|Physician Decision|0|||
130196790|NCT03214380|468678971|FG002|Lead-in|Physician Decision|0|||
130196791|NCT03214380|468678972|FG003|Lead-in|Physician Decision|0|||
130196792|NCT03214380|468678973|FG004|Lead-in|Physician Decision|0|||
130196793|NCT03214380|468678974|FG005|Lead-in|Physician Decision|0|||
130196794|NCT03214380|468678969|FG000|Lead-in|Protocol Deviation|7|||
130196795|NCT03214380|468678970|FG001|Lead-in|Protocol Deviation|0|||
130196796|NCT03214380|468678971|FG002|Lead-in|Protocol Deviation|0|||
130196797|NCT03214380|468678972|FG003|Lead-in|Protocol Deviation|3|||
130196798|NCT03214380|468678973|FG004|Lead-in|Protocol Deviation|0|||
130196799|NCT03214380|468678974|FG005|Lead-in|Protocol Deviation|0|||
130196800|NCT03214380|468678969|FG000|Lead-in|Withdrawal by Subject|41|||
130196801|NCT03214380|468678970|FG001|Lead-in|Withdrawal by Subject|0|||
130196802|NCT03214380|468678971|FG002|Lead-in|Withdrawal by Subject|0|||
130196803|NCT03214380|468678972|FG003|Lead-in|Withdrawal by Subject|14|||
130196804|NCT03214380|468678973|FG004|Lead-in|Withdrawal by Subject|0|||
130196805|NCT03214380|468678974|FG005|Lead-in|Withdrawal by Subject|0|||
130196806|NCT03214380|468678969|FG000|Lead-in|Family Emergency|1|||
130196807|NCT03214380|468678970|FG001|Lead-in|Family Emergency|0|||
130196808|NCT03214380|468678971|FG002|Lead-in|Family Emergency|0|||
130196809|NCT03214380|468678972|FG003|Lead-in|Family Emergency|0|||
130196810|NCT03214380|468678973|FG004|Lead-in|Family Emergency|0|||
130196811|NCT03214380|468678974|FG005|Lead-in|Family Emergency|0|||
130196812|NCT03214380|468678969|FG000|Lead-in|Natural Disaster|9|||
130196813|NCT03214380|468678970|FG001|Lead-in|Natural Disaster|0|||
130196814|NCT03214380|468678971|FG002|Lead-in|Natural Disaster|0|||
130196815|NCT03214380|468678972|FG003|Lead-in|Natural Disaster|0|||
130196816|NCT03214380|468678973|FG004|Lead-in|Natural Disaster|0|||
130196817|NCT03214380|468678974|FG005|Lead-in|Natural Disaster|0|||
130196818|NCT03214380|468678969|FG000|Lead-in|Non Compliance|1|||
130196819|NCT03214380|468678970|FG001|Lead-in|Non Compliance|0|||
130196820|NCT03214380|468678971|FG002|Lead-in|Non Compliance|0|||
130196821|NCT03214380|468678972|FG003|Lead-in|Non Compliance|0|||
130196822|NCT03214380|468678973|FG004|Lead-in|Non Compliance|0|||
130196823|NCT03214380|468678974|FG005|Lead-in|Non Compliance|0|||
130196824|NCT03214380|468678969|FG000|Lead-in|Participant Schedule|2|||
130196825|NCT03214380|468678970|FG001|Lead-in|Participant Schedule|0|||
130196826|NCT03214380|468678971|FG002|Lead-in|Participant Schedule|0|||
130196827|NCT03214380|468678972|FG003|Lead-in|Participant Schedule|0|||
130196828|NCT03214380|468678973|FG004|Lead-in|Participant Schedule|0|||
130196829|NCT03214380|468678974|FG005|Lead-in|Participant Schedule|0|||
130196830|NCT03214380|468678969|FG000|Treatment Period|Adverse Event|0|||
130196831|NCT03214380|468678970|FG001|Treatment Period|Adverse Event|1|||
130196832|NCT03214380|468678971|FG002|Treatment Period|Adverse Event|1|||
130196833|NCT03214380|468678972|FG003|Treatment Period|Adverse Event|0|||
130196834|NCT03214380|468678973|FG004|Treatment Period|Adverse Event|1|||
130196835|NCT03214380|468678974|FG005|Treatment Period|Adverse Event|0|||
130196836|NCT03214380|468678969|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
130196837|NCT03214380|468678970|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
130196838|NCT03214380|468678971|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
130196839|NCT03214380|468678972|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
130196840|NCT03214380|468678973|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
130196841|NCT03214380|468678974|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
130196842|NCT03214380|468678969|FG000|Treatment Period|Withdrawal by Subject|0|||
130196843|NCT03214380|468678970|FG001|Treatment Period|Withdrawal by Subject|10|||
130196844|NCT03214380|468678971|FG002|Treatment Period|Withdrawal by Subject|8|||
130196845|NCT03214380|468678972|FG003|Treatment Period|Withdrawal by Subject|0|||
130196846|NCT03214380|468678973|FG004|Treatment Period|Withdrawal by Subject|7|||
130196847|NCT03214380|468678974|FG005|Treatment Period|Withdrawal by Subject|11|||
130196848|NCT03214380|468678969|FG000|Treatment Period|Death|0|||
130196849|NCT03214380|468678970|FG001|Treatment Period|Death|1|||
130196850|NCT03214380|468678971|FG002|Treatment Period|Death|2|||
130196851|NCT03214380|468678972|FG003|Treatment Period|Death|0|||
130196852|NCT03214380|468678973|FG004|Treatment Period|Death|0|||
130196853|NCT03214380|468678974|FG005|Treatment Period|Death|0|||
130196854|NCT03214380|468678969|FG000|Treatment Period|Lost to Follow-up|0|||
130196855|NCT03214380|468678970|FG001|Treatment Period|Lost to Follow-up|6|||
130196856|NCT03214380|468678971|FG002|Treatment Period|Lost to Follow-up|3|||
130196857|NCT03214380|468678972|FG003|Treatment Period|Lost to Follow-up|0|||
130196858|NCT03214380|468678973|FG004|Treatment Period|Lost to Follow-up|0|||
130196859|NCT03214380|468678974|FG005|Treatment Period|Lost to Follow-up|0|||
130196860|NCT03214380|468678969|FG000|Treatment Period|Participant schedule|0|||
130196861|NCT03214380|468678970|FG001|Treatment Period|Participant schedule|0|||
130196862|NCT03214380|468678971|FG002|Treatment Period|Participant schedule|1|||
130196863|NCT03214380|468678972|FG003|Treatment Period|Participant schedule|0|||
130196864|NCT03214380|468678973|FG004|Treatment Period|Participant schedule|0|||
130196865|NCT03214380|468678974|FG005|Treatment Period|Participant schedule|0|||
130196866|NCT03214380|468678969|FG000|Treatment Period|Treatment Interruption|0|||
130196867|NCT03214380|468678970|FG001|Treatment Period|Treatment Interruption|0|||
130196868|NCT03214380|468678971|FG002|Treatment Period|Treatment Interruption|1|||
130196869|NCT03214380|468678972|FG003|Treatment Period|Treatment Interruption|0|||
130196870|NCT03214380|468678973|FG004|Treatment Period|Treatment Interruption|0|||
130196871|NCT03214380|468678974|FG005|Treatment Period|Treatment Interruption|0|||
130196872|NCT01905553|468678981|FG000|Period 2|Adverse Event|1|||
130196873|NCT01905553|468678982|FG001|Period 2|Adverse Event|0|||
130196874|NCT01014988|468678993|FG000|Overall Study|Adverse Event|20|||
130196875|NCT01014988|468678994|FG001|Overall Study|Adverse Event|0|||
130196876|NCT01014988|468678995|FG002|Overall Study|Adverse Event|1|||
130196877|NCT01014988|468678996|FG003|Overall Study|Adverse Event|0|||
130196878|NCT01014988|468678997|FG004|Overall Study|Adverse Event|1|||
130196879|NCT01014988|468678998|FG005|Overall Study|Adverse Event|3|||
130196880|NCT01014988|468678993|FG000|Overall Study|Lost to Follow-up|1|||
130196881|NCT01014988|468678994|FG001|Overall Study|Lost to Follow-up|0|||
130196882|NCT01014988|468678995|FG002|Overall Study|Lost to Follow-up|1|||
130196883|NCT01014988|468678996|FG003|Overall Study|Lost to Follow-up|0|||
130196884|NCT01014988|468678997|FG004|Overall Study|Lost to Follow-up|0|||
130196885|NCT01014988|468678998|FG005|Overall Study|Lost to Follow-up|0|||
130196886|NCT01014988|468678993|FG000|Overall Study|Physician Decision|1|||
130196887|NCT01014988|468678994|FG001|Overall Study|Physician Decision|0|||
130196888|NCT01014988|468678995|FG002|Overall Study|Physician Decision|0|||
130196889|NCT01014988|468678996|FG003|Overall Study|Physician Decision|0|||
130196890|NCT01014988|468678997|FG004|Overall Study|Physician Decision|0|||
130196891|NCT01014988|468678998|FG005|Overall Study|Physician Decision|0|||
130196892|NCT01014988|468678993|FG000|Overall Study|Withdrawal by Subject|1|||
130196893|NCT01014988|468678994|FG001|Overall Study|Withdrawal by Subject|0|||
130196894|NCT01014988|468678995|FG002|Overall Study|Withdrawal by Subject|0|||
130196895|NCT01014988|468678996|FG003|Overall Study|Withdrawal by Subject|0|||
130196896|NCT01014988|468678997|FG004|Overall Study|Withdrawal by Subject|0|||
130196897|NCT01014988|468678998|FG005|Overall Study|Withdrawal by Subject|0|||
130196898|NCT01683266|468678999|FG000|Overall Study|Adverse Event|5|||
130196899|NCT01683266|468679000|FG001|Overall Study|Adverse Event|4|||
130196900|NCT01683266|468678999|FG000|Overall Study|Lack of Efficacy|5|||
130196901|NCT01683266|468679000|FG001|Overall Study|Lack of Efficacy|2|||
130196902|NCT01683266|468678999|FG000|Overall Study|Protocol Violation|13|||
130196903|NCT01683266|468679000|FG001|Overall Study|Protocol Violation|6|||
130196904|NCT01683266|468678999|FG000|Overall Study|Personal Reason|17|||
130196905|NCT01683266|468679000|FG001|Overall Study|Personal Reason|25|||
130196906|NCT01683266|468678999|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
130196907|NCT01683266|468679000|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
130196908|NCT01683266|468678999|FG000|Overall Study|Lost to Follow-up|5|||
130196909|NCT01683266|468679000|FG001|Overall Study|Lost to Follow-up|0|||
130196910|NCT01683266|468678999|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
130196911|NCT01683266|468679000|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
130196912|NCT01683266|468678999|FG000|Overall Study|Nonserious Hypoglycemia|0|||
130196913|NCT01683266|468679000|FG001|Overall Study|Nonserious Hypoglycemia|3|||
130196914|NCT01683266|468678999|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130196915|NCT01683266|468679000|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130196916|NCT01683266|468678999|FG000|Overall Study|Possibly Hypoglycemia|1|||
130196917|NCT01683266|468679000|FG001|Overall Study|Possibly Hypoglycemia|0|||
130196918|NCT01683266|468678999|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
130196919|NCT01683266|468679000|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
130196920|NCT00626821|468679003|FG000|Overall Study|Adverse Event|44|||
130196921|NCT00626821|468679003|FG000|Overall Study|Protocol Violation|33|||
130196922|NCT00626821|468679003|FG000|Overall Study|Withdrawal by Subject|10|||
130196923|NCT00626821|468679003|FG000|Overall Study|Physician Decision|9|||
130196924|NCT00626821|468679003|FG000|Overall Study|Product dysfunction|21|||
130196925|NCT00626821|468679003|FG000|Overall Study|other/unknown reason|104|||
130196950|NCT01062113|468679017|FG000|Overall Study|Adverse Event|1|||
130196951|NCT01062113|468679018|FG001|Overall Study|Adverse Event|0|||
130196952|NCT01062113|468679019|FG002|Overall Study|Adverse Event|0|||
130196953|NCT01062113|468679017|FG000|Overall Study|Lack of Efficacy|38|||
130196954|NCT01062113|468679018|FG001|Overall Study|Lack of Efficacy|22|||
130196955|NCT01062113|468679019|FG002|Overall Study|Lack of Efficacy|31|||
130196956|NCT01062113|468679017|FG000|Overall Study|Withdrawal by Subject|1|||
130196957|NCT01062113|468679018|FG001|Overall Study|Withdrawal by Subject|0|||
130196958|NCT01062113|468679019|FG002|Overall Study|Withdrawal by Subject|0|||
130196959|NCT01471340|468679020|FG000|Overall Study|Death|5|||
130196960|NCT01471340|468679021|FG001|Overall Study|Death|4|||
130196961|NCT01471340|468679020|FG000|Overall Study|Lost to Follow-up|0|||
130196962|NCT01471340|468679021|FG001|Overall Study|Lost to Follow-up|1|||
130196963|NCT01471340|468679020|FG000|Overall Study|Investigational site closure|0|||
130196964|NCT01471340|468679021|FG001|Overall Study|Investigational site closure|1|||
130196965|NCT01471340|468679020|FG000|Overall Study|Invalid informed consent|1|||
130196966|NCT01471340|468679021|FG001|Overall Study|Invalid informed consent|0|||
130196967|NCT00526669|468679024|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
130196968|NCT00526669|468679025|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
130196969|NCT00526669|468679024|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
130196970|NCT00526669|468679025|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
130196971|NCT00526669|468679024|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
130196972|NCT00526669|468679025|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
130196973|NCT00526669|468679024|FG000|Combined Treatment Phase|Death|0|||
130196974|NCT00526669|468679025|FG001|Combined Treatment Phase|Death|2|||
130196975|NCT03499899|468679026|FG000|Overall Study|Adverse Event|2|||
130196976|NCT03499899|468679027|FG001|Overall Study|Adverse Event|3|||
130196977|NCT03499899|468679028|FG002|Overall Study|Adverse Event|3|||
130196978|NCT03499899|468679026|FG000|Overall Study|Death|0|||
130196979|NCT03499899|468679027|FG001|Overall Study|Death|0|||
130196980|NCT03499899|468679028|FG002|Overall Study|Death|1|||
130196981|NCT03499899|468679026|FG000|Overall Study|Physician Decision|3|||
130196982|NCT03499899|468679027|FG001|Overall Study|Physician Decision|6|||
130196983|NCT03499899|468679028|FG002|Overall Study|Physician Decision|6|||
130196984|NCT03499899|468679026|FG000|Overall Study|Progressive disease|15|||
130196985|NCT03499899|468679027|FG001|Overall Study|Progressive disease|23|||
130196986|NCT03499899|468679028|FG002|Overall Study|Progressive disease|23|||
130196987|NCT03499899|468679026|FG000|Overall Study|Patient decision|0|||
130196988|NCT03499899|468679027|FG001|Overall Study|Patient decision|1|||
130196989|NCT03499899|468679028|FG002|Overall Study|Patient decision|1|||
130196990|NCT03499899|468679026|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130196991|NCT03499899|468679027|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
130196992|NCT03499899|468679028|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130196993|NCT01082211|468679030|FG000|Overall Study|Protocol Violation|4|||
130196994|NCT01082211|468679030|FG000|Overall Study|No protocol treatment received|3|||
130196995|NCT04016779|468679043|FG000|Overall Study|Adverse Event|9|||
130196996|NCT04016779|468679044|FG001|Overall Study|Adverse Event|17|||
130196997|NCT04016779|468679043|FG000|Overall Study|Lack of Efficacy|4|||
130196998|NCT04016779|468679044|FG001|Overall Study|Lack of Efficacy|1|||
130196999|NCT04016779|468679043|FG000|Overall Study|Lost to Follow-up|5|||
130197000|NCT04016779|468679044|FG001|Overall Study|Lost to Follow-up|14|||
130197001|NCT04016779|468679043|FG000|Overall Study|Physician Decision|1|||
130197002|NCT04016779|468679044|FG001|Overall Study|Physician Decision|3|||
130197003|NCT04016779|468679043|FG000|Overall Study|Withdrawal by Subject|6|||
130197004|NCT04016779|468679044|FG001|Overall Study|Withdrawal by Subject|8|||
130197005|NCT04016779|468679043|FG000|Overall Study|Non-compliance with Study Drug|2|||
130197006|NCT04016779|468679044|FG001|Overall Study|Non-compliance with Study Drug|3|||
130197007|NCT04016779|468679043|FG000|Overall Study|Other, Multiple categories|17|||
130197008|NCT04016779|468679044|FG001|Overall Study|Other, Multiple categories|17|||
130197009|NCT02295020|468679045|FG000|Overall Study|Adverse Event|0|||
130197010|NCT02295020|468679046|FG001|Overall Study|Adverse Event|1|||
130197011|NCT02295020|468679045|FG000|Overall Study|Withdrawal by Subject|3|||
130197012|NCT02295020|468679046|FG001|Overall Study|Withdrawal by Subject|2|||
130197013|NCT06586788|468679048|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
130197014|NCT01053962|468679050|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197015|NCT01053962|468679051|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197016|NCT01053962|468679052|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197017|NCT01053962|468679053|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
130197018|NCT01053962|468679054|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
130197019|NCT01053962|468679050|FG000|Pretreatment Period|Venipuncture Failure|0|||
130197020|NCT01053962|468679051|FG001|Pretreatment Period|Venipuncture Failure|0|||
130197021|NCT01053962|468679052|FG002|Pretreatment Period|Venipuncture Failure|1|||
130197022|NCT01053962|468679053|FG003|Pretreatment Period|Venipuncture Failure|0|||
130197023|NCT01053962|468679054|FG004|Pretreatment Period|Venipuncture Failure|0|||
130197024|NCT01053962|468679050|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197025|NCT01053962|468679051|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
130197026|NCT01053962|468679052|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197027|NCT01053962|468679053|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197028|NCT01053962|468679054|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197029|NCT01053962|468679050|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197030|NCT01053962|468679051|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197031|NCT01053962|468679052|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197032|NCT01053962|468679053|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
130197033|NCT01053962|468679054|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197034|NCT01053962|468679050|FG000|Treatment Period|Lack of Efficacy|0|||
130197035|NCT01053962|468679051|FG001|Treatment Period|Lack of Efficacy|0|||
130197036|NCT01053962|468679052|FG002|Treatment Period|Lack of Efficacy|0|||
130197037|NCT01053962|468679053|FG003|Treatment Period|Lack of Efficacy|0|||
130197038|NCT01053962|468679054|FG004|Treatment Period|Lack of Efficacy|1|||
130197039|NCT01053962|468679050|FG000|Treatment Period|Adverse Event|0|||
130197040|NCT01053962|468679051|FG001|Treatment Period|Adverse Event|0|||
130197041|NCT01053962|468679052|FG002|Treatment Period|Adverse Event|0|||
130197042|NCT01053962|468679053|FG003|Treatment Period|Adverse Event|0|||
130197043|NCT01053962|468679054|FG004|Treatment Period|Adverse Event|1|||
130197044|NCT01053962|468679050|FG000|Treatment Period|Withdrawal by Subject|0|||
130197045|NCT01053962|468679051|FG001|Treatment Period|Withdrawal by Subject|0|||
130197046|NCT01053962|468679052|FG002|Treatment Period|Withdrawal by Subject|0|||
130197047|NCT01053962|468679053|FG003|Treatment Period|Withdrawal by Subject|0|||
130197048|NCT01053962|468679054|FG004|Treatment Period|Withdrawal by Subject|1|||
130197049|NCT01053962|468679050|FG000|Treatment Period|Noncompliance with protocol|1|||
130197050|NCT01053962|468679051|FG001|Treatment Period|Noncompliance with protocol|0|||
130197051|NCT01053962|468679052|FG002|Treatment Period|Noncompliance with protocol|0|||
130197052|NCT01053962|468679053|FG003|Treatment Period|Noncompliance with protocol|0|||
130197053|NCT01053962|468679054|FG004|Treatment Period|Noncompliance with protocol|0|||
130197054|NCT00679289|468679055|FG000|Overall Study|Progressive disease|4|||
130197055|NCT00679289|468679056|FG001|Overall Study|Progressive disease|5|||
130197056|NCT00679289|468679057|FG002|Overall Study|Progressive disease|18|||
130197057|NCT00679289|468679055|FG000|Overall Study|Withdrawal by Subject|0|||
130197058|NCT00679289|468679056|FG001|Overall Study|Withdrawal by Subject|1|||
130197059|NCT00679289|468679057|FG002|Overall Study|Withdrawal by Subject|1|||
130197060|NCT00679289|468679055|FG000|Overall Study|Adverse Event|0|||
130197061|NCT00679289|468679056|FG001|Overall Study|Adverse Event|0|||
130197062|NCT00679289|468679057|FG002|Overall Study|Adverse Event|3|||
130197063|NCT00679289|468679055|FG000|Overall Study|Physician Decision|1|||
130197064|NCT00679289|468679056|FG001|Overall Study|Physician Decision|0|||
130197065|NCT00679289|468679057|FG002|Overall Study|Physician Decision|1|||
130197066|NCT00937040|468679058|FG000|Overall Study|Adverse Event|5|||
130197067|NCT00937040|468679059|FG001|Overall Study|Adverse Event|8|||
130197068|NCT00937040|468679058|FG000|Overall Study|Lost to Follow-up|12|||
130197069|NCT00937040|468679059|FG001|Overall Study|Lost to Follow-up|12|||
130197070|NCT00937040|468679058|FG000|Overall Study|Protocol Violation|3|||
130197071|NCT00937040|468679059|FG001|Overall Study|Protocol Violation|0|||
130197072|NCT00937040|468679058|FG000|Overall Study|Withdrawal by Subject|13|||
130197073|NCT00937040|468679059|FG001|Overall Study|Withdrawal by Subject|7|||
130197074|NCT00937040|468679058|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
130197075|NCT00937040|468679059|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
130197076|NCT00937040|468679058|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
130197077|NCT00937040|468679059|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
130197078|NCT00638443|468679060|FG000|First Intervention|Adverse Event|2|||
130197079|NCT00638443|468679061|FG001|First Intervention|Adverse Event|1|||
130197080|NCT03502070|468679064|FG000|Overall Study|Withdrawal by Subject|1|||
130197081|NCT03502070|468679064|FG000|Overall Study|Screen Failure|1|||
130197082|NCT00595517|468679067|FG000|Overall Study|Adverse Event|6|||
130197083|NCT00595517|468679067|FG000|Overall Study|Withdrawal by Subject|4|||
130197084|NCT00595517|468679067|FG000|Overall Study|Protocol Violation|2|||
130197085|NCT00595517|468679067|FG000|Overall Study|Recurrence of ulcer|5|||
130197086|NCT00595517|468679067|FG000|Overall Study|usage of prohibited treatment|1|||
130197087|NCT00595517|468679067|FG000|Overall Study|No intention to attend regularly|1|||
130197088|NCT01167881|468679070|FG000|Overall Study|Adverse Event|47|||
130197089|NCT01167881|468679071|FG001|Overall Study|Adverse Event|51|||
130197090|NCT01167881|468679070|FG000|Overall Study|Lack of Efficacy|4|||
130197091|NCT01167881|468679071|FG001|Overall Study|Lack of Efficacy|7|||
130197092|NCT01167881|468679070|FG000|Overall Study|Non compliant with protocol|9|||
130197093|NCT01167881|468679071|FG001|Overall Study|Non compliant with protocol|18|||
130197094|NCT01167881|468679070|FG000|Overall Study|Lost to Follow-up|19|||
130197095|NCT01167881|468679071|FG001|Overall Study|Lost to Follow-up|20|||
130197096|NCT01167881|468679070|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
130197097|NCT01167881|468679071|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
130197098|NCT01167881|468679070|FG000|Overall Study|Not treated|4|||
130197099|NCT01167881|468679071|FG001|Overall Study|Not treated|0|||
130197100|NCT01167881|468679070|FG000|Overall Study|Other not defined above|31|||
130197101|NCT01167881|468679071|FG001|Overall Study|Other not defined above|55|||
130197102|NCT01894100|468679072|FG000|Overall Study|Lost to Follow-up|0|||
130197103|NCT01894100|468679073|FG001|Overall Study|Lost to Follow-up|1|||
130197104|NCT01894100|468679072|FG000|Overall Study|Withdrawal by Subject|3|||
130197105|NCT01894100|468679073|FG001|Overall Study|Withdrawal by Subject|0|||
130197106|NCT04013672|468679074|FG000|Overall Study|Withdrawal by Subject|3|||
130197107|NCT04013672|468679075|FG001|Overall Study|Withdrawal by Subject|0|||
130197108|NCT04013672|468679074|FG000|Overall Study|Death|1|||
130197109|NCT04013672|468679075|FG001|Overall Study|Death|0|||
130197110|NCT04013672|468679074|FG000|Overall Study|Physician Decision|5|||
130197111|NCT04013672|468679075|FG001|Overall Study|Physician Decision|0|||
130197112|NCT01827267|468679076|FG000|Overall Study|Did not receive study drug|1|||
130197113|NCT01827267|468679077|FG001|Overall Study|Did not receive study drug|1|||
130197114|NCT01827267|468679076|FG000|Overall Study|Physician Decision|1|||
130197115|NCT01827267|468679077|FG001|Overall Study|Physician Decision|0|||
130197116|NCT01827267|468679076|FG000|Overall Study|Disease Progression|1|||
130197117|NCT01827267|468679077|FG001|Overall Study|Disease Progression|1|||
130197118|NCT01827267|468679076|FG000|Overall Study|Sponsor Discontinued Study|2|||
130197119|NCT01827267|468679077|FG001|Overall Study|Sponsor Discontinued Study|8|||
130197120|NCT01827267|468679076|FG000|Overall Study|Still on study|0|||
130197121|NCT01827267|468679077|FG001|Overall Study|Still on study|2|||
130197122|NCT00813813|468679082|FG000|Overall Study|Withdrawal by Subject|1|||
130197123|NCT00813813|468679083|FG001|Overall Study|Withdrawal by Subject|1|||
130197124|NCT00813813|468679082|FG000|Overall Study|Lost to Follow-up|2|||
130197125|NCT00813813|468679083|FG001|Overall Study|Lost to Follow-up|7|||
130197126|NCT00813813|468679082|FG000|Overall Study|Other|0|||
130197127|NCT00813813|468679083|FG001|Overall Study|Other|1|||
130197128|NCT00986921|468679084|FG000|Overall Study|Physician Decision|1|||
130197129|NCT00986921|468679085|FG001|Overall Study|Physician Decision|0|||
130197130|NCT01684943|468679086|FG000|Overall Study|Inadequate Venous Access|3|||
130197131|NCT01684943|468679087|FG001|Overall Study|Inadequate Venous Access|0|||
130197132|NCT01684943|468679088|FG002|Overall Study|Inadequate Venous Access|0|||
130197133|NCT01684943|468679086|FG000|Overall Study|Principal Investigator Determination|1|||
130197134|NCT01684943|468679087|FG001|Overall Study|Principal Investigator Determination|0|||
130197135|NCT01684943|468679088|FG002|Overall Study|Principal Investigator Determination|0|||
130197136|NCT01684943|468679086|FG000|Overall Study|Excluded from Analysis|1|||
130197137|NCT01684943|468679087|FG001|Overall Study|Excluded from Analysis|1|||
130197138|NCT01684943|468679088|FG002|Overall Study|Excluded from Analysis|1|||
130197139|NCT01684943|468679086|FG000|Overall Study|Lost to Follow-up|3|||
130197140|NCT01684943|468679087|FG001|Overall Study|Lost to Follow-up|0|||
130197141|NCT01684943|468679088|FG002|Overall Study|Lost to Follow-up|0|||
130197142|NCT01684943|468679086|FG000|Overall Study|Planning Pregnancy|1|||
130197143|NCT01684943|468679087|FG001|Overall Study|Planning Pregnancy|0|||
130197144|NCT01684943|468679088|FG002|Overall Study|Planning Pregnancy|0|||
130197145|NCT00972816|468681380|FG000|Overall Study|Adverse Event|0|||
130197146|NCT00972816|468681381|FG001|Overall Study|Adverse Event|0|||
130197147|NCT00972816|468681382|FG002|Overall Study|Adverse Event|1|||
130197148|NCT00972816|468681383|FG003|Overall Study|Adverse Event|0|||
130197149|NCT00972816|468681384|FG004|Overall Study|Adverse Event|0|||
130197150|NCT00972816|468681385|FG005|Overall Study|Adverse Event|0|||
130197151|NCT00972816|468681386|FG006|Overall Study|Adverse Event|0|||
130197152|NCT00972816|468681387|FG007|Overall Study|Adverse Event|0|||
130197153|NCT00972816|468681380|FG000|Overall Study|Withdrawal by Subject|4|||
130197154|NCT00972816|468681381|FG001|Overall Study|Withdrawal by Subject|2|||
130197155|NCT00972816|468681382|FG002|Overall Study|Withdrawal by Subject|1|||
130197156|NCT00972816|468681383|FG003|Overall Study|Withdrawal by Subject|3|||
130197157|NCT00972816|468681384|FG004|Overall Study|Withdrawal by Subject|0|||
130197158|NCT00972816|468681385|FG005|Overall Study|Withdrawal by Subject|1|||
130197159|NCT00972816|468681386|FG006|Overall Study|Withdrawal by Subject|1|||
130197160|NCT00972816|468681387|FG007|Overall Study|Withdrawal by Subject|2|||
130197161|NCT00972816|468681380|FG000|Overall Study|Lost to Follow-up|11|||
130197162|NCT00972816|468681381|FG001|Overall Study|Lost to Follow-up|9|||
130197163|NCT00972816|468681382|FG002|Overall Study|Lost to Follow-up|7|||
130197164|NCT00972816|468681383|FG003|Overall Study|Lost to Follow-up|5|||
130197165|NCT00972816|468681384|FG004|Overall Study|Lost to Follow-up|11|||
130197166|NCT00972816|468681385|FG005|Overall Study|Lost to Follow-up|10|||
130197167|NCT00972816|468681386|FG006|Overall Study|Lost to Follow-up|7|||
130197168|NCT00972816|468681387|FG007|Overall Study|Lost to Follow-up|7|||
130197169|NCT00972816|468681380|FG000|Overall Study|Inappropriate enrolment|0|||
130197170|NCT00972816|468681381|FG001|Overall Study|Inappropriate enrolment|0|||
130197171|NCT00972816|468681382|FG002|Overall Study|Inappropriate enrolment|0|||
130197172|NCT00972816|468681383|FG003|Overall Study|Inappropriate enrolment|0|||
130197173|NCT00972816|468681384|FG004|Overall Study|Inappropriate enrolment|0|||
130197174|NCT00972816|468681385|FG005|Overall Study|Inappropriate enrolment|0|||
130197175|NCT00972816|468681386|FG006|Overall Study|Inappropriate enrolment|2|||
130197176|NCT00972816|468681387|FG007|Overall Study|Inappropriate enrolment|0|||
130197177|NCT00972816|468681380|FG000|Overall Study|Unable to classify|2|||
130197178|NCT00972816|468681381|FG001|Overall Study|Unable to classify|0|||
130197179|NCT00972816|468681382|FG002|Overall Study|Unable to classify|0|||
130197180|NCT00972816|468681383|FG003|Overall Study|Unable to classify|0|||
130197181|NCT00972816|468681384|FG004|Overall Study|Unable to classify|1|||
130197182|NCT00972816|468681385|FG005|Overall Study|Unable to classify|0|||
130197183|NCT00972816|468681386|FG006|Overall Study|Unable to classify|0|||
130197184|NCT00972816|468681387|FG007|Overall Study|Unable to classify|0|||
130197185|NCT03854370|468681390|FG000|Overall Study|samples not collected|1|||
130197186|NCT03854370|468681391|FG001|Overall Study|samples not collected|1|||
130197187|NCT03854370|468681392|FG002|Overall Study|samples not collected|1|||
130197188|NCT03854370|468681393|FG003|Overall Study|samples not collected|1|||
130197189|NCT00452673|468681394|FG000|Dose Escalation Period|Disease Progression|6|||
130197190|NCT00452673|468681395|FG001|Dose Escalation Period|Disease Progression|6|||
130197191|NCT00452673|468681396|FG002|Dose Escalation Period|Disease Progression|2|||
130197192|NCT00452673|468681397|FG003|Dose Escalation Period|Disease Progression|6|||
130197193|NCT00452673|468681398|FG004|Dose Escalation Period|Disease Progression|0|||
130197194|NCT00452673|468681394|FG000|Dose Escalation Period|study drug toxicity|1|||
130197195|NCT00452673|468681395|FG001|Dose Escalation Period|study drug toxicity|3|||
130197196|NCT00452673|468681396|FG002|Dose Escalation Period|study drug toxicity|3|||
130197197|NCT00452673|468681397|FG003|Dose Escalation Period|study drug toxicity|1|||
130197198|NCT00452673|468681398|FG004|Dose Escalation Period|study drug toxicity|0|||
130197199|NCT00452673|468681394|FG000|Dose Escalation Period|Other|0|||
130197200|NCT00452673|468681395|FG001|Dose Escalation Period|Other|0|||
130197201|NCT00452673|468681396|FG002|Dose Escalation Period|Other|1|||
130197202|NCT00452673|468681397|FG003|Dose Escalation Period|Other|0|||
130197203|NCT00452673|468681398|FG004|Dose Escalation Period|Other|0|||
130197204|NCT00452673|468681394|FG000|Dose Escalation Period|Adverse Event|0|||
130197205|NCT00452673|468681395|FG001|Dose Escalation Period|Adverse Event|0|||
130197206|NCT00452673|468681396|FG002|Dose Escalation Period|Adverse Event|0|||
130197207|NCT00452673|468681397|FG003|Dose Escalation Period|Adverse Event|1|||
130197208|NCT00452673|468681398|FG004|Dose Escalation Period|Adverse Event|0|||
130197209|NCT00452673|468681394|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
130197210|NCT00452673|468681395|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
130197211|NCT00452673|468681396|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130197212|NCT00452673|468681397|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
130197213|NCT00452673|468681398|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
130197214|NCT00452673|468681394|FG000|Dose Expansion Period|Disease Progression|0|||
130197215|NCT00452673|468681395|FG001|Dose Expansion Period|Disease Progression|0|||
130197216|NCT00452673|468681396|FG002|Dose Expansion Period|Disease Progression|0|||
130197217|NCT00452673|468681397|FG003|Dose Expansion Period|Disease Progression|0|||
130197218|NCT00452673|468681398|FG004|Dose Expansion Period|Disease Progression|19|||
130197219|NCT00452673|468681394|FG000|Dose Expansion Period|Other|0|||
130197220|NCT00452673|468681395|FG001|Dose Expansion Period|Other|0|||
130197221|NCT00452673|468681396|FG002|Dose Expansion Period|Other|0|||
130197222|NCT00452673|468681397|FG003|Dose Expansion Period|Other|0|||
130197223|NCT00452673|468681398|FG004|Dose Expansion Period|Other|2|||
130197224|NCT02656290|468681399|FG000|Overall Study|Lost to Follow-up|1|||
130197225|NCT02656290|468681399|FG000|Overall Study|Reintervention|3|||
130197226|NCT01608087|468681402|FG000|Overall Study|Lost to Follow-up|0|||
130197227|NCT01608087|468681403|FG001|Overall Study|Lost to Follow-up|1|||
130197228|NCT01608087|468681404|FG002|Overall Study|Lost to Follow-up|0|||
130197229|NCT01608087|468681402|FG000|Overall Study|Other Reason|0|||
130197230|NCT01608087|468681403|FG001|Overall Study|Other Reason|1|||
130197231|NCT01608087|468681404|FG002|Overall Study|Other Reason|0|||
130197232|NCT00348595|468681405|FG000|Overall Study|Adverse Event|5|||
130197233|NCT00348595|468681406|FG001|Overall Study|Adverse Event|8|||
130197234|NCT01942486|468681413|FG000|Overall Study|Lost to Follow-up|27|||
130197235|NCT03728426|468681414|FG000|Overall Study|Death|3|||
130197236|NCT00231114|468681416|FG000|Randomized|Withdrawal by Subject|6|||
130197237|NCT00231114|468681417|FG001|Randomized|Withdrawal by Subject|3|||
130197238|NCT00231114|468681416|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
130197239|NCT00231114|468681417|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
130197240|NCT00231114|468681416|FG000|Post-Treatment Period|Lost to Follow-up|6|||
130197241|NCT00231114|468681417|FG001|Post-Treatment Period|Lost to Follow-up|1|||
130197242|NCT00231114|468681416|FG000|Post-Treatment Period|Physician Decision|1|||
130197243|NCT00231114|468681417|FG001|Post-Treatment Period|Physician Decision|0|||
130197244|NCT00231114|468681416|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
130197245|NCT00231114|468681417|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
130197246|NCT02048826|468681419|FG000|Overall Study|Withdrawal by Subject|1|||
130197247|NCT02048826|468681420|FG001|Overall Study|Withdrawal by Subject|0|||
130197248|NCT04470544|468681421|FG000|Overall Study|Withdrawal by Subject|4|||
130197249|NCT04470544|468681422|FG001|Overall Study|Withdrawal by Subject|6|||
130197250|NCT00712881|468681424|FG000|Overall Study|Adverse Event|3|||
130197251|NCT00712881|468681425|FG001|Overall Study|Adverse Event|3|||
130197252|NCT00712881|468681424|FG000|Overall Study|Withdrawal by Subject|1|||
130197253|NCT00712881|468681425|FG001|Overall Study|Withdrawal by Subject|1|||
130197254|NCT00712881|468681424|FG000|Overall Study|Disease Progression|2|||
130197255|NCT00712881|468681425|FG001|Overall Study|Disease Progression|1|||
130197256|NCT00712881|468681424|FG000|Overall Study|Lost to Follow-up|1|||
130197257|NCT00712881|468681425|FG001|Overall Study|Lost to Follow-up|1|||
130197258|NCT00712881|468681424|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
130197259|NCT00712881|468681425|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
130197260|NCT00712881|468681424|FG000|Overall Study|Protocol Violation|1|||
130197261|NCT00712881|468681425|FG001|Overall Study|Protocol Violation|1|||
130197262|NCT00712881|468681424|FG000|Overall Study|Randomized but not treated|1|||
130197263|NCT00712881|468681425|FG001|Overall Study|Randomized but not treated|0|||
130197264|NCT01194999|468681426|FG000|Overall Study|Lost to Follow-up|17|||
130197265|NCT01011465|468681427|FG000|Overall Study|Withdrawal by Subject|2|||
130197266|NCT01011465|468681428|FG001|Overall Study|Withdrawal by Subject|1|||
130197267|NCT01011465|468681429|FG002|Overall Study|Withdrawal by Subject|0|||
130197268|NCT01011465|468681430|FG003|Overall Study|Withdrawal by Subject|0|||
130197269|NCT01011465|468681431|FG004|Overall Study|Withdrawal by Subject|1|||
130197270|NCT01011465|468681432|FG005|Overall Study|Withdrawal by Subject|0|||
130197271|NCT01011465|468681433|FG006|Overall Study|Withdrawal by Subject|1|||
130197272|NCT01011465|468681434|FG007|Overall Study|Withdrawal by Subject|0|||
130197273|NCT00723008|468681436|FG000|Enrollment|Lost to Follow-up|1|||
130197274|NCT00723008|468681437|FG001|Enrollment|Lost to Follow-up|0|||
130197275|NCT00723008|468681436|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
130197276|NCT00723008|468681437|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
130197277|NCT00723008|468681436|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
130197278|NCT00723008|468681437|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
130197279|NCT00723008|468681436|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
130197280|NCT00723008|468681437|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
130197281|NCT00723008|468681436|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
130197282|NCT00723008|468681437|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
130197283|NCT00723008|468681436|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
130197284|NCT00723008|468681437|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
130197285|NCT05835011|468681439|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130197286|NCT05835011|468681439|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
130197287|NCT03702010|468681452|FG000|Follow-up (30days)|Lack of Efficacy|2|||
130197288|NCT03702010|468681453|FG001|Follow-up (30days)|Lack of Efficacy|2|||
130197289|NCT01137110|468681454|FG000|Overall Study|Protocol Violation|1|||
130197290|NCT01137110|468681455|FG001|Overall Study|Protocol Violation|0|||
130197291|NCT03557931|468681456|FG000|Overall Study|Adverse Event|4|||
130197292|NCT03557931|468681457|FG001|Overall Study|Adverse Event|6|||
130197293|NCT03557931|468681458|FG002|Overall Study|Adverse Event|1|||
130197294|NCT03557931|468681456|FG000|Overall Study|Lost to Follow-up|4|||
130197295|NCT03557931|468681457|FG001|Overall Study|Lost to Follow-up|4|||
130197296|NCT03557931|468681458|FG002|Overall Study|Lost to Follow-up|1|||
130197297|NCT03557931|468681456|FG000|Overall Study|Protocol Violation|1|||
130197298|NCT03557931|468681457|FG001|Overall Study|Protocol Violation|4|||
130197299|NCT03557931|468681458|FG002|Overall Study|Protocol Violation|1|||
130197300|NCT03557931|468681456|FG000|Overall Study|Withdrawal by Subject|14|||
130197301|NCT03557931|468681457|FG001|Overall Study|Withdrawal by Subject|0|||
130197302|NCT03557931|468681458|FG002|Overall Study|Withdrawal by Subject|7|||
130197303|NCT03557931|468681456|FG000|Overall Study|Miscellaneous|8|||
130197304|NCT03557931|468681457|FG001|Overall Study|Miscellaneous|5|||
130197305|NCT03557931|468681458|FG002|Overall Study|Miscellaneous|3|||
130197306|NCT02829723|468681459|FG000|Overall Study|Adverse Event|0|||
130197307|NCT02829723|468681460|FG001|Overall Study|Adverse Event|0|||
130197308|NCT02829723|468681461|FG002|Overall Study|Adverse Event|1|||
130197309|NCT02829723|468681462|FG003|Overall Study|Adverse Event|1|||
130197310|NCT02829723|468681463|FG004|Overall Study|Adverse Event|0|||
130197311|NCT02829723|468681464|FG005|Overall Study|Adverse Event|0|||
130197312|NCT02829723|468681465|FG006|Overall Study|Adverse Event|0|||
130197313|NCT02829723|468681466|FG007|Overall Study|Adverse Event|1|||
130197314|NCT02829723|468681467|FG008|Overall Study|Adverse Event|0|||
130197315|NCT02829723|468681468|FG009|Overall Study|Adverse Event|0|||
130197316|NCT02829723|468681469|FG010|Overall Study|Adverse Event|0|||
130197317|NCT02829723|468681470|FG011|Overall Study|Adverse Event|0|||
130197318|NCT02829723|468681471|FG012|Overall Study|Adverse Event|0|||
130197319|NCT02829723|468681472|FG013|Overall Study|Adverse Event|0|||
130197320|NCT02829723|468681473|FG014|Overall Study|Adverse Event|1|||
130197321|NCT02829723|468681474|FG015|Overall Study|Adverse Event|1|||
130197322|NCT02829723|468681475|FG016|Overall Study|Adverse Event|1|||
130197323|NCT02829723|468681476|FG017|Overall Study|Adverse Event|2|||
130197324|NCT02829723|468681477|FG018|Overall Study|Adverse Event|1|||
130197325|NCT02829723|468681478|FG019|Overall Study|Adverse Event|1|||
130197326|NCT02829723|468681479|FG020|Overall Study|Adverse Event|3|||
130197327|NCT02829723|468681480|FG021|Overall Study|Adverse Event|0|||
130197328|NCT02829723|468681481|FG022|Overall Study|Adverse Event|0|||
130197329|NCT02829723|468681482|FG023|Overall Study|Adverse Event|1|||
130197330|NCT02829723|468681483|FG024|Overall Study|Adverse Event|1|||
130197331|NCT02829723|468681484|FG025|Overall Study|Adverse Event|3|||
130197332|NCT02829723|468681485|FG026|Overall Study|Adverse Event|5|||
130197333|NCT02829723|468681459|FG000|Overall Study|Death|1|||
130197334|NCT02829723|468681460|FG001|Overall Study|Death|0|||
130197335|NCT02829723|468681461|FG002|Overall Study|Death|1|||
130197336|NCT02829723|468681462|FG003|Overall Study|Death|1|||
130197337|NCT02829723|468681463|FG004|Overall Study|Death|0|||
130197338|NCT02829723|468681464|FG005|Overall Study|Death|0|||
130197339|NCT02829723|468681465|FG006|Overall Study|Death|2|||
130197340|NCT02829723|468681466|FG007|Overall Study|Death|0|||
130197341|NCT02829723|468681467|FG008|Overall Study|Death|1|||
130197342|NCT02829723|468681468|FG009|Overall Study|Death|0|||
130197343|NCT02829723|468681469|FG010|Overall Study|Death|0|||
130197344|NCT02829723|468681470|FG011|Overall Study|Death|0|||
130197345|NCT02829723|468681471|FG012|Overall Study|Death|2|||
130197346|NCT02829723|468681472|FG013|Overall Study|Death|1|||
130197347|NCT02829723|468681473|FG014|Overall Study|Death|0|||
130197348|NCT02829723|468681474|FG015|Overall Study|Death|0|||
130197349|NCT02829723|468681475|FG016|Overall Study|Death|0|||
130197350|NCT02829723|468681476|FG017|Overall Study|Death|0|||
130197351|NCT02829723|468681477|FG018|Overall Study|Death|0|||
130197352|NCT02829723|468681478|FG019|Overall Study|Death|0|||
130197353|NCT02829723|468681479|FG020|Overall Study|Death|0|||
130197354|NCT02829723|468681480|FG021|Overall Study|Death|2|||
130197355|NCT02829723|468681481|FG022|Overall Study|Death|0|||
130197356|NCT02829723|468681482|FG023|Overall Study|Death|0|||
130197357|NCT02829723|468681483|FG024|Overall Study|Death|0|||
130197358|NCT02829723|468681484|FG025|Overall Study|Death|1|||
130197359|NCT02829723|468681485|FG026|Overall Study|Death|2|||
130197360|NCT02829723|468681459|FG000|Overall Study|Physician Decision|0|||
130197361|NCT02829723|468681460|FG001|Overall Study|Physician Decision|0|||
130197362|NCT02829723|468681461|FG002|Overall Study|Physician Decision|0|||
130197363|NCT02829723|468681462|FG003|Overall Study|Physician Decision|0|||
130197364|NCT02829723|468681463|FG004|Overall Study|Physician Decision|0|||
130197365|NCT02829723|468681464|FG005|Overall Study|Physician Decision|0|||
130197366|NCT02829723|468681465|FG006|Overall Study|Physician Decision|0|||
130197367|NCT02829723|468681466|FG007|Overall Study|Physician Decision|0|||
130197368|NCT02829723|468681467|FG008|Overall Study|Physician Decision|0|||
130197369|NCT02829723|468681468|FG009|Overall Study|Physician Decision|1|||
130197370|NCT02829723|468681469|FG010|Overall Study|Physician Decision|1|||
130197371|NCT02829723|468681470|FG011|Overall Study|Physician Decision|0|||
130197372|NCT02829723|468681471|FG012|Overall Study|Physician Decision|0|||
130197373|NCT02829723|468681472|FG013|Overall Study|Physician Decision|1|||
130197374|NCT02829723|468681473|FG014|Overall Study|Physician Decision|0|||
130197375|NCT02829723|468681474|FG015|Overall Study|Physician Decision|0|||
130197376|NCT02829723|468681475|FG016|Overall Study|Physician Decision|2|||
130197377|NCT02829723|468681476|FG017|Overall Study|Physician Decision|0|||
130197378|NCT02829723|468681477|FG018|Overall Study|Physician Decision|0|||
130197379|NCT02829723|468681478|FG019|Overall Study|Physician Decision|0|||
130197380|NCT02829723|468681479|FG020|Overall Study|Physician Decision|0|||
130197381|NCT02829723|468681480|FG021|Overall Study|Physician Decision|0|||
130197382|NCT02829723|468681481|FG022|Overall Study|Physician Decision|1|||
130197383|NCT02829723|468681482|FG023|Overall Study|Physician Decision|1|||
130197384|NCT02829723|468681483|FG024|Overall Study|Physician Decision|1|||
130197385|NCT02829723|468681484|FG025|Overall Study|Physician Decision|1|||
130197386|NCT02829723|468681485|FG026|Overall Study|Physician Decision|3|||
130197387|NCT02829723|468681459|FG000|Overall Study|Progressive disease|4|||
130197388|NCT02829723|468681460|FG001|Overall Study|Progressive disease|6|||
130197389|NCT02829723|468681461|FG002|Overall Study|Progressive disease|3|||
130197390|NCT02829723|468681462|FG003|Overall Study|Progressive disease|3|||
130197391|NCT02829723|468681463|FG004|Overall Study|Progressive disease|3|||
130197392|NCT02829723|468681464|FG005|Overall Study|Progressive disease|5|||
130197393|NCT02829723|468681465|FG006|Overall Study|Progressive disease|4|||
130197394|NCT02829723|468681466|FG007|Overall Study|Progressive disease|6|||
130197395|NCT02829723|468681467|FG008|Overall Study|Progressive disease|8|||
130197396|NCT02829723|468681468|FG009|Overall Study|Progressive disease|4|||
130197397|NCT02829723|468681469|FG010|Overall Study|Progressive disease|9|||
130197398|NCT02829723|468681470|FG011|Overall Study|Progressive disease|0|||
130197399|NCT02829723|468681471|FG012|Overall Study|Progressive disease|3|||
130197400|NCT02829723|468681472|FG013|Overall Study|Progressive disease|4|||
130197401|NCT02829723|468681473|FG014|Overall Study|Progressive disease|2|||
130197402|NCT02829723|468681474|FG015|Overall Study|Progressive disease|4|||
130197403|NCT02829723|468681475|FG016|Overall Study|Progressive disease|5|||
130197404|NCT02829723|468681476|FG017|Overall Study|Progressive disease|3|||
130197405|NCT02829723|468681477|FG018|Overall Study|Progressive disease|4|||
130197406|NCT02829723|468681478|FG019|Overall Study|Progressive disease|4|||
130197407|NCT02829723|468681479|FG020|Overall Study|Progressive disease|7|||
130197408|NCT02829723|468681480|FG021|Overall Study|Progressive disease|6|||
130197409|NCT02829723|468681481|FG022|Overall Study|Progressive disease|3|||
130197410|NCT02829723|468681482|FG023|Overall Study|Progressive disease|3|||
130197411|NCT02829723|468681483|FG024|Overall Study|Progressive disease|3|||
130197412|NCT02829723|468681484|FG025|Overall Study|Progressive disease|16|||
130197413|NCT02829723|468681485|FG026|Overall Study|Progressive disease|10|||
130197414|NCT02829723|468681459|FG000|Overall Study|Subject/guardian decision|0|||
130197415|NCT02829723|468681460|FG001|Overall Study|Subject/guardian decision|1|||
130197416|NCT02829723|468681461|FG002|Overall Study|Subject/guardian decision|0|||
130197417|NCT02829723|468681462|FG003|Overall Study|Subject/guardian decision|1|||
130197418|NCT02829723|468681463|FG004|Overall Study|Subject/guardian decision|0|||
130197419|NCT02829723|468681464|FG005|Overall Study|Subject/guardian decision|0|||
130197420|NCT02829723|468681465|FG006|Overall Study|Subject/guardian decision|0|||
130197421|NCT02829723|468681466|FG007|Overall Study|Subject/guardian decision|1|||
130197422|NCT02829723|468681467|FG008|Overall Study|Subject/guardian decision|0|||
130197423|NCT02829723|468681468|FG009|Overall Study|Subject/guardian decision|0|||
130197424|NCT02829723|468681469|FG010|Overall Study|Subject/guardian decision|0|||
130197425|NCT02829723|468681470|FG011|Overall Study|Subject/guardian decision|0|||
130197426|NCT02829723|468681471|FG012|Overall Study|Subject/guardian decision|0|||
130197427|NCT02829723|468681472|FG013|Overall Study|Subject/guardian decision|0|||
130197428|NCT02829723|468681473|FG014|Overall Study|Subject/guardian decision|1|||
130197429|NCT02829723|468681474|FG015|Overall Study|Subject/guardian decision|0|||
130197430|NCT02829723|468681475|FG016|Overall Study|Subject/guardian decision|1|||
130197431|NCT02829723|468681476|FG017|Overall Study|Subject/guardian decision|0|||
130197432|NCT02829723|468681477|FG018|Overall Study|Subject/guardian decision|1|||
130197433|NCT02829723|468681478|FG019|Overall Study|Subject/guardian decision|0|||
130197434|NCT02829723|468681479|FG020|Overall Study|Subject/guardian decision|1|||
130197435|NCT02829723|468681480|FG021|Overall Study|Subject/guardian decision|0|||
130197436|NCT02829723|468681481|FG022|Overall Study|Subject/guardian decision|0|||
130197437|NCT02829723|468681482|FG023|Overall Study|Subject/guardian decision|1|||
130197438|NCT02829723|468681483|FG024|Overall Study|Subject/guardian decision|0|||
130197439|NCT02829723|468681484|FG025|Overall Study|Subject/guardian decision|1|||
130197440|NCT02829723|468681485|FG026|Overall Study|Subject/guardian decision|1|||
130197441|NCT02829723|468681459|FG000|Overall Study|Study terminated by sponsor|0|||
130197442|NCT02829723|468681460|FG001|Overall Study|Study terminated by sponsor|0|||
130197443|NCT02829723|468681461|FG002|Overall Study|Study terminated by sponsor|0|||
130197444|NCT02829723|468681462|FG003|Overall Study|Study terminated by sponsor|0|||
130197445|NCT02829723|468681463|FG004|Overall Study|Study terminated by sponsor|0|||
130197446|NCT02829723|468681464|FG005|Overall Study|Study terminated by sponsor|0|||
130197447|NCT02829723|468681465|FG006|Overall Study|Study terminated by sponsor|0|||
130197448|NCT02829723|468681466|FG007|Overall Study|Study terminated by sponsor|0|||
130197449|NCT02829723|468681467|FG008|Overall Study|Study terminated by sponsor|0|||
130197450|NCT02829723|468681468|FG009|Overall Study|Study terminated by sponsor|0|||
130197451|NCT02829723|468681469|FG010|Overall Study|Study terminated by sponsor|0|||
130197452|NCT02829723|468681470|FG011|Overall Study|Study terminated by sponsor|0|||
130197453|NCT02829723|468681471|FG012|Overall Study|Study terminated by sponsor|0|||
130197454|NCT02829723|468681472|FG013|Overall Study|Study terminated by sponsor|0|||
130197455|NCT02829723|468681473|FG014|Overall Study|Study terminated by sponsor|0|||
130197456|NCT02829723|468681474|FG015|Overall Study|Study terminated by sponsor|0|||
130197457|NCT02829723|468681475|FG016|Overall Study|Study terminated by sponsor|0|||
130197458|NCT02829723|468681476|FG017|Overall Study|Study terminated by sponsor|0|||
130197459|NCT02829723|468681477|FG018|Overall Study|Study terminated by sponsor|0|||
130197460|NCT02829723|468681478|FG019|Overall Study|Study terminated by sponsor|0|||
130197461|NCT02829723|468681479|FG020|Overall Study|Study terminated by sponsor|0|||
130197462|NCT02829723|468681480|FG021|Overall Study|Study terminated by sponsor|1|||
130197463|NCT02829723|468681481|FG022|Overall Study|Study terminated by sponsor|0|||
130197464|NCT02829723|468681482|FG023|Overall Study|Study terminated by sponsor|0|||
130197465|NCT02829723|468681483|FG024|Overall Study|Study terminated by sponsor|0|||
130197466|NCT02829723|468681484|FG025|Overall Study|Study terminated by sponsor|0|||
130197467|NCT02829723|468681485|FG026|Overall Study|Study terminated by sponsor|0|||
130197468|NCT02989649|468681486|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
130197469|NCT02989649|468681486|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
130197470|NCT02989649|468681486|FG000|Overall Study|Lost For Observation During Study|3|||
130197471|NCT02989649|468681486|FG000|Overall Study|Reason Not Specified|13|||
130197472|NCT02004886|468681487|FG000|Overall Study|Adverse Event|0|||
130197473|NCT02004886|468681488|FG001|Overall Study|Adverse Event|1|||
130197474|NCT02004886|468681489|FG002|Overall Study|Adverse Event|0|||
130197475|NCT02004886|468681490|FG003|Overall Study|Adverse Event|0|||
130197476|NCT02004886|468681487|FG000|Overall Study|Unable to attend future visits|1|||
130197477|NCT02004886|468681488|FG001|Overall Study|Unable to attend future visits|0|||
130197478|NCT02004886|468681489|FG002|Overall Study|Unable to attend future visits|0|||
130197479|NCT02004886|468681490|FG003|Overall Study|Unable to attend future visits|0|||
130197480|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
130197481|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
130197482|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
130197483|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
130197484|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
130197485|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
130197486|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
130197487|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
130197488|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130197489|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130197490|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Death|1|||
130197491|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Death|0|||
130197492|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
130197493|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
130197494|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
130197495|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
130197496|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
130197497|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
130197498|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
130197499|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
130197500|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Adverse Event|2|||
130197501|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Adverse Event|6|||
130197502|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
130197503|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
130197504|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Progressive disease|4|||
130197505|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Progressive disease|35|||
130197506|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
130197507|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
130197508|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
130197509|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
130197510|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Death|0|||
130197511|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Death|1|||
130197512|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Other than specified above|9|||
130197513|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Other than specified above|18|||
130197514|NCT03605862|468681495|FG000|Overall Study|Withdrawal by Subject|12|||
130197515|NCT03605862|468681496|FG001|Overall Study|Withdrawal by Subject|9|||
130197516|NCT03605862|468681495|FG000|Overall Study|Adverse Event|2|||
130197517|NCT03605862|468681496|FG001|Overall Study|Adverse Event|1|||
130197518|NCT03605862|468681495|FG000|Overall Study|Physician Decision|3|||
130197519|NCT03605862|468681496|FG001|Overall Study|Physician Decision|1|||
130197520|NCT03605862|468681495|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
130197521|NCT03605862|468681496|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
130197522|NCT03891862|468681497|FG000|Open-label Period|Adverse Event|2|||
130197523|NCT03891862|468681498|FG001|Open-label Period|Adverse Event|0|||
130197524|NCT03891862|468681499|FG002|Open-label Period|Adverse Event|0|||
130197525|NCT03891862|468681497|FG000|Open-label Period|Protocol Violation|5|||
130197526|NCT03891862|468681498|FG001|Open-label Period|Protocol Violation|0|||
130197527|NCT03891862|468681499|FG002|Open-label Period|Protocol Violation|0|||
130197528|NCT03891862|468681497|FG000|Open-label Period|Withdrawal by Subject|6|||
130197529|NCT03891862|468681498|FG001|Open-label Period|Withdrawal by Subject|0|||
130197530|NCT03891862|468681499|FG002|Open-label Period|Withdrawal by Subject|0|||
130197531|NCT03891862|468681497|FG000|Open-label Period|Death|1|||
130197532|NCT03891862|468681498|FG001|Open-label Period|Death|0|||
130197533|NCT03891862|468681499|FG002|Open-label Period|Death|0|||
130197534|NCT03891862|468681497|FG000|Open-label Period|Lost to Follow-up|2|||
130197535|NCT03891862|468681498|FG001|Open-label Period|Lost to Follow-up|0|||
130197536|NCT03891862|468681499|FG002|Open-label Period|Lost to Follow-up|0|||
130197537|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
130197538|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130197539|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130197540|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
130197541|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
130197542|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
130197543|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
130197544|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
130197545|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
130197546|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130197547|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
130197548|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130197549|NCT05239494|468681500|FG000|Overall Study|Lost to Follow-up|1|||
130197550|NCT01194531|468681501|FG000|Overall Study|Withdrawal by Subject|1|||
130197551|NCT01194531|468681502|FG001|Overall Study|Withdrawal by Subject|0|||
130197552|NCT01194531|468681501|FG000|Overall Study|Protocol Violation|4|||
130197553|NCT01194531|468681502|FG001|Overall Study|Protocol Violation|1|||
130197554|NCT01194531|468681501|FG000|Overall Study|Physician Decision|0|||
130197555|NCT01194531|468681502|FG001|Overall Study|Physician Decision|2|||
130197556|NCT04603482|468681503|FG000|Overall Study|Lost to Follow-up|15|||
130197557|NCT04603482|468681504|FG001|Overall Study|Lost to Follow-up|15|||
130197558|NCT04603482|468681505|FG002|Overall Study|Lost to Follow-up|15|||
130197559|NCT00179673|468681506|FG000|Overall Study|Adverse Event|7|||
130197560|NCT00179673|468681506|FG000|Overall Study|Lack of Efficacy|15|||
130197561|NCT00179673|468681506|FG000|Overall Study|Withdrawal by Subject|3|||
130197562|NCT00179673|468681506|FG000|Overall Study|Death|4|||
130197563|NCT00179673|468681506|FG000|Overall Study|Other Observations and options|14|||
130197564|NCT00977314|468681509|FG000|Overall Study|Withdrawal by Subject|1|||
130197565|NCT00977314|468681510|FG001|Overall Study|Withdrawal by Subject|0|||
130197566|NCT00977314|468681509|FG000|Overall Study|Physician Decision|1|||
130197567|NCT00977314|468681510|FG001|Overall Study|Physician Decision|0|||
130197568|NCT02107859|468681511|FG000|Overall Study|Withdrawal by Subject|14|||
130197569|NCT02107859|468681511|FG000|Overall Study|Adverse Event|3|||
130197570|NCT02107859|468681511|FG000|Overall Study|Study closure|41|||
130197571|NCT02107859|468681511|FG000|Overall Study|Other than specified|3|||
130197572|NCT01094301|468681514|FG000|Trial Stage|Withdrawal by Subject|1|||
130197573|NCT01094301|468681514|FG000|Implant Stage|Adverse Event|1|||
130197574|NCT01094301|468681514|FG000|Implant Stage|Protocol Violation|1|||
130197575|NCT01094301|468681514|FG000|Implant Stage|Withdrawal by Subject|2|||
130197576|NCT01094301|468681514|FG000|Implant Stage|No return of pain|4|||
130197577|NCT00135512|468681515|FG000|Overall Study|Adverse Event|56|||
130197578|NCT00135512|468681515|FG000|Overall Study|Lack of Efficacy|25|||
130197579|NCT00135512|468681515|FG000|Overall Study|Other|42|||
130197580|NCT02235077|468681516|FG000|Overall Study|Death|5|||
130197581|NCT02235077|468681517|FG001|Overall Study|Death|7|||
130197582|NCT02235077|468681516|FG000|Overall Study|Lost to Follow-up|5|||
130197583|NCT02235077|468681517|FG001|Overall Study|Lost to Follow-up|6|||
130197584|NCT02235077|468681516|FG000|Overall Study|Withdrawal by Subject|8|||
130197585|NCT02235077|468681517|FG001|Overall Study|Withdrawal by Subject|5|||
130197586|NCT02235077|468681516|FG000|Overall Study|Physician Decision|0|||
130197587|NCT02235077|468681517|FG001|Overall Study|Physician Decision|1|||
130197588|NCT03852628|468681518|FG000|Overall Study|Lost to Follow-up|7|||
130197589|NCT03852628|468681519|FG001|Overall Study|Lost to Follow-up|6|||
130197590|NCT03852628|468681518|FG000|Overall Study|Lack of Efficacy|6|||
130197591|NCT03852628|468681519|FG001|Overall Study|Lack of Efficacy|6|||
130197592|NCT00586820|468681521|FG000|Overall Study|Unsuccessful PCI|1|||
130197593|NCT00586820|468681522|FG001|Overall Study|Unsuccessful PCI|0|||
130197594|NCT03887442|468681523|FG000|Overall Study|Adverse Event|1|||
130197595|NCT03887442|468681524|FG001|Overall Study|Adverse Event|0|||
130197596|NCT01868022|468681525|FG000|Overall Study|Withdrawal by Subject|0|||
130197597|NCT01868022|468681526|FG001|Overall Study|Withdrawal by Subject|0|||
130197598|NCT01868022|468681527|FG002|Overall Study|Withdrawal by Subject|1|||
130197599|NCT01868022|468681528|FG003|Overall Study|Withdrawal by Subject|1|||
130197600|NCT01868022|468681529|FG004|Overall Study|Withdrawal by Subject|0|||
130197601|NCT01868022|468681530|FG005|Overall Study|Withdrawal by Subject|0|||
130197602|NCT01868022|468681531|FG006|Overall Study|Withdrawal by Subject|0|||
130197603|NCT01868022|468681532|FG007|Overall Study|Withdrawal by Subject|1|||
130197604|NCT01868022|468681533|FG008|Overall Study|Withdrawal by Subject|0|||
130197605|NCT01868022|468681525|FG000|Overall Study|Adverse Event|0|||
130197606|NCT01868022|468681526|FG001|Overall Study|Adverse Event|0|||
130197607|NCT01868022|468681527|FG002|Overall Study|Adverse Event|0|||
130197608|NCT01868022|468681528|FG003|Overall Study|Adverse Event|0|||
130197609|NCT01868022|468681529|FG004|Overall Study|Adverse Event|2|||
130197610|NCT01868022|468681530|FG005|Overall Study|Adverse Event|0|||
130197611|NCT01868022|468681531|FG006|Overall Study|Adverse Event|0|||
130197612|NCT01868022|468681532|FG007|Overall Study|Adverse Event|2|||
130197613|NCT01868022|468681533|FG008|Overall Study|Adverse Event|2|||
130197614|NCT01868022|468681525|FG000|Overall Study|Physician Decision|0|||
130197615|NCT01868022|468681526|FG001|Overall Study|Physician Decision|0|||
130197616|NCT01868022|468681527|FG002|Overall Study|Physician Decision|0|||
130197617|NCT01868022|468681528|FG003|Overall Study|Physician Decision|0|||
130197618|NCT01868022|468681529|FG004|Overall Study|Physician Decision|0|||
130197619|NCT01868022|468681530|FG005|Overall Study|Physician Decision|1|||
130197620|NCT01868022|468681531|FG006|Overall Study|Physician Decision|0|||
130197621|NCT01868022|468681532|FG007|Overall Study|Physician Decision|2|||
130197622|NCT01868022|468681533|FG008|Overall Study|Physician Decision|0|||
130197623|NCT01868022|468681525|FG000|Overall Study|Study closed/terminated|0|||
130197624|NCT01868022|468681526|FG001|Overall Study|Study closed/terminated|0|||
130197625|NCT01868022|468681527|FG002|Overall Study|Study closed/terminated|0|||
130197626|NCT01868022|468681528|FG003|Overall Study|Study closed/terminated|0|||
130197627|NCT01868022|468681529|FG004|Overall Study|Study closed/terminated|0|||
130197628|NCT01868022|468681530|FG005|Overall Study|Study closed/terminated|0|||
130197629|NCT01868022|468681531|FG006|Overall Study|Study closed/terminated|0|||
130197630|NCT01868022|468681532|FG007|Overall Study|Study closed/terminated|1|||
130197631|NCT01868022|468681533|FG008|Overall Study|Study closed/terminated|0|||
130197632|NCT01868022|468681525|FG000|Overall Study|Ongoing|0|||
130197633|NCT01868022|468681526|FG001|Overall Study|Ongoing|0|||
130197634|NCT01868022|468681527|FG002|Overall Study|Ongoing|0|||
130197635|NCT01868022|468681528|FG003|Overall Study|Ongoing|0|||
130197636|NCT01868022|468681529|FG004|Overall Study|Ongoing|0|||
130197637|NCT01868022|468681530|FG005|Overall Study|Ongoing|0|||
130197638|NCT01868022|468681531|FG006|Overall Study|Ongoing|0|||
130197639|NCT01868022|468681532|FG007|Overall Study|Ongoing|3|||
130197640|NCT01868022|468681533|FG008|Overall Study|Ongoing|0|||
130197641|NCT01628198|468681534|FG000|Overall Study|Lost to Follow-up|7|||
130197642|NCT01628198|468681534|FG000|Overall Study|Withdrawal by Subject|10|||
130197643|NCT01628198|468681534|FG000|Overall Study|Screen failure|1|||
130197644|NCT00833482|468681543|FG000|Days 11-20|Adverse Event|0|||
130197645|NCT00833482|468681544|FG001|Days 11-20|Adverse Event|2|||
130197646|NCT00833482|468681545|FG002|Days 11-20|Adverse Event|0|||
130197647|NCT00833482|468681546|FG003|Days 11-20|Adverse Event|0|||
130197648|NCT00833482|468681547|FG004|Days 11-20|Adverse Event|0|||
130197649|NCT00833482|468681548|FG005|Days 11-20|Adverse Event|0|||
130197650|NCT00833482|468681543|FG000|Days 11-20|Withdrawal by Subject|0|||
130197651|NCT00833482|468681544|FG001|Days 11-20|Withdrawal by Subject|1|||
130197652|NCT00833482|468681545|FG002|Days 11-20|Withdrawal by Subject|0|||
130197653|NCT00833482|468681546|FG003|Days 11-20|Withdrawal by Subject|0|||
130197654|NCT00833482|468681547|FG004|Days 11-20|Withdrawal by Subject|0|||
130197655|NCT00833482|468681548|FG005|Days 11-20|Withdrawal by Subject|0|||
130197656|NCT00833482|468681543|FG000|Days 21-30|Adverse Event|0|||
130197657|NCT00833482|468681544|FG001|Days 21-30|Adverse Event|0|||
130197658|NCT00833482|468681545|FG002|Days 21-30|Adverse Event|1|||
130197659|NCT00833482|468681546|FG003|Days 21-30|Adverse Event|0|||
130197660|NCT00833482|468681547|FG004|Days 21-30|Adverse Event|0|||
130197661|NCT00833482|468681548|FG005|Days 21-30|Adverse Event|0|||
130197662|NCT00833482|468681543|FG000|Days 21-30|Withdrawal by Subject|0|||
130197663|NCT00833482|468681544|FG001|Days 21-30|Withdrawal by Subject|0|||
130197664|NCT00833482|468681545|FG002|Days 21-30|Withdrawal by Subject|0|||
130197665|NCT00833482|468681546|FG003|Days 21-30|Withdrawal by Subject|0|||
130197666|NCT00833482|468681547|FG004|Days 21-30|Withdrawal by Subject|1|||
130197667|NCT00833482|468681548|FG005|Days 21-30|Withdrawal by Subject|0|||
130197668|NCT02778074|468681549|FG000|Overall Study|Lost to Follow-up|7|||
130197669|NCT02778074|468681550|FG001|Overall Study|Lost to Follow-up|10|||
130197670|NCT03489707|468681551|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
130197671|NCT03489707|468681552|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
130197672|NCT03489707|468681551|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
130197673|NCT03489707|468681552|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
130197674|NCT01817582|468681553|FG000|Overall Study|Withdrawal by Subject|0|||
130197675|NCT01817582|468681554|FG001|Overall Study|Withdrawal by Subject|1|||
130197676|NCT01817582|468681555|FG002|Overall Study|Withdrawal by Subject|0|||
130197677|NCT01817582|468681553|FG000|Overall Study|Participant revealed masked treatment|1|||
130197678|NCT01817582|468681554|FG001|Overall Study|Participant revealed masked treatment|0|||
130197679|NCT01817582|468681555|FG002|Overall Study|Participant revealed masked treatment|0|||
130197680|NCT01817582|468681553|FG000|Overall Study|Randomized but exclusion criteria met|1|||
130197681|NCT01817582|468681554|FG001|Overall Study|Randomized but exclusion criteria met|0|||
130197682|NCT01817582|468681555|FG002|Overall Study|Randomized but exclusion criteria met|0|||
130197683|NCT02122887|468681558|FG000|Overall Study|Withdrawal by Subject|20|||
130197684|NCT02122887|468681559|FG001|Overall Study|Withdrawal by Subject|2|||
130197685|NCT00378508|468683257|FG000|Overall Study|Withdrawal by Subject|1|||
130197686|NCT00378508|468683258|FG001|Overall Study|Withdrawal by Subject|3|||
130197687|NCT00378508|468683257|FG000|Overall Study|Lost to Follow-up|1|||
130197688|NCT00378508|468683258|FG001|Overall Study|Lost to Follow-up|0|||
130197689|NCT03917472|468683262|FG000|Overall Study|Physician Decision|4|||
130197690|NCT03917472|468683263|FG001|Overall Study|Physician Decision|0|||
130197691|NCT03917472|468683262|FG000|Overall Study|Adverse Event|3|||
130197692|NCT03917472|468683263|FG001|Overall Study|Adverse Event|1|||
130197693|NCT03917472|468683262|FG000|Overall Study|Death|7|||
130197694|NCT03917472|468683263|FG001|Overall Study|Death|5|||
130197695|NCT03917472|468683262|FG000|Overall Study|Withdrawal by Subject|11|||
130197696|NCT03917472|468683263|FG001|Overall Study|Withdrawal by Subject|4|||
130197697|NCT03917472|468683262|FG000|Overall Study|Lost to Follow-up|10|||
130197698|NCT03917472|468683263|FG001|Overall Study|Lost to Follow-up|5|||
130197699|NCT01953601|468683267|FG000|Part 1 (Base Study)|Adverse Event|24|||
130197700|NCT01953601|468683268|FG001|Part 1 (Base Study)|Adverse Event|37|||
130197701|NCT01953601|468683269|FG002|Part 1 (Base Study)|Adverse Event|15|||
130197702|NCT01953601|468683267|FG000|Part 1 (Base Study)|Death|2|||
130197703|NCT01953601|468683268|FG001|Part 1 (Base Study)|Death|0|||
130197704|NCT01953601|468683269|FG002|Part 1 (Base Study)|Death|3|||
130197705|NCT01953601|468683267|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
130197706|NCT01953601|468683268|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
130197707|NCT01953601|468683269|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
130197708|NCT01953601|468683267|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
130197709|NCT01953601|468683268|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
130197710|NCT01953601|468683269|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
130197711|NCT01953601|468683267|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
130197712|NCT01953601|468683268|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
130197713|NCT01953601|468683269|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
130197714|NCT01953601|468683267|FG000|Part 1 (Base Study)|Physician Decision|3|||
130197715|NCT01953601|468683268|FG001|Part 1 (Base Study)|Physician Decision|7|||
130197716|NCT01953601|468683269|FG002|Part 1 (Base Study)|Physician Decision|4|||
130197717|NCT01953601|468683267|FG000|Part 1 (Base Study)|Screen failure|1|||
130197718|NCT01953601|468683268|FG001|Part 1 (Base Study)|Screen failure|0|||
130197719|NCT01953601|468683269|FG002|Part 1 (Base Study)|Screen failure|1|||
130197720|NCT01953601|468683267|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
130197721|NCT01953601|468683268|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
130197722|NCT01953601|468683269|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
130197723|NCT01953601|468683267|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
130197724|NCT01953601|468683268|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
130197725|NCT01953601|468683269|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
130197726|NCT01953601|468683267|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
130197727|NCT01953601|468683268|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
130197728|NCT01953601|468683269|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
130197729|NCT01953601|468683267|FG000|Part 1 (Base Study)|Subject moved|2|||
130197730|NCT01953601|468683268|FG001|Part 1 (Base Study)|Subject moved|2|||
130197731|NCT01953601|468683269|FG002|Part 1 (Base Study)|Subject moved|1|||
130197732|NCT01953601|468683267|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
130197733|NCT01953601|468683268|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
130197734|NCT01953601|468683269|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
130197735|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Adverse Event|1|||
130197736|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Adverse Event|1|||
130197737|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Adverse Event|10|||
130197738|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Death|0|||
130197739|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Death|3|||
130197740|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Death|0|||
130197741|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
130197742|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
130197743|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
130197744|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
130197745|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
130197746|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
130197747|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Physician Decision|2|||
130197748|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Physician Decision|0|||
130197749|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Physician Decision|2|||
130197750|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
130197751|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
130197752|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
130197753|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
130197754|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
130197755|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
130197756|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
130197757|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
130197758|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
130197759|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Subject moved|0|||
130197760|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Subject moved|0|||
130197761|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Subject moved|1|||
130197762|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
130197763|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
130197764|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
130197765|NCT03991299|468683274|FG000|Overall Study|Study closed, sponsor decision|3|||
130197766|NCT03991299|468683274|FG000|Overall Study|Withdrawal by Subject|1|||
130197767|NCT04429555|468683277|FG000|Overall Study|Death|0|||
130197768|NCT04429555|468683278|FG001|Overall Study|Death|2|||
130197769|NCT04429555|468683277|FG000|Overall Study|Other|2|||
130197770|NCT04429555|468683278|FG001|Overall Study|Other|0|||
130197771|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
130197772|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
130197773|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
130197774|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
130197775|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
130197776|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197777|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197778|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197779|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197780|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
130197781|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197782|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197783|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
130197784|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197785|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
130197786|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Death|0|||
130197787|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Death|0|||
130197788|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Death|1|||
130197789|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Death|2|||
130197790|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Death|7|||
130197791|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
130197792|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
130197793|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
130197794|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
130197795|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
130197796|NCT00941863|468683281|FG000|Continued After PCD|Withdrawal by Subject|0|||
130197797|NCT00941863|468683282|FG001|Continued After PCD|Withdrawal by Subject|0|||
130197798|NCT00941863|468683283|FG002|Continued After PCD|Withdrawal by Subject|0|||
130197799|NCT00941863|468683284|FG003|Continued After PCD|Withdrawal by Subject|0|||
130197800|NCT00941863|468683285|FG004|Continued After PCD|Withdrawal by Subject|1|||
130197801|NCT00941863|468683281|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197802|NCT00941863|468683282|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197803|NCT00941863|468683283|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197804|NCT00941863|468683284|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197805|NCT00941863|468683285|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
130197806|NCT04533412|468683289|FG000|Overall Study|Withdrawal by Subject|1|||
130197807|NCT04533412|468683290|FG001|Overall Study|Withdrawal by Subject|1|||
130197808|NCT04533412|468683289|FG000|Overall Study|Lost to Follow-up|1|||
130197809|NCT04533412|468683290|FG001|Overall Study|Lost to Follow-up|4|||
130197810|NCT05113979|468683291|FG000|Overall Study|Death|2|||
130197811|NCT05113979|468683291|FG000|Overall Study|Lost to Follow-up|1|||
130197812|NCT00968981|468683294|FG000|Overall Study|Adverse Event|2|||
130197813|NCT00968981|468683295|FG001|Overall Study|Adverse Event|0|||
130197814|NCT00968981|468683296|FG002|Overall Study|Adverse Event|0|||
130197815|NCT00968981|468683294|FG000|Overall Study|Disease Progression|14|||
130197816|NCT00968981|468683295|FG001|Overall Study|Disease Progression|16|||
130197817|NCT00968981|468683296|FG002|Overall Study|Disease Progression|13|||
130197818|NCT00968981|468683294|FG000|Overall Study|Lost to Follow-up|0|||
130197819|NCT00968981|468683295|FG001|Overall Study|Lost to Follow-up|0|||
130197820|NCT00968981|468683296|FG002|Overall Study|Lost to Follow-up|1|||
130197821|NCT00968981|468683294|FG000|Overall Study|Physician Decision|5|||
130197822|NCT00968981|468683295|FG001|Overall Study|Physician Decision|3|||
130197823|NCT00968981|468683296|FG002|Overall Study|Physician Decision|5|||
130197824|NCT00968981|468683294|FG000|Overall Study|Withdrawal by Subject|1|||
130197825|NCT00968981|468683295|FG001|Overall Study|Withdrawal by Subject|3|||
130197826|NCT00968981|468683296|FG002|Overall Study|Withdrawal by Subject|3|||
130197827|NCT01489254|468683299|FG000|Double-blind Part|Adverse Event|7|||
130197828|NCT01489254|468683300|FG001|Double-blind Part|Adverse Event|2|||
130197829|NCT01489254|468683301|FG002|Double-blind Part|Adverse Event|2|||
130197830|NCT01489254|468683302|FG003|Double-blind Part|Adverse Event|0|||
130197831|NCT01489254|468683299|FG000|Double-blind Part|Pregnancy|1|||
130197832|NCT01489254|468683300|FG001|Double-blind Part|Pregnancy|3|||
130197833|NCT01489254|468683301|FG002|Double-blind Part|Pregnancy|0|||
130197834|NCT01489254|468683302|FG003|Double-blind Part|Pregnancy|0|||
130197835|NCT01489254|468683299|FG000|Double-blind Part|Withdrawal by Subject|12|||
130197836|NCT01489254|468683300|FG001|Double-blind Part|Withdrawal by Subject|20|||
130197837|NCT01489254|468683301|FG002|Double-blind Part|Withdrawal by Subject|1|||
130197838|NCT01489254|468683302|FG003|Double-blind Part|Withdrawal by Subject|0|||
130197839|NCT01489254|468683299|FG000|Double-blind Part|Lost to Follow-up|1|||
130197840|NCT01489254|468683300|FG001|Double-blind Part|Lost to Follow-up|2|||
130197841|NCT01489254|468683301|FG002|Double-blind Part|Lost to Follow-up|0|||
130197842|NCT01489254|468683302|FG003|Double-blind Part|Lost to Follow-up|0|||
130197843|NCT01489254|468683299|FG000|Double-blind Part|Other reasons for not completing study|4|||
130197844|NCT01489254|468683300|FG001|Double-blind Part|Other reasons for not completing study|6|||
130197845|NCT01489254|468683301|FG002|Double-blind Part|Other reasons for not completing study|0|||
130197846|NCT01489254|468683302|FG003|Double-blind Part|Other reasons for not completing study|0|||
130197847|NCT01489254|468683299|FG000|Open-label Extension Part|Adverse Event|0|||
130197848|NCT01489254|468683300|FG001|Open-label Extension Part|Adverse Event|0|||
130197849|NCT01489254|468683301|FG002|Open-label Extension Part|Adverse Event|0|||
130197850|NCT01489254|468683302|FG003|Open-label Extension Part|Adverse Event|10|||
130197851|NCT01489254|468683299|FG000|Open-label Extension Part|Pregnancy|0|||
130197852|NCT01489254|468683300|FG001|Open-label Extension Part|Pregnancy|0|||
130197853|NCT01489254|468683301|FG002|Open-label Extension Part|Pregnancy|0|||
130197854|NCT01489254|468683302|FG003|Open-label Extension Part|Pregnancy|3|||
130197855|NCT01489254|468683299|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
130197856|NCT01489254|468683300|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
130197857|NCT01489254|468683301|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
130197858|NCT01489254|468683302|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
130197859|NCT01489254|468683299|FG000|Open-label Extension Part|Protocol Violation|0|||
130197860|NCT01489254|468683300|FG001|Open-label Extension Part|Protocol Violation|0|||
130197861|NCT01489254|468683301|FG002|Open-label Extension Part|Protocol Violation|0|||
130197862|NCT01489254|468683302|FG003|Open-label Extension Part|Protocol Violation|1|||
130197863|NCT01489254|468683299|FG000|Open-label Extension Part|Lost to Follow-up|0|||
130197864|NCT01489254|468683300|FG001|Open-label Extension Part|Lost to Follow-up|0|||
130197865|NCT01489254|468683301|FG002|Open-label Extension Part|Lost to Follow-up|0|||
130197866|NCT01489254|468683302|FG003|Open-label Extension Part|Lost to Follow-up|9|||
130197867|NCT01489254|468683299|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
130197868|NCT01489254|468683300|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
130197869|NCT01489254|468683301|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
130197870|NCT01489254|468683302|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
130197871|NCT00281632|468683310|FG000|Overall Study|Adverse Event|7|||
130197872|NCT00281632|468683310|FG000|Overall Study|Withdrawal by Subject|2|||
130197873|NCT00281632|468683310|FG000|Overall Study|Disease Progression|22|||
130197874|NCT00281632|468683310|FG000|Overall Study|Death|1|||
130197875|NCT00281632|468683310|FG000|Overall Study|Physician Decision|1|||
130197876|NCT00281632|468683310|FG000|Overall Study|Ongoing|3|||
130197877|NCT03990571|468683311|FG000|Overall Study|Withdrawal by Subject|1|||
130197878|NCT03990571|468683311|FG000|Overall Study|Insurance Issues|3|||
130197879|NCT03990571|468683311|FG000|Overall Study|Covid Restrictions|2|||
130197880|NCT00782184|468683318|FG000|Overall Study|Adverse Event|1|||
130197881|NCT00782184|468683319|FG001|Overall Study|Adverse Event|2|||
130197882|NCT00782184|468683318|FG000|Overall Study|Protocol Violation|0|||
130197883|NCT00782184|468683319|FG001|Overall Study|Protocol Violation|1|||
130197884|NCT00782184|468683318|FG000|Overall Study|Withdrawal by Subject|3|||
130197885|NCT00782184|468683319|FG001|Overall Study|Withdrawal by Subject|2|||
130197886|NCT03614078|468683320|FG000|Overall Study|Withdrawal by Subject|2|||
130197887|NCT03614078|468683321|FG001|Overall Study|Withdrawal by Subject|2|||
130197888|NCT03614078|468683322|FG002|Overall Study|Withdrawal by Subject|3|||
130197889|NCT03614078|468683320|FG000|Overall Study|Participant Did Not Return for Visit|0|||
130197890|NCT03614078|468683321|FG001|Overall Study|Participant Did Not Return for Visit|1|||
130197891|NCT03614078|468683322|FG002|Overall Study|Participant Did Not Return for Visit|0|||
130197892|NCT03614078|468683320|FG000|Overall Study|High Neutrophils|0|||
130197893|NCT03614078|468683321|FG001|Overall Study|High Neutrophils|0|||
130197894|NCT03614078|468683322|FG002|Overall Study|High Neutrophils|2|||
130197895|NCT03614078|468683320|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
130197896|NCT03614078|468683321|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
130197897|NCT03614078|468683322|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
130197898|NCT03614078|468683320|FG000|Overall Study|Exacerbation of Psoriasis|0|||
130197899|NCT03614078|468683321|FG001|Overall Study|Exacerbation of Psoriasis|1|||
130197900|NCT03614078|468683322|FG002|Overall Study|Exacerbation of Psoriasis|0|||
130197901|NCT03614078|468683320|FG000|Overall Study|Adverse Event|0|||
130197902|NCT03614078|468683321|FG001|Overall Study|Adverse Event|2|||
130197903|NCT03614078|468683322|FG002|Overall Study|Adverse Event|0|||
130197904|NCT03614078|468683320|FG000|Overall Study|Dizziness and Rash|0|||
130197905|NCT03614078|468683321|FG001|Overall Study|Dizziness and Rash|1|||
130197906|NCT03614078|468683322|FG002|Overall Study|Dizziness and Rash|0|||
130197907|NCT04143594|468683325|FG000|Overall Study|Withdrew consent|3|||
130197908|NCT04143594|468683326|FG001|Overall Study|Withdrew consent|10|||
130197909|NCT04143594|468683327|FG002|Overall Study|Withdrew consent|3|||
130197910|NCT04143594|468683328|FG003|Overall Study|Withdrew consent|1|||
130197911|NCT04143594|468683325|FG000|Overall Study|Lost to Follow-up|3|||
130197912|NCT04143594|468683326|FG001|Overall Study|Lost to Follow-up|5|||
130197913|NCT04143594|468683327|FG002|Overall Study|Lost to Follow-up|11|||
130197914|NCT04143594|468683328|FG003|Overall Study|Lost to Follow-up|0|||
130197915|NCT04143594|468683325|FG000|Overall Study|Investigator's discretion|2|||
130197916|NCT04143594|468683326|FG001|Overall Study|Investigator's discretion|2|||
130197917|NCT04143594|468683327|FG002|Overall Study|Investigator's discretion|0|||
130197918|NCT04143594|468683328|FG003|Overall Study|Investigator's discretion|0|||
130197919|NCT04143594|468683325|FG000|Overall Study|Randomized but never treated|0|||
130197920|NCT04143594|468683326|FG001|Overall Study|Randomized but never treated|0|||
130197921|NCT04143594|468683327|FG002|Overall Study|Randomized but never treated|0|||
130197922|NCT04143594|468683328|FG003|Overall Study|Randomized but never treated|1|||
130197923|NCT04143594|468683325|FG000|Overall Study|Death|1|||
130197924|NCT04143594|468683326|FG001|Overall Study|Death|0|||
130197925|NCT04143594|468683327|FG002|Overall Study|Death|1|||
130197926|NCT04143594|468683328|FG003|Overall Study|Death|0|||
130197927|NCT04143594|468683325|FG000|Overall Study|Adverse Event|1|||
130197928|NCT04143594|468683326|FG001|Overall Study|Adverse Event|0|||
130197929|NCT04143594|468683327|FG002|Overall Study|Adverse Event|0|||
130197930|NCT04143594|468683328|FG003|Overall Study|Adverse Event|0|||
130197931|NCT04143594|468683325|FG000|Overall Study|Pregnancy|0|||
130197932|NCT04143594|468683326|FG001|Overall Study|Pregnancy|0|||
130197933|NCT04143594|468683327|FG002|Overall Study|Pregnancy|1|||
130197934|NCT04143594|468683328|FG003|Overall Study|Pregnancy|0|||
130197935|NCT04143594|468683325|FG000|Overall Study|Lack of Efficacy|1|||
130197936|NCT04143594|468683326|FG001|Overall Study|Lack of Efficacy|1|||
130197937|NCT04143594|468683327|FG002|Overall Study|Lack of Efficacy|0|||
130197938|NCT04143594|468683328|FG003|Overall Study|Lack of Efficacy|0|||
130197939|NCT01054196|468683329|FG000|Overall Study|Physician Decision|0|||
130197940|NCT01054196|468683330|FG001|Overall Study|Physician Decision|0|||
130197941|NCT01054196|468683331|FG002|Overall Study|Physician Decision|0|||
130197942|NCT01054196|468683332|FG003|Overall Study|Physician Decision|1|||
130197943|NCT01054196|468683333|FG004|Overall Study|Physician Decision|0|||
130197944|NCT01054196|468683334|FG005|Overall Study|Physician Decision|0|||
130197945|NCT01054196|468683335|FG006|Overall Study|Physician Decision|1|||
130197946|NCT00492648|468683336|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
130197947|NCT00492648|468683337|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
130197948|NCT00282113|468683338|FG000|Overall Study|Removed at parents request|1|||
130197949|NCT00282113|468683339|FG001|Overall Study|Removed at parents request|0|||
130197950|NCT00282113|468683340|FG002|Overall Study|Removed at parents request|0|||
130197951|NCT02949843|468683341|FG000|Overall Study|Withdrawal by Subject|0|||
130197952|NCT02949843|468683342|FG001|Overall Study|Withdrawal by Subject|1|||
130197953|NCT02949843|468683343|FG002|Overall Study|Withdrawal by Subject|1|||
130197954|NCT01500187|468683345|FG000|Overall Study|Lost to Follow-up|6|||
130197955|NCT01500187|468683346|FG001|Overall Study|Lost to Follow-up|0|||
130197956|NCT01343277|468683363|FG000|Overall Study|Other|3|||
130197957|NCT01343277|468683364|FG001|Overall Study|Other|3|||
130197958|NCT01343277|468683363|FG000|Overall Study|Withdrawal by Subject|18|||
130197959|NCT01343277|468683364|FG001|Overall Study|Withdrawal by Subject|13|||
130197960|NCT01343277|468683363|FG000|Overall Study|Physician Decision|1|||
130197961|NCT01343277|468683364|FG001|Overall Study|Physician Decision|2|||
130197962|NCT01343277|468683363|FG000|Overall Study|Death|10|||
130197963|NCT01343277|468683364|FG001|Overall Study|Death|1|||
130197964|NCT01343277|468683363|FG000|Overall Study|Adverse Event|67|||
130197965|NCT01343277|468683364|FG001|Overall Study|Adverse Event|13|||
130197966|NCT01343277|468683363|FG000|Overall Study|Disease progression|270|||
130197967|NCT01343277|468683364|FG001|Overall Study|Disease progression|138|||
130197968|NCT01343277|468683363|FG000|Overall Study|Randomized not treated|6|||
130197969|NCT01343277|468683364|FG001|Overall Study|Randomized not treated|21|||
130197970|NCT01343277|468683363|FG000|Overall Study|Treatment ongoing|8|||
130197971|NCT01343277|468683364|FG001|Overall Study|Treatment ongoing|2|||
130197972|NCT01343277|468683363|FG000|Overall Study|Subsequent anticancer therapy|1|||
130197973|NCT01343277|468683364|FG001|Overall Study|Subsequent anticancer therapy|0|||
130197974|NCT01582178|468683365|FG000|Overall Study|Physician Decision|6|||
130197975|NCT01582178|468683366|FG001|Overall Study|Physician Decision|5|||
130197976|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
130197977|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130197978|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130197979|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
130197980|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197981|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197982|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
130197983|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197984|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
130197985|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197986|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197987|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197988|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
130197989|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
130197990|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
130197991|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
130197992|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197993|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
130197994|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197995|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197996|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130197997|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
130197998|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130197999|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130198000|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130198001|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130198002|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130198003|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130198004|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130198005|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130198006|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130198007|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130198008|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130198009|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130198010|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130198011|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130198012|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
130198013|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
130198014|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
130198015|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
130198016|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Death|0|||
130198017|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Death|0|||
130198018|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Death|0|||
130198019|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Death|1|||
130198020|NCT01295827|468683380|FG000|Overall Study|Adverse Event|1|||
130198021|NCT01295827|468683381|FG001|Overall Study|Adverse Event|2|||
130198022|NCT01295827|468683382|FG002|Overall Study|Adverse Event|2|||
130198023|NCT01295827|468683383|FG003|Overall Study|Adverse Event|1|||
130198024|NCT01295827|468683384|FG004|Overall Study|Adverse Event|1|||
130198025|NCT01295827|468683385|FG005|Overall Study|Adverse Event|4|||
130198026|NCT01295827|468683386|FG006|Overall Study|Adverse Event|15|||
130198027|NCT01295827|468683387|FG007|Overall Study|Adverse Event|49|||
130198028|NCT01295827|468683388|FG008|Overall Study|Adverse Event|22|||
130198029|NCT01295827|468683389|FG009|Overall Study|Adverse Event|7|||
130198030|NCT01295827|468683390|FG010|Overall Study|Adverse Event|50|||
130198031|NCT01295827|468683391|FG011|Overall Study|Adverse Event|21|||
130198032|NCT01295827|468683392|FG012|Overall Study|Adverse Event|0|||
130198033|NCT01295827|468683393|FG013|Overall Study|Adverse Event|0|||
130198034|NCT01295827|468683394|FG014|Overall Study|Adverse Event|0|||
130198035|NCT01295827|468683380|FG000|Overall Study|Lost to Follow-up|0|||
130198036|NCT01295827|468683381|FG001|Overall Study|Lost to Follow-up|0|||
130198037|NCT01295827|468683382|FG002|Overall Study|Lost to Follow-up|3|||
130198038|NCT01295827|468683383|FG003|Overall Study|Lost to Follow-up|0|||
130198039|NCT01295827|468683384|FG004|Overall Study|Lost to Follow-up|1|||
130198040|NCT01295827|468683385|FG005|Overall Study|Lost to Follow-up|0|||
130198041|NCT01295827|468683386|FG006|Overall Study|Lost to Follow-up|4|||
130198042|NCT01295827|468683387|FG007|Overall Study|Lost to Follow-up|8|||
130198043|NCT01295827|468683388|FG008|Overall Study|Lost to Follow-up|7|||
130198044|NCT01295827|468683389|FG009|Overall Study|Lost to Follow-up|4|||
130198045|NCT01295827|468683390|FG010|Overall Study|Lost to Follow-up|7|||
130198046|NCT01295827|468683391|FG011|Overall Study|Lost to Follow-up|3|||
130198047|NCT01295827|468683392|FG012|Overall Study|Lost to Follow-up|0|||
130198048|NCT01295827|468683393|FG013|Overall Study|Lost to Follow-up|0|||
130198049|NCT01295827|468683394|FG014|Overall Study|Lost to Follow-up|0|||
130198050|NCT01295827|468683380|FG000|Overall Study|Not Reported|0|||
130198051|NCT01295827|468683381|FG001|Overall Study|Not Reported|0|||
130198052|NCT01295827|468683382|FG002|Overall Study|Not Reported|0|||
130198053|NCT01295827|468683383|FG003|Overall Study|Not Reported|1|||
130198054|NCT01295827|468683384|FG004|Overall Study|Not Reported|0|||
130198055|NCT01295827|468683385|FG005|Overall Study|Not Reported|0|||
130198056|NCT01295827|468683386|FG006|Overall Study|Not Reported|24|||
130198057|NCT01295827|468683387|FG007|Overall Study|Not Reported|58|||
130198058|NCT01295827|468683388|FG008|Overall Study|Not Reported|41|||
130198059|NCT01295827|468683389|FG009|Overall Study|Not Reported|2|||
130198060|NCT01295827|468683390|FG010|Overall Study|Not Reported|23|||
130198061|NCT01295827|468683391|FG011|Overall Study|Not Reported|13|||
130198062|NCT01295827|468683392|FG012|Overall Study|Not Reported|0|||
130198063|NCT01295827|468683393|FG013|Overall Study|Not Reported|0|||
130198064|NCT01295827|468683394|FG014|Overall Study|Not Reported|0|||
130198065|NCT01295827|468683380|FG000|Overall Study|Progressive Disease|2|||
130198066|NCT01295827|468683381|FG001|Overall Study|Progressive Disease|1|||
130198067|NCT01295827|468683382|FG002|Overall Study|Progressive Disease|5|||
130198068|NCT01295827|468683383|FG003|Overall Study|Progressive Disease|2|||
130198069|NCT01295827|468683384|FG004|Overall Study|Progressive Disease|0|||
130198070|NCT01295827|468683385|FG005|Overall Study|Progressive Disease|1|||
130198071|NCT01295827|468683386|FG006|Overall Study|Progressive Disease|87|||
130198072|NCT01295827|468683387|FG007|Overall Study|Progressive Disease|144|||
130198073|NCT01295827|468683388|FG008|Overall Study|Progressive Disease|85|||
130198074|NCT01295827|468683389|FG009|Overall Study|Progressive Disease|40|||
130198075|NCT01295827|468683390|FG010|Overall Study|Progressive Disease|175|||
130198076|NCT01295827|468683391|FG011|Overall Study|Progressive Disease|136|||
130198077|NCT01295827|468683392|FG012|Overall Study|Progressive Disease|0|||
130198078|NCT01295827|468683393|FG013|Overall Study|Progressive Disease|0|||
130198079|NCT01295827|468683394|FG014|Overall Study|Progressive Disease|0|||
130198080|NCT01295827|468683380|FG000|Overall Study|Screen Failure|0|||
130198081|NCT01295827|468683381|FG001|Overall Study|Screen Failure|0|||
130198082|NCT01295827|468683382|FG002|Overall Study|Screen Failure|0|||
130198083|NCT01295827|468683383|FG003|Overall Study|Screen Failure|0|||
130198084|NCT01295827|468683384|FG004|Overall Study|Screen Failure|0|||
130198085|NCT01295827|468683385|FG005|Overall Study|Screen Failure|0|||
130198086|NCT01295827|468683386|FG006|Overall Study|Screen Failure|2|||
130198087|NCT01295827|468683387|FG007|Overall Study|Screen Failure|2|||
130198088|NCT01295827|468683388|FG008|Overall Study|Screen Failure|2|||
130198089|NCT01295827|468683389|FG009|Overall Study|Screen Failure|0|||
130198090|NCT01295827|468683390|FG010|Overall Study|Screen Failure|1|||
130198091|NCT01295827|468683391|FG011|Overall Study|Screen Failure|0|||
130198092|NCT01295827|468683392|FG012|Overall Study|Screen Failure|0|||
130198093|NCT01295827|468683393|FG013|Overall Study|Screen Failure|0|||
130198094|NCT01295827|468683394|FG014|Overall Study|Screen Failure|0|||
130198095|NCT01295827|468683380|FG000|Overall Study|Withdrawal by Subject|1|||
130198096|NCT01295827|468683381|FG001|Overall Study|Withdrawal by Subject|0|||
130198097|NCT01295827|468683382|FG002|Overall Study|Withdrawal by Subject|2|||
130198098|NCT01295827|468683383|FG003|Overall Study|Withdrawal by Subject|0|||
130198099|NCT01295827|468683384|FG004|Overall Study|Withdrawal by Subject|0|||
130198100|NCT01295827|468683385|FG005|Overall Study|Withdrawal by Subject|1|||
130198101|NCT01295827|468683386|FG006|Overall Study|Withdrawal by Subject|13|||
130198102|NCT01295827|468683387|FG007|Overall Study|Withdrawal by Subject|35|||
130198103|NCT01295827|468683388|FG008|Overall Study|Withdrawal by Subject|11|||
130198104|NCT01295827|468683389|FG009|Overall Study|Withdrawal by Subject|2|||
130198105|NCT01295827|468683390|FG010|Overall Study|Withdrawal by Subject|18|||
130198106|NCT01295827|468683391|FG011|Overall Study|Withdrawal by Subject|13|||
130198107|NCT01295827|468683392|FG012|Overall Study|Withdrawal by Subject|0|||
130198108|NCT01295827|468683393|FG013|Overall Study|Withdrawal by Subject|0|||
130198109|NCT01295827|468683394|FG014|Overall Study|Withdrawal by Subject|0|||
130198110|NCT01295827|468683380|FG000|Overall Study|Other|0|||
130198111|NCT01295827|468683381|FG001|Overall Study|Other|0|||
130198112|NCT01295827|468683382|FG002|Overall Study|Other|0|||
130198113|NCT01295827|468683383|FG003|Overall Study|Other|0|||
130198114|NCT01295827|468683384|FG004|Overall Study|Other|0|||
130198115|NCT01295827|468683385|FG005|Overall Study|Other|0|||
130198116|NCT01295827|468683386|FG006|Overall Study|Other|1|||
130198117|NCT01295827|468683387|FG007|Overall Study|Other|1|||
130198118|NCT01295827|468683388|FG008|Overall Study|Other|1|||
130198119|NCT01295827|468683389|FG009|Overall Study|Other|0|||
130198120|NCT01295827|468683390|FG010|Overall Study|Other|2|||
130198121|NCT01295827|468683391|FG011|Overall Study|Other|0|||
130198122|NCT01295827|468683392|FG012|Overall Study|Other|0|||
130198123|NCT01295827|468683393|FG013|Overall Study|Other|0|||
130198124|NCT01295827|468683394|FG014|Overall Study|Other|0|||
130198125|NCT01668173|468683395|FG000|Overall Study|Adverse Event|3|||
130198126|NCT01668173|468683395|FG000|Overall Study|Trial suspension|4|||
130198127|NCT00746564|468683398|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
130198128|NCT02640677|468683402|FG000|Overall Study|Lost to Follow-up|1|||
130198129|NCT02640677|468683402|FG000|Overall Study|Withdrawal by Subject|1|||
130198130|NCT01516008|468683403|FG000|Overall Study|Adverse Event|0|||
130198131|NCT01516008|468683404|FG001|Overall Study|Adverse Event|2|||
130198132|NCT01516008|468683405|FG002|Overall Study|Adverse Event|7|||
130198133|NCT01516008|468683403|FG000|Overall Study|Lack of Efficacy|44|||
130198134|NCT01516008|468683404|FG001|Overall Study|Lack of Efficacy|14|||
130198135|NCT01516008|468683405|FG002|Overall Study|Lack of Efficacy|10|||
130198136|NCT01516008|468683403|FG000|Overall Study|Protocol Violation|1|||
130198137|NCT01516008|468683404|FG001|Overall Study|Protocol Violation|0|||
130198138|NCT01516008|468683405|FG002|Overall Study|Protocol Violation|0|||
130198139|NCT01516008|468683403|FG000|Overall Study|Reason not specified|0|||
130198140|NCT01516008|468683404|FG001|Overall Study|Reason not specified|0|||
130198141|NCT01516008|468683405|FG002|Overall Study|Reason not specified|1|||
130198142|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130198143|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
130198144|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130198145|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130198146|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
130198147|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130198148|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
130198149|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130198150|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
130198151|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
130198152|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Adverse Event|1|||
130198153|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Adverse Event|2|||
130198154|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
130198155|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
130198156|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
130198157|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130198158|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130198159|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Pregnancy|0|||
130198160|NCT03963232|468683409|FG000|Follow-up Phase|Withdrawal by Subject|7|||
130198161|NCT03963232|468683410|FG001|Follow-up Phase|Withdrawal by Subject|5|||
130198162|NCT03963232|468683409|FG000|Follow-up Phase|Protocol Violation|0|||
130198163|NCT03963232|468683410|FG001|Follow-up Phase|Protocol Violation|2|||
130198164|NCT03963232|468683409|FG000|Follow-up Phase|Adverse Event|0|||
130198165|NCT03963232|468683410|FG001|Follow-up Phase|Adverse Event|1|||
130198166|NCT03963232|468683409|FG000|Follow-up Phase|Lost to Follow-up|0|||
130198167|NCT03963232|468683410|FG001|Follow-up Phase|Lost to Follow-up|1|||
130198168|NCT03617770|468683411|FG000|Overall Study|Lost to Follow-up|1|||
130198169|NCT03617770|468683412|FG001|Overall Study|Lost to Follow-up|0|||
130198170|NCT00356135|468683413|FG000|Overall Study|Protocol Violation|1|||
130198171|NCT00356135|468683414|FG001|Overall Study|Protocol Violation|0|||
130198172|NCT00356135|468683415|FG002|Overall Study|Protocol Violation|0|||
130198173|NCT00356135|468683413|FG000|Overall Study|Adverse Event|1|||
130198174|NCT00356135|468683414|FG001|Overall Study|Adverse Event|0|||
130198175|NCT00356135|468683415|FG002|Overall Study|Adverse Event|0|||
130198176|NCT00356135|468683413|FG000|Overall Study|Lost to Follow-up|0|||
130198177|NCT00356135|468683414|FG001|Overall Study|Lost to Follow-up|0|||
130198178|NCT00356135|468683415|FG002|Overall Study|Lost to Follow-up|1|||
130198179|NCT00356135|468683413|FG000|Overall Study|Physician Decision|1|||
130198180|NCT00356135|468683414|FG001|Overall Study|Physician Decision|1|||
130198181|NCT00356135|468683415|FG002|Overall Study|Physician Decision|1|||
130198182|NCT00356135|468683413|FG000|Overall Study|Subject non-compliance|1|||
130198183|NCT00356135|468683414|FG001|Overall Study|Subject non-compliance|1|||
130198184|NCT00356135|468683415|FG002|Overall Study|Subject non-compliance|3|||
130198185|NCT03512210|468683417|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
130198186|NCT03512210|468683417|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
130198187|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Death|2|||
130198188|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
130198189|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
130198190|NCT03725761|468683418|FG000|Overall Study|still on study|1|||
130198191|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
130198192|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
130198193|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130198194|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130198195|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
130198196|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130198197|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130198198|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130198199|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130198200|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130198201|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130198202|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130198203|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130198204|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198205|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198206|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198207|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130198208|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130198209|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130198210|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
130198211|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130198212|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130198213|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
130198214|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130198215|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Death|0|||
130198216|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Death|0|||
130198217|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Death|1|||
130198218|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Death|1|||
130198219|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198220|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198221|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
130198222|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198223|NCT01806961|468686230|FG000|Overall Study|sponsor decision|16|||
130198224|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
130198225|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
130198226|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
130198227|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
130198228|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Death|0|||
130198229|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Death|0|||
130198230|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Death|1|||
130198231|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Death|0|||
130198232|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
130198233|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198234|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198235|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198236|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130198237|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130198238|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
130198239|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130198240|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
130198241|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
130198242|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
130198243|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
130198244|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130198245|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
130198246|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130198247|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
130198248|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
130198249|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130198250|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130198251|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
130198252|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130198253|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130198254|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130198255|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130198256|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130198257|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130198258|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130198259|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130198260|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130198261|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
130198262|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
130198263|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130198264|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
130198265|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
130198266|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
130198267|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
130198268|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Other|8|||
130198269|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Other|14|||
130198270|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Other|8|||
130198271|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Other|23|||
130198272|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
130198273|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
130198274|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130198275|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130198276|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130198277|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130198278|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
130198279|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
130198280|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130198281|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130198282|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130198283|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Death|1|||
130198284|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
130198285|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130198286|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130198287|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
130198288|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130198289|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198290|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198291|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198292|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130198293|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130198294|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130198295|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130198296|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130198297|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198298|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198299|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198300|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130198301|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
130198302|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130198303|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130198304|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130198305|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130198306|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
130198307|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130198308|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198309|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198310|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198311|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130198312|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Other|6|||
130198313|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130198314|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Other|8|||
130198315|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Other|5|||
130198316|NCT03937908|468686235|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
130198317|NCT03937908|468686236|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
130198318|NCT00784238|468686237|FG000|Overall Study|Adverse Event|14|||
130198319|NCT00784238|468686237|FG000|Overall Study|Death|2|||
130198320|NCT00784238|468686237|FG000|Overall Study|Lack of Efficacy|33|||
130198321|NCT00784238|468686237|FG000|Overall Study|Lost to Follow-up|29|||
130198322|NCT00784238|468686237|FG000|Overall Study|Pregnancy|1|||
130198323|NCT00784238|468686237|FG000|Overall Study|Withdrawal by Subject|26|||
130198324|NCT00784238|468686237|FG000|Overall Study|Other|14|||
130198325|NCT03693612|468686238|FG000|Overall Study|Lost to Follow-up|0|||
130198326|NCT03693612|468686239|FG001|Overall Study|Lost to Follow-up|0|||
130198327|NCT03693612|468686240|FG002|Overall Study|Lost to Follow-up|0|||
130198328|NCT03693612|468686241|FG003|Overall Study|Lost to Follow-up|0|||
130198329|NCT03693612|468686242|FG004|Overall Study|Lost to Follow-up|1|||
130198330|NCT03693612|468686243|FG005|Overall Study|Lost to Follow-up|0|||
130198331|NCT03693612|468686244|FG006|Overall Study|Lost to Follow-up|0|||
130198332|NCT03693612|468686238|FG000|Overall Study|Withdrawal by Subject|0|||
130198333|NCT03693612|468686239|FG001|Overall Study|Withdrawal by Subject|0|||
130198334|NCT03693612|468686240|FG002|Overall Study|Withdrawal by Subject|1|||
130198335|NCT03693612|468686241|FG003|Overall Study|Withdrawal by Subject|0|||
130198336|NCT03693612|468686242|FG004|Overall Study|Withdrawal by Subject|2|||
130198337|NCT03693612|468686243|FG005|Overall Study|Withdrawal by Subject|0|||
130198338|NCT03693612|468686244|FG006|Overall Study|Withdrawal by Subject|0|||
130198339|NCT03693612|468686238|FG000|Overall Study|Study Terminated by Sponsor|0|||
130198340|NCT03693612|468686239|FG001|Overall Study|Study Terminated by Sponsor|1|||
130198341|NCT03693612|468686240|FG002|Overall Study|Study Terminated by Sponsor|0|||
130198342|NCT03693612|468686241|FG003|Overall Study|Study Terminated by Sponsor|0|||
130198343|NCT03693612|468686242|FG004|Overall Study|Study Terminated by Sponsor|3|||
130198344|NCT03693612|468686243|FG005|Overall Study|Study Terminated by Sponsor|0|||
130198345|NCT03693612|468686244|FG006|Overall Study|Study Terminated by Sponsor|0|||
130198346|NCT05318092|468686245|FG000|Overall Study|Lost to Follow-up|3|||
130198347|NCT05318092|468686245|FG000|Overall Study|Withdrawal by Subject|1|||
130198348|NCT04434469|468686246|FG000|Overall Study|Death|2|||
130198349|NCT04434469|468686247|FG001|Overall Study|Death|3|||
130198350|NCT04434469|468686248|FG002|Overall Study|Death|2|||
130198351|NCT04434469|468686249|FG003|Overall Study|Death|2|||
130198352|NCT04434469|468686250|FG004|Overall Study|Death|2|||
130198353|NCT04434469|468686251|FG005|Overall Study|Death|0|||
130198354|NCT04434469|468686246|FG000|Overall Study|Lost to Follow-up|0|||
130198355|NCT04434469|468686247|FG001|Overall Study|Lost to Follow-up|0|||
130198356|NCT04434469|468686248|FG002|Overall Study|Lost to Follow-up|0|||
130198357|NCT04434469|468686249|FG003|Overall Study|Lost to Follow-up|1|||
130198358|NCT04434469|468686250|FG004|Overall Study|Lost to Follow-up|1|||
130198359|NCT04434469|468686251|FG005|Overall Study|Lost to Follow-up|0|||
130198360|NCT04434469|468686246|FG000|Overall Study|Study terminated by sponsor|1|||
130198361|NCT04434469|468686247|FG001|Overall Study|Study terminated by sponsor|1|||
130198362|NCT04434469|468686248|FG002|Overall Study|Study terminated by sponsor|1|||
130198363|NCT04434469|468686249|FG003|Overall Study|Study terminated by sponsor|2|||
130198364|NCT04434469|468686250|FG004|Overall Study|Study terminated by sponsor|3|||
130198365|NCT04434469|468686251|FG005|Overall Study|Study terminated by sponsor|3|||
130198366|NCT04434469|468686246|FG000|Overall Study|Withdrawal by Subject|0|||
130198367|NCT04434469|468686247|FG001|Overall Study|Withdrawal by Subject|0|||
130198368|NCT04434469|468686248|FG002|Overall Study|Withdrawal by Subject|1|||
130198369|NCT04434469|468686249|FG003|Overall Study|Withdrawal by Subject|0|||
130198370|NCT04434469|468686250|FG004|Overall Study|Withdrawal by Subject|0|||
130198371|NCT04434469|468686251|FG005|Overall Study|Withdrawal by Subject|0|||
130198372|NCT01154296|468686254|FG000|Randomization and Intervention|Decided to decline|1|||
130198373|NCT01154296|468686255|FG001|Randomization and Intervention|Decided to decline|1|||
130198374|NCT01154296|468686254|FG000|Randomization and Intervention|Declined by staff|1|||
130198375|NCT01154296|468686255|FG001|Randomization and Intervention|Declined by staff|0|||
130198376|NCT01154296|468686254|FG000|Randomization and Intervention|Did not return|1|||
130198377|NCT01154296|468686255|FG001|Randomization and Intervention|Did not return|0|||
130198378|NCT01154296|468686254|FG000|Randomization and Intervention|Left before test|0|||
130198379|NCT01154296|468686255|FG001|Randomization and Intervention|Left before test|1|||
130198380|NCT01154296|468686254|FG000|Randomization and Intervention|Left clinic early|2|||
130198381|NCT01154296|468686255|FG001|Randomization and Intervention|Left clinic early|0|||
130198382|NCT01154296|468686254|FG000|6-month Follow-up|Lost contact|269|||
130198383|NCT01154296|468686255|FG001|6-month Follow-up|Lost contact|275|||
130198384|NCT01154296|468686254|FG000|6-month Follow-up|Incarcerated|37|||
130198385|NCT01154296|468686255|FG001|6-month Follow-up|Incarcerated|32|||
130198386|NCT01154296|468686254|FG000|6-month Follow-up|Withdrew consent|14|||
130198387|NCT01154296|468686255|FG001|6-month Follow-up|Withdrew consent|15|||
130198388|NCT01154296|468686254|FG000|6-month Follow-up|Death|3|||
130198389|NCT01154296|468686255|FG001|6-month Follow-up|Death|2|||
130198390|NCT01154296|468686254|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
130198391|NCT01154296|468686255|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
130198392|NCT02759055|468686256|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
130198393|NCT02759055|468686257|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
130198394|NCT03692325|468686269|FG000|Overall Study|Adverse Event|2|||
130198395|NCT03692325|468686269|FG000|Overall Study|Progression/Recurrence|2|||
130198396|NCT02461524|468686272|FG000|Overall Study|Death|16|||
130198397|NCT02461524|468686272|FG000|Overall Study|Withdrawal by Subject|4|||
130198398|NCT02461524|468686272|FG000|Overall Study|Device Explanted|5|||
130198399|NCT02461524|468686272|FG000|Overall Study|Missed Visit|6|||
130198400|NCT01936181|468686277|FG000|Randomised, Double-blind|Adverse Event|27|||
130198401|NCT01936181|468686278|FG001|Randomised, Double-blind|Adverse Event|21|||
130198402|NCT01936181|468686279|FG002|Randomised, Double-blind|Adverse Event|0|||
130198403|NCT01936181|468686280|FG003|Randomised, Double-blind|Adverse Event|0|||
130198404|NCT01936181|468686277|FG000|Randomised, Double-blind|Protocol Violation|1|||
130198405|NCT01936181|468686278|FG001|Randomised, Double-blind|Protocol Violation|5|||
130198406|NCT01936181|468686279|FG002|Randomised, Double-blind|Protocol Violation|0|||
130198407|NCT01936181|468686280|FG003|Randomised, Double-blind|Protocol Violation|0|||
130198408|NCT01936181|468686277|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
130198409|NCT01936181|468686278|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
130198410|NCT01936181|468686279|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130198411|NCT01936181|468686280|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130198412|NCT01936181|468686277|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
130198413|NCT01936181|468686278|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
130198414|NCT01936181|468686279|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
130198415|NCT01936181|468686280|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
130198416|NCT01936181|468686277|FG000|Randomised, Double-blind|Pregnancy|0|||
130198417|NCT01936181|468686278|FG001|Randomised, Double-blind|Pregnancy|1|||
130198418|NCT01936181|468686279|FG002|Randomised, Double-blind|Pregnancy|0|||
130198419|NCT01936181|468686280|FG003|Randomised, Double-blind|Pregnancy|0|||
130198420|NCT01936181|468686277|FG000|Randomised, Double-blind|Physician Decision|4|||
130198421|NCT01936181|468686278|FG001|Randomised, Double-blind|Physician Decision|4|||
130198422|NCT01936181|468686279|FG002|Randomised, Double-blind|Physician Decision|0|||
130198423|NCT01936181|468686280|FG003|Randomised, Double-blind|Physician Decision|0|||
130198424|NCT01936181|468686277|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
130198425|NCT01936181|468686278|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
130198426|NCT01936181|468686279|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130198427|NCT01936181|468686280|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130198428|NCT01936181|468686277|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130198429|NCT01936181|468686278|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130198430|NCT01936181|468686279|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130198431|NCT01936181|468686280|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130198432|NCT01936181|468686277|FG000|Transition-extension|Adverse Event|3|||
130198433|NCT01936181|468686278|FG001|Transition-extension|Adverse Event|0|||
130198434|NCT01936181|468686279|FG002|Transition-extension|Adverse Event|3|||
130198435|NCT01936181|468686280|FG003|Transition-extension|Adverse Event|1|||
130198436|NCT01936181|468686277|FG000|Transition-extension|Lost to Follow-up|3|||
130198437|NCT01936181|468686278|FG001|Transition-extension|Lost to Follow-up|0|||
130198438|NCT01936181|468686279|FG002|Transition-extension|Lost to Follow-up|1|||
130198439|NCT01936181|468686280|FG003|Transition-extension|Lost to Follow-up|2|||
130198440|NCT01936181|468686277|FG000|Transition-extension|Physician Decision|2|||
130198441|NCT01936181|468686278|FG001|Transition-extension|Physician Decision|0|||
130198442|NCT01936181|468686279|FG002|Transition-extension|Physician Decision|0|||
130198443|NCT01936181|468686280|FG003|Transition-extension|Physician Decision|1|||
130198444|NCT01936181|468686277|FG000|Transition-extension|Withdrawal by Subject|7|||
130198445|NCT01936181|468686278|FG001|Transition-extension|Withdrawal by Subject|0|||
130198446|NCT01936181|468686279|FG002|Transition-extension|Withdrawal by Subject|2|||
130198447|NCT01936181|468686280|FG003|Transition-extension|Withdrawal by Subject|1|||
130198448|NCT02817516|468686281|FG000|Overall Study|Other|0|||
130198449|NCT02817516|468686282|FG001|Overall Study|Other|0|||
130198450|NCT02817516|468686283|FG002|Overall Study|Other|1|||
130198451|NCT02817516|468686284|FG003|Overall Study|Other|0|||
130198452|NCT00664859|468686285|FG000|Overall Study|Adverse Event|2|||
130198453|NCT00664859|468686286|FG001|Overall Study|Adverse Event|1|||
130198454|NCT00664859|468686287|FG002|Overall Study|Adverse Event|3|||
130198455|NCT00664859|468686285|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
130198456|NCT00664859|468686286|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130198457|NCT00664859|468686287|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130198458|NCT00664859|468686285|FG000|Overall Study|Noncompliance with protocol|1|||
130198459|NCT00664859|468686286|FG001|Overall Study|Noncompliance with protocol|0|||
130198460|NCT00664859|468686287|FG002|Overall Study|Noncompliance with protocol|4|||
130198461|NCT00664859|468686285|FG000|Overall Study|Laboratory abnormality|2|||
130198462|NCT00664859|468686286|FG001|Overall Study|Laboratory abnormality|1|||
130198463|NCT00664859|468686287|FG002|Overall Study|Laboratory abnormality|4|||
130198464|NCT00664859|468686285|FG000|Overall Study|Withdrawal by Subject|4|||
130198465|NCT00664859|468686286|FG001|Overall Study|Withdrawal by Subject|1|||
130198466|NCT00664859|468686287|FG002|Overall Study|Withdrawal by Subject|3|||
130198467|NCT00664859|468686285|FG000|Overall Study|Lost to Follow-up|2|||
130198468|NCT00664859|468686286|FG001|Overall Study|Lost to Follow-up|2|||
130198469|NCT00664859|468686287|FG002|Overall Study|Lost to Follow-up|1|||
130198470|NCT00664859|468686285|FG000|Overall Study|Other|0|||
130198471|NCT00664859|468686286|FG001|Overall Study|Other|1|||
130198472|NCT00664859|468686287|FG002|Overall Study|Other|2|||
130198473|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198474|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198475|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198476|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198477|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198478|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198479|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198480|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198481|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198482|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198483|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198484|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198485|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198486|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198487|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198488|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198489|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198490|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198491|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198492|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198493|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198494|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198495|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130198496|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198497|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198498|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130198499|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198500|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198501|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198502|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198503|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198504|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198505|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198506|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198507|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198508|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198509|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198510|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198511|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198512|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198513|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198514|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198515|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198516|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198517|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198518|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198519|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198520|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198521|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198522|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
130198523|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198524|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198525|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198526|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198527|NCT01943851|468686288|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198528|NCT01943851|468686289|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198529|NCT01943851|468686290|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198530|NCT01943851|468686291|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198531|NCT01943851|468686292|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198532|NCT01943851|468686293|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198533|NCT01943851|468686294|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198534|NCT01943851|468686295|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198535|NCT01943851|468686296|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198536|NCT01943851|468686297|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198537|NCT01943851|468686298|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198538|NCT01943851|468686299|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198539|NCT01943851|468686300|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198540|NCT01943851|468686301|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198541|NCT01943851|468686302|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198542|NCT01943851|468686303|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
130198543|NCT01943851|468686304|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198544|NCT01943851|468686305|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198545|NCT01943851|468686288|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198546|NCT01943851|468686289|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198547|NCT01943851|468686290|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198548|NCT01943851|468686291|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198549|NCT01943851|468686292|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198550|NCT01943851|468686293|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198551|NCT01943851|468686294|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198552|NCT01943851|468686295|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198553|NCT01943851|468686296|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198554|NCT01943851|468686297|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198555|NCT01943851|468686298|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198556|NCT01943851|468686299|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198557|NCT01943851|468686300|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198558|NCT01943851|468686301|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198559|NCT01943851|468686302|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198560|NCT01943851|468686303|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
130198561|NCT01943851|468686304|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
130198562|NCT01943851|468686305|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
130198563|NCT00900757|468686306|FG000|Overall Study|screen failure|19|||
130198564|NCT00748189|468686307|FG000|Overall Study|Death|99|||
130198565|NCT00748189|468686308|FG001|Overall Study|Death|84|||
130198566|NCT00748189|468686307|FG000|Overall Study|Withdrawal by Subject|23|||
130198567|NCT00748189|468686308|FG001|Overall Study|Withdrawal by Subject|29|||
130198568|NCT00748189|468686307|FG000|Overall Study|Physician Decision|16|||
130198569|NCT00748189|468686308|FG001|Overall Study|Physician Decision|5|||
130198570|NCT00748189|468686307|FG000|Overall Study|Lost to Follow-up|8|||
130198571|NCT00748189|468686308|FG001|Overall Study|Lost to Follow-up|15|||
130198572|NCT00748189|468686307|FG000|Overall Study|Study terminated by Sponsor|70|||
130198573|NCT00748189|468686308|FG001|Overall Study|Study terminated by Sponsor|79|||
130198574|NCT03320850|468686309|FG000|Overall Study|Lost to Follow-up|0|||
130198575|NCT03320850|468686310|FG001|Overall Study|Lost to Follow-up|0|||
130198576|NCT03320850|468686311|FG002|Overall Study|Lost to Follow-up|0|||
130198577|NCT03320850|468686312|FG003|Overall Study|Lost to Follow-up|0|||
130198578|NCT03320850|468686313|FG004|Overall Study|Lost to Follow-up|1|||
130198579|NCT03320850|468686314|FG005|Overall Study|Lost to Follow-up|2|||
130198580|NCT03320850|468686315|FG006|Overall Study|Lost to Follow-up|2|||
130198581|NCT03320850|468686316|FG007|Overall Study|Lost to Follow-up|0|||
130198582|NCT03320850|468686317|FG008|Overall Study|Lost to Follow-up|6|||
130198583|NCT03320850|468686318|FG009|Overall Study|Lost to Follow-up|4|||
130198584|NCT03320850|468686309|FG000|Overall Study|Withdrawal by Subject|0|||
130198585|NCT03320850|468686310|FG001|Overall Study|Withdrawal by Subject|0|||
130198586|NCT03320850|468686311|FG002|Overall Study|Withdrawal by Subject|0|||
130198587|NCT03320850|468686312|FG003|Overall Study|Withdrawal by Subject|0|||
130198588|NCT03320850|468686313|FG004|Overall Study|Withdrawal by Subject|1|||
130198589|NCT03320850|468686314|FG005|Overall Study|Withdrawal by Subject|2|||
130198590|NCT03320850|468686315|FG006|Overall Study|Withdrawal by Subject|4|||
130198591|NCT03320850|468686316|FG007|Overall Study|Withdrawal by Subject|5|||
130198592|NCT03320850|468686317|FG008|Overall Study|Withdrawal by Subject|2|||
130198593|NCT03320850|468686318|FG009|Overall Study|Withdrawal by Subject|1|||
130198594|NCT03320850|468686309|FG000|Overall Study|Lack of Efficacy|0|||
130198595|NCT03320850|468686310|FG001|Overall Study|Lack of Efficacy|0|||
130198596|NCT03320850|468686311|FG002|Overall Study|Lack of Efficacy|0|||
130198597|NCT03320850|468686312|FG003|Overall Study|Lack of Efficacy|1|||
130198598|NCT03320850|468686313|FG004|Overall Study|Lack of Efficacy|0|||
130198599|NCT03320850|468686314|FG005|Overall Study|Lack of Efficacy|1|||
130198600|NCT03320850|468686315|FG006|Overall Study|Lack of Efficacy|0|||
130198601|NCT03320850|468686316|FG007|Overall Study|Lack of Efficacy|2|||
130198602|NCT03320850|468686317|FG008|Overall Study|Lack of Efficacy|0|||
130198603|NCT03320850|468686318|FG009|Overall Study|Lack of Efficacy|3|||
130198604|NCT03320850|468686309|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130198605|NCT03320850|468686310|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130198606|NCT03320850|468686311|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130198607|NCT03320850|468686312|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
130198608|NCT03320850|468686313|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130198609|NCT03320850|468686314|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
130198610|NCT03320850|468686315|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
130198611|NCT03320850|468686316|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
130198612|NCT03320850|468686317|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
130198613|NCT03320850|468686318|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
130198614|NCT03320850|468686309|FG000|Overall Study|Adverse Event|0|||
130198615|NCT03320850|468686310|FG001|Overall Study|Adverse Event|0|||
130198616|NCT03320850|468686311|FG002|Overall Study|Adverse Event|0|||
130198617|NCT03320850|468686312|FG003|Overall Study|Adverse Event|0|||
130198618|NCT03320850|468686313|FG004|Overall Study|Adverse Event|0|||
130198619|NCT03320850|468686314|FG005|Overall Study|Adverse Event|2|||
130198620|NCT03320850|468686315|FG006|Overall Study|Adverse Event|1|||
130198621|NCT03320850|468686316|FG007|Overall Study|Adverse Event|0|||
130198622|NCT03320850|468686317|FG008|Overall Study|Adverse Event|2|||
130198623|NCT03320850|468686318|FG009|Overall Study|Adverse Event|0|||
130198624|NCT03320850|468686309|FG000|Overall Study|Reason Not Specified|0|||
130198625|NCT03320850|468686310|FG001|Overall Study|Reason Not Specified|0|||
130198626|NCT03320850|468686311|FG002|Overall Study|Reason Not Specified|0|||
130198627|NCT03320850|468686312|FG003|Overall Study|Reason Not Specified|0|||
130198628|NCT03320850|468686313|FG004|Overall Study|Reason Not Specified|0|||
130198629|NCT03320850|468686314|FG005|Overall Study|Reason Not Specified|1|||
130198630|NCT03320850|468686315|FG006|Overall Study|Reason Not Specified|0|||
130198631|NCT03320850|468686316|FG007|Overall Study|Reason Not Specified|0|||
130198632|NCT03320850|468686317|FG008|Overall Study|Reason Not Specified|0|||
130198633|NCT03320850|468686318|FG009|Overall Study|Reason Not Specified|1|||
130198634|NCT04481191|468686319|FG000|Overall Study|Withdrawn by parent/guardian|15|||
130198635|NCT04481191|468686320|FG001|Overall Study|Withdrawn by parent/guardian|10|||
130198636|NCT00546117|468686321|FG000|Overall Study|Withdrawal by Subject|3|||
130198637|NCT00546117|468686322|FG001|Overall Study|Withdrawal by Subject|0|||
130198638|NCT00546117|468686321|FG000|Overall Study|Inability to schedule follow-up visit|1|||
130198639|NCT00546117|468686322|FG001|Overall Study|Inability to schedule follow-up visit|0|||
130198640|NCT01424514|468686323|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130198641|NCT01424514|468686324|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130198642|NCT01424514|468686323|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
130198643|NCT01424514|468686324|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
130198644|NCT02487771|468686327|FG000|Overall Study|Lost to Follow-up|2|||
130198645|NCT02487771|468686328|FG001|Overall Study|Lost to Follow-up|3|||
130198646|NCT02487771|468686327|FG000|Overall Study|Moved out of area|5|||
130198647|NCT02487771|468686328|FG001|Overall Study|Moved out of area|6|||
130198648|NCT02487771|468686327|FG000|Overall Study|Withdrawal by Subject|3|||
130198649|NCT02487771|468686328|FG001|Overall Study|Withdrawal by Subject|5|||
130198650|NCT02653170|468686329|FG000|Overall Study|Withdrawal by Subject|3|||
130198651|NCT02653170|468686330|FG001|Overall Study|Withdrawal by Subject|8|||
130198652|NCT02653170|468686331|FG002|Overall Study|Withdrawal by Subject|3|||
130198653|NCT02653170|468686329|FG000|Overall Study|withdrawn by study team|2|||
130198654|NCT02653170|468686330|FG001|Overall Study|withdrawn by study team|4|||
130198655|NCT02653170|468686331|FG002|Overall Study|withdrawn by study team|5|||
130198656|NCT02653170|468686329|FG000|Overall Study|Lost to Follow-up|12|||
130198657|NCT02653170|468686330|FG001|Overall Study|Lost to Follow-up|4|||
130198658|NCT02653170|468686331|FG002|Overall Study|Lost to Follow-up|10|||
130198659|NCT04984278|468686342|FG000|Period 1|Withdrawal by Subject|1|||
130198660|NCT04984278|468686343|FG001|Period 1|Withdrawal by Subject|0|||
130198661|NCT04984278|468686342|FG000|Period 1|Other|0|||
130198662|NCT04984278|468686343|FG001|Period 1|Other|1|||
130198663|NCT04984278|468686342|FG000|Period 2|Adverse Event|1|||
130198664|NCT04984278|468686343|FG001|Period 2|Adverse Event|0|||
130198665|NCT04984278|468686342|FG000|Period 2|Other|0|||
130198666|NCT04984278|468686343|FG001|Period 2|Other|1|||
130198667|NCT04304235|468686344|FG000|Overall Study|incomplete triage data|0|||
130198668|NCT04304235|468686345|FG001|Overall Study|incomplete triage data|69|||
130198669|NCT04304235|468686346|FG002|Overall Study|incomplete triage data|0|||
130198670|NCT04304235|468686347|FG003|Overall Study|incomplete triage data|0|||
130198671|NCT04304235|468686348|FG004|Overall Study|incomplete triage data|289|||
130198672|NCT04304235|468686349|FG005|Overall Study|incomplete triage data|123|||
130198673|NCT04304235|468686350|FG006|Overall Study|incomplete triage data|65|||
130198674|NCT00425061|468686351|FG000|Overall Study|Adverse Event|1|||
130198675|NCT00425061|468686352|FG001|Overall Study|Adverse Event|0|||
130198676|NCT00425061|468686353|FG002|Overall Study|Adverse Event|0|||
130198677|NCT00425061|468686354|FG003|Overall Study|Adverse Event|2|||
130198678|NCT00425061|468686355|FG004|Overall Study|Adverse Event|2|||
130198679|NCT00425061|468686356|FG005|Overall Study|Adverse Event|0|||
130198680|NCT00425061|468686357|FG006|Overall Study|Adverse Event|0|||
130198681|NCT00425061|468686351|FG000|Overall Study|Lost to Follow-up|0|||
130198682|NCT00425061|468686352|FG001|Overall Study|Lost to Follow-up|1|||
130198683|NCT00425061|468686353|FG002|Overall Study|Lost to Follow-up|0|||
130198684|NCT00425061|468686354|FG003|Overall Study|Lost to Follow-up|0|||
130198685|NCT00425061|468686355|FG004|Overall Study|Lost to Follow-up|0|||
130198686|NCT00425061|468686356|FG005|Overall Study|Lost to Follow-up|0|||
130198687|NCT00425061|468686357|FG006|Overall Study|Lost to Follow-up|0|||
130198688|NCT00425061|468686351|FG000|Overall Study|Protocol Violation|1|||
130198689|NCT00425061|468686352|FG001|Overall Study|Protocol Violation|0|||
130198690|NCT00425061|468686353|FG002|Overall Study|Protocol Violation|0|||
130198691|NCT00425061|468686354|FG003|Overall Study|Protocol Violation|0|||
130198692|NCT00425061|468686355|FG004|Overall Study|Protocol Violation|0|||
130198693|NCT00425061|468686356|FG005|Overall Study|Protocol Violation|0|||
130198694|NCT00425061|468686357|FG006|Overall Study|Protocol Violation|0|||
130198695|NCT00425061|468686351|FG000|Overall Study|Withdrawal by Subject|0|||
130198696|NCT00425061|468686352|FG001|Overall Study|Withdrawal by Subject|1|||
130198697|NCT00425061|468686353|FG002|Overall Study|Withdrawal by Subject|0|||
130198698|NCT00425061|468686354|FG003|Overall Study|Withdrawal by Subject|0|||
130198699|NCT00425061|468686355|FG004|Overall Study|Withdrawal by Subject|1|||
130198700|NCT00425061|468686356|FG005|Overall Study|Withdrawal by Subject|0|||
130198701|NCT00425061|468686357|FG006|Overall Study|Withdrawal by Subject|3|||
130198702|NCT00425061|468686351|FG000|Overall Study|Sponsor's request|0|||
130198703|NCT00425061|468686352|FG001|Overall Study|Sponsor's request|0|||
130198704|NCT00425061|468686353|FG002|Overall Study|Sponsor's request|0|||
130198705|NCT00425061|468686354|FG003|Overall Study|Sponsor's request|0|||
130198706|NCT00425061|468686355|FG004|Overall Study|Sponsor's request|19|||
130198707|NCT00425061|468686356|FG005|Overall Study|Sponsor's request|4|||
130198708|NCT00425061|468686357|FG006|Overall Study|Sponsor's request|15|||
130198709|NCT00425061|468686351|FG000|Overall Study|Physician Decision|0|||
130198710|NCT00425061|468686352|FG001|Overall Study|Physician Decision|0|||
130198711|NCT00425061|468686353|FG002|Overall Study|Physician Decision|0|||
130198712|NCT00425061|468686354|FG003|Overall Study|Physician Decision|0|||
130198713|NCT00425061|468686355|FG004|Overall Study|Physician Decision|1|||
130198714|NCT00425061|468686356|FG005|Overall Study|Physician Decision|0|||
130198715|NCT00425061|468686357|FG006|Overall Study|Physician Decision|0|||
130198716|NCT00425061|468686351|FG000|Overall Study|Other|0|||
130198717|NCT00425061|468686352|FG001|Overall Study|Other|0|||
130198718|NCT00425061|468686353|FG002|Overall Study|Other|0|||
130198719|NCT00425061|468686354|FG003|Overall Study|Other|0|||
130198720|NCT00425061|468686355|FG004|Overall Study|Other|3|||
130198721|NCT00425061|468686356|FG005|Overall Study|Other|0|||
130198722|NCT00425061|468686357|FG006|Overall Study|Other|1|||
130198723|NCT04720911|468686360|FG000|Overall Study|Withdrawal by Subject|0|||
130198724|NCT04720911|468686361|FG001|Overall Study|Withdrawal by Subject|1|||
130198725|NCT04720911|468686362|FG002|Overall Study|Withdrawal by Subject|0|||
130198726|NCT00090220|468686363|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130198727|NCT00090220|468686364|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130198728|NCT00090220|468686365|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198729|NCT00090220|468686366|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198730|NCT00090220|468686367|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198731|NCT00090220|468686368|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198732|NCT00090220|468686363|FG000|Base Study Vaccination Period|Adverse Event|6|||
130198733|NCT00090220|468686364|FG001|Base Study Vaccination Period|Adverse Event|1|||
130198734|NCT00090220|468686365|FG002|Base Study Vaccination Period|Adverse Event|0|||
130198735|NCT00090220|468686366|FG003|Base Study Vaccination Period|Adverse Event|0|||
130198736|NCT00090220|468686367|FG004|Base Study Vaccination Period|Adverse Event|0|||
130198737|NCT00090220|468686368|FG005|Base Study Vaccination Period|Adverse Event|0|||
130198738|NCT00090220|468686363|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
130198739|NCT00090220|468686364|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
130198740|NCT00090220|468686365|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130198741|NCT00090220|468686366|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130198742|NCT00090220|468686367|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130198743|NCT00090220|468686368|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
130198744|NCT00090220|468686363|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
130198745|NCT00090220|468686364|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
130198746|NCT00090220|468686365|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198747|NCT00090220|468686366|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198748|NCT00090220|468686367|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198749|NCT00090220|468686368|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198750|NCT00090220|468686363|FG000|Base Study Vaccination Period|Patient Moved|6|||
130198751|NCT00090220|468686364|FG001|Base Study Vaccination Period|Patient Moved|2|||
130198752|NCT00090220|468686365|FG002|Base Study Vaccination Period|Patient Moved|0|||
130198753|NCT00090220|468686366|FG003|Base Study Vaccination Period|Patient Moved|0|||
130198754|NCT00090220|468686367|FG004|Base Study Vaccination Period|Patient Moved|0|||
130198755|NCT00090220|468686368|FG005|Base Study Vaccination Period|Patient Moved|0|||
130198756|NCT00090220|468686363|FG000|Base Study Vaccination Period|Other|4|||
130198757|NCT00090220|468686364|FG001|Base Study Vaccination Period|Other|4|||
130198758|NCT00090220|468686365|FG002|Base Study Vaccination Period|Other|0|||
130198759|NCT00090220|468686366|FG003|Base Study Vaccination Period|Other|0|||
130198760|NCT00090220|468686367|FG004|Base Study Vaccination Period|Other|0|||
130198761|NCT00090220|468686368|FG005|Base Study Vaccination Period|Other|0|||
130198762|NCT00090220|468686363|FG000|Base Study Follow-up Period|Adverse Event|6|||
130198763|NCT00090220|468686364|FG001|Base Study Follow-up Period|Adverse Event|1|||
130198764|NCT00090220|468686365|FG002|Base Study Follow-up Period|Adverse Event|0|||
130198765|NCT00090220|468686366|FG003|Base Study Follow-up Period|Adverse Event|0|||
130198766|NCT00090220|468686367|FG004|Base Study Follow-up Period|Adverse Event|0|||
130198767|NCT00090220|468686368|FG005|Base Study Follow-up Period|Adverse Event|0|||
130198768|NCT00090220|468686363|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
130198769|NCT00090220|468686364|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
130198770|NCT00090220|468686365|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
130198771|NCT00090220|468686366|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
130198772|NCT00090220|468686367|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130198773|NCT00090220|468686368|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
130198774|NCT00090220|468686363|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
130198775|NCT00090220|468686364|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
130198776|NCT00090220|468686365|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198777|NCT00090220|468686366|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198778|NCT00090220|468686367|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198779|NCT00090220|468686368|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198780|NCT00090220|468686363|FG000|Base Study Follow-up Period|Patient Moved|20|||
130198781|NCT00090220|468686364|FG001|Base Study Follow-up Period|Patient Moved|28|||
130198782|NCT00090220|468686365|FG002|Base Study Follow-up Period|Patient Moved|0|||
130198783|NCT00090220|468686366|FG003|Base Study Follow-up Period|Patient Moved|0|||
130198784|NCT00090220|468686367|FG004|Base Study Follow-up Period|Patient Moved|0|||
130198785|NCT00090220|468686368|FG005|Base Study Follow-up Period|Patient Moved|0|||
130198786|NCT00090220|468686363|FG000|Base Study Follow-up Period|Other|19|||
130198787|NCT00090220|468686364|FG001|Base Study Follow-up Period|Other|21|||
130198788|NCT00090220|468686365|FG002|Base Study Follow-up Period|Other|0|||
130198789|NCT00090220|468686366|FG003|Base Study Follow-up Period|Other|0|||
130198790|NCT00090220|468686367|FG004|Base Study Follow-up Period|Other|0|||
130198791|NCT00090220|468686368|FG005|Base Study Follow-up Period|Other|0|||
130198792|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Adverse Event|0|||
130198793|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Adverse Event|0|||
130198794|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Adverse Event|4|||
130198795|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Adverse Event|0|||
130198796|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Adverse Event|0|||
130198797|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Adverse Event|0|||
130198798|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198799|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198800|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
130198801|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198802|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198803|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198804|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Moved|0|||
130198805|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Moved|0|||
130198806|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Moved|2|||
130198807|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Moved|1|||
130198808|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Moved|0|||
130198809|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Moved|0|||
130198810|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198811|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198812|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
130198813|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198814|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198815|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198816|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
130198817|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
130198818|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
130198819|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
130198820|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
130198821|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
130198822|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Other reason|0|||
130198823|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Other reason|0|||
130198824|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Other reason|2|||
130198825|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Other reason|0|||
130198826|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Other reason|0|||
130198827|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Other reason|0|||
130198828|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198829|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198830|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198831|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198832|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
130198833|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
130198834|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Death|0|||
130198835|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Death|0|||
130198836|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Death|0|||
130198837|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Death|0|||
130198838|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Death|1|||
130198839|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Death|1|||
130198840|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198841|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198842|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198843|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198844|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130198845|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130198846|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Other|0|||
130198847|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Other|0|||
130198848|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Other|0|||
130198849|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Other|0|||
130198850|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Other|1|||
130198851|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Other|0|||
130198852|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
130198853|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
130198854|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
130198855|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
130198856|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
130198857|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
130198858|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
130198859|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
130198860|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
130198861|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
130198862|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
130198863|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
130198864|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
130198865|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
130198866|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
130198867|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
130198868|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
130198869|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
130198870|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198871|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
130198872|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198873|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
130198874|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
130198875|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
130198876|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
130198877|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
130198878|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
130198879|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
130198880|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
130198881|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
130198882|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Other|0|||
130198883|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Other|1|||
130198884|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Other|0|||
130198885|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
130198886|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
130198887|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
130198888|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Early site closure|0|||
130198889|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Early site closure|2|||
130198890|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Early site closure|0|||
130198891|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
130198892|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
130198893|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
130198894|NCT02137850|468686369|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
130198895|NCT02137850|468686370|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
130198896|NCT02137850|468686371|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
130198897|NCT02137850|468686369|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
130198898|NCT02137850|468686370|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
130198899|NCT02137850|468686371|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
130198900|NCT02137850|468686369|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
130198901|NCT02137850|468686370|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
130198902|NCT02137850|468686371|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
130198903|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
130198904|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
130198905|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
130198906|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
130198907|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
130198908|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
130198909|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198910|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
130198911|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198912|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Other|0|||
130198913|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Other|1|||
130198914|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Other|0|||
130198915|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
130198916|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
130198917|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
130198918|NCT00537316|468686372|FG000|Part 1|Adverse Event|7|||
130198919|NCT00537316|468686373|FG001|Part 1|Adverse Event|11|||
130198920|NCT00537316|468686374|FG002|Part 1|Adverse Event|8|||
130198921|NCT00537316|468686375|FG003|Part 1|Adverse Event|0|||
130198922|NCT00537316|468686376|FG004|Part 1|Adverse Event|0|||
130198923|NCT00537316|468686377|FG005|Part 1|Adverse Event|0|||
130198924|NCT00537316|468686378|FG006|Part 1|Adverse Event|0|||
130198925|NCT00537316|468686372|FG000|Part 1|Protocol defined clinical event|1|||
130198926|NCT00537316|468686373|FG001|Part 1|Protocol defined clinical event|0|||
130198927|NCT00537316|468686374|FG002|Part 1|Protocol defined clinical event|0|||
130198928|NCT00537316|468686375|FG003|Part 1|Protocol defined clinical event|0|||
130198929|NCT00537316|468686376|FG004|Part 1|Protocol defined clinical event|0|||
130198930|NCT00537316|468686377|FG005|Part 1|Protocol defined clinical event|0|||
130198931|NCT00537316|468686378|FG006|Part 1|Protocol defined clinical event|0|||
130198932|NCT00537316|468686372|FG000|Part 1|Lost to Follow-up|1|||
130198933|NCT00537316|468686373|FG001|Part 1|Lost to Follow-up|0|||
130198934|NCT00537316|468686374|FG002|Part 1|Lost to Follow-up|0|||
130198935|NCT00537316|468686375|FG003|Part 1|Lost to Follow-up|0|||
130198936|NCT00537316|468686376|FG004|Part 1|Lost to Follow-up|0|||
130198937|NCT00537316|468686377|FG005|Part 1|Lost to Follow-up|0|||
130198938|NCT00537316|468686378|FG006|Part 1|Lost to Follow-up|0|||
130198939|NCT00537316|468686372|FG000|Part 1|Withdrawal by Subject|3|||
130198940|NCT00537316|468686373|FG001|Part 1|Withdrawal by Subject|8|||
130198941|NCT00537316|468686374|FG002|Part 1|Withdrawal by Subject|4|||
130198942|NCT00537316|468686375|FG003|Part 1|Withdrawal by Subject|0|||
130198943|NCT00537316|468686376|FG004|Part 1|Withdrawal by Subject|0|||
130198944|NCT00537316|468686377|FG005|Part 1|Withdrawal by Subject|0|||
130198945|NCT00537316|468686378|FG006|Part 1|Withdrawal by Subject|0|||
130198946|NCT00537316|468686372|FG000|Part 1|Protocol Violation|1|||
130198947|NCT00537316|468686373|FG001|Part 1|Protocol Violation|5|||
130198948|NCT00537316|468686374|FG002|Part 1|Protocol Violation|1|||
130198949|NCT00537316|468686375|FG003|Part 1|Protocol Violation|0|||
130198950|NCT00537316|468686376|FG004|Part 1|Protocol Violation|0|||
130198951|NCT00537316|468686377|FG005|Part 1|Protocol Violation|0|||
130198952|NCT00537316|468686378|FG006|Part 1|Protocol Violation|0|||
130198953|NCT00537316|468686372|FG000|Part 1|Did not meet protocol eligibility|1|||
130198954|NCT00537316|468686373|FG001|Part 1|Did not meet protocol eligibility|3|||
130198955|NCT00537316|468686374|FG002|Part 1|Did not meet protocol eligibility|2|||
130198956|NCT00537316|468686375|FG003|Part 1|Did not meet protocol eligibility|0|||
130198957|NCT00537316|468686376|FG004|Part 1|Did not meet protocol eligibility|0|||
130198958|NCT00537316|468686377|FG005|Part 1|Did not meet protocol eligibility|0|||
130198959|NCT00537316|468686378|FG006|Part 1|Did not meet protocol eligibility|0|||
130198960|NCT00537316|468686372|FG000|Part 1|Administrative|0|||
130198961|NCT00537316|468686373|FG001|Part 1|Administrative|0|||
130198962|NCT00537316|468686374|FG002|Part 1|Administrative|2|||
130198963|NCT00537316|468686375|FG003|Part 1|Administrative|0|||
130198964|NCT00537316|468686376|FG004|Part 1|Administrative|0|||
130198965|NCT00537316|468686377|FG005|Part 1|Administrative|0|||
130198966|NCT00537316|468686378|FG006|Part 1|Administrative|0|||
130198967|NCT00537316|468686372|FG000|Part 2|Never entered follow-up|0|||
130198968|NCT00537316|468686373|FG001|Part 2|Never entered follow-up|0|||
130198969|NCT00537316|468686374|FG002|Part 2|Never entered follow-up|0|||
130198970|NCT00537316|468686375|FG003|Part 2|Never entered follow-up|0|||
130198971|NCT00537316|468686376|FG004|Part 2|Never entered follow-up|0|||
130198972|NCT00537316|468686377|FG005|Part 2|Never entered follow-up|0|||
130198973|NCT00537316|468686378|FG006|Part 2|Never entered follow-up|1|||
130198974|NCT00537316|468686372|FG000|Part 2|Adverse Event|4|||
130198975|NCT00537316|468686373|FG001|Part 2|Adverse Event|0|||
130198976|NCT00537316|468686374|FG002|Part 2|Adverse Event|2|||
130198977|NCT00537316|468686375|FG003|Part 2|Adverse Event|0|||
130198978|NCT00537316|468686376|FG004|Part 2|Adverse Event|0|||
130198979|NCT00537316|468686377|FG005|Part 2|Adverse Event|0|||
130198980|NCT00537316|468686378|FG006|Part 2|Adverse Event|0|||
130198981|NCT00537316|468686372|FG000|Part 2|Lost to Follow-up|1|||
130198982|NCT00537316|468686373|FG001|Part 2|Lost to Follow-up|0|||
130198983|NCT00537316|468686374|FG002|Part 2|Lost to Follow-up|2|||
130198984|NCT00537316|468686375|FG003|Part 2|Lost to Follow-up|0|||
130198985|NCT00537316|468686376|FG004|Part 2|Lost to Follow-up|0|||
130198986|NCT00537316|468686377|FG005|Part 2|Lost to Follow-up|0|||
130198987|NCT00537316|468686378|FG006|Part 2|Lost to Follow-up|0|||
130198988|NCT00537316|468686372|FG000|Part 2|Withdrawal by Subject|5|||
130198989|NCT00537316|468686373|FG001|Part 2|Withdrawal by Subject|1|||
130198990|NCT00537316|468686374|FG002|Part 2|Withdrawal by Subject|4|||
130198991|NCT00537316|468686375|FG003|Part 2|Withdrawal by Subject|0|||
130198992|NCT00537316|468686376|FG004|Part 2|Withdrawal by Subject|0|||
130198993|NCT00537316|468686377|FG005|Part 2|Withdrawal by Subject|0|||
130198994|NCT00537316|468686378|FG006|Part 2|Withdrawal by Subject|0|||
130198995|NCT00537316|468686372|FG000|Part 2|Administrative|16|||
130198996|NCT00537316|468686373|FG001|Part 2|Administrative|8|||
130198997|NCT00537316|468686374|FG002|Part 2|Administrative|24|||
130198998|NCT00537316|468686375|FG003|Part 2|Administrative|3|||
130198999|NCT00537316|468686376|FG004|Part 2|Administrative|1|||
130199000|NCT00537316|468686377|FG005|Part 2|Administrative|4|||
130199001|NCT00537316|468686378|FG006|Part 2|Administrative|1|||
130199002|NCT02651155|468686379|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130199003|NCT02651155|468686380|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130199004|NCT02651155|468686379|FG000|Overall Study|Voluntary Withdrawal|5|||
130199005|NCT02651155|468686380|FG001|Overall Study|Voluntary Withdrawal|0|||
130199006|NCT01609543|468686383|FG000|Overall Study|Disease Progression|28|||
130199007|NCT01609543|468686383|FG000|Overall Study|Adverse Event|5|||
130199008|NCT01609543|468686383|FG000|Overall Study|Withdrawal by Subject|1|||
130199009|NCT01609543|468686383|FG000|Overall Study|Protocol Violation|1|||
130199010|NCT01609543|468686383|FG000|Overall Study|Death|7|||
130199011|NCT00507819|468686384|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
130199012|NCT00507819|468686385|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130199013|NCT03452488|468686387|FG000|Overall Study|Adverse Event|4|||
130199014|NCT03452488|468686388|FG001|Overall Study|Adverse Event|6|||
130199015|NCT03452488|468686389|FG002|Overall Study|Adverse Event|1|||
130199016|NCT03452488|468686387|FG000|Overall Study|Death|0|||
130199017|NCT03452488|468686388|FG001|Overall Study|Death|0|||
130199018|NCT03452488|468686389|FG002|Overall Study|Death|1|||
130199019|NCT03452488|468686387|FG000|Overall Study|Lost to Follow-up|1|||
130199020|NCT03452488|468686388|FG001|Overall Study|Lost to Follow-up|2|||
130199021|NCT03452488|468686389|FG002|Overall Study|Lost to Follow-up|0|||
130199022|NCT03452488|468686387|FG000|Overall Study|PI Decision|1|||
130199023|NCT03452488|468686388|FG001|Overall Study|PI Decision|0|||
130199024|NCT03452488|468686389|FG002|Overall Study|PI Decision|0|||
130199025|NCT03452488|468686387|FG000|Overall Study|Withdrew consent|4|||
130199026|NCT03452488|468686388|FG001|Overall Study|Withdrew consent|2|||
130199027|NCT03452488|468686389|FG002|Overall Study|Withdrew consent|2|||
130199028|NCT03452488|468686387|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130199029|NCT03452488|468686388|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
130199030|NCT03452488|468686389|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130199031|NCT03452488|468686387|FG000|Overall Study|Other|0|||
130199032|NCT03452488|468686388|FG001|Overall Study|Other|2|||
130199033|NCT03452488|468686389|FG002|Overall Study|Other|2|||
130199034|NCT01254318|468686394|FG000|Overall Study|Lost to Follow-up|5|||
130199035|NCT01254318|468686394|FG000|Overall Study|Death|47|||
130199036|NCT00330343|468686397|FG000|Overall Study|Lost to Follow-up|5|||
130199037|NCT01992653|468686398|FG000|Overall Study|Death|0|||
130199038|NCT01992653|468686399|FG001|Overall Study|Death|0|||
130199039|NCT01992653|468686400|FG002|Overall Study|Death|1|||
130199040|NCT01992653|468686401|FG003|Overall Study|Death|0|||
130199041|NCT01992653|468686402|FG004|Overall Study|Death|1|||
130199042|NCT01992653|468686403|FG005|Overall Study|Death|0|||
130199043|NCT01992653|468686404|FG006|Overall Study|Death|4|||
130199044|NCT01992653|468686405|FG007|Overall Study|Death|2|||
130199045|NCT01992653|468686398|FG000|Overall Study|Lost to Follow-up|0|||
130199046|NCT01992653|468686399|FG001|Overall Study|Lost to Follow-up|0|||
130199047|NCT01992653|468686400|FG002|Overall Study|Lost to Follow-up|0|||
130199048|NCT01992653|468686401|FG003|Overall Study|Lost to Follow-up|0|||
130199049|NCT01992653|468686402|FG004|Overall Study|Lost to Follow-up|0|||
130199050|NCT01992653|468686403|FG005|Overall Study|Lost to Follow-up|0|||
130199051|NCT01992653|468686404|FG006|Overall Study|Lost to Follow-up|0|||
130199052|NCT01992653|468686405|FG007|Overall Study|Lost to Follow-up|1|||
130199053|NCT01992653|468686398|FG000|Overall Study|Study Completed|0|||
130199054|NCT01992653|468686399|FG001|Overall Study|Study Completed|0|||
130199055|NCT01992653|468686400|FG002|Overall Study|Study Completed|0|||
130199056|NCT01992653|468686401|FG003|Overall Study|Study Completed|0|||
130199057|NCT01992653|468686402|FG004|Overall Study|Study Completed|0|||
130199058|NCT01992653|468686403|FG005|Overall Study|Study Completed|0|||
130199059|NCT01992653|468686404|FG006|Overall Study|Study Completed|0|||
130199060|NCT01992653|468686405|FG007|Overall Study|Study Completed|1|||
130199061|NCT01992653|468686398|FG000|Overall Study|Disease Progression|0|||
130199062|NCT01992653|468686399|FG001|Overall Study|Disease Progression|0|||
130199063|NCT01992653|468686400|FG002|Overall Study|Disease Progression|0|||
130199064|NCT01992653|468686401|FG003|Overall Study|Disease Progression|0|||
130199065|NCT01992653|468686402|FG004|Overall Study|Disease Progression|0|||
130199066|NCT01992653|468686403|FG005|Overall Study|Disease Progression|0|||
130199067|NCT01992653|468686404|FG006|Overall Study|Disease Progression|4|||
130199068|NCT01992653|468686405|FG007|Overall Study|Disease Progression|0|||
130199069|NCT02964208|468686408|FG000|Overall Study|Death|103|||
130199070|NCT02964208|468686408|FG000|Overall Study|Withdrawal by Subject|6|||
130199071|NCT02964208|468686408|FG000|Overall Study|Lost to Follow-up|6|||
130199072|NCT02964208|468686408|FG000|Overall Study|Unsuccessful Procedure|5|||
130199073|NCT02964208|468686408|FG000|Overall Study|Device Explant|1|||
130199074|NCT02964208|468686408|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
130199075|NCT01743560|468686409|FG000|Overall Study|Disease progression|26|||
130199076|NCT01743560|468686409|FG000|Overall Study|Adverse Event|8|||
130199077|NCT01743560|468686409|FG000|Overall Study|Death|3|||
130199078|NCT01743560|468686409|FG000|Overall Study|Withdrawal by Subject|2|||
130199079|NCT01743560|468686409|FG000|Overall Study|Protocol Violation|1|||
130199080|NCT01743560|468686409|FG000|Overall Study|>1 dose of study drug|3|||
130199081|NCT03226769|468686410|FG000|Overall Study|Withdrawal by Subject|0|||
130199082|NCT03226769|468686411|FG001|Overall Study|Withdrawal by Subject|1|||
130199083|NCT00940823|468686412|FG000|Overall Study|Death|8|||
130199084|NCT00940823|468686413|FG001|Overall Study|Death|12|||
130199085|NCT00940823|468686412|FG000|Overall Study|Lost to Follow-up|27|||
130199086|NCT00940823|468686413|FG001|Overall Study|Lost to Follow-up|20|||
130199087|NCT01758731|468686414|FG000|Overall Study|Physician Decision|1|||
130199088|NCT05270395|468686427|FG000|Overall Study|Lost to Follow-up|2|||
130199089|NCT05270395|468686428|FG001|Overall Study|Lost to Follow-up|2|||
130199090|NCT05270395|468686427|FG000|Overall Study|Death|1|||
130199091|NCT05270395|468686428|FG001|Overall Study|Death|2|||
130199092|NCT05270395|468686427|FG000|Overall Study|Study Team Withdrew|1|||
130199093|NCT05270395|468686428|FG001|Overall Study|Study Team Withdrew|0|||
130199094|NCT00199797|468688197|FG000|Overall Study|Progressive Disease|1|||
130199095|NCT00199797|468688197|FG000|Overall Study|Adverse Event|1|||
130199096|NCT00199797|468688197|FG000|Overall Study|Physician Decision|1|||
130199097|NCT04250350|468688203|FG000|Overall Study|Withdrawal by Subject|13|||
130199098|NCT04250350|468688203|FG000|Overall Study|Lost to Follow-up|8|||
130199099|NCT04250350|468688203|FG000|Overall Study|Adverse Event|5|||
130199100|NCT04250350|468688203|FG000|Overall Study|Lack of Efficacy|4|||
130199101|NCT04250350|468688203|FG000|Overall Study|Physician Decision|1|||
130199102|NCT04250350|468688203|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
130199103|NCT00784550|468688204|FG000|Overall Study|Adverse Event|12|||
130199104|NCT00784550|468688205|FG001|Overall Study|Adverse Event|10|||
130199105|NCT00784550|468688204|FG000|Overall Study|Lack of Efficacy|0|||
130199106|NCT00784550|468688205|FG001|Overall Study|Lack of Efficacy|1|||
130199107|NCT00784550|468688204|FG000|Overall Study|Protocol Violation|10|||
130199108|NCT00784550|468688205|FG001|Overall Study|Protocol Violation|10|||
130199109|NCT00784550|468688204|FG000|Overall Study|Lost to Follow-up|8|||
130199110|NCT00784550|468688205|FG001|Overall Study|Lost to Follow-up|5|||
130199111|NCT00784550|468688204|FG000|Overall Study|Physician Decision|2|||
130199112|NCT00784550|468688205|FG001|Overall Study|Physician Decision|3|||
130199113|NCT00784550|468688204|FG000|Overall Study|Withdrawal by Subject|4|||
130199114|NCT00784550|468688205|FG001|Overall Study|Withdrawal by Subject|13|||
130199115|NCT00688701|468688206|FG000|Overall Study|Adverse Event|1|||
130199116|NCT00688701|468688207|FG001|Overall Study|Adverse Event|0|||
130199117|NCT00688701|468688208|FG002|Overall Study|Adverse Event|5|||
130199118|NCT00688701|468688209|FG003|Overall Study|Adverse Event|3|||
130199119|NCT00688701|468688206|FG000|Overall Study|Lack of Efficacy|0|||
130199120|NCT00688701|468688207|FG001|Overall Study|Lack of Efficacy|1|||
130199121|NCT00688701|468688208|FG002|Overall Study|Lack of Efficacy|0|||
130199122|NCT00688701|468688209|FG003|Overall Study|Lack of Efficacy|0|||
130199123|NCT00688701|468688206|FG000|Overall Study|Withdrawal by Subject|3|||
130199124|NCT00688701|468688207|FG001|Overall Study|Withdrawal by Subject|3|||
130199125|NCT00688701|468688208|FG002|Overall Study|Withdrawal by Subject|4|||
130199126|NCT00688701|468688209|FG003|Overall Study|Withdrawal by Subject|8|||
130199127|NCT00688701|468688206|FG000|Overall Study|Poor compliance to protocol|0|||
130199128|NCT00688701|468688207|FG001|Overall Study|Poor compliance to protocol|1|||
130199129|NCT00688701|468688208|FG002|Overall Study|Poor compliance to protocol|1|||
130199130|NCT00688701|468688209|FG003|Overall Study|Poor compliance to protocol|0|||
130199131|NCT03875092|468688221|FG000|Overall Study|Adverse Event|2|||
130199132|NCT03875092|468688222|FG001|Overall Study|Adverse Event|5|||
130199133|NCT03875092|468688221|FG000|Overall Study|Death|44|||
130199134|NCT03875092|468688222|FG001|Overall Study|Death|51|||
130199135|NCT03875092|468688221|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
130199136|NCT03875092|468688222|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
130199137|NCT03205761|468688223|FG000|Overall Study|Withdrawal by Subject|1|||
130199138|NCT03205761|468688223|FG000|Overall Study|Progressive Disease|10|||
130199139|NCT04420585|468688224|FG000|Overall Study|Adverse Event|1|||
130199140|NCT04420585|468688224|FG000|Overall Study|Never initiated medication|2|||
130199141|NCT02163226|468688225|FG000|Overall Study|Death|2|||
130199142|NCT02163226|468688226|FG001|Overall Study|Death|1|||
130199143|NCT02163226|468688225|FG000|Overall Study|Withdrawal by Subject|5|||
130199144|NCT02163226|468688226|FG001|Overall Study|Withdrawal by Subject|2|||
130199145|NCT02163226|468688225|FG000|Overall Study|Returned home, local radiotherapy|3|||
130199146|NCT02163226|468688226|FG001|Overall Study|Returned home, local radiotherapy|0|||
130199147|NCT02163226|468688225|FG000|Overall Study|Repeat imaging showed no disease|2|||
130199148|NCT02163226|468688226|FG001|Overall Study|Repeat imaging showed no disease|0|||
130199149|NCT02163226|468688225|FG000|Overall Study|Incomplete radiotherapy|3|||
130199150|NCT02163226|468688226|FG001|Overall Study|Incomplete radiotherapy|0|||
130199151|NCT02163226|468688225|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
130199152|NCT02163226|468688226|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
130199153|NCT02163226|468688225|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
130199154|NCT02163226|468688226|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
130199155|NCT02163226|468688225|FG000|Overall Study|ineligible|0|||
130199156|NCT02163226|468688226|FG001|Overall Study|ineligible|3|||
130199157|NCT04114357|468688227|FG000|Baseline-Randomization|Adverse Event|2|||
130199158|NCT04114357|468688228|FG001|Baseline-Randomization|Adverse Event|1|||
130199159|NCT04114357|468688227|FG000|Baseline-Randomization|Lost to Follow-up|1|||
130199160|NCT04114357|468688228|FG001|Baseline-Randomization|Lost to Follow-up|1|||
130199161|NCT04114357|468688227|FG000|Cross-over|Adverse Event|0|||
130199162|NCT04114357|468688228|FG001|Cross-over|Adverse Event|1|||
130199163|NCT03558152|468688229|FG000|Overall Study|Adverse Event|0|||
130199164|NCT03558152|468688230|FG001|Overall Study|Adverse Event|0|||
130199165|NCT03558152|468688231|FG002|Overall Study|Adverse Event|1|||
130199166|NCT03558152|468688232|FG003|Overall Study|Adverse Event|1|||
130199167|NCT03558152|468688233|FG004|Overall Study|Adverse Event|2|||
130199168|NCT03558152|468688234|FG005|Overall Study|Adverse Event|1|||
130199169|NCT03558152|468688235|FG006|Overall Study|Adverse Event|1|||
130199170|NCT03558152|468688236|FG007|Overall Study|Adverse Event|0|||
130199171|NCT03558152|468688229|FG000|Overall Study|Death|0|||
130199172|NCT03558152|468688230|FG001|Overall Study|Death|0|||
130199173|NCT03558152|468688231|FG002|Overall Study|Death|0|||
130199174|NCT03558152|468688232|FG003|Overall Study|Death|0|||
130199175|NCT03558152|468688233|FG004|Overall Study|Death|1|||
130199176|NCT03558152|468688234|FG005|Overall Study|Death|0|||
130199177|NCT03558152|468688235|FG006|Overall Study|Death|0|||
130199178|NCT03558152|468688236|FG007|Overall Study|Death|0|||
130199179|NCT03558152|468688229|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
130199180|NCT03558152|468688230|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199181|NCT03558152|468688231|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199182|NCT03558152|468688232|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199183|NCT03558152|468688233|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199184|NCT03558152|468688234|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199185|NCT03558152|468688235|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199186|NCT03558152|468688236|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199187|NCT03558152|468688229|FG000|Overall Study|Miscalculation in mmcs|0|||
130199188|NCT03558152|468688230|FG001|Overall Study|Miscalculation in mmcs|0|||
130199189|NCT03558152|468688231|FG002|Overall Study|Miscalculation in mmcs|0|||
130199190|NCT03558152|468688232|FG003|Overall Study|Miscalculation in mmcs|0|||
130199191|NCT03558152|468688233|FG004|Overall Study|Miscalculation in mmcs|0|||
130199192|NCT03558152|468688234|FG005|Overall Study|Miscalculation in mmcs|0|||
130199193|NCT03558152|468688235|FG006|Overall Study|Miscalculation in mmcs|1|||
130199194|NCT03558152|468688236|FG007|Overall Study|Miscalculation in mmcs|0|||
130199195|NCT03558152|468688229|FG000|Overall Study|Mistake in calculation|0|||
130199196|NCT03558152|468688230|FG001|Overall Study|Mistake in calculation|0|||
130199197|NCT03558152|468688231|FG002|Overall Study|Mistake in calculation|0|||
130199198|NCT03558152|468688232|FG003|Overall Study|Mistake in calculation|1|||
130199199|NCT03558152|468688233|FG004|Overall Study|Mistake in calculation|0|||
130199200|NCT03558152|468688234|FG005|Overall Study|Mistake in calculation|0|||
130199201|NCT03558152|468688235|FG006|Overall Study|Mistake in calculation|0|||
130199202|NCT03558152|468688236|FG007|Overall Study|Mistake in calculation|0|||
130199203|NCT03558152|468688229|FG000|Overall Study|Mistake in evaluation of disease status|0|||
130199204|NCT03558152|468688230|FG001|Overall Study|Mistake in evaluation of disease status|0|||
130199205|NCT03558152|468688231|FG002|Overall Study|Mistake in evaluation of disease status|0|||
130199206|NCT03558152|468688232|FG003|Overall Study|Mistake in evaluation of disease status|0|||
130199207|NCT03558152|468688233|FG004|Overall Study|Mistake in evaluation of disease status|0|||
130199208|NCT03558152|468688234|FG005|Overall Study|Mistake in evaluation of disease status|0|||
130199209|NCT03558152|468688235|FG006|Overall Study|Mistake in evaluation of disease status|0|||
130199210|NCT03558152|468688236|FG007|Overall Study|Mistake in evaluation of disease status|1|||
130199211|NCT03558152|468688229|FG000|Overall Study|Physician Decision|0|||
130199212|NCT03558152|468688230|FG001|Overall Study|Physician Decision|0|||
130199213|NCT03558152|468688231|FG002|Overall Study|Physician Decision|0|||
130199214|NCT03558152|468688232|FG003|Overall Study|Physician Decision|0|||
130199215|NCT03558152|468688233|FG004|Overall Study|Physician Decision|0|||
130199216|NCT03558152|468688234|FG005|Overall Study|Physician Decision|0|||
130199217|NCT03558152|468688235|FG006|Overall Study|Physician Decision|1|||
130199218|NCT03558152|468688236|FG007|Overall Study|Physician Decision|0|||
130199219|NCT03558152|468688229|FG000|Overall Study|Withdrawal by Subject|2|||
130199220|NCT03558152|468688230|FG001|Overall Study|Withdrawal by Subject|3|||
130199221|NCT03558152|468688231|FG002|Overall Study|Withdrawal by Subject|2|||
130199222|NCT03558152|468688232|FG003|Overall Study|Withdrawal by Subject|1|||
130199223|NCT03558152|468688233|FG004|Overall Study|Withdrawal by Subject|1|||
130199224|NCT03558152|468688234|FG005|Overall Study|Withdrawal by Subject|1|||
130199225|NCT03558152|468688235|FG006|Overall Study|Withdrawal by Subject|3|||
130199226|NCT03558152|468688236|FG007|Overall Study|Withdrawal by Subject|2|||
130199227|NCT03558152|468688229|FG000|Overall Study|Lack of Efficacy|11|||
130199228|NCT03558152|468688230|FG001|Overall Study|Lack of Efficacy|11|||
130199229|NCT03558152|468688231|FG002|Overall Study|Lack of Efficacy|10|||
130199230|NCT03558152|468688232|FG003|Overall Study|Lack of Efficacy|11|||
130199231|NCT03558152|468688233|FG004|Overall Study|Lack of Efficacy|14|||
130199232|NCT03558152|468688234|FG005|Overall Study|Lack of Efficacy|12|||
130199233|NCT03558152|468688235|FG006|Overall Study|Lack of Efficacy|14|||
130199234|NCT03558152|468688236|FG007|Overall Study|Lack of Efficacy|13|||
130199235|NCT03558152|468688229|FG000|Overall Study|Protocol Violation|1|||
130199236|NCT03558152|468688230|FG001|Overall Study|Protocol Violation|1|||
130199237|NCT03558152|468688231|FG002|Overall Study|Protocol Violation|0|||
130199238|NCT03558152|468688232|FG003|Overall Study|Protocol Violation|1|||
130199239|NCT03558152|468688233|FG004|Overall Study|Protocol Violation|1|||
130199240|NCT03558152|468688234|FG005|Overall Study|Protocol Violation|0|||
130199241|NCT03558152|468688235|FG006|Overall Study|Protocol Violation|2|||
130199242|NCT03558152|468688236|FG007|Overall Study|Protocol Violation|0|||
130199243|NCT01300338|468688242|FG000|Overall Study|Lost to Follow-up|5|||
130199244|NCT01300338|468688243|FG001|Overall Study|Lost to Follow-up|0|||
130199245|NCT00970632|468688244|FG000|Overall Study|Adverse Event|2|||
130199246|NCT00970632|468688245|FG001|Overall Study|Adverse Event|2|||
130199247|NCT00970632|468688246|FG002|Overall Study|Adverse Event|1|||
130199248|NCT00970632|468688244|FG000|Overall Study|Lack of Efficacy|3|||
130199249|NCT00970632|468688245|FG001|Overall Study|Lack of Efficacy|0|||
130199250|NCT00970632|468688246|FG002|Overall Study|Lack of Efficacy|0|||
130199251|NCT00970632|468688244|FG000|Overall Study|Lost to Follow-up|3|||
130199252|NCT00970632|468688245|FG001|Overall Study|Lost to Follow-up|0|||
130199253|NCT00970632|468688246|FG002|Overall Study|Lost to Follow-up|2|||
130199254|NCT00970632|468688244|FG000|Overall Study|Protocol Violation|8|||
130199255|NCT00970632|468688245|FG001|Overall Study|Protocol Violation|5|||
130199256|NCT00970632|468688246|FG002|Overall Study|Protocol Violation|8|||
130199257|NCT00970632|468688244|FG000|Overall Study|Withdrawal by Subject|7|||
130199258|NCT00970632|468688245|FG001|Overall Study|Withdrawal by Subject|6|||
130199259|NCT00970632|468688246|FG002|Overall Study|Withdrawal by Subject|4|||
130199260|NCT00970632|468688244|FG000|Overall Study|Entry criteria not met|0|||
130199261|NCT00970632|468688245|FG001|Overall Study|Entry criteria not met|2|||
130199262|NCT00970632|468688246|FG002|Overall Study|Entry criteria not met|2|||
130199263|NCT00970632|468688244|FG000|Overall Study|Sponsor decision|1|||
130199264|NCT00970632|468688245|FG001|Overall Study|Sponsor decision|0|||
130199265|NCT00970632|468688246|FG002|Overall Study|Sponsor decision|1|||
130199266|NCT02002533|468688253|FG000|Overall Study|Withdrawal by Subject|6|||
130199267|NCT02002533|468688254|FG001|Overall Study|Withdrawal by Subject|13|||
130199268|NCT02002533|468688253|FG000|Overall Study|Protocol Violation|0|||
130199269|NCT02002533|468688254|FG001|Overall Study|Protocol Violation|1|||
130199270|NCT02002533|468688253|FG000|Overall Study|Adverse Event|0|||
130199271|NCT02002533|468688254|FG001|Overall Study|Adverse Event|3|||
130199272|NCT02002533|468688253|FG000|Overall Study|Lost to Follow-up|0|||
130199273|NCT02002533|468688254|FG001|Overall Study|Lost to Follow-up|1|||
130199274|NCT00976820|468688257|FG000|Overall Study|Lost to Follow-up|5|||
130199275|NCT00976820|468688258|FG001|Overall Study|Lost to Follow-up|16|||
130199276|NCT00976820|468688259|FG002|Overall Study|Lost to Follow-up|2|||
130199277|NCT00976820|468688260|FG003|Overall Study|Lost to Follow-up|3|||
130199278|NCT00976820|468688257|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130199279|NCT00976820|468688258|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130199280|NCT00976820|468688259|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130199281|NCT00976820|468688260|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130199282|NCT00976820|468688257|FG000|Overall Study|Withdrawal by Subject|2|||
130199283|NCT00976820|468688258|FG001|Overall Study|Withdrawal by Subject|4|||
130199284|NCT00976820|468688259|FG002|Overall Study|Withdrawal by Subject|1|||
130199285|NCT00976820|468688260|FG003|Overall Study|Withdrawal by Subject|4|||
130199286|NCT03261674|468688261|FG000|Overall Study|Lost to Follow-up|6|||
130199287|NCT03261674|468688262|FG001|Overall Study|Lost to Follow-up|7|||
130199288|NCT03261674|468688261|FG000|Overall Study|Protocol Violation|1|||
130199289|NCT03261674|468688262|FG001|Overall Study|Protocol Violation|4|||
130199290|NCT03261674|468688261|FG000|Overall Study|Withdrawal by Subject|1|||
130199291|NCT03261674|468688262|FG001|Overall Study|Withdrawal by Subject|4|||
130199292|NCT03261674|468688261|FG000|Overall Study|Physician Decision|1|||
130199293|NCT03261674|468688262|FG001|Overall Study|Physician Decision|0|||
130199294|NCT00623935|468688263|FG000|Overall Study|Death|1|||
130199295|NCT00623935|468688263|FG000|Overall Study|Patient Declined Transplant|1|||
130199296|NCT00747474|468688266|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199297|NCT00747474|468688267|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199298|NCT00747474|468688268|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199299|NCT00747474|468688269|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199300|NCT00747474|468688270|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199301|NCT00747474|468688271|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199302|NCT00747474|468688272|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199303|NCT00747474|468688273|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
130199304|NCT00747474|468688274|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199305|NCT00747474|468688275|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199306|NCT00747474|468688276|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199307|NCT00747474|468688277|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199308|NCT00890084|468688278|FG000|Overall Study|Adverse Event|16|||
130199309|NCT00890084|468688278|FG000|Overall Study|Lost to Follow-up|126|||
130199310|NCT02691936|468688284|FG000|Overall Study|Withdrawal by Subject|2|||
130199311|NCT02691936|468688285|FG001|Overall Study|Withdrawal by Subject|5|||
130199312|NCT01878084|468688286|FG000|Overall Study|Physician Decision|2|||
130199313|NCT00749684|468688287|FG000|Overall Study|Death|1|||
130199314|NCT00749684|468688287|FG000|Overall Study|Adverse Event|27|||
130199315|NCT00749684|468688287|FG000|Overall Study|Participant's Wish|10|||
130199316|NCT00749684|468688287|FG000|Overall Study|Not Documented|1|||
130199317|NCT00749684|468688287|FG000|Overall Study|Progressive Desease|31|||
130199318|NCT00749684|468688287|FG000|Overall Study|Therapy according to protocol + AE|2|||
130199319|NCT00749684|468688287|FG000|Overall Study|AE+discontinuation on participants wish|1|||
130199320|NCT00749684|468688287|FG000|Overall Study|Missing|9|||
130199321|NCT02892422|468688292|FG000|Overall Study|Enrolled not treated|4|||
130199322|NCT02892422|468688292|FG000|Overall Study|Adverse Event|38|||
130199323|NCT02892422|468688292|FG000|Overall Study|Lack of Efficacy|32|||
130199324|NCT02892422|468688292|FG000|Overall Study|Non-compliance with study drug|11|||
130199325|NCT02892422|468688292|FG000|Overall Study|Protocol Violation|4|||
130199326|NCT02892422|468688292|FG000|Overall Study|Withdrawal by Subject|56|||
130199327|NCT02892422|468688292|FG000|Overall Study|Lost to Follow-up|5|||
130199328|NCT02892422|468688292|FG000|Overall Study|sponsor information 16159A results|21|||
130199329|NCT02892422|468688292|FG000|Overall Study|withdrawal of consent|13|||
130199330|NCT02892422|468688292|FG000|Overall Study|exclusion criteria met|3|||
130199331|NCT02892422|468688292|FG000|Overall Study|moving elsewhere|4|||
130199332|NCT02892422|468688292|FG000|Overall Study|non-compliance|10|||
130199333|NCT02892422|468688292|FG000|Overall Study|patient legally incapable|1|||
130199334|NCT02892422|468688292|FG000|Overall Study|patient decision|7|||
130199335|NCT02892422|468688292|FG000|Overall Study|Investigator decision|1|||
130199336|NCT01023256|468688293|FG000|Overall Study|Protocol Violation|2|||
130199337|NCT01023256|468688294|FG001|Overall Study|Protocol Violation|3|||
130199338|NCT01023256|468688295|FG002|Overall Study|Protocol Violation|0|||
130199339|NCT01023256|468688296|FG003|Overall Study|Protocol Violation|0|||
130199340|NCT01023256|468688293|FG000|Overall Study|Randomized but not treated|1|||
130199341|NCT01023256|468688294|FG001|Overall Study|Randomized but not treated|0|||
130199342|NCT01023256|468688295|FG002|Overall Study|Randomized but not treated|1|||
130199343|NCT01023256|468688296|FG003|Overall Study|Randomized but not treated|0|||
130199344|NCT01023256|468688293|FG000|Overall Study|Other|1|||
130199345|NCT01023256|468688294|FG001|Overall Study|Other|0|||
130199346|NCT01023256|468688295|FG002|Overall Study|Other|0|||
130199347|NCT01023256|468688296|FG003|Overall Study|Other|2|||
130199348|NCT01023256|468688293|FG000|Overall Study|Adverse Event|0|||
130199349|NCT01023256|468688294|FG001|Overall Study|Adverse Event|0|||
130199350|NCT01023256|468688295|FG002|Overall Study|Adverse Event|0|||
130199351|NCT01023256|468688296|FG003|Overall Study|Adverse Event|1|||
130199352|NCT01023256|468688293|FG000|Overall Study|Withdrawal by Subject|0|||
130199353|NCT01023256|468688294|FG001|Overall Study|Withdrawal by Subject|0|||
130199354|NCT01023256|468688295|FG002|Overall Study|Withdrawal by Subject|0|||
130199355|NCT01023256|468688296|FG003|Overall Study|Withdrawal by Subject|2|||
130199356|NCT03155178|468688297|FG000|Overall Study|Did not meet treatment day baseline|7|||
130199357|NCT03155178|468688298|FG001|Overall Study|Did not meet treatment day baseline|7|||
130199358|NCT03155178|468688299|FG002|Overall Study|Did not meet treatment day baseline|7|||
130199359|NCT03155178|468688300|FG003|Overall Study|Did not meet treatment day baseline|7|||
130199360|NCT03089697|468688301|FG000|Overall Study|Adverse Event|1|||
130199361|NCT03089697|468688302|FG001|Overall Study|Adverse Event|2|||
130199362|NCT03089697|468688301|FG000|Overall Study|Withdrawal by Subject|1|||
130199363|NCT03089697|468688302|FG001|Overall Study|Withdrawal by Subject|0|||
130199364|NCT04323306|468688303|FG000|Overall Study|Physician Decision|1|||
130199365|NCT04323306|468688304|FG001|Overall Study|Physician Decision|0|||
130199366|NCT04323306|468688305|FG002|Overall Study|Physician Decision|0|||
130199367|NCT04323306|468688306|FG003|Overall Study|Physician Decision|0|||
130199368|NCT04323306|468688307|FG004|Overall Study|Physician Decision|0|||
130199369|NCT04323306|468688308|FG005|Overall Study|Physician Decision|0|||
130199370|NCT04323306|468688309|FG006|Overall Study|Physician Decision|0|||
130199371|NCT04323306|468688310|FG007|Overall Study|Physician Decision|0|||
130199372|NCT04323306|468688311|FG008|Overall Study|Physician Decision|0|||
130199373|NCT04323306|468688303|FG000|Overall Study|Withdrawal by Subject|0|||
130199374|NCT04323306|468688304|FG001|Overall Study|Withdrawal by Subject|0|||
130199375|NCT04323306|468688305|FG002|Overall Study|Withdrawal by Subject|0|||
130199376|NCT04323306|468688306|FG003|Overall Study|Withdrawal by Subject|0|||
130199377|NCT04323306|468688307|FG004|Overall Study|Withdrawal by Subject|0|||
130199378|NCT04323306|468688308|FG005|Overall Study|Withdrawal by Subject|1|||
130199379|NCT04323306|468688309|FG006|Overall Study|Withdrawal by Subject|3|||
130199380|NCT04323306|468688310|FG007|Overall Study|Withdrawal by Subject|0|||
130199381|NCT04323306|468688311|FG008|Overall Study|Withdrawal by Subject|1|||
130199382|NCT00834639|468688312|FG000|Second Intervention|Physician Decision|0|||
130199383|NCT00834639|468688313|FG001|Second Intervention|Physician Decision|2|||
130199384|NCT05129137|468688314|FG000|Second Period|Adverse Event|1|||
130199385|NCT05129137|468688315|FG001|Second Period|Adverse Event|0|||
130199386|NCT05129137|468688316|FG002|Second Period|Adverse Event|0|||
130199387|NCT05129137|468688317|FG003|Second Period|Adverse Event|0|||
130199388|NCT05129137|468688314|FG000|Second Period|Protocol Violation|0|||
130199389|NCT05129137|468688315|FG001|Second Period|Protocol Violation|0|||
130199390|NCT05129137|468688316|FG002|Second Period|Protocol Violation|0|||
130199391|NCT05129137|468688317|FG003|Second Period|Protocol Violation|1|||
130199392|NCT05129137|468688314|FG000|Third Period|Protocol Violation|0|||
130199393|NCT05129137|468688315|FG001|Third Period|Protocol Violation|0|||
130199394|NCT05129137|468688316|FG002|Third Period|Protocol Violation|0|||
130199395|NCT05129137|468688317|FG003|Third Period|Protocol Violation|1|||
130199396|NCT05129137|468688314|FG000|Forth Period|Protocol Violation|0|||
130199397|NCT05129137|468688315|FG001|Forth Period|Protocol Violation|1|||
130199398|NCT05129137|468688316|FG002|Forth Period|Protocol Violation|0|||
130199399|NCT05129137|468688317|FG003|Forth Period|Protocol Violation|0|||
130199400|NCT05129137|468688314|FG000|Forth Period|Withdrawal by Subject|0|||
130199401|NCT05129137|468688315|FG001|Forth Period|Withdrawal by Subject|0|||
130199402|NCT05129137|468688316|FG002|Forth Period|Withdrawal by Subject|1|||
130199403|NCT05129137|468688317|FG003|Forth Period|Withdrawal by Subject|0|||
130199404|NCT03382834|468688330|FG000|Step 1|Lost to Follow-up|0|||
130199405|NCT03382834|468688331|FG001|Step 1|Lost to Follow-up|1|||
130199406|NCT03382834|468688330|FG000|Step 2|Death|1|||
130199407|NCT03382834|468688331|FG001|Step 2|Death|0|||
130199408|NCT03382834|468688330|FG000|Step 2|Lost to Follow-up|2|||
130199409|NCT03382834|468688331|FG001|Step 2|Lost to Follow-up|2|||
130199410|NCT03382834|468688330|FG000|Step 2|Site Terminated by Sponsor|1|||
130199411|NCT03382834|468688331|FG001|Step 2|Site Terminated by Sponsor|0|||
130199412|NCT02387957|468688332|FG000|Overall Study|The study was discontinued|21|||
130199413|NCT02387957|468688333|FG001|Overall Study|The study was discontinued|21|||
130199414|NCT02387957|468688334|FG002|Overall Study|The study was discontinued|20|||
130199415|NCT03613649|468688335|FG000|Second Treatment|Lost to Follow-up|0|||
130199416|NCT03613649|468688336|FG001|Second Treatment|Lost to Follow-up|0|||
130199417|NCT03613649|468688337|FG002|Second Treatment|Lost to Follow-up|1|||
130199418|NCT03613649|468688338|FG003|Second Treatment|Lost to Follow-up|0|||
130199419|NCT03613649|468688339|FG004|Second Treatment|Lost to Follow-up|0|||
130199420|NCT03613649|468688340|FG005|Second Treatment|Lost to Follow-up|0|||
130199421|NCT03613649|468688341|FG006|Second Treatment|Lost to Follow-up|0|||
130199422|NCT03613649|468688342|FG007|Second Treatment|Lost to Follow-up|0|||
130199423|NCT03613649|468688343|FG008|Second Treatment|Lost to Follow-up|0|||
130199424|NCT03613649|468688344|FG009|Second Treatment|Lost to Follow-up|0|||
130199425|NCT03613649|468688345|FG010|Second Treatment|Lost to Follow-up|0|||
130199426|NCT03613649|468688346|FG011|Second Treatment|Lost to Follow-up|0|||
130199427|NCT03613649|468688335|FG000|Second Treatment|Withdrawal by Subject|0|||
130199428|NCT03613649|468688336|FG001|Second Treatment|Withdrawal by Subject|0|||
130199429|NCT03613649|468688337|FG002|Second Treatment|Withdrawal by Subject|0|||
130199430|NCT03613649|468688338|FG003|Second Treatment|Withdrawal by Subject|0|||
130199431|NCT03613649|468688339|FG004|Second Treatment|Withdrawal by Subject|1|||
130199432|NCT03613649|468688340|FG005|Second Treatment|Withdrawal by Subject|0|||
130199433|NCT03613649|468688341|FG006|Second Treatment|Withdrawal by Subject|0|||
130199434|NCT03613649|468688342|FG007|Second Treatment|Withdrawal by Subject|0|||
130199435|NCT03613649|468688343|FG008|Second Treatment|Withdrawal by Subject|0|||
130199436|NCT03613649|468688344|FG009|Second Treatment|Withdrawal by Subject|0|||
130199437|NCT03613649|468688345|FG010|Second Treatment|Withdrawal by Subject|0|||
130199438|NCT03613649|468688346|FG011|Second Treatment|Withdrawal by Subject|0|||
130199439|NCT03613649|468688335|FG000|Third Treatment|Lost to Follow-up|0|||
130199440|NCT03613649|468688336|FG001|Third Treatment|Lost to Follow-up|0|||
130199441|NCT03613649|468688337|FG002|Third Treatment|Lost to Follow-up|0|||
130199442|NCT03613649|468688338|FG003|Third Treatment|Lost to Follow-up|0|||
130199443|NCT03613649|468688339|FG004|Third Treatment|Lost to Follow-up|1|||
130199444|NCT03613649|468688340|FG005|Third Treatment|Lost to Follow-up|0|||
130199445|NCT03613649|468688341|FG006|Third Treatment|Lost to Follow-up|0|||
130199446|NCT03613649|468688342|FG007|Third Treatment|Lost to Follow-up|0|||
130199447|NCT03613649|468688343|FG008|Third Treatment|Lost to Follow-up|0|||
130199448|NCT03613649|468688344|FG009|Third Treatment|Lost to Follow-up|0|||
130199449|NCT03613649|468688345|FG010|Third Treatment|Lost to Follow-up|0|||
130199450|NCT03613649|468688346|FG011|Third Treatment|Lost to Follow-up|1|||
130199451|NCT03613649|468688335|FG000|Third Treatment|Protocol Violation|0|||
130199452|NCT03613649|468688336|FG001|Third Treatment|Protocol Violation|0|||
130199453|NCT03613649|468688337|FG002|Third Treatment|Protocol Violation|0|||
130199454|NCT03613649|468688338|FG003|Third Treatment|Protocol Violation|0|||
130199455|NCT03613649|468688339|FG004|Third Treatment|Protocol Violation|0|||
130199456|NCT03613649|468688340|FG005|Third Treatment|Protocol Violation|0|||
130199457|NCT03613649|468688341|FG006|Third Treatment|Protocol Violation|1|||
130199458|NCT03613649|468688342|FG007|Third Treatment|Protocol Violation|0|||
130199459|NCT03613649|468688343|FG008|Third Treatment|Protocol Violation|0|||
130199460|NCT03613649|468688344|FG009|Third Treatment|Protocol Violation|0|||
130199461|NCT03613649|468688345|FG010|Third Treatment|Protocol Violation|0|||
130199462|NCT03613649|468688346|FG011|Third Treatment|Protocol Violation|1|||
130199463|NCT03613649|468688335|FG000|Fourth Treatment|Protocol Violation|1|||
130199464|NCT03613649|468688336|FG001|Fourth Treatment|Protocol Violation|0|||
130199465|NCT03613649|468688337|FG002|Fourth Treatment|Protocol Violation|0|||
130199466|NCT03613649|468688338|FG003|Fourth Treatment|Protocol Violation|0|||
130199467|NCT03613649|468688339|FG004|Fourth Treatment|Protocol Violation|1|||
130199468|NCT03613649|468688340|FG005|Fourth Treatment|Protocol Violation|0|||
130199469|NCT03613649|468688341|FG006|Fourth Treatment|Protocol Violation|0|||
130199470|NCT03613649|468688342|FG007|Fourth Treatment|Protocol Violation|0|||
130199471|NCT03613649|468688343|FG008|Fourth Treatment|Protocol Violation|0|||
130199472|NCT03613649|468688344|FG009|Fourth Treatment|Protocol Violation|0|||
130199473|NCT03613649|468688345|FG010|Fourth Treatment|Protocol Violation|0|||
130199474|NCT03613649|468688346|FG011|Fourth Treatment|Protocol Violation|0|||
130199475|NCT03613649|468688335|FG000|Fourth Treatment|Physician Decision|0|||
130199476|NCT03613649|468688336|FG001|Fourth Treatment|Physician Decision|0|||
130199477|NCT03613649|468688337|FG002|Fourth Treatment|Physician Decision|0|||
130199478|NCT03613649|468688338|FG003|Fourth Treatment|Physician Decision|0|||
130199479|NCT03613649|468688339|FG004|Fourth Treatment|Physician Decision|0|||
130199480|NCT03613649|468688340|FG005|Fourth Treatment|Physician Decision|0|||
130199481|NCT03613649|468688341|FG006|Fourth Treatment|Physician Decision|1|||
130199482|NCT03613649|468688342|FG007|Fourth Treatment|Physician Decision|0|||
130199483|NCT03613649|468688343|FG008|Fourth Treatment|Physician Decision|0|||
130199484|NCT03613649|468688344|FG009|Fourth Treatment|Physician Decision|0|||
130199485|NCT03613649|468688345|FG010|Fourth Treatment|Physician Decision|0|||
130199486|NCT03613649|468688346|FG011|Fourth Treatment|Physician Decision|0|||
130199487|NCT00675428|468688347|FG000|Overall Study|Disease Progression|2|||
130199488|NCT00675428|468688348|FG001|Overall Study|Disease Progression|2|||
130199489|NCT00675428|468688347|FG000|Overall Study|No Disease Response After Cycle 6|0|||
130199490|NCT00675428|468688348|FG001|Overall Study|No Disease Response After Cycle 6|1|||
130199491|NCT00675428|468688347|FG000|Overall Study|Physician Decision|1|||
130199492|NCT00675428|468688348|FG001|Overall Study|Physician Decision|0|||
130199493|NCT00319592|468688349|FG000|Overall Study|Protocol Violation|1|||
130199494|NCT00319592|468688350|FG001|Overall Study|Protocol Violation|0|||
130199495|NCT00319592|468688349|FG000|Overall Study|Physician Decision|0|||
130199496|NCT00319592|468688350|FG001|Overall Study|Physician Decision|1|||
130199497|NCT00750139|468688353|FG000|Overall Study|Adverse Event|1|||
130199498|NCT00750139|468688354|FG001|Overall Study|Adverse Event|2|||
130199499|NCT00750139|468688355|FG002|Overall Study|Adverse Event|0|||
130199500|NCT00750139|468688356|FG003|Overall Study|Adverse Event|1|||
130199501|NCT00750139|468688353|FG000|Overall Study|Lost to Follow-up|17|||
130199502|NCT00750139|468688354|FG001|Overall Study|Lost to Follow-up|12|||
130199503|NCT00750139|468688355|FG002|Overall Study|Lost to Follow-up|15|||
130199504|NCT00750139|468688356|FG003|Overall Study|Lost to Follow-up|6|||
130199505|NCT00750139|468688353|FG000|Overall Study|Withdrawal by Subject|3|||
130199506|NCT00750139|468688354|FG001|Overall Study|Withdrawal by Subject|2|||
130199507|NCT00750139|468688355|FG002|Overall Study|Withdrawal by Subject|6|||
130199508|NCT00750139|468688356|FG003|Overall Study|Withdrawal by Subject|2|||
130199509|NCT00750139|468688353|FG000|Overall Study|Physician Decision|1|||
130199510|NCT00750139|468688354|FG001|Overall Study|Physician Decision|1|||
130199511|NCT00750139|468688355|FG002|Overall Study|Physician Decision|0|||
130199512|NCT00750139|468688356|FG003|Overall Study|Physician Decision|0|||
130199513|NCT00750139|468688353|FG000|Overall Study|Non-compliance|1|||
130199514|NCT00750139|468688354|FG001|Overall Study|Non-compliance|0|||
130199515|NCT00750139|468688355|FG002|Overall Study|Non-compliance|1|||
130199516|NCT00750139|468688356|FG003|Overall Study|Non-compliance|3|||
130199517|NCT00750139|468688353|FG000|Overall Study|Termination by sponsor|4|||
130199518|NCT00750139|468688354|FG001|Overall Study|Termination by sponsor|0|||
130199519|NCT00750139|468688355|FG002|Overall Study|Termination by sponsor|0|||
130199520|NCT00750139|468688356|FG003|Overall Study|Termination by sponsor|1|||
130199521|NCT00750139|468688353|FG000|Overall Study|Non-specific|62|||
130199522|NCT00750139|468688354|FG001|Overall Study|Non-specific|42|||
130199523|NCT00750139|468688355|FG002|Overall Study|Non-specific|79|||
130199524|NCT00750139|468688356|FG003|Overall Study|Non-specific|33|||
130199525|NCT04439214|468688360|FG000|Overall Study|Adverse Event|13|||
130199526|NCT04439214|468688360|FG000|Overall Study|Disease progression|16|||
130199527|NCT04439214|468688360|FG000|Overall Study|Death|1|||
130199528|NCT04439214|468688360|FG000|Overall Study|Withdrawal by Subject|2|||
130199529|NCT04439214|468688360|FG000|Overall Study|Declining health|1|||
130199530|NCT04439214|468688360|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
130199531|NCT04439214|468688360|FG000|Overall Study|Ineligible|5|||
130199532|NCT04553471|468688361|FG000|Overall Study|Did not start treatment on protocol|3|||
130199533|NCT04553471|468688361|FG000|Overall Study|Death|1|||
130199534|NCT00477750|468689747|FG000|Overall Study|Currently Receiving Treatment|11|||
130199535|NCT00601172|468689748|FG000|Overall Study|Adverse Event|43|||
130199536|NCT00601172|468689749|FG001|Overall Study|Adverse Event|32|||
130199537|NCT00601172|468689748|FG000|Overall Study|Lack of Efficacy|11|||
130199538|NCT00601172|468689749|FG001|Overall Study|Lack of Efficacy|12|||
130199539|NCT00601172|468689748|FG000|Overall Study|Protocol Violation|2|||
130199540|NCT00601172|468689749|FG001|Overall Study|Protocol Violation|5|||
130199541|NCT00601172|468689748|FG000|Overall Study|Lost to Follow-up|4|||
130199542|NCT00601172|468689749|FG001|Overall Study|Lost to Follow-up|3|||
130199543|NCT00601172|468689748|FG000|Overall Study|Physician Decision|27|||
130199544|NCT00601172|468689749|FG001|Overall Study|Physician Decision|28|||
130199545|NCT00601172|468689748|FG000|Overall Study|Withdrawal by Subject|35|||
130199546|NCT00601172|468689749|FG001|Overall Study|Withdrawal by Subject|27|||
130199547|NCT00601172|468689748|FG000|Overall Study|Did not meet continuation criteria|19|||
130199548|NCT00601172|468689749|FG001|Overall Study|Did not meet continuation criteria|20|||
130199549|NCT03030989|468689750|FG000|Overall Study|Fever|2|||
130199550|NCT03030989|468689751|FG001|Overall Study|Fever|2|||
130199551|NCT03030989|468689750|FG000|Overall Study|Rash|2|||
130199552|NCT03030989|468689751|FG001|Overall Study|Rash|1|||
130199553|NCT03030989|468689750|FG000|Overall Study|Fatigue/Overwhelmed|1|||
130199554|NCT03030989|468689751|FG001|Overall Study|Fatigue/Overwhelmed|5|||
130199555|NCT03030989|468689750|FG000|Overall Study|Positive Blood Cultures|2|||
130199556|NCT03030989|468689751|FG001|Overall Study|Positive Blood Cultures|1|||
130199557|NCT03030989|468689750|FG000|Overall Study|Line Removed|0|||
130199558|NCT03030989|468689751|FG001|Overall Study|Line Removed|2|||
130199559|NCT03030989|468689750|FG000|Overall Study|No longer interested|5|||
130199560|NCT03030989|468689751|FG001|Overall Study|No longer interested|3|||
130199561|NCT02706886|468689752|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
130199562|NCT02706886|468689753|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
130199563|NCT02706886|468689754|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
130199564|NCT02706886|468689755|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
130199565|NCT02706886|468689756|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
130199566|NCT02706886|468689757|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
130199567|NCT02706886|468689758|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
130199568|NCT02706886|468689759|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
130199569|NCT02706886|468689760|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
130199570|NCT01669174|468689767|FG000|Overall Study|Subject withdrew consent|2|||
130199571|NCT01669174|468689768|FG001|Overall Study|Subject withdrew consent|2|||
130199572|NCT01669174|468689767|FG000|Overall Study|Lost to Follow-up|1|||
130199573|NCT01669174|468689768|FG001|Overall Study|Lost to Follow-up|0|||
130199574|NCT01669174|468689767|FG000|Overall Study|Adverse Event|2|||
130199575|NCT01669174|468689768|FG001|Overall Study|Adverse Event|2|||
130199576|NCT01669174|468689767|FG000|Overall Study|Administrative problems|1|||
130199577|NCT01669174|468689768|FG001|Overall Study|Administrative problems|2|||
130199578|NCT04310397|468689771|FG000|Overall Study|Lack of Efficacy|3|||
130199579|NCT04310397|468689771|FG000|Overall Study|Withdrawal by Subject|1|||
130199580|NCT00723255|468689772|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
130199581|NCT00723255|468689772|FG000|Overall Study|Ineligible: Second primary|1|||
130199582|NCT00723255|468689772|FG000|Overall Study|Ineligible: Wrong Primary|2|||
130199583|NCT00614523|468689773|FG000|Overall Study|Adverse Event|4|||
130199584|NCT00614523|468689774|FG001|Overall Study|Adverse Event|20|||
130199585|NCT00614523|468689773|FG000|Overall Study|Death|5|||
130199586|NCT00614523|468689774|FG001|Overall Study|Death|8|||
130199587|NCT00614523|468689773|FG000|Overall Study|Lack of Efficacy|9|||
130199588|NCT00614523|468689774|FG001|Overall Study|Lack of Efficacy|11|||
130199589|NCT00614523|468689773|FG000|Overall Study|Lost to Follow-up|0|||
130199590|NCT00614523|468689774|FG001|Overall Study|Lost to Follow-up|1|||
130199591|NCT00614523|468689773|FG000|Overall Study|Protocol Violation|3|||
130199592|NCT00614523|468689774|FG001|Overall Study|Protocol Violation|2|||
130199593|NCT00614523|468689773|FG000|Overall Study|Withdrawal by Subject|12|||
130199594|NCT00614523|468689774|FG001|Overall Study|Withdrawal by Subject|22|||
130199595|NCT00614523|468689773|FG000|Overall Study|Other|6|||
130199596|NCT00614523|468689774|FG001|Overall Study|Other|11|||
130199597|NCT00614523|468689773|FG000|Overall Study|Ineligibility Determined|1|||
130199598|NCT00614523|468689774|FG001|Overall Study|Ineligibility Determined|2|||
130199599|NCT00614523|468689773|FG000|Overall Study|Disease Progression|0|||
130199600|NCT00614523|468689774|FG001|Overall Study|Disease Progression|8|||
130199601|NCT00614523|468689773|FG000|Overall Study|Administrative Decision|23|||
130199602|NCT00614523|468689774|FG001|Overall Study|Administrative Decision|46|||
130199603|NCT04598451|468689780|FG000|Overall Study|Adverse Event|3|||
130199604|NCT04598451|468689781|FG001|Overall Study|Adverse Event|2|||
130199605|NCT04598451|468689780|FG000|Overall Study|Withdrawal by Subject|3|||
130199606|NCT04598451|468689781|FG001|Overall Study|Withdrawal by Subject|7|||
130199607|NCT04598451|468689780|FG000|Overall Study|Lost to Follow-up|2|||
130199608|NCT04598451|468689781|FG001|Overall Study|Lost to Follow-up|0|||
130199609|NCT04598451|468689780|FG000|Overall Study|Physician Decision|4|||
130199610|NCT04598451|468689781|FG001|Overall Study|Physician Decision|1|||
130199611|NCT04598451|468689780|FG000|Overall Study|Requires Prohibited Medication|1|||
130199612|NCT04598451|468689781|FG001|Overall Study|Requires Prohibited Medication|0|||
130199613|NCT04598451|468689780|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
130199614|NCT04598451|468689781|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
130199615|NCT01482065|468689784|FG000|Overall Study|Withdrawal by Subject|0|||
130199616|NCT01482065|468689785|FG001|Overall Study|Withdrawal by Subject|1|||
130199617|NCT02005692|468689790|FG000|Overall Study|Protocol Violation|1|||
130199618|NCT02005692|468689790|FG000|Overall Study|Withdrawal by Subject|1|||
130199619|NCT02005692|468689790|FG000|Overall Study|Discharged earlier than anticipated|5|||
130199620|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
130199621|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
130199622|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
130199623|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
130199624|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
130199625|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
130199626|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
130199627|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
130199628|NCT01895270|468689791|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
130199629|NCT01895270|468689792|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
130199630|NCT01895270|468689791|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
130199631|NCT01895270|468689792|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
130199632|NCT01895270|468689791|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
130199633|NCT01895270|468689792|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
130199634|NCT02091375|468689794|FG000|Overall Study|Adverse Event|8|||
130199635|NCT02091375|468689795|FG001|Overall Study|Adverse Event|1|||
130199636|NCT02091375|468689794|FG000|Overall Study|Lost to Follow-up|0|||
130199637|NCT02091375|468689795|FG001|Overall Study|Lost to Follow-up|1|||
130199638|NCT02091375|468689794|FG000|Overall Study|Withdrawal by Subject|0|||
130199639|NCT02091375|468689795|FG001|Overall Study|Withdrawal by Subject|1|||
130199640|NCT02091375|468689794|FG000|Overall Study|Withdrawn by the investigator|1|||
130199641|NCT02091375|468689795|FG001|Overall Study|Withdrawn by the investigator|0|||
130199642|NCT01741792|468689796|FG000|Overall Study|Death|6|||
130199643|NCT01741792|468689797|FG001|Overall Study|Death|1|||
130199644|NCT01741792|468689798|FG002|Overall Study|Death|12|||
130199645|NCT04507256|468689803|FG000|Overall Study|Withdrawal by Subject|1|||
130199646|NCT04507256|468689804|FG001|Overall Study|Withdrawal by Subject|0|||
130199647|NCT04507256|468689805|FG002|Overall Study|Withdrawal by Subject|0|||
130199648|NCT04507256|468689806|FG003|Overall Study|Withdrawal by Subject|1|||
130199649|NCT04507256|468689807|FG004|Overall Study|Withdrawal by Subject|0|||
130199650|NCT04507256|468689808|FG005|Overall Study|Withdrawal by Subject|0|||
130199651|NCT00631410|468689809|FG000|Overall Study|Adverse Event|1|||
130199652|NCT00631410|468689810|FG001|Overall Study|Adverse Event|3|||
130199653|NCT00631410|468689809|FG000|Overall Study|Objective Progression or Relapse|4|||
130199654|NCT00631410|468689810|FG001|Overall Study|Objective Progression or Relapse|3|||
130199655|NCT00631410|468689809|FG000|Overall Study|Surgery|1|||
130199656|NCT00631410|468689810|FG001|Overall Study|Surgery|0|||
130199657|NCT02980341|468689815|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199658|NCT02980341|468689816|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199659|NCT02980341|468689817|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
130199660|NCT02980341|468689818|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
130199661|NCT02980341|468689819|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199662|NCT02980341|468689820|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199663|NCT02980341|468689821|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199664|NCT02980341|468689822|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199665|NCT02980341|468689823|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199666|NCT02980341|468689824|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199667|NCT02980341|468689825|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199668|NCT02980341|468689815|FG000|Dose Escalation|Clinical progression|0|||
130199669|NCT02980341|468689816|FG001|Dose Escalation|Clinical progression|0|||
130199670|NCT02980341|468689817|FG002|Dose Escalation|Clinical progression|2|||
130199671|NCT02980341|468689818|FG003|Dose Escalation|Clinical progression|1|||
130199672|NCT02980341|468689819|FG004|Dose Escalation|Clinical progression|0|||
130199673|NCT02980341|468689820|FG005|Dose Escalation|Clinical progression|0|||
130199674|NCT02980341|468689821|FG006|Dose Escalation|Clinical progression|0|||
130199675|NCT02980341|468689822|FG007|Dose Escalation|Clinical progression|0|||
130199676|NCT02980341|468689823|FG008|Dose Escalation|Clinical progression|0|||
130199677|NCT02980341|468689824|FG009|Dose Escalation|Clinical progression|0|||
130199678|NCT02980341|468689825|FG010|Dose Escalation|Clinical progression|0|||
130199679|NCT02980341|468689815|FG000|Dose Escalation|Adverse Event|0|||
130199680|NCT02980341|468689816|FG001|Dose Escalation|Adverse Event|0|||
130199681|NCT02980341|468689817|FG002|Dose Escalation|Adverse Event|1|||
130199682|NCT02980341|468689818|FG003|Dose Escalation|Adverse Event|2|||
130199683|NCT02980341|468689819|FG004|Dose Escalation|Adverse Event|2|||
130199684|NCT02980341|468689820|FG005|Dose Escalation|Adverse Event|0|||
130199685|NCT02980341|468689821|FG006|Dose Escalation|Adverse Event|0|||
130199686|NCT02980341|468689822|FG007|Dose Escalation|Adverse Event|0|||
130199687|NCT02980341|468689823|FG008|Dose Escalation|Adverse Event|0|||
130199688|NCT02980341|468689824|FG009|Dose Escalation|Adverse Event|0|||
130199689|NCT02980341|468689825|FG010|Dose Escalation|Adverse Event|0|||
130199690|NCT02980341|468689815|FG000|Dose Escalation|Withdrawal by Subject|0|||
130199691|NCT02980341|468689816|FG001|Dose Escalation|Withdrawal by Subject|0|||
130199692|NCT02980341|468689817|FG002|Dose Escalation|Withdrawal by Subject|1|||
130199693|NCT02980341|468689818|FG003|Dose Escalation|Withdrawal by Subject|0|||
130199694|NCT02980341|468689819|FG004|Dose Escalation|Withdrawal by Subject|0|||
130199695|NCT02980341|468689820|FG005|Dose Escalation|Withdrawal by Subject|0|||
130199696|NCT02980341|468689821|FG006|Dose Escalation|Withdrawal by Subject|0|||
130199697|NCT02980341|468689822|FG007|Dose Escalation|Withdrawal by Subject|0|||
130199698|NCT02980341|468689823|FG008|Dose Escalation|Withdrawal by Subject|0|||
130199699|NCT02980341|468689824|FG009|Dose Escalation|Withdrawal by Subject|0|||
130199700|NCT02980341|468689825|FG010|Dose Escalation|Withdrawal by Subject|0|||
130199701|NCT02980341|468689815|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199702|NCT02980341|468689816|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199703|NCT02980341|468689817|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199704|NCT02980341|468689818|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
130199705|NCT02980341|468689819|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199706|NCT02980341|468689820|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199707|NCT02980341|468689821|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199708|NCT02980341|468689822|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199709|NCT02980341|468689823|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199710|NCT02980341|468689824|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199711|NCT02980341|468689825|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199712|NCT02980341|468689815|FG000|Dose Escalation|Due to investigator's decision|0|||
130199713|NCT02980341|468689816|FG001|Dose Escalation|Due to investigator's decision|0|||
130199714|NCT02980341|468689817|FG002|Dose Escalation|Due to investigator's decision|0|||
130199715|NCT02980341|468689818|FG003|Dose Escalation|Due to investigator's decision|0|||
130199716|NCT02980341|468689819|FG004|Dose Escalation|Due to investigator's decision|1|||
130199717|NCT02980341|468689820|FG005|Dose Escalation|Due to investigator's decision|0|||
130199718|NCT02980341|468689821|FG006|Dose Escalation|Due to investigator's decision|0|||
130199719|NCT02980341|468689822|FG007|Dose Escalation|Due to investigator's decision|0|||
130199720|NCT02980341|468689823|FG008|Dose Escalation|Due to investigator's decision|0|||
130199721|NCT02980341|468689824|FG009|Dose Escalation|Due to investigator's decision|0|||
130199722|NCT02980341|468689825|FG010|Dose Escalation|Due to investigator's decision|0|||
130199723|NCT02980341|468689815|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199724|NCT02980341|468689816|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199725|NCT02980341|468689817|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199726|NCT02980341|468689818|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199727|NCT02980341|468689819|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199728|NCT02980341|468689820|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
130199729|NCT02980341|468689821|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
130199730|NCT02980341|468689822|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199731|NCT02980341|468689823|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199732|NCT02980341|468689824|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199733|NCT02980341|468689825|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199734|NCT02980341|468689815|FG000|Dose Finding|Adverse Event|0|||
130199735|NCT02980341|468689816|FG001|Dose Finding|Adverse Event|0|||
130199736|NCT02980341|468689817|FG002|Dose Finding|Adverse Event|0|||
130199737|NCT02980341|468689818|FG003|Dose Finding|Adverse Event|0|||
130199738|NCT02980341|468689819|FG004|Dose Finding|Adverse Event|0|||
130199739|NCT02980341|468689820|FG005|Dose Finding|Adverse Event|3|||
130199740|NCT02980341|468689821|FG006|Dose Finding|Adverse Event|0|||
130199741|NCT02980341|468689822|FG007|Dose Finding|Adverse Event|0|||
130199742|NCT02980341|468689823|FG008|Dose Finding|Adverse Event|0|||
130199743|NCT02980341|468689824|FG009|Dose Finding|Adverse Event|0|||
130199744|NCT02980341|468689825|FG010|Dose Finding|Adverse Event|0|||
130199745|NCT02980341|468689815|FG000|Dose Finding|Withdrawal by Subject|0|||
130199746|NCT02980341|468689816|FG001|Dose Finding|Withdrawal by Subject|0|||
130199747|NCT02980341|468689817|FG002|Dose Finding|Withdrawal by Subject|0|||
130199748|NCT02980341|468689818|FG003|Dose Finding|Withdrawal by Subject|0|||
130199749|NCT02980341|468689819|FG004|Dose Finding|Withdrawal by Subject|0|||
130199750|NCT02980341|468689820|FG005|Dose Finding|Withdrawal by Subject|1|||
130199751|NCT02980341|468689821|FG006|Dose Finding|Withdrawal by Subject|1|||
130199752|NCT02980341|468689822|FG007|Dose Finding|Withdrawal by Subject|0|||
130199753|NCT02980341|468689823|FG008|Dose Finding|Withdrawal by Subject|0|||
130199754|NCT02980341|468689824|FG009|Dose Finding|Withdrawal by Subject|0|||
130199755|NCT02980341|468689825|FG010|Dose Finding|Withdrawal by Subject|0|||
130199756|NCT02980341|468689815|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199757|NCT02980341|468689816|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199758|NCT02980341|468689817|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199759|NCT02980341|468689818|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199760|NCT02980341|468689819|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199761|NCT02980341|468689820|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199762|NCT02980341|468689821|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199763|NCT02980341|468689822|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130199764|NCT02980341|468689823|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
130199765|NCT02980341|468689824|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
130199766|NCT02980341|468689825|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130199767|NCT02980341|468689815|FG000|Dose Expansion|Clinical progression|0|||
130199768|NCT02980341|468689816|FG001|Dose Expansion|Clinical progression|0|||
130199769|NCT02980341|468689817|FG002|Dose Expansion|Clinical progression|0|||
130199770|NCT02980341|468689818|FG003|Dose Expansion|Clinical progression|0|||
130199771|NCT02980341|468689819|FG004|Dose Expansion|Clinical progression|0|||
130199772|NCT02980341|468689820|FG005|Dose Expansion|Clinical progression|0|||
130199773|NCT02980341|468689821|FG006|Dose Expansion|Clinical progression|0|||
130199774|NCT02980341|468689822|FG007|Dose Expansion|Clinical progression|4|||
130199775|NCT02980341|468689823|FG008|Dose Expansion|Clinical progression|3|||
130199776|NCT02980341|468689824|FG009|Dose Expansion|Clinical progression|1|||
130199777|NCT02980341|468689825|FG010|Dose Expansion|Clinical progression|4|||
130199778|NCT02980341|468689815|FG000|Dose Expansion|Adverse Event|0|||
130199779|NCT02980341|468689816|FG001|Dose Expansion|Adverse Event|0|||
130199780|NCT02980341|468689817|FG002|Dose Expansion|Adverse Event|0|||
130199781|NCT02980341|468689818|FG003|Dose Expansion|Adverse Event|0|||
130199782|NCT02980341|468689819|FG004|Dose Expansion|Adverse Event|0|||
130199783|NCT02980341|468689820|FG005|Dose Expansion|Adverse Event|0|||
130199784|NCT02980341|468689821|FG006|Dose Expansion|Adverse Event|0|||
130199785|NCT02980341|468689822|FG007|Dose Expansion|Adverse Event|3|||
130199786|NCT02980341|468689823|FG008|Dose Expansion|Adverse Event|0|||
130199787|NCT02980341|468689824|FG009|Dose Expansion|Adverse Event|1|||
130199788|NCT02980341|468689825|FG010|Dose Expansion|Adverse Event|3|||
130199789|NCT02980341|468689815|FG000|Dose Expansion|Death|0|||
130199790|NCT02980341|468689816|FG001|Dose Expansion|Death|0|||
130199791|NCT02980341|468689817|FG002|Dose Expansion|Death|0|||
130199792|NCT02980341|468689818|FG003|Dose Expansion|Death|0|||
130199793|NCT02980341|468689819|FG004|Dose Expansion|Death|0|||
130199794|NCT02980341|468689820|FG005|Dose Expansion|Death|0|||
130199795|NCT02980341|468689821|FG006|Dose Expansion|Death|0|||
130199796|NCT02980341|468689822|FG007|Dose Expansion|Death|0|||
130199797|NCT02980341|468689823|FG008|Dose Expansion|Death|2|||
130199798|NCT02980341|468689824|FG009|Dose Expansion|Death|1|||
130199799|NCT02980341|468689825|FG010|Dose Expansion|Death|0|||
130199800|NCT02980341|468689815|FG000|Dose Expansion|Withdrawal by Subject|0|||
130199801|NCT02980341|468689816|FG001|Dose Expansion|Withdrawal by Subject|0|||
130199802|NCT02980341|468689817|FG002|Dose Expansion|Withdrawal by Subject|0|||
130199803|NCT02980341|468689818|FG003|Dose Expansion|Withdrawal by Subject|0|||
130199804|NCT02980341|468689819|FG004|Dose Expansion|Withdrawal by Subject|0|||
130199805|NCT02980341|468689820|FG005|Dose Expansion|Withdrawal by Subject|0|||
130199806|NCT02980341|468689821|FG006|Dose Expansion|Withdrawal by Subject|0|||
130199807|NCT02980341|468689822|FG007|Dose Expansion|Withdrawal by Subject|2|||
130199808|NCT02980341|468689823|FG008|Dose Expansion|Withdrawal by Subject|0|||
130199809|NCT02980341|468689824|FG009|Dose Expansion|Withdrawal by Subject|1|||
130199810|NCT02980341|468689825|FG010|Dose Expansion|Withdrawal by Subject|0|||
130199811|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199812|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199813|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199814|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199815|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199816|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199817|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199818|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
130199819|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199820|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199821|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199822|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199823|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199824|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199825|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199826|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199827|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199828|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199829|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199830|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
130199831|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199832|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199833|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199834|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199835|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199836|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199837|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199838|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199839|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199840|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199841|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
130199842|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199843|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199844|NCT02980341|468689815|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199845|NCT02980341|468689816|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199846|NCT02980341|468689817|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199847|NCT02980341|468689818|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199848|NCT02980341|468689819|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199849|NCT02980341|468689820|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199850|NCT02980341|468689821|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199851|NCT02980341|468689822|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199852|NCT02980341|468689823|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199853|NCT02980341|468689824|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199854|NCT02980341|468689825|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
130199855|NCT01647516|468689826|FG000|Induction Period (IP)|Physician Decision|2|||
130199856|NCT01647516|468689827|FG001|Induction Period (IP)|Physician Decision|0|||
130199857|NCT01647516|468689828|FG002|Induction Period (IP)|Physician Decision|0|||
130199858|NCT01647516|468689829|FG003|Induction Period (IP)|Physician Decision|0|||
130199859|NCT01647516|468689830|FG004|Induction Period (IP)|Physician Decision|0|||
130199860|NCT01647516|468689831|FG005|Induction Period (IP)|Physician Decision|0|||
130199861|NCT01647516|468689826|FG000|Induction Period (IP)|Adverse Event|1|||
130199862|NCT01647516|468689827|FG001|Induction Period (IP)|Adverse Event|2|||
130199863|NCT01647516|468689828|FG002|Induction Period (IP)|Adverse Event|0|||
130199864|NCT01647516|468689829|FG003|Induction Period (IP)|Adverse Event|0|||
130199865|NCT01647516|468689830|FG004|Induction Period (IP)|Adverse Event|0|||
130199866|NCT01647516|468689831|FG005|Induction Period (IP)|Adverse Event|0|||
130199867|NCT01647516|468689826|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
130199868|NCT01647516|468689827|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
130199869|NCT01647516|468689828|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
130199870|NCT01647516|468689829|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
130199871|NCT01647516|468689830|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
130199872|NCT01647516|468689831|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
130199873|NCT01647516|468689826|FG000|Induction Period (IP)|Participant Choice|0|||
130199874|NCT01647516|468689827|FG001|Induction Period (IP)|Participant Choice|0|||
130199875|NCT01647516|468689828|FG002|Induction Period (IP)|Participant Choice|1|||
130199876|NCT01647516|468689829|FG003|Induction Period (IP)|Participant Choice|0|||
130199877|NCT01647516|468689830|FG004|Induction Period (IP)|Participant Choice|0|||
130199878|NCT01647516|468689831|FG005|Induction Period (IP)|Participant Choice|0|||
130199879|NCT01647516|468689826|FG000|Induction Period (IP)|Lack of Efficacy|1|||
130199880|NCT01647516|468689827|FG001|Induction Period (IP)|Lack of Efficacy|0|||
130199881|NCT01647516|468689828|FG002|Induction Period (IP)|Lack of Efficacy|0|||
130199882|NCT01647516|468689829|FG003|Induction Period (IP)|Lack of Efficacy|0|||
130199883|NCT01647516|468689830|FG004|Induction Period (IP)|Lack of Efficacy|0|||
130199884|NCT01647516|468689831|FG005|Induction Period (IP)|Lack of Efficacy|0|||
130199885|NCT01647516|468689826|FG000|Induction Period (IP)|No study drug received|1|||
130199886|NCT01647516|468689827|FG001|Induction Period (IP)|No study drug received|1|||
130199887|NCT01647516|468689828|FG002|Induction Period (IP)|No study drug received|0|||
130199888|NCT01647516|468689829|FG003|Induction Period (IP)|No study drug received|0|||
130199889|NCT01647516|468689830|FG004|Induction Period (IP)|No study drug received|0|||
130199890|NCT01647516|468689831|FG005|Induction Period (IP)|No study drug received|0|||
130199891|NCT01647516|468689826|FG000|Maintenance Period (MP)|Adverse Event|2|||
130199892|NCT01647516|468689827|FG001|Maintenance Period (MP)|Adverse Event|1|||
130199893|NCT01647516|468689828|FG002|Maintenance Period (MP)|Adverse Event|0|||
130199894|NCT01647516|468689829|FG003|Maintenance Period (MP)|Adverse Event|0|||
130199895|NCT01647516|468689830|FG004|Maintenance Period (MP)|Adverse Event|0|||
130199896|NCT01647516|468689831|FG005|Maintenance Period (MP)|Adverse Event|0|||
130199897|NCT01647516|468689826|FG000|Maintenance Period (MP)|Non-compliance|1|||
130199898|NCT01647516|468689827|FG001|Maintenance Period (MP)|Non-compliance|0|||
130199899|NCT01647516|468689828|FG002|Maintenance Period (MP)|Non-compliance|0|||
130199900|NCT01647516|468689829|FG003|Maintenance Period (MP)|Non-compliance|0|||
130199901|NCT01647516|468689830|FG004|Maintenance Period (MP)|Non-compliance|0|||
130199902|NCT01647516|468689831|FG005|Maintenance Period (MP)|Non-compliance|0|||
130199903|NCT01647516|468689826|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199904|NCT01647516|468689827|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
130199905|NCT01647516|468689828|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
130199906|NCT01647516|468689829|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199907|NCT01647516|468689830|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199908|NCT01647516|468689831|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199909|NCT01647516|468689826|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
130199910|NCT01647516|468689827|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
130199911|NCT01647516|468689828|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
130199912|NCT01647516|468689829|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130199913|NCT01647516|468689830|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
130199914|NCT01647516|468689831|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130199915|NCT01647516|468689826|FG000|Open-Label Period|Adverse Event|0|||
130199916|NCT01647516|468689827|FG001|Open-Label Period|Adverse Event|0|||
130199917|NCT01647516|468689828|FG002|Open-Label Period|Adverse Event|0|||
130199918|NCT01647516|468689829|FG003|Open-Label Period|Adverse Event|5|||
130199919|NCT01647516|468689830|FG004|Open-Label Period|Adverse Event|6|||
130199920|NCT01647516|468689831|FG005|Open-Label Period|Adverse Event|3|||
130199921|NCT01647516|468689826|FG000|Open-Label Period|Pregnancy|0|||
130199922|NCT01647516|468689827|FG001|Open-Label Period|Pregnancy|0|||
130199923|NCT01647516|468689828|FG002|Open-Label Period|Pregnancy|0|||
130199924|NCT01647516|468689829|FG003|Open-Label Period|Pregnancy|0|||
130199925|NCT01647516|468689830|FG004|Open-Label Period|Pregnancy|0|||
130199926|NCT01647516|468689831|FG005|Open-Label Period|Pregnancy|1|||
130199927|NCT01647516|468689826|FG000|Open-Label Period|Non-compliance|0|||
130199928|NCT01647516|468689827|FG001|Open-Label Period|Non-compliance|0|||
130199929|NCT01647516|468689828|FG002|Open-Label Period|Non-compliance|0|||
130199930|NCT01647516|468689829|FG003|Open-Label Period|Non-compliance|1|||
130199931|NCT01647516|468689830|FG004|Open-Label Period|Non-compliance|0|||
130199932|NCT01647516|468689831|FG005|Open-Label Period|Non-compliance|1|||
130199933|NCT01647516|468689826|FG000|Open-Label Period|Physician Decision|0|||
130199934|NCT01647516|468689827|FG001|Open-Label Period|Physician Decision|0|||
130199935|NCT01647516|468689828|FG002|Open-Label Period|Physician Decision|0|||
130199936|NCT01647516|468689829|FG003|Open-Label Period|Physician Decision|1|||
130199937|NCT01647516|468689830|FG004|Open-Label Period|Physician Decision|1|||
130199938|NCT01647516|468689831|FG005|Open-Label Period|Physician Decision|0|||
130199939|NCT01647516|468689826|FG000|Open-Label Period|Withdrawal by Subject|0|||
130199940|NCT01647516|468689827|FG001|Open-Label Period|Withdrawal by Subject|0|||
130199941|NCT01647516|468689828|FG002|Open-Label Period|Withdrawal by Subject|0|||
130199942|NCT01647516|468689829|FG003|Open-Label Period|Withdrawal by Subject|9|||
130199943|NCT01647516|468689830|FG004|Open-Label Period|Withdrawal by Subject|11|||
130199944|NCT01647516|468689831|FG005|Open-Label Period|Withdrawal by Subject|6|||
130199945|NCT01647516|468689826|FG000|Open-Label Period|Lost to Follow-up|0|||
130199946|NCT01647516|468689827|FG001|Open-Label Period|Lost to Follow-up|0|||
130199947|NCT01647516|468689828|FG002|Open-Label Period|Lost to Follow-up|0|||
130199948|NCT01647516|468689829|FG003|Open-Label Period|Lost to Follow-up|1|||
130199949|NCT01647516|468689830|FG004|Open-Label Period|Lost to Follow-up|0|||
130199950|NCT01647516|468689831|FG005|Open-Label Period|Lost to Follow-up|1|||
130199951|NCT01647516|468689826|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199952|NCT01647516|468689827|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199953|NCT01647516|468689828|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199954|NCT01647516|468689829|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
130199955|NCT01647516|468689830|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
130199956|NCT01647516|468689831|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
130199957|NCT01647516|468689826|FG000|Open-Label Period|Lack of Efficacy|0|||
130199958|NCT01647516|468689827|FG001|Open-Label Period|Lack of Efficacy|0|||
130199959|NCT01647516|468689828|FG002|Open-Label Period|Lack of Efficacy|0|||
130199960|NCT01647516|468689829|FG003|Open-Label Period|Lack of Efficacy|7|||
130199961|NCT01647516|468689830|FG004|Open-Label Period|Lack of Efficacy|9|||
130199962|NCT01647516|468689831|FG005|Open-Label Period|Lack of Efficacy|10|||
130199963|NCT01647516|468689826|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199964|NCT01647516|468689827|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199965|NCT01647516|468689828|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199966|NCT01647516|468689829|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
130199967|NCT01647516|468689830|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
130199968|NCT01647516|468689831|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
130199969|NCT01647516|468689826|FG000|Open-Label Period|No completion / discontinuation visit|0|||
130199970|NCT01647516|468689827|FG001|Open-Label Period|No completion / discontinuation visit|0|||
130199971|NCT01647516|468689828|FG002|Open-Label Period|No completion / discontinuation visit|0|||
130199972|NCT01647516|468689829|FG003|Open-Label Period|No completion / discontinuation visit|0|||
130199973|NCT01647516|468689830|FG004|Open-Label Period|No completion / discontinuation visit|2|||
130199974|NCT01647516|468689831|FG005|Open-Label Period|No completion / discontinuation visit|1|||
130199975|NCT03193801|468689832|FG000|Overall Study|Physician Decision|2|||
130199976|NCT03193801|468689832|FG000|Overall Study|Withdrawal by Subject|1|||
130199977|NCT04964544|468689835|FG000|Overall Study|Screen failure or other uncategorised|10|||
130199978|NCT04964544|468689835|FG000|Overall Study|Physician Decision|4|||
130199979|NCT04964544|468689835|FG000|Overall Study|Lost to Follow-up|9|||
130199980|NCT04964544|468689835|FG000|Overall Study|Withdrawal by Subject|18|||
130199981|NCT04964544|468689835|FG000|Overall Study|Death|1|||
130199982|NCT01613222|468689836|FG000|Overall Study|Physician Decision|1|||
130199983|NCT01613222|468689836|FG000|Overall Study|Unable to place arterial line|1|||
130199984|NCT01613222|468689836|FG000|Overall Study|Reused disposable sensors|10|||
130199985|NCT03696108|468689837|FG000|Overall Study|Physician Decision|1|||
130199986|NCT03696108|468689838|FG001|Overall Study|Physician Decision|0|||
130199987|NCT03696108|468689837|FG000|Overall Study|Withdrawal by Subject|3|||
130199988|NCT03696108|468689838|FG001|Overall Study|Withdrawal by Subject|6|||
130199989|NCT03505593|468689839|FG000|Overall Study|Withdrawal by Subject|1|||
130199990|NCT03505593|468689839|FG000|Overall Study|Died before procedure|1|||
130199991|NCT03505593|468689839|FG000|Overall Study|Anatomical abnormality|1|||
130199992|NCT03505593|468689839|FG000|Overall Study|Unable to pass through esophagus|1|||
130199993|NCT03505593|468689839|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
130199994|NCT01899742|468689840|FG000|Overall Study|Adverse Event|5|||
130199995|NCT01899742|468689841|FG001|Overall Study|Adverse Event|4|||
130199996|NCT01899742|468689840|FG000|Overall Study|Lack of Efficacy|1|||
130199997|NCT01899742|468689841|FG001|Overall Study|Lack of Efficacy|5|||
130199998|NCT01899742|468689840|FG000|Overall Study|Protocol Violation|2|||
130199999|NCT01899742|468689841|FG001|Overall Study|Protocol Violation|2|||
130200000|NCT01899742|468689840|FG000|Overall Study|Withdrawal by Subject|9|||
130200001|NCT01899742|468689841|FG001|Overall Study|Withdrawal by Subject|5|||
130200002|NCT00089778|468689842|FG000|Overall Study|Protocol Violation|0|||
130200003|NCT00089778|468689843|FG001|Overall Study|Protocol Violation|0|||
130200004|NCT00089778|468689844|FG002|Overall Study|Protocol Violation|1|||
130200005|NCT01154088|468689847|FG000|Overall Study|Lost to Follow-up|4|||
130200006|NCT01154088|468689848|FG001|Overall Study|Lost to Follow-up|6|||
130200007|NCT01154088|468689849|FG002|Overall Study|Lost to Follow-up|7|||
130200008|NCT01104246|468689850|FG000|Overall Study|Withdrawal by Subject|1|||
130200009|NCT01104246|468689850|FG000|Overall Study|did not meet inclusion criteria|4|||
130200010|NCT01475851|468689851|FG000|Overall Study|Protocol defined stopping criteria|1|||
130200011|NCT01475851|468689852|FG001|Overall Study|Protocol defined stopping criteria|0|||
130200012|NCT01867294|468689855|FG000|Overall Study|Withdrawal by Subject|1|||
130200013|NCT01867294|468689856|FG001|Overall Study|Withdrawal by Subject|1|||
130200014|NCT01867294|468689857|FG002|Overall Study|Withdrawal by Subject|0|||
130200015|NCT01867294|468689858|FG003|Overall Study|Withdrawal by Subject|0|||
130200016|NCT02447497|468689859|FG000|Overall Study|Did not meet treatment day baseline.|6|||
130200017|NCT02447497|468689860|FG001|Overall Study|Did not meet treatment day baseline.|5|||
130200018|NCT02447497|468689861|FG002|Overall Study|Did not meet treatment day baseline.|2|||
130200019|NCT02447497|468689862|FG003|Overall Study|Did not meet treatment day baseline.|2|||
130200020|NCT02447497|468689859|FG000|Overall Study|Dressing was compromised|0|||
130200021|NCT02447497|468689860|FG001|Overall Study|Dressing was compromised|1|||
130200022|NCT02447497|468689861|FG002|Overall Study|Dressing was compromised|0|||
130200023|NCT02447497|468689862|FG003|Overall Study|Dressing was compromised|0|||
130200024|NCT02017912|468689863|FG000|Overall Study|Withdrawal by Subject|2|||
130200025|NCT02017912|468689864|FG001|Overall Study|Withdrawal by Subject|1|||
130200026|NCT02017912|468689863|FG000|Overall Study|miscellaneous|1|||
130200027|NCT02017912|468689864|FG001|Overall Study|miscellaneous|1|||
130200028|NCT01322035|468689865|FG000|Overall Study|Lost to Follow-up|8|||
130200029|NCT01322035|468689866|FG001|Overall Study|Lost to Follow-up|3|||
130200030|NCT02496091|468689870|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130200031|NCT02272842|468689871|FG000|Overall Study|Lost to Follow-up|8|||
130200032|NCT02272842|468689872|FG001|Overall Study|Lost to Follow-up|8|||
130200033|NCT02272842|468689871|FG000|Overall Study|Withdrawal by Subject|8|||
130200034|NCT02272842|468689872|FG001|Overall Study|Withdrawal by Subject|2|||
130200035|NCT02396420|468689875|FG000|Overall Study|Death|1|||
130200036|NCT05033262|468689876|FG000|Overall Study|Lost to Follow-up|1|||
130200037|NCT05033262|468689877|FG001|Overall Study|Lost to Follow-up|0|||
130200038|NCT05033262|468689878|FG002|Overall Study|Lost to Follow-up|0|||
130200039|NCT05033262|468689879|FG003|Overall Study|Lost to Follow-up|1|||
130200040|NCT01273623|468689882|FG000|Overall Study|did not meet IVUS criteria|29|||
130200041|NCT01493284|468689885|FG000|Overall Study|Death|29|||
130200042|NCT01493284|468689885|FG000|Overall Study|Withdrawal by Subject|32|||
130200043|NCT00325156|468689886|FG000|Overall Study|Protocol Violation|8|||
130200044|NCT00325156|468689886|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
130200045|NCT00325156|468689886|FG000|Overall Study|Migrated/moved from study area|12|||
130200046|NCT00325156|468689886|FG000|Overall Study|Adverse event, non-fatal|3|||
130200047|NCT00325156|468689886|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
130200048|NCT00325156|468689886|FG000|Overall Study|Other|1|||
130200049|NCT00325156|468689886|FG000|Overall Study|Withdrawal by Subject|31|||
130200050|NCT00519428|468689887|FG000|Overall Study|Adverse Event|5|||
130200051|NCT00519428|468689888|FG001|Overall Study|Adverse Event|2|||
130200052|NCT00519428|468689889|FG002|Overall Study|Adverse Event|10|||
130200053|NCT00519428|468689887|FG000|Overall Study|Lost to Follow-up|7|||
130200054|NCT00519428|468689888|FG001|Overall Study|Lost to Follow-up|7|||
130200055|NCT00519428|468689889|FG002|Overall Study|Lost to Follow-up|6|||
130200056|NCT00519428|468689887|FG000|Overall Study|Withdrawal by Subject|8|||
130200057|NCT00519428|468689888|FG001|Overall Study|Withdrawal by Subject|3|||
130200058|NCT00519428|468689889|FG002|Overall Study|Withdrawal by Subject|7|||
130200059|NCT00519428|468689887|FG000|Overall Study|unstated|1|||
130200060|NCT00519428|468689888|FG001|Overall Study|unstated|3|||
130200061|NCT00519428|468689889|FG002|Overall Study|unstated|2|||
130200062|NCT04064411|468689890|FG000|Overall Study|Adverse Event|29|||
130200063|NCT04064411|468689891|FG001|Overall Study|Adverse Event|19|||
130200064|NCT04064411|468689890|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
130200065|NCT04064411|468689891|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
130200066|NCT04064411|468689890|FG000|Overall Study|Protocol Deviation|0|||
130200067|NCT04064411|468689891|FG001|Overall Study|Protocol Deviation|2|||
130200068|NCT04064411|468689890|FG000|Overall Study|Withdrawal by Subject|25|||
130200069|NCT04064411|468689891|FG001|Overall Study|Withdrawal by Subject|29|||
130200070|NCT04064411|468689890|FG000|Overall Study|Lost to Follow-up|5|||
130200071|NCT04064411|468689891|FG001|Overall Study|Lost to Follow-up|2|||
130200072|NCT04064411|468689890|FG000|Overall Study|Other than Specified|4|||
130200073|NCT04064411|468689891|FG001|Overall Study|Other than Specified|1|||
130200074|NCT04064411|468689890|FG000|Overall Study|Death|1|||
130200075|NCT04064411|468689891|FG001|Overall Study|Death|0|||
130200076|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
130200077|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130200078|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130200079|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200080|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200081|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200082|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200083|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200084|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
130200085|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
130200086|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200087|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200088|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200089|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200090|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130200091|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130200092|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200093|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200094|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200095|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200096|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200097|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200098|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
130200099|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200100|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200101|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200102|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200103|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200104|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130200105|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200106|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130200107|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200108|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200109|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200110|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200111|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
130200112|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
130200113|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
130200114|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
130200115|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
130200116|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
130200117|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
130200118|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
130200119|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
130200120|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
130200121|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
130200122|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
130200123|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
130200124|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
130200125|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200126|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200127|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200128|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130200129|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
130200130|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
130200131|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130200132|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200133|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200134|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200135|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200136|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
130200137|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200138|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200139|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200140|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200141|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200142|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130200143|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
130200144|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130200145|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
130200146|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200147|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200148|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200149|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130200150|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200151|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130200152|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200153|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200154|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200155|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200156|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
130200157|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
130200158|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
130200159|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
130200160|NCT03053063|468689904|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
130200161|NCT03053063|468689905|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
130200162|NCT03053063|468689906|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
130200163|NCT03053063|468689907|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
130200164|NCT03053063|468689904|FG000|Randomized Phase|Withdrew consent|8|||
130200165|NCT03053063|468689905|FG001|Randomized Phase|Withdrew consent|11|||
130200166|NCT03053063|468689906|FG002|Randomized Phase|Withdrew consent|5|||
130200167|NCT03053063|468689907|FG003|Randomized Phase|Withdrew consent|0|||
130200168|NCT03053063|468689904|FG000|Randomized Phase|Investigator's Discretion|8|||
130200169|NCT03053063|468689905|FG001|Randomized Phase|Investigator's Discretion|6|||
130200170|NCT03053063|468689906|FG002|Randomized Phase|Investigator's Discretion|2|||
130200171|NCT03053063|468689907|FG003|Randomized Phase|Investigator's Discretion|0|||
130200172|NCT03053063|468689904|FG000|Randomized Phase|Lost to Follow-up|3|||
130200173|NCT03053063|468689905|FG001|Randomized Phase|Lost to Follow-up|5|||
130200174|NCT03053063|468689906|FG002|Randomized Phase|Lost to Follow-up|1|||
130200175|NCT03053063|468689907|FG003|Randomized Phase|Lost to Follow-up|0|||
130200176|NCT03053063|468689904|FG000|Randomized Phase|Adverse Event|0|||
130200177|NCT03053063|468689905|FG001|Randomized Phase|Adverse Event|1|||
130200178|NCT03053063|468689906|FG002|Randomized Phase|Adverse Event|0|||
130200179|NCT03053063|468689907|FG003|Randomized Phase|Adverse Event|0|||
130200180|NCT03053063|468689904|FG000|Randomized Phase|Randomized but Never Treated|1|||
130200181|NCT03053063|468689905|FG001|Randomized Phase|Randomized but Never Treated|3|||
130200182|NCT03053063|468689906|FG002|Randomized Phase|Randomized but Never Treated|2|||
130200183|NCT03053063|468689907|FG003|Randomized Phase|Randomized but Never Treated|0|||
130200184|NCT03053063|468689904|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
130200185|NCT03053063|468689905|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
130200186|NCT03053063|468689906|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
130200187|NCT03053063|468689907|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
130200188|NCT03053063|468689904|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
130200189|NCT03053063|468689905|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
130200190|NCT03053063|468689906|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
130200191|NCT03053063|468689907|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
130200192|NCT03053063|468689904|FG000|Open-Label Phase|Death|0|||
130200193|NCT03053063|468689905|FG001|Open-Label Phase|Death|0|||
130200194|NCT03053063|468689906|FG002|Open-Label Phase|Death|0|||
130200195|NCT03053063|468689907|FG003|Open-Label Phase|Death|2|||
130200196|NCT03053063|468689904|FG000|Open-Label Phase|Investigator's discretion|0|||
130200197|NCT03053063|468689905|FG001|Open-Label Phase|Investigator's discretion|0|||
130200198|NCT03053063|468689906|FG002|Open-Label Phase|Investigator's discretion|0|||
130200199|NCT03053063|468689907|FG003|Open-Label Phase|Investigator's discretion|2|||
130200200|NCT01970475|468689909|FG000|Overall Study|Withdrawal by Subject|11|||
130200201|NCT01970475|468689910|FG001|Overall Study|Withdrawal by Subject|6|||
130200202|NCT01970475|468689909|FG000|Overall Study|Adverse Event|7|||
130200203|NCT01970475|468689910|FG001|Overall Study|Adverse Event|3|||
130200204|NCT01970475|468689909|FG000|Overall Study|Lost to Follow-up|2|||
130200205|NCT01970475|468689910|FG001|Overall Study|Lost to Follow-up|2|||
130200206|NCT01970475|468689909|FG000|Overall Study|Protocol Violation|1|||
130200207|NCT01970475|468689910|FG001|Overall Study|Protocol Violation|0|||
130200208|NCT01397786|468692709|FG000|Phase A|Lost to Follow-up|0|||
130200209|NCT01397786|468692710|FG001|Phase A|Lost to Follow-up|0|||
130200210|NCT01397786|468692711|FG002|Phase A|Lost to Follow-up|6|||
130200211|NCT01397786|468692709|FG000|Phase A|Adverse Event|0|||
130200212|NCT01397786|468692710|FG001|Phase A|Adverse Event|0|||
130200213|NCT01397786|468692711|FG002|Phase A|Adverse Event|8|||
130200214|NCT01397786|468692709|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
130200215|NCT01397786|468692710|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
130200216|NCT01397786|468692711|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
130200217|NCT01397786|468692709|FG000|Phase A|Physician Decision|0|||
130200218|NCT01397786|468692710|FG001|Phase A|Physician Decision|0|||
130200219|NCT01397786|468692711|FG002|Phase A|Physician Decision|1|||
130200220|NCT01397786|468692709|FG000|Phase A|Withdrawal by Subject|0|||
130200221|NCT01397786|468692710|FG001|Phase A|Withdrawal by Subject|0|||
130200222|NCT01397786|468692711|FG002|Phase A|Withdrawal by Subject|5|||
130200223|NCT01397786|468692709|FG000|Phase A|Lack of Efficacy|0|||
130200224|NCT01397786|468692710|FG001|Phase A|Lack of Efficacy|0|||
130200225|NCT01397786|468692711|FG002|Phase A|Lack of Efficacy|1|||
130200226|NCT01397786|468692709|FG000|Phase B|Lost to Follow-up|22|||
130200227|NCT01397786|468692710|FG001|Phase B|Lost to Follow-up|12|||
130200228|NCT01397786|468692711|FG002|Phase B|Lost to Follow-up|22|||
130200229|NCT01397786|468692709|FG000|Phase B|Adverse Event|109|||
130200230|NCT01397786|468692710|FG001|Phase B|Adverse Event|23|||
130200231|NCT01397786|468692711|FG002|Phase B|Adverse Event|27|||
130200232|NCT01397786|468692709|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
130200233|NCT01397786|468692710|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
130200234|NCT01397786|468692711|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
130200235|NCT01397786|468692709|FG000|Phase B|Physician Decision|9|||
130200236|NCT01397786|468692710|FG001|Phase B|Physician Decision|1|||
130200237|NCT01397786|468692711|FG002|Phase B|Physician Decision|3|||
130200238|NCT01397786|468692709|FG000|Phase B|Withdrawal by Subject|102|||
130200239|NCT01397786|468692710|FG001|Phase B|Withdrawal by Subject|45|||
130200240|NCT01397786|468692711|FG002|Phase B|Withdrawal by Subject|30|||
130200241|NCT01397786|468692709|FG000|Phase B|Protocol Deviation|1|||
130200242|NCT01397786|468692710|FG001|Phase B|Protocol Deviation|2|||
130200243|NCT01397786|468692711|FG002|Phase B|Protocol Deviation|4|||
130200244|NCT01397786|468692709|FG000|Phase B|Lack of Efficacy|22|||
130200245|NCT01397786|468692710|FG001|Phase B|Lack of Efficacy|7|||
130200246|NCT01397786|468692711|FG002|Phase B|Lack of Efficacy|14|||
130200247|NCT03339726|468692714|FG000|Overall Study|Withdrawal by Subject|1|||
130200248|NCT03339726|468692715|FG001|Overall Study|Withdrawal by Subject|0|||
130200249|NCT03339726|468692716|FG002|Overall Study|Withdrawal by Subject|0|||
130200250|NCT03339726|468692714|FG000|Overall Study|Lost to Follow-up|0|||
130200251|NCT03339726|468692715|FG001|Overall Study|Lost to Follow-up|1|||
130200252|NCT03339726|468692716|FG002|Overall Study|Lost to Follow-up|0|||
130200253|NCT01275755|468692717|FG000|Double-blind Treatment Period|Adverse Event|0|||
130200254|NCT01275755|468692718|FG001|Double-blind Treatment Period|Adverse Event|2|||
130200255|NCT01275755|468692717|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130200256|NCT01275755|468692718|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130200257|NCT01275755|468692717|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130200258|NCT01275755|468692718|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130200259|NCT01275755|468692717|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
130200260|NCT01275755|468692718|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
130200261|NCT00636194|468692725|FG000|Overall Study|Study related symptoms and complaints|1|||
130200262|NCT00636194|468692726|FG001|Overall Study|Study related symptoms and complaints|0|||
130200263|NCT00636194|468692725|FG000|Overall Study|Protocol Violation|2|||
130200264|NCT00636194|468692726|FG001|Overall Study|Protocol Violation|0|||
130200265|NCT03962790|468692730|FG000|Period 1|Adverse Event|0|||
130200266|NCT03962790|468692731|FG001|Period 1|Adverse Event|1|||
130200267|NCT03962790|468692730|FG000|Period 1|Failed to meet all eligibility criteria|1|||
130200268|NCT03962790|468692731|FG001|Period 1|Failed to meet all eligibility criteria|1|||
130200269|NCT03962790|468692730|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
130200270|NCT03962790|468692731|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130200271|NCT03962790|468692730|FG000|Period 1|Withdrawal by Subject|1|||
130200272|NCT03962790|468692731|FG001|Period 1|Withdrawal by Subject|0|||
130200273|NCT00381238|468692734|FG000|Overall Study|Adverse Event|3|||
130200274|NCT00381238|468692734|FG000|Overall Study|Protocol Violation|1|||
130200275|NCT00381238|468692734|FG000|Overall Study|Withdrawal by Subject|4|||
130200276|NCT00381238|468692734|FG000|Overall Study|Lack of Efficacy|2|||
130200277|NCT00381238|468692734|FG000|Overall Study|Withdrew by physician|1|||
130200278|NCT00381238|468692734|FG000|Overall Study|Disease progression|1|||
130200279|NCT02086448|468692737|FG000|Overall Study|Withdrawal by Subject|1|||
130200280|NCT02086448|468692738|FG001|Overall Study|Withdrawal by Subject|0|||
130200281|NCT02086448|468692739|FG002|Overall Study|Withdrawal by Subject|0|||
130200282|NCT02086448|468692740|FG003|Overall Study|Withdrawal by Subject|2|||
130200283|NCT03535194|468692743|FG000|Induction Period|Adverse Event|2|||
130200284|NCT03535194|468692744|FG001|Induction Period|Adverse Event|2|||
130200285|NCT03535194|468692745|FG002|Induction Period|Adverse Event|1|||
130200286|NCT03535194|468692746|FG003|Induction Period|Adverse Event|3|||
130200287|NCT03535194|468692747|FG004|Induction Period|Adverse Event|0|||
130200288|NCT03535194|468692743|FG000|Induction Period|Death|0|||
130200289|NCT03535194|468692744|FG001|Induction Period|Death|1|||
130200290|NCT03535194|468692745|FG002|Induction Period|Death|0|||
130200291|NCT03535194|468692746|FG003|Induction Period|Death|0|||
130200292|NCT03535194|468692747|FG004|Induction Period|Death|0|||
130200293|NCT03535194|468692743|FG000|Induction Period|Lack of Efficacy|1|||
130200294|NCT03535194|468692744|FG001|Induction Period|Lack of Efficacy|3|||
130200295|NCT03535194|468692745|FG002|Induction Period|Lack of Efficacy|2|||
130200296|NCT03535194|468692746|FG003|Induction Period|Lack of Efficacy|2|||
130200297|NCT03535194|468692747|FG004|Induction Period|Lack of Efficacy|0|||
130200298|NCT03535194|468692743|FG000|Induction Period|Lost to Follow-up|3|||
130200299|NCT03535194|468692744|FG001|Induction Period|Lost to Follow-up|5|||
130200300|NCT03535194|468692745|FG002|Induction Period|Lost to Follow-up|2|||
130200301|NCT03535194|468692746|FG003|Induction Period|Lost to Follow-up|3|||
130200302|NCT03535194|468692747|FG004|Induction Period|Lost to Follow-up|0|||
130200303|NCT03535194|468692743|FG000|Induction Period|Physician Decision|1|||
130200304|NCT03535194|468692744|FG001|Induction Period|Physician Decision|1|||
130200305|NCT03535194|468692745|FG002|Induction Period|Physician Decision|0|||
130200306|NCT03535194|468692746|FG003|Induction Period|Physician Decision|0|||
130200307|NCT03535194|468692747|FG004|Induction Period|Physician Decision|0|||
130200308|NCT03535194|468692743|FG000|Induction Period|Protocol Violation|1|||
130200309|NCT03535194|468692744|FG001|Induction Period|Protocol Violation|0|||
130200310|NCT03535194|468692745|FG002|Induction Period|Protocol Violation|0|||
130200311|NCT03535194|468692746|FG003|Induction Period|Protocol Violation|1|||
130200312|NCT03535194|468692747|FG004|Induction Period|Protocol Violation|0|||
130200313|NCT03535194|468692743|FG000|Induction Period|Screen Failure|0|||
130200314|NCT03535194|468692744|FG001|Induction Period|Screen Failure|1|||
130200315|NCT03535194|468692745|FG002|Induction Period|Screen Failure|0|||
130200316|NCT03535194|468692746|FG003|Induction Period|Screen Failure|0|||
130200317|NCT03535194|468692747|FG004|Induction Period|Screen Failure|0|||
130200318|NCT03535194|468692743|FG000|Induction Period|Withdrawal by Subject|3|||
130200319|NCT03535194|468692744|FG001|Induction Period|Withdrawal by Subject|4|||
130200320|NCT03535194|468692745|FG002|Induction Period|Withdrawal by Subject|3|||
130200321|NCT03535194|468692746|FG003|Induction Period|Withdrawal by Subject|2|||
130200322|NCT03535194|468692747|FG004|Induction Period|Withdrawal by Subject|0|||
130200323|NCT03535194|468692743|FG000|Maintenance Period|Adverse Event|6|||
130200324|NCT03535194|468692744|FG001|Maintenance Period|Adverse Event|5|||
130200325|NCT03535194|468692745|FG002|Maintenance Period|Adverse Event|1|||
130200326|NCT03535194|468692746|FG003|Maintenance Period|Adverse Event|11|||
130200327|NCT03535194|468692747|FG004|Maintenance Period|Adverse Event|4|||
130200328|NCT03535194|468692743|FG000|Maintenance Period|Lack of Efficacy|3|||
130200329|NCT03535194|468692744|FG001|Maintenance Period|Lack of Efficacy|2|||
130200330|NCT03535194|468692745|FG002|Maintenance Period|Lack of Efficacy|5|||
130200331|NCT03535194|468692746|FG003|Maintenance Period|Lack of Efficacy|9|||
130200332|NCT03535194|468692747|FG004|Maintenance Period|Lack of Efficacy|0|||
130200333|NCT03535194|468692743|FG000|Maintenance Period|Lost to Follow-up|4|||
130200334|NCT03535194|468692744|FG001|Maintenance Period|Lost to Follow-up|2|||
130200335|NCT03535194|468692745|FG002|Maintenance Period|Lost to Follow-up|1|||
130200336|NCT03535194|468692746|FG003|Maintenance Period|Lost to Follow-up|5|||
130200337|NCT03535194|468692747|FG004|Maintenance Period|Lost to Follow-up|2|||
130200338|NCT03535194|468692743|FG000|Maintenance Period|Other|1|||
130200339|NCT03535194|468692744|FG001|Maintenance Period|Other|2|||
130200340|NCT03535194|468692745|FG002|Maintenance Period|Other|0|||
130200341|NCT03535194|468692746|FG003|Maintenance Period|Other|0|||
130200342|NCT03535194|468692747|FG004|Maintenance Period|Other|0|||
130200343|NCT03535194|468692743|FG000|Maintenance Period|Physician Decision|1|||
130200344|NCT03535194|468692744|FG001|Maintenance Period|Physician Decision|2|||
130200345|NCT03535194|468692745|FG002|Maintenance Period|Physician Decision|0|||
130200346|NCT03535194|468692746|FG003|Maintenance Period|Physician Decision|2|||
130200347|NCT03535194|468692747|FG004|Maintenance Period|Physician Decision|0|||
130200348|NCT03535194|468692743|FG000|Maintenance Period|Pregnancy|0|||
130200349|NCT03535194|468692744|FG001|Maintenance Period|Pregnancy|0|||
130200350|NCT03535194|468692745|FG002|Maintenance Period|Pregnancy|0|||
130200351|NCT03535194|468692746|FG003|Maintenance Period|Pregnancy|2|||
130200352|NCT03535194|468692747|FG004|Maintenance Period|Pregnancy|0|||
130200353|NCT03535194|468692743|FG000|Maintenance Period|Protocol Violation|0|||
130200354|NCT03535194|468692744|FG001|Maintenance Period|Protocol Violation|1|||
130200355|NCT03535194|468692745|FG002|Maintenance Period|Protocol Violation|0|||
130200356|NCT03535194|468692746|FG003|Maintenance Period|Protocol Violation|0|||
130200357|NCT03535194|468692747|FG004|Maintenance Period|Protocol Violation|0|||
130200358|NCT03535194|468692743|FG000|Maintenance Period|Withdrawal by Subject|7|||
130200359|NCT03535194|468692744|FG001|Maintenance Period|Withdrawal by Subject|2|||
130200360|NCT03535194|468692745|FG002|Maintenance Period|Withdrawal by Subject|1|||
130200361|NCT03535194|468692746|FG003|Maintenance Period|Withdrawal by Subject|8|||
130200362|NCT03535194|468692747|FG004|Maintenance Period|Withdrawal by Subject|0|||
130200363|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Adverse Event|4|||
130200364|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Adverse Event|5|||
130200365|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Adverse Event|1|||
130200366|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Adverse Event|8|||
130200367|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130200368|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
130200369|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
130200370|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
130200371|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
130200372|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
130200373|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200374|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200375|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200376|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130200377|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130200378|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Other|1|||
130200379|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Other|0|||
130200380|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Other|0|||
130200381|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Other|5|||
130200382|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Other|0|||
130200383|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Physician Decision|0|||
130200384|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Physician Decision|2|||
130200385|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Physician Decision|1|||
130200386|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Physician Decision|1|||
130200387|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Physician Decision|0|||
130200388|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130200389|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130200390|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130200391|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
130200392|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130200393|NCT02682823|468692750|FG000|Overall Study|Withdrawal by Subject|0|||
130200394|NCT02682823|468692751|FG001|Overall Study|Withdrawal by Subject|0|||
130200395|NCT02682823|468692752|FG002|Overall Study|Withdrawal by Subject|1|||
130200396|NCT02682823|468692753|FG003|Overall Study|Withdrawal by Subject|0|||
130200397|NCT02682823|468692754|FG004|Overall Study|Withdrawal by Subject|1|||
130200398|NCT02682823|468692750|FG000|Overall Study|Protocol Deviation|0|||
130200399|NCT02682823|468692751|FG001|Overall Study|Protocol Deviation|1|||
130200400|NCT02682823|468692752|FG002|Overall Study|Protocol Deviation|0|||
130200401|NCT02682823|468692753|FG003|Overall Study|Protocol Deviation|0|||
130200402|NCT02682823|468692754|FG004|Overall Study|Protocol Deviation|0|||
130200403|NCT02682823|468692750|FG000|Overall Study|Adverse Event|0|||
130200404|NCT02682823|468692751|FG001|Overall Study|Adverse Event|0|||
130200405|NCT02682823|468692752|FG002|Overall Study|Adverse Event|0|||
130200406|NCT02682823|468692753|FG003|Overall Study|Adverse Event|1|||
130200407|NCT02682823|468692754|FG004|Overall Study|Adverse Event|0|||
130200408|NCT01938430|468692755|FG000|Overall Study|Randomized but Not Treated|0|||
130200409|NCT01938430|468692756|FG001|Overall Study|Randomized but Not Treated|0|||
130200410|NCT01938430|468692757|FG002|Overall Study|Randomized but Not Treated|0|||
130200411|NCT01938430|468692758|FG003|Overall Study|Randomized but Not Treated|0|||
130200412|NCT01938430|468692759|FG004|Overall Study|Randomized but Not Treated|0|||
130200413|NCT01938430|468692760|FG005|Overall Study|Randomized but Not Treated|0|||
130200414|NCT01938430|468692761|FG006|Overall Study|Randomized but Not Treated|0|||
130200415|NCT01938430|468692762|FG007|Overall Study|Randomized but Not Treated|0|||
130200416|NCT01938430|468692763|FG008|Overall Study|Randomized but Not Treated|0|||
130200417|NCT01938430|468692764|FG009|Overall Study|Randomized but Not Treated|0|||
130200418|NCT01938430|468692765|FG010|Overall Study|Randomized but Not Treated|1|||
130200419|NCT01938430|468692766|FG011|Overall Study|Randomized but Not Treated|0|||
130200420|NCT01938430|468692767|FG012|Overall Study|Randomized but Not Treated|0|||
130200421|NCT01938430|468692768|FG013|Overall Study|Randomized but Not Treated|1|||
130200422|NCT01938430|468692755|FG000|Overall Study|Adverse Event|0|||
130200423|NCT01938430|468692756|FG001|Overall Study|Adverse Event|0|||
130200424|NCT01938430|468692757|FG002|Overall Study|Adverse Event|0|||
130200425|NCT01938430|468692758|FG003|Overall Study|Adverse Event|0|||
130200426|NCT01938430|468692759|FG004|Overall Study|Adverse Event|0|||
130200427|NCT01938430|468692760|FG005|Overall Study|Adverse Event|0|||
130200428|NCT01938430|468692761|FG006|Overall Study|Adverse Event|1|||
130200429|NCT01938430|468692762|FG007|Overall Study|Adverse Event|0|||
130200430|NCT01938430|468692763|FG008|Overall Study|Adverse Event|0|||
130200431|NCT01938430|468692764|FG009|Overall Study|Adverse Event|0|||
130200432|NCT01938430|468692765|FG010|Overall Study|Adverse Event|0|||
130200433|NCT01938430|468692766|FG011|Overall Study|Adverse Event|0|||
130200434|NCT01938430|468692767|FG012|Overall Study|Adverse Event|0|||
130200435|NCT01938430|468692768|FG013|Overall Study|Adverse Event|0|||
130200436|NCT01938430|468692755|FG000|Overall Study|Death|1|||
130200437|NCT01938430|468692756|FG001|Overall Study|Death|2|||
130200438|NCT01938430|468692757|FG002|Overall Study|Death|2|||
130200439|NCT01938430|468692758|FG003|Overall Study|Death|1|||
130200440|NCT01938430|468692759|FG004|Overall Study|Death|0|||
130200441|NCT01938430|468692760|FG005|Overall Study|Death|0|||
130200442|NCT01938430|468692761|FG006|Overall Study|Death|1|||
130200443|NCT01938430|468692762|FG007|Overall Study|Death|1|||
130200444|NCT01938430|468692763|FG008|Overall Study|Death|2|||
130200445|NCT01938430|468692764|FG009|Overall Study|Death|3|||
130200446|NCT01938430|468692765|FG010|Overall Study|Death|0|||
130200447|NCT01938430|468692766|FG011|Overall Study|Death|0|||
130200448|NCT01938430|468692767|FG012|Overall Study|Death|0|||
130200449|NCT01938430|468692768|FG013|Overall Study|Death|0|||
130200450|NCT01938430|468692755|FG000|Overall Study|Investigator's Discretion|0|||
130200451|NCT01938430|468692756|FG001|Overall Study|Investigator's Discretion|0|||
130200452|NCT01938430|468692757|FG002|Overall Study|Investigator's Discretion|1|||
130200453|NCT01938430|468692758|FG003|Overall Study|Investigator's Discretion|0|||
130200454|NCT01938430|468692759|FG004|Overall Study|Investigator's Discretion|0|||
130200455|NCT01938430|468692760|FG005|Overall Study|Investigator's Discretion|0|||
130200456|NCT01938430|468692761|FG006|Overall Study|Investigator's Discretion|0|||
130200457|NCT01938430|468692762|FG007|Overall Study|Investigator's Discretion|0|||
130200458|NCT01938430|468692763|FG008|Overall Study|Investigator's Discretion|0|||
130200459|NCT01938430|468692764|FG009|Overall Study|Investigator's Discretion|0|||
130200460|NCT01938430|468692765|FG010|Overall Study|Investigator's Discretion|0|||
130200461|NCT01938430|468692766|FG011|Overall Study|Investigator's Discretion|0|||
130200462|NCT01938430|468692767|FG012|Overall Study|Investigator's Discretion|0|||
130200463|NCT01938430|468692768|FG013|Overall Study|Investigator's Discretion|0|||
130200464|NCT01938430|468692755|FG000|Overall Study|Lack of Efficacy|3|||
130200465|NCT01938430|468692756|FG001|Overall Study|Lack of Efficacy|1|||
130200466|NCT01938430|468692757|FG002|Overall Study|Lack of Efficacy|1|||
130200467|NCT01938430|468692758|FG003|Overall Study|Lack of Efficacy|1|||
130200468|NCT01938430|468692759|FG004|Overall Study|Lack of Efficacy|0|||
130200469|NCT01938430|468692760|FG005|Overall Study|Lack of Efficacy|0|||
130200470|NCT01938430|468692761|FG006|Overall Study|Lack of Efficacy|0|||
130200471|NCT01938430|468692762|FG007|Overall Study|Lack of Efficacy|0|||
130200472|NCT01938430|468692763|FG008|Overall Study|Lack of Efficacy|1|||
130200473|NCT01938430|468692764|FG009|Overall Study|Lack of Efficacy|0|||
130200474|NCT01938430|468692765|FG010|Overall Study|Lack of Efficacy|2|||
130200475|NCT01938430|468692766|FG011|Overall Study|Lack of Efficacy|1|||
130200476|NCT01938430|468692767|FG012|Overall Study|Lack of Efficacy|0|||
130200477|NCT01938430|468692768|FG013|Overall Study|Lack of Efficacy|0|||
130200478|NCT01938430|468692755|FG000|Overall Study|Lost to Follow-up|0|||
130200479|NCT01938430|468692756|FG001|Overall Study|Lost to Follow-up|0|||
130200480|NCT01938430|468692757|FG002|Overall Study|Lost to Follow-up|1|||
130200481|NCT01938430|468692758|FG003|Overall Study|Lost to Follow-up|0|||
130200482|NCT01938430|468692759|FG004|Overall Study|Lost to Follow-up|0|||
130200483|NCT01938430|468692760|FG005|Overall Study|Lost to Follow-up|1|||
130200484|NCT01938430|468692761|FG006|Overall Study|Lost to Follow-up|0|||
130200485|NCT01938430|468692762|FG007|Overall Study|Lost to Follow-up|0|||
130200486|NCT01938430|468692763|FG008|Overall Study|Lost to Follow-up|0|||
130200487|NCT01938430|468692764|FG009|Overall Study|Lost to Follow-up|0|||
130200488|NCT01938430|468692765|FG010|Overall Study|Lost to Follow-up|0|||
130200489|NCT01938430|468692766|FG011|Overall Study|Lost to Follow-up|0|||
130200490|NCT01938430|468692767|FG012|Overall Study|Lost to Follow-up|0|||
130200491|NCT01938430|468692768|FG013|Overall Study|Lost to Follow-up|0|||
130200492|NCT01938430|468692755|FG000|Overall Study|Withdrew Consent|0|||
130200493|NCT01938430|468692756|FG001|Overall Study|Withdrew Consent|0|||
130200494|NCT01938430|468692757|FG002|Overall Study|Withdrew Consent|0|||
130200495|NCT01938430|468692758|FG003|Overall Study|Withdrew Consent|0|||
130200496|NCT01938430|468692759|FG004|Overall Study|Withdrew Consent|0|||
130200497|NCT01938430|468692760|FG005|Overall Study|Withdrew Consent|0|||
130200498|NCT01938430|468692761|FG006|Overall Study|Withdrew Consent|0|||
130200499|NCT01938430|468692762|FG007|Overall Study|Withdrew Consent|0|||
130200500|NCT01938430|468692763|FG008|Overall Study|Withdrew Consent|1|||
130200501|NCT01938430|468692764|FG009|Overall Study|Withdrew Consent|0|||
130200502|NCT01938430|468692765|FG010|Overall Study|Withdrew Consent|0|||
130200503|NCT01938430|468692766|FG011|Overall Study|Withdrew Consent|0|||
130200504|NCT01938430|468692767|FG012|Overall Study|Withdrew Consent|0|||
130200505|NCT01938430|468692768|FG013|Overall Study|Withdrew Consent|0|||
130200506|NCT02662764|468692776|FG000|Overall Study|Adverse Event|6|||
130200507|NCT02662764|468692776|FG000|Overall Study|Lack of Efficacy|8|||
130200508|NCT02662764|468692776|FG000|Overall Study|Protocol Violation|1|||
130200509|NCT02662764|468692776|FG000|Overall Study|Withdrawal by Subject|5|||
130200510|NCT02662764|468692776|FG000|Overall Study|Device failure|4|||
130200511|NCT02662764|468692776|FG000|Overall Study|Patient changed treatment|1|||
130200512|NCT02662764|468692776|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
130200513|NCT05178641|468692777|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
130200514|NCT05178641|468692778|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
130200515|NCT05178641|468692777|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
130200516|NCT05178641|468692778|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
130200517|NCT01869699|468692779|FG000|Overall Study|Withdrawal by Subject|1|||
130200518|NCT01869699|468692780|FG001|Overall Study|Withdrawal by Subject|0|||
130200519|NCT00732758|468692781|FG000|Overall Study|Lost to Follow-up|8|||
130200520|NCT00732758|468692782|FG001|Overall Study|Lost to Follow-up|16|||
130200521|NCT04240457|468692785|FG000|Overall Study|Lost to Follow-up|5|||
130200522|NCT04240457|468692786|FG001|Overall Study|Lost to Follow-up|1|||
130200523|NCT01508130|468692790|FG000|Overall Study|Adverse Event|81|||
130200524|NCT01508130|468692791|FG001|Overall Study|Adverse Event|28|||
130200525|NCT01508130|468692790|FG000|Overall Study|Death|3|||
130200526|NCT01508130|468692791|FG001|Overall Study|Death|1|||
130200527|NCT01508130|468692790|FG000|Overall Study|Protocol Violation|2|||
130200528|NCT01508130|468692791|FG001|Overall Study|Protocol Violation|0|||
130200529|NCT01508130|468692790|FG000|Overall Study|Lost to Follow-up|25|||
130200530|NCT01508130|468692791|FG001|Overall Study|Lost to Follow-up|2|||
130200531|NCT01508130|468692790|FG000|Overall Study|Withdrawal by Subject|3|||
130200532|NCT01508130|468692791|FG001|Overall Study|Withdrawal by Subject|3|||
130200533|NCT01508130|468692790|FG000|Overall Study|Subject's substantial non-compliance|25|||
130200534|NCT01508130|468692791|FG001|Overall Study|Subject's substantial non-compliance|9|||
130200535|NCT01508130|468692790|FG000|Overall Study|Insufficient therapeutic response|74|||
130200536|NCT01508130|468692791|FG001|Overall Study|Insufficient therapeutic response|23|||
130200537|NCT01508130|468692790|FG000|Overall Study|Administrative|14|||
130200538|NCT01508130|468692791|FG001|Overall Study|Administrative|3|||
130200539|NCT01680159|468692792|FG000|Screening Period|Not meet criteria for dose-up period|7|||
130200540|NCT01680159|468692792|FG000|Increased Dose Period|Adverse Event|6|||
130200541|NCT01680159|468692792|FG000|Increased Dose Period|Withdrawal by Subject|2|||
130200542|NCT01252563|468692798|FG000|Overall Study|Contract Deviation|41|||
130200543|NCT01252563|468692798|FG000|Overall Study|Centralized Registration Deviation|30|||
130200544|NCT01252563|468692798|FG000|Overall Study|Lost to Follow-up|161|||
130200545|NCT01252563|468692798|FG000|Overall Study|No visit after first day of treatment|194|||
130200546|NCT01252563|468692798|FG000|Overall Study|No drug administration|6|||
130200547|NCT03429244|468692799|FG000|Overall Study|Withdrawal by Subject|2|||
130200548|NCT03429244|468692800|FG001|Overall Study|Withdrawal by Subject|1|||
130200549|NCT03429244|468692801|FG002|Overall Study|Withdrawal by Subject|1|||
130200550|NCT03843632|468692809|FG000|Overall Study|Withdrawal by Subject|1|||
130200551|NCT03843632|468692810|FG001|Overall Study|Withdrawal by Subject|0|||
130200552|NCT03843632|468692811|FG002|Overall Study|Withdrawal by Subject|0|||
130200553|NCT03843632|468692812|FG003|Overall Study|Withdrawal by Subject|0|||
130200554|NCT01820572|468692813|FG000|Randomization|Not Treated|2|||
130200555|NCT01820572|468692814|FG001|Randomization|Not Treated|1|||
130200556|NCT01820572|468692813|FG000|Treatment Period|Adverse Event|12|||
130200557|NCT01820572|468692814|FG001|Treatment Period|Adverse Event|7|||
130200558|NCT01820572|468692813|FG000|Treatment Period|Death|3|||
130200559|NCT01820572|468692814|FG001|Treatment Period|Death|3|||
130200560|NCT01820572|468692813|FG000|Treatment Period|Lack of Efficacy|1|||
130200561|NCT01820572|468692814|FG001|Treatment Period|Lack of Efficacy|0|||
130200562|NCT01820572|468692813|FG000|Treatment Period|poor/non compliance|0|||
130200563|NCT01820572|468692814|FG001|Treatment Period|poor/non compliance|3|||
130200564|NCT01820572|468692813|FG000|Treatment Period|request to discontinue|6|||
130200565|NCT01820572|468692814|FG001|Treatment Period|request to discontinue|11|||
130200566|NCT01820572|468692813|FG000|Treatment Period|No longer meets study criteria|3|||
130200567|NCT01820572|468692814|FG001|Treatment Period|No longer meets study criteria|10|||
130200568|NCT01820572|468692813|FG000|Treatment Period|withdrew consent|1|||
130200569|NCT01820572|468692814|FG001|Treatment Period|withdrew consent|2|||
130200570|NCT05036668|468692815|FG000|Overall Study|lost to follow Up|0|||
130200571|NCT05036668|468692816|FG001|Overall Study|lost to follow Up|0|||
130200572|NCT05036668|468692817|FG002|Overall Study|lost to follow Up|1|||
130200573|NCT00658775|468692820|FG000|Overall Study|Adverse Event|4|||
130200574|NCT00658775|468692821|FG001|Overall Study|Adverse Event|6|||
130200575|NCT00658775|468692820|FG000|Overall Study|Lost to Follow-up|17|||
130200576|NCT00658775|468692821|FG001|Overall Study|Lost to Follow-up|18|||
130200577|NCT00658775|468692820|FG000|Overall Study|Withdrawal by Subject|6|||
130200578|NCT00658775|468692821|FG001|Overall Study|Withdrawal by Subject|4|||
130200579|NCT00658775|468692820|FG000|Overall Study|Withdrawal of consent|8|||
130200580|NCT00658775|468692821|FG001|Overall Study|Withdrawal of consent|7|||
130200581|NCT00658775|468692820|FG000|Overall Study|Other|7|||
130200582|NCT00658775|468692821|FG001|Overall Study|Other|8|||
130200583|NCT00387010|468692822|FG000|Dose Titration Period|Adverse Event|12|||
130200584|NCT00387010|468692822|FG000|Dose Titration Period|Lack of Efficacy|5|||
130200585|NCT00387010|468692822|FG000|Dose Titration Period|Withdrawal by Subject|3|||
130200586|NCT00387010|468692822|FG000|Dose Titration Period|Protocol Violation|1|||
130200587|NCT00387010|468692822|FG000|Dose Titration Period|Lost to Follow-up|2|||
130200588|NCT00387010|468692822|FG000|Dose Titration Period|Noncompliance with study medication|8|||
130200589|NCT00387010|468692822|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
130200590|NCT00387010|468692822|FG000|Treatment Period|Adverse Event|4|||
130200591|NCT00387010|468692822|FG000|Treatment Period|Withdrawal by Subject|1|||
130200592|NCT00387010|468692822|FG000|Treatment Period|Noncompliance with study medication|2|||
130200593|NCT00387010|468692822|FG000|Treatment Period|Noncompliance with study procedures|3|||
130200594|NCT00387010|468692822|FG000|Treatment Period|Participant reported study drug stolen|1|||
130200595|NCT01931956|468692827|FG000|Overall Study|Death|42|||
130200596|NCT01931956|468692828|FG001|Overall Study|Death|7|||
130200597|NCT01931956|468692829|FG002|Overall Study|Death|379|||
130200598|NCT01931956|468692830|FG003|Overall Study|Death|96|||
130200599|NCT01931956|468692827|FG000|Overall Study|Withdrawal by Subject|5|||
130200600|NCT01931956|468692828|FG001|Overall Study|Withdrawal by Subject|0|||
130200601|NCT01931956|468692829|FG002|Overall Study|Withdrawal by Subject|70|||
130200602|NCT01931956|468692830|FG003|Overall Study|Withdrawal by Subject|30|||
130200603|NCT01931956|468692827|FG000|Overall Study|Lost to Follow-up|2|||
130200604|NCT01931956|468692828|FG001|Overall Study|Lost to Follow-up|0|||
130200605|NCT01931956|468692829|FG002|Overall Study|Lost to Follow-up|11|||
130200606|NCT01931956|468692830|FG003|Overall Study|Lost to Follow-up|7|||
130200607|NCT01931956|468692827|FG000|Overall Study|Expected|2|||
130200608|NCT01931956|468692828|FG001|Overall Study|Expected|0|||
130200609|NCT01931956|468692829|FG002|Overall Study|Expected|6|||
130200610|NCT01931956|468692830|FG003|Overall Study|Expected|0|||
130200611|NCT01931956|468692827|FG000|Overall Study|Not due|0|||
130200612|NCT01931956|468692828|FG001|Overall Study|Not due|0|||
130200613|NCT01931956|468692829|FG002|Overall Study|Not due|21|||
130200614|NCT01931956|468692830|FG003|Overall Study|Not due|0|||
130200615|NCT02847494|468692835|FG000|Overall Study|Lost to Follow-up|8|||
130200616|NCT02847494|468692836|FG001|Overall Study|Lost to Follow-up|5|||
130200617|NCT01901653|468692837|FG000|Overall Study|Death|2|||
130200618|NCT01901653|468692838|FG001|Overall Study|Death|1|||
130200619|NCT01901653|468692839|FG002|Overall Study|Death|8|||
130200620|NCT01901653|468692840|FG003|Overall Study|Death|3|||
130200621|NCT01901653|468692841|FG004|Overall Study|Death|2|||
130200622|NCT01901653|468692842|FG005|Overall Study|Death|2|||
130200623|NCT01901653|468692843|FG006|Overall Study|Death|6|||
130200624|NCT01901653|468692844|FG007|Overall Study|Death|9|||
130200625|NCT01901653|468692845|FG008|Overall Study|Death|1|||
130200626|NCT01901653|468692846|FG009|Overall Study|Death|16|||
130200627|NCT01901653|468692847|FG010|Overall Study|Death|2|||
130200628|NCT01901653|468692848|FG011|Overall Study|Death|15|||
130200629|NCT01901653|468692849|FG012|Overall Study|Death|4|||
130200630|NCT01901653|468692837|FG000|Overall Study|Lost to Follow-up|1|||
130200631|NCT01901653|468692838|FG001|Overall Study|Lost to Follow-up|0|||
130200632|NCT01901653|468692839|FG002|Overall Study|Lost to Follow-up|2|||
130200633|NCT01901653|468692840|FG003|Overall Study|Lost to Follow-up|0|||
130200634|NCT01901653|468692841|FG004|Overall Study|Lost to Follow-up|0|||
130200635|NCT01901653|468692842|FG005|Overall Study|Lost to Follow-up|1|||
130200636|NCT01901653|468692843|FG006|Overall Study|Lost to Follow-up|0|||
130200637|NCT01901653|468692844|FG007|Overall Study|Lost to Follow-up|1|||
130200638|NCT01901653|468692845|FG008|Overall Study|Lost to Follow-up|0|||
130200639|NCT01901653|468692846|FG009|Overall Study|Lost to Follow-up|0|||
130200640|NCT01901653|468692847|FG010|Overall Study|Lost to Follow-up|0|||
130200641|NCT01901653|468692848|FG011|Overall Study|Lost to Follow-up|0|||
130200642|NCT01901653|468692849|FG012|Overall Study|Lost to Follow-up|0|||
130200643|NCT01901653|468692837|FG000|Overall Study|Withdrawal by Subject|0|||
130200644|NCT01901653|468692838|FG001|Overall Study|Withdrawal by Subject|0|||
130200645|NCT01901653|468692839|FG002|Overall Study|Withdrawal by Subject|0|||
130200646|NCT01901653|468692840|FG003|Overall Study|Withdrawal by Subject|0|||
130200647|NCT01901653|468692841|FG004|Overall Study|Withdrawal by Subject|0|||
130200648|NCT01901653|468692842|FG005|Overall Study|Withdrawal by Subject|0|||
130200649|NCT01901653|468692843|FG006|Overall Study|Withdrawal by Subject|1|||
130200650|NCT01901653|468692844|FG007|Overall Study|Withdrawal by Subject|0|||
130200651|NCT01901653|468692845|FG008|Overall Study|Withdrawal by Subject|0|||
130200652|NCT01901653|468692846|FG009|Overall Study|Withdrawal by Subject|0|||
130200653|NCT01901653|468692847|FG010|Overall Study|Withdrawal by Subject|0|||
130200654|NCT01901653|468692848|FG011|Overall Study|Withdrawal by Subject|0|||
130200655|NCT01901653|468692849|FG012|Overall Study|Withdrawal by Subject|0|||
130200656|NCT01901653|468692837|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
130200657|NCT01901653|468692838|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
130200658|NCT01901653|468692839|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
130200659|NCT01901653|468692840|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
130200660|NCT01901653|468692841|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
130200661|NCT01901653|468692842|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
130200662|NCT01901653|468692843|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
130200663|NCT01901653|468692844|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
130200664|NCT01901653|468692845|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
130200665|NCT01901653|468692846|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
130200666|NCT01901653|468692847|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
130200667|NCT01901653|468692848|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
130200668|NCT01901653|468692849|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
130200669|NCT02841280|468692852|FG000|Overall Study|Adverse Event|2|||
130200670|NCT02841280|468692853|FG001|Overall Study|Adverse Event|1|||
130200671|NCT02841280|468692852|FG000|Overall Study|Death|1|||
130200672|NCT02841280|468692853|FG001|Overall Study|Death|0|||
130200673|NCT02841280|468692852|FG000|Overall Study|Lost to Follow-up|2|||
130200674|NCT02841280|468692853|FG001|Overall Study|Lost to Follow-up|2|||
130200675|NCT02841280|468692852|FG000|Overall Study|Withdrawal by Subject|7|||
130200676|NCT02841280|468692853|FG001|Overall Study|Withdrawal by Subject|3|||
130200677|NCT02841280|468692852|FG000|Overall Study|Stop Point: BP above threshold|2|||
130200678|NCT02841280|468692853|FG001|Overall Study|Stop Point: BP above threshold|0|||
130200679|NCT02727777|468692854|FG000|Overall Study|Screen Failure|2|||
130200680|NCT02727777|468692855|FG001|Overall Study|Screen Failure|0|||
130200681|NCT02727777|468692856|FG002|Overall Study|Screen Failure|0|||
130200682|NCT02727777|468692854|FG000|Overall Study|Progressive disease|2|||
130200683|NCT02727777|468692855|FG001|Overall Study|Progressive disease|0|||
130200684|NCT02727777|468692856|FG002|Overall Study|Progressive disease|0|||
130200685|NCT00957268|468692857|FG000|Overall Study|Voluntary Withdrawal|0|||
130200686|NCT00957268|468692858|FG001|Overall Study|Voluntary Withdrawal|0|||
130200687|NCT00957268|468692859|FG002|Overall Study|Voluntary Withdrawal|1|||
130200688|NCT00957268|468692860|FG003|Overall Study|Voluntary Withdrawal|0|||
130200689|NCT00957268|468692861|FG004|Overall Study|Voluntary Withdrawal|0|||
130200690|NCT01738503|468692863|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
130200691|NCT01738503|468692864|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200692|NCT01738503|468692865|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200693|NCT01738503|468692866|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200694|NCT01738503|468692867|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200695|NCT01738503|468692868|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200696|NCT01738503|468692869|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200697|NCT01738503|468692863|FG000|Treatment Period|Adverse Event|0|||
130200698|NCT01738503|468692864|FG001|Treatment Period|Adverse Event|1|||
130200699|NCT01738503|468692865|FG002|Treatment Period|Adverse Event|0|||
130200700|NCT01738503|468692866|FG003|Treatment Period|Adverse Event|1|||
130200701|NCT01738503|468692867|FG004|Treatment Period|Adverse Event|2|||
130200702|NCT01738503|468692868|FG005|Treatment Period|Adverse Event|2|||
130200703|NCT01738503|468692869|FG006|Treatment Period|Adverse Event|2|||
130200704|NCT01738503|468692863|FG000|Treatment Period|Lost to Follow-up|0|||
130200705|NCT01738503|468692864|FG001|Treatment Period|Lost to Follow-up|0|||
130200706|NCT01738503|468692865|FG002|Treatment Period|Lost to Follow-up|3|||
130200707|NCT01738503|468692866|FG003|Treatment Period|Lost to Follow-up|4|||
130200708|NCT01738503|468692867|FG004|Treatment Period|Lost to Follow-up|1|||
130200709|NCT01738503|468692868|FG005|Treatment Period|Lost to Follow-up|1|||
130200710|NCT01738503|468692869|FG006|Treatment Period|Lost to Follow-up|5|||
130200711|NCT01738503|468692863|FG000|Treatment Period|Withdrawal by Subject|0|||
130200712|NCT01738503|468692864|FG001|Treatment Period|Withdrawal by Subject|1|||
130200713|NCT01738503|468692865|FG002|Treatment Period|Withdrawal by Subject|0|||
130200714|NCT01738503|468692866|FG003|Treatment Period|Withdrawal by Subject|1|||
130200715|NCT01738503|468692867|FG004|Treatment Period|Withdrawal by Subject|1|||
130200716|NCT01738503|468692868|FG005|Treatment Period|Withdrawal by Subject|1|||
130200717|NCT01738503|468692869|FG006|Treatment Period|Withdrawal by Subject|1|||
130200718|NCT01738503|468692863|FG000|Treatment Period|Protocol Violation|0|||
130200719|NCT01738503|468692864|FG001|Treatment Period|Protocol Violation|3|||
130200720|NCT01738503|468692865|FG002|Treatment Period|Protocol Violation|1|||
130200721|NCT01738503|468692866|FG003|Treatment Period|Protocol Violation|0|||
130200722|NCT01738503|468692867|FG004|Treatment Period|Protocol Violation|4|||
130200723|NCT01738503|468692868|FG005|Treatment Period|Protocol Violation|2|||
130200724|NCT01738503|468692869|FG006|Treatment Period|Protocol Violation|0|||
130200725|NCT01738503|468692863|FG000|Treatment Period|Other|0|||
130200726|NCT01738503|468692864|FG001|Treatment Period|Other|0|||
130200727|NCT01738503|468692865|FG002|Treatment Period|Other|1|||
130200728|NCT01738503|468692866|FG003|Treatment Period|Other|0|||
130200729|NCT01738503|468692867|FG004|Treatment Period|Other|0|||
130200730|NCT01738503|468692868|FG005|Treatment Period|Other|0|||
130200731|NCT01738503|468692869|FG006|Treatment Period|Other|0|||
130200732|NCT01738503|468692863|FG000|PET Imaging Sub-study|Adverse Event|0|||
130200733|NCT01738503|468692864|FG001|PET Imaging Sub-study|Adverse Event|0|||
130200734|NCT01738503|468692865|FG002|PET Imaging Sub-study|Adverse Event|0|||
130200735|NCT01738503|468692866|FG003|PET Imaging Sub-study|Adverse Event|0|||
130200736|NCT01738503|468692867|FG004|PET Imaging Sub-study|Adverse Event|0|||
130200737|NCT01738503|468692868|FG005|PET Imaging Sub-study|Adverse Event|1|||
130200738|NCT01738503|468692869|FG006|PET Imaging Sub-study|Adverse Event|0|||
130200739|NCT01738503|468692863|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200740|NCT01738503|468692864|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200741|NCT01738503|468692865|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200742|NCT01738503|468692866|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200743|NCT01738503|468692867|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200744|NCT01738503|468692868|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130200745|NCT01738503|468692869|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130200746|NCT03005327|468692870|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200747|NCT03005327|468692871|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200748|NCT03005327|468692872|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
130200749|NCT03005327|468692873|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200750|NCT03005327|468692870|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200751|NCT03005327|468692871|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130200752|NCT03005327|468692872|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200753|NCT03005327|468692873|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200754|NCT01340027|468692874|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
130200755|NCT01340027|468692875|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
130200756|NCT01340027|468692876|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
130200757|NCT01340027|468692877|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
130200758|NCT01340027|468692878|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
130200759|NCT01340027|468692879|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
130200760|NCT01340027|468692880|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
130200761|NCT01340027|468692881|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
130200762|NCT01340027|468692882|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
130200763|NCT01340027|468692883|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
130200764|NCT01340027|468692884|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
130200765|NCT01340027|468692885|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
130200766|NCT01340027|468692874|FG000|Overall Study|Adverse Event|0|||
130200767|NCT01340027|468692875|FG001|Overall Study|Adverse Event|1|||
130200768|NCT01340027|468692876|FG002|Overall Study|Adverse Event|2|||
130200769|NCT01340027|468692877|FG003|Overall Study|Adverse Event|0|||
130200770|NCT01340027|468692878|FG004|Overall Study|Adverse Event|1|||
130200771|NCT01340027|468692879|FG005|Overall Study|Adverse Event|2|||
130200772|NCT01340027|468692880|FG006|Overall Study|Adverse Event|2|||
130200773|NCT01340027|468692881|FG007|Overall Study|Adverse Event|1|||
130200774|NCT01340027|468692882|FG008|Overall Study|Adverse Event|4|||
130200775|NCT01340027|468692883|FG009|Overall Study|Adverse Event|1|||
130200776|NCT01340027|468692884|FG010|Overall Study|Adverse Event|1|||
130200777|NCT01340027|468692885|FG011|Overall Study|Adverse Event|3|||
130200778|NCT01340027|468692874|FG000|Overall Study|Lack of Efficacy|0|||
130200779|NCT01340027|468692875|FG001|Overall Study|Lack of Efficacy|0|||
130200780|NCT01340027|468692876|FG002|Overall Study|Lack of Efficacy|0|||
130200781|NCT01340027|468692877|FG003|Overall Study|Lack of Efficacy|0|||
130200782|NCT01340027|468692878|FG004|Overall Study|Lack of Efficacy|0|||
130200783|NCT01340027|468692879|FG005|Overall Study|Lack of Efficacy|0|||
130200784|NCT01340027|468692880|FG006|Overall Study|Lack of Efficacy|1|||
130200785|NCT01340027|468692881|FG007|Overall Study|Lack of Efficacy|1|||
130200786|NCT01340027|468692882|FG008|Overall Study|Lack of Efficacy|1|||
130200787|NCT01340027|468692883|FG009|Overall Study|Lack of Efficacy|0|||
130200788|NCT01340027|468692884|FG010|Overall Study|Lack of Efficacy|0|||
130200789|NCT01340027|468692885|FG011|Overall Study|Lack of Efficacy|0|||
130200790|NCT01340027|468692874|FG000|Overall Study|Lost to Follow-up|0|||
130200791|NCT01340027|468692875|FG001|Overall Study|Lost to Follow-up|1|||
130200792|NCT01340027|468692876|FG002|Overall Study|Lost to Follow-up|0|||
130200793|NCT01340027|468692877|FG003|Overall Study|Lost to Follow-up|0|||
130200794|NCT01340027|468692878|FG004|Overall Study|Lost to Follow-up|0|||
130200795|NCT01340027|468692879|FG005|Overall Study|Lost to Follow-up|0|||
130200796|NCT01340027|468692880|FG006|Overall Study|Lost to Follow-up|1|||
130200797|NCT01340027|468692881|FG007|Overall Study|Lost to Follow-up|0|||
130200798|NCT01340027|468692882|FG008|Overall Study|Lost to Follow-up|0|||
130200799|NCT01340027|468692883|FG009|Overall Study|Lost to Follow-up|1|||
130200800|NCT01340027|468692884|FG010|Overall Study|Lost to Follow-up|0|||
130200801|NCT01340027|468692885|FG011|Overall Study|Lost to Follow-up|0|||
130200802|NCT01340027|468692874|FG000|Overall Study|Protocol Violation|1|||
130200803|NCT01340027|468692875|FG001|Overall Study|Protocol Violation|2|||
130200804|NCT01340027|468692876|FG002|Overall Study|Protocol Violation|0|||
130200805|NCT01340027|468692877|FG003|Overall Study|Protocol Violation|0|||
130200806|NCT01340027|468692878|FG004|Overall Study|Protocol Violation|6|||
130200807|NCT01340027|468692879|FG005|Overall Study|Protocol Violation|0|||
130200808|NCT01340027|468692880|FG006|Overall Study|Protocol Violation|0|||
130200809|NCT01340027|468692881|FG007|Overall Study|Protocol Violation|1|||
130200810|NCT01340027|468692882|FG008|Overall Study|Protocol Violation|2|||
130200811|NCT01340027|468692883|FG009|Overall Study|Protocol Violation|2|||
130200812|NCT01340027|468692884|FG010|Overall Study|Protocol Violation|0|||
130200813|NCT01340027|468692885|FG011|Overall Study|Protocol Violation|0|||
130200814|NCT01340027|468692874|FG000|Overall Study|Withdrawal by Subject|4|||
130200815|NCT01340027|468692875|FG001|Overall Study|Withdrawal by Subject|3|||
130200816|NCT01340027|468692876|FG002|Overall Study|Withdrawal by Subject|1|||
130200817|NCT01340027|468692877|FG003|Overall Study|Withdrawal by Subject|3|||
130200818|NCT01340027|468692878|FG004|Overall Study|Withdrawal by Subject|3|||
130200819|NCT01340027|468692879|FG005|Overall Study|Withdrawal by Subject|2|||
130200820|NCT01340027|468692880|FG006|Overall Study|Withdrawal by Subject|3|||
130200821|NCT01340027|468692881|FG007|Overall Study|Withdrawal by Subject|4|||
130200822|NCT01340027|468692882|FG008|Overall Study|Withdrawal by Subject|1|||
130200823|NCT01340027|468692883|FG009|Overall Study|Withdrawal by Subject|2|||
130200824|NCT01340027|468692884|FG010|Overall Study|Withdrawal by Subject|0|||
130200825|NCT01340027|468692885|FG011|Overall Study|Withdrawal by Subject|1|||
130200826|NCT01340027|468692874|FG000|Overall Study|Miscellaneous|0|||
130200827|NCT01340027|468692875|FG001|Overall Study|Miscellaneous|0|||
130200828|NCT01340027|468692876|FG002|Overall Study|Miscellaneous|0|||
130200829|NCT01340027|468692877|FG003|Overall Study|Miscellaneous|1|||
130200830|NCT01340027|468692878|FG004|Overall Study|Miscellaneous|0|||
130200831|NCT01340027|468692879|FG005|Overall Study|Miscellaneous|0|||
130200832|NCT01340027|468692880|FG006|Overall Study|Miscellaneous|0|||
130200833|NCT01340027|468692881|FG007|Overall Study|Miscellaneous|0|||
130200834|NCT01340027|468692882|FG008|Overall Study|Miscellaneous|0|||
130200835|NCT01340027|468692883|FG009|Overall Study|Miscellaneous|0|||
130200836|NCT01340027|468692884|FG010|Overall Study|Miscellaneous|1|||
130200837|NCT01340027|468692885|FG011|Overall Study|Miscellaneous|0|||
130200838|NCT04687072|468692886|FG000|Overall Study|Adverse Event|2|||
130200839|NCT04687072|468692887|FG001|Overall Study|Adverse Event|0|||
130200840|NCT04687072|468692886|FG000|Overall Study|Death|1|||
130200841|NCT04687072|468692887|FG001|Overall Study|Death|0|||
130200842|NCT04687072|468692886|FG000|Overall Study|Lack of Efficacy|2|||
130200843|NCT04687072|468692887|FG001|Overall Study|Lack of Efficacy|1|||
130200844|NCT04687072|468692886|FG000|Overall Study|Physician Decision|1|||
130200845|NCT04687072|468692887|FG001|Overall Study|Physician Decision|0|||
130200846|NCT04687072|468692886|FG000|Overall Study|Pregnancy|1|||
130200847|NCT04687072|468692887|FG001|Overall Study|Pregnancy|0|||
130200848|NCT04687072|468692886|FG000|Overall Study|Requires Prohibited Medication|2|||
130200849|NCT04687072|468692887|FG001|Overall Study|Requires Prohibited Medication|0|||
130200850|NCT04687072|468692886|FG000|Overall Study|Withdrawal of Consent|11|||
130200851|NCT04687072|468692887|FG001|Overall Study|Withdrawal of Consent|6|||
130200852|NCT04687072|468692886|FG000|Overall Study|Miscellaneous|4|||
130200853|NCT04687072|468692887|FG001|Overall Study|Miscellaneous|1|||
130200854|NCT00915876|468692888|FG000|Overall Study|Adverse Event|0|||
130200855|NCT00915876|468692889|FG001|Overall Study|Adverse Event|1|||
130200856|NCT02572076|468692893|FG000|Overall Study|Protocol Violation|1|||
130200857|NCT00533702|468692896|FG000|Overall Study|Withdrawal by Subject|3|||
130200858|NCT00533702|468692897|FG001|Overall Study|Withdrawal by Subject|1|||
130200859|NCT00533702|468692896|FG000|Overall Study|Found ineligible after randomization|2|||
130200860|NCT00533702|468692897|FG001|Overall Study|Found ineligible after randomization|1|||
130200861|NCT06366087|468694621|FG000|Overall Study|Withdrawal by Subject|0|||
130200862|NCT06366087|468694622|FG001|Overall Study|Withdrawal by Subject|1|||
130200863|NCT00860249|468694624|FG000|Overall Study|trial was terminated prior to completion|21|||
130200864|NCT00860249|468694625|FG001|Overall Study|trial was terminated prior to completion|18|||
130200865|NCT00860249|468694626|FG002|Overall Study|trial was terminated prior to completion|21|||
130200866|NCT00174967|468694627|FG000|Overall Study|Adverse Event|1|||
130200867|NCT00174967|468694628|FG001|Overall Study|Adverse Event|2|||
130200868|NCT00174967|468694629|FG002|Overall Study|Adverse Event|2|||
130200869|NCT00174967|468694630|FG003|Overall Study|Adverse Event|1|||
130200870|NCT00174967|468694627|FG000|Overall Study|Gout Flare|0|||
130200871|NCT00174967|468694628|FG001|Overall Study|Gout Flare|0|||
130200872|NCT00174967|468694629|FG002|Overall Study|Gout Flare|0|||
130200873|NCT00174967|468694630|FG003|Overall Study|Gout Flare|1|||
130200874|NCT00174967|468694627|FG000|Overall Study|Other|0|||
130200875|NCT00174967|468694628|FG001|Overall Study|Other|1|||
130200876|NCT00174967|468694629|FG002|Overall Study|Other|0|||
130200877|NCT00174967|468694630|FG003|Overall Study|Other|0|||
130200878|NCT04934189|468694631|FG000|Overall Study|Lost to Follow-up|4|||
130200879|NCT04934189|468694631|FG000|Overall Study|Withdrawal by Subject|17|||
130200880|NCT01286168|468694639|FG000|Overall Study|Withdrawal by Subject|1|||
130200881|NCT01286168|468694639|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
130200882|NCT00843037|468694643|FG000|Overall Study|Lost to Follow-up|1|||
130200883|NCT02091960|468694646|FG000|Overall Study|Death|7|||
130200884|NCT02091960|468694646|FG000|Overall Study|Withdrawal by Subject|1|||
130200885|NCT02091960|468694646|FG000|Overall Study|Miscellaneous Reasons|37|||
130200886|NCT02738879|468694657|FG000|Overall Study|Adverse Event|1|||
130200887|NCT02738879|468694658|FG001|Overall Study|Adverse Event|1|||
130200888|NCT02738879|468694657|FG000|Overall Study|Death|0|||
130200889|NCT02738879|468694658|FG001|Overall Study|Death|2|||
130200890|NCT02738879|468694657|FG000|Overall Study|Lost to Follow-up|1|||
130200891|NCT02738879|468694658|FG001|Overall Study|Lost to Follow-up|5|||
130200892|NCT02738879|468694657|FG000|Overall Study|Protocol Violation|1|||
130200893|NCT02738879|468694658|FG001|Overall Study|Protocol Violation|3|||
130200894|NCT02738879|468694657|FG000|Overall Study|Physician Decision|3|||
130200895|NCT02738879|468694658|FG001|Overall Study|Physician Decision|4|||
130200896|NCT02738879|468694657|FG000|Overall Study|Pregnancy|0|||
130200897|NCT02738879|468694658|FG001|Overall Study|Pregnancy|1|||
130200898|NCT02738879|468694657|FG000|Overall Study|Screen Failure|1|||
130200899|NCT02738879|468694658|FG001|Overall Study|Screen Failure|2|||
130200900|NCT02738879|468694657|FG000|Overall Study|Site Discontinued Study Participation|1|||
130200901|NCT02738879|468694658|FG001|Overall Study|Site Discontinued Study Participation|0|||
130200902|NCT02738879|468694657|FG000|Overall Study|Withdrawal by Subject|5|||
130200903|NCT02738879|468694658|FG001|Overall Study|Withdrawal by Subject|7|||
130200904|NCT01438294|468694659|FG000|Overall Study|Lost to Follow-up|3|||
130200905|NCT01438294|468694660|FG001|Overall Study|Lost to Follow-up|7|||
130200906|NCT01346189|468694663|FG000|Overall Study|Withdrawal by Subject|7|||
130200907|NCT01346189|468694664|FG001|Overall Study|Withdrawal by Subject|5|||
130200908|NCT01346189|468694665|FG002|Overall Study|Withdrawal by Subject|3|||
130200909|NCT01346189|468694666|FG003|Overall Study|Withdrawal by Subject|5|||
130200910|NCT01346189|468694663|FG000|Overall Study|Physician Decision|4|||
130200911|NCT01346189|468694664|FG001|Overall Study|Physician Decision|0|||
130200912|NCT01346189|468694665|FG002|Overall Study|Physician Decision|0|||
130200913|NCT01346189|468694666|FG003|Overall Study|Physician Decision|0|||
130200914|NCT01346189|468694663|FG000|Overall Study|Moved|3|||
130200915|NCT01346189|468694664|FG001|Overall Study|Moved|0|||
130200916|NCT01346189|468694665|FG002|Overall Study|Moved|4|||
130200917|NCT01346189|468694666|FG003|Overall Study|Moved|0|||
130200918|NCT01346189|468694663|FG000|Overall Study|Other|2|||
130200919|NCT01346189|468694664|FG001|Overall Study|Other|4|||
130200920|NCT01346189|468694665|FG002|Overall Study|Other|7|||
130200921|NCT01346189|468694666|FG003|Overall Study|Other|3|||
130200922|NCT01346189|468694663|FG000|Overall Study|Death|0|||
130200923|NCT01346189|468694664|FG001|Overall Study|Death|3|||
130200924|NCT01346189|468694665|FG002|Overall Study|Death|0|||
130200925|NCT01346189|468694666|FG003|Overall Study|Death|0|||
130200926|NCT01346189|468694663|FG000|Overall Study|Non-health system primary care physician|0|||
130200927|NCT01346189|468694664|FG001|Overall Study|Non-health system primary care physician|5|||
130200928|NCT01346189|468694665|FG002|Overall Study|Non-health system primary care physician|0|||
130200929|NCT01346189|468694666|FG003|Overall Study|Non-health system primary care physician|0|||
130200930|NCT01346189|468694663|FG000|Overall Study|Travel|0|||
130200931|NCT01346189|468694664|FG001|Overall Study|Travel|0|||
130200932|NCT01346189|468694665|FG002|Overall Study|Travel|0|||
130200933|NCT01346189|468694666|FG003|Overall Study|Travel|3|||
130200934|NCT01730534|468694667|FG000|Overall Study|Withdrawal by Subject|97|||
130200935|NCT01730534|468694668|FG001|Overall Study|Withdrawal by Subject|127|||
130200936|NCT01730534|468694667|FG000|Overall Study|Lost to Follow-up|12|||
130200937|NCT01730534|468694668|FG001|Overall Study|Lost to Follow-up|18|||
130200938|NCT01895608|468694669|FG000|Overall Study|change in health status|0|||
130200939|NCT01895608|468694670|FG001|Overall Study|change in health status|1|||
130200940|NCT01895608|468694671|FG002|Overall Study|change in health status|1|||
130200941|NCT01895608|468694672|FG003|Overall Study|change in health status|0|||
130200942|NCT01895608|468694669|FG000|Overall Study|Withdrawal by Subject|0|||
130200943|NCT01895608|468694670|FG001|Overall Study|Withdrawal by Subject|0|||
130200944|NCT01895608|468694671|FG002|Overall Study|Withdrawal by Subject|2|||
130200945|NCT01895608|468694672|FG003|Overall Study|Withdrawal by Subject|0|||
130200946|NCT02855359|468694675|FG000|Overall Study|Death|2|||
130200947|NCT02855359|468694676|FG001|Overall Study|Death|2|||
130200948|NCT02855359|468694677|FG002|Overall Study|Death|0|||
130200949|NCT02855359|468694678|FG003|Overall Study|Death|0|||
130200950|NCT02855359|468694675|FG000|Overall Study|Study Termination by Sponsor|9|||
130200951|NCT02855359|468694676|FG001|Overall Study|Study Termination by Sponsor|11|||
130200952|NCT02855359|468694677|FG002|Overall Study|Study Termination by Sponsor|0|||
130200953|NCT02855359|468694678|FG003|Overall Study|Study Termination by Sponsor|0|||
130200954|NCT02833844|468694679|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130200955|NCT02833844|468694680|FG001|Double-Blind Period|Withdrawal by Subject|3|||
130200956|NCT02833844|468694679|FG000|Double-Blind Period|Protocol Violation|0|||
130200957|NCT02833844|468694680|FG001|Double-Blind Period|Protocol Violation|4|||
130200958|NCT02833844|468694679|FG000|Open-Label Period|Death|0|||
130200959|NCT02833844|468694680|FG001|Open-Label Period|Death|2|||
130200960|NCT02833844|468694679|FG000|Open-Label Period|Lost to Follow-up|1|||
130200961|NCT02833844|468694680|FG001|Open-Label Period|Lost to Follow-up|0|||
130200962|NCT02833844|468694679|FG000|Open-Label Period|Withdrawal by Subject|1|||
130200963|NCT02833844|468694680|FG001|Open-Label Period|Withdrawal by Subject|0|||
130200964|NCT02541669|468694683|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200965|NCT02541669|468694684|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200966|NCT02541669|468694685|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130200967|NCT02541669|468694686|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200968|NCT02541669|468694687|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130200969|NCT01084668|468694689|FG000|Overall Study|Lack of Efficacy|5|||
130200970|NCT01084668|468694689|FG000|Overall Study|Withdrawal by Subject|2|||
130200971|NCT01084668|468694689|FG000|Overall Study|Pregnancy|1|||
130200972|NCT01084668|468694689|FG000|Overall Study|Non-compliance|1|||
130200973|NCT00655733|468694696|FG000|Overall Study|Lost to Follow-up|2|||
130200974|NCT00655733|468694697|FG001|Overall Study|Lost to Follow-up|2|||
130200975|NCT00655733|468694696|FG000|Overall Study|Adverse Event|2|||
130200976|NCT00655733|468694697|FG001|Overall Study|Adverse Event|2|||
130200977|NCT00655733|468694696|FG000|Overall Study|Withdrawal by Subject|3|||
130200978|NCT00655733|468694697|FG001|Overall Study|Withdrawal by Subject|3|||
130200979|NCT00655733|468694696|FG000|Overall Study|Physician Decision|0|||
130200980|NCT00655733|468694697|FG001|Overall Study|Physician Decision|1|||
130200981|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
130200982|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200983|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
130200984|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
130200985|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200986|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200987|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Other|0|||
130200988|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Other|0|||
130200989|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Other|1|||
130200990|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Other|0|||
130200991|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Other|0|||
130200992|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Other|0|||
130200993|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200994|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
130200995|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200996|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200997|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200998|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200999|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130201000|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
130201001|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201002|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130201003|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201004|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201005|NCT02122770|468694698|FG000|Part B: Standard of Care|Adverse Event|0|||
130201006|NCT02122770|468694699|FG001|Part B: Standard of Care|Adverse Event|0|||
130201007|NCT02122770|468694700|FG002|Part B: Standard of Care|Adverse Event|0|||
130201008|NCT02122770|468694701|FG003|Part B: Standard of Care|Adverse Event|0|||
130201009|NCT02122770|468694702|FG004|Part B: Standard of Care|Adverse Event|4|||
130201010|NCT02122770|468694703|FG005|Part B: Standard of Care|Adverse Event|1|||
130201011|NCT02122770|468694698|FG000|Part B: Standard of Care|Other|0|||
130201012|NCT02122770|468694699|FG001|Part B: Standard of Care|Other|0|||
130201013|NCT02122770|468694700|FG002|Part B: Standard of Care|Other|0|||
130201014|NCT02122770|468694701|FG003|Part B: Standard of Care|Other|0|||
130201015|NCT02122770|468694702|FG004|Part B: Standard of Care|Other|0|||
130201016|NCT02122770|468694703|FG005|Part B: Standard of Care|Other|2|||
130201017|NCT02122770|468694698|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
130201018|NCT02122770|468694699|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
130201019|NCT02122770|468694700|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
130201020|NCT02122770|468694701|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
130201021|NCT02122770|468694702|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
130201022|NCT02122770|468694703|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
130201023|NCT02122770|468694698|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201024|NCT02122770|468694699|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201025|NCT02122770|468694700|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201026|NCT02122770|468694701|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201027|NCT02122770|468694702|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
130201028|NCT02122770|468694703|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201029|NCT02122770|468694698|FG000|Part B: Standard of Care|Progressive Disease|0|||
130201030|NCT02122770|468694699|FG001|Part B: Standard of Care|Progressive Disease|0|||
130201031|NCT02122770|468694700|FG002|Part B: Standard of Care|Progressive Disease|0|||
130201032|NCT02122770|468694701|FG003|Part B: Standard of Care|Progressive Disease|0|||
130201033|NCT02122770|468694702|FG004|Part B: Standard of Care|Progressive Disease|10|||
130201034|NCT02122770|468694703|FG005|Part B: Standard of Care|Progressive Disease|8|||
130201035|NCT01740128|468694704|FG000|Overall Study|Pregnancy|0|||
130201036|NCT01740128|468694705|FG001|Overall Study|Pregnancy|1|||
130201037|NCT01740128|468694704|FG000|Overall Study|Protocol Violation|1|||
130201038|NCT01740128|468694705|FG001|Overall Study|Protocol Violation|2|||
130201039|NCT01740128|468694704|FG000|Overall Study|Lost to Follow-up|2|||
130201040|NCT01740128|468694705|FG001|Overall Study|Lost to Follow-up|2|||
130201041|NCT01740128|468694704|FG000|Overall Study|Withdrawal by Subject|1|||
130201042|NCT01740128|468694705|FG001|Overall Study|Withdrawal by Subject|0|||
130201043|NCT01740128|468694704|FG000|Overall Study|Insufficient protocol compliance|2|||
130201044|NCT01740128|468694705|FG001|Overall Study|Insufficient protocol compliance|2|||
130201045|NCT02474589|468694706|FG000|Overall Study|Adverse Event|6|||
130201046|NCT02474589|468694707|FG001|Overall Study|Adverse Event|2|||
130201047|NCT02474589|468694706|FG000|Overall Study|Lost to Follow-up|6|||
130201048|NCT02474589|468694707|FG001|Overall Study|Lost to Follow-up|1|||
130201049|NCT02474589|468694706|FG000|Overall Study|Protocol Violation|4|||
130201050|NCT02474589|468694707|FG001|Overall Study|Protocol Violation|1|||
130201051|NCT02474589|468694706|FG000|Overall Study|Withdrawal by Subject|4|||
130201052|NCT02474589|468694707|FG001|Overall Study|Withdrawal by Subject|0|||
130201053|NCT02474589|468694706|FG000|Overall Study|Inability to complete study procedures|5|||
130201054|NCT02474589|468694707|FG001|Overall Study|Inability to complete study procedures|1|||
130201055|NCT02658734|468694710|FG000|Overall Study|Adverse Event|2|||
130201056|NCT02658734|468694710|FG000|Overall Study|Death|4|||
130201057|NCT02658734|468694710|FG000|Overall Study|Lost to Follow-up|7|||
130201058|NCT02658734|468694710|FG000|Overall Study|Withdrawal of Consent|16|||
130201059|NCT02658734|468694710|FG000|Overall Study|Disease Progression|28|||
130201060|NCT00459706|468694712|FG000|Overall Study|Adverse Event|19|||
130201061|NCT00459706|468694713|FG001|Overall Study|Adverse Event|13|||
130201062|NCT00459706|468694712|FG000|Overall Study|Withdrawal by Subject|1|||
130201063|NCT00459706|468694713|FG001|Overall Study|Withdrawal by Subject|6|||
130201064|NCT00459706|468694712|FG000|Overall Study|Physician Decision|2|||
130201065|NCT00459706|468694713|FG001|Overall Study|Physician Decision|0|||
130201066|NCT00459706|468694712|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130201067|NCT00459706|468694713|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130201068|NCT00459706|468694712|FG000|Overall Study|Protocol Violation|2|||
130201069|NCT00459706|468694713|FG001|Overall Study|Protocol Violation|1|||
130201070|NCT00459706|468694712|FG000|Overall Study|Failed to Return|1|||
130201071|NCT00459706|468694713|FG001|Overall Study|Failed to Return|0|||
130201072|NCT00459706|468694712|FG000|Overall Study|Other|0|||
130201073|NCT00459706|468694713|FG001|Overall Study|Other|1|||
130201074|NCT00189306|468694714|FG000|Treatment Period|Withdrawal by Subject|2|||
130201075|NCT00189306|468694714|FG000|Treatment Period|Adverse Event|2|||
130201076|NCT00189306|468694714|FG000|Treatment Period|Protocol Violation|1|||
130201077|NCT00189306|468694714|FG000|Posttreatment Period|Death|1|||
130201078|NCT00189306|468694714|FG000|Posttreatment Period|Withdrawal by Subject|2|||
130201079|NCT00189306|468694714|FG000|Posttreatment Period|Noncompliance|1|||
130201080|NCT00189306|468694714|FG000|Posttreatment Period|Target lesion excised|1|||
130201081|NCT00189306|468694714|FG000|Posttreatment Period|Protocol Violation|1|||
130201082|NCT00189306|468694714|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
130201083|NCT00189306|468694714|FG000|Posttreatment Period|Local skin reaction/sign|1|||
130201084|NCT00189306|468694714|FG000|Long-Term Follow-up|Adverse Event|2|||
130201085|NCT00189306|468694714|FG000|Long-Term Follow-up|Death|4|||
130201086|NCT00189306|468694714|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130201087|NCT00189306|468694714|FG000|Long-Term Follow-up|Intercurrent disease|2|||
130201088|NCT00189306|468694714|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
130201089|NCT00189306|468694714|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
130201090|NCT03640481|468694715|FG000|Overall Study|Death|14|||
130201091|NCT03640481|468694716|FG001|Overall Study|Death|14|||
130201092|NCT03640481|468694717|FG002|Overall Study|Death|0|||
130201093|NCT03640481|468694718|FG003|Overall Study|Death|0|||
130201094|NCT03640481|468694715|FG000|Overall Study|Lost to Follow-up|2|||
130201095|NCT03640481|468694716|FG001|Overall Study|Lost to Follow-up|0|||
130201096|NCT03640481|468694717|FG002|Overall Study|Lost to Follow-up|0|||
130201097|NCT03640481|468694718|FG003|Overall Study|Lost to Follow-up|0|||
130201098|NCT03640481|468694715|FG000|Overall Study|Site terminated by sponsor|1|||
130201099|NCT03640481|468694716|FG001|Overall Study|Site terminated by sponsor|3|||
130201100|NCT03640481|468694717|FG002|Overall Study|Site terminated by sponsor|0|||
130201101|NCT03640481|468694718|FG003|Overall Study|Site terminated by sponsor|0|||
130201102|NCT03640481|468694715|FG000|Overall Study|Study terminated by sponsor|29|||
130201103|NCT03640481|468694716|FG001|Overall Study|Study terminated by sponsor|42|||
130201104|NCT03640481|468694717|FG002|Overall Study|Study terminated by sponsor|1|||
130201105|NCT03640481|468694718|FG003|Overall Study|Study terminated by sponsor|0|||
130201106|NCT03640481|468694715|FG000|Overall Study|Withdrawal by Subject|5|||
130201107|NCT03640481|468694716|FG001|Overall Study|Withdrawal by Subject|4|||
130201108|NCT03640481|468694717|FG002|Overall Study|Withdrawal by Subject|0|||
130201109|NCT03640481|468694718|FG003|Overall Study|Withdrawal by Subject|1|||
130201110|NCT03640481|468694715|FG000|Overall Study|Other|26|||
130201111|NCT03640481|468694716|FG001|Overall Study|Other|12|||
130201112|NCT03640481|468694717|FG002|Overall Study|Other|1|||
130201113|NCT03640481|468694718|FG003|Overall Study|Other|0|||
130201114|NCT03640481|468694715|FG000|Overall Study|Randomized, but not treated|1|||
130201115|NCT03640481|468694716|FG001|Overall Study|Randomized, but not treated|3|||
130201116|NCT03640481|468694717|FG002|Overall Study|Randomized, but not treated|0|||
130201117|NCT03640481|468694718|FG003|Overall Study|Randomized, but not treated|0|||
130201118|NCT00727844|468694719|FG000|Initial Randomization|Physician Decision|2|||
130201119|NCT00727844|468694720|FG001|Initial Randomization|Physician Decision|0|||
130201120|NCT00727844|468694721|FG002|Initial Randomization|Physician Decision|0|||
130201121|NCT00727844|468694722|FG003|Initial Randomization|Physician Decision|0|||
130201122|NCT00373958|468694723|FG000|Infant Series|Withdrawal by Subject|13|||
130201123|NCT00373958|468694724|FG001|Infant Series|Withdrawal by Subject|15|||
130201124|NCT00373958|468694723|FG000|Infant Series|Failed to return|8|||
130201125|NCT00373958|468694724|FG001|Infant Series|Failed to return|13|||
130201126|NCT00373958|468694723|FG000|Infant Series|Lost to Follow-up|6|||
130201127|NCT00373958|468694724|FG001|Infant Series|Lost to Follow-up|5|||
130201128|NCT00373958|468694723|FG000|Infant Series|Protocol Violation|3|||
130201129|NCT00373958|468694724|FG001|Infant Series|Protocol Violation|7|||
130201130|NCT00373958|468694723|FG000|Infant Series|Lost Kaiser coverage|4|||
130201131|NCT00373958|468694724|FG001|Infant Series|Lost Kaiser coverage|0|||
130201132|NCT00373958|468694723|FG000|Infant Series|Child relocated|1|||
130201133|NCT00373958|468694724|FG001|Infant Series|Child relocated|0|||
130201134|NCT00373958|468694723|FG000|Infant Series|Consent was not received|1|||
130201135|NCT00373958|468694724|FG001|Infant Series|Consent was not received|0|||
130201136|NCT00373958|468694723|FG000|Infant Series|Adverse Event|3|||
130201137|NCT00373958|468694724|FG001|Infant Series|Adverse Event|1|||
130201138|NCT00373958|468694723|FG000|Infant Series|Physician Decision|1|||
130201139|NCT00373958|468694724|FG001|Infant Series|Physician Decision|1|||
130201140|NCT00373958|468694723|FG000|Toddler Dose|Lost to Follow-up|5|||
130201141|NCT00373958|468694724|FG001|Toddler Dose|Lost to Follow-up|8|||
130201142|NCT00373958|468694723|FG000|Toddler Dose|Withdrawal by Subject|2|||
130201143|NCT00373958|468694724|FG001|Toddler Dose|Withdrawal by Subject|2|||
130201144|NCT00373958|468694723|FG000|Toddler Dose|Failed to return|1|||
130201145|NCT00373958|468694724|FG001|Toddler Dose|Failed to return|2|||
130201146|NCT00373958|468694723|FG000|Toddler Dose|Protocol Violation|0|||
130201147|NCT00373958|468694724|FG001|Toddler Dose|Protocol Violation|1|||
130201148|NCT00373958|468694723|FG000|Toddler Dose|Withdrawn after infant series|22|||
130201149|NCT00373958|468694724|FG001|Toddler Dose|Withdrawn after infant series|25|||
130201150|NCT01552915|468694725|FG000|Overall Study|Adverse Event|3|||
130201151|NCT01552915|468694726|FG001|Overall Study|Adverse Event|14|||
130201152|NCT01552915|468694727|FG002|Overall Study|Adverse Event|3|||
130201153|NCT01552915|468694725|FG000|Overall Study|Lost to Follow-up|4|||
130201154|NCT01552915|468694726|FG001|Overall Study|Lost to Follow-up|6|||
130201155|NCT01552915|468694727|FG002|Overall Study|Lost to Follow-up|5|||
130201156|NCT01552915|468694725|FG000|Overall Study|Withdrawal by Subject|6|||
130201157|NCT01552915|468694726|FG001|Overall Study|Withdrawal by Subject|4|||
130201158|NCT01552915|468694727|FG002|Overall Study|Withdrawal by Subject|5|||
130201159|NCT01552915|468694725|FG000|Overall Study|Protocol Violation|0|||
130201160|NCT01552915|468694726|FG001|Overall Study|Protocol Violation|4|||
130201161|NCT01552915|468694727|FG002|Overall Study|Protocol Violation|4|||
130201162|NCT01552915|468694725|FG000|Overall Study|Lack of Efficacy|8|||
130201163|NCT01552915|468694726|FG001|Overall Study|Lack of Efficacy|1|||
130201164|NCT01552915|468694727|FG002|Overall Study|Lack of Efficacy|4|||
130201165|NCT01552915|468694725|FG000|Overall Study|Other|2|||
130201166|NCT01552915|468694726|FG001|Overall Study|Other|0|||
130201167|NCT01552915|468694727|FG002|Overall Study|Other|6|||
130201174|NCT01880086|468694733|FG000|Overall Study|Lost to Follow-up|1|||
130201175|NCT01880086|468694734|FG001|Overall Study|Lost to Follow-up|1|||
130201176|NCT03403751|468694738|FG000|Overall Study|Death|5|||
130201177|NCT03403751|468694739|FG001|Overall Study|Death|6|||
130201178|NCT03403751|468694738|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130201179|NCT03403751|468694739|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130201180|NCT00520481|468694743|FG000|Overall Study|Adverse Event|4|||
130201181|NCT00520481|468694744|FG001|Overall Study|Adverse Event|1|||
130201182|NCT00520481|468694743|FG000|Overall Study|Withdrawal by Subject|3|||
130201183|NCT00520481|468694744|FG001|Overall Study|Withdrawal by Subject|0|||
130201184|NCT02091986|468694745|FG000|Overall Study|7 rand in error 1 patient decision|2|||
130201185|NCT02091986|468694746|FG001|Overall Study|7 rand in error 1 patient decision|3|||
130201186|NCT02091986|468694747|FG002|Overall Study|7 rand in error 1 patient decision|3|||
130201187|NCT02091986|468694745|FG000|Overall Study|Lost to Follow-up|1|||
130201188|NCT02091986|468694746|FG001|Overall Study|Lost to Follow-up|0|||
130201189|NCT02091986|468694747|FG002|Overall Study|Lost to Follow-up|0|||
130201190|NCT02091986|468694745|FG000|Overall Study|Withdrawal by Subject|4|||
130201191|NCT02091986|468694746|FG001|Overall Study|Withdrawal by Subject|8|||
130201192|NCT02091986|468694747|FG002|Overall Study|Withdrawal by Subject|3|||
130201193|NCT02091986|468694745|FG000|Overall Study|Adverse Event|0|||
130201194|NCT02091986|468694746|FG001|Overall Study|Adverse Event|0|||
130201195|NCT02091986|468694747|FG002|Overall Study|Adverse Event|2|||
130201196|NCT02537431|468694751|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
130201197|NCT00794040|468694752|FG000|Overall Study|Withdrawal by Subject|3|||
130201198|NCT00794040|468694753|FG001|Overall Study|Withdrawal by Subject|4|||
130201199|NCT00794040|468694752|FG000|Overall Study|Physician Decision|0|||
130201200|NCT00794040|468694753|FG001|Overall Study|Physician Decision|1|||
130201201|NCT03626363|468694754|FG000|Overall Study|Protocol Violation|4|||
130201202|NCT03626363|468694755|FG001|Overall Study|Protocol Violation|0|||
130201203|NCT03626363|468694754|FG000|Overall Study|Lost to Follow-up|5|||
130201204|NCT03626363|468694755|FG001|Overall Study|Lost to Follow-up|7|||
130201205|NCT02600845|468694756|FG000|Overall Study|Reason Not Specified|3|||
130201206|NCT02600845|468694756|FG000|Overall Study|Non-compliance with Study Procedures|10|||
130201207|NCT02600845|468694756|FG000|Overall Study|Consent Withdrawal|5|||
130201208|NCT04413552|468694757|FG000|Overall Study|Adverse Event|0|||
130201209|NCT04413552|468694758|FG001|Overall Study|Adverse Event|0|||
130201210|NCT04413552|468694759|FG002|Overall Study|Adverse Event|0|||
130201211|NCT04413552|468694760|FG003|Overall Study|Adverse Event|0|||
130201212|NCT04413552|468694761|FG004|Overall Study|Adverse Event|0|||
130201213|NCT04413552|468694762|FG005|Overall Study|Adverse Event|0|||
130201214|NCT04413552|468694763|FG006|Overall Study|Adverse Event|1|||
130201215|NCT04413552|468694764|FG007|Overall Study|Adverse Event|0|||
130201216|NCT04413552|468694765|FG008|Overall Study|Adverse Event|0|||
130201217|NCT04413552|468694766|FG009|Overall Study|Adverse Event|0|||
130201218|NCT04852679|468694767|FG000|Main Intervention Period|Withdrawal by Subject|3|||
130201219|NCT04852679|468694767|FG000|Main Intervention Period|Adverse Event|1|||
130201220|NCT04852679|468694767|FG000|Main Intervention Period|Progressive Disease|16|||
130201221|NCT04852679|468694767|FG000|Main Intervention Period|Refused study visit|1|||
130201222|NCT04852679|468694767|FG000|Independent Injection Period|Missed study visit|1|||
130201223|NCT01294696|468694768|FG000|Overall Study|Screening failures|7|||
130201224|NCT01294696|468694768|FG000|Overall Study|Protocol Violation|8|||
130201225|NCT01294696|468694768|FG000|Overall Study|Missing BPI Response|7|||
130201226|NCT01294696|468694768|FG000|Overall Study|Site closure|52|||
130201227|NCT01871402|468696455|FG000|Overall Study|Lost to Follow-up|1|||
130201228|NCT01871402|468696456|FG001|Overall Study|Lost to Follow-up|0|||
130201229|NCT01871402|468696455|FG000|Overall Study|Withdrawal by Subject|0|||
130201230|NCT01871402|468696456|FG001|Overall Study|Withdrawal by Subject|2|||
130201231|NCT01871402|468696455|FG000|Overall Study|Non-compliance|0|||
130201232|NCT01871402|468696456|FG001|Overall Study|Non-compliance|1|||
130201233|NCT04594941|468696457|FG000|Overall Study|Other|0|||
130201234|NCT04594941|468696458|FG001|Overall Study|Other|3|||
130201235|NCT04594941|468696459|FG002|Overall Study|Other|1|||
130201236|NCT04594941|468696460|FG003|Overall Study|Other|0|||
130201237|NCT02424630|468696461|FG000|Overall Study|No rotator cuff tear|1|||
130201238|NCT02424630|468696462|FG001|Overall Study|No rotator cuff tear|2|||
130201239|NCT02424630|468696461|FG000|Overall Study|Open procedure|0|||
130201240|NCT02424630|468696462|FG001|Overall Study|Open procedure|1|||
130201241|NCT02703272|468696463|FG000|Overall Study|Death|4|||
130201242|NCT02703272|468696464|FG001|Overall Study|Death|9|||
130201243|NCT02703272|468696465|FG002|Overall Study|Death|19|||
130201244|NCT02703272|468696466|FG003|Overall Study|Death|10|||
130201245|NCT02703272|468696463|FG000|Overall Study|Withdrawal by Subject|0|||
130201246|NCT02703272|468696464|FG001|Overall Study|Withdrawal by Subject|0|||
130201247|NCT02703272|468696465|FG002|Overall Study|Withdrawal by Subject|4|||
130201248|NCT02703272|468696466|FG003|Overall Study|Withdrawal by Subject|2|||
130201249|NCT02703272|468696463|FG000|Overall Study|Study Terminated by Sponsor|6|||
130201250|NCT02703272|468696464|FG001|Overall Study|Study Terminated by Sponsor|1|||
130201251|NCT02703272|468696465|FG002|Overall Study|Study Terminated by Sponsor|12|||
130201252|NCT02703272|468696466|FG003|Overall Study|Study Terminated by Sponsor|4|||
130201253|NCT02703272|468696463|FG000|Overall Study|Other|1|||
130201254|NCT02703272|468696464|FG001|Overall Study|Other|0|||
130201255|NCT02703272|468696465|FG002|Overall Study|Other|0|||
130201256|NCT02703272|468696466|FG003|Overall Study|Other|0|||
130201257|NCT02637895|468696467|FG000|Overall Study|Lost to Follow-up|4|||
130201258|NCT02637895|468696468|FG001|Overall Study|Lost to Follow-up|0|||
130201259|NCT02637895|468696467|FG000|Overall Study|Protocol Violation|0|||
130201260|NCT02637895|468696468|FG001|Overall Study|Protocol Violation|1|||
130201261|NCT02637895|468696467|FG000|Overall Study|Lack of Efficacy|1|||
130201262|NCT02637895|468696468|FG001|Overall Study|Lack of Efficacy|0|||
130201263|NCT02637895|468696467|FG000|Overall Study|Withdrawal by Subject|1|||
130201264|NCT02637895|468696468|FG001|Overall Study|Withdrawal by Subject|1|||
130201265|NCT02637895|468696467|FG000|Overall Study|Abnormal baseline lab|0|||
130201266|NCT02637895|468696468|FG001|Overall Study|Abnormal baseline lab|1|||
130201267|NCT02031640|468696469|FG000|Screening Period|Adverse Event|1|||
130201268|NCT02031640|468696470|FG001|Screening Period|Adverse Event|0|||
130201269|NCT02031640|468696471|FG002|Screening Period|Adverse Event|0|||
130201270|NCT02031640|468696472|FG003|Screening Period|Adverse Event|0|||
130201271|NCT02031640|468696473|FG004|Screening Period|Adverse Event|0|||
130201272|NCT02031640|468696474|FG005|Screening Period|Adverse Event|0|||
130201273|NCT02031640|468696469|FG000|Screening Period|Withdrawal by Subject|29|||
130201274|NCT02031640|468696470|FG001|Screening Period|Withdrawal by Subject|0|||
130201275|NCT02031640|468696471|FG002|Screening Period|Withdrawal by Subject|0|||
130201276|NCT02031640|468696472|FG003|Screening Period|Withdrawal by Subject|0|||
130201277|NCT02031640|468696473|FG004|Screening Period|Withdrawal by Subject|0|||
130201278|NCT02031640|468696474|FG005|Screening Period|Withdrawal by Subject|0|||
130201279|NCT02031640|468696469|FG000|Screening Period|Inclusion criteria not met|312|||
130201280|NCT02031640|468696470|FG001|Screening Period|Inclusion criteria not met|0|||
130201281|NCT02031640|468696471|FG002|Screening Period|Inclusion criteria not met|0|||
130201282|NCT02031640|468696472|FG003|Screening Period|Inclusion criteria not met|0|||
130201283|NCT02031640|468696473|FG004|Screening Period|Inclusion criteria not met|0|||
130201284|NCT02031640|468696474|FG005|Screening Period|Inclusion criteria not met|0|||
130201285|NCT02031640|468696469|FG000|Screening Period|Exclusion criteria met|30|||
130201286|NCT02031640|468696470|FG001|Screening Period|Exclusion criteria met|0|||
130201287|NCT02031640|468696471|FG002|Screening Period|Exclusion criteria met|0|||
130201288|NCT02031640|468696472|FG003|Screening Period|Exclusion criteria met|0|||
130201289|NCT02031640|468696473|FG004|Screening Period|Exclusion criteria met|0|||
130201290|NCT02031640|468696474|FG005|Screening Period|Exclusion criteria met|0|||
130201291|NCT02031640|468696469|FG000|Screening Period|Lost to Follow-up|14|||
130201292|NCT02031640|468696470|FG001|Screening Period|Lost to Follow-up|0|||
130201293|NCT02031640|468696471|FG002|Screening Period|Lost to Follow-up|0|||
130201294|NCT02031640|468696472|FG003|Screening Period|Lost to Follow-up|0|||
130201295|NCT02031640|468696473|FG004|Screening Period|Lost to Follow-up|0|||
130201296|NCT02031640|468696474|FG005|Screening Period|Lost to Follow-up|0|||
130201297|NCT02031640|468696469|FG000|Screening Period|Enrollment closed|26|||
130201298|NCT02031640|468696470|FG001|Screening Period|Enrollment closed|0|||
130201299|NCT02031640|468696471|FG002|Screening Period|Enrollment closed|0|||
130201300|NCT02031640|468696472|FG003|Screening Period|Enrollment closed|0|||
130201301|NCT02031640|468696473|FG004|Screening Period|Enrollment closed|0|||
130201302|NCT02031640|468696474|FG005|Screening Period|Enrollment closed|0|||
130201303|NCT02031640|468696469|FG000|Run-In Period|Adverse Event|4|||
130201304|NCT02031640|468696470|FG001|Run-In Period|Adverse Event|0|||
130201305|NCT02031640|468696471|FG002|Run-In Period|Adverse Event|0|||
130201306|NCT02031640|468696472|FG003|Run-In Period|Adverse Event|0|||
130201307|NCT02031640|468696473|FG004|Run-In Period|Adverse Event|0|||
130201308|NCT02031640|468696474|FG005|Run-In Period|Adverse Event|0|||
130201309|NCT02031640|468696469|FG000|Run-In Period|Withdrawal by Subject|17|||
130201310|NCT02031640|468696470|FG001|Run-In Period|Withdrawal by Subject|0|||
130201311|NCT02031640|468696471|FG002|Run-In Period|Withdrawal by Subject|0|||
130201312|NCT02031640|468696472|FG003|Run-In Period|Withdrawal by Subject|0|||
130201313|NCT02031640|468696473|FG004|Run-In Period|Withdrawal by Subject|0|||
130201314|NCT02031640|468696474|FG005|Run-In Period|Withdrawal by Subject|0|||
130201315|NCT02031640|468696469|FG000|Run-In Period|Inclusion criteria not met|38|||
130201316|NCT02031640|468696470|FG001|Run-In Period|Inclusion criteria not met|0|||
130201317|NCT02031640|468696471|FG002|Run-In Period|Inclusion criteria not met|0|||
130201318|NCT02031640|468696472|FG003|Run-In Period|Inclusion criteria not met|0|||
130201319|NCT02031640|468696473|FG004|Run-In Period|Inclusion criteria not met|0|||
130201320|NCT02031640|468696474|FG005|Run-In Period|Inclusion criteria not met|0|||
130201321|NCT02031640|468696469|FG000|Run-In Period|Exclusion criteria met|8|||
130201322|NCT02031640|468696470|FG001|Run-In Period|Exclusion criteria met|0|||
130201323|NCT02031640|468696471|FG002|Run-In Period|Exclusion criteria met|0|||
130201324|NCT02031640|468696472|FG003|Run-In Period|Exclusion criteria met|0|||
130201325|NCT02031640|468696473|FG004|Run-In Period|Exclusion criteria met|0|||
130201326|NCT02031640|468696474|FG005|Run-In Period|Exclusion criteria met|0|||
130201327|NCT02031640|468696469|FG000|Run-In Period|Randomization criteria not met|85|||
130201328|NCT02031640|468696470|FG001|Run-In Period|Randomization criteria not met|0|||
130201329|NCT02031640|468696471|FG002|Run-In Period|Randomization criteria not met|0|||
130201330|NCT02031640|468696472|FG003|Run-In Period|Randomization criteria not met|0|||
130201331|NCT02031640|468696473|FG004|Run-In Period|Randomization criteria not met|0|||
130201332|NCT02031640|468696474|FG005|Run-In Period|Randomization criteria not met|0|||
130201333|NCT02031640|468696469|FG000|Run-In Period|Various administrative reasons|17|||
130201334|NCT02031640|468696470|FG001|Run-In Period|Various administrative reasons|0|||
130201335|NCT02031640|468696471|FG002|Run-In Period|Various administrative reasons|0|||
130201336|NCT02031640|468696472|FG003|Run-In Period|Various administrative reasons|0|||
130201337|NCT02031640|468696473|FG004|Run-In Period|Various administrative reasons|0|||
130201338|NCT02031640|468696474|FG005|Run-In Period|Various administrative reasons|0|||
130201339|NCT02031640|468696469|FG000|Double-blind Treatment Period|Protocol deviation|0|||
130201340|NCT02031640|468696470|FG001|Double-blind Treatment Period|Protocol deviation|2|||
130201341|NCT02031640|468696471|FG002|Double-blind Treatment Period|Protocol deviation|0|||
130201342|NCT02031640|468696472|FG003|Double-blind Treatment Period|Protocol deviation|1|||
130201343|NCT02031640|468696473|FG004|Double-blind Treatment Period|Protocol deviation|3|||
130201344|NCT02031640|468696474|FG005|Double-blind Treatment Period|Protocol deviation|1|||
130201345|NCT02031640|468696469|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130201346|NCT02031640|468696470|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
130201347|NCT02031640|468696471|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
130201348|NCT02031640|468696472|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130201349|NCT02031640|468696473|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
130201350|NCT02031640|468696474|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
130201351|NCT02031640|468696469|FG000|Double-blind Treatment Period|Non-compliance|0|||
130201352|NCT02031640|468696470|FG001|Double-blind Treatment Period|Non-compliance|1|||
130201353|NCT02031640|468696471|FG002|Double-blind Treatment Period|Non-compliance|0|||
130201354|NCT02031640|468696472|FG003|Double-blind Treatment Period|Non-compliance|1|||
130201355|NCT02031640|468696473|FG004|Double-blind Treatment Period|Non-compliance|1|||
130201356|NCT02031640|468696474|FG005|Double-blind Treatment Period|Non-compliance|0|||
130201357|NCT02031640|468696469|FG000|Double-blind Treatment Period|Adverse Event|0|||
130201358|NCT02031640|468696470|FG001|Double-blind Treatment Period|Adverse Event|0|||
130201359|NCT02031640|468696471|FG002|Double-blind Treatment Period|Adverse Event|0|||
130201360|NCT02031640|468696472|FG003|Double-blind Treatment Period|Adverse Event|2|||
130201361|NCT02031640|468696473|FG004|Double-blind Treatment Period|Adverse Event|0|||
130201362|NCT02031640|468696474|FG005|Double-blind Treatment Period|Adverse Event|0|||
130201363|NCT02031640|468696469|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130201364|NCT02031640|468696470|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130201365|NCT02031640|468696471|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
130201366|NCT02031640|468696472|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201367|NCT02031640|468696473|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201368|NCT02031640|468696474|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201369|NCT02031640|468696469|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130201370|NCT02031640|468696470|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130201371|NCT02031640|468696471|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130201372|NCT02031640|468696472|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130201373|NCT02031640|468696473|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
130201374|NCT02031640|468696474|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130201375|NCT03085238|468696479|FG000|Overall Study|Adverse Event|2|||
130201376|NCT03085238|468696479|FG000|Overall Study|Death|2|||
130201377|NCT05896527|468696480|FG000|Overall Study|Withdrawal by Subject|11|||
130201378|NCT05896527|468696481|FG001|Overall Study|Withdrawal by Subject|10|||
130201379|NCT05896527|468696482|FG002|Overall Study|Withdrawal by Subject|4|||
130201380|NCT05896527|468696483|FG003|Overall Study|Withdrawal by Subject|3|||
130201381|NCT05896527|468696484|FG004|Overall Study|Withdrawal by Subject|2|||
130201382|NCT05896527|468696480|FG000|Overall Study|Lost to Follow-up|0|||
130201383|NCT05896527|468696481|FG001|Overall Study|Lost to Follow-up|2|||
130201384|NCT05896527|468696482|FG002|Overall Study|Lost to Follow-up|2|||
130201385|NCT05896527|468696483|FG003|Overall Study|Lost to Follow-up|2|||
130201386|NCT05896527|468696484|FG004|Overall Study|Lost to Follow-up|1|||
130201387|NCT05896527|468696480|FG000|Overall Study|Significant protocol noncompliance|0|||
130201388|NCT05896527|468696481|FG001|Overall Study|Significant protocol noncompliance|1|||
130201389|NCT05896527|468696482|FG002|Overall Study|Significant protocol noncompliance|0|||
130201390|NCT05896527|468696483|FG003|Overall Study|Significant protocol noncompliance|0|||
130201391|NCT05896527|468696484|FG004|Overall Study|Significant protocol noncompliance|0|||
130201392|NCT05896527|468696480|FG000|Overall Study|Eligibility criteria not met|1|||
130201393|NCT05896527|468696481|FG001|Overall Study|Eligibility criteria not met|0|||
130201394|NCT05896527|468696482|FG002|Overall Study|Eligibility criteria not met|0|||
130201395|NCT05896527|468696483|FG003|Overall Study|Eligibility criteria not met|0|||
130201396|NCT05896527|468696484|FG004|Overall Study|Eligibility criteria not met|0|||
130201397|NCT05896527|468696480|FG000|Overall Study|Sponsor's decision|0|||
130201398|NCT05896527|468696481|FG001|Overall Study|Sponsor's decision|0|||
130201399|NCT05896527|468696482|FG002|Overall Study|Sponsor's decision|0|||
130201400|NCT05896527|468696483|FG003|Overall Study|Sponsor's decision|1|||
130201401|NCT05896527|468696484|FG004|Overall Study|Sponsor's decision|0|||
130201402|NCT05896527|468696480|FG000|Overall Study|Investigator's decision|0|||
130201403|NCT05896527|468696481|FG001|Overall Study|Investigator's decision|1|||
130201404|NCT05896527|468696482|FG002|Overall Study|Investigator's decision|0|||
130201405|NCT05896527|468696483|FG003|Overall Study|Investigator's decision|0|||
130201406|NCT05896527|468696484|FG004|Overall Study|Investigator's decision|0|||
130201407|NCT05896527|468696480|FG000|Overall Study|Pregnancy of his partner|0|||
130201408|NCT05896527|468696481|FG001|Overall Study|Pregnancy of his partner|0|||
130201409|NCT05896527|468696482|FG002|Overall Study|Pregnancy of his partner|0|||
130201410|NCT05896527|468696483|FG003|Overall Study|Pregnancy of his partner|1|||
130201411|NCT05896527|468696484|FG004|Overall Study|Pregnancy of his partner|0|||
130201412|NCT01279070|468696485|FG000|Overall Study|Withdrawal by Subject|2|||
130201413|NCT01279070|468696486|FG001|Overall Study|Withdrawal by Subject|3|||
130201414|NCT01279070|468696485|FG000|Overall Study|Acute exacerbation|3|||
130201415|NCT01279070|468696486|FG001|Overall Study|Acute exacerbation|1|||
130201416|NCT03781583|468696487|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
130201417|NCT03781583|468696488|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
130201418|NCT03781583|468696489|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
130201419|NCT03781583|468696490|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
130201420|NCT03781583|468696487|FG000|Overall Study|Technology did not work for that person in that environment|1|||
130201421|NCT03781583|468696488|FG001|Overall Study|Technology did not work for that person in that environment|0|||
130201422|NCT03781583|468696489|FG002|Overall Study|Technology did not work for that person in that environment|0|||
130201423|NCT03781583|468696490|FG003|Overall Study|Technology did not work for that person in that environment|0|||
130201424|NCT03781583|468696487|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
130201425|NCT03781583|468696488|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
130201426|NCT03781583|468696489|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
130201427|NCT03781583|468696490|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
130201428|NCT03781583|468696487|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201429|NCT03781583|468696488|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
130201430|NCT03781583|468696489|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201431|NCT03781583|468696490|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201432|NCT05139303|468696491|FG000|Overall Study|Lost to Follow-up|3|||
130201433|NCT05139303|468696492|FG001|Overall Study|Lost to Follow-up|0|||
130201434|NCT05139303|468696491|FG000|Overall Study|Adverse Event|1|||
130201435|NCT05139303|468696492|FG001|Overall Study|Adverse Event|0|||
130201436|NCT02222545|468696493|FG000|Overall Study|Adverse Event|1|||
130201437|NCT02222545|468696494|FG001|Overall Study|Adverse Event|0|||
130201438|NCT02222545|468696495|FG002|Overall Study|Adverse Event|2|||
130201439|NCT02222545|468696493|FG000|Overall Study|Death|0|||
130201440|NCT02222545|468696494|FG001|Overall Study|Death|0|||
130201441|NCT02222545|468696495|FG002|Overall Study|Death|9|||
130201442|NCT02222545|468696493|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130201443|NCT02222545|468696494|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130201444|NCT02222545|468696495|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
130201445|NCT02222545|468696493|FG000|Overall Study|Withdrawal by Subject|0|||
130201446|NCT02222545|468696494|FG001|Overall Study|Withdrawal by Subject|0|||
130201447|NCT02222545|468696495|FG002|Overall Study|Withdrawal by Subject|3|||
130201448|NCT02222545|468696493|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
130201449|NCT02222545|468696494|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
130201450|NCT02222545|468696495|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
130201451|NCT00761280|468696496|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
130201452|NCT00761280|468696497|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
130201453|NCT00761280|468696496|FG000|Randomization to First Dose|Sponsor decision|1|||
130201454|NCT00761280|468696497|FG001|Randomization to First Dose|Sponsor decision|0|||
130201455|NCT00761280|468696496|FG000|Randomization to First Dose|Other|1|||
130201456|NCT00761280|468696497|FG001|Randomization to First Dose|Other|0|||
130201457|NCT00761280|468696496|FG000|First Dose to End of Study|End of trial|5|||
130201458|NCT00761280|468696497|FG001|First Dose to End of Study|End of trial|5|||
130201459|NCT00761280|468696496|FG000|First Dose to End of Study|Progressive disease|5|||
130201460|NCT00761280|468696497|FG001|First Dose to End of Study|Progressive disease|3|||
130201461|NCT00761280|468696496|FG000|First Dose to End of Study|Sponsor decision|1|||
130201462|NCT00761280|468696497|FG001|First Dose to End of Study|Sponsor decision|2|||
130201463|NCT00761280|468696496|FG000|First Dose to End of Study|Death|1|||
130201464|NCT00761280|468696497|FG001|First Dose to End of Study|Death|0|||
130201465|NCT00761280|468696496|FG000|First Dose to End of Study|Lost to Follow-up|0|||
130201466|NCT00761280|468696497|FG001|First Dose to End of Study|Lost to Follow-up|1|||
130201467|NCT03875482|468696498|FG000|Overall Study|Adverse Event|0|||
130201468|NCT03875482|468696499|FG001|Overall Study|Adverse Event|1|||
130201469|NCT03875482|468696498|FG000|Overall Study|Withdrew consent|5|||
130201470|NCT03875482|468696499|FG001|Overall Study|Withdrew consent|6|||
130201471|NCT03875482|468696498|FG000|Overall Study|Lost to Follow-up|8|||
130201472|NCT03875482|468696499|FG001|Overall Study|Lost to Follow-up|2|||
130201473|NCT03875482|468696498|FG000|Overall Study|Lack of Efficacy|0|||
130201474|NCT03875482|468696499|FG001|Overall Study|Lack of Efficacy|11|||
130201475|NCT02045862|468696501|FG000|Overall Study|Death|0|||
130201476|NCT02045862|468696502|FG001|Overall Study|Death|0|||
130201477|NCT02045862|468696503|FG002|Overall Study|Death|1|||
130201478|NCT02045862|468696501|FG000|Overall Study|Miscellaneous|5|||
130201479|NCT02045862|468696502|FG001|Overall Study|Miscellaneous|0|||
130201480|NCT02045862|468696503|FG002|Overall Study|Miscellaneous|8|||
130201481|NCT02045862|468696501|FG000|Overall Study|Withdrawal by Patient|18|||
130201482|NCT02045862|468696502|FG001|Overall Study|Withdrawal by Patient|27|||
130201483|NCT02045862|468696503|FG002|Overall Study|Withdrawal by Patient|57|||
130201484|NCT02045862|468696501|FG000|Overall Study|Protocol Violation|0|||
130201485|NCT02045862|468696502|FG001|Overall Study|Protocol Violation|0|||
130201486|NCT02045862|468696503|FG002|Overall Study|Protocol Violation|6|||
130201487|NCT02045862|468696501|FG000|Overall Study|Lack of Efficacy|8|||
130201488|NCT02045862|468696502|FG001|Overall Study|Lack of Efficacy|4|||
130201489|NCT02045862|468696503|FG002|Overall Study|Lack of Efficacy|13|||
130201490|NCT02045862|468696501|FG000|Overall Study|Randomized but not Received Study Drug|0|||
130201491|NCT02045862|468696502|FG001|Overall Study|Randomized but not Received Study Drug|2|||
130201492|NCT02045862|468696503|FG002|Overall Study|Randomized but not Received Study Drug|8|||
130201493|NCT02045862|468696501|FG000|Overall Study|Adverse Event|7|||
130201494|NCT02045862|468696502|FG001|Overall Study|Adverse Event|5|||
130201495|NCT02045862|468696503|FG002|Overall Study|Adverse Event|27|||
130201496|NCT02045862|468696501|FG000|Overall Study|Lost to Follow-up|1|||
130201497|NCT02045862|468696502|FG001|Overall Study|Lost to Follow-up|2|||
130201498|NCT02045862|468696503|FG002|Overall Study|Lost to Follow-up|6|||
130201499|NCT02691013|468696504|FG000|Overall Study|Withdrawal by Subject|3|||
130201500|NCT02691013|468696505|FG001|Overall Study|Withdrawal by Subject|0|||
130201501|NCT02111785|468696509|FG000|Overall Study|Death|0|||
130201502|NCT02111785|468696510|FG001|Overall Study|Death|1|||
130201503|NCT02111785|468696511|FG002|Overall Study|Death|0|||
130201504|NCT02111785|468696512|FG003|Overall Study|Death|0|||
130201505|NCT01075646|468696515|FG000|Overall Study|Lost to Follow-up|4|||
130201506|NCT01075646|468696516|FG001|Overall Study|Lost to Follow-up|3|||
130201507|NCT01075646|468696517|FG002|Overall Study|Lost to Follow-up|1|||
130201508|NCT01075646|468696518|FG003|Overall Study|Lost to Follow-up|2|||
130201509|NCT01676896|468696522|FG000|Overall Study|Withdrawal by Subject|12|||
130201510|NCT01676896|468696523|FG001|Overall Study|Withdrawal by Subject|7|||
130201511|NCT01676896|468696524|FG002|Overall Study|Withdrawal by Subject|19|||
130201512|NCT02256982|468696525|FG000|Overall Study|Disease Progression|0|||
130201513|NCT02256982|468696526|FG001|Overall Study|Disease Progression|1|||
130201514|NCT02822573|468696527|FG000|Overall Study|Lost to Follow-up|5|||
130201515|NCT02822573|468696528|FG001|Overall Study|Lost to Follow-up|3|||
130201516|NCT02822573|468696527|FG000|Overall Study|Physician Decision|1|||
130201517|NCT02822573|468696528|FG001|Overall Study|Physician Decision|1|||
130201518|NCT02822573|468696527|FG000|Overall Study|Withdrawal by Subject|9|||
130201519|NCT02822573|468696528|FG001|Overall Study|Withdrawal by Subject|5|||
130201520|NCT02822573|468696527|FG000|Overall Study|Protocol Violation|6|||
130201521|NCT02822573|468696528|FG001|Overall Study|Protocol Violation|4|||
130201522|NCT02822573|468696527|FG000|Overall Study|Too sick or ill|2|||
130201523|NCT02822573|468696528|FG001|Overall Study|Too sick or ill|1|||
130201524|NCT02822573|468696527|FG000|Overall Study|Disease Progression|1|||
130201525|NCT02822573|468696528|FG001|Overall Study|Disease Progression|1|||
130201526|NCT02822573|468696527|FG000|Overall Study|No reason given|6|||
130201527|NCT02822573|468696528|FG001|Overall Study|No reason given|4|||
130201528|NCT01044290|468696529|FG000|Follow-up 1|Death|3|||
130201529|NCT01044290|468696530|FG001|Follow-up 1|Death|3|||
130201530|NCT01044290|468696531|FG002|Follow-up 1|Death|1|||
130201531|NCT01044290|468696529|FG000|Follow-up 1|Withdrawal by Subject|2|||
130201532|NCT01044290|468696530|FG001|Follow-up 1|Withdrawal by Subject|2|||
130201533|NCT01044290|468696531|FG002|Follow-up 1|Withdrawal by Subject|0|||
130201534|NCT01044290|468696529|FG000|Follow-Up 2|Death|0|||
130201535|NCT01044290|468696530|FG001|Follow-Up 2|Death|1|||
130201536|NCT01044290|468696531|FG002|Follow-Up 2|Death|1|||
130201537|NCT01044290|468696529|FG000|Follow-Up 2|Withdrawal by Subject|0|||
130201538|NCT01044290|468696530|FG001|Follow-Up 2|Withdrawal by Subject|1|||
130201539|NCT01044290|468696531|FG002|Follow-Up 2|Withdrawal by Subject|1|||
130201540|NCT00759785|468696537|FG000|Overall Study|Participant sample not evaluable|11|||
130201541|NCT00759785|468696538|FG001|Overall Study|Participant sample not evaluable|2|||
130201542|NCT00759785|468696537|FG000|Overall Study|Participant sample lost|0|||
130201543|NCT00759785|468696538|FG001|Overall Study|Participant sample lost|1|||
130201544|NCT00759785|468696537|FG000|Overall Study|Protocol Violation|1|||
130201545|NCT00759785|468696538|FG001|Overall Study|Protocol Violation|0|||
130201546|NCT00759785|468696537|FG000|Overall Study|Physician Decision|0|||
130201547|NCT00759785|468696538|FG001|Overall Study|Physician Decision|1|||
130201548|NCT00759785|468696537|FG000|Overall Study|Withdrawal by Subject|0|||
130201549|NCT00759785|468696538|FG001|Overall Study|Withdrawal by Subject|1|||
130201550|NCT01646021|468696539|FG000|Overall Study|Death|77|||
130201551|NCT01646021|468696540|FG001|Overall Study|Death|83|||
130201552|NCT01646021|468696539|FG000|Overall Study|Study Terminated by Sponsor|50|||
130201553|NCT01646021|468696540|FG001|Overall Study|Study Terminated by Sponsor|41|||
130201554|NCT01646021|468696539|FG000|Overall Study|Lost to Follow-up|2|||
130201555|NCT01646021|468696540|FG001|Overall Study|Lost to Follow-up|2|||
130201556|NCT01646021|468696539|FG000|Overall Study|Withdrawal by Subject|10|||
130201557|NCT01646021|468696540|FG001|Overall Study|Withdrawal by Subject|15|||
130201558|NCT01967706|468696548|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130201559|NCT01967706|468696549|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201560|NCT01967706|468696550|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201561|NCT01967706|468696551|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201562|NCT02777970|468696552|FG000|Overall Study|Lost to Follow-up|0|||
130201563|NCT02777970|468696553|FG001|Overall Study|Lost to Follow-up|1|||
130201564|NCT02777970|468696554|FG002|Overall Study|Lost to Follow-up|0|||
130201565|NCT02777970|468696552|FG000|Overall Study|Protocol Violation|1|||
130201566|NCT02777970|468696553|FG001|Overall Study|Protocol Violation|0|||
130201567|NCT02777970|468696554|FG002|Overall Study|Protocol Violation|0|||
130201568|NCT02347891|468696555|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
130201569|NCT02347891|468696556|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
130201570|NCT02347891|468696555|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130201571|NCT02347891|468696556|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130201572|NCT01083186|468696562|FG000|Overall Study|Lost to Follow-up|48|||
130201573|NCT01083186|468696562|FG000|Overall Study|Consent Withdrawal|7|||
130201574|NCT01083186|468696562|FG000|Overall Study|Death|3|||
130201575|NCT01083186|468696562|FG000|Overall Study|Adverse Event|3|||
130201576|NCT01083186|468696562|FG000|Overall Study|Lack of Efficacy|2|||
130201577|NCT01083186|468696562|FG000|Overall Study|Hemodialysis Initiation|28|||
130201578|NCT01083186|468696562|FG000|Overall Study|Administrative Reasons|2|||
130201579|NCT01083186|468696562|FG000|Overall Study|Non-compliance to Study Treatment|1|||
130201580|NCT03419598|468696569|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
130201581|NCT04569968|468696570|FG000|Overall Study|Lost to Follow-up|2|||
130201582|NCT04569968|468696571|FG001|Overall Study|Lost to Follow-up|5|||
130201583|NCT04569968|468696570|FG000|Overall Study|Story of head and/or neck surgery|2|||
130201584|NCT04569968|468696571|FG001|Overall Study|Story of head and/or neck surgery|2|||
130201585|NCT04569968|468696570|FG000|Overall Study|Time of stroke onset|8|||
130201586|NCT04569968|468696571|FG001|Overall Study|Time of stroke onset|7|||
130201587|NCT04569968|468696570|FG000|Overall Study|Type of strokr|12|||
130201588|NCT04569968|468696571|FG001|Overall Study|Type of strokr|8|||
130201589|NCT04569968|468696570|FG000|Overall Study|Cooperation|8|||
130201590|NCT04569968|468696571|FG001|Overall Study|Cooperation|8|||
130201591|NCT04569968|468696570|FG000|Overall Study|Age interval|17|||
130201592|NCT04569968|468696571|FG001|Overall Study|Age interval|6|||
130201593|NCT04569968|468696570|FG000|Overall Study|Denial of participation to the study|0|||
130201594|NCT04569968|468696571|FG001|Overall Study|Denial of participation to the study|3|||
130201595|NCT04569968|468696570|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
130201596|NCT04569968|468696571|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
130201597|NCT04569968|468696570|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
130201598|NCT04569968|468696571|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
130201599|NCT04569968|468696570|FG000|Overall Study|Quarantine|1|||
130201600|NCT04569968|468696571|FG001|Overall Study|Quarantine|0|||
130201601|NCT04569968|468696570|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
130201602|NCT04569968|468696571|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
130201603|NCT04569968|468696570|FG000|Overall Study|Repetitive stroke|8|||
130201604|NCT04569968|468696571|FG001|Overall Study|Repetitive stroke|0|||
130201605|NCT04569968|468696570|FG000|Overall Study|Insufficient mastication|1|||
130201606|NCT04569968|468696571|FG001|Overall Study|Insufficient mastication|0|||
130201607|NCT04569968|468696570|FG000|Overall Study|Infection|1|||
130201608|NCT04569968|468696571|FG001|Overall Study|Infection|0|||
130201609|NCT02370667|468696572|FG000|Overall Study|Lost to Follow-up|0|||
130201610|NCT02370667|468696573|FG001|Overall Study|Lost to Follow-up|1|||
130201611|NCT02370667|468696574|FG002|Overall Study|Lost to Follow-up|0|||
130201612|NCT00976209|468696577|FG000|Treatment Period 1|Protocol Violation|1|||
130201613|NCT00976209|468696578|FG001|Treatment Period 1|Protocol Violation|0|||
130201614|NCT00976209|468696577|FG000|Treatment Period 1|Lost to Follow-up|2|||
130201615|NCT00976209|468696578|FG001|Treatment Period 1|Lost to Follow-up|0|||
130201616|NCT00976209|468696577|FG000|Treatment Period 1|Other|0|||
130201617|NCT00976209|468696578|FG001|Treatment Period 1|Other|1|||
130201618|NCT00976209|468696577|FG000|Wash-out Period|Adverse Event|1|||
130201619|NCT00976209|468696578|FG001|Wash-out Period|Adverse Event|2|||
130201620|NCT00976209|468696577|FG000|Wash-out Period|Lost to Follow-up|1|||
130201621|NCT00976209|468696578|FG001|Wash-out Period|Lost to Follow-up|0|||
130201622|NCT00976209|468696577|FG000|Wash-out Period|Protocol Violation|1|||
130201623|NCT00976209|468696578|FG001|Wash-out Period|Protocol Violation|0|||
130201624|NCT00976209|468696577|FG000|Wash-out Period|Other|1|||
130201625|NCT00976209|468696578|FG001|Wash-out Period|Other|0|||
130201626|NCT00976209|468696577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130201627|NCT00976209|468696578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130201628|NCT00976209|468696577|FG000|Treatment Period 2|Lost to Follow-up|0|||
130201629|NCT00976209|468696578|FG001|Treatment Period 2|Lost to Follow-up|1|||
130201630|NCT03197870|468696582|FG000|Overall Study|Adverse Event|9|||
130201631|NCT03197870|468696583|FG001|Overall Study|Adverse Event|4|||
130201632|NCT03197870|468696584|FG002|Overall Study|Adverse Event|6|||
130201633|NCT03197870|468696582|FG000|Overall Study|Withdrawal by Subject|2|||
130201634|NCT03197870|468696583|FG001|Overall Study|Withdrawal by Subject|3|||
130201635|NCT03197870|468696584|FG002|Overall Study|Withdrawal by Subject|0|||
130201636|NCT03197870|468696582|FG000|Overall Study|Lost to Follow-up|2|||
130201637|NCT03197870|468696583|FG001|Overall Study|Lost to Follow-up|2|||
130201638|NCT03197870|468696584|FG002|Overall Study|Lost to Follow-up|0|||
130201639|NCT03197870|468696582|FG000|Overall Study|data not available|1|||
130201640|NCT03197870|468696583|FG001|Overall Study|data not available|1|||
130201641|NCT03197870|468696584|FG002|Overall Study|data not available|0|||
130201642|NCT00978250|468696588|FG000|Overall Study|Late determination of ineligibility|0|||
130201643|NCT00978250|468696589|FG001|Overall Study|Late determination of ineligibility|1|||
130201644|NCT00978250|468696590|FG002|Overall Study|Late determination of ineligibility|0|||
130201645|NCT00978250|468696591|FG003|Overall Study|Late determination of ineligibility|1|||
130201646|NCT03973918|468696595|FG000|Overall Study|Adverse Event|0|||
130201647|NCT03973918|468696596|FG001|Overall Study|Adverse Event|0|||
130201648|NCT03973918|468696597|FG002|Overall Study|Adverse Event|0|||
130201649|NCT03973918|468696598|FG003|Overall Study|Adverse Event|1|||
130201650|NCT03973918|468696595|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201651|NCT03973918|468696596|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
130201652|NCT03973918|468696597|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201653|NCT03973918|468696598|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201654|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130201655|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
130201656|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130201657|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130201658|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130201659|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
130201660|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
130201661|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
130201662|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
130201663|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130201664|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
130201665|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130201666|NCT02951533|468696601|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130201667|NCT02951533|468696602|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
130201668|NCT02951533|468696603|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130201669|NCT02951533|468696601|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
130201670|NCT02951533|468696602|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130201671|NCT02951533|468696603|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130201672|NCT02951533|468696601|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130201673|NCT02951533|468696602|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
130201674|NCT02951533|468696603|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130201675|NCT02951533|468696601|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
130201676|NCT02951533|468696602|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
130201677|NCT02951533|468696603|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
130201678|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
130201679|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130201680|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130201681|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
130201682|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130201683|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130201684|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130201685|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
130201686|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130201687|NCT05174949|468696604|FG000|Overall Study|Physician Decision|1|||
130201688|NCT05174949|468696605|FG001|Overall Study|Physician Decision|2|||
130201689|NCT05174949|468696606|FG002|Overall Study|Physician Decision|0|||
130201690|NCT05174949|468696607|FG003|Overall Study|Physician Decision|1|||
130201691|NCT05174949|468696608|FG004|Overall Study|Physician Decision|0|||
130201692|NCT05174949|468696609|FG005|Overall Study|Physician Decision|0|||
130201693|NCT05174949|468696604|FG000|Overall Study|Withdrawal by Subject|0|||
130201694|NCT05174949|468696605|FG001|Overall Study|Withdrawal by Subject|1|||
130201695|NCT05174949|468696606|FG002|Overall Study|Withdrawal by Subject|0|||
130201696|NCT05174949|468696607|FG003|Overall Study|Withdrawal by Subject|0|||
130201697|NCT05174949|468696608|FG004|Overall Study|Withdrawal by Subject|0|||
130201698|NCT05174949|468696609|FG005|Overall Study|Withdrawal by Subject|0|||
130201699|NCT05174949|468696604|FG000|Overall Study|Lost to Follow-up|0|||
130201700|NCT05174949|468696605|FG001|Overall Study|Lost to Follow-up|0|||
130201701|NCT05174949|468696606|FG002|Overall Study|Lost to Follow-up|0|||
130201702|NCT05174949|468696607|FG003|Overall Study|Lost to Follow-up|1|||
130201703|NCT05174949|468696608|FG004|Overall Study|Lost to Follow-up|0|||
130201704|NCT05174949|468696609|FG005|Overall Study|Lost to Follow-up|0|||
130201705|NCT02029989|468696610|FG000|Overall Study|Withdrawal by Subject|1|||
130201706|NCT02029989|468696611|FG001|Overall Study|Withdrawal by Subject|0|||
130201707|NCT02029989|468696610|FG000|Overall Study|Withdrawal: Fear of needles|1|||
130201708|NCT02029989|468696611|FG001|Overall Study|Withdrawal: Fear of needles|0|||
130201709|NCT02029989|468696610|FG000|Overall Study|Change of location|2|||
130201710|NCT02029989|468696611|FG001|Overall Study|Change of location|3|||
130201711|NCT02029989|468696610|FG000|Overall Study|Physician Decision|2|||
130201712|NCT02029989|468696611|FG001|Overall Study|Physician Decision|0|||
130201713|NCT02029989|468696610|FG000|Overall Study|Lost to Follow-up|9|||
130201714|NCT02029989|468696611|FG001|Overall Study|Lost to Follow-up|7|||
130201715|NCT02029989|468696610|FG000|Overall Study|Death|0|||
130201716|NCT02029989|468696611|FG001|Overall Study|Death|1|||
130201717|NCT02029989|468696610|FG000|Overall Study|Protocol Violation|1|||
130201718|NCT02029989|468696611|FG001|Overall Study|Protocol Violation|0|||
130201719|NCT04351373|468696612|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
130201720|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
130201721|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
130201722|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
130201723|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
130201724|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
130201725|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
130201726|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
130201727|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
130201728|NCT00742508|468696621|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
130201729|NCT00742508|468696622|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
130201730|NCT04696354|468696625|FG000|Overall Study|Study termination|6|||
130201731|NCT04696354|468696626|FG001|Overall Study|Study termination|6|||
130201732|NCT02730377|468698980|FG000|Overall Study|Other|5|||
130201733|NCT02730377|468698981|FG001|Overall Study|Other|4|||
130201734|NCT02730377|468698980|FG000|Overall Study|Death|1|||
130201735|NCT02730377|468698981|FG001|Overall Study|Death|8|||
130201736|NCT02730377|468698980|FG000|Overall Study|Inadequate glycaemic control|368|||
130201737|NCT02730377|468698981|FG001|Overall Study|Inadequate glycaemic control|473|||
130201738|NCT02730377|468698980|FG000|Overall Study|Adverse Event|79|||
130201739|NCT02730377|468698981|FG001|Overall Study|Adverse Event|41|||
130201740|NCT02730377|468698980|FG000|Overall Study|Protocol Violation|23|||
130201741|NCT02730377|468698981|FG001|Overall Study|Protocol Violation|30|||
130201742|NCT02730377|468698980|FG000|Overall Study|Lack of Efficacy|4|||
130201743|NCT02730377|468698981|FG001|Overall Study|Lack of Efficacy|13|||
130201744|NCT02730377|468698980|FG000|Overall Study|Pregnancy|0|||
130201745|NCT02730377|468698981|FG001|Overall Study|Pregnancy|1|||
130201746|NCT02730377|468698980|FG000|Overall Study|Withdrawal by Subject|45|||
130201747|NCT02730377|468698981|FG001|Overall Study|Withdrawal by Subject|42|||
130201748|NCT02730377|468698980|FG000|Overall Study|Lost to Follow-up|25|||
130201749|NCT02730377|468698981|FG001|Overall Study|Lost to Follow-up|21|||
130201750|NCT04045132|468698984|FG000|Overall Study|Lost to Follow-up|3|||
130201751|NCT04045132|468698985|FG001|Overall Study|Lost to Follow-up|6|||
130201752|NCT02143791|468698988|FG000|Enrolled|Withdrawal by Subject|4|||
130201753|NCT02143791|468698988|FG000|Trial Stimulation|Lack of Efficacy|21|||
130201754|NCT02143791|468698988|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
130201755|NCT02143791|468698988|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
130201756|NCT02143791|468698988|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
130201757|NCT02143791|468698988|FG000|Any Programming (3-6 Months)|Missing Data|1|||
130201758|NCT02143791|468698988|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
130201759|NCT00401544|468698989|FG000|Overall Study|Adverse Event|5|||
130201760|NCT00401544|468698990|FG001|Overall Study|Adverse Event|1|||
130201761|NCT00401544|468698991|FG002|Overall Study|Adverse Event|1|||
130201762|NCT00401544|468698992|FG003|Overall Study|Adverse Event|1|||
130201763|NCT00401544|468698989|FG000|Overall Study|Death|3|||
130201764|NCT00401544|468698990|FG001|Overall Study|Death|6|||
130201765|NCT00401544|468698991|FG002|Overall Study|Death|2|||
130201766|NCT00401544|468698992|FG003|Overall Study|Death|5|||
130201767|NCT00401544|468698989|FG000|Overall Study|Lost to Follow-up|2|||
130201768|NCT00401544|468698990|FG001|Overall Study|Lost to Follow-up|0|||
130201769|NCT00401544|468698991|FG002|Overall Study|Lost to Follow-up|1|||
130201770|NCT00401544|468698992|FG003|Overall Study|Lost to Follow-up|1|||
130201771|NCT00401544|468698989|FG000|Overall Study|Withdrawal by Subject|7|||
130201772|NCT00401544|468698990|FG001|Overall Study|Withdrawal by Subject|6|||
130201773|NCT00401544|468698991|FG002|Overall Study|Withdrawal by Subject|6|||
130201774|NCT00401544|468698992|FG003|Overall Study|Withdrawal by Subject|5|||
130201775|NCT00401544|468698989|FG000|Overall Study|Physician Decision|1|||
130201776|NCT00401544|468698990|FG001|Overall Study|Physician Decision|3|||
130201777|NCT00401544|468698991|FG002|Overall Study|Physician Decision|0|||
130201778|NCT00401544|468698992|FG003|Overall Study|Physician Decision|0|||
130201779|NCT00401544|468698989|FG000|Overall Study|Ineligibility determined|0|||
130201780|NCT00401544|468698990|FG001|Overall Study|Ineligibility determined|1|||
130201781|NCT00401544|468698991|FG002|Overall Study|Ineligibility determined|0|||
130201782|NCT00401544|468698992|FG003|Overall Study|Ineligibility determined|2|||
130201783|NCT00401544|468698989|FG000|Overall Study|Disease progression|0|||
130201784|NCT00401544|468698990|FG001|Overall Study|Disease progression|1|||
130201785|NCT00401544|468698991|FG002|Overall Study|Disease progression|0|||
130201786|NCT00401544|468698992|FG003|Overall Study|Disease progression|0|||
130201787|NCT00401544|468698989|FG000|Overall Study|Other|0|||
130201788|NCT00401544|468698990|FG001|Overall Study|Other|0|||
130201789|NCT00401544|468698991|FG002|Overall Study|Other|2|||
130201790|NCT00401544|468698992|FG003|Overall Study|Other|2|||
130201791|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Adverse Event|6|||
130201792|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Adverse Event|14|||
130201793|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Death|3|||
130201794|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Death|1|||
130201795|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
130201796|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
130201797|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
130201798|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
130201799|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
130201800|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
130201801|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
130201802|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
130201803|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
130201804|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
130201805|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Physician Decision|2|||
130201806|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Physician Decision|4|||
130201807|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Pregnancy|2|||
130201808|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Pregnancy|1|||
130201809|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
130201810|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
130201811|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
130201812|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
130201813|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
130201814|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
130201815|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
130201816|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
130201817|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
130201818|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
130201819|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
130201820|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
130201821|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
130201822|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
130201823|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
130201824|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
130201825|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
130201826|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
130201827|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
130201828|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
130201829|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
130201830|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
130201831|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
130201832|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
130201833|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
130201834|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
130201835|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
130201836|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
130201837|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130201838|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130201839|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
130201840|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
130201841|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130201842|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130201843|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
130201844|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
130201845|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
130201846|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
130201847|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130201848|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130201849|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
130201850|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
130201851|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
130201852|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
130201853|NCT00738881|468699010|FG000|Overall Study|Withdrawal by Subject|0|||
130201854|NCT00738881|468699011|FG001|Overall Study|Withdrawal by Subject|2|||
130201855|NCT00348790|468699012|FG000|Completed Treatment|Withdrawal by Subject|4|||
130201856|NCT00348790|468699012|FG000|Completed Treatment|Disease progression|14|||
130201857|NCT00348790|468699012|FG000|Completed Treatment|Adverse Event|4|||
130201858|NCT00348790|468699012|FG000|Completed Treatment|Required surgery|2|||
130201859|NCT00348790|468699012|FG000|Completed Treatment|Unable to travel to study site|1|||
130201860|NCT04712019|468699014|FG000|Overall Study|Withdrawal by Subject|2|||
130201861|NCT04712019|468699015|FG001|Overall Study|Withdrawal by Subject|2|||
130201862|NCT04712019|468699014|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130201863|NCT04712019|468699015|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130201864|NCT01282164|468699016|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
130201865|NCT01282164|468699017|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
130201866|NCT04521621|468699018|FG000|Overall Study|Death|17|||
130201867|NCT04521621|468699019|FG001|Overall Study|Death|8|||
130201868|NCT04521621|468699020|FG002|Overall Study|Death|8|||
130201869|NCT04521621|468699021|FG003|Overall Study|Death|5|||
130201870|NCT04521621|468699022|FG004|Overall Study|Death|2|||
130201871|NCT04521621|468699023|FG005|Overall Study|Death|7|||
130201872|NCT04521621|468699024|FG006|Overall Study|Death|0|||
130201873|NCT04521621|468699025|FG007|Overall Study|Death|0|||
130201874|NCT04521621|468699018|FG000|Overall Study|Study Terminated by Sponsor|4|||
130201875|NCT04521621|468699019|FG001|Overall Study|Study Terminated by Sponsor|6|||
130201876|NCT04521621|468699020|FG002|Overall Study|Study Terminated by Sponsor|8|||
130201877|NCT04521621|468699021|FG003|Overall Study|Study Terminated by Sponsor|0|||
130201878|NCT04521621|468699022|FG004|Overall Study|Study Terminated by Sponsor|1|||
130201879|NCT04521621|468699023|FG005|Overall Study|Study Terminated by Sponsor|7|||
130201880|NCT04521621|468699024|FG006|Overall Study|Study Terminated by Sponsor|0|||
130201881|NCT04521621|468699025|FG007|Overall Study|Study Terminated by Sponsor|0|||
130201882|NCT04521621|468699018|FG000|Overall Study|Withdrawal by Subject|0|||
130201883|NCT04521621|468699019|FG001|Overall Study|Withdrawal by Subject|0|||
130201884|NCT04521621|468699020|FG002|Overall Study|Withdrawal by Subject|1|||
130201885|NCT04521621|468699021|FG003|Overall Study|Withdrawal by Subject|1|||
130201886|NCT04521621|468699022|FG004|Overall Study|Withdrawal by Subject|0|||
130201887|NCT04521621|468699023|FG005|Overall Study|Withdrawal by Subject|0|||
130201888|NCT04521621|468699024|FG006|Overall Study|Withdrawal by Subject|0|||
130201889|NCT04521621|468699025|FG007|Overall Study|Withdrawal by Subject|0|||
130201890|NCT04521621|468699018|FG000|Overall Study|Allocated in error without study intervention|1|||
130201891|NCT04521621|468699019|FG001|Overall Study|Allocated in error without study intervention|0|||
130201892|NCT04521621|468699020|FG002|Overall Study|Allocated in error without study intervention|0|||
130201893|NCT04521621|468699021|FG003|Overall Study|Allocated in error without study intervention|0|||
130201894|NCT04521621|468699022|FG004|Overall Study|Allocated in error without study intervention|0|||
130201895|NCT04521621|468699023|FG005|Overall Study|Allocated in error without study intervention|0|||
130201896|NCT04521621|468699024|FG006|Overall Study|Allocated in error without study intervention|0|||
130201897|NCT04521621|468699025|FG007|Overall Study|Allocated in error without study intervention|0|||
130201898|NCT05845567|468699033|FG000|Overall Study|Withdrawal by Subject|1|||
130201899|NCT00725608|468699034|FG000|Overall Study|Lost to Follow-up|60|||
130201900|NCT00725608|468699034|FG000|Overall Study|Adverse Event|14|||
130201901|NCT00725608|468699034|FG000|Overall Study|Individual reasons|86|||
130201902|NCT00725608|468699034|FG000|Overall Study|Other|7|||
130201903|NCT03409107|468699035|FG000|Overall Study|Withdrawal by Subject|4|||
130201904|NCT03409107|468699036|FG001|Overall Study|Withdrawal by Subject|2|||
130201905|NCT03409107|468699035|FG000|Overall Study|Physician Decision|1|||
130201906|NCT03409107|468699036|FG001|Overall Study|Physician Decision|0|||
130201907|NCT03409107|468699035|FG000|Overall Study|Lost to Follow-up|7|||
130201908|NCT03409107|468699036|FG001|Overall Study|Lost to Follow-up|2|||
130201909|NCT03409107|468699035|FG000|Overall Study|Adverse Event|5|||
130201910|NCT03409107|468699036|FG001|Overall Study|Adverse Event|3|||
130201911|NCT00535847|468699038|FG000|Overall Study|Adverse Event|5|||
130201912|NCT00535847|468699039|FG001|Overall Study|Adverse Event|3|||
130201913|NCT00535847|468699040|FG002|Overall Study|Adverse Event|2|||
130201914|NCT00535847|468699038|FG000|Overall Study|Non compliance|1|||
130201915|NCT00535847|468699039|FG001|Overall Study|Non compliance|1|||
130201916|NCT00535847|468699040|FG002|Overall Study|Non compliance|0|||
130201917|NCT00535847|468699038|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
130201918|NCT00535847|468699039|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
130201919|NCT00535847|468699040|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
130201920|NCT00423189|468699041|FG000|Overall Study|Death|0|||
130201921|NCT00423189|468699042|FG001|Overall Study|Death|1|||
130201922|NCT00423189|468699043|FG002|Overall Study|Death|0|||
130201923|NCT01459718|468699046|FG000|Overall Study|Physician Decision|1|||
130201924|NCT01459718|468699046|FG000|Overall Study|Lost to Follow-up|1|||
130201925|NCT01459718|468699046|FG000|Overall Study|Adverse Event|1|||
130201926|NCT01258075|468699052|FG000|Overall Study|Adverse Event|8|||
130201927|NCT01258075|468699053|FG001|Overall Study|Adverse Event|3|||
130201928|NCT01258075|468699052|FG000|Overall Study|Lost to Follow-up|11|||
130201929|NCT01258075|468699053|FG001|Overall Study|Lost to Follow-up|6|||
130201930|NCT01258075|468699052|FG000|Overall Study|Withdrawal by Subject|10|||
130201931|NCT01258075|468699053|FG001|Overall Study|Withdrawal by Subject|7|||
130201932|NCT01258075|468699052|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
130201933|NCT01258075|468699053|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
130201934|NCT01258075|468699052|FG000|Overall Study|Other|12|||
130201935|NCT01258075|468699053|FG001|Overall Study|Other|5|||
130201936|NCT01618019|468699055|FG000|Overall Study|Withdrawal by Subject|14|||
130201937|NCT01618019|468699056|FG001|Overall Study|Withdrawal by Subject|14|||
130201938|NCT01542034|468699057|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
130201939|NCT01542034|468699058|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
130201940|NCT01542034|468699057|FG000|Overall Study|Administrative decision|0|||
130201941|NCT01542034|468699058|FG001|Overall Study|Administrative decision|3|||
130201942|NCT01542034|468699057|FG000|Overall Study|Subject Noncompliance|1|||
130201943|NCT01542034|468699058|FG001|Overall Study|Subject Noncompliance|0|||
130201944|NCT01542034|468699057|FG000|Overall Study|Adverse Event|2|||
130201945|NCT01542034|468699058|FG001|Overall Study|Adverse Event|2|||
130201946|NCT01542034|468699057|FG000|Overall Study|Lost to Follow-up|7|||
130201947|NCT01542034|468699058|FG001|Overall Study|Lost to Follow-up|6|||
130201948|NCT02612610|468699059|FG000|Overall Study|Withdrawal by Subject|1|||
130201949|NCT02612610|468699060|FG001|Overall Study|Withdrawal by Subject|1|||
130201950|NCT02612610|468699061|FG002|Overall Study|Withdrawal by Subject|0|||
130201951|NCT02612610|468699062|FG003|Overall Study|Withdrawal by Subject|2|||
130201952|NCT02612610|468699059|FG000|Overall Study|Adverse Event|2|||
130201953|NCT02612610|468699060|FG001|Overall Study|Adverse Event|2|||
130201954|NCT02612610|468699061|FG002|Overall Study|Adverse Event|3|||
130201955|NCT02612610|468699062|FG003|Overall Study|Adverse Event|10|||
130201956|NCT02612610|468699059|FG000|Overall Study|Lost to Follow-up|0|||
130201957|NCT02612610|468699060|FG001|Overall Study|Lost to Follow-up|1|||
130201958|NCT02612610|468699061|FG002|Overall Study|Lost to Follow-up|0|||
130201959|NCT02612610|468699062|FG003|Overall Study|Lost to Follow-up|0|||
130201960|NCT02612610|468699059|FG000|Overall Study|Protocol Violation|0|||
130201961|NCT02612610|468699060|FG001|Overall Study|Protocol Violation|1|||
130201962|NCT02612610|468699061|FG002|Overall Study|Protocol Violation|1|||
130201963|NCT02612610|468699062|FG003|Overall Study|Protocol Violation|0|||
130201964|NCT02612610|468699059|FG000|Overall Study|Lack of Efficacy|1|||
130201965|NCT02612610|468699060|FG001|Overall Study|Lack of Efficacy|2|||
130201966|NCT02612610|468699061|FG002|Overall Study|Lack of Efficacy|0|||
130201967|NCT02612610|468699062|FG003|Overall Study|Lack of Efficacy|1|||
130201968|NCT02612610|468699059|FG000|Overall Study|Physician Decision|0|||
130201969|NCT02612610|468699060|FG001|Overall Study|Physician Decision|1|||
130201970|NCT02612610|468699061|FG002|Overall Study|Physician Decision|0|||
130201971|NCT02612610|468699062|FG003|Overall Study|Physician Decision|0|||
130201972|NCT02612610|468699059|FG000|Overall Study|Noncompliance|1|||
130201973|NCT02612610|468699060|FG001|Overall Study|Noncompliance|0|||
130201974|NCT02612610|468699061|FG002|Overall Study|Noncompliance|0|||
130201975|NCT02612610|468699062|FG003|Overall Study|Noncompliance|0|||
130201976|NCT02612610|468699059|FG000|Overall Study|Cough Improvement|0|||
130201977|NCT02612610|468699060|FG001|Overall Study|Cough Improvement|0|||
130201978|NCT02612610|468699061|FG002|Overall Study|Cough Improvement|1|||
130201979|NCT02612610|468699062|FG003|Overall Study|Cough Improvement|0|||
130201980|NCT01801280|468699063|FG000|Period 1|Withdrawal by Subject|0|||
130201981|NCT01801280|468699064|FG001|Period 1|Withdrawal by Subject|1|||
130201982|NCT01801280|468699065|FG002|Period 1|Withdrawal by Subject|0|||
130201983|NCT01801280|468699066|FG003|Period 1|Withdrawal by Subject|0|||
130201984|NCT01801280|468699063|FG000|Period 2|Withdrawal by Subject|1|||
130201985|NCT01801280|468699064|FG001|Period 2|Withdrawal by Subject|0|||
130201986|NCT01801280|468699065|FG002|Period 2|Withdrawal by Subject|0|||
130201987|NCT01801280|468699066|FG003|Period 2|Withdrawal by Subject|0|||
130201988|NCT01801280|468699063|FG000|Period 4|Protocol Violation|0|||
130201989|NCT01801280|468699064|FG001|Period 4|Protocol Violation|0|||
130201990|NCT01801280|468699065|FG002|Period 4|Protocol Violation|1|||
130201991|NCT01801280|468699066|FG003|Period 4|Protocol Violation|0|||
130201992|NCT00176644|468699067|FG000|Overall Study|Withdrawal by Subject|1|||
130201993|NCT02783729|468699068|FG000|Overall Study|Lack of Efficacy|1|||
130201994|NCT02783729|468699069|FG001|Overall Study|Lack of Efficacy|0|||
130201995|NCT02783729|468699070|FG002|Overall Study|Lack of Efficacy|0|||
130201996|NCT02783729|468699071|FG003|Overall Study|Lack of Efficacy|0|||
130201997|NCT02783729|468699068|FG000|Overall Study|Adverse Event|2|||
130201998|NCT02783729|468699069|FG001|Overall Study|Adverse Event|6|||
130201999|NCT02783729|468699070|FG002|Overall Study|Adverse Event|2|||
130202000|NCT02783729|468699071|FG003|Overall Study|Adverse Event|3|||
130202001|NCT02783729|468699068|FG000|Overall Study|Other|1|||
130202002|NCT02783729|468699069|FG001|Overall Study|Other|6|||
130202003|NCT02783729|468699070|FG002|Overall Study|Other|2|||
130202004|NCT02783729|468699071|FG003|Overall Study|Other|3|||
130202005|NCT02783729|468699068|FG000|Overall Study|Withdrawal by Subject|2|||
130202006|NCT02783729|468699069|FG001|Overall Study|Withdrawal by Subject|3|||
130202007|NCT02783729|468699070|FG002|Overall Study|Withdrawal by Subject|1|||
130202008|NCT02783729|468699071|FG003|Overall Study|Withdrawal by Subject|2|||
130202009|NCT02783729|468699068|FG000|Overall Study|Participant's choice|2|||
130202010|NCT02783729|468699069|FG001|Overall Study|Participant's choice|1|||
130202011|NCT02783729|468699070|FG002|Overall Study|Participant's choice|2|||
130202012|NCT02783729|468699071|FG003|Overall Study|Participant's choice|1|||
130202013|NCT02783729|468699068|FG000|Overall Study|Lost to Follow-up|2|||
130202014|NCT02783729|468699069|FG001|Overall Study|Lost to Follow-up|1|||
130202015|NCT02783729|468699070|FG002|Overall Study|Lost to Follow-up|1|||
130202016|NCT02783729|468699071|FG003|Overall Study|Lost to Follow-up|0|||
130202017|NCT02693171|468699072|FG000|Overall Study|Adverse Event|1|||
130202018|NCT02693171|468699072|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
130202019|NCT01866657|468699080|FG000|Overall Study|Surgery canceled|2|||
130202020|NCT01866657|468699081|FG001|Overall Study|Surgery canceled|0|||
130202021|NCT02288091|468699088|FG000|Overall Study|Lost to Follow-up|1|||
130202022|NCT02288091|468699088|FG000|Overall Study|Screen fail|7|||
130202023|NCT04021121|468699090|FG000|Overall Study|Death|3|||
130202024|NCT04021121|468699091|FG001|Overall Study|Death|3|||
130202025|NCT04021121|468699092|FG002|Overall Study|Death|5|||
130202026|NCT04021121|468699093|FG003|Overall Study|Death|4|||
130202027|NCT03099694|468699103|FG000|Overall Study|Withdrawal by Subject|11|||
130202028|NCT03099694|468699104|FG001|Overall Study|Withdrawal by Subject|13|||
130202029|NCT03099694|468699103|FG000|Overall Study|Lost to Follow-up|9|||
130202030|NCT03099694|468699104|FG001|Overall Study|Lost to Follow-up|5|||
130202031|NCT00471718|468699110|FG000|Overall Study|Adverse Event|3|||
130202032|NCT00471718|468699110|FG000|Overall Study|other complicating disease|1|||
130202033|NCT00471718|468699110|FG000|Overall Study|disease progression|22|||
130202034|NCT00471718|468699110|FG000|Overall Study|Withdrawal by Subject|1|||
130202035|NCT02880865|468699111|FG000|Overall Study|Adverse Event|1|||
130202036|NCT02880865|468699112|FG001|Overall Study|Adverse Event|0|||
130202037|NCT02880865|468699111|FG000|Overall Study|Withdrawal by Subject|0|||
130202038|NCT02880865|468699112|FG001|Overall Study|Withdrawal by Subject|2|||
130202039|NCT02880865|468699111|FG000|Overall Study|Physician Decision|0|||
130202040|NCT02880865|468699112|FG001|Overall Study|Physician Decision|1|||
130202041|NCT01446237|468699114|FG000|Overall Study|Adverse Event|1|||
130202042|NCT01446237|468699114|FG000|Overall Study|Lost to Follow-up|2|||
130202043|NCT01446237|468699114|FG000|Overall Study|Withdrawal by Subject|7|||
130202044|NCT01190267|468699117|FG000|Overall Study|Adverse Event|10|||
130202045|NCT01190267|468699118|FG001|Overall Study|Adverse Event|0|||
130202046|NCT01190267|468699117|FG000|Overall Study|Treatment Failure|8|||
130202047|NCT01190267|468699118|FG001|Overall Study|Treatment Failure|2|||
130202048|NCT01190267|468699117|FG000|Overall Study|Lost to Follow-up|2|||
130202049|NCT01190267|468699118|FG001|Overall Study|Lost to Follow-up|0|||
130202050|NCT01190267|468699117|FG000|Overall Study|Withdrawal by Subject|13|||
130202051|NCT01190267|468699118|FG001|Overall Study|Withdrawal by Subject|1|||
130202052|NCT01190267|468699117|FG000|Overall Study|Protocol Violation|8|||
130202053|NCT01190267|468699118|FG001|Overall Study|Protocol Violation|1|||
130202054|NCT04017832|468699121|FG000|Overall Study|Withdrawal by Subject|13|||
130202055|NCT04017832|468699122|FG001|Overall Study|Withdrawal by Subject|12|||
130202056|NCT04017832|468699123|FG002|Overall Study|Withdrawal by Subject|21|||
130202057|NCT04017832|468699124|FG003|Overall Study|Withdrawal by Subject|7|||
130202058|NCT04017832|468699121|FG000|Overall Study|Lost to Follow-up|0|||
130202059|NCT04017832|468699122|FG001|Overall Study|Lost to Follow-up|3|||
130202060|NCT04017832|468699123|FG002|Overall Study|Lost to Follow-up|3|||
130202061|NCT04017832|468699124|FG003|Overall Study|Lost to Follow-up|1|||
130202062|NCT04017832|468699121|FG000|Overall Study|Physician Decision|1|||
130202063|NCT04017832|468699122|FG001|Overall Study|Physician Decision|1|||
130202064|NCT04017832|468699123|FG002|Overall Study|Physician Decision|1|||
130202065|NCT04017832|468699124|FG003|Overall Study|Physician Decision|1|||
130202066|NCT04017832|468699121|FG000|Overall Study|Death|2|||
130202067|NCT04017832|468699122|FG001|Overall Study|Death|2|||
130202068|NCT04017832|468699123|FG002|Overall Study|Death|1|||
130202069|NCT04017832|468699124|FG003|Overall Study|Death|0|||
130202070|NCT02294175|468699126|FG000|Overall Study|Withdrawal by Subject|1|||
130202071|NCT02294175|468699127|FG001|Overall Study|Withdrawal by Subject|2|||
130202072|NCT02294175|468699126|FG000|Overall Study|pt taking excluded medication|3|||
130202073|NCT02294175|468699127|FG001|Overall Study|pt taking excluded medication|1|||
130202074|NCT02294175|468699126|FG000|Overall Study|Protocol Violation|1|||
130202075|NCT02294175|468699127|FG001|Overall Study|Protocol Violation|0|||
130202076|NCT02294175|468699126|FG000|Overall Study|Lost to Follow-up|0|||
130202077|NCT02294175|468699127|FG001|Overall Study|Lost to Follow-up|1|||
130202078|NCT02294175|468699126|FG000|Overall Study|wound healed|0|||
130202079|NCT02294175|468699127|FG001|Overall Study|wound healed|2|||
130202080|NCT00965341|468699131|FG000|Overall Study|Withdrew consent|1|||
130202081|NCT00965341|468699132|FG001|Overall Study|Withdrew consent|5|||
130202082|NCT00965341|468699131|FG000|Overall Study|Lost to Follow-up|1|||
130202083|NCT00965341|468699132|FG001|Overall Study|Lost to Follow-up|0|||
130202084|NCT00965341|468699131|FG000|Overall Study|Transportation issues|4|||
130202085|NCT00965341|468699132|FG001|Overall Study|Transportation issues|3|||
130202086|NCT01077739|468699138|FG000|Overall Study|Premature withdrawal|1|||
130202087|NCT01077739|468699139|FG001|Overall Study|Premature withdrawal|3|||
130202088|NCT01077739|468699138|FG000|Overall Study|Withdrawal by Subject|1|||
130202089|NCT01077739|468699139|FG001|Overall Study|Withdrawal by Subject|0|||
130202090|NCT01077739|468699138|FG000|Overall Study|Death|0|||
130202091|NCT01077739|468699139|FG001|Overall Study|Death|3|||
130202092|NCT01077739|468699138|FG000|Overall Study|Unacceptable toxicity|1|||
130202093|NCT01077739|468699139|FG001|Overall Study|Unacceptable toxicity|2|||
130202094|NCT01077739|468699138|FG000|Overall Study|Other|2|||
130202095|NCT01077739|468699139|FG001|Overall Study|Other|2|||
130202096|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
130202097|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
130202098|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
130202099|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
130202100|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130202101|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130202102|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
130202103|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
130202104|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
130202105|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202106|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202107|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202108|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202109|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
130202110|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202111|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202112|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
130202113|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
130202114|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
130202115|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
130202116|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Death|0|||
130202117|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Death|0|||
130202118|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Death|1|||
130202119|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Death|0|||
130202120|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202121|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202122|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
130202123|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202124|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
130202125|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
130202126|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
130202127|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
130202128|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202129|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202130|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
130202131|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202132|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130202133|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
130202134|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130202135|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
130202136|NCT04464720|468699144|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
130202137|NCT00954512|468699151|FG000|Overall Study|Withdrawal by Subject|0|||
130202138|NCT00954512|468699152|FG001|Overall Study|Withdrawal by Subject|0|||
130202139|NCT00954512|468699153|FG002|Overall Study|Withdrawal by Subject|0|||
130202140|NCT00954512|468699154|FG003|Overall Study|Withdrawal by Subject|0|||
130202141|NCT00954512|468699155|FG004|Overall Study|Withdrawal by Subject|0|||
130202142|NCT00954512|468699156|FG005|Overall Study|Withdrawal by Subject|1|||
130202143|NCT00954512|468699151|FG000|Overall Study|Adverse Event|0|||
130202144|NCT00954512|468699152|FG001|Overall Study|Adverse Event|0|||
130202145|NCT00954512|468699153|FG002|Overall Study|Adverse Event|0|||
130202146|NCT00954512|468699154|FG003|Overall Study|Adverse Event|0|||
130202147|NCT00954512|468699155|FG004|Overall Study|Adverse Event|1|||
130202148|NCT00954512|468699156|FG005|Overall Study|Adverse Event|2|||
130202149|NCT00954512|468699151|FG000|Overall Study|Physician Decision|0|||
130202150|NCT00954512|468699152|FG001|Overall Study|Physician Decision|1|||
130202151|NCT00954512|468699153|FG002|Overall Study|Physician Decision|0|||
130202152|NCT00954512|468699154|FG003|Overall Study|Physician Decision|1|||
130202153|NCT00954512|468699155|FG004|Overall Study|Physician Decision|0|||
130202154|NCT00954512|468699156|FG005|Overall Study|Physician Decision|0|||
130202155|NCT00954512|468699151|FG000|Overall Study|Symptomatic Deterioration|0|||
130202156|NCT00954512|468699152|FG001|Overall Study|Symptomatic Deterioration|1|||
130202157|NCT00954512|468699153|FG002|Overall Study|Symptomatic Deterioration|0|||
130202158|NCT00954512|468699154|FG003|Overall Study|Symptomatic Deterioration|0|||
130202159|NCT00954512|468699155|FG004|Overall Study|Symptomatic Deterioration|2|||
130202160|NCT00954512|468699156|FG005|Overall Study|Symptomatic Deterioration|0|||
130202161|NCT00954512|468699151|FG000|Overall Study|Progression of Disease|2|||
130202162|NCT00954512|468699152|FG001|Overall Study|Progression of Disease|1|||
130202163|NCT00954512|468699153|FG002|Overall Study|Progression of Disease|0|||
130202164|NCT00954512|468699154|FG003|Overall Study|Progression of Disease|1|||
130202165|NCT00954512|468699155|FG004|Overall Study|Progression of Disease|1|||
130202166|NCT00954512|468699156|FG005|Overall Study|Progression of Disease|1|||
130202167|NCT01794793|468699157|FG000|Treatment Period|Withdrawal by Subject|24|||
130202168|NCT01794793|468699157|FG000|Treatment Period|Lack of Efficacy|22|||
130202169|NCT01794793|468699157|FG000|Treatment Period|Adverse Event|17|||
130202170|NCT01794793|468699157|FG000|Treatment Period|Physician Decision|14|||
130202171|NCT01794793|468699157|FG000|Treatment Period|Lost to Follow-up|7|||
130202172|NCT01794793|468699157|FG000|Treatment Period|Death|6|||
130202173|NCT01794793|468699157|FG000|Treatment Period|Protocol Violation|5|||
130202174|NCT01794793|468699157|FG000|Treatment Period|administrative problem|3|||
130202175|NCT01794793|468699157|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
130202176|NCT01794793|468699157|FG000|Post-treatment Follow-up|Adverse Event|8|||
130202177|NCT01794793|468699157|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
130202178|NCT01794793|468699157|FG000|Post-treatment Follow-up|administrative problem|5|||
130202179|NCT01794793|468699157|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
130202180|NCT01794793|468699157|FG000|Post-treatment Follow-up|Protocol Violation|3|||
130202181|NCT03495154|468699158|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
130202182|NCT03495154|468699158|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
130202183|NCT03495154|468699158|FG000|Overall Study|Screen Failures During Surgery|6|||
130202184|NCT03495154|468699158|FG000|Overall Study|Death|2|||
130202185|NCT03495154|468699158|FG000|Overall Study|Lost to Follow-up|16|||
130202186|NCT03495154|468699158|FG000|Overall Study|Withdrawal by Subject|2|||
130202187|NCT03495154|468699158|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
130202188|NCT05685732|468699159|FG000|Overall Study|Withdrawal by Subject|2|||
130202189|NCT05685732|468699160|FG001|Overall Study|Withdrawal by Subject|0|||
130202190|NCT05685732|468699161|FG002|Overall Study|Withdrawal by Subject|2|||
130202191|NCT05685732|468699162|FG003|Overall Study|Withdrawal by Subject|3|||
130202192|NCT05685732|468699159|FG000|Overall Study|Protocol Violation|1|||
130202193|NCT05685732|468699160|FG001|Overall Study|Protocol Violation|2|||
130202194|NCT05685732|468699161|FG002|Overall Study|Protocol Violation|4|||
130202195|NCT05685732|468699162|FG003|Overall Study|Protocol Violation|1|||
130202196|NCT05685732|468699159|FG000|Overall Study|Lost to Follow-up|5|||
130202197|NCT05685732|468699160|FG001|Overall Study|Lost to Follow-up|1|||
130202198|NCT05685732|468699161|FG002|Overall Study|Lost to Follow-up|3|||
130202199|NCT05685732|468699162|FG003|Overall Study|Lost to Follow-up|1|||
130202200|NCT05685732|468699159|FG000|Overall Study|Adverse Event|2|||
130202201|NCT05685732|468699160|FG001|Overall Study|Adverse Event|1|||
130202202|NCT05685732|468699161|FG002|Overall Study|Adverse Event|0|||
130202203|NCT05685732|468699162|FG003|Overall Study|Adverse Event|0|||
130202204|NCT05685732|468699159|FG000|Overall Study|Physician Decision|1|||
130202205|NCT05685732|468699160|FG001|Overall Study|Physician Decision|0|||
130202206|NCT05685732|468699161|FG002|Overall Study|Physician Decision|0|||
130202207|NCT05685732|468699162|FG003|Overall Study|Physician Decision|0|||
130202208|NCT02640404|468699163|FG000|Overall Study|Protocol Violation|1|||
130202209|NCT02640404|468699164|FG001|Overall Study|Protocol Violation|0|||
130202210|NCT02640404|468699163|FG000|Overall Study|Withdrawal by Subject|1|||
130202211|NCT02640404|468699164|FG001|Overall Study|Withdrawal by Subject|0|||
130202212|NCT05397171|468699166|FG000|Overall Study|Death|2|||
130202213|NCT05397171|468699167|FG001|Overall Study|Death|3|||
130202214|NCT05397171|468699168|FG002|Overall Study|Death|3|||
130202215|NCT05397171|468699166|FG000|Overall Study|Study Terminated By Sponsor|1|||
130202216|NCT05397171|468699167|FG001|Overall Study|Study Terminated By Sponsor|2|||
130202217|NCT05397171|468699168|FG002|Overall Study|Study Terminated By Sponsor|3|||
130202218|NCT05397171|468699166|FG000|Overall Study|Withdrawal by Subject|0|||
130202219|NCT05397171|468699167|FG001|Overall Study|Withdrawal by Subject|1|||
130202220|NCT05397171|468699168|FG002|Overall Study|Withdrawal by Subject|1|||
130202221|NCT02100670|468699169|FG000|Overall Study|Adverse Event|10|||
130202222|NCT02100670|468699170|FG001|Overall Study|Adverse Event|3|||
130202223|NCT02100670|468699171|FG002|Overall Study|Adverse Event|3|||
130202224|NCT02100670|468699172|FG003|Overall Study|Adverse Event|0|||
130202225|NCT02100670|468699169|FG000|Overall Study|Lost to Follow-up|1|||
130202226|NCT02100670|468699170|FG001|Overall Study|Lost to Follow-up|0|||
130202227|NCT02100670|468699171|FG002|Overall Study|Lost to Follow-up|0|||
130202228|NCT02100670|468699172|FG003|Overall Study|Lost to Follow-up|0|||
130202229|NCT02100670|468699169|FG000|Overall Study|Protocol Violation|0|||
130202230|NCT02100670|468699170|FG001|Overall Study|Protocol Violation|1|||
130202231|NCT02100670|468699171|FG002|Overall Study|Protocol Violation|0|||
130202232|NCT02100670|468699172|FG003|Overall Study|Protocol Violation|1|||
130202233|NCT02100670|468699169|FG000|Overall Study|Withdrawal of Consent|0|||
130202234|NCT02100670|468699170|FG001|Overall Study|Withdrawal of Consent|1|||
130202235|NCT02100670|468699171|FG002|Overall Study|Withdrawal of Consent|1|||
130202236|NCT02100670|468699172|FG003|Overall Study|Withdrawal of Consent|0|||
130202237|NCT02100670|468699169|FG000|Overall Study|No swelling no pain|1|||
130202238|NCT02100670|468699170|FG001|Overall Study|No swelling no pain|0|||
130202239|NCT02100670|468699171|FG002|Overall Study|No swelling no pain|0|||
130202240|NCT02100670|468699172|FG003|Overall Study|No swelling no pain|0|||
130202241|NCT02100670|468699169|FG000|Overall Study|Poor Efficacy|0|||
130202242|NCT02100670|468699170|FG001|Overall Study|Poor Efficacy|1|||
130202243|NCT02100670|468699171|FG002|Overall Study|Poor Efficacy|0|||
130202244|NCT02100670|468699172|FG003|Overall Study|Poor Efficacy|0|||
130202245|NCT02100670|468699169|FG000|Overall Study|Physician Decision|0|||
130202246|NCT02100670|468699170|FG001|Overall Study|Physician Decision|1|||
130202247|NCT02100670|468699171|FG002|Overall Study|Physician Decision|0|||
130202248|NCT02100670|468699172|FG003|Overall Study|Physician Decision|0|||
130202249|NCT02100670|468699169|FG000|Overall Study|Withdrawal by Subject|1|||
130202250|NCT02100670|468699170|FG001|Overall Study|Withdrawal by Subject|0|||
130202251|NCT02100670|468699171|FG002|Overall Study|Withdrawal by Subject|0|||
130202252|NCT02100670|468699172|FG003|Overall Study|Withdrawal by Subject|0|||
130202253|NCT02234596|468699173|FG000|Overall Study|Participant not treated|2|||
130202254|NCT03634033|468700824|FG000|Overall Study|Did not have a post-assessment|384|||
130202255|NCT03634033|468700825|FG001|Overall Study|Did not have a post-assessment|291|||
130202256|NCT03634033|468700826|FG002|Overall Study|Did not have a post-assessment|114|||
130202257|NCT03634033|468700827|FG003|Overall Study|Did not have a post-assessment|161|||
130202258|NCT03634033|468700828|FG004|Overall Study|Did not have a post-assessment|5|||
130202259|NCT03634033|468700829|FG005|Overall Study|Did not have a post-assessment|0|||
130202260|NCT03634033|468700830|FG006|Overall Study|Did not have a post-assessment|0|||
130202261|NCT03634033|468700824|FG000|Overall Study|Death|0|||
130202262|NCT03634033|468700825|FG001|Overall Study|Death|0|||
130202263|NCT03634033|468700826|FG002|Overall Study|Death|0|||
130202264|NCT03634033|468700827|FG003|Overall Study|Death|0|||
130202265|NCT03634033|468700828|FG004|Overall Study|Death|0|||
130202266|NCT03634033|468700829|FG005|Overall Study|Death|7|||
130202267|NCT03634033|468700830|FG006|Overall Study|Death|7|||
130202268|NCT03634033|468700824|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202269|NCT03634033|468700825|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202270|NCT03634033|468700826|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202271|NCT03634033|468700827|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202272|NCT03634033|468700828|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202273|NCT03634033|468700829|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130202274|NCT03634033|468700830|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130202275|NCT03634033|468700824|FG000|Overall Study|Lost to Follow-up|0|||
130202276|NCT03634033|468700825|FG001|Overall Study|Lost to Follow-up|0|||
130202277|NCT03634033|468700826|FG002|Overall Study|Lost to Follow-up|0|||
130202278|NCT03634033|468700827|FG003|Overall Study|Lost to Follow-up|0|||
130202279|NCT03634033|468700828|FG004|Overall Study|Lost to Follow-up|0|||
130202280|NCT03634033|468700829|FG005|Overall Study|Lost to Follow-up|1|||
130202281|NCT03634033|468700830|FG006|Overall Study|Lost to Follow-up|2|||
130202282|NCT03634033|468700824|FG000|Overall Study|Withdrawal by Subject|0|||
130202283|NCT03634033|468700825|FG001|Overall Study|Withdrawal by Subject|0|||
130202284|NCT03634033|468700826|FG002|Overall Study|Withdrawal by Subject|0|||
130202285|NCT03634033|468700827|FG003|Overall Study|Withdrawal by Subject|0|||
130202286|NCT03634033|468700828|FG004|Overall Study|Withdrawal by Subject|0|||
130202287|NCT03634033|468700829|FG005|Overall Study|Withdrawal by Subject|0|||
130202288|NCT03634033|468700830|FG006|Overall Study|Withdrawal by Subject|1|||
130202289|NCT01944670|468700833|FG000|Overall Study|Lost to Follow-up|2|||
130202290|NCT00743288|468700834|FG000|Overall Study|Adverse Event|1|||
130202291|NCT00743288|468700835|FG001|Overall Study|Adverse Event|1|||
130202292|NCT00743288|468700836|FG002|Overall Study|Adverse Event|2|||
130202293|NCT00743288|468700837|FG003|Overall Study|Adverse Event|2|||
130202294|NCT00743288|468700838|FG004|Overall Study|Adverse Event|1|||
130202295|NCT00743288|468700839|FG005|Overall Study|Adverse Event|1|||
130202296|NCT00743288|468700840|FG006|Overall Study|Adverse Event|2|||
130202297|NCT00743288|468700834|FG000|Overall Study|Withdrawal by Subject|0|||
130202298|NCT00743288|468700835|FG001|Overall Study|Withdrawal by Subject|0|||
130202299|NCT00743288|468700836|FG002|Overall Study|Withdrawal by Subject|1|||
130202300|NCT00743288|468700837|FG003|Overall Study|Withdrawal by Subject|0|||
130202301|NCT00743288|468700838|FG004|Overall Study|Withdrawal by Subject|0|||
130202302|NCT00743288|468700839|FG005|Overall Study|Withdrawal by Subject|1|||
130202303|NCT00743288|468700840|FG006|Overall Study|Withdrawal by Subject|1|||
130202304|NCT00743288|468700834|FG000|Overall Study|Progressive disease (PD)|2|||
130202305|NCT00743288|468700835|FG001|Overall Study|Progressive disease (PD)|0|||
130202306|NCT00743288|468700836|FG002|Overall Study|Progressive disease (PD)|1|||
130202307|NCT00743288|468700837|FG003|Overall Study|Progressive disease (PD)|4|||
130202308|NCT00743288|468700838|FG004|Overall Study|Progressive disease (PD)|5|||
130202309|NCT00743288|468700839|FG005|Overall Study|Progressive disease (PD)|3|||
130202310|NCT00743288|468700840|FG006|Overall Study|Progressive disease (PD)|6|||
130202311|NCT00743288|468700834|FG000|Overall Study|Worsening of condition (Not PD)|0|||
130202312|NCT00743288|468700835|FG001|Overall Study|Worsening of condition (Not PD)|2|||
130202313|NCT00743288|468700836|FG002|Overall Study|Worsening of condition (Not PD)|1|||
130202314|NCT00743288|468700837|FG003|Overall Study|Worsening of condition (Not PD)|1|||
130202315|NCT00743288|468700838|FG004|Overall Study|Worsening of condition (Not PD)|0|||
130202316|NCT00743288|468700839|FG005|Overall Study|Worsening of condition (Not PD)|0|||
130202317|NCT00743288|468700840|FG006|Overall Study|Worsening of condition (Not PD)|0|||
130202318|NCT05903924|468700841|FG000|Overall Study|Lost to Follow-up|1|||
130202319|NCT05903924|468700842|FG001|Overall Study|Lost to Follow-up|0|||
130202320|NCT05903924|468700843|FG002|Overall Study|Lost to Follow-up|0|||
130202321|NCT04338269|468700844|FG000|Overall Study|Death|86|||
130202322|NCT04338269|468700845|FG001|Overall Study|Death|89|||
130202323|NCT04338269|468700844|FG000|Overall Study|Lost to Follow-up|1|||
130202324|NCT04338269|468700845|FG001|Overall Study|Lost to Follow-up|2|||
130202325|NCT04338269|468700844|FG000|Overall Study|Physician Decision|1|||
130202326|NCT04338269|468700845|FG001|Overall Study|Physician Decision|0|||
130202327|NCT04338269|468700844|FG000|Overall Study|Withdrawal by Subject|14|||
130202328|NCT04338269|468700845|FG001|Overall Study|Withdrawal by Subject|11|||
130202329|NCT02203851|468700849|FG000|Overall Study|Lost to Follow-up|4|||
130202330|NCT02203851|468700849|FG000|Overall Study|Withdrawal by Subject|6|||
130202331|NCT02203851|468700849|FG000|Overall Study|Other|1|||
130202332|NCT01632150|468700850|FG000|Overall Study|Disease progression|27|||
130202333|NCT01632150|468700850|FG000|Overall Study|Study drug toxicity|1|||
130202334|NCT01632150|468700850|FG000|Overall Study|Unrelated adverse event|7|||
130202335|NCT01632150|468700850|FG000|Overall Study|Withdrawal by Subject|2|||
130202336|NCT01632150|468700850|FG000|Overall Study|Patient underwent autologous transplant|1|||
130202337|NCT01632150|468700850|FG000|Overall Study|Moved to compassionate program|2|||
130202338|NCT03391232|468700853|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
130202339|NCT03391232|468700854|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
130202340|NCT03391232|468700853|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
130202341|NCT03391232|468700854|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
130202342|NCT01054300|468700858|FG000|Period 1|Adverse Event|1|||
130202343|NCT01054300|468700859|FG001|Period 1|Adverse Event|0|||
130202344|NCT01054300|468700860|FG002|Period 1|Adverse Event|0|||
130202345|NCT01054300|468700861|FG003|Period 1|Adverse Event|0|||
130202346|NCT01054300|468700858|FG000|Period 2|Withdrawal by Subject|0|||
130202347|NCT01054300|468700859|FG001|Period 2|Withdrawal by Subject|0|||
130202348|NCT01054300|468700860|FG002|Period 2|Withdrawal by Subject|1|||
130202349|NCT01054300|468700861|FG003|Period 2|Withdrawal by Subject|0|||
130202350|NCT00308087|468700866|FG000|Overall Study|Progressive Disease|19|||
130202351|NCT00308087|468700867|FG001|Overall Study|Progressive Disease|21|||
130202352|NCT00308087|468700866|FG000|Overall Study|Study Closure|11|||
130202353|NCT00308087|468700867|FG001|Overall Study|Study Closure|12|||
130202354|NCT00308087|468700866|FG000|Overall Study|Withdrawal by Subject|2|||
130202355|NCT00308087|468700867|FG001|Overall Study|Withdrawal by Subject|1|||
130202356|NCT00308087|468700866|FG000|Overall Study|Other|4|||
130202357|NCT00308087|468700867|FG001|Overall Study|Other|3|||
130202358|NCT00177307|468700868|FG000|Overall Study|Withdrawal by Subject|1|||
130202359|NCT02677038|468700872|FG000|Overall Study|Physician Decision|1|||
130202360|NCT02677038|468700872|FG000|Overall Study|Withdrawal by Subject|1|||
130202361|NCT03671564|468700873|FG000|Overall Study|Progressive Disease|3|||
130202362|NCT03671564|468700874|FG001|Overall Study|Progressive Disease|5|||
130202363|NCT03671564|468700875|FG002|Overall Study|Progressive Disease|3|||
130202364|NCT03671564|468700873|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130202365|NCT03671564|468700874|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130202366|NCT03671564|468700875|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
130202367|NCT03671564|468700873|FG000|Overall Study|Withdrawal by Subject|1|||
130202368|NCT03671564|468700874|FG001|Overall Study|Withdrawal by Subject|1|||
130202369|NCT03671564|468700875|FG002|Overall Study|Withdrawal by Subject|0|||
130202370|NCT00380081|468700876|FG000|Overall Study|Withdrawal by Subject|0|||
130202371|NCT00380081|468700877|FG001|Overall Study|Withdrawal by Subject|0|||
130202372|NCT00380081|468700878|FG002|Overall Study|Withdrawal by Subject|0|||
130202373|NCT00380081|468700879|FG003|Overall Study|Withdrawal by Subject|0|||
130202374|NCT00380081|468700880|FG004|Overall Study|Withdrawal by Subject|1|||
130202375|NCT00380081|468700881|FG005|Overall Study|Withdrawal by Subject|0|||
130202376|NCT00380081|468700876|FG000|Overall Study|Family Emergency|0|||
130202377|NCT00380081|468700877|FG001|Overall Study|Family Emergency|0|||
130202378|NCT00380081|468700878|FG002|Overall Study|Family Emergency|0|||
130202379|NCT00380081|468700879|FG003|Overall Study|Family Emergency|0|||
130202380|NCT00380081|468700880|FG004|Overall Study|Family Emergency|0|||
130202381|NCT00380081|468700881|FG005|Overall Study|Family Emergency|1|||
130202382|NCT05007041|468700882|FG000|Overall Study|Missing Diary Entries|0|||
130202383|NCT05007041|468700883|FG001|Overall Study|Missing Diary Entries|1|||
130202384|NCT01546168|468700886|FG000|Overall Study|Lost to Follow-up|1|||
130202385|NCT01546168|468700887|FG001|Overall Study|Lost to Follow-up|0|||
130202386|NCT01546168|468700886|FG000|Overall Study|Withdrawal by Subject|1|||
130202387|NCT01546168|468700887|FG001|Overall Study|Withdrawal by Subject|0|||
130202388|NCT01546168|468700886|FG000|Overall Study|ineligible after signing consent|2|||
130202389|NCT01546168|468700887|FG001|Overall Study|ineligible after signing consent|0|||
130202390|NCT02850016|468700888|FG000|Overall Study|Withdrawal by Subject|1|||
130202391|NCT02850016|468700889|FG001|Overall Study|Withdrawal by Subject|2|||
130202392|NCT02954653|468700890|FG000|Overall Study|Death|3|||
130202393|NCT02954653|468700891|FG001|Overall Study|Death|1|||
130202394|NCT02954653|468700892|FG002|Overall Study|Death|0|||
130202395|NCT02954653|468700893|FG003|Overall Study|Death|0|||
130202396|NCT02954653|468700894|FG004|Overall Study|Death|0|||
130202397|NCT02954653|468700895|FG005|Overall Study|Death|0|||
130202398|NCT02954653|468700896|FG006|Overall Study|Death|0|||
130202399|NCT02954653|468700897|FG007|Overall Study|Death|0|||
130202400|NCT02954653|468700898|FG008|Overall Study|Death|0|||
130202401|NCT02954653|468700890|FG000|Overall Study|Randomized but did not receive treatment|1|||
130202402|NCT02954653|468700891|FG001|Overall Study|Randomized but did not receive treatment|0|||
130202403|NCT02954653|468700892|FG002|Overall Study|Randomized but did not receive treatment|0|||
130202404|NCT02954653|468700893|FG003|Overall Study|Randomized but did not receive treatment|0|||
130202405|NCT02954653|468700894|FG004|Overall Study|Randomized but did not receive treatment|0|||
130202406|NCT02954653|468700895|FG005|Overall Study|Randomized but did not receive treatment|0|||
130202407|NCT02954653|468700896|FG006|Overall Study|Randomized but did not receive treatment|0|||
130202408|NCT02954653|468700897|FG007|Overall Study|Randomized but did not receive treatment|0|||
130202409|NCT02954653|468700898|FG008|Overall Study|Randomized but did not receive treatment|0|||
130202410|NCT02954653|468700890|FG000|Overall Study|Started another anti-cancer therapy|0|||
130202411|NCT02954653|468700891|FG001|Overall Study|Started another anti-cancer therapy|1|||
130202412|NCT02954653|468700892|FG002|Overall Study|Started another anti-cancer therapy|0|||
130202413|NCT02954653|468700893|FG003|Overall Study|Started another anti-cancer therapy|0|||
130202414|NCT02954653|468700894|FG004|Overall Study|Started another anti-cancer therapy|0|||
130202415|NCT02954653|468700895|FG005|Overall Study|Started another anti-cancer therapy|0|||
130202416|NCT02954653|468700896|FG006|Overall Study|Started another anti-cancer therapy|0|||
130202417|NCT02954653|468700897|FG007|Overall Study|Started another anti-cancer therapy|0|||
130202418|NCT02954653|468700898|FG008|Overall Study|Started another anti-cancer therapy|0|||
130202419|NCT02954653|468700890|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
130202420|NCT02954653|468700891|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
130202421|NCT02954653|468700892|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
130202422|NCT02954653|468700893|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
130202423|NCT02954653|468700894|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
130202424|NCT02954653|468700895|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
130202425|NCT02954653|468700896|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
130202426|NCT02954653|468700897|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
130202427|NCT02954653|468700898|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
130202428|NCT00070018|468700902|FG000|Overall Study|Adverse Event|2|||
130202429|NCT00070018|468700902|FG000|Overall Study|Lack of Efficacy|1|||
130202430|NCT00070018|468700902|FG000|Overall Study|Withdrawal by Subject|1|||
130202431|NCT02939716|468700903|FG000|Overall Study|scanner failure|0|||
130202432|NCT02939716|468700904|FG001|Overall Study|scanner failure|0|||
130202433|NCT02939716|468700905|FG002|Overall Study|scanner failure|0|||
130202434|NCT02939716|468700906|FG003|Overall Study|scanner failure|1|||
130202435|NCT02939716|468700907|FG004|Overall Study|scanner failure|1|||
130202436|NCT02939716|468700908|FG005|Overall Study|scanner failure|1|||
130202437|NCT02543892|468700912|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
130202438|NCT02543892|468700913|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130202439|NCT02543892|468700914|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130202440|NCT02543892|468700915|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130202441|NCT02543892|468700916|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130202442|NCT02543892|468700917|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130202443|NCT02543892|468700918|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130202444|NCT02543892|468700919|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
130202445|NCT02543892|468700912|FG000|Received Vaccination 2|Physician Decision|0|||
130202446|NCT02543892|468700913|FG001|Received Vaccination 2|Physician Decision|0|||
130202447|NCT02543892|468700914|FG002|Received Vaccination 2|Physician Decision|0|||
130202448|NCT02543892|468700915|FG003|Received Vaccination 2|Physician Decision|0|||
130202449|NCT02543892|468700916|FG004|Received Vaccination 2|Physician Decision|0|||
130202450|NCT02543892|468700917|FG005|Received Vaccination 2|Physician Decision|1|||
130202451|NCT02543892|468700918|FG006|Received Vaccination 2|Physician Decision|0|||
130202452|NCT02543892|468700919|FG007|Received Vaccination 2|Physician Decision|0|||
130202453|NCT02543892|468700912|FG000|Received Vaccination 2|Adverse Event|0|||
130202454|NCT02543892|468700913|FG001|Received Vaccination 2|Adverse Event|1|||
130202455|NCT02543892|468700914|FG002|Received Vaccination 2|Adverse Event|0|||
130202456|NCT02543892|468700915|FG003|Received Vaccination 2|Adverse Event|0|||
130202457|NCT02543892|468700916|FG004|Received Vaccination 2|Adverse Event|0|||
130202458|NCT02543892|468700917|FG005|Received Vaccination 2|Adverse Event|0|||
130202459|NCT02543892|468700918|FG006|Received Vaccination 2|Adverse Event|0|||
130202460|NCT02543892|468700919|FG007|Received Vaccination 2|Adverse Event|0|||
130202461|NCT02543892|468700912|FG000|Had Immunology Data|Withdrawal by Subject|0|||
130202462|NCT02543892|468700913|FG001|Had Immunology Data|Withdrawal by Subject|0|||
130202463|NCT02543892|468700914|FG002|Had Immunology Data|Withdrawal by Subject|0|||
130202464|NCT02543892|468700915|FG003|Had Immunology Data|Withdrawal by Subject|0|||
130202465|NCT02543892|468700916|FG004|Had Immunology Data|Withdrawal by Subject|0|||
130202466|NCT02543892|468700917|FG005|Had Immunology Data|Withdrawal by Subject|0|||
130202467|NCT02543892|468700918|FG006|Had Immunology Data|Withdrawal by Subject|1|||
130202468|NCT02543892|468700919|FG007|Had Immunology Data|Withdrawal by Subject|0|||
130202469|NCT01500213|468700922|FG000|Overall Study|Adverse Event|35|||
130202470|NCT01500213|468700923|FG001|Overall Study|Adverse Event|35|||
130202471|NCT01500213|468700922|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
130202472|NCT01500213|468700923|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
130202473|NCT01500213|468700922|FG000|Overall Study|Withdrawal by Subject|28|||
130202474|NCT01500213|468700923|FG001|Overall Study|Withdrawal by Subject|37|||
130202475|NCT01500213|468700922|FG000|Overall Study|Death|7|||
130202476|NCT01500213|468700923|FG001|Overall Study|Death|3|||
130202477|NCT01500213|468700922|FG000|Overall Study|Disease Progression|13|||
130202478|NCT01500213|468700923|FG001|Overall Study|Disease Progression|21|||
130202479|NCT01500213|468700922|FG000|Overall Study|Protocol Violation|19|||
130202480|NCT01500213|468700923|FG001|Overall Study|Protocol Violation|19|||
130202481|NCT01500213|468700922|FG000|Overall Study|Physician Decision|12|||
130202482|NCT01500213|468700923|FG001|Overall Study|Physician Decision|10|||
130202483|NCT01500213|468700922|FG000|Overall Study|Lack of Efficacy|9|||
130202484|NCT01500213|468700923|FG001|Overall Study|Lack of Efficacy|7|||
130202485|NCT01500213|468700922|FG000|Overall Study|Lost to Follow-up|3|||
130202486|NCT01500213|468700923|FG001|Overall Study|Lost to Follow-up|6|||
130202487|NCT01500213|468700922|FG000|Overall Study|Other Reasons|7|||
130202488|NCT01500213|468700923|FG001|Overall Study|Other Reasons|5|||
130202489|NCT00785213|468700924|FG000|Quinine Sulfate Alone|Adverse Event|4|||
130202490|NCT00785213|468700924|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
130202491|NCT00525902|468700925|FG000|Overall Study|Lack of Efficacy|1|||
130202492|NCT00985959|468700926|FG000|Overall Study|Adverse Event|0|||
130202493|NCT00985959|468700927|FG001|Overall Study|Adverse Event|0|||
130202494|NCT00985959|468700928|FG002|Overall Study|Adverse Event|19|||
130202495|NCT00985959|468700926|FG000|Overall Study|Withdrawal by Subject|0|||
130202496|NCT00985959|468700927|FG001|Overall Study|Withdrawal by Subject|0|||
130202497|NCT00985959|468700928|FG002|Overall Study|Withdrawal by Subject|8|||
130202498|NCT00985959|468700926|FG000|Overall Study|Progressive disease|1|||
130202499|NCT00985959|468700927|FG001|Overall Study|Progressive disease|2|||
130202500|NCT00985959|468700928|FG002|Overall Study|Progressive disease|8|||
130202501|NCT00985959|468700926|FG000|Overall Study|Unrecovered toxicity|0|||
130202502|NCT00985959|468700927|FG001|Overall Study|Unrecovered toxicity|0|||
130202503|NCT00985959|468700928|FG002|Overall Study|Unrecovered toxicity|7|||
130202504|NCT00985959|468700926|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130202505|NCT00985959|468700927|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
130202506|NCT00985959|468700928|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130202507|NCT00985959|468700926|FG000|Overall Study|Complete response observed over 2 cycles|0|||
130202508|NCT00985959|468700927|FG001|Overall Study|Complete response observed over 2 cycles|1|||
130202509|NCT00985959|468700928|FG002|Overall Study|Complete response observed over 2 cycles|4|||
130202510|NCT00985959|468700926|FG000|Overall Study|Other|0|||
130202511|NCT00985959|468700927|FG001|Overall Study|Other|0|||
130202512|NCT00985959|468700928|FG002|Overall Study|Other|11|||
130202513|NCT00844480|468700935|FG000|Overall Study|Withdrawal by Subject|2|||
130202514|NCT00844480|468700936|FG001|Overall Study|Withdrawal by Subject|3|||
130202515|NCT02858180|468700937|FG000|Overall Study|Lost to Follow-up|0|||
130202516|NCT02858180|468700938|FG001|Overall Study|Lost to Follow-up|2|||
130202517|NCT00526331|468700939|FG000|Overall Study|Sponsor Termination|55|||
130202518|NCT00979420|468700940|FG000|Overall Study|Adverse Event|1|||
130202519|NCT00979420|468700941|FG001|Overall Study|Adverse Event|0|||
130202520|NCT00979420|468700942|FG002|Overall Study|Adverse Event|0|||
130202521|NCT00979420|468700943|FG003|Overall Study|Adverse Event|0|||
130202522|NCT00979420|468700940|FG000|Overall Study|Lack of Efficacy|3|||
130202523|NCT00979420|468700941|FG001|Overall Study|Lack of Efficacy|0|||
130202524|NCT00979420|468700942|FG002|Overall Study|Lack of Efficacy|1|||
130202525|NCT00979420|468700943|FG003|Overall Study|Lack of Efficacy|1|||
130202526|NCT00979420|468700940|FG000|Overall Study|Other reasons not related to Viramune|3|||
130202527|NCT00979420|468700941|FG001|Overall Study|Other reasons not related to Viramune|0|||
130202528|NCT00979420|468700942|FG002|Overall Study|Other reasons not related to Viramune|0|||
130202529|NCT00979420|468700943|FG003|Overall Study|Other reasons not related to Viramune|1|||
130202530|NCT00574249|468700944|FG000|Overall Study|Adverse Event|6|||
130202531|NCT00574249|468700945|FG001|Overall Study|Adverse Event|18|||
130202532|NCT00574249|468700944|FG000|Overall Study|Lack of Efficacy|5|||
130202533|NCT00574249|468700945|FG001|Overall Study|Lack of Efficacy|3|||
130202534|NCT00574249|468700944|FG000|Overall Study|Lost to Follow-up|4|||
130202535|NCT00574249|468700945|FG001|Overall Study|Lost to Follow-up|3|||
130202536|NCT00574249|468700944|FG000|Overall Study|Protocol Violation|5|||
130202537|NCT00574249|468700945|FG001|Overall Study|Protocol Violation|2|||
130202538|NCT00574249|468700944|FG000|Overall Study|History of carcinoma|1|||
130202539|NCT00574249|468700945|FG001|Overall Study|History of carcinoma|0|||
130202540|NCT00574249|468700944|FG000|Overall Study|Withdrawal by Subject|3|||
130202541|NCT00574249|468700945|FG001|Overall Study|Withdrawal by Subject|0|||
130202542|NCT00574249|468700944|FG000|Overall Study|Physician Decision|1|||
130202543|NCT00574249|468700945|FG001|Overall Study|Physician Decision|0|||
130202544|NCT00574249|468700944|FG000|Overall Study|Pregnancy|1|||
130202545|NCT00574249|468700945|FG001|Overall Study|Pregnancy|0|||
130202546|NCT00574249|468700944|FG000|Overall Study|Excluded by company|0|||
130202547|NCT00574249|468700945|FG001|Overall Study|Excluded by company|1|||
130202548|NCT00574249|468700944|FG000|Overall Study|PPD test taken twice|0|||
130202549|NCT00574249|468700945|FG001|Overall Study|PPD test taken twice|1|||
130202550|NCT00347919|468700948|FG000|Overall Study|Lost to Follow-up|11|||
130202551|NCT00347919|468700949|FG001|Overall Study|Lost to Follow-up|13|||
130202552|NCT00347919|468700950|FG002|Overall Study|Lost to Follow-up|0|||
130202553|NCT00347919|468700948|FG000|Overall Study|Withdrawal by Subject|6|||
130202554|NCT00347919|468700949|FG001|Overall Study|Withdrawal by Subject|8|||
130202555|NCT00347919|468700950|FG002|Overall Study|Withdrawal by Subject|0|||
130202556|NCT00347919|468700948|FG000|Overall Study|Physician Decision|1|||
130202557|NCT00347919|468700949|FG001|Overall Study|Physician Decision|1|||
130202558|NCT00347919|468700950|FG002|Overall Study|Physician Decision|0|||
130202559|NCT00347919|468700948|FG000|Overall Study|Sponsor terminated study|15|||
130202560|NCT00347919|468700949|FG001|Overall Study|Sponsor terminated study|10|||
130202561|NCT00347919|468700950|FG002|Overall Study|Sponsor terminated study|16|||
130202562|NCT00347919|468700948|FG000|Overall Study|Death|35|||
130202563|NCT00347919|468700949|FG001|Overall Study|Death|42|||
130202564|NCT00347919|468700950|FG002|Overall Study|Death|19|||
130202565|NCT00347919|468700948|FG000|Overall Study|Par. Started Other Treatment|1|||
130202566|NCT00347919|468700949|FG001|Overall Study|Par. Started Other Treatment|1|||
130202567|NCT00347919|468700950|FG002|Overall Study|Par. Started Other Treatment|1|||
130202568|NCT00347919|468700948|FG000|Overall Study|Missing|2|||
130202569|NCT00347919|468700949|FG001|Overall Study|Missing|1|||
130202570|NCT00347919|468700950|FG002|Overall Study|Missing|2|||
130202571|NCT01382225|468700960|FG000|Overall Study|Adverse Event|3|||
130202572|NCT01382225|468700961|FG001|Overall Study|Adverse Event|2|||
130202573|NCT01382225|468700960|FG000|Overall Study|Protocol Violation|2|||
130202574|NCT01382225|468700961|FG001|Overall Study|Protocol Violation|1|||
130202575|NCT01382225|468700960|FG000|Overall Study|Subject Withdrew Consent|5|||
130202576|NCT01382225|468700961|FG001|Overall Study|Subject Withdrew Consent|2|||
130202577|NCT01382225|468700960|FG000|Overall Study|Other|4|||
130202578|NCT01382225|468700961|FG001|Overall Study|Other|2|||
130202579|NCT02548351|468700970|FG000|Overall Study|Withdrawal by Subject|149|||
130202580|NCT02548351|468700971|FG001|Overall Study|Withdrawal by Subject|154|||
130202581|NCT02548351|468700972|FG002|Overall Study|Withdrawal by Subject|152|||
130202582|NCT02548351|468700970|FG000|Overall Study|Death|11|||
130202583|NCT02548351|468700971|FG001|Overall Study|Death|15|||
130202584|NCT02548351|468700972|FG002|Overall Study|Death|12|||
130202585|NCT02548351|468700970|FG000|Overall Study|Adverse Event|22|||
130202586|NCT02548351|468700971|FG001|Overall Study|Adverse Event|56|||
130202587|NCT02548351|468700972|FG002|Overall Study|Adverse Event|36|||
130202588|NCT02548351|468700970|FG000|Overall Study|Study Terminated by Sponsor|549|||
130202589|NCT02548351|468700971|FG001|Overall Study|Study Terminated by Sponsor|509|||
130202590|NCT02548351|468700972|FG002|Overall Study|Study Terminated by Sponsor|528|||
130202591|NCT02548351|468700970|FG000|Overall Study|Site Closure|14|||
130202592|NCT02548351|468700971|FG001|Overall Study|Site Closure|5|||
130202593|NCT02548351|468700972|FG002|Overall Study|Site Closure|7|||
130202594|NCT02548351|468700970|FG000|Overall Study|Non-compliance with Study Drug|4|||
130202595|NCT02548351|468700971|FG001|Overall Study|Non-compliance with Study Drug|2|||
130202596|NCT02548351|468700972|FG002|Overall Study|Non-compliance with Study Drug|0|||
130202597|NCT02548351|468700970|FG000|Overall Study|Protocol Violation|2|||
130202598|NCT02548351|468700971|FG001|Overall Study|Protocol Violation|1|||
130202599|NCT02548351|468700972|FG002|Overall Study|Protocol Violation|2|||
130202600|NCT02548351|468700970|FG000|Overall Study|Physician Decision|11|||
130202601|NCT02548351|468700971|FG001|Overall Study|Physician Decision|18|||
130202602|NCT02548351|468700972|FG002|Overall Study|Physician Decision|11|||
130202603|NCT02548351|468700970|FG000|Overall Study|Lost to Follow-up|43|||
130202604|NCT02548351|468700971|FG001|Overall Study|Lost to Follow-up|50|||
130202605|NCT02548351|468700972|FG002|Overall Study|Lost to Follow-up|57|||
130202606|NCT02548351|468700970|FG000|Overall Study|Other|19|||
130202607|NCT02548351|468700971|FG001|Overall Study|Other|16|||
130202608|NCT02548351|468700972|FG002|Overall Study|Other|20|||
130202609|NCT02548351|468700970|FG000|Overall Study|Missing|1|||
130202610|NCT02548351|468700971|FG001|Overall Study|Missing|1|||
130202611|NCT02548351|468700972|FG002|Overall Study|Missing|0|||
130202612|NCT00125242|468700973|FG000|Overall Study|did not qualify|7|||
130202613|NCT00125242|468700974|FG001|Overall Study|did not qualify|2|||
130202614|NCT01664949|468700977|FG000|Overall Study|Adverse Event|11|||
130202615|NCT01664949|468700978|FG001|Overall Study|Adverse Event|12|||
130202616|NCT01664949|468700977|FG000|Overall Study|Lack of Efficacy|1|||
130202617|NCT01664949|468700978|FG001|Overall Study|Lack of Efficacy|1|||
130202618|NCT01664949|468700977|FG000|Overall Study|Lost to Follow-up|1|||
130202619|NCT01664949|468700978|FG001|Overall Study|Lost to Follow-up|2|||
130202620|NCT01664949|468700977|FG000|Overall Study|Personal Reasons|3|||
130202621|NCT01664949|468700978|FG001|Overall Study|Personal Reasons|4|||
130202622|NCT01664949|468700977|FG000|Overall Study|Protocol Violation|5|||
130202623|NCT01664949|468700978|FG001|Overall Study|Protocol Violation|5|||
130202624|NCT01664949|468700977|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130202625|NCT01664949|468700978|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130202626|NCT03003494|468700980|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
130202627|NCT05238025|468700983|FG000|Overall Study|Adverse Event|2|||
130202628|NCT05238025|468700984|FG001|Overall Study|Adverse Event|2|||
130202629|NCT05238025|468700983|FG000|Overall Study|Lost to Follow-up|334|||
130202630|NCT05238025|468700984|FG001|Overall Study|Lost to Follow-up|339|||
130202631|NCT05238025|468700983|FG000|Overall Study|Withdrawal by Subject|203|||
130202632|NCT05238025|468700984|FG001|Overall Study|Withdrawal by Subject|222|||
130202633|NCT05238025|468700983|FG000|Overall Study|Physician Decision|20|||
130202634|NCT05238025|468700984|FG001|Overall Study|Physician Decision|8|||
130202635|NCT05238025|468700983|FG000|Overall Study|Protocol Violation|6|||
130202636|NCT05238025|468700984|FG001|Overall Study|Protocol Violation|2|||
130202637|NCT05238025|468700983|FG000|Overall Study|Death|38|||
130202638|NCT05238025|468700984|FG001|Overall Study|Death|32|||
130202639|NCT05238025|468700983|FG000|Overall Study|Study terminated by Sponsor|6358|||
130202640|NCT05238025|468700984|FG001|Overall Study|Study terminated by Sponsor|6358|||
130202641|NCT05238025|468700983|FG000|Overall Study|Other Reason|669|||
130202642|NCT05238025|468700984|FG001|Overall Study|Other Reason|690|||
130202643|NCT01263782|468700986|FG000|Overall Study|Death|0|||
130202644|NCT01263782|468700987|FG001|Overall Study|Death|0|||
130202645|NCT01263782|468700988|FG002|Overall Study|Death|1|||
130202646|NCT01263782|468700989|FG003|Overall Study|Death|0|||
130202647|NCT01263782|468700986|FG000|Overall Study|Progressive disease|0|||
130202648|NCT01263782|468700987|FG001|Overall Study|Progressive disease|0|||
130202649|NCT01263782|468700988|FG002|Overall Study|Progressive disease|0|||
130202650|NCT01263782|468700989|FG003|Overall Study|Progressive disease|1|||
130202651|NCT01263782|468700986|FG000|Overall Study|Too early|0|||
130202652|NCT01263782|468700987|FG001|Overall Study|Too early|0|||
130202653|NCT01263782|468700988|FG002|Overall Study|Too early|1|||
130202654|NCT01263782|468700989|FG003|Overall Study|Too early|0|||
130202655|NCT01263782|468700986|FG000|Overall Study|Inevaluable|0|||
130202656|NCT01263782|468700987|FG001|Overall Study|Inevaluable|0|||
130202657|NCT01263782|468700988|FG002|Overall Study|Inevaluable|1|||
130202658|NCT01263782|468700989|FG003|Overall Study|Inevaluable|0|||
130202659|NCT04545567|468700990|FG000|Overall Study|tested positive for SARS-co-V2|1|||
130202660|NCT04545567|468700991|FG001|Overall Study|tested positive for SARS-co-V2|1|||
130202661|NCT04545567|468700990|FG000|Overall Study|Withdrawal by Subject|0|||
130202662|NCT04545567|468700991|FG001|Overall Study|Withdrawal by Subject|1|||
130202663|NCT03814720|468700994|FG000|Overall Study|Lost to Follow-up|0|||
130202664|NCT03814720|468700995|FG001|Overall Study|Lost to Follow-up|1|||
130202665|NCT03814720|468700996|FG002|Overall Study|Lost to Follow-up|0|||
130202666|NCT03814720|468700997|FG003|Overall Study|Lost to Follow-up|0|||
130202667|NCT03814720|468700998|FG004|Overall Study|Lost to Follow-up|0|||
130202668|NCT02135107|468700999|FG000|Treatment Period|Withdrawal by Subject|11|||
130202669|NCT02135107|468701000|FG001|Treatment Period|Withdrawal by Subject|0|||
130202670|NCT02135107|468701001|FG002|Treatment Period|Withdrawal by Subject|0|||
130202671|NCT02135107|468701002|FG003|Treatment Period|Withdrawal by Subject|0|||
130202672|NCT02135107|468700999|FG000|Treatment Period|Adverse Event|5|||
130202673|NCT02135107|468701000|FG001|Treatment Period|Adverse Event|2|||
130202674|NCT02135107|468701001|FG002|Treatment Period|Adverse Event|0|||
130202675|NCT02135107|468701002|FG003|Treatment Period|Adverse Event|0|||
130202676|NCT02135107|468700999|FG000|Treatment Period|Pregnancy|1|||
130202677|NCT02135107|468701000|FG001|Treatment Period|Pregnancy|0|||
130202678|NCT02135107|468701001|FG002|Treatment Period|Pregnancy|0|||
130202679|NCT02135107|468701002|FG003|Treatment Period|Pregnancy|0|||
130202680|NCT02135107|468700999|FG000|Treatment Period|Other|115|||
130202681|NCT02135107|468701000|FG001|Treatment Period|Other|24|||
130202682|NCT02135107|468701001|FG002|Treatment Period|Other|0|||
130202683|NCT02135107|468701002|FG003|Treatment Period|Other|0|||
130202684|NCT02135107|468700999|FG000|Maintenance Therapy Period|Adverse Event|0|||
130202685|NCT02135107|468701000|FG001|Maintenance Therapy Period|Adverse Event|0|||
130202686|NCT02135107|468701001|FG002|Maintenance Therapy Period|Adverse Event|3|||
130202687|NCT02135107|468701002|FG003|Maintenance Therapy Period|Adverse Event|7|||
130202688|NCT02135107|468700999|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
130202689|NCT02135107|468701000|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
130202690|NCT02135107|468701001|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
130202691|NCT02135107|468701002|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
130202692|NCT02135107|468700999|FG000|Maintenance Therapy Period|Pregnancy|0|||
130202693|NCT02135107|468701000|FG001|Maintenance Therapy Period|Pregnancy|0|||
130202694|NCT02135107|468701001|FG002|Maintenance Therapy Period|Pregnancy|0|||
130202695|NCT02135107|468701002|FG003|Maintenance Therapy Period|Pregnancy|1|||
130202696|NCT02135107|468700999|FG000|Maintenance Therapy Period|Other|0|||
130202697|NCT02135107|468701000|FG001|Maintenance Therapy Period|Other|0|||
130202698|NCT02135107|468701001|FG002|Maintenance Therapy Period|Other|7|||
130202699|NCT02135107|468701002|FG003|Maintenance Therapy Period|Other|8|||
130202700|NCT03197324|468701003|FG000|Overall Study|Adverse Event|0|||
130202701|NCT03197324|468701004|FG001|Overall Study|Adverse Event|1|||
130202702|NCT00877071|468701005|FG000|Overall Study|disease progression|2|||
130202703|NCT01984892|468701006|FG000|Overall Study|Progressive disease|7|||
130202704|NCT05723328|468701008|FG000|Overall Study|Investigator's Decision|5|||
130202705|NCT05723328|468701009|FG001|Overall Study|Investigator's Decision|2|||
130202706|NCT03055494|468702437|FG000|Overall Study|Lost to Follow-up|6|||
130202707|NCT03055494|468702438|FG001|Overall Study|Lost to Follow-up|0|||
130202708|NCT03055494|468702437|FG000|Overall Study|Physician Decision|2|||
130202709|NCT03055494|468702438|FG001|Overall Study|Physician Decision|0|||
130202710|NCT03055494|468702437|FG000|Overall Study|Withdrawal by Subject|1|||
130202711|NCT03055494|468702438|FG001|Overall Study|Withdrawal by Subject|0|||
130202712|NCT03055494|468702437|FG000|Overall Study|Adverse Event|0|||
130202713|NCT03055494|468702438|FG001|Overall Study|Adverse Event|1|||
130202714|NCT03055494|468702437|FG000|Overall Study|Non-compliance with study treatment|1|||
130202715|NCT03055494|468702438|FG001|Overall Study|Non-compliance with study treatment|0|||
130202716|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
130202717|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
130202718|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
130202719|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
130202720|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
130202721|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
130202722|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
130202723|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
130202724|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
130202725|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
130202726|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
130202727|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
130202728|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130202729|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130202730|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
130202731|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130202732|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
130202733|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130202734|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
130202735|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
130202736|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
130202737|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
130202738|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
130202739|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
130202740|NCT04488419|468702439|FG000|Primary Analysis Population|Adverse Event|6|||
130202741|NCT04488419|468702440|FG001|Primary Analysis Population|Adverse Event|9|||
130202742|NCT04488419|468702441|FG002|Primary Analysis Population|Adverse Event|0|||
130202743|NCT04488419|468702439|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
130202744|NCT04488419|468702440|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
130202745|NCT04488419|468702441|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
130202746|NCT04488419|468702439|FG000|Primary Analysis Population|Protocol Violation|1|||
130202747|NCT04488419|468702440|FG001|Primary Analysis Population|Protocol Violation|1|||
130202748|NCT04488419|468702441|FG002|Primary Analysis Population|Protocol Violation|0|||
130202749|NCT04488419|468702439|FG000|Primary Analysis Population|Undetermined|7|||
130202750|NCT04488419|468702440|FG001|Primary Analysis Population|Undetermined|3|||
130202751|NCT04488419|468702441|FG002|Primary Analysis Population|Undetermined|0|||
130202752|NCT04488419|468702439|FG000|Primary Analysis Population|>1 Reason|2|||
130202753|NCT04488419|468702440|FG001|Primary Analysis Population|>1 Reason|4|||
130202754|NCT04488419|468702441|FG002|Primary Analysis Population|>1 Reason|0|||
130202755|NCT04166591|468702442|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130202756|NCT04166591|468702443|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130202757|NCT04166591|468702444|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202758|NCT04166591|468702445|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202759|NCT04166591|468702442|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130202760|NCT04166591|468702443|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130202761|NCT04166591|468702444|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202762|NCT04166591|468702445|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202763|NCT04161079|468702448|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
130202764|NCT02515994|468702449|FG000|Overall Study|Protocol Violation|3|||
130202765|NCT02515994|468702450|FG001|Overall Study|Protocol Violation|5|||
130202766|NCT02515994|468702449|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
130202767|NCT02515994|468702450|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130202768|NCT02515994|468702449|FG000|Overall Study|Adverse Event|3|||
130202769|NCT02515994|468702450|FG001|Overall Study|Adverse Event|1|||
130202770|NCT02515994|468702449|FG000|Overall Study|Withdrawal by Subject|2|||
130202771|NCT02515994|468702450|FG001|Overall Study|Withdrawal by Subject|0|||
130202772|NCT04186806|468702459|FG000|Period 1: 7 Days|Adverse Event|1|||
130202773|NCT04186806|468702460|FG001|Period 1: 7 Days|Adverse Event|0|||
130202774|NCT04739722|468702468|FG000|Overall Study|Lost to Follow-up|5301|||
130202775|NCT04739722|468702468|FG000|Overall Study|Withdrawal by Subject|42|||
130202776|NCT04739722|468702468|FG000|Overall Study|Non Average-risk|1157|||
130202777|NCT03047720|468702472|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
130202778|NCT03047720|468702473|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
130202779|NCT00614120|468702474|FG000|Overall Study|Adverse Event|9|||
130202780|NCT00614120|468702475|FG001|Overall Study|Adverse Event|22|||
130202781|NCT00614120|468702476|FG002|Overall Study|Adverse Event|30|||
130202782|NCT00614120|468702477|FG003|Overall Study|Adverse Event|3|||
130202783|NCT00614120|468702474|FG000|Overall Study|Lack of Efficacy|3|||
130202784|NCT00614120|468702475|FG001|Overall Study|Lack of Efficacy|3|||
130202785|NCT00614120|468702476|FG002|Overall Study|Lack of Efficacy|2|||
130202786|NCT00614120|468702477|FG003|Overall Study|Lack of Efficacy|2|||
130202787|NCT00614120|468702474|FG000|Overall Study|Protocol Violation|2|||
130202788|NCT00614120|468702475|FG001|Overall Study|Protocol Violation|5|||
130202789|NCT00614120|468702476|FG002|Overall Study|Protocol Violation|3|||
130202790|NCT00614120|468702477|FG003|Overall Study|Protocol Violation|1|||
130202791|NCT00614120|468702474|FG000|Overall Study|Withdrawal criteria|1|||
130202792|NCT00614120|468702475|FG001|Overall Study|Withdrawal criteria|0|||
130202793|NCT00614120|468702476|FG002|Overall Study|Withdrawal criteria|0|||
130202794|NCT00614120|468702477|FG003|Overall Study|Withdrawal criteria|0|||
130202795|NCT00614120|468702474|FG000|Overall Study|Withdrawal by Subject|9|||
130202796|NCT00614120|468702475|FG001|Overall Study|Withdrawal by Subject|10|||
130202797|NCT00614120|468702476|FG002|Overall Study|Withdrawal by Subject|16|||
130202798|NCT00614120|468702477|FG003|Overall Study|Withdrawal by Subject|3|||
130202799|NCT00614120|468702474|FG000|Overall Study|Did not meet trial criteria|0|||
130202800|NCT00614120|468702475|FG001|Overall Study|Did not meet trial criteria|1|||
130202801|NCT00614120|468702476|FG002|Overall Study|Did not meet trial criteria|1|||
130202802|NCT00614120|468702477|FG003|Overall Study|Did not meet trial criteria|1|||
130202803|NCT00614120|468702474|FG000|Overall Study|hCG positive (not pregnant)|0|||
130202804|NCT00614120|468702475|FG001|Overall Study|hCG positive (not pregnant)|0|||
130202805|NCT00614120|468702476|FG002|Overall Study|hCG positive (not pregnant)|1|||
130202806|NCT00614120|468702477|FG003|Overall Study|hCG positive (not pregnant)|0|||
130202807|NCT00614120|468702474|FG000|Overall Study|Hypoglycaemia|0|||
130202808|NCT00614120|468702475|FG001|Overall Study|Hypoglycaemia|0|||
130202809|NCT00614120|468702476|FG002|Overall Study|Hypoglycaemia|0|||
130202810|NCT00614120|468702477|FG003|Overall Study|Hypoglycaemia|1|||
130202811|NCT00614120|468702474|FG000|Overall Study|Lack of trial product|3|||
130202812|NCT00614120|468702475|FG001|Overall Study|Lack of trial product|3|||
130202813|NCT00614120|468702476|FG002|Overall Study|Lack of trial product|2|||
130202814|NCT00614120|468702477|FG003|Overall Study|Lack of trial product|0|||
130202815|NCT00614120|468702474|FG000|Overall Study|Late syphilis, latent|1|||
130202816|NCT00614120|468702475|FG001|Overall Study|Late syphilis, latent|0|||
130202817|NCT00614120|468702476|FG002|Overall Study|Late syphilis, latent|0|||
130202818|NCT00614120|468702477|FG003|Overall Study|Late syphilis, latent|0|||
130202819|NCT00614120|468702474|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
130202820|NCT00614120|468702475|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
130202821|NCT00614120|468702476|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
130202822|NCT00614120|468702477|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
130202823|NCT00614120|468702474|FG000|Overall Study|Lost to Follow-up|1|||
130202824|NCT00614120|468702475|FG001|Overall Study|Lost to Follow-up|2|||
130202825|NCT00614120|468702476|FG002|Overall Study|Lost to Follow-up|3|||
130202826|NCT00614120|468702477|FG003|Overall Study|Lost to Follow-up|4|||
130202827|NCT01185509|468702478|FG000|Overall Study|Progression/Relapse|9|||
130202828|NCT01185509|468702479|FG001|Overall Study|Progression/Relapse|15|||
130202829|NCT01185509|468702478|FG000|Overall Study|Physician Decision|2|||
130202830|NCT01185509|468702479|FG001|Overall Study|Physician Decision|2|||
130202831|NCT01185509|468702478|FG000|Overall Study|Withdrawal by Subject|0|||
130202832|NCT01185509|468702479|FG001|Overall Study|Withdrawal by Subject|1|||
130202833|NCT01185509|468702478|FG000|Overall Study|Death|0|||
130202834|NCT01185509|468702479|FG001|Overall Study|Death|1|||
130202835|NCT01185509|468702478|FG000|Overall Study|Intercurrent Illness|0|||
130202836|NCT01185509|468702479|FG001|Overall Study|Intercurrent Illness|1|||
130202837|NCT03687372|468702480|FG000|Overall Study|Lost to Follow-up|12|||
130202838|NCT03687372|468702481|FG001|Overall Study|Lost to Follow-up|21|||
130202839|NCT03687372|468702480|FG000|Overall Study|Withdrawal by Subject|4|||
130202840|NCT03687372|468702481|FG001|Overall Study|Withdrawal by Subject|17|||
130202841|NCT03687372|468702480|FG000|Overall Study|Investigator Decision|1|||
130202842|NCT03687372|468702481|FG001|Overall Study|Investigator Decision|1|||
130202843|NCT00108485|468702484|FG000|Overall Study|Withdrawal by Subject|3|||
130202844|NCT00108485|468702485|FG001|Overall Study|Withdrawal by Subject|0|||
130202845|NCT00108485|468702484|FG000|Overall Study|Lost to Follow-up|0|||
130202846|NCT00108485|468702485|FG001|Overall Study|Lost to Follow-up|2|||
130202847|NCT00878969|468702488|FG000|Overall Study|Physician Decision|5|||
130202848|NCT00878969|468702489|FG001|Overall Study|Physician Decision|3|||
130202849|NCT00878969|468702490|FG002|Overall Study|Physician Decision|2|||
130202850|NCT00878969|468702488|FG000|Overall Study|Withdrawal by Subject|1|||
130202851|NCT00878969|468702489|FG001|Overall Study|Withdrawal by Subject|6|||
130202852|NCT00878969|468702490|FG002|Overall Study|Withdrawal by Subject|3|||
130202853|NCT00878969|468702488|FG000|Overall Study|kidney transplant|2|||
130202854|NCT00878969|468702489|FG001|Overall Study|kidney transplant|3|||
130202855|NCT00878969|468702490|FG002|Overall Study|kidney transplant|2|||
130202856|NCT00878969|468702488|FG000|Overall Study|Adverse Event|3|||
130202857|NCT00878969|468702489|FG001|Overall Study|Adverse Event|1|||
130202858|NCT00878969|468702490|FG002|Overall Study|Adverse Event|2|||
130202859|NCT00878969|468702488|FG000|Overall Study|Lost to Follow-up|2|||
130202860|NCT00878969|468702489|FG001|Overall Study|Lost to Follow-up|1|||
130202861|NCT00878969|468702490|FG002|Overall Study|Lost to Follow-up|0|||
130202862|NCT00878969|468702488|FG000|Overall Study|Protocol Violation|2|||
130202863|NCT00878969|468702489|FG001|Overall Study|Protocol Violation|0|||
130202864|NCT00878969|468702490|FG002|Overall Study|Protocol Violation|0|||
130202865|NCT00878969|468702488|FG000|Overall Study|Death|0|||
130202866|NCT00878969|468702489|FG001|Overall Study|Death|0|||
130202867|NCT00878969|468702490|FG002|Overall Study|Death|2|||
130202868|NCT00878969|468702488|FG000|Overall Study|Pregnancy|0|||
130202869|NCT00878969|468702489|FG001|Overall Study|Pregnancy|1|||
130202870|NCT00878969|468702490|FG002|Overall Study|Pregnancy|0|||
130202871|NCT03729570|468702491|FG000|Overall Study|Lost to Follow-up|16|||
130202872|NCT03729570|468702492|FG001|Overall Study|Lost to Follow-up|20|||
130202873|NCT03729570|468702491|FG000|Overall Study|Seroconversion|5|||
130202874|NCT03729570|468702492|FG001|Overall Study|Seroconversion|0|||
130202875|NCT03729570|468702491|FG000|Overall Study|Moved out of the city|1|||
130202876|NCT03729570|468702492|FG001|Overall Study|Moved out of the city|0|||
130202877|NCT03729570|468702491|FG000|Overall Study|Time Conflict|1|||
130202878|NCT03729570|468702492|FG001|Overall Study|Time Conflict|0|||
130202879|NCT03729570|468702491|FG000|Overall Study|Time Commitment|2|||
130202880|NCT03729570|468702492|FG001|Overall Study|Time Commitment|0|||
130202881|NCT03729570|468702491|FG000|Overall Study|Bad Experience|0|||
130202882|NCT03729570|468702492|FG001|Overall Study|Bad Experience|1|||
130202883|NCT03729570|468702491|FG000|Overall Study|No reason provided|2|||
130202884|NCT03729570|468702492|FG001|Overall Study|No reason provided|1|||
130202885|NCT03729570|468702491|FG000|Overall Study|Family Conflict|0|||
130202886|NCT03729570|468702492|FG001|Overall Study|Family Conflict|1|||
130202887|NCT03729570|468702491|FG000|Overall Study|Did not want to continue taking medications|0|||
130202888|NCT03729570|468702492|FG001|Overall Study|Did not want to continue taking medications|1|||
130202889|NCT03729570|468702491|FG000|Overall Study|Found another PrEP provider|1|||
130202890|NCT03729570|468702492|FG001|Overall Study|Found another PrEP provider|0|||
130202891|NCT03729570|468702491|FG000|Overall Study|Did not enjoy being in the control group|0|||
130202892|NCT03729570|468702492|FG001|Overall Study|Did not enjoy being in the control group|1|||
130202893|NCT01701193|468702495|FG000|Overall Study|Withdrawal by Subject|2|||
130202894|NCT01701193|468702496|FG001|Overall Study|Withdrawal by Subject|2|||
130202895|NCT01701193|468702497|FG002|Overall Study|Withdrawal by Subject|1|||
130202896|NCT01701193|468702498|FG003|Overall Study|Withdrawal by Subject|2|||
130202897|NCT01701193|468702495|FG000|Overall Study|Adverse Event|1|||
130202898|NCT01701193|468702496|FG001|Overall Study|Adverse Event|0|||
130202899|NCT01701193|468702497|FG002|Overall Study|Adverse Event|0|||
130202900|NCT01701193|468702498|FG003|Overall Study|Adverse Event|0|||
130202901|NCT00278148|468702499|FG000|Phase II - Expansion Phase|Disease progression|0|||
130202902|NCT00278148|468702500|FG001|Phase II - Expansion Phase|Disease progression|0|||
130202903|NCT00278148|468702501|FG002|Phase II - Expansion Phase|Disease progression|4|||
130202904|NCT00278148|468702499|FG000|Phase II - Expansion Phase|Adverse Event|0|||
130202905|NCT00278148|468702500|FG001|Phase II - Expansion Phase|Adverse Event|0|||
130202906|NCT00278148|468702501|FG002|Phase II - Expansion Phase|Adverse Event|2|||
130202907|NCT02407457|468702502|FG000|1 Month|Death|3|||
130202908|NCT02407457|468702503|FG001|1 Month|Death|0|||
130202909|NCT02407457|468702502|FG000|1 Month|Lost to Follow-up|1|||
130202910|NCT02407457|468702503|FG001|1 Month|Lost to Follow-up|1|||
130202911|NCT02407457|468702502|FG000|1 Month|missed visit|2|||
130202912|NCT02407457|468702503|FG001|1 Month|missed visit|5|||
130202913|NCT02407457|468702502|FG000|6-Month|Death|2|||
130202914|NCT02407457|468702503|FG001|6-Month|Death|8|||
130202915|NCT02407457|468702502|FG000|6-Month|Lost to Follow-up|2|||
130202916|NCT02407457|468702503|FG001|6-Month|Lost to Follow-up|2|||
130202917|NCT02407457|468702502|FG000|6-Month|missed visit|16|||
130202918|NCT02407457|468702503|FG001|6-Month|missed visit|14|||
130202919|NCT02407457|468702502|FG000|6-Month|Open Repair|0|||
130202920|NCT02407457|468702503|FG001|6-Month|Open Repair|1|||
130202921|NCT02407457|468702502|FG000|1 Year|Death|6|||
130202922|NCT02407457|468702503|FG001|1 Year|Death|11|||
130202923|NCT02407457|468702502|FG000|1 Year|Lost to Follow-up|3|||
130202924|NCT02407457|468702503|FG001|1 Year|Lost to Follow-up|2|||
130202925|NCT02407457|468702502|FG000|1 Year|Missed Visit|24|||
130202926|NCT02407457|468702503|FG001|1 Year|Missed Visit|14|||
130202927|NCT02407457|468702502|FG000|1 Year|Open Repair|0|||
130202928|NCT02407457|468702503|FG001|1 Year|Open Repair|1|||
130202929|NCT02407457|468702502|FG000|2-year|Death|14|||
130202930|NCT02407457|468702503|FG001|2-year|Death|8|||
130202931|NCT02407457|468702502|FG000|2-year|Lost to Follow-up|7|||
130202932|NCT02407457|468702503|FG001|2-year|Lost to Follow-up|10|||
130202933|NCT02407457|468702502|FG000|2-year|Missed Visit|13|||
130202934|NCT02407457|468702503|FG001|2-year|Missed Visit|15|||
130202935|NCT02407457|468702502|FG000|2-year|Open Repair|0|||
130202936|NCT02407457|468702503|FG001|2-year|Open Repair|2|||
130202937|NCT02407457|468702502|FG000|3-year|Death|11|||
130202938|NCT02407457|468702503|FG001|3-year|Death|10|||
130202939|NCT02407457|468702502|FG000|3-year|Lost to Follow-up|9|||
130202940|NCT02407457|468702503|FG001|3-year|Lost to Follow-up|10|||
130202941|NCT02407457|468702502|FG000|3-year|Missed Visit|19|||
130202942|NCT02407457|468702503|FG001|3-year|Missed Visit|16|||
130202943|NCT02407457|468702502|FG000|4-year|Death|18|||
130202944|NCT02407457|468702503|FG001|4-year|Death|10|||
130202945|NCT02407457|468702502|FG000|4-year|Lost to Follow-up|10|||
130202946|NCT02407457|468702503|FG001|4-year|Lost to Follow-up|12|||
130202947|NCT02407457|468702502|FG000|4-year|Missed Visit|18|||
130202948|NCT02407457|468702503|FG001|4-year|Missed Visit|16|||
130202949|NCT02407457|468702502|FG000|5-year|Death|10|||
130202950|NCT02407457|468702503|FG001|5-year|Death|3|||
130202951|NCT02407457|468702502|FG000|5-year|Lost to Follow-up|22|||
130202952|NCT02407457|468702503|FG001|5-year|Lost to Follow-up|13|||
130202953|NCT02407457|468702502|FG000|5-year|Missed Visit|9|||
130202954|NCT02407457|468702503|FG001|5-year|Missed Visit|1|||
130202955|NCT02083185|468702504|FG000|Overall Study|Lost to Follow-up|0|||
130202956|NCT02083185|468702505|FG001|Overall Study|Lost to Follow-up|3|||
130202957|NCT02083185|468702506|FG002|Overall Study|Lost to Follow-up|0|||
130202958|NCT02083185|468702504|FG000|Overall Study|Withdrawal by Subject|9|||
130202959|NCT02083185|468702505|FG001|Overall Study|Withdrawal by Subject|15|||
130202960|NCT02083185|468702506|FG002|Overall Study|Withdrawal by Subject|1|||
130202961|NCT02083185|468702504|FG000|Overall Study|Death|2|||
130202962|NCT02083185|468702505|FG001|Overall Study|Death|2|||
130202963|NCT02083185|468702506|FG002|Overall Study|Death|1|||
130202964|NCT02083185|468702504|FG000|Overall Study|Reason not Specified|9|||
130202965|NCT02083185|468702505|FG001|Overall Study|Reason not Specified|6|||
130202966|NCT02083185|468702506|FG002|Overall Study|Reason not Specified|5|||
130202967|NCT02083185|468702504|FG000|Overall Study|Study Terminated by Sponsor|0|||
130202968|NCT02083185|468702505|FG001|Overall Study|Study Terminated by Sponsor|1|||
130202969|NCT02083185|468702506|FG002|Overall Study|Study Terminated by Sponsor|0|||
130202970|NCT02083185|468702504|FG000|Overall Study|Did not Receive Study Drug|0|||
130202971|NCT02083185|468702505|FG001|Overall Study|Did not Receive Study Drug|2|||
130202972|NCT02083185|468702506|FG002|Overall Study|Did not Receive Study Drug|0|||
130202973|NCT01041976|468702507|FG000|Overall Study|Withdrawal by Subject|3|||
130202974|NCT01041976|468702508|FG001|Overall Study|Withdrawal by Subject|0|||
130202975|NCT01041976|468702507|FG000|Overall Study|Incarceration|2|||
130202976|NCT01041976|468702508|FG001|Overall Study|Incarceration|0|||
130202977|NCT01041976|468702507|FG000|Overall Study|Death|0|||
130202978|NCT01041976|468702508|FG001|Overall Study|Death|4|||
130202979|NCT03054064|468702509|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
130202980|NCT03054064|468702509|FG000|Overall Study|Investigator Decision|2|||
130202981|NCT03054064|468702509|FG000|Overall Study|Bladder Issue|1|||
130202982|NCT03054064|468702509|FG000|Overall Study|High Blood Pressure|1|||
130202983|NCT03054064|468702509|FG000|Overall Study|Change in Status|1|||
130202984|NCT03787303|468702510|FG000|Overall Study|Death|1|||
130202985|NCT03787303|468702510|FG000|Overall Study|Premature Termination of Study|1|||
130202986|NCT01384019|468702513|FG000|Overall Study|Withdrawal by Subject|3|||
130202987|NCT01384019|468702514|FG001|Overall Study|Withdrawal by Subject|0|||
130202988|NCT01384019|468702513|FG000|Overall Study|Death|1|||
130202989|NCT01384019|468702514|FG001|Overall Study|Death|0|||
130202990|NCT01384019|468702513|FG000|Overall Study|MRI refusal|6|||
130202991|NCT01384019|468702514|FG001|Overall Study|MRI refusal|6|||
130202992|NCT00767039|468702517|FG000|Overall Study|Death|5|||
130202993|NCT00767039|468702518|FG001|Overall Study|Death|2|||
130202994|NCT01826370|468702519|FG000|Overall Study|Protocol Violation|6|||
130202995|NCT01826370|468702519|FG000|Overall Study|Lost to Follow-up|12|||
130202996|NCT01826370|468702519|FG000|Overall Study|Other reason not defined above|2|||
130202997|NCT04416737|468702521|FG000|Week 1 (First Injection)|Physician Decision|0|||
130202998|NCT04416737|468702522|FG001|Week 1 (First Injection)|Physician Decision|1|||
130202999|NCT03332628|468702523|FG000|Overall Study|Physician Decision|2|||
130203000|NCT01472757|468702524|FG000|Overall Study|Withdrawal by Subject|1|||
130203001|NCT01472757|468702525|FG001|Overall Study|Withdrawal by Subject|2|||
130203002|NCT01472757|468702526|FG002|Overall Study|Withdrawal by Subject|2|||
130203003|NCT01472757|468702527|FG003|Overall Study|Withdrawal by Subject|0|||
130203004|NCT01472757|468702524|FG000|Overall Study|Asthma exacerbation|4|||
130203005|NCT01472757|468702525|FG001|Overall Study|Asthma exacerbation|1|||
130203006|NCT01472757|468702526|FG002|Overall Study|Asthma exacerbation|2|||
130203007|NCT01472757|468702527|FG003|Overall Study|Asthma exacerbation|1|||
130203008|NCT01472757|468702524|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
130203009|NCT01472757|468702525|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
130203010|NCT01472757|468702526|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
130203011|NCT01472757|468702527|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
130203012|NCT01472757|468702524|FG000|Overall Study|Protocol Violation|3|||
130203013|NCT01472757|468702525|FG001|Overall Study|Protocol Violation|2|||
130203014|NCT01472757|468702526|FG002|Overall Study|Protocol Violation|4|||
130203015|NCT01472757|468702527|FG003|Overall Study|Protocol Violation|4|||
130203016|NCT01472757|468702524|FG000|Overall Study|Other reasons|1|||
130203017|NCT01472757|468702525|FG001|Overall Study|Other reasons|0|||
130203018|NCT01472757|468702526|FG002|Overall Study|Other reasons|2|||
130203019|NCT01472757|468702527|FG003|Overall Study|Other reasons|2|||
130203020|NCT04489381|468702532|FG000|Overall Study|Lost to Follow-up|2|||
130203021|NCT04489381|468702533|FG001|Overall Study|Lost to Follow-up|3|||
130203022|NCT04489381|468702532|FG000|Overall Study|Withdrawal by Subject|1|||
130203023|NCT04489381|468702533|FG001|Overall Study|Withdrawal by Subject|0|||
130203024|NCT01259375|468702539|FG000|Overall Study|Adverse Event|1|||
130203025|NCT00478699|468702542|FG000|Overall Study|Inclusion Error|1|||
130203026|NCT00478699|468702543|FG001|Overall Study|Inclusion Error|7|||
130203027|NCT00478699|468702542|FG000|Overall Study|Not receive study treatment|6|||
130203028|NCT00478699|468702543|FG001|Overall Study|Not receive study treatment|30|||
130203029|NCT01043705|468702548|FG000|Overall Study|Death|28|||
130203030|NCT01043705|468702549|FG001|Overall Study|Death|60|||
130203031|NCT01043705|468702550|FG002|Overall Study|Death|26|||
130203032|NCT01043705|468702548|FG000|Overall Study|Lost to Follow-up|27|||
130203033|NCT01043705|468702549|FG001|Overall Study|Lost to Follow-up|12|||
130203034|NCT01043705|468702550|FG002|Overall Study|Lost to Follow-up|0|||
130203035|NCT01043705|468702548|FG000|Overall Study|Multiple Reasons|4|||
130203036|NCT01043705|468702549|FG001|Overall Study|Multiple Reasons|7|||
130203037|NCT01043705|468702550|FG002|Overall Study|Multiple Reasons|0|||
130203038|NCT01043705|468702548|FG000|Overall Study|Protocol Violation|2|||
130203039|NCT01043705|468702549|FG001|Overall Study|Protocol Violation|1|||
130203040|NCT01043705|468702550|FG002|Overall Study|Protocol Violation|0|||
130203041|NCT01043705|468702548|FG000|Overall Study|Withdrawal by Subject|8|||
130203042|NCT01043705|468702549|FG001|Overall Study|Withdrawal by Subject|6|||
130203043|NCT01043705|468702550|FG002|Overall Study|Withdrawal by Subject|0|||
130203044|NCT01043705|468702548|FG000|Overall Study|Site Closure|8|||
130203045|NCT01043705|468702549|FG001|Overall Study|Site Closure|0|||
130203046|NCT01043705|468702550|FG002|Overall Study|Site Closure|0|||
130203047|NCT01043705|468702548|FG000|Overall Study|Subsequent Procedure|9|||
130203048|NCT01043705|468702549|FG001|Overall Study|Subsequent Procedure|24|||
130203049|NCT01043705|468702550|FG002|Overall Study|Subsequent Procedure|29|||
130203050|NCT01043705|468702548|FG000|Overall Study|Adverse Event|0|||
130203051|NCT01043705|468702549|FG001|Overall Study|Adverse Event|2|||
130203052|NCT01043705|468702550|FG002|Overall Study|Adverse Event|0|||
130203053|NCT01043705|468702548|FG000|Overall Study|Screen Fail|21|||
130203054|NCT01043705|468702549|FG001|Overall Study|Screen Fail|0|||
130203055|NCT01043705|468702550|FG002|Overall Study|Screen Fail|0|||
130203056|NCT01043705|468702548|FG000|Overall Study|Other|0|||
130203057|NCT01043705|468702549|FG001|Overall Study|Other|19|||
130203058|NCT01043705|468702550|FG002|Overall Study|Other|25|||
130203059|NCT01123941|468702553|FG000|Overall Study|Lost to Follow-up|2|||
130203060|NCT01123941|468702554|FG001|Overall Study|Lost to Follow-up|1|||
130203061|NCT04601103|468702555|FG000|Overall Study|Needed crown & cleaning|0|||
130203062|NCT04601103|468702556|FG001|Overall Study|Needed crown & cleaning|0|||
130203063|NCT04601103|468702557|FG002|Overall Study|Needed crown & cleaning|1|||
130203064|NCT04601103|468702555|FG000|Overall Study|study was terminated|18|||
130203065|NCT04601103|468702556|FG001|Overall Study|study was terminated|18|||
130203066|NCT04601103|468702557|FG002|Overall Study|study was terminated|16|||
130203067|NCT06011161|468702558|FG000|Overall Study|Withdrawal by Subject|2|||
130203068|NCT06011161|468702558|FG000|Overall Study|Lost to Follow-up|5|||
130203069|NCT00381043|468702559|FG000|Overall Study|Lost to Follow-up|8|||
130203070|NCT00381043|468702560|FG001|Overall Study|Lost to Follow-up|6|||
130203071|NCT00381043|468702559|FG000|Overall Study|Withdrawal by Subject|3|||
130203072|NCT00381043|468702560|FG001|Overall Study|Withdrawal by Subject|1|||
130203073|NCT00381043|468702559|FG000|Overall Study|wanted more care|0|||
130203074|NCT00381043|468702560|FG001|Overall Study|wanted more care|1|||
130203075|NCT00381043|468702559|FG000|Overall Study|incarcerated|1|||
130203076|NCT00381043|468702560|FG001|Overall Study|incarcerated|0|||
130203077|NCT03045276|468702563|FG000|Intervention Phase|Withdrawal by Subject|7|||
130203078|NCT03045276|468702564|FG001|Intervention Phase|Withdrawal by Subject|2|||
130203079|NCT03045276|468702565|FG002|Intervention Phase|Withdrawal by Subject|3|||
130203080|NCT03045276|468702566|FG003|Intervention Phase|Withdrawal by Subject|7|||
130203081|NCT03045276|468702563|FG000|Intervention Phase|Developed exclusionary criteria|3|||
130203082|NCT03045276|468702564|FG001|Intervention Phase|Developed exclusionary criteria|3|||
130203083|NCT03045276|468702565|FG002|Intervention Phase|Developed exclusionary criteria|0|||
130203084|NCT03045276|468702566|FG003|Intervention Phase|Developed exclusionary criteria|0|||
130203085|NCT03045276|468702563|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130203086|NCT03045276|468702564|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
130203087|NCT03045276|468702565|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
130203088|NCT03045276|468702566|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
130203089|NCT03045276|468702563|FG000|Follow-Up Phase|Lost to Follow-up|0|||
130203090|NCT03045276|468702564|FG001|Follow-Up Phase|Lost to Follow-up|1|||
130203091|NCT03045276|468702565|FG002|Follow-Up Phase|Lost to Follow-up|0|||
130203092|NCT03045276|468702566|FG003|Follow-Up Phase|Lost to Follow-up|1|||
130203093|NCT03045276|468702563|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
130203094|NCT03045276|468702564|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
130203095|NCT03045276|468702565|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
130203096|NCT03045276|468702566|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
130203097|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
130203098|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
130203099|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
130203100|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
130203101|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130203102|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
130203103|NCT01597375|468702567|FG000|Washout (2 Weeks)|Adverse Event|1|||
130203104|NCT01597375|468702568|FG001|Washout (2 Weeks)|Adverse Event|0|||
130203105|NCT01597375|468702567|FG000|Second Intervention|Failed to react at both Aspirin|1|||
130203106|NCT01597375|468702568|FG001|Second Intervention|Failed to react at both Aspirin|1|||
130203107|NCT04713592|468702573|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203108|NCT04713592|468702574|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
130203109|NCT04713592|468702575|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203110|NCT04713592|468702576|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203111|NCT04713592|468702573|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
130203112|NCT04713592|468702574|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
130203113|NCT04713592|468702575|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130203114|NCT04713592|468702576|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130203115|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130203116|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130203117|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
130203118|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
130203119|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130203120|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130203121|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
130203122|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
130203123|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130203124|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130203125|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130203126|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130203127|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130203128|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130203129|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130203130|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130203131|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130203132|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130203133|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
130203134|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
130203135|NCT02225366|468702579|FG000|Overall Study|Lack of Efficacy|1|||
130203136|NCT02225366|468702580|FG001|Overall Study|Lack of Efficacy|0|||
130203137|NCT03782298|468702581|FG000|Overall Study|Protocol Deviation|4|||
130203138|NCT01797081|468702582|FG000|Overall Study|Adverse Event|1|||
130203139|NCT01797081|468702583|FG001|Overall Study|Adverse Event|0|||
130203140|NCT01797081|468702584|FG002|Overall Study|Adverse Event|1|||
130203141|NCT01797081|468702585|FG003|Overall Study|Adverse Event|0|||
130203142|NCT01797081|468702582|FG000|Overall Study|Pregnancy|1|||
130203143|NCT01797081|468702583|FG001|Overall Study|Pregnancy|0|||
130203144|NCT01797081|468702584|FG002|Overall Study|Pregnancy|0|||
130203145|NCT01797081|468702585|FG003|Overall Study|Pregnancy|0|||
130203146|NCT01797081|468702582|FG000|Overall Study|Personal Reasons|12|||
130203147|NCT01797081|468702583|FG001|Overall Study|Personal Reasons|4|||
130203148|NCT01797081|468702584|FG002|Overall Study|Personal Reasons|4|||
130203149|NCT01797081|468702585|FG003|Overall Study|Personal Reasons|8|||
130203150|NCT01797081|468702582|FG000|Overall Study|Protocol Violation|0|||
130203151|NCT01797081|468702583|FG001|Overall Study|Protocol Violation|0|||
130203152|NCT01797081|468702584|FG002|Overall Study|Protocol Violation|0|||
130203153|NCT01797081|468702585|FG003|Overall Study|Protocol Violation|1|||
130203154|NCT02484651|468702592|FG000|Overall Study|Patients' data files were corrupted.|1|||
130203155|NCT02484651|468702593|FG001|Overall Study|Patients' data files were corrupted.|1|||
130203156|NCT02484651|468702592|FG000|Overall Study|BIS monitoring failed.|1|||
130203157|NCT02484651|468702593|FG001|Overall Study|BIS monitoring failed.|1|||
130203158|NCT02484651|468702592|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
130203159|NCT02484651|468702593|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
130203160|NCT02375555|468702597|FG000|Induction Period|Adverse Event|7|||
130203161|NCT02375555|468702597|FG000|Induction Period|Withdrawal by Subject|2|||
130203162|NCT02375555|468702597|FG000|Induction Period|Other|1|||
130203163|NCT02375555|468702597|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
130203164|NCT02375555|468702597|FG000|Maintenance Period|Adverse Event|2|||
130203165|NCT02375555|468702597|FG000|Maintenance Period|Withdrawal by Subject|4|||
130203166|NCT02375555|468702597|FG000|Maintenance Period|Death|1|||
130203167|NCT02375555|468702597|FG000|Maintenance Period|Disease Progression|5|||
130203168|NCT02375555|468702597|FG000|Maintenance Period|Patient Non-compliance|1|||
130203169|NCT02375555|468702597|FG000|Maintenance Period|Still on maintenance|16|||
130203170|NCT01744184|468702609|FG000|Overall Study|Adverse Event|1|||
130203171|NCT01744184|468702610|FG001|Overall Study|Adverse Event|0|||
130203172|NCT01744184|468702609|FG000|Overall Study|Withdrawal by Subject|0|||
130203173|NCT01744184|468702610|FG001|Overall Study|Withdrawal by Subject|1|||
130203174|NCT01095978|468702614|FG000|Overall Study|Did not take Klacid SR|2|||
130203175|NCT01095978|468702614|FG000|Overall Study|Adverse Event|1|||
130203176|NCT00808639|468702618|FG000|Overall Study|Disease progression before surgery.|1|||
130203177|NCT00197002|468704338|FG000|Overall Study|Adverse Event|0|||
130203178|NCT00197002|468704339|FG001|Overall Study|Adverse Event|1|||
130203179|NCT00197002|468704340|FG002|Overall Study|Adverse Event|0|||
130203180|NCT00197002|468704338|FG000|Overall Study|Protocol Violation|1|||
130203181|NCT00197002|468704339|FG001|Overall Study|Protocol Violation|0|||
130203182|NCT00197002|468704340|FG002|Overall Study|Protocol Violation|2|||
130203183|NCT00197002|468704338|FG000|Overall Study|Withdrawal by Subject|9|||
130203184|NCT00197002|468704339|FG001|Overall Study|Withdrawal by Subject|5|||
130203185|NCT00197002|468704340|FG002|Overall Study|Withdrawal by Subject|7|||
130203186|NCT00197002|468704338|FG000|Overall Study|Migrated/moved from study area|3|||
130203187|NCT00197002|468704339|FG001|Overall Study|Migrated/moved from study area|5|||
130203188|NCT00197002|468704340|FG002|Overall Study|Migrated/moved from study area|1|||
130203189|NCT00197002|468704338|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130203190|NCT00197002|468704339|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130203191|NCT00197002|468704340|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
130203192|NCT00197002|468704338|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130203193|NCT00197002|468704339|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130203194|NCT00197002|468704340|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130203195|NCT00197002|468704338|FG000|Overall Study|Others|3|||
130203196|NCT00197002|468704339|FG001|Overall Study|Others|1|||
130203197|NCT00197002|468704340|FG002|Overall Study|Others|1|||
130203198|NCT02017717|468704341|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203199|NCT02017717|468704342|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203200|NCT02017717|468704343|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203201|NCT02017717|468704344|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203202|NCT02017717|468704345|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203203|NCT02017717|468704346|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203204|NCT02017717|468704347|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203205|NCT02017717|468704348|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
130203206|NCT02017717|468704349|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203207|NCT02017717|468704341|FG000|Before Treatment Period|Participant request to stop therapy|0|||
130203208|NCT02017717|468704342|FG001|Before Treatment Period|Participant request to stop therapy|0|||
130203209|NCT02017717|468704343|FG002|Before Treatment Period|Participant request to stop therapy|0|||
130203210|NCT02017717|468704344|FG003|Before Treatment Period|Participant request to stop therapy|0|||
130203211|NCT02017717|468704345|FG004|Before Treatment Period|Participant request to stop therapy|0|||
130203212|NCT02017717|468704346|FG005|Before Treatment Period|Participant request to stop therapy|0|||
130203213|NCT02017717|468704347|FG006|Before Treatment Period|Participant request to stop therapy|0|||
130203214|NCT02017717|468704348|FG007|Before Treatment Period|Participant request to stop therapy|0|||
130203215|NCT02017717|468704349|FG008|Before Treatment Period|Participant request to stop therapy|5|||
130203216|NCT02017717|468704341|FG000|Before Treatment Period|Participant withdrew consent|0|||
130203217|NCT02017717|468704342|FG001|Before Treatment Period|Participant withdrew consent|0|||
130203218|NCT02017717|468704343|FG002|Before Treatment Period|Participant withdrew consent|0|||
130203219|NCT02017717|468704344|FG003|Before Treatment Period|Participant withdrew consent|0|||
130203220|NCT02017717|468704345|FG004|Before Treatment Period|Participant withdrew consent|0|||
130203221|NCT02017717|468704346|FG005|Before Treatment Period|Participant withdrew consent|0|||
130203222|NCT02017717|468704347|FG006|Before Treatment Period|Participant withdrew consent|2|||
130203223|NCT02017717|468704348|FG007|Before Treatment Period|Participant withdrew consent|0|||
130203224|NCT02017717|468704349|FG008|Before Treatment Period|Participant withdrew consent|11|||
130203225|NCT02017717|468704341|FG000|Before Treatment Period|Lost to Follow-up|0|||
130203226|NCT02017717|468704342|FG001|Before Treatment Period|Lost to Follow-up|0|||
130203227|NCT02017717|468704343|FG002|Before Treatment Period|Lost to Follow-up|0|||
130203228|NCT02017717|468704344|FG003|Before Treatment Period|Lost to Follow-up|0|||
130203229|NCT02017717|468704345|FG004|Before Treatment Period|Lost to Follow-up|0|||
130203230|NCT02017717|468704346|FG005|Before Treatment Period|Lost to Follow-up|0|||
130203231|NCT02017717|468704347|FG006|Before Treatment Period|Lost to Follow-up|0|||
130203232|NCT02017717|468704348|FG007|Before Treatment Period|Lost to Follow-up|0|||
130203233|NCT02017717|468704349|FG008|Before Treatment Period|Lost to Follow-up|1|||
130203234|NCT02017717|468704341|FG000|Before Treatment Period|Participant no longer met criteria|0|||
130203235|NCT02017717|468704342|FG001|Before Treatment Period|Participant no longer met criteria|0|||
130203236|NCT02017717|468704343|FG002|Before Treatment Period|Participant no longer met criteria|0|||
130203237|NCT02017717|468704344|FG003|Before Treatment Period|Participant no longer met criteria|0|||
130203238|NCT02017717|468704345|FG004|Before Treatment Period|Participant no longer met criteria|0|||
130203239|NCT02017717|468704346|FG005|Before Treatment Period|Participant no longer met criteria|1|||
130203240|NCT02017717|468704347|FG006|Before Treatment Period|Participant no longer met criteria|0|||
130203241|NCT02017717|468704348|FG007|Before Treatment Period|Participant no longer met criteria|1|||
130203242|NCT02017717|468704349|FG008|Before Treatment Period|Participant no longer met criteria|2|||
130203243|NCT02017717|468704341|FG000|Before Treatment Period|other reason|0|||
130203244|NCT02017717|468704342|FG001|Before Treatment Period|other reason|0|||
130203245|NCT02017717|468704343|FG002|Before Treatment Period|other reason|0|||
130203246|NCT02017717|468704344|FG003|Before Treatment Period|other reason|0|||
130203247|NCT02017717|468704345|FG004|Before Treatment Period|other reason|0|||
130203248|NCT02017717|468704346|FG005|Before Treatment Period|other reason|0|||
130203249|NCT02017717|468704347|FG006|Before Treatment Period|other reason|0|||
130203250|NCT02017717|468704348|FG007|Before Treatment Period|other reason|0|||
130203251|NCT02017717|468704349|FG008|Before Treatment Period|other reason|1|||
130203252|NCT02017717|468704341|FG000|Treatment Period|Disease progression|7|||
130203253|NCT02017717|468704342|FG001|Treatment Period|Disease progression|9|||
130203254|NCT02017717|468704343|FG002|Treatment Period|Disease progression|12|||
130203255|NCT02017717|468704344|FG003|Treatment Period|Disease progression|20|||
130203256|NCT02017717|468704345|FG004|Treatment Period|Disease progression|26|||
130203257|NCT02017717|468704346|FG005|Treatment Period|Disease progression|16|||
130203258|NCT02017717|468704347|FG006|Treatment Period|Disease progression|22|||
130203259|NCT02017717|468704348|FG007|Treatment Period|Disease progression|165|||
130203260|NCT02017717|468704349|FG008|Treatment Period|Disease progression|135|||
130203261|NCT02017717|468704341|FG000|Treatment Period|Study drug toxicity|3|||
130203262|NCT02017717|468704342|FG001|Treatment Period|Study drug toxicity|0|||
130203263|NCT02017717|468704343|FG002|Treatment Period|Study drug toxicity|1|||
130203264|NCT02017717|468704344|FG003|Treatment Period|Study drug toxicity|4|||
130203265|NCT02017717|468704345|FG004|Treatment Period|Study drug toxicity|4|||
130203266|NCT02017717|468704346|FG005|Treatment Period|Study drug toxicity|5|||
130203267|NCT02017717|468704347|FG006|Treatment Period|Study drug toxicity|3|||
130203268|NCT02017717|468704348|FG007|Treatment Period|Study drug toxicity|7|||
130203269|NCT02017717|468704349|FG008|Treatment Period|Study drug toxicity|11|||
130203270|NCT02017717|468704341|FG000|Treatment Period|Death|0|||
130203271|NCT02017717|468704342|FG001|Treatment Period|Death|0|||
130203272|NCT02017717|468704343|FG002|Treatment Period|Death|1|||
130203273|NCT02017717|468704344|FG003|Treatment Period|Death|0|||
130203274|NCT02017717|468704345|FG004|Treatment Period|Death|0|||
130203275|NCT02017717|468704346|FG005|Treatment Period|Death|2|||
130203276|NCT02017717|468704347|FG006|Treatment Period|Death|0|||
130203277|NCT02017717|468704348|FG007|Treatment Period|Death|0|||
130203278|NCT02017717|468704349|FG008|Treatment Period|Death|0|||
130203279|NCT02017717|468704341|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
130203280|NCT02017717|468704342|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
130203281|NCT02017717|468704343|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130203282|NCT02017717|468704344|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
130203283|NCT02017717|468704345|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
130203284|NCT02017717|468704346|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
130203285|NCT02017717|468704347|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
130203286|NCT02017717|468704348|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
130203287|NCT02017717|468704349|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
130203288|NCT02017717|468704341|FG000|Treatment Period|Participant request to stop therapy|0|||
130203289|NCT02017717|468704342|FG001|Treatment Period|Participant request to stop therapy|0|||
130203290|NCT02017717|468704343|FG002|Treatment Period|Participant request to stop therapy|3|||
130203291|NCT02017717|468704344|FG003|Treatment Period|Participant request to stop therapy|6|||
130203292|NCT02017717|468704345|FG004|Treatment Period|Participant request to stop therapy|0|||
130203293|NCT02017717|468704346|FG005|Treatment Period|Participant request to stop therapy|2|||
130203294|NCT02017717|468704347|FG006|Treatment Period|Participant request to stop therapy|1|||
130203295|NCT02017717|468704348|FG007|Treatment Period|Participant request to stop therapy|4|||
130203296|NCT02017717|468704349|FG008|Treatment Period|Participant request to stop therapy|7|||
130203297|NCT02017717|468704341|FG000|Treatment Period|Participant withdrew consent|0|||
130203298|NCT02017717|468704342|FG001|Treatment Period|Participant withdrew consent|0|||
130203299|NCT02017717|468704343|FG002|Treatment Period|Participant withdrew consent|1|||
130203300|NCT02017717|468704344|FG003|Treatment Period|Participant withdrew consent|0|||
130203301|NCT02017717|468704345|FG004|Treatment Period|Participant withdrew consent|0|||
130203302|NCT02017717|468704346|FG005|Treatment Period|Participant withdrew consent|2|||
130203303|NCT02017717|468704347|FG006|Treatment Period|Participant withdrew consent|0|||
130203304|NCT02017717|468704348|FG007|Treatment Period|Participant withdrew consent|1|||
130203305|NCT02017717|468704349|FG008|Treatment Period|Participant withdrew consent|4|||
130203306|NCT02017717|468704341|FG000|Treatment Period|Participant no longer met criteria|0|||
130203307|NCT02017717|468704342|FG001|Treatment Period|Participant no longer met criteria|0|||
130203308|NCT02017717|468704343|FG002|Treatment Period|Participant no longer met criteria|0|||
130203309|NCT02017717|468704344|FG003|Treatment Period|Participant no longer met criteria|0|||
130203310|NCT02017717|468704345|FG004|Treatment Period|Participant no longer met criteria|0|||
130203311|NCT02017717|468704346|FG005|Treatment Period|Participant no longer met criteria|0|||
130203312|NCT02017717|468704347|FG006|Treatment Period|Participant no longer met criteria|0|||
130203313|NCT02017717|468704348|FG007|Treatment Period|Participant no longer met criteria|0|||
130203314|NCT02017717|468704349|FG008|Treatment Period|Participant no longer met criteria|1|||
130203315|NCT02017717|468704341|FG000|Treatment Period|Other reasons|0|||
130203316|NCT02017717|468704342|FG001|Treatment Period|Other reasons|0|||
130203317|NCT02017717|468704343|FG002|Treatment Period|Other reasons|0|||
130203318|NCT02017717|468704344|FG003|Treatment Period|Other reasons|1|||
130203319|NCT02017717|468704345|FG004|Treatment Period|Other reasons|0|||
130203320|NCT02017717|468704346|FG005|Treatment Period|Other reasons|1|||
130203321|NCT02017717|468704347|FG006|Treatment Period|Other reasons|1|||
130203322|NCT02017717|468704348|FG007|Treatment Period|Other reasons|1|||
130203323|NCT02017717|468704349|FG008|Treatment Period|Other reasons|1|||
130203324|NCT02017717|468704341|FG000|Treatment Period|Maximum clinical benefit|0|||
130203325|NCT02017717|468704342|FG001|Treatment Period|Maximum clinical benefit|0|||
130203326|NCT02017717|468704343|FG002|Treatment Period|Maximum clinical benefit|0|||
130203327|NCT02017717|468704344|FG003|Treatment Period|Maximum clinical benefit|0|||
130203328|NCT02017717|468704345|FG004|Treatment Period|Maximum clinical benefit|0|||
130203329|NCT02017717|468704346|FG005|Treatment Period|Maximum clinical benefit|0|||
130203330|NCT02017717|468704347|FG006|Treatment Period|Maximum clinical benefit|0|||
130203331|NCT02017717|468704348|FG007|Treatment Period|Maximum clinical benefit|0|||
130203332|NCT02017717|468704349|FG008|Treatment Period|Maximum clinical benefit|1|||
130203333|NCT02017717|468704341|FG000|Treatment Period|Not reported|0|||
130203334|NCT02017717|468704342|FG001|Treatment Period|Not reported|1|||
130203335|NCT02017717|468704343|FG002|Treatment Period|Not reported|0|||
130203336|NCT02017717|468704344|FG003|Treatment Period|Not reported|0|||
130203337|NCT02017717|468704345|FG004|Treatment Period|Not reported|0|||
130203338|NCT02017717|468704346|FG005|Treatment Period|Not reported|0|||
130203339|NCT02017717|468704347|FG006|Treatment Period|Not reported|0|||
130203340|NCT02017717|468704348|FG007|Treatment Period|Not reported|0|||
130203341|NCT02017717|468704349|FG008|Treatment Period|Not reported|0|||
130203342|NCT00623597|468704354|FG000|Overall Study|Failed to return|1|||
130203343|NCT00623597|468704355|FG001|Overall Study|Failed to return|0|||
130203344|NCT02339155|468704359|FG000|Overall Study|Adverse Event|0|||
130203345|NCT02339155|468704360|FG001|Overall Study|Adverse Event|6|||
130203346|NCT02339155|468704359|FG000|Overall Study|Death|1|||
130203347|NCT02339155|468704360|FG001|Overall Study|Death|1|||
130203348|NCT02339155|468704359|FG000|Overall Study|Lost to Follow-up|8|||
130203349|NCT02339155|468704360|FG001|Overall Study|Lost to Follow-up|9|||
130203350|NCT02339155|468704359|FG000|Overall Study|Physician Decision|2|||
130203351|NCT02339155|468704360|FG001|Overall Study|Physician Decision|1|||
130203352|NCT02339155|468704359|FG000|Overall Study|Withdrawal by Subject|4|||
130203353|NCT02339155|468704360|FG001|Overall Study|Withdrawal by Subject|4|||
130203354|NCT01214252|468704363|FG000|Overall Study|Not eligible per protocol|82|||
130203355|NCT04327661|468704366|FG000|Overall Study|Withdrawal by Subject|1|||
130203356|NCT04327661|468704367|FG001|Overall Study|Withdrawal by Subject|0|||
130203357|NCT04327661|468704368|FG002|Overall Study|Withdrawal by Subject|0|||
130203358|NCT03427268|468704370|FG000|Overall Study|Progressive disease|25|||
130203359|NCT03427268|468704370|FG000|Overall Study|Never treated|2|||
130203360|NCT03427268|468704370|FG000|Overall Study|Compassionate use|1|||
130203361|NCT03427268|468704370|FG000|Overall Study|Withdrawal by Subject|1|||
130203362|NCT03427268|468704370|FG000|Overall Study|Adverse Event|3|||
130203363|NCT00345878|468704372|FG000|Overall Study|Adverse Event|1|||
130203364|NCT00345878|468704373|FG001|Overall Study|Adverse Event|0|||
130203365|NCT00345878|468704372|FG000|Overall Study|Lost to Follow-up|2|||
130203366|NCT00345878|468704373|FG001|Overall Study|Lost to Follow-up|1|||
130203367|NCT00345878|468704372|FG000|Overall Study|Other|1|||
130203368|NCT00345878|468704373|FG001|Overall Study|Other|0|||
130203369|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
130203370|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
130203371|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
130203372|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
130203373|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
130203374|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
130203375|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
130203376|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
130203377|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
130203378|NCT01877551|468704376|FG000|Overall Study|Physician Decision|0|||
130203379|NCT01877551|468704377|FG001|Overall Study|Physician Decision|1|||
130203380|NCT00984061|468704378|FG000|Clarithromycin Alone|Protocol Violation|1|||
130203381|NCT02659514|468704381|FG000|Overall Study|Adverse Event|3|||
130203382|NCT02659514|468704382|FG001|Overall Study|Adverse Event|12|||
130203383|NCT02659514|468704381|FG000|Overall Study|Disease Progression|23|||
130203384|NCT02659514|468704382|FG001|Overall Study|Disease Progression|13|||
130203385|NCT02659514|468704381|FG000|Overall Study|Withdrawal by Subject|0|||
130203386|NCT02659514|468704382|FG001|Overall Study|Withdrawal by Subject|4|||
130203387|NCT02659514|468704381|FG000|Overall Study|Lost to Follow-up|0|||
130203388|NCT02659514|468704382|FG001|Overall Study|Lost to Follow-up|1|||
130203389|NCT02659514|468704381|FG000|Overall Study|Death|6|||
130203390|NCT02659514|468704382|FG001|Overall Study|Death|1|||
130203391|NCT02659514|468704381|FG000|Overall Study|Reason Unspecified|0|||
130203392|NCT02659514|468704382|FG001|Overall Study|Reason Unspecified|3|||
130203393|NCT01968707|468704388|FG000|Overall Study|Did not meet treatment day baseline|49|||
130203394|NCT01968707|468704389|FG001|Overall Study|Did not meet treatment day baseline|12|||
130203395|NCT01968707|468704390|FG002|Overall Study|Did not meet treatment day baseline|41|||
130203396|NCT01968707|468704391|FG003|Overall Study|Did not meet treatment day baseline|44|||
130203397|NCT01968707|468704392|FG004|Overall Study|Did not meet treatment day baseline|36|||
130203398|NCT01968707|468704393|FG005|Overall Study|Did not meet treatment day baseline|11|||
130203399|NCT01968707|468704394|FG006|Overall Study|Did not meet treatment day baseline|34|||
130203400|NCT01968707|468704395|FG007|Overall Study|Did not meet treatment day baseline|35|||
130203401|NCT00916344|468704396|FG000|Overall Study|Death|2|||
130203402|NCT00916344|468704396|FG000|Overall Study|ICD upgrade|1|||
130203403|NCT00916344|468704396|FG000|Overall Study|Drop-out|5|||
130203404|NCT02062944|468704413|FG000|Overall Study|Lost to Follow-up|1|||
130203405|NCT02062944|468704413|FG000|Overall Study|New hemotological disorder identified|1|||
130203406|NCT02062944|468704413|FG000|Overall Study|Uncontrolled Hypertension|1|||
130203407|NCT02062944|468704413|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
130203408|NCT01088243|468704415|FG000|Overall Study|Adverse Event|1|||
130203409|NCT01088243|468704416|FG001|Overall Study|Adverse Event|0|||
130203410|NCT02231879|468704417|FG000|Overall Study|Adverse Event|2|||
130203411|NCT02231879|468704418|FG001|Overall Study|Adverse Event|1|||
130203412|NCT02231879|468704417|FG000|Overall Study|Lack of Efficacy|0|||
130203413|NCT02231879|468704418|FG001|Overall Study|Lack of Efficacy|1|||
130203414|NCT01210495|468704419|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
130203415|NCT01210495|468704420|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130203416|NCT01210495|468704421|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
130203417|NCT01210495|468704422|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
130203418|NCT01210495|468704419|FG000|Overall Study|Death|14|||
130203419|NCT01210495|468704420|FG001|Overall Study|Death|7|||
130203420|NCT01210495|468704421|FG002|Overall Study|Death|112|||
130203421|NCT01210495|468704422|FG003|Overall Study|Death|54|||
130203422|NCT01210495|468704419|FG000|Overall Study|Study Terminated by Sponsor|0|||
130203423|NCT01210495|468704420|FG001|Overall Study|Study Terminated by Sponsor|0|||
130203424|NCT01210495|468704421|FG002|Overall Study|Study Terminated by Sponsor|4|||
130203425|NCT01210495|468704422|FG003|Overall Study|Study Terminated by Sponsor|11|||
130203426|NCT01210495|468704419|FG000|Overall Study|Lost to Follow-up|0|||
130203427|NCT01210495|468704420|FG001|Overall Study|Lost to Follow-up|0|||
130203428|NCT01210495|468704421|FG002|Overall Study|Lost to Follow-up|1|||
130203429|NCT01210495|468704422|FG003|Overall Study|Lost to Follow-up|1|||
130203430|NCT01210495|468704419|FG000|Overall Study|Other unspecified|0|||
130203431|NCT01210495|468704420|FG001|Overall Study|Other unspecified|0|||
130203432|NCT01210495|468704421|FG002|Overall Study|Other unspecified|6|||
130203433|NCT01210495|468704422|FG003|Overall Study|Other unspecified|0|||
130203434|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
130203435|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203436|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203437|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203438|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203439|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Death|0|||
130203440|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Death|1|||
130203441|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Death|0|||
130203442|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Death|0|||
130203443|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Death|0|||
130203444|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203445|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203446|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130203447|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130203448|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203449|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203450|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130203451|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203452|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130203453|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203454|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Death|0|||
130203455|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Death|1|||
130203456|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Death|0|||
130203457|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Death|0|||
130203458|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Death|1|||
130203459|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203460|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203461|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
130203462|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203463|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
130203464|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203465|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203466|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
130203467|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203468|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
130203469|NCT02505334|468704433|FG000|Main Treatment Period|Adverse Event|3|||
130203470|NCT02505334|468704434|FG001|Main Treatment Period|Adverse Event|3|||
130203471|NCT02505334|468704433|FG000|Main Treatment Period|Lack of Efficacy|7|||
130203472|NCT02505334|468704434|FG001|Main Treatment Period|Lack of Efficacy|17|||
130203473|NCT02505334|468704433|FG000|Main Treatment Period|Protocol Violation|0|||
130203474|NCT02505334|468704434|FG001|Main Treatment Period|Protocol Violation|1|||
130203475|NCT02505334|468704433|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130203476|NCT02505334|468704434|FG001|Main Treatment Period|Withdrawal by Subject|8|||
130203477|NCT02505334|468704433|FG000|Main Treatment Period|Unclassified|4|||
130203478|NCT02505334|468704434|FG001|Main Treatment Period|Unclassified|10|||
130203479|NCT02505334|468704433|FG000|Extension Treatment Period|Adverse Event|5|||
130203480|NCT02505334|468704434|FG001|Extension Treatment Period|Adverse Event|0|||
130203481|NCT02505334|468704433|FG000|Extension Treatment Period|Lack of Efficacy|4|||
130203482|NCT02505334|468704434|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130203483|NCT02505334|468704433|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
130203484|NCT02505334|468704434|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130203485|NCT02505334|468704433|FG000|Extension Treatment Period|Unclassified|3|||
130203486|NCT02505334|468704434|FG001|Extension Treatment Period|Unclassified|0|||
130203487|NCT00581542|468704437|FG000|Overall Study|they met an exclusion criteria|2|||
130203488|NCT00581542|468704438|FG001|Overall Study|they met an exclusion criteria|2|||
130203489|NCT00581542|468704437|FG000|Overall Study|Lost to Follow-up|9|||
130203490|NCT00581542|468704438|FG001|Overall Study|Lost to Follow-up|21|||
130203491|NCT00656851|468704439|FG000|Overall Study|Withdrawal by Subject|0|||
130203492|NCT00656851|468704440|FG001|Overall Study|Withdrawal by Subject|4|||
130203493|NCT02291601|468704441|FG000|Abdomen|Did not qualify|333|||
130203494|NCT02291601|468704442|FG001|Abdomen|Did not qualify|54|||
130203495|NCT02291601|468704443|FG002|Abdomen|Did not qualify|339|||
130203496|NCT02291601|468704441|FG000|Groin|Did not qualify|183|||
130203497|NCT02291601|468704442|FG001|Groin|Did not qualify|30|||
130203498|NCT02291601|468704443|FG002|Groin|Did not qualify|177|||
130203499|NCT03379753|468704444|FG000|Overall Study|Withdrawal by Subject|2|||
130203500|NCT03379753|468704445|FG001|Overall Study|Withdrawal by Subject|1|||
130203501|NCT03379753|468704444|FG000|Overall Study|not having correct procedure|1|||
130203502|NCT03379753|468704445|FG001|Overall Study|not having correct procedure|2|||
130203503|NCT03379753|468704444|FG000|Overall Study|No primary outcome|12|||
130203504|NCT03379753|468704445|FG001|Overall Study|No primary outcome|22|||
130203505|NCT01032239|468704446|FG000|Overall Study|Lost to Follow-up|3|||
130203506|NCT01032239|468704447|FG001|Overall Study|Lost to Follow-up|2|||
130203507|NCT01032239|468704446|FG000|Overall Study|Withdrawal by Subject|2|||
130203508|NCT01032239|468704447|FG001|Overall Study|Withdrawal by Subject|3|||
130203509|NCT01032239|468704446|FG000|Overall Study|Death|1|||
130203510|NCT01032239|468704447|FG001|Overall Study|Death|0|||
130203511|NCT01032239|468704446|FG000|Overall Study|Protocol Violation|1|||
130203512|NCT01032239|468704447|FG001|Overall Study|Protocol Violation|0|||
130203513|NCT01940900|468704450|FG000|Overall Study|Physician Decision|4|||
130203514|NCT01940900|468704451|FG001|Overall Study|Physician Decision|0|||
130203515|NCT01940900|468704450|FG000|Overall Study|Adverse Event|10|||
130203516|NCT01940900|468704451|FG001|Overall Study|Adverse Event|15|||
130203517|NCT01940900|468704450|FG000|Overall Study|Withdrawal by Subject|11|||
130203518|NCT01940900|468704451|FG001|Overall Study|Withdrawal by Subject|15|||
130203519|NCT01940900|468704450|FG000|Overall Study|Lost to Follow-up|1|||
130203520|NCT01940900|468704451|FG001|Overall Study|Lost to Follow-up|0|||
130203521|NCT01940900|468704450|FG000|Overall Study|Sponsor Decision|1|||
130203522|NCT01940900|468704451|FG001|Overall Study|Sponsor Decision|0|||
130203523|NCT01940900|468704450|FG000|Overall Study|subject non-compliance|1|||
130203524|NCT01940900|468704451|FG001|Overall Study|subject non-compliance|1|||
130203525|NCT01940900|468704450|FG000|Overall Study|other|1|||
130203526|NCT01940900|468704451|FG001|Overall Study|other|0|||
130203527|NCT04972968|468704454|FG000|Overall Study|Adverse Event|3|||
130203528|NCT04972968|468704455|FG001|Overall Study|Adverse Event|1|||
130203529|NCT04972968|468704456|FG002|Overall Study|Adverse Event|1|||
130203530|NCT04972968|468704457|FG003|Overall Study|Adverse Event|7|||
130203531|NCT04972968|468704454|FG000|Overall Study|Lack of Efficacy|2|||
130203532|NCT04972968|468704455|FG001|Overall Study|Lack of Efficacy|1|||
130203533|NCT04972968|468704456|FG002|Overall Study|Lack of Efficacy|0|||
130203534|NCT04972968|468704457|FG003|Overall Study|Lack of Efficacy|0|||
130203535|NCT04972968|468704454|FG000|Overall Study|Withdrawal by Subject|7|||
130203536|NCT04972968|468704455|FG001|Overall Study|Withdrawal by Subject|4|||
130203537|NCT04972968|468704456|FG002|Overall Study|Withdrawal by Subject|3|||
130203538|NCT04972968|468704457|FG003|Overall Study|Withdrawal by Subject|2|||
130203539|NCT04972968|468704454|FG000|Overall Study|Study Terminated by Sponsor|25|||
130203540|NCT04972968|468704455|FG001|Overall Study|Study Terminated by Sponsor|28|||
130203541|NCT04972968|468704456|FG002|Overall Study|Study Terminated by Sponsor|32|||
130203542|NCT04972968|468704457|FG003|Overall Study|Study Terminated by Sponsor|27|||
130203543|NCT04972968|468704454|FG000|Overall Study|Other|1|||
130203544|NCT04972968|468704455|FG001|Overall Study|Other|0|||
130203545|NCT04972968|468704456|FG002|Overall Study|Other|1|||
130203546|NCT04972968|468704457|FG003|Overall Study|Other|1|||
130203547|NCT01698879|468704458|FG000|Overall Study|Withdrawal by Subject|1|||
130203548|NCT01698879|468704459|FG001|Overall Study|Withdrawal by Subject|0|||
130203549|NCT01698879|468704460|FG002|Overall Study|Withdrawal by Subject|0|||
130203550|NCT02419612|468704466|FG000|Short-term Treatment Period|Adverse Event|1|||
130203551|NCT02419612|468704467|FG001|Short-term Treatment Period|Adverse Event|1|||
130203552|NCT02419612|468704466|FG000|Short-term Treatment Period|Death|0|||
130203553|NCT02419612|468704467|FG001|Short-term Treatment Period|Death|2|||
130203554|NCT02419612|468704466|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
130203555|NCT02419612|468704467|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
130203556|NCT02419612|468704466|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
130203557|NCT02419612|468704467|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
130203558|NCT02419612|468704466|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130203559|NCT02419612|468704467|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130203560|NCT02419612|468704466|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
130203561|NCT02419612|468704467|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
130203562|NCT02419612|468704466|FG000|Short-term Treatment Period|Worsening of liver function|0|||
130203563|NCT02419612|468704467|FG001|Short-term Treatment Period|Worsening of liver function|1|||
130203564|NCT02419612|468704466|FG000|Short-term Treatment Period|Subject moved out of state|0|||
130203565|NCT02419612|468704467|FG001|Short-term Treatment Period|Subject moved out of state|1|||
130203566|NCT02419612|468704466|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130203567|NCT02419612|468704467|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130203568|NCT02419612|468704466|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
130203569|NCT02419612|468704467|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
130203570|NCT02419612|468704466|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
130203571|NCT02419612|468704467|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
130203572|NCT02419612|468704466|FG000|Long-term Treatment Period|Death|0|||
130203573|NCT02419612|468704467|FG001|Long-term Treatment Period|Death|1|||
130203574|NCT02419612|468704466|FG000|Long-term Treatment Period|Adverse Event|0|||
130203575|NCT02419612|468704467|FG001|Long-term Treatment Period|Adverse Event|5|||
130203576|NCT02419612|468704466|FG000|Long-term Treatment Period|Other|4|||
130203577|NCT02419612|468704467|FG001|Long-term Treatment Period|Other|4|||
130203578|NCT02419612|468704466|FG000|Long-term Treatment Period|Subject Decision|2|||
130203579|NCT02419612|468704467|FG001|Long-term Treatment Period|Subject Decision|4|||
130203580|NCT02419612|468704466|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
130203581|NCT02419612|468704467|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
130203582|NCT00474045|468704468|FG000|Overall Study|Adverse Event|18|||
130203583|NCT00474045|468704469|FG001|Overall Study|Adverse Event|8|||
130203584|NCT00474045|468704468|FG000|Overall Study|Unclassified|1|||
130203585|NCT00474045|468704469|FG001|Overall Study|Unclassified|3|||
130203586|NCT00474045|468704468|FG000|Overall Study|Lack of Efficacy|0|||
130203587|NCT00474045|468704469|FG001|Overall Study|Lack of Efficacy|9|||
130203588|NCT00474045|468704468|FG000|Overall Study|Lost to Follow-up|1|||
130203589|NCT00474045|468704469|FG001|Overall Study|Lost to Follow-up|1|||
130203590|NCT00474045|468704468|FG000|Overall Study|Protocol Violation|10|||
130203591|NCT00474045|468704469|FG001|Overall Study|Protocol Violation|12|||
130203592|NCT00474045|468704468|FG000|Overall Study|Withdrawal by Subject|16|||
130203593|NCT00474045|468704469|FG001|Overall Study|Withdrawal by Subject|18|||
130203594|NCT00474045|468704468|FG000|Overall Study|Withdrawal criteria|60|||
130203595|NCT00474045|468704469|FG001|Overall Study|Withdrawal criteria|50|||
130203596|NCT02009397|468704476|FG000|Overall Study|Protocol Violation|6|||
130203597|NCT02009397|468704476|FG000|Overall Study|Death|8|||
130203598|NCT02009397|468704476|FG000|Overall Study|Lost to Follow-up|6|||
130203599|NCT02278120|468704480|FG000|Treatment Period|Progressive disease|234|||
130203600|NCT02278120|468704481|FG001|Treatment Period|Progressive disease|260|||
130203601|NCT02278120|468704480|FG000|Treatment Period|Subject/guardian decision|23|||
130203602|NCT02278120|468704481|FG001|Treatment Period|Subject/guardian decision|20|||
130203603|NCT02278120|468704480|FG000|Treatment Period|Adverse Event|16|||
130203604|NCT02278120|468704481|FG001|Treatment Period|Adverse Event|14|||
130203605|NCT02278120|468704480|FG000|Treatment Period|Physician Decision|14|||
130203606|NCT02278120|468704481|FG001|Treatment Period|Physician Decision|27|||
130203607|NCT02278120|468704480|FG000|Treatment Period|Death|3|||
130203608|NCT02278120|468704481|FG001|Treatment Period|Death|3|||
130203609|NCT02278120|468704480|FG000|Treatment Period|Lost to Follow-up|2|||
130203610|NCT02278120|468704481|FG001|Treatment Period|Lost to Follow-up|0|||
130203611|NCT02278120|468704480|FG000|Treatment Period|Protocol deviation|0|||
130203612|NCT02278120|468704481|FG001|Treatment Period|Protocol deviation|2|||
130203613|NCT02278120|468704480|FG000|Treatment Period|Study terminated as per protocol|43|||
130203614|NCT02278120|468704481|FG001|Treatment Period|Study terminated as per protocol|11|||
130203615|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130203616|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130203617|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130203618|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130203619|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
130203620|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
130203621|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
130203622|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
130203623|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130203624|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130203625|NCT01966068|468704485|FG000|Overall Study|Withdrawal by Subject|57|||
130203626|NCT01966068|468704485|FG000|Overall Study|Lost to Follow-up|81|||
130203627|NCT00191282|468704490|FG000|Overall Study|Adverse Event|5|||
130203628|NCT00191282|468704491|FG001|Overall Study|Adverse Event|6|||
130203629|NCT00191282|468704490|FG000|Overall Study|Death|51|||
130203630|NCT00191282|468704491|FG001|Overall Study|Death|51|||
130203631|NCT00191282|468704490|FG000|Overall Study|Lack of Efficacy|11|||
130203632|NCT00191282|468704491|FG001|Overall Study|Lack of Efficacy|6|||
130203633|NCT00191282|468704490|FG000|Overall Study|Noncompliance|14|||
130203634|NCT00191282|468704491|FG001|Overall Study|Noncompliance|17|||
130203635|NCT00191282|468704490|FG000|Overall Study|Patient moved|11|||
130203636|NCT00191282|468704491|FG001|Overall Study|Patient moved|14|||
130203637|NCT00191282|468704490|FG000|Overall Study|Withdrawal by Subject|59|||
130203638|NCT00191282|468704491|FG001|Overall Study|Withdrawal by Subject|44|||
130203639|NCT00191282|468704490|FG000|Overall Study|Physician Decision|18|||
130203640|NCT00191282|468704491|FG001|Overall Study|Physician Decision|15|||
130203641|NCT00191282|468704490|FG000|Overall Study|Protocol entry criteria not met|14|||
130203642|NCT00191282|468704491|FG001|Overall Study|Protocol entry criteria not met|9|||
130203643|NCT00191282|468704490|FG000|Overall Study|Protocol Violation|9|||
130203644|NCT00191282|468704491|FG001|Overall Study|Protocol Violation|12|||
130203645|NCT00191282|468704490|FG000|Overall Study|Severity of outcome|2|||
130203646|NCT00191282|468704491|FG001|Overall Study|Severity of outcome|5|||
130203647|NCT00191282|468704490|FG000|Overall Study|Sponsor's decision|2|||
130203648|NCT00191282|468704491|FG001|Overall Study|Sponsor's decision|2|||
130203649|NCT00191282|468704490|FG000|Overall Study|Lost to Follow-up|24|||
130203650|NCT00191282|468704491|FG001|Overall Study|Lost to Follow-up|31|||
130203651|NCT00102531|468704492|FG000|Overall Study|Adverse Event|0|||
130203652|NCT00102531|468704493|FG001|Overall Study|Adverse Event|1|||
130203653|NCT00102531|468704492|FG000|Overall Study|Disease Progression|5|||
130203654|NCT00102531|468704493|FG001|Overall Study|Disease Progression|9|||
130203655|NCT00102531|468704492|FG000|Overall Study|Physician Decision|0|||
130203656|NCT00102531|468704493|FG001|Overall Study|Physician Decision|1|||
130203657|NCT04756154|468704494|FG000|Overall Study|Did not meet treatment day baseline|30|||
130203658|NCT04756154|468704495|FG001|Overall Study|Did not meet treatment day baseline|28|||
130203659|NCT04756154|468704496|FG002|Overall Study|Did not meet treatment day baseline|7|||
130203660|NCT04756154|468704494|FG000|Overall Study|Did not return for final sample collection|1|||
130203661|NCT04756154|468704495|FG001|Overall Study|Did not return for final sample collection|1|||
130203662|NCT04756154|468704496|FG002|Overall Study|Did not return for final sample collection|0|||
130203663|NCT01790828|468704497|FG000|Overall Study|Other|34|||
130203664|NCT03589976|468704499|FG000|Overall Study|Death|5|||
130203665|NCT03589976|468704500|FG001|Overall Study|Death|1|||
130203666|NCT03589976|468704499|FG000|Overall Study|Adverse Event|5|||
130203667|NCT03589976|468704500|FG001|Overall Study|Adverse Event|1|||
130203668|NCT03589976|468704499|FG000|Overall Study|Withdrawal by Subject|4|||
130203669|NCT03589976|468704500|FG001|Overall Study|Withdrawal by Subject|1|||
130203670|NCT03589976|468704499|FG000|Overall Study|Lost to Follow-up|1|||
130203671|NCT03589976|468704500|FG001|Overall Study|Lost to Follow-up|0|||
130203672|NCT03589976|468704499|FG000|Overall Study|Other|4|||
130203673|NCT03589976|468704500|FG001|Overall Study|Other|3|||
130203674|NCT03721835|468704501|FG000|Overall Study|Participant not able to return|1|||
130203675|NCT03721835|468704501|FG000|Overall Study|Lost to Follow-up|1|||
130203676|NCT03721835|468704501|FG000|Overall Study|Revision of the components of the study device|2|||
130203677|NCT03721835|468704501|FG000|Overall Study|Sponsor terminated study|6|||
130203678|NCT03721835|468704501|FG000|Overall Study|Death|1|||
130203679|NCT03721835|468704501|FG000|Overall Study|Sponsor decision|1|||
130203680|NCT01390428|468705900|FG000|Overall Study|Elective Surgery|0|||
130203681|NCT01390428|468705901|FG001|Overall Study|Elective Surgery|0|||
130203682|NCT01390428|468705902|FG002|Overall Study|Elective Surgery|0|||
130203683|NCT01390428|468705903|FG003|Overall Study|Elective Surgery|0|||
130203684|NCT01390428|468705904|FG004|Overall Study|Elective Surgery|1|||
130203685|NCT01390428|468705905|FG005|Overall Study|Elective Surgery|0|||
130203686|NCT01390428|468705900|FG000|Overall Study|Withdrawal by Subject|0|||
130203687|NCT01390428|468705901|FG001|Overall Study|Withdrawal by Subject|0|||
130203688|NCT01390428|468705902|FG002|Overall Study|Withdrawal by Subject|1|||
130203689|NCT01390428|468705903|FG003|Overall Study|Withdrawal by Subject|0|||
130203690|NCT01390428|468705904|FG004|Overall Study|Withdrawal by Subject|0|||
130203691|NCT01390428|468705905|FG005|Overall Study|Withdrawal by Subject|0|||
130203692|NCT05079750|468705906|FG000|Overall Study|Lost to Follow-up|0|||
130203693|NCT05079750|468705907|FG001|Overall Study|Lost to Follow-up|0|||
130203694|NCT05079750|468705908|FG002|Overall Study|Lost to Follow-up|1|||
130203695|NCT05897827|468705909|FG000|Overall Study|Lost to Follow-up|33|||
130203696|NCT05897827|468705910|FG001|Overall Study|Lost to Follow-up|14|||
130203697|NCT05897827|468705909|FG000|Overall Study|Withdrawal by Subject|1|||
130203698|NCT05897827|468705910|FG001|Overall Study|Withdrawal by Subject|1|||
130203699|NCT02276053|468705913|FG000|Overall Study|Death|2|||
130203700|NCT02276053|468705913|FG000|Overall Study|Adverse Event|5|||
130203701|NCT02276053|468705913|FG000|Overall Study|Lack of Efficacy|2|||
130203702|NCT02276053|468705913|FG000|Overall Study|Withdrawal by Subject|1|||
130203703|NCT02276053|468705913|FG000|Overall Study|Patient does not meet selection criteria|3|||
130203704|NCT02276053|468705913|FG000|Overall Study|Patient needs to increase baseline AED|1|||
130203705|NCT04542499|468705916|FG000|Overall Study|Adverse Event|23|||
130203706|NCT04542499|468705917|FG001|Overall Study|Adverse Event|43|||
130203707|NCT04542499|468705916|FG000|Overall Study|Lack of Efficacy|5|||
130203708|NCT04542499|468705917|FG001|Overall Study|Lack of Efficacy|2|||
130203709|NCT04542499|468705916|FG000|Overall Study|Lost to Follow-up|3|||
130203710|NCT04542499|468705917|FG001|Overall Study|Lost to Follow-up|4|||
130203711|NCT04542499|468705916|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130203712|NCT04542499|468705917|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
130203713|NCT04542499|468705916|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130203714|NCT04542499|468705917|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130203715|NCT04542499|468705916|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130203716|NCT04542499|468705917|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130203717|NCT04542499|468705916|FG000|Overall Study|Physician Decision|0|||
130203718|NCT04542499|468705917|FG001|Overall Study|Physician Decision|1|||
130203719|NCT04542499|468705916|FG000|Overall Study|Site Terminated by Sponsor|3|||
130203720|NCT04542499|468705917|FG001|Overall Study|Site Terminated by Sponsor|5|||
130203721|NCT04542499|468705916|FG000|Overall Study|Withdrawal by Subject|12|||
130203722|NCT04542499|468705917|FG001|Overall Study|Withdrawal by Subject|33|||
130203723|NCT04542499|468705916|FG000|Overall Study|Other|2|||
130203724|NCT04542499|468705917|FG001|Overall Study|Other|2|||
130203725|NCT04322539|468705924|FG000|Overall Study|Adverse Event|2|||
130203726|NCT04322539|468705925|FG001|Overall Study|Adverse Event|0|||
130203727|NCT04322539|468705924|FG000|Overall Study|Death|411|||
130203728|NCT04322539|468705925|FG001|Overall Study|Death|203|||
130203729|NCT04322539|468705924|FG000|Overall Study|Lost to Follow-up|3|||
130203730|NCT04322539|468705925|FG001|Overall Study|Lost to Follow-up|1|||
130203731|NCT04322539|468705924|FG000|Overall Study|Withdrawal of consent|14|||
130203732|NCT04322539|468705925|FG001|Overall Study|Withdrawal of consent|8|||
130203733|NCT04322539|468705924|FG000|Overall Study|Radiological Disease Progression|6|||
130203734|NCT04322539|468705925|FG001|Overall Study|Radiological Disease Progression|0|||
130203735|NCT04322539|468705924|FG000|Overall Study|Sponsor Decision|19|||
130203736|NCT04322539|468705925|FG001|Overall Study|Sponsor Decision|14|||
130203737|NCT04322539|468705924|FG000|Overall Study|Other|6|||
130203738|NCT04322539|468705925|FG001|Overall Study|Other|4|||
130203739|NCT01702532|468705928|FG000|Overall Study|Adverse Event|0|||
130203740|NCT01702532|468705929|FG001|Overall Study|Adverse Event|1|||
130203741|NCT03617861|468705930|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130203742|NCT03617861|468705931|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130203743|NCT03617861|468705932|FG002|Second Intervention (1 Day)|Adverse Event|1|||
130203744|NCT03617861|468705933|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130203745|NCT01846221|468705943|FG000|Overall Study|Catheter Failure|2|||
130203746|NCT01846221|468705944|FG001|Overall Study|Catheter Failure|0|||
130203747|NCT01846221|468705943|FG000|Overall Study|Age Exclusion|1|||
130203748|NCT01846221|468705944|FG001|Overall Study|Age Exclusion|0|||
130203749|NCT01668966|468705945|FG000|Overall Study|Withdrawal by Subject|1|||
130203750|NCT01668966|468705945|FG000|Overall Study|Death|1|||
130203751|NCT01668966|468705945|FG000|Overall Study|Not treated|2|||
130203752|NCT02879994|468705946|FG000|Overall Study|off treatment early|7|||
130203753|NCT02879994|468705946|FG000|Overall Study|Adverse Event|2|||
130203754|NCT02879994|468705946|FG000|Overall Study|Death|2|||
130203755|NCT00552032|468705947|FG000|Overall Study|Withdrawal by Subject|2|||
130203756|NCT00552032|468705948|FG001|Overall Study|Withdrawal by Subject|2|||
130203757|NCT00552032|468705947|FG000|Overall Study|Protocol Violation|7|||
130203758|NCT00552032|468705948|FG001|Overall Study|Protocol Violation|12|||
130203759|NCT00552032|468705947|FG000|Overall Study|Lost to Follow-up|8|||
130203760|NCT00552032|468705948|FG001|Overall Study|Lost to Follow-up|5|||
130203761|NCT01643798|468705949|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
130203762|NCT01643798|468705950|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
130203763|NCT03602391|468705955|FG000|Overall Study|COVID-19|7|||
130203764|NCT03602391|468705956|FG001|Overall Study|COVID-19|6|||
130203765|NCT01097421|468705957|FG000|Overall Study|Adverse Event|8|||
130203766|NCT01097421|468705957|FG000|Overall Study|Protocol Violation|2|||
130203767|NCT01097421|468705957|FG000|Overall Study|Lost to Follow-up|1|||
130203768|NCT01097421|468705957|FG000|Overall Study|Withdrawal by Subject|3|||
130203769|NCT02035748|468705965|FG000|Overall Study|Adverse Event|5|||
130203770|NCT02035748|468705965|FG000|Overall Study|Death|3|||
130203771|NCT02035748|468705965|FG000|Overall Study|Lost to Follow-up|2|||
130203772|NCT02035748|468705965|FG000|Overall Study|Physician Decision|3|||
130203773|NCT02035748|468705965|FG000|Overall Study|Withdrawal by Subject|6|||
130203774|NCT02035748|468705965|FG000|Overall Study|Progressive Disease|1|||
130203775|NCT04495816|468705966|FG000|Overall Study|Lost to Follow-up|10|||
130203776|NCT04495816|468705967|FG001|Overall Study|Lost to Follow-up|4|||
130203777|NCT04495816|468705966|FG000|Overall Study|Withdrawal by Subject|3|||
130203778|NCT04495816|468705967|FG001|Overall Study|Withdrawal by Subject|5|||
130203779|NCT02052596|468705968|FG000|Active Phase|Adverse Event|3|||
130203780|NCT02052596|468705969|FG001|Active Phase|Adverse Event|2|||
130203781|NCT02052596|468705968|FG000|Active Phase|Lost to Follow-up|8|||
130203782|NCT02052596|468705969|FG001|Active Phase|Lost to Follow-up|11|||
130203783|NCT02052596|468705968|FG000|Active Phase|Protocol Violation|1|||
130203784|NCT02052596|468705969|FG001|Active Phase|Protocol Violation|2|||
130203785|NCT02052596|468705968|FG000|Active Phase|Withdrawal by Subject|3|||
130203786|NCT02052596|468705969|FG001|Active Phase|Withdrawal by Subject|4|||
130203787|NCT02052596|468705968|FG000|Active Phase|Enrolled in error|1|||
130203788|NCT02052596|468705969|FG001|Active Phase|Enrolled in error|0|||
130203789|NCT02052596|468705968|FG000|Active Phase|Lost due to Crohn's disease|0|||
130203790|NCT02052596|468705969|FG001|Active Phase|Lost due to Crohn's disease|1|||
130203791|NCT02052596|468705968|FG000|Safety Phase|Adverse Event|6|||
130203792|NCT02052596|468705969|FG001|Safety Phase|Adverse Event|3|||
130203793|NCT02052596|468705968|FG000|Safety Phase|Lost to Follow-up|11|||
130203794|NCT02052596|468705969|FG001|Safety Phase|Lost to Follow-up|18|||
130203795|NCT02052596|468705968|FG000|Safety Phase|Protocol Violation|1|||
130203796|NCT02052596|468705969|FG001|Safety Phase|Protocol Violation|2|||
130203797|NCT02052596|468705968|FG000|Safety Phase|Withdrawal by Subject|8|||
130203798|NCT02052596|468705969|FG001|Safety Phase|Withdrawal by Subject|11|||
130203799|NCT02052596|468705968|FG000|Safety Phase|Enrolled in error|1|||
130203800|NCT02052596|468705969|FG001|Safety Phase|Enrolled in error|0|||
130203801|NCT02052596|468705968|FG000|Safety Phase|Lost due to Crohn's disease|0|||
130203802|NCT02052596|468705969|FG001|Safety Phase|Lost due to Crohn's disease|1|||
130203803|NCT00558896|468705970|FG000|Overall Study|Adverse Event|1|||
130203804|NCT00558896|468705971|FG001|Overall Study|Adverse Event|1|||
130203805|NCT00558896|468705972|FG002|Overall Study|Adverse Event|1|||
130203806|NCT00558896|468705973|FG003|Overall Study|Adverse Event|3|||
130203807|NCT00558896|468705974|FG004|Overall Study|Adverse Event|4|||
130203808|NCT00558896|468705975|FG005|Overall Study|Adverse Event|10|||
130203809|NCT00558896|468705976|FG006|Overall Study|Adverse Event|3|||
130203810|NCT00558896|468705970|FG000|Overall Study|Death|3|||
130203811|NCT00558896|468705971|FG001|Overall Study|Death|0|||
130203812|NCT00558896|468705972|FG002|Overall Study|Death|2|||
130203813|NCT00558896|468705973|FG003|Overall Study|Death|3|||
130203814|NCT00558896|468705974|FG004|Overall Study|Death|2|||
130203815|NCT00558896|468705975|FG005|Overall Study|Death|2|||
130203816|NCT00558896|468705976|FG006|Overall Study|Death|6|||
130203817|NCT00558896|468705970|FG000|Overall Study|Withdrawal by Subject|2|||
130203818|NCT00558896|468705971|FG001|Overall Study|Withdrawal by Subject|1|||
130203819|NCT00558896|468705972|FG002|Overall Study|Withdrawal by Subject|1|||
130203820|NCT00558896|468705973|FG003|Overall Study|Withdrawal by Subject|1|||
130203821|NCT00558896|468705974|FG004|Overall Study|Withdrawal by Subject|1|||
130203822|NCT00558896|468705975|FG005|Overall Study|Withdrawal by Subject|5|||
130203823|NCT00558896|468705976|FG006|Overall Study|Withdrawal by Subject|5|||
130203824|NCT00558896|468705970|FG000|Overall Study|Alternative Treatment|2|||
130203825|NCT00558896|468705971|FG001|Overall Study|Alternative Treatment|2|||
130203826|NCT00558896|468705972|FG002|Overall Study|Alternative Treatment|0|||
130203827|NCT00558896|468705973|FG003|Overall Study|Alternative Treatment|2|||
130203828|NCT00558896|468705974|FG004|Overall Study|Alternative Treatment|6|||
130203829|NCT00558896|468705975|FG005|Overall Study|Alternative Treatment|7|||
130203830|NCT00558896|468705976|FG006|Overall Study|Alternative Treatment|1|||
130203831|NCT00558896|468705970|FG000|Overall Study|Physician discretion|3|||
130203832|NCT00558896|468705971|FG001|Overall Study|Physician discretion|2|||
130203833|NCT00558896|468705972|FG002|Overall Study|Physician discretion|1|||
130203834|NCT00558896|468705973|FG003|Overall Study|Physician discretion|2|||
130203835|NCT00558896|468705974|FG004|Overall Study|Physician discretion|1|||
130203836|NCT00558896|468705975|FG005|Overall Study|Physician discretion|3|||
130203837|NCT00558896|468705976|FG006|Overall Study|Physician discretion|3|||
130203838|NCT00558896|468705970|FG000|Overall Study|Continues on treatment|10|||
130203839|NCT00558896|468705971|FG001|Overall Study|Continues on treatment|1|||
130203840|NCT00558896|468705972|FG002|Overall Study|Continues on treatment|0|||
130203841|NCT00558896|468705973|FG003|Overall Study|Continues on treatment|1|||
130203842|NCT00558896|468705974|FG004|Overall Study|Continues on treatment|9|||
130203843|NCT00558896|468705975|FG005|Overall Study|Continues on treatment|25|||
130203844|NCT00558896|468705976|FG006|Overall Study|Continues on treatment|6|||
130203845|NCT00705718|468705977|FG000|Overall Study|Death|6|||
130203846|NCT00705718|468705978|FG001|Overall Study|Death|6|||
130203847|NCT00705718|468705977|FG000|Overall Study|Not due for Visit|0|||
130203848|NCT00705718|468705978|FG001|Overall Study|Not due for Visit|12|||
130203849|NCT00705718|468705977|FG000|Overall Study|Follow up not done|1|||
130203850|NCT00705718|468705978|FG001|Overall Study|Follow up not done|4|||
130203851|NCT06137703|468705979|FG000|Overall Study|Other|0|||
130203852|NCT06137703|468705980|FG001|Overall Study|Other|1|||
130203853|NCT06137703|468705981|FG002|Overall Study|Other|0|||
130203854|NCT06137703|468705982|FG003|Overall Study|Other|0|||
130203855|NCT06137703|468705979|FG000|Overall Study|Adverse Event|0|||
130203856|NCT06137703|468705980|FG001|Overall Study|Adverse Event|0|||
130203857|NCT06137703|468705981|FG002|Overall Study|Adverse Event|1|||
130203858|NCT06137703|468705982|FG003|Overall Study|Adverse Event|0|||
130203859|NCT04329091|468705985|FG000|Overall Study|Physician Decision|5|||
130203860|NCT00741091|468705988|FG000|Overall Study|Death|13|||
130203861|NCT00741091|468705988|FG000|Overall Study|Lost to Follow-up|16|||
130203862|NCT00741091|468705988|FG000|Overall Study|Withdrawal by Subject|6|||
130203863|NCT00741091|468705988|FG000|Overall Study|Missed Visit|22|||
130203864|NCT01527487|468705989|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
130203865|NCT01527487|468705990|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
130203866|NCT01527487|468705989|FG000|Overall Study|Disease Progression|4|||
130203867|NCT01527487|468705990|FG001|Overall Study|Disease Progression|1|||
130203868|NCT01527487|468705989|FG000|Overall Study|Adverse Event|1|||
130203869|NCT01527487|468705990|FG001|Overall Study|Adverse Event|1|||
130203870|NCT01527487|468705989|FG000|Overall Study|Death|0|||
130203871|NCT01527487|468705990|FG001|Overall Study|Death|1|||
130203872|NCT00723190|468705994|FG000|Overall Study|Withdrawal by Subject|45|||
130203873|NCT00723190|468705994|FG000|Overall Study|Lost to Follow-up|37|||
130203874|NCT00723190|468705994|FG000|Overall Study|Adverse Event|18|||
130203875|NCT00723190|468705994|FG000|Overall Study|Lack of Efficacy|16|||
130203876|NCT00723190|468705994|FG000|Overall Study|Protocol Violation|15|||
130203877|NCT00723190|468705994|FG000|Overall Study|Other-Premature Discontinuation|9|||
130203878|NCT00723190|468705994|FG000|Overall Study|Other-Not included in safety population|2|||
130203879|NCT03181503|468705995|FG000|Overall Study|Adverse Event|2|||
130203880|NCT03181503|468705996|FG001|Overall Study|Adverse Event|2|||
130203881|NCT03181503|468705995|FG000|Overall Study|Protocol Violation|1|||
130203882|NCT03181503|468705996|FG001|Overall Study|Protocol Violation|0|||
130203883|NCT03181503|468705995|FG000|Overall Study|Withdrawal by Subject|3|||
130203884|NCT03181503|468705996|FG001|Overall Study|Withdrawal by Subject|0|||
130203885|NCT03181503|468705995|FG000|Overall Study|Lost to Follow-up|1|||
130203886|NCT03181503|468705996|FG001|Overall Study|Lost to Follow-up|1|||
130203887|NCT00597506|468705997|FG000|Overall Study|Subject is being followed for survival|1|||
130203888|NCT03199612|468705998|FG000|Overall Study|Adverse Event|1|||
130203889|NCT03199612|468705999|FG001|Overall Study|Adverse Event|0|||
130203890|NCT00081731|468706004|FG000|Overall Study|scientific integrity issue|8|||
130203891|NCT00081731|468706005|FG001|Overall Study|scientific integrity issue|8|||
130203892|NCT02386345|468706006|FG000|Overall Study|Not treated|14|||
130203893|NCT02386345|468706006|FG000|Overall Study|Lost to Follow-up|1|||
130203894|NCT02386345|468706006|FG000|Overall Study|Adverse Event|5|||
130203895|NCT02386345|468706006|FG000|Overall Study|Repeat Procedure|10|||
130203896|NCT02386345|468706006|FG000|Overall Study|Did not complete 12-month follow-up|72|||
130203897|NCT02258542|468706007|FG000|Overall Study|eg. not made to the visit|7|||
130203898|NCT02258542|468706008|FG001|Overall Study|eg. not made to the visit|4|||
130203899|NCT02258542|468706009|FG002|Overall Study|eg. not made to the visit|0|||
130203900|NCT02258542|468706010|FG003|Overall Study|eg. not made to the visit|1|||
130203901|NCT02258542|468706007|FG000|Overall Study|study specific discount. criteria|1|||
130203902|NCT02258542|468706008|FG001|Overall Study|study specific discount. criteria|1|||
130203903|NCT02258542|468706009|FG002|Overall Study|study specific discount. criteria|0|||
130203904|NCT02258542|468706010|FG003|Overall Study|study specific discount. criteria|0|||
130203905|NCT02258542|468706007|FG000|Overall Study|Withdrawal by Subject|20|||
130203906|NCT02258542|468706008|FG001|Overall Study|Withdrawal by Subject|20|||
130203907|NCT02258542|468706009|FG002|Overall Study|Withdrawal by Subject|7|||
130203908|NCT02258542|468706010|FG003|Overall Study|Withdrawal by Subject|1|||
130203909|NCT02258542|468706007|FG000|Overall Study|Lost to Follow-up|5|||
130203910|NCT02258542|468706008|FG001|Overall Study|Lost to Follow-up|12|||
130203911|NCT02258542|468706009|FG002|Overall Study|Lost to Follow-up|1|||
130203912|NCT02258542|468706010|FG003|Overall Study|Lost to Follow-up|2|||
130203913|NCT02258542|468706007|FG000|Overall Study|Death|5|||
130203914|NCT02258542|468706008|FG001|Overall Study|Death|4|||
130203915|NCT02258542|468706009|FG002|Overall Study|Death|0|||
130203916|NCT02258542|468706010|FG003|Overall Study|Death|1|||
130203917|NCT02258542|468706007|FG000|Overall Study|Adverse Event|3|||
130203918|NCT02258542|468706008|FG001|Overall Study|Adverse Event|4|||
130203919|NCT02258542|468706009|FG002|Overall Study|Adverse Event|0|||
130203920|NCT02258542|468706010|FG003|Overall Study|Adverse Event|0|||
130203921|NCT02258542|468706007|FG000|Overall Study|Protocol Violation|1|||
130203922|NCT02258542|468706008|FG001|Overall Study|Protocol Violation|2|||
130203923|NCT02258542|468706009|FG002|Overall Study|Protocol Violation|0|||
130203924|NCT02258542|468706010|FG003|Overall Study|Protocol Violation|0|||
130203925|NCT02258542|468706007|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130203926|NCT02258542|468706008|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130203927|NCT02258542|468706009|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130203928|NCT02258542|468706010|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130203929|NCT00514904|468706025|FG000|Overall Study|Withdrawal by Subject|3|||
130203930|NCT00514904|468706026|FG001|Overall Study|Withdrawal by Subject|2|||
130203931|NCT00514904|468706025|FG000|Overall Study|Lost to Follow-up|21|||
130203932|NCT00514904|468706026|FG001|Overall Study|Lost to Follow-up|3|||
130203933|NCT02417961|468707079|FG000|Overall Study|Adverse Event|1|||
130203934|NCT02417961|468707079|FG000|Overall Study|Lost to Follow-up|1|||
130203935|NCT02417961|468707079|FG000|Overall Study|Withdrawal by Subject|2|||
130203936|NCT03197467|468707082|FG000|Overall Study|Withdrawal by Subject|1|||
130203937|NCT03666533|468707084|FG000|Overall Study|Lost to Follow-up|2|||
130203938|NCT03666533|468707085|FG001|Overall Study|Lost to Follow-up|2|||
130203939|NCT04392167|468707103|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
130203940|NCT04063657|468707104|FG000|Overall Study|Lost to Follow-up|1|||
130203941|NCT04063657|468707105|FG001|Overall Study|Lost to Follow-up|0|||
130203942|NCT03408444|468707106|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130203943|NCT03408444|468707107|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203944|NCT03408444|468707108|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203945|NCT03408444|468707109|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203946|NCT03408444|468707106|FG000|Overall Study|Lens Discomfort|0|||
130203947|NCT03408444|468707107|FG001|Overall Study|Lens Discomfort|1|||
130203948|NCT03408444|468707108|FG002|Overall Study|Lens Discomfort|0|||
130203949|NCT03408444|468707109|FG003|Overall Study|Lens Discomfort|0|||
130203950|NCT03408444|468707106|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203951|NCT03408444|468707107|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203952|NCT03408444|468707108|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130203953|NCT03408444|468707109|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203954|NCT03408444|468707106|FG000|Overall Study|Withdrawal by Subject|0|||
130203955|NCT03408444|468707107|FG001|Overall Study|Withdrawal by Subject|2|||
130203956|NCT03408444|468707108|FG002|Overall Study|Withdrawal by Subject|3|||
130203957|NCT03408444|468707109|FG003|Overall Study|Withdrawal by Subject|0|||
130203958|NCT03408444|468707106|FG000|Overall Study|Lost to Follow-up|0|||
130203959|NCT03408444|468707107|FG001|Overall Study|Lost to Follow-up|0|||
130203960|NCT03408444|468707108|FG002|Overall Study|Lost to Follow-up|1|||
130203961|NCT03408444|468707109|FG003|Overall Study|Lost to Follow-up|0|||
130203962|NCT03408444|468707106|FG000|Overall Study|Adverse Event|0|||
130203963|NCT03408444|468707107|FG001|Overall Study|Adverse Event|0|||
130203964|NCT03408444|468707108|FG002|Overall Study|Adverse Event|0|||
130203965|NCT03408444|468707109|FG003|Overall Study|Adverse Event|1|||
130203966|NCT03408444|468707106|FG000|Overall Study|Lens Handling Difficulties|0|||
130203967|NCT03408444|468707107|FG001|Overall Study|Lens Handling Difficulties|0|||
130203968|NCT03408444|468707108|FG002|Overall Study|Lens Handling Difficulties|1|||
130203969|NCT03408444|468707109|FG003|Overall Study|Lens Handling Difficulties|0|||
130203970|NCT03408444|468707106|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203971|NCT03408444|468707107|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203972|NCT03408444|468707108|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203973|NCT03408444|468707109|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
130203974|NCT04984681|468707110|FG000|Overall Study|Lost to Follow-up|3|||
130203975|NCT04984681|468707111|FG001|Overall Study|Lost to Follow-up|1|||
130203976|NCT01473394|468707114|FG000|Overall Study|Adverse Event|13|||
130203977|NCT01473394|468707115|FG001|Overall Study|Adverse Event|16|||
130203978|NCT01473394|468707114|FG000|Overall Study|Insufficient Therapeutic Response|4|||
130203979|NCT01473394|468707115|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130203980|NCT01473394|468707114|FG000|Overall Study|Protocol Violation|7|||
130203981|NCT01473394|468707115|FG001|Overall Study|Protocol Violation|5|||
130203982|NCT01473394|468707114|FG000|Overall Study|Withdrew Consent|12|||
130203983|NCT01473394|468707115|FG001|Overall Study|Withdrew Consent|10|||
130203984|NCT01473394|468707114|FG000|Overall Study|Lost to Follow-up|9|||
130203985|NCT01473394|468707115|FG001|Overall Study|Lost to Follow-up|11|||
130203986|NCT01482962|468707118|FG000|Overall Study|Progressive Disease|65|||
130203987|NCT01482962|468707119|FG001|Overall Study|Progressive Disease|53|||
130203988|NCT01482962|468707118|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
130203989|NCT01482962|468707119|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
130203990|NCT01482962|468707118|FG000|Overall Study|Adverse Event|18|||
130203991|NCT01482962|468707119|FG001|Overall Study|Adverse Event|22|||
130203992|NCT01482962|468707118|FG000|Overall Study|Withdrawal by Participant|8|||
130203993|NCT01482962|468707119|FG001|Overall Study|Withdrawal by Participant|13|||
130203994|NCT01482962|468707118|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
130203995|NCT01482962|468707119|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
130203996|NCT01482962|468707118|FG000|Overall Study|Other Reason|1|||
130203997|NCT01482962|468707119|FG001|Overall Study|Other Reason|5|||
130203998|NCT01482962|468707118|FG000|Overall Study|Study Terminated by Sponsor|5|||
130203999|NCT01482962|468707119|FG001|Overall Study|Study Terminated by Sponsor|2|||
130204000|NCT01482962|468707118|FG000|Overall Study|Did not Receive Study Drug|1|||
130204001|NCT01482962|468707119|FG001|Overall Study|Did not Receive Study Drug|6|||
130204002|NCT00250458|468707123|FG000|Overall Study|Lost to Follow-up|4|||
130204003|NCT00250458|468707124|FG001|Overall Study|Lost to Follow-up|2|||
130204004|NCT00250458|468707123|FG000|Overall Study|Protocol Violation|0|||
130204005|NCT00250458|468707124|FG001|Overall Study|Protocol Violation|1|||
130204006|NCT00250458|468707123|FG000|Overall Study|Withdrawal by Subject|4|||
130204007|NCT00250458|468707124|FG001|Overall Study|Withdrawal by Subject|2|||
130204008|NCT00250458|468707123|FG000|Overall Study|Lack of Migraine Attack|20|||
130204009|NCT00250458|468707124|FG001|Overall Study|Lack of Migraine Attack|9|||
130204010|NCT00250458|468707123|FG000|Overall Study|Qualifying migraine but did not treat|3|||
130204011|NCT00250458|468707124|FG001|Overall Study|Qualifying migraine but did not treat|3|||
130204012|NCT00250458|468707123|FG000|Overall Study|Other|1|||
130204013|NCT00250458|468707124|FG001|Overall Study|Other|0|||
130204014|NCT01801358|468707125|FG000|Overall Study|Adverse Event|0|||
130204015|NCT01801358|468707126|FG001|Overall Study|Adverse Event|2|||
130204016|NCT01801358|468707127|FG002|Overall Study|Adverse Event|1|||
130204017|NCT01801358|468707128|FG003|Overall Study|Adverse Event|0|||
130204018|NCT01801358|468707129|FG004|Overall Study|Adverse Event|0|||
130204019|NCT01801358|468707130|FG005|Overall Study|Adverse Event|1|||
130204020|NCT01801358|468707125|FG000|Overall Study|Physician Decision|0|||
130204021|NCT01801358|468707126|FG001|Overall Study|Physician Decision|0|||
130204022|NCT01801358|468707127|FG002|Overall Study|Physician Decision|1|||
130204023|NCT01801358|468707128|FG003|Overall Study|Physician Decision|0|||
130204024|NCT01801358|468707129|FG004|Overall Study|Physician Decision|0|||
130204025|NCT01801358|468707130|FG005|Overall Study|Physician Decision|0|||
130204026|NCT01801358|468707125|FG000|Overall Study|Progressive Disease|6|||
130204027|NCT01801358|468707126|FG001|Overall Study|Progressive Disease|4|||
130204028|NCT01801358|468707127|FG002|Overall Study|Progressive Disease|4|||
130204029|NCT01801358|468707128|FG003|Overall Study|Progressive Disease|5|||
130204030|NCT01801358|468707129|FG004|Overall Study|Progressive Disease|6|||
130204031|NCT01801358|468707130|FG005|Overall Study|Progressive Disease|5|||
130204032|NCT01801358|468707125|FG000|Overall Study|Withdrawal by Subject|0|||
130204033|NCT01801358|468707126|FG001|Overall Study|Withdrawal by Subject|0|||
130204034|NCT01801358|468707127|FG002|Overall Study|Withdrawal by Subject|0|||
130204035|NCT01801358|468707128|FG003|Overall Study|Withdrawal by Subject|1|||
130204036|NCT01801358|468707129|FG004|Overall Study|Withdrawal by Subject|0|||
130204037|NCT01801358|468707130|FG005|Overall Study|Withdrawal by Subject|2|||
130204038|NCT01549041|468707138|FG000|Overall Study|Lack of Efficacy|2|||
130204039|NCT01549041|468707139|FG001|Overall Study|Lack of Efficacy|4|||
130204040|NCT01549041|468707138|FG000|Overall Study|Adverse Event|0|||
130204041|NCT01549041|468707139|FG001|Overall Study|Adverse Event|4|||
130204042|NCT01537068|468707144|FG000|Overall Study|Lost to Follow-up|2|||
130204043|NCT01537068|468707145|FG001|Overall Study|Lost to Follow-up|1|||
130204044|NCT01537068|468707144|FG000|Overall Study|Adverse Event|0|||
130204045|NCT01537068|468707145|FG001|Overall Study|Adverse Event|1|||
130204046|NCT01537068|468707144|FG000|Overall Study|Withdrawal by Subject|1|||
130204047|NCT01537068|468707145|FG001|Overall Study|Withdrawal by Subject|1|||
130204048|NCT01537068|468707144|FG000|Overall Study|Lack of Efficacy|1|||
130204049|NCT01537068|468707145|FG001|Overall Study|Lack of Efficacy|0|||
130204050|NCT00483704|468707146|FG000|Randomization|Withdrawal by Subject|19|||
130204051|NCT00483704|468707147|FG001|Randomization|Withdrawal by Subject|28|||
130204052|NCT00483704|468707148|FG002|Randomization|Withdrawal by Subject|18|||
130204053|NCT00483704|468707146|FG000|Randomization|Protocol Violation|14|||
130204054|NCT00483704|468707147|FG001|Randomization|Protocol Violation|25|||
130204055|NCT00483704|468707148|FG002|Randomization|Protocol Violation|22|||
130204056|NCT00483704|468707146|FG000|Randomization|Lost to Follow-up|14|||
130204057|NCT00483704|468707147|FG001|Randomization|Lost to Follow-up|14|||
130204058|NCT00483704|468707148|FG002|Randomization|Lost to Follow-up|19|||
130204059|NCT00483704|468707146|FG000|Randomization|Pregnancy|1|||
130204060|NCT00483704|468707147|FG001|Randomization|Pregnancy|0|||
130204061|NCT00483704|468707148|FG002|Randomization|Pregnancy|0|||
130204062|NCT00483704|468707146|FG000|Randomization|Physician Decision|2|||
130204063|NCT00483704|468707147|FG001|Randomization|Physician Decision|4|||
130204064|NCT00483704|468707148|FG002|Randomization|Physician Decision|0|||
130204065|NCT00483704|468707146|FG000|Randomization|Progressive disease|0|||
130204066|NCT00483704|468707147|FG001|Randomization|Progressive disease|0|||
130204067|NCT00483704|468707148|FG002|Randomization|Progressive disease|1|||
130204068|NCT00483704|468707146|FG000|Randomization|Lack of qualifying migraines|21|||
130204069|NCT00483704|468707147|FG001|Randomization|Lack of qualifying migraines|25|||
130204070|NCT00483704|468707148|FG002|Randomization|Lack of qualifying migraines|31|||
130204071|NCT00483704|468707146|FG000|Treatment|Lack of qualifying migraines|101|||
130204072|NCT00483704|468707147|FG001|Treatment|Lack of qualifying migraines|99|||
130204073|NCT00483704|468707148|FG002|Treatment|Lack of qualifying migraines|116|||
130204074|NCT00483704|468707146|FG000|Treatment|Adverse Event|3|||
130204075|NCT00483704|468707147|FG001|Treatment|Adverse Event|5|||
130204076|NCT00483704|468707148|FG002|Treatment|Adverse Event|4|||
130204077|NCT00483704|468707146|FG000|Treatment|Withdrawal by Subject|16|||
130204078|NCT00483704|468707147|FG001|Treatment|Withdrawal by Subject|12|||
130204079|NCT00483704|468707148|FG002|Treatment|Withdrawal by Subject|21|||
130204080|NCT00483704|468707146|FG000|Treatment|Protocol Violation|6|||
130204081|NCT00483704|468707147|FG001|Treatment|Protocol Violation|3|||
130204082|NCT00483704|468707148|FG002|Treatment|Protocol Violation|5|||
130204083|NCT00483704|468707146|FG000|Treatment|Lost to Follow-up|2|||
130204084|NCT00483704|468707147|FG001|Treatment|Lost to Follow-up|7|||
130204085|NCT00483704|468707148|FG002|Treatment|Lost to Follow-up|5|||
130204086|NCT00483704|468707146|FG000|Treatment|Lack of Efficacy|1|||
130204087|NCT00483704|468707147|FG001|Treatment|Lack of Efficacy|1|||
130204088|NCT00483704|468707148|FG002|Treatment|Lack of Efficacy|1|||
130204089|NCT00483704|468707146|FG000|Treatment|Pregnancy|0|||
130204090|NCT00483704|468707147|FG001|Treatment|Pregnancy|1|||
130204091|NCT00483704|468707148|FG002|Treatment|Pregnancy|0|||
130204092|NCT00483704|468707146|FG000|Treatment|Physician Decision|0|||
130204093|NCT00483704|468707147|FG001|Treatment|Physician Decision|1|||
130204094|NCT00483704|468707148|FG002|Treatment|Physician Decision|4|||
130204095|NCT04442269|468707149|FG000|Overall Study|Adverse Event|1|||
130204096|NCT04442269|468707150|FG001|Overall Study|Adverse Event|0|||
130204097|NCT04442269|468707149|FG000|Overall Study|Death|0|||
130204098|NCT04442269|468707150|FG001|Overall Study|Death|1|||
130204099|NCT04442269|468707149|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
130204100|NCT04442269|468707150|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
130204101|NCT04442269|468707149|FG000|Overall Study|Lost to Follow-up|1|||
130204102|NCT04442269|468707150|FG001|Overall Study|Lost to Follow-up|0|||
130204103|NCT04442269|468707149|FG000|Overall Study|Withdrawal by Subject|3|||
130204104|NCT04442269|468707150|FG001|Overall Study|Withdrawal by Subject|2|||
130204105|NCT04442269|468707149|FG000|Overall Study|Protocol Deviation|0|||
130204106|NCT04442269|468707150|FG001|Overall Study|Protocol Deviation|1|||
130204107|NCT04442269|468707149|FG000|Overall Study|Travel Limitations|1|||
130204108|NCT04442269|468707150|FG001|Overall Study|Travel Limitations|1|||
130204109|NCT01793688|468707151|FG000|Overall Study|Protocol Violation|2|||
130204110|NCT04450407|468707154|FG000|Overall Study|Withdrawal by Subject|10|||
130204111|NCT04450407|468707155|FG001|Overall Study|Withdrawal by Subject|1|||
130204112|NCT04450407|468707156|FG002|Overall Study|Withdrawal by Subject|4|||
130204113|NCT04450407|468707154|FG000|Overall Study|Adverse Event|0|||
130204114|NCT04450407|468707155|FG001|Overall Study|Adverse Event|0|||
130204115|NCT04450407|468707156|FG002|Overall Study|Adverse Event|1|||
130204116|NCT04450407|468707154|FG000|Overall Study|Lost to Follow-up|1|||
130204117|NCT04450407|468707155|FG001|Overall Study|Lost to Follow-up|0|||
130204118|NCT04450407|468707156|FG002|Overall Study|Lost to Follow-up|0|||
130204119|NCT04450407|468707154|FG000|Overall Study|Physician Decision|0|||
130204120|NCT04450407|468707155|FG001|Overall Study|Physician Decision|0|||
130204121|NCT04450407|468707156|FG002|Overall Study|Physician Decision|1|||
130204122|NCT04450407|468707154|FG000|Overall Study|Pregnancy|1|||
130204123|NCT04450407|468707155|FG001|Overall Study|Pregnancy|0|||
130204124|NCT04450407|468707156|FG002|Overall Study|Pregnancy|0|||
130204125|NCT04450407|468707154|FG000|Overall Study|Protocol Violation|2|||
130204126|NCT04450407|468707155|FG001|Overall Study|Protocol Violation|0|||
130204127|NCT04450407|468707156|FG002|Overall Study|Protocol Violation|0|||
130204128|NCT04450407|468707154|FG000|Overall Study|Investigational site terminated by sponsor|3|||
130204129|NCT04450407|468707155|FG001|Overall Study|Investigational site terminated by sponsor|0|||
130204130|NCT04450407|468707156|FG002|Overall Study|Investigational site terminated by sponsor|2|||
130204131|NCT03430895|468707160|FG000|Overall Study|Not Treated|2|||
130204132|NCT01317797|468707161|FG000|Overall Study|Other|0|||
130204133|NCT01317797|468707162|FG001|Overall Study|Other|1|||
130204134|NCT01317797|468707163|FG002|Overall Study|Other|0|||
130204135|NCT01317797|468707161|FG000|Overall Study|Withdrawal of Patient|0|||
130204136|NCT01317797|468707162|FG001|Overall Study|Withdrawal of Patient|0|||
130204137|NCT01317797|468707163|FG002|Overall Study|Withdrawal of Patient|1|||
130204138|NCT01645891|468707168|FG000|Overall Study|Adverse Event|6|||
130204139|NCT01645891|468707169|FG001|Overall Study|Adverse Event|10|||
130204140|NCT01645891|468707168|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
130204141|NCT01645891|468707169|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
130204142|NCT01645891|468707168|FG000|Overall Study|Withdrawal by Subject|3|||
130204143|NCT01645891|468707169|FG001|Overall Study|Withdrawal by Subject|3|||
130204144|NCT01645891|468707168|FG000|Overall Study|Protocol Violation|4|||
130204145|NCT01645891|468707169|FG001|Overall Study|Protocol Violation|0|||
130204146|NCT01645891|468707168|FG000|Overall Study|Lost to Follow-up|4|||
130204147|NCT01645891|468707169|FG001|Overall Study|Lost to Follow-up|1|||
130204148|NCT01645891|468707168|FG000|Overall Study|Death|0|||
130204149|NCT01645891|468707169|FG001|Overall Study|Death|2|||
130204150|NCT03026530|468707172|FG000|Overall Study|Lost to Follow-up|19|||
130204151|NCT03026530|468707173|FG001|Overall Study|Lost to Follow-up|24|||
130204152|NCT03026530|468707172|FG000|Overall Study|Protocol Violation|2|||
130204153|NCT03026530|468707173|FG001|Overall Study|Protocol Violation|5|||
130204154|NCT00138073|468707174|FG000|Overall Study|lack of resources|55|||
130204155|NCT00962091|468707176|FG000|Overall Study|Withdrawal by Subject|1|||
130204156|NCT00962091|468707177|FG001|Overall Study|Withdrawal by Subject|2|||
130204157|NCT00962091|468707178|FG002|Overall Study|Withdrawal by Subject|1|||
130204158|NCT00962091|468707179|FG003|Overall Study|Withdrawal by Subject|1|||
130204159|NCT00962091|468707180|FG004|Overall Study|Withdrawal by Subject|0|||
130204160|NCT00962091|468707181|FG005|Overall Study|Withdrawal by Subject|1|||
130204161|NCT00962091|468707182|FG006|Overall Study|Withdrawal by Subject|0|||
130204162|NCT00962091|468707176|FG000|Overall Study|Adverse Event|0|||
130204163|NCT00962091|468707177|FG001|Overall Study|Adverse Event|0|||
130204164|NCT00962091|468707178|FG002|Overall Study|Adverse Event|0|||
130204165|NCT00962091|468707179|FG003|Overall Study|Adverse Event|0|||
130204166|NCT00962091|468707180|FG004|Overall Study|Adverse Event|0|||
130204167|NCT00962091|468707181|FG005|Overall Study|Adverse Event|0|||
130204168|NCT00962091|468707182|FG006|Overall Study|Adverse Event|1|||
130204169|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204170|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204171|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130204172|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204173|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204174|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204175|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204176|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204177|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204178|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204179|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204180|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204181|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204182|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204183|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
130204184|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204185|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204186|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204187|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204188|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204189|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204190|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204191|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204192|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204193|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204194|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204195|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204196|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204197|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130204198|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130204199|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204200|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204201|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204202|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204203|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204204|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204205|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204206|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204207|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204208|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204209|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204210|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204211|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
130204212|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
130204213|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204214|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204215|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204216|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204217|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204218|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204219|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204220|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204221|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204222|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204223|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204224|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204225|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204226|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204227|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
130204228|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204229|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204230|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204231|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204232|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204233|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204234|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204235|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204236|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204237|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204238|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204239|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204240|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204241|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204242|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204243|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204244|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204245|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
130204246|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204247|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204248|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204249|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204250|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204251|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204252|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204253|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204254|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204255|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204256|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204257|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204258|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
130204259|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
130204260|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204261|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
130204262|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204263|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204264|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204265|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204266|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204267|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204268|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204269|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204270|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204271|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204272|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
130204273|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204274|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204275|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204276|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204277|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204278|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204279|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204280|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204281|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204282|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204283|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204284|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204285|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204286|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204287|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130204288|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204289|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204290|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204291|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204292|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204293|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204294|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204295|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204296|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204297|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204298|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204299|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204300|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204301|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204302|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
130204303|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204304|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204305|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204306|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204307|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204308|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204309|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204310|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204311|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204312|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204313|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204314|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204315|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
130204316|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130204317|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204318|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204319|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204320|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204321|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204322|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204323|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204324|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204325|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204326|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204327|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204328|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204329|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204330|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130204331|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204332|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204333|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204334|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204335|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204336|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204337|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204338|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204339|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204340|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204341|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204342|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
130204343|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204344|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204345|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204346|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204347|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204348|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204349|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204350|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204351|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130204352|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130204353|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130204354|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130204355|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130204356|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130204357|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130204358|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130204359|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
130204360|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
130204361|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130204362|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
130204363|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
130204364|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130204365|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204366|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204367|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204368|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204369|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204370|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204371|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204372|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204373|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204374|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204375|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204376|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130204377|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130204378|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204379|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204380|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204381|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204382|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204383|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204384|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204385|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204386|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204387|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204388|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204389|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204390|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130204391|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130204392|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204393|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204394|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204395|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204396|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204397|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204398|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204399|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204400|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204401|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204402|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204403|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204404|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204405|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204406|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
130204407|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204408|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204409|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204410|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204411|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204412|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204413|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204414|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204415|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204416|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204417|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204418|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
130204419|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
130204420|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130204421|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204422|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204423|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204424|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204425|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204426|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204427|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204428|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204429|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204430|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204431|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204432|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
130204433|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
130204434|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130204435|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204436|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204437|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204438|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204439|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204440|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204441|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204442|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204443|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204444|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204445|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204446|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130204447|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130204448|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130204449|NCT05072964|468707201|FG000|Overall Study|Withdrawal by Subject|4|||
130204450|NCT05072964|468707201|FG000|Overall Study|Death|1|||
130204451|NCT04743804|468708784|FG000|Overall Study|Other|1|||
130204452|NCT04743804|468708785|FG001|Overall Study|Other|0|||
130204453|NCT04743804|468708784|FG000|Overall Study|Withdrawal by Subject|0|||
130204454|NCT04743804|468708785|FG001|Overall Study|Withdrawal by Subject|1|||
130204455|NCT04743804|468708784|FG000|Overall Study|Study Terminated by Sponsor|1|||
130204456|NCT04743804|468708785|FG001|Overall Study|Study Terminated by Sponsor|4|||
130204457|NCT04743804|468708784|FG000|Overall Study|Physician Decision|0|||
130204458|NCT04743804|468708785|FG001|Overall Study|Physician Decision|1|||
130204459|NCT04743804|468708784|FG000|Overall Study|Death|3|||
130204460|NCT04743804|468708785|FG001|Overall Study|Death|0|||
130204461|NCT01632904|468708786|FG000|Overall Study|Adverse Event|4|||
130204462|NCT01632904|468708787|FG001|Overall Study|Adverse Event|1|||
130204463|NCT01632904|468708786|FG000|Overall Study|Physician Decision|0|||
130204464|NCT01632904|468708787|FG001|Overall Study|Physician Decision|1|||
130204465|NCT01632904|468708786|FG000|Overall Study|Subject decision|3|||
130204466|NCT01632904|468708787|FG001|Overall Study|Subject decision|2|||
130204467|NCT01632904|468708786|FG000|Overall Study|Disease Progression|0|||
130204468|NCT01632904|468708787|FG001|Overall Study|Disease Progression|1|||
130204469|NCT01632904|468708786|FG000|Overall Study|Reason for discontinuation not available|0|||
130204470|NCT01632904|468708787|FG001|Overall Study|Reason for discontinuation not available|1|||
130204471|NCT02059434|468708791|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
130204472|NCT02059434|468708792|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
130204473|NCT02059434|468708793|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
130204474|NCT02059434|468708794|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
130204475|NCT02059434|468708795|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
130204476|NCT02059434|468708796|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
130204477|NCT02059434|468708797|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
130204478|NCT02059434|468708798|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
130204479|NCT02059434|468708799|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
130204480|NCT02059434|468708791|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
130204481|NCT02059434|468708792|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
130204482|NCT02059434|468708793|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
130204483|NCT02059434|468708794|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
130204484|NCT02059434|468708795|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
130204485|NCT02059434|468708796|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
130204486|NCT02059434|468708797|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
130204487|NCT02059434|468708798|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
130204488|NCT02059434|468708799|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
130204489|NCT02059434|468708791|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
130204490|NCT02059434|468708792|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
130204491|NCT02059434|468708793|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
130204492|NCT02059434|468708794|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
130204493|NCT02059434|468708795|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
130204494|NCT02059434|468708796|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
130204495|NCT02059434|468708797|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
130204496|NCT02059434|468708798|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
130204497|NCT02059434|468708799|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
130204498|NCT02059434|468708791|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
130204499|NCT02059434|468708792|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
130204500|NCT02059434|468708793|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
130204501|NCT02059434|468708794|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
130204502|NCT02059434|468708795|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
130204503|NCT02059434|468708796|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
130204504|NCT02059434|468708797|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
130204505|NCT02059434|468708798|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
130204506|NCT02059434|468708799|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
130204507|NCT02059434|468708791|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204508|NCT02059434|468708792|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204509|NCT02059434|468708793|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204510|NCT02059434|468708794|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204511|NCT02059434|468708795|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204512|NCT02059434|468708796|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204513|NCT02059434|468708797|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204514|NCT02059434|468708798|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204515|NCT02059434|468708799|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
130204516|NCT01004406|468708804|FG000|Overall Study|Withdrawal by Subject|2|||
130204517|NCT01004406|468708805|FG001|Overall Study|Withdrawal by Subject|0|||
130204518|NCT01004406|468708804|FG000|Overall Study|Lost to Follow-up|1|||
130204519|NCT01004406|468708805|FG001|Overall Study|Lost to Follow-up|0|||
130204520|NCT02928770|468708806|FG000|Overall Study|Withdrawal by Subject|2|||
130204521|NCT03201874|468708807|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
130204522|NCT03201874|468708808|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130204523|NCT03201874|468708807|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130204524|NCT03201874|468708808|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
130204525|NCT02907593|468708811|FG000|Overall Study|Withdrawal by Subject|0|||
130204526|NCT02907593|468708812|FG001|Overall Study|Withdrawal by Subject|0|||
130204527|NCT02907593|468708813|FG002|Overall Study|Withdrawal by Subject|1|||
130204528|NCT02907593|468708814|FG003|Overall Study|Withdrawal by Subject|0|||
130204529|NCT03385304|468708815|FG000|Overall Study|Death|19|||
130204530|NCT03385304|468708816|FG001|Overall Study|Death|7|||
130204531|NCT03385304|468708815|FG000|Overall Study|Lost to Follow-up|17|||
130204532|NCT03385304|468708816|FG001|Overall Study|Lost to Follow-up|14|||
130204533|NCT03385304|468708815|FG000|Overall Study|Withdrawal by Subject|3|||
130204534|NCT03385304|468708816|FG001|Overall Study|Withdrawal by Subject|2|||
130204535|NCT03385304|468708815|FG000|Overall Study|Incarceration|2|||
130204536|NCT03385304|468708816|FG001|Overall Study|Incarceration|3|||
130204537|NCT01120249|468708817|FG000|Overall Study|No protocol treatment received|21|||
130204538|NCT01120249|468708818|FG001|Overall Study|No protocol treatment received|15|||
130204539|NCT01120249|468708817|FG000|Overall Study|Disease recurrence|107|||
130204540|NCT01120249|468708818|FG001|Overall Study|Disease recurrence|57|||
130204541|NCT01120249|468708817|FG000|Overall Study|Death|1|||
130204542|NCT01120249|468708818|FG001|Overall Study|Death|0|||
130204543|NCT01120249|468708817|FG000|Overall Study|Adverse Event|40|||
130204544|NCT01120249|468708818|FG001|Overall Study|Adverse Event|276|||
130204545|NCT01120249|468708817|FG000|Overall Study|Participant refusal|34|||
130204546|NCT01120249|468708818|FG001|Overall Study|Participant refusal|42|||
130204547|NCT01120249|468708817|FG000|Overall Study|Other reasons, not protocol specified|29|||
130204548|NCT01120249|468708818|FG001|Overall Study|Other reasons, not protocol specified|22|||
130204549|NCT01447446|468708819|FG000|Overall Study|Death|6|||
130204550|NCT01447446|468708820|FG001|Overall Study|Death|3|||
130204551|NCT01447446|468708821|FG002|Overall Study|Death|2|||
130204552|NCT01447446|468708822|FG003|Overall Study|Death|1|||
130204553|NCT01447446|468708823|FG004|Overall Study|Death|7|||
130204554|NCT01447446|468708824|FG005|Overall Study|Death|0|||
130204555|NCT01447446|468708819|FG000|Overall Study|Adverse Event|3|||
130204556|NCT01447446|468708820|FG001|Overall Study|Adverse Event|0|||
130204557|NCT01447446|468708821|FG002|Overall Study|Adverse Event|1|||
130204558|NCT01447446|468708822|FG003|Overall Study|Adverse Event|0|||
130204559|NCT01447446|468708823|FG004|Overall Study|Adverse Event|2|||
130204560|NCT01447446|468708824|FG005|Overall Study|Adverse Event|0|||
130204561|NCT01447446|468708819|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
130204562|NCT01447446|468708820|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
130204563|NCT01447446|468708821|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
130204564|NCT01447446|468708822|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
130204565|NCT01447446|468708823|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
130204566|NCT01447446|468708824|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
130204567|NCT01447446|468708819|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
130204568|NCT01447446|468708820|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
130204569|NCT01447446|468708821|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
130204570|NCT01447446|468708822|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
130204571|NCT01447446|468708823|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
130204572|NCT01447446|468708824|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
130204573|NCT01447446|468708819|FG000|Overall Study|Administrative/Other|34|||
130204574|NCT01447446|468708820|FG001|Overall Study|Administrative/Other|9|||
130204575|NCT01447446|468708821|FG002|Overall Study|Administrative/Other|10|||
130204576|NCT01447446|468708822|FG003|Overall Study|Administrative/Other|2|||
130204577|NCT01447446|468708823|FG004|Overall Study|Administrative/Other|33|||
130204578|NCT01447446|468708824|FG005|Overall Study|Administrative/Other|4|||
130204579|NCT01447446|468708819|FG000|Overall Study|SVR12 Assessment|13|||
130204580|NCT01447446|468708820|FG001|Overall Study|SVR12 Assessment|1|||
130204581|NCT01447446|468708821|FG002|Overall Study|SVR12 Assessment|2|||
130204582|NCT01447446|468708822|FG003|Overall Study|SVR12 Assessment|1|||
130204583|NCT01447446|468708823|FG004|Overall Study|SVR12 Assessment|5|||
130204584|NCT01447446|468708824|FG005|Overall Study|SVR12 Assessment|5|||
130204585|NCT01447446|468708819|FG000|Overall Study|New Treatment Started|8|||
130204586|NCT01447446|468708820|FG001|Overall Study|New Treatment Started|2|||
130204587|NCT01447446|468708821|FG002|Overall Study|New Treatment Started|1|||
130204588|NCT01447446|468708822|FG003|Overall Study|New Treatment Started|0|||
130204589|NCT01447446|468708823|FG004|Overall Study|New Treatment Started|2|||
130204590|NCT01447446|468708824|FG005|Overall Study|New Treatment Started|0|||
130204591|NCT01447446|468708819|FG000|Overall Study|Reason not Specified|1|||
130204592|NCT01447446|468708820|FG001|Overall Study|Reason not Specified|1|||
130204593|NCT01447446|468708821|FG002|Overall Study|Reason not Specified|1|||
130204594|NCT01447446|468708822|FG003|Overall Study|Reason not Specified|1|||
130204595|NCT01447446|468708823|FG004|Overall Study|Reason not Specified|1|||
130204596|NCT01447446|468708824|FG005|Overall Study|Reason not Specified|0|||
130204597|NCT01892085|468708834|FG000|Overall Study|Death|4|||
130204598|NCT01892085|468708835|FG001|Overall Study|Death|1|||
130204599|NCT01892085|468708836|FG002|Overall Study|Death|3|||
130204600|NCT01892085|468708834|FG000|Overall Study|Withdrawal by Subject|2|||
130204601|NCT01892085|468708835|FG001|Overall Study|Withdrawal by Subject|0|||
130204602|NCT01892085|468708836|FG002|Overall Study|Withdrawal by Subject|2|||
130204603|NCT01629823|468708837|FG000|Trial Period|Missed visit|11|||
130204604|NCT01629823|468708838|FG001|Trial Period|Missed visit|9|||
130204605|NCT01629823|468708839|FG002|Trial Period|Missed visit|8|||
130204606|NCT01629823|468708837|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204607|NCT01629823|468708838|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204608|NCT01629823|468708839|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204609|NCT01629823|468708837|FG000|Trial Period|Pregnancy|1|||
130204610|NCT01629823|468708838|FG001|Trial Period|Pregnancy|0|||
130204611|NCT01629823|468708839|FG002|Trial Period|Pregnancy|0|||
130204612|NCT01629823|468708837|FG000|Trial Period|Adverse Event|0|||
130204613|NCT01629823|468708838|FG001|Trial Period|Adverse Event|1|||
130204614|NCT01629823|468708839|FG002|Trial Period|Adverse Event|0|||
130204615|NCT01629823|468708837|FG000|Trial Period|Out-of-window visit|0|||
130204616|NCT01629823|468708838|FG001|Trial Period|Out-of-window visit|2|||
130204617|NCT01629823|468708839|FG002|Trial Period|Out-of-window visit|0|||
130204618|NCT01629823|468708837|FG000|Trial Period|Failed to hold medication|0|||
130204619|NCT01629823|468708838|FG001|Trial Period|Failed to hold medication|0|||
130204620|NCT01629823|468708839|FG002|Trial Period|Failed to hold medication|1|||
130204621|NCT01629823|468708837|FG000|Washout Period|Safety|2|||
130204622|NCT01629823|468708838|FG001|Washout Period|Safety|5|||
130204623|NCT01629823|468708839|FG002|Washout Period|Safety|0|||
130204624|NCT01629823|468708837|FG000|Washout Period|Pregnancy|1|||
130204625|NCT01629823|468708838|FG001|Washout Period|Pregnancy|0|||
130204626|NCT01629823|468708839|FG002|Washout Period|Pregnancy|0|||
130204627|NCT01629823|468708837|FG000|Washout Period|Protocol Violation|0|||
130204628|NCT01629823|468708838|FG001|Washout Period|Protocol Violation|1|||
130204629|NCT01629823|468708839|FG002|Washout Period|Protocol Violation|0|||
130204630|NCT02609724|468708840|FG000|Overall Study|Death|2|||
130204631|NCT02609724|468708841|FG001|Overall Study|Death|0|||
130204632|NCT02609724|468708842|FG002|Overall Study|Death|1|||
130204633|NCT02609724|468708840|FG000|Overall Study|Withdrawal by Subject|1|||
130204634|NCT02609724|468708841|FG001|Overall Study|Withdrawal by Subject|2|||
130204635|NCT02609724|468708842|FG002|Overall Study|Withdrawal by Subject|3|||
130204636|NCT02609724|468708840|FG000|Overall Study|Illness|2|||
130204637|NCT02609724|468708841|FG001|Overall Study|Illness|1|||
130204638|NCT02609724|468708842|FG002|Overall Study|Illness|0|||
130204639|NCT03077659|468708843|FG000|Overall Study|Withdrawal by Subject|0|||
130204640|NCT03077659|468708844|FG001|Overall Study|Withdrawal by Subject|0|||
130204641|NCT03077659|468708845|FG002|Overall Study|Withdrawal by Subject|1|||
130204642|NCT02844907|468708846|FG000|With Dexamethasone|No IV access|1|||
130204643|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130204644|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130204645|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
130204646|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
130204647|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
130204648|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
130204649|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204650|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
130204651|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204652|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204653|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204654|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204655|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
130204656|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204657|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204658|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204659|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204660|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
130204661|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204662|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204663|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204664|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
130204665|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204666|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204667|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204668|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204669|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204670|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204671|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204672|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
130204673|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204674|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204675|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204676|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204677|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
130204678|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204679|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204680|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204681|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204682|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
130204683|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
130204684|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
130204685|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
130204686|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
130204687|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
130204688|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204689|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204690|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204691|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204692|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
130204693|NCT03488225|468708854|FG000|Overall Study|Off Protocol Therapy|2|||
130204694|NCT03488225|468708854|FG000|Overall Study|Stem Cell Transplant|2|||
130204695|NCT00986986|468708855|FG000|Overall Study|Lost to Follow-up|0|||
130204696|NCT00986986|468708856|FG001|Overall Study|Lost to Follow-up|1|||
130204697|NCT02003963|468708859|FG000|Overall Study|Lost to Follow-up|2|||
130204698|NCT02003963|468708860|FG001|Overall Study|Lost to Follow-up|1|||
130204699|NCT05020366|468708862|FG000|Overall Study|Lost to Follow-up|2|||
130204700|NCT05020366|468708863|FG001|Overall Study|Lost to Follow-up|0|||
130204701|NCT05020366|468708862|FG000|Overall Study|Withdrawal by Subject|2|||
130204702|NCT05020366|468708863|FG001|Overall Study|Withdrawal by Subject|0|||
130204713|NCT04050124|468708867|FG000|Overall Study|Death|1|||
130204714|NCT04050124|468708868|FG001|Overall Study|Death|0|||
130204715|NCT00430352|468708870|FG000|Overall Study|Disease progression|58|||
130204716|NCT00430352|468708870|FG000|Overall Study|Withdrawal by Subject|11|||
130204717|NCT00430352|468708870|FG000|Overall Study|Adverse Event|16|||
130204718|NCT00430352|468708870|FG000|Overall Study|Death|5|||
130204719|NCT00430352|468708870|FG000|Overall Study|Other|48|||
130204720|NCT00819780|468708873|FG000|Overall Study|Did not receive study drug|3|||
130204721|NCT00819780|468708874|FG001|Overall Study|Did not receive study drug|4|||
130204722|NCT00819780|468708873|FG000|Overall Study|Still in treatment|25|||
130204723|NCT00819780|468708874|FG001|Overall Study|Still in treatment|17|||
130204724|NCT00150800|468708875|FG000|Overall Study|Adverse Event|89|||
130204725|NCT00150800|468708875|FG000|Overall Study|Death|18|||
130204726|NCT00150800|468708875|FG000|Overall Study|Lack of Efficacy|166|||
130204727|NCT00150800|468708875|FG000|Overall Study|Lost to Follow-up|58|||
130204728|NCT00150800|468708875|FG000|Overall Study|Subject's choice|90|||
130204729|NCT00150800|468708875|FG000|Overall Study|No compliance|18|||
130204730|NCT00150800|468708875|FG000|Overall Study|IP misshandling|1|||
130204731|NCT00150800|468708875|FG000|Overall Study|Site closure|24|||
130204732|NCT00150800|468708875|FG000|Overall Study|Protocol non-adherence|2|||
130204733|NCT00150800|468708875|FG000|Overall Study|Nobody to accompany patient|1|||
130204734|NCT00150800|468708875|FG000|Overall Study|Distance too long for patient|1|||
130204735|NCT00150800|468708875|FG000|Overall Study|Neurosurgery|2|||
130204736|NCT00150800|468708875|FG000|Overall Study|BRV monotherapy|1|||
130204737|NCT00150800|468708875|FG000|Overall Study|Visit refusal|3|||
130204738|NCT00150800|468708875|FG000|Overall Study|Sponsor's request|2|||
130204739|NCT00150800|468708875|FG000|Overall Study|Generalized Epilepsy|1|||
130204740|NCT00150800|468708875|FG000|Overall Study|Moved from area/country|8|||
130204741|NCT00150800|468708875|FG000|Overall Study|PI retiring|2|||
130204742|NCT00150800|468708875|FG000|Overall Study|PI leaving site|2|||
130204743|NCT00150800|468708875|FG000|Overall Study|Patient insurance|1|||
130204744|NCT00150800|468708875|FG000|Overall Study|Surgical intervention|4|||
130204745|NCT00150800|468708875|FG000|Overall Study|Pregnancy planned|1|||
130204746|NCT00150800|468708875|FG000|Overall Study|PI discontinuation request|1|||
130204747|NCT02089334|468708876|FG000|Overall Study|Withdrawal by Subject|0|||
130204748|NCT02089334|468708877|FG001|Overall Study|Withdrawal by Subject|0|||
130204749|NCT02089334|468708878|FG002|Overall Study|Withdrawal by Subject|0|||
130204750|NCT02089334|468708879|FG003|Overall Study|Withdrawal by Subject|2|||
130204751|NCT02089334|468708876|FG000|Overall Study|Adverse Event|0|||
130204752|NCT02089334|468708877|FG001|Overall Study|Adverse Event|0|||
130204753|NCT02089334|468708878|FG002|Overall Study|Adverse Event|0|||
130204754|NCT02089334|468708879|FG003|Overall Study|Adverse Event|2|||
130204755|NCT02089334|468708876|FG000|Overall Study|Progressive disease|0|||
130204756|NCT02089334|468708877|FG001|Overall Study|Progressive disease|0|||
130204757|NCT02089334|468708878|FG002|Overall Study|Progressive disease|0|||
130204758|NCT02089334|468708879|FG003|Overall Study|Progressive disease|2|||
130204759|NCT02089334|468708876|FG000|Overall Study|Physician Decision|0|||
130204760|NCT02089334|468708877|FG001|Overall Study|Physician Decision|0|||
130204761|NCT02089334|468708878|FG002|Overall Study|Physician Decision|1|||
130204762|NCT02089334|468708879|FG003|Overall Study|Physician Decision|1|||
130204763|NCT02832375|468708880|FG000|Overall Study|Lost to Follow-up|1|||
130204764|NCT02832375|468708881|FG001|Overall Study|Lost to Follow-up|0|||
130204765|NCT02832375|468708880|FG000|Overall Study|Withdrawal of Consent|1|||
130204766|NCT02832375|468708881|FG001|Overall Study|Withdrawal of Consent|0|||
130204767|NCT00084318|468708884|FG000|Overall Study|Withdrawal by Subject|5|||
130204768|NCT00084318|468708885|FG001|Overall Study|Withdrawal by Subject|2|||
130204769|NCT00084318|468708884|FG000|Overall Study|Protocol Violation|15|||
130204770|NCT00084318|468708885|FG001|Overall Study|Protocol Violation|11|||
130204771|NCT00084318|468708884|FG000|Overall Study|No protocol treatment|2|||
130204772|NCT00084318|468708885|FG001|Overall Study|No protocol treatment|0|||
130204773|NCT03301740|468708887|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
130204774|NCT03301740|468708888|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
130204775|NCT03301740|468708887|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
130204776|NCT03301740|468708888|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
130204777|NCT01037127|468708889|FG000|Overall Study|Lost to Follow-up|2|||
130204778|NCT01037127|468708890|FG001|Overall Study|Lost to Follow-up|4|||
130204779|NCT01037127|468708889|FG000|Overall Study|Physician Decision|1|||
130204780|NCT01037127|468708890|FG001|Overall Study|Physician Decision|0|||
130204781|NCT01037127|468708889|FG000|Overall Study|Study Closed Terminated|2|||
130204782|NCT01037127|468708890|FG001|Overall Study|Study Closed Terminated|17|||
130204783|NCT02637713|468708897|FG000|Overall Study|Screen Failure|2|||
130204784|NCT02847182|468708898|FG000|Overall Study|Withdrawal by Subject|0|||
130204785|NCT02847182|468708899|FG001|Overall Study|Withdrawal by Subject|1|||
130204786|NCT02345889|468708900|FG000|Overall Study|Inadequate Bowel Prep|17|||
130204787|NCT02345889|468708901|FG001|Overall Study|Inadequate Bowel Prep|16|||
130204788|NCT02345889|468708902|FG002|Overall Study|Inadequate Bowel Prep|18|||
130204789|NCT02345889|468708903|FG003|Overall Study|Inadequate Bowel Prep|14|||
130204790|NCT02345889|468708900|FG000|Overall Study|Polyposis identified during procedure|1|||
130204791|NCT02345889|468708901|FG001|Overall Study|Polyposis identified during procedure|1|||
130204792|NCT02345889|468708902|FG002|Overall Study|Polyposis identified during procedure|0|||
130204793|NCT02345889|468708903|FG003|Overall Study|Polyposis identified during procedure|1|||
130204794|NCT02345889|468708900|FG000|Overall Study|Recognized ineligible post-randomization|1|||
130204795|NCT02345889|468708901|FG001|Overall Study|Recognized ineligible post-randomization|0|||
130204796|NCT02345889|468708902|FG002|Overall Study|Recognized ineligible post-randomization|2|||
130204797|NCT02345889|468708903|FG003|Overall Study|Recognized ineligible post-randomization|1|||
130204798|NCT02345889|468708900|FG000|Overall Study|Ulcerative Colitis identified|1|||
130204799|NCT02345889|468708901|FG001|Overall Study|Ulcerative Colitis identified|0|||
130204800|NCT02345889|468708902|FG002|Overall Study|Ulcerative Colitis identified|0|||
130204801|NCT02345889|468708903|FG003|Overall Study|Ulcerative Colitis identified|0|||
130204802|NCT02345889|468708900|FG000|Overall Study|Cecum not intubated|1|||
130204803|NCT02345889|468708901|FG001|Overall Study|Cecum not intubated|0|||
130204804|NCT02345889|468708902|FG002|Overall Study|Cecum not intubated|0|||
130204805|NCT02345889|468708903|FG003|Overall Study|Cecum not intubated|0|||
130204806|NCT01173055|468708904|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130204807|NCT01173055|468708905|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130204808|NCT01173055|468708904|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
130204809|NCT01173055|468708905|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
130204810|NCT04325698|468708907|FG000|Overall Study|Study Terminated By Sponsor|1|||
130204811|NCT04325698|468708908|FG001|Overall Study|Study Terminated By Sponsor|1|||
130204812|NCT04325698|468708907|FG000|Overall Study|Withdrawal by Subject|0|||
130204813|NCT04325698|468708908|FG001|Overall Study|Withdrawal by Subject|2|||
130204814|NCT04253782|468708909|FG000|Overall Study|Death|2|||
130204815|NCT04253782|468708910|FG001|Overall Study|Death|0|||
130204816|NCT04216589|468708911|FG000|Overall Study|Withdrawal by Subject|2|||
130204817|NCT04216589|468708911|FG000|Overall Study|Protocol Violation|1|||
130204818|NCT04216589|468708911|FG000|Overall Study|Incarceration|1|||
130204819|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204820|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204821|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204822|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204823|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204824|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
130204825|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204826|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204827|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204828|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204829|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204830|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
130204831|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Adverse Event|0|||
130204832|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Adverse Event|0|||
130204833|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Adverse Event|0|||
130204834|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Adverse Event|0|||
130204835|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Adverse Event|0|||
130204836|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Adverse Event|2|||
130204837|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204838|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204839|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204840|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204841|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204842|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
130204843|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204844|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204845|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204846|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204847|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204848|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
130204849|NCT03191864|468708918|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204850|NCT03191864|468708919|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204851|NCT03191864|468708920|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130204852|NCT03191864|468708921|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204853|NCT03191864|468708922|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204854|NCT03191864|468708923|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130204855|NCT03191864|468708918|FG000|Part 1 - Induction|Adverse Event|0|||
130204856|NCT03191864|468708919|FG001|Part 1 - Induction|Adverse Event|2|||
130204857|NCT03191864|468708920|FG002|Part 1 - Induction|Adverse Event|0|||
130204858|NCT03191864|468708921|FG003|Part 1 - Induction|Adverse Event|1|||
130204859|NCT03191864|468708922|FG004|Part 1 - Induction|Adverse Event|0|||
130204860|NCT03191864|468708923|FG005|Part 1 - Induction|Adverse Event|2|||
130204861|NCT03191864|468708918|FG000|Part 1 - Induction|Randomized but never dosed|0|||
130204862|NCT03191864|468708919|FG001|Part 1 - Induction|Randomized but never dosed|0|||
130204863|NCT03191864|468708920|FG002|Part 1 - Induction|Randomized but never dosed|1|||
130204864|NCT03191864|468708921|FG003|Part 1 - Induction|Randomized but never dosed|0|||
130204865|NCT03191864|468708922|FG004|Part 1 - Induction|Randomized but never dosed|0|||
130204866|NCT03191864|468708923|FG005|Part 1 - Induction|Randomized but never dosed|0|||
130204867|NCT03191864|468708918|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
130204868|NCT03191864|468708919|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
130204869|NCT03191864|468708920|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
130204870|NCT03191864|468708921|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
130204871|NCT03191864|468708922|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
130204872|NCT03191864|468708923|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
130204873|NCT03191864|468708918|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204874|NCT03191864|468708919|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204875|NCT03191864|468708920|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
130204876|NCT03191864|468708921|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204877|NCT03191864|468708922|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204878|NCT03191864|468708923|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204879|NCT03191864|468708918|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
130204880|NCT03191864|468708919|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204881|NCT03191864|468708920|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204882|NCT03191864|468708921|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204883|NCT03191864|468708922|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204884|NCT03191864|468708923|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204885|NCT03191864|468708918|FG000|Part 2 - Maintenance|Physician Decision|1|||
130204886|NCT03191864|468708919|FG001|Part 2 - Maintenance|Physician Decision|0|||
130204887|NCT03191864|468708920|FG002|Part 2 - Maintenance|Physician Decision|0|||
130204888|NCT03191864|468708921|FG003|Part 2 - Maintenance|Physician Decision|0|||
130204889|NCT03191864|468708922|FG004|Part 2 - Maintenance|Physician Decision|0|||
130204890|NCT03191864|468708923|FG005|Part 2 - Maintenance|Physician Decision|0|||
130204891|NCT03191864|468708918|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
130204892|NCT03191864|468708919|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
130204893|NCT03191864|468708920|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
130204894|NCT03191864|468708921|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
130204895|NCT03191864|468708922|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
130204896|NCT03191864|468708923|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
130204897|NCT03191864|468708918|FG000|Part 2 - Maintenance|Adverse Event|0|||
130204898|NCT03191864|468708919|FG001|Part 2 - Maintenance|Adverse Event|0|||
130204899|NCT03191864|468708920|FG002|Part 2 - Maintenance|Adverse Event|0|||
130204900|NCT03191864|468708921|FG003|Part 2 - Maintenance|Adverse Event|0|||
130204901|NCT03191864|468708922|FG004|Part 2 - Maintenance|Adverse Event|1|||
130204902|NCT03191864|468708923|FG005|Part 2 - Maintenance|Adverse Event|0|||
130204903|NCT03191864|468708918|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
130204904|NCT03191864|468708919|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204905|NCT03191864|468708920|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204906|NCT03191864|468708921|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204907|NCT03191864|468708922|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
130204908|NCT03191864|468708923|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204909|NCT03191864|468708918|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204910|NCT03191864|468708919|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204911|NCT03191864|468708920|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204912|NCT03191864|468708921|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204913|NCT03191864|468708922|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
130204914|NCT03191864|468708923|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204915|NCT02342548|468708924|FG000|Overall Study|Adverse Event|12|||
130204916|NCT02342548|468708925|FG001|Overall Study|Adverse Event|17|||
130204917|NCT02342548|468708926|FG002|Overall Study|Adverse Event|13|||
130204918|NCT02342548|468708924|FG000|Overall Study|Lost to Follow-up|0|||
130204919|NCT02342548|468708925|FG001|Overall Study|Lost to Follow-up|1|||
130204920|NCT02342548|468708926|FG002|Overall Study|Lost to Follow-up|0|||
130204921|NCT02342548|468708924|FG000|Overall Study|Study terminated by sponsor|20|||
130204922|NCT02342548|468708925|FG001|Overall Study|Study terminated by sponsor|39|||
130204923|NCT02342548|468708926|FG002|Overall Study|Study terminated by sponsor|25|||
130204924|NCT02342548|468708924|FG000|Overall Study|Protocol Violation|0|||
130204925|NCT02342548|468708925|FG001|Overall Study|Protocol Violation|1|||
130204926|NCT02342548|468708926|FG002|Overall Study|Protocol Violation|0|||
130204927|NCT02342548|468708924|FG000|Overall Study|Withdrawal by Subject|1|||
130204928|NCT02342548|468708925|FG001|Overall Study|Withdrawal by Subject|3|||
130204929|NCT02342548|468708926|FG002|Overall Study|Withdrawal by Subject|4|||
130204930|NCT02342548|468708924|FG000|Overall Study|Other|1|||
130204931|NCT02342548|468708925|FG001|Overall Study|Other|1|||
130204932|NCT02342548|468708926|FG002|Overall Study|Other|1|||
130204933|NCT01047332|468708927|FG000|Overall Study|SEMS Obstruction|11|||
130204934|NCT01047332|468708928|FG001|Overall Study|SEMS Obstruction|20|||
130204935|NCT01047332|468708927|FG000|Overall Study|Died Unobstructed|38|||
130204936|NCT01047332|468708928|FG001|Overall Study|Died Unobstructed|41|||
130204937|NCT01047332|468708927|FG000|Overall Study|Lost to Follow-up|8|||
130204938|NCT01047332|468708928|FG001|Overall Study|Lost to Follow-up|3|||
130204939|NCT03521817|468708933|FG000|Overall Study|Protocol Violation|0|||
130204940|NCT03521817|468708934|FG001|Overall Study|Protocol Violation|1|||
130204941|NCT04240886|468710326|FG000|Treatment Phase|Death|4|||
130204942|NCT04240886|468710326|FG000|Treatment Phase|Discontinuation by Subject|1|||
130204943|NCT04240886|468710326|FG000|Treatment Phase|Adverse Event|5|||
130204944|NCT04240886|468710326|FG000|Follow-up Phase|Withdrawal by Subject|1|||
130204945|NCT04240886|468710326|FG000|Follow-up Phase|Discontinuation by Subject|1|||
130204946|NCT04240886|468710326|FG000|Follow-up Phase|Death|2|||
130204947|NCT04618471|468710327|FG000|Overall Study|Screen Failure|62|||
130204948|NCT04618471|468710327|FG000|Overall Study|Withdrawal by Subject|6|||
130204949|NCT04618471|468710327|FG000|Overall Study|Physician Decision|2|||
130204950|NCT04618471|468710327|FG000|Overall Study|Lost to Follow-up|1|||
130204951|NCT04618471|468710327|FG000|Overall Study|Various other reasons|2|||
130204952|NCT04618471|468710327|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
130204953|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204954|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204955|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204956|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130204957|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130204958|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
130204959|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204960|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
130204961|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204962|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204963|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204964|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204965|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
130204966|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130204967|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204968|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204969|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204970|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130204971|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
130204972|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204973|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
130204974|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204975|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204976|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
130204977|NCT01752634|468710328|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
130204978|NCT01752634|468710329|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
130204979|NCT01752634|468710330|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
130204980|NCT01752634|468710331|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
130204981|NCT01752634|468710332|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
130204982|NCT01752634|468710333|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
130204983|NCT01752634|468710328|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
130204984|NCT01752634|468710329|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
130204985|NCT01752634|468710330|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
130204986|NCT01752634|468710331|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
130204987|NCT01752634|468710332|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
130204988|NCT01752634|468710333|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
130204989|NCT01752634|468710328|FG000|Week 24 to Week 260|Physician Decision|1|||
130204990|NCT01752634|468710329|FG001|Week 24 to Week 260|Physician Decision|2|||
130204991|NCT01752634|468710330|FG002|Week 24 to Week 260|Physician Decision|4|||
130204992|NCT01752634|468710331|FG003|Week 24 to Week 260|Physician Decision|2|||
130204993|NCT01752634|468710332|FG004|Week 24 to Week 260|Physician Decision|1|||
130204994|NCT01752634|468710333|FG005|Week 24 to Week 260|Physician Decision|0|||
130204995|NCT01752634|468710328|FG000|Week 24 to Week 260|Death|0|||
130204996|NCT01752634|468710329|FG001|Week 24 to Week 260|Death|1|||
130204997|NCT01752634|468710330|FG002|Week 24 to Week 260|Death|0|||
130204998|NCT01752634|468710331|FG003|Week 24 to Week 260|Death|0|||
130204999|NCT01752634|468710332|FG004|Week 24 to Week 260|Death|0|||
130205000|NCT01752634|468710333|FG005|Week 24 to Week 260|Death|0|||
130205001|NCT01752634|468710328|FG000|Week 24 to Week 260|Pregnancy|0|||
130205002|NCT01752634|468710329|FG001|Week 24 to Week 260|Pregnancy|0|||
130205003|NCT01752634|468710330|FG002|Week 24 to Week 260|Pregnancy|1|||
130205004|NCT01752634|468710331|FG003|Week 24 to Week 260|Pregnancy|0|||
130205005|NCT01752634|468710332|FG004|Week 24 to Week 260|Pregnancy|0|||
130205006|NCT01752634|468710333|FG005|Week 24 to Week 260|Pregnancy|0|||
130205007|NCT01752634|468710328|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205008|NCT01752634|468710329|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205009|NCT01752634|468710330|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
130205010|NCT01752634|468710331|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205011|NCT01752634|468710332|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205012|NCT01752634|468710333|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205013|NCT01752634|468710328|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
130205014|NCT01752634|468710329|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
130205015|NCT01752634|468710330|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
130205016|NCT01752634|468710331|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
130205017|NCT01752634|468710332|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
130205018|NCT01752634|468710333|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
130205019|NCT01752634|468710328|FG000|Week 24 to Week 260|Adverse Event|4|||
130205020|NCT01752634|468710329|FG001|Week 24 to Week 260|Adverse Event|8|||
130205021|NCT01752634|468710330|FG002|Week 24 to Week 260|Adverse Event|8|||
130205022|NCT01752634|468710331|FG003|Week 24 to Week 260|Adverse Event|4|||
130205023|NCT01752634|468710332|FG004|Week 24 to Week 260|Adverse Event|2|||
130205024|NCT01752634|468710333|FG005|Week 24 to Week 260|Adverse Event|0|||
130205025|NCT01250171|468710334|FG000|Overall Study|Administrative reasons|1|||
130205026|NCT01250171|468710335|FG001|Overall Study|Administrative reasons|0|||
130205027|NCT01250171|468710336|FG002|Overall Study|Administrative reasons|0|||
130205028|NCT01451164|468710348|FG000|Overall Study|Adverse Event|19|||
130205029|NCT01451164|468710349|FG001|Overall Study|Adverse Event|12|||
130205030|NCT01451164|468710350|FG002|Overall Study|Adverse Event|18|||
130205031|NCT01451164|468710351|FG003|Overall Study|Adverse Event|21|||
130205032|NCT01451164|468710348|FG000|Overall Study|Withdrawal Criteria|1|||
130205033|NCT01451164|468710349|FG001|Overall Study|Withdrawal Criteria|1|||
130205034|NCT01451164|468710350|FG002|Overall Study|Withdrawal Criteria|1|||
130205035|NCT01451164|468710351|FG003|Overall Study|Withdrawal Criteria|1|||
130205036|NCT01451164|468710348|FG000|Overall Study|Physician Decision|2|||
130205037|NCT01451164|468710349|FG001|Overall Study|Physician Decision|0|||
130205038|NCT01451164|468710350|FG002|Overall Study|Physician Decision|1|||
130205039|NCT01451164|468710351|FG003|Overall Study|Physician Decision|0|||
130205040|NCT01451164|468710348|FG000|Overall Study|Withdrawal by Subject|14|||
130205041|NCT01451164|468710349|FG001|Overall Study|Withdrawal by Subject|11|||
130205042|NCT01451164|468710350|FG002|Overall Study|Withdrawal by Subject|16|||
130205043|NCT01451164|468710351|FG003|Overall Study|Withdrawal by Subject|17|||
130205044|NCT01451164|468710348|FG000|Overall Study|Protocol Violation|0|||
130205045|NCT01451164|468710349|FG001|Overall Study|Protocol Violation|1|||
130205046|NCT01451164|468710350|FG002|Overall Study|Protocol Violation|0|||
130205047|NCT01451164|468710351|FG003|Overall Study|Protocol Violation|0|||
130205048|NCT01451164|468710348|FG000|Overall Study|Lack of Efficacy|7|||
130205049|NCT01451164|468710349|FG001|Overall Study|Lack of Efficacy|9|||
130205050|NCT01451164|468710350|FG002|Overall Study|Lack of Efficacy|9|||
130205051|NCT01451164|468710351|FG003|Overall Study|Lack of Efficacy|7|||
130205052|NCT04599933|468710352|FG000|Overall Study|Adverse Event|4|||
130205053|NCT04599933|468710353|FG001|Overall Study|Adverse Event|1|||
130205054|NCT04599933|468710352|FG000|Overall Study|Withdrawal by Subject|4|||
130205055|NCT04599933|468710353|FG001|Overall Study|Withdrawal by Subject|2|||
130205056|NCT04599933|468710352|FG000|Overall Study|Lost to Follow-up|0|||
130205057|NCT04599933|468710353|FG001|Overall Study|Lost to Follow-up|1|||
130205058|NCT04599933|468710352|FG000|Overall Study|Physician Decision|0|||
130205059|NCT04599933|468710353|FG001|Overall Study|Physician Decision|1|||
130205060|NCT04599933|468710352|FG000|Overall Study|Screen Failure|1|||
130205061|NCT04599933|468710353|FG001|Overall Study|Screen Failure|2|||
130205062|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Adverse Event|0|||
130205063|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Adverse Event|1|||
130205064|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Adverse Event|0|||
130205065|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Adverse Event|0|||
130205066|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Adverse Event|0|||
130205067|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Adverse Event|0|||
130205068|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Death|0|||
130205069|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Death|0|||
130205070|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Death|1|||
130205071|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Death|0|||
130205072|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Death|0|||
130205073|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Death|0|||
130205074|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205075|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
130205076|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205077|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205078|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205079|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205080|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205081|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205082|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
130205083|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205084|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205085|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205086|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205087|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205088|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205089|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
130205090|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205091|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205092|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
130205093|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
130205094|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205095|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205096|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205097|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205098|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205099|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205100|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205101|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205102|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
130205103|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
130205104|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Death|0|||
130205105|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Death|0|||
130205106|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Death|0|||
130205107|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Death|0|||
130205108|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Death|0|||
130205109|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Death|1|||
130205110|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205111|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205112|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205113|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205114|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205115|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
130205116|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205117|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205118|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205119|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205120|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
130205121|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
130205122|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205123|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205124|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205125|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205126|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205127|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
130205128|NCT03117881|468710362|FG000|Baseline|Withdrawal by Subject|21|||
130205129|NCT03117881|468710363|FG001|Baseline|Withdrawal by Subject|10|||
130205130|NCT03117881|468710364|FG002|Baseline|Withdrawal by Subject|0|||
130205131|NCT03117881|468710362|FG000|Baseline|Lost to Follow-up|22|||
130205132|NCT03117881|468710363|FG001|Baseline|Lost to Follow-up|25|||
130205133|NCT03117881|468710364|FG002|Baseline|Lost to Follow-up|0|||
130205134|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
130205135|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
130205136|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
130205137|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
130205138|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
130205139|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
130205140|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
130205141|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
130205142|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
130205143|NCT03117881|468710362|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
130205144|NCT03117881|468710363|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
130205145|NCT03117881|468710364|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
130205146|NCT03117881|468710362|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
130205147|NCT03117881|468710363|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
130205148|NCT03117881|468710364|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
130205149|NCT03117881|468710362|FG000|6-Month Follow-Up|Did not complete test|53|||
130205150|NCT03117881|468710363|FG001|6-Month Follow-Up|Did not complete test|25|||
130205151|NCT03117881|468710364|FG002|6-Month Follow-Up|Did not complete test|7|||
130205152|NCT03117881|468710362|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
130205153|NCT03117881|468710363|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
130205154|NCT03117881|468710364|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
130205155|NCT03117881|468710362|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
130205156|NCT03117881|468710363|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
130205157|NCT03117881|468710364|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
130205158|NCT03117881|468710362|FG000|12-Month Follow-Up|Did not complete test|40|||
130205159|NCT03117881|468710363|FG001|12-Month Follow-Up|Did not complete test|0|||
130205160|NCT03117881|468710364|FG002|12-Month Follow-Up|Did not complete test|0|||
130205161|NCT01027897|468710365|FG000|Overall Study|Protocol Violation|1|||
130205162|NCT01027897|468710365|FG000|Overall Study|Withdrawal by Subject|1|||
130205163|NCT02045732|468710368|FG000|Overall Study|At the discretion of the investigator|1|||
130205164|NCT02045732|468710369|FG001|Overall Study|At the discretion of the investigator|1|||
130205165|NCT00473824|468710370|FG000|Overall Study|Virologic Breakthrough|1|||
130205166|NCT00473824|468710371|FG001|Overall Study|Virologic Breakthrough|0|||
130205167|NCT00473824|468710370|FG000|Overall Study|Adverse Event|1|||
130205168|NCT00473824|468710371|FG001|Overall Study|Adverse Event|0|||
130205169|NCT00473824|468710370|FG000|Overall Study|Death|1|||
130205170|NCT00473824|468710371|FG001|Overall Study|Death|0|||
130205171|NCT00473824|468710370|FG000|Overall Study|Lost to Follow-up|1|||
130205172|NCT00473824|468710371|FG001|Overall Study|Lost to Follow-up|0|||
130205173|NCT00473824|468710370|FG000|Overall Study|Withdrawal by physician|1|||
130205174|NCT00473824|468710371|FG001|Overall Study|Withdrawal by physician|0|||
130205175|NCT02560623|468710372|FG000|Overall Study|Unable to swallow sponge|0|||
130205176|NCT02560623|468710373|FG001|Overall Study|Unable to swallow sponge|1|||
130205177|NCT02560623|468710374|FG002|Overall Study|Unable to swallow sponge|0|||
130205178|NCT02560623|468710375|FG003|Overall Study|Unable to swallow sponge|0|||
130205179|NCT02560623|468710372|FG000|Overall Study|Intervention prior to sponge administration|0|||
130205180|NCT02560623|468710373|FG001|Overall Study|Intervention prior to sponge administration|1|||
130205181|NCT02560623|468710374|FG002|Overall Study|Intervention prior to sponge administration|0|||
130205182|NCT02560623|468710375|FG003|Overall Study|Intervention prior to sponge administration|0|||
130205183|NCT05014815|468710376|FG000|Overall Study|Death|63|||
130205184|NCT05014815|468710377|FG001|Overall Study|Death|70|||
130205185|NCT05014815|468710376|FG000|Overall Study|Withdrawal by Subject|10|||
130205186|NCT05014815|468710377|FG001|Overall Study|Withdrawal by Subject|10|||
130205187|NCT05014815|468710376|FG000|Overall Study|Lost to Follow-up|4|||
130205188|NCT05014815|468710377|FG001|Overall Study|Lost to Follow-up|2|||
130205189|NCT05014815|468710376|FG000|Overall Study|Physician Decision|2|||
130205190|NCT05014815|468710377|FG001|Overall Study|Physician Decision|4|||
130205191|NCT04247880|468710378|FG000|Overall Study|Lost to Follow-up|24|||
130205192|NCT04247880|468710379|FG001|Overall Study|Lost to Follow-up|17|||
130205193|NCT04247880|468710378|FG000|Overall Study|Withdrawal by Subject|3|||
130205194|NCT04247880|468710379|FG001|Overall Study|Withdrawal by Subject|0|||
130205195|NCT06303167|468710380|FG000|Overall Study|Ineligible|1|||
130205196|NCT06303167|468710380|FG000|Overall Study|Never start protocol therapy|2|||
130205197|NCT06303167|468710380|FG000|Overall Study|Disease progression|16|||
130205198|NCT02453282|468710381|FG000|Overall Study|Death|275|||
130205199|NCT02453282|468710382|FG001|Overall Study|Death|277|||
130205200|NCT02453282|468710383|FG002|Overall Study|Death|296|||
130205201|NCT02453282|468710381|FG000|Overall Study|Lost to Follow-up|1|||
130205202|NCT02453282|468710382|FG001|Overall Study|Lost to Follow-up|0|||
130205203|NCT02453282|468710383|FG002|Overall Study|Lost to Follow-up|2|||
130205204|NCT02453282|468710381|FG000|Overall Study|Withdrawal by Subject|12|||
130205205|NCT02453282|468710382|FG001|Overall Study|Withdrawal by Subject|10|||
130205206|NCT02453282|468710383|FG002|Overall Study|Withdrawal by Subject|11|||
130205207|NCT02453282|468710381|FG000|Overall Study|Participants ongoing at data cut-off|85|||
130205208|NCT02453282|468710382|FG001|Overall Study|Participants ongoing at data cut-off|84|||
130205209|NCT02453282|468710383|FG002|Overall Study|Participants ongoing at data cut-off|62|||
130205210|NCT02453282|468710381|FG000|Overall Study|Other|1|||
130205211|NCT02453282|468710382|FG001|Overall Study|Other|1|||
130205212|NCT02453282|468710383|FG002|Overall Study|Other|1|||
130205213|NCT01661933|468710385|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
130205214|NCT01661933|468710385|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
130205215|NCT03536949|468710394|FG000|Overall Study|Adverse Event|4|||
130205216|NCT03536949|468710395|FG001|Overall Study|Adverse Event|0|||
130205217|NCT03536949|468710394|FG000|Overall Study|Lost to Follow-up|2|||
130205218|NCT03536949|468710395|FG001|Overall Study|Lost to Follow-up|1|||
130205219|NCT03536949|468710394|FG000|Overall Study|Withdrawal by Subject|6|||
130205220|NCT03536949|468710395|FG001|Overall Study|Withdrawal by Subject|0|||
130205221|NCT03536949|468710394|FG000|Overall Study|Non-compliance|2|||
130205222|NCT03536949|468710395|FG001|Overall Study|Non-compliance|1|||
130205223|NCT00435487|468710413|FG000|Overall Study|Death|3|||
130205224|NCT00435487|468710414|FG001|Overall Study|Death|4|||
130205225|NCT00435487|468710413|FG000|Overall Study|Adverse Event|0|||
130205226|NCT00435487|468710414|FG001|Overall Study|Adverse Event|3|||
130205227|NCT00435487|468710413|FG000|Overall Study|Lost to Follow-up|2|||
130205228|NCT00435487|468710414|FG001|Overall Study|Lost to Follow-up|2|||
130205229|NCT00435487|468710413|FG000|Overall Study|Other|5|||
130205230|NCT00435487|468710414|FG001|Overall Study|Other|2|||
130205231|NCT00435487|468710413|FG000|Overall Study|Withdrawal by Subject|2|||
130205232|NCT00435487|468710414|FG001|Overall Study|Withdrawal by Subject|1|||
130205233|NCT00435487|468710413|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
130205234|NCT00435487|468710414|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
130205235|NCT00435487|468710413|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
130205236|NCT00435487|468710414|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
130205237|NCT03301844|468710415|FG000|Overall Study|suspected colon cancer|1|||
130205238|NCT03301844|468710416|FG001|Overall Study|suspected colon cancer|1|||
130205239|NCT05087966|468710417|FG000|Overall Study|Lost to Follow-up|1|||
130205240|NCT05087966|468710417|FG000|Overall Study|Withdrawal by Subject|5|||
130205241|NCT01267201|468710418|FG000|First Intervention Period|Withdrawal by Subject|1|||
130205242|NCT01267201|468710419|FG001|First Intervention Period|Withdrawal by Subject|0|||
130205243|NCT01267201|468710420|FG002|First Intervention Period|Withdrawal by Subject|0|||
130205244|NCT01267201|468710421|FG003|First Intervention Period|Withdrawal by Subject|0|||
130205245|NCT01267201|468710422|FG004|First Intervention Period|Withdrawal by Subject|0|||
130205246|NCT01267201|468710423|FG005|First Intervention Period|Withdrawal by Subject|0|||
130205247|NCT01267201|468710418|FG000|Second Intervention Period|Withdrawal by Subject|0|||
130205248|NCT01267201|468710419|FG001|Second Intervention Period|Withdrawal by Subject|1|||
130205249|NCT01267201|468710420|FG002|Second Intervention Period|Withdrawal by Subject|0|||
130205250|NCT01267201|468710421|FG003|Second Intervention Period|Withdrawal by Subject|0|||
130205251|NCT01267201|468710422|FG004|Second Intervention Period|Withdrawal by Subject|0|||
130205252|NCT01267201|468710423|FG005|Second Intervention Period|Withdrawal by Subject|0|||
130205253|NCT00501059|468710424|FG000|Overall Study|Protocol Violation|80|||
130205254|NCT00501059|468710425|FG001|Overall Study|Protocol Violation|69|||
130205255|NCT00501059|468710424|FG000|Overall Study|Death|140|||
130205256|NCT00501059|468710425|FG001|Overall Study|Death|137|||
130205257|NCT00501059|468710424|FG000|Overall Study|Other|236|||
130205258|NCT00501059|468710425|FG001|Overall Study|Other|239|||
130205259|NCT00501059|468710424|FG000|Overall Study|Missing end-of-study page|91|||
130205260|NCT00501059|468710425|FG001|Overall Study|Missing end-of-study page|92|||
130205261|NCT00501059|468710424|FG000|Overall Study|Clinical endpoint reached|110|||
130205262|NCT00501059|468710425|FG001|Overall Study|Clinical endpoint reached|123|||
130205263|NCT00501059|468710424|FG000|Overall Study|Insufficient therapeutic effect|4|||
130205264|NCT00501059|468710425|FG001|Overall Study|Insufficient therapeutic effect|5|||
130205265|NCT00501059|468710424|FG000|Overall Study|Consent withdrawn by subject|817|||
130205266|NCT00501059|468710425|FG001|Overall Study|Consent withdrawn by subject|873|||
130205267|NCT00501059|468710424|FG000|Overall Study|Non-compliant with study treatment|23|||
130205268|NCT00501059|468710425|FG001|Overall Study|Non-compliant with study treatment|16|||
130205269|NCT00501059|468710424|FG000|Overall Study|Reason not given|3|||
130205270|NCT00501059|468710425|FG001|Overall Study|Reason not given|1|||
130205271|NCT00501059|468710424|FG000|Overall Study|Adverse Event|129|||
130205272|NCT00501059|468710425|FG001|Overall Study|Adverse Event|122|||
130205273|NCT00501059|468710424|FG000|Overall Study|Lost to Follow-up|210|||
130205274|NCT00501059|468710425|FG001|Overall Study|Lost to Follow-up|198|||
130205275|NCT00501059|468710424|FG000|Overall Study|Not treated|25|||
130205276|NCT00501059|468710425|FG001|Overall Study|Not treated|17|||
130205277|NCT00955968|468710429|FG000|Overall Study|Death|2|||
130205278|NCT00955968|468710430|FG001|Overall Study|Death|4|||
130205279|NCT00955968|468710429|FG000|Overall Study|Withdrawal by Subject|35|||
130205280|NCT00955968|468710430|FG001|Overall Study|Withdrawal by Subject|31|||
130205281|NCT00955968|468710429|FG000|Overall Study|Lost to Follow-up|45|||
130205282|NCT00955968|468710430|FG001|Overall Study|Lost to Follow-up|39|||
130205283|NCT00955968|468710429|FG000|Overall Study|Site closed|55|||
130205284|NCT00955968|468710430|FG001|Overall Study|Site closed|52|||
130205285|NCT04326439|468710435|FG000|Overall Study|Withdrawal by Subject|1|||
130205286|NCT04326439|468710436|FG001|Overall Study|Withdrawal by Subject|0|||
130205287|NCT04326439|468710435|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
130205288|NCT04326439|468710436|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
130205289|NCT04326439|468710435|FG000|Overall Study|Relapse after Induction 2|0|||
130205290|NCT04326439|468710436|FG001|Overall Study|Relapse after Induction 2|1|||
130205291|NCT04326439|468710435|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
130205292|NCT04326439|468710436|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
130205293|NCT00204477|468710439|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
130205294|NCT00204477|468710440|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
130205295|NCT00204477|468710439|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
130205296|NCT00204477|468710440|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
130205297|NCT04272606|468710443|FG000|Overall Study|Protocol Violation|1|||
130205298|NCT04272606|468710444|FG001|Overall Study|Protocol Violation|1|||
130205299|NCT04272606|468710443|FG000|Overall Study|Physician Decision|0|||
130205300|NCT04272606|468710444|FG001|Overall Study|Physician Decision|1|||
130205301|NCT00710684|468710445|FG000|Overall Study|Adverse Event|11|||
130205302|NCT00710684|468710446|FG001|Overall Study|Adverse Event|19|||
130205303|NCT00710684|468710447|FG002|Overall Study|Adverse Event|16|||
130205304|NCT00710684|468710445|FG000|Overall Study|Lack of Efficacy|4|||
130205305|NCT00710684|468710446|FG001|Overall Study|Lack of Efficacy|3|||
130205306|NCT00710684|468710447|FG002|Overall Study|Lack of Efficacy|5|||
130205307|NCT00710684|468710445|FG000|Overall Study|Protocol Violation|5|||
130205308|NCT00710684|468710446|FG001|Overall Study|Protocol Violation|5|||
130205309|NCT00710684|468710447|FG002|Overall Study|Protocol Violation|5|||
130205310|NCT00710684|468710445|FG000|Overall Study|Lost to Follow-up|4|||
130205311|NCT00710684|468710446|FG001|Overall Study|Lost to Follow-up|6|||
130205312|NCT00710684|468710447|FG002|Overall Study|Lost to Follow-up|7|||
130205313|NCT00710684|468710445|FG000|Overall Study|Physician Decision|0|||
130205314|NCT00710684|468710446|FG001|Overall Study|Physician Decision|2|||
130205315|NCT00710684|468710447|FG002|Overall Study|Physician Decision|4|||
130205316|NCT00710684|468710445|FG000|Overall Study|Withdrawal by Subject|24|||
130205317|NCT00710684|468710446|FG001|Overall Study|Withdrawal by Subject|18|||
130205318|NCT00710684|468710447|FG002|Overall Study|Withdrawal by Subject|11|||
130205319|NCT00710684|468710445|FG000|Overall Study|Missing|1|||
130205320|NCT00710684|468710446|FG001|Overall Study|Missing|0|||
130205321|NCT00710684|468710447|FG002|Overall Study|Missing|0|||
130205322|NCT00710684|468710445|FG000|Overall Study|Did not continue after week 24|25|||
130205323|NCT00710684|468710446|FG001|Overall Study|Did not continue after week 24|21|||
130205324|NCT00710684|468710447|FG002|Overall Study|Did not continue after week 24|16|||
130205325|NCT04778059|468710448|FG000|Overall Study|Death|2|||
130205326|NCT04778059|468710449|FG001|Overall Study|Death|2|||
130205327|NCT04778059|468710450|FG002|Overall Study|Death|1|||
130205328|NCT04778059|468710451|FG003|Overall Study|Death|1|||
130205329|NCT04778059|468710452|FG004|Overall Study|Death|1|||
130205330|NCT04778059|468710448|FG000|Overall Study|Lost to Follow-up|0|||
130205331|NCT04778059|468710449|FG001|Overall Study|Lost to Follow-up|0|||
130205332|NCT04778059|468710450|FG002|Overall Study|Lost to Follow-up|0|||
130205333|NCT04778059|468710451|FG003|Overall Study|Lost to Follow-up|0|||
130205334|NCT04778059|468710452|FG004|Overall Study|Lost to Follow-up|1|||
130205335|NCT04778059|468710448|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205336|NCT04778059|468710449|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205337|NCT04778059|468710450|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205338|NCT04778059|468710451|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205339|NCT04778059|468710452|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
130205340|NCT00157248|468710457|FG000|Overall Study|Adverse Event|36|||
130205341|NCT00157248|468710458|FG001|Overall Study|Adverse Event|25|||
130205342|NCT00157248|468710459|FG002|Overall Study|Adverse Event|13|||
130205343|NCT00157248|468710460|FG003|Overall Study|Adverse Event|33|||
130205344|NCT00157248|468710457|FG000|Overall Study|Protocol Violation|4|||
130205345|NCT00157248|468710458|FG001|Overall Study|Protocol Violation|0|||
130205346|NCT00157248|468710459|FG002|Overall Study|Protocol Violation|2|||
130205347|NCT00157248|468710460|FG003|Overall Study|Protocol Violation|2|||
130205348|NCT00157248|468710457|FG000|Overall Study|Lost to Follow-up|0|||
130205349|NCT00157248|468710458|FG001|Overall Study|Lost to Follow-up|1|||
130205350|NCT00157248|468710459|FG002|Overall Study|Lost to Follow-up|0|||
130205351|NCT00157248|468710460|FG003|Overall Study|Lost to Follow-up|0|||
130205352|NCT00157248|468710457|FG000|Overall Study|Withdrawal by Subject|1|||
130205353|NCT00157248|468710458|FG001|Overall Study|Withdrawal by Subject|4|||
130205354|NCT00157248|468710459|FG002|Overall Study|Withdrawal by Subject|3|||
130205355|NCT00157248|468710460|FG003|Overall Study|Withdrawal by Subject|3|||
130205356|NCT00157248|468710457|FG000|Overall Study|site closures, subject moving|7|||
130205357|NCT00157248|468710458|FG001|Overall Study|site closures, subject moving|7|||
130205358|NCT00157248|468710459|FG002|Overall Study|site closures, subject moving|3|||
130205359|NCT00157248|468710460|FG003|Overall Study|site closures, subject moving|9|||
130205360|NCT01306045|468710463|FG000|Met General Eligibility Criteria|Screen failures|193|||
130205361|NCT01306045|468710464|FG001|Met General Eligibility Criteria|Screen failures|11|||
130205362|NCT01306045|468710465|FG002|Met General Eligibility Criteria|Screen failures|8|||
130205363|NCT00787917|468710467|FG000|Blinded Treatment|Adverse Event|1|||
130205364|NCT00787917|468710468|FG001|Blinded Treatment|Adverse Event|0|||
130205365|NCT00787917|468710467|FG000|Blinded Treatment|Lack of Efficacy|1|||
130205366|NCT00787917|468710468|FG001|Blinded Treatment|Lack of Efficacy|0|||
130205367|NCT00787917|468710467|FG000|Blinded Treatment|Administrative problems|3|||
130205368|NCT00787917|468710468|FG001|Blinded Treatment|Administrative problems|2|||
130205369|NCT00787917|468710467|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
130205370|NCT00787917|468710468|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
130205371|NCT00787917|468710467|FG000|Open Label|Administrative problems|3|||
130205372|NCT00787917|468710468|FG001|Open Label|Administrative problems|0|||
130205373|NCT00778102|468710469|FG000|Overall Study|Adverse Event|8|||
130205374|NCT00778102|468710470|FG001|Overall Study|Adverse Event|5|||
130205375|NCT00778102|468710469|FG000|Overall Study|Death|1|||
130205376|NCT00778102|468710470|FG001|Overall Study|Death|1|||
130205377|NCT00778102|468710469|FG000|Overall Study|Lost to Follow-up|1|||
130205378|NCT00778102|468710470|FG001|Overall Study|Lost to Follow-up|0|||
130205379|NCT00778102|468710469|FG000|Overall Study|Violation of Selection Criteria|1|||
130205380|NCT00778102|468710470|FG001|Overall Study|Violation of Selection Criteria|1|||
130205381|NCT00778102|468710469|FG000|Overall Study|Protocol Violation|0|||
130205382|NCT00778102|468710470|FG001|Overall Study|Protocol Violation|1|||
130205383|NCT00778102|468710469|FG000|Overall Study|Refused Treatment|2|||
130205384|NCT00778102|468710470|FG001|Overall Study|Refused Treatment|3|||
130205385|NCT00778102|468710469|FG000|Overall Study|Withdrawal by Subject|1|||
130205386|NCT00778102|468710470|FG001|Overall Study|Withdrawal by Subject|1|||
130205387|NCT00778102|468710469|FG000|Overall Study|Administrative Reason|7|||
130205388|NCT00778102|468710470|FG001|Overall Study|Administrative Reason|10|||
130205389|NCT01328548|468710471|FG000|Overall Study|Death|3|||
130205390|NCT01328548|468710472|FG001|Overall Study|Death|0|||
130205391|NCT01328548|468710471|FG000|Overall Study|Protocol Violation|1|||
130205392|NCT01328548|468710472|FG001|Overall Study|Protocol Violation|0|||
130205405|NCT05128773|468712753|FG000|Overall Study|Sponsor decision to terminate study|3|||
130205406|NCT04250714|468712754|FG000|Overall Study|Treatment - withdrawal by subject|14|||
130205407|NCT04250714|468712754|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
130205408|NCT04250714|468712754|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
130205409|NCT04250714|468712754|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
130205410|NCT04250714|468712754|FG000|Overall Study|Treatment - Death|1|||
130205411|NCT04250714|468712754|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
130205412|NCT04250714|468712754|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
130205413|NCT04250714|468712754|FG000|Overall Study|Attempt|2|||
130205414|NCT04250714|468712754|FG000|Overall Study|Intent|7|||
130205415|NCT04676412|468712755|FG000|Overall Study|Death|28|||
130205416|NCT04676412|468712756|FG001|Overall Study|Death|31|||
130205417|NCT04676412|468712755|FG000|Overall Study|Lost to Follow-up|1|||
130205418|NCT04676412|468712756|FG001|Overall Study|Lost to Follow-up|2|||
130205419|NCT04676412|468712755|FG000|Overall Study|Sponsor Decision|20|||
130205420|NCT04676412|468712756|FG001|Overall Study|Sponsor Decision|23|||
130205421|NCT04676412|468712755|FG000|Overall Study|Withdrawal by Subject|0|||
130205422|NCT04676412|468712756|FG001|Overall Study|Withdrawal by Subject|2|||
130205423|NCT04697056|468712757|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
130205424|NCT04697056|468712758|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
130205425|NCT04550832|468712759|FG000|Overall Study|Adverse Event|0|||
130205426|NCT04550832|468712760|FG001|Overall Study|Adverse Event|0|||
130205427|NCT04550832|468712761|FG002|Overall Study|Adverse Event|2|||
130205428|NCT04550832|468712762|FG003|Overall Study|Adverse Event|0|||
130205429|NCT04550832|468712763|FG004|Overall Study|Adverse Event|1|||
130205430|NCT04823130|468712764|FG000|Overall Study|Withdrawal by Subject|2|||
130205431|NCT04823130|468712765|FG001|Overall Study|Withdrawal by Subject|3|||
130205432|NCT04823130|468712764|FG000|Overall Study|Failure to meet inclusion criteria|6|||
130205433|NCT04823130|468712765|FG001|Overall Study|Failure to meet inclusion criteria|4|||
130205434|NCT04823130|468712764|FG000|Overall Study|Other-unspecified|1|||
130205435|NCT04823130|468712765|FG001|Overall Study|Other-unspecified|0|||
130205436|NCT03315455|468712767|FG000|Overall Study|Ongoing in the Study|13|||
130205437|NCT03315455|468712768|FG001|Overall Study|Ongoing in the Study|24|||
130205438|NCT03315455|468712769|FG002|Overall Study|Ongoing in the Study|17|||
130205439|NCT03315455|468712770|FG003|Overall Study|Ongoing in the Study|15|||
130205440|NCT03315455|468712767|FG000|Overall Study|Withdrawal by Subject|0|||
130205441|NCT03315455|468712768|FG001|Overall Study|Withdrawal by Subject|1|||
130205442|NCT03315455|468712769|FG002|Overall Study|Withdrawal by Subject|0|||
130205443|NCT03315455|468712770|FG003|Overall Study|Withdrawal by Subject|0|||
130205444|NCT04439357|468712774|FG000|Overall Study|Disease Progression|4|||
130205445|NCT05906836|468712777|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
130205446|NCT05906836|468712777|FG000|Overall Study|Lost to Follow-up|1|||
130205447|NCT03030118|468712778|FG000|Overall Study|Achieved SLE Diagnosis|11|||
130205448|NCT03030118|468712779|FG001|Overall Study|Achieved SLE Diagnosis|10|||
130205449|NCT03030118|468712778|FG000|Overall Study|Adverse Event|1|||
130205450|NCT03030118|468712779|FG001|Overall Study|Adverse Event|1|||
130205451|NCT03030118|468712778|FG000|Overall Study|Pregnancy|2|||
130205452|NCT03030118|468712779|FG001|Overall Study|Pregnancy|2|||
130205453|NCT03030118|468712778|FG000|Overall Study|Lost to Follow-up|5|||
130205454|NCT03030118|468712779|FG001|Overall Study|Lost to Follow-up|6|||
130205455|NCT03030118|468712778|FG000|Overall Study|Concomitant Medications|1|||
130205456|NCT03030118|468712779|FG001|Overall Study|Concomitant Medications|1|||
130205457|NCT03030118|468712778|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
130205458|NCT03030118|468712779|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
130205459|NCT03030118|468712778|FG000|Overall Study|Other|2|||
130205460|NCT03030118|468712779|FG001|Overall Study|Other|0|||
130205461|NCT03030118|468712778|FG000|Overall Study|Withdrawal by Subject|26|||
130205462|NCT03030118|468712779|FG001|Overall Study|Withdrawal by Subject|21|||
130205463|NCT03030118|468712778|FG000|Overall Study|Protocol Violation|1|||
130205464|NCT03030118|468712779|FG001|Overall Study|Protocol Violation|6|||
130205465|NCT04529850|468712780|FG000|Overall Study|Death|2|||
130205466|NCT04529850|468712780|FG000|Overall Study|Physician Decision|1|||
130205467|NCT04529850|468712780|FG000|Overall Study|Withdrawal by Subject|2|||
130205468|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
130205469|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130205470|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130205471|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130205472|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
130205473|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
130205474|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
130205475|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
130205476|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
130205477|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
130205478|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Personal reason|1|||
130205479|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Personal reason|1|||
130205480|NCT02720744|468712786|FG000|Overall Study|Protocol Violation|0|||
130205481|NCT02720744|468712787|FG001|Overall Study|Protocol Violation|2|||
130205482|NCT02720744|468712786|FG000|Overall Study|Pregnancy|2|||
130205483|NCT02720744|468712787|FG001|Overall Study|Pregnancy|0|||
130205484|NCT02720744|468712786|FG000|Overall Study|Lack of Efficacy|2|||
130205485|NCT02720744|468712787|FG001|Overall Study|Lack of Efficacy|8|||
130205486|NCT02720744|468712786|FG000|Overall Study|Adverse Event|21|||
130205487|NCT02720744|468712787|FG001|Overall Study|Adverse Event|3|||
130205488|NCT02720744|468712786|FG000|Overall Study|Withdrawal by Subject|11|||
130205489|NCT02720744|468712787|FG001|Overall Study|Withdrawal by Subject|11|||
130205490|NCT02720744|468712786|FG000|Overall Study|Lost to follow up|2|||
130205491|NCT02720744|468712787|FG001|Overall Study|Lost to follow up|0|||
130205492|NCT02720744|468712786|FG000|Overall Study|Non Compliance with Investigational Product|0|||
130205493|NCT02720744|468712787|FG001|Overall Study|Non Compliance with Investigational Product|1|||
130205494|NCT02720744|468712786|FG000|Overall Study|Excluded Concomitant Medication|0|||
130205495|NCT02720744|468712787|FG001|Overall Study|Excluded Concomitant Medication|1|||
130205496|NCT01199822|468712789|FG000|Overall Study|Investigator discontinued therapy|0|||
130205497|NCT01199822|468712790|FG001|Overall Study|Investigator discontinued therapy|1|||
130205498|NCT01199822|468712791|FG002|Overall Study|Investigator discontinued therapy|0|||
130205499|NCT00480493|468712792|FG000|Overall Study|moved|2|||
130205500|NCT00480493|468712793|FG001|Overall Study|moved|7|||
130205501|NCT03769675|468712794|FG000|Overall Study|Lost to Follow-up|1|||
130205502|NCT01032070|468712795|FG000|Overall Study|Disease progression|13|||
130205503|NCT01032070|468712796|FG001|Overall Study|Disease progression|8|||
130205504|NCT01032070|468712795|FG000|Overall Study|Medical or ethical reasons|0|||
130205505|NCT01032070|468712796|FG001|Overall Study|Medical or ethical reasons|2|||
130205506|NCT01032070|468712795|FG000|Overall Study|Withdrawal by Subject|0|||
130205507|NCT01032070|468712796|FG001|Overall Study|Withdrawal by Subject|2|||
130205508|NCT04027075|468712797|FG000|Overall Study|Lost to Follow-up|41|||
130205509|NCT04027075|468712798|FG001|Overall Study|Lost to Follow-up|22|||
130205510|NCT00738062|468712799|FG000|Open Label Treatment|Lack of Efficacy|5|||
130205511|NCT00738062|468712800|FG001|Open Label Treatment|Lack of Efficacy|0|||
130205512|NCT00738062|468712801|FG002|Open Label Treatment|Lack of Efficacy|0|||
130205513|NCT00738062|468712799|FG000|Open Label Treatment|Adverse Event|11|||
130205514|NCT00738062|468712800|FG001|Open Label Treatment|Adverse Event|0|||
130205515|NCT00738062|468712801|FG002|Open Label Treatment|Adverse Event|0|||
130205516|NCT00738062|468712799|FG000|Open Label Treatment|Protocol Violation|2|||
130205517|NCT00738062|468712800|FG001|Open Label Treatment|Protocol Violation|0|||
130205518|NCT00738062|468712801|FG002|Open Label Treatment|Protocol Violation|0|||
130205519|NCT00738062|468712799|FG000|Open Label Treatment|Withdrawal by Subject|9|||
130205520|NCT00738062|468712800|FG001|Open Label Treatment|Withdrawal by Subject|0|||
130205521|NCT00738062|468712801|FG002|Open Label Treatment|Withdrawal by Subject|0|||
130205522|NCT00738062|468712799|FG000|Open Label Treatment|Investigator Decision|1|||
130205523|NCT00738062|468712800|FG001|Open Label Treatment|Investigator Decision|0|||
130205524|NCT00738062|468712801|FG002|Open Label Treatment|Investigator Decision|0|||
130205525|NCT00738062|468712799|FG000|Open-Label Extension|Adverse Event|5|||
130205526|NCT00738062|468712800|FG001|Open-Label Extension|Adverse Event|0|||
130205527|NCT00738062|468712801|FG002|Open-Label Extension|Adverse Event|0|||
130205528|NCT00738062|468712799|FG000|Open-Label Extension|Physician Decision|1|||
130205529|NCT00738062|468712800|FG001|Open-Label Extension|Physician Decision|0|||
130205530|NCT00738062|468712801|FG002|Open-Label Extension|Physician Decision|0|||
130205531|NCT00738062|468712799|FG000|Open-Label Extension|Lack of Efficacy|2|||
130205532|NCT00738062|468712800|FG001|Open-Label Extension|Lack of Efficacy|0|||
130205533|NCT00738062|468712801|FG002|Open-Label Extension|Lack of Efficacy|0|||
130205534|NCT00738062|468712799|FG000|Open-Label Extension|Withdrawal by Subject|6|||
130205535|NCT00738062|468712800|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130205536|NCT00738062|468712801|FG002|Open-Label Extension|Withdrawal by Subject|0|||
130205537|NCT00738062|468712799|FG000|Open-Label Extension|Protocol Violation|1|||
130205538|NCT00738062|468712800|FG001|Open-Label Extension|Protocol Violation|0|||
130205539|NCT00738062|468712801|FG002|Open-Label Extension|Protocol Violation|0|||
130205540|NCT00738062|468712799|FG000|Open-Label Extension|Study Terminated|2|||
130205541|NCT00738062|468712800|FG001|Open-Label Extension|Study Terminated|0|||
130205542|NCT00738062|468712801|FG002|Open-Label Extension|Study Terminated|0|||
130205543|NCT00426660|468712802|FG000|Overall Study|Death|14|||
130205544|NCT00426660|468712802|FG000|Overall Study|Adverse Event|23|||
130205545|NCT00426660|468712802|FG000|Overall Study|Insufficient Clinical Response|22|||
130205546|NCT00426660|468712802|FG000|Overall Study|Lost to Follow-up|15|||
130205547|NCT00426660|468712802|FG000|Overall Study|Other|23|||
130205548|NCT00426660|468712802|FG000|Overall Study|Withdrawal by Subject|18|||
130205549|NCT00426660|468712802|FG000|Overall Study|Protocol Violation|1|||
130205550|NCT00426660|468712802|FG000|Overall Study|Enrolled Not Treated|15|||
130205551|NCT02772276|468712803|FG000|Overall Study|Lost to Follow-up|0|||
130205552|NCT02772276|468712804|FG001|Overall Study|Lost to Follow-up|0|||
130205553|NCT02772276|468712805|FG002|Overall Study|Lost to Follow-up|0|||
130205554|NCT02772276|468712806|FG003|Overall Study|Lost to Follow-up|0|||
130205555|NCT02772276|468712807|FG004|Overall Study|Lost to Follow-up|0|||
130205556|NCT02772276|468712808|FG005|Overall Study|Lost to Follow-up|0|||
130205557|NCT02772276|468712809|FG006|Overall Study|Lost to Follow-up|1|||
130205558|NCT02772276|468712810|FG007|Overall Study|Lost to Follow-up|0|||
130205559|NCT02772276|468712811|FG008|Overall Study|Lost to Follow-up|0|||
130205560|NCT02772276|468712812|FG009|Overall Study|Lost to Follow-up|0|||
130205561|NCT02772276|468712813|FG010|Overall Study|Lost to Follow-up|0|||
130205562|NCT02772276|468712814|FG011|Overall Study|Lost to Follow-up|0|||
130205563|NCT02772276|468712815|FG012|Overall Study|Lost to Follow-up|0|||
130205564|NCT02772276|468712803|FG000|Overall Study|Withdrew consent|0|||
130205565|NCT02772276|468712804|FG001|Overall Study|Withdrew consent|0|||
130205566|NCT02772276|468712805|FG002|Overall Study|Withdrew consent|0|||
130205567|NCT02772276|468712806|FG003|Overall Study|Withdrew consent|0|||
130205568|NCT02772276|468712807|FG004|Overall Study|Withdrew consent|0|||
130205569|NCT02772276|468712808|FG005|Overall Study|Withdrew consent|0|||
130205570|NCT02772276|468712809|FG006|Overall Study|Withdrew consent|0|||
130205571|NCT02772276|468712810|FG007|Overall Study|Withdrew consent|1|||
130205572|NCT02772276|468712811|FG008|Overall Study|Withdrew consent|0|||
130205573|NCT02772276|468712812|FG009|Overall Study|Withdrew consent|0|||
130205574|NCT02772276|468712813|FG010|Overall Study|Withdrew consent|0|||
130205575|NCT02772276|468712814|FG011|Overall Study|Withdrew consent|0|||
130205576|NCT02772276|468712815|FG012|Overall Study|Withdrew consent|0|||
130205577|NCT00980174|468712816|FG000|Overall Study|Withdrawal by Subject|1|||
130205578|NCT00980174|468712817|FG001|Overall Study|Withdrawal by Subject|4|||
130205579|NCT00980174|468712816|FG000|Overall Study|Adverse Event|0|||
130205580|NCT00980174|468712817|FG001|Overall Study|Adverse Event|3|||
130205581|NCT00980174|468712816|FG000|Overall Study|Ineligibility determined|2|||
130205582|NCT00980174|468712817|FG001|Overall Study|Ineligibility determined|1|||
130205583|NCT00980174|468712816|FG000|Overall Study|Death|1|||
130205584|NCT00980174|468712817|FG001|Overall Study|Death|1|||
130205585|NCT00980174|468712816|FG000|Overall Study|Other|0|||
130205586|NCT00980174|468712817|FG001|Overall Study|Other|1|||
130205587|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
130205588|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
130205589|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
130205590|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
130205591|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
130205592|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
130205593|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
130205594|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
130205595|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
130205596|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
130205597|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|All other|33|||
130205598|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|All other|0|||
130205599|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
130205600|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
130205601|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
130205602|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
130205603|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
130205604|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
130205605|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130205606|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130205607|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
130205608|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
130205609|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
130205610|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
130205611|NCT00783224|468712824|FG000|Overall Study|Adverse Event|0|||
130205612|NCT00783224|468712825|FG001|Overall Study|Adverse Event|0|||
130205613|NCT00783224|468712826|FG002|Overall Study|Adverse Event|1|||
130205614|NCT00783224|468712827|FG003|Overall Study|Adverse Event|0|||
130205615|NCT00783224|468712824|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
130205616|NCT00783224|468712825|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
130205617|NCT00783224|468712826|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
130205618|NCT00783224|468712827|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
130205619|NCT00783224|468712824|FG000|Overall Study|Inappropriate as a study subject|0|||
130205620|NCT00783224|468712825|FG001|Overall Study|Inappropriate as a study subject|0|||
130205621|NCT00783224|468712826|FG002|Overall Study|Inappropriate as a study subject|0|||
130205622|NCT00783224|468712827|FG003|Overall Study|Inappropriate as a study subject|1|||
130205623|NCT04631107|468712830|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
130205624|NCT04631107|468712830|FG000|Second Intervention (1 Night)|Adverse Event|1|||
130205625|NCT04631107|468712830|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
130205626|NCT04631107|468712830|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
130205627|NCT05385224|468712834|FG000|Overall Study|Unable to swallow capsule|2|||
130205628|NCT05385224|468712834|FG000|Overall Study|Withdrawal by Subject|2|||
130205629|NCT05385224|468712834|FG000|Overall Study|Did not meet study criteria|1|||
130205630|NCT00551161|468712835|FG000|Overall Study|Withdrawal by Subject|1|||
130205631|NCT01935700|468712836|FG000|Overall Study|Withdrawal by Subject|1|||
130205632|NCT01935700|468712837|FG001|Overall Study|Withdrawal by Subject|0|||
130205633|NCT01935700|468712836|FG000|Overall Study|Physician Decision|4|||
130205634|NCT01935700|468712837|FG001|Overall Study|Physician Decision|0|||
130205635|NCT00096993|468712838|FG000|Overall Study|Death|1|||
130205636|NCT00096993|468712839|FG001|Overall Study|Death|0|||
130205637|NCT00096993|468712838|FG000|Overall Study|Disease progression|56|||
130205638|NCT00096993|468712839|FG001|Overall Study|Disease progression|53|||
130205639|NCT00096993|468712838|FG000|Overall Study|Adverse Event|2|||
130205640|NCT00096993|468712839|FG001|Overall Study|Adverse Event|8|||
130205641|NCT00096993|468712838|FG000|Overall Study|Subject's decision|3|||
130205642|NCT00096993|468712839|FG001|Overall Study|Subject's decision|1|||
130205643|NCT00096993|468712838|FG000|Overall Study|Physician Decision|2|||
130205644|NCT00096993|468712839|FG001|Overall Study|Physician Decision|1|||
130205645|NCT00096993|468712838|FG000|Overall Study|Non-compliance|0|||
130205646|NCT00096993|468712839|FG001|Overall Study|Non-compliance|1|||
130205647|NCT00096993|468712838|FG000|Overall Study|Other unspecified|1|||
130205648|NCT00096993|468712839|FG001|Overall Study|Other unspecified|1|||
130205649|NCT01935128|468712840|FG000|Overall Study|Death|1|||
130205650|NCT01935128|468712840|FG000|Overall Study|Adverse Event|6|||
130205651|NCT00772005|468712841|FG000|Overall Study|Adverse Event|9|||
130205652|NCT00772005|468712842|FG001|Overall Study|Adverse Event|14|||
130205653|NCT00772005|468712843|FG002|Overall Study|Adverse Event|10|||
130205654|NCT00772005|468712844|FG003|Overall Study|Adverse Event|13|||
130205655|NCT00772005|468712841|FG000|Overall Study|Lack of Efficacy|0|||
130205656|NCT00772005|468712842|FG001|Overall Study|Lack of Efficacy|1|||
130205657|NCT00772005|468712843|FG002|Overall Study|Lack of Efficacy|0|||
130205658|NCT00772005|468712844|FG003|Overall Study|Lack of Efficacy|0|||
130205659|NCT00772005|468712841|FG000|Overall Study|Withdrawal by Subject|3|||
130205660|NCT00772005|468712842|FG001|Overall Study|Withdrawal by Subject|7|||
130205661|NCT00772005|468712843|FG002|Overall Study|Withdrawal by Subject|10|||
130205662|NCT00772005|468712844|FG003|Overall Study|Withdrawal by Subject|2|||
130205663|NCT00772005|468712841|FG000|Overall Study|Protocol Violation|2|||
130205664|NCT00772005|468712842|FG001|Overall Study|Protocol Violation|4|||
130205665|NCT00772005|468712843|FG002|Overall Study|Protocol Violation|1|||
130205666|NCT00772005|468712844|FG003|Overall Study|Protocol Violation|6|||
130205667|NCT00772005|468712841|FG000|Overall Study|Lost to Follow-up|7|||
130205668|NCT00772005|468712842|FG001|Overall Study|Lost to Follow-up|3|||
130205669|NCT00772005|468712843|FG002|Overall Study|Lost to Follow-up|6|||
130205670|NCT00772005|468712844|FG003|Overall Study|Lost to Follow-up|3|||
130205671|NCT00772005|468712841|FG000|Overall Study|Non-compliance with study procedures|1|||
130205672|NCT00772005|468712842|FG001|Overall Study|Non-compliance with study procedures|1|||
130205673|NCT00772005|468712843|FG002|Overall Study|Non-compliance with study procedures|0|||
130205674|NCT00772005|468712844|FG003|Overall Study|Non-compliance with study procedures|1|||
130205675|NCT00772005|468712841|FG000|Overall Study|Non-compliance with drug administration|3|||
130205676|NCT00772005|468712842|FG001|Overall Study|Non-compliance with drug administration|0|||
130205677|NCT00772005|468712843|FG002|Overall Study|Non-compliance with drug administration|1|||
130205678|NCT00772005|468712844|FG003|Overall Study|Non-compliance with drug administration|1|||
130205679|NCT01440569|468712848|FG000|Main Study|Enrolled but not treated|1|||
130205680|NCT01440569|468712849|FG001|Main Study|Enrolled but not treated|0|||
130205681|NCT01440569|468712848|FG000|Main Study|Adverse Event|9|||
130205682|NCT01440569|468712849|FG001|Main Study|Adverse Event|0|||
130205683|NCT01440569|468712848|FG000|Main Study|Pregnancy|1|||
130205684|NCT01440569|468712849|FG001|Main Study|Pregnancy|0|||
130205685|NCT01440569|468712848|FG000|Main Study|Investigator's Discretion|1|||
130205686|NCT01440569|468712849|FG001|Main Study|Investigator's Discretion|1|||
130205687|NCT01440569|468712848|FG000|Main Study|Withdrew Consent|7|||
130205688|NCT01440569|468712849|FG001|Main Study|Withdrew Consent|1|||
130205689|NCT01440569|468712848|FG000|Main Study|Lost to Follow-up|13|||
130205690|NCT01440569|468712849|FG001|Main Study|Lost to Follow-up|2|||
130205691|NCT01440569|468712848|FG000|Main Study|Subject Non-Compliance|3|||
130205692|NCT01440569|468712849|FG001|Main Study|Subject Non-Compliance|0|||
130205693|NCT01440569|468712848|FG000|Main Study|Protocol Violation|1|||
130205694|NCT01440569|468712849|FG001|Main Study|Protocol Violation|0|||
130205695|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Adverse Event|3|||
130205696|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Adverse Event|0|||
130205697|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Pregnancy|1|||
130205698|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Pregnancy|0|||
130205699|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
130205700|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
130205701|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
130205702|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
130205703|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
130205704|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
130205705|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
130205706|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
130205707|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130205708|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130205709|NCT02431806|468712852|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205710|NCT02431806|468712853|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
130205711|NCT02431806|468712854|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205712|NCT02431806|468712855|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205713|NCT02431806|468712852|FG000|Double-blind Treatment Period|Adverse Event|4|||
130205714|NCT02431806|468712853|FG001|Double-blind Treatment Period|Adverse Event|7|||
130205715|NCT02431806|468712854|FG002|Double-blind Treatment Period|Adverse Event|11|||
130205716|NCT02431806|468712855|FG003|Double-blind Treatment Period|Adverse Event|7|||
130205717|NCT02431806|468712852|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130205718|NCT02431806|468712853|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130205719|NCT02431806|468712854|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
130205720|NCT02431806|468712855|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130205721|NCT02431806|468712852|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
130205722|NCT02431806|468712853|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
130205723|NCT02431806|468712854|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
130205724|NCT02431806|468712855|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
130205725|NCT02431806|468712852|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
130205726|NCT02431806|468712853|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130205727|NCT02431806|468712854|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130205728|NCT02431806|468712855|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
130205729|NCT02431806|468712852|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130205730|NCT02431806|468712853|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
130205731|NCT02431806|468712854|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
130205732|NCT02431806|468712855|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130205733|NCT02431806|468712852|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
130205734|NCT02431806|468712853|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
130205735|NCT02431806|468712854|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
130205736|NCT02431806|468712855|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
130205737|NCT03627416|468712856|FG000|Overall Study|Adverse Event|0|||
130205738|NCT03627416|468712857|FG001|Overall Study|Adverse Event|1|||
130205739|NCT01294371|468712858|FG000|Overall Study|Adverse Event|1|||
130205740|NCT01294371|468712858|FG000|Overall Study|Withdrawal by Subject|12|||
130205741|NCT01294371|468712858|FG000|Overall Study|Lost to Follow-up|6|||
130205742|NCT01294371|468712858|FG000|Overall Study|Administrative Reason|1|||
130205743|NCT01294371|468712858|FG000|Overall Study|Other|14|||
130205744|NCT05619536|468712859|FG000|Overall Study|Withdrawal by Subject|0|||
130205745|NCT05619536|468712860|FG001|Overall Study|Withdrawal by Subject|1|||
130205746|NCT05619536|468712861|FG002|Overall Study|Withdrawal by Subject|0|||
130205747|NCT05619536|468712862|FG003|Overall Study|Withdrawal by Subject|1|||
130205748|NCT05619536|468712859|FG000|Overall Study|Lost to Follow-up|0|||
130205749|NCT05619536|468712860|FG001|Overall Study|Lost to Follow-up|1|||
130205750|NCT05619536|468712861|FG002|Overall Study|Lost to Follow-up|1|||
130205751|NCT05619536|468712862|FG003|Overall Study|Lost to Follow-up|0|||
130205752|NCT03619902|468712863|FG000|Overall Study|Termination of Study by Investigator|1|||
130205753|NCT03619902|468712863|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
130205754|NCT02923245|468712864|FG000|Overall Study|ultrasound order was cancelled|2|||
130205755|NCT02923245|468712865|FG001|Overall Study|ultrasound order was cancelled|1|||
130205756|NCT02520427|468712866|FG000|Overall Study|Decision by sponsor|0|||
130205757|NCT02520427|468712867|FG001|Overall Study|Decision by sponsor|0|||
130205758|NCT02520427|468712868|FG002|Overall Study|Decision by sponsor|0|||
130205759|NCT02520427|468712869|FG003|Overall Study|Decision by sponsor|0|||
130205760|NCT02520427|468712870|FG004|Overall Study|Decision by sponsor|0|||
130205761|NCT02520427|468712871|FG005|Overall Study|Decision by sponsor|0|||
130205762|NCT02520427|468712872|FG006|Overall Study|Decision by sponsor|0|||
130205763|NCT02520427|468712873|FG007|Overall Study|Decision by sponsor|0|||
130205764|NCT02520427|468712874|FG008|Overall Study|Decision by sponsor|1|||
130205765|NCT02520427|468712875|FG009|Overall Study|Decision by sponsor|1|||
130205766|NCT02520427|468712876|FG010|Overall Study|Decision by sponsor|0|||
130205767|NCT02520427|468712877|FG011|Overall Study|Decision by sponsor|0|||
130205768|NCT02520427|468712878|FG012|Overall Study|Decision by sponsor|0|||
130205769|NCT02520427|468712879|FG013|Overall Study|Decision by sponsor|0|||
130205770|NCT02520427|468712880|FG014|Overall Study|Decision by sponsor|0|||
130205771|NCT02520427|468712881|FG015|Overall Study|Decision by sponsor|0|||
130205772|NCT02520427|468712882|FG016|Overall Study|Decision by sponsor|0|||
130205773|NCT02520427|468712883|FG017|Overall Study|Decision by sponsor|0|||
130205774|NCT02520427|468712884|FG018|Overall Study|Decision by sponsor|0|||
130205775|NCT02520427|468712885|FG019|Overall Study|Decision by sponsor|0|||
130205776|NCT02520427|468712886|FG020|Overall Study|Decision by sponsor|0|||
130205777|NCT02520427|468712887|FG021|Overall Study|Decision by sponsor|0|||
130205778|NCT02520427|468712888|FG022|Overall Study|Decision by sponsor|0|||
130205779|NCT02520427|468712889|FG023|Overall Study|Decision by sponsor|0|||
130205780|NCT02520427|468712890|FG024|Overall Study|Decision by sponsor|0|||
130205781|NCT02520427|468712891|FG025|Overall Study|Decision by sponsor|0|||
130205782|NCT02520427|468712866|FG000|Overall Study|Withdrawal by Subject|0|||
130205783|NCT02520427|468712867|FG001|Overall Study|Withdrawal by Subject|0|||
130205784|NCT02520427|468712868|FG002|Overall Study|Withdrawal by Subject|1|||
130205785|NCT02520427|468712869|FG003|Overall Study|Withdrawal by Subject|0|||
130205786|NCT02520427|468712870|FG004|Overall Study|Withdrawal by Subject|0|||
130205787|NCT02520427|468712871|FG005|Overall Study|Withdrawal by Subject|0|||
130205788|NCT02520427|468712872|FG006|Overall Study|Withdrawal by Subject|0|||
130205789|NCT02520427|468712873|FG007|Overall Study|Withdrawal by Subject|0|||
130205790|NCT02520427|468712874|FG008|Overall Study|Withdrawal by Subject|0|||
130205791|NCT02520427|468712875|FG009|Overall Study|Withdrawal by Subject|0|||
130205792|NCT02520427|468712876|FG010|Overall Study|Withdrawal by Subject|0|||
130205793|NCT02520427|468712877|FG011|Overall Study|Withdrawal by Subject|0|||
130205794|NCT02520427|468712878|FG012|Overall Study|Withdrawal by Subject|1|||
130205795|NCT02520427|468712879|FG013|Overall Study|Withdrawal by Subject|1|||
130205796|NCT02520427|468712880|FG014|Overall Study|Withdrawal by Subject|1|||
130205797|NCT02520427|468712881|FG015|Overall Study|Withdrawal by Subject|0|||
130205798|NCT02520427|468712882|FG016|Overall Study|Withdrawal by Subject|1|||
130205799|NCT02520427|468712883|FG017|Overall Study|Withdrawal by Subject|0|||
130205800|NCT02520427|468712884|FG018|Overall Study|Withdrawal by Subject|0|||
130205801|NCT02520427|468712885|FG019|Overall Study|Withdrawal by Subject|3|||
130205802|NCT02520427|468712886|FG020|Overall Study|Withdrawal by Subject|2|||
130205803|NCT02520427|468712887|FG021|Overall Study|Withdrawal by Subject|0|||
130205804|NCT02520427|468712888|FG022|Overall Study|Withdrawal by Subject|0|||
130205805|NCT02520427|468712889|FG023|Overall Study|Withdrawal by Subject|0|||
130205806|NCT02520427|468712890|FG024|Overall Study|Withdrawal by Subject|0|||
130205807|NCT02520427|468712891|FG025|Overall Study|Withdrawal by Subject|0|||
130205808|NCT02520427|468712866|FG000|Overall Study|Death|1|||
130205809|NCT02520427|468712867|FG001|Overall Study|Death|0|||
130205810|NCT02520427|468712868|FG002|Overall Study|Death|0|||
130205811|NCT02520427|468712869|FG003|Overall Study|Death|0|||
130205812|NCT02520427|468712870|FG004|Overall Study|Death|0|||
130205813|NCT02520427|468712871|FG005|Overall Study|Death|0|||
130205814|NCT02520427|468712872|FG006|Overall Study|Death|0|||
130205815|NCT02520427|468712873|FG007|Overall Study|Death|0|||
130205816|NCT02520427|468712874|FG008|Overall Study|Death|0|||
130205817|NCT02520427|468712875|FG009|Overall Study|Death|0|||
130205818|NCT02520427|468712876|FG010|Overall Study|Death|0|||
130205819|NCT02520427|468712877|FG011|Overall Study|Death|0|||
130205820|NCT02520427|468712878|FG012|Overall Study|Death|0|||
130205821|NCT02520427|468712879|FG013|Overall Study|Death|0|||
130205822|NCT02520427|468712880|FG014|Overall Study|Death|0|||
130205823|NCT02520427|468712881|FG015|Overall Study|Death|0|||
130205824|NCT02520427|468712882|FG016|Overall Study|Death|2|||
130205825|NCT02520427|468712883|FG017|Overall Study|Death|1|||
130205826|NCT02520427|468712884|FG018|Overall Study|Death|3|||
130205827|NCT02520427|468712885|FG019|Overall Study|Death|2|||
130205828|NCT02520427|468712886|FG020|Overall Study|Death|0|||
130205829|NCT02520427|468712887|FG021|Overall Study|Death|0|||
130205830|NCT02520427|468712888|FG022|Overall Study|Death|1|||
130205831|NCT02520427|468712889|FG023|Overall Study|Death|0|||
130205832|NCT02520427|468712890|FG024|Overall Study|Death|1|||
130205833|NCT02520427|468712891|FG025|Overall Study|Death|0|||
130205834|NCT02987972|468712894|FG000|Overall Study|Adverse Event|1|||
130205835|NCT02987972|468712895|FG001|Overall Study|Adverse Event|1|||
130205836|NCT02987972|468712896|FG002|Overall Study|Adverse Event|0|||
130205837|NCT02987972|468712894|FG000|Overall Study|Death|1|||
130205838|NCT02987972|468712895|FG001|Overall Study|Death|0|||
130205839|NCT02987972|468712896|FG002|Overall Study|Death|0|||
130205840|NCT02987972|468712894|FG000|Overall Study|Lack of Efficacy|9|||
130205841|NCT02987972|468712895|FG001|Overall Study|Lack of Efficacy|12|||
130205842|NCT02987972|468712896|FG002|Overall Study|Lack of Efficacy|12|||
130205843|NCT02987972|468712894|FG000|Overall Study|Lost to Follow-up|7|||
130205844|NCT02987972|468712895|FG001|Overall Study|Lost to Follow-up|8|||
130205845|NCT02987972|468712896|FG002|Overall Study|Lost to Follow-up|4|||
130205846|NCT02987972|468712894|FG000|Overall Study|Physician Decision|1|||
130205847|NCT02987972|468712895|FG001|Overall Study|Physician Decision|6|||
130205848|NCT02987972|468712896|FG002|Overall Study|Physician Decision|0|||
130205849|NCT02987972|468712894|FG000|Overall Study|Protocol Violation|2|||
130205850|NCT02987972|468712895|FG001|Overall Study|Protocol Violation|1|||
130205851|NCT02987972|468712896|FG002|Overall Study|Protocol Violation|5|||
130205852|NCT02987972|468712894|FG000|Overall Study|Withdrawal by Subject|22|||
130205853|NCT02987972|468712895|FG001|Overall Study|Withdrawal by Subject|17|||
130205854|NCT02987972|468712896|FG002|Overall Study|Withdrawal by Subject|21|||
130205855|NCT00073983|468712899|FG000|Overall Study|not evaluable|1|||
130205856|NCT03800836|468712900|FG000|Overall Study|Other|2|||
130205857|NCT03800836|468712901|FG001|Overall Study|Other|1|||
130205858|NCT03800836|468712902|FG002|Overall Study|Other|0|||
130205859|NCT03800836|468712903|FG003|Overall Study|Other|2|||
130205860|NCT03800836|468712904|FG004|Overall Study|Other|0|||
130205861|NCT03800836|468712905|FG005|Overall Study|Other|1|||
130205862|NCT03800836|468712900|FG000|Overall Study|Lost to Follow-up|2|||
130205863|NCT03800836|468712901|FG001|Overall Study|Lost to Follow-up|0|||
130205864|NCT03800836|468712902|FG002|Overall Study|Lost to Follow-up|1|||
130205865|NCT03800836|468712903|FG003|Overall Study|Lost to Follow-up|1|||
130205866|NCT03800836|468712904|FG004|Overall Study|Lost to Follow-up|3|||
130205867|NCT03800836|468712905|FG005|Overall Study|Lost to Follow-up|0|||
130205868|NCT03800836|468712900|FG000|Overall Study|Withdrawal by Subject|1|||
130205869|NCT03800836|468712901|FG001|Overall Study|Withdrawal by Subject|0|||
130205870|NCT03800836|468712902|FG002|Overall Study|Withdrawal by Subject|0|||
130205871|NCT03800836|468712903|FG003|Overall Study|Withdrawal by Subject|0|||
130205872|NCT03800836|468712904|FG004|Overall Study|Withdrawal by Subject|0|||
130205873|NCT03800836|468712905|FG005|Overall Study|Withdrawal by Subject|0|||
130205874|NCT03800836|468712900|FG000|Overall Study|Physician Decision|31|||
130205875|NCT03800836|468712901|FG001|Overall Study|Physician Decision|3|||
130205876|NCT03800836|468712902|FG002|Overall Study|Physician Decision|6|||
130205877|NCT03800836|468712903|FG003|Overall Study|Physician Decision|4|||
130205878|NCT03800836|468712904|FG004|Overall Study|Physician Decision|4|||
130205879|NCT03800836|468712905|FG005|Overall Study|Physician Decision|5|||
130205880|NCT03800836|468712900|FG000|Overall Study|Death|34|||
130205881|NCT03800836|468712901|FG001|Overall Study|Death|16|||
130205882|NCT03800836|468712902|FG002|Overall Study|Death|5|||
130205883|NCT03800836|468712903|FG003|Overall Study|Death|5|||
130205884|NCT03800836|468712904|FG004|Overall Study|Death|10|||
130205885|NCT03800836|468712905|FG005|Overall Study|Death|0|||
130205886|NCT03800836|468712900|FG000|Overall Study|Symptomatic Deterioration|1|||
130205887|NCT03800836|468712901|FG001|Overall Study|Symptomatic Deterioration|0|||
130205888|NCT03800836|468712902|FG002|Overall Study|Symptomatic Deterioration|1|||
130205889|NCT03800836|468712903|FG003|Overall Study|Symptomatic Deterioration|0|||
130205890|NCT03800836|468712904|FG004|Overall Study|Symptomatic Deterioration|0|||
130205891|NCT03800836|468712905|FG005|Overall Study|Symptomatic Deterioration|0|||
130205892|NCT05072106|468714239|FG000|Overall Study|Progressive disease|3|||
130205893|NCT05072106|468714240|FG001|Overall Study|Progressive disease|3|||
130205894|NCT05072106|468714239|FG000|Overall Study|Compassionate use|3|||
130205895|NCT05072106|468714240|FG001|Overall Study|Compassionate use|1|||
130205896|NCT05072106|468714239|FG000|Overall Study|Withdrawal by Subject|1|||
130205897|NCT05072106|468714240|FG001|Overall Study|Withdrawal by Subject|0|||
130205898|NCT03839459|468714241|FG000|Overall Study|Withdrawal by Subject|2|||
130205899|NCT03839459|468714241|FG000|Overall Study|progression of disease|3|||
130205900|NCT02542293|468714246|FG000|Overall Study|Death|367|||
130205901|NCT02542293|468714247|FG001|Overall Study|Death|377|||
130205902|NCT02542293|468714246|FG000|Overall Study|Withdrawal by Subject|8|||
130205903|NCT02542293|468714247|FG001|Overall Study|Withdrawal by Subject|19|||
130205904|NCT01458951|468714250|FG000|Overall Study|Other|1|||
130205905|NCT01458951|468714251|FG001|Overall Study|Other|0|||
130205906|NCT01458951|468714252|FG002|Overall Study|Other|0|||
130205907|NCT01458951|468714250|FG000|Overall Study|Protocol Violation|5|||
130205908|NCT01458951|468714251|FG001|Overall Study|Protocol Violation|1|||
130205909|NCT01458951|468714252|FG002|Overall Study|Protocol Violation|0|||
130205910|NCT01458951|468714250|FG000|Overall Study|Withdrawal by Subject|2|||
130205911|NCT01458951|468714251|FG001|Overall Study|Withdrawal by Subject|0|||
130205912|NCT01458951|468714252|FG002|Overall Study|Withdrawal by Subject|2|||
130205913|NCT01458951|468714250|FG000|Overall Study|Adverse Event|7|||
130205914|NCT01458951|468714251|FG001|Overall Study|Adverse Event|0|||
130205915|NCT01458951|468714252|FG002|Overall Study|Adverse Event|2|||
130205916|NCT01458951|468714250|FG000|Overall Study|Insufficient Clinical Response|17|||
130205917|NCT01458951|468714251|FG001|Overall Study|Insufficient Clinical Response|0|||
130205918|NCT01458951|468714252|FG002|Overall Study|Insufficient Clinical Response|11|||
130205919|NCT02963558|468714255|FG000|Overall Study|Withdrawn by investigator|1|||
130205920|NCT02963558|468714256|FG001|Overall Study|Withdrawn by investigator|0|||
130205921|NCT02963558|468714255|FG000|Overall Study|Withdrawal by Subject|0|||
130205922|NCT02963558|468714256|FG001|Overall Study|Withdrawal by Subject|1|||
130205923|NCT01573767|468714257|FG000|Overall Study|Adverse Event|0|||
130205924|NCT01573767|468714258|FG001|Overall Study|Adverse Event|1|||
130205925|NCT01573767|468714259|FG002|Overall Study|Adverse Event|0|||
130205926|NCT01573767|468714260|FG003|Overall Study|Adverse Event|1|||
130205927|NCT01573767|468714257|FG000|Overall Study|Lack of Efficacy|18|||
130205928|NCT01573767|468714258|FG001|Overall Study|Lack of Efficacy|15|||
130205929|NCT01573767|468714259|FG002|Overall Study|Lack of Efficacy|12|||
130205930|NCT01573767|468714260|FG003|Overall Study|Lack of Efficacy|17|||
130205931|NCT01573767|468714257|FG000|Overall Study|Protocol Violation|3|||
130205932|NCT01573767|468714258|FG001|Overall Study|Protocol Violation|1|||
130205933|NCT01573767|468714259|FG002|Overall Study|Protocol Violation|1|||
130205934|NCT01573767|468714260|FG003|Overall Study|Protocol Violation|3|||
130205935|NCT01573767|468714257|FG000|Overall Study|Lost to Follow-up|0|||
130205936|NCT01573767|468714258|FG001|Overall Study|Lost to Follow-up|1|||
130205937|NCT01573767|468714259|FG002|Overall Study|Lost to Follow-up|1|||
130205938|NCT01573767|468714260|FG003|Overall Study|Lost to Follow-up|1|||
130205939|NCT01573767|468714257|FG000|Overall Study|Physician Decision|1|||
130205940|NCT01573767|468714258|FG001|Overall Study|Physician Decision|2|||
130205941|NCT01573767|468714259|FG002|Overall Study|Physician Decision|0|||
130205942|NCT01573767|468714260|FG003|Overall Study|Physician Decision|2|||
130205943|NCT01573767|468714257|FG000|Overall Study|Withdrawal by Subject|0|||
130205944|NCT01573767|468714258|FG001|Overall Study|Withdrawal by Subject|1|||
130205945|NCT01573767|468714259|FG002|Overall Study|Withdrawal by Subject|0|||
130205946|NCT01573767|468714260|FG003|Overall Study|Withdrawal by Subject|0|||
130205947|NCT01371877|468714263|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
130205948|NCT01371877|468714264|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
130205949|NCT00869557|468714265|FG000|Randomized Phase|Lost to Follow-up|2|||
130205950|NCT00869557|468714266|FG001|Randomized Phase|Lost to Follow-up|1|||
130205951|NCT00869557|468714265|FG000|Randomized Phase|Investigator's Discretion|1|||
130205952|NCT00869557|468714266|FG001|Randomized Phase|Investigator's Discretion|0|||
130205953|NCT00869557|468714265|FG000|Randomized Phase|Withdrew Consent|0|||
130205954|NCT00869557|468714266|FG001|Randomized Phase|Withdrew Consent|1|||
130205955|NCT00869557|468714265|FG000|Extension Phase|Adverse Event|2|||
130205956|NCT00869557|468714266|FG001|Extension Phase|Adverse Event|2|||
130205957|NCT00869557|468714265|FG000|Extension Phase|Lack of Efficacy|1|||
130205958|NCT00869557|468714266|FG001|Extension Phase|Lack of Efficacy|0|||
130205959|NCT00869557|468714265|FG000|Extension Phase|Lost to Follow-up|3|||
130205960|NCT00869557|468714266|FG001|Extension Phase|Lost to Follow-up|1|||
130205961|NCT00869557|468714265|FG000|Extension Phase|Investigator's Discretion|2|||
130205962|NCT00869557|468714266|FG001|Extension Phase|Investigator's Discretion|0|||
130205963|NCT00869557|468714265|FG000|Extension Phase|Withdrew Consent|2|||
130205964|NCT00869557|468714266|FG001|Extension Phase|Withdrew Consent|0|||
130205965|NCT01143064|468714269|FG000|Overall Study|Death|109|||
130205966|NCT01143064|468714270|FG001|Overall Study|Death|91|||
130205967|NCT01143064|468714269|FG000|Overall Study|Adverse Event|0|||
130205968|NCT01143064|468714270|FG001|Overall Study|Adverse Event|1|||
130205969|NCT01143064|468714269|FG000|Overall Study|Withdrawal by Subject|7|||
130205970|NCT01143064|468714270|FG001|Overall Study|Withdrawal by Subject|5|||
130205971|NCT01143064|468714269|FG000|Overall Study|Lost to Follow-up|17|||
130205972|NCT01143064|468714270|FG001|Overall Study|Lost to Follow-up|14|||
130205973|NCT01143064|468714269|FG000|Overall Study|Physician Decision|0|||
130205974|NCT01143064|468714270|FG001|Overall Study|Physician Decision|4|||
130205975|NCT02255552|468714273|FG000|Overall Study|Participants enrolled into another study|0|||
130205976|NCT02255552|468714274|FG001|Overall Study|Participants enrolled into another study|11|||
130205977|NCT02255552|468714273|FG000|Overall Study|Withdrawal by Subject|1|||
130205978|NCT02255552|468714274|FG001|Overall Study|Withdrawal by Subject|4|||
130205979|NCT03747302|468714277|FG000|Overall Study|Withdrawal by Subject|1|||
130205980|NCT03747302|468714278|FG001|Overall Study|Withdrawal by Subject|2|||
130205981|NCT03448939|468714281|FG000|Overall Study|Adverse Event|5|||
130205982|NCT03448939|468714282|FG001|Overall Study|Adverse Event|1|||
130205983|NCT03448939|468714281|FG000|Overall Study|Lost to Follow-up|6|||
130205984|NCT03448939|468714282|FG001|Overall Study|Lost to Follow-up|6|||
130205985|NCT03448939|468714281|FG000|Overall Study|Pregnancy|1|||
130205986|NCT03448939|468714282|FG001|Overall Study|Pregnancy|1|||
130205987|NCT03448939|468714281|FG000|Overall Study|Withdrawal by Subject|9|||
130205988|NCT03448939|468714282|FG001|Overall Study|Withdrawal by Subject|3|||
130205989|NCT00894790|468714283|FG000|Overall Study|Protocol Violation|0|||
130205990|NCT00894790|468714284|FG001|Overall Study|Protocol Violation|1|||
130205991|NCT00894790|468714283|FG000|Overall Study|Lost to Follow-up|0|||
130205992|NCT00894790|468714284|FG001|Overall Study|Lost to Follow-up|1|||
130205993|NCT00894790|468714283|FG000|Overall Study|Did not meet entrance criteria|1|||
130205994|NCT00894790|468714284|FG001|Overall Study|Did not meet entrance criteria|0|||
130205995|NCT01472965|468714285|FG000|Overall Study|Withdrawal by Subject|1|||
130205996|NCT01472965|468714286|FG001|Overall Study|Withdrawal by Subject|0|||
130205997|NCT00628095|468714287|FG000|Overall Study|Adverse Event|5|||
130205998|NCT00628095|468714288|FG001|Overall Study|Adverse Event|3|||
130205999|NCT00628095|468714287|FG000|Overall Study|Lack of Efficacy|0|||
130206000|NCT00628095|468714288|FG001|Overall Study|Lack of Efficacy|3|||
130206001|NCT00628095|468714287|FG000|Overall Study|Withdrawal by Subject|2|||
130206002|NCT00628095|468714288|FG001|Overall Study|Withdrawal by Subject|0|||
130206003|NCT00628095|468714287|FG000|Overall Study|Other|0|||
130206004|NCT00628095|468714288|FG001|Overall Study|Other|1|||
130206005|NCT03235115|468714292|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206006|NCT03235115|468714293|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206007|NCT03235115|468714294|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206008|NCT03235115|468714295|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206009|NCT03235115|468714296|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206010|NCT03235115|468714297|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
130206011|NCT00006305|468714298|FG000|Overall Study|Withdrawal by Subject|17|||
130206012|NCT00006305|468714299|FG001|Overall Study|Withdrawal by Subject|10|||
130206013|NCT00006305|468714300|FG002|Overall Study|Withdrawal by Subject|15|||
130206014|NCT00006305|468714301|FG003|Overall Study|Withdrawal by Subject|14|||
130206015|NCT00662558|468714304|FG000|Overall Study|Adverse Event|21|||
130206016|NCT00662558|468714305|FG001|Overall Study|Adverse Event|59|||
130206017|NCT00662558|468714304|FG000|Overall Study|Lack of Efficacy|4|||
130206018|NCT00662558|468714305|FG001|Overall Study|Lack of Efficacy|7|||
130206019|NCT00662558|468714304|FG000|Overall Study|Lost to Follow-up|13|||
130206020|NCT00662558|468714305|FG001|Overall Study|Lost to Follow-up|10|||
130206021|NCT00662558|468714304|FG000|Overall Study|Other|9|||
130206022|NCT00662558|468714305|FG001|Overall Study|Other|14|||
130206023|NCT00662558|468714304|FG000|Overall Study|Withdrawal by Subject|7|||
130206024|NCT00662558|468714305|FG001|Overall Study|Withdrawal by Subject|12|||
130206025|NCT00662558|468714304|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
130206026|NCT00662558|468714305|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
130206027|NCT01711619|468714306|FG000|Overall Study|Early study termination|10|||
130206028|NCT01711619|468714307|FG001|Overall Study|Early study termination|14|||
130206029|NCT01711619|468714306|FG000|Overall Study|Withdrawal by Subject|3|||
130206030|NCT01711619|468714307|FG001|Overall Study|Withdrawal by Subject|7|||
130206031|NCT01711619|468714306|FG000|Overall Study|Protocol Violation|2|||
130206032|NCT01711619|468714307|FG001|Overall Study|Protocol Violation|3|||
130206033|NCT01711619|468714306|FG000|Overall Study|Adverse Event|2|||
130206034|NCT01711619|468714307|FG001|Overall Study|Adverse Event|0|||
130206035|NCT01711619|468714306|FG000|Overall Study|Lost to Follow-up|1|||
130206036|NCT01711619|468714307|FG001|Overall Study|Lost to Follow-up|0|||
130206037|NCT00503997|468714308|FG000|Overall Study|disease progression|1|||
130206038|NCT00503997|468714308|FG000|Overall Study|Adverse Event|5|||
130206039|NCT00503997|468714308|FG000|Overall Study|Death|1|||
130206040|NCT00503997|468714308|FG000|Overall Study|Withdrawal by Subject|1|||
130206041|NCT01195844|468714309|FG000|Overall Study|Fecal sample not collected|40|||
130206042|NCT01432275|468714313|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
130206043|NCT01432275|468714314|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
130206044|NCT01432275|468714313|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
130206045|NCT01432275|468714314|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
130206046|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
130206047|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
130206048|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
130206049|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
130206050|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
130206051|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
130206052|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
130206053|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
130206054|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
130206055|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
130206056|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
130206057|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
130206058|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
130206059|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
130206060|NCT02565706|468714315|FG000|Overall Study|Withdrawal by Subject|5|||
130206061|NCT02565706|468714316|FG001|Overall Study|Withdrawal by Subject|7|||
130206062|NCT02565706|468714317|FG002|Overall Study|Withdrawal by Subject|7|||
130206063|NCT02565706|468714318|FG003|Overall Study|Withdrawal by Subject|11|||
130206064|NCT02565706|468714315|FG000|Overall Study|Lost to Follow-up|72|||
130206065|NCT02565706|468714316|FG001|Overall Study|Lost to Follow-up|75|||
130206066|NCT02565706|468714317|FG002|Overall Study|Lost to Follow-up|82|||
130206067|NCT02565706|468714318|FG003|Overall Study|Lost to Follow-up|74|||
130206068|NCT00835679|468714324|FG000|Overall Study|Withdrawal by Subject|1|||
130206069|NCT00835679|468714325|FG001|Overall Study|Withdrawal by Subject|0|||
130206070|NCT00835679|468714326|FG002|Overall Study|Withdrawal by Subject|0|||
130206071|NCT00835679|468714327|FG003|Overall Study|Withdrawal by Subject|0|||
130206072|NCT03802565|468714330|FG000|Overall Study|Adverse Event|0|||
130206073|NCT03802565|468714331|FG001|Overall Study|Adverse Event|1|||
130206074|NCT03802565|468714332|FG002|Overall Study|Adverse Event|2|||
130206075|NCT03802565|468714333|FG003|Overall Study|Adverse Event|1|||
130206076|NCT03802565|468714334|FG004|Overall Study|Adverse Event|1|||
130206077|NCT03802565|468714330|FG000|Overall Study|Withdrawal by Subject|2|||
130206078|NCT03802565|468714331|FG001|Overall Study|Withdrawal by Subject|2|||
130206079|NCT03802565|468714332|FG002|Overall Study|Withdrawal by Subject|2|||
130206080|NCT03802565|468714333|FG003|Overall Study|Withdrawal by Subject|0|||
130206081|NCT03802565|468714334|FG004|Overall Study|Withdrawal by Subject|1|||
130206082|NCT03802565|468714330|FG000|Overall Study|Protocol Violation|2|||
130206083|NCT03802565|468714331|FG001|Overall Study|Protocol Violation|1|||
130206084|NCT03802565|468714332|FG002|Overall Study|Protocol Violation|4|||
130206085|NCT03802565|468714333|FG003|Overall Study|Protocol Violation|5|||
130206086|NCT03802565|468714334|FG004|Overall Study|Protocol Violation|1|||
130206087|NCT03802565|468714330|FG000|Overall Study|Lost to Follow-up|0|||
130206088|NCT03802565|468714331|FG001|Overall Study|Lost to Follow-up|0|||
130206089|NCT03802565|468714332|FG002|Overall Study|Lost to Follow-up|1|||
130206090|NCT03802565|468714333|FG003|Overall Study|Lost to Follow-up|0|||
130206091|NCT03802565|468714334|FG004|Overall Study|Lost to Follow-up|0|||
130206092|NCT03802565|468714330|FG000|Overall Study|Subjects Related to Each Other|1|||
130206093|NCT03802565|468714331|FG001|Overall Study|Subjects Related to Each Other|0|||
130206094|NCT03802565|468714332|FG002|Overall Study|Subjects Related to Each Other|0|||
130206095|NCT03802565|468714333|FG003|Overall Study|Subjects Related to Each Other|2|||
130206096|NCT03802565|468714334|FG004|Overall Study|Subjects Related to Each Other|1|||
130206097|NCT03802565|468714330|FG000|Overall Study|Elevated Enzymes|0|||
130206098|NCT03802565|468714331|FG001|Overall Study|Elevated Enzymes|0|||
130206099|NCT03802565|468714332|FG002|Overall Study|Elevated Enzymes|0|||
130206100|NCT03802565|468714333|FG003|Overall Study|Elevated Enzymes|0|||
130206101|NCT03802565|468714334|FG004|Overall Study|Elevated Enzymes|2|||
130206102|NCT05020899|468714335|FG000|8 Week Follow-up|Lost to Follow-up|3|||
130206103|NCT05020899|468714336|FG001|8 Week Follow-up|Lost to Follow-up|6|||
130206104|NCT05020899|468714335|FG000|12 Week Follow-up|Lost to Follow-up|1|||
130206105|NCT05020899|468714336|FG001|12 Week Follow-up|Lost to Follow-up|0|||
130206106|NCT05020899|468714335|FG000|12 Week Follow-up|Death|0|||
130206107|NCT05020899|468714336|FG001|12 Week Follow-up|Death|1|||
130206108|NCT02124759|468714337|FG000|Overall Study|Withdrawal by Subject|3|||
130206109|NCT02124759|468714338|FG001|Overall Study|Withdrawal by Subject|1|||
130206110|NCT02124759|468714339|FG002|Overall Study|Withdrawal by Subject|1|||
130206111|NCT02124759|468714337|FG000|Overall Study|Screen Fail|2|||
130206112|NCT02124759|468714338|FG001|Overall Study|Screen Fail|2|||
130206113|NCT02124759|468714339|FG002|Overall Study|Screen Fail|3|||
130206114|NCT01068626|468714340|FG000|Overall Study|Adverse Event|3|||
130206115|NCT01068626|468714341|FG001|Overall Study|Adverse Event|0|||
130206116|NCT01068626|468714340|FG000|Overall Study|Withdrawal by Subject|0|||
130206117|NCT01068626|468714341|FG001|Overall Study|Withdrawal by Subject|2|||
130206118|NCT01785849|468714344|FG000|Overall Study|Death|7|||
130206119|NCT01785849|468714345|FG001|Overall Study|Death|9|||
130206120|NCT01785849|468714344|FG000|Overall Study|Protocol Specified Criteria|29|||
130206121|NCT01785849|468714345|FG001|Overall Study|Protocol Specified Criteria|1|||
130206122|NCT01785849|468714344|FG000|Overall Study|Withdrawal by Subject|15|||
130206123|NCT01785849|468714345|FG001|Overall Study|Withdrawal by Subject|12|||
130206124|NCT01785849|468714344|FG000|Overall Study|Sponsor Decision|0|||
130206125|NCT01785849|468714345|FG001|Overall Study|Sponsor Decision|1|||
130206126|NCT01785849|468714344|FG000|Overall Study|Lost to Follow-up|10|||
130206127|NCT01785849|468714345|FG001|Overall Study|Lost to Follow-up|11|||
130206128|NCT04340843|468714346|FG000|Overall Study|Adverse Event|0|||
130206129|NCT04340843|468714347|FG001|Overall Study|Adverse Event|2|||
130206130|NCT04340843|468714346|FG000|Overall Study|Withdrawal by Subject|0|||
130206131|NCT04340843|468714347|FG001|Overall Study|Withdrawal by Subject|2|||
130206132|NCT04249622|468714348|FG000|Overall Study|Withdrawal by Subject|1|||
130206133|NCT04249622|468714349|FG001|Overall Study|Withdrawal by Subject|1|||
130206134|NCT04249622|468714348|FG000|Overall Study|Alternative therapy|1|||
130206135|NCT04249622|468714349|FG001|Overall Study|Alternative therapy|0|||
130206136|NCT04249622|468714348|FG000|Overall Study|Discontinuation of pertuzumab|1|||
130206137|NCT04249622|468714349|FG001|Overall Study|Discontinuation of pertuzumab|0|||
130206138|NCT01634659|468714353|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
130206139|NCT01634659|468714354|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
130206140|NCT01634659|468714353|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
130206141|NCT01634659|468714354|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
130206142|NCT00875433|468714355|FG000|Overall Study|Progressive disease|41|||
130206143|NCT00875433|468714355|FG000|Overall Study|Other Adverse Event|14|||
130206144|NCT00875433|468714355|FG000|Overall Study|Withdrawal by Subject|2|||
130206145|NCT00875433|468714355|FG000|Overall Study|Other|3|||
130206146|NCT00793624|468714356|FG000|Overall Study|Adverse Event|18|||
130206147|NCT00793624|468714357|FG001|Overall Study|Adverse Event|16|||
130206148|NCT00793624|468714358|FG002|Overall Study|Adverse Event|15|||
130206149|NCT00793624|468714359|FG003|Overall Study|Adverse Event|20|||
130206150|NCT00793624|468714356|FG000|Overall Study|Lost to Follow-up|2|||
130206151|NCT00793624|468714357|FG001|Overall Study|Lost to Follow-up|2|||
130206152|NCT00793624|468714358|FG002|Overall Study|Lost to Follow-up|4|||
130206153|NCT00793624|468714359|FG003|Overall Study|Lost to Follow-up|0|||
130206154|NCT00793624|468714356|FG000|Overall Study|Withdrawal by Subject|20|||
130206155|NCT00793624|468714357|FG001|Overall Study|Withdrawal by Subject|9|||
130206156|NCT00793624|468714358|FG002|Overall Study|Withdrawal by Subject|11|||
130206157|NCT00793624|468714359|FG003|Overall Study|Withdrawal by Subject|14|||
130206158|NCT00793624|468714356|FG000|Overall Study|Lack of Efficacy|9|||
130206159|NCT00793624|468714357|FG001|Overall Study|Lack of Efficacy|2|||
130206160|NCT00793624|468714358|FG002|Overall Study|Lack of Efficacy|1|||
130206161|NCT00793624|468714359|FG003|Overall Study|Lack of Efficacy|3|||
130206162|NCT00793624|468714356|FG000|Overall Study|Non compliance with protocol|2|||
130206163|NCT00793624|468714357|FG001|Overall Study|Non compliance with protocol|3|||
130206164|NCT00793624|468714358|FG002|Overall Study|Non compliance with protocol|2|||
130206165|NCT00793624|468714359|FG003|Overall Study|Non compliance with protocol|3|||
130206166|NCT00793624|468714356|FG000|Overall Study|Other reason not described above|6|||
130206167|NCT00793624|468714357|FG001|Overall Study|Other reason not described above|4|||
130206168|NCT00793624|468714358|FG002|Overall Study|Other reason not described above|6|||
130206169|NCT00793624|468714359|FG003|Overall Study|Other reason not described above|3|||
130206170|NCT02921750|468715614|FG000|Overall Study|Adverse Event|1|||
130206171|NCT02921750|468715615|FG001|Overall Study|Adverse Event|2|||
130206172|NCT02921750|468715614|FG000|Overall Study|Withdrawal by Subject|1|||
130206173|NCT02921750|468715615|FG001|Overall Study|Withdrawal by Subject|1|||
130206174|NCT02921750|468715614|FG000|Overall Study|Lost to Follow-up|3|||
130206175|NCT02921750|468715615|FG001|Overall Study|Lost to Follow-up|3|||
130206176|NCT02921750|468715614|FG000|Overall Study|Wound healed|3|||
130206177|NCT02921750|468715615|FG001|Overall Study|Wound healed|3|||
130206178|NCT02921750|468715614|FG000|Overall Study|Serious Adverse Event|1|||
130206179|NCT02921750|468715615|FG001|Overall Study|Serious Adverse Event|2|||
130206180|NCT03309696|468715616|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
130206181|NCT03309696|468715617|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
130206182|NCT03309696|468715618|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
130206183|NCT03309696|468715619|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
130206184|NCT05940077|468715620|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
130206185|NCT00328094|468715621|FG000|Overall Study|Physician Decision|3|||
130206186|NCT00328094|468715622|FG001|Overall Study|Physician Decision|3|||
130206187|NCT02368210|468715623|FG000|Overall Study|Withdrawal by Subject|1|||
130206188|NCT02368210|468715624|FG001|Overall Study|Withdrawal by Subject|0|||
130206189|NCT02368210|468715623|FG000|Overall Study|Adverse Event|0|||
130206190|NCT02368210|468715624|FG001|Overall Study|Adverse Event|1|||
130206191|NCT00078949|468715625|FG000|Overall Study|No treated|4|||
130206192|NCT00078949|468715626|FG001|Overall Study|No treated|5|||
130206193|NCT00078949|468715627|FG002|Overall Study|No treated|3|||
130206194|NCT00078949|468715628|FG003|Overall Study|No treated|3|||
130206195|NCT02309723|468715629|FG000|Overall Study|Withdrawal by Subject|24|||
130206196|NCT02309723|468715630|FG001|Overall Study|Withdrawal by Subject|23|||
130206197|NCT02309723|468715631|FG002|Overall Study|Withdrawal by Subject|24|||
130206198|NCT01565668|468715632|FG000|Overall Study|Death|2|||
130206199|NCT01565668|468715633|FG001|Overall Study|Death|1|||
130206200|NCT01565668|468715632|FG000|Overall Study|Lack of Efficacy|4|||
130206201|NCT01565668|468715633|FG001|Overall Study|Lack of Efficacy|2|||
130206202|NCT01565668|468715632|FG000|Overall Study|Participant went on Hospice Care|1|||
130206203|NCT01565668|468715633|FG001|Overall Study|Participant went on Hospice Care|0|||
130206204|NCT01565668|468715632|FG000|Overall Study|Adverse Event|6|||
130206205|NCT01565668|468715633|FG001|Overall Study|Adverse Event|1|||
130206206|NCT01565668|468715632|FG000|Overall Study|Randomized, but never received drug|0|||
130206207|NCT01565668|468715633|FG001|Overall Study|Randomized, but never received drug|2|||
130206208|NCT01565668|468715632|FG000|Overall Study|Progressive disease|13|||
130206209|NCT01565668|468715633|FG001|Overall Study|Progressive disease|14|||
130206210|NCT01565668|468715632|FG000|Overall Study|Withdrawal by Subject|1|||
130206211|NCT01565668|468715633|FG001|Overall Study|Withdrawal by Subject|3|||
130206212|NCT01565668|468715632|FG000|Overall Study|HSCT Transplant|11|||
130206213|NCT01565668|468715633|FG001|Overall Study|HSCT Transplant|15|||
130206214|NCT03570554|468715634|FG000|Overall Study|Non-compliance with study drug|0|||
130206215|NCT03570554|468715635|FG001|Overall Study|Non-compliance with study drug|0|||
130206216|NCT03570554|468715636|FG002|Overall Study|Non-compliance with study drug|1|||
130206217|NCT03570554|468715637|FG003|Overall Study|Non-compliance with study drug|0|||
130206218|NCT03570554|468715634|FG000|Overall Study|Adverse Event|0|||
130206219|NCT03570554|468715635|FG001|Overall Study|Adverse Event|0|||
130206220|NCT03570554|468715636|FG002|Overall Study|Adverse Event|0|||
130206221|NCT03570554|468715637|FG003|Overall Study|Adverse Event|1|||
130206222|NCT02604550|468715640|FG000|Overall Study|Lost to Follow-up|7|||
130206223|NCT02604550|468715641|FG001|Overall Study|Lost to Follow-up|6|||
130206224|NCT02604550|468715640|FG000|Overall Study|Withdrawal by Subject|0|||
130206225|NCT02604550|468715641|FG001|Overall Study|Withdrawal by Subject|1|||
130206226|NCT02604550|468715640|FG000|Overall Study|Incomplete data using paper journal|18|||
130206227|NCT02604550|468715641|FG001|Overall Study|Incomplete data using paper journal|19|||
130206228|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
130206229|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
130206230|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
130206231|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
130206232|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Death|1|||
130206233|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Death|1|||
130206234|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130206235|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
130206236|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
130206237|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
130206238|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
130206239|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
130206240|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
130206241|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
130206242|NCT00033657|468715645|FG000|Surgical Resection|not complete resection|0|||
130206243|NCT00033657|468715646|FG001|Surgical Resection|not complete resection|3|||
130206244|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
130206245|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
130206246|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
130206247|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
130206248|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Death|2|||
130206249|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Death|1|||
130206250|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
130206251|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
130206252|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
130206253|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
130206254|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Other|0|||
130206255|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Other|2|||
130206256|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
130206257|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
130206258|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130206259|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130206260|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|No response|5|||
130206261|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|No response|5|||
130206262|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|No response|5|||
130206263|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|No response|2|||
130206264|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206265|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206266|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206267|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
130206268|NCT04093492|468715647|FG000|30 Weeks GA|Delivered before assessment|1|||
130206269|NCT04093492|468715648|FG001|30 Weeks GA|Delivered before assessment|2|||
130206270|NCT04093492|468715649|FG002|30 Weeks GA|Delivered before assessment|0|||
130206271|NCT04093492|468715650|FG003|30 Weeks GA|Delivered before assessment|0|||
130206272|NCT04093492|468715647|FG000|30 Weeks GA|No response|7|||
130206273|NCT04093492|468715648|FG001|30 Weeks GA|No response|5|||
130206274|NCT04093492|468715649|FG002|30 Weeks GA|No response|5|||
130206275|NCT04093492|468715650|FG003|30 Weeks GA|No response|2|||
130206276|NCT04093492|468715647|FG000|30 Weeks GA|Lost to Follow-up|0|||
130206277|NCT04093492|468715648|FG001|30 Weeks GA|Lost to Follow-up|1|||
130206278|NCT04093492|468715649|FG002|30 Weeks GA|Lost to Follow-up|0|||
130206279|NCT04093492|468715650|FG003|30 Weeks GA|Lost to Follow-up|0|||
130206280|NCT04093492|468715647|FG000|34 Weeks GA|Delivered before assessment|6|||
130206281|NCT04093492|468715648|FG001|34 Weeks GA|Delivered before assessment|3|||
130206282|NCT04093492|468715649|FG002|34 Weeks GA|Delivered before assessment|0|||
130206283|NCT04093492|468715650|FG003|34 Weeks GA|Delivered before assessment|0|||
130206284|NCT04093492|468715647|FG000|34 Weeks GA|No response|0|||
130206285|NCT04093492|468715648|FG001|34 Weeks GA|No response|7|||
130206286|NCT04093492|468715649|FG002|34 Weeks GA|No response|5|||
130206287|NCT04093492|468715650|FG003|34 Weeks GA|No response|3|||
130206288|NCT04093492|468715647|FG000|34 Weeks GA|Lost to Follow-up|0|||
130206289|NCT04093492|468715648|FG001|34 Weeks GA|Lost to Follow-up|1|||
130206290|NCT04093492|468715649|FG002|34 Weeks GA|Lost to Follow-up|0|||
130206291|NCT04093492|468715650|FG003|34 Weeks GA|Lost to Follow-up|0|||
130206292|NCT00329641|468715651|FG000|Overall Study|Did not start treatment|1|||
130206293|NCT00329641|468715651|FG000|Overall Study|Not eligible|1|||
130206294|NCT00329641|468715651|FG000|Overall Study|Adverse Event|3|||
130206295|NCT00329641|468715651|FG000|Overall Study|Other reason, not protocol specified|1|||
130206296|NCT02945254|468715654|FG000|Overall Study|Lost to Follow-up|1|||
130206297|NCT02945254|468715655|FG001|Overall Study|Lost to Follow-up|0|||
130206298|NCT02945254|468715654|FG000|Overall Study|Withdrawal by Subject|1|||
130206299|NCT02945254|468715655|FG001|Overall Study|Withdrawal by Subject|0|||
130206300|NCT03422159|468715656|FG000|Overall Study|Exclusion due to terminal disease|2|||
130206301|NCT03422159|468715657|FG001|Overall Study|Exclusion due to terminal disease|1|||
130206302|NCT02631070|468715662|FG000|Overall Study|Withdrawal by Subject|35|||
130206303|NCT02631070|468715663|FG001|Overall Study|Withdrawal by Subject|13|||
130206304|NCT02631070|468715662|FG000|Overall Study|Death|45|||
130206305|NCT02631070|468715663|FG001|Overall Study|Death|24|||
130206306|NCT02631070|468715662|FG000|Overall Study|Lost to Follow-up|5|||
130206307|NCT02631070|468715663|FG001|Overall Study|Lost to Follow-up|1|||
130206308|NCT02631070|468715662|FG000|Overall Study|Transition to rollover protocol|52|||
130206309|NCT02631070|468715663|FG001|Overall Study|Transition to rollover protocol|21|||
130206310|NCT02631070|468715662|FG000|Overall Study|Other reasons|12|||
130206311|NCT02631070|468715663|FG001|Overall Study|Other reasons|5|||
130206312|NCT00980018|468715669|FG000|Overall Study|Adverse Event|8|||
130206313|NCT00980018|468715669|FG000|Overall Study|Patient withdrew consent|3|||
130206314|NCT00980018|468715669|FG000|Overall Study|Lost to Follow-up|1|||
130206315|NCT00087126|468715670|FG000|Overall Study|Ineligible - second primary|1|||
130206316|NCT00087126|468715670|FG000|Overall Study|Never treated|1|||
130206317|NCT01832818|468715671|FG000|Overall Study|Lost to Follow-up|6|||
130206318|NCT00934856|468715674|FG000|Feasibility Part|Progressive disease|4|||
130206319|NCT00934856|468715675|FG001|Feasibility Part|Progressive disease|4|||
130206320|NCT00934856|468715676|FG002|Feasibility Part|Progressive disease|2|||
130206321|NCT00934856|468715677|FG003|Feasibility Part|Progressive disease|3|||
130206322|NCT00934856|468715678|FG004|Feasibility Part|Progressive disease|0|||
130206323|NCT00934856|468715679|FG005|Feasibility Part|Progressive disease|0|||
130206324|NCT00934856|468715674|FG000|Feasibility Part|Physician Decision|0|||
130206325|NCT00934856|468715675|FG001|Feasibility Part|Physician Decision|0|||
130206326|NCT00934856|468715676|FG002|Feasibility Part|Physician Decision|1|||
130206327|NCT00934856|468715677|FG003|Feasibility Part|Physician Decision|0|||
130206328|NCT00934856|468715678|FG004|Feasibility Part|Physician Decision|0|||
130206329|NCT00934856|468715679|FG005|Feasibility Part|Physician Decision|0|||
130206330|NCT00934856|468715674|FG000|Feasibility Part|Adverse Event|1|||
130206331|NCT00934856|468715675|FG001|Feasibility Part|Adverse Event|1|||
130206332|NCT00934856|468715676|FG002|Feasibility Part|Adverse Event|0|||
130206333|NCT00934856|468715677|FG003|Feasibility Part|Adverse Event|1|||
130206334|NCT00934856|468715678|FG004|Feasibility Part|Adverse Event|0|||
130206335|NCT00934856|468715679|FG005|Feasibility Part|Adverse Event|2|||
130206336|NCT00934856|468715674|FG000|Feasibility Part|Withdrawal by Subject|0|||
130206337|NCT00934856|468715675|FG001|Feasibility Part|Withdrawal by Subject|0|||
130206338|NCT00934856|468715676|FG002|Feasibility Part|Withdrawal by Subject|0|||
130206339|NCT00934856|468715677|FG003|Feasibility Part|Withdrawal by Subject|1|||
130206340|NCT00934856|468715678|FG004|Feasibility Part|Withdrawal by Subject|0|||
130206341|NCT00934856|468715679|FG005|Feasibility Part|Withdrawal by Subject|1|||
130206342|NCT00934856|468715674|FG000|Extension Part|Adverse Event|0|||
130206343|NCT00934856|468715675|FG001|Extension Part|Adverse Event|0|||
130206344|NCT00934856|468715676|FG002|Extension Part|Adverse Event|0|||
130206345|NCT00934856|468715677|FG003|Extension Part|Adverse Event|1|||
130206346|NCT00934856|468715678|FG004|Extension Part|Adverse Event|4|||
130206347|NCT00934856|468715679|FG005|Extension Part|Adverse Event|4|||
130206348|NCT00934856|468715674|FG000|Extension Part|Progressive disease|0|||
130206349|NCT00934856|468715675|FG001|Extension Part|Progressive disease|0|||
130206350|NCT00934856|468715676|FG002|Extension Part|Progressive disease|0|||
130206351|NCT00934856|468715677|FG003|Extension Part|Progressive disease|1|||
130206352|NCT00934856|468715678|FG004|Extension Part|Progressive disease|0|||
130206353|NCT00934856|468715679|FG005|Extension Part|Progressive disease|0|||
130206354|NCT00934856|468715674|FG000|Extension Part|Non-compliance with drug|0|||
130206355|NCT00934856|468715675|FG001|Extension Part|Non-compliance with drug|0|||
130206356|NCT00934856|468715676|FG002|Extension Part|Non-compliance with drug|0|||
130206357|NCT00934856|468715677|FG003|Extension Part|Non-compliance with drug|0|||
130206358|NCT00934856|468715678|FG004|Extension Part|Non-compliance with drug|0|||
130206359|NCT00934856|468715679|FG005|Extension Part|Non-compliance with drug|1|||
130206360|NCT01256385|468715680|FG000|Overall Study|Physician Decision|1|||
130206361|NCT01256385|468715681|FG001|Overall Study|Physician Decision|1|||
130206362|NCT01256385|468715680|FG000|Overall Study|Withdrawal by Subject|2|||
130206363|NCT01256385|468715681|FG001|Overall Study|Withdrawal by Subject|2|||
130206364|NCT00401960|468715684|FG000|Overall Study|Lost to Follow-up|3|||
130206365|NCT00401960|468715685|FG001|Overall Study|Lost to Follow-up|0|||
130206366|NCT00401960|468715684|FG000|Overall Study|Death|2|||
130206367|NCT00401960|468715685|FG001|Overall Study|Death|0|||
130206368|NCT02649426|468715686|FG000|Overall Study|Follow-up on going|1|||
130206369|NCT02649426|468715687|FG001|Overall Study|Follow-up on going|26|||
130206370|NCT02649426|468715688|FG002|Overall Study|Follow-up on going|28|||
130206371|NCT02649426|468715689|FG003|Overall Study|Follow-up on going|31|||
130206372|NCT01606202|468715690|FG000|Overall Study|Adverse Event|5|||
130206373|NCT01606202|468715691|FG001|Overall Study|Adverse Event|0|||
130206374|NCT01606202|468715690|FG000|Overall Study|Withdrawal by Subject|2|||
130206375|NCT01606202|468715691|FG001|Overall Study|Withdrawal by Subject|1|||
130206376|NCT01606202|468715690|FG000|Overall Study|Personal problems|0|||
130206377|NCT01606202|468715691|FG001|Overall Study|Personal problems|1|||
130206378|NCT01606202|468715690|FG000|Overall Study|Problems with administration|0|||
130206379|NCT01606202|468715691|FG001|Overall Study|Problems with administration|1|||
130206380|NCT02584959|468715692|FG000|Period 1|Withdrawn from study|3|||
130206381|NCT02584959|468715693|FG001|Period 1|Withdrawn from study|4|||
130206382|NCT02584959|468715694|FG002|Period 1|Withdrawn from study|0|||
130206383|NCT02584959|468715692|FG000|Period 2|Withdrawn from study|6|||
130206384|NCT02584959|468715693|FG001|Period 2|Withdrawn from study|1|||
130206385|NCT02584959|468715694|FG002|Period 2|Withdrawn from study|2|||
130206386|NCT00195494|468715699|FG000|Year 1|Adverse Event|0|||
130206387|NCT00195494|468715700|FG001|Year 1|Adverse Event|0|||
130206388|NCT00195494|468715701|FG002|Year 1|Adverse Event|0|||
130206389|NCT00195494|468715702|FG003|Year 1|Adverse Event|0|||
130206390|NCT00195494|468715703|FG004|Year 1|Adverse Event|34|||
130206391|NCT00195494|468715704|FG005|Year 1|Adverse Event|27|||
130206392|NCT00195494|468715699|FG000|Year 1|System Toxicity|0|||
130206393|NCT00195494|468715700|FG001|Year 1|System Toxicity|0|||
130206394|NCT00195494|468715701|FG002|Year 1|System Toxicity|0|||
130206395|NCT00195494|468715702|FG003|Year 1|System Toxicity|0|||
130206396|NCT00195494|468715703|FG004|Year 1|System Toxicity|0|||
130206397|NCT00195494|468715704|FG005|Year 1|System Toxicity|1|||
130206398|NCT00195494|468715699|FG000|Year 1|Lack of Efficacy|0|||
130206399|NCT00195494|468715700|FG001|Year 1|Lack of Efficacy|0|||
130206400|NCT00195494|468715701|FG002|Year 1|Lack of Efficacy|0|||
130206401|NCT00195494|468715702|FG003|Year 1|Lack of Efficacy|0|||
130206402|NCT00195494|468715703|FG004|Year 1|Lack of Efficacy|24|||
130206403|NCT00195494|468715704|FG005|Year 1|Lack of Efficacy|9|||
130206404|NCT00195494|468715699|FG000|Year 1|Compliance|0|||
130206405|NCT00195494|468715700|FG001|Year 1|Compliance|0|||
130206406|NCT00195494|468715701|FG002|Year 1|Compliance|0|||
130206407|NCT00195494|468715702|FG003|Year 1|Compliance|0|||
130206408|NCT00195494|468715703|FG004|Year 1|Compliance|5|||
130206409|NCT00195494|468715704|FG005|Year 1|Compliance|1|||
130206410|NCT00195494|468715699|FG000|Year 1|Lost to Follow-up|0|||
130206411|NCT00195494|468715700|FG001|Year 1|Lost to Follow-up|0|||
130206412|NCT00195494|468715701|FG002|Year 1|Lost to Follow-up|0|||
130206413|NCT00195494|468715702|FG003|Year 1|Lost to Follow-up|0|||
130206414|NCT00195494|468715703|FG004|Year 1|Lost to Follow-up|1|||
130206415|NCT00195494|468715704|FG005|Year 1|Lost to Follow-up|0|||
130206416|NCT00195494|468715699|FG000|Year 1|Missed >4 consecutive doses|0|||
130206417|NCT00195494|468715700|FG001|Year 1|Missed >4 consecutive doses|0|||
130206418|NCT00195494|468715701|FG002|Year 1|Missed >4 consecutive doses|0|||
130206419|NCT00195494|468715702|FG003|Year 1|Missed >4 consecutive doses|0|||
130206420|NCT00195494|468715703|FG004|Year 1|Missed >4 consecutive doses|3|||
130206421|NCT00195494|468715704|FG005|Year 1|Missed >4 consecutive doses|2|||
130206422|NCT00195494|468715699|FG000|Year 1|Protocol deviation|0|||
130206423|NCT00195494|468715700|FG001|Year 1|Protocol deviation|0|||
130206424|NCT00195494|468715701|FG002|Year 1|Protocol deviation|0|||
130206425|NCT00195494|468715702|FG003|Year 1|Protocol deviation|0|||
130206426|NCT00195494|468715703|FG004|Year 1|Protocol deviation|2|||
130206427|NCT00195494|468715704|FG005|Year 1|Protocol deviation|3|||
130206428|NCT00195494|468715699|FG000|Year 1|Physician Decision|0|||
130206429|NCT00195494|468715700|FG001|Year 1|Physician Decision|0|||
130206430|NCT00195494|468715701|FG002|Year 1|Physician Decision|0|||
130206431|NCT00195494|468715702|FG003|Year 1|Physician Decision|0|||
130206432|NCT00195494|468715703|FG004|Year 1|Physician Decision|1|||
130206433|NCT00195494|468715704|FG005|Year 1|Physician Decision|0|||
130206434|NCT00195494|468715699|FG000|Year 1|Withdrawal by Subject|0|||
130206435|NCT00195494|468715700|FG001|Year 1|Withdrawal by Subject|0|||
130206436|NCT00195494|468715701|FG002|Year 1|Withdrawal by Subject|0|||
130206437|NCT00195494|468715702|FG003|Year 1|Withdrawal by Subject|0|||
130206438|NCT00195494|468715703|FG004|Year 1|Withdrawal by Subject|8|||
130206439|NCT00195494|468715704|FG005|Year 1|Withdrawal by Subject|9|||
130206440|NCT00195494|468715699|FG000|Year 1|Protocol Violation|0|||
130206441|NCT00195494|468715700|FG001|Year 1|Protocol Violation|0|||
130206442|NCT00195494|468715701|FG002|Year 1|Protocol Violation|0|||
130206443|NCT00195494|468715702|FG003|Year 1|Protocol Violation|0|||
130206444|NCT00195494|468715703|FG004|Year 1|Protocol Violation|1|||
130206445|NCT00195494|468715704|FG005|Year 1|Protocol Violation|1|||
130206446|NCT00195494|468715699|FG000|Year 2|Adverse Event|3|||
130206447|NCT00195494|468715700|FG001|Year 2|Adverse Event|7|||
130206448|NCT00195494|468715701|FG002|Year 2|Adverse Event|5|||
130206449|NCT00195494|468715702|FG003|Year 2|Adverse Event|9|||
130206450|NCT00195494|468715703|FG004|Year 2|Adverse Event|0|||
130206451|NCT00195494|468715704|FG005|Year 2|Adverse Event|0|||
130206452|NCT00195494|468715699|FG000|Year 2|Lack of Efficacy|0|||
130206453|NCT00195494|468715700|FG001|Year 2|Lack of Efficacy|1|||
130206454|NCT00195494|468715701|FG002|Year 2|Lack of Efficacy|7|||
130206455|NCT00195494|468715702|FG003|Year 2|Lack of Efficacy|7|||
130206456|NCT00195494|468715703|FG004|Year 2|Lack of Efficacy|0|||
130206457|NCT00195494|468715704|FG005|Year 2|Lack of Efficacy|0|||
130206458|NCT00195494|468715699|FG000|Year 2|Compliance|1|||
130206459|NCT00195494|468715700|FG001|Year 2|Compliance|0|||
130206460|NCT00195494|468715701|FG002|Year 2|Compliance|0|||
130206461|NCT00195494|468715702|FG003|Year 2|Compliance|2|||
130206462|NCT00195494|468715703|FG004|Year 2|Compliance|0|||
130206463|NCT00195494|468715704|FG005|Year 2|Compliance|0|||
130206464|NCT00195494|468715699|FG000|Year 2|Lost to Follow-up|0|||
130206465|NCT00195494|468715700|FG001|Year 2|Lost to Follow-up|0|||
130206466|NCT00195494|468715701|FG002|Year 2|Lost to Follow-up|1|||
130206467|NCT00195494|468715702|FG003|Year 2|Lost to Follow-up|1|||
130206468|NCT00195494|468715703|FG004|Year 2|Lost to Follow-up|0|||
130206469|NCT00195494|468715704|FG005|Year 2|Lost to Follow-up|0|||
130206470|NCT00195494|468715699|FG000|Year 2|Missed >4 consecutive doses|1|||
130206471|NCT00195494|468715700|FG001|Year 2|Missed >4 consecutive doses|1|||
130206472|NCT00195494|468715701|FG002|Year 2|Missed >4 consecutive doses|1|||
130206473|NCT00195494|468715702|FG003|Year 2|Missed >4 consecutive doses|0|||
130206474|NCT00195494|468715703|FG004|Year 2|Missed >4 consecutive doses|0|||
130206475|NCT00195494|468715704|FG005|Year 2|Missed >4 consecutive doses|0|||
130206476|NCT00195494|468715699|FG000|Year 2|Protocol deviation|0|||
130206477|NCT00195494|468715700|FG001|Year 2|Protocol deviation|1|||
130206478|NCT00195494|468715701|FG002|Year 2|Protocol deviation|0|||
130206479|NCT00195494|468715702|FG003|Year 2|Protocol deviation|0|||
130206480|NCT00195494|468715703|FG004|Year 2|Protocol deviation|0|||
130206481|NCT00195494|468715704|FG005|Year 2|Protocol deviation|0|||
130206482|NCT00195494|468715699|FG000|Year 2|Physician Decision|1|||
130206483|NCT00195494|468715700|FG001|Year 2|Physician Decision|1|||
130206484|NCT00195494|468715701|FG002|Year 2|Physician Decision|0|||
130206485|NCT00195494|468715702|FG003|Year 2|Physician Decision|0|||
130206486|NCT00195494|468715703|FG004|Year 2|Physician Decision|0|||
130206487|NCT00195494|468715704|FG005|Year 2|Physician Decision|0|||
130206488|NCT00195494|468715699|FG000|Year 2|Withdrawal by Subject|1|||
130206489|NCT00195494|468715700|FG001|Year 2|Withdrawal by Subject|5|||
130206490|NCT00195494|468715701|FG002|Year 2|Withdrawal by Subject|4|||
130206491|NCT00195494|468715702|FG003|Year 2|Withdrawal by Subject|3|||
130206492|NCT00195494|468715703|FG004|Year 2|Withdrawal by Subject|0|||
130206493|NCT00195494|468715704|FG005|Year 2|Withdrawal by Subject|0|||
130206494|NCT00195494|468715699|FG000|Year 2|System toxicity|0|||
130206495|NCT00195494|468715700|FG001|Year 2|System toxicity|0|||
130206496|NCT00195494|468715701|FG002|Year 2|System toxicity|0|||
130206497|NCT00195494|468715702|FG003|Year 2|System toxicity|1|||
130206498|NCT00195494|468715703|FG004|Year 2|System toxicity|0|||
130206499|NCT00195494|468715704|FG005|Year 2|System toxicity|0|||
130206500|NCT02020512|468715705|FG000|Overall Study|Adverse Event|1|||
130206501|NCT02020512|468715705|FG000|Overall Study|Lost to Follow-up|3|||
130206502|NCT02020512|468715705|FG000|Overall Study|Protocol Violation|4|||
130206503|NCT04769739|468715714|FG000|Overall Study|Colorectal cancer obstruction|2|||
130206504|NCT04769739|468715715|FG001|Overall Study|Colorectal cancer obstruction|0|||
130206505|NCT04769739|468715716|FG002|Overall Study|Colorectal cancer obstruction|0|||
130206506|NCT04769739|468715717|FG003|Overall Study|Colorectal cancer obstruction|0|||
130206507|NCT04769739|468715714|FG000|Overall Study|Failed cecal intubation|1|||
130206508|NCT04769739|468715715|FG001|Overall Study|Failed cecal intubation|0|||
130206509|NCT04769739|468715716|FG002|Overall Study|Failed cecal intubation|0|||
130206510|NCT04769739|468715717|FG003|Overall Study|Failed cecal intubation|1|||
130206511|NCT04769739|468715714|FG000|Overall Study|Poor bowel preparation|0|||
130206512|NCT04769739|468715715|FG001|Overall Study|Poor bowel preparation|0|||
130206513|NCT04769739|468715716|FG002|Overall Study|Poor bowel preparation|0|||
130206514|NCT04769739|468715717|FG003|Overall Study|Poor bowel preparation|1|||
130206515|NCT03689543|468715718|FG000|Overall Study|Adverse Event|0|||
130206516|NCT03689543|468715719|FG001|Overall Study|Adverse Event|0|||
130206517|NCT03689543|468715720|FG002|Overall Study|Adverse Event|1|||
130206518|NCT00932451|468715721|FG000|Overall Study|Withdrawal by Subject|69|||
130206519|NCT00932451|468715721|FG000|Overall Study|Lost to Follow-up|22|||
130206520|NCT00932451|468715721|FG000|Overall Study|Death|726|||
130206521|NCT00932451|468715721|FG000|Overall Study|Other reasons|5|||
130206522|NCT02968433|468715739|FG000|Overall Study|Withdrawal by Subject|1|||
130206523|NCT00637806|468715740|FG000|Double-blind Phase|Study Discontinued|2|||
130206524|NCT00637806|468715741|FG001|Double-blind Phase|Study Discontinued|0|||
130206525|NCT00637806|468715742|FG002|Double-blind Phase|Study Discontinued|1|||
130206526|NCT00637806|468715743|FG003|Double-blind Phase|Study Discontinued|0|||
130206527|NCT00637806|468715740|FG000|Extension Phase|Study Discontinued|0|||
130206528|NCT00637806|468715741|FG001|Extension Phase|Study Discontinued|0|||
130206529|NCT00637806|468715742|FG002|Extension Phase|Study Discontinued|0|||
130206530|NCT00637806|468715743|FG003|Extension Phase|Study Discontinued|1|||
130206531|NCT00622336|468715744|FG000|Treatment Phase|Progression of Disease|181|||
130206532|NCT00622336|468715744|FG000|Treatment Phase|Adverse Event|46|||
130206533|NCT00622336|468715744|FG000|Treatment Phase|Other|40|||
130206534|NCT00622336|468715744|FG000|Treatment Phase|Death|14|||
130206535|NCT00622336|468715744|FG000|Treatment Phase|Lack of therapeutic effect|13|||
130206536|NCT00622336|468715744|FG000|Treatment Phase|Withdrawal by Subject|13|||
130206537|NCT00622336|468715744|FG000|Treatment Phase|Lost to Follow-up|2|||
130206538|NCT00622336|468715744|FG000|Extension Phase|Adverse Event|2|||
130206539|NCT00622336|468715744|FG000|Extension Phase|Progressive Disease|6|||
130206540|NCT00622336|468715744|FG000|Extension Phase|Lack of therapeutic effect|2|||
130206541|NCT00622336|468715744|FG000|Extension Phase|Withdrawal by Subject|1|||
130206542|NCT00622336|468715744|FG000|Extension Phase|Lost to Follow-up|1|||
130206543|NCT00622336|468715744|FG000|Extension Phase|Other|9|||
130206544|NCT04506905|468715747|FG000|Overall Study|Lost to Follow-up|1|||
130206545|NCT04506905|468715748|FG001|Overall Study|Lost to Follow-up|0|||
130206546|NCT04506905|468715749|FG002|Overall Study|Lost to Follow-up|0|||
130206547|NCT04506905|468715750|FG003|Overall Study|Lost to Follow-up|1|||
130206548|NCT04506905|468715751|FG004|Overall Study|Lost to Follow-up|0|||
130206549|NCT04506905|468715752|FG005|Overall Study|Lost to Follow-up|0|||
130206550|NCT04506905|468715753|FG006|Overall Study|Lost to Follow-up|0|||
130206551|NCT04506905|468715754|FG007|Overall Study|Lost to Follow-up|0|||
130206552|NCT04506905|468715755|FG008|Overall Study|Lost to Follow-up|0|||
130206553|NCT04506905|468715747|FG000|Overall Study|Withdrawal by Subject|0|||
130206554|NCT04506905|468715748|FG001|Overall Study|Withdrawal by Subject|0|||
130206555|NCT04506905|468715749|FG002|Overall Study|Withdrawal by Subject|0|||
130206556|NCT04506905|468715750|FG003|Overall Study|Withdrawal by Subject|2|||
130206557|NCT04506905|468715751|FG004|Overall Study|Withdrawal by Subject|0|||
130206558|NCT04506905|468715752|FG005|Overall Study|Withdrawal by Subject|0|||
130206559|NCT04506905|468715753|FG006|Overall Study|Withdrawal by Subject|0|||
130206560|NCT04506905|468715754|FG007|Overall Study|Withdrawal by Subject|0|||
130206561|NCT04506905|468715755|FG008|Overall Study|Withdrawal by Subject|0|||
130206562|NCT02502266|468716787|FG000|Overall Study|Adverse Event|0|||
130206563|NCT02502266|468716788|FG001|Overall Study|Adverse Event|0|||
130206564|NCT02502266|468716789|FG002|Overall Study|Adverse Event|0|||
130206565|NCT02502266|468716790|FG003|Overall Study|Adverse Event|0|||
130206566|NCT02502266|468716791|FG004|Overall Study|Adverse Event|1|||
130206567|NCT02502266|468716792|FG005|Overall Study|Adverse Event|1|||
130206568|NCT02502266|468716793|FG006|Overall Study|Adverse Event|1|||
130206569|NCT02502266|468716787|FG000|Overall Study|Withdrawal by Subject|30|||
130206570|NCT02502266|468716788|FG001|Overall Study|Withdrawal by Subject|15|||
130206571|NCT02502266|468716789|FG002|Overall Study|Withdrawal by Subject|16|||
130206572|NCT02502266|468716790|FG003|Overall Study|Withdrawal by Subject|0|||
130206573|NCT02502266|468716791|FG004|Overall Study|Withdrawal by Subject|0|||
130206574|NCT02502266|468716792|FG005|Overall Study|Withdrawal by Subject|0|||
130206575|NCT02502266|468716793|FG006|Overall Study|Withdrawal by Subject|0|||
130206576|NCT02502266|468716787|FG000|Overall Study|Still on Treatment|0|||
130206577|NCT02502266|468716788|FG001|Overall Study|Still on Treatment|0|||
130206578|NCT02502266|468716789|FG002|Overall Study|Still on Treatment|1|||
130206579|NCT02502266|468716790|FG003|Overall Study|Still on Treatment|0|||
130206580|NCT02502266|468716791|FG004|Overall Study|Still on Treatment|0|||
130206581|NCT02502266|468716792|FG005|Overall Study|Still on Treatment|0|||
130206582|NCT02502266|468716793|FG006|Overall Study|Still on Treatment|0|||
130206583|NCT02502266|468716787|FG000|Overall Study|Other Reasons|19|||
130206584|NCT02502266|468716788|FG001|Overall Study|Other Reasons|6|||
130206585|NCT02502266|468716789|FG002|Overall Study|Other Reasons|14|||
130206586|NCT02502266|468716790|FG003|Overall Study|Other Reasons|0|||
130206587|NCT02502266|468716791|FG004|Overall Study|Other Reasons|1|||
130206588|NCT02502266|468716792|FG005|Overall Study|Other Reasons|1|||
130206589|NCT02502266|468716793|FG006|Overall Study|Other Reasons|0|||
130206590|NCT02502266|468716787|FG000|Overall Study|Arm 4 Discontinued|0|||
130206591|NCT02502266|468716788|FG001|Overall Study|Arm 4 Discontinued|0|||
130206592|NCT02502266|468716789|FG002|Overall Study|Arm 4 Discontinued|0|||
130206593|NCT02502266|468716790|FG003|Overall Study|Arm 4 Discontinued|52|||
130206594|NCT02502266|468716791|FG004|Overall Study|Arm 4 Discontinued|0|||
130206595|NCT02502266|468716792|FG005|Overall Study|Arm 4 Discontinued|0|||
130206596|NCT02502266|468716793|FG006|Overall Study|Arm 4 Discontinued|0|||
130206597|NCT02502266|468716787|FG000|Overall Study|Never treated|0|||
130206598|NCT02502266|468716788|FG001|Overall Study|Never treated|0|||
130206599|NCT02502266|468716789|FG002|Overall Study|Never treated|0|||
130206600|NCT02502266|468716790|FG003|Overall Study|Never treated|0|||
130206601|NCT02502266|468716791|FG004|Overall Study|Never treated|0|||
130206602|NCT02502266|468716792|FG005|Overall Study|Never treated|1|||
130206603|NCT02502266|468716793|FG006|Overall Study|Never treated|0|||
130206604|NCT03605849|468716795|FG000|Overall Study|Adverse Event|20|||
130206605|NCT03605849|468716796|FG001|Overall Study|Adverse Event|21|||
130206606|NCT03605849|468716797|FG002|Overall Study|Adverse Event|29|||
130206607|NCT03605849|468716798|FG003|Overall Study|Adverse Event|11|||
130206608|NCT03605849|468716795|FG000|Overall Study|Lack of Efficacy|4|||
130206609|NCT03605849|468716796|FG001|Overall Study|Lack of Efficacy|7|||
130206610|NCT03605849|468716797|FG002|Overall Study|Lack of Efficacy|9|||
130206611|NCT03605849|468716798|FG003|Overall Study|Lack of Efficacy|2|||
130206612|NCT03605849|468716795|FG000|Overall Study|Lost to Follow-up|8|||
130206613|NCT03605849|468716796|FG001|Overall Study|Lost to Follow-up|8|||
130206614|NCT03605849|468716797|FG002|Overall Study|Lost to Follow-up|14|||
130206615|NCT03605849|468716798|FG003|Overall Study|Lost to Follow-up|11|||
130206616|NCT03605849|468716795|FG000|Overall Study|Non-compliance With IMP|6|||
130206617|NCT03605849|468716796|FG001|Overall Study|Non-compliance With IMP|5|||
130206618|NCT03605849|468716797|FG002|Overall Study|Non-compliance With IMP|2|||
130206619|NCT03605849|468716798|FG003|Overall Study|Non-compliance With IMP|1|||
130206620|NCT03605849|468716795|FG000|Overall Study|Protocol Deviation|1|||
130206621|NCT03605849|468716796|FG001|Overall Study|Protocol Deviation|2|||
130206622|NCT03605849|468716797|FG002|Overall Study|Protocol Deviation|1|||
130206623|NCT03605849|468716798|FG003|Overall Study|Protocol Deviation|3|||
130206624|NCT03605849|468716795|FG000|Overall Study|Withdrawal by Subject|33|||
130206625|NCT03605849|468716796|FG001|Overall Study|Withdrawal by Subject|28|||
130206626|NCT03605849|468716797|FG002|Overall Study|Withdrawal by Subject|30|||
130206627|NCT03605849|468716798|FG003|Overall Study|Withdrawal by Subject|28|||
130206628|NCT03605849|468716795|FG000|Overall Study|Site Terminated by Sponsor|0|||
130206629|NCT03605849|468716796|FG001|Overall Study|Site Terminated by Sponsor|0|||
130206630|NCT03605849|468716797|FG002|Overall Study|Site Terminated by Sponsor|0|||
130206631|NCT03605849|468716798|FG003|Overall Study|Site Terminated by Sponsor|1|||
130206632|NCT03605849|468716795|FG000|Overall Study|Physician Decision|2|||
130206633|NCT03605849|468716796|FG001|Overall Study|Physician Decision|1|||
130206634|NCT03605849|468716797|FG002|Overall Study|Physician Decision|2|||
130206635|NCT03605849|468716798|FG003|Overall Study|Physician Decision|1|||
130206636|NCT03605849|468716795|FG000|Overall Study|Enrolled, but not Treated|2|||
130206637|NCT03605849|468716796|FG001|Overall Study|Enrolled, but not Treated|2|||
130206638|NCT03605849|468716797|FG002|Overall Study|Enrolled, but not Treated|3|||
130206639|NCT03605849|468716798|FG003|Overall Study|Enrolled, but not Treated|2|||
130206640|NCT03605849|468716795|FG000|Overall Study|Other (COVID-19 Related)|0|||
130206641|NCT03605849|468716796|FG001|Overall Study|Other (COVID-19 Related)|1|||
130206642|NCT03605849|468716797|FG002|Overall Study|Other (COVID-19 Related)|1|||
130206643|NCT03605849|468716798|FG003|Overall Study|Other (COVID-19 Related)|0|||
130206644|NCT03605849|468716795|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
130206645|NCT03605849|468716796|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
130206646|NCT03605849|468716797|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
130206647|NCT03605849|468716798|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
130206648|NCT00577005|468716799|FG000|Overall Study|Lost to Follow-up|3|||
130206649|NCT00577005|468716800|FG001|Overall Study|Lost to Follow-up|2|||
130206650|NCT00577005|468716799|FG000|Overall Study|Withdrawal by Subject|2|||
130206651|NCT00577005|468716800|FG001|Overall Study|Withdrawal by Subject|1|||
130206652|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
130206653|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206654|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206655|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206656|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206657|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
130206658|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206659|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206660|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206661|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206662|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
130206663|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206664|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206665|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206666|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206667|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
130206668|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206669|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206670|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206671|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206672|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
130206673|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206674|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206675|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206676|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206677|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130206678|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
130206679|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
130206680|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
130206681|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130206682|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130206683|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130206684|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130206685|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
130206686|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130206687|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130206688|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
130206689|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
130206690|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
130206691|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130206692|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206693|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206694|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206695|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
130206696|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206697|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130206698|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
130206699|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
130206700|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
130206701|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130206702|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130206703|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130206704|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
130206705|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130206706|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130206707|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206708|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206709|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206710|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206711|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
130206712|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206713|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206714|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206715|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206716|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
130206717|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206718|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206719|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206720|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206721|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
130206722|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206723|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206724|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206725|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206726|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
130206727|NCT02667626|468716806|FG000|Overall Study|Withdrawal by Subject|0|||
130206728|NCT02667626|468716807|FG001|Overall Study|Withdrawal by Subject|1|||
130206729|NCT00590538|468716808|FG000|Overall Study|Study terminated before completed|2|||
130206730|NCT02539134|468716809|FG000|Overall Study|Lost to Follow-up|1|||
130206731|NCT02539134|468716810|FG001|Overall Study|Lost to Follow-up|0|||
130206732|NCT02539134|468716811|FG002|Overall Study|Lost to Follow-up|0|||
130206733|NCT02539134|468716812|FG003|Overall Study|Lost to Follow-up|0|||
130206734|NCT02539134|468716813|FG004|Overall Study|Lost to Follow-up|0|||
130206735|NCT02539134|468716814|FG005|Overall Study|Lost to Follow-up|0|||
130206736|NCT00985426|468716815|FG000|Overall Study|Adverse Event|0|||
130206737|NCT00985426|468716816|FG001|Overall Study|Adverse Event|1|||
130206738|NCT00985426|468716815|FG000|Overall Study|Subject Non-Compliance|3|||
130206739|NCT00985426|468716816|FG001|Overall Study|Subject Non-Compliance|3|||
130206740|NCT00985426|468716815|FG000|Overall Study|Withdrawal by Subject|12|||
130206741|NCT00985426|468716816|FG001|Overall Study|Withdrawal by Subject|16|||
130206742|NCT00985426|468716815|FG000|Overall Study|Lost to Follow-up|8|||
130206743|NCT00985426|468716816|FG001|Overall Study|Lost to Follow-up|10|||
130206744|NCT00985426|468716815|FG000|Overall Study|Death|7|||
130206745|NCT00985426|468716816|FG001|Overall Study|Death|3|||
130206746|NCT00985426|468716815|FG000|Overall Study|Protocol Violation|2|||
130206747|NCT00985426|468716816|FG001|Overall Study|Protocol Violation|0|||
130206748|NCT00985426|468716815|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130206749|NCT00985426|468716816|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130206750|NCT02971800|468716817|FG000|Overall Study|Protocol Violation|1|||
130206751|NCT02971800|468716817|FG000|Overall Study|Withdrawal by Subject|1|||
130206752|NCT02971800|468716817|FG000|Overall Study|Exclusion criteria prior intervention|1|||
130206753|NCT02971800|468716817|FG000|Overall Study|Number evaluable participant already reached|4|||
130206754|NCT01149421|468716818|FG000|Overall Study|Adverse Event|22|||
130206755|NCT01149421|468716819|FG001|Overall Study|Adverse Event|6|||
130206756|NCT01149421|468716820|FG002|Overall Study|Adverse Event|11|||
130206757|NCT01149421|468716818|FG000|Overall Study|Withdrawal by Subject|20|||
130206758|NCT01149421|468716819|FG001|Overall Study|Withdrawal by Subject|12|||
130206759|NCT01149421|468716820|FG002|Overall Study|Withdrawal by Subject|13|||
130206760|NCT01149421|468716818|FG000|Overall Study|Sponsor Decision|0|||
130206761|NCT01149421|468716819|FG001|Overall Study|Sponsor Decision|1|||
130206762|NCT01149421|468716820|FG002|Overall Study|Sponsor Decision|1|||
130206763|NCT01149421|468716818|FG000|Overall Study|Lost to Follow-up|2|||
130206764|NCT01149421|468716819|FG001|Overall Study|Lost to Follow-up|4|||
130206765|NCT01149421|468716820|FG002|Overall Study|Lost to Follow-up|5|||
130206766|NCT01149421|468716818|FG000|Overall Study|Physician Decision|5|||
130206767|NCT01149421|468716819|FG001|Overall Study|Physician Decision|3|||
130206768|NCT01149421|468716820|FG002|Overall Study|Physician Decision|6|||
130206769|NCT01149421|468716818|FG000|Overall Study|Entry Criteria Not Met|1|||
130206770|NCT01149421|468716819|FG001|Overall Study|Entry Criteria Not Met|1|||
130206771|NCT01149421|468716820|FG002|Overall Study|Entry Criteria Not Met|2|||
130206772|NCT01149421|468716818|FG000|Overall Study|Protocol Violation|2|||
130206773|NCT01149421|468716819|FG001|Overall Study|Protocol Violation|2|||
130206774|NCT01149421|468716820|FG002|Overall Study|Protocol Violation|6|||
130206775|NCT03738800|468716825|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130206776|NCT03738800|468716826|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130206777|NCT03738800|468716827|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130206778|NCT03738800|468716825|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
130206779|NCT03738800|468716826|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130206780|NCT03738800|468716827|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130206781|NCT03738800|468716825|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130206782|NCT03738800|468716826|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130206783|NCT03738800|468716827|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130206784|NCT00766467|468716828|FG000|Overall Study|Withdrawal by Subject|7|||
130206785|NCT00766467|468716829|FG001|Overall Study|Withdrawal by Subject|2|||
130206786|NCT00766467|468716828|FG000|Overall Study|Adverse Event|1|||
130206787|NCT00766467|468716829|FG001|Overall Study|Adverse Event|1|||
130206788|NCT00766467|468716828|FG000|Overall Study|Protocol Violation|2|||
130206789|NCT00766467|468716829|FG001|Overall Study|Protocol Violation|4|||
130206790|NCT00766467|468716828|FG000|Overall Study|Tumor Progression on Study|0|||
130206791|NCT00766467|468716829|FG001|Overall Study|Tumor Progression on Study|1|||
130206792|NCT00766467|468716828|FG000|Overall Study|Physician Decision|1|||
130206793|NCT00766467|468716829|FG001|Overall Study|Physician Decision|0|||
130206794|NCT01404208|468716835|FG000|Overall Study|Discontinued|3|||
130206795|NCT01404208|468716836|FG001|Overall Study|Discontinued|0|||
130206796|NCT01522235|468716838|FG000|Overall Study|Physician Decision|1|||
130206797|NCT01522235|468716839|FG001|Overall Study|Physician Decision|1|||
130206798|NCT01870297|468716842|FG000|Overall Study|Adverse Event|0|||
130206799|NCT01870297|468716843|FG001|Overall Study|Adverse Event|0|||
130206800|NCT01870297|468716844|FG002|Overall Study|Adverse Event|0|||
130206801|NCT01870297|468716845|FG003|Overall Study|Adverse Event|0|||
130206802|NCT01870297|468716846|FG004|Overall Study|Adverse Event|2|||
130206803|NCT01870297|468716847|FG005|Overall Study|Adverse Event|0|||
130206804|NCT01870297|468716848|FG006|Overall Study|Adverse Event|0|||
130206805|NCT01870297|468716842|FG000|Overall Study|Lost to Follow-up|0|||
130206806|NCT01870297|468716843|FG001|Overall Study|Lost to Follow-up|1|||
130206807|NCT01870297|468716844|FG002|Overall Study|Lost to Follow-up|1|||
130206808|NCT01870297|468716845|FG003|Overall Study|Lost to Follow-up|0|||
130206809|NCT01870297|468716846|FG004|Overall Study|Lost to Follow-up|0|||
130206810|NCT01870297|468716847|FG005|Overall Study|Lost to Follow-up|0|||
130206811|NCT01870297|468716848|FG006|Overall Study|Lost to Follow-up|0|||
130206812|NCT01870297|468716842|FG000|Overall Study|Withdrawal by Subject|0|||
130206813|NCT01870297|468716843|FG001|Overall Study|Withdrawal by Subject|0|||
130206814|NCT01870297|468716844|FG002|Overall Study|Withdrawal by Subject|0|||
130206815|NCT01870297|468716845|FG003|Overall Study|Withdrawal by Subject|0|||
130206816|NCT01870297|468716846|FG004|Overall Study|Withdrawal by Subject|1|||
130206817|NCT01870297|468716847|FG005|Overall Study|Withdrawal by Subject|1|||
130206818|NCT01870297|468716848|FG006|Overall Study|Withdrawal by Subject|1|||
130206819|NCT01870297|468716842|FG000|Overall Study|Sponsor Decision|0|||
130206820|NCT01870297|468716843|FG001|Overall Study|Sponsor Decision|6|||
130206821|NCT01870297|468716844|FG002|Overall Study|Sponsor Decision|0|||
130206822|NCT01870297|468716845|FG003|Overall Study|Sponsor Decision|0|||
130206823|NCT01870297|468716846|FG004|Overall Study|Sponsor Decision|0|||
130206824|NCT01870297|468716847|FG005|Overall Study|Sponsor Decision|0|||
130206825|NCT01870297|468716848|FG006|Overall Study|Sponsor Decision|1|||
130206826|NCT00337779|468716849|FG000|Overall Study|Withdrawal by Subject|10|||
130206827|NCT00337779|468716850|FG001|Overall Study|Withdrawal by Subject|12|||
130206828|NCT00337779|468716849|FG000|Overall Study|Sponsor decision|1|||
130206829|NCT00337779|468716850|FG001|Overall Study|Sponsor decision|1|||
130206830|NCT00337779|468716849|FG000|Overall Study|Physician Decision|3|||
130206831|NCT00337779|468716850|FG001|Overall Study|Physician Decision|6|||
130206832|NCT00337779|468716849|FG000|Overall Study|Protocol Violation|1|||
130206833|NCT00337779|468716850|FG001|Overall Study|Protocol Violation|1|||
130206834|NCT00337779|468716849|FG000|Overall Study|Lost to Follow-up|6|||
130206835|NCT00337779|468716850|FG001|Overall Study|Lost to Follow-up|5|||
130206836|NCT00337779|468716849|FG000|Overall Study|Adverse Event|28|||
130206837|NCT00337779|468716850|FG001|Overall Study|Adverse Event|51|||
130206838|NCT00337779|468716849|FG000|Overall Study|Pregnancy|3|||
130206839|NCT00337779|468716850|FG001|Overall Study|Pregnancy|2|||
130206840|NCT00337779|468716849|FG000|Overall Study|Death|0|||
130206841|NCT00337779|468716850|FG001|Overall Study|Death|1|||
130206842|NCT03008278|468716851|FG000|Overall Study|Progressive Disease|0|||
130206843|NCT03008278|468716852|FG001|Overall Study|Progressive Disease|0|||
130206844|NCT03008278|468716853|FG002|Overall Study|Progressive Disease|32|||
130206845|NCT03008278|468716851|FG000|Overall Study|Adverse Event|0|||
130206846|NCT03008278|468716852|FG001|Overall Study|Adverse Event|0|||
130206847|NCT03008278|468716853|FG002|Overall Study|Adverse Event|4|||
130206848|NCT03008278|468716851|FG000|Overall Study|Withdrawal by Subject|0|||
130206849|NCT03008278|468716852|FG001|Overall Study|Withdrawal by Subject|0|||
130206850|NCT03008278|468716853|FG002|Overall Study|Withdrawal by Subject|3|||
130206851|NCT03008278|468716851|FG000|Overall Study|Physician Decision|0|||
130206852|NCT03008278|468716852|FG001|Overall Study|Physician Decision|2|||
130206853|NCT03008278|468716853|FG002|Overall Study|Physician Decision|0|||
130206854|NCT00513357|468716854|FG000|Overall Study|did not receive allocated placebo|2|||
130206855|NCT00513357|468716855|FG001|Overall Study|did not receive allocated placebo|3|||
130206856|NCT00513357|468716854|FG000|Overall Study|Adverse Event|4|||
130206857|NCT00513357|468716855|FG001|Overall Study|Adverse Event|2|||
130206858|NCT00513357|468716854|FG000|Overall Study|Death|2|||
130206859|NCT00513357|468716855|FG001|Overall Study|Death|0|||
130206860|NCT00513357|468716854|FG000|Overall Study|Withdrawal by Subject|5|||
130206861|NCT00513357|468716855|FG001|Overall Study|Withdrawal by Subject|4|||
130206862|NCT00513357|468716854|FG000|Overall Study|Disease Progression|2|||
130206863|NCT00513357|468716855|FG001|Overall Study|Disease Progression|1|||
130206864|NCT01162122|468716856|FG000|Overall Study|Withdrawal by Subject|52|||
130206865|NCT01162122|468716857|FG001|Overall Study|Withdrawal by Subject|43|||
130206866|NCT01162122|468716856|FG000|Overall Study|Lost to Follow-up|73|||
130206867|NCT01162122|468716857|FG001|Overall Study|Lost to Follow-up|91|||
130206868|NCT01162122|468716856|FG000|Overall Study|Adverse Event|3|||
130206869|NCT01162122|468716857|FG001|Overall Study|Adverse Event|2|||
130206870|NCT01162122|468716856|FG000|Overall Study|Death|51|||
130206871|NCT01162122|468716857|FG001|Overall Study|Death|46|||
130206872|NCT01162122|468716856|FG000|Overall Study|Protocol Violation|2|||
130206873|NCT01162122|468716857|FG001|Overall Study|Protocol Violation|2|||
130206874|NCT01162122|468716856|FG000|Overall Study|Inappropriate enrollment|5|||
130206875|NCT01162122|468716857|FG001|Overall Study|Inappropriate enrollment|4|||
130206876|NCT01162122|468716856|FG000|Overall Study|Administrative reason|1|||
130206877|NCT01162122|468716857|FG001|Overall Study|Administrative reason|1|||
130206878|NCT01162122|468716856|FG000|Overall Study|Unable to classify|3|||
130206879|NCT01162122|468716857|FG001|Overall Study|Unable to classify|7|||
130206880|NCT01162122|468716856|FG000|Overall Study|Missing primary reason|1|||
130206881|NCT01162122|468716857|FG001|Overall Study|Missing primary reason|0|||
130206882|NCT00422422|468716861|FG000|Overall Study|Lack of Efficacy|1|||
130206883|NCT00422422|468716861|FG000|Overall Study|Protocol Violation|1|||
130206884|NCT00422422|468716861|FG000|Overall Study|Withdrawal by Subject|2|||
130206885|NCT00422422|468716861|FG000|Overall Study|SAE, non-fatal|1|||
130206886|NCT00422422|468716861|FG000|Overall Study|AE, non-serious non-fatal|5|||
130206887|NCT03313310|468716862|FG000|Phase 2|Lost to Follow-up|4|||
130206888|NCT03313310|468716863|FG001|Phase 2|Lost to Follow-up|0|||
130206889|NCT03313310|468716862|FG000|Phase 3|Lost to Follow-up|0|||
130206890|NCT03313310|468716863|FG001|Phase 3|Lost to Follow-up|1|||
130206891|NCT01217385|468716864|FG000|Overall Study|Withdrawal by Subject|3|||
130206892|NCT01217385|468716864|FG000|Overall Study|DOSI not performed/not eval|12|||
130206893|NCT01217385|468716864|FG000|Overall Study|Central Path not Available|1|||
130206894|NCT01217385|468716864|FG000|Overall Study|Normal Breast TOI not available|10|||
130206895|NCT00090987|468716865|FG000|Overall Study|Adverse Event|5|||
130206896|NCT00090987|468716865|FG000|Overall Study|Lack of Efficacy|7|||
130206897|NCT00090987|468716865|FG000|Overall Study|Withdrawal by Subject|3|||
130206898|NCT00090987|468716865|FG000|Overall Study|alternative therapy|1|||
130206899|NCT00090987|468716865|FG000|Overall Study|Non-compliance|4|||
130206900|NCT00090987|468716865|FG000|Overall Study|Incarcerated|1|||
130206901|NCT02079636|468716867|FG000|Overall Study|Death|2|||
130206902|NCT02079636|468716868|FG001|Overall Study|Death|1|||
130206903|NCT02079636|468716869|FG002|Overall Study|Death|0|||
130206904|NCT02079636|468716870|FG003|Overall Study|Death|5|||
130206905|NCT02079636|468716871|FG004|Overall Study|Death|1|||
130206906|NCT02079636|468716872|FG005|Overall Study|Death|2|||
130206907|NCT02079636|468716873|FG006|Overall Study|Death|1|||
130206908|NCT02079636|468716874|FG007|Overall Study|Death|0|||
130206909|NCT02079636|468716875|FG008|Overall Study|Death|0|||
130206910|NCT02079636|468716876|FG009|Overall Study|Death|0|||
130206911|NCT02079636|468716877|FG010|Overall Study|Death|0|||
130206912|NCT02079636|468716878|FG011|Overall Study|Death|1|||
130206913|NCT02079636|468716879|FG012|Overall Study|Death|1|||
130206914|NCT02079636|468716880|FG013|Overall Study|Death|0|||
130206915|NCT02079636|468716881|FG014|Overall Study|Death|2|||
130206916|NCT02079636|468716867|FG000|Overall Study|Adverse Event|1|||
130206917|NCT02079636|468716868|FG001|Overall Study|Adverse Event|1|||
130206918|NCT02079636|468716869|FG002|Overall Study|Adverse Event|0|||
130206919|NCT02079636|468716870|FG003|Overall Study|Adverse Event|1|||
130206920|NCT02079636|468716871|FG004|Overall Study|Adverse Event|1|||
130206921|NCT02079636|468716872|FG005|Overall Study|Adverse Event|2|||
130206922|NCT02079636|468716873|FG006|Overall Study|Adverse Event|0|||
130206923|NCT02079636|468716874|FG007|Overall Study|Adverse Event|0|||
130206924|NCT02079636|468716875|FG008|Overall Study|Adverse Event|0|||
130206925|NCT02079636|468716876|FG009|Overall Study|Adverse Event|0|||
130206926|NCT02079636|468716877|FG010|Overall Study|Adverse Event|0|||
130206927|NCT02079636|468716878|FG011|Overall Study|Adverse Event|0|||
130206928|NCT02079636|468716879|FG012|Overall Study|Adverse Event|0|||
130206929|NCT02079636|468716880|FG013|Overall Study|Adverse Event|0|||
130206930|NCT02079636|468716881|FG014|Overall Study|Adverse Event|0|||
130206931|NCT02079636|468716867|FG000|Overall Study|Progressive disease|0|||
130206932|NCT02079636|468716868|FG001|Overall Study|Progressive disease|0|||
130206933|NCT02079636|468716869|FG002|Overall Study|Progressive disease|0|||
130206934|NCT02079636|468716870|FG003|Overall Study|Progressive disease|2|||
130206935|NCT02079636|468716871|FG004|Overall Study|Progressive disease|0|||
130206936|NCT02079636|468716872|FG005|Overall Study|Progressive disease|0|||
130206937|NCT02079636|468716873|FG006|Overall Study|Progressive disease|0|||
130206938|NCT02079636|468716874|FG007|Overall Study|Progressive disease|0|||
130206939|NCT02079636|468716875|FG008|Overall Study|Progressive disease|0|||
130206940|NCT02079636|468716876|FG009|Overall Study|Progressive disease|0|||
130206941|NCT02079636|468716877|FG010|Overall Study|Progressive disease|0|||
130206942|NCT02079636|468716878|FG011|Overall Study|Progressive disease|0|||
130206943|NCT02079636|468716879|FG012|Overall Study|Progressive disease|1|||
130206944|NCT02079636|468716880|FG013|Overall Study|Progressive disease|0|||
130206945|NCT02079636|468716881|FG014|Overall Study|Progressive disease|0|||
130206946|NCT02079636|468716867|FG000|Overall Study|Withdrawal by Subject|0|||
130206947|NCT02079636|468716868|FG001|Overall Study|Withdrawal by Subject|0|||
130206948|NCT02079636|468716869|FG002|Overall Study|Withdrawal by Subject|0|||
130206949|NCT02079636|468716870|FG003|Overall Study|Withdrawal by Subject|4|||
130206950|NCT02079636|468716871|FG004|Overall Study|Withdrawal by Subject|0|||
130206951|NCT02079636|468716872|FG005|Overall Study|Withdrawal by Subject|1|||
130206952|NCT02079636|468716873|FG006|Overall Study|Withdrawal by Subject|0|||
130206953|NCT02079636|468716874|FG007|Overall Study|Withdrawal by Subject|0|||
130206954|NCT02079636|468716875|FG008|Overall Study|Withdrawal by Subject|0|||
130206955|NCT02079636|468716876|FG009|Overall Study|Withdrawal by Subject|2|||
130206956|NCT02079636|468716877|FG010|Overall Study|Withdrawal by Subject|1|||
130206957|NCT02079636|468716878|FG011|Overall Study|Withdrawal by Subject|1|||
130206958|NCT02079636|468716879|FG012|Overall Study|Withdrawal by Subject|1|||
130206959|NCT02079636|468716880|FG013|Overall Study|Withdrawal by Subject|0|||
130206960|NCT02079636|468716881|FG014|Overall Study|Withdrawal by Subject|2|||
130206961|NCT02079636|468716867|FG000|Overall Study|Physician Decision|0|||
130206962|NCT02079636|468716868|FG001|Overall Study|Physician Decision|0|||
130206963|NCT02079636|468716869|FG002|Overall Study|Physician Decision|0|||
130206964|NCT02079636|468716870|FG003|Overall Study|Physician Decision|0|||
130206965|NCT02079636|468716871|FG004|Overall Study|Physician Decision|0|||
130206966|NCT02079636|468716872|FG005|Overall Study|Physician Decision|1|||
130206967|NCT02079636|468716873|FG006|Overall Study|Physician Decision|0|||
130206968|NCT02079636|468716874|FG007|Overall Study|Physician Decision|0|||
130206969|NCT02079636|468716875|FG008|Overall Study|Physician Decision|0|||
130206970|NCT02079636|468716876|FG009|Overall Study|Physician Decision|1|||
130206971|NCT02079636|468716877|FG010|Overall Study|Physician Decision|1|||
130206972|NCT02079636|468716878|FG011|Overall Study|Physician Decision|0|||
130206973|NCT02079636|468716879|FG012|Overall Study|Physician Decision|0|||
130206974|NCT02079636|468716880|FG013|Overall Study|Physician Decision|0|||
130206975|NCT02079636|468716881|FG014|Overall Study|Physician Decision|1|||
130206976|NCT02079636|468716867|FG000|Overall Study|Lost to Follow-up|0|||
130206977|NCT02079636|468716868|FG001|Overall Study|Lost to Follow-up|0|||
130206978|NCT02079636|468716869|FG002|Overall Study|Lost to Follow-up|0|||
130206979|NCT02079636|468716870|FG003|Overall Study|Lost to Follow-up|0|||
130206980|NCT02079636|468716871|FG004|Overall Study|Lost to Follow-up|0|||
130206981|NCT02079636|468716872|FG005|Overall Study|Lost to Follow-up|0|||
130206982|NCT02079636|468716873|FG006|Overall Study|Lost to Follow-up|0|||
130206983|NCT02079636|468716874|FG007|Overall Study|Lost to Follow-up|1|||
130206984|NCT02079636|468716875|FG008|Overall Study|Lost to Follow-up|0|||
130206985|NCT02079636|468716876|FG009|Overall Study|Lost to Follow-up|0|||
130206986|NCT02079636|468716877|FG010|Overall Study|Lost to Follow-up|0|||
130206987|NCT02079636|468716878|FG011|Overall Study|Lost to Follow-up|0|||
130206988|NCT02079636|468716879|FG012|Overall Study|Lost to Follow-up|0|||
130206989|NCT02079636|468716880|FG013|Overall Study|Lost to Follow-up|0|||
130206990|NCT02079636|468716881|FG014|Overall Study|Lost to Follow-up|0|||
130206991|NCT00725101|468716882|FG000|Overall Study|Death|3|||
130206992|NCT00725101|468716882|FG000|Overall Study|Lost to Follow-up|353|||
130206993|NCT00725101|468716882|FG000|Overall Study|Protocol Violation|1|||
130206994|NCT00725101|468716882|FG000|Overall Study|Withdrawal by Subject|127|||
130206995|NCT00725101|468716882|FG000|Overall Study|not specified/no reason given|11|||
130206996|NCT01592292|468716883|FG000|Overall Study|Follow-up loss|3|||
130206997|NCT01592292|468716884|FG001|Overall Study|Follow-up loss|3|||
130206998|NCT01592292|468716885|FG002|Overall Study|Follow-up loss|1|||
130206999|NCT01592292|468716886|FG003|Overall Study|Follow-up loss|0|||
130207000|NCT01592292|468716883|FG000|Overall Study|Withdrew consent|2|||
130207001|NCT01592292|468716884|FG001|Overall Study|Withdrew consent|1|||
130207002|NCT01592292|468716885|FG002|Overall Study|Withdrew consent|0|||
130207003|NCT01592292|468716886|FG003|Overall Study|Withdrew consent|0|||
130207004|NCT01592292|468716883|FG000|Overall Study|Other|1|||
130207005|NCT01592292|468716884|FG001|Overall Study|Other|1|||
130207006|NCT01592292|468716885|FG002|Overall Study|Other|2|||
130207007|NCT01592292|468716886|FG003|Overall Study|Other|1|||
130207008|NCT04148287|468716888|FG000|Overall Study|Death|2|||
130207009|NCT03164265|468716889|FG000|Overall Study|Physician Decision|3|||
130207010|NCT03912428|468716892|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207011|NCT03912428|468716893|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
130207012|NCT03912428|468716894|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207013|NCT03912428|468716895|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207014|NCT03912428|468716892|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130207015|NCT03912428|468716893|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
130207016|NCT03912428|468716894|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
130207017|NCT03912428|468716895|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130207018|NCT03912428|468716892|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207019|NCT03912428|468716893|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207020|NCT03912428|468716894|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207021|NCT03912428|468716895|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
130207022|NCT03233204|468716896|FG000|Overall Study|Adverse Event|1|||
130207023|NCT03233204|468716896|FG000|Overall Study|Death|1|||
130207024|NCT03233204|468716896|FG000|Overall Study|Withdrawal by Subject|1|||
130207025|NCT03233204|468716896|FG000|Overall Study|Progressive Disease|3|||
130207026|NCT02680834|468716897|FG000|Overall Study|Physician Decision|5|||
130207027|NCT02680834|468716898|FG001|Overall Study|Physician Decision|2|||
130207028|NCT02680834|468716897|FG000|Overall Study|Withdrawal by Subject|6|||
130207029|NCT02680834|468716898|FG001|Overall Study|Withdrawal by Subject|0|||
130207030|NCT02680834|468716897|FG000|Overall Study|Lost to Follow-up|0|||
130207031|NCT02680834|468716898|FG001|Overall Study|Lost to Follow-up|1|||
130207032|NCT02889835|468716899|FG000|Overall Study|Lost to Follow-up|13|||
130207033|NCT02889835|468716900|FG001|Overall Study|Lost to Follow-up|13|||
130207034|NCT02889835|468716901|FG002|Overall Study|Lost to Follow-up|13|||
130207035|NCT02889835|468716899|FG000|Overall Study|Withdrawal by Subject|2|||
130207036|NCT02889835|468716900|FG001|Overall Study|Withdrawal by Subject|2|||
130207037|NCT02889835|468716901|FG002|Overall Study|Withdrawal by Subject|2|||
130207038|NCT02889835|468716899|FG000|Overall Study|Protocol Violation|1|||
130207039|NCT02889835|468716900|FG001|Overall Study|Protocol Violation|1|||
130207040|NCT02889835|468716901|FG002|Overall Study|Protocol Violation|1|||
130207041|NCT02889835|468716899|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
130207042|NCT02889835|468716900|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
130207043|NCT02889835|468716901|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
130207044|NCT02889835|468716899|FG000|Overall Study|Death|1|||
130207045|NCT02889835|468716900|FG001|Overall Study|Death|1|||
130207046|NCT02889835|468716901|FG002|Overall Study|Death|1|||
